journal	article_id	pubmed_id	sentence_id	mention1_offset_start	mention1_offset_end	mention2_offset_start	mention2_offset_end	mention1	mention2	geneids	disease_ids	probability
NULL	Front_Synaptic_Neurosci_2010_Feb_22_2_1.nxml.txt.nlp	21423487	SENT96	27	27	13	13	bumetanide	NKCC1	PA448682	6558	1
NULL	Sci_Rep_2015_Jan_6_5_7641.nxml.txt.nlp	25560734	SENT16	0	0	32	32	tamoxifen	aromatase	PA451581	1588	1
NULL	Cell_Death_Dis_2013_Oct_3_4(10)_e827.nxml.txt.nlp	24091670	SENT93	39	39	21	21	nilotinib	CD34	PA165958345	947	1
NULL	Case_Rep_Gastroenterol_2010_Oct_16_4(3)_435-442.nxml.txt.nlp	21103203	SENT121	16	16	2	2	imatinib	KIT	PA10804	3815	1
NULL	Br_J_Cancer_2013_Apr_16_108(7)_1402-1407.nxml.txt.nlp	23511558	SENT245	30	30	5	5	tamoxifen	CA125	PA451581	4077;94025	1
NULL	Gastric_Cancer_2013_Jul_12_16(3)_345-354.nxml.txt.nlp	22968820	SENT142	45	45	8	8	oxaliplatin	MLH1	PA131285527	4292	1
NULL	Front_Oncol_2014_Mar_14_4_52.nxml.txt.nlp	24672773	SENT64	23	23	3	3	temozolomide	STAT3	PA451609	6774	1
NULL	Biomed_Imaging_Interv_J_2008_Jul_1_4(3)_e38.nxml.txt.nlp	21611004	SENT148	30	30	1	1	tamoxifen	aromatase	PA451581	1588	1
NULL	Facts_Views_Vis_Obgyn_2010_2(4)_278-286.nxml.txt.nlp	25009715	SENT113	0	0	25	25	vinblastine	P-gp	PA451877	5243	1
NULL	J_Exp_Med_1996_Dec_1_184(6)_2207-2216.nxml.txt.nlp	8976176	SENT71	12	12	46	46	calcein	IL-2	PA132595336	3558	1
NULL	Diabetes_Care_2011_Aug_16_34(8)_1854-1859.nxml.txt.nlp	21715518	SENT19	40	40	6	6	estradiol	aromatase	PA449503	1588	1
NULL	Exp_Diabetes_Res_2012_Oct_15_2012_465282.nxml.txt.nlp	23118742	SENT94	0	0	19	19	metformin	FGF21	PA450395	26291	1
NULL	Oncogene_2013_Sep_26_32(39)_10_1038_onc_2012_491.nxml.txt.nlp	23108394	SENT131	24	24	2	2	hydroxyurea	BRIP1	PA449942	64979;83990	1
NULL	Onco_Targets_Ther_2014_Dec_3_7_2227-2236.nxml.txt.nlp	25506226	SENT104	4	4	40	40	trastuzumab	DM1	PA451743	338023;1760;28509	1
NULL	ISRN_AIDS_2012_Aug_23_2012_960178.nxml.txt.nlp	24052885	SENT75	8	8	37	37	stavudine	CD4	PA451494	920	1
NULL	Oncol_Lett_2013_Apr_22_5(4)_1093-1100.nxml.txt.nlp	23599746	SENT69	8	8	39	39	tamoxifen	P-gp	PA451581	5243	1
NULL	EMBO_Mol_Med_2009_Apr_1(1)_66-78.nxml.txt.nlp	20049704	SENT33	5	5	18	18	erlotinib	HIF-1	PA134687924	29072	1
NULL	Br_J_Cancer_2010_Jun_8_102(12)_1707-1716.nxml.txt.nlp	20461078	SENT141	1	1	21	21	bortezomib	TRAIL	PA10252	8743	1
NULL	Br_J_Cancer_2013_Jul_9_109(1)_100-108.nxml.txt.nlp	23756858	SENT25	40	40	8	8	tamoxifen	aromatase	PA451581	1588	1
NULL	Korean_Circ_J_2013_Aug_31_43(8)_541-549.nxml.txt.nlp	24044013	SENT26	20	20	4	4	clopidogrel	P2Y12	PA449053	64805	1
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT139	6	6	21	21	maraviroc	CYP3A	PA164768835	1574	1
NULL	Arthritis_Res_Ther_2014_Apr_28_16(2)_R104.nxml.txt.nlp	24774748	SENT102	25	25	10	10	cyclophosphamide	CD4	PA449165	920	1
NULL	J_Ophthalmol_2011_Dec_23_2011_292040.nxml.txt.nlp	21253505	SENT83	3	3	22	22	nilvadipine	rd1	PA165958385	5158	1
NULL	Cancers_(Basel)_2013_Jan_21_5(1)_64-91.nxml.txt.nlp	24216699	SENT41	15	15	1	1	cetuximab	EGFR	PA10040	1956	1
NULL	Onco_Targets_Ther_2014_Dec_4_7_2249-2255.nxml.txt.nlp	25587220	SENT55	6	6	41	41	diethylstilbestrol	MRP1	PA449307	4437	1
NULL	Emerg_Infect_Dis_2012_Jul_18(7)_1128-1131.nxml.txt.nlp	22710273	SENT59	32	32	21	21	rifampin	CD4	PA451250	920	1
NULL	Indian_J_Nephrol_2013_Nov-Dec_23(6)_413-414.nxml.txt.nlp	24339517	SENT16	25	25	3	3	cyclosporine	IL2RA	PA449167	3559	1
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT119	22	22	46	46	dasatinib	ABCB1	PA162372878	5243	1
NULL	Breast_Cancer_Res_2005_Nov_11_7(6)_255-257.nxml.txt.nlp	16457700	SENT38	39	39	4	4	tamoxifen	aromatase	PA451581	1588	1
NULL	Oncotarget_2011_Mar_19_2(3)_239-244.nxml.txt.nlp	21608150	SENT4	15	15	26	26	sorafenib	Mcl-1	PA7000	4170	1
NULL	Oncoimmunology_2013_Jun_1_2(6)_e24677.nxml.txt.nlp	23894722	SENT90	26	26	7	7	cetuximab	CD107a	PA10040	3916	1
NULL	Cell_Death_Differ_2010_Sep_5_17(9)_1511-1523.nxml.txt.nlp	20203690	SENT293	29	29	3	3	ethanol	PC-3	PA448073	692094	1
NULL	Br_J_Cancer_2010_Mar_16_102(6)_1003-1009.nxml.txt.nlp	20179710	SENT129	21	21	4	4	efavirenz	CYP2B6	PA449441	1555	1
NULL	Int_J_Gen_Med_2013_Dec_4_6_877-895.nxml.txt.nlp	24403842	SENT55	0	0	36	36	exenatide	GLP-1	PA164749238	100125288	1
NULL	Mol_Cell_Biol_2013_Oct_33(20)_4041-4050.nxml.txt.nlp	23959798	SENT148	34	34	22	22	hydroxyurea	CTR1	PA449942	1317	1
NULL	Cancer_Cell_Int_2014_Jan_14_14_4.nxml.txt.nlp	24423208	SENT154	8	8	37	37	sorafenib	VEGFR	PA7000	3791	1
NULL	Br_J_Cancer_2012_Sep_4_107(6)_947-955.nxml.txt.nlp	22892392	SENT154	11	11	2	2	tamoxifen	ERBB2	PA451581	2064	1
NULL	Mol_Cancer_2009_Jun_23_8_39.nxml.txt.nlp	19549337	SENT239	41	41	5	5	etoposide	XIAP	PA449552	331	1
NULL	Br_J_Pharmacol_2013_Jun_27_169(4)_736-747.nxml.txt.nlp	23489111	SENT146	0	0	30	30	picrotoxin	5-HT3R	PA164777007	3359	1
NULL	Chin_J_Cancer_2012_Feb_31(2)_73-99.nxml.txt.nlp	22098950	SENT117	1	1	29	29	imatinib	CD34	PA10804	947	1
NULL	Carcinogenesis_2014_Nov_12_35(11)_2485-2494.nxml.txt.nlp	25115442	SENT337	21	21	11	11	heparin	RRH	PA449855	10692	1
NULL	Cell_Cycle_2013_Jan_15_12(2)_203.nxml.txt.nlp	23287473	SENT23	3	3	20	20	cisplatin	p53	PA449014	7157	1
NULL	Front_Behav_Neurosci_2011_Sep_13_5_57.nxml.txt.nlp	21949506	SENT27	13	13	34	34	rimonabant	CB1	PA152407999	1268	1
NULL	Inflamm_Res_2010_Sep_26_59(9)_699-709.nxml.txt.nlp	20339899	SENT29	33	33	9	9	trypsin	PAR2	PA451806	2150;55065;8856	1
NULL	Oncol_Lett_2013_Apr_22_5(4)_1093-1100.nxml.txt.nlp	23599746	SENT127	6	6	44	44	cisplatin	CYP3A4	PA449014	1576	1
NULL	Diabetes_2009_Jun_31_58(6)_1434-1439.nxml.txt.nlp	19336679	SENT154	33	33	15	15	metformin	SLC22A2	PA450395	6582	1
NULL	Viruses_2014_May_23_6(5)_2155-2185.nxml.txt.nlp	24859341	SENT155	16	16	0	0	cisplatin	p38	PA449014	10598;1432;7965	1
NULL	Eur_J_Endocrinol_2013_Apr_168(4)_557-564.nxml.txt.nlp	23345197	SENT166	19	19	4	4	diazoxide	ABCC8	PA449285	6833	1
NULL	J_Inflamm_(Lond)_2008_Dec_5_5_23.nxml.txt.nlp	19061493	SENT162	28	28	0	0	hemin	HO-1	PA449849	3162	1
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT214	39	39	1	1	metformin	DPI	PA450395	1832	1
NULL	J_Med_Life_2011_Feb_15_4(1)_11-20.nxml.txt.nlp	21505570	SENT190	7	7	40	40	sulindac	CB2	PA451565	1269	1
NULL	Onco_Targets_Ther_2014_Nov_28_7_2197-2204.nxml.txt.nlp	25506224	SENT115	41	41	14	14	cetuximab	p16	PA10040	1029	1
NULL	Breast_Cancer_Res_2005_Dec_7_7(1)_R156-R163.nxml.txt.nlp	15642164	SENT22	11	11	1	1	tamoxifen	aromatase	PA451581	1588	1
NULL	Biosci_Rep_2012_Dec_1_32(Pt_6)_631-639.nxml.txt.nlp	NULL	SENT222	0	0	24	24	methotrexate	DHFR	PA450428	1719	1
NULL	Arthritis_Res_Ther_2006_Feb_3_8(2)_R43.nxml.txt.nlp	16507142	SENT84	0	0	19	19	heparin	CXCL12	PA449855	6387	1
NULL	Exp_Cell_Res_2011_Apr_15_317(7)_1028-1039.nxml.txt.nlp	21237154	SENT98	23	23	3	3	staurosporine	JIP1	PA165109623	9479	1
NULL	Int_J_Surg_Oncol_2012_Jun_24_2012_868645.nxml.txt.nlp	22778942	SENT95	18	18	2	2	fluorouracil	VEGF-A	PA128406956	7422	1
NULL	Adolesc_Health_Med_Ther_2014_Mar_26_5_35-48.nxml.txt.nlp	24729739	SENT35	4	4	29	29	canakinumab	TNF-alpha	PA165958358	7124	1
NULL	J_Geriatr_Cardiol_2013_Jun_10(2)_151-158.nxml.txt.nlp	23888175	SENT165	23	23	0	0	rosuvastatin	ACE2	PA134308647	59272	1
NULL	Eur_J_Immunol_2012_Nov_18_42(11)_3049-3061.nxml.txt.nlp	22806397	SENT96	32	32	14	14	imiquimod	CCR7	PA449972	1236	1
NULL	J_Carcinog_2014_Feb_20_13_3.nxml.txt.nlp	24737951	SENT97	28	28	5	5	bevacizumab	PI3K	PA130232992	5290	1
NULL	Oncol_Lett_2014_Jul_12_8(1)_17-24.nxml.txt.nlp	24959213	SENT142	26	26	4	4	cetuximab	KRAS	PA10040	3845	1
NULL	Acta_Neuropathol_Commun_2014_Jul_22_2(1)_84.nxml.txt.nlp	NULL	SENT219	0	0	36	36	minocycline	IFN	PA450519	3439	1
NULL	Cancer_Microenviron_2013_Jan_22_6(3)_231-240.nxml.txt.nlp	23335094	SENT71	28	28	5	5	simvastatin	ANOVA	PA451363	4858	1
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT139	6	6	35	35	maraviroc	CYP3A	PA164768835	1574	1
NULL	Oncoimmunology_2014_Jan_1_3_e27048.nxml.txt.nlp	24605265	SENT104	0	0	31	31	ofatumumab	IL-18	PA165291493	3606	1
NULL	Turk_J_Haematol_2013_Dec_5_30(4)_387-393.nxml.txt.nlp	24385829	SENT119	38	38	15	15	imatinib	KIT	PA10804	3815	1
NULL	Cell_Death_Dis_2014_Jan_16_5(1)_e1000.nxml.txt.nlp	24434508	SENT64	9	9	34	34	nutlin-3	p53		7157	1
NULL	Ann_Rheum_Dis_2011_Apr_8_70(7)_1208-1215.nxml.txt.nlp	21478189	SENT47	4	4	36	36	infliximab	ACR	PA452639	49	1
NULL	Tuberc_Respir_Dis_(Seoul)_2013_Dec_24_75(6)_231-235.nxml.txt.nlp	24416052	SENT46	16	16	3	3	dasatinib	DDR2	PA162372878	4921	1
NULL	Clin_Pharmacokinet_2014_Jun_27_53(8)_741-751.nxml.txt.nlp	24968986	SENT250	6	6	21	21	docetaxel	OATP1B3	PA449383	28234	1
NULL	J_Cell_Biol_2001_Apr_2_153(1)_207-220.nxml.txt.nlp	11285286	SENT110	6	6	15	15	carbachol	DGK	PA448784	8526;1607	1
NULL	Inflamm_Res_2010_Sep_26_59(9)_699-709.nxml.txt.nlp	20339899	SENT29	31	31	3	3	thrombin	PAR1	PA451674	79581;2149	1
NULL	Front_Oncol_2014_Apr_17_4_78.nxml.txt.nlp	24860780	SENT141	42	42	14	14	panitumumab	KRAS	PA162373091	3845	1
NULL	Breast_Cancer_Res_2012_Dec_5_14(6)_R153.nxml.txt.nlp	23216744	SENT29	35	35	11	11	auranofin	SNO	PA448510	6498	1
NULL	Iran_J_Pharm_Res_2013_Winter_12(Suppl)_37-46.nxml.txt.nlp	24250670	SENT27	4	4	17	17	verapamil	P-gp	PA451868	5243	1
NULL	Acta_Pharmacol_Sin_2010_Nov_18_31(11)_1447-1453.nxml.txt.nlp	20953204	SENT124	44	44	4	4	rimonabant	CB1	PA152407999	1268	1
NULL	Ann_Clin_Microbiol_Antimicrob_2008_May_30_7_12.nxml.txt.nlp	18513394	SENT55	23	23	1	1	meropenem	PA1	PA164764445	79447	1
NULL	Oncotarget_2014_Aug_12_5(20)_9710-9726.nxml.txt.nlp	25339152	SENT214	3	3	18	18	pp2	DGK		8526;1607	1
NULL	Mol_Cancer_2009_Jun_23_8_39.nxml.txt.nlp	19549337	SENT239	39	39	5	5	doxorubicin	XIAP	PA449412	331	1
NULL	Oncologist_2010_Sep_26_15(9)_944-953.nxml.txt.nlp	20798196	SENT168	27	27	6	6	capecitabine	HER-2	PA448771	2064	1
NULL	Int_Semin_Surg_Oncol_2008_Apr_28_5_9.nxml.txt.nlp	18442393	SENT82	23	23	15	15	tamoxifen	HER2	PA451581	2064	1
NULL	Oncotarget_2014_Feb_25_5(7)_1812-1828.nxml.txt.nlp	24729020	SENT23	0	0	14	14	trastuzumab	HER2	PA451743	2064	1
NULL	Ann_Oncol_2014_Sep_13_25(9)_1813-1820.nxml.txt.nlp	24928832	SENT39	25	25	3	3	cetuximab	EGFR	PA10040	1956	1
NULL	Mol_Cancer_2007_Sep_26_6_61.nxml.txt.nlp	17894897	SENT184	6	6	37	37	etoposide	HIF-1	PA449552	29072	1
NULL	Mol_Biol_Cell_2012_Sep_15_23(18)_3499-3510.nxml.txt.nlp	22833567	SENT218	10	10	1	1	arsenite	JNK	PA452638	5599	1
NULL	Indian_J_Pharmacol_2008_Aug_40(4)_137-143.nxml.txt.nlp	20040945	SENT114	7	7	32	32	trastuzumab	HER2	PA451743	2064	1
NULL	Mol_Cancer_2009_Jun_23_8_39.nxml.txt.nlp	19549337	SENT239	36	36	5	5	mitomycin	XIAP	PA450524	331	1
NULL	Pharmaceuticals_(Basel)_2013_Aug_6_6(8)_929-959.nxml.txt.nlp	24276377	SENT101	3	3	28	28	oxaliplatin	survivin	PA131285527	332	1
NULL	Genome_Med_2009_Sep_4_1(9)_83.nxml.txt.nlp	19732436	SENT295	8	8	31	31	irinotecan	UGT1A	PA450085	7361;54658	1
NULL	Breast_Cancer_(Auckl)_2011_Jul_27_5_175-199.nxml.txt.nlp	21863131	SENT206	3	3	29	29	carboplatin	EGFR	PA448803	1956	1
NULL	Oncol_Lett_2013_Feb_9_5(2)_552-558.nxml.txt.nlp	23420128	SENT28	0	0	26	26	imatinib	KIT	PA10804	3815	1
NULL	Oncogene_2013_Sep_26_32(39)_10_1038_onc_2012_491.nxml.txt.nlp	23108394	SENT27	31	31	4	4	gefitinib	FOXM1	PA131301952	2305	1
NULL	Diabetes_2008_Sep_57(9)_2332-2340.nxml.txt.nlp	18567824	SENT38	45	45	5	5	atropine	ghrelin	PA448505	51738	1
NULL	Mol_Cancer_2009_Aug_25_8_66.nxml.txt.nlp	19706164	SENT78	21	21	2	2	celecoxib	p53	PA448871	7157	1
NULL	Anal_Chem_Insights_2008_Aug_13_3_91-101.nxml.txt.nlp	19609393	SENT17	0	0	39	39	letrozole	aromatase	PA450196	1588	1
NULL	Int_J_Biol_Sci_2014_Jun_10_10(7)_654-663.nxml.txt.nlp	25013375	SENT228	29	29	8	8	nitroxoline	p53	PA164754993	7157	1
NULL	Eur_J_Immunol_2014_Jun_10_44(6)_1759-1769.nxml.txt.nlp	24595810	SENT128	3	3	35	35	fludrocortisone	CXCR4	PA164743961	7852	1
NULL	Oncologist_2010_Feb_15_15(2)_122-129.nxml.txt.nlp	20156908	SENT131	21	21	5	5	tamoxifen	aromatase	PA451581	1588	1
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT218	11	11	29	29	metformin	AMPK	PA450395	5563	1
NULL	ScientificWorldJournal_2014_Oct_14_2014_745802.nxml.txt.nlp	25541625	SENT121	25	25	5	5	thrombin	p38	PA451674	10598;1432;7965	1
NULL	Oncol_Lett_2014_May_25_7(5)_1537-1543.nxml.txt.nlp	24765172	SENT19	34	34	5	5	cisplatin	COL6A3	PA449014	1293	1
NULL	Patient_Prefer_Adherence_2011_Dec_23_6_1-9.nxml.txt.nlp	22272064	SENT109	8	8	36	36	telmisartan	ACE	PA451605	1636	1
NULL	Arch_Trauma_Res_2013_Aug_1_2(2)_97-98.nxml.txt.nlp	24396803	SENT15	2	2	21	21	gabapentin	P-gp	PA449720	5243	1
NULL	Mol_Biol_Cell_2014_Jul_1_25(13)_2116-2127.nxml.txt.nlp	24807908	SENT268	4	4	29	29	hemin	NQO1	PA449849	1728	1
NULL	Neural_Regen_Res_2013_Jul_15_8(20)_1853-1862.nxml.txt.nlp	25206494	SENT166	25	25	2	2	ethanol	JNK	PA448073	5599	1
NULL	Calcif_Tissue_Int_2010_Dec_16_87(6)_485-492.nxml.txt.nlp	20953593	SENT52	6	6	29	29	teriparatide	PTH	PA451620	5741	1
NULL	Oncogene_2013_Sep_26_32(39)_10_1038_onc_2012_491.nxml.txt.nlp	23108394	SENT27	26	26	4	4	paclitaxel	FOXM1	PA450761	2305	1
NULL	Cancer_Cell_Int_2011_Mar_10_11_6.nxml.txt.nlp	21392380	SENT125	0	0	32	32	imipramine	HERG	PA449969	3757	1
NULL	Diabetes_Care_2012_Feb_16_35(2)_327-333.nxml.txt.nlp	22179958	SENT120	13	13	32	32	metformin	B12	PA450395	7126;4709	1
NULL	J_Cell_Biol_1978_May_1_77(2)_507-516.nxml.txt.nlp	206563	SENT3	21	21	3	3	aminoglutethimide	ACTH	PA448375	5443	1
NULL	Eur_J_Clin_Pharmacol_2012_Jan_8_68(1)_29-37.nxml.txt.nlp	21739267	SENT28	3	3	19	19	fluvoxamine	CYP3A4	PA449690	1576	1
NULL	J_Cancer_2014_Jan_5_5(2)_86-97.nxml.txt.nlp	24494026	SENT195	38	38	7	7	topotecan	WEE1	PA451729	7465	1
NULL	Inflamm_Res_2010_Sep_26_59(9)_699-709.nxml.txt.nlp	20339899	SENT29	23	23	3	3	thrombin	PAR1	PA451674	79581;2149	1
NULL	Nat_Commun_2014_Aug_1_5_4563.nxml.txt.nlp	25081057	SENT244	28	28	6	6	ketamine	E16	PA450144	8140	1
NULL	Br_J_Cancer_2009_Mar_10_100(5)_758-763.nxml.txt.nlp	19259094	SENT18	33	33	1	1	cisplatin	MLH1	PA449014	4292	1
NULL	Clin_Mol_Allergy_2007_Jan_25_5_1.nxml.txt.nlp	17254346	SENT138	39	39	3	3	curcumin	IFN	PA151958596	3439	1
NULL	Pharm_Pract_(Granada)_2011_Mar_15_Jan-Mar_9(1)_1-10.nxml.txt.nlp	25132883	SENT167	2	2	45	45	rivaroxaban	SPAF	PA165958360	166378	1
NULL	Int_J_Endocrinol_2011_Mar_6_2011_415719.nxml.txt.nlp	21461394	SENT148	8	8	36	36	cinacalcet	PTH	PA164776671	5741	1
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT119	22	22	44	44	dasatinib	ABCG2	PA162372878	9429	1
NULL	J_Clin_Exp_Pathol_2012_May_17_Suppl_4_7327.nxml.txt.nlp	25379357	SENT27	32	32	2	2	resveratrol	AMPK		5563	1
NULL	Clin_Med_Insights_Oncol_2013_Aug_21_7_221-234.nxml.txt.nlp	24179413	SENT140	15	15	46	46	erlotinib	EGFR	PA134687924	1956	1
NULL	Curr_Oncol_2009_Jul_16(Suppl_2)_S14-S23.nxml.txt.nlp	19672417	SENT120	2	2	28	28	tamoxifen	CYP2D6	PA451581	1565	1
NULL	J_Thromb_Haemost_2014_May_22_12(5)_748-760.nxml.txt.nlp	24612393	SENT19	16	16	38	38	thrombin	P2Y12	PA451674	64805	1
NULL	Mol_Cancer_2009_Jan_7_8_1.nxml.txt.nlp	19128456	SENT34	34	34	0	0	doxorubicin	MDR1	PA449412	5243	1
NULL	Arthritis_Res_Ther_2012_Jul_12_14(4)_R163.nxml.txt.nlp	22784880	SENT113	34	34	1	1	leflunomide	CYP2C19	PA450192	1557	1
NULL	Indian_J_Dermatol_2012_Jul-Aug_57(4)_288-290.nxml.txt.nlp	22837564	SENT20	17	17	1	1	zidovudine	CD4	PA451954	920	1
NULL	Nat_Chem_Biol_2013_Feb_2_9(2)_97-104.nxml.txt.nlp	23201900	SENT98	11	11	24	24	clonazepam	TSPO	PA449050	706	1
NULL	Biomed_Res_Int_2014_Jun_30_2014_921296.nxml.txt.nlp	25101299	SENT161	31	31	3	3	bleomycin	BLMH	PA448645	642	1
NULL	Br_J_Cancer_2012_Jul_10_107(2)_291-299.nxml.txt.nlp	22713662	SENT231	34	34	9	9	temozolomide	CDK2	PA451609	1017	1
NULL	J_Oncol_2010_Jul_7_2010_645376.nxml.txt.nlp	20631908	SENT210	24	24	0	0	urokinase	TSP-1	PA451836	7057	1
NULL	Pharmaceuticals_(Basel)_2013_Aug_6_6(8)_929-959.nxml.txt.nlp	24276377	SENT101	3	3	26	26	oxaliplatin	Bcl-2	PA131285527	596	1
NULL	Clin_Psychopharmacol_Neurosci_2013_Dec_24_11(3)_144-151.nxml.txt.nlp	24465251	SENT101	44	44	6	6	risperidone	IL-10	PA451257	3586	1
NULL	Aging_(Albany_NY)_2012_Jul_31_4(7)_499-508.nxml.txt.nlp	22868943	SENT121	0	0	36	36	resveratrol	SIRT1		23411	1
NULL	Mediators_Inflamm_2010_Jun_9_2010_704202.nxml.txt.nlp	20628516	SENT110	9	9	34	34	cyclosporine	TLR2	PA449167	7097	1
NULL	J_Nutr_Metab_2010_Jan_9_2010_721365.nxml.txt.nlp	21274445	SENT98	0	0	35	35	paricalcitol	p27	PA450798	5715;10534	1
NULL	J_Res_Med_Sci_2012_Feb_17(2)_159-163.nxml.txt.nlp	23264790	SENT29	9	9	2	2	imatinib	CD117	PA10804	3815	1
NULL	Oncotarget_2013_Dec_15_4(12)_2577-2590.nxml.txt.nlp	24342878	SENT143	8	8	19	19	curcumin	NF-kappaB	PA151958596	4790	1
NULL	Exp_Ther_Med_2014_Jun_28_7(6)_1653-1658.nxml.txt.nlp	24926361	SENT96	32	32	14	14	curcumin	p65	PA151958596	5970	1
NULL	Hum_Genomics_2010_Apr_1_4(4)_238-249.nxml.txt.nlp	20511137	SENT106	20	20	41	41	sn-38	UGT1A1		54658	1
NULL	Breast_Cancer_Res_2012_Jun_19_14(3)_208.nxml.txt.nlp	22731805	SENT93	24	24	0	0	bevacizumab	FGF2	PA130232992	2247;2258	1
NULL	Br_J_Cancer_2010_Oct_26_103(9)_1325-1330.nxml.txt.nlp	20940720	SENT163	30	30	11	11	docetaxel	EGFR	PA449383	1956	1
NULL	J_Hematol_Oncol_2009_Apr_22_2_18.nxml.txt.nlp	19386128	SENT147	30	30	16	16	cetuximab	KRAS	PA10040	3845	1
NULL	J_Hematol_Oncol_2009_Apr_22_2_18.nxml.txt.nlp	19386128	SENT199	27	27	1	1	bevacizumab	EGFR	PA130232992	1956	1
NULL	Patient_Prefer_Adherence_2010_Mar_24_4_61-68.nxml.txt.nlp	20361006	SENT90	4	4	38	38	exenatide	GLP-1	PA164749238	100125288	1
NULL	J_Cell_Mol_Med_2014_May_14_18(5)_811-823.nxml.txt.nlp	24628949	SENT226	11	11	25	25	docetaxel	FOXM1	PA449383	2305	1
NULL	Diabetes_Care_2012_Dec_14_35(12)_e84.nxml.txt.nlp	23173145	SENT15	0	0	24	24	metformin	B12	PA450395	7126;4709	1
NULL	Exp_Ther_Med_2014_May_24_7(5)_1271-1278.nxml.txt.nlp	24940424	SENT20	0	0	31	31	capecitabine	ACRC	PA448771	93953	1
NULL	Acta_Pharmacol_Sin_2010_Sep_16_31(9)_1075-1084.nxml.txt.nlp	20711221	SENT132	40	40	2	2	phenobarbital	LKB1	PA450911	6794	1
NULL	Oncol_Lett_2014_Nov_13_8(5)_2043-2048.nxml.txt.nlp	25289090	SENT90	32	32	7	7	doxorubicin	p53	PA449412	7157	1
NULL	Br_J_Clin_Pharmacol_2014_Nov_20_78(5)_1050-1057.nxml.txt.nlp	24962564	SENT38	0	0	30	30	ketoconazole	CYP3A4	PA450146	1576	1
NULL	Cancers_(Basel)_2013_Aug_22_5(3)_1103-1119.nxml.txt.nlp	24202336	SENT91	24	24	7	7	temozolomide	EGFR	PA451609	1956	1
NULL	Curr_Genomics_2014_Jun_15(3)_190-202.nxml.txt.nlp	24955027	SENT224	5	5	31	31	gefitinib	EGFR	PA131301952	1956	1
NULL	Oncotarget_2013_Nov_24_4(12)_2430-2438.nxml.txt.nlp	24280348	SENT14	28	28	12	12	gefitinib	EGFR	PA131301952	1956	1
NULL	Hum_Mol_Genet_2013_Jun_1_22(11)_2247-2262.nxml.txt.nlp	23424202	SENT213	7	7	44	44	haloperidol	AMPH	PA449841	273	1
NULL	Oncol_Lett_2013_Apr_22_5(4)_1093-1100.nxml.txt.nlp	23599746	SENT69	20	20	39	39	paclitaxel	P-gp	PA450761	5243	1
NULL	Exp_Hematol_Oncol_2012_Jun_18_1_14.nxml.txt.nlp	23210689	SENT108	24	24	10	10	imatinib	PDGFRA	PA10804	5156	1
NULL	J_Int_AIDS_Soc_2013_Feb_25_16(1)_10_7448_IAS_16_1_18472.nxml.txt.nlp	23443042	SENT47	25	25	1	1	stavudine	CD4	PA451494	920	1
NULL	Hum_Genomics_2009_Dec_1_4(2)_91-106.nxml.txt.nlp	20038497	SENT145	15	15	33	33	rivastigmine	APOE	PA451262	348	1
NULL	Oncotarget_2014_Jun_6_5(12)_4516-4528.nxml.txt.nlp	24980831	SENT202	16	16	1	1	vemurafenib	CCL2	PA165946873	6347	1
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2013_Dec_8_6_75-79.nxml.txt.nlp	24348081	SENT66	14	14	36	36	colesevelam	GLP-1	PA449095	100125288	1
NULL	J_Geriatr_Cardiol_2013_Jun_10(2)_151-158.nxml.txt.nlp	23888175	SENT165	23	23	5	5	rosuvastatin	AT1	PA134308647	9197;185	1
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT168	33	33	8	8	atorvastatin	p38	PA448500	10598;1432;7965	1
NULL	Ther_Clin_Risk_Manag_2006_Dec_2(4)_435-445.nxml.txt.nlp	18360654	SENT84	15	15	27	27	erlotinib	EGFR	PA134687924	1956	1
NULL	Front_Genet_2014_Nov_14_5_391.nxml.txt.nlp	25452763	SENT54	40	40	0	0	cisplatin	ERCC1	PA449014	2067	1
NULL	Leukemia_2014_Apr_14_28(4)_961-964.nxml.txt.nlp	24418991	SENT23	40	40	6	6	nilotinib	P-gp	PA165958345	5243	1
NULL	Oncotarget_2013_Feb_26_4(2)_298-309.nxml.txt.nlp	23593653	SENT214	26	26	1	1	decitabine	LSD1	PA164749631	23028	1
NULL	J_Pregnancy_2012_Nov_1_2012_379271.nxml.txt.nlp	22132339	SENT215	0	0	45	45	isoniazid	IPT	PA450112	54802	1
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1013.nxml.txt.nlp	24457957	SENT27	46	46	0	0	cisplatin	NOXA	PA449014	5366	1
NULL	Onco_Targets_Ther_2014_Nov_28_7_2197-2204.nxml.txt.nlp	25506224	SENT115	41	41	6	6	cetuximab	EGFR	PA10040	1956	1
NULL	Diabetes_Metab_Syndr_Obes_2014_Jun_24_7_229-239.nxml.txt.nlp	25018644	SENT41	0	0	41	41	exenatide	GLP-1	PA164749238	100125288	1
NULL	Eur_J_Endocrinol_2010_May_162(5)_987-992.nxml.txt.nlp	20164212	SENT32	22	22	1	1	diazoxide	GCK	PA449285	5871;2645	1
NULL	Arch_Med_Sci_2012_Jul_4_8(3)_578-581.nxml.txt.nlp	22852019	SENT58	5	5	29	29	diethylstilbestrol	DES	PA449307	1674	1
NULL	Br_J_Cancer_2004_Mar_5_90(Suppl_1)_S7-S10.nxml.txt.nlp	15094758	SENT104	9	9	44	44	fulvestrant	CYP3A4	PA164747170	1576	1
NULL	Diabetes_Metab_Syndr_Obes_2010_Oct_27_3_363-372.nxml.txt.nlp	21437106	SENT117	6	6	41	41	sitagliptin	GLP-1	PA164748978	100125288	1
NULL	Pediatr_Nephrol_2008_Feb_28_23(2)_195-207.nxml.txt.nlp	18046581	SENT184	2	2	17	17	alfacalcidol	PTH	PA164746469	5741	1
NULL	Indian_Dermatol_Online_J_2010_Jul-Dec_1(1)_14-17.nxml.txt.nlp	23130185	SENT87	6	6	25	25	imatinib	EGFR	PA10804	1956	1
NULL	Cardiovasc_Diabetol_2010_Jul_27_9_31.nxml.txt.nlp	20663195	SENT85	30	30	2	2	irbesartan	FSP1	PA450084	6275;51062	1
NULL	Clin_Pharmacol_2013_Dec_9_5_185-192.nxml.txt.nlp	24353446	SENT10	4	4	21	21	clopidogrel	CYP3A4	PA449053	1576	1
NULL	Indian_J_Ophthalmol_2011_May-Jun_59(3)_197-200.nxml.txt.nlp	21586839	SENT46	10	10	25	25	methotrexate	mol	PA450428	90527	1
NULL	Cardiol_Res_Pract_2013_Feb_21_2013_127270.nxml.txt.nlp	23509665	SENT47	0	0	14	14	ticagrelor	CYP3A4	PA165374673	1576	1
NULL	Breast_Cancer_Res_2009_Jun_16_11(3)_R35.nxml.txt.nlp	19531217	SENT118	4	4	38	38	exemestane	aromatase	PA449563	1588	1
NULL	Oncogene_2013_Sep_26_32(39)_10_1038_onc_2012_491.nxml.txt.nlp	23108394	SENT116	39	39	7	7	gefitinib	FOXM1	PA131301952	2305	1
NULL	Cancer_Manag_Res_2014_Jun_6_6_267-278.nxml.txt.nlp	24944518	SENT141	32	32	0	0	finasteride	PC3	PA449627	57332;7832;5122	1
NULL	Cancers_(Basel)_2014_Jul_7_6(3)_1441-1463.nxml.txt.nlp	25003395	SENT254	29	29	3	3	everolimus	PI3K	PA164746311	5290	1
NULL	Chin_J_Cancer_2011_May_30(5)_287-292.nxml.txt.nlp	21527061	SENT61	17	17	0	0	erlotinib	EGFR	PA134687924	1956	1
NULL	Endocr_Connect_2012_Jul_21_1(1)_37-47.nxml.txt.nlp	23781302	SENT27	22	22	2	2	mitotane	CYP11B1	PA164746157	1584	1
NULL	Patient_Prefer_Adherence_2013_Mar_27_7_245-258.nxml.txt.nlp	23569364	SENT95	39	39	4	4	tamoxifen	aromatase	PA451581	1588	1
NULL	Ther_Clin_Risk_Manag_2006_Sep_2(3)_303-308.nxml.txt.nlp	18360605	SENT44	2	2	15	15	frovatriptan	5-HT7	PA164754891	3363	1
NULL	Acta_Pharmacol_Sin_2010_Jun_4_31(6)_741-745.nxml.txt.nlp	20523344	SENT12	5	5	37	37	gemcitabine	Bcl-2	PA449748	596	1
NULL	Curr_Oncol_2010_Feb_17(1)_81-86.nxml.txt.nlp	20179808	SENT57	2	2	43	43	tamoxifen	aromatase	PA451581	1588	1
NULL	Basic_Clin_Pharmacol_Toxicol_2013_Feb_5_112(2)_132-137.nxml.txt.nlp	22900583	SENT155	7	7	43	43	ketoconazole	CYP3A4	PA450146	1576	1
NULL	Oncol_Lett_2013_Apr_22_5(4)_1093-1100.nxml.txt.nlp	23599746	SENT69	12	12	39	39	vinblastine	P-gp	PA451877	5243	1
NULL	Clin_Med_Insights_Oncol_2012_Mar_19_6_165-178.nxml.txt.nlp	22474408	SENT220	9	9	47	47	cisplatin	NHL	PA449014	51750	1
NULL	Exp_Eye_Res_2009_Jun_1_88(6)_1137-1151.nxml.txt.nlp	19450442	SENT295	36	36	22	22	staurosporine	Bcl-2	PA165109623	596	1
NULL	Oncol_Rep_2013_Jan_1_29(1)_13-20.nxml.txt.nlp	23128605	SENT168	0	0	17	17	lapatinib	HER2	PA152241907	2064	1
NULL	J_Exp_Bot_2012_Apr_20_63(7)_2479-2489.nxml.txt.nlp	22268152	SENT236	22	22	2	2	amiloride	SOS1	PA448368	6654	1
NULL	Cell_Death_Dis_2010_Nov_18_1(11)_e102.nxml.txt.nlp	21368867	SENT96	21	21	6	6	gentamicin	CLIMP-63	PA449753	10970	1
NULL	Cancer_Med_2014_Oct_18_3(5)_1294-1301.nxml.txt.nlp	24941936	SENT176	42	42	10	10	cetuximab	KRAS	PA10040	3845	1
NULL	Open_Access_J_Urol_2011_May_10_3_69-82.nxml.txt.nlp	24198638	SENT63	35	35	7	7	doxorubicin	CYP3A4	PA449412	1576	1
NULL	Indian_J_Endocrinol_Metab_2011_Jan-Mar_15(1)_9-17.nxml.txt.nlp	21584160	SENT73	0	0	18	18	liraglutide	GLP-1	PA165958364	100125288	1
NULL	Mol_Cancer_2009_Sep_7_8_72.nxml.txt.nlp	19735553	SENT192	22	22	0	0	cisplatin	HMGB1	PA449014	3146	1
NULL	J_Immunol_Res_2014_Jul_13_2014_964069.nxml.txt.nlp	25126586	SENT99	14	14	3	3	methotrexate	IL-6	PA450428	3569	1
NULL	Oncol_Rep_2013_Sep_1_30(3)_1045-1052.nxml.txt.nlp	23817662	SENT154	21	21	37	37	afatinib	EGFR	PA165981154	1956	1
NULL	J_Cancer_2014_Jan_5_5(2)_86-97.nxml.txt.nlp	24494026	SENT195	36	36	7	7	cisplatin	WEE1	PA449014	7465	1
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_79-96.nxml.txt.nlp	19305789	SENT135	6	6	35	35	evodiamine	TRPV1	PA165860788	7442	1
NULL	J_Mol_Signal_2010_May_10_5_4.nxml.txt.nlp	20459745	SENT118	30	30	2	2	cisplatin	p53	PA449014	7157	1
NULL	Ann_Hematol_2010_Sep_13_89(9)_861-871.nxml.txt.nlp	20387067	SENT199	4	4	9	9	dasatinib	CD34	PA162372878	947	1
NULL	Biologics_2010_Aug_9_4_173-185.nxml.txt.nlp	20714355	SENT158	42	42	0	0	doxycycline	EGFR	PA449415	1956	1
NULL	Acta_Pharmacol_Sin_2010_Oct_13_31(10)_1350-1358.nxml.txt.nlp	20835264	SENT136	26	26	8	8	simvastatin	gamma	PA451363	9913	1
NULL	Oncogene_2013_Sep_26_32(39)_10_1038_onc_2012_491.nxml.txt.nlp	23108394	SENT116	34	34	7	7	paclitaxel	FOXM1	PA450761	2305	1
NULL	Cancer_Cell_Int_2013_Jun_17_13_61.nxml.txt.nlp	23773282	SENT235	0	0	27	27	artesunate	survivin	PA165111697	332	1
NULL	Blood_Cancer_J_2013_Nov_22_3(11)_e163.nxml.txt.nlp	24270325	SENT14	45	45	16	16	vemurafenib	BRAF	PA165946873	673	1
NULL	Nat_Commun_2013_Sep_20_4_2444.nxml.txt.nlp	24051492	SENT78	18	18	4	4	nutlin-3	p53		7157	1
NULL	Pharmaceuticals_(Basel)_2013_Aug_21_6(8)_988-1038.nxml.txt.nlp	24276379	SENT498	20	20	0	0	oxaliplatin	CD133	PA131285527	8842	1
NULL	Int_J_Mol_Sci_2014_Nov_10_15(11)_20607-20637.nxml.txt.nlp	25391045	SENT217	2	2	24	24	atorvastatin	RhoA	PA448500	387	1
NULL	Cardiovasc_Diabetol_2007_Apr_3_6_12.nxml.txt.nlp	17407587	SENT7	0	0	18	18	irbesartan	gamma	PA450084	9913	1
NULL	J_Gen_Physiol_1989_Aug_1_94(2)_385-400.nxml.txt.nlp	2552001	SENT10	1	1	31	31	glutaraldehyde	NO3	PA449777	4681	1
NULL	Clin_Med_Insights_Oncol_2012_Mar_19_6_165-178.nxml.txt.nlp	22474408	SENT220	3	3	47	47	fludarabine	NHL	PA449655	51750	1
NULL	Diabetes_2009_Jun_31_58(6)_1434-1439.nxml.txt.nlp	19336679	SENT154	9	9	35	35	metformin	SLC22A1	PA450395	6580	1
NULL	Front_Genet_2012_Nov_12_3_235.nxml.txt.nlp	23162568	SENT172	22	22	7	7	methamphetamine	CYP2D6	PA450403	1565	1
NULL	Oncol_Lett_2013_Jun_3_5(6)_1760-1764.nxml.txt.nlp	23833637	SENT116	6	6	42	42	gemcitabine	TRAIL	PA449748	8743	1
NULL	Leukemia_2014_Jan_12_28(1)_15-33.nxml.txt.nlp	23778311	SENT576	44	44	13	13	imatinib	SIRT1	PA10804	23411	1
NULL	Breast_Cancer_(Auckl)_2011_Jan_13_5_1-14.nxml.txt.nlp	21494397	SENT198	21	21	6	6	capecitabine	CYP3A4	PA448771	1576	1
NULL	Case_Rep_Oncol_2011_Sep_23_4(3)_481-486.nxml.txt.nlp	22114574	SENT106	41	41	4	4	hydroxyurea	N-myc	PA449942	4613	1
NULL	JAKSTAT_2014_Jun_12_3_e29554.nxml.txt.nlp	25105067	SENT48	23	23	3	3	propofol	STAT3	PA451141	6774	1
NULL	Clin_Med_Insights_Oncol_2012_Mar_19_6_165-178.nxml.txt.nlp	22474408	SENT220	5	5	47	47	cytarabine	NHL	PA449177	51750	1
NULL	Cell_Death_Dis_2010_Oct_21_1(10)_e86.nxml.txt.nlp	21368859	SENT74	28	28	1	1	doxorubicin	Mcl-1	PA449412	4170	1
NULL	J_Korean_Med_Sci_1996_Jun_11(3)_250-257.nxml.txt.nlp	8843008	SENT7	10	10	43	43	diltiazem	NIF	PA449334	6280	1
NULL	Oncol_Lett_2013_Sep_3_6(3)_801-806.nxml.txt.nlp	24137414	SENT155	30	30	16	16	doxorubicin	LDM	PA449412	1595	1
NULL	Clin_Pharmacol_2011_Jun_22_3_13-25.nxml.txt.nlp	22287853	SENT209	8	8	22	22	saxagliptin	CYP3A4	PA165958362	1576	1
NULL	Front_Neural_Circuits_2014_Aug_5_8_93.nxml.txt.nlp	25140130	SENT116	7	7	38	38	levodopa	spatial	PA450213	219793	1
NULL	J_Invest_Dermatol_2013_Jun_14_133(6)_1541-1549.nxml.txt.nlp	23407395	SENT122	15	15	5	5	imiquimod	CXCL2	PA449972	2920	1
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT28	31	31	9	9	coumarin	VKORC1	PA134521193	79001	1
NULL	Nucleic_Acids_Res_2005_Dec_9_33(22)_6972-6981.nxml.txt.nlp	16340007	SENT419	25	25	8	8	bleomycin	DNA-PKcs	PA448645	5591	1
NULL	Cell_Death_Dis_2013_Oct_3_4(10)_e827.nxml.txt.nlp	24091670	SENT93	39	39	3	3	nilotinib	PI3K	PA165958345	5290	1
NULL	Oncogene_2013_Sep_26_32(39)_10_1038_onc_2012_491.nxml.txt.nlp	23108394	SENT116	27	27	7	7	cisplatin	FOXM1	PA449014	2305	1
NULL	J_Hematol_Oncol_2011_Dec_1_4_49.nxml.txt.nlp	22128838	SENT132	11	11	25	25	bortezomib	Mcl-1	PA10252	4170	1
NULL	Arthritis_2012_Nov_8_2012_601763.nxml.txt.nlp	23243507	SENT100	6	6	27	27	tacrolimus	P-gp	PA451578	5243	1
NULL	Clin_Interv_Aging_2015_Jan_6_10_157-174.nxml.txt.nlp	25609933	SENT160	7	7	42	42	anastrozole	aromatase	PA448432	1588	1
NULL	JAKSTAT_2012_Jul_1_1(3)_216-218.nxml.txt.nlp	24058776	SENT18	6	6	26	26	leflunomide	STAT6	PA450192	6778	1
NULL	Breast_Cancer_Res_2011_Apr_1_13(2)_R35.nxml.txt.nlp	21457545	SENT30	32	32	1	1	erlotinib	EGFR	PA134687924	1956	1
NULL	Clin_Epigenetics_2011_Dec_5_3(1)_8.nxml.txt.nlp	22414275	SENT37	6	6	42	42	ribavirin	ESR1	PA451241	2099	1
NULL	Curr_Pharm_Des_2011_Dec_17(35)_3846-3853.nxml.txt.nlp	21933140	SENT38	30	30	3	3	nadh	PDH	PA164755085	54704	1
NULL	Chin_J_Cancer_2012_Feb_31(2)_73-99.nxml.txt.nlp	22098950	SENT199	0	0	40	40	imatinib	CD34	PA10804	947	1
NULL	Viruses_2014_May_23_6(5)_2155-2185.nxml.txt.nlp	24859341	SENT155	16	16	2	2	cisplatin	p38	PA449014	10598;1432;7965	1
NULL	Clin_Genet_2011_Jun_79(6)_582-587.nxml.txt.nlp	20573158	SENT10	24	24	2	2	diazoxide	ABCC8	PA449285	6833	1
NULL	Br_J_Cancer_2012_Jan_3_106(1)_141-147.nxml.txt.nlp	22108515	SENT149	40	40	7	7	paclitaxel	IDO1	PA450761	3620	1
NULL	Psychol_Res_Behav_Manag_2010_Dec_6_3_109-118.nxml.txt.nlp	22110334	SENT114	0	0	39	39	fluvoxamine	CYP2D6	PA449690	1565	1
NULL	Leukemia_2013_Jan_11_27(1)_32-40.nxml.txt.nlp	22781593	SENT32	0	0	14	14	ponatinib	CML	PA165980594	613	1
NULL	Curr_Neuropharmacol_2013_Jul_11(4)_388-413.nxml.txt.nlp	24381530	SENT51	8	8	35	35	berberine	BACE1	PA165860812	23621	1
NULL	Eur_Heart_J_2013_May_21_34(20)_1498-1505.nxml.txt.nlp	23487517	SENT163	3	3	26	26	warfarin	TTR	PA451906	7276	1
NULL	J_Clin_Biochem_Nutr_2009_Jan_27_44(1)_79-84.nxml.txt.nlp	19177192	SENT93	2	2	37	37	curcumin	HO-1	PA151958596	3162	1
NULL	FEBS_Open_Bio_2013_May_10_3_225-230.nxml.txt.nlp	23772398	SENT33	21	21	4	4	etoposide	CD9	PA449552	928	1
NULL	Environ_Health_Perspect_2004_Nov_28_112(15)_1512-1518.nxml.txt.nlp	15531436	SENT38	27	27	0	0	coumarin	CYP2A6	PA134521193	1548	1
NULL	Arthritis_Res_Ther_2010_Dec_17_12(6)_221.nxml.txt.nlp	21205283	SENT189	0	0	38	38	ustekinumab	ACR	PA166048654	49	0.999
NULL	Oncotarget_2013_Aug_8_4(8)_1130-1142.nxml.txt.nlp	24029073	SENT117	14	14	3	3	cisplatin	NRF2	PA449014	2551;4780	0.999
NULL	Drug_Saf_2014_Oct_29_37(Suppl_1)_57-62.nxml.txt.nlp	25352328	SENT71	3	3	24	24	atazanavir	UGT1A1	PA10251	54658	0.999
NULL	Cardiovasc_Diabetol_2010_Jul_27_9_31.nxml.txt.nlp	20663195	SENT13	21	21	3	3	irbesartan	FSP1	PA450084	6275;51062	0.999
NULL	Case_Rep_Oncol_2014_Feb_20_7(1)_126-131.nxml.txt.nlp	24707260	SENT29	4	4	42	42	gefitinib	FDG	PA131301952	23583	0.999
NULL	Arch_Virol_2014_Jul_16_159(1)_29-37.nxml.txt.nlp	23857507	SENT188	0	0	30	30	entecavir	LAM	PA164784025	7249;7248	0.999
NULL	Br_J_Clin_Pharmacol_2011_Oct_72(4)_647-657.nxml.txt.nlp	21518389	SENT212	23	23	10	10	cangrelor	P2Y12	PA165945763	64805	0.999
NULL	J_Hematol_Oncol_2010_Apr_23_3_17.nxml.txt.nlp	20416083	SENT112	6	6	19	19	sorafenib	FLT3	PA7000	2322	0.999
NULL	Br_J_Cancer_2013_Aug_6_109(3)_686-693.nxml.txt.nlp	23839492	SENT134	3	3	30	30	sunitinib	HIF-1	PA162372840	29072	0.999
NULL	J_Vet_Med_Sci_2014_Mar_1_76(3)_323-330.nxml.txt.nlp	24189582	SENT25	16	16	38	38	leflunomide	DHODH	PA450192	1723	0.999
NULL	Oncol_Lett_2013_Oct_26_6(4)_1063-1067.nxml.txt.nlp	24137465	SENT97	7	7	36	36	afatinib	HER2	PA165981154	2064	0.999
NULL	Hum_Genomics_2004_Nov_1_1(6)_444-455.nxml.txt.nlp	15606999	SENT160	27	27	14	14	tranilast	UGT1A1	PA131890628	54658	0.999
NULL	Cancers_(Basel)_2014_Feb_10_6(1)_376-395.nxml.txt.nlp	24518612	SENT185	2	2	10	10	temozolomide	STAT3	PA451609	6774	0.999
NULL	J_Exerc_Nutrition_Biochem_2014_Sep_11_18(3)_259-266.nxml.txt.nlp	25566462	SENT99	24	24	4	4	nadh	NAMPT	PA164755085	10135	0.999
NULL	Oncoscience_2014_Dec_18_1(12)_777-802.nxml.txt.nlp	25621294	SENT290	0	0	18	18	l-alanine	PKM	PA448055	5315	0.999
NULL	Oncol_Rep_2013_Sep_1_30(3)_1045-1052.nxml.txt.nlp	23817662	SENT139	30	30	5	5	erlotinib	EGFR	PA134687924	1956	0.999
NULL	Case_Rep_Hematol_2012_Apr_1_2012_396395.nxml.txt.nlp	22937327	SENT83	25	25	2	2	vincristine	IL-6	PA451879	3569	0.999
NULL	J_Korean_Med_Sci_2010_Aug_21_25(8)_1182-1186.nxml.txt.nlp	20676330	SENT98	16	16	26	26	sirolimus	LAM	PA451365	7249;7248	0.999
NULL	Breast_Cancer_Res_2009_Nov_18_11(6)_R85.nxml.txt.nlp	19922614	SENT187	13	13	34	34	tamoxifen	BCS	PA451581	617	0.999
NULL	Cancer_Cell_Int_2010_Jan_11_10_1.nxml.txt.nlp	20142996	SENT152	29	29	0	0	erlotinib	ASPM	PA134687924	259266	0.999
NULL	Nucleic_Acids_Res_2011_Jun_9_39(11)_4640-4652.nxml.txt.nlp	21310710	SENT328	19	19	5	5	camptothecin	SATB1	PA153590860	6304	0.999
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT309	15	15	1	1	curcumin	p38	PA151958596	10598;1432;7965	0.999
NULL	Breast_Cancer_Res_2010_Aug_23_12(4)_R64.nxml.txt.nlp	20731819	SENT218	46	46	21	21	tamoxifen	TTR	PA451581	7276	0.999
NULL	Ther_Clin_Risk_Manag_2005_Jun_1(2)_125-140.nxml.txt.nlp	18360552	SENT185	37	37	9	9	cyclophosphamide	TNF-alpha	PA449165	7124	0.999
NULL	Br_J_Cancer_2010_Oct_26_103(9)_1325-1330.nxml.txt.nlp	20940720	SENT163	28	28	11	11	cisplatin	EGFR	PA449014	1956	0.999
NULL	J_Korean_Med_Sci_2011_Jul_20_26(7)_893-899.nxml.txt.nlp	21738342	SENT95	21	21	0	0	resveratrol	CD97		976	0.999
NULL	Breast_Cancer_Res_2008_Jul_8_10(4)_R56.nxml.txt.nlp	18611244	SENT224	6	6	41	41	letrozole	PI3K	PA450196	5290	0.999
NULL	Semin_Immunol_2011_Feb_23(1)_28-41.nxml.txt.nlp	21295490	SENT253	0	0	38	38	efalizumab	CD11c	PA164748817	3687	0.999
NULL	Biochemistry_2011_May_10_50(18)_3609-3620.nxml.txt.nlp	21410224	SENT33	35	35	1	1	l-tryptophan	DHFR	PA10323	1719	0.999
NULL	J_Med_Life_2011_Feb_15_4(1)_11-20.nxml.txt.nlp	21505570	SENT190	9	9	40	40	ketoprofen	CB2	PA450149	1269	0.999
NULL	Mediators_Inflamm_2011_Jun_19_2011_385780.nxml.txt.nlp	21765617	SENT146	26	26	6	6	celecoxib	5-LOX	PA448871	240	0.999
NULL	Br_J_Cancer_2012_Jan_3_106(1)_148-156.nxml.txt.nlp	22045191	SENT248	13	13	27	27	erlotinib	EGFR	PA134687924	1956	0.999
NULL	Iran_J_Pharm_Res_2014_Summer_13(3)_975-985.nxml.txt.nlp	25276199	SENT174	34	34	10	10	naloxone	SON	PA450586	6651	0.999
NULL	Clin_Transl_Allergy_2014_Mar_14_4(Suppl_1)_O4.nxml.txt.nlp	NULL	SENT13	25	25	0	0	montelukast	RANTES	PA450546	6352	0.999
NULL	Inflamm_Res_2010_Sep_26_59(9)_699-709.nxml.txt.nlp	20339899	SENT29	31	31	9	9	thrombin	PAR2	PA451674	2150;55065;8856	0.999
NULL	Patient_Prefer_Adherence_2008_Feb_2_2_387-392.nxml.txt.nlp	19920986	SENT112	25	25	3	3	azathioprine	TPMT	PA448515	7172	0.999
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT105	35	35	26	26	trastuzumab	HER2	PA451743	2064	0.999
NULL	Br_J_Haematol_2008_Jun_141(5)_659-671.nxml.txt.nlp	18410446	SENT123	27	27	1	1	cerulenin	IL-6	PA164764551	3569	0.999
NULL	Int_Semin_Surg_Oncol_2009_Feb_9_6_5.nxml.txt.nlp	19203387	SENT49	18	18	7	7	tamoxifen	aromatase	PA451581	1588	0.999
NULL	Patient_Prefer_Adherence_2013_Mar_27_7_245-258.nxml.txt.nlp	23569364	SENT7	3	3	15	15	everolimus	aromatase	PA164746311	1588	0.999
NULL	Comput_Struct_Biotechnol_J_2012_Mar_19_1_e201204005.nxml.txt.nlp	22737296	SENT250	20	20	4	4	olaparib	BRCA1		672	0.999
NULL	Mol_Cancer_2012_Jun_18_11_41.nxml.txt.nlp	22709873	SENT285	30	30	14	14	lapatinib	PAX9	PA152241907	5083	0.999
NULL	Exp_Ther_Med_2013_Mar_17_5(3)_797-802.nxml.txt.nlp	23403698	SENT148	29	29	6	6	triciribine	PI3K	PA165958661	5290	0.999
NULL	Front_Mol_Neurosci_2012_Nov_12_5_99.nxml.txt.nlp	23162427	SENT265	39	39	5	5	cocaine	SIRT2	PA449072	22933	0.999
NULL	Indian_J_Endocrinol_Metab_2013_Jan-Feb_17(1)_91-94.nxml.txt.nlp	23776858	SENT95	0	0	10	10	exenatide	GLP-1	PA164749238	100125288	0.999
NULL	Environ_Health_Perspect_2005_Oct_14_113(10)_1330-1335.nxml.txt.nlp	16203242	SENT157	11	11	29	29	phenylephrine	MLC	PA450935	23209	0.999
NULL	Curr_Cardiol_Rev_2012_Aug_8(3)_239-249.nxml.txt.nlp	22935021	SENT130	23	23	0	0	clopidogrel	PAR-1	PA449053	2011;2149	0.999
NULL	Nucleic_Acids_Res_2012_Sep_28_40(17)_8440-8448.nxml.txt.nlp	22753029	SENT158	36	36	5	5	hydroxyurea	CHK1	PA449942	1111	0.999
NULL	Int_Semin_Surg_Oncol_2008_Apr_28_5_9.nxml.txt.nlp	18442393	SENT72	27	27	5	5	tamoxifen	HER2	PA451581	2064	0.999
NULL	Mol_Cancer_2014_Apr_28_13_92.nxml.txt.nlp	24775712	SENT228	30	30	3	3	lapatinib	HER2	PA152241907	2064	0.999
NULL	Mol_Cancer_2010_Apr_23_9_87.nxml.txt.nlp	20416058	SENT44	25	25	1	1	doxorubicin	TRAIL	PA449412	8743	0.999
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1098-1105.nxml.txt.nlp	21386838	SENT158	2	2	23	23	cisplatin	DTD	PA449014	1728	0.999
NULL	Cancer_Cell_2007_Dec_11_12(6)_514-527.nxml.txt.nlp	18068629	SENT52	8	8	23	23	paclitaxel	MDR1	PA450761	5243	0.999
NULL	Int_J_Biol_Sci_2011_Nov_26_8(1)_108-117.nxml.txt.nlp	22211109	SENT167	6	6	39	39	calcein	CXCL12	PA132595336	6387	0.999
NULL	Arthritis_Res_Ther_2014_Apr_3_16(2)_R86.nxml.txt.nlp	24708674	SENT199	29	29	2	2	bosentan	Fli1	PA10034	2314	0.999
NULL	Int_J_Mol_Sci_2013_Apr_18_14(4)_8570-8584.nxml.txt.nlp	23598418	SENT10	21	21	5	5	bevacizumab	MMP2	PA130232992	4313	0.999
NULL	Cancer_Immunol_Immunother_2013_Aug_27_62(10)_1637-1648.nxml.txt.nlp	23982484	SENT188	32	32	7	7	lenalidomide	STAT3	PA162363968	6774	0.999
NULL	Cell_Death_Dis_2013_Sep_5_4(9)_e791.nxml.txt.nlp	24008735	SENT133	7	7	34	34	gemcitabine	p53	PA449748	7157	0.999
NULL	Curr_Oncol_2009_Aug_16(4)_25-35.nxml.txt.nlp	19672422	SENT140	16	16	1	1	trastuzumab	Hsp90	PA451743	3320	0.999
NULL	Acta_Pharmacol_Sin_2009_Jul_22_30(7)_956-964.nxml.txt.nlp	19543298	SENT33	18	18	0	0	pravastatin	OATP1B1	PA451089	10599	0.999
NULL	Breast_Cancer_Res_2005_Jan_12_7(2)_48-51.nxml.txt.nlp	15743510	SENT46	0	0	21	21	celecoxib	aromatase	PA448871	1588	0.999
NULL	Aging_(Albany_NY)_2009_Mar_31_1(4)_412-424.nxml.txt.nlp	20195491	SENT80	30	30	9	9	resveratrol	TXNIP		10628	0.999
NULL	Curr_HIV_Res_2009_Jan_7(1)_73-82.nxml.txt.nlp	19149556	SENT184	28	28	7	7	maraviroc	CCR5	PA164768835	1234	0.999
NULL	Mol_Cancer_2008_Mar_6_7_24.nxml.txt.nlp	18325101	SENT153	24	24	13	13	cisplatin	BRCA1	PA449014	672	0.999
NULL	J_Biol_Chem_2011_Oct_7_286(40)_34998-35006.nxml.txt.nlp	21757733	SENT40	7	7	31	31	lipase	PLIN1	PA450239	5346	0.999
NULL	Chemother_Res_Pract_2011_Sep_25_2011_730360.nxml.txt.nlp	22295205	SENT33	28	28	4	4	docetaxel	HER2	PA449383	2064	0.999
NULL	Int_J_Breast_Cancer_2011_Feb_24_2011_967419.nxml.txt.nlp	22332018	SENT227	28	28	0	0	cyclophosphamide	MRP1	PA449165	4437	0.999
NULL	Genet_Mol_Biol_2010_Dec_1_Oct-Dec_33(4)_615-626.nxml.txt.nlp	21637567	SENT181	39	39	4	4	estradiol	MDM2	PA449503	4193	0.999
NULL	Patient_Prefer_Adherence_2013_Jul_3_7_633-641.nxml.txt.nlp	23861580	SENT200	0	0	43	43	acetazolamide	CO2	PA448018	4513	0.999
NULL	Cancers_(Basel)_2014_Jul_7_6(3)_1441-1463.nxml.txt.nlp	25003395	SENT254	27	27	3	3	temsirolimus	PI3K	PA164746890	5290	0.999
NULL	Oncotarget_2012_Nov_8_3(11)_1472-1482.nxml.txt.nlp	23178531	SENT86	4	4	31	31	iron	IRP1	PA450087	48	0.999
NULL	Oncotarget_2014_Oct_16_5(20)_9546-9563.nxml.txt.nlp	25337673	SENT114	23	23	3	3	erlotinib	AXL	PA134687924	558	0.999
NULL	J_Oncol_2012_Apr_5_2012_416927.nxml.txt.nlp	22570651	SENT42	4	4	37	37	temsirolimus	S6K1	PA164746890	6198	0.999
NULL	J_Hematol_Oncol_2008_Oct_23_1_19.nxml.txt.nlp	18947412	SENT124	5	5	24	24	alemtuzumab	CD34	PA164783958	947	0.999
NULL	Int_J_Mol_Sci_2014_Nov_7_15(11)_20500-20517.nxml.txt.nlp	25387078	SENT125	33	33	7	7	sorafenib	c-FLIP	PA7000	8837	0.999
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Aug_27_6_145-150.nxml.txt.nlp	25249759	SENT25	38	38	14	14	letrozole	aromatase	PA450196	1588	0.999
NULL	Inflamm_Res_2010_Sep_26_59(9)_699-709.nxml.txt.nlp	20339899	SENT29	33	33	3	3	trypsin	PAR1	PA451806	79581;2149	0.999
NULL	Mol_Cancer_2010_Aug_16_9_217.nxml.txt.nlp	20712901	SENT100	36	36	9	9	curcumin	PI3K	PA151958596	5290	0.999
NULL	Indian_J_Pharmacol_2014_Jan-Feb_46(1)_3-12.nxml.txt.nlp	24550577	SENT222	5	5	25	25	vismodegib	P-gp		5243	0.999
NULL	Oncol_Rep_2013_Sep_5_30(3)_1053-1058.nxml.txt.nlp	23836376	SENT111	0	0	24	24	camptothecin	MDR1	PA153590860	5243	0.999
NULL	Breast_Cancer_Res_2011_Nov_16_13(Suppl_2)_O11.nxml.txt.nlp	NULL	SENT6	5	5	47	47	trastuzumab	PIK3CA	PA451743	5290	0.999
NULL	Behav_Brain_Funct_2012_May_28_8_25.nxml.txt.nlp	22640745	SENT162	8	8	37	37	methylphenidate	spatial	PA450464	219793	0.999
NULL	Case_Rep_Rheumatol_2012_Apr_9_2012_517059.nxml.txt.nlp	22937453	SENT78	25	25	41	41	methimazole	ANA	PA450422	10950	0.999
NULL	Breast_Cancer_Res_2004_Jun_4_6(4)_153-159.nxml.txt.nlp	15217486	SENT60	36	36	4	4	estradiol	S100A7	PA449503	6278	0.999
NULL	Alcohol_Res_2012_34(3)_339-344.nxml.txt.nlp	23134050	SENT31	36	36	2	2	ethanol	ADH5	PA448073	128	0.999
NULL	Surg_Neurol_Int_2014_May_8_5_64.nxml.txt.nlp	24991467	SENT225	0	0	20	20	perifosine	PI3K	PA165291471	5290	0.999
NULL	Biologics_2013_Jun_11_7_139-148.nxml.txt.nlp	23788831	SENT134	31	31	13	13	sunitinib	IL-6	PA162372840	3569	0.999
NULL	Br_J_Cancer_2010_Oct_12_103(8)_1192-1200.nxml.txt.nlp	20877358	SENT190	25	25	1	1	cisplatin	BRCA2	PA449014	675	0.999
NULL	J_Oncol_2010_Dec_15_2010_821717.nxml.txt.nlp	20049172	SENT161	27	27	0	0	paclitaxel	TUBB3	PA450761	10381	0.999
NULL	F1000Res_2013_Oct_3_2_202.nxml.txt.nlp	24795806	SENT41	22	22	1	1	gefitinib	EGFR	PA131301952	1956	0.999
NULL	Curr_Neuropharmacol_2008_Jun_6(2)_151-163.nxml.txt.nlp	19305794	SENT297	29	29	1	1	capsaicin	TRPV1	PA448776	7442	0.999
NULL	Biomed_Res_Int_2013_Aug_4_2013_152909.nxml.txt.nlp	23984319	SENT29	17	17	5	5	methotrexate	MSH2	PA450428	4436	0.999
NULL	Cancers_(Basel)_2013_Mar_11_5(1)_255-280.nxml.txt.nlp	24216707	SENT111	0	0	32	32	genistein	CYP24A1	PA165109660	1591	0.999
NULL	Open_Access_J_Urol_2011_May_10_3_69-82.nxml.txt.nlp	24198638	SENT63	33	33	7	7	oxaliplatin	CYP3A4	PA131285527	1576	0.999
NULL	Nucleic_Acids_Res_2007_Jan_7_35(1)_223-233.nxml.txt.nlp	17158160	SENT75	3	3	16	16	neomycin	p16	PA450608	1029	0.999
NULL	Neuroscience_2009_Jun_30_161(2-3)_572-577.nxml.txt.nlp	19327387	SENT83	18	18	3	3	capsaicin	TRPV1	PA448776	7442	0.999
NULL	Oncol_Lett_2013_Jul_14_6(1)_69-74.nxml.txt.nlp	23946779	SENT123	0	0	15	15	axitinib	VEGFR	PA164924493	3791	0.999
NULL	Open_Virol_J_2012_Dec_28_6_204-215.nxml.txt.nlp	23341856	SENT123	34	34	7	7	paclitaxel	p53	PA450761	7157	0.999
NULL	Mol_Cancer_2010_Mar_25_9_68.nxml.txt.nlp	20338046	SENT89	41	41	8	8	doxorubicin	ABCB1	PA449412	5243	0.999
NULL	Int_J_Crit_Illn_Inj_Sci_2013_Jan-Mar_3(1)_64-68.nxml.txt.nlp	23724388	SENT94	4	4	23	23	lipase	FES	PA450239	2242	0.999
NULL	Breast_Cancer_Res_2005_Jul_20_7(5)_205-211.nxml.txt.nlp	16168139	SENT113	6	6	15	15	tamoxifen	aromatase	PA451581	1588	0.999
NULL	J_Cardiovasc_Dis_Res_2012_Oct-Dec_3(4)_319-322.nxml.txt.nlp	23233778	SENT13	5	5	29	29	erythromycin	CYP3A4	PA449493	1576	0.999
NULL	Cancer_Manag_Res_2013_Aug_23_5_251-269.nxml.txt.nlp	24049458	SENT88	34	34	0	0	rituximab	CD22	PA451261	933	0.999
NULL	Cancers_(Basel)_2014_Mar_13_6(1)_595-624.nxml.txt.nlp	24633084	SENT222	43	43	9	9	trastuzumab	HER2	PA451743	2064	0.999
NULL	EMBO_Mol_Med_2009_Apr_1(1)_66-78.nxml.txt.nlp	20049704	SENT225	9	9	28	28	gefitinib	HIF-1	PA131301952	29072	0.999
NULL	Clin_Exp_Reprod_Med_2014_Sep_30_41(3)_120-124.nxml.txt.nlp	25309856	SENT28	34	34	11	11	estradiol	ADAMTS16	PA449503	170690	0.999
NULL	Mol_Cancer_2003_Jan_7_2_10.nxml.txt.nlp	12575899	SENT268	12	12	27	27	resveratrol	COX		1351	0.999
NULL	Prostate_Int_2014_Sep_21_2(3)_105-113.nxml.txt.nlp	25325021	SENT147	0	0	17	17	dutasteride	SRD5A2	PA164749300	6716	0.999
NULL	Br_J_Cancer_2009_May_5_100(9)_1379-1384.nxml.txt.nlp	19401697	SENT37	4	4	34	34	bortezomib	EGFR	PA10252	1956	0.999
NULL	Allergy_Asthma_Clin_Immunol_2010_Jul_28_6(1)_15.nxml.txt.nlp	20667118	SENT68	29	29	10	10	captopril	C1-INH	PA448780	710	0.999
NULL	Case_Rep_Neurol_2011_Oct_24_3(3)_284-288.nxml.txt.nlp	22125530	SENT50	31	31	5	5	hydroxyurea	JAK2	PA449942	3717	0.999
NULL	Korean_Circ_J_2013_Aug_31_43(8)_541-549.nxml.txt.nlp	24044013	SENT129	23	23	4	4	clopidogrel	CYP2C19	PA449053	1557	0.999
NULL	J_Korean_Neurosurg_Soc_2013_Oct_31_54(4)_329-335.nxml.txt.nlp	24294457	SENT183	31	31	0	0	trastuzumab	HER-2	PA451743	2064	0.999
NULL	Int_J_Surg_Oncol_2011_Jun_28_2011_154673.nxml.txt.nlp	22312493	SENT58	32	32	7	7	mitomycin	PALB2	PA450524	79728	0.999
NULL	Ann_Hematol_2010_Sep_13_89(9)_861-871.nxml.txt.nlp	20387067	SENT199	4	4	15	15	dasatinib	IL-3	PA162372878	3562	0.999
NULL	J_Oncol_2009_Jul_14_2009_896407.nxml.txt.nlp	19636423	SENT102	25	25	9	9	cetuximab	PIK3CA	PA10040	5290	0.999
NULL	Cardiol_Res_Pract_2011_May_10_2011_816897.nxml.txt.nlp	21629798	SENT126	0	0	10	10	pazopanib	CYP3A4	PA165291492	1576	0.999
NULL	Cancer_Biol_Med_2012_Mar_9(1)_18-22.nxml.txt.nlp	23691449	SENT11	37	37	14	14	gefitinib	EGFR	PA131301952	1956	0.999
NULL	Front_Oncol_2014_Mar_24_4_47.nxml.txt.nlp	24716189	SENT167	19	19	8	8	erlotinib	PTEN	PA134687924	5728	0.999
NULL	Arthritis_Res_Ther_2009_May_21_11(3)_R76.nxml.txt.nlp	19460157	SENT50	4	4	19	19	etanercept	ACR	PA449515	49	0.999
NULL	Drugs_R_D_2010_Nov_25_10(4)_219-224.nxml.txt.nlp	21171668	SENT87	0	0	34	34	clopidogrel	ADP	PA449053	23038	0.999
NULL	Hum_Genomics_2009_Dec_1_4(2)_91-106.nxml.txt.nlp	20038497	SENT145	13	13	33	33	donepezil	APOE	PA449394	348	0.999
NULL	J_Cell_Biol_1998_Jan_26_140(2)_335-345.nxml.txt.nlp	9442109	SENT81	5	5	33	33	chloroquine	NHE	PA448948	285335	0.999
NULL	Cancer_Med_2014_Apr_27_3(2)_245-251.nxml.txt.nlp	24464861	SENT25	2	2	25	25	metformin	HIF1	PA450395	3091	0.999
NULL	Oncol_Lett_2014_Sep_13_8(3)_1249-1254.nxml.txt.nlp	25120700	SENT77	4	4	17	17	sorafenib	BRAF	PA7000	673	0.999
NULL	Int_Semin_Surg_Oncol_2006_Sep_18_3_31.nxml.txt.nlp	16981992	SENT18	26	26	1	1	tamoxifen	ATAC	PA451581	6375	0.999
NULL	J_Cell_Biol_1998_Jan_26_140(2)_335-345.nxml.txt.nlp	9442109	SENT246	15	15	4	4	amiloride	NHE	PA448368	285335	0.999
NULL	Hum_Mol_Genet_2008_Aug_1_17(15)_2293-2309.nxml.txt.nlp	18424448	SENT236	41	41	8	8	aripiprazole	EGR4	PA10026	1961	0.999
NULL	Case_Rep_Oncol_2011_Sep_16_4(3)_464-466.nxml.txt.nlp	22114570	SENT10	16	16	36	36	erlotinib	EGFR	PA134687924	1956	0.999
NULL	Cancer_2014_Jan_15_120(2)_229-237.nxml.txt.nlp	24122122	SENT167	0	0	17	17	sorafenib	VEGF-A	PA7000	7422	0.999
NULL	Tuberc_Respir_Dis_(Seoul)_2013_Nov_29_75(5)_188-198.nxml.txt.nlp	24348666	SENT26	32	32	7	7	gefitinib	EGFR	PA131301952	1956	0.999
NULL	Front_Genet_2012_Nov_22_3_249.nxml.txt.nlp	23189085	SENT65	23	23	7	7	ifosfamide	GSTP1	PA449964	2950	0.999
NULL	Cardiovasc_Res_2012_Mar_15_93(4)_674-681.nxml.txt.nlp	22166712	SENT137	0	0	16	16	clopidogrel	ADP	PA449053	23038	0.999
NULL	Chem_Rev_2012_May_9_112(5)_2593-2603.nxml.txt.nlp	22335786	SENT52	27	27	0	0	choline	ATX	PA448976	5168;23049	0.999
NULL	J_Geriatr_Cardiol_2013_Jun_10(2)_151-158.nxml.txt.nlp	23888175	SENT157	24	24	0	0	rosuvastatin	ACE2	PA134308647	59272	0.999
NULL	EPMA_J_2011_Jun_1_2(2)_231-239.nxml.txt.nlp	23199151	SENT53	2	2	31	31	azathioprine	TPMT	PA448515	7172	0.999
NULL	Chemother_Res_Pract_2011_Sep_25_2011_730360.nxml.txt.nlp	22295205	SENT33	35	35	4	4	etoposide	HER2	PA449552	2064	0.999
NULL	Br_J_Cancer_2009_Oct_20_101(8)_1253-1260.nxml.txt.nlp	19755984	SENT126	27	27	4	4	letrozole	HER-2	PA450196	2064	0.999
NULL	Cell_Commun_Signal_2013_Oct_21_11_79.nxml.txt.nlp	24144181	SENT403	27	27	1	1	chloramphenicol	IL-8	PA448927	3576	0.999
NULL	Eur_J_Endocrinol_2013_Apr_168(4)_557-564.nxml.txt.nlp	23345197	SENT96	19	19	4	4	diazoxide	ABCC8	PA449285	6833	0.999
NULL	Cancers_(Basel)_2011_Oct_14_3(4)_3894-3908.nxml.txt.nlp	24213116	SENT102	38	38	4	4	irinotecan	EGFR	PA450085	1956	0.999
NULL	Braz_J_Med_Biol_Res_2013_Aug_13_46(8)_659-669.nxml.txt.nlp	24036938	SENT8	21	21	45	45	resveratrol	SIRT1		23411	0.999
NULL	Target_Oncol_2010_Jun_14_5(2)_95-112.nxml.txt.nlp	20625845	SENT241	42	42	3	3	everolimus	FDG	PA164746311	23583	0.999
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT259	1	1	29	29	metformin	GLP-1	PA450395	100125288	0.999
NULL	J_Young_Pharm_2010_Jul-Sep_2(3)_326-331.nxml.txt.nlp	21042495	SENT127	10	10	28	28	lovastatin	CYP2C9	PA450272	1559	0.999
NULL	J_Oncol_2009_Jul_14_2009_896407.nxml.txt.nlp	19636423	SENT102	27	27	9	9	panitumumab	PIK3CA	PA162373091	5290	0.999
NULL	Hum_Genomics_Proteomics_2010_Sep_13_2010_754919.nxml.txt.nlp	20981234	SENT103	24	24	3	3	acenocoumarol	VKORC1	PA452632	79001	0.999
NULL	Oncogene_2014_Jan_23_33(4)_421-428.nxml.txt.nlp	23318437	SENT118	36	36	3	3	etoposide	RNF2	PA449552	6045	0.999
NULL	Ann_Rheum_Dis_2014_Sep_3_73(9)_1616-1625.nxml.txt.nlp	24699939	SENT27	2	2	38	38	tocilizumab	IL-6	PA165292659	3569	0.999
NULL	Cancer_Manag_Res_2014_Feb_3_6_53-61.nxml.txt.nlp	24520204	SENT73	3	3	39	39	decitabine	P15	PA164749631	1030;29107	0.999
NULL	Clin_Med_Insights_Cardiol_2011_Oct_6_5_103-119.nxml.txt.nlp	22084608	SENT44	0	0	25	25	warfarin	CYP2C9	PA451906	1559	0.999
NULL	Pharm_Pract_(Granada)_2011_Mar_15_Jan-Mar_9(1)_1-10.nxml.txt.nlp	25132883	SENT167	0	0	45	45	dabigatran	SPAF		166378	0.999
NULL	ScientificWorldJournal_2012_Apr_26_2012_358102.nxml.txt.nlp	22645419	SENT149	4	4	35	35	captopril	AT2	PA448780	186	0.999
NULL	J_Med_Case_Reports_2011_Sep_19_5_465.nxml.txt.nlp	21929779	SENT69	35	35	6	6	efavirenz	CD4	PA449441	920	0.999
NULL	Breast_Cancer_(Auckl)_2012_Nov_19_6_191-207.nxml.txt.nlp	23226023	SENT105	5	5	40	40	trastuzumab	HER2	PA451743	2064	0.999
NULL	Mol_Cancer_2008_Mar_26_7_27.nxml.txt.nlp	18366759	SENT84	27	27	0	0	etoposide	BAK1	PA449552	578	0.999
NULL	Front_Genet_2014_Nov_14_5_391.nxml.txt.nlp	25452763	SENT54	40	40	2	2	cisplatin	ERCC2	PA449014	2068	0.999
NULL	Clin_Transl_Allergy_2014_Mar_14_4(Suppl_1)_O4.nxml.txt.nlp	NULL	SENT13	25	25	2	2	montelukast	IL-6	PA450546	3569	0.999
NULL	Clin_Epigenetics_2011_Jul_16_2(2)_411-416.nxml.txt.nlp	22704352	SENT72	2	2	19	19	vorinostat	IFN	PA164748224	3439	0.999
NULL	Oncol_Lett_2013_Apr_22_5(4)_1093-1100.nxml.txt.nlp	23599746	SENT69	18	18	39	39	docetaxel	P-gp	PA449383	5243	0.999
NULL	Arch_Drug_Inf_2009_Mar_2(1)_1-7.nxml.txt.nlp	19381337	SENT26	1	1	35	35	saquinavir	CYP3A4	PA451305	1576	0.999
NULL	Clin_Med_Insights_Oncol_2012_Dec_20_7_1-12.nxml.txt.nlp	23362372	SENT37	45	45	3	3	cabazitaxel	CYP3A4	PA165958401	1576	0.999
NULL	J_Int_AIDS_Soc_2013_Feb_25_16(1)_10_7448_IAS_16_1_18472.nxml.txt.nlp	23443042	SENT47	27	27	1	1	lamivudine	CD4	PA450163	920	0.999
NULL	Arthritis_Res_Ther_2005_Aug_30_7(5)_215-224.nxml.txt.nlp	16207351	SENT202	0	0	19	19	chloroquine	TLR9	PA448948	54106	0.999
NULL	Arthritis_2013_Nov_10_2013_154812.nxml.txt.nlp	24324885	SENT365	15	15	0	0	hyaluronan	ADAMTS5	PA165958431	11096	0.999
NULL	Cell_Death_Differ_2010_Apr_16_17(4)_666-676.nxml.txt.nlp	19834494	SENT283	25	25	0	0	oxaliplatin	RAGE	PA131285527	177	0.999
NULL	Exp_Ther_Med_2014_Oct_24_8(4)_1092-1096.nxml.txt.nlp	25187802	SENT83	9	9	37	37	carvedilol	TLR4	PA448817	7099	0.999
NULL	Diabetes_2009_Jul_14_58(7)_1715-1720.nxml.txt.nlp	19366866	SENT31	34	34	0	0	tolbutamide	KCNQ1	PA451718	3784	0.999
NULL	EMBO_J_2008_Jan_23_27(2)_384-393.nxml.txt.nlp	18188154	SENT77	20	20	5	5	forskolin	spatial	PA146096022	219793	0.999
NULL	Br_J_Cancer_2012_Jun_5_106(12)_1997-2003.nxml.txt.nlp	22596232	SENT16	37	37	9	9	sorafenib	CD133	PA7000	8842	0.999
NULL	Breast_Cancer_Res_2009_Jun_29_11(3)_R41.nxml.txt.nlp	19563669	SENT248	26	26	1	1	trastuzumab	XIAP	PA451743	331	0.999
NULL	Int_J_Gen_Med_2011_Mar_15_4_211-219.nxml.txt.nlp	21475632	SENT30	31	31	6	6	fenofibrate	HPD	PA449594	3242	0.999
NULL	J_Biomed_Biotechnol_2011_Jul_6_2011_783528.nxml.txt.nlp	21785566	SENT149	3	3	10	10	ritonavir	P-gp	PA451260	5243	0.999
NULL	Oncol_Rep_2014_Aug_12_32(2)_469-474.nxml.txt.nlp	24926795	SENT31	23	23	3	3	oxaliplatin	CTR	PA131285527	799	0.999
NULL	Cancers_(Basel)_2014_Mar_13_6(1)_595-624.nxml.txt.nlp	24633084	SENT221	0	0	21	21	trastuzumab	HER2	PA451743	2064	0.999
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT116	20	20	3	3	gefitinib	KRAS	PA131301952	3845	0.999
NULL	J_Biol_Chem_2010_Aug_20_285(34)_25928-25940.nxml.txt.nlp	20547488	SENT25	40	40	6	6	cisplatin	JNK	PA449014	5599	0.999
NULL	Cancer_Metastasis_Rev_2010_Dec_10_29(4)_581-594.nxml.txt.nlp	20830503	SENT71	2	2	31	31	letrozole	aromatase	PA450196	1588	0.999
NULL	Acta_Pharmacol_Sin_2012_Jun_6_33(6)_798-808.nxml.txt.nlp	22669117	SENT190	20	20	4	4	heparin	14-3-3	PA449855	10971	0.999
NULL	Acta_Pharmacol_Sin_2011_Jan_6_32(1)_133-138.nxml.txt.nlp	21131997	SENT45	36	36	2	2	heparin	ACT	PA449855	12;11332;9457;641455	0.999
NULL	Curr_Oncol_2009_Jul_16(Suppl_2)_S1-S13.nxml.txt.nlp	19672416	SENT72	2	2	23	23	letrozole	aromatase	PA450196	1588	0.999
NULL	Orphanet_J_Rare_Dis_2014_Dec_5_9(1)_194.nxml.txt.nlp	NULL	SENT401	8	8	31	31	desogestrel	PHOX2B	PA449238	8929	0.999
NULL	Br_J_Cancer_2009_Sep_15_101(6)_957-966.nxml.txt.nlp	19738618	SENT15	11	11	30	30	dexrazoxane	THBS-1	PA449259	7057	0.999
NULL	Biomed_Res_Int_2013_Jul_21_2013_150478.nxml.txt.nlp	23971023	SENT203	13	13	3	3	docetaxel	P-gp	PA449383	5243	0.999
NULL	Korean_Circ_J_2013_Mar_31_43(3)_204-206.nxml.txt.nlp	23613701	SENT41	0	0	17	17	warfarin	MELAS	PA451906	4219	0.999
NULL	Mol_Neurodegener_2010_Nov_10_5_49.nxml.txt.nlp	21067594	SENT28	18	18	0	0	zinc	PTEN	PA451956	5728	0.999
NULL	J_Int_AIDS_Soc_2013_Feb_25_16(1)_10_7448_IAS_16_1_18472.nxml.txt.nlp	23443042	SENT47	29	29	1	1	nevirapine	CD4	PA450616	920	0.999
NULL	Mol_Biol_Int_2012_Apr_11_2012_141732.nxml.txt.nlp	22577550	SENT164	29	29	6	6	cisplatin	DNMT3B	PA449014	1789	0.999
NULL	Diabetologia_2009_Oct_14_52(10)_2046-2055.nxml.txt.nlp	19688338	SENT214	16	16	29	29	liraglutide	GLP-1	PA165958364	100125288	0.999
NULL	Breast_Cancer_(Auckl)_2014_Jul_29_8_109-118.nxml.txt.nlp	25125981	SENT14	0	0	35	35	trastuzumab	HER2	PA451743	2064	0.999
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1013.nxml.txt.nlp	24457957	SENT124	22	22	9	9	bortezomib	NOXA	PA10252	5366	0.999
NULL	Mol_Biol_Cell_2012_Oct_15_23(20)_4097-4108.nxml.txt.nlp	22918955	SENT233	33	33	2	2	tetracycline	MMP3	PA451640	4314	0.999
NULL	Front_Genet_2012_Oct_31_3_224.nxml.txt.nlp	23118737	SENT43	21	21	4	4	resveratrol	SIRT2		22933	0.999
NULL	Core_Evid_2010_Oct_22_5_91-105.nxml.txt.nlp	21468365	SENT72	3	3	25	25	fluvastatin	CYP3A4	PA449688	1576	0.999
NULL	Oncotarget_2013_Aug_8_4(8)_1130-1142.nxml.txt.nlp	24029073	SENT117	14	14	5	5	cisplatin	HO-1	PA449014	3162	0.999
NULL	Breast_Cancer_Res_2011_Nov_16_13(Suppl_2)_O11.nxml.txt.nlp	NULL	SENT6	5	5	36	36	trastuzumab	PI3	PA451743	5266	0.999
NULL	Mol_Neurodegener_2011_Jul_19_6_51.nxml.txt.nlp	21771318	SENT104	11	11	30	30	pioglitazone	SOD1	PA450970	6647	0.999
NULL	Br_J_Haematol_2014_Mar_6_164(6)_759-766.nxml.txt.nlp	24387053	SENT155	3	3	18	18	eculizumab	PEX	PA164776637	5251	0.999
NULL	Oncotarget_2011_Nov_9_2(11)_850-861.nxml.txt.nlp	22081665	SENT11	20	20	4	4	idarubicin	DNMT3A	PA449961	1788	0.999
NULL	Case_Rep_Oncol_2011_Sep_16_4(3)_464-466.nxml.txt.nlp	22114570	SENT10	14	14	36	36	gefitinib	EGFR	PA131301952	1956	0.999
NULL	J_Immunol_Methods_2009_Jan_1_340(1)_11-24.nxml.txt.nlp	18929568	SENT237	3	3	37	37	dasatinib	San	PA162372878	80218	0.999
NULL	Mol_Cancer_2012_Jun_18_11_41.nxml.txt.nlp	22709873	SENT318	9	9	28	28	lapatinib	CCND1	PA152241907	595	0.999
NULL	J_Hematol_Oncol_2014_Aug_1_7_52.nxml.txt.nlp	25085632	SENT178	11	11	30	30	sunitinib	VEGFR	PA162372840	3791	0.999
NULL	Acta_Pharmacol_Sin_2010_Sep_16_31(9)_1075-1084.nxml.txt.nlp	20711221	SENT115	8	8	36	36	metformin	eNOS	PA450395	4846	0.999
NULL	Exp_Ther_Med_2015_Jan_5_9(1)_84-88.nxml.txt.nlp	25452780	SENT17	0	0	39	39	vildagliptin	GLP-1	PA165958346	100125288	0.999
NULL	Mol_Cancer_2007_Sep_26_6_61.nxml.txt.nlp	17894897	SENT184	6	6	41	41	etoposide	BNIP3	PA449552	664	0.999
NULL	Breast_Cancer_Res_2012_Nov_5_14(6)_R143.nxml.txt.nlp	23127292	SENT166	39	39	6	6	tamoxifen	p53	PA451581	7157	0.999
NULL	Oncol_Lett_2013_Feb_27_5(2)_435-439.nxml.txt.nlp	23420613	SENT28	1	1	27	27	erlotinib	EGFR	PA134687924	1956	0.999
NULL	Br_J_Cancer_2012_Oct_9_107(8)_1268-1276.nxml.txt.nlp	22996612	SENT143	15	15	33	33	paclitaxel	mol	PA450761	90527	0.999
NULL	Oncoimmunology_2012_Aug_1_1(5)_618-629.nxml.txt.nlp	22934254	SENT192	35	35	4	4	nilotinib	IL8	PA165958345	3576	0.999
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Aug_27_6_145-150.nxml.txt.nlp	25249759	SENT25	36	36	14	14	anastrozole	aromatase	PA448432	1588	0.999
NULL	Korean_Circ_J_2013_Aug_31_43(8)_541-549.nxml.txt.nlp	24044013	SENT116	2	2	19	19	clopidogrel	DES	PA449053	1674	0.999
NULL	J_Gen_Physiol_2009_Jul_134(1)_79.nxml.txt.nlp	NULL	SENT363	23	23	1	1	pp2	TRPC1		7220	0.999
NULL	Cancer_Med_2014_Oct_25_3(5)_1099-1111.nxml.txt.nlp	24961511	SENT331	24	24	0	0	cisplatin	LOXL2	PA449014	4017	0.999
NULL	Evid_Based_Complement_Alternat_Med_2011_Apr_7_2011_127641.nxml.txt.nlp	21584267	SENT6	35	35	1	1	glibenclamide	STZ	PA449782	6484	0.999
NULL	Korean_Circ_J_2013_Aug_31_43(8)_541-549.nxml.txt.nlp	24044013	SENT22	0	0	30	30	clopidogrel	P2Y12	PA449053	64805	0.999
NULL	Indian_J_Endocrinol_Metab_2011_Jan-Mar_15(1)_9-17.nxml.txt.nlp	21584160	SENT109	0	0	21	21	liraglutide	PPG	PA165958364	5552	0.999
NULL	Clin_Interv_Aging_2012_Sep_3_7_331-338.nxml.txt.nlp	22977302	SENT96	37	37	16	16	denosumab	RANKL	PA166048634	8600	0.999
NULL	Mol_Cancer_2010_Aug_23_9_222.nxml.txt.nlp	20731837	SENT184	6	6	25	25	gefitinib	EGFR	PA131301952	1956	0.999
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_1-2.nxml.txt.nlp	17221160	SENT2	30	30	17	17	tamoxifen	aromatase	PA451581	1588	0.999
NULL	Aging_(Albany_NY)_2014_Jan_14_6(1)_70-81.nxml.txt.nlp	24429382	SENT100	21	21	8	8	bleomycin	WRN	PA448645	7486	0.999
NULL	Int_J_Mol_Sci_2014_Nov_21_15(11)_21433-21454.nxml.txt.nlp	25421240	SENT148	0	0	29	29	heparin	EGFR	PA449855	1956	0.999
NULL	Breast_Cancer_(Auckl)_2012_Mar_7_6_67-77.nxml.txt.nlp	22438669	SENT114	34	34	4	4	letrozole	aromatase	PA450196	1588	0.999
NULL	Br_J_Cancer_2002_Feb_1_86(3)_463-469.nxml.txt.nlp	11875716	SENT214	35	35	5	5	cisplatin	Bcl-2	PA449014	596	0.999
NULL	J_Oncol_2009_Jul_14_2009_896407.nxml.txt.nlp	19636423	SENT120	39	39	4	4	irinotecan	EGFR	PA450085	1956	0.999
NULL	Acta_Pharmacol_Sin_2009_Jul_22_30(7)_956-964.nxml.txt.nlp	19543298	SENT169	21	21	5	5	ezetimibe	ABCB1	PA10816	5243	0.999
NULL	Mol_Imaging_Biol_2009_Jul_31_11(4)_241-245.nxml.txt.nlp	19333655	SENT54	4	4	31	31	aprepitant	NK1	PA164747039	11126	0.999
NULL	Cancers_(Basel)_2010_Nov_5_2(4)_1838-1860.nxml.txt.nlp	24281204	SENT161	30	30	11	11	etoposide	TAL1	PA449552	6886	0.999
NULL	Diabetes_2008_Sep_57(9)_2332-2340.nxml.txt.nlp	18567824	SENT38	45	45	10	10	atropine	ghrelin	PA448505	51738	0.999
NULL	J_Oncol_2012_Dec_22_2012_682480.nxml.txt.nlp	22235203	SENT144	11	11	0	0	lapatinib	EGFR	PA152241907	1956	0.999
NULL	Clin_Pharmacol_2013_Dec_9_5_185-192.nxml.txt.nlp	24353446	SENT94	34	34	9	9	clopidogrel	CYP3A4	PA449053	1576	0.999
NULL	Clin_Sci_(Lond)_2012_May_1_122(Pt_9)_421-428.nxml.txt.nlp	22092038	SENT31	3	3	17	17	doxycycline	JNK1	PA449415	5599	0.999
NULL	J_Geriatr_Cardiol_2013_Jun_10(2)_151-158.nxml.txt.nlp	23888175	SENT123	34	34	0	0	rosuvastatin	AT1	PA134308647	9197;185	0.999
NULL	Clin_Med_Insights_Cardiol_2013_Aug_11_7_127-140.nxml.txt.nlp	23997577	SENT66	2	2	20	20	amiodarone	NCX	PA448383	3196	0.999
NULL	Clin_Med_Insights_Oncol_2012_Mar_19_6_165-178.nxml.txt.nlp	22474408	SENT220	7	7	47	47	cyclophosphamide	NHL	PA449165	51750	0.999
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S31-S40.nxml.txt.nlp	20680106	SENT12	13	13	3	3	cetuximab	KRAS	PA10040	3845	0.999
NULL	Crit_Care_2005_Aug_11_9(1)_86-91.nxml.txt.nlp	15693989	SENT108	1	1	19	19	dantrolene	CHS	PA449208	1130	0.999
NULL	Gastroenterol_Hepatol_Bed_Bench_2014_Winter_7(1)_76-78.nxml.txt.nlp	25436102	SENT31	31	31	0	0	oxaliplatin	RNF8	PA131285527	9025	0.999
NULL	Cancer_Cell_Int_2013_Jun_26_13_64.nxml.txt.nlp	23802572	SENT98	6	6	32	32	curcumin	Bcl-2	PA151958596	596	0.999
NULL	Breast_Cancer_Res_2014_Jul_24_16(4)_411.nxml.txt.nlp	25056669	SENT191	28	28	0	0	tamoxifen	ITGA6	PA451581	3655	0.999
NULL	Mol_Cancer_2010_Nov_8_9_291.nxml.txt.nlp	21059223	SENT185	41	41	11	11	doxorubicin	ZNF217	PA449412	7764	0.999
NULL	Oncol_Lett_2014_Jan_6_7(1)_255-259.nxml.txt.nlp	24348859	SENT137	36	36	0	0	cisplatin	EGFR	PA449014	1956	0.999
NULL	Br_J_Cancer_2010_Sep_7_103(6)_845-851.nxml.txt.nlp	20700125	SENT45	24	24	8	8	capecitabine	ERCC1	PA448771	2067	0.999
NULL	Cancer_Med_2012_Aug_15_1(1)_28-38.nxml.txt.nlp	23342251	SENT23	33	33	3	3	cetuximab	HER2	PA10040	2064	0.999
NULL	Int_J_Mol_Sci_2013_Apr_29_14(5)_9338-9364.nxml.txt.nlp	23629668	SENT91	18	18	1	1	bevacizumab	IL-6	PA130232992	3569	0.999
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Apr_6_5_8.nxml.txt.nlp	16600049	SENT217	0	0	18	18	tenofovir	LAM	PA10204	7249;7248	0.999
NULL	Case_Rep_Med_2010_Jul_6_2010_426804.nxml.txt.nlp	20671989	SENT73	6	6	31	31	capecitabine	CYP1A2	PA448771	1544	0.999
NULL	Oncol_Lett_2013_Apr_22_5(4)_1093-1100.nxml.txt.nlp	23599746	SENT127	11	11	44	44	paclitaxel	CYP3A4	PA450761	1576	0.999
NULL	Eur_J_Med_Res_2009_Dec_7_14(Suppl_4)_71-77.nxml.txt.nlp	20156730	SENT149	8	8	18	18	tobramycin	gamma	PA451704	9913	0.999
NULL	Arthritis_Res_Ther_2013_Dec_23_15(6)_130.nxml.txt.nlp	24364924	SENT35	13	13	0	0	tocilizumab	IL-6	PA165292659	3569	0.999
NULL	Int_J_Surg_Oncol_2012_Jun_24_2012_868645.nxml.txt.nlp	22778942	SENT95	23	23	2	2	cisplatin	VEGF-A	PA449014	7422	0.999
NULL	J_Int_AIDS_Soc_2013_Feb_25_16(1)_10_7448_IAS_16_1_18472.nxml.txt.nlp	23443042	SENT47	31	31	1	1	efavirenz	CD4	PA449441	920	0.999
NULL	J_Exp_Clin_Cancer_Res_2009_Jul_10_28(1)_99.nxml.txt.nlp	19591692	SENT30	0	0	20	20	tariquidar	ABCG2		9429	0.999
NULL	Cell_Div_2012_Mar_29_7_11.nxml.txt.nlp	22458775	SENT4	0	0	23	23	flavopiridol	CDK9	PA452627	1025	0.999
NULL	Nucleic_Acids_Res_2014_Jan_1_42(1)_553-566.nxml.txt.nlp	24097443	SENT25	19	19	2	2	cisplatin	ALKBH2	PA449014	121642	0.999
NULL	Cancers_(Basel)_2010_Dec_22_2(4)_2153-2170.nxml.txt.nlp	21390244	SENT245	17	17	2	2	gefitinib	AREG	PA131301952	374	0.999
NULL	Child_Adolesc_Psychiatry_Ment_Health_2012_Jun_22_6_25.nxml.txt.nlp	22726236	SENT71	0	0	44	44	risperidone	B12	PA451257	7126;4709	0.999
NULL	Acta_Vet_Scand_2013_Jun_3_55(1)_44.nxml.txt.nlp	23731650	SENT179	3	3	13	13	amoxicillin	NOT	PA448406	4929	0.999
NULL	Int_J_Breast_Cancer_2012_Nov_2_2012_217185.nxml.txt.nlp	22295242	SENT82	34	34	13	13	cisplatin	CHEK1	PA449014	1111	0.999
NULL	Ann_Gen_Psychiatry_2010_Apr_22_9(Suppl_1)_S142.nxml.txt.nlp	NULL	SENT3	0	0	18	18	donepezil	CYP2D6	PA449394	1565	0.999
NULL	Breast_Cancer_Res_2012_Nov_5_14(6)_R143.nxml.txt.nlp	23127292	SENT169	37	37	4	4	tamoxifen	p53	PA451581	7157	0.999
NULL	Pharmaceuticals_(Basel)_2011_Nov_11_4(11)_1503-1517.nxml.txt.nlp	NULL	SENT147	16	16	24	24	capsaicin	TRPV1	PA448776	7442	0.999
NULL	eLife_2013_Nov_5_2_e00969.nxml.txt.nlp	24192036	SENT106	16	16	3	3	vemurafenib	p53	PA165946873	7157	0.999
NULL	Basic_Clin_Pharmacol_Toxicol_2013_Feb_5_112(2)_132-137.nxml.txt.nlp	22900583	SENT33	2	2	20	20	ritonavir	CYP2C9	PA451260	1559	0.999
NULL	Oncotarget_2013_Nov_24_4(12)_2186-2207.nxml.txt.nlp	24327604	SENT210	4	4	45	45	melphalan	LFA-1	PA450354	3683;3689	0.999
NULL	Tumour_Biol_2014_Mar_19_35(3)_2211-2218.nxml.txt.nlp	24142530	SENT173	22	22	8	8	etoposide	APAF-1	PA449552	317	0.999
NULL	Mol_Cancer_2014_Jun_24_13_157.nxml.txt.nlp	24958351	SENT169	38	38	3	3	lapatinib	HER2	PA152241907	2064	0.999
NULL	Arthritis_Res_Ther_2012_Apr_18_14(2)_R80.nxml.txt.nlp	22513098	SENT155	19	19	1	1	hydroxychloroquine	TLR7	PA164777036	51284	0.999
NULL	Curr_Cardiol_Rev_2010_Nov_6(4)_309-324.nxml.txt.nlp	22043207	SENT204	18	18	3	3	hemin	HO-1	PA449849	3162	0.999
NULL	Ann_Hematol_2010_Sep_13_89(9)_861-871.nxml.txt.nlp	20387067	SENT169	4	4	14	14	dasatinib	IL-3	PA162372878	3562	0.999
NULL	Acta_Pharmacol_Sin_2014_Jan_9_35(1)_1-10.nxml.txt.nlp	24317012	SENT45	37	37	0	0	methotrexate	SLC19A1	PA450428	6573	0.999
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_19_2012_967573.nxml.txt.nlp	23304232	SENT49	30	30	4	4	indomethacin	MSU	PA449982	593	0.999
NULL	Int_J_Mol_Sci_2014_Jun_18_15(6)_11013-11029.nxml.txt.nlp	24945311	SENT38	7	7	16	16	celecoxib	STAT3	PA448871	6774	0.999
NULL	Br_J_Cancer_2009_May_19_100(10)_1549-1557.nxml.txt.nlp	19384296	SENT122	29	29	11	11	capecitabine	TYMS	PA448771	7298	0.999
NULL	Breast_Cancer_Res_2009_Mar_23_11(2)_R17.nxml.txt.nlp	19309506	SENT168	35	35	3	3	tamoxifen	TLE3	PA451581	7090	0.999
NULL	FEBS_Open_Bio_2013_May_10_3_225-230.nxml.txt.nlp	23772398	SENT33	19	19	4	4	cisplatin	CD9	PA449014	928	0.999
NULL	Int_J_Biol_Sci_2012_Feb_9_8(3)_310-327.nxml.txt.nlp	22355267	SENT160	37	37	4	4	simvastatin	PCSK9	PA451363	255738	0.999
NULL	J_Hematol_Oncol_2013_Jun_3_6_38.nxml.txt.nlp	23731980	SENT57	10	10	29	29	paclitaxel	HER2	PA450761	2064	0.999
NULL	Diabetologia_2014_Sep_29_57(1)_192-203.nxml.txt.nlp	24078137	SENT15	26	26	0	0	metformin	VGLUT1	PA450395	57030	0.999
NULL	Clinics_(Sao_Paulo)_2014_Jun_69(6)_438-446.nxml.txt.nlp	24964310	SENT139	20	20	4	4	denosumab	RANKL	PA166048634	8600	0.999
NULL	Mol_Cancer_2012_Jun_18_11_41.nxml.txt.nlp	22709873	SENT285	30	30	16	16	lapatinib	ZNF143	PA152241907	7702	0.999
NULL	J_Young_Pharm_2010_Jul-Sep_2(3)_326-331.nxml.txt.nlp	21042495	SENT127	10	10	22	22	lovastatin	CYP3A4	PA450272	1576	0.999
NULL	Mol_Cancer_2007_Sep_26_6_61.nxml.txt.nlp	17894897	SENT184	6	6	43	43	etoposide	ALDOA	PA449552	226	0.999
NULL	Breast_Cancer_Res_2005_Jul_20_7(5)_205-211.nxml.txt.nlp	16168139	SENT27	37	37	0	0	tamoxifen	AF-1	PA451581	3460;5710	0.999
NULL	Breast_Cancer_Res_2008_Dec_4_10(6)_R103.nxml.txt.nlp	19055788	SENT184	6	6	15	15	tamoxifen	aromatase	PA451581	1588	0.999
NULL	Cardiovasc_Diabetol_2010_Jul_27_9_31.nxml.txt.nlp	20663195	SENT74	32	32	6	6	irbesartan	FSP1	PA450084	6275;51062	0.999
NULL	J_Cancer_Prev_2013_Jun_18(2)_186-191.nxml.txt.nlp	25337545	SENT7	20	20	5	5	curcumin	p53	PA151958596	7157	0.999
NULL	Mol_Cancer_2012_Jul_25_11_47.nxml.txt.nlp	22830443	SENT195	6	6	12	12	panitumumab	EGFR	PA162373091	1956	0.999
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_O4.nxml.txt.nlp	NULL	SENT10	44	44	4	4	allopurinol	HLA-B	PA448320	3106	0.999
NULL	Oncogene_2013_Sep_26_32(39)_10_1038_onc_2012_491.nxml.txt.nlp	23108394	SENT116	44	44	7	7	epirubicin	FOXM1	PA449476	2305	0.999
NULL	Br_J_Cancer_2010_Mar_16_102(6)_1003-1009.nxml.txt.nlp	20179710	SENT120	14	14	0	0	cyclophosphamide	CYP2B6	PA449165	1555	0.999
NULL	Oncotarget_2013_Nov_24_4(12)_2186-2207.nxml.txt.nlp	24327604	SENT210	2	2	45	45	doxorubicin	LFA-1	PA449412	3683;3689	0.999
NULL	Br_J_Pharmacol_2014_Jan_23_171(2)_523-535.nxml.txt.nlp	24372553	SENT125	35	35	10	10	metformin	Bcl-2	PA450395	596	0.999
NULL	Breast_Cancer_Res_2005_Apr_4_7(4)_R422-R435.nxml.txt.nlp	15987447	SENT139	25	25	1	1	celecoxib	COX	PA448871	1351	0.999
NULL	Oncotarget_2012_Oct_20_3(10)_1068-1111.nxml.txt.nlp	23085539	SENT415	20	20	1	1	celecoxib	PDK1	PA448871	5170;5163	0.999
NULL	Acta_Pharmacol_Sin_2014_Jan_9_35(1)_1-10.nxml.txt.nlp	24317012	SENT73	13	13	0	0	cisplatin	MRP4	PA449014	10257	0.999
NULL	J_Infect_Dis_2014_Aug_15_210(4)_656-666.nxml.txt.nlp	24634497	SENT163	12	12	25	25	zileuton	TLR2	PA451955	7097	0.999
NULL	Ther_Clin_Risk_Manag_2007_Aug_3(4)_641-651.nxml.txt.nlp	18472987	SENT175	1	1	7	7	tipranavir	CYP3A4	PA163522473	1576	0.999
NULL	Mol_Cancer_2010_Apr_12_9_75.nxml.txt.nlp	20385023	SENT212	2	2	15	15	sunitinib	ABCB1	PA162372840	5243	0.999
NULL	Basic_Clin_Pharmacol_Toxicol_2013_Feb_5_112(2)_132-137.nxml.txt.nlp	22900583	SENT24	7	7	17	17	prasugrel	CYP3A	PA154410481	1574	0.999
NULL	Acta_Pharmacol_Sin_2011_Jul_13_32(7)_967-972.nxml.txt.nlp	21666702	SENT138	17	17	37	37	ticlopidine	CYP2C9	PA451686	1559	0.999
NULL	Cancer_Cell_Int_2013_Jun_17_13_61.nxml.txt.nlp	23773282	SENT235	0	0	29	29	artesunate	XIAP	PA165111697	331	0.999
NULL	Int_J_Mol_Sci_2014_Nov_17_15(11)_21229-21252.nxml.txt.nlp	25407528	SENT260	6	6	27	27	resveratrol	ACT		12;11332;9457;641455	0.999
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_105-115.nxml.txt.nlp	17912640	SENT59	19	19	31	31	lapatinib	HER2	PA152241907	2064	0.999
NULL	Oncotarget_2012_May_18_3(5)_525-534.nxml.txt.nlp	22619113	SENT132	29	29	12	12	fludarabine	AKT	PA449655	207	0.999
NULL	Pharmaceuticals_(Basel)_2013_Aug_21_6(8)_988-1038.nxml.txt.nlp	24276379	SENT477	23	23	5	5	vemurafenib	EGFR	PA165946873	1956	0.999
NULL	Cancer_Med_2012_Aug_15_1(1)_28-38.nxml.txt.nlp	23342251	SENT23	21	21	1	1	erlotinib	EGFR	PA134687924	1956	0.999
NULL	Osteoporos_Int_2013_Oct_19_24(1)_23-57.nxml.txt.nlp	23079689	SENT511	34	34	2	2	teriparatide	PTH	PA451620	5741	0.999
NULL	Genome_Biol_2011_May_25_12(5)_R46.nxml.txt.nlp	21609475	SENT131	28	28	3	3	etoposide	CCND1	PA449552	595	0.999
NULL	Mol_Neurodegener_2011_Jul_19_6_51.nxml.txt.nlp	21771318	SENT104	9	9	30	30	rosiglitazone	SOD1	PA451283	6647	0.999
NULL	Breast_Cancer_Res_2006_Nov_6_8(6)_215.nxml.txt.nlp	17096862	SENT107	4	4	33	33	lapatinib	HER2	PA152241907	2064	0.999
NULL	Genome_Med_2009_Sep_4_1(9)_83.nxml.txt.nlp	19732436	SENT295	10	10	31	31	sn-38	UGT1A		7361;54658	0.999
NULL	Biologics_2010_May_25_4_139-145.nxml.txt.nlp	20531970	SENT62	25	25	1	1	eltrombopag	TPO	PA165981594	7066;7173	0.999
NULL	Reprod_Biol_Endocrinol_2003_Oct_7_1_66.nxml.txt.nlp	14609433	SENT130	22	22	32	32	paclitaxel	PI3K	PA450761	5290	0.999
NULL	Front_Oncol_2014_Nov_5_4_281.nxml.txt.nlp	25414829	SENT103	38	38	16	16	gefitinib	EGF	PA131301952	1950	0.999
NULL	Acta_Pharmacol_Sin_2010_Jun_4_31(6)_709-717.nxml.txt.nlp	20523342	SENT140	28	28	1	1	repaglinide	IGF2BP2	PA451234	10644	0.999
NULL	Curr_Neuropharmacol_2014_Jul_12(4)_365-379.nxml.txt.nlp	25342944	SENT18	24	24	12	12	fluoxetine	5-HT2B	PA449673	3357	0.999
NULL	Oncogene_2014_Jun_5_33(23)_3033-3042.nxml.txt.nlp	23851504	SENT174	26	26	0	0	tamoxifen	AIB1	PA451581	8202	0.999
NULL	J_Oncol_2012_Aug_14_2012_408131.nxml.txt.nlp	22934112	SENT109	9	9	41	41	mitotane	CYP3A4	PA164746157	1576	0.999
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT36	19	19	2	2	lapatinib	PI3K	PA152241907	5290	0.999
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_45-53.nxml.txt.nlp	17912635	SENT32	0	0	8	8	tamoxifen	aromatase	PA451581	1588	0.999
NULL	Indian_J_Nephrol_2011_Oct-Dec_21(4)_286-288.nxml.txt.nlp	22022093	SENT67	4	4	26	26	cyclosporine	IL-2	PA449167	3558	0.999
NULL	Br_J_Cancer_2014_Jan_21_110(2)_384-391.nxml.txt.nlp	24346286	SENT136	32	32	7	7	trastuzumab	PTEN	PA451743	5728	0.999
NULL	Mol_Cancer_2004_May_4_3_14.nxml.txt.nlp	15125777	SENT46	23	23	0	0	cisplatin	CHK2	PA449014	11200	0.999
NULL	Mol_Cancer_2006_Oct_18_5_46.nxml.txt.nlp	17044945	SENT173	27	27	6	6	gemcitabine	KIT	PA449748	3815	0.999
NULL	Breast_Cancer_Res_2012_Nov_14_14(6)_R146.nxml.txt.nlp	23151593	SENT188	0	0	23	23	tamoxifen	HER2	PA451581	2064	0.999
NULL	Cancer_Med_2013_Jun_2_2(3)_325-333.nxml.txt.nlp	23930209	SENT34	3	3	23	23	everolimus	PI3K	PA164746311	5290	0.999
NULL	Core_Evid_2010_Jul_27_5_1-10.nxml.txt.nlp	20694135	SENT41	8	8	24	24	entacapone	CLE	PA164748726	51637	0.999
NULL	Br_J_Cancer_2012_Jun_5_106(12)_1997-2003.nxml.txt.nlp	22596232	SENT16	37	37	3	3	sorafenib	JNK	PA7000	5599	0.999
NULL	Arthritis_Res_Ther_2007_May_30_9(3)_212.nxml.txt.nlp	17561993	SENT167	14	14	2	2	capsaicin	TRPA1	PA448776	8989	0.999
NULL	Breast_Cancer_Res_2010_Aug_23_12(4)_R64.nxml.txt.nlp	20731819	SENT218	46	46	8	8	tamoxifen	CYP2D6	PA451581	1565	0.999
NULL	Clin_Psychopharmacol_Neurosci_2013_Dec_24_11(3)_144-151.nxml.txt.nlp	24465251	SENT39	4	4	31	31	haloperidol	IFN	PA449841	3439	0.999
NULL	Cancer_Med_2013_Aug_10_2(4)_545-552.nxml.txt.nlp	24156027	SENT27	0	0	33	33	everolimus	VEGFR	PA164746311	3791	0.999
NULL	Hum_Genomics_2009_Dec_1_4(2)_91-106.nxml.txt.nlp	20038497	SENT248	8	8	27	27	donepezil	APOE	PA449394	348	0.999
NULL	Basic_Clin_Pharmacol_Toxicol_2013_Feb_5_112(2)_132-137.nxml.txt.nlp	22900583	SENT155	9	9	43	43	ritonavir	CYP3A4	PA451260	1576	0.999
NULL	Pharmaceutics_2010_Jun_2_2(2)_258-274.nxml.txt.nlp	NULL	SENT172	2	2	20	20	risperidone	P-gp	PA451257	5243	0.999
NULL	J_Inherit_Metab_Dis_2011_Jun_23_34(3)_677-694.nxml.txt.nlp	21431622	SENT21	30	30	1	1	l-tryptophan	GCDH	PA10323	2639	0.999
NULL	Arthritis_Res_Ther_2009_Feb_23_11(1)_216.nxml.txt.nlp	19291269	SENT107	9	9	35	35	infliximab	ACR	PA452639	49	0.999
NULL	Breast_Cancer_Res_2005_Jul_20_7(5)_205-211.nxml.txt.nlp	16168139	SENT113	6	6	20	20	tamoxifen	HER2	PA451581	2064	0.999
NULL	Front_Pharmacol_2014_Nov_26_5_258.nxml.txt.nlp	25505415	SENT110	12	12	30	30	triazolam	CYP3A	PA451753	1574	0.999
NULL	BMJ_Open_2014_Feb_18_4(2)_e004289.nxml.txt.nlp	24549164	SENT126	8	8	20	20	gatifloxacin	DPD	PA449738	1806	0.999
NULL	Cancer_Manag_Res_2011_Mar_3_3_57-64.nxml.txt.nlp	21556317	SENT10	6	6	20	20	cisplatin	HER-2	PA449014	2064	0.999
NULL	Chin_J_Cancer_2011_Jan_30(1)_5-12.nxml.txt.nlp	21192840	SENT117	11	11	36	36	cetuximab	HER2	PA10040	2064	0.999
NULL	Acta_Pharmacol_Sin_2012_May_16_33(5)_682-690.nxml.txt.nlp	22504904	SENT35	0	0	36	36	celecoxib	STAT3	PA448871	6774	0.999
NULL	Breast_Cancer_Res_2004_Oct_24_6(1)_R8-R17.nxml.txt.nlp	14680495	SENT97	37	37	8	8	tamoxifen	BRCA2	PA451581	675	0.999
NULL	Ann_Surg_Oncol_2012_Aug_7_19(8)_2685-2692.nxml.txt.nlp	22396006	SENT57	26	26	7	7	cisplatin	CRT	PA449014	811	0.999
NULL	Clin_Exp_Reprod_Med_2013_Sep_30_40(3)_115-121.nxml.txt.nlp	24179868	SENT24	0	0	5	5	letrozole	aromatase	PA450196	1588	0.999
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Apr_6_5_8.nxml.txt.nlp	16600049	SENT217	0	0	31	31	tenofovir	LAM	PA10204	7249;7248	0.999
NULL	Br_J_Cancer_2013_Feb_19_108(3)_668-675.nxml.txt.nlp	23348520	SENT110	23	23	3	3	panitumumab	KRAS	PA162373091	3845	0.999
NULL	Acta_Vet_Scand_2009_Jan_22_51(1)_5.nxml.txt.nlp	19161609	SENT87	29	29	0	0	estradiol	FXI	PA449503	2160	0.999
NULL	J_Vet_Med_Sci_2014_Aug_15_76(8)_1119-1127.nxml.txt.nlp	24829081	SENT27	20	20	0	0	trypsin	PAR-1	PA451806	2011;2149	0.999
NULL	Clinicoecon_Outcomes_Res_2014_Dec_15_7_9-15.nxml.txt.nlp	25548525	SENT94	8	8	21	21	gefitinib	EGFR	PA131301952	1956	0.999
NULL	Oncologist_2010_Sep_26_15(9)_944-953.nxml.txt.nlp	20798196	SENT168	25	25	6	6	lapatinib	HER-2	PA152241907	2064	0.998
NULL	Oncotarget_2013_Nov_22_5(4)_933-943.nxml.txt.nlp	24659749	SENT55	23	23	4	4	nutlin-3	p53		7157	0.998
NULL	Reprod_Biol_Endocrinol_2003_Apr_11_1_35.nxml.txt.nlp	12747806	SENT54	1	1	26	26	estradiol	aromatase	PA449503	1588	0.998
NULL	Br_J_Clin_Pharmacol_2014_Nov_20_78(5)_1043-1049.nxml.txt.nlp	24838177	SENT169	2	2	17	17	telaprevir	CYP3A4	PA165958354	1576	0.998
NULL	Exp_Diabetes_Res_2012_Apr_17_2012_635472.nxml.txt.nlp	22577369	SENT75	20	20	2	2	exenatide	GLP-1	PA164749238	100125288	0.998
NULL	Oncotarget_2011_Mar_11_2(3)_135-164.nxml.txt.nlp	21411864	SENT413	25	25	8	8	cisplatin	PTEN	PA449014	5728	0.998
NULL	J_Thromb_Thrombolysis_2012_Feb_20_33(2)_143-153.nxml.txt.nlp	22183178	SENT60	0	0	13	13	ticagrelor	P2Y12	PA165374673	64805	0.998
NULL	J_Oncol_2011_Apr_14_2011_853931.nxml.txt.nlp	21559248	SENT30	29	29	17	17	bevacizumab	EGFR	PA130232992	1956	0.998
NULL	Mol_Cancer_2014_Jun_24_13_157.nxml.txt.nlp	24958351	SENT170	23	23	5	5	trastuzumab	PTEN	PA451743	5728	0.998
NULL	Breast_Cancer_Res_2008_Jan_20_10(1)_R7.nxml.txt.nlp	18205950	SENT201	32	32	6	6	staurosporine	derlin-1	PA165109623	79139	0.998
NULL	Arthritis_Res_Ther_2010_Jul_19_12(4)_R148.nxml.txt.nlp	20642840	SENT116	35	35	13	13	etanercept	CCL2	PA449515	6347	0.998
NULL	Diabetes_Metab_Syndr_Obes_2014_Jun_24_7_229-239.nxml.txt.nlp	25018644	SENT41	32	32	41	41	exenatide	GLP-1	PA164749238	100125288	0.998
NULL	Clin_Interv_Aging_2008_Sep_3(3)_421-430.nxml.txt.nlp	18982913	SENT227	0	0	14	14	buprenorphine	CYP3A4	PA448685	1576	0.998
NULL	Oncol_Lett_2013_Apr_1_5(4)_1331-1334.nxml.txt.nlp	23599789	SENT18	0	0	35	35	cetuximab	KRAS	PA10040	3845	0.998
NULL	Br_J_Pharmacol_2013_Jun_27_169(4)_736-747.nxml.txt.nlp	23489111	SENT161	6	6	21	21	morphine	5-HT3B	PA450550	9177	0.998
NULL	Front_Oncol_2013_Aug_5_3_195.nxml.txt.nlp	23936763	SENT207	35	35	13	13	gefitinib	EGF	PA131301952	1950	0.998
NULL	Exp_Ther_Med_2014_Jun_28_7(6)_1539-1544.nxml.txt.nlp	24926340	SENT25	20	20	5	5	tanespimycin	Hsp90	PA165291490	3320	0.998
NULL	Front_Oncol_2014_May_7_4_95.nxml.txt.nlp	24847444	SENT344	24	24	12	12	cytarabine	CD19	PA449177	930	0.998
NULL	Cardiovasc_Diabetol_2013_Mar_18_12_46.nxml.txt.nlp	23497197	SENT170	17	17	0	0	metformin	APPL1	PA450395	26060	0.998
NULL	Oncol_Rep_2012_Apr_30_27(4)_923-928.nxml.txt.nlp	22209766	SENT70	2	2	18	18	erlotinib	EGF	PA134687924	1950	0.998
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT171	4	4	19	19	tenofovir	CD4	PA10204	920	0.998
NULL	Oncol_Lett_2014_Jul_12_8(1)_17-24.nxml.txt.nlp	24959213	SENT142	13	13	4	4	cetuximab	KRAS	PA10040	3845	0.998
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_315-322.nxml.txt.nlp	20049735	SENT163	13	13	3	3	olaparib	BRCA1		672	0.998
NULL	Exp_Ther_Med_2014_Oct_24_8(4)_1092-1096.nxml.txt.nlp	25187802	SENT23	3	3	40	40	carvedilol	TLR4	PA448817	7099	0.998
NULL	Br_J_Cancer_2009_Jul_21_101(2)_312-319.nxml.txt.nlp	19568237	SENT110	31	31	3	3	pp2	FAK1		5747	0.998
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT256	37	37	15	15	lapatinib	HER3	PA152241907	2065	0.998
NULL	Inflammation_2014_Sep_5_37(1)_1-9.nxml.txt.nlp	24005897	SENT152	13	13	28	28	diclofenac	COX	PA449293	1351	0.998
NULL	Nucleic_Acids_Res_2011_Dec_31_39(22)_9536-9548.nxml.txt.nlp	21880590	SENT161	27	27	8	8	etoposide	BRCA1	PA449552	672	0.998
NULL	Int_J_Mol_Sci_2013_Aug_13_14(8)_16685-16705.nxml.txt.nlp	23945562	SENT61	6	6	21	21	zinc	MIA	PA451956	8190	0.998
NULL	Arthritis_Res_Ther_2012_Sep_24_14(5)_R200.nxml.txt.nlp	23006144	SENT168	10	10	24	24	alefacept	IL-10	PA164748040	3586	0.998
NULL	Lipids_Health_Dis_2011_Jan_18_10_8.nxml.txt.nlp	21241519	SENT117	24	24	8	8	simvastatin	SR-BI	PA451363	949	0.998
NULL	Int_J_Gen_Med_2014_Mar_3_7_143-148.nxml.txt.nlp	24623988	SENT105	19	19	8	8	buprenorphine	OST	PA448685	1650;23263	0.998
NULL	Arthritis_Res_Ther_2005_Nov_29_7(1)_R139-R148.nxml.txt.nlp	15642134	SENT30	28	28	0	0	cyclosporine	IL-15	PA449167	3600	0.998
NULL	Acta_Pharmacol_Sin_2010_Sep_23_31(9)_1223-1240.nxml.txt.nlp	20729872	SENT199	14	14	26	26	celecoxib	PC-3	PA448871	692094	0.998
NULL	Proteome_Sci_2009_Dec_21_7_45.nxml.txt.nlp	20025764	SENT173	14	14	31	31	trypsin	OASIS	PA451806	90993	0.998
NULL	Acta_Pharmacol_Sin_2013_Jun_8_34(6)_830-836.nxml.txt.nlp	23564080	SENT106	29	29	5	5	simvastatin	MCP-1	PA451363	6347	0.998
NULL	Breast_Cancer_Res_2011_Nov_1_13(6)_224.nxml.txt.nlp	22114931	SENT126	31	31	7	7	trastuzumab	HER2	PA451743	2064	0.998
NULL	Br_J_Cancer_2010_Oct_12_103(8)_1192-1200.nxml.txt.nlp	20877358	SENT190	27	27	1	1	mitomycin	BRCA2	PA450524	675	0.998
NULL	Diabetes_Care_2009_Sep_19_32(9)_1663-1668.nxml.txt.nlp	19542207	SENT117	40	40	5	5	anakinra	IL-6	PA10799	3569	0.998
NULL	Environ_Health_Perspect_2007_Jan_115(1)_A24-A26.nxml.txt.nlp	17366806	SENT86	40	40	26	26	capsaicin	TRPA1	PA448776	8989	0.998
NULL	Mol_Cancer_2006_Oct_17_5_45.nxml.txt.nlp	17044934	SENT119	17	17	23	23	resveratrol	COX		1351	0.998
NULL	Clin_Exp_Otorhinolaryngol_2012_Sep_27_5(3)_117-121.nxml.txt.nlp	22977707	SENT118	1	1	29	29	kanamycin	NKCC1	PA450137	6558	0.998
NULL	Nat_Chem_Biol_2010_Jun_2_6(6)_411-417.nxml.txt.nlp	20436487	SENT185	26	26	0	0	curcumin	COX	PA151958596	1351	0.998
NULL	Crit_Care_2011_Mar_11_15(Suppl_1)_P291.nxml.txt.nlp	NULL	SENT3	2	2	25	25	amiodarone	NIF	PA448383	6280	0.998
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1239-1245.nxml.txt.nlp	22353804	SENT97	33	33	9	9	irinotecan	TTR	PA450085	7276	0.998
NULL	J_Hypertens_2014_Dec_12_32(12)_2488-2498.nxml.txt.nlp	25144296	SENT32	0	0	12	12	candesartan	AT-1	PA448765	9197	0.998
NULL	Allergy_Asthma_Immunol_Res_2014_Jul_27_6(4)_288-295.nxml.txt.nlp	24991451	SENT74	20	20	2	2	montelukast	IL-5	PA450546	3567	0.998
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1542-1553.nxml.txt.nlp	21970874	SENT251	6	6	16	16	carboplatin	ERCC1	PA448803	2067	0.998
NULL	Acta_Pharmacol_Sin_2010_Nov_18_31(11)_1447-1453.nxml.txt.nlp	20953204	SENT146	36	36	10	10	rimonabant	PI3K	PA152407999	5290	0.998
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_3_2013_867893.nxml.txt.nlp	23690860	SENT168	13	13	0	0	metformin	AMPK	PA450395	5563	0.998
NULL	Arthritis_Res_Ther_2006_Jul_28_8(Suppl_2)_S4.nxml.txt.nlp	16899108	SENT4	27	27	0	0	tocilizumab	IL-6	PA165292659	3569	0.998
NULL	Bone_Marrow_Res_2012_Oct_18_2012_180391.nxml.txt.nlp	23119165	SENT278	11	11	25	25	alemtuzumab	NOD2	PA164783958	64127	0.998
NULL	J_Oncol_2010_Aug_24_2010_654348.nxml.txt.nlp	20871846	SENT56	35	35	7	7	anastrozole	ATAC	PA448432	6375	0.998
NULL	Biosci_Rep_2012_Dec_1_32(Pt_6)_619-629.nxml.txt.nlp	NULL	SENT96	37	37	2	2	troglitazone	PPARG	PA451799	5468	0.998
NULL	Cell_Death_Dis_2013_Sep_5_4(9)_e791.nxml.txt.nlp	24008735	SENT68	33	33	2	2	gemcitabine	PUMA	PA449748	27113	0.998
NULL	Int_J_Biol_Sci_2011_May_24_7(5)_673-684.nxml.txt.nlp	21647250	SENT40	4	4	13	13	berberine	AMPK	PA165860812	5563	0.998
NULL	J_Cell_Biol_1998_Jan_26_140(2)_335-345.nxml.txt.nlp	9442109	SENT341	28	28	7	7	chloroquine	NHE	PA448948	285335	0.998
NULL	Cancer_Metastasis_Rev_2011_Dec_20_30(3-4)_465-480.nxml.txt.nlp	22012553	SENT434	21	21	2	2	sulindac	EP4	PA451565	5734	0.998
NULL	Eur_J_Endocrinol_2011_Jan_164(1)_69-74.nxml.txt.nlp	20961967	SENT14	33	33	1	1	metformin	adiponectin	PA450395	9370	0.998
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT92	8	8	46	46	doxorubicin	B7-H1	PA449412	29126	0.998
NULL	Onco_Targets_Ther_2014_May_16_7_761-770.nxml.txt.nlp	24876785	SENT192	40	40	11	11	gefitinib	EGFR	PA131301952	1956	0.998
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT168	33	33	16	16	atorvastatin	RANKL	PA448500	8600	0.998
NULL	Exp_Diabetes_Res_2012_Oct_15_2012_465282.nxml.txt.nlp	23118742	SENT94	0	0	27	27	metformin	AMPK	PA450395	5563	0.998
NULL	Cardiovasc_J_Afr_2013_Apr_24(3)_58-65.nxml.txt.nlp	23736127	SENT167	9	9	45	45	telmisartan	AT1	PA451605	9197;185	0.998
NULL	Psychiatry_Investig_2013_Dec_16_10(4)_425-427.nxml.txt.nlp	24474994	SENT41	0	0	22	22	ziprasidone	CYP3A4	PA451974	1576	0.998
NULL	Int_J_Biol_Sci_2012_Feb_9_8(3)_310-327.nxml.txt.nlp	22355267	SENT160	37	37	24	24	simvastatin	PCSK9	PA451363	255738	0.998
NULL	Infect_Dis_Obstet_Gynecol_2008_May_29_2008_493508.nxml.txt.nlp	18528520	SENT88	15	15	4	4	estradiol	CDR1	PA449503	1038	0.998
NULL	Oncogene_2010_Sep_16_29(37)_5193-5203.nxml.txt.nlp	20581867	SENT252	9	9	16	16	trastuzumab	PI3K	PA451743	5290	0.998
NULL	Gastric_Cancer_2014_Apr_7_17(1)_1-12.nxml.txt.nlp	23563986	SENT173	34	34	3	3	trastuzumab	HER2	PA451743	2064	0.998
NULL	Diabetes_Metab_Syndr_Obes_2014_Jun_24_7_229-239.nxml.txt.nlp	25018644	SENT41	0	0	35	35	exenatide	GLP-1	PA164749238	100125288	0.998
NULL	Expert_Rev_Mol_Med_2009_May_11_e16.nxml.txt.nlp	19467172	SENT446	14	14	4	4	artesunate	NAC	PA165111697	22861	0.998
NULL	Br_J_Cancer_2012_Jan_31_106(3)_468-474.nxml.txt.nlp	22223088	SENT31	5	5	17	17	olaparib	PARP-1		25976	0.998
NULL	J_Gen_Physiol_2012_Sep_140(3)_243-244.nxml.txt.nlp	22930800	SENT30	16	16	0	0	capsaicin	TRPV1	PA448776	7442	0.998
NULL	Cell_Death_Dis_2010_Oct_21_1(10)_e86.nxml.txt.nlp	21368859	SENT63	30	30	2	2	doxorubicin	JNK	PA449412	5599	0.998
NULL	Reprod_Biol_Endocrinol_2003_Apr_28_1_39.nxml.txt.nlp	12737634	SENT182	27	27	1	1	heparin	BSP	PA449855	3381	0.998
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S31-S40.nxml.txt.nlp	20680106	SENT38	10	10	31	31	cetuximab	KRAS	PA10040	3845	0.998
NULL	Oncotarget_2013_Nov_24_4(12)_2430-2438.nxml.txt.nlp	24280348	SENT14	30	30	12	12	erlotinib	EGFR	PA134687924	1956	0.998
NULL	Indian_J_Pharmacol_2012_Sep-Oct_44(5)_624-628.nxml.txt.nlp	23112426	SENT22	5	5	23	23	nimodipine	P-gp	PA450633	5243	0.998
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT7	2	2	18	18	heparin	FGF1	PA449855	2246	0.998
NULL	Oncotarget_2013_Feb_27_4(2)_329-345.nxml.txt.nlp	23593654	SENT188	14	14	27	27	paclitaxel	CD44	PA450761	960	0.998
NULL	Mol_Cancer_2007_Jun_12_6_42.nxml.txt.nlp	17565690	SENT216	25	25	2	2	flavopiridol	p53	PA452627	7157	0.998
NULL	Biomed_Res_Int_2013_Dec_10_2013_565218.nxml.txt.nlp	24386638	SENT242	6	6	35	35	desipramine	DIO3	PA449233	1735	0.998
NULL	Onco_Targets_Ther_2014_Jun_18_7_1095-1100.nxml.txt.nlp	24971019	SENT22	30	30	1	1	lenalidomide	CS-1	PA162363968	6744;51778	0.998
NULL	Br_J_Cancer_2013_Feb_19_108(3)_668-675.nxml.txt.nlp	23348520	SENT113	17	17	9	9	cetuximab	HER2	PA10040	2064	0.998
NULL	Oncol_Lett_2013_Apr_22_5(4)_1093-1100.nxml.txt.nlp	23599746	SENT69	10	10	39	39	vincristine	P-gp	PA451879	5243	0.998
NULL	Oncol_Lett_2013_Apr_28_5(4)_1149-1154.nxml.txt.nlp	23599754	SENT123	17	17	33	33	cisplatin	Dicer	PA449014	23405	0.998
NULL	Nat_Commun_2014_Dec_8_5_5736.nxml.txt.nlp	25484020	SENT27	32	32	0	0	capsaicin	TRPA1	PA448776	8989	0.998
NULL	J_Cancer_2013_Jan_11_4(2)_117-132.nxml.txt.nlp	23386910	SENT233	16	16	30	30	vinorelbine	HER2	PA451881	2064	0.998
NULL	Acta_Pharmacol_Sin_2010_Mar_8_31(3)_382-386.nxml.txt.nlp	20140004	SENT72	39	39	6	6	pravastatin	SLCO1B1	PA451089	10599	0.998
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Jun_25_3(6)_e120.nxml.txt.nlp	24964282	SENT111	15	15	1	1	ketoconazole	CYP3A4	PA450146	1576	0.998
NULL	J_Cardiothorac_Surg_2014_Sep_17_9(1)_129.nxml.txt.nlp	NULL	SENT32	32	32	5	5	heparin	ACT	PA449855	12;11332;9457;641455	0.998
NULL	Int_J_Breast_Cancer_2011_Feb_14_2011_618757.nxml.txt.nlp	22332014	SENT149	20	20	6	6	tamoxifen	aromatase	PA451581	1588	0.998
NULL	Diabetes_Metab_Syndr_Obes_2010_May_17_3_165-172.nxml.txt.nlp	21437086	SENT29	6	6	26	26	exenatide	AMIGO	PA164749238	57463	0.998
NULL	Int_J_Cell_Biol_2012_Sep_3_2012_139573.nxml.txt.nlp	22973314	SENT160	12	12	5	5	temozolomide	CD74	PA451609	972	0.998
NULL	Allergy_2015_Jan_28_70(1)_80-89.nxml.txt.nlp	25331546	SENT170	1	1	32	32	clodronate	IL-4	PA10239	3565	0.998
NULL	Cancer_Imaging_2005_Jan_17_5(1)_1-7.nxml.txt.nlp	16154810	SENT57	0	0	24	24	choline	FDG	PA448976	23583	0.998
NULL	Mol_Cancer_2012_Jul_25_11_46.nxml.txt.nlp	22830422	SENT134	36	36	5	5	rolipram	AKT	PA153906323	207	0.998
NULL	Tuberc_Respir_Dis_(Seoul)_2013_Mar_29_74(3)_129-133.nxml.txt.nlp	23579627	SENT66	31	31	9	9	gefitinib	EGFR	PA131301952	1956	0.998
NULL	Nat_Commun_2013_4_10_1038_ncomms3472.nxml.txt.nlp	24045463	SENT99	34	34	1	1	propranolol	FDG	PA451145	23583	0.998
NULL	J_Oncol_2010_Jan_3_2010_709678.nxml.txt.nlp	21274259	SENT29	5	5	43	43	erlotinib	EGFR	PA134687924	1956	0.998
NULL	J_Oncol_2012_Oct_22_2012_391629.nxml.txt.nlp	23133451	SENT136	0	0	31	31	sorafenib	BRAF	PA7000	673	0.998
NULL	Cell_Biochem_Biophys_2013_May_24_66(1)_53-63.nxml.txt.nlp	22918821	SENT272	23	23	8	8	lubiprostone	ClC-2	PA164777012	1181	0.998
NULL	Allergy_Asthma_Clin_Immunol_2010_Mar_17_6(1)_5.nxml.txt.nlp	20236545	SENT78	33	33	7	7	cyclosporine	IL-13	PA449167	3596	0.998
NULL	J_Bras_Pneumol_2013_Jan-Feb_39(1)_5-15.nxml.txt.nlp	23503480	SENT59	35	35	23	23	doxycycline	LAM	PA449415	7249;7248	0.998
NULL	Eur_J_Clin_Pharmacol_2010_Nov_29_66(11)_1131-1136.nxml.txt.nlp	20669013	SENT29	12	12	28	28	voriconazole	CYP3A4	PA10233	1576	0.998
NULL	ISRN_Cardiol_2013_Nov_6_2013_478597.nxml.txt.nlp	24307952	SENT104	17	17	1	1	simvastatin	NNT	PA451363	23530	0.998
NULL	Oncotarget_2014_Jun_27_5(13)_4694-4708.nxml.txt.nlp	25051361	SENT320	8	8	0	0	fludarabine	MEC1	PA449655	545	0.998
NULL	Clin_Pharmacokinet_2014_Jun_27_53(8)_741-751.nxml.txt.nlp	24968986	SENT250	6	6	42	42	docetaxel	OATP1B1	PA449383	10599	0.998
NULL	Front_Immunol_2013_Nov_7_4_360.nxml.txt.nlp	24223576	SENT164	0	0	13	13	imiquimod	TLR8	PA449972	51311	0.998
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT256	37	37	21	21	lapatinib	HRG	PA152241907	3084;3273	0.998
NULL	Leukemia_2014_Apr_14_28(4)_961-964.nxml.txt.nlp	24418991	SENT2	0	0	32	32	nilotinib	P-gp	PA165958345	5243	0.998
NULL	EMBO_Mol_Med_2009_Apr_1(1)_66-78.nxml.txt.nlp	20049704	SENT33	10	10	18	18	everolimus	HIF-1	PA164746311	29072	0.998
NULL	Hum_Genomics_2011_Oct_1_5(6)_577-622.nxml.txt.nlp	22155605	SENT626	17	17	5	5	gefitinib	EGFR	PA131301952	1956	0.998
NULL	Clin_Med_Insights_Cardiol_2013_Aug_11_7_127-140.nxml.txt.nlp	23997577	SENT66	4	4	20	20	dronedarone	NCX	PA153619853	3196	0.998
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT29	1	1	33	33	lapatinib	HER2	PA152241907	2064	0.998
NULL	Front_Genet_2012_Nov_12_3_235.nxml.txt.nlp	23162568	SENT187	3	3	17	17	methamphetamine	CYP2D6	PA450403	1565	0.998
NULL	J_Cell_Sci_2014_May_1_127(9)_2106-2119.nxml.txt.nlp	24569881	SENT382	19	19	2	2	isoproterenol	SUR1	PA450121	6833	0.998
NULL	Br_J_Clin_Pharmacol_2014_Nov_20_78(5)_1050-1057.nxml.txt.nlp	24962564	SENT191	0	0	17	17	ketoconazole	MDR1	PA450146	5243	0.998
NULL	Environ_Health_Perspect_2006_Apr_13_114(4)_494-499.nxml.txt.nlp	16581535	SENT36	0	0	21	21	chlorzoxazone	CYP2E1	PA448971	1571	0.998
NULL	J_Hematol_Oncol_2010_Oct_27_3_42.nxml.txt.nlp	20979652	SENT177	19	19	5	5	gemcitabine	EGFR	PA449748	1956	0.998
NULL	Neural_Regen_Res_2013_Mar_25_8(9)_825-832.nxml.txt.nlp	25206730	SENT22	6	6	11	11	isoflurane	P2X7	PA450106	5027	0.998
NULL	J_Immunol_Methods_2009_Jan_1_340(1)_11-24.nxml.txt.nlp	18929568	SENT128	38	38	4	4	staurosporine	PP2	PA165109623	4888	0.998
NULL	Ann_Hematol_2010_Sep_13_89(9)_861-871.nxml.txt.nlp	20387067	SENT169	4	4	16	16	dasatinib	TPO	PA162372878	7066;7173	0.998
NULL	Pharmaceuticals_(Basel)_2012_Jan_5_5(1)_79-93.nxml.txt.nlp	24288044	SENT13	0	0	33	33	trastuzumab	HER2	PA451743	2064	0.998
NULL	Viruses_2014_May_23_6(5)_2155-2185.nxml.txt.nlp	24859341	SENT155	18	18	2	2	doxorubicin	p38	PA449412	10598;1432;7965	0.998
NULL	eLife_2013_Oct_29_2_e01236.nxml.txt.nlp	24171104	SENT465	12	12	3	3	bortezomib	PERK	PA10252	9451	0.998
NULL	Cancers_(Basel)_2010_Sep_17_2(3)_1717-1730.nxml.txt.nlp	24281184	SENT150	12	12	3	3	capecitabine	DPD	PA448771	1806	0.998
NULL	Blood_Cancer_J_2013_Sep_13_3(9)_e146.nxml.txt.nlp	24036945	SENT11	30	30	1	1	ribavirin	AKT	PA451241	207	0.998
NULL	Breast_Cancer_Res_2013_Oct_18_15(5)_R97.nxml.txt.nlp	24135425	SENT20	26	26	8	8	trastuzumab	aromatase	PA451743	1588	0.998
NULL	Genome_Med_2009_Oct_27_1(10)_99.nxml.txt.nlp	19863774	SENT93	34	34	6	6	gemcitabine	BRCA1	PA449748	672	0.998
NULL	Breast_Cancer_Res_2009_Oct_28_11(5)_211.nxml.txt.nlp	19889200	SENT240	25	25	3	3	letrozole	HER2	PA450196	2064	0.998
NULL	Breast_Cancer_Res_2011_Feb_23_13(1)_203.nxml.txt.nlp	21392408	SENT95	15	15	41	41	tamoxifen	aromatase	PA451581	1588	0.998
NULL	Biomed_Res_Int_2013_Jul_28_2013_627907.nxml.txt.nlp	23984390	SENT176	27	27	8	8	clozapine	CYP1A2	PA449061	1544	0.998
NULL	J_Antimicrob_Chemother_2014_Dec_20_69(12)_3329-3334.nxml.txt.nlp	25147095	SENT137	35	35	10	10	nevirapine	CD4	PA450616	920	0.998
NULL	Allergy_Asthma_Immunol_Res_2014_Nov_19_6(6)_548-557.nxml.txt.nlp	25374755	SENT121	26	26	4	4	lovastatin	MUC5AC	PA450272	4586	0.998
NULL	Onco_Targets_Ther_2014_Sep_9_7_1571-1582.nxml.txt.nlp	25228815	SENT155	32	32	6	6	sunitinib	VEGFR2	PA162372840	3791	0.998
NULL	Case_Rep_Dermatol_2012_Sep_16_4(3)_256-260.nxml.txt.nlp	23275770	SENT89	18	18	26	26	pyridostigmine	OMG	PA451185	4974	0.998
NULL	Mol_Cancer_2012_Dec_12_11_91.nxml.txt.nlp	23234355	SENT29	0	0	22	22	erlotinib	EGFR	PA134687924	1956	0.998
NULL	Case_Rep_Oncol_Med_2014_Jun_11_2014_826584.nxml.txt.nlp	25018886	SENT63	22	22	6	6	imatinib	EGFR	PA10804	1956	0.998
NULL	Onco_Targets_Ther_2014_Jul_31_7_1367-1373.nxml.txt.nlp	25114575	SENT18	0	0	12	12	trastuzumab	HER2	PA451743	2064	0.998
NULL	Cell_Cycle_2013_Apr_1_12(7)_1020.nxml.txt.nlp	23511169	SENT28	34	34	6	6	bortezomib	p53	PA10252	7157	0.998
NULL	eLife_2013_Nov_5_2_e00969.nxml.txt.nlp	24192036	SENT104	18	18	2	2	vemurafenib	MCL1	PA165946873	4170	0.998
NULL	Indian_J_Pharmacol_2012_Sep-Oct_44(5)_624-628.nxml.txt.nlp	23112426	SENT22	5	5	21	21	nimodipine	CYP3A4	PA450633	1576	0.998
NULL	Bioinformation_2012_Jan_6_8(1)_13-19.nxml.txt.nlp	22359429	SENT140	10	10	44	44	curcumin	MRP1	PA151958596	4437	0.998
NULL	Clin_Epigenetics_2011_Jul_16_2(2)_411-416.nxml.txt.nlp	22704352	SENT79	2	2	26	26	decitabine	CD25	PA164749631	3669;3559	0.998
NULL	J_Bras_Pneumol_2013_Jan-Feb_39(1)_5-15.nxml.txt.nlp	23503480	SENT188	5	5	24	24	doxycycline	LAM	PA449415	7249;7248	0.998
NULL	Int_J_Mol_Sci_2014_Oct_23_15(10)_19265-19280.nxml.txt.nlp	25342321	SENT161	3	3	11	11	sc-560	COX		1351	0.998
NULL	Oncol_Lett_2014_Jun_28_7(6)_1747-1754.nxml.txt.nlp	24932227	SENT103	21	21	0	0	trypsin	SPINK1	PA451806	6690	0.998
NULL	Brief_Bioinform_2013_Jul_9_14(4)_491-505.nxml.txt.nlp	22877768	SENT112	23	23	5	5	warfarin	VKORC1	PA451906	79001	0.998
NULL	Oncol_Lett_2013_Apr_22_5(4)_1093-1100.nxml.txt.nlp	23599746	SENT69	16	16	39	39	ifosfamide	P-gp	PA449964	5243	0.998
NULL	Br_J_Cancer_1997_75(9)_1279-1283.nxml.txt.nlp	9155046	SENT14	13	13	30	30	losartan	AT2	PA450268	186	0.998
NULL	Patient_Prefer_Adherence_2013_Mar_27_7_245-258.nxml.txt.nlp	23569364	SENT95	30	30	4	4	tamoxifen	aromatase	PA451581	1588	0.998
NULL	Cancer_Res_Treat_2013_Sep_30_45(3)_178-185.nxml.txt.nlp	24155676	SENT31	17	17	30	30	gefitinib	EGFR	PA131301952	1956	0.998
NULL	Balkan_J_Med_Genet_2011_Jun_25_14(1)_25-30.nxml.txt.nlp	24052699	SENT82	10	10	22	22	lamotrigine	MRP1	PA450164	4437	0.998
NULL	Br_J_Cancer_2006_Dec_4_95(11)_1483-1489.nxml.txt.nlp	17106442	SENT32	5	5	12	12	gefitinib	EGFR	PA131301952	1956	0.998
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT53	6	6	19	19	lapatinib	HER2	PA152241907	2064	0.998
NULL	J_Carcinog_2013_Dec_31_12_22.nxml.txt.nlp	24574860	SENT252	12	12	5	5	vemurafenib	BRAF	PA165946873	673	0.998
NULL	Exp_Neurobiol_2013_Mar_31_22(1)_45-50.nxml.txt.nlp	23585722	SENT124	13	13	1	1	fluoxetine	EPO	PA449673	7076;8288;2056	0.998
NULL	Breast_Cancer_Res_2005_Nov_21_7(6)_R1153-R1158.nxml.txt.nlp	16457695	SENT69	19	19	29	29	tamoxifen	BRCA2	PA451581	675	0.998
NULL	Curr_Pharm_Des_2008_Oct_14(28)_2983-2998.nxml.txt.nlp	18991714	SENT72	21	21	8	8	vatalanib	VEGFR	PA7001	3791	0.998
NULL	Acta_Pharmacol_Sin_2009_Mar_5_30(3)_307-313.nxml.txt.nlp	19262554	SENT24	3	3	21	21	losartan	AT1	PA450268	9197;185	0.998
NULL	Eur_J_Med_Res_2009_Mar_17_14(3)_136-138.nxml.txt.nlp	19380285	SENT42	2	2	21	21	etravirine	San	PA166014703	80218	0.998
NULL	Breast_Cancer_Res_2000_Apr_13_2(3)_E007.nxml.txt.nlp	NULL	SENT102	9	9	16	16	tamoxifen	p53	PA451581	7157	0.998
NULL	Front_Pharmacol_2014_May_30_5_132.nxml.txt.nlp	24910615	SENT140	15	15	3	3	risperidone	PDE7B	PA451257	27115	0.998
NULL	J_Biol_2009_Apr_15_8(3)_30.nxml.txt.nlp	19435483	SENT39	22	22	6	6	imatinib	NQO2	PA10804	4835	0.998
NULL	Br_J_Cancer_2012_Nov_6_107(10)_1714-1721.nxml.txt.nlp	23073173	SENT111	9	9	23	23	docetaxel	RUNX2	PA449383	860	0.998
NULL	Mol_Biol_Cell_2013_Sep_1_24(17)_2714-2726.nxml.txt.nlp	23885127	SENT374	8	8	27	27	trypsin	TMT	PA451806	25823	0.998
NULL	Oncol_Lett_2014_Mar_16_7(3)_871-877.nxml.txt.nlp	24527095	SENT25	2	2	14	14	paclitaxel	TLR4	PA450761	7099	0.998
NULL	J_Exp_Med_1998_Jun_1_187(11)_1885-1892.nxml.txt.nlp	9607928	SENT159	6	6	22	22	thalidomide	CD4	PA451644	920	0.998
NULL	Comput_Math_Methods_Med_2013_Sep_24_2013_340678.nxml.txt.nlp	24174989	SENT177	29	29	35	35	imatinib	TGFBR1	PA10804	7046	0.998
NULL	Brain_Res_2012_Feb_3_1436(C)_111-121.nxml.txt.nlp	22200378	SENT138	0	0	19	19	pentamidine	P-gp	PA450850	5243	0.998
NULL	J_Hematol_Oncol_2013_Jan_17_6_8.nxml.txt.nlp	23327547	SENT45	38	38	9	9	sulindac	JNK1	PA451565	5599	0.998
NULL	Aging_(Albany_NY)_2014_Jan_14_6(1)_70-81.nxml.txt.nlp	24429382	SENT83	26	26	20	20	bleomycin	WRN	PA448645	7486	0.998
NULL	Front_Oncol_2014_Mar_25_4_54.nxml.txt.nlp	24724051	SENT421	39	39	26	26	nilotinib	LYN	PA165958345	4067	0.998
NULL	J_Oncol_2010_Jun_27_2010_757908.nxml.txt.nlp	20652061	SENT138	4	4	31	31	creatine	HIF-1	PA164778930	29072	0.998
NULL	Breast_Cancer_Res_2011_Jun_29_13(3)_R70.nxml.txt.nlp	21707964	SENT185	42	42	1	1	tamoxifen	14-3-3	PA451581	10971	0.998
NULL	Am_J_Transplant_2012_Aug_12(8)_2008-2016.nxml.txt.nlp	22500984	SENT172	30	30	9	9	cyclosporine	FOXP3	PA449167	50943	0.998
NULL	Oxid_Med_Cell_Longev_2013_Apr_21_2013_412576.nxml.txt.nlp	23710286	SENT112	4	4	10	10	curcumin	NRF2	PA151958596	2551;4780	0.998
NULL	FEBS_Open_Bio_2014_Mar_19_4_301-309.nxml.txt.nlp	24918042	SENT191	1	1	46	46	gentamicin	HBA	PA449753	85340	0.998
NULL	Scientifica_(Cairo)_2012_Sep_3_2012_757890.nxml.txt.nlp	24278738	SENT93	5	5	10	10	curcumin	NOD2	PA151958596	64127	0.998
NULL	Core_Evid_2011_Feb_8_6_23-29.nxml.txt.nlp	21468240	SENT98	1	1	12	12	plerixafor	CD34	PA165958410	947	0.998
NULL	Oncogene_2013_Sep_26_32(39)_10_1038_onc_2012_491.nxml.txt.nlp	23108394	SENT97	29	29	5	5	epirubicin	FOXM1	PA449476	2305	0.998
NULL	Infect_Dis_Rep_2010_Feb_2_2(1)_e1.nxml.txt.nlp	24470884	SENT130	0	0	27	27	tigecycline	CABP	PA164746412	6277	0.998
NULL	Br_J_Cancer_2006_Dec_4_95(11)_1483-1489.nxml.txt.nlp	17106442	SENT64	0	0	26	26	gefitinib	EGFR	PA131301952	1956	0.998
NULL	Clin_Ophthalmol_2011_Apr_18_5_495-502.nxml.txt.nlp	21573098	SENT119	30	30	10	10	gatifloxacin	BAK	PA449738	578	0.998
NULL	Breast_Cancer_Res_2009_Oct_28_11(5)_211.nxml.txt.nlp	19889200	SENT240	11	11	34	34	tamoxifen	HER2	PA451581	2064	0.998
NULL	Psychiatry_Investig_2011_Dec_14_8(4)_381-383.nxml.txt.nlp	22216051	SENT55	1	1	22	22	aripiprazole	IFN	PA10026	3439	0.998
NULL	Mol_Cancer_2014_Jan_15_13_9.nxml.txt.nlp	24428911	SENT28	0	0	28	28	trastuzumab	HER2	PA451743	2064	0.998
NULL	Clin_Ophthalmol_2009_Jun_2_3_199-210.nxml.txt.nlp	19668566	SENT53	6	6	28	28	bromfenac	COX	PA448670	1351	0.998
NULL	Open_Cardiovasc_Med_J_2010_Jul_20_4_151-156.nxml.txt.nlp	20922049	SENT55	3	3	37	37	heparin	ACT	PA449855	12;11332;9457;641455	0.998
NULL	Hum_Genomics_2009_Dec_1_4(2)_91-106.nxml.txt.nlp	20038497	SENT120	46	46	7	7	donepezil	BCHE	PA449394	590	0.998
NULL	Cell_Commun_Signal_2009_Aug_13_7_19.nxml.txt.nlp	19678929	SENT47	7	7	35	35	panitumumab	EGFR	PA162373091	1956	0.998
NULL	Acta_Pharmacol_Sin_2010_Feb_5_31(2)_184-190.nxml.txt.nlp	20139901	SENT26	5	5	23	23	metformin	OCT1	PA450395	5451;6580	0.998
NULL	Cancer_Med_2012_Aug_15_1(1)_28-38.nxml.txt.nlp	23342251	SENT23	19	19	1	1	gefitinib	EGFR	PA131301952	1956	0.998
NULL	Curr_Chem_Genomics_2010_Mar_19_4_9-18.nxml.txt.nlp	20502647	SENT167	29	29	4	4	triciribine	DM1	PA165958661	338023;1760;28509	0.998
NULL	Hum_Genomics_2009_Dec_1_4(2)_91-106.nxml.txt.nlp	20038497	SENT145	11	11	33	33	tacrine	APOE	PA451576	348	0.998
NULL	Exp_Ther_Med_2013_Nov_13_6(5)_1317-1321.nxml.txt.nlp	24223665	SENT68	29	29	20	20	cisplatin	CD133	PA449014	8842	0.998
NULL	Br_J_Cancer_2009_Jul_21_101(2)_312-319.nxml.txt.nlp	19568237	SENT109	27	27	7	7	pp2	PAX1		5075	0.998
NULL	Curr_Gerontol_Geriatr_Res_2012_Mar_4_2012_361218.nxml.txt.nlp	22474448	SENT145	5	5	30	30	estradiol	HSD17B1	PA449503	3292	0.998
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT87	14	14	21	21	trastuzumab	HER2	PA451743	2064	0.998
NULL	Breast_Cancer_Res_2011_Mar_24_13(2)_R32.nxml.txt.nlp	21435239	SENT258	25	25	0	0	curcumin	ARNT	PA151958596	405	0.998
NULL	Curr_Hepat_Rep_2011_Mar_24_10(1)_33-40.nxml.txt.nlp	21423320	SENT152	17	17	2	2	ribavirin	ITPA	PA451241	3704	0.998
NULL	Curr_Gerontol_Geriatr_Res_2012_Mar_4_2012_361218.nxml.txt.nlp	22474448	SENT145	5	5	28	28	estradiol	aromatase	PA449503	1588	0.998
NULL	Int_J_Mol_Imaging_2011_Oct_26_2011_874585.nxml.txt.nlp	21490735	SENT149	43	43	11	11	doxorubicin	FDG	PA449412	23583	0.998
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Feb_15_5_3.nxml.txt.nlp	16480505	SENT177	2	2	24	24	cyclosporine	CYP3A4	PA449167	1576	0.998
NULL	Mol_Cancer_2009_Nov_10_8_99.nxml.txt.nlp	19903356	SENT112	35	35	5	5	imatinib	IGFBP3	PA10804	3486	0.998
NULL	Cancer_Metastasis_Rev_2011_Jun_23_30(2)_185-197.nxml.txt.nlp	21340664	SENT179	21	21	41	41	gemcitabine	RAD51	PA449748	5888	0.998
NULL	Diagn_Pathol_2006_Aug_15_1_19.nxml.txt.nlp	16911776	SENT54	24	24	9	9	gefitinib	HER2	PA131301952	2064	0.998
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Dec_10_3(12)_e151.nxml.txt.nlp	25494035	SENT110	11	11	32	32	pravastatin	OATP1B3	PA451089	28234	0.998
NULL	Oncol_Lett_2014_May_4_7(5)_1352-1362.nxml.txt.nlp	24765137	SENT70	38	38	8	8	doxorubicin	GSTP1	PA449412	2950	0.998
NULL	J_Med_Chem_2014_Feb_13_57(3)_578-599.nxml.txt.nlp	24417566	SENT162	0	0	37	37	flavopiridol	CDK4	PA452627	1019	0.998
NULL	Breast_Cancer_Res_Treat_2013_Jan_6_137(1)_167-174.nxml.txt.nlp	23129173	SENT191	32	32	5	5	letrozole	CYP19A1	PA450196	1588	0.998
NULL	F1000Prime_Rep_2014_Aug_1_6_68.nxml.txt.nlp	25165567	SENT107	0	0	15	15	clomipramine	CYP1A2	PA449048	1544	0.998
NULL	J_Biomed_Sci_2013_Jul_2_20(1)_46.nxml.txt.nlp	23815815	SENT226	4	4	14	14	indomethacin	EPAC	PA449982	10411	0.998
NULL	Nat_Commun_2014_Nov_25_5_5437.nxml.txt.nlp	25421715	SENT181	7	7	30	30	doxorubicin	NPM1	PA449412	4869	0.998
NULL	Diabetes_Care_2013_Aug_17_36(Suppl_2)_S292-S300.nxml.txt.nlp	23882062	SENT226	3	3	29	29	pioglitazone	GLP-1	PA450970	100125288	0.998
NULL	Int_J_Surg_Oncol_2011_Jun_28_2011_154673.nxml.txt.nlp	22312493	SENT58	32	32	5	5	mitomycin	BRCA2	PA450524	675	0.998
NULL	J_Cell_Biol_2001_Nov_12_155(4)_661-674.nxml.txt.nlp	11706054	SENT231	30	30	0	0	lovastatin	ADAM10	PA450272	102	0.998
NULL	Front_Oncol_2013_Sep_11_3_229.nxml.txt.nlp	24062982	SENT55	42	42	1	1	vemurafenib	STAT3	PA165946873	6774	0.998
NULL	Chemother_Res_Pract_2012_Aug_29_2012_817297.nxml.txt.nlp	22970367	SENT150	22	22	5	5	erlotinib	EGFR	PA134687924	1956	0.998
NULL	Acta_Histochem_Cytochem_2012_Apr_26_45(2)_139-146.nxml.txt.nlp	22685356	SENT110	29	29	1	1	forskolin	AQP2	PA146096022	359	0.998
NULL	Acta_Orthop_2009_Jun_5_80(3)_357-362.nxml.txt.nlp	19421912	SENT142	2	2	12	12	hydrocortisone	MMP2	PA449905	4313	0.998
NULL	Front_Oncol_2014_Sep_23_4_264.nxml.txt.nlp	25295231	SENT132	40	40	6	6	lenalidomide	TP53	PA162363968	7157	0.998
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2012_Oct_10_1(10)_e10.nxml.txt.nlp	23887362	SENT95	2	2	16	16	zidovudine	UGT2B7	PA451954	7364	0.998
NULL	Int_J_Biol_Sci_2014_Jun_10_10(7)_654-663.nxml.txt.nlp	25013375	SENT101	5	5	21	21	nelfinavir	PI3K	PA450606	5290	0.998
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT100	16	16	2	2	tenofovir	ABCC4	PA10204	10257	0.998
NULL	Cancer_Med_2014_Oct_2_3(5)_1256-1265.nxml.txt.nlp	24890382	SENT20	0	0	39	39	trastuzumab	HER2	PA451743	2064	0.998
NULL	Stroke_Res_Treat_2010_Jul_11_2010_468412.nxml.txt.nlp	20721332	SENT29	22	22	1	1	warfarin	SPAF	PA451906	166378	0.998
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT629	7	7	14	14	trastuzumab	PI3K	PA451743	5290	0.998
NULL	Core_Evid_2011_Mar_17_6_31-42.nxml.txt.nlp	21468241	SENT143	7	7	21	21	ticagrelor	CYP2C19	PA165374673	1557	0.998
NULL	Ann_Lab_Med_2014_Jul_19_34(4)_321-324.nxml.txt.nlp	24982839	SENT50	18	18	3	3	ciprofloxacin	DST	PA449009	667	0.998
NULL	Sci_Rep_2014_Nov_28_4_7237.nxml.txt.nlp	25429875	SENT123	11	11	41	41	hesperidin	JNK	PA449867	5599	0.998
NULL	Acta_Pharmacol_Sin_2013_Jul_5_34(7)_870-879.nxml.txt.nlp	23624759	SENT95	5	5	32	32	gefitinib	EGFR	PA131301952	1956	0.998
NULL	Oncol_Rep_2013_Jun_22_29(6)_2479-2485.nxml.txt.nlp	23525656	SENT139	34	34	11	11	paclitaxel	P-gp	PA450761	5243	0.998
NULL	Cancer_Imaging_2010_Sep_29_10(1A)_S51-S53.nxml.txt.nlp	20880772	SENT60	3	3	38	38	olaparib	BRCA1		672	0.998
NULL	Diabetes_Care_2013_Jul_12_36(7)_1913-1918.nxml.txt.nlp	23359361	SENT14	25	25	1	1	sitagliptin	GLP-1	PA164748978	100125288	0.998
NULL	J_Cell_Biol_2001_Feb_19_152(4)_683-692.nxml.txt.nlp	11266460	SENT151	36	36	4	4	trypsin	DHFR	PA451806	1719	0.998
NULL	CNS_Drugs_2012_Dec_13_26(12)_1033-1049.nxml.txt.nlp	23192413	SENT184	16	16	26	26	trazodone	5-HT2A	PA451744	3356	0.998
NULL	Ecancermedicalscience_2009_Oct_29_3_157.nxml.txt.nlp	22276018	SENT71	17	17	37	37	tamoxifen	HER3	PA451581	2065	0.998
NULL	Cancer_Manag_Res_2012_Aug_8_4_243-252.nxml.txt.nlp	22904646	SENT137	9	9	31	31	vemurafenib	BRAF	PA165946873	673	0.998
NULL	Oncotarget_2013_Nov_24_4(12)_2186-2207.nxml.txt.nlp	24327604	SENT236	20	20	3	3	doxorubicin	survivin	PA449412	332	0.998
NULL	Mol_Clin_Oncol_2013_Jul_27_1(4)_711-715.nxml.txt.nlp	24649233	SENT87	0	0	30	30	gefitinib	EGFR	PA131301952	1956	0.998
NULL	Braz_J_Med_Biol_Res_2014_Mar_21_47(4)_273-278.nxml.txt.nlp	24676475	SENT126	17	17	30	30	doxorubicin	CIAPIN1	PA449412	57019	0.998
NULL	Cancer_Manag_Res_2013_Jun_7_5_91-101.nxml.txt.nlp	23785245	SENT53	33	33	25	25	carboplatin	EGFR	PA448803	1956	0.998
NULL	Emerg_Infect_Dis_2012_Mar_18(3)_392-400.nxml.txt.nlp	22377231	SENT184	16	16	1	1	metronidazole	NAP1	PA450484	4673;64343;9476;3576;51531	0.998
NULL	Front_Neurosci_2014_May_22_8_113.nxml.txt.nlp	24904259	SENT218	29	29	1	1	amantadine	5-HT1A	PA448360	3350	0.998
NULL	Oncogene_2010_Mar_18_29(11)_1622-1632.nxml.txt.nlp	19966853	SENT33	12	12	0	0	etoposide	FGF1	PA449552	2246	0.998
NULL	Oncotarget_2013_Nov_15_5(6)_1458-1474.nxml.txt.nlp	24681547	SENT242	8	8	34	34	celecoxib	CDH11	PA448871	1009	0.998
NULL	Breast_Cancer_Res_2005_Aug_5_7(5)_212-214.nxml.txt.nlp	16168140	SENT27	8	8	31	31	celecoxib	PI3K	PA448871	5290	0.998
NULL	J_Biol_Chem_2010_Aug_20_285(34)_25928-25940.nxml.txt.nlp	20547488	SENT251	17	17	1	1	cisplatin	JNK	PA449014	5599	0.998
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT6	1	1	30	30	cetuximab	KRAS	PA10040	3845	0.998
NULL	Br_J_Cancer_2014_Jan_21_110(2)_510-519.nxml.txt.nlp	24327015	SENT154	28	28	9	9	cisplatin	NDC80	PA449014	10403	0.998
NULL	Int_J_Biol_Sci_2014_Feb_20_10(3)_268-277.nxml.txt.nlp	24644425	SENT128	3	3	18	18	metformin	EEF2	PA450395	1938	0.998
NULL	Eur_J_Clin_Pharmacol_2007_Apr_21_63(4)_335-343.nxml.txt.nlp	17318526	SENT234	2	2	42	42	sulfamethoxazole	CYP2C8	PA451544	1558	0.998
NULL	Case_Rep_Dermatol_2013_Mar_12_5(1)_69-72.nxml.txt.nlp	23626542	SENT18	0	0	25	25	vemurafenib	BRAF	PA165946873	673	0.998
NULL	Br_J_Cancer_2013_Aug_6_109(3)_686-693.nxml.txt.nlp	23839492	SENT23	31	31	3	3	pazopanib	IL-8	PA165291492	3576	0.998
NULL	Br_J_Cancer_2011_Dec_6_105(12)_1920-1926.nxml.txt.nlp	22095222	SENT78	25	25	2	2	gefitinib	EGFR	PA131301952	1956	0.998
NULL	Br_J_Haematol_2014_Mar_6_164(6)_759-766.nxml.txt.nlp	24387053	SENT174	37	37	3	3	eculizumab	ADAMTS13	PA164776637	11093	0.998
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT218	7	7	29	29	erlotinib	AMPK	PA134687924	5563	0.998
NULL	Case_Reports_Immunol_2014_Jul_23_2014_804761.nxml.txt.nlp	25379310	SENT111	23	23	5	5	praziquantel	IL-17	PA164764583	3605	0.998
NULL	J_Oncol_2012_Mar_28_2012_853797.nxml.txt.nlp	22545053	SENT188	9	9	37	37	doxazosin	TRAMP	PA449407	8718;23471;9189	0.998
NULL	Allergy_Asthma_Clin_Immunol_2010_Mar_17_6(1)_5.nxml.txt.nlp	20236545	SENT78	33	33	5	5	cyclosporine	IL-5	PA449167	3567	0.998
NULL	Diabetes_Care_2012_Jan_9_35(1)_4-11.nxml.txt.nlp	22040840	SENT166	28	28	13	13	exenatide	GLP-1	PA164749238	100125288	0.998
NULL	Mol_Cells_2014_Jun_30_37(6)_441-448.nxml.txt.nlp	24850149	SENT156	3	3	23	23	amitriptyline	NLRP3	PA448385	114548	0.998
NULL	Clinics_(Sao_Paulo)_2014_Feb_69(2)_145-149.nxml.txt.nlp	24519206	SENT143	13	13	23	23	candesartan	AT-1	PA448765	9197	0.998
NULL	Orphanet_J_Rare_Dis_2014_Dec_10_9(1)_200.nxml.txt.nlp	NULL	SENT94	15	15	29	29	teriparatide	HCS	PA451620	3141;54205	0.998
NULL	Oncogene_2010_Jun_24_29(25)_3639-3649.nxml.txt.nlp	20453883	SENT38	33	33	5	5	ethanol	HEXIM1	PA448073	10614	0.998
NULL	J_Korean_Med_Sci_2011_Jul_20_26(7)_893-899.nxml.txt.nlp	21738342	SENT95	19	19	0	0	genistein	CD97	PA165109660	976	0.998
NULL	Case_Rep_Oncol_2013_May_18_6(2)_275-279.nxml.txt.nlp	23741223	SENT34	23	23	2	2	panitumumab	KRAS	PA162373091	3845	0.998
NULL	Nucleic_Acids_Res_2014_Jan_1_42(1)_643-660.nxml.txt.nlp	24097436	SENT184	37	37	1	1	doxycycline	DIS3	PA449415	22894	0.998
NULL	Br_J_Cancer_2013_Jan_15_108(1)_82-90.nxml.txt.nlp	23321512	SENT144	15	15	4	4	paclitaxel	TUBB3	PA450761	10381	0.998
NULL	J_Cardiothorac_Surg_2014_May_9_9_81.nxml.txt.nlp	24885948	SENT154	20	20	8	8	sorafenib	GATA4	PA7000	2626	0.998
NULL	Br_J_Cancer_2013_Feb_5_108(2)_342-350.nxml.txt.nlp	23322205	SENT170	21	21	5	5	bortezomib	HDAC6	PA10252	10013	0.998
NULL	Environ_Health_Perspect_2005_Oct_14_113(10)_1330-1335.nxml.txt.nlp	16203242	SENT157	26	26	8	8	arsenite	MLC	PA452638	23209	0.998
NULL	Oncol_Rep_2013_Sep_1_30(3)_1045-1052.nxml.txt.nlp	23817662	SENT19	24	24	5	5	gefitinib	EGFR	PA131301952	1956	0.998
NULL	J_Hematol_Oncol_2009_Feb_23_2_9.nxml.txt.nlp	19236713	SENT310	0	0	42	42	sorafenib	SHARP	PA7000	23013	0.998
NULL	J_RNAi_Gene_Silencing_2009_Mar_9_5(1)_321-330.nxml.txt.nlp	19771229	SENT23	39	39	15	15	gemcitabine	RRM2	PA449748	6241	0.998
NULL	Crit_Care_2004_Oct_27_8(6)_R474-R482.nxml.txt.nlp	15566594	SENT36	0	0	12	12	lornoxicam	PGD2	PA165958395	27306	0.998
NULL	Oncotarget_2013_Feb_27_4(2)_329-345.nxml.txt.nlp	23593654	SENT65	0	0	18	18	disulfiram	CD44	PA449376	960	0.998
NULL	Oncotarget_2014_Aug_8_5(17)_7902-7916.nxml.txt.nlp	25277203	SENT155	8	8	24	24	erlotinib	EGFR	PA134687924	1956	0.998
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1046.nxml.txt.nlp	24503538	SENT12	23	23	4	4	oxaliplatin	FGFR4	PA131285527	2264	0.998
NULL	Oncotarget_2014_Jun_1_5(13)_4868-4880.nxml.txt.nlp	24947902	SENT32	0	0	24	24	afatinib	HER2	PA165981154	2064	0.998
NULL	Oncoimmunology_2013_Aug_1_2(8)_e25218.nxml.txt.nlp	24167759	SENT20	37	37	13	13	vemurafenib	CD14	PA165946873	929	0.998
NULL	J_Adv_Pract_Oncol_2013_Mar_1_Mar-Apr_4(2)_118-122.nxml.txt.nlp	25031991	SENT88	5	5	15	15	diltiazem	CYP3A4	PA449334	1576	0.998
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_79-96.nxml.txt.nlp	19305789	SENT393	44	44	12	12	capsaicin	TRPV1	PA448776	7442	0.998
NULL	Cancer_Manag_Res_2014_Sep_10_6_349-356.nxml.txt.nlp	25228821	SENT98	26	26	4	4	vemurafenib	BRAF	PA165946873	673	0.998
NULL	J_Hematol_Oncol_2011_Sep_9_4_35.nxml.txt.nlp	21906310	SENT237	0	0	30	30	gefitinib	EGFR	PA131301952	1956	0.998
NULL	Clin_Psychopharmacol_Neurosci_2014_Aug_12_12(2)_94-110.nxml.txt.nlp	25191500	SENT65	22	22	2	2	haloperidol	DARPP-32	PA449841	84152	0.998
NULL	J_Int_AIDS_Soc_2013_Feb_25_16(1)_10_7448_IAS_16_1_18472.nxml.txt.nlp	23443042	SENT47	23	23	1	1	zidovudine	CD4	PA451954	920	0.998
NULL	Insights_Imaging_2011_Sep_9_2(6)_679-698.nxml.txt.nlp	22347986	SENT99	8	8	24	24	propranolol	FDG	PA451145	23583	0.998
NULL	Mol_Cell_Biol_2013_Oct_33(20)_4041-4050.nxml.txt.nlp	23959798	SENT148	34	34	3	3	hydroxyurea	CTR1	PA449942	1317	0.998
NULL	Int_J_Mol_Sci_2014_Sep_30_15(10)_17686-17704.nxml.txt.nlp	25272226	SENT82	43	43	23	23	cetuximab	EGFR	PA10040	1956	0.998
NULL	J_Hematol_Oncol_2009_Apr_22_2_18.nxml.txt.nlp	19386128	SENT111	40	40	14	14	cetuximab	KRAS	PA10040	3845	0.998
NULL	Cancer_Metastasis_Rev_2014_Dec_28_33(1)_161-171.nxml.txt.nlp	24375389	SENT175	8	8	31	31	docetaxel	CHFR	PA449383	55743	0.998
NULL	Cancer_Med_2014_Dec_13_3(6)_1579-1594.nxml.txt.nlp	25124282	SENT146	19	19	3	3	cisplatin	DNA-PKcs	PA449014	5591	0.998
NULL	Br_J_Cancer_2009_May_19_100(10)_1549-1557.nxml.txt.nlp	19384296	SENT122	29	29	5	5	capecitabine	MTHFR	PA448771	4524	0.998
NULL	Clin_Sci_(Lond)_2009_Apr_1_116(Pt_8)_607-620.nxml.txt.nlp	19275766	SENT225	22	22	9	9	fluvastatin	AMPK	PA449688	5563	0.998
NULL	J_Cancer_2013_Sep_10_4(8)_614-625.nxml.txt.nlp	24155773	SENT132	13	13	0	0	bortezomib	CRM1	PA10252	7514	0.998
NULL	Br_J_Cancer_2012_Sep_4_107(6)_947-955.nxml.txt.nlp	22892392	SENT16	28	28	5	5	tamoxifen	BCAR4	PA451581	400500	0.998
NULL	Case_Rep_Hematol_2012_Apr_1_2012_396395.nxml.txt.nlp	22937327	SENT83	27	27	2	2	paclitaxel	IL-6	PA450761	3569	0.998
NULL	Eur_J_Neurosci_2011_Jul_34(2)_213-220.nxml.txt.nlp	21749490	SENT231	2	2	33	33	nifedipine	P2X4	PA450631	5025	0.998
NULL	Clin_Transl_Allergy_2014_Mar_14_4(Suppl_1)_O4.nxml.txt.nlp	NULL	SENT13	25	25	4	4	montelukast	IP-10	PA450546	3627	0.998
NULL	Breast_Cancer_Res_Treat_2013_Jun_5_139(3)_649-655.nxml.txt.nlp	23736997	SENT134	29	29	13	13	tamoxifen	CYP2C19	PA451581	1557	0.998
NULL	Diabetes_Care_2008_Nov_31(11)_2169-2176.nxml.txt.nlp	18678611	SENT25	29	29	4	4	metformin	CB1	PA450395	1268	0.998
NULL	Oncoimmunology_2012_May_1_1(3)_326-333.nxml.txt.nlp	22737608	SENT72	7	7	42	42	daclizumab	CD25	PA164764446	3669;3559	0.998
NULL	Indian_Dermatol_Online_J_2010_Jul-Dec_1(1)_14-17.nxml.txt.nlp	23130185	SENT7	6	6	25	25	imatinib	EGFR	PA10804	1956	0.998
NULL	Clinics_(Sao_Paulo)_2011_Dec_66(12)_2121-2124.nxml.txt.nlp	22189739	SENT24	8	8	16	16	curcumin	p53	PA151958596	7157	0.998
NULL	Front_Oncol_2013_Sep_9_3_235.nxml.txt.nlp	24058902	SENT65	28	28	9	9	gefitinib	BIM	PA131301952	10018	0.998
NULL	J_Infect_Dis_2012_Feb_15_205(4)_680-683.nxml.txt.nlp	22194628	SENT32	18	18	34	34	primaquine	G6PD	PA451103	2539	0.998
NULL	Inflamm_Res_2010_Sep_26_59(9)_699-709.nxml.txt.nlp	20339899	SENT29	31	31	19	19	thrombin	PAR3	PA451674	56288;2151	0.998
NULL	J_Thromb_Haemost_2011_Oct_9(10)_2050-2056.nxml.txt.nlp	21794076	SENT11	16	16	26	26	prasugrel	ADP	PA154410481	23038	0.998
NULL	Aging_(Albany_NY)_2010_Mar_18_2(3)_160-165.nxml.txt.nlp	20378935	SENT25	35	35	16	16	doxorubicin	p53	PA449412	7157	0.998
NULL	Acta_Pharmacol_Sin_2010_Sep_16_31(9)_1075-1084.nxml.txt.nlp	20711221	SENT132	40	40	4	4	phenobarbital	AMPK	PA450911	5563	0.998
NULL	Iran_J_Neurol_2013_12(4)_129-135.nxml.txt.nlp	24250922	SENT34	17	17	0	0	trypsin	PAR-1	PA451806	2011;2149	0.998
NULL	Mol_Cancer_2014_Jun_24_13_157.nxml.txt.nlp	24958351	SENT169	38	38	5	5	lapatinib	EGFR	PA152241907	1956	0.998
NULL	Mol_Med_Rep_2015_Jan_20_11(1)_37-42.nxml.txt.nlp	25333459	SENT28	6	6	41	41	tacrolimus	IL-2	PA451578	3558	0.998
NULL	Breast_Cancer_Res_2010_Aug_9_12(4)_R62.nxml.txt.nlp	20696059	SENT3	17	17	0	0	trastuzumab	HER2	PA451743	2064	0.998
NULL	Curr_Med_Chem_2011_Dec_18(35)_5424-5429.nxml.txt.nlp	22087835	SENT149	33	33	10	10	doxorubicin	Bcl-2	PA449412	596	0.998
NULL	Br_J_Cancer_2004_May_17_90(10)_2032-2041.nxml.txt.nlp	15138490	SENT232	5	5	11	11	trastuzumab	HER-2	PA451743	2064	0.998
NULL	J_Oncol_2010_Jun_27_2010_757908.nxml.txt.nlp	20652061	SENT138	10	10	31	31	taurine	HIF-1	PA451590	29072	0.998
NULL	Cancer_Cell_Int_2012_Jun_7_12_25.nxml.txt.nlp	22676581	SENT163	22	22	0	0	tamoxifen	EKLF	PA451581	10661	0.998
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT43	28	28	4	4	pemetrexed	UNG	PA10810	7374	0.998
NULL	Cell_Commun_Signal_2013_Jan_11_11_2.nxml.txt.nlp	23305203	SENT137	26	26	4	4	forskolin	TIMAP	PA146096022	26051	0.998
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S31-S40.nxml.txt.nlp	20680106	SENT61	8	8	14	14	cetuximab	BRAF	PA10040	673	0.998
NULL	J_Headache_Pain_2013_Jan_30_14(1)_6.nxml.txt.nlp	23565828	SENT180	44	44	4	4	gentamicin	PTGDS	PA449753	5730	0.998
NULL	Indian_J_Nucl_Med_2013_Dec_28(Suppl_1)_S16-S20.nxml.txt.nlp	NULL	SENT108	0	0	31	31	tinidazole	GIT	PA10813	5034	0.998
NULL	Clin_Psychopharmacol_Neurosci_2014_Aug_12_12(2)_94-110.nxml.txt.nlp	25191500	SENT65	24	24	2	2	clozapine	DARPP-32	PA449061	84152	0.998
NULL	Oncol_Lett_2013_Sep_15_6(3)_648-654.nxml.txt.nlp	24137384	SENT37	27	27	4	4	cisplatin	ERCC1	PA449014	2067	0.998
NULL	Clin_Med_Insights_Cardiol_2011_Oct_6_5_103-119.nxml.txt.nlp	22084608	SENT39	0	0	19	19	dronedarone	CYP2D6	PA153619853	1565	0.998
NULL	EMBO_Mol_Med_2009_Apr_1(1)_66-78.nxml.txt.nlp	20049704	SENT33	7	7	18	18	trastuzumab	HIF-1	PA451743	29072	0.998
NULL	Indian_J_Nephrol_2012_Sep-Oct_22(5)_374-376.nxml.txt.nlp	23326050	SENT56	33	33	18	18	meropenem	ISPD	PA164764445	729920	0.998
NULL	Oncogene_2013_Oct_10_32(41)_4903-4912.nxml.txt.nlp	23208499	SENT73	35	35	7	7	fulvestrant	ORF1	PA164747170	54806;51517	0.998
NULL	Core_Evid_2008_Jun_3(1)_31-43.nxml.txt.nlp	20694082	SENT286	1	1	20	20	conivaptan	CYP3A4	PA164742939	1576	0.998
NULL	Cancer_Metastasis_Rev_2011_Dec_20_30(3-4)_465-480.nxml.txt.nlp	22012553	SENT434	19	19	2	2	troglitazone	EP4	PA451799	5734	0.998
NULL	Acta_Vet_Scand_2005_Dec_31_46(4)_249-256.nxml.txt.nlp	16398336	SENT94	10	10	30	30	vasopressin	ACTH	PA451858	5443	0.998
NULL	Clin_Interv_Aging_2015_Jan_6_10_157-174.nxml.txt.nlp	25609933	SENT160	5	5	42	42	fulvestrant	aromatase	PA164747170	1588	0.998
NULL	Mol_Cancer_2008_Mar_6_7_24.nxml.txt.nlp	18325101	SENT20	4	4	38	38	cisplatin	FANCD2	PA449014	2177	0.998
NULL	Core_Evid_2010_Oct_22_5_91-105.nxml.txt.nlp	21468365	SENT72	6	6	25	25	rosuvastatin	CYP3A4	PA134308647	1576	0.998
NULL	Cancer_Med_2014_Dec_13_3(6)_1579-1594.nxml.txt.nlp	25124282	SENT150	20	20	0	0	cisplatin	DNA-PKcs	PA449014	5591	0.998
NULL	Aging_(Albany_NY)_2009_Jun_22_1(6)_529-541.nxml.txt.nlp	20157536	SENT147	36	36	14	14	resveratrol	AMPK		5563	0.998
NULL	Arthritis_Res_Ther_2012_Dec_3_14(6)_R262.nxml.txt.nlp	23206933	SENT221	32	32	2	2	tocilizumab	IL-6	PA165292659	3569	0.998
NULL	Clin_Med_Pathol_2008_Jul_28_1_83-91.nxml.txt.nlp	21876656	SENT168	32	32	1	1	saxagliptin	GLP-1	PA165958362	100125288	0.998
NULL	Daru_2013_Jan_11_21(1)_7.nxml.txt.nlp	23351604	SENT26	4	4	11	11	metformin	BCS	PA450395	617	0.998
NULL	Br_J_Haematol_2014_Feb_16_164(4)_469-480.nxml.txt.nlp	24372186	SENT235	40	40	9	9	primaquine	G6PD	PA451103	2539	0.998
NULL	J_Geriatr_Cardiol_2013_Jun_10(2)_151-158.nxml.txt.nlp	23888175	SENT157	24	24	6	6	rosuvastatin	AT1	PA134308647	9197;185	0.998
NULL	Biology_(Basel)_2012_Dec_31_2(1)_40-63.nxml.txt.nlp	24832651	SENT153	34	34	5	5	mitomycin	PALB2	PA450524	79728	0.998
NULL	FEBS_Open_Bio_2012_Nov_30_3_30-34.nxml.txt.nlp	23772371	SENT25	34	34	3	3	glucosamine	FGF2	PA164747613	2247;2258	0.998
NULL	J_Mol_Psychiatry_2013_Nov_4_1(1)_19.nxml.txt.nlp	25408910	SENT84	13	13	0	0	olanzapine	DRD5	PA450688	1816	0.998
NULL	Front_Oncol_2013_Apr_23_3_86.nxml.txt.nlp	23630663	SENT168	16	16	32	32	lapatinib	ERBB2	PA152241907	2064	0.998
NULL	Front_Neurosci_2014_May_22_8_113.nxml.txt.nlp	24904259	SENT148	0	0	29	29	topiramate	GluK1	PA451728	2897	0.998
NULL	Clin_Epigenetics_2011_Jun_14_2(2)_151-169.nxml.txt.nlp	22704335	SENT387	19	19	1	1	pargyline	LSD1	PA450797	23028	0.998
NULL	Br_J_Cancer_2014_Jan_21_110(2)_510-519.nxml.txt.nlp	24327015	SENT154	28	28	5	5	cisplatin	PLK1	PA449014	5347	0.998
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S279-S284.nxml.txt.nlp	21525469	SENT131	8	8	37	37	exenatide	GLP-1	PA164749238	100125288	0.998
NULL	Oncol_Lett_2013_Apr_22_5(4)_1093-1100.nxml.txt.nlp	23599746	SENT69	14	14	39	39	flutamide	P-gp	PA449685	5243	0.998
NULL	Breast_Cancer_Res_Treat_2013_Aug_20_141(1)_43-53.nxml.txt.nlp	23959396	SENT239	6	6	13	13	trastuzumab	PI3K	PA451743	5290	0.998
NULL	J_Adv_Pract_Oncol_2013_Jul_1_Jul-Aug_4(4)_263-268.nxml.txt.nlp	25032007	SENT41	3	3	30	30	temsirolimus	CYP3A4	PA164746890	1576	0.998
NULL	Breast_Cancer_Res_2009_Jun_16_11(3)_R35.nxml.txt.nlp	19531217	SENT25	34	34	5	5	tamoxifen	aromatase	PA451581	1588	0.998
NULL	Int_J_Mol_Imaging_2011_Oct_26_2011_874585.nxml.txt.nlp	21490735	SENT149	41	41	11	11	tamoxifen	FDG	PA451581	23583	0.998
NULL	Front_Oncol_2013_Sep_11_3_229.nxml.txt.nlp	24062982	SENT55	42	42	13	13	vemurafenib	STAT3	PA165946873	6774	0.998
NULL	Front_Oncol_2014_Sep_29_4_251.nxml.txt.nlp	25325012	SENT238	33	33	3	3	pemetrexed	TYMS	PA10810	7298	0.998
NULL	Cancer_Cell_Int_2009_Sep_10_9_25.nxml.txt.nlp	19744341	SENT180	28	28	1	1	glucosamine	survivin	PA164747613	332	0.998
NULL	J_Oncol_2010_Jan_14_2010_740472.nxml.txt.nlp	20130818	SENT116	0	0	18	18	gefitinib	EGF	PA131301952	1950	0.998
NULL	J_Invest_Dermatol_2013_Jun_14_133(6)_1541-1549.nxml.txt.nlp	23407395	SENT122	15	15	3	3	imiquimod	CXCL1	PA449972	2919	0.998
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT6	3	3	30	30	panitumumab	KRAS	PA162373091	3845	0.998
NULL	Arch_Drug_Inf_2011_Mar_4(1)_1-9.nxml.txt.nlp	21572514	SENT21	9	9	34	34	ciprofloxacin	P-gp	PA449009	5243	0.998
NULL	Arthritis_Res_Ther_2011_Mar_24_13(2)_R51.nxml.txt.nlp	21435232	SENT222	32	32	5	5	infliximab	TWEAK	PA452639	8742	0.998
NULL	J_Neuroinflammation_2011_Feb_4_8_10.nxml.txt.nlp	21294877	SENT26	11	11	32	32	capsaicin	TRPV1	PA448776	7442	0.998
NULL	J_Lipid_Res_2015_Jan_56(1)_109-121.nxml.txt.nlp	25421061	SENT358	26	26	3	3	lipase	G0S2	PA450239	50486	0.998
NULL	Exp_Ther_Med_2013_Nov_13_6(5)_1317-1321.nxml.txt.nlp	24223665	SENT68	29	29	9	9	cisplatin	CD133	PA449014	8842	0.998
NULL	Patient_Prefer_Adherence_2014_Apr_8_8_463-471.nxml.txt.nlp	24748775	SENT126	1	1	37	37	denosumab	RANKL	PA166048634	8600	0.998
NULL	Diabetes_Metab_Syndr_Obes_2010_May_17_3_155-163.nxml.txt.nlp	21437085	SENT59	0	0	16	16	liraglutide	GLP-1	PA165958364	100125288	0.998
NULL	Int_J_Hypertens_2012_Sep_22_2012_915057.nxml.txt.nlp	21961055	SENT269	35	35	3	3	isoproterenol	CTRL	PA450121	1506	0.998
NULL	Core_Evid_2009_Jun_15_4_83-92.nxml.txt.nlp	20694067	SENT45	17	17	1	1	conivaptan	AVP	PA164742939	114548;551	0.998
NULL	Diagn_Pathol_2006_Aug_15_1_19.nxml.txt.nlp	16911776	SENT54	31	31	9	9	gefitinib	HER2	PA131301952	2064	0.998
NULL	Environ_Health_Perspect_2004_Nov_28_112(15)_1481-1487.nxml.txt.nlp	15531431	SENT95	0	0	11	11	pp2	PI3K		5290	0.998
NULL	J_Biol_Chem_2010_Aug_20_285(34)_25928-25940.nxml.txt.nlp	20547488	SENT25	40	40	4	4	cisplatin	p38	PA449014	10598;1432;7965	0.998
NULL	Front_Genet_2013_Aug_30_4_166.nxml.txt.nlp	24009623	SENT199	32	32	6	6	everolimus	ABCC1	PA164746311	4363	0.998
NULL	Cell_Cycle_2013_Apr_1_12(7)_1020.nxml.txt.nlp	23511169	SENT21	6	6	29	29	bortezomib	p53	PA10252	7157	0.998
NULL	Adv_Hematol_2012_Jul_24_2012_513702.nxml.txt.nlp	22888354	SENT93	4	4	15	15	lenalidomide	IL-2	PA162363968	3558	0.998
NULL	Onco_Targets_Ther_2014_Mar_5_7_375-385.nxml.txt.nlp	24623980	SENT42	3	3	38	38	crizotinib	KIT	PA165946122	3815	0.998
NULL	J_Immunother_Cancer_2014_Jul_15_2_24.nxml.txt.nlp	25089198	SENT106	11	11	3	3	erlotinib	PD-L1	PA134687924	29126	0.998
NULL	Case_Rep_Infect_Dis_2013_Oct_8_2013_693480.nxml.txt.nlp	24223316	SENT122	0	0	30	30	fluconazole	CYP3A4	PA449653	1576	0.998
NULL	Pharmaceuticals_(Basel)_2013_Aug_6_6(8)_929-959.nxml.txt.nlp	24276377	SENT109	11	11	0	0	cisplatin	CXCL8	PA449014	3576	0.998
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Aug_27_6_145-150.nxml.txt.nlp	25249759	SENT25	45	45	14	14	exemestane	aromatase	PA449563	1588	0.998
NULL	Cardiovasc_Drugs_Ther_2013_Jul_26_27(6)_521-530.nxml.txt.nlp	23887740	SENT157	22	22	5	5	clopidogrel	CD62P	PA449053	6403	0.998
NULL	Channels_(Austin)_2010_Jan_1_4(1)_22-41.nxml.txt.nlp	19934650	SENT418	1	1	40	40	quinidine	Slo3	PA451209	157855	0.998
NULL	J_Exp_Clin_Cancer_Res_2009_Jul_10_28(1)_99.nxml.txt.nlp	19591692	SENT30	0	0	18	18	tariquidar	ABCB1		5243	0.998
NULL	J_Clin_Biochem_Nutr_2011_Mar_10_48(2)_161-166.nxml.txt.nlp	21373270	SENT30	6	6	21	21	curcumin	HO-1	PA151958596	3162	0.998
NULL	Osteoporos_Int_2013_May_4_24(10)_2659-2670.nxml.txt.nlp	23644877	SENT268	0	0	18	18	metformin	RANKL	PA450395	8600	0.998
NULL	Gastric_Cancer_2013_Jul_12_16(3)_345-354.nxml.txt.nlp	22968820	SENT142	45	45	10	10	oxaliplatin	PMS2	PA131285527	5395	0.998
NULL	Clin_Interv_Aging_2014_Aug_28_9_1437-1452.nxml.txt.nlp	25210448	SENT60	6	6	47	47	tamoxifen	SRC1	PA451581	8648	0.998
NULL	J_Oncol_2010_Dec_28_2010_414676.nxml.txt.nlp	20066160	SENT118	0	0	28	28	canertinib	EGF	PA134687925	1950	0.998
NULL	Biologics_2009_Jul_13_3_289-301.nxml.txt.nlp	19707416	SENT83	43	43	7	7	trastuzumab	HER2	PA451743	2064	0.998
NULL	Ther_Clin_Risk_Manag_2006_Mar_2(1)_87-98.nxml.txt.nlp	18360584	SENT209	10	10	1	1	bevacizumab	EGFR	PA130232992	1956	0.998
NULL	J_Carcinog_2011_Dec_8_10_32.nxml.txt.nlp	22279417	SENT117	38	38	2	2	tamoxifen	EPO	PA451581	7076;8288;2056	0.998
NULL	Cancer_Metastasis_Rev_2011_Dec_20_30(3-4)_465-480.nxml.txt.nlp	22012553	SENT434	24	24	2	2	indomethacin	EP4	PA449982	5734	0.998
NULL	Cell_Death_Dis_2012_Nov_15_3(11)_e422.nxml.txt.nlp	23152058	SENT89	33	33	3	3	cisplatin	ZNF143	PA449014	7702	0.998
NULL	Drugs_R_D_2013_Mar_22_13(1)_53-61.nxml.txt.nlp	23519656	SENT168	1	1	9	9	guanfacine	CYP3A4	PA449825	1576	0.998
NULL	J_Cancer_2013_Jan_11_4(2)_117-132.nxml.txt.nlp	23386910	SENT85	0	0	24	24	pertuzumab	HER2		2064	0.998
NULL	Oncogene_2013_Sep_26_32(39)_10_1038_onc_2012_491.nxml.txt.nlp	23108394	SENT27	19	19	4	4	cisplatin	FOXM1	PA449014	2305	0.998
NULL	Ther_Clin_Risk_Manag_2006_Mar_2(1)_87-98.nxml.txt.nlp	18360584	SENT74	0	0	15	15	sorafenib	BRAF	PA7000	673	0.998
NULL	Front_Oncol_2014_Apr_17_4_78.nxml.txt.nlp	24860780	SENT141	42	42	34	34	panitumumab	KRAS	PA162373091	3845	0.998
NULL	Br_J_Cancer_2009_Oct_20_101(8)_1253-1260.nxml.txt.nlp	19755984	SENT126	29	29	4	4	tamoxifen	HER-2	PA451581	2064	0.998
NULL	Mol_Cancer_2009_Dec_10_8_118.nxml.txt.nlp	20003259	SENT108	19	19	3	3	imatinib	ERM	PA10804	2119	0.998
NULL	Crit_Care_2007_Dec_21_11(6)_181.nxml.txt.nlp	18190727	SENT51	48	48	1	1	heparin	EPO	PA449855	7076;8288;2056	0.998
NULL	Breast_Cancer_Res_2010_Oct_22_12(Suppl_2)_S2.nxml.txt.nlp	21050423	SENT107	36	36	3	3	doxorubicin	p53	PA449412	7157	0.998
NULL	Int_J_Surg_Oncol_2012_May_17_2012_406830.nxml.txt.nlp	22675625	SENT50	4	4	15	15	cetuximab	KRAS	PA10040	3845	0.998
NULL	Curr_Med_Chem_2011_Dec_18(35)_5424-5429.nxml.txt.nlp	22087835	SENT149	33	33	15	15	doxorubicin	c-IAP1	PA449412	329	0.998
NULL	Acta_Pharmacol_Sin_2010_Nov_18_31(11)_1447-1453.nxml.txt.nlp	20953204	SENT120	30	30	13	13	rimonabant	CB1	PA152407999	1268	0.998
NULL	Oncoimmunology_2014_May_29_3_e28925.nxml.txt.nlp	25083322	SENT40	32	32	5	5	dasatinib	CD4	PA162372878	920	0.998
NULL	Mol_Immunol_2009_Mar_46(6)_1149-1162.nxml.txt.nlp	19100624	SENT218	16	16	41	41	nystatin	C5L2	PA450666	27202	0.998
NULL	Cell_Death_Dis_2013_Oct_3_4(10)_e827.nxml.txt.nlp	24091670	SENT120	24	24	5	5	nilotinib	PI3K	PA165958345	5290	0.998
NULL	Cancer_Cell_Int_2013_Jun_17_13_61.nxml.txt.nlp	23773282	SENT235	0	0	17	17	artesunate	TRAIL	PA165111697	8743	0.998
NULL	Respir_Med_Case_Rep_2013_Apr_24_9_8-10.nxml.txt.nlp	NULL	SENT118	22	22	0	0	gefitinib	EGF	PA131301952	1950	0.998
NULL	Acta_Pharmacol_Sin_2010_Mar_8_31(3)_382-386.nxml.txt.nlp	20140004	SENT72	17	17	6	6	pravastatin	SLCO1B1	PA451089	10599	0.997
NULL	J_Physiol_2009_Oct_15_587(Pt_20)_4769-4783.nxml.txt.nlp	19703964	SENT320	3	3	22	22	halothane	TASK	PA449845	3777	0.997
NULL	Int_J_Mol_Imaging_2011_Oct_26_2011_874585.nxml.txt.nlp	21490735	SENT25	0	0	30	30	tamoxifen	aromatase	PA451581	1588	0.997
NULL	Hum_Genomics_Proteomics_2010_Aug_3_2010_159761.nxml.txt.nlp	20981231	SENT238	36	36	13	13	lithium	PLCG1	PA450243	5335	0.997
NULL	F1000Res_2013_Oct_3_2_202.nxml.txt.nlp	24795806	SENT41	28	28	1	1	panitumumab	EGFR	PA162373091	1956	0.997
NULL	Cancer_Med_2014_Apr_27_3(2)_245-251.nxml.txt.nlp	24464861	SENT120	13	13	38	38	metformin	HIF1	PA450395	3091	0.997
NULL	Oncogene_2013_Sep_5_32(36)_4252-4263.nxml.txt.nlp	23045288	SENT291	18	18	4	4	cisplatin	CD49f	PA449014	3655	0.997
NULL	Breast_Cancer_Res_2005_Jul_20_7(5)_205-211.nxml.txt.nlp	16168139	SENT27	37	37	13	13	tamoxifen	AF-1	PA451581	3460;5710	0.997
NULL	FASEB_J_2009_Feb_23(2)_575-585.nxml.txt.nlp	18957574	SENT332	29	29	2	2	oxygen	L11	PA450744	90861;6135	0.997
NULL	Clin_Drug_Investig_2015_Dec_4_35_45-51.nxml.txt.nlp	25471740	SENT146	34	34	6	6	rosiglitazone	CYP3A4	PA451283	1576	0.997
NULL	Allergy_Asthma_Clin_Immunol_2010_Mar_17_6(1)_5.nxml.txt.nlp	20236545	SENT78	33	33	3	3	cyclosporine	IL-4	PA449167	3565	0.997
NULL	Diabetes_Metab_Syndr_Obes_2010_Dec_6_3_421-429.nxml.txt.nlp	21437112	SENT43	9	9	36	36	curcumin	STZ	PA151958596	6484	0.997
NULL	Breast_Cancer_Res_Treat_2007_Dec_27_106(2)_161-170.nxml.txt.nlp	17260092	SENT20	12	12	2	2	anastrozole	aromatase	PA448432	1588	0.997
NULL	Arthritis_Res_Ther_2007_Mar_3_9(2)_R23.nxml.txt.nlp	17335581	SENT127	6	6	29	29	sulfasalazine	NAT2	PA451547	10;81539	0.997
NULL	Cancers_(Basel)_2014_Aug_12_6(3)_1631-1669.nxml.txt.nlp	25119536	SENT414	3	3	21	21	bortezomib	MPN	PA10252	83886	0.997
NULL	Breast_Cancer_Res_2013_Oct_18_15(5)_R97.nxml.txt.nlp	24135425	SENT20	28	28	8	8	lapatinib	aromatase	PA152241907	1588	0.997
NULL	Cancers_(Basel)_2014_Sep_5_6(3)_1769-1792.nxml.txt.nlp	25198391	SENT100	23	23	6	6	tamoxifen	HER2	PA451581	2064	0.997
NULL	Eur_J_Clin_Pharmacol_2012_Jan_8_68(1)_29-37.nxml.txt.nlp	21739267	SENT28	3	3	21	21	fluvoxamine	CYP2D6	PA449690	1565	0.997
NULL	J_Res_Pharm_Pract_2013_Apr-Jun_2(2)_70-74.nxml.txt.nlp	24991607	SENT13	24	24	2	2	levofloxacin	CEA	PA450214	5670;1087	0.997
NULL	J_Biol_Chem_2013_Nov_22_288(47)_34217-34229.nxml.txt.nlp	24106270	SENT262	30	30	4	4	thrombin	RhoG	PA451674	391	0.997
NULL	Arch_Drug_Inf_2011_Mar_4(1)_1-9.nxml.txt.nlp	21572514	SENT171	9	9	21	21	ciprofloxacin	OAT3	PA449009	9376	0.997
NULL	Case_Rep_Oncol_Med_2013_Sep_26_2013_234391.nxml.txt.nlp	24191208	SENT14	18	18	7	7	lapatinib	HER-2	PA152241907	2064	0.997
NULL	Chemother_Res_Pract_2011_Sep_25_2011_730360.nxml.txt.nlp	22295205	SENT213	8	8	36	36	trastuzumab	HER2	PA451743	2064	0.997
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT265	5	5	17	17	methotrexate	MLH1	PA450428	4292	0.997
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT182	28	28	5	5	cimetidine	SLC22A2	PA449001	6582	0.997
NULL	Case_Rep_Rheumatol_2011_Dec_15_2011_185657.nxml.txt.nlp	22937439	SENT58	22	22	7	7	etanercept	TNF-alpha	PA449515	7124	0.997
NULL	Adv_Appl_Bioinforma_Chem_2008_Oct_30_1_85-98.nxml.txt.nlp	21918608	SENT80	39	39	6	6	bortezomib	SPARC	PA10252	6678	0.997
NULL	Clin_Pharmacol_2012_Feb_20_4_13-20.nxml.txt.nlp	22427735	SENT58	30	30	4	4	clopidogrel	PON1	PA449053	5444	0.997
NULL	J_Korean_Med_Sci_2010_Oct_17_25(10)_1427-1430.nxml.txt.nlp	20890421	SENT22	18	18	3	3	atazanavir	UGT1A1	PA10251	54658	0.997
NULL	Oncotarget_2014_Jun_8_5(13)_5040-5053.nxml.txt.nlp	24970815	SENT90	18	18	4	4	cisplatin	LOX	PA449014	4015	0.997
NULL	Biomed_Res_Int_2014_May_19_2014_456037.nxml.txt.nlp	24967371	SENT254	9	9	26	26	bortezomib	HDAC6	PA10252	10013	0.997
NULL	Clinics_(Sao_Paulo)_2010_Jan_65(1)_29-34.nxml.txt.nlp	20126343	SENT141	32	32	6	6	ropivacaine	LPSB	PA451271	8991	0.997
NULL	Br_J_Cancer_2009_May_5_100(9)_1444-1451.nxml.txt.nlp	19352387	SENT160	22	22	2	2	gemcitabine	CXCR4	PA449748	7852	0.997
NULL	Chemother_Res_Pract_2012_Aug_29_2012_817297.nxml.txt.nlp	22970367	SENT168	34	34	2	2	erlotinib	EGFR	PA134687924	1956	0.997
NULL	Hum_Genomics_2008_Sep_1_3(1)_7-16.nxml.txt.nlp	19129086	SENT163	20	20	4	4	pioglitazone	CYP2C8	PA450970	1558	0.997
NULL	Cancer_Cell_Int_2010_Jan_21_10_2.nxml.txt.nlp	20142997	SENT199	41	41	16	16	doxorubicin	PLAU	PA449412	5328	0.997
NULL	Cell_Cycle_2012_Dec_15_11(24)_4661-4672.nxml.txt.nlp	23187802	SENT164	9	9	29	29	doxorubicin	p53	PA449412	7157	0.997
NULL	Onco_Targets_Ther_2014_Oct_4_7_1817-1828.nxml.txt.nlp	25336973	SENT62	0	0	12	12	tegafur	DPD	PA452620	1806	0.997
NULL	Eur_J_Clin_Pharmacol_2013_Jun_17_69(6)_1211-1221.nxml.txt.nlp	23325436	SENT182	0	0	16	16	fluconazole	CYP1A2	PA449653	1544	0.997
NULL	Indian_J_Pharm_Sci_2014_Sep-Oct_76(5)_415-422.nxml.txt.nlp	25425755	SENT22	0	0	25	25	curcumin	LOX	PA151958596	4015	0.997
NULL	Eur_J_Med_Res_2009_Nov_24_14(Suppl_3)_5-16.nxml.txt.nlp	19959411	SENT138	1	1	22	22	raltegravir	UGT1A1		54658	0.997
NULL	Acta_Pharmacol_Sin_2013_Sep_5_34(9)_1208-1216.nxml.txt.nlp	23852087	SENT118	27	27	8	8	disulfiram	CA9	PA449376	768	0.997
NULL	Clin_Exp_Otorhinolaryngol_2012_Sep_27_5(3)_117-121.nxml.txt.nlp	22977707	SENT118	1	1	27	27	kanamycin	KCC2	PA450137	57468	0.997
NULL	Cancer_Med_2012_Oct_13_1(2)_218-229.nxml.txt.nlp	23342271	SENT209	2	2	9	9	paclitaxel	p53	PA450761	7157	0.997
NULL	Oncogene_2010_Oct_7_29(40)_5500-5510.nxml.txt.nlp	20661224	SENT240	10	10	17	17	trastuzumab	PI3K	PA451743	5290	0.997
NULL	J_Cancer_Prev_2014_Mar_19(1)_1-6.nxml.txt.nlp	25337566	SENT52	0	0	20	20	noscapine	survivin		332	0.997
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT144	6	6	40	40	vinorelbine	ASC	PA451881	29108	0.997
NULL	N_Am_J_Med_Sci_2012_Dec_4(12)_648-650.nxml.txt.nlp	23272308	SENT20	30	30	2	2	piperacillin	CRA	PA450975	51747;10903	0.997
NULL	J_Cell_Biol_1988_Apr_1_106(4)_1171-1183.nxml.txt.nlp	3283148	SENT6	47	47	11	11	urea	p67	PA451831	945;10988	0.997
NULL	Br_J_Cancer_2011_Jun_28_105(1)_1-8.nxml.txt.nlp	21654681	SENT78	28	28	4	4	gefitinib	EGFR	PA131301952	1956	0.997
NULL	Exp_Ther_Med_2015_Feb_3_9(2)_585-590.nxml.txt.nlp	25574239	SENT90	16	16	1	1	indomethacin	CD50	PA449982	3385	0.997
NULL	Int_J_Endocrinol_2010_Jul_18_2010_205357.nxml.txt.nlp	20706540	SENT146	18	18	0	0	galactose	GLUT8	PA449725	29988;154091	0.997
NULL	Biosci_Rep_2012_Dec_13_33(1)_e00007.nxml.txt.nlp	23095119	SENT306	11	11	2	2	forskolin	AMPK	PA146096022	5563	0.997
NULL	Br_J_Clin_Pharmacol_2014_Nov_20_78(5)_1050-1057.nxml.txt.nlp	24962564	SENT38	0	0	14	14	ketoconazole	MDR1	PA450146	5243	0.997
NULL	J_Exp_Clin_Cancer_Res_2010_Apr_30_29(1)_41.nxml.txt.nlp	20433702	SENT195	24	24	1	1	doxorubicin	HSP60	PA449412	3329	0.997
NULL	Curr_Neuropharmacol_2011_Dec_9(4)_530-552.nxml.txt.nlp	22654714	SENT348	17	17	4	4	clozapine	BDNF	PA449061	627	0.997
NULL	Mol_Cancer_2009_Apr_16_8_24.nxml.txt.nlp	19371427	SENT14	25	25	1	1	cisplatin	CHK1	PA449014	1111	0.997
NULL	Iran_J_Basic_Med_Sci_2012_Nov-Dec_15(6)_1110-1126.nxml.txt.nlp	23653839	SENT119	14	14	25	25	bevacizumab	VEGF-A	PA130232992	7422	0.997
NULL	Chemother_Res_Pract_2012_Dec_20_2012_743193.nxml.txt.nlp	23320171	SENT16	0	0	20	20	trastuzumab	HER2	PA451743	2064	0.997
NULL	Ann_Clin_Microbiol_Antimicrob_2008_Jan_28_7_3.nxml.txt.nlp	18226256	SENT62	5	5	32	32	rifabutin	SXR	PA451249	8856	0.997
NULL	Cancer_Metastasis_Rev_2010_Dec_10_29(4)_581-594.nxml.txt.nlp	20830503	SENT280	45	45	5	5	tamoxifen	STA	PA451581	2010;2656	0.997
NULL	Crit_Care_2005_Nov_16_9(6)_R790-R797.nxml.txt.nlp	16356228	SENT39	33	33	9	9	octreotide	IL-6	PA450678	3569	0.997
NULL	Oncol_Lett_2014_Oct_28_8(4)_1563-1566.nxml.txt.nlp	25202368	SENT28	2	2	13	13	erlotinib	EGFR	PA134687924	1956	0.997
NULL	Hum_Genomics_2009_Apr_1_3(3)_213-220.nxml.txt.nlp	19403456	SENT43	2	2	28	28	ethanol	ALDH2	PA448073	217	0.997
NULL	Cardiovasc_Diabetol_2013_May_30_12(Suppl_1)_S2.nxml.txt.nlp	23819752	SENT129	5	5	18	18	atorvastatin	CYP2C9	PA448500	1559	0.997
NULL	ARYA_Atheroscler_2011_Fall_7(3)_106-110.nxml.txt.nlp	22577456	SENT4	13	13	1	1	clopidogrel	CYP2C19	PA449053	1557	0.997
NULL	Mol_Vis_2012_Jun_22_18_1696-1700.nxml.txt.nlp	22773907	SENT14	17	17	26	26	colchicine	MTHFR	PA449092	4524	0.997
NULL	Breast_Cancer_(Auckl)_2012_Mar_7_6_67-77.nxml.txt.nlp	22438669	SENT33	1	1	22	22	lapatinib	HER2	PA152241907	2064	0.997
NULL	Int_J_Biol_Sci_2014_Jun_10_10(7)_654-663.nxml.txt.nlp	25013375	SENT101	5	5	24	24	nelfinavir	AKT	PA450606	207	0.997
NULL	Br_J_Cancer_2009_Jun_2_100(11)_1697-1703.nxml.txt.nlp	19384299	SENT88	4	4	32	32	fludarabine	CD25	PA449655	3669;3559	0.997
NULL	F1000Prime_Rep_2014_Apr_1_6_21.nxml.txt.nlp	24765526	SENT52	5	5	23	23	anakinra	IL-6	PA10799	3569	0.997
NULL	Clin_Ophthalmol_2014_Dec_18_8_73-81.nxml.txt.nlp	24379650	SENT67	0	0	15	15	daclizumab	IL-2	PA164764446	3558	0.997
NULL	Br_J_Cancer_2003_Mar_10_88(5)_754-759.nxml.txt.nlp	12618886	SENT136	6	6	25	25	amifostine	p53	PA448365	7157	0.997
NULL	Pharmaceuticals_(Basel)_2011_Jun_30_4(7)_976-991.nxml.txt.nlp	NULL	SENT43	44	44	9	9	rimonabant	CB1	PA152407999	1268	0.997
NULL	Aging_Cell_2009_Apr_8(2)_113-127.nxml.txt.nlp	19239417	SENT126	33	33	5	5	resveratrol	AMPK		5563	0.997
NULL	Nat_Med_2012_Jan_8_18(2)_281-285.nxml.txt.nlp	22231557	SENT40	1	1	11	11	ezetimibe	NPC1L1	PA10816	29881	0.997
NULL	EMBO_Mol_Med_2012_Jul_25_4(7)_545-556.nxml.txt.nlp	22730341	SENT177	10	10	18	18	vincristine	MCL1	PA451879	4170	0.997
NULL	Braz_J_Med_Biol_Res_2013_Aug_13_46(8)_650-658.nxml.txt.nlp	23969971	SENT10	1	1	44	44	oxaliplatin	STAT3	PA131285527	6774	0.997
NULL	Breast_Cancer_Res_2008_Jul_16_10(4)_R60.nxml.txt.nlp	18631394	SENT149	0	0	16	16	lapatinib	HER2	PA152241907	2064	0.997
NULL	J_Adv_Pract_Oncol_2013_Mar_1_Mar-Apr_4(2)_118-122.nxml.txt.nlp	25031991	SENT88	3	3	15	15	verapamil	CYP3A4	PA451868	1576	0.997
NULL	Oncol_Rep_2014_Dec_13_32(6)_2307-2318.nxml.txt.nlp	25310523	SENT33	39	39	1	1	gemcitabine	S100A4	PA449748	6275	0.997
NULL	Br_J_Cancer_2013_Apr_16_108(7)_1408-1414.nxml.txt.nlp	23511562	SENT112	19	19	1	1	tamoxifen	ATAC	PA451581	6375	0.997
NULL	Eur_J_Clin_Pharmacol_2010_Aug_21_66(8)_811-812.nxml.txt.nlp	20407763	SENT29	16	16	4	4	proguanil	CYP2C19	PA451124	1557	0.997
NULL	EMBO_Mol_Med_2009_Apr_1(1)_66-78.nxml.txt.nlp	20049704	SENT225	11	11	28	28	trastuzumab	HIF-1	PA451743	29072	0.997
NULL	Oncotarget_2014_Jun_19_5(15)_6540-6551.nxml.txt.nlp	25153728	SENT103	31	31	12	12	paclitaxel	CDK4	PA450761	1019	0.997
NULL	Arthritis_Res_Ther_2014_Jul_18_16(4)_R153.nxml.txt.nlp	25037855	SENT199	6	6	38	38	adalimumab	CD14	PA10004	929	0.997
NULL	Ther_Clin_Risk_Manag_2007_Aug_3(4)_665-673.nxml.txt.nlp	18472989	SENT172	4	4	8	8	lapatinib	CYP3A4	PA152241907	1576	0.997
NULL	Mol_Cancer_2009_Jun_9_8_37.nxml.txt.nlp	19508729	SENT63	46	46	11	11	gemcitabine	HO-1	PA449748	3162	0.997
NULL	J_Adv_Pract_Oncol_2013_Jul_1_Jul-Aug_4(4)_263-268.nxml.txt.nlp	25032007	SENT34	1	1	15	15	imatinib	CYP3A	PA10804	1574	0.997
NULL	Leukemia_2013_Feb_10_27(2)_507-510.nxml.txt.nlp	22810506	SENT68	30	30	4	4	fludarabine	TRAC	PA449655	28755	0.997
NULL	Endocr_Rev_2013_Jun_10_34(3)_339-376.nxml.txt.nlp	23575763	SENT581	27	27	0	0	cisplatin	GGT1	PA449014	2678	0.997
NULL	EMBO_Mol_Med_2009_Apr_1(1)_66-78.nxml.txt.nlp	20049704	SENT33	12	12	18	18	temsirolimus	HIF-1	PA164746890	29072	0.997
NULL	Cell_Commun_Signal_2013_Apr_24_11_31.nxml.txt.nlp	23618389	SENT131	37	37	9	9	cisplatin	PP1A	PA449014	5499	0.997
NULL	Acta_Pharmacol_Sin_2010_May_5_31(5)_540-545.nxml.txt.nlp	20364157	SENT98	2	2	39	39	hemin	HO-1	PA449849	3162	0.997
NULL	Clin_Interv_Aging_2008_Mar_3(1)_45-50.nxml.txt.nlp	18488877	SENT39	0	0	13	13	raloxifene	BMD	PA451221	1756;7439	0.997
NULL	Adv_Appl_Bioinforma_Chem_2008_Oct_30_1_85-98.nxml.txt.nlp	21918608	SENT107	4	4	15	15	bortezomib	SPARC	PA10252	6678	0.997
NULL	Dement_Geriatr_Cogn_Dis_Extra_2014_Nov_15_4(3)_450-456.nxml.txt.nlp	25538729	SENT92	39	39	18	18	donepezil	APOE	PA449394	348	0.997
NULL	Europace_2011_Feb_7_13(2)_161-173.nxml.txt.nlp	21138930	SENT188	0	0	34	34	flecainide	CAST	PA449646	10849;26059;831	0.997
NULL	J_RNAi_Gene_Silencing_2009_Mar_9_5(1)_321-330.nxml.txt.nlp	19771229	SENT26	36	36	2	2	hydroxyurea	RRM1	PA449942	6240	0.997
NULL	Br_J_Cancer_2010_Mar_2_102(5)_867-872.nxml.txt.nlp	20145619	SENT63	17	17	42	42	lapatinib	IL-21	PA152241907	59067;50616;27189	0.997
NULL	J_Biomed_Biotechnol_2010_Mar_2_2010_793843.nxml.txt.nlp	20204133	SENT112	1	1	34	34	trypsin	CYP11B2	PA451806	1585	0.997
NULL	Infect_Drug_Resist_2011_Feb_22_4_65-76.nxml.txt.nlp	21694910	SENT246	6	6	17	17	raltegravir	N155		9631	0.997
NULL	Int_J_Biol_Sci_2011_Nov_5_8(1)_1-14.nxml.txt.nlp	22211100	SENT30	4	4	42	42	evodiamine	Bcl-2	PA165860788	596	0.997
NULL	Curr_Neuropharmacol_2008_Sep_6(3)_215-234.nxml.txt.nlp	19506722	SENT119	5	5	29	29	fluoxetine	5-HT2C	PA449673	3358	0.997
NULL	Br_J_Anaesth_2011_Oct_17_107(4)_490-502.nxml.txt.nlp	21852280	SENT68	12	12	28	28	capsaicin	TRPV1	PA448776	7442	0.997
NULL	Breast_Cancer_Res_2001_Mar_26_3(3)_180-182.nxml.txt.nlp	11305952	SENT27	33	33	17	17	letrozole	HER-2	PA450196	2064	0.997
NULL	Int_J_Surg_Oncol_2012_Jun_24_2012_868645.nxml.txt.nlp	22778942	SENT76	0	0	22	22	pertuzumab	HER3		2065	0.997
NULL	Arthritis_Res_Ther_2012_Feb_9_14(Suppl_1)_O37.nxml.txt.nlp	NULL	SENT7	10	10	4	4	tocilizumab	IL-6	PA165292659	3569	0.997
NULL	Br_J_Pharmacol_2013_Jun_27_169(4)_933-948.nxml.txt.nlp	23517055	SENT286	19	19	2	2	phenylephrine	NCX	PA450935	3196	0.997
NULL	Scientifica_(Cairo)_2012_Dec_20_2012_106576.nxml.txt.nlp	24278664	SENT433	2	2	15	15	bosentan	ETB	PA10034	1910	0.997
NULL	Arthritis_Res_Ther_2010_Sep_8_12(5)_R167.nxml.txt.nlp	20825639	SENT175	11	11	34	34	resveratrol	AP-1		2353;3727;2354;3725	0.997
NULL	Clin_Med_Oncol_2008_Feb_9_2_47-61.nxml.txt.nlp	21892266	SENT67	2	2	29	29	gefitinib	EGFR	PA131301952	1956	0.997
NULL	Arthritis_Res_Ther_2014_Apr_28_16(2)_R104.nxml.txt.nlp	24774748	SENT110	24	24	4	4	cyclophosphamide	CD4	PA449165	920	0.997
NULL	Indian_J_Ophthalmol_2014_Oct_62(10)_985-991.nxml.txt.nlp	25449931	SENT171	23	23	17	17	pyridostigmine	OMG	PA451185	4974	0.997
NULL	Br_J_Pharmacol_2010_Sep_161(2)_288-307.nxml.txt.nlp	20735416	SENT245	32	32	14	14	halothane	TREK-1	PA449845	3776	0.997
NULL	Br_J_Cancer_2009_Jun_2_100(11)_1697-1703.nxml.txt.nlp	19384299	SENT88	4	4	30	30	fludarabine	CD4	PA449655	920	0.997
NULL	Arthritis_Res_Ther_2013_Jul_9_15(4)_R73.nxml.txt.nlp	23837669	SENT248	1	1	41	41	colchicine	MICL	PA449092	160364	0.997
NULL	Gastric_Cancer_2012_Jul_13_15(3)_245-251.nxml.txt.nlp	21993850	SENT113	0	0	28	28	trastuzumab	HER2	PA451743	2064	0.997
NULL	Arthritis_Res_Ther_2014_Sep_26_16(5)_429.nxml.txt.nlp	25606593	SENT106	2	2	20	20	anakinra	IL-6	PA10799	3569	0.997
NULL	CNS_Drugs_2014_Feb_7_28(3)_185-193.nxml.txt.nlp	24504829	SENT84	7	7	15	15	resveratrol	SIRT1		23411	0.997
NULL	Oncol_Lett_2013_Apr_22_5(4)_1093-1100.nxml.txt.nlp	23599746	SENT127	6	6	39	39	cisplatin	MDR1	PA449014	5243	0.997
NULL	Mol_Biol_Int_2014_Sep_7_2014_852748.nxml.txt.nlp	25276427	SENT159	0	0	12	12	pertuzumab	HER2		2064	0.997
NULL	Drugs_R_D_2013_Jun_5_13(2)_153-157.nxml.txt.nlp	23737454	SENT30	3	3	34	34	clopidogrel	P2Y12	PA449053	64805	0.997
NULL	J_Cell_Biol_2005_Jul_4_170(1)_49-59.nxml.txt.nlp	15983061	SENT145	48	48	3	3	forskolin	MITF	PA146096022	4286	0.997
NULL	Core_Evid_2010_Oct_21_5_77-90.nxml.txt.nlp	21042544	SENT178	0	0	28	28	aprepitant	CYP3A4	PA164747039	1576	0.997
NULL	Spermatogenesis_2013_Apr_1_3(2)_e24194.nxml.txt.nlp	23885303	SENT150	3	3	26	26	doxorubicin	PARP	PA449412	142	0.997
NULL	ScientificWorldJournal_2014_Mar_2_2014_794078.nxml.txt.nlp	24723825	SENT172	14	14	5	5	clopidogrel	CYP2C19	PA449053	1557	0.997
NULL	Breast_Cancer_Res_2009_Jun_29_11(3)_R41.nxml.txt.nlp	19563669	SENT154	0	0	29	29	lapatinib	EGFR	PA152241907	1956	0.997
NULL	Arthritis_2012_Nov_8_2012_601763.nxml.txt.nlp	23243507	SENT100	6	6	19	19	tacrolimus	P-gp	PA451578	5243	0.997
NULL	Mol_Cancer_2014_Jun_19_13_154.nxml.txt.nlp	24941944	SENT196	5	5	28	28	methotrexate	BRAF	PA450428	673	0.997
NULL	Ann_Neurosci_2014_Jul_21(3)_97-103.nxml.txt.nlp	25206073	SENT32	33	33	14	14	bumetanide	NKCC1	PA448682	6558	0.997
NULL	Hum_Genomics_2009_Jan_1_3(2)_128-142.nxml.txt.nlp	19164090	SENT184	42	42	3	3	carboplatin	CD44	PA448803	960	0.997
NULL	Curr_HIV_Res_2014_May_12(3)_174-188.nxml.txt.nlp	24862327	SENT162	0	0	45	45	curcumin	HO-1	PA151958596	3162	0.997
NULL	Trials_2014_Dec_3_15(1)_474.nxml.txt.nlp	NULL	SENT154	8	8	35	35	sorafenib	SHARP	PA7000	23013	0.997
NULL	Breast_Cancer_Res_2011_Nov_16_13(Suppl_2)_O11.nxml.txt.nlp	NULL	SENT6	5	5	30	30	trastuzumab	HER2	PA451743	2064	0.997
NULL	Hum_Reprod_2008_Oct_16_23(10)_2273-2281.nxml.txt.nlp	18635530	SENT155	7	7	3	3	etoposide	CTB	PA449552	9468	0.997
NULL	Oncol_Lett_2013_Apr_4_5(4)_1165-1170.nxml.txt.nlp	23599757	SENT133	0	0	15	15	pemetrexed	SLC19A1	PA10810	6573	0.997
NULL	Oncotarget_2010_Jun_7_1(2)_156-160.nxml.txt.nlp	21297225	SENT14	41	41	6	6	imatinib	CD34	PA10804	947	0.997
NULL	JRSM_Cardiovasc_Dis_2012_Sep_24_1(6)_cvd_2012_012015.nxml.txt.nlp	24175073	SENT38	30	30	7	7	clopidogrel	CYP2C19	PA449053	1557	0.997
NULL	Int_J_Breast_Cancer_2012_May_9_2012_415170.nxml.txt.nlp	22649737	SENT213	24	24	11	11	trastuzumab	HER3	PA451743	2065	0.997
NULL	Cardiol_Res_Pract_2013_Jan_31_2013_128795.nxml.txt.nlp	23431496	SENT162	30	30	18	18	clopidogrel	CYP2C19	PA449053	1557	0.997
NULL	J_Biol_Chem_2008_Jun_20_283(25)_17194-17204.nxml.txt.nlp	18442977	SENT169	3	3	40	40	fluoxetine	5-HT1A	PA449673	3350	0.997
NULL	Breast_Cancer_Res_2005_May_27_7(Suppl_1)_S19.nxml.txt.nlp	NULL	SENT8	33	33	1	1	tamoxifen	aromatase	PA451581	1588	0.997
NULL	Balkan_J_Med_Genet_2011_Jun_25_14(1)_25-30.nxml.txt.nlp	24052699	SENT82	8	8	22	22	phenytoin	MRP1	PA450947	4437	0.997
NULL	Int_J_Alzheimers_Dis_2011_Oct_19_2011_864753.nxml.txt.nlp	22028985	SENT107	15	15	0	0	picrotoxin	CA3	PA164777007	761	0.997
NULL	Tumour_Biol_2012_Feb_22_33(1)_141-148.nxml.txt.nlp	22105734	SENT177	38	38	3	3	iohexol	HE4	PA450061	10406	0.997
NULL	Mol_Biol_Cell_2012_Mar_15_23(6)_996-1009.nxml.txt.nlp	22278744	SENT210	22	22	3	3	forskolin	14-3-3	PA146096022	10971	0.997
NULL	Mol_Brain_2014_Apr_3_7_25.nxml.txt.nlp	24708812	SENT248	10	10	27	27	chlorpheniramine	ERK	PA448960	5594	0.997
NULL	Clin_Epigenetics_2011_Jul_16_2(2)_411-416.nxml.txt.nlp	22704352	SENT79	2	2	28	28	decitabine	FOXP3	PA164749631	50943	0.997
NULL	Breast_Cancer_Res_2013_Oct_18_15(5)_R97.nxml.txt.nlp	24135425	SENT20	30	30	8	8	pertuzumab	aromatase		1588	0.997
NULL	Clin_Pharmacol_2011_Jun_22_3_13-25.nxml.txt.nlp	22287853	SENT17	8	8	22	22	saxagliptin	CYP3A4	PA165958362	1576	0.997
NULL	Oncoimmunology_2013_Sep_1_2(9)_e25770.nxml.txt.nlp	24327936	SENT37	8	8	41	41	simvastatin	CRT	PA451363	811	0.997
NULL	J_Anaesthesiol_Clin_Pharmacol_2012_Oct-Dec_28(4)_426-427.nxml.txt.nlp	23225918	SENT32	0	0	24	24	alvimopan	GIT	PA164754864	5034	0.997
NULL	Oncogene_2011_Apr_14_30(15)_1798-1811.nxml.txt.nlp	21170087	SENT260	17	17	9	9	etoposide	p53	PA449552	7157	0.997
NULL	Oncol_Rep_2014_Feb_13_31(2)_581-588.nxml.txt.nlp	24337105	SENT148	9	9	41	41	capsaicin	Bcl-2	PA448776	596	0.997
NULL	J_Med_Case_Reports_2011_Sep_19_5_465.nxml.txt.nlp	21929779	SENT69	39	39	6	6	lamivudine	CD4	PA450163	920	0.997
NULL	Kidney_Int_Suppl_(2011)_2013_Dec_27_3(5)_451-456.nxml.txt.nlp	25019029	SENT81	1	1	40	40	cinacalcet	PTH	PA164776671	5741	0.997
NULL	Breast_Cancer_Res_2011_Apr_15_13(2)_R44.nxml.txt.nlp	21496232	SENT439	10	10	17	17	trastuzumab	PI3K	PA451743	5290	0.997
NULL	Arthritis_Res_Ther_2011_Feb_16_13(1)_R25.nxml.txt.nlp	21324169	SENT131	40	40	6	6	abatacept	ACR	PA164747080	49	0.997
NULL	Oncol_Lett_2013_Mar_8_5(3)_805-812.nxml.txt.nlp	23426281	SENT190	39	39	13	13	gemcitabine	survivin	PA449748	332	0.997
NULL	ASN_Neuro_2009_Aug_26_1(3)_e00015.nxml.txt.nlp	19663807	SENT239	39	39	4	4	thrombin	TSP-1	PA451674	7057	0.997
NULL	Hum_Genomics_2009_Dec_1_4(2)_91-106.nxml.txt.nlp	20038497	SENT145	17	17	33	33	galantamine	APOE	PA449726	348	0.997
NULL	J_Gynecol_Oncol_2014_Jan_8_25(1)_58-63.nxml.txt.nlp	24459582	SENT115	30	30	2	2	paclitaxel	ARID1A	PA450761	8289	0.997
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2011_Mar_14_4_13-24.nxml.txt.nlp	22879790	SENT154	0	0	16	16	exenatide	PPG	PA164749238	5552	0.997
NULL	Oncogene_2013_Sep_26_32(39)_10_1038_onc_2012_491.nxml.txt.nlp	23108394	SENT116	32	32	7	7	trastuzumab	FOXM1	PA451743	2305	0.997
NULL	Exp_Ther_Med_2013_Jun_3_5(6)_1631-1636.nxml.txt.nlp	23837045	SENT88	21	21	5	5	propranolol	ANGPTL2	PA451145	23452	0.997
NULL	EMBO_Mol_Med_2012_Jun_13_4(6)_515-527.nxml.txt.nlp	22416035	SENT99	4	4	30	30	olaparib	p53		7157	0.997
NULL	ISRN_AIDS_2012_Aug_23_2012_960178.nxml.txt.nlp	24052885	SENT75	5	5	37	37	zidovudine	CD4	PA451954	920	0.997
NULL	Cell_Death_Differ_2010_Apr_16_17(4)_666-676.nxml.txt.nlp	19834494	SENT283	25	25	13	13	oxaliplatin	p53	PA131285527	7157	0.997
NULL	Acta_Pharmacol_Sin_2010_Apr_22_31(4)_501-508.nxml.txt.nlp	20305682	SENT32	0	0	34	34	rabeprazole	CYP2C19	PA451216	1557	0.997
NULL	Iran_J_Public_Health_2012_Jun_30_41(6)_65-71.nxml.txt.nlp	23113195	SENT88	37	37	9	9	methotrexate	DHFR	PA450428	1719	0.997
NULL	J_Clin_Biochem_Nutr_2007_Jul_27_41(1)_32-42.nxml.txt.nlp	18392098	SENT211	16	16	4	4	curcumin	PARP	PA151958596	142	0.997
NULL	J_Biol_Chem_2013_Nov_29_288(48)_34638-34646.nxml.txt.nlp	24106277	SENT244	25	25	8	8	hyaluronan	gC1qR	PA165958431	708	0.997
NULL	Oncotarget_2013_Aug_25_4(10)_1647-1661.nxml.txt.nlp	24072592	SENT23	32	32	10	10	cisplatin	RPS6	PA449014	6194	0.997
NULL	J_Carcinog_2014_Feb_7_13_1.nxml.txt.nlp	24737949	SENT185	11	11	26	26	sorafenib	KIT	PA7000	3815	0.997
NULL	Front_Genet_2012_Nov_5_3_236.nxml.txt.nlp	23133441	SENT132	34	34	24	24	efavirenz	ABCB1	PA449441	5243	0.997
NULL	Onco_Targets_Ther_2014_Sep_9_7_1571-1582.nxml.txt.nlp	25228815	SENT194	39	39	21	21	sunitinib	VEGFR2	PA162372840	3791	0.997
NULL	Oncogene_2009_Dec_10_28(49)_4326-4343.nxml.txt.nlp	19826415	SENT328	13	13	9	9	pp2	PI3K		5290	0.997
NULL	Mol_Cancer_2010_Dec_2_9_309.nxml.txt.nlp	21122157	SENT11	7	7	19	19	paclitaxel	IL-6	PA450761	3569	0.997
NULL	Tuberc_Respir_Dis_(Seoul)_2014_Feb_27_76(2)_66-74.nxml.txt.nlp	24624215	SENT94	3	3	10	10	vancomycin	HCAP	PA451850	117159;9126	0.997
NULL	Endocrinol_Metab_(Seoul)_2014_Sep_25_29(3)_211-216.nxml.txt.nlp	25309777	SENT78	0	0	20	20	sunitinib	RET	PA162372840	5979	0.997
NULL	FEBS_J_2009_Oct_276(19)_5571-5578.nxml.txt.nlp	19702827	SENT36	27	27	15	15	gefitinib	EGFR	PA131301952	1956	0.997
NULL	Anemia_2012_Oct_3_2012_563251.nxml.txt.nlp	23091709	SENT420	6	6	18	18	berberine	AMPK	PA165860812	5563	0.997
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT124	6	6	41	41	cisplatin	GS-X	PA449014	4363	0.997
NULL	Emerg_Infect_Dis_2013_Mar_19(3)_449-455.nxml.txt.nlp	23622714	SENT128	36	36	22	22	rifampin	DST	PA451250	667	0.997
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1522-1532.nxml.txt.nlp	21997136	SENT33	46	46	24	24	irinotecan	EGFR	PA450085	1956	0.997
NULL	Nat_Med_2014_Jan_15_20(1)_54-61.nxml.txt.nlp	24336249	SENT116	6	6	39	39	anakinra	IL-23	PA10799	51561	0.997
NULL	Biologics_2011_Aug_9_5_87-94.nxml.txt.nlp	21847344	SENT58	0	0	32	32	pertuzumab	HER2		2064	0.997
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_33-43.nxml.txt.nlp	17912634	SENT195	19	19	2	2	tamoxifen	HER2	PA451581	2064	0.997
NULL	Biologics_2012_Jun_20_6_137-146.nxml.txt.nlp	22807624	SENT135	29	29	2	2	panitumumab	KRAS	PA162373091	3845	0.997
NULL	Eur_J_Endocrinol_2013_Apr_168(4)_557-564.nxml.txt.nlp	23345197	SENT105	28	28	3	3	diazoxide	ABCC8	PA449285	6833	0.997
NULL	J_Biol_Chem_2011_Oct_7_286(40)_34998-35006.nxml.txt.nlp	21757733	SENT40	7	7	23	23	lipase	ABHD5	PA450239	51099	0.997
NULL	Arch_Drug_Inf_2011_Mar_4(1)_1-9.nxml.txt.nlp	21572514	SENT34	3	3	27	27	vinblastine	P-gp	PA451877	5243	0.997
NULL	Int_J_Biol_Sci_2014_Jun_3_10(6)_602-613.nxml.txt.nlp	24948873	SENT175	18	18	5	5	metyrapone	CYP11B1	PA450486	1584	0.997
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1098-1105.nxml.txt.nlp	21386838	SENT158	27	27	14	14	cisplatin	DTD	PA449014	1728	0.997
NULL	Front_Hum_Neurosci_2012_Apr_12_6_79.nxml.txt.nlp	22518101	SENT336	7	7	15	15	levodopa	gamma	PA450213	9913	0.997
NULL	Mol_Vis_2012_Oct_11_18_2509-2517.nxml.txt.nlp	23112566	SENT9	22	22	3	3	bevacizumab	VEGF-A	PA130232992	7422	0.997
NULL	Int_J_Mol_Sci_2014_Jun_25_15(7)_11234-11244.nxml.txt.nlp	24968266	SENT34	7	7	38	38	docetaxel	PC-3	PA449383	692094	0.997
NULL	Case_Rep_Oncol_2010_Apr_22_3(2)_98-105.nxml.txt.nlp	20740181	SENT20	9	9	34	34	erlotinib	EGFR	PA134687924	1956	0.997
NULL	Exp_Ther_Med_2013_Aug_5_6(2)_469-474.nxml.txt.nlp	24137210	SENT121	6	6	35	35	clofibrate	FES	PA449045	2242	0.997
NULL	Acta_Pharmacol_Sin_2011_Jan_6_32(1)_133-138.nxml.txt.nlp	21131997	SENT47	18	18	6	6	protamine	ACT	PA10366	12;11332;9457;641455	0.997
NULL	Arthritis_Res_Ther_2012_May_1_14(3)_R99.nxml.txt.nlp	22546542	SENT212	27	27	3	3	infliximab	IL-17	PA452639	3605	0.997
NULL	Cancer_Med_2012_Aug_15_1(1)_28-38.nxml.txt.nlp	23342251	SENT23	35	35	1	1	panitumumab	EGFR	PA162373091	1956	0.997
NULL	Oncotarget_2011_Dec_24_2(12)_896-917.nxml.txt.nlp	22203527	SENT157	13	13	7	7	metformin	p53	PA450395	7157	0.997
NULL	Case_Rep_Dent_2014_Feb_20_2014_479584.nxml.txt.nlp	24707409	SENT63	2	2	10	10	chlorhexidine	SCAP	PA164776863	22937	0.997
NULL	Cell_Commun_Signal_2009_Feb_26_7(Suppl_1)_A20.nxml.txt.nlp	NULL	SENT10	44	44	8	8	arsenite	Bcl-2	PA452638	596	0.997
NULL	Biomed_Res_Int_2014_Jan_29_2014_232870.nxml.txt.nlp	24592384	SENT182	11	11	28	28	doxorubicin	p53	PA449412	7157	0.997
NULL	Exp_Ther_Med_2015_Feb_3_9(2)_585-590.nxml.txt.nlp	25574239	SENT112	17	17	32	32	indomethacin	COX	PA449982	1351	0.997
NULL	Breast_Cancer_Res_2007_Jun_15_9(3)_R38.nxml.txt.nlp	17573968	SENT174	37	37	5	5	fulvestrant	BMI1	PA164747170	648	0.997
NULL	Cancer_Med_2012_Oct_1_1(2)_114-127.nxml.txt.nlp	23342262	SENT34	34	34	4	4	sirolimus	EGFR	PA451365	1956	0.997
NULL	Mol_Cancer_2010_May_19_9_111.nxml.txt.nlp	20482821	SENT21	29	29	5	5	tamoxifen	BEX2	PA451581	84707	0.997
NULL	Oncotarget_2011_Sep_9_2(9)_658-668.nxml.txt.nlp	21911919	SENT7	19	19	5	5	daunorubicin	HO-1	PA449212	3162	0.997
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Apr_17_6_43-57.nxml.txt.nlp	24833916	SENT298	3	3	20	20	everolimus	aromatase	PA164746311	1588	0.997
NULL	Clin_Dev_Immunol_2013_Nov_25_2013_271246.nxml.txt.nlp	24371445	SENT352	18	18	3	3	irinotecan	CD166	PA450085	214	0.997
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT144	42	42	4	4	vinorelbine	ASC	PA451881	29108	0.997
NULL	Arch_Med_Sci_2012_Sep_8_8(4)_659-671.nxml.txt.nlp	23056078	SENT46	30	30	3	3	doxorubicin	MRP2	PA449412	100130958;57626;1244	0.997
NULL	Br_J_Cancer_2011_May_24_104(11)_1762-1769.nxml.txt.nlp	21559019	SENT177	20	20	8	8	tamoxifen	HOXB13	PA451581	10481	0.997
NULL	Front_Pharmacol_2014_Mar_20_5_44.nxml.txt.nlp	24688470	SENT301	13	13	1	1	ethanol	5-HT1B	PA448073	3351	0.997
NULL	Cell_Cycle_2012_Nov_1_11(21)_3983-3996.nxml.txt.nlp	22987153	SENT91	14	14	0	0	cisplatin	DNA2	PA449014	1763	0.997
NULL	Breast_Cancer_Res_2012_Aug_13_14(4)_109.nxml.txt.nlp	22889086	SENT24	1	1	21	21	tamoxifen	aromatase	PA451581	1588	0.997
NULL	Nat_Commun_2013_Oct_1_4_2516.nxml.txt.nlp	24084631	SENT49	39	39	47	47	losartan	CCN2	PA450268	1490	0.997
NULL	Indian_J_Pharmacol_2014_Jan-Feb_46(1)_3-12.nxml.txt.nlp	24550577	SENT226	39	39	16	16	vismodegib	CYP2C8		1558	0.997
NULL	Oncol_Lett_2013_Feb_9_5(2)_552-558.nxml.txt.nlp	23420128	SENT30	13	13	20	20	imatinib	KIT	PA10804	3815	0.997
NULL	J_Hematol_Oncol_2014_Apr_28_7_37.nxml.txt.nlp	24775308	SENT198	20	20	1	1	imatinib	JAK2	PA10804	3717	0.997
NULL	Oncol_Lett_2014_Jan_12_7(1)_17-22.nxml.txt.nlp	24348813	SENT124	22	22	9	9	curcumin	AKR1B10	PA151958596	57016	0.997
NULL	Oxid_Med_Cell_Longev_2012_Aug_9_2012_680304.nxml.txt.nlp	22928083	SENT144	2	2	26	26	ethanol	CLS	PA448073	1210	0.997
NULL	Cancer_Med_2012_Aug_15_1(1)_28-38.nxml.txt.nlp	23342251	SENT23	33	33	1	1	cetuximab	EGFR	PA10040	1956	0.997
NULL	Arthritis_Res_Ther_2009_Feb_23_11(1)_216.nxml.txt.nlp	19291269	SENT107	9	9	31	31	infliximab	ACR	PA452639	49	0.997
NULL	Am_J_Case_Rep_2014_Feb_14_15_69-73.nxml.txt.nlp	24587852	SENT109	4	4	11	11	paroxetine	5-HT2C	PA450801	3358	0.997
NULL	Cancer_Manag_Res_2013_Oct_8_5_337-347.nxml.txt.nlp	24204170	SENT40	39	39	9	9	sorafenib	EGFR	PA7000	1956	0.997
NULL	Mol_Cancer_2010_Apr_12_9_75.nxml.txt.nlp	20385023	SENT211	30	30	5	5	nilotinib	P-gp	PA165958345	5243	0.997
NULL	J_Invest_Dermatol_2012_Jan_1_132(1)_105-113.nxml.txt.nlp	21881590	SENT123	23	23	0	0	etanercept	IL-23A	PA449515	51561	0.997
NULL	J_Med_Life_2011_Feb_15_4(1)_11-20.nxml.txt.nlp	21505570	SENT190	11	11	40	40	naproxen	CB2	PA450595	1269	0.997
NULL	Chem_Res_Toxicol_2012_Nov_19_25(11)_2333-2339.nxml.txt.nlp	22917110	SENT27	7	7	33	33	arsenite	TERT	PA452638	7015	0.997
NULL	J_Cachexia_Sarcopenia_Muscle_2010_Sep_26_1(1)_43-128.nxml.txt.nlp	22477519	SENT1782	45	45	17	17	clenbuterol	gamma	PA164745640	9913	0.997
NULL	Clin_Pharmacokinet_2014_Jun_27_53(8)_741-751.nxml.txt.nlp	24968986	SENT250	6	6	44	44	docetaxel	OATP1B3	PA449383	28234	0.997
NULL	ARYA_Atheroscler_2011_Summer_7(2)_78-86.nxml.txt.nlp	22577451	SENT89	24	24	2	2	choline	CRP	PA448976	1401;140913	0.997
NULL	Mol_Vis_2012_Jan_28_18_234-240.nxml.txt.nlp	22312192	SENT27	22	22	6	6	bevacizumab	VEGF-A	PA130232992	7422	0.997
NULL	Ann_Rheum_Dis_2014_Sep_3_73(9)_1616-1625.nxml.txt.nlp	24699939	SENT27	2	2	32	32	tocilizumab	IL-6	PA165292659	3569	0.997
NULL	Allergy_Asthma_Immunol_Res_2014_Nov_19_6(6)_548-557.nxml.txt.nlp	25374755	SENT84	23	23	2	2	lovastatin	MUC5AC	PA450272	4586	0.997
NULL	Clinics_(Sao_Paulo)_2011_Aug_66(8)_1485-1487.nxml.txt.nlp	21915505	SENT41	37	37	3	3	abacavir	HLA-B	PA448004	3106	0.997
NULL	Breast_Cancer_Res_2012_Jul_19_14(4)_R108.nxml.txt.nlp	22812534	SENT210	10	10	37	37	pargyline	aromatase	PA450797	1588	0.997
NULL	Clin_Drug_Investig_2013_Aug_23_33(10)_727-736.nxml.txt.nlp	23975654	SENT172	12	12	31	31	paroxetine	CYP1A2	PA450801	1544	0.997
NULL	Br_J_Cancer_2009_Jul_21_101(2)_238-243.nxml.txt.nlp	19568242	SENT139	17	17	37	37	bevacizumab	IFN	PA130232992	3439	0.997
NULL	Crit_Care_2003_Jul_16_7(5)_374-384.nxml.txt.nlp	12974970	SENT179	4	4	18	18	fenoldopam	DA1	PA164784034	28495;7169	0.997
NULL	Trials_2013_May_4_14_125.nxml.txt.nlp	23782591	SENT39	5	5	20	20	bupropion	CYP2D6	PA448687	1565	0.997
NULL	Nat_Med_2013_Dec_10_19(12)_10_1038_nm_3385.nxml.txt.nlp	24216752	SENT67	11	11	32	32	thrombin	PAR1	PA451674	79581;2149	0.997
NULL	Prostate_Int_2014_Sep_21_2(3)_105-113.nxml.txt.nlp	25325021	SENT158	9	9	1	1	dutasteride	SRD5A3	PA164749300	79644	0.997
NULL	EMBO_Mol_Med_2014_Oct_17_6(10)_1294-1311.nxml.txt.nlp	25231413	SENT144	27	27	2	2	calcein	CD4	PA132595336	920	0.997
NULL	Arthritis_Res_Ther_2009_Oct_14_11(5)_246.nxml.txt.nlp	19849823	SENT208	4	4	30	30	estradiol	IL-4	PA449503	3565	0.997
NULL	Arthritis_Res_Ther_2007_Mar_3_9(2)_R23.nxml.txt.nlp	17335581	SENT127	6	6	35	35	sulfasalazine	NAT2	PA451547	10;81539	0.997
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT863	22	22	0	0	estradiol	MRP2	PA449503	100130958;57626;1244	0.997
NULL	Breast_Cancer_Res_2010_May_10_12(3)_R26.nxml.txt.nlp	20459744	SENT137	30	30	9	9	docetaxel	CYP3A5	PA449383	1577	0.997
NULL	Oncol_Lett_2013_Feb_9_5(2)_552-558.nxml.txt.nlp	23420128	SENT32	5	5	19	19	imatinib	KIT	PA10804	3815	0.997
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_15_2012_591654.nxml.txt.nlp	23118793	SENT182	7	7	41	41	berberine	PPG	PA165860812	5552	0.997
NULL	Oncotarget_2014_Oct_16_5(20)_9546-9563.nxml.txt.nlp	25337673	SENT121	38	38	18	18	lapatinib	AXL	PA152241907	558	0.997
NULL	Indian_J_Psychiatry_2011_Oct-Dec_53(4)_283-286.nxml.txt.nlp	22303034	SENT67	14	14	43	43	fluoxetine	spatial	PA449673	219793	0.997
NULL	Int_J_Med_Sci_2014_May_1_11(7)_663-673.nxml.txt.nlp	24843314	SENT47	31	31	6	6	tamoxifen	TFF1	PA451581	7031	0.997
NULL	J_Oncol_2011_Sep_15_2011_528353.nxml.txt.nlp	21941546	SENT195	44	44	0	0	cisplatin	Bcl-2	PA449014	596	0.997
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT389	3	3	45	45	resveratrol	IL-6		3569	0.997
NULL	Oncotarget_2013_Nov_7_4(12)_2550-2566.nxml.txt.nlp	24334291	SENT121	20	20	2	2	dasatinib	AMPK	PA162372878	5563	0.997
NULL	Clin_Med_Insights_Oncol_2012_May_16_6_205-217.nxml.txt.nlp	22654526	SENT197	7	7	37	37	vorinostat	CXCR4	PA164748224	7852	0.997
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2675-2684.nxml.txt.nlp	24129246	SENT198	37	37	12	12	etoposide	p53	PA449552	7157	0.997
NULL	Ann_Lab_Med_2015_Jan_8_35(1)_15-21.nxml.txt.nlp	25553275	SENT60	36	36	0	0	thrombin	Lag	PA451674	3925	0.997
NULL	Oncotarget_2013_Aug_21_4(9)_1484-1495.nxml.txt.nlp	23986086	SENT162	42	42	16	16	trastuzumab	PTEN	PA451743	5728	0.997
NULL	Curr_Oncol_2009_Aug_16(4)_9-21.nxml.txt.nlp	19672420	SENT231	41	41	1	1	erlotinib	EGFR	PA134687924	1956	0.997
NULL	Biomed_Res_Int_2013_Dec_10_2013_565218.nxml.txt.nlp	24386638	SENT242	6	6	25	25	desipramine	DIO2	PA449233	1734	0.997
NULL	Front_Physiol_2013_Jul_12_4_178.nxml.txt.nlp	23874303	SENT249	6	6	43	43	aprotinin	EMMPRIN	PA448472	682	0.997
NULL	Mol_Cancer_2010_Apr_23_9_87.nxml.txt.nlp	20416058	SENT276	4	4	26	26	doxorubicin	DR5	PA449412	8795	0.997
NULL	Genome_Med_2009_Sep_4_1(9)_83.nxml.txt.nlp	19732436	SENT295	6	6	31	31	topotecan	UGT1A	PA451729	7361;54658	0.997
NULL	Br_J_Clin_Pharmacol_2014_Nov_20_78(5)_1050-1057.nxml.txt.nlp	24962564	SENT186	0	0	11	11	midazolam	CYP3A4	PA450496	1576	0.997
NULL	Crit_Care_2011_Feb_3_15(1)_R49.nxml.txt.nlp	21291554	SENT128	34	34	8	8	cefepime	CLCR	PA164754876	11330	0.997
NULL	Front_Endocrinol_(Lausanne)_2014_Jan_16_5_1.nxml.txt.nlp	24474947	SENT89	40	40	1	1	estradiol	GPER	PA449503	2852	0.997
NULL	Front_Oncol_2014_Nov_25_4_329.nxml.txt.nlp	25505733	SENT118	0	0	22	22	everolimus	EGFR	PA164746311	1956	0.997
NULL	Arthritis_Res_Ther_2012_Jul_12_14(4)_R163.nxml.txt.nlp	22784880	SENT159	32	32	6	6	methotrexate	DHODH	PA450428	1723	0.997
NULL	J_Gen_Physiol_2003_Mar_121(3)_181-197.nxml.txt.nlp	12601083	SENT396	10	10	26	26	forskolin	SUR1	PA146096022	6833	0.997
NULL	Breast_Cancer_Res_2005_Jun_17_7(Suppl_2)_P1_20.nxml.txt.nlp	NULL	SENT3	22	22	0	0	tamoxifen	NCOA3	PA451581	8202	0.997
NULL	Arthritis_Res_Ther_2006_Jul_28_8(Suppl_2)_S4.nxml.txt.nlp	16899108	SENT90	27	27	0	0	tocilizumab	IL-6	PA165292659	3569	0.997
NULL	J_Hematol_Oncol_2010_Mar_13_3_10.nxml.txt.nlp	20226083	SENT13	5	5	16	16	gemcitabine	RRM1	PA449748	6240	0.997
NULL	Leukemia_2014_Jan_12_28(1)_15-33.nxml.txt.nlp	23778311	SENT577	35	35	19	19	imatinib	p53	PA10804	7157	0.997
NULL	EPMA_J_2011_Jun_1_2(2)_231-239.nxml.txt.nlp	23199151	SENT53	6	6	31	31	thioguanine	TPMT	PA451663	7172	0.997
NULL	Mol_Cancer_2009_Nov_19_8_108.nxml.txt.nlp	19925669	SENT126	31	31	12	12	doxorubicin	CRT	PA449412	811	0.997
NULL	Nat_Commun_2013_Sep_17_4_2464.nxml.txt.nlp	24043118	SENT42	5	5	36	36	estradiol	FGFR2	PA449503	2263	0.997
NULL	Oncol_Lett_2014_Jun_24_7(6)_1951-1953.nxml.txt.nlp	24932266	SENT48	0	0	15	15	trastuzumab	HER-2	PA451743	2064	0.997
NULL	J_Korean_Med_Sci_2011_Dec_29_26(12)_1563-1568.nxml.txt.nlp	22147992	SENT90	0	0	21	21	sorafenib	VEGFR	PA7000	3791	0.997
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT119	35	35	46	46	nilotinib	ABCB1	PA165958345	5243	0.997
NULL	Oxid_Med_Cell_Longev_2013_Nov_10_2013_680414.nxml.txt.nlp	24319532	SENT205	8	8	14	14	minocycline	PARP-1	PA450519	25976	0.997
NULL	Case_Rep_Med_2014_Oct_7_2014_958414.nxml.txt.nlp	25349620	SENT58	0	0	20	20	sunitinib	VEGFR	PA162372840	3791	0.997
NULL	Exp_Cell_Res_2011_Apr_15_317(7)_1028-1039.nxml.txt.nlp	21237154	SENT107	7	7	46	46	staurosporine	JIP1	PA165109623	9479	0.997
NULL	Mol_Cancer_2010_Aug_23_9_222.nxml.txt.nlp	20731837	SENT174	8	8	31	31	gefitinib	ATM	PA131301952	472	0.997
NULL	Diabetes_Metab_Syndr_Obes_2010_May_17_3_165-172.nxml.txt.nlp	21437086	SENT29	4	4	26	26	exenatide	AMIGO	PA164749238	57463	0.997
NULL	Oncotarget_2014_Oct_11_5(20)_10070-10083.nxml.txt.nlp	25301722	SENT225	27	27	5	5	cetuximab	EGFR	PA10040	1956	0.997
NULL	Pharmaceuticals_(Basel)_2012_Sep_12_5(9)_1008-1020.nxml.txt.nlp	24280702	SENT779	5	5	19	19	geldanamycin	Hsp90	PA152031327	3320	0.997
NULL	Core_Evid_2011_Mar_17_6_31-42.nxml.txt.nlp	21468241	SENT143	7	7	23	23	ticagrelor	ABCB1	PA165374673	5243	0.997
NULL	Gene_Regul_Syst_Bio_2014_Mar_4_8_63-73.nxml.txt.nlp	24634581	SENT9	0	0	42	42	minocycline	STAT3	PA450519	6774	0.997
NULL	Breast_Cancer_Res_2011_Nov_30_13(6)_221.nxml.txt.nlp	22217398	SENT174	21	21	3	3	everolimus	IRS1	PA164746311	3667	0.997
NULL	Oncotarget_2013_Jul_21_4(8)_1253-1265.nxml.txt.nlp	23896512	SENT148	25	25	33	33	gefitinib	AKT	PA131301952	207	0.997
NULL	J_Cell_Biol_1998_Jan_26_140(2)_335-345.nxml.txt.nlp	9442109	SENT130	21	21	14	14	chloroquine	NHE	PA448948	285335	0.997
NULL	Int_J_Environ_Res_Public_Health_2013_Aug_2_10(8)_3233-3245.nxml.txt.nlp	23917811	SENT169	30	30	9	9	thyroglobulin	PAX8	PA164754910	7849	0.997
NULL	Oncol_Lett_2014_Jan_7_7(1)_50-52.nxml.txt.nlp	24348819	SENT40	3	3	9	9	sorafenib	SHARP	PA7000	23013	0.997
NULL	Curr_Pharm_Des_2008_Oct_14(28)_2983-2998.nxml.txt.nlp	18991714	SENT82	4	4	15	15	gefitinib	EGFR	PA131301952	1956	0.997
NULL	Mol_Cancer_2012_Apr_5_11_20.nxml.txt.nlp	22480225	SENT51	15	15	6	6	cisplatin	SPARC	PA449014	6678	0.997
NULL	Mol_Brain_2014_Oct_9_7(1)_74.nxml.txt.nlp	NULL	SENT20	29	29	8	8	methamphetamine	DTNBP1	PA450403	84062	0.997
NULL	Drugs_Aging_2014_Apr_29_31(6)_461-470.nxml.txt.nlp	24777691	SENT46	4	4	34	34	colesevelam	GLP-1	PA449095	100125288	0.997
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2009_Sep_1_65(Pt_9)_913-920.nxml.txt.nlp	19690369	SENT65	2	2	33	33	trypsin	p53	PA451806	7157	0.997
NULL	Alcohol_Res_Health_2011_34(1)_106-120.nxml.txt.nlp	23580048	SENT143	6	6	22	22	ethanol	CA1	PA448073	759	0.997
NULL	Br_J_Cancer_2010_May_25_102(11)_1578-1591.nxml.txt.nlp	20502461	SENT223	2	2	22	22	geldanamycin	p53	PA152031327	7157	0.997
NULL	Br_J_Cancer_2009_Mar_10_100(5)_758-763.nxml.txt.nlp	19259094	SENT110	31	31	0	0	decitabine	MLH1	PA164749631	4292	0.997
NULL	J_Korean_Med_Sci_2005_Jun_30_20(3)_456-460.nxml.txt.nlp	15953869	SENT96	26	26	0	0	l-alanine	UPP1	PA448055	7378	0.997
NULL	Oncol_Rep_2013_May_5_29(5)_1697-1700.nxml.txt.nlp	23467750	SENT31	7	7	17	17	imatinib	ABCG2	PA10804	9429	0.997
NULL	Oncoimmunology_2013_Sep_1_2(9)_e26198.nxml.txt.nlp	24228232	SENT27	28	28	12	12	cisplatin	p53	PA449014	7157	0.997
NULL	Neural_Plast_2014_Mar_17_2014_123026.nxml.txt.nlp	24757568	SENT168	0	0	35	35	estradiol	CA3	PA449503	761	0.997
NULL	Neuropsychopharmacology_2009_Apr_2_34(5)_1135-1148.nxml.txt.nlp	18596687	SENT333	36	36	0	0	betaxolol	CRF	PA448611	1392;10882	0.997
NULL	Case_Rep_Pulmonol_2013_Sep_5_2013_813786.nxml.txt.nlp	24093069	SENT50	8	8	33	33	montelukast	CysLT1	PA450546	10800	0.997
NULL	Oncoimmunology_2012_Aug_1_1(5)_726-734.nxml.txt.nlp	22934264	SENT63	39	39	8	8	imiquimod	CCL2	PA449972	6347	0.997
NULL	J_Hematol_Oncol_2013_Jan_17_6_8.nxml.txt.nlp	23327547	SENT45	38	38	4	4	sulindac	JNK1	PA451565	5599	0.997
NULL	J_Biol_Chem_2012_Apr_13_287(16)_13382-13395.nxml.txt.nlp	22367194	SENT204	29	29	3	3	marimastat	TIMP1	PA164748329	7076	0.997
NULL	Cell_Commun_Signal_2013_Nov_11_11_86.nxml.txt.nlp	24215724	SENT330	42	42	10	10	thrombin	PAR1	PA451674	79581;2149	0.997
NULL	Oncotarget_2012_Nov_8_3(11)_1472-1482.nxml.txt.nlp	23178531	SENT86	4	4	46	46	iron	IRP1	PA450087	48	0.997
NULL	EMBO_Mol_Med_2012_Jul_25_4(7)_545-556.nxml.txt.nlp	22730341	SENT177	10	10	20	20	vincristine	FBW7	PA451879	55294	0.997
NULL	Int_J_Mol_Imaging_2011_Oct_26_2011_874585.nxml.txt.nlp	21490735	SENT161	28	28	15	15	glucose	FDG	PA449773	23583	0.997
NULL	Pharmaceuticals_(Basel)_2013_May_23_6(6)_689-699.nxml.txt.nlp	24276256	SENT111	0	0	14	14	nicardipine	PTB	PA450620	58155	0.997
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_315-322.nxml.txt.nlp	20049735	SENT163	13	13	5	5	olaparib	BRCA2		675	0.997
NULL	F1000Res_2013_Aug_20_2_147.nxml.txt.nlp	24555068	SENT280	0	0	30	30	curcumin	p65	PA151958596	5970	0.997
NULL	Am_J_Case_Rep_2013_Jun_17_14_205-209.nxml.txt.nlp	23826469	SENT117	0	0	35	35	ivermectin	CYP2C9	PA450133	1559	0.997
NULL	eLife_2013_Oct_29_2_e01236.nxml.txt.nlp	24171104	SENT464	17	17	0	0	bortezomib	HSF1	PA10252	3297	0.997
NULL	Cancers_(Basel)_2014_Feb_10_6(1)_376-395.nxml.txt.nlp	24518612	SENT184	0	0	15	15	resveratrol	STAT3		6774	0.997
NULL	Int_J_Appl_Basic_Med_Res_2013_Jan-Jun_3(1)_3-10.nxml.txt.nlp	23776832	SENT104	4	4	16	16	retapamulin	CYP3A4	PA164749341	1576	0.997
NULL	Curr_Opin_Oncol_2014_Jul_6_26(4)_428-433.nxml.txt.nlp	24840521	SENT111	7	7	39	39	olaparib	MRI		78996	0.997
NULL	Cancer_Med_2014_Oct_18_3(5)_1294-1301.nxml.txt.nlp	24941936	SENT176	14	14	24	24	cetuximab	KRAS	PA10040	3845	0.997
NULL	J_Cell_Biol_2001_Apr_16_153(2)_429-434.nxml.txt.nlp	11309421	SENT218	25	25	8	8	forskolin	TDAG8	PA146096022	8477	0.997
NULL	Nucl_Recept_Signal_2012_Feb_27_10_e003.nxml.txt.nlp	22438793	SENT232	29	29	3	3	tamoxifen	RALDH3	PA451581	220	0.997
NULL	J_Cancer_Prev_2013_Jun_18(2)_186-191.nxml.txt.nlp	25337545	SENT83	19	19	3	3	curcumin	p53	PA151958596	7157	0.997
NULL	Br_J_Cancer_2011_Mar_1_104(5)_750-755.nxml.txt.nlp	21326243	SENT152	29	29	1	1	dacarbazine	MPG	PA449197	4350	0.997
NULL	J_Med_Phys_2006_Jan-Mar_31(1)_13-21.nxml.txt.nlp	21206635	SENT22	21	21	4	4	glucose	FDG	PA449773	23583	0.997
NULL	J_Ophthalmic_Inflamm_Infect_2011_May_11_1(3)_105-110.nxml.txt.nlp	21559864	SENT111	37	37	19	19	albendazole	CD4	PA164746058	920	0.997
NULL	Ther_Clin_Risk_Manag_2007_Aug_3(4)_533-542.nxml.txt.nlp	18472974	SENT143	3	3	33	33	posaconazole	MDR1	PA151958574	5243	0.997
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1107-1116.nxml.txt.nlp	22343619	SENT323	28	28	1	1	carboplatin	EGFR	PA448803	1956	0.997
NULL	Indian_J_Endocrinol_Metab_2013_Dec_17(Suppl_3)_S674-S679.nxml.txt.nlp	24910836	SENT144	7	7	26	26	acarbose	PPG	PA448010	5552	0.997
NULL	Anal_Chem_Insights_2009_Apr_7_4_1-9.nxml.txt.nlp	19652757	SENT99	35	35	14	14	escitalopram	mol	PA10074	90527	0.997
NULL	J_Cell_Biol_1992_Apr_1_117(1)_27-38.nxml.txt.nlp	1556155	SENT8	17	17	1	1	trypsin	p200	PA451806	10565	0.997
NULL	Lancet_2010_Sep_4_376(9743)_794-801.nxml.txt.nlp	20800271	SENT62	7	7	41	41	heparin	CFHR5	PA449855	81494	0.997
NULL	Breast_Cancer_Res_2010_Nov_16_12(6)_R96.nxml.txt.nlp	21080941	SENT155	27	27	4	4	lapatinib	HRG	PA152241907	3084;3273	0.997
NULL	Front_Neurosci_2012_May_30_6_77.nxml.txt.nlp	22661925	SENT149	16	16	6	6	ethanol	HEC	PA448073	10403	0.997
NULL	Crit_Care_2010_Apr_19_14(2)_R70.nxml.txt.nlp	20403177	SENT312	28	28	2	2	thrombin	cPLA2	PA451674	10524	0.997
NULL	Ecancermedicalscience_2009_Oct_29_3_157.nxml.txt.nlp	22276018	SENT71	22	22	37	37	gefitinib	HER3	PA131301952	2065	0.997
NULL	Pharmaceuticals_(Basel)_2013_Aug_6_6(8)_929-959.nxml.txt.nlp	24276377	SENT107	27	27	19	19	oxaliplatin	CXCL8	PA131285527	3576	0.997
NULL	J_Gynecol_Oncol_2013_Jul_4_24(3)_273-279.nxml.txt.nlp	23875078	SENT102	12	12	38	38	paclitaxel	COX	PA450761	1351	0.997
NULL	J_Ophthalmol_2011_Dec_23_2011_292040.nxml.txt.nlp	21253505	SENT83	3	3	30	30	nilvadipine	rd2	PA165958385	5961	0.997
NULL	Evid_Based_Complement_Alternat_Med_2013_Mar_17_2013_684071.nxml.txt.nlp	23573143	SENT252	4	4	12	12	vanillin	PI3K	PA451852	5290	0.997
NULL	Cell_Cycle_2012_Nov_1_11(21)_3983-3996.nxml.txt.nlp	22987153	SENT91	14	14	2	2	cisplatin	EXO1	PA449014	9156	0.997
NULL	Breast_Cancer_Res_2011_Nov_4_13(6)_R111.nxml.txt.nlp	22053985	SENT184	18	18	3	3	doxorubicin	IRF5	PA449412	3663	0.997
NULL	Breast_Cancer_Res_2010_Dec_20_12(Suppl_4)_S4.nxml.txt.nlp	21172088	SENT22	31	31	3	3	trastuzumab	HER2	PA451743	2064	0.997
NULL	Acta_Pharmacol_Sin_2014_Aug_30_35(8)_1045-1054.nxml.txt.nlp	24976155	SENT128	6	6	20	20	resveratrol	STAT3		6774	0.997
NULL	Cancer_Cell_Int_2011_Mar_10_11_6.nxml.txt.nlp	21392380	SENT125	0	0	26	26	imipramine	HERG	PA449969	3757	0.997
NULL	Nat_Commun_2014_Apr_28_5_3695.nxml.txt.nlp	24770583	SENT296	16	16	6	6	doxycycline	p97	PA449415	50628;10428;1982;7415	0.997
NULL	J_Cancer_2013_Nov_21_4(9)_727-735.nxml.txt.nlp	24312143	SENT159	25	25	2	2	cisplatin	SRPK1	PA449014	6732	0.997
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT105	35	35	4	4	trastuzumab	HRG	PA451743	3084;3273	0.997
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT310	5	5	33	33	panitumumab	KRAS	PA162373091	3845	0.997
NULL	Curr_Chem_Genomics_2010_Mar_1_4_1-8.nxml.txt.nlp	20448812	SENT93	7	7	26	26	piperazine	OATP1B3	PA450977	28234	0.997
NULL	eLife_2013_Nov_5_2_e00969.nxml.txt.nlp	24192036	SENT20	19	19	35	35	vemurafenib	JNK	PA165946873	5599	0.997
NULL	J_Asthma_Allergy_2010_Jul_16_3_57-63.nxml.txt.nlp	21437040	SENT111	40	40	7	7	simvastatin	CD4	PA451363	920	0.997
NULL	Breast_Cancer_Res_2009_Oct_7_11(5)_R73.nxml.txt.nlp	19811637	SENT71	16	16	7	7	trastuzumab	HER2	PA451743	2064	0.997
NULL	Oncotarget_2013_Nov_24_4(12)_2186-2207.nxml.txt.nlp	24327604	SENT210	6	6	45	45	vincristine	LFA-1	PA451879	3683;3689	0.997
NULL	Acta_Pharmacol_Sin_2010_Sep_23_31(9)_1223-1240.nxml.txt.nlp	20729872	SENT199	12	12	26	26	atorvastatin	PC-3	PA448500	692094	0.997
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Feb_17_6_29-36.nxml.txt.nlp	24648767	SENT47	13	13	33	33	tamoxifen	BRCA1	PA451581	672	0.997
NULL	Onco_Targets_Ther_2014_Dec_3_7_2227-2236.nxml.txt.nlp	25506226	SENT105	0	0	43	43	trastuzumab	ADC	PA451743	113451	0.997
NULL	Cancers_(Basel)_2014_Jul_7_6(3)_1441-1463.nxml.txt.nlp	25003395	SENT181	2	2	20	20	vincristine	Bcl-2	PA451879	596	0.997
NULL	Dermatoendocrinol_2013_Apr_1_5(2)_239-251.nxml.txt.nlp	24194964	SENT209	36	36	3	3	dacarbazine	HIF-1	PA449197	29072	0.997
NULL	Gut_Pathog_2014_Aug_20_6_34.nxml.txt.nlp	25349629	SENT178	0	0	23	23	metronidazole	ST4	PA450484	202;6763	0.997
NULL	Target_Oncol_2010_Jun_14_5(2)_95-112.nxml.txt.nlp	20625845	SENT241	42	42	26	26	everolimus	FDG	PA164746311	23583	0.997
NULL	Br_J_Haematol_2014_Mar_6_164(6)_759-766.nxml.txt.nlp	24387053	SENT155	3	3	23	23	eculizumab	PEX	PA164776637	5251	0.997
NULL	Open_Access_J_Urol_2011_May_10_3_69-82.nxml.txt.nlp	24198638	SENT63	31	31	7	7	gemcitabine	CYP3A4	PA449748	1576	0.997
NULL	Acta_Pharmacol_Sin_2010_Jul_28_31(7)_867-873.nxml.txt.nlp	20581857	SENT145	41	41	5	5	docetaxel	P-gp	PA449383	5243	0.997
NULL	Diabetol_Metab_Syndr_2014_Oct_15_6(1)_110.nxml.txt.nlp	NULL	SENT90	22	22	34	34	metformin	GLP-1	PA450395	100125288	0.997
NULL	Oncogene_2014_Jun_12_33(24)_3151-3160.nxml.txt.nlp	23851502	SENT102	7	7	38	38	everolimus	TSC1	PA164746311	7248	0.997
NULL	Cancers_(Basel)_2011_Nov_23_3(4)_4170-4190.nxml.txt.nlp	24213132	SENT145	3	3	16	16	flavopiridol	CDK9	PA452627	1025	0.997
NULL	Cancers_(Basel)_2012_Sep_25_4(4)_969-988.nxml.txt.nlp	24213497	SENT201	3	3	12	12	fulvestrant	aromatase	PA164747170	1588	0.997
NULL	Arthritis_Res_Ther_2013_Sep_27_15(5)_R138.nxml.txt.nlp	24289726	SENT26	15	15	42	42	anakinra	IL-6	PA10799	3569	0.997
NULL	Mol_Cancer_2009_Jun_9_8_37.nxml.txt.nlp	19508729	SENT63	46	46	5	5	gemcitabine	HO-1	PA449748	3162	0.997
NULL	Breast_Cancer_Res_2007_Jun_7_9(3)_R37.nxml.txt.nlp	17555561	SENT212	32	32	3	3	raloxifene	CD36	PA451221	948	0.997
NULL	Mol_Biol_Cell_2013_Sep_1_24(17)_2678-2688.nxml.txt.nlp	23864716	SENT84	10	10	22	22	thrombin	PP2	PA451674	4888	0.997
NULL	Breast_Cancer_Res_2011_Jun_15_13(3)_R67.nxml.txt.nlp	21699723	SENT149	9	9	20	20	trastuzumab	HER-2	PA451743	2064	0.997
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT310	3	3	33	33	cetuximab	KRAS	PA10040	3845	0.997
NULL	Neural_Plast_2007_Oct_10_2007_23250.nxml.txt.nlp	NULL	SENT164	15	15	3	3	citalopram	TPH2	PA449015	6999;121278	0.997
NULL	Breast_Cancer_Res_Treat_2013_Aug_20_141(1)_43-53.nxml.txt.nlp	23959396	SENT27	44	44	5	5	pertuzumab	HER3		2065	0.997
NULL	Arthritis_Res_Ther_2013_Aug_30_15(4)_R100.nxml.txt.nlp	24000795	SENT123	25	25	0	0	methotrexate	STAT1	PA450428	6772	0.997
NULL	Am_J_Case_Rep_2014_Dec_9_15_550-553.nxml.txt.nlp	25488633	SENT52	0	0	28	28	mesalazine	CDAI	PA450384	146059	0.997
NULL	EJNMMI_Res_2011_Aug_17_1_15.nxml.txt.nlp	22214307	SENT24	30	30	7	7	trastuzumab	HER2	PA451743	2064	0.997
NULL	Cancer_Res_Treat_2012_Jun_30_44(2)_74-84.nxml.txt.nlp	22802745	SENT254	0	0	27	27	neratinib	EGFR	PA165291472	1956	0.997
NULL	Adv_Hematol_2012_Mar_8_2012_856341.nxml.txt.nlp	22496694	SENT181	23	23	5	5	verapamil	P-gp	PA451868	5243	0.997
NULL	J_Clin_Exp_Pathol_2012_May_17_Suppl_4_7327.nxml.txt.nlp	25379357	SENT47	10	10	33	33	resveratrol	SIRT1		23411	0.997
NULL	Breast_Cancer_(Auckl)_2014_Jul_29_8_109-118.nxml.txt.nlp	25125981	SENT14	0	0	21	21	trastuzumab	HER2	PA451743	2064	0.997
NULL	Int_J_Endocrinol_Metab_2013_Dec_21_Winter_11(1)_57-61.nxml.txt.nlp	23853622	SENT122	1	1	22	22	bromocriptine	PRL	PA448671	5617	0.997
NULL	Cancers_(Basel)_2014_Mar_6_6(1)_494-525.nxml.txt.nlp	24662938	SENT1869	22	22	0	0	gefitinib	EGF	PA131301952	1950	0.997
NULL	Biology_(Basel)_2012_Dec_31_2(1)_40-63.nxml.txt.nlp	24832651	SENT153	34	34	3	3	mitomycin	BRCA1	PA450524	672	0.997
NULL	Curr_Cardiol_Rev_2011_Nov_7(4)_221-233.nxml.txt.nlp	22758623	SENT179	19	19	4	4	tamoxifen	aromatase	PA451581	1588	0.997
NULL	Hum_Genomics_2012_Aug_2_6(1)_9.nxml.txt.nlp	23245743	SENT164	30	30	9	9	atorvastatin	CXCL5	PA448500	6374	0.997
NULL	Ann_Lab_Med_2014_Jul_19_34(4)_321-324.nxml.txt.nlp	24982839	SENT50	20	20	3	3	linezolid	DST	PA450233	667	0.997
NULL	J_Cell_Sci_2012_Sep_15_125(18)_4297-4305.nxml.txt.nlp	22718348	SENT225	28	28	6	6	geldanamycin	Hsp90	PA152031327	3320	0.997
NULL	Brief_Bioinform_2014_Jul_31_15(4)_648-659.nxml.txt.nlp	23376192	SENT227	13	13	4	4	cisplatin	KIT	PA449014	3815	0.997
NULL	Mol_Cancer_2012_Aug_6_11_52.nxml.txt.nlp	22867098	SENT198	6	6	17	17	vorinostat	EZH2	PA164748224	2146	0.997
NULL	Am_J_Transplant_2012_Aug_12(8)_2008-2016.nxml.txt.nlp	22500984	SENT172	30	30	5	5	cyclosporine	CD4	PA449167	920	0.997
NULL	Cardiol_Res_Pract_2013_Jan_31_2013_128795.nxml.txt.nlp	23431496	SENT153	26	26	8	8	clopidogrel	CYP2C19	PA449053	1557	0.997
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2011_Mar_14_4_13-24.nxml.txt.nlp	22879790	SENT119	13	13	39	39	liraglutide	GLP-1	PA165958364	100125288	0.997
NULL	Cancer_Cell_Int_2005_Jun_1_5_18.nxml.txt.nlp	15929791	SENT7	2	2	10	10	bortezomib	p27	PA10252	5715;10534	0.997
NULL	Br_J_Cancer_2011_Apr_26_104(9)_1393-1400.nxml.txt.nlp	21448163	SENT53	4	4	16	16	tamoxifen	aromatase	PA451581	1588	0.997
NULL	Cell_Death_Dis_2013_Oct_3_4(10)_e827.nxml.txt.nlp	24091670	SENT93	39	39	24	24	nilotinib	CD38	PA165958345	952	0.997
NULL	Patient_Prefer_Adherence_2013_Mar_27_7_245-258.nxml.txt.nlp	23569364	SENT104	25	25	13	13	exemestane	aromatase	PA449563	1588	0.997
NULL	Arthritis_Res_Ther_2012_Apr_26_14(2)_R90.nxml.txt.nlp	22537858	SENT226	42	42	6	6	atorvastatin	IFN	PA448500	3439	0.997
NULL	Oncol_Rep_2014_Apr_28_31(4)_1605-1612.nxml.txt.nlp	24481648	SENT37	0	0	8	8	nilotinib	P-gp	PA165958345	5243	0.997
NULL	Breast_Cancer_Res_2010_Aug_3_12(4)_403.nxml.txt.nlp	20727234	SENT3	15	15	42	42	ibandronate	aromatase	PA10270	1588	0.997
NULL	Indian_J_Med_Paediatr_Oncol_2014_Apr-Jun_35(2)_176-180.nxml.txt.nlp	25197183	SENT43	22	22	1	1	tamoxifen	aromatase	PA451581	1588	0.997
NULL	Mar_Drugs_2010_Mar_25_8(4)_835-880.nxml.txt.nlp	20479958	SENT203	18	18	40	40	l-isoleucine	C-1	PA164750430	5203	0.997
NULL	Clin_Pharmacol_2012_Feb_20_4_13-20.nxml.txt.nlp	22427735	SENT58	30	30	2	2	clopidogrel	CYP2C19	PA449053	1557	0.997
NULL	Biologics_2010_Aug_9_4_173-185.nxml.txt.nlp	20714355	SENT158	44	44	0	0	minocycline	EGFR	PA450519	1956	0.997
NULL	Curr_Pharm_Des_2011_Apr_17(10)_985-989.nxml.txt.nlp	21524255	SENT85	8	8	22	22	phencyclidine	PAC1	PA128406980	8624;1316;117	0.997
NULL	Br_J_Cancer_2012_Oct_9_107(8)_1268-1276.nxml.txt.nlp	22996612	SENT143	7	7	39	39	axitinib	CYP2C8	PA164924493	1558	0.997
NULL	Oncoimmunology_2014_Apr_25_3_e28518.nxml.txt.nlp	25071979	SENT119	32	32	5	5	carboplatin	CRT	PA448803	811	0.997
NULL	Ann_Hematol_2010_Sep_13_89(9)_861-871.nxml.txt.nlp	20387067	SENT199	4	4	17	17	dasatinib	TPO	PA162372878	7066;7173	0.997
NULL	J_Cell_Biol_1979_Nov_1_83(2)_394-402.nxml.txt.nlp	500787	SENT1	1	1	38	38	methotrexate	DHFR	PA450428	1719	0.997
NULL	ACS_Med_Chem_Lett_2013_Mar_25_4(5)_486-490.nxml.txt.nlp	23687559	SENT73	1	1	42	42	indomethacin	COX	PA449982	1351	0.997
NULL	Allergy_2015_Jan_28_70(1)_80-89.nxml.txt.nlp	25331546	SENT170	1	1	34	34	clodronate	IL-5	PA10239	3567	0.997
NULL	Asia_Pac_Allergy_2013_Oct_31_3(4)_215-223.nxml.txt.nlp	24260726	SENT119	25	25	13	13	allopurinol	HLA-B	PA448320	3106	0.997
NULL	Springerplus_2013_Jan_11_2_5.nxml.txt.nlp	23520572	SENT18	32	32	10	10	tamoxifen	aromatase	PA451581	1588	0.997
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S31-S40.nxml.txt.nlp	20680106	SENT61	8	8	21	21	cetuximab	KRAS	PA10040	3845	0.997
NULL	J_Mol_Psychiatry_2013_Nov_4_1(1)_19.nxml.txt.nlp	25408910	SENT128	11	11	28	28	olanzapine	CTCF	PA450688	10664	0.997
NULL	Mol_Clin_Oncol_2013_Sep_23_1(5)_828-832.nxml.txt.nlp	24649255	SENT21	0	0	27	27	erlotinib	EGFR	PA134687924	1956	0.997
NULL	Int_J_Gen_Med_2009_Jul_30_2_77-81.nxml.txt.nlp	20360891	SENT17	6	6	23	23	hyaluronan	HAS2	PA165958431	3037	0.997
NULL	Cancer_Biol_Med_2012_Mar_9(1)_18-22.nxml.txt.nlp	23691449	SENT84	2	2	20	20	gefitinib	PTEN	PA131301952	5728	0.997
NULL	Nat_Commun_2013_Apr_3_4_1659.nxml.txt.nlp	23552074	SENT37	16	16	3	3	staurosporine	GRASP	PA165109623	160622	0.997
NULL	Curr_Neuropharmacol_2014_Mar_12(2)_120-139.nxml.txt.nlp	24669207	SENT221	19	19	0	0	ethanol	GLO1	PA448073	2739	0.997
NULL	Br_J_Cancer_2009_Oct_6_101(7)_1224.nxml.txt.nlp	NULL	SENT12	0	0	24	24	sunitinib	CYP3A4	PA162372840	1576	0.996
NULL	Basic_Clin_Pharmacol_Toxicol_2013_Feb_5_112(2)_132-137.nxml.txt.nlp	22900583	SENT23	8	8	25	25	prasugrel	CYP3A	PA154410481	1574	0.996
NULL	Oncotarget_2013_Aug_8_4(8)_1130-1142.nxml.txt.nlp	24029073	SENT193	17	17	11	11	cisplatin	NRF2	PA449014	2551;4780	0.996
NULL	Int_J_Mol_Sci_2012_Sep_26_13(10)_12268-12286.nxml.txt.nlp	23202898	SENT138	6	6	29	29	trastuzumab	gamma	PA451743	9913	0.996
NULL	Mol_Cancer_2014_Jun_14_13_150.nxml.txt.nlp	24927996	SENT262	7	7	23	23	geldanamycin	Hsp90	PA152031327	3320	0.996
NULL	Indian_J_Dermatol_2012_Jul-Aug_57(4)_288-290.nxml.txt.nlp	22837564	SENT20	19	19	1	1	efavirenz	CD4	PA449441	920	0.996
NULL	Br_J_Cancer_2010_Jan_5_102(1)_97-103.nxml.txt.nlp	19904270	SENT157	12	12	5	5	vinorelbine	XIAP	PA451881	331	0.996
NULL	Arthritis_Res_Ther_2004_Mar_8_6(2)_60-72.nxml.txt.nlp	15059266	SENT109	5	5	27	27	infliximab	IL-8	PA452639	3576	0.996
NULL	Cell_Cycle_2012_Dec_15_11(24)_4661-4672.nxml.txt.nlp	23187802	SENT164	9	9	23	23	doxorubicin	E2F4	PA449412	1874	0.996
NULL	Br_J_Cancer_2012_Nov_6_107(10)_1714-1721.nxml.txt.nlp	23073173	SENT217	17	17	3	3	docetaxel	PC3	PA449383	57332;7832;5122	0.996
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT163	23	23	9	9	vinorelbine	HER2	PA451881	2064	0.996
NULL	Oncol_Lett_2013_Mar_8_5(3)_805-812.nxml.txt.nlp	23426281	SENT198	38	38	13	13	gemcitabine	B7-H3	PA449748	80381	0.996
NULL	Int_J_Gen_Med_2009_Jul_30_2_129-140.nxml.txt.nlp	20360896	SENT199	25	25	15	15	tamoxifen	aromatase	PA451581	1588	0.996
NULL	Cancers_(Basel)_2014_Mar_13_6(1)_595-624.nxml.txt.nlp	24633084	SENT222	43	43	11	11	trastuzumab	EGFR	PA451743	1956	0.996
NULL	Br_J_Clin_Pharmacol_2011_Oct_72(4)_647-657.nxml.txt.nlp	21518389	SENT140	1	1	30	30	cangrelor	P2Y12	PA165945763	64805	0.996
NULL	Clinics_(Sao_Paulo)_2013_May_68(5)_694-701.nxml.txt.nlp	23778405	SENT177	26	26	3	3	curcumin	MDR1	PA151958596	5243	0.996
NULL	Acta_Crystallogr_Sect_F_Struct_Biol_Cryst_Commun_2009_Sep_25_65(Pt_10)_1030-1034.nxml.txt.nlp	19851015	SENT26	28	28	2	2	fluorouracil	dUTPase	PA128406956	1854	0.996
NULL	Mol_Cancer_2010_Aug_20_9_220.nxml.txt.nlp	20727180	SENT137	8	8	34	34	nicotine	p53	PA450626	7157	0.996
NULL	Exp_Diabetes_Res_2012_Oct_15_2012_465282.nxml.txt.nlp	23118742	SENT131	25	25	3	3	metformin	FGF21	PA450395	26291	0.996
NULL	J_Med_Case_Reports_2011_Sep_19_5_465.nxml.txt.nlp	21929779	SENT69	19	19	6	6	lamivudine	CD4	PA450163	920	0.996
NULL	Oncogene_2013_Sep_26_32(39)_10_1038_onc_2012_491.nxml.txt.nlp	23108394	SENT27	24	24	4	4	trastuzumab	FOXM1	PA451743	2305	0.996
NULL	Curr_Chem_Genomics_2010_Mar_1_4_1-8.nxml.txt.nlp	20448812	SENT9	0	0	11	11	estropipate	OATP1B1	PA165958342	10599	0.996
NULL	Basic_Clin_Pharmacol_Toxicol_2013_Feb_5_112(2)_132-137.nxml.txt.nlp	22900583	SENT155	26	26	43	43	ritonavir	CYP3A4	PA451260	1576	0.996
NULL	Eur_J_Med_Res_2011_Dec_2_16(12)_553-556.nxml.txt.nlp	22112363	SENT66	28	28	33	33	tamoxifen	aromatase	PA451581	1588	0.996
NULL	Cancer_Metastasis_Rev_2010_Dec_10_29(4)_581-594.nxml.txt.nlp	20830503	SENT71	0	0	31	31	anastrozole	aromatase	PA448432	1588	0.996
NULL	J_Obes_2011_Feb_15_2011_490650.nxml.txt.nlp	21403826	SENT125	28	28	6	6	rosiglitazone	adiponectin	PA451283	9370	0.996
NULL	Clin_Ophthalmol_2012_Aug_10_6_1287-1291.nxml.txt.nlp	22927741	SENT16	47	47	12	12	ranibizumab	hole	PA164746012	80757	0.996
NULL	Acta_Pharmacol_Sin_2013_Oct_7_34(10)_1349-1358.nxml.txt.nlp	23892274	SENT29	0	0	24	24	ritonavir	P-gp	PA451260	5243	0.996
NULL	Acta_Pharmacol_Sin_2011_Aug_11_32(8)_999-1008.nxml.txt.nlp	21743486	SENT147	39	39	3	3	fasudil	JNK	PA165946121	5599	0.996
NULL	Oncotarget_2014_Aug_4_5(17)_7776-7787.nxml.txt.nlp	25277200	SENT179	8	8	0	0	paclitaxel	ANXA4	PA450761	307	0.996
NULL	Exp_Ther_Med_2013_Apr_11_5(4)_1147-1152.nxml.txt.nlp	23599738	SENT142	4	4	44	44	fentanyl	OPRM1	PA449599	4988	0.996
NULL	Oncogene_2013_Sep_12_32(37)_4355-4365.nxml.txt.nlp	23108409	SENT35	43	43	7	7	hyaluronan	HAS2	PA165958431	3037	0.996
NULL	Patient_Prefer_Adherence_2011_Dec_23_6_1-9.nxml.txt.nlp	22272064	SENT72	6	6	20	20	telmisartan	ACE	PA451605	1636	0.996
NULL	Biochimie_2010_Nov_92(11)_1546-1567.nxml.txt.nlp	20615447	SENT204	4	4	12	12	heparin	KLK2	PA449855	3817	0.996
NULL	Amino_Acids_2012_Apr_20_42(4)_1193-1204.nxml.txt.nlp	20960212	SENT212	19	19	33	33	rosiglitazone	RAGE	PA451283	177	0.996
NULL	Open_Cardiovasc_Med_J_2013_Nov_29_7_122-126.nxml.txt.nlp	24358062	SENT106	8	8	21	21	amiodarone	TPO	PA448383	7066;7173	0.996
NULL	Mol_Cancer_2013_Sep_11_12_104.nxml.txt.nlp	24025152	SENT208	15	15	2	2	gemcitabine	STAT3	PA449748	6774	0.996
NULL	Breast_Cancer_Res_2003_Oct_9_5(6)_R250-R256.nxml.txt.nlp	14580261	SENT23	4	4	33	33	estradiol	aromatase	PA449503	1588	0.996
NULL	JRSM_Short_Rep_2013_Mar_27_4(4)_30.nxml.txt.nlp	23560230	SENT165	13	13	5	5	clopidogrel	CYP3A4	PA449053	1576	0.996
NULL	Int_J_Cell_Biol_2013_May_20_2013_647975.nxml.txt.nlp	23762064	SENT195	5	5	15	15	metformin	AMPK	PA450395	5563	0.996
NULL	Br_J_Cancer_2013_Feb_19_108(3)_668-675.nxml.txt.nlp	23348520	SENT18	3	3	34	34	panitumumab	KRAS	PA162373091	3845	0.996
NULL	Cancers_(Basel)_2014_Mar_25_6(2)_684-707.nxml.txt.nlp	24670368	SENT124	20	20	1	1	trastuzumab	HER2	PA451743	2064	0.996
NULL	Croat_Med_J_2013_Apr_54(2)_171-179.nxml.txt.nlp	23630144	SENT166	5	5	14	14	taurine	AT2	PA451590	186	0.996
NULL	Oncoimmunology_2012_May_1_1(3)_377-379.nxml.txt.nlp	22737621	SENT24	13	13	19	19	vorinostat	CD11c	PA164748224	3687	0.996
NULL	Biologics_2010_Nov_9_4_289-298.nxml.txt.nlp	21116327	SENT19	25	25	14	14	erlotinib	EGFR	PA134687924	1956	0.996
NULL	Br_J_Clin_Pharmacol_2014_Nov_20_78(5)_1050-1057.nxml.txt.nlp	24962564	SENT38	0	0	8	8	ketoconazole	CYP3A4	PA450146	1576	0.996
NULL	Cancer_Metab_2013_Mar_7_1_10.nxml.txt.nlp	24280167	SENT178	0	0	22	22	phenformin	AMPK	PA1000	5563	0.996
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT10	1	1	35	35	methotrexate	MSH2	PA450428	4436	0.996
NULL	Mucosal_Immunol_2013_Nov_10_6(6)_1179-1190.nxml.txt.nlp	23571504	SENT123	28	28	0	0	auranofin	GRX	PA448510	2745	0.996
NULL	Biomed_Res_Int_2013_Dec_23_2013_676192.nxml.txt.nlp	24455715	SENT72	22	22	2	2	indomethacin	COX	PA449982	1351	0.996
NULL	Acta_Pharmacol_Sin_2010_Nov_11_31(11)_1407-1408.nxml.txt.nlp	20935670	SENT14	19	19	7	7	imatinib	GSAP	PA10804	54103	0.996
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_3-5.nxml.txt.nlp	17912632	SENT42	7	7	14	14	letrozole	aromatase	PA450196	1588	0.996
NULL	J_Cell_Biol_2000_Jul_10_150(1)_213-224.nxml.txt.nlp	10893269	SENT134	30	30	3	3	chymotrypsin	AP-1	PA448994	2353;3727;2354;3725	0.996
NULL	Biologics_2013_Apr_26_7_91-101.nxml.txt.nlp	23671386	SENT110	7	7	45	45	crizotinib	KIT	PA165946122	3815	0.996
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT35	1	1	28	28	warfarin	CYP3A4	PA451906	1576	0.996
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S31-S40.nxml.txt.nlp	20680106	SENT39	39	39	11	11	panitumumab	KRAS	PA162373091	3845	0.996
NULL	Acta_Orthop_2013_Dec_2_84(6)_585-592.nxml.txt.nlp	24237425	SENT198	38	38	2	2	hyaluronan	TLR4	PA165958431	7099	0.996
NULL	Oncol_Rep_2014_Apr_28_31(4)_1605-1612.nxml.txt.nlp	24481648	SENT36	0	0	19	19	imatinib	MRP7	PA10804	89845;1080	0.996
NULL	Osteoporos_Int_2008_Apr_12_19(4)_399-428.nxml.txt.nlp	18266020	SENT249	33	33	2	2	teriparatide	PTH	PA451620	5741	0.996
NULL	Breast_Cancer_Res_2002_Mar_20_4(3)_R3.nxml.txt.nlp	12052255	SENT119	8	8	12	12	doxorubicin	COX	PA449412	1351	0.996
NULL	J_Bras_Pneumol_2014_May-Jun_40(3)_313-318.nxml.txt.nlp	25029655	SENT85	0	0	24	24	venlafaxine	CYP3A4	PA451866	1576	0.996
NULL	Biomed_Res_Int_2014_Apr_28_2014_549742.nxml.txt.nlp	24877113	SENT139	27	27	4	4	bevacizumab	BMP4	PA130232992	652	0.996
NULL	Nucleic_Acids_Res_2011_Sep_11_39(17)_7750-7763.nxml.txt.nlp	21666256	SENT123	13	13	5	5	doxycycline	PDE12	PA449415	201626	0.996
NULL	Arthritis_Res_2001_Sep_18_3(6)_381-388.nxml.txt.nlp	11714393	SENT76	29	29	1	1	collagenase	c-Jun	PA449107	3725	0.996
NULL	Breast_Cancer_Res_2005_Nov_11_7(6)_255-257.nxml.txt.nlp	16457700	SENT38	17	17	4	4	tamoxifen	aromatase	PA451581	1588	0.996
NULL	J_Thyroid_Res_2011_Apr_10_2011_895923.nxml.txt.nlp	21603172	SENT68	41	41	0	0	thyroglobulin	IL-2	PA164754910	3558	0.996
NULL	Cell_Commun_Signal_2011_May_15_9_13.nxml.txt.nlp	21569639	SENT347	0	0	33	33	quinacrine	AKT	PA164745551	207	0.996
NULL	Clinics_(Sao_Paulo)_2013_Feb_68(2)_253-262.nxml.txt.nlp	23525324	SENT60	2	2	32	32	genistein	P35	PA165109660	2220	0.996
NULL	Br_J_Pharmacol_2014_Oct_26_171(20)_4785-4796.nxml.txt.nlp	25074741	SENT204	4	4	11	11	guanfacine	NK1R	PA449825	6869	0.996
NULL	Cell_Death_Dis_2010_Jul_1_1(7)_e51.nxml.txt.nlp	21364656	SENT73	7	7	16	16	gentamicin	survivin	PA449753	332	0.996
NULL	Iran_J_Pharm_Res_2013_Winter_12(Suppl)_37-46.nxml.txt.nlp	24250670	SENT27	6	6	17	17	cyclosporine	P-gp	PA449167	5243	0.996
NULL	Nat_Commun_2014_Nov_21_5_5383.nxml.txt.nlp	25415230	SENT198	23	23	4	4	tamoxifen	NEAT1	PA451581	283131	0.996
NULL	Diabetes_2008_Sep_57(9)_2461-2469.nxml.txt.nlp	18511846	SENT60	1	1	39	39	trypsin	HMGB1	PA451806	3146	0.996
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1098-1105.nxml.txt.nlp	21386838	SENT158	2	2	14	14	cisplatin	DTD	PA449014	1728	0.996
NULL	Indian_J_Hum_Genet_2014_Apr-Jun_20(2)_175-184.nxml.txt.nlp	25400347	SENT139	12	12	29	29	warfarin	CYP2C9	PA451906	1559	0.996
NULL	Eur_J_Clin_Pharmacol_2013_Jun_17_69(6)_1211-1221.nxml.txt.nlp	23325436	SENT182	0	0	14	14	fluconazole	CYP3A	PA449653	1574	0.996
NULL	Leukemia_2013_Jan_11_27(1)_32-40.nxml.txt.nlp	22781593	SENT9	17	17	36	36	ponatinib	FGFR1	PA165980594	2260	0.996
NULL	Front_Genet_2012_Sep_6_3_174.nxml.txt.nlp	22973298	SENT56	33	33	0	0	cisplatin	POLB	PA449014	5423	0.996
NULL	J_Antimicrob_Chemother_2014_Jul_14_69(7)_1945-1953.nxml.txt.nlp	24633206	SENT199	29	29	8	8	tigecycline	RGM	PA164746412	56963	0.996
NULL	Cancer_Microenviron_2013_Jan_22_6(3)_231-240.nxml.txt.nlp	23335094	SENT68	13	13	0	0	simvastatin	PC-3	PA451363	692094	0.996
NULL	Curr_Pharm_Des_2008_Oct_14(28)_2983-2998.nxml.txt.nlp	18991714	SENT82	6	6	15	15	erlotinib	EGFR	PA134687924	1956	0.996
NULL	Cancer_Cell_Int_2010_May_11_10_16.nxml.txt.nlp	20459793	SENT15	8	8	26	26	cisplatin	ABCC6	PA449014	368	0.996
NULL	Case_Rep_Transplant_2012_Aug_30_2012_672923.nxml.txt.nlp	23259137	SENT17	16	16	24	24	caspofungin	IPA	PA164743013	3160	0.996
NULL	Environ_Health_Perspect_2008_Jan_5_116(1)_1-6.nxml.txt.nlp	18197291	SENT205	30	30	17	17	arsenite	p85	PA452638	5296;5295;54776;23368	0.996
NULL	Curr_Cardiol_Rev_2012_Aug_8(3)_239-249.nxml.txt.nlp	22935021	SENT130	25	25	0	0	prasugrel	PAR-1	PA154410481	2011;2149	0.996
NULL	Acta_Pharmacol_Sin_2012_Nov_4_33(11)_1379-1386.nxml.txt.nlp	22659626	SENT163	8	8	15	15	exenatide	GLP-1	PA164749238	100125288	0.996
NULL	Breast_Cancer_Res_2004_Nov_7_6(1)_39-52.nxml.txt.nlp	14680484	SENT135	22	22	4	4	exemestane	aromatase	PA449563	1588	0.996
NULL	Oncotarget_2013_Dec_18_5(2)_375-385.nxml.txt.nlp	24495868	SENT50	7	7	40	40	flavopiridol	CD34	PA452627	947	0.996
NULL	Clin_Ophthalmol_2011_Aug_15_5_1127-1133.nxml.txt.nlp	21887094	SENT68	10	10	30	30	bevacizumab	ARMS2	PA130232992	387715	0.996
NULL	Br_J_Pharmacol_2013_Jun_27_169(4)_736-747.nxml.txt.nlp	23489111	SENT155	0	0	19	19	diltiazem	5-HT3A	PA449334	3359	0.996
NULL	J_Carcinog_2011_Nov_30_10_28.nxml.txt.nlp	22190870	SENT167	26	26	4	4	paclitaxel	PI3K	PA450761	5290	0.996
NULL	Br_J_Cancer_2010_Mar_16_102(6)_1003-1009.nxml.txt.nlp	20179710	SENT122	32	32	0	0	cyclophosphamide	CYP2B6	PA449165	1555	0.996
NULL	J_Adv_Pharm_Technol_Res_2012_Oct-Dec_3(4)_202-209.nxml.txt.nlp	23378940	SENT180	9	9	2	2	aprepitant	NK-1	PA164747039	27087	0.996
NULL	Int_J_Environ_Res_Public_Health_2011_Jul_30_8(7)_2747-2757.nxml.txt.nlp	21845156	SENT50	35	35	1	1	trypsin	SPINK1	PA451806	6690	0.996
NULL	Exp_Mol_Med_2012_Feb_29_44(2)_159-166.nxml.txt.nlp	22127053	SENT26	0	0	18	18	simvastatin	RhoA	PA451363	387	0.996
NULL	Drugs_R_D_2010_Nov_25_10(4)_219-224.nxml.txt.nlp	21171668	SENT87	0	0	33	33	clopidogrel	P2Y12	PA449053	64805	0.996
NULL	Br_J_Cancer_2012_Jan_31_106(3)_468-474.nxml.txt.nlp	22223088	SENT30	0	0	29	29	olaparib	BRCA1		672	0.996
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_45-53.nxml.txt.nlp	17912635	SENT41	21	21	11	11	tamoxifen	aromatase	PA451581	1588	0.996
NULL	J_Oncol_2009_May_6_2009_567486.nxml.txt.nlp	19424511	SENT149	3	3	18	18	sunitinib	VEGFR	PA162372840	3791	0.996
NULL	Cardiovasc_Diabetol_2013_Mar_28_12_53.nxml.txt.nlp	23537430	SENT125	5	5	9	9	sitagliptin	DPP4	PA164748978	1803	0.996
NULL	Acta_Crystallogr_Sect_F_Struct_Biol_Cryst_Commun_2009_Sep_25_65(Pt_10)_1030-1034.nxml.txt.nlp	19851015	SENT26	28	28	10	10	fluorouracil	dUTPase	PA128406956	1854	0.996
NULL	F1000Prime_Rep_2014_Aug_1_6_66.nxml.txt.nlp	25165565	SENT112	0	0	37	37	pertuzumab	PI3K		5290	0.996
NULL	Iran_J_Pharm_Res_2013_Winter_12(Suppl)_169-174.nxml.txt.nlp	24250685	SENT30	3	3	32	32	clopidogrel	CYP2C19	PA449053	1557	0.996
NULL	Alcohol_Res_Health_2011_34(1)_106-120.nxml.txt.nlp	23580048	SENT194	16	16	2	2	ethanol	5-HT1A	PA448073	3350	0.996
NULL	Cardiovasc_Diabetol_2013_May_30_12(Suppl_1)_S2.nxml.txt.nlp	23819752	SENT129	5	5	43	43	atorvastatin	CYP2C9	PA448500	1559	0.996
NULL	Diabetologia_2009_Oct_14_52(10)_2046-2055.nxml.txt.nlp	19688338	SENT222	21	21	7	7	exenatide	GLP-1	PA164749238	100125288	0.996
NULL	Mol_Cells_2014_Sep_30_37(9)_691-698.nxml.txt.nlp	25234469	SENT155	16	16	7	7	docetaxel	BRCA2	PA449383	675	0.996
NULL	Arthritis_Res_Ther_2014_Apr_3_16(2)_R86.nxml.txt.nlp	24708674	SENT199	29	29	17	17	bosentan	Fli1	PA10034	2314	0.996
NULL	Core_Evid_2010_Oct_21_5_77-90.nxml.txt.nlp	21042544	SENT45	29	29	3	3	fosaprepitant	NK1	PA165958390	11126	0.996
NULL	Case_Rep_Oncol_2014_Mar_19_7(1)_210-216.nxml.txt.nlp	24803897	SENT71	4	4	23	23	trastuzumab	HER2	PA451743	2064	0.996
NULL	Drug_Target_Insights_2012_Aug_6_6_19-39.nxml.txt.nlp	22915839	SENT260	16	16	33	33	doxorubicin	Hsp90	PA449412	3320	0.996
NULL	Mol_Cancer_2014_Jun_12_13_148.nxml.txt.nlp	24924916	SENT90	14	14	32	32	tetracaine	PTP	PA451638	5967;10076	0.996
NULL	EPMA_J_2010_Sep_9_1(3)_503-512.nxml.txt.nlp	23199092	SENT80	27	27	13	13	gefitinib	EGFR	PA131301952	1956	0.996
NULL	Mol_Cancer_2010_Apr_12_9_75.nxml.txt.nlp	20385023	SENT212	2	2	17	17	sunitinib	ABCG2	PA162372840	9429	0.996
NULL	Clin_Ophthalmol_2014_Sep_15_8_1855-1858.nxml.txt.nlp	25258507	SENT6	1	1	33	33	tafluprost	BAK	PA165958432	578	0.996
NULL	Sensors_(Basel)_2012_Nov_22_12(12)_16037-16045.nxml.txt.nlp	23443365	SENT92	30	30	6	6	rituximab	FGFR3	PA451261	2261	0.996
NULL	Curr_Mol_Med_2012_Jan_12(1)_96-110.nxml.txt.nlp	22082486	SENT251	12	12	2	2	erlotinib	EGFR	PA134687924	1956	0.996
NULL	J_Immunother_Cancer_2014_Nov_6_2(Suppl_3)_P187.nxml.txt.nlp	NULL	SENT6	28	28	9	9	carboplatin	EGFR	PA448803	1956	0.996
NULL	Mol_Syst_Biol_2009_Jul_28_5_290.nxml.txt.nlp	19638971	SENT373	5	5	37	37	thrombin	EGFR	PA451674	1956	0.996
NULL	Oncotarget_2013_Dec_15_4(12)_2577-2590.nxml.txt.nlp	24342878	SENT143	10	10	19	19	resveratrol	NF-kappaB		4790	0.996
NULL	Cancer_Med_2013_Jun_25_2(3)_277-285.nxml.txt.nlp	23930204	SENT76	30	30	15	15	bevacizumab	PTEN	PA130232992	5728	0.996
NULL	Bioinformation_2012_Jan_6_8(1)_13-19.nxml.txt.nlp	22359429	SENT140	40	40	2	2	curcumin	P-gp	PA151958596	5243	0.996
NULL	Clin_Dev_Immunol_2013_Nov_26_2013_875343.nxml.txt.nlp	24371449	SENT50	0	0	31	31	rituximab	PRIMA	PA451261	145270	0.996
NULL	Braz_J_Med_Biol_Res_2012_Feb_17_45(3)_244-249.nxml.txt.nlp	22331137	SENT95	38	38	0	0	gentamicin	PAG	PA449753	55824	0.996
NULL	Mol_Cancer_2007_Nov_17_6_73.nxml.txt.nlp	18021420	SENT45	39	39	6	6	bortezomib	Mcl-1	PA10252	4170	0.996
NULL	Oncotarget_2013_Jul_5_4(7)_984-994.nxml.txt.nlp	23846322	SENT27	3	3	13	13	resveratrol	SIRT1		23411	0.996
NULL	Viruses_2014_May_23_6(5)_2155-2185.nxml.txt.nlp	24859341	SENT155	18	18	0	0	doxorubicin	p38	PA449412	10598;1432;7965	0.996
NULL	Breast_Cancer_Res_2003_Oct_9_5(6)_320-328.nxml.txt.nlp	14580250	SENT169	5	5	17	17	tamoxifen	BRCA1	PA451581	672	0.996
NULL	Mol_Cancer_2012_Jun_18_11_41.nxml.txt.nlp	22709873	SENT285	30	30	8	8	lapatinib	ARNT	PA152241907	405	0.996
NULL	Scientifica_(Cairo)_2012_Sep_3_2012_757890.nxml.txt.nlp	24278738	SENT70	20	20	11	11	curcumin	GATA4	PA151958596	2626	0.996
NULL	Gut_Liver_2013_Jan_5_7(1)_106-111.nxml.txt.nlp	23423146	SENT137	4	4	36	36	gemcitabine	CRT	PA449748	811	0.996
NULL	Breast_Cancer_Res_2010_Jul_22_12(4)_R53.nxml.txt.nlp	20649975	SENT24	26	26	8	8	tamoxifen	HOXB13	PA451581	10481	0.996
NULL	J_Infect_Dis_2014_Aug_15_210(4)_656-666.nxml.txt.nlp	24634497	SENT163	12	12	33	33	zileuton	TLR4	PA451955	7099	0.996
NULL	Ann_Indian_Acad_Neurol_2013_Apr-Jun_16(2)_208-210.nxml.txt.nlp	23956565	SENT80	0	0	13	13	ephedrine	Dok-7	PA449466	285489	0.996
NULL	Int_J_Mol_Sci_2007_Jan_29_8(1)_13-28.nxml.txt.nlp	NULL	SENT19	22	22	11	11	galactose	NAG	PA449725	51594;4669	0.996
NULL	Arthritis_Res_Ther_2005_May_27_7(5)_R915-R926.nxml.txt.nlp	16207333	SENT187	21	21	3	3	curcumin	JNK	PA151958596	5599	0.996
NULL	Breast_Cancer_Res_2000_Apr_13_2(3)_E007.nxml.txt.nlp	NULL	SENT62	35	35	11	11	doxorubicin	EGF	PA449412	1950	0.996
NULL	Front_Endocrinol_(Lausanne)_2011_Dec_6_2_93.nxml.txt.nlp	22654833	SENT297	36	36	17	17	trastuzumab	HER2	PA451743	2064	0.996
NULL	Indian_J_Pharmacol_2014_Jan-Feb_46(1)_3-12.nxml.txt.nlp	24550577	SENT228	5	5	24	24	vismodegib	CYP1A2		1544	0.996
NULL	Clin_Mol_Allergy_2007_Jan_25_5_1.nxml.txt.nlp	17254346	SENT229	2	2	11	11	curcumin	IL-4	PA151958596	3565	0.996
NULL	J_Physiol_2013_Mar_15_591(6)_1463-1474.nxml.txt.nlp	23297308	SENT146	18	18	37	37	clotrimazole	NO3	PA449057	4681	0.996
NULL	Breast_Cancer_Res_2002_Sep_10_4(6)_218-221.nxml.txt.nlp	12473166	SENT38	28	28	7	7	anastrozole	ATAC	PA448432	6375	0.996
NULL	Biologics_2010_Aug_9_4_173-185.nxml.txt.nlp	20714355	SENT190	25	25	6	6	cetuximab	EGFR	PA10040	1956	0.996
NULL	Case_Rep_Oncol_2011_Aug_18_4(2)_385-391.nxml.txt.nlp	21941487	SENT94	0	0	34	34	sunitinib	CYP3A4	PA162372840	1576	0.996
NULL	Crit_Care_2004_Oct_27_8(6)_R474-R482.nxml.txt.nlp	15566594	SENT151	32	32	3	3	phenylephrine	COX	PA450935	1351	0.996
NULL	Ann_Neurosci_2011_Apr_18(2)_48-55.nxml.txt.nlp	25205921	SENT142	27	27	6	6	forskolin	SOD1	PA146096022	6647	0.996
NULL	Mol_Cell_Neurosci_2013_Jul_55(100)_62-76.nxml.txt.nlp	22960139	SENT217	4	4	29	29	staurosporine	OPA1	PA165109623	4976;9968	0.996
NULL	Chin_J_Cancer_2012_Jun_31(6)_266-280.nxml.txt.nlp	22313597	SENT243	29	29	0	0	tamoxifen	IGFBP5	PA451581	3488	0.996
NULL	Oncol_Lett_2013_Sep_3_6(3)_801-806.nxml.txt.nlp	24137414	SENT155	28	28	16	16	mitomycin	LDM	PA450524	1595	0.996
NULL	Hum_Genomics_2010_Oct_1_5(1)_61-72.nxml.txt.nlp	21106490	SENT60	12	12	29	29	midazolam	CYP3A	PA450496	1574	0.996
NULL	Indian_Dermatol_Online_J_2010_Jul-Dec_1(1)_14-17.nxml.txt.nlp	23130185	SENT64	3	3	40	40	lapatinib	EGFR	PA152241907	1956	0.996
NULL	Acta_Inform_Med_2012_Mar_20(1)_18-21.nxml.txt.nlp	23322949	SENT90	6	6	22	22	diclofenac	NNT	PA449293	23530	0.996
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S31-S40.nxml.txt.nlp	20680106	SENT37	17	17	33	33	cetuximab	KRAS	PA10040	3845	0.996
NULL	Br_J_Cancer_2011_Apr_12_104(8)_1342-1348.nxml.txt.nlp	21427727	SENT24	7	7	21	21	trastuzumab	HER2	PA451743	2064	0.996
NULL	Exp_Cell_Res_2013_Apr_1_319(6)_800-809.nxml.txt.nlp	23247073	SENT205	3	3	34	34	curcumin	AKT	PA151958596	207	0.996
NULL	J_Antimicrob_Chemother_2009_Nov_18_64(5)_910-928.nxml.txt.nlp	19767318	SENT225	0	0	27	27	efavirenz	CYP3A4	PA449441	1576	0.996
NULL	Cancer_Med_2012_Aug_15_1(1)_28-38.nxml.txt.nlp	23342251	SENT23	19	19	3	3	gefitinib	HER2	PA131301952	2064	0.996
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_75-89.nxml.txt.nlp	17912638	SENT223	23	23	8	8	tamoxifen	ATAC	PA451581	6375	0.996
NULL	Cancer_Med_2014_Dec_1_3(6)_1493-1501.nxml.txt.nlp	25081631	SENT201	33	33	10	10	erlotinib	FDG	PA134687924	23583	0.996
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT171	6	6	19	19	tenofovir	CD4	PA10204	920	0.996
NULL	Clinics_(Sao_Paulo)_2013_May_68(5)_694-701.nxml.txt.nlp	23778405	SENT177	26	26	7	7	curcumin	P-gp	PA151958596	5243	0.996
NULL	J_Exp_Med_2000_Nov_20_192(10)_1403-1414.nxml.txt.nlp	11085743	SENT103	17	17	36	36	staurosporine	Bcl-2	PA165109623	596	0.996
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_105-115.nxml.txt.nlp	17912640	SENT59	19	19	24	24	lapatinib	HER2	PA152241907	2064	0.996
NULL	Case_Rep_Oncol_2014_Feb_20_7(1)_126-131.nxml.txt.nlp	24707260	SENT29	18	18	42	42	gefitinib	FDG	PA131301952	23583	0.996
NULL	Clin_Epigenetics_2010_May_30_1(1-2)_13-24.nxml.txt.nlp	22704086	SENT192	2	2	27	27	resveratrol	SIRT1		23411	0.996
NULL	Mol_Cancer_2014_Jul_5_13_165.nxml.txt.nlp	24996221	SENT181	24	24	3	3	docetaxel	HMGB1	PA449383	3146	0.996
NULL	Breast_Cancer_Res_2011_Aug_12_13(4)_215.nxml.txt.nlp	21884641	SENT47	3	3	25	25	trastuzumab	HER2	PA451743	2064	0.996
NULL	J_Med_Case_Reports_2011_Sep_19_5_465.nxml.txt.nlp	21929779	SENT69	37	37	6	6	abacavir	CD4	PA448004	920	0.996
NULL	Breast_Cancer_Res_2011_Jun_9_13(3)_R57.nxml.txt.nlp	21658222	SENT140	45	45	10	10	tamoxifen	UGT2B7	PA451581	7364	0.996
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT151	16	16	2	2	chloroquine	BMPR-II	PA448948	659	0.996
NULL	Gene_Regul_Syst_Bio_2014_Mar_4_8_63-73.nxml.txt.nlp	24634581	SENT101	0	0	28	28	minocycline	MT1-MMP	PA450519	4323	0.996
NULL	Ann_Clin_Microbiol_Antimicrob_2008_Jan_28_7_3.nxml.txt.nlp	18226256	SENT62	23	23	32	32	rifabutin	SXR	PA451249	8856	0.996
NULL	Indian_J_Crit_Care_Med_2009_Apr-Jun_13(2)_108-112.nxml.txt.nlp	19881196	SENT94	3	3	23	23	heparin	CAGE	PA449855	168400	0.996
NULL	J_Exp_Med_1998_Jun_15_187(12)_2045-2053.nxml.txt.nlp	9625764	SENT176	3	3	25	25	indomethacin	CHS	PA449982	1130	0.996
NULL	Br_J_Cancer_2014_Jan_21_110(2)_384-391.nxml.txt.nlp	24346286	SENT22	23	23	6	6	trastuzumab	PTEN	PA451743	5728	0.996
NULL	Onco_Targets_Ther_2014_Nov_3_7_2035-2042.nxml.txt.nlp	25395862	SENT116	25	25	3	3	temozolomide	Bcl-2	PA451609	596	0.996
NULL	Eur_J_Clin_Pharmacol_2010_Nov_29_66(11)_1131-1136.nxml.txt.nlp	20669013	SENT130	14	14	34	34	voriconazole	CYP3A4	PA10233	1576	0.996
NULL	J_Exp_Clin_Cancer_Res_2009_Jun_29_28(1)_91.nxml.txt.nlp	19563645	SENT26	0	0	24	24	cisplatin	NAC	PA449014	22861	0.996
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1033-1038.nxml.txt.nlp	22374460	SENT106	31	31	22	22	trastuzumab	HER2	PA451743	2064	0.996
NULL	Chemother_Res_Pract_2011_Sep_25_2011_730360.nxml.txt.nlp	22295205	SENT33	30	30	4	4	doxorubicin	HER2	PA449412	2064	0.996
NULL	Cell_Death_Dis_2010_Oct_21_1(10)_e86.nxml.txt.nlp	21368859	SENT64	10	10	19	19	doxorubicin	JNK	PA449412	5599	0.996
NULL	Hematol_Rep_2014_Dec_4_6(4)_5600.nxml.txt.nlp	25568760	SENT59	37	37	6	6	zidovudine	EPO	PA451954	7076;8288;2056	0.996
NULL	Bioinformation_2012_Jan_6_8(1)_13-19.nxml.txt.nlp	22359429	SENT42	20	20	5	5	calcein	MRP1	PA132595336	4437	0.996
NULL	Indian_J_Nephrol_2011_Jan-Mar_21(1)_56-58.nxml.txt.nlp	21655173	SENT87	2	2	26	26	rituximab	PRL	PA451261	5617	0.996
NULL	Int_J_Biol_Sci_2012_Mar_7_8(4)_470-485.nxml.txt.nlp	22419892	SENT262	32	32	5	5	tamoxifen	SRC-3	PA451581	8202	0.996
NULL	Acta_Pharmacol_Sin_2010_May_12_31(5)_578-584.nxml.txt.nlp	20383171	SENT115	23	23	7	7	berberine	ORP150	PA165860812	10525	0.996
NULL	Cell_Mol_Life_Sci_2011_Jan_17_68(2)_289-301.nxml.txt.nlp	20640477	SENT45	0	0	34	34	forskolin	MK3	PA146096022	3738	0.996
NULL	Mol_Cancer_2014_Jun_24_13_157.nxml.txt.nlp	24958351	SENT170	23	23	0	0	trastuzumab	PI3K	PA451743	5290	0.996
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_127043.nxml.txt.nlp	23227093	SENT195	26	26	2	2	gemfibrozil	RYR	PA449750	6261	0.996
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT105	35	35	23	23	trastuzumab	HER3	PA451743	2065	0.996
NULL	Mol_Cell_Proteomics_2012_Jul_11(7)_M111_013243.nxml.txt.nlp	22442257	SENT159	15	15	0	0	doxorubicin	ILF3	PA449412	3609	0.996
NULL	Front_Mol_Neurosci_2012_Nov_12_5_99.nxml.txt.nlp	23162427	SENT265	39	39	3	3	cocaine	SIRT1	PA449072	23411	0.996
NULL	Indian_J_Nephrol_2012_Mar-Apr_22(2)_139-142.nxml.txt.nlp	22787319	SENT111	8	8	24	24	tacrolimus	MRP2	PA451578	100130958;57626;1244	0.996
NULL	J_Biomed_Biotechnol_2006_May_25_2006_62079.nxml.txt.nlp	17047309	SENT268	19	19	13	13	chloroquine	p62	PA448948	8878;10657;23636	0.996
NULL	Mol_Cancer_2012_Jun_18_11_41.nxml.txt.nlp	22709873	SENT292	32	32	5	5	lapatinib	PAX9	PA152241907	5083	0.996
NULL	Hum_Genomics_2011_May_1_5(4)_265-282.nxml.txt.nlp	21712189	SENT145	47	47	19	19	tenofovir	UGT1A1	PA10204	54658	0.996
NULL	Open_Access_J_Urol_2011_May_10_3_69-82.nxml.txt.nlp	24198638	SENT69	18	18	26	26	sorafenib	CYP1A2	PA7000	1544	0.996
NULL	Arthritis_Res_Ther_2009_Nov_19_11(6)_255.nxml.txt.nlp	19939293	SENT123	39	39	5	5	rituximab	CD40	PA451261	958	0.996
NULL	Oncotarget_2012_Nov_17_3(12)_1600-1614.nxml.txt.nlp	23307622	SENT98	9	9	46	46	trastuzumab	ATG12	PA451743	9140	0.996
NULL	Mol_Cancer_2012_Jul_12_11_45.nxml.txt.nlp	22788833	SENT109	17	17	3	3	cisplatin	EGFR	PA449014	1956	0.996
NULL	Nanoscale_Res_Lett_2013_Sep_13_8(1)_386.nxml.txt.nlp	24034341	SENT187	23	23	2	2	ethanol	CO2	PA448073	4513	0.996
NULL	Int_J_Breast_Cancer_2012_Nov_2_2012_217185.nxml.txt.nlp	22295242	SENT82	34	34	15	15	cisplatin	RAD51	PA449014	5888	0.996
NULL	Acta_Pharmacol_Sin_2013_Jul_5_34(7)_870-879.nxml.txt.nlp	23624759	SENT95	17	17	32	32	panitumumab	EGFR	PA162373091	1956	0.996
NULL	Oncol_Lett_2014_Jan_12_7(1)_17-22.nxml.txt.nlp	24348813	SENT92	3	3	13	13	curcumin	raptor	PA151958596	57521	0.996
NULL	Adv_Hematol_2012_Feb_6_2012_485943.nxml.txt.nlp	22400030	SENT101	3	3	26	26	rituximab	CHOP	PA451261	1649	0.996
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT293	9	9	25	25	gefitinib	EGFR	PA131301952	1956	0.996
NULL	Indian_J_Nephrol_2009_Jul_19(3)_119-121.nxml.txt.nlp	20436733	SENT59	8	8	24	24	tacrolimus	MRP2	PA451578	100130958;57626;1244	0.996
NULL	Cancers_(Basel)_2014_Mar_26_6(2)_708-722.nxml.txt.nlp	24675568	SENT688	22	22	0	0	gefitinib	EGF	PA131301952	1950	0.996
NULL	Gut_Pathog_2014_Aug_20_6_34.nxml.txt.nlp	25349629	SENT178	15	15	23	23	metronidazole	ST4	PA450484	202;6763	0.996
NULL	J_Korean_Med_Sci_2014_Jan_26_29(1)_43-47.nxml.txt.nlp	24431904	SENT90	31	31	4	4	amoxicillin	CD203c	PA448406	5169	0.996
NULL	Cancer_Med_2014_Apr_27_3(2)_293-299.nxml.txt.nlp	24464780	SENT32	20	20	1	1	capecitabine	TYMP	PA448771	1890	0.996
NULL	J_Surg_Case_Rep_2013_Feb_15_2013(2)_rjs039.nxml.txt.nlp	24964408	SENT6	0	0	12	12	diclofenac	COX	PA449293	1351	0.996
NULL	Cancer_Res_Treat_2012_Jun_30_44(2)_74-84.nxml.txt.nlp	22802745	SENT154	0	0	16	16	bevacizumab	VEGFR	PA130232992	3791	0.996
NULL	Oncotarget_2010_Oct_25_1(7)_497-514.nxml.txt.nlp	21165163	SENT122	31	31	1	1	gefitinib	EGFR	PA131301952	1956	0.996
NULL	Aging_Cell_2009_Apr_8(2)_113-127.nxml.txt.nlp	19239417	SENT236	4	4	14	14	resveratrol	AMPK		5563	0.996
NULL	Curr_Neuropharmacol_2008_Sep_6(3)_215-234.nxml.txt.nlp	19506722	SENT71	4	4	13	13	venlafaxine	5-HT1B	PA451866	3351	0.996
NULL	J_Oncol_2010_Dec_28_2010_414676.nxml.txt.nlp	20066160	SENT88	0	0	21	21	gefitinib	aromatase	PA131301952	1588	0.996
NULL	Lab_Invest_2010_Oct_28_90(10)_1415-1424.nxml.txt.nlp	20585313	SENT165	24	24	0	0	carbachol	EGFR	PA448784	1956	0.996
NULL	Diabetes_Care_2012_Aug_14_35(8)_1701-1707.nxml.txt.nlp	22584136	SENT170	5	5	17	17	pioglitazone	NEFA	PA450970	4925	0.996
NULL	Acta_Pharmacol_Sin_2012_Jan_3_33(1)_49-56.nxml.txt.nlp	22212430	SENT14	0	0	21	21	thrombin	JNK	PA451674	5599	0.996
NULL	Dement_Geriatr_Cogn_Dis_Extra_2014_Nov_15_4(3)_450-456.nxml.txt.nlp	25538729	SENT100	27	27	4	4	donepezil	CYP2D6	PA449394	1565	0.996
NULL	Breast_Cancer_Res_2007_Dec_20_9(Suppl_2)_S25.nxml.txt.nlp	NULL	SENT13	5	5	27	27	trastuzumab	aromatase	PA451743	1588	0.996
NULL	Breast_Cancer_Res_2012_Dec_7_14(6)_R155.nxml.txt.nlp	23216814	SENT250	19	19	5	5	etoposide	HIF1	PA449552	3091	0.996
NULL	Contemp_Oncol_(Pozn)_2012_Nov_20_16(5)_363-370.nxml.txt.nlp	23788912	SENT147	4	4	13	13	imatinib	KIT	PA10804	3815	0.996
NULL	Clin_Ophthalmol_2009_Jun_2_3_189-194.nxml.txt.nlp	19668564	SENT95	41	41	1	1	travoprost	BAK	PA164781371	578	0.996
NULL	Oncogene_2010_Jul_22_29(29)_4170-4182.nxml.txt.nlp	20498638	SENT132	42	42	3	3	cetuximab	EGFR	PA10040	1956	0.996
NULL	Cancer_Med_2012_Aug_15_1(1)_28-38.nxml.txt.nlp	23342251	SENT228	7	7	14	14	trastuzumab	PI3K	PA451743	5290	0.996
NULL	Exp_Ther_Med_2013_Jun_3_5(6)_1631-1636.nxml.txt.nlp	23837045	SENT88	28	28	5	5	phentolamine	ANGPTL2	PA450926	23452	0.996
NULL	Breast_Cancer_Res_2009_Jun_16_11(3)_R35.nxml.txt.nlp	19531217	SENT118	19	19	38	38	exemestane	aromatase	PA449563	1588	0.996
NULL	Clin_Psychopharmacol_Neurosci_2012_Apr_30_10(1)_59-60.nxml.txt.nlp	23431323	SENT14	8	8	22	22	ketamine	Met	PA450144	79811	0.996
NULL	Cell_Death_Dis_2014_Feb_13_5(2)_e1055.nxml.txt.nlp	24525731	SENT92	25	25	6	6	cisplatin	XRCC1	PA449014	7515	0.996
NULL	Case_Rep_Med_2010_Jun_21_2010_517178.nxml.txt.nlp	20593037	SENT55	36	36	4	4	cyclosporine	XLP	PA449167	4068	0.996
NULL	Cell_Death_Dis_2010_Nov_4_1(11)_e96.nxml.txt.nlp	21368872	SENT138	31	31	17	17	resveratrol	B27		56246	0.996
NULL	Mol_Cancer_2012_Jul_25_11_47.nxml.txt.nlp	22830443	SENT30	1	1	14	14	panitumumab	EGFR	PA162373091	1956	0.996
NULL	J_RNAi_Gene_Silencing_2010_Nov_26_6(2)_416-421.nxml.txt.nlp	21350684	SENT23	26	26	3	3	pentobarbital	POR	PA450859	5447	0.996
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT182	28	28	7	7	cimetidine	SLC47A1	PA449001	55244	0.996
NULL	Case_Rep_Transplant_2012_Aug_30_2012_672923.nxml.txt.nlp	23259137	SENT46	28	28	16	16	rituximab	CD19	PA451261	930	0.996
NULL	Clin_Mol_Hepatol_2012_Jun_26_18(2)_109-162.nxml.txt.nlp	22893865	SENT688	1	1	25	25	lamivudine	IFN	PA450163	3439	0.996
NULL	Neuropsychopharmacology_2009_Apr_2_34(5)_1135-1148.nxml.txt.nlp	18596687	SENT333	38	38	0	0	cocaine	CRF	PA449072	1392;10882	0.996
NULL	Int_J_Cell_Biol_2013_Nov_17_2013_769536.nxml.txt.nlp	24348564	SENT21	23	23	8	8	tamoxifen	HSD1	PA451581	26871	0.996
NULL	Front_Oncol_2014_Nov_25_4_329.nxml.txt.nlp	25505733	SENT133	12	12	22	22	olaparib	EGFR		1956	0.996
NULL	J_Biol_Chem_2010_Aug_20_285(34)_26406-26416.nxml.txt.nlp	20530490	SENT36	27	27	11	11	artemisinin	SERCA1	PA165111696	487	0.996
NULL	Adv_Hematol_2011_Apr_10_2011_960137.nxml.txt.nlp	21547266	SENT78	13	13	44	44	rituximab	NHL	PA451261	51750	0.996
NULL	Int_J_Gen_Med_2012_May_4_5_403-411.nxml.txt.nlp	22615536	SENT83	16	16	0	0	rosiglitazone	RBP4	PA451283	5433;5950	0.996
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_33-43.nxml.txt.nlp	17912634	SENT196	10	10	27	27	letrozole	HER2	PA450196	2064	0.996
NULL	Allergy_Asthma_Clin_Immunol_2009_Oct_22_5(1)_4.nxml.txt.nlp	20016776	SENT218	0	0	16	16	pitrakinra	IL-4	PA165983754	3565	0.996
NULL	Acta_Pharmacol_Sin_2013_Jun_8_34(6)_830-836.nxml.txt.nlp	23564080	SENT103	23	23	8	8	simvastatin	HMHB1	PA451363	57824	0.996
NULL	Br_J_Cancer_2013_Jul_9_109(1)_68-75.nxml.txt.nlp	23807173	SENT12	19	19	1	1	cisplatin	ERCC1	PA449014	2067	0.996
NULL	J_Mol_Signal_2010_May_10_5_4.nxml.txt.nlp	20459745	SENT118	30	30	15	15	cisplatin	p53	PA449014	7157	0.996
NULL	Clin_Pharmacol_2011_Jun_22_3_13-25.nxml.txt.nlp	22287853	SENT186	1	1	18	18	saxagliptin	CYP3A4	PA165958362	1576	0.996
NULL	Eur_J_Clin_Pharmacol_2010_Nov_29_66(11)_1131-1136.nxml.txt.nlp	20669013	SENT130	2	2	34	34	erythromycin	CYP3A4	PA449493	1576	0.996
NULL	Ann_Oncol_2013_Aug_12_24(8)_1994-1999.nxml.txt.nlp	23670096	SENT154	35	35	0	0	tamoxifen	AIB1	PA451581	8202	0.996
NULL	Front_Oncol_2011_Jun_17_1_10.nxml.txt.nlp	22655230	SENT145	39	39	2	2	panitumumab	KRAS	PA162373091	3845	0.996
NULL	Mol_Biol_Cell_2012_Mar_15_23(6)_996-1009.nxml.txt.nlp	22278744	SENT89	27	27	3	3	forskolin	14-3-3	PA146096022	10971	0.996
NULL	J_Invest_Dermatol_2014_Apr_11_134(4)_984-991.nxml.txt.nlp	24352038	SENT78	20	20	0	0	adalimumab	P21	PA10004	1026;9338	0.996
NULL	Oncogene_2014_Sep_11_33(37)_4579-4588.nxml.txt.nlp	24662835	SENT70	32	32	6	6	tamoxifen	MAGEA2	PA451581	4101;266740	0.996
NULL	Case_Rep_Med_2010_Jul_6_2010_426804.nxml.txt.nlp	20671989	SENT57	10	10	22	22	capecitabine	CYP2C9	PA448771	1559	0.996
NULL	Comp_Hepatol_2005_Feb_8_4_2.nxml.txt.nlp	15701172	SENT151	5	5	24	24	ketoconazole	CYP3A4	PA450146	1576	0.996
NULL	J_Hematol_Oncol_2011_Sep_9_4_35.nxml.txt.nlp	21906310	SENT212	0	0	32	32	sunitinib	FLT3	PA162372840	2322	0.996
NULL	J_Inflamm_(Lond)_2007_Jul_16_4_15.nxml.txt.nlp	17634120	SENT134	35	35	11	11	apomorphine	LOX	PA164781163	4015	0.996
NULL	Diabetes_Metab_Syndr_Obes_2010_May_17_3_165-172.nxml.txt.nlp	21437086	SENT29	1	1	26	26	exenatide	AMIGO	PA164749238	57463	0.996
NULL	Cell_Death_Dis_2013_Oct_3_4(10)_e827.nxml.txt.nlp	24091670	SENT94	19	19	8	8	nilotinib	PI3K	PA165958345	5290	0.996
NULL	Cancer_Med_2014_Oct_17_3(5)_1284-1293.nxml.txt.nlp	24935402	SENT30	2	2	7	7	atorvastatin	Rho	PA448500	29984	0.996
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_33-43.nxml.txt.nlp	17912634	SENT7	4	4	27	27	letrozole	HER2	PA450196	2064	0.996
NULL	Arch_Toxicol_2014_Nov_5_88(12)_2135-2190.nxml.txt.nlp	25370008	SENT243	9	9	36	36	minoxidil	SULT	PA450521	6816	0.996
NULL	Nat_Commun_2011_Feb_8_2_190.nxml.txt.nlp	21304519	SENT153	16	16	6	6	dextran	COX	PA449261	1351	0.996
NULL	Can_J_Infect_Dis_Med_Microbiol_2014_Nov-Dec_25(6)_327-343.nxml.txt.nlp	25587296	SENT304	39	39	9	9	fluconazole	CYP3A4	PA449653	1576	0.996
NULL	Breast_Cancer_Res_2013_Oct_18_15(5)_R97.nxml.txt.nlp	24135425	SENT20	26	26	20	20	trastuzumab	HER2	PA451743	2064	0.996
NULL	Int_J_Med_Sci_2013_Feb_11_10(3)_320-330.nxml.txt.nlp	23423768	SENT157	10	10	29	29	cetuximab	EGFR	PA10040	1956	0.996
NULL	J_Biol_Chem_2009_Mar_27_284(13)_8855-8865.nxml.txt.nlp	19171933	SENT41	13	13	19	19	thrombin	AKT	PA451674	207	0.996
NULL	Hum_Genomics_2011_May_1_5(4)_265-282.nxml.txt.nlp	21712189	SENT145	47	47	10	10	tenofovir	UGT1A1	PA10204	54658	0.996
NULL	Arthritis_Res_Ther_2012_Sep_24_14(5)_R200.nxml.txt.nlp	23006144	SENT168	10	10	29	29	alefacept	IL-24	PA164748040	11009	0.996
NULL	Front_Endocrinol_(Lausanne)_2014_Sep_3_5_138.nxml.txt.nlp	25232350	SENT115	2	2	30	30	metformin	4E-BP1	PA450395	1978	0.996
NULL	Arthritis_Res_Ther_2014_Apr_28_16(2)_R104.nxml.txt.nlp	24774748	SENT151	44	44	8	8	cyclophosphamide	CD4	PA449165	920	0.996
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Feb_17_6_29-36.nxml.txt.nlp	24648767	SENT47	13	13	35	35	tamoxifen	BRCA2	PA451581	675	0.996
NULL	Mol_Cancer_2010_Apr_12_9_75.nxml.txt.nlp	20385023	SENT212	0	0	15	15	dasatinib	ABCB1	PA162372878	5243	0.996
NULL	Mol_Cancer_2008_Jun_5_7_50.nxml.txt.nlp	18534018	SENT147	36	36	8	8	bortezomib	Mcl-1	PA10252	4170	0.996
NULL	Mol_Cancer_2012_Sep_25_11_73.nxml.txt.nlp	23009336	SENT256	7	7	23	23	erlotinib	PP2	PA134687924	4888	0.996
NULL	Int_J_Endocrinol_Metab_2013_Dec_21_Winter_11(1)_57-61.nxml.txt.nlp	23853622	SENT122	31	31	7	7	bromocriptine	PRL	PA448671	5617	0.996
NULL	Curr_Neuropharmacol_2007_Sep_5(3)_180-186.nxml.txt.nlp	19305800	SENT136	7	7	25	25	cinacalcet	PTH	PA164776671	5741	0.996
NULL	J_Korean_Med_Sci_2013_Aug_31_28(8)_1145-1153.nxml.txt.nlp	23960440	SENT100	43	43	1	1	sulfasalazine	ST2	PA451547	9173;6761	0.996
NULL	Oncoimmunology_2014_May_29_3_e28925.nxml.txt.nlp	25083322	SENT40	37	37	5	5	nilotinib	CD4	PA165958345	920	0.996
NULL	Am_J_Cardiovasc_Drugs_2013_Jun_20_13(5)_331-342.nxml.txt.nlp	23784266	SENT194	4	4	35	35	atorvastatin	P-gp	PA448500	5243	0.996
NULL	Acta_Pharmacol_Sin_2013_Sep_5_34(9)_1208-1216.nxml.txt.nlp	23852087	SENT118	27	27	6	6	disulfiram	EPO	PA449376	7076;8288;2056	0.996
NULL	J_Med_Case_Reports_2011_Sep_19_5_465.nxml.txt.nlp	21929779	SENT69	21	21	6	6	zidovudine	CD4	PA451954	920	0.996
NULL	Arthritis_Res_2002_Feb_4_4(Suppl_1)_40.nxml.txt.nlp	NULL	SENT4	17	17	2	2	trypsin	PAR3	PA451806	56288;2151	0.996
NULL	Front_Endocrinol_(Lausanne)_2014_Feb_19_5_16.nxml.txt.nlp	24600438	SENT109	1	1	39	39	eplerenone	AT1	PA164749044	9197;185	0.996
NULL	Br_J_Cancer_2011_Mar_1_104(5)_856-862.nxml.txt.nlp	21285991	SENT154	24	24	7	7	cetuximab	KRAS	PA10040	3845	0.996
NULL	Chin_J_Cancer_2012_Feb_31(2)_110-118.nxml.txt.nlp	22098951	SENT28	0	0	10	10	imatinib	P-gp	PA10804	5243	0.996
NULL	Breast_Cancer_Res_Treat_2013_Jan_13_137(2)_471-482.nxml.txt.nlp	23239151	SENT25	0	0	15	15	lapatinib	EGFR	PA152241907	1956	0.996
NULL	Mol_Cancer_2010_Apr_23_9_87.nxml.txt.nlp	20416058	SENT44	27	27	1	1	etoposide	TRAIL	PA449552	8743	0.996
NULL	Mol_Biol_Cell_2014_Mar_15_25(6)_828-840.nxml.txt.nlp	24478456	SENT109	18	18	41	41	mitoxantrone	LIMK1	PA450526	3984	0.996
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT168	33	33	12	12	atorvastatin	TNF	PA448500	7124	0.996
NULL	Clin_Pharmacol_2011_Jun_22_3_13-25.nxml.txt.nlp	22287853	SENT186	5	5	18	18	simvastatin	CYP3A4	PA451363	1576	0.996
NULL	J_Hematol_Oncol_2011_Jan_21_4_5.nxml.txt.nlp	21255411	SENT220	34	34	23	23	gefitinib	EGFR	PA131301952	1956	0.996
NULL	Arthritis_Res_Ther_2009_Aug_28_11(4)_R131.nxml.txt.nlp	19715572	SENT12	2	2	13	13	rituximab	CD19	PA451261	930	0.996
NULL	Case_Rep_Oncol_2014_Jul_16_7(2)_478-483.nxml.txt.nlp	25202262	SENT27	26	26	9	9	gefitinib	EGFR	PA131301952	1956	0.996
NULL	Chemother_Res_Pract_2011_Sep_25_2011_730360.nxml.txt.nlp	22295205	SENT33	26	26	4	4	paclitaxel	HER2	PA450761	2064	0.996
NULL	J_Young_Pharm_2010_Jul-Sep_2(3)_326-331.nxml.txt.nlp	21042495	SENT127	33	33	15	15	rosuvastatin	CYP3A4	PA134308647	1576	0.996
NULL	Breast_Cancer_Res_2012_May_2_14(3)_R70.nxml.txt.nlp	22551440	SENT259	29	29	15	15	docetaxel	p53	PA449383	7157	0.996
NULL	Oxid_Med_Cell_Longev_2013_Jun_11_2013_870472.nxml.txt.nlp	23840921	SENT108	3	3	19	19	chloroquine	HO-1	PA448948	3162	0.996
NULL	Cancer_Microenviron_2013_Jan_22_6(3)_231-240.nxml.txt.nlp	23335094	SENT122	0	0	17	17	simvastatin	PC-3	PA451363	692094	0.996
NULL	Oncotarget_2013_Nov_24_4(12)_2186-2207.nxml.txt.nlp	24327604	SENT210	8	8	45	45	bortezomib	LFA-1	PA10252	3683;3689	0.996
NULL	Nucl_Recept_Signal_2006_Jul_7_4_e013.nxml.txt.nlp	16862219	SENT31	40	40	6	6	tamoxifen	p85	PA451581	5296;5295;54776;23368	0.996
NULL	Diabetes_2011_Nov_17_60(11)_2691-2700.nxml.txt.nlp	21896928	SENT259	26	26	7	7	resveratrol	SIRT1		23411	0.996
NULL	Int_J_Mol_Sci_2007_Mar_13_8(3)_229-240.nxml.txt.nlp	NULL	SENT11	23	23	7	7	acetazolamide	AQP1	PA448018	358	0.996
NULL	ScientificWorldJournal_2012_Jun_18_2012_373709.nxml.txt.nlp	22761550	SENT37	38	38	27	27	halothane	NALCN	PA449845	259232	0.996
NULL	Pharmaceuticals_(Basel)_2013_Apr_8_6(4)_500-509.nxml.txt.nlp	24276120	SENT128	42	42	7	7	benserazide	GPR35		2859	0.996
NULL	Biomed_Imaging_Interv_J_2008_Jul_1_4(3)_e38.nxml.txt.nlp	21611004	SENT147	4	4	21	21	tamoxifen	aromatase	PA451581	1588	0.996
NULL	J_Oncol_2010_Aug_24_2010_654348.nxml.txt.nlp	20871846	SENT4	38	38	11	11	tamoxifen	aromatase	PA451581	1588	0.996
NULL	Case_Rep_Oncol_2014_Jun_18_7(2)_393-400.nxml.txt.nlp	25076890	SENT7	23	23	31	31	erlotinib	EGFR	PA134687924	1956	0.996
NULL	Oncoimmunology_2013_Jul_1_2(7)_e24720.nxml.txt.nlp	24073365	SENT29	43	43	8	8	trastuzumab	HER2	PA451743	2064	0.996
NULL	Oncotarget_2014_Jun_1_5(13)_4868-4880.nxml.txt.nlp	24947902	SENT34	9	9	19	19	afatinib	HER2	PA165981154	2064	0.996
NULL	Breast_Cancer_Res_2013_Sep_25_15(5)_R88.nxml.txt.nlp	24063698	SENT29	5	5	33	33	olaparib	BRCA2		675	0.996
NULL	Breast_Cancer_Res_2011_Nov_1_13(6)_224.nxml.txt.nlp	22114931	SENT112	20	20	0	0	trastuzumab	HER2	PA451743	2064	0.996
NULL	FASEB_J_2009_Feb_23(2)_575-585.nxml.txt.nlp	18957574	SENT332	29	29	0	0	oxygen	L10	PA450744	6134	0.996
NULL	J_Breast_Cancer_2014_Sep_30_17(3)_287-290.nxml.txt.nlp	25320628	SENT58	13	13	24	24	temsirolimus	PIK3CA	PA164746890	5290	0.996
NULL	Front_Immunol_2013_Nov_12_4_370.nxml.txt.nlp	24273542	SENT196	6	6	31	31	gemcitabine	NLRP3	PA449748	114548	0.996
NULL	Breast_Cancer_(Auckl)_2014_Oct_15_8_145-155.nxml.txt.nlp	25368521	SENT84	7	7	15	15	cisplatin	BRCA1	PA449014	672	0.996
NULL	Iran_J_Ped_Hematol_Oncol_2014_Mar_15_4(1)_32-38.nxml.txt.nlp	24734162	SENT35	0	0	12	12	mercaptopurine	TPMT	PA450379	7172	0.996
NULL	J_Biol_Chem_2008_Oct_31_283(44)_29841-29846.nxml.txt.nlp	18765669	SENT9	0	0	45	45	suramin	P2X1	PA10292	5023	0.996
NULL	Biomed_Res_Int_2013_Aug_6_2013_602987.nxml.txt.nlp	24027759	SENT274	12	12	36	36	paclitaxel	SMF	PA450761	22993	0.996
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1420-1426.nxml.txt.nlp	24056704	SENT128	5	5	33	33	ketoconazole	CYP3A	PA450146	1574	0.996
NULL	Br_J_Cancer_1995_May_71(5)_907-913.nxml.txt.nlp	7734314	SENT16	33	33	16	16	etoposide	MDR1	PA449552	5243	0.996
NULL	Oncol_Lett_2013_Apr_4_5(4)_1165-1170.nxml.txt.nlp	23599757	SENT134	39	39	5	5	pemetrexed	SLC19A1	PA10810	6573	0.996
NULL	Ann_Rheum_Dis_2014_Sep_3_73(9)_1616-1625.nxml.txt.nlp	24699939	SENT27	2	2	22	22	tocilizumab	IL-6	PA165292659	3569	0.996
NULL	Hum_Genomics_2010_Apr_1_4(4)_238-249.nxml.txt.nlp	20511137	SENT106	13	13	41	41	sn-38	UGT1A1		54658	0.996
NULL	Front_Genet_2012_Nov_22_3_249.nxml.txt.nlp	23189085	SENT151	32	32	3	3	s-adenosylmethionine	MTHFR	PA164754994	4524	0.996
NULL	Oncoscience_2014_Mar_12_1(2)_167-179.nxml.txt.nlp	25126591	SENT183	0	0	41	41	crizotinib	PTPRD	PA165946122	5789	0.996
NULL	Ann_Hematol_2014_Sep_12_93(1)_13-32.nxml.txt.nlp	24026426	SENT270	3	3	20	20	posaconazole	BII	PA151958574	777	0.996
NULL	Braz_J_Med_Biol_Res_2013_Nov_25_46(12)_1074-1081.nxml.txt.nlp	24345917	SENT128	8	8	24	24	trastuzumab	HER2	PA451743	2064	0.996
NULL	Br_J_Cancer_1998_Aug_78(3)_375-381.nxml.txt.nlp	9703286	SENT10	21	21	1	1	paclitaxel	TP53	PA450761	7157	0.996
NULL	J_Oncol_2009_Jul_14_2009_896407.nxml.txt.nlp	19636423	SENT113	21	21	5	5	gefitinib	EGFR	PA131301952	1956	0.996
NULL	J_Cancer_2013_Jan_11_4(2)_117-132.nxml.txt.nlp	23386910	SENT85	0	0	10	10	pertuzumab	HER2		2064	0.996
NULL	Oncoimmunology_2012_Aug_1_1(5)_618-629.nxml.txt.nlp	22934254	SENT192	20	20	4	4	nilotinib	IL8	PA165958345	3576	0.996
NULL	Front_Genet_2014_Jun_2_5_154.nxml.txt.nlp	24917878	SENT134	5	5	28	28	ethanol	POMC	PA448073	5443	0.996
NULL	Oncol_Lett_2013_Apr_4_5(4)_1165-1170.nxml.txt.nlp	23599757	SENT34	34	34	15	15	pemetrexed	MTHFR	PA10810	4524	0.996
NULL	Acta_Pharmacol_Sin_2011_Jun_32(6)_758-764.nxml.txt.nlp	21642947	SENT89	18	18	29	29	fluphenazine	TRAAK	PA449676	50801	0.996
NULL	Cancer_Cell_Int_2013_Mar_4_13_21.nxml.txt.nlp	23497288	SENT125	16	16	4	4	doxorubicin	p53	PA449412	7157	0.996
NULL	Am_J_Transplant_2012_Aug_12(8)_2008-2016.nxml.txt.nlp	22500984	SENT172	30	30	7	7	cyclosporine	CD25	PA449167	3669;3559	0.996
NULL	Cell_Cycle_2012_Nov_1_11(21)_4069-4078.nxml.txt.nlp	23095523	SENT150	21	21	6	6	imatinib	PERK	PA10804	9451	0.996
NULL	Br_J_Pharmacol_2010_Sep_161(2)_288-307.nxml.txt.nlp	20735416	SENT245	32	32	9	9	halothane	TREK-1	PA449845	3776	0.996
NULL	Cancer_Metastasis_Rev_2010_Dec_10_29(4)_581-594.nxml.txt.nlp	20830503	SENT96	8	8	26	26	anastrozole	TTR	PA448432	7276	0.996
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT69	35	35	7	7	capecitabine	HER2	PA448771	2064	0.996
NULL	Nat_Med_2010_Jun_9_16(6)_662-664.nxml.txt.nlp	20473307	SENT55	46	46	11	11	ganciclovir	EGFR	PA449733	1956	0.996
NULL	Clin_Psychopharmacol_Neurosci_2013_Dec_24_11(3)_144-151.nxml.txt.nlp	24465251	SENT39	4	4	17	17	haloperidol	IL-2	PA449841	3558	0.996
NULL	J_Cancer_Prev_2013_Jun_18(2)_186-191.nxml.txt.nlp	25337545	SENT99	11	11	0	0	curcumin	p53	PA151958596	7157	0.996
NULL	Ann_Saudi_Med_2011_Jul-Aug_31(4)_417-420.nxml.txt.nlp	21293067	SENT36	21	21	7	7	zidovudine	CD4	PA451954	920	0.996
NULL	Genome_Biol_2005_Jul_29_6(8)_228.nxml.txt.nlp	16086858	SENT43	6	6	19	19	daunorubicin	CBR1	PA449212	873	0.996
NULL	Cancer_Imaging_2010_Jul_6_10(1)_144-152.nxml.txt.nlp	20605761	SENT80	0	0	32	32	lapatinib	EGF	PA152241907	1950	0.996
NULL	Br_J_Cancer_2012_Sep_4_107(6)_977-987.nxml.txt.nlp	22892389	SENT95	11	11	1	1	orlistat	VEGFA	PA164776864	7422	0.996
NULL	Oncol_Rep_2013_Mar_8_29(3)_917-924.nxml.txt.nlp	23314174	SENT125	36	36	4	4	sorafenib	CD24	PA7000	100133941	0.996
NULL	Oncotarget_2012_Nov_16_3(11)_1439-1454.nxml.txt.nlp	23183822	SENT178	23	23	2	2	temozolomide	CD133	PA451609	8842	0.996
NULL	Open_Virol_J_2012_Dec_28_6_204-215.nxml.txt.nlp	23341856	SENT123	23	23	7	7	doxorubicin	p53	PA449412	7157	0.996
NULL	Case_Rep_Oncol_Med_2014_Jun_11_2014_712040.nxml.txt.nlp	25018885	SENT39	0	0	23	23	sunitinib	CYP3A4	PA162372840	1576	0.996
NULL	Contemp_Oncol_(Pozn)_2012_Nov_20_16(5)_401-406.nxml.txt.nlp	23788917	SENT159	6	6	28	28	afatinib	EGFR	PA165981154	1956	0.996
NULL	Int_J_Surg_Oncol_2012_May_17_2012_406830.nxml.txt.nlp	22675625	SENT50	6	6	15	15	panitumumab	KRAS	PA162373091	3845	0.996
NULL	Case_Rep_Med_2010_Jun_21_2010_517178.nxml.txt.nlp	20593037	SENT55	38	38	4	4	etoposide	XLP	PA449552	4068	0.996
NULL	Oncol_Lett_2013_Feb_9_5(2)_552-558.nxml.txt.nlp	23420128	SENT33	20	20	29	29	imatinib	KIT	PA10804	3815	0.996
NULL	Chin_J_Cancer_2012_Feb_31(2)_73-99.nxml.txt.nlp	22098950	SENT238	9	9	39	39	erlotinib	P-gp	PA134687924	5243	0.996
NULL	Mol_Cancer_2014_Jun_24_13_157.nxml.txt.nlp	24958351	SENT169	40	40	3	3	trastuzumab	HER2	PA451743	2064	0.996
NULL	Antimicrob_Agents_Chemother_2014_Oct_58(10)_6032-6043.nxml.txt.nlp	25070106	SENT19	21	21	5	5	artemisinin	ACT	PA165111696	12;11332;9457;641455	0.996
NULL	Cancers_(Basel)_2010_Dec_30_3(1)_106-125.nxml.txt.nlp	24212609	SENT936	17	17	6	6	doxycycline	MRP5	PA449415	10057	0.996
NULL	Cancers_(Basel)_2013_Nov_26_5(4)_1601-1618.nxml.txt.nlp	24287743	SENT161	15	15	4	4	cisplatin	Met	PA449014	79811	0.996
NULL	Carcinogenesis_2014_May_13_35(5)_1055-1066.nxml.txt.nlp	24419232	SENT192	31	31	14	14	metformin	CYP1B1	PA450395	1545	0.996
NULL	Evid_Based_Complement_Alternat_Med_2011_Mar_14_2011_635058.nxml.txt.nlp	21437195	SENT248	10	10	19	19	genistein	IFN	PA165109660	3439	0.996
NULL	AMB_Express_2012_Dec_7_2_65.nxml.txt.nlp	23217124	SENT27	6	6	41	41	ethanol	CO2	PA448073	4513	0.996
NULL	Clin_Med_Insights_Oncol_2012_Dec_20_7_1-12.nxml.txt.nlp	23362372	SENT37	45	45	5	5	cabazitaxel	CYP3A5	PA165958401	1577	0.996
NULL	Front_Microbiol_2012_Mar_2_3_73.nxml.txt.nlp	22403576	SENT179	34	34	19	19	tocilizumab	IL-6	PA165292659	3569	0.996
NULL	Mar_Drugs_2014_Jun_27_12(7)_3818-3837.nxml.txt.nlp	24979269	SENT194	1	1	5	5	calcein	P-gp	PA132595336	5243	0.996
NULL	J_Oncol_2009_May_6_2009_567486.nxml.txt.nlp	19424511	SENT74	19	19	8	8	cetuximab	KRAS	PA10040	3845	0.996
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Jan_10_6_1-13.nxml.txt.nlp	24648765	SENT80	15	15	35	35	doxorubicin	MDR1	PA449412	5243	0.996
NULL	Diabetes_Metab_Syndr_Obes_2014_Jul_3_7_277-288.nxml.txt.nlp	25050071	SENT72	24	24	4	4	metformin	PPG	PA450395	5552	0.996
NULL	eLife_2013_Nov_5_2_e00969.nxml.txt.nlp	24192036	SENT104	18	18	0	0	vemurafenib	BIM	PA165946873	10018	0.996
NULL	Indian_J_Endocrinol_Metab_2013_Oct_17(Suppl1)_S301-S303.nxml.txt.nlp	24251194	SENT9	0	0	14	14	liraglutide	GLP-1	PA165958364	100125288	0.996
NULL	Mol_Cancer_2012_Jun_18_11_41.nxml.txt.nlp	22709873	SENT303	17	17	2	2	lapatinib	CCND1	PA152241907	595	0.996
NULL	Cell_Death_Dis_2014_Jan_16_5(1)_e1000.nxml.txt.nlp	24434508	SENT59	33	33	6	6	etoposide	p53	PA449552	7157	0.996
NULL	Iran_J_Ped_Hematol_Oncol_2014_Mar_15_4(1)_32-38.nxml.txt.nlp	24734162	SENT42	6	6	13	13	mercaptopurine	XDH	PA450379	7498	0.996
NULL	Am_J_Case_Rep_2013_Jun_17_14_205-209.nxml.txt.nlp	23826469	SENT117	0	0	33	33	ivermectin	CYP2D6	PA450133	1565	0.996
NULL	Cell_Death_Differ_2011_Oct_8_18(10)_1598-1607.nxml.txt.nlp	21475306	SENT53	27	27	3	3	tetracycline	ULK1	PA451640	8408	0.996
NULL	J_Immunother_2014_Apr_12_37(3)_180-186.nxml.txt.nlp	24598448	SENT189	20	20	6	6	sorafenib	IL-2	PA7000	3558	0.996
NULL	Chemother_Res_Pract_2012_Feb_12_2012_192362.nxml.txt.nlp	22400111	SENT80	28	28	6	6	temozolomide	CD133	PA451609	8842	0.996
NULL	Oncotarget_2010_Oct_25_1(7)_497-514.nxml.txt.nlp	21165163	SENT134	19	19	7	7	gefitinib	SRC-3	PA131301952	8202	0.996
NULL	Psychol_Res_Behav_Manag_2011_Sep_12_4_119-128.nxml.txt.nlp	22114542	SENT59	29	29	20	20	bupropion	CYP2B6	PA448687	1555	0.996
NULL	Carcinogenesis_2011_Nov_1_32(11)_1724-1733.nxml.txt.nlp	21890461	SENT168	6	6	14	14	tamoxifen	ROS	PA451581	6098	0.996
NULL	Sci_Rep_2014_Dec_3_4_7298.nxml.txt.nlp	25466238	SENT270	13	13	2	2	chloroquine	UCHL1	PA448948	7345	0.996
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S31-S40.nxml.txt.nlp	20680106	SENT38	12	12	31	31	panitumumab	KRAS	PA162373091	3845	0.996
NULL	Onco_Targets_Ther_2014_Jul_14_7_1285-1289.nxml.txt.nlp	25053886	SENT33	3	3	14	14	trastuzumab	HER2	PA451743	2064	0.996
NULL	Mar_Drugs_2014_Jun_27_12(7)_3818-3837.nxml.txt.nlp	24979269	SENT195	16	16	1	1	calcein	P-gp	PA132595336	5243	0.996
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Apr_17_6_43-57.nxml.txt.nlp	24833916	SENT300	9	9	29	29	everolimus	PI3K	PA164746311	5290	0.996
NULL	J_Gynecol_Oncol_2013_Jul_4_24(3)_273-279.nxml.txt.nlp	23875078	SENT157	5	5	15	15	paclitaxel	COX	PA450761	1351	0.996
NULL	Case_Rep_Oncol_Med_2013_Dec_5_2013_487205.nxml.txt.nlp	24381772	SENT78	19	19	7	7	rituximab	IL-6	PA451261	3569	0.996
NULL	ScientificWorldJournal_2012_Apr_26_2012_358102.nxml.txt.nlp	22645419	SENT149	4	4	33	33	captopril	AT1	PA448780	9197;185	0.996
NULL	J_Breast_Cancer_2011_Jun_18_14(2)_135-139.nxml.txt.nlp	21847409	SENT105	3	3	21	21	fulvestrant	aromatase	PA164747170	1588	0.996
NULL	Diabetes_Care_2009_Apr_32(4)_531-540.nxml.txt.nlp	19336638	SENT16	0	0	12	12	ticlopidine	P2Y12	PA451686	64805	0.996
NULL	Oncol_Lett_2013_Apr_22_5(4)_1093-1100.nxml.txt.nlp	23599746	SENT127	11	11	39	39	paclitaxel	MDR1	PA450761	5243	0.996
NULL	J_Biomed_Biotechnol_2011_Dec_6_2011_475641.nxml.txt.nlp	21188171	SENT91	9	9	37	37	vorinostat	HERG	PA164748224	3757	0.996
NULL	Br_J_Haematol_2014_Feb_16_164(4)_469-480.nxml.txt.nlp	24372186	SENT7	42	42	4	4	primaquine	G6PD	PA451103	2539	0.996
NULL	Evid_Based_Complement_Alternat_Med_2011_Mar_1_2011_207034.nxml.txt.nlp	21423686	SENT16	8	8	30	30	clopidogrel	ADP	PA449053	23038	0.996
NULL	Allergy_Rhinol_(Providence)_2013_Apr_2_Spring_4(1)_e13-e16.nxml.txt.nlp	23772319	SENT143	23	23	1	1	gefitinib	EGF	PA131301952	1950	0.996
NULL	Cancers_(Basel)_2011_Apr_1_3(2)_1861-1876.nxml.txt.nlp	24212786	SENT154	36	36	1	1	gefitinib	EGFR	PA131301952	1956	0.996
NULL	Endocr_Connect_2012_Jul_21_1(1)_37-47.nxml.txt.nlp	23781302	SENT27	22	22	6	6	mitotane	CYP11B2	PA164746157	1585	0.996
NULL	Blood_Res_2013_Mar_25_48(1)_35-39.nxml.txt.nlp	23589793	SENT86	0	0	35	35	thalidomide	CD4	PA451644	920	0.996
NULL	Cancers_(Basel)_2010_Dec_30_3(1)_106-125.nxml.txt.nlp	24212609	SENT99	29	29	4	4	gemcitabine	MRP5	PA449748	10057	0.996
NULL	Hum_Genomics_Proteomics_2009_Dec_8_2009_239204.nxml.txt.nlp	20948568	SENT250	39	39	5	5	trypsin	ICAT	PA451806	56998	0.996
NULL	Biosci_Rep_2012_Aug_1_32(Pt_4)_361-374.nxml.txt.nlp	22762204	SENT188	18	18	5	5	cisplatin	TAZ	PA449014	25937;6901	0.996
NULL	Cancers_(Basel)_2011_Aug_19_3(3)_3370-3393.nxml.txt.nlp	24212958	SENT193	36	36	16	16	rituximab	CD16a	PA451261	2214	0.996
NULL	Breast_Cancer_Res_2005_Nov_21_7(6)_R1153-R1158.nxml.txt.nlp	16457695	SENT69	19	19	34	34	tamoxifen	BRCA1	PA451581	672	0.996
NULL	Acta_Pharmacol_Sin_2012_May_16_33(5)_682-690.nxml.txt.nlp	22504904	SENT11	23	23	4	4	celecoxib	STAT3	PA448871	6774	0.996
NULL	Breast_Cancer_Res_2010_Dec_20_12(Suppl_4)_S18.nxml.txt.nlp	21172080	SENT22	12	12	22	22	venlafaxine	CYP2D6	PA451866	1565	0.996
NULL	Br_J_Cancer_2012_Feb_14_106(4)_685-692.nxml.txt.nlp	22294184	SENT157	25	25	7	7	lovastatin	survivin	PA450272	332	0.996
NULL	J_Cell_Physiol_2011_Nov_15_226(11)_2979-2986.nxml.txt.nlp	21328349	SENT149	10	10	0	0	econazole	TRPV5	PA164746010	56302	0.996
NULL	Pharmaceuticals_(Basel)_2012_Aug_10_5(8)_802-836.nxml.txt.nlp	24280676	SENT247	24	24	7	7	sulfasalazine	PCFT	PA451547	113235	0.996
NULL	Int_Clin_Psychopharmacol_2014_Nov_3_29(6)_351-356.nxml.txt.nlp	24978955	SENT30	5	5	21	21	buspirone	5-HT1A	PA448689	3350	0.996
NULL	Oncotarget_2012_May_19_3(5)_535-545.nxml.txt.nlp	22619121	SENT67	0	0	26	26	camptothecin	MYCN	PA153590860	4613	0.996
NULL	Patient_Prefer_Adherence_2011_Dec_23_6_1-9.nxml.txt.nlp	22272064	SENT17	10	10	34	34	telmisartan	ACE	PA451605	1636	0.996
NULL	Pharmaceuticals_(Basel)_2013_Aug_21_6(8)_988-1038.nxml.txt.nlp	24276379	SENT224	29	29	4	4	oxaliplatin	ERCC5	PA131285527	2073	0.996
NULL	Autoimmunity_2011_Feb_23_45(1)_7-35.nxml.txt.nlp	21939410	SENT314	2	2	11	11	sirolimus	c-Myc	PA451365	4609	0.995
NULL	J_Cell_Biol_2005_May_23_169(4)_681-691.nxml.txt.nlp	15911882	SENT69	32	32	15	15	aprotinin	TIMP2	PA448472	7077	0.995
NULL	Mol_Cancer_2009_Nov_10_8_99.nxml.txt.nlp	19903356	SENT42	37	37	1	1	imatinib	IGFBP3	PA10804	3486	0.995
NULL	Arthritis_Res_Ther_2005_Apr_25_7(4)_R817-R824.nxml.txt.nlp	15987483	SENT157	0	0	39	39	methotrexate	RAGE	PA450428	177	0.995
NULL	J_Exp_Med_1998_Mar_16_187(6)_855-864.nxml.txt.nlp	9500788	SENT121	0	0	34	34	trypsin	CD4	PA451806	920	0.995
NULL	Indian_J_Nucl_Med_2014_Jan-Mar_29(1)_34-37.nxml.txt.nlp	24591781	SENT9	9	9	13	13	tamoxifen	aromatase	PA451581	1588	0.995
NULL	Breast_Cancer_(Auckl)_2011_Jul_27_5_175-199.nxml.txt.nlp	21863131	SENT206	5	5	29	29	docetaxel	EGFR	PA449383	1956	0.995
NULL	Cancers_(Basel)_2014_Sep_5_6(3)_1769-1792.nxml.txt.nlp	25198391	SENT100	23	23	4	4	tamoxifen	EGFR	PA451581	1956	0.995
NULL	Curr_Oncol_2010_Feb_17(1)_81-86.nxml.txt.nlp	20179808	SENT57	0	0	43	43	letrozole	aromatase	PA450196	1588	0.995
NULL	Ecancermedicalscience_2009_Feb_23_3_128.nxml.txt.nlp	22275997	SENT84	0	0	33	33	methotrexate	c-Myc	PA450428	4609	0.995
NULL	Cancers_(Basel)_2012_Sep_25_4(4)_969-988.nxml.txt.nlp	24213497	SENT129	10	10	30	30	estradiol	aromatase	PA449503	1588	0.995
NULL	Ecancermedicalscience_2009_Oct_29_3_157.nxml.txt.nlp	22276018	SENT71	22	22	35	35	gefitinib	EGFR	PA131301952	1956	0.995
NULL	Front_Neuroanat_2011_Aug_26_5_50.nxml.txt.nlp	21904525	SENT348	24	24	9	9	forskolin	ARPP-16	PA146096022	10776	0.995
NULL	F1000Res_2013_Aug_20_2_147.nxml.txt.nlp	24555068	SENT375	4	4	15	15	curcumin	MMP3	PA151958596	4314	0.995
NULL	Clin_Drug_Investig_2013_Aug_23_33(10)_727-736.nxml.txt.nlp	23975654	SENT172	12	12	39	39	paroxetine	CYP2C9	PA450801	1559	0.995
NULL	Cell_Death_Dis_2014_Feb_13_5(2)_e1055.nxml.txt.nlp	24525731	SENT71	17	17	4	4	irinotecan	XRCC1	PA450085	7515	0.995
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2011_Jan_12_4_1-12.nxml.txt.nlp	22879789	SENT43	17	17	37	37	metformin	GLP-1	PA450395	100125288	0.995
NULL	J_Gen_Physiol_2000_Jun_1_115(6)_799-814.nxml.txt.nlp	10828252	SENT97	12	12	23	23	spermine	IRK1	PA164781199	3759	0.995
NULL	Arthritis_Res_Ther_2004_Mar_8_6(2)_60-72.nxml.txt.nlp	15059266	SENT109	5	5	29	29	infliximab	MCP-1	PA452639	6347	0.995
NULL	Eur_J_Clin_Pharmacol_2010_Nov_29_66(11)_1131-1136.nxml.txt.nlp	20669013	SENT130	4	4	34	34	voriconazole	CYP3A4	PA10233	1576	0.995
NULL	BMB_Rep_2013_Aug_46(8)_410-415.nxml.txt.nlp	23977989	SENT101	31	31	36	36	curcumin	HO-1	PA151958596	3162	0.995
NULL	Cancers_(Basel)_2014_Apr_16_6(2)_926-957.nxml.txt.nlp	24743778	SENT350	0	0	28	28	niclosamide	STAT3	PA165958408	6774	0.995
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1149.nxml.txt.nlp	24675467	SENT31	39	39	6	6	trastuzumab	HER2	PA451743	2064	0.995
NULL	Cell_Death_Dis_2013_Jun_27_4(6)_e694.nxml.txt.nlp	23807223	SENT90	20	20	6	6	chloroquine	JNK	PA448948	5599	0.995
NULL	Cancer_Res_Treat_2013_Sep_30_45(3)_178-185.nxml.txt.nlp	24155676	SENT87	18	18	27	27	gefitinib	EGFR	PA131301952	1956	0.995
NULL	Allergy_Asthma_Immunol_Res_2015_Jan_25_7(1)_83-87.nxml.txt.nlp	25553267	SENT69	21	21	42	42	methacholine	ACT	PA165958382	12;11332;9457;641455	0.995
NULL	Curr_Med_Chem_2011_Jun_18(18)_2686-2714.nxml.txt.nlp	21649578	SENT286	6	6	35	35	erlotinib	PI3K	PA134687924	5290	0.995
NULL	Mol_Biol_Cell_2013_Jul_15_24(14)_2186-2200.nxml.txt.nlp	23699397	SENT93	27	27	3	3	staurosporine	TRAIL	PA165109623	8743	0.995
NULL	J_Clin_Biochem_Nutr_2011_Mar_26_48(2)_126-133.nxml.txt.nlp	21373265	SENT122	9	9	26	26	lansoprazole	HO-1	PA450180	3162	0.995
NULL	Cell_Death_Dis_2014_Mar_13_5(3)_e1113.nxml.txt.nlp	24625972	SENT331	14	14	0	0	bleomycin	BI-1	PA448645	7009	0.995
NULL	Case_Rep_Hematol_2012_Apr_1_2012_396395.nxml.txt.nlp	22937327	SENT83	30	30	2	2	cisplatin	IL-6	PA449014	3569	0.995
NULL	Nucleic_Acids_Res_2013_May_3_41(10)_e107.nxml.txt.nlp	23558748	SENT334	19	19	1	1	doxycycline	Bsr	PA449415	79104	0.995
NULL	J_Biol_Chem_2010_Aug_20_285(34)_26406-26416.nxml.txt.nlp	20530490	SENT37	12	12	33	33	artemisinin	SERCA1	PA165111696	487	0.995
NULL	Oncogene_2014_Sep_11_33(37)_4579-4588.nxml.txt.nlp	24662835	SENT125	33	33	15	15	tamoxifen	p53	PA451581	7157	0.995
NULL	Cardiovasc_Psychiatry_Neurol_2009_Sep_9_2009_969752.nxml.txt.nlp	20029636	SENT28	30	30	0	0	entacapone	COMT	PA164748726	1312	0.995
NULL	Dermatoendocrinol_2013_Apr_1_5(2)_239-251.nxml.txt.nlp	24194964	SENT196	6	6	38	38	vemurafenib	BRAF	PA165946873	673	0.995
NULL	Nucl_Recept_Signal_2012_Feb_27_10_e003.nxml.txt.nlp	22438793	SENT232	27	27	3	3	fulvestrant	RALDH3	PA164747170	220	0.995
NULL	Eur_J_Neurosci_2009_Jul_30(2)_299-306.nxml.txt.nlp	19614978	SENT19	12	12	33	33	piperazine	5-HT2C	PA450977	3358	0.995
NULL	Open_Cardiovasc_Med_J_2010_Jun_17_4_135-145.nxml.txt.nlp	20700394	SENT106	0	0	18	18	abciximab	alpha-chain	PA448006	2217	0.995
NULL	BMJ_2010_Feb_8_340_c693.nxml.txt.nlp	20142325	SENT26	3	3	36	36	paroxetine	CYP2D6	PA450801	1565	0.995
NULL	Indian_J_Hum_Genet_2014_Apr-Jun_20(2)_175-184.nxml.txt.nlp	25400347	SENT139	12	12	36	36	warfarin	CYP2C9	PA451906	1559	0.995
NULL	Br_J_Cancer_2013_Feb_19_108(3)_579-586.nxml.txt.nlp	23370212	SENT144	22	22	2	2	cisplatin	Oct4	PA449014	5460	0.995
NULL	Int_J_Endocrinol_2010_Feb_10_2010_625852.nxml.txt.nlp	20169119	SENT137	20	20	6	6	paricalcitol	PTH	PA450798	5741	0.995
NULL	Front_Immunol_2013_Nov_7_4_360.nxml.txt.nlp	24223576	SENT171	23	23	4	4	imiquimod	IL-10	PA449972	3586	0.995
NULL	Cell_Death_Dis_2010_Nov_18_1(11)_e102.nxml.txt.nlp	21368867	SENT229	4	4	34	34	gentamicin	CO2	PA449753	4513	0.995
NULL	Oncol_Lett_2013_Apr_4_5(4)_1165-1170.nxml.txt.nlp	23599757	SENT34	34	34	3	3	pemetrexed	MTHFR	PA10810	4524	0.995
NULL	Breast_Cancer_Res_2007_Jun_7_9(3)_R37.nxml.txt.nlp	17555561	SENT23	23	23	5	5	tamoxifen	aromatase	PA451581	1588	0.995
NULL	Arthritis_Res_Ther_2012_Jan_17_14(1)_R9.nxml.txt.nlp	22251404	SENT277	5	5	14	14	celecoxib	IFN	PA448871	3439	0.995
NULL	Oncol_Lett_2013_Sep_15_6(3)_648-654.nxml.txt.nlp	24137384	SENT37	29	29	8	8	oxaliplatin	GSTP1	PA131285527	2950	0.995
NULL	Angew_Chem_Int_Ed_Engl_2013_Jan_2_52(1)_325-330.nxml.txt.nlp	23080482	SENT30	31	31	12	12	thrombin	PAR1	PA451674	79581;2149	0.995
NULL	Acta_Pharmacol_Sin_2013_Jul_5_34(7)_870-879.nxml.txt.nlp	23624759	SENT95	5	5	24	24	gefitinib	EGFR	PA131301952	1956	0.995
NULL	Oncoimmunology_2012_Oct_1_1(7)_1004-1016.nxml.txt.nlp	23170249	SENT47	31	31	12	12	paclitaxel	HER-2	PA450761	2064	0.995
NULL	Biomed_Res_Int_2014_Aug_6_2014_967826.nxml.txt.nlp	25165721	SENT69	13	13	6	6	cisplatin	p53	PA449014	7157	0.995
NULL	J_Hum_Genet_2013_Jun_23_58(6)_339-345.nxml.txt.nlp	23697979	SENT80	31	31	19	19	clopidogrel	ABCB1	PA449053	5243	0.995
NULL	J_Oncol_2009_May_6_2009_567486.nxml.txt.nlp	19424511	SENT149	3	3	16	16	sunitinib	EGFR	PA162372840	1956	0.995
NULL	Mol_Brain_2014_Aug_21_7_59.nxml.txt.nlp	25139109	SENT108	16	16	8	8	capsaicin	TLR4	PA448776	7099	0.995
NULL	Br_J_Cancer_2000_Jun_82(11)_1851-1859.nxml.txt.nlp	10839301	SENT7	38	38	4	4	topotecan	CD95	PA451729	355	0.995
NULL	Int_J_Mol_Sci_2014_Oct_6_15(10)_17886-17900.nxml.txt.nlp	25290095	SENT11	27	27	35	35	resveratrol	SIRT1		23411	0.995
NULL	Cancer_Res_Treat_2012_Mar_31_44(1)_1-10.nxml.txt.nlp	22500155	SENT96	0	0	16	16	gefitinib	EGFR	PA131301952	1956	0.995
NULL	Cardiovasc_Drugs_Ther_2013_Jul_26_27(6)_521-530.nxml.txt.nlp	23887740	SENT117	16	16	4	4	clopidogrel	CD41	PA449053	3674	0.995
NULL	Cancer_Inform_2014_Feb_12_13(Suppl_1)_1-16.nxml.txt.nlp	24558298	SENT179	5	5	11	11	pertuzumab	ERBB2		2064	0.995
NULL	Br_J_Cancer_2013_Aug_6_109(3)_686-693.nxml.txt.nlp	23839492	SENT134	3	3	40	40	sunitinib	IL-8	PA162372840	3576	0.995
NULL	Diabetes_Care_2011_Oct_15_34(10)_2323-2328.nxml.txt.nlp	21949223	SENT24	4	4	47	47	metformin	LKB1	PA450395	6794	0.995
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT28	31	31	18	18	coumarin	VKORC1	PA134521193	79001	0.995
NULL	Niger_Med_J_2012_Jul-Sep_53(3)_172-174.nxml.txt.nlp	23293420	SENT64	15	15	32	32	raloxifene	aromatase	PA451221	1588	0.995
NULL	Br_J_Pharmacol_2013_Feb_16_168(3)_607-617.nxml.txt.nlp	22946487	SENT242	26	26	8	8	metyrapone	spatial	PA450486	219793	0.995
NULL	Diabetes_Metab_Syndr_Obes_2010_Dec_6_3_421-429.nxml.txt.nlp	21437112	SENT43	42	42	17	17	curcumin	STZ	PA151958596	6484	0.995
NULL	J_Oncol_2010_Jan_3_2010_709678.nxml.txt.nlp	21274259	SENT29	5	5	28	28	erlotinib	EGFR	PA134687924	1956	0.995
NULL	Indian_J_Med_Res_2012_Aug_136(2)_249-259.nxml.txt.nlp	22960892	SENT125	19	19	2	2	irinotecan	UGT1A1	PA450085	54658	0.995
NULL	Osteoporos_Int_2014_Aug_15_25(10)_2359-2381.nxml.txt.nlp	25182228	SENT547	3	3	21	21	denosumab	BMD	PA166048634	1756;7439	0.995
NULL	J_Physiol_2013_Mar_15_591(6)_1463-1474.nxml.txt.nlp	23297308	SENT146	12	12	37	37	bumetanide	NO3	PA448682	4681	0.995
NULL	Ann_Gen_Psychiatry_2009_Aug_13_8_18.nxml.txt.nlp	19674486	SENT140	3	3	16	16	fluoxetine	B12	PA449673	7126;4709	0.995
NULL	Oncol_Lett_2013_Aug_20_6(2)_612-616.nxml.txt.nlp	24137380	SENT16	9	9	31	31	sorafenib	BCS	PA7000	617	0.995
NULL	Indian_J_Dermatol_2011_May-Jun_56(3)_262-265.nxml.txt.nlp	21772584	SENT101	11	11	32	32	pimecrolimus	IL-2	PA164783790	3558	0.995
NULL	Front_Immunol_2014_Apr_1_5_131.nxml.txt.nlp	24744755	SENT279	9	9	37	37	imiquimod	IFN	PA449972	3439	0.995
NULL	Cancer_Cell_Int_2005_Feb_9_5_2.nxml.txt.nlp	15703065	SENT136	11	11	18	18	daunorubicin	P-gp	PA449212	5243	0.995
NULL	Crit_Care_2008_Jul_2_12(4)_163.nxml.txt.nlp	18620550	SENT14	24	24	6	6	hydrocortisone	RAI	PA449905	10848;6050	0.995
NULL	Core_Evid_2012_Jul_9_7_49-59.nxml.txt.nlp	22826692	SENT136	0	0	28	28	rivaroxaban	CYP3A4	PA165958360	1576	0.995
NULL	Breast_Cancer_Res_Treat_2014_Nov_11_148(3)_563-570.nxml.txt.nlp	25385180	SENT19	0	0	20	20	lapatinib	EGFR	PA152241907	1956	0.995
NULL	Mediators_Inflamm_2010_Sep_22_2010_628171.nxml.txt.nlp	20886028	SENT20	4	4	18	18	pranlukast	CysLT1	PA134698661	10800	0.995
NULL	Curr_Oncol_2009_Jul_16(Suppl_2)_S14-S23.nxml.txt.nlp	19672417	SENT120	30	30	15	15	paroxetine	CYP2D6	PA450801	1565	0.995
NULL	J_Cancer_2013_Nov_23_4(9)_736-754.nxml.txt.nlp	24312144	SENT272	30	30	10	10	erlotinib	VEGFR2	PA134687924	3791	0.995
NULL	Comb_Chem_High_Throughput_Screen_2010_Feb_13(2)_188-206.nxml.txt.nlp	20053163	SENT246	3	3	25	25	fluconazole	CYP3A4	PA449653	1576	0.995
NULL	Exp_Ther_Med_2013_Apr_30_5(4)_1083-1088.nxml.txt.nlp	23599733	SENT112	22	22	0	0	methylcholanthrene	U14	PA165816878	85388;26822	0.995
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_33-43.nxml.txt.nlp	17912634	SENT131	0	0	18	18	letrozole	HER2	PA450196	2064	0.995
NULL	Cell_Commun_Signal_2011_May_15_9_13.nxml.txt.nlp	21569639	SENT347	0	0	27	27	quinacrine	p53	PA164745551	7157	0.995
NULL	Breast_Cancer_Res_2003_Oct_7_5(1)_8-15.nxml.txt.nlp	12559039	SENT265	6	6	20	20	geldanamycin	Hsp90	PA152031327	3320	0.995
NULL	Cancer_Med_2014_Oct_18_3(5)_1294-1301.nxml.txt.nlp	24941936	SENT176	42	42	24	24	cetuximab	KRAS	PA10040	3845	0.995
NULL	Cell_Death_Dis_2013_Jun_13_4(6)_e665.nxml.txt.nlp	23764846	SENT46	18	18	3	3	sorafenib	BLM	PA7000	641	0.995
NULL	Endocrinol_Diabetes_Metab_Case_Rep_2014_Jul_1_2014_140050.nxml.txt.nlp	25045523	SENT67	15	15	43	43	cinacalcet	PTH	PA164776671	5741	0.995
NULL	Mol_Cytogenet_2014_Jan_21_7(Suppl_1)_P100.nxml.txt.nlp	NULL	SENT18	38	38	5	5	metformin	TCF7L2	PA450395	6934	0.995
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT300	9	9	32	32	ranibizumab	VEGFR2	PA164746012	3791	0.995
NULL	Int_J_Chron_Obstruct_Pulmon_Dis_2007_Dec_2(4)_541-550.nxml.txt.nlp	18268927	SENT181	8	8	0	0	thrombin	SERPINE2	PA451674	5270	0.995
NULL	ScientificWorldJournal_2014_Feb_5_2014_465151.nxml.txt.nlp	24683343	SENT255	25	25	6	6	ethanol	DAC	PA448073	13	0.995
NULL	J_Biol_Chem_2012_Apr_13_287(16)_12952-12965.nxml.txt.nlp	22371491	SENT217	0	0	24	24	terazosin	CXCR2	PA451612	3579	0.995
NULL	Breast_Cancer_Res_2005_May_24_7(5)_R589-R597.nxml.txt.nlp	16168102	SENT161	15	15	33	33	doxorubicin	FAK	PA449412	5747	0.995
NULL	Eur_J_Clin_Pharmacol_2011_May_8_67(5)_493-506.nxml.txt.nlp	21140139	SENT156	10	10	1	1	verapamil	CYP3A4	PA451868	1576	0.995
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT143	13	13	6	6	curcumin	PC-3	PA151958596	692094	0.995
NULL	J_Cancer_2014_Jan_5_5(2)_86-97.nxml.txt.nlp	24494026	SENT116	21	21	5	5	cisplatin	EGFR	PA449014	1956	0.995
NULL	Diabetes_Metab_J_2012_Aug_20_36(4)_293-299.nxml.txt.nlp	22950061	SENT112	33	33	0	0	metformin	POMC	PA450395	5443	0.995
NULL	Cancers_(Basel)_2013_Apr_11_5(2)_404-417.nxml.txt.nlp	24216983	SENT37	28	28	0	0	hydrocortisone	CD31	PA449905	5175	0.995
NULL	Int_J_Endocrinol_2014_Jun_25_2014_534904.nxml.txt.nlp	25053942	SENT37	20	20	11	11	amiodarone	AIT	PA448383	160728	0.995
NULL	Oncotarget_2013_Dec_17_5(1)_67-77.nxml.txt.nlp	24393766	SENT139	0	0	36	36	lapatinib	NF2	PA152241907	4771	0.995
NULL	Int_J_Breast_Cancer_2012_Feb_26_2012_761917.nxml.txt.nlp	22482061	SENT188	10	10	0	0	saracatinib	EGFR		1956	0.995
NULL	Nucleic_Acids_Res_2007_Jan_6_35(Database_issue)_D794-D799.nxml.txt.nlp	17151074	SENT64	15	15	35	35	fluphenazine	CYP2D6	PA449676	1565	0.995
NULL	Acta_Pharmacol_Sin_2011_Jul_6_32(7)_921-929.nxml.txt.nlp	21643005	SENT218	23	23	11	11	cerulenin	5-LOX	PA164764551	240	0.995
NULL	Hum_Genomics_2009_Jan_1_3(2)_106-120.nxml.txt.nlp	19164088	SENT121	3	3	19	19	vigabatrin	ALDH5A1	PA10231	7915	0.995
NULL	Oncotarget_2014_Mar_16_5(12)_4087-4102.nxml.txt.nlp	24961479	SENT179	18	18	7	7	hemin	HO-1	PA449849	3162	0.995
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Oct_14_6_159-168.nxml.txt.nlp	25339848	SENT123	5	5	24	24	trastuzumab	HER2	PA451743	2064	0.995
NULL	Cell_Death_Dis_2013_Oct_3_4(10)_e834.nxml.txt.nlp	24091677	SENT219	18	18	7	7	vinblastine	Mcl-1	PA451877	4170	0.995
NULL	Acta_Pharmacol_Sin_2010_May_12_31(5)_578-584.nxml.txt.nlp	20383171	SENT14	17	17	3	3	berberine	ORP150	PA165860812	10525	0.995
NULL	Breast_Cancer_(Auckl)_2011_Jul_27_5_175-199.nxml.txt.nlp	21863131	SENT206	0	0	29	29	gefitinib	EGFR	PA131301952	1956	0.995
NULL	Clin_Med_Insights_Arthritis_Musculoskelet_Disord_2013_Aug_8_6_35-43.nxml.txt.nlp	23997576	SENT188	0	0	16	16	abatacept	CD80	PA164747080	941	0.995
NULL	Breast_Cancer_Res_2009_Jun_29_11(3)_R41.nxml.txt.nlp	19563669	SENT248	23	23	1	1	trastuzumab	XIAP	PA451743	331	0.995
NULL	Biomed_Res_Int_2013_Jul_28_2013_627907.nxml.txt.nlp	23984390	SENT176	29	29	8	8	theophylline	CYP1A2	PA451647	1544	0.995
NULL	Neuro_Oncol_2010_Mar_6_12(3)_233-242.nxml.txt.nlp	20167811	SENT170	16	16	2	2	bevacizumab	VIII	PA130232992	1351	0.995
NULL	Diabetes_2013_Jun_20_62(6)_2122-2129.nxml.txt.nlp	23378607	SENT20	4	4	32	32	pioglitazone	AMPK	PA450970	5563	0.995
NULL	Eur_J_Clin_Pharmacol_2009_Aug_30_65(8)_809-821.nxml.txt.nlp	19404632	SENT28	0	0	33	33	amodiaquine	CYP2C8	PA448404	1558	0.995
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT268	12	12	1	1	ethanol	IL-6	PA448073	3569	0.995
NULL	Indian_J_Endocrinol_Metab_2013_Dec_17(Suppl_3)_S674-S679.nxml.txt.nlp	24910836	SENT78	8	8	33	33	acarbose	PPG	PA448010	5552	0.995
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2007_Dec_6_64(Pt_1)_o161.nxml.txt.nlp	21200727	SENT62	39	39	12	12	ethanol	mol	PA448073	90527	0.995
NULL	Breast_Cancer_Res_2011_Oct_12_13(5)_220.nxml.txt.nlp	22018398	SENT49	32	32	5	5	trastuzumab	EPOR	PA451743	2057	0.995
NULL	J_RNAi_Gene_Silencing_2009_Mar_9_5(1)_321-330.nxml.txt.nlp	19771229	SENT23	41	41	15	15	hydroxyurea	RRM2	PA449942	6241	0.995
NULL	Breast_Cancer_Res_2008_Apr_29_10(2)_206.nxml.txt.nlp	18492214	SENT123	30	30	3	3	estradiol	aromatase	PA449503	1588	0.995
NULL	Oncoimmunology_2012_Oct_1_1(7)_1048-1060.nxml.txt.nlp	23170253	SENT195	0	0	31	31	trastuzumab	HER-2	PA451743	2064	0.995
NULL	Emerg_Med_Int_2014_Jun_1_2014_702053.nxml.txt.nlp	24982807	SENT12	25	25	20	20	oseltamivir	PED	PA450721	8682	0.995
NULL	Child_Adolesc_Psychiatry_Ment_Health_2012_May_29_6_21.nxml.txt.nlp	22643087	SENT205	4	4	11	11	fluoxetine	CYP2D6	PA449673	1565	0.995
NULL	Int_J_Mol_Sci_2014_Oct_14_15(10)_18557-18573.nxml.txt.nlp	25318057	SENT160	6	6	18	18	bortezomib	TRAIL-R2	PA10252	8795	0.995
NULL	Oncol_Lett_2013_Sep_15_6(3)_648-654.nxml.txt.nlp	24137384	SENT37	27	27	8	8	cisplatin	GSTP1	PA449014	2950	0.995
NULL	Mol_Vis_2013_Apr_17_19_894-903.nxml.txt.nlp	23687426	SENT169	11	11	31	31	adalimumab	CRALBP	PA10004	6017	0.995
NULL	Clin_Ophthalmol_2010_Apr_26_4_307-314.nxml.txt.nlp	20463798	SENT78	4	4	31	31	bevacizumab	HER2	PA130232992	2064	0.995
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT258	22	22	4	4	trastuzumab	HRG	PA451743	3084;3273	0.995
NULL	Cancer_Manag_Res_2013_Aug_27_5_225-233.nxml.txt.nlp	24023523	SENT10	4	4	22	22	maytansine	CHOP	PA165291473	1649	0.995
NULL	Int_J_Chron_Obstruct_Pulmon_Dis_2006_Dec_1(4)_409-423.nxml.txt.nlp	18044097	SENT245	0	0	23	23	roflumilast	PDE4D	PA165948052	5144	0.995
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2014_Sep_27_70(Pt_10)_2740-2753.nxml.txt.nlp	25286857	SENT311	0	0	11	11	bsi-201	PARP-1		25976	0.995
NULL	J_Biol_Chem_2013_Mar_29_288(13)_9035-9048.nxml.txt.nlp	23362266	SENT233	4	4	25	25	tamoxifen	CCND1	PA451581	595	0.995
NULL	Diabetes_2009_Jun_31_58(6)_1434-1439.nxml.txt.nlp	19336679	SENT154	22	22	35	35	metformin	SLC22A1	PA450395	6580	0.995
NULL	Mol_Cancer_2010_Apr_23_9_87.nxml.txt.nlp	20416058	SENT253	22	22	6	6	doxorubicin	DR5	PA449412	8795	0.995
NULL	Front_Endocrinol_(Lausanne)_2014_Sep_3_5_138.nxml.txt.nlp	25232350	SENT115	2	2	28	28	metformin	S6K1	PA450395	6198	0.995
NULL	Ther_Clin_Risk_Manag_2006_Dec_2(4)_337-346.nxml.txt.nlp	18360646	SENT60	0	0	33	33	brimonidine	ERG	PA448665	2078	0.995
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Dec_17_3(12)_e152.nxml.txt.nlp	25518025	SENT12	5	5	26	26	oxycodone	CYP3A4	PA450741	1576	0.995
NULL	Acta_Pharmacol_Sin_2012_Oct_3_33(10)_1311-1318.nxml.txt.nlp	22941289	SENT153	9	9	15	15	sorafenib	VEGFR2	PA7000	3791	0.995
NULL	Br_J_Cancer_2011_Jul_26_105(3)_372-381.nxml.txt.nlp	21730979	SENT13	5	5	26	26	cisplatin	p53	PA449014	7157	0.995
NULL	Breast_Cancer_Res_2012_Jun_7_14(3)_R89.nxml.txt.nlp	22676470	SENT193	36	36	12	12	trastuzumab	HER2	PA451743	2064	0.995
NULL	Mol_Pain_2013_Mar_4_9_9.nxml.txt.nlp	23497345	SENT182	7	7	39	39	capsaicin	TRPA1	PA448776	8989	0.995
NULL	Clin_Med_Oncol_2008_Jun_11_2_469-470.nxml.txt.nlp	21892319	SENT22	31	31	8	8	doxorubicin	HER2	PA449412	2064	0.995
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_67-74.nxml.txt.nlp	17912637	SENT2	15	15	2	2	tamoxifen	aromatase	PA451581	1588	0.995
NULL	Breast_Cancer_Res_Treat_2012_Jul_8_134(2)_603-615.nxml.txt.nlp	22678159	SENT287	0	0	15	15	phenytoin	HERG	PA450947	3757	0.995
NULL	Mol_Cancer_2012_Apr_26_11_26.nxml.txt.nlp	22537224	SENT175	14	14	1	1	cisplatin	CHK1	PA449014	1111	0.995
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT248	2	2	28	28	perifosine	AKT	PA165291471	207	0.995
NULL	Breast_Cancer_Res_Treat_2013_Oct_8_141(3)_437-446.nxml.txt.nlp	24101324	SENT28	0	0	33	33	everolimus	aromatase	PA164746311	1588	0.995
NULL	Contemp_Oncol_(Pozn)_2013_Apr_29_17(2)_137-143.nxml.txt.nlp	23788980	SENT180	32	32	11	11	cabergoline	PRL	PA448708	5617	0.995
NULL	J_Mol_Signal_2012_Aug_16_7_12.nxml.txt.nlp	22898329	SENT20	0	0	26	26	cetuximab	EGF	PA10040	1950	0.995
NULL	Arch_Drug_Inf_2011_Mar_4(1)_1-9.nxml.txt.nlp	21572514	SENT47	3	3	27	27	ciprofloxacin	MRP2	PA449009	100130958;57626;1244	0.995
NULL	Hum_Genomics_2008_Sep_1_3(1)_7-16.nxml.txt.nlp	19129086	SENT170	26	26	7	7	gemfibrozil	OATP1B1	PA449750	10599	0.995
NULL	Cancer_Med_2013_Feb_3_2(1)_99-107.nxml.txt.nlp	24133632	SENT167	22	22	5	5	metformin	AMPK	PA450395	5563	0.995
NULL	Front_Neuroanat_2011_Aug_26_5_50.nxml.txt.nlp	21904525	SENT348	24	24	11	11	forskolin	ENSA	PA146096022	2029	0.995
NULL	Aging_(Albany_NY)_2013_Jun_23_5(7)_515-530.nxml.txt.nlp	24018842	SENT199	0	0	21	21	resveratrol	AMPK		5563	0.995
NULL	Genome_Med_2009_Sep_4_1(9)_83.nxml.txt.nlp	19732436	SENT295	19	19	31	31	doxorubicin	UGT1A	PA449412	7361;54658	0.995
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT105	29	29	2	2	tenofovir	ABCB1	PA10204	5243	0.995
NULL	Front_Immunol_2013_Nov_7_4_360.nxml.txt.nlp	24223576	SENT188	11	11	3	3	imiquimod	IRF5	PA449972	3663	0.995
NULL	Clin_Ophthalmol_2014_Dec_30_9_43-49.nxml.txt.nlp	25565767	SENT88	35	35	15	15	acetazolamide	RPE	PA448018	6120	0.995
NULL	Environ_Health_Perspect_1999_Nov_107(11)_855-860.nxml.txt.nlp	10544151	SENT8	12	12	1	1	aminoglutethimide	aromatase	PA448375	1588	0.995
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT115	5	5	32	32	cisplatin	p53	PA449014	7157	0.995
NULL	Br_J_Cancer_2010_Sep_28_103(7)_1001-1007.nxml.txt.nlp	20842117	SENT220	28	28	13	13	everolimus	PI3K	PA164746311	5290	0.995
NULL	Br_J_Cancer_2011_Jun_28_105(1)_1-8.nxml.txt.nlp	21654681	SENT95	32	32	14	14	erlotinib	ABCG2	PA134687924	9429	0.995
NULL	Front_Oncol_2014_Aug_11_4_204.nxml.txt.nlp	25157335	SENT125	41	41	13	13	crizotinib	HER-2	PA165946122	2064	0.995
NULL	Cancer_Inform_2014_Feb_12_13(Suppl_1)_1-16.nxml.txt.nlp	24558298	SENT179	3	3	11	11	trastuzumab	ERBB2	PA451743	2064	0.995
NULL	J_Lipid_Res_2015_Jan_56(1)_109-121.nxml.txt.nlp	25421061	SENT358	26	26	6	6	lipase	ATGL	PA450239	57104	0.995
NULL	Adv_Biomed_Res_2012_Jul_6_1_21.nxml.txt.nlp	23210080	SENT87	3	3	16	16	cetuximab	HER2	PA10040	2064	0.995
NULL	Breast_Cancer_Res_2010_May_10_12(3)_R26.nxml.txt.nlp	20459744	SENT137	30	30	5	5	docetaxel	CYP3A4	PA449383	1576	0.995
NULL	Case_Rep_Rheumatol_2014_Nov_11_2014_536856.nxml.txt.nlp	25436167	SENT40	28	28	7	7	iron	HFE	PA450087	3077	0.995
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT47	14	14	2	2	metformin	p53	PA450395	7157	0.995
NULL	Diabetes_2009_Apr_15_58(4)_984-991.nxml.txt.nlp	19074982	SENT233	12	12	17	17	rosiglitazone	adiponectin	PA451283	9370	0.995
NULL	Br_J_Cancer_2011_Apr_12_104(8)_1278-1287.nxml.txt.nlp	21487429	SENT170	22	22	28	28	cisplatin	p53	PA449014	7157	0.995
NULL	Drug_Des_Devel_Ther_2014_Sep_26_8_1595-1611.nxml.txt.nlp	25302015	SENT112	7	7	21	21	docetaxel	EGFR	PA449383	1956	0.995
NULL	Hum_Genomics_2008_Sep_1_3(1)_7-16.nxml.txt.nlp	19129086	SENT170	3	3	31	31	rosiglitazone	OATP1B1	PA451283	10599	0.995
NULL	Aging_(Albany_NY)_2009_Jun_3_1(6)_515-528.nxml.txt.nlp	20157535	SENT76	23	23	3	3	resveratrol	JNK		5599	0.995
NULL	Curr_Chem_Genomics_2010_Mar_1_4_1-8.nxml.txt.nlp	20448812	SENT119	0	0	39	39	fexofenadine	OATP1B3	PA449621	28234	0.995
NULL	Brain_Res_2011_Mar_25_1382(C)_29-36.nxml.txt.nlp	21276431	SENT110	1	1	22	22	ketanserin	5-HT2C	PA131053734	3358	0.995
NULL	BMJ_Open_2014_Feb_18_4(2)_e004289.nxml.txt.nlp	24549164	SENT89	6	6	28	28	gatifloxacin	DPD	PA449738	1806	0.995
NULL	Case_Rep_Oncol_2014_Sep_25_7(3)_669-672.nxml.txt.nlp	25408661	SENT58	21	21	0	0	aprepitant	CYP3A4	PA164747039	1576	0.995
NULL	J_Oncol_2012_Feb_6_2012_737981.nxml.txt.nlp	22481932	SENT48	40	40	5	5	olaparib	ABCB1		5243	0.995
NULL	Head_Face_Med_2008_Jun_9_4_9.nxml.txt.nlp	18541034	SENT87	5	5	12	12	felbamate	LGS	PA449590	51557	0.995
NULL	Cell_Commun_Signal_2009_Feb_26_7(Suppl_1)_A99.nxml.txt.nlp	NULL	SENT8	16	16	2	2	trypsin	PAR3	PA451806	56288;2151	0.995
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT2400	33	33	11	11	tamoxifen	CYP3A4	PA451581	1576	0.995
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2735-2743.nxml.txt.nlp	24129244	SENT177	12	12	31	31	crizotinib	ALK	PA165946122	238	0.995
NULL	Cancer_Cell_Int_2010_Jan_11_10_1.nxml.txt.nlp	20142996	SENT152	29	29	8	8	erlotinib	U87	PA134687924	677775;641648	0.995
NULL	Int_J_Womens_Health_2013_Dec_21_6_35-39.nxml.txt.nlp	24379702	SENT17	0	0	16	16	resveratrol	aromatase		1588	0.995
NULL	Breast_Cancer_Res_2009_Jun_23_11(Suppl_1)_S16.nxml.txt.nlp	NULL	SENT10	0	0	9	9	denosumab	RANKL	PA166048634	8600	0.995
NULL	Pediatr_Nephrol_2007_May_9_22(5)_638-644.nxml.txt.nlp	17347836	SENT51	15	15	3	3	cyclosporine	NPHS2	PA449167	7827	0.995
NULL	Clin_Sci_(Lond)_2012_May_1_122(Pt_9)_421-428.nxml.txt.nlp	22092038	SENT31	3	3	32	32	doxycycline	AP-1	PA449415	2353;3727;2354;3725	0.995
NULL	J_Korean_Med_Sci_2014_Jul_11_29(7)_965-972.nxml.txt.nlp	25045229	SENT25	33	33	6	6	metformin	B12	PA450395	7126;4709	0.995
NULL	Oncotarget_2011_Dec_31_2(12)_894-895.nxml.txt.nlp	22248868	SENT12	12	12	4	4	cetuximab	KRAS	PA10040	3845	0.995
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT158	11	11	0	0	tacrolimus	SOCS3	PA451578	9021	0.995
NULL	Int_J_Chron_Obstruct_Pulmon_Dis_2007_Sep_2(3)_205-228.nxml.txt.nlp	18229560	SENT309	6	6	40	40	cilomilast	CD68	PA165948031	968	0.995
NULL	Front_Oncol_2014_Mar_25_4_54.nxml.txt.nlp	24724051	SENT421	39	39	14	14	nilotinib	LYN	PA165958345	4067	0.995
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Apr_6_5_8.nxml.txt.nlp	16600049	SENT127	22	22	6	6	lamivudine	LAM	PA450163	7249;7248	0.995
NULL	ScientificWorldJournal_2012_Sep_17_2012_637953.nxml.txt.nlp	23028251	SENT625	0	0	6	6	naringin	CYP3A4	PA151958360	1576	0.995
NULL	Cancer_Cell_Int_2013_Feb_11_13_13.nxml.txt.nlp	23394714	SENT65	28	28	0	0	imatinib	WT1	PA10804	7490	0.995
NULL	Environ_Health_2004_Sep_23_3_9.nxml.txt.nlp	15387888	SENT239	14	14	0	0	malathion	DDH	PA164748092	1645	0.995
NULL	Clin_Med_Insights_Oncol_2012_Feb_28_6_125-135.nxml.txt.nlp	22408376	SENT215	0	0	14	14	panitumumab	EGFR	PA162373091	1956	0.995
NULL	Ann_Rheum_Dis_2013_Apr_21_72(4)_482-492.nxml.txt.nlp	23172750	SENT197	17	17	7	7	rituximab	IL-6	PA451261	3569	0.995
NULL	Cells_2014_May_23_3(2)_517-545.nxml.txt.nlp	24861977	SENT165	8	8	16	16	gentamicin	TRPV1	PA449753	7442	0.995
NULL	Clin_Pediatr_Endocrinol_2007_Aug_8_16(3)_75-80.nxml.txt.nlp	24790349	SENT11	2	2	9	9	octreotide	PHHI	PA450678	6833	0.995
NULL	Cardiovasc_Res_2011_Sep_1_91(4)_694-702.nxml.txt.nlp	21606183	SENT135	6	6	25	25	forskolin	AC5	PA146096022	111	0.995
NULL	J_Biomed_Biotechnol_2011_Dec_6_2011_856985.nxml.txt.nlp	21188173	SENT206	8	8	30	30	tamoxifen	pS2	PA451581	7031	0.995
NULL	Int_J_Gen_Med_2012_May_4_5_403-411.nxml.txt.nlp	22615536	SENT83	18	18	0	0	pioglitazone	RBP4	PA450970	5433;5950	0.995
NULL	Curr_Chem_Genomics_2008_Nov_26_2_51-61.nxml.txt.nlp	20161844	SENT56	13	13	20	20	simvastatin	PON1	PA451363	5444	0.995
NULL	Br_J_Cancer_2012_Feb_14_106(4)_617-618.nxml.txt.nlp	22333706	SENT19	2	2	17	17	everolimus	TKR	PA164746311	8277	0.995
NULL	Breast_Cancer_Res_2011_Jun_29_13(3)_R70.nxml.txt.nlp	21707964	SENT237	32	32	4	4	tamoxifen	14-3-3	PA451581	10971	0.995
NULL	Lipids_Health_Dis_2011_Feb_12_10_31.nxml.txt.nlp	21314960	SENT124	30	30	6	6	hemin	HO-1	PA449849	3162	0.995
NULL	Ann_Gastroenterol_2014_27(4)_313-319.nxml.txt.nlp	25331779	SENT143	29	29	45	45	infliximab	POR	PA452639	5447	0.995
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT147	28	28	8	8	sitagliptin	HIP	PA164748978	6767;6159;64399;5068	0.995
NULL	Biochem_Res_Int_2012_Apr_24_2012_896751.nxml.txt.nlp	22593827	SENT166	3	3	21	21	curcumin	Bcl-2	PA151958596	596	0.995
NULL	Crit_Care_2006_Mar_21_10(Suppl_1)_P257.nxml.txt.nlp	NULL	SENT15	5	5	23	23	hydrocortisone	ACTH	PA449905	5443	0.995
NULL	Braz_J_Med_Biol_Res_2012_Mar_9_45(4)_357-365.nxml.txt.nlp	22392189	SENT129	9	9	2	2	capsaicin	PAG	PA448776	55824	0.995
NULL	Br_J_Cancer_2011_May_10_104(10)_1587-1593.nxml.txt.nlp	21487405	SENT37	16	16	46	46	docetaxel	PTEN	PA449383	5728	0.995
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT53	4	4	19	19	letrozole	HER2	PA450196	2064	0.995
NULL	Oncotarget_2014_Jun_1_5(13)_4868-4880.nxml.txt.nlp	24947902	SENT207	0	0	7	7	lapatinib	HER2	PA152241907	2064	0.995
NULL	Mol_Biol_Cell_2014_Feb_1_25(3)_324-336.nxml.txt.nlp	24336522	SENT367	28	28	2	2	heparin	MMP9	PA449855	4318	0.995
NULL	Oncotarget_2014_Nov_8_5(21)_10280-10292.nxml.txt.nlp	25373733	SENT32	11	11	33	33	bortezomib	HIF-1	PA10252	29072	0.995
NULL	Br_J_Cancer_2014_Jan_21_110(2)_510-519.nxml.txt.nlp	24327015	SENT154	28	28	7	7	cisplatin	CDK1	PA449014	983	0.995
NULL	Open_Access_J_Urol_2010_Sep_2_2_161-170.nxml.txt.nlp	24198624	SENT109	45	45	19	19	sevelamer	PTH	PA164781197	5741	0.995
NULL	Clin_Mol_Allergy_2007_Jan_25_5_1.nxml.txt.nlp	17254346	SENT212	36	36	0	0	curcumin	IFN	PA151958596	3439	0.995
NULL	Case_Rep_Gastroenterol_2012_May_3_6(2)_223-231.nxml.txt.nlp	22679409	SENT84	18	18	7	7	carbamazepine	DIP	PA448785	23151;1831	0.995
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT28	31	31	12	12	coumarin	VKORC1	PA134521193	79001	0.995
NULL	Anesth_Pain_Med_2013_Jul_1_Summer_3(1)_214-218.nxml.txt.nlp	24223365	SENT43	19	19	2	2	acetaminophen	COX	PA448015	1351	0.995
NULL	Cell_Biochem_Biophys_2013_May_24_66(1)_53-63.nxml.txt.nlp	22918821	SENT303	24	24	46	46	lubiprostone	ClC-2	PA164777012	1181	0.995
NULL	Clin_Interv_Aging_2009_May_14_4_179-186.nxml.txt.nlp	19503779	SENT55	22	22	5	5	levodopa	COMT	PA450213	1312	0.995
NULL	Front_Oncol_2013_Sep_11_3_229.nxml.txt.nlp	24062982	SENT55	42	42	4	4	vemurafenib	PAX3	PA165946873	5077	0.995
NULL	Mol_Cancer_2008_Mar_26_7_27.nxml.txt.nlp	18366759	SENT76	6	6	31	31	etoposide	HIF-1	PA449552	29072	0.995
NULL	Oncogene_2014_Feb_6_33(6)_713-723.nxml.txt.nlp	23435429	SENT216	34	34	13	13	etoposide	BRCA1	PA449552	672	0.995
NULL	Case_Rep_Transplant_2014_Jan_2_2014_548243.nxml.txt.nlp	24575309	SENT12	1	1	28	28	ranolazine	CYP3A4	PA164746007	1576	0.995
NULL	Ther_Clin_Risk_Manag_2007_Aug_3(4)_553-562.nxml.txt.nlp	18472976	SENT81	4	4	31	31	lenalidomide	IL-2	PA162363968	3558	0.995
NULL	J_Korean_Med_Sci_2011_Apr_28_26(4)_521-527.nxml.txt.nlp	21468259	SENT70	3	3	12	12	cilostazol	DES	PA164746334	1674	0.995
NULL	Exp_Ther_Med_2013_Aug_5_6(2)_469-474.nxml.txt.nlp	24137210	SENT121	13	13	35	35	heparin	FES	PA449855	2242	0.995
NULL	Nat_Commun_2014_5_3361.nxml.txt.nlp	24553445	SENT81	25	25	11	11	temozolomide	HRD	PA451609	6905;3271	0.995
NULL	Oncotarget_2014_Jan_11_5(3)_693-703.nxml.txt.nlp	24525337	SENT232	45	45	5	5	ethanol	p53	PA448073	7157	0.995
NULL	J_Cell_Biol_2004_Apr_26_165(2)_175-180.nxml.txt.nlp	15096524	SENT87	23	23	3	3	forskolin	VASP	PA146096022	7408	0.995
NULL	Oncol_Rep_2014_Feb_13_31(2)_581-588.nxml.txt.nlp	24337105	SENT148	25	25	5	5	capsaicin	Bcl-2	PA448776	596	0.995
NULL	Diabetologia_2014_Sep_29_57(1)_192-203.nxml.txt.nlp	24078137	SENT199	24	24	0	0	metformin	VGLUT1	PA450395	57030	0.995
NULL	Case_Rep_Genet_2014_Jan_22_2014_413743.nxml.txt.nlp	24627811	SENT66	17	17	3	3	warfarin	CYP2C9	PA451906	1559	0.995
NULL	Arthritis_Res_Ther_2012_Feb_20_14(1)_203.nxml.txt.nlp	22356717	SENT196	8	8	25	25	azathioprine	CD34	PA448515	947	0.995
NULL	Diabetes_2008_Oct_57(10)_2801-2808.nxml.txt.nlp	18633115	SENT109	27	27	7	7	sulfasalazine	p50	PA451547	958;4790	0.995
NULL	Chin_J_Cancer_2012_Feb_31(2)_51-57.nxml.txt.nlp	22257384	SENT115	3	3	11	11	nilotinib	P-gp	PA165958345	5243	0.995
NULL	J_Cell_Mol_Med_2014_Mar_25_18(3)_492-502.nxml.txt.nlp	24460759	SENT272	13	13	29	29	gemcitabine	IFN	PA449748	3439	0.995
NULL	Pan_Afr_Med_J_2012_Sep_12_13_9.nxml.txt.nlp	23308316	SENT94	38	38	13	13	heparin	PF4	PA449855	5196	0.995
NULL	Breast_Cancer_Res_2011_Jan_28_13(1)_R11.nxml.txt.nlp	21276249	SENT273	33	33	4	4	tamoxifen	PRL	PA451581	5617	0.995
NULL	Int_J_Mol_Sci_2014_Nov_10_15(11)_20607-20637.nxml.txt.nlp	25391045	SENT294	3	3	36	36	simvastatin	PI3K	PA451363	5290	0.995
NULL	Inflammation_2014_Apr_6_37(5)_1476-1485.nxml.txt.nlp	24706026	SENT133	37	37	13	13	curcumin	GATA3	PA151958596	2625	0.995
NULL	Braz_J_Med_Biol_Res_2013_Apr_12_46(4)_327-338.nxml.txt.nlp	23579631	SENT197	0	0	6	6	estradiol	AT1	PA449503	9197;185	0.995
NULL	Mol_Cancer_2012_Mar_21_11_13.nxml.txt.nlp	22436134	SENT17	15	15	5	5	doxorubicin	HuR	PA449412	1994	0.995
NULL	Cancer_Med_2012_Aug_15_1(1)_28-38.nxml.txt.nlp	23342251	SENT23	35	35	3	3	panitumumab	HER2	PA162373091	2064	0.995
NULL	Indian_J_Endocrinol_Metab_2014_Jan-Feb_18(1)_77-82.nxml.txt.nlp	24701434	SENT29	3	3	17	17	liraglutide	GLP-1	PA165958364	100125288	0.995
NULL	Br_J_Cancer_2010_Jun_29_103(1)_61-72.nxml.txt.nlp	20588279	SENT224	4	4	14	14	trastuzumab	HER-2	PA451743	2064	0.995
NULL	Curr_Cardiol_Rev_2010_Aug_6(3)_238-244.nxml.txt.nlp	21804783	SENT163	10	10	33	33	levodopa	GMP	PA450213	22978	0.995
NULL	Environ_Health_Perspect_2009_Feb_28_117(2)_223-230.nxml.txt.nlp	19270792	SENT168	17	17	1	1	estradiol	CYP3A	PA449503	1574	0.995
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_26_2012_579321.nxml.txt.nlp	22110545	SENT57	0	0	11	11	paroxetine	CYP2D6	PA450801	1565	0.995
NULL	F1000_Biol_Rep_2012_Mar_1_4_5.nxml.txt.nlp	22403588	SENT45	18	18	35	35	boceprevir	IFN	PA165948902	3439	0.995
NULL	Breast_Cancer_Res_Treat_2014_Apr_6_145(1)_33-44.nxml.txt.nlp	24706169	SENT28	11	11	0	0	trastuzumab	HER2	PA451743	2064	0.995
NULL	Ther_Clin_Risk_Manag_2006_Dec_2(4)_435-445.nxml.txt.nlp	18360654	SENT131	28	28	0	0	erlotinib	EGFR	PA134687924	1956	0.995
NULL	Neuropsychopharmacology_2009_Nov_5_34(12)_2560-2573.nxml.txt.nlp	19657330	SENT101	6	6	40	40	ethanol	ANOVA	PA448073	4858	0.995
NULL	Clin_Ophthalmol_2009_Jun_2_3_189-194.nxml.txt.nlp	19668564	SENT95	35	35	1	1	latanoprost	BAK	PA164774763	578	0.995
NULL	Case_Rep_Psychiatry_2013_Mar_4_2013_617251.nxml.txt.nlp	23533900	SENT25	0	0	42	42	amitriptyline	5-HT1A	PA448385	3350	0.995
NULL	J_Immunother_2014_Apr_12_37(3)_180-186.nxml.txt.nlp	24598448	SENT30	0	0	16	16	sorafenib	IL-2	PA7000	3558	0.995
NULL	Int_J_Gen_Med_2011_Jul_20_4_539-545.nxml.txt.nlp	21845063	SENT94	18	18	36	36	miglitol	adiponectin	PA164776726	9370	0.995
NULL	Korean_Circ_J_2013_Jun_30_43(6)_400-407.nxml.txt.nlp	23882289	SENT88	19	19	3	3	doxorubicin	survivin	PA449412	332	0.995
NULL	Hum_Genomics_2008_Sep_1_3(1)_7-16.nxml.txt.nlp	19129086	SENT30	39	39	6	6	rosiglitazone	CYP2C8	PA451283	1558	0.995
NULL	Case_Rep_Med_2010_Jul_6_2010_426804.nxml.txt.nlp	20671989	SENT73	6	6	29	29	capecitabine	CYP3A4	PA448771	1576	0.995
NULL	Cell_Res_2012_Aug_22_22(8)_1227-1245.nxml.txt.nlp	22613949	SENT110	34	34	12	12	camptothecin	KRAS	PA153590860	3845	0.995
NULL	Nat_Cell_Biol_2014_Mar_9_16(3)_245-254.nxml.txt.nlp	24509793	SENT14	12	12	5	5	tamoxifen	HER2	PA451581	2064	0.995
NULL	Int_J_Environ_Res_Public_Health_2013_Aug_2_10(8)_3233-3245.nxml.txt.nlp	23917811	SENT169	30	30	7	7	thyroglobulin	TTF1	PA164754910	7080;7270	0.995
NULL	Cancer_Med_2013_Dec_31_2(6)_826-835.nxml.txt.nlp	24403256	SENT199	0	0	30	30	nutlin-3	p53		7157	0.995
NULL	Clin_Med_Insights_Oncol_2012_Mar_12_6_137-147.nxml.txt.nlp	22550402	SENT36	0	0	21	21	erlotinib	CYP3A4	PA134687924	1576	0.995
NULL	Indian_J_Ophthalmol_2014_Jan_62(1)_74-81.nxml.txt.nlp	24492505	SENT201	0	0	19	19	tocilizumab	IL-6	PA165292659	3569	0.995
NULL	Ther_Clin_Risk_Manag_2007_Dec_3(6)_975-981.nxml.txt.nlp	18516312	SENT23	28	28	0	0	sildenafil	Men	PA451346	8178	0.995
NULL	Arch_Trauma_Res_2013_Aug_1_2(2)_97-98.nxml.txt.nlp	24396803	SENT15	18	18	6	6	meperidine	P-gp	PA450369	5243	0.995
NULL	Acta_Pharmacol_Sin_2012_Oct_3_33(10)_1311-1318.nxml.txt.nlp	22941289	SENT153	9	9	29	29	sorafenib	VEGFR2	PA7000	3791	0.995
NULL	Arch_Drug_Inf_2011_Mar_4(1)_1-9.nxml.txt.nlp	21572514	SENT47	3	3	25	25	ciprofloxacin	MRP1	PA449009	4437	0.995
NULL	Oncotarget_2013_Aug_15_4(9)_1438-1448.nxml.txt.nlp	23988457	SENT118	44	44	18	18	lenalidomide	RINF	PA162363968	51523	0.995
NULL	CNS_Spectr_2014_Apr_1_19(2)_121-133.nxml.txt.nlp	23903233	SENT157	40	40	3	3	citalopram	5-HT7	PA449015	3363	0.995
NULL	Oncogene_2014_Apr_24_33(17)_2169-2178.nxml.txt.nlp	23728349	SENT258	21	21	3	3	imatinib	CD19	PA10804	930	0.995
NULL	Adv_Hematol_2012_Nov_20_2012_861060.nxml.txt.nlp	23251161	SENT42	0	0	21	21	lenalidomide	IL-10	PA162363968	3586	0.995
NULL	Int_J_Biol_Sci_2011_Nov_5_8(1)_1-14.nxml.txt.nlp	22211100	SENT178	20	20	8	8	evodiamine	PI3K	PA165860788	5290	0.995
NULL	Gut_Pathog_2014_Aug_20_6_34.nxml.txt.nlp	25349629	SENT178	0	0	25	25	metronidazole	ST7	PA450484	7982;29967	0.995
NULL	Front_Oncol_2013_Sep_11_3_229.nxml.txt.nlp	24062982	SENT55	42	42	15	15	vemurafenib	PAX3	PA165946873	5077	0.995
NULL	Int_J_Genomics_2013_Mar_26_2013_145450.nxml.txt.nlp	23671839	SENT9	23	23	2	2	staurosporine	SP2	PA165109623	6668	0.995
NULL	Cell_Commun_Signal_2011_May_15_9_13.nxml.txt.nlp	21569639	SENT282	4	4	16	16	quinacrine	p53	PA164745551	7157	0.995
NULL	Support_Care_Cancer_2011_Aug_1_19(8)_1079-1095.nxml.txt.nlp	21630130	SENT177	16	16	5	5	erlotinib	NK-1	PA134687924	27087	0.995
NULL	Biomed_Res_Int_2014_Jan_29_2014_458592.nxml.txt.nlp	24592391	SENT82	8	8	25	25	curcumin	HO-1	PA151958596	3162	0.995
NULL	Gut_Liver_2011_Dec_21_5(4)_454-459.nxml.txt.nlp	22195243	SENT70	0	0	16	16	pantoprazole	ESD	PA450774	2098	0.995
NULL	J_Med_Case_Reports_2011_Dec_21_5_593.nxml.txt.nlp	22188652	SENT36	2	2	20	20	gefitinib	EGFR	PA131301952	1956	0.995
NULL	Biomed_Res_Int_2014_Feb_2_2014_532594.nxml.txt.nlp	24672789	SENT7	7	7	46	46	indomethacin	EP1	PA449982	5731	0.995
NULL	Arthritis_Res_Ther_2007_Nov_21_9(6)_R121.nxml.txt.nlp	18031579	SENT33	17	17	0	0	trypsin	PAR-1	PA451806	2011;2149	0.995
NULL	Breast_Cancer_Res_Treat_2013_Jan_8_137(2)_457-464.nxml.txt.nlp	23224144	SENT43	35	35	5	5	lapatinib	HER3	PA152241907	2065	0.995
NULL	Oncol_Lett_2013_Sep_15_6(3)_648-654.nxml.txt.nlp	24137384	SENT37	27	27	6	6	cisplatin	ERCC2	PA449014	2068	0.995
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT144	6	6	34	34	vinorelbine	MVP	PA451881	9961	0.995
NULL	Breast_Cancer_Res_2007_Oct_26_9(5)_R74.nxml.txt.nlp	17963511	SENT26	11	11	2	2	trastuzumab	HER2	PA451743	2064	0.995
NULL	FASEB_J_2009_Sep_23(9)_3179-3192.nxml.txt.nlp	19447881	SENT255	10	10	0	0	capsaicin	TRPV1	PA448776	7442	0.995
NULL	Br_J_Cancer_2011_Jul_12_105(2)_246-254.nxml.txt.nlp	21712828	SENT35	5	5	20	20	cetuximab	PIK3CA	PA10040	5290	0.995
NULL	Arch_Med_Sci_2013_Oct_31_9(5)_916-921.nxml.txt.nlp	24273579	SENT89	33	33	5	5	bleomycin	AQP1	PA448645	358	0.995
NULL	AIDS_Res_Treat_2011_Jun_7_2011_354908.nxml.txt.nlp	21716719	SENT219	2	2	19	19	probenecid	OAT1	PA451106	9356	0.995
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT248	2	2	15	15	perifosine	JNK	PA165291471	5599	0.995
NULL	Acta_Pharmacol_Sin_2013_Feb_31_34(2)_191-198.nxml.txt.nlp	23274413	SENT93	24	24	3	3	etoposide	DIO-1	PA449552	11083	0.995
NULL	J_Thyroid_Res_2011_Apr_10_2011_895923.nxml.txt.nlp	21603172	SENT68	41	41	13	13	thyroglobulin	GM-CSF	PA164754910	1437	0.995
NULL	Breast_Cancer_Res_2009_Jan_16_11(1)_201.nxml.txt.nlp	19216727	SENT20	6	6	23	23	trastuzumab	HER2	PA451743	2064	0.995
NULL	Oncoimmunology_2012_Aug_1_1(5)_618-629.nxml.txt.nlp	22934254	SENT199	16	16	37	37	imatinib	p38	PA10804	10598;1432;7965	0.995
NULL	Biomed_Res_Int_2013_Dec_23_2013_676192.nxml.txt.nlp	24455715	SENT191	0	0	7	7	indomethacin	COX	PA449982	1351	0.995
NULL	Breast_Cancer_Res_2008_Mar_27_10(2)_R27.nxml.txt.nlp	18371219	SENT146	20	20	1	1	paclitaxel	PI3K	PA450761	5290	0.995
NULL	Biomed_Res_Int_2013_Aug_6_2013_909613.nxml.txt.nlp	24027765	SENT334	24	24	1	1	hydrocortisone	IL-10	PA449905	3586	0.995
NULL	Oncol_Lett_2014_Apr_24_7(4)_1027-1032.nxml.txt.nlp	24944663	SENT109	0	0	36	36	bevacizumab	VEGF-A	PA130232992	7422	0.995
NULL	Diabetes_Metab_Syndr_Obes_2014_Jun_24_7_229-239.nxml.txt.nlp	25018644	SENT215	20	20	3	3	metformin	GLP-1	PA450395	100125288	0.995
NULL	EMBO_Mol_Med_2012_Aug_16_4(8)_743-760.nxml.txt.nlp	22593025	SENT197	5	5	22	22	docetaxel	DIAPH3	PA449383	81624	0.995
NULL	Mol_Cancer_2013_Oct_8_12_119.nxml.txt.nlp	24103454	SENT201	4	4	40	40	nutlin-3	p53		7157	0.995
NULL	Breast_Cancer_Res_2010_Dec_20_12(Suppl_4)_S15.nxml.txt.nlp	21172077	SENT16	33	33	13	13	tamoxifen	aromatase	PA451581	1588	0.995
NULL	Ther_Clin_Risk_Manag_2007_Aug_3(4)_553-562.nxml.txt.nlp	18472976	SENT81	4	4	29	29	lenalidomide	IL-10	PA162363968	3586	0.995
NULL	Aging_(Albany_NY)_2012_Jul_22_4(7)_480-498.nxml.txt.nlp	22837425	SENT17	29	29	9	9	metformin	AMPK	PA450395	5563	0.995
NULL	Diabetes_Care_2012_Jun_11_35(6)_1225-1231.nxml.txt.nlp	22432104	SENT21	24	24	8	8	liraglutide	GLP-1	PA165958364	100125288	0.995
NULL	Am_J_Cardiovasc_Drugs_2013_Jun_20_13(5)_331-342.nxml.txt.nlp	23784266	SENT196	1	1	8	8	amiodarone	P-gp	PA448383	5243	0.995
NULL	Pharmaceuticals_(Basel)_2012_Aug_10_5(8)_802-836.nxml.txt.nlp	24280676	SENT247	22	22	7	7	aminopterin	PCFT	PA165109541	113235	0.995
NULL	Clin_Psychopharmacol_Neurosci_2014_Apr_24_12(1)_67-68.nxml.txt.nlp	24851124	SENT54	38	38	3	3	risperidone	5-HT2A	PA451257	3356	0.995
NULL	Sci_Rep_2014_Dec_15_4_7490.nxml.txt.nlp	25502402	SENT23	30	30	9	9	cetuximab	EGFR	PA10040	1956	0.995
NULL	Diabetes_Metab_Syndr_Obes_2014_Feb_13_7_55-64.nxml.txt.nlp	24611020	SENT36	7	7	17	17	metformin	AMPK	PA450395	5563	0.995
NULL	Br_J_Cancer_2010_Mar_16_102(6)_1003-1009.nxml.txt.nlp	20179710	SENT28	0	0	15	15	cyclophosphamide	CYP2B6	PA449165	1555	0.995
NULL	Nucleic_Acids_Res_2011_Mar_23_39(4)_1526-1537.nxml.txt.nlp	20972225	SENT193	38	38	9	9	tetracycline	BCS	PA451640	617	0.995
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1013.nxml.txt.nlp	24457957	SENT128	13	13	40	40	orlistat	NOXA	PA164776864	5366	0.995
NULL	Aging_(Albany_NY)_2012_Mar_4_4(3)_144-145.nxml.txt.nlp	22388573	SENT25	6	6	11	11	rolipram	AMPK	PA153906323	5563	0.995
NULL	Clin_Med_Insights_Oncol_2012_Dec_6_6_407-421.nxml.txt.nlp	23239933	SENT48	8	8	28	28	gefitinib	EGFR	PA131301952	1956	0.995
NULL	Ann_Hematol_2011_May_12_90(5)_557-568.nxml.txt.nlp	20938660	SENT168	19	19	6	6	rituximab	CD34	PA451261	947	0.995
NULL	Front_Behav_Neurosci_2014_Dec_22_8_441.nxml.txt.nlp	25566008	SENT89	45	45	21	21	isoflurane	EGR1	PA450106	1958	0.995
NULL	J_Signal_Transduct_2011_Jan_5_2011_821615.nxml.txt.nlp	21637381	SENT96	4	4	37	37	metformin	aromatase	PA450395	1588	0.995
NULL	Mol_Cancer_2004_May_4_3_14.nxml.txt.nlp	15125777	SENT155	13	13	6	6	cisplatin	CHK2	PA449014	11200	0.995
NULL	J_Biol_Chem_2009_Apr_3_284(14)_9558-9565.nxml.txt.nlp	19202191	SENT71	13	13	26	26	camptothecin	CtIP	PA153590860	5932	0.995
NULL	Acta_Pharmacol_Sin_2010_Oct_30_31(10)_1258-1266.nxml.txt.nlp	20802503	SENT32	4	4	19	19	raloxifene	PI3K	PA451221	5290	0.995
NULL	Nat_Med_2011_Dec_11_18(1)_74-82.nxml.txt.nlp	22157681	SENT62	4	4	8	8	gefitinib	BIM	PA131301952	10018	0.995
NULL	Ann_Clin_Microbiol_Antimicrob_2005_Sep_13_4_13.nxml.txt.nlp	16159399	SENT161	9	9	5	5	ribavirin	IFN	PA451241	3439	0.995
NULL	Br_J_Cancer_2013_Jul_9_109(1)_68-75.nxml.txt.nlp	23807173	SENT18	23	23	3	3	cisplatin	ERCC1	PA449014	2067	0.995
NULL	Sensors_(Basel)_2012_Dec_3_12(12)_16614-16627.nxml.txt.nlp	23208557	SENT155	19	19	0	0	cetuximab	KRAS	PA10040	3845	0.995
NULL	Crit_Care_2008_Mar_13_12(Suppl_2)_P262.nxml.txt.nlp	NULL	SENT19	4	4	39	39	dobutamine	PAWP	PA449381	164684	0.995
NULL	Biomed_Res_Int_2013_Jul_28_2013_627907.nxml.txt.nlp	23984390	SENT176	34	34	8	8	verapamil	CYP1A2	PA451868	1544	0.995
NULL	Oncol_Rep_2014_Dec_13_32(6)_2307-2318.nxml.txt.nlp	25310523	SENT34	13	13	2	2	methotrexate	S100A4	PA450428	6275	0.995
NULL	J_Biol_2009_Apr_15_8(3)_30.nxml.txt.nlp	19435483	SENT49	45	45	7	7	imatinib	SYK	PA10804	6850	0.995
NULL	BMJ_Open_2014_Aug_19_4(8)_e006005.nxml.txt.nlp	25138814	SENT29	8	8	1	1	chloroquine	ACT	PA448948	12;11332;9457;641455	0.995
NULL	Breast_Cancer_Res_2005_Apr_6_7(3)_119-130.nxml.txt.nlp	15987442	SENT35	0	0	29	29	tamoxifen	AP-1	PA451581	2353;3727;2354;3725	0.995
NULL	Oncol_Rep_2013_Apr_23_29(4)_1268-1274.nxml.txt.nlp	23354756	SENT126	6	6	22	22	paclitaxel	SLC25A43	PA450761	203427	0.995
NULL	Cancers_(Basel)_2013_Aug_22_5(3)_1103-1119.nxml.txt.nlp	24202336	SENT165	18	18	2	2	temozolomide	p53	PA451609	7157	0.995
NULL	Cancer_Med_2014_Aug_7_3(4)_796-811.nxml.txt.nlp	24802970	SENT214	5	5	18	18	amiloride	CD49f	PA448368	3655	0.995
NULL	Case_Rep_Oncol_Med_2014_Dec_8_2014_361748.nxml.txt.nlp	25548695	SENT26	24	24	1	1	tamoxifen	CYP2D6	PA451581	1565	0.995
NULL	J_Cell_Mol_Med_2013_Oct_16_17(10)_1261-1270.nxml.txt.nlp	23855452	SENT41	16	16	5	5	cisplatin	CHK2	PA449014	11200	0.995
NULL	Mol_Cancer_2014_Jan_13_13_7.nxml.txt.nlp	24418169	SENT41	26	26	7	7	sorafenib	EGFR	PA7000	1956	0.995
NULL	Clinics_(Sao_Paulo)_2014_Jun_69(6)_438-446.nxml.txt.nlp	24964310	SENT82	8	8	16	16	raloxifene	OPG	PA451221	690	0.995
NULL	Cell_Cycle_2012_Dec_15_11(24)_4661-4672.nxml.txt.nlp	23187802	SENT164	9	9	31	31	doxorubicin	LIN9	PA449412	286826	0.995
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1554-1562.nxml.txt.nlp	21970876	SENT38	0	0	27	27	afatinib	EGFR	PA165981154	1956	0.995
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1554-1562.nxml.txt.nlp	21970876	SENT143	21	21	12	12	gemcitabine	EGFR	PA449748	1956	0.995
NULL	Indian_J_Endocrinol_Metab_2013_Dec_17(Suppl_3)_S674-S679.nxml.txt.nlp	24910836	SENT144	9	9	26	26	metformin	PPG	PA450395	5552	0.995
NULL	Mol_Cancer_2007_Aug_21_6_53.nxml.txt.nlp	17711579	SENT212	30	30	4	4	cisplatin	p53	PA449014	7157	0.995
NULL	Genet_Vaccines_Ther_2009_Jan_30_7_2.nxml.txt.nlp	19178753	SENT3	3	3	31	31	gefitinib	EGFR	PA131301952	1956	0.995
NULL	J_Invest_Dermatol_2014_Feb_10_134(2)_319-325.nxml.txt.nlp	24108405	SENT88	18	18	8	8	vemurafenib	MEK1	PA165946873	5604	0.995
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT248	2	2	24	24	perifosine	JNK	PA165291471	5599	0.995
NULL	Cell_Death_Dis_2014_Feb_27_5(2)_e1096.nxml.txt.nlp	24577094	SENT133	2	2	32	32	riluzole	PTEN	PA451251	5728	0.995
NULL	Case_Rep_Transplant_2011_Jun_30_2011_250674.nxml.txt.nlp	23213601	SENT45	1	1	28	28	ceftizoxime	DAT	PA164748758	6531	0.995
NULL	Indian_J_Med_Res_2011_Sep_134(3)_253-255.nxml.txt.nlp	21985806	SENT27	0	0	15	15	phenytoin	RLIP76	PA450947	10928	0.995
NULL	Br_J_Cancer_2012_Jan_3_106(1)_18-24.nxml.txt.nlp	22108516	SENT55	37	37	7	7	camptothecin	ERCC1	PA153590860	2067	0.995
NULL	Breast_Cancer_Res_2008_Jul_16_10(4)_R60.nxml.txt.nlp	18631394	SENT21	0	0	22	22	trastuzumab	HER2	PA451743	2064	0.995
NULL	Acta_Pharmacol_Sin_2010_Jul_28_31(7)_867-873.nxml.txt.nlp	20581857	SENT145	41	41	7	7	docetaxel	MRP1	PA449383	4437	0.995
NULL	Int_J_Gen_Med_2009_Jul_30_2_129-140.nxml.txt.nlp	20360896	SENT79	40	40	8	8	tamoxifen	aromatase	PA451581	1588	0.995
NULL	CNS_Drugs_2012_Dec_13_26(12)_1033-1049.nxml.txt.nlp	23192413	SENT55	3	3	31	31	trazodone	5-HT2A	PA451744	3356	0.995
NULL	Br_J_Cancer_2011_Nov_22_105(11)_1654-1662.nxml.txt.nlp	22045187	SENT91	39	39	14	14	irinotecan	TYMS	PA450085	7298	0.995
NULL	Exp_Cell_Res_2013_Apr_1_319(6)_800-809.nxml.txt.nlp	23247073	SENT205	31	31	8	8	curcumin	AKT	PA151958596	207	0.995
NULL	Int_J_Cell_Biol_2013_May_20_2013_647975.nxml.txt.nlp	23762064	SENT195	5	5	9	9	metformin	AMPK	PA450395	5563	0.995
NULL	Diabetes_Metab_Syndr_Obes_2014_Jun_24_7_229-239.nxml.txt.nlp	25018644	SENT214	1	1	27	27	metformin	GLP-1	PA450395	100125288	0.995
NULL	Ann_Rheum_Dis_2008_Apr_13_68(3)_367-372.nxml.txt.nlp	18408253	SENT157	12	12	32	32	diclofenac	COX2	PA449293	4513;5743	0.995
NULL	J_Neuroinflammation_2010_Sep_7_7_51.nxml.txt.nlp	20822529	SENT16	23	23	3	3	hemin	p38	PA449849	10598;1432;7965	0.995
NULL	Arthritis_Res_Ther_2014_Jul_18_16(4)_R153.nxml.txt.nlp	25037855	SENT119	23	23	5	5	adalimumab	CD14	PA10004	929	0.995
NULL	Front_Oncol_2014_Sep_23_4_264.nxml.txt.nlp	25295231	SENT126	3	3	11	11	lenalidomide	TP53	PA162363968	7157	0.995
NULL	Exp_Ther_Med_2013_Dec_23_6(6)_1494-1498.nxml.txt.nlp	24255680	SENT75	27	27	8	8	losartan	ILK	PA450268	3611	0.995
NULL	J_Biomed_Biotechnol_2010_Mar_2_2010_793843.nxml.txt.nlp	20204133	SENT138	3	3	9	9	trypsin	PAR-1	PA451806	2011;2149	0.995
NULL	Cancer_Cell_Int_2011_Nov_17_11_40.nxml.txt.nlp	22088142	SENT193	30	30	5	5	gefitinib	EGFR	PA131301952	1956	0.995
NULL	Cancer_Cell_Int_2013_Jun_26_13_64.nxml.txt.nlp	23802572	SENT125	27	27	13	13	curcumin	Bcl-2	PA151958596	596	0.995
NULL	Chin_J_Cancer_2011_Jul_30(7)_490-496.nxml.txt.nlp	21718595	SENT91	31	31	0	0	oxaliplatin	LC3	PA131285527	84557	0.995
NULL	J_Gen_Physiol_1997_Apr_1_109(4)_477-490.nxml.txt.nlp	9101406	SENT175	21	21	10	10	staurosporine	GIRK1	PA165109623	3760	0.995
NULL	Environ_Health_Perspect_2005_Sep_26_113(9)_1243-1249.nxml.txt.nlp	16140636	SENT157	2	2	10	10	paroxetine	CYP2D6	PA450801	1565	0.995
NULL	Braz_J_Med_Biol_Res_2014_Feb_17_47(2)_90-100.nxml.txt.nlp	24519124	SENT154	15	15	26	26	losartan	AT2	PA450268	186	0.995
NULL	Asian-Australas_J_Anim_Sci_2014_Dec_27(12)_1783-1793.nxml.txt.nlp	25358373	SENT43	0	0	25	25	capsaicin	gamma	PA448776	9913	0.995
NULL	Pharmaceuticals_(Basel)_2012_Jun_28_5(7)_674-689.nxml.txt.nlp	24281706	SENT329	5	5	19	19	geldanamycin	Hsp90	PA152031327	3320	0.995
NULL	EPMA_J_2010_Sep_9_1(3)_503-512.nxml.txt.nlp	23199092	SENT85	12	12	4	4	gefitinib	EGFR	PA131301952	1956	0.995
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT265	31	31	3	3	lapatinib	HER2	PA152241907	2064	0.995
NULL	Cancer_Med_2012_Oct_1_1(2)_114-127.nxml.txt.nlp	23342262	SENT316	39	39	18	18	sirolimus	EGFR	PA451365	1956	0.995
NULL	J_Exp_Clin_Cancer_Res_2010_Apr_30_29(1)_41.nxml.txt.nlp	20433702	SENT195	34	34	1	1	staurosporine	HSP60	PA165109623	3329	0.995
NULL	Biologics_2014_Mar_17_8_91-105.nxml.txt.nlp	24669185	SENT166	11	11	18	18	denosumab	RANKL	PA166048634	8600	0.995
NULL	Oncotarget_2013_Aug_6_5(1)_108-119.nxml.txt.nlp	24334679	SENT151	32	32	3	3	estradiol	p53	PA449503	7157	0.995
NULL	Cent_European_J_Urol_2013_Nov_18_66(3)_344-349.nxml.txt.nlp	24707382	SENT131	37	37	18	18	tacrolimus	CYP3A4	PA451578	1576	0.995
NULL	Basic_Clin_Pharmacol_Toxicol_2013_Feb_5_112(2)_132-137.nxml.txt.nlp	22900583	SENT168	16	16	6	6	imatinib	CYP3A	PA10804	1574	0.995
NULL	Nat_Commun_2013_Nov_27_4_2821.nxml.txt.nlp	24281726	SENT243	0	0	26	26	pp2	PP2		4888	0.995
NULL	Breast_Cancer_Res_2011_Jun_29_13(3)_R70.nxml.txt.nlp	21707964	SENT185	42	42	7	7	tamoxifen	FOXM1	PA451581	2305	0.995
NULL	Int_J_Mol_Imaging_2011_Oct_26_2011_874585.nxml.txt.nlp	21490735	SENT29	7	7	17	17	tamoxifen	FDG	PA451581	23583	0.995
NULL	J_Oncol_2009_Mar_10_2009_831626.nxml.txt.nlp	20300583	SENT26	17	17	34	34	cetuximab	BRAF	PA10040	673	0.995
NULL	Indian_J_Pharmacol_2009_Dec_41(6)_262-267.nxml.txt.nlp	20407557	SENT154	6	6	1	1	ezetimibe	STZ	PA10816	6484	0.995
NULL	Br_J_Cancer_2012_Apr_10_106(8)_1367-1373.nxml.txt.nlp	22454081	SENT152	4	4	16	16	trastuzumab	IGF1R	PA451743	3480	0.995
NULL	Mol_Cancer_2012_Jun_18_11_41.nxml.txt.nlp	22709873	SENT292	32	32	7	7	lapatinib	ZNF143	PA152241907	7702	0.995
NULL	J_Adv_Pract_Oncol_2012_Jul_1_Jul-Aug_3(4)_267-272.nxml.txt.nlp	25031955	SENT107	37	37	11	11	crizotinib	EGFR	PA165946122	1956	0.995
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_11_2013_910451.nxml.txt.nlp	23840269	SENT251	33	33	4	4	doxorubicin	CD44	PA449412	960	0.995
NULL	Front_Oncol_2013_Sep_23_3_250.nxml.txt.nlp	24069582	SENT147	33	33	19	19	lapatinib	HER2	PA152241907	2064	0.995
NULL	J_Oncol_2010_Dec_15_2010_821717.nxml.txt.nlp	20049172	SENT225	17	17	4	4	paclitaxel	TUBB3	PA450761	10381	0.995
NULL	J_Oncol_2010_Apr_11_2010_251231.nxml.txt.nlp	20414333	SENT194	0	0	20	20	gefitinib	EGF	PA131301952	1950	0.995
NULL	Core_Evid_2011_Feb_8_6_23-29.nxml.txt.nlp	21468240	SENT60	25	25	39	39	plerixafor	CD34	PA165958410	947	0.995
NULL	Drug_Des_Devel_Ther_2014_Sep_26_8_1595-1611.nxml.txt.nlp	25302015	SENT108	16	16	31	31	docetaxel	EGFR	PA449383	1956	0.995
NULL	Curr_Med_Chem_2011_Jun_18(18)_2686-2714.nxml.txt.nlp	21649578	SENT340	4	4	32	32	erlotinib	PI3K	PA134687924	5290	0.995
NULL	Mar_Drugs_2014_Nov_19_12(11)_5468-5502.nxml.txt.nlp	25415349	SENT255	36	36	10	10	clopidogrel	ADP	PA449053	23038	0.995
NULL	Curr_Chem_Genomics_2010_Mar_1_4_1-8.nxml.txt.nlp	20448812	SENT28	2	2	14	14	methotrexate	OATP1B3	PA450428	28234	0.995
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1522-1532.nxml.txt.nlp	21997136	SENT33	13	13	24	24	irinotecan	EGFR	PA450085	1956	0.995
NULL	J_Bras_Pneumol_2013_Jan-Feb_39(1)_5-15.nxml.txt.nlp	23503480	SENT217	4	4	15	15	doxycycline	LAM	PA449415	7249;7248	0.995
NULL	Mol_Cancer_2014_Jun_24_13_157.nxml.txt.nlp	24958351	SENT170	28	28	0	0	lapatinib	PI3K	PA152241907	5290	0.995
NULL	JRSM_Cardiovasc_Dis_2012_Sep_24_1(6)_cvd_2012_012015.nxml.txt.nlp	24175073	SENT38	30	30	3	3	clopidogrel	CYP2C19	PA449053	1557	0.995
NULL	J_Cancer_2012_Apr_1_3_145-151.nxml.txt.nlp	22481980	SENT69	1	1	8	8	trastuzumab	HER2	PA451743	2064	0.995
NULL	Oncogene_2014_Jun_26_33(26)_3422-3431.nxml.txt.nlp	23912457	SENT189	21	21	7	7	trastuzumab	HER2	PA451743	2064	0.995
NULL	Breast_Cancer_Res_2009_Jun_29_11(3)_R41.nxml.txt.nlp	19563669	SENT171	25	25	16	16	trastuzumab	XIAP	PA451743	331	0.995
NULL	Evid_Based_Complement_Alternat_Med_2012_Feb_16_2012_430262.nxml.txt.nlp	22454664	SENT107	7	7	25	25	clopidogrel	CYP2C19	PA449053	1557	0.995
NULL	Infect_Dis_Obstet_Gynecol_2012_Aug_14_2012_890160.nxml.txt.nlp	22927715	SENT121	0	0	10	10	efavirenz	CYP3A4	PA449441	1576	0.995
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT32	9	9	26	26	erlotinib	CYP3A	PA134687924	1574	0.995
NULL	Environ_Health_Perspect_2005_Aug_15_113(8)_1009-1014.nxml.txt.nlp	16079071	SENT156	12	12	7	7	captopril	p38	PA448780	10598;1432;7965	0.995
NULL	Cancers_(Basel)_2011_May_9_3(2)_2286-2301.nxml.txt.nlp	24212810	SENT176	16	16	8	8	capecitabine	EGFR	PA448771	1956	0.995
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT197	27	27	6	6	cetuximab	KRAS	PA10040	3845	0.995
NULL	Clin_Exp_Reprod_Med_2013_Jun_30_40(2)_67-75.nxml.txt.nlp	23875162	SENT157	9	9	21	21	estradiol	HSD17B2	PA449503	3294	0.995
NULL	Int_J_Mol_Sci_2014_Sep_30_15(10)_17686-17704.nxml.txt.nlp	25272226	SENT82	43	43	7	7	cetuximab	EGFR	PA10040	1956	0.995
NULL	Inflamm_Res_2010_Sep_26_59(9)_699-709.nxml.txt.nlp	20339899	SENT29	23	23	9	9	thrombin	PAR2	PA451674	2150;55065;8856	0.995
NULL	Oxid_Med_Cell_Longev_2012_May_28_2012_386527.nxml.txt.nlp	22690271	SENT153	4	4	38	38	resveratrol	SIRT1		23411	0.995
NULL	Viruses_2014_Feb_18_6(2)_875-892.nxml.txt.nlp	24553110	SENT188	6	6	34	34	erlotinib	IFN	PA134687924	3439	0.995
NULL	Front_Behav_Neurosci_2012_Aug_28_6_53.nxml.txt.nlp	22973209	SENT154	16	16	38	38	physostigmine	gamma	PA450957	9913	0.995
NULL	J_Clin_Biochem_Nutr_2007_Jan_27_40(1)_13-23.nxml.txt.nlp	18437209	SENT142	22	22	11	11	trypsin	PAR4	PA451806	9002;5074	0.995
NULL	Cancer_Metastasis_Rev_2011_Dec_20_30(3-4)_465-480.nxml.txt.nlp	22012553	SENT276	8	8	27	27	indomethacin	EP2	PA449982	5732;10407	0.995
NULL	Biomed_Opt_Express_2013_May_17_4(6)_900-908.nxml.txt.nlp	23761851	SENT78	36	36	14	14	etanercept	TSPO	PA449515	706	0.995
NULL	Mol_Cancer_2007_Jan_14_6_5.nxml.txt.nlp	17222355	SENT25	23	23	2	2	doxorubicin	HMGA2	PA449412	8091	0.995
NULL	Br_J_Cancer_2012_Jun_5_106(12)_1901-1906.nxml.txt.nlp	22596239	SENT59	28	28	6	6	asparaginase	ASNS	PA448492	440	0.995
NULL	Arthritis_Res_Ther_2012_Sep_24_14(5)_R200.nxml.txt.nlp	23006144	SENT168	10	10	27	27	alefacept	IL-19	PA164748040	29949	0.995
NULL	Front_Oncol_2013_Apr_29_3_92.nxml.txt.nlp	23641361	SENT101	21	21	14	14	bevacizumab	NF2	PA130232992	4771	0.995
NULL	Hum_Genomics_2010_Apr_1_4(4)_238-249.nxml.txt.nlp	20511137	SENT86	3	3	11	11	raltegravir	UGT1A1		54658	0.995
NULL	Iran_J_Neurol_2013_12(4)_157-165.nxml.txt.nlp	24250926	SENT116	0	0	20	20	topiramate	LGS	PA451728	51557	0.995
NULL	Curr_Nutr_Rep_2013_Jan_8_2(1)_19-26.nxml.txt.nlp	23396869	SENT63	5	5	13	13	metformin	AMPK	PA450395	5563	0.995
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT43	0	0	23	23	nutlin-3	p53		7157	0.995
NULL	Biomed_Res_Int_2013_Dec_5_2013_642848.nxml.txt.nlp	24381940	SENT193	0	0	7	7	telmisartan	AT1	PA451605	9197;185	0.995
NULL	Cell_Death_Dis_2010_Oct_21_1(10)_e86.nxml.txt.nlp	21368859	SENT74	28	28	6	6	doxorubicin	BimEL	PA449412	10018	0.995
NULL	Int_J_Endocrinol_2011_Aug_21_2011_742719.nxml.txt.nlp	21869886	SENT134	0	0	21	21	cilostazol	P2Y12	PA164746334	64805	0.995
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT17	18	18	7	7	capecitabine	EGFR	PA448771	1956	0.995
NULL	Int_J_Mol_Sci_2014_Jun_18_15(6)_11013-11029.nxml.txt.nlp	24945311	SENT4	0	0	13	13	celecoxib	STAT3	PA448871	6774	0.995
NULL	Cells_2012_Aug_21_1(3)_535-557.nxml.txt.nlp	24710489	SENT267	19	19	6	6	cisplatin	p38	PA449014	10598;1432;7965	0.995
NULL	Br_J_Cancer_1996_Jul_74(2)_274-279.nxml.txt.nlp	8688335	SENT13	42	42	12	12	cyclophosphamide	IL-8	PA449165	3576	0.995
NULL	Basic_Clin_Pharmacol_Toxicol_2013_Feb_5_112(2)_132-137.nxml.txt.nlp	22900583	SENT151	10	10	15	15	ritonavir	CYP3A	PA451260	1574	0.995
NULL	J_Exp_Med_1996_Dec_1_184(6)_2207-2216.nxml.txt.nlp	8976176	SENT71	20	20	46	46	calcein	IL-2	PA132595336	3558	0.995
NULL	Clin_Drug_Investig_2013_Aug_23_33(10)_727-736.nxml.txt.nlp	23975654	SENT172	8	8	39	39	bupropion	CYP2C9	PA448687	1559	0.995
NULL	Oncol_Discov_2013_1(4)_10_7243_2052-6199-1-4.nxml.txt.nlp	25383193	SENT194	5	5	12	12	sulindac	COX	PA451565	1351	0.995
NULL	BMB_Rep_2014_Oct_47(10)_575-580.nxml.txt.nlp	24499675	SENT50	4	4	48	48	arsenite	p53	PA452638	7157	0.995
NULL	Case_Rep_Hematol_2013_Dec_18_2013_703027.nxml.txt.nlp	24455336	SENT20	22	22	6	6	cyclophosphamide	FVIII	PA449165	2157	0.995
NULL	J_Thromb_Haemost_2011_Oct_9(10)_2050-2056.nxml.txt.nlp	21794076	SENT167	40	40	15	15	prasugrel	P2Y12	PA154410481	64805	0.995
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT196	15	15	4	4	cetuximab	KRAS	PA10040	3845	0.995
NULL	Clin_Exp_Pharmacol_Physiol_2009_Oct_36(10)_969-980.nxml.txt.nlp	19298534	SENT250	0	0	46	46	nifedipine	spatial	PA450631	219793	0.995
NULL	Mol_Cancer_2010_Jun_27_9_168.nxml.txt.nlp	20579391	SENT121	4	4	35	35	dasatinib	FOXM1	PA162372878	2305	0.995
NULL	Front_Endocrinol_(Lausanne)_2011_Nov_10_2_65.nxml.txt.nlp	22649380	SENT20	14	14	2	2	estradiol	AVP	PA449503	114548;551	0.995
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1046.nxml.txt.nlp	24503538	SENT84	26	26	0	0	oxaliplatin	FGFR4	PA131285527	2264	0.995
NULL	Acta_Pharmacol_Sin_2013_Feb_12_34(2)_255-261.nxml.txt.nlp	23147557	SENT126	1	1	14	14	pioglitazone	CYP2C8	PA450970	1558	0.995
NULL	Breast_Cancer_Res_2009_Oct_28_11(5)_211.nxml.txt.nlp	19889200	SENT240	30	30	3	3	tamoxifen	HER2	PA451581	2064	0.995
NULL	J_Oncol_2013_Aug_20_2013_732047.nxml.txt.nlp	24027583	SENT151	29	29	2	2	lapatinib	HER2	PA152241907	2064	0.995
NULL	Environ_Health_Perspect_2006_Sep_23_114(9)_1401-1406.nxml.txt.nlp	16966095	SENT165	44	44	1	1	arsenite	ANOVA	PA452638	4858	0.995
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT277	26	26	1	1	methotrexate	ABCC3	PA450428	8714	0.995
NULL	J_Gen_Physiol_2009_May_133(5)_511-524.nxml.txt.nlp	19398777	SENT60	0	0	22	22	nifedipine	DHPR	PA450631	5860	0.995
NULL	Oncoscience_2014_Mar_12_1(2)_167-179.nxml.txt.nlp	25126591	SENT183	0	0	37	37	crizotinib	CCNE1	PA165946122	898	0.995
NULL	Int_J_Biol_Sci_2014_Jun_10_10(7)_654-663.nxml.txt.nlp	25013375	SENT106	1	1	6	6	nelfinavir	AKT	PA450606	207	0.995
NULL	Breast_Cancer_Res_2005_Nov_16_7(1)_R82-R92.nxml.txt.nlp	15642172	SENT193	29	29	4	4	tamoxifen	BCAR1	PA451581	9564	0.995
NULL	Mol_Cancer_2014_Jun_5_13_143.nxml.txt.nlp	24898067	SENT171	29	29	3	3	trastuzumab	HER-2	PA451743	2064	0.995
NULL	Mol_Cancer_2009_Jul_3_8_43.nxml.txt.nlp	19575780	SENT8	15	15	2	2	cisplatin	survivin	PA449014	332	0.995
NULL	Chem_Rev_2012_May_9_112(5)_2593-2603.nxml.txt.nlp	22335786	SENT83	0	0	44	44	l-histidine	ATX	PA449882	5168;23049	0.995
NULL	Gut_2013_Apr_14_62(4)_540-549.nxml.txt.nlp	22798500	SENT42	16	16	5	5	cetuximab	EGFR	PA10040	1956	0.995
NULL	Front_Immunol_2013_Nov_7_4_360.nxml.txt.nlp	24223576	SENT351	0	0	26	26	etoposide	TRAIL	PA449552	8743	0.995
NULL	J_Korean_Med_Sci_2009_Jun_12_24(3)_448-452.nxml.txt.nlp	19543508	SENT5	36	36	5	5	gefitinib	EGFR	PA131301952	1956	0.995
NULL	Cases_J_2009_May_29_2_6910.nxml.txt.nlp	19829882	SENT37	20	20	10	10	gefitinib	EGFR	PA131301952	1956	0.995
NULL	Mol_Cell_2013_Jun_27_50(6)_805-817.nxml.txt.nlp	23747015	SENT98	23	23	16	16	doxycycline	p53	PA449415	7157	0.995
NULL	J_Am_Heart_Assoc_2013_Dec_19_2(6)_e000433.nxml.txt.nlp	24275630	SENT138	41	41	29	29	perhexiline	CPT1	PA130150436	56994	0.995
NULL	Cancer_Biol_Med_2012_Mar_9(1)_18-22.nxml.txt.nlp	23691449	SENT84	2	2	28	28	gefitinib	PTEN	PA131301952	5728	0.995
NULL	Breast_Cancer_Res_2014_Sep_12_16(5)_436.nxml.txt.nlp	25213081	SENT13	48	48	4	4	tamoxifen	FOXM1	PA451581	2305	0.995
NULL	J_Cell_Biol_2000_Dec_11_151(6)_1257-1268.nxml.txt.nlp	11121440	SENT122	30	30	3	3	arsenite	TIAR	PA452638	7073	0.995
NULL	Oncotarget_2013_Nov_19_5(2)_309-325.nxml.txt.nlp	24525395	SENT340	15	15	25	25	resveratrol	Mcl-1		4170	0.995
NULL	Br_J_Cancer_2012_Jun_5_106(12)_1997-2003.nxml.txt.nlp	22596232	SENT135	17	17	5	5	sorafenib	CD133	PA7000	8842	0.995
NULL	Cardiol_Ther_2013_Jun_1_2(1)_111-124.nxml.txt.nlp	25135294	SENT123	7	7	14	14	dabigatran	P-gp		5243	0.995
NULL	Br_J_Cancer_2010_Mar_16_102(6)_1003-1009.nxml.txt.nlp	20179710	SENT28	0	0	26	26	cyclophosphamide	CYP2C19	PA449165	1557	0.995
NULL	Oncol_Lett_2013_Sep_28_6(3)_795-800.nxml.txt.nlp	24137413	SENT26	5	5	16	16	paclitaxel	p38	PA450761	10598;1432;7965	0.995
NULL	Oncol_Rep_2013_Mar_8_29(3)_917-924.nxml.txt.nlp	23314174	SENT125	36	36	2	2	sorafenib	CD44	PA7000	960	0.995
NULL	Mol_Cancer_2012_Jul_25_11_46.nxml.txt.nlp	22830422	SENT75	36	36	10	10	rolipram	ZO-1	PA153906323	7082	0.995
NULL	Evid_Based_Complement_Alternat_Med_2011_Feb_14_2011_650263.nxml.txt.nlp	21799686	SENT186	34	34	6	6	atropine	STZ	PA448505	6484	0.995
NULL	Chemother_Res_Pract_2011_Feb_27_2011_175054.nxml.txt.nlp	22295203	SENT60	35	35	2	2	cisplatin	MBT	PA449014	5657	0.995
NULL	Chemother_Res_Pract_2011_Sep_25_2011_730360.nxml.txt.nlp	22295205	SENT184	4	4	17	17	lapatinib	HER2	PA152241907	2064	0.995
NULL	Chem_Rev_2014_Jun_11_114(11)_5753-5774.nxml.txt.nlp	24758331	SENT77	3	3	19	19	tariquidar	P-gp		5243	0.995
NULL	Breast_Cancer_Res_2007_May_19_9(3)_R31.nxml.txt.nlp	17511881	SENT157	10	10	17	17	trastuzumab	HER2	PA451743	2064	0.995
NULL	Br_J_Cancer_2012_Jun_5_106(12)_1997-2003.nxml.txt.nlp	22596232	SENT16	37	37	24	24	sorafenib	JNK	PA7000	5599	0.995
NULL	J_Exp_Med_2003_Aug_4_198(3)_513-520.nxml.txt.nlp	12900525	SENT11	16	16	5	5	chloroquine	TLR9	PA448948	54106	0.995
NULL	Biol_Proced_Online_2004_Jun_7_6_105-112.nxml.txt.nlp	15192755	SENT209	1	1	29	29	valinomycin	VGLUT1	PA151917011	57030	0.994
NULL	Breast_Cancer_Res_2007_Mar_2_9(2)_205.nxml.txt.nlp	NULL	SENT13	0	0	33	33	trastuzumab	HER-2	PA451743	2064	0.994
NULL	Breast_Cancer_Res_2012_May_2_14(3)_R70.nxml.txt.nlp	22551440	SENT42	18	18	4	4	docetaxel	p53	PA449383	7157	0.994
NULL	Br_J_Cancer_2011_Aug_23_105(5)_649-657.nxml.txt.nlp	21811251	SENT118	4	4	21	21	gefitinib	IGF1R	PA131301952	3480	0.994
NULL	Exp_Ther_Med_2013_Dec_23_6(6)_1494-1498.nxml.txt.nlp	24255680	SENT75	27	27	16	16	losartan	ILK	PA450268	3611	0.994
NULL	Cell_Death_Dis_2012_Jun_21_3(6)_e327.nxml.txt.nlp	22717582	SENT198	21	21	14	14	doxorubicin	Mcl-1	PA449412	4170	0.994
NULL	Biomed_Res_Int_2014_Apr_23_2014_408683.nxml.txt.nlp	24864240	SENT137	35	35	8	8	cisplatin	Bcl-2	PA449014	596	0.994
NULL	Case_Rep_Oncol_2010_May_7_3(2)_154-159.nxml.txt.nlp	20740189	SENT26	0	0	20	20	panitumumab	KRAS	PA162373091	3845	0.994
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1137-1144.nxml.txt.nlp	20234366	SENT31	40	40	12	12	cetuximab	KRAS	PA10040	3845	0.994
NULL	J_Hematol_Oncol_2010_Mar_13_3_10.nxml.txt.nlp	20226083	SENT4	14	14	3	3	gemcitabine	RRM1	PA449748	6240	0.994
NULL	Ecancermedicalscience_2008_Feb_18_2_75.nxml.txt.nlp	22275966	SENT152	15	15	7	7	cisplatin	ERCC1	PA449014	2067	0.994
NULL	Cardiovasc_Psychiatry_Neurol_2009_Oct_13_2009_475108.nxml.txt.nlp	20029624	SENT95	4	4	32	32	olanzapine	5-HT2A	PA450688	3356	0.994
NULL	Crit_Care_2008_Feb_2_12(1)_R11.nxml.txt.nlp	18252006	SENT172	0	0	34	34	vasopressin	ACTH	PA451858	5443	0.994
NULL	Asia_Pac_Allergy_2013_Oct_31_3(4)_215-223.nxml.txt.nlp	24260726	SENT28	13	13	0	0	carbamazepine	HLA-B	PA448785	3106	0.994
NULL	Ann_Rheum_Dis_2014_Sep_18_73(9)_1607-1615.nxml.txt.nlp	24641941	SENT235	23	23	40	40	methotrexate	IL-6	PA450428	3569	0.994
NULL	Onco_Targets_Ther_2014_Dec_4_7_2249-2255.nxml.txt.nlp	25587220	SENT55	6	6	30	30	diethylstilbestrol	P-gp	PA449307	5243	0.994
NULL	J_Hematol_Oncol_2009_Feb_23_2_9.nxml.txt.nlp	19236713	SENT65	12	12	28	28	bevacizumab	KRAS	PA130232992	3845	0.994
NULL	Mol_Cancer_2010_Apr_15_9_77.nxml.txt.nlp	20398291	SENT49	28	28	7	7	geldanamycin	Hsp90	PA152031327	3320	0.994
NULL	Exp_Cell_Res_2009_Nov_15_315(19)_3433-3441.nxml.txt.nlp	19716819	SENT444	12	12	22	22	hyaluronan	IL-4	PA165958431	3565	0.994
NULL	Dement_Geriatr_Cogn_Dis_Extra_2014_Nov_15_4(3)_450-456.nxml.txt.nlp	25538729	SENT10	16	16	31	31	donepezil	CYP2D6	PA449394	1565	0.994
NULL	Cancer_Manag_Res_2012_Nov_9_4_383-395.nxml.txt.nlp	23204869	SENT123	42	42	4	4	carmustine	PC-3	PA448810	692094	0.994
NULL	Br_J_Cancer_2011_Jul_26_105(3)_366-371.nxml.txt.nlp	21750556	SENT138	12	12	0	0	trastuzumab	T-bet	PA451743	30009	0.994
NULL	Arthritis_Res_2002_Feb_4_4(Suppl_1)_40.nxml.txt.nlp	NULL	SENT4	17	17	0	0	trypsin	PAR1	PA451806	79581;2149	0.994
NULL	Evid_Based_Complement_Alternat_Med_2004_Sep_1(2)_207-209.nxml.txt.nlp	15480447	SENT44	32	32	6	6	cisplatin	HER-2	PA449014	2064	0.994
NULL	Basic_Clin_Pharmacol_Toxicol_2013_Feb_5_112(2)_132-137.nxml.txt.nlp	22900583	SENT23	18	18	25	25	prasugrel	CYP3A	PA154410481	1574	0.994
NULL	Br_J_Cancer_2004_Mar_5_90(Suppl_1)_S7-S10.nxml.txt.nlp	15094758	SENT95	7	7	28	28	fulvestrant	CYP3A4	PA164747170	1576	0.994
NULL	Br_J_Cancer_2012_May_22_106(11)_1728-1734.nxml.txt.nlp	22531637	SENT128	0	0	12	12	paclitaxel	CYP2C8	PA450761	1558	0.994
NULL	Oncol_Rep_2012_Nov_4_28(5)_1559-1566.nxml.txt.nlp	22949056	SENT117	6	6	0	0	paclitaxel	PIK3CA	PA450761	5290	0.994
NULL	Gut_Liver_2011_Jun_24_5(2)_171-180.nxml.txt.nlp	21814597	SENT135	46	46	5	5	imatinib	DOG1	PA10804	55107	0.994
NULL	Arthritis_Res_Ther_2009_Aug_28_11(4)_R131.nxml.txt.nlp	19715572	SENT12	2	2	15	15	rituximab	CD27	PA451261	939	0.994
NULL	Clin_Interv_Aging_2012_Sep_3_7_331-338.nxml.txt.nlp	22977302	SENT126	0	0	19	19	denosumab	RANKL	PA166048634	8600	0.994
NULL	Biomed_Res_Int_2013_Mar_28_2013_154073.nxml.txt.nlp	23607088	SENT14	0	0	18	18	clopidogrel	P2Y12	PA449053	64805	0.994
NULL	Cancers_(Basel)_2010_Sep_17_2(3)_1717-1730.nxml.txt.nlp	24281184	SENT149	33	33	1	1	capecitabine	DPD	PA448771	1806	0.994
NULL	Br_J_Pharmacol_2010_Sep_161(2)_288-307.nxml.txt.nlp	20735416	SENT245	32	32	7	7	halothane	TASK	PA449845	3777	0.994
NULL	Iran_J_Pharm_Res_2013_Winter_12(1)_223-227.nxml.txt.nlp	24250593	SENT107	13	13	40	40	mupirocin	solo	PA164764568	55701	0.994
NULL	Oncoscience_2014_Jun_30_1(6)_400-406.nxml.txt.nlp	25594038	SENT107	2	2	10	10	panitumumab	EGFR	PA162373091	1956	0.994
NULL	Exp_Dermatol_2014_Apr_28_23(4)_247-252.nxml.txt.nlp	24533866	SENT39	29	29	2	2	estradiol	ABCC11	PA449503	85320	0.994
NULL	Blood_Res_2014_Sep_25_49(3)_162-169.nxml.txt.nlp	25325035	SENT48	28	28	16	16	rituximab	CHOP	PA451261	1649	0.994
NULL	Commun_Integr_Biol_2013_Nov_1_6(6)_e26316.nxml.txt.nlp	24567774	SENT40	11	11	1	1	doxorubicin	p53	PA449412	7157	0.994
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT39	0	0	16	16	nutlin-3	p53		7157	0.994
NULL	Nat_Chem_Biol_2010_Apr_28_6(4)_291-299.nxml.txt.nlp	20190765	SENT144	6	6	31	31	dasatinib	AKT	PA162372878	207	0.994
NULL	FEBS_Open_Bio_2012_Nov_30_3_30-34.nxml.txt.nlp	23772371	SENT25	34	34	5	5	glucosamine	FGF4	PA164747613	2249	0.994
NULL	Chin_J_Cancer_2012_Feb_31(2)_73-99.nxml.txt.nlp	22098950	SENT238	29	29	39	39	erlotinib	P-gp	PA134687924	5243	0.994
NULL	J_Biol_Chem_2013_Mar_22_288(12)_8279-8288.nxml.txt.nlp	23400816	SENT42	5	5	12	12	ezetimibe	PCSK9	PA10816	255738	0.994
NULL	Pharmaceutics_2011_Oct_12_3(4)_680-705.nxml.txt.nlp	24309303	SENT75	5	5	14	14	glibenclamide	OATP2B1	PA449782	11309	0.994
NULL	Cancer_Cell_Int_2010_Jan_11_10_1.nxml.txt.nlp	20142996	SENT152	29	29	21	21	erlotinib	ASPM	PA134687924	259266	0.994
NULL	Chem_Rev_2012_May_9_112(5)_2593-2603.nxml.txt.nlp	22335786	SENT52	30	30	0	0	betaine	ATX	PA448603	5168;23049	0.994
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT293	6	6	25	25	erlotinib	EGFR	PA134687924	1956	0.994
NULL	Chin_J_Cancer_2012_Mar_31(3)_126-133.nxml.txt.nlp	22237041	SENT95	3	3	33	33	imatinib	MDR1	PA10804	5243	0.994
NULL	Br_J_Pharmacol_2010_Sep_161(2)_288-307.nxml.txt.nlp	20735416	SENT245	34	34	14	14	isoflurane	TREK-1	PA450106	3776	0.994
NULL	Case_Rep_Med_2014_Mar_31_2014_801805.nxml.txt.nlp	24799913	SENT38	2	2	13	13	amikacin	TMP	PA164744372	2012	0.994
NULL	Diabetes_Metab_Syndr_Obes_2014_Mar_18_7_107-120.nxml.txt.nlp	24672252	SENT194	31	31	8	8	liraglutide	GLP-1	PA165958364	100125288	0.994
NULL	J_Biol_Chem_2012_Apr_13_287(16)_13382-13395.nxml.txt.nlp	22367194	SENT204	29	29	9	9	marimastat	TIMP4	PA164748329	7079	0.994
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT83	25	25	10	10	capecitabine	HER2	PA448771	2064	0.994
NULL	Int_J_Endocrinol_Metab_2013_Oct_1_11(4)_e8156.nxml.txt.nlp	24719630	SENT85	15	15	41	41	octreotide	gamma	PA450678	9913	0.994
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT39	0	0	23	23	nutlin-3	p53		7157	0.994
NULL	Diabetologia_2014_Sep_29_57(1)_192-203.nxml.txt.nlp	24078137	SENT243	23	23	4	4	metformin	VGLUT1	PA450395	57030	0.994
NULL	Int_J_Mol_Imaging_2011_Oct_26_2011_874585.nxml.txt.nlp	21490735	SENT149	41	41	28	28	tamoxifen	FDG	PA451581	23583	0.994
NULL	Cell_Death_Dis_2013_Sep_5_4(9)_e792.nxml.txt.nlp	24008736	SENT118	16	16	3	3	tamoxifen	WWOX	PA451581	51741	0.994
NULL	Oncogene_2014_Sep_11_33(37)_4579-4588.nxml.txt.nlp	24662835	SENT125	33	33	5	5	tamoxifen	MAGEA3	PA451581	4102	0.994
NULL	Virchows_Arch_2012_Feb_16_460(2)_141-149.nxml.txt.nlp	22173329	SENT184	19	19	0	0	cetuximab	KRAS	PA10040	3845	0.994
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT291	23	23	4	4	cisplatin	JNK	PA449014	5599	0.994
NULL	Breast_Cancer_Res_2011_Nov_16_13(Suppl_2)_O11.nxml.txt.nlp	NULL	SENT6	5	5	43	43	trastuzumab	PTEN	PA451743	5728	0.994
NULL	Cancer_Cell_Int_2013_Feb_12_13_14.nxml.txt.nlp	23402310	SENT128	30	30	5	5	celecoxib	bcl-xL	PA448871	598	0.994
NULL	Cells_2013_Jul_18_2(3)_545-573.nxml.txt.nlp	24709797	SENT516	13	13	4	4	imatinib	BIM	PA10804	10018	0.994
NULL	J_Cell_Biol_2008_Jul_14_182(1)_197-213.nxml.txt.nlp	18625847	SENT363	14	14	5	5	nutlin-3	p53		7157	0.994
NULL	Exp_Ther_Med_2013_Feb_13_5(2)_581-585.nxml.txt.nlp	23403473	SENT5	46	46	21	21	etanercept	HMGB1	PA449515	3146	0.994
NULL	Clinics_(Sao_Paulo)_2013_Feb_68(2)_253-262.nxml.txt.nlp	23525324	SENT151	31	31	7	7	genistein	Gen	PA165109660	348654	0.994
NULL	Br_J_Cancer_1998_Aug_78(3)_375-381.nxml.txt.nlp	9703286	SENT10	25	25	1	1	cyclophosphamide	TP53	PA449165	7157	0.994
NULL	Diabetes_2011_Jun_21_60(6)_1705-1715.nxml.txt.nlp	21521872	SENT134	26	26	7	7	doxycycline	STZ	PA449415	6484	0.994
NULL	Br_J_Cancer_2004_Mar_5_90(Suppl_1)_S2-S6.nxml.txt.nlp	15094757	SENT100	33	33	0	0	fulvestrant	pS2	PA164747170	7031	0.994
NULL	Front_Oncol_2014_Mar_25_4_54.nxml.txt.nlp	24724051	SENT421	39	39	28	28	nilotinib	SYK	PA165958345	6850	0.994
NULL	Aging_(Albany_NY)_2010_Mar_18_2(3)_160-165.nxml.txt.nlp	20378935	SENT25	35	35	10	10	doxorubicin	p53	PA449412	7157	0.994
NULL	Breast_Cancer_Res_2008_Jul_24_10(4)_211.nxml.txt.nlp	18671839	SENT199	19	19	8	8	paclitaxel	EGFR	PA450761	1956	0.994
NULL	Br_J_Cancer_2012_Sep_4_107(6)_947-955.nxml.txt.nlp	22892392	SENT90	2	2	16	16	lapatinib	BCAR4	PA152241907	400500	0.994
NULL	Mol_Cancer_2007_Oct_22_6_66.nxml.txt.nlp	17953743	SENT150	29	29	16	16	cisplatin	ICAD	PA449014	1676	0.994
NULL	Breast_Cancer_Res_2010_Oct_22_12(Suppl_2)_S1.nxml.txt.nlp	21050422	SENT81	0	0	27	27	trastuzumab	HER2	PA451743	2064	0.994
NULL	Arthritis_Res_Ther_2012_Mar_14_14(2)_R62.nxml.txt.nlp	22417670	SENT306	34	34	7	7	chloroquine	LC3	PA448948	84557	0.994
NULL	Onco_Targets_Ther_2014_May_16_7_761-770.nxml.txt.nlp	24876785	SENT192	42	42	11	11	erlotinib	EGFR	PA134687924	1956	0.994
NULL	Biologics_2010_Aug_9_4_173-185.nxml.txt.nlp	20714355	SENT160	22	22	12	12	cetuximab	EGFR	PA10040	1956	0.994
NULL	Int_J_Breast_Cancer_2014_Jan_16_2014_769790.nxml.txt.nlp	24551455	SENT76	13	13	3	3	trastuzumab	HER2	PA451743	2064	0.994
NULL	Acta_Pharmacol_Sin_2012_Mar_27_33(3)_342-350.nxml.txt.nlp	22367283	SENT193	35	35	23	23	trypsin	PAR4	PA451806	9002;5074	0.994
NULL	Br_J_Cancer_1996_Jul_74(2)_274-279.nxml.txt.nlp	8688335	SENT13	42	42	19	19	cyclophosphamide	gamma	PA449165	9913	0.994
NULL	Clin_Pharmacokinet_2014_Jun_27_53(8)_741-751.nxml.txt.nlp	24968986	SENT250	6	6	19	19	docetaxel	OATP1B1	PA449383	10599	0.994
NULL	Indian_J_Endocrinol_Metab_2014_Jul-Aug_18(4)_455-467.nxml.txt.nlp	25143899	SENT121	14	14	4	4	metformin	TDD	PA450395	6994	0.994
NULL	Clin_Dev_Immunol_2011_Oct_20_2011_947858.nxml.txt.nlp	22046194	SENT132	4	4	18	18	doxorubicin	B7-H1	PA449412	29126	0.994
NULL	Clin_Exp_Vaccine_Res_2013_Jul_3_2(2)_128-134.nxml.txt.nlp	23858404	SENT133	6	6	1	1	cisplatin	TC-1	PA449014	56892	0.994
NULL	Front_Genet_2012_Nov_22_3_249.nxml.txt.nlp	23189085	SENT98	0	0	20	20	mitoxantrone	ABCB1	PA450526	5243	0.994
NULL	Oncol_Lett_2013_Dec_18_6(6)_1539-1542.nxml.txt.nlp	24260043	SENT84	0	0	17	17	doxorubicin	p53	PA449412	7157	0.994
NULL	J_Gen_Physiol_2004_Jul_124(1)_1b.nxml.txt.nlp	NULL	SENT880	31	31	0	0	halothane	TREK-2	PA449845	54207	0.994
NULL	Exp_Mol_Med_2012_Apr_30_44(4)_251-259.nxml.txt.nlp	22198296	SENT61	32	32	3	3	doxorubicin	CD44	PA449412	960	0.994
NULL	BMJ_2011_Aug_4_343_d4588.nxml.txt.nlp	21816733	SENT441	22	22	3	3	clopidogrel	CYP2C19	PA449053	1557	0.994
NULL	Mol_Cytogenet_2010_Sep_15_3_17.nxml.txt.nlp	20840797	SENT187	24	24	2	2	topotecan	FISH	PA451729	9644	0.994
NULL	Aging_(Albany_NY)_2012_Jul_22_4(7)_480-498.nxml.txt.nlp	22837425	SENT93	15	15	44	44	metformin	AMPK	PA450395	5563	0.994
NULL	Acta_Otolaryngol_2010_Nov_30_130(11)_1278-1286.nxml.txt.nlp	20586674	SENT168	17	17	2	2	capsaicin	TRPV1	PA448776	7442	0.994
NULL	Br_J_Clin_Pharmacol_2012_Apr_7_73(4)_518-535.nxml.txt.nlp	22053916	SENT178	0	0	31	31	pitavastatin	adiponectin	PA142650384	9370	0.994
NULL	Breast_Cancer_(Auckl)_2012_Mar_7_6_67-77.nxml.txt.nlp	22438669	SENT114	30	30	4	4	lapatinib	aromatase	PA152241907	1588	0.994
NULL	Behav_Brain_Funct_2009_Jun_4_5_23.nxml.txt.nlp	19497110	SENT127	13	13	4	4	ethanol	P90	PA448073	821	0.994
NULL	J_Cell_Biol_2002_Mar_4_156(5)_791-795.nxml.txt.nlp	11877457	SENT72	33	33	10	10	staurosporine	AAK1	PA165109623	22848	0.994
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT192	0	0	14	14	quinidine	CYP2D6	PA451209	1565	0.994
NULL	Biomed_Res_Int_2014_Aug_6_2014_967826.nxml.txt.nlp	25165721	SENT111	27	27	12	12	cisplatin	LC3	PA449014	84557	0.994
NULL	Br_J_Cancer_2011_Mar_1_104(5)_750-755.nxml.txt.nlp	21326243	SENT141	1	1	18	18	olaparib	PARP-1		25976	0.994
NULL	Br_J_Cancer_2010_Oct_26_103(9)_1331-1334.nxml.txt.nlp	20877352	SENT29	4	4	12	12	trastuzumab	HER2	PA451743	2064	0.994
NULL	J_Vet_Med_Sci_2014_Jun_15_76(6)_813-817.nxml.txt.nlp	24531829	SENT98	7	7	27	27	artesunate	DPT	PA165111697	1805	0.994
NULL	Mol_Cancer_2014_Jan_13_13_7.nxml.txt.nlp	24418169	SENT234	29	29	5	5	sorafenib	STAT3	PA7000	6774	0.994
NULL	Eur_J_Clin_Pharmacol_2012_Jan_7_68(1)_55-64.nxml.txt.nlp	21735164	SENT5	0	0	18	18	oxycodone	CYP2D6	PA450741	1565	0.994
NULL	Crit_Care_2006_Dec_7_10(6)_239.nxml.txt.nlp	17169139	SENT72	0	0	30	30	thrombin	PAR1	PA451674	79581;2149	0.994
NULL	Br_J_Pharmacol_2014_Jun_15_171(11)_2705-2725.nxml.txt.nlp	24467436	SENT123	7	7	42	42	isoniazid	NAT2	PA450112	10;81539	0.994
NULL	J_Gen_Physiol_1934_Jan_20_17(3)_365-373.nxml.txt.nlp	19872786	SENT10	6	6	24	24	trypsin	PDF	PA451806	64146;9518	0.994
NULL	eLife_2013_Nov_5_2_e00969.nxml.txt.nlp	24192036	SENT214	0	0	17	17	vemurafenib	JNK	PA165946873	5599	0.994
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_75-89.nxml.txt.nlp	17912638	SENT72	10	10	42	42	anastrozole	ATAC	PA448432	6375	0.994
NULL	Br_J_Pharmacol_2014_Aug_25_171(16)_3827-3844.nxml.txt.nlp	24750014	SENT87	8	8	28	28	forskolin	CO2	PA146096022	4513	0.994
NULL	Biomed_Res_Int_2013_Feb_28_2013_749078.nxml.txt.nlp	23555095	SENT107	4	4	20	20	chymotrypsin	CD31	PA448994	5175	0.994
NULL	Front_Mol_Neurosci_2014_Dec_1_7_94.nxml.txt.nlp	25520615	SENT12	4	4	33	33	ketamine	CA1	PA450144	759	0.994
NULL	J_Carcinog_2014_Feb_7_13_1.nxml.txt.nlp	24737949	SENT185	9	9	26	26	nilotinib	KIT	PA165958345	3815	0.994
NULL	J_Gynecol_Oncol_2013_Jul_4_24(3)_273-279.nxml.txt.nlp	23875078	SENT102	36	36	16	16	paclitaxel	COX	PA450761	1351	0.994
NULL	Neural_Regen_Res_2014_May_15_9(10)_1055-1062.nxml.txt.nlp	25206759	SENT39	9	9	25	25	furosemide	KCC2	PA449719	57468	0.994
NULL	Breast_Cancer_Res_2007_Mar_2_9(2)_205.nxml.txt.nlp	NULL	SENT28	3	3	35	35	ekb-569	EGFR		1956	0.994
NULL	Biomed_Res_Int_2014_Feb_4_2014_975927.nxml.txt.nlp	24689066	SENT133	0	0	18	18	denosumab	RANK	PA166048634	8792	0.994
NULL	Int_J_Mol_Sci_2014_Oct_27_15(11)_19417-19443.nxml.txt.nlp	25350109	SENT103	18	18	2	2	allopurinol	XOR	PA448320	7498	0.994
NULL	Am_J_Trop_Med_Hyg_2014_Sep_3_91(3)_439.nxml.txt.nlp	25187668	SENT19	0	0	17	17	erythromycin	CD4	PA449493	920	0.994
NULL	Cardiol_Res_Pract_2013_Jan_31_2013_128795.nxml.txt.nlp	23431496	SENT162	7	7	39	39	clopidogrel	P2Y12	PA449053	64805	0.994
NULL	J_Gen_Physiol_2013_Dec_142(6)_561-573.nxml.txt.nlp	24277600	SENT255	0	0	11	11	amrinone	ADP	PA164746803	23038	0.994
NULL	Curr_Oncol_2009_Jul_16(Suppl_2)_S1-S13.nxml.txt.nlp	19672416	SENT224	10	10	19	19	letrozole	HER2	PA450196	2064	0.994
NULL	Tuberc_Respir_Dis_(Seoul)_2014_Mar_29_76(3)_114-119.nxml.txt.nlp	24734098	SENT131	7	7	42	42	paclitaxel	Bcl-2	PA450761	596	0.994
NULL	Nat_Commun_2013_Nov_27_4_2821.nxml.txt.nlp	24281726	SENT243	26	26	0	0	pp2	PP2		4888	0.994
NULL	Clin_Med_Insights_Oncol_2012_Dec_6_6_407-421.nxml.txt.nlp	23239933	SENT27	43	43	31	31	gefitinib	EGFR	PA131301952	1956	0.994
NULL	Psychiatry_Investig_2012_Dec_12_9(4)_422-424.nxml.txt.nlp	23251210	SENT8	10	10	15	15	perphenazine	CYP2D6	PA450882	1565	0.994
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Jul_21_9_20.nxml.txt.nlp	20663145	SENT78	33	33	7	7	clarithromycin	LBH	PA449028	81606;221491	0.994
NULL	Breast_Cancer_Res_2012_May_2_14(3)_R70.nxml.txt.nlp	22551440	SENT259	29	29	8	8	docetaxel	p53	PA449383	7157	0.994
NULL	Clin_Pharmacol_2013_Dec_9_5_185-192.nxml.txt.nlp	24353446	SENT77	11	11	37	37	clopidogrel	CYP3A4	PA449053	1576	0.994
NULL	Curr_Oncol_2009_May_16(Suppl_1)_S52-S59.nxml.txt.nlp	19478903	SENT178	0	0	11	11	pravastatin	CYP3A4	PA451089	1576	0.994
NULL	Int_J_Vasc_Med_2012_Jan_4_2012_657025.nxml.txt.nlp	22347626	SENT110	22	22	5	5	pitavastatin	PTX3	PA142650384	5806	0.994
NULL	Arthritis_Res_Ther_2013_Jul_9_15(4)_R73.nxml.txt.nlp	23837669	SENT248	1	1	21	21	colchicine	MICL	PA449092	160364	0.994
NULL	Virchows_Arch_2012_Feb_16_460(2)_141-149.nxml.txt.nlp	22173329	SENT184	30	30	0	0	panitumumab	KRAS	PA162373091	3845	0.994
NULL	Br_J_Cancer_2012_Nov_20_107(11)_1844-1852.nxml.txt.nlp	23169337	SENT217	35	35	15	15	bortezomib	c-Myc	PA10252	4609	0.994
NULL	Br_J_Cancer_2012_Jul_24_107(3)_435-441.nxml.txt.nlp	22767144	SENT147	9	9	19	19	docetaxel	TTP	PA449383	7538;11093	0.994
NULL	Arthritis_Res_2000_Mar_31_2(3)_175-178.nxml.txt.nlp	11094424	SENT107	17	17	28	28	methotrexate	p53	PA450428	7157	0.994
NULL	J_Midlife_Health_2012_Jul-Dec_3(2)_56-58.nxml.txt.nlp	23372317	SENT56	0	0	23	23	metformin	AMPK	PA450395	5563	0.994
NULL	Crit_Care_2011_Feb_3_15(1)_R49.nxml.txt.nlp	21291554	SENT128	36	36	8	8	vancomycin	CLCR	PA451850	11330	0.994
NULL	Cell_Tissue_Res_2013_Mar_5_351(3)_465-475.nxml.txt.nlp	23212463	SENT7	6	6	14	14	atropine	EGFR	PA448505	1956	0.994
NULL	Open_Access_J_Urol_2011_May_10_3_69-82.nxml.txt.nlp	24198638	SENT69	18	18	2	2	sorafenib	CYP3A4	PA7000	1576	0.994
NULL	Oncogenesis_2014_Dec_15_3(12)_e133.nxml.txt.nlp	25500906	SENT144	44	44	10	10	trastuzumab	HER2	PA451743	2064	0.994
NULL	Br_J_Cancer_2012_Nov_6_107(10)_1714-1721.nxml.txt.nlp	23073173	SENT120	10	10	23	23	docetaxel	RUNX2	PA449383	860	0.994
NULL	Case_Rep_Oncol_2013_Jan_8_6(1)_15-20.nxml.txt.nlp	23466741	SENT15	10	10	22	22	gefitinib	EGFR	PA131301952	1956	0.994
NULL	Patient_Prefer_Adherence_2011_Dec_23_6_1-9.nxml.txt.nlp	22272064	SENT81	17	17	38	38	telmisartan	ACE	PA451605	1636	0.994
NULL	Clin_Pharmacokinet_2014_Sep_3_53(1)_1-16.nxml.txt.nlp	23999929	SENT139	4	4	40	40	rivaroxaban	CLCR	PA165958360	11330	0.994
NULL	Br_J_Cancer_2013_Mar_19_108(5)_1126-1132.nxml.txt.nlp	23511629	SENT124	29	29	14	14	sunitinib	VEGFR	PA162372840	3791	0.994
NULL	Surg_Res_Pract_2014_Feb_6_2014_801643.nxml.txt.nlp	25379560	SENT13	18	18	9	9	sirolimus	CD95	PA451365	355	0.994
NULL	Chemother_Res_Pract_2012_Dec_20_2012_743193.nxml.txt.nlp	23320171	SENT14	0	0	8	8	trastuzumab	HER2	PA451743	2064	0.994
NULL	Nat_Commun_2014_Jul_16_5_4425.nxml.txt.nlp	25028121	SENT26	30	30	9	9	pp2	p47phox		653361	0.994
NULL	Lipids_Health_Dis_2011_Feb_28_10_38.nxml.txt.nlp	21352602	SENT89	38	38	10	10	atorvastatin	PCSK9	PA448500	255738	0.994
NULL	Iran_Red_Crescent_Med_J_2014_Sep_5_16(9)_e20153.nxml.txt.nlp	25593732	SENT87	3	3	11	11	enflurane	CYP2E1	PA449461	1571	0.994
NULL	Case_Rep_Oncol_2012_Dec_6_5(3)_644-650.nxml.txt.nlp	23275780	SENT31	24	24	12	12	gefitinib	EGFR	PA131301952	1956	0.994
NULL	Br_J_Cancer_2012_Sep_4_107(6)_947-955.nxml.txt.nlp	22892392	SENT154	11	11	0	0	tamoxifen	BCAR4	PA451581	400500	0.994
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1150.nxml.txt.nlp	24675468	SENT100	4	4	34	34	metformin	adiponectin	PA450395	9370	0.994
NULL	Biochim_Biophys_Acta_2013_Jul_1832(7)_905-910.nxml.txt.nlp	23032152	SENT57	11	11	34	34	cabergoline	5-HT2B	PA448708	3357	0.994
NULL	Mol_Cell_Proteomics_2013_Sep_7_12(9)_2615-2622.nxml.txt.nlp	23653450	SENT211	23	23	3	3	tamoxifen	PAK1	PA451581	5585;5058	0.994
NULL	J_Bras_Pneumol_2013_Jan-Feb_39(1)_5-15.nxml.txt.nlp	23503480	SENT188	18	18	24	24	doxycycline	LAM	PA449415	7249;7248	0.994
NULL	J_Korean_Med_Sci_1996_Jun_11(3)_250-257.nxml.txt.nlp	8843008	SENT7	0	0	43	43	nifedipine	NIF	PA450631	6280	0.994
NULL	Breast_Cancer_Res_2005_Jan_28_7(3)_R284-R290.nxml.txt.nlp	15987423	SENT12	16	16	3	3	tamoxifen	CYP2D6	PA451581	1565	0.994
NULL	Breast_Cancer_Res_2007_Oct_26_9(5)_112.nxml.txt.nlp	17980056	SENT148	31	31	10	10	letrozole	aromatase	PA450196	1588	0.994
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT143	4	4	32	32	resveratrol	cIAP2		330	0.994
NULL	Cancer_Manag_Res_2014_Mar_4_6_105-117.nxml.txt.nlp	24623991	SENT118	33	33	8	8	letrozole	aromatase	PA450196	1588	0.994
NULL	Breast_Cancer_Res_2011_Nov_16_13(Suppl_2)_O11.nxml.txt.nlp	NULL	SENT6	5	5	20	20	trastuzumab	HER2	PA451743	2064	0.994
NULL	Cell_Res_2009_Aug_19(8)_950-961.nxml.txt.nlp	19546888	SENT23	37	37	10	10	hydrocortisone	CARP	PA449905	27063;80013;767	0.994
NULL	EMBO_Mol_Med_2009_Apr_1(1)_66-78.nxml.txt.nlp	20049704	SENT221	4	4	16	16	temsirolimus	HIF-1	PA164746890	29072	0.994
NULL	Front_Oncol_2013_Nov_15_3_281.nxml.txt.nlp	24298448	SENT118	13	13	11	11	nutlin-3	HDM2		4193	0.994
NULL	Eur_J_Endocrinol_2014_Mar_170(3)_451-459.nxml.txt.nlp	24362411	SENT201	30	30	41	41	exenatide	GLP1	PA164749238	100125288;2641	0.994
NULL	Endocrinol_Metab_(Seoul)_2014_Mar_14_29(1)_54-61.nxml.txt.nlp	24741455	SENT119	0	0	26	26	curcumin	NIK	PA151958596	9020;9448	0.994
NULL	Cancer_Med_2014_Aug_6_3(4)_988-997.nxml.txt.nlp	24905030	SENT20	41	41	2	2	gefitinib	IGFR	PA131301952	3480	0.994
NULL	Target_Oncol_2010_Jun_14_5(2)_95-112.nxml.txt.nlp	20625845	SENT240	25	25	10	10	semaxanib	FDG	PA131887911	23583	0.994
NULL	Breast_Cancer_Res_2011_Aug_31_13(4)_R84.nxml.txt.nlp	21884573	SENT267	23	23	7	7	lapatinib	FAK	PA152241907	5747	0.994
NULL	Korean_J_Anesthesiol_2013_Dec_26_65(6)_501-507.nxml.txt.nlp	24427455	SENT90	31	31	13	13	neostigmine	ANOVA	PA450611	4858	0.994
NULL	Oncotarget_2012_May_18_3(5)_525-534.nxml.txt.nlp	22619113	SENT46	17	17	5	5	fludarabine	Hsp90	PA449655	3320	0.994
NULL	Oxid_Med_Cell_Longev_2013_Nov_10_2013_680414.nxml.txt.nlp	24319532	SENT137	27	27	33	33	minocycline	PARP-1	PA450519	25976	0.994
NULL	Cancers_(Basel)_2014_Apr_16_6(2)_926-957.nxml.txt.nlp	24743778	SENT338	0	0	22	22	curcumin	STAT3	PA151958596	6774	0.994
NULL	Indian_J_Med_Res_2012_Aug_136(2)_249-259.nxml.txt.nlp	22960892	SENT21	26	26	6	6	irinotecan	UGT1A1	PA450085	54658	0.994
NULL	Allergy_Asthma_Immunol_Res_2014_Nov_19_6(6)_548-557.nxml.txt.nlp	25374755	SENT145	15	15	21	21	lovastatin	IL-13	PA450272	3596	0.994
NULL	Cancer_Manag_Res_2012_Aug_8_4_243-252.nxml.txt.nlp	22904646	SENT80	4	4	18	18	dacarbazine	BRAF	PA449197	673	0.994
NULL	Chemother_Res_Pract_2012_Dec_20_2012_743193.nxml.txt.nlp	23320171	SENT7	3	3	25	25	trastuzumab	HER2	PA451743	2064	0.994
NULL	Diabetes_Care_2009_Sep_29_32(9)_1620-1625.nxml.txt.nlp	19564453	SENT157	4	4	26	26	metformin	TSC2	PA450395	7249	0.994
NULL	Core_Evid_2009_Jun_15_4_1-11.nxml.txt.nlp	20694060	SENT95	0	0	13	13	valsartan	AT1	PA451848	9197;185	0.994
NULL	Breast_Cancer_Res_2008_Dec_18_10(Suppl_4)_S4.nxml.txt.nlp	19128442	SENT35	28	28	3	3	trastuzumab	HER2	PA451743	2064	0.994
NULL	Clin_Dev_Immunol_2007_Jan_20_2007_76396.nxml.txt.nlp	18317531	SENT91	13	13	21	21	sertraline	IL-2	PA451333	3558	0.994
NULL	Breast_Cancer_Res_2009_Oct_28_11(5)_211.nxml.txt.nlp	19889200	SENT240	11	11	3	3	tamoxifen	HER2	PA451581	2064	0.994
NULL	Oncotarget_2014_Oct_21_5(22)_11252-11268.nxml.txt.nlp	25361004	SENT141	4	4	37	37	metformin	CLIC1	PA450395	1192	0.994
NULL	Exp_Mol_Med_2013_Aug_16_45(8)_e36.nxml.txt.nlp	23949442	SENT38	21	21	2	2	doxycycline	LRRK2	PA449415	120892	0.994
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_19_2013_746486.nxml.txt.nlp	23861712	SENT145	22	22	6	6	irinotecan	UGT	PA450085	7361;7355	0.994
NULL	Br_J_Cancer_2012_Jan_17_106(2)_348-357.nxml.txt.nlp	22146521	SENT117	25	25	20	20	gemcitabine	TP53	PA449748	7157	0.994
NULL	Cell_Death_Dis_2013_Oct_3_4(10)_e827.nxml.txt.nlp	24091670	SENT97	33	33	1	1	nilotinib	PI3K	PA165958345	5290	0.994
NULL	Front_Neuroanat_2011_Jul_12_5_38.nxml.txt.nlp	21808606	SENT99	3	3	12	12	haloperidol	DARPP-32	PA449841	84152	0.994
NULL	Br_J_Cancer_2011_Jun_28_105(1)_53-57.nxml.txt.nlp	21654688	SENT130	19	19	34	34	irinotecan	UGT1A1	PA450085	54658	0.994
NULL	Ann_Indian_Acad_Neurol_2010_Apr-Jun_13(2)_136-138.nxml.txt.nlp	20814499	SENT58	8	8	20	20	methotrexate	CD4	PA450428	920	0.994
NULL	Breast_Cancer_Res_2011_Jun_15_13(3)_R67.nxml.txt.nlp	21699723	SENT123	43	43	5	5	bevacizumab	HER-2	PA130232992	2064	0.994
NULL	J_Immunol_Res_2014_Jan_19_2014_103780.nxml.txt.nlp	24741572	SENT129	16	16	43	43	salmeterol	EPAC	PA451300	10411	0.994
NULL	Mol_Cell_Proteomics_2014_May_17_13(5)_1273-1285.nxml.txt.nlp	24637012	SENT165	19	19	5	5	ergotamine	5-HT2A	PA164747651	3356	0.994
NULL	Anemia_2012_Oct_3_2012_563251.nxml.txt.nlp	23091709	SENT420	8	8	18	18	curcumin	AMPK	PA151958596	5563	0.994
NULL	Pharmaceuticals_(Basel)_2012_Nov_9_5(11)_1210-1235.nxml.txt.nlp	24281307	SENT199	5	5	20	20	isoniazid	p55	PA450112	6624;2078;8503;5718	0.994
NULL	Target_Oncol_2013_Jun_27_8(2)_127-136.nxml.txt.nlp	23625191	SENT124	43	43	4	4	panitumumab	KRAS	PA162373091	3845	0.994
NULL	Breast_Cancer_Res_2010_Apr_30_12(2)_203.nxml.txt.nlp	20459590	SENT133	3	3	16	16	cisplatin	FANCF	PA449014	2188	0.994
NULL	Int_J_Environ_Res_Public_Health_2014_Aug_18_11(8)_8414-8442.nxml.txt.nlp	25153469	SENT21	10	10	36	36	nitrogen	PTB	PA450643	58155	0.994
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT326	18	18	0	0	nutlin-3	IBP		706;50619	0.994
NULL	BMJ_2010_Feb_8_340_c693.nxml.txt.nlp	20142325	SENT137	39	39	8	8	fluoxetine	CYP2D6	PA449673	1565	0.994
NULL	Cell_Death_Dis_2014_Jan_16_5(1)_e1000.nxml.txt.nlp	24434508	SENT64	9	9	16	16	nutlin-3	p53		7157	0.994
NULL	Drug_Des_Devel_Ther_2014_Sep_26_8_1595-1611.nxml.txt.nlp	25302015	SENT108	16	16	23	23	docetaxel	EGFR	PA449383	1956	0.994
NULL	EJC_Suppl_2013_Sep_5_11(2)_254-256.nxml.txt.nlp	NULL	SENT41	37	37	31	31	exemestane	aromatase	PA449563	1588	0.994
NULL	Emerg_Infect_Dis_2012_Jul_18(7)_1128-1131.nxml.txt.nlp	22710273	SENT59	34	34	21	21	isoniazid	CD4	PA450112	920	0.994
NULL	J_Res_Med_Sci_2012_Feb_17(2)_159-163.nxml.txt.nlp	23264790	SENT79	42	42	0	0	imatinib	CD117	PA10804	3815	0.994
NULL	Arthritis_Res_Ther_2012_May_1_14(3)_R99.nxml.txt.nlp	22546542	SENT35	29	29	19	19	infliximab	CD4	PA452639	920	0.994
NULL	Clin_Sci_(Lond)_2011_Nov_1_121(Pt_10)_449-458.nxml.txt.nlp	21671887	SENT149	14	14	5	5	simvastatin	AMPK	PA451363	5563	0.994
NULL	Acta_Pharmacol_Sin_2010_Jul_28_31(7)_867-873.nxml.txt.nlp	20581857	SENT151	15	15	2	2	cisplatin	PDCD4	PA449014	27250	0.994
NULL	Nat_Methods_2011_May_10_8(5)_424-429.nxml.txt.nlp	21478862	SENT66	21	21	42	42	hydrocortisone	NODAL	PA449905	4838	0.994
NULL	Drug_Des_Devel_Ther_2014_Sep_26_8_1595-1611.nxml.txt.nlp	25302015	SENT112	7	7	13	13	docetaxel	EGFR	PA449383	1956	0.994
NULL	Case_Rep_Obstet_Gynecol_2011_Sep_22_2011_896964.nxml.txt.nlp	22567519	SENT15	22	22	2	2	lamivudine	CD4	PA450163	920	0.994
NULL	Afr_J_Infect_Dis_2010_4(2)_29-42.nxml.txt.nlp	23878698	SENT16	22	22	0	0	chloroquine	ACT	PA448948	12;11332;9457;641455	0.994
NULL	Br_J_Cancer_1995_May_71(5)_907-913.nxml.txt.nlp	7734314	SENT16	35	35	16	16	vincristine	MDR1	PA451879	5243	0.994
NULL	F1000_Biol_Rep_2011_Nov_1_3_23.nxml.txt.nlp	22065982	SENT123	23	23	7	7	mitoxantrone	ABCG2	PA450526	9429	0.994
NULL	Front_Genet_2014_May_30_5_152.nxml.txt.nlp	24910641	SENT52	29	29	0	0	vemurafenib	BRAF	PA165946873	673	0.994
NULL	Clin_Interv_Aging_2014_Apr_8_9_593-601.nxml.txt.nlp	24748777	SENT70	0	0	26	26	denosumab	RANK	PA166048634	8792	0.994
NULL	Breast_Cancer_Res_2011_Feb_3_13(1)_R16.nxml.txt.nlp	21291529	SENT116	19	19	0	0	tamoxifen	PHD1	PA451581	112398	0.994
NULL	Brain_Behav_2012_Jan_2(1)_68-73.nxml.txt.nlp	22574275	SENT7	41	41	4	4	oxaliplatin	TRPM8	PA131285527	79054	0.994
NULL	Front_Endocrinol_(Lausanne)_2014_Feb_19_5_16.nxml.txt.nlp	24600438	SENT134	4	4	11	11	aliskiren	AT1	PA143487910	9197;185	0.994
NULL	Biomed_Res_Int_2014_Apr_10_2014_580852.nxml.txt.nlp	24812624	SENT167	12	12	2	2	resveratrol	PTEN		5728	0.994
NULL	Int_J_Med_Sci_2012_Aug_10_9(6)_472-479.nxml.txt.nlp	22927772	SENT42	47	47	30	30	warfarin	CYP2C9	PA451906	1559	0.994
NULL	Eur_J_Clin_Pharmacol_2012_Jan_7_68(1)_55-64.nxml.txt.nlp	21735164	SENT5	0	0	16	16	oxycodone	CYP3A4	PA450741	1576	0.994
NULL	Epigenetics_2012_Nov_1_7(11)_1249-1257.nxml.txt.nlp	22983262	SENT116	34	34	6	6	taurine	CDO1	PA451590	1036	0.994
NULL	Diabetol_Metab_Syndr_2014_Mar_31_6_47.nxml.txt.nlp	24684779	SENT148	29	29	13	13	simvastatin	IL-6	PA451363	3569	0.994
NULL	Br_J_Cancer_2003_Mar_24_88(6)_848-854.nxml.txt.nlp	12644821	SENT161	40	40	21	21	cisplatin	TP53	PA449014	7157	0.994
NULL	Front_Cell_Neurosci_2015_Jan_15_8_459.nxml.txt.nlp	25642166	SENT107	18	18	43	43	hemin	HO-1	PA449849	3162	0.994
NULL	J_Thromb_Haemost_2014_May_22_12(5)_748-760.nxml.txt.nlp	24612393	SENT176	30	30	7	7	thrombin	TSC2	PA451674	7249	0.994
NULL	Cancers_(Basel)_2014_May_6_6(2)_1065-1097.nxml.txt.nlp	24805867	SENT449	5	5	19	19	geldanamycin	Hsp90	PA152031327	3320	0.994
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Nov_21_65(Pt_12)_o3168.nxml.txt.nlp	21578884	SENT64	37	37	3	3	ethanol	mol	PA448073	90527	0.994
NULL	Exp_Diabetes_Res_2012_Oct_15_2012_465282.nxml.txt.nlp	23118742	SENT94	0	0	11	11	metformin	AMPK	PA450395	5563	0.994
NULL	J_Biol_Chem_2009_Jan_2_284(1)_77-84.nxml.txt.nlp	18854318	SENT128	36	36	11	11	forskolin	AMPK	PA146096022	5563	0.994
NULL	J_Cancer_Prev_2013_Sep_18(3)_227-234.nxml.txt.nlp	25337550	SENT70	6	6	0	0	cisplatin	STAT1	PA449014	6772	0.994
NULL	Exp_Hematol_Oncol_2014_Jan_11_3_2.nxml.txt.nlp	24410791	SENT16	2	2	18	18	erlotinib	EGFR	PA134687924	1956	0.994
NULL	Nature_2012_Jan_25_481(7382)_457-462.nxml.txt.nlp	22281595	SENT64	27	27	0	0	tamoxifen	CD150	PA451581	6504	0.994
NULL	Nat_Med_2012_Aug_22_18(8)_10_1038_nm_2827.nxml.txt.nlp	22820645	SENT68	19	19	5	5	capsaicin	TRPV1	PA448776	7442	0.994
NULL	Leukemia_2013_Feb_10_27(2)_507-510.nxml.txt.nlp	22810506	SENT68	28	28	4	4	chlorambucil	TRAC	PA448926	28755	0.994
NULL	Oncol_Rep_2013_Sep_1_30(3)_1045-1052.nxml.txt.nlp	23817662	SENT134	15	15	2	2	gefitinib	KRAS	PA131301952	3845	0.994
NULL	Scientifica_(Cairo)_2012_Oct_9_2012_821549.nxml.txt.nlp	24278743	SENT207	10	10	26	26	tropisetron	5-HT2C	PA161925594	3358	0.994
NULL	Biomed_Res_Int_2013_Jul_28_2013_627907.nxml.txt.nlp	23984390	SENT176	31	31	8	8	tacrine	CYP1A2	PA451576	1544	0.994
NULL	Gut_Liver_2012_Apr_17_6(2)_210-217.nxml.txt.nlp	22570750	SENT154	37	37	21	21	indomethacin	cPLA2	PA449982	10524	0.994
NULL	Cancer_Med_2012_Oct_1_1(2)_114-127.nxml.txt.nlp	23342262	SENT280	3	3	34	34	sirolimus	AKT	PA451365	207	0.994
NULL	Mol_Cancer_2008_Jan_25_7_14.nxml.txt.nlp	18221502	SENT233	26	26	2	2	mercaptopurine	PSAT1	PA450379	29968	0.994
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT245	8	8	39	39	pertuzumab	HER3		2065	0.994
NULL	J_Oncol_2010_Mar_4_2010_824571.nxml.txt.nlp	20224651	SENT176	10	10	3	3	cisplatin	survivin	PA449014	332	0.994
NULL	J_Immunol_Res_2014_Apr_28_2014_286170.nxml.txt.nlp	24868562	SENT77	7	7	14	14	docetaxel	ANOVA	PA449383	4858	0.994
NULL	Osteoporos_Int_2013_May_4_24(10)_2659-2670.nxml.txt.nlp	23644877	SENT274	0	0	18	18	metformin	AMPK	PA450395	5563	0.994
NULL	J_Hematol_Oncol_2013_Jan_17_6_8.nxml.txt.nlp	23327547	SENT96	5	5	32	32	sulindac	JNK1	PA451565	5599	0.994
NULL	Cell_Commun_Signal_2009_Aug_27_7_20.nxml.txt.nlp	19712465	SENT298	23	23	39	39	carbachol	EGF	PA448784	1950	0.994
NULL	Drug_Saf_2014_Feb_19_37(4)_201-211.nxml.txt.nlp	24550106	SENT88	23	23	3	3	prasugrel	CYP2C19	PA154410481	1557	0.994
NULL	Oncogenesis_2014_Dec_15_3(12)_e133.nxml.txt.nlp	25500906	SENT9	38	38	2	2	trastuzumab	HER2	PA451743	2064	0.994
NULL	Biomed_Res_Int_2013_Jan_21_2013_581631.nxml.txt.nlp	23484133	SENT211	0	0	19	19	infliximab	IL-15	PA452639	3600	0.994
NULL	Cell_Death_Dis_2014_Jul_10_5(7)_e1322.nxml.txt.nlp	25010988	SENT125	19	19	1	1	temozolomide	BNIP3	PA451609	664	0.994
NULL	Br_J_Cancer_2010_Sep_28_103(7)_1008-1018.nxml.txt.nlp	20736947	SENT149	38	38	6	6	docetaxel	CD147	PA449383	682	0.994
NULL	Cell_Death_Dis_2012_Jun_21_3(6)_e330.nxml.txt.nlp	22717585	SENT327	18	18	10	10	simvastatin	ATG5	PA451363	9474	0.994
NULL	Acta_Pharmacol_Sin_2012_Mar_27_33(3)_342-350.nxml.txt.nlp	22367283	SENT193	35	35	21	21	trypsin	PAR3	PA451806	56288;2151	0.994
NULL	Autoimmune_Dis_2014_Apr_7_2014_743616.nxml.txt.nlp	24804084	SENT79	5	5	18	18	estradiol	BAFF	PA449503	10673	0.994
NULL	Cases_J_2009_Jul_29_2_6449.nxml.txt.nlp	19829805	SENT15	10	10	33	33	cabergoline	PRL	PA448708	5617	0.994
NULL	Br_J_Cancer_2010_May_11_102(10)_1456-1460.nxml.txt.nlp	20461090	SENT156	21	21	6	6	temsirolimus	IFN	PA164746890	3439	0.994
NULL	Case_Rep_Oncol_Med_2014_Dec_28_2014_343178.nxml.txt.nlp	25610678	SENT76	30	30	3	3	imatinib	KIT	PA10804	3815	0.994
NULL	ScientificWorldJournal_2014_Feb_5_2014_912640.nxml.txt.nlp	24688447	SENT200	3	3	36	36	indomethacin	COX	PA449982	1351	0.994
NULL	J_Cancer_2011_Mar_8_2_142-152.nxml.txt.nlp	21475719	SENT144	9	9	0	0	capecitabine	TYMS	PA448771	7298	0.994
NULL	Breast_Cancer_Res_2013_Oct_3_15(5)_R93.nxml.txt.nlp	24088226	SENT134	21	21	4	4	tamoxifen	CYP2D6	PA451581	1565	0.994
NULL	J_Hepatol_2010_Dec_53(6)_1101-1107.nxml.txt.nlp	20801540	SENT150	39	39	9	9	deferasirox	ACP	PA164760843	4706	0.994
NULL	Drug_Target_Insights_2006_Oct_23_1_5-10.nxml.txt.nlp	21901053	SENT123	7	7	19	19	dalteparin	INCA	PA165958404	440068	0.994
NULL	Cancer_Imaging_2008_Nov_25_8(1)_199-205.nxml.txt.nlp	19028612	SENT88	8	8	24	24	cetuximab	EGFR	PA10040	1956	0.994
NULL	Diabetes_Care_2009_Sep_29_32(9)_1620-1625.nxml.txt.nlp	19564453	SENT157	4	4	11	11	metformin	AMPK	PA450395	5563	0.994
NULL	Cell_Death_Differ_2010_Oct_30_17(10)_1624-1635.nxml.txt.nlp	20431602	SENT41	25	25	1	1	paclitaxel	Bcl-2	PA450761	596	0.994
NULL	Nucl_Recept_Signal_2006_Jul_7_4_e013.nxml.txt.nlp	16862219	SENT31	40	40	12	12	tamoxifen	PI3K	PA451581	5290	0.994
NULL	BMB_Rep_2014_Nov_47(11)_649-654.nxml.txt.nlp	25301019	SENT107	23	23	15	15	l-alanine	STAT3	PA448055	6774	0.994
NULL	Ann_Hematol_2010_Sep_13_89(9)_861-871.nxml.txt.nlp	20387067	SENT208	4	4	13	13	dasatinib	GM-CSF	PA162372878	1437	0.994
NULL	Cancer_Res_Treat_2014_Jan_15_46(1)_55-64.nxml.txt.nlp	24520224	SENT145	15	15	9	9	oxaliplatin	TRAP1	PA131285527	9392;10131	0.994
NULL	Clin_Med_Oncol_2008_Jun_11_2_469-470.nxml.txt.nlp	21892319	SENT22	38	38	8	8	paclitaxel	HER2	PA450761	2064	0.994
NULL	Cancers_(Basel)_2013_Mar_11_5(1)_255-280.nxml.txt.nlp	24216707	SENT111	0	0	34	34	genistein	CYP27B1	PA165109660	1594	0.994
NULL	Mol_Cancer_2012_Jun_18_11_41.nxml.txt.nlp	22709873	SENT306	13	13	5	5	lapatinib	CDKN1B	PA152241907	1027	0.994
NULL	J_Invest_Dermatol_2013_Jul_13_133(7)_1742-1751.nxml.txt.nlp	23407402	SENT78	14	14	1	1	etanercept	TREM-1	PA449515	54210	0.994
NULL	Curr_Immunol_Rev_2013_Nov_9(4)_214-221.nxml.txt.nlp	24876829	SENT94	9	9	34	34	papain	IL-6	PA450778	3569	0.994
NULL	Nat_Commun_2013_Apr_23_4_1772.nxml.txt.nlp	23612313	SENT90	11	11	0	0	cyclophosphamide	CD11b	PA449165	3684	0.994
NULL	Breast_Cancer_Res_2014_Jul_24_16(4)_411.nxml.txt.nlp	25056669	SENT191	28	28	6	6	tamoxifen	CD49f	PA451581	3655	0.994
NULL	J_Med_Case_Reports_2011_Dec_21_5_593.nxml.txt.nlp	22188652	SENT52	3	3	26	26	gefitinib	CYP1A2	PA131301952	1544	0.994
NULL	Oncotarget_2011_Dec_22_2(12)_1176-1190.nxml.txt.nlp	22202492	SENT119	6	6	16	16	lovastatin	PLA2G7	PA450272	7941	0.994
NULL	J_Biomed_Biotechnol_2011_Jul_6_2011_783528.nxml.txt.nlp	21785566	SENT150	3	3	9	9	ritonavir	P-gp	PA451260	5243	0.994
NULL	Exp_Mol_Med_2012_Sep_30_44(9)_536-544.nxml.txt.nlp	22771771	SENT28	4	4	28	28	ns-398	COX		1351	0.994
NULL	Int_J_Mol_Sci_2014_May_12_15(5)_8335-8351.nxml.txt.nlp	24823879	SENT131	19	19	6	6	bevacizumab	CD133	PA130232992	8842	0.994
NULL	J_Vet_Med_Sci_2014_Mar_1_76(3)_323-330.nxml.txt.nlp	24189582	SENT25	3	3	38	38	atovaquone	DHODH	PA448502	1723	0.994
NULL	Br_J_Cancer_2011_Jul_12_105(2)_221-230.nxml.txt.nlp	21750559	SENT37	24	24	6	6	fludarabine	Bcl-2	PA449655	596	0.994
NULL	Cancers_(Basel)_2011_Apr_13_3(2)_1957-1974.nxml.txt.nlp	24212791	SENT150	5	5	35	35	cetuximab	KRAS	PA10040	3845	0.994
NULL	Biomed_Res_Int_2014_Mar_6_2014_757461.nxml.txt.nlp	24734243	SENT91	12	12	31	31	estradiol	MCH	PA449503	5367	0.994
NULL	Eur_Heart_J_2014_Aug_14_35(31)_2083-2093.nxml.txt.nlp	24727884	SENT21	21	21	28	28	ticagrelor	P2Y12	PA165374673	64805	0.994
NULL	Biomed_Res_Int_2014_Jan_29_2014_361020.nxml.txt.nlp	24605326	SENT166	0	0	27	27	celecoxib	CCND1	PA448871	595	0.994
NULL	J_Immunother_Cancer_2013_May_29_1_4.nxml.txt.nlp	NULL	SENT286	16	16	5	5	cetuximab	FOXP3	PA10040	50943	0.994
NULL	Front_Neurol_2011_Dec_16_2_72.nxml.txt.nlp	22203815	SENT49	10	10	6	6	protamine	VSOP	PA10366	84329	0.994
NULL	Mol_Cancer_2009_Dec_23_8_129.nxml.txt.nlp	20030852	SENT163	25	25	0	0	curcumin	ABCA1	PA151958596	19	0.994
NULL	Exp_Ther_Med_2013_Oct_20_6(4)_899-903.nxml.txt.nlp	24137286	SENT94	44	44	5	5	rosuvastatin	MMP2	PA134308647	4313	0.994
NULL	Oxid_Med_Cell_Longev_2013_Nov_10_2013_680414.nxml.txt.nlp	24319532	SENT170	2	2	7	7	minocycline	PARP-1	PA450519	25976	0.994
NULL	Nat_Med_2013_Nov_27_19(11)_10_1038_nm_3352.nxml.txt.nlp	24162815	SENT55	5	5	20	20	crizotinib	TRKA	PA165946122	4914	0.994
NULL	J_RNAi_Gene_Silencing_2009_Mar_9_5(1)_321-330.nxml.txt.nlp	19771229	SENT23	39	39	0	0	gemcitabine	RRM1	PA449748	6240	0.994
NULL	Breast_Cancer_Res_2000_Mar_12_2(Suppl_1)_P8_05.nxml.txt.nlp	NULL	SENT5	22	22	3	3	melphalan	GSTP1	PA450354	2950	0.994
NULL	Mol_Cancer_2013_Oct_8_12_119.nxml.txt.nlp	24103454	SENT188	16	16	21	21	nutlin-3	p53		7157	0.994
NULL	Chem_Rev_2011_Oct_12_111(10)_5899-5921.nxml.txt.nlp	21923193	SENT139	16	16	1	1	aspirin	COX	PA448497	1351	0.994
NULL	J_Cell_Mol_Med_2014_May_14_18(5)_811-823.nxml.txt.nlp	24628949	SENT256	39	39	11	11	docetaxel	FOXM1	PA449383	2305	0.994
NULL	Cell_Biochem_Biophys_2013_May_24_66(1)_53-63.nxml.txt.nlp	22918821	SENT270	4	4	21	21	lubiprostone	ClC-2	PA164777012	1181	0.994
NULL	Breast_Cancer_Res_Treat_2012_Jul_8_134(2)_603-615.nxml.txt.nlp	22678159	SENT287	0	0	6	6	phenytoin	HERG	PA450947	3757	0.994
NULL	Biomed_Res_Int_2013_Dec_23_2013_186563.nxml.txt.nlp	24455677	SENT30	0	0	8	8	vemurafenib	BRAF	PA165946873	673	0.994
NULL	Cell_Death_Dis_2010_Feb_4_1(2)_e23.nxml.txt.nlp	21364631	SENT56	19	19	3	3	desipramine	c-Jun	PA449233	3725	0.994
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT119	14	14	44	44	dasatinib	ABCG2	PA162372878	9429	0.994
NULL	Sensors_(Basel)_2012_Dec_3_12(12)_16614-16627.nxml.txt.nlp	23208557	SENT155	21	21	0	0	panitumumab	KRAS	PA162373091	3845	0.994
NULL	J_Immunol_Res_2014_May_12_2014_897249.nxml.txt.nlp	24901013	SENT31	19	19	10	10	natalizumab	miR-17-92	PA164747191	407975	0.994
NULL	Open_Med_Chem_J_2010_May_27_4_20-36.nxml.txt.nlp	21160908	SENT75	38	38	11	11	ketamine	mGlu5	PA450144	2915	0.994
NULL	Pharmaceuticals_(Basel)_2012_Aug_10_5(8)_802-836.nxml.txt.nlp	24280676	SENT247	35	35	7	7	omeprazole	PCFT	PA450704	113235	0.994
NULL	Clin_Sci_(Lond)_2009_Apr_1_116(Pt_8)_607-620.nxml.txt.nlp	19275766	SENT202	3	3	9	9	pioglitazone	AMPK	PA450970	5563	0.994
NULL	Case_Rep_Oncol_Med_2013_Sep_26_2013_234391.nxml.txt.nlp	24191208	SENT11	0	0	14	14	trastuzumab	HER2	PA451743	2064	0.994
NULL	J_Immunother_Cancer_2013_Nov_7_1(Suppl_1)_P175.nxml.txt.nlp	NULL	SENT7	3	3	20	20	cetuximab	EGFR	PA10040	1956	0.994
NULL	Acta_Pharmacol_Sin_2009_May_5_30(5)_646-652.nxml.txt.nlp	19417737	SENT59	42	42	4	4	midazolam	CYP3A4	PA450496	1576	0.994
NULL	J_Oncol_2013_Apr_29_2013_854121.nxml.txt.nlp	23737784	SENT9	9	9	1	1	trastuzumab	HER2	PA451743	2064	0.994
NULL	Infect_Drug_Resist_2011_Feb_22_4_65-76.nxml.txt.nlp	21694910	SENT90	45	45	27	27	raltegravir	N155		9631	0.994
NULL	Diabetes_2013_May_16_62(5)_1689-1696.nxml.txt.nlp	23274908	SENT40	11	11	25	25	diazoxide	GCK	PA449285	5871;2645	0.994
NULL	Mol_Cancer_2006_Oct_17_5_45.nxml.txt.nlp	17044934	SENT55	0	0	21	21	resveratrol	AKT		207	0.994
NULL	Cancer_Immunol_Immunother_2011_Jun_24_60(6)_771-780.nxml.txt.nlp	21347809	SENT231	4	4	17	17	rituximab	p38	PA451261	10598;1432;7965	0.994
NULL	J_Korean_Med_Sci_2006_Feb_20_21(1)_52-57.nxml.txt.nlp	16479065	SENT16	4	4	27	27	capecitabine	LARC	PA448771	6364	0.994
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT120	36	36	7	7	pp2	PP2		4888	0.994
NULL	Oncol_Rep_2013_Oct_22_30(4)_1535-1541.nxml.txt.nlp	23877481	SENT42	0	0	28	28	gefitinib	EGFR	PA131301952	1956	0.994
NULL	Cell_Death_Dis_2014_Apr_24_5(4)_e1197.nxml.txt.nlp	24763054	SENT89	18	18	0	0	cisplatin	RUNX3	PA449014	864	0.994
NULL	Mol_Cancer_2013_Sep_11_12_104.nxml.txt.nlp	24025152	SENT95	2	2	14	14	gemcitabine	EGFR	PA449748	1956	0.994
NULL	J_Exp_Med_1996_Jul_1_184(1)_41-50.nxml.txt.nlp	8691148	SENT4	22	22	4	4	heparin	CD31	PA449855	5175	0.994
NULL	Breast_Cancer_Res_2007_Dec_20_9(Suppl_2)_S17.nxml.txt.nlp	NULL	SENT37	34	34	15	15	trastuzumab	HER2	PA451743	2064	0.994
NULL	Cancers_(Basel)_2014_Mar_13_6(1)_595-624.nxml.txt.nlp	24633084	SENT222	43	43	22	22	trastuzumab	HER2	PA451743	2064	0.994
NULL	Mol_Cells_2014_Jun_30_37(6)_441-448.nxml.txt.nlp	24850149	SENT156	3	3	17	17	amitriptyline	IL-18	PA448385	3606	0.994
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT273	11	11	3	3	vincristine	ABCC1	PA451879	4363	0.994
NULL	Br_J_Pharmacol_2011_Feb_162(4)_989-999.nxml.txt.nlp	21054342	SENT222	3	3	10	10	ketoconazole	CYP2C8	PA450146	1558	0.994
NULL	J_Biol_Chem_2008_Jun_20_283(25)_17194-17204.nxml.txt.nlp	18442977	SENT169	3	3	9	9	fluoxetine	5-HT1A	PA449673	3350	0.994
NULL	Int_J_Nanomedicine_2010_Aug_9_5_385-399.nxml.txt.nlp	20957160	SENT155	0	0	26	26	dextran	VSOP	PA449261	84329	0.994
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT43	25	25	8	8	chloroquine	BMPR-II	PA448948	659	0.994
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1717-1723.nxml.txt.nlp	19844230	SENT125	0	0	17	17	sunitinib	GM-CSF	PA162372840	1437	0.994
NULL	J_Thromb_Haemost_2014_May_22_12(5)_748-760.nxml.txt.nlp	24612393	SENT19	16	16	24	24	thrombin	TSC2	PA451674	7249	0.994
NULL	Oncotarget_2012_Jan_28_3(1)_78-83.nxml.txt.nlp	22289679	SENT43	10	10	38	38	paclitaxel	PLK2	PA450761	10769	0.994
NULL	Diabetes_Care_2009_Nov_32(Suppl_2)_S223-S231.nxml.txt.nlp	19875556	SENT85	35	35	0	0	exenatide	GLP-1	PA164749238	100125288	0.994
NULL	Clin_Interv_Aging_2008_Sep_3(3)_431-444.nxml.txt.nlp	18982914	SENT53	16	16	0	0	bleomycin	WRN	PA448645	7486	0.994
NULL	Br_J_Cancer_2012_Nov_20_107(11)_1853-1863.nxml.txt.nlp	23169338	SENT148	45	45	27	27	cisplatin	BRCA1	PA449014	672	0.994
NULL	J_Biol_Chem_2010_Aug_20_285(34)_25928-25940.nxml.txt.nlp	20547488	SENT26	17	17	1	1	cisplatin	JNK	PA449014	5599	0.994
NULL	J_Hematol_Oncol_2013_Jan_15_6_5.nxml.txt.nlp	23320987	SENT116	25	25	40	40	heparin	PI-PLC	PA449855	2923	0.994
NULL	J_Asthma_Allergy_2008_Sep_7_1_11-18.nxml.txt.nlp	21436981	SENT95	9	9	25	25	ciclesonide	CYP3A4	PA164781399	1576	0.994
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT132	41	41	1	1	cisplatin	IBP	PA449014	706;50619	0.994
NULL	Pharmaceuticals_(Basel)_2012_Aug_30_5(9)_890-898.nxml.txt.nlp	24280696	SENT70	34	34	6	6	cisplatin	Hsp90	PA449014	3320	0.994
NULL	Int_J_Fertil_Steril_2013_Mar_6_Apr-Jun_7(1)_7-12.nxml.txt.nlp	24520457	SENT47	0	0	6	6	celecoxib	IL6	PA448871	3569	0.994
NULL	Cancers_(Basel)_2011_Oct_26_3(4)_4024-4045.nxml.txt.nlp	24213123	SENT160	2	2	32	32	resveratrol	SP1		6667	0.994
NULL	Korean_J_Anesthesiol_2013_Feb_15_64(2)_105-111.nxml.txt.nlp	23459312	SENT55	4	4	9	9	heparin	ACT	PA449855	12;11332;9457;641455	0.994
NULL	Clin_Epigenetics_2011_Jul_16_2(2)_411-416.nxml.txt.nlp	22704352	SENT79	2	2	24	24	decitabine	CD4	PA164749631	920	0.994
NULL	Curr_Immunol_Rev_2013_Nov_9(4)_214-221.nxml.txt.nlp	24876829	SENT94	9	9	37	37	papain	IL-13	PA450778	3596	0.994
NULL	Front_Immunol_2013_Nov_7_4_360.nxml.txt.nlp	24223576	SENT164	0	0	11	11	imiquimod	TLR7	PA449972	51284	0.994
NULL	Diabetes_Care_2009_Jan_32(1)_14-18.nxml.txt.nlp	18931099	SENT27	16	16	42	42	exenatide	GLP-1	PA164749238	100125288	0.994
NULL	Diabetes_Care_2010_Nov_33(11)_2399-2405.nxml.txt.nlp	20980427	SENT38	0	0	18	18	ranibizumab	VEGF-A	PA164746012	7422	0.994
NULL	Nucleic_Acids_Res_2007_Jul_18_35(13)_4313-4321.nxml.txt.nlp	17576692	SENT69	40	40	7	7	phenol	APE	PA450913	55704;328	0.994
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT210	0	0	9	9	omeprazole	CYP2C19	PA450704	1557	0.994
NULL	Mol_Cancer_2013_Sep_11_12_104.nxml.txt.nlp	24025152	SENT193	2	2	21	21	gemcitabine	EGFR	PA449748	1956	0.994
NULL	Oncotarget_2011_Dec_24_2(12)_896-917.nxml.txt.nlp	22203527	SENT156	4	4	17	17	metformin	p53	PA450395	7157	0.994
NULL	J_Oncol_2012_Mar_26_2012_986725.nxml.txt.nlp	22545054	SENT18	21	21	6	6	lapatinib	EGFR	PA152241907	1956	0.994
NULL	Oncotarget_2011_Mar_10_2(3)_186-196.nxml.txt.nlp	21406729	SENT171	10	10	23	23	orlistat	TRAIL	PA164776864	8743	0.994
NULL	Biomed_Res_Int_2014_Apr_10_2014_237437.nxml.txt.nlp	24818133	SENT125	8	8	42	42	flumazenil	SOD1	PA449659	6647	0.994
NULL	Eur_J_Nucl_Med_Mol_Imaging_2005_Feb_4_32(2)_153-162.nxml.txt.nlp	15690223	SENT37	40	40	12	12	imatinib	FDG	PA10804	23583	0.994
NULL	Diabetes_Care_2013_Feb_17_36(2)_422-428.nxml.txt.nlp	23033246	SENT95	3	3	35	35	simvastatin	PPL	PA451363	5493	0.994
NULL	Indian_J_Med_Res_2011_Sep_134(3)_253-255.nxml.txt.nlp	21985806	SENT27	0	0	9	9	phenytoin	P-gp	PA450947	5243	0.994
NULL	Oncotarget_2011_May_14_2(5)_407-417.nxml.txt.nlp	21576760	SENT2	21	21	0	0	geldanamycin	Hsp90	PA152031327	3320	0.994
NULL	Biomed_Res_Int_2013_Feb_28_2013_749078.nxml.txt.nlp	23555095	SENT107	4	4	14	14	chymotrypsin	CD4	PA448994	920	0.994
NULL	Clin_Interv_Aging_2012_Sep_3_7_331-338.nxml.txt.nlp	22977302	SENT2	0	0	14	14	denosumab	RANK	PA166048634	8792	0.994
NULL	J_Hepatol_2008_Dec_49(6-2)_908-915.nxml.txt.nlp	18845353	SENT149	23	23	39	39	amantadine	p13	PA448360	51013	0.994
NULL	Cardiovasc_Res_2011_Sep_1_91(4)_694-702.nxml.txt.nlp	21606183	SENT135	6	6	18	18	forskolin	AC3	PA146096022	109	0.994
NULL	Ann_Indian_Acad_Neurol_2014_Jan-Mar_17(1)_58-61.nxml.txt.nlp	24753661	SENT70	2	2	27	27	iron	SWI	PA450087	6594	0.994
NULL	Mol_Cytogenet_2010_Sep_15_3_17.nxml.txt.nlp	20840797	SENT187	13	13	2	2	nicotine	FISH	PA450626	9644	0.994
NULL	Diabetes_Metab_J_2014_Aug_20_38(4)_245-251.nxml.txt.nlp	25215270	SENT66	24	24	3	3	metformin	FGF21	PA450395	26291	0.994
NULL	Diabetes_Care_2011_Jul_17_34(7)_e115-e120.nxml.txt.nlp	21709286	SENT111	36	36	1	1	metformin	AMPK	PA450395	5563	0.994
NULL	Cancers_(Basel)_2010_May_28_2(2)_1027-1039.nxml.txt.nlp	24281105	SENT49	16	16	1	1	bevacizumab	ICAM1	PA130232992	3383	0.994
NULL	Oncol_Lett_2013_Jun_29_5(6)_1943-1947.nxml.txt.nlp	23833672	SENT41	12	12	2	2	celecoxib	AKT	PA448871	207	0.994
NULL	Pharmaceuticals_(Basel)_2013_Aug_21_6(8)_988-1038.nxml.txt.nlp	24276379	SENT2699	7	7	1	1	panitumumab	BRAF	PA162373091	673	0.994
NULL	Cell_Res_2012_Aug_22_22(8)_1227-1245.nxml.txt.nlp	22613949	SENT110	38	38	12	12	doxorubicin	KRAS	PA449412	3845	0.994
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_297-299.nxml.txt.nlp	20049732	SENT56	10	10	25	25	methotrexate	MSH2	PA450428	4436	0.994
NULL	Mol_Cancer_2014_Jan_13_13_7.nxml.txt.nlp	24418169	SENT41	26	26	13	13	sorafenib	STAT3	PA7000	6774	0.994
NULL	Breast_Cancer_Res_2012_Nov_5_14(6)_R143.nxml.txt.nlp	23127292	SENT169	24	24	4	4	tamoxifen	p53	PA451581	7157	0.994
NULL	Front_Comput_Neurosci_2014_Oct_17_8_133.nxml.txt.nlp	25368573	SENT172	4	4	22	22	ketamine	gamma	PA450144	9913	0.994
NULL	Exp_Mol_Med_2013_Aug_16_45(8)_e36.nxml.txt.nlp	23949442	SENT38	21	21	10	10	doxycycline	LRRK2	PA449415	120892	0.994
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT256	37	37	11	11	lapatinib	HRG	PA152241907	3084;3273	0.994
NULL	Environ_Health_Perspect_2008_Feb_8_116(2)_149-157.nxml.txt.nlp	18288311	SENT191	15	15	2	2	estradiol	DES	PA449503	1674	0.994
NULL	Cancer_Res_Treat_2012_Mar_31_44(1)_1-10.nxml.txt.nlp	22500155	SENT97	0	0	12	12	erlotinib	EGFR	PA134687924	1956	0.994
NULL	BMB_Rep_2013_Apr_46(4)_181-187.nxml.txt.nlp	23615258	SENT158	0	0	19	19	metformin	AMPK	PA450395	5563	0.994
NULL	Front_Oncol_2014_Aug_11_4_204.nxml.txt.nlp	25157335	SENT247	36	36	14	14	gefitinib	EGF	PA131301952	1950	0.994
NULL	Mol_Cell_Proteomics_2012_Feb_6_11(2)_M111_015222.nxml.txt.nlp	22147731	SENT335	24	24	7	7	cetuximab	CLDN4	PA10040	1364	0.994
NULL	Br_J_Cancer_2009_Sep_15_101(6)_998-1004.nxml.txt.nlp	19672255	SENT119	26	26	2	2	oxaliplatin	XRCC1	PA131285527	7515	0.994
NULL	Contemp_Oncol_(Pozn)_2012_Jul_6_16(3)_197-200.nxml.txt.nlp	23788878	SENT83	7	7	35	35	temsirolimus	BRAF	PA164746890	673	0.994
NULL	J_Biol_Chem_2009_Sep_18_284(38)_26096-26105.nxml.txt.nlp	19628870	SENT193	15	15	23	23	pp2	IL-2		3558	0.994
NULL	CNS_Drugs_2012_Dec_13_26(12)_1033-1049.nxml.txt.nlp	23192413	SENT46	0	0	32	32	trazodone	5-HT2A	PA451744	3356	0.994
NULL	Mol_Cancer_2014_Jun_19_13_154.nxml.txt.nlp	24941944	SENT190	12	12	1	1	methotrexate	IMPDH2	PA450428	3615	0.994
NULL	J_Geriatr_Cardiol_2013_Jun_10(2)_151-158.nxml.txt.nlp	23888175	SENT165	23	23	13	13	rosuvastatin	ACE2	PA134308647	59272	0.994
NULL	Leukemia_2014_Apr_8_28(4)_894-903.nxml.txt.nlp	23925045	SENT157	0	0	15	15	tamoxifen	ESR1	PA451581	2099	0.994
NULL	J_Biol_Chem_2012_Apr_27_287(18)_14644-14658.nxml.txt.nlp	22375002	SENT81	23	23	33	33	neomycin	CC2D1A	PA450608	54862	0.994
NULL	J_Exp_Med_1998_Jun_1_187(11)_1885-1892.nxml.txt.nlp	9607928	SENT72	27	27	4	4	thalidomide	CD4	PA451644	920	0.994
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1224-1233.nxml.txt.nlp	22353810	SENT67	20	20	3	3	verapamil	MRP-1	PA451868	928	0.994
NULL	Br_J_Clin_Pharmacol_2011_Oct_72(4)_647-657.nxml.txt.nlp	21518389	SENT135	0	0	23	23	cangrelor	P2Y12	PA165945763	64805	0.994
NULL	Open_Med_2007_Dec_18_1(3)_e184-e190.nxml.txt.nlp	21673951	SENT80	20	20	39	39	tamoxifen	BRCA1	PA451581	672	0.994
NULL	Oncoimmunology_2014_May_29_3_e28925.nxml.txt.nlp	25083322	SENT40	34	34	5	5	imatinib	CD4	PA10804	920	0.994
NULL	Oncogene_2009_Aug_27_28(34)_3022-3032.nxml.txt.nlp	19543317	SENT160	44	44	1	1	etoposide	XIAP	PA449552	331	0.994
NULL	Indian_Dermatol_Online_J_2014_Jan-Mar_5(1)_7-13.nxml.txt.nlp	24616847	SENT178	3	3	12	12	methotrexate	CLE	PA450428	51637	0.994
NULL	Drugs_R_D_2013_Jun_5_13(2)_153-157.nxml.txt.nlp	23737454	SENT30	5	5	34	34	prasugrel	P2Y12	PA154410481	64805	0.994
NULL	Acta_Pharmacol_Sin_2009_Sep_24_30(9)_1330-1336.nxml.txt.nlp	19701234	SENT21	5	5	9	9	ilaprazole	CYP3A5	PA165947499	1577	0.994
NULL	J_Geriatr_Cardiol_2013_Jun_10(2)_151-158.nxml.txt.nlp	23888175	SENT157	24	24	14	14	rosuvastatin	ACE2	PA134308647	59272	0.994
NULL	J_RNAi_Gene_Silencing_2009_Mar_9_5(1)_321-330.nxml.txt.nlp	19771229	SENT26	36	36	4	4	hydroxyurea	RRM2	PA449942	6241	0.994
NULL	Nucleic_Acids_Res_2012_Jun_22_40(11)_4861-4878.nxml.txt.nlp	22362753	SENT254	21	21	6	6	trypsin	NPM3	PA451806	10360	0.994
NULL	Arch_Med_Sci_2013_Oct_31_9(5)_916-921.nxml.txt.nlp	24273579	SENT89	33	33	7	7	bleomycin	AQP5	PA448645	362	0.994
NULL	Balkan_J_Med_Genet_2011_Jun_25_14(1)_25-30.nxml.txt.nlp	24052699	SENT82	6	6	22	22	levetiracetam	MRP1	PA450206	4437	0.994
NULL	Int_J_Mol_Imaging_2011_Oct_26_2011_874585.nxml.txt.nlp	21490735	SENT149	46	46	11	11	docetaxel	FDG	PA449383	23583	0.994
NULL	Cell_Commun_Signal_2009_Feb_26_7(Suppl_1)_A20.nxml.txt.nlp	NULL	SENT10	44	44	14	14	arsenite	Bcl-2	PA452638	596	0.994
NULL	Braz_J_Med_Biol_Res_2014_Sep_5_47(11)_929-939.nxml.txt.nlp	25296354	SENT94	5	5	26	26	afatinib	EGFR	PA165981154	1956	0.994
NULL	Oncotarget_2014_Jun_3_5(13)_4920-4928.nxml.txt.nlp	24952482	SENT22	4	4	37	37	geldanamycin	Hsp90	PA152031327	3320	0.994
NULL	J_Oncol_2012_Feb_15_2012_168303.nxml.txt.nlp	22481917	SENT76	22	22	13	13	gemcitabine	NET	PA449748	2004;6530	0.994
NULL	Br_J_Pharmacol_2011_Apr_162(8)_1832-1842.nxml.txt.nlp	21232033	SENT162	8	8	22	22	resveratrol	SAP97		1739	0.994
NULL	Indian_J_Med_Res_2014_Feb_139(2)_205-215.nxml.txt.nlp	24718394	SENT105	15	15	37	37	arteether	ACT	PA165260403	12;11332;9457;641455	0.994
NULL	Biologics_2009_Jul_13_3_77-97.nxml.txt.nlp	19707398	SENT361	0	0	23	23	daclizumab	IL-2	PA164764446	3558	0.994
NULL	Clin_Pharmacol_2013_Dec_9_5_185-192.nxml.txt.nlp	24353446	SENT75	43	43	14	14	clopidogrel	CYP3A4	PA449053	1576	0.994
NULL	Arthritis_Res_2000_Dec_22_2(1)_65-74.nxml.txt.nlp	11219391	SENT188	4	4	44	44	heparin	IL-15	PA449855	3600	0.994
NULL	Oxid_Med_Cell_Longev_2013_Nov_28_2013_568093.nxml.txt.nlp	24379901	SENT50	1	1	21	21	resveratrol	SIRT1		23411	0.994
NULL	Front_Oncol_2014_Aug_11_4_204.nxml.txt.nlp	25157335	SENT125	41	41	9	9	crizotinib	EGFR	PA165946122	1956	0.994
NULL	Drugs_R_D_2014_Dec_30_14(4)_241-251.nxml.txt.nlp	25265895	SENT223	0	0	40	40	propranolol	CYP3A4	PA451145	1576	0.994
NULL	Onco_Targets_Ther_2014_Dec_4_7_2249-2255.nxml.txt.nlp	25587220	SENT55	22	22	41	41	verapamil	MRP1	PA451868	4437	0.994
NULL	EMBO_Mol_Med_2012_Aug_16_4(8)_743-760.nxml.txt.nlp	22593025	SENT197	3	3	22	22	paclitaxel	DIAPH3	PA450761	81624	0.994
NULL	J_Gynecol_Oncol_2014_Apr_9_25(2)_130-135.nxml.txt.nlp	24761217	SENT120	17	17	9	9	cyclosporine	P-gp	PA449167	5243	0.994
NULL	Breast_Cancer_Res_2011_Dec_8_13(6)_R126.nxml.txt.nlp	22151962	SENT235	0	0	16	16	cyclophosphamide	TRAIL	PA449165	8743	0.994
NULL	Front_Oncol_2014_May_7_4_95.nxml.txt.nlp	24847444	SENT307	10	10	2	2	vincristine	CD133	PA451879	8842	0.994
NULL	Int_J_Breast_Cancer_2011_Sep_6_2011_352182.nxml.txt.nlp	22295219	SENT43	6	6	17	17	trastuzumab	HER2	PA451743	2064	0.994
NULL	Clin_Pharmacol_2013_Jul_4_5_117-129.nxml.txt.nlp	23861604	SENT138	18	18	1	1	denosumab	RANKL	PA166048634	8600	0.994
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Jul_9_3(7)_e124.nxml.txt.nlp	25006781	SENT50	0	0	24	24	rosuvastatin	OATP1B1	PA134308647	10599	0.994
NULL	Stroke_Res_Treat_2011_Jun_22_2011_607852.nxml.txt.nlp	21822469	SENT448	3	3	37	37	rivaroxaban	TKR	PA165958360	8277	0.994
NULL	Cancer_Cell_Int_2010_Jan_21_10_2.nxml.txt.nlp	20142997	SENT199	41	41	18	18	doxorubicin	CDH1	PA449412	51343;999	0.994
NULL	Clin_Med_Insights_Ear_Nose_Throat_2012_Apr_3_5_1-16.nxml.txt.nlp	24179404	SENT42	0	0	43	43	cetuximab	EGFR	PA10040	1956	0.994
NULL	Clin_Interv_Aging_2010_May_25_5_149-156.nxml.txt.nlp	20517484	SENT133	0	0	13	13	rasagiline	CYP1A2	PA164764584	1544	0.994
NULL	Cell_Res_2012_Aug_22_22(8)_1227-1245.nxml.txt.nlp	22613949	SENT217	3	3	26	26	bortezomib	NRAS	PA10252	4893	0.994
NULL	Mol_Cancer_2010_Mar_25_9_68.nxml.txt.nlp	20338046	SENT95	26	26	19	19	doxorubicin	ABCB1	PA449412	5243	0.994
NULL	Angiogenesis_2010_Mar_11_13(1)_1-14.nxml.txt.nlp	20012482	SENT274	17	17	4	4	sunitinib	KIT	PA162372840	3815	0.994
NULL	Br_J_Cancer_2014_Jan_21_110(2)_510-519.nxml.txt.nlp	24327015	SENT37	22	22	0	0	doxorubicin	CHEK1	PA449412	1111	0.994
NULL	J_Biol_Chem_2013_Nov_22_288(47)_34217-34229.nxml.txt.nlp	24106270	SENT15	24	24	5	5	thrombin	RhoG	PA451674	391	0.994
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1126-1134.nxml.txt.nlp	21364592	SENT132	39	39	9	9	capecitabine	CYP2A6	PA448771	1548	0.994
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT165	21	21	6	6	doxorubicin	ABCB1	PA449412	5243	0.994
NULL	Cardiovasc_Diabetol_2013_May_4_12_73.nxml.txt.nlp	23642288	SENT13	10	10	20	20	acarbose	GLP-1	PA448010	100125288	0.994
NULL	Breast_Cancer_(Auckl)_2009_Sep_2_3_61-75.nxml.txt.nlp	19809577	SENT86	5	5	16	16	resveratrol	BRCA1		672	0.994
NULL	Hum_Genomics_Proteomics_2010_Aug_3_2010_159761.nxml.txt.nlp	20981231	SENT245	16	16	5	5	lithium	IMPA1	PA450243	3612	0.994
NULL	Acta_Pharmacol_Sin_2011_Jun_32(6)_758-764.nxml.txt.nlp	21642947	SENT89	18	18	24	24	fluphenazine	TREK-1	PA449676	3776	0.994
NULL	Brief_Bioinform_2013_Jul_9_14(4)_491-505.nxml.txt.nlp	22877768	SENT112	23	23	3	3	warfarin	CYP2C9	PA451906	1559	0.994
NULL	Oncol_Rep_2014_Apr_28_31(4)_1605-1612.nxml.txt.nlp	24481648	SENT141	29	29	8	8	paclitaxel	MRP7	PA450761	89845;1080	0.994
NULL	Nat_Med_2014_Jun_18_20(6)_624-632.nxml.txt.nlp	24836577	SENT377	12	12	34	34	isoproterenol	ANOVA	PA450121	4858	0.994
NULL	Clin_Transl_Allergy_2013_Sep_2_3_29.nxml.txt.nlp	24004581	SENT141	3	3	19	19	omalizumab	IL-4	PA164752253	3565	0.994
NULL	Oncoscience_2014_Aug_7_1(8)_522-528.nxml.txt.nlp	25594059	SENT104	12	12	42	42	erlotinib	TTF-1	PA134687924	7080	0.994
NULL	Diabetes_2009_Feb_58(2)_352-359.nxml.txt.nlp	19011168	SENT21	0	0	16	16	exenatide	GLP-1	PA164749238	100125288	0.994
NULL	Acta_Pharmacol_Sin_2013_Jul_5_34(7)_870-879.nxml.txt.nlp	23624759	SENT95	15	15	32	32	cetuximab	EGFR	PA10040	1956	0.994
NULL	J_Cancer_Prev_2014_Sep_19(3)_153-160.nxml.txt.nlp	25337584	SENT90	4	4	22	22	betaine	AOM	PA448603	315	0.994
NULL	Eur_J_Med_Res_2009_Nov_24_14(Suppl_3)_43-46.nxml.txt.nlp	19959416	SENT13	5	5	31	31	raltegravir	CYP2D6		1565	0.994
NULL	Oncotarget_2013_Nov_19_5(1)_95-102.nxml.txt.nlp	24395633	SENT84	19	19	24	24	sirolimus	CD8A	PA451365	925	0.994
NULL	J_Hum_Genet_2012_Jul_24_57(7)_459-464.nxml.txt.nlp	22622361	SENT117	0	0	27	27	eculizumab	CFHR5	PA164776637	81494	0.994
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT80	15	15	37	37	metformin	AMPK	PA450395	5563	0.994
NULL	Mol_Cancer_2009_Jun_9_8_37.nxml.txt.nlp	19508729	SENT13	2	2	15	15	gemcitabine	HO-1	PA449748	3162	0.994
NULL	Br_J_Cancer_2010_Oct_12_103(8)_1192-1200.nxml.txt.nlp	20877358	SENT190	32	32	1	1	etoposide	BRCA2	PA449552	675	0.994
NULL	Br_J_Cancer_2004_Mar_5_90(Suppl_1)_S11-S14.nxml.txt.nlp	15094759	SENT17	4	4	10	10	fulvestrant	aromatase	PA164747170	1588	0.994
NULL	Clin_Med_Insights_Oncol_2012_Dec_6_6_407-421.nxml.txt.nlp	23239933	SENT48	8	8	30	30	gefitinib	KRAS	PA131301952	3845	0.994
NULL	Curr_Neuropharmacol_2010_Jun_8(2)_122-127.nxml.txt.nlp	21119883	SENT41	32	32	3	3	capsaicin	AQP1	PA448776	358	0.994
NULL	Acta_Pharmacol_Sin_2014_Jan_9_35(1)_1-10.nxml.txt.nlp	24317012	SENT45	11	11	0	0	methotrexate	SLC19A1	PA450428	6573	0.994
NULL	Ann_Hematol_2010_Nov_25_89(11)_1115-1124.nxml.txt.nlp	20499237	SENT148	9	9	37	37	simvastatin	CD38	PA451363	952	0.994
NULL	Cell_Death_Differ_2009_Aug_20_16(8)_1135-1145.nxml.txt.nlp	19300452	SENT81	22	22	3	3	chloroquine	PUMA	PA448948	27113	0.994
NULL	Ther_Clin_Risk_Manag_2006_Mar_2(1)_59-75.nxml.txt.nlp	18360582	SENT243	26	26	5	5	cisapride	CYP3A4	PA449011	1576	0.994
NULL	Mol_Cancer_2010_Jun_24_9_164.nxml.txt.nlp	20576107	SENT173	0	0	30	30	etoposide	p53	PA449552	7157	0.994
NULL	Ther_Clin_Risk_Manag_2007_Dec_3(6)_1077-1086.nxml.txt.nlp	18516259	SENT185	0	0	10	10	entecavir	LAM	PA164784025	7249;7248	0.994
NULL	Arthritis_Res_Ther_2011_Sep_30_13(5)_242.nxml.txt.nlp	21996023	SENT172	3	3	35	35	denosumab	RANKL	PA166048634	8600	0.994
NULL	Cancer_Sci_2012_Nov_17_103(11)_1907-1912.nxml.txt.nlp	22809142	SENT97	3	3	23	23	perifosine	PI3K	PA165291471	5290	0.994
NULL	Cancer_Immunol_Immunother_2011_Jan_21_60(1)_75-85.nxml.txt.nlp	20857100	SENT225	5	5	23	23	fludarabine	CD2	PA449655	914	0.994
NULL	J_Cardiothorac_Surg_2014_Sep_17_9(1)_129.nxml.txt.nlp	NULL	SENT105	26	26	0	0	heparin	ACT	PA449855	12;11332;9457;641455	0.994
NULL	Mol_Cancer_2009_Nov_24_8_109.nxml.txt.nlp	19930708	SENT179	46	46	4	4	exemestane	aromatase	PA449563	1588	0.994
NULL	Ann_Hematol_2010_Nov_25_89(11)_1115-1124.nxml.txt.nlp	20499237	SENT148	9	9	28	28	simvastatin	ZAP-70	PA451363	7535	0.994
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Jul_21_9_20.nxml.txt.nlp	20663145	SENT78	31	31	7	7	ciprofloxacin	LBH	PA449009	81606;221491	0.994
NULL	Drug_Des_Devel_Ther_2014_Dec_1_8_2391-2400.nxml.txt.nlp	25489237	SENT118	0	0	29	29	naloxone	GLP-1	PA450586	100125288	0.994
NULL	Diabetes_Metab_J_2013_Oct_17_37(5)_315-325.nxml.txt.nlp	24199159	SENT183	0	0	23	23	resveratrol	SIRT1		23411	0.994
NULL	Mol_Cancer_2012_Sep_21_11_72.nxml.txt.nlp	22995644	SENT50	19	19	6	6	imatinib	PRL-3	PA10804	11156	0.994
NULL	F1000Res_2014_Aug_19_3_198.nxml.txt.nlp	25400908	SENT189	26	26	2	2	trastuzumab	HER2	PA451743	2064	0.994
NULL	eLife_2013_Nov_5_2_e00969.nxml.txt.nlp	24192036	SENT214	0	0	15	15	vemurafenib	MKK4	PA165946873	6416	0.994
NULL	Cancer_Biol_Med_2012_Mar_9(1)_18-22.nxml.txt.nlp	23691449	SENT78	17	17	8	8	gefitinib	KRAS	PA131301952	3845	0.994
NULL	Anal_Biochem_2014_Jun_1_454(100)_17-22.nxml.txt.nlp	24637157	SENT39	33	33	11	11	camptothecin	TDP1	PA153590860	55775	0.994
NULL	Cancer_Res_Treat_2012_Sep_30_44(3)_195-201.nxml.txt.nlp	23091446	SENT108	14	14	24	24	irinotecan	JNK	PA450085	5599	0.994
NULL	Cardiovasc_Diabetol_2013_May_30_12(Suppl_1)_S2.nxml.txt.nlp	23819752	SENT129	3	3	43	43	simvastatin	CYP2C9	PA451363	1559	0.994
NULL	J_Korean_Med_Sci_2010_Dec_24_25(12)_1792-1797.nxml.txt.nlp	21165296	SENT26	0	0	21	21	desmopressin	AVP	PA449237	114548;551	0.994
NULL	Br_J_Cancer_2006_Dec_4_95(11)_1504-1513.nxml.txt.nlp	17088902	SENT206	42	42	11	11	gefitinib	HER2	PA131301952	2064	0.994
NULL	J_Thorac_Oncol_2014_Feb_23_9(2)_189-194.nxml.txt.nlp	24419415	SENT8	33	33	15	15	gefitinib	EGFR	PA131301952	1956	0.994
NULL	Oncotarget_2011_Dec_24_2(12)_896-917.nxml.txt.nlp	22203527	SENT182	18	18	34	34	metformin	HER2	PA450395	2064	0.994
NULL	Case_Rep_Oncol_2012_Dec_6_5(3)_651-656.nxml.txt.nlp	23275781	SENT109	28	28	11	11	sunitinib	KIT	PA162372840	3815	0.994
NULL	Arch_Drug_Inf_2008_Sep_1(2)_50-55.nxml.txt.nlp	19915714	SENT42	16	16	35	35	fentanyl	CYP3A4	PA449599	1576	0.994
NULL	Br_J_Cancer_2012_Jun_26_107(1)_43-52.nxml.txt.nlp	22644306	SENT226	32	32	6	6	tamoxifen	SMARCA4	PA451581	6597	0.994
NULL	Oncotarget_2013_Nov_24_4(12)_2186-2207.nxml.txt.nlp	24327604	SENT210	10	10	45	45	mitoxantrone	LFA-1	PA450526	3683;3689	0.994
NULL	Case_Rep_Oncol_2013_Feb_19_6(1)_98-103.nxml.txt.nlp	23626552	SENT88	3	3	16	16	sorafenib	HCC	PA7000	84668	0.994
NULL	Acta_Pharmacol_Sin_2014_Oct_15_35(10)_1227-1246.nxml.txt.nlp	25220640	SENT209	32	32	5	5	phencyclidine	STEP	PA128406980	84867	0.993
NULL	Cancer_Cell_Int_2009_Feb_17_9_4.nxml.txt.nlp	19222856	SENT30	27	27	3	3	cisplatin	p53	PA449014	7157	0.993
NULL	Br_J_Cancer_2002_Jan_21_86(2)_218-221.nxml.txt.nlp	11870509	SENT71	8	8	43	43	tamoxifen	BRCA2	PA451581	675	0.993
NULL	Eur_J_Med_Res_2009_Nov_24_14(Suppl_3)_36-42.nxml.txt.nlp	19959415	SENT37	15	15	36	36	raltegravir	gamma		9913	0.993
NULL	Angiogenesis_2010_Dec_7_13(4)_305-315.nxml.txt.nlp	20927579	SENT211	20	20	11	11	resveratrol	p53		7157	0.993
NULL	J_Korean_Med_Sci_2009_Jun_12_24(3)_448-452.nxml.txt.nlp	19543508	SENT27	28	28	7	7	gefitinib	EGFR	PA131301952	1956	0.993
NULL	Biomed_Res_Int_2013_Aug_6_2013_602987.nxml.txt.nlp	24027759	SENT264	7	7	22	22	cisplatin	SMF	PA449014	22993	0.993
NULL	Cancers_(Basel)_2013_Jan_21_5(1)_64-91.nxml.txt.nlp	24216699	SENT126	2	2	13	13	gefitinib	EGFR	PA131301952	1956	0.993
NULL	Front_Oncol_2013_Oct_9_3_261.nxml.txt.nlp	24130964	SENT205	17	17	30	30	gefitinib	EGFR	PA131301952	1956	0.993
NULL	Curr_Neuropharmacol_2008_Sep_6(3)_215-234.nxml.txt.nlp	19506722	SENT119	5	5	14	14	fluoxetine	5-HT2C	PA449673	3358	0.993
NULL	Front_Genet_2012_Oct_26_3_213.nxml.txt.nlp	23112805	SENT278	20	20	2	2	oltipraz	CYP1A2		1544	0.993
NULL	Acta_Pharmacol_Sin_2014_Jun_5_35(6)_727-737.nxml.txt.nlp	24793312	SENT169	4	4	12	12	telmisartan	Bcl-2	PA451605	596	0.993
NULL	Oncol_Rep_2013_Mar_8_29(3)_917-924.nxml.txt.nlp	23314174	SENT125	36	36	10	10	sorafenib	CD24	PA7000	100133941	0.993
NULL	Exp_Ther_Med_2014_Feb_25_7(2)_397-400.nxml.txt.nlp	24396413	SENT68	8	8	13	13	isoniazid	LOX	PA450112	4015	0.993
NULL	Oncol_Lett_2014_May_25_7(5)_1537-1543.nxml.txt.nlp	24765172	SENT5	16	16	3	3	cisplatin	COL6A3	PA449014	1293	0.993
NULL	Eur_J_Hosp_Pharm_Sci_Pract_2013_Aug_21_20(4)_227-231.nxml.txt.nlp	23888248	SENT26	0	0	28	28	denosumab	RANK	PA166048634	8792	0.993
NULL	Ther_Clin_Risk_Manag_2006_Mar_2(1)_115-125.nxml.txt.nlp	18360586	SENT215	0	0	6	6	buprenorphine	CYP3A4	PA448685	1576	0.993
NULL	J_Gen_Physiol_2012_Jun_139(6)_445-454.nxml.txt.nlp	22641639	SENT154	4	4	34	34	propranolol	LETM1	PA451145	3954	0.993
NULL	J_Cell_Biol_1997_Jun_30_137(7)_1663-1681.nxml.txt.nlp	9199179	SENT190	40	40	22	22	trypsin	RGDS	PA451806	5900	0.993
NULL	Lipids_Health_Dis_2011_Feb_28_10_38.nxml.txt.nlp	21352602	SENT89	6	6	45	45	atorvastatin	PCSK9	PA448500	255738	0.993
NULL	Evid_Based_Complement_Alternat_Med_2011_Feb_14_2011_248231.nxml.txt.nlp	19233878	SENT228	5	5	35	35	rosiglitazone	DBT	PA451283	1629	0.993
NULL	Cancer_Cell_Int_2005_Jun_1_5_18.nxml.txt.nlp	15929791	SENT7	2	2	13	13	bortezomib	p53	PA10252	7157	0.993
NULL	Cell_Microbiol_2014_Apr_6_16(4)_519-534.nxml.txt.nlp	24152255	SENT74	17	17	32	32	glucosamine	DC-SIGN	PA164747613	30835	0.993
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_650809.nxml.txt.nlp	23258995	SENT150	30	30	22	22	forskolin	AQP2	PA146096022	359	0.993
NULL	Onco_Targets_Ther_2014_Jul_14_7_1285-1289.nxml.txt.nlp	25053886	SENT33	3	3	19	19	trastuzumab	HER2	PA451743	2064	0.993
NULL	Protein_Cell_2014_Jun_19_5(6)_469-479.nxml.txt.nlp	24748116	SENT70	13	13	8	8	paclitaxel	EB1	PA450761	9167;22919;10982	0.993
NULL	Aging_(Albany_NY)_2011_Jan_18_3(1)_33-43.nxml.txt.nlp	21248371	SENT131	40	40	11	11	zinc	Bcl-2	PA451956	596	0.993
NULL	Int_J_Mol_Sci_2014_Sep_29_15(10)_17469-17477.nxml.txt.nlp	25268618	SENT32	4	4	25	25	lidocaine	zeta	PA450226	9907	0.993
NULL	Environ_Health_Perspect_2008_Mar_26_116(3)_322-328.nxml.txt.nlp	18335098	SENT134	13	13	32	32	estradiol	PMI	PA449503	8834;5373	0.993
NULL	Mol_Cytogenet_2014_Jan_21_7(Suppl_1)_P100.nxml.txt.nlp	NULL	SENT18	38	38	10	10	metformin	KCNJ11	PA450395	3767	0.993
NULL	J_Cancer_2013_Sep_27_4(8)_662-670.nxml.txt.nlp	24155778	SENT53	19	19	4	4	cisplatin	UCHL1	PA449014	7345	0.993
NULL	Exp_Mol_Med_2013_Apr_19_45(4)_e19.nxml.txt.nlp	23598593	SENT32	2	2	18	18	paclitaxel	Tech	PA450761	57449	0.993
NULL	AIDS_Res_Ther_2013_May_1_10_10.nxml.txt.nlp	23634877	SENT116	22	22	0	0	lovastatin	CXCR4	PA450272	7852	0.993
NULL	Br_J_Cancer_2009_Jan_27_100(2)_298-304.nxml.txt.nlp	19127259	SENT144	4	4	12	12	cetuximab	EGFR	PA10040	1956	0.993
NULL	Acta_Pharmacol_Sin_2009_Sep_24_30(9)_1220-1226.nxml.txt.nlp	19701239	SENT182	19	19	5	5	cyclosporine	KCNQ4	PA449167	9132	0.993
NULL	Mol_Cancer_2010_Apr_15_9_77.nxml.txt.nlp	20398291	SENT38	4	4	24	24	geldanamycin	survivin	PA152031327	332	0.993
NULL	Arthritis_Res_Ther_2014_Apr_28_16(2)_R104.nxml.txt.nlp	24774748	SENT103	19	19	6	6	chloroquine	CD4	PA448948	920	0.993
NULL	Evid_Based_Complement_Alternat_Med_2012_May_7_2012_242810.nxml.txt.nlp	22645625	SENT201	0	0	10	10	ketoconazole	CYP3A4	PA450146	1576	0.993
NULL	J_Ophthalmic_Inflamm_Infect_2013_Jan_28_3_22.nxml.txt.nlp	23514095	SENT95	2	2	13	13	travoprost	BAK	PA164781371	578	0.993
NULL	Clin_Med_Insights_Cardiol_2011_Oct_6_5_103-119.nxml.txt.nlp	22084608	SENT39	7	7	19	19	dronedarone	CYP2D6	PA153619853	1565	0.993
NULL	Onco_Targets_Ther_2014_Nov_3_7_2035-2042.nxml.txt.nlp	25395862	SENT116	23	23	3	3	paclitaxel	Bcl-2	PA450761	596	0.993
NULL	Mol_Cancer_2010_Aug_23_9_222.nxml.txt.nlp	20731837	SENT215	0	0	28	28	gefitinib	ATM	PA131301952	472	0.993
NULL	Mol_Cancer_2009_Apr_22_8_26.nxml.txt.nlp	19386116	SENT126	3	3	10	10	ritonavir	AKT	PA451260	207	0.993
NULL	Arthritis_Res_Ther_2003_Aug_5_5(5)_214-222.nxml.txt.nlp	12932280	SENT68	34	34	13	13	alendronate	PTH	PA448082	5741	0.993
NULL	Ther_Clin_Risk_Manag_2005_Mar_1(1)_3-13.nxml.txt.nlp	18360537	SENT61	7	7	12	12	carbamazepine	CYP3A4	PA448785	1576	0.993
NULL	Breast_Cancer_Res_2011_May_26_13(3)_209.nxml.txt.nlp	21635709	SENT203	19	19	5	5	letrozole	aromatase	PA450196	1588	0.993
NULL	J_Skin_Cancer_2012_Dec_13_2012_147863.nxml.txt.nlp	23316365	SENT182	1	1	30	30	curcumin	IL-6	PA151958596	3569	0.993
NULL	Oncol_Lett_2013_Sep_28_6(3)_795-800.nxml.txt.nlp	24137413	SENT12	20	20	4	4	paclitaxel	P-gp	PA450761	5243	0.993
NULL	Breast_Cancer_Res_2007_Dec_20_9(Suppl_2)_S22.nxml.txt.nlp	NULL	SENT13	16	16	3	3	tamoxifen	aromatase	PA451581	1588	0.993
NULL	Arch_Drug_Inf_2011_Mar_4(1)_1-9.nxml.txt.nlp	21572514	SENT168	3	3	20	20	indomethacin	P-gp	PA449982	5243	0.993
NULL	Arthritis_Res_Ther_2007_Jun_29_9(Suppl_1)_S7.nxml.txt.nlp	17634146	SENT37	0	0	8	8	denosumab	RANKL	PA166048634	8600	0.993
NULL	Biomed_Res_Int_2013_Feb_28_2013_749078.nxml.txt.nlp	23555095	SENT107	4	4	22	22	chymotrypsin	CD62L	PA448994	6402	0.993
NULL	Biomed_Res_Int_2014_Jan_29_2014_232870.nxml.txt.nlp	24592384	SENT182	13	13	28	28	etoposide	p53	PA449552	7157	0.993
NULL	Int_J_Environ_Res_Public_Health_2014_Aug_18_11(8)_8414-8442.nxml.txt.nlp	25153469	SENT21	8	8	36	36	formaldehyde	PTB	PA449703	58155	0.993
NULL	Cell_Death_Dis_2014_Jan_16_5(1)_e1000.nxml.txt.nlp	24434508	SENT64	9	9	22	22	nutlin-3	p53		7157	0.993
NULL	Front_Behav_Neurosci_2011_Sep_13_5_57.nxml.txt.nlp	21949506	SENT295	28	28	2	2	rimonabant	FAAH	PA152407999	79152;2166	0.993
NULL	Nat_Med_2011_Dec_11_18(1)_74-82.nxml.txt.nlp	22157681	SENT62	4	4	10	10	gefitinib	APAF-1	PA131301952	317	0.993
NULL	J_Cell_Mol_Med_2013_Dec_6_17(12)_1588-1597.nxml.txt.nlp	24199964	SENT9	17	17	0	0	doxycycline	APT	PA449415	653639	0.993
NULL	Mol_Cancer_2013_Sep_11_12_104.nxml.txt.nlp	24025152	SENT5	0	0	25	25	gemcitabine	EGFR	PA449748	1956	0.993
NULL	BMJ_2013_Sep_17_347_f5307.nxml.txt.nlp	24046285	SENT26	6	6	25	25	prasugrel	CYP1A2	PA154410481	1544	0.993
NULL	Exp_Mol_Med_2012_May_31_44(5)_311-318.nxml.txt.nlp	22282402	SENT77	30	30	1	1	cilostazol	MCP-1	PA164746334	6347	0.993
NULL	Clin_Med_Pathol_2008_Mar_1_1_17-34.nxml.txt.nlp	21876648	SENT150	11	11	29	29	tamoxifen	p53	PA451581	7157	0.993
NULL	J_Inherit_Metab_Dis_2011_Jun_23_34(3)_677-694.nxml.txt.nlp	21431622	SENT21	26	26	1	1	l-lysine	GCDH	PA450280	2639	0.993
NULL	J_Adv_Pharm_Technol_Res_2014_Jul-Sep_5(3)_140-146.nxml.txt.nlp	25126536	SENT15	5	5	27	27	ciprofloxacin	BCS	PA449009	617	0.993
NULL	Oncologist_2010_Mar_3_15(3)_216-235.nxml.txt.nlp	20200040	SENT110	12	12	25	25	trastuzumab	HER-2	PA451743	2064	0.993
NULL	Int_J_Biol_Sci_2013_Mar_7_9(3)_279-288.nxml.txt.nlp	23493630	SENT179	12	12	22	22	tocilizumab	CD4	PA165292659	920	0.993
NULL	Front_Oncol_2014_Aug_11_4_204.nxml.txt.nlp	25157335	SENT82	0	0	13	13	crizotinib	ROS1	PA165946122	6098	0.993
NULL	Eur_J_Clin_Pharmacol_2007_Apr_21_63(4)_335-343.nxml.txt.nlp	17318526	SENT234	2	2	44	44	sulfamethoxazole	CYP2C9	PA451544	1559	0.993
NULL	Ther_Clin_Risk_Manag_2006_Sep_2(3)_303-308.nxml.txt.nlp	18360605	SENT41	0	0	8	8	frovatriptan	5-HT1B	PA164754891	3351	0.993
NULL	Br_J_Cancer_2011_Sep_6_105(6)_807-813.nxml.txt.nlp	21847121	SENT82	32	32	4	4	pha-665752	HER3		2065	0.993
NULL	Diabetes_Care_2009_Sep_19_32(9)_1663-1668.nxml.txt.nlp	19542207	SENT130	45	45	17	17	anakinra	IL-6	PA10799	3569	0.993
NULL	Brain_Res_2011_Mar_25_1382(C)_29-36.nxml.txt.nlp	21276431	SENT139	28	28	7	7	ondansetron	5-HT2A	PA450705	3356	0.993
NULL	Diabetologia_2009_Oct_4_52(10)_2182-2189.nxml.txt.nlp	19652946	SENT103	20	20	2	2	rosiglitazone	SNARK	PA451283	81788	0.993
NULL	J_Immunother_Cancer_2013_Jul_15_1_10.nxml.txt.nlp	24829747	SENT180	0	0	10	10	sunitinib	VEGFR	PA162372840	3791	0.993
NULL	Oncol_Lett_2013_Sep_15_6(3)_648-654.nxml.txt.nlp	24137384	SENT37	29	29	10	10	oxaliplatin	GSTT1	PA131285527	2952	0.993
NULL	Br_J_Cancer_2011_Mar_1_104(5)_750-755.nxml.txt.nlp	21326243	SENT152	27	27	1	1	olaparib	MPG		4350	0.993
NULL	Int_J_Breast_Cancer_2011_Sep_6_2011_352182.nxml.txt.nlp	22295219	SENT258	0	0	15	15	trastuzumab	HER2	PA451743	2064	0.993
NULL	Korean_J_Anesthesiol_2013_Dec_26_65(6_Suppl)_S62-S64.nxml.txt.nlp	24478876	SENT24	10	10	19	19	protamine	ACT	PA10366	12;11332;9457;641455	0.993
NULL	Arthritis_Res_Ther_2013_Feb_11_15(Suppl_1)_S1.nxml.txt.nlp	23566714	SENT221	0	0	42	42	dextran	IL-10	PA449261	3586	0.993
NULL	Cells_2014_May_23_3(2)_517-545.nxml.txt.nlp	24861977	SENT210	3	3	26	26	cyclophosphamide	TRPV1	PA449165	7442	0.993
NULL	Gene_Regul_Syst_Bio_2014_Mar_4_8_63-73.nxml.txt.nlp	24634581	SENT101	0	0	30	30	minocycline	NANOS1	PA450519	340719	0.993
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT4	37	37	6	6	panitumumab	EGFR	PA162373091	1956	0.993
NULL	Curr_Pharm_Biotechnol_2012_May_13(6)_969-986.nxml.txt.nlp	22039792	SENT16	19	19	30	30	colchicine	P-gp	PA449092	5243	0.993
NULL	Crit_Care_2008_Nov_26_12(Suppl_6)_S3.nxml.txt.nlp	19105796	SENT120	0	0	15	15	thrombin	PAR3	PA451674	56288;2151	0.993
NULL	Brain_Sci_2013_Jun_14_3(2)_941-963.nxml.txt.nlp	24961432	SENT200	18	18	2	2	ethanol	COX	PA448073	1351	0.993
NULL	Bone_Marrow_Transplant_2014_Feb_4_49(2)_201-205.nxml.txt.nlp	24185588	SENT103	12	12	26	26	lenalidomide	CD34	PA162363968	947	0.993
NULL	Arthritis_Res_2002_Feb_4_4(Suppl_1)_40.nxml.txt.nlp	NULL	SENT4	17	17	5	5	trypsin	PAR4	PA451806	9002;5074	0.993
NULL	EJC_Suppl_2013_Sep_5_11(2)_254-256.nxml.txt.nlp	NULL	SENT41	44	44	31	31	everolimus	aromatase	PA164746311	1588	0.993
NULL	J_Hematol_Oncol_2013_Jun_3_6_38.nxml.txt.nlp	23731980	SENT19	2	2	15	15	trastuzumab	HER2	PA451743	2064	0.993
NULL	Case_Rep_Med_2009_Aug_9_2009_378287.nxml.txt.nlp	19721707	SENT60	9	9	14	14	simvastatin	CYP3A4	PA451363	1576	0.993
NULL	Nucleic_Acids_Res_2013_Dec_4_41(22)_10124-10134.nxml.txt.nlp	24005039	SENT83	26	26	5	5	ethanol	CYC1	PA448073	1537	0.993
NULL	Arthritis_Res_Ther_2009_Jun_30_11(3)_234.nxml.txt.nlp	19591653	SENT73	0	0	21	21	abatacept	CD28	PA164747080	1493;940	0.993
NULL	Breast_Cancer_Res_2011_Nov_7_13(6)_R112.nxml.txt.nlp	22060274	SENT335	23	23	0	0	tamoxifen	ARTN	PA451581	9048	0.993
NULL	Breast_Cancer_Res_2009_Jun_16_11(3)_R35.nxml.txt.nlp	19531217	SENT42	39	39	10	10	tamoxifen	aromatase	PA451581	1588	0.993
NULL	Br_J_Cancer_2012_Feb_28_106(5)_858-866.nxml.txt.nlp	22343622	SENT115	4	4	23	23	docetaxel	PD2	PA449383	54623	0.993
NULL	Carcinogenesis_2013_Jan_8_34(1)_102-108.nxml.txt.nlp	23054610	SENT15	32	32	6	6	cisplatin	BRCA1	PA449014	672	0.993
NULL	Adv_Hematol_2012_Aug_2_2012_842945.nxml.txt.nlp	22919394	SENT159	38	38	4	4	lenalidomide	CRBN	PA162363968	51185	0.993
NULL	Clin_Sci_(Lond)_2012_May_1_122(Pt_9)_421-428.nxml.txt.nlp	22092038	SENT31	1	1	17	17	tetracycline	JNK1	PA451640	5599	0.993
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2014_Jun_29_70(Pt_7)_1922-1933.nxml.txt.nlp	25004969	SENT105	11	11	28	28	cycloserine	PLP	PA164764600	25824;5744	0.993
NULL	Oxid_Med_Cell_Longev_2013_Nov_28_2013_568093.nxml.txt.nlp	24379901	SENT85	6	6	22	22	resveratrol	SIRT1		23411	0.993
NULL	Int_J_Cell_Biol_2013_Nov_17_2013_769536.nxml.txt.nlp	24348564	SENT21	23	23	12	12	tamoxifen	HSD2	PA451581	6060	0.993
NULL	Hum_Genomics_2009_Jan_1_3(2)_128-142.nxml.txt.nlp	19164090	SENT248	18	18	8	8	cisplatin	CD44	PA449014	960	0.993
NULL	Indian_J_Endocrinol_Metab_2015_Jan-Feb_19(1)_30-38.nxml.txt.nlp	25593823	SENT107	10	10	16	16	vildagliptin	adiponectin	PA165958346	9370	0.993
NULL	Int_J_Mol_Sci_2014_Jun_26_15(7)_11403-11415.nxml.txt.nlp	24972136	SENT119	14	14	6	6	abacavir	HLA-B	PA448004	3106	0.993
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_11_2013_910451.nxml.txt.nlp	23840269	SENT251	33	33	6	6	doxorubicin	CD24	PA449412	100133941	0.993
NULL	EPMA_J_2012_Jun_18_3(1)_6.nxml.txt.nlp	22738201	SENT157	10	10	37	37	gefitinib	EGFR	PA131301952	1956	0.993
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1651-1657.nxml.txt.nlp	19904273	SENT181	3	3	20	20	olaparib	BRCA2		675	0.993
NULL	J_Gen_Physiol_2010_Jul_136(1)_101-116.nxml.txt.nlp	20548054	SENT195	5	5	42	42	tetracaine	RYR	PA451638	6261	0.993
NULL	J_Carcinog_2011_Jun_17_10_15.nxml.txt.nlp	NULL	SENT952	15	15	10	10	vinblastine	E2F3	PA451877	1871	0.993
NULL	Cell_Death_Dis_2012_Mar_15_3(3)_e286.nxml.txt.nlp	22419115	SENT195	41	41	22	22	cisplatin	p53	PA449014	7157	0.993
NULL	Infect_Dis_Ther_2013_Dec_2_2(2)_123-144.nxml.txt.nlp	25134476	SENT267	23	23	0	0	azithromycin	DIP	PA448519	23151;1831	0.993
NULL	Oncol_Lett_2013_Feb_3_5(2)_505-510.nxml.txt.nlp	23420812	SENT109	38	38	8	8	cisplatin	AEG-1	PA449014	92140	0.993
NULL	Cell_Cycle_2014_Jan_1_13(1)_90-95.nxml.txt.nlp	24196441	SENT90	11	11	36	36	camptothecin	CtIP	PA153590860	5932	0.993
NULL	Biochimie_2010_Nov_92(11)_1546-1567.nxml.txt.nlp	20615447	SENT204	4	4	23	23	heparin	KLK2	PA449855	3817	0.993
NULL	Br_J_Cancer_2010_Sep_28_103(7)_1019-1024.nxml.txt.nlp	20842128	SENT115	22	22	8	8	cetuximab	EGFR	PA10040	1956	0.993
NULL	Int_J_Hypertens_2012_Feb_8_2012_189512.nxml.txt.nlp	22518281	SENT132	4	4	25	25	hemin	RVR	PA449849	9975	0.993
NULL	Neuropsychopharmacology_2012_Feb_2_37(3)_641-650.nxml.txt.nlp	22048466	SENT134	19	19	9	9	bupropion	CYP2B6	PA448687	1555	0.993
NULL	Genetics_2012_Oct_192(2)_483-493.nxml.txt.nlp	22446960	SENT133	30	30	3	3	tetracycline	CO3	PA451640	4514	0.993
NULL	Clin_Med_Insights_Cardiol_2011_Oct_6_5_103-119.nxml.txt.nlp	22084608	SENT39	0	0	13	13	dronedarone	CYP3A4	PA153619853	1576	0.993
NULL	Aging_(Albany_NY)_2011_Feb_21_3(2)_148-157.nxml.txt.nlp	21386129	SENT140	3	3	17	17	metformin	HER-2	PA450395	2064	0.993
NULL	Indian_J_Pharm_Sci_2008_Mar-Apr_70(2)_251-255.nxml.txt.nlp	20046726	SENT10	2	2	38	38	fluoxetine	TLC	PA449673	3933	0.993
NULL	Evid_Based_Complement_Alternat_Med_2007_Jun_23_4(2)_181-190.nxml.txt.nlp	17549234	SENT66	2	2	15	15	curcumin	p300	PA151958596	2033	0.993
NULL	eLife_2013_Nov_5_2_e00969.nxml.txt.nlp	24192036	SENT101	17	17	11	11	vemurafenib	ERK	PA165946873	5594	0.993
NULL	Arch_Med_Sci_2012_Sep_8_8(4)_659-671.nxml.txt.nlp	23056078	SENT46	32	32	3	3	etoposide	MRP2	PA449552	100130958;57626;1244	0.993
NULL	Arthritis_Res_Ther_2009_Aug_28_11(4)_R131.nxml.txt.nlp	19715572	SENT17	3	3	11	11	rituximab	CD27	PA451261	939	0.993
NULL	Br_J_Cancer_2009_Sep_15_101(6)_998-1004.nxml.txt.nlp	19672255	SENT119	26	26	0	0	oxaliplatin	ERCC1	PA131285527	2067	0.993
NULL	Eur_J_Med_Res_2009_Nov_24_14(Suppl_3)_43-46.nxml.txt.nlp	19959416	SENT13	5	5	21	21	raltegravir	CYP1A2		1544	0.993
NULL	Curr_Chem_Genomics_2010_Mar_19_4_9-18.nxml.txt.nlp	20502647	SENT167	29	29	6	6	triciribine	DMPK	PA165958661	1760	0.993
NULL	Cancers_(Basel)_2014_Jul_7_6(3)_1441-1463.nxml.txt.nlp	25003395	SENT314	14	14	2	2	trastuzumab	PI3K	PA451743	5290	0.993
NULL	Clin_Drug_Investig_2012_Dec_13_32(8)_e1-e15.nxml.txt.nlp	22712629	SENT24	27	27	14	14	dextromethorphan	CYP2D6	PA449273	1565	0.993
NULL	Oncol_Rep_2014_Apr_28_31(4)_1605-1612.nxml.txt.nlp	24481648	SENT37	0	0	12	12	nilotinib	MRP7	PA165958345	89845;1080	0.993
NULL	Eur_J_Clin_Pharmacol_2014_Oct_8_70(1)_37-45.nxml.txt.nlp	24100471	SENT195	0	0	34	34	midazolam	CYP2C19	PA450496	1557	0.993
NULL	Curr_Oncol_2009_Aug_16(4)_9-21.nxml.txt.nlp	19672420	SENT110	42	42	12	12	gefitinib	EGFR	PA131301952	1956	0.993
NULL	Oncotarget_2014_Mar_14_5(10)_3029-3038.nxml.txt.nlp	24912489	SENT20	30	30	20	20	everolimus	aromatase	PA164746311	1588	0.993
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT259	17	17	0	0	ethanol	IL-6	PA448073	3569	0.993
NULL	Clin_Epigenetics_2010_Nov_9_1(3-4)_117-136.nxml.txt.nlp	21258646	SENT277	3	3	17	17	vorinostat	EGFR	PA164748224	1956	0.993
NULL	Ann_Pediatr_Cardiol_2013_Jan-Jun_6(1)_59-64.nxml.txt.nlp	23626438	SENT22	2	2	12	12	clopidogrel	ADP	PA449053	23038	0.993
NULL	Case_Rep_Ophthalmol_Med_2013_Sep_12_2013_213124.nxml.txt.nlp	24109538	SENT10	4	4	15	15	gefitinib	EGFR	PA131301952	1956	0.993
NULL	Arthritis_Res_Ther_2012_Apr_26_14(2)_R90.nxml.txt.nlp	22537858	SENT226	1	1	6	6	atorvastatin	IFN	PA448500	3439	0.993
NULL	Curr_Immunol_Rev_2013_Nov_9(4)_214-221.nxml.txt.nlp	24876829	SENT94	9	9	32	32	papain	IL-5	PA450778	3567	0.993
NULL	Diabetes_Care_2010_Jul_31_33(7)_1607-1609.nxml.txt.nlp	20357375	SENT69	7	7	30	30	sitagliptin	KDR	PA164748978	3791	0.993
NULL	Biomed_Res_Int_2014_Aug_5_2014_312847.nxml.txt.nlp	25162007	SENT230	36	36	8	8	resveratrol	p53		7157	0.993
NULL	Mol_Syst_Biol_2009_Jul_28_5_289.nxml.txt.nlp	19638970	SENT38	2	2	34	34	resveratrol	HuR		1994	0.993
NULL	Appl_Clin_Genet_2012_Aug_29_5_81-91.nxml.txt.nlp	23776383	SENT52	0	0	24	24	resveratrol	SIRT1		23411	0.993
NULL	EMBO_Mol_Med_2012_Jul_18_4(7)_557-560.nxml.txt.nlp	22610822	SENT39	7	7	13	13	resveratrol	AMPK		5563	0.993
NULL	eLife_2014_May_6_3_e02482.nxml.txt.nlp	24843002	SENT607	8	8	19	19	etoposide	SETD2	PA449552	29072	0.993
NULL	J_Cell_Mol_Med_2014_Sep_7_18(9)_1785-1796.nxml.txt.nlp	24909956	SENT19	13	13	1	1	cangrelor	GPR17	PA165945763	2840	0.993
NULL	Acta_Pharmacol_Sin_2014_Jan_9_35(1)_1-10.nxml.txt.nlp	24317012	SENT44	32	32	7	7	methotrexate	SLC19A1	PA450428	6573	0.993
NULL	Cancers_(Basel)_2010_Apr_20_2(2)_611-623.nxml.txt.nlp	24281084	SENT211	20	20	1	1	aprepitant	NK-1	PA164747039	27087	0.993
NULL	Mol_Cancer_2010_Jun_7_9_139.nxml.txt.nlp	20529262	SENT26	27	27	15	15	cetuximab	KRAS	PA10040	3845	0.993
NULL	Oncogene_2013_Sep_26_32(39)_10_1038_onc_2012_491.nxml.txt.nlp	23108394	SENT27	40	40	4	4	epirubicin	FOXM1	PA449476	2305	0.993
NULL	Gut_2008_Jan_1_58(1)_41-48.nxml.txt.nlp	18829978	SENT160	8	8	13	13	mannitol	IL10	PA450320	3586	0.993
NULL	Acta_Pharmacol_Sin_2013_Jan_17_34(1)_157-166.nxml.txt.nlp	23247593	SENT234	21	21	4	4	berberine	Bcl-2	PA165860812	596	0.993
NULL	Int_J_Surg_Oncol_2011_Jun_6_2011_285840.nxml.txt.nlp	22312501	SENT58	7	7	23	23	panitumumab	KRAS	PA162373091	3845	0.993
NULL	Antiviral_Res_2009_May_82(2)_A99-A109.nxml.txt.nlp	19176219	SENT283	21	21	36	36	saquinavir	P85	PA451305	8874	0.993
NULL	Leukemia_2013_Feb_10_27(2)_507-510.nxml.txt.nlp	22810506	SENT21	11	11	0	0	cyclophosphamide	TRAC	PA449165	28755	0.993
NULL	Patient_Prefer_Adherence_2013_Mar_27_7_245-258.nxml.txt.nlp	23569364	SENT108	1	1	8	8	exemestane	aromatase	PA449563	1588	0.993
NULL	J_Carcinog_2014_Feb_7_13_1.nxml.txt.nlp	24737949	SENT128	0	0	13	13	perifosine	AKT	PA165291471	207	0.993
NULL	Osteoporos_Int_2008_Apr_12_19(4)_399-428.nxml.txt.nlp	18266020	SENT249	20	20	2	2	teriparatide	PTH	PA451620	5741	0.993
NULL	Mol_Cancer_2009_Oct_30_8_93.nxml.txt.nlp	19878573	SENT108	5	5	40	40	noscapine	p53		7157	0.993
NULL	Breast_Cancer_Res_2011_Feb_23_13(1)_203.nxml.txt.nlp	21392408	SENT107	21	21	6	6	tamoxifen	aromatase	PA451581	1588	0.993
NULL	Indian_J_Pharm_Sci_2014_Mar-Apr_76(2)_138-147.nxml.txt.nlp	24843187	SENT169	0	0	10	10	phenacetin	CYP1A2	PA450897	1544	0.993
NULL	Clin_Transl_Allergy_2013_Sep_2_3_29.nxml.txt.nlp	24004581	SENT141	3	3	22	22	omalizumab	CD40	PA164752253	958	0.993
NULL	Clin_Pharmacol_2012_Feb_20_4_13-20.nxml.txt.nlp	22427735	SENT118	12	12	36	36	clopidogrel	PON1	PA449053	5444	0.993
NULL	Oncotarget_2013_Aug_21_4(9)_1484-1495.nxml.txt.nlp	23986086	SENT163	20	20	2	2	trastuzumab	PI3K	PA451743	5290	0.993
NULL	Br_J_Cancer_2012_May_22_106(11)_1728-1734.nxml.txt.nlp	22531637	SENT127	0	0	10	10	saracatinib	CYP3A4		1576	0.993
NULL	Nucleic_Acids_Res_2011_Mar_17_39(6)_2144-2152.nxml.txt.nlp	21087997	SENT185	29	29	5	5	etoposide	CtIP	PA449552	5932	0.993
NULL	Nat_Med_2013_Mar_10_19(3)_313-321.nxml.txt.nlp	23396211	SENT153	23	23	33	33	amlexanox	TBK1	PA164745310	29110	0.993
NULL	Front_Neurosci_2014_Jan_10_7_270.nxml.txt.nlp	24454277	SENT144	0	0	17	17	resveratrol	SIRT1		23411	0.993
NULL	Case_Rep_Ophthalmol_2014_Dec_10_5(3)_451-454.nxml.txt.nlp	25606038	SENT30	2	2	16	16	tamoxifen	aromatase	PA451581	1588	0.993
NULL	Chin_J_Cancer_2012_Jun_31(6)_266-280.nxml.txt.nlp	22313597	SENT277	14	14	0	0	exemestane	IGFBP5	PA449563	3488	0.993
NULL	Breast_Cancer_Res_2011_Jan_17_13(1)_R5.nxml.txt.nlp	21241485	SENT316	33	33	3	3	estradiol	Brn-3b	PA449503	5458	0.993
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Jul_23_3(7)_e126.nxml.txt.nlp	25054314	SENT64	8	8	19	19	docetaxel	MRP2	PA449383	100130958;57626;1244	0.993
NULL	Br_J_Cancer_2011_Jun_28_105(1)_1-8.nxml.txt.nlp	21654681	SENT95	32	32	3	3	erlotinib	EGFR	PA134687924	1956	0.993
NULL	Br_J_Cancer_2009_Sep_15_101(6)_957-966.nxml.txt.nlp	19738618	SENT160	13	13	25	25	dexrazoxane	THBS-1	PA449259	7057	0.993
NULL	Aging_(Albany_NY)_2009_Feb_18_1(3)_335-349.nxml.txt.nlp	20195489	SENT307	14	14	0	0	etoposide	p65	PA449552	5970	0.993
NULL	Mol_Vis_2007_Jul_9_13_1083-1093.nxml.txt.nlp	17653053	SENT179	2	2	36	36	minocycline	p65	PA450519	5970	0.993
NULL	Cell_Commun_Signal_2014_Mar_28_12_23.nxml.txt.nlp	24679124	SENT119	0	0	16	16	resveratrol	CAMKK2		10645	0.993
NULL	Oncotarget_2014_Oct_21_5(22)_11709-11722.nxml.txt.nlp	25365944	SENT162	14	14	5	5	metformin	JNK	PA450395	5599	0.993
NULL	Biologics_2012_Jun_20_6_147-154.nxml.txt.nlp	22807625	SENT81	10	10	26	26	paclitaxel	PIK3CA	PA450761	5290	0.993
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_3_2014_473213.nxml.txt.nlp	25538791	SENT109	0	0	29	29	fexofenadine	P-gp	PA449621	5243	0.993
NULL	Br_J_Cancer_1998_Dec_78(12)_1586-1593.nxml.txt.nlp	9862568	SENT16	25	25	7	7	etoposide	MDR1	PA449552	5243	0.993
NULL	Clin_Med_Insights_Oncol_2012_Apr_3_6_179-187.nxml.txt.nlp	22518088	SENT3	0	0	15	15	trastuzumab	HER2	PA451743	2064	0.993
NULL	Basic_Clin_Pharmacol_Toxicol_2013_Feb_5_112(2)_132-137.nxml.txt.nlp	22900583	SENT33	2	2	11	11	ritonavir	CYP3A	PA451260	1574	0.993
NULL	Mol_Cells_2014_Dec_31_37(12)_899a-906.nxml.txt.nlp	25431425	SENT135	35	35	4	4	curcumin	EP2	PA151958596	5732;10407	0.993
NULL	Oncotarget_2014_Feb_7_5(3)_775-787.nxml.txt.nlp	24519956	SENT232	28	28	3	3	dasatinib	PC3	PA162372878	57332;7832;5122	0.993
NULL	Oncol_Lett_2014_May_11_7(5)_1401-1408.nxml.txt.nlp	24765145	SENT108	3	3	36	36	paclitaxel	PI3K	PA450761	5290	0.993
NULL	Breast_Cancer_Res_2003_May_30_5(4)_198-201.nxml.txt.nlp	12817991	SENT18	13	13	29	29	tamoxifen	aromatase	PA451581	1588	0.993
NULL	Indian_J_Dermatol_2009_Jan-Mar_54(1)_65-67.nxml.txt.nlp	20049275	SENT67	9	9	22	22	adapalene	CO2	PA448047	4513	0.993
NULL	Front_Genet_2014_Nov_14_5_391.nxml.txt.nlp	25452763	SENT169	6	6	20	20	cisplatin	GSTM1	PA449014	2944	0.993
NULL	ScientificWorldJournal_2014_Nov_26_2014_546192.nxml.txt.nlp	25525621	SENT81	30	30	2	2	taurine	PC1	PA451590	5122	0.993
NULL	Diabetes_2009_Aug_15_58(8)_1893-1901.nxml.txt.nlp	19528375	SENT236	0	0	15	15	metformin	AMPK	PA450395	5563	0.993
NULL	Front_Neurosci_2013_Jun_12_7_100.nxml.txt.nlp	23781169	SENT254	14	14	1	1	hyaluronan	TLR4	PA165958431	7099	0.993
NULL	Br_J_Cancer_2010_Oct_12_103(8)_1182-1191.nxml.txt.nlp	20842125	SENT231	10	10	26	26	indomethacin	COX	PA449982	1351	0.993
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_7-17.nxml.txt.nlp	17912633	SENT113	28	28	7	7	letrozole	aromatase	PA450196	1588	0.993
NULL	Breast_Cancer_Res_2007_Oct_8_9(5)_R68.nxml.txt.nlp	17922920	SENT25	0	0	16	16	trastuzumab	HER2	PA451743	2064	0.993
NULL	Clin_Pharmacol_2013_Dec_9_5_185-192.nxml.txt.nlp	24353446	SENT80	11	11	33	33	clopidogrel	CYP3A4	PA449053	1576	0.993
NULL	Br_J_Cancer_2012_Nov_20_107(11)_1815-1819.nxml.txt.nlp	23099804	SENT34	27	27	2	2	tamoxifen	ATAC	PA451581	6375	0.993
NULL	Breast_Cancer_Res_2002_Sep_10_4(6)_218-221.nxml.txt.nlp	12473166	SENT37	7	7	13	13	tamoxifen	aromatase	PA451581	1588	0.993
NULL	J_Cell_Mol_Med_2013_May_20_17(5)_648-656.nxml.txt.nlp	23601074	SENT167	26	26	10	10	gefitinib	EGFR	PA131301952	1956	0.993
NULL	J_Biol_Chem_2009_Jan_2_284(1)_77-84.nxml.txt.nlp	18854318	SENT128	36	36	4	4	forskolin	LKB1	PA146096022	6794	0.993
NULL	Gut_Liver_2013_Sep_14_7(5)_585-593.nxml.txt.nlp	24073317	SENT150	18	18	33	33	ribavirin	IFN	PA451241	3439	0.993
NULL	J_Cell_Mol_Med_2014_May_14_18(5)_811-823.nxml.txt.nlp	24628949	SENT256	21	21	11	11	docetaxel	FOXM1	PA449383	2305	0.993
NULL	Breast_Cancer_Res_2011_Nov_17_13(6)_R114.nxml.txt.nlp	22087758	SENT130	22	22	2	2	tamoxifen	TMEM135	PA451581	65084	0.993
NULL	Cells_2014_May_23_3(2)_517-545.nxml.txt.nlp	24861977	SENT210	3	3	35	35	cyclophosphamide	TRPV1	PA449165	7442	0.993
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_21-38.nxml.txt.nlp	19305786	SENT141	27	27	0	0	capsaicin	TRPV1	PA448776	7442	0.993
NULL	Onco_Targets_Ther_2014_Jun_11_7_969-983.nxml.txt.nlp	24959084	SENT85	40	40	20	20	erlotinib	KRAS	PA134687924	3845	0.993
NULL	ACS_Chem_Biol_2011_Feb_18_6(2)_169-175.nxml.txt.nlp	20886892	SENT3	6	6	18	18	indomethacin	AKR1C3	PA449982	8644	0.993
NULL	JAKSTAT_2014_Jun_12_3_e29554.nxml.txt.nlp	25105067	SENT99	32	32	6	6	propofol	STAT3	PA451141	6774	0.993
NULL	J_Biol_Chem_2009_Jan_2_284(1)_77-84.nxml.txt.nlp	18854318	SENT165	27	27	0	0	forskolin	LKB1	PA146096022	6794	0.993
NULL	Mol_Cancer_2014_Jun_24_13_157.nxml.txt.nlp	24958351	SENT169	25	25	3	3	lapatinib	HER2	PA152241907	2064	0.993
NULL	J_Vet_Med_Sci_2014_Jun_15_76(6)_813-817.nxml.txt.nlp	24531829	SENT98	9	9	27	27	primaquine	DPT	PA451103	1805	0.993
NULL	Int_J_Gen_Med_2012_Apr_13_5_331-334.nxml.txt.nlp	22536089	SENT76	5	5	37	37	cidofovir	CD4	PA448997	920	0.993
NULL	Cancer_Med_2014_Jun_14_3(3)_580-591.nxml.txt.nlp	24574330	SENT244	15	15	0	0	bevacizumab	VEGF-D	PA130232992	2277	0.993
NULL	Chin_J_Cancer_2012_Jun_31(6)_266-280.nxml.txt.nlp	22313597	SENT305	13	13	32	32	letrozole	CA125	PA450196	4077;94025	0.993
NULL	Adv_Ther_2014_Jul_9_31(7)_657-682.nxml.txt.nlp	25005168	SENT139	0	0	26	26	fentanyl	CYP3A4	PA449599	1576	0.993
NULL	Oncotarget_2013_Aug_30_4(10)_1698-1711.nxml.txt.nlp	24091605	SENT131	10	10	0	0	cisplatin	CD44	PA449014	960	0.993
NULL	Cardiovasc_Res_2011_Feb_15_89(3)_604-613.nxml.txt.nlp	21088116	SENT156	12	12	18	18	pp2	JNK		5599	0.993
NULL	South_Asian_J_Cancer_2014_Jul-Sep_3(3)_154-158.nxml.txt.nlp	25136521	SENT144	14	14	19	19	ethanol	CYP2C9	PA448073	1559	0.993
NULL	Front_Oncol_2014_Nov_5_4_281.nxml.txt.nlp	25414829	SENT103	40	40	16	16	erlotinib	EGF	PA134687924	1950	0.993
NULL	Mol_Cancer_2009_Nov_19_8_108.nxml.txt.nlp	19925669	SENT40	1	1	31	31	doxorubicin	CRT	PA449412	811	0.993
NULL	Blood_Cancer_J_2012_Mar_9_2(3)_e60.nxml.txt.nlp	22829255	SENT124	24	24	4	4	flavopiridol	FLT3	PA452627	2322	0.993
NULL	Br_J_Pharmacol_2008_Oct_18_155(4)_596-605.nxml.txt.nlp	18852694	SENT300	7	7	23	23	fenofibrate	PI3K	PA449594	5290	0.993
NULL	Clinics_(Sao_Paulo)_2013_May_68(5)_694-701.nxml.txt.nlp	23778405	SENT184	24	24	3	3	curcumin	survivin	PA151958596	332	0.993
NULL	Brain_Sci_2013_Apr_22_3(2)_561-598.nxml.txt.nlp	24961415	SENT284	0	0	20	20	atorvastatin	p47phox	PA448500	653361	0.993
NULL	Oncol_Lett_2014_Jun_28_7(6)_1747-1754.nxml.txt.nlp	24932227	SENT106	47	47	23	23	trypsin	SPINK1	PA451806	6690	0.993
NULL	Front_Neurosci_2014_Jun_3_8_128.nxml.txt.nlp	24917782	SENT59	14	14	28	28	ethanol	ACTH	PA448073	5443	0.993
NULL	Cancer_Metastasis_Rev_2011_Jun_23_30(2)_185-197.nxml.txt.nlp	21340664	SENT179	21	21	31	31	gemcitabine	CHK1	PA449748	1111	0.993
NULL	Acta_Pharmacol_Sin_2012_Jul_18_33(7)_861-872.nxml.txt.nlp	22705730	SENT118	10	10	41	41	atorvastatin	PI3K	PA448500	5290	0.993
NULL	Open_Biochem_J_2011_Sep_23_5_45-51.nxml.txt.nlp	21966325	SENT88	13	13	24	24	diclofenac	JNK	PA449293	5599	0.993
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT7	18	18	2	2	trastuzumab	HER3	PA451743	2065	0.993
NULL	Breast_Cancer_Res_Treat_2013_Jan_6_137(1)_167-174.nxml.txt.nlp	23129173	SENT29	4	4	14	14	letrozole	aromatase	PA450196	1588	0.993
NULL	Br_J_Cancer_2010_Jun_8_102(12)_1762-1768.nxml.txt.nlp	20485284	SENT131	16	16	5	5	cetuximab	BRAF	PA10040	673	0.993
NULL	Front_Oncol_2014_Mar_11_4_45.nxml.txt.nlp	24653979	SENT257	22	22	5	5	paclitaxel	CD44	PA450761	960	0.993
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1717-1723.nxml.txt.nlp	19844230	SENT133	4	4	13	13	sunitinib	GM-CSF	PA162372840	1437	0.993
NULL	Evid_Based_Complement_Alternat_Med_2012_Feb_16_2012_430262.nxml.txt.nlp	22454664	SENT107	7	7	27	27	clopidogrel	CYP2C9	PA449053	1559	0.993
NULL	J_Hematol_Oncol_2013_Jun_3_6_38.nxml.txt.nlp	23731980	SENT57	8	8	29	29	doxorubicin	HER2	PA449412	2064	0.993
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT144	6	6	32	32	vinorelbine	ASC	PA451881	29108	0.993
NULL	Int_J_Gen_Med_2012_Jun_18_5_535-540.nxml.txt.nlp	22807641	SENT81	20	20	39	39	pitavastatin	adiponectin	PA142650384	9370	0.993
NULL	Cancer_Med_2014_Jun_25_3(3)_674-680.nxml.txt.nlp	24668895	SENT186	8	8	2	2	panitumumab	BRAF	PA162373091	673	0.993
NULL	Diabetes_Care_2010_Aug_33(8)_1905-1907.nxml.txt.nlp	20668158	SENT57	38	38	4	4	valsartan	AT-1	PA451848	9197	0.993
NULL	J_Hematol_Oncol_2008_Oct_23_1_19.nxml.txt.nlp	18947412	SENT110	34	34	4	4	alemtuzumab	CD52	PA164783958	1043	0.993
NULL	Open_Biochem_J_2012_Dec_11_6_131-138.nxml.txt.nlp	23264832	SENT50	30	30	3	3	benserazide	DDC		1644	0.993
NULL	Mediators_Inflamm_2001_Jun_10(3)_125-133.nxml.txt.nlp	11545249	SENT9	18	18	12	12	metyrapone	CTX	PA450486	1593	0.993
NULL	Br_J_Pharmacol_2014_Jan_23_171(2)_523-535.nxml.txt.nlp	24372553	SENT39	13	13	3	3	metformin	SIRT1	PA450395	23411	0.993
NULL	Crit_Care_2005_Nov_16_9(6)_R790-R797.nxml.txt.nlp	16356228	SENT39	33	33	14	14	octreotide	IL-18	PA450678	3606	0.993
NULL	Oncol_Lett_2013_Sep_15_6(3)_648-654.nxml.txt.nlp	24137384	SENT37	27	27	12	12	cisplatin	GSTM1	PA449014	2944	0.993
NULL	Acta_Pharmacol_Sin_2010_Sep_16_31(9)_1075-1084.nxml.txt.nlp	20711221	SENT115	8	8	19	19	metformin	AMPK	PA450395	5563	0.993
NULL	Breast_Cancer_Res_Treat_2012_Jun_18_133(3)_937-947.nxml.txt.nlp	22094936	SENT185	12	12	5	5	tamoxifen	CDC2	PA451581	5424	0.993
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT83	22	22	10	10	capecitabine	HER2	PA448771	2064	0.993
NULL	Braz_J_Microbiol_2009_Dec_1_Oct-Dec_40(4)_838-845.nxml.txt.nlp	24031431	SENT139	23	23	0	0	chloramphenicol	TAK1	PA448927	7182	0.993
NULL	Mol_Cancer_2007_Mar_7_6_18.nxml.txt.nlp	17343740	SENT389	15	15	3	3	paraformaldehyde	CD44	PA450790	960	0.993
NULL	J_Cell_Mol_Med_2014_Sep_3_18(9)_1840-1850.nxml.txt.nlp	24894955	SENT239	29	29	5	5	ethanol	EPO	PA448073	7076;8288;2056	0.993
NULL	Breast_Cancer_Res_2013_Sep_25_15(5)_R88.nxml.txt.nlp	24063698	SENT29	5	5	31	31	olaparib	BRCA1		672	0.993
NULL	Cancer_Metab_2014_May_28_2(Suppl_1)_P24.nxml.txt.nlp	NULL	SENT19	12	12	6	6	etoposide	p53	PA449552	7157	0.993
NULL	Acta_Pharmacol_Sin_2009_Aug_13_30(8)_1132-1137.nxml.txt.nlp	19597528	SENT164	10	10	39	39	losartan	AT2	PA450268	186	0.993
NULL	Arch_Med_Sci_2011_Dec_31_7(6)_977-983.nxml.txt.nlp	22328880	SENT121	30	30	1	1	heparin	PAPP-A	PA449855	5069	0.993
NULL	J_Cachexia_Sarcopenia_Muscle_2011_Mar_16_2(1)_9-25.nxml.txt.nlp	21475675	SENT198	31	31	8	8	rosiglitazone	PI3K	PA451283	5290	0.993
NULL	Oncol_Lett_2013_Feb_9_5(2)_552-558.nxml.txt.nlp	23420128	SENT32	5	5	13	13	imatinib	KIT	PA10804	3815	0.993
NULL	Br_J_Cancer_2009_Jul_21_101(2)_269-277.nxml.txt.nlp	19603033	SENT92	19	19	2	2	cisplatin	MLH1	PA449014	4292	0.993
NULL	EMBO_Mol_Med_2012_Jun_13_4(6)_515-527.nxml.txt.nlp	22416035	SENT130	36	36	20	20	olaparib	p53		7157	0.993
NULL	Mar_Drugs_2014_Jun_27_12(7)_3818-3837.nxml.txt.nlp	24979269	SENT66	5	5	31	31	calcein	P-gp	PA132595336	5243	0.993
NULL	Arthritis_Res_Ther_2009_Feb_23_11(1)_216.nxml.txt.nlp	19291269	SENT222	0	0	15	15	tocilizumab	IL-6	PA165292659	3569	0.993
NULL	Int_J_Endocrinol_2011_Mar_6_2011_415719.nxml.txt.nlp	21461394	SENT98	7	7	15	15	cinacalcet	PTH	PA164776671	5741	0.993
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1554-1562.nxml.txt.nlp	21970876	SENT38	39	39	27	27	erlotinib	EGFR	PA134687924	1956	0.993
NULL	Diabetes_2011_May_23_60(5)_1493-1503.nxml.txt.nlp	21478464	SENT251	0	0	6	6	metformin	AMPK	PA450395	5563	0.993
NULL	Allergy_Asthma_Clin_Immunol_2010_Jul_28_6(1)_15.nxml.txt.nlp	20667118	SENT68	31	31	10	10	enalapril	C1-INH	PA449456	710	0.993
NULL	Eur_Respir_J_2012_Nov_26_40(5)_1106-1114.nxml.txt.nlp	23060624	SENT171	28	28	1	1	tiotropium	NNT	PA164769056	23530	0.993
NULL	Curr_Neuropharmacol_2009_Dec_7(4)_296-301.nxml.txt.nlp	20514209	SENT53	4	4	25	25	vasopressin	gamma	PA451858	9913	0.993
NULL	Braz_J_Med_Biol_Res_2014_Nov_4_48(1)_13-24.nxml.txt.nlp	25493378	SENT87	3	3	27	27	cisplatin	ERCC1	PA449014	2067	0.993
NULL	Curr_Chem_Genomics_2008_Feb_25_1_34-42.nxml.txt.nlp	20161826	SENT18	4	4	25	25	metformin	AMPK	PA450395	5563	0.993
NULL	Clin_Med_Insights_Oncol_2012_Dec_20_7_1-12.nxml.txt.nlp	23362372	SENT34	0	0	36	36	cabazitaxel	CYP2C8	PA165958401	1558	0.993
NULL	Behav_Brain_Funct_2014_Feb_13_10_5.nxml.txt.nlp	24524628	SENT8	8	8	21	21	capsaicin	TRPV1	PA448776	7442	0.993
NULL	AIDS_Res_Ther_2013_May_1_10_10.nxml.txt.nlp	23634877	SENT111	22	22	2	2	lovastatin	CCR5	PA450272	1234	0.993
NULL	Mol_Cells_2014_Mar_31_37(3)_257-263.nxml.txt.nlp	24658385	SENT10	13	13	1	1	chloroquine	TRPV1	PA448948	7442	0.993
NULL	Oncotarget_2014_Oct_16_5(20)_9546-9563.nxml.txt.nlp	25337673	SENT146	39	39	10	10	gefitinib	CDCP1	PA131301952	64866	0.993
NULL	Allergy_2012_Jul_15_67(7)_858-868.nxml.txt.nlp	22583069	SENT28	28	28	45	45	cladribine	ASM	PA449027	6609;283120	0.993
NULL	J_Hematol_Oncol_2008_Oct_1_1_16.nxml.txt.nlp	18828924	SENT79	14	14	4	4	trastuzumab	HER2	PA451743	2064	0.993
NULL	Leukemia_2014_Apr_14_28(4)_961-964.nxml.txt.nlp	24418991	SENT2	2	2	32	32	imatinib	P-gp	PA10804	5243	0.993
NULL	Multidiscip_Respir_Med_2013_Feb_27_8(1)_16.nxml.txt.nlp	23442499	SENT94	32	32	5	5	warfarin	VKORC1	PA451906	79001	0.993
NULL	Int_J_Mol_Imaging_2013_May_9_2013_278607.nxml.txt.nlp	23762549	SENT164	12	12	33	33	ethanol	FES	PA448073	2242	0.993
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT240	16	16	8	8	metformin	LKB1	PA450395	6794	0.993
NULL	Case_Rep_Med_2014_Dec_23_2014_381480.nxml.txt.nlp	25587282	SENT45	15	15	2	2	maraviroc	CCR5	PA164768835	1234	0.993
NULL	Oncotarget_2014_Feb_25_5(5)_1304-1314.nxml.txt.nlp	24675421	SENT42	23	23	12	12	cisplatin	RIP1	PA449014	10928;7386	0.993
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT355	24	24	5	5	heparin	FGF1	PA449855	2246	0.993
NULL	Br_J_Cancer_2012_Jan_3_106(1)_53-60.nxml.txt.nlp	22068817	SENT208	22	22	0	0	cetuximab	KRAS	PA10040	3845	0.993
NULL	Cancer_Inform_2008_Jun_10_6_315-355.nxml.txt.nlp	19259415	SENT333	23	23	9	9	cisplatin	IL-1B	PA449014	3553	0.993
NULL	Endocrinol_Diabetes_Metab_Case_Rep_2014_Sep_1_2014_140072.nxml.txt.nlp	25332771	SENT59	21	21	4	4	sitagliptin	DPP4	PA164748978	1803	0.993
NULL	J_Neurovirol_2013_Jun_4_19(4)_351-358.nxml.txt.nlp	23733308	SENT163	16	16	45	45	mefloquine	SOC	PA450348	91544	0.993
NULL	Lab_Invest_2014_Jul_5_94(7)_716-725.nxml.txt.nlp	24791744	SENT130	3	3	16	16	aprotinin	GZMB	PA448472	3002	0.993
NULL	Breast_Cancer_Res_2014_May_28_16(3)_R53.nxml.txt.nlp	24886537	SENT311	8	8	0	0	erlotinib	VAV3	PA134687924	10451	0.993
NULL	Clin_Mol_Allergy_2007_Jan_25_5_1.nxml.txt.nlp	17254346	SENT138	39	39	24	24	curcumin	IFN	PA151958596	3439	0.993
NULL	Br_J_Cancer_2012_Jun_26_107(1)_129-136.nxml.txt.nlp	22644295	SENT199	21	21	4	4	ethanol	TAK1	PA448073	7182	0.993
NULL	Breast_Cancer_(Auckl)_2012_Mar_7_6_67-77.nxml.txt.nlp	22438669	SENT6	0	0	17	17	lapatinib	HER2	PA152241907	2064	0.993
NULL	Nat_Med_2013_Dec_10_19(12)_10_1038_nm_3385.nxml.txt.nlp	24216752	SENT116	3	3	45	45	thrombin	PAR4	PA451674	9002;5074	0.993
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Aug_27_6_145-150.nxml.txt.nlp	25249759	SENT5	38	38	4	4	letrozole	aromatase	PA450196	1588	0.993
NULL	J_Cell_Biol_2001_Aug_6_154(3)_659-666.nxml.txt.nlp	11489922	SENT187	34	34	4	4	warfarin	MGP	PA451906	4256	0.993
NULL	Acta_Pharmacol_Sin_2013_Jan_17_34(1)_157-166.nxml.txt.nlp	23247593	SENT234	21	21	8	8	berberine	PUMA	PA165860812	27113	0.993
NULL	Br_J_Cancer_2011_Mar_1_104(5)_750-755.nxml.txt.nlp	21326243	SENT61	21	21	1	1	dacarbazine	MPG	PA449197	4350	0.993
NULL	Front_Neurol_2014_Apr_29_5_63.nxml.txt.nlp	24808888	SENT238	32	32	11	11	carbamazepine	ghrelin	PA448785	51738	0.993
NULL	Mol_Cancer_2010_Nov_8_9_291.nxml.txt.nlp	21059223	SENT118	1	1	25	25	paclitaxel	ZNF217	PA450761	7764	0.993
NULL	Virulence_2012_Oct_1_3(6)_518-520.nxml.txt.nlp	23076286	SENT46	13	13	3	3	propranolol	IL-8	PA451145	3576	0.993
NULL	Eur_J_Haematol_2010_Oct_85(4)_290-299.nxml.txt.nlp	20528908	SENT217	10	10	22	22	bortezomib	DKK-1	PA10252	22943	0.993
NULL	Infect_Dis_Ther_2013_Dec_2_2(2)_123-144.nxml.txt.nlp	25134476	SENT267	25	25	0	0	gentamicin	DIP	PA449753	23151;1831	0.993
NULL	J_Cell_Biol_2008_Jul_28_182(2)_367-379.nxml.txt.nlp	18644892	SENT74	28	28	4	4	pp2	PP2		4888	0.993
NULL	Anat_Cell_Biol_2012_Jun_30_45(2)_73-78.nxml.txt.nlp	22822460	SENT85	17	17	0	0	paclitaxel	EGFR	PA450761	1956	0.993
NULL	Mol_Biol_Cell_2014_Jun_1_25(11)_1782-1792.nxml.txt.nlp	24719457	SENT206	7	7	33	33	nicotine	KRAS	PA450626	3845	0.993
NULL	Cancer_Metastasis_Rev_2010_Dec_10_29(4)_581-594.nxml.txt.nlp	20830503	SENT298	4	4	31	31	anastrozole	ATAC	PA448432	6375	0.993
NULL	BMJ_2013_Nov_6_347_f6530.nxml.txt.nlp	24196498	SENT192	11	11	26	26	everolimus	DES	PA164746311	1674	0.993
NULL	Cough_2006_Dec_15_2_10.nxml.txt.nlp	17173683	SENT165	11	11	27	27	capsaicin	TRPV1	PA448776	7442	0.993
NULL	Mar_Drugs_2011_Dec_13_9(12)_2622-2642.nxml.txt.nlp	22363243	SENT224	12	12	0	0	staurosporine	HSC71	PA165109623	3312	0.993
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT226	16	16	0	0	cisplatin	p53	PA449014	7157	0.993
NULL	Depress_Res_Treat_2012_Dec_18_2012_752563.nxml.txt.nlp	23320155	SENT125	16	16	3	3	haloperidol	AKT	PA449841	207	0.993
NULL	J_Immunother_Cancer_2014_Jan_27_2_2.nxml.txt.nlp	24829759	SENT106	14	14	21	21	sorafenib	IL-21	PA7000	59067;50616;27189	0.993
NULL	J_Biol_Chem_2009_Sep_25_284(39)_26447-26455.nxml.txt.nlp	19633293	SENT17	18	18	38	38	hyaluronan	TSHR	PA165958431	7253	0.993
NULL	Diabetes_Care_2013_Aug_17_36(Suppl_2)_S292-S300.nxml.txt.nlp	23882062	SENT226	1	1	29	29	metformin	GLP-1	PA450395	100125288	0.993
NULL	FEBS_Open_Bio_2012_Jul_20_2_179-186.nxml.txt.nlp	23650597	SENT141	17	17	24	24	imiquimod	IFN	PA449972	3439	0.993
NULL	Stroke_Res_Treat_2011_Nov_10_2011_212485.nxml.txt.nlp	22135769	SENT47	18	18	0	0	atenolol	GRK2	PA448499	156	0.993
NULL	J_Biol_Chem_2009_Jan_2_284(1)_77-84.nxml.txt.nlp	18854318	SENT128	36	36	13	13	forskolin	BRSK1	PA146096022	84446	0.993
NULL	Oncotarget_2014_Oct_18_5(22)_11588-11603.nxml.txt.nlp	25473890	SENT16	42	42	3	3	imatinib	KIT	PA10804	3815	0.993
NULL	Biologics_2013_Dec_16_8_13-25.nxml.txt.nlp	24368879	SENT103	23	23	3	3	ranibizumab	PlGF-2	PA164746012	5228	0.993
NULL	Ann_Neurosci_2013_Jul_20(3)_115.nxml.txt.nlp	25206027	SENT22	17	17	0	0	axitinib	VEGFR2	PA164924493	3791	0.993
NULL	Int_J_Hypertens_2012_Sep_22_2012_915057.nxml.txt.nlp	21961055	SENT269	12	12	3	3	phenylephrine	CTRL	PA450935	1506	0.993
NULL	J_Cell_Sci_2014_May_1_127(9)_2106-2119.nxml.txt.nlp	24569881	SENT382	21	21	2	2	rolipram	SUR1	PA153906323	6833	0.993
NULL	Indian_J_Endocrinol_Metab_2012_Dec_16(Suppl_3)_S529-S531.nxml.txt.nlp	23565485	SENT33	3	3	11	11	metformin	NPY	PA450395	4852	0.993
NULL	Oncotarget_2014_Feb_21_5(10)_3012-3022.nxml.txt.nlp	24931142	SENT175	6	6	12	12	sorafenib	MCL1	PA7000	4170	0.993
NULL	Nucleic_Acids_Res_2005_Oct_27_33(18)_6024-6033.nxml.txt.nlp	16254079	SENT166	19	19	0	0	bicalutamide	HDAC2	PA164746255	3066	0.993
NULL	Cardiol_Ther_2013_Jun_7_2(1)_57-68.nxml.txt.nlp	25135289	SENT47	12	12	23	23	prasugrel	P2Y12	PA154410481	64805	0.993
NULL	Arthritis_Res_Ther_2006_Jul_28_8(Suppl_2)_S5.nxml.txt.nlp	16899109	SENT33	0	0	13	13	tocilizumab	IL-6	PA165292659	3569	0.993
NULL	Cell_Death_Dis_2010_May_13_1(5)_e41.nxml.txt.nlp	21364648	SENT7	31	31	18	18	etoposide	p53	PA449552	7157	0.993
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT36	13	13	5	5	pemetrexed	UNG	PA10810	7374	0.993
NULL	Oncotarget_2011_Dec_22_2(12)_1176-1190.nxml.txt.nlp	22202492	SENT119	4	4	11	11	fluvastatin	PLA2G7	PA449688	7941	0.993
NULL	Acta_Pharmacol_Sin_2009_May_5_30(5)_646-652.nxml.txt.nlp	19417737	SENT59	42	42	6	6	midazolam	CYP3A4	PA450496	1576	0.993
NULL	Biosci_Rep_2012_Aug_1_32(Pt_4)_361-374.nxml.txt.nlp	22762204	SENT163	24	24	17	17	cisplatin	BRCA1	PA449014	672	0.993
NULL	J_Immunother_Cancer_2013_Nov_7_1(Suppl_1)_P252.nxml.txt.nlp	NULL	SENT18	9	9	3	3	doxorubicin	CD19	PA449412	930	0.993
NULL	J_Cancer_Res_Clin_Oncol_2011_May_8_137(5)_821-828.nxml.txt.nlp	20694797	SENT116	28	28	9	9	tamoxifen	aromatase	PA451581	1588	0.993
NULL	Ther_Clin_Risk_Manag_2006_Mar_2(1)_59-75.nxml.txt.nlp	18360582	SENT239	21	21	11	11	clarithromycin	CYP3A4	PA449028	1576	0.993
NULL	Cardiovasc_Psychiatry_Neurol_2009_Oct_13_2009_475108.nxml.txt.nlp	20029624	SENT73	8	8	31	31	ketanserin	5-HT2A	PA131053734	3356	0.993
NULL	Biomed_Res_Int_2014_Feb_24_2014_540238.nxml.txt.nlp	24707490	SENT136	10	10	20	20	lamotrigine	GluK1	PA450164	2897	0.993
NULL	J_Cell_Mol_Med_2013_Oct_23_17(10)_1207-1217.nxml.txt.nlp	24106980	SENT87	36	36	5	5	docetaxel	E2F3	PA449383	1871	0.993
NULL	Front_Immunol_2014_Aug_22_5_406.nxml.txt.nlp	25202312	SENT172	0	0	29	29	eculizumab	CD59	PA164776637	966	0.993
NULL	Br_J_Cancer_2012_Sep_4_107(6)_947-955.nxml.txt.nlp	22892392	SENT16	28	28	7	7	tamoxifen	ERBB2	PA451581	2064	0.993
NULL	J_Oncol_2009_Mar_24_2009_491985.nxml.txt.nlp	19325924	SENT139	12	12	2	2	estradiol	CXCL12	PA449503	6387	0.993
NULL	BioDrugs_2013_May_7_27(5)_495-507.nxml.txt.nlp	23649935	SENT297	18	18	1	1	rituximab	AF4	PA451261	4299	0.993
NULL	Exp_Diabetes_Res_2012_Apr_17_2012_635472.nxml.txt.nlp	22577369	SENT72	22	22	7	7	liraglutide	GLP-1	PA165958364	100125288	0.993
NULL	Breast_Cancer_Res_2004_Aug_5_6(5)_R601-R607.nxml.txt.nlp	15318941	SENT27	7	7	16	16	docetaxel	p27	PA449383	5715;10534	0.993
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT206	8	8	25	25	chloroquine	BMPR-II	PA448948	659	0.993
NULL	Arthritis_Res_Ther_2009_May_18_11(3)_222.nxml.txt.nlp	19519927	SENT109	39	39	7	7	adalimumab	MRI	PA10004	78996	0.993
NULL	Biomed_Res_Int_2013_Jul_1_2013_964743.nxml.txt.nlp	23936861	SENT198	23	23	3	3	erlotinib	VEGFR	PA134687924	3791	0.993
NULL	Ther_Clin_Risk_Manag_2006_Mar_2(1)_87-98.nxml.txt.nlp	18360584	SENT88	8	8	36	36	sorafenib	BRAF	PA7000	673	0.993
NULL	Breast_Cancer_Res_2011_Mar_1_13(2)_R21.nxml.txt.nlp	21362200	SENT233	4	4	43	43	fulvestrant	aromatase	PA164747170	1588	0.993
NULL	Cerebrospinal_Fluid_Res_2006_Jan_3_3_1.nxml.txt.nlp	16390539	SENT180	0	0	26	26	probenecid	OAT	PA451106	4942	0.993
NULL	Oncol_Lett_2014_Sep_19_8(3)_1320-1322.nxml.txt.nlp	25120716	SENT19	2	2	21	21	gefitinib	EGFR	PA131301952	1956	0.993
NULL	J_Invest_Dermatol_2014_Jan_25_134(1)_268-271.nxml.txt.nlp	23812303	SENT47	2	2	12	12	etanercept	p40	PA449515	3921;339541;10314	0.993
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Nov_21_65(Pt_12)_o3168.nxml.txt.nlp	21578884	SENT64	37	37	11	11	ethanol	mol	PA448073	90527	0.993
NULL	Clinics_(Sao_Paulo)_2013_Feb_68(Suppl_1)_75-79.nxml.txt.nlp	23503956	SENT82	27	27	2	2	estradiol	aromatase	PA449503	1588	0.993
NULL	Int_J_Mol_Sci_2014_Sep_29_15(10)_17469-17477.nxml.txt.nlp	25268618	SENT3	4	4	21	21	lidocaine	zeta	PA450226	9907	0.993
NULL	Breast_Cancer_Res_2008_Dec_18_10(Suppl_4)_S26.nxml.txt.nlp	19128440	SENT13	36	36	4	4	anastrozole	ATAC	PA448432	6375	0.993
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT150	19	19	3	3	doxorubicin	SLK	PA449412	9748;2534	0.993
NULL	Acta_Pharmacol_Sin_2014_Jan_9_35(1)_1-10.nxml.txt.nlp	24317012	SENT49	23	23	10	10	imatinib	SLC22A1	PA10804	6580	0.993
NULL	Cancer_Growth_Metastasis_2013_Aug_8_6_35-52.nxml.txt.nlp	24665206	SENT38	13	13	30	30	curcumin	LPA	PA151958596	4018	0.993
NULL	J_Invest_Dermatol_2013_Jun_14_133(6)_1541-1549.nxml.txt.nlp	23407395	SENT73	15	15	1	1	imiquimod	CXCL1	PA449972	2919	0.993
NULL	J_Cancer_2014_Jul_4_5(7)_559-571.nxml.txt.nlp	25057307	SENT208	33	33	1	1	trastuzumab	PIK3CA	PA451743	5290	0.993
NULL	Br_J_Cancer_2014_Aug_12_111(4)_640-645.nxml.txt.nlp	24642617	SENT120	25	25	8	8	vemurafenib	BRAF	PA165946873	673	0.993
NULL	J_Oncol_2010_Oct_7_2010_576384.nxml.txt.nlp	20953378	SENT50	22	22	11	11	estradiol	VEGFR2	PA449503	3791	0.993
NULL	Aging_(Albany_NY)_2011_Jan_18_3(1)_33-43.nxml.txt.nlp	21248371	SENT131	40	40	4	4	zinc	HIPK2	PA451956	28996	0.993
NULL	Exp_Brain_Res_2014_Jun_27_232(8)_2637-2644.nxml.txt.nlp	24969614	SENT27	18	18	0	0	palonosetron	NK1	PA10352	11126	0.993
NULL	Ital_J_Pediatr_2012_Jun_26_38_29.nxml.txt.nlp	22734451	SENT107	32	32	4	4	montelukast	URI	PA450546	8725	0.993
NULL	Ann_N_Y_Acad_Sci_2013_Apr_6_1281(1)_36-50.nxml.txt.nlp	23387439	SENT157	26	26	0	0	liraglutide	GLP-1	PA165958364	100125288	0.993
NULL	Breast_Cancer_Res_2014_Oct_31_16(5)_447.nxml.txt.nlp	25358600	SENT173	8	8	35	35	tamoxifen	CXCR4	PA451581	7852	0.993
NULL	J_Mol_Med_(Berl)_2014_May_10_92(7)_709-722.nxml.txt.nlp	24811491	SENT90	29	29	1	1	cetuximab	BRAF	PA10040	673	0.993
NULL	Front_Endocrinol_(Lausanne)_2013_Nov_11_4_166.nxml.txt.nlp	24273531	SENT244	38	38	4	4	losartan	AT1	PA450268	9197;185	0.993
NULL	J_Cell_Biol_2001_Oct_29_155(3)_447-458.nxml.txt.nlp	11684709	SENT319	7	7	33	33	pp2	EGF		1950	0.993
NULL	Breast_Cancer_Res_2004_Oct_24_6(1)_R8-R17.nxml.txt.nlp	14680495	SENT95	12	12	0	0	tamoxifen	BRCA1	PA451581	672	0.993
NULL	Int_J_Biol_Sci_2011_Nov_5_8(1)_1-14.nxml.txt.nlp	22211100	SENT30	4	4	40	40	evodiamine	XIAP	PA165860788	331	0.993
NULL	Cell_Biol_Int_Rep_(2010)_2012_Jun_21_19(1)_e00017.nxml.txt.nlp	23124518	SENT6	10	10	22	22	etoposide	TRAIL	PA449552	8743	0.993
NULL	Mol_Cancer_2014_Aug_22_13(1)_195.nxml.txt.nlp	NULL	SENT162	12	12	5	5	cisplatin	TBL1XR1	PA449014	79718	0.993
NULL	Adv_Biomed_Res_2014_Sep_8_3_189.nxml.txt.nlp	25298958	SENT90	35	35	11	11	omeprazole	NAC	PA450704	22861	0.993
NULL	Hum_Genomics_Proteomics_2009_Jun_24_2009_453634.nxml.txt.nlp	20981323	SENT37	5	5	27	27	thalidomide	CCL5	PA451644	6352	0.993
NULL	Nucleic_Acids_Res_2013_Apr_17_41(7)_4129-4143.nxml.txt.nlp	23420868	SENT161	13	13	21	21	hemin	GATA-1	PA449849	2623	0.993
NULL	Curr_Oncol_2009_May_16(Suppl_1)_S52-S59.nxml.txt.nlp	19478903	SENT160	0	0	20	20	sunitinib	CYP3A4	PA162372840	1576	0.993
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT214	31	31	1	1	metformin	DPI	PA450395	1832	0.993
NULL	J_Exp_Med_1998_Jun_1_187(11)_1885-1892.nxml.txt.nlp	9607928	SENT155	14	14	34	34	thalidomide	CD4	PA451644	920	0.993
NULL	Acta_Vet_Scand_2014_May_20_56(1)_33.nxml.txt.nlp	24884817	SENT188	10	10	3	3	heparin	IL-6	PA449855	3569	0.993
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1047.nxml.txt.nlp	24503539	SENT35	2	2	20	20	resveratrol	SIRT3		23410	0.993
NULL	Case_Rep_Oncol_2013_Jul_20_6(2)_382-386.nxml.txt.nlp	23904849	SENT51	36	36	5	5	panitumumab	ERBB2	PA162373091	2064	0.993
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT150	22	22	7	7	erlotinib	AKT	PA134687924	207	0.993
NULL	EMBO_Mol_Med_2013_Jan_29_5(1)_137-148.nxml.txt.nlp	23197407	SENT109	22	22	6	6	losartan	TR3	PA450268	8718;3164;10587	0.993
NULL	Clin_Med_Insights_Oncol_2011_Sep_21_5_265-314.nxml.txt.nlp	22084619	SENT457	2	2	26	26	erlotinib	EGFR	PA134687924	1956	0.993
NULL	Mol_Cancer_2004_May_4_3_14.nxml.txt.nlp	15125777	SENT40	13	13	3	3	cisplatin	CHK2	PA449014	11200	0.993
NULL	Biosci_Rep_2012_Aug_1_32(Pt_4)_361-374.nxml.txt.nlp	22762204	SENT163	24	24	3	3	cisplatin	BRCA1	PA449014	672	0.993
NULL	Indian_J_Med_Res_2013_Apr_137(4)_659-668.nxml.txt.nlp	23703333	SENT135	37	37	1	1	latanoprost	Rho	PA164774763	29984	0.993
NULL	EMBO_Mol_Med_2013_Aug_8_5(8)_1227-1246.nxml.txt.nlp	23836498	SENT110	18	18	7	7	2-methoxyestradiol	HIF-1	PA134967247	29072	0.993
NULL	Diabetes_2009_Jun_16_58(6)_1382-1390.nxml.txt.nlp	19289456	SENT228	31	31	3	3	losartan	Bcl-2	PA450268	596	0.993
NULL	Cancer_Manag_Res_2013_Jun_7_5_91-101.nxml.txt.nlp	23785245	SENT14	19	19	35	35	gefitinib	EGFR	PA131301952	1956	0.993
NULL	Breast_Cancer_Res_2010_Jun_24_12(3)_R41.nxml.txt.nlp	20576088	SENT176	44	44	10	10	paclitaxel	RPS6KB1	PA450761	6198	0.993
NULL	Breast_Cancer_Res_2011_Aug_16_13(4)_312.nxml.txt.nlp	21861853	SENT20	37	37	1	1	tamoxifen	CUEDC2	PA451581	79004	0.993
NULL	Cancer_Cell_Int_2010_Jan_11_10_1.nxml.txt.nlp	20142996	SENT152	29	29	17	17	erlotinib	U87	PA134687924	677775;641648	0.993
NULL	Int_J_Biomed_Sci_2014_Sep_10(3)_217-220.nxml.txt.nlp	25324704	SENT68	0	0	13	13	amiodarone	APT	PA448383	653639	0.993
NULL	Breast_Cancer_Res_2010_Apr_16_12(2)_R24.nxml.txt.nlp	20398352	SENT150	17	17	1	1	tamoxifen	ATAC	PA451581	6375	0.993
NULL	Diabetes_Obes_Metab_2012_Dec_19_14(12)_1097-1103.nxml.txt.nlp	22734440	SENT28	0	0	7	7	exenatide	GLP-1	PA164749238	100125288	0.993
NULL	J_Thromb_Haemost_2007_May_1_5(5)_910-917.nxml.txt.nlp	17362227	SENT76	43	43	3	3	cangrelor	P2X1	PA165945763	5023	0.993
NULL	Int_J_Gen_Med_2009_Jul_30_2_129-140.nxml.txt.nlp	20360896	SENT81	28	28	8	8	letrozole	aromatase	PA450196	1588	0.993
NULL	Exp_Diabetes_Res_2011_Nov_30_2011_162092.nxml.txt.nlp	22203828	SENT27	0	0	37	37	sitagliptin	GLP-1	PA164748978	100125288	0.993
NULL	Clin_Med_Insights_Cardiol_2011_Oct_6_5_103-119.nxml.txt.nlp	22084608	SENT251	30	30	9	9	dronedarone	ARTEMIS	PA153619853	64421	0.993
NULL	Breast_Cancer_Res_2008_Dec_18_10(Suppl_4)_S26.nxml.txt.nlp	19128440	SENT13	42	42	4	4	tamoxifen	ATAC	PA451581	6375	0.993
NULL	J_RNAi_Gene_Silencing_2010_May_29_6(1)_386-400.nxml.txt.nlp	20628499	SENT258	6	6	1	1	flavopiridol	ACH2	PA452627	641371	0.993
NULL	Pharmaceuticals_(Basel)_2013_Aug_21_6(8)_988-1038.nxml.txt.nlp	24276379	SENT477	14	14	5	5	vemurafenib	EGFR	PA165946873	1956	0.993
NULL	Curr_Oncol_2009_May_16(Suppl_1)_S52-S59.nxml.txt.nlp	19478903	SENT48	2	2	36	36	sorafenib	CYP2C8	PA7000	1558	0.993
NULL	Breast_Cancer_Res_2010_Jul_22_12(4)_R53.nxml.txt.nlp	20649975	SENT15	26	26	2	2	tamoxifen	HOXB13	PA451581	10481	0.993
NULL	J_Cardiothorac_Surg_2014_May_9_9_81.nxml.txt.nlp	24885948	SENT29	0	0	22	22	sorafenib	VEGFR	PA7000	3791	0.993
NULL	Breast_Cancer_Res_2012_Nov_12_14(6)_R145.nxml.txt.nlp	23146280	SENT41	21	21	2	2	bevacizumab	VEGF-A	PA130232992	7422	0.993
NULL	Psychiatry_Investig_2012_Dec_12_9(4)_422-424.nxml.txt.nlp	23251210	SENT14	10	10	15	15	perphenazine	CYP2D6	PA450882	1565	0.993
NULL	Clinics_(Sao_Paulo)_2012_Apr_67(Suppl_1)_131-139.nxml.txt.nlp	22584718	SENT24	3	3	34	34	cinacalcet	PTH	PA164776671	5741	0.993
NULL	Clin_Sci_(Lond)_2011_Nov_1_121(Pt_10)_449-458.nxml.txt.nlp	21671887	SENT182	5	5	13	13	simvastatin	AMPK	PA451363	5563	0.993
NULL	Drugs_R_D_2011_Mar_27_11(1)_37-51.nxml.txt.nlp	21410294	SENT246	8	8	23	23	itraconazole	CYP3A4	PA450132	1576	0.993
NULL	J_Cancer_2012_Aug_24_3_354-361.nxml.txt.nlp	22962562	SENT170	36	36	6	6	cisplatin	MDM2	PA449014	4193	0.993
NULL	Oncol_Lett_2014_Jan_29_7(1)_183-188.nxml.txt.nlp	24348845	SENT132	19	19	3	3	etoposide	PDCD4	PA449552	27250	0.993
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT3332	0	0	26	26	troglitazone	gamma	PA451799	9913	0.993
NULL	Acta_Pharmacol_Sin_2009_Dec_4_30(12)_1607-1615.nxml.txt.nlp	19960007	SENT51	2	2	8	8	berberine	AMPK	PA165860812	5563	0.993
NULL	Aging_(Albany_NY)_2013_Mar_6_5(3)_174-182.nxml.txt.nlp	23525956	SENT90	30	30	12	12	ethanol	SIRT1	PA448073	23411	0.993
NULL	Int_J_Surg_Oncol_2012_May_17_2012_406830.nxml.txt.nlp	22675625	SENT49	39	39	0	0	gefitinib	EGFR	PA131301952	1956	0.993
NULL	Hum_Genomics_2004_May_1_1(4)_300-306.nxml.txt.nlp	15588489	SENT147	8	8	19	19	midazolam	CYP3A4	PA450496	1576	0.993
NULL	Case_Rep_Med_2014_Mar_4_2014_923496.nxml.txt.nlp	24715926	SENT132	34	34	20	20	tocilizumab	IL-6	PA165292659	3569	0.993
NULL	Br_J_Cancer_2012_Jul_24_107(3)_491-500.nxml.txt.nlp	22722314	SENT131	32	32	4	4	vinblastine	PIM1	PA451877	5292;9361	0.993
NULL	BMB_Rep_2013_Mar_46(3)_157-162.nxml.txt.nlp	23527859	SENT110	42	42	1	1	galactose	mol	PA449725	90527	0.993
NULL	Oncol_Lett_2014_Nov_12_8(5)_2203-2208.nxml.txt.nlp	25295109	SENT128	11	11	35	35	celecoxib	SMO	PA448871	6608;54498	0.993
NULL	Diabetes_2011_Nov_17_60(11)_2691-2700.nxml.txt.nlp	21896928	SENT154	5	5	25	25	resveratrol	SIRT1		23411	0.993
NULL	Oncotarget_2013_Dec_15_4(12)_2577-2590.nxml.txt.nlp	24342878	SENT143	12	12	19	19	genistein	NF-kappaB	PA165109660	4790	0.993
NULL	Contemp_Oncol_(Pozn)_2013_Apr_29_17(2)_128-133.nxml.txt.nlp	23788978	SENT44	0	0	33	33	oxycodone	CYP2D6	PA450741	1565	0.993
NULL	Case_Rep_Transplant_2012_Sep_27_2012_493758.nxml.txt.nlp	23259133	SENT62	12	12	4	4	ganciclovir	IFN	PA449733	3439	0.993
NULL	ScientificWorldJournal_2012_Apr_24_2012_184362.nxml.txt.nlp	22619618	SENT115	11	11	25	25	lenalidomide	CD34	PA162363968	947	0.993
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Jul_21_9_20.nxml.txt.nlp	20663145	SENT78	37	37	7	7	erythromycin	LBH	PA449493	81606;221491	0.993
NULL	Oncol_Rep_2012_Oct_13_28(4)_1146-1152.nxml.txt.nlp	22797812	SENT47	9	9	1	1	camptothecin	WRN	PA153590860	7486	0.993
NULL	Biomed_Imaging_Interv_J_2011_Oct_1_7(4)_e25.nxml.txt.nlp	22279502	SENT197	5	5	20	20	oxaliplatin	LARC	PA131285527	6364	0.993
NULL	Breast_Cancer_Res_2004_Nov_7_6(1)_39-52.nxml.txt.nlp	14680484	SENT160	32	32	10	10	tamoxifen	N-CoR	PA451581	9611	0.993
NULL	Inflamm_Res_2010_Sep_26_59(9)_699-709.nxml.txt.nlp	20339899	SENT29	13	13	3	3	trypsin	PAR1	PA451806	79581;2149	0.993
NULL	J_Cancer_2013_Jan_11_4(2)_117-132.nxml.txt.nlp	23386910	SENT233	14	14	30	30	everolimus	HER2	PA164746311	2064	0.993
NULL	J_Adv_Pharm_Technol_Res_2012_Jul-Sep_3(3)_147-159.nxml.txt.nlp	23057001	SENT259	3	3	13	13	foscarnet	GIT	PA449706	5034	0.993
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_7-17.nxml.txt.nlp	17912633	SENT63	5	5	23	23	letrozole	aromatase	PA450196	1588	0.993
NULL	Fibrogenesis_Tissue_Repair_2012_Jul_23_5_11.nxml.txt.nlp	22824096	SENT407	4	4	31	31	thrombin	PAR-1	PA451674	2011;2149	0.993
NULL	J_Exp_Med_1998_Jun_1_187(11)_1885-1892.nxml.txt.nlp	9607928	SENT155	14	14	24	24	thalidomide	CD4	PA451644	920	0.993
NULL	Mol_Cancer_2010_Jun_25_9_165.nxml.txt.nlp	20576164	SENT164	21	21	12	12	curcumin	IRF1	PA151958596	3659	0.993
NULL	Breast_Cancer_Res_2012_May_3_14(3)_R71.nxml.txt.nlp	22554015	SENT145	0	0	7	7	trastuzumab	HER2	PA451743	2064	0.993
NULL	Cancers_(Basel)_2013_Jun_24_5(3)_739-761.nxml.txt.nlp	24202319	SENT101	0	0	8	8	olaparib	PARP1		142	0.993
NULL	Am_J_Cardiovasc_Drugs_2013_Jun_20_13(5)_331-342.nxml.txt.nlp	23784266	SENT196	1	1	13	13	amiodarone	P-gp	PA448383	5243	0.993
NULL	Pharmaceuticals_(Basel)_2013_Aug_6_6(8)_929-959.nxml.txt.nlp	24276377	SENT108	15	15	3	3	oxaliplatin	CXCR2	PA131285527	3579	0.993
NULL	Clin_Sci_(Lond)_2012_May_1_122(Pt_9)_421-428.nxml.txt.nlp	22092038	SENT31	3	3	25	25	doxycycline	JNK2	PA449415	5601	0.993
NULL	Clin_Ophthalmol_2011_Apr_18_5_495-502.nxml.txt.nlp	21573098	SENT118	30	30	11	11	gatifloxacin	BAK	PA449738	578	0.993
NULL	Ann_Indian_Acad_Neurol_2010_Apr-Jun_13(2)_136-138.nxml.txt.nlp	20814499	SENT58	3	3	20	20	cyclophosphamide	CD4	PA449165	920	0.993
NULL	Open_Virol_J_2009_Oct_23_3_67-83.nxml.txt.nlp	19915722	SENT76	8	8	29	29	imiquimod	CD4	PA449972	920	0.993
NULL	Cardiovasc_Diabetol_2013_May_30_12(Suppl_1)_S2.nxml.txt.nlp	23819752	SENT129	14	14	18	18	rosuvastatin	CYP2C9	PA134308647	1559	0.993
NULL	Acta_Pharmacol_Sin_2012_Apr_5_33(4)_551-557.nxml.txt.nlp	22388075	SENT42	20	20	4	4	imatinib	Wip1	PA10804	8493	0.993
NULL	Mol_Cancer_2014_Jun_24_13_157.nxml.txt.nlp	24958351	SENT169	40	40	5	5	trastuzumab	EGFR	PA451743	1956	0.993
NULL	Mol_Cancer_2014_Jun_24_13_157.nxml.txt.nlp	24958351	SENT170	28	28	5	5	lapatinib	PTEN	PA152241907	5728	0.993
NULL	Br_J_Cancer_2003_Mar_24_88(6)_848-854.nxml.txt.nlp	12644821	SENT161	40	40	9	9	cisplatin	TP53	PA449014	7157	0.993
NULL	Br_J_Cancer_2010_Oct_12_103(8)_1192-1200.nxml.txt.nlp	20877358	SENT190	29	29	1	1	doxorubicin	BRCA2	PA449412	675	0.993
NULL	Cancers_(Basel)_2011_Apr_19_3(2)_2106-2130.nxml.txt.nlp	24212798	SENT161	26	26	13	13	tamoxifen	EGFR	PA451581	1956	0.993
NULL	Mol_Vis_2012_Nov_12_18_2658-2672.nxml.txt.nlp	23170059	SENT96	36	36	3	3	tamoxifen	E14	PA451581	4863	0.993
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT226	8	8	1	1	panitumumab	KRAS	PA162373091	3845	0.993
NULL	Clin_Epigenetics_2011_Jul_16_2(2)_411-416.nxml.txt.nlp	22704352	SENT64	24	24	10	10	decitabine	JAK2	PA164749631	3717	0.993
NULL	Ann_Rheum_Dis_2013_Apr_11_72(4)_583-589.nxml.txt.nlp	23144446	SENT137	22	22	39	39	methotrexate	IL-6	PA450428	3569	0.993
NULL	Infect_Dis_Obstet_Gynecol_2008_May_29_2008_493508.nxml.txt.nlp	18528520	SENT88	17	17	4	4	coumarin	CDR1	PA134521193	1038	0.993
NULL	South_Asian_J_Cancer_2014_Jul-Sep_3(3)_154-158.nxml.txt.nlp	25136521	SENT29	18	18	0	0	cyclophosphamide	CYP2C9	PA449165	1559	0.993
NULL	Oncotarget_2013_Aug_21_4(9)_1484-1495.nxml.txt.nlp	23986086	SENT166	33	33	16	16	metformin	EGFR	PA450395	1956	0.993
NULL	Curr_Neuropharmacol_2014_Jul_12(4)_365-379.nxml.txt.nlp	25342944	SENT66	23	23	11	11	fluoxetine	5-HT2B	PA449673	3357	0.993
NULL	Clin_Pharmacol_2013_Apr_19_5_67-83.nxml.txt.nlp	23650452	SENT46	26	26	6	6	clopidogrel	LTA	PA449053	4049	0.993
NULL	Eur_J_Neurol_2012_Nov_19_19(11)_1470-1476.nxml.txt.nlp	22607270	SENT55	8	8	3	3	mexiletine	DM1	PA450488	338023;1760;28509	0.993
NULL	Braz_J_Med_Biol_Res_2014_Mar_21_47(4)_273-278.nxml.txt.nlp	24676475	SENT87	18	18	4	4	doxorubicin	CIAPIN1	PA449412	57019	0.993
NULL	Infect_Dis_Ther_2013_Dec_2_2(2)_123-144.nxml.txt.nlp	25134476	SENT267	27	27	0	0	sertraline	DIP	PA451333	23151;1831	0.993
NULL	Cancer_Metab_2014_May_28_2(Suppl_1)_O23.nxml.txt.nlp	NULL	SENT10	14	14	35	35	metformin	AMPK	PA450395	5563	0.993
NULL	Breast_Cancer_Res_2012_Jun_19_14(3)_209.nxml.txt.nlp	22713170	SENT102	0	0	17	17	pertuzumab	HER2		2064	0.993
NULL	Braz_J_Med_Biol_Res_2014_Sep_5_47(11)_1008-1015.nxml.txt.nlp	25296365	SENT12	32	32	12	12	tamoxifen	CYP2D6	PA451581	1565	0.993
NULL	Arthritis_Res_Ther_2012_May_1_14(3)_R99.nxml.txt.nlp	22546542	SENT35	29	29	6	6	infliximab	IL-17	PA452639	3605	0.993
NULL	Leukemia_2013_Feb_10_27(2)_507-510.nxml.txt.nlp	22810506	SENT21	24	24	0	0	doxorubicin	TRAC	PA449412	28755	0.993
NULL	Oncologist_2010_Feb_15_15(2)_122-129.nxml.txt.nlp	20156908	SENT130	0	0	10	10	lapatinib	HER-2	PA152241907	2064	0.993
NULL	Int_J_Surg_Oncol_2011_Jun_6_2011_285840.nxml.txt.nlp	22312501	SENT58	5	5	23	23	cetuximab	KRAS	PA10040	3845	0.993
NULL	Breast_Cancer_Res_2006_Oct_2_8(5)_R56.nxml.txt.nlp	17014703	SENT204	37	37	13	13	tamoxifen	PSAT1	PA451581	29968	0.993
NULL	Oncoimmunology_2013_Sep_1_2(9)_e26198.nxml.txt.nlp	24228232	SENT27	28	28	0	0	cisplatin	p53	PA449014	7157	0.993
NULL	Ann_Dermatol_2014_Jun_12_26(3)_363-373.nxml.txt.nlp	24966637	SENT130	14	14	2	2	imiquimod	MT1-MMP	PA449972	4323	0.993
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT176	3	3	17	17	tacrolimus	IL-6	PA451578	3569	0.993
NULL	Int_J_Biol_Sci_2014_Jan_11_10(2)_142-148.nxml.txt.nlp	24520212	SENT103	31	31	1	1	tamoxifen	WWOX	PA451581	51741	0.993
NULL	Oncotarget_2014_Nov_5_5(22)_11381-11398.nxml.txt.nlp	25359767	SENT140	8	8	34	34	hydroxyurea	CHK1	PA449942	1111	0.993
NULL	Diabetes_2013_Nov_18_62(11)_3851-3862.nxml.txt.nlp	23884890	SENT23	43	43	4	4	metformin	AMPK	PA450395	5563	0.993
NULL	Patient_Prefer_Adherence_2013_Mar_27_7_245-258.nxml.txt.nlp	23569364	SENT163	8	8	39	39	exemestane	aromatase	PA449563	1588	0.993
NULL	Diabetes_Care_2012_Jun_11_35(6)_1225-1231.nxml.txt.nlp	22432104	SENT21	16	16	8	8	exenatide	GLP-1	PA164749238	100125288	0.993
NULL	Nucl_Recept_Signal_2009_Jan_16_7_e001.nxml.txt.nlp	19240808	SENT117	10	10	37	37	troglitazone	SXR	PA451799	8856	0.993
NULL	J_Immunol_Res_2014_May_25_2014_608930.nxml.txt.nlp	24971371	SENT88	5	5	39	39	montelukast	IL-8	PA450546	3576	0.993
NULL	J_Immunol_Res_2014_Feb_3_2014_671431.nxml.txt.nlp	24741615	SENT57	0	0	44	44	paraformaldehyde	p38	PA450790	10598;1432;7965	0.993
NULL	Biomed_Res_Int_2013_Jan_8_2013_252158.nxml.txt.nlp	23509696	SENT72	10	10	0	0	perindopril	CD34	PA450877	947	0.993
NULL	Cancer_Med_2014_Dec_13_3(6)_1579-1594.nxml.txt.nlp	25124282	SENT232	3	3	9	9	olaparib	AKT		207	0.993
NULL	Acta_Pharmacol_Sin_2014_Jun_4_35(6)_752-757.nxml.txt.nlp	24902786	SENT94	12	12	21	21	flutamide	STZ	PA449685	6484	0.993
NULL	BMB_Rep_2013_Aug_46(8)_410-415.nxml.txt.nlp	23977989	SENT54	3	3	23	23	curcumin	HO-1	PA151958596	3162	0.993
NULL	Indian_J_Urol_2009_Oct-Dec_25(4)_427-436.nxml.txt.nlp	19955664	SENT80	0	0	23	23	sunitinib	KIT	PA162372840	3815	0.993
NULL	Br_J_Cancer_1997_75(9)_1279-1283.nxml.txt.nlp	9155046	SENT14	13	13	42	42	losartan	AT1	PA450268	9197;185	0.993
NULL	Breast_Cancer_(Auckl)_2012_Mar_7_6_67-77.nxml.txt.nlp	22438669	SENT168	3	3	21	21	lapatinib	HER2	PA152241907	2064	0.993
NULL	Braz_J_Med_Biol_Res_2014_Sep_5_47(11)_929-939.nxml.txt.nlp	25296354	SENT64	28	28	35	35	afatinib	EGFR	PA165981154	1956	0.992
NULL	J_Lipid_Res_2014_Jul_55(7)_1298-1309.nxml.txt.nlp	24823941	SENT236	25	25	14	14	ethanol	p10	PA448073	51010	0.992
NULL	Cancers_(Basel)_2012_Nov_2_4(4)_1161-1179.nxml.txt.nlp	24213503	SENT230	9	9	14	14	ribavirin	FLT3	PA451241	2322	0.992
NULL	Int_J_Breast_Cancer_2012_Oct_4_2012_439023.nxml.txt.nlp	23091732	SENT85	25	25	7	7	fulvestrant	CEA	PA164747170	5670;1087	0.992
NULL	Nat_Biotechnol_2009_Apr_29_27(4)_387-394.nxml.txt.nlp	19329999	SENT126	28	28	2	2	omeprazole	GSTO1	PA450704	9446	0.992
NULL	J_Hematol_Oncol_2011_Sep_9_4_35.nxml.txt.nlp	21906310	SENT244	0	0	14	14	lapatinib	HER2	PA152241907	2064	0.992
NULL	Mar_Drugs_2014_Jun_27_12(7)_3818-3837.nxml.txt.nlp	24979269	SENT194	1	1	13	13	calcein	P-gp	PA132595336	5243	0.992
NULL	Front_Behav_Neurosci_2014_Sep_3_8_303.nxml.txt.nlp	25232310	SENT27	19	19	0	0	amphetamine	DAT	PA448408	6531	0.992
NULL	J_Korean_Med_Sci_2011_Jul_20_26(7)_893-899.nxml.txt.nlp	21738342	SENT104	8	8	37	37	resveratrol	COMT		1312	0.992
NULL	Oxid_Med_Cell_Longev_2012_Aug_9_2012_794237.nxml.txt.nlp	22928087	SENT265	6	6	27	27	probucol	HO-1	PA451107	3162	0.992
NULL	Cell_Cycle_2014_Jan_1_13(1)_90-95.nxml.txt.nlp	24196441	SENT95	31	31	11	11	camptothecin	CtIP	PA153590860	5932	0.992
NULL	Indian_J_Nephrol_2012_Mar-Apr_22(2)_139-142.nxml.txt.nlp	22787319	SENT111	8	8	22	22	tacrolimus	P-gp	PA451578	5243	0.992
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_P124.nxml.txt.nlp	NULL	SENT12	33	33	0	0	lamotrigine	HLA-B	PA450164	3106	0.992
NULL	Breast_Cancer_Res_2011_Nov_1_13(6)_225.nxml.txt.nlp	22078060	SENT102	11	11	16	16	pargyline	LSD1	PA450797	23028	0.992
NULL	Int_J_Biol_Sci_2011_Nov_26_8(1)_108-117.nxml.txt.nlp	22211109	SENT167	6	6	18	18	calcein	CXCR4	PA132595336	7852	0.992
NULL	Indian_J_Endocrinol_Metab_2014_Jul-Aug_18(4)_455-467.nxml.txt.nlp	25143899	SENT121	16	16	4	4	metformin	TDD	PA450395	6994	0.992
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT92	38	38	14	14	dasatinib	ABCG2	PA162372878	9429	0.992
NULL	Fibrogenesis_Tissue_Repair_2012_Jul_23_5_11.nxml.txt.nlp	22824096	SENT407	4	4	24	24	thrombin	PAR-1	PA451674	2011;2149	0.992
NULL	Cancer_2014_Jan_15_120(2)_229-237.nxml.txt.nlp	24122122	SENT167	7	7	17	17	bevacizumab	VEGF-A	PA130232992	7422	0.992
NULL	Acta_Pharmacol_Sin_2012_Mar_27_33(3)_342-350.nxml.txt.nlp	22367283	SENT193	35	35	14	14	trypsin	PAR2	PA451806	2150;55065;8856	0.992
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_127043.nxml.txt.nlp	23227093	SENT181	19	19	6	6	nifedipine	RYR	PA450631	6261	0.992
NULL	Mol_Cancer_2014_Jan_13_13_7.nxml.txt.nlp	24418169	SENT40	4	4	36	36	sorafenib	STAT3	PA7000	6774	0.992
NULL	Clin_Sci_(Lond)_2013_Apr_1_124(Pt_8)_543-552.nxml.txt.nlp	23130652	SENT118	41	41	8	8	enalapril	STZ	PA449456	6484	0.992
NULL	Cancer_Imaging_2005_Jan_3_4(Spec_No_B)_S111-S135.nxml.txt.nlp	NULL	SENT542	3	3	25	25	azathioprine	GIT	PA448515	5034	0.992
NULL	Br_J_Cancer_2010_Oct_26_103(9)_1391-1399.nxml.txt.nlp	20924380	SENT123	26	26	4	4	gemcitabine	p53	PA449748	7157	0.992
NULL	Ecancermedicalscience_2009_Oct_29_3_157.nxml.txt.nlp	22276018	SENT71	17	17	35	35	tamoxifen	EGFR	PA451581	1956	0.992
NULL	Case_Rep_Dermatol_2011_Jun_30_3(2)_130-136.nxml.txt.nlp	21743808	SENT57	5	5	16	16	adapalene	EGFR	PA448047	1956	0.992
NULL	Int_J_Gen_Med_2012_May_4_5_403-411.nxml.txt.nlp	22615536	SENT25	43	43	12	12	metformin	RBP4	PA450395	5433;5950	0.992
NULL	Indian_J_Nephrol_2009_Jul_19(3)_119-121.nxml.txt.nlp	20436733	SENT59	8	8	22	22	tacrolimus	P-gp	PA451578	5243	0.992
NULL	EMBO_Mol_Med_2012_Jan_4(1)_52-67.nxml.txt.nlp	22174013	SENT6	18	18	4	4	tamoxifen	NR2E3	PA451581	10002	0.992
NULL	Cell_Commun_Signal_2004_Aug_6_2_8.nxml.txt.nlp	15296508	SENT52	13	13	4	4	genistein	STAT1	PA165109660	6772	0.992
NULL	Mol_Cancer_2013_Nov_5_12_133.nxml.txt.nlp	24192080	SENT190	2	2	28	28	leflunomide	STAT6	PA450192	6778	0.992
NULL	Biomed_Res_Int_2013_Dec_4_2013_685308.nxml.txt.nlp	23509762	SENT134	8	8	31	31	bevacizumab	HIF-1	PA130232992	29072	0.992
NULL	Anal_Chem_Insights_2007_Nov_14_2_93-106.nxml.txt.nlp	19662183	SENT184	21	21	0	0	imatinib	P-gp	PA10804	5243	0.992
NULL	Diabetes_Metab_J_2012_Aug_20_36(4)_293-299.nxml.txt.nlp	22950061	SENT151	6	6	25	25	metformin	STAT3	PA450395	6774	0.992
NULL	Front_Oncol_2013_Sep_23_3_250.nxml.txt.nlp	24069582	SENT101	32	32	5	5	tamoxifen	STAR	PA451581	6770;2984	0.992
NULL	Psychol_Res_Behav_Manag_2010_Dec_6_3_109-118.nxml.txt.nlp	22110334	SENT114	0	0	28	28	fluvoxamine	CYP2D6	PA449690	1565	0.992
NULL	Clin_Interv_Aging_2009_May_14_4_81-89.nxml.txt.nlp	19503770	SENT124	0	0	11	11	hydroquinone	OTC	PA449924	5009	0.992
NULL	Biomed_Res_Int_2014_Jan_29_2014_458592.nxml.txt.nlp	24592391	SENT143	14	14	7	7	curcumin	HO-1	PA151958596	3162	0.992
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT51	34	34	24	24	nutlin-3	p53		7157	0.992
NULL	Oncotarget_2014_Jun_8_5(13)_5040-5053.nxml.txt.nlp	24970815	SENT150	23	23	3	3	cisplatin	EGFR	PA449014	1956	0.992
NULL	J_Oncol_2012_Apr_10_2012_931071.nxml.txt.nlp	22570654	SENT50	36	36	5	5	plerixafor	CD34	PA165958410	947	0.992
NULL	Breast_Cancer_Res_Treat_2014_Apr_6_145(1)_33-44.nxml.txt.nlp	24706169	SENT151	0	0	6	6	trastuzumab	HER2	PA451743	2064	0.992
NULL	Aging_(Albany_NY)_2013_Mar_8_5(3)_142-143.nxml.txt.nlp	23474671	SENT28	18	18	9	9	resveratrol	SIRT1		23411	0.992
NULL	Front_Oncol_2014_Mar_25_4_54.nxml.txt.nlp	24724051	SENT421	39	39	30	30	nilotinib	AXL	PA165958345	558	0.992
NULL	Cancers_(Basel)_2010_Nov_5_2(4)_1838-1860.nxml.txt.nlp	24281204	SENT161	30	30	3	3	etoposide	p50	PA449552	958;4790	0.992
NULL	Pharmaceuticals_(Basel)_2012_Aug_17_5(8)_837-852.nxml.txt.nlp	24280677	SENT44	42	42	9	9	capsaicin	TRPV1	PA448776	7442	0.992
NULL	J_Invest_Dermatol_2014_Apr_12_134(4)_992-1000.nxml.txt.nlp	24213371	SENT146	18	18	0	0	calcein	IFN	PA132595336	3439	0.992
NULL	Emerg_Microbes_Infect_2014_Jul_16_3(7)_e53.nxml.txt.nlp	NULL	SENT83	42	42	24	24	chlorpromazine	AP-2	PA448964	7020	0.992
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Jan_10_6_1-13.nxml.txt.nlp	24648765	SENT49	3	3	22	22	trastuzumab	HER2	PA451743	2064	0.992
NULL	Cell_Death_Differ_2010_Apr_16_17(4)_666-676.nxml.txt.nlp	19834494	SENT280	24	24	8	8	oxaliplatin	p53	PA131285527	7157	0.992
NULL	Acta_Pharmacol_Sin_2010_Jan_5_31(1)_93-101.nxml.txt.nlp	20048748	SENT132	32	32	5	5	cisplatin	DAPK	PA449014	1612	0.992
NULL	J_Obes_2010_Jan_14_2010_970865.nxml.txt.nlp	20798864	SENT131	18	18	36	36	berberine	MCP-1	PA165860812	6347	0.992
NULL	Oncotarget_2014_Aug_8_5(17)_7936-7944.nxml.txt.nlp	25277205	SENT20	11	11	31	31	vemurafenib	NRAS	PA165946873	4893	0.992
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT174	14	14	19	19	tacrolimus	RANKL	PA451578	8600	0.992
NULL	Arthritis_Res_Ther_2009_Aug_28_11(4)_R131.nxml.txt.nlp	19715572	SENT17	3	3	9	9	rituximab	CD19	PA451261	930	0.992
NULL	Oxid_Med_Cell_Longev_2012_May_28_2012_386527.nxml.txt.nlp	22690271	SENT78	6	6	30	30	curcumin	IL-6	PA151958596	3569	0.992
NULL	Oncotarget_2012_Oct_20_3(10)_1236-1245.nxml.txt.nlp	23100449	SENT11	21	21	3	3	doxorubicin	NGAL	PA449412	3934	0.992
NULL	BMJ_Open_2013_Oct_14_3(10)_e003912.nxml.txt.nlp	24127058	SENT36	19	19	35	35	linezolid	HAP	PA450233	5915;10313	0.992
NULL	Ther_Clin_Risk_Manag_2005_Mar_1(1)_3-13.nxml.txt.nlp	18360537	SENT132	0	0	21	21	tamoxifen	CYP3A4	PA451581	1576	0.992
NULL	Arch_Drug_Inf_2008_Sep_1(2)_56-62.nxml.txt.nlp	19915709	SENT51	4	4	35	35	fentanyl	CYP3A4	PA449599	1576	0.992
NULL	Curr_Pharm_Des_2008_Oct_14(28)_2983-2998.nxml.txt.nlp	18991714	SENT72	19	19	8	8	semaxanib	VEGFR	PA131887911	3791	0.992
NULL	Exp_Diabetes_Res_2009_Oct_20_2009_363787.nxml.txt.nlp	19859566	SENT27	3	3	24	24	antipyrine	CYP1A2	PA448453	1544	0.992
NULL	Indian_J_Ophthalmol_2013_Jun_61(6)_277-283.nxml.txt.nlp	23803479	SENT168	0	0	18	18	alemtuzumab	CD52	PA164783958	1043	0.992
NULL	Br_J_Cancer_2013_Jan_15_108(1)_82-90.nxml.txt.nlp	23321512	SENT217	14	14	2	2	vincristine	TUBB3	PA451879	10381	0.992
NULL	Rare_Tumors_2010_Jun_30_2(2)_e34.nxml.txt.nlp	21139836	SENT97	1	1	27	27	cladribine	CD52	PA449027	1043	0.992
NULL	J_Hematol_Oncol_2013_Jan_17_6_8.nxml.txt.nlp	23327547	SENT96	5	5	28	28	sulindac	p53	PA451565	7157	0.992
NULL	Biologics_2012_Jun_20_6_147-154.nxml.txt.nlp	22807625	SENT44	0	0	20	20	pertuzumab	EGFR		1956	0.992
NULL	Mol_Biol_Cell_2013_Sep_1_24(17)_2727-2738.nxml.txt.nlp	23864707	SENT370	12	12	30	30	fluorescein	GOS-28	PA164746009	9527	0.992
NULL	Curr_Genomics_2014_Jun_15(3)_217-230.nxml.txt.nlp	24955029	SENT622	10	10	32	32	nadh	Q10	PA164755085	27161	0.992
NULL	Oncotarget_2014_Feb_7_5(3)_775-787.nxml.txt.nlp	24519956	SENT232	7	7	3	3	docetaxel	PC3	PA449383	57332;7832;5122	0.992
NULL	Indian_J_Med_Res_2014_Jan_139(1)_27-65.nxml.txt.nlp	24604039	SENT56	35	35	3	3	imipramine	CYP1A2	PA449969	1544	0.992
NULL	Oncogene_2014_Jun_12_33(24)_3151-3160.nxml.txt.nlp	23851502	SENT19	16	16	10	10	everolimus	TSC2	PA164746311	7249	0.992
NULL	Cancer_Med_2012_Oct_1_1(2)_114-127.nxml.txt.nlp	23342262	SENT34	8	8	28	28	sirolimus	EGFR	PA451365	1956	0.992
NULL	Nat_Commun_2014_Apr_7_5_3554.nxml.txt.nlp	24704861	SENT37	2	2	18	18	sunitinib	PKR	PA162372840	5610	0.992
NULL	Clinics_(Sao_Paulo)_2012_Sep_67(9)_1093-1099.nxml.txt.nlp	23018309	SENT141	0	0	25	25	sorafenib	Mcl-1	PA7000	4170	0.992
NULL	Cell_Death_Dis_2012_Mar_1_3(3)_e275.nxml.txt.nlp	22378068	SENT203	6	6	15	15	metformin	AKT	PA450395	207	0.992
NULL	Br_J_Cancer_2011_Apr_12_104(8)_1278-1287.nxml.txt.nlp	21487429	SENT248	37	37	11	11	cisplatin	p53	PA449014	7157	0.992
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT327	3	3	35	35	ranibizumab	VEGF-A	PA164746012	7422	0.992
NULL	Hum_Genomics_2008_Sep_1_3(1)_7-16.nxml.txt.nlp	19129086	SENT172	8	8	26	26	rosiglitazone	SLCO1B1	PA451283	10599	0.992
NULL	Leukemia_2014_Jan_12_28(1)_15-33.nxml.txt.nlp	23778311	SENT576	30	30	13	13	imatinib	SIRT1	PA10804	23411	0.992
NULL	Mol_Cancer_2009_Nov_13_8_101.nxml.txt.nlp	19912650	SENT196	18	18	1	1	cisplatin	c-FLIP	PA449014	8837	0.992
NULL	Front_Oncol_2013_Sep_23_3_250.nxml.txt.nlp	24069582	SENT216	0	0	26	26	metformin	HER2	PA450395	2064	0.992
NULL	Clin_Pharmacol_2010_Sep_6_2_155-162.nxml.txt.nlp	22291500	SENT21	2	2	23	23	clopidogrel	CYP2C19	PA449053	1557	0.992
NULL	J_Biol_Chem_2010_Apr_16_285(16)_11892-11902.nxml.txt.nlp	20177059	SENT86	43	43	5	5	ampicillin	CMBL	PA448419	134147	0.992
NULL	Nat_Commun_2014_Mar_25_5_3496.nxml.txt.nlp	24667209	SENT102	33	33	8	8	doxycycline	NDP52	PA449415	10241	0.992
NULL	Br_J_Cancer_2010_Jun_29_103(1)_61-72.nxml.txt.nlp	20588279	SENT29	0	0	22	22	trastuzumab	HER-2	PA451743	2064	0.992
NULL	Cancer_Med_2012_Aug_15_1(1)_28-38.nxml.txt.nlp	23342251	SENT23	21	21	3	3	erlotinib	HER2	PA134687924	2064	0.992
NULL	Br_J_Cancer_2011_Jan_4_104(1)_91-100.nxml.txt.nlp	21139584	SENT12	7	7	21	21	bortezomib	p53	PA10252	7157	0.992
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S31-S40.nxml.txt.nlp	20680106	SENT190	8	8	2	2	panitumumab	BRAF	PA162373091	673	0.992
NULL	Acta_Physiol_(Oxf)_2014_Apr_17_210(4)_832-844.nxml.txt.nlp	24279649	SENT144	21	21	10	10	losartan	AT1	PA450268	9197;185	0.992
NULL	Br_J_Cancer_2009_Sep_15_101(6)_957-966.nxml.txt.nlp	19738618	SENT149	8	8	32	32	dexrazoxane	THBS-1	PA449259	7057	0.992
NULL	Acta_Pharmacol_Sin_2014_Oct_25_35(10)_1293-1301.nxml.txt.nlp	25152022	SENT182	28	28	5	5	enalapril	NLRP3	PA449456	114548	0.992
NULL	J_Cell_Biol_2008_Jul_28_182(2)_367-379.nxml.txt.nlp	18644892	SENT74	28	28	19	19	pp2	spatial		219793	0.992
NULL	J_Clin_Biochem_Nutr_2007_Jan_27_40(1)_13-23.nxml.txt.nlp	18437209	SENT142	22	22	6	6	trypsin	PAR1	PA451806	79581;2149	0.992
NULL	Gene_Regul_Syst_Bio_2014_Mar_4_8_63-73.nxml.txt.nlp	24634581	SENT222	16	16	3	3	minocycline	MT1-MMP	PA450519	4323	0.992
NULL	Basic_Clin_Pharmacol_Toxicol_2013_Feb_5_112(2)_132-137.nxml.txt.nlp	22900583	SENT23	8	8	39	39	prasugrel	CYP3A	PA154410481	1574	0.992
NULL	Indian_J_Pharmacol_2013_Mar-Apr_45(2)_145-148.nxml.txt.nlp	23716890	SENT107	0	0	34	34	nevirapine	CD4	PA450616	920	0.992
NULL	Mol_Pain_2013_Feb_15_9_3.nxml.txt.nlp	23413875	SENT235	11	11	31	31	capsaicin	TRPA1	PA448776	8989	0.992
NULL	Target_Oncol_2010_Jun_14_5(2)_95-112.nxml.txt.nlp	20625845	SENT236	24	24	8	8	sorafenib	FDG	PA7000	23583	0.992
NULL	Diabetes_2008_Oct_57(10)_2801-2808.nxml.txt.nlp	18633115	SENT113	27	27	14	14	sulfasalazine	p65	PA451547	5970	0.992
NULL	Eur_J_Med_Res_2009_Nov_24_14(Suppl_3)_43-46.nxml.txt.nlp	19959416	SENT13	5	5	33	33	raltegravir	CYP3A		1574	0.992
NULL	Mol_Cancer_2008_Oct_23_7_82.nxml.txt.nlp	18947424	SENT336	4	4	11	11	procainamide	DNMT1	PA451108	1786	0.992
NULL	Breast_Cancer_Res_2004_Jun_29_6(5)_R488-R498.nxml.txt.nlp	15318931	SENT175	5	5	21	21	estradiol	UGT2B15	PA449503	7366	0.992
NULL	Clin_Epigenetics_2011_Jun_27_2(2)_171-185.nxml.txt.nlp	21949547	SENT143	31	31	9	9	tamoxifen	EZH2	PA451581	2146	0.992
NULL	Arthritis_Res_Ther_2010_Jul_19_12(4)_R148.nxml.txt.nlp	20642840	SENT116	35	35	10	10	etanercept	MCP-1	PA449515	6347	0.992
NULL	Open_Virol_J_2014_Mar_7_8_1-8.nxml.txt.nlp	24799968	SENT146	4	4	29	29	telaprevir	PKR	PA165958354	5610	0.992
NULL	Cancer_2014_Dec_15_120(24)_3862-3865.nxml.txt.nlp	25155780	SENT16	26	26	0	0	cetuximab	KRAS	PA10040	3845	0.992
NULL	J_Hematol_Oncol_2011_Jan_21_4_5.nxml.txt.nlp	21255411	SENT191	28	28	8	8	paclitaxel	EGFR	PA450761	1956	0.992
NULL	Front_Oncol_2014_Sep_23_4_264.nxml.txt.nlp	25295231	SENT132	40	40	17	17	lenalidomide	TP53	PA162363968	7157	0.992
NULL	Diabetes_Obes_Metab_2009_Dec_11(12)_1153-1162.nxml.txt.nlp	19930005	SENT19	0	0	27	27	exenatide	GLP-1	PA164749238	100125288	0.992
NULL	Acta_Pharmacol_Sin_2012_May_16_33(5)_682-690.nxml.txt.nlp	22504904	SENT35	0	0	9	9	celecoxib	STAT3	PA448871	6774	0.992
NULL	Br_J_Cancer_2010_Jan_5_102(1)_151-161.nxml.txt.nlp	19935791	SENT9	19	19	10	10	cetuximab	TOPK	PA10040	55872	0.992
NULL	Breast_Cancer_Res_Treat_2013_Jan_10_137(1)_1-12.nxml.txt.nlp	23143215	SENT95	0	0	14	14	trastuzumab	HER2	PA451743	2064	0.992
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1554-1562.nxml.txt.nlp	21970876	SENT38	41	41	27	27	gefitinib	EGFR	PA131301952	1956	0.992
NULL	EMBO_Mol_Med_2013_Jan_29_5(1)_137-148.nxml.txt.nlp	23197407	SENT109	30	30	6	6	propranolol	TR3	PA451145	8718;3164;10587	0.992
NULL	J_Mol_Signal_2010_Jul_12_5_8.nxml.txt.nlp	20624308	SENT42	16	16	4	4	gefitinib	Met	PA131301952	79811	0.992
NULL	Acta_Pharmacol_Sin_2013_Mar_21_34(3)_352-359.nxml.txt.nlp	23334241	SENT113	23	23	2	2	eplerenone	NOX4	PA164749044	50507	0.992
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT1911	17	17	0	0	acetaminophen	CYP3A	PA448015	1574	0.992
NULL	Arthritis_Res_Ther_2010_Jan_22_12(1)_R11.nxml.txt.nlp	20096109	SENT147	7	7	17	17	infliximab	IFN	PA452639	3439	0.992
NULL	Breast_Cancer_Res_2010_Oct_22_12(Suppl_2)_S2.nxml.txt.nlp	21050423	SENT110	32	32	12	12	trastuzumab	p27	PA451743	5715;10534	0.992
NULL	EMBO_Mol_Med_2012_Sep_7_4(9)_896-909.nxml.txt.nlp	22887866	SENT275	0	0	9	9	lovastatin	c-Myc	PA450272	4609	0.992
NULL	Br_J_Cancer_2014_Jan_21_110(2)_384-391.nxml.txt.nlp	24346286	SENT23	14	14	2	2	trastuzumab	PTEN	PA451743	5728	0.992
NULL	Scientifica_(Cairo)_2012_Dec_16_2012_402783.nxml.txt.nlp	24278688	SENT152	24	24	0	0	thrombin	MASP1	PA451674	5648	0.992
NULL	Oncotarget_2012_Dec_18_3(12)_1615-1628.nxml.txt.nlp	23271044	SENT210	34	34	5	5	temsirolimus	STAT3	PA164746890	6774	0.992
NULL	Breast_Cancer_Res_2009_Jun_29_11(3)_R41.nxml.txt.nlp	19563669	SENT154	0	0	16	16	lapatinib	EGFR	PA152241907	1956	0.992
NULL	Case_Rep_Psychiatry_2013_Jan_30_2013_381261.nxml.txt.nlp	23424703	SENT15	5	5	34	34	atomoxetine	CYP2D6	PA134688071	1565	0.992
NULL	Oncogene_2014_Aug_21_33(34)_4316-4329.nxml.txt.nlp	24362530	SENT267	6	6	0	0	epirubicin	FOXM1	PA449476	2305	0.992
NULL	Front_Cell_Neurosci_2015_Jan_15_8_459.nxml.txt.nlp	25642166	SENT90	18	18	6	6	hemin	HO-1	PA449849	3162	0.992
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2013_Dec_8_6_75-79.nxml.txt.nlp	24348081	SENT71	8	8	15	15	colesevelam	GLP-1	PA449095	100125288	0.992
NULL	Indian_J_Med_Res_2012_Aug_136(2)_249-259.nxml.txt.nlp	22960892	SENT21	26	26	14	14	irinotecan	UGT1A1	PA450085	54658	0.992
NULL	J_Oncol_2012_Mar_11_2012_359246.nxml.txt.nlp	22481925	SENT9	0	0	25	25	thyroglobulin	TPO	PA164754910	7066;7173	0.992
NULL	J_Bras_Pneumol_2014_May-Jun_40(3)_313-318.nxml.txt.nlp	25029655	SENT85	0	0	15	15	venlafaxine	CYP2D6	PA451866	1565	0.992
NULL	Biol_Open_2014_May_2_3(6)_418-430.nxml.txt.nlp	24795145	SENT137	18	18	7	7	etoposide	RanBPM	PA449552	10048	0.992
NULL	Exp_Cell_Res_2013_Apr_1_319(6)_800-809.nxml.txt.nlp	23247073	SENT205	3	3	22	22	curcumin	AKT	PA151958596	207	0.992
NULL	Mol_Cancer_2013_Oct_8_12_119.nxml.txt.nlp	24103454	SENT127	30	30	18	18	etoposide	TOP1	PA449552	7150	0.992
NULL	Ann_Surg_Oncol_2010_Apr_20_17(4)_1168-1176.nxml.txt.nlp	19936839	SENT65	9	9	16	16	panitumumab	KRAS	PA162373091	3845	0.992
NULL	Int_J_Mol_Sci_2014_Jun_18_15(6)_11013-11029.nxml.txt.nlp	24945311	SENT137	0	0	15	15	celecoxib	STAT3	PA448871	6774	0.992
NULL	Cancers_(Basel)_2013_May_27_5(2)_617-638.nxml.txt.nlp	24216994	SENT291	0	0	8	8	curcumin	MMP9	PA151958596	4318	0.992
NULL	J_Gastroenterol_2013_Feb_22_48(2)_222-237.nxml.txt.nlp	22722906	SENT270	32	32	9	9	ethanol	CYP2C9	PA448073	1559	0.992
NULL	Br_J_Cancer_2013_Jul_9_109(1)_68-75.nxml.txt.nlp	23807173	SENT18	23	23	11	11	cisplatin	ERCC1	PA449014	2067	0.992
NULL	Br_J_Pharmacol_2011_Apr_162(8)_1832-1842.nxml.txt.nlp	21232033	SENT162	8	8	0	0	resveratrol	HL-1		55600	0.992
NULL	Nat_Med_2013_Nov_27_19(11)_10_1038_nm_3352.nxml.txt.nlp	24162815	SENT135	17	17	2	2	thyroglobulin	TTF-1	PA164754910	7080	0.992
NULL	Cell_Commun_Signal_2003_Nov_24_1_5.nxml.txt.nlp	14636425	SENT77	0	0	9	9	heparin	CCN5	PA449855	8839	0.992
NULL	Mol_Cancer_2013_Mar_2_12_16.nxml.txt.nlp	23452820	SENT105	5	5	13	13	chloroquine	Mcl-1	PA448948	4170	0.992
NULL	Cell_Cycle_2012_Nov_1_11(21)_3983-3996.nxml.txt.nlp	22987153	SENT78	11	11	4	4	cisplatin	DNA2	PA449014	1763	0.992
NULL	Cell_Death_Dis_2010_May_13_1(5)_e41.nxml.txt.nlp	21364648	SENT31	0	0	25	25	etoposide	p65	PA449552	5970	0.992
NULL	Oncotarget_2014_Nov_1_5(19)_9396-9409.nxml.txt.nlp	25238049	SENT120	22	22	11	11	hydroxyurea	DNA2	PA449942	1763	0.992
NULL	Cell_Cycle_2014_Jan_1_13(1)_90-95.nxml.txt.nlp	24196441	SENT29	24	24	9	9	camptothecin	P21	PA153590860	1026;9338	0.992
NULL	Cancers_(Basel)_2012_Sep_25_4(4)_969-988.nxml.txt.nlp	24213497	SENT131	9	9	30	30	estradiol	aromatase	PA449503	1588	0.992
NULL	Biomed_Imaging_Interv_J_2010_Apr_1_6(2)_e15.nxml.txt.nlp	21611036	SENT128	0	0	16	16	midazolam	FUS	PA450496	2521	0.992
NULL	CNS_Drugs_2014_Apr_11_28(6)_535-558.nxml.txt.nlp	24723124	SENT329	0	0	27	27	daclizumab	CD25	PA164764446	3669;3559	0.992
NULL	J_Oncol_2010_Dec_23_2010_372547.nxml.txt.nlp	20072701	SENT157	0	0	11	11	vatalanib	PDGFRB	PA7001	5159	0.992
NULL	Arthritis_Res_Ther_2012_Apr_26_14(2)_R90.nxml.txt.nlp	22537858	SENT226	42	42	15	15	atorvastatin	IFN	PA448500	3439	0.992
NULL	Nucleic_Acids_Res_2013_Nov_16_41(20)_9349-9360.nxml.txt.nlp	23956219	SENT276	37	37	8	8	cisplatin	RMI1	PA449014	80010	0.992
NULL	J_Hematol_Oncol_2009_Aug_12_2_36.nxml.txt.nlp	19674465	SENT54	0	0	27	27	lenalidomide	IL-10	PA162363968	3586	0.992
NULL	Nucleic_Acids_Res_2011_Nov_8_39(21)_9224-9237.nxml.txt.nlp	21824916	SENT135	30	30	10	10	trypsin	PNKP	PA451806	11284	0.992
NULL	Diabetes_Metab_Syndr_Obes_2009_Sep_25_2_165-172.nxml.txt.nlp	21437130	SENT79	0	0	10	10	pioglitazone	IL-8	PA450970	3576	0.992
NULL	Breast_Cancer_Res_2007_Oct_26_9(5)_112.nxml.txt.nlp	17980056	SENT36	25	25	15	15	tamoxifen	EGFR	PA451581	1956	0.992
NULL	Oncoimmunology_2012_Oct_1_1(7)_1048-1060.nxml.txt.nlp	23170253	SENT76	6	6	13	13	pertuzumab	HER-2		2064	0.992
NULL	Clin_Ophthalmol_2014_Dec_30_9_43-49.nxml.txt.nlp	25565767	SENT88	35	35	10	10	acetazolamide	RPE	PA448018	6120	0.992
NULL	Arthritis_Res_Ther_2013_Jul_11_15(4)_216.nxml.txt.nlp	23856014	SENT105	10	10	16	16	daclizumab	CD4	PA164764446	920	0.992
NULL	Mol_Cancer_2012_Dec_12_11_91.nxml.txt.nlp	23234355	SENT30	0	0	12	12	gefitinib	EGFR	PA131301952	1956	0.992
NULL	Front_Oncol_2013_Apr_23_3_86.nxml.txt.nlp	23630663	SENT136	32	32	9	9	neratinib	EGFR	PA165291472	1956	0.992
NULL	Colorectal_Dis_2012_Feb_14(2)_e31-e47.nxml.txt.nlp	21848897	SENT41	2	2	31	31	panitumumab	KRAS	PA162373091	3845	0.992
NULL	J_Biol_Chem_2013_Mar_29_288(13)_9035-9048.nxml.txt.nlp	23362266	SENT233	4	4	33	33	tamoxifen	OPG	PA451581	690	0.992
NULL	Scientifica_(Cairo)_2012_Dec_23_2012_857516.nxml.txt.nlp	24278747	SENT270	4	4	20	20	bortezomib	TRAIL	PA10252	8743	0.992
NULL	Breast_Cancer_Res_2011_Feb_3_13(1)_R16.nxml.txt.nlp	21291529	SENT116	19	19	4	4	tamoxifen	PHD3	PA451581	112399	0.992
NULL	Biomed_Res_Int_2013_Dec_30_2013_396839.nxml.txt.nlp	24490159	SENT192	0	0	27	27	berberine	AP-1	PA165860812	2353;3727;2354;3725	0.992
NULL	Oncol_Rep_2014_Apr_28_31(4)_1605-1612.nxml.txt.nlp	24481648	SENT36	0	0	17	17	imatinib	MRP1	PA10804	4437	0.992
NULL	Br_J_Cancer_1996_Jul_74(2)_274-279.nxml.txt.nlp	8688335	SENT13	42	42	10	10	cyclophosphamide	IL-6	PA449165	3569	0.992
NULL	EMBO_Mol_Med_2012_Jan_4(1)_52-67.nxml.txt.nlp	22174013	SENT121	5	5	16	16	estradiol	NR2E3	PA449503	10002	0.992
NULL	Front_Neurosci_2013_Feb_22_7_19.nxml.txt.nlp	23440036	SENT118	5	5	35	35	fenfluramine	ARC	PA449592	8996;23237	0.992
NULL	Br_J_Cancer_2013_Feb_19_108(3)_549-556.nxml.txt.nlp	23329233	SENT35	46	46	7	7	trastuzumab	HER-2	PA451743	2064	0.992
NULL	Acta_Pharmacol_Sin_2010_Jan_5_31(1)_81-92.nxml.txt.nlp	20048747	SENT186	0	0	25	25	resveratrol	Bcl-2		596	0.992
NULL	J_Oncol_2011_Dec_5_2011_465343.nxml.txt.nlp	21188169	SENT185	23	23	30	30	gemcitabine	CD133	PA449748	8842	0.992
NULL	Cardiovasc_Res_2014_Mar_1_101(3)_513-521.nxml.txt.nlp	24323316	SENT25	0	0	13	13	maraviroc	CCR5	PA164768835	1234	0.992
NULL	Clin_Drug_Investig_2013_Aug_23_33(10)_727-736.nxml.txt.nlp	23975654	SENT172	10	10	39	39	fluoxetine	CYP2C9	PA449673	1559	0.992
NULL	J_Biol_Chem_2008_May_30_283(22)_15419-15430.nxml.txt.nlp	18378687	SENT201	25	25	3	3	pp2	PP2		4888	0.992
NULL	J_Korean_Med_Sci_1996_Jun_11(3)_250-257.nxml.txt.nlp	8843008	SENT7	5	5	43	43	verapamil	NIF	PA451868	6280	0.992
NULL	Psychiatry_Investig_2010_Sep_9_7(3)_220-223.nxml.txt.nlp	20927312	SENT20	0	0	15	15	aripiprazole	5-HT1A	PA10026	3350	0.992
NULL	Onco_Targets_Ther_2014_Mar_5_7_375-385.nxml.txt.nlp	24623980	SENT42	3	3	36	36	crizotinib	EGFR	PA165946122	1956	0.992
NULL	Ann_Clin_Transl_Neurol_2014_Mar_3_1(3)_190-198.nxml.txt.nlp	24839611	SENT165	25	25	7	7	memantine	GRIN2A	PA10364	2903	0.992
NULL	J_Histochem_Cytochem_2012_Oct_60(10)_749-760.nxml.txt.nlp	22821669	SENT191	8	8	30	30	hyaluronan	ITIH2	PA165958431	3698	0.992
NULL	J_Biol_Chem_2009_Oct_16_284(42)_28885-28895.nxml.txt.nlp	19687008	SENT286	24	24	3	3	simvastatin	SREBP2	PA451363	6721	0.992
NULL	Front_Neurosci_2014_Dec_5_8_398.nxml.txt.nlp	25538552	SENT21	3	3	16	16	glucose	gamma	PA449773	9913	0.992
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT218	17	17	29	29	erlotinib	AMPK	PA134687924	5563	0.992
NULL	Br_J_Pharmacol_2008_Oct_18_155(4)_596-605.nxml.txt.nlp	18852694	SENT163	12	12	31	31	fenofibrate	PI3K	PA449594	5290	0.992
NULL	Antimicrob_Resist_Infect_Control_2014_May_14_3_17.nxml.txt.nlp	24883183	SENT158	6	6	17	17	imipenem	HAI	PA449968	6692;6768	0.992
NULL	Curr_Oncol_2009_May_16(Suppl_1)_S52-S59.nxml.txt.nlp	19478903	SENT50	3	3	31	31	sunitinib	CYP3A4	PA162372840	1576	0.992
NULL	Biomed_Res_Int_2014_Jan_29_2014_361020.nxml.txt.nlp	24605326	SENT166	0	0	25	25	celecoxib	CCNB1	PA448871	891	0.992
NULL	Neural_Regen_Res_2013_Mar_25_8(9)_825-832.nxml.txt.nlp	25206730	SENT108	22	22	11	11	isoflurane	P2X7	PA450106	5027	0.992
NULL	Acta_Pharmacol_Sin_2012_Oct_17_33(10)_1301-1310.nxml.txt.nlp	22983390	SENT108	28	28	10	10	cisplatin	migfilin	PA449014	54751	0.992
NULL	Eur_J_Haematol_2009_May_82(5)_339-349.nxml.txt.nlp	19187276	SENT230	0	0	24	24	dabigatran	TKR		8277	0.992
NULL	Exp_Hematol_Oncol_2013_Sep_5_2_24.nxml.txt.nlp	24007855	SENT55	36	36	5	5	imatinib	JAK2	PA10804	3717	0.992
NULL	Oncol_Lett_2013_Feb_9_5(2)_552-558.nxml.txt.nlp	23420128	SENT142	16	16	8	8	imatinib	KIT	PA10804	3815	0.992
NULL	Arthritis_Res_Ther_2003_Sep_12_5(Suppl_3)_55.nxml.txt.nlp	NULL	SENT7	29	29	3	3	rosiglitazone	ARC	PA451283	8996;23237	0.992
NULL	Clinics_(Sao_Paulo)_2011_Aug_66(8)_1485-1487.nxml.txt.nlp	21915505	SENT12	4	4	20	20	abacavir	HLA-B	PA448004	3106	0.992
NULL	Oncotarget_2012_Sep_20_3(9)_954-987.nxml.txt.nlp	23006971	SENT245	17	17	4	4	vemurafenib	BRAF	PA165946873	673	0.992
NULL	Front_Oncol_2014_Mar_3_4_34.nxml.txt.nlp	24624361	SENT275	14	14	19	19	vorinostat	BRCA1	PA164748224	672	0.992
NULL	Cardiovasc_Res_2014_Mar_1_101(3)_513-521.nxml.txt.nlp	24323316	SENT25	0	0	38	38	maraviroc	CCR5	PA164768835	1234	0.992
NULL	Oncotarget_2014_Jun_1_5(13)_4868-4880.nxml.txt.nlp	24947902	SENT200	0	0	36	36	afatinib	EGFR	PA165981154	1956	0.992
NULL	Br_J_Pharmacol_2010_Mar_8_159(5)_1092-1105.nxml.txt.nlp	20148890	SENT323	6	6	18	18	montelukast	GPR17	PA450546	2840	0.992
NULL	Front_Endocrinol_(Lausanne)_2013_May_16_4_51.nxml.txt.nlp	23720652	SENT169	6	6	18	18	diclofenac	CYP2C8	PA449293	1558	0.992
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT191	29	29	11	11	cimetidine	NAPA	PA449001	9476;8775	0.992
NULL	Arch_Drug_Inf_2011_Mar_4(1)_1-9.nxml.txt.nlp	21572514	SENT152	2	2	6	6	indomethacin	MRP2	PA449982	100130958;57626;1244	0.992
NULL	Br_J_Cancer_2013_Jul_23_109(2)_502-511.nxml.txt.nlp	23799850	SENT234	4	4	9	9	gemcitabine	SMARCC1	PA449748	6599	0.992
NULL	Cancers_(Basel)_2011_Aug_8_3(3)_3156-3168.nxml.txt.nlp	24212950	SENT78	15	15	3	3	celecoxib	5-LOX	PA448871	240	0.992
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT86	0	0	29	29	cyclophosphamide	B7-H1	PA449165	29126	0.992
NULL	Indian_J_Med_Res_2011_Sep_134(3)_295-301.nxml.txt.nlp	21985811	SENT109	22	22	0	0	phenytoin	CYP2C9	PA450947	1559	0.992
NULL	Cancer_Cell_Int_2005_Aug_24_5_28.nxml.txt.nlp	16120219	SENT166	16	16	7	7	etoposide	p53	PA449552	7157	0.992
NULL	Arthritis_Res_Ther_2009_Jan_20_11(1)_201.nxml.txt.nlp	19222864	SENT206	5	5	11	11	2-methoxyestradiol	HIF-1	PA134967247	29072	0.992
NULL	J_Cell_Biol_2008_Jul_14_182(1)_117-127.nxml.txt.nlp	18625845	SENT97	29	29	17	17	novobiocin	CK8	PA164768819	3856	0.992
NULL	Ann_Dermatol_2011_Dec_27_23(Suppl_3)_S350-S353.nxml.txt.nlp	22346276	SENT20	0	0	18	18	erlotinib	EGFR	PA134687924	1956	0.992
NULL	Emerg_Infect_Dis_2012_Jan_18(1)_29-37.nxml.txt.nlp	22260950	SENT57	36	36	0	0	rifampin	DST	PA451250	667	0.992
NULL	Mol_Biol_Cell_2012_Jul_1_23(13)_2583-2592.nxml.txt.nlp	22593214	SENT117	14	14	29	29	paclitaxel	GEF-H1	PA450761	9181	0.992
NULL	J_Med_Case_Reports_2011_Feb_25_5_83.nxml.txt.nlp	21352527	SENT40	5	5	34	34	neostigmine	USP30	PA450611	84749	0.992
NULL	Aging_(Albany_NY)_2014_Oct_28_6(10)_820-834.nxml.txt.nlp	25361036	SENT249	2	2	32	32	resveratrol	PARP-1		25976	0.992
NULL	Br_J_Pharmacol_2013_Jun_27_169(4)_736-747.nxml.txt.nlp	23489111	SENT164	0	0	17	17	methadone	5-HT3A	PA450401	3359	0.992
NULL	Onco_Targets_Ther_2014_Dec_4_7_2249-2255.nxml.txt.nlp	25587220	SENT95	19	19	5	5	doxorubicin	P-gp	PA449412	5243	0.992
NULL	Ann_Oncol_2011_Aug_27_22(8)_1736-1747.nxml.txt.nlp	21709140	SENT165	6	6	27	27	tamoxifen	aromatase	PA451581	1588	0.992
NULL	Breast_Cancer_Res_2005_Nov_11_7(6)_255-257.nxml.txt.nlp	16457700	SENT54	14	14	25	25	tamoxifen	aromatase	PA451581	1588	0.992
NULL	Curr_Hematol_Malig_Rep_2013_Mar_8_8(1)_28-36.nxml.txt.nlp	23296408	SENT154	24	24	3	3	imatinib	PI3K	PA10804	5290	0.992
NULL	Eur_J_Med_Res_2009_Nov_24_14(Suppl_3)_17-21.nxml.txt.nlp	19959412	SENT78	3	3	43	43	raltegravir	UGT		7361;7355	0.992
NULL	Clin_Interv_Aging_2012_Dec_30_7_1-13.nxml.txt.nlp	22291468	SENT56	30	30	1	1	dronedarone	CYP3A4	PA153619853	1576	0.992
NULL	Cardiol_Ther_2013_Jun_7_2(1)_57-68.nxml.txt.nlp	25135289	SENT168	12	12	5	5	thrombin	PAR-1	PA451674	2011;2149	0.992
NULL	Gut_Liver_2011_Jun_24_5(2)_171-180.nxml.txt.nlp	21814597	SENT119	41	41	11	11	imatinib	KIT	PA10804	3815	0.992
NULL	Lipids_Health_Dis_2011_Feb_28_10_38.nxml.txt.nlp	21352602	SENT89	38	38	18	18	atorvastatin	PCSK9	PA448500	255738	0.992
NULL	Clinics_(Sao_Paulo)_2014_Oct_69(10)_655-659.nxml.txt.nlp	25518015	SENT97	3	3	41	41	sevoflurane	NGAL	PA451341	3934	0.992
NULL	Cancer_Res_Treat_2013_Dec_31_45(4)_251-262.nxml.txt.nlp	24453997	SENT141	16	16	1	1	cisplatin	ASS1	PA449014	445	0.992
NULL	J_Hematol_Oncol_2014_Aug_1_7_52.nxml.txt.nlp	25085632	SENT155	10	10	35	35	sunitinib	EGFR	PA162372840	1956	0.992
NULL	Front_Oncol_2014_Sep_23_4_264.nxml.txt.nlp	25295231	SENT121	41	41	2	2	lenalidomide	p53	PA162363968	7157	0.992
NULL	Pharmaceuticals_(Basel)_2013_Apr_17_6(4)_557-578.nxml.txt.nlp	24276125	SENT234	35	35	9	9	ustekinumab	IL-23	PA166048654	51561	0.992
NULL	Anticancer_Agents_Med_Chem_2012_Feb_12(2)_163-171.nxml.txt.nlp	22043994	SENT24	5	5	12	12	cetuximab	KRAS	PA10040	3845	0.992
NULL	Exp_Neurobiol_2013_Mar_31_22(1)_51-57.nxml.txt.nlp	23585723	SENT15	12	12	2	2	capsaicin	TRPV1	PA448776	7442	0.992
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Apr_16_64(Pt_5)_o862.nxml.txt.nlp	21202349	SENT59	39	39	3	3	ethanol	mol	PA448073	90527	0.992
NULL	Clin_Ophthalmol_2007_Sep_1(3)_273-284.nxml.txt.nlp	19668481	SENT141	38	38	7	7	ranibizumab	San	PA164746012	80218	0.992
NULL	Breast_Cancer_Res_2004_Nov_7_6(1)_39-52.nxml.txt.nlp	14680484	SENT157	34	34	12	12	tamoxifen	N-CoR	PA451581	9611	0.992
NULL	Oncotarget_2013_Nov_24_4(12)_2430-2438.nxml.txt.nlp	24280348	SENT76	4	4	15	15	gefitinib	STAT3	PA131301952	6774	0.992
NULL	Pharmaceuticals_(Basel)_2011_Mar_17_4(3)_551-566.nxml.txt.nlp	NULL	SENT123	16	16	5	5	epirubicin	IL-6	PA449476	3569	0.992
NULL	Clin_Med_Insights_Arthritis_Musculoskelet_Disord_2012_Jan_5_5_1-14.nxml.txt.nlp	22267947	SENT150	41	41	5	5	risedronate	HIP	PA451255	6767;6159;64399;5068	0.992
NULL	Mol_Cancer_2007_Jan_14_6_5.nxml.txt.nlp	17222355	SENT3	21	21	0	0	doxorubicin	HMGA2	PA449412	8091	0.992
NULL	Arthritis_Res_Ther_2010_Oct_28_12(5)_219.nxml.txt.nlp	21062511	SENT135	29	29	10	10	infliximab	IFN	PA452639	3439	0.992
NULL	Ann_Hematol_2010_Nov_25_89(11)_1115-1124.nxml.txt.nlp	20499237	SENT148	9	9	34	34	simvastatin	CD38	PA451363	952	0.992
NULL	Emerg_Infect_Dis_2012_Jul_18(7)_1128-1131.nxml.txt.nlp	22710273	SENT59	38	38	21	21	ethambutol	CD4	PA164784021	920	0.992
NULL	Mol_Cancer_2014_Jan_28_13_17.nxml.txt.nlp	24472312	SENT120	18	18	5	5	ponatinib	Mcl-1	PA165980594	4170	0.992
NULL	Eur_J_Clin_Pharmacol_2013_Mar_11_69(3)_327-339.nxml.txt.nlp	22782539	SENT272	0	0	10	10	clopidogrel	P-gp	PA449053	5243	0.992
NULL	Gene_Regul_Syst_Bio_2014_Mar_4_8_63-73.nxml.txt.nlp	24634581	SENT86	27	27	1	1	minocycline	MT1-MMP	PA450519	4323	0.992
NULL	J_Korean_Med_Sci_2011_Aug_27_26(8)_1001-1006.nxml.txt.nlp	21860549	SENT17	13	13	3	3	trastuzumab	HER-2	PA451743	2064	0.992
NULL	Blood_Cancer_J_2014_Oct_31_4(10)_e255.nxml.txt.nlp	25360901	SENT28	0	0	29	29	plerixafor	CXCL12	PA165958410	6387	0.992
NULL	Antimicrob_Agents_Chemother_2014_Nov_10_59(1)_490-497.nxml.txt.nlp	25385107	SENT202	4	4	16	16	primaquine	ACT	PA451103	12;11332;9457;641455	0.992
NULL	Open_Access_J_Urol_2011_May_10_3_69-82.nxml.txt.nlp	24198638	SENT69	18	18	28	28	sorafenib	CYP3A4	PA7000	1576	0.992
NULL	Clin_Pharmacokinet_2014_Jan_16_53(3)_213-225.nxml.txt.nlp	24430725	SENT190	0	0	13	13	verapamil	P-gp	PA451868	5243	0.992
NULL	Exp_Diabetes_Res_2012_Oct_15_2012_465282.nxml.txt.nlp	23118742	SENT8	17	17	24	24	metformin	FGF21	PA450395	26291	0.992
NULL	Breast_Cancer_Res_2007_Jun_4_9(3)_207.nxml.txt.nlp	17561991	SENT13	0	0	10	10	trastuzumab	HER-2	PA451743	2064	0.992
NULL	Cells_2014_Sep_12_3(3)_914-938.nxml.txt.nlp	25222270	SENT85	4	4	32	32	capsaicin	TRPM1	PA448776	4308	0.992
NULL	Breast_Cancer_Res_2012_Aug_8_14(4)_R116.nxml.txt.nlp	22873525	SENT273	5	5	14	14	trastuzumab	HER2	PA451743	2064	0.992
NULL	Acta_Pharmacol_Sin_2012_Dec_29_33(12)_1518-1524.nxml.txt.nlp	23103625	SENT116	5	5	14	14	telmisartan	ACE2	PA451605	59272	0.992
NULL	Curr_Neuropharmacol_2013_Mar_11(2)_160-170.nxml.txt.nlp	23997751	SENT84	48	48	14	14	mianserin	5-HT2C	PA134687937	3358	0.992
NULL	BMJ_2011_Aug_4_343_d4588.nxml.txt.nlp	21816733	SENT360	12	12	1	1	clopidogrel	CYP2C19	PA449053	1557	0.992
NULL	Cancer_Microenviron_2009_Sep_26_2(Suppl_1)_19-204.nxml.txt.nlp	NULL	SENT6587	11	11	22	22	docetaxel	CD44	PA449383	960	0.992
NULL	Cancer_Inform_2008_Jun_10_6_315-355.nxml.txt.nlp	19259415	SENT333	23	23	11	11	cisplatin	IL-6	PA449014	3569	0.992
NULL	Arthritis_2011_May_26_2011_765624.nxml.txt.nlp	22046525	SENT32	0	0	13	13	tocilizumab	IL-6	PA165292659	3569	0.992
NULL	Biomed_Res_Int_2013_Oct_27_2013_725410.nxml.txt.nlp	24282820	SENT104	0	0	6	6	sorafenib	VEGFR	PA7000	3791	0.992
NULL	Cardiovasc_Res_2010_Mar_1_85(4)_825-835.nxml.txt.nlp	19840952	SENT110	2	2	21	21	staurosporine	CX3CL1	PA165109623	6376	0.992
NULL	Br_J_Cancer_2012_Nov_6_107(10)_1702-1713.nxml.txt.nlp	23047550	SENT241	0	0	17	17	sunitinib	KDR	PA162372840	3791	0.992
NULL	Neuropsychopharmacology_2011_Apr_2_36(5)_1033-1046.nxml.txt.nlp	21289603	SENT45	7	7	13	13	ethanol	P14	PA448073	11102;;6280;56259	0.992
NULL	Cancer_Cell_Int_2011_Aug_19_11_29.nxml.txt.nlp	21854619	SENT219	25	25	33	33	cisplatin	HDAC	PA449014	9734	0.992
NULL	J_Cereb_Blood_Flow_Metab_2012_Oct_18_32(10)_1831-1840.nxml.txt.nlp	22805877	SENT65	33	33	10	10	heparin	FIX	PA449855	2158	0.992
NULL	Chemother_Res_Pract_2011_Feb_27_2011_175054.nxml.txt.nlp	22295203	SENT114	6	6	37	37	cisplatin	GPC	PA449014	2995	0.992
NULL	Eur_J_Med_Res_2009_Nov_24_14(Suppl_3)_43-46.nxml.txt.nlp	19959416	SENT13	5	5	23	23	raltegravir	CYP2B6		1555	0.992
NULL	Indian_J_Med_Res_2012_Aug_136(2)_249-259.nxml.txt.nlp	22960892	SENT21	26	26	10	10	irinotecan	UGT1A1	PA450085	54658	0.992
NULL	Front_Microbiol_2014_Sep_11_5_477.nxml.txt.nlp	25309517	SENT206	2	2	19	19	daclizumab	IL-2	PA164764446	3558	0.992
NULL	J_Oncol_2012_Aug_24_2012_281261.nxml.txt.nlp	21876693	SENT202	0	0	18	18	trastuzumab	HER2	PA451743	2064	0.992
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S31-S40.nxml.txt.nlp	20680106	SENT61	10	10	21	21	panitumumab	KRAS	PA162373091	3845	0.992
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1522-1532.nxml.txt.nlp	21997136	SENT142	34	34	17	17	lapatinib	p53	PA152241907	7157	0.992
NULL	F1000_Biol_Rep_2011_Nov_1_3_23.nxml.txt.nlp	22065982	SENT122	10	10	23	23	mitoxantrone	ABCG2	PA450526	9429	0.992
NULL	EMBO_Mol_Med_2009_Apr_1(1)_66-78.nxml.txt.nlp	20049704	SENT225	13	13	28	28	topotecan	HIF-1	PA451729	29072	0.992
NULL	Ann_Rheum_Dis_2013_Dec_5_72(12)_1897-1904.nxml.txt.nlp	23918035	SENT247	23	23	40	40	methotrexate	IL-6	PA450428	3569	0.992
NULL	Ther_Clin_Risk_Manag_2007_Dec_3(6)_1009-1020.nxml.txt.nlp	18516316	SENT184	4	4	28	28	palonosetron	NK1	PA10352	11126	0.992
NULL	Cell_Commun_Signal_2013_Feb_20_11_13.nxml.txt.nlp	23425659	SENT119	34	34	5	5	clonazepam	IL-6	PA449050	3569	0.992
NULL	Mol_Cell_Proteomics_2012_Feb_6_11(2)_M111_015222.nxml.txt.nlp	22147731	SENT335	24	24	12	12	cetuximab	JUN	PA10040	3725	0.992
NULL	Biomed_Res_Int_2013_Sep_4_2013_419176.nxml.txt.nlp	24093097	SENT112	9	9	20	20	vorinostat	AKT	PA164748224	207	0.992
NULL	Arthritis_Res_Ther_2012_Jul_12_14(4)_R163.nxml.txt.nlp	22784880	SENT159	23	23	6	6	leflunomide	DHODH	PA450192	1723	0.992
NULL	Int_J_Gen_Med_2012_Apr_13_5_317-322.nxml.txt.nlp	22536087	SENT4	0	0	15	15	liraglutide	GLP-1	PA165958364	100125288	0.992
NULL	Arch_Drug_Inf_2011_Mar_4(1)_1-9.nxml.txt.nlp	21572514	SENT47	3	3	23	23	ciprofloxacin	P-gp	PA449009	5243	0.992
NULL	Orphanet_J_Rare_Dis_2011_Jul_29_6_52.nxml.txt.nlp	21801394	SENT13	18	18	9	9	allopurinol	HLA-B	PA448320	3106	0.992
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_May_11_67(Pt_6)_o1383.nxml.txt.nlp	21754773	SENT59	3	3	13	13	nimesulide	aromatase	PA137179528	1588	0.992
NULL	Cancers_(Basel)_2010_Jul_27_2(3)_1528-1554.nxml.txt.nlp	24281171	SENT326	4	4	18	18	doxorubicin	ABCB5	PA449412	340273	0.992
NULL	Chin_J_Cancer_2012_Jul_31(7)_319-326.nxml.txt.nlp	22257382	SENT106	28	28	6	6	erlotinib	EGFR	PA134687924	1956	0.992
NULL	J_Exp_Med_1998_Jun_1_187(11)_1885-1892.nxml.txt.nlp	9607928	SENT72	27	27	12	12	thalidomide	CD4	PA451644	920	0.992
NULL	J_Korean_Med_Sci_2013_Aug_31_28(8)_1145-1153.nxml.txt.nlp	23960440	SENT100	28	28	1	1	azathioprine	ST2	PA448515	9173;6761	0.992
NULL	J_Neurochem_2012_Dec_11_123(5)_725-735.nxml.txt.nlp	22971236	SENT4	15	15	4	4	trypsin	P2X1	PA451806	5023	0.992
NULL	Br_J_Cancer_2014_Jan_21_110(2)_384-391.nxml.txt.nlp	24346286	SENT15	20	20	2	2	trastuzumab	PTEN	PA451743	5728	0.992
NULL	Eur_J_Med_Res_2009_Nov_24_14(Suppl_3)_17-21.nxml.txt.nlp	19959412	SENT69	0	0	5	5	atazanavir	UGT1A1	PA10251	54658	0.992
NULL	Am_J_Cardiovasc_Drugs_2014_Jan_3_14(3)_167-173.nxml.txt.nlp	24385234	SENT103	13	13	1	1	candesartan	SPICE	PA448765	152185	0.992
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2011_Mar_14_4_13-24.nxml.txt.nlp	22879790	SENT154	2	2	16	16	liraglutide	PPG	PA165958364	5552	0.992
NULL	J_Young_Pharm_2010_Apr-Jun_2(2)_196-200.nxml.txt.nlp	21264125	SENT30	3	3	15	15	rosuvastatin	CYP2C9	PA134308647	1559	0.992
NULL	J_Hematol_Oncol_2010_Apr_23_3_17.nxml.txt.nlp	20416083	SENT122	5	5	13	13	sorafenib	FLT3	PA7000	2322	0.992
NULL	Target_Oncol_2013_Mar_30_8(1)_27-33.nxml.txt.nlp	23361373	SENT78	18	18	32	32	erlotinib	EGFR	PA134687924	1956	0.992
NULL	Core_Evid_2010_Jul_27_5_1-10.nxml.txt.nlp	20694135	SENT41	6	6	24	24	carbidopa	CLE	PA448794	51637	0.992
NULL	J_Korean_Med_Sci_2005_Dec_31_20(6)_1076-1078.nxml.txt.nlp	16361827	SENT59	20	20	0	0	vasopressin	AQP2	PA451858	359	0.992
NULL	Acta_Oncol_2013_May_13_52(4)_776-782.nxml.txt.nlp	23480638	SENT5	3	3	9	9	imatinib	KIT	PA10804	3815	0.992
NULL	Protein_Cell_2014_Jun_19_5(6)_469-479.nxml.txt.nlp	24748116	SENT57	14	14	6	6	paclitaxel	EB1	PA450761	9167;22919;10982	0.992
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S31-S40.nxml.txt.nlp	20680106	SENT37	19	19	33	33	panitumumab	KRAS	PA162373091	3845	0.992
NULL	Arthritis_Res_Ther_2014_Jul_18_16(4)_R153.nxml.txt.nlp	25037855	SENT122	21	21	6	6	adalimumab	CD14	PA10004	929	0.992
NULL	Mol_Clin_Oncol_2013_Sep_23_1(5)_887-893.nxml.txt.nlp	24649266	SENT102	14	14	5	5	cisplatin	BRCA1	PA449014	672	0.992
NULL	BMB_Rep_2013_Feb_46(2)_92-96.nxml.txt.nlp	23433111	SENT31	18	18	4	4	etoposide	BRCA1	PA449552	672	0.992
NULL	Biomed_Res_Int_2014_Jan_2_2014_126586.nxml.txt.nlp	24527434	SENT151	0	0	12	12	metformin	FOXO3	PA450395	2309	0.992
NULL	Hum_Genomics_2009_Apr_1_3(3)_213-220.nxml.txt.nlp	19403456	SENT43	2	2	17	17	ethanol	ALDH2	PA448073	217	0.992
NULL	Oncotarget_2011_Dec_22_2(12)_1176-1190.nxml.txt.nlp	22202492	SENT119	6	6	11	11	lovastatin	PLA2G7	PA450272	7941	0.992
NULL	Hum_Genomics_Proteomics_2010_Aug_3_2010_159761.nxml.txt.nlp	20981231	SENT60	10	10	28	28	topiramate	GBP	PA451728	54972;3030;3956;8554	0.992
NULL	Diabetes_Metab_Syndr_Obes_2010_Jul_20_3_263-273.nxml.txt.nlp	21437094	SENT109	3	3	18	18	liraglutide	GLP-1	PA165958364	100125288	0.992
NULL	Breast_Cancer_Res_2004_Oct_6_6(6)_269-274.nxml.txt.nlp	15535858	SENT54	30	30	40	40	letrozole	HER2	PA450196	2064	0.992
NULL	J_Oncol_2010_May_24_2010_729725.nxml.txt.nlp	20508816	SENT96	0	0	15	15	vatalanib	VEGFR	PA7001	3791	0.992
NULL	Br_J_Cancer_2003_Mar_10_88(5)_754-759.nxml.txt.nlp	12618886	SENT136	18	18	25	25	amifostine	p53	PA448365	7157	0.992
NULL	Vet_Res_2013_Oct_2_44(1)_89.nxml.txt.nlp	24088531	SENT277	14	14	6	6	hemin	HO-1	PA449849	3162	0.992
NULL	J_Hematol_Oncol_2009_Feb_23_2_10.nxml.txt.nlp	19236716	SENT107	9	9	32	32	dasatinib	CYP3A4	PA162372878	1576	0.992
NULL	Case_Rep_Rheumatol_2011_Dec_15_2011_185657.nxml.txt.nlp	22937439	SENT53	1	1	35	35	etanercept	TNF-alpha	PA449515	7124	0.992
NULL	Cardiovasc_Ther_2009_27(4)_259-274.nxml.txt.nlp	19604248	SENT50	1	1	40	40	ticagrelor	ADP	PA165374673	23038	0.992
NULL	Acta_Pharmacol_Sin_2011_Jan_6_32(1)_133-138.nxml.txt.nlp	21131997	SENT45	15	15	22	22	heparin	ACT	PA449855	12;11332;9457;641455	0.992
NULL	Pharm_Methods_2011_Jan-Mar_2(1)_3-8.nxml.txt.nlp	23781422	SENT142	32	32	10	10	codeine	TLC	PA449088	3933	0.992
NULL	Biomed_Res_Int_2014_Apr_10_2014_580852.nxml.txt.nlp	24812624	SENT130	11	11	23	23	resveratrol	PTEN		5728	0.992
NULL	Front_Endocrinol_(Lausanne)_2013_Jan_7_3_180.nxml.txt.nlp	23316185	SENT67	30	30	7	7	glucose	CRF2	PA449773	1395	0.992
NULL	Adv_Virol_2011_Oct_23_2011_975801.nxml.txt.nlp	22312361	SENT33	31	31	5	5	heparin	CAT-1	PA449855	6541	0.992
NULL	Clin_Med_Insights_Oncol_2012_Feb_28_6_125-135.nxml.txt.nlp	22408376	SENT268	9	9	3	3	panitumumab	BRAF	PA162373091	673	0.992
NULL	Biologics_2010_Nov_9_4_289-298.nxml.txt.nlp	21116327	SENT29	35	35	9	9	cetuximab	EGFR	PA10040	1956	0.992
NULL	Breast_Cancer_Res_2014_Sep_17_16(5)_435.nxml.txt.nlp	25228385	SENT214	17	17	2	2	cisplatin	BRCA1	PA449014	672	0.992
NULL	Oncol_Rep_2013_Apr_5_29(4)_1671-1677.nxml.txt.nlp	23404329	SENT165	14	14	3	3	aspirin	MIA	PA448497	8190	0.992
NULL	Oncotarget_2014_Jun_30_5(14)_5637-5650.nxml.txt.nlp	25026298	SENT199	10	10	18	18	cisplatin	BRCA1	PA449014	672	0.992
NULL	Br_J_Cancer_2011_Nov_22_105(11)_1654-1662.nxml.txt.nlp	22045187	SENT178	40	40	7	7	irinotecan	MTHFR	PA450085	4524	0.992
NULL	Anal_Chem_Insights_2009_Apr_7_4_1-9.nxml.txt.nlp	19652757	SENT99	35	35	23	23	escitalopram	mol	PA10074	90527	0.992
NULL	Environ_Health_Perspect_2007_Dec_8_115(Suppl_1)_69-76.nxml.txt.nlp	18174953	SENT174	6	6	16	16	estradiol	CYP1A1	PA449503	1543	0.992
NULL	Mol_Cancer_2014_Jun_4_13_141.nxml.txt.nlp	24894453	SENT44	19	19	6	6	cetuximab	BRAF	PA10040	673	0.992
NULL	Oncol_Lett_2014_Aug_19_8(2)_809-812.nxml.txt.nlp	25009658	SENT86	7	7	17	17	metformin	AMPK	PA450395	5563	0.992
NULL	Arthritis_Res_Ther_2013_Dec_2_15(6)_R204.nxml.txt.nlp	24295403	SENT24	0	0	8	8	tocilizumab	IL-6	PA165292659	3569	0.992
NULL	Br_J_Cancer_2011_Dec_6_105(12)_1850-1855.nxml.txt.nlp	22095231	SENT92	0	0	10	10	erlotinib	EGFR	PA134687924	1956	0.992
NULL	Indian_J_Endocrinol_Metab_2013_Oct_17(Suppl1)_S307-S309.nxml.txt.nlp	24251196	SENT45	5	5	11	11	acarbose	PPG	PA448010	5552	0.992
NULL	Br_J_Cancer_2013_Sep_3_109(5)_1214-1222.nxml.txt.nlp	23922104	SENT172	2	2	15	15	dasatinib	MDM2	PA162372878	4193	0.992
NULL	Case_Rep_Dermatol_2011_Feb_5_3(1)_13-17.nxml.txt.nlp	21931572	SENT6	3	3	27	27	bexarotene	IL-2	PA164752250	3558	0.992
NULL	J_Oncol_2009_Jan_17_2009_581939.nxml.txt.nlp	20145720	SENT214	22	22	3	3	collagenase	IL-8	PA449107	3576	0.992
NULL	Eur_J_Clin_Pharmacol_2012_Sep_15_68(9)_1267-1274.nxml.txt.nlp	22418828	SENT148	34	34	12	12	clopidogrel	CYP2C19	PA449053	1557	0.992
NULL	Eur_J_Pharm_Sci_2012_Jul_16_46(4)_244-258.nxml.txt.nlp	22085636	SENT319	24	24	15	15	pertuzumab	PTEN		5728	0.992
NULL	Adv_Appl_Bioinforma_Chem_2008_Oct_30_1_85-98.nxml.txt.nlp	21918608	SENT163	14	14	0	0	bortezomib	SPARC	PA10252	6678	0.992
NULL	Exp_Ther_Med_2014_Aug_11_8(2)_671-675.nxml.txt.nlp	25009638	SENT177	20	20	3	3	scopolamine	FAE	PA451308	2178	0.992
NULL	Oncoimmunology_2013_Jul_1_2(7)_e24720.nxml.txt.nlp	24073365	SENT29	43	43	21	21	trastuzumab	HER2	PA451743	2064	0.992
NULL	Front_Immunol_2013_Nov_7_4_360.nxml.txt.nlp	24223576	SENT303	19	19	6	6	imiquimod	TLR7	PA449972	51284	0.992
NULL	Indian_J_Dermatol_2013_Jul-Aug_58(4)_299-305.nxml.txt.nlp	23919003	SENT37	7	7	32	32	methotrexate	IL-6	PA450428	3569	0.992
NULL	Breast_Cancer_Res_2000_Mar_6_2(3)_170-175.nxml.txt.nlp	11250706	SENT83	29	29	8	8	estradiol	AKT1	PA449503	207	0.992
NULL	Br_J_Cancer_1997_76(4)_480-485.nxml.txt.nlp	9275025	SENT15	26	26	38	38	doxorubicin	p53	PA449412	7157	0.992
NULL	Breast_Cancer_Res_2007_Oct_26_9(5)_112.nxml.txt.nlp	17980056	SENT53	17	17	4	4	erlotinib	EGFR	PA134687924	1956	0.992
NULL	Mol_Biol_Rep_2013_May_11_40(8)_5013-5026.nxml.txt.nlp	23666059	SENT147	11	11	23	23	resveratrol	14-3-3		10971	0.992
NULL	Springerplus_2013_Jan_23_2_22.nxml.txt.nlp	23420789	SENT20	0	0	30	30	gefitinib	EGFR	PA131301952	1956	0.992
NULL	Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.nxml.txt.nlp	24736980	SENT35	22	22	0	0	rosuvastatin	OATP1B1	PA134308647	10599	0.992
NULL	Mol_Biol_Rep_2013_May_11_40(8)_5013-5026.nxml.txt.nlp	23666059	SENT147	11	11	29	29	resveratrol	p53		7157	0.992
NULL	Adolesc_Health_Med_Ther_2012_Jun_20_3_85-93.nxml.txt.nlp	24600289	SENT138	0	0	19	19	adalimumab	TNF	PA10004	7124	0.992
NULL	Front_Physiol_2013_Dec_24_4_386.nxml.txt.nlp	24399968	SENT363	13	13	25	25	diazoxide	SUR1	PA449285	6833	0.992
NULL	Iran_Red_Crescent_Med_J_2013_Mar_5_15(3)_249-253.nxml.txt.nlp	23984007	SENT15	7	7	36	36	carbamazepine	B12	PA448785	7126;4709	0.992
NULL	Br_J_Cancer_2010_Dec_7_103(12)_1858-1869.nxml.txt.nlp	21063399	SENT242	7	7	26	26	trastuzumab	EGFR	PA451743	1956	0.992
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S202-S209.nxml.txt.nlp	21525456	SENT159	14	14	6	6	exenatide	GLP-1	PA164749238	100125288	0.992
NULL	J_Inflamm_(Lond)_2006_Jul_12_3_10.nxml.txt.nlp	16834783	SENT143	14	14	0	0	mometasone	GM-CSF	PA450541	1437	0.992
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT119	35	35	44	44	nilotinib	ABCG2	PA165958345	9429	0.992
NULL	Br_J_Cancer_2013_Jul_23_109(2)_351-359.nxml.txt.nlp	23799854	SENT77	24	24	2	2	trypsin	BLT2	PA451806	56413	0.992
NULL	Oncol_Lett_2013_Sep_15_6(3)_648-654.nxml.txt.nlp	24137384	SENT37	29	29	6	6	oxaliplatin	ERCC2	PA131285527	2068	0.992
NULL	Mol_Cancer_2010_Jun_24_9_164.nxml.txt.nlp	20576107	SENT176	42	42	6	6	etoposide	Mcl-1	PA449552	4170	0.992
NULL	Arch_Drug_Inf_2011_Mar_4(1)_1-9.nxml.txt.nlp	21572514	SENT169	20	20	5	5	ciprofloxacin	MRP1	PA449009	4437	0.992
NULL	Pharmaceuticals_(Basel)_2012_Aug_30_5(9)_890-898.nxml.txt.nlp	24280696	SENT51	30	30	4	4	geldanamycin	Hsp90	PA152031327	3320	0.992
NULL	Reprod_Biol_Endocrinol_2013_Jun_19_11_53.nxml.txt.nlp	23782518	SENT138	10	10	0	0	cisplatin	CD133	PA449014	8842	0.992
NULL	Front_Neurosci_2010_Jun_17_4_35.nxml.txt.nlp	20661455	SENT90	0	0	18	18	pindolol	5-HT1A	PA450966	3350	0.992
NULL	Arthritis_Res_Ther_2014_Jul_18_16(4)_R153.nxml.txt.nlp	25037855	SENT120	19	19	8	8	adalimumab	CD14	PA10004	929	0.992
NULL	J_Infect_Dis_2012_Apr_15_205(8)_1278-1286.nxml.txt.nlp	22396598	SENT158	6	6	18	18	artemisinin	DHODH	PA165111696	1723	0.992
NULL	J_Oncol_2010_Nov_19_2010_568938.nxml.txt.nlp	20037743	SENT141	21	21	1	1	bevacizumab	EGFR	PA130232992	1956	0.992
NULL	Acta_Pharmacol_Sin_2009_Sep_24_30(9)_1262-1275.nxml.txt.nlp	19701231	SENT213	43	43	10	10	lovastatin	PDZD3	PA450272	79849	0.992
NULL	Breast_Cancer_Res_2011_Jun_29_13(3)_R70.nxml.txt.nlp	21707964	SENT3	48	48	8	8	tamoxifen	14-3-3	PA451581	10971	0.992
NULL	Curr_Pain_Headache_Rep_2013_May_13_17(5)_334.nxml.txt.nlp	23584563	SENT206	0	0	13	13	sumatriptan	MELAS	PA451566	4219	0.992
NULL	Exp_Mol_Med_2012_Sep_30_44(9)_545-553.nxml.txt.nlp	22809901	SENT62	3	3	15	15	clozapine	PRDM16	PA449061	63976	0.992
NULL	Biomed_Res_Int_2013_Sep_4_2013_419176.nxml.txt.nlp	24093097	SENT114	33	33	5	5	sorafenib	AKT	PA7000	207	0.992
NULL	Curr_Chem_Genomics_2010_Mar_1_4_1-8.nxml.txt.nlp	20448812	SENT93	0	0	26	26	estropipate	OATP1B3	PA165958342	28234	0.992
NULL	Nat_Commun_2013_Oct_23_4_10_1038_ncomms3626.nxml.txt.nlp	24149709	SENT117	43	43	0	0	doxycycline	CD34	PA449415	947	0.992
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT416	8	8	2	2	panitumumab	BRAF	PA162373091	673	0.992
NULL	Environ_Health_Perspect_2008_Apr_16_116(4)_426-433.nxml.txt.nlp	18414622	SENT169	36	36	15	15	resveratrol	AP-1		2353;3727;2354;3725	0.992
NULL	Oncotarget_2014_Aug_29_5(18)_8052-8082.nxml.txt.nlp	25211298	SENT483	5	5	16	16	itraconazole	SMO	PA450132	6608;54498	0.992
NULL	Diabetes_Care_2011_Jul_17_34(7)_e115-e120.nxml.txt.nlp	21709286	SENT99	6	6	33	33	metformin	AMPK	PA450395	5563	0.992
NULL	Korean_Circ_J_2013_Oct_30_43(10)_699-701.nxml.txt.nlp	24255655	SENT13	14	14	0	0	amiodarone	APT	PA448383	653639	0.992
NULL	Cell_Cycle_2012_Dec_15_11(24)_4661-4672.nxml.txt.nlp	23187802	SENT164	9	9	25	25	doxorubicin	p130	PA449412	5934	0.992
NULL	Patient_Prefer_Adherence_2010_Mar_24_4_61-68.nxml.txt.nlp	20361006	SENT90	20	20	38	38	liraglutide	GLP-1	PA165958364	100125288	0.992
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1137-1144.nxml.txt.nlp	20234366	SENT189	29	29	38	38	cetuximab	MKP-1	PA10040	1843	0.992
NULL	Breast_Cancer_(Auckl)_2011_Jan_13_5_1-14.nxml.txt.nlp	21494397	SENT208	15	15	27	27	ixabepilone	CYP3A4		1576	0.992
NULL	Oncogene_2011_Apr_21_30(16)_1892-1900.nxml.txt.nlp	21217782	SENT36	8	8	17	17	metformin	AMPK	PA450395	5563	0.992
NULL	Clin_Ophthalmol_2009_Jun_2_3_175-182.nxml.txt.nlp	19668562	SENT117	0	0	27	27	bevacizumab	VEGF-A	PA130232992	7422	0.992
NULL	Viruses_2014_Oct_24_6(10)_4095-4139.nxml.txt.nlp	25341668	SENT375	3	3	26	26	maraviroc	CD4	PA164768835	920	0.992
NULL	Oncoimmunology_2012_Sep_1_1(6)_810-821.nxml.txt.nlp	23162748	SENT186	29	29	22	22	trastuzumab	HER2	PA451743	2064	0.992
NULL	Clinics_(Sao_Paulo)_2012_Sep_67(9)_1093-1099.nxml.txt.nlp	23018309	SENT113	21	21	7	7	sorafenib	Mcl-1	PA7000	4170	0.992
NULL	Oncol_Lett_2014_May_10_7(5)_1651-1656.nxml.txt.nlp	24765194	SENT27	30	30	6	6	capsaicin	TRPV1	PA448776	7442	0.992
NULL	Evid_Based_Complement_Alternat_Med_2004_Sep_1(2)_207-209.nxml.txt.nlp	15480447	SENT44	28	28	6	6	cisplatin	HER-2	PA449014	2064	0.992
NULL	Oncol_Rep_2014_Feb_13_31(2)_581-588.nxml.txt.nlp	24337105	SENT148	25	25	41	41	capsaicin	Bcl-2	PA448776	596	0.992
NULL	Exp_Neurobiol_2013_Mar_31_22(1)_51-57.nxml.txt.nlp	23585723	SENT16	37	37	0	0	capsaicin	TRPV1	PA448776	7442	0.992
NULL	Mol_Biol_Cell_2014_Mar_15_25(6)_828-840.nxml.txt.nlp	24478456	SENT54	8	8	44	44	staurosporine	LIMK1	PA165109623	3984	0.992
NULL	Mol_Cancer_2014_Jun_24_13_157.nxml.txt.nlp	24958351	SENT169	12	12	3	3	lapatinib	HER2	PA152241907	2064	0.992
NULL	Appl_Clin_Genet_2011_Jan_26_4_21-27.nxml.txt.nlp	23776364	SENT140	0	0	19	19	anakinra	NLRP3	PA10799	114548	0.992
NULL	eLife_2014_May_20_3_e01763.nxml.txt.nlp	24844244	SENT381	25	25	10	10	doxycycline	MELK	PA449415	9833	0.992
NULL	Cell_Death_Dis_2014_Apr_17_5(4)_e1185.nxml.txt.nlp	24743740	SENT49	1	1	33	33	pha-665752	Met		79811	0.992
NULL	Curr_Neuropharmacol_2013_Jan_11(1)_59-79.nxml.txt.nlp	23814539	SENT163	33	33	8	8	levodopa	PARK14	PA450213	8398	0.992
NULL	Indian_J_Pharmacol_2009_Dec_41(6)_252-254.nxml.txt.nlp	20407554	SENT107	10	10	17	17	irbesartan	AT2	PA450084	186	0.992
NULL	Stroke_Res_Treat_2011_Nov_10_2011_212485.nxml.txt.nlp	22135769	SENT47	18	18	9	9	atenolol	GRK5	PA448499	2869	0.992
NULL	Anticancer_Agents_Med_Chem_2010_Oct_10(8)_617-624.nxml.txt.nlp	21182469	SENT53	12	12	5	5	estradiol	ABCC11	PA449503	85320	0.992
NULL	Br_J_Cancer_2014_Aug_12_111(4)_696-707.nxml.txt.nlp	24937672	SENT231	10	10	4	4	sorafenib	ABCC10	PA7000	89845	0.992
NULL	Protein_Pept_Lett_2014_Aug_21(8)_828-839.nxml.txt.nlp	23855671	SENT213	25	25	4	4	ribavirin	TNFAIP6	PA451241	7130	0.992
NULL	Ann_Rehabil_Med_2012_Aug_27_36(4)_466-473.nxml.txt.nlp	22977771	SENT22	4	4	22	22	triamcinolone	ILEI	PA451749	10447	0.992
NULL	Clin_Med_Insights_Oncol_2013_Aug_21_7_221-234.nxml.txt.nlp	24179413	SENT49	11	11	17	17	gefitinib	EGFR	PA131301952	1956	0.992
NULL	Clin_Pharmacol_2013_May_23_5(Suppl_1)_13-19.nxml.txt.nlp	23723721	SENT46	6	6	21	21	imiquimod	TLR9	PA449972	54106	0.992
NULL	Breast_Cancer_Res_2010_Oct_22_12(Suppl_2)_S2.nxml.txt.nlp	21050423	SENT108	27	27	4	4	methotrexate	p53	PA450428	7157	0.992
NULL	Breast_Cancer_Res_2006_Nov_6_8(6)_215.nxml.txt.nlp	17096862	SENT40	2	2	12	12	trastuzumab	MUC4	PA451743	4585	0.992
NULL	Oncotarget_2011_Dec_31_2(12)_1322-1328.nxml.txt.nlp	22249159	SENT45	0	0	15	15	resveratrol	AMPK		5563	0.992
NULL	Int_J_Mol_Sci_2014_Mar_5_15(3)_3970-3988.nxml.txt.nlp	24603537	SENT29	22	22	0	0	curcumin	MCH	PA151958596	5367	0.992
NULL	Mol_Cell_Proteomics_2012_Feb_6_11(2)_M111_015222.nxml.txt.nlp	22147731	SENT335	24	24	9	9	cetuximab	JAG1	PA10040	182	0.992
NULL	Mol_Cancer_2008_Jun_5_7_50.nxml.txt.nlp	18534018	SENT149	44	44	11	11	bortezomib	ATF4	PA10252	468	0.992
NULL	Mol_Pain_2012_Sep_22_8_71.nxml.txt.nlp	22998838	SENT217	38	38	7	7	paclitaxel	CXCR4	PA450761	7852	0.992
NULL	Ann_Neurosci_2013_Apr_20(2)_67-70.nxml.txt.nlp	25206016	SENT39	11	11	0	0	tamoxifen	NeuN	PA451581	146713	0.992
NULL	Indian_J_Pharmacol_2008_Jan-Feb_40(1)_10-14.nxml.txt.nlp	21264154	SENT124	10	10	20	20	vildagliptin	GLP-1	PA165958346	100125288	0.992
NULL	Int_J_Breast_Cancer_2013_Jan_16_2013_872743.nxml.txt.nlp	23401782	SENT47	29	29	10	10	tamoxifen	PAK1	PA451581	5585;5058	0.992
NULL	Ann_N_Y_Acad_Sci_2013_Apr_6_1281(1)_36-50.nxml.txt.nlp	23387439	SENT157	28	28	0	0	exenatide	GLP-1	PA164749238	100125288	0.992
NULL	Acta_Pharmacol_Sin_2010_Sep_16_31(9)_1133-1140.nxml.txt.nlp	20711219	SENT42	4	4	25	25	infliximab	IL-6	PA452639	3569	0.992
NULL	Cell_Death_Dis_2014_Jan_9_5(1)_e986.nxml.txt.nlp	24407239	SENT138	12	12	0	0	fludarabine	STAT1	PA449655	6772	0.992
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R92.nxml.txt.nlp	22541845	SENT137	3	3	20	20	bumetanide	SLC17A3	PA448682	10786	0.992
NULL	Mediators_Inflamm_1995_May_4(3)_209-216.nxml.txt.nlp	18475641	SENT7	23	23	40	40	theophylline	IFN	PA451647	3439	0.992
NULL	Nat_Chem_Biol_2009_Jan_23_5(1)_37-44.nxml.txt.nlp	19029917	SENT115	9	9	21	21	rimonabant	CB1	PA152407999	1268	0.992
NULL	Cancers_(Basel)_2012_Oct_29_4(4)_1146-1160.nxml.txt.nlp	24213502	SENT81	11	11	25	25	letrozole	aromatase	PA450196	1588	0.992
NULL	Nat_Genet_2011_Jun_5_43(7)_621-629.nxml.txt.nlp	21642992	SENT102	44	44	19	19	doxorubicin	CDKN1A	PA449412	1026	0.992
NULL	J_Inherit_Metab_Dis_2010_Oct_3_33(5)_625-632.nxml.txt.nlp	20814828	SENT77	13	13	43	43	simvastatin	RhoA	PA451363	387	0.992
NULL	Arch_Dis_Child_2008_Jul_1_93(7)_620-625.nxml.txt.nlp	18381346	SENT195	2	2	20	20	oxygen	PAP	PA450744	11333;10884;10914;11334;8853;50807	0.992
NULL	Scientifica_(Cairo)_2012_Nov_25_2012_473829.nxml.txt.nlp	24278698	SENT391	5	5	21	21	oxaliplatin	MATE2-K	PA131285527	146802	0.992
NULL	Anesth_Pain_Med_2013_Dec_27_4(1)_e11906.nxml.txt.nlp	24660144	SENT39	14	14	26	26	rituximab	VIII	PA451261	1351	0.992
NULL	J_Oral_Pathol_Med_2013_Jul_18_42(6)_499-506.nxml.txt.nlp	23331485	SENT39	0	0	6	6	indomethacin	COX	PA449982	1351	0.992
NULL	Br_J_Cancer_2012_Oct_23_107(9)_1474-1480.nxml.txt.nlp	23033004	SENT153	28	28	14	14	erlotinib	EGFR	PA134687924	1956	0.992
NULL	Oncogene_2014_May_1_33(18)_2307-2316.nxml.txt.nlp	23686305	SENT121	7	7	26	26	trypsin	spatial	PA451806	219793	0.992
NULL	J_Gynecol_Oncol_2013_Jul_4_24(3)_265-272.nxml.txt.nlp	23875077	SENT127	0	0	8	8	thrombin	PAR1	PA451674	79581;2149	0.992
NULL	Mol_Pain_2013_Jun_10_9_27.nxml.txt.nlp	23758830	SENT153	3	3	10	10	tetracaine	ASIC3	PA451638	9311	0.992
NULL	J_Anim_Sci_Biotechnol_2013_Jun_26_4(1)_23.nxml.txt.nlp	23800120	SENT50	16	16	4	4	estradiol	OXTR	PA449503	5021	0.992
NULL	Oncotarget_2014_May_26_5(21)_10368-10381.nxml.txt.nlp	25362644	SENT186	20	20	0	0	trastuzumab	IL-6	PA451743	3569	0.992
NULL	Acta_Pharmacol_Sin_2010_Mar_22_31(3)_329-340.nxml.txt.nlp	20173759	SENT27	23	23	6	6	ethanol	AMPK	PA448073	5563	0.992
NULL	Ann_Hematol_2010_Nov_25_89(11)_1115-1124.nxml.txt.nlp	20499237	SENT148	9	9	25	25	simvastatin	ZAP-70	PA451363	7535	0.992
NULL	Br_J_Cancer_2012_Jul_24_107(3)_455-461.nxml.txt.nlp	22767146	SENT22	0	0	25	25	sorafenib	BRAF	PA7000	673	0.992
NULL	Front_Genet_2014_Jul_22_5_239.nxml.txt.nlp	25101118	SENT232	6	6	22	22	minocycline	FMRP	PA450519	2332	0.992
NULL	Mol_Cancer_2009_Apr_22_8_26.nxml.txt.nlp	19386116	SENT189	24	24	3	3	ritonavir	Bcl-2	PA451260	596	0.992
NULL	J_Thromb_Thrombolysis_2012_Feb_20_33(2)_143-153.nxml.txt.nlp	22183178	SENT60	0	0	21	21	ticagrelor	ADP	PA165374673	23038	0.992
NULL	J_Hematol_Oncol_2012_May_8_5_21.nxml.txt.nlp	22569033	SENT77	12	12	36	36	imatinib	KIT	PA10804	3815	0.992
NULL	Anticancer_Agents_Med_Chem_2012_Feb_12(2)_163-171.nxml.txt.nlp	22043994	SENT24	28	28	12	12	panitumumab	KRAS	PA162373091	3845	0.992
NULL	AIDS_Res_Treat_2014_Feb_25_2014_636584.nxml.txt.nlp	24715982	SENT64	31	31	2	2	raltegravir	DUET		8997	0.992
NULL	Ann_Hematol_2010_Jul_1_89(Suppl_1)_5-10.nxml.txt.nlp	NULL	SENT16	3	3	30	30	rituximab	TPO	PA451261	7066;7173	0.992
NULL	Cancers_(Basel)_2014_Oct_27_6(4)_2224-2242.nxml.txt.nlp	25349887	SENT140	0	0	20	20	aprepitant	CYP3A4	PA164747039	1576	0.992
NULL	ScientificWorldJournal_2014_Feb_11_2014_898361.nxml.txt.nlp	24678280	SENT12	30	30	9	9	curcumin	IL-4	PA151958596	3565	0.992
NULL	Oncogene_2010_Sep_23_29(38)_5286-5298.nxml.txt.nlp	20603611	SENT92	19	19	28	28	heparin	Met	PA449855	79811	0.992
NULL	J_Oncol_2010_Dec_15_2010_821717.nxml.txt.nlp	20049172	SENT166	22	22	9	9	paclitaxel	TUBB3	PA450761	10381	0.992
NULL	Br_J_Cancer_2013_Feb_19_108(3)_668-675.nxml.txt.nlp	23348520	SENT113	31	31	9	9	cetuximab	HER2	PA10040	2064	0.992
NULL	J_Oncol_2010_Dec_28_2010_414676.nxml.txt.nlp	20066160	SENT121	0	0	14	14	pertuzumab	EGF		1950	0.992
NULL	Indian_Dermatol_Online_J_2010_Jul-Dec_1(1)_14-17.nxml.txt.nlp	23130185	SENT59	0	0	10	10	lapatinib	EGFR	PA152241907	1956	0.992
NULL	Front_Behav_Neurosci_2011_Sep_28_5_64.nxml.txt.nlp	21991251	SENT27	30	30	7	7	estradiol	CB1	PA449503	1268	0.992
NULL	Oncotarget_2014_Sep_8_5(19)_9444-9459.nxml.txt.nlp	25275294	SENT221	4	4	19	19	vemurafenib	BRAF	PA165946873	673	0.992
NULL	Ann_Hematol_2010_Sep_13_89(9)_861-871.nxml.txt.nlp	20387067	SENT208	4	4	16	16	dasatinib	KIT	PA162372878	3815	0.992
NULL	Arthritis_Res_Ther_2013_Oct_17_15(5)_R154.nxml.txt.nlp	24286344	SENT309	27	27	8	8	ivermectin	P2X7	PA450133	5027	0.992
NULL	Exp_Ther_Med_2014_Aug_11_8(2)_671-675.nxml.txt.nlp	25009638	SENT184	20	20	3	3	scopolamine	FAE	PA451308	2178	0.992
NULL	Mol_Biol_Cell_2013_Aug_1_24(15)_2328-2339.nxml.txt.nlp	23783029	SENT335	47	47	7	7	glucose	GEF	PA449773	56731	0.992
NULL	Curr_Genomics_2014_Feb_15(1)_18-27.nxml.txt.nlp	24653660	SENT147	40	40	17	17	levodopa	DYT2	PA450213	1862	0.992
NULL	Diabetol_Metab_Syndr_2014_Oct_15_6(1)_110.nxml.txt.nlp	NULL	SENT40	14	14	0	0	liraglutide	GLP-1	PA165958364	100125288	0.992
NULL	Oncoimmunology_2012_Oct_1_1(7)_1004-1016.nxml.txt.nlp	23170249	SENT16	0	0	11	11	pertuzumab	HER-2		2064	0.992
NULL	Chem_Rev_2012_May_9_112(5)_2593-2603.nxml.txt.nlp	22335786	SENT68	35	35	4	4	fluorescein	ATX	PA164746009	5168;23049	0.992
NULL	Leukemia_2013_Feb_10_27(2)_507-510.nxml.txt.nlp	22810506	SENT21	28	28	0	0	cladribine	TRAC	PA449027	28755	0.992
NULL	Mol_Cancer_2010_Aug_16_9_217.nxml.txt.nlp	20712901	SENT93	41	41	11	11	curcumin	STAT3	PA151958596	6774	0.992
NULL	Curr_Neuropharmacol_2014_Jul_12(4)_342-352.nxml.txt.nlp	25342942	SENT62	24	24	0	0	levodopa	COMT	PA450213	1312	0.992
NULL	J_Cell_Biol_1997_May_19_137(4)_939-952.nxml.txt.nlp	9151695	SENT58	0	0	36	36	neomycin	CEA	PA450608	5670;1087	0.992
NULL	Biosci_Rep_2014_Dec_12_34(6)_e00160.nxml.txt.nlp	25495645	SENT94	36	36	1	1	rosiglitazone	ANGPTL3	PA451283	27329	0.992
NULL	Br_J_Cancer_2011_Jun_7_104(12)_1848-1853.nxml.txt.nlp	21610704	SENT48	31	31	37	37	panitumumab	REL	PA162373091	5966	0.992
NULL	Psychiatry_Investig_2012_Dec_12_9(4)_422-424.nxml.txt.nlp	23251210	SENT14	33	33	7	7	perphenazine	CYP2D6	PA450882	1565	0.992
NULL	Braz_J_Med_Biol_Res_2014_Mar_21_47(4)_273-278.nxml.txt.nlp	24676475	SENT98	10	10	16	16	doxorubicin	P-gp	PA449412	5243	0.992
NULL	Biomed_Res_Int_2014_Aug_6_2014_621827.nxml.txt.nlp	25165710	SENT275	2	2	12	12	dexmedetomidine	CD68	PA449256	968	0.992
NULL	Hum_Mol_Genet_2010_Jan_15_19(2)_313-328.nxml.txt.nlp	19864493	SENT269	7	7	20	20	hyaluronan	CD44	PA165958431	960	0.992
NULL	Diabetes_Care_2010_Feb_23_33(2)_246-251.nxml.txt.nlp	19933994	SENT135	3	3	12	12	metformin	B12	PA450395	7126;4709	0.992
NULL	Comp_Hepatol_2004_Jan_14_3(Suppl_1)_S20.nxml.txt.nlp	14960172	SENT40	1	1	15	15	collagenase	MT1-MMP	PA449107	4323	0.992
NULL	F1000Res_2013_Mar_5_2_74.nxml.txt.nlp	24358880	SENT229	0	0	24	24	capsaicin	TRPV1	PA448776	7442	0.992
NULL	Mol_Cancer_2013_Apr_22_12_29.nxml.txt.nlp	23601052	SENT240	24	24	8	8	hydroxyurea	CO2	PA449942	4513	0.992
NULL	Arch_Med_Sci_2014_Feb_24_10(1)_1-9.nxml.txt.nlp	24701207	SENT121	17	17	48	48	irinotecan	PIK3CA	PA450085	5290	0.992
NULL	Br_J_Cancer_2014_Jan_21_110(2)_384-391.nxml.txt.nlp	24346286	SENT21	26	26	13	13	trastuzumab	HER3	PA451743	2065	0.992
NULL	Sci_Rep_2015_Jan_21_5_7916.nxml.txt.nlp	25604905	SENT416	34	34	21	21	neomycin	CD34	PA450608	947	0.992
NULL	J_Hematol_Oncol_2010_May_2_3_18.nxml.txt.nlp	20433767	SENT184	14	14	0	0	gefitinib	EGFR	PA131301952	1956	0.992
NULL	Cancer_Microenviron_2009_Sep_26_2(Suppl_1)_19-204.nxml.txt.nlp	NULL	SENT6587	11	11	24	24	docetaxel	MDR1	PA449383	5243	0.992
NULL	Mol_Cancer_2010_Nov_2_9_289.nxml.txt.nlp	21044322	SENT10	3	3	12	12	cisplatin	RGS10	PA449014	6001	0.992
NULL	Front_Oncol_2014_Mar_14_4_52.nxml.txt.nlp	24672773	SENT86	0	0	7	7	pioglitazone	CTNNB1	PA450970	1499	0.992
NULL	Int_J_Endocrinol_2014_Jun_25_2014_534904.nxml.txt.nlp	25053942	SENT94	15	15	36	36	amiodarone	AIT	PA448383	160728	0.992
NULL	Cardiol_Res_Pract_2011_May_10_2011_816897.nxml.txt.nlp	21629798	SENT126	0	0	17	17	pazopanib	CYP2C8	PA165291492	1558	0.992
NULL	Cancers_(Basel)_2011_Apr_1_3(2)_1844-1860.nxml.txt.nlp	24212785	SENT68	18	18	10	10	cetuximab	KRAS	PA10040	3845	0.992
NULL	Breast_Cancer_Res_2002_Aug_27_4(6)_213-217.nxml.txt.nlp	12473165	SENT92	30	30	7	7	tamoxifen	ATAC	PA451581	6375	0.992
NULL	J_Nat_Sci_Biol_Med_2011_Jan-Jun_2(1)_13-25.nxml.txt.nlp	22470230	SENT57	14	14	3	3	capsaicin	TRPV3	PA448776	162514	0.992
NULL	J_Young_Pharm_2010_Apr-Jun_2(2)_196-200.nxml.txt.nlp	21264125	SENT123	4	4	10	10	glimepiride	CYP3A4	PA449761	1576	0.992
NULL	Clin_Med_Insights_Cardiol_2011_Sep_19_5_85-101.nxml.txt.nlp	22084607	SENT177	0	0	17	17	rosiglitazone	CYP2C8	PA451283	1558	0.992
NULL	J_Korean_Med_Sci_2008_Aug_25_23(4)_737-739.nxml.txt.nlp	18756069	SENT64	11	11	20	20	saquinavir	ATV	PA451305	4683	0.992
NULL	Oncologist_2011_Mar_21_16(3)_264-275.nxml.txt.nlp	21339259	SENT134	44	44	23	23	docetaxel	VEGFR	PA449383	3791	0.991
NULL	Exp_Anim_2014_Apr_26_63(2)_257-267.nxml.txt.nlp	24770651	SENT115	29	29	6	6	olmesartan	apelin	PA164742950	8862	0.991
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2014_Sep_27_70(Pt_10)_2740-2753.nxml.txt.nlp	25286857	SENT311	0	0	4	4	bsi-201	PARP1		142	0.991
NULL	Front_Immunol_2013_Mar_8_4_50.nxml.txt.nlp	23483669	SENT201	3	3	13	13	metformin	NLRP3	PA450395	114548	0.991
NULL	J_Pregnancy_2012_Nov_1_2012_379271.nxml.txt.nlp	22132339	SENT200	5	5	32	32	rifabutin	CYP3A	PA451249	1574	0.991
NULL	Cancer_Med_2014_Jun_25_3(3)_674-680.nxml.txt.nlp	24668895	SENT157	3	3	15	15	trastuzumab	KRAS	PA451743	3845	0.991
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT142	13	13	6	6	curcumin	PC-3	PA151958596	692094	0.991
NULL	Br_J_Cancer_2013_May_28_108(10)_2013-2020.nxml.txt.nlp	23632482	SENT4	0	0	18	18	paclitaxel	HER2	PA450761	2064	0.991
NULL	Curr_Neuropharmacol_2014_May_12(3)_219-238.nxml.txt.nlp	24851087	SENT319	5	5	28	28	rolipram	GluA1	PA153906323	2890	0.991
NULL	Br_J_Cancer_2013_Sep_3_109(5)_1172-1180.nxml.txt.nlp	23949153	SENT37	0	0	9	9	tamoxifen	aromatase	PA451581	1588	0.991
NULL	Br_J_Cancer_2012_Sep_25_107(7)_1093-1099.nxml.txt.nlp	22935583	SENT27	2	2	18	18	everolimus	4E-BP1	PA164746311	1978	0.991
NULL	Exp_Anim_2014_Apr_26_63(2)_257-267.nxml.txt.nlp	24770651	SENT160	40	40	6	6	perindopril	apelin	PA450877	8862	0.991
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1522-1532.nxml.txt.nlp	21997136	SENT142	47	47	17	17	lapatinib	p53	PA152241907	7157	0.991
NULL	J_Inflamm_(Lond)_2007_Apr_24_4_8.nxml.txt.nlp	17456234	SENT106	0	0	18	18	imiquimod	IFN	PA449972	3439	0.991
NULL	Oncotarget_2014_Mar_14_5(10)_3029-3038.nxml.txt.nlp	24912489	SENT102	8	8	16	16	everolimus	aromatase	PA164746311	1588	0.991
NULL	J_Oncol_2010_Jan_3_2010_709678.nxml.txt.nlp	21274259	SENT30	0	0	10	10	gefitinib	EGFR	PA131301952	1956	0.991
NULL	J_Vet_Med_Sci_2014_Jun_15_76(6)_813-817.nxml.txt.nlp	24531829	SENT90	13	13	33	33	artesunate	DPT	PA165111697	1805	0.991
NULL	Oncotarget_2014_Aug_4_5(17)_7776-7787.nxml.txt.nlp	25277200	SENT160	29	29	10	10	carboplatin	ATP7A	PA448803	538	0.991
NULL	J_Inflamm_(Lond)_2006_Jul_12_3_10.nxml.txt.nlp	16834783	SENT129	0	0	9	9	mometasone	IL-8	PA450541	3576	0.991
NULL	Mol_Cancer_2010_Nov_8_9_291.nxml.txt.nlp	21059223	SENT91	13	13	4	4	paclitaxel	ZNF217	PA450761	7764	0.991
NULL	Front_Oncol_2014_Jun_16_4_146.nxml.txt.nlp	24982847	SENT109	0	0	12	12	denosumab	RANKL	PA166048634	8600	0.991
NULL	Breast_Cancer_(Auckl)_2011_Jan_13_5_1-14.nxml.txt.nlp	21494397	SENT48	23	23	5	5	saquinavir	CYP3A4	PA451305	1576	0.991
NULL	Int_J_Appl_Basic_Med_Res_2012_Jul-Dec_2(2)_77-83.nxml.txt.nlp	23776817	SENT181	27	27	10	10	rifampin	CYP3A4	PA451250	1576	0.991
NULL	Nat_Neurosci_2012_Sep_5_15(9)_1245-1254.nxml.txt.nlp	22864611	SENT519	19	19	8	8	clozapine	mGlu2	PA449061	2912	0.991
NULL	Evid_Based_Complement_Alternat_Med_2012_May_7_2012_242810.nxml.txt.nlp	22645625	SENT46	21	21	7	7	rifampin	CYP3A4	PA451250	1576	0.991
NULL	Exp_Diabetes_Res_2012_Oct_15_2012_465282.nxml.txt.nlp	23118742	SENT96	3	3	25	25	metformin	FGF21	PA450395	26291	0.991
NULL	Br_J_Cancer_1997_75(11)_1559-1566.nxml.txt.nlp	9184169	SENT6	20	20	15	15	genistein	p53	PA165109660	7157	0.991
NULL	Hum_Genomics_2009_Jan_1_3(2)_128-142.nxml.txt.nlp	19164090	SENT252	14	14	2	2	etoposide	CD44	PA449552	960	0.991
NULL	Patient_Prefer_Adherence_2011_Dec_23_6_1-9.nxml.txt.nlp	22272064	SENT36	6	6	20	20	telmisartan	ACE	PA451605	1636	0.991
NULL	J_Cerebrovasc_Endovasc_Neurosurg_2012_Sep_28_14(3)_157-163.nxml.txt.nlp	23210041	SENT102	5	5	36	36	aspirin	PTA	PA448497	171558	0.991
NULL	Case_Rep_Gastroenterol_2010_Sep_4_4(3)_307-312.nxml.txt.nlp	21060691	SENT46	6	6	0	0	propofol	ESD	PA451141	2098	0.991
NULL	J_Biol_Chem_2009_Jan_2_284(1)_77-84.nxml.txt.nlp	18854318	SENT128	36	36	16	16	forskolin	BRSK2	PA146096022	9024	0.991
NULL	Br_J_Cancer_2010_Jul_27_103(3)_315-323.nxml.txt.nlp	20661248	SENT244	12	12	33	33	irinotecan	IFL	PA450085	3439	0.991
NULL	Pharmaceuticals_(Basel)_2011_Oct_25_4(11)_1400-1422.nxml.txt.nlp	NULL	SENT213	7	7	24	24	imatinib	Hsp90	PA10804	3320	0.991
NULL	Case_Rep_Oncol_Med_2014_Jun_5_2014_904581.nxml.txt.nlp	24995140	SENT165	3	3	24	24	sirolimus	LAM	PA451365	7249;7248	0.991
NULL	BMB_Rep_2014_Apr_47(4)_221-226.nxml.txt.nlp	24286312	SENT30	0	0	10	10	nutlin-3	p53		7157	0.991
NULL	Cancers_(Basel)_2013_Mar_11_5(1)_255-280.nxml.txt.nlp	24216707	SENT110	9	9	20	20	ketoconazole	CYP24A1	PA450146	1591	0.991
NULL	Aging_(Albany_NY)_2012_Jul_31_4(7)_499-508.nxml.txt.nlp	22868943	SENT121	32	32	6	6	resveratrol	SIRT1		23411	0.991
NULL	Cardiol_Res_Pract_2013_Feb_21_2013_127270.nxml.txt.nlp	23509665	SENT173	17	17	23	23	ticagrelor	ADP	PA165374673	23038	0.991
NULL	J_Oncol_2012_Aug_24_2012_281261.nxml.txt.nlp	21876693	SENT257	0	0	13	13	lapatinib	HER2	PA152241907	2064	0.991
NULL	Adv_Bioinformatics_2012_Dec_19_2012_705435.nxml.txt.nlp	23316227	SENT83	5	5	36	36	resveratrol	SIRT1		23411	0.991
NULL	Oncotarget_2014_Mar_16_5(12)_4087-4102.nxml.txt.nlp	24961479	SENT294	16	16	0	0	hemin	PC3	PA449849	57332;7832;5122	0.991
NULL	Acta_Histochem_Cytochem_2012_Apr_26_45(2)_139-146.nxml.txt.nlp	22685356	SENT110	29	29	18	18	forskolin	AQP2	PA146096022	359	0.991
NULL	Biomed_Res_Int_2014_Apr_10_2014_580852.nxml.txt.nlp	24812624	SENT176	0	0	36	36	resveratrol	PTEN		5728	0.991
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_127043.nxml.txt.nlp	23227093	SENT191	5	5	24	24	lovastatin	CYP2C8	PA450272	1558	0.991
NULL	F1000Res_2013_Aug_20_2_147.nxml.txt.nlp	24555068	SENT280	0	0	26	26	curcumin	p65	PA151958596	5970	0.991
NULL	Acta_Pharmacol_Sin_2011_Jun_3_32(6)_845-852.nxml.txt.nlp	21642952	SENT92	12	12	27	27	capsaicin	TRPV1	PA448776	7442	0.991
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2675-2684.nxml.txt.nlp	24129246	SENT187	29	29	5	5	doxorubicin	p53	PA449412	7157	0.991
NULL	Breast_Cancer_Res_2007_Dec_20_9(Suppl_2)_S18.nxml.txt.nlp	NULL	SENT60	4	4	24	24	letrozole	aromatase	PA450196	1588	0.991
NULL	Int_J_Biol_Sci_2012_Oct_24_8(9)_1227-1236.nxml.txt.nlp	23136551	SENT29	11	11	39	39	tocilizumab	IL-6	PA165292659	3569	0.991
NULL	Cell_Death_Differ_2010_Apr_16_17(4)_666-676.nxml.txt.nlp	19834494	SENT280	24	24	0	0	oxaliplatin	RAGE	PA131285527	177	0.991
NULL	ASN_Neuro_2012_Jan_23_4(1)_e00075.nxml.txt.nlp	22268447	SENT89	19	19	10	10	nadh	GDH	PA164755085	51084;2746	0.991
NULL	Toxins_(Basel)_2010_Oct_28_2(11)_2584-2592.nxml.txt.nlp	22069565	SENT111	4	4	10	10	sertraline	CYP2D6	PA451333	1565	0.991
NULL	Oncol_Lett_2013_Mar_11_5(3)_1010-1016.nxml.txt.nlp	23426784	SENT103	31	31	13	13	midazolam	TRPM7	PA450496	54822	0.991
NULL	AIDS_Res_Ther_2013_May_1_10_10.nxml.txt.nlp	23634877	SENT116	22	22	2	2	lovastatin	CCR5	PA450272	1234	0.991
NULL	Cell_Death_Dis_2012_Nov_15_3(11)_e422.nxml.txt.nlp	23152058	SENT316	11	11	6	6	cisplatin	ZNF143	PA449014	7702	0.991
NULL	Breast_Cancer_Res_Treat_2013_Oct_8_141(3)_437-446.nxml.txt.nlp	24101324	SENT18	9	9	34	34	pertuzumab	HER2		2064	0.991
NULL	Mol_Cancer_2012_Jul_25_11_46.nxml.txt.nlp	22830422	SENT76	23	23	1	1	rolipram	ZO-1	PA153906323	7082	0.991
NULL	Pharmaceuticals_(Basel)_2012_Nov_20_5(11)_1236-1264.nxml.txt.nlp	24281308	SENT158	12	12	10	10	erlotinib	EGFR	PA134687924	1956	0.991
NULL	Oncogene_2014_Aug_21_33(34)_4316-4329.nxml.txt.nlp	24362530	SENT112	21	21	9	9	epirubicin	FOXM1	PA449476	2305	0.991
NULL	Cancer_Growth_Metastasis_2013_Nov_27_6_61-80.nxml.txt.nlp	24665208	SENT121	0	0	23	23	denosumab	RANK	PA166048634	8792	0.991
NULL	Crit_Care_2007_Mar_22_11(Suppl_2)_P25.nxml.txt.nlp	NULL	SENT16	19	19	9	9	physostigmine	IL-6	PA450957	3569	0.991
NULL	J_Skin_Cancer_2012_Sep_13_2012_907543.nxml.txt.nlp	23024864	SENT155	7	7	26	26	itraconazole	SMO	PA450132	6608;54498	0.991
NULL	J_Clin_Biochem_Nutr_2007_Jan_27_40(1)_13-23.nxml.txt.nlp	18437209	SENT144	27	27	4	4	trypsin	PAR2	PA451806	2150;55065;8856	0.991
NULL	Oxid_Med_Cell_Longev_2012_Aug_22_2012_534705.nxml.txt.nlp	22966415	SENT234	14	14	23	23	riluzole	GLAST	PA451251	6507	0.991
NULL	Mol_Cancer_2013_Sep_11_12_104.nxml.txt.nlp	24025152	SENT47	16	16	4	4	gemcitabine	STAT3	PA449748	6774	0.991
NULL	Mol_Cancer_2007_Apr_2_6_25.nxml.txt.nlp	17407558	SENT204	0	0	10	10	cetuximab	EGFR	PA10040	1956	0.991
NULL	J_Oncol_2010_Mar_4_2010_460859.nxml.txt.nlp	20224640	SENT18	3	3	16	16	nilotinib	CD34	PA165958345	947	0.991
NULL	Int_J_Genomics_2013_Nov_4_2013_464720.nxml.txt.nlp	24364026	SENT143	9	9	1	1	cisplatin	ERCC1	PA449014	2067	0.991
NULL	Int_J_Biomed_Sci_2008_Mar_4(1)_29-37.nxml.txt.nlp	23675063	SENT91	9	9	46	46	trypsin	CO2	PA451806	4513	0.991
NULL	Br_J_Cancer_2011_Jul_12_105(2)_212-220.nxml.txt.nlp	21694723	SENT189	0	0	7	7	curcumin	STAT3	PA151958596	6774	0.991
NULL	Aging_(Albany_NY)_2011_Jan_18_3(1)_33-43.nxml.txt.nlp	21248371	SENT131	40	40	16	16	zinc	CYP1B1	PA451956	1545	0.991
NULL	Int_J_Mol_Sci_2014_Mar_24_15(3)_5140-5162.nxml.txt.nlp	24663085	SENT103	16	16	1	1	cyclophosphamide	LP1	PA449165	6176	0.991
NULL	Br_J_Cancer_2012_Jun_5_106(12)_1997-2003.nxml.txt.nlp	22596232	SENT149	18	18	2	2	sorafenib	JNK	PA7000	5599	0.991
NULL	J_Hematol_Oncol_2012_May_8_5_21.nxml.txt.nlp	22569033	SENT32	0	0	14	14	imatinib	KIT	PA10804	3815	0.991
NULL	J_Radiat_Res_2013_Sep_7_54(5)_872-879.nxml.txt.nlp	23397075	SENT158	4	4	16	16	tamoxifen	BRCA1	PA451581	672	0.991
NULL	Biosci_Rep_2012_Aug_1_32(Pt_4)_361-374.nxml.txt.nlp	22762204	SENT145	23	23	7	7	trastuzumab	PTEN	PA451743	5728	0.991
NULL	Nat_Chem_Biol_2010_Apr_28_6(4)_291-299.nxml.txt.nlp	20190765	SENT138	33	33	22	22	dasatinib	EGFR	PA162372878	1956	0.991
NULL	Nat_Genet_2011_Jun_5_43(7)_621-629.nxml.txt.nlp	21642992	SENT102	44	44	38	38	doxorubicin	CDKN1A	PA449412	1026	0.991
NULL	Breast_Cancer_Res_2009_Jul_15_11(4)_207.nxml.txt.nlp	19664181	SENT52	20	20	4	4	trastuzumab	HER2	PA451743	2064	0.991
NULL	J_Immunother_2014_Apr_12_37(3)_180-186.nxml.txt.nlp	24598448	SENT52	14	14	1	1	sorafenib	IL-2	PA7000	3558	0.991
NULL	Cardiovasc_Psychiatry_Neurol_2009_Oct_13_2009_475108.nxml.txt.nlp	20029624	SENT95	6	6	32	32	clozapine	5-HT2A	PA449061	3356	0.991
NULL	Cardiovasc_Drugs_Ther_2013_Jul_26_27(6)_521-530.nxml.txt.nlp	23887740	SENT160	39	39	16	16	clopidogrel	CD41	PA449053	3674	0.991
NULL	J_Oncol_2009_May_6_2009_567486.nxml.txt.nlp	19424511	SENT35	12	12	0	0	erlotinib	EGFR	PA134687924	1956	0.991
NULL	J_Biol_Chem_2009_Sep_18_284(38)_26096-26105.nxml.txt.nlp	19628870	SENT117	10	10	1	1	pp2	PP2		4888	0.991
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1145.nxml.txt.nlp	24675463	SENT97	12	12	31	31	erlotinib	JNK	PA134687924	5599	0.991
NULL	Cell_Commun_Signal_2009_Feb_26_7(Suppl_1)_A99.nxml.txt.nlp	NULL	SENT8	16	16	0	0	trypsin	PAR1	PA451806	79581;2149	0.991
NULL	EMBO_Mol_Med_2009_Apr_1(1)_66-78.nxml.txt.nlp	20049704	SENT33	3	3	18	18	gefitinib	HIF-1	PA131301952	29072	0.991
NULL	Diabetes_Obes_Metab_2011_Nov_13(11)_982-989.nxml.txt.nlp	21615670	SENT156	13	13	32	32	sitagliptin	PPG	PA164748978	5552	0.991
NULL	J_Gastrointest_Cancer_2014_May_7_45(3)_262-267.nxml.txt.nlp	24802226	SENT121	30	30	3	3	imatinib	KIT	PA10804	3815	0.991
NULL	Acta_Pharmacol_Sin_2011_Jul_13_32(7)_967-972.nxml.txt.nlp	21666702	SENT138	17	17	26	26	ticlopidine	CYP2C19	PA451686	1557	0.991
NULL	Case_Rep_Oncol_2014_Jun_6_7(2)_383-388.nxml.txt.nlp	25028579	SENT6	17	17	4	4	fulvestrant	aromatase	PA164747170	1588	0.991
NULL	Oncol_Lett_2014_Aug_19_8(2)_809-812.nxml.txt.nlp	25009658	SENT79	24	24	33	33	metformin	AMPK	PA450395	5563	0.991
NULL	Biologics_2012_Sep_25_6_337-345.nxml.txt.nlp	23055691	SENT39	33	33	8	8	cisplatin	EGFR	PA449014	1956	0.991
NULL	Biomed_Res_Int_2013_Dec_4_2013_685308.nxml.txt.nlp	23509762	SENT134	28	28	11	11	bevacizumab	HIF-1	PA130232992	29072	0.991
NULL	Clin_Interv_Aging_2012_Dec_30_7_1-13.nxml.txt.nlp	22291468	SENT56	6	6	26	26	ketoconazole	CYP3A4	PA450146	1576	0.991
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT121	4	4	18	18	panitumumab	EGFR	PA162373091	1956	0.991
NULL	Cell_Commun_Signal_2009_Feb_26_7(Suppl_1)_A99.nxml.txt.nlp	NULL	SENT8	16	16	4	4	trypsin	PAR4	PA451806	9002;5074	0.991
NULL	J_Mol_Signal_2006_Dec_6_1_8.nxml.txt.nlp	17224083	SENT89	33	33	5	5	thrombin	Rho	PA451674	29984	0.991
NULL	Clin_Epidemiol_2014_Oct_24_6_379-393.nxml.txt.nlp	25368531	SENT153	0	0	7	7	tocilizumab	IL-6	PA165292659	3569	0.991
NULL	Cancers_(Basel)_2013_Jan_21_5(1)_64-91.nxml.txt.nlp	24216699	SENT91	0	0	12	12	panitumumab	EGFR	PA162373091	1956	0.991
NULL	Cancers_(Basel)_2014_Apr_23_6(2)_998-1019.nxml.txt.nlp	24762634	SENT771	2	2	7	7	paclitaxel	Bcl-2	PA450761	596	0.991
NULL	Biomed_Res_Int_2013_Feb_28_2013_749078.nxml.txt.nlp	23555095	SENT107	4	4	25	25	chymotrypsin	CD102	PA448994	3384	0.991
NULL	Clin_Mol_Allergy_2009_Mar_12_7_5.nxml.txt.nlp	19284628	SENT180	5	5	15	15	estradiol	CD25	PA449503	3669;3559	0.991
NULL	Oncotarget_2014_Dec_4_5(22)_11365-11380.nxml.txt.nlp	25426548	SENT44	23	23	12	12	nutlin-3	p53		7157	0.991
NULL	eLife_2013_Nov_5_2_e00969.nxml.txt.nlp	24192036	SENT92	26	26	2	2	vemurafenib	BCL2	PA165946873	596	0.991
NULL	Braz_J_Med_Biol_Res_2012_Jul_20_45(10)_935-941.nxml.txt.nlp	22801415	SENT155	22	22	5	5	pioglitazone	ghrelin	PA450970	51738	0.991
NULL	Oncol_Lett_2013_Feb_16_5(2)_559-563.nxml.txt.nlp	23420289	SENT85	7	7	1	1	trastuzumab	HER2	PA451743	2064	0.991
NULL	Br_J_Cancer_2013_Feb_19_108(3)_557-563.nxml.txt.nlp	23361053	SENT147	29	29	13	13	tamoxifen	PAK1	PA451581	5585;5058	0.991
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2007_Dec_6_64(Pt_1)_o161.nxml.txt.nlp	21200727	SENT62	39	39	3	3	ethanol	mol	PA448073	90527	0.991
NULL	Indian_J_Dermatol_2014_Sep-Oct_59(5)_425-441.nxml.txt.nlp	25284845	SENT100	0	0	12	12	ustekinumab	p40	PA166048654	3921;339541;10314	0.991
NULL	Mol_Cancer_2009_Nov_19_8_108.nxml.txt.nlp	19925669	SENT130	22	22	3	3	doxorubicin	CRT	PA449412	811	0.991
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1522-1532.nxml.txt.nlp	21997136	SENT259	23	23	3	3	lapatinib	ABCG2	PA152241907	9429	0.991
NULL	CNS_Drugs_2014_Apr_11_28(6)_535-558.nxml.txt.nlp	24723124	SENT329	0	0	25	25	daclizumab	CD4	PA164764446	920	0.991
NULL	J_Cell_Biol_2005_Nov_21_171(4)_729-738.nxml.txt.nlp	16286510	SENT170	35	35	20	20	heparin	MMP7	PA449855	4316	0.991
NULL	Diabetes_Care_2010_Feb_23_33(2)_246-251.nxml.txt.nlp	19933994	SENT141	14	14	31	31	metformin	B12	PA450395	7126;4709	0.991
NULL	J_Oncol_2009_May_6_2009_567486.nxml.txt.nlp	19424511	SENT158	0	0	11	11	sunitinib	IFN	PA162372840	3439	0.991
NULL	Mol_Cancer_2009_Jul_3_8_43.nxml.txt.nlp	19575780	SENT87	24	24	5	5	colchicine	survivin	PA449092	332	0.991
NULL	J_Pain_Res_2014_Aug_30_7_531-545.nxml.txt.nlp	25210474	SENT185	0	0	15	15	bosentan	ETB	PA10034	1910	0.991
NULL	Mol_Biol_Evol_2013_Dec_11_30(12)_2568-2578.nxml.txt.nlp	23938868	SENT219	37	37	9	9	ethanol	IRA1	PA448073	79718	0.991
NULL	Arch_Drug_Inf_2008_Sep_1(2)_56-62.nxml.txt.nlp	19915709	SENT51	16	16	35	35	fentanyl	CYP3A4	PA449599	1576	0.991
NULL	Breast_Cancer_Res_2008_May_2_10(3)_R39.nxml.txt.nlp	18454852	SENT39	3	3	30	30	resveratrol	CYP1B1		1545	0.991
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT137	9	9	33	33	maraviroc	CYP3A	PA164768835	1574	0.991
NULL	Oncogene_2010_Sep_2_29(35)_4905-4913.nxml.txt.nlp	20581869	SENT139	20	20	5	5	cisplatin	PEO1	PA449014	56652	0.991
NULL	Int_J_Med_Sci_2015_Jan_1_12(1)_63-71.nxml.txt.nlp	25552920	SENT182	10	10	3	3	berberine	PC-3	PA165860812	692094	0.991
NULL	Front_Oncol_2014_Apr_9_4_75.nxml.txt.nlp	24782986	SENT200	28	28	3	3	paclitaxel	Oct4	PA450761	5460	0.991
NULL	Oncotarget_2013_Apr_13_4(4)_502-530.nxml.txt.nlp	23594434	SENT299	36	36	3	3	sertraline	AKT	PA451333	207	0.991
NULL	Clin_Epidemiol_2013_May_16_5_147-162.nxml.txt.nlp	23700373	SENT98	3	3	29	29	doxorubicin	HER2	PA449412	2064	0.991
NULL	Int_J_Mol_Sci_2014_Mar_12_15(3)_4356-4392.nxml.txt.nlp	24625663	SENT275	21	21	5	5	etoposide	NEU3	PA449552	10825	0.991
NULL	Front_Oncol_2011_Jun_17_1_10.nxml.txt.nlp	22655230	SENT145	37	37	2	2	cetuximab	KRAS	PA10040	3845	0.991
NULL	Br_J_Cancer_2011_May_10_104(10)_1587-1593.nxml.txt.nlp	21487405	SENT37	16	16	41	41	docetaxel	PC3	PA449383	57332;7832;5122	0.991
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT3268	25	25	1	1	flucloxacillin	HLA-B	PA164781042	3106	0.991
NULL	Osteoporos_Int_2013_Oct_19_24(1)_23-57.nxml.txt.nlp	23079689	SENT511	21	21	2	2	teriparatide	PTH	PA451620	5741	0.991
NULL	Cell_Death_Dis_2010_Feb_4_1(2)_e23.nxml.txt.nlp	21364631	SENT56	21	21	3	3	imipramine	c-Jun	PA449969	3725	0.991
NULL	Breast_Cancer_Res_2014_Jul_29_16(4)_412.nxml.txt.nlp	25410383	SENT63	27	27	8	8	tamoxifen	PITX2	PA451581	5308	0.991
NULL	Breast_Cancer_Res_2011_Aug_12_13(4)_215.nxml.txt.nlp	21884641	SENT47	3	3	10	10	trastuzumab	HER2	PA451743	2064	0.991
NULL	Aging_(Albany_NY)_2012_Mar_7_4(3)_166-175.nxml.txt.nlp	22411934	SENT163	7	7	16	16	curcumin	AMPK	PA151958596	5563	0.991
NULL	J_Biol_Chem_2012_Apr_20_287(17)_13868-13876.nxml.txt.nlp	22389490	SENT172	31	31	2	2	capsaicin	TRPV1	PA448776	7442	0.991
NULL	Cell_Death_Dis_2014_Mar_13_5(3)_e1113.nxml.txt.nlp	24625972	SENT342	14	14	0	0	bleomycin	BI-1	PA448645	7009	0.991
NULL	ACS_Med_Chem_Lett_2011_May_16_2(7)_549-554.nxml.txt.nlp	21765967	SENT53	30	30	5	5	maraviroc	CCR5	PA164768835	1234	0.991
NULL	J_Nat_Sci_Biol_Med_2011_Jan-Jun_2(1)_13-25.nxml.txt.nlp	22470230	SENT247	38	38	21	21	capsaicin	TRPV1	PA448776	7442	0.991
NULL	ScientificWorldJournal_2012_Sep_10_2012_168953.nxml.txt.nlp	22997489	SENT113	0	0	12	12	indomethacin	PI3K	PA449982	5290	0.991
NULL	EMBO_Mol_Med_2012_Jan_4(1)_52-67.nxml.txt.nlp	22174013	SENT23	25	25	5	5	tamoxifen	NR2E3	PA451581	10002	0.991
NULL	Int_J_Surg_Oncol_2012_May_17_2012_406830.nxml.txt.nlp	22675625	SENT213	0	0	16	16	perifosine	JNK	PA165291471	5599	0.991
NULL	Anal_Chem_Insights_2009_Apr_7_4_1-9.nxml.txt.nlp	19652757	SENT99	39	39	14	14	citalopram	mol	PA449015	90527	0.991
NULL	Front_Neuroanat_2014_Oct_9_8_112.nxml.txt.nlp	25346662	SENT213	21	21	11	11	yohimbine	NTR2	PA451946	23620	0.991
NULL	Biologics_2012_Sep_25_6_337-345.nxml.txt.nlp	23055691	SENT96	18	18	41	41	afatinib	EGFR	PA165981154	1956	0.991
NULL	An_Bras_Dermatol_2014_Nov-Dec_89(6)_891-897.nxml.txt.nlp	25387493	SENT158	2	2	9	9	etanercept	VEGF-D	PA449515	2277	0.991
NULL	Cell_Death_Dis_2012_Jun_21_3(6)_e327.nxml.txt.nlp	22717582	SENT194	46	46	29	29	doxorubicin	NOXA	PA449412	5366	0.991
NULL	Br_J_Haematol_2014_Mar_13_164(1)_811-821.nxml.txt.nlp	24328678	SENT22	41	41	22	22	lenalidomide	IKZF1	PA162363968	10320	0.991
NULL	Exp_Neurobiol_2013_Mar_31_22(1)_45-50.nxml.txt.nlp	23585722	SENT126	10	10	17	17	fluoxetine	EPO	PA449673	7076;8288;2056	0.991
NULL	J_Cell_Mol_Med_2014_Oct_11_18(10)_2031-2043.nxml.txt.nlp	25109475	SENT338	6	6	18	18	valsartan	AMPK	PA451848	5563	0.991
NULL	Curr_Cardiol_Rev_2010_Aug_6(3)_238-244.nxml.txt.nlp	21804783	SENT163	8	8	33	33	methylphenidate	GMP	PA450464	22978	0.991
NULL	Oncotarget_2014_Dec_4_5(22)_11365-11380.nxml.txt.nlp	25426548	SENT42	21	21	10	10	nutlin-3	p53		7157	0.991
NULL	Oncogene_2014_Jun_5_33(23)_3004-3013.nxml.txt.nlp	23831571	SENT30	7	7	31	31	etoposide	RIP3	PA449552	11035	0.991
NULL	Clin_Psychopharmacol_Neurosci_2011_Apr_30_9(1)_36-43.nxml.txt.nlp	23431025	SENT29	12	12	24	24	haloperidol	NAC	PA449841	22861	0.991
NULL	Breast_Cancer_Res_2009_Jun_29_11(3)_R41.nxml.txt.nlp	19563669	SENT154	12	12	29	29	gefitinib	EGFR	PA131301952	1956	0.991
NULL	Curr_Chem_Genomics_2008_Oct_17_2_16-28.nxml.txt.nlp	20161840	SENT302	22	22	8	8	suramin	P2X1	PA10292	5023	0.991
NULL	Br_J_Pharmacol_2013_Jun_27_169(4)_736-747.nxml.txt.nlp	23489111	SENT165	22	22	3	3	morphine	5-HT3A	PA450550	3359	0.991
NULL	Curr_Chem_Genomics_2008_Dec_19_2_62-75.nxml.txt.nlp	19768139	SENT246	27	27	3	3	fluoxetine	SAPAP3	PA449673	58512	0.991
NULL	ARYA_Atheroscler_2011_Summer_7(2)_78-86.nxml.txt.nlp	22577451	SENT89	27	27	2	2	betaine	CRP	PA448603	1401;140913	0.991
NULL	Diabetes_2011_Nov_17_60(11)_2691-2700.nxml.txt.nlp	21896928	SENT259	13	13	33	33	resveratrol	SIRT1		23411	0.991
NULL	Case_Rep_Med_2012_Oct_9_2012_358024.nxml.txt.nlp	23093969	SENT17	26	26	5	5	argatroban	PF4	PA164745516	5196	0.991
NULL	Pharmaceuticals_(Basel)_2013_Aug_21_6(8)_1039-1054.nxml.txt.nlp	24276380	SENT58	18	18	5	5	curcumin	NR1	PA151958596	27158	0.991
NULL	Chin_J_Cancer_2011_Jan_30(1)_62-68.nxml.txt.nlp	21192845	SENT47	3	3	24	24	arsenite	COX2	PA452638	4513;5743	0.991
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT148	1	1	26	26	lapatinib	EGFR	PA152241907	1956	0.991
NULL	Indian_J_Med_Res_2012_Mar_135(3)_359-364.nxml.txt.nlp	22561623	SENT115	29	29	3	3	cefotaxime	ACC-1	PA448852	597	0.991
NULL	Front_Chem_2014_Mar_25_2_13.nxml.txt.nlp	24790982	SENT59	28	28	14	14	ethanol	CO2	PA448073	4513	0.991
NULL	Cell_Death_Differ_2010_Apr_16_17(4)_666-676.nxml.txt.nlp	19834494	SENT286	7	7	0	0	oxaliplatin	RAGE	PA131285527	177	0.991
NULL	Leukemia_2014_Jan_12_28(1)_15-33.nxml.txt.nlp	23778311	SENT577	35	35	17	17	imatinib	p53	PA10804	7157	0.991
NULL	Ann_Dermatol_2014_Aug_31_26(4)_517-520.nxml.txt.nlp	25143685	SENT30	19	19	3	3	tazarotene	TIG3	PA164746821	5920	0.991
NULL	Gastric_Cancer_2014_Feb_28_17(1)_76-86.nxml.txt.nlp	23455716	SENT32	30	30	0	0	trastuzumab	HER2	PA451743	2064	0.991
NULL	Front_Physiol_2013_Dec_24_4_386.nxml.txt.nlp	24399968	SENT195	9	9	41	41	glibenclamide	SUR1	PA449782	6833	0.991
NULL	Chemother_Res_Pract_2011_Sep_25_2011_730360.nxml.txt.nlp	22295205	SENT227	0	0	8	8	pertuzumab	HER2		2064	0.991
NULL	Am_J_Trop_Med_Hyg_2011_Jan_5_84(1)_5-14.nxml.txt.nlp	21212194	SENT46	0	0	24	24	ivermectin	STH	PA450133	246744	0.991
NULL	Blood_Cancer_J_2013_Aug_2_3(8)_e130.nxml.txt.nlp	23912610	SENT16	8	8	34	34	tacrolimus	WT1	PA451578	7490	0.991
NULL	J_Med_Life_2011_Feb_15_4(1)_11-20.nxml.txt.nlp	21505570	SENT190	7	7	38	38	sulindac	CB1	PA451565	1268	0.991
NULL	Oncol_Rep_2013_Mar_8_29(3)_917-924.nxml.txt.nlp	23314174	SENT125	36	36	9	9	sorafenib	CD44	PA7000	960	0.991
NULL	Mutat_Res_2011_Jun_3_711(1-2)_134-141.nxml.txt.nlp	21130102	SENT183	34	34	4	4	temozolomide	FEN1	PA451609	2237	0.991
NULL	J_Cell_Mol_Med_2014_Oct_11_18(10)_2031-2043.nxml.txt.nlp	25109475	SENT213	24	24	15	15	valsartan	IL-6	PA451848	3569	0.991
NULL	Breast_Cancer_Res_2011_Dec_9_13(6)_R127.nxml.txt.nlp	22151997	SENT30	24	24	44	44	estradiol	aromatase	PA449503	1588	0.991
NULL	Oncotarget_2014_Mar_16_5(12)_4087-4102.nxml.txt.nlp	24961479	SENT89	32	32	6	6	hemin	HO-1	PA449849	3162	0.991
NULL	J_Signal_Transduct_2011_Jun_7_2011_982879.nxml.txt.nlp	21776391	SENT145	2	2	12	12	cetuximab	EGFR	PA10040	1956	0.991
NULL	Viruses_2014_Apr_14_6(4)_1715-1758.nxml.txt.nlp	24736215	SENT322	2	2	36	36	hydroxychloroquine	CD4	PA164777036	920	0.991
NULL	Indian_J_Pharm_Sci_2008_Mar-Apr_70(2)_251-255.nxml.txt.nlp	20046726	SENT50	8	8	26	26	olanzapine	TLC	PA450688	3933	0.991
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT167	3	3	15	15	neratinib	HER2	PA165291472	2064	0.991
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT319	23	23	3	3	nutlin-3	DR5		8795	0.991
NULL	Exp_Mol_Med_2012_Sep_30_44(9)_545-553.nxml.txt.nlp	22809901	SENT70	42	42	21	21	clozapine	PRDM16	PA449061	63976	0.991
NULL	Front_Synaptic_Neurosci_2010_Feb_22_2_1.nxml.txt.nlp	21423487	SENT96	27	27	33	33	bumetanide	NKCC1	PA448682	6558	0.991
NULL	Oncotarget_2014_Feb_8_5(6)_1609-1620.nxml.txt.nlp	24742492	SENT210	40	40	5	5	doxorubicin	LGMN	PA449412	5641	0.991
NULL	Oncotarget_2012_May_4_3(4)_395-398.nxml.txt.nlp	22565037	SENT25	31	31	0	0	metformin	CD44	PA450395	960	0.991
NULL	Clin_Exp_Otorhinolaryngol_2011_Jun_31_4(2)_77-82.nxml.txt.nlp	21716954	SENT155	19	19	8	8	minocycline	PARP-1	PA450519	25976	0.991
NULL	J_Asthma_Allergy_2009_May_8_2_49-62.nxml.txt.nlp	21437144	SENT107	14	14	42	42	omalizumab	IL-4	PA164752253	3565	0.991
NULL	J_Cell_Mol_Med_2014_Nov_8_18(11)_2176-2188.nxml.txt.nlp	25103256	SENT61	13	13	4	4	thrombin	MCP-1	PA451674	6347	0.991
NULL	Acta_Pharmacol_Sin_2010_Feb_5_31(2)_137-144.nxml.txt.nlp	20139896	SENT33	18	18	16	16	zileuton	5-LOX	PA451955	240	0.991
NULL	Ann_Oncol_2014_Sep_13_25(9)_1813-1820.nxml.txt.nlp	24928832	SENT14	0	0	19	19	afatinib	EGFR	PA165981154	1956	0.991
NULL	Drug_Healthc_Patient_Saf_2012_Nov_29_4_173-180.nxml.txt.nlp	23236256	SENT66	12	12	48	48	ziprasidone	FGA	PA451974	2243	0.991
NULL	Br_J_Cancer_2012_Aug_7_107(4)_626-631.nxml.txt.nlp	22805329	SENT32	25	25	3	3	cetuximab	KRAS	PA10040	3845	0.991
NULL	Nat_Med_2014_Apr_16_20(4)_385-397.nxml.txt.nlp	24633305	SENT56	8	8	0	0	triciribine	PI3K	PA165958661	5290	0.991
NULL	J_Breast_Cancer_2013_Sep_30_16(3)_266-273.nxml.txt.nlp	24155755	SENT148	5	5	19	19	lapatinib	HER2	PA152241907	2064	0.991
NULL	Indian_J_Med_Res_2013_Jan_137(1)_36-47.nxml.txt.nlp	23481050	SENT76	1	1	26	26	primaquine	G6PD	PA451103	2539	0.991
NULL	Mol_Cancer_2008_Mar_26_7_27.nxml.txt.nlp	18366759	SENT76	6	6	35	35	etoposide	BNIP3	PA449552	664	0.991
NULL	Int_J_Mol_Imaging_2011_Oct_26_2011_874585.nxml.txt.nlp	21490735	SENT135	15	15	5	5	doxorubicin	OMG	PA449412	4974	0.991
NULL	Arthritis_Res_Ther_2014_Feb_11_16(1)_R51.nxml.txt.nlp	24517398	SENT211	25	25	11	11	rituximab	BAFF	PA451261	10673	0.991
NULL	Cancer_Cell_Int_2013_Sep_23_13_94.nxml.txt.nlp	24059699	SENT146	20	20	0	0	bevacizumab	VEGFR1	PA130232992	2321	0.991
NULL	Chin_J_Cancer_2012_Feb_31(2)_58-72.nxml.txt.nlp	22098952	SENT132	3	3	11	11	etoposide	MRP1	PA449552	4437	0.991
NULL	Inflamm_Res_2010_Sep_26_59(9)_699-709.nxml.txt.nlp	20339899	SENT29	33	33	19	19	trypsin	PAR3	PA451806	56288;2151	0.991
NULL	J_Immunol_Res_2014_Jul_13_2014_964069.nxml.txt.nlp	25126586	SENT117	2	2	23	23	imiquimod	IL-6	PA449972	3569	0.991
NULL	J_Thyroid_Res_2011_Apr_10_2011_895923.nxml.txt.nlp	21603172	SENT68	41	41	6	6	thyroglobulin	IL-4	PA164754910	3565	0.991
NULL	Balkan_J_Med_Genet_2011_Jun_25_14(1)_25-30.nxml.txt.nlp	24052699	SENT82	2	2	22	22	carbamazepine	MRP1	PA448785	4437	0.991
NULL	Ann_Oncol_2011_Mar_8_22(3)_503-514.nxml.txt.nlp	20616198	SENT7	17	17	11	11	tamoxifen	aromatase	PA451581	1588	0.991
NULL	Drugs_R_D_2013_Jun_5_13(2)_145-151.nxml.txt.nlp	23737453	SENT136	10	10	33	33	simvastatin	CYP2C9	PA451363	1559	0.991
NULL	Aging_(Albany_NY)_2010_Dec_14_2(12)_945-958.nxml.txt.nlp	21164223	SENT191	3	3	14	14	metformin	HER-2	PA450395	2064	0.991
NULL	Oncotarget_2014_Jun_26_5(14)_5559-5569.nxml.txt.nlp	24980819	SENT147	15	15	3	3	vemurafenib	p53	PA165946873	7157	0.991
NULL	Eur_J_Pediatr_2012_Jan_29_171(1)_1-10.nxml.txt.nlp	21800040	SENT63	10	10	18	18	desmopressin	VWF	PA449237	7450	0.991
NULL	J_Oncol_2010_Nov_19_2010_568938.nxml.txt.nlp	20037743	SENT117	13	13	6	6	gemcitabine	HER2	PA449748	2064	0.991
NULL	J_Carcinog_2014_Feb_20_13_4.nxml.txt.nlp	24737952	SENT231	0	0	11	11	vatalanib	EGFR	PA7001	1956	0.991
NULL	Cancers_(Basel)_2010_Jul_27_2(3)_1528-1554.nxml.txt.nlp	24281171	SENT325	23	23	0	0	doxorubicin	CD133	PA449412	8842	0.991
NULL	J_Oncol_2012_Dec_22_2012_682480.nxml.txt.nlp	22235203	SENT116	0	0	7	7	bevacizumab	VEGF-A	PA130232992	7422	0.991
NULL	Int_J_Endocrinol_2014_Jun_25_2014_534904.nxml.txt.nlp	25053942	SENT128	17	17	28	28	amiodarone	AIT	PA448383	160728	0.991
NULL	Acta_Pharmacol_Sin_2009_Sep_24_30(9)_1323-1329.nxml.txt.nlp	19701237	SENT28	15	15	4	4	midazolam	CYP3A	PA450496	1574	0.991
NULL	J_Clin_Exp_Pathol_2012_May_17_Suppl_4_7327.nxml.txt.nlp	25379357	SENT32	34	34	8	8	resveratrol	SIRT1		23411	0.991
NULL	Aging_(Albany_NY)_2012_Mar_4_4(3)_144-145.nxml.txt.nlp	22388573	SENT4	3	3	13	13	resveratrol	STAC		6769	0.991
NULL	Front_Genet_2014_Nov_14_5_391.nxml.txt.nlp	25452763	SENT169	6	6	16	16	cisplatin	GSTP1	PA449014	2950	0.991
NULL	J_Clin_Exp_Pathol_2012_May_17_Suppl_4_7327.nxml.txt.nlp	25379357	SENT27	15	15	2	2	resveratrol	AMPK		5563	0.991
NULL	Adv_Hematol_2012_Feb_16_2012_535709.nxml.txt.nlp	22400031	SENT84	33	33	5	5	imatinib	JAK2	PA10804	3717	0.991
NULL	Cancers_(Basel)_2011_May_3_3(2)_2255-2273.nxml.txt.nlp	24212808	SENT138	26	26	8	8	cetuximab	EGFR	PA10040	1956	0.991
NULL	Int_J_Mol_Sci_2012_Aug_24_13(9)_10697-10721.nxml.txt.nlp	23109817	SENT134	18	18	25	25	taurine	JNK	PA451590	5599	0.991
NULL	CNS_Drugs_2014_Apr_11_28(6)_535-558.nxml.txt.nlp	24723124	SENT329	0	0	17	17	daclizumab	IL-2	PA164764446	3558	0.991
NULL	Br_J_Cancer_2009_Jan_27_100(2)_298-304.nxml.txt.nlp	19127259	SENT146	13	13	4	4	gefitinib	EGFR	PA131301952	1956	0.991
NULL	Front_Neurol_2014_Sep_11_5_173.nxml.txt.nlp	25309501	SENT167	35	35	4	4	hyaluronan	CD44	PA165958431	960	0.991
NULL	J_Cancer_2013_Sep_27_4(8)_662-670.nxml.txt.nlp	24155778	SENT50	12	12	5	5	cisplatin	UCHL1	PA449014	7345	0.991
NULL	Curr_Neuropharmacol_2013_Dec_11(6)_641-651.nxml.txt.nlp	24396339	SENT33	11	11	0	0	capsaicin	TRPV1	PA448776	7442	0.991
NULL	Autism_Res_Treat_2013_Sep_15_2013_826156.nxml.txt.nlp	24151554	SENT83	22	22	36	36	vasopressin	OXTR	PA451858	5021	0.991
NULL	Diabetes_Care_2009_Nov_32(Suppl_2)_S322-S325.nxml.txt.nlp	19875573	SENT106	7	7	21	21	exenatide	GLP-1	PA164749238	100125288	0.991
NULL	Cardiovasc_Diabetol_2013_May_30_12(Suppl_1)_S2.nxml.txt.nlp	23819752	SENT129	3	3	18	18	simvastatin	CYP2C9	PA451363	1559	0.991
NULL	Case_Rep_Nephrol_Urol_2012_Jul_24_2(2)_102-107.nxml.txt.nlp	23197964	SENT86	11	11	21	21	tacrolimus	IL-2	PA451578	3558	0.991
NULL	Asian_J_Androl_2014_Mar_7_Jul-Aug_16(4)_647-649.nxml.txt.nlp	24625882	SENT56	41	41	9	9	fosinopril	WT1	PA449710	7490	0.991
NULL	Hum_Genomics_2011_Oct_1_5(6)_577-622.nxml.txt.nlp	22155605	SENT620	10	10	22	22	trastuzumab	aromatase	PA451743	1588	0.991
NULL	Oncotarget_2010_Oct_22_1(7)_530-543.nxml.txt.nlp	21317449	SENT289	11	11	0	0	trastuzumab	PI3K	PA451743	5290	0.991
NULL	Arthritis_Res_Ther_2014_Jul_18_16(4)_R153.nxml.txt.nlp	25037855	SENT99	14	14	24	24	adalimumab	CD14	PA10004	929	0.991
NULL	Breast_Cancer_Res_2004_Nov_7_6(1)_39-52.nxml.txt.nlp	14680484	SENT157	25	25	10	10	tamoxifen	SMRT	PA451581	9612	0.991
NULL	Emerg_Infect_Dis_2003_Jun_9(6)_657-664.nxml.txt.nlp	12781004	SENT14	7	7	2	2	vancomycin	VISA	PA451850	57506	0.991
NULL	Drug_Healthc_Patient_Saf_2012_Nov_29_4_173-180.nxml.txt.nlp	23236256	SENT66	10	10	48	48	sertindole	FGA	PA164784002	2243	0.991
NULL	Oncotarget_2014_Jun_19_5(15)_6540-6551.nxml.txt.nlp	25153728	SENT114	33	33	6	6	paclitaxel	p53	PA450761	7157	0.991
NULL	Cancers_(Basel)_2011_Apr_1_3(2)_1844-1860.nxml.txt.nlp	24212785	SENT410	8	8	0	0	cetuximab	KRAS	PA10040	3845	0.991
NULL	Eur_J_Histochem_2012_Aug_29_56(3)_e33.nxml.txt.nlp	23027349	SENT47	34	34	1	1	trypsin	EGF	PA451806	1950	0.991
NULL	J_Med_Chem_2014_Feb_13_57(3)_723-732.nxml.txt.nlp	24387306	SENT142	12	12	34	34	indinavir	S19	PA449977	6223	0.991
NULL	Diabetes_Care_2012_Jun_11_35(6)_1380-1387.nxml.txt.nlp	22619289	SENT106	33	33	1	1	metformin	ADA	PA450395	100	0.991
NULL	Acta_Pharmacol_Sin_2009_May_5_30(5)_646-652.nxml.txt.nlp	19417737	SENT59	16	16	4	4	midazolam	CYP3A4	PA450496	1576	0.991
NULL	Biochim_Biophys_Acta_2014_Apr_1841(4)_588-594.nxml.txt.nlp	24440819	SENT13	22	22	4	4	lipase	ATGL	PA450239	57104	0.991
NULL	Br_J_Cancer_2013_Jul_9_109(1)_100-108.nxml.txt.nlp	23756858	SENT149	25	25	5	5	letrozole	aromatase	PA450196	1588	0.991
NULL	Case_Rep_Anesthesiol_2012_Sep_3_2012_349046.nxml.txt.nlp	22973525	SENT33	2	2	22	22	heparin	ACT	PA449855	12;11332;9457;641455	0.991
NULL	Front_Immunol_2013_Mar_27_4_76.nxml.txt.nlp	23543707	SENT101	4	4	17	17	alemtuzumab	CD52	PA164783958	1043	0.991
NULL	Biologics_2013_Dec_9_8_1-12.nxml.txt.nlp	24353404	SENT144	5	5	20	20	anakinra	ACR	PA10799	49	0.991
NULL	Cancer_Res_Treat_2014_Jan_15_46(1)_48-54.nxml.txt.nlp	24520223	SENT109	20	20	1	1	bevacizumab	KRAS	PA130232992	3845	0.991
NULL	J_Biol_Chem_2008_May_30_283(22)_15419-15430.nxml.txt.nlp	18378687	SENT201	3	3	25	25	pp2	PP2		4888	0.991
NULL	Biomed_Res_Int_2013_Jun_6_2013_928271.nxml.txt.nlp	23841099	SENT25	29	29	1	1	ticagrelor	P2Y12	PA165374673	64805	0.991
NULL	Aging_(Albany_NY)_2009_Feb_18_1(3)_335-349.nxml.txt.nlp	20195489	SENT192	23	23	5	5	etoposide	p65	PA449552	5970	0.991
NULL	Curr_Pharm_Biotechnol_2012_May_13(6)_969-986.nxml.txt.nlp	22039792	SENT260	3	3	17	17	cimetidine	MDR1	PA449001	5243	0.991
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT196	15	15	34	34	cetuximab	KRAS	PA10040	3845	0.991
NULL	Acta_Pharmacol_Sin_2011_Oct_12_32(10)_1259-1265.nxml.txt.nlp	21909126	SENT97	16	16	4	4	losartan	MCP-1	PA450268	6347	0.991
NULL	J_Immunol_Res_2014_Feb_5_2014_632307.nxml.txt.nlp	24741610	SENT39	0	0	23	23	ranibizumab	VEGF-A	PA164746012	7422	0.991
NULL	Bone_Marrow_Res_2013_Dec_12_2013_269107.nxml.txt.nlp	24416592	SENT66	4	4	38	38	imatinib	CML	PA10804	613	0.991
NULL	Oncogenesis_2014_Dec_15_3(12)_e133.nxml.txt.nlp	25500906	SENT108	13	13	31	31	trastuzumab	HER2	PA451743	2064	0.991
NULL	Cell_Death_Dis_2010_Sep_23_1(9)_e78.nxml.txt.nlp	21364680	SENT32	4	4	30	30	cisplatin	P31	PA449014	529	0.991
NULL	Oncol_Lett_2014_Nov_12_8(5)_2203-2208.nxml.txt.nlp	25295109	SENT13	12	12	30	30	celecoxib	GLI1	PA448871	2735	0.991
NULL	J_Hematol_Oncol_2011_Mar_22_4_10.nxml.txt.nlp	21418662	SENT95	3	3	17	17	omalizumab	MCAD	PA164752253	34	0.991
NULL	Mol_Cells_2014_Mar_31_37(3)_234-240.nxml.txt.nlp	24642709	SENT117	9	9	16	16	capsaicin	HO-1	PA448776	3162	0.991
NULL	Clin_Sci_(Lond)_2013_Feb_1_124(Pt_3)_153-164.nxml.txt.nlp	23075334	SENT261	14	14	35	35	resveratrol	AGTR1		185	0.991
NULL	J_Hematol_Oncol_2012_Feb_14_5_3.nxml.txt.nlp	22333219	SENT168	10	10	32	32	vemurafenib	BRAF	PA165946873	673	0.991
NULL	Breast_Cancer_Res_2007_Dec_20_9(Suppl_2)_S22.nxml.txt.nlp	NULL	SENT34	8	8	23	23	tamoxifen	aromatase	PA451581	1588	0.991
NULL	J_Oncol_2010_Feb_11_2010_361836.nxml.txt.nlp	20169138	SENT36	30	30	3	3	bevacizumab	VEGF-A	PA130232992	7422	0.991
NULL	Oncologist_2010_Feb_15_15(2)_122-129.nxml.txt.nlp	20156908	SENT21	5	5	34	34	letrozole	HER-2	PA450196	2064	0.991
NULL	Oncotarget_2013_Feb_27_4(2)_329-345.nxml.txt.nlp	23593654	SENT181	4	4	15	15	paclitaxel	CD44	PA450761	960	0.991
NULL	Case_Rep_Hematol_2013_Sep_30_2013_628513.nxml.txt.nlp	24198984	SENT94	16	16	3	3	cladribine	FVIII	PA449027	2157	0.991
NULL	Pharmaceuticals_(Basel)_2013_Aug_6_6(8)_929-959.nxml.txt.nlp	24276377	SENT176	0	0	10	10	curcumin	AP-1	PA151958596	2353;3727;2354;3725	0.991
NULL	Eur_J_Endocrinol_2014_Mar_170(3)_451-459.nxml.txt.nlp	24362411	SENT170	29	29	6	6	orlistat	GLP1	PA164776864	100125288;2641	0.991
NULL	Cancer_Cell_Int_2003_Jul_15_3_11.nxml.txt.nlp	12904267	SENT104	33	33	11	11	vinblastine	p53	PA451877	7157	0.991
NULL	J_Young_Pharm_2010_Jul-Sep_2(3)_326-331.nxml.txt.nlp	21042495	SENT129	31	31	18	18	simvastatin	CYP3A4	PA451363	1576	0.991
NULL	F1000Res_2013_Mar_5_2_74.nxml.txt.nlp	24358880	SENT269	28	28	7	7	benzaldehyde	TRPV1	PA448571	7442	0.991
NULL	Curr_Med_Chem_2013_Jan_21(3)_261-269.nxml.txt.nlp	24164192	SENT119	0	0	12	12	anakinra	PAPA	PA10799	2737;5069	0.991
NULL	Exp_Neurobiol_2013_Mar_31_22(1)_1-10.nxml.txt.nlp	23585716	SENT108	34	34	11	11	scopolamine	spatial	PA451308	219793	0.991
NULL	Oncogene_2010_Jul_15_29(28)_4090-4100.nxml.txt.nlp	20473326	SENT92	22	22	12	12	doxorubicin	MDM2	PA449412	4193	0.991
NULL	Cancers_(Basel)_2014_Mar_26_6(2)_708-722.nxml.txt.nlp	24675568	SENT122	12	12	3	3	erlotinib	STAT3	PA134687924	6774	0.991
NULL	BMB_Rep_2013_Aug_46(8)_410-415.nxml.txt.nlp	23977989	SENT107	35	35	5	5	curcumin	HO-1	PA151958596	3162	0.991
NULL	Indian_J_Endocrinol_Metab_2013_May-Jun_17(3)_413-421.nxml.txt.nlp	23869296	SENT200	36	36	6	6	liraglutide	GLP-1	PA165958364	100125288	0.991
NULL	Gene_Regul_Syst_Bio_2014_Mar_4_8_63-73.nxml.txt.nlp	24634581	SENT105	22	22	5	5	minocycline	NANOS1	PA450519	340719	0.991
NULL	Int_J_Mol_Sci_2012_Sep_25_13(10)_12153-12168.nxml.txt.nlp	23202889	SENT564	8	8	2	2	panitumumab	BRAF	PA162373091	673	0.991
NULL	Breast_Cancer_Res_2005_Jul_18_7(5)_187-189.nxml.txt.nlp	16168136	SENT19	36	36	17	17	tamoxifen	HER2	PA451581	2064	0.991
NULL	Breast_Cancer_2013_Mar_1_20(4)_302-309.nxml.txt.nlp	23456736	SENT52	12	12	16	16	tamoxifen	HER2	PA451581	2064	0.991
NULL	Osteoporos_Int_2008_Apr_12_19(4)_399-428.nxml.txt.nlp	18266020	SENT304	20	20	8	8	alendronate	PTH	PA448082	5741	0.991
NULL	Mol_Cancer_2010_Dec_20_9_317.nxml.txt.nlp	21172025	SENT99	18	18	40	40	tamoxifen	HER2	PA451581	2064	0.991
NULL	Indian_J_Nephrol_2011_Jan-Mar_21(1)_56-58.nxml.txt.nlp	21655173	SENT87	2	2	17	17	rituximab	PRL	PA451261	5617	0.991
NULL	Oncotarget_2012_May_4_3(4)_395-398.nxml.txt.nlp	22565037	SENT25	31	31	2	2	metformin	CD24	PA450395	100133941	0.991
NULL	J_Obes_2011_Dec_12_2011_179674.nxml.txt.nlp	21197148	SENT294	0	0	9	9	pramlintide	GLP-1	PA164781394	100125288	0.991
NULL	Cancers_(Basel)_2014_Jul_7_6(3)_1441-1463.nxml.txt.nlp	25003395	SENT181	2	2	23	23	vincristine	XIAP	PA451879	331	0.991
NULL	Nat_Commun_2013_Sep_20_4_2444.nxml.txt.nlp	24051492	SENT388	26	26	5	5	nutlin-3	p53		7157	0.991
NULL	Acta_Pharmacol_Sin_2009_Nov_12_30(11)_1566-1572.nxml.txt.nlp	19820718	SENT7	3	3	23	23	omeprazole	P-gp	PA450704	5243	0.991
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1137-1144.nxml.txt.nlp	20234366	SENT159	37	37	19	19	cetuximab	BRAF	PA10040	673	0.991
NULL	Arch_Med_Sci_2012_Sep_8_8(4)_659-671.nxml.txt.nlp	23056078	SENT46	34	34	3	3	vincristine	MRP2	PA451879	100130958;57626;1244	0.991
NULL	Diabetes_Metab_Syndr_Obes_2014_Jan_18_7_15-24.nxml.txt.nlp	24465132	SENT56	24	24	0	0	metformin	GLP-1	PA450395	100125288	0.991
NULL	Indian_J_Pharmacol_2013_Jul-Aug_45(4)_365-370.nxml.txt.nlp	24014912	SENT21	0	0	22	22	capsaicin	TRPV1	PA448776	7442	0.991
NULL	Eur_J_Histochem_2010_Mar_20_54(1)_e4.nxml.txt.nlp	20353911	SENT169	38	38	10	10	levamisole	CD21	PA450205	1380	0.991
NULL	Hum_Reprod_2014_Oct_10_29(10)_2302-2316.nxml.txt.nlp	25139174	SENT80	0	0	7	7	metformin	AMPK	PA450395	5563	0.991
NULL	Indian_J_Med_Res_2013_Nov_138(5)_663-681.nxml.txt.nlp	24434320	SENT114	2	2	17	17	nevirapine	DRB1	PA450616	129831	0.991
NULL	Front_Neurosci_2014_Jun_24_8_176.nxml.txt.nlp	25009459	SENT1004	0	0	7	7	ethanol	P2X4	PA448073	5025	0.991
NULL	Clin_Sci_(Lond)_2009_Apr_1_116(Pt_8)_607-620.nxml.txt.nlp	19275766	SENT202	1	1	9	9	rosiglitazone	AMPK	PA451283	5563	0.991
NULL	Cardiovasc_Res_2014_Mar_1_101(3)_513-521.nxml.txt.nlp	24323316	SENT134	9	9	27	27	maraviroc	CCL2	PA164768835	6347	0.991
NULL	Brain_2008_Nov_22_131(11)_3072-3080.nxml.txt.nlp	18945724	SENT93	17	17	3	3	rituximab	CD19	PA451261	930	0.991
NULL	Br_J_Cancer_2011_Apr_12_104(8)_1278-1287.nxml.txt.nlp	21487429	SENT135	34	34	4	4	cisplatin	DR5	PA449014	8795	0.991
NULL	Environ_Health_Perspect_2010_Dec_12_118(12)_1707-1713.nxml.txt.nlp	20705543	SENT187	5	5	39	39	bleomycin	XRCC1	PA448645	7515	0.991
NULL	Cancer_Med_2014_Oct_25_3(5)_1099-1111.nxml.txt.nlp	24961511	SENT331	24	24	19	19	cisplatin	TMEM158	PA449014	25907	0.991
NULL	Oncol_Lett_2013_Mar_8_5(3)_805-812.nxml.txt.nlp	23426281	SENT193	30	30	5	5	gemcitabine	B7-H3	PA449748	80381	0.991
NULL	J_Asthma_Allergy_2010_Jul_16_3_57-63.nxml.txt.nlp	21437040	SENT111	40	40	24	24	simvastatin	CD4	PA451363	920	0.991
NULL	Arthritis_Res_Ther_2014_Sep_18_16(5)_427.nxml.txt.nlp	25230745	SENT208	22	22	0	0	bevacizumab	ADAMTS5	PA130232992	11096	0.991
NULL	Cell_Cycle_2012_Nov_1_11(21)_3983-3996.nxml.txt.nlp	22987153	SENT209	16	16	9	9	cisplatin	DNA-PKcs	PA449014	5591	0.991
NULL	Br_J_Cancer_2011_Jun_7_104(12)_1828-1835.nxml.txt.nlp	21559012	SENT187	38	38	11	11	vorinostat	HDAC2	PA164748224	3066	0.991
NULL	Exp_Ther_Med_2014_Mar_19_7(3)_669-674.nxml.txt.nlp	24520265	SENT150	3	3	9	9	thalidomide	JNK	PA451644	5599	0.991
NULL	Br_J_Pharmacol_2011_Apr_162(7)_1509-1520.nxml.txt.nlp	21108630	SENT252	13	13	34	34	allopregnanolone	TRPC5	PA142320763	7224	0.991
NULL	Cancer_Res_Treat_2014_Jan_15_46(1)_55-64.nxml.txt.nlp	24520224	SENT148	21	21	3	3	oxaliplatin	TRAP1	PA131285527	9392;10131	0.991
NULL	Clin_Exp_Gastroenterol_2012_May_14_5_49-59.nxml.txt.nlp	22649281	SENT71	39	39	1	1	esomeprazole	CYP2C19	PA10075	1557	0.991
NULL	CNS_Neurosci_Ther_2010_Oct_16(5)_e138-e156.nxml.txt.nlp	20626426	SENT101	28	28	1	1	vasopressin	ACTH	PA451858	5443	0.991
NULL	J_Cell_Mol_Med_2014_Dec_9_18(12)_2425-2436.nxml.txt.nlp	25297942	SENT177	32	32	6	6	cisplatin	HOTAIR	PA449014	100124700	0.991
NULL	Am_J_Rhinol_Allergy_2015_Jan-Feb_29(1)_35-40.nxml.txt.nlp	25590316	SENT110	21	21	3	3	ketorolac	CD34	PA450150	947	0.991
NULL	Cancer_Cell_Int_2012_Jul_4_12_19.nxml.txt.nlp	22631225	SENT304	25	25	7	7	heparin	PPIA	PA449855	5478	0.991
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT14	24	24	4	4	erlotinib	CYP3A	PA134687924	1574	0.991
NULL	Arch_Toxicol_2013_Jan_21_87(1)_123-143.nxml.txt.nlp	23179753	SENT227	8	8	25	25	mannitol	OTX2	PA450320	5015	0.991
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1012.nxml.txt.nlp	24457956	SENT258	13	13	26	26	cilengitide	MDC	PA164924491	6367	0.991
NULL	Cardiol_Res_Pract_2011_May_10_2011_816897.nxml.txt.nlp	21629798	SENT126	0	0	15	15	pazopanib	CYP1A2	PA165291492	1544	0.991
NULL	Breast_Cancer_Res_2010_Oct_22_12(Suppl_2)_S1.nxml.txt.nlp	21050422	SENT100	0	0	22	22	erlotinib	EGFR	PA134687924	1956	0.991
NULL	Breast_Cancer_(Dove_Med_Press)_2014_May_2_6_59-71.nxml.txt.nlp	24833917	SENT131	23	23	38	38	exemestane	aromatase	PA449563	1588	0.991
NULL	J_Hematol_Oncol_2013_Jan_17_6_8.nxml.txt.nlp	23327547	SENT45	38	38	15	15	sulindac	p27	PA451565	5715;10534	0.991
NULL	Hum_Genomics_2008_Sep_1_3(1)_7-16.nxml.txt.nlp	19129086	SENT170	19	19	31	31	rosiglitazone	OATP1B1	PA451283	10599	0.991
NULL	Nucl_Recept_Signal_2009_Jan_16_7_e001.nxml.txt.nlp	19240808	SENT410	33	33	8	8	paclitaxel	SXR	PA450761	8856	0.991
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT75	34	34	20	20	lapatinib	HER2	PA152241907	2064	0.991
NULL	FEBS_Open_Bio_2014_Jan_6_4_77-89.nxml.txt.nlp	24490132	SENT203	16	16	2	2	ebselen	GDH	PA161660841	51084;2746	0.991
NULL	Acta_Naturae_2013_Apr-Jun_5(2)_19-39.nxml.txt.nlp	23819034	SENT209	5	5	16	16	thrombin	FVIII	PA451674	2157	0.991
NULL	ScientificWorldJournal_2014_Feb_5_2014_465151.nxml.txt.nlp	24683343	SENT249	25	25	6	6	ethanol	DAC	PA448073	13	0.991
NULL	Mol_Imaging_Radionucl_Ther_2012_Apr_1_21(1)_38-41.nxml.txt.nlp	23487501	SENT30	12	12	42	42	thyroglobulin	WBS	PA164754910	2006	0.991
NULL	Chin_J_Cancer_2012_Feb_31(2)_73-99.nxml.txt.nlp	22098950	SENT209	0	0	12	12	nilotinib	P-gp	PA165958345	5243	0.991
NULL	J_Cheminform_2012_Mar_8_4_6.nxml.txt.nlp	22401035	SENT317	37	37	5	5	troglitazone	CYP3A4	PA451799	1576	0.991
NULL	Adolesc_Health_Med_Ther_2012_Jun_20_3_85-93.nxml.txt.nlp	24600289	SENT27	3	3	15	15	etanercept	TNF	PA449515	7124	0.991
NULL	Antimicrob_Agents_Chemother_2013_Dec_57(12)_5792-5807.nxml.txt.nlp	24002099	SENT217	46	46	28	28	mefloquine	ACT	PA450348	12;11332;9457;641455	0.991
NULL	Exp_Ther_Med_2015_Jan_18_9(1)_105-111.nxml.txt.nlp	25452783	SENT181	5	5	19	19	celecoxib	ABCG2	PA448871	9429	0.991
NULL	Part_Fibre_Toxicol_2013_Aug_13_10_39.nxml.txt.nlp	23937860	SENT29	47	47	6	6	anakinra	NLRP3	PA10799	114548	0.991
NULL	Theranostics_2014_Feb_12_4(4)_432-444.nxml.txt.nlp	24578726	SENT92	0	0	38	38	doxorubicin	FUS	PA449412	2521	0.991
NULL	Acta_Pharmacol_Sin_2010_Feb_5_31(2)_137-144.nxml.txt.nlp	20139896	SENT185	24	24	10	10	zileuton	5-LOX	PA451955	240	0.991
NULL	Oncotarget_2013_Feb_27_4(2)_329-345.nxml.txt.nlp	23593654	SENT306	5	5	34	34	staurosporine	RSK1	PA165109623	6195	0.991
NULL	Cancers_(Basel)_2011_Mar_29_3(2)_1732-1743.nxml.txt.nlp	21738852	SENT76	8	8	21	21	methotrexate	CASP8	PA450428	841	0.991
NULL	J_Cell_Sci_2013_Sep_1_126(17)_3873-3883.nxml.txt.nlp	23843614	SENT233	18	18	0	0	forskolin	PICK1	PA146096022	9463	0.991
NULL	Curr_Neuropharmacol_2014_Jan_12(1)_2-36.nxml.txt.nlp	24533013	SENT228	6	6	15	15	donepezil	BACE1	PA449394	23621	0.991
NULL	Cardiol_Res_Pract_2011_Apr_3_2011_320983.nxml.txt.nlp	21559260	SENT17	9	9	23	23	paclitaxel	DES	PA450761	1674	0.991
NULL	Br_J_Pharmacol_2010_Sep_161(2)_288-307.nxml.txt.nlp	20735416	SENT245	34	34	9	9	isoflurane	TREK-1	PA450106	3776	0.991
NULL	Acta_Vet_Scand_2013_Jun_3_55(1)_44.nxml.txt.nlp	23731650	SENT179	7	7	13	13	colistin	NOT	PA164760862	4929	0.991
NULL	Pharmaceutics_2011_Nov_18_3(4)_865-913.nxml.txt.nlp	24309312	SENT161	8	8	19	19	nevirapine	P-gp	PA450616	5243	0.991
NULL	Clin_Med_Insights_Oncol_2012_Dec_6_6_407-421.nxml.txt.nlp	23239933	SENT146	3	3	13	13	docetaxel	EGFR	PA449383	1956	0.991
NULL	Front_Immunol_2012_Mar_21_3_57.nxml.txt.nlp	22566938	SENT53	5	5	16	16	vasopressin	IRAP	PA451858	3557	0.991
NULL	Cell_Death_Differ_2010_Oct_30_17(10)_1624-1635.nxml.txt.nlp	20431602	SENT270	5	5	27	27	paclitaxel	Mcl-1	PA450761	4170	0.991
NULL	Diabetes_2011_Nov_17_60(11)_2691-2700.nxml.txt.nlp	21896928	SENT146	9	9	38	38	resveratrol	SIRT1		23411	0.991
NULL	Eur_J_Haematol_2013_Feb_22_90(2)_89-98.nxml.txt.nlp	23181448	SENT136	2	2	37	37	nilotinib	KIT	PA165958345	3815	0.991
NULL	J_Invest_Dermatol_2012_Nov_21_132(11)_2642-2651.nxml.txt.nlp	22718118	SENT201	33	33	4	4	imiquimod	TLR7	PA449972	51284	0.991
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S31-S40.nxml.txt.nlp	20680106	SENT21	16	16	6	6	cetuximab	KRAS	PA10040	3845	0.991
NULL	Oncol_Rep_2013_Oct_22_30(4)_1535-1541.nxml.txt.nlp	23877481	SENT43	36	36	11	11	docetaxel	EGFR	PA449383	1956	0.991
NULL	Oncotarget_2014_Oct_21_5(22)_11252-11268.nxml.txt.nlp	25361004	SENT32	20	20	8	8	metformin	CLIC1	PA450395	1192	0.991
NULL	Anticancer_Agents_Med_Chem_2010_Oct_10(8)_617-624.nxml.txt.nlp	21182469	SENT54	15	15	8	8	tamoxifen	ABCC11	PA451581	85320	0.991
NULL	Br_J_Haematol_2014_Mar_13_164(1)_811-821.nxml.txt.nlp	24328678	SENT22	41	41	16	16	lenalidomide	Aiolos	PA162363968	22806	0.991
NULL	Case_Rep_Dent_2014_Apr_29_2014_649086.nxml.txt.nlp	24872899	SENT10	0	0	26	26	tocilizumab	IL-6	PA165292659	3569	0.991
NULL	Am_J_Transplant_2010_Jan_10(1)_69-80.nxml.txt.nlp	19889125	SENT115	26	26	8	8	fludarabine	CD4	PA449655	920	0.991
NULL	Int_J_Genomics_2013_Oct_7_2013_480534.nxml.txt.nlp	24222893	SENT30	30	30	2	2	estradiol	HOTAIR	PA449503	100124700	0.991
NULL	J_Oncol_2011_Dec_5_2011_465343.nxml.txt.nlp	21188169	SENT185	23	23	33	33	gemcitabine	CD24	PA449748	100133941	0.991
NULL	EMBO_Mol_Med_2014_Oct_17_6(10)_1294-1311.nxml.txt.nlp	25231413	SENT427	16	16	5	5	forskolin	CD4	PA146096022	920	0.991
NULL	Brain_Sci_2014_Mar_14_4(1)_136-149.nxml.txt.nlp	24961704	SENT81	3	3	13	13	sevoflurane	NR1	PA451341	27158	0.991
NULL	Oncogene_2014_Jun_5_33(23)_3004-3013.nxml.txt.nlp	23831571	SENT30	7	7	12	12	etoposide	c-IAP1	PA449552	329	0.991
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Feb_17_6_29-36.nxml.txt.nlp	24648767	SENT93	0	0	12	12	exemestane	aromatase	PA449563	1588	0.991
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT124	12	12	41	41	cisplatin	GS-X	PA449014	4363	0.991
NULL	Br_J_Cancer_2009_Mar_10_100(5)_758-763.nxml.txt.nlp	19259094	SENT110	33	33	0	0	belinostat	MLH1		4292	0.991
NULL	Springerplus_2015_Jan_23_4_29.nxml.txt.nlp	25628986	SENT18	1	1	30	30	dapsone	G6PD	PA449211	2539	0.991
NULL	Apoptosis_2012_Sep_30_17(9)_989-997.nxml.txt.nlp	22460505	SENT147	9	9	15	15	thioridazine	PI3K	PA451666	5290	0.991
NULL	Cancers_(Basel)_2014_Jul_17_6(3)_1500-1521.nxml.txt.nlp	25037020	SENT202	3	3	20	20	curcumin	5-LOX	PA151958596	240	0.991
NULL	J_Adv_Pharm_Technol_Res_2012_Jul-Sep_3(3)_193-198.nxml.txt.nlp	23057007	SENT56	21	21	1	1	simvastatin	VIII	PA451363	1351	0.991
NULL	Biologics_2014_Feb_15_8_67-81.nxml.txt.nlp	24600203	SENT147	0	0	30	30	basiliximab	IL-2	PA164747126	3558	0.991
NULL	Toxins_(Basel)_2010_Mar_31_2(4)_517-551.nxml.txt.nlp	22069598	SENT226	0	0	12	12	genistein	EGF	PA165109660	1950	0.991
NULL	Leukemia_2013_Feb_3_27(2)_315-324.nxml.txt.nlp	22751450	SENT168	14	14	0	0	sorafenib	Bcl-2	PA7000	596	0.991
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S258-S263.nxml.txt.nlp	21525465	SENT104	7	7	24	24	exenatide	GLP-1	PA164749238	100125288	0.991
NULL	Br_J_Cancer_2009_May_5_100(9)_1379-1384.nxml.txt.nlp	19401697	SENT29	0	0	13	13	cetuximab	EGFR	PA10040	1956	0.991
NULL	Acta_Pharmacol_Sin_2013_Jul_5_34(7)_870-879.nxml.txt.nlp	23624759	SENT95	15	15	24	24	cetuximab	EGFR	PA10040	1956	0.991
NULL	Lab_Invest_2013_Aug_3_93(8)_868-879.nxml.txt.nlp	23732814	SENT29	17	17	4	4	tamoxifen	mer	PA451581	10461	0.991
NULL	Nat_Biotechnol_2012_Nov_14_30(11)_1125-1130.nxml.txt.nlp	23064238	SENT85	0	0	23	23	nitazoxanide	B17	PA164754874	29980;4712	0.991
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT138	5	5	16	16	lovastatin	AKT	PA450272	207	0.991
NULL	Mol_Cancer_2007_Oct_11_6_63.nxml.txt.nlp	17931419	SENT164	3	3	22	22	cetuximab	EGFR	PA10040	1956	0.991
NULL	Cancer_Immunol_Immunother_2015_Oct_7_64_61-73.nxml.txt.nlp	25287778	SENT250	22	22	46	46	lenalidomide	LFA-1	PA162363968	3683;3689	0.991
NULL	J_Cancer_Res_Clin_Oncol_2013_Aug_7_139(10)_1667-1672.nxml.txt.nlp	23918349	SENT142	19	19	12	12	hydrocortisone	STEPP	PA449905	222659	0.991
NULL	Biomed_Res_Int_2013_Jul_31_2013_692071.nxml.txt.nlp	23984399	SENT180	0	0	25	25	bleomycin	OCT1	PA448645	5451;6580	0.991
NULL	J_Clin_Exp_Pathol_2012_May_17_Suppl_4_7327.nxml.txt.nlp	25379357	SENT47	10	10	27	27	resveratrol	p300		2033	0.991
NULL	Breast_Cancer_Res_2005_Jul_29_7(5)_E6.nxml.txt.nlp	16168100	SENT10	18	18	6	6	tamoxifen	CYP2D6	PA451581	1565	0.991
NULL	J_Oncol_2010_Jan_14_2010_740472.nxml.txt.nlp	20130818	SENT142	0	0	11	11	pertuzumab	EGFR		1956	0.991
NULL	Clin_Med_Insights_Cardiol_2011_Oct_6_5_103-119.nxml.txt.nlp	22084608	SENT39	7	7	13	13	dronedarone	CYP3A4	PA153619853	1576	0.991
NULL	Int_J_Mol_Sci_2014_Sep_29_15(10)_17411-17441.nxml.txt.nlp	25268615	SENT313	16	16	3	3	methotrexate	CD147	PA450428	682	0.991
NULL	Oncotarget_2013_Nov_24_4(12)_2430-2438.nxml.txt.nlp	24280348	SENT114	1	1	7	7	gefitinib	STAT3	PA131301952	6774	0.991
NULL	Cell_Commun_Signal_2013_Oct_1_11_73.nxml.txt.nlp	24083678	SENT26	0	0	17	17	sulindac	COX	PA451565	1351	0.991
NULL	Front_Genet_2014_Dec_19_5_438.nxml.txt.nlp	25566322	SENT104	0	0	9	9	procainamide	DNMT1	PA451108	1786	0.991
NULL	Clin_Mol_Hepatol_2012_Jun_26_18(2)_109-162.nxml.txt.nlp	22893865	SENT688	1	1	19	19	lamivudine	IFN	PA450163	3439	0.991
NULL	Int_J_Gen_Med_2009_Jul_30_2_129-140.nxml.txt.nlp	20360896	SENT211	17	17	5	5	tamoxifen	aromatase	PA451581	1588	0.991
NULL	Case_Rep_Oncol_2014_Jul_23_7(2)_503-508.nxml.txt.nlp	25232318	SENT58	17	17	4	4	crizotinib	KRAS	PA165946122	3845	0.991
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1522-1532.nxml.txt.nlp	21997136	SENT259	23	23	5	5	lapatinib	UGT1A1	PA152241907	54658	0.991
NULL	Arthritis_Res_Ther_2013_Dec_30_15(6)_R223.nxml.txt.nlp	24373218	SENT150	28	28	3	3	carprofen	TSP-1	PA164781361	7057	0.991
NULL	Front_Comput_Neurosci_2013_Apr_5_7_22.nxml.txt.nlp	23576979	SENT51	16	16	3	3	ketamine	HCN1	PA450144	348980	0.991
NULL	Breast_Cancer_Res_Treat_2014_Sep_25_148(1)_81-90.nxml.txt.nlp	25253174	SENT7	4	4	39	39	metformin	adiponectin	PA450395	9370	0.991
NULL	Breast_Cancer_Res_2004_Oct_6_6(6)_269-274.nxml.txt.nlp	15535858	SENT83	27	27	18	18	letrozole	aromatase	PA450196	1588	0.991
NULL	Clin_Med_Insights_Case_Rep_2014_Jun_2_7_41-47.nxml.txt.nlp	24948869	SENT76	1	1	9	9	tocilizumab	IL-6	PA165292659	3569	0.991
NULL	J_Cancer_2013_Nov_23_4(9)_736-754.nxml.txt.nlp	24312144	SENT91	11	11	41	41	afatinib	EGFR	PA165981154	1956	0.991
NULL	Oncol_Lett_2013_Sep_15_6(3)_648-654.nxml.txt.nlp	24137384	SENT37	29	29	4	4	oxaliplatin	ERCC1	PA131285527	2067	0.991
NULL	Mol_Cancer_2013_May_24_12_47.nxml.txt.nlp	23705854	SENT253	4	4	8	8	celecoxib	P-gp	PA448871	5243	0.991
NULL	BMB_Rep_2014_May_47(5)_292-297.nxml.txt.nlp	24286321	SENT64	18	18	4	4	ranibizumab	Rpn2	PA164746012	5707	0.991
NULL	Oncogene_2010_Jun_3_29(22)_3208-3216.nxml.txt.nlp	20383201	SENT125	16	16	0	0	dasatinib	EGF	PA162372878	1950	0.991
NULL	Cancers_(Basel)_2011_Apr_18_3(2)_2014-2031.nxml.txt.nlp	24212794	SENT171	8	8	0	0	cetuximab	KRAS	PA10040	3845	0.991
NULL	Biologics_2013_Apr_15_7_77-90.nxml.txt.nlp	23723688	SENT9	0	0	37	37	cetuximab	CRT	PA10040	811	0.991
NULL	Breast_Cancer_Res_2009_Jun_16_11(3)_R35.nxml.txt.nlp	19531217	SENT126	23	23	41	41	exemestane	TRG	PA449563	6965	0.991
NULL	Front_Oncol_2013_Sep_9_3_235.nxml.txt.nlp	24058902	SENT65	14	14	9	9	vorinostat	BIM	PA164748224	10018	0.991
NULL	Br_J_Cancer_2011_Jul_26_105(3)_420-427.nxml.txt.nlp	21730982	SENT217	16	16	9	9	cetuximab	KRAS	PA10040	3845	0.991
NULL	Oncogenesis_2014_Dec_15_3(12)_e133.nxml.txt.nlp	25500906	SENT26	20	20	40	40	trastuzumab	HER2	PA451743	2064	0.991
NULL	Nat_Commun_2013_4_10_1038_ncomms3472.nxml.txt.nlp	24045463	SENT99	34	34	15	15	propranolol	FDG	PA451145	23583	0.991
NULL	Nanoscale_Res_Lett_2010_May_6_5(7)_1161-1169.nxml.txt.nlp	20596457	SENT189	42	42	10	10	docetaxel	zeta	PA449383	9907	0.991
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1126-1134.nxml.txt.nlp	21364592	SENT108	39	39	2	2	tegafur	TTP	PA452620	7538;11093	0.991
NULL	EMBO_Mol_Med_2012_Jun_13_4(6)_515-527.nxml.txt.nlp	22416035	SENT130	36	36	12	12	olaparib	p53		7157	0.991
NULL	J_Cell_Biol_2005_May_23_169(4)_657-667.nxml.txt.nlp	15911880	SENT80	28	28	4	4	forskolin	EGFR	PA146096022	1956	0.991
NULL	Oncogenesis_2014_Dec_15_3(12)_e133.nxml.txt.nlp	25500906	SENT9	38	38	4	4	trastuzumab	HER3	PA451743	2065	0.991
NULL	Biologics_2013_Apr_26_7_91-101.nxml.txt.nlp	23671386	SENT101	3	3	24	24	crizotinib	KIT	PA165946122	3815	0.991
NULL	Curr_Oncol_2006_Feb_13(1)_2-7.nxml.txt.nlp	17576435	SENT76	19	19	28	28	tamoxifen	HER2	PA451581	2064	0.991
NULL	CNS_Spectr_2014_Apr_1_19(2)_121-133.nxml.txt.nlp	23903233	SENT171	0	0	7	7	vilazodone	5-HT1A	PA165958365	3350	0.991
NULL	Bioinformation_2012_Dec_19_8(25)_1249-1254.nxml.txt.nlp	23275729	SENT8	13	13	19	19	finasteride	VEGFR	PA449627	3791	0.991
NULL	Int_J_Gen_Med_2012_Jun_18_5_535-540.nxml.txt.nlp	22807641	SENT8	5	5	14	14	pitavastatin	adiponectin	PA142650384	9370	0.991
NULL	Nat_Commun_2014_Dec_8_5_5736.nxml.txt.nlp	25484020	SENT215	13	13	0	0	capsaicin	TRPV1	PA448776	7442	0.991
NULL	Biomed_Res_Int_2014_Apr_28_2014_549742.nxml.txt.nlp	24877113	SENT123	33	33	8	8	temozolomide	BMP2	PA451609	650	0.991
NULL	Clin_Med_Oncol_2008_Jun_11_2_469-470.nxml.txt.nlp	21892319	SENT22	33	33	8	8	cyclophosphamide	HER2	PA449165	2064	0.991
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT195	11	11	33	33	phenprocoumon	CYP2C9	PA450921	1559	0.991
NULL	Oncol_Rep_2014_Apr_28_31(4)_1605-1612.nxml.txt.nlp	24481648	SENT36	0	0	13	13	imatinib	P-gp	PA10804	5243	0.991
NULL	Acta_Pharmacol_Sin_2014_Jun_4_35(6)_792-805.nxml.txt.nlp	24902787	SENT257	3	3	24	24	paroxetine	S6K1	PA450801	6198	0.991
NULL	Sci_Rep_2014_Dec_15_4_7490.nxml.txt.nlp	25502402	SENT26	10	10	28	28	gefitinib	EGFR	PA131301952	1956	0.991
NULL	Clin_Dev_Immunol_2013_Nov_25_2013_271246.nxml.txt.nlp	24371445	SENT211	18	18	4	4	irinotecan	CD166	PA450085	214	0.991
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1449-1456.nxml.txt.nlp	24077631	SENT110	17	17	1	1	lornoxicam	CYP2C9	PA165958395	1559	0.991
NULL	Mol_Cancer_2013_Nov_5_12_133.nxml.txt.nlp	24192080	SENT107	7	7	12	12	leflunomide	AKT	PA450192	207	0.991
NULL	Paediatr_Drugs_2013_Apr_20_15(2)_119-131.nxml.txt.nlp	23512128	SENT87	6	6	24	24	ilaprazole	CYP3A4	PA165947499	1576	0.991
NULL	Br_J_Ophthalmol_2010_May_94(5)_639-642.nxml.txt.nlp	20447966	SENT96	0	0	33	33	rimexolone	MYOC	PA164752251	4653	0.991
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_May_11_67(Pt_6)_o1383.nxml.txt.nlp	21754773	SENT56	0	0	11	11	nimesulide	aromatase	PA137179528	1588	0.991
NULL	Br_J_Cancer_2006_Dec_4_95(11)_1483-1489.nxml.txt.nlp	17106442	SENT8	0	0	7	7	gefitinib	EGFR	PA131301952	1956	0.991
NULL	Arch_Drug_Inf_2009_Mar_2(1)_1-7.nxml.txt.nlp	19381337	SENT26	1	1	5	5	saquinavir	CYP3A4	PA451305	1576	0.991
NULL	Breast_Cancer_Res_2012_Jul_6_14(4)_R102.nxml.txt.nlp	22770227	SENT148	7	7	18	18	tamoxifen	aromatase	PA451581	1588	0.991
NULL	Arthritis_Res_Ther_2013_May_29_15(3)_R64.nxml.txt.nlp	23718630	SENT182	10	10	1	1	anakinra	S100A12	PA10799	6283	0.991
NULL	J_Carcinog_2014_Feb_20_13_4.nxml.txt.nlp	24737952	SENT298	28	28	11	11	imatinib	KIT	PA10804	3815	0.991
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Sep_27_64(Pt_10)_o2027.nxml.txt.nlp	21201221	SENT58	17	17	6	6	ethanol	mol	PA448073	90527	0.991
NULL	Br_J_Cancer_2012_May_8_106(10)_1638-1647.nxml.txt.nlp	22498643	SENT198	2	2	12	12	imatinib	HIF-1	PA10804	29072	0.991
NULL	Adv_Hematol_2012_Mar_8_2012_856341.nxml.txt.nlp	22496694	SENT181	25	25	5	5	quinidine	P-gp	PA451209	5243	0.991
NULL	Nucl_Recept_Signal_2006_Jul_7_4_e013.nxml.txt.nlp	16862219	SENT31	40	40	9	9	tamoxifen	PI3K	PA451581	5290	0.991
NULL	Biologics_2012_Jul_26_6_233-244.nxml.txt.nlp	22904615	SENT79	32	32	8	8	gefitinib	EGFR	PA131301952	1956	0.991
NULL	Int_J_Mol_Sci_2013_Aug_15_14(8)_16836-16850.nxml.txt.nlp	23955267	SENT3	0	0	19	19	trastuzumab	HER2	PA451743	2064	0.991
NULL	Case_Rep_Med_2014_Nov_11_2014_964612.nxml.txt.nlp	25435881	SENT116	2	2	8	8	rifabutin	CD4	PA451249	920	0.991
NULL	Diabetes_Metab_Syndr_Obes_2014_Aug_28_7_391-400.nxml.txt.nlp	25210468	SENT99	38	38	8	8	exenatide	GLP-1	PA164749238	100125288	0.991
NULL	J_Cell_Mol_Med_2014_Aug_1_18(8)_1599-1611.nxml.txt.nlp	24889822	SENT126	17	17	9	9	resveratrol	p62		8878;10657;23636	0.991
NULL	Aging_(Albany_NY)_2009_Jun_3_1(6)_515-528.nxml.txt.nlp	20157535	SENT111	8	8	26	26	resveratrol	S6K1		6198	0.991
NULL	J_Hematol_Oncol_2009_Apr_22_2_18.nxml.txt.nlp	19386128	SENT147	39	39	16	16	irinotecan	KRAS	PA450085	3845	0.991
NULL	Onco_Targets_Ther_2014_May_28_7_841-852.nxml.txt.nlp	24920926	SENT67	5	5	35	35	erlotinib	DELTA	PA134687924	7528;5694	0.991
NULL	Exp_Ther_Med_2014_Aug_11_8(2)_533-538.nxml.txt.nlp	25009615	SENT20	24	24	0	0	trypsin	PAR-1	PA451806	2011;2149	0.991
NULL	Oncoimmunology_2013_Jun_1_2(6)_e24786.nxml.txt.nlp	23894723	SENT48	19	19	7	7	doxorubicin	CT26	PA449412	168400	0.991
NULL	Br_J_Pharmacol_2013_Jun_27_169(4)_736-747.nxml.txt.nlp	23489111	SENT165	24	24	3	3	methadone	5-HT3A	PA450401	3359	0.991
NULL	J_Gastrointest_Cancer_2013_Aug_7_44(4)_385-392.nxml.txt.nlp	23921604	SENT64	8	8	38	38	imatinib	PDGFRA	PA10804	5156	0.991
NULL	Breast_Cancer_Res_2002_Sep_10_4(6)_218-221.nxml.txt.nlp	12473166	SENT38	26	26	7	7	tamoxifen	ATAC	PA451581	6375	0.991
NULL	Biologics_2013_Feb_25_7_47-60.nxml.txt.nlp	23459471	SENT77	3	3	42	42	vorinostat	CTCL	PA164748224	64061	0.991
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT11	9	9	31	31	lapatinib	HER3	PA152241907	2065	0.991
NULL	Adv_Hematol_2012_Aug_2_2012_842945.nxml.txt.nlp	22919394	SENT144	31	31	9	9	lenalidomide	OPG	PA162363968	690	0.991
NULL	Cancer_Med_2014_Oct_24_3(5)_1159-1169.nxml.txt.nlp	25060396	SENT201	0	0	15	15	bortezomib	SP1	PA10252	6667	0.991
NULL	Mol_Cancer_2014_Jun_19_13_154.nxml.txt.nlp	24941944	SENT160	20	20	12	12	aminopterin	NRAS	PA165109541	4893	0.991
NULL	Curr_Cardiol_Rev_2012_Aug_8(3)_239-249.nxml.txt.nlp	22935021	SENT101	0	0	13	13	cangrelor	P2Y12	PA165945763	64805	0.991
NULL	Hum_Genomics_2011_Oct_1_5(6)_577-622.nxml.txt.nlp	22155605	SENT620	12	12	22	22	tamoxifen	aromatase	PA451581	1588	0.991
NULL	Hum_Genomics_2008_Sep_1_3(1)_7-16.nxml.txt.nlp	19129086	SENT169	3	3	20	20	rosiglitazone	OATP1B1	PA451283	10599	0.991
NULL	Biologics_2014_Apr_23_8_183-192.nxml.txt.nlp	24790411	SENT33	0	0	24	24	afatinib	HER2	PA165981154	2064	0.991
NULL	Br_J_Cancer_2013_May_14_108(9)_1862-1869.nxml.txt.nlp	23579219	SENT12	5	5	34	34	cetuximab	ANXA11	PA10040	311	0.991
NULL	Cardiovasc_Ther_2009_27(4)_259-274.nxml.txt.nlp	19604248	SENT266	0	0	12	12	ticagrelor	P2Y12	PA165374673	64805	0.991
NULL	J_Mol_Med_(Berl)_2014_Jan_10_92(5)_497-507.nxml.txt.nlp	24408111	SENT11	3	3	31	31	pioglitazone	HIF-1	PA450970	29072	0.991
NULL	Breast_Cancer_Res_2001_Mar_26_3(3)_180-182.nxml.txt.nlp	11305952	SENT24	30	30	12	12	tamoxifen	aromatase	PA451581	1588	0.991
NULL	Diagn_Pathol_2014_Aug_9_9(1)_153.nxml.txt.nlp	NULL	SENT221	9	9	3	3	panitumumab	BRAF	PA162373091	673	0.991
NULL	J_Cell_Mol_Med_2013_Sep_11_17(9)_1160-1172.nxml.txt.nlp	23844832	SENT276	26	26	7	7	gefitinib	EGF	PA131301952	1950	0.991
NULL	EMBO_Mol_Med_2011_Apr_3(4)_235-245.nxml.txt.nlp	21374818	SENT80	39	39	10	10	doxycycline	CLDN5	PA449415	7122	0.991
NULL	Adv_Hematol_2012_Mar_8_2012_856341.nxml.txt.nlp	22496694	SENT79	12	12	44	44	thrombin	VIII	PA451674	1351	0.991
NULL	Oncol_Rep_2013_Sep_1_30(3)_1045-1052.nxml.txt.nlp	23817662	SENT149	26	26	6	6	erlotinib	EGFR	PA134687924	1956	0.991
NULL	Oncol_Rep_2014_Apr_28_31(4)_1605-1612.nxml.txt.nlp	24481648	SENT45	3	3	17	17	ponatinib	MRP7	PA165980594	89845;1080	0.991
NULL	Cell_Death_Dis_2013_Sep_19_4(9)_e810.nxml.txt.nlp	24052078	SENT67	20	20	5	5	erlotinib	EGFR	PA134687924	1956	0.991
NULL	Breast_Cancer_Res_2011_Mar_14_13(2)_205.nxml.txt.nlp	21457526	SENT33	17	17	2	2	tamoxifen	ATAC	PA451581	6375	0.991
NULL	Gastric_Cancer_2013_Jul_12_16(3)_345-354.nxml.txt.nlp	22968820	SENT142	45	45	28	28	oxaliplatin	FANCJ	PA131285527	83990	0.991
NULL	Chin_J_Cancer_2012_Feb_31(2)_51-57.nxml.txt.nlp	22257384	SENT115	3	3	15	15	nilotinib	MRP7	PA165958345	89845;1080	0.991
NULL	Eur_J_Neurosci_2007_Mar_1_25(6)_1619-1630.nxml.txt.nlp	17408433	SENT195	23	23	5	5	dextran	CB1	PA449261	1268	0.991
NULL	Biochim_Biophys_Acta_2013_Jun_1833(6)_1443-1453.nxml.txt.nlp	23485397	SENT65	39	39	1	1	chymotrypsin	HIPK2	PA448994	28996	0.991
NULL	Brain_Sci_2013_Jun_3_3(2)_877-907.nxml.txt.nlp	24961429	SENT170	4	4	14	14	taurine	CHOP	PA451590	1649	0.991
NULL	Drugs_R_D_2014_Sep_31_14(3)_177-184.nxml.txt.nlp	25079671	SENT120	22	22	9	9	miglitol	FABP4	PA164776726	2167	0.991
NULL	Breast_Cancer_Res_2011_Feb_2_13(1)_R15.nxml.txt.nlp	21288332	SENT20	26	26	0	0	trastuzumab	HER2	PA451743	2064	0.991
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT145	3	3	22	22	trastuzumab	STAT3	PA451743	6774	0.991
NULL	Allergy_Asthma_Immunol_Res_2013_Jan_29_5(1)_55-58.nxml.txt.nlp	23277879	SENT20	26	26	5	5	caffeine	IPA	PA448710	3160	0.991
NULL	Mol_Brain_2014_Nov_18_7(1)_82.nxml.txt.nlp	NULL	SENT209	21	21	3	3	tamoxifen	p35	PA451581	3592;80761	0.991
NULL	Cancers_(Basel)_2011_Mar_7_3(1)_1158-1181.nxml.txt.nlp	24212658	SENT255	29	29	44	44	doxorubicin	HSF1	PA449412	3297	0.991
NULL	Arch_Med_Sci_2012_Feb_29_8(1)_154-161.nxml.txt.nlp	22457689	SENT30	19	19	4	4	cimetidine	IL-2	PA449001	3558	0.991
NULL	South_Asian_J_Cancer_2014_Jul-Sep_3(3)_154-158.nxml.txt.nlp	25136521	SENT29	20	20	0	0	etoposide	CYP2C9	PA449552	1559	0.991
NULL	J_Biol_Chem_2013_Jun_14_288(24)_17745-17758.nxml.txt.nlp	23589285	SENT193	44	44	13	13	isoproterenol	KLF11	PA450121	8462	0.991
NULL	J_Cancer_2012_Dec_25_4(1)_57-65.nxml.txt.nlp	23386905	SENT106	20	20	2	2	bleomycin	CD4	PA448645	920	0.991
NULL	Cell_Death_Dis_2013_Oct_3_4(10)_e834.nxml.txt.nlp	24091677	SENT77	37	37	7	7	vinblastine	Bcl-2	PA451877	596	0.991
NULL	Oncogene_2010_Jun_3_29(22)_3208-3216.nxml.txt.nlp	20383201	SENT125	16	16	2	2	dasatinib	IL-6	PA162372878	3569	0.991
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2013_Mar_1_69(Pt_3)_420-431.nxml.txt.nlp	23519417	SENT45	4	4	32	32	meropenem	hole	PA164764445	80757	0.991
NULL	Exp_Ther_Med_2014_Oct_17_8(4)_1164-1166.nxml.txt.nlp	25187816	SENT63	17	17	3	3	ganciclovir	IL-11	PA449733	3589	0.991
NULL	J_Gynecol_Oncol_2014_Apr_9_25(2)_130-135.nxml.txt.nlp	24761217	SENT120	19	19	11	11	ritonavir	CYP3A4	PA451260	1576	0.991
NULL	Mol_Cancer_2008_Jun_5_7_50.nxml.txt.nlp	18534018	SENT149	44	44	15	15	bortezomib	c-Jun	PA10252	3725	0.991
NULL	J_Cell_Biol_1998_Jan_26_140(2)_335-345.nxml.txt.nlp	9442109	SENT94	33	33	27	27	chloroquine	NHE	PA448948	285335	0.991
NULL	Breast_Cancer_Res_2010_Jun_28_12(3)_R43.nxml.txt.nlp	20579400	SENT28	12	12	5	5	paclitaxel	MAPT	PA450761	4137	0.991
NULL	Br_J_Cancer_2012_Feb_28_106(5)_858-866.nxml.txt.nlp	22343622	SENT115	4	4	21	21	docetaxel	PD1	PA449383	9825;6622;5133	0.991
NULL	Mol_Cancer_2012_Sep_25_11_73.nxml.txt.nlp	23009336	SENT256	5	5	23	23	gefitinib	PP2	PA131301952	4888	0.99
NULL	Curr_Neuropharmacol_2013_Mar_11(2)_160-170.nxml.txt.nlp	23997751	SENT102	13	13	23	23	mianserin	5-HT2C	PA134687937	3358	0.99
NULL	Ann_Gastroenterol_2012_25(3)_207-217.nxml.txt.nlp	24713803	SENT235	0	0	21	21	exenatide	DM2	PA164749238	28508	0.99
NULL	J_Gen_Physiol_2010_Aug_136(2)_149-154.nxml.txt.nlp	20660658	SENT40	5	5	41	41	suramin	P2X1	PA10292	5023	0.99
NULL	AIDS_Res_Ther_2014_Aug_4_11_25.nxml.txt.nlp	25120580	SENT63	1	1	11	11	esomeprazole	CYP2C19	PA10075	1557	0.99
NULL	Breast_Cancer_Res_2004_Nov_7_6(1)_39-52.nxml.txt.nlp	14680484	SENT165	21	21	11	11	tamoxifen	AF-1	PA451581	3460;5710	0.99
NULL	Front_Cell_Neurosci_2013_Dec_18_7_250.nxml.txt.nlp	24391538	SENT328	29	29	4	4	suramin	P2X4	PA10292	5025	0.99
NULL	Oncotarget_2011_Dec_31_2(12)_1352-1367.nxml.txt.nlp	22267462	SENT126	2	2	6	6	cisplatin	p53	PA449014	7157	0.99
NULL	Br_J_Cancer_2011_Sep_6_105(6)_807-813.nxml.txt.nlp	21847121	SENT82	32	32	0	0	pha-665752	EGFR		1956	0.99
NULL	Mucosal_Immunol_2013_Nov_10_6(6)_1179-1190.nxml.txt.nlp	23571504	SENT123	28	28	22	22	auranofin	TRX	PA448510	7295	0.99
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1699-1708.nxml.txt.nlp	19861960	SENT159	43	43	5	5	dasatinib	HER2	PA162372878	2064	0.99
NULL	Autoimmune_Dis_2012_Dec_5_2012_815753.nxml.txt.nlp	23251792	SENT13	0	0	10	10	hyaluronan	ECM	PA165958431	22915	0.99
NULL	Mol_Cancer_2008_May_21_7_42.nxml.txt.nlp	18492291	SENT100	0	0	21	21	gefitinib	EGFR	PA131301952	1956	0.99
NULL	Case_Rep_Oncol_2012_Mar_16_5(1)_114-118.nxml.txt.nlp	22666198	SENT7	41	41	28	28	carboplatin	CD56	PA448803	4684	0.99
NULL	Cell_Death_Dis_2014_Apr_17_5(4)_e1182.nxml.txt.nlp	24743737	SENT68	30	30	36	36	capsaicin	TRPV1	PA448776	7442	0.99
NULL	Environ_Health_Perspect_2010_Dec_12_118(12)_1707-1713.nxml.txt.nlp	20705543	SENT18	2	2	14	14	bleomycin	XRCC1	PA448645	7515	0.99
NULL	Mol_Cancer_2013_May_1_12_34.nxml.txt.nlp	23634843	SENT4	26	26	40	40	estradiol	aromatase	PA449503	1588	0.99
NULL	Oncol_Lett_2013_Mar_11_5(3)_1010-1016.nxml.txt.nlp	23426784	SENT103	31	31	38	38	midazolam	TRPM7	PA450496	54822	0.99
NULL	Cancer_Cell_Int_2009_Sep_10_9_25.nxml.txt.nlp	19744341	SENT135	4	4	10	10	glucosamine	survivin	PA164747613	332	0.99
NULL	Breast_Cancer_Res_2011_Nov_7_13(6)_R112.nxml.txt.nlp	22060274	SENT35	15	15	2	2	tamoxifen	ARTN	PA451581	9048	0.99
NULL	Neural_Regen_Res_2013_Mar_25_8(9)_825-832.nxml.txt.nlp	25206730	SENT106	0	0	40	40	isoflurane	P2X7	PA450106	5027	0.99
NULL	Indian_J_Pharm_Sci_2009_Nov-Dec_71(6)_608-614.nxml.txt.nlp	20376212	SENT66	0	0	9	9	exenatide	GLP-1	PA164749238	100125288	0.99
NULL	Int_J_Mol_Sci_2014_Jun_5_15(6)_10034-10051.nxml.txt.nlp	24905404	SENT144	3	3	13	13	cisplatin	Bcl-2	PA449014	596	0.99
NULL	Antimicrob_Agents_Chemother_2014_Nov_10_59(1)_490-497.nxml.txt.nlp	25385107	SENT199	5	5	0	0	proguanil	ATV	PA451124	4683	0.99
NULL	Cancer_Med_2012_Oct_16_1(2)_207-217.nxml.txt.nlp	23342270	SENT152	26	26	10	10	saracatinib	PIK3CA		5290	0.99
NULL	Exp_Ther_Med_2013_Apr_5_5(4)_1259-1263.nxml.txt.nlp	23596498	SENT76	16	16	0	0	capsaicin	TRPV1	PA448776	7442	0.99
NULL	Clin_Ophthalmol_2007_Sep_1(3)_225-232.nxml.txt.nlp	19668476	SENT4	0	0	26	26	bimatoprost	C-1	PA164748867	5203	0.99
NULL	Diabetes_2009_Apr_9_58(4)_965-974.nxml.txt.nlp	19136651	SENT40	0	0	14	14	nadh	NQO1	PA164755085	1728	0.99
NULL	Cardiovasc_Res_2012_Mar_15_93(4)_674-681.nxml.txt.nlp	22166712	SENT137	0	0	10	10	clopidogrel	ADP	PA449053	23038	0.99
NULL	Br_J_Cancer_2010_Nov_9_103(10)_1542-1547.nxml.txt.nlp	20959822	SENT68	6	6	20	20	cetuximab	KRAS	PA10040	3845	0.99
NULL	Exp_Ther_Med_2015_Feb_8_9(2)_303-310.nxml.txt.nlp	25574190	SENT12	6	6	33	33	calcipotriol	IL-8	PA448714	3576	0.99
NULL	Br_J_Haematol_2011_Sep_28_154(6)_670-679.nxml.txt.nlp	21623767	SENT67	22	22	12	12	thrombin	CD36	PA451674	948	0.99
NULL	Aging_(Albany_NY)_2011_Dec_16_3(12)_1142-1153.nxml.txt.nlp	22184279	SENT155	0	0	11	11	resveratrol	AMPK		5563	0.99
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT203	0	0	17	17	amiodarone	CYP3A4	PA448383	1576	0.99
NULL	Clin_Interv_Aging_2014_Oct_21_9_1783-1791.nxml.txt.nlp	25364236	SENT149	16	16	33	33	donepezil	APOE	PA449394	348	0.99
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1699-1708.nxml.txt.nlp	19861960	SENT159	43	43	12	12	dasatinib	STAT3	PA162372878	6774	0.99
NULL	Front_Physiol_2010_Dec_30_1_166.nxml.txt.nlp	21423401	SENT75	10	10	36	36	thrombin	ADP	PA451674	23038	0.99
NULL	Biologics_2011_Aug_9_5_87-94.nxml.txt.nlp	21847344	SENT60	0	0	13	13	lapatinib	HER2	PA152241907	2064	0.99
NULL	Exp_Ther_Med_2013_Nov_13_6(5)_1317-1321.nxml.txt.nlp	24223665	SENT4	7	7	19	19	cisplatin	CD133	PA449014	8842	0.99
NULL	Cancer_Cell_Int_2014_Jun_11_14_49.nxml.txt.nlp	24991192	SENT76	34	34	3	3	berberine	AMPK	PA165860812	5563	0.99
NULL	J_Hematol_Oncol_2011_Sep_9_4_35.nxml.txt.nlp	21906310	SENT212	0	0	19	19	sunitinib	EGFR	PA162372840	1956	0.99
NULL	J_Nutr_Metab_2011_Jun_1_2011_708183.nxml.txt.nlp	21773024	SENT184	6	6	18	18	liraglutide	GLP-1	PA165958364	100125288	0.99
NULL	Exp_Diabetes_Res_2012_Mar_4_2012_653678.nxml.txt.nlp	22474428	SENT73	1	1	16	16	repaglinide	LPO	PA451234	4025	0.99
NULL	Int_J_Breast_Cancer_2011_Sep_8_2011_595092.nxml.txt.nlp	22295229	SENT115	20	20	12	12	bortezomib	ATF4	PA10252	468	0.99
NULL	Breast_Cancer_Res_2010_Apr_30_12(2)_203.nxml.txt.nlp	20459590	SENT133	3	3	19	19	cisplatin	FANCF	PA449014	2188	0.99
NULL	J_Hematol_Oncol_2013_Jan_4_6_1.nxml.txt.nlp	23286345	SENT114	10	10	25	25	rituximab	FCGR3A	PA451261	2214	0.99
NULL	Arthritis_Res_Ther_2006_Feb_3_8(2)_R43.nxml.txt.nlp	16507142	SENT98	33	33	8	8	heparin	CXCL12	PA449855	6387	0.99
NULL	Cell_Death_Dis_2013_Sep_19_4(9)_e807.nxml.txt.nlp	24052075	SENT215	13	13	0	0	doxorubicin	p53	PA449412	7157	0.99
NULL	Scientifica_(Cairo)_2013_Feb_7_2013_249101.nxml.txt.nlp	24278770	SENT188	2	2	36	36	alemtuzumab	IFN	PA164783958	3439	0.99
NULL	Int_J_Breast_Cancer_2011_Feb_24_2011_967419.nxml.txt.nlp	22332018	SENT142	34	34	0	0	topotecan	BRCA1	PA451729	672	0.99
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT75	32	32	20	20	trastuzumab	HER2	PA451743	2064	0.99
NULL	Semin_Immunopathol_2013_May_10_35(3)_351-373.nxml.txt.nlp	23572207	SENT371	13	13	6	6	bortezomib	XBP1	PA10252	7494	0.99
NULL	Ann_Lab_Med_2014_Jan_6_34(1)_68-70.nxml.txt.nlp	24422201	SENT24	3	3	26	26	methotrexate	PML-RAR	PA450428	84106	0.99
NULL	Mol_Clin_Oncol_2013_Sep_26_1(5)_799-804.nxml.txt.nlp	24649249	SENT118	0	0	5	5	lapatinib	EGFR	PA152241907	1956	0.99
NULL	J_Antimicrob_Chemother_2011_Jun_25_66(6)_1332-1339.nxml.txt.nlp	21441248	SENT6	0	0	9	9	nevirapine	CYP2B6	PA450616	1555	0.99
NULL	Mol_Cancer_2010_Oct_12_9_269.nxml.txt.nlp	20939893	SENT137	28	28	4	4	isoproterenol	STAT3	PA450121	6774	0.99
NULL	Ther_Clin_Risk_Manag_2006_Mar_2(1)_77-86.nxml.txt.nlp	18360583	SENT113	41	41	28	28	alendronate	PTH	PA448082	5741	0.99
NULL	Eur_J_Haematol_2013_Feb_22_90(2)_89-98.nxml.txt.nlp	23181448	SENT125	25	25	32	32	imatinib	ASM	PA10804	6609;283120	0.99
NULL	Daru_2011_19(6)_433-439.nxml.txt.nlp	23008689	SENT94	23	23	11	11	ethanol	IPA	PA448073	3160	0.99
NULL	Nat_Chem_Biol_2010_Apr_28_6(4)_291-299.nxml.txt.nlp	20190765	SENT280	29	29	6	6	dasatinib	EGFR	PA162372878	1956	0.99
NULL	Blood_Res_2014_Dec_23_49(4)_216-227.nxml.txt.nlp	25548754	SENT228	24	24	7	7	lenalidomide	p53	PA162363968	7157	0.99
NULL	Clin_Med_Insights_Oncol_2012_Jun_11_6_253-262.nxml.txt.nlp	22745566	SENT81	8	8	14	14	erlotinib	EGFR	PA134687924	1956	0.99
NULL	Clin_Pharmacol_2013_Dec_9_5_185-192.nxml.txt.nlp	24353446	SENT79	27	27	2	2	clopidogrel	CYP3A4	PA449053	1576	0.99
NULL	Neural_Plast_2013_Aug_18_2013_753656.nxml.txt.nlp	24024042	SENT64	0	0	30	30	minocycline	p38	PA450519	10598;1432;7965	0.99
NULL	Int_J_Surg_Case_Rep_2014_Oct_22_5(12)_893-895.nxml.txt.nlp	25460429	SENT63	3	3	12	12	diclofenac	COX1	PA449293	4512;5742	0.99
NULL	Int_J_Vasc_Med_2012_Dec_6_2012_293641.nxml.txt.nlp	22187650	SENT313	22	22	9	9	simvastatin	RhoA	PA451363	387	0.99
NULL	Case_Rep_Oncol_2014_Jan_16_7(1)_52-57.nxml.txt.nlp	24575017	SENT65	17	17	10	10	gemcitabine	RRM1	PA449748	6240	0.99
NULL	J_Hematol_Oncol_2013_Jun_3_6_38.nxml.txt.nlp	23731980	SENT96	0	0	14	14	pertuzumab	HER3		2065	0.99
NULL	Cardiovasc_Ther_2012_Aug_17_30(4)_e174-e182.nxml.txt.nlp	21883999	SENT120	10	10	31	31	clopidogrel	P2Y12	PA449053	64805	0.99
NULL	Neuropsychopharmacology_2011_Apr_2_36(5)_1033-1046.nxml.txt.nlp	21289603	SENT45	7	7	18	18	ethanol	P21	PA448073	1026;9338	0.99
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_33-43.nxml.txt.nlp	17912634	SENT125	8	8	30	30	tamoxifen	HER2	PA451581	2064	0.99
NULL	Mol_Cancer_2010_Nov_2_9_289.nxml.txt.nlp	21044322	SENT136	19	19	10	10	cisplatin	RGS17	PA449014	26575	0.99
NULL	Scientifica_(Cairo)_2013_Dec_12_2013_635203.nxml.txt.nlp	24416617	SENT496	24	24	0	0	doxorubicin	ABCB5	PA449412	340273	0.99
NULL	Open_Access_J_Urol_2011_May_10_3_69-82.nxml.txt.nlp	24198638	SENT69	18	18	0	0	sorafenib	CYP1A2	PA7000	1544	0.99
NULL	Drug_Des_Devel_Ther_2014_Dec_1_8_2321-2332.nxml.txt.nlp	25525331	SENT190	12	12	4	4	mazindol	FFM	PA450326	24	0.99
NULL	Adv_Hematol_2011_Nov_29_2011_517561.nxml.txt.nlp	22190942	SENT49	8	8	24	24	plerixafor	CD34	PA165958410	947	0.99
NULL	Ann_Rheum_Dis_2013_Apr_21_72(4)_482-492.nxml.txt.nlp	23172750	SENT341	27	27	44	44	methotrexate	IL-6	PA450428	3569	0.99
NULL	Arthritis_2011_May_26_2011_765624.nxml.txt.nlp	22046525	SENT32	0	0	25	25	tocilizumab	IL-6	PA165292659	3569	0.99
NULL	J_Hematol_Oncol_2011_Jan_21_4_5.nxml.txt.nlp	21255411	SENT28	10	10	28	28	gefitinib	EGFR	PA131301952	1956	0.99
NULL	Biomed_Res_Int_2013_Feb_28_2013_749078.nxml.txt.nlp	23555095	SENT107	1	1	14	14	trypsin	CD4	PA451806	920	0.99
NULL	J_Hematol_Oncol_2011_Apr_20_4_16.nxml.txt.nlp	21504625	SENT51	14	14	10	10	nutlin-3	MDM2		4193	0.99
NULL	Orphanet_J_Rare_Dis_2006_Nov_16_1_46.nxml.txt.nlp	17109744	SENT76	16	16	6	6	thrombin	ADP	PA451674	23038	0.99
NULL	Acta_Pharmacol_Sin_2012_Nov_4_33(11)_1387-1394.nxml.txt.nlp	22659624	SENT128	33	33	0	0	bivalirudin	ACT	PA10032	12;11332;9457;641455	0.99
NULL	Cell_Death_Dis_2012_Jun_21_3(6)_e330.nxml.txt.nlp	22717585	SENT327	18	18	12	12	simvastatin	ATG5	PA451363	9474	0.99
NULL	Oncol_Rep_2014_Apr_28_31(4)_1605-1612.nxml.txt.nlp	24481648	SENT38	2	2	23	23	lapatinib	P-gp	PA152241907	5243	0.99
NULL	J_Invest_Dermatol_2013_Jun_14_133(6)_1541-1549.nxml.txt.nlp	23407395	SENT76	22	22	16	16	imiquimod	CXCL1	PA449972	2919	0.99
NULL	EMBO_Mol_Med_2011_Jul_3(7)_367-369.nxml.txt.nlp	21591260	SENT41	30	30	15	15	thrombin	PAR1	PA451674	79581;2149	0.99
NULL	Case_Rep_Nephrol_Urol_2012_Apr_11_2(1)_20-24.nxml.txt.nlp	23197951	SENT69	39	39	3	3	colchicine	NAC	PA449092	22861	0.99
NULL	Int_J_Hypertens_2012_Dec_4_2012_789671.nxml.txt.nlp	23304452	SENT172	12	12	23	23	vasopressin	IRAP	PA451858	3557	0.99
NULL	J_Breast_Cancer_2012_Jun_28_15(2)_197-202.nxml.txt.nlp	22807937	SENT101	0	0	13	13	cisplatin	BRCA1	PA449014	672	0.99
NULL	Exp_Ther_Med_2014_Aug_11_8(2)_671-675.nxml.txt.nlp	25009638	SENT170	20	20	3	3	scopolamine	FAE	PA451308	2178	0.99
NULL	EMBO_Mol_Med_2013_Apr_25_5(4)_531-547.nxml.txt.nlp	23526793	SENT256	38	38	8	8	rosiglitazone	MAP2	PA451283	4133;10988	0.99
NULL	Mol_Cancer_2010_Nov_2_9_289.nxml.txt.nlp	21044322	SENT149	32	32	8	8	docetaxel	RGS5	PA449383	8490	0.99
NULL	J_Anim_Sci_Biotechnol_2013_Jun_26_4(1)_23.nxml.txt.nlp	23800120	SENT50	16	16	2	2	estradiol	ESR1	PA449503	2099	0.99
NULL	Angiogenesis_2012_Dec_28_15(4)_623-641.nxml.txt.nlp	22843200	SENT333	25	25	4	4	sunitinib	CD11b	PA162372840	3684	0.99
NULL	Front_Oncol_2014_Nov_5_4_281.nxml.txt.nlp	25414829	SENT21	26	26	1	1	gefitinib	EGFR	PA131301952	1956	0.99
NULL	Mol_Cancer_2014_Jun_24_13_157.nxml.txt.nlp	24958351	SENT169	42	42	3	3	gefitinib	HER2	PA131301952	2064	0.99
NULL	Int_J_Hypertens_2012_Feb_1_2012_859235.nxml.txt.nlp	22518295	SENT281	13	13	3	3	hemin	HO-1	PA449849	3162	0.99
NULL	Br_J_Cancer_2012_May_22_106(11)_1722-1727.nxml.txt.nlp	22568966	SENT143	24	24	3	3	panitumumab	KRAS	PA162373091	3845	0.99
NULL	J_Res_Med_Sci_2011_Mar_16(Suppl1)_S395-S400.nxml.txt.nlp	22247724	SENT43	1	1	47	47	halothane	CO2	PA449845	4513	0.99
NULL	eLife_2014_May_20_3_e01763.nxml.txt.nlp	24844244	SENT380	40	40	5	5	doxycycline	MELK	PA449415	9833	0.99
NULL	Front_Comput_Neurosci_2014_Oct_17_8_133.nxml.txt.nlp	25368573	SENT172	4	4	10	10	ketamine	gamma	PA450144	9913	0.99
NULL	Curr_Chem_Genomics_2008_Feb_25_1_43-53.nxml.txt.nlp	20161827	SENT142	0	0	7	7	staurosporine	ERK2	PA165109623	5594	0.99
NULL	Exp_Diabetes_Res_2012_Oct_15_2012_465282.nxml.txt.nlp	23118742	SENT94	0	0	6	6	metformin	AMPK	PA450395	5563	0.99
NULL	J_Cell_Biol_1997_Mar_10_136(5)_995-1005.nxml.txt.nlp	9060465	SENT62	9	9	23	23	fluorescein	spatial	PA164746009	219793	0.99
NULL	Surg_Res_Pract_2014_Feb_6_2014_801643.nxml.txt.nlp	25379560	SENT13	18	18	7	7	sirolimus	CD25	PA451365	3669;3559	0.99
NULL	Curr_Med_Chem_2014_May_21(14)_1595-1606.nxml.txt.nlp	23992330	SENT84	13	13	2	2	bortezomib	REC1	PA10252	5810	0.99
NULL	Indian_J_Endocrinol_Metab_2013_May-Jun_17(3)_413-421.nxml.txt.nlp	23869296	SENT200	38	38	6	6	exenatide	GLP-1	PA164749238	100125288	0.99
NULL	Front_Oncol_2014_Jun_18_4_159.nxml.txt.nlp	24995161	SENT222	22	22	0	0	estradiol	AKR1C3	PA449503	8644	0.99
NULL	J_Clin_Exp_Pathol_2012_May_17_Suppl_4_7327.nxml.txt.nlp	25379357	SENT137	3	3	34	34	metformin	raptor	PA450395	57521	0.99
NULL	Breast_Cancer_Res_2008_Jul_24_10(4)_211.nxml.txt.nlp	18671839	SENT135	11	11	30	30	flavopiridol	PI3K	PA452627	5290	0.99
NULL	Oxid_Med_Cell_Longev_2013_Jun_6_2013_891748.nxml.txt.nlp	23840922	SENT133	0	0	23	23	resveratrol	gamma		9913	0.99
NULL	Semin_Immunol_2011_Feb_23(1)_28-41.nxml.txt.nlp	21295490	SENT233	0	0	7	7	etanercept	DDC	PA449515	1644	0.99
NULL	Endocrinol_Metab_(Seoul)_2014_Sep_25_29(3)_211-216.nxml.txt.nlp	25309777	SENT64	15	15	10	10	sorafenib	RAI	PA7000	10848;6050	0.99
NULL	Acta_Pharmacol_Sin_2013_Sep_5_34(9)_1192-1200.nxml.txt.nlp	23685957	SENT168	19	19	7	7	curcumin	FasL	PA151958596	356	0.99
NULL	J_Med_Chem_2014_Jan_23_57(2)_449-461.nxml.txt.nlp	24387105	SENT147	0	0	27	27	benzaldehyde	ALDH3A1	PA448571	218	0.99
NULL	Neural_Plast_2013_Jun_26_2013_605079.nxml.txt.nlp	23936678	SENT95	13	13	3	3	fluoxetine	MMP2	PA449673	4313	0.99
NULL	Int_J_Med_Sci_2015_Jan_1_12(1)_63-71.nxml.txt.nlp	25552920	SENT183	10	10	3	3	berberine	PC-3	PA165860812	692094	0.99
NULL	Cell_Death_Dis_2013_Sep_5_4(9)_e791.nxml.txt.nlp	24008735	SENT234	9	9	40	40	gemcitabine	14-3-3	PA449748	10971	0.99
NULL	Br_J_Cancer_2013_Apr_16_108(7)_1408-1414.nxml.txt.nlp	23511562	SENT44	4	4	21	21	tamoxifen	aromatase	PA451581	1588	0.99
NULL	J_Hematol_Oncol_2009_Aug_12_2_36.nxml.txt.nlp	19674465	SENT54	0	0	16	16	lenalidomide	IL-6	PA162363968	3569	0.99
NULL	Clin_Dev_Immunol_2011_Dec_5_2011_894704.nxml.txt.nlp	22190975	SENT229	4	4	28	28	rituximab	p38	PA451261	10598;1432;7965	0.99
NULL	Exp_Diabetes_Res_2012_Sep_27_2012_210821.nxml.txt.nlp	23056035	SENT161	0	0	6	6	metformin	AMPK	PA450395	5563	0.99
NULL	Ann_Oncol_2010_Feb_21(2)_217-222.nxml.txt.nlp	20110292	SENT15	15	15	4	4	erlotinib	EGFR	PA134687924	1956	0.99
NULL	J_Biol_Chem_2009_Jan_2_284(1)_77-84.nxml.txt.nlp	18854318	SENT165	27	27	2	2	forskolin	STRAD	PA146096022	92335	0.99
NULL	Br_J_Cancer_1995_Sep_72(3)_543-549.nxml.txt.nlp	7669559	SENT17	8	8	39	39	genistein	P-gp	PA165109660	5243	0.99
NULL	Br_J_Cancer_2011_Jun_28_105(1)_1-8.nxml.txt.nlp	21654681	SENT73	30	30	5	5	docetaxel	EGFR	PA449383	1956	0.99
NULL	Cancers_(Basel)_2010_Jul_27_2(3)_1528-1554.nxml.txt.nlp	24281171	SENT320	29	29	1	1	doxorubicin	CD133	PA449412	8842	0.99
NULL	J_Hematol_Oncol_2008_Oct_23_1_19.nxml.txt.nlp	18947412	SENT68	45	45	8	8	alemtuzumab	CD19	PA164783958	930	0.99
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT44	0	0	20	20	ranibizumab	VEGF-A	PA164746012	7422	0.99
NULL	Cell_Cycle_2013_Sep_15_12(18)_3025-3036.nxml.txt.nlp	23974102	SENT31	25	25	1	1	infliximab	CD4	PA452639	920	0.99
NULL	Mol_Med_Rep_2015_Feb_29_11(2)_865-870.nxml.txt.nlp	25352342	SENT63	17	17	6	6	mannitol	RANKL	PA450320	8600	0.99
NULL	Front_Oncol_2014_Nov_25_4_329.nxml.txt.nlp	25505733	SENT118	5	5	22	22	temsirolimus	EGFR	PA164746890	1956	0.99
NULL	Br_J_Cancer_2010_Jul_13_103(2)_178-185.nxml.txt.nlp	20551959	SENT91	10	10	15	15	doxorubicin	MDR1	PA449412	5243	0.99
NULL	Antimicrob_Agents_Chemother_2014_Nov_10_59(1)_490-497.nxml.txt.nlp	25385107	SENT202	4	4	33	33	primaquine	ACT	PA451103	12;11332;9457;641455	0.99
NULL	Mol_Cancer_2009_Nov_24_8_109.nxml.txt.nlp	19930708	SENT155	31	31	14	14	anastrozole	aromatase	PA448432	1588	0.99
NULL	Angew_Chem_Int_Ed_Engl_2013_Jan_2_52(1)_325-330.nxml.txt.nlp	23080482	SENT30	31	31	4	4	thrombin	ACPP	PA451674	55	0.99
NULL	Exp_Hematol_Oncol_2014_Mar_11_3_7.nxml.txt.nlp	24618035	SENT135	7	7	21	21	imatinib	CRKL	PA10804	1399	0.99
NULL	Cell_Commun_Signal_2011_May_15_9_13.nxml.txt.nlp	21569639	SENT282	4	4	11	11	quinacrine	AKT	PA164745551	207	0.99
NULL	Nat_Genet_2011_Feb_26_43(2)_117-120.nxml.txt.nlp	21186350	SENT81	17	17	7	7	metformin	AMPK	PA450395	5563	0.99
NULL	Br_J_Cancer_2013_Jul_23_109(2)_502-511.nxml.txt.nlp	23799850	SENT14	7	7	11	11	gemcitabine	SMARCC1	PA449748	6599	0.99
NULL	Evid_Based_Complement_Alternat_Med_2014_Mar_31_2014_892073.nxml.txt.nlp	24799945	SENT82	0	0	19	19	forskolin	MITF	PA146096022	4286	0.99
NULL	Cases_J_2009_Jul_23_2_7288.nxml.txt.nlp	19829941	SENT51	0	0	26	26	aripiprazole	5-HT1A	PA10026	3350	0.99
NULL	J_Gen_Physiol_1997_Aug_1_110(2)_185-200.nxml.txt.nlp	9236211	SENT319	15	15	46	46	methazolamide	NO3	PA450413	4681	0.99
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT168	24	24	4	4	tacrolimus	RANKL	PA451578	8600	0.99
NULL	Blood_Res_2013_Mar_25_48(1)_35-39.nxml.txt.nlp	23589793	SENT78	24	24	10	10	bortezomib	CD4	PA10252	920	0.99
NULL	EPMA_J_2011_Dec_22_3(1)_1.nxml.txt.nlp	22738081	SENT189	10	10	0	0	sunitinib	CAIX	PA162372840	768	0.99
NULL	Cell_Cycle_2012_Nov_1_11(21)_4069-4078.nxml.txt.nlp	23095523	SENT98	15	15	25	25	imatinib	PERK	PA10804	9451	0.99
NULL	Mol_Vis_2007_Jul_9_13_1083-1093.nxml.txt.nlp	17653053	SENT187	2	2	38	38	minocycline	p65	PA450519	5970	0.99
NULL	Int_J_Mol_Sci_2014_Oct_14_15(10)_18557-18573.nxml.txt.nlp	25318057	SENT160	6	6	14	14	bortezomib	TRAIL	PA10252	8743	0.99
NULL	Oncotarget_2012_Sep_21_3(9)_909-910.nxml.txt.nlp	23006984	SENT18	12	12	38	38	fasudil	ROCK2	PA165946121	9475	0.99
NULL	Front_Genet_2014_Jun_2_5_162.nxml.txt.nlp	24917882	SENT92	15	15	7	7	vemurafenib	BRAF	PA165946873	673	0.99
NULL	Aging_(Albany_NY)_2012_Mar_4_4(3)_144-145.nxml.txt.nlp	22388573	SENT12	34	34	12	12	resveratrol	AMPK		5563	0.99
NULL	Mol_Vis_2012_Apr_11_18_901-908.nxml.txt.nlp	22539869	SENT8	26	26	18	18	curcumin	HO-1	PA151958596	3162	0.99
NULL	Eur_J_Clin_Pharmacol_2007_Apr_21_63(4)_335-343.nxml.txt.nlp	17318526	SENT173	6	6	13	13	phenprocoumon	CYP2C9	PA450921	1559	0.99
NULL	Br_J_Cancer_2014_Jan_21_110(2)_384-391.nxml.txt.nlp	24346286	SENT136	32	32	10	10	trastuzumab	HER3	PA451743	2065	0.99
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1651-1657.nxml.txt.nlp	19904273	SENT178	29	29	8	8	olaparib	BRCA1		672	0.99
NULL	JAKSTAT_2013_Jul_1_2(3)_e24574.nxml.txt.nlp	24069558	SENT150	20	20	6	6	doxycycline	HEK	PA449415	2042	0.99
NULL	Arq_Bras_Cardiol_2014_Sep_103(3)_174-182.nxml.txt.nlp	25098375	SENT150	6	6	28	28	clopidogrel	DES	PA449053	1674	0.99
NULL	Hum_Genomics_Proteomics_2010_Sep_13_2010_754919.nxml.txt.nlp	20981234	SENT94	5	5	16	16	phenprocoumon	CYP2C9	PA450921	1559	0.99
NULL	Lipids_Health_Dis_2011_Jan_18_10_8.nxml.txt.nlp	21241519	SENT107	31	31	15	15	simvastatin	ABCA1	PA451363	19	0.99
NULL	Int_J_Biol_Sci_2013_Mar_7_9(3)_279-288.nxml.txt.nlp	23493630	SENT179	12	12	19	19	tocilizumab	IL-21	PA165292659	59067;50616;27189	0.99
NULL	Sci_Rep_2014_Nov_28_4_7237.nxml.txt.nlp	25429875	SENT123	11	11	32	32	hesperidin	p38	PA449867	10598;1432;7965	0.99
NULL	Mol_Cancer_2010_Nov_8_9_291.nxml.txt.nlp	21059223	SENT141	8	8	25	25	paclitaxel	Bcl-2	PA450761	596	0.99
NULL	Cough_2007_Oct_31_3_9.nxml.txt.nlp	17971242	SENT163	4	4	28	28	capsaicin	TRPV1	PA448776	7442	0.99
NULL	Arch_Drug_Inf_2011_Mar_4(1)_1-9.nxml.txt.nlp	21572514	SENT129	3	3	8	8	ciprofloxacin	P-gp	PA449009	5243	0.99
NULL	Cell_Death_Differ_2010_Apr_16_17(4)_666-676.nxml.txt.nlp	19834494	SENT298	7	7	0	0	oxaliplatin	RAGE	PA131285527	177	0.99
NULL	Onco_Targets_Ther_2014_Mar_6_7_387-393.nxml.txt.nlp	24623981	SENT55	11	11	5	5	gefitinib	EGFR	PA131301952	1956	0.99
NULL	Ann_Rheum_Dis_2011_Oct_12_71(4)_541-548.nxml.txt.nlp	21994233	SENT163	3	3	20	20	infliximab	IMPACT	PA452639	55364	0.99
NULL	Breast_Cancer_Res_2005_Jul_29_7(5)_E6.nxml.txt.nlp	16168100	SENT13	8	8	25	25	tamoxifen	CYP2D6	PA451581	1565	0.99
NULL	Curr_Chem_Genomics_2010_Mar_1_4_1-8.nxml.txt.nlp	20448812	SENT119	0	0	24	24	fexofenadine	BSP	PA449621	3381	0.99
NULL	J_Biomed_Biotechnol_2011_Dec_6_2011_856985.nxml.txt.nlp	21188173	SENT240	20	20	0	0	tamoxifen	HDAC4	PA451581	9759	0.99
NULL	Cancer_Med_2013_Feb_3_2(1)_76-85.nxml.txt.nlp	24133630	SENT226	12	12	19	19	vemurafenib	PI3K	PA165946873	5290	0.99
NULL	Cancer_Med_2012_Oct_1_1(2)_114-127.nxml.txt.nlp	23342262	SENT309	28	28	8	8	sirolimus	EGFR	PA451365	1956	0.99
NULL	Mol_Cancer_2010_Apr_15_9_77.nxml.txt.nlp	20398291	SENT89	32	32	6	6	geldanamycin	survivin	PA152031327	332	0.99
NULL	Br_J_Ophthalmol_2014_Jun_98(Suppl_1)_i11-i16.nxml.txt.nlp	24836865	SENT147	27	27	6	6	ranibizumab	VEGF-A	PA164746012	7422	0.99
NULL	Aging_(Albany_NY)_2010_Dec_14_2(12)_945-958.nxml.txt.nlp	21164223	SENT170	33	33	8	8	metformin	LKB1	PA450395	6794	0.99
NULL	ScientificWorldJournal_2014_Mar_11_2014_946265.nxml.txt.nlp	24741367	SENT109	24	24	2	2	exenatide	GLP-1	PA164749238	100125288	0.99
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT163	25	25	9	9	gemcitabine	HER2	PA449748	2064	0.99
NULL	Arthritis_Res_Ther_2012_Apr_26_14(2)_R90.nxml.txt.nlp	22537858	SENT226	1	1	15	15	atorvastatin	IFN	PA448500	3439	0.99
NULL	Front_Pharmacol_2014_Dec_2_5_252.nxml.txt.nlp	25520658	SENT128	9	9	31	31	vemurafenib	c-Raf	PA165946873	5894	0.99
NULL	Indian_J_Pharmacol_2008_Jun_40(3)_95-102.nxml.txt.nlp	20040934	SENT167	0	0	10	10	basiliximab	CD25	PA164747126	3669;3559	0.99
NULL	Drugs_Aging_2012_Nov_5_29(11)_863-869.nxml.txt.nlp	23038608	SENT129	1	1	23	23	capsaicin	NNT	PA448776	23530	0.99
NULL	Open_Access_J_Urol_2010_Dec_6_2_193-199.nxml.txt.nlp	24198628	SENT123	20	20	1	1	cisplatin	TFI	PA449014	7035	0.99
NULL	Cardiovasc_Diabetol_2007_Apr_3_6_12.nxml.txt.nlp	17407587	SENT151	8	8	32	32	irbesartan	adiponectin	PA450084	9370	0.99
NULL	Breast_Cancer_Res_2010_Oct_22_12(Suppl_2)_S2.nxml.txt.nlp	21050423	SENT108	30	30	4	4	fluorouracil	p53	PA128406956	7157	0.99
NULL	Clin_Transl_Allergy_2013_Sep_2_3_29.nxml.txt.nlp	24004581	SENT110	10	10	25	25	omalizumab	IL-6	PA164752253	3569	0.99
NULL	Breast_Cancer_Res_2008_Jul_8_10(4)_R56.nxml.txt.nlp	18611244	SENT95	15	15	39	39	letrozole	aromatase	PA450196	1588	0.99
NULL	J_Inflamm_(Lond)_2006_May_4_3_8.nxml.txt.nlp	16674821	SENT195	0	0	7	7	pp2	p38		10598;1432;7965	0.99
NULL	Case_Rep_Transplant_2011_Jan_5_2011_210178.nxml.txt.nlp	23213600	SENT39	0	0	21	21	tacrolimus	CYP3A	PA451578	1574	0.99
NULL	Springerplus_2013_Jan_11_2_5.nxml.txt.nlp	23520572	SENT3	16	16	7	7	estradiol	aromatase	PA449503	1588	0.99
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT143	4	4	30	30	resveratrol	cIAP1		329	0.99
NULL	Infection_2013_Sep_14_41(Suppl_2)_91-115.nxml.txt.nlp	24037688	SENT523	43	43	22	22	rifabutin	CD4	PA451249	920	0.99
NULL	Oncol_Lett_2014_May_11_7(5)_1401-1408.nxml.txt.nlp	24765145	SENT133	9	9	0	0	paclitaxel	PI3K	PA450761	5290	0.99
NULL	Indian_J_Dermatol_2010_Apr-Jun_55(2)_161-170.nxml.txt.nlp	20606887	SENT42	20	20	6	6	ustekinumab	p40	PA166048654	3921;339541;10314	0.99
NULL	Breast_Cancer_Res_2005_Jan_28_7(3)_R284-R290.nxml.txt.nlp	15987423	SENT103	31	31	10	10	tamoxifen	CYP2D6	PA451581	1565	0.99
NULL	Ann_Hematol_2010_Sep_13_89(9)_861-871.nxml.txt.nlp	20387067	SENT223	4	4	9	9	dasatinib	KIT	PA162372878	3815	0.99
NULL	Oncotarget_2014_Feb_7_5(3)_775-787.nxml.txt.nlp	24519956	SENT232	22	22	3	3	docetaxel	PC3	PA449383	57332;7832;5122	0.99
NULL	J_Clin_Biochem_Nutr_2009_Jan_27_44(1)_79-84.nxml.txt.nlp	19177192	SENT81	3	3	26	26	curcumin	HO-1	PA151958596	3162	0.99
NULL	J_Inflamm_(Lond)_2006_Jul_12_3_10.nxml.txt.nlp	16834783	SENT156	27	27	3	3	mometasone	IL-5	PA450541	3567	0.99
NULL	Sci_Rep_2014_Dec_4_4_7310.nxml.txt.nlp	25472472	SENT124	19	19	3	3	decitabine	CD34	PA164749631	947	0.99
NULL	Nucleic_Acids_Res_2011_Dec_31_39(22)_9536-9548.nxml.txt.nlp	21880590	SENT177	16	16	8	8	etoposide	BRCA1	PA449552	672	0.99
NULL	Anemia_2012_May_24_2012_481583.nxml.txt.nlp	22693661	SENT61	11	11	3	3	bortezomib	FANCD2	PA10252	2177	0.99
NULL	J_Occup_Med_Toxicol_2008_Feb_27_3(Suppl_1)_S6.nxml.txt.nlp	18315837	SENT73	1	1	19	19	rolipram	IL-13	PA153906323	3596	0.99
NULL	Cardiol_Res_Pract_2013_Feb_21_2013_127270.nxml.txt.nlp	23509665	SENT173	15	15	23	23	prasugrel	ADP	PA154410481	23038	0.99
NULL	Chemother_Res_Pract_2012_Aug_29_2012_817297.nxml.txt.nlp	22970367	SENT137	8	8	17	17	cetuximab	ERBB2	PA10040	2064	0.99
NULL	EPMA_J_2010_Sep_25_1(3)_495-502.nxml.txt.nlp	23199091	SENT70	23	23	33	33	capecitabine	DPD	PA448771	1806	0.99
NULL	Clin_Interv_Aging_2009_Dec_29_4_463-472.nxml.txt.nlp	20054411	SENT110	10	10	33	33	vardenafil	SEP2	PA10229	23176;23157	0.99
NULL	Oncologist_2010_Mar_3_15(3)_216-235.nxml.txt.nlp	20200040	SENT122	3	3	33	33	trastuzumab	HER-2	PA451743	2064	0.99
NULL	Adolesc_Health_Med_Ther_2013_Aug_27_4_79-87.nxml.txt.nlp	24600298	SENT46	10	10	24	24	rifampin	UGT1A1	PA451250	54658	0.99
NULL	Mol_Vis_2011_Dec_27_17_3415-3422.nxml.txt.nlp	22219637	SENT144	28	28	6	6	estradiol	p38	PA449503	10598;1432;7965	0.99
NULL	Exp_Diabetes_Res_2012_Sep_27_2012_210821.nxml.txt.nlp	23056035	SENT162	6	6	21	21	metformin	AMPK	PA450395	5563	0.99
NULL	Acta_Pharmacol_Sin_2011_Apr_28_32(4)_441-448.nxml.txt.nlp	21441944	SENT52	13	13	6	6	sildenafil	STZ	PA451346	6484	0.99
NULL	Ann_Gastroenterol_2014_27(3)_193-199.nxml.txt.nlp	24976007	SENT61	8	8	0	0	fluorescein	CLE	PA164746009	51637	0.99
NULL	Arthritis_Res_Ther_2010_Dec_17_12(6)_221.nxml.txt.nlp	21205283	SENT128	13	13	1	1	infliximab	ACR	PA452639	49	0.99
NULL	Acta_Neuropathol_Commun_2014_Dec_20_2(1)_160.nxml.txt.nlp	NULL	SENT95	16	16	2	2	paraformaldehyde	CD133	PA450790	8842	0.99
NULL	J_Hematol_Oncol_2013_Jul_9_6_49.nxml.txt.nlp	23837843	SENT213	31	31	16	16	verapamil	Rho	PA451868	29984	0.99
NULL	Diabetes_2011_Jun_21_60(6)_1770-1778.nxml.txt.nlp	21562078	SENT37	15	15	5	5	metformin	AMPK	PA450395	5563	0.99
NULL	Br_J_Cancer_2010_Oct_12_103(8)_1284-1291.nxml.txt.nlp	20859285	SENT107	21	21	11	11	tamoxifen	BCAR4	PA451581	400500	0.99
NULL	Ann_Hematol_2011_May_12_90(5)_557-568.nxml.txt.nlp	20938660	SENT132	13	13	33	33	plerixafor	CD34	PA165958410	947	0.99
NULL	Acta_Neuropathol_Commun_2014_Sep_25_2(1)_145.nxml.txt.nlp	NULL	SENT149	30	30	0	0	papain	E16	PA450778	8140	0.99
NULL	Case_Rep_Oncol_Med_2013_Dec_19_2013_208213.nxml.txt.nlp	24455357	SENT74	28	28	0	0	thyroglobulin	TTF-1	PA164754910	7080	0.99
NULL	Diabetes_Care_2013_Aug_17_36(Suppl_2)_S139-S144.nxml.txt.nlp	23882038	SENT84	12	12	1	1	exenatide	GLP-1	PA164749238	100125288	0.99
NULL	Ann_Indian_Acad_Neurol_2010_Apr-Jun_13(2)_136-138.nxml.txt.nlp	20814499	SENT58	10	10	20	20	azathioprine	CD4	PA448515	920	0.99
NULL	Breast_Cancer_Res_2008_Dec_18_10(Suppl_4)_S25.nxml.txt.nlp	19128439	SENT27	29	29	23	23	tamoxifen	aromatase	PA451581	1588	0.99
NULL	Antimicrob_Agents_Chemother_2014_Dec_58(12)_7340-7346.nxml.txt.nlp	25267661	SENT2	32	32	7	7	primaquine	ACT	PA451103	12;11332;9457;641455	0.99
NULL	J_Invest_Dermatol_2012_Nov_21_132(11)_2642-2651.nxml.txt.nlp	22718118	SENT52	29	29	2	2	collagenase	CD11b	PA449107	3684	0.99
NULL	Cancers_(Basel)_2011_Apr_1_3(2)_1844-1860.nxml.txt.nlp	24212785	SENT543	8	8	2	2	panitumumab	BRAF	PA162373091	673	0.99
NULL	Breast_Cancer_Res_2011_Nov_16_13(Suppl_2)_O11.nxml.txt.nlp	NULL	SENT6	5	5	22	22	trastuzumab	HER3	PA451743	2065	0.99
NULL	Mol_Cell_Proteomics_2014_Jun_2_13(6)_1495-1509.nxml.txt.nlp	24696502	SENT411	10	10	26	26	imatinib	DDR2	PA10804	4921	0.99
NULL	Iran_J_Pharm_Res_2014_Autumn_13(4)_1387-1392.nxml.txt.nlp	25587328	SENT79	17	17	9	9	chlorambucil	Mcl-1	PA448926	4170	0.99
NULL	Exp_Ther_Med_2013_Oct_20_6(4)_899-903.nxml.txt.nlp	24137286	SENT94	44	44	7	7	rosuvastatin	MMP9	PA134308647	4318	0.99
NULL	Ann_Med_Health_Sci_Res_2014_Jul-Aug_4(4)_466-471.nxml.txt.nlp	25221689	SENT112	3	3	6	6	piperaquine	CYP3A4	PA166104279	1576	0.99
NULL	Anticancer_Agents_Med_Chem_2012_Feb_12(2)_163-171.nxml.txt.nlp	22043994	SENT174	37	37	19	19	cetuximab	BRAF	PA10040	673	0.99
NULL	Br_J_Cancer_2012_Nov_6_107(10)_1745-1753.nxml.txt.nlp	23099808	SENT162	13	13	9	9	gefitinib	CEACAM6	PA131301952	4680	0.99
NULL	Br_J_Cancer_2003_Mar_24_88(6)_822-827.nxml.txt.nlp	12644816	SENT128	0	0	6	6	thalidomide	PSA	PA451644	29968;9520;354	0.99
NULL	Mol_Cancer_2009_Aug_25_8_66.nxml.txt.nlp	19706164	SENT78	21	21	10	10	celecoxib	p53	PA448871	7157	0.99
NULL	Br_J_Anaesth_2014_Jul_22_113(1)_157-167.nxml.txt.nlp	24154701	SENT20	5	5	21	21	sevoflurane	TREK-1	PA451341	3776	0.99
NULL	Nat_Med_2013_Dec_10_19(12)_10_1038_nm_3385.nxml.txt.nlp	24216752	SENT116	3	3	48	48	thrombin	PAR1	PA451674	79581;2149	0.99
NULL	Case_Rep_Oncol_2013_Aug_14_6(2)_430-433.nxml.txt.nlp	24019783	SENT9	4	4	16	16	crizotinib	Met	PA165946122	79811	0.99
NULL	Mol_Cell_Proteomics_2014_Jun_2_13(6)_1495-1509.nxml.txt.nlp	24696502	SENT411	8	8	26	26	dasatinib	DDR2	PA162372878	4921	0.99
NULL	J_Gastroenterol_2013_Feb_22_48(2)_222-237.nxml.txt.nlp	22722906	SENT270	32	32	7	7	ethanol	CYP3A4	PA448073	1576	0.99
NULL	Oncogenesis_2014_Dec_15_3(12)_e133.nxml.txt.nlp	25500906	SENT106	31	31	11	11	trastuzumab	HER2	PA451743	2064	0.99
NULL	Front_Oncol_2014_May_16_4_108.nxml.txt.nlp	24904824	SENT45	18	18	33	33	sirolimus	Mcl-1	PA451365	4170	0.99
NULL	Cancer_Imaging_2013_May_2_13(2)_197-211.nxml.txt.nlp	23649384	SENT97	29	29	10	10	imatinib	FDG	PA10804	23583	0.99
NULL	F1000_Biol_Rep_2012_Mar_1_4_5.nxml.txt.nlp	22403588	SENT74	5	5	18	18	ribavirin	IFN	PA451241	3439	0.99
NULL	Breast_Cancer_(Auckl)_2010_Feb_16_4_1-3.nxml.txt.nlp	20697527	SENT12	0	0	20	20	curcumin	FANCD2	PA151958596	2177	0.99
NULL	Br_J_Cancer_2009_Jan_13_100(1)_19-23.nxml.txt.nlp	19018262	SENT40	4	4	38	38	sorafenib	SHARP	PA7000	23013	0.99
NULL	Hum_Genomics_2010_Apr_1_4(4)_238-249.nxml.txt.nlp	20511137	SENT65	11	11	27	27	irinotecan	UGT1A1	PA450085	54658	0.99
NULL	Oncotarget_2012_Aug_31_3(9)_998-1010.nxml.txt.nlp	22948175	SENT100	10	10	43	43	camptothecin	ABCG2	PA153590860	9429	0.99
NULL	Clin_Med_Insights_Oncol_2012_Nov_20_6_381-393.nxml.txt.nlp	23226079	SENT137	4	4	15	15	sunitinib	CYP3A4	PA162372840	1576	0.99
NULL	Ann_Clin_Microbiol_Antimicrob_2009_Jun_24_8_22.nxml.txt.nlp	19552801	SENT171	3	3	31	31	linezolid	San	PA450233	80218	0.99
NULL	Biomed_Res_Int_2014_May_19_2014_456037.nxml.txt.nlp	24967371	SENT195	0	0	4	4	perifosine	AKT	PA165291471	207	0.99
NULL	Cases_J_2009_Jun_17_2_7246.nxml.txt.nlp	19829938	SENT58	33	33	8	8	iron	HFE	PA450087	3077	0.99
NULL	Ann_Oncol_2013_Aug_12_24(8)_1994-1999.nxml.txt.nlp	23670096	SENT130	45	45	14	14	tamoxifen	AIB1	PA451581	8202	0.99
NULL	J_Biol_Chem_2008_Nov_14_283(46)_31679-31689.nxml.txt.nlp	18755684	SENT320	12	12	3	3	iron	FTH1	PA450087	2495	0.99
NULL	Oncotarget_2011_Aug_30_2(8)_610-626.nxml.txt.nlp	21881167	SENT183	21	21	34	34	doxorubicin	Raf-1	PA449412	5894	0.99
NULL	Br_J_Cancer_2014_Jan_7_110(1)_55-62.nxml.txt.nlp	24263064	SENT17	1	1	11	11	gefitinib	EGFR	PA131301952	1956	0.99
NULL	Cancer_Res_Treat_2013_Sep_30_45(3)_178-185.nxml.txt.nlp	24155676	SENT115	26	26	36	36	gefitinib	EGFR	PA131301952	1956	0.99
NULL	Crit_Care_2008_Nov_26_12(Suppl_6)_S3.nxml.txt.nlp	19105796	SENT120	0	0	13	13	thrombin	PAR1	PA451674	79581;2149	0.99
NULL	Arthritis_Res_Ther_2012_Mar_30_14(2)_206.nxml.txt.nlp	22494482	SENT100	16	16	4	4	naloxone	PAG	PA450586	55824	0.99
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1117-1122.nxml.txt.nlp	22361631	SENT165	23	23	6	6	phenformin	AMPK	PA1000	5563	0.99
NULL	Cancer_Metastasis_Rev_2010_Dec_10_29(4)_581-594.nxml.txt.nlp	20830503	SENT71	18	18	31	31	exemestane	aromatase	PA449563	1588	0.99
NULL	Clin_Pharmacol_2013_Dec_9_5_185-192.nxml.txt.nlp	24353446	SENT94	34	34	17	17	clopidogrel	ARNT	PA449053	405	0.99
NULL	J_Gastrointest_Cancer_2014_May_7_45(3)_262-267.nxml.txt.nlp	24802226	SENT121	30	30	22	22	imatinib	PDGFRA	PA10804	5156	0.99
NULL	Diabetes_2009_Jan_58(1)_174-184.nxml.txt.nlp	18984736	SENT376	36	36	4	4	nifedipine	TRPV2	PA450631	51393	0.99
NULL	Mol_Cancer_2013_Mar_5_12_17.nxml.txt.nlp	23497256	SENT218	4	4	19	19	sunitinib	STAT3	PA162372840	6774	0.99
NULL	Oncol_Lett_2013_Mar_28_5(3)_935-942.nxml.txt.nlp	23426424	SENT114	15	15	3	3	cisplatin	ERCC1	PA449014	2067	0.99
NULL	Breast_Cancer_Res_2011_Feb_23_13(1)_203.nxml.txt.nlp	21392408	SENT95	9	9	41	41	anastrozole	aromatase	PA448432	1588	0.99
NULL	Cancer_Biol_Med_2012_Mar_9(1)_18-22.nxml.txt.nlp	23691449	SENT84	4	4	20	20	erlotinib	PTEN	PA134687924	5728	0.99
NULL	Mol_Vis_2012_Jan_11_18_55-63.nxml.txt.nlp	22259224	SENT102	0	0	25	25	losartan	TGFBR2	PA450268	7048	0.99
NULL	J_Clin_Biochem_Nutr_2007_Jan_27_40(1)_13-23.nxml.txt.nlp	18437209	SENT142	22	22	8	8	trypsin	PAR3	PA451806	56288;2151	0.99
NULL	Nat_Commun_2014_Mar_17_5_3480.nxml.txt.nlp	24633012	SENT130	4	4	28	28	cisplatin	PFKFB3	PA449014	5209	0.99
NULL	Breast_Cancer_Res_2004_Oct_6_6(6)_269-274.nxml.txt.nlp	15535858	SENT54	30	30	48	48	letrozole	HER2	PA450196	2064	0.99
NULL	Eur_J_Clin_Pharmacol_2010_Nov_29_66(11)_1131-1136.nxml.txt.nlp	20669013	SENT130	12	12	34	34	erythromycin	CYP3A4	PA449493	1576	0.99
NULL	Nat_Chem_Biol_2010_Apr_28_6(4)_291-299.nxml.txt.nlp	20190765	SENT138	33	33	11	11	dasatinib	EGFR	PA162372878	1956	0.99
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT188	23	23	9	9	cisplatin	p53	PA449014	7157	0.99
NULL	Pharmaceuticals_(Basel)_2013_Aug_6_6(8)_929-959.nxml.txt.nlp	24276377	SENT176	0	0	18	18	curcumin	JNK	PA151958596	5599	0.99
NULL	Breast_Cancer_Res_2010_Jun_28_12(3)_R43.nxml.txt.nlp	20579400	SENT116	43	43	5	5	vinorelbine	MAPT	PA451881	4137	0.99
NULL	Exp_Ther_Med_2014_Nov_29_8(5)_1473-1478.nxml.txt.nlp	25289044	SENT140	5	5	17	17	heparin	AZU	PA449855	566	0.99
NULL	Exp_Diabetes_Res_2012_May_14_2012_470851.nxml.txt.nlp	22666230	SENT45	0	0	6	6	exenatide	GLP-1	PA164749238	100125288	0.99
NULL	Crit_Care_2011_Aug_11_15(4)_226.nxml.txt.nlp	21892977	SENT58	28	28	1	1	vasopressin	P2X5	PA451858	5026	0.99
NULL	Cancer_Metastasis_Rev_2013_Jun_6_32(1-2)_179-188.nxml.txt.nlp	23129208	SENT162	24	24	3	3	trastuzumab	HER2	PA451743	2064	0.99
NULL	Br_J_Cancer_2013_Dec_10_109(12)_3067-3072.nxml.txt.nlp	24263065	SENT33	32	32	11	11	irinotecan	BRAF	PA450085	673	0.99
NULL	Clin_Pharmacokinet_2014_Sep_3_53(1)_1-16.nxml.txt.nlp	23999929	SENT338	3	3	27	27	dabigatran	CLCR		11330	0.99
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT314	5	5	19	19	cetuximab	KRAS	PA10040	3845	0.99
NULL	EMBO_Mol_Med_2013_Aug_8_5(8)_1227-1246.nxml.txt.nlp	23836498	SENT83	22	22	11	11	2-methoxyestradiol	HIF-1	PA134967247	29072	0.99
NULL	Oncoimmunology_2014_Apr_25_3_e28518.nxml.txt.nlp	25071979	SENT119	32	32	24	24	carboplatin	CRT	PA448803	811	0.99
NULL	BMB_Rep_2014_May_47(5)_274-279.nxml.txt.nlp	24286313	SENT20	28	28	8	8	bortezomib	PSMB5	PA10252	5693	0.99
NULL	Front_Immunol_2012_Mar_21_3_57.nxml.txt.nlp	22566938	SENT53	5	5	12	12	vasopressin	IRAP	PA451858	3557	0.99
NULL	Breast_Cancer_Res_2012_Jul_19_14(4)_R108.nxml.txt.nlp	22812534	SENT338	19	19	6	6	pargyline	aromatase	PA450797	1588	0.99
NULL	Acta_Pharmacol_Sin_2012_Mar_27_33(3)_342-350.nxml.txt.nlp	22367283	SENT193	35	35	16	16	trypsin	PAR3	PA451806	56288;2151	0.99
NULL	Daru_2012_Nov_28_20(1)_81.nxml.txt.nlp	23351280	SENT338	16	16	0	0	atropine	MARK	PA448505	4139	0.99
NULL	Chemother_Res_Pract_2011_Nov_2_2011_878912.nxml.txt.nlp	22295207	SENT153	22	22	3	3	temozolomide	TSP-1	PA451609	7057	0.99
NULL	Mol_Cancer_2010_Apr_29_9_95.nxml.txt.nlp	20429933	SENT25	10	10	37	37	camptothecin	AMPK	PA153590860	5563	0.99
NULL	Biologics_2012_Jul_13_6_221-231.nxml.txt.nlp	22904614	SENT72	0	0	17	17	cetuximab	EGFR	PA10040	1956	0.99
NULL	Evid_Based_Complement_Alternat_Med_2015_Jan_6_2015_802903.nxml.txt.nlp	25632291	SENT111	4	4	31	31	berberine	CYP2D6	PA165860812	1565	0.99
NULL	Basic_Clin_Pharmacol_Toxicol_2013_Feb_5_112(2)_132-137.nxml.txt.nlp	22900583	SENT25	8	8	13	13	prasugrel	CYP3A	PA154410481	1574	0.99
NULL	Front_Genet_2013_Aug_29_4_163.nxml.txt.nlp	24009622	SENT34	6	6	32	32	ethanol	DDP	PA448073	1678	0.99
NULL	Cancer_Manag_Res_2011_May_10_3_157-175.nxml.txt.nlp	21625399	SENT136	5	5	32	32	midazolam	CYP2C9	PA450496	1559	0.99
NULL	Crit_Care_2012_Nov_14_16(Suppl_3)_P98.nxml.txt.nlp	NULL	SENT5	17	17	4	4	vancomycin	NGAL	PA451850	3934	0.99
NULL	Indian_J_Ophthalmol_2013_Sep_61(9)_475-478.nxml.txt.nlp	24104704	SENT17	0	0	19	19	ranibizumab	VEGF-A	PA164746012	7422	0.99
NULL	Arthritis_Res_Ther_2012_Dec_3_14(6)_R262.nxml.txt.nlp	23206933	SENT82	3	3	13	13	tocilizumab	IL-6	PA165292659	3569	0.99
NULL	Mediators_Inflamm_1998_7(6)_391-396.nxml.txt.nlp	9927231	SENT4	35	35	5	5	forskolin	GM-CSF	PA146096022	1437	0.99
NULL	Breast_Cancer_Res_2014_May_5_16(3)_R45.nxml.txt.nlp	24887236	SENT289	8	8	32	32	lapatinib	HER2	PA152241907	2064	0.99
NULL	Ann_Rehabil_Med_2012_Aug_27_36(4)_466-473.nxml.txt.nlp	22977771	SENT22	6	6	22	22	hyaluronidase	ILEI	PA164745713	10447	0.99
NULL	J_Inflamm_(Lond)_2008_Jul_29_5_11.nxml.txt.nlp	18664275	SENT79	19	19	8	8	ciprofloxacin	IL-8	PA449009	3576	0.99
NULL	Chemother_Res_Pract_2012_Aug_29_2012_817297.nxml.txt.nlp	22970367	SENT168	36	36	13	13	gefitinib	EGFR	PA131301952	1956	0.99
NULL	ACS_Med_Chem_Lett_2011_May_16_2(7)_549-554.nxml.txt.nlp	21765967	SENT53	41	41	5	5	maraviroc	CCR5	PA164768835	1234	0.99
NULL	Leukemia_2013_Feb_10_27(2)_507-510.nxml.txt.nlp	22810506	SENT21	30	30	0	0	fludarabine	TRAC	PA449655	28755	0.99
NULL	Case_Rep_Hematol_2013_Sep_16_2013_490740.nxml.txt.nlp	24109527	SENT53	35	35	25	25	imatinib	ABL1	PA10804	25	0.99
NULL	Acta_Pharmacol_Sin_2012_Mar_27_33(3)_342-350.nxml.txt.nlp	22367283	SENT193	35	35	12	12	trypsin	PAR1	PA451806	79581;2149	0.99
NULL	Mol_Cell_Proteomics_2014_May_20_13(5)_1184-1197.nxml.txt.nlp	24556848	SENT307	42	42	9	9	pp2	MST3		8428	0.99
NULL	EMBO_Mol_Med_2014_Oct_17_6(10)_1294-1311.nxml.txt.nlp	25231413	SENT144	9	9	2	2	calcein	CD4	PA132595336	920	0.99
NULL	Mol_Cancer_2009_Nov_13_8_101.nxml.txt.nlp	19912650	SENT196	20	20	1	1	doxorubicin	c-FLIP	PA449412	8837	0.99
NULL	Multidiscip_Respir_Med_2012_Aug_29_7(1)_26.nxml.txt.nlp	22958272	SENT84	5	5	12	12	paroxetine	CYP2D6	PA450801	1565	0.99
NULL	Drugs_Context_2012_Dec_11_2012_212244.nxml.txt.nlp	24432033	SENT41	38	38	6	6	gemcitabine	EGFR	PA449748	1956	0.99
NULL	Cancer_Cell_Int_2009_Sep_10_9_25.nxml.txt.nlp	19744341	SENT180	28	28	8	8	glucosamine	STAT3	PA164747613	6774	0.99
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT119	14	14	46	46	dasatinib	ABCB1	PA162372878	5243	0.99
NULL	J_Cell_Biol_2004_Jun_7_165(5)_653-662.nxml.txt.nlp	15173192	SENT178	5	5	35	35	amiloride	GAD1	PA448368	2571	0.99
NULL	Acta_Pharmacol_Sin_2012_Jan_28_33(1)_75-81.nxml.txt.nlp	22120969	SENT88	0	0	4	4	exenatide	GLP-1	PA164749238	100125288	0.99
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT373	2	2	7	7	aripiprazole	PRL	PA10026	5617	0.99
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_11_2014_274786.nxml.txt.nlp	25505920	SENT527	7	7	0	0	oxaliplatin	ERCC1	PA131285527	2067	0.99
NULL	Cancer_Med_2013_Dec_31_2(6)_826-835.nxml.txt.nlp	24403256	SENT199	0	0	24	24	nutlin-3	HDM2		4193	0.99
NULL	Clin_Med_Insights_Oncol_2011_May_10_5_131-144.nxml.txt.nlp	21695100	SENT113	5	5	34	34	vinorelbine	EGFR	PA451881	1956	0.99
NULL	Oncol_Rep_2014_Feb_13_31(2)_581-588.nxml.txt.nlp	24337105	SENT202	22	22	0	0	capsaicin	Bcl-2	PA448776	596	0.99
NULL	Front_Neurosci_2010_Mar_19_4_22.nxml.txt.nlp	20582262	SENT195	16	16	27	27	mecamylamine	P2X3	PA450334	5024	0.99
NULL	Virol_J_2011_Sep_22_8_447.nxml.txt.nlp	21939525	SENT182	7	7	26	26	trypsin	CO2	PA451806	4513	0.99
NULL	Indian_J_Med_Res_2011_Dec_134(6)_787-800.nxml.txt.nlp	22310814	SENT33	0	0	33	33	efavirenz	CD4	PA449441	920	0.99
NULL	Infect_Dis_Ther_2013_Dec_2_2(2)_123-144.nxml.txt.nlp	25134476	SENT267	30	30	0	0	clozapine	DIP	PA449061	23151;1831	0.99
NULL	Clin_Mol_Allergy_2007_Jan_25_5_1.nxml.txt.nlp	17254346	SENT139	17	17	2	2	curcumin	IL-4	PA151958596	3565	0.99
NULL	Front_Immunol_2013_Nov_7_4_360.nxml.txt.nlp	24223576	SENT248	30	30	4	4	etoposide	p53	PA449552	7157	0.99
NULL	Mol_Imaging_Radionucl_Ther_2011_Dec_1_20(3)_114-116.nxml.txt.nlp	23486704	SENT7	23	23	5	5	metformin	FDG	PA450395	23583	0.99
NULL	J_Korean_Med_Sci_2006_Jun_21_21(3)_418-424.nxml.txt.nlp	16778382	SENT12	9	9	1	1	hemin	HO-1	PA449849	3162	0.99
NULL	Indian_Dermatol_Online_J_2014_Jul-Sep_5(3)_250-259.nxml.txt.nlp	25165639	SENT136	40	40	24	24	rituximab	CD4	PA451261	920	0.99
NULL	Mol_Biol_Cell_2012_Sep_1_23(17)_3473-3484.nxml.txt.nlp	22787275	SENT219	12	12	5	5	doxorubicin	ABCC1	PA449412	4363	0.99
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT639	4	4	20	20	phenobarbital	CAR	PA450911	1525;6687;9970	0.99
NULL	Cancer_Microenviron_2009_Jul_11_2(Suppl_1)_227-237.nxml.txt.nlp	19593676	SENT131	30	30	1	1	pioglitazone	PPARgamma	PA450970	5468	0.99
NULL	Br_J_Cancer_2012_Sep_25_107(7)_1059-1068.nxml.txt.nlp	22935581	SENT74	27	27	8	8	sunitinib	IFN	PA162372840	3439	0.99
NULL	Br_J_Cancer_2012_Nov_6_107(10)_1745-1753.nxml.txt.nlp	23099808	SENT24	0	0	14	14	erlotinib	EGFR	PA134687924	1956	0.99
NULL	Br_J_Cancer_2012_Sep_4_107(6)_977-987.nxml.txt.nlp	22892389	SENT93	20	20	7	7	orlistat	VEGFA	PA164776864	7422	0.99
NULL	BMB_Rep_2014_Mar_47(3)_167-172.nxml.txt.nlp	24499665	SENT86	0	0	14	14	nutlin-3	MDM2		4193	0.99
NULL	Arch_Toxicol_2014_Nov_5_88(12)_2135-2190.nxml.txt.nlp	25370008	SENT1064	6	6	32	32	minoxidil	SULT	PA450521	6816	0.99
NULL	Arch_Med_Sci_2011_Oct_8_7(5)_864-869.nxml.txt.nlp	22291833	SENT32	19	19	1	1	debrisoquine	CYP2D6	PA452616	1565	0.99
NULL	Clin_Med_Insights_Oncol_2013_Jul_4_7_159-163.nxml.txt.nlp	23885182	SENT88	17	17	29	29	rituximab	CHOP	PA451261	1649	0.99
NULL	J_Immunol_Res_2014_May_25_2014_608930.nxml.txt.nlp	24971371	SENT88	7	7	39	39	pranlukast	IL-8	PA134698661	3576	0.99
NULL	J_Thromb_Thrombolysis_2011_Nov_26_32(4)_459-466.nxml.txt.nlp	21706290	SENT99	31	31	14	14	prasugrel	CYP2C19	PA154410481	1557	0.99
NULL	Front_Genet_2014_Oct_14_5_314.nxml.txt.nlp	25352860	SENT115	17	17	3	3	napqi	CYP1A2		1544	0.99
NULL	J_Cancer_2014_Jan_5_5(2)_86-97.nxml.txt.nlp	24494026	SENT94	5	5	27	27	cisplatin	EGFR	PA449014	1956	0.99
NULL	Breast_Cancer_Res_2005_Jun_17_7(Suppl_2)_S_09.nxml.txt.nlp	NULL	SENT16	20	20	2	2	tamoxifen	aromatase	PA451581	1588	0.99
NULL	Drug_Healthc_Patient_Saf_2012_Nov_29_4_173-180.nxml.txt.nlp	23236256	SENT66	8	8	48	48	quetiapine	FGA	PA451201	2243	0.99
NULL	J_Cell_Mol_Med_2013_Sep_24_17(9)_1065-1087.nxml.txt.nlp	24151975	SENT246	32	32	0	0	palifermin	IL7	PA164744014	3574	0.99
NULL	Onco_Targets_Ther_2014_May_28_7_841-852.nxml.txt.nlp	24920926	SENT149	3	3	20	20	gefitinib	EGFR	PA131301952	1956	0.99
NULL	Aging_(Albany_NY)_2013_Feb_21_5(2)_94-95.nxml.txt.nlp	23518473	SENT14	4	4	23	23	resveratrol	SIRT1		23411	0.99
NULL	Core_Evid_2010_Oct_21_5_23-37.nxml.txt.nlp	21042540	SENT165	1	1	19	19	saxagliptin	P-gp	PA165958362	5243	0.99
NULL	Korean_Circ_J_2013_Aug_31_43(8)_541-549.nxml.txt.nlp	24044013	SENT80	41	41	10	10	clopidogrel	CYP2C19	PA449053	1557	0.99
NULL	Br_J_Cancer_2013_Aug_6_109(3)_686-693.nxml.txt.nlp	23839492	SENT23	31	31	21	21	pazopanib	IL-8	PA165291492	3576	0.99
NULL	Oncogene_2014_Jun_5_33(23)_3004-3013.nxml.txt.nlp	23831571	SENT30	7	7	27	27	etoposide	RIP1	PA449552	10928;7386	0.99
NULL	J_Cell_Mol_Med_2013_May_12_17(5)_636-647.nxml.txt.nlp	23577651	SENT160	43	43	33	33	sirolimus	raptor	PA451365	57521	0.99
NULL	Eur_J_Endocrinol_2009_Nov_161(5)_655-662.nxml.txt.nlp	19729432	SENT28	24	24	0	0	metformin	AMPK	PA450395	5563	0.99
NULL	Arthritis_Res_Ther_2006_Jul_21_8(4)_R130.nxml.txt.nlp	16859540	SENT114	40	40	29	29	atorvastatin	CD59	PA448500	966	0.99
NULL	Ann_Dermatol_2011_Nov_3_23(4)_526-528.nxml.txt.nlp	22148027	SENT14	0	0	15	15	erlotinib	EGFR	PA134687924	1956	0.99
NULL	Diabetes_Metab_J_2013_Dec_12_37(6)_415-422.nxml.txt.nlp	24404512	SENT65	2	2	44	44	pravastatin	adiponectin	PA451089	9370	0.99
NULL	Eur_J_Med_Res_2010_Aug_20_15(8)_337-344.nxml.txt.nlp	20947470	SENT114	6	6	29	29	methotrexate	BLM	PA450428	641	0.99
NULL	Oncol_Lett_2014_Jan_5_7(1)_171-176.nxml.txt.nlp	24348843	SENT96	6	6	14	14	everolimus	EGFR	PA164746311	1956	0.99
NULL	Nat_Chem_Biol_2010_Apr_28_6(4)_291-299.nxml.txt.nlp	20190765	SENT189	30	30	21	21	dasatinib	EGFR	PA162372878	1956	0.99
NULL	FEBS_Open_Bio_2012_Jul_20_2_179-186.nxml.txt.nlp	23650597	SENT141	17	17	30	30	imiquimod	MxA	PA449972	4599	0.99
NULL	Front_Mol_Neurosci_2012_Nov_12_5_99.nxml.txt.nlp	23162427	SENT278	18	18	0	0	cocaine	HDAC	PA449072	9734	0.99
NULL	Acta_Pharmacol_Sin_2010_Mar_22_31(3)_329-340.nxml.txt.nlp	20173759	SENT232	24	24	5	5	ethanol	AMPK	PA448073	5563	0.99
NULL	Mol_Cancer_2009_Jul_3_8_43.nxml.txt.nlp	19575780	SENT8	22	22	2	2	paclitaxel	survivin	PA450761	332	0.99
NULL	Ann_Oncol_2011_Mar_8_22(3)_503-514.nxml.txt.nlp	20616198	SENT118	18	18	9	9	tamoxifen	aromatase	PA451581	1588	0.99
NULL	Front_Oncol_2014_Sep_15_4_244.nxml.txt.nlp	25309870	SENT111	4	4	26	26	afatinib	EGFR	PA165981154	1956	0.99
NULL	Indian_J_Endocrinol_Metab_2011_Oct-Dec_15(4)_251-260.nxml.txt.nlp	22028995	SENT72	4	4	19	19	amprenavir	CYP3A	PA448422	1574	0.99
NULL	Br_J_Cancer_2012_Oct_9_107(8)_1277-1285.nxml.txt.nlp	22990652	SENT164	38	38	5	5	axitinib	CYP2C8	PA164924493	1558	0.99
NULL	Curr_Oncol_2007_Dec_14(Suppl_1)_S11-S19.nxml.txt.nlp	18087604	SENT3	29	29	14	14	tamoxifen	aromatase	PA451581	1588	0.99
NULL	Cardiovasc_Diabetol_2013_May_30_12(Suppl_1)_S2.nxml.txt.nlp	23819752	SENT129	14	14	31	31	rosuvastatin	CYP3A4	PA134308647	1576	0.99
NULL	J_Korean_Med_Sci_2001_Oct_16(5)_677-682.nxml.txt.nlp	11641544	SENT18	2	2	23	23	vasopressin	AVP	PA451858	114548;551	0.99
NULL	Crit_Care_2007_Sep_19_11(5)_229.nxml.txt.nlp	17903310	SENT72	41	41	1	1	ethanol	HMGB1	PA448073	3146	0.99
NULL	Front_Oncol_2013_Nov_15_3_281.nxml.txt.nlp	24298448	SENT187	11	11	5	5	panitumumab	BRAF	PA162373091	673	0.99
NULL	Stroke_Res_Treat_2011_Nov_10_2011_212485.nxml.txt.nlp	22135769	SENT141	0	0	15	15	clopidogrel	ADP	PA449053	23038	0.99
NULL	Clin_Pract_2011_Nov_2_1(4)_e83.nxml.txt.nlp	24765383	SENT190	0	0	6	6	metoclopramide	CYP2D6	PA450475	1565	0.99
NULL	Breast_Cancer_Res_2004_Oct_24_6(1)_R8-R17.nxml.txt.nlp	14680495	SENT181	9	9	37	37	tamoxifen	BRCA2	PA451581	675	0.99
NULL	Front_Genet_2014_Nov_14_5_391.nxml.txt.nlp	25452763	SENT54	40	40	25	25	cisplatin	ERCC1	PA449014	2067	0.99
NULL	Cell_Death_Differ_2010_Oct_30_17(10)_1624-1635.nxml.txt.nlp	20431602	SENT354	17	17	3	3	paclitaxel	Bcl-2	PA450761	596	0.99
NULL	F1000Res_2014_Aug_19_3_198.nxml.txt.nlp	25400908	SENT203	7	7	12	12	pertuzumab	HER2		2064	0.99
NULL	Infect_Drug_Resist_2010_Oct_13_3_103-114.nxml.txt.nlp	21694899	SENT3	0	0	27	27	raltegravir	TRIO		7204	0.99
NULL	Oncotarget_2011_Sep_9_2(9)_658-668.nxml.txt.nlp	21911919	SENT61	7	7	29	29	daunorubicin	HO-1	PA449212	3162	0.99
NULL	Hum_Genomics_2008_Sep_1_3(1)_7-16.nxml.txt.nlp	19129086	SENT149	2	2	25	25	rosiglitazone	CYP2C8	PA451283	1558	0.99
NULL	Cell_Res_2014_Feb_12_24(2)_143-160.nxml.txt.nlp	24217768	SENT67	29	29	4	4	heparin	FGF2	PA449855	2247;2258	0.99
NULL	Mol_Cancer_2008_Jun_5_7_50.nxml.txt.nlp	18534018	SENT72	26	26	0	0	bortezomib	Mcl-1	PA10252	4170	0.99
NULL	Mol_Cancer_2014_Jun_5_13_143.nxml.txt.nlp	24898067	SENT37	28	28	35	35	trastuzumab	HER-2	PA451743	2064	0.99
NULL	Adipocyte_2012_Jul_1_1(3)_123-131.nxml.txt.nlp	23145367	SENT24	30	30	5	5	lipase	CGI-58	PA450239	51099	0.99
NULL	Br_J_Ophthalmol_2014_Jun_98(Suppl_1)_i11-i16.nxml.txt.nlp	24836865	SENT21	2	2	14	14	bevacizumab	VEGF-A	PA130232992	7422	0.99
NULL	Oncologist_2010_Mar_3_15(3)_216-235.nxml.txt.nlp	20200040	SENT109	24	24	2	2	trastuzumab	HER-2	PA451743	2064	0.99
NULL	Eur_J_Med_Chem_2014_Dec_17_88_89-100.nxml.txt.nlp	25159123	SENT255	10	10	26	26	entacapone	PRL	PA164748726	5617	0.99
NULL	Cell_Death_Dis_2012_Jun_21_3(6)_e327.nxml.txt.nlp	22717582	SENT206	28	28	21	21	doxorubicin	p53	PA449412	7157	0.99
NULL	Semin_Immunol_2011_Feb_23(1)_28-41.nxml.txt.nlp	21295490	SENT233	0	0	17	17	etanercept	IL-20	PA449515	27190;50604	0.99
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT290	0	0	6	6	metformin	AMPK	PA450395	5563	0.99
NULL	Br_J_Pharmacol_2013_Apr_25_168(8)_1868-1877.nxml.txt.nlp	23194305	SENT213	4	4	47	47	bortezomib	ALDH2	PA10252	217	0.99
NULL	J_Young_Pharm_2011_Oct-Dec_3(4)_259-266.nxml.txt.nlp	22224031	SENT146	33	33	1	1	cephalexin	ANOVA	PA448883	4858	0.99
NULL	Nat_Chem_Biol_2010_Apr_28_6(4)_291-299.nxml.txt.nlp	20190765	SENT280	29	29	13	13	dasatinib	EGFR	PA162372878	1956	0.99
NULL	Br_J_Cancer_2009_Sep_15_101(6)_957-966.nxml.txt.nlp	19738618	SENT170	25	25	4	4	dexrazoxane	THBS-1	PA449259	7057	0.99
NULL	Osteoporos_Int_2010_Oct_18_21(10)_1657-1680.nxml.txt.nlp	20480148	SENT159	23	23	2	2	tamoxifen	STAR	PA451581	6770;2984	0.99
NULL	BMB_Rep_2014_Feb_47(2)_60-68.nxml.txt.nlp	24411465	SENT135	0	0	10	10	ustekinumab	p40	PA166048654	3921;339541;10314	0.99
NULL	Int_J_Med_Sci_2012_Jul_25_9(6)_435-440.nxml.txt.nlp	22859903	SENT68	6	6	18	18	sevoflurane	CO2	PA451341	4513	0.99
NULL	J_Korean_Med_Sci_2011_Dec_29_26(12)_1563-1568.nxml.txt.nlp	22147992	SENT21	0	0	15	15	sorafenib	VEGFR	PA7000	3791	0.99
NULL	Oncol_Lett_2014_Jan_29_7(1)_121-124.nxml.txt.nlp	24348832	SENT106	21	21	26	26	cisplatin	p53	PA449014	7157	0.99
NULL	Mol_Cancer_2010_Mar_2_9_47.nxml.txt.nlp	20196847	SENT175	16	16	10	10	paclitaxel	SFN	PA450761	25996;2810	0.99
NULL	J_Inflamm_(Lond)_2008_Jul_29_5_11.nxml.txt.nlp	18664275	SENT128	36	36	17	17	erythromycin	IL-8	PA449493	3576	0.99
NULL	Cancer_Cell_Int_2013_Feb_12_13_14.nxml.txt.nlp	23402310	SENT152	16	16	10	10	celecoxib	p27	PA448871	5715;10534	0.99
NULL	Clin_Ophthalmol_2008_Jun_2(2)_355-368.nxml.txt.nlp	19668727	SENT82	27	27	9	9	nepafenac	COX	PA165958407	1351	0.99
NULL	EMBO_Mol_Med_2013_Jun_30_5(6)_935-948.nxml.txt.nlp	23629957	SENT73	17	17	4	4	cisplatin	COL6A3	PA449014	1293	0.99
NULL	Oncol_Rep_2012_Oct_13_28(4)_1146-1152.nxml.txt.nlp	22797812	SENT52	25	25	42	42	irinotecan	WRN	PA450085	7486	0.99
NULL	Cell_Death_Dis_2010_Nov_18_1(11)_e102.nxml.txt.nlp	21368867	SENT148	14	14	26	26	gentamicin	CLIMP-63	PA449753	10970	0.99
NULL	Oncol_Lett_2013_Sep_8_6(3)_789-794.nxml.txt.nlp	24137412	SENT144	4	4	26	26	cisplatin	survivin	PA449014	332	0.99
NULL	Int_J_Mol_Sci_2014_Mar_12_15(3)_4356-4392.nxml.txt.nlp	24625663	SENT121	20	20	4	4	paclitaxel	CERT	PA450761	10087	0.99
NULL	Int_J_Breast_Cancer_2012_Nov_9_2012_716564.nxml.txt.nlp	22295250	SENT105	14	14	0	0	bicalutamide	TLR9	PA164746255	54106	0.99
NULL	Mol_Brain_2014_Apr_5_7_27.nxml.txt.nlp	24708859	SENT231	9	9	18	18	capsaicin	CA1	PA448776	759	0.99
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1150.nxml.txt.nlp	24675468	SENT170	15	15	6	6	ethanol	G17	PA448073	5089;10991	0.99
NULL	Clin_Med_Insights_Oncol_2013_Aug_21_7_221-234.nxml.txt.nlp	24179413	SENT140	22	22	46	46	erlotinib	EGFR	PA134687924	1956	0.99
NULL	Oncol_Lett_2013_Mar_8_5(3)_805-812.nxml.txt.nlp	23426281	SENT197	21	21	42	42	gemcitabine	survivin	PA449748	332	0.99
NULL	J_Cell_Biol_2005_May_23_169(4)_657-667.nxml.txt.nlp	15911880	SENT82	28	28	6	6	pp2	EGF		1950	0.99
NULL	Arthritis_Res_Ther_2012_Apr_18_14(2)_R80.nxml.txt.nlp	22513098	SENT155	10	10	1	1	hydroxychloroquine	TLR7	PA164777036	51284	0.99
NULL	Front_Oncol_2013_Aug_5_3_195.nxml.txt.nlp	23936763	SENT207	37	37	13	13	erlotinib	EGF	PA134687924	1950	0.99
NULL	Exp_Diabetes_Res_2012_Apr_17_2012_635472.nxml.txt.nlp	22577369	SENT75	22	22	2	2	liraglutide	GLP-1	PA165958364	100125288	0.99
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT217	0	0	19	19	curcumin	CD31	PA151958596	5175	0.99
NULL	Mol_Cancer_2010_Mar_25_9_68.nxml.txt.nlp	20338046	SENT16	23	23	0	0	doxorubicin	FOXC1	PA449412	2296	0.99
NULL	Acta_Crystallogr_Sect_F_Struct_Biol_Cryst_Commun_2009_Sep_25_65(Pt_10)_1030-1034.nxml.txt.nlp	19851015	SENT26	28	28	18	18	fluorouracil	p53	PA128406956	7157	0.99
NULL	Breast_Cancer_Res_2007_Jun_4_9(3)_207.nxml.txt.nlp	17561991	SENT180	0	0	21	21	lapatinib	HER-2	PA152241907	2064	0.99
NULL	Mol_Cancer_2010_Aug_20_9_220.nxml.txt.nlp	20727180	SENT142	8	8	23	23	nicotine	p53	PA450626	7157	0.99
NULL	Diabetes_Metab_Syndr_Obes_2010_Dec_6_3_421-429.nxml.txt.nlp	21437112	SENT43	9	9	17	17	curcumin	STZ	PA151958596	6484	0.99
NULL	Chin_J_Cancer_2011_May_30(5)_327-335.nxml.txt.nlp	21527065	SENT179	12	12	3	3	trastuzumab	PIK3CA	PA451743	5290	0.99
NULL	Patient_Prefer_Adherence_2014_Apr_8_8_463-471.nxml.txt.nlp	24748775	SENT135	23	23	1	1	denosumab	RANK	PA166048634	8792	0.99
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2009_Sep_1_65(Pt_9)_913-920.nxml.txt.nlp	19690369	SENT65	2	2	19	19	trypsin	p53	PA451806	7157	0.99
NULL	Cancer_Med_2012_Oct_1_1(2)_114-127.nxml.txt.nlp	23342262	SENT280	3	3	38	38	sirolimus	AKT	PA451365	207	0.99
NULL	Ann_Surg_Oncol_2010_Apr_20_17(4)_1168-1176.nxml.txt.nlp	19936839	SENT208	8	8	2	2	panitumumab	BRAF	PA162373091	673	0.99
NULL	Cell_Death_Dis_2012_Mar_15_3(3)_e283.nxml.txt.nlp	22419112	SENT45	26	26	6	6	doxorubicin	p33ING1	PA449412	3621	0.99
NULL	Neural_Dev_2011_Feb_1_6_4.nxml.txt.nlp	21284844	SENT325	15	15	20	20	bumetanide	NKCC1	PA448682	6558	0.99
NULL	Cell_Cycle_2012_Nov_1_11(21)_3983-3996.nxml.txt.nlp	22987153	SENT110	6	6	19	19	cisplatin	RAD51	PA449014	5888	0.99
NULL	Pharm_Methods_2011_Jan-Mar_2(1)_3-8.nxml.txt.nlp	23781422	SENT142	30	30	10	10	morphine	TLC	PA450550	3933	0.99
NULL	EJNMMI_Res_2011_Jul_29_1_12.nxml.txt.nlp	22214199	SENT183	29	29	11	11	cyclosporine	P-gp	PA449167	5243	0.99
NULL	Case_Rep_Oncol_2011_Jun_20_6(2)_325-330.nxml.txt.nlp	23898269	SENT4	16	16	1	1	docetaxel	CYP17A1	PA449383	1586	0.99
NULL	J_Biol_Chem_2009_Sep_25_284(39)_26447-26455.nxml.txt.nlp	19633293	SENT17	0	0	38	38	hyaluronan	TSHR	PA165958431	7253	0.99
NULL	Br_J_Pharmacol_2008_Oct_18_155(4)_596-605.nxml.txt.nlp	18852694	SENT163	12	12	17	17	fenofibrate	PI3K	PA449594	5290	0.99
NULL	Cancer_Biol_Med_2012_Mar_9(1)_18-22.nxml.txt.nlp	23691449	SENT84	4	4	28	28	erlotinib	PTEN	PA134687924	5728	0.99
NULL	Mol_Cancer_2008_Jan_10_7_4.nxml.txt.nlp	18186929	SENT127	21	21	8	8	trastuzumab	HER-2	PA451743	2064	0.99
NULL	Int_J_Breast_Cancer_2011_Sep_6_2011_352182.nxml.txt.nlp	22295219	SENT4	0	0	8	8	trastuzumab	HER2	PA451743	2064	0.99
NULL	Allergy_Asthma_Clin_Immunol_2010_Mar_17_6(1)_5.nxml.txt.nlp	20236545	SENT79	10	10	28	28	cyclosporine	IL-2	PA449167	3558	0.99
NULL	J_Oncol_2010_May_24_2010_729725.nxml.txt.nlp	20508816	SENT96	0	0	41	41	vatalanib	VEGFR	PA7001	3791	0.99
NULL	Breast_Cancer_Res_2007_Oct_26_9(5)_112.nxml.txt.nlp	17980056	SENT126	17	17	0	0	tamoxifen	PTEN	PA451581	5728	0.99
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT105	29	29	4	4	tenofovir	ABCG2	PA10204	9429	0.99
NULL	Exp_Ther_Med_2013_Nov_13_6(5)_1317-1321.nxml.txt.nlp	24223665	SENT6	33	33	11	11	cisplatin	CD133	PA449014	8842	0.99
NULL	Cancers_(Basel)_2014_Jan_27_6(1)_226-239.nxml.txt.nlp	24473088	SENT87	23	23	8	8	temozolomide	MSH6	PA451609	2956	0.99
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_75-89.nxml.txt.nlp	17912638	SENT580	4	4	31	31	anastrozole	ATAC	PA448432	6375	0.99
NULL	Clin_Ophthalmol_2009_Jun_2_3_57-67.nxml.txt.nlp	19668545	SENT52	8	8	26	26	doxycycline	JNK	PA449415	5599	0.99
NULL	Arthritis_Res_Ther_2012_Oct_18_14(5)_R224.nxml.txt.nlp	23079134	SENT170	1	1	25	25	alendronate	PTH	PA448082	5741	0.99
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT230	8	8	25	25	chloroquine	BMPR-II	PA448948	659	0.99
NULL	Cell_Death_Dis_2014_Feb_27_5(2)_e1088.nxml.txt.nlp	24577086	SENT80	29	29	4	4	metformin	Bcl-2	PA450395	596	0.99
NULL	Breast_Cancer_Res_2011_Feb_2_13(1)_R15.nxml.txt.nlp	21288332	SENT24	26	26	38	38	trastuzumab	HER2	PA451743	2064	0.99
NULL	J_Hematol_Oncol_2012_Sep_18_5_57.nxml.txt.nlp	22989009	SENT255	4	4	43	43	nutlin-3	HDM2		4193	0.99
NULL	Pharmaceuticals_(Basel)_2013_Aug_6_6(8)_929-959.nxml.txt.nlp	24276377	SENT177	9	9	29	29	curcumin	IL-6	PA151958596	3569	0.99
NULL	J_Mol_Signal_2008_Dec_2_3_19.nxml.txt.nlp	19055733	SENT62	22	22	13	13	isoproterenol	AKAP5	PA450121	9495	0.99
NULL	Cancers_(Basel)_2010_Nov_29_2(4)_2026-2043.nxml.txt.nlp	24281216	SENT38	35	35	20	20	gemcitabine	EGFR	PA449748	1956	0.99
NULL	Brain_Sci_2014_May_6_4(2)_356-375.nxml.txt.nlp	24961766	SENT207	17	17	34	34	propofol	P28	PA451141	9446;7802;9527	0.99
NULL	Int_J_Genomics_2014_Jan_30_2014_820248.nxml.txt.nlp	24616890	SENT144	23	23	6	6	doxorubicin	Wip1	PA449412	8493	0.99
NULL	Behav_Brain_Funct_2009_Jan_15_5_3.nxml.txt.nlp	19146665	SENT225	19	19	3	3	ethanol	ANOVA	PA448073	4858	0.99
NULL	Acta_Histochem_Cytochem_2011_Apr_28_44(2)_51-60.nxml.txt.nlp	21614166	SENT160	36	36	11	11	thalidomide	HSP47	PA451644	871	0.99
NULL	Curr_Immunol_Rev_2013_Nov_9(4)_214-221.nxml.txt.nlp	24876829	SENT94	9	9	27	27	papain	IL-9	PA450778	3578	0.99
NULL	Mol_Cancer_2010_Aug_16_9_217.nxml.txt.nlp	20712901	SENT155	0	0	11	11	curcumin	STAT3	PA151958596	6774	0.99
NULL	Ann_Oncol_2013_Aug_12_24(8)_1994-1999.nxml.txt.nlp	23670096	SENT90	28	28	12	12	tamoxifen	AIB1	PA451581	8202	0.99
NULL	Int_J_Breast_Cancer_2012_Oct_25_2012_829315.nxml.txt.nlp	22295252	SENT55	21	21	1	1	olaparib	PARP1		142	0.99
NULL	Int_J_Emerg_Med_2010_May_26_3(2)_81-84.nxml.txt.nlp	20606815	SENT90	9	9	24	24	lopinavir	CYP1A2	PA450264	1544	0.99
NULL	Exp_Ther_Med_2015_Feb_15_9(2)_384-388.nxml.txt.nlp	25574202	SENT42	9	9	4	4	pentoxifylline	HLP	PA450864	6499;9001;3002	0.99
NULL	Evid_Based_Complement_Alternat_Med_2013_Aug_12_2013_982689.nxml.txt.nlp	23997806	SENT174	8	8	14	14	tolbutamide	APE	PA451718	55704;328	0.99
NULL	eLife_2013_Nov_5_2_e00969.nxml.txt.nlp	24192036	SENT586	14	14	31	31	vemurafenib	CRAF	PA165946873	5894	0.99
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_33-43.nxml.txt.nlp	17912634	SENT131	0	0	22	22	letrozole	HER2	PA450196	2064	0.99
NULL	Br_J_Cancer_2012_Jun_26_107(1)_43-52.nxml.txt.nlp	22644306	SENT226	32	32	8	8	tamoxifen	HSP90AA1	PA451581	3320	0.99
NULL	J_Vet_Med_Sci_2014_Jun_15_76(6)_813-817.nxml.txt.nlp	24531829	SENT98	9	9	15	15	primaquine	DPT	PA451103	1805	0.99
NULL	Cancer_Med_2013_Feb_3_2(1)_76-85.nxml.txt.nlp	24133630	SENT181	29	29	5	5	vemurafenib	PI3K	PA165946873	5290	0.99
NULL	Mol_Cancer_2009_Nov_24_8_109.nxml.txt.nlp	19930708	SENT90	26	26	9	9	exemestane	aromatase	PA449563	1588	0.99
NULL	Diagn_Pathol_2006_Aug_15_1_19.nxml.txt.nlp	16911776	SENT151	20	20	33	33	gefitinib	EGFR	PA131301952	1956	0.99
NULL	Br_J_Cancer_2010_Feb_2_102(3)_541-552.nxml.txt.nlp	20087344	SENT207	16	16	37	37	cisplatin	NRP1	PA449014	8829	0.99
NULL	Diabetol_Metab_Syndr_2014_Sep_23_6(1)_102.nxml.txt.nlp	NULL	SENT168	24	24	13	13	atorvastatin	RAGE	PA448500	177	0.99
NULL	Aging_(Albany_NY)_2010_Dec_20_2(12)_959-968.nxml.txt.nlp	21191146	SENT67	30	30	11	11	cisplatin	TSC2	PA449014	7249	0.99
NULL	Arq_Bras_Cardiol_2014_Jul_103(1)_33b-40.nxml.txt.nlp	25120083	SENT181	0	0	16	16	simvastatin	CYP2C8	PA451363	1558	0.99
NULL	Braz_J_Med_Biol_Res_2014_Sep_5_47(11)_929-939.nxml.txt.nlp	25296354	SENT97	5	5	23	23	afatinib	EGFR	PA165981154	1956	0.99
NULL	Cell_Biochem_Biophys_2013_May_24_66(1)_53-63.nxml.txt.nlp	22918821	SENT272	23	23	16	16	lubiprostone	ClC-2	PA164777012	1181	0.99
NULL	Mol_Cancer_2014_Jan_15_13_8.nxml.txt.nlp	24423412	SENT92	24	24	7	7	cisplatin	CD44	PA449014	960	0.99
NULL	Clin_Pharmacol_2011_Jun_22_3_13-25.nxml.txt.nlp	22287853	SENT206	11	11	22	22	saxagliptin	CYP3A4	PA165958362	1576	0.99
NULL	Oncogene_2014_Jun_12_33(24)_3151-3160.nxml.txt.nlp	23851502	SENT102	7	7	21	21	everolimus	TSC2	PA164746311	7249	0.99
NULL	Mol_Cancer_2013_Sep_11_12_104.nxml.txt.nlp	24025152	SENT95	2	2	7	7	gemcitabine	EGFR	PA449748	1956	0.99
NULL	J_Breast_Cancer_2012_Sep_28_15(3)_273-282.nxml.txt.nlp	23091539	SENT17	6	6	26	26	doxycycline	TRAIL	PA449415	8743	0.99
NULL	Oncol_Lett_2013_Sep_8_6(3)_789-794.nxml.txt.nlp	24137412	SENT144	4	4	24	24	cisplatin	BCL2	PA449014	596	0.99
NULL	Gastric_Cancer_2013_Jul_12_16(3)_345-354.nxml.txt.nlp	22968820	SENT142	45	45	39	39	oxaliplatin	FANCJ	PA131285527	83990	0.99
NULL	J_Oncol_2012_Aug_14_2012_408131.nxml.txt.nlp	22934112	SENT109	9	9	18	18	mitotane	CYP3A4	PA164746157	1576	0.99
NULL	Chin_J_Cancer_2012_Feb_31(2)_73-99.nxml.txt.nlp	22098950	SENT184	0	0	29	29	mitoxantrone	P-gp	PA450526	5243	0.99
NULL	Trials_2013_Dec_10_14_424.nxml.txt.nlp	24325953	SENT98	15	15	2	2	oxycodone	PCA	PA450741	28982	0.99
NULL	Br_J_Cancer_2010_Mar_16_102(6)_1003-1009.nxml.txt.nlp	20179710	SENT28	0	0	35	35	cyclophosphamide	CYP3A5	PA449165	1577	0.99
NULL	Aging_(Albany_NY)_2013_Jan_19_5(1)_67-83.nxml.txt.nlp	23425686	SENT221	4	4	28	28	nadh	CLS	PA164755085	1210	0.99
NULL	Int_Clin_Psychopharmacol_2014_Nov_3_29(6)_351-356.nxml.txt.nlp	24978955	SENT128	25	25	3	3	buspirone	STAR	PA448689	6770;2984	0.99
NULL	Exp_Ther_Med_2013_May_15_5(5)_1327-1331.nxml.txt.nlp	23737873	SENT131	28	28	8	8	imidapril	AVP	PA452640	114548;551	0.99
NULL	Indian_J_Endocrinol_Metab_2013_Jul-Aug_17(4)_636-646.nxml.txt.nlp	23961479	SENT146	22	22	4	4	fluconazole	CYP2C9	PA449653	1559	0.99
NULL	Front_Oncol_2014_Aug_11_4_204.nxml.txt.nlp	25157335	SENT125	41	41	11	11	crizotinib	KRAS	PA165946122	3845	0.99
NULL	Int_J_Biol_Sci_2014_Jun_10_10(7)_654-663.nxml.txt.nlp	25013375	SENT214	0	0	25	25	nelfinavir	AKT	PA450606	207	0.99
NULL	Clin_Interv_Aging_2008_Mar_3(1)_45-50.nxml.txt.nlp	18488877	SENT107	0	0	15	15	raloxifene	BMD	PA451221	1756;7439	0.99
NULL	Anat_Cell_Biol_2012_Jun_30_45(2)_73-78.nxml.txt.nlp	22822460	SENT85	15	15	0	0	cisplatin	EGFR	PA449014	1956	0.99
NULL	Neural_Regen_Res_2013_Mar_25_8(9)_825-832.nxml.txt.nlp	25206730	SENT14	8	8	27	27	isoflurane	P2X7	PA450106	5027	0.99
NULL	Ann_Indian_Acad_Neurol_2014_Mar_17(Suppl_1)_S32-S36.nxml.txt.nlp	24791086	SENT117	15	15	5	5	propofol	PTB	PA451141	58155	0.99
NULL	CNS_Drugs_2014_Jun_24_28(10)_875-886.nxml.txt.nlp	24958205	SENT150	7	7	28	28	exenatide	GLP-1	PA164749238	100125288	0.99
NULL	J_Physiol_2009_Oct_15_587(Pt_20)_4769-4783.nxml.txt.nlp	19703964	SENT320	3	3	34	34	halothane	TASK-1	PA449845	3777	0.99
NULL	Ecancermedicalscience_2009_Sep_24_3_153.nxml.txt.nlp	22276017	SENT8	36	36	0	0	oxaliplatin	ERCC1	PA131285527	2067	0.99
NULL	Exp_Anim_2014_Jul_22_63(4)_475-481.nxml.txt.nlp	25048264	SENT106	16	16	6	6	busulfan	CD34	PA448691	947	0.99
NULL	J_Cancer_Prev_2014_Mar_19(1)_7-13.nxml.txt.nlp	25337567	SENT82	3	3	15	15	evodiamine	Bcl-2	PA165860788	596	0.99
NULL	Leukemia_2013_Apr_8_27(4)_762-772.nxml.txt.nlp	23385376	SENT246	31	31	47	47	rituximab	CD52	PA451261	1043	0.99
NULL	Cell_Death_Dis_2010_May_13_1(5)_e41.nxml.txt.nlp	21364648	SENT31	0	0	7	7	etoposide	p65	PA449552	5970	0.99
NULL	Oncotarget_2012_Nov_14_3(12)_1557-1565.nxml.txt.nlp	23238683	SENT107	5	5	26	26	ponatinib	CRKL	PA165980594	1399	0.99
NULL	Open_Med_2007_Dec_18_1(3)_e184-e190.nxml.txt.nlp	21673951	SENT80	20	20	30	30	tamoxifen	BRCA2	PA451581	675	0.99
NULL	Oncologist_2010_Mar_3_15(3)_216-235.nxml.txt.nlp	20200040	SENT136	2	2	13	13	trastuzumab	HER-2	PA451743	2064	0.99
NULL	Arch_Gynecol_Obstet_2014_May_13_290(4)_757-762.nxml.txt.nlp	24818590	SENT18	5	5	35	35	heparin	CD16	PA449855	2215;2214	0.99
NULL	Indian_J_Med_Res_2014_Jan_139(1)_27-65.nxml.txt.nlp	24604039	SENT56	19	19	3	3	clozapine	CYP1A2	PA449061	1544	0.99
NULL	Breast_Cancer_Res_2010_Aug_9_12(4)_R62.nxml.txt.nlp	20696059	SENT3	22	22	0	0	tamoxifen	HER2	PA451581	2064	0.99
NULL	Biologics_2014_Dec_4_8_281-291.nxml.txt.nlp	25506209	SENT114	0	0	7	7	vemurafenib	BRAF	PA165946873	673	0.99
NULL	Int_J_Surg_Oncol_2012_Jun_12_2012_862879.nxml.txt.nlp	22778941	SENT88	22	22	9	9	cisplatin	XPA	PA449014	7507	0.99
NULL	Chemother_Res_Pract_2011_Sep_25_2011_730360.nxml.txt.nlp	22295205	SENT68	17	17	6	6	tamoxifen	aromatase	PA451581	1588	0.99
NULL	J_Biomed_Sci_2012_Nov_21_19(1)_99.nxml.txt.nlp	23170833	SENT13	5	5	28	28	atorvastatin	CXCR4	PA448500	7852	0.99
NULL	Br_J_Cancer_2013_May_28_108(10)_2039-2044.nxml.txt.nlp	23652306	SENT83	3	3	16	16	tamoxifen	SRC3	PA451581	8202	0.99
NULL	Onco_Targets_Ther_2014_Dec_4_7_2249-2255.nxml.txt.nlp	25587220	SENT95	19	19	7	7	doxorubicin	ABCG2	PA449412	9429	0.99
NULL	Breast_Cancer_Res_2010_Jul_20_12(4)_R52.nxml.txt.nlp	20646288	SENT127	14	14	26	26	letrozole	COLEC12	PA450196	81035	0.99
NULL	Emerg_Infect_Dis_2012_Jul_18(7)_1128-1131.nxml.txt.nlp	22710273	SENT59	36	36	21	21	pyrazinamide	CD4	PA451182	920	0.99
NULL	Patient_Prefer_Adherence_2014_Apr_8_8_463-471.nxml.txt.nlp	24748775	SENT135	23	23	3	3	denosumab	RANKL	PA166048634	8600	0.99
NULL	J_Clin_Biochem_Nutr_2011_Nov_29_49(3)_216-221.nxml.txt.nlp	22128222	SENT129	1	1	10	10	clopidogrel	CYP2C19	PA449053	1557	0.99
NULL	Autophagy_2012_Dec_1_8(12)_1724-1740.nxml.txt.nlp	22948227	SENT102	10	10	5	5	doxycycline	MAPK15	PA449415	225689	0.99
NULL	Indian_J_Urol_2009_Apr-Jun_25(2)_186-189.nxml.txt.nlp	19672343	SENT50	17	17	2	2	cisplatin	GTS	PA449014	2973	0.99
NULL	Case_Rep_Transplant_2014_Jan_2_2014_548243.nxml.txt.nlp	24575309	SENT91	41	41	10	10	sirolimus	CYP3A4	PA451365	1576	0.99
NULL	Mol_Cancer_2009_Jul_31_8_57.nxml.txt.nlp	19646263	SENT218	6	6	44	44	docetaxel	IL-8	PA449383	3576	0.99
NULL	Exp_Ther_Med_2013_Jan_10_5(1)_287-291.nxml.txt.nlp	23251285	SENT104	1	1	36	36	aspirin	APS	PA448497	10603	0.989
NULL	Br_J_Cancer_2010_Jan_5_102(1)_188-195.nxml.txt.nlp	19920824	SENT69	27	27	0	0	heparin	FGF1	PA449855	2246	0.989
NULL	Basic_Clin_Pharmacol_Toxicol_2013_Feb_5_112(2)_132-137.nxml.txt.nlp	22900583	SENT13	4	4	10	10	ritonavir	CYP3A4	PA451260	1576	0.989
NULL	Nat_Med_2013_Oct_8_19(10)_1345-1350.nxml.txt.nlp	24013701	SENT41	15	15	9	9	fluorescein	FDG	PA164746009	23583	0.989
NULL	Cancer_Res_Treat_2012_Jun_30_44(2)_121-126.nxml.txt.nlp	22802750	SENT91	37	37	1	1	estradiol	APOE	PA449503	348	0.989
NULL	Acta_Orthop_2009_Jun_5_80(3)_357-362.nxml.txt.nlp	19421912	SENT142	2	2	14	14	hydrocortisone	MMP9	PA449905	4318	0.989
NULL	Cancer_Med_2013_Dec_27_2(6)_751-762.nxml.txt.nlp	24403249	SENT159	13	13	18	18	paclitaxel	CD44	PA450761	960	0.989
NULL	Eplasty_2009_Jan_15_9_e6.nxml.txt.nlp	19221583	SENT103	0	0	31	31	anastrozole	aromatase	PA448432	1588	0.989
NULL	Oncol_Lett_2013_Mar_28_5(3)_935-942.nxml.txt.nlp	23426424	SENT142	38	38	7	7	cisplatin	ERCC1	PA449014	2067	0.989
NULL	J_Cell_Biol_2002_Jun_24_157(7)_1151-1160.nxml.txt.nlp	12082077	SENT180	8	8	21	21	trypsin	COX	PA451806	1351	0.989
NULL	Acta_Histochem_Cytochem_2012_Oct_31_45(5)_251-259.nxml.txt.nlp	23209334	SENT108	28	28	11	11	isoproterenol	AQP5	PA450121	362	0.989
NULL	J_Hematol_Oncol_2008_Oct_23_1_19.nxml.txt.nlp	18947412	SENT107	22	22	1	1	alemtuzumab	CD34	PA164783958	947	0.989
NULL	Gut_2012_May_7_61(5)_673-684.nxml.txt.nlp	22315472	SENT326	17	17	9	9	cetuximab	KRAS	PA10040	3845	0.989
NULL	Arch_Drug_Inf_2011_Mar_4(1)_1-9.nxml.txt.nlp	21572514	SENT147	6	6	12	12	vinblastine	P-gp	PA451877	5243	0.989
NULL	Arthritis_Res_Ther_2013_Nov_6_15(6)_124.nxml.txt.nlp	24229459	SENT27	16	16	3	3	tocilizumab	IL-6	PA165292659	3569	0.989
NULL	J_Gen_Physiol_2010_Jan_135(1)_3-13.nxml.txt.nlp	20038523	SENT273	1	1	32	32	bumetanide	ANOVA	PA448682	4858	0.989
NULL	BMJ_Open_2014_Oct_31_4(10)_e005781.nxml.txt.nlp	25361837	SENT18	29	29	2	2	ticagrelor	ADP	PA165374673	23038	0.989
NULL	Biomed_Res_Int_2014_Mar_5_2014_193095.nxml.txt.nlp	24734227	SENT257	2	2	25	25	resveratrol	SIRT1		23411	0.989
NULL	Anat_Cell_Biol_2012_Jun_30_45(2)_73-78.nxml.txt.nlp	22822460	SENT86	3	3	17	17	gefitinib	HIF-1	PA131301952	29072	0.989
NULL	Infect_Drug_Resist_2009_Apr_24_2_13-26.nxml.txt.nlp	21694884	SENT82	6	6	23	23	atazanavir	TDF	PA10251	6736	0.989
NULL	Br_J_Cancer_2013_Jul_9_109(1)_68-75.nxml.txt.nlp	23807173	SENT188	11	11	4	4	cisplatin	ERCC1	PA449014	2067	0.989
NULL	Clin_Epigenetics_2011_Jun_14_2(2)_151-169.nxml.txt.nlp	22704335	SENT300	3	3	18	18	procainamide	GSTP1	PA451108	2950	0.989
NULL	J_Neuroinflammation_2010_Sep_7_7_51.nxml.txt.nlp	20822529	SENT102	5	5	17	17	hemin	HO-2	PA449849	3163	0.989
NULL	Diabetes_Metab_Syndr_Obes_2014_Jan_18_7_15-24.nxml.txt.nlp	24465132	SENT50	23	23	7	7	liraglutide	GLP-1	PA165958364	100125288	0.989
NULL	Clin_Pharmacol_2013_Apr_19_5_67-83.nxml.txt.nlp	23650452	SENT28	0	0	37	37	ticagrelor	CYP3A4	PA165374673	1576	0.989
NULL	Indian_J_Endocrinol_Metab_2011_Jan-Mar_15(1)_9-17.nxml.txt.nlp	21584160	SENT109	0	0	12	12	liraglutide	PPG	PA165958364	5552	0.989
NULL	Ther_Clin_Risk_Manag_2007_Jun_3(2)_341-348.nxml.txt.nlp	18360643	SENT25	6	6	12	12	sunitinib	CYP3A4	PA162372840	1576	0.989
NULL	Int_J_Mol_Sci_2014_Jun_25_15(7)_11220-11233.nxml.txt.nlp	24968265	SENT93	38	38	9	9	sunitinib	REST	PA162372840	5978	0.989
NULL	Acta_Pharmacol_Sin_2009_Jun_11_30(6)_723-739.nxml.txt.nlp	19434058	SENT170	7	7	13	13	selegiline	CYP2A6	PA451316	1548	0.989
NULL	Mol_Cancer_2014_Aug_16_13(1)_193.nxml.txt.nlp	NULL	SENT151	21	21	39	39	cisplatin	RKIP	PA449014	5037	0.989
NULL	Br_J_Cancer_2010_May_11_102(10)_1456-1460.nxml.txt.nlp	20461090	SENT85	9	9	20	20	temsirolimus	IFN	PA164746890	3439	0.989
NULL	Front_Chem_2014_Mar_14_2_12.nxml.txt.nlp	24790981	SENT123	14	14	3	3	curcumin	P19	PA151958596	51561	0.989
NULL	Biomed_Res_Int_2013_Aug_19_2013_143202.nxml.txt.nlp	24024181	SENT102	17	17	32	32	cisplatin	MRP1	PA449014	4437	0.989
NULL	J_Oncol_2013_Apr_29_2013_854121.nxml.txt.nlp	23737784	SENT9	20	20	1	1	pertuzumab	HER2		2064	0.989
NULL	Breast_Cancer_Res_2010_Apr_16_12(2)_R24.nxml.txt.nlp	20398352	SENT150	12	12	1	1	anastrozole	ATAC	PA448432	6375	0.989
NULL	Eur_J_Endocrinol_2011_Jan_164(1)_69-74.nxml.txt.nlp	20961967	SENT14	20	20	1	1	pioglitazone	adiponectin	PA450970	9370	0.989
NULL	Mol_Cancer_2010_Apr_29_9_95.nxml.txt.nlp	20429933	SENT142	16	16	3	3	etoposide	LC3	PA449552	84557	0.989
NULL	Mol_Cancer_2012_Sep_14_11_69.nxml.txt.nlp	22978347	SENT30	17	17	0	0	cisplatin	TRAP1	PA449014	9392;10131	0.989
NULL	Cancer_Biol_Med_2012_Mar_9(1)_18-22.nxml.txt.nlp	23691449	SENT63	11	11	4	4	gefitinib	EGFR	PA131301952	1956	0.989
NULL	Br_J_Haematol_2008_Jun_141(5)_659-671.nxml.txt.nlp	18410446	SENT144	4	4	8	8	cerulenin	Apo2	PA164764551	8797	0.989
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT17	18	18	9	9	capecitabine	HER2	PA448771	2064	0.989
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT320	20	20	12	12	cetuximab	KRAS	PA10040	3845	0.989
NULL	Biochemistry_2013_May_14_52(19)_3194-3196.nxml.txt.nlp	23634976	SENT52	0	0	21	21	verapamil	P-gp	PA451868	5243	0.989
NULL	Oncol_Lett_2013_Mar_8_5(3)_805-812.nxml.txt.nlp	23426281	SENT134	12	12	4	4	gemcitabine	B7-H3	PA449748	80381	0.989
NULL	Front_Immunol_2013_Nov_7_4_360.nxml.txt.nlp	24223576	SENT223	20	20	28	28	imiquimod	IRF5	PA449972	3663	0.989
NULL	FEBS_Open_Bio_2014_Jan_6_4_77-89.nxml.txt.nlp	24490132	SENT252	4	4	13	13	ebselen	GDH	PA161660841	51084;2746	0.989
NULL	Cardiovasc_Res_2013_Jul_1_99(1)_24-34.nxml.txt.nlp	23519266	SENT219	41	41	20	20	2-methoxyestradiol	CYP1B1	PA134967247	1545	0.989
NULL	Cardiovasc_Diabetol_2013_Jun_19_12_92.nxml.txt.nlp	23777506	SENT201	3	3	9	9	miglitol	GLP-1	PA164776726	100125288	0.989
NULL	Clin_Dev_Immunol_2011_Dec_26_2011_890758.nxml.txt.nlp	22235224	SENT155	0	0	12	12	cetuximab	EGFR	PA10040	1956	0.989
NULL	Drugs_2014_Jul_18_74(11)_1209-1231.nxml.txt.nlp	25034361	SENT239	10	10	1	1	enoxaparin	STARS	PA449463	137735	0.989
NULL	Breast_Cancer_Res_2006_Jul_25_8(4)_R48.nxml.txt.nlp	16869955	SENT103	17	17	5	5	tamoxifen	p53	PA451581	7157	0.989
NULL	Front_Oncol_2014_Sep_29_4_262.nxml.txt.nlp	25325014	SENT558	35	35	21	21	trastuzumab	CD44	PA451743	960	0.989
NULL	J_Oncol_2010_Dec_23_2010_372547.nxml.txt.nlp	20072701	SENT157	0	0	13	13	vatalanib	VEGFR1	PA7001	2321	0.989
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT319	23	23	5	5	nutlin-3	DcR2		8793	0.989
NULL	Adv_Hematol_2012_Mar_25_2012_302570.nxml.txt.nlp	22536253	SENT222	35	35	4	4	rituximab	p110	PA451261	9733	0.989
NULL	Mol_Vis_2011_Feb_1_17_332-340.nxml.txt.nlp	21297899	SENT145	2	2	15	15	telmisartan	NAC	PA451605	22861	0.989
NULL	Oncotarget_2014_Oct_21_5(22)_11252-11268.nxml.txt.nlp	25361004	SENT235	35	35	1	1	metformin	CLIC1	PA450395	1192	0.989
NULL	J_Immune_Based_Ther_Vaccines_2005_May_18_3_3.nxml.txt.nlp	15904525	SENT30	17	17	2	2	zidovudine	GM-CSF	PA451954	1437	0.989
NULL	Oncotarget_2012_May_4_3(4)_395-398.nxml.txt.nlp	22565037	SENT41	27	27	17	17	metformin	CD24	PA450395	100133941	0.989
NULL	Clin_Mol_Allergy_2007_Jan_25_5_1.nxml.txt.nlp	17254346	SENT229	2	2	13	13	curcumin	IL-5	PA151958596	3567	0.989
NULL	Mol_Cancer_2010_Nov_2_9_289.nxml.txt.nlp	21044322	SENT10	3	3	14	14	cisplatin	RGS17	PA449014	26575	0.989
NULL	Mol_Cancer_2013_Oct_8_12_119.nxml.txt.nlp	24103454	SENT36	20	20	2	2	etoposide	TOP1	PA449552	7150	0.989
NULL	Arthritis_Res_Ther_2004_Feb_24_6(Suppl_1)_24.nxml.txt.nlp	NULL	SENT7	26	26	2	2	etanercept	OPGL	PA449515	8600	0.989
NULL	Endocrinol_Metab_(Seoul)_2014_Jun_26_29(2)_105-111.nxml.txt.nlp	25031882	SENT64	0	0	19	19	fenofibrate	FGF21	PA449594	26291	0.989
NULL	Br_J_Cancer_2009_Jun_16_100(12)_1879-1888.nxml.txt.nlp	19513078	SENT68	9	9	32	32	gentamicin	CO2	PA449753	4513	0.989
NULL	Breast_Cancer_Res_2000_Mar_12_2(Suppl_1)_P8_05.nxml.txt.nlp	NULL	SENT5	24	24	3	3	etoposide	GSTP1	PA449552	2950	0.989
NULL	Breast_Cancer_Res_2012_Jul_19_14(4)_R108.nxml.txt.nlp	22812534	SENT330	8	8	21	21	pargyline	GREB1	PA450797	9687	0.989
NULL	Int_J_Inflam_2012_Apr_26_2012_480373.nxml.txt.nlp	22611516	SENT88	14	14	5	5	tocilizumab	IL-6	PA165292659	3569	0.989
NULL	Oncol_Lett_2013_Feb_5_5(2)_427-434.nxml.txt.nlp	23420099	SENT166	15	15	6	6	cisplatin	ERCC1	PA449014	2067	0.989
NULL	Breast_Cancer_Res_2010_Aug_3_12(4)_403.nxml.txt.nlp	20727234	SENT3	10	10	42	42	risedronate	aromatase	PA451255	1588	0.989
NULL	Br_J_Cancer_2012_Jan_3_106(1)_18-24.nxml.txt.nlp	22108516	SENT54	9	9	29	29	camptothecin	TDP1	PA153590860	55775	0.989
NULL	Mol_Cells_2014_Apr_30_37(4)_322-329.nxml.txt.nlp	24722415	SENT295	9	9	29	29	nadh	NAGK	PA164755085	55577	0.989
NULL	Front_Genet_2012_Nov_5_3_236.nxml.txt.nlp	23133441	SENT132	34	34	21	21	efavirenz	CYP2B6	PA449441	1555	0.989
NULL	Mol_Cancer_2010_Aug_23_9_222.nxml.txt.nlp	20731837	SENT104	20	20	8	8	cetuximab	ATM	PA10040	472	0.989
NULL	Breast_Cancer_Res_2009_Oct_28_11(5)_211.nxml.txt.nlp	19889200	SENT240	25	25	34	34	letrozole	HER2	PA450196	2064	0.989
NULL	Adv_Urol_2012_Oct_26_2012_812398.nxml.txt.nlp	22110495	SENT48	5	5	21	21	cisplatin	ERCC1	PA449014	2067	0.989
NULL	J_Immunol_Res_2014_May_15_2014_175265.nxml.txt.nlp	24949488	SENT259	0	0	19	19	cyclophosphamide	CD25	PA449165	3669;3559	0.989
NULL	Mol_Cancer_2012_May_14_11_33.nxml.txt.nlp	22583829	SENT14	17	17	4	4	cisplatin	TLR4	PA449014	7099	0.989
NULL	Cardiol_Res_Pract_2013_Feb_21_2013_127270.nxml.txt.nlp	23509665	SENT33	5	5	10	10	ticagrelor	P2Y12	PA165374673	64805	0.989
NULL	Br_J_Cancer_2012_Sep_4_107(6)_947-955.nxml.txt.nlp	22892392	SENT175	10	10	28	28	lapatinib	ERBB2	PA152241907	2064	0.989
NULL	Int_J_Biol_Sci_2013_Mar_16_9(3)_303-312.nxml.txt.nlp	23569435	SENT146	15	15	1	1	cetuximab	KRAS	PA10040	3845	0.989
NULL	Mol_Vis_2012_Apr_11_18_901-908.nxml.txt.nlp	22539869	SENT8	26	26	22	22	curcumin	HO-1	PA151958596	3162	0.989
NULL	Mol_Biol_Cell_2012_Nov_1_23(21)_4212-4225.nxml.txt.nlp	22956765	SENT174	25	25	12	12	thrombin	SHP2	PA451674	5781	0.989
NULL	Cancer_Manag_Res_2014_Feb_3_6_63-75.nxml.txt.nlp	24520205	SENT187	2	2	13	13	afatinib	EGF	PA165981154	1950	0.989
NULL	Int_J_Breast_Cancer_2013_Dec_5_2013_354579.nxml.txt.nlp	24383004	SENT72	7	7	14	14	tamoxifen	aromatase	PA451581	1588	0.989
NULL	Evid_Based_Complement_Alternat_Med_2011_Feb_14_2011_650263.nxml.txt.nlp	21799686	SENT186	34	34	22	22	atropine	STZ	PA448505	6484	0.989
NULL	Open_Virol_J_2009_Apr_1_3_21-25.nxml.txt.nlp	19572053	SENT104	20	20	6	6	pp2	CD4		920	0.989
NULL	Mol_Biol_Int_2014_Sep_7_2014_852748.nxml.txt.nlp	25276427	SENT149	0	0	12	12	lapatinib	HER2	PA152241907	2064	0.989
NULL	Indian_J_Psychol_Med_2009_Jan-Jun_31(1)_3-10.nxml.txt.nlp	21938084	SENT176	11	11	26	26	haloperidol	5-HT2A	PA449841	3356	0.989
NULL	J_Hematol_Oncol_2012_Jun_18_5_31.nxml.txt.nlp	22709792	SENT110	0	0	8	8	panitumumab	EGFR	PA162373091	1956	0.989
NULL	Exp_Hematol_Oncol_2014_Nov_7_3(1)_26.nxml.txt.nlp	NULL	SENT120	25	25	2	2	erlotinib	KRAS	PA134687924	3845	0.989
NULL	J_Young_Pharm_2010_Jul-Sep_2(3)_326-331.nxml.txt.nlp	21042495	SENT127	33	33	22	22	rosuvastatin	CYP3A4	PA134308647	1576	0.989
NULL	Front_Oncol_2014_Oct_21_4_285.nxml.txt.nlp	25374842	SENT677	2	2	17	17	nutlin-3	p53		7157	0.989
NULL	F1000_Med_Rep_2009_Jun_29_1_50.nxml.txt.nlp	20948730	SENT50	0	0	5	5	rimonabant	CB1	PA152407999	1268	0.989
NULL	Eur_J_Immunol_2014_Jun_10_44(6)_1759-1769.nxml.txt.nlp	24595810	SENT128	3	3	20	20	fludrocortisone	CXCR4	PA164743961	7852	0.989
NULL	Br_J_Cancer_2013_Jul_23_109(2)_342-350.nxml.txt.nlp	23807172	SENT146	18	18	4	4	sorafenib	NAC	PA7000	22861	0.989
NULL	Mol_Cancer_2010_Jun_25_9_165.nxml.txt.nlp	20576164	SENT164	21	21	9	9	curcumin	IFN	PA151958596	3439	0.989
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1522-1532.nxml.txt.nlp	21997136	SENT155	31	31	4	4	lapatinib	ABCG2	PA152241907	9429	0.989
NULL	Front_Neurol_2011_Jul_4_2_36.nxml.txt.nlp	21772826	SENT65	0	0	28	28	clopidogrel	ADP	PA449053	23038	0.989
NULL	J_Gen_Physiol_2008_Oct_132(4)_397-405.nxml.txt.nlp	18794377	SENT165	22	22	5	5	nifedipine	NCX	PA450631	3196	0.989
NULL	EMBO_J_2008_Sep_17_27(18)_2400-2410.nxml.txt.nlp	18756267	SENT135	1	1	36	36	camptothecin	EXO1	PA153590860	9156	0.989
NULL	Eur_J_Med_Res_2009_Nov_24_14(Suppl_3)_43-46.nxml.txt.nlp	19959416	SENT13	5	5	27	27	raltegravir	CYP2C9		1559	0.989
NULL	Mol_Cancer_2014_Jun_24_13_157.nxml.txt.nlp	24958351	SENT169	25	25	5	5	lapatinib	EGFR	PA152241907	1956	0.989
NULL	Front_Neuroenergetics_2013_Mar_27_5_2.nxml.txt.nlp	23543638	SENT178	36	36	8	8	vildagliptin	GLP-1	PA165958346	100125288	0.989
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT100	0	0	11	11	afatinib	HER2	PA165981154	2064	0.989
NULL	Cancer_Inform_2008_Jun_10_6_315-355.nxml.txt.nlp	19259415	SENT333	23	23	13	13	cisplatin	IL-8	PA449014	3576	0.989
NULL	Nat_Med_2011_Aug_28_17(9)_1094-1100.nxml.txt.nlp	21873989	SENT27	4	4	15	15	imatinib	CD4	PA10804	920	0.989
NULL	Br_J_Cancer_2012_Nov_20_107(11)_1844-1852.nxml.txt.nlp	23169337	SENT164	17	17	3	3	bortezomib	c-Myc	PA10252	4609	0.989
NULL	Arch_Drug_Inf_2011_Mar_4(1)_1-9.nxml.txt.nlp	21572514	SENT171	9	9	14	14	ciprofloxacin	OAT3	PA449009	9376	0.989
NULL	Biologics_2012_Apr_12_6_89-99.nxml.txt.nlp	22532777	SENT64	18	18	1	1	denosumab	RANKL	PA166048634	8600	0.989
NULL	Mol_Cell_Proteomics_2014_Dec_9_13(12)_3435-3445.nxml.txt.nlp	25205226	SENT202	37	37	27	27	thrombin	PAR1	PA451674	79581;2149	0.989
NULL	Br_J_Cancer_2013_May_14_108(9)_1807-1809.nxml.txt.nlp	23612454	SENT22	23	23	19	19	trastuzumab	PIK3CA	PA451743	5290	0.989
NULL	Mol_Vis_2012_May_1_18_1115-1122.nxml.txt.nlp	22605923	SENT155	37	37	11	11	estradiol	p38	PA449503	10598;1432;7965	0.989
NULL	Arthritis_Res_Ther_2010_Jul_15_12(4)_R142.nxml.txt.nlp	20633267	SENT168	13	13	4	4	infliximab	IFN	PA452639	3439	0.989
NULL	Ann_Oncol_2009_Aug_17_20(8)_1319-1329.nxml.txt.nlp	19535820	SENT259	5	5	17	17	tamoxifen	aromatase	PA451581	1588	0.989
NULL	Exp_Mol_Med_2012_Aug_31_44(8)_473-482.nxml.txt.nlp	22627808	SENT82	30	30	16	16	lapatinib	HRG	PA152241907	3084;3273	0.989
NULL	Mol_Cancer_2009_Nov_19_8_108.nxml.txt.nlp	19925669	SENT111	23	23	5	5	doxorubicin	MRP3	PA449412	8714	0.989
NULL	Mol_Cancer_2010_Aug_23_9_222.nxml.txt.nlp	20731837	SENT184	6	6	18	18	gefitinib	EGFR	PA131301952	1956	0.989
NULL	Oncol_Lett_2013_Sep_15_6(3)_648-654.nxml.txt.nlp	24137384	SENT37	27	27	10	10	cisplatin	GSTT1	PA449014	2952	0.989
NULL	EPMA_J_2012_Sep_27_3(1)_10.nxml.txt.nlp	23016735	SENT152	24	24	7	7	warfarin	MAF	PA451906	4094	0.989
NULL	Acta_Pharmacol_Sin_2009_Nov_5_30(11)_1522-1528.nxml.txt.nlp	19890360	SENT78	18	18	5	5	fenoterol	CD14	PA10079	929	0.989
NULL	Cell_Death_Dis_2013_Sep_5_4(9)_e789.nxml.txt.nlp	24008733	SENT141	1	1	22	22	minocycline	TTR	PA450519	7276	0.989
NULL	J_Korean_Med_Sci_2007_Feb_28_22(1)_26-29.nxml.txt.nlp	17297247	SENT21	5	5	24	24	pyrazinamide	DST	PA451182	667	0.989
NULL	Carcinogenesis_2013_Feb_3_34(2)_351-360.nxml.txt.nlp	23125222	SENT252	0	0	8	8	curcumin	SMC2	PA151958596	10592	0.989
NULL	Mol_Biol_Cell_2012_Mar_15_23(6)_996-1009.nxml.txt.nlp	22278744	SENT202	20	20	40	40	forskolin	14-3-3	PA146096022	10971	0.989
NULL	Pharmaceuticals_(Basel)_2013_Aug_6_6(8)_929-959.nxml.txt.nlp	24276377	SENT171	0	0	9	9	bortezomib	CXCL8	PA10252	3576	0.989
NULL	Biosensors_(Basel)_2013_Jun_28_3(3)_238-258.nxml.txt.nlp	25506422	SENT262	33	33	13	13	etoposide	p53	PA449552	7157	0.989
NULL	F1000Res_2014_Aug_19_3_198.nxml.txt.nlp	25400908	SENT172	0	0	18	18	trastuzumab	HER2	PA451743	2064	0.989
NULL	JRSM_Cardiovasc_Dis_2012_Sep_24_1(6)_cvd_2012_012015.nxml.txt.nlp	24175073	SENT56	20	20	8	8	clopidogrel	CYP2C19	PA449053	1557	0.989
NULL	Front_Psychiatry_2014_May_19_5_47.nxml.txt.nlp	24904434	SENT65	5	5	19	19	olanzapine	5-HT2A	PA450688	3356	0.989
NULL	J_Lipid_Res_2015_Jan_56(1)_109-121.nxml.txt.nlp	25421061	SENT229	22	22	2	2	trypsin	CGI-58	PA451806	51099	0.989
NULL	Crit_Care_2009_Mar_13_13(Suppl_1)_P402.nxml.txt.nlp	NULL	SENT2	0	0	26	26	dexmedetomidine	CFB	PA449256	629	0.989
NULL	Breast_Cancer_Res_2011_Jan_28_13(1)_R11.nxml.txt.nlp	21276249	SENT273	17	17	4	4	tamoxifen	PRL	PA451581	5617	0.989
NULL	J_Int_Soc_Sports_Nutr_2008_Feb_13_5_4.nxml.txt.nlp	18269769	SENT180	0	0	15	15	creatine	ADP	PA164778930	23038	0.989
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT126	11	11	28	28	pp2	PP2		4888	0.989
NULL	Oncotarget_2013_Nov_15_5(6)_1458-1474.nxml.txt.nlp	24681547	SENT242	27	27	34	34	celecoxib	CDH11	PA448871	1009	0.989
NULL	Diabetol_Metab_Syndr_2014_Oct_15_6(1)_110.nxml.txt.nlp	NULL	SENT40	21	21	0	0	exenatide	GLP-1	PA164749238	100125288	0.989
NULL	Diabetes_Care_2010_Feb_33(2)_453-455.nxml.txt.nlp	20103562	SENT61	31	31	4	4	metformin	HIP	PA450395	6767;6159;64399;5068	0.989
NULL	Acta_Neuropathol_Commun_2014_May_30_2_57.nxml.txt.nlp	24887326	SENT195	17	17	3	3	vardenafil	MED1	PA10229	5469;8930	0.989
NULL	Br_J_Cancer_1997_76(4)_474-479.nxml.txt.nlp	9275024	SENT12	26	26	17	17	cisplatin	p53	PA449014	7157	0.989
NULL	J_Oncol_2013_Apr_29_2013_854121.nxml.txt.nlp	23737784	SENT153	27	27	20	20	trastuzumab	HER2	PA451743	2064	0.989
NULL	Int_J_Mol_Sci_2014_Sep_29_15(10)_17469-17477.nxml.txt.nlp	25268618	SENT164	4	4	21	21	lidocaine	zeta	PA450226	9907	0.989
NULL	Exp_Ther_Med_2014_Mar_10_7(3)_640-648.nxml.txt.nlp	24520260	SENT30	0	0	10	10	resveratrol	SIRT1		23411	0.989
NULL	Ann_Rheum_Dis_2013_Aug_21_72(8)_1287-1294.nxml.txt.nlp	22915624	SENT143	30	30	14	14	abatacept	MRI	PA164747080	78996	0.989
NULL	Eur_J_Haematol_2013_Feb_22_90(2)_89-98.nxml.txt.nlp	23181448	SENT136	2	2	21	21	nilotinib	ASM	PA165958345	6609;283120	0.989
NULL	Int_J_Mol_Sci_2014_Oct_20_15(10)_18985-18999.nxml.txt.nlp	25334066	SENT124	26	26	10	10	genistein	HOTAIR	PA165109660	100124700	0.989
NULL	Breast_Cancer_Res_2009_Jun_29_11(3)_R41.nxml.txt.nlp	19563669	SENT171	38	38	16	16	gefitinib	XIAP	PA131301952	331	0.989
NULL	Theranostics_2013_Jan_15_3(1)_47-75.nxml.txt.nlp	23382786	SENT56	0	0	11	11	plerixafor	CXCR4	PA165958410	7852	0.989
NULL	Oncogene_2010_Jun_10_29(23)_3335-3348.nxml.txt.nlp	20383197	SENT250	15	15	21	21	lapatinib	JNK	PA152241907	5599	0.989
NULL	J_Biol_Chem_2009_Jan_2_284(1)_77-84.nxml.txt.nlp	18854318	SENT36	12	12	32	32	phenformin	AMPK	PA1000	5563	0.989
NULL	Mol_Biol_Cell_2013_Sep_1_24(17)_2678-2688.nxml.txt.nlp	23864716	SENT79	7	7	28	28	thrombin	PP2	PA451674	4888	0.989
NULL	Nat_Chem_Biol_2010_Apr_28_6(4)_291-299.nxml.txt.nlp	20190765	SENT280	24	24	6	6	erlotinib	EGFR	PA134687924	1956	0.989
NULL	Oncogene_2010_Sep_23_29(38)_5299-5310.nxml.txt.nlp	20622903	SENT48	5	5	12	12	melphalan	p62	PA450354	8878;10657;23636	0.989
NULL	Mol_Biol_Cell_2013_Dec_15_24(24)_3787-3804.nxml.txt.nlp	24152733	SENT384	9	9	19	19	dextran	JACOP	PA449261	84952	0.989
NULL	Cancer_Med_2012_Aug_15_1(1)_28-38.nxml.txt.nlp	23342251	SENT23	24	24	3	3	lapatinib	HER2	PA152241907	2064	0.989
NULL	Hum_Genomics_2010_Apr_1_4(4)_238-249.nxml.txt.nlp	20511137	SENT176	20	20	12	12	irinotecan	UGT1A1	PA450085	54658	0.989
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT41	31	31	23	23	docetaxel	HER2	PA449383	2064	0.989
NULL	Open_Virol_J_2012_Dec_28_6_204-215.nxml.txt.nlp	23341856	SENT123	25	25	7	7	gemcitabine	p53	PA449748	7157	0.989
NULL	Breast_Cancer_Res_2008_Jul_8_10(4)_R56.nxml.txt.nlp	18611244	SENT242	7	7	36	36	letrozole	aromatase	PA450196	1588	0.989
NULL	Onco_Targets_Ther_2014_Sep_9_7_1571-1582.nxml.txt.nlp	25228815	SENT155	8	8	27	27	sunitinib	VEGFA	PA162372840	7422	0.989
NULL	Fibrogenesis_Tissue_Repair_2011_Jun_2_4_13.nxml.txt.nlp	21635730	SENT182	14	14	3	3	thrombin	TSP-1	PA451674	7057	0.989
NULL	Environ_Health_Perspect_2007_Mar_19_115(3)_346-353.nxml.txt.nlp	17431482	SENT126	35	35	8	8	arsenite	FBS	PA452638	64319;26269	0.989
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2014_Sep_27_70(Pt_10)_2740-2753.nxml.txt.nlp	25286857	SENT270	0	0	4	4	bsi-201	PARP1		142	0.989
NULL	Hum_Genomics_Proteomics_2010_Sep_13_2010_754919.nxml.txt.nlp	20981234	SENT94	5	5	20	20	phenprocoumon	CYP2C9	PA450921	1559	0.989
NULL	Clin_Dev_Immunol_2013_May_22_2013_701305.nxml.txt.nlp	23762095	SENT78	33	33	21	21	vincristine	FBW7	PA451879	55294	0.989
NULL	Drugs_2014_Nov_12_74(18)_2129-2139.nxml.txt.nlp	25389048	SENT77	37	37	2	2	tocilizumab	DREAM	PA165292659	30818	0.989
NULL	Curr_Med_Chem_2011_Jun_18(18)_2686-2714.nxml.txt.nlp	21649578	SENT286	6	6	4	4	erlotinib	EGFR	PA134687924	1956	0.989
NULL	Anal_Chem_Insights_2007_Nov_14_2_93-106.nxml.txt.nlp	19662183	SENT184	21	21	26	26	imatinib	P-gp	PA10804	5243	0.989
NULL	Lipids_Health_Dis_2011_Feb_12_10_31.nxml.txt.nlp	21314960	SENT189	2	2	21	21	hemin	HO-1	PA449849	3162	0.989
NULL	Int_J_Mol_Sci_2014_Oct_6_15(10)_17886-17900.nxml.txt.nlp	25290095	SENT222	28	28	36	36	resveratrol	SIRT1		23411	0.989
NULL	Int_J_Endocrinol_2013_Sep_9_2013_483145.nxml.txt.nlp	24106499	SENT157	11	11	4	4	vasopressin	obestatin	PA451858	51738	0.989
NULL	Clin_Drug_Investig_2013_Aug_23_33(10)_727-736.nxml.txt.nlp	23975654	SENT172	8	8	31	31	bupropion	CYP1A2	PA448687	1544	0.989
NULL	Chin_J_Cancer_2012_Feb_31(2)_73-99.nxml.txt.nlp	22098950	SENT212	1	1	10	10	nilotinib	P-gp	PA165958345	5243	0.989
NULL	Mol_Cancer_2009_Jan_7_8_1.nxml.txt.nlp	19128456	SENT34	34	34	6	6	doxorubicin	HIF-1	PA449412	29072	0.989
NULL	Mol_Pain_2013_Feb_15_9_3.nxml.txt.nlp	23413875	SENT183	15	15	38	38	resveratrol	TRPA1		8989	0.989
NULL	Arthritis_Res_Ther_2013_Dec_23_15(6)_130.nxml.txt.nlp	24364924	SENT35	13	13	19	19	tocilizumab	IL-6	PA165292659	3569	0.989
NULL	Indian_J_Occup_Environ_Med_2008_Dec_12(3)_136-138.nxml.txt.nlp	20040973	SENT37	45	45	5	5	fluorescein	ERG	PA164746009	2078	0.989
NULL	Commun_Integr_Biol_2013_Nov_1_6(6)_e26316.nxml.txt.nlp	24567774	SENT40	16	16	1	1	etoposide	p53	PA449552	7157	0.989
NULL	Clin_Sci_(Lond)_2013_May_1_124(Pt_9)_567-578.nxml.txt.nlp	23113760	SENT632	8	8	2	2	panitumumab	BRAF	PA162373091	673	0.989
NULL	Mol_Cancer_2012_Jun_26_11_43.nxml.txt.nlp	22731636	SENT86	28	28	15	15	pp2	CD24		100133941	0.989
NULL	Hum_Mol_Genet_2013_Nov_15_22(22)_4602-4615.nxml.txt.nlp	23814040	SENT144	4	4	40	40	l-cysteine	TRMU	PA449173	55687	0.989
NULL	Interdiscip_Perspect_Infect_Dis_2014_May_7_2014_849432.nxml.txt.nlp	24895495	SENT123	0	0	17	17	ritonavir	CYP3A4	PA451260	1576	0.989
NULL	Cardiovasc_Ther_2009_27(4)_259-274.nxml.txt.nlp	19604248	SENT23	7	7	29	29	prasugrel	ADP	PA154410481	23038	0.989
NULL	Breast_Cancer_Res_2007_Jun_4_9(3)_207.nxml.txt.nlp	17561991	SENT178	17	17	33	33	trastuzumab	HER-2	PA451743	2064	0.989
NULL	Acta_Pharmacol_Sin_2014_Jun_4_35(6)_792-805.nxml.txt.nlp	24902787	SENT270	5	5	13	13	paroxetine	CYP2D6	PA450801	1565	0.989
NULL	Case_Rep_Pediatr_2012_Aug_9_2012_323681.nxml.txt.nlp	22924145	SENT73	12	12	2	2	tocilizumab	IL-6	PA165292659	3569	0.989
NULL	Eur_J_Clin_Pharmacol_2010_Nov_29_66(11)_1131-1136.nxml.txt.nlp	20669013	SENT112	5	5	13	13	voriconazole	CYP2C19	PA10233	1557	0.989
NULL	Clin_Med_Insights_Oncol_2011_Oct_31_5_333-342.nxml.txt.nlp	22084622	SENT125	14	14	29	29	pazopanib	IL-6	PA165291492	3569	0.989
NULL	Biomed_Res_Int_2014_Apr_15_2014_175721.nxml.txt.nlp	24822180	SENT119	22	22	0	0	cisplatin	HIPK2	PA449014	28996	0.989
NULL	Biosci_Rep_2012_Aug_1_32(Pt_4)_361-374.nxml.txt.nlp	22762204	SENT163	24	24	6	6	cisplatin	BRCA1	PA449014	672	0.989
NULL	Breast_Cancer_Res_2000_Mar_12_2(Suppl_1)_P8_05.nxml.txt.nlp	NULL	SENT5	20	20	3	3	cisplatin	GSTP1	PA449014	2950	0.989
NULL	Oncotarget_2010_Nov_16_1(7)_483-496.nxml.txt.nlp	21317447	SENT217	34	34	12	12	imatinib	PDGFRB	PA10804	5159	0.989
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT446	13	13	34	34	risperidone	PRL	PA451257	5617	0.989
NULL	Breast_Cancer_Res_Treat_2014_Nov_11_148(3)_563-570.nxml.txt.nlp	25385180	SENT174	9	9	19	19	pertuzumab	EGFR		1956	0.989
NULL	Oncotarget_2014_Jun_1_5(13)_4868-4880.nxml.txt.nlp	24947902	SENT207	0	0	23	23	lapatinib	BIM	PA152241907	10018	0.989
NULL	J_Appl_Genet_2014_Apr_11_55(3)_337-341.nxml.txt.nlp	24722858	SENT111	14	14	17	17	cetuximab	EGFR	PA10040	1956	0.989
NULL	Int_J_Mol_Sci_2014_Mar_10_15(3)_4201-4220.nxml.txt.nlp	24619193	SENT20	23	23	11	11	cisplatin	IFN	PA449014	3439	0.989
NULL	Pain_2014_Jan_155(1)_168-178.nxml.txt.nlp	24076162	SENT44	6	6	0	0	isoflurane	PAG	PA450106	55824	0.989
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT87	5	5	0	0	curcumin	PC-3	PA151958596	692094	0.989
NULL	Oncologist_2010_Nov_4_15(11)_1135-1146.nxml.txt.nlp	21051659	SENT133	0	0	25	25	sorafenib	IFN	PA7000	3439	0.989
NULL	Autoimmune_Dis_2013_Nov_5_2013_716813.nxml.txt.nlp	24294521	SENT140	7	7	28	28	pazopanib	KIT	PA165291492	3815	0.989
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT192	20	20	4	4	propafenone	CYP3A4	PA451131	1576	0.989
NULL	Mol_Brain_2014_May_15_7_37.nxml.txt.nlp	24886748	SENT101	24	24	5	5	vorinostat	HDAC2	PA164748224	3066	0.989
NULL	BMB_Rep_2013_Feb_46(2)_92-96.nxml.txt.nlp	23433111	SENT31	18	18	13	13	etoposide	BRCA1	PA449552	672	0.989
NULL	Trials_2014_May_15_15_171.nxml.txt.nlp	24885324	SENT17	9	9	1	1	anastrozole	aromatase	PA448432	1588	0.989
NULL	J_Physiol_2011_Feb_1_589(Pt_3)_755-766.nxml.txt.nlp	21173081	SENT262	5	5	30	30	vasopressin	AVP	PA451858	114548;551	0.989
NULL	Comput_Math_Methods_Med_2014_Feb_3_2014_813067.nxml.txt.nlp	24639887	SENT230	22	22	5	5	tamoxifen	MYB	PA451581	4602	0.989
NULL	Cell_Commun_Signal_2009_Oct_27_7_25.nxml.txt.nlp	19860902	SENT392	2	2	9	9	dipyridamole	NFATc	PA449367	4772	0.989
NULL	Breast_Cancer_Res_2014_Dec_19_16(6)_499.nxml.txt.nlp	25522654	SENT27	23	23	0	0	estradiol	CYP19A1	PA449503	1588	0.989
NULL	Crit_Care_2011_Feb_3_15(1)_R49.nxml.txt.nlp	21291554	SENT128	38	38	8	8	amikacin	CLCR	PA164744372	11330	0.989
NULL	Br_J_Clin_Pharmacol_2014_Nov_20_78(5)_1043-1049.nxml.txt.nlp	24838177	SENT161	15	15	21	21	telaprevir	CYP3A4	PA165958354	1576	0.989
NULL	Arthritis_Res_Ther_2008_Apr_16_10(2)_R43.nxml.txt.nlp	18416822	SENT53	6	6	30	30	ketorolac	FAAH	PA450150	79152;2166	0.989
NULL	Neural_Plast_2012_Jun_26_2012_892784.nxml.txt.nlp	22792496	SENT86	39	39	18	18	diazepam	GAD65	PA449283	2572	0.989
NULL	Evid_Based_Complement_Alternat_Med_2013_May_13_2013_506324.nxml.txt.nlp	23818927	SENT142	9	9	26	26	doxorubicin	STAT3	PA449412	6774	0.989
NULL	J_Invest_Dermatol_2014_Jul_6_134(7)_1811-1816.nxml.txt.nlp	24599174	SENT132	10	10	1	1	tazarotene	TIG3	PA164746821	5920	0.989
NULL	Ther_Clin_Risk_Manag_2007_Jun_3(3)_467-474.nxml.txt.nlp	18488080	SENT140	4	4	33	33	rasagiline	GAPDH	PA164764584	2597	0.989
NULL	Nucleic_Acids_Res_2011_Dec_31_39(22)_9536-9548.nxml.txt.nlp	21880590	SENT178	31	31	6	6	etoposide	BRCA1	PA449552	672	0.989
NULL	Clin_Med_Insights_Arthritis_Musculoskelet_Disord_2010_Dec_19_3_81-89.nxml.txt.nlp	21234291	SENT20	31	31	8	8	tocilizumab	IL-6	PA165292659	3569	0.989
NULL	Oxid_Med_Cell_Longev_2013_Jun_2_2013_793525.nxml.txt.nlp	23819014	SENT123	0	0	21	21	resveratrol	AMPK		5563	0.989
NULL	Front_Genet_2012_Nov_26_3_246.nxml.txt.nlp	23226153	SENT81	8	8	14	14	trimethoprim	DHFR	PA451788	1719	0.989
NULL	Cancer_Manag_Res_2014_Jun_6_6_267-278.nxml.txt.nlp	24944518	SENT141	32	32	26	26	finasteride	PC3	PA449627	57332;7832;5122	0.989
NULL	Crit_Care_2007_Sep_19_11(5)_229.nxml.txt.nlp	17903310	SENT30	42	42	32	32	staurosporine	HMGB1	PA165109623	3146	0.989
NULL	Scientifica_(Cairo)_2012_Nov_25_2012_473829.nxml.txt.nlp	24278698	SENT394	31	31	38	38	oxaliplatin	OCTN1	PA131285527	6583	0.989
NULL	Pharmaceuticals_(Basel)_2013_Aug_21_6(8)_988-1038.nxml.txt.nlp	24276379	SENT235	8	8	0	0	cisplatin	GSTP1	PA449014	2950	0.989
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT137	12	12	45	45	doxorubicin	SLK	PA449412	9748;2534	0.989
NULL	Br_J_Cancer_2011_Nov_22_105(11)_1654-1662.nxml.txt.nlp	22045187	SENT178	40	40	12	12	irinotecan	MTHFR	PA450085	4524	0.989
NULL	J_Oncol_2010_Dec_23_2010_372547.nxml.txt.nlp	20072701	SENT72	29	29	1	1	erlotinib	EGFR	PA134687924	1956	0.989
NULL	Cancer_Med_2014_Aug_7_3(4)_796-811.nxml.txt.nlp	24802970	SENT302	25	25	17	17	amiloride	CD49f	PA448368	3655	0.989
NULL	Mol_Cancer_2014_Jun_4_13_141.nxml.txt.nlp	24894453	SENT44	19	19	4	4	cetuximab	KRAS	PA10040	3845	0.989
NULL	Case_Rep_Hematol_2012_Apr_1_2012_396395.nxml.txt.nlp	22937327	SENT82	3	3	18	18	mitomycin	IL-6	PA450524	3569	0.989
NULL	Br_J_Cancer_2009_Oct_6_101(7)_1155-1161.nxml.txt.nlp	19738614	SENT31	11	11	4	4	gemcitabine	MUC4	PA449748	4585	0.989
NULL	Biomed_Res_Int_2013_Sep_4_2013_419176.nxml.txt.nlp	24093097	SENT119	20	20	1	1	bevacizumab	PI3K	PA130232992	5290	0.989
NULL	J_Biol_Chem_2010_Aug_20_285(34)_26406-26416.nxml.txt.nlp	20530490	SENT37	12	12	26	26	artemisinin	SERCA1	PA165111696	487	0.989
NULL	Diabetes_Metab_Syndr_Obes_2014_Jan_18_7_15-24.nxml.txt.nlp	24465132	SENT56	42	42	0	0	exenatide	GLP-1	PA164749238	100125288	0.989
NULL	eLife_2014_May_6_3_e02482.nxml.txt.nlp	24843002	SENT221	13	13	0	0	etoposide	SETD2	PA449552	29072	0.989
NULL	Breast_Cancer_Res_2010_Jun_28_12(3)_R43.nxml.txt.nlp	20579400	SENT102	29	29	5	5	paclitaxel	MAPT	PA450761	4137	0.989
NULL	Int_J_Mol_Sci_2014_Sep_16_15(9)_16381-16417.nxml.txt.nlp	25229821	SENT89	6	6	18	18	tocilizumab	IL-6	PA165292659	3569	0.989
NULL	Cancer_Cell_Int_2013_Jun_26_13_63.nxml.txt.nlp	23800022	SENT159	12	12	25	25	genistein	XIAP	PA165109660	331	0.989
NULL	J_Cell_Biol_1998_Jan_26_140(2)_335-345.nxml.txt.nlp	9442109	SENT340	8	8	17	17	chloroquine	NHE	PA448948	285335	0.989
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2013_Dec_8_6_75-79.nxml.txt.nlp	24348081	SENT20	42	42	8	8	colesevelam	GLP-1	PA449095	100125288	0.989
NULL	Mol_Cancer_2009_Jun_9_8_37.nxml.txt.nlp	19508729	SENT13	2	2	6	6	gemcitabine	HO-1	PA449748	3162	0.989
NULL	Mol_Cancer_2014_Jun_19_13_154.nxml.txt.nlp	24941944	SENT160	20	20	10	10	aminopterin	BRAF	PA165109541	673	0.989
NULL	Exp_Cell_Res_2011_Apr_15_317(7)_1028-1039.nxml.txt.nlp	21237154	SENT208	23	23	6	6	staurosporine	JNK	PA165109623	5599	0.989
NULL	Mol_Cancer_2007_Oct_11_6_63.nxml.txt.nlp	17931419	SENT108	44	44	9	9	cetuximab	STAT3	PA10040	6774	0.989
NULL	Curr_Obes_Rep_2014_Feb_2_3(2)_235-241.nxml.txt.nlp	24818073	SENT40	8	8	42	42	rosiglitazone	PRDM16	PA451283	63976	0.989
NULL	Nat_Commun_2011_Oct_25_2_513.nxml.txt.nlp	22027593	SENT167	11	11	16	16	nutlin-3	RBM38		55544	0.989
NULL	Adv_Urol_2012_Oct_26_2012_812398.nxml.txt.nlp	22110495	SENT48	15	15	21	21	cisplatin	ERCC1	PA449014	2067	0.989
NULL	Clin_Med_Insights_Oncol_2012_Dec_6_6_407-421.nxml.txt.nlp	23239933	SENT159	8	8	21	21	gefitinib	EGFR	PA131301952	1956	0.989
NULL	Front_Endocrinol_(Lausanne)_2013_Oct_25_4_158.nxml.txt.nlp	24298267	SENT169	10	10	15	15	losartan	AT2	PA450268	186	0.989
NULL	Pharmaceuticals_(Basel)_2014_Sep_17_7(9)_943-953.nxml.txt.nlp	25232798	SENT23	5	5	21	21	pertuzumab	HER2		2064	0.989
NULL	Diabetologia_2007_Jun_6_50(6)_1288-1293.nxml.txt.nlp	17415544	SENT53	32	32	5	5	hyaluronan	ASAT	PA165958431	22	0.989
NULL	Oncol_Rep_2013_May_26_29(5)_1689-1696.nxml.txt.nlp	23446517	SENT35	32	32	19	19	doxorubicin	p53	PA449412	7157	0.989
NULL	Brain_Behav_2012_May_2(3)_270-282.nxml.txt.nlp	22741101	SENT273	15	15	7	7	cerulenin	BACE1	PA164764551	23621	0.989
NULL	J_Cell_Biol_2000_Jan_10_148(1)_7-16.nxml.txt.nlp	10629214	SENT178	18	18	2	2	genistein	ERK2	PA165109660	5594	0.989
NULL	Clin_Ophthalmol_2008_Jun_2(2)_339-346.nxml.txt.nlp	19668725	SENT127	11	11	26	26	ranibizumab	VEGF-A	PA164746012	7422	0.989
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_O12.nxml.txt.nlp	NULL	SENT6	10	10	0	0	carbamazepine	HLA-B	PA448785	3106	0.989
NULL	Breast_Cancer_Res_2012_Jul_19_14(4)_R109.nxml.txt.nlp	22812567	SENT292	47	47	13	13	gemcitabine	CHK1	PA449748	1111	0.989
NULL	J_Biol_Chem_2009_Mar_20_284(12)_7623-7630.nxml.txt.nlp	19131342	SENT54	32	32	2	2	thrombin	L-PGDS	PA451674	5730	0.989
NULL	Oncol_Lett_2014_Jun_14_7(6)_2130-2134.nxml.txt.nlp	24932302	SENT5	22	22	2	2	eltrombopag	TPO	PA165981594	7066;7173	0.989
NULL	Onco_Targets_Ther_2014_Sep_9_7_1571-1582.nxml.txt.nlp	25228815	SENT247	9	9	0	0	sorafenib	VEGFR2	PA7000	3791	0.989
NULL	Trials_2013_Sep_24_14_311.nxml.txt.nlp	24063608	SENT177	17	17	5	5	albendazole	STH	PA164746058	246744	0.989
NULL	Case_Rep_Transplant_2014_Jan_2_2014_548243.nxml.txt.nlp	24575309	SENT91	28	28	10	10	sirolimus	CYP3A4	PA451365	1576	0.989
NULL	Mol_Cancer_2014_Jun_24_13_157.nxml.txt.nlp	24958351	SENT169	42	42	5	5	gefitinib	EGFR	PA131301952	1956	0.989
NULL	Front_Oncol_2013_Apr_2_3_64.nxml.txt.nlp	23565502	SENT84	2	2	14	14	nutlin-3	MDM2		4193	0.989
NULL	Front_Oncol_2014_Apr_9_4_75.nxml.txt.nlp	24782986	SENT249	7	7	33	33	paclitaxel	CD117	PA450761	3815	0.989
NULL	J_Exp_Med_1998_Jun_1_187(11)_1885-1892.nxml.txt.nlp	9607928	SENT145	27	27	5	5	thalidomide	CD4	PA451644	920	0.989
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_15_2012_591654.nxml.txt.nlp	23118793	SENT182	7	7	17	17	berberine	PPG	PA165860812	5552	0.989
NULL	J_Vet_Med_Sci_2014_Sep_30_76(9)_1225-1229.nxml.txt.nlp	24881651	SENT29	13	13	0	0	trypsin	PAR2	PA451806	2150;55065;8856	0.989
NULL	Oncotarget_2014_Oct_16_5(20)_9546-9563.nxml.txt.nlp	25337673	SENT135	9	9	0	0	nilotinib	AXL	PA165958345	558	0.989
NULL	Br_J_Cancer_2012_Jan_31_106(3)_468-474.nxml.txt.nlp	22223088	SENT30	0	0	32	32	olaparib	BRCA2		675	0.989
NULL	AIDS_Res_Ther_2007_Feb_23_4_3.nxml.txt.nlp	17316455	SENT33	2	2	38	38	stavudine	CD4	PA451494	920	0.989
NULL	Acta_Pharmacol_Sin_2012_Oct_17_33(10)_1301-1310.nxml.txt.nlp	22983390	SENT97	3	3	21	21	cisplatin	migfilin	PA449014	54751	0.989
NULL	Br_J_Cancer_2012_Jul_24_107(3)_455-461.nxml.txt.nlp	22767146	SENT22	0	0	22	22	sorafenib	CRAF	PA7000	5894	0.989
NULL	Oncoimmunology_2013_Sep_1_2(9)_e26011.nxml.txt.nlp	24327939	SENT147	3	3	21	21	bortezomib	MICA	PA10252	100507436	0.989
NULL	Biomed_Res_Int_2013_Feb_28_2013_749078.nxml.txt.nlp	23555095	SENT107	1	1	22	22	trypsin	CD62L	PA451806	6402	0.989
NULL	Cancer_Immunol_Immunother_2013_Aug_27_62(10)_1637-1648.nxml.txt.nlp	23982484	SENT218	32	32	19	19	lenalidomide	STAT3	PA162363968	6774	0.989
NULL	Alzheimers_Res_Ther_2011_Jan_6_3(1)_1.nxml.txt.nlp	21211070	SENT189	19	19	3	3	atorvastatin	PSEN1	PA448500	5663	0.989
NULL	Oncotarget_2012_Dec_18_3(12)_1615-1628.nxml.txt.nlp	23271044	SENT210	32	32	5	5	clofarabine	STAT3	PA164754863	6774	0.989
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S31-S40.nxml.txt.nlp	20680106	SENT38	12	12	26	26	panitumumab	KRAS	PA162373091	3845	0.989
NULL	Cell_Biol_Int_Rep_(2010)_2012_Jun_21_19(1)_e00017.nxml.txt.nlp	23124518	SENT196	16	16	4	4	etoposide	DR4	PA449552	8797	0.989
NULL	Patient_Prefer_Adherence_2014_Apr_8_8_463-471.nxml.txt.nlp	24748775	SENT6	0	0	15	15	denosumab	RANK	PA166048634	8792	0.989
NULL	Basic_Clin_Neurosci_2014_Summer_5(3)_191-198.nxml.txt.nlp	25337379	SENT157	10	10	2	2	diazoxide	ANOVA	PA449285	4858	0.989
NULL	Cardiovasc_Diabetol_2013_Jun_19_12_92.nxml.txt.nlp	23777506	SENT201	3	3	16	16	miglitol	GLP-1	PA164776726	100125288	0.989
NULL	Allergy_Asthma_Immunol_Res_2012_Sep_21_4(5)_290-294.nxml.txt.nlp	22950035	SENT65	4	4	10	10	atorvastatin	ACT	PA448500	12;11332;9457;641455	0.989
NULL	Drug_Healthc_Patient_Saf_2012_Nov_29_4_173-180.nxml.txt.nlp	23236256	SENT66	6	6	48	48	aripiprazole	FGA	PA10026	2243	0.989
NULL	Cancers_(Basel)_2010_Dec_22_2(4)_2153-2170.nxml.txt.nlp	21390244	SENT7	17	17	15	15	gefitinib	EGFR	PA131301952	1956	0.989
NULL	Gut_Liver_2011_Jun_24_5(2)_171-180.nxml.txt.nlp	21814597	SENT135	46	46	27	27	imatinib	DOG1	PA10804	55107	0.989
NULL	Int_J_Endocrinol_2014_Aug_7_2014_313519.nxml.txt.nlp	25180035	SENT179	19	19	4	4	cosyntropin	ACTH	PA164749052	5443	0.989
NULL	Biomed_Res_Int_2013_Jul_1_2013_964743.nxml.txt.nlp	23936861	SENT198	25	25	3	3	cetuximab	VEGFR	PA10040	3791	0.989
NULL	Mol_Cancer_2009_Jun_23_8_39.nxml.txt.nlp	19549337	SENT239	16	16	5	5	cisplatin	XIAP	PA449014	331	0.989
NULL	Breast_Cancer_Res_2007_Jan_23_9(1)_R7.nxml.txt.nlp	17244352	SENT15	6	6	46	46	tamoxifen	SULT1A1	PA451581	6817	0.989
NULL	Mol_Cancer_2010_Nov_2_9_289.nxml.txt.nlp	21044322	SENT136	19	19	8	8	cisplatin	RGS10	PA449014	6001	0.989
NULL	Cell_Death_Dis_2014_Apr_24_5(4)_e1197.nxml.txt.nlp	24763054	SENT335	12	12	22	22	cisplatin	ARC	PA449014	8996;23237	0.989
NULL	Oncol_Lett_2013_Apr_22_5(4)_1093-1100.nxml.txt.nlp	23599746	SENT69	16	16	26	26	ifosfamide	P-gp	PA449964	5243	0.989
NULL	Br_J_Cancer_2011_Nov_22_105(11)_1635-1639.nxml.txt.nlp	22033275	SENT47	0	0	22	22	sorafenib	IFN	PA7000	3439	0.989
NULL	Iran_Red_Crescent_Med_J_2014_Jul_5_16(7)_e16388.nxml.txt.nlp	25237564	SENT161	23	23	0	0	sevoflurane	Erb	PA451341	2100	0.989
NULL	J_Hepatol_2010_Dec_53(6)_1101-1107.nxml.txt.nlp	20801540	SENT45	4	4	16	16	deferoxamine	ACP	PA164746490	4706	0.989
NULL	Breast_Cancer_Res_2012_Jun_7_14(3)_R89.nxml.txt.nlp	22676470	SENT242	7	7	12	12	lapatinib	HER2	PA152241907	2064	0.989
NULL	Br_J_Pharmacol_2011_Feb_162(4)_989-999.nxml.txt.nlp	21054342	SENT222	3	3	15	15	ketoconazole	CYP3A4	PA450146	1576	0.989
NULL	Neural_Regen_Res_2013_May_25_8(15)_1368-1375.nxml.txt.nlp	25206431	SENT17	0	0	25	25	curcumin	Bcl-2	PA151958596	596	0.989
NULL	Ann_Dermatol_2014_Aug_31_26(4)_517-520.nxml.txt.nlp	25143685	SENT17	17	17	0	0	tazarotene	TIG3	PA164746821	5920	0.989
NULL	Front_Neurosci_2011_Sep_9_5_102.nxml.txt.nlp	21927595	SENT32	27	27	38	38	baclofen	EPM	PA448533	2054	0.989
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Dec_17_3(12)_e152.nxml.txt.nlp	25518025	SENT72	10	10	18	18	oxycodone	CYP3A	PA450741	1574	0.989
NULL	Arthritis_Res_Ther_2012_Jul_12_14(4)_R163.nxml.txt.nlp	22784880	SENT118	48	48	24	24	leflunomide	CYP2C19	PA450192	1557	0.989
NULL	Breast_Cancer_Res_2011_Mar_14_13(2)_205.nxml.txt.nlp	21457526	SENT203	17	17	4	4	letrozole	aromatase	PA450196	1588	0.989
NULL	Acta_Pharmacol_Sin_2014_Jun_5_35(6)_727-737.nxml.txt.nlp	24793312	SENT170	3	3	23	23	rosiglitazone	Bcl-2	PA451283	596	0.989
NULL	Cell_Host_Microbe_2014_Sep_10_16(3)_291-303.nxml.txt.nlp	25211072	SENT568	29	29	4	4	pp2	CD4		920	0.989
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1137-1144.nxml.txt.nlp	20234366	SENT158	17	17	12	12	cetuximab	BRAF	PA10040	673	0.989
NULL	J_Hematol_Oncol_2009_Feb_23_2_9.nxml.txt.nlp	19236713	SENT65	20	20	4	4	panitumumab	KRAS	PA162373091	3845	0.989
NULL	Biomed_Res_Int_2013_Aug_6_2013_602987.nxml.txt.nlp	24027759	SENT309	6	6	24	24	doxorubicin	SMF	PA449412	22993	0.989
NULL	Int_J_Surg_Oncol_2012_Aug_27_2012_180574.nxml.txt.nlp	22970358	SENT26	4	4	26	26	tamoxifen	aromatase	PA451581	1588	0.989
NULL	Front_Pharmacol_2014_Dec_8_5_265.nxml.txt.nlp	25538618	SENT147	17	17	25	25	chloroquine	TLR7	PA448948	51284	0.989
NULL	Crit_Care_2008_Jul_2_12(4)_163.nxml.txt.nlp	18620550	SENT14	24	24	19	19	hydrocortisone	RAI	PA449905	10848;6050	0.989
NULL	Curr_Neuropharmacol_2013_Sep_11(5)_477-483.nxml.txt.nlp	24403871	SENT77	5	5	18	18	capsaicin	GluK2	PA448776	2898	0.989
NULL	Arthritis_Res_Ther_2004_Oct_17_6(1)_R7-R14.nxml.txt.nlp	14979933	SENT9	44	44	10	10	naloxone	POMC	PA450586	5443	0.989
NULL	Oncoimmunology_2014_Apr_25_3_e28518.nxml.txt.nlp	25071979	SENT119	14	14	5	5	oxaliplatin	CRT	PA131285527	811	0.989
NULL	Open_Orthop_J_2008_Jul_14_2_121-125.nxml.txt.nlp	19572021	SENT60	3	3	34	34	pamidronate	PROC	PA450767	5624	0.989
NULL	Arthritis_Res_Ther_2012_Sep_24_14(5)_R200.nxml.txt.nlp	23006144	SENT24	0	0	19	19	alefacept	CD2	PA164748040	914	0.989
NULL	Arch_Drug_Inf_2011_Mar_4(1)_1-9.nxml.txt.nlp	21572514	SENT21	9	9	14	14	ciprofloxacin	P-gp	PA449009	5243	0.989
NULL	Hum_Genomics_2009_Jan_1_3(2)_128-142.nxml.txt.nlp	19164090	SENT184	42	42	37	37	carboplatin	CD44	PA448803	960	0.989
NULL	Indian_J_Dermatol_2012_Nov-Dec_57(6)_459-465.nxml.txt.nlp	23248364	SENT129	3	3	29	29	cyclosporine	IFN	PA449167	3439	0.989
NULL	Breast_Cancer_Res_2006_Nov_27_8(6)_R66.nxml.txt.nlp	17129383	SENT76	13	13	26	26	paclitaxel	HER2	PA450761	2064	0.989
NULL	Arch_Gynecol_Obstet_2013_Jul_7_288(1)_41-48.nxml.txt.nlp	23389246	SENT32	7	7	21	21	heparin	APO	PA449855	84909	0.989
NULL	J_Immunother_Cancer_2013_Nov_7_1(Suppl_1)_P74.nxml.txt.nlp	NULL	SENT8	27	27	10	10	cyclophosphamide	TLR9	PA449165	54106	0.989
NULL	Iran_J_Pharm_Res_2014_Autumn_13(4)_1387-1392.nxml.txt.nlp	25587328	SENT25	39	39	10	10	fludarabine	Bcl-2	PA449655	596	0.989
NULL	Int_J_Chron_Obstruct_Pulmon_Dis_2007_Dec_2(4)_541-550.nxml.txt.nlp	18268927	SENT181	10	10	0	0	urokinase	SERPINE2	PA451836	5270	0.989
NULL	Diabetes_Metab_Syndr_Obes_2009_Jul_31_2_135-144.nxml.txt.nlp	21437127	SENT1	0	0	3	3	exenatide	GLP-1	PA164749238	100125288	0.989
NULL	J_Gynecol_Oncol_2014_Oct_7_25(4)_328-333.nxml.txt.nlp	25142624	SENT105	20	20	9	9	cisplatin	IL-6	PA449014	3569	0.989
NULL	Front_Microbiol_2014_Mar_14_5_99.nxml.txt.nlp	24672516	SENT81	18	18	28	28	caspofungin	TLR2	PA164743013	7097	0.989
NULL	Br_J_Cancer_2012_Feb_28_106(5)_931-938.nxml.txt.nlp	22333599	SENT114	20	20	3	3	oxaliplatin	SATB2	PA131285527	23314	0.989
NULL	Arthritis_Res_Ther_2008_Sep_24_10(5)_R115.nxml.txt.nlp	18816401	SENT16	2	2	39	39	etanercept	BMP7	PA449515	655	0.989
NULL	J_Cancer_Epidemiol_2012_Aug_9_2012_957467.nxml.txt.nlp	22927849	SENT129	15	15	45	45	s-adenosylmethionine	MTHFR	PA164754994	4524	0.989
NULL	Iran_J_Psychiatry_2014_Apr_9(2)_115-117.nxml.txt.nlp	25632289	SENT42	13	13	4	4	sertraline	ACT	PA451333	12;11332;9457;641455	0.989
NULL	Breast_Cancer_(Auckl)_2011_Jan_13_5_1-14.nxml.txt.nlp	21494397	SENT48	25	25	5	5	telithromycin	CYP3A4	PA10202	1576	0.989
NULL	Allergy_Asthma_Clin_Immunol_2010_Jul_28_6(1)_21.nxml.txt.nlp	20667124	SENT8	40	40	15	15	icatibant	C1-INH	PA164749185	710	0.989
NULL	Biologics_2012_Jan_5_6_13-20.nxml.txt.nlp	22291463	SENT124	0	0	28	28	pertuzumab	HER2		2064	0.989
NULL	Indian_J_Med_Res_2012_Dec_136(6)_907-925.nxml.txt.nlp	23391787	SENT512	29	29	13	13	primaquine	ACT	PA451103	12;11332;9457;641455	0.989
NULL	Oncol_Rep_2013_Sep_1_30(3)_1045-1052.nxml.txt.nlp	23817662	SENT134	17	17	2	2	erlotinib	KRAS	PA134687924	3845	0.989
NULL	Cancer_Microenviron_2009_Sep_26_2(Suppl_1)_19-204.nxml.txt.nlp	NULL	SENT6587	11	11	20	20	docetaxel	CD147	PA449383	682	0.989
NULL	Breast_Cancer_Res_2005_May_27_7(Suppl_1)_S19.nxml.txt.nlp	NULL	SENT8	14	14	1	1	tamoxifen	aromatase	PA451581	1588	0.989
NULL	Biosci_Rep_2013_Sep_4_33(5)_e00064.nxml.txt.nlp	23889169	SENT61	30	30	6	6	thrombin	PAR1	PA451674	79581;2149	0.989
NULL	Mol_Cancer_2009_Apr_16_8_24.nxml.txt.nlp	19371427	SENT14	11	11	1	1	cisplatin	CHK1	PA449014	1111	0.989
NULL	Mol_Syst_Biol_2009_Jul_28_5_288.nxml.txt.nlp	19638969	SENT217	13	13	45	45	geldanamycin	HuR	PA152031327	1994	0.989
NULL	Biosci_Rep_2012_Aug_1_32(Pt_4)_361-374.nxml.txt.nlp	22762204	SENT188	16	16	5	5	paclitaxel	TAZ	PA450761	25937;6901	0.989
NULL	J_Nucl_Cardiol_2012_Dec_17_19(6)_1211-1225.nxml.txt.nlp	23073913	SENT109	20	20	2	2	simvastatin	FDG	PA451363	23583	0.989
NULL	Clin_Sci_(Lond)_2011_Nov_1_121(Pt_10)_449-458.nxml.txt.nlp	21671887	SENT183	16	16	38	38	simvastatin	AMPK	PA451363	5563	0.989
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1411-1419.nxml.txt.nlp	24077634	SENT135	20	20	30	30	chloroquine	p53	PA448948	7157	0.989
NULL	Eur_J_Pharm_Sci_2012_Jul_16_46(4)_244-258.nxml.txt.nlp	22085636	SENT391	37	37	12	12	pertuzumab	PI3K		5290	0.989
NULL	Cancer_Manag_Res_2013_Jul_31_5_197-203.nxml.txt.nlp	23940421	SENT35	0	0	5	5	vismodegib	SMO		6608;54498	0.989
NULL	Br_J_Cancer_2010_Jun_29_103(1)_61-72.nxml.txt.nlp	20588279	SENT242	41	41	6	6	trastuzumab	RhoB	PA451743	388	0.989
NULL	Oncotarget_2014_Oct_21_5(22)_11709-11722.nxml.txt.nlp	25365944	SENT113	6	6	22	22	metformin	JNK	PA450395	5599	0.989
NULL	Eur_J_Clin_Pharmacol_2014_May_27_70(8)_975-981.nxml.txt.nlp	24858823	SENT64	5	5	30	30	rivaroxaban	CYP3A4	PA165958360	1576	0.989
NULL	Int_J_Endocrinol_2014_Jun_25_2014_534904.nxml.txt.nlp	25053942	SENT12	19	19	10	10	amiodarone	AIT	PA448383	160728	0.989
NULL	Ecancermedicalscience_2010_Nov_3_4_178.nxml.txt.nlp	22276032	SENT107	21	21	8	8	erlotinib	CEA	PA134687924	5670;1087	0.989
NULL	Int_J_Gen_Med_2009_Jul_30_2_77-81.nxml.txt.nlp	20360891	SENT17	6	6	26	26	hyaluronan	HAS3	PA165958431	3038	0.989
NULL	Acta_Neuropathol_Commun_2014_May_30_2_57.nxml.txt.nlp	24887326	SENT195	13	13	3	3	etoposide	MED1	PA449552	5469;8930	0.989
NULL	Curr_Chem_Genomics_2010_Mar_1_4_1-8.nxml.txt.nlp	20448812	SENT94	3	3	38	38	estropipate	OATP1B3	PA165958342	28234	0.989
NULL	EMBO_Mol_Med_2012_Dec_15_4(12)_1276-1293.nxml.txt.nlp	23065753	SENT144	4	4	23	23	cisplatin	NLRP3	PA449014	114548	0.989
NULL	Cell_Death_Dis_2014_Feb_13_5(2)_e1055.nxml.txt.nlp	24525731	SENT92	25	25	11	11	cisplatin	TXNL1	PA449014	9352	0.989
NULL	J_Gen_Physiol_2004_Aug_124(2)_125-137.nxml.txt.nlp	15277574	SENT233	4	4	0	0	forskolin	CFTR	PA146096022	1080	0.989
NULL	Cell_Commun_Signal_2011_May_20_9_14.nxml.txt.nlp	21599982	SENT73	22	22	28	28	pp2	ERK		5594	0.989
NULL	Curr_Neuropharmacol_2008_Jun_6(2)_151-163.nxml.txt.nlp	19305794	SENT158	36	36	0	0	capsaicin	TRPV1	PA448776	7442	0.989
NULL	J_Cell_Biol_1992_Feb_2_116(4)_1055-1062.nxml.txt.nlp	1370836	SENT3	25	25	9	9	hyaluronan	CD44	PA165958431	960	0.989
NULL	Oncotarget_2013_Feb_27_4(2)_329-345.nxml.txt.nlp	23593654	SENT188	14	14	8	8	paclitaxel	RSK	PA450761	6195;6196;6197	0.989
NULL	J_Hematol_Oncol_2009_Feb_23_2_10.nxml.txt.nlp	19236716	SENT107	9	9	18	18	dasatinib	CYP3A4	PA162372878	1576	0.989
NULL	Core_Evid_2009_Jun_15_4_83-92.nxml.txt.nlp	20694067	SENT73	4	4	14	14	conivaptan	CYP3A4	PA164742939	1576	0.989
NULL	Aging_(Albany_NY)_2010_Nov_11_2(11)_760-774.nxml.txt.nlp	21084729	SENT70	31	31	6	6	metformin	LKB1	PA450395	6794	0.989
NULL	Patient_Prefer_Adherence_2011_Dec_23_6_1-9.nxml.txt.nlp	22272064	SENT36	6	6	24	24	telmisartan	ACE	PA451605	1636	0.989
NULL	Patient_Prefer_Adherence_2010_Mar_24_4_61-68.nxml.txt.nlp	20361006	SENT33	4	4	9	9	liraglutide	GLP-1	PA165958364	100125288	0.989
NULL	Oncotarget_2014_Oct_21_5(22)_11709-11722.nxml.txt.nlp	25365944	SENT113	6	6	24	24	metformin	p38	PA450395	10598;1432;7965	0.989
NULL	Cell_Biol_Int_Rep_(2010)_2012_Jun_21_19(1)_e00017.nxml.txt.nlp	23124518	SENT6	25	25	1	1	etoposide	TRAIL-R2	PA449552	8795	0.989
NULL	Commun_Integr_Biol_2013_Sep_1_6(5)_e25145.nxml.txt.nlp	24255740	SENT50	11	11	4	4	neomycin	DAG	PA450608	1605	0.989
NULL	Acta_Pharmacol_Sin_2010_Feb_5_31(2)_184-190.nxml.txt.nlp	20139901	SENT29	13	13	24	24	metformin	OCT1	PA450395	5451;6580	0.989
NULL	Cancers_(Basel)_2010_Jan_14_2(1)_1-19.nxml.txt.nlp	24281029	SENT176	22	22	1	1	trastuzumab	HER2	PA451743	2064	0.989
NULL	Indian_J_Pharmacol_2008_Jun_40(3)_95-102.nxml.txt.nlp	20040934	SENT161	0	0	8	8	daclizumab	CD25	PA164764446	3669;3559	0.989
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT41	6	6	23	23	trastuzumab	HER2	PA451743	2064	0.989
NULL	Acta_Pharmacol_Sin_2010_Jan_5_31(1)_93-101.nxml.txt.nlp	20048748	SENT12	10	10	1	1	cisplatin	DAPK	PA449014	1612	0.989
NULL	Breast_Cancer_Res_2014_Sep_9_16(5)_437.nxml.txt.nlp	25200860	SENT140	11	11	9	9	pha-665752	Met		79811	0.989
NULL	Biosci_Rep_2013_Sep_4_33(5)_e00064.nxml.txt.nlp	23889169	SENT61	30	30	8	8	thrombin	PAR3	PA451674	56288;2151	0.989
NULL	Ann_Hematol_2014_Sep_12_93(1)_13-32.nxml.txt.nlp	24026426	SENT92	1	1	13	13	caspofungin	BII	PA164743013	777	0.989
NULL	Acta_Pharmacol_Sin_2010_Jan_5_31(1)_93-101.nxml.txt.nlp	20048748	SENT108	23	23	4	4	cisplatin	DAPK	PA449014	1612	0.989
NULL	Genome_Med_2010_Sep_15_2(9)_66.nxml.txt.nlp	20854646	SENT28	20	20	0	0	oxycodone	CYP2D6	PA450741	1565	0.989
NULL	Front_Oncol_2013_Sep_23_3_250.nxml.txt.nlp	24069582	SENT147	31	31	19	19	trastuzumab	HER2	PA451743	2064	0.989
NULL	Indian_J_Nephrol_2012_Jul-Aug_22(4)_275-279.nxml.txt.nlp	23162271	SENT57	33	33	0	0	azathioprine	IL-2	PA448515	3558	0.989
NULL	Leukemia_2013_Dec_27_27(12)_2322-2331.nxml.txt.nlp	24072044	SENT114	48	48	41	41	plerixafor	CXCR4	PA165958410	7852	0.989
NULL	Open_Biochem_J_2011_Sep_23_5_45-51.nxml.txt.nlp	21966325	SENT119	17	17	32	32	diclofenac	XBP1	PA449293	7494	0.989
NULL	Acta_Pharmacol_Sin_2012_Mar_27_33(3)_342-350.nxml.txt.nlp	22367283	SENT193	35	35	18	18	trypsin	PAR4	PA451806	9002;5074	0.989
NULL	Mol_Cell_Proteomics_2014_May_17_13(5)_1273-1285.nxml.txt.nlp	24637012	SENT230	15	15	4	4	ergotamine	5-HT2A	PA164747651	3356	0.989
NULL	Clin_Psychopharmacol_Neurosci_2013_Aug_26_11(2)_60-66.nxml.txt.nlp	24023549	SENT23	0	0	24	24	aripiprazole	5-HT2A	PA10026	3356	0.989
NULL	Leukemia_2013_Jan_11_27(1)_32-40.nxml.txt.nlp	22781593	SENT159	6	6	13	13	ponatinib	FGFR1	PA165980594	2260	0.989
NULL	Diabetes_Metab_Syndr_Obes_2013_Sep_2_6_317-325.nxml.txt.nlp	24039439	SENT120	4	4	21	21	mitiglinide	GLP-1	PA164748124	100125288	0.989
NULL	Oncoimmunology_2013_Jun_1_2(6)_e24677.nxml.txt.nlp	23894722	SENT98	42	42	11	11	cetuximab	CD107a	PA10040	3916	0.989
NULL	Eur_J_Haematol_2009_Apr_82(4)_277-287.nxml.txt.nlp	19187270	SENT80	0	0	17	17	pha-665752	IL-6		3569	0.989
NULL	Cancer_Manag_Res_2011_May_10_3_157-175.nxml.txt.nlp	21625399	SENT136	5	5	27	27	midazolam	CYP3A4	PA450496	1576	0.989
NULL	Cancers_(Basel)_2014_Nov_25_6(4)_2313-2329.nxml.txt.nlp	25534569	SENT32	0	0	11	11	cabozantinib	Met	PA165906891	79811	0.989
NULL	JAKSTAT_2012_Apr_1_1(2)_83-89.nxml.txt.nlp	24058756	SENT150	13	13	4	4	losartan	AT2	PA450268	186	0.989
NULL	Anticancer_Agents_Med_Chem_2012_Feb_12(2)_163-171.nxml.txt.nlp	22043994	SENT143	21	21	8	8	cetuximab	KRAS	PA10040	3845	0.989
NULL	Cancer_Res_Treat_2012_Sep_30_44(3)_195-201.nxml.txt.nlp	23091446	SENT156	25	25	6	6	irinotecan	MKP-1	PA450085	1843	0.989
NULL	Clin_Mol_Allergy_2009_Mar_12_7_5.nxml.txt.nlp	19284628	SENT180	5	5	13	13	estradiol	CD4	PA449503	920	0.989
NULL	Br_J_Cancer_2010_Oct_26_103(9)_1380-1390.nxml.txt.nlp	20877355	SENT213	0	0	7	7	doxorubicin	DR5	PA449412	8795	0.989
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT52	21	21	9	9	chloroquine	BMPR-II	PA448948	659	0.989
NULL	Environ_Health_Perspect_1999_May_107(5)_397-405.nxml.txt.nlp	10210696	SENT8	2	2	21	21	tamoxifen	DES	PA451581	1674	0.989
NULL	Br_J_Cancer_2001_Jan_1_84(1)_42-47.nxml.txt.nlp	11139311	SENT1	3	3	25	25	paclitaxel	P-gp	PA450761	5243	0.989
NULL	Cerebrospinal_Fluid_Res_2010_Aug_12_7_11.nxml.txt.nlp	20704740	SENT236	2	2	14	14	calcein	P-gp	PA132595336	5243	0.989
NULL	Ther_Clin_Risk_Manag_2006_Mar_2(1)_59-75.nxml.txt.nlp	18360582	SENT243	28	28	5	5	pimozide	CYP3A4	PA450965	1576	0.989
NULL	Br_J_Cancer_2012_Apr_24_106(9)_1543-1550.nxml.txt.nlp	22531721	SENT156	9	9	29	29	trastuzumab	CD55	PA451743	1604	0.989
NULL	Oncotarget_2013_Jul_26_4(8)_1317-1328.nxml.txt.nlp	23945331	SENT175	10	10	29	29	trastuzumab	ATG12	PA451743	9140	0.989
NULL	Cells_2014_May_23_3(2)_517-545.nxml.txt.nlp	24861977	SENT240	5	5	20	20	capsaicin	TRPV1	PA448776	7442	0.989
NULL	Cancer_Res_Treat_2012_Sep_30_44(3)_195-201.nxml.txt.nlp	23091446	SENT16	22	22	10	10	irinotecan	MKP-1	PA450085	1843	0.989
NULL	Indian_J_Med_Res_2012_Feb_135(2)_211-216.nxml.txt.nlp	22446863	SENT113	0	0	21	21	zoxazolamine	CYP2E1	PA452606	1571	0.989
NULL	Surg_Neurol_Int_2014_May_8_5_64.nxml.txt.nlp	24991467	SENT173	20	20	12	12	cetuximab	EGFR	PA10040	1956	0.989
NULL	Acta_Pharmacol_Sin_2009_Sep_24_30(9)_1323-1329.nxml.txt.nlp	19701237	SENT110	17	17	12	12	clarithromycin	CYP3A	PA449028	1574	0.989
NULL	J_Skin_Cancer_2012_Dec_13_2012_147863.nxml.txt.nlp	23316365	SENT182	1	1	8	8	curcumin	IL-6	PA151958596	3569	0.989
NULL	Gut_2013_Apr_14_62(4)_540-549.nxml.txt.nlp	22798500	SENT254	15	15	9	9	panitumumab	BRAF	PA162373091	673	0.989
NULL	Europace_2014_Oct_12_16(10)_1443-1449.nxml.txt.nlp	25115168	SENT68	17	17	6	6	protamine	ACT	PA10366	12;11332;9457;641455	0.989
NULL	Breast_Cancer_Res_2006_Nov_6_8(6)_215.nxml.txt.nlp	17096862	SENT41	12	12	0	0	trastuzumab	MUC4	PA451743	4585	0.989
NULL	J_Hematol_Oncol_2012_Jul_16_5_39.nxml.txt.nlp	22800464	SENT28	2	2	23	23	sorafenib	FLT3	PA7000	2322	0.989
NULL	J_Oncol_2010_Dec_15_2010_821717.nxml.txt.nlp	20049172	SENT161	27	27	13	13	paclitaxel	TUBB3	PA450761	10381	0.989
NULL	Oncotarget_2013_Dec_18_5(2)_375-385.nxml.txt.nlp	24495868	SENT255	16	16	1	1	fludarabine	Hsp90	PA449655	3320	0.989
NULL	Indian_J_Ophthalmol_2014_Jan_62(1)_74-81.nxml.txt.nlp	24492505	SENT201	0	0	9	9	tocilizumab	IL-6	PA165292659	3569	0.989
NULL	Int_J_Biol_Sci_2014_Jun_21_10(7)_702-714.nxml.txt.nlp	25013379	SENT140	0	0	7	7	gefitinib	EGFR	PA131301952	1956	0.989
NULL	Exp_Cell_Res_2013_Apr_1_319(6)_800-809.nxml.txt.nlp	23247073	SENT205	14	14	34	34	curcumin	AKT	PA151958596	207	0.989
NULL	Braz_J_Med_Biol_Res_2014_Sep_5_47(11)_929-939.nxml.txt.nlp	25296354	SENT94	0	0	26	26	gefitinib	EGFR	PA131301952	1956	0.989
NULL	Cancer_Manag_Res_2013_Oct_8_5_337-347.nxml.txt.nlp	24204170	SENT40	16	16	9	9	sorafenib	EGFR	PA7000	1956	0.989
NULL	Mol_Pain_2013_Feb_15_9_3.nxml.txt.nlp	23413875	SENT177	11	11	17	17	resveratrol	TRPA1		8989	0.989
NULL	Curr_Immunol_Rev_2013_Nov_9(4)_214-221.nxml.txt.nlp	24876829	SENT94	9	9	18	18	papain	IL-9	PA450778	3578	0.989
NULL	Breast_Cancer_Res_2011_Jun_29_13(3)_R70.nxml.txt.nlp	21707964	SENT230	17	17	7	7	tamoxifen	14-3-3	PA451581	10971	0.989
NULL	Open_Dent_J_2014_May_30_8_109-124.nxml.txt.nlp	24976875	SENT180	0	0	17	17	minocycline	PARP-1	PA450519	25976	0.989
NULL	Arthritis_Res_Ther_2013_Oct_10_15(5)_R151.nxml.txt.nlp	24289089	SENT38	16	16	0	0	bleomycin	IL-17A	PA448645	3605	0.989
NULL	Oncotarget_2013_Apr_16_4(5)_677-690.nxml.txt.nlp	23633472	SENT107	36	36	10	10	doxorubicin	XIAP	PA449412	331	0.989
NULL	Evid_Based_Complement_Alternat_Med_2006_Sep_20_3(3)_365-372.nxml.txt.nlp	16951721	SENT103	1	1	17	17	ginseng	Bcl-2	PA164781150	596	0.989
NULL	Front_Neurosci_2014_Jun_3_8_128.nxml.txt.nlp	24917782	SENT11	24	24	1	1	ethanol	MC3R	PA448073	4159	0.989
NULL	EJC_Suppl_2013_Sep_5_11(2)_97-105.nxml.txt.nlp	NULL	SENT243	3	3	21	21	vemurafenib	BRAF	PA165946873	673	0.989
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT42	21	21	10	10	adalimumab	CD36	PA10004	948	0.989
NULL	Br_J_Cancer_2012_Jan_3_106(1)_18-24.nxml.txt.nlp	22108516	SENT96	9	9	23	23	irinotecan	XRCC1	PA450085	7515	0.989
NULL	Cancers_(Basel)_2014_Mar_26_6(2)_708-722.nxml.txt.nlp	24675568	SENT109	17	17	9	9	afatinib	IL-6	PA165981154	3569	0.989
NULL	Breast_Cancer_Res_Treat_2014_Nov_11_148(3)_563-570.nxml.txt.nlp	25385180	SENT174	7	7	19	19	trastuzumab	EGFR	PA451743	1956	0.989
NULL	Breast_Cancer_Res_Treat_2014_Oct_22_148(2)_315-325.nxml.txt.nlp	25338319	SENT16	17	17	0	0	trastuzumab	HER2	PA451743	2064	0.989
NULL	Br_J_Pharmacol_2013_Jun_27_169(4)_736-747.nxml.txt.nlp	23489111	SENT115	3	3	26	26	granisetron	5-HT3A	PA449809	3359	0.989
NULL	Oncogene_2013_Oct_24_32(43)_5176-5185.nxml.txt.nlp	23208500	SENT136	26	26	1	1	camptothecin	TP53	PA153590860	7157	0.989
NULL	Int_J_Surg_Oncol_2012_May_17_2012_406830.nxml.txt.nlp	22675625	SENT49	41	41	0	0	erlotinib	EGFR	PA134687924	1956	0.989
NULL	Case_Rep_Oncol_Med_2011_Jul_2_2011_985242.nxml.txt.nlp	22606451	SENT91	15	15	5	5	imatinib	KIT	PA10804	3815	0.989
NULL	Mol_Cancer_2010_Apr_12_9_75.nxml.txt.nlp	20385023	SENT211	12	12	5	5	imatinib	P-gp	PA10804	5243	0.989
NULL	J_Cancer_2013_Jan_11_4(2)_117-132.nxml.txt.nlp	23386910	SENT58	0	0	11	11	lapatinib	HER2	PA152241907	2064	0.989
NULL	Cancer_Med_2013_Jun_2_2(3)_286-295.nxml.txt.nlp	23930205	SENT200	5	5	20	20	gefitinib	EGFR	PA131301952	1956	0.989
NULL	Mol_Cancer_2014_Aug_16_13(1)_193.nxml.txt.nlp	NULL	SENT142	21	21	6	6	cisplatin	RKIP	PA449014	5037	0.989
NULL	Arthritis_Res_Ther_2009_Jan_30_11(1)_206.nxml.txt.nlp	19232066	SENT107	13	13	5	5	etanercept	TNF	PA449515	7124	0.989
NULL	Front_Genet_2013_Aug_30_4_166.nxml.txt.nlp	24009623	SENT199	32	32	8	8	everolimus	PITPNM3	PA164746311	83394	0.989
NULL	Br_J_Cancer_1987_Mar_55(3)_255-257.nxml.txt.nlp	3567059	SENT11	16	16	0	0	tamoxifen	IFN	PA451581	3439	0.989
NULL	J_Immunol_Res_2014_May_8_2014_565320.nxml.txt.nlp	24901010	SENT65	17	17	4	4	phenytoin	HLA-B	PA450947	3106	0.989
NULL	Evid_Based_Complement_Alternat_Med_2011_Jan_20_2011_713523.nxml.txt.nlp	21318104	SENT18	0	0	6	6	verapamil	P-gp	PA451868	5243	0.989
NULL	Core_Evid_2010_Oct_21_5_61-76.nxml.txt.nlp	21042543	SENT421	34	34	4	4	cetuximab	KRAS	PA10040	3845	0.989
NULL	J_Biomed_Biotechnol_2011_Dec_6_2011_856985.nxml.txt.nlp	21188173	SENT258	16	16	24	24	tamoxifen	aromatase	PA451581	1588	0.989
NULL	Breast_Cancer_Res_2010_May_18_12(Suppl_1)_P58.nxml.txt.nlp	NULL	SENT5	2	2	25	25	doxorubicin	TRAIL	PA449412	8743	0.989
NULL	Front_Plant_Sci_2011_Jun_6_2_18.nxml.txt.nlp	22645527	SENT121	33	33	9	9	chymotrypsin	MP17	PA448994	3982	0.989
NULL	Ann_Hematol_2014_Apr_1_93(8)_1371-1380.nxml.txt.nlp	24687382	SENT32	7	7	29	29	lenalidomide	IL-2	PA162363968	3558	0.989
NULL	Aging_(Albany_NY)_2009_Jun_3_1(6)_515-528.nxml.txt.nlp	20157535	SENT9	26	26	4	4	resveratrol	S6K1		6198	0.989
NULL	J_Cancer_2013_Aug_28_4(7)_585-596.nxml.txt.nlp	24069069	SENT158	33	33	5	5	verteporfin	LC3	PA451871	84557	0.989
NULL	Breast_Cancer_(Auckl)_2012_Mar_7_6_67-77.nxml.txt.nlp	22438669	SENT160	20	20	7	7	lapatinib	HER2	PA152241907	2064	0.989
NULL	Mol_Cancer_2010_Mar_25_9_68.nxml.txt.nlp	20338046	SENT192	29	29	1	1	doxorubicin	FOXC1	PA449412	2296	0.989
NULL	Mol_Vis_2007_Jul_9_13_1083-1093.nxml.txt.nlp	17653053	SENT14	2	2	39	39	minocycline	p65	PA450519	5970	0.989
NULL	Indian_J_Dermatol_2014_Nov-Dec_59(6)_592-594.nxml.txt.nlp	25484391	SENT74	1	1	20	20	dapsone	EED	PA449211	8726	0.989
NULL	Asian_J_Androl_2015_Oct_24_Jan-Feb_17(1)_61-67.nxml.txt.nlp	25370206	SENT10	22	22	1	1	sildenafil	SEP2	PA451346	23176;23157	0.989
NULL	Nucleic_Acids_Res_2014_Jan_2_42(Database_issue)_D178-D183.nxml.txt.nlp	24302579	SENT144	27	27	10	10	imatinib	GATA1	PA10804	2623	0.989
NULL	Acta_Pharmacol_Sin_2009_Sep_24_30(9)_1262-1275.nxml.txt.nlp	19701231	SENT130	14	14	2	2	lovastatin	CYP1A1	PA450272	1543	0.989
NULL	Cardiovasc_Res_2009_May_1_82(2)_296-302.nxml.txt.nlp	19088082	SENT178	22	22	3	3	desipramine	nSMase	PA449233	6610	0.989
NULL	Braz_J_Med_Biol_Res_2014_Sep_5_47(11)_1008-1015.nxml.txt.nlp	25296365	SENT50	28	28	9	9	tamoxifen	CYP2D6	PA451581	1565	0.989
NULL	Neuropsychopharmacology_2012_Feb_2_37(3)_641-650.nxml.txt.nlp	22048466	SENT133	23	23	42	42	bupropion	CYP2B6	PA448687	1555	0.989
NULL	Case_Rep_Oncol_Med_2014_Sep_14_2014_858265.nxml.txt.nlp	25295203	SENT90	38	38	32	32	gefitinib	EGFR	PA131301952	1956	0.989
NULL	Mol_Cells_2014_Mar_31_37(3)_234-240.nxml.txt.nlp	24642709	SENT15	6	6	20	20	capsaicin	HO-1	PA448776	3162	0.989
NULL	Commun_Integr_Biol_2013_Jan_1_6(1)_e22278.nxml.txt.nlp	23802033	SENT30	12	12	43	43	nifedipine	Dicer	PA450631	23405	0.989
NULL	Br_J_Pharmacol_2014_Apr_28_171(8)_1798-1817.nxml.txt.nlp	24116962	SENT208	7	7	19	19	taurine	MELAS	PA451590	4219	0.989
NULL	Breast_Cancer_Res_2010_Jun_24_12(3)_R41.nxml.txt.nlp	20576088	SENT247	4	4	39	39	paclitaxel	MT3	PA450761	4504	0.989
NULL	Cardiol_Res_Pract_2013_Feb_21_2013_127270.nxml.txt.nlp	23509665	SENT38	2	2	10	10	ticagrelor	P2Y12	PA165374673	64805	0.989
NULL	Ann_Oncol_2013_Aug_12_24(8)_1994-1999.nxml.txt.nlp	23670096	SENT17	14	14	5	5	tamoxifen	AIB1	PA451581	8202	0.989
NULL	Int_J_Endocrinol_2010_Feb_10_2010_625852.nxml.txt.nlp	20169119	SENT189	6	6	16	16	paricalcitol	PTH	PA450798	5741	0.989
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT177	19	19	8	8	phenprocoumon	VKORC1	PA450921	79001	0.989
NULL	Acta_Pharmacol_Sin_2011_Feb_4_32(2)_223-229.nxml.txt.nlp	21293474	SENT158	25	25	12	12	isoproterenol	FKBP12	PA450121	2280	0.989
NULL	Breast_Cancer_Res_Treat_2007_Oct_27_105(Suppl_1)_19-29.nxml.txt.nlp	17333340	SENT40	22	22	6	6	aminoglutethimide	aromatase	PA448375	1588	0.989
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_650809.nxml.txt.nlp	23258995	SENT170	0	0	20	20	vasopressin	AQP2	PA451858	359	0.989
NULL	Oncogene_2014_Jun_5_33(23)_3033-3042.nxml.txt.nlp	23851504	SENT174	26	26	16	16	tamoxifen	AIB1	PA451581	8202	0.989
NULL	J_Clin_Biochem_Nutr_2007_Jul_27_41(1)_32-42.nxml.txt.nlp	18392098	SENT165	24	24	7	7	curcumin	PARP	PA151958596	142	0.989
NULL	Indian_J_Med_Res_2014_Apr_139(4)_572-578.nxml.txt.nlp	24927344	SENT11	9	9	16	16	acenocoumarol	GGCX	PA452632	2677	0.989
NULL	BMJ_2011_Aug_4_343_d4588.nxml.txt.nlp	21816733	SENT317	11	11	15	15	clopidogrel	CYP2C19	PA449053	1557	0.989
NULL	Acta_Pharmacol_Sin_2013_Jan_23_34(1)_33-38.nxml.txt.nlp	22820909	SENT71	3	3	29	29	amiloride	ASIC3	PA448368	9311	0.989
NULL	Int_J_Biol_Sci_2014_Sep_6_10(9)_1007-1017.nxml.txt.nlp	25210499	SENT103	3	3	30	30	tamoxifen	p63	PA451581	8626	0.989
NULL	J_Cell_Biol_2001_Apr_30_153(3)_613-620.nxml.txt.nlp	11331310	SENT7	25	25	0	0	etoposide	53BP1	PA449552	7158	0.989
NULL	Front_Chem_2014_Nov_26_2_105.nxml.txt.nlp	25505783	SENT214	3	3	9	9	trastuzumab	HER2	PA451743	2064	0.989
NULL	Nucleic_Acids_Res_2010_Oct_21_38(18)_6159-6175.nxml.txt.nlp	20494973	SENT461	11	11	5	5	panitumumab	BRAF	PA162373091	673	0.989
NULL	Cancers_(Basel)_2013_Jun_24_5(3)_762-785.nxml.txt.nlp	24202320	SENT323	4	4	14	14	levamisole	VEGFR	PA450205	3791	0.989
NULL	Mol_Brain_2013_Feb_12_6_8.nxml.txt.nlp	23402298	SENT134	8	8	20	20	remifentanil	OPRM1	PA451232	4988	0.989
NULL	Indian_J_Nephrol_2012_Mar-Apr_22(2)_139-142.nxml.txt.nlp	22787319	SENT111	6	6	22	22	cyclosporine	P-gp	PA449167	5243	0.989
NULL	Orphanet_J_Rare_Dis_2011_Oct_3_6_63.nxml.txt.nlp	21967988	SENT74	1	1	16	16	diazoxide	ABCC8	PA449285	6833	0.989
NULL	Arthritis_Res_Ther_2012_Apr_16_14(2)_R76.nxml.txt.nlp	22507741	SENT134	20	20	4	4	estradiol	IFN	PA449503	3439	0.989
NULL	Front_Oncol_2014_May_1_4_80.nxml.txt.nlp	24822169	SENT364	34	34	26	26	tamoxifen	NCOR1	PA451581	9611	0.989
NULL	Blood_Cancer_J_2014_Feb_28_4(2)_e187.nxml.txt.nlp	24583533	SENT42	35	35	10	10	azacitidine	CD25	PA451996	3669;3559	0.989
NULL	Int_J_Biol_Sci_2012_Mar_7_8(4)_470-485.nxml.txt.nlp	22419892	SENT265	2	2	16	16	tamoxifen	SRC-3	PA451581	8202	0.989
NULL	Mol_Cancer_2014_Jun_30_13_160.nxml.txt.nlp	24976026	SENT153	30	30	9	9	bortezomib	AGR2	PA10252	10551	0.989
NULL	Breast_Cancer_Res_2004_Aug_5_6(5)_R601-R607.nxml.txt.nlp	15318941	SENT123	28	28	7	7	paclitaxel	p27	PA450761	5715;10534	0.989
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT191	31	31	11	11	trimethoprim	NAPA	PA451788	9476;8775	0.989
NULL	Breast_Cancer_Res_2008_Mar_29_10(2)_R28.nxml.txt.nlp	18373870	SENT154	18	18	4	4	estradiol	HSPC111	PA449503	51491	0.989
NULL	Pharmaceuticals_(Basel)_2013_Aug_2_6(8)_915-928.nxml.txt.nlp	24276376	SENT72	35	35	18	18	aspirin	PAR-1	PA448497	2011;2149	0.989
NULL	Br_J_Cancer_1996_Feb_73(4)_539-542.nxml.txt.nlp	8595171	SENT11	23	23	7	7	tamoxifen	aromatase	PA451581	1588	0.989
NULL	Int_J_Breast_Cancer_2011_Sep_6_2011_352182.nxml.txt.nlp	22295219	SENT201	24	24	9	9	erlotinib	HER3	PA134687924	2065	0.989
NULL	Oncotarget_2014_Oct_18_5(22)_11588-11603.nxml.txt.nlp	25473890	SENT16	42	42	5	5	imatinib	PDGFRA	PA10804	5156	0.989
NULL	Breast_Cancer_Res_2011_Dec_16_13(6)_R131.nxml.txt.nlp	22177475	SENT188	32	32	4	4	trastuzumab	HER2	PA451743	2064	0.989
NULL	Biomed_Res_Int_2013_Sep_4_2013_419176.nxml.txt.nlp	24093097	SENT114	35	35	5	5	sunitinib	AKT	PA162372840	207	0.989
NULL	Eur_J_Clin_Pharmacol_2011_May_8_67(5)_493-506.nxml.txt.nlp	21140139	SENT13	17	17	0	0	oxycodone	CYP3A4	PA450741	1576	0.989
NULL	Br_J_Cancer_2012_Oct_9_107(8)_1268-1276.nxml.txt.nlp	22996612	SENT143	7	7	33	33	axitinib	mol	PA164924493	90527	0.989
NULL	Biomed_Res_Int_2014_Jun_24_2014_132702.nxml.txt.nlp	25050322	SENT179	0	0	32	32	metformin	HIF-1	PA450395	29072	0.989
NULL	Br_J_Cancer_2012_Jun_5_106(12)_1997-2003.nxml.txt.nlp	22596232	SENT118	11	11	6	6	sorafenib	CD133	PA7000	8842	0.989
NULL	Leukemia_2013_Jan_11_27(1)_32-40.nxml.txt.nlp	22781593	SENT112	3	3	40	40	ponatinib	FGFR1	PA165980594	2260	0.989
NULL	Breast_Cancer_Res_2012_Feb_13_14(1)_R28.nxml.txt.nlp	22330809	SENT153	23	23	15	15	trastuzumab	PIK3CA	PA451743	5290	0.989
NULL	Environ_Health_Perspect_2007_Oct_19_115(10)_1454-1459.nxml.txt.nlp	17938735	SENT139	2	2	6	6	procainamide	DNMT1	PA451108	1786	0.989
NULL	Br_J_Cancer_2009_Sep_15_101(6)_924-934.nxml.txt.nlp	19690550	SENT228	29	29	7	7	capecitabine	CRT	PA448771	811	0.989
NULL	Ann_Saudi_Med_2011_Jul-Aug_31(4)_402-406.nxml.txt.nlp	21727749	SENT4	30	30	10	10	metformin	DPP4	PA450395	1803	0.989
NULL	Oxid_Med_Cell_Longev_2013_Nov_28_2013_568093.nxml.txt.nlp	24379901	SENT85	6	6	13	13	resveratrol	SIRT1		23411	0.989
NULL	Mol_Cancer_2013_May_24_12_47.nxml.txt.nlp	23705854	SENT117	6	6	25	25	vinblastine	P-gp	PA451877	5243	0.989
NULL	J_Immunother_Cancer_2013_Nov_7_1(Suppl_1)_P34.nxml.txt.nlp	NULL	SENT10	24	24	9	9	alemtuzumab	CD52	PA164783958	1043	0.989
NULL	Clin_Med_Insights_Arthritis_Musculoskelet_Disord_2013_Aug_8_6_35-43.nxml.txt.nlp	23997576	SENT201	0	0	6	6	tocilizumab	IL-6	PA165292659	3569	0.989
NULL	Anesth_Essays_Res_2013_Sep-Dec_7(3)_302-306.nxml.txt.nlp	NULL	SENT151	27	27	15	15	neostigmine	NMB	PA450611	10457;4828	0.989
NULL	Biomed_Res_Int_2014_May_20_2014_418975.nxml.txt.nlp	24967364	SENT201	0	0	8	8	resveratrol	MCP-1		6347	0.989
NULL	Acta_Neuropathol_2007_Nov_6_114(5)_443-458.nxml.txt.nlp	17805551	SENT263	17	17	0	0	gefitinib	EGFR	PA131301952	1956	0.989
NULL	Nat_Med_2012_Jul_18(7)_1118-1122.nxml.txt.nlp	22683780	SENT40	19	19	8	8	crizotinib	HGF	PA165946122	3569;6654;3082	0.989
NULL	J_Korean_Med_Sci_2007_Dec_20_22(6)_1055-1059.nxml.txt.nlp	18162722	SENT86	3	3	14	14	pantoprazole	ESD	PA450774	2098	0.989
NULL	Br_J_Cancer_2012_Dec_4_107(12)_1950-1955.nxml.txt.nlp	23169295	SENT95	3	3	13	13	oxaliplatin	DPD	PA131285527	1806	0.989
NULL	Mol_Vis_2012_Jan_28_18_234-240.nxml.txt.nlp	22312192	SENT27	33	33	6	6	pegaptanib	VEGF-A	PA164771236	7422	0.989
NULL	Daru_2011_19(1)_57-64.nxml.txt.nlp	22615640	SENT132	0	0	37	37	lovastatin	GIT	PA450272	5034	0.989
NULL	Anat_Cell_Biol_2012_Jun_30_45(2)_73-78.nxml.txt.nlp	22822460	SENT85	19	19	0	0	gemcitabine	EGFR	PA449748	1956	0.989
NULL	Cell_Death_Dis_2013_Sep_19_4(9)_e807.nxml.txt.nlp	24052075	SENT64	12	12	30	30	doxorubicin	p63	PA449412	8626	0.989
NULL	Indian_J_Med_Res_2014_Feb_139(2)_205-215.nxml.txt.nlp	24718394	SENT105	13	13	37	37	artemether	ACT	PA165111698	12;11332;9457;641455	0.989
NULL	Breast_Cancer_Res_Treat_2013_Jan_10_137(1)_1-12.nxml.txt.nlp	23143215	SENT105	0	0	16	16	lapatinib	HER2	PA152241907	2064	0.989
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT54	15	15	8	8	chloroquine	BMPR-II	PA448948	659	0.989
NULL	Cancer_Cell_Int_2013_Mar_4_13_21.nxml.txt.nlp	23497288	SENT109	12	12	1	1	doxorubicin	p53	PA449412	7157	0.989
NULL	Br_J_Cancer_2010_Sep_7_103(6)_765-771.nxml.txt.nlp	20700120	SENT135	31	31	14	14	tamoxifen	CYP2D6	PA451581	1565	0.989
NULL	Br_J_Cancer_2009_May_19_100(10)_1523-1529.nxml.txt.nlp	19401686	SENT64	26	26	7	7	gefitinib	EGFR	PA131301952	1956	0.989
NULL	EMBO_J_2013_Oct_16_32(20)_2751-2763.nxml.txt.nlp	24065129	SENT109	24	24	17	17	doxorubicin	STAT1	PA449412	6772	0.989
NULL	Breast_Cancer_Res_Treat_2012_Jun_18_133(3)_937-947.nxml.txt.nlp	22094936	SENT13	22	22	12	12	tamoxifen	EZH2	PA451581	2146	0.989
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1059-1066.nxml.txt.nlp	21364577	SENT5	36	36	2	2	tamoxifen	aromatase	PA451581	1588	0.989
NULL	Mol_Biol_Cell_2013_Sep_1_24(17)_2678-2688.nxml.txt.nlp	23864716	SENT82	7	7	28	28	thrombin	PP2	PA451674	4888	0.989
NULL	Diabetes_Metab_J_2013_Feb_15_37(1)_36-39.nxml.txt.nlp	23441298	SENT45	17	17	8	8	vildagliptin	PPG	PA165958346	5552	0.989
NULL	Mol_Cancer_2009_Apr_16_8_24.nxml.txt.nlp	19371427	SENT275	6	6	1	1	cisplatin	CHK1	PA449014	1111	0.989
NULL	Biomed_Res_Int_2013_Mar_28_2013_154073.nxml.txt.nlp	23607088	SENT14	0	0	47	47	clopidogrel	ADP	PA449053	23038	0.989
NULL	Ann_Oncol_2013_Sep_4_24(9)_2206-2223.nxml.txt.nlp	23917950	SENT252	5	5	15	15	tamoxifen	aromatase	PA451581	1588	0.989
NULL	Front_Endocrinol_(Lausanne)_2014_Aug_18_5_129.nxml.txt.nlp	25183960	SENT104	36	36	13	13	cabergoline	ghrelin	PA448708	51738	0.989
NULL	Oncol_Lett_2014_Apr_24_7(4)_1027-1032.nxml.txt.nlp	24944663	SENT109	0	0	7	7	bevacizumab	VEGF-A	PA130232992	7422	0.989
NULL	Cancer_Cell_Int_2011_Apr_25_11_11.nxml.txt.nlp	21518433	SENT122	4	4	20	20	colchicine	TRF2	PA449092	7014;9519	0.989
NULL	Case_Rep_Oncol_2014_May_24_7(2)_343-348.nxml.txt.nlp	24987354	SENT69	14	14	27	27	vemurafenib	BRAF	PA165946873	673	0.989
NULL	Br_J_Cancer_2011_Jul_26_105(3)_403-406.nxml.txt.nlp	21730978	SENT5	0	0	12	12	cetuximab	KRAS	PA10040	3845	0.989
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_55-78.nxml.txt.nlp	19305788	SENT207	5	5	40	40	memantine	spatial	PA10364	219793	0.989
NULL	Ann_Clin_Microbiol_Antimicrob_2005_Jan_20_4_3.nxml.txt.nlp	15659247	SENT20	20	20	26	26	efavirenz	P-gp	PA449441	5243	0.989
NULL	Curr_Neuropharmacol_2008_Sep_6(3)_215-234.nxml.txt.nlp	19506722	SENT98	7	7	17	17	imipramine	5-HT2A	PA449969	3356	0.989
NULL	J_Korean_Med_Sci_2014_Jul_11_29(7)_965-972.nxml.txt.nlp	25045229	SENT23	17	17	2	2	metformin	B12	PA450395	7126;4709	0.989
NULL	Breast_Cancer_Res_2008_Jul_16_10(4)_R60.nxml.txt.nlp	18631394	SENT21	0	0	10	10	trastuzumab	HER2	PA451743	2064	0.989
NULL	Oncotarget_2011_Sep_9_2(9)_658-668.nxml.txt.nlp	21911919	SENT5	17	17	4	4	daunorubicin	HO-1	PA449212	3162	0.989
NULL	Diabetes_Care_2009_Oct_10_32(10)_1880-1886.nxml.txt.nlp	19592625	SENT32	0	0	13	13	exenatide	GLP-1	PA164749238	100125288	0.989
NULL	Neural_Regen_Res_2013_Mar_25_8(9)_825-832.nxml.txt.nlp	25206730	SENT176	15	15	33	33	isoflurane	P2X7	PA450106	5027	0.989
NULL	Comp_Hepatol_2005_Feb_8_4_2.nxml.txt.nlp	15701172	SENT151	10	10	1	1	ketoconazole	CYP3A	PA450146	1574	0.989
NULL	Diabetes_Metab_J_2012_Aug_20_36(4)_293-299.nxml.txt.nlp	22950061	SENT151	6	6	30	30	metformin	PI3K	PA450395	5290	0.989
NULL	Front_Neurosci_2012_Feb_8_6_10.nxml.txt.nlp	22347156	SENT210	40	40	7	7	finasteride	TSPO	PA449627	706	0.989
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S279-S284.nxml.txt.nlp	21525469	SENT53	0	0	13	13	liraglutide	GLP-1	PA165958364	100125288	0.989
NULL	J_Mol_Med_(Berl)_2014_May_10_92(7)_709-722.nxml.txt.nlp	24811491	SENT90	31	31	1	1	panitumumab	BRAF	PA162373091	673	0.989
NULL	Ann_Clin_Transl_Neurol_2014_Jan_20_1(1)_15-26.nxml.txt.nlp	25356379	SENT108	37	37	17	17	isoflurane	EGO	PA450106	100126791	0.989
NULL	J_Cancer_2013_Nov_23_4(9)_736-754.nxml.txt.nlp	24312144	SENT54	13	13	0	0	gefitinib	EGFR	PA131301952	1956	0.989
NULL	Br_J_Cancer_2010_Oct_12_103(8)_1309-1310.nxml.txt.nlp	NULL	SENT17	23	23	31	31	sunitinib	IFN	PA162372840	3439	0.989
NULL	Environ_Health_Perspect_2008_Mar_26_116(3)_322-328.nxml.txt.nlp	18335098	SENT134	13	13	23	23	estradiol	PMI	PA449503	8834;5373	0.989
NULL	Contemp_Oncol_(Pozn)_2012_Nov_20_16(5)_401-406.nxml.txt.nlp	23788917	SENT60	7	7	29	29	afatinib	EGFR	PA165981154	1956	0.989
NULL	Oncol_Rep_2014_Apr_28_31(4)_1605-1612.nxml.txt.nlp	24481648	SENT135	15	15	22	22	calcein	P-gp	PA132595336	5243	0.989
NULL	Oncotarget_2013_Jul_15_4(8)_1126-1127.nxml.txt.nlp	23907591	SENT38	0	0	7	7	denosumab	RANKL	PA166048634	8600	0.989
NULL	Ther_Clin_Risk_Manag_2006_Mar_2(1)_87-98.nxml.txt.nlp	18360584	SENT88	8	8	33	33	sorafenib	BRAF	PA7000	673	0.989
NULL	J_Cardiothorac_Surg_2010_Mar_25_5_14.nxml.txt.nlp	20334704	SENT47	10	10	0	0	heparin	ACT	PA449855	12;11332;9457;641455	0.989
NULL	Cancer_Med_2014_Oct_24_3(5)_1159-1169.nxml.txt.nlp	25060396	SENT201	0	0	9	9	bortezomib	SP1	PA10252	6667	0.989
NULL	Oncotarget_2014_Sep_10_5(20)_9877-9888.nxml.txt.nlp	25245676	SENT170	8	8	23	23	cetuximab	EGFR	PA10040	1956	0.989
NULL	Breast_Cancer_Res_2004_Jul_29_6(5)_204-210.nxml.txt.nlp	15318926	SENT57	0	0	4	4	ekb-569	EGFR		1956	0.989
NULL	Evid_Based_Complement_Alternat_Med_2011_Feb_14_2011_650263.nxml.txt.nlp	21799686	SENT145	20	20	8	8	atropine	AKT2	PA448505	208	0.989
NULL	Mol_Cancer_2006_Sep_5_5_34.nxml.txt.nlp	16953886	SENT9	13	13	1	1	doxorubicin	XIAP	PA449412	331	0.989
NULL	Br_J_Cancer_2014_Jan_21_110(2)_384-391.nxml.txt.nlp	24346286	SENT15	20	20	0	0	trastuzumab	HER3	PA451743	2065	0.989
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_67-74.nxml.txt.nlp	17912637	SENT43	37	37	17	17	estradiol	aromatase	PA449503	1588	0.988
NULL	Int_J_Biol_Sci_2013_Mar_7_9(3)_279-288.nxml.txt.nlp	23493630	SENT170	16	16	10	10	tocilizumab	IL-17	PA165292659	3605	0.988
NULL	Libyan_J_Med_2009_Jun_1_4(2)_83-85.nxml.txt.nlp	21483516	SENT15	0	0	9	9	imatinib	KIT	PA10804	3815	0.988
NULL	EPMA_J_2010_Sep_4_1(3)_485-494.nxml.txt.nlp	23199090	SENT194	35	35	9	9	leucovorin	GSTP1	PA450198	2950	0.988
NULL	Cancer_Res_Treat_2013_Mar_31_45(1)_55-62.nxml.txt.nlp	23613671	SENT137	16	16	6	6	oxaliplatin	KRAS	PA131285527	3845	0.988
NULL	Basic_Clin_Pharmacol_Toxicol_2013_Feb_5_112(2)_132-137.nxml.txt.nlp	22900583	SENT23	8	8	32	32	prasugrel	CYP3A	PA154410481	1574	0.988
NULL	Front_Oncol_2014_Aug_11_4_204.nxml.txt.nlp	25157335	SENT107	33	33	18	18	erlotinib	KRAS	PA134687924	3845	0.988
NULL	Arch_Osteoporos_2013_Oct_11_8(1-2)_136.nxml.txt.nlp	24113837	SENT3087	19	19	0	0	teriparatide	PTH	PA451620	5741	0.988
NULL	Mol_Cancer_2012_May_14_11_33.nxml.txt.nlp	22583829	SENT174	20	20	7	7	cisplatin	TLR4	PA449014	7099	0.988
NULL	Biomed_Res_Int_2014_Aug_6_2014_967826.nxml.txt.nlp	25165721	SENT349	11	11	0	0	cisplatin	HO-1	PA449014	3162	0.988
NULL	Breast_Cancer_Res_Treat_2014_Dec_21_143(3)_459-467.nxml.txt.nlp	24362951	SENT19	10	10	27	27	exemestane	HER2	PA449563	2064	0.988
NULL	J_Oncol_2010_Dec_23_2010_372547.nxml.txt.nlp	20072701	SENT157	0	0	15	15	vatalanib	VEGFR2	PA7001	3791	0.988
NULL	Diabetes_2013_Jun_17_62(6)_2141-2150.nxml.txt.nlp	23378610	SENT178	0	0	17	17	betaine	SLC6A12	PA448603	6539	0.988
NULL	Genome_Med_2009_Sep_4_1(9)_83.nxml.txt.nlp	19732436	SENT305	9	9	3	3	cisplatin	EEF1A1	PA449014	1915	0.988
NULL	J_Obes_2011_Sep_19_2011_984245.nxml.txt.nlp	20885921	SENT170	5	5	15	15	vildagliptin	GLP-1	PA165958346	100125288	0.988
NULL	Mol_Cancer_2010_Jun_25_9_166.nxml.txt.nlp	20579378	SENT242	25	25	0	0	gefitinib	SMAD5	PA131301952	4090	0.988
NULL	Oncol_Rep_2013_Mar_8_29(3)_917-924.nxml.txt.nlp	23314174	SENT29	0	0	22	22	sorafenib	HCC	PA7000	84668	0.988
NULL	J_Gen_Physiol_2003_Jul_122(1)_45-61.nxml.txt.nlp	12835470	SENT363	5	5	13	13	capsaicin	VR1	PA448776	56664	0.988
NULL	Mol_Cancer_2012_Jun_26_11_43.nxml.txt.nlp	22731636	SENT242	1	1	29	29	pp2	PP2		4888	0.988
NULL	Cancer_Manag_Res_2013_Nov_21_5_387-400.nxml.txt.nlp	24294007	SENT47	0	0	29	29	cetuximab	EGFR	PA10040	1956	0.988
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT133	16	16	22	22	trastuzumab	STAT3	PA451743	6774	0.988
NULL	Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.nxml.txt.nlp	24736980	SENT110	1	1	27	27	rosuvastatin	BSP	PA134308647	3381	0.988
NULL	Breast_Cancer_Res_2007_Oct_11_9(5)_R70.nxml.txt.nlp	17931406	SENT201	18	18	3	3	tamoxifen	aromatase	PA451581	1588	0.988
NULL	J_Neuroinflammation_2011_Aug_5_8_91.nxml.txt.nlp	21819568	SENT154	12	12	23	23	pioglitazone	ANOVA	PA450970	4858	0.988
NULL	Oncol_Lett_2013_Apr_22_5(4)_1093-1100.nxml.txt.nlp	23599746	SENT69	14	14	26	26	flutamide	P-gp	PA449685	5243	0.988
NULL	Oncoimmunology_2012_Oct_1_1(7)_1004-1016.nxml.txt.nlp	23170249	SENT46	38	38	5	5	paclitaxel	HER-2	PA450761	2064	0.988
NULL	Exp_Ther_Med_2014_Aug_6_8(2)_585-590.nxml.txt.nlp	25009624	SENT28	17	17	6	6	glucose	ROS	PA449773	6098	0.988
NULL	Surg_Neurol_Int_2013_Apr_17_4(Suppl_3)_S136-S150.nxml.txt.nlp	23682340	SENT126	40	40	11	11	naloxone	PAG	PA450586	55824	0.988
NULL	Oncol_Rep_2012_Apr_12_27(4)_1027-1034.nxml.txt.nlp	22245869	SENT156	25	25	7	7	paclitaxel	AKT2	PA450761	208	0.988
NULL	J_Invest_Dermatol_2014_Jan_25_134(1)_268-271.nxml.txt.nlp	23812303	SENT47	2	2	18	18	etanercept	IL-23	PA449515	51561	0.988
NULL	J_Biomed_Biotechnol_2011_Jan_24_2011_250860.nxml.txt.nlp	21318107	SENT162	4	4	25	25	lenalidomide	IL-2	PA162363968	3558	0.988
NULL	Cancer_Med_2013_Dec_31_2(6)_826-835.nxml.txt.nlp	24403256	SENT199	0	0	7	7	nutlin-3	p53		7157	0.988
NULL	Indian_J_Pharmacol_2014_Jan-Feb_46(1)_3-12.nxml.txt.nlp	24550577	SENT228	5	5	10	10	vismodegib	CYP2C8		1558	0.988
NULL	EPMA_J_2012_Jun_18_3(1)_6.nxml.txt.nlp	22738201	SENT152	27	27	36	36	erlotinib	EGFR	PA134687924	1956	0.988
NULL	Oncotarget_2014_Dec_4_5(22)_11365-11380.nxml.txt.nlp	25426548	SENT47	14	14	7	7	nutlin-3	p53		7157	0.988
NULL	Int_J_Surg_Oncol_2012_Jun_12_2012_862879.nxml.txt.nlp	22778941	SENT88	22	22	11	11	cisplatin	ERCC1	PA449014	2067	0.988
NULL	Breast_Cancer_Res_2008_May_13_10(Suppl_2)_P13.nxml.txt.nlp	NULL	SENT15	35	35	5	5	lapatinib	XIAP	PA152241907	331	0.988
NULL	Arthritis_Res_Ther_2014_Apr_11_16(2)_R93.nxml.txt.nlp	24725461	SENT215	19	19	5	5	letrozole	CYP1A1	PA450196	1543	0.988
NULL	J_Biol_Chem_2013_Jun_14_288(24)_17713-17724.nxml.txt.nlp	23653359	SENT37	21	21	0	0	neomycin	U87	PA450608	677775;641648	0.988
NULL	Drug_Healthc_Patient_Saf_2014_Jun_24_6_77-88.nxml.txt.nlp	25018652	SENT36	33	33	12	12	vemurafenib	BRAF	PA165946873	673	0.988
NULL	BMJ_2009_Feb_25_338_b438.nxml.txt.nlp	19244302	SENT47	1	1	10	10	tamoxifen	aromatase	PA451581	1588	0.988
NULL	Exp_Ther_Med_2013_Apr_5_5(4)_1259-1263.nxml.txt.nlp	23596498	SENT75	20	20	11	11	capsaicin	TRPV1	PA448776	7442	0.988
NULL	Biochem_Res_Int_2012_Mar_20_2012_951539.nxml.txt.nlp	22482055	SENT262	5	5	16	16	imatinib	c-Jun	PA10804	3725	0.988
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_P119.nxml.txt.nlp	NULL	SENT5	3	3	27	27	carbamazepine	HLA-A	PA448785	3105	0.988
NULL	Cell_Cycle_2014_Jan_1_13(1)_90-95.nxml.txt.nlp	24196441	SENT95	31	31	7	7	camptothecin	CtIP	PA153590860	5932	0.988
NULL	Calcif_Tissue_Int_2010_Nov_20_87(5)_375-384.nxml.txt.nlp	20725827	SENT219	36	36	11	11	teriparatide	DANCE	PA451620	10516	0.988
NULL	J_Lipid_Res_2014_Feb_55(2)_307-312.nxml.txt.nlp	24262094	SENT159	29	29	13	13	lipase	PNLIP	PA450239	5406	0.988
NULL	Eur_J_Haematol_2014_Feb_25_92(2)_127-136.nxml.txt.nlp	24118452	SENT25	16	16	36	36	anagrelide	CRT	PA164742986	811	0.988
NULL	Arthritis_Care_Res_(Hoboken)_2014_Nov_24_66(11)_1653-1661.nxml.txt.nlp	24942540	SENT37	0	0	22	22	tocilizumab	IL-6	PA165292659	3569	0.988
NULL	Biologics_2009_Sep_15_3_419-428.nxml.txt.nlp	19774209	SENT162	19	19	8	8	gefitinib	PI3K	PA131301952	5290	0.988
NULL	Oncologist_2010_Mar_3_15(3)_216-235.nxml.txt.nlp	20200040	SENT259	4	4	18	18	sunitinib	HER-2	PA162372840	2064	0.988
NULL	Eur_Heart_J_2014_Jun_14_35(23)_1510-1514.nxml.txt.nlp	24748565	SENT54	0	0	9	9	ticagrelor	P2Y12	PA165374673	64805	0.988
NULL	Cardiovasc_Diabetol_2005_Oct_5_4_16.nxml.txt.nlp	16207378	SENT11	4	4	10	10	glucosamine	perlecan	PA164747613	3339	0.988
NULL	J_Breast_Cancer_2014_Sep_30_17(3)_287-290.nxml.txt.nlp	25320628	SENT58	8	8	24	24	doxorubicin	PIK3CA	PA449412	5290	0.988
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT45	35	35	24	24	neratinib	HER2	PA165291472	2064	0.988
NULL	ScientificWorldJournal_2012_May_1_2012_489830.nxml.txt.nlp	22623900	SENT69	37	37	3	3	levodopa	DJ-1	PA450213	11315	0.988
NULL	Anticancer_Agents_Med_Chem_2012_Feb_12(2)_163-171.nxml.txt.nlp	22043994	SENT24	26	26	12	12	cetuximab	KRAS	PA10040	3845	0.988
NULL	Anat_Cell_Biol_2012_Jun_30_45(2)_73-78.nxml.txt.nlp	22822460	SENT76	0	0	5	5	doxorubicin	HIF-1	PA449412	29072	0.988
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT7	5	5	0	0	sitagliptin	HIP	PA164748978	6767;6159;64399;5068	0.988
NULL	Nucleic_Acids_Res_2005_Jun_8_33(10)_3283-3291.nxml.txt.nlp	15944449	SENT116	19	19	11	11	melphalan	ERCC1	PA450354	2067	0.988
NULL	Allergy_Rhinol_(Providence)_2013_Apr_2_Spring_4(1)_e13-e16.nxml.txt.nlp	23772319	SENT143	25	25	1	1	erlotinib	EGF	PA134687924	1950	0.988
NULL	eLife_2013_Nov_5_2_e00969.nxml.txt.nlp	24192036	SENT108	21	21	0	0	vemurafenib	PUMA	PA165946873	27113	0.988
NULL	Oncologist_2010_Jul_24_15(7)_665-672.nxml.txt.nlp	20576644	SENT31	29	29	16	16	trastuzumab	HER-2	PA451743	2064	0.988
NULL	J_Cell_Biol_2001_Apr_30_153(3)_613-620.nxml.txt.nlp	11331310	SENT7	23	23	0	0	camptothecin	53BP1	PA153590860	7158	0.988
NULL	Mol_Cancer_2008_Jun_5_7_50.nxml.txt.nlp	18534018	SENT126	20	20	7	7	bortezomib	NOXA	PA10252	5366	0.988
NULL	Breast_Cancer_Res_2012_Nov_6_14(6)_325.nxml.txt.nlp	23131146	SENT4	12	12	4	4	cyclophosphamide	TP53	PA449165	7157	0.988
NULL	Exp_Diabetes_Res_2012_Dec_12_2012_716404.nxml.txt.nlp	22194737	SENT215	0	0	5	5	metformin	AMPK	PA450395	5563	0.988
NULL	Cancers_(Basel)_2011_Apr_1_3(2)_1844-1860.nxml.txt.nlp	24212785	SENT112	0	0	27	27	bevacizumab	ACRC	PA130232992	93953	0.988
NULL	EMBO_J_2010_Mar_17_29(6)_1116-1125.nxml.txt.nlp	20186120	SENT98	26	26	1	1	galactose	PTH	PA449725	5741	0.988
NULL	Ther_Clin_Risk_Manag_2006_Mar_2(1)_87-98.nxml.txt.nlp	18360584	SENT106	5	5	22	22	sorafenib	VEGFR2	PA7000	3791	0.988
NULL	Blood_Cancer_J_2013_Oct_4_3(10)_e150.nxml.txt.nlp	24096714	SENT87	13	13	26	26	bortezomib	IFNG	PA10252	3458	0.988
NULL	J_Korean_Med_Sci_2010_Aug_21_25(8)_1182-1186.nxml.txt.nlp	20676330	SENT97	12	12	22	22	sirolimus	LAM	PA451365	7249;7248	0.988
NULL	Chem_Rev_2014_Jun_11_114(11)_5753-5774.nxml.txt.nlp	24758331	SENT404	40	40	46	46	flavopiridol	P-gp	PA452627	5243	0.988
NULL	Acta_Diabetol_2012_Aug_11_49(4)_277-289.nxml.txt.nlp	21833779	SENT134	17	17	35	35	carbachol	GLP-1	PA448784	100125288	0.988
NULL	Mol_Cancer_2009_Jan_7_8_1.nxml.txt.nlp	19128456	SENT34	34	34	41	41	doxorubicin	MDR1	PA449412	5243	0.988
NULL	Breast_Cancer_Res_Treat_2007_Oct_27_105(Suppl_1)_19-29.nxml.txt.nlp	17333340	SENT2	12	12	2	2	tamoxifen	aromatase	PA451581	1588	0.988
NULL	Oxid_Med_Cell_Longev_2013_Mar_18_2013_746432.nxml.txt.nlp	23577226	SENT53	39	39	43	43	cisplatin	NRF2	PA449014	2551;4780	0.988
NULL	Diabetes_2013_May_16_62(5)_1689-1696.nxml.txt.nlp	23274908	SENT40	11	11	22	22	diazoxide	KCNJ11	PA449285	3767	0.988
NULL	Curr_Med_Chem_2011_Jun_18(18)_2686-2714.nxml.txt.nlp	21649578	SENT340	4	4	34	34	erlotinib	EGFR	PA134687924	1956	0.988
NULL	J_Korean_Med_Sci_2008_Aug_25_23(4)_685-690.nxml.txt.nlp	18756058	SENT86	33	33	19	19	olanzapine	ghrelin	PA450688	51738	0.988
NULL	Hum_Genomics_Proteomics_2010_Aug_3_2010_159761.nxml.txt.nlp	20981231	SENT128	0	0	6	6	lithium	AP-1	PA450243	2353;3727;2354;3725	0.988
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT188	23	23	12	12	cisplatin	p53	PA449014	7157	0.988
NULL	Apoptosis_2014_Nov_9_19(4)_629-642.nxml.txt.nlp	24213561	SENT212	1	1	42	42	cisplatin	TRAIL	PA449014	8743	0.988
NULL	Front_Oncol_2014_Aug_11_4_204.nxml.txt.nlp	25157335	SENT247	38	38	14	14	erlotinib	EGF	PA134687924	1950	0.988
NULL	Oncol_Rep_2013_Apr_23_29(4)_1268-1274.nxml.txt.nlp	23354756	SENT98	20	20	9	9	trastuzumab	SLC25A43	PA451743	203427	0.988
NULL	Cancer_Immunol_Immunother_2011_Jun_25_60(6)_793-808.nxml.txt.nlp	21350947	SENT224	11	11	37	37	sorafenib	IFN	PA7000	3439	0.988
NULL	Oncotarget_2013_Aug_30_4(10)_1698-1711.nxml.txt.nlp	24091605	SENT128	26	26	0	0	ethanol	CD44	PA448073	960	0.988
NULL	Cancer_Metastasis_Rev_2013_May_1_32(3-4)_341-352.nxml.txt.nlp	23633034	SENT194	10	10	4	4	panitumumab	BRAF	PA162373091	673	0.988
NULL	Int_J_Mol_Sci_2014_Mar_24_15(3)_5140-5162.nxml.txt.nlp	24663085	SENT103	16	16	7	7	cyclophosphamide	IL-2	PA449165	3558	0.988
NULL	J_Clin_Exp_Pathol_2012_May_17_Suppl_4_7327.nxml.txt.nlp	25379357	SENT33	42	42	8	8	resveratrol	SIRT1		23411	0.988
NULL	Ann_Surg_Oncol_2014_Aug_7_21(10)_3261-3267.nxml.txt.nlp	25099655	SENT124	25	25	3	3	trastuzumab	HER2	PA451743	2064	0.988
NULL	Case_Rep_Oncol_2013_Mar_20_6(1)_148-153.nxml.txt.nlp	23569450	SENT59	0	0	14	14	imatinib	KIT	PA10804	3815	0.988
NULL	Br_J_Cancer_2011_Jul_26_105(3)_403-406.nxml.txt.nlp	21730978	SENT9	12	12	38	38	cetuximab	MUT	PA10040	4594	0.988
NULL	Acta_Neuropathol_Commun_2014_May_30_2_57.nxml.txt.nlp	24887326	SENT185	31	31	38	38	etoposide	ABCB1	PA449552	5243	0.988
NULL	Interdiscip_Perspect_Infect_Dis_2014_May_7_2014_849432.nxml.txt.nlp	24895495	SENT128	4	4	14	14	ritonavir	CYP3A4	PA451260	1576	0.988
NULL	Mol_Cancer_2013_Sep_11_12_104.nxml.txt.nlp	24025152	SENT23	21	21	4	4	gemcitabine	STAT3	PA449748	6774	0.988
NULL	Oncoscience_2014_Oct_22_1(10)_614-623.nxml.txt.nlp	25593991	SENT92	0	0	32	32	trastuzumab	KIT	PA451743	3815	0.988
NULL	Korean_Circ_J_2013_Aug_31_43(8)_541-549.nxml.txt.nlp	24044013	SENT9	46	46	1	1	clopidogrel	CYP2C19	PA449053	1557	0.988
NULL	J_Mol_Med_(Berl)_2014_May_10_92(7)_709-722.nxml.txt.nlp	24811491	SENT74	39	39	5	5	cetuximab	KRAS	PA10040	3845	0.988
NULL	AAPS_J_2012_Jan_4_14(1)_87-96.nxml.txt.nlp	22215264	SENT259	0	0	9	9	phenytoin	P-gp	PA450947	5243	0.988
NULL	Int_J_Endocrinol_2014_Jun_25_2014_534904.nxml.txt.nlp	25053942	SENT98	13	13	4	4	amiodarone	AIT	PA448383	160728	0.988
NULL	Ann_Dermatol_2014_Aug_31_26(4)_517-520.nxml.txt.nlp	25143685	SENT29	8	8	0	0	tazarotene	TIG3	PA164746821	5920	0.988
NULL	Br_J_Cancer_2009_Mar_24_100(6)_971-978.nxml.txt.nlp	19240722	SENT138	5	5	12	12	bevacizumab	VEGF-A	PA130232992	7422	0.988
NULL	Indian_J_Dermatol_2009_Jan-Mar_54(1)_65-67.nxml.txt.nlp	20049275	SENT67	4	4	22	22	isotretinoin	CO2	PA450128	4513	0.988
NULL	Ann_Dermatol_2014_Jun_12_26(3)_363-373.nxml.txt.nlp	24966637	SENT128	24	24	5	5	imiquimod	MT1-MMP	PA449972	4323	0.988
NULL	Open_Biochem_J_2011_Sep_23_5_45-51.nxml.txt.nlp	21966325	SENT187	26	26	37	37	indomethacin	XBP1	PA449982	7494	0.988
NULL	Breast_Cancer_Res_2008_Jul_16_10(4)_R60.nxml.txt.nlp	18631394	SENT39	37	37	26	26	trastuzumab	HER2	PA451743	2064	0.988
NULL	J_Vet_Emerg_Crit_Care_(San_Antonio)_2013_Mar_8_23(2)_134-162.nxml.txt.nlp	23566108	SENT148	48	48	8	8	calcidiol	PTG	PA164745614	5507	0.988
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_9_2013_486047.nxml.txt.nlp	23662138	SENT125	46	46	12	12	glibenclamide	GDH	PA449782	51084;2746	0.988
NULL	Curr_Pain_Headache_Rep_2011_Aug_12_15(4)_271-279.nxml.txt.nlp	21479998	SENT150	9	9	15	15	oxymorphone	CYP3A4	PA450748	1576	0.988
NULL	J_Immunother_Cancer_2014_Nov_6_2(Suppl_3)_P187.nxml.txt.nlp	NULL	SENT6	30	30	9	9	paclitaxel	EGFR	PA450761	1956	0.988
NULL	Case_Rep_Gastroenterol_2010_Oct_16_4(3)_435-442.nxml.txt.nlp	21103203	SENT116	24	24	4	4	imatinib	PDGFRA	PA10804	5156	0.988
NULL	Oncogene_2014_Sep_18_33(38)_4664-4674.nxml.txt.nlp	24096486	SENT57	33	33	2	2	erlotinib	PI3K	PA134687924	5290	0.988
NULL	Biologics_2009_Jul_13_3_289-301.nxml.txt.nlp	19707416	SENT210	24	24	7	7	trastuzumab	PTEN	PA451743	5728	0.988
NULL	Cancers_(Basel)_2014_Jul_8_6(3)_1487-1499.nxml.txt.nlp	25006835	SENT522	7	7	22	22	cisplatin	p38	PA449014	10598;1432;7965	0.988
NULL	Breast_Cancer_Res_2005_Jan_28_7(3)_R284-R290.nxml.txt.nlp	15987423	SENT87	5	5	17	17	tamoxifen	SULT1A1	PA451581	6817	0.988
NULL	Med_Sci_Monit_2012_Jul_1_18(7)_CS57-CS62.nxml.txt.nlp	22739739	SENT162	17	17	0	0	napqi	CYP2E1		1571	0.988
NULL	Arthritis_Res_Ther_2013_Jul_11_15(4)_216.nxml.txt.nlp	23856014	SENT105	10	10	22	22	daclizumab	IL-2	PA164764446	3558	0.988
NULL	Oncotarget_2014_Mar_16_5(12)_4087-4102.nxml.txt.nlp	24961479	SENT83	13	13	2	2	hemin	PC3	PA449849	57332;7832;5122	0.988
NULL	Daru_2013_Dec_20_21(1)_78.nxml.txt.nlp	24359941	SENT12	22	22	6	6	gentamicin	EPO	PA449753	7076;8288;2056	0.988
NULL	Brief_Bioinform_2013_Jul_9_14(4)_491-505.nxml.txt.nlp	22877768	SENT115	4	4	16	16	gefitinib	EGFR	PA131301952	1956	0.988
NULL	J_Biol_Chem_2010_Apr_16_285(16)_11892-11902.nxml.txt.nlp	20177059	SENT32	22	22	6	6	olmesartan	PON1	PA164742950	5444	0.988
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1724-1730.nxml.txt.nlp	19861964	SENT25	4	4	15	15	temozolomide	BRAF	PA451609	673	0.988
NULL	Br_J_Pharmacol_2012_Apr_165(8)_2611-2619.nxml.txt.nlp	21718301	SENT10	4	4	15	15	rimonabant	GPR55	PA152407999	9290	0.988
NULL	Oncol_Lett_2014_May_25_7(5)_1711-1717.nxml.txt.nlp	24765206	SENT123	8	8	21	21	resveratrol	FOXM1		2305	0.988
NULL	Clin_Psychopharmacol_Neurosci_2013_Dec_24_11(3)_144-151.nxml.txt.nlp	24465251	SENT101	44	44	23	23	risperidone	IL-10	PA451257	3586	0.988
NULL	J_Neuroinflammation_2010_Sep_7_7_51.nxml.txt.nlp	20822529	SENT101	14	14	5	5	hemin	HO-1	PA449849	3162	0.988
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Feb_15_5_3.nxml.txt.nlp	16480505	SENT195	0	0	18	18	bupropion	CYP2B6	PA448687	1555	0.988
NULL	Oncotarget_2012_Nov_17_4(1)_18-28.nxml.txt.nlp	23248157	SENT155	8	8	3	3	pargyline	U87	PA450797	677775;641648	0.988
NULL	Gene_Regul_Syst_Bio_2014_Mar_4_8_63-73.nxml.txt.nlp	24634581	SENT9	0	0	32	32	minocycline	MT1-MMP	PA450519	4323	0.988
NULL	Drug_Target_Insights_2013_Aug_19_7_27-34.nxml.txt.nlp	24023511	SENT65	4	4	17	17	paclitaxel	P-gp	PA450761	5243	0.988
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1013.nxml.txt.nlp	24457957	SENT71	10	10	27	27	orlistat	NOXA	PA164776864	5366	0.988
NULL	Gut_Liver_2011_Jun_24_5(2)_117-132.nxml.txt.nlp	21814590	SENT159	7	7	40	40	ribavirin	IFN	PA451241	3439	0.988
NULL	Br_J_Cancer_1996_Apr_73(7)_849-855.nxml.txt.nlp	8611394	SENT12	11	11	25	25	calcein	MDR1	PA132595336	5243	0.988
NULL	Genome_Biol_2005_Jul_29_6(8)_228.nxml.txt.nlp	16086858	SENT39	19	19	4	4	daunorubicin	CBR1	PA449212	873	0.988
NULL	Drugs_2014_Oct_10_74(17)_2015-2032.nxml.txt.nlp	25300410	SENT60	6	6	10	10	dronedarone	P-gp	PA153619853	5243	0.988
NULL	Cardiol_Res_Pract_2013_Jan_31_2013_128795.nxml.txt.nlp	23431496	SENT123	35	35	11	11	clopidogrel	CYP2C19	PA449053	1557	0.988
NULL	J_Korean_Med_Sci_2008_Aug_25_23(4)_685-690.nxml.txt.nlp	18756058	SENT86	33	33	7	7	olanzapine	ghrelin	PA450688	51738	0.988
NULL	Breast_Cancer_Res_2008_May_2_10(3)_R39.nxml.txt.nlp	18454852	SENT39	3	3	28	28	resveratrol	CYP1A1		1543	0.988
NULL	J_Oncol_2010_Dec_28_2010_414676.nxml.txt.nlp	20066160	SENT88	9	9	21	21	carboplatin	aromatase	PA448803	1588	0.988
NULL	Int_J_Mol_Sci_2012_Aug_13_13(8)_10091-10112.nxml.txt.nlp	22949849	SENT112	45	45	5	5	ethanol	PPL	PA448073	5493	0.988
NULL	Apoptosis_2012_Sep_30_17(9)_989-997.nxml.txt.nlp	22460505	SENT19	12	12	26	26	chlorpromazine	PI3K	PA448964	5290	0.988
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R91.nxml.txt.nlp	22541814	SENT163	22	22	9	9	pp2	HO-1		3162	0.988
NULL	Arthritis_Res_Ther_2013_Sep_9_15(5)_R108.nxml.txt.nlp	24016860	SENT108	44	44	2	2	fluorescein	CD148	PA164746009	5795	0.988
NULL	N_Am_J_Med_Sci_2012_Dec_4(12)_638-640.nxml.txt.nlp	23272306	SENT48	20	20	1	1	exenatide	GLP-1	PA164749238	100125288	0.988
NULL	Breast_Cancer_Res_2004_Nov_7_6(1)_39-52.nxml.txt.nlp	14680484	SENT194	16	16	4	4	tamoxifen	AIB1	PA451581	8202	0.988
NULL	J_Cancer_2012_Oct_13_3_432-448.nxml.txt.nlp	23074383	SENT164	28	28	9	9	trastuzumab	PTEN	PA451743	5728	0.988
NULL	Neuro_Oncol_2010_Mar_6_12(3)_233-242.nxml.txt.nlp	20167811	SENT41	27	27	0	0	bevacizumab	U87	PA130232992	677775;641648	0.988
NULL	Allergy_Asthma_Clin_Immunol_2009_Oct_22_5(1)_4.nxml.txt.nlp	20016776	SENT218	0	0	18	18	pitrakinra	IL-13	PA165983754	3596	0.988
NULL	J_Adv_Pract_Oncol_2014_Jan_1_Jan-Feb_5(1)_47-50.nxml.txt.nlp	25032033	SENT44	13	13	4	4	cabozantinib	CYP3A4	PA165906891	1576	0.988
NULL	Br_J_Cancer_2013_Sep_3_109(5)_1147-1156.nxml.txt.nlp	23942076	SENT147	33	33	6	6	tamoxifen	HER2	PA451581	2064	0.988
NULL	Nucleic_Acids_Res_2013_Dec_17_41(22)_10228-10240.nxml.txt.nlp	24049078	SENT19	18	18	29	29	tamoxifen	aromatase	PA451581	1588	0.988
NULL	Korean_Circ_J_2014_Jan_14_44(1)_42-44.nxml.txt.nlp	24497889	SENT45	33	33	26	26	enoxaparin	P2Y12	PA449463	64805	0.988
NULL	Oncotarget_2013_Aug_21_4(9)_1484-1495.nxml.txt.nlp	23986086	SENT162	42	42	3	3	trastuzumab	PI3K	PA451743	5290	0.988
NULL	Med_Sci_Monit_2013_Oct_31_19_916-926.nxml.txt.nlp	24172537	SENT113	31	31	4	4	chlorambucil	FANCC	PA448926	2176	0.988
NULL	Int_J_Med_Sci_2013_Feb_11_10(3)_320-330.nxml.txt.nlp	23423768	SENT157	10	10	18	18	cetuximab	EGFR	PA10040	1956	0.988
NULL	Exp_Diabetes_Res_2011_Apr_6_2011_928523.nxml.txt.nlp	21603181	SENT155	0	0	12	12	haloperidol	DRD4	PA449841	1815	0.988
NULL	Oxid_Med_Cell_Longev_2012_May_28_2012_632959.nxml.txt.nlp	22690272	SENT133	2	2	19	19	genistein	FAK	PA165109660	5747	0.988
NULL	J_Invest_Dermatol_2012_Oct_24_132(10)_2440-2450.nxml.txt.nlp	22622430	SENT78	17	17	45	45	temozolomide	IL-8	PA451609	3576	0.988
NULL	Clin_Ophthalmol_2010_Apr_26_4_275-283.nxml.txt.nlp	20463795	SENT63	0	0	14	14	ranibizumab	VEGF-A	PA164746012	7422	0.988
NULL	Br_J_Pharmacol_2008_Oct_18_155(4)_596-605.nxml.txt.nlp	18852694	SENT156	24	24	6	6	fenofibrate	SREBP2	PA449594	6721	0.988
NULL	Biomed_Res_Int_2013_Jan_14_2013_930962.nxml.txt.nlp	23509810	SENT97	18	18	0	0	paraformaldehyde	VASA	PA450790	54514	0.988
NULL	Inflammation_2014_Apr_6_37(5)_1476-1485.nxml.txt.nlp	24706026	SENT133	39	39	13	13	budesonide	GATA3	PA448681	2625	0.988
NULL	Front_Genet_2014_Jun_4_5_167.nxml.txt.nlp	24926315	SENT186	5	5	20	20	cisplatin	KIT	PA449014	3815	0.988
NULL	Core_Evid_2009_Jun_15_4_131-147.nxml.txt.nlp	20694070	SENT8	4	4	19	19	raltegravir	CD4		920	0.988
NULL	AIDS_Res_Treat_2012_Mar_5_2012_703604.nxml.txt.nlp	22500218	SENT107	0	0	15	15	nevirapine	CYP3A4	PA450616	1576	0.988
NULL	Clin_Ophthalmol_2011_Sep_14_5_1303-1308.nxml.txt.nlp	21966206	SENT18	0	0	22	22	ranibizumab	VEGF-A	PA164746012	7422	0.988
NULL	J_Oncol_2010_Jan_14_2010_740472.nxml.txt.nlp	20130818	SENT142	0	0	13	13	pertuzumab	ERBB3		2065	0.988
NULL	Pharmaceuticals_(Basel)_2013_Nov_11_6(11)_1429-1450.nxml.txt.nlp	24287465	SENT278	32	32	8	8	vismodegib	SMO		6608;54498	0.988
NULL	Diabetes_2011_May_23_60(5)_1361-1369.nxml.txt.nlp	21525507	SENT79	29	29	9	9	creatine	ADP	PA164778930	23038	0.988
NULL	Oncoimmunology_2014_May_29_3_e28925.nxml.txt.nlp	25083322	SENT102	4	4	23	23	dasatinib	CD4	PA162372878	920	0.988
NULL	Ann_Oncol_2011_Mar_8_22(3)_503-514.nxml.txt.nlp	20616198	SENT77	13	13	18	18	letrozole	aromatase	PA450196	1588	0.988
NULL	Front_Neurosci_2013_Feb_22_7_19.nxml.txt.nlp	23440036	SENT118	5	5	31	31	fenfluramine	POMC	PA449592	5443	0.988
NULL	J_Biomed_Biotechnol_2011_Jan_23_2011_464701.nxml.txt.nlp	21331357	SENT141	3	3	1	1	minocycline	PARP-1	PA450519	25976	0.988
NULL	Indian_J_Pharm_Sci_2011_Nov-Dec_73(6)_678-682.nxml.txt.nlp	23112405	SENT56	4	4	14	14	olanzapine	GLP	PA450688	342096	0.988
NULL	Int_J_Breast_Cancer_2012_Feb_26_2012_761917.nxml.txt.nlp	22482061	SENT182	23	23	27	27	trastuzumab	PTEN	PA451743	5728	0.988
NULL	Neural_Regen_Res_2014_Mar_15_9(6)_622-629.nxml.txt.nlp	25206865	SENT13	38	38	27	27	vasopressin	p38	PA451858	10598;1432;7965	0.988
NULL	Clin_Pharmacokinet_2014_Jul_24_53(1)_73-87.nxml.txt.nlp	23881596	SENT242	20	20	42	42	rosuvastatin	MRP2	PA134308647	100130958;57626;1244	0.988
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S31-S40.nxml.txt.nlp	20680106	SENT21	18	18	6	6	panitumumab	KRAS	PA162373091	3845	0.988
NULL	Breast_Cancer_Res_Treat_2014_Sep_25_148(1)_81-90.nxml.txt.nlp	25253174	SENT23	5	5	22	22	metformin	HER2	PA450395	2064	0.988
NULL	Acta_Pharmacol_Sin_2010_Nov_18_31(11)_1447-1453.nxml.txt.nlp	20953204	SENT124	17	17	4	4	rimonabant	CB1	PA152407999	1268	0.988
NULL	Arthritis_Res_Ther_2005_Feb_17_7(Suppl_1)_P81.nxml.txt.nlp	NULL	SENT5	24	24	0	0	etanercept	OPG	PA449515	690	0.988
NULL	Diabetes_Care_2010_Nov_33(11)_2399-2405.nxml.txt.nlp	20980427	SENT112	5	5	15	15	ranibizumab	CRT	PA164746012	811	0.988
NULL	Nat_Methods_2012_Sep_12_9(9)_923-928.nxml.txt.nlp	22886092	SENT112	0	0	24	24	erlotinib	EGFR	PA134687924	1956	0.988
NULL	Indian_J_Pharmacol_2014_Jan-Feb_46(1)_3-12.nxml.txt.nlp	24550577	SENT228	5	5	26	26	vismodegib	CYP2B6		1555	0.988
NULL	Ann_Oncol_2011_May_3_22(5)_1078-1087.nxml.txt.nlp	21048039	SENT131	42	42	5	5	cetuximab	KRAS	PA10040	3845	0.988
NULL	Biochemistry_2009_Aug_4_48(30)_7261-7270.nxml.txt.nlp	19527073	SENT175	32	32	8	8	fluorescein	MOB	PA164746009	259230	0.988
NULL	Mol_Med_Rep_2015_Jan_21_11(1)_212-218.nxml.txt.nlp	25333745	SENT75	5	5	45	45	trypsin	CO2	PA451806	4513	0.988
NULL	Oxid_Med_Cell_Longev_2012_May_28_2012_386527.nxml.txt.nlp	22690271	SENT177	7	7	15	15	resveratrol	HO-1		3162	0.988
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT174	11	11	19	19	tacrolimus	RANKL	PA451578	8600	0.988
NULL	Acta_Crystallogr_Sect_F_Struct_Biol_Cryst_Commun_2009_Sep_25_65(Pt_10)_1030-1034.nxml.txt.nlp	19851015	SENT26	13	13	2	2	oxaliplatin	dUTPase	PA131285527	1854	0.988
NULL	J_Adv_Pract_Oncol_2013_Jul_1_Jul-Aug_4(4)_263-268.nxml.txt.nlp	25032007	SENT91	5	5	14	14	metoclopramide	CYP2D6	PA450475	1565	0.988
NULL	Crit_Care_2011_Oct_27_15(Suppl_3)_P28.nxml.txt.nlp	NULL	SENT18	19	19	4	4	thalidomide	IL-10	PA451644	3586	0.988
NULL	Exp_Mol_Med_2012_Feb_29_44(2)_159-166.nxml.txt.nlp	22127053	SENT48	14	14	4	4	simvastatin	RhoA	PA451363	387	0.988
NULL	Br_J_Cancer_2011_Jul_26_105(3)_420-427.nxml.txt.nlp	21730982	SENT218	7	7	22	22	cetuximab	KRAS	PA10040	3845	0.988
NULL	Int_J_Mol_Sci_2014_Oct_6_15(10)_17886-17900.nxml.txt.nlp	25290095	SENT41	26	26	34	34	resveratrol	SIRT1		23411	0.988
NULL	Breast_Cancer_Res_2004_Jul_29_6(5)_204-210.nxml.txt.nlp	15318926	SENT11	6	6	15	15	trastuzumab	HER2	PA451743	2064	0.988
NULL	J_Biol_Eng_2012_Sep_11_6_17.nxml.txt.nlp	22967455	SENT204	9	9	35	35	calcein	CO2	PA132595336	4513	0.988
NULL	Diabetes_Care_2009_Oct_8_32(10)_1873-1879.nxml.txt.nlp	19587362	SENT107	7	7	20	20	irbesartan	ANG	PA450084	283	0.988
NULL	BMJ_2013_Feb_5_346_e5793.nxml.txt.nlp	23386361	SENT14	11	11	25	25	trastuzumab	HER-2	PA451743	2064	0.988
NULL	Mol_Cancer_2013_Oct_8_12_119.nxml.txt.nlp	24103454	SENT188	16	16	14	14	nutlin-3	MDM2		4193	0.988
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1147.nxml.txt.nlp	24675465	SENT323	38	38	5	5	calcein	CTX	PA132595336	1593	0.988
NULL	Mol_Vis_2012_Nov_29_18_2839-2846.nxml.txt.nlp	23233786	SENT12	5	5	14	14	geldanamycin	CB2	PA152031327	1269	0.988
NULL	Breast_Cancer_Res_2013_Nov_29_15(6)_R114.nxml.txt.nlp	24289103	SENT212	4	4	27	27	ethanol	EGFR	PA448073	1956	0.988
NULL	Cardiol_Ther_2013_Jun_7_2(1)_57-68.nxml.txt.nlp	25135289	SENT113	27	27	15	15	thrombin	PAR-1	PA451674	2011;2149	0.988
NULL	Cancers_(Basel)_2013_May_27_5(2)_617-638.nxml.txt.nlp	24216994	SENT291	0	0	6	6	curcumin	MMP2	PA151958596	4313	0.988
NULL	J_Inflamm_(Lond)_2006_Jul_19_3_11.nxml.txt.nlp	16854215	SENT154	30	30	11	11	genistein	FasL	PA165109660	356	0.988
NULL	Trials_2014_Jan_9_15_14.nxml.txt.nlp	24405833	SENT115	5	5	24	24	adalimumab	ACR	PA10004	49	0.988
NULL	EMBO_Mol_Med_2013_Dec_8_5(12)_1821-1834.nxml.txt.nlp	24293316	SENT186	3	3	23	23	doxorubicin	p53	PA449412	7157	0.988
NULL	Arthritis_Res_Ther_2011_May_25_13(Suppl_1)_S5.nxml.txt.nlp	21624184	SENT269	0	0	9	9	ustekinumab	p40	PA166048654	3921;339541;10314	0.988
NULL	Cell_Commun_Signal_2014_Mar_28_12_23.nxml.txt.nlp	24679124	SENT119	0	0	13	13	resveratrol	AMPK		5563	0.988
NULL	Core_Evid_2009_Jun_15_4_25-36.nxml.txt.nlp	20694062	SENT138	6	6	18	18	febuxostat	FACT	PA165958521	11198	0.988
NULL	J_Oncol_2009_May_6_2009_567486.nxml.txt.nlp	19424511	SENT74	21	21	8	8	panitumumab	KRAS	PA162373091	3845	0.988
NULL	Cancer_Cell_Int_2011_Aug_19_11_29.nxml.txt.nlp	21854619	SENT160	18	18	4	4	cisplatin	HDAC	PA449014	9734	0.988
NULL	Chin_J_Cancer_2012_Feb_31(2)_58-72.nxml.txt.nlp	22098952	SENT222	37	37	25	25	etoposide	MRP6	PA449552	368;6283	0.988
NULL	F1000Res_2013_Mar_5_2_74.nxml.txt.nlp	24358880	SENT17	34	34	10	10	capsaicin	TRPV1	PA448776	7442	0.988
NULL	Br_J_Cancer_2011_Jul_26_105(3)_420-427.nxml.txt.nlp	21730982	SENT217	16	16	36	36	cetuximab	KRAS	PA10040	3845	0.988
NULL	J_Cell_Biol_2005_Nov_7_171(3)_505-516.nxml.txt.nlp	16275754	SENT212	6	6	17	17	pp2	HRG		3084;3273	0.988
NULL	Mol_Cancer_2012_Sep_28_11_74.nxml.txt.nlp	23021083	SENT210	16	16	2	2	gemcitabine	CEACAM6	PA449748	4680	0.988
NULL	Cancers_(Basel)_2014_Apr_9_6(2)_829-859.nxml.txt.nlp	24722453	SENT200	5	5	20	20	curcumin	STAT3	PA151958596	6774	0.988
NULL	Neural_Regen_Res_2013_Mar_25_8(9)_825-832.nxml.txt.nlp	25206730	SENT115	5	5	14	14	isoflurane	P2X7	PA450106	5027	0.988
NULL	Acta_Pharmacol_Sin_2009_Jul_22_30(7)_956-964.nxml.txt.nlp	19543298	SENT36	0	0	9	9	atorvastatin	OATP2B1	PA448500	11309	0.988
NULL	J_Viral_Hepat_2009_May_16(5)_315-324.nxml.txt.nlp	19243499	SENT36	12	12	1	1	imiquimod	TLR7	PA449972	51284	0.988
NULL	F1000Res_2013_Oct_3_2_202.nxml.txt.nlp	24795806	SENT121	22	22	12	12	erlotinib	EGFR	PA134687924	1956	0.988
NULL	Cardiovasc_Drugs_Ther_2013_Jul_26_27(6)_521-530.nxml.txt.nlp	23887740	SENT167	39	39	21	21	clopidogrel	CD62P	PA449053	6403	0.988
NULL	ScientificWorldJournal_2014_Feb_6_2014_328513.nxml.txt.nlp	24683330	SENT98	29	29	5	5	isoflurane	IL-6	PA450106	3569	0.988
NULL	Physiol_Rep_2014_Sep_11_2(9)_e12144.nxml.txt.nlp	25214522	SENT171	0	0	22	22	resveratrol	NOX4		50507	0.988
NULL	Br_J_Cancer_2012_Jul_24_107(3)_516-526.nxml.txt.nlp	22782351	SENT283	5	5	11	11	tamoxifen	TIGAR	PA451581	57103	0.988
NULL	Diabetes_2011_May_23_60(5)_1493-1503.nxml.txt.nlp	21478464	SENT109	0	0	13	13	metformin	AMPK	PA450395	5563	0.988
NULL	Biosci_Rep_2012_Aug_1_32(Pt_4)_361-374.nxml.txt.nlp	22762204	SENT147	24	24	19	19	gefitinib	EGFR	PA131301952	1956	0.988
NULL	Anticancer_Agents_Med_Chem_2012_Feb_12(2)_163-171.nxml.txt.nlp	22043994	SENT214	27	27	6	6	cetuximab	BRAF	PA10040	673	0.988
NULL	Diabetes_Care_2009_Apr_32(4)_531-540.nxml.txt.nlp	19336638	SENT23	5	5	10	10	clopidogrel	P2Y12	PA449053	64805	0.988
NULL	Int_J_Cell_Biol_2014_Feb_6_2014_572097.nxml.txt.nlp	24648844	SENT241	5	5	0	0	doxorubicin	AKR1B1	PA449412	231	0.988
NULL	J_Antimicrob_Chemother_2014_Jul_14_69(7)_1945-1953.nxml.txt.nlp	24633206	SENT199	31	31	8	8	tobramycin	RGM	PA451704	56963	0.988
NULL	Acta_Pharmacol_Sin_2013_Sep_5_34(9)_1208-1216.nxml.txt.nlp	23852087	SENT126	26	26	9	9	disulfiram	EPO	PA449376	7076;8288;2056	0.988
NULL	Am_J_Cardiovasc_Drugs_2013_Jun_20_13(5)_331-342.nxml.txt.nlp	23784266	SENT223	4	4	16	16	rivaroxaban	P-gp	PA165958360	5243	0.988
NULL	Nat_Commun_2014_Dec_8_5_5736.nxml.txt.nlp	25484020	SENT164	11	11	21	21	letrozole	PAR2	PA450196	2150;55065;8856	0.988
NULL	Clin_Med_Insights_Womens_Health_2013_Jan_22_6_1-11.nxml.txt.nlp	24665209	SENT37	4	4	22	22	tamoxifen	aromatase	PA451581	1588	0.988
NULL	Oxid_Med_Cell_Longev_2013_Jun_6_2013_891748.nxml.txt.nlp	23840922	SENT188	2	2	16	16	resveratrol	HO-1		3162	0.988
NULL	Oncotarget_2013_Aug_11_4(9)_1416-1426.nxml.txt.nlp	23965832	SENT42	25	25	10	10	doxycycline	FANCD2	PA449415	2177	0.988
NULL	Drugs_Context_2013_Aug_21_2013_212256.nxml.txt.nlp	24432043	SENT81	19	19	7	7	metformin	GLP-1	PA450395	100125288	0.988
NULL	Oncogene_2010_Jun_10_29(23)_3335-3348.nxml.txt.nlp	20383197	SENT92	21	21	35	35	cetuximab	EGFR	PA10040	1956	0.988
NULL	Adv_Appl_Bioinforma_Chem_2008_Oct_30_1_85-98.nxml.txt.nlp	21918608	SENT75	12	12	3	3	bortezomib	SPARC	PA10252	6678	0.988
NULL	Arch_Drug_Inf_2008_Sep_1(2)_50-55.nxml.txt.nlp	19915714	SENT42	4	4	35	35	fentanyl	CYP3A4	PA449599	1576	0.988
NULL	Exp_Brain_Res_2014_Jun_27_232(8)_2637-2644.nxml.txt.nlp	24969614	SENT160	16	16	0	0	palonosetron	NK1	PA10352	11126	0.988
NULL	Arthritis_Res_Ther_2011_Sep_21_13(5)_239.nxml.txt.nlp	21955617	SENT204	1	1	11	11	celecoxib	EP2	PA448871	5732;10407	0.988
NULL	Iran_J_Reprod_Med_2012_Jan_10(1)_33-40.nxml.txt.nlp	25242972	SENT32	0	0	6	6	letrozole	aromatase	PA450196	1588	0.988
NULL	Leukemia_2014_Apr_14_28(4)_961-964.nxml.txt.nlp	24418991	SENT29	14	14	43	43	nilotinib	P-gp	PA165958345	5243	0.988
NULL	Eur_J_Med_Res_2009_Nov_24_14(Suppl_3)_17-21.nxml.txt.nlp	19959412	SENT94	0	0	10	10	rifampin	UGT	PA451250	7361;7355	0.988
NULL	Int_J_Hypertens_2012_Oct_29_2012_536426.nxml.txt.nlp	22121478	SENT89	5	5	12	12	methacholine	ANOVA	PA165958382	4858	0.988
NULL	Core_Evid_2009_Jun_15_4_83-92.nxml.txt.nlp	20694067	SENT72	0	0	21	21	conivaptan	CYP3A4	PA164742939	1576	0.988
NULL	Oncotarget_2011_Dec_31_2(12)_1314-1321.nxml.txt.nlp	22248929	SENT136	17	17	7	7	lapatinib	HER2	PA152241907	2064	0.988
NULL	Mol_Biol_Cell_2012_Nov_1_23(21)_4212-4225.nxml.txt.nlp	22956765	SENT84	18	18	0	0	thrombin	SHP2	PA451674	5781	0.988
NULL	J_Thromb_Thrombolysis_2012_Feb_20_33(2)_143-153.nxml.txt.nlp	22183178	SENT143	4	4	35	35	prasugrel	P2Y12	PA154410481	64805	0.988
NULL	Arthritis_Res_Ther_2005_May_18_7(Suppl_3)_S19-S25.nxml.txt.nlp	15960818	SENT12	13	13	24	24	rituximab	CHOP	PA451261	1649	0.988
NULL	Breast_Cancer_Res_2010_Oct_22_12(Suppl_2)_S1.nxml.txt.nlp	21050422	SENT213	0	0	8	8	ertumaxomab	HER2	PA165291442	2064	0.988
NULL	Front_Pharmacol_2014_Dec_23_5_286.nxml.txt.nlp	25566078	SENT57	16	16	42	42	paclitaxel	FOXM1	PA450761	2305	0.988
NULL	J_Oncol_2012_Mar_11_2012_382159.nxml.txt.nlp	22481926	SENT132	33	33	5	5	irinotecan	p38	PA450085	10598;1432;7965	0.988
NULL	Ther_Clin_Risk_Manag_2007_Aug_3(4)_665-673.nxml.txt.nlp	18472989	SENT172	4	4	12	12	lapatinib	CYP2C19	PA152241907	1557	0.988
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R91.nxml.txt.nlp	22541814	SENT217	3	3	21	21	thrombin	HO-1	PA451674	3162	0.988
NULL	Clin_Mol_Allergy_2007_Jan_25_5_1.nxml.txt.nlp	17254346	SENT152	0	0	40	40	curcumin	CD80	PA151958596	941	0.988
NULL	Oncotarget_2011_Mar_27_2(3)_209-221.nxml.txt.nlp	21444945	SENT32	13	13	9	9	cisplatin	Hsp90	PA449014	3320	0.988
NULL	EMBO_Mol_Med_2012_Jan_4(1)_52-67.nxml.txt.nlp	22174013	SENT188	4	4	24	24	tamoxifen	NR2E3	PA451581	10002	0.988
NULL	Breast_Cancer_Res_2005_Jan_28_7(3)_R284-R290.nxml.txt.nlp	15987423	SENT102	20	20	27	27	tamoxifen	CYP2D6	PA451581	1565	0.988
NULL	Europace_2013_Mar_7_15(3)_317-324.nxml.txt.nlp	23220484	SENT44	4	4	31	31	ranolazine	LQT3	PA164746007	6331	0.988
NULL	Br_J_Cancer_2011_Jul_12_105(2)_221-230.nxml.txt.nlp	21750559	SENT164	0	0	25	25	sorafenib	Mcl-1	PA7000	4170	0.988
NULL	Arch_Med_Sci_2013_Feb_21_9(1)_146-150.nxml.txt.nlp	23516061	SENT124	0	0	7	7	berberine	OTC	PA165860812	5009	0.988
NULL	J_Oncol_2009_Mar_10_2009_831626.nxml.txt.nlp	20300583	SENT26	17	17	28	28	cetuximab	KRAS	PA10040	3845	0.988
NULL	Anal_Biochem_2014_Jun_1_454(100)_17-22.nxml.txt.nlp	24637157	SENT36	39	39	0	0	temozolomide	TDP1	PA451609	55775	0.988
NULL	Breast_Cancer_Res_Treat_2014_Apr_9_145(1)_73-82.nxml.txt.nlp	24715380	SENT7	22	22	8	8	tamoxifen	CXCL10	PA451581	3627	0.988
NULL	Mol_Cells_2014_Dec_31_37(12)_899a-906.nxml.txt.nlp	25431425	SENT135	13	13	20	20	curcumin	EP2	PA151958596	5732;10407	0.988
NULL	Mediators_Inflamm_2010_Jun_21_2010_194896.nxml.txt.nlp	20652055	SENT141	5	5	15	15	berberine	IL-6	PA165860812	3569	0.988
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT10	18	18	12	12	chloroquine	BMPR-II	PA448948	659	0.988
NULL	Leukemia_2013_Feb_10_27(2)_507-510.nxml.txt.nlp	22810506	SENT21	26	26	0	0	mitoxantrone	TRAC	PA450526	28755	0.988
NULL	J_Hematol_Oncol_2011_Apr_20_4_16.nxml.txt.nlp	21504625	SENT47	0	0	15	15	nutlin-3	p53		7157	0.988
NULL	J_Gen_Physiol_2000_Jun_1_115(6)_685-696.nxml.txt.nlp	10828243	SENT163	6	6	19	19	genistein	OLF	PA165109660	83857	0.988
NULL	Mol_Cancer_2010_Apr_23_9_87.nxml.txt.nlp	20416058	SENT251	14	14	4	4	doxorubicin	DR5	PA449412	8795	0.988
NULL	Scientifica_(Cairo)_2013_Feb_7_2013_249101.nxml.txt.nlp	24278770	SENT270	0	0	17	17	daclizumab	IL-2	PA164764446	3558	0.988
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2011_Mar_14_4_13-24.nxml.txt.nlp	22879790	SENT119	11	11	39	39	exenatide	GLP-1	PA164749238	100125288	0.988
NULL	Mol_Clin_Oncol_2013_Sep_26_1(5)_799-804.nxml.txt.nlp	24649249	SENT119	25	25	3	3	temsirolimus	PTEN	PA164746890	5728	0.988
NULL	Breast_Cancer_Res_2001_Mar_26_3(3)_180-182.nxml.txt.nlp	11305952	SENT27	35	35	17	17	tamoxifen	HER-2	PA451581	2064	0.988
NULL	Oncotarget_2014_Dec_4_5(22)_11365-11380.nxml.txt.nlp	25426548	SENT42	21	21	8	8	nutlin-3	p53		7157	0.988
NULL	Case_Rep_Med_2012_May_28_2012_757696.nxml.txt.nlp	22685471	SENT52	3	3	12	12	lorazepam	CHS	PA450267	1130	0.988
NULL	Indian_J_Endocrinol_Metab_2013_Jul-Aug_17(4)_636-646.nxml.txt.nlp	23961479	SENT153	5	5	10	10	rosuvastatin	CYP2C9	PA134308647	1559	0.988
NULL	Arch_Drug_Inf_2011_Mar_4(1)_1-9.nxml.txt.nlp	21572514	SENT208	8	8	15	15	ciprofloxacin	P-gp	PA449009	5243	0.988
NULL	Acta_Pharmacol_Sin_2011_Jun_30_32(6)_853-860.nxml.txt.nlp	21623392	SENT148	2	2	22	22	capsaicin	TRPV1	PA448776	7442	0.988
NULL	J_Res_Pharm_Pract_2013_Apr-Jun_2(2)_70-74.nxml.txt.nlp	24991607	SENT13	8	8	2	2	ceftriaxone	CEA	PA448866	5670;1087	0.988
NULL	Cardiovasc_Diabetol_2005_May_15_4_6.nxml.txt.nlp	15892894	SENT128	33	33	8	8	telmisartan	DBP	PA451605	3295;1628;2638	0.988
NULL	Core_Evid_2011_Mar_17_6_31-42.nxml.txt.nlp	21468241	SENT146	8	8	22	22	ticagrelor	ADP	PA165374673	23038	0.988
NULL	Exp_Ther_Med_2014_Mar_10_7(3)_640-648.nxml.txt.nlp	24520260	SENT108	15	15	24	24	resveratrol	PI3K		5290	0.988
NULL	Pharmaceuticals_(Basel)_2013_Apr_8_6(4)_500-509.nxml.txt.nlp	24276120	SENT39	5	5	38	38	benserazide	GPR35		2859	0.988
NULL	Cancers_(Basel)_2011_Aug_9_3(3)_3189-3205.nxml.txt.nlp	24212952	SENT129	5	5	9	9	hyaluronan	TSG-6	PA165958431	7130	0.988
NULL	Case_Rep_Oncol_2014_Jan_31_7(1)_97-101.nxml.txt.nlp	24575024	SENT60	28	28	43	43	cisplatin	EGFR	PA449014	1956	0.988
NULL	Int_J_Mol_Sci_2012_Dec_7_13(12)_16751-16768.nxml.txt.nlp	23222680	SENT170	8	8	12	12	tranylcypromine	LSD2	PA451741	221656	0.988
NULL	Comp_Hepatol_2005_Feb_8_4_2.nxml.txt.nlp	15701172	SENT16	5	5	17	17	ketoconazole	CYP3A	PA450146	1574	0.988
NULL	Chin_J_Cancer_2011_Sep_30(9)_645-654.nxml.txt.nlp	21880186	SENT176	22	22	3	3	cisplatin	NACT	PA449014	284111	0.988
NULL	Environ_Health_Perspect_2009_Feb_8_117(2)_175-180.nxml.txt.nlp	19270784	SENT137	3	3	21	21	doxorubicin	BPA	PA449412	667	0.988
NULL	Asia_Pac_Allergy_2014_Oct_29_4(4)_257-260.nxml.txt.nlp	25379486	SENT8	39	39	3	3	omalizumab	6-16	PA164752253	2537	0.988
NULL	Angiogenesis_2011_Dec_11_14(4)_481-489.nxml.txt.nlp	21833622	SENT139	16	16	32	32	sunitinib	VEGFR	PA162372840	3791	0.988
NULL	Acta_Pharmacol_Sin_2009_Jul_22_30(7)_956-964.nxml.txt.nlp	19543298	SENT166	24	24	11	11	simvastatin	SLCO2B1	PA451363	11309	0.988
NULL	AIDS_Res_Ther_2007_May_1_4_8.nxml.txt.nlp	17472747	SENT106	27	27	9	9	ritonavir	adiponectin	PA451260	9370	0.988
NULL	Int_Semin_Surg_Oncol_2006_Sep_18_3_31.nxml.txt.nlp	16981992	SENT16	13	13	5	5	tamoxifen	aromatase	PA451581	1588	0.988
NULL	Curr_Gerontol_Geriatr_Res_2010_Jun_20_2010_348174.nxml.txt.nlp	20672050	SENT57	38	38	5	5	gefitinib	EGFR	PA131301952	1956	0.988
NULL	Ann_Oncol_2011_Mar_8_22(3)_503-514.nxml.txt.nlp	20616198	SENT77	8	8	18	18	exemestane	aromatase	PA449563	1588	0.988
NULL	Arthritis_Res_Ther_2014_Apr_3_16(2)_R86.nxml.txt.nlp	24708674	SENT199	29	29	19	19	bosentan	COL1A2	PA10034	1278	0.988
NULL	Front_Pharmacol_2014_Nov_28_5_255.nxml.txt.nlp	25506327	SENT191	0	0	7	7	maraviroc	CCR5	PA164768835	1234	0.988
NULL	Reprod_Biol_Endocrinol_2003_Oct_7_1_66.nxml.txt.nlp	14609433	SENT82	4	4	19	19	cisplatin	FasL	PA449014	356	0.988
NULL	Biomed_Res_Int_2013_Aug_6_2013_602987.nxml.txt.nlp	24027759	SENT309	4	4	24	24	cisplatin	SMF	PA449014	22993	0.988
NULL	Case_Rep_Oncol_2013_Jan_8_6(1)_15-20.nxml.txt.nlp	23466741	SENT13	33	33	18	18	gefitinib	EGFR	PA131301952	1956	0.988
NULL	Clin_Psychopharmacol_Neurosci_2014_Dec_26_12(3)_180-188.nxml.txt.nlp	25598820	SENT41	0	0	7	7	minocycline	Bcl-2	PA450519	596	0.988
NULL	Curr_Med_Chem_2014_Feb_21_1129-1145.nxml.txt.nlp	24304271	SENT344	7	7	35	35	tamoxifen	GPER	PA451581	2852	0.988
NULL	Mol_Cancer_2007_Mar_7_6_18.nxml.txt.nlp	17343740	SENT230	27	27	9	9	paraformaldehyde	CD44	PA450790	960	0.988
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT222	6	6	37	37	metformin	AKT	PA450395	207	0.988
NULL	Cancer_Med_2012_Oct_16_1(2)_207-217.nxml.txt.nlp	23342270	SENT209	23	23	15	15	saracatinib	PIK3CA		5290	0.988
NULL	Aging_(Albany_NY)_2010_Nov_11_2(11)_760-774.nxml.txt.nlp	21084729	SENT70	31	31	2	2	metformin	AMPK	PA450395	5563	0.988
NULL	J_Immunother_Cancer_2013_Nov_7_1(Suppl_1)_P252.nxml.txt.nlp	NULL	SENT17	5	5	19	19	doxorubicin	CD4	PA449412	920	0.988
NULL	Mol_Cancer_2008_Mar_26_7_27.nxml.txt.nlp	18366759	SENT76	6	6	37	37	etoposide	ALDOA	PA449552	226	0.988
NULL	Mol_Cancer_2010_Nov_2_9_289.nxml.txt.nlp	21044322	SENT10	8	8	12	12	docetaxel	RGS10	PA449383	6001	0.988
NULL	Breast_Cancer_Res_2007_Mar_2_9(2)_205.nxml.txt.nlp	NULL	SENT122	22	22	0	0	trastuzumab	HER-2	PA451743	2064	0.988
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT106	30	30	13	13	pp2	PP2		4888	0.988
NULL	J_Oncol_2010_Jun_6_2010_921682.nxml.txt.nlp	20628483	SENT99	6	6	18	18	sorafenib	VEGFR	PA7000	3791	0.988
NULL	Drug_Des_Devel_Ther_2014_Oct_31_8_2121-2128.nxml.txt.nlp	25382970	SENT98	0	0	20	20	curcumin	TTR	PA151958596	7276	0.988
NULL	Br_J_Cancer_2014_Mar_4_110(5)_1221-1227.nxml.txt.nlp	24496456	SENT43	17	17	7	7	cetuximab	CD16	PA10040	2215;2214	0.988
NULL	Cancer_Cell_Int_2013_Jun_26_13_63.nxml.txt.nlp	23800022	SENT159	12	12	18	18	genistein	MDM2	PA165109660	4193	0.988
NULL	Cardiovasc_Diabetol_2010_Sep_23_9_57.nxml.txt.nlp	20863381	SENT171	9	9	22	22	pioglitazone	TDI	PA450970	100038246	0.988
NULL	Cancers_(Basel)_2010_Dec_22_2(4)_2153-2170.nxml.txt.nlp	21390244	SENT247	9	9	30	30	gefitinib	BAX	PA131301952	581	0.988
NULL	Chin_J_Cancer_2012_Feb_31(2)_51-57.nxml.txt.nlp	22257384	SENT117	2	2	21	21	lapatinib	P-gp	PA152241907	5243	0.988
NULL	Braz_J_Med_Biol_Res_2013_Apr_12_46(4)_327-338.nxml.txt.nlp	23579631	SENT209	0	0	7	7	estradiol	AVP	PA449503	114548;551	0.988
NULL	Nutr_J_2014_Jun_19_13_63.nxml.txt.nlp	24943896	SENT77	10	10	3	3	felodipine	CYP3A4	PA449591	1576	0.988
NULL	Diabetes_Care_2009_Apr_32(4)_531-540.nxml.txt.nlp	19336638	SENT239	0	0	15	15	prasugrel	ADP	PA154410481	23038	0.988
NULL	J_Acquir_Immune_Defic_Syndr_2014_Jan_1_65(1)_72-77.nxml.txt.nlp	24025339	SENT118	5	5	14	14	ritonavir	CYP3A4	PA451260	1576	0.988
NULL	Adv_Urol_2010_Jul_20_2010_687043.nxml.txt.nlp	20721275	SENT18	0	0	30	30	bevacizumab	IFN	PA130232992	3439	0.988
NULL	Anal_Chem_Insights_2008_Jan_31_3_1-7.nxml.txt.nlp	19609385	SENT173	7	7	27	27	irinotecan	UGT1A1	PA450085	54658	0.988
NULL	J_Mol_Signal_2013_Dec_30_8_15.nxml.txt.nlp	24377906	SENT253	0	0	17	17	bevacizumab	VEGFR2	PA130232992	3791	0.988
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT150	19	19	11	11	doxorubicin	ABCB1	PA449412	5243	0.988
NULL	BioData_Min_2012_Dec_12_5_21.nxml.txt.nlp	23234571	SENT47	20	20	6	6	fluorouracil	CHN2	PA128406956	1124	0.988
NULL	Pharmaceutics_2011_Sep_14_3(3)_615-635.nxml.txt.nlp	24310600	SENT111	0	0	22	22	gefitinib	EGFR	PA131301952	1956	0.988
NULL	Cardiovasc_Diabetol_2013_May_30_12(Suppl_1)_S2.nxml.txt.nlp	23819752	SENT129	14	14	43	43	rosuvastatin	CYP2C9	PA134308647	1559	0.988
NULL	Oncol_Lett_2013_Sep_15_6(3)_648-654.nxml.txt.nlp	24137384	SENT37	29	29	12	12	oxaliplatin	GSTM1	PA131285527	2944	0.988
NULL	Mol_Brain_2014_Sep_3_7_64.nxml.txt.nlp	25182223	SENT117	3	3	19	19	minocycline	MMP9	PA450519	4318	0.988
NULL	Cancer_Res_Treat_2014_Jul_15_46(3)_234-242.nxml.txt.nlp	25038758	SENT157	20	20	6	6	paclitaxel	P-gp	PA450761	5243	0.988
NULL	Cancers_(Basel)_2014_Mar_6_6(1)_494-525.nxml.txt.nlp	24662938	SENT1869	24	24	0	0	erlotinib	EGF	PA134687924	1950	0.988
NULL	Br_J_Cancer_2012_Jan_17_106(2)_348-357.nxml.txt.nlp	22146521	SENT116	10	10	38	38	gemcitabine	TP53	PA449748	7157	0.988
NULL	Pharmaceuticals_(Basel)_2013_Nov_11_6(11)_1429-1450.nxml.txt.nlp	24287465	SENT278	32	32	6	6	vismodegib	GLI2		2736	0.988
NULL	Clin_Med_Insights_Arthritis_Musculoskelet_Disord_2013_Aug_8_6_35-43.nxml.txt.nlp	23997576	SENT188	0	0	26	26	abatacept	CD28	PA164747080	1493;940	0.988
NULL	Gut_Liver_2011_Jun_24_5(2)_117-132.nxml.txt.nlp	21814590	SENT119	27	27	3	3	ribavirin	RVR	PA451241	9975	0.988
NULL	Br_J_Cancer_2012_Apr_24_106(9)_1543-1550.nxml.txt.nlp	22531721	SENT156	9	9	31	31	trastuzumab	CD59	PA451743	966	0.988
NULL	Nat_Commun_2014_Jun_2_5_3983.nxml.txt.nlp	24886709	SENT70	7	7	40	40	lipase	LIPC	PA450239	3990	0.988
NULL	Infect_Dis_Obstet_Gynecol_2012_Feb_25_2012_157159.nxml.txt.nlp	22505797	SENT102	13	13	27	27	metronidazole	PTB	PA450484	58155	0.988
NULL	Case_Rep_Gastroenterol_2010_Feb_6_4(1)_57-65.nxml.txt.nlp	21103229	SENT108	19	19	4	4	propofol	CYP2B6	PA451141	1555	0.988
NULL	Patient_Prefer_Adherence_2013_Mar_27_7_245-258.nxml.txt.nlp	23569364	SENT22	0	0	10	10	exemestane	aromatase	PA449563	1588	0.988
NULL	Oncotarget_2014_Feb_25_5(5)_1304-1314.nxml.txt.nlp	24675421	SENT210	22	22	0	0	cisplatin	RIP1	PA449014	10928;7386	0.988
NULL	Mol_Cancer_2010_Aug_20_9_220.nxml.txt.nlp	20727180	SENT90	8	8	22	22	nicotine	XIAP	PA450626	331	0.988
NULL	J_Aging_Res_2012_Jul_19_2012_194821.nxml.txt.nlp	22888430	SENT313	3	3	32	32	resveratrol	AMPK		5563	0.988
NULL	Clin_Drug_Investig_2013_Aug_23_33(10)_727-736.nxml.txt.nlp	23975654	SENT172	12	12	41	41	paroxetine	CYP3A4	PA450801	1576	0.988
NULL	Int_J_Biol_Sci_2013_Mar_7_9(3)_279-288.nxml.txt.nlp	23493630	SENT51	12	12	19	19	tocilizumab	IL-21	PA165292659	59067;50616;27189	0.988
NULL	J_Cell_Biol_2005_Nov_7_171(3)_505-516.nxml.txt.nlp	16275754	SENT143	33	33	26	26	pp2	HRG		3084;3273	0.988
NULL	Stroke_Res_Treat_2011_Jun_22_2011_607852.nxml.txt.nlp	21822469	SENT448	0	0	37	37	dabigatran	TKR		8277	0.988
NULL	EPMA_J_2011_Jun_26_2(2)_211-230.nxml.txt.nlp	23199150	SENT212	3	3	28	28	apomorphine	MAP2	PA164781163	4133;10988	0.988
NULL	Exp_Mol_Med_2012_May_31_44(5)_319-329.nxml.txt.nlp	22314196	SENT91	7	7	15	15	methacholine	VDBP	PA165958382	2638	0.988
NULL	Cell_Death_Dis_2014_Jan_9_5(1)_e986.nxml.txt.nlp	24407239	SENT76	0	0	9	9	fludarabine	STAT1	PA449655	6772	0.988
NULL	Nat_Prod_Bioprospect_2012_Mar_8_2(2)_59-64.nxml.txt.nlp	NULL	SENT7	31	31	11	11	calcein	P-gp	PA132595336	5243	0.988
NULL	Acta_Pharmacol_Sin_2014_Jun_4_35(6)_752-757.nxml.txt.nlp	24902786	SENT94	16	16	21	21	tamoxifen	STZ	PA451581	6484	0.988
NULL	Case_Rep_Gastrointest_Med_2011_Jul_10_2011_908514.nxml.txt.nlp	22606429	SENT32	15	15	6	6	octreotide	CD117	PA450678	3815	0.988
NULL	Nat_Commun_2013_Sep_20_4_2444.nxml.txt.nlp	24051492	SENT51	15	15	3	3	nutlin-3	PER2		8864	0.988
NULL	Korean_J_Anesthesiol_2013_Feb_15_64(2)_105-111.nxml.txt.nlp	23459312	SENT55	22	22	9	9	protamine	ACT	PA10366	12;11332;9457;641455	0.988
NULL	Int_J_Environ_Res_Public_Health_2010_Apr_29_7(4)_1392-1431.nxml.txt.nlp	20617037	SENT260	8	8	21	21	ethanol	CRF1	PA448073	1394	0.988
NULL	Stroke_Res_Treat_2011_Nov_10_2011_212485.nxml.txt.nlp	22135769	SENT141	0	0	12	12	clopidogrel	P2Y12	PA449053	64805	0.988
NULL	Clin_Pharmacokinet_2014_Jul_24_53(1)_73-87.nxml.txt.nlp	23881596	SENT268	5	5	24	24	rosuvastatin	OATP1B3	PA134308647	28234	0.988
NULL	Arthritis_Res_Ther_2009_Nov_13_11(6)_R172.nxml.txt.nlp	19912653	SENT186	41	41	2	2	simvastatin	IVD	PA451363	3712	0.988
NULL	Br_J_Cancer_2013_Aug_6_109(3)_686-693.nxml.txt.nlp	23839492	SENT23	12	12	3	3	sunitinib	IL-8	PA162372840	3576	0.988
NULL	Int_J_Biomed_Sci_2007_Mar_3(1)_1-8.nxml.txt.nlp	23675014	SENT149	29	29	2	2	thrombin	ILK	PA451674	3611	0.988
NULL	J_Oncol_2012_Sep_10_2012_370481.nxml.txt.nlp	22997517	SENT164	7	7	25	25	resveratrol	AP-1		2353;3727;2354;3725	0.988
NULL	Breast_Cancer_Res_2011_Jun_15_13(3)_R67.nxml.txt.nlp	21699723	SENT149	9	9	15	15	trastuzumab	HER-2	PA451743	2064	0.988
NULL	J_Thromb_Thrombolysis_2009_Nov_6_28(4)_410-417.nxml.txt.nlp	19504052	SENT39	34	34	9	9	clopidogrel	DES	PA449053	1674	0.988
NULL	J_Hematol_Oncol_2013_Jul_9_6_49.nxml.txt.nlp	23837843	SENT213	31	31	23	23	verapamil	Rho	PA451868	29984	0.988
NULL	Pharmaceuticals_(Basel)_2012_Aug_10_5(8)_802-836.nxml.txt.nlp	24280676	SENT40	0	0	33	33	gemcitabine	CNT2	PA449748	9153	0.988
NULL	J_Cell_Biol_2000_Jul_24_150(2)_309-320.nxml.txt.nlp	10908574	SENT64	14	14	1	1	trypsin	p130	PA451806	5934	0.988
NULL	Cancers_(Basel)_2014_Oct_24_6(4)_2187-2223.nxml.txt.nlp	25347122	SENT359	22	22	11	11	olaparib	PI3K		5290	0.988
NULL	JAKSTAT_2012_Apr_1_1(2)_55-64.nxml.txt.nlp	24058751	SENT108	3	3	30	30	pimozide	CD34	PA450965	947	0.988
NULL	J_Immunol_Res_2014_Jul_13_2014_964069.nxml.txt.nlp	25126586	SENT117	2	2	32	32	imiquimod	IL-17	PA449972	3605	0.988
NULL	J_Oncol_2010_Dec_28_2010_414676.nxml.txt.nlp	20066160	SENT89	5	5	13	13	carboplatin	VEGFR	PA448803	3791	0.988
NULL	Br_J_Cancer_2012_Nov_6_107(10)_1692-1701.nxml.txt.nlp	23037716	SENT200	15	15	2	2	paclitaxel	P-gp	PA450761	5243	0.988
NULL	Mol_Biol_Cell_2014_Feb_1_25(3)_324-336.nxml.txt.nlp	24336522	SENT367	28	28	19	19	heparin	MMP7	PA449855	4316	0.988
NULL	Acta_Pharmacol_Sin_2009_Aug_13_30(8)_1186-1194.nxml.txt.nlp	19597523	SENT28	44	44	10	10	tadalafil	GMP	PA10333	22978	0.988
NULL	Curr_Chem_Genomics_2010_Mar_1_4_1-8.nxml.txt.nlp	20448812	SENT93	0	0	12	12	estropipate	OATP1B1	PA165958342	10599	0.988
NULL	Br_J_Cancer_2010_Nov_9_103(10)_1580-1587.nxml.txt.nlp	20959823	SENT20	2	2	30	30	bortezomib	San	PA10252	80218	0.988
NULL	Oncogene_2014_Jul_24_33(30)_3927-3938.nxml.txt.nlp	23995784	SENT269	7	7	0	0	doxycycline	B2M	PA449415	567	0.988
NULL	Scientifica_(Cairo)_2012_Oct_14_2012_428139.nxml.txt.nlp	24278693	SENT227	3	3	8	8	zosuquidar	MDR1		5243	0.988
NULL	Nat_Commun_2014_Jun_20_5_4122.nxml.txt.nlp	24947823	SENT218	16	16	7	7	capsaicin	TRPV1	PA448776	7442	0.988
NULL	Virulence_2012_Oct_1_3(6)_518-520.nxml.txt.nlp	23076286	SENT46	13	13	16	16	propranolol	DAG	PA451145	1605	0.988
NULL	Biomed_Res_Int_2014_Jan_23_2014_761264.nxml.txt.nlp	24587990	SENT364	37	37	13	13	resveratrol	CYP2E1		1571	0.988
NULL	Endocr_Relat_Cancer_2014_Apr_21(2)_355-369.nxml.txt.nlp	24481325	SENT255	2	2	15	15	genistein	aromatase	PA165109660	1588	0.988
NULL	Oncol_Lett_2013_Jun_4_5(6)_1915-1920.nxml.txt.nlp	23833666	SENT20	0	0	9	9	cetuximab	EGFR	PA10040	1956	0.988
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Jul_21_9_20.nxml.txt.nlp	20663145	SENT78	35	35	7	7	clindamycin	LBH	PA449035	81606;221491	0.988
NULL	Cells_2013_May_22_2(2)_330-348.nxml.txt.nlp	24709704	SENT142	5	5	3	3	flavopiridol	CDK9	PA452627	1025	0.988
NULL	Biomed_Res_Int_2014_Jan_29_2014_458592.nxml.txt.nlp	24592391	SENT170	12	12	27	27	curcumin	HO-1	PA151958596	3162	0.988
NULL	Oncogene_2014_Feb_6_33(6)_713-723.nxml.txt.nlp	23435429	SENT7	13	13	24	24	etoposide	BRCA1	PA449552	672	0.988
NULL	BMJ_2011_Oct_31_343_d6333.nxml.txt.nlp	22042753	SENT181	12	12	25	25	dabigatran	C10		113246	0.988
NULL	J_Invest_Dermatol_2012_Oct_24_132(10)_2440-2450.nxml.txt.nlp	22622430	SENT60	16	16	10	10	paclitaxel	ABCB5	PA450761	340273	0.988
NULL	J_Adv_Pract_Oncol_2013_Jul_1_Jul-Aug_4(4)_263-268.nxml.txt.nlp	25032007	SENT62	11	11	15	15	paroxetine	CYP2D6	PA450801	1565	0.988
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT161	1	1	21	21	metformin	p53	PA450395	7157	0.988
NULL	Br_J_Pharmacol_2014_May_171(10)_2659-2670.nxml.txt.nlp	24116661	SENT190	4	4	12	12	naringenin	TRPP2	PA151958361	5311	0.988
NULL	Environ_Health_Perspect_2006_Sep_23_114(9)_1401-1406.nxml.txt.nlp	16966095	SENT195	7	7	0	0	arsenite	HMOX1	PA452638	3162	0.988
NULL	Br_J_Cancer_2009_Jul_21_101(2)_312-319.nxml.txt.nlp	19568237	SENT109	27	27	1	1	pp2	PLCG1		5335	0.988
NULL	Cell_Death_Dis_2012_Mar_15_3(3)_e286.nxml.txt.nlp	22419115	SENT195	41	41	16	16	cisplatin	p53	PA449014	7157	0.988
NULL	Brain_Sci_2013_Jun_14_3(2)_941-963.nxml.txt.nlp	24961432	SENT237	44	44	6	6	ethanol	AP-1	PA448073	2353;3727;2354;3725	0.988
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT105	33	33	15	15	cisplatin	p53	PA449014	7157	0.988
NULL	Lipids_Health_Dis_2011_Feb_28_10_38.nxml.txt.nlp	21352602	SENT10	3	3	27	27	fenofibrate	PCSK9	PA449594	255738	0.988
NULL	J_Cardiothorac_Surg_2010_Apr_19_5_26.nxml.txt.nlp	20403156	SENT152	33	33	6	6	etomidate	ACTH	PA164743987	5443	0.988
NULL	Oncotarget_2014_Mar_13_5(4)_1101-1110.nxml.txt.nlp	24658355	SENT141	18	18	13	13	tamoxifen	MKP-2	PA451581	1846	0.988
NULL	Leukemia_2013_Apr_8_27(4)_762-772.nxml.txt.nlp	23385376	SENT246	25	25	47	47	ofatumumab	CD52	PA165291493	1043	0.988
NULL	J_Hematol_Oncol_2013_Oct_12_6_78.nxml.txt.nlp	24283803	SENT16	32	32	15	15	daunorubicin	STAT3	PA449212	6774	0.988
NULL	Eur_J_Med_Res_2009_Nov_24_14(Suppl_3)_43-46.nxml.txt.nlp	19959416	SENT13	5	5	29	29	raltegravir	CYP2C19		1557	0.988
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_45-53.nxml.txt.nlp	17912635	SENT41	16	16	11	11	letrozole	aromatase	PA450196	1588	0.988
NULL	Asian_J_Androl_2014_Apr_8_May-Jun_16(3)_372-377.nxml.txt.nlp	24759579	SENT54	0	0	25	25	bevacizumab	VEGF-A	PA130232992	7422	0.988
NULL	Br_J_Cancer_2004_Mar_22_90(6)_1285-1292.nxml.txt.nlp	15026814	SENT154	34	34	11	11	doxorubicin	p53	PA449412	7157	0.988
NULL	Cell_Death_Dis_2012_Jun_21_3(6)_e327.nxml.txt.nlp	22717582	SENT194	46	46	14	14	doxorubicin	BIM	PA449412	10018	0.988
NULL	Breast_Cancer_Res_2007_May_19_9(3)_R31.nxml.txt.nlp	17511881	SENT29	19	19	7	7	trastuzumab	HER2	PA451743	2064	0.988
NULL	Hum_Genomics_2008_Sep_1_3(1)_53-70.nxml.txt.nlp	19129090	SENT206	13	13	4	4	perifosine	CACNA2D1	PA165291471	781	0.988
NULL	Case_Rep_Med_2014_Mar_4_2014_923496.nxml.txt.nlp	24715926	SENT23	4	4	0	0	tocilizumab	IL-6	PA165292659	3569	0.988
NULL	Biomed_Res_Int_2013_Dec_5_2013_642848.nxml.txt.nlp	24381940	SENT193	0	0	3	3	telmisartan	AT1	PA451605	9197;185	0.988
NULL	Front_Neurosci_2012_May_30_6_77.nxml.txt.nlp	22661925	SENT149	16	16	11	11	ethanol	HEC	PA448073	10403	0.988
NULL	Eukaryot_Cell_2014_Aug_13(8)_1077-1084.nxml.txt.nlp	24951438	SENT188	11	11	2	2	doxycycline	RSP5	PA449415	23327	0.988
NULL	Biomed_Res_Int_2014_Jan_29_2014_232870.nxml.txt.nlp	24592384	SENT129	39	39	1	1	tamoxifen	HEXIM1	PA451581	10614	0.988
NULL	Brain_Sci_2013_Jun_19_3(2)_964-991.nxml.txt.nlp	24961433	SENT305	31	31	6	6	choline	spatial	PA448976	219793	0.988
NULL	eLife_2013_Nov_5_2_e00969.nxml.txt.nlp	24192036	SENT114	28	28	5	5	vemurafenib	BIM	PA165946873	10018	0.988
NULL	Biomed_Res_Int_2014_Jun_2_2014_971569.nxml.txt.nlp	24991576	SENT47	13	13	0	0	iodine	TLC	PA450049	3933	0.988
NULL	Breast_Cancer_Res_2012_Aug_13_14(4)_109.nxml.txt.nlp	22889086	SENT8	17	17	29	29	tamoxifen	aromatase	PA451581	1588	0.988
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT70	21	21	0	0	methotrexate	MSH2	PA450428	4436	0.988
NULL	Oncogene_2010_Sep_16_29(37)_5193-5203.nxml.txt.nlp	20581867	SENT114	23	23	16	16	lapatinib	PI3K	PA152241907	5290	0.988
NULL	Antiviral_Res_2009_May_82(2)_A99-A109.nxml.txt.nlp	19176219	SENT283	19	19	36	36	nelfinavir	P85	PA450606	8874	0.988
NULL	Diabetes_2008_Oct_57(10)_2768-2773.nxml.txt.nlp	18599519	SENT80	21	21	0	0	rolipram	PDE4B	PA153906323	5142	0.988
NULL	Nucleic_Acids_Res_2006_Jul_4_34(11)_3299-3308.nxml.txt.nlp	16820530	SENT533	15	15	7	7	ethanol	APOBEC-1	PA448073	339	0.988
NULL	J_Adv_Pract_Oncol_2012_Jul_1_Jul-Aug_3(4)_267-272.nxml.txt.nlp	25031955	SENT37	0	0	16	16	crizotinib	CYP3A4	PA165946122	1576	0.988
NULL	Biol_Open_2013_Sep_13_2(11)_1148-1159.nxml.txt.nlp	24244851	SENT50	0	0	23	23	nilotinib	DDR1	PA165958345	780	0.988
NULL	Contemp_Oncol_(Pozn)_2013_Apr_29_17(2)_128-133.nxml.txt.nlp	23788978	SENT44	0	0	35	35	oxycodone	CYP3A4	PA450741	1576	0.988
NULL	Mol_Vis_2012_Feb_16_18_471-478.nxml.txt.nlp	22393273	SENT191	1	1	16	16	atropine	FGF2	PA448505	2247;2258	0.988
NULL	Front_Behav_Neurosci_2009_Jun_29_3_10.nxml.txt.nlp	19587848	SENT156	16	16	2	2	estradiol	DES	PA449503	1674	0.988
NULL	Arthritis_Res_Ther_2005_Feb_17_7(Suppl_1)_P81.nxml.txt.nlp	NULL	SENT5	24	24	2	2	etanercept	RANKL	PA449515	8600	0.988
NULL	J_Hematol_Oncol_2012_May_8_5_21.nxml.txt.nlp	22569033	SENT89	0	0	21	21	sunitinib	VEGFR	PA162372840	3791	0.988
NULL	Kidney_Int_Suppl_(2011)_2012_Mar_29_2(1)_69-88.nxml.txt.nlp	25018920	SENT379	25	25	47	47	fenoldopam	NAC	PA164784034	22861	0.988
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT112	0	0	12	12	tenofovir	SLC22A8	PA10204	9376	0.988
NULL	Oncoimmunology_2013_Jan_1_2(1)_e22890.nxml.txt.nlp	23483066	SENT106	32	32	3	3	vemurafenib	IFN	PA165946873	3439	0.988
NULL	Biomed_Res_Int_2013_Nov_27_2013_564804.nxml.txt.nlp	24377092	SENT90	4	4	36	36	ethanol	MAX	PA448073	4149	0.988
NULL	Mol_Cancer_2013_Sep_11_12_104.nxml.txt.nlp	24025152	SENT254	11	11	2	2	gemcitabine	EGFR	PA449748	1956	0.988
NULL	Environ_Health_Perspect_2009_Feb_8_117(2)_175-180.nxml.txt.nlp	19270784	SENT138	22	22	4	4	doxorubicin	Bcl-2	PA449412	596	0.988
NULL	Oncotarget_2013_Apr_23_4(6)_816-829.nxml.txt.nlp	23615731	SENT94	10	10	0	0	doxycycline	HSF1	PA449415	3297	0.988
NULL	Open_Med_Chem_J_2013_Oct_31_7_23-29.nxml.txt.nlp	24222802	SENT71	0	0	13	13	perifosine	AKT	PA165291471	207	0.988
NULL	Br_J_Cancer_2011_Jun_7_104(12)_1816-1821.nxml.txt.nlp	21610711	SENT51	0	0	14	14	cisplatin	mol	PA449014	90527	0.988
NULL	Autophagy_2013_May_1_9(5)_789-790.nxml.txt.nlp	23388383	SENT23	7	7	23	23	docetaxel	NRP2	PA449383	8828;4753	0.988
NULL	Br_J_Cancer_2010_Jul_13_103(2)_186-195.nxml.txt.nlp	20588277	SENT32	0	0	19	19	nutlin-3	p53		7157	0.988
NULL	J_Gynecol_Oncol_2014_Apr_9_25(2)_130-135.nxml.txt.nlp	24761217	SENT120	19	19	9	9	ritonavir	P-gp	PA451260	5243	0.988
NULL	Breast_Cancer_Res_2011_Mar_11_13(2)_R30.nxml.txt.nlp	21396117	SENT12	18	18	9	9	erlotinib	p53	PA134687924	7157	0.988
NULL	Arthritis_Res_Ther_2013_Jul_9_15(4)_R73.nxml.txt.nlp	23837669	SENT251	3	3	28	28	colchicine	MICL	PA449092	160364	0.988
NULL	Target_Oncol_2013_Mar_30_8(1)_27-33.nxml.txt.nlp	23361373	SENT37	18	18	41	41	docetaxel	EGFR	PA449383	1956	0.988
NULL	Breast_Cancer_Res_2004_Nov_7_6(1)_39-52.nxml.txt.nlp	14680484	SENT157	34	34	10	10	tamoxifen	SMRT	PA451581	9612	0.988
NULL	Br_J_Cancer_1997_76(10)_1328-1332.nxml.txt.nlp	9374379	SENT11	27	27	16	16	cisplatin	IFN	PA449014	3439	0.988
NULL	Arthritis_Res_Ther_2010_Feb_24_12(1)_R32.nxml.txt.nlp	20181277	SENT213	48	48	17	17	imatinib	M-CSF	PA10804	1435	0.988
NULL	Cell_Death_Dis_2014_Feb_13_5(2)_e1055.nxml.txt.nlp	24525731	SENT43	18	18	4	4	cisplatin	XRCC1	PA449014	7515	0.988
NULL	Clinics_(Sao_Paulo)_2013_May_68(5)_694-701.nxml.txt.nlp	23778405	SENT177	15	15	7	7	curcumin	P-gp	PA151958596	5243	0.988
NULL	J_Inflamm_(Lond)_2007_Apr_24_4_8.nxml.txt.nlp	17456234	SENT106	0	0	21	21	imiquimod	IFN	PA449972	3439	0.988
NULL	Oncoimmunology_2012_Oct_1_1(7)_1048-1060.nxml.txt.nlp	23170253	SENT57	11	11	35	35	pertuzumab	HRG		3084;3273	0.988
NULL	Diabetes_Care_2013_May_13_36(5)_1074-1082.nxml.txt.nlp	23275352	SENT233	24	24	3	3	liraglutide	ZAG	PA165958364	563	0.988
NULL	J_Inherit_Metab_Dis_2012_Nov_24_35(6)_1137-1145.nxml.txt.nlp	22447153	SENT25	0	0	13	13	fenofibrate	ALDR	PA449594	225	0.988
NULL	Clinics_(Sao_Paulo)_2014_Oct_69(10)_655-659.nxml.txt.nlp	25518015	SENT97	1	1	41	41	propofol	NGAL	PA451141	3934	0.988
NULL	Acta_Pharmacol_Sin_2012_May_16_33(5)_682-690.nxml.txt.nlp	22504904	SENT11	23	23	12	12	celecoxib	Bcl-2	PA448871	596	0.988
NULL	Basic_Clin_Pharmacol_Toxicol_2013_Feb_5_112(2)_132-137.nxml.txt.nlp	22900583	SENT23	18	18	32	32	prasugrel	CYP3A	PA154410481	1574	0.988
NULL	Mol_Cancer_2006_Oct_18_5_46.nxml.txt.nlp	17044945	SENT173	12	12	6	6	gemcitabine	KIT	PA449748	3815	0.988
NULL	Acta_Pharmacol_Sin_2013_Apr_18_34(4)_555-560.nxml.txt.nlp	23503472	SENT17	29	29	7	7	cyclosporine	NFKB1	PA449167	4790	0.988
NULL	Ann_Gastroenterol_2012_25(2)_106-118.nxml.txt.nlp	24713845	SENT185	0	0	13	13	imatinib	KIT	PA10804	3815	0.988
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT189	11	11	18	18	neratinib	HER2	PA165291472	2064	0.988
NULL	Mol_Cancer_2012_Sep_25_11_73.nxml.txt.nlp	23009336	SENT117	18	18	8	8	gefitinib	EGFR	PA131301952	1956	0.988
NULL	Nat_Genet_2011_Feb_26_43(2)_117-120.nxml.txt.nlp	21186350	SENT77	13	13	3	3	metformin	ATM	PA450395	472	0.988
NULL	Oncotarget_2014_Feb_7_5(3)_775-787.nxml.txt.nlp	24519956	SENT110	5	5	0	0	docetaxel	PC3	PA449383	57332;7832;5122	0.988
NULL	Mol_Biol_Rep_2013_Sep_28_40(10)_5573-5585.nxml.txt.nlp	24078156	SENT272	42	42	4	4	iron	FPN1	PA450087	30061	0.988
NULL	Front_Genet_2013_Aug_29_4_163.nxml.txt.nlp	24009622	SENT34	6	6	19	19	ethanol	ABCG2	PA448073	9429	0.988
NULL	Curr_Cardiol_Rev_2010_Nov_6(4)_309-324.nxml.txt.nlp	22043207	SENT204	18	18	27	27	hemin	HO-1	PA449849	3162	0.988
NULL	Blood_Cancer_J_2014_Aug_8_4(8)_e237.nxml.txt.nlp	25105536	SENT11	0	0	7	7	sorafenib	CYP3A4	PA7000	1576	0.988
NULL	J_Oncol_2010_Dec_15_2010_821717.nxml.txt.nlp	20049172	SENT12	34	34	18	18	paclitaxel	ZEB1	PA450761	6935	0.988
NULL	Breast_Cancer_Res_2008_Jul_8_10(4)_R56.nxml.txt.nlp	18611244	SENT25	0	0	5	5	letrozole	aromatase	PA450196	1588	0.988
NULL	Cancer_Cell_Int_2005_Jun_1_5_18.nxml.txt.nlp	15929791	SENT106	6	6	27	27	bortezomib	IL-6	PA10252	3569	0.988
NULL	J_Biol_Chem_2008_Nov_14_283(46)_31679-31689.nxml.txt.nlp	18755684	SENT321	24	24	5	5	iron	FTH1	PA450087	2495	0.988
NULL	Oncologist_2010_Mar_9_15(3)_236-245.nxml.txt.nlp	20215359	SENT33	0	0	9	9	everolimus	VEGFR	PA164746311	3791	0.988
NULL	Cancer_Med_2012_Dec_26_1(3)_318-327.nxml.txt.nlp	23342281	SENT6	0	0	10	10	tamoxifen	aromatase	PA451581	1588	0.988
NULL	Cell_Death_Dis_2014_Apr_24_5(4)_e1197.nxml.txt.nlp	24763054	SENT89	20	20	0	0	doxorubicin	RUNX3	PA449412	864	0.988
NULL	Front_Neurosci_2012_Jul_26_6_112.nxml.txt.nlp	22855669	SENT141	36	36	9	9	diazepam	CA3	PA449283	761	0.988
NULL	J_Mol_Med_(Berl)_2014_Feb_20_92(3)_217-225.nxml.txt.nlp	24553779	SENT60	14	14	23	23	vasopressin	MRCK	PA451858	8476	0.988
NULL	Oncoscience_2014_Mar_24_1(3)_196-204.nxml.txt.nlp	25594012	SENT22	3	3	16	16	trastuzumab	EGFR	PA451743	1956	0.988
NULL	J_Cancer_2013_Aug_10_4(7)_536-548.nxml.txt.nlp	23983818	SENT18	27	27	0	0	curcumin	ACAM	PA151958596	79827	0.988
NULL	Nat_Med_2013_Dec_10_19(12)_10_1038_nm_3385.nxml.txt.nlp	24216752	SENT17	0	0	31	31	thrombin	PAR1	PA451674	79581;2149	0.988
NULL	Front_Immunol_2013_Mar_6_4_60.nxml.txt.nlp	23508943	SENT286	4	4	27	27	rolipram	Mcl-1	PA153906323	4170	0.988
NULL	AIDS_Res_Ther_2009_Apr_9_6_3.nxml.txt.nlp	19358725	SENT7	38	38	19	19	atazanavir	CD4	PA10251	920	0.988
NULL	Acta_Pharmacol_Sin_2014_Jan_9_35(1)_1-10.nxml.txt.nlp	24317012	SENT96	27	27	1	1	paclitaxel	MDR1	PA450761	5243	0.988
NULL	Mol_Cancer_2012_Sep_28_11_74.nxml.txt.nlp	23021083	SENT210	16	16	44	44	gemcitabine	PI3K	PA449748	5290	0.988
NULL	J_Cancer_2011_Mar_8_2_142-152.nxml.txt.nlp	21475719	SENT143	9	9	0	0	methotrexate	DHFR	PA450428	1719	0.988
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT106	13	13	30	30	pp2	PP2		4888	0.988
NULL	Arthritis_Res_Ther_2008_May_27_10(3)_110.nxml.txt.nlp	18510784	SENT214	27	27	4	4	etanercept	RAC	PA449515	207	0.988
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1013.nxml.txt.nlp	24457957	SENT76	23	23	15	15	bortezomib	NOXA	PA10252	5366	0.988
NULL	Breast_Cancer_Res_2008_Apr_1_10(2)_R30.nxml.txt.nlp	18380893	SENT19	24	24	2	2	tamoxifen	HER2	PA451581	2064	0.988
NULL	Exp_Ther_Med_2013_Nov_13_6(5)_1317-1321.nxml.txt.nlp	24223665	SENT69	3	3	10	10	cisplatin	CD133	PA449014	8842	0.988
NULL	Mol_Vis_2014_May_13_20_649-660.nxml.txt.nlp	24868139	SENT212	19	19	4	4	ranibizumab	VEGFR1	PA164746012	2321	0.988
NULL	Front_Immunol_2012_Mar_1_3_36.nxml.txt.nlp	22566919	SENT257	10	10	33	33	alefacept	CD28	PA164748040	1493;940	0.988
NULL	Environ_Health_Perspect_2010_Dec_12_118(12)_1707-1713.nxml.txt.nlp	20705543	SENT143	15	15	3	3	paclitaxel	XRCC1	PA450761	7515	0.988
NULL	Oncotarget_2014_Oct_21_5(22)_11252-11268.nxml.txt.nlp	25361004	SENT181	5	5	26	26	metformin	CLIC1	PA450395	1192	0.988
NULL	Curr_Neuropharmacol_2014_Jul_12(4)_365-379.nxml.txt.nlp	25342944	SENT97	8	8	28	28	fluoxetine	cPLA2	PA449673	10524	0.988
NULL	Diabetes_Metab_Syndr_Obes_2014_Mar_6_7_85-94.nxml.txt.nlp	24623984	SENT82	13	13	37	37	metformin	GLP	PA450395	342096	0.988
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT158	23	23	0	0	tacrolimus	SOCS3	PA451578	9021	0.988
NULL	Breast_Cancer_Res_2009_Jul_15_11(4)_207.nxml.txt.nlp	19664181	SENT40	20	20	5	5	trastuzumab	PTEN	PA451743	5728	0.988
NULL	Int_J_Inflam_2012_Apr_26_2012_480373.nxml.txt.nlp	22611516	SENT88	14	14	21	21	tocilizumab	IL-6	PA165292659	3569	0.988
NULL	Arthritis_Res_Ther_2012_Feb_9_14(Suppl_1)_O42.nxml.txt.nlp	NULL	SENT8	27	27	7	7	etanercept	IL-17	PA449515	3605	0.988
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT42	22	22	6	6	trastuzumab	AKT	PA451743	207	0.988
NULL	Breast_Cancer_Res_2007_May_30_9(3)_R34.nxml.txt.nlp	17537232	SENT172	25	25	10	10	tamoxifen	TP53	PA451581	7157	0.988
NULL	J_Headache_Pain_2013_Aug_13_14(1)_71.nxml.txt.nlp	23941062	SENT72	14	14	39	39	etodolac	TRPA1	PA449550	8989	0.988
NULL	Front_Oncol_2013_Nov_14_3_279.nxml.txt.nlp	24294592	SENT68	38	38	14	14	docetaxel	PARP-1	PA449383	25976	0.988
NULL	Epilepsia_2012_Jun_21_53(Suppl_1)_18-25.nxml.txt.nlp	22612805	SENT142	6	6	13	13	furosemide	KCC2	PA449719	57468	0.988
NULL	Oncotarget_2011_Sep_9_2(9)_658-668.nxml.txt.nlp	21911919	SENT5	35	35	4	4	cytarabine	HO-1	PA449177	3162	0.988
NULL	Clin_Interv_Aging_2014_Apr_8_9_593-601.nxml.txt.nlp	24748777	SENT137	4	4	21	21	denosumab	RANK	PA166048634	8792	0.988
NULL	EMBO_Mol_Med_2012_Jan_4(1)_52-67.nxml.txt.nlp	22174013	SENT190	6	6	26	26	tamoxifen	NR2E3	PA451581	10002	0.988
NULL	Biomed_Res_Int_2014_Apr_10_2014_580852.nxml.txt.nlp	24812624	SENT51	8	8	12	12	resveratrol	PTEN		5728	0.988
NULL	Sci_Rep_2014_Dec_15_4_7490.nxml.txt.nlp	25502402	SENT26	14	14	28	28	cetuximab	EGFR	PA10040	1956	0.988
NULL	Nucleic_Acids_Res_2011_Jun_9_39(11)_4640-4652.nxml.txt.nlp	21310710	SENT328	19	19	10	10	camptothecin	SATB1	PA153590860	6304	0.988
NULL	Oncogene_2014_Jan_23_33(4)_421-428.nxml.txt.nlp	23318437	SENT118	36	36	21	21	etoposide	p53	PA449552	7157	0.988
NULL	Oncotarget_2010_May_1_1(1)_48-58.nxml.txt.nlp	21293053	SENT117	15	15	0	0	cisplatin	ID4	PA449014	3400	0.988
NULL	Inflamm_Res_2010_Sep_26_59(9)_699-709.nxml.txt.nlp	20339899	SENT29	7	7	26	26	thrombin	PAR4	PA451674	9002;5074	0.988
NULL	Front_Oncol_2011_Aug_22_1_22.nxml.txt.nlp	22666659	SENT134	22	22	7	7	pemetrexed	EGF	PA10810	1950	0.988
NULL	Int_J_Biol_Sci_2012_Oct_24_8(9)_1227-1236.nxml.txt.nlp	23136551	SENT72	15	15	33	33	tocilizumab	IL-6	PA165292659	3569	0.988
NULL	Asia_Pac_Allergy_2013_Oct_31_3(4)_215-223.nxml.txt.nlp	24260726	SENT30	17	17	3	3	allopurinol	HLA-B	PA448320	3106	0.987
NULL	Cardiol_Res_Pract_2013_Feb_19_2013_195456.nxml.txt.nlp	23533940	SENT46	4	4	8	8	prasugrel	P2Y12	PA154410481	64805	0.987
NULL	Apoptosis_2014_Apr_23_19(7)_1055-1068.nxml.txt.nlp	24756955	SENT166	16	16	36	36	nutlin-3	MDMX		4194	0.987
NULL	Br_J_Haematol_2014_Mar_13_164(1)_811-821.nxml.txt.nlp	24328678	SENT6	35	35	20	20	lenalidomide	Aiolos	PA162363968	22806	0.987
NULL	Thorax_2012_Sep_11_67(9)_796-803.nxml.txt.nlp	22496351	SENT114	6	6	16	16	bleomycin	TRAIL	PA448645	8743	0.987
NULL	Asian_J_Androl_2014_Mar_7_Jul-Aug_16(4)_647-649.nxml.txt.nlp	24625882	SENT56	41	41	5	5	fosinopril	WT1	PA449710	7490	0.987
NULL	Scand_J_Med_Sci_Sports_2013_Dec_31_23(6)_687-696.nxml.txt.nlp	22292987	SENT215	14	14	33	33	clonidine	ANOVA	PA449051	4858	0.987
NULL	Inflammation_2012_Aug_26_35(4)_1294-1301.nxml.txt.nlp	22367599	SENT55	26	26	3	3	pentobarbital	STZ	PA450859	6484	0.987
NULL	Case_Rep_Neurol_2014_Mar_29_6(1)_101-108.nxml.txt.nlp	24761147	SENT108	16	16	29	29	rituximab	IVL	PA451261	3713	0.987
NULL	Chemother_Res_Pract_2012_Aug_29_2012_817297.nxml.txt.nlp	22970367	SENT39	21	21	11	11	erlotinib	BRCA1	PA134687924	672	0.987
NULL	BMB_Rep_2014_Apr_47(4)_221-226.nxml.txt.nlp	24286312	SENT6	29	29	4	4	nutlin-3	p53		7157	0.987
NULL	Arthritis_Res_Ther_2011_Jan_11_13(1)_R3.nxml.txt.nlp	21223583	SENT175	15	15	4	4	bleomycin	TLR3	PA448645	7098	0.987
NULL	Mol_Cancer_2007_Sep_26_6_61.nxml.txt.nlp	17894897	SENT52	0	0	10	10	etoposide	p53	PA449552	7157	0.987
NULL	Oncotarget_2014_Feb_8_5(6)_1609-1620.nxml.txt.nlp	24742492	SENT210	35	35	5	5	etoposide	LGMN	PA449552	5641	0.987
NULL	J_Cell_Biol_2005_Nov_7_171(3)_505-516.nxml.txt.nlp	16275754	SENT296	13	13	0	0	pp2	EGF		1950	0.987
NULL	Arch_Med_Sci_2012_Sep_8_8(4)_659-671.nxml.txt.nlp	23056078	SENT174	15	15	0	0	cisplatin	MRP2	PA449014	100130958;57626;1244	0.987
NULL	FEBS_Lett_2014_Sep_17_588(18)_3361-3366.nxml.txt.nlp	25084564	SENT48	13	13	2	2	tetracycline	AMPK	PA451640	5563	0.987
NULL	Arthritis_Res_Ther_2005_Sep_22_7(6)_R1325-R1337.nxml.txt.nlp	16277686	SENT132	17	17	7	7	rosiglitazone	adiponectin	PA451283	9370	0.987
NULL	Asian-Australas_J_Anim_Sci_2012_Feb_1_25(2)_207-212.nxml.txt.nlp	25049553	SENT120	0	0	46	46	urea	CO2	PA451831	4513	0.987
NULL	Mol_Cancer_2010_Apr_23_9_87.nxml.txt.nlp	20416058	SENT276	4	4	15	15	doxorubicin	TRAIL	PA449412	8743	0.987
NULL	Int_J_Biol_Sci_2013_Mar_7_9(3)_279-288.nxml.txt.nlp	23493630	SENT194	3	3	37	37	tocilizumab	IL-4	PA165292659	3565	0.987
NULL	Br_J_Cancer_2012_Nov_6_107(10)_1714-1721.nxml.txt.nlp	23073173	SENT115	3	3	21	21	bicalutamide	RUNX2	PA164746255	860	0.987
NULL	Curr_Chem_Genomics_2010_Mar_19_4_9-18.nxml.txt.nlp	20502647	SENT167	29	29	27	27	triciribine	AKT	PA165958661	207	0.987
NULL	Breast_Cancer_Res_2004_May_7_6(4)_R352-R365.nxml.txt.nlp	15217502	SENT235	29	29	7	7	estradiol	CYP1A2	PA449503	1544	0.987
NULL	J_Adv_Pharm_Technol_Res_2014_Oct-Dec_5(4)_185-190.nxml.txt.nlp	25364697	SENT16	14	14	30	30	metoprolol	CYP2D6	PA450480	1565	0.987
NULL	AIDS_Res_Treat_2012_Mar_21_2012_186987.nxml.txt.nlp	22536495	SENT184	21	21	1	1	etravirine	TYPE	PA166014703	6445	0.987
NULL	Mol_Cancer_2012_Dec_12_11_91.nxml.txt.nlp	23234355	SENT116	33	33	13	13	cetuximab	IL-2	PA10040	3558	0.987
NULL	J_Cancer_2011_Sep_23_2_474-477.nxml.txt.nlp	21980321	SENT8	7	7	5	5	erlotinib	EGFR	PA134687924	1956	0.987
NULL	J_Clin_Biochem_Nutr_2009_Jan_27_44(1)_79-84.nxml.txt.nlp	19177192	SENT14	7	7	28	28	curcumin	HO-1	PA151958596	3162	0.987
NULL	Clinics_(Sao_Paulo)_2013_Apr_68(4)_469-474.nxml.txt.nlp	23778343	SENT75	16	16	24	24	hyperforin	CYP3A4	PA165985514	1576	0.987
NULL	Arch_Trauma_Res_2013_Aug_1_2(2)_97-98.nxml.txt.nlp	24396803	SENT15	18	18	21	21	meperidine	P-gp	PA450369	5243	0.987
NULL	Oncoimmunology_2013_Jun_1_2(6)_e24452.nxml.txt.nlp	23894705	SENT10	0	0	6	6	imatinib	KIT	PA10804	3815	0.987
NULL	J_Radiat_Res_2013_Sep_7_54(5)_872-879.nxml.txt.nlp	23397075	SENT158	4	4	18	18	tamoxifen	BRCA2	PA451581	675	0.987
NULL	Breast_Cancer_Res_2012_Apr_4_14(2)_R57.nxml.txt.nlp	22475046	SENT3	14	14	0	0	tamoxifen	CCND1	PA451581	595	0.987
NULL	Cardiovasc_Diabetol_2013_Mar_28_12_53.nxml.txt.nlp	23537430	SENT61	4	4	8	8	sitagliptin	DPP4	PA164748978	1803	0.987
NULL	Nature_2012_Aug_16_488(7411)_394-398.nxml.txt.nlp	22810587	SENT90	18	18	5	5	forskolin	APJ	PA146096022	187	0.987
NULL	Basic_Clin_Pharmacol_Toxicol_2013_Feb_5_112(2)_132-137.nxml.txt.nlp	22900583	SENT5	0	0	4	4	ritonavir	CYP3A	PA451260	1574	0.987
NULL	Breast_Cancer_Res_2011_Nov_1_13(6)_225.nxml.txt.nlp	22078060	SENT102	6	6	16	16	tranylcypromine	LSD1	PA451741	23028	0.987
NULL	Expert_Rev_Endocrinol_Metab_2014_Jul_9_9(4)_397-409.nxml.txt.nlp	25264451	SENT286	41	41	3	3	estradiol	CYP19A1	PA449503	1588	0.987
NULL	Exp_Ther_Med_2013_Apr_5_5(4)_1259-1263.nxml.txt.nlp	23596498	SENT50	3	3	10	10	capsaicin	TRPV1	PA448776	7442	0.987
NULL	Indian_J_Ophthalmol_2007_Nov-Dec_55(6)_421-425.nxml.txt.nlp	17951897	SENT65	13	13	35	35	ranibizumab	VEGF-A	PA164746012	7422	0.987
NULL	J_Headache_Pain_2008_Oct_31_9(5)_267-276.nxml.txt.nlp	18668197	SENT136	0	0	24	24	fenfluramine	5-HT2C	PA449592	3358	0.987
NULL	Front_Neurosci_2012_May_30_6_77.nxml.txt.nlp	22661925	SENT165	8	8	0	0	ethanol	HEC	PA448073	10403	0.987
NULL	J_Histochem_Cytochem_2012_Oct_60(10)_749-760.nxml.txt.nlp	22821669	SENT191	8	8	28	28	hyaluronan	ITIH1	PA165958431	3697	0.987
NULL	Int_J_Hypertens_2012_Feb_1_2012_859235.nxml.txt.nlp	22518295	SENT291	18	18	0	0	cisplatin	HO-1	PA449014	3162	0.987
NULL	Avicenna_J_Med_Biotechnol_2013_Apr-Jun_5(2)_87-95.nxml.txt.nlp	23799177	SENT26	3	3	34	34	trastuzumab	HER2	PA451743	2064	0.987
NULL	J_Hematol_Oncol_2012_Apr_25_5(Suppl_1)_A1.nxml.txt.nlp	22738713	SENT10	15	15	7	7	cisplatin	HER2	PA449014	2064	0.987
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT126	28	28	11	11	pp2	PP2		4888	0.987
NULL	Indian_J_Nephrol_2009_Jul_19(3)_119-121.nxml.txt.nlp	20436733	SENT59	6	6	22	22	cyclosporine	P-gp	PA449167	5243	0.987
NULL	Exp_Ther_Med_2015_Jan_10_9(1)_267-271.nxml.txt.nlp	25452814	SENT28	13	13	20	20	clopidogrel	ABCB1	PA449053	5243	0.987
NULL	Eur_J_Neurosci_2008_Apr_1_27(7)_1722-1730.nxml.txt.nlp	18380669	SENT170	25	25	22	22	sr144528	CB2		1269	0.987
NULL	Acta_Pharmacol_Sin_2011_Oct_12_32(10)_1259-1265.nxml.txt.nlp	21909126	SENT97	14	14	4	4	fluvastatin	MCP-1	PA449688	6347	0.987
NULL	Exp_Ther_Med_2013_Jan_10_5(1)_11-16.nxml.txt.nlp	23251234	SENT19	0	0	15	15	cetuximab	EGFR	PA10040	1956	0.987
NULL	Ann_Oncol_2014_Oct_23_25(10)_1941-1948.nxml.txt.nlp	25057173	SENT15	11	11	3	3	docetaxel	KRAS	PA449383	3845	0.987
NULL	Front_Endocrinol_(Lausanne)_2014_Jan_16_5_1.nxml.txt.nlp	24474947	SENT63	24	24	37	37	estradiol	GPER	PA449503	2852	0.987
NULL	Breast_Cancer_Res_Treat_2014_Oct_22_148(2)_315-325.nxml.txt.nlp	25338319	SENT16	21	21	0	0	pertuzumab	HER2		2064	0.987
NULL	Gene_Ther_2010_Jan_27_17(1)_117-131.nxml.txt.nlp	19710705	SENT285	28	28	1	1	phenylephrine	ERG	PA450935	2078	0.987
NULL	Arch_Trauma_Res_2013_Aug_1_2(2)_97-98.nxml.txt.nlp	24396803	SENT15	2	2	6	6	gabapentin	P-gp	PA449720	5243	0.987
NULL	Case_Rep_Dermatol_2011_Feb_5_3(1)_13-17.nxml.txt.nlp	21931572	SENT6	20	20	27	27	bexarotene	IL-2	PA164752250	3558	0.987
NULL	Support_Care_Cancer_2009_Sep_10_17(9)_1187-1193.nxml.txt.nlp	19205754	SENT139	2	2	18	18	palonosetron	CYP2D6	PA10352	1565	0.987
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT51	34	34	22	22	nutlin-3	p53		7157	0.987
NULL	Emerg_Infect_Dis_2003_Jun_9(6)_657-664.nxml.txt.nlp	12781004	SENT143	23	23	7	7	vancomycin	VISA	PA451850	57506	0.987
NULL	Chin_J_Cancer_2011_May_30(5)_327-335.nxml.txt.nlp	21527065	SENT183	33	33	17	17	trastuzumab	PIK3CA	PA451743	5290	0.987
NULL	Ther_Clin_Risk_Manag_2006_Sep_2(3)_297-301.nxml.txt.nlp	18360604	SENT8	4	4	10	10	paricalcitol	PTH	PA450798	5741	0.987
NULL	Breast_Cancer_Res_2010_Nov_16_12(6)_R96.nxml.txt.nlp	21080941	SENT235	2	2	19	19	lapatinib	HER2	PA152241907	2064	0.987
NULL	J_Hematol_Oncol_2013_Oct_12_6_78.nxml.txt.nlp	24283803	SENT212	26	26	4	4	daunorubicin	STAT3	PA449212	6774	0.987
NULL	eLife_2013_Nov_5_2_e00969.nxml.txt.nlp	24192036	SENT114	28	28	3	3	vemurafenib	MCL1	PA165946873	4170	0.987
NULL	Neuroscience_2013_Oct_10_250(100)_493-506.nxml.txt.nlp	23892006	SENT183	7	7	16	16	ethanol	ZO-1	PA448073	7082	0.987
NULL	J_Mol_Signal_2012_Aug_16_7_12.nxml.txt.nlp	22898329	SENT19	7	7	15	15	cetuximab	EGF	PA10040	1950	0.987
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Jul_5_64(Pt_8)_o1398.nxml.txt.nlp	21203118	SENT60	39	39	12	12	ethanol	mol	PA448073	90527	0.987
NULL	BMJ_2011_Aug_4_343_d4588.nxml.txt.nlp	21816733	SENT294	15	15	20	20	clopidogrel	CYP3A	PA449053	1574	0.987
NULL	Arthritis_Res_Ther_2009_Aug_28_11(4)_R131.nxml.txt.nlp	19715572	SENT85	25	25	12	12	rituximab	CD19	PA451261	930	0.987
NULL	Cancer_Res_Treat_2013_Sep_30_45(3)_178-185.nxml.txt.nlp	24155676	SENT28	37	37	13	13	gefitinib	EGFR	PA131301952	1956	0.987
NULL	Toxins_(Basel)_2010_Oct_26_2(11)_2490-2518.nxml.txt.nlp	22069563	SENT216	6	6	20	20	cisplatin	TLR4	PA449014	7099	0.987
NULL	Diabetes_2009_Feb_58(2)_344-351.nxml.txt.nlp	19008341	SENT8	4	4	0	0	resveratrol	SIRT1		23411	0.987
NULL	Breast_Cancer_Res_2010_Oct_22_12(Suppl_2)_S1.nxml.txt.nlp	21050422	SENT94	0	0	6	6	gefitinib	EGFR	PA131301952	1956	0.987
NULL	Acta_Pharmacol_Sin_2010_Nov_18_31(11)_1409-1420.nxml.txt.nlp	20953207	SENT222	0	0	22	22	sorafenib	p38	PA7000	10598;1432;7965	0.987
NULL	Curr_Med_Chem_2011_Dec_18(35)_5424-5429.nxml.txt.nlp	22087835	SENT155	3	3	11	11	doxorubicin	FKBP51	PA449412	2289	0.987
NULL	Br_J_Cancer_1998_Aug_78(3)_375-381.nxml.txt.nlp	9703286	SENT10	23	23	1	1	cisplatin	TP53	PA449014	7157	0.987
NULL	Protein_Cell_2014_Jun_19_5(6)_469-479.nxml.txt.nlp	24748116	SENT86	11	11	6	6	paclitaxel	EB1	PA450761	9167;22919;10982	0.987
NULL	Trials_2013_Dec_10_14_424.nxml.txt.nlp	24325953	SENT98	30	30	2	2	acetaminophen	PCA	PA448015	28982	0.987
NULL	Oncotarget_2014_Mar_16_5(12)_4087-4102.nxml.txt.nlp	24961479	SENT124	25	25	18	18	hemin	PC3	PA449849	57332;7832;5122	0.987
NULL	J_Exp_Clin_Cancer_Res_2009_Feb_15_28(1)_19.nxml.txt.nlp	19216799	SENT135	7	7	14	14	cisplatin	AEG-1	PA449014	92140	0.987
NULL	Ann_Gen_Psychiatry_2013_Aug_13_12_26.nxml.txt.nlp	23941527	SENT177	13	13	1	1	fluoxetine	NMA	PA449673	25805	0.987
NULL	Front_Endocrinol_(Lausanne)_2013_Jan_7_3_180.nxml.txt.nlp	23316185	SENT124	34	34	3	3	glucose	CRF2	PA449773	1395	0.987
NULL	Br_J_Cancer_2013_Jul_23_109(2)_351-359.nxml.txt.nlp	23799854	SENT34	27	27	5	5	paclitaxel	BLT2	PA450761	56413	0.987
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT45	11	11	24	24	neratinib	HER2	PA165291472	2064	0.987
NULL	Mol_Cell_Biol_2014_Oct_34(19)_3754-3764.nxml.txt.nlp	25071155	SENT266	21	21	9	9	cisplatin	WWP2	PA449014	11060	0.987
NULL	Hum_Genomics_2010_Apr_1_4(4)_238-249.nxml.txt.nlp	20511137	SENT103	8	8	34	34	irinotecan	ABCB1	PA450085	5243	0.987
NULL	Mol_Cancer_2013_Mar_5_12_17.nxml.txt.nlp	23497256	SENT233	36	36	13	13	sunitinib	HDM2	PA162372840	4193	0.987
NULL	J_Immunother_Cancer_2013_Nov_7_1(Suppl_1)_P34.nxml.txt.nlp	NULL	SENT10	24	24	34	34	alemtuzumab	CD19	PA164783958	930	0.987
NULL	Oncotarget_2014_Jun_27_5(13)_4694-4708.nxml.txt.nlp	25051361	SENT279	16	16	4	4	fludarabine	p27	PA449655	5715;10534	0.987
NULL	Cancer_Res_Treat_2012_Sep_30_44(3)_195-201.nxml.txt.nlp	23091446	SENT106	2	2	21	21	irinotecan	MKP-1	PA450085	1843	0.987
NULL	Front_Oncol_2013_Sep_9_3_235.nxml.txt.nlp	24058902	SENT67	1	1	12	12	vorinostat	BIM	PA164748224	10018	0.987
NULL	Indian_J_Med_Paediatr_Oncol_2014_Apr-Jun_35(2)_176-180.nxml.txt.nlp	25197183	SENT83	19	19	3	3	bevacizumab	KRAS	PA130232992	3845	0.987
NULL	Eur_J_Med_Res_2010_Nov_30_15(12)_533-543.nxml.txt.nlp	21163728	SENT139	9	9	18	18	rifampin	ABCB1	PA451250	5243	0.987
NULL	Cell_Death_Dis_2010_Nov_18_1(11)_e102.nxml.txt.nlp	21368867	SENT335	26	26	21	21	gentamicin	14-3-3	PA449753	10971	0.987
NULL	Neural_Regen_Res_2013_Mar_25_8(9)_825-832.nxml.txt.nlp	25206730	SENT101	26	26	30	30	isoflurane	P2X7	PA450106	5027	0.987
NULL	J_Hematol_Oncol_2009_Jul_30_2_33.nxml.txt.nlp	19642998	SENT16	26	26	6	6	trastuzumab	HER2	PA451743	2064	0.987
NULL	Clin_Psychopharmacol_Neurosci_2013_Dec_24_11(3)_144-151.nxml.txt.nlp	24465251	SENT39	4	4	11	11	haloperidol	IL-2	PA449841	3558	0.987
NULL	J_Hematol_Oncol_2010_May_2_3_18.nxml.txt.nlp	20433767	SENT139	24	24	1	1	carboplatin	KRAS	PA448803	3845	0.987
NULL	Mol_Cancer_2009_Apr_22_8_26.nxml.txt.nlp	19386116	SENT145	17	17	5	5	ritonavir	AKT	PA451260	207	0.987
NULL	Breast_Cancer_Res_2013_Nov_8_15(6)_R107.nxml.txt.nlp	24207099	SENT180	29	29	7	7	etoposide	p53	PA449552	7157	0.987
NULL	Biomed_Res_Int_2013_Jul_1_2013_964743.nxml.txt.nlp	23936861	SENT198	21	21	3	3	bevacizumab	VEGFR	PA130232992	3791	0.987
NULL	Breast_Cancer_(Auckl)_2011_Jan_13_5_1-14.nxml.txt.nlp	21494397	SENT48	17	17	5	5	clarithromycin	CYP3A4	PA449028	1576	0.987
NULL	Diabetes_2011_Nov_17_60(11)_2691-2700.nxml.txt.nlp	21896928	SENT259	26	26	33	33	resveratrol	SIRT1		23411	0.987
NULL	Clin_Pharmacol_2010_Dec_7_2_225-236.nxml.txt.nlp	22291509	SENT83	0	0	40	40	retigabine	UGT1A1	PA144997862	54658	0.987
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT43	28	28	17	17	pemetrexed	UNG	PA10810	7374	0.987
NULL	Int_J_Cell_Biol_2014_Nov_17_2014_280638.nxml.txt.nlp	25477962	SENT27	4	4	2	2	flavopiridol	CDK2	PA452627	1017	0.987
NULL	Oncotarget_2014_Oct_21_5(22)_11723-11736.nxml.txt.nlp	25375091	SENT164	3	3	7	7	temsirolimus	MTOR	PA164746890	2475	0.987
NULL	Bioinformation_2012_Apr_30_8(8)_353-358.nxml.txt.nlp	22570515	SENT22	3	3	11	11	flurbiprofen	COX2	PA449683	4513;5743	0.987
NULL	J_Cancer_2012_Oct_13_3_432-448.nxml.txt.nlp	23074383	SENT164	21	21	9	9	trastuzumab	PTEN	PA451743	5728	0.987
NULL	Virol_J_2009_Apr_28_6_44.nxml.txt.nlp	19400954	SENT307	10	10	3	3	lipase	p37	PA450239	902;137886	0.987
NULL	J_Exp_Med_2000_Nov_20_192(10)_1403-1414.nxml.txt.nlp	11085743	SENT112	6	6	25	25	staurosporine	Bcl-2	PA165109623	596	0.987
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_21-38.nxml.txt.nlp	19305786	SENT142	0	0	9	9	capsaicin	TRPV1	PA448776	7442	0.987
NULL	Int_J_Appl_Basic_Med_Res_2013_Jan-Jun_3(1)_19-21.nxml.txt.nlp	23776835	SENT6	3	3	21	21	clopidogrel	P2Y12	PA449053	64805	0.987
NULL	Cell_Commun_Signal_2004_Aug_6_2_8.nxml.txt.nlp	15296508	SENT52	13	13	7	7	genistein	JAK1	PA165109660	3716	0.987
NULL	Breast_Cancer_Res_Treat_2014_Oct_22_148(2)_315-325.nxml.txt.nlp	25338319	SENT16	19	19	0	0	lapatinib	HER2	PA152241907	2064	0.987
NULL	Ther_Clin_Risk_Manag_2007_Jun_3(3)_363-379.nxml.txt.nlp	18488081	SENT308	12	12	17	17	rabeprazole	CYP2C19	PA451216	1557	0.987
NULL	J_Korean_Med_Sci_2013_Aug_31_28(8)_1145-1153.nxml.txt.nlp	23960440	SENT100	6	6	1	1	colchicine	ST2	PA449092	9173;6761	0.987
NULL	J_Biol_2003_Sep_24_2(4)_28.nxml.txt.nlp	14511394	SENT356	30	30	5	5	phenformin	LKB1	PA1000	6794	0.987
NULL	J_Burns_Wounds_2007_Jul_10_7_e2.nxml.txt.nlp	17846661	SENT119	8	8	17	17	trypsin	TFPI-2	PA451806	7980	0.987
NULL	Nat_Chem_Biol_2010_Apr_28_6(4)_291-299.nxml.txt.nlp	20190765	SENT278	16	16	6	6	dasatinib	EGFR	PA162372878	1956	0.987
NULL	Arthritis_Res_Ther_2013_Sep_27_15(5)_R138.nxml.txt.nlp	24289726	SENT26	34	34	27	27	tocilizumab	IL-6	PA165292659	3569	0.987
NULL	Breast_Cancer_Res_2004_Oct_24_6(1)_R8-R17.nxml.txt.nlp	14680495	SENT181	9	9	33	33	tamoxifen	BRCA1	PA451581	672	0.987
NULL	Front_Neuroanat_2010_Sep_28_4_135.nxml.txt.nlp	21048892	SENT62	7	7	21	21	fluorescein	VGLUT1	PA164746009	57030	0.987
NULL	Iran_J_Basic_Med_Sci_2011_Sep-Oct_14(5)_414-421.nxml.txt.nlp	23493814	SENT8	27	27	7	7	doxepin	CB1	PA449409	1268	0.987
NULL	Oncotarget_2014_Jan_11_5(3)_693-703.nxml.txt.nlp	24525337	SENT91	44	44	7	7	ethanol	AKT	PA448073	207	0.987
NULL	Breast_Cancer_Res_2009_Mar_17_11(2)_203.nxml.txt.nlp	19344488	SENT105	5	5	25	25	paclitaxel	AGO	PA450761	55294	0.987
NULL	Front_Genet_2012_Nov_5_3_236.nxml.txt.nlp	23133441	SENT66	34	34	3	3	efavirenz	ABCB1	PA449441	5243	0.987
NULL	Br_J_Pharmacol_2010_Sep_161(2)_288-307.nxml.txt.nlp	20735416	SENT245	34	34	7	7	isoflurane	TASK	PA450106	3777	0.987
NULL	J_Cell_Biol_2001_Apr_30_153(3)_613-620.nxml.txt.nlp	11331310	SENT7	21	21	0	0	hydroxyurea	53BP1	PA449942	7158	0.987
NULL	Oncotarget_2014_Oct_21_5(22)_11252-11268.nxml.txt.nlp	25361004	SENT251	2	2	7	7	metformin	CLIC1	PA450395	1192	0.987
NULL	Breast_Cancer_Res_2011_Jun_14_13(3)_R63.nxml.txt.nlp	21679465	SENT30	18	18	1	1	trastuzumab	HER2	PA451743	2064	0.987
NULL	Oxid_Med_Cell_Longev_2012_Aug_22_2012_534705.nxml.txt.nlp	22966415	SENT234	14	14	25	25	riluzole	GLT-1	PA451251	6506	0.987
NULL	J_Immunother_Cancer_2014_Jan_27_2_2.nxml.txt.nlp	24829759	SENT106	14	14	39	39	sorafenib	IL-21	PA7000	59067;50616;27189	0.987
NULL	Oncogene_2010_Sep_16_29(37)_5193-5203.nxml.txt.nlp	20581867	SENT21	6	6	16	16	trastuzumab	PI3K	PA451743	5290	0.987
NULL	Int_J_Mol_Sci_2014_Nov_10_15(11)_20607-20637.nxml.txt.nlp	25391045	SENT294	13	13	36	36	lovastatin	PI3K	PA450272	5290	0.987
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_11_2014_274786.nxml.txt.nlp	25505920	SENT243	29	29	20	20	oxaliplatin	ERCC1	PA131285527	2067	0.987
NULL	Patient_Prefer_Adherence_2014_Apr_15_8_473-475.nxml.txt.nlp	24790414	SENT16	20	20	25	25	metformin	FDC	PA450395	1218	0.987
NULL	Neural_Plast_2007_Oct_10_2007_23250.nxml.txt.nlp	NULL	SENT273	24	24	41	41	methamphetamine	CB1	PA450403	1268	0.987
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT27	0	0	10	10	lapatinib	HER2	PA152241907	2064	0.987
NULL	Eur_J_Haematol_2014_Feb_25_92(2)_127-136.nxml.txt.nlp	24118452	SENT69	19	19	3	3	anagrelide	CRT	PA164742986	811	0.987
NULL	EMBO_Mol_Med_2011_Jul_3(7)_367-369.nxml.txt.nlp	21591260	SENT40	13	13	0	0	thrombin	PAR1	PA451674	79581;2149	0.987
NULL	Breast_Cancer_Res_Treat_2008_Feb_22_107(3)_309-330.nxml.txt.nlp	17377838	SENT153	10	10	0	0	trastuzumab	HER-2	PA451743	2064	0.987
NULL	Clin_Exp_Gastroenterol_2012_May_14_5_49-59.nxml.txt.nlp	22649281	SENT75	0	0	20	20	esomeprazole	CYP3A4	PA10075	1576	0.987
NULL	Allergy_Asthma_Clin_Immunol_2010_May_13_6(1)_9.nxml.txt.nlp	20465788	SENT175	26	26	2	2	etoposide	XLP	PA449552	4068	0.987
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT421	19	19	1	1	tamoxifen	STAT3	PA451581	6774	0.987
NULL	J_Inflamm_(Lond)_2005_Oct_31_2_14.nxml.txt.nlp	16259633	SENT297	3	3	14	14	staurosporine	CCR2	PA165109623	729230	0.987
NULL	J_Korean_Med_Sci_2008_Aug_25_23(4)_737-739.nxml.txt.nlp	18756069	SENT64	14	14	20	20	saquinavir	ATV	PA451305	4683	0.987
NULL	J_Exp_Clin_Cancer_Res_2009_Aug_19_28(1)_116.nxml.txt.nlp	19689822	SENT106	29	29	25	25	rituximab	CHOP	PA451261	1649	0.987
NULL	Diabetes_2013_Mar_14_62(3)_789-800.nxml.txt.nlp	22966074	SENT229	15	15	25	25	liraglutide	GLP-1	PA165958364	100125288	0.987
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT159	27	27	3	3	atorvastatin	CD14	PA448500	929	0.987
NULL	Cancer_2011_Apr_15_117(8)_1670-1678.nxml.txt.nlp	21472714	SENT125	14	14	30	30	cisplatin	SIRT3	PA449014	23410	0.987
NULL	Arthritis_Res_Ther_2009_Apr_23_11(2)_R57.nxml.txt.nlp	19389237	SENT12	46	46	31	31	adalimumab	IL-18	PA10004	3606	0.987
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_7-17.nxml.txt.nlp	17912633	SENT152	0	0	15	15	letrozole	aromatase	PA450196	1588	0.987
NULL	Cancers_(Basel)_2014_Mar_13_6(1)_595-624.nxml.txt.nlp	24633084	SENT222	43	43	30	30	trastuzumab	HER2	PA451743	2064	0.987
NULL	Indian_J_Endocrinol_Metab_2014_Mar-Apr_18(2)_150-158.nxml.txt.nlp	24741509	SENT243	0	0	7	7	anastrozole	aromatase	PA448432	1588	0.987
NULL	J_Gen_Intern_Med_2009_Nov_18_24(Suppl_2)_389-394.nxml.txt.nlp	19838837	SENT57	20	20	30	30	denosumab	RANKL	PA166048634	8600	0.987
NULL	J_Cell_Biol_1997_Jun_30_137(7)_1639-1649.nxml.txt.nlp	9199177	SENT165	29	29	7	7	paraformaldehyde	ZAP-70	PA450790	7535	0.987
NULL	Open_Med_2007_Dec_18_1(3)_e184-e190.nxml.txt.nlp	21673951	SENT68	4	4	16	16	tamoxifen	BRCA2	PA451581	675	0.987
NULL	AIDS_Res_Ther_2013_May_1_10_10.nxml.txt.nlp	23634877	SENT111	22	22	0	0	lovastatin	CXCR4	PA450272	7852	0.987
NULL	Br_J_Cancer_2012_Sep_4_107(6)_977-987.nxml.txt.nlp	22892389	SENT95	9	9	1	1	cerulenin	VEGFA	PA164764551	7422	0.987
NULL	Hematol_Rep_2013_Jul_3_5(2)_26-27.nxml.txt.nlp	23888243	SENT40	8	8	2	2	dasatinib	SMO	PA162372878	6608;54498	0.987
NULL	Contemp_Oncol_(Pozn)_2013_Apr_29_17(2)_128-133.nxml.txt.nlp	23788978	SENT44	26	26	33	33	oxymorphone	CYP2D6	PA450748	1565	0.987
NULL	Indian_Dermatol_Online_J_2010_Jul-Dec_1(1)_14-17.nxml.txt.nlp	23130185	SENT87	22	22	25	25	lapatinib	EGFR	PA152241907	1956	0.987
NULL	Br_J_Ophthalmol_2014_Dec_7_98(12)_1636-1641.nxml.txt.nlp	25001321	SENT47	3	3	21	21	bevacizumab	VEGF-A	PA130232992	7422	0.987
NULL	Oncotarget_2010_Oct_25_1(7)_497-514.nxml.txt.nlp	21165163	SENT266	42	42	3	3	docetaxel	EGFR	PA449383	1956	0.987
NULL	J_Gen_Intern_Med_2012_Jun_31_27(Suppl_1)_83-93.nxml.txt.nlp	22648679	SENT145	11	11	3	3	warfarin	VKORC1	PA451906	79001	0.987
NULL	Cancer_Cell_Int_2009_Sep_10_9_25.nxml.txt.nlp	19744341	SENT178	16	16	3	3	glucosamine	p27	PA164747613	5715;10534	0.987
NULL	Cancer_Cell_Int_2004_Aug_17_4_5.nxml.txt.nlp	15315711	SENT154	15	15	32	32	genistein	CO2	PA165109660	4513	0.987
NULL	Mol_Cancer_2009_Jun_9_8_37.nxml.txt.nlp	19508729	SENT61	13	13	6	6	gemcitabine	HO-1	PA449748	3162	0.987
NULL	Int_J_Breast_Cancer_2011_Sep_6_2011_352182.nxml.txt.nlp	22295219	SENT201	22	22	9	9	gefitinib	HER3	PA131301952	2065	0.987
NULL	Patient_Prefer_Adherence_2010_Mar_24_4_61-68.nxml.txt.nlp	20361006	SENT22	0	0	22	22	liraglutide	GLP-1	PA165958364	100125288	0.987
NULL	Breast_Cancer_Res_2013_Oct_18_15(5)_R97.nxml.txt.nlp	24135425	SENT20	32	32	8	8	trastuzumab	aromatase	PA451743	1588	0.987
NULL	Oncogene_2013_Oct_24_32(43)_5176-5185.nxml.txt.nlp	23208500	SENT136	24	24	1	1	cisplatin	TP53	PA449014	7157	0.987
NULL	Diabetes_Care_2012_Feb_16_35(2)_327-333.nxml.txt.nlp	22179958	SENT80	12	12	31	31	metformin	B12	PA450395	7126;4709	0.987
NULL	Curr_Neuropharmacol_2008_Jun_6(2)_151-163.nxml.txt.nlp	19305794	SENT50	18	18	0	0	capsaicin	TRPV1	PA448776	7442	0.987
NULL	Exp_Mol_Med_2012_Aug_31_44(8)_473-482.nxml.txt.nlp	22627808	SENT83	12	12	8	8	lapatinib	HER3	PA152241907	2065	0.987
NULL	Arthritis_Res_Ther_2010_Apr_1_12(2)_R60.nxml.txt.nlp	20359365	SENT13	37	37	44	44	bleomycin	SPARC	PA448645	6678	0.987
NULL	Chin_J_Cancer_2011_Jan_30(1)_5-12.nxml.txt.nlp	21192840	SENT72	2	2	12	12	gefitinib	EGFR	PA131301952	1956	0.987
NULL	Br_J_Cancer_2004_Mar_22_90(6)_1285-1292.nxml.txt.nlp	15026814	SENT197	23	23	5	5	doxorubicin	p53	PA449412	7157	0.987
NULL	Hum_Genomics_2008_Sep_1_3(1)_53-70.nxml.txt.nlp	19129090	SENT11	18	18	11	11	perifosine	EXOC4	PA165291471	60412	0.987
NULL	J_Hematol_Oncol_2014_Aug_1_7_52.nxml.txt.nlp	25085632	SENT131	14	14	20	20	sunitinib	PTEN	PA162372840	5728	0.987
NULL	Breast_Cancer_Res_2004_Nov_7_6(1)_39-52.nxml.txt.nlp	14680484	SENT196	15	15	8	8	tamoxifen	N-CoR	PA451581	9611	0.987
NULL	Exp_Ther_Med_2013_Apr_5_5(4)_1259-1263.nxml.txt.nlp	23596498	SENT92	11	11	4	4	propofol	TRPV1	PA451141	7442	0.987
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1013.nxml.txt.nlp	24457957	SENT75	24	24	1	1	orlistat	NOXA	PA164776864	5366	0.987
NULL	Br_J_Clin_Pharmacol_2013_Aug_23_76(2)_299-315.nxml.txt.nlp	23701319	SENT240	6	6	13	13	basiliximab	IL-2	PA164747126	3558	0.987
NULL	Front_Oncol_2014_Mar_25_4_54.nxml.txt.nlp	24724051	SENT421	3	3	14	14	dasatinib	LYN	PA162372878	4067	0.987
NULL	Ann_Oncol_2013_Sep_4_24(9)_2206-2223.nxml.txt.nlp	23917950	SENT250	29	29	2	2	tamoxifen	aromatase	PA451581	1588	0.987
NULL	J_Vet_Med_Sci_2014_Jun_15_76(6)_813-817.nxml.txt.nlp	24531829	SENT93	7	7	26	26	chloroquine	DPT	PA448948	1805	0.987
NULL	Indian_J_Med_Res_2011_Sep_134(3)_295-301.nxml.txt.nlp	21985811	SENT30	15	15	3	3	phenytoin	CYP2C19	PA450947	1557	0.987
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Jul_5_64(Pt_8)_o1398.nxml.txt.nlp	21203118	SENT60	39	39	3	3	ethanol	mol	PA448073	90527	0.987
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Apr_16_64(Pt_5)_o862.nxml.txt.nlp	21202349	SENT59	39	39	12	12	ethanol	mol	PA448073	90527	0.987
NULL	Mol_Cancer_2009_Nov_10_8_99.nxml.txt.nlp	19903356	SENT95	15	15	24	24	imatinib	IGFBP3	PA10804	3486	0.987
NULL	Front_Neural_Circuits_2014_Jun_17_8_65.nxml.txt.nlp	24987336	SENT179	3	3	24	24	furosemide	KCC2	PA449719	57468	0.987
NULL	J_Cell_Mol_Med_2014_May_14_18(5)_811-823.nxml.txt.nlp	24628949	SENT15	12	12	28	28	docetaxel	FOXM1	PA449383	2305	0.987
NULL	Acta_Pharmacol_Sin_2013_Sep_5_34(9)_1208-1216.nxml.txt.nlp	23852087	SENT35	4	4	18	18	disulfiram	B12	PA449376	7126;4709	0.987
NULL	Acta_Orthop_2012_Aug_25_83(4)_401-405.nxml.txt.nlp	22880716	SENT141	23	23	21	21	denosumab	RANKL	PA166048634	8600	0.987
NULL	Cancer_Immunol_Immunother_2013_Aug_27_62(10)_1637-1648.nxml.txt.nlp	23982484	SENT37	0	0	11	11	lenalidomide	IL-2	PA162363968	3558	0.987
NULL	Oncotarget_2014_Oct_18_5(22)_11641-11652.nxml.txt.nlp	25361002	SENT82	13	13	31	31	cisplatin	NAC	PA449014	22861	0.987
NULL	Mol_Cells_2014_Jan_31_37(1)_43-50.nxml.txt.nlp	24552709	SENT85	9	9	22	22	deferoxamine	HIF-1	PA164746490	29072	0.987
NULL	J_Oncol_2010_Nov_19_2010_568938.nxml.txt.nlp	20037743	SENT210	9	9	13	13	gefitinib	PTEN	PA131301952	5728	0.987
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT2428	19	19	31	31	acetaminophen	CYP2E1	PA448015	1571	0.987
NULL	Exp_Diabetes_Res_2012_Sep_20_2012_936518.nxml.txt.nlp	23049542	SENT134	0	0	19	19	mannitol	TRPV4	PA450320	59341	0.987
NULL	J_Clin_Exp_Pathol_2012_May_17_Suppl_4_7327.nxml.txt.nlp	25379357	SENT148	7	7	24	24	metformin	LKB1	PA450395	6794	0.987
NULL	Breast_Cancer_Res_2011_Feb_23_13(1)_203.nxml.txt.nlp	21392408	SENT16	21	21	3	3	estradiol	aromatase	PA449503	1588	0.987
NULL	Evid_Based_Complement_Alternat_Med_2012_Sep_3_2012_696230.nxml.txt.nlp	22973403	SENT97	20	20	14	14	indomethacin	COX	PA449982	1351	0.987
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT52	14	14	4	4	curcumin	PC-3	PA151958596	692094	0.987
NULL	Virol_J_2010_Oct_27_7_285.nxml.txt.nlp	20979618	SENT10	28	28	9	9	isoproterenol	c-fos	PA450121	2353	0.987
NULL	Contemp_Oncol_(Pozn)_2012_Jul_6_16(3)_197-200.nxml.txt.nlp	23788878	SENT83	11	11	35	35	bevacizumab	BRAF	PA130232992	673	0.987
NULL	Cancer_Cell_Int_2014_Jun_16_14_53.nxml.txt.nlp	24966801	SENT214	12	12	34	34	metformin	p62	PA450395	8878;10657;23636	0.987
NULL	Cell_Death_Differ_2010_Apr_16_17(4)_666-676.nxml.txt.nlp	19834494	SENT126	19	19	2	2	oxaliplatin	RAGE	PA131285527	177	0.987
NULL	Biosci_Rep_2012_Dec_1_32(Pt_6)_531-537.nxml.txt.nlp	NULL	SENT110	12	12	24	24	resveratrol	K15		3866	0.987
NULL	Oncogene_2010_Jun_10_29(23)_3335-3348.nxml.txt.nlp	20383197	SENT92	21	21	15	15	cetuximab	HER2	PA10040	2064	0.987
NULL	Br_J_Pharmacol_2014_Jun_15_171(11)_2705-2725.nxml.txt.nlp	24467436	SENT82	8	8	18	18	procainamide	NAT1	PA451108	9;1982	0.987
NULL	J_Korean_Med_Sci_2014_Jul_11_29(7)_965-972.nxml.txt.nlp	25045229	SENT25	10	10	18	18	metformin	B12	PA450395	7126;4709	0.987
NULL	Front_Genet_2014_Jun_11_5_171.nxml.txt.nlp	24966867	SENT310	5	5	24	24	hemin	APAF-1	PA449849	317	0.987
NULL	Clin_Ophthalmol_2014_Dec_18_8_73-81.nxml.txt.nlp	24379650	SENT67	0	0	11	11	daclizumab	CD25	PA164764446	3669;3559	0.987
NULL	J_Korean_Med_Sci_2006_Oct_31_21(5)_891-896.nxml.txt.nlp	17043425	SENT21	22	22	0	0	tamoxifen	RERG	PA451581	85004	0.987
NULL	Front_Neural_Circuits_2015_Jan_12_8_150.nxml.txt.nlp	25628540	SENT283	4	4	9	9	carbachol	gamma	PA448784	9913	0.987
NULL	Nucleic_Acids_Res_2012_Jul_30_40(13)_6319-6337.nxml.txt.nlp	22467215	SENT345	22	22	6	6	cisplatin	HER2	PA449014	2064	0.987
NULL	Acta_Pharmacol_Sin_2011_Jan_6_32(1)_133-138.nxml.txt.nlp	21131997	SENT45	15	15	2	2	heparin	ACT	PA449855	12;11332;9457;641455	0.987
NULL	Eur_J_Med_Res_2009_Nov_24_14(Suppl_3)_43-46.nxml.txt.nlp	19959416	SENT13	5	5	25	25	raltegravir	CYP2C8		1558	0.987
NULL	Int_J_Biomed_Sci_2014_Sep_10(3)_146-157.nxml.txt.nlp	25324695	SENT134	3	3	22	22	pravastatin	RANTES	PA451089	6352	0.987
NULL	Int_J_Biol_Sci_2013_Jan_16_9(2)_134-141.nxml.txt.nlp	23411595	SENT126	15	15	9	9	vincristine	CD137	PA451879	3604	0.987
NULL	Indian_J_Med_Res_2010_Dec_132(6)_676-682.nxml.txt.nlp	21245614	SENT94	9	9	24	24	zinc	p53	PA451956	7157	0.987
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT119	8	8	34	34	cisplatin	MDM2	PA449014	4193	0.987
NULL	Curr_Cardiol_Rev_2012_Aug_8(3)_239-249.nxml.txt.nlp	22935021	SENT130	27	27	0	0	ticagrelor	PAR-1	PA165374673	2011;2149	0.987
NULL	Front_Pharmacol_2014_Nov_7_5_240.nxml.txt.nlp	25426072	SENT201	5	5	11	11	bosentan	MRP4	PA10034	10257	0.987
NULL	Gastric_Cancer_2014_Apr_7_17(1)_1-12.nxml.txt.nlp	23563986	SENT86	7	7	40	40	trastuzumab	HER2	PA451743	2064	0.987
NULL	Cell_Death_Dis_2014_Jan_9_5(1)_e986.nxml.txt.nlp	24407239	SENT138	32	32	0	0	fludarabine	STAT1	PA449655	6772	0.987
NULL	Genet_Vaccines_Ther_2009_Jan_30_7_2.nxml.txt.nlp	19178753	SENT3	3	3	17	17	gefitinib	EGFR	PA131301952	1956	0.987
NULL	Int_J_Tryptophan_Res_2013_Aug_19_6_35-45.nxml.txt.nlp	24023520	SENT93	39	39	5	5	hydroquinone	NQO1	PA449924	1728	0.987
NULL	Evid_Based_Complement_Alternat_Med_2014_May_8_2014_364819.nxml.txt.nlp	24899907	SENT197	3	3	8	8	tacrolimus	PPIase	PA451578	2281;2289;8468;2286;2287	0.987
NULL	Breast_Cancer_Res_2010_Dec_20_12(Suppl_4)_S19.nxml.txt.nlp	21172081	SENT36	30	30	16	16	irinotecan	HIF-1	PA450085	29072	0.987
NULL	Exp_Ther_Med_2015_Feb_3_9(2)_585-590.nxml.txt.nlp	25574239	SENT43	18	18	40	40	indomethacin	CD50	PA449982	3385	0.987
NULL	Cancers_(Basel)_2013_Apr_15_5(2)_430-461.nxml.txt.nlp	24216985	SENT361	30	30	15	15	doxorubicin	p53	PA449412	7157	0.987
NULL	Breast_Cancer_Res_2013_Oct_18_15(5)_R97.nxml.txt.nlp	24135425	SENT20	30	30	20	20	pertuzumab	HER2		2064	0.987
NULL	Br_J_Cancer_2009_Oct_20_101(8)_1253-1260.nxml.txt.nlp	19755984	SENT128	6	6	37	37	letrozole	HER-2	PA450196	2064	0.987
NULL	Nucleic_Acids_Res_2012_Sep_28_40(17)_8440-8448.nxml.txt.nlp	22753029	SENT7	13	13	4	4	hydroxyurea	CHK1	PA449942	1111	0.987
NULL	Oncotarget_2014_Oct_23_5(21)_10816-10829.nxml.txt.nlp	25333261	SENT147	22	22	13	13	doxorubicin	MTDH	PA449412	92140	0.987
NULL	J_Cell_Biol_2008_Jul_28_182(2)_233-239.nxml.txt.nlp	18644891	SENT95	16	16	2	2	staurosporine	MICA	PA165109623	100507436	0.987
NULL	Br_J_Cancer_2010_Feb_2_102(3)_541-552.nxml.txt.nlp	20087344	SENT207	11	11	37	37	paclitaxel	NRP1	PA450761	8829	0.987
NULL	Br_J_Cancer_2012_Sep_25_107(7)_1009-1016.nxml.txt.nlp	22948724	SENT47	16	16	1	1	sorafenib	CAIX	PA7000	768	0.987
NULL	Oncologist_2011_Feb_25_16(2)_155-164.nxml.txt.nlp	21266401	SENT161	14	14	9	9	trastuzumab	HER-2	PA451743	2064	0.987
NULL	Exp_Ther_Med_2013_Oct_20_6(4)_899-903.nxml.txt.nlp	24137286	SENT74	16	16	11	11	rosuvastatin	MMP9	PA134308647	4318	0.987
NULL	Indian_J_Pharmacol_2008_Oct_40(Suppl_2)_S112-S142.nxml.txt.nlp	21593965	SENT1777	27	27	11	11	ethanol	NPY	PA448073	4852	0.987
NULL	Diabetes_Metab_J_2012_Feb_17_36(1)_13-25.nxml.txt.nlp	22363917	SENT155	4	4	23	23	exenatide	GLP-1	PA164749238	100125288	0.987
NULL	Cancer_Med_2014_Dec_13_3(6)_1579-1594.nxml.txt.nlp	25124282	SENT150	26	26	0	0	cisplatin	DNA-PKcs	PA449014	5591	0.987
NULL	Front_Oncol_2013_Aug_5_3_195.nxml.txt.nlp	23936763	SENT52	0	0	19	19	dasatinib	DDR2	PA162372878	4921	0.987
NULL	Breast_Cancer_Res_2011_Mar_11_13(2)_R30.nxml.txt.nlp	21396117	SENT11	8	8	6	6	erlotinib	EGFR	PA134687924	1956	0.987
NULL	Exp_Diabetes_Res_2012_Oct_15_2012_465282.nxml.txt.nlp	23118742	SENT94	21	21	6	6	metformin	AMPK	PA450395	5563	0.987
NULL	Drug_Target_Insights_2011_Jun_7_5_11-32.nxml.txt.nlp	22087060	SENT153	7	7	18	18	novobiocin	Hsp90	PA164768819	3320	0.987
NULL	Cases_J_2009_Jun_9_2_8099.nxml.txt.nlp	19918269	SENT13	5	5	13	13	trastuzumab	HER-2	PA451743	2064	0.987
NULL	Clin_Exp_Otorhinolaryngol_2011_Mar_17_4(1)_18-23.nxml.txt.nlp	21461058	SENT74	37	37	16	16	bumetanide	NKCC1	PA448682	6558	0.987
NULL	Mol_Brain_2013_May_4_6_22.nxml.txt.nlp	23641686	SENT195	27	27	2	2	tropicamide	NR2D	PA164749389	2906	0.987
NULL	J_Korean_Med_Sci_2011_Dec_29_26(12)_1563-1568.nxml.txt.nlp	22147992	SENT24	0	0	12	12	brivanib	VEGFR	PA164924492	3791	0.987
NULL	Blood_Cancer_J_2013_Apr_12_3(4)_e108.nxml.txt.nlp	23584398	SENT180	37	37	14	14	sn-38	ROCK1		6093	0.987
NULL	Br_J_Cancer_2009_Sep_15_101(6)_957-966.nxml.txt.nlp	19738618	SENT46	3	3	23	23	dexrazoxane	THBS-1	PA449259	7057	0.987
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Feb_17_6_29-36.nxml.txt.nlp	24648767	SENT93	0	0	3	3	exemestane	aromatase	PA449563	1588	0.987
NULL	Br_J_Pharmacol_2008_Oct_18_155(4)_596-605.nxml.txt.nlp	18852694	SENT261	16	16	6	6	fenofibrate	aP2	PA449594	2167	0.987
NULL	Nat_Biotechnol_2010_Jul_27_28(7)_743-747.nxml.txt.nlp	20581846	SENT141	18	18	1	1	ethanol	FKBP12	PA448073	2280	0.987
NULL	Aging_(Albany_NY)_2012_Jul_22_4(7)_480-498.nxml.txt.nlp	22837425	SENT132	8	8	35	35	pemetrexed	AMPK	PA10810	5563	0.987
NULL	Int_J_Mol_Sci_2014_Oct_8_15(10)_17974-17999.nxml.txt.nlp	25299695	SENT102	11	11	0	0	curcumin	HO-1	PA151958596	3162	0.987
NULL	Ann_Oncol_2011_Dec_17_22(12)_2610-2615.nxml.txt.nlp	21415234	SENT224	22	22	12	12	lapatinib	HER2	PA152241907	2064	0.987
NULL	Mol_Cells_2014_Jan_31_37(1)_43-50.nxml.txt.nlp	24552709	SENT85	9	9	0	0	deferoxamine	HIF-1	PA164746490	29072	0.987
NULL	Acta_Pharmacol_Sin_2010_May_12_31(5)_578-584.nxml.txt.nlp	20383171	SENT118	18	18	8	8	berberine	JNK	PA165860812	5599	0.987
NULL	Acta_Pharmacol_Sin_2010_Sep_16_31(9)_1085-1094.nxml.txt.nlp	20711226	SENT87	11	11	7	7	deferoxamine	HIF-1alpha	PA164746490	3091	0.987
NULL	Clinics_(Sao_Paulo)_2012_Apr_67(4)_335-340.nxml.txt.nlp	22522758	SENT190	17	17	5	5	citalopram	HTR1B	PA449015	3351	0.987
NULL	J_Hematol_Oncol_2013_Jan_17_6_8.nxml.txt.nlp	23327547	SENT84	15	15	21	21	sulindac	JNK1	PA451565	5599	0.987
NULL	Int_J_Biol_Sci_2013_Mar_7_9(3)_279-288.nxml.txt.nlp	23493630	SENT45	6	6	17	17	tocilizumab	IL-6	PA165292659	3569	0.987
NULL	Allergy_Asthma_Immunol_Res_2014_Nov_19_6(6)_548-557.nxml.txt.nlp	25374755	SENT84	12	12	2	2	lovastatin	MUC5AC	PA450272	4586	0.987
NULL	Cells_2014_Jun_11_3(2)_616-626.nxml.txt.nlp	24921186	SENT10	18	18	0	0	capsaicin	TRPV1	PA448776	7442	0.987
NULL	Mol_Cancer_2013_May_24_12_47.nxml.txt.nlp	23705854	SENT259	9	9	30	30	celecoxib	P-gp	PA448871	5243	0.987
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT13	4	4	19	19	neratinib	HER2	PA165291472	2064	0.987
NULL	Infect_Dis_Ther_2014_Dec_24_3(2)_159-174.nxml.txt.nlp	25134687	SENT181	25	25	7	7	mimosine	HIF-1	PA164752445	29072	0.987
NULL	Environ_Health_Perspect_2006_Sep_23_114(9)_1401-1406.nxml.txt.nlp	16966095	SENT62	21	21	9	9	tetracycline	p53	PA451640	7157	0.987
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT272	4	4	10	10	aripiprazole	PRL	PA10026	5617	0.987
NULL	Breast_Cancer_Res_2007_Oct_1_9(5)_R64.nxml.txt.nlp	17908324	SENT23	9	9	0	0	trastuzumab	HER2	PA451743	2064	0.987
NULL	Gynecol_Oncol_Case_Rep_2013_Jun_12_6_34-35.nxml.txt.nlp	24371715	SENT58	0	0	5	5	aprepitant	CYP3A4	PA164747039	1576	0.987
NULL	Nat_Med_2013_Nov_27_19(11)_10_1038_nm_3352.nxml.txt.nlp	24162815	SENT134	5	5	24	24	thyroglobulin	TTF-1	PA164754910	7080	0.987
NULL	Avicenna_J_Phytomed_2014_Jan-Feb_4(1)_59-71.nxml.txt.nlp	25050302	SENT151	0	0	14	14	diazepam	EPM	PA449283	2054	0.987
NULL	Cell_Res_2013_Jul_21_23(7)_915-930.nxml.txt.nlp	23689279	SENT115	27	27	5	5	staurosporine	ALDH2	PA165109623	217	0.987
NULL	J_Gynecol_Oncol_2013_Jul_4_24(3)_273-279.nxml.txt.nlp	23875078	SENT102	12	12	16	16	paclitaxel	COX	PA450761	1351	0.987
NULL	Orphanet_J_Rare_Dis_2014_Dec_5_9(1)_194.nxml.txt.nlp	NULL	SENT401	8	8	24	24	desogestrel	CO2	PA449238	4513	0.987
NULL	Cough_2007_Oct_31_3_9.nxml.txt.nlp	17971242	SENT163	4	4	14	14	capsaicin	TRPV1	PA448776	7442	0.987
NULL	Oncogene_2014_Sep_11_33(37)_4579-4588.nxml.txt.nlp	24662835	SENT125	33	33	9	9	tamoxifen	MAGEA2	PA451581	4101;266740	0.987
NULL	Adv_Biomed_Res_2012_Jul_6_1_21.nxml.txt.nlp	23210080	SENT87	12	12	16	16	pertuzumab	HER2		2064	0.987
NULL	Front_Oncol_2014_Mar_14_4_52.nxml.txt.nlp	24672773	SENT95	34	34	8	8	troglitazone	CASP3	PA451799	836	0.987
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT264	26	26	9	9	methotrexate	MLH1	PA450428	4292	0.987
NULL	Oncotarget_2014_Jun_3_5(13)_4920-4928.nxml.txt.nlp	24952482	SENT132	7	7	0	0	crizotinib	Hsp90	PA165946122	3320	0.987
NULL	Acta_Pharmacol_Sin_2014_Jun_5_35(6)_727-737.nxml.txt.nlp	24793312	SENT152	36	36	27	27	telmisartan	AT1	PA451605	9197;185	0.987
NULL	Oncogene_2014_Jun_26_33(26)_3422-3431.nxml.txt.nlp	23912457	SENT158	0	0	14	14	trastuzumab	PI3K	PA451743	5290	0.987
NULL	BMJ_2010_Feb_8_340_c693.nxml.txt.nlp	20142325	SENT137	48	48	8	8	tamoxifen	CYP2D6	PA451581	1565	0.987
NULL	Tuberc_Respir_Dis_(Seoul)_2012_Dec_28_73(6)_303-311.nxml.txt.nlp	23319992	SENT36	0	0	9	9	gefitinib	EGFR	PA131301952	1956	0.987
NULL	Environ_Health_Perspect_2008_Apr_16_116(4)_426-433.nxml.txt.nlp	18414622	SENT169	0	0	31	31	resveratrol	AP-1		2353;3727;2354;3725	0.987
NULL	Br_J_Cancer_1998_Dec_78(12)_1586-1593.nxml.txt.nlp	9862568	SENT16	23	23	7	7	vincristine	MDR1	PA451879	5243	0.987
NULL	Breast_Cancer_Res_2004_Aug_5_6(5)_R601-R607.nxml.txt.nlp	15318941	SENT119	17	17	9	9	docetaxel	p27	PA449383	5715;10534	0.987
NULL	Breast_Cancer_Res_2011_Feb_4_13(1)_R17.nxml.txt.nlp	21294885	SENT180	32	32	9	9	trastuzumab	HER2	PA451743	2064	0.987
NULL	Acta_Naturae_2011_Jul-Sep_3(3)_12-28.nxml.txt.nlp	22649690	SENT212	4	4	24	24	raltegravir	CD4		920	0.987
NULL	Cancer_Metastasis_Rev_2010_Sep_24_29(3)_465-482.nxml.txt.nlp	20730632	SENT295	5	5	16	16	genistein	CXCR4	PA165109660	7852	0.987
NULL	Front_Aging_Neurosci_2010_May_21_2_19.nxml.txt.nlp	20725517	SENT229	4	4	12	12	indomethacin	BACE1	PA449982	23621	0.987
NULL	Mediators_Inflamm_2010_Sep_22_2010_628171.nxml.txt.nlp	20886028	SENT20	2	2	18	18	zafirlukast	CysLT1	PA451949	10800	0.987
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT193	27	27	12	12	trastuzumab	HER3	PA451743	2065	0.987
NULL	Acta_Pharmacol_Sin_2012_Mar_27_33(3)_342-350.nxml.txt.nlp	22367283	SENT193	35	35	19	19	trypsin	PAR1	PA451806	79581;2149	0.987
NULL	Acta_Pharmacol_Sin_2013_Sep_5_34(9)_1192-1200.nxml.txt.nlp	23685957	SENT168	19	19	5	5	curcumin	Bcl-2	PA151958596	596	0.987
NULL	Mol_Cells_2014_Oct_31_37(10)_759-765.nxml.txt.nlp	25256221	SENT101	7	7	23	23	curcumin	NDRG2	PA151958596	57447	0.987
NULL	Drugs_Context_2012_Nov_19_2012_212242.nxml.txt.nlp	24432031	SENT238	0	0	15	15	axitinib	VEGFR	PA164924493	3791	0.987
NULL	Drug_Saf_2014_Feb_19_37(4)_201-211.nxml.txt.nlp	24550106	SENT163	28	28	1	1	rabeprazole	CYP2C19	PA451216	1557	0.987
NULL	Iran_J_Pharm_Res_2014_Autumn_13(4)_1387-1392.nxml.txt.nlp	25587328	SENT25	39	39	8	8	fludarabine	Mcl-1	PA449655	4170	0.987
NULL	Eur_J_Med_Res_2009_Nov_24_14(Suppl_3)_17-21.nxml.txt.nlp	19959412	SENT71	6	6	25	25	raltegravir	UGT1A1		54658	0.987
NULL	AAPS_J_2013_Aug_20_15(4)_1119-1127.nxml.txt.nlp	23959685	SENT45	31	31	5	5	ketoprofen	CPE	PA450149	1363	0.987
NULL	J_Indian_Assoc_Pediatr_Surg_2012_Jul-Sep_17(3)_104-106.nxml.txt.nlp	22869974	SENT24	15	15	5	5	praziquantel	HSM	PA164764583	94030	0.987
NULL	J_Adv_Pract_Oncol_2012_Nov_1_Nov-Dec_3(6)_391-394.nxml.txt.nlp	25031970	SENT78	0	0	21	21	pertuzumab	HER2		2064	0.987
NULL	Hum_Reprod_Update_2008_Sep_23_Nov-Dec_14(6)_571-582.nxml.txt.nlp	18812422	SENT9	0	0	4	4	letrozole	aromatase	PA450196	1588	0.987
NULL	Br_J_Cancer_2013_Mar_5_108(4)_836-847.nxml.txt.nlp	23462806	SENT319	44	44	25	25	trypsin	YB-1	PA451806	4904	0.987
NULL	Breast_Cancer_(Auckl)_2011_Jan_13_5_1-14.nxml.txt.nlp	21494397	SENT48	29	29	5	5	amprenavir	CYP3A4	PA448422	1576	0.987
NULL	Mol_Cells_2014_Sep_30_37(9)_699-704.nxml.txt.nlp	25245523	SENT118	19	19	5	5	doxorubicin	MTA1	PA449412	9112	0.987
NULL	Front_Cell_Neurosci_2013_Dec_18_7_250.nxml.txt.nlp	24391538	SENT328	29	29	11	11	suramin	P2X1	PA10292	5023	0.987
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1522-1532.nxml.txt.nlp	21997136	SENT174	45	45	3	3	irinotecan	EGFR	PA450085	1956	0.987
NULL	Indian_J_Pharm_Sci_2008_Mar-Apr_70(2)_251-255.nxml.txt.nlp	20046726	SENT21	4	4	11	11	fluoxetine	TRD	PA449673	6964	0.987
NULL	Acta_Pharmacol_Sin_2010_Jul_28_31(7)_867-873.nxml.txt.nlp	20581857	SENT46	6	6	0	0	docetaxel	PC3	PA449383	57332;7832;5122	0.987
NULL	Acta_Naturae_2010_Oct-Dec_2(4)_31-35.nxml.txt.nlp	22649661	SENT120	8	8	0	0	cisplatin	BRCA1	PA449014	672	0.987
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT243	26	26	35	35	sitagliptin	GLP-1	PA164748978	100125288	0.987
NULL	EMBO_Mol_Med_2014_Oct_17_6(10)_1294-1311.nxml.txt.nlp	25231413	SENT448	11	11	5	5	calcein	PC3	PA132595336	57332;7832;5122	0.987
NULL	Oncotarget_2011_Jun_15_2(6)_518-524.nxml.txt.nlp	21680956	SENT33	7	7	28	28	pyrimethamine	STAT3	PA451193	6774	0.987
NULL	Br_J_Cancer_2011_Oct_25_105(9)_1273-1278.nxml.txt.nlp	21959871	SENT29	6	6	15	15	trastuzumab	HER2	PA451743	2064	0.987
NULL	J_Gastroenterol_2013_Feb_22_48(2)_222-237.nxml.txt.nlp	22722906	SENT270	32	32	14	14	ethanol	CYP1A2	PA448073	1544	0.987
NULL	Mol_Cancer_2010_Aug_16_9_217.nxml.txt.nlp	20712901	SENT37	30	30	11	11	curcumin	STAT3	PA151958596	6774	0.987
NULL	Diabetes_Care_2010_Jun_23_33(6)_1294-1296.nxml.txt.nlp	20332358	SENT29	0	0	4	4	exenatide	GLP-1	PA164749238	100125288	0.987
NULL	Curr_Neuropharmacol_2008_Jun_6(2)_151-163.nxml.txt.nlp	19305794	SENT133	10	10	1	1	amiloride	TRPV1	PA448368	7442	0.987
NULL	Diagn_Pathol_2013_May_15_8_81.nxml.txt.nlp	23675804	SENT21	26	26	2	2	doxorubicin	CD5	PA449412	921	0.987
NULL	Oncol_Rep_2014_Feb_13_31(2)_581-588.nxml.txt.nlp	24337105	SENT142	34	34	0	0	capsaicin	SERCA2	PA448776	488	0.987
NULL	Blood_Cancer_J_2013_Oct_18_3(10)_e153.nxml.txt.nlp	24141622	SENT114	8	8	31	31	fludarabine	Mcl-1	PA449655	4170	0.987
NULL	Crit_Care_2011_Feb_3_15(1)_R49.nxml.txt.nlp	21291554	SENT128	32	32	8	8	ceftazidime	CLCR	PA448861	11330	0.987
NULL	J_Biomed_Biotechnol_2011_Jul_6_2011_783528.nxml.txt.nlp	21785566	SENT118	3	3	22	22	ritonavir	P-gp	PA451260	5243	0.987
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Jul_23_6_103-113.nxml.txt.nlp	25114588	SENT42	24	24	35	35	pertuzumab	HER2		2064	0.987
NULL	Oncol_Lett_2013_Jun_3_5(6)_1760-1764.nxml.txt.nlp	23833637	SENT49	18	18	1	1	gemcitabine	TRAIL	PA449748	8743	0.987
NULL	J_Korean_Med_Sci_2010_Jun_24_25(6)_829-834.nxml.txt.nlp	20514301	SENT6	20	20	1	1	papain	IL-25	PA450778	64806;56005	0.987
NULL	Int_J_Chron_Obstruct_Pulmon_Dis_2006_Dec_1(4)_345-354.nxml.txt.nlp	18044091	SENT107	28	28	9	9	salmeterol	NNT	PA451300	23530	0.987
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Apr_21_68(Pt_5)_o1466.nxml.txt.nlp	22590340	SENT66	47	47	6	6	ethanol	mol	PA448073	90527	0.987
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT167	3	3	24	24	neratinib	HER2	PA165291472	2064	0.987
NULL	Arthritis_Res_Ther_2011_Apr_27_13(2)_404.nxml.txt.nlp	21542887	SENT7	16	16	41	41	infliximab	ghrelin	PA452639	51738	0.987
NULL	Blood_Cancer_J_2013_Oct_18_3(10)_e153.nxml.txt.nlp	24141622	SENT114	8	8	33	33	fludarabine	XIAP	PA449655	331	0.987
NULL	Chemother_Res_Pract_2012_Aug_29_2012_817297.nxml.txt.nlp	22970367	SENT168	34	34	13	13	erlotinib	EGFR	PA134687924	1956	0.987
NULL	Biomed_Res_Int_2014_Feb_23_2014_168949.nxml.txt.nlp	24707474	SENT19	43	43	21	21	trastuzumab	HER2	PA451743	2064	0.987
NULL	Oncoscience_2014_Mar_31_1(3)_216-228.nxml.txt.nlp	25594014	SENT228	0	0	9	9	curcumin	STAT3	PA151958596	6774	0.987
NULL	Mol_Cancer_2010_Aug_20_9_220.nxml.txt.nlp	20727180	SENT169	1	1	20	20	nicotine	p53	PA450626	7157	0.987
NULL	Cells_2014_May_23_3(2)_517-545.nxml.txt.nlp	24861977	SENT14	5	5	0	0	capsaicin	TRPV1	PA448776	7442	0.987
NULL	Int_J_Biol_Sci_2005_Apr_1_1(2)_51-66.nxml.txt.nlp	15951850	SENT51	15	15	4	4	carbachol	RGS1	PA448784	5996	0.987
NULL	Cancers_(Basel)_2014_Mar_26_6(2)_708-722.nxml.txt.nlp	24675568	SENT64	16	16	7	7	sunitinib	STAT3	PA162372840	6774	0.987
NULL	Br_J_Pharmacol_2010_Sep_161(2)_288-307.nxml.txt.nlp	20735416	SENT245	23	23	14	14	halothane	TREK-1	PA449845	3776	0.987
NULL	Acta_Pharmacol_Sin_2010_Oct_27_31(10)_1277-1283.nxml.txt.nlp	20871619	SENT133	5	5	1	1	resveratrol	SHP2		5781	0.987
NULL	Br_J_Cancer_2010_Oct_26_103(9)_1335-1342.nxml.txt.nlp	20978512	SENT131	10	10	29	29	trastuzumab	HER-2	PA451743	2064	0.987
NULL	Cancer_Metastasis_Rev_2010_Sep_24_29(3)_465-482.nxml.txt.nlp	20730632	SENT295	5	5	18	18	genistein	CXCL12	PA165109660	6387	0.987
NULL	Br_J_Cancer_2010_Mar_2_102(5)_815-826.nxml.txt.nlp	20145614	SENT154	11	11	31	31	trastuzumab	AKT	PA451743	207	0.987
NULL	Clin_Mol_Allergy_2009_Mar_12_7_5.nxml.txt.nlp	19284628	SENT180	5	5	24	24	estradiol	IL-10	PA449503	3586	0.987
NULL	Aging_(Albany_NY)_2012_Mar_4_4(3)_144-145.nxml.txt.nlp	22388573	SENT12	34	34	23	23	resveratrol	AMPK		5563	0.987
NULL	Arch_Drug_Inf_2011_Mar_4(1)_1-9.nxml.txt.nlp	21572514	SENT195	40	40	46	46	ciprofloxacin	P-gp	PA449009	5243	0.987
NULL	J_Radiat_Res_2012_Jul_53(4)_545-550.nxml.txt.nlp	22843619	SENT27	17	17	4	4	geldanamycin	Hsp90	PA152031327	3320	0.987
NULL	J_Mol_Signal_2011_May_9_6_3.nxml.txt.nlp	21554706	SENT79	35	35	0	0	isoproterenol	AKAP12	PA450121	9590	0.987
NULL	Oncol_Lett_2013_Jun_22_5(6)_1948-1954.nxml.txt.nlp	23833673	SENT139	4	4	11	11	mitomycin	BRCA2	PA450524	675	0.987
NULL	Breast_Cancer_Res_2007_Aug_8_9(4)_R50.nxml.txt.nlp	17686159	SENT236	12	12	39	39	gefitinib	AKT	PA131301952	207	0.987
NULL	Pain_Res_Treat_2011_Aug_14_2011_864605.nxml.txt.nlp	22110933	SENT118	0	0	20	20	tramadol	PLP	PA451735	25824;5744	0.987
NULL	Ann_Indian_Acad_Neurol_2010_Apr-Jun_13(2)_136-138.nxml.txt.nlp	20814499	SENT58	10	10	24	24	azathioprine	CD4	PA448515	920	0.987
NULL	Int_J_Surg_Oncol_2012_May_16_2012_863034.nxml.txt.nlp	22666572	SENT152	5	5	19	19	capecitabine	KRAS	PA448771	3845	0.987
NULL	Oncogene_2014_Jun_26_33(26)_3422-3431.nxml.txt.nlp	23912457	SENT1	13	13	2	2	trastuzumab	HER2	PA451743	2064	0.987
NULL	Iran_J_Basic_Med_Sci_2013_Apr_16(4)_610-614.nxml.txt.nlp	24250937	SENT32	31	31	1	1	coumarin	CYP2A6	PA134521193	1548	0.987
NULL	Breast_Cancer_Res_Treat_2013_Jan_10_137(1)_1-12.nxml.txt.nlp	23143215	SENT107	1	1	31	31	lapatinib	BCRP1	PA152241907	317687	0.987
NULL	Chem_Rev_2012_May_9_112(5)_2593-2603.nxml.txt.nlp	22335786	SENT83	0	0	10	10	l-histidine	ATX	PA449882	5168;23049	0.987
NULL	Breast_Cancer_Res_2012_May_4_14(3)_R72.nxml.txt.nlp	22559056	SENT4	25	25	7	7	tamoxifen	CENP-A	PA451581	1058	0.987
NULL	Arthritis_Res_Ther_2008_Jan_7_10(1)_R1.nxml.txt.nlp	18179697	SENT188	8	8	0	0	oxaliplatin	HMGB1	PA131285527	3146	0.987
NULL	J_Immunol_Res_2014_Oct_12_2014_570685.nxml.txt.nlp	25371908	SENT145	2	2	15	15	levofloxacin	IL-8	PA450214	3576	0.987
NULL	Eur_J_Med_Res_2011_Nov_10_16(11)_491-494.nxml.txt.nlp	22027642	SENT60	0	0	23	23	sunitinib	CSF1	PA162372840	1435	0.987
NULL	Adv_Hematol_2011_Apr_10_2011_960137.nxml.txt.nlp	21547266	SENT59	19	19	6	6	rituximab	NHL	PA451261	51750	0.987
NULL	Biologics_2013_Feb_28_7_39-46.nxml.txt.nlp	23467578	SENT35	0	0	14	14	bevacizumab	VEGFR	PA130232992	3791	0.987
NULL	Oncotarget_2012_Sep_11_3(9)_1026-1035.nxml.txt.nlp	22976441	SENT95	11	11	4	4	etoposide	ATM	PA449552	472	0.987
NULL	Mol_Biol_Cell_2013_Jul_15_24(14)_2186-2200.nxml.txt.nlp	23699397	SENT93	29	29	3	3	doxorubicin	TRAIL	PA449412	8743	0.987
NULL	F1000Res_2014_Aug_19_3_198.nxml.txt.nlp	25400908	SENT189	26	26	14	14	trastuzumab	HER2	PA451743	2064	0.987
NULL	Br_J_Cancer_2010_Nov_2_103(11)_1680-1691.nxml.txt.nlp	21045833	SENT171	7	7	18	18	capecitabine	LCK	PA448771	3932	0.987
NULL	Oncogene_2014_Jan_23_33(4)_421-428.nxml.txt.nlp	23318437	SENT118	36	36	23	23	etoposide	MDM2	PA449552	4193	0.987
NULL	EPMA_J_2010_Sep_4_1(3)_485-494.nxml.txt.nlp	23199090	SENT194	35	35	11	11	leucovorin	MTHFR	PA450198	4524	0.987
NULL	J_Invest_Dermatol_2013_Sep_31_133(9)_2247-2254.nxml.txt.nlp	23370537	SENT215	21	21	5	5	etoposide	PUMA	PA449552	27113	0.987
NULL	Iran_J_Pharm_Res_2015_Winter_14(1)_263-269.nxml.txt.nlp	25561932	SENT114	23	23	9	9	morphine	HAAH	PA450550	444	0.987
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_55-66.nxml.txt.nlp	17912636	SENT21	24	24	11	11	tamoxifen	aromatase	PA451581	1588	0.987
NULL	Oncoimmunology_2014_Jan_17_3_e27574.nxml.txt.nlp	24800167	SENT21	10	10	19	19	cyclophosphamide	CD4	PA449165	920	0.987
NULL	Br_J_Pharmacol_2012_Apr_165(8)_2611-2619.nxml.txt.nlp	21718301	SENT159	9	9	1	1	rimonabant	GPR55	PA152407999	9290	0.987
NULL	Ann_Dermatol_2014_Apr_30_26(2)_236-240.nxml.txt.nlp	24882980	SENT85	2	2	12	12	imipenem	RGM	PA449968	56963	0.987
NULL	Oncotarget_2011_Mar_27_2(3)_209-221.nxml.txt.nlp	21444945	SENT161	4	4	20	20	bortezomib	p53	PA10252	7157	0.987
NULL	Breast_Cancer_Res_2011_Jun_29_13(3)_R70.nxml.txt.nlp	21707964	SENT184	42	42	1	1	tamoxifen	FOXM1	PA451581	2305	0.987
NULL	Blood_Cancer_J_2012_Mar_9_2(3)_e60.nxml.txt.nlp	22829255	SENT123	20	20	6	6	flavopiridol	FLT3	PA452627	2322	0.987
NULL	Pharmaceuticals_(Basel)_2012_Aug_10_5(8)_802-836.nxml.txt.nlp	24280676	SENT247	37	37	7	7	pantoprazole	PCFT	PA450774	113235	0.987
NULL	Basic_Res_Cardiol_2010_Sep_30_105(5)_583-595.nxml.txt.nlp	20352235	SENT237	14	14	3	3	vasopressin	RGS2	PA451858	5997	0.987
NULL	Int_J_Mol_Sci_2014_Sep_19_15(9)_16698-16718.nxml.txt.nlp	25244018	SENT95	25	25	3	3	geldanamycin	LKB1	PA152031327	6794	0.987
NULL	Case_Rep_Oncol_2013_Dec_12_6(3)_602-608.nxml.txt.nlp	24474924	SENT22	36	36	11	11	gemcitabine	EGFR	PA449748	1956	0.987
NULL	Curr_Med_Chem_2014_Feb_21_1129-1145.nxml.txt.nlp	24304271	SENT344	7	7	16	16	tamoxifen	GPER	PA451581	2852	0.987
NULL	Br_J_Cancer_2012_Jan_17_106(2)_348-357.nxml.txt.nlp	22146521	SENT234	39	39	9	9	ethanol	TP53	PA448073	7157	0.987
NULL	Cerebrovasc_Dis_Extra_2012_Mar_14_2(1)_9-16.nxml.txt.nlp	22566991	SENT76	11	11	27	27	heparin	ACT	PA449855	12;11332;9457;641455	0.987
NULL	Cancers_(Basel)_2012_Oct_12_4(4)_989-1035.nxml.txt.nlp	24213498	SENT178	11	11	2	2	gemcitabine	periostin	PA449748	10631	0.987
NULL	Br_J_Cancer_2013_May_14_108(9)_1807-1809.nxml.txt.nlp	23612454	SENT52	8	8	20	20	trastuzumab	PIK3CA	PA451743	5290	0.987
NULL	N_Am_J_Med_Sci_2011_Mar_3(3)_129-136.nxml.txt.nlp	22540078	SENT164	6	6	42	42	tetracycline	SMG	PA451640	23034	0.987
NULL	Turk_J_Haematol_2013_Dec_5_30(4)_351-358.nxml.txt.nlp	24385824	SENT98	4	4	25	25	imatinib	ELN	PA10804	2006	0.987
NULL	Clin_Med_Insights_Oncol_2012_Mar_19_6_165-178.nxml.txt.nlp	22474408	SENT190	14	14	0	0	rituximab	BCR	PA451261	613	0.987
NULL	Clin_Sci_(Lond)_2012_May_1_122(Pt_9)_421-428.nxml.txt.nlp	22092038	SENT31	1	1	32	32	tetracycline	AP-1	PA451640	2353;3727;2354;3725	0.987
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_55-78.nxml.txt.nlp	19305788	SENT73	5	5	27	27	memantine	NR1	PA10364	27158	0.987
NULL	Cell_Commun_Signal_2013_Aug_27_11_63.nxml.txt.nlp	24103640	SENT197	34	34	7	7	doxorubicin	YB-1	PA449412	4904	0.987
NULL	Front_Immunol_2012_May_15_3_99.nxml.txt.nlp	22615707	SENT126	6	6	16	16	imiquimod	TLR7	PA449972	51284	0.987
NULL	Cancers_(Basel)_2014_Mar_25_6(2)_684-707.nxml.txt.nlp	24670368	SENT124	22	22	1	1	lapatinib	HER2	PA152241907	2064	0.987
NULL	Front_Physiol_2011_Jun_30_2_33.nxml.txt.nlp	21747769	SENT256	9	9	15	15	berberine	p38	PA165860812	10598;1432;7965	0.987
NULL	Oncotarget_2014_Jun_6_5(13)_4935-4944.nxml.txt.nlp	24952732	SENT74	15	15	40	40	doxazosin	PI3K	PA449407	5290	0.987
NULL	Sci_Rep_2014_Dec_23_4_7593.nxml.txt.nlp	25534349	SENT68	26	26	4	4	atorvastatin	PC-3	PA448500	692094	0.987
NULL	Cancer_Microenviron_2009_Jul_11_2(Suppl_1)_227-237.nxml.txt.nlp	19593676	SENT131	32	32	1	1	rofecoxib	PPARgamma	PA451268	5468	0.987
NULL	Emerg_Infect_Dis_2003_Jul_9(7)_864-867.nxml.txt.nlp	12890330	SENT9	0	0	12	12	dapsone	DHPS	PA449211	1725	0.987
NULL	Oncologist_2011_Feb_1_16(2)_136-145.nxml.txt.nlp	21285392	SENT97	0	0	31	31	denosumab	OPG	PA166048634	690	0.987
NULL	Br_J_Pharmacol_2014_Feb_24_171(1)_1019-1032.nxml.txt.nlp	24251620	SENT48	6	6	29	29	nifedipine	TRPM3	PA450631	80036	0.987
NULL	Chin_J_Cancer_2011_Dec_30(12)_815-820.nxml.txt.nlp	22059910	SENT91	29	29	2	2	cetuximab	EGFR	PA10040	1956	0.987
NULL	Cell_Div_2012_Jun_20_7_16.nxml.txt.nlp	22892065	SENT185	0	0	6	6	alemtuzumab	CD52	PA164783958	1043	0.987
NULL	Iran_J_Basic_Med_Sci_2012_May-Jun_15(3)_795-802.nxml.txt.nlp	23493622	SENT26	15	15	5	5	capsaicin	TRPV1	PA448776	7442	0.987
NULL	Nucleic_Acids_Res_2011_Mar_17_39(6)_2144-2152.nxml.txt.nlp	21087997	SENT96	18	18	3	3	etoposide	HSF1	PA449552	3297	0.987
NULL	Ann_Lab_Med_2015_Jan_8_35(1)_15-21.nxml.txt.nlp	25553275	SENT60	26	26	0	0	thrombin	Lag	PA451674	3925	0.987
NULL	Clin_Med_Insights_Oncol_2013_Feb_21_7_41-51.nxml.txt.nlp	23471238	SENT72	22	22	33	33	trastuzumab	HER2	PA451743	2064	0.987
NULL	Br_J_Cancer_2013_Jan_15_108(1)_82-90.nxml.txt.nlp	23321512	SENT219	10	10	2	2	doxorubicin	TUBB3	PA449412	10381	0.987
NULL	Pharmaceuticals_(Basel)_2011_Nov_11_4(11)_1503-1517.nxml.txt.nlp	NULL	SENT116	6	6	16	16	capsaicin	TRPV1	PA448776	7442	0.987
NULL	J_Gynecol_Oncol_2013_Jan_8_24(1)_83-91.nxml.txt.nlp	23346317	SENT122	0	0	9	9	pazopanib	VEGFR	PA165291492	3791	0.987
NULL	J_Exp_Med_2003_Feb_17_197(4)_403-411.nxml.txt.nlp	12591899	SENT25	18	18	29	29	hyaluronan	TLR-4	PA165958431	7099	0.987
NULL	Cancer_Inform_2008_Jun_10_6_315-355.nxml.txt.nlp	19259415	SENT277	19	19	8	8	cisplatin	IRF3	PA449014	3661	0.987
NULL	Evid_Based_Complement_Alternat_Med_2011_Mar_20_2011_612464.nxml.txt.nlp	21799683	SENT169	28	28	12	12	estradiol	SP8	PA449503	221833	0.987
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT253	24	24	8	8	cetuximab	KRAS	PA10040	3845	0.987
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT133	37	37	22	22	chloroquine	BMPR-II	PA448948	659	0.987
NULL	Am_J_Case_Rep_2014_Mar_25_15_123-127.nxml.txt.nlp	24711885	SENT129	0	0	24	24	sunitinib	FLT3	PA162372840	2322	0.987
NULL	Patient_Prefer_Adherence_2014_Apr_8_8_463-471.nxml.txt.nlp	24748775	SENT6	0	0	13	13	denosumab	RANKL	PA166048634	8600	0.987
NULL	Cancer_Cell_Int_2009_Sep_10_9_25.nxml.txt.nlp	19744341	SENT130	35	35	4	4	glucosamine	survivin	PA164747613	332	0.987
NULL	Am_J_Transplant_2010_Jan_10(1)_69-80.nxml.txt.nlp	19889125	SENT115	26	26	10	10	fludarabine	CD25	PA449655	3669;3559	0.987
NULL	J_Exp_Med_2003_Aug_4_198(3)_505-512.nxml.txt.nlp	12900524	SENT138	25	25	12	12	collagenase	CCL21	PA449107	6366	0.987
NULL	Toxins_(Basel)_2010_Oct_26_2(11)_2490-2518.nxml.txt.nlp	22069563	SENT136	12	12	0	0	cisplatin	PUMA	PA449014	27113	0.987
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT39	0	0	7	7	nutlin-3	MDM2		4193	0.987
NULL	Diabetes_Metab_Syndr_Obes_2010_Mar_26_3_43-48.nxml.txt.nlp	21437075	SENT75	0	0	8	8	bromocriptine	CYP3A4	PA448671	1576	0.987
NULL	Cell_Death_Dis_2012_Mar_15_3(3)_e283.nxml.txt.nlp	22419112	SENT45	22	22	6	6	cisplatin	p33ING1	PA449014	3621	0.987
NULL	Drugs_R_D_2011_Jun_27_11(2)_101-111.nxml.txt.nlp	21679003	SENT264	9	9	3	3	panitumumab	BRAF	PA162373091	673	0.987
NULL	Ann_Oncol_2013_Aug_12_24(8)_1994-1999.nxml.txt.nlp	23670096	SENT130	45	45	36	36	tamoxifen	AIB1	PA451581	8202	0.987
NULL	Aging_(Albany_NY)_2012_Dec_6_4(11)_823-842.nxml.txt.nlp	23235539	SENT328	17	17	9	9	bleomycin	HCA2	PA448645	139081;55811;338442	0.987
NULL	Acta_Naturae_2011_Oct-Dec_3(4)_12-29.nxml.txt.nlp	22649701	SENT390	4	4	15	15	fluorescein	PTK7	PA164746009	5754	0.987
NULL	Front_Oncol_2014_Sep_16_4_249.nxml.txt.nlp	25279352	SENT44	21	21	19	19	vemurafenib	BRAF	PA165946873	673	0.987
NULL	Br_J_Cancer_2010_Oct_26_103(9)_1335-1342.nxml.txt.nlp	20978512	SENT139	27	27	8	8	trastuzumab	HER-2	PA451743	2064	0.987
NULL	Oncologist_2010_Mar_3_15(3)_216-235.nxml.txt.nlp	20200040	SENT259	9	9	18	18	docetaxel	HER-2	PA449383	2064	0.987
NULL	Oncologist_2010_Mar_9_15(3)_236-245.nxml.txt.nlp	20215359	SENT95	8	8	41	41	sorafenib	IFN	PA7000	3439	0.987
NULL	ScientificWorldJournal_2014_Feb_6_2014_328513.nxml.txt.nlp	24683330	SENT98	19	19	5	5	propofol	IL-6	PA451141	3569	0.987
NULL	Acta_Pharmacol_Sin_2014_Sep_4_35(9)_1157-1166.nxml.txt.nlp	25088002	SENT102	15	15	4	4	curcumin	STAT3	PA151958596	6774	0.987
NULL	J_Obes_2010_Jan_14_2010_970865.nxml.txt.nlp	20798864	SENT36	0	0	6	6	metformin	AMPK	PA450395	5563	0.987
NULL	Acta_Histochem_Cytochem_2011_Apr_28_44(2)_113-118.nxml.txt.nlp	21614172	SENT71	0	0	14	14	everolimus	HIF-1	PA164746311	29072	0.987
NULL	Tob_Induc_Dis_2002_Jan_15_1(1)_3.nxml.txt.nlp	NULL	SENT253	0	0	14	14	nicotine	CD44	PA450626	960	0.987
NULL	Clin_Drug_Investig_2013_Aug_23_33(10)_727-736.nxml.txt.nlp	23975654	SENT172	14	14	39	39	duloxetine	CYP2C9	PA10066	1559	0.987
NULL	Ann_Surg_Treat_Res_2014_Feb_22_86(2)_100-104.nxml.txt.nlp	24761416	SENT40	0	0	17	17	sorafenib	Raf-1	PA7000	5894	0.987
NULL	Front_Neurosci_2009_May_1_3(1)_25-33.nxml.txt.nlp	19753094	SENT112	28	28	7	7	pilocarpine	CA1	PA450962	759	0.987
NULL	Front_Chem_2014_Dec_23_2_113.nxml.txt.nlp	25566531	SENT261	3	3	16	16	curcumin	STAT3	PA151958596	6774	0.987
NULL	Clin_Pract_2012_Nov_13_2(4)_e82.nxml.txt.nlp	24765481	SENT74	38	38	4	4	octreotide	ACTH	PA450678	5443	0.987
NULL	Oncol_Lett_2013_Mar_11_5(3)_1010-1016.nxml.txt.nlp	23426784	SENT103	31	31	5	5	midazolam	TRPM7	PA450496	54822	0.987
NULL	J_Adv_Pract_Oncol_2014_Mar_1_Mar-Apr_5(2)_134-139.nxml.txt.nlp	25032047	SENT16	0	0	11	11	trastuzumab	HER2	PA451743	2064	0.987
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT120	7	7	36	36	pp2	PP2		4888	0.987
NULL	Arthritis_Res_Ther_2011_Oct_26_13(5)_R177.nxml.txt.nlp	22029963	SENT25	0	0	22	22	abatacept	CD4	PA164747080	920	0.987
NULL	Int_J_Cell_Biol_2013_May_16_2013_639401.nxml.txt.nlp	23762063	SENT339	2	2	13	13	curcumin	AMPK	PA151958596	5563	0.987
NULL	J_Korean_Med_Sci_2006_Jun_21_21(3)_418-424.nxml.txt.nlp	16778382	SENT56	18	18	12	12	hemin	INS-1	PA449849	2305	0.987
NULL	Orphanet_J_Rare_Dis_2007_Jan_4_2_1.nxml.txt.nlp	17204147	SENT135	7	7	18	18	trypsin	SPINK1	PA451806	6690	0.987
NULL	Front_Endocrinol_(Lausanne)_2013_Jul_16_4_89.nxml.txt.nlp	23882261	SENT121	5	5	16	16	vasopressin	SON	PA451858	6651	0.987
NULL	Orphanet_J_Rare_Dis_2010_Dec_16_5_39.nxml.txt.nlp	21162721	SENT80	15	15	17	17	allopurinol	HLA-B	PA448320	3106	0.987
NULL	Curr_Neuropharmacol_2013_Mar_11(2)_160-170.nxml.txt.nlp	23997751	SENT102	13	13	18	18	mianserin	5-HT2C	PA134687937	3358	0.987
NULL	Oxid_Med_Cell_Longev_2013_Nov_28_2013_568093.nxml.txt.nlp	24379901	SENT75	7	7	22	22	resveratrol	4E-BP1		1978	0.987
NULL	Breast_Cancer_Res_2007_Mar_2_9(2)_205.nxml.txt.nlp	NULL	SENT147	30	30	2	2	trastuzumab	HER-2	PA451743	2064	0.987
NULL	Arthritis_Res_Ther_2004_Feb_24_6(Suppl_1)_24.nxml.txt.nlp	NULL	SENT7	26	26	4	4	etanercept	CD31	PA449515	5175	0.987
NULL	Mol_Vis_2012_Nov_29_18_2839-2846.nxml.txt.nlp	23233786	SENT183	10	10	18	18	geldanamycin	CB2	PA152031327	1269	0.987
NULL	Apoptosis_2012_Sep_30_17(9)_989-997.nxml.txt.nlp	22460505	SENT33	7	7	17	17	thioridazine	PI3K	PA451666	5290	0.987
NULL	Mol_Biol_Cell_2012_Sep_1_23(17)_3473-3484.nxml.txt.nlp	22787275	SENT72	0	0	12	12	doxorubicin	ABCC1	PA449412	4363	0.987
NULL	J_Korean_Med_Sci_2011_Apr_28_26(4)_521-527.nxml.txt.nlp	21468259	SENT35	18	18	37	37	clopidogrel	DES	PA449053	1674	0.987
NULL	Iran_J_Reprod_Med_2012_Jul_10(4)_373-376.nxml.txt.nlp	25246900	SENT44	23	23	3	3	levothyroxine	TPO	PA450221	7066;7173	0.987
NULL	Clin_Mol_Allergy_2007_Jan_25_5_1.nxml.txt.nlp	17254346	SENT152	0	0	33	33	curcumin	CD80	PA151958596	941	0.987
NULL	Gut_Pathog_2014_Aug_20_6_34.nxml.txt.nlp	25349629	SENT178	15	15	25	25	metronidazole	ST7	PA450484	7982;29967	0.987
NULL	J_Korean_Med_Sci_2011_Feb_24_26(2)_214-221.nxml.txt.nlp	21286012	SENT30	6	6	29	29	gefitinib	EGFR	PA131301952	1956	0.987
NULL	Croat_Med_J_2012_Jun_53(3)_224-233.nxml.txt.nlp	22661135	SENT244	0	0	10	10	cabergoline	PRL	PA448708	5617	0.987
NULL	Acta_Pharmacol_Sin_2011_Jul_13_32(7)_967-972.nxml.txt.nlp	21666702	SENT15	7	7	25	25	losartan	CYP2C9	PA450268	1559	0.987
NULL	Front_Chem_2013_Jun_26_1_8.nxml.txt.nlp	24790937	SENT23	22	22	3	3	lithium	CO2	PA450243	4513	0.987
NULL	Curr_Pain_Headache_Rep_2011_Aug_12_15(4)_271-279.nxml.txt.nlp	21479998	SENT162	9	9	24	24	oxycodone	CYP2D6	PA450741	1565	0.987
NULL	J_Cell_Mol_Med_2014_Apr_20_18(4)_709-720.nxml.txt.nlp	24444314	SENT228	0	0	12	12	metformin	AMPK	PA450395	5563	0.987
NULL	Br_J_Cancer_2010_Oct_12_103(8)_1284-1291.nxml.txt.nlp	20859285	SENT156	28	28	9	9	tamoxifen	BCAR4	PA451581	400500	0.987
NULL	Mol_Vis_2014_May_13_20_649-660.nxml.txt.nlp	24868139	SENT227	0	0	20	20	ranibizumab	VEGF-A	PA164746012	7422	0.987
NULL	Cancer_Cell_Int_2014_Feb_28_14_18.nxml.txt.nlp	24576043	SENT103	2	2	6	6	flavopiridol	CDK9	PA452627	1025	0.987
NULL	Br_J_Clin_Pharmacol_2014_Nov_20_78(5)_1043-1049.nxml.txt.nlp	24838177	SENT169	0	0	17	17	boceprevir	CYP3A4	PA165948902	1576	0.987
NULL	Biomed_Res_Int_2013_Jul_31_2013_692071.nxml.txt.nlp	23984399	SENT173	16	16	31	31	atropine	OCT1	PA448505	5451;6580	0.987
NULL	Mol_Cancer_2012_Apr_26_11_26.nxml.txt.nlp	22537224	SENT16	41	41	22	22	cisplatin	CHK1	PA449014	1111	0.987
NULL	Oncotarget_2013_Apr_13_4(4)_502-530.nxml.txt.nlp	23594434	SENT49	0	0	9	9	maraviroc	CCR5	PA164768835	1234	0.987
NULL	J_Hematol_Oncol_2014_Aug_1_7_52.nxml.txt.nlp	25085632	SENT131	14	14	23	23	sunitinib	EGFR	PA162372840	1956	0.987
NULL	Neuro_Oncol_2011_Jan_25_13(1)_70-83.nxml.txt.nlp	20978004	SENT266	17	17	3	3	etoposide	CD133	PA449552	8842	0.987
NULL	Oncotarget_2012_May_18_3(5)_525-534.nxml.txt.nlp	22619113	SENT90	29	29	8	8	fludarabine	CFLAR	PA449655	8837	0.987
NULL	Acta_Pharmacol_Sin_2013_Jan_23_34(1)_33-38.nxml.txt.nlp	22820909	SENT71	3	3	16	16	amiloride	ASIC2a	PA448368	40	0.987
NULL	Acta_Pharmacol_Sin_2009_Dec_4_30(12)_1607-1615.nxml.txt.nlp	19960007	SENT51	0	0	8	8	metformin	AMPK	PA450395	5563	0.987
NULL	Acta_Pharmacol_Sin_2014_Jun_5_35(6)_727-737.nxml.txt.nlp	24793312	SENT152	36	36	11	11	telmisartan	AT2	PA451605	186	0.987
NULL	Br_J_Cancer_2009_Jun_2_100(11)_1697-1703.nxml.txt.nlp	19384299	SENT175	9	9	41	41	lenalidomide	FOXP3	PA162363968	50943	0.987
NULL	Int_J_Gen_Med_2009_Jul_30_2_77-81.nxml.txt.nlp	20360891	SENT17	6	6	21	21	hyaluronan	HAS1	PA165958431	3036	0.987
NULL	Front_Genet_2013_Dec_16_4_281.nxml.txt.nlp	24379827	SENT376	25	25	7	7	amlodipine	CACNA1F	PA448388	778	0.986
NULL	Eur_J_Clin_Pharmacol_2014_Mar_22_70(6)_685-693.nxml.txt.nlp	24658827	SENT4	5	5	13	13	cyclosporine	CYP3A4	PA449167	1576	0.986
NULL	Arq_Bras_Cardiol_2013_Jul_101(1)_2-3.nxml.txt.nlp	23917505	SENT25	0	0	14	14	trastuzumab	HER2	PA451743	2064	0.986
NULL	Anal_Bioanal_Chem_2010_Oct_22_398(4)_1771-1780.nxml.txt.nlp	20730527	SENT127	11	11	18	18	diclofenac	p38	PA449293	10598;1432;7965	0.986
NULL	J_Korean_Med_Sci_2010_Jun_24_25(6)_829-834.nxml.txt.nlp	20514301	SENT90	15	15	1	1	papain	IL-25	PA450778	64806;56005	0.986
NULL	Hum_Mol_Genet_2013_Nov_15_22(22)_4616-4626.nxml.txt.nlp	23814041	SENT143	0	0	19	19	simvastatin	SREBP2	PA451363	6721	0.986
NULL	Indian_J_Anaesth_2013_Mar-Apr_57(2)_203-204.nxml.txt.nlp	23825828	SENT28	10	10	22	22	rocuronium	RTS	PA164754992	1387	0.986
NULL	Oncol_Lett_2013_Apr_4_5(4)_1165-1170.nxml.txt.nlp	23599757	SENT134	41	41	5	5	bevacizumab	SLC19A1	PA130232992	6573	0.986
NULL	ScientificWorldJournal_2014_Jan_12_2014_171439.nxml.txt.nlp	24672293	SENT93	14	14	2	2	fluorescein	CD99	PA164746009	4267	0.986
NULL	Oncoimmunology_2014_Jan_1_3_e27359.nxml.txt.nlp	24653963	SENT13	35	35	22	22	doxorubicin	CD4	PA449412	920	0.986
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT244	2	2	14	14	amisulpride	PRL	PA162565877	5617	0.986
NULL	Front_Genet_2014_Nov_19_5_361.nxml.txt.nlp	25477897	SENT189	12	12	24	24	hemin	CD41	PA449849	3674	0.986
NULL	J_Cardiothorac_Surg_2013_Apr_18_8_101.nxml.txt.nlp	23597154	SENT73	6	6	12	12	sirolimus	LAM	PA451365	7249;7248	0.986
NULL	Case_Rep_Dermatol_2013_Sep_26_5(3)_254-259.nxml.txt.nlp	24163658	SENT21	0	0	12	12	ustekinumab	p40	PA166048654	3921;339541;10314	0.986
NULL	J_Cell_Mol_Med_2013_Sep_11_17(9)_1160-1172.nxml.txt.nlp	23844832	SENT276	28	28	7	7	erlotinib	EGF	PA134687924	1950	0.986
NULL	Int_J_Mol_Sci_2014_Nov_7_15(11)_20500-20517.nxml.txt.nlp	25387078	SENT122	7	7	19	19	sorafenib	Mcl-1	PA7000	4170	0.986
NULL	Case_Rep_Oncol_2013_Aug_14_6(2)_430-433.nxml.txt.nlp	24019783	SENT32	4	4	19	19	crizotinib	Met	PA165946122	79811	0.986
NULL	Ther_Clin_Risk_Manag_2007_Aug_3(4)_665-673.nxml.txt.nlp	18472989	SENT6	4	4	25	25	lapatinib	CYP2C19	PA152241907	1557	0.986
NULL	Arthritis_Res_Ther_2009_Apr_23_11(2)_R57.nxml.txt.nlp	19389237	SENT252	43	43	12	12	adalimumab	IL-18	PA10004	3606	0.986
NULL	Ann_Rheum_Dis_2008_Aug_20_67(8)_1121-1126.nxml.txt.nlp	18029384	SENT107	28	28	3	3	bosentan	LFA-1	PA10034	3683;3689	0.986
NULL	Clin_Pharmacol_2010_Sep_6_2_155-162.nxml.txt.nlp	22291500	SENT166	20	20	34	34	prasugrel	CYP2C19	PA154410481	1557	0.986
NULL	Ann_Oncol_2011_Mar_8_22(3)_503-514.nxml.txt.nlp	20616198	SENT185	26	26	7	7	tamoxifen	aromatase	PA451581	1588	0.986
NULL	Chem_Rev_2011_Oct_12_111(10)_5899-5921.nxml.txt.nlp	21923193	SENT600	8	8	18	18	valdecoxib	CB1	PA10226	1268	0.986
NULL	Arthritis_Res_Ther_2013_Oct_2_15(5)_R141.nxml.txt.nlp	24286116	SENT61	18	18	3	3	tocilizumab	IL-6	PA165292659	3569	0.986
NULL	Oncogene_2014_Sep_4_33(36)_4521-4530.nxml.txt.nlp	24662833	SENT64	36	36	3	3	bicalutamide	AMPK	PA164746255	5563	0.986
NULL	Breast_Cancer_Res_2004_Mar_11_6(3)_109-118.nxml.txt.nlp	15084231	SENT92	5	5	15	15	trastuzumab	HER-2	PA451743	2064	0.986
NULL	Breast_Cancer_(Auckl)_2009_Aug_17_3_47-60.nxml.txt.nlp	21556249	SENT48	8	8	41	41	tamoxifen	AF-1	PA451581	3460;5710	0.986
NULL	Indian_J_Pharm_Sci_2008_Mar-Apr_70(2)_251-255.nxml.txt.nlp	20046726	SENT10	0	0	38	38	olanzapine	TLC	PA450688	3933	0.986
NULL	Pharmaceuticals_(Basel)_2011_Mar_17_4(3)_551-566.nxml.txt.nlp	NULL	SENT157	10	10	23	23	carvedilol	MCP-1	PA448817	6347	0.986
NULL	Cardiovasc_Diabetol_2013_May_30_12(Suppl_1)_S2.nxml.txt.nlp	23819752	SENT129	3	3	31	31	simvastatin	CYP3A4	PA451363	1576	0.986
NULL	Semin_Immunol_2011_Feb_23(1)_28-41.nxml.txt.nlp	21295490	SENT275	4	4	15	15	calcipotriol	ILT3	PA448714	11006	0.986
NULL	Int_J_Inflam_2014_Dec_9_2014_959271.nxml.txt.nlp	25574420	SENT144	3	3	18	18	carrageenan	TLR2	PA448814	7097	0.986
NULL	Ann_Surg_Oncol_2010_Apr_20_17(4)_1168-1176.nxml.txt.nlp	19936839	SENT117	13	13	38	38	bevacizumab	KRAS	PA130232992	3845	0.986
NULL	AIDS_Res_Ther_2008_Oct_28_5_24.nxml.txt.nlp	18957095	SENT155	36	36	13	13	zidovudine	CD4	PA451954	920	0.986
NULL	Mol_Biol_Cell_2014_Jan_1_25(1)_145-159.nxml.txt.nlp	24196833	SENT450	18	18	7	7	valinomycin	Fis1	PA151917011	51024	0.986
NULL	Front_Neuroenergetics_2014_Jan_9_5_13.nxml.txt.nlp	24409143	SENT229	2	2	29	29	ketamine	FDG	PA450144	23583	0.986
NULL	Oncotarget_2013_Aug_30_4(10)_1698-1711.nxml.txt.nlp	24091605	SENT187	16	16	5	5	erlotinib	IL6	PA134687924	3569	0.986
NULL	J_Hematol_Oncol_2011_Dec_21_4_53.nxml.txt.nlp	22189016	SENT36	2	2	17	17	dabigatran	ADP		23038	0.986
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_297-299.nxml.txt.nlp	20049732	SENT55	24	24	3	3	methotrexate	MSH2	PA450428	4436	0.986
NULL	Mol_Vis_2014_May_13_20_649-660.nxml.txt.nlp	24868139	SENT212	19	19	8	8	ranibizumab	VEGFR2	PA164746012	3791	0.986
NULL	Indian_J_Med_Res_2014_Jan_139(1)_27-65.nxml.txt.nlp	24604039	SENT56	31	31	3	3	propranolol	CYP1A2	PA451145	1544	0.986
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT159	14	14	19	19	raltegravir	SLC22A6		9356	0.986
NULL	J_Oncol_2012_Apr_23_2012_901956.nxml.txt.nlp	22619676	SENT49	7	7	0	0	cisplatin	eIF3a	PA449014	8661	0.986
NULL	Br_J_Cancer_2012_May_22_106(11)_1779-1789.nxml.txt.nlp	22549178	SENT31	6	6	24	24	pertuzumab	HER2		2064	0.986
NULL	Evid_Based_Complement_Alternat_Med_2012_Dec_17_2012_857123.nxml.txt.nlp	23365602	SENT78	7	7	0	0	capsaicin	TRPV1	PA448776	7442	0.986
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT125	21	21	8	8	atorvastatin	RANKL	PA448500	8600	0.986
NULL	Mol_Pain_2013_Feb_15_9_3.nxml.txt.nlp	23413875	SENT178	28	28	35	35	resveratrol	TRPA1		8989	0.986
NULL	Int_J_Breast_Cancer_2011_Feb_24_2011_967419.nxml.txt.nlp	22332018	SENT227	32	32	0	0	fluorouracil	MRP1	PA128406956	4437	0.986
NULL	Br_J_Cancer_2013_Jul_23_109(2)_502-511.nxml.txt.nlp	23799850	SENT199	13	13	0	0	gemcitabine	SMARCC1	PA449748	6599	0.986
NULL	Mol_Cancer_2012_Dec_12_11_91.nxml.txt.nlp	23234355	SENT192	9	9	31	31	erlotinib	EGFR	PA134687924	1956	0.986
NULL	Acta_Pharmacol_Sin_2009_Sep_24_30(9)_1323-1329.nxml.txt.nlp	19701237	SENT148	37	37	11	11	clarithromycin	CYP3A	PA449028	1574	0.986
NULL	Diabetes_Metab_J_2012_Oct_18_36(5)_364-370.nxml.txt.nlp	23130321	SENT24	0	0	16	16	exenatide	GLP-1	PA164749238	100125288	0.986
NULL	Mol_Cancer_2009_Aug_25_8_66.nxml.txt.nlp	19706164	SENT230	15	15	21	21	sulindac	p53	PA451565	7157	0.986
NULL	J_Clin_Biochem_Nutr_2008_Sep_30_43(2)_109-117.nxml.txt.nlp	18818744	SENT118	4	4	36	36	genistein	CD74	PA165109660	972	0.986
NULL	Cancers_(Basel)_2014_Oct_24_6(4)_2187-2223.nxml.txt.nlp	25347122	SENT177	22	22	3	3	panitumumab	EGFR	PA162373091	1956	0.986
NULL	Cardiovasc_Diabetol_2013_Jan_9_12_8.nxml.txt.nlp	23298374	SENT140	24	24	40	40	miglitol	GLP-1	PA164776726	100125288	0.986
NULL	Br_J_Cancer_2011_Jan_4_104(1)_91-100.nxml.txt.nlp	21139584	SENT12	9	9	21	21	doxorubicin	p53	PA449412	7157	0.986
NULL	Cancers_(Basel)_2014_Mar_13_6(1)_595-624.nxml.txt.nlp	24633084	SENT222	14	14	30	30	pertuzumab	HER2		2064	0.986
NULL	Clin_Interv_Aging_2010_Dec_3_5_403-416.nxml.txt.nlp	21152242	SENT131	33	33	3	3	ramipril	ACE	PA451223	1636	0.986
NULL	Arthritis_Res_Ther_2006_Jul_26_8(4)_R132.nxml.txt.nlp	16872482	SENT215	9	9	21	21	pp2	JNK		5599	0.986
NULL	Oncotarget_2013_Aug_6_5(1)_108-119.nxml.txt.nlp	24334679	SENT151	32	32	22	22	estradiol	p53	PA449503	7157	0.986
NULL	Cell_Cycle_2013_Dec_15_12(24)_3791-3803.nxml.txt.nlp	24107631	SENT117	30	30	9	9	doxorubicin	YB-1	PA449412	4904	0.986
NULL	Arthritis_Res_2002_Mar_27_4(Suppl_2)_S29-S33.nxml.txt.nlp	12110155	SENT145	5	5	25	25	infliximab	NNT	PA452639	23530	0.986
NULL	Front_Neurol_2014_Feb_4_5_13.nxml.txt.nlp	24550886	SENT82	35	35	11	11	cyclophosphamide	ABRA	PA449165	137735	0.986
NULL	Br_J_Cancer_2002_Jan_21_86(2)_218-221.nxml.txt.nlp	11870509	SENT11	6	6	21	21	tamoxifen	BRCA2	PA451581	675	0.986
NULL	J_Int_Soc_Sports_Nutr_2008_Aug_12_5_12.nxml.txt.nlp	18700016	SENT5	20	20	11	11	estradiol	aromatase	PA449503	1588	0.986
NULL	J_Cancer_2013_Jan_11_4(2)_117-132.nxml.txt.nlp	23386910	SENT85	0	0	31	31	pertuzumab	HER2		2064	0.986
NULL	Breast_Cancer_Res_2013_Nov_8_15(6)_R107.nxml.txt.nlp	24207099	SENT168	16	16	28	28	ethanol	CYP2E1	PA448073	1571	0.986
NULL	Oncotarget_2012_May_18_3(5)_525-534.nxml.txt.nlp	22619113	SENT90	29	29	10	10	fludarabine	BIRC5	PA449655	332	0.986
NULL	Evid_Based_Complement_Alternat_Med_2014_Oct_19_2014_628712.nxml.txt.nlp	25389442	SENT122	33	33	5	5	erlotinib	PTEN	PA134687924	5728	0.986
NULL	Case_Rep_Psychiatry_2012_Oct_9_2012_642752.nxml.txt.nlp	23094178	SENT66	17	17	22	22	agomelatine	CYP1A2	PA165958363	1544	0.986
NULL	Oncotarget_2014_Mar_16_5(12)_4087-4102.nxml.txt.nlp	24961479	SENT140	7	7	2	2	hemin	PC3	PA449849	57332;7832;5122	0.986
NULL	Diabetes_2014_Jan_13_63(1)_39-41.nxml.txt.nlp	24357692	SENT28	11	11	29	29	febuxostat	XOR	PA165958521	7498	0.986
NULL	Clin_Med_Insights_Oncol_2011_Jun_23_5_185-199.nxml.txt.nlp	21792346	SENT226	2	2	25	25	imatinib	ABL1	PA10804	25	0.986
NULL	Clin_Epigenetics_2010_Sep_18_1(3-4)_101-116.nxml.txt.nlp	21258631	SENT249	0	0	27	27	curcumin	p300	PA151958596	2033	0.986
NULL	Acta_Histochem_Cytochem_2010_May_1_43(2)_61-68.nxml.txt.nlp	20514293	SENT61	21	21	1	1	hyaluronan	LYVE-1	PA165958431	10894	0.986
NULL	Open_Med_Chem_J_2013_Oct_31_7_23-29.nxml.txt.nlp	24222802	SENT99	14	14	5	5	haloperidol	AKT	PA449841	207	0.986
NULL	Br_J_Haematol_2009_Nov_2_147(3)_396-410.nxml.txt.nlp	19758122	SENT51	22	22	7	7	dasatinib	p53	PA162372878	7157	0.986
NULL	Arthritis_Res_Ther_2012_Aug_7_14(4)_R182.nxml.txt.nlp	22871034	SENT157	41	41	8	8	deferoxamine	IL-6	PA164746490	3569	0.986
NULL	Oxid_Med_Cell_Longev_2008_Oct-Dec_1(1)_39-45.nxml.txt.nlp	19794907	SENT41	2	2	17	17	taurine	ALAD	PA451590	210	0.986
NULL	Oxid_Med_Cell_Longev_2012_May_28_2012_632959.nxml.txt.nlp	22690272	SENT133	2	2	16	16	genistein	p38	PA165109660	10598;1432;7965	0.986
NULL	Breast_Cancer_(Auckl)_2014_Mar_23_8_51-56.nxml.txt.nlp	24678242	SENT98	18	18	45	45	carboplatin	BRCA1	PA448803	672	0.986
NULL	Int_J_Mol_Imaging_2011_Oct_26_2011_874585.nxml.txt.nlp	21490735	SENT135	26	26	5	5	tamoxifen	OMG	PA451581	4974	0.986
NULL	Curr_Med_Chem_2014_May_21(14)_1595-1606.nxml.txt.nlp	23992330	SENT40	36	36	3	3	cetuximab	EGFR	PA10040	1956	0.986
NULL	Br_J_Cancer_2013_Sep_3_109(5)_1085-1092.nxml.txt.nlp	23942080	SENT130	19	19	11	11	docetaxel	PI3K	PA449383	5290	0.986
NULL	Acta_Pharmacol_Sin_2012_Apr_12_33(4)_542-550.nxml.txt.nlp	22407228	SENT181	14	14	37	37	perifosine	JNK	PA165291471	5599	0.986
NULL	Arthritis_Res_Ther_2011_Feb_28_13(1)_205.nxml.txt.nlp	21371351	SENT42	0	0	11	11	infliximab	TNF	PA452639	7124	0.986
NULL	J_Cardiothorac_Surg_2012_Jan_11_7_5.nxml.txt.nlp	22236692	SENT26	1	1	6	6	protamine	ACT	PA10366	12;11332;9457;641455	0.986
NULL	Oncogene_2014_Apr_3_33(14)_1828-1839.nxml.txt.nlp	23624914	SENT87	14	14	6	6	doxycycline	survivin	PA449415	332	0.986
NULL	Int_J_Hypertens_2012_Feb_22_2012_127910.nxml.txt.nlp	22518279	SENT121	13	13	6	6	ns-398	HO-1		3162	0.986
NULL	Breast_Cancer_Res_2011_Mar_1_13(2)_R21.nxml.txt.nlp	21362200	SENT158	26	26	32	32	estradiol	PI3K	PA449503	5290	0.986
NULL	Br_J_Cancer_2010_Sep_7_103(6)_765-771.nxml.txt.nlp	20700120	SENT41	21	21	2	2	tamoxifen	CYP2D6	PA451581	1565	0.986
NULL	Endocrinol_Metab_(Seoul)_2014_Sep_25_29(3)_379-387.nxml.txt.nlp	25309798	SENT184	26	26	6	6	resveratrol	BMAL1		406	0.986
NULL	Int_J_Biol_Sci_2012_Mar_7_8(4)_470-485.nxml.txt.nlp	22419892	SENT262	32	32	20	20	tamoxifen	HER2	PA451581	2064	0.986
NULL	Biologics_2013_Mar_3_7_61-68.nxml.txt.nlp	23493885	SENT58	8	8	36	36	erlotinib	EGFR	PA134687924	1956	0.986
NULL	Ther_Clin_Risk_Manag_2006_Mar_2(1)_77-86.nxml.txt.nlp	18360583	SENT113	10	10	33	33	raloxifene	PTH	PA451221	5741	0.986
NULL	Evid_Based_Complement_Alternat_Med_2013_May_26_2013_161628.nxml.txt.nlp	23781255	SENT256	13	13	2	2	sorafenib	STAT3	PA7000	6774	0.986
NULL	Cancer_Inform_2008_Jun_10_6_315-355.nxml.txt.nlp	19259415	SENT277	19	19	10	10	cisplatin	IRF6	PA449014	3664	0.986
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT80	5	5	0	0	resveratrol	TRAIL		8743	0.986
NULL	Ann_Clin_Transl_Neurol_2014_Dec_21_1(12)_996-1005.nxml.txt.nlp	25574474	SENT178	0	0	18	18	riluzole	P-gp	PA451251	5243	0.986
NULL	Front_Oncol_2013_Nov_15_3_281.nxml.txt.nlp	24298448	SENT85	38	38	11	11	panitumumab	BRAF	PA162373091	673	0.986
NULL	Breast_Cancer_Res_2008_Feb_15_10(1)_R18.nxml.txt.nlp	18279516	SENT19	19	19	42	42	celecoxib	aromatase	PA448871	1588	0.986
NULL	Evid_Based_Complement_Alternat_Med_2013_May_13_2013_506324.nxml.txt.nlp	23818927	SENT145	24	24	32	32	doxorubicin	SHP2	PA449412	5781	0.986
NULL	Breast_Cancer_Res_2009_May_11_11(3)_R27.nxml.txt.nlp	19432961	SENT302	21	21	5	5	mitoxantrone	ABCG2	PA450526	9429	0.986
NULL	Oncotarget_2014_Jun_6_5(13)_4945-4958.nxml.txt.nlp	24970814	SENT117	6	6	30	30	cisplatin	PTB	PA449014	58155	0.986
NULL	J_Korean_Med_Sci_2009_Oct_24_24(5)_910-917.nxml.txt.nlp	19794992	SENT19	14	14	22	22	paclitaxel	HER2	PA450761	2064	0.986
NULL	Chemother_Res_Pract_2012_Dec_20_2012_743193.nxml.txt.nlp	23320171	SENT9	7	7	33	33	trastuzumab	HER2	PA451743	2064	0.986
NULL	Front_Oncol_2014_Apr_8_4_71.nxml.txt.nlp	24782983	SENT248	34	34	4	4	paclitaxel	TUBB3	PA450761	10381	0.986
NULL	Mol_Cancer_2012_Aug_6_11_52.nxml.txt.nlp	22867098	SENT182	3	3	10	10	pargyline	KDM1A	PA450797	23028	0.986
NULL	Clin_Transl_Allergy_2013_Sep_2_3_29.nxml.txt.nlp	24004581	SENT106	23	23	33	33	omalizumab	gamma	PA164752253	9913	0.986
NULL	Open_Med_2007_Dec_18_1(3)_e184-e190.nxml.txt.nlp	21673951	SENT80	20	20	13	13	tamoxifen	BRCA2	PA451581	675	0.986
NULL	Oxid_Med_Cell_Longev_2013_Apr_21_2013_412576.nxml.txt.nlp	23710286	SENT105	4	4	8	8	curcumin	NRF2	PA151958596	2551;4780	0.986
NULL	Bone_2012_Jan_50(1)_218-225.nxml.txt.nlp	22023931	SENT220	4	4	26	26	iron	FGF23	PA450087	8074	0.986
NULL	J_Korean_Med_Sci_2007_Jun_30_22(3)_577-579.nxml.txt.nlp	17596676	SENT47	0	0	19	19	clopidogrel	P2Y12	PA449053	64805	0.986
NULL	Oncotarget_2014_Jun_1_5(13)_4868-4880.nxml.txt.nlp	24947902	SENT200	0	0	21	21	afatinib	EGFR	PA165981154	1956	0.986
NULL	Acta_Pharmacol_Sin_2012_Oct_3_33(10)_1311-1318.nxml.txt.nlp	22941289	SENT170	4	4	16	16	sorafenib	VEGFR2	PA7000	3791	0.986
NULL	Br_J_Cancer_2013_Dec_10_109(12)_2959-2964.nxml.txt.nlp	24157828	SENT31	16	16	26	26	tamoxifen	aromatase	PA451581	1588	0.986
NULL	Clinicoecon_Outcomes_Res_2014_Oct_17_6_451-461.nxml.txt.nlp	25378939	SENT18	37	37	17	17	linezolid	HAP	PA450233	5915;10313	0.986
NULL	Ther_Clin_Risk_Manag_2007_Aug_3(4)_665-673.nxml.txt.nlp	18472989	SENT172	4	4	10	10	lapatinib	CYP3A5	PA152241907	1577	0.986
NULL	Diabetes_2011_Nov_17_60(11)_2691-2700.nxml.txt.nlp	21896928	SENT148	13	13	1	1	resveratrol	SIRT1		23411	0.986
NULL	Diabetes_2013_Nov_18_62(11)_3851-3862.nxml.txt.nlp	23884890	SENT23	38	38	4	4	rosiglitazone	AMPK	PA451283	5563	0.986
NULL	Pharmaceuticals_(Basel)_2012_Jun_28_5(7)_674-689.nxml.txt.nlp	24281706	SENT156	34	34	7	7	trastuzumab	Hsp90	PA451743	3320	0.986
NULL	Am_J_Case_Rep_2014_Apr_14_15_152-154.nxml.txt.nlp	24753783	SENT46	18	18	43	43	metformin	DPP4	PA450395	1803	0.986
NULL	Oncogene_2014_Aug_21_33(34)_4316-4329.nxml.txt.nlp	24362530	SENT340	42	42	11	11	fluorescein	FOXM1	PA164746009	2305	0.986
NULL	Iran_J_Reprod_Med_2011_Winter_9(1)_31-36.nxml.txt.nlp	25356079	SENT122	12	12	8	8	letrozole	aromatase	PA450196	1588	0.986
NULL	Diabetes_Care_2012_Feb_16_35(2)_327-333.nxml.txt.nlp	22179958	SENT68	1	1	29	29	metformin	B12	PA450395	7126;4709	0.986
NULL	Biomed_Res_Int_2014_Feb_10_2014_708593.nxml.txt.nlp	24689050	SENT239	5	5	28	28	etoposide	P-gp	PA449552	5243	0.986
NULL	Br_J_Cancer_2014_Jan_21_110(2)_304-312.nxml.txt.nlp	24300978	SENT139	16	16	2	2	gemcitabine	NT5C2	PA449748	22978	0.986
NULL	Diabetes_Care_2010_Feb_23_33(2)_246-251.nxml.txt.nlp	19933994	SENT135	3	3	30	30	metformin	B12	PA450395	7126;4709	0.986
NULL	AIDS_Res_Ther_2007_Feb_23_4_3.nxml.txt.nlp	17316455	SENT33	16	16	38	38	efavirenz	CD4	PA449441	920	0.986
NULL	Br_J_Cancer_2012_May_22_106(11)_1779-1789.nxml.txt.nlp	22549178	SENT15	32	32	8	8	pertuzumab	p27		5715;10534	0.986
NULL	Int_J_Hypertens_2012_Apr_9_2012_690785.nxml.txt.nlp	22577520	SENT47	22	22	30	30	candesartan	AT2	PA448765	186	0.986
NULL	Behav_Brain_Funct_2005_Jul_15_1_9.nxml.txt.nlp	16022733	SENT71	25	25	3	3	methylphenidate	DAT1	PA450464	55885	0.986
NULL	Cancers_(Basel)_2013_Jan_21_5(1)_64-91.nxml.txt.nlp	24216699	SENT265	0	0	24	24	sorafenib	Raf-1	PA7000	5894	0.986
NULL	Mol_Cancer_2009_Dec_10_8_118.nxml.txt.nlp	20003259	SENT108	19	19	10	10	imatinib	KIT	PA10804	3815	0.986
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT249	8	8	18	18	lapatinib	HER2	PA152241907	2064	0.986
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2014_Sep_27_70(Pt_10)_2740-2753.nxml.txt.nlp	25286857	SENT270	0	0	10	10	bsi-201	PARP1		142	0.986
NULL	Korean_J_Anesthesiol_2013_Feb_15_64(2)_105-111.nxml.txt.nlp	23459312	SENT55	27	27	9	9	heparin	ACT	PA449855	12;11332;9457;641455	0.986
NULL	Mol_Cancer_2013_Sep_11_12_104.nxml.txt.nlp	24025152	SENT120	17	17	11	11	gemcitabine	STAT3	PA449748	6774	0.986
NULL	J_Gen_Physiol_2009_May_133(5)_511-524.nxml.txt.nlp	19398777	SENT317	6	6	23	23	nifedipine	DHPR	PA450631	5860	0.986
NULL	Cancer_Cell_2007_Dec_11_12(6)_514-527.nxml.txt.nlp	18068629	SENT4	25	25	10	10	paclitaxel	TGFBI	PA450761	7045	0.986
NULL	Exp_Ther_Med_2013_Oct_2_6(4)_1062-1066.nxml.txt.nlp	24137317	SENT118	0	0	4	4	erlotinib	EGFR	PA134687924	1956	0.986
NULL	Breast_Cancer_Res_2012_Aug_14_14(4)_R117.nxml.txt.nlp	22889108	SENT203	16	16	0	0	trastuzumab	HER2	PA451743	2064	0.986
NULL	J_Cell_Biol_2000_Dec_11_151(6)_1281-1294.nxml.txt.nlp	11121442	SENT103	34	34	2	2	paraformaldehyde	CCR5	PA450790	1234	0.986
NULL	Cancer_Med_2013_Dec_31_2(6)_826-835.nxml.txt.nlp	24403256	SENT199	0	0	26	26	nutlin-3	p53		7157	0.986
NULL	Diabetes_2013_Oct_17_62(10)_3500-3513.nxml.txt.nlp	23884882	SENT203	10	10	15	15	resveratrol	SIRT1		23411	0.986
NULL	Int_J_Mol_Sci_2013_Apr_22_14(4)_8638-8683.nxml.txt.nlp	23609496	SENT237	5	5	19	19	meloxicam	IFN	PA450353	3439	0.986
NULL	Europace_2014_Aug_19_16(8)_1145-1153.nxml.txt.nlp	24843051	SENT78	3	3	28	28	heparin	ACT	PA449855	12;11332;9457;641455	0.986
NULL	Int_J_Gen_Med_2014_Jan_7_7_49-58.nxml.txt.nlp	24470767	SENT58	0	0	9	9	denosumab	RANKL	PA166048634	8600	0.986
NULL	Acta_Pharmacol_Sin_2011_Oct_5_32(10)_1285-1293.nxml.txt.nlp	21892200	SENT32	8	8	29	29	ciprofloxacin	CYP1A2	PA449009	1544	0.986
NULL	Cardiovasc_Diabetol_2013_Nov_12_12_169.nxml.txt.nlp	24215514	SENT307	6	6	35	35	valsartan	AT2	PA451848	186	0.986
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_3_2014_473213.nxml.txt.nlp	25538791	SENT113	1	1	9	9	fexofenadine	MDR1	PA449621	5243	0.986
NULL	Patient_Prefer_Adherence_2011_Dec_23_6_1-9.nxml.txt.nlp	22272064	SENT4	40	40	8	8	telmisartan	ACE	PA451605	1636	0.986
NULL	J_Immunol_Res_2014_May_8_2014_565320.nxml.txt.nlp	24901010	SENT80	8	8	26	26	allopurinol	HLA-B	PA448320	3106	0.986
NULL	Indian_J_Med_Res_2012_Mar_135(3)_359-364.nxml.txt.nlp	22561623	SENT115	25	25	3	3	cefoxitin	ACC-1	PA448856	597	0.986
NULL	Oncogene_2010_Jun_24_29(25)_3639-3649.nxml.txt.nlp	20453883	SENT38	42	42	5	5	estradiol	HEXIM1	PA449503	10614	0.986
NULL	Oncotarget_2014_Dec_4_5(22)_11365-11380.nxml.txt.nlp	25426548	SENT30	0	0	7	7	nutlin-3	p53		7157	0.986
NULL	Clin_Ophthalmol_2014_Aug_4_8_1447-1458.nxml.txt.nlp	25120351	SENT166	4	4	39	39	cyclosporine	CD4	PA449167	920	0.986
NULL	Exp_Diabetes_Res_2012_Oct_15_2012_465282.nxml.txt.nlp	23118742	SENT94	21	21	11	11	metformin	AMPK	PA450395	5563	0.986
NULL	Clin_Interv_Aging_2013_Jul_16_8_889-897.nxml.txt.nlp	23898224	SENT95	37	37	3	3	gemcitabine	SIRT1	PA449748	23411	0.986
NULL	Ann_Lab_Med_2015_Jan_8_35(1)_15-21.nxml.txt.nlp	25553275	SENT160	24	24	0	0	thrombin	Lag	PA451674	3925	0.986
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT159	1	1	15	15	neratinib	HER2	PA165291472	2064	0.986
NULL	Acta_Pharmacol_Sin_2014_Aug_30_35(8)_1045-1054.nxml.txt.nlp	24976155	SENT35	16	16	0	0	resveratrol	SIRT1		23411	0.986
NULL	Mol_Cancer_2013_Nov_5_12_133.nxml.txt.nlp	24192080	SENT107	7	7	16	16	leflunomide	STAT6	PA450192	6778	0.986
NULL	Cancers_(Basel)_2012_Sep_25_4(4)_969-988.nxml.txt.nlp	24213497	SENT175	20	20	15	15	gefitinib	aromatase	PA131301952	1588	0.986
NULL	Exp_Ther_Med_2012_Sep_29_4(3)_524-532.nxml.txt.nlp	23181130	SENT129	0	0	12	12	mk-571	MRP1		4437	0.986
NULL	Oncologist_2010_Mar_9_15(3)_236-245.nxml.txt.nlp	20215359	SENT95	10	10	41	41	sunitinib	IFN	PA162372840	3439	0.986
NULL	Cardiovasc_Drugs_Ther_2013_Jul_26_27(6)_521-530.nxml.txt.nlp	23887740	SENT167	39	39	12	12	clopidogrel	CD62P	PA449053	6403	0.986
NULL	Br_J_Pharmacol_2008_Sep_9_155(1)_127-137.nxml.txt.nlp	18536750	SENT197	36	36	4	4	piroxicam	IL-10	PA450985	3586	0.986
NULL	Ann_Gastroenterol_2014_27(4)_313-319.nxml.txt.nlp	25331779	SENT143	29	29	36	36	infliximab	POR	PA452639	5447	0.986
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT394	22	22	1	1	tamoxifen	TFF3	PA451581	7033	0.986
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT217	14	14	4	4	panitumumab	KRAS	PA162373091	3845	0.986
NULL	Int_J_Breast_Cancer_2011_Sep_6_2011_352182.nxml.txt.nlp	22295219	SENT134	7	7	2	2	trastuzumab	PI3K	PA451743	5290	0.986
NULL	Mol_Cancer_2010_Jun_27_9_168.nxml.txt.nlp	20579391	SENT121	4	4	33	33	dasatinib	TTK	PA162372878	7272	0.986
NULL	Clin_Ophthalmol_2009_Jun_2_3_219-226.nxml.txt.nlp	19668569	SENT71	5	5	23	23	nepafenac	ANOVA	PA165958407	4858	0.986
NULL	Cancer_Imaging_2008_Nov_25_8(1)_199-205.nxml.txt.nlp	19028612	SENT118	10	10	6	6	erlotinib	EGFR	PA134687924	1956	0.986
NULL	Mol_Cancer_2013_Sep_11_12_104.nxml.txt.nlp	24025152	SENT146	3	3	9	9	gemcitabine	STAT3	PA449748	6774	0.986
NULL	J_Hematol_Oncol_2013_Sep_5_6_66.nxml.txt.nlp	24010946	SENT83	11	11	31	31	leucovorin	CRT	PA450198	811	0.986
NULL	Exp_Ther_Med_2012_Oct_16_4(4)_705-710.nxml.txt.nlp	23170130	SENT8	20	20	15	15	cyclophosphamide	P-gp	PA449165	5243	0.986
NULL	Cancer_Cell_Int_2010_May_11_10_16.nxml.txt.nlp	20459793	SENT86	9	9	40	40	cisplatin	CDKN1A	PA449014	1026	0.986
NULL	J_Oncol_2012_Jun_4_2012_928127.nxml.txt.nlp	22701483	SENT166	30	30	6	6	metformin	CD44	PA450395	960	0.986
NULL	Curr_Genomics_2014_Jun_15(3)_190-202.nxml.txt.nlp	24955027	SENT169	0	0	16	16	sunitinib	STAT3	PA162372840	6774	0.986
NULL	Onco_Targets_Ther_2014_Sep_9_7_1571-1582.nxml.txt.nlp	25228815	SENT247	7	7	0	0	pazopanib	VEGFR2	PA165291492	3791	0.986
NULL	J_Cell_Biol_2005_Jul_4_170(1)_37-47.nxml.txt.nlp	15998798	SENT365	5	5	0	0	doxycycline	CRT	PA449415	811	0.986
NULL	Ann_Hematol_2010_Sep_13_89(9)_861-871.nxml.txt.nlp	20387067	SENT205	4	4	12	12	dasatinib	GM-CSF	PA162372878	1437	0.986
NULL	J_Cardiothorac_Surg_2010_Apr_19_5_26.nxml.txt.nlp	20403156	SENT152	33	33	11	11	etomidate	RAI	PA164743987	10848;6050	0.986
NULL	Exp_Ther_Med_2013_Nov_13_6(5)_1317-1321.nxml.txt.nlp	24223665	SENT14	32	32	20	20	cisplatin	CD133	PA449014	8842	0.986
NULL	Oncol_Lett_2013_Aug_17_6(2)_295-305.nxml.txt.nlp	24137320	SENT165	42	42	27	27	tamoxifen	TIMP3	PA451581	7078	0.986
NULL	Curr_Oncol_2009_Jan_16(1)_27-48.nxml.txt.nlp	19229369	SENT235	21	21	7	7	erlotinib	EGFR	PA134687924	1956	0.986
NULL	J_Gen_Physiol_2009_Jun_133(6)_623-625.nxml.txt.nlp	19468076	SENT23	3	3	25	25	menthol	TRPA1	PA164776605	8989	0.986
NULL	Bioinformation_2011_Oct_31_7(5)_246-250.nxml.txt.nlp	22125393	SENT23	5	5	1	1	celecoxib	COX	PA448871	1351	0.986
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT263	29	29	17	17	lapatinib	HER2	PA152241907	2064	0.986
NULL	Acta_Pharmacol_Sin_2010_Sep_9_31(9)_1181-1188.nxml.txt.nlp	20694025	SENT109	0	0	15	15	bevacizumab	VEGFR	PA130232992	3791	0.986
NULL	Oncol_Lett_2014_Sep_11_8(3)_1222-1228.nxml.txt.nlp	25120693	SENT41	22	22	16	16	cisplatin	PARP1	PA449014	142	0.986
NULL	Braz_J_Med_Biol_Res_2014_Sep_5_47(11)_929-939.nxml.txt.nlp	25296354	SENT64	23	23	35	35	gefitinib	EGFR	PA131301952	1956	0.986
NULL	Cancers_(Basel)_2011_Mar_7_3(1)_1158-1181.nxml.txt.nlp	24212658	SENT251	11	11	3	3	genistein	HSF1	PA165109660	3297	0.986
NULL	Br_J_Cancer_2010_Feb_2_102(3)_500-505.nxml.txt.nlp	20068568	SENT27	0	0	14	14	cetuximab	EGFR	PA10040	1956	0.986
NULL	Aging_(Albany_NY)_2012_Mar_7_4(3)_166-175.nxml.txt.nlp	22411934	SENT163	5	5	16	16	berberine	AMPK	PA165860812	5563	0.986
NULL	Front_Oncol_2014_Apr_9_4_75.nxml.txt.nlp	24782986	SENT249	7	7	29	29	paclitaxel	Oct4	PA450761	5460	0.986
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT11	16	16	1	1	paclitaxel	SLK	PA450761	9748;2534	0.986
NULL	Breast_Cancer_Res_2012_Feb_6_14(1)_R22.nxml.txt.nlp	22309939	SENT34	23	23	13	13	trastuzumab	aromatase	PA451743	1588	0.986
NULL	Clin_Endosc_2011_Sep_30_44(1)_22-26.nxml.txt.nlp	22741108	SENT112	4	4	30	30	midazolam	ESD	PA450496	2098	0.986
NULL	J_Cancer_2013_Nov_21_4(9)_727-735.nxml.txt.nlp	24312143	SENT159	25	25	43	43	cisplatin	SRPK1	PA449014	6732	0.986
NULL	Chin_J_Cancer_2012_Feb_31(2)_110-118.nxml.txt.nlp	22098951	SENT27	20	20	4	4	imatinib	P-gp	PA10804	5243	0.986
NULL	Mol_Clin_Oncol_2013_Sep_23_1(5)_887-893.nxml.txt.nlp	24649266	SENT136	35	35	26	26	imatinib	KIT	PA10804	3815	0.986
NULL	Oncotarget_2013_Apr_13_4(4)_502-530.nxml.txt.nlp	23594434	SENT429	10	10	2	2	sertraline	AKT	PA451333	207	0.986
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S272-S275.nxml.txt.nlp	21525467	SENT20	0	0	4	4	exenatide	GLP-1	PA164749238	100125288	0.986
NULL	Ann_Neurosci_2011_Apr_18(2)_48-55.nxml.txt.nlp	25205921	SENT116	12	12	3	3	forskolin	SOD1	PA146096022	6647	0.986
NULL	Nature_2007_Jan_25_445(7126)_437-441.nxml.txt.nlp	17206155	SENT50	24	24	3	3	staurosporine	HER3	PA165109623	2065	0.986
NULL	Clin_Ophthalmol_2007_Dec_1(4)_383-391.nxml.txt.nlp	19668515	SENT151	0	0	19	19	ranibizumab	VEGF-A	PA164746012	7422	0.986
NULL	Oncol_Lett_2013_Dec_4_6(6)_1665-1672.nxml.txt.nlp	24273604	SENT141	32	32	6	6	chloroquine	TLR9	PA448948	54106	0.986
NULL	Br_J_Pharmacol_2010_Sep_161(2)_241-270.nxml.txt.nlp	20735414	SENT424	22	22	2	2	clarithromycin	RhoA	PA449028	387	0.986
NULL	Nat_Commun_2014_Nov_25_5_5582.nxml.txt.nlp	25420773	SENT648	10	10	8	8	erlotinib	EGFR	PA134687924	1956	0.986
NULL	Environ_Health_Perspect_2011_Apr_16_119(4)_534-541.nxml.txt.nlp	21081300	SENT107	32	32	4	4	flutamide	PGD2	PA449685	27306	0.986
NULL	Chin_J_Cancer_2012_Feb_31(2)_110-118.nxml.txt.nlp	22098951	SENT27	34	34	4	4	imatinib	P-gp	PA10804	5243	0.986
NULL	Cell_Death_Dis_2013_Sep_19_4(9)_e807.nxml.txt.nlp	24052075	SENT75	20	20	3	3	doxorubicin	p53	PA449412	7157	0.986
NULL	Br_J_Cancer_2011_Jul_26_105(3)_366-371.nxml.txt.nlp	21750556	SENT93	10	10	0	0	trastuzumab	T-bet	PA451743	30009	0.986
NULL	Breast_Cancer_Res_2005_Jul_20_7(5)_205-211.nxml.txt.nlp	16168139	SENT61	14	14	1	1	tamoxifen	AP-1	PA451581	2353;3727;2354;3725	0.986
NULL	Cell_Death_Dis_2012_Mar_15_3(3)_e286.nxml.txt.nlp	22419115	SENT64	11	11	39	39	cisplatin	p53	PA449014	7157	0.986
NULL	J_Bras_Pneumol_2013_Jan-Feb_39(1)_5-15.nxml.txt.nlp	23503480	SENT96	13	13	8	8	doxycycline	LAM	PA449415	7249;7248	0.986
NULL	Cardiol_Res_Pract_2011_Apr_26_2011_874802.nxml.txt.nlp	21577272	SENT116	5	5	12	12	verapamil	CYP3A4	PA451868	1576	0.986
NULL	Case_Rep_Gastroenterol_2011_Dec_10_5(3)_667-671.nxml.txt.nlp	22220142	SENT20	0	0	12	12	infliximab	CD40	PA452639	958	0.986
NULL	Oncol_Lett_2013_Feb_27_5(2)_435-439.nxml.txt.nlp	23420613	SENT23	5	5	13	13	gefitinib	EGFR	PA131301952	1956	0.986
NULL	Exp_Ther_Med_2015_Jan_18_9(1)_105-111.nxml.txt.nlp	25452783	SENT182	9	9	34	34	celecoxib	ABCG2	PA448871	9429	0.986
NULL	Breast_Cancer_Res_Treat_2014_Jan_9_143(3)_493-505.nxml.txt.nlp	24402830	SENT166	3	3	17	17	lapatinib	aromatase	PA152241907	1588	0.986
NULL	Ther_Clin_Risk_Manag_2007_Dec_3(6)_1097-1104.nxml.txt.nlp	18516268	SENT148	7	7	20	20	didanosine	CD4	PA449301	920	0.986
NULL	Mol_Cancer_2013_Sep_11_12_104.nxml.txt.nlp	24025152	SENT244	22	22	8	8	gemcitabine	STAT3	PA449748	6774	0.986
NULL	Arthritis_Res_Ther_2005_Feb_18_7(3)_R476-R484.nxml.txt.nlp	15899034	SENT100	0	0	41	41	thrombin	Rho	PA451674	29984	0.986
NULL	Int_J_Inflam_2012_Apr_26_2012_480373.nxml.txt.nlp	22611516	SENT101	5	5	20	20	tocilizumab	IL-6	PA165292659	3569	0.986
NULL	Exp_Hematol_Oncol_2012_Sep_6_1_26.nxml.txt.nlp	23210433	SENT33	7	7	27	27	eculizumab	BCS	PA164776637	617	0.986
NULL	Diabetes_2011_Nov_17_60(11)_2701-2709.nxml.txt.nlp	21885869	SENT203	38	38	12	12	dexmedetomidine	PPG	PA449256	5552	0.986
NULL	Adipocyte_2013_Jan_1_2(1)_28-32.nxml.txt.nlp	23700549	SENT70	9	9	35	35	valsartan	p65	PA451848	5970	0.986
NULL	Mol_Cancer_2006_Oct_17_5_45.nxml.txt.nlp	17044934	SENT55	0	0	6	6	resveratrol	AKT		207	0.986
NULL	Pharmaceutics_2011_Oct_12_3(4)_680-705.nxml.txt.nlp	24309303	SENT96	22	22	29	29	gefitinib	OCT1	PA131301952	5451;6580	0.986
NULL	Arthritis_Rheum_2013_Sep_26_65(9)_2290-2300.nxml.txt.nlp	23740547	SENT204	26	26	30	30	doxycycline	S100A9	PA449415	6280	0.986
NULL	J_Cell_Mol_Med_2013_Oct_23_17(10)_1207-1217.nxml.txt.nlp	24106980	SENT130	26	26	9	9	cisplatin	YB-1	PA449014	4904	0.986
NULL	Cancers_(Basel)_2013_May_24_5(2)_569-590.nxml.txt.nlp	24216992	SENT1338	18	18	4	4	cyclophosphamide	CD25	PA449165	3669;3559	0.986
NULL	Biologics_2013_Dec_16_8_13-25.nxml.txt.nlp	24368879	SENT103	21	21	3	3	bevacizumab	PlGF-2	PA130232992	5228	0.986
NULL	Exp_Ther_Med_2015_Feb_16_9(2)_289-293.nxml.txt.nlp	25574188	SENT55	0	0	6	6	nicardipine	ABCG2	PA450620	9429	0.986
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S31-S40.nxml.txt.nlp	20680106	SENT38	10	10	26	26	cetuximab	KRAS	PA10040	3845	0.986
NULL	Br_J_Cancer_2010_Oct_12_103(8)_1182-1191.nxml.txt.nlp	20842125	SENT199	19	19	3	3	indomethacin	COX	PA449982	1351	0.986
NULL	Cell_Res_2012_Aug_22_22(8)_1227-1245.nxml.txt.nlp	22613949	SENT217	3	3	24	24	bortezomib	KRAS	PA10252	3845	0.986
NULL	Basic_Clin_Neurosci_2014_Summer_5(3)_191-198.nxml.txt.nlp	25337379	SENT136	10	10	2	2	nimodipine	ANOVA	PA450633	4858	0.986
NULL	Cancer_Immunol_Immunother_2011_Jan_21_60(1)_75-85.nxml.txt.nlp	20857100	SENT217	21	21	5	5	fludarabine	CD4	PA449655	920	0.986
NULL	Breast_Cancer_Res_2011_Apr_21_13(2)_R46.nxml.txt.nlp	21510863	SENT34	3	3	10	10	trastuzumab	DM1	PA451743	338023;1760;28509	0.986
NULL	Front_Neurol_2013_May_1_4_10.nxml.txt.nlp	23641231	SENT124	9	9	21	21	natalizumab	IFN	PA164747191	3439	0.986
NULL	Int_J_Gen_Med_2013_Dec_4_6_877-895.nxml.txt.nlp	24403842	SENT63	0	0	17	17	liraglutide	GLP-1	PA165958364	100125288	0.986
NULL	Ann_Rheum_Dis_2010_Dec_27_70(5)_755-759.nxml.txt.nlp	21187298	SENT161	23	23	40	40	methotrexate	IL-6	PA450428	3569	0.986
NULL	Acta_Pharmacol_Sin_2010_Jul_28_31(7)_775-783.nxml.txt.nlp	20581849	SENT210	8	8	21	21	mirtazapine	5-HT2C	PA450522	3358	0.986
NULL	Oncotarget_2014_Jun_19_5(15)_6540-6551.nxml.txt.nlp	25153728	SENT141	10	10	17	17	paclitaxel	PI3	PA450761	5266	0.986
NULL	Chin_J_Cancer_2012_Jun_31(6)_266-280.nxml.txt.nlp	22313597	SENT305	13	13	25	25	letrozole	IGFBP4	PA450196	3487	0.986
NULL	Eur_J_Clin_Pharmacol_2013_Mar_11_69(3)_327-339.nxml.txt.nlp	22782539	SENT31	0	0	10	10	clopidogrel	P-gp	PA449053	5243	0.986
NULL	Orphanet_J_Rare_Dis_2011_May_28_6_32.nxml.txt.nlp	21619687	SENT244	22	22	10	10	diethylstilbestrol	HOXA9	PA449307	3205	0.986
NULL	J_Carcinog_2011_Nov_30_10_28.nxml.txt.nlp	22190870	SENT200	29	29	11	11	trastuzumab	VEGF-A	PA451743	7422	0.986
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_P124.nxml.txt.nlp	NULL	SENT12	12	12	0	0	carbamazepine	HLA-B	PA448785	3106	0.986
NULL	Nucleic_Acids_Res_2011_Dec_31_39(22)_9536-9548.nxml.txt.nlp	21880590	SENT31	29	29	5	5	etoposide	BRCA1	PA449552	672	0.986
NULL	Clin_Drug_Investig_2013_Aug_23_33(10)_727-736.nxml.txt.nlp	23975654	SENT172	14	14	33	33	duloxetine	CYP2C19	PA10066	1557	0.986
NULL	Acta_Pharmacol_Sin_2012_Dec_22_33(12)_1511-1517.nxml.txt.nlp	23085741	SENT17	2	2	25	25	zileuton	CysLT1	PA451955	10800	0.986
NULL	Biochem_Res_Int_2012_Feb_12_2012_346972.nxml.txt.nlp	22400115	SENT65	11	11	19	19	hyaluronan	CD44	PA165958431	960	0.986
NULL	Oncotarget_2013_Jul_18_4(10)_1582-1591.nxml.txt.nlp	24123600	SENT126	42	42	4	4	imatinib	ABCG2	PA10804	9429	0.986
NULL	Int_J_Biomed_Sci_2014_Sep_10(3)_146-157.nxml.txt.nlp	25324695	SENT9	5	5	16	16	lovastatin	LFA-1	PA450272	3683;3689	0.986
NULL	J_Breast_Cancer_2012_Sep_28_15(3)_273-282.nxml.txt.nlp	23091539	SENT17	6	6	11	11	doxycycline	TRAIL	PA449415	8743	0.986
NULL	Drug_Saf_2014_Feb_19_37(4)_201-211.nxml.txt.nlp	24550106	SENT88	21	21	3	3	lansoprazole	CYP2C19	PA450180	1557	0.986
NULL	Curr_Med_Chem_2011_Jun_18(18)_2686-2714.nxml.txt.nlp	21649578	SENT656	27	27	18	18	paclitaxel	PI3K	PA450761	5290	0.986
NULL	Acta_Pharmacol_Sin_2011_Nov_10_32(11)_1402-1410.nxml.txt.nlp	21986579	SENT203	40	40	18	18	curcumin	CDK2	PA151958596	1017	0.986
NULL	Breast_Cancer_Res_2009_Jul_15_11(4)_207.nxml.txt.nlp	19664181	SENT151	0	0	9	9	pertuzumab	HER2		2064	0.986
NULL	Nucleic_Acids_Res_2012_Jun_10_40(11)_4804-4815.nxml.txt.nlp	22328728	SENT239	14	14	4	4	hemin	SIRT1	PA449849	23411	0.986
NULL	Open_Cardiovasc_Med_J_2010_Feb_23_4_71-77.nxml.txt.nlp	20360979	SENT57	20	20	0	0	heparin	TFPI	PA449855	7035	0.986
NULL	Nat_Commun_2014_5_3361.nxml.txt.nlp	24553445	SENT79	23	23	14	14	olaparib	HRD		6905;3271	0.986
NULL	Indian_J_Dermatol_2009_Jul-Sep_54(3)_280-282.nxml.txt.nlp	20161864	SENT42	0	0	35	35	thrombin	C5a	PA451674	727	0.986
NULL	Clin_Transl_Allergy_2014_Mar_14_4(Suppl_1)_O4.nxml.txt.nlp	NULL	SENT13	25	25	17	17	montelukast	IL-11	PA450546	3589	0.986
NULL	Arch_Med_Sci_2013_Apr_20_9(2)_368-371.nxml.txt.nlp	23671451	SENT8	7	7	33	33	malathion	EPM	PA164748092	2054	0.986
NULL	Nucleic_Acids_Res_2011_Dec_31_39(22)_9536-9548.nxml.txt.nlp	21880590	SENT229	16	16	2	2	etoposide	BRCA1	PA449552	672	0.986
NULL	AIDS_Res_Ther_2014_Aug_4_11_25.nxml.txt.nlp	25120580	SENT56	0	0	3	3	atazanavir	CYP3A4	PA10251	1576	0.986
NULL	EMBO_J_2008_Oct_22_27(20)_2789-2798.nxml.txt.nlp	18818696	SENT307	19	19	17	17	geldanamycin	Hsp90	PA152031327	3320	0.986
NULL	Clin_Sci_(Lond)_2009_Apr_1_116(Pt_8)_607-620.nxml.txt.nlp	19275766	SENT117	14	14	34	34	rosiglitazone	AMPK	PA451283	5563	0.986
NULL	Front_Immunol_2012_May_4_3_103.nxml.txt.nlp	22566975	SENT623	14	14	2	2	cyclophosphamide	CD25	PA449165	3669;3559	0.986
NULL	Adv_Hematol_2012_Aug_2_2012_842945.nxml.txt.nlp	22919394	SENT159	19	19	42	42	lenalidomide	CRBN	PA162363968	51185	0.986
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Dec_17_3(12)_e152.nxml.txt.nlp	25518025	SENT72	10	10	14	14	oxycodone	CYP2D6	PA450741	1565	0.986
NULL	Int_J_Mol_Sci_2012_Apr_16_13(4)_4831-4838.nxml.txt.nlp	22606012	SENT109	20	20	2	2	curcumin	JNK	PA151958596	5599	0.986
NULL	Cardiovasc_Drugs_Ther_2013_Jul_26_27(6)_521-530.nxml.txt.nlp	23887740	SENT167	39	39	7	7	clopidogrel	CD41	PA449053	3674	0.986
NULL	Indian_J_Nucl_Med_2013_Dec_28(Suppl_1)_S36-S54.nxml.txt.nlp	NULL	SENT79	0	0	10	10	bevacizumab	VEGF-A	PA130232992	7422	0.986
NULL	Case_Rep_Oncol_Med_2013_Mar_14_2013_793418.nxml.txt.nlp	23573438	SENT25	0	0	18	18	anastrozole	aromatase	PA448432	1588	0.986
NULL	Br_J_Cancer_2012_Sep_4_107(6)_947-955.nxml.txt.nlp	22892392	SENT214	30	30	8	8	lapatinib	ERBB2	PA152241907	2064	0.986
NULL	Diagn_Pathol_2013_May_15_8_81.nxml.txt.nlp	23675804	SENT21	28	28	2	2	vincristine	CD5	PA451879	921	0.986
NULL	Br_J_Cancer_2010_Nov_9_103(10)_1580-1587.nxml.txt.nlp	20959823	SENT138	22	22	8	8	bortezomib	PMP22	PA10252	5376;5827	0.986
NULL	Cancer_Metastasis_Rev_2010_Dec_10_29(4)_581-594.nxml.txt.nlp	20830503	SENT298	20	20	31	31	tamoxifen	ATAC	PA451581	6375	0.986
NULL	Oncotarget_2014_Oct_16_5(20)_9546-9563.nxml.txt.nlp	25337673	SENT146	39	39	8	8	gefitinib	AXL	PA131301952	558	0.986
NULL	Arthritis_Res_Ther_2009_Aug_28_11(4)_R131.nxml.txt.nlp	19715572	SENT119	5	5	19	19	rituximab	CD4	PA451261	920	0.986
NULL	Clin_Med_Insights_Oncol_2012_Feb_28_6_125-135.nxml.txt.nlp	22408376	SENT28	0	0	25	25	panitumumab	EGFR	PA162373091	1956	0.986
NULL	Part_Fibre_Toxicol_2013_Aug_13_10_39.nxml.txt.nlp	23937860	SENT29	47	47	10	10	anakinra	IL-6	PA10799	3569	0.986
NULL	Br_J_Haematol_2009_Nov_2_147(3)_396-410.nxml.txt.nlp	19758122	SENT51	18	18	7	7	dasatinib	p53	PA162372878	7157	0.986
NULL	Br_J_Cancer_2009_Oct_6_101(7)_1155-1161.nxml.txt.nlp	19738614	SENT191	15	15	4	4	gemcitabine	HER2	PA449748	2064	0.986
NULL	J_Biol_Chem_2011_Oct_7_286(40)_34998-35006.nxml.txt.nlp	21757733	SENT40	7	7	19	19	lipase	ATGL	PA450239	57104	0.986
NULL	CNS_Spectr_2014_Apr_1_19(2)_121-133.nxml.txt.nlp	23903233	SENT199	3	3	24	24	vilazodone	5-HT1A	PA165958365	3350	0.986
NULL	Biosci_Rep_2014_Dec_12_34(6)_e00162.nxml.txt.nlp	25385088	SENT167	10	10	6	6	chymotrypsin	XPA	PA448994	7507	0.986
NULL	Oxid_Med_Cell_Longev_2012_May_30_2012_452902.nxml.txt.nlp	22701146	SENT182	37	37	3	3	ceftazidime	OCTN2	PA448861	6584	0.986
NULL	J_Hum_Genet_2013_Jun_16_58(6)_353-361.nxml.txt.nlp	23677058	SENT160	34	34	4	4	cytarabine	SLC28A3	PA449177	64078	0.986
NULL	Indian_J_Med_Paediatr_Oncol_2014_Apr-Jun_35(2)_140-142.nxml.txt.nlp	25197175	SENT47	32	32	25	25	bevacizumab	EGFR	PA130232992	1956	0.986
NULL	Int_J_Chron_Obstruct_Pulmon_Dis_2006_Dec_1(4)_373-379.nxml.txt.nlp	18044094	SENT41	8	8	27	27	cilomilast	PDE4B	PA165948031	5142	0.986
NULL	Ann_Occup_Hyg_2010_Aug_21_54(6)_697-709.nxml.txt.nlp	20660144	SENT186	33	33	6	6	fluorescein	GK2	PA164746009	2712;2585	0.986
NULL	Oncotarget_2014_Mar_14_5(10)_3029-3038.nxml.txt.nlp	24912489	SENT23	11	11	5	5	everolimus	aromatase	PA164746311	1588	0.986
NULL	Clin_Genet_2011_Jun_79(6)_582-587.nxml.txt.nlp	20573158	SENT109	35	35	7	7	diazoxide	ABCC8	PA449285	6833	0.986
NULL	Exp_Ther_Med_2014_Aug_10_8(2)_454-458.nxml.txt.nlp	25009600	SENT9	29	29	12	12	genistein	Bcl-2	PA165109660	596	0.986
NULL	Br_J_Cancer_2006_Dec_4_95(11)_1504-1513.nxml.txt.nlp	17088902	SENT202	13	13	25	25	gefitinib	EGF	PA131301952	1950	0.986
NULL	Biomed_Res_Int_2013_Dec_31_2013_795103.nxml.txt.nlp	23710462	SENT166	12	12	30	30	fenofibrate	adiponectin	PA449594	9370	0.986
NULL	Crit_Care_2007_Dec_13_11(6)_R129.nxml.txt.nlp	18078508	SENT114	11	11	26	26	vasopressin	ANOVA	PA451858	4858	0.986
NULL	Iran_J_Basic_Med_Sci_2012_Jul-Aug_15(4)_965-974.nxml.txt.nlp	23493093	SENT156	16	16	0	0	ethanol	CYP2E1	PA448073	1571	0.986
NULL	Breast_Cancer_(Auckl)_2012_Mar_7_6_67-77.nxml.txt.nlp	22438669	SENT46	0	0	5	5	lapatinib	CYP3A4	PA152241907	1576	0.986
NULL	J_Cell_Mol_Med_2013_Feb_10_17(2)_233-241.nxml.txt.nlp	23301673	SENT49	0	0	18	18	cisplatin	PARP1	PA449014	142	0.986
NULL	Br_J_Clin_Pharmacol_2011_Oct_72(4)_647-657.nxml.txt.nlp	21518389	SENT50	14	14	1	1	clopidogrel	P2Y12	PA449053	64805	0.986
NULL	Blood_Cancer_J_2013_Jun_7_3(6)_e120.nxml.txt.nlp	23749045	SENT154	3	3	32	32	imatinib	IGF1	PA10804	3479	0.986
NULL	Core_Evid_2011_Mar_17_6_31-42.nxml.txt.nlp	21468241	SENT77	5	5	8	8	cangrelor	P2Y12	PA165945763	64805	0.986
NULL	Crit_Care_2011_Aug_11_15(4)_226.nxml.txt.nlp	21892977	SENT58	8	8	1	1	vasopressin	P2X5	PA451858	5026	0.986
NULL	Nucleic_Acids_Res_2005_Jun_30_33(11)_3678-3690.nxml.txt.nlp	15994460	SENT253	25	25	1	1	cisplatin	Hel308	PA449014	113510	0.986
NULL	Biomed_Res_Int_2014_Jan_29_2014_232870.nxml.txt.nlp	24592384	SENT182	15	15	28	28	flavopiridol	p53	PA452627	7157	0.986
NULL	Target_Oncol_2010_Jun_14_5(2)_95-112.nxml.txt.nlp	20625845	SENT231	20	20	10	10	sunitinib	FDG	PA162372840	23583	0.986
NULL	Cancer_Manag_Res_2013_Dec_11_9_1-3.nxml.txt.nlp	24376362	SENT3	0	0	6	6	trastuzumab	HER-2	PA451743	2064	0.986
NULL	Exp_Lung_Res_2013_Oct_1_39(8)_336-348.nxml.txt.nlp	23919450	SENT131	8	8	15	15	thrombin	PAR-1	PA451674	2011;2149	0.986
NULL	Mol_Cancer_2012_Jun_18_11_41.nxml.txt.nlp	22709873	SENT302	15	15	2	2	lapatinib	CCND1	PA152241907	595	0.986
NULL	Diabetes_Care_2009_Aug_9_32(8)_1485-1490.nxml.txt.nlp	19509012	SENT122	22	22	8	8	valsartan	REN	PA451848	5972;147040	0.986
NULL	F1000Res_2014_Aug_19_3_198.nxml.txt.nlp	25400908	SENT291	0	0	30	30	pertuzumab	HER3		2065	0.986
NULL	eLife_2013_Nov_5_2_e00969.nxml.txt.nlp	24192036	SENT108	21	21	4	4	vemurafenib	BCL2	PA165946873	596	0.986
NULL	Diabetes_Care_2010_Jun_23_33(6)_1294-1296.nxml.txt.nlp	20332358	SENT29	0	0	12	12	exenatide	GLP-1	PA164749238	100125288	0.986
NULL	Oncotarget_2014_Nov_5_5(22)_11381-11398.nxml.txt.nlp	25359767	SENT140	8	8	37	37	hydroxyurea	RPA2	PA449942	6118;84172	0.986
NULL	Cancer_Cell_2007_Dec_11_12(6)_514-527.nxml.txt.nlp	18068629	SENT210	31	31	0	0	paclitaxel	Rho	PA450761	29984	0.986
NULL	Mol_Cancer_2014_Jun_5_13_143.nxml.txt.nlp	24898067	SENT28	34	34	9	9	afatinib	EGFR	PA165981154	1956	0.986
NULL	Mol_Cancer_2009_Oct_8_8_83.nxml.txt.nlp	19814803	SENT164	16	16	3	3	triciribine	AKT	PA165958661	207	0.986
NULL	J_Vet_Med_Sci_2014_Jun_15_76(6)_813-817.nxml.txt.nlp	24531829	SENT90	13	13	40	40	artesunate	DPT	PA165111697	1805	0.986
NULL	Carcinogenesis_2014_May_13_35(5)_1055-1066.nxml.txt.nlp	24419232	SENT143	23	23	10	10	metformin	AMPK	PA450395	5563	0.986
NULL	J_Biomed_Biotechnol_2011_Jan_24_2011_250860.nxml.txt.nlp	21318107	SENT162	2	2	25	25	thalidomide	IL-2	PA451644	3558	0.986
NULL	Breast_Cancer_Res_2005_Jul_29_7(5)_E6.nxml.txt.nlp	16168100	SENT18	7	7	27	27	tamoxifen	CYP2D6	PA451581	1565	0.986
NULL	Breast_Cancer_Res_Treat_2013_Jan_8_137(2)_457-464.nxml.txt.nlp	23224144	SENT43	39	39	5	5	trastuzumab	HER3	PA451743	2065	0.986
NULL	An_Bras_Dermatol_2013_Nov-Dec_88(6)_937-944.nxml.txt.nlp	24474103	SENT118	0	0	21	21	itraconazole	CYP3A4	PA450132	1576	0.986
NULL	Acta_Vet_Scand_2014_May_20_56(1)_33.nxml.txt.nlp	24884817	SENT178	3	3	11	11	heparin	IL-17A	PA449855	3605	0.986
NULL	Cell_Commun_Signal_2014_Sep_25_12(1)_61.nxml.txt.nlp	NULL	SENT97	21	21	7	7	doxycycline	INPP4B	PA449415	8821	0.986
NULL	J_Hematol_Oncol_2009_Feb_23_2_10.nxml.txt.nlp	19236716	SENT107	15	15	18	18	ketoconazole	CYP3A4	PA450146	1576	0.986
NULL	J_Immunother_Cancer_2014_Nov_6_2(Suppl_3)_P185.nxml.txt.nlp	NULL	SENT7	0	0	20	20	cabozantinib	VEGFR2	PA165906891	3791	0.986
NULL	Cardiol_Res_Pract_2013_Feb_21_2013_127270.nxml.txt.nlp	23509665	SENT175	34	34	21	21	ticagrelor	ADP	PA165374673	23038	0.986
NULL	Indian_J_Endocrinol_Metab_2012_Mar-Apr_16(2)_158-163.nxml.txt.nlp	22470850	SENT125	17	17	0	0	vasopressin	AQP2	PA451858	359	0.986
NULL	Diabetes_2011_Nov_17_60(11)_2691-2700.nxml.txt.nlp	21896928	SENT230	13	13	28	28	resveratrol	SIRT1		23411	0.986
NULL	Br_J_Cancer_2012_Sep_4_107(6)_947-955.nxml.txt.nlp	22892392	SENT173	20	20	1	1	lapatinib	BCAR4	PA152241907	400500	0.986
NULL	J_Cell_Biol_1998_Jan_26_140(2)_335-345.nxml.txt.nlp	9442109	SENT187	25	25	9	9	chloroquine	NHE	PA448948	285335	0.986
NULL	Ann_Lab_Med_2012_Jul_20_32(4)_264-269.nxml.txt.nlp	22779067	SENT46	10	10	29	29	isoniazid	DST	PA450112	667	0.986
NULL	Br_J_Cancer_2012_Apr_10_106(8)_1367-1373.nxml.txt.nlp	22454081	SENT152	4	4	10	10	trastuzumab	p27	PA451743	5715;10534	0.986
NULL	BMB_Rep_2014_Jul_47(7)_376-381.nxml.txt.nlp	24286332	SENT145	26	26	6	6	thrombin	PPG	PA451674	5552	0.986
NULL	Korean_Circ_J_2013_May_31_43(5)_343-346.nxml.txt.nlp	23755082	SENT42	7	7	15	15	clopidogrel	DES	PA449053	1674	0.986
NULL	Breast_Cancer_Res_2008_Dec_18_10(Suppl_4)_S18.nxml.txt.nlp	19128431	SENT62	15	15	35	35	tamoxifen	aromatase	PA451581	1588	0.986
NULL	Br_J_Cancer_2011_Oct_25_105(9)_1362-1369.nxml.txt.nlp	21952621	SENT182	8	8	2	2	tamoxifen	FGFR1	PA451581	2260	0.986
NULL	Orphanet_J_Rare_Dis_2014_Jan_27_9_13.nxml.txt.nlp	24461084	SENT124	4	4	25	25	cetuximab	KRAS	PA10040	3845	0.986
NULL	Nat_Commun_2013_Sep_27_4_2519.nxml.txt.nlp	24071738	SENT694	22	22	11	11	bortezomib	OTUB1	PA10252	55611	0.986
NULL	J_Biol_Chem_2013_Nov_15_288(46)_33049-33059.nxml.txt.nlp	24089524	SENT277	39	39	7	7	nicotine	SCC-112	PA450626	23244	0.986
NULL	Neural_Regen_Res_2013_Mar_25_8(9)_825-832.nxml.txt.nlp	25206730	SENT116	19	19	14	14	isoflurane	P2X7	PA450106	5027	0.986
NULL	Oncol_Lett_2013_Apr_28_5(4)_1149-1154.nxml.txt.nlp	23599754	SENT111	28	28	8	8	cisplatin	Dicer	PA449014	23405	0.986
NULL	Hum_Genomics_2008_Sep_1_3(1)_7-16.nxml.txt.nlp	19129086	SENT164	3	3	21	21	pioglitazone	CYP3A4	PA450970	1576	0.986
NULL	Apoptosis_2012_Mar_30_17(3)_219-228.nxml.txt.nlp	22127644	SENT74	6	6	13	13	cisplatin	MDR1	PA449014	5243	0.986
NULL	Mol_Cell_Biochem_2014_Oct_26_386(1-2)_117-124.nxml.txt.nlp	24158524	SENT194	10	10	1	1	gefitinib	HER2	PA131301952	2064	0.986
NULL	Breast_Cancer_Res_2008_Mar_27_10(2)_R27.nxml.txt.nlp	18371219	SENT23	19	19	5	5	paclitaxel	PIK3CA	PA450761	5290	0.986
NULL	Oncol_Lett_2013_Mar_8_5(3)_805-812.nxml.txt.nlp	23426281	SENT250	30	30	11	11	gemcitabine	B7-H3	PA449748	80381	0.986
NULL	Adv_Urol_2012_Oct_26_2012_812398.nxml.txt.nlp	22110495	SENT46	29	29	5	5	cisplatin	ERCC1	PA449014	2067	0.986
NULL	Nat_Commun_2013_Sep_20_4_2444.nxml.txt.nlp	24051492	SENT146	10	10	26	26	nutlin-3	p53		7157	0.986
NULL	J_Oncol_2009_Jun_14_2009_814140.nxml.txt.nlp	19547715	SENT6	4	4	26	26	etoposide	MDR1	PA449552	5243	0.986
NULL	J_Korean_Med_Sci_2010_Aug_21_25(8)_1222-1227.nxml.txt.nlp	20676337	SENT161	21	21	8	8	aminophylline	LPA	PA164781029	4018	0.986
NULL	Breast_Cancer_Res_2008_Jul_8_10(4)_R56.nxml.txt.nlp	18611244	SENT244	15	15	18	18	gefitinib	EGFR	PA131301952	1956	0.986
NULL	Acta_Pharmacol_Sin_2010_Jan_5_31(1)_93-101.nxml.txt.nlp	20048748	SENT211	8	8	12	12	cisplatin	DAPK	PA449014	1612	0.986
NULL	Environ_Health_Perspect_2008_Jan_5_116(1)_1-6.nxml.txt.nlp	18197291	SENT53	23	23	0	0	arsenite	FBS	PA452638	64319;26269	0.986
NULL	Mol_Cancer_2010_Apr_29_9_95.nxml.txt.nlp	20429933	SENT56	24	24	39	39	cisplatin	p53	PA449014	7157	0.986
NULL	Oncotarget_2010_Oct_25_1(7)_497-514.nxml.txt.nlp	21165163	SENT309	29	29	5	5	neratinib	EGFR	PA165291472	1956	0.986
NULL	EPMA_J_2013_Jan_28_4(1)_3.nxml.txt.nlp	23356214	SENT87	0	0	10	10	bevacizumab	VEGF-A	PA130232992	7422	0.986
NULL	Oncogene_2013_Sep_26_32(39)_10_1038_onc_2012_491.nxml.txt.nlp	23108394	SENT90	23	23	11	11	epirubicin	FOXM1	PA449476	2305	0.986
NULL	N_Am_J_Med_Sci_2011_Mar_3(3)_129-136.nxml.txt.nlp	22540078	SENT152	4	4	12	12	lipase	SMG	PA450239	23034	0.986
NULL	Arthritis_Res_Ther_2008_Mar_17_10(2)_R33.nxml.txt.nlp	18346273	SENT39	0	0	13	13	oxaliplatin	HMGB1	PA131285527	3146	0.986
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_33-43.nxml.txt.nlp	17912634	SENT44	29	29	19	19	tamoxifen	aromatase	PA451581	1588	0.986
NULL	Core_Evid_2010_Oct_21_5_61-76.nxml.txt.nlp	21042543	SENT254	10	10	0	0	panitumumab	PIK3CA	PA162373091	5290	0.986
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT330	16	16	2	2	resveratrol	AMPK		5563	0.986
NULL	Breast_Cancer_Res_2014_Aug_6_16(4)_420.nxml.txt.nlp	25096718	SENT316	17	17	2	2	cisplatin	AMPK	PA449014	5563	0.986
NULL	Mol_Cancer_2013_Oct_8_12_119.nxml.txt.nlp	24103454	SENT127	30	30	16	16	etoposide	TOP2A	PA449552	7153	0.986
NULL	Front_Neurol_2011_Dec_26_2_83.nxml.txt.nlp	22363312	SENT76	0	0	14	14	clopidogrel	ADP	PA449053	23038	0.986
NULL	Int_J_Biol_Sci_2013_May_15_9(5)_472-479.nxml.txt.nlp	23781140	SENT151	10	10	4	4	doxorubicin	CD133	PA449412	8842	0.986
NULL	Br_J_Cancer_2011_Mar_1_104(5)_856-862.nxml.txt.nlp	21285991	SENT138	30	30	6	6	cetuximab	BRAF	PA10040	673	0.986
NULL	J_Cancer_2013_Nov_23_4(9)_736-754.nxml.txt.nlp	24312144	SENT56	10	10	22	22	erlotinib	EGFR	PA134687924	1956	0.986
NULL	Curr_Control_Trials_Cardiovasc_Med_2001_Feb_2_2(1)_20-23.nxml.txt.nlp	11806769	SENT35	44	44	3	3	carvedilol	BEST	PA448817	7439	0.986
NULL	J_Geriatr_Cardiol_2014_Mar_11(1)_63-73.nxml.txt.nlp	24748884	SENT184	0	0	28	28	levodopa	DR5	PA450213	8795	0.986
NULL	Ther_Clin_Risk_Manag_2007_Jun_3(3)_361-362.nxml.txt.nlp	18488067	SENT35	34	34	1	1	alefacept	CD4	PA164748040	920	0.986
NULL	Oncol_Lett_2014_Aug_19_8(2)_809-812.nxml.txt.nlp	25009658	SENT79	24	24	1	1	metformin	AMPK	PA450395	5563	0.986
NULL	Indian_J_Psychol_Med_2009_Jan-Jun_31(1)_3-10.nxml.txt.nlp	21938084	SENT177	11	11	22	22	fluoxetine	5-HT2A	PA449673	3356	0.986
NULL	J_Adv_Pract_Oncol_2012_Nov_1_Nov-Dec_3(6)_391-394.nxml.txt.nlp	25031970	SENT15	0	0	35	35	pertuzumab	HER3		2065	0.986
NULL	Cancer_Inform_2012_Apr_19_11_87-111.nxml.txt.nlp	22553414	SENT217	1	1	32	32	gefitinib	ERBB2	PA131301952	2064	0.986
NULL	Diabetes_2008_Sep_57(9)_2332-2340.nxml.txt.nlp	18567824	SENT38	45	45	22	22	atropine	ghrelin	PA448505	51738	0.986
NULL	Comp_Hepatol_2005_Feb_8_4_2.nxml.txt.nlp	15701172	SENT151	10	10	24	24	ketoconazole	CYP3A4	PA450146	1576	0.986
NULL	Biomed_Res_Int_2013_Dec_5_2013_642848.nxml.txt.nlp	24381940	SENT145	1	1	4	4	telmisartan	AT1	PA451605	9197;185	0.986
NULL	Nucleic_Acids_Res_2013_Dec_4_41(22)_10124-10134.nxml.txt.nlp	24005039	SENT240	9	9	5	5	ethanol	CYC1	PA448073	1537	0.986
NULL	Acta_Pharmacol_Sin_2013_Jul_5_34(7)_870-879.nxml.txt.nlp	23624759	SENT95	7	7	24	24	erlotinib	EGFR	PA134687924	1956	0.986
NULL	Int_J_Biol_Sci_2014_Jun_10_10(7)_654-663.nxml.txt.nlp	25013375	SENT106	1	1	19	19	nelfinavir	AKT	PA450606	207	0.986
NULL	Cancer_Cell_Int_2014_Jun_11_14_49.nxml.txt.nlp	24991192	SENT132	15	15	7	7	berberine	AMPK	PA165860812	5563	0.986
NULL	Oncotarget_2013_Jun_4_4(5)_772-784.nxml.txt.nlp	23800712	SENT125	45	45	19	19	erlotinib	EGFR	PA134687924	1956	0.986
NULL	Clin_Interv_Aging_2013_Sep_30_8_1323-1328.nxml.txt.nlp	24109180	SENT27	10	10	1	1	vancomycin	HAP	PA451850	5915;10313	0.986
NULL	Drugs_R_D_2014_Jun_2_14(2)_63-71.nxml.txt.nlp	24691742	SENT81	4	4	8	8	moxifloxacin	API	PA450555	5345	0.986
NULL	J_Korean_Med_Sci_2010_Oct_17_25(10)_1427-1430.nxml.txt.nlp	20890421	SENT8	23	23	9	9	atazanavir	UGT1A1	PA10251	54658	0.986
NULL	J_Breast_Cancer_2013_Jun_28_16(2)_220-228.nxml.txt.nlp	23843857	SENT124	13	13	22	22	tamoxifen	aromatase	PA451581	1588	0.986
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT245	17	17	10	10	pertuzumab	HER3		2065	0.986
NULL	Ther_Clin_Risk_Manag_2007_Aug_3(4)_543-552.nxml.txt.nlp	18472975	SENT24	4	4	19	19	thalidomide	gamma	PA451644	9913	0.986
NULL	Cancer_Manag_Res_2013_Jun_7_5_91-101.nxml.txt.nlp	23785245	SENT2	16	16	0	0	gefitinib	EGFR	PA131301952	1956	0.986
NULL	Cancers_(Basel)_2014_Oct_24_6(4)_2187-2223.nxml.txt.nlp	25347122	SENT177	35	35	3	3	erlotinib	EGFR	PA134687924	1956	0.986
NULL	Chin_J_Cancer_2012_Feb_31(2)_73-99.nxml.txt.nlp	22098950	SENT210	31	31	7	7	nilotinib	CD34	PA165958345	947	0.986
NULL	J_Cancer_2013_Aug_28_4(7)_585-596.nxml.txt.nlp	24069069	SENT158	33	33	2	2	verteporfin	LC3	PA451871	84557	0.986
NULL	Mol_Cytogenet_2010_Sep_15_3_17.nxml.txt.nlp	20840797	SENT187	26	26	2	2	irinotecan	FISH	PA450085	9644	0.986
NULL	J_Cancer_2014_Jul_4_5(7)_559-571.nxml.txt.nlp	25057307	SENT229	15	15	11	11	tamoxifen	STAT3	PA451581	6774	0.986
NULL	Cell_Biochem_Biophys_2013_May_28_67(1)_25-43.nxml.txt.nlp	23712866	SENT108	13	13	2	2	camptothecin	USP1	PA153590860	7398	0.986
NULL	Croat_Med_J_2011_Apr_52(2)_171-177.nxml.txt.nlp	21495200	SENT44	6	6	14	14	trastuzumab	HER-2	PA451743	2064	0.986
NULL	Environ_Health_Perspect_2008_Jan_5_116(1)_1-6.nxml.txt.nlp	18197291	SENT214	18	18	13	13	arsenite	p85	PA452638	5296;5295;54776;23368	0.986
NULL	Chemother_Res_Pract_2012_Dec_20_2012_743193.nxml.txt.nlp	23320171	SENT121	0	0	25	25	pertuzumab	HER2		2064	0.986
NULL	Mucosal_Immunol_2012_May_22_5(3)_320-331.nxml.txt.nlp	22354319	SENT34	34	34	6	6	mitomycin	CD4	PA450524	920	0.986
NULL	Environ_Toxicol_Chem_2014_Oct_25_33(10)_2363-2367.nxml.txt.nlp	25043914	SENT82	34	34	7	7	galactose	ARNT	PA449725	405	0.986
NULL	Int_J_Breast_Cancer_2011_Feb_24_2011_967419.nxml.txt.nlp	22332018	SENT142	32	32	0	0	doxorubicin	BRCA1	PA449412	672	0.986
NULL	Biologics_2009_Oct_12_3_469-474.nxml.txt.nlp	19851472	SENT80	42	42	9	9	mometasone	IL-5	PA450541	3567	0.986
NULL	Br_J_Cancer_2012_Jun_26_107(1)_129-136.nxml.txt.nlp	22644295	SENT197	23	23	11	11	ethanol	TAK1	PA448073	7182	0.986
NULL	Evid_Based_Complement_Alternat_Med_2013_Aug_28_2013_516017.nxml.txt.nlp	24066014	SENT53	11	11	1	1	indomethacin	EDH	PA449982	10804	0.986
NULL	Oncol_Rep_2014_Aug_12_32(2)_469-474.nxml.txt.nlp	24926795	SENT31	12	12	3	3	carboplatin	CTR	PA448803	799	0.986
NULL	Mol_Cancer_2009_Jun_9_8_37.nxml.txt.nlp	19508729	SENT44	11	11	0	0	gemcitabine	HO-1	PA449748	3162	0.986
NULL	Front_Genet_2012_Nov_5_3_236.nxml.txt.nlp	23133441	SENT26	7	7	30	30	indinavir	ABCB1	PA449977	5243	0.986
NULL	Int_J_Cell_Biol_2014_Aug_14_2014_236246.nxml.txt.nlp	25197279	SENT78	4	4	8	8	denosumab	RANKL	PA166048634	8600	0.986
NULL	Leukemia_2014_Apr_14_28(4)_961-964.nxml.txt.nlp	24418991	SENT38	2	2	15	15	imatinib	P-gp	PA10804	5243	0.986
NULL	Mol_Cancer_2008_Jun_5_7_50.nxml.txt.nlp	18534018	SENT149	44	44	13	13	bortezomib	ATF5	PA10252	22809	0.986
NULL	Front_Neurosci_2014_Jan_28_8_5.nxml.txt.nlp	24478625	SENT197	38	38	4	4	alprazolam	c-fos	PA448333	2353	0.986
NULL	Mol_Cancer_2009_Nov_10_8_99.nxml.txt.nlp	19903356	SENT47	17	17	7	7	imatinib	IGFBP3	PA10804	3486	0.986
NULL	Clin_Ophthalmol_2007_Dec_1(4)_383-391.nxml.txt.nlp	19668515	SENT145	0	0	12	12	pegaptanib	VEGF-A	PA164771236	7422	0.986
NULL	Cell_Cycle_2013_Apr_1_12(7)_1020.nxml.txt.nlp	23511169	SENT4	13	13	19	19	cetuximab	EGF	PA10040	1950	0.986
NULL	Mol_Cancer_2012_Jun_18_11_41.nxml.txt.nlp	22709873	SENT306	28	28	5	5	lapatinib	CDKN1B	PA152241907	1027	0.986
NULL	Breast_Cancer_Res_2014_Sep_9_16(5)_433.nxml.txt.nlp	25212966	SENT379	6	6	17	17	aprotinin	ILEI	PA448472	10447	0.986
NULL	Front_Neurol_2011_Dec_26_2_83.nxml.txt.nlp	22363312	SENT275	36	36	11	11	clopidogrel	LTA	PA449053	4049	0.986
NULL	Clin_Ophthalmol_2014_Jun_25_8_1209-1212.nxml.txt.nlp	25028534	SENT55	3	3	29	29	nepafenac	COX2	PA165958407	4513;5743	0.986
NULL	J_Oncol_2010_Jun_3_2010_732680.nxml.txt.nlp	20613952	SENT65	2	2	25	25	thalidomide	IL-2	PA451644	3558	0.986
NULL	Cent_European_J_Urol_2013_Aug_13_66(2)_144-149.nxml.txt.nlp	24579014	SENT41	0	0	34	34	resveratrol	survivin		332	0.986
NULL	Indian_J_Endocrinol_Metab_2013_Oct_17(Suppl1)_S32-S34.nxml.txt.nlp	24251201	SENT55	11	11	2	2	estradiol	aromatase	PA449503	1588	0.986
NULL	CNS_Drugs_2014_Apr_11_28(6)_535-558.nxml.txt.nlp	24723124	SENT190	0	0	12	12	alemtuzumab	CD52	PA164783958	1043	0.986
NULL	Oncotarget_2011_Mar_1_2(1-2)_5-7.nxml.txt.nlp	21378415	SENT19	7	7	39	39	flavopiridol	TBP	PA452627	6908	0.986
NULL	Cell_Res_2012_Aug_22_22(8)_1227-1245.nxml.txt.nlp	22613949	SENT160	0	0	18	18	gemcitabine	KRAS	PA449748	3845	0.986
NULL	Ann_Rheum_Dis_2008_Aug_29_67(8)_1096-1103.nxml.txt.nlp	18055472	SENT119	21	21	8	8	abatacept	ACR	PA164747080	49	0.986
NULL	Indian_J_Pharmacol_2014_Jan-Feb_46(1)_3-12.nxml.txt.nlp	24550577	SENT228	5	5	14	14	vismodegib	CYP2C19		1557	0.986
NULL	Oncol_Lett_2013_Jun_4_5(6)_1872-1876.nxml.txt.nlp	23833659	SENT13	12	12	20	20	flavopiridol	Bcl-2	PA452627	596	0.986
NULL	Breast_Cancer_Res_2001_Aug_10_3(5)_E004.nxml.txt.nlp	NULL	SENT16	13	13	19	19	trastuzumab	HER2	PA451743	2064	0.986
NULL	Dement_Geriatr_Cogn_Dis_Extra_2014_Nov_15_4(3)_450-456.nxml.txt.nlp	25538729	SENT12	16	16	9	9	donepezil	APOE	PA449394	348	0.986
NULL	Clin_Med_Case_Rep_2008_Aug_29_1_119-122.nxml.txt.nlp	24179360	SENT19	3	3	11	11	teriparatide	PTH	PA451620	5741	0.986
NULL	Diabetes_Metab_Syndr_Obes_2010_May_17_3_155-163.nxml.txt.nlp	21437085	SENT59	0	0	7	7	liraglutide	GLP-1	PA165958364	100125288	0.986
NULL	Cell_Biosci_2011_Apr_19_1_16.nxml.txt.nlp	21711917	SENT269	0	0	29	29	l-glutamine	GDH	PA10090	51084;2746	0.986
NULL	Oncol_Rep_2014_Apr_28_31(4)_1605-1612.nxml.txt.nlp	24481648	SENT38	2	2	27	27	lapatinib	MRP7	PA152241907	89845;1080	0.986
NULL	Drug_Des_Devel_Ther_2014_Sep_26_8_1595-1611.nxml.txt.nlp	25302015	SENT128	34	34	22	22	gefitinib	EGFR	PA131301952	1956	0.986
NULL	Int_J_Endocrinol_2010_May_26_2010_906163.nxml.txt.nlp	20585352	SENT74	4	4	13	13	cinacalcet	PTH	PA164776671	5741	0.986
NULL	Oncol_Lett_2013_Dec_4_6(6)_1665-1672.nxml.txt.nlp	24273604	SENT82	7	7	26	26	chloroquine	TLR9	PA448948	54106	0.986
NULL	Breast_Cancer_Res_Treat_2014_Apr_9_145(1)_73-82.nxml.txt.nlp	24715380	SENT7	22	22	10	10	tamoxifen	CXCR3	PA451581	2833	0.986
NULL	Br_J_Cancer_2010_Jul_13_103(2)_186-195.nxml.txt.nlp	20588277	SENT32	0	0	24	24	nutlin-3	p53		7157	0.986
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT157	13	13	18	18	neratinib	ADAM17	PA165291472	6868	0.986
NULL	Biologics_2010_May_25_4_83-90.nxml.txt.nlp	20531966	SENT97	25	25	8	8	gefitinib	EGFR	PA131301952	1956	0.986
NULL	J_Cancer_2013_Jan_11_4(2)_117-132.nxml.txt.nlp	23386910	SENT58	0	0	19	19	lapatinib	HER-2	PA152241907	2064	0.986
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT143	4	4	28	28	resveratrol	survivin		332	0.986
NULL	Br_J_Cancer_2012_May_22_106(11)_1722-1727.nxml.txt.nlp	22568966	SENT29	14	14	23	23	panitumumab	KRAS	PA162373091	3845	0.986
NULL	Mol_Biol_Cell_2013_Jul_1_24(13)_2134-2145.nxml.txt.nlp	23657817	SENT80	9	9	1	1	pp2	RhoA		387	0.986
NULL	Int_J_Mol_Sci_2013_Apr_29_14(5)_9338-9364.nxml.txt.nlp	23629668	SENT93	35	35	6	6	bevacizumab	ACT	PA130232992	12;11332;9457;641455	0.986
NULL	Nat_Commun_2014_Apr_28_5_3695.nxml.txt.nlp	24770583	SENT296	16	16	10	10	doxycycline	p97	PA449415	50628;10428;1982;7415	0.986
NULL	Int_J_Mol_Sci_2014_May_12_15(5)_8360-8371.nxml.txt.nlp	24823881	SENT141	10	10	1	1	l-glutamine	SV2	PA10090	9900	0.986
NULL	Environ_Health_Perspect_2011_Apr_16_119(4)_534-541.nxml.txt.nlp	21081300	SENT107	26	26	4	4	diethylstilbestrol	PGD2	PA449307	27306	0.986
NULL	EMBO_Mol_Med_2009_Apr_1(1)_66-78.nxml.txt.nlp	20049704	SENT34	4	4	18	18	topotecan	HIF-1	PA451729	29072	0.986
NULL	ISRN_Neurosci_2013_Dec_19_2013_626290.nxml.txt.nlp	25006573	SENT152	2	2	9	9	nelfinavir	survivin	PA450606	332	0.986
NULL	J_Anaesthesiol_Clin_Pharmacol_2011_Jul-Sep_27(3)_307-314.nxml.txt.nlp	21897498	SENT71	3	3	30	30	oxycodone	P600	PA450741	3596	0.986
NULL	J_Hematol_Oncol_2012_Jul_27_5_42.nxml.txt.nlp	22839530	SENT13	24	24	7	7	vincristine	PRMT1	PA451879	3276	0.986
NULL	Oncogene_2010_Jun_10_29(23)_3335-3348.nxml.txt.nlp	20383197	SENT40	24	24	20	20	lapatinib	HER2	PA152241907	2064	0.986
NULL	Onco_Targets_Ther_2014_Jul_14_7_1285-1289.nxml.txt.nlp	25053886	SENT33	5	5	14	14	lapatinib	HER2	PA152241907	2064	0.986
NULL	Core_Evid_2010_Jul_27_5_1-10.nxml.txt.nlp	20694135	SENT41	4	4	24	24	levodopa	CLE	PA450213	51637	0.986
NULL	Br_J_Cancer_2012_Nov_6_107(10)_1714-1721.nxml.txt.nlp	23073173	SENT111	9	9	14	14	docetaxel	RUNX2	PA449383	860	0.986
NULL	Eur_J_Clin_Pharmacol_2010_Nov_29_66(11)_1131-1136.nxml.txt.nlp	20669013	SENT30	0	0	7	7	erythromycin	CYP3A4	PA449493	1576	0.986
NULL	Biomed_Res_Int_2014_Jan_2_2014_682010.nxml.txt.nlp	24524084	SENT89	12	12	6	6	imatinib	IL-2	PA10804	3558	0.986
NULL	J_Signal_Transduct_2011_Jun_27_2011_541851.nxml.txt.nlp	21776386	SENT95	9	9	0	0	calcein	PC-3	PA132595336	692094	0.986
NULL	Br_J_Cancer_2013_Jul_9_109(1)_68-75.nxml.txt.nlp	23807173	SENT112	12	12	0	0	cisplatin	ERCC1	PA449014	2067	0.986
NULL	Front_Syst_Neurosci_2014_Dec_22_8_238.nxml.txt.nlp	25565991	SENT319	15	15	5	5	haloperidol	CB1	PA449841	1268	0.986
NULL	Acta_Pharmacol_Sin_2010_Jul_21_31(7)_839-848.nxml.txt.nlp	20562900	SENT223	39	39	3	3	fluorescein	COL1A1	PA164746009	1277	0.986
NULL	J_Hematol_Oncol_2009_Feb_23_2_9.nxml.txt.nlp	19236713	SENT65	20	20	28	28	panitumumab	KRAS	PA162373091	3845	0.986
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT160	11	11	33	33	doxorubicin	ABCB1	PA449412	5243	0.986
NULL	Environ_Health_Perspect_2013_Oct_1_121(10)_A313.nxml.txt.nlp	24218666	SENT23	7	7	25	25	estradiol	SULT1E1	PA449503	6783	0.986
NULL	Mol_Cancer_2010_Dec_20_9_317.nxml.txt.nlp	21172025	SENT4	7	7	16	16	tamoxifen	HER2	PA451581	2064	0.986
NULL	ScientificWorldJournal_2014_May_19_2014_567148.nxml.txt.nlp	24971383	SENT183	22	22	7	7	doxorubicin	MRP-1	PA449412	928	0.986
NULL	J_Asthma_Allergy_2010_Jul_16_3_57-63.nxml.txt.nlp	21437040	SENT90	30	30	3	3	simvastatin	CD4	PA451363	920	0.986
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT237	28	28	9	9	perifosine	DR5	PA165291471	8795	0.986
NULL	Clin_Exp_Reprod_Med_2013_Jun_30_40(2)_67-75.nxml.txt.nlp	23875162	SENT157	1	1	21	21	estradiol	HSD17B2	PA449503	3294	0.986
NULL	Emerg_Infect_Dis_2011_Mar_17(3)_432-440.nxml.txt.nlp	21392434	SENT117	12	12	34	34	rifampin	DST	PA451250	667	0.986
NULL	Exp_Ther_Med_2014_May_24_7(5)_1271-1278.nxml.txt.nlp	24940424	SENT22	9	9	34	34	capecitabine	ACRC	PA448771	93953	0.986
NULL	Nat_Commun_2011_Apr_5_2_269.nxml.txt.nlp	21468021	SENT116	28	28	8	8	tamoxifen	CD4	PA451581	920	0.986
NULL	Cancer_Med_2013_Dec_31_2(6)_826-835.nxml.txt.nlp	24403256	SENT199	0	0	13	13	nutlin-3	p53		7157	0.986
NULL	Case_Rep_Hematol_2013_Nov_7_2013_615189.nxml.txt.nlp	24312736	SENT117	0	0	4	4	exemestane	aromatase	PA449563	1588	0.986
NULL	Cancer_Res_Treat_2011_Sep_30_43(3)_148-153.nxml.txt.nlp	22022291	SENT120	10	10	14	14	sn-38	UGT1A1		54658	0.986
NULL	Oncoscience_2014_Oct_22_1(10)_614-623.nxml.txt.nlp	25593991	SENT92	2	2	32	32	pertuzumab	KIT		3815	0.986
NULL	Clin_Med_Insights_Oncol_2011_Oct_31_5_333-342.nxml.txt.nlp	22084622	SENT125	14	14	31	31	pazopanib	IL-8	PA165291492	3576	0.986
NULL	Arch_Drug_Inf_2011_Mar_4(1)_1-9.nxml.txt.nlp	21572514	SENT207	19	19	25	25	ciprofloxacin	P-gp	PA449009	5243	0.986
NULL	Oncotarget_2013_Nov_22_5(4)_933-943.nxml.txt.nlp	24659749	SENT119	19	19	7	7	nutlin-3	AML3		860	0.986
NULL	Onco_Targets_Ther_2014_Dec_16_8_7-14.nxml.txt.nlp	25565860	SENT95	16	16	7	7	cetuximab	EGFR	PA10040	1956	0.986
NULL	Mol_Cancer_2004_Nov_17_3_31.nxml.txt.nlp	15548330	SENT214	14	14	26	26	etoposide	PI3K	PA449552	5290	0.986
NULL	Allergy_Asthma_Clin_Immunol_2010_Mar_17_6(1)_5.nxml.txt.nlp	20236545	SENT79	12	12	28	28	azathioprine	IL-2	PA448515	3558	0.986
NULL	Front_Aging_Neurosci_2010_Nov_29_2_150.nxml.txt.nlp	21151819	SENT338	7	7	23	23	resveratrol	SIRT1		23411	0.986
NULL	Open_Neurol_J_2013_May_31_7_23-31.nxml.txt.nlp	23894259	SENT97	7	7	23	23	olanzapine	FGA	PA450688	2243	0.986
NULL	Breast_Cancer_Res_2009_Jun_23_11(Suppl_1)_S22.nxml.txt.nlp	NULL	SENT5	0	0	16	16	lapatinib	HER2	PA152241907	2064	0.986
NULL	Oncotarget_2013_Jul_21_4(8)_1266-1279.nxml.txt.nlp	23907540	SENT90	12	12	5	5	doxycycline	PTEN	PA449415	5728	0.986
NULL	J_Cell_Biol_2002_Mar_18_156(6)_951-957.nxml.txt.nlp	11901164	SENT56	13	13	1	1	pp2	CD46		4179	0.986
NULL	Breast_Cancer_Res_Treat_2012_Jul_5_134(2)_693-700.nxml.txt.nlp	22562123	SENT29	16	16	5	5	tamoxifen	SULT1A1	PA451581	6817	0.986
NULL	Br_J_Cancer_2013_Nov_26_109(11)_2803-2809.nxml.txt.nlp	24169346	SENT19	7	7	12	12	erlotinib	CYP2C19	PA134687924	1557	0.986
NULL	J_Oncol_2011_Dec_5_2011_465343.nxml.txt.nlp	21188169	SENT185	23	23	35	35	gemcitabine	CD44	PA449748	960	0.986
NULL	Mol_Cancer_2009_Jul_31_8_57.nxml.txt.nlp	19646263	SENT218	8	8	44	44	staurosporine	IL-8	PA165109623	3576	0.986
NULL	Exp_Ther_Med_2012_Sep_7_4(3)_452-458.nxml.txt.nlp	23181117	SENT6	22	22	13	13	cisplatin	MLC	PA449014	23209	0.986
NULL	Ann_Rheum_Dis_2009_Oct_17_68(10)_1580-1584.nxml.txt.nlp	19019888	SENT18	0	0	5	5	tocilizumab	IL-6	PA165292659	3569	0.986
NULL	Cancers_(Basel)_2014_Oct_24_6(4)_2187-2223.nxml.txt.nlp	25347122	SENT300	4	4	9	9	dasatinib	EGFR	PA162372878	1956	0.986
NULL	Anticancer_Agents_Med_Chem_2012_Feb_12(2)_163-171.nxml.txt.nlp	22043994	SENT25	15	15	7	7	panitumumab	BRAF	PA162373091	673	0.986
NULL	Oncotarget_2014_Aug_4_5(17)_7776-7787.nxml.txt.nlp	25277200	SENT160	29	29	5	5	carboplatin	CTR1	PA448803	1317	0.986
NULL	Cells_2014_Apr_8_3(2)_258-287.nxml.txt.nlp	24717323	SENT206	12	12	2	2	capsaicin	TRPV1	PA448776	7442	0.986
NULL	Breast_Cancer_Res_2009_Sep_16_11(5)_R69.nxml.txt.nlp	19758440	SENT185	28	28	21	21	tamoxifen	HER2	PA451581	2064	0.986
NULL	Oncogene_2014_Sep_11_33(37)_4579-4588.nxml.txt.nlp	24662835	SENT34	32	32	3	3	tamoxifen	MAGEA2	PA451581	4101;266740	0.986
NULL	J_Gastrointest_Cancer_2013_Aug_7_44(4)_385-392.nxml.txt.nlp	23921604	SENT151	2	2	18	18	imatinib	BSC	PA10804	6558	0.986
NULL	Br_J_Cancer_2012_Jan_3_106(1)_107-115.nxml.txt.nlp	22116303	SENT240	4	4	17	17	vorinostat	AKT	PA164748224	207	0.986
NULL	Mol_Cancer_2013_May_24_12_47.nxml.txt.nlp	23705854	SENT259	9	9	32	32	celecoxib	MRP1	PA448871	4437	0.986
NULL	J_Mol_Med_(Berl)_2014_Feb_20_92(3)_217-225.nxml.txt.nlp	24553779	SENT112	13	13	19	19	staurosporine	MRCK	PA165109623	8476	0.986
NULL	Asian_J_Transfus_Sci_2010_Jul_4(2)_137a.nxml.txt.nlp	20859521	SENT19	21	21	6	6	warfarin	ACT	PA451906	12;11332;9457;641455	0.986
NULL	Eur_J_Med_Res_2011_Apr_28_16(4)_139-144.nxml.txt.nlp	21486727	SENT141	12	12	18	18	posaconazole	CYP3A4	PA151958574	1576	0.986
NULL	Oncol_Lett_2013_Mar_8_5(3)_805-812.nxml.txt.nlp	23426281	SENT250	33	33	11	11	gemcitabine	B7-H3	PA449748	80381	0.986
NULL	Indian_J_Endocrinol_Metab_2012_Mar_16(Suppl1)_S79-S82.nxml.txt.nlp	22701852	SENT84	9	9	24	24	metformin	B12	PA450395	7126;4709	0.986
NULL	Biomed_Res_Int_2014_Feb_6_2014_323594.nxml.txt.nlp	24689036	SENT373	18	18	0	0	raloxifene	PC3	PA451221	57332;7832;5122	0.986
NULL	Breast_Cancer_Res_2010_Dec_20_12(Suppl_4)_S19.nxml.txt.nlp	21172081	SENT36	30	30	13	13	irinotecan	CA9	PA450085	768	0.986
NULL	Cancer_Cell_Int_2013_Apr_15_13_35.nxml.txt.nlp	23587008	SENT101	0	0	16	16	metformin	AMPK	PA450395	5563	0.986
NULL	J_Mol_Signal_2010_Apr_22_5_3.nxml.txt.nlp	20412577	SENT99	12	12	5	5	isoproterenol	AKAP12	PA450121	9590	0.986
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1018.nxml.txt.nlp	24457962	SENT63	0	0	10	10	cetuximab	EGFR	PA10040	1956	0.986
NULL	Int_Semin_Surg_Oncol_2006_Sep_18_3_31.nxml.txt.nlp	16981992	SENT18	22	22	1	1	anastrozole	ATAC	PA448432	6375	0.986
NULL	Br_J_Haematol_2014_Mar_13_164(1)_811-821.nxml.txt.nlp	24328678	SENT6	35	35	16	16	lenalidomide	IKZF1	PA162363968	10320	0.986
NULL	Br_J_Cancer_2011_Jul_26_105(3)_372-381.nxml.txt.nlp	21730979	SENT140	4	4	33	33	caffeine	ATR	PA448710	390502;84168;545	0.985
NULL	Oncol_Lett_2014_Jul_16_8(1)_211-217.nxml.txt.nlp	24959248	SENT96	7	7	27	27	cisplatin	ALDOA	PA449014	226	0.985
NULL	Eur_J_Clin_Pharmacol_2010_Nov_29_66(11)_1131-1136.nxml.txt.nlp	20669013	SENT111	2	2	35	35	voriconazole	CYP2C19	PA10233	1557	0.985
NULL	Exp_Diabetes_Res_2012_Dec_12_2012_716404.nxml.txt.nlp	22194737	SENT120	21	21	1	1	metformin	AMPK	PA450395	5563	0.985
NULL	J_Cancer_Prev_2014_Mar_19(1)_39-46.nxml.txt.nlp	25337571	SENT21	28	28	0	0	ethanol	JNK	PA448073	5599	0.985
NULL	Nat_Genet_2013_Jul_2_45(7)_747-755.nxml.txt.nlp	23727860	SENT129	5	5	3	3	dutasteride	SRD5A1	PA164749300	6715	0.985
NULL	Clinics_(Sao_Paulo)_2013_May_68(5)_694-701.nxml.txt.nlp	23778405	SENT184	13	13	3	3	curcumin	survivin	PA151958596	332	0.985
NULL	Oncotarget_2013_Aug_21_4(9)_1484-1495.nxml.txt.nlp	23986086	SENT162	42	42	27	27	trastuzumab	PI3K	PA451743	5290	0.985
NULL	Basic_Clin_Pharmacol_Toxicol_2013_Feb_5_112(2)_132-137.nxml.txt.nlp	22900583	SENT149	5	5	16	16	ritonavir	CYP3A	PA451260	1574	0.985
NULL	Br_J_Cancer_2009_Oct_20_101(8)_1290-1297.nxml.txt.nlp	19755992	SENT33	15	15	33	33	oxaliplatin	HIF-1	PA131285527	29072	0.985
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT197	12	12	6	6	cisplatin	p53	PA449014	7157	0.985
NULL	Environ_Health_Perspect_2005_Aug_15_113(8)_1009-1014.nxml.txt.nlp	16079071	SENT107	16	16	12	12	losartan	p38	PA450268	10598;1432;7965	0.985
NULL	Ann_Oncol_2014_Mar_25(3)_682-688.nxml.txt.nlp	24567516	SENT33	28	28	12	12	cisplatin	EGFR	PA449014	1956	0.985
NULL	Mar_Drugs_2014_Nov_19_12(11)_5468-5502.nxml.txt.nlp	25415349	SENT255	12	12	10	10	clopidogrel	ADP	PA449053	23038	0.985
NULL	Aging_(Albany_NY)_2009_Sep_25_1(10)_845-854.nxml.txt.nlp	20157557	SENT167	16	16	4	4	doxorubicin	p53	PA449412	7157	0.985
NULL	Biologics_2013_Apr_26_7_91-101.nxml.txt.nlp	23671386	SENT110	7	7	26	26	crizotinib	KIT	PA165946122	3815	0.985
NULL	J_Thorac_Oncol_2014_Jun_30_9(6)_775-783.nxml.txt.nlp	24828661	SENT262	6	6	17	17	gefitinib	EGFR	PA131301952	1956	0.985
NULL	Ann_Lab_Med_2015_Jan_8_35(1)_15-21.nxml.txt.nlp	25553275	SENT60	22	22	0	0	thrombin	Lag	PA451674	3925	0.985
NULL	Int_J_Mol_Sci_2013_Apr_15_14(4)_8213-8227.nxml.txt.nlp	23591839	SENT143	18	18	1	1	metformin	AMPK	PA450395	5563	0.985
NULL	Case_Rep_Oncol_2014_Jun_18_7(2)_393-400.nxml.txt.nlp	25076890	SENT92	25	25	8	8	thyroglobulin	RAI	PA164754910	10848;6050	0.985
NULL	Breast_Cancer_(Auckl)_2009_Sep_2_3_61-75.nxml.txt.nlp	19809577	SENT242	18	18	41	41	ethanol	p65	PA448073	5970	0.985
NULL	Crit_Care_2011_Jun_24_15(3)_R153.nxml.txt.nlp	21702944	SENT205	5	5	30	30	dexmedetomidine	Bcl-2	PA449256	596	0.985
NULL	Clin_Drug_Investig_2013_Aug_23_33(10)_727-736.nxml.txt.nlp	23975654	SENT175	17	17	29	29	ketoconazole	CYP2C19	PA450146	1557	0.985
NULL	Front_Genet_2012_Nov_5_3_236.nxml.txt.nlp	23133441	SENT26	12	12	30	30	ritonavir	ABCB1	PA451260	5243	0.985
NULL	Oncogene_2013_Sep_12_32(37)_4355-4365.nxml.txt.nlp	23108409	SENT92	4	4	18	18	hyaluronan	HAS2	PA165958431	3037	0.985
NULL	Br_J_Cancer_2014_Jan_7_110(1)_55-62.nxml.txt.nlp	24263064	SENT23	14	14	9	9	gefitinib	EGFR	PA131301952	1956	0.985
NULL	Mol_Cancer_2009_Jun_8_8_34.nxml.txt.nlp	19500427	SENT57	2	2	8	8	gemcitabine	p53	PA449748	7157	0.985
NULL	Acta_Pharmacol_Sin_2012_Apr_12_33(4)_542-550.nxml.txt.nlp	22407228	SENT100	0	0	6	6	perifosine	JNK	PA165291471	5599	0.985
NULL	Eur_J_Neurosci_2014_Feb_4_39(3)_363-374.nxml.txt.nlp	24494677	SENT103	2	2	14	14	capsaicin	TRPV1	PA448776	7442	0.985
NULL	JAKSTAT_2013_Jul_1_2(3)_e24574.nxml.txt.nlp	24069558	SENT226	14	14	1	1	doxycycline	JAK2	PA449415	3717	0.985
NULL	Oxid_Med_Cell_Longev_2013_Jul_24_2013_825928.nxml.txt.nlp	23983900	SENT77	21	21	29	29	curcumin	SIRT1	PA151958596	23411	0.985
NULL	Br_J_Cancer_2010_Nov_2_103(11)_1680-1691.nxml.txt.nlp	21045833	SENT250	27	27	4	4	vorinostat	BAX	PA164748224	581	0.985
NULL	Trials_2013_May_4_14_125.nxml.txt.nlp	23782591	SENT39	3	3	20	20	paroxetine	CYP2D6	PA450801	1565	0.985
NULL	Front_Physiol_2010_Nov_2_1_145.nxml.txt.nlp	21423385	SENT49	19	19	17	17	celecoxib	COX2	PA448871	4513;5743	0.985
NULL	Cell_Death_Dis_2012_Mar_15_3(3)_e285.nxml.txt.nlp	22419114	SENT48	17	17	29	29	cisplatin	MLH1	PA449014	4292	0.985
NULL	Core_Evid_2007_Nov_30_2(2)_81-88.nxml.txt.nlp	21221177	SENT203	0	0	13	13	panitumumab	EGFR	PA162373091	1956	0.985
NULL	Arthritis_Res_Ther_2005_Feb_17_7(Suppl_1)_P81.nxml.txt.nlp	NULL	SENT5	30	30	0	0	infliximab	OPG	PA452639	690	0.985
NULL	Ann_Oncol_2011_Aug_27_22(8)_1736-1747.nxml.txt.nlp	21709140	SENT205	1	1	13	13	tamoxifen	aromatase	PA451581	1588	0.985
NULL	JAKSTAT_2013_Jan_1_2(1)_e22925.nxml.txt.nlp	24058789	SENT125	7	7	19	19	carbachol	JAK2	PA448784	3717	0.985
NULL	Open_Access_J_Urol_2011_May_10_3_69-82.nxml.txt.nlp	24198638	SENT69	14	14	28	28	sorafenib	CYP3A4	PA7000	1576	0.985
NULL	Dis_Markers_2010_Jun_29_28(5)_307-313.nxml.txt.nlp	20592455	SENT13	26	26	8	8	atorvastatin	ABCG8	PA448500	64241	0.985
NULL	Pharmaceuticals_(Basel)_2013_Apr_8_6(4)_500-509.nxml.txt.nlp	24276120	SENT39	7	7	38	38	fenoldopam	GPR35	PA164784034	2859	0.985
NULL	Chin_J_Cancer_2012_Feb_31(2)_58-72.nxml.txt.nlp	22098952	SENT251	22	22	2	2	paclitaxel	MRP7	PA450761	89845;1080	0.985
NULL	Mol_Cancer_2010_May_20_9_115.nxml.txt.nlp	20487546	SENT242	35	35	2	2	fludarabine	CASP2	PA449655	835	0.985
NULL	Drug_Des_Devel_Ther_2014_Dec_1_8_2391-2400.nxml.txt.nlp	25489237	SENT171	17	17	25	25	liraglutide	GLP-1	PA165958364	100125288	0.985
NULL	Mol_Cancer_2010_Jun_25_9_166.nxml.txt.nlp	20579378	SENT31	14	14	10	10	gefitinib	EGFR	PA131301952	1956	0.985
NULL	Clin_Sarcoma_Res_2014_Aug_10_4_10.nxml.txt.nlp	25132955	SENT34	0	0	8	8	imatinib	KIT	PA10804	3815	0.985
NULL	Breast_Cancer_Res_2008_Mar_29_10(2)_R28.nxml.txt.nlp	18373870	SENT154	18	18	2	2	estradiol	MYC	PA449503	4609	0.985
NULL	J_Anaesthesiol_Clin_Pharmacol_2011_Oct-Dec_27(4)_447-458.nxml.txt.nlp	22096275	SENT210	3	3	32	32	propofol	gamma	PA451141	9913	0.985
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_105-115.nxml.txt.nlp	17912640	SENT4	0	0	28	28	letrozole	aromatase	PA450196	1588	0.985
NULL	Br_J_Cancer_2012_Jun_26_107(1)_129-136.nxml.txt.nlp	22644295	SENT197	23	23	6	6	ethanol	TAK1	PA448073	7182	0.985
NULL	Oncotarget_2012_Nov_8_3(11)_1472-1482.nxml.txt.nlp	23178531	SENT6	1	1	45	45	iron	HIF1	PA450087	3091	0.985
NULL	Oxid_Med_Cell_Longev_2013_Jun_2_2013_793525.nxml.txt.nlp	23819014	SENT247	18	18	3	3	resveratrol	SIRT1		23411	0.985
NULL	J_Hematol_Oncol_2008_Aug_11_1_11.nxml.txt.nlp	18694493	SENT141	0	0	11	11	bevacizumab	IL-2	PA130232992	3558	0.985
NULL	Oncotarget_2014_Oct_15_5(21)_10763-10777.nxml.txt.nlp	25333257	SENT68	16	16	5	5	sn-38	P-gp		5243	0.985
NULL	Clin_Med_Pathol_2008_Mar_1_1_17-34.nxml.txt.nlp	21876648	SENT19	2	2	8	8	tamoxifen	aromatase	PA451581	1588	0.985
NULL	Environ_Health_Perspect_2005_Jan_30_113(1)_17-24.nxml.txt.nlp	15626642	SENT162	0	0	31	31	quinidine	P-gp	PA451209	5243	0.985
NULL	J_Young_Pharm_2010_Jan-Mar_2(1)_21-26.nxml.txt.nlp	21331186	SENT21	0	0	10	10	aceclofenac	BCS	PA166049185	617	0.985
NULL	Breast_Cancer_Res_2004_Oct_24_6(2)_65-68.nxml.txt.nlp	14979908	SENT31	10	10	43	43	heparin	EGFR	PA449855	1956	0.985
NULL	Vet_Res_Forum_2013_Winter_4(1)_19-24.nxml.txt.nlp	25593681	SENT11	24	24	6	6	diclofenac	B12	PA449293	7126;4709	0.985
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT199	9	9	17	17	dronedarone	NAPA	PA153619853	9476;8775	0.985
NULL	Front_Oncol_2013_Apr_2_3_64.nxml.txt.nlp	23565502	SENT83	7	7	28	28	nutlin-3	p53		7157	0.985
NULL	J_Cell_Biol_2005_Nov_21_171(4)_729-738.nxml.txt.nlp	16286510	SENT170	35	35	11	11	heparin	MMP7	PA449855	4316	0.985
NULL	Bioimpacts_2014_Sep_21_4(3)_113-116.nxml.txt.nlp	25337463	SENT11	16	16	2	2	lipase	MCU	PA450239	90550	0.985
NULL	Breast_Cancer_Res_2012_Apr_4_14(2)_R57.nxml.txt.nlp	22475046	SENT127	19	19	9	9	tamoxifen	CCND1	PA451581	595	0.985
NULL	Acta_Pharmacol_Sin_2009_Sep_24_30(9)_1323-1329.nxml.txt.nlp	19701237	SENT148	37	37	20	20	clarithromycin	CYP3A	PA449028	1574	0.985
NULL	J_Antimicrob_Chemother_2009_Nov_18_64(5)_910-928.nxml.txt.nlp	19767318	SENT225	36	36	19	19	efavirenz	CYP3A4	PA449441	1576	0.985
NULL	Braz_J_Med_Biol_Res_2013_Jun_25_46(6)_528-532.nxml.txt.nlp	23802228	SENT35	33	33	15	15	metformin	PON1	PA450395	5444	0.985
NULL	Int_J_Gen_Med_2013_Dec_4_6_877-895.nxml.txt.nlp	24403842	SENT63	0	0	7	7	liraglutide	GLP-1	PA165958364	100125288	0.985
NULL	Front_Genet_2013_Aug_30_4_166.nxml.txt.nlp	24009623	SENT234	26	26	10	10	everolimus	NDUFAF2	PA164746311	91942	0.985
NULL	Breast_Cancer_Res_2009_Mar_19_11(2)_204.nxml.txt.nlp	19344489	SENT218	12	12	25	25	docetaxel	HER2	PA449383	2064	0.985
NULL	Drugs_R_D_2013_Jun_25_13(2)_119-128.nxml.txt.nlp	23615868	SENT177	0	0	7	7	guanfacine	CYP3A4	PA449825	1576	0.985
NULL	Chromatographia_2009_Jun_26_69(Suppl_2)_167-173.nxml.txt.nlp	19554204	SENT133	15	15	25	25	hesperetin	MS2	PA164742902	101	0.985
NULL	Int_J_Mol_Sci_2013_Aug_14_14(8)_16719-16731.nxml.txt.nlp	23949634	SENT68	12	12	22	22	thrombin	PAR-1	PA451674	2011;2149	0.985
NULL	Indian_J_Endocrinol_Metab_2012_Mar-Apr_16(2)_252-257.nxml.txt.nlp	22470863	SENT75	0	0	4	4	fenoldopam	DA1	PA164784034	28495;7169	0.985
NULL	Breast_Cancer_Res_2010_Oct_22_12(Suppl_2)_S2.nxml.txt.nlp	21050423	SENT108	25	25	4	4	cyclophosphamide	p53	PA449165	7157	0.985
NULL	Ther_Clin_Risk_Manag_2007_Mar_3(1)_133-148.nxml.txt.nlp	18360621	SENT119	18	18	1	1	adalimumab	ACR	PA10004	49	0.985
NULL	Cell_J_2014_May_25_Summer_16(2)_163-170.nxml.txt.nlp	24567946	SENT14	27	27	40	40	naloxone	CA1	PA450586	759	0.985
NULL	Acta_Pharmacol_Sin_2010_Oct_13_31(10)_1350-1358.nxml.txt.nlp	20835264	SENT15	0	0	25	25	simvastatin	gamma	PA451363	9913	0.985
NULL	Adolesc_Health_Med_Ther_2013_Aug_27_4_79-87.nxml.txt.nlp	24600298	SENT61	1	1	18	18	raltegravir	UGT1A1		54658	0.985
NULL	Int_J_Breast_Cancer_2012_Oct_25_2012_829315.nxml.txt.nlp	22295252	SENT79	8	8	19	19	olaparib	BRCA2		675	0.985
NULL	Cancer_Imaging_2010_Jul_6_10(1)_144-152.nxml.txt.nlp	20605761	SENT80	0	0	8	8	lapatinib	HER2	PA152241907	2064	0.985
NULL	Int_J_Mol_Sci_2012_Sep_25_13(10)_12153-12168.nxml.txt.nlp	23202889	SENT434	8	8	0	0	cetuximab	KRAS	PA10040	3845	0.985
NULL	Core_Evid_2013_May_16_8_37-45.nxml.txt.nlp	23717217	SENT218	10	10	1	1	rituximab	BTK	PA451261	695	0.985
NULL	Pharmaceuticals_(Basel)_2013_May_23_6(6)_689-699.nxml.txt.nlp	24276256	SENT106	0	0	27	27	nicardipine	PTB	PA450620	58155	0.985
NULL	Oncotarget_2014_Feb_7_5(3)_775-787.nxml.txt.nlp	24519956	SENT219	40	40	0	0	dasatinib	PC3	PA162372878	57332;7832;5122	0.985
NULL	Breast_Cancer_Res_2012_Mar_20_14(2)_R53.nxml.txt.nlp	22433433	SENT222	16	16	0	0	doxorubicin	CCNE1	PA449412	898	0.985
NULL	Breast_Cancer_Res_2013_Oct_18_15(5)_R97.nxml.txt.nlp	24135425	SENT20	6	6	34	34	tamoxifen	DM1	PA451581	338023;1760;28509	0.985
NULL	Br_J_Cancer_2013_Jan_15_108(1)_82-90.nxml.txt.nlp	23321512	SENT212	27	27	10	10	paclitaxel	TUBB3	PA450761	10381	0.985
NULL	Arch_Med_Sci_2013_Oct_31_9(5)_916-921.nxml.txt.nlp	24273579	SENT146	24	24	14	14	bleomycin	AQP5	PA448645	362	0.985
NULL	Breast_Cancer_Res_2008_Jul_15_10(4)_R58.nxml.txt.nlp	18627608	SENT209	18	18	3	3	paclitaxel	ISG15	PA450761	9636	0.985
NULL	Arthritis_Res_Ther_2009_Aug_17_11(4)_R123.nxml.txt.nlp	19686595	SENT204	32	32	3	3	rituximab	CD27	PA451261	939	0.985
NULL	Clinics_(Sao_Paulo)_2013_May_68(5)_694-701.nxml.txt.nlp	23778405	SENT176	18	18	9	9	curcumin	MDR1	PA151958596	5243	0.985
NULL	Cancer_Cell_Int_2009_Sep_10_9_25.nxml.txt.nlp	19744341	SENT151	16	16	27	27	glucosamine	STAT3	PA164747613	6774	0.985
NULL	Oxid_Med_Cell_Longev_2013_Jul_14_2013_593761.nxml.txt.nlp	23936611	SENT148	0	0	15	15	resveratrol	PON1		5444	0.985
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1224-1233.nxml.txt.nlp	22353810	SENT191	11	11	29	29	doxorubicin	MRP-1	PA449412	928	0.985
NULL	Diabetes_Care_2013_Aug_17_36(Suppl_2)_S139-S144.nxml.txt.nlp	23882038	SENT88	9	9	22	22	exenatide	GLP-1	PA164749238	100125288	0.985
NULL	Oncotarget_2012_Sep_21_3(9)_909-910.nxml.txt.nlp	23006984	SENT18	12	12	36	36	fasudil	ROCK1	PA165946121	6093	0.985
NULL	Inflammation_2014_Sep_5_37(1)_1-9.nxml.txt.nlp	24005897	SENT130	2	2	27	27	diclofenac	COX	PA449293	1351	0.985
NULL	Breast_Cancer_Res_2007_Jan_23_9(1)_R7.nxml.txt.nlp	17244352	SENT148	38	38	1	1	tamoxifen	SULT1A1	PA451581	6817	0.985
NULL	J_Gerontol_A_Biol_Sci_Med_Sci_2014_Jun_8_69(Suppl_1)_S21-S27.nxml.txt.nlp	24833582	SENT77	11	11	32	32	resveratrol	AMPK		5563	0.985
NULL	Breast_Cancer_(Auckl)_2011_Jan_13_5_1-14.nxml.txt.nlp	21494397	SENT48	27	27	5	5	ritonavir	CYP3A4	PA451260	1576	0.985
NULL	Iran_J_Pharm_Res_2013_Winter_12(1)_223-227.nxml.txt.nlp	24250593	SENT107	15	15	40	40	rifampin	solo	PA451250	55701	0.985
NULL	J_Biomed_Biotechnol_2010_Oct_4_2010_641025.nxml.txt.nlp	20976270	SENT8	0	0	33	33	thrombin	VIII	PA451674	1351	0.985
NULL	Oncotarget_2014_Jan_11_5(3)_693-703.nxml.txt.nlp	24525337	SENT167	33	33	12	12	resveratrol	p53		7157	0.985
NULL	Infect_Dis_Ther_2013_Dec_2_2(2)_123-144.nxml.txt.nlp	25134476	SENT267	21	21	0	0	amiodarone	DIP	PA448383	23151;1831	0.985
NULL	Front_Pharmacol_2014_Nov_26_5_258.nxml.txt.nlp	25505415	SENT110	32	32	30	30	ketoconazole	CYP3A	PA450146	1574	0.985
NULL	Mol_Cancer_2009_Mar_5_8_14.nxml.txt.nlp	19265551	SENT80	4	4	38	38	camptothecin	p53	PA153590860	7157	0.985
NULL	Breast_Cancer_Res_2012_May_2_14(3)_R70.nxml.txt.nlp	22551440	SENT260	37	37	23	23	docetaxel	p53	PA449383	7157	0.985
NULL	Exp_Ther_Med_2015_Feb_3_9(2)_377-383.nxml.txt.nlp	25574201	SENT89	4	4	15	15	curcumin	TSP-1	PA151958596	7057	0.985
NULL	Indian_J_Anaesth_2014_Jan-Feb_58(1)_66-68.nxml.txt.nlp	24700904	SENT84	29	29	5	5	tramadol	flower	PA451735	11094	0.985
NULL	Gut_2013_Apr_14_62(4)_540-549.nxml.txt.nlp	22798500	SENT207	8	8	29	29	cetuximab	KRAS	PA10040	3845	0.985
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT100	8	8	2	2	tenofovir	ABCC4	PA10204	10257	0.985
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT784	32	32	5	5	fexofenadine	OATP1A2	PA449621	6579	0.985
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT72	4	4	15	15	resveratrol	TRAIL		8743	0.985
NULL	Environ_Health_Perspect_2008_Apr_16_116(4)_426-433.nxml.txt.nlp	18414622	SENT169	0	0	15	15	resveratrol	AP-1		2353;3727;2354;3725	0.985
NULL	Oncotarget_2011_Sep_9_2(9)_658-668.nxml.txt.nlp	21911919	SENT84	7	7	27	27	cytarabine	HO-1	PA449177	3162	0.985
NULL	Arthritis_Res_Ther_2013_Oct_1_15(5)_R140.nxml.txt.nlp	24286543	SENT30	23	23	12	12	methotrexate	ACPA	PA450428	5657	0.985
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT163	14	14	1	1	doxorubicin	ABCB1	PA449412	5243	0.985
NULL	Int_J_Mol_Sci_2014_Nov_21_15(11)_21505-21537.nxml.txt.nlp	25421245	SENT95	0	0	4	4	rimonabant	CB1	PA152407999	1268	0.985
NULL	Scientifica_(Cairo)_2013_Dec_12_2013_635203.nxml.txt.nlp	24416617	SENT407	18	18	43	43	vemurafenib	BRAF	PA165946873	673	0.985
NULL	Oncogene_2013_Sep_26_32(39)_10_1038_onc_2012_491.nxml.txt.nlp	23108394	SENT103	27	27	12	12	epirubicin	BRIP1	PA449476	64979;83990	0.985
NULL	EMBO_Mol_Med_2011_Aug_3(8)_451-464.nxml.txt.nlp	21656687	SENT18	23	23	3	3	trypsin	SPINK1	PA451806	6690	0.985
NULL	Mol_Cancer_2013_Mar_5_12_17.nxml.txt.nlp	23497256	SENT179	23	23	3	3	sunitinib	HDM2	PA162372840	4193	0.985
NULL	Oncotarget_2011_Apr_20_2(4)_274-276.nxml.txt.nlp	21512204	SENT17	18	18	10	10	nutlin-3	p53		7157	0.985
NULL	Br_J_Cancer_2010_Feb_16_102(4)_658-664.nxml.txt.nlp	20104222	SENT159	7	7	16	16	sunitinib	IFN	PA162372840	3439	0.985
NULL	J_Cell_Biol_2001_Aug_6_154(3)_659-666.nxml.txt.nlp	11489922	SENT177	4	4	14	14	warfarin	MGP	PA451906	4256	0.985
NULL	Front_Neurosci_2014_Dec_5_8_398.nxml.txt.nlp	25538552	SENT114	14	14	33	33	physostigmine	CA3	PA450957	761	0.985
NULL	Diabetes_Care_2010_Aug_27_33(8)_1734-1737.nxml.txt.nlp	20424219	SENT64	9	9	20	20	exenatide	IL-6	PA164749238	3569	0.985
NULL	Diabetes_2009_Feb_58(2)_329-336.nxml.txt.nlp	19171749	SENT128	5	5	42	42	imatinib	JNK	PA10804	5599	0.985
NULL	Biologics_2012_Jun_20_6_147-154.nxml.txt.nlp	22807625	SENT44	24	24	6	6	gefitinib	EGFR	PA131301952	1956	0.985
NULL	J_Vis_Exp_2014_Jun_28_(88)_51278.nxml.txt.nlp	24998179	SENT255	0	0	24	24	verapamil	P-gp	PA451868	5243	0.985
NULL	Neuroscience_2009_Jun_30_161(2-3)_572-577.nxml.txt.nlp	19327387	SENT29	24	24	6	6	capsaicin	NAPE-PLD	PA448776	222236	0.985
NULL	Ann_Rheum_Dis_2009_Oct_17_68(10)_1580-1584.nxml.txt.nlp	19019888	SENT20	36	36	13	13	tocilizumab	IL-6	PA165292659	3569	0.985
NULL	Biologics_2013_Dec_16_8_13-25.nxml.txt.nlp	24368879	SENT79	0	0	10	10	bevacizumab	VEGF-A	PA130232992	7422	0.985
NULL	Autophagy_2013_May_1_9(5)_789-790.nxml.txt.nlp	23388383	SENT23	7	7	21	21	docetaxel	VEGFC	PA449383	7424	0.985
NULL	Leukemia_2014_Mar_13_28(3)_629-641.nxml.txt.nlp	24263804	SENT170	32	32	9	9	flavopiridol	CDK8	PA452627	1024	0.985
NULL	Contemp_Clin_Dent_2013_Jan-Mar_4(1)_1.nxml.txt.nlp	23853443	SENT12	12	12	25	25	vemurafenib	BRAF	PA165946873	673	0.985
NULL	Mol_Cancer_2008_Mar_26_7_27.nxml.txt.nlp	18366759	SENT258	6	6	29	29	etoposide	p53	PA449552	7157	0.985
NULL	Oncotarget_2013_Dec_11_4(12)_2208-2211.nxml.txt.nlp	24368541	SENT69	19	19	5	5	vismodegib	GLI1		2735	0.985
NULL	Tuberc_Respir_Dis_(Seoul)_2012_Apr_30_72(4)_343-351.nxml.txt.nlp	23227075	SENT118	26	26	11	11	temsirolimus	LC3	PA164746890	84557	0.985
NULL	Nucleic_Acids_Res_2012_Jul_30_40(13)_6319-6337.nxml.txt.nlp	22467215	SENT22	0	0	33	33	trastuzumab	HER2	PA451743	2064	0.985
NULL	Diabetes_2011_Jan_4_60(1)_119-126.nxml.txt.nlp	20921208	SENT242	10	10	20	20	forskolin	TRPM2	PA146096022	7226	0.985
NULL	Cancer_Manag_Res_2013_Jun_7_5_91-101.nxml.txt.nlp	23785245	SENT14	21	21	35	35	erlotinib	EGFR	PA134687924	1956	0.985
NULL	Acta_Vet_Scand_2013_Jun_3_55(1)_44.nxml.txt.nlp	23731650	SENT179	5	5	13	13	ampicillin	NOT	PA448419	4929	0.985
NULL	Pharmaceuticals_(Basel)_2013_Aug_21_6(8)_988-1038.nxml.txt.nlp	24276379	SENT291	16	16	12	12	cetuximab	EGFR	PA10040	1956	0.985
NULL	Contemp_Oncol_(Pozn)_2012_Jan_4_16(6)_582-585.nxml.txt.nlp	23788948	SENT17	0	0	15	15	lapatinib	HER-2	PA152241907	2064	0.985
NULL	J_Biol_Chem_2012_Aug_10_287(33)_28169-28179.nxml.txt.nlp	22584573	SENT156	19	19	12	12	rosiglitazone	aP2	PA451283	2167	0.985
NULL	Breast_Cancer_(Auckl)_2011_Jan_13_5_1-14.nxml.txt.nlp	21494397	SENT48	33	33	5	5	nelfinavir	CYP3A4	PA450606	1576	0.985
NULL	Ther_Clin_Risk_Manag_2007_Jun_3(2)_245-258.nxml.txt.nlp	18360633	SENT60	6	6	14	14	etanercept	TNF-alpha	PA449515	7124	0.985
NULL	Front_Neurosci_2012_Dec_13_6_180.nxml.txt.nlp	23248581	SENT166	3	3	16	16	paroxetine	GRK2	PA450801	156	0.985
NULL	Patient_Prefer_Adherence_2014_Apr_15_8_473-475.nxml.txt.nlp	24790414	SENT16	2	2	25	25	metformin	FDC	PA450395	1218	0.985
NULL	Oncotarget_2014_Oct_18_5(22)_11604-11619.nxml.txt.nlp	25344099	SENT181	33	33	22	22	cisplatin	RYBP	PA449014	23429	0.985
NULL	Arch_Immunol_Ther_Exp_(Warsz)_2014_Jun_11_62(6)_475-482.nxml.txt.nlp	24917428	SENT45	10	10	18	18	thrombin	CD44	PA451674	960	0.985
NULL	J_Cancer_2013_Nov_23_4(9)_736-754.nxml.txt.nlp	24312144	SENT93	15	15	23	23	afatinib	EGFR	PA165981154	1956	0.985
NULL	Ann_Rheum_Dis_2015_Jan_28_74(1)_35-43.nxml.txt.nlp	25169728	SENT205	25	25	42	42	methotrexate	IL-6	PA450428	3569	0.985
NULL	J_Cancer_2014_Jan_5_5(2)_86-97.nxml.txt.nlp	24494026	SENT116	0	0	27	27	panitumumab	KRAS	PA162373091	3845	0.985
NULL	Acta_Pharmacol_Sin_2012_May_16_33(5)_682-690.nxml.txt.nlp	22504904	SENT11	23	23	10	10	celecoxib	Mcl-1	PA448871	4170	0.985
NULL	J_Gen_Physiol_2012_Nov_140(5)_541-555.nxml.txt.nlp	23109716	SENT20	8	8	0	0	capsaicin	TRPV1	PA448776	7442	0.985
NULL	Cancers_(Basel)_2010_Feb_23_2(1)_88-113.nxml.txt.nlp	24281034	SENT193	0	0	20	20	olaparib	PARP1		142	0.985
NULL	Front_Neurol_2014_Aug_28_5_161.nxml.txt.nlp	25221540	SENT185	33	33	11	11	estradiol	CB1	PA449503	1268	0.985
NULL	Cancer_Med_2014_Dec_1_3(6)_1493-1501.nxml.txt.nlp	25081631	SENT202	19	19	7	7	erlotinib	EGFR	PA134687924	1956	0.985
NULL	Nucleic_Acids_Res_2005_Dec_9_33(22)_6972-6981.nxml.txt.nlp	16340007	SENT137	11	11	7	7	bleomycin	DNA-PKcs	PA448645	5591	0.985
NULL	Biologics_2010_May_25_4_83-90.nxml.txt.nlp	20531966	SENT89	10	10	0	0	gefitinib	EGFR	PA131301952	1956	0.985
NULL	Breast_Cancer_Res_2010_Nov_16_12(6)_R96.nxml.txt.nlp	21080941	SENT235	2	2	7	7	lapatinib	HER2	PA152241907	2064	0.985
NULL	Nat_Neurosci_2012_Sep_5_15(9)_1245-1254.nxml.txt.nlp	22864611	SENT52	22	22	10	10	clozapine	mGlu2	PA449061	2912	0.985
NULL	Braz_J_Med_Biol_Res_2013_Aug_13_46(8)_650-658.nxml.txt.nlp	23969971	SENT156	12	12	2	2	cisplatin	STAT3	PA449014	6774	0.985
NULL	CNS_Neurosci_Ther_2010_Jun_16(3)_e1-e17.nxml.txt.nlp	20406250	SENT207	41	41	8	8	olanzapine	5-HT2A	PA450688	3356	0.985
NULL	Clin_Genet_2014_Feb_9_86(1)_1-11.nxml.txt.nlp	24665880	SENT148	5	5	19	19	ranibizumab	VEGFR	PA164746012	3791	0.985
NULL	Br_J_Pharmacol_2014_Jun_15_171(11)_2705-2725.nxml.txt.nlp	24467436	SENT49	2	2	35	35	hydralazine	C4B	PA449894	720;721	0.985
NULL	J_Immune_Based_Ther_Vaccines_2005_Sep_2_3_6.nxml.txt.nlp	16138929	SENT184	0	0	16	16	efalizumab	LFA-1	PA164748817	3683;3689	0.985
NULL	Breast_Cancer_Res_2010_Jul_1_12(4)_R45.nxml.txt.nlp	20594311	SENT196	0	0	14	14	nelfinavir	AKT	PA450606	207	0.985
NULL	Cancer_Cell_Int_2009_Feb_17_9_4.nxml.txt.nlp	19222856	SENT195	44	44	3	3	cisplatin	p53	PA449014	7157	0.985
NULL	Biosci_Rep_2012_Dec_1_32(Pt_6)_559-566.nxml.txt.nlp	NULL	SENT24	11	11	30	30	colchicine	P-gp	PA449092	5243	0.985
NULL	Front_Microbiol_2014_Sep_11_5_477.nxml.txt.nlp	25309517	SENT207	0	0	28	28	daclizumab	IFN	PA164764446	3439	0.985
NULL	Breast_Cancer_Res_2011_Jan_21_13(1)_R9.nxml.txt.nlp	21255398	SENT214	35	35	5	5	etoposide	RAD21	PA449552	5885	0.985
NULL	Cell_Death_Dis_2012_Mar_15_3(3)_e283.nxml.txt.nlp	22419112	SENT45	24	24	6	6	etoposide	p33ING1	PA449552	3621	0.985
NULL	Biologics_2013_Feb_28_7_39-46.nxml.txt.nlp	23467578	SENT43	38	38	32	32	sorafenib	IL-2	PA7000	3558	0.985
NULL	Br_J_Cancer_2012_Nov_6_107(10)_1793-1794.nxml.txt.nlp	NULL	SENT11	6	6	20	20	cetuximab	KRAS	PA10040	3845	0.985
NULL	Clin_Med_Insights_Oncol_2011_Sep_21_5_265-314.nxml.txt.nlp	22084619	SENT457	0	0	26	26	gefitinib	EGFR	PA131301952	1956	0.985
NULL	Indian_J_Endocrinol_Metab_2013_Jul-Aug_17(4)_636-646.nxml.txt.nlp	23961479	SENT155	1	1	17	17	fluvastatin	CYP2C9	PA449688	1559	0.985
NULL	Case_Rep_Med_2014_Jul_8_2014_612496.nxml.txt.nlp	25104960	SENT39	10	10	19	19	everolimus	aromatase	PA164746311	1588	0.985
NULL	Mol_Cancer_2008_Mar_26_7_27.nxml.txt.nlp	18366759	SENT40	0	0	20	20	etoposide	p53	PA449552	7157	0.985
NULL	Indian_J_Pharmacol_2008_Oct_40(Suppl_2)_S91-S97.nxml.txt.nlp	21593983	SENT161	3	3	14	14	pioglitazone	CYP3A	PA450970	1574	0.985
NULL	J_Mol_Signal_2011_Aug_12_6_9.nxml.txt.nlp	21838893	SENT181	3	3	19	19	formoterol	SSTR5	PA134687907	6755	0.985
NULL	Indian_J_Pharmacol_2013_Jan-Feb_45(1)_49-53.nxml.txt.nlp	23543858	SENT137	0	0	4	4	buspirone	5-HT1A	PA448689	3350	0.985
NULL	Br_J_Cancer_2011_Oct_25_105(9)_1362-1369.nxml.txt.nlp	21952621	SENT182	21	21	2	2	cisplatin	FGFR1	PA449014	2260	0.985
NULL	Br_J_Cancer_2004_Mar_5_90(Suppl_1)_S15-S18.nxml.txt.nlp	15094760	SENT33	8	8	17	17	fulvestrant	aromatase	PA164747170	1588	0.985
NULL	Behav_Brain_Funct_2014_Mar_11_10_6.nxml.txt.nlp	24618126	SENT233	0	0	5	5	meloxicam	COX2	PA450353	4513;5743	0.985
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT119	17	17	3	3	nutlin-3	MDM2		4193	0.985
NULL	Appl_Microbiol_Biotechnol_2014_Apr_25_98(14)_6365-6373.nxml.txt.nlp	24764015	SENT52	4	4	19	19	chloramphenicol	ARM	PA448927	80210	0.985
NULL	Cell_Death_Dis_2012_Mar_15_3(3)_e286.nxml.txt.nlp	22419115	SENT195	41	41	30	30	cisplatin	p53	PA449014	7157	0.985
NULL	Front_Pharmacol_2014_Mar_20_5_44.nxml.txt.nlp	24688470	SENT46	25	25	6	6	ethanol	5-HT1B	PA448073	3351	0.985
NULL	Br_J_Cancer_2010_Oct_12_103(8)_1309-1310.nxml.txt.nlp	NULL	SENT29	10	10	19	19	sunitinib	IFN	PA162372840	3439	0.985
NULL	Mol_Biol_Cell_2014_Jun_1_25(11)_1793-1807.nxml.txt.nlp	24694595	SENT352	41	41	1	1	benzbromarone	ANO1	PA134852920	55107	0.985
NULL	J_Int_Soc_Sports_Nutr_2009_Aug_5_6_16.nxml.txt.nlp	19656392	SENT281	0	0	17	17	creatine	p38	PA164778930	10598;1432;7965	0.985
NULL	Pharmaceuticals_(Basel)_2013_Apr_8_6(4)_500-509.nxml.txt.nlp	24276120	SENT101	5	5	8	8	benserazide	GPR35		2859	0.985
NULL	Food_Addit_Contam_Part_A_Chem_Anal_Control_Expo_Risk_Assess_2014_Oct_3_31(10)_176916-1782.nxml.txt.nlp	25105506	SENT109	11	11	26	26	ethanol	AF4	PA448073	4299	0.985
NULL	Basic_Clin_Pharmacol_Toxicol_2014_Dec_22_115(6)_552-559.nxml.txt.nlp	24766668	SENT216	33	33	15	15	bupropion	CYP2D6	PA448687	1565	0.985
NULL	Bioinformation_2011_Mar_26_6(2)_74-77.nxml.txt.nlp	21544169	SENT18	6	6	26	26	chloroquine	DHFR	PA448948	1719	0.985
NULL	Arch_Med_Sci_2010_Mar_1_6(1)_19-23.nxml.txt.nlp	22371715	SENT115	0	0	7	7	infliximab	TNF	PA452639	7124	0.985
NULL	Oncotarget_2011_Jun_15_2(6)_518-524.nxml.txt.nlp	21680956	SENT137	2	2	24	24	pimozide	BRAF	PA450965	673	0.985
NULL	J_Exp_Clin_Cancer_Res_2009_Jun_6_28(1)_76.nxml.txt.nlp	19500405	SENT240	6	6	15	15	gemcitabine	p53	PA449748	7157	0.985
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Sep_24_3(9)_e137.nxml.txt.nlp	25250527	SENT62	9	9	30	30	clopidogrel	COX	PA449053	1351	0.985
NULL	Exp_Ther_Med_2013_Nov_13_6(5)_1317-1321.nxml.txt.nlp	24223665	SENT105	3	3	12	12	cisplatin	CD133	PA449014	8842	0.985
NULL	Indian_J_Pharmacol_2013_Sep-Oct_45(5)_458-463.nxml.txt.nlp	24130379	SENT36	17	17	7	7	carvedilol	TLR4	PA448817	7099	0.985
NULL	Leukemia_2013_Feb_10_27(2)_507-510.nxml.txt.nlp	22810506	SENT21	32	32	0	0	pentostatin	TRAC	PA450863	28755	0.985
NULL	Indian_J_Anaesth_2013_Jan-Feb_57(1)_41-45.nxml.txt.nlp	23716765	SENT120	29	29	2	2	granisetron	HERG	PA449809	3757	0.985
NULL	Br_J_Pharmacol_2014_Jun_15_171(11)_2705-2725.nxml.txt.nlp	24467436	SENT82	6	6	18	18	hydralazine	NAT1	PA449894	9;1982	0.985
NULL	BMB_Rep_2013_Mar_46(3)_157-162.nxml.txt.nlp	23527859	SENT110	17	17	1	1	galactose	mol	PA449725	90527	0.985
NULL	Curr_Neuropharmacol_2010_Jun_8(2)_122-127.nxml.txt.nlp	21119883	SENT46	26	26	0	0	capsaicin	AQP1	PA448776	358	0.985
NULL	Br_J_Cancer_2010_Mar_16_102(6)_1003-1009.nxml.txt.nlp	20179710	SENT139	16	16	0	0	doxorubicin	SLC22A16	PA449412	85413	0.985
NULL	Acta_Pharmacol_Sin_2010_Sep_16_31(9)_1085-1094.nxml.txt.nlp	20711226	SENT139	2	2	18	18	carvedilol	HIF-1	PA448817	29072	0.985
NULL	Br_J_Cancer_2010_Mar_16_102(6)_995-1002.nxml.txt.nlp	20179708	SENT22	33	33	17	17	trastuzumab	HER2	PA451743	2064	0.985
NULL	Int_J_Womens_Health_2012_Oct_10_4_543-549.nxml.txt.nlp	23091400	SENT34	4	4	18	18	resveratrol	aromatase		1588	0.985
NULL	Eur_Heart_J_2014_Jun_14_35(23)_1510-1514.nxml.txt.nlp	24748565	SENT74	0	0	14	14	cangrelor	P2Y12	PA165945763	64805	0.985
NULL	Eur_J_Clin_Pharmacol_2012_Jan_8_68(1)_29-37.nxml.txt.nlp	21739267	SENT17	0	0	32	32	aripiprazole	5-HT2A	PA10026	3356	0.985
NULL	Acta_Pharmacol_Sin_2011_May_18_32(5)_591-600.nxml.txt.nlp	21499286	SENT204	5	5	33	33	bezafibrate	AMPK	PA162364313	5563	0.985
NULL	Nat_Med_2014_Jun_11_20(6)_599-606.nxml.txt.nlp	24813251	SENT54	13	13	38	38	doxorubicin	ABL1	PA449412	25	0.985
NULL	J_Cell_Biol_2001_Feb_19_152(4)_683-692.nxml.txt.nlp	11266460	SENT151	36	36	23	23	trypsin	DHFR	PA451806	1719	0.985
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Jan_18_70(Pt_2)_o169-o170.nxml.txt.nlp	24764886	SENT78	15	15	34	34	l-phenylalanine	mol	PA450931	90527	0.985
NULL	Breast_Cancer_Res_2013_Nov_29_15(6)_R114.nxml.txt.nlp	24289103	SENT342	16	16	5	5	tamoxifen	EGFR	PA451581	1956	0.985
NULL	Indian_J_Psychiatry_2011_Oct-Dec_53(4)_370-371.nxml.txt.nlp	22303049	SENT39	0	0	10	10	olanzapine	B12	PA450688	7126;4709	0.985
NULL	Environ_Health_Perspect_2006_Aug_30_114(8)_1237-1242.nxml.txt.nlp	16882532	SENT54	31	31	7	7	ethanol	ALDH2	PA448073	217	0.985
NULL	Open_Access_J_Urol_2010_Mar_12_2_35-40.nxml.txt.nlp	24198612	SENT4	5	5	9	9	pazopanib	VEGFR	PA165291492	3791	0.985
NULL	Oncotarget_2011_Nov_9_2(11)_850-861.nxml.txt.nlp	22081665	SENT196	25	25	15	15	idarubicin	DNMT3A	PA449961	1788	0.985
NULL	Oncotarget_2011_Oct_17_2(10)_797-809.nxml.txt.nlp	22006582	SENT146	8	8	16	16	propranolol	ABCB1	PA451145	5243	0.985
NULL	BMJ_2011_Aug_4_343_d4588.nxml.txt.nlp	21816733	SENT23	46	46	10	10	clopidogrel	CYP2C19	PA449053	1557	0.985
NULL	Breast_Cancer_Res_2008_Apr_29_10(2)_206.nxml.txt.nlp	18492214	SENT123	14	14	3	3	letrozole	aromatase	PA450196	1588	0.985
NULL	Front_Aging_Neurosci_2010_Nov_29_2_150.nxml.txt.nlp	21151819	SENT338	16	16	23	23	resveratrol	SIRT1		23411	0.985
NULL	Int_J_Hypertens_2012_Nov_21_2012_474870.nxml.txt.nlp	23227311	SENT87	2	2	27	27	losartan	AT1	PA450268	9197;185	0.985
NULL	Adv_Urol_2011_Oct_20_2011_854792.nxml.txt.nlp	22046183	SENT157	20	20	23	23	letrozole	aromatase	PA450196	1588	0.985
NULL	Indian_J_Psychiatry_2009_Jan-Mar_51(1)_68b.nxml.txt.nlp	19742207	SENT21	0	0	12	12	tramadol	CYP2D6	PA451735	1565	0.985
NULL	Cell_Res_2012_Aug_22_22(8)_1227-1245.nxml.txt.nlp	22613949	SENT110	36	36	12	12	daunorubicin	KRAS	PA449212	3845	0.985
NULL	Eur_J_Pharmacol_2013_Sep_15_716(1-3)_188-202.nxml.txt.nlp	23500200	SENT155	30	30	4	4	naloxone	TRPM8	PA450586	79054	0.985
NULL	Breast_Cancer_Res_Treat_2014_Nov_24_143(1)_125-133.nxml.txt.nlp	24272078	SENT12	37	37	17	17	tamoxifen	aromatase	PA451581	1588	0.985
NULL	Case_Rep_Oncol_Med_2012_Dec_26_2012_390702.nxml.txt.nlp	23326741	SENT60	22	22	10	10	axitinib	VEGFR	PA164924493	3791	0.985
NULL	Braz_J_Med_Biol_Res_2012_Feb_17_45(3)_244-249.nxml.txt.nlp	22331137	SENT44	38	38	0	0	gentamicin	PAG	PA449753	55824	0.985
NULL	Breast_Cancer_Res_2010_Oct_22_12(Suppl_2)_S1.nxml.txt.nlp	21050422	SENT189	0	0	19	19	canertinib	EGFR	PA134687925	1956	0.985
NULL	J_Exp_Med_2000_May_15_191(10)_1789-1798.nxml.txt.nlp	10811871	SENT90	15	15	0	0	tetracycline	TSP-1	PA451640	7057	0.985
NULL	Biomed_Res_Int_2014_Jan_29_2014_458592.nxml.txt.nlp	24592391	SENT23	0	0	12	12	curcumin	HO-1	PA151958596	3162	0.985
NULL	Indian_J_Med_Res_2012_Mar_135(3)_312-317.nxml.txt.nlp	22561616	SENT97	13	13	0	0	tamoxifen	HER2	PA451581	2064	0.985
NULL	Case_Rep_Med_2012_Oct_18_2012_597348.nxml.txt.nlp	23118765	SENT65	5	5	20	20	ribavirin	IFN	PA451241	3439	0.985
NULL	Int_J_Mol_Sci_2012_Dec_5_13(12)_16624-16635.nxml.txt.nlp	23443122	SENT22	23	23	31	31	doxorubicin	MDR1	PA449412	5243	0.985
NULL	Arthritis_Res_2001_Jan_26_3(Suppl_A)_P090.nxml.txt.nlp	NULL	SENT5	35	35	13	13	etanercept	TNF-alpha	PA449515	7124	0.985
NULL	J_Cardiothorac_Surg_2010_May_4_5_32.nxml.txt.nlp	20441584	SENT55	17	17	5	5	ketamine	TSP-1	PA450144	7057	0.985
NULL	Nat_Chem_Biol_2010_Apr_28_6(4)_291-299.nxml.txt.nlp	20190765	SENT280	24	24	13	13	erlotinib	EGFR	PA134687924	1956	0.985
NULL	J_Cancer_2014_Jan_5_5(2)_86-97.nxml.txt.nlp	24494026	SENT171	7	7	14	14	lopinavir	p53	PA450264	7157	0.985
NULL	Br_J_Cancer_2013_Feb_19_108(3)_668-675.nxml.txt.nlp	23348520	SENT110	21	21	3	3	cetuximab	KRAS	PA10040	3845	0.985
NULL	Breast_Cancer_Res_2006_Nov_6_8(6)_215.nxml.txt.nlp	17096862	SENT83	16	16	5	5	trastuzumab	HER2	PA451743	2064	0.985
NULL	Cell_Death_Dis_2014_Feb_13_5(2)_e1055.nxml.txt.nlp	24525731	SENT7	21	21	8	8	cisplatin	XRCC1	PA449014	7515	0.985
NULL	Ann_Indian_Acad_Neurol_2009_Oct-Dec_12(4)_283-290.nxml.txt.nlp	20182576	SENT49	0	0	20	20	daclizumab	IL-2	PA164764446	3558	0.985
NULL	Indian_J_Nephrol_2013_Jan-Feb_23(1)_71-73.nxml.txt.nlp	23580812	SENT20	32	32	11	11	tacrolimus	CYP3A5	PA451578	1577	0.985
NULL	Case_Rep_Transplant_2012_Aug_30_2012_672923.nxml.txt.nlp	23259137	SENT46	38	38	16	16	cytarabine	CD19	PA449177	930	0.985
NULL	J_Oncol_2009_May_6_2009_567486.nxml.txt.nlp	19424511	SENT149	1	1	16	16	sorafenib	EGFR	PA7000	1956	0.985
NULL	J_Oncol_2009_Jun_14_2009_814140.nxml.txt.nlp	19547715	SENT6	10	10	26	26	paclitaxel	MDR1	PA450761	5243	0.985
NULL	Arthritis_Res_Ther_2007_Jun_29_9(Suppl_1)_S7.nxml.txt.nlp	17634146	SENT30	21	21	32	32	pamidronate	OPG	PA450767	690	0.985
NULL	Front_Cell_Neurosci_2015_Jan_15_8_459.nxml.txt.nlp	25642166	SENT116	34	34	4	4	hemin	HO-1	PA449849	3162	0.985
NULL	Curr_Oncol_2009_May_16(Suppl_1)_S52-S59.nxml.txt.nlp	19478903	SENT48	0	0	34	34	sunitinib	CYP2B6	PA162372840	1555	0.985
NULL	J_Cell_Biol_2001_Apr_2_153(1)_207-220.nxml.txt.nlp	11285286	SENT80	17	17	7	7	carbachol	DGK	PA448784	8526;1607	0.985
NULL	Clinics_(Sao_Paulo)_2012_Apr_67(Suppl_1)_125-129.nxml.txt.nlp	22584717	SENT61	12	12	28	28	cabozantinib	VEGFR	PA165906891	3791	0.985
NULL	Drug_Saf_2014_Oct_29_37(Suppl_1)_57-62.nxml.txt.nlp	25352328	SENT71	3	3	9	9	atazanavir	UGT	PA10251	7361;7355	0.985
NULL	Pharmaceuticals_(Basel)_2012_Jan_5_5(1)_79-93.nxml.txt.nlp	24288044	SENT2	0	0	13	13	trastuzumab	HER2	PA451743	2064	0.985
NULL	Br_J_Cancer_1998_May_77(9)_1469-1473.nxml.txt.nlp	9652763	SENT12	10	10	29	29	teniposide	P-gp	PA451611	5243	0.985
NULL	Br_J_Cancer_2003_Mar_24_88(6)_822-827.nxml.txt.nlp	12644816	SENT128	0	0	26	26	thalidomide	PSA	PA451644	29968;9520;354	0.985
NULL	J_Cell_Biol_1998_Jan_26_140(2)_335-345.nxml.txt.nlp	9442109	SENT330	19	19	2	2	chloroquine	NHE	PA448948	285335	0.985
NULL	Environ_Health_Perspect_2009_Feb_8_117(2)_175-180.nxml.txt.nlp	19270784	SENT110	3	3	10	10	cisplatin	BPA	PA449014	667	0.985
NULL	Arch_Med_Sci_2013_Aug_30_9(4)_731-738.nxml.txt.nlp	24049537	SENT30	21	21	10	10	sn-38	UGT1A1		54658	0.985
NULL	Front_Endocrinol_(Lausanne)_2014_Oct_14_5_160.nxml.txt.nlp	25352829	SENT324	19	19	6	6	abatacept	B7-1	PA164747080	941	0.985
NULL	Br_J_Cancer_2012_Jul_24_107(3)_516-526.nxml.txt.nlp	22782351	SENT277	3	3	20	20	tamoxifen	TIGAR	PA451581	57103	0.985
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_39-54.nxml.txt.nlp	19305787	SENT323	36	36	17	17	ethanol	CDK5	PA448073	1020	0.985
NULL	J_Oncol_2012_Dec_7_2012_192464.nxml.txt.nlp	22187555	SENT251	0	0	15	15	curcumin	EGFR	PA151958596	1956	0.985
NULL	Oncogene_2013_Sep_5_32(36)_4252-4263.nxml.txt.nlp	23045288	SENT291	20	20	4	4	doxorubicin	CD49f	PA449412	3655	0.985
NULL	Oncotarget_2013_Jul_18_4(10)_1582-1591.nxml.txt.nlp	24123600	SENT143	17	17	9	9	imatinib	ABCG1	PA10804	9619	0.985
NULL	Curr_Pharm_Biotechnol_2011_Jan_12(1)_35-41.nxml.txt.nlp	20932261	SENT117	7	7	27	27	hyperforin	CYP3A	PA165985514	1574	0.985
NULL	Br_J_Cancer_2012_Nov_6_107(10)_1714-1721.nxml.txt.nlp	23073173	SENT111	32	32	14	14	docetaxel	RUNX2	PA449383	860	0.985
NULL	Breast_Cancer_Res_2011_Aug_16_13(4)_218.nxml.txt.nlp	21884642	SENT9	15	15	20	20	trastuzumab	aromatase	PA451743	1588	0.985
NULL	Br_J_Cancer_2010_Jun_29_103(1)_61-72.nxml.txt.nlp	20588279	SENT260	17	17	3	3	trastuzumab	PTEN	PA451743	5728	0.985
NULL	J_Headache_Pain_2012_Nov_16_13(8)_677-684.nxml.txt.nlp	23070400	SENT160	8	8	17	17	nabilone	DAI	PA164746998	81030	0.985
NULL	Contemp_Oncol_(Pozn)_2012_Jul_6_16(3)_197-200.nxml.txt.nlp	23788878	SENT74	0	0	5	5	cabozantinib	VEGFR2	PA165906891	3791	0.985
NULL	Diabetes_Care_2011_Apr_21_34(4)_789-794.nxml.txt.nlp	21447659	SENT55	4	4	33	33	bromocriptine	CYP3A4	PA448671	1576	0.985
NULL	Diabetes_Care_2010_Jul_31_33(7)_1607-1609.nxml.txt.nlp	20357375	SENT53	6	6	29	29	sitagliptin	CD34	PA164748978	947	0.985
NULL	J_Korean_Med_Sci_2011_Jul_20_26(7)_893-899.nxml.txt.nlp	21738342	SENT95	21	21	13	13	resveratrol	EGF		1950	0.985
NULL	Indian_J_Pharm_Sci_2013_May-Jun_75(3)_251-261.nxml.txt.nlp	24082340	SENT63	0	0	13	13	olaparib	BRCA1		672	0.985
NULL	Front_Physiol_2013_Dec_24_4_386.nxml.txt.nlp	24399968	SENT195	11	11	41	41	glimepiride	SUR1	PA449761	6833	0.985
NULL	Oxid_Med_Cell_Longev_2013_Nov_28_2013_568093.nxml.txt.nlp	24379901	SENT75	7	7	17	17	resveratrol	AMPK		5563	0.985
NULL	Diabetol_Metab_Syndr_2014_Sep_8_6(1)_95.nxml.txt.nlp	NULL	SENT37	14	14	1	1	liraglutide	GLP-1	PA165958364	100125288	0.985
NULL	Arthritis_Res_Ther_2012_Jun_12_14(3)_R141.nxml.txt.nlp	22691241	SENT211	42	42	15	15	abatacept	AKT	PA164747080	207	0.985
NULL	J_Adv_Pract_Oncol_2013_Jul_1_Jul-Aug_4(4)_263-268.nxml.txt.nlp	25032007	SENT34	1	1	18	18	imatinib	CYP3A	PA10804	1574	0.985
NULL	Dermatoendocrinol_2013_Apr_1_5(2)_252-263.nxml.txt.nlp	24194965	SENT136	2	2	20	20	metformin	AMPK	PA450395	5563	0.985
NULL	EMBO_Mol_Med_2013_Aug_8_5(8)_1227-1246.nxml.txt.nlp	23836498	SENT83	22	22	20	20	2-methoxyestradiol	HIF-1	PA134967247	29072	0.985
NULL	Oncogene_2010_Jun_3_29(22)_3208-3216.nxml.txt.nlp	20383201	SENT183	22	22	40	40	dasatinib	EGF	PA162372878	1950	0.985
NULL	Cardiovasc_Diabetol_2013_Mar_23_12_48.nxml.txt.nlp	23522121	SENT68	14	14	1	1	exenatide	NNT	PA164749238	23530	0.985
NULL	Semin_Immunol_2011_Feb_23(1)_28-41.nxml.txt.nlp	21295490	SENT243	1	1	12	12	ustekinumab	p40	PA166048654	3921;339541;10314	0.985
NULL	Front_Behav_Neurosci_2011_Sep_8_5_56.nxml.txt.nlp	21927600	SENT225	9	9	0	0	caffeine	DARPP-32	PA448710	84152	0.985
NULL	J_Headache_Pain_2013_Feb_21_14(Suppl_1)_P75.nxml.txt.nlp	NULL	SENT10	18	18	8	8	sumatriptan	5-HT1D	PA451566	3352	0.985
NULL	Cent_European_J_Urol_2013_Aug_13_66(2)_144-149.nxml.txt.nlp	24579014	SENT61	30	30	0	0	resveratrol	TRAMP		8718;23471;9189	0.985
NULL	Oncol_Rep_2013_Sep_1_30(3)_1045-1052.nxml.txt.nlp	23817662	SENT5	27	27	6	6	erlotinib	EGFR	PA134687924	1956	0.985
NULL	Indian_J_Dermatol_2014_Sep-Oct_59(5)_425-441.nxml.txt.nlp	25284845	SENT136	0	0	34	34	efalizumab	LFA-1	PA164748817	3683;3689	0.985
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT330	8	8	0	0	cisplatin	IBP	PA449014	706;50619	0.985
NULL	Br_J_Cancer_2009_Jul_21_101(2)_238-243.nxml.txt.nlp	19568242	SENT113	3	3	20	20	sunitinib	IFN	PA162372840	3439	0.985
NULL	Curr_Cardiol_Rev_2012_Aug_8(3)_181-191.nxml.txt.nlp	22920489	SENT113	14	14	2	2	prasugrel	ADP	PA154410481	23038	0.985
NULL	Ann_Rehabil_Med_2012_Aug_27_36(4)_466-473.nxml.txt.nlp	22977771	SENT22	26	26	0	0	triamcinolone	ILEI	PA451749	10447	0.985
NULL	Breast_Cancer_Res_2011_Feb_23_13(1)_203.nxml.txt.nlp	21392408	SENT17	11	11	6	6	tamoxifen	aromatase	PA451581	1588	0.985
NULL	Nucleic_Acids_Res_2013_May_5_41(10)_5210-5222.nxml.txt.nlp	23563151	SENT76	13	13	0	0	arsenite	GADD45	PA452638	1647	0.985
NULL	Biologics_2012_Jul_26_6_233-244.nxml.txt.nlp	22904615	SENT79	16	16	8	8	gefitinib	EGFR	PA131301952	1956	0.985
NULL	Curr_Neuropharmacol_2011_Dec_9(4)_530-552.nxml.txt.nlp	22654714	SENT401	7	7	34	34	imipramine	VGF	PA449969	7425	0.985
NULL	Clin_Ophthalmol_2009_Jun_2_3_155-166.nxml.txt.nlp	19668560	SENT145	28	28	15	15	bevacizumab	ERG	PA130232992	2078	0.985
NULL	Appl_Microbiol_Biotechnol_2013_Jan_1_97(1)_143-152.nxml.txt.nlp	22851018	SENT107	23	23	0	0	nadh	ADP	PA164755085	23038	0.985
NULL	Cell_Death_Dis_2012_Mar_15_3(3)_e286.nxml.txt.nlp	22419115	SENT195	41	41	8	8	cisplatin	p53	PA449014	7157	0.985
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT133	37	37	10	10	chloroquine	BMPR-II	PA448948	659	0.985
NULL	Front_Immunol_2014_Aug_22_5_406.nxml.txt.nlp	25202312	SENT172	0	0	27	27	eculizumab	CD55	PA164776637	1604	0.985
NULL	Breast_Cancer_Res_2008_Dec_3_10(6)_R101.nxml.txt.nlp	19055754	SENT30	18	18	32	32	dasatinib	EGFR	PA162372878	1956	0.985
NULL	Cell_Commun_Signal_2011_May_15_9_13.nxml.txt.nlp	21569639	SENT289	0	0	17	17	quinacrine	p53	PA164745551	7157	0.985
NULL	Arthritis_Res_Ther_2010_Jun_3_12(3)_R109.nxml.txt.nlp	20525258	SENT108	11	11	19	19	cyclosporine	gamma	PA449167	9913	0.985
NULL	Br_J_Cancer_2013_Jul_23_109(2)_351-359.nxml.txt.nlp	23799854	SENT18	19	19	6	6	paclitaxel	BLT2	PA450761	56413	0.985
NULL	Br_J_Clin_Pharmacol_2012_Apr_7_73(4)_518-535.nxml.txt.nlp	22053916	SENT63	4	4	16	16	pitavastatin	CYP3A4	PA142650384	1576	0.985
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1411-1419.nxml.txt.nlp	24077634	SENT142	4	4	27	27	metformin	AMPK	PA450395	5563	0.985
NULL	Cell_Death_Dis_2012_Jun_21_3(6)_e327.nxml.txt.nlp	22717582	SENT187	34	34	13	13	doxorubicin	BAK	PA449412	578	0.985
NULL	Br_J_Cancer_2001_Jul_85(2)_303-311.nxml.txt.nlp	11461094	SENT2	4	4	13	13	paclitaxel	EGF	PA450761	1950	0.985
NULL	Br_J_Cancer_2012_May_22_106(11)_1779-1789.nxml.txt.nlp	22549178	SENT181	7	7	2	2	trastuzumab	p27	PA451743	5715;10534	0.985
NULL	Indian_J_Med_Paediatr_Oncol_2014_Oct-Dec_35(4)_253-262.nxml.txt.nlp	25538401	SENT55	0	0	12	12	bevacizumab	VEGF-A	PA130232992	7422	0.985
NULL	Br_J_Cancer_2004_Mar_8_90(5)_1053-1058.nxml.txt.nlp	14997207	SENT121	9	9	22	22	marimastat	ADAM9	PA164748329	8754	0.985
NULL	Drugs_R_D_2010_Nov_25_10(4)_219-224.nxml.txt.nlp	21171668	SENT98	27	27	3	3	clopidogrel	CYP2C19	PA449053	1557	0.985
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT267	19	19	8	8	heparin	FGF1	PA449855	2246	0.985
NULL	Cell_Commun_Signal_2010_Dec_22_8_31.nxml.txt.nlp	21176168	SENT202	5	5	10	10	doxycycline	PARP-1	PA449415	25976	0.985
NULL	Breast_Cancer_Res_2008_Aug_5_10(4)_R68.nxml.txt.nlp	18681966	SENT161	9	9	34	34	doxorubicin	PRL	PA449412	5617	0.985
NULL	Int_J_Endocrinol_Metab_2013_Jul_1_Summer_11(3)_129-136.nxml.txt.nlp	24348584	SENT44	13	13	27	27	estradiol	aromatase	PA449503	1588	0.985
NULL	Arthritis_Res_Ther_2010_Jan_8_12(1)_R4.nxml.txt.nlp	20064200	SENT218	42	42	40	40	diclofenac	COX2	PA449293	4513;5743	0.985
NULL	J_Headache_Pain_2014_Dec_8_15(1)_85.nxml.txt.nlp	25488888	SENT182	7	7	28	28	rizatriptan	5-HT1D	PA451264	3352	0.985
NULL	Cell_Death_Differ_2010_Apr_16_17(4)_666-676.nxml.txt.nlp	19834494	SENT269	17	17	0	0	oxaliplatin	RAGE	PA131285527	177	0.985
NULL	Front_Oncol_2014_Mar_14_4_52.nxml.txt.nlp	24672773	SENT95	34	34	17	17	troglitazone	CASP7	PA451799	840	0.985
NULL	Indian_J_Med_Res_2014_Jan_139(1)_27-65.nxml.txt.nlp	24604039	SENT56	21	21	3	3	olanzapine	CYP1A2	PA450688	1544	0.985
NULL	J_Gen_Physiol_2012_Jun_139(6)_407-414.nxml.txt.nlp	22641635	SENT111	4	4	35	35	nadh	ADP	PA164755085	23038	0.985
NULL	J_Neuroinflammation_2010_Sep_7_7_51.nxml.txt.nlp	20822529	SENT200	24	24	29	29	hemin	HO-1	PA449849	3162	0.985
NULL	Mol_Vis_2014_May_13_20_649-660.nxml.txt.nlp	24868139	SENT26	7	7	24	24	ranibizumab	VEGFR1	PA164746012	2321	0.985
NULL	Thorax_2012_Sep_11_67(9)_796-803.nxml.txt.nlp	22496351	SENT122	15	15	0	0	bleomycin	TRAIL	PA448645	8743	0.985
NULL	Oncogene_2014_Aug_28_33(35)_4407-4417.nxml.txt.nlp	24469038	SENT242	26	26	14	14	cisplatin	p53	PA449014	7157	0.985
NULL	Br_J_Pharmacol_2012_Apr_165(7)_2191-2202.nxml.txt.nlp	21958009	SENT215	9	9	3	3	ketanserin	5-HT2A	PA131053734	3356	0.985
NULL	J_Cell_Mol_Med_2014_Feb_28_18(2)_293-304.nxml.txt.nlp	24286368	SENT26	7	7	22	22	metformin	AMPK	PA450395	5563	0.985
NULL	Mol_Cancer_2009_Apr_22_8_26.nxml.txt.nlp	19386116	SENT140	0	0	28	28	ritonavir	AKT	PA451260	207	0.985
NULL	Ecancermedicalscience_2009_Apr_2_3_141.nxml.txt.nlp	22276006	SENT27	29	29	5	5	bortezomib	TRAIL	PA10252	8743	0.985
NULL	Lab_Invest_2011_Sep_23_91(9)_1396-1409.nxml.txt.nlp	21606925	SENT138	5	5	15	15	genistein	PP2	PA165109660	4888	0.985
NULL	F1000Res_2013_Feb_28_2_65.nxml.txt.nlp	24358861	SENT57	7	7	0	0	naloxone	TLR4	PA450586	7099	0.985
NULL	Patient_Prefer_Adherence_2013_Jan_9_7_35-45.nxml.txt.nlp	23341736	SENT153	0	0	7	7	liraglutide	GLP-1	PA165958364	100125288	0.985
NULL	Br_J_Cancer_2010_May_11_102(10)_1495-1502.nxml.txt.nlp	20461092	SENT131	15	15	13	13	gefitinib	EGFR	PA131301952	1956	0.985
NULL	Aging_(Albany_NY)_2009_Jun_3_1(6)_515-528.nxml.txt.nlp	20157535	SENT111	30	30	12	12	resveratrol	S6K1		6198	0.985
NULL	Indian_J_Psychol_Med_2009_Jan-Jun_31(1)_3-10.nxml.txt.nlp	21938084	SENT176	9	9	26	26	pimozide	5-HT2A	PA450965	3356	0.985
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1224-1233.nxml.txt.nlp	22353810	SENT155	23	23	1	1	doxorubicin	MRP-1	PA449412	928	0.985
NULL	Exp_Ther_Med_2013_Dec_15_6(6)_1565-1569.nxml.txt.nlp	24255692	SENT99	31	31	4	4	atorvastatin	adiponectin	PA448500	9370	0.985
NULL	Oncogene_2013_Sep_26_32(39)_10_1038_onc_2012_491.nxml.txt.nlp	23108394	SENT103	41	41	12	12	epirubicin	BRIP1	PA449476	64979;83990	0.985
NULL	Oncol_Lett_2014_Nov_12_8(5)_2203-2208.nxml.txt.nlp	25295109	SENT81	7	7	26	26	celecoxib	GLI1	PA448871	2735	0.985
NULL	Nucleic_Acids_Res_2013_Dec_30_41(22)_10268-10282.nxml.txt.nlp	23997120	SENT218	23	23	6	6	olaparib	TRF1		7013	0.985
NULL	Br_J_Cancer_1998_Oct_78(8)_1024-1029.nxml.txt.nlp	9792145	SENT12	34	34	24	24	etoposide	CD34	PA449552	947	0.985
NULL	J_Cell_Biol_2002_Jun_24_157(7)_1151-1160.nxml.txt.nlp	12082077	SENT161	8	8	19	19	trypsin	COX	PA451806	1351	0.985
NULL	Clin_Med_Oncol_2008_Mar_27_2_275-287.nxml.txt.nlp	21892289	SENT264	9	9	21	21	rituximab	CD19	PA451261	930	0.985
NULL	Open_Cardiovasc_Med_J_2014_Feb_7_8_12-17.nxml.txt.nlp	24653785	SENT20	0	0	21	21	simvastatin	CYP3A4	PA451363	1576	0.985
NULL	Mar_Drugs_2014_May_27_12(6)_3231-3244.nxml.txt.nlp	24879546	SENT107	0	0	19	19	curcumin	CRT	PA151958596	811	0.985
NULL	Eur_J_Clin_Pharmacol_2014_Oct_8_70(12)_1433-1441.nxml.txt.nlp	25291992	SENT130	8	8	16	16	olanzapine	B12	PA450688	7126;4709	0.985
NULL	Mucosal_Immunol_2012_May_8_5(3)_267-276.nxml.txt.nlp	22318492	SENT190	36	36	24	24	omalizumab	CD203c	PA164752253	5169	0.985
NULL	Exp_Ther_Med_2015_Feb_3_9(2)_377-383.nxml.txt.nlp	25574201	SENT12	38	38	10	10	curcumin	TSP-1	PA151958596	7057	0.985
NULL	Indian_J_Dermatol_2013_Mar-Apr_58(2)_164c.nxml.txt.nlp	23716858	SENT12	2	2	18	18	panitumumab	CEA	PA162373091	5670;1087	0.985
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT29	1	1	8	8	lapatinib	HER2	PA152241907	2064	0.985
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1039-1044.nxml.txt.nlp	22343617	SENT28	0	0	16	16	everolimus	S6K1	PA164746311	6198	0.985
NULL	Nat_Commun_2013_Oct_25_4_2667.nxml.txt.nlp	24157709	SENT85	24	24	7	7	nutlin-3	p53		7157	0.985
NULL	Breast_Cancer_Res_Treat_2013_Jun_5_139(3)_649-655.nxml.txt.nlp	23736997	SENT149	31	31	20	20	tamoxifen	CYP2C19	PA451581	1557	0.985
NULL	J_Biol_Chem_2009_Oct_16_284(42)_28885-28895.nxml.txt.nlp	19687008	SENT286	24	24	14	14	simvastatin	PCSK9	PA451363	255738	0.985
NULL	Mol_Cancer_2008_Oct_23_7_82.nxml.txt.nlp	18947424	SENT333	9	9	16	16	procainamide	GSTP1	PA451108	2950	0.985
NULL	Br_J_Cancer_2012_Sep_4_107(6)_977-987.nxml.txt.nlp	22892389	SENT127	23	23	15	15	orlistat	HIF-1	PA164776864	29072	0.985
NULL	Adv_Hematol_2010_Dec_30_2010_624040.nxml.txt.nlp	21234357	SENT162	0	0	11	11	gemcitabine	CHOP	PA449748	1649	0.985
NULL	Int_J_Cell_Biol_2010_Feb_21_2010_214074.nxml.txt.nlp	20182529	SENT261	31	31	5	5	staurosporine	p35	PA165109623	3592;80761	0.985
NULL	Anticancer_Agents_Med_Chem_2012_Feb_12(2)_163-171.nxml.txt.nlp	22043994	SENT23	29	29	0	0	cetuximab	KRAS	PA10040	3845	0.985
NULL	Br_J_Cancer_2013_Mar_5_108(4)_983-992.nxml.txt.nlp	23361057	SENT237	11	11	32	32	cytarabine	MLH1	PA449177	4292	0.985
NULL	Arthritis_Res_Ther_2013_Jul_9_15(4)_R73.nxml.txt.nlp	23837669	SENT259	0	0	12	12	colchicine	MICL	PA449092	160364	0.985
NULL	Front_Endocrinol_(Lausanne)_2013_May_16_4_51.nxml.txt.nlp	23720652	SENT169	6	6	16	16	diclofenac	CYP2C9	PA449293	1559	0.985
NULL	Breast_Cancer_Res_2014_Nov_3_16(Suppl_1)_P44.nxml.txt.nlp	NULL	SENT13	20	20	8	8	trastuzumab	NACT	PA451743	284111	0.985
NULL	Br_J_Pharmacol_2014_Jan_23_171(2)_523-535.nxml.txt.nlp	24372553	SENT183	6	6	13	13	metformin	SIRT1	PA450395	23411	0.985
NULL	Environ_Health_Perspect_2005_Jun_14_113(6)_801-807.nxml.txt.nlp	15929907	SENT182	23	23	5	5	heparin	CXCL4	PA449855	5196	0.985
NULL	Mol_Cancer_2009_Aug_25_8_66.nxml.txt.nlp	19706164	SENT195	4	4	28	28	celecoxib	p53	PA448871	7157	0.985
NULL	Case_Rep_Gastroenterol_2012_May_3_6(2)_223-231.nxml.txt.nlp	22679409	SENT84	16	16	7	7	erythromycin	DIP	PA449493	23151;1831	0.985
NULL	Oncogene_2014_Sep_11_33(37)_4579-4588.nxml.txt.nlp	24662835	SENT125	33	33	28	28	tamoxifen	MAGEA3	PA451581	4102	0.985
NULL	Br_J_Cancer_2009_Sep_15_101(6)_957-966.nxml.txt.nlp	19738618	SENT246	8	8	13	13	dexrazoxane	THBS-1	PA449259	7057	0.985
NULL	Mol_Vis_2012_May_1_18_1115-1122.nxml.txt.nlp	22605923	SENT106	44	44	4	4	estradiol	IL-6	PA449503	3569	0.985
NULL	J_Carcinog_2011_Nov_30_10_28.nxml.txt.nlp	22190870	SENT171	39	39	8	8	perifosine	PI3K	PA165291471	5290	0.985
NULL	Oncogene_2013_Sep_26_32(39)_10_1038_onc_2012_491.nxml.txt.nlp	23108394	SENT5	8	8	3	3	epirubicin	FOXM1	PA449476	2305	0.985
NULL	CNS_Spectr_2014_Apr_1_19(2)_121-133.nxml.txt.nlp	23903233	SENT106	23	23	2	2	phencyclidine	5-HT1A	PA128406980	3350	0.985
NULL	Cancers_(Basel)_2011_Aug_15_3(3)_3331-3352.nxml.txt.nlp	24212957	SENT264	18	18	32	32	cetuximab	VEGFR	PA10040	3791	0.985
NULL	Cancer_Res_Treat_2011_Sep_30_43(3)_148-153.nxml.txt.nlp	22022291	SENT120	0	0	14	14	irinotecan	UGT1A1	PA450085	54658	0.985
NULL	Oncotarget_2011_Dec_22_2(12)_1176-1190.nxml.txt.nlp	22202492	SENT119	2	2	11	11	simvastatin	PLA2G7	PA451363	7941	0.985
NULL	Br_J_Cancer_2012_Sep_4_107(6)_977-987.nxml.txt.nlp	22892389	SENT181	15	15	1	1	orlistat	VEGFA	PA164776864	7422	0.985
NULL	Cell_Death_Dis_2014_Jan_9_5(1)_e986.nxml.txt.nlp	24407239	SENT76	0	0	14	14	fludarabine	STAT1	PA449655	6772	0.985
NULL	Cell_Death_Dis_2010_Oct_21_1(10)_e86.nxml.txt.nlp	21368859	SENT87	48	48	11	11	doxorubicin	TRAIL	PA449412	8743	0.985
NULL	Arthritis_Res_Ther_2012_Jul_27_14(4)_R175.nxml.txt.nlp	22838733	SENT189	41	41	20	20	adalimumab	CD14	PA10004	929	0.985
NULL	Oncogene_2010_Jul_15_29(28)_4090-4100.nxml.txt.nlp	20473326	SENT123	21	21	9	9	doxorubicin	p53	PA449412	7157	0.985
NULL	Nat_Chem_Biol_2009_Apr_26_5(4)_236-243.nxml.txt.nlp	19172146	SENT74	15	15	21	21	nimesulide	COX	PA137179528	1351	0.985
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R91.nxml.txt.nlp	22541814	SENT194	9	9	18	18	thrombin	PP2	PA451674	4888	0.985
NULL	Pharmaceuticals_(Basel)_2012_Aug_30_5(9)_890-898.nxml.txt.nlp	24280696	SENT75	2	2	11	11	cisplatin	Hsp90	PA449014	3320	0.985
NULL	Cell_Res_2013_Jul_21_23(7)_915-930.nxml.txt.nlp	23689279	SENT97	6	6	10	10	ethanol	ALDH2	PA448073	217	0.985
NULL	J_Oncol_2011_Jun_12_2011_542358.nxml.txt.nlp	21772843	SENT364	40	40	6	6	doxorubicin	p53	PA449412	7157	0.985
NULL	Oncotarget_2014_Sep_2_5(19)_9308-9321.nxml.txt.nlp	25301721	SENT73	20	20	2	2	rolipram	MRP4	PA153906323	10257	0.985
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT171	6	6	28	28	cisplatin	p53	PA449014	7157	0.985
NULL	Curr_Med_Chem_2009_Aug_16(23)_3041-3053.nxml.txt.nlp	19689281	SENT179	7	7	14	14	troglitazone	SOD2	PA451799	6648	0.985
NULL	Breast_Cancer_Res_2011_Apr_1_13(2)_R35.nxml.txt.nlp	21457545	SENT206	23	23	34	34	gefitinib	EGFR	PA131301952	1956	0.985
NULL	Cells_2014_May_23_3(2)_517-545.nxml.txt.nlp	24861977	SENT76	13	13	7	7	capsaicin	TRPV1	PA448776	7442	0.985
NULL	J_Cancer_2013_Nov_23_4(9)_736-754.nxml.txt.nlp	24312144	SENT91	22	22	41	41	afatinib	EGFR	PA165981154	1956	0.985
NULL	Arch_Drug_Inf_2008_Sep_1(2)_50-55.nxml.txt.nlp	19915714	SENT42	14	14	35	35	fentanyl	CYP3A4	PA449599	1576	0.985
NULL	Front_Psychiatry_2014_Jul_31_5_92.nxml.txt.nlp	25132823	SENT91	7	7	14	14	sr144528	CB1		1268	0.985
NULL	Int_J_Gen_Med_2009_Jul_30_2_129-140.nxml.txt.nlp	20360896	SENT28	22	22	1	1	tamoxifen	aromatase	PA451581	1588	0.985
NULL	Clin_Pharmacokinet_2014_Sep_3_53(1)_1-16.nxml.txt.nlp	23999929	SENT342	26	26	13	13	rivaroxaban	P-gp	PA165958360	5243	0.985
NULL	BMJ_2010_Feb_8_340_c693.nxml.txt.nlp	20142325	SENT26	3	3	8	8	paroxetine	CYP2D6	PA450801	1565	0.985
NULL	Br_J_Pharmacol_2008_Oct_18_155(4)_596-605.nxml.txt.nlp	18852694	SENT299	7	7	18	18	fenofibrate	PI3K	PA449594	5290	0.985
NULL	Br_J_Cancer_2010_Jul_27_103(3)_315-323.nxml.txt.nlp	20661248	SENT22	0	0	22	22	irinotecan	UGT	PA450085	7361;7355	0.985
NULL	Ann_Gen_Psychiatry_2013_Aug_13_12_26.nxml.txt.nlp	23941527	SENT146	0	0	23	23	venlafaxine	NMA	PA451866	25805	0.985
NULL	Biomed_Res_Int_2013_Jul_1_2013_964743.nxml.txt.nlp	23936861	SENT198	21	21	5	5	bevacizumab	EGFR	PA130232992	1956	0.985
NULL	Diabetes_Metab_Syndr_Obes_2014_Aug_28_7_391-400.nxml.txt.nlp	25210468	SENT99	40	40	8	8	liraglutide	GLP-1	PA165958364	100125288	0.985
NULL	Acta_Pharmacol_Sin_2011_Jul_13_32(7)_967-972.nxml.txt.nlp	21666702	SENT141	15	15	44	44	ticlopidine	P-gp	PA451686	5243	0.985
NULL	Acta_Pharmacol_Sin_2012_Apr_19_33(4)_470-478.nxml.txt.nlp	22426698	SENT210	20	20	3	3	nifedipine	MMP9	PA450631	4318	0.985
NULL	Psychiatry_Investig_2009_Sep_3_6(3)_222-225.nxml.txt.nlp	20046399	SENT9	27	27	15	15	risperidone	DRD4	PA451257	1815	0.985
NULL	Cilia_2013_Dec_13_2_17.nxml.txt.nlp	24330727	SENT294	5	5	3	3	geldanamycin	Hsp90	PA152031327	3320	0.985
NULL	J_Hematol_Oncol_2009_Feb_23_2_10.nxml.txt.nlp	19236716	SENT107	15	15	32	32	ketoconazole	CYP3A4	PA450146	1576	0.985
NULL	Breast_Cancer_Res_2010_Jul_1_12(4)_R45.nxml.txt.nlp	20594311	SENT204	16	16	7	7	nelfinavir	AKT	PA450606	207	0.985
NULL	Breast_Cancer_(Auckl)_2011_Jan_13_5_1-14.nxml.txt.nlp	21494397	SENT48	19	19	5	5	atazanavir	CYP3A4	PA10251	1576	0.985
NULL	Cancer_Cell_Int_2010_May_11_10_16.nxml.txt.nlp	20459793	SENT86	9	9	29	29	cisplatin	ABCC1	PA449014	4363	0.985
NULL	Br_J_Cancer_2010_Sep_7_103(6)_889-898.nxml.txt.nlp	20664599	SENT198	17	17	27	27	paclitaxel	AKT	PA450761	207	0.985
NULL	Exp_Diabetes_Res_2011_Jun_4_2011_489708.nxml.txt.nlp	21747829	SENT112	3	3	31	31	aliskiren	GLP-1	PA143487910	100125288	0.985
NULL	Acta_Histochem_Cytochem_2012_Apr_26_45(2)_139-146.nxml.txt.nlp	22685356	SENT136	22	22	5	5	forskolin	AQP2	PA146096022	359	0.985
NULL	Environ_Health_Perspect_1996_Dec_104(Suppl_6)_1325-1329.nxml.txt.nlp	9118914	SENT4	14	14	4	4	hydroquinone	FISH	PA449924	9644	0.985
NULL	Nucleic_Acids_Res_2011_Mar_23_39(4)_1526-1537.nxml.txt.nlp	20972225	SENT193	30	30	9	9	tetracycline	BCS	PA451640	617	0.985
NULL	EJC_Suppl_2013_Sep_5_11(2)_3-22.nxml.txt.nlp	NULL	SENT316	29	29	3	3	tamoxifen	aromatase	PA451581	1588	0.985
NULL	Oncotarget_2014_Nov_3_5(20)_10127-10139.nxml.txt.nlp	25333256	SENT153	5	5	0	0	vemurafenib	TRIM16	PA165946873	10626	0.985
NULL	Tuberc_Respir_Dis_(Seoul)_2013_Nov_29_75(5)_188-198.nxml.txt.nlp	24348666	SENT38	29	29	5	5	gefitinib	HER2	PA131301952	2064	0.985
NULL	Br_J_Cancer_1995_Oct_72(4)_1007-1012.nxml.txt.nlp	7547212	SENT12	4	4	16	16	exemestane	aromatase	PA449563	1588	0.985
NULL	Biochim_Biophys_Acta_2014_Apr_1841(4)_588-594.nxml.txt.nlp	24440819	SENT430	6	6	21	21	lipase	CGI-58	PA450239	51099	0.985
NULL	J_Oncol_2010_Jun_3_2010_732680.nxml.txt.nlp	20613952	SENT65	4	4	25	25	lenalidomide	IL-2	PA162363968	3558	0.985
NULL	Br_J_Cancer_2011_Sep_6_105(6)_796-806.nxml.txt.nlp	21847123	SENT166	16	16	8	8	lapatinib	AKT1	PA152241907	207	0.985
NULL	Br_J_Cancer_2012_Apr_10_106(8)_1374-1378.nxml.txt.nlp	22421948	SENT87	2	2	23	23	metformin	Bcl-2	PA450395	596	0.985
NULL	Br_J_Cancer_2010_Sep_28_103(7)_993-1000.nxml.txt.nlp	20717111	SENT157	25	25	0	0	irinotecan	UGT1A1	PA450085	54658	0.985
NULL	Front_Oncol_2013_Sep_12_3_232.nxml.txt.nlp	24062985	SENT94	5	5	18	18	daunorubicin	Raf-1	PA449212	5894	0.985
NULL	Breast_Cancer_Res_2014_Sep_11_16(5)_430.nxml.txt.nlp	25212826	SENT300	16	16	29	29	fulvestrant	PTEN	PA164747170	5728	0.985
NULL	Mol_Cancer_2010_Jun_27_9_168.nxml.txt.nlp	20579391	SENT121	4	4	31	31	dasatinib	MMP1	PA162372878	4312	0.985
NULL	Br_J_Pharmacol_2014_Jan_23_171(2)_523-535.nxml.txt.nlp	24372553	SENT224	19	19	30	30	metformin	SIRT1	PA450395	23411	0.985
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT33	25	25	4	4	gefitinib	KRAS	PA131301952	3845	0.985
NULL	Br_J_Cancer_2011_Jul_26_105(3)_372-381.nxml.txt.nlp	21730979	SENT197	41	41	28	28	hydroxyurea	CHK1	PA449942	1111	0.985
NULL	Ann_Coloproctol_2014_Aug_26_30(4)_165-174.nxml.txt.nlp	25210685	SENT140	26	26	19	19	cetuximab	KRAS	PA10040	3845	0.985
NULL	Emerg_Infect_Dis_2014_Mar_20(3)_506-507.nxml.txt.nlp	24565423	SENT21	13	13	5	5	ethambutol	DST	PA164784021	667	0.985
NULL	Cancer_Cell_Int_2013_Nov_8_13_111.nxml.txt.nlp	24209962	SENT159	9	9	3	3	fluvastatin	A20	PA449688	7128;28935	0.985
NULL	Curr_Oncol_2009_Jul_16(Suppl_2)_S1-S13.nxml.txt.nlp	19672416	SENT72	2	2	11	11	letrozole	aromatase	PA450196	1588	0.985
NULL	Int_J_Cell_Biol_2013_Mar_19_2013_834684.nxml.txt.nlp	23573093	SENT91	0	0	18	18	orlistat	PC3	PA164776864	57332;7832;5122	0.985
NULL	EJC_Suppl_2013_Sep_5_11(2)_80.nxml.txt.nlp	NULL	SENT14	0	0	3	3	vemurafenib	BRAF	PA165946873	673	0.985
NULL	J_Oncol_2009_Jun_14_2009_814140.nxml.txt.nlp	19547715	SENT127	20	20	7	7	cisplatin	MRP1	PA449014	4437	0.985
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT335	20	20	0	0	resveratrol	TNF		7124	0.985
NULL	Br_J_Cancer_2010_Nov_9_103(11)_1692-1697.nxml.txt.nlp	21063402	SENT64	11	11	25	25	mitomycin	TRAIL	PA450524	8743	0.985
NULL	Mol_Pain_2014_Aug_1_10_50.nxml.txt.nlp	25085415	SENT19	23	23	0	0	capsaicin	TRPV1	PA448776	7442	0.985
NULL	Front_Behav_Neurosci_2011_Sep_8_5_56.nxml.txt.nlp	21927600	SENT208	7	7	24	24	cocaine	DARPP-32	PA449072	84152	0.985
NULL	Breast_Cancer_(Auckl)_2011_Jan_13_5_1-14.nxml.txt.nlp	21494397	SENT48	21	21	5	5	nefazodone	CYP3A4	PA450603	1576	0.985
NULL	F1000Prime_Rep_2013_Jul_1_5_23.nxml.txt.nlp	23864930	SENT31	35	35	9	9	ketanserin	LTF	PA131053734	4057	0.985
NULL	Diabetes_2011_Jan_4_60(1)_119-126.nxml.txt.nlp	20921208	SENT234	11	11	25	25	glucose	TRPM2	PA449773	7226	0.985
NULL	Breast_Cancer_Res_Treat_2012_Jul_28_134(1)_267-276.nxml.txt.nlp	22453754	SENT36	29	29	8	8	tamoxifen	ATAC	PA451581	6375	0.985
NULL	Blood_Cancer_J_2013_Oct_4_3(10)_e150.nxml.txt.nlp	24096714	SENT87	13	13	28	28	bortezomib	TNFSF2	PA10252	7124	0.985
NULL	Indian_J_Nephrol_2012_Jan-Feb_22(1)_26-32.nxml.txt.nlp	22279339	SENT79	10	10	38	38	ketamine	CO2	PA450144	4513	0.985
NULL	Cell_Death_Dis_2014_Feb_27_5(2)_e1088.nxml.txt.nlp	24577086	SENT80	16	16	4	4	metformin	Bcl-2	PA450395	596	0.985
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_75-89.nxml.txt.nlp	17912638	SENT580	20	20	31	31	tamoxifen	ATAC	PA451581	6375	0.985
NULL	Exp_Ther_Med_2013_Nov_13_6(5)_1317-1321.nxml.txt.nlp	24223665	SENT71	27	27	10	10	curcumin	CD133	PA151958596	8842	0.985
NULL	Endocrinol_Metab_(Seoul)_2014_Mar_14_29(1)_54-61.nxml.txt.nlp	24741455	SENT119	0	0	29	29	curcumin	AKT	PA151958596	207	0.985
NULL	Case_Rep_Transplant_2013_Jun_13_2013_375263.nxml.txt.nlp	23844312	SENT21	0	0	6	6	tacrolimus	CYP3A4	PA451578	1576	0.985
NULL	Vet_Res_2013_Oct_2_44(1)_89.nxml.txt.nlp	24088531	SENT277	14	14	36	36	hemin	HO-1	PA449849	3162	0.985
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Apr_21_68(Pt_5)_o1466.nxml.txt.nlp	22590340	SENT66	47	47	12	12	ethanol	mol	PA448073	90527	0.985
NULL	Oncoscience_2014_Oct_22_1(10)_614-623.nxml.txt.nlp	25593991	SENT92	4	4	32	32	lapatinib	KIT	PA152241907	3815	0.985
NULL	Chin_J_Cancer_2012_Feb_31(2)_73-99.nxml.txt.nlp	22098950	SENT25	22	22	10	10	doxorubicin	MRP1	PA449412	4437	0.985
NULL	Core_Evid_2009_Jun_15_4_43-48.nxml.txt.nlp	20694064	SENT26	0	0	17	17	axitinib	VEGFR	PA164924493	3791	0.985
NULL	Aging_(Albany_NY)_2009_Jun_3_1(6)_515-528.nxml.txt.nlp	20157535	SENT130	3	3	34	34	resveratrol	SIRT1		23411	0.985
NULL	Braz_J_Med_Biol_Res_2013_Aug_13_46(8)_650-658.nxml.txt.nlp	23969971	SENT31	40	40	35	35	cisplatin	STAT3	PA449014	6774	0.985
NULL	J_Biomed_Sci_2012_Nov_21_19(1)_99.nxml.txt.nlp	23170833	SENT13	5	5	16	16	atorvastatin	CXCR4	PA448500	7852	0.985
NULL	Am_J_Trop_Med_Hyg_2014_Mar_5_90(3)_530-534.nxml.txt.nlp	24420779	SENT80	10	10	23	23	nevirapine	CYP3A	PA450616	1574	0.985
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT422	4	4	13	13	tamoxifen	STAT3	PA451581	6774	0.985
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT823	18	18	0	0	glucose	GLUT10	PA449773	81031;66035	0.985
NULL	F1000_Med_Rep_2010_Feb_24_2_16.nxml.txt.nlp	20948870	SENT55	7	7	25	25	lenalidomide	JAK2	PA162363968	3717	0.985
NULL	EMBO_Mol_Med_2013_Jun_22_5(6)_949-964.nxml.txt.nlp	23606570	SENT73	15	15	28	28	etoposide	p53	PA449552	7157	0.985
NULL	Open_Biochem_J_2011_Sep_23_5_45-51.nxml.txt.nlp	21966325	SENT31	1	1	9	9	diclofenac	PERK	PA449293	9451	0.985
NULL	Nat_Methods_2010_Feb_24_7(2)_148-155.nxml.txt.nlp	20101245	SENT104	14	14	2	2	heparin	FGFR1	PA449855	2260	0.985
NULL	Ann_Oncol_2012_Aug_6_23(8)_2103-2108.nxml.txt.nlp	22228446	SENT23	0	0	13	13	sorafenib	VEGFR	PA7000	3791	0.984
NULL	Cancer_Cell_Int_2011_Nov_17_11_40.nxml.txt.nlp	22088142	SENT119	18	18	3	3	gemcitabine	EGF	PA449748	1950	0.984
NULL	Int_J_Endocrinol_2011_Mar_6_2011_415719.nxml.txt.nlp	21461394	SENT68	6	6	29	29	cinacalcet	PTH	PA164776671	5741	0.984
NULL	Cell_Death_Dis_2014_Feb_13_5(2)_e1055.nxml.txt.nlp	24525731	SENT114	11	11	27	27	cisplatin	XRCC1	PA449014	7515	0.984
NULL	Mol_Biol_Int_2014_Sep_7_2014_852748.nxml.txt.nlp	25276427	SENT182	0	0	9	9	neratinib	HER2	PA165291472	2064	0.984
NULL	Curr_Med_Chem_2011_Jun_18(18)_2686-2714.nxml.txt.nlp	21649578	SENT656	32	32	18	18	carboplatin	PI3K	PA448803	5290	0.984
NULL	Oncotarget_2014_Oct_23_5(21)_10816-10829.nxml.txt.nlp	25333261	SENT181	7	7	43	43	doxorubicin	p53	PA449412	7157	0.984
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2735-2743.nxml.txt.nlp	24129244	SENT177	12	12	24	24	crizotinib	ALK	PA165946122	238	0.984
NULL	Front_Oncol_2013_Nov_15_3_281.nxml.txt.nlp	24298448	SENT98	7	7	26	26	sorafenib	BRAF	PA7000	673	0.984
NULL	Ann_Rheum_Dis_2011_Oct_12_71(4)_541-548.nxml.txt.nlp	21994233	SENT163	3	3	11	11	infliximab	IMPACT	PA452639	55364	0.984
NULL	Emerg_Infect_Dis_2003_Jul_9(7)_833-837.nxml.txt.nlp	12890324	SENT43	32	32	7	7	reserpine	BSP	PA451236	3381	0.984
NULL	J_Breast_Cancer_2014_Jun_27_17(2)_143-148.nxml.txt.nlp	25013435	SENT24	24	24	2	2	trastuzumab	HER2	PA451743	2064	0.984
NULL	Ann_Indian_Acad_Neurol_2010_Apr-Jun_13(2)_136-138.nxml.txt.nlp	20814499	SENT58	3	3	24	24	cyclophosphamide	CD4	PA449165	920	0.984
NULL	Environ_Health_Perspect_2006_Apr_21_114(Suppl_1)_142-146.nxml.txt.nlp	16818260	SENT32	7	7	22	22	diethylstilbestrol	DES	PA449307	1674	0.984
NULL	Br_J_Cancer_2013_Oct_15_109(8)_2131-2141.nxml.txt.nlp	24052043	SENT50	13	13	0	0	l-glutamine	PC-3	PA10090	692094	0.984
NULL	J_RNAi_Gene_Silencing_2010_May_29_6(1)_386-400.nxml.txt.nlp	20628499	SENT269	5	5	0	0	flavopiridol	ACH2	PA452627	641371	0.984
NULL	Clinicoecon_Outcomes_Res_2014_Oct_17_6_451-461.nxml.txt.nlp	25378939	SENT28	2	2	34	34	linezolid	HAP	PA450233	5915;10313	0.984
NULL	Mol_Cancer_2010_May_26_9_121.nxml.txt.nlp	20500904	SENT63	34	34	12	12	gefitinib	EGFR	PA131301952	1956	0.984
NULL	Arch_Drug_Inf_2011_Mar_4(1)_1-9.nxml.txt.nlp	21572514	SENT179	14	14	3	3	cyclosporine	P-gp	PA449167	5243	0.984
NULL	Mol_Cancer_2010_May_26_9_121.nxml.txt.nlp	20500904	SENT101	19	19	33	33	doxycycline	EGF	PA449415	1950	0.984
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_91-103.nxml.txt.nlp	17912639	SENT497	3	3	42	42	estradiol	aromatase	PA449503	1588	0.984
NULL	Curr_Control_Trials_Cardiovasc_Med_2001_Feb_2_2(1)_20-23.nxml.txt.nlp	11806769	SENT35	42	42	3	3	bucindolol	BEST	PA165945764	7439	0.984
NULL	ScientificWorldJournal_2013_Apr_9_2013_825375.nxml.txt.nlp	23710151	SENT116	5	5	11	11	ribavirin	IFN	PA451241	3439	0.984
NULL	Ann_Dermatol_2013_May_10_25(2)_135-144.nxml.txt.nlp	23717002	SENT18	0	0	8	8	vemurafenib	BRAF	PA165946873	673	0.984
NULL	Breast_Cancer_Res_2005_Nov_21_7(6)_R1153-R1158.nxml.txt.nlp	16457695	SENT96	11	11	20	20	tamoxifen	AIB1	PA451581	8202	0.984
NULL	Oncol_Rep_2013_Mar_8_29(3)_917-924.nxml.txt.nlp	23314174	SENT187	21	21	8	8	sorafenib	CD44	PA7000	960	0.984
NULL	Oncotarget_2014_Dec_4_5(22)_11365-11380.nxml.txt.nlp	25426548	SENT30	0	0	16	16	nutlin-3	MDM2		4193	0.984
NULL	J_Headache_Pain_2014_Dec_8_15(1)_85.nxml.txt.nlp	25488888	SENT182	4	4	28	28	eletriptan	5-HT1D	PA134687947	3352	0.984
NULL	Cancer_Med_2013_Feb_3_2(1)_11-20.nxml.txt.nlp	24133623	SENT246	9	9	1	1	cetuximab	KRAS	PA10040	3845	0.984
NULL	Acta_Pharmacol_Sin_2014_Sep_4_35(9)_1157-1166.nxml.txt.nlp	25088002	SENT123	27	27	10	10	curcumin	STAT3	PA151958596	6774	0.984
NULL	Ital_J_Pediatr_2012_Mar_30_38_11.nxml.txt.nlp	22464080	SENT13	11	11	19	19	oxatomide	CYP3A4	PA163522137	1576	0.984
NULL	Brain_2013_May_4_136(5)_1462-1475.nxml.txt.nlp	23460667	SENT265	28	28	19	19	bevacizumab	CD133	PA130232992	8842	0.984
NULL	Behav_Brain_Funct_2010_Aug_30_6_50.nxml.txt.nlp	20799992	SENT120	11	11	20	20	amphetamine	ADORA2A	PA448408	135	0.984
NULL	Br_J_Haematol_2008_Jun_141(5)_659-671.nxml.txt.nlp	18410446	SENT110	40	40	9	9	bortezomib	CD138	PA10252	6382	0.984
NULL	FEBS_Open_Bio_2014_Jan_6_4_77-89.nxml.txt.nlp	24490132	SENT114	33	33	2	2	ebselen	GDH	PA161660841	51084;2746	0.984
NULL	Breast_Cancer_Res_2004_Oct_6_6(6)_269-274.nxml.txt.nlp	15535858	SENT100	29	29	2	2	tamoxifen	ATAC	PA451581	6375	0.984
NULL	Int_J_Mol_Imaging_2011_Oct_26_2011_874585.nxml.txt.nlp	21490735	SENT156	14	14	3	3	glucose	FDG	PA449773	23583	0.984
NULL	Iran_J_Pharm_Res_2014_Autumn_13(4)_1393-1401.nxml.txt.nlp	25587329	SENT6	31	31	3	3	celecoxib	ABCG2	PA448871	9429	0.984
NULL	Arch_Drug_Inf_2011_Mar_4(1)_1-9.nxml.txt.nlp	21572514	SENT147	10	10	12	12	quinidine	P-gp	PA451209	5243	0.984
NULL	Pharmaceuticals_(Basel)_2011_Jun_15_4(6)_822-847.nxml.txt.nlp	NULL	SENT896	0	0	8	8	memantine	spatial	PA10364	219793	0.984
NULL	J_Neuroinflammation_2010_Nov_24_7_84.nxml.txt.nlp	21092323	SENT134	33	33	7	7	hydroxyurea	LTA	PA449942	4049	0.984
NULL	JAKSTAT_2013_Apr_1_2(2)_e23353.nxml.txt.nlp	24058806	SENT69	8	8	32	32	doxorubicin	STAT1	PA449412	6772	0.984
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT184	23	23	17	17	cisplatin	p53	PA449014	7157	0.984
NULL	Breast_Cancer_Res_2008_Mar_27_10(2)_R27.nxml.txt.nlp	18371219	SENT146	22	22	1	1	doxorubicin	PI3K	PA449412	5290	0.984
NULL	Pain_2014_Nov_155(11)_2243-2252.nxml.txt.nlp	24978826	SENT175	38	38	4	4	capsaicin	PTGER2	PA448776	5732	0.984
NULL	Oncol_Lett_2014_Oct_22_8(4)_1603-1607.nxml.txt.nlp	25202376	SENT86	4	4	18	18	cisplatin	XRCC1	PA449014	7515	0.984
NULL	Mol_Biol_Int_2014_Sep_7_2014_852748.nxml.txt.nlp	25276427	SENT139	0	0	17	17	trastuzumab	HER2	PA451743	2064	0.984
NULL	Ann_Hematol_2010_Sep_13_89(9)_861-871.nxml.txt.nlp	20387067	SENT91	3	3	24	24	dasatinib	CD34	PA162372878	947	0.984
NULL	Mol_Cancer_2007_Aug_21_6_53.nxml.txt.nlp	17711579	SENT133	32	32	5	5	cisplatin	p53	PA449014	7157	0.984
NULL	Protein_Cell_2014_May_26_5(5)_343-347.nxml.txt.nlp	24668462	SENT21	5	5	0	0	heparin	FGF18	PA449855	8817	0.984
NULL	BMB_Rep_2013_Nov_46(11)_544-549.nxml.txt.nlp	24152910	SENT65	27	27	10	10	thrombin	HMGB1	PA451674	3146	0.984
NULL	Case_Rep_Gastroenterol_2012_Jun_19_6(2)_381-386.nxml.txt.nlp	22855656	SENT75	0	0	5	5	clarithromycin	CYP3A	PA449028	1574	0.984
NULL	Endocrinol_Metab_(Seoul)_2014_Sep_25_29(3)_379-387.nxml.txt.nlp	25309798	SENT184	26	26	4	4	resveratrol	CLOCK		9575	0.984
NULL	Br_J_Cancer_1996_Jul_74(2)_274-279.nxml.txt.nlp	8688335	SENT13	42	42	16	16	cyclophosphamide	IFN	PA449165	3439	0.984
NULL	Biomed_Res_Int_2014_May_28_2014_203601.nxml.txt.nlp	24991539	SENT162	5	5	28	28	bevacizumab	VEGFR	PA130232992	3791	0.984
NULL	Breast_Cancer_Res_Treat_2013_Feb_4_137(3)_721-731.nxml.txt.nlp	23288344	SENT180	16	16	4	4	tamoxifen	SRC-3	PA451581	8202	0.984
NULL	Biologics_2009_Jul_13_3_289-301.nxml.txt.nlp	19707416	SENT107	21	21	13	13	lapatinib	HER2	PA152241907	2064	0.984
NULL	Blood_Cancer_J_2012_Jul_20_2(7)_e79.nxml.txt.nlp	22852048	SENT108	6	6	26	26	tubercidin	XBP1	PA152530738	7494	0.984
NULL	ScientificWorldJournal_2013_Apr_24_2013_928197.nxml.txt.nlp	23737732	SENT44	6	6	20	20	candesartan	ACR	PA448765	49	0.984
NULL	Int_J_Mol_Sci_2014_Sep_17_15(9)_16430-16457.nxml.txt.nlp	25233127	SENT92	9	9	21	21	capsaicin	TRPV1	PA448776	7442	0.984
NULL	Fibrogenesis_Tissue_Repair_2012_Jul_23_5_11.nxml.txt.nlp	22824096	SENT400	10	10	18	18	thrombin	PAR-1	PA451674	2011;2149	0.984
NULL	J_Mol_Med_(Berl)_2014_May_10_92(7)_709-722.nxml.txt.nlp	24811491	SENT247	9	9	3	3	panitumumab	BRAF	PA162373091	673	0.984
NULL	Oncol_Rep_2013_Jan_1_29(1)_13-20.nxml.txt.nlp	23128605	SENT169	17	17	4	4	trastuzumab	EGFR	PA451743	1956	0.984
NULL	Comput_Math_Methods_Med_2013_Mar_20_2013_802512.nxml.txt.nlp	23573174	SENT81	20	20	0	0	doxycycline	MYC	PA449415	4609	0.984
NULL	Blood_Cancer_J_2013_Jun_7_3(6)_e120.nxml.txt.nlp	23749045	SENT156	8	8	21	21	bortezomib	IGF1R	PA10252	3480	0.984
NULL	Breast_Cancer_Res_2007_Oct_1_9(5)_R64.nxml.txt.nlp	17908324	SENT24	0	0	11	11	trastuzumab	HER2	PA451743	2064	0.984
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Oct_30_66(Pt_11)_o2955.nxml.txt.nlp	21589123	SENT51	0	0	12	12	pazopanib	VEGFR	PA165291492	3791	0.984
NULL	Br_J_Cancer_2004_May_4_90(9)_1710-1714.nxml.txt.nlp	15150625	SENT89	11	11	22	22	oxaliplatin	GEM	PA131285527	2669	0.984
NULL	Behav_Genet_2008_Jul_7_38(4)_396-406.nxml.txt.nlp	18461434	SENT222	35	35	5	5	glucose	GLUT8	PA449773	29988;154091	0.984
NULL	J_Oncol_2010_Jan_14_2010_740472.nxml.txt.nlp	20130818	SENT148	1	1	30	30	gemcitabine	ERBB3	PA449748	2065	0.984
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT182	7	7	40	40	cisplatin	ASC	PA449014	29108	0.984
NULL	Pharmaceuticals_(Basel)_2013_Apr_17_6(4)_557-578.nxml.txt.nlp	24276125	SENT246	0	0	34	34	alefacept	CD2	PA164748040	914	0.984
NULL	Arch_Drug_Inf_2011_Mar_4(1)_1-9.nxml.txt.nlp	21572514	SENT35	25	25	29	29	vinblastine	P-gp	PA451877	5243	0.984
NULL	J_Hematol_Oncol_2013_Jan_15_6_5.nxml.txt.nlp	23320987	SENT195	19	19	2	2	heparin	PI-PLC	PA449855	2923	0.984
NULL	J_Oncol_2010_Nov_19_2010_568938.nxml.txt.nlp	20037743	SENT163	15	15	19	19	erlotinib	EGFR	PA134687924	1956	0.984
NULL	Front_Cell_Neurosci_2014_Jun_17_8_174.nxml.txt.nlp	24987335	SENT81	30	30	21	21	finasteride	TSPO	PA449627	706	0.984
NULL	Ann_Oncol_2009_Aug_17_20(8)_1319-1329.nxml.txt.nlp	19535820	SENT222	2	2	6	6	tamoxifen	aromatase	PA451581	1588	0.984
NULL	Oncotarget_2014_Jun_26_5(14)_5559-5569.nxml.txt.nlp	24980819	SENT193	18	18	10	10	vemurafenib	BRAF	PA165946873	673	0.984
NULL	Neuropsychopharmacology_2011_Dec_10_36(13)_2689-2697.nxml.txt.nlp	21832988	SENT125	13	13	39	39	citalopram	ANOVA	PA449015	4858	0.984
NULL	J_Cachexia_Sarcopenia_Muscle_2011_Dec_8_2(4)_209-261.nxml.txt.nlp	22476871	SENT92	7	7	17	17	resveratrol	SIRT1		23411	0.984
NULL	Diabetes_Care_2010_May_15_33(5)_1134-1139.nxml.txt.nlp	20185740	SENT114	10	10	24	24	ezetimibe	IL-6	PA10816	3569	0.984
NULL	Adv_Urol_2012_Sep_9_2012_181964.nxml.txt.nlp	22991510	SENT32	5	5	3	3	gefitinib	EGFR	PA131301952	1956	0.984
NULL	Arthritis_Res_Ther_2004_Feb_24_6(Suppl_1)_24.nxml.txt.nlp	NULL	SENT7	26	26	0	0	etanercept	OPG	PA449515	690	0.984
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_P124.nxml.txt.nlp	NULL	SENT12	22	22	0	0	phenytoin	HLA-B	PA450947	3106	0.984
NULL	J_Pregnancy_2012_Sep_17_2012_482690.nxml.txt.nlp	23029616	SENT181	11	11	0	0	glucose	GLP-1	PA449773	100125288	0.984
NULL	Int_J_Biol_Sci_2014_Jun_10_10(7)_654-663.nxml.txt.nlp	25013375	SENT210	0	0	25	25	itraconazole	SMO	PA450132	6608;54498	0.984
NULL	Breast_Cancer_Res_2005_Jul_29_7(5)_E6.nxml.txt.nlp	16168100	SENT10	18	18	28	28	tamoxifen	SULT1A1	PA451581	6817	0.984
NULL	J_Hematol_Oncol_2011_Apr_20_4_16.nxml.txt.nlp	21504625	SENT51	14	14	20	20	nutlin-3	MDM4		4194	0.984
NULL	Curr_Opin_Pharmacol_2012_Dec_12(6)_653-658.nxml.txt.nlp	23063456	SENT83	23	23	15	15	dextran	GPR55	PA449261	9290	0.984
NULL	Acta_Pharmacol_Sin_2010_Feb_5_31(2)_184-190.nxml.txt.nlp	20139901	SENT120	7	7	18	18	metformin	OCT1	PA450395	5451;6580	0.984
NULL	J_Oncol_2012_Aug_14_2012_408131.nxml.txt.nlp	22934112	SENT216	14	14	17	17	erlotinib	EGFR	PA134687924	1956	0.984
NULL	J_Cancer_2013_Nov_21_4(9)_727-735.nxml.txt.nlp	24312143	SENT159	34	34	2	2	cisplatin	SRPK1	PA449014	6732	0.984
NULL	Front_Neurosci_2013_Jul_31_7_132.nxml.txt.nlp	23914152	SENT210	31	31	17	17	imipramine	NAT	PA449969	6046	0.984
NULL	J_Oncol_2012_Mar_11_2012_382159.nxml.txt.nlp	22481926	SENT89	2	2	8	8	pertuzumab	HER2		2064	0.984
NULL	Case_Rep_Oncol_2012_Mar_17_5(1)_125-133.nxml.txt.nlp	22666200	SENT44	0	0	23	23	trastuzumab	ERBB2	PA451743	2064	0.984
NULL	Gynecol_Oncol_Case_Rep_2013_Jun_12_6_34-35.nxml.txt.nlp	24371715	SENT63	0	0	4	4	ifosfamide	CYP3A4	PA449964	1576	0.984
NULL	Biomed_Res_Int_2014_Jan_15_2014_859871.nxml.txt.nlp	24527460	SENT18	13	13	41	41	bevacizumab	EGFR	PA130232992	1956	0.984
NULL	Cancers_(Basel)_2010_Jul_27_2(3)_1528-1554.nxml.txt.nlp	24281171	SENT332	10	10	0	0	daunorubicin	CD34	PA449212	947	0.984
NULL	J_Oncol_2012_Aug_9_2012_685213.nxml.txt.nlp	22934113	SENT226	7	7	22	22	gefitinib	POMC	PA131301952	5443	0.984
NULL	Cell_Death_Dis_2010_Oct_21_1(10)_e86.nxml.txt.nlp	21368859	SENT69	21	21	2	2	doxorubicin	BimEL	PA449412	10018	0.984
NULL	Open_Med_2007_Dec_18_1(3)_e184-e190.nxml.txt.nlp	21673951	SENT80	20	20	11	11	tamoxifen	BRCA1	PA451581	672	0.984
NULL	J_Cell_Biol_2000_Aug_7_150(3)_613-626.nxml.txt.nlp	10931872	SENT703	18	18	3	3	paraformaldehyde	CEA	PA450790	5670;1087	0.984
NULL	J_Cell_Mol_Med_2013_Oct_23_17(10)_1207-1217.nxml.txt.nlp	24106980	SENT75	9	9	1	1	paclitaxel	MAD2	PA450761	4085;4601	0.984
NULL	J_Cardiovasc_Dis_Res_2012_Oct-Dec_3(4)_319-322.nxml.txt.nlp	23233778	SENT13	5	5	9	9	erythromycin	CYP3A4	PA449493	1576	0.984
NULL	Cell_Death_Dis_2013_Sep_5_4(9)_e791.nxml.txt.nlp	24008735	SENT55	23	23	38	38	gemcitabine	p53	PA449748	7157	0.984
NULL	Cell_Microbiol_2014_Apr_6_16(4)_519-534.nxml.txt.nlp	24152255	SENT264	23	23	29	29	glucosamine	DC-SIGN	PA164747613	30835	0.984
NULL	Ann_Lab_Med_2014_Jul_19_34(4)_321-324.nxml.txt.nlp	24982839	SENT50	22	22	3	3	moxifloxacin	DST	PA450555	667	0.984
NULL	Oncol_Lett_2014_Jul_25_8(1)_313-316.nxml.txt.nlp	24959268	SENT56	8	8	18	18	sulindac	PC-3	PA451565	692094	0.984
NULL	Breast_Cancer_Res_2010_Mar_5_12(2)_R16.nxml.txt.nlp	20205716	SENT346	3	3	10	10	lovastatin	DJ-1	PA450272	11315	0.984
NULL	Chin_J_Cancer_2012_Feb_31(2)_73-99.nxml.txt.nlp	22098950	SENT251	8	8	16	16	sunitinib	P-gp	PA162372840	5243	0.984
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT143	30	30	42	42	dasatinib	JNK	PA162372878	5599	0.984
NULL	J_Thromb_Thrombolysis_2011_Nov_26_32(4)_459-466.nxml.txt.nlp	21706290	SENT99	21	21	14	14	prasugrel	CYP2C19	PA154410481	1557	0.984
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S31-S40.nxml.txt.nlp	20680106	SENT12	15	15	3	3	panitumumab	KRAS	PA162373091	3845	0.984
NULL	Acta_Pharmacol_Sin_2010_Jul_28_31(7)_867-873.nxml.txt.nlp	20581857	SENT46	17	17	0	0	docetaxel	PC3	PA449383	57332;7832;5122	0.984
NULL	J_Cell_Biol_2004_Jan_19_164(2)_219-231.nxml.txt.nlp	14734533	SENT221	0	0	14	14	galactose	CDC20	PA449725	991	0.984
NULL	Ecancermedicalscience_2009_Oct_29_3_157.nxml.txt.nlp	22276018	SENT71	6	6	37	37	tamoxifen	HER3	PA451581	2065	0.984
NULL	J_Immunol_Res_2014_Oct_12_2014_570685.nxml.txt.nlp	25371908	SENT145	2	2	13	13	levofloxacin	IL-6	PA450214	3569	0.984
NULL	Int_J_Gen_Med_2013_Dec_4_6_877-895.nxml.txt.nlp	24403842	SENT55	0	0	14	14	exenatide	GLP-1	PA164749238	100125288	0.984
NULL	Iran_J_Pharm_Res_2013_Winter_12(Suppl)_37-46.nxml.txt.nlp	24250670	SENT19	0	0	9	9	etoposide	P-gp	PA449552	5243	0.984
NULL	Cardiol_Res_Pract_2011_May_10_2011_816897.nxml.txt.nlp	21629798	SENT92	0	0	16	16	sorafenib	UGT1A9	PA7000	54600	0.984
NULL	J_Gen_Intern_Med_2012_Jun_31_27(Suppl_1)_83-93.nxml.txt.nlp	22648679	SENT145	11	11	5	5	warfarin	CYP2C9	PA451906	1559	0.984
NULL	Biologics_2012_Sep_25_6_337-345.nxml.txt.nlp	23055691	SENT104	20	20	11	11	afatinib	EGFR	PA165981154	1956	0.984
NULL	Braz_J_Med_Biol_Res_2013_Jun_25_46(6)_528-532.nxml.txt.nlp	23802228	SENT84	25	25	8	8	rosiglitazone	PON1	PA451283	5444	0.984
NULL	Cardiovasc_Diabetol_2010_Nov_16_9_76.nxml.txt.nlp	21080957	SENT28	31	31	5	5	exenatide	GLP-1	PA164749238	100125288	0.984
NULL	Diabetes_Care_2013_May_13_36(5)_1074-1082.nxml.txt.nlp	23275352	SENT215	21	21	8	8	liraglutide	ZAG	PA165958364	563	0.984
NULL	J_Oncol_2010_Jan_14_2010_740472.nxml.txt.nlp	20130818	SENT69	0	0	7	7	bevacizumab	VEGF-A	PA130232992	7422	0.984
NULL	Exp_Ther_Med_2013_Apr_29_5(4)_1093-1096.nxml.txt.nlp	23596475	SENT96	3	3	33	33	ketamine	IL-6	PA450144	3569	0.984
NULL	Eplasty_2009_Jan_15_9_e6.nxml.txt.nlp	19221583	SENT103	27	27	31	31	anastrozole	aromatase	PA448432	1588	0.984
NULL	Cancer_Cell_Int_2013_Nov_8_13_111.nxml.txt.nlp	24209962	SENT155	9	9	3	3	fluvastatin	A20	PA449688	7128;28935	0.984
NULL	Breast_Cancer_Res_2000_Oct_20_2(1)_E002.nxml.txt.nlp	NULL	SENT34	20	20	1	1	tamoxifen	aromatase	PA451581	1588	0.984
NULL	Acta_Physiol_(Oxf)_2012_Feb_204(2)_227-237.nxml.txt.nlp	21624095	SENT192	4	4	21	21	propofol	TRPC5	PA451141	7224	0.984
NULL	Biosci_Rep_2013_Jun_11_33(3)_e00042.nxml.txt.nlp	23634903	SENT45	17	17	3	3	l-glutamine	PC3	PA10090	57332;7832;5122	0.984
NULL	J_Headache_Pain_2013_Jan_30_14(1)_6.nxml.txt.nlp	23565828	SENT180	44	44	28	28	gentamicin	PTGDS	PA449753	5730	0.984
NULL	Front_Behav_Neurosci_2011_Sep_8_5_56.nxml.txt.nlp	21927600	SENT216	4	4	19	19	morphine	CPP	PA450550	340451	0.984
NULL	Int_J_Surg_Oncol_2012_May_17_2012_406830.nxml.txt.nlp	22675625	SENT81	22	22	8	8	cetuximab	KRAS	PA10040	3845	0.984
NULL	Oncogene_2014_Jun_5_33(23)_3004-3013.nxml.txt.nlp	23831571	SENT30	7	7	29	29	etoposide	FADD	PA449552	8772	0.984
NULL	Breast_Cancer_(Auckl)_2009_Aug_17_3_47-60.nxml.txt.nlp	21556249	SENT48	45	45	24	24	tamoxifen	AF-1	PA451581	3460;5710	0.984
NULL	Acta_Pharmacol_Sin_2009_Jul_22_30(7)_956-964.nxml.txt.nlp	19543298	SENT11	5	5	26	26	simvastatin	ABCB1	PA451363	5243	0.984
NULL	Indian_J_Med_Paediatr_Oncol_2013_Apr-Jun_34(2)_101-103.nxml.txt.nlp	24049297	SENT23	14	14	35	35	etoposide	FDG	PA449552	23583	0.984
NULL	Tuberc_Respir_Dis_(Seoul)_2012_Dec_28_73(6)_303-311.nxml.txt.nlp	23319992	SENT130	18	18	8	8	gefitinib	EGFR	PA131301952	1956	0.984
NULL	Nucleic_Acids_Res_2013_Dec_17_41(22)_10371-10378.nxml.txt.nlp	24049076	SENT158	30	30	2	2	cisplatin	MEC1	PA449014	545	0.984
NULL	Cardiovasc_Ther_2009_27(4)_259-274.nxml.txt.nlp	19604248	SENT60	38	38	5	5	prasugrel	P2Y12	PA154410481	64805	0.984
NULL	Ann_Rheum_Dis_2008_Jul_22_68(8)_1303-1309.nxml.txt.nlp	18647851	SENT16	28	28	6	6	adalimumab	MMP13	PA10004	4322	0.984
NULL	ScientificWorldJournal_2012_Apr_1_2012_381434.nxml.txt.nlp	22545017	SENT323	48	48	1	1	aprepitant	NK-1	PA164747039	27087	0.984
NULL	Br_J_Pharmacol_2008_Dec_25_155(7)_1056-1065.nxml.txt.nlp	18724386	SENT128	18	18	0	0	diazoxide	GLP-1	PA449285	100125288	0.984
NULL	Braz_J_Med_Biol_Res_2014_Feb_17_47(2)_101-109.nxml.txt.nlp	24519125	SENT128	30	30	8	8	propranolol	IL-6	PA451145	3569	0.984
NULL	J_Invest_Dermatol_2014_Feb_10_134(2)_319-325.nxml.txt.nlp	24108405	SENT119	14	14	7	7	vemurafenib	PTEN	PA165946873	5728	0.984
NULL	J_Ayurveda_Integr_Med_2010_Oct-Dec_1(4)_273-279.nxml.txt.nlp	21731374	SENT13	11	11	15	15	letrozole	aromatase	PA450196	1588	0.984
NULL	Fibrogenesis_Tissue_Repair_2012_Jul_23_5_11.nxml.txt.nlp	22824096	SENT392	23	23	29	29	thrombin	PAR-1	PA451674	2011;2149	0.984
NULL	Ann_Rheum_Dis_2011_Feb_22_70(6)_1160-1162.nxml.txt.nlp	21345816	SENT73	23	23	8	8	adalimumab	CD14	PA10004	929	0.984
NULL	Clin_Interv_Aging_2013_Sep_27_8_1313-1321.nxml.txt.nlp	24101867	SENT75	33	33	12	12	alfacalcidol	BSAP	PA164746469	5079	0.984
NULL	Oxid_Med_Cell_Longev_2013_Jun_11_2013_870472.nxml.txt.nlp	23840921	SENT108	3	3	14	14	chloroquine	CD163	PA448948	9332	0.984
NULL	Oncogene_2010_Jul_15_29(28)_4090-4100.nxml.txt.nlp	20473326	SENT92	24	24	6	6	camptothecin	p53	PA153590860	7157	0.984
NULL	Clin_Epigenetics_2011_Jun_27_2(2)_171-185.nxml.txt.nlp	21949547	SENT143	33	33	9	9	fulvestrant	EZH2	PA164747170	2146	0.984
NULL	Int_J_Surg_Oncol_2012_Jun_12_2012_862879.nxml.txt.nlp	22778941	SENT64	30	30	5	5	cisplatin	MRP2	PA449014	100130958;57626;1244	0.984
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT544	8	8	25	25	domperidone	PRL	PA134711056	5617	0.984
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Jul_21_9_20.nxml.txt.nlp	20663145	SENT69	25	25	1	1	ciprofloxacin	LBH	PA449009	81606;221491	0.984
NULL	Indian_J_Nephrol_2009_Jul_19(3)_119-121.nxml.txt.nlp	20436733	SENT59	6	6	24	24	cyclosporine	MRP2	PA449167	100130958;57626;1244	0.984
NULL	Breast_Cancer_Res_2008_Dec_4_10(6)_R103.nxml.txt.nlp	19055788	SENT28	26	26	34	34	tamoxifen	14-3-3	PA451581	10971	0.984
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Aug_30_64(Pt_9)_o1863.nxml.txt.nlp	21201832	SENT56	17	17	6	6	ethanol	mol	PA448073	90527	0.984
NULL	Am_J_Pathol_2011_Mar_178(3)_1245-1256.nxml.txt.nlp	21356375	SENT233	13	13	11	11	indomethacin	COX	PA449982	1351	0.984
NULL	Exp_Ther_Med_2014_Jul_8_8(1)_165-168.nxml.txt.nlp	24944616	SENT55	22	22	39	39	fluorescein	CD4	PA164746009	920	0.984
NULL	Bioinformation_2012_Apr_30_8(8)_353-358.nxml.txt.nlp	22570515	SENT22	3	3	1	1	flurbiprofen	COX2	PA449683	4513;5743	0.984
NULL	Biomed_Res_Int_2014_Apr_28_2014_549742.nxml.txt.nlp	24877113	SENT87	20	20	1	1	vincristine	CD133	PA451879	8842	0.984
NULL	Cell_Death_Dis_2014_Feb_13_5(2)_e1055.nxml.txt.nlp	24525731	SENT92	19	19	6	6	cisplatin	XRCC1	PA449014	7515	0.984
NULL	Arthritis_Res_Ther_2012_May_1_14(3)_R99.nxml.txt.nlp	22546542	SENT59	40	40	1	1	infliximab	CD4	PA452639	920	0.984
NULL	Oncotarget_2011_Mar_10_2(3)_186-196.nxml.txt.nlp	21406729	SENT120	21	21	2	2	orlistat	FADD	PA164776864	8772	0.984
NULL	Front_Zool_2011_Nov_29_8_31.nxml.txt.nlp	22126599	SENT129	3	3	33	33	pp2	PP2		4888	0.984
NULL	Curr_Neuropharmacol_2013_Dec_11(6)_652-663.nxml.txt.nlp	24396340	SENT79	4	4	28	28	paclitaxel	TRPA1	PA450761	8989	0.984
NULL	Emerg_Infect_Dis_2012_Apr_18(4)_689-691.nxml.txt.nlp	22469015	SENT32	28	28	5	5	ribavirin	IFN	PA451241	3439	0.984
NULL	Gastric_Cancer_2013_Jul_12_16(3)_345-354.nxml.txt.nlp	22968820	SENT150	21	21	8	8	oxaliplatin	FANCJ	PA131285527	83990	0.984
NULL	Am_J_Cardiovasc_Drugs_2013_Jun_20_13(5)_331-342.nxml.txt.nlp	23784266	SENT183	10	10	33	33	verapamil	P-gp	PA451868	5243	0.984
NULL	Nature_2007_Jan_25_445(7126)_437-441.nxml.txt.nlp	17206155	SENT42	6	6	24	24	gefitinib	HER2	PA131301952	2064	0.984
NULL	BMJ_2010_Feb_8_340_c693.nxml.txt.nlp	20142325	SENT147	0	0	20	20	tamoxifen	CYP2D6	PA451581	1565	0.984
NULL	Tumour_Biol_2012_Jun_21_33(3)_607-615.nxml.txt.nlp	22270450	SENT89	37	37	3	3	bevacizumab	HER2	PA130232992	2064	0.984
NULL	Exp_Ther_Med_2015_Jan_18_9(1)_105-111.nxml.txt.nlp	25452783	SENT35	6	6	19	19	celecoxib	ABCG2	PA448871	9429	0.984
NULL	J_Hum_Genet_2009_Sep_24_54(9)_516-524.nxml.txt.nlp	19629138	SENT116	18	18	10	10	doxycycline	POLG	PA449415	5428	0.984
NULL	Case_Rep_Oncol_2014_Apr_25_7(1)_273-276.nxml.txt.nlp	24926256	SENT16	3	3	33	33	sorafenib	EGFR	PA7000	1956	0.984
NULL	Cancers_(Basel)_2013_Jan_21_5(1)_64-91.nxml.txt.nlp	24216699	SENT46	0	0	15	15	cetuximab	EGFR	PA10040	1956	0.984
NULL	Mol_Cancer_2007_Sep_26_6_61.nxml.txt.nlp	17894897	SENT48	0	0	20	20	etoposide	p53	PA449552	7157	0.984
NULL	Breast_Cancer_Res_2008_Feb_15_10(1)_R18.nxml.txt.nlp	18279516	SENT223	19	19	39	39	celecoxib	aromatase	PA448871	1588	0.984
NULL	J_Gen_Physiol_2003_Jan_121(1)_61-72.nxml.txt.nlp	12508054	SENT207	0	0	7	7	tetracaine	CNGA1	PA451638	1259	0.984
NULL	Clin_Interv_Aging_2013_Apr_29_8_467-483.nxml.txt.nlp	23766636	SENT44	0	0	15	15	ranibizumab	VEGF-A	PA164746012	7422	0.984
NULL	Clinics_(Sao_Paulo)_2014_Jun_69(6)_438-446.nxml.txt.nlp	24964310	SENT82	8	8	13	13	raloxifene	RANKL	PA451221	8600	0.984
NULL	Biologics_2013_Apr_26_7_91-101.nxml.txt.nlp	23671386	SENT101	3	3	26	26	crizotinib	KRAS	PA165946122	3845	0.984
NULL	Arthritis_Res_Ther_2008_Jan_7_10(1)_R1.nxml.txt.nlp	18179697	SENT10	0	0	13	13	oxaliplatin	HMGB1	PA131285527	3146	0.984
NULL	Cancers_(Basel)_2011_May_9_3(2)_2286-2301.nxml.txt.nlp	24212810	SENT177	13	13	3	3	gemcitabine	EGFR	PA449748	1956	0.984
NULL	Br_J_Cancer_2013_Jul_23_109(2)_351-359.nxml.txt.nlp	23799854	SENT146	2	2	24	24	verapamil	P-gp	PA451868	5243	0.984
NULL	Cell_Death_Dis_2014_Feb_13_5(2)_e1055.nxml.txt.nlp	24525731	SENT90	33	33	11	11	cisplatin	TXNL1	PA449014	9352	0.984
NULL	ScientificWorldJournal_2013_Jun_5_2013_704912.nxml.txt.nlp	23844410	SENT19	14	14	31	31	ribavirin	SOC	PA451241	91544	0.984
NULL	Oncol_Lett_2014_Mar_16_7(3)_871-877.nxml.txt.nlp	24527095	SENT4	0	0	17	17	paclitaxel	TLR4	PA450761	7099	0.984
NULL	Oncogene_2014_Feb_6_33(6)_713-723.nxml.txt.nlp	23435429	SENT7	15	15	24	24	camptothecin	BRCA1	PA153590860	672	0.984
NULL	Antiviral_Res_2009_May_82(2)_A99-A109.nxml.txt.nlp	19176219	SENT116	31	31	7	7	abacavir	MRP-1	PA448004	928	0.984
NULL	Neuro_Oncol_2010_Apr_27_12(4)_389-400.nxml.txt.nlp	20308316	SENT78	46	46	32	32	chloroquine	p53	PA448948	7157	0.984
NULL	Br_J_Cancer_2006_Dec_4_95(11)_1483-1489.nxml.txt.nlp	17106442	SENT15	0	0	28	28	gefitinib	EGFR	PA131301952	1956	0.984
NULL	Cell_Death_Dis_2013_Oct_3_4(10)_e828.nxml.txt.nlp	24091671	SENT76	0	0	12	12	cetuximab	EGFR	PA10040	1956	0.984
NULL	Cancers_(Basel)_2014_Oct_24_6(4)_2187-2223.nxml.txt.nlp	25347122	SENT119	28	28	0	0	cisplatin	BRCA1	PA449014	672	0.984
NULL	J_Mol_Signal_2011_Jul_20_6_7.nxml.txt.nlp	21774804	SENT6	12	12	28	28	dasatinib	CD133	PA162372878	8842	0.984
NULL	Mol_Cancer_2014_Jun_9_13_146.nxml.txt.nlp	24913494	SENT246	12	12	27	27	metformin	MID1	PA450395	4281	0.984
NULL	Case_Rep_Oncol_Med_2013_Sep_26_2013_234391.nxml.txt.nlp	24191208	SENT12	0	0	17	17	lapatinib	HER2	PA152241907	2064	0.984
NULL	BMJ_Open_2014_Feb_27_4(2)_e004071.nxml.txt.nlp	24578536	SENT136	15	15	22	22	warfarin	TTR	PA451906	7276	0.984
NULL	Arthritis_Res_Ther_2005_Feb_17_7(Suppl_1)_P74.nxml.txt.nlp	NULL	SENT7	21	21	25	25	losartan	AT1	PA450268	9197;185	0.984
NULL	Atherosclerosis_2011_Nov_219(1)_109-115.nxml.txt.nlp	21820657	SENT36	14	14	12	12	torcetrapib	CETP	PA145007158	1071	0.984
NULL	J_Biol_Chem_2010_Aug_20_285(34)_26406-26416.nxml.txt.nlp	20530490	SENT8	28	28	8	8	artemisinin	SERCA1	PA165111696	487	0.984
NULL	Oncotarget_2012_Oct_20_3(10)_1068-1111.nxml.txt.nlp	23085539	SENT74	2	2	5	5	sorafenib	Raf-1	PA7000	5894	0.984
NULL	Clin_Ophthalmol_2014_Sep_22_8_1891-1911.nxml.txt.nlp	25284976	SENT140	0	0	23	23	daclizumab	IL-2	PA164764446	3558	0.984
NULL	Cell_Death_Dis_2014_Feb_13_5(2)_e1055.nxml.txt.nlp	24525731	SENT282	14	14	1	1	cisplatin	XRCC1	PA449014	7515	0.984
NULL	EPMA_J_2012_Sep_27_3(1)_10.nxml.txt.nlp	23016735	SENT124	20	20	7	7	warfarin	CYP2C9	PA451906	1559	0.984
NULL	Endocr_Relat_Cancer_2014_Apr_21(2)_355-369.nxml.txt.nlp	24481325	SENT31	6	6	25	25	estradiol	GPER	PA449503	2852	0.984
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT321	30	30	10	10	cisplatin	XIAP	PA449014	331	0.984
NULL	Br_J_Pharmacol_2012_Jan_165(2)_380-389.nxml.txt.nlp	21585347	SENT134	28	28	9	9	rosiglitazone	ATGL	PA451283	57104	0.984
NULL	Clin_Epigenetics_2010_Sep_18_1(3-4)_101-116.nxml.txt.nlp	21258631	SENT260	4	4	23	23	resveratrol	p300		2033	0.984
NULL	Expert_Rev_Mol_Med_2009_May_11_e16.nxml.txt.nlp	19467172	SENT481	32	32	20	20	fasudil	Rho	PA165946121	29984	0.984
NULL	Breast_Cancer_Res_2012_Feb_14_14(1)_R31.nxml.txt.nlp	22333393	SENT270	12	12	5	5	tamoxifen	NAT1	PA451581	9;1982	0.984
NULL	Hum_Genomics_Proteomics_2010_Aug_3_2010_159761.nxml.txt.nlp	20981231	SENT148	19	19	42	42	lithium	HDAC	PA450243	9734	0.984
NULL	Arthritis_Res_2001_Nov_9_3(1)_65-71.nxml.txt.nlp	11178128	SENT132	13	13	5	5	methotrexate	CXCL8	PA450428	3576	0.984
NULL	Oncotarget_2014_Aug_4_5(17)_7776-7787.nxml.txt.nlp	25277200	SENT160	29	29	12	12	carboplatin	ATP7B	PA448803	540	0.984
NULL	F1000Prime_Rep_2014_Aug_1_6_66.nxml.txt.nlp	25165565	SENT112	0	0	26	26	pertuzumab	HER2		2064	0.984
NULL	Cell_Biochem_Biophys_2013_May_28_67(1)_25-43.nxml.txt.nlp	23712866	SENT273	34	34	0	0	etoposide	OTUB1	PA449552	55611	0.984
NULL	Arthritis_Res_Ther_2006_May_5_8(3)_R83.nxml.txt.nlp	16677395	SENT165	15	15	41	41	rituximab	CD4	PA451261	920	0.984
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1427-1436.nxml.txt.nlp	24096601	SENT162	0	0	10	10	erlotinib	EGFR	PA134687924	1956	0.984
NULL	J_Cell_Biol_2002_Nov_25_159(4)_637-648.nxml.txt.nlp	12438416	SENT162	18	18	12	12	etoposide	p115	PA449552	8615;393	0.984
NULL	Arq_Bras_Cardiol_2013_Nov_101(5)_379-387.nxml.txt.nlp	24100691	SENT33	24	24	4	4	sirolimus	DES	PA451365	1674	0.984
NULL	Diabetes_Care_2010_Jul_31_33(7)_1509-1515.nxml.txt.nlp	20357372	SENT133	4	4	22	22	exenatide	GLP-1	PA164749238	100125288	0.984
NULL	J_Cell_Mol_Med_2014_May_14_18(5)_811-823.nxml.txt.nlp	24628949	SENT138	2	2	35	35	docetaxel	FOXM1	PA449383	2305	0.984
NULL	Arthritis_Res_Ther_2011_Feb_4_13(1)_R14.nxml.txt.nlp	21294864	SENT115	38	38	12	12	indomethacin	M-CSF	PA449982	1435	0.984
NULL	Case_Rep_Hematol_2013_Sep_30_2013_628513.nxml.txt.nlp	24198984	SENT94	14	14	3	3	cyclosporine	FVIII	PA449167	2157	0.984
NULL	Br_J_Cancer_2009_Jul_21_101(2)_263-268.nxml.txt.nlp	19603032	SENT172	29	29	2	2	denosumab	RANKL	PA166048634	8600	0.984
NULL	Antiviral_Res_2009_May_82(2)_A99-A109.nxml.txt.nlp	19176219	SENT116	33	33	7	7	emtricitabine	MRP-1	PA10069	928	0.984
NULL	Oncotarget_2014_Jun_30_5(12)_4011-4025.nxml.txt.nlp	24994117	SENT106	8	8	0	0	estradiol	ISG15	PA449503	9636	0.984
NULL	Eur_J_Clin_Pharmacol_2014_Mar_22_70(6)_685-693.nxml.txt.nlp	24658827	SENT4	5	5	15	15	cyclosporine	CYP3A5	PA449167	1577	0.984
NULL	J_Clin_Biochem_Nutr_2009_Jan_27_44(1)_79-84.nxml.txt.nlp	19177192	SENT81	3	3	9	9	curcumin	HO-1	PA151958596	3162	0.984
NULL	Acta_Neuropathol_2013_May_22_125(5)_683-698.nxml.txt.nlp	23429996	SENT233	11	11	0	0	cetuximab	EGFR	PA10040	1956	0.984
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT264	17	17	25	25	resveratrol	TRAIL		8743	0.984
NULL	Mol_Cancer_2007_Oct_11_6_63.nxml.txt.nlp	17931419	SENT84	25	25	34	34	cetuximab	EGFR	PA10040	1956	0.984
NULL	Arch_Drug_Inf_2011_Mar_4(1)_1-9.nxml.txt.nlp	21572514	SENT136	3	3	27	27	ciprofloxacin	P-gp	PA449009	5243	0.984
NULL	Lab_Invest_2012_Mar_12_92(3)_420-436.nxml.txt.nlp	22157717	SENT306	30	30	3	3	carbachol	CD133	PA448784	8842	0.984
NULL	Mol_Cancer_2010_May_28_9_130.nxml.txt.nlp	20509890	SENT67	19	19	4	4	paclitaxel	TGFBI	PA450761	7045	0.984
NULL	J_Cheminform_2012_Mar_8_4_6.nxml.txt.nlp	22401035	SENT317	29	29	5	5	rosiglitazone	CYP3A4	PA451283	1576	0.984
NULL	Ann_Dermatol_2012_May_26_24(2)_230-232.nxml.txt.nlp	22577282	SENT39	13	13	35	35	phenytoin	CYP2C19	PA450947	1557	0.984
NULL	J_Cell_Mol_Med_2013_Jan_10_17(1)_30-54.nxml.txt.nlp	23301832	SENT222	18	18	24	24	daunorubicin	HIF-1	PA449212	29072	0.984
NULL	Clin_Med_Insights_Oncol_2011_Sep_21_5_315-323.nxml.txt.nlp	22084620	SENT138	9	9	39	39	gemcitabine	pT1	PA449748	58492	0.984
NULL	Cardiovasc_Diabetol_2013_Nov_12_12_169.nxml.txt.nlp	24215514	SENT290	4	4	14	14	aliskiren	ANG	PA143487910	283	0.984
NULL	J_Aging_Res_2011_Sep_28_2011_251517.nxml.txt.nlp	21969914	SENT136	15	15	18	18	letrozole	aromatase	PA450196	1588	0.984
NULL	Behav_Genet_2012_Jul_17_42(4)_509-527.nxml.txt.nlp	22426781	SENT138	10	10	8	8	letrozole	aromatase	PA450196	1588	0.984
NULL	Angiogenesis_2010_Dec_7_13(4)_305-315.nxml.txt.nlp	20927579	SENT209	7	7	3	3	resveratrol	p53		7157	0.984
NULL	Acta_Pharmacol_Sin_2013_Sep_5_34(9)_1208-1216.nxml.txt.nlp	23852087	SENT101	20	20	2	2	disulfiram	HIF-1	PA449376	29072	0.984
NULL	Chemother_Res_Pract_2012_Dec_20_2012_743193.nxml.txt.nlp	23320171	SENT5	0	0	3	3	trastuzumab	HER2	PA451743	2064	0.984
NULL	Scientifica_(Cairo)_2013_Dec_10_2013_691251.nxml.txt.nlp	24386592	SENT73	5	5	25	25	nadh	P2X7	PA164755085	5027	0.984
NULL	Indian_J_Med_Res_2013_Mar_137(3)_527-532.nxml.txt.nlp	23640560	SENT90	38	38	8	8	cisplatin	PARP-1	PA449014	25976	0.984
NULL	Mol_Brain_2014_Apr_3_7_25.nxml.txt.nlp	24708812	SENT242	20	20	5	5	chlorpheniramine	ERK	PA448960	5594	0.984
NULL	Respir_Med_Case_Rep_2013_Jul_17_10_10-12.nxml.txt.nlp	NULL	SENT59	18	18	8	8	erlotinib	EGFR	PA134687924	1956	0.984
NULL	Ann_Lab_Med_2012_Sep_13_32(5)_370-374.nxml.txt.nlp	22950075	SENT49	40	40	1	1	mannitol	API	PA450320	5345	0.984
NULL	Acta_Oncol_2013_May_13_52(4)_776-782.nxml.txt.nlp	23480638	SENT150	41	41	15	15	imatinib	KIT	PA10804	3815	0.984
NULL	Oncotarget_2014_Aug_27_5(17)_7328-7341.nxml.txt.nlp	25193862	SENT132	30	30	14	14	dasatinib	EPHB1	PA162372878	2047	0.984
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT7	17	17	0	0	cisplatin	IBP	PA449014	706;50619	0.984
NULL	Ann_Clin_Transl_Neurol_2014_Jan_20_1(1)_15-26.nxml.txt.nlp	25356379	SENT110	33	33	1	1	isoflurane	gamma	PA450106	9913	0.984
NULL	Mol_Cancer_2008_Jan_7_7_2.nxml.txt.nlp	18179710	SENT111	26	26	0	0	hyaluronan	TSG-6	PA165958431	7130	0.984
NULL	Int_J_Biol_Sci_2013_Mar_7_9(3)_279-288.nxml.txt.nlp	23493630	SENT50	12	12	21	21	tocilizumab	IL-21	PA165292659	59067;50616;27189	0.984
NULL	Clinics_(Sao_Paulo)_2012_May_67(5)_419-424.nxml.txt.nlp	22666783	SENT104	32	32	26	26	gefitinib	EGFR	PA131301952	1956	0.984
NULL	Oncotarget_2013_Nov_24_4(12)_2430-2438.nxml.txt.nlp	24280348	SENT142	10	10	28	28	gefitinib	STAT3	PA131301952	6774	0.984
NULL	Ther_Clin_Risk_Manag_2007_Dec_3(6)_1097-1104.nxml.txt.nlp	18516268	SENT148	7	7	14	14	didanosine	CD4	PA449301	920	0.984
NULL	Balkan_J_Med_Genet_2011_Jun_25_14(1)_25-30.nxml.txt.nlp	24052699	SENT81	14	14	21	21	primidone	ABCB1	PA451105	5243	0.984
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1016.nxml.txt.nlp	24457960	SENT64	22	22	3	3	paclitaxel	PC-3	PA450761	692094	0.984
NULL	Oncologist_2010_Apr_15(4)_372-381.nxml.txt.nlp	20413642	SENT193	0	0	23	23	erlotinib	EGFR	PA134687924	1956	0.984
NULL	Pharmaceutics_2010_Jun_2_2(2)_258-274.nxml.txt.nlp	NULL	SENT173	40	40	3	3	risperidone	P-gp	PA451257	5243	0.984
NULL	ScientificWorldJournal_2014_Feb_6_2014_328513.nxml.txt.nlp	24683330	SENT98	29	29	8	8	isoflurane	IL-10	PA450106	3586	0.984
NULL	Chin_J_Cancer_2012_Oct_31(10)_476-483.nxml.txt.nlp	22692073	SENT140	15	15	45	45	gemcitabine	RRM1	PA449748	6240	0.984
NULL	Front_Zool_2013_Feb_21_10_8.nxml.txt.nlp	23433033	SENT98	16	16	14	14	letrozole	aromatase	PA450196	1588	0.984
NULL	Core_Evid_2010_Jul_27_5_1-10.nxml.txt.nlp	20694135	SENT49	11	11	38	38	levodopa	COMT	PA450213	1312	0.984
NULL	Indian_J_Pharmacol_2014_Sep-Oct_46(5)_547-548.nxml.txt.nlp	25298587	SENT10	10	10	19	19	ranolazine	CYP3A	PA164746007	1574	0.984
NULL	Br_J_Cancer_2012_Jul_24_107(3)_516-526.nxml.txt.nlp	22782351	SENT108	37	37	1	1	tamoxifen	TIGAR	PA451581	57103	0.984
NULL	Pharmaceuticals_(Basel)_2013_Aug_2_6(8)_915-928.nxml.txt.nlp	24276376	SENT63	4	4	32	32	thrombin	PAR-1	PA451674	2011;2149	0.984
NULL	Br_J_Cancer_2013_Sep_3_109(5)_1147-1156.nxml.txt.nlp	23942076	SENT147	33	33	25	25	tamoxifen	HER2	PA451581	2064	0.984
NULL	J_Korean_Med_Sci_2007_Oct_31_22(5)_832-838.nxml.txt.nlp	17982231	SENT34	9	9	19	19	methacholine	AHR	PA165958382	196	0.984
NULL	Arthritis_Res_Ther_2005_Feb_17_7(Suppl_1)_P74.nxml.txt.nlp	NULL	SENT14	5	5	9	9	losartan	EXP	PA450268	4154	0.984
NULL	Blood_Cancer_J_2013_Oct_4_3(10)_e150.nxml.txt.nlp	24096714	SENT87	13	13	24	24	bortezomib	IL2	PA10252	3558	0.984
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S279-S284.nxml.txt.nlp	21525469	SENT37	28	28	1	1	liraglutide	GLP-1	PA165958364	100125288	0.984
NULL	Int_J_Hypertens_2012_Dec_25_2012_351758.nxml.txt.nlp	23320146	SENT209	27	27	10	10	losartan	AT2	PA450268	186	0.984
NULL	Contemp_Oncol_(Pozn)_2012_Nov_20_16(5)_363-370.nxml.txt.nlp	23788912	SENT72	4	4	17	17	vemurafenib	BRAF	PA165946873	673	0.984
NULL	Int_J_Biol_Sci_2011_Nov_5_8(1)_1-14.nxml.txt.nlp	22211100	SENT239	5	5	28	28	evodiamine	PI3K	PA165860788	5290	0.984
NULL	Arch_Drug_Inf_2011_Mar_4(1)_1-9.nxml.txt.nlp	21572514	SENT169	20	20	28	28	ciprofloxacin	MRP2	PA449009	100130958;57626;1244	0.984
NULL	Kidney_Int_Suppl_(2011)_2013_Dec_27_3(5)_451-456.nxml.txt.nlp	25019029	SENT81	1	1	19	19	cinacalcet	PTH	PA164776671	5741	0.984
NULL	Semin_Immunol_2011_Feb_23(1)_28-41.nxml.txt.nlp	21295490	SENT967	5	5	11	11	etanercept	IL-17	PA449515	3605	0.984
NULL	Mol_Cancer_2013_May_24_12_47.nxml.txt.nlp	23705854	SENT218	4	4	8	8	celecoxib	P-gp	PA448871	5243	0.984
NULL	Br_J_Cancer_2013_Dec_10_109(12)_2954-2958.nxml.txt.nlp	24231949	SENT72	29	29	13	13	gemcitabine	p53	PA449748	7157	0.984
NULL	J_Oncol_2012_Jun_4_2012_928127.nxml.txt.nlp	22701483	SENT104	8	8	15	15	metformin	AMPK	PA450395	5563	0.984
NULL	Anticancer_Drugs_2015_Jan_28_26(1)_46-55.nxml.txt.nlp	25099621	SENT92	15	15	5	5	cisplatin	KE-3	PA449014	6222	0.984
NULL	ScientificWorldJournal_2013_Apr_24_2013_928197.nxml.txt.nlp	23737732	SENT103	31	31	7	7	pioglitazone	ACR	PA450970	49	0.984
NULL	Indian_J_Pharmacol_2009_Aug_41(4)_167-172.nxml.txt.nlp	20523867	SENT139	1	1	15	15	imatinib	CYP3A5	PA10804	1577	0.984
NULL	Breast_Cancer_Res_2011_Feb_3_13(1)_R16.nxml.txt.nlp	21291529	SENT116	19	19	2	2	tamoxifen	PHD2	PA451581	54583	0.984
NULL	Front_Oncol_2014_Mar_24_4_47.nxml.txt.nlp	24716189	SENT168	2	2	18	18	erlotinib	PTEN	PA134687924	5728	0.984
NULL	Pharmaceuticals_(Basel)_2011_Nov_10_4(11)_1488-1502.nxml.txt.nlp	NULL	SENT18	11	11	0	0	geldanamycin	HER2	PA152031327	2064	0.984
NULL	Cardiol_Res_Pract_2012_Dec_31_2012_201742.nxml.txt.nlp	23346455	SENT103	30	30	6	6	warfarin	ADP	PA451906	23038	0.984
NULL	Breast_Cancer_Res_2011_Nov_1_13(6)_224.nxml.txt.nlp	22114931	SENT126	31	31	17	17	trastuzumab	PIK3CA	PA451743	5290	0.984
NULL	Cancers_(Basel)_2014_Aug_12_6(3)_1631-1669.nxml.txt.nlp	25119536	SENT426	0	0	28	28	bortezomib	THPO	PA10252	7066	0.984
NULL	Carcinogenesis_2014_Nov_12_35(11)_2485-2494.nxml.txt.nlp	25115442	SENT224	14	14	3	3	heparin	RRH	PA449855	10692	0.984
NULL	J_Inherit_Metab_Dis_2010_Oct_3_33(5)_625-632.nxml.txt.nlp	20814828	SENT106	26	26	10	10	simvastatin	GGTI	PA451363	5229	0.984
NULL	Ann_Rheum_Dis_2009_Dec_1_68(12)_1819-1826.nxml.txt.nlp	19054822	SENT41	12	12	4	4	abatacept	CDP	PA164747080	1523	0.984
NULL	Diagn_Pathol_2014_Jul_10_9_143.nxml.txt.nlp	25012722	SENT126	31	31	23	23	cisplatin	PDCD4	PA449014	27250	0.984
NULL	Vet_Res_2013_Oct_2_44(1)_89.nxml.txt.nlp	24088531	SENT267	38	38	7	7	hemin	HO-1	PA449849	3162	0.984
NULL	Breast_Cancer_Res_2010_Jul_1_12(4)_R45.nxml.txt.nlp	20594311	SENT128	0	0	7	7	nelfinavir	AKT	PA450606	207	0.984
NULL	Biochim_Biophys_Acta_2013_Oct_1833(10)_2233-2243.nxml.txt.nlp	23688635	SENT90	15	15	9	9	galactose	GAL	PA449725	51083	0.984
NULL	Ther_Clin_Risk_Manag_2006_Sep_2(3)_303-308.nxml.txt.nlp	18360605	SENT44	26	26	15	15	sumatriptan	5-HT7	PA451566	3363	0.984
NULL	Cell_Death_Dis_2012_Jun_21_3(6)_e327.nxml.txt.nlp	22717582	SENT194	46	46	24	24	doxorubicin	PUMA	PA449412	27113	0.984
NULL	Drugs_R_D_2013_Jun_5_13(2)_153-157.nxml.txt.nlp	23737454	SENT30	22	22	34	34	ticagrelor	P2Y12	PA165374673	64805	0.984
NULL	Cancer_Immunol_Immunother_2013_Feb_26_62(2)_309-320.nxml.txt.nlp	22923191	SENT270	39	39	9	9	gefitinib	EGFR	PA131301952	1956	0.984
NULL	Chem_Rev_2011_Oct_12_111(10)_5899-5921.nxml.txt.nlp	21923193	SENT559	5	5	34	34	flurbiprofen	FAAH	PA449683	79152;2166	0.984
NULL	Diabetes_Metab_Syndr_Obes_2010_May_17_3_155-163.nxml.txt.nlp	21437085	SENT52	36	36	18	18	exenatide	GLP-1	PA164749238	100125288	0.984
NULL	Clin_Dev_Immunol_2013_May_29_2013_289458.nxml.txt.nlp	23818912	SENT169	10	10	7	7	denosumab	RANKL	PA166048634	8600	0.984
NULL	Asian_J_Androl_2014_Apr_15_Sep-Oct_16(5)_792-793.nxml.txt.nlp	24759591	SENT23	28	28	2	2	tamsulosin	UPP	PA451583	7378	0.984
NULL	Exp_Ther_Med_2014_Jun_28_7(6)_1539-1544.nxml.txt.nlp	24926340	SENT25	20	20	18	18	tanespimycin	Hsp90	PA165291490	3320	0.984
NULL	Br_J_Cancer_2013_Dec_10_109(12)_2954-2958.nxml.txt.nlp	24231949	SENT72	20	20	13	13	nutlin-3	p53		7157	0.984
NULL	Br_J_Cancer_2011_Mar_1_104(5)_856-862.nxml.txt.nlp	21285991	SENT154	24	24	34	34	cetuximab	KRAS	PA10040	3845	0.984
NULL	Cancers_(Basel)_2011_Dec_8_3(4)_4245-4257.nxml.txt.nlp	24213136	SENT109	0	0	8	8	bevacizumab	VEGF-A	PA130232992	7422	0.984
NULL	Cell_Biol_Int_Rep_(2010)_2012_Jun_21_19(1)_e00017.nxml.txt.nlp	23124518	SENT113	17	17	4	4	etoposide	Mcl-1	PA449552	4170	0.984
NULL	Acta_Pharmacol_Sin_2010_Jan_28_31(1)_102-110.nxml.txt.nlp	20037603	SENT94	7	7	26	26	salbutamol	HIF-1	PA448068	29072	0.984
NULL	Indian_J_Endocrinol_Metab_2012_Mar-Apr_16(2)_324-325.nxml.txt.nlp	22470884	SENT11	31	31	29	29	sitagliptin	DPP4	PA164748978	1803	0.984
NULL	Nat_Med_2013_Mar_3_19(3)_295-304.nxml.txt.nlp	23377280	SENT66	24	24	5	5	erlotinib	EGFR	PA134687924	1956	0.984
NULL	Pharmaceutics_2010_Oct_27_2(4)_339-350.nxml.txt.nlp	NULL	SENT24	0	0	8	8	piroxicam	BCS	PA450985	617	0.984
NULL	Mol_Cancer_2010_Nov_8_9_291.nxml.txt.nlp	21059223	SENT90	19	19	5	5	paclitaxel	ZNF217	PA450761	7764	0.984
NULL	J_Biol_2006_Nov_30_5(7)_22.nxml.txt.nlp	17125495	SENT241	27	27	12	12	cytarabine	DCX	PA449177	1641	0.984
NULL	Basic_Clin_Pharmacol_Toxicol_2013_Feb_5_112(2)_132-137.nxml.txt.nlp	22900583	SENT155	35	35	20	20	ketoconazole	CYP3A4	PA450146	1576	0.984
NULL	Br_J_Cancer_2010_Mar_16_102(6)_1010-1017.nxml.txt.nlp	20160726	SENT15	0	0	5	5	letrozole	aromatase	PA450196	1588	0.984
NULL	Arthritis_Res_Ther_2014_Apr_11_16(2)_R93.nxml.txt.nlp	24725461	SENT202	19	19	17	17	letrozole	aromatase	PA450196	1588	0.984
NULL	Exp_Brain_Res_2014_Jun_27_232(8)_2637-2644.nxml.txt.nlp	24969614	SENT141	10	10	16	16	palonosetron	NK1	PA10352	11126	0.984
NULL	F1000Prime_Rep_2014_Apr_1_6_21.nxml.txt.nlp	24765526	SENT53	23	23	30	30	tocilizumab	IL-6	PA165292659	3569	0.984
NULL	Curr_Genomics_2013_Nov_14(7)_441-452.nxml.txt.nlp	24396276	SENT102	13	13	2	2	cisplatin	CPS1	PA449014	1373;1589	0.984
NULL	Pharmaceutics_2010_Jun_2_2(2)_258-274.nxml.txt.nlp	NULL	SENT26	39	39	6	6	risperidone	P-gp	PA451257	5243	0.984
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1018.nxml.txt.nlp	24457962	SENT62	43	43	0	0	erlotinib	EGFR	PA134687924	1956	0.984
NULL	Indian_J_Endocrinol_Metab_2013_Jan-Feb_17(1)_91-94.nxml.txt.nlp	23776858	SENT92	0	0	3	3	exenatide	GLP-1	PA164749238	100125288	0.984
NULL	J_Exp_Clin_Cancer_Res_2009_Sep_23_28(1)_131.nxml.txt.nlp	19775450	SENT37	17	17	31	31	palonosetron	HEC	PA10352	10403	0.984
NULL	Nucleic_Acids_Res_2011_Oct_9_39(19)_8355-8365.nxml.txt.nlp	21745816	SENT176	14	14	32	32	doxycycline	USP7	PA449415	7874	0.984
NULL	Acta_Orthop_2010_Dec_26_81(6)_748-755.nxml.txt.nlp	21067431	SENT75	9	9	17	17	sc-560	ANOVA		4858	0.984
NULL	Environ_Health_Perspect_2011_Aug_4_119(8)_1077-1083.nxml.txt.nlp	21543280	SENT69	17	17	5	5	heparin	PON1	PA449855	5444	0.984
NULL	Clin_Ophthalmol_2008_Sep_2(3)_613-621.nxml.txt.nlp	19668762	SENT33	16	16	7	7	latanoprost	BAK	PA164774763	578	0.984
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT148	1	1	30	30	lapatinib	HER2	PA152241907	2064	0.984
NULL	Neural_Develop_2008_Oct_22_3_27.nxml.txt.nlp	18945340	SENT388	23	23	31	31	mimosine	Rho	PA164752445	29984	0.984
NULL	Mol_Breed_2012_Oct_8_30(3)_1237-1252.nxml.txt.nlp	23024595	SENT143	33	33	7	7	acetone	ANOVA	PA448025	4858	0.984
NULL	Oncotarget_2013_Nov_26_4(12)_2502-2511.nxml.txt.nlp	24318446	SENT106	13	13	8	8	doxycycline	PHGDH	PA449415	26227	0.984
NULL	AIDS_Res_Ther_2013_May_1_10_10.nxml.txt.nlp	23634877	SENT148	5	5	18	18	atorvastatin	CXCR4	PA448500	7852	0.984
NULL	Alzheimers_Res_Ther_2013_May_14_5(3)_25.nxml.txt.nlp	23673233	SENT15	5	5	28	28	donepezil	spatial	PA449394	219793	0.984
NULL	Nat_Genet_2011_Feb_26_43(2)_117-120.nxml.txt.nlp	21186350	SENT25	40	40	3	3	metformin	ATM	PA450395	472	0.984
NULL	Acta_Pharmacol_Sin_2014_Aug_21_35(8)_1082-1092.nxml.txt.nlp	25047514	SENT163	33	33	14	14	tamoxifen	aromatase	PA451581	1588	0.984
NULL	Patient_Prefer_Adherence_2013_Jan_9_7_35-45.nxml.txt.nlp	23341736	SENT260	21	21	6	6	liraglutide	GLP-1	PA165958364	100125288	0.984
NULL	Braz_J_Med_Biol_Res_2013_Aug_13_46(8)_650-658.nxml.txt.nlp	23969971	SENT3	28	28	20	20	cisplatin	STAT3	PA449014	6774	0.984
NULL	Exp_Hematol_Oncol_2013_Aug_8_2_21.nxml.txt.nlp	23927414	SENT94	12	12	25	25	enoxaparin	HARE	PA449463	55576	0.984
NULL	Scientifica_(Cairo)_2012_Oct_14_2012_428139.nxml.txt.nlp	24278693	SENT151	8	8	0	0	cisplatin	CTR2	PA449014	1318	0.984
NULL	J_Immunol_Res_2014_Nov_11_2014_385352.nxml.txt.nlp	25436214	SENT125	12	12	3	3	infliximab	STAT3	PA452639	6774	0.984
NULL	Mol_Cancer_2010_Apr_12_9_75.nxml.txt.nlp	20385023	SENT188	7	7	13	13	imatinib	AXL	PA10804	558	0.984
NULL	Biomed_Res_Int_2013_Aug_6_2013_602987.nxml.txt.nlp	24027759	SENT271	24	24	9	9	paclitaxel	SMF	PA450761	22993	0.984
NULL	Diabetes_2011_Nov_17_60(11)_2701-2709.nxml.txt.nlp	21885869	SENT203	36	36	12	12	clonidine	PPG	PA449051	5552	0.984
NULL	Acta_Pharmacol_Sin_2010_Mar_22_31(3)_329-340.nxml.txt.nlp	20173759	SENT27	17	17	6	6	ethanol	AMPK	PA448073	5563	0.984
NULL	Int_J_Breast_Cancer_2011_Sep_6_2011_352182.nxml.txt.nlp	22295219	SENT201	22	22	7	7	gefitinib	Met	PA131301952	79811	0.984
NULL	Biosci_Rep_2012_Dec_20_33(1)_e00011.nxml.txt.nlp	23137297	SENT250	3	3	10	10	heparin	RPSA	PA449855	3921	0.984
NULL	Indian_J_Crit_Care_Med_2009_Apr-Jun_13(2)_108-112.nxml.txt.nlp	19881196	SENT92	3	3	18	18	lidocaine	CAGE	PA450226	168400	0.984
NULL	Am_J_Case_Rep_2014_Feb_24_15_85-89.nxml.txt.nlp	24587856	SENT47	10	10	42	42	letrozole	aromatase	PA450196	1588	0.984
NULL	Br_J_Haematol_2014_Mar_13_164(1)_811-821.nxml.txt.nlp	24328678	SENT6	35	35	27	27	lenalidomide	IKZF3	PA162363968	22806	0.984
NULL	Contemp_Oncol_(Pozn)_2012_Jul_6_16(3)_197-200.nxml.txt.nlp	23788878	SENT149	27	27	20	20	dacarbazine	BRAF	PA449197	673	0.984
NULL	Niger_Med_J_2014_Jul-Aug_55(4)_327-332.nxml.txt.nlp	25114369	SENT15	14	14	0	0	pyrazinamide	DST	PA451182	667	0.984
NULL	Adv_Pharmacol_Sci_2014_Nov_20_2014_373295.nxml.txt.nlp	25505905	SENT89	3	3	18	18	curcumin	p65	PA151958596	5970	0.984
NULL	Br_J_Cancer_2006_Dec_4_95(11)_1504-1513.nxml.txt.nlp	17088902	SENT206	42	42	16	16	gefitinib	PTEN	PA131301952	5728	0.984
NULL	Arthritis_Res_Ther_2005_Jun_9_7(4)_145-154.nxml.txt.nlp	15987497	SENT140	10	10	22	22	daclizumab	IL-2	PA164764446	3558	0.984
NULL	Clin_Drug_Investig_2013_Aug_23_33(10)_727-736.nxml.txt.nlp	23975654	SENT172	12	12	33	33	paroxetine	CYP2C19	PA450801	1557	0.984
NULL	Int_J_Mol_Sci_2012_Feb_10_13(2)_1886-1918.nxml.txt.nlp	22408430	SENT239	3	3	18	18	bevacizumab	VEGFR	PA130232992	3791	0.984
NULL	Adv_Hematol_2012_Aug_2_2012_842945.nxml.txt.nlp	22919394	SENT159	38	38	42	42	lenalidomide	CRBN	PA162363968	51185	0.984
NULL	Br_J_Cancer_1995_Oct_72(4)_917-921.nxml.txt.nlp	7547240	SENT10	34	34	0	0	nadh	DTD	PA164755085	1728	0.984
NULL	Eur_J_Cancer_2014_Sep_50(14)_2367-2374.nxml.txt.nlp	25027307	SENT136	6	6	42	42	tamoxifen	AMH	PA451581	268	0.984
NULL	Int_J_Med_Sci_2015_Jan_1_12(1)_63-71.nxml.txt.nlp	25552920	SENT143	20	20	13	13	berberine	BMP7	PA165860812	655	0.984
NULL	Orphanet_J_Rare_Dis_2014_Aug_18_9(1)_132.nxml.txt.nlp	NULL	SENT185	4	4	21	21	busulfan	CHS	PA448691	1130	0.984
NULL	Basic_Res_Cardiol_2011_Jan_20_106(1)_51-63.nxml.txt.nlp	20725733	SENT116	21	21	46	46	rolipram	PLB	PA153906323	151056	0.984
NULL	Oncol_Lett_2014_May_11_7(5)_1401-1408.nxml.txt.nlp	24765145	SENT62	26	26	11	11	paclitaxel	PI3K	PA450761	5290	0.984
NULL	J_Gen_Physiol_2009_Jun_133(6)_623-625.nxml.txt.nlp	19468076	SENT28	2	2	12	12	caffeine	TRPA1	PA448710	8989	0.984
NULL	Med_Sci_Monit_2013_Oct_31_19_916-926.nxml.txt.nlp	24172537	SENT113	23	23	4	4	mitomycin	FANCC	PA450524	2176	0.984
NULL	Exp_Ther_Med_2014_Mar_19_7(3)_669-674.nxml.txt.nlp	24520265	SENT148	2	2	9	9	thalidomide	JNK	PA451644	5599	0.984
NULL	Clin_Interv_Aging_2009_May_14_4_109-113.nxml.txt.nlp	19503773	SENT4	24	24	9	9	levodopa	COMT	PA450213	1312	0.984
NULL	Int_J_Chron_Obstruct_Pulmon_Dis_2007_Sep_2(3)_205-228.nxml.txt.nlp	18229560	SENT373	8	8	19	19	theophylline	HDAC2	PA451647	3066	0.984
NULL	Mol_Imaging_Biol_2013_Apr_11_15(2)_136-147.nxml.txt.nlp	22886728	SENT216	40	40	29	29	orlistat	FDG	PA164776864	23583	0.984
NULL	Arthritis_Res_Ther_2012_Sep_24_14(5)_R200.nxml.txt.nlp	23006144	SENT43	16	16	4	4	alefacept	IL-20	PA164748040	27190;50604	0.984
NULL	Acta_Pharmacol_Sin_2013_Sep_5_34(9)_1192-1200.nxml.txt.nlp	23685957	SENT189	18	18	6	6	curcumin	AP-2	PA151958596	7020	0.984
NULL	J_Cell_Biol_2000_Jul_10_150(1)_213-224.nxml.txt.nlp	10893269	SENT655	11	11	0	0	neomycin	AP-1	PA450608	2353;3727;2354;3725	0.984
NULL	Curr_Neuropharmacol_2012_Sep_10(3)_212-218.nxml.txt.nlp	23449551	SENT119	22	22	1	1	rimonabant	CB1	PA152407999	1268	0.984
NULL	Oncotarget_2014_Nov_3_5(20)_9798-9810.nxml.txt.nlp	25229255	SENT183	27	27	6	6	rituximab	DAPK1	PA451261	1612	0.984
NULL	Arthritis_Res_Ther_2010_Jan_22_12(1)_R11.nxml.txt.nlp	20096109	SENT193	16	16	5	5	infliximab	IFN	PA452639	3439	0.984
NULL	Mol_Pain_2013_Feb_28_9_7.nxml.txt.nlp	23448290	SENT31	9	9	0	0	capsaicin	TRPV1	PA448776	7442	0.984
NULL	BMB_Rep_2014_Sep_47(9)_483-487.nxml.txt.nlp	25027595	SENT35	27	27	3	3	gefitinib	TM4SF5	PA131301952	9032	0.984
NULL	Nat_Med_2013_Dec_3_19(12)_10_1038_nm_3384.nxml.txt.nlp	24185693	SENT62	6	6	14	14	furosemide	NKCC2	PA449719	6557	0.984
NULL	Indian_J_Orthop_2011_Sep-Oct_45(5)_450-453.nxml.txt.nlp	21886928	SENT107	28	28	43	43	heparin	ACL	PA449855	47	0.984
NULL	J_Cell_Biol_2000_Jan_10_148(1)_59-72.nxml.txt.nlp	10629218	SENT235	14	14	0	0	staurosporine	Bcl-2	PA165109623	596	0.984
NULL	Cancer_Manag_Res_2013_Nov_21_5_387-400.nxml.txt.nlp	24294007	SENT89	25	25	31	31	cetuximab	NRAS	PA10040	4893	0.984
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT148	2	2	15	15	raltegravir	UGT1A1		54658	0.984
NULL	Cancer_Med_2014_Oct_25_3(5)_1099-1111.nxml.txt.nlp	24961511	SENT316	7	7	0	0	cisplatin	AKAP12	PA449014	9590	0.984
NULL	Crit_Care_2001_Jun_26_5(Suppl_3)_P62.nxml.txt.nlp	NULL	SENT9	37	37	4	4	vancomycin	MRB	PA451850	54538	0.984
NULL	J_Hematol_Oncol_2008_Oct_1_1_16.nxml.txt.nlp	18828924	SENT35	21	21	8	8	lapatinib	HER2	PA152241907	2064	0.984
NULL	Breast_Cancer_(Auckl)_2011_Jan_13_5_1-14.nxml.txt.nlp	21494397	SENT198	13	13	27	27	ixabepilone	CYP3A4		1576	0.984
NULL	Br_J_Cancer_2012_Jan_3_106(1)_18-24.nxml.txt.nlp	22108516	SENT96	9	9	18	18	irinotecan	TDP1	PA450085	55775	0.984
NULL	J_Hematol_Oncol_2008_Oct_1_1_16.nxml.txt.nlp	18828924	SENT370	33	33	12	12	docetaxel	VEGFR	PA449383	3791	0.984
NULL	J_Cell_Mol_Med_2015_Jan_30_19(1)_210-226.nxml.txt.nlp	25266063	SENT282	4	4	34	34	forskolin	EP2	PA146096022	5732;10407	0.984
NULL	Nat_Genet_2011_Feb_26_43(2)_117-120.nxml.txt.nlp	21186350	SENT81	17	17	3	3	metformin	ATM	PA450395	472	0.984
NULL	Indian_J_Med_Res_2014_Feb_139(2)_205-215.nxml.txt.nlp	24718394	SENT105	18	18	37	37	artemisinin	ACT	PA165111696	12;11332;9457;641455	0.984
NULL	Biologics_2010_May_25_4_139-145.nxml.txt.nlp	20531970	SENT4	14	14	5	5	eltrombopag	TPO	PA165981594	7066;7173	0.984
NULL	Biology_(Basel)_2012_Dec_31_2(1)_40-63.nxml.txt.nlp	24832651	SENT54	22	22	9	9	hydroxyurea	BRCA1	PA449942	672	0.984
NULL	Diabetologia_2010_Sep_6_53(9)_2056-2065.nxml.txt.nlp	20526760	SENT174	22	22	3	3	irbesartan	ETS-1	PA450084	2113	0.984
NULL	Saudi_J_Anaesth_2013_Apr-Jun_7(2)_151-154.nxml.txt.nlp	23956714	SENT95	21	21	7	7	theophylline	NAC	PA451647	22861	0.984
NULL	Br_J_Cancer_2010_Jan_5_102(1)_97-103.nxml.txt.nlp	19904270	SENT156	11	11	0	0	paclitaxel	XIAP	PA450761	331	0.984
NULL	Cell_Cycle_2012_Nov_1_11(21)_4069-4078.nxml.txt.nlp	23095523	SENT71	21	21	3	3	imatinib	PERK	PA10804	9451	0.984
NULL	Oxid_Med_Cell_Longev_2013_Mar_5_2013_264935.nxml.txt.nlp	23533686	SENT125	6	6	18	18	hemin	HO-1	PA449849	3162	0.984
NULL	Extremophiles_2009_Nov_23_13(6)_885-894.nxml.txt.nlp	19701714	SENT138	23	23	2	2	ethanol	mol	PA448073	90527	0.984
NULL	Cancer_Res_Treat_2014_Jan_15_46(1)_55-64.nxml.txt.nlp	24520224	SENT180	9	9	1	1	irinotecan	TRAP1	PA450085	9392;10131	0.984
NULL	Case_Rep_Hematol_2013_Jul_10_2013_709164.nxml.txt.nlp	23936692	SENT130	8	8	19	19	imatinib	PDGFRB	PA10804	5159	0.984
NULL	Anesthesiol_Res_Pract_2011_Nov_3_2011_748031.nxml.txt.nlp	22110499	SENT245	0	0	4	4	aprepitant	NK1	PA164747039	11126	0.984
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT119	5	5	16	16	resveratrol	TRAIL		8743	0.984
NULL	Clin_Epigenetics_2010_Sep_18_1(3-4)_101-116.nxml.txt.nlp	21258631	SENT248	4	4	24	24	curcumin	GATA4	PA151958596	2626	0.984
NULL	Oncotarget_2014_Sep_10_5(20)_9877-9888.nxml.txt.nlp	25245676	SENT10	13	13	16	16	cetuximab	EGFR	PA10040	1956	0.984
NULL	Breast_Cancer_Res_Treat_2013_Jan_6_137(1)_167-174.nxml.txt.nlp	23129173	SENT29	4	4	2	2	letrozole	aromatase	PA450196	1588	0.984
NULL	Front_Endocrinol_(Lausanne)_2014_Aug_18_5_129.nxml.txt.nlp	25183960	SENT104	27	27	13	13	cabergoline	ghrelin	PA448708	51738	0.984
NULL	Cell_Death_Dis_2014_Mar_6_5(3)_e1108.nxml.txt.nlp	24603336	SENT64	16	16	24	24	etoposide	p53	PA449552	7157	0.984
NULL	Pak_J_Med_Sci_2013_Nov-Dec_29(6)_1459-1461.nxml.txt.nlp	24550976	SENT7	12	12	22	22	protamine	ACT	PA10366	12;11332;9457;641455	0.984
NULL	EMBO_Rep_2013_Jan_30_14(1)_49-56.nxml.txt.nlp	23196367	SENT90	30	30	2	2	granisetron	5-HT3R	PA449809	3359	0.984
NULL	Oncogene_2014_Feb_6_33(6)_713-723.nxml.txt.nlp	23435429	SENT205	30	30	8	8	etoposide	BRCA1	PA449552	672	0.984
NULL	Cell_Death_Dis_2014_Feb_13_5(2)_e1055.nxml.txt.nlp	24525731	SENT90	33	33	13	13	cisplatin	XRCC1	PA449014	7515	0.984
NULL	J_Hematol_Oncol_2013_Jun_3_6_38.nxml.txt.nlp	23731980	SENT176	20	20	12	12	trastuzumab	HER2	PA451743	2064	0.984
NULL	AIDS_Res_Ther_2012_May_3_9_13.nxml.txt.nlp	22554313	SENT121	19	19	3	3	nevirapine	CD4	PA450616	920	0.984
NULL	Clin_Sci_(Lond)_2011_Nov_1_121(Pt_10)_449-458.nxml.txt.nlp	21671887	SENT150	24	24	15	15	simvastatin	AMPK	PA451363	5563	0.984
NULL	Cardiovasc_Diabetol_2010_Oct_18_9_64.nxml.txt.nlp	20955583	SENT130	5	5	24	24	telmisartan	PPARgamma	PA451605	5468	0.984
NULL	Oncoimmunology_2012_Oct_1_1(7)_1048-1060.nxml.txt.nlp	23170253	SENT57	1	1	35	35	trastuzumab	HRG	PA451743	3084;3273	0.984
NULL	Cancers_(Basel)_2013_Dec_27_6(1)_67-78.nxml.txt.nlp	24378752	SENT53	5	5	19	19	etoposide	p53	PA449552	7157	0.984
NULL	Behav_Brain_Funct_2010_May_28_6_29.nxml.txt.nlp	20509936	SENT61	31	31	22	22	methylphenidate	DRD2	PA450464	1813	0.984
NULL	Vet_Res_2013_Oct_2_44(1)_89.nxml.txt.nlp	24088531	SENT154	17	17	3	3	hemin	HO-1	PA449849	3162	0.984
NULL	Cancers_(Basel)_2014_Mar_26_6(2)_708-722.nxml.txt.nlp	24675568	SENT112	29	29	1	1	afatinib	IL-6	PA165981154	3569	0.984
NULL	Front_Neuroanat_2010_Sep_28_4_135.nxml.txt.nlp	21048892	SENT62	7	7	35	35	fluorescein	VGLUT2	PA164746009	57084	0.984
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1699-1708.nxml.txt.nlp	19861960	SENT9	4	4	39	39	dasatinib	mol	PA162372878	90527	0.984
NULL	Eur_J_Dent_2009_Jan_3(1)_3-9.nxml.txt.nlp	19262725	SENT101	40	40	46	46	glutaraldehyde	HEMA	PA449777	2157	0.984
NULL	Arthritis_Res_Ther_2012_Apr_16_14(2)_R76.nxml.txt.nlp	22507741	SENT134	20	20	7	7	estradiol	IL-17A	PA449503	3605	0.984
NULL	Nucleic_Acids_Res_2005_Jun_8_33(10)_3283-3291.nxml.txt.nlp	15944449	SENT116	19	19	13	13	melphalan	XRCC3	PA450354	7517	0.984
NULL	Drugs_R_D_2011_Jun_27_11(2)_113-126.nxml.txt.nlp	21679004	SENT100	13	13	2	2	axitinib	CYP3A4	PA164924493	1576	0.984
NULL	Br_J_Cancer_2010_Sep_7_103(6)_787-795.nxml.txt.nlp	20823887	SENT195	2	2	27	27	tocilizumab	IL-6	PA165292659	3569	0.984
NULL	Pharmaceutics_2011_Oct_12_3(4)_680-705.nxml.txt.nlp	24309303	SENT103	23	23	8	8	sitagliptin	AMPK	PA164748978	5563	0.984
NULL	Cancer_Microenviron_2009_May_6_2(1)_59-67.nxml.txt.nlp	19418243	SENT140	18	18	3	3	doxycycline	CCL21	PA449415	6366	0.984
NULL	Reprod_Biol_Endocrinol_2003_Oct_7_1_66.nxml.txt.nlp	14609433	SENT82	4	4	16	16	cisplatin	FasL	PA449014	356	0.984
NULL	Cell_Death_Dis_2013_Jun_6_4(6)_e654.nxml.txt.nlp	23744354	SENT86	39	39	2	2	galactose	B4GALT2	PA449725	8704	0.984
NULL	Front_Behav_Neurosci_2014_Sep_19_8_332.nxml.txt.nlp	25285073	SENT150	11	11	27	27	memantine	ANOVA	PA10364	4858	0.984
NULL	Dement_Geriatr_Cogn_Dis_Extra_2014_Nov_15_4(3)_450-456.nxml.txt.nlp	25538729	SENT10	16	16	36	36	donepezil	APOE	PA449394	348	0.984
NULL	Chemother_Res_Pract_2011_Dec_1_2011_715469.nxml.txt.nlp	22312557	SENT105	8	8	21	21	cisplatin	p53	PA449014	7157	0.984
NULL	Neuropsychopharmacology_2009_Sep_13_34(10)_2197-2207.nxml.txt.nlp	19440190	SENT131	3	3	18	18	fluoxetine	EPM	PA449673	2054	0.984
NULL	Cancer_Metab_2014_May_28_2(Suppl_1)_P24.nxml.txt.nlp	NULL	SENT19	12	12	4	4	etoposide	SIRT1	PA449552	23411	0.984
NULL	Ann_Hematol_2010_Sep_13_89(9)_861-871.nxml.txt.nlp	20387067	SENT204	17	17	4	4	dasatinib	GM-CSF	PA162372878	1437	0.984
NULL	Environ_Health_Perspect_2007_May_5_115(5)_756-763.nxml.txt.nlp	17520064	SENT174	36	36	23	23	trypsin	C3a	PA451806	718	0.984
NULL	Front_Oncol_2013_Sep_23_3_250.nxml.txt.nlp	24069582	SENT145	22	22	20	20	gefitinib	EGFR	PA131301952	1956	0.984
NULL	J_Cancer_2013_Jan_11_4(2)_117-132.nxml.txt.nlp	23386910	SENT104	0	0	27	27	ertumaxomab	HER-2	PA165291442	2064	0.984
NULL	Mol_Vis_2012_Jan_28_18_234-240.nxml.txt.nlp	22312192	SENT27	27	27	6	6	ranibizumab	VEGF-A	PA164746012	7422	0.984
NULL	Nat_Med_2013_Mar_3_19(3)_368-371.nxml.txt.nlp	23377281	SENT54	14	14	8	8	nelarabine	NT5C2	PA164752425	22978	0.984
NULL	Angiogenesis_2010_Mar_11_13(1)_1-14.nxml.txt.nlp	20012482	SENT149	3	3	12	12	sunitinib	CYP3A4	PA162372840	1576	0.984
NULL	Oncotarget_2014_Aug_19_5(18)_8737-8749.nxml.txt.nlp	25228590	SENT77	25	25	16	16	doxycycline	MYCN	PA449415	4613	0.984
NULL	Cancers_(Basel)_2011_Apr_19_3(2)_2080-2105.nxml.txt.nlp	24212797	SENT1116	8	8	0	0	cetuximab	KRAS	PA10040	3845	0.984
NULL	Oncotarget_2011_Sep_9_2(9)_658-668.nxml.txt.nlp	21911919	SENT84	9	9	27	27	daunorubicin	HO-1	PA449212	3162	0.984
NULL	Clin_Sci_(Lond)_2012_Apr_1_122(Pt_7)_349-359.nxml.txt.nlp	21992080	SENT36	2	2	33	33	resveratrol	DEPTOR		64798	0.984
NULL	Clin_Drug_Investig_2013_Aug_23_33(10)_727-736.nxml.txt.nlp	23975654	SENT175	17	17	27	27	ketoconazole	CYP2C9	PA450146	1559	0.984
NULL	eLife_2014_Apr_22_3_e01730.nxml.txt.nlp	24755287	SENT325	7	7	19	19	nadh	SIRT1	PA164755085	23411	0.984
NULL	Biomed_Res_Int_2013_Dec_5_2013_642848.nxml.txt.nlp	24381940	SENT168	8	8	29	29	telmisartan	IL-6	PA451605	3569	0.984
NULL	Cell_Cycle_2013_Dec_15_12(24)_3791-3803.nxml.txt.nlp	24107631	SENT26	15	15	7	7	doxycycline	YB-1	PA449415	4904	0.984
NULL	Oncol_Rep_2014_Aug_12_32(2)_469-474.nxml.txt.nlp	24926795	SENT31	10	10	3	3	cisplatin	CTR	PA449014	799	0.984
NULL	Br_J_Cancer_2011_Jul_12_105(2)_221-230.nxml.txt.nlp	21750559	SENT164	0	0	15	15	sorafenib	Mcl-1	PA7000	4170	0.984
NULL	J_Exerc_Nutrition_Biochem_2014_Mar_11_18(1)_1-7.nxml.txt.nlp	25566433	SENT19	16	16	0	0	resveratrol	SIRT1		23411	0.984
NULL	Int_J_Endocrinol_2013_Nov_27_2013_259676.nxml.txt.nlp	24369462	SENT193	22	22	7	7	sr144528	CB2		1269	0.984
NULL	Breast_Cancer_Res_Treat_2013_Jul_5_140(1)_63-71.nxml.txt.nlp	23828499	SENT192	39	39	16	16	carboplatin	HER2	PA448803	2064	0.984
NULL	Oncol_Rep_2013_Jun_22_29(6)_2479-2485.nxml.txt.nlp	23525656	SENT139	3	3	11	11	nilotinib	P-gp	PA165958345	5243	0.984
NULL	Ann_Rheum_Dis_2013_Apr_11_72(4)_583-589.nxml.txt.nlp	23144446	SENT9	0	0	4	4	tocilizumab	IL-6	PA165292659	3569	0.984
NULL	Ther_Clin_Risk_Manag_2007_Aug_3(4)_553-562.nxml.txt.nlp	18472976	SENT81	4	4	35	35	lenalidomide	IFN	PA162363968	3439	0.984
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT104	26	26	12	12	docetaxel	B7-H1	PA449383	29126	0.984
NULL	Mol_Biol_Cell_2013_Jun_15_24(12)_1933-1946.nxml.txt.nlp	23615437	SENT419	21	21	0	0	thrombin	14-3-3	PA451674	10971	0.984
NULL	Curr_Cardiol_Rev_2009_Aug_5(3)_166-176.nxml.txt.nlp	20676275	SENT201	25	25	4	4	ketoconazole	CYP3A4	PA450146	1576	0.984
NULL	Neural_Plast_2007_Jun_19_2007_52908.nxml.txt.nlp	17641734	SENT233	28	28	4	4	rimonabant	FAAH	PA152407999	79152;2166	0.984
NULL	Dermatoendocrinol_2013_Apr_1_5(2)_239-251.nxml.txt.nlp	24194964	SENT194	0	0	28	28	vemurafenib	BRAF	PA165946873	673	0.984
NULL	Case_Rep_Nephrol_Urol_2012_Jul_11_2(2)_92-101.nxml.txt.nlp	23197963	SENT146	19	19	0	0	rituximab	CD19	PA451261	930	0.984
NULL	J_Int_AIDS_Soc_2012_Oct_22_15(Suppl_3)_18439.nxml.txt.nlp	NULL	SENT296	3	3	22	22	fluconazole	CD4	PA449653	920	0.984
NULL	Breast_Cancer_Res_2008_Jul_24_10(4)_211.nxml.txt.nlp	18671839	SENT145	21	21	12	12	flavopiridol	HER2	PA452627	2064	0.984
NULL	J_Cell_Mol_Med_2014_Aug_1_18(8)_1599-1611.nxml.txt.nlp	24889822	SENT261	8	8	4	4	resveratrol	FOXO1		2308	0.984
NULL	Acta_Pharmacol_Sin_2011_Feb_4_32(2)_182-187.nxml.txt.nlp	21293470	SENT26	17	17	7	7	riluzole	TREK-1	PA451251	3776	0.984
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1224-1233.nxml.txt.nlp	22353810	SENT198	7	7	17	17	doxorubicin	MRP-1	PA449412	928	0.984
NULL	Environ_Health_Perspect_2011_Aug_7_119(8)_1117-1122.nxml.txt.nlp	21382770	SENT102	18	18	6	6	mk-571	GCL		64396;25801	0.984
NULL	Indian_J_Pharmacol_2014_Mar-Apr_46(2)_161-165.nxml.txt.nlp	24741186	SENT40	0	0	20	20	carvedilol	STZ	PA448817	6484	0.984
NULL	Int_J_Mol_Sci_2012_Aug_24_13(9)_10697-10721.nxml.txt.nlp	23109817	SENT133	11	11	26	26	arsenite	c-Jun	PA452638	3725	0.984
NULL	Clin_Interv_Aging_2010_Sep_7_5_253-258.nxml.txt.nlp	20852672	SENT68	18	18	0	0	aripiprazole	Men	PA10026	8178	0.984
NULL	Case_Rep_Oncol_2013_Mar_29_6(1)_189-196.nxml.txt.nlp	23626560	SENT49	2	2	22	22	gefitinib	EGFR	PA131301952	1956	0.984
NULL	Cancer_Med_2014_Oct_17_3(5)_1284-1293.nxml.txt.nlp	24935402	SENT30	2	2	18	18	atorvastatin	RhoC	PA448500	389	0.984
NULL	Braz_J_Med_Biol_Res_2014_Mar_21_47(4)_273-278.nxml.txt.nlp	24676475	SENT26	24	24	6	6	verapamil	P-gp	PA451868	5243	0.984
NULL	J_Biol_Chem_2010_Aug_20_285(34)_26406-26416.nxml.txt.nlp	20530490	SENT37	37	37	26	26	artemisinin	SERCA1	PA165111696	487	0.984
NULL	Br_J_Clin_Pharmacol_2014_Sep_20_78(3)_509-523.nxml.txt.nlp	25279405	SENT23	5	5	25	25	tacrolimus	CYP3A5	PA451578	1577	0.984
NULL	Alzheimers_Res_Ther_2011_Jan_6_3(1)_1.nxml.txt.nlp	21211070	SENT189	21	21	3	3	simvastatin	PSEN1	PA451363	5663	0.984
NULL	Onco_Targets_Ther_2014_Mar_24_7_491-500.nxml.txt.nlp	24711706	SENT85	21	21	12	12	capecitabine	HER2	PA448771	2064	0.984
NULL	Oncotarget_2013_Nov_24_4(12)_2186-2207.nxml.txt.nlp	24327604	SENT236	22	22	3	3	melphalan	survivin	PA450354	332	0.984
NULL	Oncol_Lett_2013_Apr_22_5(4)_1093-1100.nxml.txt.nlp	23599746	SENT69	20	20	26	26	paclitaxel	P-gp	PA450761	5243	0.984
NULL	Cancer_Cell_2007_Dec_11_12(6)_514-527.nxml.txt.nlp	18068629	SENT52	25	25	23	23	verapamil	MDR1	PA451868	5243	0.984
NULL	Front_Genet_2011_Jul_18_2_49.nxml.txt.nlp	22303345	SENT148	33	33	15	15	estradiol	EFNB2	PA449503	1948	0.984
NULL	J_Lipid_Res_2014_Oct_55(10)_2103-2112.nxml.txt.nlp	25139399	SENT113	28	28	1	1	atorvastatin	LDLR	PA448500	3949	0.984
NULL	J_Thromb_Thrombolysis_2012_Feb_20_33(2)_143-153.nxml.txt.nlp	22183178	SENT69	15	15	9	9	cangrelor	P2Y12	PA165945763	64805	0.984
NULL	J_Mol_Signal_2014_Aug_8_9_8.nxml.txt.nlp	25237386	SENT200	29	29	3	3	ns-398	PTGS1		5742	0.984
NULL	J_Cell_Biol_2008_Jul_28_182(2)_233-239.nxml.txt.nlp	18644891	SENT80	24	24	2	2	staurosporine	MICA	PA165109623	100507436	0.984
NULL	Arthritis_Res_Ther_2009_Oct_14_11(5)_247.nxml.txt.nlp	19849820	SENT84	12	12	0	0	cyclophosphamide	CD27	PA449165	939	0.984
NULL	Nano_Rev_2010_Nov_8_1_10_3402_nano_v1i0_5705.nxml.txt.nlp	22110857	SENT15	37	37	24	24	doxorubicin	PK1	PA449412	84432	0.984
NULL	Exp_Lung_Res_2013_Oct_1_39(8)_336-348.nxml.txt.nlp	23919450	SENT183	4	4	25	25	thrombin	PAR-1	PA451674	2011;2149	0.984
NULL	Breast_Cancer_Res_Treat_2014_Jan_9_143(3)_493-505.nxml.txt.nlp	24402830	SENT29	38	38	8	8	trastuzumab	HER2	PA451743	2064	0.984
NULL	J_Clin_Biochem_Nutr_2010_Jan_29_46(1)_87-92.nxml.txt.nlp	20104270	SENT101	22	22	4	4	hesperidin	adiponectin	PA449867	9370	0.984
NULL	Biosci_Rep_2012_Dec_13_33(1)_e00007.nxml.txt.nlp	23095119	SENT130	25	25	8	8	metformin	AMPK	PA450395	5563	0.984
NULL	J_Oncol_2010_Nov_19_2010_568938.nxml.txt.nlp	20037743	SENT184	34	34	11	11	erlotinib	EGFR	PA134687924	1956	0.984
NULL	Int_J_Mol_Sci_2014_Mar_10_15(3)_4201-4220.nxml.txt.nlp	24619193	SENT20	23	23	5	5	cisplatin	IL-2	PA449014	3558	0.984
NULL	J_Immunol_Res_2014_May_8_2014_565320.nxml.txt.nlp	24901010	SENT80	8	8	18	18	allopurinol	HLA-B	PA448320	3106	0.984
NULL	EMBO_J_2013_Oct_16_32(20)_2751-2763.nxml.txt.nlp	24065129	SENT99	8	8	29	29	doxorubicin	IRF9	PA449412	10379	0.984
NULL	Cancers_(Basel)_2012_Feb_8_4(1)_113-129.nxml.txt.nlp	24213230	SENT145	0	0	13	13	sunitinib	VEGFR	PA162372840	3791	0.984
NULL	Mediators_Inflamm_2001_Feb_10(1)_33-36.nxml.txt.nlp	11324902	SENT7	22	22	5	5	indomethacin	MUC5AC	PA449982	4586	0.984
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT120	0	0	5	5	maraviroc	CCR5	PA164768835	1234	0.984
NULL	Br_J_Cancer_2009_Sep_15_101(6)_957-966.nxml.txt.nlp	19738618	SENT17	3	3	24	24	dexrazoxane	THBS-1	PA449259	7057	0.984
NULL	Biomed_Res_Int_2014_Feb_24_2014_540238.nxml.txt.nlp	24707490	SENT136	7	7	20	20	topiramate	GluK1	PA451728	2897	0.984
NULL	Front_Genet_2012_Nov_5_3_236.nxml.txt.nlp	23133441	SENT132	14	14	1	1	efavirenz	CYP2B6	PA449441	1555	0.984
NULL	Neural_Regen_Res_2013_Mar_25_8(9)_825-832.nxml.txt.nlp	25206730	SENT9	34	34	4	4	isoflurane	P2X7	PA450106	5027	0.984
NULL	Mol_Pain_2013_Aug_12_9_41.nxml.txt.nlp	23937887	SENT146	1	1	24	24	fluvoxamine	5-HT2A	PA449690	3356	0.984
NULL	J_Med_Case_Rep_2013_Mar_19_7_80.nxml.txt.nlp	23509950	SENT65	25	25	3	3	hydrocortisone	ACTH	PA449905	5443	0.984
NULL	Cancers_(Basel)_2014_Mar_26_6(2)_708-722.nxml.txt.nlp	24675568	SENT117	24	24	1	1	erlotinib	STAT3	PA134687924	6774	0.984
NULL	Cancers_(Basel)_2013_May_24_5(2)_569-590.nxml.txt.nlp	24216992	SENT1338	18	18	0	0	cyclophosphamide	CD4	PA449165	920	0.984
NULL	Breast_Cancer_Res_2010_Mar_12_12(2)_R20.nxml.txt.nlp	20226014	SENT157	12	12	18	18	trastuzumab	PI3K	PA451743	5290	0.984
NULL	Breast_Cancer_Res_2011_Nov_7_13(6)_R112.nxml.txt.nlp	22060274	SENT345	17	17	3	3	vincristine	TWIST1	PA451879	7291	0.984
NULL	Oncogene_2014_Jan_23_33(4)_421-428.nxml.txt.nlp	23318437	SENT118	36	36	10	10	etoposide	p53	PA449552	7157	0.984
NULL	J_Korean_Med_Sci_2010_Dec_24_25(12)_1766-1770.nxml.txt.nlp	21165292	SENT64	15	15	34	34	glucose	GFR	PA449773	9771	0.984
NULL	Br_J_Cancer_2010_Mar_16_102(6)_1010-1017.nxml.txt.nlp	20160726	SENT15	0	0	13	13	letrozole	aromatase	PA450196	1588	0.984
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1018.nxml.txt.nlp	24457962	SENT176	0	0	13	13	metformin	AMPK	PA450395	5563	0.984
NULL	Gut_2015_Jan_19_64(1)_111-120.nxml.txt.nlp	24647007	SENT223	33	33	9	9	capecitabine	DPYD	PA448771	1806	0.984
NULL	J_Clin_Biochem_Nutr_2011_Mar_26_48(2)_170-177.nxml.txt.nlp	21373272	SENT156	35	35	19	19	pioglitazone	HSPCA	PA450970	3324	0.984
NULL	Eur_J_Immunol_2013_Apr_11_43(5)_1153-1161.nxml.txt.nlp	23400868	SENT161	20	20	4	4	chloroquine	MARCH9	PA448948	92979	0.983
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1699-1708.nxml.txt.nlp	19861960	SENT154	34	34	9	9	dasatinib	Yes	PA162372878	7525	0.983
NULL	Case_Rep_Med_2012_Jun_19_2012_680431.nxml.txt.nlp	22778751	SENT92	4	4	18	18	rituximab	CHOP	PA451261	1649	0.983
NULL	Arthritis_Res_Ther_2009_Jan_26_11(1)_R12.nxml.txt.nlp	19171052	SENT322	29	29	8	8	dipyridamole	POMC	PA449367	5443	0.983
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT265	31	31	15	15	lapatinib	HER3	PA152241907	2065	0.983
NULL	Pharmaceuticals_(Basel)_2011_Mar_25_4(4)_567-589.nxml.txt.nlp	NULL	SENT95	0	0	3	3	maraviroc	CCR5	PA164768835	1234	0.983
NULL	Br_J_Clin_Pharmacol_2012_Apr_7_73(4)_518-535.nxml.txt.nlp	22053916	SENT64	2	2	7	7	rosuvastatin	CYP2C9	PA134308647	1559	0.983
NULL	Br_J_Cancer_2013_Jul_23_109(2)_502-511.nxml.txt.nlp	23799850	SENT164	9	9	0	0	gemcitabine	SMARCC1	PA449748	6599	0.983
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Apr_17_6_43-57.nxml.txt.nlp	24833916	SENT122	12	12	14	14	tamoxifen	aromatase	PA451581	1588	0.983
NULL	Br_J_Cancer_2012_Jan_31_106(3)_440-446.nxml.txt.nlp	22233926	SENT146	6	6	16	16	trastuzumab	HER-2	PA451743	2064	0.983
NULL	Int_J_Mol_Imaging_2011_Oct_26_2011_874585.nxml.txt.nlp	21490735	SENT167	24	24	8	8	doxorubicin	FDG	PA449412	23583	0.983
NULL	Clin_Exp_Reprod_Med_2011_Jun_30_38(2)_98-102.nxml.txt.nlp	22384426	SENT110	4	4	30	30	rosiglitazone	IL-6	PA451283	3569	0.983
NULL	Ann_Clin_Microbiol_Antimicrob_2009_Jan_15_8_2.nxml.txt.nlp	19146672	SENT26	8	8	1	1	isoniazid	EMB	PA450112	133418	0.983
NULL	JAKSTAT_2012_Oct_1_1(4)_292-299.nxml.txt.nlp	24058786	SENT155	13	13	38	38	pyrimethamine	STAT3	PA451193	6774	0.983
NULL	Clin_Med_Insights_Oncol_2013_Jun_3_7_103-122.nxml.txt.nlp	23843721	SENT364	16	16	2	2	hydroxyurea	CHK2	PA449942	11200	0.983
NULL	J_Ophthalmol_2011_Oct_20_2011_252549.nxml.txt.nlp	22046503	SENT122	9	9	25	25	ranibizumab	APOE	PA164746012	348	0.983
NULL	Breast_Cancer_Res_2010_Jun_28_12(3)_R43.nxml.txt.nlp	20579400	SENT279	35	35	1	1	paclitaxel	MTS	PA450761	1678	0.983
NULL	Br_J_Cancer_2010_Oct_12_103(8)_1182-1191.nxml.txt.nlp	20842125	SENT199	19	19	17	17	indomethacin	COX	PA449982	1351	0.983
NULL	Eur_J_Med_Res_2009_Dec_7_14(Suppl_4)_45-48.nxml.txt.nlp	20156724	SENT94	13	13	24	24	capsaicin	DAN	PA448776	5073;4681	0.983
NULL	Mol_Cancer_2012_Aug_8_11_53.nxml.txt.nlp	22871047	SENT296	10	10	36	36	paclitaxel	HIN-1	PA450761	92304	0.983
NULL	Br_J_Cancer_2009_Jan_27_100(2)_233-239.nxml.txt.nlp	19088716	SENT26	5	5	24	24	s-adenosylmethionine	MTHFR	PA164754994	4524	0.983
NULL	J_Exp_Clin_Cancer_Res_2009_Jul_10_28(1)_99.nxml.txt.nlp	19591692	SENT112	2	2	7	7	imatinib	ABCB1	PA10804	5243	0.983
NULL	Breast_Cancer_Res_2011_Feb_2_13(1)_R15.nxml.txt.nlp	21288332	SENT24	9	9	38	38	trastuzumab	HER2	PA451743	2064	0.983
NULL	Front_Endocrinol_(Lausanne)_2014_Oct_27_5_183.nxml.txt.nlp	25386167	SENT30	12	12	1	1	hyaluronidase	OGA	PA164745713	10724	0.983
NULL	Adv_Biomed_Res_2014_Nov_29_3_234.nxml.txt.nlp	25538920	SENT74	34	34	2	2	isoflurane	ANOVA	PA450106	4858	0.983
NULL	Exp_Ther_Med_2012_Oct_3_4(4)_594-604.nxml.txt.nlp	23170111	SENT100	31	31	8	8	propranolol	p38	PA451145	10598;1432;7965	0.983
NULL	Clin_Ophthalmol_2012_May_7_6_673-678.nxml.txt.nlp	22654492	SENT85	7	7	19	19	tafluprost	EP3	PA165958432	5733	0.983
NULL	Mol_Cancer_2010_Aug_27_9_226.nxml.txt.nlp	20799951	SENT149	25	25	0	0	cisplatin	PRAME	PA449014	23532	0.983
NULL	Onco_Targets_Ther_2014_Dec_4_7_2249-2255.nxml.txt.nlp	25587220	SENT55	16	16	41	41	cyclosporine	MRP1	PA449167	4437	0.983
NULL	Int_J_Med_Sci_2015_Jan_1_12(1)_78-82.nxml.txt.nlp	25552922	SENT24	17	17	0	0	warfarin	CYP2C9	PA451906	1559	0.983
NULL	Braz_J_Med_Biol_Res_2013_Aug_13_46(8)_650-658.nxml.txt.nlp	23969971	SENT153	39	39	28	28	cisplatin	STAT3	PA449014	6774	0.983
NULL	Indian_J_Nephrol_2010_Jan-Mar_20(1)_9-14.nxml.txt.nlp	20535264	SENT45	19	19	26	26	lovastatin	PON3	PA450272	5446	0.983
NULL	Exp_Brain_Res_2014_Jun_27_232(8)_2637-2644.nxml.txt.nlp	24969614	SENT157	4	4	31	31	palonosetron	NK1	PA10352	11126	0.983
NULL	J_Gen_Physiol_2009_Oct_134(4)_323-337.nxml.txt.nlp	19786585	SENT229	6	6	11	11	dantrolene	ClC-1	PA449208	1180	0.983
NULL	Mol_Cancer_2010_Nov_25_9_305.nxml.txt.nlp	21108789	SENT107	8	8	25	25	decitabine	p53	PA164749631	7157	0.983
NULL	Scientifica_(Cairo)_2013_Dec_10_2013_691251.nxml.txt.nlp	24386592	SENT194	28	28	5	5	paclitaxel	SIRT6	PA450761	51548	0.983
NULL	Ital_J_Pediatr_2012_Mar_30_38_11.nxml.txt.nlp	22464080	SENT35	24	24	38	38	oxatomide	CYP2D6	PA163522137	1565	0.983
NULL	Indian_J_Dermatol_2009_Jan-Mar_54(1)_65-67.nxml.txt.nlp	20049275	SENT67	7	7	22	22	tretinoin	CO2	PA451746	4513	0.983
NULL	Ther_Clin_Risk_Manag_2007_Jun_3(2)_259-268.nxml.txt.nlp	18360634	SENT150	20	20	30	30	natalizumab	IFN	PA164747191	3439	0.983
NULL	Mol_Cancer_2008_Mar_6_7_23.nxml.txt.nlp	18325094	SENT181	11	11	25	25	hyaluronan	CD44	PA165958431	960	0.983
NULL	Gut_2012_Aug_24_61(8)_1146-1153.nxml.txt.nlp	22115910	SENT211	32	32	11	11	fluorescein	CLE	PA164746009	51637	0.983
NULL	Cancer_Manag_Res_2013_Nov_21_5_387-400.nxml.txt.nlp	24294007	SENT89	10	10	31	31	irinotecan	NRAS	PA450085	4893	0.983
NULL	Front_Oncol_2014_Sep_23_4_263.nxml.txt.nlp	25295230	SENT88	12	12	10	10	sorafenib	FLT3	PA7000	2322	0.983
NULL	Adipocyte_2013_Jan_1_2(1)_28-32.nxml.txt.nlp	23700549	SENT70	9	9	39	39	valsartan	c-Jun	PA451848	3725	0.983
NULL	Oxid_Med_Cell_Longev_2008_Oct-Dec_1(1)_39-45.nxml.txt.nlp	19794907	SENT42	6	6	18	18	taurine	ALAD	PA451590	210	0.983
NULL	Cancer_Cell_Int_2012_Jul_4_12_19.nxml.txt.nlp	22631225	SENT181	34	34	1	1	heparin	PPIA	PA449855	5478	0.983
NULL	Cancer_Cell_2007_Dec_11_12(6)_514-527.nxml.txt.nlp	18068629	SENT176	14	14	27	27	cisplatin	PI3K	PA449014	5290	0.983
NULL	Case_Rep_Surg_2012_Nov_28_2012_179407.nxml.txt.nlp	23243548	SENT63	37	37	15	15	thyroglobulin	TTF-1	PA164754910	7080	0.983
NULL	Oxid_Med_Cell_Longev_2013_Jun_6_2013_891748.nxml.txt.nlp	23840922	SENT133	0	0	15	15	resveratrol	SIRT1		23411	0.983
NULL	Scientifica_(Cairo)_2012_Dec_16_2012_402783.nxml.txt.nlp	24278688	SENT171	13	13	2	2	thrombin	C5a	PA451674	727	0.983
NULL	Hum_Genomics_2008_Sep_1_3(1)_53-70.nxml.txt.nlp	19129090	SENT188	9	9	2	2	perifosine	DZIP3	PA165291471	9666	0.983
NULL	Bioinformation_2012_Jan_6_8(1)_13-19.nxml.txt.nlp	22359429	SENT136	5	5	11	11	curcumin	MRP1	PA151958596	4437	0.983
NULL	Chemother_Res_Pract_2011_Sep_25_2011_730360.nxml.txt.nlp	22295205	SENT213	30	30	36	36	trastuzumab	HER2	PA451743	2064	0.983
NULL	F1000Res_2014_Aug_19_3_198.nxml.txt.nlp	25400908	SENT469	6	6	10	10	lapatinib	EGFR	PA152241907	1956	0.983
NULL	Cancer_Med_2014_Apr_27_3(2)_293-299.nxml.txt.nlp	24464780	SENT32	20	20	25	25	capecitabine	TYMP	PA448771	1890	0.983
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT301	26	26	3	3	nutlin-3	MDM2		4193	0.983
NULL	J_RNAi_Gene_Silencing_2010_Apr_15_6(1)_367-375.nxml.txt.nlp	NULL	SENT32	26	26	4	4	camptothecin	RAD51	PA153590860	5888	0.983
NULL	Clin_Pharmacol_2013_Dec_9_5_185-192.nxml.txt.nlp	24353446	SENT9	17	17	26	26	clopidogrel	CYP3A4	PA449053	1576	0.983
NULL	Mol_Cancer_2012_Aug_24_11_61.nxml.txt.nlp	22917467	SENT221	43	43	5	5	doxorubicin	B27	PA449412	56246	0.983
NULL	J_Hematol_Oncol_2013_Nov_5_6_83.nxml.txt.nlp	24283248	SENT117	37	37	13	13	etoposide	TP53	PA449552	7157	0.983
NULL	Fibrogenesis_Tissue_Repair_2009_Dec_4_2_6.nxml.txt.nlp	19961576	SENT193	34	34	6	6	hyaluronan	TLR4	PA165958431	7099	0.983
NULL	Cancer_Metab_2014_May_28_2(Suppl_1)_P65.nxml.txt.nlp	NULL	SENT18	9	9	4	4	resveratrol	NAMPT		10135	0.983
NULL	Pharmaceuticals_(Basel)_2013_Apr_8_6(4)_500-509.nxml.txt.nlp	24276120	SENT128	29	29	7	7	tolcapone	GPR35	PA451720	2859	0.983
NULL	Oncogene_2014_Jul_24_33(30)_3927-3938.nxml.txt.nlp	23995784	SENT269	7	7	32	32	doxycycline	FOXO1	PA449415	2308	0.983
NULL	Int_J_Mol_Sci_2012_Dec_5_13(12)_16624-16635.nxml.txt.nlp	23443122	SENT79	25	25	8	8	docetaxel	ABCB5	PA449383	340273	0.983
NULL	Arch_Drug_Inf_2011_Mar_4(1)_1-9.nxml.txt.nlp	21572514	SENT34	3	3	8	8	vinblastine	P-gp	PA451877	5243	0.983
NULL	Ann_Oncol_2011_Mar_8_22(3)_503-514.nxml.txt.nlp	20616198	SENT222	2	2	13	13	exemestane	aromatase	PA449563	1588	0.983
NULL	Int_J_Med_Sci_2013_Jul_5_10(9)_1121-1134.nxml.txt.nlp	23869188	SENT34	1	1	25	25	forskolin	SLC26A6	PA146096022	65010	0.983
NULL	Braz_J_Med_Biol_Res_2014_Mar_21_47(4)_273-278.nxml.txt.nlp	24676475	SENT87	18	18	7	7	doxorubicin	CIAPIN1	PA449412	57019	0.983
NULL	Oncotarget_2012_Nov_17_3(12)_1600-1614.nxml.txt.nlp	23307622	SENT50	18	18	0	0	trastuzumab	ATG12	PA451743	9140	0.983
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1554-1562.nxml.txt.nlp	21970876	SENT138	7	7	16	16	afatinib	EGF	PA165981154	1950	0.983
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT209	10	10	42	42	bevacizumab	VEGFR2	PA130232992	3791	0.983
NULL	Biomed_Res_Int_2014_May_18_2014_756078.nxml.txt.nlp	24949467	SENT144	36	36	5	5	bevacizumab	IL-6	PA130232992	3569	0.983
NULL	Cholesterol_2013_Dec_10_2013_314170.nxml.txt.nlp	24386561	SENT112	2	2	11	11	pitavastatin	adiponectin	PA142650384	9370	0.983
NULL	Indian_J_Dermatol_2009_Apr-Jun_54(2)_100-109.nxml.txt.nlp	20101303	SENT146	0	0	8	8	tocilizumab	IL-6	PA165292659	3569	0.983
NULL	Eur_J_Haematol_2013_Feb_22_90(2)_89-98.nxml.txt.nlp	23181448	SENT124	2	2	19	19	imatinib	ASM	PA10804	6609;283120	0.983
NULL	Gut_2013_Apr_14_62(4)_540-549.nxml.txt.nlp	22798500	SENT253	17	17	9	9	cetuximab	KRAS	PA10040	3845	0.983
NULL	Allergy_Asthma_Immunol_Res_2014_Nov_28_6(6)_567-572.nxml.txt.nlp	25374757	SENT88	25	25	34	34	fexofenadine	p38	PA449621	10598;1432;7965	0.983
NULL	Autophagy_2013_Jul_1_9(7)_985-995.nxml.txt.nlp	23584039	SENT177	7	7	34	34	chloramphenicol	SQSTM1	PA448927	8878	0.983
NULL	Cancer_Med_2013_Dec_27_2(6)_751-762.nxml.txt.nlp	24403249	SENT137	16	16	6	6	paclitaxel	CD44	PA450761	960	0.983
NULL	Cases_J_2009_Jan_6_2_15.nxml.txt.nlp	19126225	SENT100	16	16	12	12	gefitinib	EGFR	PA131301952	1956	0.983
NULL	Ther_Clin_Risk_Manag_2007_Jun_3(3)_411-420.nxml.txt.nlp	18488075	SENT140	8	8	36	36	alefacept	CD4	PA164748040	920	0.983
NULL	Mol_Pain_2014_Aug_15_10_53.nxml.txt.nlp	25127716	SENT74	22	22	8	8	paclitaxel	SDH	PA450761	1757;10993	0.983
NULL	BMJ_Open_2013_Nov_4_3(11)_e003995.nxml.txt.nlp	24189085	SENT313	9	9	19	19	liraglutide	DMC	PA165958364	284340;54808	0.983
NULL	Indian_J_Endocrinol_Metab_2012_Sep-Oct_16(5)_833-835.nxml.txt.nlp	23087877	SENT15	5	5	19	19	bromocriptine	PRL	PA448671	5617	0.983
NULL	Acta_Pharmacol_Sin_2014_Jun_5_35(6)_727-737.nxml.txt.nlp	24793312	SENT25	6	6	20	20	telmisartan	gamma	PA451605	9913	0.983
NULL	J_Invest_Dermatol_2012_Oct_24_132(10)_2440-2450.nxml.txt.nlp	22622430	SENT60	16	16	8	8	paclitaxel	ABCB1	PA450761	5243	0.983
NULL	Drugs_2014_Oct_10_74(17)_2015-2032.nxml.txt.nlp	25300410	SENT60	3	3	10	10	quinidine	P-gp	PA451209	5243	0.983
NULL	Mol_Cancer_2008_Jan_25_7_14.nxml.txt.nlp	18221502	SENT218	31	31	7	7	tamoxifen	PSAT1	PA451581	29968	0.983
NULL	Curr_Oncol_2009_May_16(Suppl_1)_S52-S59.nxml.txt.nlp	19478903	SENT48	0	0	36	36	sunitinib	CYP2C8	PA162372840	1558	0.983
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT7	20	20	2	2	neratinib	HER3	PA165291472	2065	0.983
NULL	AIDS_Res_Ther_2014_Aug_4_11_25.nxml.txt.nlp	25120580	SENT59	0	0	4	4	ritonavir	CYP3A4	PA451260	1576	0.983
NULL	Int_J_Endocrinol_Metab_2013_Jul_1_Summer_11(3)_184-190.nxml.txt.nlp	24348591	SENT124	23	23	1	1	liraglutide	MDC	PA165958364	6367	0.983
NULL	Br_J_Cancer_2011_Sep_6_105(6)_807-813.nxml.txt.nlp	21847121	SENT82	32	32	2	2	pha-665752	HER2		2064	0.983
NULL	J_Oncol_2010_Feb_11_2010_361836.nxml.txt.nlp	20169138	SENT108	0	0	28	28	sorafenib	c-Raf	PA7000	5894	0.983
NULL	Acta_Pharmacol_Sin_2011_Oct_15_32(10)_1225-1232.nxml.txt.nlp	21841809	SENT170	4	4	15	15	aripiprazole	CYP3A4	PA10026	1576	0.983
NULL	Indian_J_Med_Res_2012_Sep_136(3)_391-403.nxml.txt.nlp	23041732	SENT168	31	31	45	45	mitoxantrone	HCC	PA450526	84668	0.983
NULL	Arthritis_Res_Ther_2005_Jun_21_7(4)_160-169.nxml.txt.nlp	15987500	SENT42	38	38	11	11	heparin	ADAMTS-4	PA449855	9508	0.983
NULL	Cell_Death_Differ_2010_Apr_16_17(4)_666-676.nxml.txt.nlp	19834494	SENT283	25	25	8	8	oxaliplatin	p53	PA131285527	7157	0.983
NULL	Nucleic_Acids_Res_2013_Nov_11_41(20)_e195.nxml.txt.nlp	24030711	SENT34	23	23	40	40	galactose	ACT1	PA449725	10758	0.983
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT143	30	30	11	11	dasatinib	LYN	PA162372878	4067	0.983
NULL	Biologics_2009_Sep_15_3_419-428.nxml.txt.nlp	19774209	SENT167	4	4	12	12	everolimus	EGFR	PA164746311	1956	0.983
NULL	J_Cheminform_2012_Mar_8_4_6.nxml.txt.nlp	22401035	SENT308	15	15	0	0	troglitazone	ABCB11	PA451799	8647	0.983
NULL	Biomed_Res_Int_2013_Jul_25_2013_295132.nxml.txt.nlp	23984335	SENT350	14	14	0	0	tocilizumab	IL-6	PA165292659	3569	0.983
NULL	Hum_Genomics_2009_Dec_1_4(2)_91-106.nxml.txt.nlp	20038497	SENT201	14	14	3	3	tacrine	IL-6	PA451576	3569	0.983
NULL	Hum_Genomics_2009_Dec_1_4(2)_91-106.nxml.txt.nlp	20038497	SENT180	7	7	29	29	rivastigmine	BCHE	PA451262	590	0.983
NULL	Br_J_Ophthalmol_2014_Jul_98(Suppl_2)_ii24-ii29.nxml.txt.nlp	24934220	SENT93	26	26	12	12	fluorescein	OCT	PA164746009	5362	0.983
NULL	Ann_Surg_Treat_Res_2014_Feb_22_86(2)_68-75.nxml.txt.nlp	24761411	SENT119	3	3	12	12	resveratrol	survivin		332	0.983
NULL	Acta_Pharmacol_Sin_2014_Oct_25_35(10)_1293-1301.nxml.txt.nlp	25152022	SENT182	28	28	12	12	enalapril	IL-18	PA449456	3606	0.983
NULL	Diabetes_Care_2010_Jul_31_33(7)_1607-1609.nxml.txt.nlp	20357375	SENT69	7	7	28	28	sitagliptin	CD34	PA164748978	947	0.983
NULL	Diabetes_Care_2013_Aug_17_36(Suppl_2)_S180-S189.nxml.txt.nlp	23882044	SENT79	21	21	30	30	metformin	GLP-1	PA450395	100125288	0.983
NULL	J_Cardiothorac_Surg_2013_Nov_9_8_208.nxml.txt.nlp	24209453	SENT153	19	19	2	2	nesiritide	NAPA	PA164781045	9476;8775	0.983
NULL	Eur_J_Clin_Pharmacol_2011_May_8_67(5)_493-506.nxml.txt.nlp	21140139	SENT156	15	15	1	1	nelfinavir	CYP3A4	PA450606	1576	0.983
NULL	Acta_Pharmacol_Sin_2010_Sep_16_31(9)_1149-1153.nxml.txt.nlp	20711224	SENT37	13	13	4	4	clopidogrel	P2Y12	PA449053	64805	0.983
NULL	Pain_Res_Treat_2011_Aug_14_2011_864605.nxml.txt.nlp	22110933	SENT146	9	9	17	17	nifedipine	PLP	PA450631	25824;5744	0.983
NULL	Gastric_Cancer_2013_Jul_12_16(3)_345-354.nxml.txt.nlp	22968820	SENT106	30	30	4	4	oxaliplatin	FANCJ	PA131285527	83990	0.983
NULL	JSLS_2003_Oct-Dec_7(4)_371-375.nxml.txt.nlp	14626406	SENT93	14	14	1	1	estradiol	aromatase	PA449503	1588	0.983
NULL	Mol_Cell_Biochem_2012_Apr_3_363(1-2)_135-145.nxml.txt.nlp	22139302	SENT252	14	14	12	12	curcumin	survivin	PA151958596	332	0.983
NULL	Arthritis_Res_Ther_2009_Apr_23_11(2)_R57.nxml.txt.nlp	19389237	SENT252	43	43	10	10	adalimumab	CXCL11	PA10004	6373	0.983
NULL	Br_J_Cancer_2010_Mar_16_102(6)_1003-1009.nxml.txt.nlp	20179710	SENT28	0	0	24	24	cyclophosphamide	CYP2C9	PA449165	1559	0.983
NULL	Mol_Cell_Biochem_2014_Jan_3_389(1-2)_177-185.nxml.txt.nlp	24385108	SENT176	23	23	3	3	bortezomib	ORP150	PA10252	10525	0.983
NULL	Clin_Med_Insights_Oncol_2012_Dec_20_7_1-12.nxml.txt.nlp	23362372	SENT35	3	3	37	37	cabazitaxel	CYP3A	PA165958401	1574	0.983
NULL	Cancer_Cell_2007_Dec_11_12(6)_514-527.nxml.txt.nlp	18068629	SENT176	14	14	29	29	cisplatin	AKT	PA449014	207	0.983
NULL	Oncol_Rep_2013_Jun_22_29(6)_2479-2485.nxml.txt.nlp	23525656	SENT125	4	4	25	25	lapatinib	MRP7	PA152241907	89845;1080	0.983
NULL	J_Cancer_Prev_2014_Sep_19(3)_153-160.nxml.txt.nlp	25337584	SENT97	25	25	15	15	betaine	IL-6	PA448603	3569	0.983
NULL	Breast_Cancer_Res_2009_Jun_29_11(3)_R41.nxml.txt.nlp	19563669	SENT171	31	31	16	16	lapatinib	XIAP	PA152241907	331	0.983
NULL	Int_J_Mol_Sci_2014_Mar_5_15(3)_3970-3988.nxml.txt.nlp	24603537	SENT118	7	7	22	22	curcumin	HO-1	PA151958596	3162	0.983
NULL	Colomb_Med_(Cali)_43(4)_305-311.nxml.txt.nlp	24893304	SENT59	3	3	16	16	ganciclovir	CD4	PA449733	920	0.983
NULL	J_Hematol_Oncol_2008_Oct_1_1_16.nxml.txt.nlp	18828924	SENT126	0	0	11	11	cetuximab	EGFR	PA10040	1956	0.983
NULL	Oncotarget_2011_May_16_2(5)_418-421.nxml.txt.nlp	21789791	SENT26	27	27	7	7	bortezomib	TRAIL	PA10252	8743	0.983
NULL	Breast_Cancer_Res_2012_Jun_7_14(3)_R89.nxml.txt.nlp	22676470	SENT242	7	7	21	21	lapatinib	HER2	PA152241907	2064	0.983
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT172	28	28	5	5	heparin	FGF1	PA449855	2246	0.983
NULL	Arch_Drug_Inf_2009_Mar_2(1)_1-7.nxml.txt.nlp	19381337	SENT26	26	26	5	5	ritonavir	CYP3A4	PA451260	1576	0.983
NULL	Cell_Commun_Signal_2013_Jan_11_11_2.nxml.txt.nlp	23305203	SENT160	17	17	4	4	forskolin	RACK1	PA146096022	10399	0.983
NULL	Mol_Cancer_2014_Jun_19_13_154.nxml.txt.nlp	24941944	SENT160	22	22	10	10	pyrimethamine	BRAF	PA451193	673	0.983
NULL	Diabetes_Care_2010_Jan_21_33(1)_156-161.nxml.txt.nlp	19846797	SENT5	3	3	10	10	metformin	B12	PA450395	7126;4709	0.983
NULL	EMBO_Mol_Med_2013_Aug_1_5(8)_1196-1212.nxml.txt.nlp	23818228	SENT398	17	17	8	8	temozolomide	ZEB1	PA451609	6935	0.983
NULL	Indian_J_Pharm_Sci_2013_May-Jun_75(3)_251-261.nxml.txt.nlp	24082340	SENT115	0	0	6	6	exemestane	aromatase	PA449563	1588	0.983
NULL	Int_J_Inflam_2014_Dec_9_2014_959271.nxml.txt.nlp	25574420	SENT144	3	3	20	20	carrageenan	TLR4	PA448814	7099	0.983
NULL	ISRN_Obstet_Gynecol_2011_Nov_17_2011_242864.nxml.txt.nlp	22191042	SENT20	29	29	6	6	estradiol	aromatase	PA449503	1588	0.983
NULL	Neural_Dev_2013_Mar_7_8_4.nxml.txt.nlp	23497494	SENT152	34	34	9	9	chlorpheniramine	FOXP2	PA448960	93986	0.983
NULL	Case_Rep_Dermatol_2014_Sep_6_6(3)_213-217.nxml.txt.nlp	25408648	SENT13	0	0	3	3	vemurafenib	BRAF	PA165946873	673	0.983
NULL	EMBO_Mol_Med_2013_Mar_22_5(3)_353-365.nxml.txt.nlp	23341130	SENT240	20	20	5	5	nilotinib	CD34	PA165958345	947	0.983
NULL	Clin_Med_Insights_Oncol_2011_Jul_20_5_213-221.nxml.txt.nlp	21836817	SENT145	0	0	8	8	sunitinib	VEGFR	PA162372840	3791	0.983
NULL	J_Oncol_2009_May_6_2009_567486.nxml.txt.nlp	19424511	SENT124	0	0	12	12	sorafenib	EGFR	PA7000	1956	0.983
NULL	J_Cancer_Prev_2014_Sep_19(3)_153-160.nxml.txt.nlp	25337584	SENT97	25	25	19	19	betaine	iNOS	PA448603	4843	0.983
NULL	Br_J_Cancer_2010_Jul_13_103(2)_186-195.nxml.txt.nlp	20588277	SENT109	33	33	2	2	nutlin-3	p53		7157	0.983
NULL	Br_J_Cancer_2006_Dec_4_95(11)_1483-1489.nxml.txt.nlp	17106442	SENT15	0	0	10	10	gefitinib	EGFR	PA131301952	1956	0.983
NULL	Environ_Health_Perspect_2006_Jan_17_114(1)_85-91.nxml.txt.nlp	16393663	SENT265	34	34	3	3	staurosporine	CD4	PA165109623	920	0.983
NULL	Br_J_Haematol_2014_Jan_28_164(2)_233-244.nxml.txt.nlp	24206017	SENT206	37	37	23	23	lenalidomide	CRBN	PA162363968	51185	0.983
NULL	Cell_Death_Dis_2014_Jul_31_5(7)_e1358.nxml.txt.nlp	25077544	SENT40	35	35	13	13	etoposide	ALDH1L1	PA449552	10840	0.983
NULL	Hum_Genomics_2008_Sep_1_3(1)_7-16.nxml.txt.nlp	19129086	SENT164	3	3	19	19	pioglitazone	CYP2C9	PA450970	1559	0.983
NULL	Arch_Drug_Inf_2011_Mar_4(1)_1-9.nxml.txt.nlp	21572514	SENT147	4	4	12	12	ketoconazole	P-gp	PA450146	5243	0.983
NULL	Nat_Med_2010_Sep_22_16(9)_998-1000.nxml.txt.nlp	20729864	SENT30	16	16	37	37	sorafenib	LRRK2	PA7000	120892	0.983
NULL	Ann_Oncol_2011_Mar_8_22(3)_503-514.nxml.txt.nlp	20616198	SENT206	11	11	25	25	tamoxifen	aromatase	PA451581	1588	0.983
NULL	Neural_Plast_2007_Jan_1_2007_30585.nxml.txt.nlp	25148070	SENT2884	1	1	14	14	forskolin	AC5	PA146096022	111	0.983
NULL	Ther_Clin_Risk_Manag_2006_Mar_2(1)_87-98.nxml.txt.nlp	18360584	SENT94	0	0	10	10	sorafenib	BRAF	PA7000	673	0.983
NULL	Ann_Indian_Acad_Neurol_2008_Jan-Mar_11(1)_13-19.nxml.txt.nlp	19966973	SENT97	5	5	10	10	curcumin	CNP	PA151958596	4880;1267	0.983
NULL	Cancer_Cell_Int_2013_Feb_13_13_15.nxml.txt.nlp	23402326	SENT164	11	11	20	20	erlotinib	EGFR	PA134687924	1956	0.983
NULL	Bone_Marrow_Transplant_2013_Jul_14_48(7)_922-925.nxml.txt.nlp	23318540	SENT4	4	4	13	13	filgrastim	CD34	PA449626	947	0.983
NULL	Indian_J_Ophthalmol_2011_May-Jun_59(3)_191-196.nxml.txt.nlp	21586838	SENT28	0	0	20	20	ranibizumab	VEGF-A	PA164746012	7422	0.983
NULL	J_Clin_Exp_Ophthalmol_2013_Dec_18_4(6)_314.nxml.txt.nlp	25068073	SENT36	4	4	23	23	fenofibrate	LOX-1	PA449594	4973	0.983
NULL	Evid_Based_Complement_Alternat_Med_2013_Aug_12_2013_982689.nxml.txt.nlp	23997806	SENT10	12	12	17	17	tolbutamide	APE	PA451718	55704;328	0.983
NULL	Oncogene_2013_Sep_12_32(37)_4355-4365.nxml.txt.nlp	23108409	SENT23	6	6	30	30	hyaluronan	HAS2	PA165958431	3037	0.983
NULL	Pharmaceuticals_(Basel)_2011_Nov_11_4(11)_1503-1517.nxml.txt.nlp	NULL	SENT41	0	0	31	31	capsaicin	TRPV1	PA448776	7442	0.983
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT24	0	0	15	15	metformin	AKT	PA450395	207	0.983
NULL	J_Viral_Hepat_2007_Nov_14(11)_751-766.nxml.txt.nlp	17927611	SENT331	30	30	9	9	lamivudine	IFN	PA450163	3439	0.983
NULL	Indian_J_Pharm_Sci_2008_Mar-Apr_70(2)_251-255.nxml.txt.nlp	20046726	SENT50	17	17	26	26	fluoxetine	TLC	PA449673	3933	0.983
NULL	J_Ind_Microbiol_Biotechnol_2008_Jun_5_35(6)_569-578.nxml.txt.nlp	18247072	SENT47	34	34	1	1	nadh	XDH	PA164755085	7498	0.983
NULL	Infect_Dis_Obstet_Gynecol_2008_May_29_2008_493508.nxml.txt.nlp	18528520	SENT135	3	3	16	16	tetracycline	CDR1	PA451640	1038	0.983
NULL	Mol_Cell_Proteomics_2014_May_17_13(5)_1273-1285.nxml.txt.nlp	24637012	SENT165	17	17	5	5	lisuride	5-HT2A	PA164749019	3356	0.983
NULL	Breast_Cancer_(Dove_Med_Press)_2013_Aug_22_5_73-78.nxml.txt.nlp	24648760	SENT22	33	33	5	5	tamoxifen	aromatase	PA451581	1588	0.983
NULL	Leukemia_2013_Feb_10_27(2)_507-510.nxml.txt.nlp	22810506	SENT21	22	22	0	0	vincristine	TRAC	PA451879	28755	0.983
NULL	Pharmaceuticals_(Basel)_2012_Aug_30_5(9)_890-898.nxml.txt.nlp	24280696	SENT82	17	17	26	26	fludarabine	TP53	PA449655	7157	0.983
NULL	Hum_Genomics_Proteomics_2010_Aug_3_2010_159761.nxml.txt.nlp	20981231	SENT60	5	5	28	28	gabapentin	GBP	PA449720	54972;3030;3956;8554	0.983
NULL	Br_J_Cancer_2012_Jun_26_107(1)_43-52.nxml.txt.nlp	22644306	SENT226	32	32	0	0	tamoxifen	TP53	PA451581	7157	0.983
NULL	Int_J_Endocrinol_2014_Jun_25_2014_534904.nxml.txt.nlp	25053942	SENT94	26	26	9	9	amiodarone	AIT	PA448383	160728	0.983
NULL	Cell_Death_Dis_2014_Feb_13_5(2)_e1055.nxml.txt.nlp	24525731	SENT45	33	33	7	7	cisplatin	XRCC1	PA449014	7515	0.983
NULL	Int_J_Endocrinol_2010_Mar_2_2010_621687.nxml.txt.nlp	20204178	SENT90	23	23	8	8	paricalcitol	PTH	PA450798	5741	0.983
NULL	Cancer_Cell_Int_2014_Jan_23_14_6.nxml.txt.nlp	24456610	SENT284	9	9	18	18	erlotinib	EGFR	PA134687924	1956	0.983
NULL	Cancers_(Basel)_2014_Nov_25_6(4)_2313-2329.nxml.txt.nlp	25534569	SENT32	0	0	13	13	cabozantinib	VEGFR2	PA165906891	3791	0.983
NULL	Allergy_Asthma_Clin_Immunol_2011_Nov_14_7(Suppl_2)_A37.nxml.txt.nlp	NULL	SENT12	33	33	0	0	ceftazidime	CD25	PA448861	3669;3559	0.983
NULL	Nucleic_Acids_Res_2011_Mar_19_39(4)_1266-1279.nxml.txt.nlp	20959290	SENT187	22	22	32	32	doxorubicin	p53	PA449412	7157	0.983
NULL	Cell_Death_Dis_2014_Mar_13_5(3)_e1113.nxml.txt.nlp	24625972	SENT331	14	14	5	5	bleomycin	BI-1	PA448645	7009	0.983
NULL	Nucleic_Acids_Res_2010_Oct_28_38(19)_6418-6432.nxml.txt.nlp	20511593	SENT314	15	15	6	6	hydroxyurea	TREX1	PA449942	11277	0.983
NULL	Clin_Interv_Aging_2015_Jan_6_10_157-174.nxml.txt.nlp	25609933	SENT113	21	21	3	3	tamoxifen	aromatase	PA451581	1588	0.983
NULL	J_Cell_Biol_2002_Nov_25_159(4)_637-648.nxml.txt.nlp	12438416	SENT162	18	18	9	9	etoposide	p115	PA449552	8615;393	0.983
NULL	Biologics_2013_Feb_28_7_39-46.nxml.txt.nlp	23467578	SENT27	0	0	7	7	pazopanib	VEGFR	PA165291492	3791	0.983
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT171	6	6	32	32	cisplatin	MDM2	PA449014	4193	0.983
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT1	0	0	10	10	trastuzumab	HER2	PA451743	2064	0.983
NULL	Mol_Cancer_2012_Dec_12_11_91.nxml.txt.nlp	23234355	SENT192	11	11	31	31	lapatinib	EGFR	PA152241907	1956	0.983
NULL	Front_Genet_2014_Mar_26_5_50.nxml.txt.nlp	24723935	SENT102	24	24	9	9	carbamazepine	HLA-B	PA448785	3106	0.983
NULL	J_Oncol_2014_Mar_26_2014_625060.nxml.txt.nlp	24795759	SENT28	24	24	10	10	tamoxifen	aromatase	PA451581	1588	0.983
NULL	Oncoimmunology_2014_Apr_25_3_e28518.nxml.txt.nlp	25071979	SENT119	32	32	20	20	carboplatin	CRT	PA448803	811	0.983
NULL	Case_Rep_Psychiatry_2012_Oct_9_2012_642752.nxml.txt.nlp	23094178	SENT66	17	17	36	36	agomelatine	CYP2D6	PA165958363	1565	0.983
NULL	AAPS_J_2012_Jan_4_14(1)_87-96.nxml.txt.nlp	22215264	SENT26	22	22	20	20	tariquidar	P-gp		5243	0.983
NULL	Mol_Cancer_2012_Aug_24_11_61.nxml.txt.nlp	22917467	SENT221	43	43	23	23	doxorubicin	EGF	PA449412	1950	0.983
NULL	Pharmaceuticals_(Basel)_2013_Aug_6_6(8)_929-959.nxml.txt.nlp	24276377	SENT190	12	12	35	35	sulindac	COX	PA451565	1351	0.983
NULL	Cardiol_Res_Pract_2013_Feb_21_2013_127270.nxml.txt.nlp	23509665	SENT176	12	12	26	26	clopidogrel	ADP	PA449053	23038	0.983
NULL	Aging_(Albany_NY)_2009_Mar_28_1(3)_275-277.nxml.txt.nlp	20157515	SENT6	10	10	36	36	etoposide	p65	PA449552	5970	0.983
NULL	Ann_Dermatol_2014_Aug_31_26(4)_517-520.nxml.txt.nlp	25143685	SENT56	19	19	7	7	tazarotene	p53	PA164746821	7157	0.983
NULL	FEBS_Open_Bio_2012_Mar_5_2_32-36.nxml.txt.nlp	23650578	SENT310	16	16	0	0	isoproterenol	PDK4	PA450121	5166	0.983
NULL	Indian_J_Pharmacol_2012_Nov-Dec_44(6)_704-709.nxml.txt.nlp	23248398	SENT66	14	14	43	43	terbinafine	ANOVA	PA451614	4858	0.983
NULL	Oncol_Lett_2013_Apr_28_5(4)_1149-1154.nxml.txt.nlp	23599754	SENT130	19	19	4	4	cisplatin	EZH2	PA449014	2146	0.983
NULL	J_Immunol_Res_2014_Jul_13_2014_964069.nxml.txt.nlp	25126586	SENT91	0	0	8	8	tocilizumab	IL-6	PA165292659	3569	0.983
NULL	Gut_Liver_2015_Jan_15_9(1)_43-51.nxml.txt.nlp	NULL	SENT55	17	17	25	25	warfarin	ESD	PA451906	2098	0.983
NULL	Genetics_2013_Mar_193(3)_853-864.nxml.txt.nlp	23267056	SENT115	12	12	3	3	hydroxyurea	GPN2	PA449942	54707	0.983
NULL	Br_J_Cancer_2009_Jul_21_101(2)_238-243.nxml.txt.nlp	19568242	SENT12	5	5	33	33	bevacizumab	IFN	PA130232992	3439	0.983
NULL	Oncogene_2010_Jul_22_29(29)_4170-4182.nxml.txt.nlp	20498638	SENT132	10	10	3	3	gefitinib	EGFR	PA131301952	1956	0.983
NULL	J_Cell_Physiol_2011_Nov_15_226(11)_2979-2986.nxml.txt.nlp	21328349	SENT9	17	17	37	37	econazole	TRPV5	PA164746010	56302	0.983
NULL	Int_J_Endocrinol_2013_Nov_13_2013_686315.nxml.txt.nlp	24324494	SENT7	15	15	2	2	metformin	SLC47A1	PA450395	55244	0.983
NULL	Oncotarget_2012_Sep_27_3(10)_1137-1145.nxml.txt.nlp	23087155	SENT23	24	24	5	5	decitabine	THP1	PA164749631	2736	0.983
NULL	Cell_Death_Dis_2014_Feb_27_5(2)_e1093.nxml.txt.nlp	24577091	SENT134	7	7	26	26	curcumin	JNK	PA151958596	5599	0.983
NULL	Psychiatry_Investig_2012_Dec_12_9(4)_422-424.nxml.txt.nlp	23251210	SENT14	22	22	7	7	perphenazine	CYP2D6	PA450882	1565	0.983
NULL	Oncol_Lett_2013_Sep_12_6(3)_860-864.nxml.txt.nlp	24137426	SENT85	37	37	14	14	ketoconazole	CYP3A4	PA450146	1576	0.983
NULL	Acta_Pharmacol_Sin_2009_May_5_30(5)_646-652.nxml.txt.nlp	19417737	SENT59	16	16	21	21	midazolam	CYP3A4	PA450496	1576	0.983
NULL	Clin_Sci_(Lond)_2009_Nov_16_118(Pt_4)_269-279.nxml.txt.nlp	19698082	SENT139	23	23	12	12	ramipril	ACE2	PA451223	59272	0.983
NULL	Curr_Oncol_2009_May_16(Suppl_1)_S52-S59.nxml.txt.nlp	19478903	SENT50	3	3	15	15	sunitinib	CYP3A4	PA162372840	1576	0.983
NULL	Indian_J_Endocrinol_Metab_2012_Dec_16(Suppl_2)_S245-S247.nxml.txt.nlp	23565390	SENT65	0	0	14	14	sitagliptin	RAGE	PA164748978	177	0.983
NULL	Contemp_Oncol_(Pozn)_2012_Nov_20_16(5)_363-370.nxml.txt.nlp	23788912	SENT203	10	10	20	20	vemurafenib	BRAF	PA165946873	673	0.983
NULL	Nat_Med_2012_Jul_18(7)_1118-1122.nxml.txt.nlp	22683780	SENT40	19	19	11	11	crizotinib	MET	PA165946122	4233	0.983
NULL	Mol_Biol_Cell_2012_Mar_15_23(6)_996-1009.nxml.txt.nlp	22278744	SENT202	20	20	9	9	forskolin	14-3-3	PA146096022	10971	0.983
NULL	Indian_J_Med_Res_2010_Dec_132(6)_676-682.nxml.txt.nlp	21245614	SENT94	0	0	24	24	zinc	p53	PA451956	7157	0.983
NULL	Cell_Death_Differ_2010_Apr_16_17(4)_666-676.nxml.txt.nlp	19834494	SENT269	26	26	0	0	melphalan	RAGE	PA450354	177	0.983
NULL	Gut_Liver_2012_Oct_18_6(4)_464-470.nxml.txt.nlp	23170151	SENT103	4	4	19	19	propofol	ESD	PA451141	2098	0.983
NULL	J_Immune_Based_Ther_Vaccines_2011_Oct_24_9_7.nxml.txt.nlp	22024351	SENT52	7	7	29	29	cyclophosphamide	EGF	PA449165	1950	0.983
NULL	Br_J_Cancer_2012_Nov_6_107(10)_1714-1721.nxml.txt.nlp	23073173	SENT10	14	14	21	21	docetaxel	RUNX2	PA449383	860	0.983
NULL	J_Lipid_Res_2012_May_53(5)_1000-1011.nxml.txt.nlp	22368281	SENT309	21	21	5	5	simvastatin	HMGCR	PA451363	3156	0.983
NULL	J_Cell_Biol_2000_Jul_24_150(2)_309-320.nxml.txt.nlp	10908574	SENT97	34	34	6	6	trypsin	p130	PA451806	5934	0.983
NULL	Breast_Cancer_(Auckl)_2010_Feb_16_4_1-3.nxml.txt.nlp	20697527	SENT15	29	29	4	4	curcumin	BRCA1	PA151958596	672	0.983
NULL	Oncol_Lett_2013_Mar_28_5(3)_935-942.nxml.txt.nlp	23426424	SENT114	29	29	3	3	oxaliplatin	ERCC1	PA131285527	2067	0.983
NULL	Acta_Pharmacol_Sin_2014_Jun_4_35(6)_792-805.nxml.txt.nlp	24902787	SENT270	5	5	10	10	paroxetine	CYP2D6	PA450801	1565	0.983
NULL	Cancer_Cell_Int_2011_Aug_19_11_29.nxml.txt.nlp	21854619	SENT219	17	17	33	33	platinum	HDAC	PA150595617	9734	0.983
NULL	Endocrinol_Metab_(Seoul)_2013_Dec_12_28(4)_297-308.nxml.txt.nlp	24396695	SENT44	26	26	10	10	deferoxamine	SREBP1	PA164746490	6720	0.983
NULL	Aging_(Albany_NY)_2014_Mar_26_6(3)_187-206.nxml.txt.nlp	24753144	SENT204	16	16	5	5	metformin	GLP-1	PA450395	100125288	0.983
NULL	J_Cardiovasc_Dis_Res_2012_Oct-Dec_3(4)_319-322.nxml.txt.nlp	23233778	SENT13	3	3	29	29	clarithromycin	CYP3A4	PA449028	1576	0.983
NULL	Oncotarget_2014_Aug_29_5(19)_8947-8958.nxml.txt.nlp	25333254	SENT104	9	9	3	3	cytarabine	CXCR4	PA449177	7852	0.983
NULL	Front_Pharmacol_2014_Dec_23_5_286.nxml.txt.nlp	25566078	SENT57	22	22	42	42	gefitinib	FOXM1	PA131301952	2305	0.983
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT398	39	39	12	12	heparin	FGF2	PA449855	2247;2258	0.983
NULL	J_Cancer_2014_Jan_1_5(1)_3-24.nxml.txt.nlp	24396494	SENT100	4	4	16	16	denosumab	RANK	PA166048634	8792	0.983
NULL	Cancers_(Basel)_2013_Nov_11_5(4)_1522-1544.nxml.txt.nlp	24351670	SENT193	16	16	8	8	cisplatin	CD9	PA449014	928	0.983
NULL	Mol_Cancer_2008_Mar_26_7_27.nxml.txt.nlp	18366759	SENT84	27	27	13	13	etoposide	Bcl-2	PA449552	596	0.983
NULL	Indian_J_Med_Res_2012_Aug_136(2)_249-259.nxml.txt.nlp	22960892	SENT137	43	43	34	34	irinotecan	UGT1A1	PA450085	54658	0.983
NULL	Br_J_Cancer_2013_Jan_15_108(1)_82-90.nxml.txt.nlp	23321512	SENT219	12	12	2	2	cisplatin	TUBB3	PA449014	10381	0.983
NULL	Clin_Med_Insights_Cardiol_2012_Feb_1_6_17-33.nxml.txt.nlp	22442638	SENT185	4	4	31	31	rosuvastatin	CYP3A4	PA134308647	1576	0.983
NULL	Breast_Cancer_Res_2014_Oct_28_16(5)_456.nxml.txt.nlp	25349073	SENT72	40	40	28	28	trastuzumab	HER2	PA451743	2064	0.983
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT62	18	18	5	5	cetuximab	EGFR	PA10040	1956	0.983
NULL	Cardiovasc_Res_2014_Mar_1_101(3)_513-521.nxml.txt.nlp	24323316	SENT134	9	9	24	24	maraviroc	CCL4	PA164768835	6351	0.983
NULL	Breast_Cancer_Res_2013_Oct_3_15(5)_R93.nxml.txt.nlp	24088226	SENT94	3	3	17	17	tamoxifen	CYP2D6	PA451581	1565	0.983
NULL	Antiviral_Res_2009_May_82(2)_A99-A109.nxml.txt.nlp	19176219	SENT116	24	24	7	7	efavirenz	MRP-1	PA449441	928	0.983
NULL	J_Hematol_Oncol_2008_Oct_23_1_19.nxml.txt.nlp	18947412	SENT7	0	0	9	9	alemtuzumab	CD52	PA164783958	1043	0.983
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Dec_17_3(12)_e152.nxml.txt.nlp	25518025	SENT77	6	6	10	10	oxycodone	P-gp	PA450741	5243	0.983
NULL	Cardiovasc_Diabetol_2010_Sep_23_9_57.nxml.txt.nlp	20863381	SENT144	2	2	16	16	rosiglitazone	DM2	PA451283	28508	0.983
NULL	Eur_J_Pharmacol_2011_Mar_5_654(2)_155-159.nxml.txt.nlp	21172341	SENT71	5	5	22	22	staurosporine	mGlu1	PA165109623	2911	0.983
NULL	J_Thromb_Thrombolysis_2011_Nov_26_32(4)_459-466.nxml.txt.nlp	21706290	SENT63	32	32	16	16	clopidogrel	CYP2C19	PA449053	1557	0.983
NULL	Breast_Cancer_Res_2008_Jul_8_10(4)_R56.nxml.txt.nlp	18611244	SENT4	0	0	5	5	letrozole	aromatase	PA450196	1588	0.983
NULL	Br_J_Pharmacol_2014_May_171(10)_2659-2670.nxml.txt.nlp	24116661	SENT314	26	26	8	8	naringenin	TRPP2	PA151958361	5311	0.983
NULL	Br_J_Cancer_1998_Aug_78(3)_375-381.nxml.txt.nlp	9703286	SENT10	27	27	1	1	cisplatin	TP53	PA449014	7157	0.983
NULL	J_Oncol_2012_Apr_10_2012_931071.nxml.txt.nlp	22570654	SENT8	3	3	13	13	plerixafor	CD34	PA165958410	947	0.983
NULL	Acta_Histochem_Cytochem_2006_Dec_28_39(6)_163-172.nxml.txt.nlp	17327903	SENT173	16	16	5	5	staurosporine	ERK	PA165109623	5594	0.983
NULL	Neural_Plast_2007_Apr_15_2007_78970.nxml.txt.nlp	18060012	SENT348	17	17	6	6	metyrapone	CA3	PA450486	761	0.983
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1059-1066.nxml.txt.nlp	21364577	SENT32	23	23	38	38	letrozole	aromatase	PA450196	1588	0.983
NULL	Knee_Surg_Relat_Res_2014_Mar_27_26(1)_33-42.nxml.txt.nlp	24639945	SENT138	0	0	10	10	aceclofenac	CYP2C9	PA166049185	1559	0.983
NULL	Crit_Care_2009_Mar_13_13(Suppl_1)_P328.nxml.txt.nlp	NULL	SENT13	0	0	9	9	etomidate	RAI	PA164743987	10848;6050	0.983
NULL	Breast_Cancer_Res_Treat_2014_Sep_25_148(1)_81-90.nxml.txt.nlp	25253174	SENT112	7	7	18	18	metformin	adiponectin	PA450395	9370	0.983
NULL	Br_J_Cancer_2010_Nov_2_103(11)_1671-1679.nxml.txt.nlp	21045835	SENT216	12	12	22	22	gemcitabine	CXCL12	PA449748	6387	0.983
NULL	Acta_Pharmacol_Sin_2009_Sep_24_30(9)_1262-1275.nxml.txt.nlp	19701231	SENT225	11	11	4	4	lovastatin	gamma	PA450272	9913	0.983
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Oct_14_6_159-168.nxml.txt.nlp	25339848	SENT123	5	5	11	11	trastuzumab	HER2	PA451743	2064	0.983
NULL	Br_J_Pharmacol_2008_Oct_18_155(4)_596-605.nxml.txt.nlp	18852694	SENT159	14	14	32	32	fenofibrate	PI3K	PA449594	5290	0.983
NULL	Diabetes_Metab_Syndr_Obes_2010_May_17_3_155-163.nxml.txt.nlp	21437085	SENT52	36	36	8	8	exenatide	GLP-1	PA164749238	100125288	0.983
NULL	J_Biol_Chem_2013_Nov_22_288(47)_34217-34229.nxml.txt.nlp	24106270	SENT382	34	34	16	16	thrombin	RhoG	PA451674	391	0.983
NULL	Pain_2014_Nov_155(11)_2243-2252.nxml.txt.nlp	24978826	SENT175	38	38	2	2	capsaicin	IL10	PA448776	3586	0.983
NULL	Hum_Genomics_2010_Oct_1_5(1)_61-72.nxml.txt.nlp	21106490	SENT59	41	41	20	20	midazolam	CYP3A	PA450496	1574	0.983
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jul_25_68(Pt_8)_o2545.nxml.txt.nlp	22904977	SENT62	12	12	4	4	glutaraldehyde	mol	PA449777	90527	0.983
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_39-54.nxml.txt.nlp	19305787	SENT149	13	13	4	4	ethanol	NR1	PA448073	27158	0.983
NULL	Breast_Cancer_Res_Treat_2014_Apr_9_145(1)_73-82.nxml.txt.nlp	24715380	SENT144	27	27	16	16	tamoxifen	CXCR3	PA451581	2833	0.983
NULL	Biomed_Res_Int_2013_Jul_1_2013_964743.nxml.txt.nlp	23936861	SENT198	28	28	5	5	gefitinib	EGFR	PA131301952	1956	0.983
NULL	Pharm_Pract_(Granada)_2011_Mar_15_Jan-Mar_9(1)_1-10.nxml.txt.nlp	25132883	SENT167	17	17	45	45	warfarin	SPAF	PA451906	166378	0.983
NULL	Br_J_Cancer_2011_Sep_27_105(7)_1030-1038.nxml.txt.nlp	21863025	SENT11	27	27	20	20	saracatinib	ALK4		91	0.983
NULL	Oncotarget_2014_Nov_12_5(20)_9626-9640.nxml.txt.nlp	25275299	SENT82	24	24	7	7	thrombin	RhoA	PA451674	387	0.983
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT3	5	5	20	20	curcumin	TRAIL	PA151958596	8743	0.983
NULL	Target_Oncol_2010_Jun_14_5(2)_95-112.nxml.txt.nlp	20625845	SENT231	22	22	10	10	sorafenib	FDG	PA7000	23583	0.983
NULL	Cell_Biosci_2015_Jan_5_5(1)_1.nxml.txt.nlp	NULL	SENT152	11	11	18	18	ribavirin	IMPDH2	PA451241	3615	0.983
NULL	Support_Care_Cancer_2012_May_1_20(5)_941-949.nxml.txt.nlp	21533811	SENT30	31	31	18	18	granisetron	HEC	PA449809	10403	0.983
NULL	Br_J_Cancer_2010_Jan_5_102(1)_134-143.nxml.txt.nlp	19920829	SENT179	12	12	44	44	pertuzumab	IL-2		3558	0.983
NULL	Cancer_Cell_Int_2014_Jun_11_14_49.nxml.txt.nlp	24991192	SENT97	27	27	9	9	berberine	AMPK	PA165860812	5563	0.983
NULL	Osteoporos_Int_2013_Oct_19_24(1)_23-57.nxml.txt.nlp	23079689	SENT551	3	3	25	25	denosumab	RANK	PA166048634	8792	0.983
NULL	Case_Rep_Dermatol_2011_Oct_11_3(3)_223-227.nxml.txt.nlp	22135629	SENT5	0	0	17	17	trastuzumab	HER2	PA451743	2064	0.983
NULL	Br_J_Cancer_1998_Dec_78(12)_1586-1593.nxml.txt.nlp	9862568	SENT16	21	21	7	7	doxorubicin	MDR1	PA449412	5243	0.983
NULL	Br_J_Cancer_2012_Jan_3_106(1)_148-156.nxml.txt.nlp	22045191	SENT133	5	5	24	24	erlotinib	ZEB1	PA134687924	6935	0.983
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT10	40	40	0	0	cisplatin	IBP	PA449014	706;50619	0.983
NULL	J_Cell_Biol_2005_May_23_169(4)_681-691.nxml.txt.nlp	15911882	SENT61	6	6	17	17	heparin	MMP3	PA449855	4314	0.983
NULL	Clin_Ophthalmol_2011_Nov_1_5_1575-1583.nxml.txt.nlp	22125404	SENT159	8	8	34	34	latanoprost	BAK	PA164774763	578	0.983
NULL	Cardiovasc_Res_2013_May_1_98(2)_286-296.nxml.txt.nlp	23334259	SENT225	39	39	2	2	flecainide	NCX	PA449646	3196	0.983
NULL	Case_Rep_Med_2011_May_10_2011_107928.nxml.txt.nlp	21629846	SENT45	0	0	20	20	ustekinumab	p40	PA166048654	3921;339541;10314	0.983
NULL	Cancers_(Basel)_2014_Apr_16_6(2)_897-925.nxml.txt.nlp	24743777	SENT116	4	4	27	27	thrombin	STAT3	PA451674	6774	0.983
NULL	Exp_Diabetes_Res_2012_Jan_16_2012_230342.nxml.txt.nlp	22291696	SENT57	1	1	33	33	gliclazide	STZ	PA10892	6484	0.983
NULL	Anat_Res_Int_2012_Jan_22_2012_951836.nxml.txt.nlp	22567317	SENT29	6	6	36	36	ethanol	LIPI	PA448073	149998	0.983
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Aug_27_6_145-150.nxml.txt.nlp	25249759	SENT5	0	0	4	4	letrozole	aromatase	PA450196	1588	0.983
NULL	Cancer_Cell_Int_2013_Jan_15_13_3.nxml.txt.nlp	23320839	SENT101	22	22	13	13	gemcitabine	MRP1	PA449748	4437	0.983
NULL	J_Oncol_2010_Aug_24_2010_398564.nxml.txt.nlp	20862373	SENT79	0	0	6	6	sorafenib	VEGFR	PA7000	3791	0.983
NULL	Lancet_2011_Jun_9_377(9784)_2181-2192.nxml.txt.nlp	21663949	SENT125	35	35	2	2	ezetimibe	SHARP	PA10816	23013	0.983
NULL	Bioanal_Rev_2012_Mar_17_4(1)_1-30.nxml.txt.nlp	22389661	SENT883	0	0	20	20	vasopressin	SERS	PA451858	6301;54938	0.983
NULL	Oncotarget_2012_Nov_9_3(11)_1401-1415.nxml.txt.nlp	23211466	SENT166	11	11	36	36	doxorubicin	MCT-1	PA449412	28985	0.983
NULL	Mol_Cells_2014_Aug_31_37(8)_585-591.nxml.txt.nlp	25134539	SENT7	15	15	4	4	indacaterol	ADRB2	PA165958348	154	0.983
NULL	Oncotarget_2014_Mar_16_5(12)_4087-4102.nxml.txt.nlp	24961479	SENT130	17	17	10	10	hemin	PC3	PA449849	57332;7832;5122	0.983
NULL	Indian_J_Pharmacol_2014_Jan-Feb_46(1)_3-12.nxml.txt.nlp	24550577	SENT228	5	5	12	12	vismodegib	CYP2C9		1559	0.983
NULL	Evid_Based_Complement_Alternat_Med_2014_May_5_2014_730678.nxml.txt.nlp	24883070	SENT133	36	36	22	22	epirubicin	CXCR4	PA449476	7852	0.983
NULL	Tuberc_Respir_Dis_(Seoul)_2013_Sep_30_75(3)_95-103.nxml.txt.nlp	24101933	SENT121	5	5	16	16	gefitinib	EGFR	PA131301952	1956	0.983
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Nov_5_67(Pt_12)_o3196.nxml.txt.nlp	22199716	SENT72	1	1	17	17	benzaldehyde	mol	PA448571	90527	0.983
NULL	J_Hematol_Oncol_2013_Nov_5_6_83.nxml.txt.nlp	24283248	SENT27	13	13	29	29	nutlin-3	TP53		7157	0.983
NULL	Case_Rep_Transplant_2014_Jan_2_2014_548243.nxml.txt.nlp	24575309	SENT12	1	1	7	7	ranolazine	CYP3A	PA164746007	1574	0.983
NULL	Niger_Med_J_2014_Jul-Aug_55(4)_327-332.nxml.txt.nlp	25114369	SENT15	24	24	0	0	streptomycin	DST	PA451512	667	0.983
NULL	Nat_Biotechnol_2012_Nov_14_30(11)_1125-1130.nxml.txt.nlp	23064238	SENT85	0	0	20	20	nitazoxanide	C17	PA164754874	54360	0.983
NULL	Br_J_Cancer_2009_Jun_2_100(11)_1704-1719.nxml.txt.nlp	19436303	SENT103	26	26	8	8	cetuximab	EGFR	PA10040	1956	0.983
NULL	Cells_2014_May_23_3(2)_517-545.nxml.txt.nlp	24861977	SENT151	0	0	20	20	capsaicin	TRPV1	PA448776	7442	0.983
NULL	Int_J_Surg_Oncol_2012_Aug_27_2012_180574.nxml.txt.nlp	22970358	SENT113	5	5	1	1	tamoxifen	aromatase	PA451581	1588	0.983
NULL	Acta_Pharmacol_Sin_2011_Jun_3_32(6)_741-748.nxml.txt.nlp	21642945	SENT42	10	10	21	21	verapamil	CACNA1A	PA451868	773	0.983
NULL	Br_J_Cancer_2010_Mar_16_102(6)_1003-1009.nxml.txt.nlp	20179710	SENT27	0	0	7	7	doxorubicin	ABCB1	PA449412	5243	0.983
NULL	J_Biol_Chem_2008_Jun_20_283(25)_17194-17204.nxml.txt.nlp	18442977	SENT132	27	27	3	3	ketanserin	5-HT2A	PA131053734	3356	0.983
NULL	J_Breast_Cancer_2014_Dec_26_17(4)_332-338.nxml.txt.nlp	25548580	SENT107	23	23	39	39	capsaicin	TRPV1	PA448776	7442	0.983
NULL	J_Oncol_2010_Aug_11_2010_969084.nxml.txt.nlp	19680458	SENT281	14	14	1	1	tamoxifen	BCAR1	PA451581	9564	0.983
NULL	Patient_Prefer_Adherence_2011_Dec_23_6_1-9.nxml.txt.nlp	22272064	SENT36	37	37	20	20	ramipril	ACE	PA451223	1636	0.983
NULL	Int_J_Biol_Sci_2015_Jan_1_11(1)_48-58.nxml.txt.nlp	25552929	SENT206	19	19	0	0	paclitaxel	LDM	PA450761	1595	0.983
NULL	Oncol_Lett_2013_Mar_8_5(3)_805-812.nxml.txt.nlp	23426281	SENT198	38	38	30	30	gemcitabine	B7-H3	PA449748	80381	0.983
NULL	Nat_Commun_2013_Apr_9_4_1684.nxml.txt.nlp	23575688	SENT75	3	3	26	26	rolipram	CYLD	PA153906323	1540	0.983
NULL	Br_J_Cancer_2011_Jun_28_105(1)_1-8.nxml.txt.nlp	21654681	SENT95	30	30	14	14	gefitinib	ABCG2	PA131301952	9429	0.983
NULL	J_Oncol_2013_Apr_29_2013_854121.nxml.txt.nlp	23737784	SENT117	10	10	0	0	lapatinib	PI3K	PA152241907	5290	0.983
NULL	Pharmaceuticals_(Basel)_2014_Apr_14_7(4)_453-463.nxml.txt.nlp	24736104	SENT24	14	14	35	35	diclofenac	GIT	PA449293	5034	0.983
NULL	J_Lipid_Res_2015_Jan_56(1)_109-121.nxml.txt.nlp	25421061	SENT101	26	26	3	3	chymotrypsin	CGI-58	PA448994	51099	0.983
NULL	Clin_Pharmacokinet_2014_Aug_3_53(1)_89-102.nxml.txt.nlp	23912563	SENT132	4	4	17	17	rivaroxaban	P-gp	PA165958360	5243	0.983
NULL	Mol_Cancer_2010_Jun_25_9_166.nxml.txt.nlp	20579378	SENT233	6	6	0	0	gefitinib	DUSP4	PA131301952	1846	0.983
NULL	Cancers_(Basel)_2014_Mar_6_6(1)_494-525.nxml.txt.nlp	24662938	SENT21	2	2	23	23	auranofin	JAK1	PA448510	3716	0.983
NULL	Infect_Dis_Rep_2010_Feb_2_2(1)_e1.nxml.txt.nlp	24470884	SENT29	42	42	11	11	tigecycline	HAP	PA164746412	5915;10313	0.983
NULL	Breast_Cancer_Res_2011_Jun_29_13(3)_R70.nxml.txt.nlp	21707964	SENT3	48	48	0	0	tamoxifen	14-3-3	PA451581	10971	0.983
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT245	31	31	10	10	pertuzumab	HER3		2065	0.983
NULL	Nat_Neurosci_2013_Apr_3_16(4)_394-406.nxml.txt.nlp	23455607	SENT464	37	37	27	27	doxycycline	LRRK2	PA449415	120892	0.983
NULL	J_Cancer_Prev_2014_Mar_19(1)_7-13.nxml.txt.nlp	25337567	SENT111	4	4	33	33	evodiamine	p38	PA165860788	10598;1432;7965	0.983
NULL	Expert_Rev_Mol_Med_2014_16_e1.nxml.txt.nlp	24456939	SENT204	27	27	33	33	trastuzumab	ERBB2	PA451743	2064	0.983
NULL	Chem_Rev_2011_Oct_12_111(10)_5899-5921.nxml.txt.nlp	21923193	SENT139	18	18	1	1	ibuprofen	COX	PA449957	1351	0.983
NULL	Nat_Commun_2013_Sep_20_4_2443.nxml.txt.nlp	24051437	SENT611	6	6	10	10	tamoxifen	BIG3	PA451581	57221	0.983
NULL	J_Neuroinflammation_2011_Feb_4_8_10.nxml.txt.nlp	21294877	SENT122	12	12	7	7	capsaicin	NK1	PA448776	11126	0.983
NULL	Front_Neurosci_2014_Feb_6_8_12.nxml.txt.nlp	24567701	SENT294	7	7	18	18	tranilast	San	PA131890628	80218	0.983
NULL	J_Cell_Biol_1998_Jul_27_142(2)_537-544.nxml.txt.nlp	9679150	SENT160	23	23	29	29	staurosporine	Bcl-2	PA165109623	596	0.983
NULL	Ann_Indian_Acad_Neurol_2009_Apr-Jun_12(2)_89-98.nxml.txt.nlp	20142853	SENT188	9	9	13	13	phenytoin	MDR1	PA450947	5243	0.983
NULL	Front_Oncol_2013_Nov_15_3_281.nxml.txt.nlp	24298448	SENT85	31	31	11	11	fluorouracil	BRAF	PA128406956	673	0.983
NULL	J_Gen_Physiol_2008_Sep_132(3)_339-349.nxml.txt.nlp	18725529	SENT145	18	18	5	5	suramin	P2Y4	PA10292	5030	0.983
NULL	Eur_J_Clin_Pharmacol_2012_Jan_7_68(1)_55-64.nxml.txt.nlp	21735164	SENT229	16	16	3	3	oxycodone	CYP2D6	PA450741	1565	0.983
NULL	Cells_2014_Nov_27_3(4)_1089-1101.nxml.txt.nlp	25437439	SENT66	4	4	9	9	spermine	TRPM7	PA164781199	54822	0.983
NULL	Acta_Pharmacol_Sin_2011_Oct_12_32(10)_1259-1265.nxml.txt.nlp	21909126	SENT122	6	6	30	30	rosuvastatin	LOX-1	PA134308647	4973	0.983
NULL	Chem_Rev_2014_Jun_11_114(11)_5753-5774.nxml.txt.nlp	24758331	SENT396	35	35	4	4	verapamil	MRP1	PA451868	4437	0.983
NULL	Indian_J_Med_Res_2011_Nov_134(5)_717-724.nxml.txt.nlp	22199113	SENT6	22	22	11	11	curcumin	gamma	PA151958596	9913	0.983
NULL	Eur_J_Clin_Pharmacol_2011_May_2_67(Suppl_1)_87-107.nxml.txt.nlp	21287160	SENT149	0	0	7	7	nutlin-3	MDM2		4193	0.983
NULL	Breast_Cancer_Res_Treat_2007_Oct_27_105(Suppl_1)_19-29.nxml.txt.nlp	17333340	SENT25	21	21	2	2	tamoxifen	aromatase	PA451581	1588	0.983
NULL	Oncotarget_2014_Nov_6_5(22)_11038-11053.nxml.txt.nlp	25402820	SENT285	16	16	6	6	gemcitabine	RRM2	PA449748	6241	0.983
NULL	J_Hematol_Oncol_2009_Jan_21_2_2.nxml.txt.nlp	19159467	SENT370	0	0	18	18	bexarotene	gamma	PA164752250	9913	0.983
NULL	Oncotarget_2011_Jun_7_2(6)_491-496.nxml.txt.nlp	21653999	SENT17	30	30	10	10	tamoxifen	PAK1	PA451581	5585;5058	0.983
NULL	Indian_J_Dermatol_2013_Jul-Aug_58(4)_255-268.nxml.txt.nlp	23918994	SENT243	26	26	17	17	methotrexate	IL-2	PA450428	3558	0.983
NULL	Viruses_2014_Feb_10_6(2)_709-726.nxml.txt.nlp	24517971	SENT420	7	7	26	26	maraviroc	CCR5	PA164768835	1234	0.983
NULL	Cardiovasc_Psychiatry_Neurol_2009_Oct_13_2009_475108.nxml.txt.nlp	20029624	SENT73	8	8	22	22	ketanserin	HERG	PA131053734	3757	0.983
NULL	Cell_Cycle_2014_Jan_1_13(1)_90-95.nxml.txt.nlp	24196441	SENT95	31	31	23	23	camptothecin	P21	PA153590860	1026;9338	0.983
NULL	Hum_Genomics_2008_Sep_1_3(1)_7-16.nxml.txt.nlp	19129086	SENT164	3	3	11	11	pioglitazone	CYP2C8	PA450970	1558	0.983
NULL	Int_J_Med_Sci_2012_Jan_17_9(2)_163-173.nxml.txt.nlp	22275855	SENT102	0	0	15	15	trastuzumab	HER2	PA451743	2064	0.983
NULL	Cell_Death_Dis_2013_Jan_31_4(1)_e480.nxml.txt.nlp	23370280	SENT109	13	13	5	5	cisplatin	WWOX	PA449014	51741	0.983
NULL	Front_Oncol_2014_Oct_31_4_306.nxml.txt.nlp	25401091	SENT126	17	17	29	29	doxorubicin	MDR1	PA449412	5243	0.983
NULL	Br_J_Cancer_2009_Jul_21_101(2)_269-277.nxml.txt.nlp	19603033	SENT107	31	31	11	11	cisplatin	MLH1	PA449014	4292	0.983
NULL	Eur_J_Neurosci_2009_Apr_29(8)_1604-1614.nxml.txt.nlp	19419423	SENT9	25	25	13	13	ketanserin	5-HT2C	PA131053734	3358	0.983
NULL	Ann_Rheum_Dis_2012_Sep_71(9)_1510-1516.nxml.txt.nlp	22440821	SENT103	39	39	9	9	methotrexate	adiponectin	PA450428	9370	0.983
NULL	Acta_Pharmacol_Sin_2013_Jan_17_34(1)_157-166.nxml.txt.nlp	23247593	SENT160	3	3	21	21	berberine	IL-6	PA165860812	3569	0.983
NULL	Cancer_Immunol_Immunother_2013_Jul_20_62(9)_1533-1545.nxml.txt.nlp	23873089	SENT115	27	27	11	11	paclitaxel	CD4	PA450761	920	0.983
NULL	Clin_Transl_Allergy_2013_Sep_2_3_29.nxml.txt.nlp	24004581	SENT110	10	10	27	27	omalizumab	IL-8	PA164752253	3576	0.983
NULL	Breast_Cancer_Res_2011_Mar_4_13(2)_R23.nxml.txt.nlp	21375726	SENT15	30	30	4	4	tamoxifen	TFAP2A	PA451581	7020	0.983
NULL	CNS_Drugs_2014_Jul_20_28(11)_1059-1069.nxml.txt.nlp	25038977	SENT2	40	40	16	16	methylphenidate	ATX	PA450464	5168;23049	0.983
NULL	J_Immunol_Res_2014_May_15_2014_175265.nxml.txt.nlp	24949488	SENT259	0	0	17	17	cyclophosphamide	CD4	PA449165	920	0.983
NULL	J_Korean_Med_Sci_2012_Sep_22_27(9)_1037-1043.nxml.txt.nlp	22969249	SENT41	16	16	9	9	paricalcitol	CO2	PA450798	4513	0.983
NULL	J_Hematol_Oncol_2013_Jan_4_6_1.nxml.txt.nlp	23286345	SENT135	0	0	13	13	cetuximab	EGFR	PA10040	1956	0.983
NULL	J_Korean_Med_Sci_2008_Aug_25_23(4)_657-661.nxml.txt.nlp	18756053	SENT74	20	20	0	0	estradiol	AMH	PA449503	268	0.983
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1126-1134.nxml.txt.nlp	21364592	SENT132	44	44	9	9	platinum	CYP2A6	PA150595617	1548	0.983
NULL	J_Clin_Biochem_Nutr_2011_Mar_26_48(2)_149-153.nxml.txt.nlp	21373268	SENT50	18	18	29	29	indomethacin	COX	PA449982	1351	0.983
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1449-1456.nxml.txt.nlp	24077631	SENT109	21	21	29	29	tolbutamide	CYP2C9	PA451718	1559	0.983
NULL	Br_J_Cancer_2006_Feb_13_94(3)_363-371.nxml.txt.nlp	16465172	SENT224	25	25	1	1	oxaliplatin	NACT	PA131285527	284111	0.983
NULL	Br_J_Cancer_2011_Nov_22_105(11)_1654-1662.nxml.txt.nlp	22045187	SENT127	26	26	3	3	irinotecan	MTHFR	PA450085	4524	0.983
NULL	J_Cell_Mol_Med_2013_Oct_23_17(10)_1207-1217.nxml.txt.nlp	24106980	SENT147	10	10	3	3	paclitaxel	MDR1	PA450761	5243	0.983
NULL	Evid_Based_Complement_Alternat_Med_2011_Jun_12_2011_380923.nxml.txt.nlp	21760824	SENT172	11	11	24	24	colchicine	Bcl-2	PA449092	596	0.983
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2696-2704.nxml.txt.nlp	24129240	SENT27	11	11	1	1	nutlin-3	p53		7157	0.983
NULL	Int_J_Gen_Med_2009_Jul_30_2_129-140.nxml.txt.nlp	20360896	SENT79	32	32	8	8	letrozole	aromatase	PA450196	1588	0.983
NULL	Oncotarget_2013_Nov_24_4(12)_2186-2207.nxml.txt.nlp	24327604	SENT39	5	5	39	39	trastuzumab	AKT1	PA451743	207	0.983
NULL	Clin_Interv_Aging_2008_Sep_3(3)_491-501.nxml.txt.nlp	18982919	SENT34	0	0	13	13	aripiprazole	5-HT2A	PA10026	3356	0.983
NULL	J_Mol_Med_(Berl)_2012_Oct_20_90(10)_1223-1231.nxml.txt.nlp	22527886	SENT7	30	30	5	5	mk-571	CysLT1		10800	0.983
NULL	Breast_Cancer_Res_2006_Nov_1_8(Suppl_2)_P31.nxml.txt.nlp	NULL	SENT15	40	40	6	6	tamoxifen	FOXP3	PA451581	50943	0.983
NULL	Cancer_Metastasis_Rev_2010_Dec_10_29(4)_581-594.nxml.txt.nlp	20830503	SENT71	2	2	15	15	letrozole	aromatase	PA450196	1588	0.983
NULL	Breast_Cancer_Res_2012_Nov_13_14(6)_115.nxml.txt.nlp	23146216	SENT2	21	21	14	14	cisplatin	BRCA1	PA449014	672	0.983
NULL	Biologics_2011_Aug_9_5_87-94.nxml.txt.nlp	21847344	SENT58	0	0	15	15	pertuzumab	HER2		2064	0.983
NULL	Diabetes_Care_2010_Jul_31_33(7)_1607-1609.nxml.txt.nlp	20357375	SENT69	7	7	22	22	sitagliptin	CXCR4	PA164748978	7852	0.983
NULL	Mol_Cancer_2014_Jun_24_13_157.nxml.txt.nlp	24958351	SENT163	26	26	13	13	lapatinib	SRC	PA152241907	6714	0.983
NULL	Mol_Cancer_2012_Jul_25_11_46.nxml.txt.nlp	22830422	SENT75	36	36	5	5	rolipram	PDE4B	PA153906323	5142	0.983
NULL	J_Skin_Cancer_2011_Oct_11_2011_521947.nxml.txt.nlp	22007305	SENT187	0	0	31	31	sorafenib	BRAF	PA7000	673	0.983
NULL	Br_J_Cancer_2011_Oct_11_105(8)_1131-1136.nxml.txt.nlp	21915126	SENT22	0	0	3	3	gefitinib	EGFR	PA131301952	1956	0.983
NULL	Patient_Prefer_Adherence_2013_Mar_27_7_245-258.nxml.txt.nlp	23569364	SENT166	24	24	4	4	exemestane	aromatase	PA449563	1588	0.983
NULL	Int_J_Mol_Sci_2012_Apr_16_13(4)_4831-4838.nxml.txt.nlp	22606012	SENT51	17	17	4	4	curcumin	JNK	PA151958596	5599	0.983
NULL	Biomed_Res_Int_2014_Jan_29_2014_196249.nxml.txt.nlp	24605321	SENT207	12	12	2	2	bortezomib	NOXA	PA10252	5366	0.983
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT785	22	22	8	8	quinidine	OATP1A2	PA451209	6579	0.983
NULL	J_Cachexia_Sarcopenia_Muscle_2010_Sep_26_1(1)_43-128.nxml.txt.nlp	22477519	SENT887	8	8	2	2	fluvoxamine	ghrelin	PA449690	51738	0.983
NULL	Biologics_2009_Jul_13_3_77-97.nxml.txt.nlp	19707398	SENT361	0	0	9	9	daclizumab	IL-2	PA164764446	3558	0.983
NULL	Front_Immunol_2014_Apr_15_5_174.nxml.txt.nlp	24782871	SENT50	2	2	10	10	cyclophosphamide	CD4	PA449165	920	0.983
NULL	Nat_Commun_2013_Sep_3_4_2394.nxml.txt.nlp	23999152	SENT67	10	10	18	18	dextran	PI3K	PA449261	5290	0.983
NULL	Nucleic_Acids_Res_2005_Apr_11_33(7)_2061-2077.nxml.txt.nlp	15824059	SENT86	19	19	1	1	thrombin	p53	PA451674	7157	0.983
NULL	Int_J_Biol_Sci_2014_Jun_3_10(6)_602-613.nxml.txt.nlp	24948873	SENT175	18	18	21	21	metyrapone	CYP11B1	PA450486	1584	0.983
NULL	Indian_J_Pharm_Sci_2013_May-Jun_75(3)_251-261.nxml.txt.nlp	24082340	SENT63	0	0	15	15	olaparib	BRCA2		675	0.983
NULL	Biomed_Imaging_Interv_J_2006_Jan_1_2(1)_e2.nxml.txt.nlp	21614218	SENT53	46	46	11	11	irinotecan	EGFR	PA450085	1956	0.983
NULL	eLife_2013_Nov_5_2_e00969.nxml.txt.nlp	24192036	SENT108	21	21	9	9	vemurafenib	BCL2A1	PA165946873	597	0.983
NULL	ScientificWorldJournal_2014_Jan_29_2014_156464.nxml.txt.nlp	24605049	SENT65	14	14	34	34	isotretinoin	IL-6	PA450128	3569	0.983
NULL	Acta_Pharmacol_Sin_2014_Aug_30_35(8)_1045-1054.nxml.txt.nlp	24976155	SENT136	22	22	3	3	resveratrol	STAT3		6774	0.983
NULL	Scientifica_(Cairo)_2012_Oct_9_2012_821549.nxml.txt.nlp	24278743	SENT338	11	11	0	0	olanzapine	5-HT2A	PA450688	3356	0.983
NULL	F1000_Med_Rep_2009_Jan_21_1_8.nxml.txt.nlp	20948699	SENT8	2	2	20	20	ticlopidine	ADP	PA451686	23038	0.983
NULL	Arthritis_Res_Ther_2007_Jun_29_9(Suppl_1)_S7.nxml.txt.nlp	17634146	SENT6	7	7	24	24	denosumab	RANKL	PA166048634	8600	0.983
NULL	Case_Rep_Oncol_2011_Aug_18_4(2)_385-391.nxml.txt.nlp	21941487	SENT67	35	35	13	13	imatinib	EGFR	PA10804	1956	0.983
NULL	Br_J_Cancer_2011_May_10_104(10)_1587-1593.nxml.txt.nlp	21487405	SENT37	16	16	37	37	docetaxel	PTEN	PA449383	5728	0.983
NULL	J_Hematol_Oncol_2009_Apr_22_2_18.nxml.txt.nlp	19386128	SENT189	3	3	15	15	cetuximab	KRAS	PA10040	3845	0.983
NULL	Br_J_Cancer_2011_Mar_1_104(5)_750-755.nxml.txt.nlp	21326243	SENT123	37	37	4	4	olaparib	MPG		4350	0.983
NULL	Cell_Cycle_2012_Nov_1_11(21)_3983-3996.nxml.txt.nlp	22987153	SENT209	16	16	7	7	cisplatin	FANCD2	PA449014	2177	0.983
NULL	Acta_Pharmacol_Sin_2014_Jan_9_35(1)_1-10.nxml.txt.nlp	24317012	SENT132	16	16	35	35	tegafur	CYP2A6	PA452620	1548	0.983
NULL	Aquat_Biosyst_2012_Apr_17_8_9.nxml.txt.nlp	22510370	SENT57	12	12	0	0	nadh	PHB	PA164755085	5245	0.983
NULL	J_Anaesthesiol_Clin_Pharmacol_2012_Jan-Mar_28(1)_106-110.nxml.txt.nlp	22345956	SENT85	6	6	43	43	argatroban	ACT	PA164745516	12;11332;9457;641455	0.983
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jul_11_65(Pt_8)_o1829.nxml.txt.nlp	21583531	SENT54	42	42	18	18	ethanol	mol	PA448073	90527	0.983
NULL	Clin_Sci_(Lond)_2009_Nov_23_118(Pt_5)_315-332.nxml.txt.nlp	19922415	SENT222	6	6	30	30	metformin	adiponectin	PA450395	9370	0.983
NULL	J_Med_Internet_Res_2013_Jul_12_15(7)_e138.nxml.txt.nlp	23853350	SENT188	22	22	3	3	warfarin	TTR	PA451906	7276	0.983
NULL	Curr_Neuropharmacol_2008_Sep_6(3)_215-234.nxml.txt.nlp	19506722	SENT140	21	21	5	5	fluoxetine	5-HT6	PA449673	3362	0.983
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT24	0	0	6	6	metformin	EGFR	PA450395	1956	0.983
NULL	Case_Rep_Oncol_2010_May_7_3(2)_154-159.nxml.txt.nlp	20740189	SENT37	10	10	2	2	panitumumab	KRAS	PA162373091	3845	0.983
NULL	Acta_Pharmacol_Sin_2009_Apr_9_30(4)_451-457.nxml.txt.nlp	19270722	SENT43	0	0	7	7	imatinib	DING	PA10804	6045	0.983
NULL	Infect_Dis_Obstet_Gynecol_2012_Aug_14_2012_890160.nxml.txt.nlp	22927715	SENT47	0	0	23	23	ritonavir	CYP3A4	PA451260	1576	0.983
NULL	J_Nat_Med_2014_Feb_19_68(2)_253-266.nxml.txt.nlp	24550097	SENT207	5	5	23	23	curcumin	CPT1	PA151958596	56994	0.983
NULL	Breast_Cancer_Res_Treat_2014_Nov_27_143(1)_19-31.nxml.txt.nlp	24281828	SENT171	4	4	23	23	indomethacin	COX	PA449982	1351	0.983
NULL	Br_J_Cancer_2010_Oct_26_103(9)_1331-1334.nxml.txt.nlp	20877352	SENT92	8	8	31	31	trastuzumab	GM-CSF	PA451743	1437	0.983
NULL	Appl_Clin_Genet_2010_Oct_29_3_85-101.nxml.txt.nlp	23776354	SENT12	8	8	6	6	imatinib	KIT	PA10804	3815	0.983
NULL	J_Thromb_Haemost_2014_May_22_12(5)_748-760.nxml.txt.nlp	24612393	SENT247	6	6	23	23	thrombin	PI3	PA451674	5266	0.983
NULL	J_Breast_Cancer_2014_Sep_30_17(3)_287-290.nxml.txt.nlp	25320628	SENT58	10	10	24	24	bevacizumab	PIK3CA	PA130232992	5290	0.983
NULL	Mol_Cancer_2012_Jul_12_11_45.nxml.txt.nlp	22788833	SENT94	6	6	25	25	cisplatin	HER2	PA449014	2064	0.983
NULL	Case_Rep_Oncol_2014_Jan_16_7(1)_52-57.nxml.txt.nlp	24575017	SENT56	11	11	2	2	erlotinib	EGFR	PA134687924	1956	0.983
NULL	J_Mol_Med_2008_Aug_27_86(8)_909-924.nxml.txt.nlp	18504532	SENT292	18	18	24	24	cisplatin	EGFR	PA449014	1956	0.983
NULL	Orphanet_J_Rare_Dis_2007_Jan_8_2_3.nxml.txt.nlp	17210076	SENT321	3	3	29	29	anagrelide	AIT	PA164742986	160728	0.983
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1196-1204.nxml.txt.nlp	22315058	SENT229	12	12	24	24	gefitinib	EGF	PA131301952	1950	0.983
NULL	Oncogene_2014_Feb_6_33(6)_713-723.nxml.txt.nlp	23435429	SENT84	39	39	10	10	etoposide	BRCA1	PA449552	672	0.983
NULL	Clin_Cosmet_Investig_Dermatol_2013_Sep_26_6_233-244.nxml.txt.nlp	24101875	SENT122	30	30	9	9	sunitinib	IFN	PA162372840	3439	0.983
NULL	J_Hematol_Oncol_2009_Apr_28_2_19.nxml.txt.nlp	19400935	SENT98	22	22	0	0	bortezomib	IL-6	PA10252	3569	0.983
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1137-1144.nxml.txt.nlp	20234366	SENT174	23	23	14	14	cetuximab	p53	PA10040	7157	0.983
NULL	Oncogene_2010_Sep_16_29(37)_5193-5203.nxml.txt.nlp	20581867	SENT117	3	3	22	22	lapatinib	PI3K	PA152241907	5290	0.983
NULL	Exp_Mol_Med_2012_Feb_29_44(2)_159-166.nxml.txt.nlp	22127053	SENT26	0	0	9	9	simvastatin	RhoA	PA451363	387	0.983
NULL	Scientifica_(Cairo)_2013_Dec_10_2013_691251.nxml.txt.nlp	24386592	SENT194	31	31	5	5	epirubicin	SIRT6	PA449476	51548	0.983
NULL	Contemp_Oncol_(Pozn)_2013_Apr_29_17(2)_137-143.nxml.txt.nlp	23788980	SENT180	23	23	11	11	bromocriptine	PRL	PA448671	5617	0.983
NULL	Indian_J_Nephrol_2009_Jul_19(3)_119-121.nxml.txt.nlp	20436733	SENT59	8	8	15	15	tacrolimus	CYP3A	PA451578	1574	0.983
NULL	Int_J_Biomed_Sci_2014_Dec_10(4)_229-235.nxml.txt.nlp	25598752	SENT141	15	15	32	32	methotrexate	IL-6	PA450428	3569	0.983
NULL	BMB_Rep_2013_Feb_46(2)_92-96.nxml.txt.nlp	23433111	SENT104	15	15	8	8	etoposide	BRCA1	PA449552	672	0.983
NULL	Clin_Drug_Investig_2013_Aug_23_33(10)_727-736.nxml.txt.nlp	23975654	SENT172	25	25	39	39	fluvoxamine	CYP2C9	PA449690	1559	0.983
NULL	Cancer_Med_2013_Feb_3_2(1)_86-98.nxml.txt.nlp	24133631	SENT5	0	0	17	17	cisplatin	HAI	PA449014	6692;6768	0.983
NULL	Case_Rep_Oncol_2012_Dec_6_5(3)_651-656.nxml.txt.nlp	23275781	SENT29	0	0	32	32	imatinib	KIT	PA10804	3815	0.983
NULL	J_Antimicrob_Chemother_2011_Feb_31_66(2)_265-272.nxml.txt.nlp	21196489	SENT52	25	25	3	3	maraviroc	RTR	PA164768835	2649	0.983
NULL	Cancer_Manag_Res_2014_Mar_4_6_105-117.nxml.txt.nlp	24623991	SENT118	31	31	8	8	tamoxifen	aromatase	PA451581	1588	0.983
NULL	Oncologist_2010_Mar_3_15(3)_216-235.nxml.txt.nlp	20200040	SENT258	10	10	3	3	trastuzumab	HER-2	PA451743	2064	0.983
NULL	Biologics_2012_Sep_25_6_337-345.nxml.txt.nlp	23055691	SENT58	24	24	9	9	erlotinib	EGFR	PA134687924	1956	0.983
NULL	Oncotarget_2012_Nov_17_4(1)_18-28.nxml.txt.nlp	23248157	SENT243	18	18	0	0	pargyline	U87	PA450797	677775;641648	0.983
NULL	Front_Neurol_2011_Mar_18_2_14.nxml.txt.nlp	21516258	SENT137	12	12	5	5	fluoxetine	MCH	PA449673	5367	0.983
NULL	Clin_Sarcoma_Res_2014_Jul_29_4_7.nxml.txt.nlp	25089183	SENT48	25	25	7	7	bevacizumab	VEGFA	PA130232992	7422	0.983
NULL	Antiviral_Res_2009_May_82(2)_A99-A109.nxml.txt.nlp	19176219	SENT102	19	19	4	4	ritonavir	P-gp	PA451260	5243	0.983
NULL	Emerg_Infect_Dis_2012_Jan_18(1)_29-37.nxml.txt.nlp	22260950	SENT57	38	38	0	0	isoniazid	DST	PA450112	667	0.983
NULL	Int_J_Vasc_Med_2012_Jan_4_2012_657025.nxml.txt.nlp	22347626	SENT5	16	16	32	32	pitavastatin	PTX3	PA142650384	5806	0.983
NULL	Indian_J_Dermatol_2014_Sep-Oct_59(5)_425-441.nxml.txt.nlp	25284845	SENT100	0	0	20	20	ustekinumab	IL-23	PA166048654	51561	0.983
NULL	Breast_Cancer_Res_2012_Nov_5_14(6)_R143.nxml.txt.nlp	23127292	SENT170	15	15	3	3	tamoxifen	p53	PA451581	7157	0.983
NULL	Exp_Ther_Med_2013_Oct_20_6(4)_899-903.nxml.txt.nlp	24137286	SENT74	16	16	9	9	rosuvastatin	MMP2	PA134308647	4313	0.983
NULL	Clin_Pharmacol_2011_Jun_22_3_13-25.nxml.txt.nlp	22287853	SENT206	6	6	22	22	saxagliptin	CYP3A4	PA165958362	1576	0.983
NULL	Breast_Cancer_Res_2014_Sep_9_16(5)_433.nxml.txt.nlp	25212966	SENT379	6	6	33	33	aprotinin	ILEI	PA448472	10447	0.983
NULL	Patient_Prefer_Adherence_2013_Apr_26_7_369-377.nxml.txt.nlp	23641151	SENT192	0	0	9	9	ustekinumab	p40	PA166048654	3921;339541;10314	0.983
NULL	Cancer_Cell_Int_2011_Dec_29_11_44.nxml.txt.nlp	22206574	SENT171	39	39	12	12	irinotecan	IKK2	PA450085	3551	0.983
NULL	Breast_Cancer_Res_2009_Jun_29_11(3)_R41.nxml.txt.nlp	19563669	SENT247	5	5	14	14	trastuzumab	XIAP	PA451743	331	0.983
NULL	Arch_Drug_Inf_2011_Mar_4(1)_1-9.nxml.txt.nlp	21572514	SENT31	23	23	27	27	ciprofloxacin	P-gp	PA449009	5243	0.983
NULL	Mol_Cancer_2009_Dec_10_8_118.nxml.txt.nlp	20003259	SENT246	29	29	8	8	sorafenib	ERM	PA7000	2119	0.983
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_39-54.nxml.txt.nlp	19305787	SENT323	40	40	17	17	ethanol	CDK5	PA448073	1020	0.983
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_P119.nxml.txt.nlp	NULL	SENT5	3	3	23	23	carbamazepine	HLA-B	PA448785	3106	0.983
NULL	Oncotarget_2011_Dec_15_2(12)_984-996.nxml.txt.nlp	22184287	SENT221	14	14	12	12	olaparib	PARP1		142	0.983
NULL	Front_Synaptic_Neurosci_2013_Sep_18_5_6.nxml.txt.nlp	24065916	SENT101	16	16	2	2	amphetamine	DCC	PA448408	1630	0.983
NULL	Cancer_2014_Jan_15_120(2)_229-237.nxml.txt.nlp	24122122	SENT159	9	9	29	29	bevacizumab	VEGF-A	PA130232992	7422	0.983
NULL	Oncol_Rep_2014_Feb_16_31(2)_573-580.nxml.txt.nlp	24337632	SENT150	31	31	9	9	cisplatin	AKT	PA449014	207	0.983
NULL	Clin_Sarcoma_Res_2013_Mar_7_3_3.nxml.txt.nlp	23497641	SENT157	30	30	11	11	imatinib	KIT	PA10804	3815	0.983
NULL	Cancer_Immunol_Immunother_2011_Jun_25_60(6)_793-808.nxml.txt.nlp	21350947	SENT285	41	41	21	21	sorafenib	IFNAR2	PA7000	3455	0.983
NULL	Clin_Ophthalmol_2008_Dec_2(4)_829-836.nxml.txt.nlp	19668437	SENT115	4	4	26	26	cyclosporine	KCS	PA449167	3771	0.983
NULL	Mol_Cancer_2014_Jun_5_13_143.nxml.txt.nlp	24898067	SENT105	42	42	34	34	gefitinib	HER-2	PA131301952	2064	0.983
NULL	Exp_Diabetes_Res_2012_Dec_16_2012_410579.nxml.txt.nlp	23304117	SENT144	21	21	26	26	metformin	activin	PA450395	83729	0.983
NULL	J_Aging_Res_2011_Sep_28_2011_251517.nxml.txt.nlp	21969914	SENT8	13	13	16	16	letrozole	aromatase	PA450196	1588	0.983
NULL	J_Neurovirol_2013_Jun_4_19(4)_351-358.nxml.txt.nlp	23733308	SENT42	9	9	1	1	mefloquine	SOC	PA450348	91544	0.983
NULL	J_Hematol_Oncol_2014_Aug_1_7_52.nxml.txt.nlp	25085632	SENT131	14	14	25	25	sunitinib	KRAS	PA162372840	3845	0.983
NULL	Blood_Cancer_J_2013_Sep_6_3(9)_e143.nxml.txt.nlp	24013664	SENT32	20	20	4	4	lenalidomide	c-fos	PA162363968	2353	0.983
NULL	Front_Neurosci_2012_Feb_21_6_26.nxml.txt.nlp	22363256	SENT183	14	14	19	19	estradiol	COX	PA449503	1351	0.983
NULL	Oncotarget_2014_Mar_16_5(12)_4087-4102.nxml.txt.nlp	24961479	SENT117	20	20	15	15	hemin	PC3	PA449849	57332;7832;5122	0.983
NULL	J_Korean_Med_Sci_2006_Oct_31_21(5)_781-789.nxml.txt.nlp	17043406	SENT195	13	13	27	27	didanosine	CD4	PA449301	920	0.983
NULL	Clin_Drug_Investig_2013_Aug_23_33(10)_727-736.nxml.txt.nlp	23975654	SENT172	8	8	41	41	bupropion	CYP3A4	PA448687	1576	0.983
NULL	Mol_Cancer_2009_Nov_10_8_99.nxml.txt.nlp	19903356	SENT23	2	2	14	14	imatinib	KIT	PA10804	3815	0.983
NULL	J_Immunother_Cancer_2014_Jan_27_2_2.nxml.txt.nlp	24829759	SENT170	11	11	20	20	sorafenib	IL-21	PA7000	59067;50616;27189	0.983
NULL	Hum_Mol_Genet_2013_Dec_1_22(23)_4857-4869.nxml.txt.nlp	23873044	SENT30	26	26	2	2	heparin	CFHR3	PA449855	10878	0.983
NULL	Oncogene_2014_Jun_5_33(23)_3033-3042.nxml.txt.nlp	23851504	SENT174	26	26	18	18	tamoxifen	HER2	PA451581	2064	0.983
NULL	Int_J_Biomed_Sci_2007_Mar_3(1)_31-37.nxml.txt.nlp	23675018	SENT142	39	39	4	4	spermine	IL-6	PA164781199	3569	0.983
NULL	Genome_Med_2009_Oct_27_1(10)_99.nxml.txt.nlp	19863774	SENT73	16	16	14	14	olaparib	PARP1		142	0.983
NULL	Braz_J_Med_Biol_Res_2014_Mar_21_47(4)_273-278.nxml.txt.nlp	24676475	SENT25	21	21	13	13	doxorubicin	MDR1	PA449412	5243	0.983
NULL	Evid_Based_Complement_Alternat_Med_2012_May_7_2012_242810.nxml.txt.nlp	22645625	SENT201	0	0	24	24	ketoconazole	HNF4	PA450146	3172	0.983
NULL	J_Oncol_2010_Jan_14_2010_740472.nxml.txt.nlp	20130818	SENT142	0	0	9	9	pertuzumab	ERBB2		2064	0.983
NULL	Hematol_Rep_2013_Apr_4_5(1)_21-25.nxml.txt.nlp	23888242	SENT109	8	8	35	35	palifermin	HCST	PA164744014	10870	0.983
NULL	BMB_Rep_2013_Feb_46(2)_97-102.nxml.txt.nlp	23433112	SENT66	2	2	16	16	metformin	AMPK	PA450395	5563	0.983
NULL	Endocrinol_Diabetes_Metab_Case_Rep_2014_Sep_1_2014_140047.nxml.txt.nlp	25298880	SENT79	11	11	28	28	everolimus	MTOR	PA164746311	2475	0.983
NULL	Oncotarget_2013_Jun_25_4(7)_995-1007.nxml.txt.nlp	23828551	SENT132	22	22	45	45	doxycycline	FOXO3	PA449415	2309	0.983
NULL	Indian_J_Endocrinol_Metab_2013_May-Jun_17(3)_402-412.nxml.txt.nlp	23869295	SENT168	23	23	9	9	clopidogrel	PON1	PA449053	5444	0.983
NULL	Curr_Opin_Genet_Dev_2014_Feb_24(100)_114-119.nxml.txt.nlp	24607840	SENT32	12	12	20	20	imatinib	ABL1	PA10804	25	0.983
NULL	Oncotarget_2014_Jun_6_5(13)_4935-4944.nxml.txt.nlp	24952732	SENT73	13	13	28	28	doxazosin	PI3K	PA449407	5290	0.983
NULL	Int_J_Gen_Med_2012_Apr_13_5_317-322.nxml.txt.nlp	22536087	SENT36	0	0	26	26	liraglutide	GLP-1	PA165958364	100125288	0.983
NULL	Diabetes_Care_2010_Jul_31_33(7)_1544-1548.nxml.txt.nlp	20357370	SENT26	27	27	17	17	metformin	STK11	PA450395	6794	0.983
NULL	J_Hematol_Oncol_2008_Aug_11_1_11.nxml.txt.nlp	18694493	SENT50	4	4	15	15	sunitinib	VEGFR	PA162372840	3791	0.983
NULL	Exp_Ther_Med_2014_Jun_27_7(6)_1752-1756.nxml.txt.nlp	24926379	SENT72	4	4	11	11	vildagliptin	PPG	PA165958346	5552	0.983
NULL	Br_J_Cancer_2012_Feb_28_106(5)_867-875.nxml.txt.nlp	22333600	SENT19	24	24	11	11	gefitinib	EGFR	PA131301952	1956	0.983
NULL	Exp_Mol_Med_2012_Aug_31_44(8)_473-482.nxml.txt.nlp	22627808	SENT82	30	30	21	21	lapatinib	HER2	PA152241907	2064	0.983
NULL	J_Cell_Mol_Med_2014_Sep_7_18(9)_1785-1796.nxml.txt.nlp	24909956	SENT195	24	24	16	16	cangrelor	CD44	PA165945763	960	0.983
NULL	Clin_Med_Insights_Cardiol_2010_Dec_1_4_117-128.nxml.txt.nlp	21151850	SENT199	10	10	27	27	cilostazol	CYP2C19	PA164746334	1557	0.983
NULL	Indian_J_Nucl_Med_2014_Jan-Mar_29(1)_34-37.nxml.txt.nlp	24591781	SENT36	20	20	25	25	tamoxifen	aromatase	PA451581	1588	0.983
NULL	J_Korean_Med_Sci_2008_Apr_20_23(2)_262-269.nxml.txt.nlp	18437010	SENT193	44	44	10	10	forskolin	PI3	PA146096022	5266	0.983
NULL	Acta_Pharmacol_Sin_2012_Oct_3_33(10)_1311-1318.nxml.txt.nlp	22941289	SENT100	23	23	31	31	sorafenib	KDR	PA7000	3791	0.983
NULL	Case_Rep_Dent_2014_Apr_29_2014_649086.nxml.txt.nlp	24872899	SENT10	0	0	17	17	tocilizumab	IL-6	PA165292659	3569	0.983
NULL	Eur_J_Clin_Pharmacol_2014_Oct_8_70(1)_37-45.nxml.txt.nlp	24100471	SENT195	0	0	32	32	midazolam	CYP3A4	PA450496	1576	0.983
NULL	Front_Neurosci_2010_Nov_19_4_191.nxml.txt.nlp	21151372	SENT236	11	11	9	9	elacridar	P-gp		5243	0.983
NULL	Exp_Diabetes_Res_2012_May_14_2012_470851.nxml.txt.nlp	22666230	SENT45	0	0	20	20	exenatide	GLP-1	PA164749238	100125288	0.983
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2013_Dec_8_6_75-79.nxml.txt.nlp	24348081	SENT8	0	0	10	10	colesevelam	GLP-1	PA449095	100125288	0.983
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S244-S250.nxml.txt.nlp	21525463	SENT29	6	6	18	18	colesevelam	GLP-1	PA449095	100125288	0.983
NULL	Nat_Commun_2013_Sep_20_4_2443.nxml.txt.nlp	24051437	SENT182	16	16	12	12	tamoxifen	AP-1	PA451581	2353;3727;2354;3725	0.983
NULL	Semin_Immunopathol_2012_Jan_4_34(1)_93-106.nxml.txt.nlp	21845431	SENT188	36	36	4	4	thrombin	PAR-1	PA451674	2011;2149	0.983
NULL	Breast_Cancer_Res_2012_Aug_8_14(4)_R116.nxml.txt.nlp	22873525	SENT19	0	0	18	18	trastuzumab	HER2	PA451743	2064	0.983
NULL	J_Histochem_Cytochem_2012_Oct_60(10)_749-760.nxml.txt.nlp	22821669	SENT191	8	8	20	20	hyaluronan	TSG-6	PA165958431	7130	0.983
NULL	Cancer_Immunol_Immunother_2015_Oct_7_64_61-73.nxml.txt.nlp	25287778	SENT137	2	2	22	22	lenalidomide	CD54	PA162363968	3383	0.983
NULL	J_Inflamm_(Lond)_2008_Dec_5_5_23.nxml.txt.nlp	19061493	SENT14	29	29	7	7	hemin	HO-1	PA449849	3162	0.983
NULL	J_Korean_Med_Sci_2014_Jul_11_29(7)_965-972.nxml.txt.nlp	25045229	SENT31	1	1	16	16	metformin	B12	PA450395	7126;4709	0.983
NULL	Int_J_Fertil_Steril_2014_Dec_22_Jan-Mar_7(4)_331-336.nxml.txt.nlp	24520503	SENT95	27	27	9	9	flutamide	adiponectin	PA449685	9370	0.982
NULL	J_Hematol_Oncol_2009_Feb_23_2_10.nxml.txt.nlp	19236716	SENT107	29	29	18	18	rifampin	CYP3A4	PA451250	1576	0.982
NULL	Front_Genet_2012_Nov_12_3_235.nxml.txt.nlp	23162568	SENT43	1	1	10	10	methamphetamine	CYP2D6	PA450403	1565	0.982
NULL	Clin_Sci_(Lond)_2012_May_1_122(Pt_9)_421-428.nxml.txt.nlp	22092038	SENT31	3	3	19	19	doxycycline	c-Jun	PA449415	3725	0.982
NULL	Eur_J_Med_Res_2010_Nov_30_15(12)_533-543.nxml.txt.nlp	21163728	SENT136	0	0	26	26	linezolid	ABCB1	PA450233	5243	0.982
NULL	Mol_Cancer_2010_Aug_20_9_220.nxml.txt.nlp	20727180	SENT222	11	11	29	29	nicotine	p53	PA450626	7157	0.982
NULL	Oncogene_2014_Aug_21_33(34)_4316-4329.nxml.txt.nlp	24362530	SENT8	17	17	3	3	epirubicin	FOXM1	PA449476	2305	0.982
NULL	Biomed_Res_Int_2013_Sep_4_2013_419176.nxml.txt.nlp	24093097	SENT112	0	0	20	20	ridaforolimus	AKT	PA165291475	207	0.982
NULL	Aging_Cell_2009_Apr_8(2)_113-127.nxml.txt.nlp	19239417	SENT10	12	12	2	2	resveratrol	AMPK		5563	0.982
NULL	Drug_Saf_2014_Feb_19_37(4)_201-211.nxml.txt.nlp	24550106	SENT163	30	30	1	1	rabeprazole	CYP2C19	PA451216	1557	0.982
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_297-299.nxml.txt.nlp	20049732	SENT51	0	0	25	25	methotrexate	MSH2	PA450428	4436	0.982
NULL	Front_Mol_Neurosci_2012_Nov_12_5_99.nxml.txt.nlp	23162427	SENT279	18	18	5	5	nicotine	HDAC	PA450626	9734	0.982
NULL	Breast_Cancer_Res_2010_Oct_22_12(Suppl_2)_S1.nxml.txt.nlp	21050422	SENT81	0	0	17	17	trastuzumab	HER2	PA451743	2064	0.982
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1059-1066.nxml.txt.nlp	21364577	SENT38	14	14	2	2	tamoxifen	aromatase	PA451581	1588	0.982
NULL	Arthritis_Res_Ther_2004_Feb_19_6(3)_R181-R189.nxml.txt.nlp	15142263	SENT24	7	7	26	26	leflunomide	DHODH	PA450192	1723	0.982
NULL	J_Hematol_Oncol_2008_Oct_1_1_16.nxml.txt.nlp	18828924	SENT79	29	29	4	4	trastuzumab	HER2	PA451743	2064	0.982
NULL	Acta_Pharmacol_Sin_2014_Aug_21_35(8)_1082-1092.nxml.txt.nlp	25047514	SENT183	4	4	24	24	letrozole	aromatase	PA450196	1588	0.982
NULL	Acta_Pharmacol_Sin_2010_Jun_4_31(6)_709-717.nxml.txt.nlp	20523342	SENT153	24	24	9	9	repaglinide	IGF2BP2	PA451234	10644	0.982
NULL	Curr_Pharm_Des_2011_Feb_17(6)_578-590.nxml.txt.nlp	21391908	SENT176	3	3	15	15	nutlin-3	p53		7157	0.982
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT163	21	21	9	9	capecitabine	HER2	PA448771	2064	0.982
NULL	Scientifica_(Cairo)_2012_Dec_17_2012_502378.nxml.txt.nlp	24278706	SENT103	15	15	24	24	dabigatran	P-gp		5243	0.982
NULL	JAKSTAT_2013_Jul_1_2(3)_e24574.nxml.txt.nlp	24069558	SENT79	20	20	6	6	doxycycline	HEK	PA449415	2042	0.982
NULL	Oncotarget_2014_Jun_19_5(15)_6540-6551.nxml.txt.nlp	25153728	SENT204	25	25	11	11	paclitaxel	PI3K	PA450761	5290	0.982
NULL	Ann_Rheum_Dis_2011_Aug_17_70(12)_2148-2151.nxml.txt.nlp	21852254	SENT120	16	16	33	33	methotrexate	IL-6	PA450428	3569	0.982
NULL	Basic_Clin_Pharmacol_Toxicol_2013_Feb_5_112(2)_132-137.nxml.txt.nlp	22900583	SENT168	18	18	6	6	ketoconazole	CYP3A	PA450146	1574	0.982
NULL	Cancers_(Basel)_2014_Jul_8_6(3)_1487-1499.nxml.txt.nlp	25006835	SENT428	13	13	5	5	cisplatin	STAT3	PA449014	6774	0.982
NULL	Case_Rep_Transplant_2012_Aug_30_2012_672923.nxml.txt.nlp	23259137	SENT46	36	36	16	16	vincristine	CD19	PA451879	930	0.982
NULL	J_Hematol_Oncol_2012_Sep_18_5_57.nxml.txt.nlp	22989009	SENT225	2	2	21	21	nutlin-3	p53		7157	0.982
NULL	JAKSTAT_2014_Jun_12_3_e29554.nxml.txt.nlp	25105067	SENT48	7	7	3	3	propofol	STAT3	PA451141	6774	0.982
NULL	Front_Genet_2014_Nov_14_5_391.nxml.txt.nlp	25452763	SENT169	6	6	18	18	cisplatin	GSTM3	PA449014	2947	0.982
NULL	Infect_Dis_Obstet_Gynecol_2012_Feb_25_2012_157159.nxml.txt.nlp	22505797	SENT102	3	3	27	27	erythromycin	PTB	PA449493	58155	0.982
NULL	Int_J_Mol_Sci_2013_Aug_14_14(8)_16719-16731.nxml.txt.nlp	23949634	SENT68	8	8	22	22	thrombin	PAR-1	PA451674	2011;2149	0.982
NULL	Oncol_Lett_2014_Nov_14_8(5)_2086-2092.nxml.txt.nlp	25295095	SENT118	41	41	6	6	gemcitabine	LKB1	PA449748	6794	0.982
NULL	Oncotarget_2013_Oct_19_4(11)_2045-2056.nxml.txt.nlp	24185104	SENT79	0	0	12	12	cisplatin	14-3-3	PA449014	10971	0.982
NULL	Cancer_Res_Treat_2012_Sep_30_44(3)_195-201.nxml.txt.nlp	23091446	SENT156	30	30	6	6	etoposide	MKP-1	PA449552	1843	0.982
NULL	Diabetes_Care_2011_Aug_16_34(8)_1854-1859.nxml.txt.nlp	21715518	SENT176	11	11	27	27	estradiol	aromatase	PA449503	1588	0.982
NULL	Clinics_(Sao_Paulo)_2013_May_68(5)_694-701.nxml.txt.nlp	23778405	SENT156	0	0	9	9	curcumin	P-gp	PA151958596	5243	0.982
NULL	J_Hum_Genet_2013_Jun_23_58(6)_339-345.nxml.txt.nlp	23697979	SENT91	0	0	8	8	prasugrel	CYP2C19	PA154410481	1557	0.982
NULL	Diabetes_Metab_J_2012_Aug_20_36(4)_293-299.nxml.txt.nlp	22950061	SENT121	11	11	38	38	metformin	POMC	PA450395	5443	0.982
NULL	Breast_Cancer_Res_2005_Jun_17_7(Suppl_2)_P1_20.nxml.txt.nlp	NULL	SENT3	22	22	17	17	tamoxifen	NCOA3	PA451581	8202	0.982
NULL	Open_Med_Chem_J_2010_May_27_4_20-36.nxml.txt.nlp	21160908	SENT111	43	43	4	4	clozapine	mGlu1	PA449061	2911	0.982
NULL	Clin_Sci_(Lond)_2013_Feb_1_124(Pt_3)_153-164.nxml.txt.nlp	23075334	SENT175	31	31	8	8	resveratrol	SIRT1		23411	0.982
NULL	Int_J_Mol_Sci_2014_Nov_18_15(11)_21366-21380.nxml.txt.nlp	25411800	SENT40	25	25	37	37	aminohippurate	OAT	PA134711723	4942	0.982
NULL	Front_Aging_Neurosci_2010_Aug_26_2_138.nxml.txt.nlp	20838473	SENT202	10	10	33	33	diazoxide	SDH	PA449285	1757;10993	0.982
NULL	Biomed_Res_Int_2013_Jul_31_2013_692071.nxml.txt.nlp	23984399	SENT194	10	10	19	19	imatinib	OCT1	PA10804	5451;6580	0.982
NULL	Genome_Biol_2011_May_25_12(5)_R46.nxml.txt.nlp	21609475	SENT57	11	11	3	3	carboplatin	SELL	PA448803	6402	0.982
NULL	Clin_Med_Insights_Oncol_2012_Nov_20_6_381-393.nxml.txt.nlp	23226079	SENT139	4	4	14	14	sunitinib	CYP3A4	PA162372840	1576	0.982
NULL	J_Gynecol_Oncol_2013_Jul_4_24(3)_273-279.nxml.txt.nlp	23875078	SENT99	16	16	5	5	paclitaxel	COX	PA450761	1351	0.982
NULL	Sensors_(Basel)_2012_Dec_3_12(12)_16614-16627.nxml.txt.nlp	23208557	SENT118	20	20	12	12	irinotecan	UGT1A1	PA450085	54658	0.982
NULL	Br_J_Cancer_2012_Sep_4_107(6)_947-955.nxml.txt.nlp	22892392	SENT200	11	11	0	0	tamoxifen	EGFR	PA451581	1956	0.982
NULL	Oncol_Lett_2013_Sep_12_6(3)_860-864.nxml.txt.nlp	24137426	SENT85	37	37	12	12	ketoconazole	CYP1A2	PA450146	1544	0.982
NULL	Braz_J_Med_Biol_Res_2013_Aug_13_46(8)_650-658.nxml.txt.nlp	23969971	SENT10	27	27	44	44	cisplatin	STAT3	PA449014	6774	0.982
NULL	Case_Rep_Psychiatry_2014_Mar_18_2014_842349.nxml.txt.nlp	24744941	SENT63	0	0	37	37	lamotrigine	ANK3	PA450164	288	0.982
NULL	Mol_Cancer_2012_Dec_12_11_91.nxml.txt.nlp	23234355	SENT116	27	27	13	13	erlotinib	IL-2	PA134687924	3558	0.982
NULL	Breast_Cancer_Res_Treat_2013_Jan_6_137(1)_167-174.nxml.txt.nlp	23129173	SENT155	0	0	13	13	letrozole	aromatase	PA450196	1588	0.982
NULL	J_Hematol_Oncol_2008_Oct_1_1_16.nxml.txt.nlp	18828924	SENT103	0	0	19	19	pertuzumab	HER2		2064	0.982
NULL	J_Cell_Biol_1998_Jan_26_140(2)_335-345.nxml.txt.nlp	9442109	SENT338	6	6	12	12	chloroquine	NHE	PA448948	285335	0.982
NULL	Ann_Hematol_2014_Apr_1_93(8)_1371-1380.nxml.txt.nlp	24687382	SENT32	7	7	35	35	lenalidomide	IKZF1	PA162363968	10320	0.982
NULL	Bioinformation_2011_Sep_28_7(3)_130-133.nxml.txt.nlp	22125383	SENT48	11	11	26	26	miconazole	PLP1	PA450494	5354	0.982
NULL	Arthritis_Res_Ther_2013_Apr_17_15(2)_R51.nxml.txt.nlp	23594962	SENT15	15	15	6	6	muraglitazar	IL-6	PA162356187	3569	0.982
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT107	26	26	17	17	neratinib	HER2	PA165291472	2064	0.982
NULL	Antimicrob_Agents_Chemother_2014_Nov_10_59(1)_490-497.nxml.txt.nlp	25385107	SENT38	7	7	17	17	artemether	ACT	PA165111698	12;11332;9457;641455	0.982
NULL	Clin_Pharmacol_2010_Sep_6_2_155-162.nxml.txt.nlp	22291500	SENT166	22	22	34	34	ticagrelor	CYP2C19	PA165374673	1557	0.982
NULL	Cardiovasc_Res_2012_Dec_1_96(3)_552-560.nxml.txt.nlp	22918977	SENT266	15	15	3	3	losartan	ANG	PA450268	283	0.982
NULL	Int_J_Mol_Sci_2012_Dec_7_13(12)_16751-16768.nxml.txt.nlp	23222680	SENT170	8	8	37	37	tranylcypromine	LSD2	PA451741	221656	0.982
NULL	J_Young_Pharm_2010_Jul-Sep_2(3)_326-331.nxml.txt.nlp	21042495	SENT127	17	17	22	22	atorvastatin	CYP3A4	PA448500	1576	0.982
NULL	J_Oncol_2009_Jun_14_2009_814140.nxml.txt.nlp	19547715	SENT127	15	15	7	7	etoposide	MRP1	PA449552	4437	0.982
NULL	Case_Rep_Oncol_2013_Sep_10_6(3)_450-455.nxml.txt.nlp	24163659	SENT67	23	23	13	13	paclitaxel	HER2	PA450761	2064	0.982
NULL	Food_Addit_Contam_Part_A_Chem_Anal_Control_Expo_Risk_Assess_2014_Oct_3_31(10)_176916-1782.nxml.txt.nlp	25105506	SENT140	2	2	10	10	ethanol	AF4	PA448073	4299	0.982
NULL	Breast_Cancer_Res_2011_Nov_1_13(6)_224.nxml.txt.nlp	22114931	SENT131	18	18	14	14	trastuzumab	TORC1	PA451743	23373	0.982
NULL	J_Cell_Biol_1998_Aug_10_142(3)_625-633.nxml.txt.nlp	9700154	SENT232	18	18	0	0	estradiol	p42	PA449503	5706;23552	0.982
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_39-54.nxml.txt.nlp	19305787	SENT323	36	36	22	22	ethanol	PP1	PA448073	5540;5464	0.982
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT184	23	23	10	10	cisplatin	p53	PA449014	7157	0.982
NULL	Emerg_Infect_Dis_2012_Jul_18(7)_1072-1080.nxml.txt.nlp	22709685	SENT193	3	3	11	11	vancomycin	VISA	PA451850	57506	0.982
NULL	Oncogene_2014_Jul_24_33(30)_3959-3969.nxml.txt.nlp	24096481	SENT159	17	17	4	4	doxorubicin	p53	PA449412	7157	0.982
NULL	ScientificWorldJournal_2013_Apr_18_2013_978394.nxml.txt.nlp	23710154	SENT108	11	11	30	30	oxaliplatin	IFL	PA131285527	3439	0.982
NULL	J_Hematop_2009_May_14_2(2)_97-102.nxml.txt.nlp	19669192	SENT117	38	38	9	9	alemtuzumab	CD52	PA164783958	1043	0.982
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT335	20	20	8	8	resveratrol	p65		5970	0.982
NULL	J_Cell_Biol_1998_Mar_23_140(6)_1357-1367.nxml.txt.nlp	9508769	SENT313	42	42	10	10	trypsin	TGN	PA451806	7038	0.982
NULL	J_Oncol_2012_Mar_26_2012_198412.nxml.txt.nlp	22536237	SENT70	6	6	13	13	trastuzumab	HER2	PA451743	2064	0.982
NULL	Breast_Cancer_Res_2006_Nov_27_8(6)_R66.nxml.txt.nlp	17129383	SENT41	29	29	5	5	paclitaxel	MAP4	PA450761	4134	0.982
NULL	Case_Rep_Oncol_2012_Oct_10_5(3)_546-553.nxml.txt.nlp	23139670	SENT15	12	12	41	41	bevacizumab	EGFR	PA130232992	1956	0.982
NULL	Clin_Mol_Hepatol_2014_Jun_30_20(2)_89-136.nxml.txt.nlp	25032178	SENT334	10	10	20	20	telaprevir	CYP3A4	PA165958354	1576	0.982
NULL	Oxid_Med_Cell_Longev_2013_Nov_28_2013_568093.nxml.txt.nlp	24379901	SENT71	41	41	17	17	resveratrol	c-Jun		3725	0.982
NULL	Curr_Neuropharmacol_2007_Dec_5(4)_224-231.nxml.txt.nlp	19305739	SENT220	10	10	18	18	amitriptyline	5-HT7	PA448385	3363	0.982
NULL	Mol_Cancer_2012_Mar_21_11_13.nxml.txt.nlp	22436134	SENT41	35	35	1	1	doxorubicin	HuR	PA449412	1994	0.982
NULL	J_Biol_Chem_2013_Nov_15_288(46)_33049-33059.nxml.txt.nlp	24089524	SENT50	23	23	13	13	nicotine	GATA2	PA450626	2624	0.982
NULL	J_Clin_Biochem_Nutr_2009_Jul_30_45(1)_9-13.nxml.txt.nlp	19590701	SENT51	8	8	15	15	lansoprazole	HO-1	PA450180	3162	0.982
NULL	Breast_Cancer_Res_2009_Jun_23_11(Suppl_1)_S21.nxml.txt.nlp	NULL	SENT12	34	34	5	5	paclitaxel	SPARC	PA450761	6678	0.982
NULL	Sci_Rep_2014_Dec_12_4_7456.nxml.txt.nlp	25503852	SENT54	16	16	8	8	resveratrol	SIRT1		23411	0.982
NULL	Indian_J_Med_Res_2012_Sep_136(3)_391-403.nxml.txt.nlp	23041732	SENT168	29	29	45	45	gemcitabine	HCC	PA449748	84668	0.982
NULL	Cancer_Immunol_Immunother_2013_Aug_27_62(10)_1637-1648.nxml.txt.nlp	23982484	SENT188	32	32	21	21	lenalidomide	STAT3	PA162363968	6774	0.982
NULL	Br_J_Clin_Pharmacol_2012_Feb_73(2)_203-209.nxml.txt.nlp	21848574	SENT37	3	3	39	39	cisapride	5-HT4	PA449011	3360	0.982
NULL	Pharm_Pract_(Granada)_2006_Dec_12_Oct-Dec_4(4)_168-178.nxml.txt.nlp	25214906	SENT11	0	0	14	14	gefitinib	EGFR	PA131301952	1956	0.982
NULL	Pharmaceutics_2011_Nov_18_3(4)_865-913.nxml.txt.nlp	24309312	SENT500	4	4	16	16	ximelagatran	P-gp	PA161748474	5243	0.982
NULL	Biomed_Res_Int_2014_Jan_29_2014_232870.nxml.txt.nlp	24592384	SENT182	20	20	28	28	nutlin-3	p53		7157	0.982
NULL	Curr_Oncol_2009_Aug_16(4)_9-21.nxml.txt.nlp	19672420	SENT217	5	5	15	15	erlotinib	KRAS	PA134687924	3845	0.982
NULL	Oncotarget_2011_Mar_23_2(3)_165-177.nxml.txt.nlp	21444946	SENT28	19	19	1	1	gefitinib	EGFR	PA131301952	1956	0.982
NULL	Oncotarget_2012_May_18_3(5)_525-534.nxml.txt.nlp	22619113	SENT155	4	4	19	19	fludarabine	IL-4	PA449655	3565	0.982
NULL	Breast_Cancer_Res_Treat_2007_Oct_27_105(Suppl_1)_19-29.nxml.txt.nlp	17333340	SENT179	0	0	4	4	letrozole	aromatase	PA450196	1588	0.982
NULL	Antiviral_Res_2009_May_82(2)_A99-A109.nxml.txt.nlp	19176219	SENT75	16	16	6	6	abacavir	P-gp	PA448004	5243	0.982
NULL	Arthritis_Res_Ther_2005_Sep_22_7(6)_R1325-R1337.nxml.txt.nlp	16277686	SENT163	3	3	8	8	rosiglitazone	adiponectin	PA451283	9370	0.982
NULL	Front_Physiol_2011_Jun_30_2_33.nxml.txt.nlp	21747769	SENT236	13	13	7	7	berberine	KCNQ1	PA165860812	3784	0.982
NULL	Clinics_(Sao_Paulo)_2012_May_67(5)_419-424.nxml.txt.nlp	22666783	SENT38	16	16	0	0	gefitinib	KRAS	PA131301952	3845	0.982
NULL	Cardiovasc_Drugs_Ther_2013_Jul_26_27(6)_521-530.nxml.txt.nlp	23887740	SENT160	39	39	27	27	clopidogrel	CD62P	PA449053	6403	0.982
NULL	Clin_Med_Insights_Oncol_2012_Dec_6_6_407-421.nxml.txt.nlp	23239933	SENT152	14	14	23	23	gefitinib	EGFR	PA131301952	1956	0.982
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_127043.nxml.txt.nlp	23227093	SENT20	0	0	16	16	lovastatin	P-gp	PA450272	5243	0.982
NULL	Pharmaceuticals_(Basel)_2013_Aug_21_6(8)_988-1038.nxml.txt.nlp	24276379	SENT257	24	24	3	3	sn-38	UGT1A1		54658	0.982
NULL	EJC_Suppl_2013_Sep_5_11(2)_92-96.nxml.txt.nlp	NULL	SENT187	27	27	20	20	dacarbazine	BRAF	PA449197	673	0.982
NULL	Nature_2008_Dec_11_456(7223)_819-823.nxml.txt.nlp	18849970	SENT207	34	34	7	7	etoposide	CD69	PA449552	969	0.982
NULL	Cell_Cycle_2012_Nov_1_11(21)_4069-4078.nxml.txt.nlp	23095523	SENT72	18	18	2	2	imatinib	PERK	PA10804	9451	0.982
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT287	11	11	28	28	resveratrol	IL-6		3569	0.982
NULL	Br_J_Haematol_2011_Apr_153(1)_83-91.nxml.txt.nlp	21332705	SENT111	26	26	2	2	cangrelor	ADP	PA165945763	23038	0.982
NULL	Clin_Pract_2014_Apr_30_4(1)_635.nxml.txt.nlp	24847435	SENT13	0	0	21	21	sunitinib	VEGFR	PA162372840	3791	0.982
NULL	J_Cancer_2013_Jan_11_4(2)_117-132.nxml.txt.nlp	23386910	SENT282	0	0	9	9	tanespimycin	HER2	PA165291490	2064	0.982
NULL	Cell_Death_Dis_2014_Mar_20_5(3)_e1133.nxml.txt.nlp	24651436	SENT67	0	0	21	21	gemcitabine	TACSTD2	PA449748	4070	0.982
NULL	Br_J_Cancer_2012_Jan_3_106(1)_6-13.nxml.txt.nlp	22215104	SENT20	3	3	36	36	pertuzumab	HER3		2065	0.982
NULL	Neural_Plast_2008_Nov_17_2008_401645.nxml.txt.nlp	19043593	SENT139	11	11	1	1	carbachol	gamma	PA448784	9913	0.982
NULL	Ann_Oncol_2010_Feb_21(2)_217-222.nxml.txt.nlp	20110292	SENT142	25	25	9	9	erlotinib	PSPH	PA134687924	5723	0.982
NULL	Arthritis_Res_Ther_2013_Dec_3_15(6)_R205.nxml.txt.nlp	24295447	SENT173	10	10	25	25	etanercept	OPG	PA449515	690	0.982
NULL	Int_J_Nanomedicine_2012_Sep_14_7_4983-4994.nxml.txt.nlp	23028226	SENT222	13	13	35	35	trypsin	GLP-1	PA451806	100125288	0.982
NULL	Europace_2014_Feb_12_16(2)_195-201.nxml.txt.nlp	24036378	SENT143	30	30	2	2	warfarin	SPAF	PA451906	166378	0.982
NULL	J_Mol_Signal_2008_Mar_31_3_8.nxml.txt.nlp	18377662	SENT63	3	3	30	30	pp2	PP2		4888	0.982
NULL	Orphanet_J_Rare_Dis_2014_Aug_18_9(1)_132.nxml.txt.nlp	NULL	SENT185	10	10	21	21	etoposide	CHS	PA449552	1130	0.982
NULL	Mol_Cancer_2012_Jul_25_11_47.nxml.txt.nlp	22830443	SENT28	0	0	9	9	panitumumab	EGFR	PA162373091	1956	0.982
NULL	J_Hematol_Oncol_2009_Aug_12_2_36.nxml.txt.nlp	19674465	SENT95	4	4	14	14	thalidomide	IL-2	PA451644	3558	0.982
NULL	Int_J_Biochem_Cell_Biol_2013_Oct_45(10)_2121-2129.nxml.txt.nlp	23665154	SENT248	3	3	23	23	clenbuterol	IGF1	PA164745640	3479	0.982
NULL	Cell_Biosci_2015_Jan_5_5(1)_1.nxml.txt.nlp	NULL	SENT188	14	14	8	8	ribavirin	IMPDH2	PA451241	3615	0.982
NULL	Diabetes_Metab_J_2012_Aug_20_36(4)_293-299.nxml.txt.nlp	22950061	SENT121	11	11	32	32	metformin	PI3K	PA450395	5290	0.982
NULL	Cancers_(Basel)_2014_Mar_6_6(1)_494-525.nxml.txt.nlp	24662938	SENT99	13	13	1	1	dasatinib	STAT3	PA162372878	6774	0.982
NULL	Cell_Commun_Signal_2014_May_15_12_34.nxml.txt.nlp	24885272	SENT279	19	19	8	8	heparin	EGF	PA449855	1950	0.982
NULL	Br_J_Cancer_2010_Feb_16_102(4)_665-672.nxml.txt.nlp	20104227	SENT32	25	25	9	9	docetaxel	MIC-1	PA449383	29919;9518	0.982
NULL	Biomed_Res_Int_2013_Dec_5_2013_642848.nxml.txt.nlp	24381940	SENT201	3	3	9	9	telmisartan	IL-6	PA451605	3569	0.982
NULL	Oncol_Lett_2013_Mar_8_5(3)_805-812.nxml.txt.nlp	23426281	SENT250	40	40	11	11	gemcitabine	B7-H3	PA449748	80381	0.982
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT319	34	34	5	5	nutlin-3	DcR2		8793	0.982
NULL	Mol_Cancer_2014_Jan_15_13_8.nxml.txt.nlp	24423412	SENT151	9	9	27	27	cisplatin	CD44	PA449014	960	0.982
NULL	Oncogenesis_2014_Dec_15_3(12)_e133.nxml.txt.nlp	25500906	SENT11	19	19	14	14	trastuzumab	PI3K	PA451743	5290	0.982
NULL	Int_J_Mol_Sci_2014_Nov_14_15(11)_20927-20947.nxml.txt.nlp	25405729	SENT14	20	20	2	2	letrozole	aromatase	PA450196	1588	0.982
NULL	Cancers_(Basel)_2012_Apr_18_4(2)_420-441.nxml.txt.nlp	24213318	SENT197	11	11	30	30	docetaxel	CEA	PA449383	5670;1087	0.982
NULL	AIDS_Res_Ther_2013_Dec_13_10_32.nxml.txt.nlp	24330597	SENT64	14	14	45	45	glucose	IL-6	PA449773	3569	0.982
NULL	J_Cell_Biol_1988_Apr_1_106(4)_1171-1183.nxml.txt.nlp	3283148	SENT6	31	31	11	11	lithium	p67	PA450243	945;10988	0.982
NULL	Exp_Mol_Med_2012_Dec_17_44(12)_749-755.nxml.txt.nlp	23178275	SENT15	25	25	2	2	glibenclamide	CAL	PA449782	54751;57120	0.982
NULL	Front_Oncol_2014_Apr_9_4_75.nxml.txt.nlp	24782986	SENT276	19	19	42	42	paclitaxel	Oct4	PA450761	5460	0.982
NULL	Mol_Pain_2013_Jun_10_9_27.nxml.txt.nlp	23758830	SENT109	7	7	21	21	tetracaine	ASIC2a	PA451638	40	0.982
NULL	Biologics_2013_Dec_16_8_13-25.nxml.txt.nlp	24368879	SENT179	0	0	15	15	bevacizumab	IFL	PA130232992	3439	0.982
NULL	EMBO_Mol_Med_2012_Mar_4(3)_218-233.nxml.txt.nlp	22294553	SENT217	5	5	25	25	erlotinib	EGFR	PA134687924	1956	0.982
NULL	Bioinorg_Chem_Appl_2014_Sep_14_2014_764085.nxml.txt.nlp	25298760	SENT258	30	30	7	7	amoxicillin	BEF	PA448406	10189	0.982
NULL	Indian_J_Pharm_Sci_2011_Sep-Oct_73(5)_543-549.nxml.txt.nlp	22923867	SENT48	4	4	10	10	salbutamol	P11	PA448068	8909;6281	0.982
NULL	Mol_Biol_Cell_2013_Dec_15_24(24)_3819-3831.nxml.txt.nlp	24152729	SENT328	14	14	1	1	paclitaxel	AURKA	PA450761	6790	0.982
NULL	Diabetes_2011_Nov_17_60(11)_2691-2700.nxml.txt.nlp	21896928	SENT118	7	7	13	13	resveratrol	SIRT1		23411	0.982
NULL	Psychiatry_Investig_2009_Sep_3_6(3)_222-225.nxml.txt.nlp	20046399	SENT9	30	30	15	15	perospirone	DRD4	PA165291546	1815	0.982
NULL	Acta_Orthop_2009_Feb_26_80(1)_46-50.nxml.txt.nlp	19234885	SENT11	5	5	21	21	celecoxib	TKR	PA448871	8277	0.982
NULL	Cell_Death_Dis_2014_Apr_17_5(4)_e1182.nxml.txt.nlp	24743737	SENT35	5	5	35	35	capsaicin	TRPV1	PA448776	7442	0.982
NULL	Clin_Med_Insights_Oncol_2012_Dec_6_6_407-421.nxml.txt.nlp	23239933	SENT132	3	3	24	24	gefitinib	CTL1	PA131301952	23446	0.982
NULL	Acta_Pharmacol_Sin_2010_Jul_28_31(7)_867-873.nxml.txt.nlp	20581857	SENT144	1	1	23	23	docetaxel	P-gp	PA449383	5243	0.982
NULL	Cancers_(Basel)_2014_May_7_6(2)_1098-1110.nxml.txt.nlp	24810425	SENT152	18	18	10	10	cisplatin	CCL21	PA449014	6366	0.982
NULL	Crit_Care_2008_Mar_13_12(Suppl_2)_P21.nxml.txt.nlp	NULL	SENT10	20	20	5	5	caspofungin	MICA	PA164743013	100507436	0.982
NULL	Mol_Pain_2013_Jul_31_9_38.nxml.txt.nlp	23898828	SENT63	20	20	31	31	losartan	AT2	PA450268	186	0.982
NULL	Case_Rep_Rheumatol_2013_Jul_24_2013_249471.nxml.txt.nlp	23984159	SENT51	15	15	9	9	colchicine	MEFV	PA449092	4210	0.982
NULL	Endocr_Connect_2012_Jun_8_1(1)_1-12.nxml.txt.nlp	23781298	SENT231	42	42	3	3	fenofibrate	adiponectin	PA449594	9370	0.982
NULL	Nucleic_Acids_Res_2013_May_5_41(10)_5210-5222.nxml.txt.nlp	23563151	SENT88	13	13	0	0	arsenite	GADD45	PA452638	1647	0.982
NULL	Case_Rep_Oncol_2010_Dec_17_3(3)_480-488.nxml.txt.nlp	21611102	SENT21	0	0	15	15	cetuximab	EGFR	PA10040	1956	0.982
NULL	Biomed_Res_Int_2014_Jan_23_2014_761264.nxml.txt.nlp	24587990	SENT364	37	37	11	11	resveratrol	CYP1A1		1543	0.982
NULL	Breast_Cancer_Res_2008_Jul_24_10(4)_211.nxml.txt.nlp	18671839	SENT167	9	9	2	2	cisplatin	p53	PA449014	7157	0.982
NULL	Neuro_Oncol_2011_Nov_22_13(11)_1178-1191.nxml.txt.nlp	21940738	SENT170	6	6	25	25	imatinib	SOX2	PA10804	6657	0.982
NULL	Mol_Immunol_2009_Mar_46(6)_1149-1162.nxml.txt.nlp	19100624	SENT218	0	0	41	41	nystatin	C5L2	PA450666	27202	0.982
NULL	Int_J_Biomed_Sci_2014_Sep_10(3)_217-220.nxml.txt.nlp	25324704	SENT81	12	12	0	0	amiodarone	APT	PA448383	653639	0.982
NULL	Oncologist_2010_Apr_15(4)_372-381.nxml.txt.nlp	20413642	SENT185	17	17	6	6	bortezomib	EGFR	PA10252	1956	0.982
NULL	Acta_Pharmacol_Sin_2011_Jul_13_32(7)_967-972.nxml.txt.nlp	21666702	SENT22	0	0	12	12	losartan	P-gp	PA450268	5243	0.982
NULL	Curr_Pain_Headache_Rep_2011_Aug_12_15(4)_271-279.nxml.txt.nlp	21479998	SENT48	5	5	22	22	ondansetron	CYP2D6	PA450705	1565	0.982
NULL	Blood_Cancer_J_2013_Oct_4_3(10)_e150.nxml.txt.nlp	24096714	SENT87	13	13	32	32	bortezomib	IL6	PA10252	3569	0.982
NULL	BMJ_Open_2013_Oct_14_3(10)_e003912.nxml.txt.nlp	24127058	SENT165	13	13	19	19	linezolid	HAP	PA450233	5915;10313	0.982
NULL	Front_Oncol_2013_Apr_30_3_106.nxml.txt.nlp	23641364	SENT48	18	18	1	1	sorafenib	FLT3	PA7000	2322	0.982
NULL	Behav_Brain_Funct_2008_Aug_15_4_37.nxml.txt.nlp	18702828	SENT101	39	39	4	4	methamphetamine	FZD3	PA450403	7976;8326	0.982
NULL	Am_J_Case_Rep_2014_Feb_24_15_85-89.nxml.txt.nlp	24587856	SENT47	8	8	42	42	anastrozole	aromatase	PA448432	1588	0.982
NULL	J_Cell_Biol_2007_Apr_23_177(2)_265-275.nxml.txt.nlp	17452530	SENT348	37	37	17	17	imiquimod	TLR9	PA449972	54106	0.982
NULL	Indian_J_Urol_2009_Oct-Dec_25(4)_427-436.nxml.txt.nlp	19955664	SENT102	9	9	34	34	temsirolimus	AKT	PA164746890	207	0.982
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT316	7	7	21	21	cetuximab	KRAS	PA10040	3845	0.982
NULL	Clin_Med_Insights_Oncol_2013_Jun_3_7_103-122.nxml.txt.nlp	23843721	SENT139	41	41	10	10	trastuzumab	PTEN	PA451743	5728	0.982
NULL	Mol_Cancer_2006_Oct_17_5_45.nxml.txt.nlp	17044934	SENT100	42	42	14	14	resveratrol	COX		1351	0.982
NULL	Indian_J_Ophthalmol_2010_Mar-Apr_58(2)_173-175.nxml.txt.nlp	20195055	SENT8	1	1	14	14	fluorescein	PED	PA164746009	8682	0.982
NULL	Indian_J_Pharm_Sci_2014_Jan-Feb_76(1)_72-77.nxml.txt.nlp	24799741	SENT33	23	23	2	2	phenytoin	CYP2C9	PA450947	1559	0.982
NULL	Br_J_Cancer_2009_Jan_27_100(2)_251-258.nxml.txt.nlp	19165196	SENT20	0	0	15	15	cetuximab	ACRC	PA10040	93953	0.982
NULL	J_Physiol_2011_Mar_1_589(Pt_5)_1081-1093.nxml.txt.nlp	21224236	SENT146	28	28	2	2	diazoxide	GLP-1	PA449285	100125288	0.982
NULL	Front_Genet_2014_May_30_5_152.nxml.txt.nlp	24910641	SENT48	5	5	14	14	trastuzumab	ERBB2	PA451743	2064	0.982
NULL	Breast_Cancer_Res_2008_Jul_24_10(4)_211.nxml.txt.nlp	18671839	SENT199	21	21	8	8	gefitinib	EGFR	PA131301952	1956	0.982
NULL	Oncol_Lett_2014_Aug_19_8(2)_809-812.nxml.txt.nlp	25009658	SENT70	3	3	15	15	metformin	AMPK	PA450395	5563	0.982
NULL	Indian_J_Ophthalmol_2007_Nov-Dec_55(6)_482-483.nxml.txt.nlp	17951917	SENT16	23	23	6	6	vancomycin	API	PA451850	5345	0.982
NULL	Diabetes_2009_Feb_58(2)_329-336.nxml.txt.nlp	19171749	SENT128	37	37	10	10	imatinib	JNK	PA10804	5599	0.982
NULL	Breast_Cancer_Res_2004_Oct_24_6(1)_R8-R17.nxml.txt.nlp	14680495	SENT97	37	37	15	15	tamoxifen	BRCA1	PA451581	672	0.982
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Nov_25_65(Pt_12)_o3189.nxml.txt.nlp	21578901	SENT73	42	42	13	13	ethanol	mol	PA448073	90527	0.982
NULL	Acta_Pharmacol_Sin_2013_Apr_18_34(4)_561-569.nxml.txt.nlp	23416928	SENT168	10	10	0	0	selegiline	CYP2B6	PA451316	1555	0.982
NULL	Surg_Neurol_Int_2013_Jun_19_4_85.nxml.txt.nlp	23869285	SENT114	19	19	3	3	abciximab	Penumbra	PA448006	340348	0.982
NULL	Int_J_Gen_Med_2009_Dec_29_2_209-217.nxml.txt.nlp	20360906	SENT139	18	18	28	28	bromocriptine	PRL	PA448671	5617	0.982
NULL	Oncotarget_2012_May_9_3(4)_363-364.nxml.txt.nlp	22622047	SENT17	45	45	3	3	camptothecin	SIRT1	PA153590860	23411	0.982
NULL	Breast_Cancer_Res_2014_Sep_11_16(5)_430.nxml.txt.nlp	25212826	SENT300	16	16	12	12	fulvestrant	AKT	PA164747170	207	0.982
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT263	12	12	25	25	erlotinib	PTEN	PA134687924	5728	0.982
NULL	Oncotarget_2014_Nov_2_5(21)_10222-10236.nxml.txt.nlp	25400118	SENT100	11	11	4	4	trastuzumab	AKT	PA451743	207	0.982
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT214	31	31	41	41	metformin	HIF-1	PA450395	29072	0.982
NULL	Cardiovasc_Res_2013_May_1_98(2)_286-296.nxml.txt.nlp	23334259	SENT225	39	39	28	28	flecainide	NCX	PA449646	3196	0.982
NULL	Front_Neurosci_2012_May_30_6_77.nxml.txt.nlp	22661925	SENT59	8	8	0	0	ethanol	HEC	PA448073	10403	0.982
NULL	Tumour_Biol_2014_Mar_19_35(3)_2211-2218.nxml.txt.nlp	24142530	SENT173	22	22	26	26	etoposide	APAF-1	PA449552	317	0.982
NULL	Diabetes_2009_Jun_31_58(6)_1434-1439.nxml.txt.nlp	19336679	SENT24	5	5	23	23	metformin	SLC22A1	PA450395	6580	0.982
NULL	Cancer_Metab_2014_May_28_2(Suppl_1)_P4.nxml.txt.nlp	NULL	SENT4	0	0	15	15	metformin	AMPK	PA450395	5563	0.982
NULL	Arch_Med_Sci_2010_Mar_1_6(1)_19-23.nxml.txt.nlp	22371715	SENT120	0	0	3	3	anakinra	IL-6	PA10799	3569	0.982
NULL	J_Res_Pharm_Pract_2013_Apr-Jun_2(2)_64-69.nxml.txt.nlp	24991606	SENT91	7	7	21	21	gabapentin	gamma	PA449720	9913	0.982
NULL	Breast_Cancer_Res_2004_Aug_5_6(5)_R601-R607.nxml.txt.nlp	15318941	SENT130	9	9	4	4	cisplatin	p27	PA449014	5715;10534	0.982
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_O3.nxml.txt.nlp	NULL	SENT5	8	8	30	30	flucloxacillin	HLA-B	PA164781042	3106	0.982
NULL	Indian_J_Endocrinol_Metab_2013_Jul-Aug_17(4)_636-646.nxml.txt.nlp	23961479	SENT153	3	3	10	10	pravastatin	CYP2C9	PA451089	1559	0.982
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_650809.nxml.txt.nlp	23258995	SENT170	0	0	22	22	vasopressin	AQP3	PA451858	360	0.982
NULL	Mol_Cancer_2007_Sep_26_6_61.nxml.txt.nlp	17894897	SENT184	6	6	21	21	etoposide	MDM2	PA449552	4193	0.982
NULL	J_Radiat_Res_2012_Jul_12_53(4)_551-557.nxml.txt.nlp	22843620	SENT142	2	2	32	32	pp2	EGFR		1956	0.982
NULL	Nat_Med_2014_Jul_1_20(7)_715-724.nxml.txt.nlp	24880616	SENT113	43	43	29	29	estradiol	VAMP7	PA449503	6845	0.982
NULL	Carcinogenesis_2010_Dec_27_31(12)_2049-2057.nxml.txt.nlp	20876285	SENT232	12	12	2	2	tamoxifen	HER2	PA451581	2064	0.982
NULL	Br_J_Cancer_2010_Sep_28_103(7)_1008-1018.nxml.txt.nlp	20736947	SENT37	0	0	13	13	hyaluronan	CD147	PA165958431	682	0.982
NULL	Oncotarget_2013_Aug_30_4(10)_1698-1711.nxml.txt.nlp	24091605	SENT131	27	27	0	0	gefitinib	CD44	PA131301952	960	0.982
NULL	Clin_Pediatr_Endocrinol_2011_Jul_7_20(3)_65-71.nxml.txt.nlp	23926398	SENT13	18	18	26	26	zoledronate	HHM	PA10235	5744	0.982
NULL	Cancer_Sci_2012_Nov_17_103(11)_1907-1912.nxml.txt.nlp	22809142	SENT85	14	14	27	27	bortezomib	HDAC6	PA10252	10013	0.982
NULL	Oncotarget_2011_Sep_9_2(9)_658-668.nxml.txt.nlp	21911919	SENT111	16	16	10	10	cytarabine	HO-1	PA449177	3162	0.982
NULL	Eur_J_Med_Res_2011_Nov_10_16(11)_491-494.nxml.txt.nlp	22027642	SENT60	0	0	18	18	sunitinib	KIT	PA162372840	3815	0.982
NULL	Mol_Biol_Cell_2012_Jul_1_23(13)_2560-2570.nxml.txt.nlp	22593210	SENT104	1	1	25	25	galactose	NUF2	PA449725	83540	0.982
NULL	Int_J_Mol_Sci_2012_Dec_5_13(12)_16624-16635.nxml.txt.nlp	23443122	SENT22	21	21	31	31	etoposide	MDR1	PA449552	5243	0.982
NULL	Bioconjug_Chem_2014_Feb_19_25(2)_424-432.nxml.txt.nlp	24410055	SENT172	23	23	10	10	paclitaxel	Mcl-1	PA450761	4170	0.982
NULL	Front_Genet_2014_Nov_14_5_391.nxml.txt.nlp	25452763	SENT169	6	6	23	23	cisplatin	GSTT1	PA449014	2952	0.982
NULL	Oxid_Med_Cell_Longev_2013_Jun_2_2013_793525.nxml.txt.nlp	23819014	SENT185	6	6	16	16	resveratrol	AMPK		5563	0.982
NULL	Iran_J_Basic_Med_Sci_2011_Nov-Dec_14(6)_485-498.nxml.txt.nlp	23493821	SENT121	12	12	8	8	ketoconazole	CYP3A	PA450146	1574	0.982
NULL	Mol_Cancer_2006_Oct_17_5_45.nxml.txt.nlp	17044934	SENT13	29	29	1	1	resveratrol	COX		1351	0.982
NULL	J_Hematol_Oncol_2013_Jul_18_6_53.nxml.txt.nlp	23866964	SENT56	23	23	8	8	temsirolimus	LC3	PA164746890	84557	0.982
NULL	J_Cancer_Prev_2013_Jun_18(2)_186-191.nxml.txt.nlp	25337545	SENT101	3	3	24	24	curcumin	STAT3	PA151958596	6774	0.982
NULL	Indian_J_Ophthalmol_2014_Jan_62(1)_74-81.nxml.txt.nlp	24492505	SENT193	0	0	25	25	daclizumab	CD25	PA164764446	3669;3559	0.982
NULL	J_Immunol_Res_2014_Apr_30_2014_857143.nxml.txt.nlp	24877157	SENT322	0	0	10	10	sirolimus	IL-2	PA451365	3558	0.982
NULL	Cancer_Res_Treat_2012_Jun_30_44(2)_85-96.nxml.txt.nlp	22802746	SENT206	19	19	10	10	imatinib	PDGFRA	PA10804	5156	0.982
NULL	Cancers_(Basel)_2014_Aug_12_6(3)_1631-1669.nxml.txt.nlp	25119536	SENT442	5	5	13	13	nilotinib	GM-CSF	PA165958345	1437	0.982
NULL	Arthritis_Res_Ther_2012_Apr_18_14(2)_R80.nxml.txt.nlp	22513098	SENT212	15	15	2	2	hydroxychloroquine	TLR9	PA164777036	54106	0.982
NULL	Gut_Microbes_2013_Mar_1_4(2)_158-164.nxml.txt.nlp	23333861	SENT85	33	33	9	9	vancomycin	CD25	PA451850	3669;3559	0.982
NULL	Front_Genet_2012_Nov_5_3_236.nxml.txt.nlp	23133441	SENT15	31	31	1	1	efavirenz	ABCB1	PA449441	5243	0.982
NULL	Dement_Geriatr_Cogn_Dis_Extra_2014_Oct_29_4(3)_395-401.nxml.txt.nlp	25493089	SENT100	14	14	25	25	rivastigmine	spatial	PA451262	219793	0.982
NULL	Mol_Cancer_2013_Mar_5_12_17.nxml.txt.nlp	23497256	SENT223	28	28	10	10	sunitinib	p53	PA162372840	7157	0.982
NULL	Br_J_Pharmacol_2014_Feb_24_171(1)_1019-1032.nxml.txt.nlp	24251620	SENT177	23	23	6	6	nicardipine	TRPA1	PA450620	8989	0.982
NULL	Ann_Rheum_Dis_2008_Apr_20_67(4)_511-517.nxml.txt.nlp	17644552	SENT147	4	4	38	38	infliximab	IL-6	PA452639	3569	0.982
NULL	Acta_Pharmacol_Sin_2011_Jun_23_32(6)_675-684.nxml.txt.nlp	21602838	SENT121	21	21	9	9	simvastatin	ClC-3	PA451363	1182	0.982
NULL	Clin_Exp_Gastroenterol_2012_May_14_5_49-59.nxml.txt.nlp	22649281	SENT2	2	2	13	13	omeprazole	CYP2C19	PA450704	1557	0.982
NULL	Colorectal_Dis_2012_Feb_14(2)_e31-e47.nxml.txt.nlp	21848897	SENT21	6	6	15	15	panitumumab	KRAS	PA162373091	3845	0.982
NULL	Viruses_2014_Apr_14_6(4)_1715-1758.nxml.txt.nlp	24736215	SENT322	4	4	36	36	chloroquine	CD4	PA448948	920	0.982
NULL	Stroke_Res_Treat_2011_Jun_22_2011_607852.nxml.txt.nlp	21822469	SENT448	6	6	37	37	thrombin	TKR	PA451674	8277	0.982
NULL	Adolesc_Health_Med_Ther_2013_Aug_27_4_79-87.nxml.txt.nlp	24600298	SENT61	1	1	6	6	raltegravir	UGT1A1		54658	0.982
NULL	Oncol_Lett_2014_Mar_2_7(3)_791-796.nxml.txt.nlp	24527087	SENT126	29	29	8	8	imatinib	CDK1	PA10804	983	0.982
NULL	Drugs_Context_2013_Jan_3_2013_212245.nxml.txt.nlp	24432034	SENT105	7	7	39	39	duloxetine	TTR	PA10066	7276	0.982
NULL	Arthritis_Res_Ther_2011_Mar_24_13(2)_R51.nxml.txt.nlp	21435232	SENT222	16	16	5	5	etanercept	TWEAK	PA449515	8742	0.982
NULL	Leukemia_2013_Jan_11_27(1)_32-40.nxml.txt.nlp	22781593	SENT103	1	1	30	30	ponatinib	FGFR1	PA165980594	2260	0.982
NULL	Breast_Cancer_Res_2010_Jun_28_12(3)_R43.nxml.txt.nlp	20579400	SENT95	9	9	0	0	paclitaxel	MTS	PA450761	1678	0.982
NULL	Acta_Pharmacol_Sin_2010_Sep_16_31(9)_1075-1084.nxml.txt.nlp	20711221	SENT142	13	13	3	3	oxygen	AMPK	PA450744	5563	0.982
NULL	Front_Oncol_2014_Sep_23_4_264.nxml.txt.nlp	25295231	SENT182	29	29	5	5	lenalidomide	TP53	PA162363968	7157	0.982
NULL	Aging_(Albany_NY)_2011_Jan_18_3(1)_33-43.nxml.txt.nlp	21248371	SENT213	24	24	17	17	bleomycin	p53	PA448645	7157	0.982
NULL	Br_J_Cancer_1998_May_77(9)_1469-1473.nxml.txt.nlp	9652763	SENT12	8	8	29	29	etoposide	P-gp	PA449552	5243	0.982
NULL	Front_Oncol_2013_Oct_9_3_261.nxml.txt.nlp	24130964	SENT205	14	14	30	30	erlotinib	EGFR	PA134687924	1956	0.982
NULL	Nucleic_Acids_Res_2012_Sep_28_40(17)_8440-8448.nxml.txt.nlp	22753029	SENT190	27	27	6	6	hydroxyurea	CHK1	PA449942	1111	0.982
NULL	Diabetes_2009_Feb_58(2)_329-336.nxml.txt.nlp	19171749	SENT128	5	5	19	19	imatinib	JNK	PA10804	5599	0.982
NULL	EMBO_Mol_Med_2013_Jul_30_5(7)_932-948.nxml.txt.nlp	23723167	SENT94	2	2	18	18	pilocarpine	MMP13	PA450962	4322	0.982
NULL	FASEB_J_2013_Jun_27(6)_2328-2341.nxml.txt.nlp	23447581	SENT37	2	2	10	10	curcumin	IL-6	PA151958596	3569	0.982
NULL	J_Cell_Biol_1998_Jan_26_140(2)_335-345.nxml.txt.nlp	9442109	SENT185	2	2	12	12	chloroquine	NHE	PA448948	285335	0.982
NULL	Front_Oncol_2014_Apr_10_4_74.nxml.txt.nlp	24782985	SENT328	9	9	14	14	paclitaxel	IFN	PA450761	3439	0.982
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT271	5	5	24	24	maraviroc	CYP3A4	PA164768835	1576	0.982
NULL	J_Cell_Mol_Med_2014_Dec_6_18(12)_2331-2339.nxml.txt.nlp	25284457	SENT132	10	10	25	25	curcumin	HMGB1	PA151958596	3146	0.982
NULL	Theranostics_2013_Jan_13_3(1)_34-39.nxml.txt.nlp	23382784	SENT125	39	39	30	30	mitoxantrone	CXCR4	PA450526	7852	0.982
NULL	Cell_Cycle_2012_Nov_1_11(21)_3983-3996.nxml.txt.nlp	22987153	SENT78	11	11	1	1	cisplatin	DNA2	PA449014	1763	0.982
NULL	Breast_Cancer_Res_2007_Mar_2_9(2)_205.nxml.txt.nlp	NULL	SENT26	39	39	4	4	erlotinib	HER-2	PA134687924	2064	0.982
NULL	Front_Immunol_2012_Jul_18_3_198.nxml.txt.nlp	22826708	SENT423	10	10	0	0	alemtuzumab	BAFF	PA164783958	10673	0.982
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1699-1708.nxml.txt.nlp	19861960	SENT198	17	17	8	8	dasatinib	IGFBP2	PA162372878	3485	0.982
NULL	Cancers_(Basel)_2013_May_24_5(2)_569-590.nxml.txt.nlp	24216992	SENT243	36	36	6	6	cyclophosphamide	CD4	PA449165	920	0.982
NULL	Korean_Circ_J_2014_Mar_12_44(2)_97-104.nxml.txt.nlp	24653739	SENT26	0	0	21	21	bosentan	ETB	PA10034	1910	0.982
NULL	Cell_Death_Dis_2013_Sep_5_4(9)_e791.nxml.txt.nlp	24008735	SENT34	16	16	35	35	gemcitabine	p53	PA449748	7157	0.982
NULL	Apoptosis_2012_Sep_30_17(9)_989-997.nxml.txt.nlp	22460505	SENT140	22	22	3	3	thioridazine	EGF	PA451666	1950	0.982
NULL	Br_J_Pharmacol_2008_Oct_18_155(4)_596-605.nxml.txt.nlp	18852694	SENT153	3	3	8	8	fenofibrate	SCAP	PA449594	22937	0.982
NULL	Case_Rep_Med_2011_Dec_27_2011_416842.nxml.txt.nlp	22242029	SENT63	4	4	29	29	cyclosporine	IL-2	PA449167	3558	0.982
NULL	Oncologist_2010_Mar_3_15(3)_216-235.nxml.txt.nlp	20200040	SENT110	12	12	30	30	trastuzumab	HER-2	PA451743	2064	0.982
NULL	J_Ginseng_Res_2011_Sep_35(3)_339-343.nxml.txt.nlp	23717078	SENT3	3	3	19	19	ginseng	PAH	PA164781150	5053	0.982
NULL	Semin_Immunopathol_2012_Jan_4_34(1)_93-106.nxml.txt.nlp	21845431	SENT188	36	36	12	12	thrombin	PAR-1	PA451674	2011;2149	0.982
NULL	Eur_J_Med_Res_2009_Dec_7_14(Suppl_4)_71-77.nxml.txt.nlp	20156730	SENT121	9	9	31	31	tobramycin	PARI	PA451704	55010	0.982
NULL	J_Headache_Pain_2011_Dec_22_12(6)_603-608.nxml.txt.nlp	22030984	SENT115	28	28	0	0	vasopressin	KCNN3	PA451858	3782	0.982
NULL	Gene_Regul_Syst_Bio_2014_Mar_4_8_63-73.nxml.txt.nlp	24634581	SENT119	23	23	4	4	minocycline	NANOS1	PA450519	340719	0.982
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_P120.nxml.txt.nlp	NULL	SENT13	3	3	14	14	allopurinol	HLA-B	PA448320	3106	0.982
NULL	Oncotarget_2013_Nov_23_5(1)_196-210.nxml.txt.nlp	24344116	SENT180	36	36	3	3	doxorubicin	p53	PA449412	7157	0.982
NULL	Oncotarget_2014_Aug_4_5(17)_7776-7787.nxml.txt.nlp	25277200	SENT226	2	2	24	24	cisplatin	ANXA4	PA449014	307	0.982
NULL	J_Gen_Physiol_2008_Oct_132(4)_397-405.nxml.txt.nlp	18794377	SENT165	40	40	5	5	nifedipine	NCX	PA450631	3196	0.982
NULL	Am_J_Cardiovasc_Drugs_2014_Oct_31_14(2)_79-87.nxml.txt.nlp	24174174	SENT24	0	0	7	7	simvastatin	adiponectin	PA451363	9370	0.982
NULL	Med_Sci_Monit_2013_Oct_31_19_916-926.nxml.txt.nlp	24172537	SENT113	29	29	4	4	cisplatin	FANCC	PA449014	2176	0.982
NULL	Ann_Clin_Microbiol_Antimicrob_2005_Sep_13_4_13.nxml.txt.nlp	16159399	SENT161	22	22	5	5	ribavirin	IFN	PA451241	3439	0.982
NULL	Oxid_Med_Cell_Longev_2012_Nov_28_2012_162934.nxml.txt.nlp	23251719	SENT116	15	15	2	2	oxygen	TSPO	PA450744	706	0.982
NULL	eLife_2013_Nov_5_2_e00969.nxml.txt.nlp	24192036	SENT92	26	26	10	10	vemurafenib	ERK	PA165946873	5594	0.982
NULL	Cell_Div_2012_Dec_26_7_26.nxml.txt.nlp	23268747	SENT115	2	2	9	9	bortezomib	JNK	PA10252	5599	0.982
NULL	Biomed_Res_Int_2013_Feb_28_2013_749078.nxml.txt.nlp	23555095	SENT107	1	1	25	25	trypsin	CD102	PA451806	3384	0.982
NULL	Cancer_Imaging_2013_May_2_13(2)_197-211.nxml.txt.nlp	23649384	SENT60	0	0	24	24	imatinib	CSF1R	PA10804	1436	0.982
NULL	Paediatr_Drugs_2013_Apr_20_15(2)_119-131.nxml.txt.nlp	23512128	SENT87	6	6	16	16	ilaprazole	CYP3A5	PA165947499	1577	0.982
NULL	AIDS_Res_Treat_2014_Feb_25_2014_636584.nxml.txt.nlp	24715982	SENT4	15	15	2	2	etravirine	DUET	PA166014703	8997	0.982
NULL	Arthritis_Res_Ther_2006_Nov_8_8(6)_R167.nxml.txt.nlp	17092341	SENT14	31	31	13	13	rituximab	BAFF	PA451261	10673	0.982
NULL	Cancers_(Basel)_2013_Nov_26_5(4)_1601-1618.nxml.txt.nlp	24287743	SENT205	0	0	7	7	crizotinib	Met	PA165946122	79811	0.982
NULL	Case_Rep_Oncol_2010_Apr_29_3(2)_131-136.nxml.txt.nlp	20740185	SENT72	24	24	4	4	anastrozole	HER2	PA448432	2064	0.982
NULL	J_Exp_Med_1998_Jun_1_187(11)_1885-1892.nxml.txt.nlp	9607928	SENT127	25	25	33	33	thalidomide	IL-2	PA451644	3558	0.982
NULL	Br_J_Cancer_2009_Mar_24_100(6)_870-873.nxml.txt.nlp	19293806	SENT56	2	2	13	13	gemcitabine	CDA	PA449748	978	0.982
NULL	Br_J_Cancer_2013_May_28_108(10)_2013-2020.nxml.txt.nlp	23632482	SENT148	20	20	2	2	paclitaxel	CENP-A	PA450761	1058	0.982
NULL	Biomed_Res_Int_2013_Feb_28_2013_749078.nxml.txt.nlp	23555095	SENT107	1	1	20	20	trypsin	CD31	PA451806	5175	0.982
NULL	Indian_J_Endocrinol_Metab_2011_Jan-Mar_15(1)_9-17.nxml.txt.nlp	21584160	SENT72	0	0	25	25	liraglutide	GLP-1	PA165958364	100125288	0.982
NULL	J_Ophthalmol_2011_Oct_20_2011_252549.nxml.txt.nlp	22046503	SENT118	9	9	18	18	ranibizumab	HTRA1	PA164746012	5654	0.982
NULL	Arthritis_Res_Ther_2014_Apr_11_16(2)_R93.nxml.txt.nlp	24725461	SENT18	8	8	6	6	letrozole	aromatase	PA450196	1588	0.982
NULL	J_Oncol_2012_Sep_12_2012_417673.nxml.txt.nlp	23008712	SENT21	0	0	9	9	bevacizumab	VEGF-A	PA130232992	7422	0.982
NULL	Ther_Clin_Risk_Manag_2007_Aug_3(4)_543-552.nxml.txt.nlp	18472975	SENT24	4	4	21	21	thalidomide	IL-2	PA451644	3558	0.982
NULL	Breast_Cancer_Res_2004_Oct_21_6(1)_13-21.nxml.txt.nlp	14680481	SENT106	20	20	8	8	lovastatin	p27	PA450272	5715;10534	0.982
NULL	Evid_Based_Complement_Alternat_Med_2015_Jan_6_2015_802903.nxml.txt.nlp	25632291	SENT105	10	10	0	0	berberine	CYP2D6	PA165860812	1565	0.982
NULL	Diagn_Pathol_2013_May_15_8_81.nxml.txt.nlp	23675804	SENT21	24	24	2	2	cyclophosphamide	CD5	PA449165	921	0.982
NULL	Biomed_Res_Int_2013_Jul_1_2013_964743.nxml.txt.nlp	23936861	SENT198	25	25	5	5	cetuximab	EGFR	PA10040	1956	0.982
NULL	Oncoimmunology_2013_Aug_1_2(8)_e25218.nxml.txt.nlp	24167759	SENT4	14	14	20	20	vemurafenib	BRAF	PA165946873	673	0.982
NULL	J_Clin_Exp_Pathol_2012_May_17_Suppl_4_7327.nxml.txt.nlp	25379357	SENT33	42	42	2	2	resveratrol	AMPK		5563	0.982
NULL	Cancer_Med_2014_Jun_19_3(3)_555-564.nxml.txt.nlp	24648042	SENT136	13	13	33	33	chlorambucil	NOTCH1	PA448926	4851	0.982
NULL	J_Carcinog_2011_Dec_8_10_32.nxml.txt.nlp	22279417	SENT155	11	11	28	28	pimozide	CML	PA450965	613	0.982
NULL	Int_J_Inflam_2011_Oct_30_2011_642612.nxml.txt.nlp	22121495	SENT60	6	6	13	13	atorvastatin	FABP4	PA448500	2167	0.982
NULL	Arthritis_Res_Ther_2012_Jul_12_14(4)_R163.nxml.txt.nlp	22784880	SENT127	13	13	42	42	leflunomide	CYP2C19	PA450192	1557	0.982
NULL	J_Mol_Signal_2013_Jan_26_8_1.nxml.txt.nlp	23351368	SENT82	0	0	7	7	estradiol	TRAF6	PA449503	7189	0.982
NULL	Ann_Rheum_Dis_2012_Sep_71(9)_1510-1516.nxml.txt.nlp	22440821	SENT103	27	27	9	9	adalimumab	adiponectin	PA10004	9370	0.982
NULL	Ther_Clin_Risk_Manag_2007_Aug_3(4)_553-562.nxml.txt.nlp	18472976	SENT72	24	24	15	15	lenalidomide	KDR	PA162363968	3791	0.982
NULL	J_Thromb_Haemost_2011_Oct_9(10)_2103-2105.nxml.txt.nlp	21812912	SENT42	16	16	32	32	ticagrelor	mol	PA165374673	90527	0.982
NULL	Oncoimmunology_2013_Jan_1_2(1)_e22246.nxml.txt.nlp	23482454	SENT17	15	15	2	2	cyclophosphamide	HLA-A	PA449165	3105	0.982
NULL	Oxid_Med_Cell_Longev_2013_Jun_2_2013_793525.nxml.txt.nlp	23819014	SENT238	9	9	0	0	resveratrol	SGBS		2719	0.982
NULL	Apoptosis_2012_Sep_30_17(9)_989-997.nxml.txt.nlp	22460505	SENT118	28	28	3	3	thioridazine	p27	PA451666	5715;10534	0.982
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT172	14	14	3	3	nutlin-3	p53		7157	0.982
NULL	Indian_J_Pharmacol_2012_Nov-Dec_44(6)_805-806.nxml.txt.nlp	23248418	SENT13	0	0	16	16	dronedarone	CYP3A4	PA153619853	1576	0.982
NULL	Indian_J_Dermatol_2011_May-Jun_56(3)_262-265.nxml.txt.nlp	21772584	SENT101	1	1	32	32	tacrolimus	IL-2	PA451578	3558	0.982
NULL	Cancer_Cell_Int_2006_Mar_30_6_9.nxml.txt.nlp	16573823	SENT138	21	21	8	8	lovastatin	CT50	PA450272	93273	0.982
NULL	J_Headache_Pain_2014_Feb_8_15(1)_7.nxml.txt.nlp	24506953	SENT196	7	7	29	29	capsaicin	TRPV1	PA448776	7442	0.982
NULL	Curr_Cardiol_Rev_2012_May_8(2)_158-165.nxml.txt.nlp	22708914	SENT123	3	3	12	12	ketoconazole	CYP3A4	PA450146	1576	0.982
NULL	Am_J_Physiol_Cell_Physiol_2014_Jan_15_306(2)_C89-C97.nxml.txt.nlp	24133067	SENT46	0	0	27	27	hyaluronan	CD44	PA165958431	960	0.982
NULL	Mol_Cancer_2014_Jun_30_13_160.nxml.txt.nlp	24976026	SENT156	30	30	9	9	bortezomib	AGR2	PA10252	10551	0.982
NULL	Br_J_Clin_Pharmacol_2013_Aug_23_76(2)_299-315.nxml.txt.nlp	23701319	SENT68	21	21	2	2	muromonab	IL-2	PA164743097	3558	0.982
NULL	Front_Pharmacol_2014_Dec_23_5_286.nxml.txt.nlp	25566078	SENT57	24	24	42	42	imatinib	FOXM1	PA10804	2305	0.982
NULL	Oncotarget_2012_May_18_3(5)_525-534.nxml.txt.nlp	22619113	SENT70	6	6	15	15	fludarabine	IL-4	PA449655	3565	0.982
NULL	Sci_Rep_2014_Dec_12_4_7456.nxml.txt.nlp	25503852	SENT57	21	21	5	5	resveratrol	SIRT1		23411	0.982
NULL	Oncotarget_2014_Aug_19_5(18)_8737-8749.nxml.txt.nlp	25228590	SENT189	7	7	21	21	crizotinib	PI3K	PA165946122	5290	0.982
NULL	Chin_J_Cancer_2012_Jun_31(6)_306-314.nxml.txt.nlp	22640627	SENT161	11	11	41	41	rituximab	Bcl-2	PA451261	596	0.982
NULL	Exp_Diabetes_Res_2011_Apr_6_2011_928523.nxml.txt.nlp	21603181	SENT154	15	15	25	25	haloperidol	DRD2	PA449841	1813	0.982
NULL	Orphanet_J_Rare_Dis_2014_Dec_10_9(1)_200.nxml.txt.nlp	NULL	SENT94	3	3	29	29	alendronate	HCS	PA448082	3141;54205	0.982
NULL	Virol_J_2012_Dec_6_9_303.nxml.txt.nlp	23216755	SENT136	6	6	12	12	geldanamycin	Hsp90	PA152031327	3320	0.982
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT180	9	9	28	28	probenecid	SLC22A8	PA451106	9376	0.982
NULL	Acta_Pharmacol_Sin_2010_Sep_16_31(9)_1075-1084.nxml.txt.nlp	20711221	SENT114	5	5	30	30	metformin	eNOS	PA450395	4846	0.982
NULL	Biochimie_2010_Nov_92(11)_1546-1567.nxml.txt.nlp	20615447	SENT206	17	17	6	6	heparin	KLK6	PA449855	5653	0.982
NULL	Crit_Care_2011_Mar_11_15(Suppl_1)_P232.nxml.txt.nlp	NULL	SENT4	11	11	39	39	vancomycin	VISA	PA451850	57506	0.982
NULL	Asian_J_Androl_2014_Apr_25_Sep-Oct_16(5)_761-766.nxml.txt.nlp	24799635	SENT126	13	13	33	33	fructose	DAN	PA449716	5073;4681	0.982
NULL	Nat_Commun_2013_Aug_15_4_2130.nxml.txt.nlp	23945651	SENT721	7	7	34	34	etoposide	ATG5	PA449552	9474	0.982
NULL	Oncoimmunology_2014_May_29_3_e28925.nxml.txt.nlp	25083322	SENT46	3	3	9	9	dasatinib	CD4	PA162372878	920	0.982
NULL	Oncogene_2010_Jul_15_29(28)_4090-4100.nxml.txt.nlp	20473326	SENT79	6	6	23	23	doxorubicin	MDM2	PA449412	4193	0.982
NULL	Br_J_Cancer_2014_Oct_14_111(8)_1552-1561.nxml.txt.nlp	25117814	SENT158	15	15	6	6	doxorubicin	AKT	PA449412	207	0.982
NULL	Oncotarget_2013_Jul_21_4(8)_1266-1279.nxml.txt.nlp	23907540	SENT84	12	12	5	5	doxycycline	PTEN	PA449415	5728	0.982
NULL	Int_J_Nanomedicine_2012_Oct_25_7_5565-5575.nxml.txt.nlp	23118538	SENT140	19	19	29	29	fenofibrate	CO2	PA449594	4513	0.982
NULL	Onco_Targets_Ther_2014_Jul_12_7_1273-1284.nxml.txt.nlp	25050069	SENT36	0	0	9	9	trabectedin	CYP3A4	PA165958349	1576	0.982
NULL	Acta_Pharmacol_Sin_2010_Jul_28_31(7)_867-873.nxml.txt.nlp	20581857	SENT117	13	13	4	4	docetaxel	PDCD4	PA449383	27250	0.982
NULL	Br_J_Cancer_2011_Jul_12_105(2)_189-193.nxml.txt.nlp	21694726	SENT29	18	18	9	9	tamoxifen	aromatase	PA451581	1588	0.982
NULL	Environ_Health_Perspect_2006_Apr_13_114(4)_494-499.nxml.txt.nlp	16581535	SENT212	0	0	7	7	ethanol	CYP2E1	PA448073	1571	0.982
NULL	Arthritis_Res_Ther_2008_Jan_31_10(1)_R16.nxml.txt.nlp	18234118	SENT111	11	11	2	2	colchicine	HO-1	PA449092	3162	0.982
NULL	Exp_Ther_Med_2014_Jul_2_8(1)_38-48.nxml.txt.nlp	24944594	SENT236	17	17	3	3	lovastatin	Xin	PA450272	165904	0.982
NULL	Endocrinol_Metab_(Seoul)_2014_Dec_29_29(4)_410-417.nxml.txt.nlp	25559569	SENT45	30	30	7	7	dexfenfluramine	5-HT2B	PA164747936	3357	0.982
NULL	Aging_Cell_2009_Apr_8(2)_113-127.nxml.txt.nlp	19239417	SENT110	0	0	7	7	resveratrol	AMPK		5563	0.982
NULL	Exp_Hematol_Oncol_2012_Sep_11_1_27.nxml.txt.nlp	23210501	SENT71	14	14	5	5	lenalidomide	CRBN	PA162363968	51185	0.982
NULL	Ann_Gen_Psychiatry_2014_Jun_13_13_17.nxml.txt.nlp	25053968	SENT137	22	22	9	9	citalopram	STAR	PA449015	6770;2984	0.982
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT13	23	23	4	4	doxorubicin	ABCB1	PA449412	5243	0.982
NULL	Front_Pharmacol_2014_Oct_31_5_231.nxml.txt.nlp	25400580	SENT4338	4	4	15	15	debrisoquine	OCT1	PA452616	5451;6580	0.982
NULL	Mol_Cancer_2014_Jun_19_13_154.nxml.txt.nlp	24941944	SENT160	22	22	12	12	pyrimethamine	NRAS	PA451193	4893	0.982
NULL	Oncoimmunology_2012_Nov_1_1(8)_1422-1424.nxml.txt.nlp	23243615	SENT34	4	4	37	37	cyclophosphamide	CD25	PA449165	3669;3559	0.982
NULL	Pain_Res_Treat_2011_Aug_14_2011_864605.nxml.txt.nlp	22110933	SENT133	0	0	14	14	carbamazepine	PLP	PA448785	25824;5744	0.982
NULL	Arch_Drug_Inf_2011_Mar_4(1)_1-9.nxml.txt.nlp	21572514	SENT165	9	9	15	15	ciprofloxacin	PEPT1	PA449009	6564	0.982
NULL	Evid_Based_Complement_Alternat_Med_2012_Feb_16_2012_430262.nxml.txt.nlp	22454664	SENT107	7	7	23	23	clopidogrel	CYP3A	PA449053	1574	0.982
NULL	Oncogene_2009_Dec_10_28(49)_4353-4363.nxml.txt.nlp	19826413	SENT7	33	33	12	12	paclitaxel	TRIF	PA450761	148022	0.982
NULL	Br_J_Clin_Pharmacol_2013_Aug_23_76(2)_299-315.nxml.txt.nlp	23701319	SENT230	18	18	5	5	bevacizumab	IL-2	PA130232992	3558	0.982
NULL	Case_Rep_Oncol_2013_Sep_12_6(3)_456-461.nxml.txt.nlp	24163660	SENT72	0	0	8	8	cetuximab	EGFR	PA10040	1956	0.982
NULL	Diabetes_2009_Jan_58(1)_156-164.nxml.txt.nlp	18984740	SENT94	19	19	40	40	fluorescein	San	PA164746009	80218	0.982
NULL	Int_J_Mol_Sci_2014_Mar_20_15(3)_4946-4964.nxml.txt.nlp	24658439	SENT63	9	9	39	39	capsaicin	GBF	PA448776	1316	0.982
NULL	Nat_Commun_2014_Dec_8_5_5736.nxml.txt.nlp	25484020	SENT18	21	21	1	1	tamoxifen	aromatase	PA451581	1588	0.982
NULL	Anemia_2011_Mar_3_2011_740235.nxml.txt.nlp	21490765	SENT192	39	39	12	12	montelukast	SLCO2B1	PA450546	11309	0.982
NULL	Arthritis_Res_Ther_2010_Jan_29_12(1)_R18.nxml.txt.nlp	20113495	SENT262	14	14	5	5	glucosamine	NAPA	PA164747613	9476;8775	0.982
NULL	Diabetes_Care_2010_Nov_33(11)_2484-2485.nxml.txt.nlp	20980428	SENT38	2	2	7	7	bevacizumab	VEGF-A	PA130232992	7422	0.982
NULL	Breast_Cancer_Res_2010_May_10_12(3)_R26.nxml.txt.nlp	20459744	SENT152	33	33	6	6	thiotepa	CYP2B6	PA451668	1555	0.982
NULL	J_Hematol_Oncol_2008_Oct_1_1_16.nxml.txt.nlp	18828924	SENT79	14	14	21	21	trastuzumab	HER2	PA451743	2064	0.982
NULL	Cell_Rep_2012_Feb_23_1(2)_99-109.nxml.txt.nlp	22832160	SENT94	18	18	41	41	doxycycline	Oct4	PA449415	5460	0.982
NULL	J_Clin_Biochem_Nutr_2011_May_13_48(3)_237-244.nxml.txt.nlp	21562645	SENT171	35	35	25	25	resveratrol	AMPK		5563	0.982
NULL	Mediators_Inflamm_2010_Sep_22_2010_628171.nxml.txt.nlp	20886028	SENT20	0	0	18	18	montelukast	CysLT1	PA450546	10800	0.982
NULL	Arthritis_Res_Ther_2005_Jan_10_7(2)_R250-R255.nxml.txt.nlp	15743471	SENT100	20	20	7	7	adalimumab	CD69	PA10004	969	0.982
NULL	Breast_Cancer_Res_2002_May_23_4(4)_141-144.nxml.txt.nlp	12100738	SENT57	8	8	24	24	letrozole	HER-2	PA450196	2064	0.982
NULL	Amino_Acids_2012_Oct_10_43(4)_1751-1759.nxml.txt.nlp	22407485	SENT195	40	40	9	9	carrageenan	DAG	PA448814	1605	0.982
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT168	24	24	19	19	tacrolimus	OPG	PA451578	690	0.982
NULL	Onco_Targets_Ther_2014_Jul_31_7_1367-1373.nxml.txt.nlp	25114575	SENT19	0	0	9	9	lapatinib	HER2	PA152241907	2064	0.982
NULL	J_Gen_Physiol_2013_Apr_141(4)_413-430.nxml.txt.nlp	23530136	SENT138	16	16	5	5	tetracaine	CNGA3	PA451638	1261	0.982
NULL	Acta_Pharmacol_Sin_2009_Apr_3_30(4)_478-484.nxml.txt.nlp	19343062	SENT102	12	12	0	0	cyclosporine	CYP3A4	PA449167	1576	0.982
NULL	AAPS_J_2013_Aug_20_15(4)_1119-1127.nxml.txt.nlp	23959685	SENT45	24	24	5	5	caffeine	CPE	PA448710	1363	0.982
NULL	J_Inflamm_(Lond)_2005_Oct_31_2_14.nxml.txt.nlp	16259633	SENT311	16	16	25	25	staurosporine	CCR2	PA165109623	729230	0.982
NULL	Anal_Bioanal_Chem_2014_Jan_23_406(15)_3667-3680.nxml.txt.nlp	24452745	SENT189	4	4	28	28	ketoprofen	KET	PA450149	8626	0.982
NULL	Pharmaceutics_2011_Jul_13_3(3)_425-439.nxml.txt.nlp	24310588	SENT84	39	39	1	1	oxycodone	SERS	PA450741	6301;54938	0.982
NULL	Br_J_Cancer_2014_Jan_7_110(1)_55-62.nxml.txt.nlp	24263064	SENT140	7	7	17	17	gefitinib	EGFR	PA131301952	1956	0.982
NULL	Scientifica_(Cairo)_2012_Oct_14_2012_428139.nxml.txt.nlp	24278693	SENT116	20	20	5	5	imatinib	OCT1	PA10804	5451;6580	0.982
NULL	J_Cell_Biol_2003_Aug_18_162(4)_661-671.nxml.txt.nlp	12925710	SENT60	18	18	3	3	pp2	P19		51561	0.982
NULL	Diabetes_2011_Jan_4_60(1)_119-126.nxml.txt.nlp	20921208	SENT17	12	12	4	4	glucose	TRPM2	PA449773	7226	0.982
NULL	J_Am_Heart_Assoc_2013_Dec_19_2(6)_e000439.nxml.txt.nlp	24334905	SENT303	11	11	4	4	doxorubicin	p62	PA449412	8878;10657;23636	0.982
NULL	Front_Immunol_2014_Apr_22_5_169.nxml.txt.nlp	24795716	SENT175	18	18	28	28	dextran	NLRP3	PA449261	114548	0.982
NULL	Br_J_Cancer_1998_Sep_78(Suppl_4)_12-15.nxml.txt.nlp	9741783	SENT3	0	0	4	4	anastrozole	aromatase	PA448432	1588	0.982
NULL	Breast_Cancer_Res_Treat_2013_Aug_20_141(1)_43-53.nxml.txt.nlp	23959396	SENT31	46	46	4	4	trastuzumab	HER3	PA451743	2065	0.982
NULL	Mol_Cancer_2009_Nov_24_8_109.nxml.txt.nlp	19930708	SENT217	3	3	1	1	exemestane	aromatase	PA449563	1588	0.982
NULL	F1000_Biol_Rep_2009_Mar_24_1_23.nxml.txt.nlp	20948663	SENT13	40	40	2	2	mirtazapine	ABCB1	PA450522	5243	0.982
NULL	Can_J_Infect_Dis_Med_Microbiol_2014_Nov-Dec_25(6)_327-343.nxml.txt.nlp	25587296	SENT382	10	10	28	28	itraconazole	CYP3A4	PA450132	1576	0.982
NULL	Mol_Immunol_2009_Mar_46(6)_1149-1162.nxml.txt.nlp	19100624	SENT262	36	36	18	18	nystatin	C5L2	PA450666	27202	0.982
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Jul_23_3(7)_e126.nxml.txt.nlp	25054314	SENT88	10	10	15	15	docetaxel	OATP1B3	PA449383	28234	0.982
NULL	Trials_2014_May_15_15_171.nxml.txt.nlp	24885324	SENT17	11	11	1	1	letrozole	aromatase	PA450196	1588	0.982
NULL	Acta_Pharmacol_Sin_2011_Aug_11_32(8)_999-1008.nxml.txt.nlp	21743486	SENT147	39	39	30	30	fasudil	JNK	PA165946121	5599	0.982
NULL	Pharmaceutics_2011_Apr_14_3(2)_171-185.nxml.txt.nlp	24310494	SENT168	18	18	4	4	vinblastine	CD19	PA451877	930	0.982
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Apr_17_6_43-57.nxml.txt.nlp	24833916	SENT300	13	13	29	29	exemestane	PI3K	PA449563	5290	0.982
NULL	Br_J_Pharmacol_2010_Nov_161(5)_961-971.nxml.txt.nlp	20977449	SENT217	27	27	10	10	suramin	P2X2	PA10292	22953	0.982
NULL	Cell_Death_Dis_2014_Jan_16_5(1)_e1005.nxml.txt.nlp	24434513	SENT7	8	8	3	3	dasatinib	Met	PA162372878	79811	0.982
NULL	Cancer_Cell_Int_2009_Jan_8_9_3.nxml.txt.nlp	19128511	SENT96	9	9	20	20	oxaliplatin	PI3K	PA131285527	5290	0.982
NULL	Mol_Syst_Biol_2009_Jul_28_5_288.nxml.txt.nlp	19638969	SENT216	18	18	0	0	geldanamycin	Hsp90	PA152031327	3320	0.982
NULL	J_Cell_Biol_2001_Oct_15_155(2)_207-216.nxml.txt.nlp	11591730	SENT103	18	18	29	29	camptothecin	p53	PA153590860	7157	0.982
NULL	Oncotarget_2014_Mar_26_5(21)_10342-10355.nxml.txt.nlp	25431950	SENT117	31	31	3	3	doxycycline	EZH2	PA449415	2146	0.982
NULL	Front_Pharmacol_2014_May_27_5_115.nxml.txt.nlp	24904418	SENT194	19	19	32	32	hyaluronan	CD44	PA165958431	960	0.982
NULL	Front_Immunol_2013_May_31_4_129.nxml.txt.nlp	23755052	SENT99	17	17	0	0	anakinra	IL-10	PA10799	3586	0.982
NULL	Curr_Neuropharmacol_2012_Sep_10(3)_212-218.nxml.txt.nlp	23449551	SENT154	26	26	7	7	rimonabant	CB1	PA152407999	1268	0.982
NULL	Acta_Pharmacol_Sin_2010_Jul_28_31(7)_867-873.nxml.txt.nlp	20581857	SENT91	14	14	0	0	docetaxel	PC3	PA449383	57332;7832;5122	0.982
NULL	J_Biol_Chem_2013_Jun_14_288(24)_17285-17295.nxml.txt.nlp	23615912	SENT291	16	16	37	37	heparin	spatial	PA449855	219793	0.982
NULL	Environ_Health_Perspect_2005_Oct_14_113(10)_1330-1335.nxml.txt.nlp	16203242	SENT158	31	31	9	9	arsenite	MLC	PA452638	23209	0.982
NULL	Drugs_R_D_2011_Mar_27_11(1)_37-51.nxml.txt.nlp	21410294	SENT36	35	35	39	39	itraconazole	CYP3A4	PA450132	1576	0.982
NULL	Cancer_Metab_2014_May_28_2(Suppl_1)_P23.nxml.txt.nlp	NULL	SENT23	0	0	5	5	metformin	AMPK	PA450395	5563	0.982
NULL	Cancer_Immunol_Immunother_2012_Jul_23_61(7)_1101-1111.nxml.txt.nlp	22193989	SENT199	7	7	12	12	oxaliplatin	STAT6	PA131285527	6778	0.982
NULL	Croat_Med_J_2012_Aug_53(4)_314-320.nxml.txt.nlp	22911523	SENT113	19	19	29	29	trastuzumab	HER2	PA451743	2064	0.982
NULL	Case_Rep_Neurol_2014_Mar_29_6(1)_101-108.nxml.txt.nlp	24761147	SENT108	5	5	29	29	doxorubicin	IVL	PA449412	3713	0.982
NULL	J_Korean_Assoc_Oral_Maxillofac_Surg_2014_Dec_26_40(6)_291-296.nxml.txt.nlp	25551094	SENT19	11	11	5	5	alendronate	M-CSF	PA448082	1435	0.982
NULL	Oncoimmunology_2012_Oct_1_1(7)_1004-1016.nxml.txt.nlp	23170249	SENT31	8	8	14	14	paclitaxel	HER-2	PA450761	2064	0.982
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT174	14	14	25	25	tacrolimus	IL-6	PA451578	3569	0.982
NULL	Nat_Commun_2013_Aug_15_4_2130.nxml.txt.nlp	23945651	SENT92	27	27	5	5	etoposide	ATG5	PA449552	9474	0.982
NULL	Endocrinol_Metab_(Seoul)_2014_Sep_25_29(3)_211-216.nxml.txt.nlp	25309777	SENT45	19	19	0	0	iodine	BRAF	PA450049	673	0.982
NULL	Front_Oncol_2014_Mar_24_4_47.nxml.txt.nlp	24716189	SENT245	17	17	20	20	vemurafenib	BRAF	PA165946873	673	0.982
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1137-1144.nxml.txt.nlp	20234366	SENT205	33	33	20	20	cetuximab	MKP-1	PA10040	1843	0.982
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT273	15	15	3	3	cisplatin	ABCC1	PA449014	4363	0.982
NULL	Breast_Cancer_Res_2005_Apr_6_7(3)_119-130.nxml.txt.nlp	15987442	SENT35	0	0	8	8	tamoxifen	AP-1	PA451581	2353;3727;2354;3725	0.982
NULL	Aging_Cell_2012_Aug_11(4)_579-587.nxml.txt.nlp	22435726	SENT149	38	38	23	23	etoposide	CD28	PA449552	1493;940	0.982
NULL	Clin_Dev_Immunol_2011_Oct_20_2011_947858.nxml.txt.nlp	22046194	SENT132	4	4	22	22	doxorubicin	CD274	PA449412	29126	0.982
NULL	Br_J_Cancer_2010_Jan_5_102(1)_188-195.nxml.txt.nlp	19920824	SENT69	27	27	11	11	heparin	FGF2	PA449855	2247;2258	0.982
NULL	Cancers_(Basel)_2013_Jun_5_5(2)_676-713.nxml.txt.nlp	24216997	SENT369	7	7	15	15	vorinostat	TYMS	PA164748224	7298	0.982
NULL	Oncol_Lett_2014_May_25_7(5)_1537-1543.nxml.txt.nlp	24765172	SENT19	34	34	30	30	cisplatin	COL6A3	PA449014	1293	0.982
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S279-S284.nxml.txt.nlp	21525469	SENT63	3	3	11	11	liraglutide	GLP-1	PA165958364	100125288	0.982
NULL	J_Cell_Mol_Med_2014_Sep_7_18(9)_1785-1796.nxml.txt.nlp	24909956	SENT19	13	13	31	31	cangrelor	GPR17	PA165945763	2840	0.982
NULL	Brain_Sci_2014_May_6_4(2)_356-375.nxml.txt.nlp	24961766	SENT290	36	36	23	23	propofol	spatial	PA451141	219793	0.982
NULL	Core_Evid_2009_Jun_15_4_181-189.nxml.txt.nlp	20694074	SENT204	15	15	32	32	methotrexate	IL-6	PA450428	3569	0.982
NULL	Clin_Med_Insights_Oncol_2012_Feb_28_6_125-135.nxml.txt.nlp	22408376	SENT101	16	16	3	3	cetuximab	KRAS	PA10040	3845	0.982
NULL	Ann_Oncol_2011_Mar_8_22(3)_503-514.nxml.txt.nlp	20616198	SENT126	33	33	17	17	tamoxifen	aromatase	PA451581	1588	0.982
NULL	Clin_Pharmacokinet_2014_Sep_3_53(1)_1-16.nxml.txt.nlp	23999929	SENT129	18	18	25	25	rivaroxaban	CLCR	PA165958360	11330	0.982
NULL	Mol_Cancer_2010_Apr_14_9_76.nxml.txt.nlp	20398285	SENT321	21	21	9	9	tamoxifen	VEGFR2	PA451581	3791	0.982
NULL	Breast_Cancer_Res_Treat_2013_Jan_8_137(2)_457-464.nxml.txt.nlp	23224144	SENT31	4	4	7	7	letrozole	aromatase	PA450196	1588	0.982
NULL	J_Insect_Physiol_2014_Feb_61(100)_8-15.nxml.txt.nlp	24374107	SENT217	0	0	6	6	ketanserin	5-HT2A	PA131053734	3356	0.982
NULL	J_Hematol_Oncol_2013_Jan_4_6_1.nxml.txt.nlp	23286345	SENT22	20	20	9	9	cetuximab	KRAS	PA10040	3845	0.982
NULL	Oncotarget_2014_Jun_8_5(17)_7446-7457.nxml.txt.nlp	25277184	SENT96	28	28	5	5	nutlin-3	TRIM8		81603	0.982
NULL	Exp_Ther_Med_2014_Sep_4_8(3)_851-855.nxml.txt.nlp	25120613	SENT130	9	9	1	1	lopinavir	IRS1	PA450264	3667	0.982
NULL	J_Immunol_Res_2014_May_8_2014_565320.nxml.txt.nlp	24901010	SENT65	19	19	4	4	oxcarbazepine	HLA-B	PA450732	3106	0.982
NULL	Oncotarget_2014_Aug_4_5(17)_7776-7787.nxml.txt.nlp	25277200	SENT226	2	2	36	36	cisplatin	ANXA4	PA449014	307	0.982
NULL	Ann_Neurosci_2014_Jul_21(3)_97-103.nxml.txt.nlp	25206073	SENT5	5	5	3	3	bumetanide	NKCC1	PA448682	6558	0.982
NULL	Cancer_Res_Treat_2013_Mar_31_45(1)_55-62.nxml.txt.nlp	23613671	SENT18	10	10	0	0	oxaliplatin	KRAS	PA131285527	3845	0.982
NULL	Acta_Neuropathol_2010_Feb_21_119(2)_157-175.nxml.txt.nlp	19936768	SENT246	7	7	26	26	etoposide	MKP-1	PA449552	1843	0.982
NULL	Aging_(Albany_NY)_2009_Jun_3_1(6)_515-528.nxml.txt.nlp	20157535	SENT111	30	30	26	26	resveratrol	S6K1		6198	0.982
NULL	Mol_Cancer_2006_Oct_17_5_45.nxml.txt.nlp	17044934	SENT91	27	27	37	37	resveratrol	COX		1351	0.982
NULL	Indian_J_Med_Paediatr_Oncol_2014_Apr-Jun_35(2)_176-180.nxml.txt.nlp	25197183	SENT28	29	29	24	24	trastuzumab	HER-2	PA451743	2064	0.982
NULL	Biochem_Res_Int_2012_Mar_4_2012_875742.nxml.txt.nlp	22500233	SENT203	29	29	0	0	collagenase	MMP13	PA449107	4322	0.982
NULL	J_Hematol_Oncol_2009_Feb_23_2_10.nxml.txt.nlp	19236716	SENT71	23	23	5	5	imatinib	LYN	PA10804	4067	0.982
NULL	Oncotarget_2013_Dec_17_5(1)_67-77.nxml.txt.nlp	24393766	SENT144	0	0	13	13	sunitinib	VEGFR	PA162372840	3791	0.982
NULL	Oncotarget_2010_Oct_9_1(6)_387-395.nxml.txt.nlp	21311095	SENT158	12	12	30	30	tamoxifen	CD133	PA451581	8842	0.982
NULL	Oncotarget_2012_Jan_28_3(1)_78-83.nxml.txt.nlp	22289679	SENT86	7	7	18	18	gefitinib	TNF-alpha	PA131301952	7124	0.982
NULL	Case_Rep_Gastroenterol_2011_Oct_4_5(3)_583-589.nxml.txt.nlp	22110419	SENT18	0	0	10	10	imatinib	KIT	PA10804	3815	0.982
NULL	J_Korean_Med_Sci_2011_Jul_20_26(7)_954-958.nxml.txt.nlp	21738352	SENT96	3	3	11	11	sorafenib	BRAF	PA7000	673	0.982
NULL	J_Cell_Biol_2005_Nov_21_171(4)_663-673.nxml.txt.nlp	16301332	SENT294	5	5	0	0	trypsin	HC11	PA451806	6347	0.982
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1717-1723.nxml.txt.nlp	19844230	SENT95	11	11	2	2	pazopanib	DDR2	PA165291492	4921	0.982
NULL	Adv_Virol_2012_Aug_13_2012_815465.nxml.txt.nlp	22924042	SENT135	21	21	1	1	cyclophosphamide	IFN	PA449165	3439	0.982
NULL	Gastric_Cancer_2012_Jul_17_15(3)_313-322.nxml.txt.nlp	22179434	SENT22	0	0	15	15	trastuzumab	HER2	PA451743	2064	0.982
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1420-1426.nxml.txt.nlp	24056704	SENT122	18	18	22	22	ketoconazole	CYP3A	PA450146	1574	0.982
NULL	Cancer_Immunol_Immunother_2014_Sep_4_63(12)_1297-1306.nxml.txt.nlp	25186613	SENT232	9	9	1	1	indomethacin	COX	PA449982	1351	0.982
NULL	Am_J_Physiol_Cell_Physiol_2014_Jan_15_306(2)_C89-C97.nxml.txt.nlp	24133067	SENT174	20	20	11	11	hyaluronan	PC-3	PA165958431	692094	0.982
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1137-1144.nxml.txt.nlp	20234366	SENT189	29	29	34	34	cetuximab	KRAS	PA10040	3845	0.982
NULL	J_Nucl_Cardiol_2012_Dec_17_19(6)_1211-1225.nxml.txt.nlp	23073913	SENT104	32	32	18	18	simvastatin	FDG	PA451363	23583	0.982
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT111	4	4	11	11	everolimus	PTEN	PA164746311	5728	0.982
NULL	J_Cancer_2013_Sep_27_4(8)_662-670.nxml.txt.nlp	24155778	SENT203	9	9	2	2	cisplatin	UCHL1	PA449014	7345	0.982
NULL	Oncogene_2010_Sep_2_29(35)_4905-4913.nxml.txt.nlp	20581869	SENT52	16	16	0	0	cisplatin	PEO1	PA449014	56652	0.982
NULL	Surg_Neurol_Int_2014_May_8_5_64.nxml.txt.nlp	24991467	SENT172	0	0	11	11	cetuximab	EGFR	PA10040	1956	0.982
NULL	Mol_Vis_2011_Aug_25_17_2297-2310.nxml.txt.nlp	21921981	SENT216	23	23	0	0	estradiol	HSD17B1	PA449503	3292	0.982
NULL	Br_J_Cancer_2010_Jul_13_103(2)_186-195.nxml.txt.nlp	20588277	SENT115	7	7	17	17	nutlin-3	p53		7157	0.982
NULL	Pediatr_Nephrol_2009_Jul_20_24(7)_1355-1361.nxml.txt.nlp	19301038	SENT105	43	43	11	11	sevelamer	PTH	PA164781197	5741	0.982
NULL	Br_J_Cancer_2013_Jul_23_109(2)_502-511.nxml.txt.nlp	23799850	SENT201	3	3	15	15	gemcitabine	SMARCC1	PA449748	6599	0.982
NULL	Front_Oncol_2014_Sep_23_4_263.nxml.txt.nlp	25295230	SENT314	20	20	4	4	sorafenib	FLT3	PA7000	2322	0.982
NULL	Arch_Med_Sci_2014_Feb_24_10(1)_1-9.nxml.txt.nlp	24701207	SENT121	19	19	48	48	oxaliplatin	PIK3CA	PA131285527	5290	0.982
NULL	Mol_Cell_Biochem_2014_Jan_3_389(1-2)_177-185.nxml.txt.nlp	24385108	SENT205	5	5	25	25	bortezomib	BIK	PA10252	638	0.981
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT53	34	34	1	1	lopinavir	SLK	PA450264	9748;2534	0.981
NULL	Clin_Med_Insights_Circ_Respir_Pulm_Med_2013_Apr_9_7_7-15.nxml.txt.nlp	23641160	SENT69	4	4	9	9	roflumilast	CYP3A4	PA165948052	1576	0.981
NULL	Nat_Methods_2011_Jun_24_8(6)_487-493.nxml.txt.nlp	21516115	SENT69	16	16	0	0	gefitinib	EGFR	PA131301952	1956	0.981
NULL	J_Oncol_2013_Aug_20_2013_732047.nxml.txt.nlp	24027583	SENT156	0	0	18	18	pertuzumab	HER3		2065	0.981
NULL	Cancer_Med_2013_Apr_6_2(2)_234-242.nxml.txt.nlp	23634291	SENT20	0	0	11	11	bevacizumab	VEGF-A	PA130232992	7422	0.981
NULL	Arthritis_Res_Ther_2009_Jun_29_11(3)_R100.nxml.txt.nlp	19563672	SENT147	34	34	1	1	infliximab	IFN	PA452639	3439	0.981
NULL	Anticancer_Agents_Med_Chem_2013_Jun_13(5)_681-688.nxml.txt.nlp	23092289	SENT106	0	0	20	20	trastuzumab	HER-2	PA451743	2064	0.981
NULL	Curr_Neuropharmacol_2014_Jul_12(4)_308-323.nxml.txt.nlp	25342939	SENT470	29	29	8	8	bumetanide	EGF	PA448682	1950	0.981
NULL	Cancers_(Basel)_2014_Aug_12_6(3)_1631-1669.nxml.txt.nlp	25119536	SENT435	5	5	14	14	gefitinib	NK4	PA131301952	9235	0.981
NULL	Oncol_Lett_2014_Sep_19_8(3)_1269-1274.nxml.txt.nlp	25120704	SENT123	35	35	18	18	cisplatin	Met	PA449014	79811	0.981
NULL	Front_Microbiol_2013_Aug_19_4_241.nxml.txt.nlp	23966991	SENT231	4	4	19	19	ceftriaxone	SLC7A11	PA448866	23657	0.981
NULL	Breast_Cancer_Res_2004_Jun_28_6(5)_185-187.nxml.txt.nlp	15318922	SENT70	37	37	7	7	tamoxifen	San	PA451581	80218	0.981
NULL	Front_Neural_Circuits_2014_Jun_17_8_65.nxml.txt.nlp	24987336	SENT179	3	3	13	13	furosemide	KCC2	PA449719	57468	0.981
NULL	Mar_Drugs_2012_Dec_11_10(12)_2782-2794.nxml.txt.nlp	23342393	SENT398	14	14	2	2	cyclophosphamide	CD25	PA449165	3669;3559	0.981
NULL	Gut_Liver_2012_Oct_18_6(4)_464-470.nxml.txt.nlp	23170151	SENT14	5	5	13	13	propofol	ESD	PA451141	2098	0.981
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1059-1066.nxml.txt.nlp	21364577	SENT74	31	31	16	16	tamoxifen	BCS	PA451581	617	0.981
NULL	Clin_Pharmacokinet_2014_Sep_3_53(1)_1-16.nxml.txt.nlp	23999929	SENT338	3	3	9	9	dabigatran	CLCR		11330	0.981
NULL	EMBO_Mol_Med_2012_Mar_4(3)_218-233.nxml.txt.nlp	22294553	SENT217	5	5	35	35	erlotinib	JUN	PA134687924	3725	0.981
NULL	Curr_Neuropharmacol_2013_Dec_11(6)_592-597.nxml.txt.nlp	24396335	SENT92	33	33	4	4	naloxone	PAR1	PA450586	79581;2149	0.981
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT117	8	8	3	3	chloroquine	BMPR-II	PA448948	659	0.981
NULL	Arthritis_Res_Ther_2009_Aug_24_11(4)_R127.nxml.txt.nlp	19703304	SENT142	13	13	26	26	adalimumab	OASIS	PA10004	90993	0.981
NULL	Cell_Death_Dis_2014_Apr_17_5(4)_e1182.nxml.txt.nlp	24743737	SENT68	30	30	12	12	capsaicin	TRPV1	PA448776	7442	0.981
NULL	Allergy_Asthma_Clin_Immunol_2009_Oct_22_5(1)_4.nxml.txt.nlp	20016776	SENT226	14	14	18	18	etanercept	TNF-alpha	PA449515	7124	0.981
NULL	Breast_Cancer_Res_2004_Nov_7_6(1)_39-52.nxml.txt.nlp	14680484	SENT194	16	16	6	6	tamoxifen	HER-2	PA451581	2064	0.981
NULL	Cancers_(Basel)_2010_Nov_5_2(4)_1838-1860.nxml.txt.nlp	24281204	SENT161	30	30	14	14	etoposide	p50	PA449552	958;4790	0.981
NULL	Cell_Death_Dis_2012_Mar_1_3(3)_e275.nxml.txt.nlp	22378068	SENT53	8	8	3	3	metformin	AKT	PA450395	207	0.981
NULL	Cancer_Imaging_2011_Mar_1_11(1)_1-8.nxml.txt.nlp	21362586	SENT72	15	15	38	38	verapamil	P-gp	PA451868	5243	0.981
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT85	27	27	6	6	heparin	FGFR1	PA449855	2260	0.981
NULL	Br_J_Cancer_2010_Jan_5_102(1)_1-7.nxml.txt.nlp	19935796	SENT133	43	43	11	11	orlistat	PI3K	PA164776864	5290	0.981
NULL	Acta_Neuropathol_Commun_2013_Aug_9_1_49.nxml.txt.nlp	24252504	SENT123	17	17	10	10	arsenite	TDP-43	PA452638	23435	0.981
NULL	Tumour_Biol_2014_Aug_12_35(8)_7807-7819.nxml.txt.nlp	24817012	SENT377	15	15	4	4	cisplatin	RRM1	PA449014	6240	0.981
NULL	Arch_Med_Sci_2010_Mar_1_6(1)_19-23.nxml.txt.nlp	22371715	SENT117	0	0	8	8	adalimumab	TNF	PA10004	7124	0.981
NULL	Front_Oncol_2014_May_7_4_95.nxml.txt.nlp	24847444	SENT344	24	24	14	14	cytarabine	CD22	PA449177	933	0.981
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT143	4	4	26	26	resveratrol	XIAP		331	0.981
NULL	Br_J_Cancer_2012_Nov_20_107(11)_1815-1819.nxml.txt.nlp	23099804	SENT34	19	19	2	2	anastrozole	ATAC	PA448432	6375	0.981
NULL	Crit_Care_2008_Jan_24_12(1)_R27.nxml.txt.nlp	18304335	SENT152	1	1	6	6	thrombin	Rho	PA451674	29984	0.981
NULL	Clin_Med_Insights_Womens_Health_2013_Jan_22_6_1-11.nxml.txt.nlp	24665209	SENT50	43	43	10	10	tamoxifen	aromatase	PA451581	1588	0.981
NULL	Exp_Mol_Med_2012_Dec_17_44(12)_749-755.nxml.txt.nlp	23178275	SENT15	25	25	15	15	glibenclamide	CAL	PA449782	54751;57120	0.981
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT157	3	3	18	18	pertuzumab	HER2		2064	0.981
NULL	Mol_Cancer_2010_Nov_2_9_289.nxml.txt.nlp	21044322	SENT204	3	3	8	8	cisplatin	RGS10	PA449014	6001	0.981
NULL	Exp_Cell_Res_2013_Jul_1_319(11)_1671-1678.nxml.txt.nlp	23664839	SENT43	7	7	5	5	exemestane	aromatase	PA449563	1588	0.981
NULL	J_Young_Pharm_2010_Jan-Mar_2(1)_15-20.nxml.txt.nlp	21331185	SENT106	17	17	3	3	galactose	C-1	PA449725	5203	0.981
NULL	Exp_Ther_Med_2014_Jun_27_7(6)_1703-1707.nxml.txt.nlp	24926370	SENT97	25	25	0	0	heparin	TLR3	PA449855	7098	0.981
NULL	Ann_Surg_Treat_Res_2014_Feb_22_86(2)_68-75.nxml.txt.nlp	24761411	SENT34	18	18	5	5	oxaliplatin	survivin	PA131285527	332	0.981
NULL	Cancer_Med_2012_Oct_16_1(2)_207-217.nxml.txt.nlp	23342270	SENT219	20	20	12	12	saracatinib	PIK3CA		5290	0.981
NULL	Arthritis_Res_Ther_2014_Apr_28_16(2)_R104.nxml.txt.nlp	24774748	SENT103	23	23	6	6	azathioprine	CD4	PA448515	920	0.981
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jul_11_65(Pt_8)_o1830.nxml.txt.nlp	21583532	SENT58	42	42	18	18	ethanol	mol	PA448073	90527	0.981
NULL	Cell_Death_Dis_2014_Jul_10_5(7)_e1321.nxml.txt.nlp	25010987	SENT331	41	41	10	10	staurosporine	HuR	PA165109623	1994	0.981
NULL	Cases_J_2009_Jul_30_2_7134.nxml.txt.nlp	19829918	SENT62	3	3	28	28	ropinirole	LCE	PA164749035	79071	0.981
NULL	Oncol_Lett_2013_Mar_28_5(3)_983-991.nxml.txt.nlp	23426861	SENT27	31	31	6	6	fluorouracil	BRCA1	PA128406956	672	0.981
NULL	Cancers_(Basel)_2010_Apr_20_2(2)_611-623.nxml.txt.nlp	24281084	SENT31	12	12	9	9	aprepitant	NK-1	PA164747039	27087	0.981
NULL	Cancer_Cell_Int_2010_Jul_8_10_23.nxml.txt.nlp	20615241	SENT73	38	38	6	6	perifosine	D54	PA165291471	7165	0.981
NULL	Cancer_Manag_Res_2014_May_23_6_225-252.nxml.txt.nlp	24904222	SENT117	13	13	9	9	letrozole	aromatase	PA450196	1588	0.981
NULL	Oncol_Lett_2013_Apr_4_5(4)_1165-1170.nxml.txt.nlp	23599757	SENT31	0	0	26	26	pemetrexed	FPGS	PA10810	2356	0.981
NULL	Indian_J_Palliat_Care_2011_Jan-Apr_17(1)_78b-79.nxml.txt.nlp	21633628	SENT12	24	24	8	8	fosaprepitant	NK1	PA165958390	11126	0.981
NULL	Diabetes_Metab_Syndr_Obes_2010_Aug_24_3_297-299.nxml.txt.nlp	21437098	SENT35	10	10	19	19	vildagliptin	GLP-1	PA165958346	100125288	0.981
NULL	J_Oncol_2009_May_6_2009_567486.nxml.txt.nlp	19424511	SENT149	1	1	18	18	sorafenib	VEGFR	PA7000	3791	0.981
NULL	Arthritis_Res_Ther_2009_Aug_17_11(4)_R123.nxml.txt.nlp	19686595	SENT173	33	33	7	7	rituximab	CD38	PA451261	952	0.981
NULL	Crit_Care_2011_Oct_25_15(5)_R255.nxml.txt.nlp	22026977	SENT146	4	4	24	24	vasopressin	AVP	PA451858	114548;551	0.981
NULL	Breast_Cancer_Res_2011_Apr_21_13(2)_R46.nxml.txt.nlp	21510863	SENT111	23	23	14	14	trastuzumab	HER2	PA451743	2064	0.981
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_55-66.nxml.txt.nlp	17912636	SENT8	11	11	9	9	letrozole	aromatase	PA450196	1588	0.981
NULL	Indian_J_Endocrinol_Metab_2011_Oct-Dec_15(4)_251-260.nxml.txt.nlp	22028995	SENT72	6	6	19	19	saquinavir	CYP3A	PA451305	1574	0.981
NULL	Diabetes_Care_2010_Jul_33(7)_1691-1692.nxml.txt.nlp	20587731	SENT30	16	16	5	5	exenatide	GLP-1	PA164749238	100125288	0.981
NULL	J_Korean_Med_Sci_2011_Dec_29_26(12)_1563-1568.nxml.txt.nlp	22147992	SENT111	7	7	20	20	ekb-569	EGFR		1956	0.981
NULL	Breast_Cancer_Res_2005_Nov_11_7(6)_255-257.nxml.txt.nlp	16457700	SENT3	20	20	7	7	tamoxifen	aromatase	PA451581	1588	0.981
NULL	Br_J_Pharmacol_2012_Jan_165(2)_390-400.nxml.txt.nlp	21671897	SENT31	0	0	15	15	suramin	P2X7	PA10292	5027	0.981
NULL	Arthritis_Res_Ther_2005_Feb_18_7(3)_R476-R484.nxml.txt.nlp	15899034	SENT216	19	19	41	41	thrombin	Rho	PA451674	29984	0.981
NULL	Oncotarget_2012_Oct_20_3(10)_1068-1111.nxml.txt.nlp	23085539	SENT117	15	15	2	2	sorafenib	BRAF	PA7000	673	0.981
NULL	Evid_Based_Complement_Alternat_Med_2011_Jan_20_2011_751671.nxml.txt.nlp	21318106	SENT142	8	8	14	14	verapamil	P-gp	PA451868	5243	0.981
NULL	Cancer_Biol_Med_2012_Mar_9(1)_1-8.nxml.txt.nlp	23691447	SENT95	0	0	40	40	camptothecin	p53	PA153590860	7157	0.981
NULL	Environ_Health_Perspect_2005_Oct_14_113(10)_1330-1335.nxml.txt.nlp	16203242	SENT157	15	15	29	29	arsenite	MLC	PA452638	23209	0.981
NULL	Arthritis_Res_Ther_2012_Dec_3_14(6)_R262.nxml.txt.nlp	23206933	SENT212	2	2	30	30	tocilizumab	IL-6	PA165292659	3569	0.981
NULL	Biomed_Res_Int_2014_Jan_29_2014_232870.nxml.txt.nlp	24592384	SENT131	32	32	14	14	tamoxifen	HEXIM1	PA451581	10614	0.981
NULL	J_Immunother_Cancer_2013_Nov_7_1(Suppl_1)_P252.nxml.txt.nlp	NULL	SENT17	5	5	11	11	doxorubicin	CD4	PA449412	920	0.981
NULL	Front_Oncol_2014_Nov_25_4_329.nxml.txt.nlp	25505733	SENT214	20	20	27	27	gefitinib	ERBB3	PA131301952	2065	0.981
NULL	Sci_Rep_2014_Nov_28_4_7237.nxml.txt.nlp	25429875	SENT123	22	22	41	41	hesperidin	JNK	PA449867	5599	0.981
NULL	Cell_Death_Dis_2012_Jun_21_3(6)_e327.nxml.txt.nlp	22717582	SENT194	46	46	34	34	doxorubicin	NOXA	PA449412	5366	0.981
NULL	Cell_Death_Dis_2014_Apr_17_5(4)_e1185.nxml.txt.nlp	24743740	SENT86	16	16	4	4	temsirolimus	Met	PA164746890	79811	0.981
NULL	J_Org_Chem_2008_Jun_6_73(11)_3975-3984.nxml.txt.nlp	18459734	SENT119	8	8	17	17	docetaxel	C10	PA449383	113246	0.981
NULL	Evid_Based_Complement_Alternat_Med_2013_Mar_14_2013_429706.nxml.txt.nlp	23573127	SENT66	0	0	39	39	indomethacin	DAI	PA449982	81030	0.981
NULL	Front_Neural_Circuits_2014_Jun_17_8_65.nxml.txt.nlp	24987336	SENT179	26	26	13	13	furosemide	KCC2	PA449719	57468	0.981
NULL	Clin_Dev_Immunol_2011_Dec_26_2011_890758.nxml.txt.nlp	22235224	SENT145	0	0	11	11	pertuzumab	HER2		2064	0.981
NULL	J_Thromb_Thrombolysis_2012_Feb_20_33(2)_143-153.nxml.txt.nlp	22183178	SENT145	0	0	21	21	clopidogrel	ADP	PA449053	23038	0.981
NULL	CNS_Drugs_2012_Dec_13_26(12)_1033-1049.nxml.txt.nlp	23192413	SENT46	0	0	34	34	trazodone	5-HT2C	PA451744	3358	0.981
NULL	Breast_Cancer_Res_2007_Oct_26_9(5)_112.nxml.txt.nlp	17980056	SENT70	28	28	7	7	trastuzumab	HER2	PA451743	2064	0.981
NULL	Br_J_Cancer_2012_Sep_4_107(6)_956-960.nxml.txt.nlp	22892393	SENT113	33	33	8	8	lapatinib	HER2	PA152241907	2064	0.981
NULL	J_Korean_Assoc_Oral_Maxillofac_Surg_2014_Feb_25_40(1)_3-10.nxml.txt.nlp	24627836	SENT10	29	29	34	34	thrombin	hole	PA451674	80757	0.981
NULL	J_Biol_Chem_2013_Mar_22_288(12)_8279-8288.nxml.txt.nlp	23400816	SENT76	14	14	39	39	chloroquine	PCSK9	PA448948	255738	0.981
NULL	J_Korean_Med_Sci_2008_Aug_25_23(4)_685-690.nxml.txt.nlp	18756058	SENT104	21	21	10	10	olanzapine	ghrelin	PA450688	51738	0.981
NULL	Oncoimmunology_2013_Aug_1_2(8)_e25238.nxml.txt.nlp	24083080	SENT67	30	30	10	10	cetuximab	TLR8	PA10040	51311	0.981
NULL	Case_Rep_Dermatol_2014_Sep_6_6(3)_213-217.nxml.txt.nlp	25408648	SENT29	17	17	6	6	vemurafenib	BRAF	PA165946873	673	0.981
NULL	Int_J_Alzheimers_Dis_2010_Dec_27_2011_231595.nxml.txt.nlp	21234401	SENT122	17	17	4	4	iron	HFE	PA450087	3077	0.981
NULL	J_Biomed_Biotechnol_2011_Dec_6_2011_856985.nxml.txt.nlp	21188173	SENT240	15	15	0	0	estradiol	HDAC4	PA449503	9759	0.981
NULL	Clin_Interv_Aging_2013_Aug_19_8_1089-1095.nxml.txt.nlp	23983461	SENT28	0	0	11	11	minocycline	STZ	PA450519	6484	0.981
NULL	Acta_Pharmacol_Sin_2013_Aug_5_34(8)_1101-1107.nxml.txt.nlp	23708556	SENT31	0	0	12	12	artemisinin	HIF1	PA165111696	3091	0.981
NULL	Oncol_Lett_2013_May_20_5(5)_1659-1663.nxml.txt.nlp	23761830	SENT30	13	13	5	5	bicalutamide	TLR9	PA164746255	54106	0.981
NULL	Breast_Cancer_Res_2012_Apr_18_14(2)_R63.nxml.txt.nlp	22513257	SENT37	22	22	2	2	mitomycin	BRCA2	PA450524	675	0.981
NULL	Oncotarget_2011_Jun_15_2(6)_518-524.nxml.txt.nlp	21680956	SENT136	20	20	6	6	pimozide	BRAF	PA450965	673	0.981
NULL	BMB_Rep_2013_Aug_46(8)_410-415.nxml.txt.nlp	23977989	SENT101	8	8	36	36	curcumin	HO-1	PA151958596	3162	0.981
NULL	EMBO_Mol_Med_2013_Jun_30_5(6)_935-948.nxml.txt.nlp	23629957	SENT4	7	7	0	0	cisplatin	COL6A3	PA449014	1293	0.981
NULL	Am_J_Cardiovasc_Drugs_2013_Jun_20_13(5)_331-342.nxml.txt.nlp	23784266	SENT194	4	4	19	19	atorvastatin	P-gp	PA448500	5243	0.981
NULL	Adv_Hematol_2012_May_8_2012_393864.nxml.txt.nlp	22851972	SENT34	34	34	16	16	lenalidomide	CD40	PA162363968	958	0.981
NULL	Acta_Pharmacol_Sin_2012_May_16_33(5)_682-690.nxml.txt.nlp	22504904	SENT227	12	12	29	29	celecoxib	STAT3	PA448871	6774	0.981
NULL	Ann_Dermatol_2014_Jun_12_26(3)_363-373.nxml.txt.nlp	24966637	SENT65	27	27	5	5	imiquimod	MT1-MMP	PA449972	4323	0.981
NULL	J_Cell_Biol_2001_Apr_2_153(1)_207-220.nxml.txt.nlp	11285286	SENT481	11	11	32	32	carbachol	CD69	PA448784	969	0.981
NULL	Mol_Cancer_2008_Jun_5_7_50.nxml.txt.nlp	18534018	SENT147	36	36	15	15	bortezomib	p38	PA10252	10598;1432;7965	0.981
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT667	10	10	23	23	acetaminophen	CYP2E1	PA448015	1571	0.981
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1150.nxml.txt.nlp	24675468	SENT97	0	0	24	24	metformin	AMPK	PA450395	5563	0.981
NULL	J_Invest_Dermatol_2013_Jun_14_133(6)_1541-1549.nxml.txt.nlp	23407395	SENT73	15	15	9	9	imiquimod	IL-8	PA449972	3576	0.981
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT259	8	8	21	21	metformin	PI3K	PA450395	5290	0.981
NULL	Mol_Cancer_2009_Apr_22_8_26.nxml.txt.nlp	19386116	SENT188	7	7	40	40	ritonavir	AKT	PA451260	207	0.981
NULL	Indian_J_Anaesth_2014_Jan-Feb_58(1)_66-68.nxml.txt.nlp	24700904	SENT84	27	27	5	5	fentanyl	flower	PA449599	11094	0.981
NULL	Br_J_Cancer_2010_May_11_102(10)_1456-1460.nxml.txt.nlp	20461090	SENT99	9	9	23	23	temsirolimus	IFN	PA164746890	3439	0.981
NULL	Mol_Cancer_2014_Jan_15_13_8.nxml.txt.nlp	24423412	SENT146	6	6	17	17	cisplatin	CD44	PA449014	960	0.981
NULL	EMBO_Mol_Med_2013_Aug_5_5(8)_1213-1226.nxml.txt.nlp	23918228	SENT315	17	17	6	6	neomycin	EGFR	PA450608	1956	0.981
NULL	J_Cardiovasc_Magn_Reson_2012_Feb_1_14(Suppl_1)_M14.nxml.txt.nlp	NULL	SENT9	19	19	10	10	iohexol	MRI	PA450061	78996	0.981
NULL	J_Oncol_2009_Nov_12_2009_457418.nxml.txt.nlp	19920864	SENT20	6	6	44	44	paclitaxel	ERCC1	PA450761	2067	0.981
NULL	Breast_Cancer_Res_2007_Aug_10_9(4)_R51.nxml.txt.nlp	17692113	SENT174	28	28	12	12	tamoxifen	aromatase	PA451581	1588	0.981
NULL	Cancer_Res_Treat_2012_Sep_30_44(3)_195-201.nxml.txt.nlp	23091446	SENT100	23	23	8	8	irinotecan	MKP-1	PA450085	1843	0.981
NULL	Oncoimmunology_2012_Aug_1_1(5)_618-629.nxml.txt.nlp	22934254	SENT199	18	18	37	37	dasatinib	p38	PA162372878	10598;1432;7965	0.981
NULL	Front_Immunol_2014_Apr_1_5_131.nxml.txt.nlp	24744755	SENT278	16	16	30	30	imiquimod	IFN	PA449972	3439	0.981
NULL	Mol_Cancer_2010_Aug_16_9_217.nxml.txt.nlp	20712901	SENT100	36	36	23	23	curcumin	AKT	PA151958596	207	0.981
NULL	Br_J_Cancer_2000_Jun_82(11)_1851-1859.nxml.txt.nlp	10839301	SENT7	40	40	4	4	bleomycin	CD95	PA448645	355	0.981
NULL	Front_Pharmacol_2014_Nov_26_5_258.nxml.txt.nlp	25505415	SENT30	11	11	41	41	rosuvastatin	OATP1B1	PA134308647	10599	0.981
NULL	Oncotarget_2012_May_4_3(4)_395-398.nxml.txt.nlp	22565037	SENT41	27	27	10	10	metformin	CD24	PA450395	100133941	0.981
NULL	Diabetes_Care_2012_Dec_14_35(12)_e84.nxml.txt.nlp	23173145	SENT20	4	4	29	29	metformin	B12	PA450395	7126;4709	0.981
NULL	Diabetes_2009_Dec_15_58(12)_2766-2775.nxml.txt.nlp	19755527	SENT233	10	10	28	28	glucose	PEPCK	PA449773	5106	0.981
NULL	Nat_Neurosci_2012_Sep_5_15(9)_1245-1254.nxml.txt.nlp	22864611	SENT52	26	26	10	10	haloperidol	mGlu2	PA449841	2912	0.981
NULL	Diabetes_Care_2009_Jan_32(1)_84-90.nxml.txt.nlp	18931095	SENT33	5	5	21	21	liraglutide	GLP-1	PA165958364	100125288	0.981
NULL	Cell_Death_Differ_2009_Aug_20_16(8)_1135-1145.nxml.txt.nlp	19300452	SENT329	14	14	2	2	doxycycline	PUMA	PA449415	27113	0.981
NULL	Cancer_Med_2012_Oct_1_1(2)_114-127.nxml.txt.nlp	23342262	SENT183	5	5	19	19	cetuximab	EGF	PA10040	1950	0.981
NULL	Br_J_Cancer_1996_Apr_73(7)_856-860.nxml.txt.nlp	8611395	SENT4	0	0	19	19	dipyridamole	P-gp	PA449367	5243	0.981
NULL	Oncogene_2013_Sep_5_32(36)_4252-4263.nxml.txt.nlp	23045288	SENT83	8	8	31	31	idarubicin	CD49f	PA449961	3655	0.981
NULL	Cell_Death_Dis_2014_Jul_31_5(7)_e1359.nxml.txt.nlp	25077545	SENT22	0	0	20	20	erlotinib	EGFR	PA134687924	1956	0.981
NULL	Aging_(Albany_NY)_2010_Oct_31_2(10)_669-677.nxml.txt.nlp	21076179	SENT27	14	14	5	5	vorinostat	PERK	PA164748224	9451	0.981
NULL	Cancer_Med_2013_Aug_2_2(4)_571-582.nxml.txt.nlp	24156030	SENT12	1	1	32	32	curcumin	CD4	PA151958596	920	0.981
NULL	Arthritis_Res_Ther_2014_Sep_27_16(5)_439.nxml.txt.nlp	25261100	SENT132	12	12	6	6	colchicine	MEFV	PA449092	4210	0.981
NULL	Oncotarget_2011_Sep_9_2(9)_658-668.nxml.txt.nlp	21911919	SENT7	17	17	5	5	cytarabine	HO-1	PA449177	3162	0.981
NULL	Diabetes_2009_Mar_58(3)_579-589.nxml.txt.nlp	19074989	SENT98	18	18	6	6	troglitazone	ANGPTL4	PA451799	51129	0.981
NULL	Emerg_Infect_Dis_2011_Mar_17(3)_556-558.nxml.txt.nlp	21392461	SENT45	26	26	4	4	amikacin	RGM	PA164744372	56963	0.981
NULL	Breast_Cancer_Res_Treat_2007_Oct_27_105(Suppl_1)_19-29.nxml.txt.nlp	17333340	SENT9	0	0	5	5	letrozole	aromatase	PA450196	1588	0.981
NULL	Curr_Colorectal_Cancer_Rep_2012_Mar_14_8(1)_66-81.nxml.txt.nlp	22389639	SENT177	9	9	15	15	curcumin	p300	PA151958596	2033	0.981
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT174	5	5	16	16	resveratrol	TRAIL		8743	0.981
NULL	Ann_Oncol_2013_Aug_12_24(8)_1994-1999.nxml.txt.nlp	23670096	SENT10	21	21	0	0	tamoxifen	AIB1	PA451581	8202	0.981
NULL	Arthritis_Res_Ther_2010_Jan_22_12(1)_R11.nxml.txt.nlp	20096109	SENT177	22	22	13	13	etanercept	IFN	PA449515	3439	0.981
NULL	Br_J_Cancer_2014_Jan_21_110(2)_304-312.nxml.txt.nlp	24300978	SENT11	3	3	18	18	gemcitabine	NT5C2	PA449748	22978	0.981
NULL	Acta_Pharmacol_Sin_2009_Sep_24_30(9)_1262-1275.nxml.txt.nlp	19701231	SENT226	39	39	6	6	lovastatin	TM4SF1	PA450272	4071	0.981
NULL	Clin_Pharmacokinet_2014_Aug_21_53(10)_931-941.nxml.txt.nlp	25141974	SENT35	23	23	1	1	midazolam	CYP3A	PA450496	1574	0.981
NULL	Can_J_Infect_Dis_Med_Microbiol_2014_Nov-Dec_25(6)_327-343.nxml.txt.nlp	25587296	SENT184	17	17	10	10	voriconazole	CYP3A4	PA10233	1576	0.981
NULL	Breast_Cancer_Res_Treat_2013_Jul_5_140(1)_63-71.nxml.txt.nlp	23828499	SENT52	16	16	1	1	paclitaxel	HER2	PA450761	2064	0.981
NULL	Clin_Ophthalmol_2008_Dec_2(4)_727-733.nxml.txt.nlp	19668423	SENT21	2	2	13	13	bevacizumab	VEGF-A	PA130232992	7422	0.981
NULL	Br_J_Pharmacol_2013_Jun_27_169(4)_736-747.nxml.txt.nlp	23489111	SENT140	11	11	26	26	topotecan	5-HT3B	PA451729	9177	0.981
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT146	7	7	0	0	curcumin	PC-3	PA151958596	692094	0.981
NULL	Cancer_Cell_Int_2013_Feb_13_13_15.nxml.txt.nlp	23402326	SENT10	3	3	1	1	gefitinib	EGFR	PA131301952	1956	0.981
NULL	Endocrinol_Diabetes_Metab_Case_Rep_2014_Mar_1_2014_140001.nxml.txt.nlp	24683487	SENT118	9	9	18	18	cabergoline	ACTH	PA448708	5443	0.981
NULL	Br_J_Cancer_2010_Oct_12_103(8)_1192-1200.nxml.txt.nlp	20877358	SENT190	25	25	15	15	cisplatin	BRCA2	PA449014	675	0.981
NULL	Breast_Cancer_2013_Mar_1_20(4)_302-309.nxml.txt.nlp	23456736	SENT40	13	13	8	8	tegafur	DPD	PA452620	1806	0.981
NULL	South_Asian_J_Cancer_2014_Jul-Sep_3(3)_182-184.nxml.txt.nlp	25136528	SENT82	22	22	0	0	saquinavir	CYP3A4	PA451305	1576	0.981
NULL	J_Invest_Dermatol_2012_May_16_132(5)_1435-1442.nxml.txt.nlp	22336948	SENT58	5	5	21	21	aprotinin	TLSP	PA448472	11012	0.981
NULL	J_Gen_Physiol_2008_Nov_132(5)_521-535.nxml.txt.nlp	18852303	SENT126	10	10	6	6	aprotinin	CAP2	PA448472	5271;10486	0.981
NULL	Mol_Cell_Proteomics_2014_Dec_9_13(12)_3435-3445.nxml.txt.nlp	25205226	SENT202	37	37	29	29	thrombin	PAR4	PA451674	9002;5074	0.981
NULL	Breast_Cancer_Res_Treat_2013_Aug_20_141(1)_43-53.nxml.txt.nlp	23959396	SENT29	25	25	35	35	trastuzumab	HER3	PA451743	2065	0.981
NULL	J_Cancer_2013_Jan_11_4(2)_117-132.nxml.txt.nlp	23386910	SENT96	6	6	18	18	pertuzumab	HER-2		2064	0.981
NULL	F1000Prime_Rep_2013_Dec_3_5_56.nxml.txt.nlp	24381731	SENT51	0	0	7	7	ticagrelor	P2Y12	PA165374673	64805	0.981
NULL	Clin_Pharmacol_2013_Apr_19_5_67-83.nxml.txt.nlp	23650452	SENT28	0	0	15	15	ticagrelor	CYP3A4	PA165374673	1576	0.981
NULL	Clin_Pharmacol_2013_Apr_19_5_67-83.nxml.txt.nlp	23650452	SENT204	0	0	4	4	ticagrelor	P2Y12	PA165374673	64805	0.981
NULL	Mol_Cancer_2010_Nov_25_9_305.nxml.txt.nlp	21108789	SENT93	21	21	7	7	cisplatin	MLH1	PA449014	4292	0.981
NULL	Colorectal_Dis_2012_Feb_14(2)_e31-e47.nxml.txt.nlp	21848897	SENT41	2	2	7	7	panitumumab	KRAS	PA162373091	3845	0.981
NULL	Orphanet_J_Rare_Dis_2009_Dec_15_4_28.nxml.txt.nlp	20003495	SENT30	0	0	13	13	nitisinone	FAH	PA164777037	2175;2184	0.981
NULL	Eur_J_Med_Res_2009_Dec_7_14(Suppl_4)_71-77.nxml.txt.nlp	20156730	SENT121	9	9	36	36	tobramycin	PARI	PA451704	55010	0.981
NULL	Braz_J_Microbiol_2010_Mar_1_Jan-Mar_41(1)_59-65.nxml.txt.nlp	24031464	SENT46	9	9	17	17	furazolidone	API	PA164746760	5345	0.981
NULL	Chin_J_Cancer_2012_Jul_31(7)_319-326.nxml.txt.nlp	22257382	SENT112	0	0	10	10	lapatinib	HER2	PA152241907	2064	0.981
NULL	Exp_Diabetes_Res_2012_Jun_9_2012_872504.nxml.txt.nlp	21822425	SENT187	10	10	25	25	rosiglitazone	p47	PA451283	3621;55968	0.981
NULL	Case_Rep_Oncol_Med_2012_Dec_26_2012_390702.nxml.txt.nlp	23326741	SENT60	2	2	10	10	axitinib	VEGFR	PA164924493	3791	0.981
NULL	Appl_Clin_Genet_2011_Jan_26_4_21-27.nxml.txt.nlp	23776364	SENT103	5	5	21	21	canakinumab	NLRP3	PA165958358	114548	0.981
NULL	Indian_J_Endocrinol_Metab_2013_Jul-Aug_17(4)_636-646.nxml.txt.nlp	23961479	SENT146	25	25	4	4	sulfaphenazole	CYP2C9	PA130231310	1559	0.981
NULL	Comb_Chem_High_Throughput_Screen_2010_Feb_13(2)_188-206.nxml.txt.nlp	20053163	SENT247	29	29	9	9	warfarin	CYP2C9	PA451906	1559	0.981
NULL	Cancer_Cell_2007_Dec_11_12(6)_514-527.nxml.txt.nlp	18068629	SENT140	12	12	0	0	paclitaxel	THBS1	PA450761	7057	0.981
NULL	Oncoimmunology_2013_Dec_1_2(12)_e27058.nxml.txt.nlp	24498564	SENT62	10	10	23	23	cyclophosphamide	THBS1	PA449165	7057	0.981
NULL	Mol_Cancer_2012_Oct_22_11_80.nxml.txt.nlp	23088607	SENT122	8	8	30	30	estradiol	YC1	PA449503	5937	0.981
NULL	Indian_J_Med_Res_2011_Sep_134(3)_314-319.nxml.txt.nlp	21985814	SENT67	12	12	1	1	cabergoline	ANOVA	PA448708	4858	0.981
NULL	Br_J_Cancer_2009_Mar_24_100(6)_870-873.nxml.txt.nlp	19293806	SENT37	2	2	27	27	gemcitabine	CDA	PA449748	978	0.981
NULL	EMBO_Mol_Med_2012_Mar_4(3)_218-233.nxml.txt.nlp	22294553	SENT276	36	36	14	14	tamoxifen	EGFR	PA451581	1956	0.981
NULL	Clin_Sci_(Lond)_2012_Oct_1_123(Pt_8)_473-486.nxml.txt.nlp	22757958	SENT218	15	15	39	39	glucosamine	HBP	PA164747613	3069;50865;7884;566	0.981
NULL	J_Hematol_Oncol_2008_Oct_23_1_19.nxml.txt.nlp	18947412	SENT184	36	36	24	24	alemtuzumab	CD34	PA164783958	947	0.981
NULL	Arthritis_Res_Ther_2012_Jul_27_14(4)_R175.nxml.txt.nlp	22838733	SENT189	41	41	15	15	adalimumab	CD14	PA10004	929	0.981
NULL	Diabetes_Care_2010_Apr_12_33(4)_730-732.nxml.txt.nlp	20067974	SENT44	14	14	2	2	vildagliptin	GLP-1	PA165958346	100125288	0.981
NULL	Clin_Med_Insights_Ear_Nose_Throat_2012_Apr_3_5_1-16.nxml.txt.nlp	24179404	SENT58	0	0	13	13	panitumumab	EGF	PA162373091	1950	0.981
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT198	12	12	5	5	cisplatin	IBP	PA449014	706;50619	0.981
NULL	J_Biol_Chem_2013_Jul_19_288(29)_21448-21457.nxml.txt.nlp	23760505	SENT237	30	30	9	9	haloperidol	BiP	PA449841	3309	0.981
NULL	Cardiovasc_Res_2012_Mar_15_93(4)_674-681.nxml.txt.nlp	22166712	SENT143	14	14	34	34	clopidogrel	ADP	PA449053	23038	0.981
NULL	Diabetes_2011_Mar_21_60(3)_797-809.nxml.txt.nlp	21266330	SENT214	20	20	6	6	rosiglitazone	ADRP	PA451283	123	0.981
NULL	Chin_J_Cancer_2012_Sep_31(9)_413-420.nxml.txt.nlp	22776233	SENT73	15	15	24	24	sunitinib	HIF1A	PA162372840	3091	0.981
NULL	J_Neuroinflammation_2010_Sep_7_7_51.nxml.txt.nlp	20822529	SENT200	24	24	37	37	hemin	p38	PA449849	10598;1432;7965	0.981
NULL	Pain_2011_Aug_152(8)_1899-1908.nxml.txt.nlp	21600693	SENT143	7	7	17	17	capsaicin	ADP	PA448776	23038	0.981
NULL	Diabetol_Metab_Syndr_2014_Mar_31_6_47.nxml.txt.nlp	24684779	SENT154	15	15	7	7	simvastatin	MCP-1	PA451363	6347	0.981
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT218	29	29	17	17	efavirenz	UGT	PA449441	7361;7355	0.981
NULL	Ital_J_Pediatr_2012_Mar_30_38_11.nxml.txt.nlp	22464080	SENT35	10	10	36	36	oxatomide	CYP3A4	PA163522137	1576	0.981
NULL	Nat_Commun_2014_Nov_25_5_5548.nxml.txt.nlp	25420520	SENT38	42	42	3	3	cabazitaxel	ERG	PA165958401	2078	0.981
NULL	Br_J_Cancer_2009_Mar_10_100(5)_758-763.nxml.txt.nlp	19259094	SENT110	16	16	0	0	decitabine	MLH1	PA164749631	4292	0.981
NULL	J_Clin_Biochem_Nutr_2011_Mar_26_48(2)_170-177.nxml.txt.nlp	21373272	SENT156	35	35	26	26	pioglitazone	HSPA5	PA450970	3309	0.981
NULL	Brain_Behav_2011_Sep_1(1)_44-54.nxml.txt.nlp	22398980	SENT238	6	6	22	22	cocaine	LSD	PA449072	1776	0.981
NULL	Breast_Cancer_Res_2011_Apr_15_13(2)_R44.nxml.txt.nlp	21496232	SENT334	1	1	30	30	lapatinib	HER2	PA152241907	2064	0.981
NULL	Oxid_Med_Cell_Longev_2012_May_28_2012_386527.nxml.txt.nlp	22690271	SENT164	2	2	7	7	resveratrol	AMPK		5563	0.981
NULL	Indian_J_Med_Res_2012_Jul_136(1)_3-6.nxml.txt.nlp	22885256	SENT69	10	10	31	31	telaprevir	IFN	PA165958354	3439	0.981
NULL	Eur_J_Med_Res_2013_Dec_6_18(1)_53.nxml.txt.nlp	24313983	SENT150	9	9	32	32	cilostazol	COX	PA164746334	1351	0.981
NULL	Biologics_2009_Jul_13_3_215-224.nxml.txt.nlp	19707410	SENT4	0	0	14	14	cetuximab	EGFR	PA10040	1956	0.981
NULL	Blood_Cancer_J_2012_Oct_12_2(10)_e93.nxml.txt.nlp	23064741	SENT134	19	19	30	30	alemtuzumab	CHOP	PA164783958	1649	0.981
NULL	J_Thromb_Thrombolysis_2011_Nov_26_32(4)_459-466.nxml.txt.nlp	21706290	SENT78	29	29	4	4	clopidogrel	CYP2C19	PA449053	1557	0.981
NULL	Clin_Mol_Hepatol_2014_Sep_25_20(3)_283-290.nxml.txt.nlp	25320732	SENT124	5	5	42	42	propranolol	EVL	PA451145	51466	0.981
NULL	Mol_Cancer_2010_Apr_15_9_77.nxml.txt.nlp	20398291	SENT263	17	17	0	0	geldanamycin	Hsp90	PA152031327	3320	0.981
NULL	Cardiovasc_Diabetol_2013_May_30_12(Suppl_1)_S2.nxml.txt.nlp	23819752	SENT129	5	5	10	10	atorvastatin	CYP3A4	PA448500	1576	0.981
NULL	Crit_Care_2002_Sep_12_6(6)_491-499.nxml.txt.nlp	12493070	SENT181	1	1	15	15	nadh	PARP-1	PA164755085	25976	0.981
NULL	Exp_Neurobiol_2013_Mar_31_22(1)_45-50.nxml.txt.nlp	23585722	SENT108	17	17	11	11	fluoxetine	EPO	PA449673	7076;8288;2056	0.981
NULL	Breast_Cancer_Res_2014_May_5_16(3)_R45.nxml.txt.nlp	24887236	SENT289	17	17	32	32	cetuximab	HER2	PA10040	2064	0.981
NULL	Front_Genet_2014_Feb_3_5_12.nxml.txt.nlp	24550933	SENT392	2	2	4	4	celecoxib	COX2	PA448871	4513;5743	0.981
NULL	Ther_Clin_Risk_Manag_2006_Mar_2(1)_87-98.nxml.txt.nlp	18360584	SENT85	0	0	12	12	sorafenib	BRAF	PA7000	673	0.981
NULL	Asian-Australas_J_Anim_Sci_2012_Feb_1_25(2)_207-212.nxml.txt.nlp	25049553	SENT115	26	26	4	4	oxygen	CO2	PA450744	4513	0.981
NULL	Arch_Drug_Inf_2011_Mar_4(1)_1-9.nxml.txt.nlp	21572514	SENT32	9	9	22	22	ciprofloxacin	MDR1	PA449009	5243	0.981
NULL	Cardiovasc_Ther_2012_Aug_17_30(4)_e174-e182.nxml.txt.nlp	21883999	SENT82	17	17	6	6	clopidogrel	CYP2C19	PA449053	1557	0.981
NULL	Iran_Red_Crescent_Med_J_2012_Jan_1_14(1)_53-55.nxml.txt.nlp	22737557	SENT32	14	14	37	37	isoniazid	PTB	PA450112	58155	0.981
NULL	Breast_Cancer_Res_2006_Jul_17_8(4)_R36.nxml.txt.nlp	16846533	SENT66	18	18	9	9	trastuzumab	HER-2	PA451743	2064	0.981
NULL	Anat_Cell_Biol_2012_Jun_30_45(2)_73-78.nxml.txt.nlp	22822460	SENT101	6	6	24	24	resveratrol	HIF-1		29072	0.981
NULL	Patient_Prefer_Adherence_2013_Mar_27_7_245-258.nxml.txt.nlp	23569364	SENT6	6	6	17	17	fulvestrant	aromatase	PA164747170	1588	0.981
NULL	Clinics_(Sao_Paulo)_2014_Jun_69(6)_438-446.nxml.txt.nlp	24964310	SENT139	0	0	4	4	denosumab	RANKL	PA166048634	8600	0.981
NULL	Eur_J_Med_Res_2009_Nov_24_14(Suppl_3)_5-16.nxml.txt.nlp	19959411	SENT138	1	1	6	6	raltegravir	UGT1A1		54658	0.981
NULL	Chin_J_Cancer_2011_May_30(5)_293-302.nxml.txt.nlp	21527062	SENT127	0	0	26	26	denosumab	RANKL	PA166048634	8600	0.981
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Jul_23_3(7)_e126.nxml.txt.nlp	25054314	SENT88	10	10	18	18	docetaxel	MRP2	PA449383	100130958;57626;1244	0.981
NULL	Indian_J_Pharmacol_2012_Sep-Oct_44(5)_624-628.nxml.txt.nlp	23112426	SENT22	17	17	21	21	nimodipine	CYP3A4	PA450633	1576	0.981
NULL	J_Cell_Mol_Med_2013_Jan_4_17(1)_90-102.nxml.txt.nlp	23205502	SENT280	28	28	14	14	celecoxib	PTB	PA448871	58155	0.981
NULL	Clin_Drug_Investig_2015_Dec_4_35_45-51.nxml.txt.nlp	25471740	SENT146	8	8	26	26	atorvastatin	CYP2C19	PA448500	1557	0.981
NULL	BMB_Rep_2014_Sep_47(9)_483-487.nxml.txt.nlp	25027595	SENT35	27	27	5	5	gefitinib	EGFR	PA131301952	1956	0.981
NULL	Aliment_Pharmacol_Ther_2012_Apr_22_35(7)_745-767.nxml.txt.nlp	22356640	SENT163	0	0	3	3	tegaserod	5-HT4	PA130413154	3360	0.981
NULL	J_Clin_Biochem_Nutr_2011_Mar_26_48(2)_126-133.nxml.txt.nlp	21373265	SENT114	20	20	30	30	ketamine	HO-1	PA450144	3162	0.981
NULL	Cancers_(Basel)_2013_Jan_10_5(1)_15-26.nxml.txt.nlp	24216696	SENT131	16	16	11	11	vincristine	HIF-1	PA451879	29072	0.981
NULL	Open_Med_2007_Dec_18_1(3)_e184-e190.nxml.txt.nlp	21673951	SENT68	4	4	14	14	tamoxifen	BRCA1	PA451581	672	0.981
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT264	17	17	5	5	resveratrol	NAC		22861	0.981
NULL	Braz_J_Med_Biol_Res_2013_Aug_13_46(8)_650-658.nxml.txt.nlp	23969971	SENT31	40	40	19	19	cisplatin	STAT3	PA449014	6774	0.981
NULL	Oncotarget_2012_May_4_3(4)_395-398.nxml.txt.nlp	22565037	SENT9	24	24	9	9	trastuzumab	CD44	PA451743	960	0.981
NULL	Arthritis_Res_Ther_2014_Apr_15_16(2)_R95.nxml.txt.nlp	24735586	SENT226	21	21	0	0	rituximab	CD27	PA451261	939	0.981
NULL	Nat_Med_2010_Jun_23_16(6)_671-677.nxml.txt.nlp	20495567	SENT78	13	13	4	4	sorafenib	ATF5	PA7000	22809	0.981
NULL	Acta_Pharmacol_Sin_2011_Jul_13_32(7)_967-972.nxml.txt.nlp	21666702	SENT15	13	13	25	25	ticlopidine	CYP2C9	PA451686	1559	0.981
NULL	Oncotarget_2013_Dec_28_5(6)_1475-1490.nxml.txt.nlp	24721996	SENT136	2	2	12	12	celecoxib	PTEN	PA448871	5728	0.981
NULL	Nucl_Recept_Signal_2009_Jan_16_7_e001.nxml.txt.nlp	19240808	SENT117	10	10	27	27	troglitazone	SXR	PA451799	8856	0.981
NULL	J_Anaesthesiol_Clin_Pharmacol_2012_Jan-Mar_28(1)_106-110.nxml.txt.nlp	22345956	SENT11	20	20	4	4	argatroban	ACT	PA164745516	12;11332;9457;641455	0.981
NULL	Niger_Med_J_2014_Jul-Aug_55(4)_327-332.nxml.txt.nlp	25114369	SENT15	4	4	0	0	isoniazid	DST	PA450112	667	0.981
NULL	Cancer_Med_2014_Oct_5_3(5)_1458-1466.nxml.txt.nlp	25091592	SENT24	6	6	35	35	metformin	AMPK	PA450395	5563	0.981
NULL	Oncotarget_2013_Jun_4_4(5)_772-784.nxml.txt.nlp	23800712	SENT125	47	47	19	19	dasatinib	EGFR	PA162372878	1956	0.981
NULL	Oncotarget_2013_Nov_24_4(12)_2430-2438.nxml.txt.nlp	24280348	SENT114	1	1	34	34	gefitinib	STAT3	PA131301952	6774	0.981
NULL	Curr_Cardiol_Rev_2012_Aug_8(3)_181-191.nxml.txt.nlp	22920489	SENT113	38	38	2	2	clopidogrel	ADP	PA449053	23038	0.981
NULL	Clin_Mol_Allergy_2008_May_20_6_4.nxml.txt.nlp	18489791	SENT75	15	15	32	32	omalizumab	San	PA164752253	80218	0.981
NULL	Front_Behav_Neurosci_2015_Jan_15_8_453.nxml.txt.nlp	25642174	SENT137	12	12	33	33	clozapine	5-HT1A	PA449061	3350	0.981
NULL	Diabetes_2011_Nov_17_60(11)_2691-2700.nxml.txt.nlp	21896928	SENT159	0	0	6	6	resveratrol	AMPK		5563	0.981
NULL	Front_Oncol_2014_Mar_3_4_34.nxml.txt.nlp	24624361	SENT220	27	27	8	8	flavopiridol	CDK1	PA452627	983	0.981
NULL	Int_J_Mol_Imaging_2011_Oct_26_2011_874585.nxml.txt.nlp	21490735	SENT167	24	24	16	16	doxorubicin	FDG	PA449412	23583	0.981
NULL	Mol_Cell_2013_Jun_27_50(6)_805-817.nxml.txt.nlp	23747015	SENT573	20	20	6	6	doxycycline	p53	PA449415	7157	0.981
NULL	J_Hematol_Oncol_2013_Jan_17_6_8.nxml.txt.nlp	23327547	SENT96	5	5	26	26	sulindac	p27	PA451565	5715;10534	0.981
NULL	Br_J_Cancer_2012_Jan_31_106(3)_440-446.nxml.txt.nlp	22233926	SENT132	13	13	22	22	lapatinib	EGFR	PA152241907	1956	0.981
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT112	0	0	4	4	tenofovir	SLC22A6	PA10204	9356	0.981
NULL	Mol_Cancer_2012_Dec_12_11_91.nxml.txt.nlp	23234355	SENT184	9	9	7	7	gefitinib	EGFR	PA131301952	1956	0.981
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_P120.nxml.txt.nlp	NULL	SENT17	16	16	5	5	allopurinol	HLA-B	PA448320	3106	0.981
NULL	Oncol_Lett_2014_May_11_7(5)_1401-1408.nxml.txt.nlp	24765145	SENT174	27	27	7	7	paclitaxel	HIF-1	PA450761	29072	0.981
NULL	Int_J_Endocrinol_Metab_2013_Jul_1_Summer_11(3)_184-190.nxml.txt.nlp	24348591	SENT130	30	30	7	7	liraglutide	MDC	PA165958364	6367	0.981
NULL	Int_J_Mol_Sci_2014_Sep_5_15(9)_15754-15765.nxml.txt.nlp	25198898	SENT57	9	9	21	21	curcumin	NAC	PA151958596	22861	0.981
NULL	Indian_J_Ophthalmol_2011_Jan-Feb_59(1)_73-74.nxml.txt.nlp	21157086	SENT33	1	1	8	8	bevacizumab	ERG	PA130232992	2078	0.981
NULL	Ann_Oncol_2011_Aug_27_22(8)_1736-1747.nxml.txt.nlp	21709140	SENT168	11	11	25	25	tamoxifen	aromatase	PA451581	1588	0.981
NULL	Front_Genet_2013_Aug_30_4_166.nxml.txt.nlp	24009623	SENT234	26	26	8	8	everolimus	FBXW7	PA164746311	55294	0.981
NULL	Indian_J_Med_Paediatr_Oncol_2014_Apr-Jun_35(2)_140-142.nxml.txt.nlp	25197175	SENT18	33	33	18	18	oxaliplatin	KRAS	PA131285527	3845	0.981
NULL	Clin_Exp_Metastasis_2014_Sep_17_31(1)_135-147.nxml.txt.nlp	24043563	SENT187	19	19	8	8	cisplatin	KLK4	PA449014	9622	0.981
NULL	Br_J_Cancer_2009_Jul_21_101(2)_357-362.nxml.txt.nlp	19536092	SENT115	19	19	4	4	oxaliplatin	ERCC2	PA131285527	2068	0.981
NULL	J_Adv_Pract_Oncol_2013_Sep_1_Sep-Oct_4(5)_348-352.nxml.txt.nlp	25032013	SENT15	17	17	28	28	panitumumab	KRAS	PA162373091	3845	0.981
NULL	J_Biol_Chem_2013_Nov_22_288(47)_34217-34229.nxml.txt.nlp	24106270	SENT262	30	30	19	19	thrombin	RhoG	PA451674	391	0.981
NULL	Cancer_Metastasis_Rev_2010_Dec_10_29(4)_581-594.nxml.txt.nlp	20830503	SENT26	27	27	13	13	tamoxifen	aromatase	PA451581	1588	0.981
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT278	10	10	43	43	lapatinib	HRG	PA152241907	3084;3273	0.981
NULL	Cancers_(Basel)_2010_Dec_22_2(4)_2153-2170.nxml.txt.nlp	21390244	SENT265	14	14	27	27	gefitinib	EGFR	PA131301952	1956	0.981
NULL	Vet_Res_2012_Nov_16_43(1)_80.nxml.txt.nlp	23157617	SENT60	14	14	34	34	l-glutamine	CO2	PA10090	4513	0.981
NULL	Int_J_Vasc_Med_2013_Mar_31_2013_543141.nxml.txt.nlp	23606968	SENT240	16	16	10	10	methylprednisolone	IL-17	PA450466	3605	0.981
NULL	Cancer_Manag_Res_2013_Jun_7_5_91-101.nxml.txt.nlp	23785245	SENT53	35	35	25	25	paclitaxel	EGFR	PA450761	1956	0.981
NULL	Eur_J_Pharm_Sci_2012_Jul_16_46(4)_244-258.nxml.txt.nlp	22085636	SENT391	37	37	6	6	pertuzumab	PDK1		5170;5163	0.981
NULL	Ital_J_Pediatr_2012_Mar_30_38_11.nxml.txt.nlp	22464080	SENT35	24	24	36	36	oxatomide	CYP3A4	PA163522137	1576	0.981
NULL	Cancer_Biol_Med_2012_Mar_9(1)_18-22.nxml.txt.nlp	23691449	SENT144	18	18	5	5	gefitinib	EGFR	PA131301952	1956	0.981
NULL	Int_J_Environ_Res_Public_Health_2010_Apr_30_7(4)_1448-1466.nxml.txt.nlp	20617039	SENT156	10	10	32	32	ethanol	L1CAM	PA448073	3897	0.981
NULL	Biologics_2009_Oct_12_3_469-474.nxml.txt.nlp	19851472	SENT83	48	48	10	10	desloratadine	IL-4	PA164776964	3565	0.981
NULL	Nucleic_Acids_Res_2011_Oct_1_39(18)_7931-7945.nxml.txt.nlp	21727091	SENT258	27	27	2	2	ethanol	ASF1A	PA448073	25842	0.981
NULL	Case_Rep_Endocrinol_2012_Nov_8_2012_875764.nxml.txt.nlp	23198184	SENT40	3	3	18	18	mitotane	MDR1	PA164746157	5243	0.981
NULL	J_Oncol_2013_Feb_28_2013_897025.nxml.txt.nlp	23533410	SENT85	20	20	10	10	temsirolimus	AKT	PA164746890	207	0.981
NULL	Indian_J_Med_Res_2011_Sep_134(3)_295-301.nxml.txt.nlp	21985811	SENT30	17	17	3	3	phenobarbital	CYP2C19	PA450911	1557	0.981
NULL	Diabetes_2011_Nov_17_60(11)_2691-2700.nxml.txt.nlp	21896928	SENT158	5	5	22	22	resveratrol	AMPK		5563	0.981
NULL	J_Cell_Mol_Med_2013_May_20_17(5)_648-656.nxml.txt.nlp	23601074	SENT181	24	24	2	2	erlotinib	KRAS	PA134687924	3845	0.981
NULL	Br_J_Cancer_2013_Dec_10_109(12)_3067-3072.nxml.txt.nlp	24263065	SENT43	28	28	16	16	irinotecan	BRAF	PA450085	673	0.981
NULL	Br_J_Cancer_2011_Apr_12_104(8)_1278-1287.nxml.txt.nlp	21487429	SENT103	15	15	8	8	cisplatin	DR5	PA449014	8795	0.981
NULL	Oncol_Lett_2013_Jun_3_5(6)_1760-1764.nxml.txt.nlp	23833637	SENT116	6	6	29	29	gemcitabine	XIAP	PA449748	331	0.981
NULL	Cancers_(Basel)_2011_Aug_5_3(3)_3114-3142.nxml.txt.nlp	24212948	SENT96	11	11	21	21	cyclophosphamide	CD4	PA449165	920	0.981
NULL	Scientifica_(Cairo)_2012_Oct_18_2012_796808.nxml.txt.nlp	24278741	SENT52	35	35	17	17	etoposide	BRCA1	PA449552	672	0.981
NULL	Patient_Prefer_Adherence_2011_Dec_23_6_1-9.nxml.txt.nlp	22272064	SENT36	37	37	24	24	ramipril	ACE	PA451223	1636	0.981
NULL	Fibrogenesis_Tissue_Repair_2010_Aug_25_3_15.nxml.txt.nlp	20738867	SENT163	20	20	0	0	bleomycin	IL-13	PA448645	3596	0.981
NULL	Oncogene_2010_Sep_16_29(37)_5193-5203.nxml.txt.nlp	20581867	SENT11	15	15	1	1	lapatinib	PI3K	PA152241907	5290	0.981
NULL	Clin_Epigenetics_2010_May_29_1(1-2)_3-6.nxml.txt.nlp	22704084	SENT23	20	20	36	36	vorinostat	HDAC1	PA164748224	3065	0.981
NULL	Eur_J_Clin_Pharmacol_2014_May_21_70(8)_915-920.nxml.txt.nlp	24839948	SENT27	4	4	18	18	midazolam	CYP3A4	PA450496	1576	0.981
NULL	Cell_Commun_Signal_2013_Oct_1_11_73.nxml.txt.nlp	24083678	SENT204	5	5	27	27	sulindac	A20	PA451565	7128;28935	0.981
NULL	Antimicrob_Agents_Chemother_2013_Oct_57(10)_5096-5103.nxml.txt.nlp	23917320	SENT193	0	0	5	5	lumefantrine	CYP3A4	PA165111722	1576	0.981
NULL	Arthritis_Res_Ther_2010_Apr_1_12(2)_R59.nxml.txt.nlp	20359360	SENT204	6	6	24	24	methylprednisolone	OAZ	PA450466	23090	0.981
NULL	Int_J_Nanomedicine_2012_Sep_24_7_5109-5117.nxml.txt.nlp	23055723	SENT127	20	20	0	0	resveratrol	Q10		27161	0.981
NULL	Oncol_Lett_2013_Mar_8_5(3)_805-812.nxml.txt.nlp	23426281	SENT198	43	43	13	13	gemcitabine	B7-H3	PA449748	80381	0.981
NULL	Br_J_Cancer_2009_Mar_10_100(5)_758-763.nxml.txt.nlp	19259094	SENT111	28	28	7	7	decitabine	MLH1	PA164749631	4292	0.981
NULL	J_Cell_Biol_1997_May_19_137(4)_939-952.nxml.txt.nlp	9151695	SENT58	0	0	27	27	neomycin	CEA	PA450608	5670;1087	0.981
NULL	Arthritis_Res_Ther_2011_Sep_21_13(5)_239.nxml.txt.nlp	21955617	SENT204	1	1	13	13	celecoxib	EP4	PA448871	5734	0.981
NULL	Oncogene_2014_Aug_21_33(34)_4316-4329.nxml.txt.nlp	24362530	SENT61	16	16	5	5	paclitaxel	SUMO1	PA450761	7341	0.981
NULL	Breast_Cancer_(Auckl)_2012_Mar_7_6_67-77.nxml.txt.nlp	22438669	SENT168	37	37	14	14	letrozole	HER2	PA450196	2064	0.981
NULL	J_RNAi_Gene_Silencing_2009_Mar_9_5(1)_321-330.nxml.txt.nlp	19771229	SENT23	41	41	0	0	hydroxyurea	RRM1	PA449942	6240	0.981
NULL	Mol_Cancer_2010_Aug_20_9_220.nxml.txt.nlp	20727180	SENT146	27	27	3	3	nicotine	p53	PA450626	7157	0.981
NULL	J_Mol_Signal_2006_Dec_6_1_8.nxml.txt.nlp	17224083	SENT111	13	13	10	10	thrombin	Rho	PA451674	29984	0.981
NULL	Psychiatry_Investig_2012_Dec_12_9(4)_422-424.nxml.txt.nlp	23251210	SENT14	5	5	15	15	terbinafine	CYP2D6	PA451614	1565	0.981
NULL	Front_Oncol_2013_Nov_15_3_281.nxml.txt.nlp	24298448	SENT85	29	29	11	11	oxaliplatin	BRAF	PA131285527	673	0.981
NULL	Ann_Rheum_Dis_2014_Jun_6_73(6)_1052-1059.nxml.txt.nlp	23831963	SENT160	2	2	38	38	hydroxychloroquine	MxA	PA164777036	4599	0.981
NULL	Dement_Geriatr_Cogn_Dis_Extra_2014_Nov_15_4(3)_450-456.nxml.txt.nlp	25538729	SENT99	31	31	8	8	donepezil	CYP2D6	PA449394	1565	0.981
NULL	AIDS_Res_Ther_2013_Dec_13_10_32.nxml.txt.nlp	24330597	SENT64	14	14	42	42	glucose	TNF	PA449773	7124	0.981
NULL	Nat_Commun_2013_Apr_9_4_1684.nxml.txt.nlp	23575688	SENT595	17	17	3	3	rolipram	CYLD	PA153906323	1540	0.981
NULL	J_Thorac_Oncol_2015_Jan_29_10(1)_156-163.nxml.txt.nlp	25247337	SENT9	0	0	14	14	afatinib	EGFR	PA165981154	1956	0.981
NULL	Braz_J_Med_Biol_Res_2012_Jul_20_45(10)_935-941.nxml.txt.nlp	22801415	SENT145	21	21	4	4	pioglitazone	adiponectin	PA450970	9370	0.981
NULL	J_Oncol_2012_Aug_8_2012_608406.nxml.txt.nlp	22927846	SENT161	5	5	27	27	dacarbazine	CXCL10	PA449197	3627	0.981
NULL	Br_J_Cancer_2013_Mar_19_108(5)_1113-1118.nxml.txt.nlp	23412104	SENT116	24	24	8	8	galactose	MUC1	PA449725	4582	0.981
NULL	Genome_Biol_2003_Sep_24_4(10)_230.nxml.txt.nlp	14519191	SENT38	12	12	17	17	galactose	UBR1	PA449725	197131	0.981
NULL	Cancer_Metastasis_Rev_2014_Dec_28_33(1)_161-171.nxml.txt.nlp	24375389	SENT175	8	8	3	3	docetaxel	CHFR	PA449383	55743	0.981
NULL	Arthritis_Res_Ther_2014_Apr_28_16(2)_R104.nxml.txt.nlp	24774748	SENT103	21	21	6	6	methotrexate	CD4	PA450428	920	0.981
NULL	Diabetes_Care_2013_Feb_17_36(2)_369-375.nxml.txt.nlp	23043163	SENT186	11	11	17	17	troglitazone	PPARgamma	PA451799	5468	0.981
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT408	23	23	3	3	risperidone	PRL	PA451257	5617	0.981
NULL	Case_Rep_Oncol_2010_Apr_29_3(2)_131-136.nxml.txt.nlp	20740185	SENT70	3	3	14	14	fulvestrant	HER2	PA164747170	2064	0.981
NULL	Clin_Drug_Investig_2013_Aug_23_33(10)_727-736.nxml.txt.nlp	23975654	SENT172	25	25	31	31	fluvoxamine	CYP1A2	PA449690	1544	0.981
NULL	Oncotarget_2012_May_18_3(5)_525-534.nxml.txt.nlp	22619113	SENT90	29	29	6	6	fludarabine	MCL1	PA449655	4170	0.981
NULL	Ann_Surg_Oncol_2012_Dec_6_19(13)_4287-4299.nxml.txt.nlp	22766981	SENT131	0	0	7	7	bevacizumab	VEGF-A	PA130232992	7422	0.981
NULL	Arthritis_Res_Ther_2011_Feb_16_13(1)_R25.nxml.txt.nlp	21324169	SENT131	27	27	6	6	tocilizumab	ACR	PA165292659	49	0.981
NULL	Cell_Biol_Int_Rep_(2010)_2012_Jun_21_19(1)_e00017.nxml.txt.nlp	23124518	SENT42	41	41	27	27	etoposide	TRAIL	PA449552	8743	0.981
NULL	J_Oncol_2010_Jun_21_2010_430142.nxml.txt.nlp	20652056	SENT196	10	10	13	13	erlotinib	EGFR	PA134687924	1956	0.981
NULL	Contemp_Oncol_(Pozn)_2013_Apr_29_17(2)_128-133.nxml.txt.nlp	23788978	SENT44	0	0	11	11	oxycodone	CYP3A4	PA450741	1576	0.981
NULL	Br_J_Cancer_2010_Mar_16_102(6)_1076-1077.nxml.txt.nlp	NULL	SENT12	37	37	24	24	cetuximab	KRAS	PA10040	3845	0.981
NULL	Br_J_Cancer_2010_Mar_2_102(5)_852-861.nxml.txt.nlp	20145622	SENT22	9	9	22	22	thyroglobulin	TPO	PA164754910	7066;7173	0.981
NULL	JAKSTAT_2012_Oct_1_1(4)_292-299.nxml.txt.nlp	24058786	SENT126	18	18	7	7	pimozide	CD34	PA450965	947	0.981
NULL	Exp_Cell_Res_2011_Apr_15_317(7)_1028-1039.nxml.txt.nlp	21237154	SENT122	14	14	35	35	staurosporine	TRAIL	PA165109623	8743	0.981
NULL	Mol_Cancer_2012_Jun_18_11_41.nxml.txt.nlp	22709873	SENT312	6	6	0	0	lapatinib	CCND1	PA152241907	595	0.981
NULL	Case_Rep_Oncol_2010_Apr_22_3(2)_98-105.nxml.txt.nlp	20740181	SENT57	0	0	11	11	erlotinib	CYP3A4	PA134687924	1576	0.981
NULL	Br_J_Cancer_2012_Feb_28_106(5)_916-922.nxml.txt.nlp	22333602	SENT152	16	16	24	24	doxorubicin	TOP2A	PA449412	7153	0.981
NULL	Breast_Cancer_Res_2014_Oct_30_16(5)_462.nxml.txt.nlp	25358638	SENT338	26	26	5	5	etoposide	VEGFC	PA449552	7424	0.981
NULL	Br_J_Cancer_2009_Jan_13_100(1)_145-152.nxml.txt.nlp	19050706	SENT15	28	28	4	4	erlotinib	EGFR	PA134687924	1956	0.981
NULL	Exp_Ther_Med_2013_Apr_11_5(4)_1147-1152.nxml.txt.nlp	23599738	SENT123	4	4	16	16	fentanyl	OPRM1	PA449599	4988	0.981
NULL	J_Cell_Biol_1997_Jun_30_137(7)_1639-1649.nxml.txt.nlp	9199177	SENT88	38	38	4	4	paraformaldehyde	ZAP-70	PA450790	7535	0.981
NULL	Acta_Pharmacol_Sin_2012_Dec_22_33(12)_1511-1517.nxml.txt.nlp	23085741	SENT183	32	32	15	15	zileuton	CysLT1	PA451955	10800	0.981
NULL	Arthritis_Res_Ther_2013_Nov_1_15(6)_R176.nxml.txt.nlp	24456929	SENT385	24	24	4	4	colchicine	MSU	PA449092	593	0.981
NULL	Breast_Cancer_Res_2011_Jan_24_13(1)_401.nxml.txt.nlp	21349137	SENT17	0	0	20	20	trastuzumab	AMPK	PA451743	5563	0.981
NULL	Clin_Sarcoma_Res_2013_Mar_7_3_3.nxml.txt.nlp	23497641	SENT154	41	41	6	6	imatinib	KIT	PA10804	3815	0.981
NULL	Br_J_Cancer_2010_Jul_13_103(2)_265-274.nxml.txt.nlp	20551953	SENT204	16	16	0	0	cisplatin	JNK	PA449014	5599	0.981
NULL	Br_J_Pharmacol_2013_Mar_25_168(6)_1445-1455.nxml.txt.nlp	23121507	SENT215	9	9	0	0	nifedipine	TRPM3	PA450631	80036	0.981
NULL	Br_J_Haematol_2014_Mar_13_164(1)_811-821.nxml.txt.nlp	24328678	SENT147	11	11	3	3	lenalidomide	CRBN	PA162363968	51185	0.981
NULL	Crit_Care_2006_Dec_7_10(6)_239.nxml.txt.nlp	17169139	SENT76	7	7	18	18	thrombin	PAR1	PA451674	79581;2149	0.981
NULL	J_Cell_Mol_Med_2013_Feb_5_17(2)_293-302.nxml.txt.nlp	23379308	SENT100	7	7	36	36	carbachol	PS1	PA448784	5663	0.981
NULL	J_Hematol_Oncol_2009_Oct_27_2_45.nxml.txt.nlp	19860903	SENT238	10	10	6	6	gefitinib	EGFR	PA131301952	1956	0.981
NULL	Anesth_Pain_Med_2013_Dec_27_4(1)_e11906.nxml.txt.nlp	24660144	SENT39	7	7	26	26	cyclophosphamide	VIII	PA449165	1351	0.981
NULL	J_Oncol_2012_Mar_11_2012_382159.nxml.txt.nlp	22481926	SENT84	0	0	7	7	pazopanib	VEGFR	PA165291492	3791	0.981
NULL	J_Oncol_2012_Mar_26_2012_198412.nxml.txt.nlp	22536237	SENT13	6	6	13	13	trastuzumab	HER2	PA451743	2064	0.981
NULL	Curr_Oncol_2009_Jul_16(Suppl_2)_S1-S13.nxml.txt.nlp	19672416	SENT72	0	0	23	23	anastrozole	aromatase	PA448432	1588	0.981
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Aug_4_6_123-133.nxml.txt.nlp	25177151	SENT93	6	6	18	18	tamoxifen	aromatase	PA451581	1588	0.981
NULL	Asia_Pac_Allergy_2011_Apr_26_1(1)_2-11.nxml.txt.nlp	22053290	SENT26	37	37	10	10	allopurinol	CD4	PA448320	920	0.981
NULL	Anal_Chem_Insights_2011_Mar_10_6_21-28.nxml.txt.nlp	21760706	SENT25	7	7	25	25	emtricitabine	API	PA10069	5345	0.981
NULL	J_Inflamm_(Lond)_2005_Oct_31_2_14.nxml.txt.nlp	16259633	SENT41	37	37	2	2	staurosporine	CCR2	PA165109623	729230	0.981
NULL	Ann_Surg_Treat_Res_2014_Feb_22_86(2)_68-75.nxml.txt.nlp	24761411	SENT145	33	33	17	17	resveratrol	survivin		332	0.981
NULL	Biologics_2012_Jun_20_6_147-154.nxml.txt.nlp	22807625	SENT81	12	12	26	26	carboplatin	PIK3CA	PA448803	5290	0.981
NULL	Arthritis_Res_Ther_2012_Feb_9_14(Suppl_1)_O41.nxml.txt.nlp	NULL	SENT14	26	26	13	13	infliximab	gamma	PA452639	9913	0.981
NULL	Crit_Care_2008_Nov_26_12(Suppl_6)_S3.nxml.txt.nlp	19105796	SENT120	0	0	18	18	thrombin	PAR4	PA451674	9002;5074	0.981
NULL	ISRN_Otolaryngol_2014_Feb_13_2014_859621.nxml.txt.nlp	24693453	SENT32	0	0	38	38	sunitinib	FLT3	PA162372840	2322	0.981
NULL	Evid_Based_Complement_Alternat_Med_2012_May_22_2012_601018.nxml.txt.nlp	22675385	SENT76	26	26	3	3	isoflurane	FDG	PA450106	23583	0.981
NULL	Alcohol_Res_2013_35(1)_6-16.nxml.txt.nlp	24313160	SENT111	4	4	13	13	rosiglitazone	adiponectin	PA451283	9370	0.981
NULL	Endocr_Relat_Cancer_2014_Apr_21(2)_311-326.nxml.txt.nlp	24478054	SENT290	17	17	9	9	denosumab	RANKL	PA166048634	8600	0.981
NULL	AIDS_Res_Ther_2007_Feb_23_4_3.nxml.txt.nlp	17316455	SENT33	9	9	38	38	lamivudine	CD4	PA450163	920	0.981
NULL	Oncotarget_2013_Dec_2_4(12)_2523-2531.nxml.txt.nlp	24344114	SENT198	8	8	1	1	fluorescein	p53	PA164746009	7157	0.981
NULL	Ther_Clin_Risk_Manag_2005_Dec_1(4)_299-306.nxml.txt.nlp	18360572	SENT84	1	1	27	27	terbinafine	CYP2C8	PA451614	1558	0.981
NULL	Orphanet_J_Rare_Dis_2010_Dec_16_5_39.nxml.txt.nlp	21162721	SENT76	15	15	5	5	sulfamethoxazole	HLA-B	PA451544	3106	0.981
NULL	Eur_J_Cancer_2014_Sep_50(14)_2375-2389.nxml.txt.nlp	25065293	SENT56	3	3	26	26	tamoxifen	aromatase	PA451581	1588	0.981
NULL	Acta_Pharmacol_Sin_2011_Oct_15_32(10)_1303-1308.nxml.txt.nlp	21841812	SENT102	1	1	13	13	losartan	CYP2C9	PA450268	1559	0.981
NULL	Neural_Regen_Res_2013_Mar_25_8(9)_825-832.nxml.txt.nlp	25206730	SENT113	12	12	16	16	isoflurane	P2X7	PA450106	5027	0.981
NULL	Breast_Cancer_Res_2010_Jun_28_12(3)_R43.nxml.txt.nlp	20579400	SENT15	22	22	0	0	fulvestrant	MAPT	PA164747170	4137	0.981
NULL	J_Cell_Biol_2008_Jul_28_182(2)_233-239.nxml.txt.nlp	18644891	SENT95	16	16	0	0	staurosporine	Dicer	PA165109623	23405	0.981
NULL	Case_Rep_Transplant_2013_Jun_13_2013_375263.nxml.txt.nlp	23844312	SENT77	0	0	7	7	tacrolimus	CYP3A	PA451578	1574	0.981
NULL	Drug_Des_Devel_Ther_2014_Oct_31_8_2121-2128.nxml.txt.nlp	25382970	SENT82	17	17	4	4	curcumin	TTR	PA151958596	7276	0.981
NULL	Atherosclerosis_2010_Jul_211(1)_271-277.nxml.txt.nlp	20138279	SENT261	18	18	26	26	salbutamol	CAD	PA448068	1677;790	0.981
NULL	Cancer_Med_2013_Dec_27_2(6)_751-762.nxml.txt.nlp	24403249	SENT159	13	13	28	28	paclitaxel	CD44	PA450761	960	0.981
NULL	Acta_Pharmacol_Sin_2011_Apr_28_32(4)_441-448.nxml.txt.nlp	21441944	SENT65	22	22	0	0	sildenafil	CASQ2	PA451346	845	0.981
NULL	Open_Dent_J_2014_May_30_8_109-124.nxml.txt.nlp	24976875	SENT179	0	0	13	13	minocycline	PARP-1	PA450519	25976	0.981
NULL	Niger_Med_J_2014_Jul-Aug_55(4)_327-332.nxml.txt.nlp	25114369	SENT15	19	19	0	0	ethambutol	DST	PA164784021	667	0.981
NULL	Neuropsychopharmacology_2009_Nov_5_34(12)_2560-2573.nxml.txt.nlp	19657330	SENT195	7	7	12	12	ethanol	CB1	PA448073	1268	0.981
NULL	Ann_Rheum_Dis_2008_May_21_68(2)_175-182.nxml.txt.nlp	18495735	SENT140	25	25	8	8	infliximab	IL-6	PA452639	3569	0.981
NULL	Cancers_(Basel)_2011_May_9_3(2)_2286-2301.nxml.txt.nlp	24212810	SENT184	21	21	7	7	gemcitabine	VEGFR2	PA449748	3791	0.981
NULL	Asian_J_Androl_2014_Dec_19_Mar-Apr_16(2)_314-318.nxml.txt.nlp	24407181	SENT70	38	38	5	5	sulfanilamide	NO3	PA451545	4681	0.981
NULL	Breast_Cancer_Res_2011_Nov_1_13(6)_227.nxml.txt.nlp	22078026	SENT172	0	0	7	7	denosumab	RANKL	PA166048634	8600	0.981
NULL	Arthritis_Res_Ther_2012_Sep_24_14(5)_R200.nxml.txt.nlp	23006144	SENT161	1	1	25	25	alefacept	IL-20	PA164748040	27190;50604	0.981
NULL	Biomed_Res_Int_2013_Aug_6_2013_602987.nxml.txt.nlp	24027759	SENT308	24	24	6	6	cisplatin	SMF	PA449014	22993	0.981
NULL	Br_J_Cancer_2013_Sep_3_109(5)_1214-1222.nxml.txt.nlp	23922104	SENT175	6	6	35	35	dasatinib	TP53	PA162372878	7157	0.981
NULL	Hum_Mol_Genet_2013_Dec_1_22(23)_4857-4869.nxml.txt.nlp	23873044	SENT30	26	26	0	0	heparin	CFHR1	PA449855	3078	0.981
NULL	Oncogene_2014_Jun_26_33(26)_3422-3431.nxml.txt.nlp	23912457	SENT159	10	10	20	20	trastuzumab	MUC1	PA451743	4582	0.981
NULL	Adv_Ther_2014_May_13_31(5)_473-493.nxml.txt.nlp	24821599	SENT140	5	5	19	19	rivaroxaban	TTR	PA165958360	7276	0.981
NULL	Exp_Ther_Med_2014_Mar_17_7(3)_703-708.nxml.txt.nlp	24520271	SENT79	3	3	33	33	doxorubicin	IFN	PA449412	3439	0.981
NULL	Cancer_Res_Treat_2012_Sep_30_44(3)_195-201.nxml.txt.nlp	23091446	SENT100	25	25	8	8	etoposide	MKP-1	PA449552	1843	0.981
NULL	Mol_Cancer_2008_Mar_6_7_23.nxml.txt.nlp	18325094	SENT181	11	11	0	0	hyaluronan	LYVE-1	PA165958431	10894	0.981
NULL	Asia_Pac_Allergy_2011_Apr_26_1(1)_2-11.nxml.txt.nlp	22053290	SENT26	37	37	8	8	allopurinol	CD25	PA448320	3669;3559	0.981
NULL	Breast_Cancer_Res_2012_Jun_19_14(3)_209.nxml.txt.nlp	22713170	SENT139	0	0	9	9	cetuximab	EGFR	PA10040	1956	0.981
NULL	J_Invest_Dermatol_2014_Apr_11_134(4)_1083-1090.nxml.txt.nlp	24335898	SENT83	37	37	27	27	nutlin-3	p53		7157	0.981
NULL	Endocrinology_2012_Jul_5_153(7)_3190-3198.nxml.txt.nlp	22669896	SENT100	4	4	18	18	genistein	PI3K	PA165109660	5290	0.981
NULL	Pharmacogn_Rev_2011_Jul-Dec_5(10)_120-137.nxml.txt.nlp	22279370	SENT301	18	18	24	24	evodiamine	COX2	PA165860788	4513;5743	0.981
NULL	FEBS_Open_Bio_2012_Aug_22_2_279-283.nxml.txt.nlp	23650611	SENT111	2	2	23	23	raloxifene	IFN	PA451221	3439	0.981
NULL	Int_J_Mol_Sci_2014_Oct_6_15(10)_17886-17900.nxml.txt.nlp	25290095	SENT142	8	8	12	12	resveratrol	SIRT1		23411	0.981
NULL	Oncotarget_2013_Nov_4_5(1)_161-172.nxml.txt.nlp	24389287	SENT37	19	19	5	5	propranolol	p53	PA451145	7157	0.981
NULL	Curr_Colorectal_Cancer_Rep_2011_Dec_17_7(4)_253-259.nxml.txt.nlp	22131911	SENT60	22	22	12	12	cisplatin	CD133	PA449014	8842	0.981
NULL	Cancer_Immunol_Immunother_2013_Aug_27_62(10)_1637-1648.nxml.txt.nlp	23982484	SENT249	3	3	33	33	lenalidomide	IL-2	PA162363968	3558	0.981
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT127	18	18	8	8	chloroquine	BMPR-II	PA448948	659	0.981
NULL	Chin_J_Cancer_2011_Sep_30(9)_645-654.nxml.txt.nlp	21880186	SENT199	43	43	10	10	cisplatin	NACT	PA449014	284111	0.981
NULL	Crit_Care_2001_Mar_2_5(Suppl_1)_P208.nxml.txt.nlp	NULL	SENT12	19	19	7	7	propofol	PTH	PA451141	5741	0.981
NULL	Nature_2012_Aug_16_488(7411)_384-388.nxml.txt.nlp	22820255	SENT191	28	28	6	6	doxycycline	CD4	PA449415	920	0.981
NULL	Crit_Care_2006_Dec_7_10(6)_239.nxml.txt.nlp	17169139	SENT72	0	0	16	16	thrombin	PAR1	PA451674	79581;2149	0.981
NULL	JAKSTAT_2013_Jan_1_2(1)_e22925.nxml.txt.nlp	24058789	SENT125	7	7	21	21	carbachol	STAT3	PA448784	6774	0.981
NULL	J_Thorac_Oncol_2015_Jan_29_10(1)_156-163.nxml.txt.nlp	25247337	SENT104	4	4	10	10	afatinib	TTF	PA165981154	399	0.981
NULL	Drug_Saf_2014_Feb_19_37(4)_201-211.nxml.txt.nlp	24550106	SENT67	0	0	21	21	ritonavir	CYP3A4	PA451260	1576	0.981
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1051.nxml.txt.nlp	24503543	SENT46	22	22	39	39	thioridazine	EGFR	PA451666	1956	0.981
NULL	Mol_Vis_2007_Jul_9_13_1083-1093.nxml.txt.nlp	17653053	SENT165	4	4	11	11	minocycline	p38	PA450519	10598;1432;7965	0.981
NULL	Oncoimmunology_2012_Jul_1_1(4)_493-506.nxml.txt.nlp	22754768	SENT148	24	24	11	11	carboplatin	CD40	PA448803	958	0.981
NULL	Am_J_Cardiovasc_Drugs_2013_Jun_20_13(5)_331-342.nxml.txt.nlp	23784266	SENT223	23	23	13	13	ketoconazole	CYP3A4	PA450146	1576	0.981
NULL	J_Immunol_Res_2014_Nov_11_2014_385352.nxml.txt.nlp	25436214	SENT135	8	8	30	30	infliximab	IL-6	PA452639	3569	0.981
NULL	Breast_Cancer_Res_2002_Feb_12_4(2)_70-76.nxml.txt.nlp	11879567	SENT151	14	14	6	6	paclitaxel	p53	PA450761	7157	0.981
NULL	J_Korean_Med_Sci_2011_Dec_29_26(12)_1634-1637.nxml.txt.nlp	22148003	SENT82	18	18	9	9	candesartan	CYP2C9	PA448765	1559	0.981
NULL	Adv_Biomed_Res_2014_Jan_9_3_11.nxml.txt.nlp	24592364	SENT104	10	10	15	15	simvastatin	IFN	PA451363	3439	0.981
NULL	Exp_Brain_Res_2014_Jun_27_232(8)_2637-2644.nxml.txt.nlp	24969614	SENT24	4	4	14	14	palonosetron	NK1	PA10352	11126	0.981
NULL	Int_J_Endocrinol_Metab_2013_Dec_21_Winter_11(1)_57-61.nxml.txt.nlp	23853622	SENT105	2	2	10	10	risperidone	PRL	PA451257	5617	0.981
NULL	Oncol_Rep_2013_Oct_22_30(4)_1535-1541.nxml.txt.nlp	23877481	SENT149	28	28	17	17	gefitinib	CXCR4	PA131301952	7852	0.981
NULL	F1000Res_2014_Jul_1_3_149.nxml.txt.nlp	25352980	SENT109	13	13	33	33	galactose	GAL4	PA449725	3960	0.981
NULL	Indian_Pacing_Electrophysiol_J_2014_May_25_14(3)_133-149.nxml.txt.nlp	24948852	SENT209	0	0	13	13	flecainide	SCN5A	PA449646	6331	0.981
NULL	Biomed_Res_Int_2014_Aug_5_2014_312847.nxml.txt.nlp	25162007	SENT230	26	26	8	8	cisplatin	p53	PA449014	7157	0.981
NULL	Breast_Cancer_Res_2012_May_2_14(3)_R70.nxml.txt.nlp	22551440	SENT209	17	17	33	33	docetaxel	p53	PA449383	7157	0.981
NULL	EMBO_Mol_Med_2012_Mar_4(3)_218-233.nxml.txt.nlp	22294553	SENT44	13	13	6	6	tamoxifen	EGFR	PA451581	1956	0.981
NULL	Ann_Clin_Transl_Neurol_2014_Aug_8_1(8)_519-533.nxml.txt.nlp	25356424	SENT197	12	12	27	27	cilostazol	BACE1	PA164746334	23621	0.981
NULL	Oncol_Lett_2013_Apr_22_5(4)_1093-1100.nxml.txt.nlp	23599746	SENT69	18	18	26	26	docetaxel	P-gp	PA449383	5243	0.981
NULL	Acta_Pharmacol_Sin_2010_Dec_22_31(12)_1576-1582.nxml.txt.nlp	21102485	SENT136	34	34	42	42	ethanol	PI3K	PA448073	5290	0.981
NULL	Trials_2013_Dec_10_14_424.nxml.txt.nlp	24325953	SENT96	6	6	1	1	hydromorphone	PCA	PA449918	28982	0.981
NULL	Br_J_Cancer_2012_Jun_5_106(12)_1926-1933.nxml.txt.nlp	22596235	SENT20	21	21	11	11	bevacizumab	MVD	PA130232992	4597	0.981
NULL	Cardiovasc_Diabetol_2013_Mar_23_12_48.nxml.txt.nlp	23522121	SENT211	28	28	11	11	liraglutide	NNT	PA165958364	23530	0.981
NULL	Int_J_Med_Sci_2013_Feb_11_10(3)_320-330.nxml.txt.nlp	23423768	SENT81	2	2	16	16	erlotinib	EGFR	PA134687924	1956	0.981
NULL	Int_J_Gen_Med_2012_Jun_18_5_535-540.nxml.txt.nlp	22807641	SENT94	28	28	25	25	pitavastatin	adiponectin	PA142650384	9370	0.981
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT177	4	4	22	22	cisplatin	PUMA	PA449014	27113	0.981
NULL	Evid_Based_Complement_Alternat_Med_2013_May_13_2013_506324.nxml.txt.nlp	23818927	SENT142	9	9	14	14	doxorubicin	STAT3	PA449412	6774	0.981
NULL	Pharmaceutics_2010_Jun_2_2(2)_258-274.nxml.txt.nlp	NULL	SENT28	3	3	21	21	risperidone	CYP3A4	PA451257	1576	0.981
NULL	Clin_Pharmacol_2011_Jun_22_3_13-25.nxml.txt.nlp	22287853	SENT202	4	4	12	12	ketoconazole	CYP3A4	PA450146	1576	0.981
NULL	Exp_Diabetes_Res_2011_Jun_22_2011_279530.nxml.txt.nlp	21747825	SENT164	13	13	0	0	exenatide	GLP-1	PA164749238	100125288	0.981
NULL	Pain_2011_Aug_152(8)_1899-1908.nxml.txt.nlp	21600693	SENT75	10	10	2	2	capsaicin	TRPV1	PA448776	7442	0.981
NULL	Aging_(Albany_NY)_2009_Dec_12_1(12)_971-978.nxml.txt.nlp	20157580	SENT39	21	21	4	4	hydroxyurea	STRA8	PA449942	346673	0.981
NULL	Arthritis_Res_Ther_2005_Feb_18_7(3)_R476-R484.nxml.txt.nlp	15899034	SENT100	0	0	36	36	thrombin	GEF	PA451674	56731	0.981
NULL	BioDrugs_2013_Jun_7_27(6)_591-603.nxml.txt.nlp	23743670	SENT102	5	5	16	16	doxorubicin	IFN	PA449412	3439	0.981
NULL	Aging_(Albany_NY)_2013_Feb_21_5(2)_94-95.nxml.txt.nlp	23518473	SENT21	2	2	32	32	resveratrol	SIRT1		23411	0.981
NULL	EMBO_Mol_Med_2013_Dec_8_5(12)_1821-1834.nxml.txt.nlp	24293316	SENT98	6	6	13	13	doxorubicin	UNC5B	PA449412	219699	0.981
NULL	Oncol_Rep_2013_May_5_29(5)_1962-1968.nxml.txt.nlp	23467841	SENT29	31	31	1	1	trypsin	SLPI	PA451806	6590	0.981
NULL	Case_Rep_Ophthalmol_Med_2012_Apr_9_2012_654502.nxml.txt.nlp	22606499	SENT19	8	8	38	38	fluorescein	FAF	PA164746009	8239;2188	0.981
NULL	Front_Oncol_2014_Sep_29_4_251.nxml.txt.nlp	25325012	SENT233	0	0	21	21	pemetrexed	DHFR	PA10810	1719	0.981
NULL	Br_J_Cancer_2013_Sep_3_109(5)_1137-1146.nxml.txt.nlp	23942078	SENT32	16	16	11	11	sunitinib	RSK4	PA162372840	27330	0.981
NULL	Exp_Mol_Med_2012_Sep_30_44(9)_545-553.nxml.txt.nlp	22809901	SENT70	44	44	21	21	quetiapine	PRDM16	PA451201	63976	0.981
NULL	Biologics_2013_Apr_26_7_91-101.nxml.txt.nlp	23671386	SENT101	3	3	22	22	crizotinib	EGFR	PA165946122	1956	0.981
NULL	Breast_Cancer_Res_2007_Jun_4_9(3)_207.nxml.txt.nlp	17561991	SENT46	40	40	9	9	trastuzumab	CISH	PA451743	1154	0.981
NULL	Cancer_Cell_Int_2007_Sep_10_7_14.nxml.txt.nlp	17845729	SENT206	42	42	7	7	decitabine	PDCD5	PA164749631	9141	0.981
NULL	Breast_Cancer_Res_2002_Apr_4_4(3)_85-89.nxml.txt.nlp	12052249	SENT38	0	0	23	23	tamoxifen	SULT1A1	PA451581	6817	0.981
NULL	Cancers_(Basel)_2013_Jun_5_5(2)_676-713.nxml.txt.nlp	24216997	SENT359	23	23	2	2	decitabine	SPARC	PA164749631	6678	0.981
NULL	Clin_Sci_(Lond)_2012_May_1_122(Pt_9)_421-428.nxml.txt.nlp	22092038	SENT31	1	1	25	25	tetracycline	JNK2	PA451640	5601	0.981
NULL	J_Invest_Dermatol_2014_Apr_11_134(4)_984-991.nxml.txt.nlp	24352038	SENT126	21	21	4	4	adalimumab	P21	PA10004	1026;9338	0.981
NULL	Cancer_Cell_Int_2013_Apr_16_13_36.nxml.txt.nlp	23590596	SENT88	24	24	30	30	doxorubicin	TRAIL	PA449412	8743	0.981
NULL	J_Oncol_2010_Jan_14_2010_740472.nxml.txt.nlp	20130818	SENT148	3	3	30	30	pertuzumab	ERBB3		2065	0.981
NULL	Br_J_Cancer_2012_Jan_31_106(3)_440-446.nxml.txt.nlp	22233926	SENT132	13	13	24	24	lapatinib	HER-2	PA152241907	2064	0.981
NULL	J_Hematol_Oncol_2012_Sep_18_5_57.nxml.txt.nlp	22989009	SENT191	33	33	0	0	disulfiram	HDM2	PA449376	4193	0.981
NULL	Clin_Interv_Aging_2014_Oct_21_9_1783-1791.nxml.txt.nlp	25364236	SENT149	16	16	8	8	donepezil	FOXO1	PA449394	2308	0.981
NULL	Breast_Cancer_Res_2013_Oct_18_15(5)_R97.nxml.txt.nlp	24135425	SENT92	6	6	35	35	letrozole	PI3K	PA450196	5290	0.981
NULL	Nucleic_Acids_Res_2011_Dec_31_39(22)_9536-9548.nxml.txt.nlp	21880590	SENT224	23	23	5	5	paclitaxel	BRCA1	PA450761	672	0.981
NULL	Oncogene_2010_Sep_23_29(38)_5299-5310.nxml.txt.nlp	20622903	SENT48	5	5	22	22	melphalan	HMGB1	PA450354	3146	0.981
NULL	Mol_Cancer_2013_Oct_8_12_119.nxml.txt.nlp	24103454	SENT127	30	30	9	9	etoposide	TOP2A	PA449552	7153	0.981
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Dec_10_3(12)_e151.nxml.txt.nlp	25494035	SENT114	1	1	31	31	rosuvastatin	OATP1B1	PA134308647	10599	0.981
NULL	Curr_Mol_Med_2012_Jan_12(1)_96-110.nxml.txt.nlp	22082486	SENT246	23	23	14	14	carboplatin	EGFR	PA448803	1956	0.981
NULL	Indian_J_Anaesth_2014_Mar-Apr_58(2)_238-239.nxml.txt.nlp	24963210	SENT44	9	9	26	26	dexmedetomidine	LGS	PA449256	51557	0.981
NULL	Leukemia_2013_Feb_24_27(2)_336-343.nxml.txt.nlp	22858986	SENT54	18	18	4	4	paraformaldehyde	CD34	PA450790	947	0.981
NULL	Iran_J_Pharm_Res_2014_Summer_13(3)_919-926.nxml.txt.nlp	25276192	SENT122	4	4	12	12	hesperidin	p53	PA449867	7157	0.981
NULL	Ther_Clin_Risk_Manag_2005_Mar_1(1)_3-13.nxml.txt.nlp	18360537	SENT60	30	30	6	6	sildenafil	CYP3A4	PA451346	1576	0.981
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1427-1436.nxml.txt.nlp	24096601	SENT3	0	0	19	19	erlotinib	EGFR	PA134687924	1956	0.981
NULL	Nat_Commun_2013_Apr_23_4_1758.nxml.txt.nlp	23612299	SENT64	2	2	9	9	isoproterenol	SOD1	PA450121	6647	0.981
NULL	Virol_J_2011_May_17_8_234.nxml.txt.nlp	21575275	SENT101	11	11	19	19	ribavirin	IFN	PA451241	3439	0.981
NULL	Open_Biol_2014_Feb_4(2)_130210.nxml.txt.nlp	24554596	SENT164	10	10	6	6	trypsin	ALK3	PA451806	657	0.981
NULL	Mol_Cancer_2006_Oct_17_5_45.nxml.txt.nlp	17044934	SENT75	17	17	10	10	resveratrol	COX		1351	0.981
NULL	Cancer_Manag_Res_2011_May_10_3_157-175.nxml.txt.nlp	21625399	SENT136	10	10	27	27	dextromethorphan	CYP3A4	PA449273	1576	0.981
NULL	Oncoimmunology_2013_Apr_1_2(4)_e24117.nxml.txt.nlp	23734336	SENT93	3	3	26	26	docetaxel	STAT3	PA449383	6774	0.981
NULL	Contemp_Oncol_(Pozn)_2012_Feb_29_16(1)_86-89.nxml.txt.nlp	23788860	SENT98	11	11	18	18	capecitabine	DDP	PA448771	1678	0.981
NULL	Diabetes_2011_Jul_20_60(7)_1872-1881.nxml.txt.nlp	21602511	SENT133	17	17	8	8	metformin	AMPK	PA450395	5563	0.981
NULL	Oncotarget_2014_Feb_7_5(3)_775-787.nxml.txt.nlp	24519956	SENT197	42	42	0	0	dasatinib	PC3	PA162372878	57332;7832;5122	0.981
NULL	J_Neuroinflammation_2011_Feb_4_8_10.nxml.txt.nlp	21294877	SENT115	28	28	12	12	capsaicin	NK1	PA448776	11126	0.981
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT125	7	7	20	20	tenofovir	ABCC2	PA10204	1244	0.981
NULL	Int_J_Biol_Sci_2011_Nov_2_7(9)_1427-1442.nxml.txt.nlp	22110393	SENT202	14	14	0	0	thrombin	RANTES	PA451674	6352	0.981
NULL	Ann_Rheum_Dis_2009_Oct_17_68(10)_1580-1584.nxml.txt.nlp	19019888	SENT155	36	36	1	1	tocilizumab	IL-6	PA165292659	3569	0.981
NULL	Mol_Cancer_2004_May_4_3_14.nxml.txt.nlp	15125777	SENT42	28	28	1	1	cisplatin	CHK2	PA449014	11200	0.981
NULL	Basic_Clin_Neurosci_2014_Winter_5(1)_74-79.nxml.txt.nlp	25436087	SENT111	9	9	17	17	fluoxetine	AQP4	PA449673	361	0.981
NULL	Front_Cell_Neurosci_2015_Jan_15_8_459.nxml.txt.nlp	25642166	SENT107	18	18	1	1	hemin	HO-1	PA449849	3162	0.981
NULL	Cell_Biol_Int_Rep_(2010)_2012_Jun_21_19(1)_e00017.nxml.txt.nlp	23124518	SENT6	10	10	1	1	etoposide	TRAIL-R2	PA449552	8795	0.981
NULL	Exp_Ther_Med_2015_Jan_5_9(1)_84-88.nxml.txt.nlp	25452780	SENT99	11	11	9	9	vildagliptin	DPP4	PA165958346	1803	0.981
NULL	Oncoscience_2014_Oct_22_1(10)_614-623.nxml.txt.nlp	25593991	SENT92	25	25	32	32	imatinib	KIT	PA10804	3815	0.981
NULL	Biomed_Res_Int_2014_Jun_3_2014_534969.nxml.txt.nlp	25136593	SENT100	0	0	8	8	bevacizumab	VEGF-A	PA130232992	7422	0.981
NULL	Oncol_Lett_2014_Jul_25_8(1)_313-316.nxml.txt.nlp	24959268	SENT7	27	27	13	13	sulindac	PC-3	PA451565	692094	0.981
NULL	Mol_Med_Rep_2015_Jan_20_11(1)_37-42.nxml.txt.nlp	25333459	SENT28	0	0	41	41	cyclosporine	IL-2	PA449167	3558	0.981
NULL	Front_Oncol_2013_Nov_15_3_281.nxml.txt.nlp	24298448	SENT88	9	9	24	24	irinotecan	BRAF	PA450085	673	0.981
NULL	Int_J_Chron_Obstruct_Pulmon_Dis_2006_Dec_1(4)_373-379.nxml.txt.nlp	18044094	SENT41	8	8	15	15	cilomilast	PDE4D	PA165948031	5144	0.981
NULL	Curr_Genomics_2013_Nov_14(7)_441-452.nxml.txt.nlp	24396276	SENT68	22	22	6	6	cisplatin	HDAC9	PA449014	9734	0.981
NULL	Chin_J_Cancer_2012_Feb_31(2)_73-99.nxml.txt.nlp	22098950	SENT255	6	6	14	14	sorafenib	P-gp	PA7000	5243	0.981
NULL	Oncoimmunology_2013_May_1_2(5)_e23850.nxml.txt.nlp	23762785	SENT37	6	6	16	16	denosumab	RANKL	PA166048634	8600	0.981
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1699-1708.nxml.txt.nlp	19861960	SENT155	36	36	30	30	dasatinib	IGFBP2	PA162372878	3485	0.981
NULL	Braz_J_Med_Biol_Res_2014_Sep_5_47(11)_929-939.nxml.txt.nlp	25296354	SENT102	8	8	29	29	afatinib	EGFR	PA165981154	1956	0.981
NULL	Int_J_Breast_Cancer_2011_Sep_6_2011_352182.nxml.txt.nlp	22295219	SENT134	17	17	2	2	lapatinib	PI3K	PA152241907	5290	0.981
NULL	Mol_Cancer_2010_Mar_10_9_55.nxml.txt.nlp	20219091	SENT212	27	27	16	16	doxycycline	WNT11	PA449415	7481	0.981
NULL	Biomed_Res_Int_2014_Apr_10_2014_580852.nxml.txt.nlp	24812624	SENT171	13	13	31	31	resveratrol	PTEN		5728	0.981
NULL	Cancer_Res_Treat_2014_Jul_15_46(3)_261-269.nxml.txt.nlp	25038761	SENT56	13	13	25	25	vincristine	CRT	PA451879	811	0.981
NULL	Exp_Ther_Med_2014_Sep_14_8(3)_836-840.nxml.txt.nlp	25120610	SENT107	0	0	10	10	fasudil	ROCK1	PA165946121	6093	0.981
NULL	Exp_Ther_Med_2015_Jan_5_9(1)_84-88.nxml.txt.nlp	25452780	SENT21	18	18	6	6	vildagliptin	DPP4	PA165958346	1803	0.981
NULL	Cell_Res_2013_Jul_21_23(7)_915-930.nxml.txt.nlp	23689279	SENT42	23	23	4	4	ethanol	ALDH2	PA448073	217	0.981
NULL	Br_J_Pharmacol_2014_May_11_171(9)_2385-2398.nxml.txt.nlp	24467222	SENT178	13	13	24	24	rolipram	Rho	PA153906323	29984	0.981
NULL	Biomed_Res_Int_2014_Apr_10_2014_580852.nxml.txt.nlp	24812624	SENT180	5	5	23	23	resveratrol	PTEN		5728	0.981
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT245	46	46	10	10	pertuzumab	HER3		2065	0.981
NULL	Pain_2011_Apr_152(4)_742-754.nxml.txt.nlp	21345591	SENT167	6	6	35	35	terfenadine	HERG	PA451619	3757	0.981
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1013.nxml.txt.nlp	24457957	SENT76	25	25	15	15	orlistat	NOXA	PA164776864	5366	0.981
NULL	Biomed_Imaging_Interv_J_2008_Jul_1_4(3)_e40.nxml.txt.nlp	21611006	SENT142	12	12	36	36	lapatinib	HER2	PA152241907	2064	0.981
NULL	Curr_Cardiol_Rev_2010_Nov_6(4)_356-362.nxml.txt.nlp	22043212	SENT64	0	0	14	14	bosentan	ETB	PA10034	1910	0.981
NULL	Toxins_(Basel)_2010_Mar_31_2(4)_517-551.nxml.txt.nlp	22069598	SENT117	12	12	26	26	curcumin	STAT3	PA151958596	6774	0.981
NULL	Cancer_Cell_Int_2014_Jun_11_14_49.nxml.txt.nlp	24991192	SENT81	20	20	6	6	berberine	AMPK	PA165860812	5563	0.981
NULL	Eur_J_Clin_Pharmacol_2011_May_8_67(5)_493-506.nxml.txt.nlp	21140139	SENT156	20	20	1	1	itraconazole	CYP3A4	PA450132	1576	0.981
NULL	Iran_J_Basic_Med_Sci_2011_Nov-Dec_14(6)_485-498.nxml.txt.nlp	23493821	SENT121	2	2	8	8	tacrolimus	CYP3A	PA451578	1574	0.981
NULL	Curr_Opin_Pharmacol_2013_Aug_13(4)_497-503.nxml.txt.nlp	23664091	SENT306	28	28	7	7	gefitinib	EGFR	PA131301952	1956	0.981
NULL	Indian_J_Ophthalmol_2007_Nov-Dec_55(6)_445-450.nxml.txt.nlp	17951902	SENT42	0	0	26	26	ranibizumab	VEGF-A	PA164746012	7422	0.981
NULL	Br_J_Cancer_2010_Oct_26_103(9)_1391-1399.nxml.txt.nlp	20924380	SENT123	17	17	4	4	cytarabine	p53	PA449177	7157	0.981
NULL	Breast_Cancer_2013_Mar_1_20(4)_302-309.nxml.txt.nlp	23456736	SENT39	3	3	15	15	tegafur	DPD	PA452620	1806	0.981
NULL	Oncoimmunology_2012_Dec_1_1(9)_1661-1663.nxml.txt.nlp	23264929	SENT17	35	35	3	3	imiquimod	CCR2	PA449972	729230	0.981
NULL	Biologics_2012_Sep_25_6_337-345.nxml.txt.nlp	23055691	SENT164	8	8	17	17	erlotinib	EGFR	PA134687924	1956	0.981
NULL	Eur_J_Med_Res_2009_Nov_24_14(Suppl_3)_36-42.nxml.txt.nlp	19959415	SENT111	26	26	9	9	elvitegravir	CYP3A	PA165291498	1574	0.981
NULL	Ther_Clin_Risk_Manag_2006_Mar_2(1)_87-98.nxml.txt.nlp	18360584	SENT94	0	0	7	7	sorafenib	BRAF	PA7000	673	0.981
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT167	21	21	3	3	tacrolimus	OPG	PA451578	690	0.981
NULL	J_Biol_Chem_2008_May_30_283(22)_15419-15430.nxml.txt.nlp	18378687	SENT152	7	7	16	16	pp2	ZAP-70		7535	0.981
NULL	Clin_Med_Insights_Cardiol_2012_Feb_1_6_17-33.nxml.txt.nlp	22442638	SENT69	8	8	12	12	simvastatin	CYP3A4	PA451363	1576	0.981
NULL	Case_Rep_Oncol_2013_Nov_23_6(3)_579-584.nxml.txt.nlp	24348397	SENT57	21	21	1	1	imatinib	PDGFRA	PA10804	5156	0.981
NULL	Diabetes_Metab_Syndr_Obes_2010_May_10_3_145-154.nxml.txt.nlp	21437084	SENT55	24	24	1	1	repaglinide	CYP2C8	PA451234	1558	0.981
NULL	Mol_Cell_2014_Jun_5_54(5)_858-869.nxml.txt.nlp	24905007	SENT57	34	34	4	4	hydroxyurea	FANCD2	PA449942	2177	0.981
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT203	0	0	19	19	amiodarone	CYP2C9	PA448383	1559	0.981
NULL	Curr_Pharm_Biotechnol_2011_Jan_12(1)_35-41.nxml.txt.nlp	20932261	SENT117	7	7	29	29	hyperforin	CYP2C	PA165985514	1562	0.981
NULL	Cancer_Immunol_Immunother_2013_Jul_20_62(9)_1533-1545.nxml.txt.nlp	23873089	SENT102	31	31	12	12	paclitaxel	CD4	PA450761	920	0.98
NULL	J_Hematol_Oncol_2008_Oct_17_1_18.nxml.txt.nlp	18928548	SENT49	17	17	1	1	sorafenib	SHARP	PA7000	23013	0.98
NULL	Vet_Res_2013_Oct_2_44(1)_89.nxml.txt.nlp	24088531	SENT9	27	27	7	7	hemin	HO-1	PA449849	3162	0.98
NULL	Scientifica_(Cairo)_2012_Nov_25_2012_473829.nxml.txt.nlp	24278698	SENT394	31	31	40	40	oxaliplatin	OCTN2	PA131285527	6584	0.98
NULL	Acta_Pharmacol_Sin_2009_May_6_30(5)_576-581.nxml.txt.nlp	19349965	SENT124	14	14	29	29	genistein	VR1	PA165109660	56664	0.98
NULL	Biomed_Res_Int_2014_May_12_2014_436123.nxml.txt.nlp	24900965	SENT71	3	3	17	17	celecoxib	PC3	PA448871	57332;7832;5122	0.98
NULL	Am_J_Transplant_2013_Aug_24_13(8)_2006-2018.nxml.txt.nlp	23710625	SENT284	22	22	2	2	isoflurane	HIF-1	PA450106	29072	0.98
NULL	Cell_Cycle_2012_Nov_1_11(21)_3983-3996.nxml.txt.nlp	22987153	SENT225	10	10	0	0	cisplatin	DNA2	PA449014	1763	0.98
NULL	J_Adv_Pract_Oncol_2012_Sep_1_Sep-Oct_3(5)_289-298.nxml.txt.nlp	25031958	SENT68	23	23	10	10	estradiol	aromatase	PA449503	1588	0.98
NULL	Biomed_Res_Int_2013_Jun_5_2013_348167.nxml.txt.nlp	23862143	SENT109	18	18	35	35	choline	NAC	PA448976	22861	0.98
NULL	Orphanet_J_Rare_Dis_2007_Jan_4_2_1.nxml.txt.nlp	17204147	SENT122	27	27	1	1	trypsin	PRSS1	PA451806	5644	0.98
NULL	Contemp_Oncol_(Pozn)_2012_Jan_4_16(6)_480-484.nxml.txt.nlp	23788933	SENT132	29	29	18	18	crizotinib	KRAS	PA165946122	3845	0.98
NULL	Cells_2012_Jul_27_1(3)_346-371.nxml.txt.nlp	24710480	SENT244	5	5	22	22	staurosporine	PI3K	PA165109623	5290	0.98
NULL	Environ_Health_Perspect_2004_Nov_16_112(15)_1519-1526.nxml.txt.nlp	15531437	SENT172	11	11	47	47	estradiol	AQP1	PA449503	358	0.98
NULL	Oncol_Lett_2013_Feb_7_5(2)_440-446.nxml.txt.nlp	23420122	SENT12	36	36	19	19	sorafenib	EGFR	PA7000	1956	0.98
NULL	J_Korean_Med_Sci_2014_Jul_11_29(7)_934-940.nxml.txt.nlp	25045225	SENT35	24	24	3	3	trypsin	spatial	PA451806	219793	0.98
NULL	Mol_Biol_Rep_2013_May_11_40(8)_5013-5026.nxml.txt.nlp	23666059	SENT217	5	5	14	14	resveratrol	p53		7157	0.98
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1563-1573.nxml.txt.nlp	22015557	SENT171	17	17	28	28	sunitinib	c-Myc	PA162372840	4609	0.98
NULL	Brain_Sci_2014_Jan_28_4(1)_73-90.nxml.txt.nlp	24961701	SENT135	0	0	13	13	ketamine	NR1	PA450144	27158	0.98
NULL	Chemother_Res_Pract_2012_Dec_20_2012_743193.nxml.txt.nlp	23320171	SENT116	0	0	6	6	lapatinib	HER2	PA152241907	2064	0.98
NULL	Acta_Pharmacol_Sin_2014_Jan_9_35(1)_1-10.nxml.txt.nlp	24317012	SENT23	24	24	0	0	methotrexate	OATP1B1	PA450428	10599	0.98
NULL	Br_J_Cancer_2013_Jan_15_108(1)_82-90.nxml.txt.nlp	23321512	SENT213	17	17	34	34	paclitaxel	TUBB3	PA450761	10381	0.98
NULL	Int_J_Mol_Sci_2014_Mar_12_15(3)_4356-4392.nxml.txt.nlp	24625663	SENT1309	9	9	16	16	cisplatin	p38	PA449014	10598;1432;7965	0.98
NULL	J_Cell_Mol_Med_2014_May_14_18(5)_811-823.nxml.txt.nlp	24628949	SENT11	12	12	4	4	docetaxel	FOXM1	PA449383	2305	0.98
NULL	Infect_Drug_Resist_2009_Apr_24_2_13-26.nxml.txt.nlp	21694884	SENT82	4	4	23	23	didanosine	TDF	PA449301	6736	0.98
NULL	Drugs_2014_Jul_18_74(11)_1209-1231.nxml.txt.nlp	25034361	SENT235	10	10	1	1	enoxaparin	STARS	PA449463	137735	0.98
NULL	Front_Endocrinol_(Lausanne)_2013_Jun_26_4_75.nxml.txt.nlp	23805127	SENT216	3	3	26	26	oxazepam	UGT1A9	PA450731	54600	0.98
NULL	J_Invest_Dermatol_2015_Jan_21_135(1)_279-288.nxml.txt.nlp	25050597	SENT182	30	30	36	36	salbutamol	FGF2	PA448068	2247;2258	0.98
NULL	Cells_2014_Nov_27_3(4)_1089-1101.nxml.txt.nlp	25437439	SENT104	19	19	24	24	morphine	TRPM7	PA450550	54822	0.98
NULL	Cancer_Cell_Int_2011_Nov_2_11_39.nxml.txt.nlp	22047021	SENT392	39	39	11	11	cisplatin	REV1	PA449014	51455	0.98
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT241	6	6	27	27	perifosine	DR5	PA165291471	8795	0.98
NULL	Anticancer_Agents_Med_Chem_2012_Feb_12(2)_163-171.nxml.txt.nlp	22043994	SENT23	29	29	2	2	cetuximab	BRAF	PA10040	673	0.98
NULL	Oncogene_2014_Jul_17_33(29)_3784-3793.nxml.txt.nlp	24013225	SENT330	27	27	7	7	clodronate	EGF	PA10239	1950	0.98
NULL	Clin_Mol_Allergy_2007_Jan_25_5_1.nxml.txt.nlp	17254346	SENT212	36	36	23	23	curcumin	IFN	PA151958596	3439	0.98
NULL	Cancer_Cell_Int_2002_Jul_5_2_7.nxml.txt.nlp	12234376	SENT7	8	8	2	2	staurosporine	BRCA1	PA165109623	672	0.98
NULL	Blood_Coagul_Fibrinolysis_2014_Sep_4_25(6)_561-570.nxml.txt.nlp	24717423	SENT55	0	0	9	9	heparin	ACT	PA449855	12;11332;9457;641455	0.98
NULL	Oncogene_2014_Jun_12_33(24)_3151-3160.nxml.txt.nlp	23851502	SENT19	16	16	8	8	everolimus	TSC1	PA164746311	7248	0.98
NULL	AJP_Rep_2013_May_3_3(1)_21-24.nxml.txt.nlp	23943704	SENT20	13	13	11	11	indomethacin	COX	PA449982	1351	0.98
NULL	J_Cancer_2012_Aug_24_3_354-361.nxml.txt.nlp	22962562	SENT88	13	13	1	1	chlorambucil	p53	PA448926	7157	0.98
NULL	J_Vet_Med_Sci_2014_Jun_15_76(6)_813-817.nxml.txt.nlp	24531829	SENT98	7	7	15	15	artesunate	DPT	PA165111697	1805	0.98
NULL	Colorectal_Dis_2012_Feb_14(2)_e31-e47.nxml.txt.nlp	21848897	SENT41	0	0	31	31	cetuximab	KRAS	PA10040	3845	0.98
NULL	J_Hematol_Oncol_2013_Jan_4_6_1.nxml.txt.nlp	23286345	SENT64	0	0	16	16	trastuzumab	HER2	PA451743	2064	0.98
NULL	Blood_Res_2013_Jun_25_48(2)_72-73.nxml.txt.nlp	23826573	SENT11	0	0	31	31	plerixafor	CD34	PA165958410	947	0.98
NULL	J_Biol_2009_Apr_15_8(3)_30.nxml.txt.nlp	19435483	SENT53	4	4	27	27	imatinib	KIT	PA10804	3815	0.98
NULL	EPMA_J_2011_Mar_10_2(1)_27-38.nxml.txt.nlp	21654904	SENT169	4	4	43	43	darapladib	IL-6	PA165884699	3569	0.98
NULL	Indian_J_Pharm_Sci_2013_Jan-Feb_75(1)_31-35.nxml.txt.nlp	23901158	SENT49	23	23	8	8	cefpodoxime	DCX	PA164746385	1641	0.98
NULL	Cancer_Cell_Int_2013_Nov_8_13_111.nxml.txt.nlp	24209962	SENT78	27	27	21	21	fluvastatin	A20	PA449688	7128;28935	0.98
NULL	Case_Rep_Oncol_2012_Dec_6_5(3)_651-656.nxml.txt.nlp	23275781	SENT30	0	0	34	34	sunitinib	FLT3	PA162372840	2322	0.98
NULL	Curr_Neuropharmacol_2014_Jul_12(4)_365-379.nxml.txt.nlp	25342944	SENT97	8	8	20	20	fluoxetine	ADAR2	PA449673	104	0.98
NULL	Cancer_Cell_Int_2014_Jun_11_14_49.nxml.txt.nlp	24991192	SENT73	33	33	10	10	berberine	AMPK	PA165860812	5563	0.98
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_67-74.nxml.txt.nlp	17912637	SENT58	24	24	14	14	anastrozole	ATAC	PA448432	6375	0.98
NULL	Endocrinol_Metab_(Seoul)_2014_Jun_26_29(2)_206-207.nxml.txt.nlp	25031895	SENT12	19	19	2	2	thyroglobulin	WBS	PA164754910	2006	0.98
NULL	Clin_Drug_Investig_2013_Aug_23_33(10)_727-736.nxml.txt.nlp	23975654	SENT172	8	8	33	33	bupropion	CYP2C19	PA448687	1557	0.98
NULL	Indian_J_Psychiatry_2010_Jan_52(Suppl1)_S120-S127.nxml.txt.nlp	21836667	SENT301	12	12	0	0	clozapine	CYP1A2	PA449061	1544	0.98
NULL	Nucleic_Acids_Res_2005_Oct_31_33(19)_6251-6257.nxml.txt.nlp	16260474	SENT165	19	19	3	3	mitomycin	RecQL1	PA450524	5965	0.98
NULL	Chemother_Res_Pract_2012_Dec_20_2012_743193.nxml.txt.nlp	23320171	SENT121	0	0	7	7	pertuzumab	HER2		2064	0.98
NULL	J_Biol_Chem_2013_Aug_23_288(34)_24799-24808.nxml.txt.nlp	23836892	SENT184	4	4	30	30	s-adenosylmethionine	NDUFAF7	PA164754994	55471	0.98
NULL	Breast_Cancer_Res_2010_Jul_22_12(4)_R53.nxml.txt.nlp	20649975	SENT15	26	26	15	15	tamoxifen	HOXB13	PA451581	10481	0.98
NULL	Breast_Cancer_Res_2012_Jul_20_14(4)_R110.nxml.txt.nlp	22817698	SENT167	35	35	22	22	cisplatin	BRCA1	PA449014	672	0.98
NULL	Clin_Med_Insights_Arthritis_Musculoskelet_Disord_2012_Jan_5_5_1-14.nxml.txt.nlp	22267947	SENT122	33	33	19	19	risedronate	NNT	PA451255	23530	0.98
NULL	J_Hematol_Oncol_2008_Oct_1_1_16.nxml.txt.nlp	18828924	SENT114	0	0	11	11	tanespimycin	Hsp90	PA165291490	3320	0.98
NULL	J_Neural_Transm_2014_Mar_27_121(10)_1221-1232.nxml.txt.nlp	24671607	SENT243	28	28	0	0	ethanol	PSD-95	PA448073	1742	0.98
NULL	Oncotarget_2014_Aug_29_5(19)_8947-8958.nxml.txt.nlp	25333254	SENT166	7	7	13	13	plerixafor	CXCR4	PA165958410	7852	0.98
NULL	Acta_Pharmacol_Sin_2010_Nov_18_31(11)_1447-1453.nxml.txt.nlp	20953204	SENT99	1	1	13	13	rimonabant	PI3K	PA152407999	5290	0.98
NULL	Int_J_Biol_Sci_2014_Jun_10_10(7)_654-663.nxml.txt.nlp	25013375	SENT225	0	0	10	10	nitroxoline	SIRT1	PA164754993	23411	0.98
NULL	Eur_J_Clin_Pharmacol_2013_Mar_5_69(3)_467-475.nxml.txt.nlp	22864379	SENT29	34	34	15	15	coumarin	VKORC1	PA134521193	79001	0.98
NULL	Libyan_J_Med_2007_Jun_1_2(2)_66-72.nxml.txt.nlp	21503256	SENT169	13	13	19	19	cinnarizine	DIP	PA164749342	23151;1831	0.98
NULL	Nat_Commun_2013_Apr_23_4_1758.nxml.txt.nlp	23612299	SENT133	0	0	20	20	isoproterenol	SOD1	PA450121	6647	0.98
NULL	Oncotarget_2014_Aug_29_5(19)_8947-8958.nxml.txt.nlp	25333254	SENT104	14	14	3	3	plerixafor	CXCR4	PA165958410	7852	0.98
NULL	Mol_Cancer_2010_Apr_12_9_75.nxml.txt.nlp	20385023	SENT124	0	0	3	3	lapatinib	EGFR	PA152241907	1956	0.98
NULL	Indian_J_Endocrinol_Metab_2013_Jul-Aug_17(4)_636-646.nxml.txt.nlp	23961479	SENT138	5	5	16	16	atorvastatin	CYP2C9	PA448500	1559	0.98
NULL	Indian_J_Endocrinol_Metab_2013_Jul-Aug_17(4)_636-646.nxml.txt.nlp	23961479	SENT138	5	5	9	9	atorvastatin	CYP3A4	PA448500	1576	0.98
NULL	Int_Semin_Surg_Oncol_2008_Apr_28_5_9.nxml.txt.nlp	18442393	SENT70	24	24	14	14	tamoxifen	HER-2	PA451581	2064	0.98
NULL	Oncogene_2014_Oct_23_33(43)_5109-5120.nxml.txt.nlp	24858043	SENT81	32	32	9	9	pp2	MCT-1		28985	0.98
NULL	eLife_2014_May_6_3_e02482.nxml.txt.nlp	24843002	SENT73	9	9	2	2	etoposide	SETD2	PA449552	29072	0.98
NULL	EMBO_Mol_Med_2011_Jul_3(7)_410-427.nxml.txt.nlp	21567994	SENT402	5	5	23	23	bezafibrate	COX10	PA162364313	1352	0.98
NULL	J_Mol_Signal_2008_Dec_1_3_18.nxml.txt.nlp	19046439	SENT98	5	5	25	25	metformin	AMPK	PA450395	5563	0.98
NULL	Oncol_Rep_2014_Dec_13_32(6)_2307-2318.nxml.txt.nlp	25310523	SENT33	39	39	21	21	gemcitabine	S100A4	PA449748	6275	0.98
NULL	Cancer_Cell_Int_2014_Jan_29_14_10.nxml.txt.nlp	24472145	SENT197	27	27	41	41	cisplatin	HER-2	PA449014	2064	0.98
NULL	Evid_Based_Complement_Alternat_Med_2011_Mar_20_2011_612464.nxml.txt.nlp	21799683	SENT169	28	28	10	10	estradiol	SP6	PA449503	80320	0.98
NULL	Ann_Med_2014_Nov_21_46(7)_475-489.nxml.txt.nlp	25045928	SENT156	0	0	16	16	ticlopidine	ADP	PA451686	23038	0.98
NULL	Glia_2013_Aug_6_61(8)_1331-1346.nxml.txt.nlp	23832647	SENT304	25	25	4	4	clodronate	CXCR4	PA10239	7852	0.98
NULL	Cancer_Imaging_2012_May_25_12(1)_225-235.nxml.txt.nlp	22743083	SENT23	0	0	7	7	bevacizumab	VEGF-A	PA130232992	7422	0.98
NULL	Nat_Commun_2012_Dec_4_3_1248.nxml.txt.nlp	23212377	SENT571	4	4	36	36	nadh	NADK	PA164755085	65220	0.98
NULL	Ann_Gastroenterol_2014_27(3)_200-206.nxml.txt.nlp	24976114	SENT138	6	6	1	1	capsaicin	TRPV1	PA448776	7442	0.98
NULL	Mol_Cytogenet_2013_Jul_16_6_27.nxml.txt.nlp	23866735	SENT31	12	12	22	22	imatinib	ELN	PA10804	2006	0.98
NULL	AIDS_Res_Treat_2014_Feb_25_2014_636584.nxml.txt.nlp	24715982	SENT33	0	0	27	27	nevirapine	CD4	PA450616	920	0.98
NULL	Br_J_Clin_Pharmacol_2012_Apr_7_73(4)_518-535.nxml.txt.nlp	22053916	SENT50	3	3	15	15	pitavastatin	OATP1B1	PA142650384	10599	0.98
NULL	Br_J_Pharmacol_2014_Jun_15_171(11)_2705-2725.nxml.txt.nlp	24467436	SENT59	3	3	14	14	hydralazine	NAT	PA449894	6046	0.98
NULL	Ann_Thorac_Med_2014_Jul-Sep_9(Suppl_1)_S79-S91.nxml.txt.nlp	25077002	SENT146	0	0	8	8	bosentan	ETB	PA10034	1910	0.98
NULL	EMBO_Mol_Med_2011_Aug_3(8)_465-479.nxml.txt.nlp	21674808	SENT36	5	5	19	19	doxycycline	Erb	PA449415	2100	0.98
NULL	Cancers_(Basel)_2014_Jul_8_6(3)_1487-1499.nxml.txt.nlp	25006835	SENT522	7	7	20	20	cisplatin	ERK	PA449014	5594	0.98
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT190	22	22	2	2	trastuzumab	COL17A1	PA451743	1308	0.98
NULL	Exp_Lung_Res_2013_Oct_1_39(8)_336-348.nxml.txt.nlp	23919450	SENT103	4	4	10	10	thrombin	PAR-1	PA451674	2011;2149	0.98
NULL	Cancer_Cell_Int_2006_Aug_9_6_20.nxml.txt.nlp	16899133	SENT218	2	2	17	17	l-methionine	p27	PA450423	5715;10534	0.98
NULL	Braz_J_Med_Biol_Res_2013_Aug_13_46(8)_650-658.nxml.txt.nlp	23969971	SENT164	18	18	9	9	cisplatin	STAT3	PA449014	6774	0.98
NULL	Ann_Gen_Psychiatry_2009_May_18_8_13.nxml.txt.nlp	19450269	SENT134	5	5	18	18	naratriptan	5-HT2C	PA450597	3358	0.98
NULL	Structure_2013_Jun_4_21(6)_910-919.nxml.txt.nlp	23727230	SENT63	9	9	29	29	glutaraldehyde	ADP	PA449777	23038	0.98
NULL	Front_Zool_2011_Nov_29_8_31.nxml.txt.nlp	22126599	SENT129	33	33	3	3	pp2	PP2		4888	0.98
NULL	Br_J_Cancer_2013_Jul_23_109(2)_351-359.nxml.txt.nlp	23799854	SENT119	16	16	6	6	paclitaxel	BLT2	PA450761	56413	0.98
NULL	J_Clin_Biochem_Nutr_2010_Jan_29_46(1)_87-92.nxml.txt.nlp	20104270	SENT103	10	10	18	18	hesperidin	adiponectin	PA449867	9370	0.98
NULL	ACS_Med_Chem_Lett_2011_May_16_2(7)_549-554.nxml.txt.nlp	21765967	SENT80	29	29	19	19	maraviroc	CCR5	PA164768835	1234	0.98
NULL	Oncol_Rep_2014_Feb_13_31(2)_581-588.nxml.txt.nlp	24337105	SENT146	4	4	19	19	capsaicin	Bcl-2	PA448776	596	0.98
NULL	Contemp_Oncol_(Pozn)_2012_Nov_20_16(5)_401-406.nxml.txt.nlp	23788917	SENT150	4	4	27	27	afatinib	HER2	PA165981154	2064	0.98
NULL	Clin_Dev_Immunol_2013_Nov_25_2013_271246.nxml.txt.nlp	24371445	SENT352	18	18	5	5	irinotecan	ALCAM	PA450085	214	0.98
NULL	J_Oncol_2010_Nov_19_2010_568938.nxml.txt.nlp	20037743	SENT114	18	18	31	31	trastuzumab	HER2	PA451743	2064	0.98
NULL	Breast_Cancer_Res_2013_Nov_29_15(6)_R114.nxml.txt.nlp	24289103	SENT41	20	20	10	10	tamoxifen	EGFR	PA451581	1956	0.98
NULL	Mol_Cancer_2008_Mar_26_7_27.nxml.txt.nlp	18366759	SENT43	0	0	10	10	etoposide	p53	PA449552	7157	0.98
NULL	Braz_J_Med_Biol_Res_2014_Oct_14_47(12)_1068-1074.nxml.txt.nlp	25387674	SENT128	24	24	3	3	taurine	HCS	PA451590	3141;54205	0.98
NULL	Ann_Surg_Oncol_2010_Apr_20_17(4)_1168-1176.nxml.txt.nlp	19936839	SENT117	16	16	38	38	cetuximab	KRAS	PA10040	3845	0.98
NULL	J_Adv_Pract_Oncol_2014_Mar_1_Mar-Apr_5(2)_134-139.nxml.txt.nlp	25032047	SENT46	5	5	9	9	trastuzumab	HER2	PA451743	2064	0.98
NULL	Mar_Drugs_2014_Jun_27_12(7)_3818-3837.nxml.txt.nlp	24979269	SENT66	5	5	36	36	calcein	P-gp	PA132595336	5243	0.98
NULL	Allergy_2014_Jul_29_69(7)_817-827.nxml.txt.nlp	24773466	SENT209	2	2	16	16	imatinib	IL-4	PA10804	3565	0.98
NULL	J_Cardiothorac_Surg_2012_Sep_27_7_97.nxml.txt.nlp	23013706	SENT25	25	25	10	10	warfarin	CYP4F2	PA451906	8529	0.98
NULL	Core_Evid_2010_Oct_21_5_77-90.nxml.txt.nlp	21042544	SENT185	4	4	1	1	aprepitant	NK1	PA164747039	11126	0.98
NULL	Int_J_Biol_Sci_2015_Jan_1_11(2)_144-155.nxml.txt.nlp	25561897	SENT209	22	22	4	4	cisplatin	POLB	PA449014	5423	0.98
NULL	Breast_Cancer_Res_2010_Jun_28_12(3)_R43.nxml.txt.nlp	20579400	SENT27	26	26	6	6	cyclophosphamide	MAPT	PA449165	4137	0.98
NULL	Adipocyte_2012_Oct_1_1(4)_256-258.nxml.txt.nlp	23700542	SENT33	20	20	6	6	resveratrol	AMPK		5563	0.98
NULL	J_Cell_Mol_Med_2013_Oct_23_17(10)_1207-1217.nxml.txt.nlp	24106980	SENT130	26	26	6	6	cisplatin	PDCD4	PA449014	27250	0.98
NULL	J_Exp_Med_1995_Aug_1_182(2)_419-429.nxml.txt.nlp	7543137	SENT1	21	21	1	1	hyaluronan	CD44	PA165958431	960	0.98
NULL	Diabetes_Care_2011_May_20_34(5)_1199-1204.nxml.txt.nlp	21464461	SENT8	34	34	13	13	ramipril	NPR3	PA451223	4883;8131	0.98
NULL	Arthritis_Res_Ther_2012_Jul_27_14(4)_R175.nxml.txt.nlp	22838733	SENT189	41	41	10	10	adalimumab	CD14	PA10004	929	0.98
NULL	Breast_Cancer_Res_2014_May_5_16(3)_R45.nxml.txt.nlp	24887236	SENT278	12	12	5	5	lapatinib	HER3	PA152241907	2065	0.98
NULL	J_Thromb_Thrombolysis_2012_Feb_20_33(2)_143-153.nxml.txt.nlp	22183178	SENT20	23	23	2	2	clopidogrel	P2Y12	PA449053	64805	0.98
NULL	Cell_Death_Dis_2010_Jul_1_1(7)_e51.nxml.txt.nlp	21364656	SENT70	34	34	6	6	gentamicin	survivin	PA449753	332	0.98
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT42	22	22	3	3	trastuzumab	PTEN	PA451743	5728	0.98
NULL	Cancers_(Basel)_2011_Sep_21_3(3)_3676-3686.nxml.txt.nlp	24212973	SENT123	11	11	2	2	gemcitabine	CXCR4	PA449748	7852	0.98
NULL	Pain_2014_Nov_155(11)_2243-2252.nxml.txt.nlp	24978826	SENT175	38	38	7	7	capsaicin	IL4	PA448776	3565	0.98
NULL	Eur_Radiol_2011_Jun_3_21(6)_1188-1199.nxml.txt.nlp	21127880	SENT211	16	16	6	6	trastuzumab	HER2	PA451743	2064	0.98
NULL	Arthritis_Res_Ther_2012_Jan_8_14(1)_R6.nxml.txt.nlp	22225620	SENT196	31	31	1	1	rituximab	CXCL13	PA451261	10563	0.98
NULL	Breast_Cancer_(Auckl)_2009_Sep_2_3_61-75.nxml.txt.nlp	19809577	SENT127	38	38	30	30	curcumin	survivin	PA151958596	332	0.98
NULL	Oncol_Rep_2013_Aug_27_30(2)_545-552.nxml.txt.nlp	23708326	SENT142	14	14	23	23	sunitinib	VEGFR	PA162372840	3791	0.98
NULL	Braz_J_Med_Biol_Res_2012_Sep_21_45(12)_1240-1243.nxml.txt.nlp	22983178	SENT101	29	29	6	6	indomethacin	CB1	PA449982	1268	0.98
NULL	Diabetes_Metab_Syndr_Obes_2010_Oct_27_3_363-372.nxml.txt.nlp	21437106	SENT51	2	2	11	11	metformin	GLP-1	PA450395	100125288	0.98
NULL	Oncotarget_2012_Jul_22_3(7)_678-685.nxml.txt.nlp	22824673	SENT66	9	9	3	3	trypsin	rTS	PA451806	55556	0.98
NULL	J_Korean_Med_Sci_2012_Sep_22_27(9)_1037-1043.nxml.txt.nlp	22969249	SENT97	19	19	7	7	paricalcitol	CDK6	PA450798	1021	0.98
NULL	Exp_Brain_Res_2014_Jun_27_232(8)_2637-2644.nxml.txt.nlp	24969614	SENT140	19	19	10	10	palonosetron	NK1	PA10352	11126	0.98
NULL	Breast_Cancer_Res_2010_Jul_20_12(4)_R52.nxml.txt.nlp	20646288	SENT26	11	11	15	15	letrozole	aromatase	PA450196	1588	0.98
NULL	Cell_Cycle_2014_Jan_15_13(2)_303-314.nxml.txt.nlp	24247149	SENT168	14	14	1	1	gemcitabine	p53	PA449748	7157	0.98
NULL	Pain_2014_Jan_155(1)_168-178.nxml.txt.nlp	24076162	SENT88	13	13	2	2	pentobarbital	P21	PA450859	1026;9338	0.98
NULL	Oncogene_2010_Jul_15_29(28)_4090-4100.nxml.txt.nlp	20473326	SENT92	24	24	12	12	camptothecin	MDM2	PA153590860	4193	0.98
NULL	Mol_Cancer_2010_Nov_2_9_289.nxml.txt.nlp	21044322	SENT10	5	5	14	14	vincristine	RGS17	PA451879	26575	0.98
NULL	Indian_J_Anaesth_2009_Oct_53(5)_582-591.nxml.txt.nlp	20640109	SENT81	19	19	31	31	clopidogrel	CYP3A4	PA449053	1576	0.98
NULL	Oxid_Med_Cell_Longev_2012_May_28_2012_632959.nxml.txt.nlp	22690272	SENT85	0	0	24	24	resveratrol	PC-3		692094	0.98
NULL	Cell_Death_Dis_2013_Oct_3_4(10)_e827.nxml.txt.nlp	24091670	SENT88	17	17	37	37	nilotinib	CD34	PA165958345	947	0.98
NULL	JAKSTAT_2013_Jan_1_2(1)_e22882.nxml.txt.nlp	24058788	SENT123	33	33	12	12	doxorubicin	STAT3	PA449412	6774	0.98
NULL	Diabetes_Metab_Syndr_Obes_2014_Aug_1_7_381-389.nxml.txt.nlp	25120374	SENT143	12	12	6	6	salsalate	AMPK	PA164745462	5563	0.98
NULL	Clin_Sci_(Lond)_2011_Feb_1_120(Pt_4)_161-167.nxml.txt.nlp	20828371	SENT79	29	29	18	18	propranolol	CTRL	PA451145	1506	0.98
NULL	JAKSTAT_2013_Jan_1_2(1)_e23576.nxml.txt.nlp	24058797	SENT191	20	20	4	4	staurosporine	IFN	PA165109623	3439	0.98
NULL	Cancers_(Basel)_2013_Nov_26_5(4)_1601-1618.nxml.txt.nlp	24287743	SENT122	12	12	21	21	gefitinib	Met	PA131301952	79811	0.98
NULL	Cancers_(Basel)_2011_May_18_3(2)_2444-2461.nxml.txt.nlp	24212818	SENT165	40	40	5	5	sorafenib	EGFR	PA7000	1956	0.98
NULL	Curr_Cardiol_Rev_2012_Aug_8(3)_239-249.nxml.txt.nlp	22935021	SENT187	0	0	21	21	thrombin	VIII	PA451674	1351	0.98
NULL	Br_J_Cancer_2013_Jul_23_109(2)_351-359.nxml.txt.nlp	23799854	SENT146	2	2	5	5	verapamil	MDR1	PA451868	5243	0.98
NULL	Springerplus_2014_Sep_9_3_510.nxml.txt.nlp	25279302	SENT34	3	3	21	21	creatine	AGAT	PA164778930	2628	0.98
NULL	Biomed_Res_Int_2014_Jun_4_2014_253243.nxml.txt.nlp	24995279	SENT81	5	5	17	17	chlorambucil	CHOP	PA448926	1649	0.98
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT319	34	34	3	3	nutlin-3	DR5		8795	0.98
NULL	Int_J_Mol_Sci_2014_Nov_14_15(11)_20927-20947.nxml.txt.nlp	25405729	SENT14	18	18	2	2	anastrozole	aromatase	PA448432	1588	0.98
NULL	Nat_Med_2010_Feb_24_16(2)_214-218.nxml.txt.nlp	20098429	SENT69	35	35	1	1	epirubicin	MTDH	PA449476	92140	0.98
NULL	Diabetes_Metab_Syndr_Obes_2010_Mar_29_3_31-41.nxml.txt.nlp	21437074	SENT157	20	20	2	2	liraglutide	GLP-1	PA165958364	100125288	0.98
NULL	Oncotarget_2011_Dec_22_2(12)_1176-1190.nxml.txt.nlp	22202492	SENT119	4	4	16	16	fluvastatin	PLA2G7	PA449688	7941	0.98
NULL	J_Adv_Pract_Oncol_2012_Jul_1_Jul-Aug_3(4)_267-272.nxml.txt.nlp	25031955	SENT107	37	37	24	24	crizotinib	BRAF	PA165946122	673	0.98
NULL	Ann_Oncol_2010_Feb_21(2)_217-222.nxml.txt.nlp	20110292	SENT158	24	24	11	11	erlotinib	PSPH	PA134687924	5723	0.98
NULL	Diabetes_2011_Jun_21_60(6)_1797-1804.nxml.txt.nlp	21536946	SENT187	2	2	11	11	diazoxide	SUR1	PA449285	6833	0.98
NULL	Acta_Pharmacol_Sin_2010_Mar_22_31(3)_329-340.nxml.txt.nlp	20173759	SENT28	11	11	5	5	ethanol	AMPK	PA448073	5563	0.98
NULL	Int_J_Endocrinol_2010_May_26_2010_906163.nxml.txt.nlp	20585352	SENT34	0	0	16	16	cinacalcet	PTH	PA164776671	5741	0.98
NULL	Food_Addit_Contam_Part_A_Chem_Anal_Control_Expo_Risk_Assess_2014_Oct_3_31(10)_176916-1782.nxml.txt.nlp	25105506	SENT141	6	6	12	12	ethanol	AF4	PA448073	4299	0.98
NULL	Mol_Cancer_2014_Jun_5_13_143.nxml.txt.nlp	24898067	SENT37	28	28	15	15	trastuzumab	DM1	PA451743	338023;1760;28509	0.98
NULL	Aging_(Albany_NY)_2011_Apr_6_3(4)_444-449.nxml.txt.nlp	21483037	SENT15	0	0	19	19	resveratrol	SIRT1		23411	0.98
NULL	Diabetes_Metab_J_2012_Feb_17_36(1)_13-25.nxml.txt.nlp	22363917	SENT155	6	6	23	23	liraglutide	GLP-1	PA165958364	100125288	0.98
NULL	Acta_Pharmacol_Sin_2009_Feb_26_30(2)_175-183.nxml.txt.nlp	19169269	SENT111	33	33	20	20	iptakalim	NUP54	PA165949694	53371	0.98
NULL	Br_J_Pharmacol_2014_Oct_26_171(20)_4785-4796.nxml.txt.nlp	25074741	SENT8	5	5	10	10	guanfacine	EPM	PA449825	2054	0.98
NULL	Osteoporos_Int_2012_Feb_4_23(Suppl_1)_S1-S23.nxml.txt.nlp	22311111	SENT434	0	0	20	20	denosumab	RANKL	PA166048634	8600	0.98
NULL	Br_J_Cancer_2012_Feb_14_106(4)_685-692.nxml.txt.nlp	22294184	SENT115	19	19	8	8	lovastatin	Bcl-2	PA450272	596	0.98
NULL	Mol_Cancer_2014_Jan_28_13_17.nxml.txt.nlp	24472312	SENT239	23	23	3	3	ponatinib	Mcl-1	PA165980594	4170	0.98
NULL	Ann_Hematol_2014_Sep_10_93(1)_1-11.nxml.txt.nlp	24018623	SENT135	27	27	20	20	lenalidomide	CDC25C	PA162363968	995	0.98
NULL	J_Biol_Chem_2008_Oct_31_283(44)_29841-29846.nxml.txt.nlp	18765669	SENT186	19	19	7	7	suramin	P2X4	PA10292	5025	0.98
NULL	Adv_Hematol_2012_Jun_19_2012_851674.nxml.txt.nlp	22778745	SENT224	7	7	11	11	indomethacin	COX	PA449982	1351	0.98
NULL	Mol_Cancer_2012_Jul_12_11_45.nxml.txt.nlp	22788833	SENT153	9	9	17	17	cisplatin	HER2	PA449014	2064	0.98
NULL	Biologics_2014_Apr_23_8_183-192.nxml.txt.nlp	24790411	SENT160	3	3	31	31	afatinib	EGFR	PA165981154	1956	0.98
NULL	J_Cell_Mol_Med_2014_May_14_18(5)_811-823.nxml.txt.nlp	24628949	SENT144	15	15	19	19	docetaxel	FOXM1	PA449383	2305	0.98
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT327	26	26	9	9	pegaptanib	VEGF-A	PA164771236	7422	0.98
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT158	19	19	0	0	trastuzumab	MUC1	PA451743	4582	0.98
NULL	Int_J_Mol_Sci_2014_Oct_15_15(10)_18574-18592.nxml.txt.nlp	25322151	SENT79	22	22	5	5	sirolimus	IL-2	PA451365	3558	0.98
NULL	Arthritis_Res_Ther_2012_Feb_9_14(Suppl_1)_O24.nxml.txt.nlp	NULL	SENT17	1	1	20	20	nitroprusside	IL-17	PA451406	3605	0.98
NULL	Oncotarget_2011_Mar_7_2(3)_122-134.nxml.txt.nlp	21399234	SENT32	31	31	3	3	urokinase	FGF2	PA451836	2247;2258	0.98
NULL	Oncotarget_2014_Jun_6_5(13)_4935-4944.nxml.txt.nlp	24952732	SENT90	8	8	21	21	doxazosin	PI3K	PA449407	5290	0.98
NULL	J_Cell_Biol_1984_Oct_1_99(4)_1259-1265.nxml.txt.nlp	6090469	SENT10	10	10	25	25	chloroquine	EGF	PA448948	1950	0.98
NULL	Oncol_Lett_2014_May_11_7(5)_1401-1408.nxml.txt.nlp	24765145	SENT6	22	22	12	12	paclitaxel	PI3K	PA450761	5290	0.98
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Dec_10_3(12)_e151.nxml.txt.nlp	25494035	SENT114	1	1	26	26	rosuvastatin	OATP1B1	PA134308647	10599	0.98
NULL	Arthritis_Res_Ther_2013_Aug_30_15(4)_R100.nxml.txt.nlp	24000795	SENT123	25	25	4	4	methotrexate	IL-6	PA450428	3569	0.98
NULL	Gut_Liver_2011_Jun_24_5(2)_117-132.nxml.txt.nlp	21814590	SENT159	7	7	33	33	ribavirin	IFN	PA451241	3439	0.98
NULL	J_Hematol_Oncol_2010_Oct_27_3_42.nxml.txt.nlp	20979652	SENT177	21	21	5	5	carboplatin	EGFR	PA448803	1956	0.98
NULL	Int_J_Biol_Sci_2012_Mar_7_8(4)_470-485.nxml.txt.nlp	22419892	SENT262	32	32	22	22	tamoxifen	SRC-3	PA451581	8202	0.98
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT176	3	3	11	11	tacrolimus	RANKL	PA451578	8600	0.98
NULL	Arthritis_Res_Ther_2010_Jan_22_12(1)_R11.nxml.txt.nlp	20096109	SENT177	29	29	13	13	infliximab	IFN	PA452639	3439	0.98
NULL	Int_J_Biol_Sci_2013_Apr_22_9(4)_350-360.nxml.txt.nlp	23630447	SENT141	6	6	11	11	doxorubicin	MDR1	PA449412	5243	0.98
NULL	Anticancer_Drugs_2015_Jan_28_26(1)_46-55.nxml.txt.nlp	25099621	SENT92	42	42	5	5	hydroxyurea	KE-3	PA449942	6222	0.98
NULL	Exp_Ther_Med_2012_Sep_29_4(3)_524-532.nxml.txt.nlp	23181130	SENT129	0	0	22	22	mk-571	MRP4		10257	0.98
NULL	Braz_J_Med_Biol_Res_2013_Aug_13_46(8)_650-658.nxml.txt.nlp	23969971	SENT31	1	1	35	35	oxaliplatin	STAT3	PA131285527	6774	0.98
NULL	Eur_J_Clin_Pharmacol_2011_May_8_67(5)_493-506.nxml.txt.nlp	21140139	SENT156	5	5	1	1	clarithromycin	CYP3A4	PA449028	1576	0.98
NULL	Cell_Death_Dis_2012_Mar_15_3(3)_e283.nxml.txt.nlp	22419112	SENT45	22	22	8	8	cisplatin	CSIG	PA449014	26156	0.98
NULL	J_Mol_Med_(Berl)_2014_May_10_92(7)_709-722.nxml.txt.nlp	24811491	SENT97	28	28	16	16	vemurafenib	EGFR	PA165946873	1956	0.98
NULL	Evid_Based_Complement_Alternat_Med_2013_Nov_5_2013_715040.nxml.txt.nlp	24302969	SENT82	22	22	2	2	gentamicin	OPG	PA449753	690	0.98
NULL	Cancer_Imaging_2008_Nov_25_8(1)_199-205.nxml.txt.nlp	19028612	SENT125	19	19	37	37	sorafenib	VEGFR	PA7000	3791	0.98
NULL	Eur_J_Clin_Pharmacol_2010_Nov_29_66(11)_1131-1136.nxml.txt.nlp	20669013	SENT128	44	44	10	10	voriconazole	CYP3A4	PA10233	1576	0.98
NULL	Breast_Cancer_Res_2004_Jun_29_6(5)_R488-R498.nxml.txt.nlp	15318931	SENT175	5	5	12	12	estradiol	UGT2B15	PA449503	7366	0.98
NULL	Int_J_Gen_Med_2012_May_4_5_403-411.nxml.txt.nlp	22615536	SENT11	12	12	1	1	metformin	RBP4	PA450395	5433;5950	0.98
NULL	Oncotarget_2014_Aug_29_5(18)_8052-8082.nxml.txt.nlp	25211298	SENT126	0	0	13	13	aprepitant	NK-1	PA164747039	27087	0.98
NULL	Br_J_Cancer_2010_Jan_5_102(1)_80-86.nxml.txt.nlp	19920817	SENT78	12	12	23	23	sunitinib	IFN	PA162372840	3439	0.98
NULL	J_Biomed_Biotechnol_2010_Jun_7_2010_150960.nxml.txt.nlp	20617134	SENT200	28	28	9	9	cetuximab	KRAS	PA10040	3845	0.98
NULL	Cardiovasc_Res_2014_Mar_1_101(3)_513-521.nxml.txt.nlp	24323316	SENT134	9	9	22	22	maraviroc	CCL3	PA164768835	6348	0.98
NULL	Br_J_Cancer_2010_May_11_102(10)_1495-1502.nxml.txt.nlp	20461092	SENT131	7	7	13	13	lapatinib	EGFR	PA152241907	1956	0.98
NULL	Cancer_Imaging_2011_Jan_11_11(1)_259-265.nxml.txt.nlp	22245974	SENT163	27	27	4	4	sunitinib	FDG	PA162372840	23583	0.98
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT120	16	16	6	6	trastuzumab	STAT3	PA451743	6774	0.98
NULL	Case_Rep_Gastroenterol_2011_Jun_10_5(2)_336-343.nxml.txt.nlp	21712950	SENT84	31	31	1	1	ezetimibe	NPC1L1	PA10816	29881	0.98
NULL	ScientificWorldJournal_2012_Apr_26_2012_358102.nxml.txt.nlp	22645419	SENT144	11	11	24	24	losartan	AT2	PA450268	186	0.98
NULL	Braz_J_Med_Biol_Res_2013_Aug_13_46(8)_650-658.nxml.txt.nlp	23969971	SENT206	19	19	11	11	cisplatin	STAT3	PA449014	6774	0.98
NULL	Semin_Immunopathol_2013_May_10_35(3)_351-373.nxml.txt.nlp	23572207	SENT371	24	24	6	6	bortezomib	XBP1	PA10252	7494	0.98
NULL	Cancer_Cell_Int_2010_May_11_10_16.nxml.txt.nlp	20459793	SENT86	9	9	31	31	cisplatin	ABCC5	PA449014	10057	0.98
NULL	Diabetes_Care_2009_Oct_8_32(10)_1873-1879.nxml.txt.nlp	19587362	SENT107	7	7	16	16	irbesartan	ANG	PA450084	283	0.98
NULL	Breast_Cancer_Res_2005_Apr_12_7(4)_R570-R579.nxml.txt.nlp	15987464	SENT41	6	6	31	31	gefitinib	EGFR	PA131301952	1956	0.98
NULL	Br_J_Cancer_2012_Jan_17_106(2)_348-357.nxml.txt.nlp	22146521	SENT114	20	20	3	3	gemcitabine	TP53	PA449748	7157	0.98
NULL	Arch_Drug_Inf_2009_Mar_2(1)_8-16.nxml.txt.nlp	19381336	SENT28	2	2	8	8	ritonavir	CYP3A4	PA451260	1576	0.98
NULL	Acta_Pharmacol_Sin_2011_Oct_15_32(10)_1225-1232.nxml.txt.nlp	21841809	SENT170	4	4	18	18	aripiprazole	CYP2D6	PA10026	1565	0.98
NULL	Iran_Red_Crescent_Med_J_2014_Aug_5_16(8)_e6915.nxml.txt.nlp	25389496	SENT14	12	12	5	5	simvastatin	adiponectin	PA451363	9370	0.98
NULL	J_Cancer_2012_Mar_12_3_137-144.nxml.txt.nlp	22481979	SENT31	15	15	6	6	capecitabine	HER2	PA448771	2064	0.98
NULL	Mol_Cancer_2012_Jul_25_11_47.nxml.txt.nlp	22830443	SENT33	16	16	4	4	panitumumab	KRAS	PA162373091	3845	0.98
NULL	Front_Oncol_2014_Aug_11_4_204.nxml.txt.nlp	25157335	SENT69	0	0	8	8	afatinib	EGFR	PA165981154	1956	0.98
NULL	Int_J_Mol_Sci_2013_Apr_2_14(4)_7405-7432.nxml.txt.nlp	23549272	SENT61	26	26	0	0	spermine	Met	PA164781199	79811	0.98
NULL	Oncogene_2009_Jan_15_28(2)_279-288.nxml.txt.nlp	18836480	SENT117	28	28	12	12	pp2	EGF		1950	0.98
NULL	Cardiol_Ther_2013_Jun_7_2(1)_57-68.nxml.txt.nlp	25135289	SENT58	20	20	6	6	trypsin	PAR-1	PA451806	2011;2149	0.98
NULL	Aging_(Albany_NY)_2010_Dec_14_2(12)_945-958.nxml.txt.nlp	21164223	SENT170	16	16	8	8	metformin	LKB1	PA450395	6794	0.98
NULL	Cancer_Manag_Res_2012_Sep_12_4_299-307.nxml.txt.nlp	23049279	SENT28	0	0	14	14	vemurafenib	BRAF	PA165946873	673	0.98
NULL	Cerebrospinal_Fluid_Res_2009_Dec_11_6_16.nxml.txt.nlp	20003330	SENT88	5	5	18	18	ketamine	MRI	PA450144	78996	0.98
NULL	Nat_Commun_2014_Jun_4_5_4048.nxml.txt.nlp	24893992	SENT86	21	21	39	39	etoposide	PLK1	PA449552	5347	0.98
NULL	Pharmaceuticals_(Basel)_2014_Sep_17_7(9)_943-953.nxml.txt.nlp	25232798	SENT82	10	10	21	21	trastuzumab	HER2	PA451743	2064	0.98
NULL	Mol_Cell_Biochem_2013_Jun_13_378(1-2)_229-236.nxml.txt.nlp	23483428	SENT156	19	19	22	22	methotrexate	DHFR	PA450428	1719	0.98
NULL	Breast_Cancer_Res_2010_Jun_28_12(3)_R43.nxml.txt.nlp	20579400	SENT102	29	29	11	11	paclitaxel	MTS	PA450761	1678	0.98
NULL	J_Clin_Biochem_Nutr_2007_Sep_29_41(2)_84-91.nxml.txt.nlp	18193101	SENT29	3	3	21	21	lansoprazole	IL-8	PA450180	3576	0.98
NULL	Clin_Pharmacokinet_2014_Sep_3_53(1)_1-16.nxml.txt.nlp	23999929	SENT337	5	5	17	17	dabigatran	CLCR		11330	0.98
NULL	J_Korean_Med_Sci_2013_Jun_3_28(6)_939-945.nxml.txt.nlp	23772162	SENT28	0	0	43	43	resveratrol	IVD		3712	0.98
NULL	Br_J_Haematol_2014_Sep_17_166(6)_818-829.nxml.txt.nlp	24935654	SENT161	9	9	28	28	methylprednisolone	IL6	PA450466	3569	0.98
NULL	Ther_Clin_Risk_Manag_2006_Sep_2(3)_235-249.nxml.txt.nlp	18360599	SENT342	24	24	4	4	alendronate	PTH	PA448082	5741	0.98
NULL	Core_Evid_2011_Sep_8_6_67-79.nxml.txt.nlp	22022289	SENT23	2	2	8	8	liraglutide	GLP-1	PA165958364	100125288	0.98
NULL	Support_Care_Cancer_2012_May_1_20(5)_941-949.nxml.txt.nlp	21533811	SENT21	6	6	35	35	palonosetron	HEC	PA10352	10403	0.98
NULL	Cancer_Cell_Int_2014_Jan_29_14_10.nxml.txt.nlp	24472145	SENT197	29	29	41	41	paclitaxel	HER-2	PA450761	2064	0.98
NULL	Autoimmune_Dis_2011_Mar_15_2011_961702.nxml.txt.nlp	21547093	SENT53	35	35	12	12	methylprednisolone	PLP	PA450466	25824;5744	0.98
NULL	Neuro_Oncol_2011_Jan_25_13(1)_70-83.nxml.txt.nlp	20978004	SENT258	30	30	44	44	etoposide	ABCG2	PA449552	9429	0.98
NULL	Biosci_Rep_2012_Dec_6_33(1)_e00006.nxml.txt.nlp	23050906	SENT232	17	17	11	11	lovastatin	DHCR24	PA450272	1718	0.98
NULL	Eur_J_Med_Res_2009_Dec_7_14(Suppl_4)_45-48.nxml.txt.nlp	20156724	SENT94	13	13	30	30	capsaicin	DAN	PA448776	5073;4681	0.98
NULL	Cell_Commun_Signal_2013_Oct_1_11_73.nxml.txt.nlp	24083678	SENT26	8	8	17	17	sulindac	COX	PA451565	1351	0.98
NULL	Genome_Biol_2008_May_15_9(5)_309.nxml.txt.nlp	18492227	SENT55	12	12	4	4	trastuzumab	PIK3CA	PA451743	5290	0.98
NULL	Arthritis_Res_Ther_2013_Mar_25_15(Suppl_1)_S3.nxml.txt.nlp	23566754	SENT80	43	43	16	16	rituximab	BAFF	PA451261	10673	0.98
NULL	Oncotarget_2012_Nov_9_3(11)_1401-1415.nxml.txt.nlp	23211466	SENT180	6	6	18	18	camptothecin	MCT-1	PA153590860	28985	0.98
NULL	J_Cerebrovasc_Endovasc_Neurosurg_2012_Sep_28_14(3)_148-156.nxml.txt.nlp	23210040	SENT50	11	11	21	21	clopidogrel	San	PA449053	80218	0.98
NULL	Cardiol_Res_Pract_2013_Feb_19_2013_195456.nxml.txt.nlp	23533940	SENT67	0	0	9	9	ticagrelor	IPA	PA165374673	3160	0.98
NULL	J_Cardiothorac_Surg_2010_Mar_25_5_14.nxml.txt.nlp	20334704	SENT47	10	10	14	14	heparin	ACT	PA449855	12;11332;9457;641455	0.98
NULL	Clin_Pharmacokinet_2014_Sep_3_53(1)_1-16.nxml.txt.nlp	23999929	SENT129	5	5	25	25	rivaroxaban	CLCR	PA165958360	11330	0.98
NULL	Int_J_Emerg_Med_2010_May_26_3(2)_81-84.nxml.txt.nlp	20606815	SENT92	5	5	11	11	perphenazine	CYP2D6	PA450882	1565	0.98
NULL	Indian_J_Nephrol_2012_Mar-Apr_22(2)_139-142.nxml.txt.nlp	22787319	SENT111	8	8	15	15	tacrolimus	CYP3A4	PA451578	1576	0.98
NULL	Oncotarget_2014_Jun_26_5(14)_5510-5522.nxml.txt.nlp	24980816	SENT53	30	30	3	3	doxycycline	BSP	PA449415	3381	0.98
NULL	Mol_Cancer_2014_Jun_19_13_154.nxml.txt.nlp	24941944	SENT170	17	17	15	15	aminopterin	DHFR	PA165109541	1719	0.98
NULL	Diabetes_Care_2010_Feb_33(2)_428-433.nxml.txt.nlp	20103558	SENT33	0	0	18	18	sitagliptin	GLP-1	PA164748978	100125288	0.98
NULL	Breast_Cancer_Res_2004_Nov_7_6(1)_39-52.nxml.txt.nlp	14680484	SENT137	18	18	3	3	tamoxifen	aromatase	PA451581	1588	0.98
NULL	Biomed_Res_Int_2013_Sep_5_2013_730714.nxml.txt.nlp	24083238	SENT103	25	25	8	8	hydroxyurea	WRN	PA449942	7486	0.98
NULL	J_Oncol_2010_Jun_3_2010_732680.nxml.txt.nlp	20613952	SENT65	2	2	27	27	thalidomide	IFN	PA451644	3439	0.98
NULL	Mol_Biol_Cell_2012_Mar_15_23(6)_996-1009.nxml.txt.nlp	22278744	SENT85	39	39	14	14	forskolin	14-3-3	PA146096022	10971	0.98
NULL	Chin_J_Cancer_2012_Feb_31(2)_51-57.nxml.txt.nlp	22257384	SENT35	19	19	6	6	imatinib	P-gp	PA10804	5243	0.98
NULL	Breast_Cancer_Res_2004_Oct_28_6(1)_E1.nxml.txt.nlp	14680487	SENT23	10	10	2	2	tamoxifen	aromatase	PA451581	1588	0.98
NULL	Nature_2007_Jan_25_445(7126)_437-441.nxml.txt.nlp	17206155	SENT42	6	6	22	22	gefitinib	EGFR	PA131301952	1956	0.98
NULL	Exp_Mol_Med_2012_Feb_29_44(2)_159-166.nxml.txt.nlp	22127053	SENT61	4	4	20	20	simvastatin	Rho	PA451363	29984	0.98
NULL	Aging_(Albany_NY)_2014_Jan_14_6(1)_70-81.nxml.txt.nlp	24429382	SENT21	8	8	18	18	bleomycin	WRN	PA448645	7486	0.98
NULL	Oncoscience_2014_Jul_29_1(8)_504-512.nxml.txt.nlp	25594057	SENT28	28	28	6	6	gefitinib	EGFR	PA131301952	1956	0.98
NULL	Indian_J_Endocrinol_Metab_2013_Jan-Feb_17(1)_91-94.nxml.txt.nlp	23776858	SENT34	0	0	4	4	exenatide	GLP-1	PA164749238	100125288	0.98
NULL	Mol_Cancer_2012_Mar_23_11_14.nxml.txt.nlp	22439738	SENT222	26	26	11	11	doxorubicin	CD133	PA449412	8842	0.98
NULL	Cell_Death_Dis_2010_Oct_21_1(10)_e86.nxml.txt.nlp	21368859	SENT127	10	10	29	29	doxorubicin	TRAIL	PA449412	8743	0.98
NULL	Bioinformation_2011_Sep_28_7(3)_130-133.nxml.txt.nlp	22125383	SENT48	9	9	26	26	ketoconazole	PLP1	PA450146	5354	0.98
NULL	Support_Care_Cancer_2009_Sep_10_17(9)_1187-1193.nxml.txt.nlp	19205754	SENT28	3	3	8	8	granisetron	CYP1A1	PA449809	1543	0.98
NULL	Oncotarget_2014_Jun_3_5(13)_4920-4928.nxml.txt.nlp	24952482	SENT22	32	32	37	37	geldanamycin	Hsp90	PA152031327	3320	0.98
NULL	Oncotarget_2013_Nov_24_4(12)_2430-2438.nxml.txt.nlp	24280348	SENT142	10	10	21	21	gefitinib	EGFR	PA131301952	1956	0.98
NULL	Front_Behav_Neurosci_2011_Sep_8_5_56.nxml.txt.nlp	21927600	SENT237	29	29	3	3	fluoxetine	DARPP-32	PA449673	84152	0.98
NULL	Calcif_Tissue_Int_2010_Dec_16_87(6)_485-492.nxml.txt.nlp	20953593	SENT51	27	27	13	13	teriparatide	PTH	PA451620	5741	0.98
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT259	1	1	8	8	metformin	GLP-1	PA450395	100125288	0.98
NULL	JAKSTAT_2013_Jul_1_2(3)_e24574.nxml.txt.nlp	24069558	SENT96	7	7	17	17	doxycycline	JAK2	PA449415	3717	0.98
NULL	Drugs_R_D_2010_Sep_27_10(3)_203-210.nxml.txt.nlp	20945949	SENT143	12	12	0	0	boceprevir	RVR	PA165948902	9975	0.98
NULL	Br_J_Cancer_2009_Jul_21_101(2)_238-243.nxml.txt.nlp	19568242	SENT12	3	3	33	33	sunitinib	IFN	PA162372840	3439	0.98
NULL	Pharmacogn_Rev_2013_Jan-Jun_7(13)_42-46.nxml.txt.nlp	23922455	SENT99	10	10	24	24	curcumin	LOX	PA151958596	4015	0.98
NULL	Acta_Pharmacol_Sin_2011_Jul_9_32(7)_879-887.nxml.txt.nlp	21552292	SENT135	10	10	14	14	metformin	AMPK	PA450395	5563	0.98
NULL	Oncotarget_2013_Apr_23_4(6)_816-829.nxml.txt.nlp	23615731	SENT124	22	22	6	6	doxycycline	HSF1	PA449415	3297	0.98
NULL	Breast_Cancer_Res_2006_Nov_27_8(6)_R66.nxml.txt.nlp	17129383	SENT41	29	29	17	17	paclitaxel	p53	PA450761	7157	0.98
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1542-1553.nxml.txt.nlp	21970874	SENT132	28	28	17	17	carboplatin	FPGS	PA448803	2356	0.98
NULL	Nat_Commun_2011_Feb_8_2_190.nxml.txt.nlp	21304519	SENT113	8	8	2	2	indomethacin	PTGER4	PA449982	5734	0.98
NULL	Br_J_Cancer_2000_Jun_82(11)_1827-1834.nxml.txt.nlp	10839298	SENT4	39	39	16	16	camptothecin	FasL	PA153590860	356	0.98
NULL	Exp_Mol_Med_2012_May_31_44(5)_319-329.nxml.txt.nlp	22314196	SENT91	7	7	23	23	methacholine	VDBP	PA165958382	2638	0.98
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R91.nxml.txt.nlp	22541814	SENT223	0	0	11	11	thrombin	PAR3	PA451674	56288;2151	0.98
NULL	Clin_Med_Insights_Cardiol_2012_Feb_1_6_17-33.nxml.txt.nlp	22442638	SENT185	4	4	18	18	rosuvastatin	CYP2C19	PA134308647	1557	0.98
NULL	Breast_Cancer_Res_2007_Jan_23_9(1)_R7.nxml.txt.nlp	17244352	SENT15	6	6	44	44	tamoxifen	CYP2D6	PA451581	1565	0.98
NULL	Front_Endocrinol_(Lausanne)_2014_Aug_18_5_129.nxml.txt.nlp	25183960	SENT96	24	24	4	4	cabergoline	ghrelin	PA448708	51738	0.98
NULL	Breast_Cancer_Res_2003_Jul_28_5(5)_228-231.nxml.txt.nlp	12927029	SENT18	32	32	4	4	tamoxifen	ATAC	PA451581	6375	0.98
NULL	Oncotarget_2014_Oct_18_5(22)_11564-11575.nxml.txt.nlp	25344919	SENT44	13	13	41	41	cisplatin	P14	PA449014	11102;;6280;56259	0.98
NULL	Br_J_Cancer_1998_Apr_77(8)_1311-1317.nxml.txt.nlp	9579838	SENT13	0	0	11	11	tamoxifen	IL-2	PA451581	3558	0.98
NULL	Ann_Hematol_2011_May_12_90(5)_557-568.nxml.txt.nlp	20938660	SENT250	18	18	10	10	plerixafor	CD34	PA165958410	947	0.98
NULL	Acta_Pharmacol_Sin_2009_Oct_21_30(10)_1392-1398.nxml.txt.nlp	19767766	SENT91	0	0	34	34	atorvastatin	DPI	PA448500	1832	0.98
NULL	Trials_2014_Aug_15_15(1)_324.nxml.txt.nlp	NULL	SENT144	4	4	31	31	everolimus	CD4	PA164746311	920	0.98
NULL	Oncotarget_2013_Apr_13_4(4)_502-530.nxml.txt.nlp	23594434	SENT278	10	10	27	27	nelfinavir	AKT	PA450606	207	0.98
NULL	Front_Neural_Circuits_2015_Jan_12_8_150.nxml.txt.nlp	25628540	SENT37	0	0	10	10	atropine	CA1	PA448505	759	0.98
NULL	Hum_Mol_Genet_2013_Nov_15_22(22)_4616-4626.nxml.txt.nlp	23814041	SENT161	9	9	3	3	simvastatin	neuroserpin	PA451363	5274	0.98
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Jun_29_69(Pt_7)_o1177-o1178.nxml.txt.nlp	24046719	SENT82	22	22	6	6	ethanol	mol	PA448073	90527	0.98
NULL	Anemia_2012_May_24_2012_481583.nxml.txt.nlp	22693661	SENT61	15	15	3	3	curcumin	FANCD2	PA151958596	2177	0.98
NULL	Breast_Cancer_Res_2008_Dec_18_10(Suppl_4)_S20.nxml.txt.nlp	19128434	SENT50	38	38	12	12	lapatinib	HER2	PA152241907	2064	0.98
NULL	Nucleic_Acids_Res_2011_Sep_7_39(17)_7465-7476.nxml.txt.nlp	21653549	SENT153	27	27	12	12	etoposide	DNA-PKcs	PA449552	5591	0.98
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R91.nxml.txt.nlp	22541814	SENT40	20	20	3	3	trypsin	PAR-1	PA451806	2011;2149	0.98
NULL	Breast_Cancer_Res_2009_Sep_29_11(5)_209.nxml.txt.nlp	19818165	SENT155	18	18	30	30	tamoxifen	AKT	PA451581	207	0.98
NULL	Breast_Cancer_Res_2005_Jan_28_7(3)_R284-R290.nxml.txt.nlp	15987423	SENT102	20	20	12	12	tamoxifen	CYP2D6	PA451581	1565	0.98
NULL	Oncotarget_2013_Nov_4_5(1)_161-172.nxml.txt.nlp	24389287	SENT155	25	25	13	13	propranolol	p53	PA451145	7157	0.98
NULL	N_Am_J_Med_Sci_2011_Apr_3(4)_167-175.nxml.txt.nlp	22540086	SENT167	0	0	7	7	pazopanib	VEGFR	PA165291492	3791	0.98
NULL	Oncotarget_2014_Aug_27_5(17)_7328-7341.nxml.txt.nlp	25193862	SENT132	34	34	14	14	erlotinib	EPHB1	PA134687924	2047	0.98
NULL	J_Gynecol_Oncol_2013_Jul_4_24(3)_273-279.nxml.txt.nlp	23875078	SENT112	7	7	11	11	paclitaxel	COX	PA450761	1351	0.98
NULL	Genome_Med_2010_Aug_11_2(8)_53.nxml.txt.nlp	20701793	SENT132	15	15	8	8	paclitaxel	CERT	PA450761	10087	0.98
NULL	Biochem_Res_Int_2012_Jul_1_2012_832059.nxml.txt.nlp	22811914	SENT3	3	3	19	19	docetaxel	PC3	PA449383	57332;7832;5122	0.98
NULL	Oncogene_2010_Sep_16_29(37)_5135-5145.nxml.txt.nlp	20622897	SENT76	18	18	8	8	cetuximab	STAT3	PA10040	6774	0.98
NULL	Biomed_Res_Int_2014_Apr_15_2014_175721.nxml.txt.nlp	24822180	SENT119	24	24	0	0	doxorubicin	HIPK2	PA449412	28996	0.98
NULL	Clin_Pediatr_Endocrinol_2007_Aug_8_16(3)_75-80.nxml.txt.nlp	24790349	SENT122	10	10	38	38	octreotide	PHHI	PA450678	6833	0.98
NULL	J_Biol_Chem_2012_Apr_20_287(17)_13868-13876.nxml.txt.nlp	22389490	SENT11	16	16	0	0	capsaicin	TRPV1	PA448776	7442	0.98
NULL	Br_J_Cancer_2010_Jun_8_102(12)_1762-1768.nxml.txt.nlp	20485284	SENT135	28	28	23	23	cetuximab	BRAF	PA10040	673	0.98
NULL	J_Mol_Med_2011_Apr_1_89(4)_389-398.nxml.txt.nlp	21120444	SENT2	23	23	15	15	gentamicin	MECP2	PA449753	4204	0.98
NULL	Core_Evid_2010_Oct_21_5_61-76.nxml.txt.nlp	21042543	SENT33	3	3	13	13	panitumumab	EGFR	PA162373091	1956	0.98
NULL	Sensors_(Basel)_2012_Feb_16_12(2)_2284-2308.nxml.txt.nlp	22438764	SENT683	16	16	9	9	infliximab	HLA-DRB1	PA452639	3123	0.98
NULL	Oncotarget_2014_Aug_29_5(18)_8052-8082.nxml.txt.nlp	25211298	SENT465	0	0	13	13	vismodegib	SMO		6608;54498	0.98
NULL	Exp_Ther_Med_2015_Jan_5_9(1)_84-88.nxml.txt.nlp	25452780	SENT80	18	18	6	6	vildagliptin	DPP4	PA165958346	1803	0.98
NULL	J_Oncol_2013_Aug_20_2013_732047.nxml.txt.nlp	24027583	SENT156	0	0	8	8	pertuzumab	HER2		2064	0.98
NULL	Clin_Interv_Aging_2008_Mar_3(1)_45-50.nxml.txt.nlp	18488877	SENT6	0	0	15	15	raloxifene	BMD	PA451221	1756;7439	0.98
NULL	Neural_Regen_Res_2013_Jul_15_8(20)_1853-1862.nxml.txt.nlp	25206494	SENT178	30	30	19	19	ethanol	p53	PA448073	7157	0.98
NULL	Adv_Virol_2011_Sep_19_2011_165871.nxml.txt.nlp	22312334	SENT13	0	0	39	39	enfuvirtide	CD4	PA164744517	920	0.98
NULL	Front_Endocrinol_(Lausanne)_2011_Aug_11_2_21.nxml.txt.nlp	22654797	SENT16	0	0	13	13	estradiol	aromatase	PA449503	1588	0.98
NULL	Ann_Gastroenterol_2012_25(2)_96-99.nxml.txt.nlp	24714074	SENT77	0	0	4	4	buspirone	5-HT1A	PA448689	3350	0.98
NULL	Oncotarget_2013_Nov_15_4(11)_1866-1867.nxml.txt.nlp	24272818	SENT36	18	18	7	7	trastuzumab	PIK3CA	PA451743	5290	0.98
NULL	Cancer_Inform_2013_Feb_13_12_31-51.nxml.txt.nlp	23470717	SENT189	29	29	39	39	cisplatin	PTTG1	PA449014	9232	0.98
NULL	Int_J_Environ_Res_Public_Health_2010_Apr_29_7(4)_1392-1431.nxml.txt.nlp	20617037	SENT260	8	8	26	26	ethanol	CRF2	PA448073	1395	0.98
NULL	Evid_Based_Complement_Alternat_Med_2013_May_26_2013_161628.nxml.txt.nlp	23781255	SENT255	8	8	0	0	sorafenib	STAT3	PA7000	6774	0.98
NULL	Breast_Cancer_Res_Treat_2012_Jun_15_133(3)_1057-1065.nxml.txt.nlp	22418700	SENT164	34	34	6	6	trastuzumab	HER2	PA451743	2064	0.98
NULL	Protein_Eng_Des_Sel_2013_Jul_24_26(7)_463-470.nxml.txt.nlp	23708321	SENT48	30	30	9	9	trimethoprim	DHFR	PA451788	1719	0.98
NULL	Expert_Rev_Mol_Med_2009_May_11_e16.nxml.txt.nlp	19467172	SENT246	22	22	11	11	heparin	DBL	PA449855	4168	0.98
NULL	Breast_Cancer_Res_2005_Apr_6_7(3)_119-130.nxml.txt.nlp	15987442	SENT36	11	11	3	3	tamoxifen	AP-1	PA451581	2353;3727;2354;3725	0.98
NULL	Case_Rep_Dent_2014_Apr_29_2014_649086.nxml.txt.nlp	24872899	SENT10	0	0	21	21	tocilizumab	IL-6	PA165292659	3569	0.98
NULL	J_Biol_Chem_2012_Apr_27_287(18)_14644-14658.nxml.txt.nlp	22375002	SENT421	18	18	8	8	forskolin	CC2D1A	PA146096022	54862	0.98
NULL	Br_J_Cancer_2010_Oct_26_103(9)_1331-1334.nxml.txt.nlp	20877352	SENT75	11	11	20	20	trastuzumab	HER2	PA451743	2064	0.98
NULL	Curr_Cardiol_Rev_2014_May_10(2)_161-171.nxml.txt.nlp	24527681	SENT95	2	2	43	43	losartan	AGTR2	PA450268	186	0.98
NULL	Oncol_Lett_2014_Jul_25_8(1)_313-316.nxml.txt.nlp	24959268	SENT67	8	8	18	18	sulindac	JNK1	PA451565	5599	0.98
NULL	J_Cardiothorac_Surg_2011_Apr_8_6_44.nxml.txt.nlp	21477293	SENT104	21	21	9	9	lepirudin	ACT	PA450195	12;11332;9457;641455	0.98
NULL	Oncol_Rep_2013_Oct_22_30(4)_1535-1541.nxml.txt.nlp	23877481	SENT149	11	11	31	31	sunitinib	COX2	PA162372840	4513;5743	0.98
NULL	Front_Neurosci_2013_Feb_26_7_21.nxml.txt.nlp	23550224	SENT277	12	12	0	0	levetiracetam	SV2A	PA450206	9900	0.98
NULL	Front_Genet_2014_Jun_2_5_154.nxml.txt.nlp	24917878	SENT134	5	5	17	17	ethanol	POMC	PA448073	5443	0.98
NULL	Asia_Pac_Allergy_2013_Oct_31_3(4)_215-223.nxml.txt.nlp	24260726	SENT98	33	33	12	12	abacavir	HLA-B	PA448004	3106	0.98
NULL	Mol_Cancer_2009_Mar_5_8_14.nxml.txt.nlp	19265551	SENT80	4	4	28	28	camptothecin	p53	PA153590860	7157	0.98
NULL	Crit_Care_2010_Aug_11_14(4)_R153.nxml.txt.nlp	20701787	SENT155	9	9	22	22	exenatide	GLP-1	PA164749238	100125288	0.98
NULL	Diabetes_Metab_J_2012_Aug_20_36(4)_293-299.nxml.txt.nlp	22950061	SENT121	11	11	40	40	metformin	NPY	PA450395	4852	0.98
NULL	Br_J_Haematol_2014_Mar_13_164(1)_811-821.nxml.txt.nlp	24328678	SENT125	4	4	18	18	lenalidomide	Aiolos	PA162363968	22806	0.98
NULL	Aging_(Albany_NY)_2014_May_17_6(5)_369-379.nxml.txt.nlp	24860943	SENT80	8	8	38	38	l-arginine	S6K1	PA448478	6198	0.98
NULL	Clin_Pharmacol_2011_Jun_22_3_13-25.nxml.txt.nlp	22287853	SENT127	22	22	0	0	ketoconazole	ANOVA	PA450146	4858	0.98
NULL	Arthritis_Res_Ther_2012_May_1_14(3)_R99.nxml.txt.nlp	22546542	SENT126	29	29	9	9	infliximab	IL-4	PA452639	3565	0.98
NULL	Cancers_(Basel)_2014_Apr_16_6(2)_926-957.nxml.txt.nlp	24743778	SENT338	0	0	12	12	curcumin	STAT3	PA151958596	6774	0.98
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT49	11	11	5	5	trastuzumab	PTEN	PA451743	5728	0.98
NULL	Int_J_Endocrinol_2013_Nov_27_2013_259676.nxml.txt.nlp	24369462	SENT214	9	9	1	1	lipase	DAG	PA450239	1605	0.98
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_P80.nxml.txt.nlp	NULL	SENT17	4	4	21	21	cefuroxime	OPT	PA448868	51430	0.98
NULL	Hum_Genomics_2009_Jan_1_3(2)_128-142.nxml.txt.nlp	19164090	SENT246	25	25	0	0	etoposide	CD44	PA449552	960	0.98
NULL	J_Med_Chem_2014_Jan_23_57(2)_449-461.nxml.txt.nlp	24387105	SENT143	27	27	12	12	cyclophosphamide	ALDH3A1	PA449165	218	0.98
NULL	Patient_Prefer_Adherence_2010_May_13_4_105-113.nxml.txt.nlp	20517471	SENT23	0	0	8	8	valsartan	AT1	PA451848	9197;185	0.98
NULL	Int_J_Surg_Oncol_2012_May_17_2012_406830.nxml.txt.nlp	22675625	SENT86	30	30	7	7	cetuximab	KRAS	PA10040	3845	0.98
NULL	Endocrinol_Metab_(Seoul)_2014_Mar_14_29(1)_54-61.nxml.txt.nlp	24741455	SENT103	23	23	7	7	curcumin	p65	PA151958596	5970	0.98
NULL	Drugs_2014_Oct_10_74(17)_2015-2032.nxml.txt.nlp	25300410	SENT61	12	12	1	1	itraconazole	P-gp	PA450132	5243	0.98
NULL	Breast_Cancer_Res_2004_Aug_5_6(5)_R601-R607.nxml.txt.nlp	15318941	SENT137	29	29	2	2	docetaxel	p27	PA449383	5715;10534	0.98
NULL	Balkan_J_Med_Genet_2011_Jun_25_14(1)_25-30.nxml.txt.nlp	24052699	SENT81	14	14	23	23	primidone	ABCC1	PA451105	4363	0.98
NULL	J_Korean_Med_Sci_2010_Nov_26_25(11)_1543-1552.nxml.txt.nlp	21060741	SENT231	7	7	31	31	sunitinib	VEGFR	PA162372840	3791	0.98
NULL	Ann_Indian_Acad_Neurol_2010_Apr-Jun_13(2)_136-138.nxml.txt.nlp	20814499	SENT58	8	8	24	24	methotrexate	CD4	PA450428	920	0.98
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Oct_23_66(Pt_11)_o2909.nxml.txt.nlp	21589083	SENT60	33	33	6	6	ethanol	mol	PA448073	90527	0.98
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT128	16	16	4	4	chloroquine	BMPR-II	PA448948	659	0.98
NULL	Oncol_Rep_2013_Mar_8_29(3)_917-924.nxml.txt.nlp	23314174	SENT160	3	3	17	17	sorafenib	HIF-1	PA7000	29072	0.98
NULL	Cancer_Cell_Int_2010_Sep_9_10_32.nxml.txt.nlp	20828393	SENT196	0	0	30	30	cisplatin	ATF3	PA449014	467	0.98
NULL	J_Inflamm_(Lond)_2008_Jul_29_5_11.nxml.txt.nlp	18664275	SENT79	21	21	8	8	clarithromycin	IL-8	PA449028	3576	0.98
NULL	Case_Rep_Gastroenterol_2010_Oct_16_4(3)_435-442.nxml.txt.nlp	21103203	SENT30	10	10	2	2	pravastatin	NF1	PA451089	4763	0.98
NULL	Int_J_Endocrinol_2013_Nov_13_2013_686315.nxml.txt.nlp	24324494	SENT166	31	31	5	5	metformin	OCT1	PA450395	5451;6580	0.98
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1420-1426.nxml.txt.nlp	24056704	SENT3	29	29	33	33	ketoconazole	CYP3A	PA450146	1574	0.98
NULL	Curr_Gerontol_Geriatr_Res_2010_Jun_20_2010_348174.nxml.txt.nlp	20672050	SENT123	19	19	8	8	gefitinib	EGFR	PA131301952	1956	0.98
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Jun_29_69(Pt_7)_o1177-o1178.nxml.txt.nlp	24046719	SENT82	22	22	17	17	ethanol	mol	PA448073	90527	0.98
NULL	Breast_Cancer_Res_2002_Sep_10_4(6)_218-221.nxml.txt.nlp	12473166	SENT61	21	21	1	1	raloxifene	STAR	PA451221	6770;2984	0.98
NULL	Oncol_Rep_2013_Sep_1_30(3)_1045-1052.nxml.txt.nlp	23817662	SENT149	26	26	15	15	erlotinib	EGFR	PA134687924	1956	0.98
NULL	Aging_Cell_2012_Aug_11(4)_579-587.nxml.txt.nlp	22435726	SENT10	7	7	26	26	etoposide	CD28	PA449552	1493;940	0.98
NULL	Br_J_Cancer_2013_Mar_5_108(4)_973-982.nxml.txt.nlp	23299537	SENT126	18	18	1	1	doxorubicin	BTG2	PA449412	7832	0.98
NULL	J_Exp_Med_1998_Jun_15_187(12)_1995-2007.nxml.txt.nlp	9625759	SENT29	7	7	0	0	chymotrypsin	Bcl-2	PA448994	596	0.98
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_127043.nxml.txt.nlp	23227093	SENT15	19	19	4	4	lovastatin	RYR	PA450272	6261	0.98
NULL	Oncotarget_2013_Nov_15_5(6)_1458-1474.nxml.txt.nlp	24681547	SENT248	5	5	18	18	celecoxib	CDH11	PA448871	1009	0.98
NULL	Br_J_Cancer_2012_Sep_25_107(7)_1059-1068.nxml.txt.nlp	22935581	SENT74	6	6	25	25	sunitinib	IFN	PA162372840	3439	0.98
NULL	J_Thorac_Oncol_2014_Sep_22_9(9)_1345-1353.nxml.txt.nlp	25122430	SENT83	11	11	4	4	gefitinib	EGFR	PA131301952	1956	0.98
NULL	Pharmaceuticals_(Basel)_2012_Aug_10_5(8)_802-836.nxml.txt.nlp	24280676	SENT247	40	40	7	7	lansoprazole	PCFT	PA450180	113235	0.98
NULL	Biomed_Res_Int_2013_Nov_7_2013_928562.nxml.txt.nlp	24312913	SENT42	23	23	8	8	tamoxifen	BRCA1	PA451581	672	0.98
NULL	Biologics_2012_Jun_20_6_137-146.nxml.txt.nlp	22807624	SENT121	0	0	6	6	lapatinib	EGFR	PA152241907	1956	0.98
NULL	Crit_Care_2005_Aug_11_9(1)_86-91.nxml.txt.nlp	15693989	SENT67	3	3	12	12	dantrolene	CHS	PA449208	1130	0.98
NULL	FEBS_Open_Bio_2014_Oct_22_4_905-914.nxml.txt.nlp	25383314	SENT141	11	11	4	4	atropine	L-FABP	PA448505	2168	0.98
NULL	Angiogenesis_2010_Mar_11_13(1)_1-14.nxml.txt.nlp	20012482	SENT189	0	0	15	15	sorafenib	VEGFR	PA7000	3791	0.98
NULL	Mol_Vis_2011_Feb_1_17_332-340.nxml.txt.nlp	21297899	SENT190	2	2	15	15	benazepril	DPI	PA448561	1832	0.98
NULL	Br_J_Cancer_2013_Sep_3_109(5)_1214-1222.nxml.txt.nlp	23922104	SENT172	17	17	15	15	nutlin-3	MDM2		4193	0.98
NULL	Cancer_Cell_Int_2013_Oct_22_13_103.nxml.txt.nlp	24148306	SENT133	12	12	0	0	etoposide	PRL	PA449552	5617	0.98
NULL	Indian_J_Anaesth_2010_Nov-Dec_54(6)_489-495.nxml.txt.nlp	21224964	SENT69	6	6	25	25	aprotinin	PAR1	PA448472	79581;2149	0.98
NULL	J_Cell_Biol_1998_Mar_23_140(6)_1485-1495.nxml.txt.nlp	9508780	SENT18	14	14	29	29	staurosporine	Bcl-2	PA165109623	596	0.98
NULL	Exp_Ther_Med_2014_Nov_17_8(5)_1484-1488.nxml.txt.nlp	25289046	SENT53	10	10	28	28	cisplatin	ECRG2	PA449014	84651	0.98
NULL	Biochemistry_2011_May_10_50(18)_3609-3620.nxml.txt.nlp	21410224	SENT33	35	35	10	10	l-tryptophan	DHFR	PA10323	1719	0.98
NULL	J_Invest_Dermatol_2013_Jun_14_133(6)_1541-1549.nxml.txt.nlp	23407395	SENT76	34	34	16	16	imiquimod	CXCL1	PA449972	2919	0.98
NULL	Oncol_Lett_2013_Dec_7_6(6)_1673-1680.nxml.txt.nlp	24260061	SENT85	36	36	18	18	trypsin	CO2	PA451806	4513	0.98
NULL	Int_J_Vasc_Med_2013_Jun_26_2013_456852.nxml.txt.nlp	23878738	SENT95	17	17	24	24	indomethacin	COX	PA449982	1351	0.98
NULL	Oncol_Lett_2013_Apr_22_5(4)_1093-1100.nxml.txt.nlp	23599746	SENT69	8	8	26	26	tamoxifen	P-gp	PA451581	5243	0.98
NULL	J_Cell_Biol_2001_Nov_12_155(4)_543-556.nxml.txt.nlp	11696556	SENT80	41	41	12	12	dextran	giantin	PA449261	2804	0.98
NULL	Scientifica_(Cairo)_2012_Nov_25_2012_473829.nxml.txt.nlp	24278698	SENT420	11	11	1	1	oxaliplatin	OCT2	PA131285527	6582;5452	0.98
NULL	Int_J_Nanomedicine_2012_Oct_25_7_5565-5575.nxml.txt.nlp	23118538	SENT140	19	19	24	24	fenofibrate	CO2	PA449594	4513	0.98
NULL	Int_J_Endocrinol_2011_Mar_6_2011_415719.nxml.txt.nlp	21461394	SENT15	0	0	21	21	cinacalcet	PTH	PA164776671	5741	0.98
NULL	Open_Neurol_J_2009_Apr_2_3_27-44.nxml.txt.nlp	19461897	SENT204	4	4	18	18	rosiglitazone	APO	PA451283	84909	0.98
NULL	J_Cancer_2013_Jan_11_4(2)_117-132.nxml.txt.nlp	23386910	SENT277	0	0	14	14	tanespimycin	HER-2	PA165291490	2064	0.98
NULL	Arthritis_Res_Ther_2009_Apr_23_11(2)_R57.nxml.txt.nlp	19389237	SENT12	46	46	39	39	adalimumab	MKI67	PA10004	4288	0.98
NULL	Br_J_Cancer_2012_Oct_23_107(9)_1474-1480.nxml.txt.nlp	23033004	SENT153	28	28	40	40	erlotinib	EGFR	PA134687924	1956	0.98
NULL	JAKSTAT_2013_Jul_1_2(3)_e24574.nxml.txt.nlp	24069558	SENT129	13	13	3	3	doxycycline	HEK	PA449415	2042	0.98
NULL	Int_J_Mol_Sci_2014_Jun_26_15(7)_11416-11434.nxml.txt.nlp	24972137	SENT156	1	1	7	7	sitagliptin	GLP-1	PA164748978	100125288	0.98
NULL	Mol_Biol_Cell_2013_Jul_1_24(13)_2134-2145.nxml.txt.nlp	23657817	SENT182	23	23	7	7	pp2	RhoA		387	0.98
NULL	Clin_Med_Insights_Oncol_2012_May_16_6_205-217.nxml.txt.nlp	22654526	SENT158	13	13	22	22	sorafenib	FLT3	PA7000	2322	0.98
NULL	Ann_Neurosci_2014_Jul_21(3)_97-103.nxml.txt.nlp	25206073	SENT32	33	33	31	31	bumetanide	NKCC1	PA448682	6558	0.98
NULL	Breast_Cancer_Res_2004_Oct_6_6(6)_269-274.nxml.txt.nlp	15535858	SENT17	2	2	14	14	aminoglutethimide	aromatase	PA448375	1588	0.98
NULL	J_Korean_Med_Sci_2007_Apr_30_22(2)_283-289.nxml.txt.nlp	17449938	SENT102	25	25	6	6	minoxidil	Bcl-2	PA450521	596	0.98
NULL	Arthritis_Res_Ther_2013_Jul_9_15(4)_R73.nxml.txt.nlp	23837669	SENT250	15	15	7	7	colchicine	MICL	PA449092	160364	0.98
NULL	Nucleic_Acids_Res_2006_Jul_5_34(11)_3399-3407.nxml.txt.nlp	16822860	SENT136	28	28	9	9	doxycycline	TFIIIC110	PA449415	2976	0.98
NULL	J_Antimicrob_Chemother_2009_Nov_18_64(5)_910-928.nxml.txt.nlp	19767318	SENT203	5	5	13	13	efavirenz	CD4	PA449441	920	0.98
NULL	Front_Oncol_2014_Jun_12_4_144.nxml.txt.nlp	24971229	SENT180	15	15	4	4	cisplatin	EZH2	PA449014	2146	0.98
NULL	Nucl_Recept_Signal_2014_Nov_4_12_e005.nxml.txt.nlp	25422595	SENT139	17	17	15	15	geldanamycin	Hsp90	PA152031327	3320	0.98
NULL	Infect_Dis_Obstet_Gynecol_2012_Feb_25_2012_157159.nxml.txt.nlp	22505797	SENT102	5	5	27	27	azithromycin	PTB	PA448519	58155	0.98
NULL	Mol_Biol_Cell_2014_Jul_1_25(13)_2116-2127.nxml.txt.nlp	24807908	SENT66	8	8	41	41	hemin	NQO1	PA449849	1728	0.98
NULL	Int_J_Nanomedicine_2012_May_7_7_2307-2314.nxml.txt.nlp	22661887	SENT109	20	20	1	1	gemcitabine	zeta	PA449748	9907	0.98
NULL	Br_J_Cancer_2012_Jun_5_106(12)_1997-2003.nxml.txt.nlp	22596232	SENT16	20	20	3	3	sorafenib	JNK	PA7000	5599	0.98
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_105-115.nxml.txt.nlp	17912640	SENT34	13	13	4	4	tamoxifen	HER2	PA451581	2064	0.98
NULL	J_Cell_Biol_2001_Nov_12_155(4)_543-556.nxml.txt.nlp	11696556	SENT80	41	41	14	14	dextran	GM130	PA449261	2801	0.98
NULL	ScientificWorldJournal_2012_Jul_31_2012_392734.nxml.txt.nlp	22919315	SENT86	0	0	17	17	gemfibrozil	CYP2C8	PA449750	1558	0.98
NULL	Oncol_Rep_2012_Sep_26_28(3)_777-784.nxml.txt.nlp	22751903	SENT116	3	3	21	21	celecoxib	MVD	PA448871	4597	0.98
NULL	Acta_Pharmacol_Sin_2010_Feb_5_31(2)_137-144.nxml.txt.nlp	20139896	SENT136	0	0	4	4	zileuton	5-LOX	PA451955	240	0.98
NULL	J_Mol_Signal_2011_Aug_10_6_8.nxml.txt.nlp	21831305	SENT170	22	22	6	6	isoproterenol	AKAP12	PA450121	9590	0.98
NULL	Front_Pharmacol_2014_Oct_31_5_231.nxml.txt.nlp	25400580	SENT276	1	1	13	13	atorvastatin	OATP1B1	PA448500	10599	0.98
NULL	Apoptosis_2014_Apr_23_19(7)_1055-1068.nxml.txt.nlp	24756955	SENT152	13	13	2	2	cisplatin	RITA	PA449014	55422;84934	0.98
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT197	2	2	12	12	metformin	HIF-1	PA450395	29072	0.98
NULL	Breast_Cancer_Res_2012_Mar_14_14(2)_R45.nxml.txt.nlp	22417809	SENT380	20	20	9	9	tamoxifen	CLU	PA451581	1191	0.98
NULL	Allergy_Asthma_Clin_Immunol_2010_Jul_28_6(1)_21.nxml.txt.nlp	20667124	SENT88	27	27	6	6	icatibant	C1-INH	PA164749185	710	0.98
NULL	J_Exp_Med_1977_Jul_1_146(1)_257-270.nxml.txt.nlp	301546	SENT12	33	33	3	3	trypsin	C3b	PA451806	718	0.98
NULL	Arthritis_Res_Ther_2006_Jul_3_8(4)_216.nxml.txt.nlp	16879719	SENT105	31	31	9	9	methotrexate	ACR	PA450428	49	0.98
NULL	Br_J_Ophthalmol_2012_May_7_96(5)_688-693.nxml.txt.nlp	22399690	SENT22	0	0	41	41	ranibizumab	VEGF-A	PA164746012	7422	0.98
NULL	Breast_Cancer_Res_2000_Mar_25_2(3)_184-190.nxml.txt.nlp	11250708	SENT42	6	6	24	24	carbachol	EGFR	PA448784	1956	0.98
NULL	Cancers_(Basel)_2013_Jan_24_5(1)_92-130.nxml.txt.nlp	24216700	SENT277	3	3	7	7	sulindac	COX	PA451565	1351	0.98
NULL	Biosci_Rep_2012_Aug_1_32(Pt_4)_361-374.nxml.txt.nlp	22762204	SENT147	24	24	4	4	gefitinib	PTEN	PA131301952	5728	0.98
NULL	Cell_Res_2014_Jul_30_24(7)_809-819.nxml.txt.nlp	24874954	SENT45	14	14	2	2	estradiol	WHSC1	PA449503	7468	0.98
NULL	Indian_J_Anaesth_2009_Oct_53(5)_582-591.nxml.txt.nlp	20640109	SENT81	15	15	31	31	clopidogrel	CYP3A4	PA449053	1576	0.98
NULL	J_Biol_Chem_2013_Feb_8_288(6)_3918-3928.nxml.txt.nlp	23239877	SENT23	0	0	15	15	thrombin	PAR1	PA451674	79581;2149	0.98
NULL	EMBO_Mol_Med_2013_Jul_13_5(7)_983-998.nxml.txt.nlp	23666744	SENT301	18	18	7	7	vincristine	NAT10	PA451879	55226	0.98
NULL	Biologics_2011_Feb_14_5_21-31.nxml.txt.nlp	21383913	SENT87	35	35	6	6	prednicarbate	CLE	PA164749394	51637	0.98
NULL	Antiviral_Res_2009_May_82(2)_A99-A109.nxml.txt.nlp	19176219	SENT116	22	22	7	7	delavirdine	MRP-1	PA449223	928	0.98
NULL	Cell_Death_Dis_2014_Apr_24_5(4)_e1197.nxml.txt.nlp	24763054	SENT91	36	36	3	3	cisplatin	RUNX3	PA449014	864	0.98
NULL	JAKSTAT_2013_Jul_1_2(3)_e24574.nxml.txt.nlp	24069558	SENT116	4	4	14	14	doxycycline	JAK2	PA449415	3717	0.98
NULL	Clin_Pediatr_Endocrinol_2007_Aug_8_16(3)_75-80.nxml.txt.nlp	24790349	SENT4	23	23	6	6	octreotide	PHHI	PA450678	6833	0.98
NULL	Diabetes_Care_2013_Aug_17_36(Suppl_2)_S245-S252.nxml.txt.nlp	23882053	SENT32	23	23	9	9	sitagliptin	HIP	PA164748978	6767;6159;64399;5068	0.98
NULL	J_Biol_Chem_2013_Nov_22_288(47)_34217-34229.nxml.txt.nlp	24106270	SENT38	16	16	10	10	thrombin	RhoG	PA451674	391	0.98
NULL	Cardiovasc_Diabetol_2010_Jan_28_9_6.nxml.txt.nlp	20109208	SENT26	0	0	3	3	exenatide	GLP-1	PA164749238	100125288	0.98
NULL	Acta_Neuropathol_Commun_2013_May_20_1_17.nxml.txt.nlp	24252689	SENT58	20	20	6	6	celecoxib	IQGAP1	PA448871	8826	0.98
NULL	Eur_J_Clin_Pharmacol_2011_May_8_67(5)_493-506.nxml.txt.nlp	21140139	SENT231	18	18	25	25	oxycodone	CYP3A4	PA450741	1576	0.98
NULL	Br_J_Cancer_2009_Mar_24_100(6)_941-949.nxml.txt.nlp	19240716	SENT18	5	5	19	19	erlotinib	EGFR	PA134687924	1956	0.98
NULL	J_Cell_Mol_Med_2014_Aug_6_18(8)_1519-1539.nxml.txt.nlp	25100284	SENT19	16	16	1	1	erlotinib	EGFR	PA134687924	1956	0.98
NULL	Drug_Healthc_Patient_Saf_2014_Mar_31_6_37-45.nxml.txt.nlp	24729731	SENT43	10	10	13	13	ritonavir	CYP3A	PA451260	1574	0.98
NULL	Endocrinol_Metab_(Seoul)_2014_Mar_14_29(1)_54-61.nxml.txt.nlp	24741455	SENT103	19	19	7	7	curcumin	p65	PA151958596	5970	0.98
NULL	J_Oncol_2009_Mar_24_2009_491985.nxml.txt.nlp	19325924	SENT84	12	12	5	5	genistein	CXCR4	PA165109660	7852	0.98
NULL	Leukemia_2013_Feb_10_27(2)_507-510.nxml.txt.nlp	22810506	SENT21	9	9	0	0	chlorambucil	TRAC	PA448926	28755	0.98
NULL	Clin_Interv_Aging_2008_Mar_3(1)_45-50.nxml.txt.nlp	18488877	SENT5	0	0	16	16	raloxifene	BMD	PA451221	1756;7439	0.98
NULL	Gut_Liver_2013_Jul_11_7(4)_385-393.nxml.txt.nlp	23898376	SENT99	7	7	15	15	trastuzumab	HER2	PA451743	2064	0.98
NULL	Breast_Cancer_Res_2001_Mar_26_3(3)_180-182.nxml.txt.nlp	11305952	SENT25	11	11	1	1	tamoxifen	aromatase	PA451581	1588	0.98
NULL	J_Hematol_Oncol_2010_May_2_3_18.nxml.txt.nlp	20433767	SENT145	11	11	23	23	cetuximab	KRAS	PA10040	3845	0.98
NULL	Evid_Based_Complement_Alternat_Med_2011_Jun_12_2011_380923.nxml.txt.nlp	21760824	SENT172	8	8	24	24	vincristine	Bcl-2	PA451879	596	0.98
NULL	Biomed_Res_Int_2014_Feb_12_2014_612798.nxml.txt.nlp	24678511	SENT151	6	6	13	13	pregabalin	p50	PA164754814	958;4790	0.98
NULL	Arch_Drug_Inf_2008_Jul_1(1)_14-22.nxml.txt.nlp	20157364	SENT147	26	26	7	7	pravastatin	IL-6	PA451089	3569	0.98
NULL	F1000_Med_Rep_2009_Jun_29_1_50.nxml.txt.nlp	20948730	SENT50	0	0	15	15	rimonabant	adiponectin	PA152407999	9370	0.98
NULL	J_Oncol_2009_Mar_24_2009_491985.nxml.txt.nlp	19325924	SENT51	21	21	4	4	genistein	CXCR4	PA165109660	7852	0.98
NULL	Mol_Vis_2012_Jun_22_18_1696-1700.nxml.txt.nlp	22773907	SENT97	29	29	17	17	colchicine	MTHFR	PA449092	4524	0.98
NULL	J_Oncol_2010_Dec_15_2010_821717.nxml.txt.nlp	20049172	SENT224	23	23	3	3	paclitaxel	TUBB3	PA450761	10381	0.98
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1427-1436.nxml.txt.nlp	24096601	SENT33	0	0	21	21	cetuximab	EGFR	PA10040	1956	0.98
NULL	Br_J_Cancer_2012_Jun_5_106(12)_1945-1952.nxml.txt.nlp	22588555	SENT118	12	12	3	3	sorafenib	Mcl-1	PA7000	4170	0.98
NULL	Exp_Mol_Med_2012_Apr_30_44(4)_251-259.nxml.txt.nlp	22198296	SENT61	32	32	6	6	doxorubicin	CD24	PA449412	100133941	0.98
NULL	Cell_Death_Differ_2009_Aug_20_16(8)_1135-1145.nxml.txt.nlp	19300452	SENT274	9	9	4	4	doxycycline	PUMA	PA449415	27113	0.98
NULL	Onco_Targets_Ther_2014_May_28_7_841-852.nxml.txt.nlp	24920926	SENT45	20	20	11	11	gefitinib	EGFR	PA131301952	1956	0.98
NULL	Oncotarget_2013_Nov_24_4(12)_2430-2438.nxml.txt.nlp	24280348	SENT151	33	33	8	8	gefitinib	EGFR	PA131301952	1956	0.98
NULL	Chin_J_Cancer_2011_May_30(5)_293-302.nxml.txt.nlp	21527062	SENT127	0	0	31	31	denosumab	RANK	PA166048634	8792	0.98
NULL	Core_Evid_2010_Oct_21_5_61-76.nxml.txt.nlp	21042543	SENT252	8	8	42	42	panitumumab	PIK3CA	PA162373091	5290	0.98
NULL	Indian_J_Endocrinol_Metab_2012_Dec_16(Suppl_2)_S245-S247.nxml.txt.nlp	23565390	SENT65	0	0	7	7	sitagliptin	PPG	PA164748978	5552	0.98
NULL	Br_J_Cancer_2003_Mar_10_88(5)_754-759.nxml.txt.nlp	12618886	SENT91	3	3	23	23	amifostine	p53	PA448365	7157	0.979
NULL	Case_Rep_Oncol_2014_Feb_27_7(1)_132-138.nxml.txt.nlp	24707261	SENT57	32	32	30	30	letrozole	aromatase	PA450196	1588	0.979
NULL	Oncol_Lett_2014_Jun_28_7(6)_1843-1846.nxml.txt.nlp	24932245	SENT90	20	20	32	32	cyclophosphamide	CHOP	PA449165	1649	0.979
NULL	Diabetes_Care_2011_Feb_20_34(2)_375-380.nxml.txt.nlp	20980414	SENT141	0	0	15	15	metformin	LKB1	PA450395	6794	0.979
NULL	Cell_Death_Dis_2012_Jun_21_3(6)_e327.nxml.txt.nlp	22717582	SENT194	46	46	37	37	doxorubicin	PUMA	PA449412	27113	0.979
NULL	Int_J_Surg_Oncol_2011_Jun_6_2011_285840.nxml.txt.nlp	22312501	SENT58	5	5	3	3	cetuximab	EGFR	PA10040	1956	0.979
NULL	Cancer_Manag_Res_2014_Jan_28_6_39-51.nxml.txt.nlp	24501545	SENT137	13	13	17	17	bicalutamide	CYP3A4	PA164746255	1576	0.979
NULL	Fibrogenesis_Tissue_Repair_2012_Jul_23_5_11.nxml.txt.nlp	22824096	SENT181	32	32	8	8	bleomycin	FasL	PA448645	356	0.979
NULL	Mol_Brain_2014_Apr_3_7_25.nxml.txt.nlp	24708812	SENT189	29	29	7	7	chloroquine	ERK	PA448948	5594	0.979
NULL	Nat_Biotechnol_2013_Jul_30_31(7)_630-637.nxml.txt.nlp	23811600	SENT179	29	29	2	2	crizotinib	NTRK3	PA165946122	4916	0.979
NULL	Anat_Cell_Biol_2012_Jun_30_45(2)_73-78.nxml.txt.nlp	22822460	SENT101	8	8	24	24	genistein	HIF-1	PA165109660	29072	0.979
NULL	Oxid_Med_Cell_Longev_2012_Aug_9_2012_794237.nxml.txt.nlp	22928087	SENT21	16	16	0	0	hemin	HO-1	PA449849	3162	0.979
NULL	Acta_Pharmacol_Sin_2013_Apr_18_34(4)_555-560.nxml.txt.nlp	23503472	SENT17	13	13	5	5	cyclosporine	ABCB1	PA449167	5243	0.979
NULL	Toxins_(Basel)_2010_Mar_31_2(4)_517-551.nxml.txt.nlp	22069598	SENT126	11	11	35	35	curcumin	IL-6	PA151958596	3569	0.979
NULL	Oncoimmunology_2014_Apr_25_3_e28518.nxml.txt.nlp	25071979	SENT119	14	14	24	24	oxaliplatin	CRT	PA131285527	811	0.979
NULL	Br_J_Cancer_2006_Feb_13_94(3)_363-371.nxml.txt.nlp	16465172	SENT209	27	27	1	1	oxaliplatin	NACT	PA131285527	284111	0.979
NULL	Br_J_Pharmacol_2014_Feb_24_171(1)_1019-1032.nxml.txt.nlp	24251620	SENT177	23	23	3	3	nicardipine	TRPM3	PA450620	80036	0.979
NULL	Int_J_Cell_Biol_2013_Jun_11_2013_703545.nxml.txt.nlp	23840214	SENT127	15	15	4	4	aprotinin	LRP1	PA448472	10438;4035	0.979
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT5	23	23	30	30	pertuzumab	HER2		2064	0.979
NULL	Cells_2012_Jul_27_1(3)_346-371.nxml.txt.nlp	24710480	SENT244	13	13	22	22	genistein	PI3K	PA165109660	5290	0.979
NULL	Arthritis_Res_Ther_2006_Jul_26_8(4)_R132.nxml.txt.nlp	16872482	SENT215	9	9	2	2	pp2	JNK		5599	0.979
NULL	Indian_J_Pharmacol_2012_Sep-Oct_44(5)_624-628.nxml.txt.nlp	23112426	SENT22	5	5	10	10	nimodipine	P-gp	PA450633	5243	0.979
NULL	J_Invest_Dermatol_2012_Nov_14_132(11)_2601-2609.nxml.txt.nlp	22696056	SENT194	17	17	10	10	guanabenz	IL8	PA164774903	3576	0.979
NULL	Oncogene_2014_Jul_24_33(30)_3927-3938.nxml.txt.nlp	23995784	SENT252	32	32	23	23	doxycycline	FOXO1	PA449415	2308	0.979
NULL	Diabetes_Care_2010_Jul_5_33(7)_1438-1442.nxml.txt.nlp	20368410	SENT59	9	9	4	4	aprotinin	GLP-1	PA448472	100125288	0.979
NULL	Case_Rep_Infect_Dis_2013_Oct_8_2013_693480.nxml.txt.nlp	24223316	SENT122	0	0	10	10	fluconazole	CYP3A4	PA449653	1576	0.979
NULL	Cell_Death_Dis_2012_Mar_1_3(3)_e275.nxml.txt.nlp	22378068	SENT89	5	5	10	10	metformin	AKT	PA450395	207	0.979
NULL	J_Korean_Med_Sci_2010_Apr_19_25(4)_557-563.nxml.txt.nlp	20357998	SENT8	35	35	17	17	cisplatin	MCP-1	PA449014	6347	0.979
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1150.nxml.txt.nlp	24675468	SENT79	25	25	6	6	ethanol	PARP-1	PA448073	25976	0.979
NULL	BMB_Rep_2013_Jan_46(1)_59-64.nxml.txt.nlp	23351386	SENT7	12	12	0	0	auranofin	STAT3	PA448510	6774	0.979
NULL	Biologics_2012_Sep_25_6_337-345.nxml.txt.nlp	23055691	SENT39	35	35	8	8	gemcitabine	EGFR	PA449748	1956	0.979
NULL	Acta_Pharmacol_Sin_2012_Oct_17_33(10)_1301-1310.nxml.txt.nlp	22983390	SENT109	23	23	2	2	cisplatin	migfilin	PA449014	54751	0.979
NULL	Int_J_Breast_Cancer_2011_Jul_12_2011_232435.nxml.txt.nlp	22295213	SENT264	8	8	22	22	trastuzumab	aromatase	PA451743	1588	0.979
NULL	Cancers_(Basel)_2014_Mar_26_6(2)_708-722.nxml.txt.nlp	24675568	SENT688	24	24	0	0	erlotinib	EGF	PA134687924	1950	0.979
NULL	Arthritis_Res_Ther_2010_Apr_1_12(2)_R60.nxml.txt.nlp	20359365	SENT13	37	37	0	0	bleomycin	SPARC	PA448645	6678	0.979
NULL	EPMA_J_2010_Sep_20_1(3)_421-437.nxml.txt.nlp	23199086	SENT228	27	27	12	12	doxorubicin	MTSS1	PA449412	9788	0.979
NULL	Pharmacogn_Rev_2013_Jan-Jun_7(13)_42-46.nxml.txt.nlp	23922455	SENT81	7	7	27	27	curcumin	IL-6	PA151958596	3569	0.979
NULL	Clin_Sarcoma_Res_2014_Jul_29_4_7.nxml.txt.nlp	25089183	SENT52	14	14	35	35	sunitinib	FLT3	PA162372840	2322	0.979
NULL	Balkan_J_Med_Genet_2011_Jun_25_14(1)_25-30.nxml.txt.nlp	24052699	SENT81	14	14	25	25	primidone	ABCC2	PA451105	1244	0.979
NULL	Mol_Cancer_2010_Apr_23_9_87.nxml.txt.nlp	20416058	SENT251	14	14	8	8	doxorubicin	DR4	PA449412	8797	0.979
NULL	J_Antimicrob_Chemother_2009_Nov_18_64(5)_910-928.nxml.txt.nlp	19767318	SENT225	0	0	19	19	efavirenz	CYP3A4	PA449441	1576	0.979
NULL	Theranostics_2013_Jan_15_3(1)_47-75.nxml.txt.nlp	23382786	SENT89	16	16	3	3	plerixafor	CXCR4	PA165958410	7852	0.979
NULL	Biochemistry_2009_Aug_4_48(30)_7261-7270.nxml.txt.nlp	19527073	SENT147	26	26	18	18	trypsin	FUT1	PA451806	2523	0.979
NULL	Case_Rep_Oncol_2014_Apr_25_7(1)_277-284.nxml.txt.nlp	24926257	SENT23	42	42	24	24	lenalidomide	p53	PA162363968	7157	0.979
NULL	Eur_J_Clin_Pharmacol_2012_Jan_7_68(1)_55-64.nxml.txt.nlp	21735164	SENT26	2	2	9	9	oxymorphone	CYP2D6	PA450748	1565	0.979
NULL	Arthritis_Res_Ther_2014_Oct_29_16(5)_469.nxml.txt.nlp	25606596	SENT131	22	22	8	8	abatacept	CD28	PA164747080	1493;940	0.979
NULL	Diagn_Pathol_2013_Nov_21_8_191.nxml.txt.nlp	24261710	SENT123	13	13	18	18	trastuzumab	HER2	PA451743	2064	0.979
NULL	ACS_Appl_Mater_Interfaces_2013_Aug_14_5(15)_7509-7516.nxml.txt.nlp	23834261	SENT167	28	28	11	11	oxaliplatin	p53	PA131285527	7157	0.979
NULL	JAKSTAT_2012_Oct_1_1(4)_292-299.nxml.txt.nlp	24058786	SENT155	13	13	33	33	pyrimethamine	STAT3	PA451193	6774	0.979
NULL	Front_Genet_2012_Sep_6_3_174.nxml.txt.nlp	22973298	SENT56	33	33	23	23	cisplatin	POLB	PA449014	5423	0.979
NULL	Open_Virol_J_2010_Jun_23_4_157-162.nxml.txt.nlp	20835359	SENT153	13	13	5	5	pp2	CD4		920	0.979
NULL	Infect_Drug_Resist_2011_Feb_3_4_43-53.nxml.txt.nlp	21694908	SENT117	28	28	1	1	voriconazole	CYP3A4	PA10233	1576	0.979
NULL	Mol_Brain_2014_Apr_3_7_25.nxml.txt.nlp	24708812	SENT168	14	14	35	35	chlorpheniramine	ERK	PA448960	5594	0.979
NULL	Cell_Death_Differ_2010_Apr_16_17(4)_666-676.nxml.txt.nlp	19834494	SENT127	21	21	7	7	oxaliplatin	RAGE	PA131285527	177	0.979
NULL	J_Invest_Dermatol_2013_Sep_31_133(9)_2247-2254.nxml.txt.nlp	23370537	SENT214	10	10	23	23	etoposide	PUMA	PA449552	27113	0.979
NULL	Int_J_Mol_Sci_2012_Dec_5_13(12)_16624-16635.nxml.txt.nlp	23443122	SENT22	16	16	31	31	cisplatin	MDR1	PA449014	5243	0.979
NULL	Ann_Oncol_2011_Mar_8_22(3)_503-514.nxml.txt.nlp	20616198	SENT126	31	31	17	17	exemestane	aromatase	PA449563	1588	0.979
NULL	Aging_(Albany_NY)_2009_Feb_18_1(3)_335-349.nxml.txt.nlp	20195489	SENT51	29	29	11	11	etoposide	p65	PA449552	5970	0.979
NULL	J_Clin_Biochem_Nutr_2009_Jul_30_45(1)_29-36.nxml.txt.nlp	19590704	SENT111	24	24	4	4	tolbutamide	STZ	PA451718	6484	0.979
NULL	Breast_Cancer_Res_2012_Jun_7_14(3)_R89.nxml.txt.nlp	22676470	SENT201	23	23	3	3	lapatinib	HER2	PA152241907	2064	0.979
NULL	Breast_Cancer_Res_2012_Jul_20_14(4)_R110.nxml.txt.nlp	22817698	SENT149	32	32	17	17	cyclophosphamide	BRCA1	PA449165	672	0.979
NULL	Environ_Health_Perspect_2009_Feb_8_117(2)_175-180.nxml.txt.nlp	19270784	SENT138	15	15	4	4	doxorubicin	Bcl-2	PA449412	596	0.979
NULL	Nat_Med_2010_Feb_24_16(2)_214-218.nxml.txt.nlp	20098429	SENT69	37	37	1	1	cisplatin	MTDH	PA449014	92140	0.979
NULL	Diabetes_Metab_J_2012_Aug_20_36(4)_293-299.nxml.txt.nlp	22950061	SENT121	11	11	30	30	metformin	STAT3	PA450395	6774	0.979
NULL	Braz_J_Med_Biol_Res_2014_Mar_3_47(3)_245-251.nxml.txt.nlp	24554037	SENT139	8	8	13	13	atorvastatin	IL-6	PA448500	3569	0.979
NULL	J_Invest_Dermatol_2013_Aug_133(8)_1928-1929.nxml.txt.nlp	23856932	SENT21	5	5	7	7	vemurafenib	STAT3	PA165946873	6774	0.979
NULL	Acta_Orthop_2010_Apr_6_81(2)_263-267.nxml.txt.nlp	20148646	SENT128	4	4	15	15	taurine	CHOP	PA451590	1649	0.979
NULL	Oncogene_2014_Feb_6_33(6)_713-723.nxml.txt.nlp	23435429	SENT64	29	29	8	8	etoposide	p65	PA449552	5970	0.979
NULL	Am_J_Cardiovasc_Drugs_2013_Jun_20_13(5)_331-342.nxml.txt.nlp	23784266	SENT223	25	25	13	13	ritonavir	CYP3A4	PA451260	1576	0.979
NULL	Oncol_Rep_2013_Mar_8_29(3)_917-924.nxml.txt.nlp	23314174	SENT34	6	6	22	22	sorafenib	HIF-1	PA7000	29072	0.979
NULL	CNS_Drugs_2014_Jun_24_28(10)_875-886.nxml.txt.nlp	24958205	SENT150	9	9	28	28	liraglutide	GLP-1	PA165958364	100125288	0.979
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT167	46	46	16	16	trastuzumab	STAT3	PA451743	6774	0.979
NULL	Exp_Hematol_2012_Feb_40(2)_97-106.nxml.txt.nlp	22085453	SENT146	0	0	25	25	sitagliptin	DPPIV	PA164748978	2191;1803	0.979
NULL	Int_J_Chron_Obstruct_Pulmon_Dis_2007_Sep_2(3)_205-228.nxml.txt.nlp	18229560	SENT309	27	27	40	40	cilomilast	CD68	PA165948031	968	0.979
NULL	Breast_Cancer_Res_2000_Apr_13_2(3)_E007.nxml.txt.nlp	NULL	SENT100	24	24	16	16	tamoxifen	p53	PA451581	7157	0.979
NULL	Pharmaceuticals_(Basel)_2013_Aug_6_6(8)_929-959.nxml.txt.nlp	24276377	SENT177	9	9	36	36	curcumin	CXCL8	PA151958596	3576	0.979
NULL	J_Biol_Chem_2010_Aug_20_285(34)_25913-25927.nxml.txt.nlp	20452970	SENT208	2	2	21	21	iloprost	EP4	PA164746843	5734	0.979
NULL	Stroke_Res_Treat_2011_Nov_10_2011_212485.nxml.txt.nlp	22135769	SENT151	2	2	13	13	ticagrelor	ABCB1	PA165374673	5243	0.979
NULL	Reprod_Biol_Endocrinol_2003_Oct_7_1_66.nxml.txt.nlp	14609433	SENT31	3	3	12	12	cisplatin	p53	PA449014	7157	0.979
NULL	Curr_Cardiol_Rev_2010_Nov_6(4)_291-297.nxml.txt.nlp	22043205	SENT94	2	2	10	10	captopril	AT1	PA448780	9197;185	0.979
NULL	Niger_Med_J_2013_Mar-Apr_54(2)_100-106.nxml.txt.nlp	23798795	SENT83	4	4	25	25	indomethacin	PTEN	PA449982	5728	0.979
NULL	Br_J_Cancer_2010_Mar_2_102(5)_815-826.nxml.txt.nlp	20145614	SENT154	11	11	28	28	trastuzumab	HER3	PA451743	2065	0.979
NULL	J_Cancer_2013_Nov_21_4(9)_727-735.nxml.txt.nlp	24312143	SENT159	25	25	38	38	cisplatin	HIF-1	PA449014	29072	0.979
NULL	Br_J_Cancer_2014_Jan_21_110(2)_510-519.nxml.txt.nlp	24327015	SENT212	27	27	10	10	docetaxel	PLK1	PA449383	5347	0.979
NULL	J_Cell_Biol_2007_Apr_23_177(2)_317-328.nxml.txt.nlp	17452533	SENT615	17	17	0	0	genistein	ADP	PA165109660	23038	0.979
NULL	Indian_J_Anaesth_2013_Jan-Feb_57(1)_41-45.nxml.txt.nlp	23716765	SENT120	31	31	2	2	ondansetron	HERG	PA450705	3757	0.979
NULL	Oncotarget_2011_Mar_27_2(3)_209-221.nxml.txt.nlp	21444945	SENT161	4	4	27	27	bortezomib	p53	PA10252	7157	0.979
NULL	Mol_Cancer_2014_Jan_15_13_9.nxml.txt.nlp	24428911	SENT9	33	33	36	36	gefitinib	EGFR	PA131301952	1956	0.979
NULL	Indian_J_Endocrinol_Metab_2013_Jan-Feb_17(1)_19-30.nxml.txt.nlp	23776849	SENT114	29	29	8	8	diazoxide	HNF4A	PA449285	3172	0.979
NULL	Ecancermedicalscience_2010_Oct_7_4_192.nxml.txt.nlp	22276040	SENT33	8	8	1	1	trastuzumab	PTEN	PA451743	5728	0.979
NULL	J_Oncol_2010_Aug_19_2010_932803.nxml.txt.nlp	20847951	SENT138	15	15	11	11	pp2	U87		677775;641648	0.979
NULL	Cancer_2014_Aug_1_120(15)_2325-2333.nxml.txt.nlp	24737415	SENT102	16	16	41	41	imatinib	STEPP	PA10804	222659	0.979
NULL	Clin_Exp_Gastroenterol_2013_Aug_5_6_139-148.nxml.txt.nlp	23950655	SENT113	7	7	23	23	thrombin	ADP	PA451674	23038	0.979
NULL	Antimicrob_Agents_Chemother_2014_Dec_58(12)_7340-7346.nxml.txt.nlp	25267661	SENT203	5	5	9	9	primaquine	CYP2D6	PA451103	1565	0.979
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT188	5	5	14	14	lapatinib	EGFR	PA152241907	1956	0.979
NULL	Drugs_R_D_2014_Dec_18_14(4)_233-239.nxml.txt.nlp	25231707	SENT132	11	11	1	1	clopidogrel	PTX3	PA449053	5806	0.979
NULL	Exp_Hematol_Oncol_2014_Jul_1_3_17.nxml.txt.nlp	25006537	SENT115	28	28	2	2	imatinib	San	PA10804	80218	0.979
NULL	Curr_Chem_Genomics_2010_Mar_19_4_9-18.nxml.txt.nlp	20502647	SENT167	29	29	40	40	triciribine	CLCN1	PA165958661	1180	0.979
NULL	Ann_Lab_Med_2012_Jul_20_32(4)_264-269.nxml.txt.nlp	22779067	SENT104	30	30	3	3	isoniazid	DST	PA450112	667	0.979
NULL	Breast_Cancer_Res_2007_Jun_4_9(3)_207.nxml.txt.nlp	17561991	SENT46	40	40	7	7	trastuzumab	FISH	PA451743	9644	0.979
NULL	Brain_Sci_2012_Oct_1_2(4)_434-482.nxml.txt.nlp	24961256	SENT82	24	24	20	20	fluoxetine	5-HTT	PA449673	6532	0.979
NULL	Onco_Targets_Ther_2014_Sep_9_7_1571-1582.nxml.txt.nlp	25228815	SENT32	33	33	40	40	sunitinib	VEGFR2	PA162372840	3791	0.979
NULL	Front_Chem_2014_Dec_23_2_113.nxml.txt.nlp	25566531	SENT160	27	27	18	18	curcumin	AREG	PA151958596	374	0.979
NULL	Breast_Cancer_Res_2004_Oct_24_6(1)_R8-R17.nxml.txt.nlp	14680495	SENT179	9	9	41	41	tamoxifen	BRCA1	PA451581	672	0.979
NULL	Int_J_Endocrinol_2014_Aug_4_2014_795283.nxml.txt.nlp	25165473	SENT24	0	0	6	6	exenatide	GLP-1	PA164749238	100125288	0.979
NULL	Cancer_Metab_2013_Jan_23_1_4.nxml.txt.nlp	24280026	SENT202	32	32	7	7	docetaxel	TK1	PA449383	7083	0.979
NULL	Mol_Cancer_2013_Nov_5_12_133.nxml.txt.nlp	24192080	SENT190	2	2	8	8	leflunomide	STAT6	PA450192	6778	0.979
NULL	Front_Neurol_2014_Feb_18_5_17.nxml.txt.nlp	24600432	SENT33	3	3	13	13	levetiracetam	SV2A	PA450206	9900	0.979
NULL	Chemother_Res_Pract_2011_Apr_7_2011_393976.nxml.txt.nlp	22312553	SENT37	8	8	13	13	lumefantrine	CYP3A4	PA165111722	1576	0.979
NULL	Oncotarget_2014_Jun_1_5(13)_4881-4894.nxml.txt.nlp	24952679	SENT109	28	28	21	21	bortezomib	IRE1	PA10252	2081	0.979
NULL	Oncotarget_2011_Jun_15_2(6)_518-524.nxml.txt.nlp	21680956	SENT137	14	14	24	24	pimozide	BRAF	PA450965	673	0.979
NULL	Adv_Hematol_2012_Aug_2_2012_842945.nxml.txt.nlp	22919394	SENT73	20	20	12	12	lenalidomide	CDK2	PA162363968	1017	0.979
NULL	JAKSTAT_2012_Apr_1_1(2)_55-64.nxml.txt.nlp	24058751	SENT108	3	3	13	13	pimozide	CD34	PA450965	947	0.979
NULL	Chin_J_Cancer_2012_Jul_31(7)_319-326.nxml.txt.nlp	22257382	SENT90	13	13	7	7	cetuximab	EGFR	PA10040	1956	0.979
NULL	Pharmaceuticals_(Basel)_2013_Apr_3_6(4)_480-499.nxml.txt.nlp	24276119	SENT143	5	5	14	14	fluoxetine	GluN2B	PA449673	2904	0.979
NULL	eLife_2013_Nov_5_2_e00969.nxml.txt.nlp	24192036	SENT104	18	18	8	8	vemurafenib	NOXA	PA165946873	5366	0.979
NULL	Br_J_Cancer_2004_May_4_90(9)_1710-1714.nxml.txt.nlp	15150625	SENT87	29	29	9	9	oxaliplatin	GEM	PA131285527	2669	0.979
NULL	EJC_Suppl_2013_Sep_5_11(2)_3-22.nxml.txt.nlp	NULL	SENT316	31	31	3	3	anastrozole	aromatase	PA448432	1588	0.979
NULL	Front_Microbiol_2013_Aug_19_4_241.nxml.txt.nlp	23966991	SENT231	4	4	17	17	ceftriaxone	GLT-1	PA448866	6506	0.979
NULL	Clin_Interv_Aging_2009_May_14_4_179-186.nxml.txt.nlp	19503779	SENT90	0	0	11	11	ciprofloxacin	CYP1A2	PA449009	1544	0.979
NULL	Biomed_Res_Int_2014_May_18_2014_756078.nxml.txt.nlp	24949467	SENT144	36	36	7	7	bevacizumab	IL-8	PA130232992	3576	0.979
NULL	Emerg_Infect_Dis_2014_Mar_20(3)_506-507.nxml.txt.nlp	24565423	SENT21	15	15	5	5	pyrazinamide	DST	PA451182	667	0.979
NULL	J_Oral_Pathol_Med_2013_Jul_18_42(6)_499-506.nxml.txt.nlp	23331485	SENT100	20	20	5	5	indomethacin	COX	PA449982	1351	0.979
NULL	Oncoimmunology_2012_Jul_1_1(4)_493-506.nxml.txt.nlp	22754768	SENT122	12	12	4	4	bevacizumab	IFN	PA130232992	3439	0.979
NULL	J_Neurovirol_2011_Feb_19_17(1)_63-69.nxml.txt.nlp	21246320	SENT9	18	18	9	9	memantine	IL-8	PA10364	3576	0.979
NULL	Front_Neurol_2012_Aug_1_3_120.nxml.txt.nlp	23015798	SENT476	15	15	0	0	ethanol	RhoA	PA448073	387	0.979
NULL	Cell_Death_Differ_2011_Oct_8_18(10)_1598-1607.nxml.txt.nlp	21475306	SENT53	27	27	9	9	tetracycline	p53	PA451640	7157	0.979
NULL	Oncogene_2013_Nov_28_32(48)_5439-5448.nxml.txt.nlp	23563182	SENT180	2	2	19	19	vincristine	Mcl-1	PA451879	4170	0.979
NULL	ASN_Neuro_2012_Jul_10_4(5)_e00092.nxml.txt.nlp	22625652	SENT63	16	16	3	3	papain	E14	PA450778	4863	0.979
NULL	J_Oncol_2011_Mar_30_2011_456743.nxml.txt.nlp	21541211	SENT111	26	26	16	16	cisplatin	AKT	PA449014	207	0.979
NULL	Daru_2011_19(4)_266-269.nxml.txt.nlp	22615667	SENT96	18	18	23	23	buspirone	CYP3A4	PA448689	1576	0.979
NULL	Sci_Rep_2014_Dec_4_4_7310.nxml.txt.nlp	25472472	SENT122	22	22	12	12	decitabine	CD34	PA164749631	947	0.979
NULL	Breast_Cancer_Res_2010_Jun_24_12(3)_R41.nxml.txt.nlp	20576088	SENT176	44	44	17	17	paclitaxel	PI3K	PA450761	5290	0.979
NULL	Oncogene_2014_Sep_18_33(38)_4664-4674.nxml.txt.nlp	24096486	SENT56	3	3	1	1	erlotinib	EGFR	PA134687924	1956	0.979
NULL	Hum_Genomics_2008_Sep_1_3(1)_53-70.nxml.txt.nlp	19129090	SENT119	37	37	18	18	perifosine	DZIP3	PA165291471	9666	0.979
NULL	Pharmaceuticals_(Basel)_2013_Apr_3_6(4)_480-499.nxml.txt.nlp	24276119	SENT143	8	8	14	14	desipramine	GluN2B	PA449233	2904	0.979
NULL	Br_J_Cancer_2011_Sep_6_105(6)_778-786.nxml.txt.nlp	21847128	SENT70	16	16	29	29	zoledronate	IL-2	PA10235	3558	0.979
NULL	Brain_2013_May_4_136(5)_1462-1475.nxml.txt.nlp	23460667	SENT277	22	22	9	9	bevacizumab	CD133	PA130232992	8842	0.979
NULL	Clin_Drug_Investig_2014_Nov_9_34(2)_107-115.nxml.txt.nlp	24214232	SENT37	5	5	12	12	cinacalcet	IMPACT	PA164776671	55364	0.979
NULL	J_Young_Pharm_2010_Jul-Sep_2(3)_326-331.nxml.txt.nlp	21042495	SENT127	10	10	15	15	lovastatin	CYP3A4	PA450272	1576	0.979
NULL	Thorax_2012_Sep_11_67(9)_796-803.nxml.txt.nlp	22496351	SENT9	8	8	0	0	bleomycin	TRAIL	PA448645	8743	0.979
NULL	Oncotarget_2013_Nov_7_4(12)_2550-2566.nxml.txt.nlp	24334291	SENT126	26	26	12	12	dasatinib	TIGAR	PA162372878	57103	0.979
NULL	EPMA_J_2013_Jan_28_4(1)_3.nxml.txt.nlp	23356214	SENT286	38	38	20	20	cetuximab	BRAF	PA10040	673	0.979
NULL	Case_Rep_Oncol_Med_2013_Dec_23_2013_794239.nxml.txt.nlp	24455362	SENT29	15	15	7	7	vemurafenib	BRAF	PA165946873	673	0.979
NULL	Ann_Rheum_Dis_2008_Sep_11_68(7)_1146-1152.nxml.txt.nlp	18794178	SENT86	31	31	5	5	sulfasalazine	ACR	PA451547	49	0.979
NULL	Cancer_Cell_Int_2012_Jul_4_12_19.nxml.txt.nlp	22631225	SENT304	25	25	2	2	heparin	PPIA	PA449855	5478	0.979
NULL	Int_J_Biomed_Sci_2014_Mar_10(1)_1-7.nxml.txt.nlp	24711742	SENT25	16	16	0	0	thrombin	PAR-1	PA451674	2011;2149	0.979
NULL	Mol_Brain_2014_Nov_6_7(1)_78.nxml.txt.nlp	NULL	SENT63	46	46	5	5	nitrogen	CA1	PA450643	759	0.979
NULL	Cancer_Cell_Int_2003_Jul_15_3_11.nxml.txt.nlp	12904267	SENT94	30	30	0	0	vinblastine	p53	PA451877	7157	0.979
NULL	Exp_Ther_Med_2014_Sep_4_8(3)_851-855.nxml.txt.nlp	25120613	SENT70	15	15	3	3	lopinavir	IRS1	PA450264	3667	0.979
NULL	Cancers_(Basel)_2014_Apr_9_6(2)_829-859.nxml.txt.nlp	24722453	SENT200	5	5	17	17	curcumin	JAK2	PA151958596	3717	0.979
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1224-1233.nxml.txt.nlp	22353810	SENT191	11	11	37	37	doxorubicin	MRP-1	PA449412	928	0.979
NULL	Ann_Pediatr_Endocrinol_Metab_2014_Jun_30_19(2)_57-68.nxml.txt.nlp	25077087	SENT210	0	0	9	9	diazoxide	SUR1	PA449285	6833	0.979
NULL	J_Carcinog_2014_Feb_20_13_4.nxml.txt.nlp	24737952	SENT297	0	0	12	12	trastuzumab	HER2	PA451743	2064	0.979
NULL	Nat_Med_2013_Nov_27_19(11)_10_1038_nm_3352.nxml.txt.nlp	24162815	SENT53	28	28	17	17	crizotinib	TRKA	PA165946122	4914	0.979
NULL	Oncoscience_2014_Mar_12_1(2)_158-166.nxml.txt.nlp	25594008	SENT121	36	36	26	26	dasatinib	IGFBP2	PA162372878	3485	0.979
NULL	Clin_Exp_Metastasis_2013_Apr_27_30(4)_447-455.nxml.txt.nlp	23187934	SENT40	22	22	7	7	oxaliplatin	HAI	PA131285527	6692;6768	0.979
NULL	Oncotarget_2013_Dec_18_5(2)_375-385.nxml.txt.nlp	24495868	SENT6	22	22	11	11	fludarabine	MCL1	PA449655	4170	0.979
NULL	Breast_Cancer_Res_2010_Oct_22_12(Suppl_2)_S1.nxml.txt.nlp	21050422	SENT124	27	27	12	12	carboplatin	TRN	PA448803	3842	0.979
NULL	Carcinogenesis_2014_May_13_35(5)_1055-1066.nxml.txt.nlp	24419232	SENT192	7	7	14	14	metformin	CYP1B1	PA450395	1545	0.979
NULL	Indian_J_Pharmacol_2014_Nov-Dec_46(6)_627-632.nxml.txt.nlp	25538335	SENT137	37	37	5	5	metformin	Q10	PA450395	27161	0.979
NULL	Mol_Cancer_2012_Oct_22_11_80.nxml.txt.nlp	23088607	SENT72	11	11	20	20	estradiol	HIF-1	PA449503	29072	0.979
NULL	Br_J_Cancer_2013_Sep_3_109(5)_1214-1222.nxml.txt.nlp	23922104	SENT172	2	2	9	9	dasatinib	p53	PA162372878	7157	0.979
NULL	Cardiovasc_Drugs_Ther_2010_Dec_13_24(5-6)_391-399.nxml.txt.nlp	20640495	SENT197	13	13	5	5	atorvastatin	COX2	PA448500	4513;5743	0.979
NULL	Oncotarget_2014_Jun_8_5(13)_5040-5053.nxml.txt.nlp	24970815	SENT280	10	10	1	1	cisplatin	PI3K	PA449014	5290	0.979
NULL	Arthritis_Res_Ther_2009_Oct_14_11(5)_246.nxml.txt.nlp	19849823	SENT208	4	4	15	15	estradiol	IFN	PA449503	3439	0.979
NULL	Oncol_Lett_2013_Mar_11_5(3)_1010-1016.nxml.txt.nlp	23426784	SENT147	13	13	32	32	midazolam	TRPM7	PA450496	54822	0.979
NULL	Mol_Cancer_2014_Jul_5_13_165.nxml.txt.nlp	24996221	SENT133	26	26	42	42	docetaxel	p62	PA449383	8878;10657;23636	0.979
NULL	J_Cell_Biol_2002_Nov_11_159(3)_453-463.nxml.txt.nlp	12427868	SENT318	0	0	29	29	marimastat	TIMP2	PA164748329	7077	0.979
NULL	AAPS_J_2011_Dec_22_14(1)_68-78.nxml.txt.nlp	22189899	SENT27	0	0	17	17	rifampin	CYP3A4	PA451250	1576	0.979
NULL	Diabetes_Metab_Syndr_Obes_2010_Jul_20_3_263-273.nxml.txt.nlp	21437094	SENT109	3	3	6	6	liraglutide	GLP-1	PA165958364	100125288	0.979
NULL	Tuberc_Respir_Dis_(Seoul)_2014_Aug_29_77(2)_49-54.nxml.txt.nlp	25237374	SENT68	4	4	11	11	ponatinib	FGFR1	PA165980594	2260	0.979
NULL	Indian_J_Pharmacol_2012_Nov-Dec_44(6)_759-764.nxml.txt.nlp	23248408	SENT96	18	18	22	22	sitagliptin	ANOVA	PA164748978	4858	0.979
NULL	Nucleic_Acids_Res_2011_Sep_7_39(17)_7465-7476.nxml.txt.nlp	21653549	SENT243	11	11	21	21	hydroxyurea	DEK	PA449942	7913	0.979
NULL	Acta_Pharmacol_Sin_2011_Jul_13_32(7)_967-972.nxml.txt.nlp	21666702	SENT23	2	2	11	11	losartan	P-gp	PA450268	5243	0.979
NULL	Cancers_(Basel)_2011_Aug_15_3(3)_3331-3352.nxml.txt.nlp	24212957	SENT242	11	11	35	35	bevacizumab	CD105	PA130232992	2022	0.979
NULL	Int_J_Mol_Sci_2014_Mar_20_15(3)_4946-4964.nxml.txt.nlp	24658439	SENT63	20	20	39	39	capsaicin	GBF	PA448776	1316	0.979
NULL	Oncotarget_2012_Oct_20_3(10)_1236-1245.nxml.txt.nlp	23100449	SENT108	32	32	1	1	doxorubicin	NGAL	PA449412	3934	0.979
NULL	Acta_Pharmacol_Sin_2014_Jan_9_35(1)_1-10.nxml.txt.nlp	24317012	SENT23	22	22	7	7	flavopiridol	SLCO1B1	PA452627	10599	0.979
NULL	EPMA_J_2010_Jun_9_1(2)_329-341.nxml.txt.nlp	23199068	SENT252	0	0	6	6	ceftriaxone	EAAT2	PA448866	6506	0.979
NULL	Biosci_Rep_2013_Sep_4_33(5)_e00064.nxml.txt.nlp	23889169	SENT61	30	30	10	10	thrombin	PAR4	PA451674	9002;5074	0.979
NULL	Oncotarget_2012_Nov_17_3(12)_1600-1614.nxml.txt.nlp	23307622	SENT79	11	11	19	19	lapatinib	ATG12	PA152241907	9140	0.979
NULL	Mol_Biol_Rep_2013_May_11_40(8)_5013-5026.nxml.txt.nlp	23666059	SENT268	34	34	6	6	resveratrol	p53		7157	0.979
NULL	Indian_J_Med_Res_2014_Feb_139(2)_205-215.nxml.txt.nlp	24718394	SENT105	11	11	37	37	artesunate	ACT	PA165111697	12;11332;9457;641455	0.979
NULL	EMBO_Mol_Med_2013_Aug_8_5(8)_1227-1246.nxml.txt.nlp	23836498	SENT110	18	18	16	16	2-methoxyestradiol	HIF-1	PA134967247	29072	0.979
NULL	Diabetes_Obes_Metab_2011_Nov_13(11)_982-989.nxml.txt.nlp	21615670	SENT105	18	18	4	4	sitagliptin	PPG	PA164748978	5552	0.979
NULL	J_Cerebrovasc_Endovasc_Neurosurg_2012_Sep_28_14(3)_157-163.nxml.txt.nlp	23210041	SENT102	3	3	36	36	warfarin	PTA	PA451906	171558	0.979
NULL	Cancers_(Basel)_2011_Apr_1_3(2)_1844-1860.nxml.txt.nlp	24212785	SENT98	27	27	7	7	cetuximab	PTEN	PA10040	5728	0.979
NULL	Core_Evid_2011_Sep_8_6_67-79.nxml.txt.nlp	22022289	SENT176	24	24	11	11	exenatide	GLP-1	PA164749238	100125288	0.979
NULL	Breast_Cancer_Res_2012_Aug_8_14(4)_R116.nxml.txt.nlp	22873525	SENT3	0	0	25	25	trastuzumab	HER2	PA451743	2064	0.979
NULL	Diabetes_Care_2009_Nov_32(Suppl_2)_S414-S419.nxml.txt.nlp	19875591	SENT160	5	5	24	24	capsaicin	NNT	PA448776	23530	0.979
NULL	Oncoimmunology_2013_Oct_1_2(10)_e27025.nxml.txt.nlp	24353914	SENT176	27	27	17	17	docetaxel	ICOS	PA449383	29851;1493	0.979
NULL	Breast_Cancer_Res_2005_May_27_7(Suppl_1)_S16.nxml.txt.nlp	NULL	SENT4	8	8	6	6	letrozole	aromatase	PA450196	1588	0.979
NULL	Paediatr_Drugs_2014_Feb_27_16(3)_199-211.nxml.txt.nlp	24574047	SENT123	26	26	8	8	doxylamine	PLP	PA449419	25824;5744	0.979
NULL	Cancers_(Basel)_2014_Oct_24_6(4)_2187-2223.nxml.txt.nlp	25347122	SENT321	0	0	10	10	bevacizumab	VEGF-A	PA130232992	7422	0.979
NULL	Int_J_Med_Sci_2014_May_1_11(7)_663-673.nxml.txt.nlp	24843314	SENT139	34	34	5	5	tamoxifen	TFF1	PA451581	7031	0.979
NULL	Basic_Clin_Pharmacol_Toxicol_2013_Feb_5_112(2)_132-137.nxml.txt.nlp	22900583	SENT23	18	18	39	39	prasugrel	CYP3A	PA154410481	1574	0.979
NULL	Clin_Interv_Aging_2013_Jul_16_8_889-897.nxml.txt.nlp	23898224	SENT95	12	12	3	3	gemcitabine	SIRT1	PA449748	23411	0.979
NULL	Curr_HIV_Res_2014_May_12(3)_174-188.nxml.txt.nlp	24862327	SENT147	25	25	42	42	hemin	MCP-1	PA449849	6347	0.979
NULL	Mol_Cancer_2012_Apr_26_11_26.nxml.txt.nlp	22537224	SENT14	43	43	10	10	cisplatin	CHK1	PA449014	1111	0.979
NULL	Acta_Pharmacol_Sin_2011_Aug_11_32(8)_999-1008.nxml.txt.nlp	21743486	SENT255	30	30	8	8	fasudil	JNK	PA165946121	5599	0.979
NULL	Indian_J_Radiol_Imaging_2008_Aug_18(3)_256-263.nxml.txt.nlp	19774171	SENT30	39	39	13	13	aspirin	ACT	PA448497	12;11332;9457;641455	0.979
NULL	Evid_Based_Complement_Alternat_Med_2013_Mar_26_2013_974313.nxml.txt.nlp	23589723	SENT222	6	6	30	30	metformin	AMPK	PA450395	5563	0.979
NULL	J_Hematol_Oncol_2011_Aug_15_4_34.nxml.txt.nlp	21843362	SENT20	11	11	28	28	vincristine	CHOP	PA451879	1649	0.979
NULL	Neural_Regen_Res_2013_Jul_15_8(20)_1853-1862.nxml.txt.nlp	25206494	SENT168	15	15	9	9	ethanol	JNK	PA448073	5599	0.979
NULL	Oncogene_2014_Feb_6_33(6)_713-723.nxml.txt.nlp	23435429	SENT64	29	29	6	6	etoposide	p50	PA449552	958;4790	0.979
NULL	Clin_Exp_Otorhinolaryngol_2011_Jun_31_4(2)_77-82.nxml.txt.nlp	21716954	SENT184	14	14	25	25	cisplatin	Bcl-2	PA449014	596	0.979
NULL	Acta_Pharmacol_Sin_2011_Jul_13_32(7)_967-972.nxml.txt.nlp	21666702	SENT141	13	13	44	44	losartan	P-gp	PA450268	5243	0.979
NULL	Springerplus_2013_Dec_18_2_679.nxml.txt.nlp	24386625	SENT90	0	0	13	13	vemurafenib	BRAF	PA165946873	673	0.979
NULL	J_Breast_Cancer_2014_Jun_27_17(2)_113-120.nxml.txt.nlp	25013431	SENT35	16	16	2	2	trastuzumab	aromatase	PA451743	1588	0.979
NULL	Cancer_Cell_Int_2009_Sep_10_9_25.nxml.txt.nlp	19744341	SENT42	19	19	15	15	glucosamine	STAT3	PA164747613	6774	0.979
NULL	Chem_Rev_2011_Oct_12_111(10)_5899-5921.nxml.txt.nlp	21923193	SENT139	21	21	1	1	indomethacin	COX	PA449982	1351	0.979
NULL	Pharmaceutics_2011_Oct_12_3(4)_680-705.nxml.txt.nlp	24309303	SENT96	22	22	31	31	gefitinib	OCT2	PA131301952	6582;5452	0.979
NULL	Breast_Cancer_Res_2010_May_10_12(3)_R26.nxml.txt.nlp	20459744	SENT137	16	16	9	9	docetaxel	CYP3A5	PA449383	1577	0.979
NULL	Pharmaceuticals_(Basel)_2013_Aug_21_6(8)_988-1038.nxml.txt.nlp	24276379	SENT2531	8	8	0	0	cetuximab	KRAS	PA10040	3845	0.979
NULL	Anesthesiol_Res_Pract_2013_Sep_23_2013_297141.nxml.txt.nlp	24174934	SENT135	16	16	6	6	lidocaine	mol	PA450226	90527	0.979
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT168	18	18	10	10	simvastatin	PI3K	PA451363	5290	0.979
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT376	2	2	27	27	aripiprazole	PRL	PA10026	5617	0.979
NULL	eLife_2013_Oct_29_2_e01236.nxml.txt.nlp	24171104	SENT524	34	34	46	46	bortezomib	MM1	PA10252	23654	0.979
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2011_Sep_13_4_47-62.nxml.txt.nlp	22879794	SENT108	6	6	22	22	exenatide	GLP-1	PA164749238	100125288	0.979
NULL	J_Oncol_2011_Dec_9_2011_352616.nxml.txt.nlp	21197469	SENT324	21	21	24	24	erlotinib	EGFR	PA134687924	1956	0.979
NULL	Contemp_Oncol_(Pozn)_2012_Jul_6_16(3)_197-200.nxml.txt.nlp	23788878	SENT99	10	10	20	20	vemurafenib	BRAF	PA165946873	673	0.979
NULL	J_Korean_Med_Sci_2014_Feb_28_29(2)_230-237.nxml.txt.nlp	24550650	SENT139	16	16	6	6	doxorubicin	p38	PA449412	10598;1432;7965	0.979
NULL	Front_Physiol_2011_Jun_30_2_33.nxml.txt.nlp	21747769	SENT234	15	15	10	10	berberine	KCNQ1	PA165860812	3784	0.979
NULL	Int_J_Biol_Sci_2013_Mar_8_9(3)_295-302.nxml.txt.nlp	23493786	SENT124	29	29	6	6	choline	MYC	PA448976	4609	0.979
NULL	Int_J_Mol_Sci_2014_Oct_8_15(10)_17974-17999.nxml.txt.nlp	25299695	SENT356	3	3	7	7	curcumin	HO-1	PA151958596	3162	0.979
NULL	Aging_(Albany_NY)_2010_Dec_31_2(12)_924-935.nxml.txt.nlp	21212465	SENT231	19	19	4	4	etoposide	p53	PA449552	7157	0.979
NULL	Indian_Dermatol_Online_J_2010_Jul-Dec_1(1)_14-17.nxml.txt.nlp	23130185	SENT7	22	22	25	25	lapatinib	EGFR	PA152241907	1956	0.979
NULL	Diabetes_Care_2011_Feb_20_34(2)_375-380.nxml.txt.nlp	20980414	SENT141	0	0	6	6	metformin	AMPK	PA450395	5563	0.979
NULL	Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.nxml.txt.nlp	24736980	SENT35	22	22	9	9	rosuvastatin	OATP1B1	PA134308647	10599	0.979
NULL	Exp_Diabetes_Res_2011_Apr_6_2011_928523.nxml.txt.nlp	21603181	SENT155	0	0	32	32	haloperidol	5-HT1A	PA449841	3350	0.979
NULL	Ann_Rehabil_Med_2012_Aug_27_36(4)_466-473.nxml.txt.nlp	22977771	SENT22	29	29	0	0	hyaluronidase	ILEI	PA164745713	10447	0.979
NULL	Mol_Cancer_2013_Mar_5_12_17.nxml.txt.nlp	23497256	SENT190	13	13	0	0	sunitinib	HDMX	PA162372840	4194;4193	0.979
NULL	Cancer_Res_Treat_2013_Mar_31_45(1)_63-69.nxml.txt.nlp	23613672	SENT31	42	42	6	6	cisplatin	survivin	PA449014	332	0.979
NULL	Cancers_(Basel)_2011_Aug_15_3(3)_3331-3352.nxml.txt.nlp	24212957	SENT182	10	10	24	24	gefitinib	CD133	PA131301952	8842	0.979
NULL	J_Cell_Mol_Med_2014_Sep_7_18(9)_1785-1796.nxml.txt.nlp	24909956	SENT195	24	24	7	7	cangrelor	GPR17	PA165945763	2840	0.979
NULL	J_Clin_Biochem_Nutr_2009_Jan_27_44(1)_79-84.nxml.txt.nlp	19177192	SENT93	2	2	15	15	curcumin	HO-1	PA151958596	3162	0.979
NULL	Br_J_Cancer_2012_Apr_24_106(9)_1543-1550.nxml.txt.nlp	22531721	SENT164	29	29	6	6	rituximab	CD59	PA451261	966	0.979
NULL	Nucleic_Acids_Res_2005_Dec_9_33(22)_6972-6981.nxml.txt.nlp	16340007	SENT63	18	18	4	4	bleomycin	DNA-PKcs	PA448645	5591	0.979
NULL	Clinics_(Sao_Paulo)_2010_Jun_65(6)_645-646.nxml.txt.nlp	20613942	SENT16	9	9	34	34	orlistat	CEA	PA164776864	5670;1087	0.979
NULL	Indian_J_Psychiatry_2009_Jul-Sep_51(3)_222-224.nxml.txt.nlp	19881055	SENT63	3	3	12	12	fluoxetine	CYP2D6	PA449673	1565	0.979
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT784	37	37	5	5	aliskiren	OATP1A2	PA143487910	6579	0.979
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT38	9	9	29	29	lapatinib	HER3	PA152241907	2065	0.979
NULL	Breast_Cancer_Res_2004_Jun_28_6(5)_185-187.nxml.txt.nlp	15318922	SENT58	32	32	0	0	tamoxifen	HER2	PA451581	2064	0.979
NULL	Oncoimmunology_2013_Jan_1_2(1)_e22890.nxml.txt.nlp	23483066	SENT130	3	3	13	13	vemurafenib	IFN	PA165946873	3439	0.979
NULL	Anat_Cell_Biol_2011_Mar_31_44(1)_14-24.nxml.txt.nlp	21519545	SENT99	22	22	6	6	cyclophosphamide	CK8	PA449165	3856	0.979
NULL	Iran_J_Neurol_2013_12(4)_157-165.nxml.txt.nlp	24250926	SENT46	0	0	19	19	felbamate	LGS	PA449590	51557	0.979
NULL	Indian_J_Pharm_Sci_2013_Jan-Feb_75(1)_31-35.nxml.txt.nlp	23901158	SENT75	23	23	8	8	cefpodoxime	DCX	PA164746385	1641	0.979
NULL	Biomed_Res_Int_2014_Aug_6_2014_967826.nxml.txt.nlp	25165721	SENT146	0	0	5	5	cisplatin	p38	PA449014	10598;1432;7965	0.979
NULL	Eur_J_Med_Res_2011_Nov_10_16(11)_491-494.nxml.txt.nlp	22027642	SENT11	0	0	21	21	sunitinib	FLT3	PA162372840	2322	0.979
NULL	Indian_J_Med_Res_2014_Apr_139(4)_572-578.nxml.txt.nlp	24927344	SENT11	9	9	14	14	acenocoumarol	CYP4F2	PA452632	8529	0.979
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT166	27	27	7	7	cisplatin	p53	PA449014	7157	0.979
NULL	Oncotarget_2011_Mar_23_2(3)_165-177.nxml.txt.nlp	21444946	SENT60	21	21	1	1	gefitinib	EGFR	PA131301952	1956	0.979
NULL	Arthritis_Res_Ther_2012_Mar_9_14(2)_R53.nxml.txt.nlp	22404969	SENT30	0	0	9	9	tocilizumab	IL-6	PA165292659	3569	0.979
NULL	Oncotarget_2011_Jun_30_2(7)_562-568.nxml.txt.nlp	21725138	SENT89	15	15	3	3	trastuzumab	HER-2	PA451743	2064	0.979
NULL	J_Oncol_2012_Apr_10_2012_931071.nxml.txt.nlp	22570654	SENT68	3	3	24	24	plerixafor	CD34	PA165958410	947	0.979
NULL	Patient_Prefer_Adherence_2011_Dec_23_6_1-9.nxml.txt.nlp	22272064	SENT7	20	20	15	15	telmisartan	ACE	PA451605	1636	0.979
NULL	Oncotarget_2014_Oct_18_5(22)_11641-11652.nxml.txt.nlp	25361002	SENT85	3	3	20	20	cisplatin	NAC	PA449014	22861	0.979
NULL	Front_Oncol_2013_Sep_11_3_228.nxml.txt.nlp	24062981	SENT190	19	19	4	4	topotecan	PARP1	PA451729	142	0.979
NULL	Chem_Res_Toxicol_2010_Jul_19_23(7)_1151-1162.nxml.txt.nlp	20536192	SENT337	14	14	27	27	etoposide	p53	PA449552	7157	0.979
NULL	Crit_Care_2006_Mar_21_10(Suppl_1)_P168.nxml.txt.nlp	NULL	SENT13	23	23	4	4	aprotinin	ACT	PA448472	12;11332;9457;641455	0.979
NULL	J_Skin_Cancer_2011_Oct_11_2011_521947.nxml.txt.nlp	22007305	SENT188	17	17	37	37	vemurafenib	BRAF	PA165946873	673	0.979
NULL	Br_J_Cancer_2011_Dec_6_105(12)_1850-1855.nxml.txt.nlp	22095231	SENT21	2	2	21	21	erlotinib	EGFR	PA134687924	1956	0.979
NULL	Indian_J_Psychol_Med_2009_Jan-Jun_31(1)_3-10.nxml.txt.nlp	21938084	SENT176	13	13	26	26	fluphenazine	5-HT2A	PA449676	3356	0.979
NULL	J_Hematol_Oncol_2008_Oct_1_1_16.nxml.txt.nlp	18828924	SENT103	0	0	14	14	pertuzumab	HER2		2064	0.979
NULL	J_Hematol_Oncol_2013_Dec_10_6_92.nxml.txt.nlp	24326130	SENT160	5	5	13	13	imatinib	KIT	PA10804	3815	0.979
NULL	Acta_Pharmacol_Sin_2012_Aug_23_33(8)_1095-1100.nxml.txt.nlp	22820908	SENT108	34	34	47	47	omeprazole	CYP3A4	PA450704	1576	0.979
NULL	Cell_Death_Dis_2014_Jan_30_5(1)_e1030.nxml.txt.nlp	24481444	SENT18	0	0	13	13	sorafenib	VEGFR2	PA7000	3791	0.979
NULL	Nucl_Recept_Signal_2009_Jan_16_7_e001.nxml.txt.nlp	19240808	SENT413	17	17	6	6	paclitaxel	SXR	PA450761	8856	0.979
NULL	Biologics_2012_Sep_25_6_337-345.nxml.txt.nlp	23055691	SENT164	6	6	17	17	gefitinib	EGFR	PA131301952	1956	0.979
NULL	EMBO_Mol_Med_2010_May_2(5)_146-158.nxml.txt.nlp	20432502	SENT25	23	23	14	14	trastuzumab	PTEN	PA451743	5728	0.979
NULL	Breast_Cancer_Res_2002_Apr_4_4(3)_85-89.nxml.txt.nlp	12052249	SENT40	41	41	4	4	tamoxifen	SULT1A1	PA451581	6817	0.979
NULL	Oncol_Lett_2013_Dec_4_6(6)_1665-1672.nxml.txt.nlp	24273604	SENT137	0	0	13	13	chloroquine	p53	PA448948	7157	0.979
NULL	Indian_J_Anaesth_2009_Jun_53(3)_268-269.nxml.txt.nlp	20640133	SENT15	0	0	17	17	aprotinin	PAR1	PA448472	79581;2149	0.979
NULL	Exp_Diabetes_Res_2011_Jun_23_2011_898913.nxml.txt.nlp	21747834	SENT178	17	17	7	7	exenatide	GLP-1	PA164749238	100125288	0.979
NULL	Cancer_Med_2012_Oct_17_1(2)_230-236.nxml.txt.nlp	23342272	SENT150	11	11	28	28	vismodegib	SMO		6608;54498	0.979
NULL	Clin_Ophthalmol_2012_Jul_19_6_1149-1157.nxml.txt.nlp	22973087	SENT26	0	0	13	13	bevacizumab	VEGF-A	PA130232992	7422	0.979
NULL	Front_Immunol_2012_Jan_2_2_82.nxml.txt.nlp	22566871	SENT170	2	2	16	16	baclofen	CX3CR1	PA448533	1524	0.979
NULL	Exp_Cell_Res_2011_Apr_15_317(7)_1028-1039.nxml.txt.nlp	21237154	SENT107	7	7	29	29	staurosporine	JIP1	PA165109623	9479	0.979
NULL	Br_J_Cancer_2013_Jul_23_109(2)_351-359.nxml.txt.nlp	23799854	SENT165	13	13	22	22	paclitaxel	BLT2	PA450761	56413	0.979
NULL	Breast_Cancer_Res_2010_Mar_5_12(2)_R16.nxml.txt.nlp	20205716	SENT343	20	20	2	2	lovastatin	PTEN	PA450272	5728	0.979
NULL	Comb_Chem_High_Throughput_Screen_2010_Feb_13(2)_188-206.nxml.txt.nlp	20053163	SENT247	38	38	9	9	fluconazole	CYP2C9	PA449653	1559	0.979
NULL	Breast_Cancer_(Auckl)_2009_Aug_17_3_47-60.nxml.txt.nlp	21556249	SENT48	27	27	41	41	tamoxifen	AF-1	PA451581	3460;5710	0.979
NULL	Breast_Cancer_Res_2007_Oct_26_9(5)_306.nxml.txt.nlp	17980055	SENT24	14	14	37	37	tamoxifen	aromatase	PA451581	1588	0.979
NULL	Clin_Ophthalmol_2008_Mar_2(1)_1-14.nxml.txt.nlp	19668384	SENT32	0	0	12	12	ranibizumab	VEGF-A	PA164746012	7422	0.979
NULL	Nucleic_Acids_Res_2010_Oct_22_38(19)_6502-6512.nxml.txt.nlp	20571088	SENT239	11	11	1	1	galactose	GAL	PA449725	51083	0.979
NULL	J_Mol_Signal_2008_Dec_2_3_19.nxml.txt.nlp	19055733	SENT43	21	21	12	12	isoproterenol	AKAP5	PA450121	9495	0.979
NULL	Basic_Clin_Pharmacol_Toxicol_2013_Feb_5_112(2)_132-137.nxml.txt.nlp	22900583	SENT23	22	22	25	25	ketoconazole	CYP3A	PA450146	1574	0.979
NULL	Ther_Clin_Risk_Manag_2006_Mar_2(1)_87-98.nxml.txt.nlp	18360584	SENT184	14	14	12	12	gefitinib	EGFR	PA131301952	1956	0.979
NULL	Breast_Cancer_Res_2011_Feb_2_13(1)_R15.nxml.txt.nlp	21288332	SENT192	11	11	25	25	trastuzumab	TOP2A	PA451743	7153	0.979
NULL	Scientifica_(Cairo)_2013_Feb_7_2013_249101.nxml.txt.nlp	24278770	SENT188	2	2	15	15	alemtuzumab	IFN	PA164783958	3439	0.979
NULL	Case_Rep_Oncol_Med_2013_Sep_26_2013_234391.nxml.txt.nlp	24191208	SENT14	20	20	7	7	capecitabine	HER-2	PA448771	2064	0.979
NULL	Oncogene_2010_Sep_16_29(37)_5193-5203.nxml.txt.nlp	20581867	SENT147	5	5	21	21	lapatinib	PI3K	PA152241907	5290	0.979
NULL	Exp_Ther_Med_2015_Jan_10_9(1)_267-271.nxml.txt.nlp	25452814	SENT24	30	30	37	37	clopidogrel	ADP	PA449053	23038	0.979
NULL	J_Cell_Biol_2001_Nov_26_155(5)_711-718.nxml.txt.nlp	11724813	SENT86	28	28	4	4	hydroxyurea	GAL	PA449942	51083	0.979
NULL	Exp_Ther_Med_2013_Nov_13_6(5)_1317-1321.nxml.txt.nlp	24223665	SENT6	23	23	11	11	curcumin	CD133	PA151958596	8842	0.979
NULL	Indian_J_Nucl_Med_2010_Jul-Sep_25(3)_78-87.nxml.txt.nlp	NULL	SENT314	0	0	15	15	diclofenac	OTC	PA449293	5009	0.979
NULL	Breast_Cancer_Res_2012_Jul_19_14(4)_314.nxml.txt.nlp	22809213	SENT33	17	17	8	8	tamoxifen	FOXA1	PA451581	3169	0.979
NULL	Diabetes_2009_Feb_58(2)_344-351.nxml.txt.nlp	19008341	SENT159	19	19	10	10	resveratrol	p65		5970	0.979
NULL	Pharmaceuticals_(Basel)_2012_Aug_30_5(9)_890-898.nxml.txt.nlp	24280696	SENT299	11	11	2	2	fludarabine	Hsp90	PA449655	3320	0.979
NULL	Diabetes_Care_2010_Sep_33(9)_2074-2076.nxml.txt.nlp	20805279	SENT62	0	0	33	33	exenatide	GLP-1	PA164749238	100125288	0.979
NULL	J_Immunotoxicol_2013_Jan_11_10(1)_75-82.nxml.txt.nlp	22967038	SENT84	33	33	7	7	rituximab	IFN	PA451261	3439	0.979
NULL	Br_J_Cancer_2013_May_28_108(10)_2013-2020.nxml.txt.nlp	23632482	SENT149	20	20	10	10	paclitaxel	CENP-A	PA450761	1058	0.979
NULL	Front_Behav_Neurosci_2015_Jan_15_8_453.nxml.txt.nlp	25642174	SENT137	12	12	19	19	clozapine	5-HT7	PA449061	3363	0.979
NULL	J_Hematol_Oncol_2013_Jan_4_6_1.nxml.txt.nlp	23286345	SENT120	33	33	14	14	cyclophosphamide	FCGR3A	PA449165	2214	0.979
NULL	Front_Immunol_2013_Mar_8_4_50.nxml.txt.nlp	23483669	SENT176	16	16	1	1	anakinra	IL-6	PA10799	3569	0.979
NULL	Indian_J_Med_Res_2012_Aug_136(2)_249-259.nxml.txt.nlp	22960892	SENT37	27	27	7	7	irinotecan	UGT1A1	PA450085	54658	0.979
NULL	Mol_Cancer_2010_Nov_2_9_289.nxml.txt.nlp	21044322	SENT141	14	14	2	2	cisplatin	RGS10	PA449014	6001	0.979
NULL	Exp_Lung_Res_2013_Oct_1_39(8)_336-348.nxml.txt.nlp	23919450	SENT227	4	4	9	9	thrombin	PAR-1	PA451674	2011;2149	0.979
NULL	Acta_Histochem_Cytochem_2012_Apr_26_45(2)_139-146.nxml.txt.nlp	22685356	SENT114	21	21	5	5	forskolin	AQP2	PA146096022	359	0.979
NULL	Cardiovasc_Diabetol_2013_Mar_4_12_42.nxml.txt.nlp	23452502	SENT220	2	2	11	11	liraglutide	GLP1	PA165958364	100125288;2641	0.979
NULL	J_Immunother_Cancer_2014_Jan_27_2_2.nxml.txt.nlp	24829759	SENT170	11	11	24	24	sorafenib	IL-21	PA7000	59067;50616;27189	0.979
NULL	Mar_Drugs_2012_Dec_11_10(12)_2782-2794.nxml.txt.nlp	23342393	SENT398	14	14	0	0	cyclophosphamide	CD4	PA449165	920	0.979
NULL	Int_J_Breast_Cancer_2011_Sep_6_2011_352182.nxml.txt.nlp	22295219	SENT214	32	32	10	10	trastuzumab	HER2	PA451743	2064	0.979
NULL	J_Invest_Dermatol_2014_Feb_10_134(2)_319-325.nxml.txt.nlp	24108405	SENT87	16	16	39	39	vemurafenib	BRAF	PA165946873	673	0.979
NULL	Acta_Naturae_2013_Oct-Dec_5(4)_83-93.nxml.txt.nlp	24455187	SENT142	21	21	31	31	tamoxifen	7SL	PA451581	6029	0.979
NULL	Oncol_Lett_2014_May_4_7(5)_1352-1362.nxml.txt.nlp	24765137	SENT70	38	38	26	26	doxorubicin	GSTP1	PA449412	2950	0.979
NULL	Breast_Cancer_Res_2008_Aug_5_10(4)_R68.nxml.txt.nlp	18681966	SENT237	24	24	32	32	doxorubicin	PRLR	PA449412	5618	0.979
NULL	Oncotarget_2010_Oct_25_1(7)_497-514.nxml.txt.nlp	21165163	SENT266	38	38	3	3	gefitinib	EGFR	PA131301952	1956	0.979
NULL	Cell_Death_Differ_2011_Oct_8_18(10)_1598-1607.nxml.txt.nlp	21475306	SENT53	27	27	19	19	tetracycline	p53	PA451640	7157	0.979
NULL	Oncotarget_2013_Dec_28_5(6)_1475-1490.nxml.txt.nlp	24721996	SENT174	25	25	11	11	celecoxib	CD44	PA448871	960	0.979
NULL	F1000_Biol_Rep_2012_Mar_1_4_5.nxml.txt.nlp	22403588	SENT116	32	32	10	10	ribavirin	IFN	PA451241	3439	0.979
NULL	Biomed_Res_Int_2013_Aug_6_2013_602987.nxml.txt.nlp	24027759	SENT274	38	38	10	10	paclitaxel	SMF	PA450761	22993	0.979
NULL	Acta_Pharmacol_Sin_2012_Jan_28_33(1)_75-81.nxml.txt.nlp	22120969	SENT89	34	34	6	6	exenatide	GLP-1	PA164749238	100125288	0.979
NULL	Gut_2013_Apr_14_62(4)_540-549.nxml.txt.nlp	22798500	SENT250	27	27	9	9	cetuximab	KRAS	PA10040	3845	0.979
NULL	Cardiovasc_Drugs_Ther_2013_Jul_26_27(6)_521-530.nxml.txt.nlp	23887740	SENT160	39	39	25	25	clopidogrel	CD41	PA449053	3674	0.979
NULL	Cell_Commun_Signal_2014_Sep_25_12(1)_61.nxml.txt.nlp	NULL	SENT60	23	23	16	16	doxycycline	INPP4B	PA449415	8821	0.979
NULL	Carcinogenesis_2014_May_13_35(5)_1055-1066.nxml.txt.nlp	24419232	SENT39	26	26	12	12	metformin	CYP1B1	PA450395	1545	0.979
NULL	Breast_Cancer_Res_2005_Jan_26_7(2)_R256-R266.nxml.txt.nlp	15743506	SENT27	10	10	16	16	tamoxifen	HER-2	PA451581	2064	0.979
NULL	Blood_Press_Monit_2014_Jun_9_19(3)_123-128.nxml.txt.nlp	24637789	SENT3	42	42	1	1	amlodipine	ACS1	PA448388	2180	0.979
NULL	Clin_Mol_Hepatol_2014_Sep_25_20(3)_283-290.nxml.txt.nlp	25320732	SENT74	41	41	29	29	propranolol	EVL	PA451145	51466	0.979
NULL	Cancers_(Basel)_2014_Mar_6_6(1)_494-525.nxml.txt.nlp	24662938	SENT207	13	13	11	11	erlotinib	EGFR	PA134687924	1956	0.979
NULL	Nat_Genet_2011_Jan_12_43(1)_27-33.nxml.txt.nlp	21151129	SENT296	14	14	3	3	tamoxifen	FOXA1	PA451581	3169	0.979
NULL	Chemother_Res_Pract_2012_Aug_29_2012_817297.nxml.txt.nlp	22970367	SENT193	9	9	20	20	erlotinib	EGFR	PA134687924	1956	0.979
NULL	Anal_Chem_Insights_2007_Nov_14_2_93-106.nxml.txt.nlp	19662183	SENT184	10	10	26	26	imatinib	P-gp	PA10804	5243	0.979
NULL	Mediators_Inflamm_2010_Jun_21_2010_194896.nxml.txt.nlp	20652055	SENT141	5	5	18	18	berberine	MCP-1	PA165860812	6347	0.979
NULL	Aging_(Albany_NY)_2014_May_17_6(5)_369-379.nxml.txt.nlp	24860943	SENT80	8	8	1	1	l-arginine	S6K1	PA448478	6198	0.979
NULL	J_Hematol_Oncol_2013_Dec_17_6_93.nxml.txt.nlp	24341609	SENT23	26	26	9	9	gefitinib	EGFR	PA131301952	1956	0.979
NULL	Arthritis_Res_Ther_2012_May_1_14(3)_R99.nxml.txt.nlp	22546542	SENT111	41	41	0	0	infliximab	CD4	PA452639	920	0.979
NULL	Arch_Med_Sci_2011_Apr_17_7(2)_230-234.nxml.txt.nlp	22291761	SENT11	6	6	16	16	curcumin	SMN2	PA151958596	6607	0.979
NULL	Nucleic_Acids_Res_2013_May_3_41(10)_e107.nxml.txt.nlp	23558748	SENT338	22	22	9	9	doxycycline	CENP-A	PA449415	1058	0.979
NULL	Br_J_Pharmacol_2008_Sep_9_155(1)_127-137.nxml.txt.nlp	18536750	SENT60	35	35	13	13	piroxicam	IL-10	PA450985	3586	0.979
NULL	EMBO_Mol_Med_2013_Mar_22_5(3)_353-365.nxml.txt.nlp	23341130	SENT255	7	7	21	21	imatinib	S12	PA10804	3351;6206;5713;6268	0.979
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT43	28	28	13	13	pemetrexed	UNG	PA10810	7374	0.979
NULL	Br_J_Cancer_2010_Jul_13_103(2)_186-195.nxml.txt.nlp	20588277	SENT32	0	0	13	13	nutlin-3	MDM2		4193	0.979
NULL	Ann_Oncol_2012_Dec_2_23(12)_3007-3016.nxml.txt.nlp	22865781	SENT171	9	9	20	20	trastuzumab	IGF1R	PA451743	3480	0.979
NULL	Mol_Cancer_2007_Sep_18_6_56.nxml.txt.nlp	17877814	SENT260	27	27	36	36	erlotinib	EGFR	PA134687924	1956	0.979
NULL	Pharmaceuticals_(Basel)_2011_May_24_4(5)_770-781.nxml.txt.nlp	NULL	SENT114	21	21	8	8	carvedilol	CD4	PA448817	920	0.979
NULL	J_Mol_Signal_2008_Dec_2_3_19.nxml.txt.nlp	19055733	SENT43	21	21	10	10	isoproterenol	AKAP12	PA450121	9590	0.979
NULL	Indian_J_Med_Res_2012_Mar_135(3)_359-364.nxml.txt.nlp	22561623	SENT115	12	12	3	3	cefotaxime	ACC-1	PA448852	597	0.979
NULL	Br_J_Pharmacol_2010_Sep_161(2)_288-307.nxml.txt.nlp	20735416	SENT245	23	23	9	9	halothane	TREK-1	PA449845	3776	0.979
NULL	Cell_Death_Differ_2009_Aug_20_16(8)_1135-1145.nxml.txt.nlp	19300452	SENT351	4	4	9	9	doxycycline	PUMA	PA449415	27113	0.979
NULL	South_Asian_J_Cancer_2014_Jul-Sep_3(3)_182-184.nxml.txt.nlp	25136528	SENT82	16	16	0	0	ritonavir	CYP3A4	PA451260	1576	0.979
NULL	Gut_Microbes_2013_Mar_1_4(2)_158-164.nxml.txt.nlp	23333861	SENT85	33	33	18	18	vancomycin	CD4	PA451850	920	0.979
NULL	Autism_Res_Treat_2012_Nov_28_2012_870391.nxml.txt.nlp	23243505	SENT238	16	16	30	30	cyproheptadine	CARS	PA164749366	833	0.979
NULL	Oncotarget_2014_Oct_21_5(22)_11709-11722.nxml.txt.nlp	25365944	SENT169	13	13	4	4	metformin	Rho	PA450395	29984	0.979
NULL	HSR_Proc_Intensive_Care_Cardiovasc_Anesth_2009_1(1)_45-53.nxml.txt.nlp	23439587	SENT32	9	9	19	19	heparin	ACT	PA449855	12;11332;9457;641455	0.979
NULL	J_Carcinog_2011_Nov_30_10_28.nxml.txt.nlp	22190870	SENT54	5	5	22	22	trastuzumab	PTEN	PA451743	5728	0.979
NULL	J_Hematol_Oncol_2011_Feb_7_4_6.nxml.txt.nlp	21299849	SENT73	15	15	25	25	nilotinib	ABCB1	PA165958345	5243	0.979
NULL	JAKSTAT_2012_Apr_1_1(2)_83-89.nxml.txt.nlp	24058756	SENT9	0	0	20	20	losartan	AT2	PA450268	186	0.979
NULL	Oncol_Lett_2014_Sep_11_8(3)_1222-1228.nxml.txt.nlp	25120693	SENT30	12	12	10	10	olaparib	PARP1		142	0.979
NULL	Clin_Med_Insights_Cardiol_2010_Dec_1_4_117-128.nxml.txt.nlp	21151850	SENT38	23	23	7	7	clopidogrel	P2Y12	PA449053	64805	0.979
NULL	Cancer_Manag_Res_2012_Aug_8_4_243-252.nxml.txt.nlp	22904646	SENT116	17	17	7	7	vemurafenib	BRAF	PA165946873	673	0.979
NULL	Open_Biol_2014_Nov_4(11)_140180.nxml.txt.nlp	25392452	SENT216	24	24	5	5	imatinib	LEF1	PA10804	51176	0.979
NULL	Nucleic_Acids_Res_2013_Nov_27_41(21)_9786-9799.nxml.txt.nlp	23982513	SENT264	4	4	18	18	arsenite	ZBP1	PA452638	81030	0.979
NULL	Diabetes_Care_2010_Jul_31_33(7)_1607-1609.nxml.txt.nlp	20357375	SENT53	6	6	39	39	sitagliptin	KDR	PA164748978	3791	0.979
NULL	Br_J_Cancer_2013_May_14_108(9)_1862-1869.nxml.txt.nlp	23579219	SENT57	18	18	12	12	cetuximab	ANXA11	PA10040	311	0.979
NULL	Breast_Cancer_Res_2013_Nov_29_15(6)_R114.nxml.txt.nlp	24289103	SENT186	27	27	2	2	tamoxifen	EGFR	PA451581	1956	0.979
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT168	16	16	10	10	sulindac	PI3K	PA451565	5290	0.979
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT41	4	4	23	23	pertuzumab	HER2		2064	0.979
NULL	Front_Oncol_2014_Nov_5_4_281.nxml.txt.nlp	25414829	SENT104	30	30	19	19	gefitinib	EGFR	PA131301952	1956	0.979
NULL	Case_Rep_Endocrinol_2014_Feb_10_2014_479641.nxml.txt.nlp	24660072	SENT61	29	29	7	7	cinacalcet	PTH	PA164776671	5741	0.979
NULL	Nucleic_Acids_Res_2010_Oct_28_38(19)_6418-6432.nxml.txt.nlp	20511593	SENT314	20	20	6	6	camptothecin	TREX1	PA153590860	11277	0.979
NULL	Int_J_Endocrinol_2011_Mar_6_2011_415719.nxml.txt.nlp	21461394	SENT123	48	48	39	39	cinacalcet	MEN1	PA164776671	4221	0.979
NULL	Br_J_Cancer_2012_Jun_26_107(1)_53-62.nxml.txt.nlp	22677907	SENT303	28	28	4	4	cisplatin	PC-3	PA449014	692094	0.979
NULL	BMJ_2013_Feb_5_346_e5793.nxml.txt.nlp	23386361	SENT69	26	26	4	4	warfarin	CYP2C9	PA451906	1559	0.979
NULL	Indian_J_Med_Paediatr_Oncol_2013_Oct-Dec_34(4)_299-304.nxml.txt.nlp	24604961	SENT15	13	13	0	0	rituximab	CHOP	PA451261	1649	0.979
NULL	Int_J_Hypertens_2012_Sep_22_2012_915057.nxml.txt.nlp	21961055	SENT111	24	24	12	12	isoproterenol	CXCR4	PA450121	7852	0.979
NULL	Mol_Vis_2012_Feb_11_18_431-438.nxml.txt.nlp	22355254	SENT116	4	4	14	14	timolol	CXCL8	PA451690	3576	0.979
NULL	Int_J_Biol_Sci_2013_Mar_7_9(3)_279-288.nxml.txt.nlp	23493630	SENT194	3	3	20	20	tocilizumab	IL-21	PA165292659	59067;50616;27189	0.979
NULL	Part_Fibre_Toxicol_2013_Aug_13_10_39.nxml.txt.nlp	23937860	SENT29	47	47	21	21	anakinra	IL-8	PA10799	3576	0.979
NULL	Cancer_Metastasis_Rev_2014_Dec_28_33(1)_161-171.nxml.txt.nlp	24375389	SENT167	24	24	10	10	docetaxel	CHFR	PA449383	55743	0.979
NULL	J_Biol_2003_Sep_24_2(4)_28.nxml.txt.nlp	14511394	SENT356	30	30	10	10	phenformin	LKB1	PA1000	6794	0.979
NULL	J_Korean_Med_Sci_2010_Apr_19_25(4)_557-563.nxml.txt.nlp	20357998	SENT8	35	35	25	25	cisplatin	IL-10	PA449014	3586	0.979
NULL	Cell_Death_Dis_2012_Mar_15_3(3)_e283.nxml.txt.nlp	22419112	SENT45	26	26	8	8	doxorubicin	CSIG	PA449412	26156	0.979
NULL	J_Biomed_Biotechnol_2011_Jan_24_2011_250860.nxml.txt.nlp	21318107	SENT162	2	2	27	27	thalidomide	IFN	PA451644	3439	0.979
NULL	Mol_Cancer_2010_Nov_22_9_298.nxml.txt.nlp	21092190	SENT112	33	33	15	15	gemcitabine	SRM	PA449748	6723;6725	0.979
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT26	3	3	26	26	imatinib	ABCG2	PA10804	9429	0.979
NULL	Mol_Biol_Rep_2013_Sep_28_40(10)_5573-5585.nxml.txt.nlp	24078156	SENT31	1	1	14	14	iron	DMT1	PA450087	4891;1761	0.979
NULL	Cancer_Cell_Int_2013_Feb_12_13_14.nxml.txt.nlp	23402310	SENT96	15	15	5	5	celecoxib	p65	PA448871	5970	0.979
NULL	Toxins_(Basel)_2011_Apr_4_3(4)_398-408.nxml.txt.nlp	22069715	SENT185	3	3	15	15	galactose	castor	PA449725	54897	0.979
NULL	J_Biol_Chem_2013_Nov_22_288(47)_34217-34229.nxml.txt.nlp	24106270	SENT271	26	26	6	6	thrombin	RhoG	PA451674	391	0.979
NULL	Breast_Cancer_Res_2009_Jun_23_11(Suppl_1)_S22.nxml.txt.nlp	NULL	SENT12	3	3	14	14	trastuzumab	HER2	PA451743	2064	0.979
NULL	F1000Res_2013_Oct_7_2_206.nxml.txt.nlp	24555101	SENT208	20	20	26	26	etanercept	IL-17	PA449515	3605	0.979
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT117	5	5	11	11	ranibizumab	VEGFR1	PA164746012	2321	0.979
NULL	J_Int_Soc_Sports_Nutr_2009_Aug_5_6_16.nxml.txt.nlp	19656392	SENT52	0	0	12	12	creatine	p38	PA164778930	10598;1432;7965	0.979
NULL	Open_Cardiovasc_Med_J_2012_Mar_22_6_28-32.nxml.txt.nlp	22481984	SENT91	26	26	38	38	atorvastatin	DAN	PA448500	5073;4681	0.979
NULL	Br_J_Cancer_2012_Jan_3_106(1)_85-91.nxml.txt.nlp	22127285	SENT24	25	25	12	12	vemurafenib	BRAF	PA165946873	673	0.979
NULL	Curr_Neuropharmacol_2010_Sep_8(3)_254-267.nxml.txt.nlp	21358975	SENT168	0	0	10	10	felbamate	CYP2C19	PA449590	1557	0.979
NULL	Clin_Med_Insights_Oncol_2013_Jul_4_7_159-163.nxml.txt.nlp	23885182	SENT86	18	18	46	46	cyclophosphamide	CHOP	PA449165	1649	0.979
NULL	Oncotarget_2014_Oct_21_5(22)_11252-11268.nxml.txt.nlp	25361004	SENT67	6	6	31	31	metformin	CLIC1	PA450395	1192	0.979
NULL	F1000_Med_Rep_2010_Jul_22_2_53.nxml.txt.nlp	21173853	SENT29	2	2	17	17	moxifloxacin	c-Jun	PA450555	3725	0.979
NULL	Cell_Death_Dis_2012_Jun_21_3(6)_e330.nxml.txt.nlp	22717585	SENT152	27	27	7	7	simvastatin	Rho	PA451363	29984	0.979
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1117-1122.nxml.txt.nlp	22361631	SENT160	28	28	6	6	phenformin	AMPK	PA1000	5563	0.979
NULL	Oncologist_2010_Apr_29_15(4)_390-404.nxml.txt.nlp	20350999	SENT130	20	20	8	8	irinotecan	KRAS	PA450085	3845	0.979
NULL	Breast_Cancer_Res_2012_Mar_20_14(2)_R53.nxml.txt.nlp	22433433	SENT349	29	29	5	5	cisplatin	CCNE1	PA449014	898	0.979
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT300	23	23	12	12	cisplatin	JNK	PA449014	5599	0.979
NULL	Comb_Chem_High_Throughput_Screen_2010_Feb_13(2)_188-206.nxml.txt.nlp	20053163	SENT247	31	31	9	9	sulfamethoxazole	CYP2C9	PA451544	1559	0.979
NULL	Arthritis_Res_Ther_2014_Sep_26_16(5)_429.nxml.txt.nlp	25606593	SENT105	2	2	16	16	tocilizumab	IL-6	PA165292659	3569	0.979
NULL	Chin_J_Cancer_2012_Feb_31(2)_51-57.nxml.txt.nlp	22257384	SENT113	0	0	10	10	imatinib	P-gp	PA10804	5243	0.979
NULL	Cancer_Cell_Int_2010_Jan_21_10_2.nxml.txt.nlp	20142997	SENT199	26	26	16	16	cetuximab	PLAU	PA10040	5328	0.979
NULL	Leukemia_2013_Jan_11_27(1)_32-40.nxml.txt.nlp	22781593	SENT163	3	3	14	14	ponatinib	CD34	PA165980594	947	0.979
NULL	Chem_Rev_2011_Oct_12_111(10)_5899-5921.nxml.txt.nlp	21923193	SENT550	8	8	16	16	flurbiprofen	CB1	PA449683	1268	0.979
NULL	Ann_Surg_Oncol_2010_Apr_20_17(4)_1168-1176.nxml.txt.nlp	19936839	SENT86	17	17	46	46	cetuximab	KRAS	PA10040	3845	0.979
NULL	J_Hematol_Oncol_2009_Feb_23_2_9.nxml.txt.nlp	19236713	SENT25	2	2	9	9	panitumumab	EGFR	PA162373091	1956	0.979
NULL	Breast_Cancer_Res_2012_May_23_14(3)_R84.nxml.txt.nlp	22621373	SENT25	0	0	26	26	hyaluronan	CD44	PA165958431	960	0.979
NULL	Cell_Commun_Signal_2013_Nov_11_11_86.nxml.txt.nlp	24215724	SENT501	27	27	6	6	thrombin	PAR2	PA451674	2150;55065;8856	0.979
NULL	Bioinformation_2012_Jan_6_8(1)_13-19.nxml.txt.nlp	22359429	SENT140	40	40	19	19	curcumin	MRP1	PA151958596	4437	0.979
NULL	Ther_Clin_Risk_Manag_2006_Jun_2(2)_187-192.nxml.txt.nlp	18360592	SENT49	9	9	30	30	fluoxetine	5-HT2A	PA449673	3356	0.979
NULL	Oncoimmunology_2013_Apr_1_2(4)_e23714.nxml.txt.nlp	23734324	SENT2	24	24	14	14	dacarbazine	BRAF	PA449197	673	0.979
NULL	Exp_Ther_Med_2014_Oct_24_8(4)_1092-1096.nxml.txt.nlp	25187802	SENT22	20	20	10	10	carvedilol	TLR4	PA448817	7099	0.979
NULL	Patient_Prefer_Adherence_2013_Mar_27_7_245-258.nxml.txt.nlp	23569364	SENT163	8	8	22	22	exemestane	aromatase	PA449563	1588	0.979
NULL	J_Cardiothorac_Surg_2014_Sep_17_9(1)_129.nxml.txt.nlp	NULL	SENT170	27	27	12	12	protamine	ACT	PA10366	12;11332;9457;641455	0.979
NULL	Case_Rep_Med_2010_Jun_17_2010_472389.nxml.txt.nlp	20589221	SENT10	12	12	28	28	procaine	BCHE	PA451110	590	0.979
NULL	Evid_Based_Complement_Alternat_Med_2011_Feb_14_2011_248231.nxml.txt.nlp	19233878	SENT198	21	21	3	3	rosiglitazone	AS160	PA451283	9882	0.979
NULL	Exp_Ther_Med_2013_Nov_13_6(5)_1317-1321.nxml.txt.nlp	24223665	SENT106	28	28	3	3	cisplatin	CD133	PA449014	8842	0.979
NULL	ScientificWorldJournal_2012_May_1_2012_489830.nxml.txt.nlp	22623900	SENT69	37	37	8	8	levodopa	PARK7	PA450213	11315	0.979
NULL	Cell_Commun_Signal_2014_Mar_28_12_23.nxml.txt.nlp	24679124	SENT66	2	2	27	27	hyperforin	spatial	PA165985514	219793	0.979
NULL	Arthritis_Res_2002_Feb_4_4(Suppl_1)_110.nxml.txt.nlp	NULL	SENT9	11	11	3	3	simvastatin	IL-6	PA451363	3569	0.979
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_75-89.nxml.txt.nlp	17912638	SENT21	12	12	2	2	exemestane	aromatase	PA449563	1588	0.979
NULL	F1000Res_2013_Feb_28_2_65.nxml.txt.nlp	24358861	SENT365	5	5	19	19	naloxone	TLR4	PA450586	7099	0.979
NULL	Indian_J_Pharm_Sci_2014_May-Jun_76(3)_235-239.nxml.txt.nlp	25035536	SENT57	8	8	3	3	ethanol	VIII	PA448073	1351	0.979
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2012_Jan_1_68(Pt_1)_82-92.nxml.txt.nlp	22194336	SENT26	32	32	11	11	vancomycin	VISA	PA451850	57506	0.979
NULL	Br_J_Cancer_2010_Dec_7_103(12)_1765-1772.nxml.txt.nlp	21139621	SENT74	28	28	16	16	cetuximab	PTEN	PA10040	5728	0.979
NULL	Exp_Ther_Med_2014_Oct_24_8(4)_1092-1096.nxml.txt.nlp	25187802	SENT91	36	36	8	8	carvedilol	Bcl-2	PA448817	596	0.979
NULL	J_Cell_Biol_1998_Jan_26_140(2)_335-345.nxml.txt.nlp	9442109	SENT220	14	14	28	28	chloroquine	NHE	PA448948	285335	0.979
NULL	Arthritis_Res_Ther_2014_Jul_18_16(4)_R153.nxml.txt.nlp	25037855	SENT17	5	5	21	21	adalimumab	CD14	PA10004	929	0.979
NULL	Bone_2012_Jan_50(1)_218-225.nxml.txt.nlp	22023931	SENT220	4	4	11	11	iron	FGF23	PA450087	8074	0.979
NULL	Mol_Vis_2014_May_13_20_649-660.nxml.txt.nlp	24868139	SENT26	7	7	34	34	ranibizumab	VEGFR2	PA164746012	3791	0.979
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1044.nxml.txt.nlp	24503536	SENT132	13	13	6	6	cisplatin	XIAP	PA449014	331	0.979
NULL	Ther_Clin_Risk_Manag_2007_Mar_3(1)_133-148.nxml.txt.nlp	18360621	SENT147	20	20	2	2	adalimumab	ACR	PA10004	49	0.979
NULL	Br_J_Cancer_2012_Dec_4_107(12)_1950-1955.nxml.txt.nlp	23169295	SENT87	4	4	15	15	oxaliplatin	Rho	PA131285527	29984	0.979
NULL	Pharmaceuticals_(Basel)_2012_Aug_10_5(8)_802-836.nxml.txt.nlp	24280676	SENT294	14	14	22	22	naproxen	MRP2	PA450595	100130958;57626;1244	0.979
NULL	Mol_Biol_Cell_2013_Sep_1_24(17)_2739-2752.nxml.txt.nlp	23825024	SENT78	7	7	17	17	tetracycline	p53	PA451640	7157	0.979
NULL	Br_J_Cancer_2010_Jan_5_102(1)_104-114.nxml.txt.nlp	20051961	SENT162	25	25	11	11	tamoxifen	PDK1	PA451581	5170;5163	0.979
NULL	Breast_Cancer_Res_2004_May_18_6(4)_148-152.nxml.txt.nlp	15217485	SENT38	22	22	38	38	tamoxifen	aromatase	PA451581	1588	0.979
NULL	Oncotarget_2014_Jun_26_5(12)_3996-4010.nxml.txt.nlp	24994118	SENT71	23	23	7	7	dasatinib	AKT	PA162372878	207	0.979
NULL	Anticancer_Agents_Med_Chem_2012_Feb_12(2)_163-171.nxml.txt.nlp	22043994	SENT40	19	19	11	11	cetuximab	EGFR	PA10040	1956	0.979
NULL	Clin_Ophthalmol_2008_Mar_2(1)_1-14.nxml.txt.nlp	19668384	SENT84	0	0	16	16	pegaptanib	VEGF-A	PA164771236	7422	0.979
NULL	Br_J_Cancer_2009_Oct_20_101(8)_1253-1260.nxml.txt.nlp	19755984	SENT135	39	39	12	12	letrozole	HER-2	PA450196	2064	0.979
NULL	Mol_Cancer_2008_Jan_25_7_14.nxml.txt.nlp	18221502	SENT213	25	25	6	6	oxaliplatin	PSAT1	PA131285527	29968	0.979
NULL	Carcinogenesis_2010_Jan_27_31(1)_2-8.nxml.txt.nlp	19861649	SENT107	16	16	8	8	gefitinib	AKT	PA131301952	207	0.979
NULL	Eur_J_Neurosci_2008_Apr_1_27(7)_1722-1730.nxml.txt.nlp	18380669	SENT189	21	21	18	18	sr144528	CB2		1269	0.979
NULL	Ann_Oncol_2010_Oct_19_21(10)_1952-1960.nxml.txt.nlp	20305037	SENT57	17	17	4	4	docetaxel	p53	PA449383	7157	0.979
NULL	Int_J_Breast_Cancer_2013_Dec_5_2013_354579.nxml.txt.nlp	24383004	SENT64	29	29	9	9	cyclophosphamide	NAC	PA449165	22861	0.979
NULL	J_Cell_Biol_2005_Jul_4_170(1)_49-59.nxml.txt.nlp	15983061	SENT64	16	16	31	31	forskolin	HIF1	PA146096022	3091	0.979
NULL	Cancer_Metab_2014_May_28_2(Suppl_1)_P24.nxml.txt.nlp	NULL	SENT19	19	19	4	4	etoposide	SIRT1	PA449552	23411	0.979
NULL	Crit_Care_2008_Jan_24_12(1)_R27.nxml.txt.nlp	18304335	SENT153	6	6	22	22	thrombin	PAR-1	PA451674	2011;2149	0.979
NULL	Pharmaceuticals_(Basel)_2012_Aug_10_5(8)_802-836.nxml.txt.nlp	24280676	SENT247	26	26	7	7	pyrimethamine	PCFT	PA451193	113235	0.979
NULL	Front_Synaptic_Neurosci_2013_Sep_18_5_6.nxml.txt.nlp	24065916	SENT50	17	17	9	9	cocaine	DCC	PA449072	1630	0.979
NULL	Chin_J_Cancer_2012_Feb_31(2)_58-72.nxml.txt.nlp	22098952	SENT114	6	6	11	11	cisplatin	MRP1	PA449014	4437	0.979
NULL	Acta_Pharmacol_Sin_2010_Sep_9_31(9)_1181-1188.nxml.txt.nlp	20694025	SENT109	0	0	9	9	bevacizumab	VEGF-A	PA130232992	7422	0.979
NULL	Mar_Drugs_2011_Apr_28_9(5)_719-738.nxml.txt.nlp	21673885	SENT189	10	10	5	5	ethanol	CO2	PA448073	4513	0.979
NULL	Breast_Cancer_Res_2005_Dec_7_7(1)_R156-R163.nxml.txt.nlp	15642164	SENT22	3	3	1	1	letrozole	aromatase	PA450196	1588	0.979
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_33-43.nxml.txt.nlp	17912634	SENT196	10	10	18	18	letrozole	HER2	PA450196	2064	0.979
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT167	8	8	0	0	methotrexate	MSH2	PA450428	4436	0.979
NULL	J_Headache_Pain_2014_Dec_8_15(1)_85.nxml.txt.nlp	25488888	SENT182	7	7	15	15	rizatriptan	5-HT1D	PA451264	3352	0.979
NULL	Eukaryot_Cell_2014_Aug_13(8)_1077-1084.nxml.txt.nlp	24951438	SENT117	24	24	44	44	doxycycline	ACT1	PA449415	10758	0.979
NULL	Gynecol_Oncol_Case_Rep_2013_Jun_12_6_34-35.nxml.txt.nlp	24371715	SENT58	0	0	10	10	aprepitant	CYP2C9	PA164747039	1559	0.979
NULL	Cell_Death_Dis_2013_Oct_3_4(10)_e834.nxml.txt.nlp	24091677	SENT90	27	27	6	6	vinblastine	Bcl-2	PA451877	596	0.979
NULL	ScientificWorldJournal_2014_Feb_6_2014_328513.nxml.txt.nlp	24683330	SENT98	19	19	8	8	propofol	IL-10	PA451141	3586	0.979
NULL	Br_J_Cancer_2010_Mar_16_102(6)_1003-1009.nxml.txt.nlp	20179710	SENT35	28	28	17	17	doxorubicin	NHS	PA449412	4810	0.979
NULL	Chem_Rev_2011_Oct_12_111(10)_5899-5921.nxml.txt.nlp	21923193	SENT559	5	5	43	43	flurbiprofen	NAPE-PLD	PA449683	222236	0.979
NULL	Cancers_(Basel)_2010_Sep_17_2(3)_1717-1730.nxml.txt.nlp	24281184	SENT140	3	3	20	20	capecitabine	DPD	PA448771	1806	0.979
NULL	J_Inflamm_(Lond)_2006_May_4_3_8.nxml.txt.nlp	16674821	SENT209	25	25	31	31	pp2	PI3K		5290	0.979
NULL	Indian_J_Pharm_Sci_2013_Jan-Feb_75(1)_94-98.nxml.txt.nlp	23901167	SENT82	3	3	31	31	tolbutamide	CYP2C9	PA451718	1559	0.979
NULL	Breast_Cancer_Res_2005_May_27_7(Suppl_1)_S5.nxml.txt.nlp	NULL	SENT10	24	24	4	4	trastuzumab	HER2	PA451743	2064	0.979
NULL	Br_J_Cancer_2013_Jun_25_108(12)_2426-2432.nxml.txt.nlp	23756869	SENT103	7	7	14	14	trastuzumab	IL-6	PA451743	3569	0.979
NULL	Ther_Clin_Risk_Manag_2006_Dec_2(4)_335-480.nxml.txt.nlp	18360645	SENT37	0	0	13	13	abatacept	CTLA4	PA164747080	1493	0.979
NULL	Acta_Naturae_2011_Jul-Sep_3(3)_77-84.nxml.txt.nlp	22649697	SENT17	8	8	16	16	heparin	FGFR3	PA449855	2261	0.979
NULL	Leukemia_2013_Jan_11_27(1)_32-40.nxml.txt.nlp	22781593	SENT244	19	19	33	33	ponatinib	FGFR1	PA165980594	2260	0.979
NULL	Acta_Pharmacol_Sin_2014_Jun_4_35(6)_752-757.nxml.txt.nlp	24902786	SENT91	21	21	10	10	flutamide	STZ	PA449685	6484	0.979
NULL	Breast_Cancer_Res_2012_Jun_7_14(3)_R89.nxml.txt.nlp	22676470	SENT193	36	36	28	28	trastuzumab	HER2	PA451743	2064	0.979
NULL	Cell_Commun_Signal_2013_Apr_17_11_27.nxml.txt.nlp	23594441	SENT93	4	4	28	28	doxorubicin	p53	PA449412	7157	0.979
NULL	Endocrinol_Metab_(Seoul)_2014_Sep_25_29(3)_379-387.nxml.txt.nlp	25309798	SENT143	1	1	31	31	resveratrol	SIRT1		23411	0.979
NULL	Cells_2014_Jun_26_3(3)_662-673.nxml.txt.nlp	24971848	SENT86	16	16	10	10	capsaicin	TRPV1	PA448776	7442	0.979
NULL	Arthritis_Res_Ther_2011_Oct_7_13(5)_R161.nxml.txt.nlp	21982514	SENT4	9	9	17	17	trastuzumab	EGF	PA451743	1950	0.979
NULL	J_Cell_Biol_1998_Jul_27_142(2)_537-544.nxml.txt.nlp	9679150	SENT112	39	39	7	7	staurosporine	Bcl-2	PA165109623	596	0.979
NULL	Clin_Med_Insights_Oncol_2013_May_20_7_87-102.nxml.txt.nlp	23761989	SENT129	0	0	4	4	sunitinib	CYP3A4	PA162372840	1576	0.979
NULL	Indian_J_Pharm_Sci_2009_Nov-Dec_71(6)_622-629.nxml.txt.nlp	20376214	SENT170	12	12	24	24	captopril	B10	PA448780	5169	0.979
NULL	Acta_Pharmacol_Sin_2013_Feb_3_34(2)_221-230.nxml.txt.nlp	23202797	SENT124	4	4	17	17	verapamil	mol	PA451868	90527	0.979
NULL	J_Breast_Cancer_2012_Mar_28_15(1)_71-78.nxml.txt.nlp	22493631	SENT105	21	21	1	1	trastuzumab	HER2	PA451743	2064	0.979
NULL	Eur_J_Clin_Pharmacol_2009_Dec_16_65(12)_1211-1228.nxml.txt.nlp	19756557	SENT169	13	13	4	4	infliximab	ACT	PA452639	12;11332;9457;641455	0.979
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT228	34	34	10	10	methotrexate	MSH2	PA450428	4436	0.979
NULL	Clin_Ophthalmol_2014_Aug_4_8_1447-1458.nxml.txt.nlp	25120351	SENT166	4	4	32	32	cyclosporine	IFN	PA449167	3439	0.979
NULL	Reprod_Biol_Endocrinol_2013_Feb_26_11_15.nxml.txt.nlp	23442442	SENT195	20	20	4	4	l-arginine	BCL2	PA448478	596	0.979
NULL	Oncotarget_2014_Nov_3_5(20)_10127-10139.nxml.txt.nlp	25333256	SENT161	22	22	3	3	vemurafenib	TRIM16	PA165946873	10626	0.979
NULL	Cancer_Med_2014_Jun_27_3(3)_613-622.nxml.txt.nlp	24574362	SENT180	16	16	22	22	gefitinib	EGFR	PA131301952	1956	0.979
NULL	Indian_J_Urol_2007_Apr-Jun_23(2)_91-96.nxml.txt.nlp	19675781	SENT176	26	26	2	2	finasteride	NNT	PA449627	23530	0.979
NULL	Int_J_Surg_Oncol_2012_May_16_2012_863034.nxml.txt.nlp	22666572	SENT152	0	0	19	19	bevacizumab	KRAS	PA130232992	3845	0.979
NULL	Cell_Death_Dis_2014_Jul_10_5(7)_e1318.nxml.txt.nlp	25010984	SENT257	10	10	15	15	nutlin-3	RITA		55422;84934	0.979
NULL	Front_Microbiol_2014_Sep_11_5_477.nxml.txt.nlp	25309517	SENT206	0	0	19	19	basiliximab	IL-2	PA164747126	3558	0.979
NULL	Cancer_Metab_2014_May_28_2(Suppl_1)_P24.nxml.txt.nlp	NULL	SENT19	19	19	6	6	etoposide	p53	PA449552	7157	0.979
NULL	Breast_Cancer_Res_Treat_2013_Jun_5_139(3)_649-655.nxml.txt.nlp	23736997	SENT130	27	27	11	11	tamoxifen	CYP2C19	PA451581	1557	0.979
NULL	Breast_Cancer_Res_2005_Jul_27_7(5)_R765-R774.nxml.txt.nlp	16168122	SENT219	12	12	3	3	doxorubicin	p53	PA449412	7157	0.979
NULL	Iran_J_Pharm_Res_2014_Autumn_13(4)_1393-1401.nxml.txt.nlp	25587329	SENT10	1	1	26	26	celecoxib	ABCG2	PA448871	9429	0.979
NULL	J_Exp_Med_2000_Mar_6_191(5)_859-870.nxml.txt.nlp	10704466	SENT118	25	25	5	5	neomycin	p38	PA450608	10598;1432;7965	0.979
NULL	Oncol_Lett_2013_Feb_28_5(2)_699-701.nxml.txt.nlp	23420084	SENT63	0	0	11	11	sunitinib	KIT	PA162372840	3815	0.979
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT141	1	1	8	8	trastuzumab	HER2	PA451743	2064	0.979
NULL	Arthritis_Res_Ther_2006_Nov_16_8(6)_R173.nxml.txt.nlp	17109745	SENT146	18	18	6	6	glucosamine	IL-13	PA164747613	3596	0.979
NULL	Mol_Cancer_2010_Jun_23_9_162.nxml.txt.nlp	20573255	SENT33	29	29	0	0	paclitaxel	WIF1	PA450761	11197	0.979
NULL	Inflamm_Res_2010_Sep_26_59(9)_699-709.nxml.txt.nlp	20339899	SENT29	13	13	9	9	trypsin	PAR2	PA451806	2150;55065;8856	0.979
NULL	Oncogene_2010_May_20_29(20)_2983-2995.nxml.txt.nlp	20208560	SENT139	21	21	6	6	tamoxifen	FOXM1	PA451581	2305	0.979
NULL	Br_J_Cancer_2010_May_11_102(10)_1503-1510.nxml.txt.nlp	20461093	SENT150	12	12	17	17	tamoxifen	aromatase	PA451581	1588	0.979
NULL	J_Biomed_Sci_2013_Aug_19_20(1)_61.nxml.txt.nlp	23957306	SENT354	1	1	13	13	tenofovir	MRP4	PA10204	10257	0.979
NULL	Curr_Oncol_2009_May_16(Suppl_1)_S52-S59.nxml.txt.nlp	19478903	SENT74	15	15	3	3	temsirolimus	CYP3A4	PA164746890	1576	0.979
NULL	Acta_Naturae_2013_Jul-Sep_5(3)_84-91.nxml.txt.nlp	24303204	SENT179	2	2	16	16	memantine	spatial	PA10364	219793	0.979
NULL	Br_J_Ophthalmol_2014_Jun_98(Suppl_1)_i11-i16.nxml.txt.nlp	24836865	SENT21	2	2	30	30	bevacizumab	VEGF-A	PA130232992	7422	0.979
NULL	Nature_2012_Jan_11_481(7381)_329-334.nxml.txt.nlp	22237022	SENT131	12	12	33	33	carboplatin	SYK	PA448803	6850	0.979
NULL	Biomed_Res_Int_2014_Mar_4_2014_836769.nxml.txt.nlp	24724101	SENT76	21	21	31	31	fulvestrant	aromatase	PA164747170	1588	0.979
NULL	Eur_J_Nucl_Med_Mol_Imaging_2008_May_22_35(5)_1008-1018.nxml.txt.nlp	18157531	SENT228	35	35	19	19	trastuzumab	HER2	PA451743	2064	0.979
NULL	Arthritis_Res_Ther_2014_May_16_16(3)_R113.nxml.txt.nlp	24886859	SENT12	11	11	3	3	tranylcypromine	LSD1	PA451741	23028	0.979
NULL	J_Biol_2003_Sep_24_2(4)_28.nxml.txt.nlp	14511394	SENT113	28	28	11	11	metformin	AMPK	PA450395	5563	0.979
NULL	EJC_Suppl_2013_Sep_5_11(2)_307-309.nxml.txt.nlp	NULL	SENT50	6	6	20	20	neratinib	EGFR	PA165291472	1956	0.978
NULL	Oncotarget_2013_Dec_18_5(2)_375-385.nxml.txt.nlp	24495868	SENT255	16	16	5	5	fludarabine	NF-kappaB	PA449655	4790	0.978
NULL	Int_J_Alzheimers_Dis_2010_Dec_8_2011_741974.nxml.txt.nlp	21197086	SENT175	0	0	11	11	ramelteon	BZP	PA164744896	6935	0.978
NULL	Arch_Med_Sci_2012_Nov_9_8(5)_907-917.nxml.txt.nlp	23185203	SENT154	22	22	14	14	metformin	HER2	PA450395	2064	0.978
NULL	J_Vet_Med_Sci_2014_Oct_19_76(10)_1339-1345.nxml.txt.nlp	24942113	SENT117	15	15	26	26	losartan	AT2	PA450268	186	0.978
NULL	Curr_Oncol_2009_Jul_16(Suppl_2)_S14-S23.nxml.txt.nlp	19672417	SENT17	22	22	15	15	exemestane	aromatase	PA449563	1588	0.978
NULL	Arch_Med_Sci_2013_Oct_31_9(5)_916-921.nxml.txt.nlp	24273579	SENT138	27	27	10	10	bleomycin	AQP1	PA448645	358	0.978
NULL	Mol_Cancer_2010_Aug_23_9_222.nxml.txt.nlp	20731837	SENT174	8	8	13	13	gefitinib	EGFR	PA131301952	1956	0.978
NULL	Gene_Regul_Syst_Bio_2014_Mar_4_8_63-73.nxml.txt.nlp	24634581	SENT9	0	0	24	24	minocycline	NANOS1	PA450519	340719	0.978
NULL	Diabetes_2013_Oct_17_62(10)_3316-3323.nxml.txt.nlp	23818527	SENT141	9	9	33	33	exenatide	GLP	PA164749238	342096	0.978
NULL	Cancer_Cell_Int_2008_Mar_18_8_3.nxml.txt.nlp	18348720	SENT36	0	0	6	6	gefitinib	EGFR	PA131301952	1956	0.978
NULL	Oncol_Lett_2013_Feb_7_5(2)_440-446.nxml.txt.nlp	23420122	SENT18	2	2	13	13	erlotinib	EGFR	PA134687924	1956	0.978
NULL	AIDS_Res_Ther_2012_May_3_9_13.nxml.txt.nlp	22554313	SENT119	34	34	5	5	atazanavir	CD4	PA10251	920	0.978
NULL	Med_Sci_Monit_2013_Oct_31_19_916-926.nxml.txt.nlp	24172537	SENT113	23	23	2	2	mitomycin	BRCA2	PA450524	675	0.978
NULL	Case_Rep_Med_2014_Mar_4_2014_923496.nxml.txt.nlp	24715926	SENT51	0	0	6	6	etanercept	IL-6	PA449515	3569	0.978
NULL	Int_J_Vasc_Med_2013_Mar_31_2013_543141.nxml.txt.nlp	23606968	SENT153	32	32	11	11	etanercept	IL-13	PA449515	3596	0.978
NULL	Clin_Dev_Immunol_2011_Oct_20_2011_947858.nxml.txt.nlp	22046194	SENT162	21	21	0	0	lenalidomide	p110	PA162363968	9733	0.978
NULL	J_Hematol_Oncol_2013_Jun_3_6_38.nxml.txt.nlp	23731980	SENT96	0	0	20	20	pertuzumab	HER3		2065	0.978
NULL	Clin_Pharmacokinet_2014_Sep_3_53(1)_1-16.nxml.txt.nlp	23999929	SENT287	19	19	28	28	erythromycin	CYP3A4	PA449493	1576	0.978
NULL	J_Headache_Pain_2007_Apr_11_8(2)_83-89.nxml.txt.nlp	17497262	SENT7	9	9	23	23	ketanserin	5-HT1B	PA131053734	3351	0.978
NULL	J_Oncol_2012_Dec_7_2012_192464.nxml.txt.nlp	22187555	SENT324	9	9	19	19	docetaxel	IGFR	PA449383	3480	0.978
NULL	Int_J_Mol_Sci_2014_Oct_8_15(10)_17974-17999.nxml.txt.nlp	25299695	SENT103	11	11	29	29	curcumin	GAPDH	PA151958596	2597	0.978
NULL	Allergy_Asthma_Immunol_Res_2012_Mar_16_4(2)_104-106.nxml.txt.nlp	22379606	SENT46	30	30	11	11	capsaicin	IL-8	PA448776	3576	0.978
NULL	Cancer_Res_Treat_2013_Mar_31_45(1)_63-69.nxml.txt.nlp	23613672	SENT31	42	42	17	17	cisplatin	ERCC1	PA449014	2067	0.978
NULL	JRSM_Cardiovasc_Dis_2012_Sep_24_1(6)_cvd_2012_012015.nxml.txt.nlp	24175073	SENT115	0	0	17	17	clopidogrel	HPR	PA449053	3250	0.978
NULL	FEBS_Open_Bio_2013_Jun_27_3_291-301.nxml.txt.nlp	23905012	SENT325	2	2	8	8	genistein	TFPI-2	PA165109660	7980	0.978
NULL	Crit_Care_2011_Jan_17_15(1)_R23.nxml.txt.nlp	21241489	SENT200	12	12	21	21	enoxaparin	PPIC	PA449463	5480	0.978
NULL	Ther_Clin_Risk_Manag_2006_Sep_2(3)_297-301.nxml.txt.nlp	18360604	SENT104	0	0	10	10	paricalcitol	PTH	PA450798	5741	0.978
NULL	Oncotarget_2013_Dec_18_5(3)_634-648.nxml.txt.nlp	24504138	SENT249	5	5	13	13	bortezomib	Bcl-2	PA10252	596	0.978
NULL	Aging_(Albany_NY)_2011_Jan_18_3(1)_33-43.nxml.txt.nlp	21248371	SENT143	22	22	17	17	zinc	p53	PA451956	7157	0.978
NULL	J_Oncol_2013_Feb_17_2013_872957.nxml.txt.nlp	23476648	SENT7	29	29	6	6	cisplatin	SFN	PA449014	25996;2810	0.978
NULL	Behav_Brain_Funct_2010_May_28_6_29.nxml.txt.nlp	20509936	SENT61	31	31	4	4	methylphenidate	IL-6	PA450464	3569	0.978
NULL	J_Cell_Mol_Med_2014_Oct_11_18(10)_2031-2043.nxml.txt.nlp	25109475	SENT149	3	3	13	13	valsartan	LKB1	PA451848	6794	0.978
NULL	Acta_Pharmacol_Sin_2012_Jan_3_33(1)_49-56.nxml.txt.nlp	22212430	SENT15	3	3	1	1	curcumin	AP-1	PA151958596	2353;3727;2354;3725	0.978
NULL	Case_Rep_Rheumatol_2011_Dec_15_2011_185657.nxml.txt.nlp	22937439	SENT58	22	22	17	17	etanercept	TNF-alpha	PA449515	7124	0.978
NULL	Pharmaceuticals_(Basel)_2012_Jul_25_5(8)_779-801.nxml.txt.nlp	24280675	SENT148	2	2	30	30	imatinib	FLT3	PA10804	2322	0.978
NULL	Biosci_Rep_2014_Aug_6_34(4)_e00131.nxml.txt.nlp	24975826	SENT147	19	19	0	0	pp2	TRPA1		8989	0.978
NULL	Br_J_Cancer_2010_May_11_102(10)_1503-1510.nxml.txt.nlp	20461093	SENT46	18	18	38	38	tamoxifen	HER2	PA451581	2064	0.978
NULL	Cell_Death_Dis_2013_Sep_5_4(9)_e791.nxml.txt.nlp	24008735	SENT62	3	3	23	23	gemcitabine	p53	PA449748	7157	0.978
NULL	J_Adv_Pract_Oncol_2012_Jul_1_Jul-Aug_3(4)_267-272.nxml.txt.nlp	25031955	SENT37	0	0	20	20	crizotinib	P-gp	PA165946122	5243	0.978
NULL	J_Carcinog_2014_Nov_27_13_13.nxml.txt.nlp	25525412	SENT113	8	8	18	18	panitumumab	KRAS	PA162373091	3845	0.978
NULL	Mol_Cancer_2009_Nov_10_8_99.nxml.txt.nlp	19903356	SENT142	40	40	3	3	imatinib	IGFBP3	PA10804	3486	0.978
NULL	Clin_Epigenetics_2011_Jun_27_2(2)_171-185.nxml.txt.nlp	21949547	SENT96	19	19	35	35	cisplatin	BCL6	PA449014	604	0.978
NULL	Breast_Cancer_Res_2004_Oct_24_6(1)_R8-R17.nxml.txt.nlp	14680495	SENT123	14	14	3	3	tamoxifen	BRCA1	PA451581	672	0.978
NULL	Crit_Care_2011_Jan_31_15(1)_R45.nxml.txt.nlp	21281508	SENT182	12	12	3	3	glucose	CNP	PA449773	4880;1267	0.978
NULL	Mol_Biol_Cell_2013_Jul_15_24(14)_2160-2170.nxml.txt.nlp	23676665	SENT145	43	43	28	28	doxycycline	ALR	PA449415	2671;8085;10327	0.978
NULL	Case_Rep_Neurol_Med_2014_Feb_23_2014_549271.nxml.txt.nlp	24711940	SENT80	31	31	13	13	mefloquine	CD4	PA450348	920	0.978
NULL	J_Hematol_Oncol_2011_Apr_20_4_16.nxml.txt.nlp	21504625	SENT46	0	0	25	25	nutlin-3	p53		7157	0.978
NULL	Core_Evid_2010_Jul_27_5_1-10.nxml.txt.nlp	20694135	SENT49	34	34	38	38	entacapone	COMT	PA164748726	1312	0.978
NULL	Curr_Pharm_Des_2011_Feb_17(6)_578-590.nxml.txt.nlp	21391908	SENT176	3	3	9	9	nutlin-3	MDM2		4193	0.978
NULL	Acta_Pharmacol_Sin_2010_Nov_18_31(11)_1447-1453.nxml.txt.nlp	20953204	SENT145	4	4	16	16	rimonabant	PI3K	PA152407999	5290	0.978
NULL	Br_J_Cancer_2012_Jul_10_107(2)_360-369.nxml.txt.nlp	22713663	SENT119	25	25	8	8	bevacizumab	DDP	PA130232992	1678	0.978
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT92	23	23	46	46	daunorubicin	B7-H1	PA449212	29126	0.978
NULL	Reprod_Biol_Endocrinol_2003_Oct_7_1_73.nxml.txt.nlp	14577831	SENT141	14	14	12	12	letrozole	aromatase	PA450196	1588	0.978
NULL	Nat_Methods_2011_Jun_24_8(6)_487-493.nxml.txt.nlp	21516115	SENT69	14	14	0	0	erlotinib	EGFR	PA134687924	1956	0.978
NULL	Oncotarget_2011_Mar_11_2(3)_135-164.nxml.txt.nlp	21411864	SENT233	15	15	2	2	sorafenib	BRAF	PA7000	673	0.978
NULL	Mucosal_Immunol_2014_May_13_7(3)_730-740.nxml.txt.nlp	24220298	SENT68	14	14	4	4	papain	DR3	PA450778	8718	0.978
NULL	Cancers_(Basel)_2013_Jan_21_5(1)_64-91.nxml.txt.nlp	24216699	SENT386	0	0	24	24	lapatinib	HER-2	PA152241907	2064	0.978
NULL	Pharmaceutics_2011_Jul_13_3(3)_425-439.nxml.txt.nlp	24310588	SENT84	28	28	1	1	meperidine	SERS	PA450369	6301;54938	0.978
NULL	Breast_Cancer_Res_2011_Feb_23_13(1)_203.nxml.txt.nlp	21392408	SENT13	18	18	13	13	anastrozole	aromatase	PA448432	1588	0.978
NULL	Nucleic_Acids_Res_2005_Jun_9_33(10)_3323-3330.nxml.txt.nlp	15947132	SENT12	20	20	0	0	cisplatin	MSH2	PA449014	4436	0.978
NULL	J_Korean_Med_Sci_2001_Dec_16(6)_712-718.nxml.txt.nlp	11748350	SENT2	7	7	34	34	oxygen	ROS	PA450744	6098	0.978
NULL	Cell_Commun_Signal_2003_Nov_24_1_5.nxml.txt.nlp	14636425	SENT191	11	11	3	3	heparin	CCN5	PA449855	8839	0.978
NULL	Crit_Care_2007_Jun_8_11(3)_215.nxml.txt.nlp	17567927	SENT189	8	8	18	18	vasopressin	MARS	PA451858	4141	0.978
NULL	Indian_J_Pharm_Sci_2008_Jul-Aug_70(4)_511-513.nxml.txt.nlp	20046783	SENT16	0	0	48	48	metoprolol	USP3	PA450480	9960	0.978
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_P115.nxml.txt.nlp	NULL	SENT11	24	24	1	1	piperacillin	CD4	PA450975	920	0.978
NULL	J_Korean_Assoc_Oral_Maxillofac_Surg_2014_Dec_26_40(6)_291-296.nxml.txt.nlp	25551094	SENT19	11	11	2	2	alendronate	RANKL	PA448082	8600	0.978
NULL	Mol_Cancer_2010_Aug_20_9_220.nxml.txt.nlp	20727180	SENT90	8	8	25	25	nicotine	survivin	PA450626	332	0.978
NULL	Oncotarget_2013_Nov_15_5(6)_1458-1474.nxml.txt.nlp	24681547	SENT248	5	5	35	35	celecoxib	CDH11	PA448871	1009	0.978
NULL	Br_J_Cancer_2009_Oct_20_101(8)_1253-1260.nxml.txt.nlp	19755984	SENT8	40	40	38	38	anastrozole	aromatase	PA448432	1588	0.978
NULL	Cancers_(Basel)_2013_Jul_24_5(3)_901-918.nxml.txt.nlp	24202326	SENT51	41	41	8	8	bortezomib	CD138	PA10252	6382	0.978
NULL	Mol_Vis_2007_Jul_9_13_1083-1093.nxml.txt.nlp	17653053	SENT178	4	4	32	32	minocycline	p65	PA450519	5970	0.978
NULL	Open_Cardiovasc_Med_J_2011_Feb_24_5_49-63.nxml.txt.nlp	21643501	SENT202	3	3	10	10	rosuvastatin	CYP3A4	PA134308647	1576	0.978
NULL	Cancer_Cell_Int_2011_Dec_2_11_42.nxml.txt.nlp	22136382	SENT102	6	6	23	23	ethanol	TRAIL	PA448073	8743	0.978
NULL	J_Mol_Med_(Berl)_2014_Jan_10_92(5)_497-507.nxml.txt.nlp	24408111	SENT249	3	3	32	32	pioglitazone	HIF-1	PA450970	29072	0.978
NULL	J_Med_Life_2011_Feb_15_4(1)_11-20.nxml.txt.nlp	21505570	SENT190	11	11	38	38	naproxen	CB1	PA450595	1268	0.978
NULL	Mol_Cancer_2012_Dec_12_11_91.nxml.txt.nlp	23234355	SENT196	39	39	2	2	cetuximab	EGFR	PA10040	1956	0.978
NULL	Daru_2011_19(6)_433-439.nxml.txt.nlp	23008689	SENT42	2	2	35	35	flurbiprofen	IPA	PA449683	3160	0.978
NULL	Genome_Biol_2008_May_9_9(5)_221.nxml.txt.nlp	18492217	SENT29	16	16	21	21	cisplatin	p53	PA449014	7157	0.978
NULL	Daru_2013_Dec_20_21(1)_78.nxml.txt.nlp	24359941	SENT18	22	22	2	2	gentamicin	EPO	PA449753	7076;8288;2056	0.978
NULL	An_Bras_Dermatol_2014_Jul-Aug_89(4)_652-654.nxml.txt.nlp	25054756	SENT16	23	23	43	43	ustekinumab	IL-23	PA166048654	51561	0.978
NULL	Biologics_2009_Sep_15_3_419-428.nxml.txt.nlp	19774209	SENT4	8	8	4	4	gemcitabine	EGFR	PA449748	1956	0.978
NULL	Oncologist_2010_Aug_29_15(8)_799-809.nxml.txt.nlp	20671105	SENT197	26	26	35	35	trastuzumab	HER-2	PA451743	2064	0.978
NULL	Blood_Cancer_J_2013_Sep_6_3(9)_e144.nxml.txt.nlp	24013665	SENT10	19	19	9	9	doxorubicin	PKR	PA449412	5610	0.978
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1135-1143.nxml.txt.nlp	21364580	SENT24	14	14	0	0	trastuzumab	ERBB2	PA451743	2064	0.978
NULL	Mol_Vis_2012_Nov_29_18_2839-2846.nxml.txt.nlp	23233786	SENT182	0	0	16	16	geldanamycin	Hsp90	PA152031327	3320	0.978
NULL	Br_J_Cancer_2012_Feb_14_106(4)_727-732.nxml.txt.nlp	22240789	SENT69	16	16	5	5	fluorescein	FGFR2	PA164746009	2263	0.978
NULL	Oncotarget_2013_Dec_17_5(1)_67-77.nxml.txt.nlp	24393766	SENT170	30	30	11	11	erlotinib	EGFR	PA134687924	1956	0.978
NULL	Clin_Interv_Aging_2013_Jul_16_8_889-897.nxml.txt.nlp	23898224	SENT7	40	40	3	3	gemcitabine	ADP	PA449748	23038	0.978
NULL	J_Exp_Clin_Cancer_Res_2010_Apr_27_29(1)_38.nxml.txt.nlp	20423465	SENT146	4	4	16	16	pemetrexed	B12	PA10810	7126;4709	0.978
NULL	Drug_Des_Devel_Ther_2014_Oct_31_8_2121-2128.nxml.txt.nlp	25382970	SENT74	3	3	11	11	curcumin	TTR	PA151958596	7276	0.978
NULL	Cancer_Cell_Int_2008_Mar_18_8_3.nxml.txt.nlp	18348720	SENT69	25	25	23	23	gefitinib	EGFR	PA131301952	1956	0.978
NULL	Mol_Cancer_2006_Oct_17_5_45.nxml.txt.nlp	17044934	SENT91	4	4	37	37	ns-398	COX		1351	0.978
NULL	EMBO_Mol_Med_2013_Jan_29_5(1)_137-148.nxml.txt.nlp	23197407	SENT111	15	15	7	7	losartan	TR3	PA450268	8718;3164;10587	0.978
NULL	Endocr_Relat_Cancer_2014_Feb_21(1)_85-99.nxml.txt.nlp	24189182	SENT164	40	40	23	23	amiloride	FGFR1	PA448368	2260	0.978
NULL	Anemia_2012_May_24_2012_481583.nxml.txt.nlp	22693661	SENT62	0	0	16	16	curcumin	FANCD2	PA151958596	2177	0.978
NULL	Cancers_(Basel)_2012_Feb_21_4(1)_165-183.nxml.txt.nlp	24213234	SENT23	0	0	28	28	sorafenib	SHARP	PA7000	23013	0.978
NULL	J_Mol_Signal_2008_Dec_1_3_18.nxml.txt.nlp	19046439	SENT4	0	0	11	11	metformin	AMPK	PA450395	5563	0.978
NULL	Nat_Commun_2014_Nov_19_5_5479.nxml.txt.nlp	25407222	SENT99	33	33	0	0	dextran	YTS	PA449261	8565	0.978
NULL	Cell_Death_Dis_2010_Feb_4_1(2)_e23.nxml.txt.nlp	21364631	SENT29	35	35	23	23	curcumin	JNK	PA151958596	5599	0.978
NULL	Cancer_Cell_Int_2012_Dec_21_12_54.nxml.txt.nlp	23256568	SENT34	4	4	0	0	geldanamycin	Hsp90	PA152031327	3320	0.978
NULL	Ann_Hematol_2014_May_29_93(8)_1263-1277.nxml.txt.nlp	24870942	SENT277	3	3	19	19	bortezomib	BCL6	PA10252	604	0.978
NULL	Aging_(Albany_NY)_2013_Feb_21_5(2)_94-95.nxml.txt.nlp	23518473	SENT21	2	2	19	19	resveratrol	SIRT1		23411	0.978
NULL	J_Korean_Med_Sci_2007_Feb_28_22(1)_26-29.nxml.txt.nlp	17297247	SENT19	18	18	5	5	isoniazid	DST	PA450112	667	0.978
NULL	Indian_J_Anaesth_2011_Nov-Dec_55(6)_567-572.nxml.txt.nlp	22223899	SENT154	18	18	0	0	isoflurane	NAC	PA450106	22861	0.978
NULL	Diabetes_Care_2010_Sep_33(9)_2074-2076.nxml.txt.nlp	20805279	SENT62	0	0	10	10	exenatide	GLP-1	PA164749238	100125288	0.978
NULL	Cardiovasc_Res_2013_Sep_1_99(4)_657-664.nxml.txt.nlp	23708738	SENT65	26	26	9	9	ketamine	HMGB1	PA450144	3146	0.978
NULL	Oncotarget_2013_Apr_15_4(4)_636-646.nxml.txt.nlp	23592437	SENT66	18	18	10	10	decitabine	XAGE3	PA164749631	170626	0.978
NULL	Front_Immunol_2013_Mar_8_4_50.nxml.txt.nlp	23483669	SENT200	0	0	12	12	metformin	NLRP3	PA450395	114548	0.978
NULL	Cancer_Res_Treat_2014_Jan_15_46(1)_55-64.nxml.txt.nlp	24520224	SENT29	17	17	8	8	oxaliplatin	TRAP1	PA131285527	9392;10131	0.978
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_15_2012_591654.nxml.txt.nlp	23118793	SENT228	5	5	13	13	berberine	PPG	PA165860812	5552	0.978
NULL	Breast_Cancer_Res_2010_Mar_5_12(2)_R16.nxml.txt.nlp	20205716	SENT343	20	20	0	0	lovastatin	DJ-1	PA450272	11315	0.978
NULL	Arthritis_Res_Ther_2014_Jan_24_16(1)_R23.nxml.txt.nlp	24460726	SENT243	21	21	15	15	cisplatin	STAT1	PA449014	6772	0.978
NULL	Acta_Pharmacol_Sin_2013_Jun_8_34(6)_830-836.nxml.txt.nlp	23564080	SENT143	47	47	7	7	simvastatin	HMGB1	PA451363	3146	0.978
NULL	Clin_Interv_Aging_2014_Nov_18_9_1963-1980.nxml.txt.nlp	25429208	SENT141	3	3	13	13	pioglitazone	DPP4	PA450970	1803	0.978
NULL	Oncotarget_2011_Sep_9_2(9)_658-668.nxml.txt.nlp	21911919	SENT5	15	15	4	4	cytarabine	HO-1	PA449177	3162	0.978
NULL	Br_J_Cancer_2012_Feb_14_106(4)_685-692.nxml.txt.nlp	22294184	SENT115	33	33	8	8	docetaxel	Bcl-2	PA449383	596	0.978
NULL	Oncotarget_2013_Nov_19_5(1)_95-102.nxml.txt.nlp	24395633	SENT84	19	19	27	27	sirolimus	FOXP3	PA451365	50943	0.978
NULL	Cancer_Cell_Int_2012_Dec_21_12_54.nxml.txt.nlp	23256568	SENT34	4	4	38	38	geldanamycin	Hsp90	PA152031327	3320	0.978
NULL	Arthritis_Res_Ther_2005_Feb_17_7(Suppl_1)_P54.nxml.txt.nlp	NULL	SENT23	19	19	7	7	chloroquine	CD86	PA448948	942	0.978
NULL	Environ_Health_Perspect_2011_Aug_7_119(8)_1117-1122.nxml.txt.nlp	21382770	SENT182	22	22	10	10	mk-571	GCL		64396;25801	0.978
NULL	Oncol_Lett_2013_Feb_5_5(2)_427-434.nxml.txt.nlp	23420099	SENT166	15	15	8	8	cisplatin	ERCC2	PA449014	2068	0.978
NULL	Arthritis_Res_Ther_2008_Sep_9_10(5)_R107.nxml.txt.nlp	18782442	SENT280	19	19	9	9	glucose	HNE	PA449773	1991	0.978
NULL	Eur_J_Haematol_2009_Apr_82(4)_277-287.nxml.txt.nlp	19187270	SENT200	20	20	6	6	pha-665752	STAT3		6774	0.978
NULL	Oncol_Lett_2013_Feb_9_5(2)_552-558.nxml.txt.nlp	23420128	SENT66	10	10	0	0	imatinib	KIT	PA10804	3815	0.978
NULL	Tuberc_Res_Treat_2014_May_20_2014_349141.nxml.txt.nlp	24967101	SENT170	3	3	20	20	ethionamide	DST	PA164768738	667	0.978
NULL	Br_J_Cancer_2013_Feb_19_108(3)_668-675.nxml.txt.nlp	23348520	SENT18	1	1	34	34	cetuximab	KRAS	PA10040	3845	0.978
NULL	Evid_Based_Complement_Alternat_Med_2014_Jan_9_2014_506735.nxml.txt.nlp	24523822	SENT85	7	7	24	24	fluoxetine	CORT	PA449673	1325	0.978
NULL	Neuropsychopharmacology_2011_Dec_10_36(13)_2616-2628.nxml.txt.nlp	21832989	SENT22	32	32	12	12	phencyclidine	spatial	PA128406980	219793	0.978
NULL	Aging_(Albany_NY)_2011_Jan_18_3(1)_33-43.nxml.txt.nlp	21248371	SENT143	22	22	15	15	zinc	HIPK2	PA451956	28996	0.978
NULL	ARYA_Atheroscler_2011_Fall_7(3)_106-110.nxml.txt.nlp	22577456	SENT25	0	0	15	15	clopidogrel	ADP	PA449053	23038	0.978
NULL	Leukemia_2013_Jan_11_27(1)_32-40.nxml.txt.nlp	22781593	SENT117	8	8	17	17	ponatinib	FGFR1	PA165980594	2260	0.978
NULL	Clin_Ophthalmol_2014_Sep_22_8_1891-1911.nxml.txt.nlp	25284976	SENT174	0	0	38	38	everolimus	IL-2	PA164746311	3558	0.978
NULL	Br_J_Cancer_2012_Jul_24_107(3)_516-526.nxml.txt.nlp	22782351	SENT99	9	9	30	30	tamoxifen	TIGAR	PA451581	57103	0.978
NULL	Behav_Genet_2012_Jul_17_42(4)_509-527.nxml.txt.nlp	22426781	SENT142	21	21	19	19	letrozole	aromatase	PA450196	1588	0.978
NULL	J_Ophthalmic_Inflamm_Infect_2013_Jan_28_3_22.nxml.txt.nlp	23514095	SENT95	0	0	13	13	latanoprost	BAK	PA164774763	578	0.978
NULL	Nat_Commun_2011_Jul_5_2_380.nxml.txt.nlp	21730960	SENT60	15	15	28	28	pentazocine	PGRMC1	PA164744326	10857	0.978
NULL	Nat_Commun_2012_Jan_31_3_649.nxml.txt.nlp	22337127	SENT189	16	16	4	4	ketamine	TRPC6	PA450144	7225	0.978
NULL	Breast_Cancer_Res_2010_Oct_22_12(Suppl_2)_S2.nxml.txt.nlp	21050423	SENT145	0	0	13	13	ixabepilone	P-gp		5243	0.978
NULL	Front_Neurosci_2013_Jan_11_6_182.nxml.txt.nlp	23335873	SENT96	19	19	9	9	staurosporine	OXT	PA165109623	5020	0.978
NULL	J_Hematol_Oncol_2012_Sep_18_5_57.nxml.txt.nlp	22989009	SENT160	15	15	1	1	nutlin-3	p53		7157	0.978
NULL	Breast_Cancer_Res_2014_Oct_3_16(5)_452.nxml.txt.nlp	25277819	SENT30	3	3	5	5	tamoxifen	aromatase	PA451581	1588	0.978
NULL	Toxins_(Basel)_2011_Jul_14_3(7)_848-883.nxml.txt.nlp	22069744	SENT402	9	9	30	30	trastuzumab	DM1	PA451743	338023;1760;28509	0.978
NULL	Br_J_Cancer_2012_Jul_24_107(3)_516-526.nxml.txt.nlp	22782351	SENT279	20	20	6	6	tamoxifen	TIGAR	PA451581	57103	0.978
NULL	Mol_Cancer_2010_Aug_23_9_222.nxml.txt.nlp	20731837	SENT175	30	30	3	3	gefitinib	ATM	PA131301952	472	0.978
NULL	Virol_J_2011_Nov_28_8_523.nxml.txt.nlp	22122911	SENT6	11	11	36	36	heparin	DARC	PA449855	2532	0.978
NULL	Cancer_Manag_Res_2013_Oct_8_5_337-347.nxml.txt.nlp	24204170	SENT36	21	21	4	4	sorafenib	VEGFR	PA7000	3791	0.978
NULL	Indian_J_Pharm_Sci_2013_Nov-Dec_75(6)_680-687.nxml.txt.nlp	24591743	SENT29	4	4	20	20	gemfibrozil	CYP2C8	PA449750	1558	0.978
NULL	Mol_Cell_Biochem_2014_Oct_9_385(1-2)_265-275.nxml.txt.nlp	24104452	SENT13	6	6	12	12	bortezomib	U87	PA10252	677775;641648	0.978
NULL	Diabetes_Care_2010_Aug_11_33(8)_1759-1765.nxml.txt.nlp	20460445	SENT42	5	5	8	8	exenatide	GLP-1	PA164749238	100125288	0.978
NULL	Mol_Cancer_2010_Nov_2_9_289.nxml.txt.nlp	21044322	SENT149	30	30	8	8	vincristine	RGS5	PA451879	8490	0.978
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT237	4	4	19	19	resveratrol	TRAIL		8743	0.978
NULL	Ann_Hematol_2014_Mar_18_93(8)_1335-1344.nxml.txt.nlp	24638841	SENT163	4	4	12	12	rituximab	CLB	PA451261	171425	0.978
NULL	J_Mol_Psychiatry_2013_Nov_4_1(1)_19.nxml.txt.nlp	25408910	SENT79	37	37	4	4	olanzapine	ADCY3	PA450688	109	0.978
NULL	Infect_Dis_Obstet_Gynecol_2012_Feb_25_2012_157159.nxml.txt.nlp	22505797	SENT102	10	10	27	27	clindamycin	PTB	PA449035	58155	0.978
NULL	Int_J_Mol_Sci_2012_Sep_26_13(10)_12287-12314.nxml.txt.nlp	23202899	SENT333	24	24	13	13	dasatinib	FYN	PA162372878	2534	0.978
NULL	J_Cell_Biol_2001_May_14_153(4)_785-794.nxml.txt.nlp	11352939	SENT617	13	13	25	25	tetracycline	EPM	PA451640	2054	0.978
NULL	Cell_Commun_Signal_2010_Sep_22_8_27.nxml.txt.nlp	20860841	SENT160	28	28	0	0	hydroxyurea	PP5	PA449942	7980;5536	0.978
NULL	Trials_2014_May_15_15_171.nxml.txt.nlp	24885324	SENT17	13	13	1	1	exemestane	aromatase	PA449563	1588	0.978
NULL	J_Young_Pharm_2010_Jul-Sep_2(3)_326-331.nxml.txt.nlp	21042495	SENT127	24	24	28	28	fluvastatin	CYP2C9	PA449688	1559	0.978
NULL	Ther_Clin_Risk_Manag_2007_Jun_3(3)_467-474.nxml.txt.nlp	18488080	SENT122	5	5	18	18	rasagiline	CYP1A2	PA164764584	1544	0.978
NULL	Acta_Pharmacol_Sin_2011_Oct_5_32(10)_1285-1293.nxml.txt.nlp	21892200	SENT32	14	14	29	29	grepafloxacin	CYP1A2	PA449812	1544	0.978
NULL	Int_Semin_Surg_Oncol_2005_Oct_26_2_23.nxml.txt.nlp	16250911	SENT124	0	0	14	14	ketoconazole	5-LOX	PA450146	240	0.978
NULL	Mol_Cytogenet_2014_Feb_27_7_15.nxml.txt.nlp	24576355	SENT30	30	30	15	15	hydroquinone	CYP2E1	PA449924	1571	0.978
NULL	Int_Clin_Psychopharmacol_2014_Jul_26_29(4)_185-196.nxml.txt.nlp	24424469	SENT99	6	6	12	12	paroxetine	CYP2D6	PA450801	1565	0.978
NULL	J_Mol_Med_(Berl)_2014_May_10_92(7)_709-722.nxml.txt.nlp	24811491	SENT97	28	28	9	9	vemurafenib	EGFR	PA165946873	1956	0.978
NULL	Oncogene_2014_Jul_24_33(30)_3927-3938.nxml.txt.nlp	23995784	SENT248	7	7	26	26	doxycycline	FOXO3	PA449415	2309	0.978
NULL	Cancer_Res_Treat_2014_Jan_15_46(1)_2-18.nxml.txt.nlp	24520218	SENT94	1	1	9	9	curcumin	CO2	PA151958596	4513	0.978
NULL	J_Biol_Chem_2009_Feb_27_284(9)_5645-5653.nxml.txt.nlp	19095655	SENT93	15	15	30	30	forskolin	AMPK	PA146096022	5563	0.978
NULL	Arthritis_Res_Ther_2012_Dec_13_14(6)_R269.nxml.txt.nlp	23237573	SENT158	3	3	17	17	heparin	C5a	PA449855	727	0.978
NULL	Exp_Ther_Med_2014_May_5_7(5)_1420-1426.nxml.txt.nlp	24940450	SENT91	0	0	31	31	sorafenib	FLT3	PA7000	2322	0.978
NULL	J_Int_Soc_Sports_Nutr_2012_Apr_17_9_17.nxml.txt.nlp	22510253	SENT136	21	21	5	5	l-arginine	AAKG	PA448478	51422	0.978
NULL	Chemother_Res_Pract_2012_Apr_11_2012_283181.nxml.txt.nlp	22567280	SENT261	15	15	3	3	imatinib	DDR1	PA10804	780	0.978
NULL	Indian_J_Dermatol_2013_May-Jun_58(3)_227-231.nxml.txt.nlp	23723476	SENT66	24	24	9	9	clofazimine	G6PD	PA164748759	2539	0.978
NULL	Environ_Health_Perspect_2009_Feb_8_117(2)_175-180.nxml.txt.nlp	19270784	SENT187	19	19	6	6	doxorubicin	Bcl-2	PA449412	596	0.978
NULL	Oncotarget_2013_Aug_24_4(10)_1618-1631.nxml.txt.nlp	24113128	SENT201	10	10	3	3	sorafenib	p53	PA7000	7157	0.978
NULL	Cell_J_2012_Dec_22_Winter_13(4)_265-274.nxml.txt.nlp	23507995	SENT291	3	3	25	25	ethanol	CA3	PA448073	761	0.978
NULL	Biogerontology_2010_Feb_9_11(1)_45-52.nxml.txt.nlp	19430925	SENT66	27	27	2	2	lamotrigine	ANOVA	PA450164	4858	0.978
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT121	6	6	13	13	simvastatin	AKT	PA451363	207	0.978
NULL	Front_Oncol_2014_Oct_31_4_306.nxml.txt.nlp	25401091	SENT128	7	7	20	20	doxorubicin	MDR1	PA449412	5243	0.978
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT50	12	12	4	4	curcumin	PC-3	PA151958596	692094	0.978
NULL	Drug_Target_Insights_2006_Oct_23_1_5-10.nxml.txt.nlp	21901053	SENT123	12	12	19	19	heparin	INCA	PA449855	440068	0.978
NULL	Acta_Pharmacol_Sin_2014_Jan_9_35(1)_1-10.nxml.txt.nlp	24317012	SENT23	24	24	7	7	methotrexate	SLCO1B1	PA450428	10599	0.978
NULL	Int_J_Gen_Med_2011_Jul_20_4_539-545.nxml.txt.nlp	21845063	SENT94	18	18	15	15	miglitol	adiponectin	PA164776726	9370	0.978
NULL	J_Mol_Signal_2014_Aug_8_9_8.nxml.txt.nlp	25237386	SENT200	27	27	3	3	sc-560	PTGS1		5742	0.978
NULL	J_Cereb_Blood_Flow_Metab_2012_Jul_2_32(7)_1393-1415.nxml.txt.nlp	22549622	SENT167	2	2	14	14	minocycline	TSPO	PA450519	706	0.978
NULL	J_Med_Chem_2014_Feb_27_57(4)_1557-1572.nxml.txt.nlp	24471976	SENT141	41	41	4	4	reserpine	ANOVA	PA451236	4858	0.978
NULL	Clin_Exp_Reprod_Med_2013_Jun_30_40(2)_67-75.nxml.txt.nlp	23875162	SENT164	9	9	3	3	rosiglitazone	aromatase	PA451283	1588	0.978
NULL	Brain_Sci_2013_Jun_3_3(2)_877-907.nxml.txt.nlp	24961429	SENT172	4	4	28	28	taurine	PERK	PA451590	9451	0.978
NULL	Scand_J_Infect_Dis_2012_Dec_9_44(12)_997-1000.nxml.txt.nlp	22776013	SENT28	18	18	1	1	zidovudine	CD4	PA451954	920	0.978
NULL	Oncotarget_2014_Oct_21_5(22)_11180-11192.nxml.txt.nlp	25361003	SENT130	11	11	36	36	doxycycline	NTRK1	PA449415	4914	0.978
NULL	EPMA_J_2013_Jan_28_4(1)_3.nxml.txt.nlp	23356214	SENT164	0	0	14	14	cetuximab	EGFR	PA10040	1956	0.978
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Jul_23_6_103-113.nxml.txt.nlp	25114588	SENT43	24	24	39	39	lapatinib	HER2	PA152241907	2064	0.978
NULL	Breast_Cancer_Res_2005_Jul_20_7(5)_205-211.nxml.txt.nlp	16168139	SENT125	32	32	12	12	tamoxifen	EGF	PA451581	1950	0.978
NULL	ScientificWorldJournal_2012_Apr_1_2012_381434.nxml.txt.nlp	22545017	SENT404	10	10	7	7	aprepitant	NK-1	PA164747039	27087	0.978
NULL	J_Mol_Med_2008_Sep_4_86(9)_1045-1056.nxml.txt.nlp	18600309	SENT248	3	3	9	9	salmeterol	IL-8	PA451300	3576	0.978
NULL	ScientificWorldJournal_2013_Dec_5_2013_247102.nxml.txt.nlp	24381515	SENT58	2	2	8	8	cilostazol	EVI	PA164746334	79971	0.978
NULL	Clinics_(Sao_Paulo)_2012_Dec_67(12)_1501-1504.nxml.txt.nlp	23295609	SENT24	42	42	6	6	doxycycline	LAM	PA449415	7249;7248	0.978
NULL	Br_J_Cancer_2003_Mar_10_88(5)_754-759.nxml.txt.nlp	12618886	SENT130	23	23	27	27	amifostine	p53	PA448365	7157	0.978
NULL	Viruses_2014_Feb_10_6(2)_709-726.nxml.txt.nlp	24517971	SENT420	7	7	13	13	maraviroc	CCR5	PA164768835	1234	0.978
NULL	J_Biol_Chem_2013_Apr_26_288(17)_11865-11876.nxml.txt.nlp	23449983	SENT286	6	6	22	22	forskolin	CXCL12	PA146096022	6387	0.978
NULL	Int_J_Vasc_Med_2013_Mar_31_2013_543141.nxml.txt.nlp	23606968	SENT153	32	32	13	13	etanercept	IL-17	PA449515	3605	0.978
NULL	Oncol_Lett_2013_Apr_7_5(4)_1382-1384.nxml.txt.nlp	23599798	SENT58	10	10	37	37	temsirolimus	IFN	PA164746890	3439	0.978
NULL	Case_Rep_Med_2013_Nov_12_2013_640216.nxml.txt.nlp	24319464	SENT57	35	35	18	18	tenofovir	CD4	PA10204	920	0.978
NULL	Oncol_Lett_2014_Jun_28_7(6)_1747-1754.nxml.txt.nlp	24932227	SENT102	16	16	0	0	trypsin	SPINK1	PA451806	6690	0.978
NULL	AMB_Express_2012_Dec_7_2_65.nxml.txt.nlp	23217124	SENT295	11	11	22	22	ethanol	SHF	PA448073	90525	0.978
NULL	Virol_J_2010_Dec_3_7_354.nxml.txt.nlp	21129188	SENT52	27	27	10	10	raltegravir	p24		11261;140767	0.978
NULL	J_Mol_Signal_2008_Dec_2_3_19.nxml.txt.nlp	19055733	SENT62	22	22	11	11	isoproterenol	AKAP12	PA450121	9590	0.978
NULL	Cardiovasc_Diabetol_2013_Nov_21_12_172.nxml.txt.nlp	24261558	SENT291	27	27	4	4	eplerenone	FABP3	PA164749044	2170	0.978
NULL	Comp_Hepatol_2003_Jan_31_2_3.nxml.txt.nlp	12622871	SENT325	16	16	11	11	indomethacin	gamma	PA449982	9913	0.978
NULL	Acta_Naturae_2011_Oct-Dec_3(4)_83-93.nxml.txt.nlp	22649707	SENT106	26	26	12	12	cisplatin	TLR2	PA449014	7097	0.978
NULL	Oncotarget_2014_Feb_25_5(5)_1304-1314.nxml.txt.nlp	24675421	SENT78	29	29	19	19	cisplatin	RIP1	PA449014	10928;7386	0.978
NULL	Open_Med_Chem_J_2013_Oct_31_7_23-29.nxml.txt.nlp	24222802	SENT71	0	0	22	22	perifosine	AKT	PA165291471	207	0.978
NULL	Cancer_Cell_Int_2013_Jun_26_13_63.nxml.txt.nlp	23800022	SENT155	10	10	23	23	genistein	XIAP	PA165109660	331	0.978
NULL	Front_Genet_2014_Dec_19_5_438.nxml.txt.nlp	25566322	SENT105	0	0	11	11	hydralazine	DNMT1	PA449894	1786	0.978
NULL	Patient_Prefer_Adherence_2011_Dec_23_6_1-9.nxml.txt.nlp	22272064	SENT61	0	0	10	10	telmisartan	ACE	PA451605	1636	0.978
NULL	Diabetes_Care_2010_Sep_33(9)_1919-1924.nxml.txt.nlp	20724646	SENT20	39	39	3	3	metformin	HNF1A	PA450395	6927	0.978
NULL	Cancer_Cell_Int_2010_Jan_21_10_2.nxml.txt.nlp	20142997	SENT199	26	26	18	18	cetuximab	CDH1	PA10040	51343;999	0.978
NULL	Mol_Syst_Biol_2010_Jun_8_6_378.nxml.txt.nlp	20531407	SENT213	9	9	24	24	ethanol	Rho	PA448073	29984	0.978
NULL	Iran_J_Ped_Hematol_Oncol_2014_Mar_15_4(1)_32-38.nxml.txt.nlp	24734162	SENT40	1	1	14	14	mercaptopurine	XDH	PA450379	7498	0.978
NULL	Adv_Prev_Med_2012_Dec_5_2012_316871.nxml.txt.nlp	23304535	SENT34	20	20	5	5	buprenorphine	OST	PA448685	1650;23263	0.978
NULL	Arthritis_Res_Ther_2014_Oct_30_16(5)_474.nxml.txt.nlp	25359291	SENT6	32	32	1	1	adalimumab	OX40	PA10004	7293	0.978
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT201	25	25	4	4	pp2	EGFR		1956	0.978
NULL	Viruses_2014_Aug_19_6(8)_3181-3227.nxml.txt.nlp	25196285	SENT540	3	3	13	13	enfuvirtide	CCR5	PA164744517	1234	0.978
NULL	Chin_J_Cancer_2011_Jan_30(1)_5-12.nxml.txt.nlp	21192840	SENT110	3	3	8	8	erlotinib	ABCG2	PA134687924	9429	0.978
NULL	Clin_Med_Insights_Oncol_2012_Feb_28_6_125-135.nxml.txt.nlp	22408376	SENT101	16	16	5	5	cetuximab	BRAF	PA10040	673	0.978
NULL	Indian_J_Nephrol_2012_Jul-Aug_22(4)_275-279.nxml.txt.nlp	23162271	SENT57	28	28	0	0	tacrolimus	IL-2	PA451578	3558	0.978
NULL	Eur_J_Clin_Pharmacol_2010_Nov_29_66(11)_1131-1136.nxml.txt.nlp	20669013	SENT130	39	39	7	7	voriconazole	CYP3A4	PA10233	1576	0.978
NULL	Nucleic_Acids_Res_2014_Jan_1_42(1)_643-660.nxml.txt.nlp	24097436	SENT184	37	37	19	19	doxycycline	DIS3	PA449415	22894	0.978
NULL	BMB_Rep_2013_Nov_46(11)_544-549.nxml.txt.nlp	24152910	SENT56	5	5	36	36	thrombin	HMGB1	PA451674	3146	0.978
NULL	Cell_Death_Dis_2014_Mar_13_5(3)_e1113.nxml.txt.nlp	24625972	SENT342	14	14	5	5	bleomycin	BI-1	PA448645	7009	0.978
NULL	J_Cheminform_2012_Mar_8_4_6.nxml.txt.nlp	22401035	SENT245	40	40	8	8	troglitazone	PPARG	PA451799	5468	0.978
NULL	Curr_Opin_Pharmacol_2012_Dec_12(6)_653-658.nxml.txt.nlp	23063456	SENT83	23	23	9	9	dextran	CB1	PA449261	1268	0.978
NULL	Ann_Indian_Acad_Neurol_2009_Apr-Jun_12(2)_89-98.nxml.txt.nlp	20142853	SENT193	19	19	7	7	carbamazepine	MDR1	PA448785	5243	0.978
NULL	Clin_Med_Oncol_2008_Mar_27_2_275-287.nxml.txt.nlp	21892289	SENT257	15	15	5	5	rituximab	CD138	PA451261	6382	0.978
NULL	Cardiovasc_Diabetol_2006_May_15_5_11.nxml.txt.nlp	16700915	SENT98	33	33	19	19	telmisartan	adiponectin	PA451605	9370	0.978
NULL	Oncogenesis_2012_Apr_2_1(4)_e5.nxml.txt.nlp	23552603	SENT234	20	20	3	3	celecoxib	Bcl-2	PA448871	596	0.978
NULL	Cell_Death_Dis_2010_Nov_18_1(11)_e102.nxml.txt.nlp	21368867	SENT149	18	18	2	2	gentamicin	CLIMP-63	PA449753	10970	0.978
NULL	Crit_Care_1998_May_22_2(2)_49-55.nxml.txt.nlp	11056709	SENT53	0	0	7	7	telmisartan	ANG	PA451605	283	0.978
NULL	Blood_Res_2014_Dec_23_49(4)_253-258.nxml.txt.nlp	25548759	SENT114	7	7	25	25	rituximab	CHOP	PA451261	1649	0.978
NULL	Chin_J_Cancer_2012_Feb_31(2)_73-99.nxml.txt.nlp	22098950	SENT25	22	22	8	8	doxorubicin	P-gp	PA449412	5243	0.978
NULL	J_Korean_Med_Sci_2010_Oct_17_25(10)_1427-1430.nxml.txt.nlp	20890421	SENT78	26	26	7	7	atazanavir	UGT1A1	PA10251	54658	0.978
NULL	Arthritis_Res_Ther_2007_Oct_10_9(5)_R105.nxml.txt.nlp	17927818	SENT160	29	29	4	4	pp2	PP2		4888	0.978
NULL	Front_Oncol_2014_Sep_29_4_262.nxml.txt.nlp	25325014	SENT558	35	35	23	23	trastuzumab	CD24	PA451743	100133941	0.978
NULL	J_Cancer_Res_Clin_Oncol_2010_Jul_21_136(7)_1007-1022.nxml.txt.nlp	20091186	SENT183	15	15	5	5	glucose	FDG	PA449773	23583	0.978
NULL	Leukemia_2013_Jan_11_27(1)_32-40.nxml.txt.nlp	22781593	SENT174	11	11	17	17	ponatinib	FGFR1	PA165980594	2260	0.978
NULL	Cancer_Res_Treat_2013_Mar_31_45(1)_55-62.nxml.txt.nlp	23613671	SENT147	13	13	3	3	oxaliplatin	KRAS	PA131285527	3845	0.978
NULL	J_Midlife_Health_2010_Jul-Dec_1(2)_59-62.nxml.txt.nlp	21716774	SENT107	25	25	4	4	estradiol	aromatase	PA449503	1588	0.978
NULL	Comb_Chem_High_Throughput_Screen_2010_Feb_13(2)_188-206.nxml.txt.nlp	20053163	SENT244	14	14	21	21	ketoconazole	CYP3A4	PA450146	1576	0.978
NULL	Antiviral_Res_2009_May_82(2)_A99-A109.nxml.txt.nlp	19176219	SENT178	14	14	21	21	indinavir	OCT2	PA449977	6582;5452	0.978
NULL	Oncol_Lett_2014_Nov_12_8(5)_2203-2208.nxml.txt.nlp	25295109	SENT126	7	7	17	17	celecoxib	GLI1	PA448871	2735	0.978
NULL	Braz_J_Med_Biol_Res_2014_Sep_5_47(11)_1008-1015.nxml.txt.nlp	25296365	SENT11	17	17	1	1	tamoxifen	CYP2D6	PA451581	1565	0.978
NULL	J_Viral_Hepat_2009_May_16(5)_315-324.nxml.txt.nlp	19243499	SENT101	14	14	7	7	imiquimod	TLR9	PA449972	54106	0.978
NULL	Pharmaceuticals_(Basel)_2012_Aug_10_5(8)_802-836.nxml.txt.nlp	24280676	SENT40	29	29	33	33	ribavirin	CNT2	PA451241	9153	0.978
NULL	J_Cancer_Prev_2014_Sep_19(3)_153-160.nxml.txt.nlp	25337584	SENT97	25	25	12	12	betaine	TNF	PA448603	7124	0.978
NULL	Curr_Oncol_2009_Jul_16(Suppl_2)_S14-S23.nxml.txt.nlp	19672417	SENT9	8	8	1	1	tamoxifen	aromatase	PA451581	1588	0.978
NULL	EMBO_Mol_Med_2011_Mar_15_3(3)_153-166.nxml.txt.nlp	21328542	SENT91	32	32	4	4	estradiol	ZNF703	PA449503	80139	0.978
NULL	Oncoscience_2014_Mar_12_1(2)_158-166.nxml.txt.nlp	25594008	SENT121	36	36	18	18	dasatinib	ANXA1	PA162372878	301	0.978
NULL	J_Cell_Mol_Med_2013_May_14_17(5)_579-596.nxml.txt.nlp	23490277	SENT208	15	15	1	1	clopidogrel	P2Y12	PA449053	64805	0.978
NULL	J_Thorac_Oncol_2014_Feb_23_9(2)_189-194.nxml.txt.nlp	24419415	SENT8	41	41	15	15	gefitinib	EGFR	PA131301952	1956	0.978
NULL	Oxid_Med_Cell_Longev_2013_Jun_2_2013_793525.nxml.txt.nlp	23819014	SENT204	42	42	16	16	resveratrol	PI3K		5290	0.978
NULL	Case_Rep_Neurol_2014_Mar_29_6(1)_101-108.nxml.txt.nlp	24761147	SENT108	3	3	29	29	cyclophosphamide	IVL	PA449165	3713	0.978
NULL	Int_J_Mol_Sci_2014_Sep_2_15(9)_15512-15529.nxml.txt.nlp	25184950	SENT27	22	22	3	3	resveratrol	IL-10		3586	0.978
NULL	Biomed_Res_Int_2013_May_22_2013_430791.nxml.txt.nlp	23762845	SENT118	17	17	4	4	fasudil	SDH	PA165946121	1757;10993	0.978
NULL	Osteoporos_Int_2010_Oct_18_21(10)_1657-1680.nxml.txt.nlp	20480148	SENT427	4	4	13	13	denosumab	RANKL	PA166048634	8600	0.978
NULL	Diabetes_Care_2009_Apr_32(4)_531-540.nxml.txt.nlp	19336638	SENT24	4	4	9	9	cangrelor	P2Y12	PA165945763	64805	0.978
NULL	Neural_Plast_2012_Jul_30_2012_976164.nxml.txt.nlp	22919518	SENT47	8	8	0	0	ketamine	P15	PA450144	1030;29107	0.978
NULL	Case_Rep_Endocrinol_2014_Feb_10_2014_479641.nxml.txt.nlp	24660072	SENT26	0	0	24	24	cinacalcet	PTH	PA164776671	5741	0.978
NULL	EMBO_J_2008_Mar_19_27(6)_852-864.nxml.txt.nlp	18309296	SENT116	32	32	10	10	nutlin-3	MDM2		4193	0.978
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT75	30	30	20	20	capecitabine	HER2	PA448771	2064	0.978
NULL	J_Radiat_Res_2013_Jul_26_54(4)_649-662.nxml.txt.nlp	23447694	SENT173	29	29	6	6	hydroxyurea	THRAP3	PA449942	9967	0.978
NULL	F1000Prime_Rep_2014_Aug_1_6_66.nxml.txt.nlp	25165565	SENT125	12	12	21	21	everolimus	aromatase	PA164746311	1588	0.978
NULL	Cancer_Metastasis_Rev_2014_Apr_18_33(2-3)_695-720.nxml.txt.nlp	24744103	SENT310	20	20	18	18	gefitinib	EGFR	PA131301952	1956	0.978
NULL	Br_J_Cancer_2004_May_17_90(10)_1933-1941.nxml.txt.nlp	15138474	SENT148	14	14	1	1	tamoxifen	p27	PA451581	5715;10534	0.978
NULL	Nat_Med_2013_Mar_10_19(3)_313-321.nxml.txt.nlp	23396211	SENT90	26	26	6	6	amlexanox	HSL	PA164745310	3991	0.978
NULL	Int_J_Breast_Cancer_2011_Sep_6_2011_352182.nxml.txt.nlp	22295219	SENT201	24	24	7	7	erlotinib	Met	PA134687924	79811	0.978
NULL	Clin_Sci_(Lond)_2012_Aug_1_123(Pt_4)_241-249.nxml.txt.nlp	22369073	SENT124	30	30	12	12	donepezil	PLGF	PA449394	5228	0.978
NULL	J_Gen_Physiol_2009_Mar_133(3)_231-237.nxml.txt.nlp	19237587	SENT86	15	15	3	3	capsaicin	TRPV1	PA448776	7442	0.978
NULL	Cancer_Cell_Int_2007_Apr_3_7_4.nxml.txt.nlp	17407577	SENT161	21	21	35	35	cisplatin	CO2	PA449014	4513	0.978
NULL	Cancers_(Basel)_2012_Jun_18_4(2)_581-600.nxml.txt.nlp	24213326	SENT706	14	14	0	0	cyclophosphamide	CD4	PA449165	920	0.978
NULL	Breast_Cancer_Res_2011_Feb_23_13(1)_203.nxml.txt.nlp	21392408	SENT6	35	35	13	13	tamoxifen	aromatase	PA451581	1588	0.978
NULL	J_Exp_Clin_Cancer_Res_2010_Apr_30_29(1)_41.nxml.txt.nlp	20433702	SENT195	34	34	30	30	staurosporine	PC3	PA165109623	57332;7832;5122	0.978
NULL	Biosci_Rep_2012_Aug_1_32(Pt_4)_361-374.nxml.txt.nlp	22762204	SENT147	22	22	4	4	cetuximab	PTEN	PA10040	5728	0.978
NULL	Evid_Based_Complement_Alternat_Med_2012_Dec_17_2012_857123.nxml.txt.nlp	23365602	SENT106	8	8	2	2	capsaicin	TRPV1	PA448776	7442	0.978
NULL	Arthritis_Res_Ther_2008_Oct_10_10(5)_224.nxml.txt.nlp	18947376	SENT95	21	21	6	6	natalizumab	LFA-1	PA164747191	3683;3689	0.978
NULL	Exp_Ther_Med_2012_Sep_29_4(3)_524-532.nxml.txt.nlp	23181130	SENT129	0	0	17	17	mk-571	MRP2		100130958;57626;1244	0.978
NULL	Europace_2013_Mar_7_15(3)_317-324.nxml.txt.nlp	23220484	SENT44	4	4	33	33	ranolazine	SCN5A	PA164746007	6331	0.978
NULL	Support_Care_Cancer_2012_Jul_27_20(7)_1353-1360.nxml.txt.nlp	22539050	SENT220	20	20	1	1	denosumab	NNT	PA166048634	23530	0.978
NULL	Curr_Oncol_2009_Jul_16(Suppl_2)_S1-S13.nxml.txt.nlp	19672416	SENT214	37	37	18	18	tamoxifen	CYP2D6	PA451581	1565	0.978
NULL	Breast_Cancer_Res_2004_Aug_5_6(5)_R601-R607.nxml.txt.nlp	15318941	SENT123	26	26	7	7	cisplatin	p27	PA449014	5715;10534	0.978
NULL	Br_J_Cancer_2011_Dec_6_105(12)_1920-1926.nxml.txt.nlp	22095222	SENT24	40	40	32	32	gefitinib	PTEN	PA131301952	5728	0.978
NULL	Br_J_Clin_Pharmacol_2010_Dec_70(6)_807-814.nxml.txt.nlp	21175436	SENT98	8	8	41	41	liraglutide	Mal	PA165958364	114609	0.978
NULL	Br_J_Cancer_2011_Jul_26_105(3)_372-381.nxml.txt.nlp	21730979	SENT163	10	10	29	29	cisplatin	ATR	PA449014	390502;84168;545	0.978
NULL	Br_J_Pharmacol_2008_Sep_9_155(1)_127-137.nxml.txt.nlp	18536750	SENT197	9	9	31	31	piroxicam	IL-10	PA450985	3586	0.978
NULL	Oncotarget_2014_Oct_11_5(20)_10070-10083.nxml.txt.nlp	25301722	SENT33	5	5	12	12	cetuximab	KRAS	PA10040	3845	0.978
NULL	J_Physiol_2014_Nov_15_592(22)_5093-5107.nxml.txt.nlp	25239460	SENT118	8	8	47	47	sc-560	ERF		2077	0.978
NULL	Indian_J_Pharmacol_2008_Oct_40(Suppl_2)_S150-S160.nxml.txt.nlp	21593968	SENT70	5	5	31	31	pioglitazone	TNF-alpha	PA450970	7124	0.978
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT237	28	28	7	7	perifosine	DR4	PA165291471	8797	0.978
NULL	Breast_Cancer_Res_Treat_2012_Jun_18_133(3)_937-947.nxml.txt.nlp	22094936	SENT201	20	20	9	9	tamoxifen	EZH2	PA451581	2146	0.978
NULL	Br_J_Cancer_2012_Jul_24_107(3)_516-526.nxml.txt.nlp	22782351	SENT104	19	19	4	4	tamoxifen	TIGAR	PA451581	57103	0.978
NULL	Biochem_Res_Int_2012_Mar_20_2012_951539.nxml.txt.nlp	22482055	SENT215	0	0	11	11	doxorubicin	p53	PA449412	7157	0.978
NULL	Ann_Oncol_2014_Oct_23_25(10)_1941-1948.nxml.txt.nlp	25057173	SENT113	15	15	11	11	docetaxel	KRAS	PA449383	3845	0.978
NULL	Behav_Brain_Funct_2008_Feb_28_4_12.nxml.txt.nlp	18304369	SENT124	2	2	11	11	guanfacine	spatial	PA449825	219793	0.978
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT96	9	9	23	23	resveratrol	TRAIL		8743	0.978
NULL	J_Oncol_2012_Aug_7_2012_803294.nxml.txt.nlp	22919383	SENT127	7	7	34	34	resveratrol	p53		7157	0.978
NULL	Chin_J_Cancer_2013_Apr_32(4)_213-223.nxml.txt.nlp	22776235	SENT129	16	16	24	24	imatinib	CD34	PA10804	947	0.978
NULL	Acta_Pharmacol_Sin_2014_Jan_16_35(1)_135-142.nxml.txt.nlp	24335841	SENT130	8	8	3	3	chloroquine	Bcl-2	PA448948	596	0.978
NULL	Breast_Cancer_Res_2000_Mar_12_2(Suppl_1)_S_32.nxml.txt.nlp	NULL	SENT6	40	40	25	25	tamoxifen	TP53	PA451581	7157	0.978
NULL	Oncotarget_2012_Nov_17_4(1)_18-28.nxml.txt.nlp	23248157	SENT83	26	26	3	3	pargyline	U87	PA450797	677775;641648	0.978
NULL	Ther_Clin_Risk_Manag_2006_Mar_2(1)_45-57.nxml.txt.nlp	18360581	SENT48	0	0	33	33	etoricoxib	CYP3A	PA164776853	1574	0.978
NULL	Chin_J_Cancer_2012_Feb_31(2)_73-99.nxml.txt.nlp	22098950	SENT258	0	0	23	23	axitinib	VEGFR	PA164924493	3791	0.978
NULL	Clin_Sarcoma_Res_2014_Oct_1_4_14.nxml.txt.nlp	25302110	SENT26	0	0	32	32	pazopanib	KIT	PA165291492	3815	0.978
NULL	Brain_Sci_2013_Jun_14_3(2)_941-963.nxml.txt.nlp	24961432	SENT237	44	44	29	29	ethanol	AP-1	PA448073	2353;3727;2354;3725	0.978
NULL	Acta_Pharmacol_Sin_2009_Sep_24_30(9)_1262-1275.nxml.txt.nlp	19701231	SENT125	15	15	0	0	lovastatin	GAPDH	PA450272	2597	0.978
NULL	Iran_J_Pharm_Res_2013_Winter_12(1)_175-184.nxml.txt.nlp	24250586	SENT126	1	1	7	7	diclofenac	COX2	PA449293	4513;5743	0.978
NULL	J_Biol_Chem_2013_Aug_23_288(34)_24799-24808.nxml.txt.nlp	23836892	SENT184	4	4	28	28	s-adenosylmethionine	MidA	PA164754994	55471	0.978
NULL	Case_Rep_Med_2012_Dec_25_2012_168785.nxml.txt.nlp	23326271	SENT95	46	46	6	6	bortezomib	EMP	PA10252	10296	0.978
NULL	Oncol_Rep_2013_Oct_24_30(4)_1587-1592.nxml.txt.nlp	23900512	SENT132	3	3	17	17	pargyline	NOXA	PA450797	5366	0.978
NULL	Antimicrob_Agents_Chemother_2014_Oct_58(10)_5900-5908.nxml.txt.nlp	25070091	SENT118	1	1	8	8	metoprolol	CYP2D6	PA450480	1565	0.978
NULL	Cancers_(Basel)_2014_Mar_13_6(1)_595-624.nxml.txt.nlp	24633084	SENT222	0	0	30	30	lapatinib	HER2	PA152241907	2064	0.978
NULL	Front_Oncol_2014_Jun_18_4_159.nxml.txt.nlp	24995161	SENT224	8	8	41	41	estradiol	HSD1	PA449503	26871	0.978
NULL	J_Parasitol_Res_2013_Apr_3_2013_429736.nxml.txt.nlp	23691276	SENT177	0	0	13	13	curcumin	TLR2	PA151958596	7097	0.978
NULL	Mol_Microbiol_2014_Jul_23_93(2)_369-389.nxml.txt.nlp	24912400	SENT328	14	14	42	42	ethanol	S11	PA448073	6205;6267	0.978
NULL	Exp_Diabetes_Res_2012_Mar_4_2012_653678.nxml.txt.nlp	22474428	SENT9	1	1	16	16	repaglinide	LPO	PA451234	4025	0.978
NULL	Arthritis_Res_Ther_2013_Aug_30_15(4)_R100.nxml.txt.nlp	24000795	SENT123	25	25	18	18	methotrexate	IL-6	PA450428	3569	0.978
NULL	J_Cell_Biol_2004_Feb_2_164(3)_441-449.nxml.txt.nlp	14744997	SENT212	4	4	22	22	heparin	HMGB1	PA449855	3146	0.978
NULL	Mediators_Inflamm_2011_Jun_28_2011_949072.nxml.txt.nlp	21772670	SENT143	6	6	17	17	estradiol	APOE	PA449503	348	0.978
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2014_Apr_30_70(Pt_5)_1484-1490.nxml.txt.nlp	24816116	SENT82	14	14	28	28	nadh	mol	PA164755085	90527	0.978
NULL	Oncotarget_2014_Feb_7_5(3)_775-787.nxml.txt.nlp	24519956	SENT188	41	41	0	0	dasatinib	PC3	PA162372878	57332;7832;5122	0.978
NULL	Front_Genet_2014_Jul_22_5_239.nxml.txt.nlp	25101118	SENT248	21	21	10	10	nifedipine	NOS1	PA450631	340719;4842	0.978
NULL	Front_Oncol_2014_Mar_25_4_54.nxml.txt.nlp	24724051	SENT421	3	3	28	28	dasatinib	SYK	PA162372878	6850	0.978
NULL	Clin_Epigenetics_2011_Jun_27_2(2)_171-185.nxml.txt.nlp	21949547	SENT96	21	21	35	35	doxorubicin	BCL6	PA449412	604	0.978
NULL	Breast_Cancer_Res_2007_Oct_8_9(5)_R68.nxml.txt.nlp	17922920	SENT172	20	20	3	3	trastuzumab	HER2	PA451743	2064	0.978
NULL	Cancer_Immunol_Immunother_2011_Jun_25_60(6)_793-808.nxml.txt.nlp	21350947	SENT285	41	41	12	12	sorafenib	IFNAR2	PA7000	3455	0.978
NULL	Indian_J_Endocrinol_Metab_2012_Dec_16(Suppl_2)_S195-S198.nxml.txt.nlp	23565377	SENT38	12	12	0	0	cisplatin	PRL	PA449014	5617	0.978
NULL	Contemp_Oncol_(Pozn)_2012_Jul_6_16(3)_197-200.nxml.txt.nlp	23788878	SENT151	22	22	14	14	dacarbazine	BRAF	PA449197	673	0.978
NULL	Front_Immunol_2012_May_7_3_101.nxml.txt.nlp	22783250	SENT244	3	3	37	37	papain	CD90	PA450778	7070	0.978
NULL	Clin_Interv_Aging_2013_Jul_16_8_889-897.nxml.txt.nlp	23898224	SENT7	47	47	3	3	gemcitabine	ADP	PA449748	23038	0.978
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_2_2012_692625.nxml.txt.nlp	23082083	SENT29	30	30	42	42	vancomycin	AFM	PA451850	173	0.978
NULL	Int_J_Biol_Sci_2011_Nov_5_8(1)_1-14.nxml.txt.nlp	22211100	SENT239	5	5	23	23	evodiamine	PTEN	PA165860788	5728	0.978
NULL	Oncogene_2011_Apr_21_30(16)_1855-1867.nxml.txt.nlp	21151168	SENT55	30	30	19	19	chloroquine	p62	PA448948	8878;10657;23636	0.978
NULL	Br_J_Cancer_1999_Aug_80(12)_1912-1919.nxml.txt.nlp	10471039	SENT10	6	6	27	27	cisplatin	p53	PA449014	7157	0.978
NULL	J_Antimicrob_Chemother_2009_Nov_18_64(5)_910-928.nxml.txt.nlp	19767318	SENT107	0	0	21	21	maraviroc	CD4	PA164768835	920	0.978
NULL	Biomed_Res_Int_2014_Mar_6_2014_757461.nxml.txt.nlp	24734243	SENT91	12	12	4	4	estradiol	MCH	PA449503	5367	0.978
NULL	F1000Prime_Rep_2014_Aug_1_6_66.nxml.txt.nlp	25165565	SENT125	18	18	21	21	exemestane	aromatase	PA449563	1588	0.978
NULL	Biomed_Res_Int_2013_Jul_24_2013_581684.nxml.txt.nlp	23984383	SENT127	13	13	37	37	lomustine	PHB	PA164749407	5245	0.978
NULL	Br_J_Cancer_2012_Jul_24_107(3)_516-526.nxml.txt.nlp	22782351	SENT107	20	20	5	5	tamoxifen	TIGAR	PA451581	57103	0.978
NULL	Curr_Med_Chem_2013_Jan_21(3)_261-269.nxml.txt.nlp	24164192	SENT199	36	36	2	2	anakinra	NLRP3	PA10799	114548	0.978
NULL	Aging_(Albany_NY)_2010_Sep_17_2(10)_659-668.nxml.txt.nlp	20930262	SENT115	11	11	22	22	doxorubicin	p53	PA449412	7157	0.978
NULL	Ann_Surg_Oncol_2010_Apr_20_17(4)_1168-1176.nxml.txt.nlp	19936839	SENT72	4	4	29	29	cetuximab	KRAS	PA10040	3845	0.978
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT70	4	4	26	26	curcumin	TRAIL	PA151958596	8743	0.978
NULL	Nat_Commun_2014_Aug_5_5_4408.nxml.txt.nlp	25093291	SENT88	25	25	9	9	dasatinib	HRH2	PA162372878	1665;3274	0.978
NULL	Cell_Cycle_2014_Jan_15_13(2)_303-314.nxml.txt.nlp	24247149	SENT168	14	14	39	39	gemcitabine	p53	PA449748	7157	0.978
NULL	J_Adv_Pharm_Technol_Res_2012_Oct-Dec_3(4)_202-209.nxml.txt.nlp	23378940	SENT147	4	4	25	25	aprepitant	HEC	PA164747039	10403	0.978
NULL	Front_Genet_2011_Nov_3_2_78.nxml.txt.nlp	22114584	SENT214	0	0	14	14	methotrexate	DHFR	PA450428	1719	0.978
NULL	Open_Virol_J_2012_Dec_28_6_204-215.nxml.txt.nlp	23341856	SENT117	44	44	24	24	cisplatin	p53	PA449014	7157	0.978
NULL	Mol_Cancer_2010_Apr_15_9_77.nxml.txt.nlp	20398291	SENT89	32	32	15	15	geldanamycin	Hsp90	PA152031327	3320	0.978
NULL	J_Gen_Physiol_1997_Aug_1_110(2)_185-200.nxml.txt.nlp	9236211	SENT187	7	7	20	20	amiloride	NHE	PA448368	285335	0.978
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT115	25	25	10	10	cisplatin	p53	PA449014	7157	0.978
NULL	Oncotarget_2014_Sep_2_5(19)_9308-9321.nxml.txt.nlp	25301721	SENT243	34	34	12	12	forskolin	CD34	PA146096022	947	0.978
NULL	Mol_Cancer_2012_Dec_12_11_91.nxml.txt.nlp	23234355	SENT196	37	37	2	2	erlotinib	EGFR	PA134687924	1956	0.978
NULL	Brain_Res_2011_Mar_25_1382(C)_29-36.nxml.txt.nlp	21276431	SENT183	3	3	18	18	ketanserin	ANOVA	PA131053734	4858	0.978
NULL	Diabetes_2011_Mar_21_60(3)_757-765.nxml.txt.nlp	21282370	SENT42	16	16	2	2	isoproterenol	PTRF	PA450121	284119	0.978
NULL	Mol_Cancer_2012_Mar_21_11_13.nxml.txt.nlp	22436134	SENT156	18	18	34	34	doxorubicin	PAIP2	PA449412	51247	0.978
NULL	Arthritis_Res_Ther_2008_Jun_30_10(3)_209.nxml.txt.nlp	18598385	SENT258	15	15	4	4	infliximab	HMGB1	PA452639	3146	0.978
NULL	Exp_Neurobiol_2013_Mar_31_22(1)_45-50.nxml.txt.nlp	23585722	SENT108	17	17	6	6	fluoxetine	EPO	PA449673	7076;8288;2056	0.978
NULL	Arthritis_Res_Ther_2012_Dec_3_14(6)_R262.nxml.txt.nlp	23206933	SENT81	9	9	2	2	tocilizumab	IL-6	PA165292659	3569	0.978
NULL	Br_J_Cancer_2010_Nov_9_103(11)_1692-1697.nxml.txt.nlp	21063402	SENT88	11	11	26	26	mitomycin	TRAIL	PA450524	8743	0.978
NULL	Br_J_Cancer_2009_Jul_21_101(2)_238-243.nxml.txt.nlp	19568242	SENT139	13	13	37	37	sunitinib	IFN	PA162372840	3439	0.978
NULL	Ann_Rheum_Dis_2010_Oct_27_70(2)_299-304.nxml.txt.nlp	20980704	SENT84	23	23	11	11	infliximab	FCGR3B	PA452639	2215	0.978
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT10	18	18	2	2	nifedipine	CYP3A	PA450631	1574	0.978
NULL	BioDrugs_2014_Jul_8_28(5)_451-459.nxml.txt.nlp	25001079	SENT2	0	0	16	16	trastuzumab	HER2	PA451743	2064	0.978
NULL	Acta_Histochem_Cytochem_2006_Aug_30_39(4)_107-112.nxml.txt.nlp	17327897	SENT50	6	6	24	24	ethanol	RW1	PA448073	23505	0.978
NULL	Arthritis_Res_Ther_2014_Sep_26_16(5)_429.nxml.txt.nlp	25606593	SENT105	41	41	16	16	methotrexate	IL-6	PA450428	3569	0.978
NULL	Breast_Cancer_Res_Treat_2012_Jul_8_134(2)_603-615.nxml.txt.nlp	22678159	SENT290	6	6	35	35	phenytoin	HERG	PA450947	3757	0.978
NULL	Curr_HIV_Res_2014_May_12(3)_174-188.nxml.txt.nlp	24862327	SENT147	25	25	46	46	hemin	HO-1	PA449849	3162	0.978
NULL	Front_Oncol_2014_May_16_4_108.nxml.txt.nlp	24904824	SENT92	0	0	8	8	everolimus	JAK2	PA164746311	3717	0.978
NULL	Ann_Intensive_Care_2012_Dec_27_2_49.nxml.txt.nlp	23270646	SENT230	29	29	3	3	quetiapine	Yes	PA451201	7525	0.978
NULL	Front_Oncol_2014_Jun_11_4_145.nxml.txt.nlp	24967214	SENT370	16	16	4	4	cyclophosphamide	CD25	PA449165	3669;3559	0.978
NULL	J_Hematol_Oncol_2013_Jun_3_6_38.nxml.txt.nlp	23731980	SENT96	0	0	12	12	pertuzumab	HER2		2064	0.978
NULL	Appl_Clin_Genet_2010_Oct_29_3_85-101.nxml.txt.nlp	23776354	SENT35	38	38	13	13	sunitinib	PDGFRA	PA162372840	5156	0.978
NULL	Arthritis_Res_Ther_2009_Aug_17_11(4)_R123.nxml.txt.nlp	19686595	SENT243	9	9	17	17	rituximab	CD38	PA451261	952	0.978
NULL	Indian_J_Pharmacol_2012_Sep-Oct_44(5)_624-628.nxml.txt.nlp	23112426	SENT101	27	27	32	32	pravastatin	P-gp	PA451089	5243	0.978
NULL	Chin_J_Cancer_2012_Feb_31(2)_110-118.nxml.txt.nlp	22098951	SENT33	29	29	21	21	imatinib	MDR1	PA10804	5243	0.978
NULL	J_Hum_Reprod_Sci_2008_Jul-Dec_1(2)_86-89.nxml.txt.nlp	19562053	SENT12	28	28	4	4	estradiol	EFS	PA449503	10278	0.978
NULL	Br_J_Ophthalmol_2014_Dec_7_98(12)_1636-1641.nxml.txt.nlp	25001321	SENT47	1	1	21	21	ranibizumab	VEGF-A	PA164746012	7422	0.978
NULL	Am_J_Cardiovasc_Drugs_2013_Jun_20_13(5)_331-342.nxml.txt.nlp	23784266	SENT183	12	12	33	33	quinidine	P-gp	PA451209	5243	0.978
NULL	Nat_Med_2013_Mar_10_19(3)_313-321.nxml.txt.nlp	23396211	SENT152	31	31	7	7	amlexanox	TBK1	PA164745310	29110	0.978
NULL	Breast_Cancer_Res_2011_Mar_11_13(2)_R30.nxml.txt.nlp	21396117	SENT323	7	7	24	24	erlotinib	EGFR	PA134687924	1956	0.978
NULL	Aging_(Albany_NY)_2011_Jan_18_3(1)_33-43.nxml.txt.nlp	21248371	SENT123	20	20	2	2	zinc	p53	PA451956	7157	0.978
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT88	0	0	16	16	efavirenz	CYP2C9	PA449441	1559	0.978
NULL	Pediatr_Dermatol_2012_Nov_20_29(6)_725-731.nxml.txt.nlp	22515571	SENT122	0	0	20	20	thalidomide	gamma	PA451644	9913	0.978
NULL	Anesth_Essays_Res_2011_Jul-Dec_5(2)_182-186.nxml.txt.nlp	NULL	SENT24	23	23	28	28	palonosetron	CYP3A4	PA10352	1576	0.978
NULL	Acta_Pharmacol_Sin_2012_May_16_33(5)_682-690.nxml.txt.nlp	22504904	SENT115	21	21	6	6	celecoxib	STAT3	PA448871	6774	0.978
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT171	6	6	11	11	cisplatin	p53	PA449014	7157	0.978
NULL	Braz_J_Med_Biol_Res_2011_Nov_18_45(1)_86-92.nxml.txt.nlp	22086466	SENT141	2	2	10	10	thrombin	PAR-1	PA451674	2011;2149	0.978
NULL	Br_J_Cancer_2009_Jan_27_100(2)_315-321.nxml.txt.nlp	19127256	SENT17	0	0	18	18	everolimus	S6K1	PA164746311	6198	0.978
NULL	Cell_Death_Dis_2014_Mar_6_5(3)_e1108.nxml.txt.nlp	24603336	SENT233	12	12	3	3	cetuximab	CYP3A4	PA10040	1576	0.978
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT85	7	7	32	32	trastuzumab	EGF	PA451743	1950	0.978
NULL	FEBS_Open_Bio_2013_Dec_30_4_96-104.nxml.txt.nlp	24490130	SENT526	3	3	9	9	cisplatin	BRCA1	PA449014	672	0.978
NULL	Angew_Chem_Int_Ed_Engl_2013_Jan_2_52(1)_325-330.nxml.txt.nlp	23080482	SENT30	19	19	12	12	thrombin	PAR1	PA451674	79581;2149	0.978
NULL	Aging_(Albany_NY)_2012_Dec_6_4(11)_823-842.nxml.txt.nlp	23235539	SENT352	15	15	5	5	bleomycin	HCA2	PA448645	139081;55811;338442	0.978
NULL	Carcinogenesis_2014_May_13_35(5)_1055-1066.nxml.txt.nlp	24419232	SENT75	23	23	7	7	metformin	AMPK	PA450395	5563	0.978
NULL	Anal_Bioanal_Chem_2014_Jan_23_406(15)_3667-3680.nxml.txt.nlp	24452745	SENT189	4	4	25	25	ketoprofen	KET	PA450149	8626	0.978
NULL	Br_J_Cancer_2013_Jul_23_109(2)_351-359.nxml.txt.nlp	23799854	SENT77	35	35	2	2	paraformaldehyde	BLT2	PA450790	56413	0.978
NULL	Acta_Pharmacol_Sin_2012_Oct_17_33(10)_1301-1310.nxml.txt.nlp	22983390	SENT108	28	28	3	3	cisplatin	migfilin	PA449014	54751	0.978
NULL	Drug_Des_Devel_Ther_2014_Sep_1_8_1183-1194.nxml.txt.nlp	25210441	SENT217	26	26	39	39	tacrolimus	CYP3A5	PA451578	1577	0.978
NULL	J_Cell_Biol_2001_Nov_12_155(4)_661-674.nxml.txt.nlp	11706054	SENT231	30	30	13	13	lovastatin	ADAM10	PA450272	102	0.978
NULL	Breast_Cancer_Res_2008_Mar_29_10(2)_R28.nxml.txt.nlp	18373870	SENT129	23	23	34	34	estradiol	c-Myc	PA449503	4609	0.978
NULL	Int_J_Biol_Sci_2014_Jun_10_10(7)_654-663.nxml.txt.nlp	25013375	SENT214	0	0	32	32	nelfinavir	HIF-1	PA450606	29072	0.978
NULL	J_Hematol_Oncol_2012_Dec_13_5_75.nxml.txt.nlp	23237230	SENT118	5	5	15	15	rasburicase	G6PD	PA10176	2539	0.978
NULL	Front_Genet_2013_Dec_16_4_281.nxml.txt.nlp	24379827	SENT376	30	30	7	7	diltiazem	CACNA1F	PA449334	778	0.978
NULL	J_Hematol_Oncol_2013_Jun_3_6_38.nxml.txt.nlp	23731980	SENT172	12	12	4	4	afatinib	HER2	PA165981154	2064	0.978
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT229	7	7	21	21	erlotinib	EGFR	PA134687924	1956	0.978
NULL	Balkan_J_Med_Genet_2011_Jun_25_14(1)_25-30.nxml.txt.nlp	24052699	SENT16	16	16	4	4	doxorubicin	RLIP76	PA449412	10928	0.978
NULL	Clin_Ophthalmol_2012_May_30_6_837-844.nxml.txt.nlp	22701085	SENT76	2	2	13	13	ranibizumab	VEGF-A	PA164746012	7422	0.978
NULL	Exp_Cell_Res_2013_Apr_1_319(6)_800-809.nxml.txt.nlp	23247073	SENT205	14	14	22	22	curcumin	AKT	PA151958596	207	0.978
NULL	Eur_J_Cardiothorac_Surg_2011_Sep_40(3)_722-729.nxml.txt.nlp	21353585	SENT50	1	1	27	27	heparin	ACT	PA449855	12;11332;9457;641455	0.978
NULL	Mol_Cancer_2007_Oct_11_6_63.nxml.txt.nlp	17931419	SENT30	27	27	4	4	cetuximab	HIF-1	PA10040	29072	0.978
NULL	Clin_J_Gastroenterol_2013_Feb_29_6(1)_55-62.nxml.txt.nlp	23396631	SENT136	0	0	18	18	sorafenib	EGFR	PA7000	1956	0.978
NULL	Br_J_Cancer_1999_Mar_79(9-10)_1356-1365.nxml.txt.nlp	10188876	SENT8	24	24	38	38	vinblastine	KAR	PA451877	51144	0.978
NULL	J_Int_AIDS_Soc_2011_Sep_28_14_46.nxml.txt.nlp	21955541	SENT184	35	35	8	8	zidovudine	CD4	PA451954	920	0.978
NULL	Biomed_Res_Int_2013_Feb_12_2013_760236.nxml.txt.nlp	23509775	SENT70	17	17	4	4	hyaluronidase	perlecan	PA164745713	3339	0.978
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT161	19	19	7	7	tacrolimus	RANKL	PA451578	8600	0.978
NULL	Aging_(Albany_NY)_2009_Jun_3_1(6)_515-528.nxml.txt.nlp	20157535	SENT111	8	8	12	12	resveratrol	S6K1		6198	0.978
NULL	Int_J_Alzheimers_Dis_2012_Feb_1_2012_109324.nxml.txt.nlp	22506129	SENT115	38	38	25	25	simvastatin	ZO-1	PA451363	7082	0.978
NULL	Adv_Ther_2013_Nov_28_30(12)_1067-1085.nxml.txt.nlp	24287690	SENT59	11	11	23	23	metformin	GLP-1	PA450395	100125288	0.978
NULL	Cell_Death_Dis_2014_Feb_13_5(2)_e1055.nxml.txt.nlp	24525731	SENT60	22	22	6	6	cisplatin	EM9	PA449014	2068	0.978
NULL	Oncol_Rep_2013_Sep_5_30(3)_1053-1058.nxml.txt.nlp	23836376	SENT111	17	17	24	24	camptothecin	MDR1	PA153590860	5243	0.978
NULL	EMBO_J_2010_Sep_15_29(18)_3170-3183.nxml.txt.nlp	20676059	SENT248	8	8	31	31	fluoxetine	P15	PA449673	1030;29107	0.978
NULL	Curr_Chem_Genomics_2010_Mar_1_4_1-8.nxml.txt.nlp	20448812	SENT93	7	7	12	12	piperazine	OATP1B1	PA450977	10599	0.978
NULL	Eur_J_Med_Res_2011_Nov_10_16(11)_491-494.nxml.txt.nlp	22027642	SENT60	0	0	21	21	sunitinib	FLT3	PA162372840	2322	0.978
NULL	Nat_Chem_Biol_2013_May_24_9(5)_326-332.nxml.txt.nlp	23524984	SENT72	3	3	34	34	tamoxifen	AF1	PA451581	1946	0.978
NULL	Biologics_2011_Feb_14_5_21-31.nxml.txt.nlp	21383913	SENT181	38	38	5	5	tacrolimus	CLE	PA451578	51637	0.978
NULL	Br_J_Cancer_2011_Mar_1_104(5)_856-862.nxml.txt.nlp	21285991	SENT154	26	26	7	7	irinotecan	KRAS	PA450085	3845	0.978
NULL	Breast_Cancer_Res_2012_Jun_12_14(3)_R92.nxml.txt.nlp	22691413	SENT2	26	26	8	8	estradiol	HSD1	PA449503	26871	0.978
NULL	Oncogene_2014_Mar_20_33(12)_1495-1505.nxml.txt.nlp	23604115	SENT75	15	15	4	4	nilotinib	RAD51	PA165958345	5888	0.978
NULL	Tuberc_Respir_Dis_(Seoul)_2014_Jan_29_76(1)_8-14.nxml.txt.nlp	24523812	SENT139	0	0	18	18	afatinib	EGFR	PA165981154	1956	0.978
NULL	Gut_Liver_2014_Jul_23_8(4)_421-427.nxml.txt.nlp	25071908	SENT53	28	28	7	7	ribavirin	IL-28B	PA451241	282617	0.978
NULL	Ther_Clin_Risk_Manag_2005_Dec_1(4)_299-306.nxml.txt.nlp	18360572	SENT79	21	21	32	32	ritonavir	CYP3A4	PA451260	1576	0.978
NULL	Oncotarget_2012_Jul_22_3(7)_678-685.nxml.txt.nlp	22824673	SENT192	9	9	3	3	trypsin	rTS	PA451806	55556	0.978
NULL	Br_J_Pharmacol_2008_Oct_18_155(4)_596-605.nxml.txt.nlp	18852694	SENT154	12	12	7	7	fenofibrate	SCAP	PA449594	22937	0.978
NULL	Oncotarget_2013_Aug_24_4(10)_1618-1631.nxml.txt.nlp	24113128	SENT102	17	17	10	10	sorafenib	p53	PA7000	7157	0.978
NULL	J_Adv_Pract_Oncol_2014_Mar_1_Mar-Apr_5(2)_134-139.nxml.txt.nlp	25032047	SENT47	24	24	12	12	trastuzumab	HER2	PA451743	2064	0.978
NULL	Oncoimmunology_2013_Jan_1_2(1)_e22890.nxml.txt.nlp	23483066	SENT46	16	16	5	5	vemurafenib	IFN	PA165946873	3439	0.978
NULL	eLife_2013_Nov_12_2_e01213.nxml.txt.nlp	24220509	SENT84	16	16	42	42	probenecid	CO2	PA451106	4513	0.978
NULL	Genetics_2013_Jan_193(1)_1-50.nxml.txt.nlp	23275493	SENT410	20	20	3	3	lipase	ATGL	PA450239	57104	0.978
NULL	Mol_Cells_2014_Mar_31_37(3)_234-240.nxml.txt.nlp	24642709	SENT140	13	13	17	17	cisplatin	TLR4	PA449014	7099	0.978
NULL	Biosci_Rep_2013_Sep_17_33(5)_e00068.nxml.txt.nlp	23919527	SENT217	23	23	1	1	guanidine	CXCL8	PA164781028	3576	0.978
NULL	Anat_Cell_Biol_2010_Sep_30_43(3)_194-200.nxml.txt.nlp	21212859	SENT112	13	13	38	38	ethanol	PLP	PA448073	25824;5744	0.978
NULL	Hum_Genomics_2009_Jan_1_3(2)_128-142.nxml.txt.nlp	19164090	SENT174	39	39	7	7	carboplatin	CD44	PA448803	960	0.978
NULL	Cancers_(Basel)_2010_Mar_12_2(1)_153-164.nxml.txt.nlp	24281038	SENT339	17	17	5	5	tamoxifen	VEGFR2	PA451581	3791	0.978
NULL	Ann_Oncol_2014_Sep_13_25(9)_1813-1820.nxml.txt.nlp	24928832	SENT160	31	31	6	6	afatinib	HER2	PA165981154	2064	0.978
NULL	Oncologist_2010_May_28_15(5)_436-446.nxml.txt.nlp	20427383	SENT147	0	0	18	18	vatalanib	KIT	PA7001	3815	0.978
NULL	Springerplus_2014_Sep_9_3_510.nxml.txt.nlp	25279302	SENT34	3	3	19	19	creatine	GATM	PA164778930	2628	0.978
NULL	Drugs_R_D_2011_Jun_27_11(2)_113-126.nxml.txt.nlp	21679004	SENT3	0	0	27	27	axitinib	VEGFR	PA164924493	3791	0.978
NULL	Cancer_Med_2012_Aug_12_1(1)_68-75.nxml.txt.nlp	23342255	SENT121	7	7	27	27	sunitinib	EGFR	PA162372840	1956	0.978
NULL	Eur_J_Clin_Pharmacol_2012_Jan_7_68(1)_55-64.nxml.txt.nlp	21735164	SENT311	4	4	21	21	oxycodone	CYP2D6	PA450741	1565	0.978
NULL	Pharmaceutics_2011_Jul_13_3(3)_425-439.nxml.txt.nlp	24310588	SENT84	33	33	1	1	hydrocodone	SERS	PA449900	6301;54938	0.978
NULL	J_Gastroenterol_2013_Jan_27_48(1)_22-30.nxml.txt.nlp	23104468	SENT52	8	8	15	15	ribavirin	RVR	PA451241	9975	0.978
NULL	J_Cell_Biol_2008_Jun_2_181(5)_714a.nxml.txt.nlp	NULL	SENT21	19	19	0	0	nadh	SIRT1	PA164755085	23411	0.978
NULL	Diabetes_Metab_J_2012_Aug_20_36(4)_293-299.nxml.txt.nlp	22950061	SENT121	9	9	30	30	metformin	STAT3	PA450395	6774	0.978
NULL	Nat_Genet_2013_Sep_28_45(9)_1004-1012.nxml.txt.nlp	23892607	SENT74	40	40	0	0	doxycycline	PC2	PA449415	5126;5311;8535	0.978
NULL	Aging_(Albany_NY)_2011_Dec_12_3(11)_1063-1077.nxml.txt.nlp	22170748	SENT23	45	45	19	19	metformin	AMPK	PA450395	5563	0.978
NULL	Iran_J_Pharm_Res_2014_Autumn_13(4)_1393-1401.nxml.txt.nlp	25587329	SENT11	25	25	17	17	celecoxib	ABCG2	PA448871	9429	0.978
NULL	Dement_Geriatr_Cogn_Dis_Extra_2014_Nov_15_4(3)_450-456.nxml.txt.nlp	25538729	SENT93	16	16	4	4	donepezil	APOE	PA449394	348	0.978
NULL	Oncotarget_2014_Jun_8_5(13)_5040-5053.nxml.txt.nlp	24970815	SENT280	10	10	6	6	cisplatin	EGFR	PA449014	1956	0.978
NULL	Oncotarget_2011_Sep_9_2(9)_658-668.nxml.txt.nlp	21911919	SENT125	25	25	8	8	cytarabine	HO-1	PA449177	3162	0.978
NULL	Cardiovasc_Diabetol_2013_May_30_12(Suppl_1)_S2.nxml.txt.nlp	23819752	SENT129	12	12	18	18	fluvastatin	CYP2C9	PA449688	1559	0.978
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_33-43.nxml.txt.nlp	17912634	SENT131	12	12	22	22	tamoxifen	HER2	PA451581	2064	0.978
NULL	Mol_Cancer_2010_May_28_9_130.nxml.txt.nlp	20509890	SENT82	32	32	5	5	etoposide	PARP-1	PA449552	25976	0.978
NULL	Clinics_(Sao_Paulo)_2014_Oct_69(10)_706-708.nxml.txt.nlp	25518024	SENT79	0	0	8	8	trastuzumab	HER-2	PA451743	2064	0.978
NULL	Arthritis_Res_Ther_2005_Mar_16_7(Suppl_2)_S4-S14.nxml.txt.nlp	15833146	SENT225	5	5	16	16	cyclosporine	IL-2	PA449167	3558	0.978
NULL	Oncogene_2013_Sep_26_32(39)_10_1038_onc_2012_491.nxml.txt.nlp	23108394	SENT49	36	36	28	28	epirubicin	FOXM1	PA449476	2305	0.978
NULL	Allergy_Asthma_Clin_Immunol_2010_Jul_28_6(1)_21.nxml.txt.nlp	20667124	SENT84	24	24	16	16	icatibant	C1-INH	PA164749185	710	0.978
NULL	Exp_Brain_Res_2012_Apr_28_217(3-4)_389-395.nxml.txt.nlp	21952790	SENT44	1	1	36	36	heparin	APLP2	PA449855	334	0.978
NULL	Oncotarget_2014_Jun_6_5(12)_4516-4528.nxml.txt.nlp	24980831	SENT158	16	16	0	0	temozolomide	CCL2	PA451609	6347	0.978
NULL	J_Med_Phys_2006_Jan-Mar_31(1)_13-21.nxml.txt.nlp	21206635	SENT3	3	3	26	26	glucose	FDG	PA449773	23583	0.978
NULL	Patient_Prefer_Adherence_2013_Apr_26_7_369-377.nxml.txt.nlp	23641151	SENT192	0	0	14	14	ustekinumab	IL-23	PA166048654	51561	0.978
NULL	J_Hematol_Oncol_2008_Oct_23_1_19.nxml.txt.nlp	18947412	SENT185	38	38	3	3	alemtuzumab	CD34	PA164783958	947	0.978
NULL	J_Oncol_2010_Jun_10_2010_652320.nxml.txt.nlp	20628530	SENT188	15	15	6	6	sunitinib	VEGFR2	PA162372840	3791	0.978
NULL	Arthritis_Res_Ther_2013_Sep_27_15(5)_R138.nxml.txt.nlp	24289726	SENT303	38	38	9	9	etanercept	IL10	PA449515	3586	0.978
NULL	Hum_Genomics_2009_Jan_1_3(2)_128-142.nxml.txt.nlp	19164090	SENT10	14	14	2	2	carboplatin	CD44	PA448803	960	0.978
NULL	Breast_Cancer_Res_2008_Dec_18_10(Suppl_4)_S6.nxml.txt.nlp	19128444	SENT19	29	29	22	22	trastuzumab	aromatase	PA451743	1588	0.978
NULL	Breast_Cancer_Res_2011_Jun_21_13(3)_R66.nxml.txt.nlp	21693010	SENT245	28	28	0	0	sunitinib	VEGFR	PA162372840	3791	0.978
NULL	J_Cancer_2012_Oct_13_3_432-448.nxml.txt.nlp	23074383	SENT161	3	3	19	19	trastuzumab	PTEN	PA451743	5728	0.978
NULL	Arthritis_Res_Ther_2014_Jul_18_16(4)_R153.nxml.txt.nlp	25037855	SENT125	32	32	5	5	adalimumab	CD14	PA10004	929	0.978
NULL	Ann_Pediatr_Cardiol_2013_Jan-Jun_6(1)_59-64.nxml.txt.nlp	23626438	SENT22	0	0	12	12	ticlopidine	ADP	PA451686	23038	0.978
NULL	Cancer_Cell_Int_2010_Apr_29_10_12.nxml.txt.nlp	20429927	SENT202	24	24	9	9	arsenite	HDAC6	PA452638	10013	0.978
NULL	Case_Rep_Psychiatry_2012_Oct_9_2012_642752.nxml.txt.nlp	23094178	SENT66	17	17	34	34	agomelatine	CYP2C19	PA165958363	1557	0.978
NULL	Arch_Med_Sci_2011_Dec_31_7(6)_977-983.nxml.txt.nlp	22328880	SENT128	42	42	1	1	heparin	PAPP-A	PA449855	5069	0.978
NULL	Ann_Oncol_2012_Dec_2_23(12)_3007-3016.nxml.txt.nlp	22865781	SENT104	22	22	17	17	trastuzumab	PTEN	PA451743	5728	0.978
NULL	Breast_Cancer_Res_2010_Jun_24_12(3)_R41.nxml.txt.nlp	20576088	SENT11	27	27	18	18	paclitaxel	SP1	PA450761	6667	0.978
NULL	Diabetol_Metab_Syndr_2014_Mar_31_6_48.nxml.txt.nlp	24684803	SENT86	0	0	34	34	mitiglinide	STEP	PA164748124	84867	0.978
NULL	J_Indian_Soc_Periodontol_2014_Jan-Feb_18(1)_59-64.nxml.txt.nlp	24744546	SENT25	7	7	16	16	diclofenac	COX	PA449293	1351	0.978
NULL	Case_Rep_Oncol_2010_Jul_31_3(2)_282-286.nxml.txt.nlp	21347194	SENT38	1	1	34	34	cetuximab	KRAS	PA10040	3845	0.978
NULL	Oncogene_2011_Apr_21_30(16)_1855-1867.nxml.txt.nlp	21151168	SENT55	30	30	14	14	chloroquine	GABARAP	PA448948	11337	0.978
NULL	Clin_Ophthalmol_2014_Apr_28_8_807-812.nxml.txt.nlp	24812486	SENT29	43	43	13	13	bevacizumab	CRT	PA130232992	811	0.978
NULL	Mol_Cytogenet_2014_Jan_21_7(Suppl_1)_P100.nxml.txt.nlp	NULL	SENT18	38	38	28	28	metformin	SLC30A8	PA450395	169026	0.978
NULL	Endocrinol_Metab_(Seoul)_2014_Mar_14_29(1)_54-61.nxml.txt.nlp	24741455	SENT103	25	25	7	7	docetaxel	p65	PA449383	5970	0.978
NULL	Ann_Rheum_Dis_2012_Aug_71(8)_1289-1296.nxml.txt.nlp	22307942	SENT208	15	15	1	1	rituximab	ACR	PA451261	49	0.977
NULL	Acta_Pharmacol_Sin_2014_Jan_9_35(1)_1-10.nxml.txt.nlp	24317012	SENT23	26	26	7	7	paclitaxel	SLCO1B1	PA450761	10599	0.977
NULL	Int_J_Biol_Sci_2014_Apr_8_10(4)_457-465.nxml.txt.nlp	24719563	SENT58	25	25	11	11	genistein	Bcl-2	PA165109660	596	0.977
NULL	BMB_Rep_2013_Oct_46(10)_490-494.nxml.txt.nlp	24148769	SENT109	25	25	19	19	cisplatin	BAG5	PA449014	9529	0.977
NULL	Br_J_Cancer_2009_Oct_6_101(7)_1155-1161.nxml.txt.nlp	19738614	SENT104	19	19	4	4	gemcitabine	MUC4	PA449748	4585	0.977
NULL	J_Oncol_2013_Aug_20_2013_732047.nxml.txt.nlp	24027583	SENT190	13	13	6	6	lapatinib	HER2	PA152241907	2064	0.977
NULL	EMBO_Mol_Med_2012_Jun_13_4(6)_515-527.nxml.txt.nlp	22416035	SENT194	3	3	28	28	olaparib	p53		7157	0.977
NULL	Clinics_(Sao_Paulo)_2013_May_68(5)_694-701.nxml.txt.nlp	23778405	SENT177	15	15	3	3	curcumin	MDR1	PA151958596	5243	0.977
NULL	Br_J_Pharmacol_2013_Mar_25_168(6)_1445-1455.nxml.txt.nlp	23121507	SENT284	4	4	11	11	resveratrol	TRPC5		7224	0.977
NULL	Eur_J_Neurosci_2010_Jul_32(1)_29-40.nxml.txt.nlp	20608967	SENT223	27	27	15	15	cyclothiazide	NG2	PA449168	1464;6048	0.977
NULL	Cardiovasc_Diabetol_2013_Mar_23_12_48.nxml.txt.nlp	23522121	SENT71	25	25	6	6	exenatide	NNT	PA164749238	23530	0.977
NULL	Oncologist_2010_Sep_26_15(9)_944-953.nxml.txt.nlp	20798196	SENT41	24	24	13	13	capecitabine	EGFR	PA448771	1956	0.977
NULL	Cancer_Cell_Int_2013_Apr_4_13_32.nxml.txt.nlp	23556431	SENT121	8	8	23	23	vorinostat	survivin	PA164748224	332	0.977
NULL	Br_J_Cancer_2013_Jul_23_109(2)_351-359.nxml.txt.nlp	23799854	SENT170	7	7	3	3	paclitaxel	BLT2	PA450761	56413	0.977
NULL	J_Ophthalmol_2010_Jun_22_2010_170393.nxml.txt.nlp	20652047	SENT145	7	7	20	20	telmisartan	RAGE	PA451605	177	0.977
NULL	Infect_Dis_Obstet_Gynecol_2011_Oct_27_2011_353297.nxml.txt.nlp	22114461	SENT143	28	28	9	9	medroxyprogesterone	TLR-4	PA450344	7099	0.977
NULL	Neural_Regen_Res_2013_Jul_15_8(20)_1853-1862.nxml.txt.nlp	25206494	SENT61	14	14	7	7	ethanol	JNK	PA448073	5599	0.977
NULL	Indian_J_Endocrinol_Metab_2011_Jul-Sep_15(3)_175-181.nxml.txt.nlp	21897893	SENT151	0	0	5	5	denosumab	RANK	PA166048634	8792	0.977
NULL	Br_J_Cancer_2012_Apr_24_106(9)_1486-1494.nxml.txt.nlp	22472882	SENT120	11	11	17	17	rosiglitazone	MMP13	PA451283	4322	0.977
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_127043.nxml.txt.nlp	23227093	SENT202	45	45	2	2	nifedipine	RYR	PA450631	6261	0.977
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1986-2011.nxml.txt.nlp	25268165	SENT191	30	30	10	10	doxorubicin	STAT3	PA449412	6774	0.977
NULL	Indian_J_Pharmacol_2014_Jul-Aug_46(4)_372-377.nxml.txt.nlp	25097273	SENT46	0	0	8	8	chlordiazepoxide	gamma	PA448932	9913	0.977
NULL	Evid_Based_Complement_Alternat_Med_2012_Aug_27_2012_361516.nxml.txt.nlp	22969825	SENT109	11	11	5	5	verapamil	P-gp	PA451868	5243	0.977
NULL	J_Exp_Med_1977_Apr_1_145(4)_857-865.nxml.txt.nlp	870607	SENT6	3	3	20	20	collagenase	PTH	PA449107	5741	0.977
NULL	Oncoimmunology_2012_Dec_1_1(9)_1661-1663.nxml.txt.nlp	23264929	SENT14	27	27	8	8	imiquimod	TLR7	PA449972	51284	0.977
NULL	Br_J_Cancer_1986_Apr_53(4)_529-537.nxml.txt.nlp	3011054	SENT12	12	12	3	3	verapamil	ADM	PA451868	133	0.977
NULL	Oncogene_2009_Aug_27_28(34)_3022-3032.nxml.txt.nlp	19543317	SENT43	31	31	5	5	etoposide	BMI1	PA449552	648	0.977
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT157	24	24	10	10	trastuzumab	HER2	PA451743	2064	0.977
NULL	Diabetes_Care_2010_Jul_31_33(7)_1544-1548.nxml.txt.nlp	20357370	SENT94	13	13	5	5	metformin	STK11	PA450395	6794	0.977
NULL	J_Clin_Biochem_Nutr_2007_Jul_27_41(1)_32-42.nxml.txt.nlp	18392098	SENT187	22	22	4	4	curcumin	ROS	PA151958596	6098	0.977
NULL	EMBO_Mol_Med_2013_Aug_5_5(8)_1213-1226.nxml.txt.nlp	23918228	SENT13	0	0	13	13	cetuximab	EGFR	PA10040	1956	0.977
NULL	Exp_Diabetes_Res_2012_Oct_15_2012_465282.nxml.txt.nlp	23118742	SENT7	17	17	5	5	metformin	FGF21	PA450395	26291	0.977
NULL	Curr_Neuropharmacol_2013_Jul_11(4)_338-378.nxml.txt.nlp	24381528	SENT570	7	7	31	31	curcumin	p53	PA151958596	7157	0.977
NULL	Cell_Biol_Int_Rep_(2010)_2012_Jun_21_19(1)_e00017.nxml.txt.nlp	23124518	SENT137	27	27	5	5	etoposide	TRAIL-R2	PA449552	8795	0.977
NULL	Mol_Cancer_2014_Jun_24_13_157.nxml.txt.nlp	24958351	SENT189	13	13	22	22	lapatinib	HER2	PA152241907	2064	0.977
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT282	24	24	5	5	pertuzumab	HER2		2064	0.977
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Dec_17_3(12)_e152.nxml.txt.nlp	25518025	SENT57	0	0	7	7	oxycodone	CYP3A4	PA450741	1576	0.977
NULL	Cancer_Med_2013_Jun_25_2(3)_277-285.nxml.txt.nlp	23930204	SENT31	29	29	10	10	cetuximab	PTEN	PA10040	5728	0.977
NULL	Clin_Med_Insights_Cardiol_2010_Dec_1_4_117-128.nxml.txt.nlp	21151850	SENT53	40	40	16	16	clopidogrel	ADP	PA449053	23038	0.977
NULL	Eur_J_Neurosci_2011_Apr_33(8)_1471-1482.nxml.txt.nlp	21395866	SENT33	25	25	4	4	vigabatrin	SOC	PA10231	91544	0.977
NULL	Carcinogenesis_2012_Nov_8_33(11)_2007-2017.nxml.txt.nlp	22822097	SENT226	24	24	33	33	doxorubicin	p53	PA449412	7157	0.977
NULL	Biogerontology_2014_Nov_16_15(1)_47-64.nxml.txt.nlp	24243065	SENT366	0	0	10	10	doxorubicin	TRF2	PA449412	7014;9519	0.977
NULL	Front_Oncol_2014_Apr_9_4_75.nxml.txt.nlp	24782986	SENT200	28	28	19	19	paclitaxel	Oct4	PA450761	5460	0.977
NULL	Front_Oncol_2014_Apr_2_4_70.nxml.txt.nlp	24765614	SENT71	25	25	35	35	sorafenib	VEGFR	PA7000	3791	0.977
NULL	Eur_J_Clin_Pharmacol_2012_Sep_15_68(9)_1267-1274.nxml.txt.nlp	22418828	SENT9	28	28	2	2	pantoprazole	CYP2C19	PA450774	1557	0.977
NULL	Balkan_J_Med_Genet_2011_Jun_25_14(1)_25-30.nxml.txt.nlp	24052699	SENT81	12	12	23	23	lamotrigine	ABCC1	PA450164	4363	0.977
NULL	J_Clin_Biochem_Nutr_2009_Sep_28_45(2)_125-130.nxml.txt.nlp	19794918	SENT80	3	3	17	17	lansoprazole	HO-1	PA450180	3162	0.977
NULL	Adv_Hematol_2011_Apr_10_2011_960137.nxml.txt.nlp	21547266	SENT64	35	35	10	10	rituximab	NHL	PA451261	51750	0.977
NULL	J_Oncol_2010_Jun_10_2010_652320.nxml.txt.nlp	20628530	SENT92	2	2	15	15	sorafenib	VEGFR1	PA7000	2321	0.977
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT58	10	10	1	1	doxorubicin	SLK	PA449412	9748;2534	0.977
NULL	World_Allergy_Organ_J_2012_Feb_17_5(Suppl_2)_S137c-S138.nxml.txt.nlp	NULL	SENT9	6	6	24	24	indomethacin	CD63	PA449982	967	0.977
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT212	10	10	3	3	pp2	CD19		930	0.977
NULL	Reprod_Biol_Endocrinol_2013_Jun_19_11_53.nxml.txt.nlp	23782518	SENT180	20	20	4	4	doxorubicin	CD44	PA449412	960	0.977
NULL	Clin_Dev_Immunol_2011_Dec_5_2011_894704.nxml.txt.nlp	22190975	SENT230	0	0	7	7	rituximab	CHOP	PA451261	1649	0.977
NULL	Acta_Pharmacol_Sin_2012_Dec_22_33(12)_1511-1517.nxml.txt.nlp	23085741	SENT146	20	20	4	4	zileuton	CysLT1	PA451955	10800	0.977
NULL	J_Mol_Psychiatry_2013_Nov_4_1(1)_19.nxml.txt.nlp	25408910	SENT128	11	11	3	3	olanzapine	DRD5	PA450688	1816	0.977
NULL	Breast_Cancer_Res_2002_Apr_4_4(3)_85-89.nxml.txt.nlp	12052249	SENT38	0	0	29	29	tamoxifen	CYP3A4	PA451581	1576	0.977
NULL	Case_Rep_Oncol_2014_Jan_31_7(1)_97-101.nxml.txt.nlp	24575024	SENT35	2	2	24	24	erlotinib	EGFR	PA134687924	1956	0.977
NULL	Mol_Biol_Cell_2014_Jan_1_25(1)_76-86.nxml.txt.nlp	24173717	SENT285	5	5	18	18	colchicine	NLRP3	PA449092	114548	0.977
NULL	Oncogene_2014_Jun_5_33(23)_3033-3042.nxml.txt.nlp	23851504	SENT174	26	26	4	4	tamoxifen	HER2	PA451581	2064	0.977
NULL	Diabetes_2013_Sep_15_62(9)_3224-3231.nxml.txt.nlp	23545707	SENT159	18	18	8	8	losartan	ACR	PA450268	49	0.977
NULL	Cell_Death_Dis_2013_Oct_3_4(10)_e827.nxml.txt.nlp	24091670	SENT93	11	11	21	21	nilotinib	CD34	PA165958345	947	0.977
NULL	Iran_J_Ped_Hematol_Oncol_2014_Jul_20_4(3)_118-126.nxml.txt.nlp	25254091	SENT108	23	23	9	9	imatinib	ABCA2	PA10804	20	0.977
NULL	Breast_Cancer_Res_2014_May_30_16(3)_R55.nxml.txt.nlp	24886669	SENT39	41	41	12	12	doxorubicin	HER2	PA449412	2064	0.977
NULL	J_Cell_Biol_2008_Jul_28_182(2)_233-239.nxml.txt.nlp	18644891	SENT80	24	24	8	8	staurosporine	Dicer	PA165109623	23405	0.977
NULL	Drug_Saf_2014_Feb_19_37(4)_201-211.nxml.txt.nlp	24550106	SENT88	23	23	36	36	prasugrel	CYP2C19	PA154410481	1557	0.977
NULL	Breast_Cancer_Res_2004_Oct_28_6(1)_E1.nxml.txt.nlp	14680487	SENT34	4	4	15	15	tamoxifen	aromatase	PA451581	1588	0.977
NULL	AJP_Rep_2014_May_28_4(1)_13-16.nxml.txt.nlp	25032053	SENT71	10	10	48	48	trypsin	CLE	PA451806	51637	0.977
NULL	Curr_Med_Chem_2011_Jun_18(18)_2686-2714.nxml.txt.nlp	21649578	SENT286	19	19	4	4	erlotinib	EGFR	PA134687924	1956	0.977
NULL	Breast_Cancer_Res_2014_Jul_31_16(4)_413.nxml.txt.nlp	25074648	SENT91	18	18	9	9	anastrozole	aromatase	PA448432	1588	0.977
NULL	J_Cell_Mol_Med_2014_May_14_18(5)_811-823.nxml.txt.nlp	24628949	SENT247	20	20	14	14	paclitaxel	MCAK	PA450761	11004	0.977
NULL	ACS_Med_Chem_Lett_2014_May_14_5(7)_736-741.nxml.txt.nlp	25057340	SENT87	15	15	21	21	sulindac	AKT	PA451565	207	0.977
NULL	J_Korean_Med_Sci_2010_Jun_24_25(6)_829-834.nxml.txt.nlp	20514301	SENT67	11	11	1	1	papain	IL-25	PA450778	64806;56005	0.977
NULL	Front_Mol_Neurosci_2012_Nov_12_5_99.nxml.txt.nlp	23162427	SENT261	21	21	4	4	cocaine	HDAC5	PA449072	10014	0.977
NULL	Biochemistry_2013_May_14_52(19)_3194-3196.nxml.txt.nlp	23634976	SENT56	24	24	4	4	cyclosporine	P-gp	PA449167	5243	0.977
NULL	Biologics_2014_Apr_23_8_183-192.nxml.txt.nlp	24790411	SENT33	0	0	22	22	afatinib	EGFR	PA165981154	1956	0.977
NULL	Breast_Cancer_Res_2011_Jun_21_13(3)_R66.nxml.txt.nlp	21693010	SENT227	0	0	13	13	sunitinib	VEGFR2	PA162372840	3791	0.977
NULL	J_Med_Chem_2014_Jan_23_57(2)_449-461.nxml.txt.nlp	24387105	SENT147	0	0	6	6	benzaldehyde	ALDH1A1	PA448571	216	0.977
NULL	Exp_Mol_Med_2013_Aug_16_45(8)_e36.nxml.txt.nlp	23949442	SENT56	13	13	2	2	doxycycline	LRRK2	PA449415	120892	0.977
NULL	Gut_Liver_2011_Jun_24_5(2)_171-180.nxml.txt.nlp	21814597	SENT135	46	46	23	23	imatinib	PDGFRA	PA10804	5156	0.977
NULL	Nat_Commun_2013_Apr_23_4_1758.nxml.txt.nlp	23612299	SENT133	0	0	12	12	isoproterenol	SOD1	PA450121	6647	0.977
NULL	J_Med_Case_Rep_2013_Jun_20_7_161.nxml.txt.nlp	23786681	SENT88	11	11	3	3	epirubicin	pT1	PA449476	58492	0.977
NULL	Acta_Naturae_2011_Jul-Sep_3(3)_12-28.nxml.txt.nlp	22649690	SENT206	28	28	16	16	raltegravir	CD4		920	0.977
NULL	Arch_Toxicol_2014_Nov_5_88(12)_2135-2190.nxml.txt.nlp	25370008	SENT788	14	14	6	6	sulfamethoxazole	FMO3	PA451544	2328	0.977
NULL	Int_J_Vasc_Med_2013_Jun_26_2013_456852.nxml.txt.nlp	23878738	SENT28	9	9	11	11	losartan	AT1	PA450268	9197;185	0.977
NULL	Nat_Med_2014_Apr_16_20(4)_385-397.nxml.txt.nlp	24633305	SENT56	8	8	2	2	triciribine	AKT	PA165958661	207	0.977
NULL	ScientificWorldJournal_2012_Apr_1_2012_381434.nxml.txt.nlp	22545017	SENT323	11	11	1	1	aprepitant	NK-1	PA164747039	27087	0.977
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT3318	3	3	25	25	acetaminophen	CYP2E1	PA448015	1571	0.977
NULL	J_Cachexia_Sarcopenia_Muscle_2011_Dec_8_2(4)_209-261.nxml.txt.nlp	22476871	SENT2518	0	0	17	17	tocilizumab	IL-6	PA165292659	3569	0.977
NULL	Pharmaceuticals_(Basel)_2013_Apr_17_6(4)_557-578.nxml.txt.nlp	24276125	SENT95	0	0	16	16	efalizumab	LFA-1	PA164748817	3683;3689	0.977
NULL	Nucleic_Acids_Res_2013_Dec_17_41(22)_10228-10240.nxml.txt.nlp	24049078	SENT19	20	20	29	29	fulvestrant	aromatase	PA164747170	1588	0.977
NULL	Protein_J_2012_Aug_5_31(6)_511-518.nxml.txt.nlp	22763563	SENT134	29	29	3	3	atorvastatin	CD36	PA448500	948	0.977
NULL	Oncogene_2010_Jun_3_29(22)_3208-3216.nxml.txt.nlp	20383201	SENT231	8	8	20	20	dasatinib	EGF	PA162372878	1950	0.977
NULL	Oncotarget_2013_Nov_26_4(12)_2502-2511.nxml.txt.nlp	24318446	SENT99	13	13	25	25	doxycycline	GAPDH	PA449415	2597	0.977
NULL	Orphanet_J_Rare_Dis_2011_Jul_29_6_52.nxml.txt.nlp	21801394	SENT162	19	19	34	34	allopurinol	HLA-B	PA448320	3106	0.977
NULL	Br_J_Clin_Pharmacol_2014_Nov_20_78(5)_1043-1049.nxml.txt.nlp	24838177	SENT38	0	0	5	5	telaprevir	CYP3A4	PA165958354	1576	0.977
NULL	Breast_Cancer_(Auckl)_2011_Jan_13_5_1-14.nxml.txt.nlp	21494397	SENT48	15	15	5	5	itraconazole	CYP3A4	PA450132	1576	0.977
NULL	Ther_Clin_Risk_Manag_2006_Jun_2(2)_213-218.nxml.txt.nlp	18360595	SENT17	10	10	19	19	capsaicin	TRPV1	PA448776	7442	0.977
NULL	Arthritis_Res_Ther_2013_May_29_15(3)_R64.nxml.txt.nlp	23718630	SENT9	14	14	9	9	anakinra	NLRP3	PA10799	114548	0.977
NULL	Acta_Pharmacol_Sin_2012_Dec_29_33(12)_1518-1524.nxml.txt.nlp	23103625	SENT144	7	7	18	18	telmisartan	ACE2	PA451605	59272	0.977
NULL	J_Med_Life_2011_Feb_15_4(1)_11-20.nxml.txt.nlp	21505570	SENT190	9	9	38	38	ketoprofen	CB1	PA450149	1268	0.977
NULL	Cancers_(Basel)_2010_Nov_5_2(4)_1838-1860.nxml.txt.nlp	24281204	SENT161	30	30	21	21	etoposide	c-Rel	PA449552	5966	0.977
NULL	J_Hematol_Oncol_2013_Jun_3_6_38.nxml.txt.nlp	23731980	SENT175	0	0	19	19	neratinib	HER2	PA165291472	2064	0.977
NULL	Chin_J_Cancer_2011_Sep_30(9)_645-654.nxml.txt.nlp	21880186	SENT199	43	43	19	19	cisplatin	NACT	PA449014	284111	0.977
NULL	Emerg_Infect_Dis_2014_Mar_20(3)_506-507.nxml.txt.nlp	24565423	SENT21	17	17	5	5	amikacin	DST	PA164744372	667	0.977
NULL	Biomed_Res_Int_2013_Sep_2_2013_968518.nxml.txt.nlp	24078931	SENT47	1	1	16	16	oxytetracycline	OTC	PA450757	5009	0.977
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1033-1038.nxml.txt.nlp	22374460	SENT66	33	33	25	25	capecitabine	HER2	PA448771	2064	0.977
NULL	Acta_Neuropathol_Commun_2014_Mar_7_2_27.nxml.txt.nlp	24606807	SENT308	17	17	7	7	natalizumab	CD4	PA164747191	920	0.977
NULL	J_Gen_Physiol_2009_Apr_133(4)_421-438.nxml.txt.nlp	19289574	SENT297	16	16	7	7	forskolin	SLC26A9	PA146096022	115019	0.977
NULL	Ann_Rheum_Dis_2010_Sep_1_69(9)_1629-1635.nxml.txt.nlp	20488885	SENT119	2	2	10	10	rituximab	CD19	PA451261	930	0.977
NULL	Clin_Med_Insights_Cardiol_2012_Feb_1_6_17-33.nxml.txt.nlp	22442638	SENT185	4	4	16	16	rosuvastatin	CYP2C9	PA134308647	1559	0.977
NULL	Arthritis_Res_Ther_2010_Sep_20_12(5)_R176.nxml.txt.nlp	20854662	SENT155	32	32	8	8	etanercept	IL-6	PA449515	3569	0.977
NULL	Antimicrob_Agents_Chemother_2013_Oct_57(10)_5096-5103.nxml.txt.nlp	23917320	SENT186	0	0	31	31	artemether	UGT	PA165111698	7361;7355	0.977
NULL	Diabetes_Care_2009_Jan_32(1)_84-90.nxml.txt.nlp	18931095	SENT30	0	0	12	12	liraglutide	GLP-1	PA165958364	100125288	0.977
NULL	Br_J_Cancer_2012_Jun_26_107(1)_108-115.nxml.txt.nlp	22627319	SENT133	39	39	18	18	doxorubicin	TOP2A	PA449412	7153	0.977
NULL	Hum_Genomics_2008_Sep_1_3(1)_53-70.nxml.txt.nlp	19129090	SENT119	37	37	4	4	perifosine	U95	PA165291471	619570	0.977
NULL	Exp_Ther_Med_2014_Nov_29_8(5)_1473-1478.nxml.txt.nlp	25289044	SENT134	3	3	12	12	heparin	AZU	PA449855	566	0.977
NULL	Bioinformation_2013_Nov_11_9(18)_929-936.nxml.txt.nlp	24307772	SENT32	23	23	0	0	s-adenosylmethionine	MTHFR	PA164754994	4524	0.977
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2014_Nov_22_70(Pt_12)_3177-3186.nxml.txt.nlp	25478836	SENT24	17	17	0	0	l-serine	SHMT	PA451330	6470	0.977
NULL	Cell_Death_Dis_2014_Feb_13_5(2)_e1055.nxml.txt.nlp	24525731	SENT114	11	11	35	35	cisplatin	TXNL1	PA449014	9352	0.977
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_33-43.nxml.txt.nlp	17912634	SENT168	8	8	1	1	letrozole	aromatase	PA450196	1588	0.977
NULL	Arthritis_Res_Ther_2012_Apr_16_14(2)_R76.nxml.txt.nlp	22507741	SENT173	2	2	25	25	estradiol	IL-10	PA449503	3586	0.977
NULL	F1000_Med_Rep_2012_Feb_1_4_4.nxml.txt.nlp	22312414	SENT52	16	16	3	3	vancomycin	VISA	PA451850	57506	0.977
NULL	Neural_Plast_2007_Apr_15_2007_78970.nxml.txt.nlp	18060012	SENT348	17	17	2	2	metyrapone	spatial	PA450486	219793	0.977
NULL	Br_J_Cancer_2010_May_11_102(10)_1456-1460.nxml.txt.nlp	20461090	SENT91	5	5	16	16	temsirolimus	IFN	PA164746890	3439	0.977
NULL	Oncogene_2010_Jul_15_29(28)_4090-4100.nxml.txt.nlp	20473326	SENT92	22	22	6	6	doxorubicin	p53	PA449412	7157	0.977
NULL	Ann_Thorac_Med_2013_Oct-Dec_8(4)_204-208.nxml.txt.nlp	24250733	SENT26	2	2	22	22	erlotinib	EGFR	PA134687924	1956	0.977
NULL	Aging_(Albany_NY)_2010_Nov_11_2(11)_760-774.nxml.txt.nlp	21084729	SENT70	14	14	6	6	metformin	LKB1	PA450395	6794	0.977
NULL	Protein_Cell_2014_Sep_11_5(9)_673-691.nxml.txt.nlp	24916440	SENT373	3	3	32	32	imatinib	HER2	PA10804	2064	0.977
NULL	J_Oncol_2012_Jun_19_2012_521215.nxml.txt.nlp	22778735	SENT198	2	2	8	8	erlotinib	EGFR	PA134687924	1956	0.977
NULL	Oncol_Lett_2013_Feb_27_5(2)_435-439.nxml.txt.nlp	23420613	SENT24	4	4	8	8	gefitinib	EGFR	PA131301952	1956	0.977
NULL	Oncotarget_2011_Dec_22_2(12)_1176-1190.nxml.txt.nlp	22202492	SENT119	2	2	16	16	simvastatin	PLA2G7	PA451363	7941	0.977
NULL	Braz_J_Med_Biol_Res_2014_Mar_21_47(4)_273-278.nxml.txt.nlp	24676475	SENT26	29	29	6	6	cyclosporine	P-gp	PA449167	5243	0.977
NULL	Evid_Based_Complement_Alternat_Med_2012_Dec_29_2012_138954.nxml.txt.nlp	23346188	SENT192	20	20	2	2	indomethacin	IL-6	PA449982	3569	0.977
NULL	Cancer_Cell_Int_2014_Jan_23_14_6.nxml.txt.nlp	24456610	SENT31	7	7	1	1	gefitinib	EGFR	PA131301952	1956	0.977
NULL	Oncotarget_2013_Dec_18_5(1)_78-94.nxml.txt.nlp	24393789	SENT66	27	27	16	16	gemcitabine	SMAD4	PA449748	4089	0.977
NULL	Mol_Biol_Int_2012_Jul_10_2012_401965.nxml.txt.nlp	22848825	SENT138	0	0	30	30	delavirdine	CYP3A4	PA449223	1576	0.977
NULL	Oncogene_2010_Sep_16_29(37)_5193-5203.nxml.txt.nlp	20581867	SENT171	26	26	24	24	trastuzumab	HER2	PA451743	2064	0.977
NULL	Breast_Cancer_Res_Treat_2012_Jul_5_134(2)_693-700.nxml.txt.nlp	22562123	SENT20	16	16	1	1	tamoxifen	aromatase	PA451581	1588	0.977
NULL	Acta_Pharmacol_Sin_2012_May_16_33(5)_682-690.nxml.txt.nlp	22504904	SENT13	4	4	25	25	celecoxib	STAT3	PA448871	6774	0.977
NULL	Onco_Targets_Ther_2014_Mar_6_7_387-393.nxml.txt.nlp	24623981	SENT55	13	13	5	5	erlotinib	EGFR	PA134687924	1956	0.977
NULL	Facts_Views_Vis_Obgyn_2011_3(3)_189-202.nxml.txt.nlp	24753865	SENT133	3	3	26	26	imatinib	KIT	PA10804	3815	0.977
NULL	Breast_Cancer_Res_2009_Nov_17_11(6)_R84.nxml.txt.nlp	19919679	SENT119	10	10	2	2	trastuzumab	HER2	PA451743	2064	0.977
NULL	Br_J_Pharmacol_2014_Feb_24_171(1)_1019-1032.nxml.txt.nlp	24251620	SENT48	6	6	13	13	nifedipine	TRPM3	PA450631	80036	0.977
NULL	BMB_Rep_2014_Oct_47(10)_575-580.nxml.txt.nlp	24499675	SENT102	0	0	17	17	arsenite	SSB	PA452638	6741	0.977
NULL	Cancer_Res_Treat_2011_Sep_30_43(3)_181-188.nxml.txt.nlp	22022296	SENT113	7	7	5	5	sulindac	COX	PA451565	1351	0.977
NULL	Pharmaceuticals_(Basel)_2013_Aug_6_6(8)_929-959.nxml.txt.nlp	24276377	SENT109	13	13	0	0	paclitaxel	CXCL8	PA450761	3576	0.977
NULL	J_Indian_Soc_Periodontol_2014_May-Jun_18(3)_282-288.nxml.txt.nlp	25024538	SENT87	26	26	9	9	denosumab	RANKL	PA166048634	8600	0.977
NULL	Breast_Cancer_Res_2012_Dec_5_14(6)_R153.nxml.txt.nlp	23216744	SENT105	39	39	6	6	auranofin	SNO	PA448510	6498	0.977
NULL	ScientificWorldJournal_2012_Apr_1_2012_381434.nxml.txt.nlp	22545017	SENT315	19	19	16	16	aprepitant	NK-1	PA164747039	27087	0.977
NULL	Gut_Pathog_2011_Sep_25_3_14.nxml.txt.nlp	21943280	SENT150	5	5	13	13	tetracycline	IL-4	PA451640	3565	0.977
NULL	J_Gen_Physiol_2009_Apr_133(4)_421-438.nxml.txt.nlp	19289574	SENT293	13	13	7	7	forskolin	SLC26A9	PA146096022	115019	0.977
NULL	Chromatographia_2011_Jan_9_73(1-2)_123-128.nxml.txt.nlp	21423319	SENT32	26	26	3	3	formaldehyde	CAS	PA449703	1434;9564	0.977
NULL	J_Invest_Dermatol_2013_Jul_13_133(7)_1742-1751.nxml.txt.nlp	23407402	SENT122	30	30	9	9	etanercept	IL-8	PA449515	3576	0.977
NULL	Br_J_Cancer_2014_Oct_14_111(8)_1552-1561.nxml.txt.nlp	25117814	SENT149	20	20	9	9	doxorubicin	XIAP	PA449412	331	0.977
NULL	Br_J_Clin_Pharmacol_2013_Apr_10_75(4)_979-989.nxml.txt.nlp	22882281	SENT31	0	0	12	12	exenatide	GLP-1	PA164749238	100125288	0.977
NULL	Br_J_Cancer_2010_Feb_2_102(3)_513-519.nxml.txt.nlp	20051960	SENT23	2	2	16	16	trastuzumab	MUC4	PA451743	4585	0.977
NULL	F1000_Biol_Rep_2011_Nov_1_3_23.nxml.txt.nlp	22065982	SENT140	6	6	37	37	probenecid	URAT1	PA451106	116085	0.977
NULL	Breast_Cancer_Res_2007_Jan_23_9(1)_R7.nxml.txt.nlp	17244352	SENT15	6	6	48	48	tamoxifen	UGT2B15	PA451581	7366	0.977
NULL	J_Hematol_Oncol_2012_May_15_5_23.nxml.txt.nlp	22587422	SENT23	0	0	9	9	dasatinib	SRC	PA162372878	6714	0.977
NULL	Br_J_Cancer_2009_Jul_21_101(2)_269-277.nxml.txt.nlp	19603033	SENT11	5	5	15	15	cisplatin	XIAP	PA449014	331	0.977
NULL	Exp_Ther_Med_2013_Nov_2_6(5)_1251-1258.nxml.txt.nlp	24223654	SENT50	6	6	41	41	pentobarbital	MCH	PA450859	5367	0.977
NULL	Surg_Neurol_Int_2014_Jul_5_5_104.nxml.txt.nlp	25101199	SENT59	10	10	2	2	heparin	ACT	PA449855	12;11332;9457;641455	0.977
NULL	J_Cell_Physiol_2011_Nov_15_226(11)_2979-2986.nxml.txt.nlp	21328349	SENT9	17	17	15	15	econazole	TRPV5	PA164746010	56302	0.977
NULL	Oncotarget_2013_Aug_25_4(10)_1647-1661.nxml.txt.nlp	24072592	SENT23	32	32	28	28	cisplatin	S6K1	PA449014	6198	0.977
NULL	Int_J_Vasc_Med_2012_Dec_6_2012_293641.nxml.txt.nlp	22187650	SENT313	22	22	4	4	simvastatin	CCM2	PA451363	83605	0.977
NULL	Breast_Cancer_Res_2009_Mar_17_11(2)_203.nxml.txt.nlp	19344488	SENT105	4	4	25	25	epirubicin	AGO	PA449476	55294	0.977
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S31-S40.nxml.txt.nlp	20680106	SENT61	10	10	14	14	panitumumab	BRAF	PA162373091	673	0.977
NULL	Curr_Neuropharmacol_2014_Jul_12(4)_365-379.nxml.txt.nlp	25342944	SENT168	33	33	3	3	fluoxetine	GluK2	PA449673	2898	0.977
NULL	J_Cell_Mol_Med_2014_Dec_6_18(12)_2331-2339.nxml.txt.nlp	25284457	SENT132	10	10	23	23	curcumin	TLR4	PA151958596	7099	0.977
NULL	Eur_J_Clin_Pharmacol_2011_May_8_67(5)_493-506.nxml.txt.nlp	21140139	SENT225	3	3	33	33	oxycodone	CYP2D6	PA450741	1565	0.977
NULL	Case_Rep_Oncol_2012_Dec_6_5(3)_644-650.nxml.txt.nlp	23275780	SENT76	9	9	29	29	gefitinib	EGFR	PA131301952	1956	0.977
NULL	Clinicoecon_Outcomes_Res_2014_Dec_15_7_9-15.nxml.txt.nlp	25548525	SENT92	6	6	0	0	gefitinib	EGFR	PA131301952	1956	0.977
NULL	Diabetes_Care_2009_Apr_32(4)_531-540.nxml.txt.nlp	19336638	SENT151	0	0	11	11	clopidogrel	ADP	PA449053	23038	0.977
NULL	Nucleic_Acids_Res_2010_Oct_22_38(19)_6502-6512.nxml.txt.nlp	20571088	SENT100	9	9	20	20	galactose	SMC6	PA449725	79677	0.977
NULL	Emerg_Infect_Dis_2011_Oct_17(10)_1917-1920.nxml.txt.nlp	22000371	SENT76	9	9	29	29	bacitracin	OTC	PA448531	5009	0.977
NULL	Oncotarget_2014_Sep_2_5(19)_9308-9321.nxml.txt.nlp	25301721	SENT243	41	41	12	12	mk-571	CD34		947	0.977
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1063.nxml.txt.nlp	24556678	SENT70	7	7	24	24	thioridazine	c-FLIP	PA451666	8837	0.977
NULL	Ital_J_Pediatr_2012_Mar_30_38_11.nxml.txt.nlp	22464080	SENT35	10	10	38	38	oxatomide	CYP2D6	PA163522137	1565	0.977
NULL	Cell_Commun_Signal_2009_Feb_26_7(Suppl_1)_A63.nxml.txt.nlp	NULL	SENT20	9	9	4	4	pp2	GRHL3		57822	0.977
NULL	J_Oncol_2010_Feb_22_2010_891059.nxml.txt.nlp	20182637	SENT65	15	15	5	5	cisplatin	PARP-1	PA449014	25976	0.977
NULL	BMB_Rep_2013_Aug_46(8)_410-415.nxml.txt.nlp	23977989	SENT39	30	30	4	4	curcumin	HO-1	PA151958596	3162	0.977
NULL	Clin_Ophthalmol_2010_Apr_26_4_307-314.nxml.txt.nlp	20463798	SENT78	44	44	31	31	bevacizumab	HER2	PA130232992	2064	0.977
NULL	Front_Endocrinol_(Lausanne)_2013_Jul_29_4_94.nxml.txt.nlp	23908645	SENT176	0	0	8	8	estradiol	UGT2B17	PA449503	7367	0.977
NULL	Cancer_Cell_Int_2011_Nov_17_11_40.nxml.txt.nlp	22088142	SENT194	0	0	21	21	gefitinib	EGFR	PA131301952	1956	0.977
NULL	J_Cancer_Prev_2014_Mar_19(1)_39-46.nxml.txt.nlp	25337571	SENT110	35	35	8	8	ethanol	JNK	PA448073	5599	0.977
NULL	Mol_Clin_Oncol_2013_Sep_23_1(5)_887-893.nxml.txt.nlp	24649266	SENT119	13	13	4	4	paclitaxel	TUBB3	PA450761	10381	0.977
NULL	Cardiol_Res_Pract_2013_Feb_21_2013_127270.nxml.txt.nlp	23509665	SENT175	11	11	21	21	ticagrelor	ADP	PA165374673	23038	0.977
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_127043.nxml.txt.nlp	23227093	SENT169	0	0	4	4	lovastatin	CYP3A4	PA450272	1576	0.977
NULL	Bioinformation_2012_Jan_6_8(1)_13-19.nxml.txt.nlp	22359429	SENT140	10	10	19	19	curcumin	MRP1	PA151958596	4437	0.977
NULL	J_Immunol_Res_2014_Mar_24_2014_320674.nxml.txt.nlp	24741588	SENT223	6	6	0	0	thrombin	FVIII	PA451674	2157	0.977
NULL	Evid_Based_Complement_Alternat_Med_2014_May_8_2014_494528.nxml.txt.nlp	24949077	SENT16	6	6	23	23	cyclophosphamide	CD25	PA449165	3669;3559	0.977
NULL	Front_Endocrinol_(Lausanne)_2011_Dec_21_2_84.nxml.txt.nlp	22654830	SENT40	7	7	28	28	rosiglitazone	MGL	PA451283	11343	0.977
NULL	Biomed_Res_Int_2013_Jun_9_2013_654354.nxml.txt.nlp	23841084	SENT34	16	16	14	14	gefitinib	EGFR	PA131301952	1956	0.977
NULL	Cancer_Immunol_Immunother_2013_May_16_62(5)_897-908.nxml.txt.nlp	23589107	SENT257	15	15	3	3	cyclophosphamide	CD25	PA449165	3669;3559	0.977
NULL	Br_J_Cancer_2013_Dec_10_109(12)_2998-3004.nxml.txt.nlp	24169357	SENT52	0	0	15	15	bevacizumab	IFN	PA130232992	3439	0.977
NULL	Biomed_Res_Int_2013_Jul_31_2013_692071.nxml.txt.nlp	23984399	SENT126	13	13	1	1	prazosin	OCT1	PA451093	5451;6580	0.977
NULL	Drugs_R_D_2014_Sep_25_14(3)_165-176.nxml.txt.nlp	24962635	SENT241	18	18	4	4	glimepiride	CYP2C9	PA449761	1559	0.977
NULL	EMBO_Mol_Med_2012_Dec_15_4(12)_1276-1293.nxml.txt.nlp	23065753	SENT183	15	15	0	0	cisplatin	HK-1	PA449014	255061	0.977
NULL	Core_Evid_2008_Jun_3(1)_45-54.nxml.txt.nlp	20694083	SENT198	20	20	15	15	tegaserod	5-HT4	PA130413154	3360	0.977
NULL	Cancers_(Basel)_2011_May_3_3(2)_2255-2273.nxml.txt.nlp	24212808	SENT77	0	0	20	20	cetuximab	EGFR	PA10040	1956	0.977
NULL	Ann_Rheum_Dis_2014_Jan_31_73(1)_69-74.nxml.txt.nlp	23904473	SENT28	0	0	10	10	tocilizumab	IL-6	PA165292659	3569	0.977
NULL	Oncol_Lett_2013_Mar_8_5(3)_805-812.nxml.txt.nlp	23426281	SENT245	16	16	0	0	gemcitabine	B7-H3	PA449748	80381	0.977
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1420-1426.nxml.txt.nlp	24056704	SENT35	0	0	6	6	ketoconazole	CYP3A4	PA450146	1576	0.977
NULL	Protein_Expr_Purif_2009_Aug_66(2)_181-184.nxml.txt.nlp	19269329	SENT50	9	9	22	22	thrombin	AMPK	PA451674	5563	0.977
NULL	Mol_Vis_2012_Nov_29_18_2839-2846.nxml.txt.nlp	23233786	SENT151	30	30	11	11	sr144528	CB2		1269	0.977
NULL	Iran_J_Public_Health_2013_Jul_1_42(7)_681-690.nxml.txt.nlp	24427747	SENT145	10	10	14	14	sitagliptin	DPP4	PA164748978	1803	0.977
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_127043.nxml.txt.nlp	23227093	SENT195	26	26	15	15	gemfibrozil	RYR	PA449750	6261	0.977
NULL	Diabetes_Care_2012_Feb_16_35(2)_327-333.nxml.txt.nlp	22179958	SENT18	3	3	13	13	metformin	B12	PA450395	7126;4709	0.977
NULL	Br_J_Haematol_2014_Jan_28_164(2)_233-244.nxml.txt.nlp	24206017	SENT245	9	9	33	33	lenalidomide	CRBN	PA162363968	51185	0.977
NULL	Ann_Oncol_2012_Dec_2_23(12)_3007-3016.nxml.txt.nlp	22865781	SENT71	31	31	11	11	trastuzumab	DM1	PA451743	338023;1760;28509	0.977
NULL	Curr_Oncol_2009_May_16(Suppl_1)_S27-S32.nxml.txt.nlp	19478894	SENT49	4	4	40	40	sorafenib	C-Kit	PA7000	3815	0.977
NULL	Mol_Clin_Oncol_2013_Sep_24_1(5)_918-924.nxml.txt.nlp	24649271	SENT93	18	18	4	4	gemcitabine	EGFR	PA449748	1956	0.977
NULL	Cardiovasc_Ther_2009_Summer_27(2)_77-82.nxml.txt.nlp	19426243	SENT101	10	10	27	27	heparin	ACT	PA449855	12;11332;9457;641455	0.977
NULL	Breast_Cancer_Res_2008_Aug_13_10(4)_R70.nxml.txt.nlp	18700973	SENT238	20	20	8	8	trastuzumab	PTEN	PA451743	5728	0.977
NULL	Mol_Biol_Cell_2012_Sep_1_23(17)_3473-3484.nxml.txt.nlp	22787275	SENT72	0	0	16	16	doxorubicin	ABCC6	PA449412	368	0.977
NULL	Mol_Cancer_2013_Sep_11_12_104.nxml.txt.nlp	24025152	SENT130	17	17	4	4	gemcitabine	STAT3	PA449748	6774	0.977
NULL	Adv_Urol_2012_Oct_26_2012_812398.nxml.txt.nlp	22110495	SENT48	5	5	9	9	cisplatin	ERCC1	PA449014	2067	0.977
NULL	Arthritis_Res_Ther_2012_Nov_29_14(6)_R260.nxml.txt.nlp	23193984	SENT215	38	38	11	11	tocilizumab	IL-6	PA165292659	3569	0.977
NULL	Cell_Host_Microbe_2014_Sep_10_16(3)_291-303.nxml.txt.nlp	25211072	SENT81	37	37	5	5	genistein	tetherin	PA165109660	684	0.977
NULL	Int_J_Mol_Sci_2012_Sep_26_13(10)_12336-12348.nxml.txt.nlp	23202901	SENT92	3	3	29	29	phenol	P90	PA450913	821	0.977
NULL	Eur_Arch_Psychiatry_Clin_Neurosci_2012_Oct_28_262(7)_549-556.nxml.txt.nlp	22454242	SENT17	22	22	0	0	methamphetamine	DAOA	PA450403	267012	0.977
NULL	Breast_Cancer_Res_2010_Jul_20_12(4)_R52.nxml.txt.nlp	20646288	SENT127	14	14	28	28	letrozole	HTRA1	PA450196	5654	0.977
NULL	Blood_Cancer_J_2014_Apr_25_4(4)_e206.nxml.txt.nlp	24769647	SENT195	26	26	4	4	rituximab	YB-1	PA451261	4904	0.977
NULL	Int_J_Vasc_Med_2013_Mar_31_2013_543141.nxml.txt.nlp	23606968	SENT153	32	32	7	7	etanercept	IL-6	PA449515	3569	0.977
NULL	Curr_Pharm_Des_2011_Feb_17(6)_578-590.nxml.txt.nlp	21391908	SENT176	3	3	19	19	nutlin-3	p53		7157	0.977
NULL	J_Cell_Mol_Med_2013_Sep_24_17(9)_1065-1087.nxml.txt.nlp	24151975	SENT241	0	0	19	19	palifermin	CD4	PA164744014	920	0.977
NULL	J_Cell_Biol_1999_Feb_22_144(4)_789-801.nxml.txt.nlp	10037799	SENT83	27	27	6	6	heparin	LYVE-1	PA449855	10894	0.977
NULL	Arch_Drug_Inf_2008_Jul_1(1)_14-22.nxml.txt.nlp	20157364	SENT146	4	4	9	9	pravastatin	IL-6	PA451089	3569	0.977
NULL	Oncol_Lett_2014_Jul_25_8(1)_313-316.nxml.txt.nlp	24959268	SENT70	5	5	41	41	sulindac	JNK1	PA451565	5599	0.977
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT160	15	15	6	6	dasatinib	p54	PA162372878	9295	0.977
NULL	Patient_Prefer_Adherence_2011_Dec_23_6_1-9.nxml.txt.nlp	22272064	SENT81	14	14	38	38	ramipril	ACE	PA451223	1636	0.977
NULL	Breast_Cancer_Res_2005_Jan_26_7(2)_R256-R266.nxml.txt.nlp	15743506	SENT36	19	19	2	2	trastuzumab	HER-2	PA451743	2064	0.977
NULL	Mol_Cancer_2010_Apr_23_9_87.nxml.txt.nlp	20416058	SENT179	12	12	4	4	doxorubicin	survivin	PA449412	332	0.977
NULL	Mol_Cancer_2010_Nov_8_9_291.nxml.txt.nlp	21059223	SENT140	3	3	15	15	paclitaxel	Bcl-2	PA450761	596	0.977
NULL	Acta_Pharmacol_Sin_2010_Jul_28_31(7)_775-783.nxml.txt.nlp	20581849	SENT210	10	10	21	21	trazodone	5-HT2C	PA451744	3358	0.977
NULL	ASN_Neuro_2009_Apr_14_1(1)_e00004.nxml.txt.nlp	19570023	SENT56	11	11	5	5	pentobarbital	P14	PA450859	11102;;6280;56259	0.977
NULL	Mol_Cancer_2007_Sep_26_6_61.nxml.txt.nlp	17894897	SENT184	6	6	17	17	etoposide	GADD45	PA449552	1647	0.977
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT1054	4	4	13	13	resveratrol	AMPK		5563	0.977
NULL	Acta_Pharmacol_Sin_2012_Jan_5_33(1)_137-144.nxml.txt.nlp	22139004	SENT32	5	5	0	0	dextran	EPO	PA449261	7076;8288;2056	0.977
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT170	21	21	6	6	cisplatin	p53	PA449014	7157	0.977
NULL	Biochim_Biophys_Acta_2014_Apr_1841(4)_588-594.nxml.txt.nlp	24440819	SENT135	18	18	2	2	lipase	ATGL	PA450239	57104	0.977
NULL	Arthritis_Res_Ther_2006_Nov_8_8(6)_R167.nxml.txt.nlp	17092341	SENT170	25	25	7	7	rituximab	BAFF	PA451261	10673	0.977
NULL	J_Vet_Med_Sci_2014_Mar_5_76(3)_431-433.nxml.txt.nlp	24189617	SENT19	4	4	11	11	clarithromycin	CYP3A	PA449028	1574	0.977
NULL	J_Biomed_Sci_2013_Dec_20_20(1)_95.nxml.txt.nlp	24359494	SENT126	25	25	11	11	doxorubicin	HSP60	PA449412	3329	0.977
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT61	10	10	2	2	neratinib	HER2	PA165291472	2064	0.977
NULL	Breast_Cancer_Res_2010_Aug_9_12(4)_R62.nxml.txt.nlp	20696059	SENT63	18	18	7	7	l-glutamine	HER2	PA10090	2064	0.977
NULL	Br_J_Cancer_2010_Nov_9_103(11)_1692-1697.nxml.txt.nlp	21063402	SENT76	14	14	5	5	doxycycline	TRAIL	PA449415	8743	0.977
NULL	Mol_Cancer_2014_Aug_4_13_161.nxml.txt.nlp	NULL	SENT17	20	20	3	3	metformin	AMPK	PA450395	5563	0.977
NULL	Oncotarget_2014_Jun_7_5(14)_5257-5271.nxml.txt.nlp	24913448	SENT18	23	23	4	4	imatinib	CRKL	PA10804	1399	0.977
NULL	J_Hematol_Oncol_2009_Feb_23_2_10.nxml.txt.nlp	19236716	SENT107	9	9	25	25	dasatinib	CYP3A4	PA162372878	1576	0.977
NULL	Nat_Commun_2012_Dec_4_3_1248.nxml.txt.nlp	23212377	SENT85	6	6	2	2	nadh	NADK	PA164755085	65220	0.977
NULL	Structure_2013_Jun_4_21(6)_986-996.nxml.txt.nlp	23665168	SENT207	13	13	6	6	trypsin	DYRK1A	PA451806	1859	0.977
NULL	Cancer_Biol_Med_2013_Dec_10(4)_192-205.nxml.txt.nlp	24349829	SENT341	24	24	22	22	gefitinib	EGFR	PA131301952	1956	0.977
NULL	Oncotarget_2014_Oct_16_5(20)_9546-9563.nxml.txt.nlp	25337673	SENT121	40	40	18	18	erlotinib	AXL	PA134687924	558	0.977
NULL	Mol_Cancer_2010_Apr_15_9_77.nxml.txt.nlp	20398291	SENT47	26	26	6	6	geldanamycin	Hsp90	PA152031327	3320	0.977
NULL	J_Invest_Dermatol_2014_Feb_10_134(2)_319-325.nxml.txt.nlp	24108405	SENT136	20	20	0	0	lapatinib	ERBB3	PA152241907	2065	0.977
NULL	J_Oncol_2011_Dec_15_2011_852970.nxml.txt.nlp	21209724	SENT224	0	0	9	9	nutlin-3	MDM2		4193	0.977
NULL	Front_Neurol_2011_Dec_26_2_83.nxml.txt.nlp	22363312	SENT105	23	23	2	2	clopidogrel	P2Y12	PA449053	64805	0.977
NULL	Mol_Cancer_2014_Jan_15_13_9.nxml.txt.nlp	24428911	SENT9	33	33	13	13	gefitinib	SRSF2	PA131301952	6427	0.977
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT53	5	5	13	13	cisplatin	CTR1	PA449014	1317	0.977
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT136	0	0	6	6	capsaicin	p53	PA448776	7157	0.977
NULL	Br_J_Pharmacol_2008_Sep_9_155(1)_127-137.nxml.txt.nlp	18536750	SENT177	6	6	0	0	piroxicam	IL-10	PA450985	3586	0.977
NULL	J_Headache_Pain_2011_Aug_29_12(4)_411-417.nxml.txt.nlp	21626018	SENT108	0	0	24	24	capsaicin	c-fos	PA448776	2353	0.977
NULL	Int_J_Environ_Res_Public_Health_2005_May_30_2(1)_156-163.nxml.txt.nlp	16705813	SENT6	20	20	0	0	estradiol	CD4	PA449503	920	0.977
NULL	J_Nat_Med_2014_Feb_19_68(2)_253-266.nxml.txt.nlp	24550097	SENT207	5	5	20	20	curcumin	AMPK	PA151958596	5563	0.977
NULL	Br_J_Cancer_2013_Jun_25_108(12)_2464-2469.nxml.txt.nlp	23695016	SENT55	11	11	1	1	cisplatin	NACT	PA449014	284111	0.977
NULL	Int_J_Med_Sci_2013_Jan_3_10(2)_141-147.nxml.txt.nlp	23329885	SENT60	26	26	1	1	creatine	AGAT	PA164778930	2628	0.977
NULL	Oncol_Lett_2014_Aug_16_8(2)_673-678.nxml.txt.nlp	25009649	SENT36	6	6	27	27	thrombin	San	PA451674	80218	0.977
NULL	Oncogene_2014_Feb_6_33(6)_713-723.nxml.txt.nlp	23435429	SENT82	28	28	4	4	etoposide	p65	PA449552	5970	0.977
NULL	eLife_2014_May_27_3_e02200.nxml.txt.nlp	24867637	SENT106	17	17	8	8	doxorubicin	p53	PA449412	7157	0.977
NULL	Acta_Pharmacol_Sin_2011_Jul_13_32(7)_967-972.nxml.txt.nlp	21666702	SENT141	13	13	27	27	losartan	CYP2C	PA450268	1562	0.977
NULL	Oxid_Med_Cell_Longev_2010_Mar-Apr_3(2)_101-108.nxml.txt.nlp	20716934	SENT42	27	27	2	2	rosiglitazone	RAGE	PA451283	177	0.977
NULL	Diabetes_2011_Nov_17_60(11)_3044-3054.nxml.txt.nlp	21926268	SENT102	16	16	36	36	nitroprusside	APPL1	PA451406	26060	0.977
NULL	Exp_Diabetes_Res_2011_Jun_4_2011_489708.nxml.txt.nlp	21747829	SENT158	3	3	31	31	aliskiren	GLP-1	PA143487910	100125288	0.977
NULL	J_Oncol_2010_Feb_11_2010_361836.nxml.txt.nlp	20169138	SENT77	0	0	24	24	bevacizumab	VEGF-A	PA130232992	7422	0.977
NULL	Oncotarget_2013_Feb_27_4(2)_178-179.nxml.txt.nlp	23563503	SENT11	3	3	22	22	nutlin-3	p53		7157	0.977
NULL	Front_Physiol_2010_Nov_2_1_145.nxml.txt.nlp	21423385	SENT180	8	8	6	6	celecoxib	COX2	PA448871	4513;5743	0.977
NULL	Indian_J_Med_Res_2013_Apr_137(4)_734-741.nxml.txt.nlp	23703341	SENT29	18	18	8	8	coumarin	VKORC1	PA134521193	79001	0.977
NULL	Cell_Death_Dis_2014_Feb_13_5(2)_e1055.nxml.txt.nlp	24525731	SENT93	22	22	3	3	cisplatin	XRCC1	PA449014	7515	0.977
NULL	Leukemia_2014_Jun_25_28(6)_1280-1288.nxml.txt.nlp	24270737	SENT24	32	32	0	0	cytarabine	THP1	PA449177	2736	0.977
NULL	Indian_J_Med_Res_2013_Apr_137(4)_659-668.nxml.txt.nlp	23703333	SENT204	4	4	20	20	memantine	DARC	PA10364	2532	0.977
NULL	Diabetes_Care_2009_Sep_29_32(9)_1620-1625.nxml.txt.nlp	19564453	SENT4	4	4	17	17	metformin	AMPK	PA450395	5563	0.977
NULL	Clin_Med_Insights_Oncol_2013_May_20_7_87-102.nxml.txt.nlp	23761989	SENT206	0	0	31	31	cetuximab	EGF	PA10040	1950	0.977
NULL	Cardiol_Res_Pract_2013_Feb_19_2013_195456.nxml.txt.nlp	23533940	SENT121	17	17	3	3	clopidogrel	PON1	PA449053	5444	0.977
NULL	Tuberc_Respir_Dis_(Seoul)_2012_Dec_28_73(6)_303-311.nxml.txt.nlp	23319992	SENT142	18	18	7	7	gefitinib	EGFR	PA131301952	1956	0.977
NULL	Pharmaceuticals_(Basel)_2013_Aug_2_6(8)_915-928.nxml.txt.nlp	24276376	SENT127	28	28	38	38	aspirin	CAD	PA448497	1677;790	0.977
NULL	Front_Oncol_2014_Jun_16_4_148.nxml.txt.nlp	24982848	SENT101	4	4	34	34	doxorubicin	p38	PA449412	10598;1432;7965	0.977
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT408	21	21	3	3	olanzapine	PRL	PA450688	5617	0.977
NULL	J_Autom_Methods_Manag_Chem_2010_Oct_13_2010_913207.nxml.txt.nlp	20981343	SENT86	3	3	12	12	gentamicin	mol	PA449753	90527	0.977
NULL	Chemother_Res_Pract_2011_Dec_18_2011_965826.nxml.txt.nlp	22295208	SENT31	6	6	21	21	s-adenosylmethionine	DNMT1	PA164754994	1786	0.977
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1059-1066.nxml.txt.nlp	21364577	SENT75	0	0	23	23	letrozole	BCS	PA450196	617	0.977
NULL	J_Oncol_2010_Dec_28_2010_135354.nxml.txt.nlp	21318160	SENT32	7	7	14	14	eltrombopag	TPO	PA165981594	7066;7173	0.977
NULL	Mol_Cancer_2013_Sep_11_12_104.nxml.txt.nlp	24025152	SENT228	9	9	24	24	gemcitabine	EGFR	PA449748	1956	0.977
NULL	Evid_Based_Complement_Alternat_Med_2014_May_8_2014_494528.nxml.txt.nlp	24949077	SENT16	6	6	21	21	cyclophosphamide	CD4	PA449165	920	0.977
NULL	Braz_J_Med_Biol_Res_2012_Jul_20_45(10)_935-941.nxml.txt.nlp	22801415	SENT173	0	0	9	9	pioglitazone	adiponectin	PA450970	9370	0.977
NULL	Oxid_Med_Cell_Longev_2011_Sep_20_2011_143269.nxml.txt.nlp	21941604	SENT60	2	2	16	16	suramin	HDAC6	PA10292	10013	0.977
NULL	Diabetes_2013_Mar_14_62(3)_953-964.nxml.txt.nlp	23223176	SENT220	8	8	16	16	paroxetine	ROS	PA450801	6098	0.977
NULL	Oncogene_2010_Jul_15_29(28)_4090-4100.nxml.txt.nlp	20473326	SENT79	8	8	23	23	nutlin-3	MDM2		4193	0.977
NULL	Ann_Indian_Acad_Neurol_2012_Apr-Jun_15(2)_151-157.nxml.txt.nlp	22566735	SENT96	2	2	14	14	carbamazepine	AVP	PA448785	114548;551	0.977
NULL	Int_J_Alzheimers_Dis_2011_Oct_19_2011_864753.nxml.txt.nlp	22028985	SENT72	1	1	13	13	picrotoxin	CA3	PA164777007	761	0.977
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_209.nxml.txt.nlp	22546362	SENT54	19	19	4	4	infliximab	IFN	PA452639	3439	0.977
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT222	8	8	37	37	erlotinib	AKT	PA134687924	207	0.977
NULL	Eur_J_Pediatr_2014_Nov_20_173(12)_1639-1642.nxml.txt.nlp	24253372	SENT95	4	4	8	8	haloperidol	CYP2D6	PA449841	1565	0.977
NULL	Mol_Cancer_2009_Jun_23_8_39.nxml.txt.nlp	19549337	SENT37	8	8	0	0	cisplatin	XIAP	PA449014	331	0.977
NULL	Arthritis_Res_Ther_2014_Oct_30_16(5)_474.nxml.txt.nlp	25359291	SENT6	30	30	1	1	methotrexate	OX40	PA450428	7293	0.977
NULL	J_Hematol_Oncol_2012_Feb_14_5_3.nxml.txt.nlp	22333219	SENT146	0	0	8	8	vemurafenib	BRAF	PA165946873	673	0.977
NULL	Braz_J_Med_Biol_Res_2013_Aug_13_46(8)_650-658.nxml.txt.nlp	23969971	SENT153	8	8	28	28	cisplatin	STAT3	PA449014	6774	0.977
NULL	Biomed_Res_Int_2013_Jun_6_2013_626910.nxml.txt.nlp	23841079	SENT194	18	18	26	26	rituximab	CHOP	PA451261	1649	0.977
NULL	Oncotarget_2014_Nov_3_5(20)_10127-10139.nxml.txt.nlp	25333256	SENT176	15	15	43	43	vemurafenib	BRAF	PA165946873	673	0.977
NULL	Neuropsychopharmacology_2011_Apr_2_36(5)_1033-1046.nxml.txt.nlp	21289603	SENT366	3	3	8	8	ethanol	MSN	PA448073	4478	0.977
NULL	Oncoimmunology_2014_Jan_17_3_e27574.nxml.txt.nlp	24800167	SENT21	10	10	44	44	cyclophosphamide	IL-6	PA449165	3569	0.977
NULL	Addict_Sci_Clin_Pract_2013_Dec_21_8(1)_22.nxml.txt.nlp	24359680	SENT45	13	13	19	19	bupropion	CYP2D6	PA448687	1565	0.977
NULL	Front_Neurol_2011_Aug_5_2_48.nxml.txt.nlp	21886636	SENT96	10	10	3	3	vasopressin	AQP2	PA451858	359	0.977
NULL	Br_J_Haematol_2014_Jan_28_164(2)_233-244.nxml.txt.nlp	24206017	SENT206	10	10	23	23	lenalidomide	CRBN	PA162363968	51185	0.977
NULL	Toxins_(Basel)_2010_May_28_2(6)_1207-1224.nxml.txt.nlp	22069634	SENT238	4	4	11	11	curcumin	MRP1	PA151958596	4437	0.977
NULL	Acta_Pharmacol_Sin_2012_Jan_5_33(1)_137-144.nxml.txt.nlp	22139004	SENT19	12	12	1	1	zidovudine	EPO	PA451954	7076;8288;2056	0.977
NULL	Psychiatry_Investig_2012_Dec_12_9(4)_422-424.nxml.txt.nlp	23251210	SENT8	5	5	15	15	terbinafine	CYP2D6	PA451614	1565	0.977
NULL	BMB_Rep_2014_Feb_47(2)_60-68.nxml.txt.nlp	24411465	SENT82	0	0	15	15	alefacept	CD2	PA164748040	914	0.977
NULL	Crit_Care_2008_Mar_13_12(Suppl_2)_P254.nxml.txt.nlp	NULL	SENT8	17	17	0	0	cisplatin	HIC	PA449014	29969	0.977
NULL	Int_J_Biol_Sci_2011_Nov_5_8(1)_1-14.nxml.txt.nlp	22211100	SENT167	18	18	5	5	gemcitabine	survivin	PA449748	332	0.977
NULL	Curr_Cardiol_Rev_2008_Nov_4(4)_309-322.nxml.txt.nlp	20066139	SENT253	10	10	33	33	etanercept	AT1	PA449515	9197;185	0.977
NULL	J_Biol_Chem_2013_Apr_5_288(14)_9767-9778.nxml.txt.nlp	23439651	SENT207	21	21	3	3	nutlin-3	p53		7157	0.977
NULL	J_Cancer_2013_Sep_27_4(8)_662-670.nxml.txt.nlp	24155778	SENT200	23	23	4	4	cisplatin	UCHL1	PA449014	7345	0.977
NULL	Clin_Dev_Immunol_2011_Oct_20_2011_947858.nxml.txt.nlp	22046194	SENT135	0	0	9	9	dasatinib	PI3K	PA162372878	5290	0.977
NULL	Pharmaceuticals_(Basel)_2012_Sep_10_5(9)_944-962.nxml.txt.nlp	24280699	SENT51	13	13	17	17	novobiocin	p23	PA164768819	10728	0.977
NULL	J_Exp_Bot_2011_Oct_4_62(14)_4787-4803.nxml.txt.nlp	21821598	SENT249	27	27	1	1	mannitol	M6PR	PA450320	4074	0.977
NULL	Clin_Ophthalmol_2011_Jun_30_5_897-900.nxml.txt.nlp	21760719	SENT9	27	27	1	1	fluorescein	F10	PA164746009	2159	0.977
NULL	Clin_Drug_Investig_2013_Aug_23_33(10)_727-736.nxml.txt.nlp	23975654	SENT172	14	14	41	41	duloxetine	CYP3A4	PA10066	1576	0.977
NULL	Hum_Genomics_Proteomics_2010_Sep_13_2010_754919.nxml.txt.nlp	20981234	SENT57	14	14	3	3	warfarin	CYP2C9	PA451906	1559	0.977
NULL	Aging_(Albany_NY)_2009_Jan_16_1(1)_28-37.nxml.txt.nlp	19851476	SENT81	21	21	42	42	camptothecin	HGPS	PA153590860	4000;10269;64221	0.977
NULL	J_Parasitol_Res_2010_Jun_22_2010_719856.nxml.txt.nlp	20798751	SENT182	23	23	13	13	auranofin	DTNB	PA448510	1838	0.977
NULL	Int_J_Mol_Imaging_2011_Oct_26_2011_874585.nxml.txt.nlp	21490735	SENT135	39	39	5	5	docetaxel	OMG	PA449383	4974	0.977
NULL	Eur_J_Clin_Pharmacol_2010_Nov_29_66(11)_1131-1136.nxml.txt.nlp	20669013	SENT139	33	33	24	24	voriconazole	CYP3A4	PA10233	1576	0.977
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT118	11	11	25	25	dasatinib	ABCG2	PA162372878	9429	0.977
NULL	Drugs_R_D_2011_Jun_27_11(2)_101-111.nxml.txt.nlp	21679003	SENT98	3	3	14	14	bevacizumab	VEGF-A	PA130232992	7422	0.977
NULL	Cancer_Metab_2014_May_28_2(Suppl_1)_P28.nxml.txt.nlp	NULL	SENT11	3	3	21	21	metformin	TSC1	PA450395	7248	0.977
NULL	Nat_Med_2011_May_1_17(5)_618-622.nxml.txt.nlp	21532596	SENT77	10	10	3	3	rosiglitazone	DAG	PA451283	1605	0.977
NULL	Oxid_Med_Cell_Longev_2013_Nov_28_2013_568093.nxml.txt.nlp	24379901	SENT134	15	15	4	4	resveratrol	SIRT1		23411	0.977
NULL	Cancer_Res_Treat_2014_Jan_15_46(1)_55-64.nxml.txt.nlp	24520224	SENT160	18	18	5	5	oxaliplatin	ERCC1	PA131285527	2067	0.977
NULL	Cancer_Immunol_Immunother_2015_Oct_7_64_61-73.nxml.txt.nlp	25287778	SENT200	19	19	1	1	lenalidomide	IL-2	PA162363968	3558	0.977
NULL	Case_Rep_Rheumatol_2012_Dec_10_2012_250537.nxml.txt.nlp	23304613	SENT44	37	37	26	26	methotrexate	B19	PA450428	59271	0.977
NULL	Front_Oncol_2013_Oct_31_3_271.nxml.txt.nlp	24199171	SENT82	14	14	3	3	erlotinib	EGFR	PA134687924	1956	0.977
NULL	J_Int_Soc_Sports_Nutr_2014_Jun_14_11_29.nxml.txt.nlp	25006332	SENT159	41	41	0	0	estradiol	AKR1C3	PA449503	8644	0.977
NULL	Breast_Cancer_Res_2013_Oct_3_15(5)_R93.nxml.txt.nlp	24088226	SENT103	17	17	44	44	tamoxifen	CYP2D6	PA451581	1565	0.977
NULL	Front_Physiol_2011_Dec_19_2_104.nxml.txt.nlp	22194727	SENT110	25	25	23	23	triciribine	AKT	PA165958661	207	0.977
NULL	Oncotarget_2011_Dec_21_2(12)_1134-1144.nxml.txt.nlp	22193779	SENT116	15	15	9	9	gefitinib	EGFR	PA131301952	1956	0.977
NULL	Clin_Drug_Investig_2013_Aug_23_33(10)_727-736.nxml.txt.nlp	23975654	SENT172	10	10	22	22	fluoxetine	CYP2D6	PA449673	1565	0.977
NULL	Diabetes_Care_2013_Mar_13_36(3)_529-536.nxml.txt.nlp	23048188	SENT187	6	6	12	12	metformin	HDL2	PA450395	57338	0.977
NULL	Oncol_Rep_2013_Jan_26_29(1)_297-305.nxml.txt.nlp	23129017	SENT62	23	23	33	33	doxycycline	TRA16	PA449415	126382	0.977
NULL	Tumour_Biol_2011_Oct_16_32(5)_965-976.nxml.txt.nlp	21678067	SENT213	11	11	29	29	methotrexate	BIRC3	PA450428	330	0.977
NULL	Med_Sci_Monit_2013_Oct_31_19_916-926.nxml.txt.nlp	24172537	SENT113	31	31	7	7	chlorambucil	FANCG	PA448926	2189	0.977
NULL	Ecancermedicalscience_2009_Jun_9_3_148.nxml.txt.nlp	22276013	SENT13	0	0	8	8	anastrozole	aromatase	PA448432	1588	0.977
NULL	J_Cell_Mol_Med_2014_May_14_18(5)_811-823.nxml.txt.nlp	24628949	SENT138	2	2	16	16	docetaxel	FOXM1	PA449383	2305	0.977
NULL	Oncologist_2010_Mar_3_15(3)_216-235.nxml.txt.nlp	20200040	SENT85	0	0	8	8	trastuzumab	HER-2	PA451743	2064	0.977
NULL	Med_Sci_Monit_2013_Sep_9_19_751-756.nxml.txt.nlp	24019010	SENT50	15	15	2	2	entecavir	LAM	PA164784025	7249;7248	0.977
NULL	J_Korean_Med_Sci_2009_Oct_24_24(5)_910-917.nxml.txt.nlp	19794992	SENT20	20	20	0	0	trastuzumab	HER2	PA451743	2064	0.977
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R91.nxml.txt.nlp	22541814	SENT223	0	0	9	9	thrombin	PAR1	PA451674	79581;2149	0.977
NULL	Ann_Gastroenterol_2013_26(3)_226-232.nxml.txt.nlp	24714278	SENT49	33	33	10	10	fluorescein	ACT	PA164746009	12;11332;9457;641455	0.977
NULL	Nat_Prod_Bioprospect_2014_Apr_18_4(2)_73-79.nxml.txt.nlp	24859375	SENT44	20	20	6	6	hyperforin	C-1	PA165985514	5203	0.977
NULL	Drug_Target_Insights_2011_Jun_7_5_11-32.nxml.txt.nlp	22087060	SENT153	5	5	18	18	cisplatin	Hsp90	PA449014	3320	0.977
NULL	Arch_Drug_Inf_2008_Sep_1(2)_56-62.nxml.txt.nlp	19915709	SENT51	14	14	35	35	fentanyl	CYP3A4	PA449599	1576	0.977
NULL	Br_J_Cancer_2012_Sep_4_107(6)_947-955.nxml.txt.nlp	22892392	SENT198	27	27	8	8	lapatinib	ERBB3	PA152241907	2065	0.977
NULL	Comput_Struct_Biotechnol_J_2013_Jan_18_3_e201210019.nxml.txt.nlp	24688679	SENT158	0	0	37	37	ethanol	PHB	PA448073	5245	0.977
NULL	Cancer_2011_Apr_15_117(8)_1670-1678.nxml.txt.nlp	21472714	SENT11	3	3	9	9	cisplatin	SIRT3	PA449014	23410	0.977
NULL	Pharmaceutics_2010_Apr_27_2(2)_136-158.nxml.txt.nlp	NULL	SENT173	13	13	44	44	diclofenac	HSM	PA449293	94030	0.977
NULL	Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.nxml.txt.nlp	24736980	SENT222	4	4	22	22	rosuvastatin	OATP1B1	PA134308647	10599	0.977
NULL	J_Hematol_Oncol_2012_Apr_25_5(Suppl_1)_A1.nxml.txt.nlp	22738713	SENT20	0	0	7	7	pertuzumab	HER2		2064	0.977
NULL	Exp_Ther_Med_2014_Sep_14_8(3)_836-840.nxml.txt.nlp	25120610	SENT86	16	16	6	6	fasudil	RhoA	PA165946121	387	0.977
NULL	Br_J_Cancer_2011_Jul_26_105(3)_372-381.nxml.txt.nlp	21730979	SENT13	5	5	12	12	cisplatin	p53	PA449014	7157	0.977
NULL	Adolesc_Health_Med_Ther_2014_Mar_26_5_35-48.nxml.txt.nlp	24729739	SENT35	22	22	29	29	tocilizumab	TNF-alpha	PA165292659	7124	0.977
NULL	Open_Dent_J_2014_May_30_8_109-124.nxml.txt.nlp	24976875	SENT175	3	3	27	27	minocycline	HMGB1	PA450519	3146	0.977
NULL	Nat_Med_2011_May_1_17(5)_604-609.nxml.txt.nlp	21532597	SENT228	37	37	26	26	daclizumab	CD25	PA164764446	3669;3559	0.977
NULL	Biomed_Res_Int_2014_Feb_27_2014_897653.nxml.txt.nlp	24719894	SENT61	33	33	19	19	risperidone	MTHFR	PA451257	4524	0.977
NULL	Front_Behav_Neurosci_2014_Nov_5_8_388.nxml.txt.nlp	25414651	SENT16	21	21	4	4	ketamine	NAC	PA450144	22861	0.977
NULL	Oncotarget_2014_Nov_11_5(22)_10963-10964.nxml.txt.nlp	25460503	SENT15	29	29	13	13	trastuzumab	ADAM10	PA451743	102	0.977
NULL	Clin_Pharmacol_2013_Apr_19_5_67-83.nxml.txt.nlp	23650452	SENT46	23	23	6	6	ticagrelor	LTA	PA165374673	4049	0.977
NULL	Case_Rep_Oncol_2010_May_7_3(2)_154-159.nxml.txt.nlp	20740189	SENT70	3	3	1	1	cetuximab	EGFR	PA10040	1956	0.977
NULL	J_Cell_Biol_1999_Dec_27_147(7)_1481-1492.nxml.txt.nlp	10613906	SENT640	26	26	10	10	paraformaldehyde	AKAP18	PA450790	9465	0.977
NULL	Avicenna_J_Med_Biotechnol_2013_Apr-Jun_5(2)_87-95.nxml.txt.nlp	23799177	SENT34	0	0	11	11	trastuzumab	HER2	PA451743	2064	0.977
NULL	Mol_Biol_Int_2014_Sep_7_2014_852748.nxml.txt.nlp	25276427	SENT188	0	0	10	10	afatinib	HER2	PA165981154	2064	0.977
NULL	Acta_Pharmacol_Sin_2012_May_16_33(5)_682-690.nxml.txt.nlp	22504904	SENT10	0	0	28	28	celecoxib	STAT3	PA448871	6774	0.977
NULL	Orphanet_J_Rare_Dis_2010_Dec_16_5_39.nxml.txt.nlp	21162721	SENT76	13	13	5	5	carbamazepine	HLA-B	PA448785	3106	0.977
NULL	Exp_Neurobiol_2013_Mar_31_22(1)_45-50.nxml.txt.nlp	23585722	SENT108	4	4	22	22	fluoxetine	EPO	PA449673	7076;8288;2056	0.977
NULL	Arch_Drug_Inf_2011_Mar_4(1)_1-9.nxml.txt.nlp	21572514	SENT148	4	4	6	6	erythromycin	P-gp	PA449493	5243	0.977
NULL	Mol_Cancer_2007_Sep_26_6_61.nxml.txt.nlp	17894897	SENT13	18	18	40	40	etoposide	p53	PA449552	7157	0.977
NULL	Br_J_Cancer_2013_Feb_19_108(3)_557-563.nxml.txt.nlp	23361053	SENT105	6	6	0	0	tamoxifen	PAK1	PA451581	5585;5058	0.977
NULL	Arthritis_Res_Ther_2007_May_30_9(3)_212.nxml.txt.nlp	17561993	SENT167	14	14	9	9	capsaicin	TRPV1	PA448776	7442	0.977
NULL	Oncol_Rep_2014_Feb_13_31(2)_581-588.nxml.txt.nlp	24337105	SENT142	26	26	0	0	capsaicin	SERCA2	PA448776	488	0.977
NULL	Cell_Biosci_2011_Nov_7_1_36.nxml.txt.nlp	22060137	SENT56	28	28	0	0	doxorubicin	AEG-1	PA449412	92140	0.977
NULL	Oncol_Rep_2013_Oct_22_30(4)_1535-1541.nxml.txt.nlp	23877481	SENT149	11	11	17	17	sunitinib	CXCR4	PA162372840	7852	0.977
NULL	Br_J_Cancer_2012_Feb_14_106(4)_719-726.nxml.txt.nlp	22240798	SENT177	24	24	11	11	erlotinib	PTEN	PA134687924	5728	0.977
NULL	J_Thromb_Haemost_2011_Oct_9(10)_2103-2105.nxml.txt.nlp	21812912	SENT43	4	4	25	25	ticagrelor	P2Y12	PA165374673	64805	0.977
NULL	J_Hematol_Oncol_2009_Apr_22_2_18.nxml.txt.nlp	19386128	SENT106	27	27	5	5	cetuximab	KRAS	PA10040	3845	0.977
NULL	J_Adv_Pract_Oncol_2014_May_1_May-Jun_5(3)_205-210.nxml.txt.nlp	25089219	SENT97	25	25	7	7	leucovorin	DPD	PA450198	1806	0.977
NULL	J_Gen_Physiol_2008_Nov_132(5)_521-535.nxml.txt.nlp	18852303	SENT296	29	29	3	3	trypsin	CAP2	PA451806	5271;10486	0.977
NULL	Clinicoecon_Outcomes_Res_2014_Oct_17_6_451-461.nxml.txt.nlp	25378939	SENT29	24	24	4	4	vancomycin	HAP	PA451850	5915;10313	0.977
NULL	Arthritis_Res_Ther_2012_Nov_11_14(6)_R244.nxml.txt.nlp	23140401	SENT153	24	24	2	2	imiquimod	IL-6	PA449972	3569	0.977
NULL	Sci_Rep_2014_Dec_12_4_7456.nxml.txt.nlp	25503852	SENT54	16	16	30	30	resveratrol	SIRT1		23411	0.977
NULL	EMBO_Mol_Med_2013_Dec_8_5(12)_1821-1834.nxml.txt.nlp	24293316	SENT170	13	13	3	3	doxorubicin	p53	PA449412	7157	0.977
NULL	Ann_Oncol_2011_May_3_22(5)_1078-1087.nxml.txt.nlp	21048039	SENT10	29	29	10	10	cetuximab	EGFR	PA10040	1956	0.977
NULL	Clin_Med_Insights_Oncol_2012_Dec_20_7_1-12.nxml.txt.nlp	23362372	SENT34	0	0	12	12	cabazitaxel	CYP3A5	PA165958401	1577	0.977
NULL	Ann_Hematol_2010_Sep_13_89(9)_861-871.nxml.txt.nlp	20387067	SENT2	8	8	21	21	dasatinib	CD34	PA162372878	947	0.977
NULL	Cell_Commun_Signal_2014_May_15_12_34.nxml.txt.nlp	24885272	SENT279	22	22	8	8	heparin	EGF	PA449855	1950	0.977
NULL	Arthritis_Res_Ther_2012_Jun_18_14(3)_R149.nxml.txt.nlp	22709525	SENT239	8	8	21	21	methotrexate	RANKL	PA450428	8600	0.977
NULL	Br_J_Cancer_2012_Aug_21_107(5)_793-799.nxml.txt.nlp	22850551	SENT114	18	18	7	7	lapatinib	HER2	PA152241907	2064	0.977
NULL	Br_J_Cancer_2000_Jun_82(11)_1827-1834.nxml.txt.nlp	10839298	SENT6	0	0	20	20	camptothecin	c-Jun	PA153590860	3725	0.977
NULL	Oncotarget_2011_Mar_27_2(3)_209-221.nxml.txt.nlp	21444945	SENT155	9	9	33	33	bortezomib	p53	PA10252	7157	0.977
NULL	Cancer_Biol_Med_2012_Mar_9(1)_18-22.nxml.txt.nlp	23691449	SENT178	11	11	18	18	gefitinib	ERBB3	PA131301952	2065	0.977
NULL	Chin_J_Cancer_2012_Jul_31(7)_327-334.nxml.txt.nlp	22640628	SENT144	11	11	13	13	tamoxifen	aromatase	PA451581	1588	0.977
NULL	AAPS_J_2011_May_11_13(3)_365-377.nxml.txt.nlp	21560017	SENT180	19	19	44	44	ethanol	GAPDH	PA448073	2597	0.977
NULL	J_Gen_Physiol_2000_Jun_1_115(6)_685-696.nxml.txt.nlp	10828243	SENT163	6	6	25	25	genistein	OLF	PA165109660	83857	0.977
NULL	Front_Neurol_2014_Oct_20_5_210.nxml.txt.nlp	25368599	SENT269	7	7	32	32	carbachol	PPN	PA448784	64840	0.977
NULL	Mol_Pain_2014_Apr_9_10_24.nxml.txt.nlp	24716552	SENT170	38	38	28	28	capsaicin	NK1R	PA448776	6869	0.977
NULL	Breast_Cancer_Res_2009_Oct_7_11(5)_R73.nxml.txt.nlp	19811637	SENT190	16	16	1	1	estradiol	MUC1	PA449503	4582	0.977
NULL	Oncol_Lett_2014_Jun_8_7(6)_1761-1766.nxml.txt.nlp	24932229	SENT84	35	35	7	7	cetuximab	KRAS	PA10040	3845	0.977
NULL	Endocrinol_Metab_(Seoul)_2013_Dec_12_28(4)_262-274.nxml.txt.nlp	24396690	SENT76	37	37	8	8	exenatide	GLP-1	PA164749238	100125288	0.977
NULL	Front_Oncol_2013_Sep_11_3_228.nxml.txt.nlp	24062981	SENT190	17	17	4	4	camptothecin	PARP1	PA153590860	142	0.977
NULL	Ann_Oncol_2010_Feb_21(2)_217-222.nxml.txt.nlp	20110292	SENT146	39	39	8	8	erlotinib	EGFR	PA134687924	1956	0.977
NULL	Mol_Cancer_2013_May_24_12_47.nxml.txt.nlp	23705854	SENT259	9	9	34	34	celecoxib	ABCG2	PA448871	9429	0.977
NULL	Acta_Pharmacol_Sin_2012_Aug_23_33(8)_1095-1100.nxml.txt.nlp	22820908	SENT112	25	25	29	29	verapamil	CYP3A	PA451868	1574	0.977
NULL	Mol_Cancer_2010_Aug_23_9_222.nxml.txt.nlp	20731837	SENT215	14	14	28	28	cetuximab	ATM	PA10040	472	0.977
NULL	Drug_Healthc_Patient_Saf_2012_Jun_6_4_39-54.nxml.txt.nlp	22792008	SENT201	21	21	13	13	lamotrigine	UGT	PA450164	7361;7355	0.977
NULL	Neural_Regen_Res_2014_May_15_9(10)_1055-1062.nxml.txt.nlp	25206759	SENT218	25	25	6	6	furosemide	KCC2	PA449719	57468	0.977
NULL	Diabetes_2011_Nov_17_60(11)_2691-2700.nxml.txt.nlp	21896928	SENT261	16	16	9	9	resveratrol	SIRT1		23411	0.977
NULL	Biologics_2009_Jul_13_3_319-336.nxml.txt.nlp	19707418	SENT18	8	8	24	24	basiliximab	IL-2	PA164747126	3558	0.977
NULL	Arch_Drug_Inf_2011_Mar_4(1)_1-9.nxml.txt.nlp	21572514	SENT21	28	28	34	34	ciprofloxacin	P-gp	PA449009	5243	0.977
NULL	Evid_Based_Complement_Alternat_Med_2011_May_24_2011_841564.nxml.txt.nlp	21716682	SENT117	32	32	9	9	epirubicin	JNK	PA449476	5599	0.977
NULL	Cancer_Immunol_Immunother_2011_Jan_21_60(1)_75-85.nxml.txt.nlp	20857100	SENT224	36	36	15	15	fludarabine	CD2	PA449655	914	0.977
NULL	Oncogene_2009_Aug_27_28(34)_3022-3032.nxml.txt.nlp	19543317	SENT160	21	21	1	1	etoposide	XIAP	PA449552	331	0.977
NULL	Br_J_Cancer_2010_Oct_26_103(9)_1331-1334.nxml.txt.nlp	20877352	SENT49	3	3	11	11	trastuzumab	GM-CSF	PA451743	1437	0.977
NULL	Oncotarget_2014_Oct_23_5(21)_10816-10829.nxml.txt.nlp	25333261	SENT146	27	27	22	22	doxorubicin	p53	PA449412	7157	0.977
NULL	Breast_Cancer_Res_Treat_2014_Nov_24_143(1)_125-133.nxml.txt.nlp	24272078	SENT8	4	4	31	31	everolimus	aromatase	PA164746311	1588	0.977
NULL	Clinics_(Sao_Paulo)_2012_Apr_67(4)_335-340.nxml.txt.nlp	22522758	SENT152	22	22	6	6	citalopram	HTR1B	PA449015	3351	0.977
NULL	Ann_Pediatr_Cardiol_2009_Jan-Jun_2(1)_65-73.nxml.txt.nlp	20300273	SENT50	15	15	36	36	vasopressin	AVP	PA451858	114548;551	0.977
NULL	Cell_Death_Dis_2014_Mar_6_5(3)_e1108.nxml.txt.nlp	24603336	SENT235	13	13	7	7	etoposide	p53	PA449552	7157	0.977
NULL	Nat_Commun_2013_Aug_15_4_2130.nxml.txt.nlp	23945651	SENT707	13	13	5	5	etoposide	ATG5	PA449552	9474	0.977
NULL	Adv_Biomed_Res_2014_Aug_22_3_177.nxml.txt.nlp	25250291	SENT27	4	4	31	31	dapsone	G6PD	PA449211	2539	0.977
NULL	Ann_Dermatol_2014_Oct_26_26(5)_645-646.nxml.txt.nlp	25324664	SENT31	10	10	3	3	methazolamide	HLA-B	PA450413	3106	0.977
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2675-2684.nxml.txt.nlp	24129246	SENT187	23	23	5	5	etoposide	p53	PA449552	7157	0.977
NULL	Clin_Pharmacokinet_2014_Jul_24_53(1)_73-87.nxml.txt.nlp	23881596	SENT268	5	5	22	22	rosuvastatin	OATP1B1	PA134308647	10599	0.977
NULL	Drug_Des_Devel_Ther_2014_Sep_26_8_1595-1611.nxml.txt.nlp	25302015	SENT185	19	19	11	11	afatinib	EGFR	PA165981154	1956	0.977
NULL	Br_J_Cancer_2002_Feb_1_86(3)_402-408.nxml.txt.nlp	11875707	SENT118	21	21	10	10	tamoxifen	p53	PA451581	7157	0.977
NULL	Indian_J_Pharm_Sci_2014_Mar-Apr_76(2)_125-131.nxml.txt.nlp	24843185	SENT165	16	16	4	4	resveratrol	S100B		6285	0.977
NULL	Osteoporos_Int_2010_Oct_18_21(10)_1657-1680.nxml.txt.nlp	20480148	SENT427	4	4	26	26	denosumab	RANK	PA166048634	8792	0.977
NULL	Exp_Diabetes_Res_2012_May_14_2012_470851.nxml.txt.nlp	22666230	SENT51	10	10	2	2	liraglutide	GLP-1	PA165958364	100125288	0.977
NULL	Br_J_Cancer_2009_Jul_21_101(2)_327-334.nxml.txt.nlp	19568240	SENT217	8	8	36	36	pp2	PP2		4888	0.977
NULL	Clin_Pharmacol_2012_Feb_20_4_13-20.nxml.txt.nlp	22427735	SENT15	14	14	0	0	clopidogrel	PON1	PA449053	5444	0.977
NULL	Cancer_Microenviron_2009_Sep_26_2(Suppl_1)_19-204.nxml.txt.nlp	NULL	SENT3307	21	21	13	13	nelfinavir	PI3K	PA450606	5290	0.977
NULL	Biomed_Res_Int_2013_Jul_25_2013_295132.nxml.txt.nlp	23984335	SENT339	0	0	16	16	ustekinumab	p40	PA166048654	3921;339541;10314	0.977
NULL	Curr_Pharm_Biotechnol_2012_May_13(6)_969-986.nxml.txt.nlp	22039792	SENT81	5	5	34	34	acepromazine	MDR1	PA164783999	5243	0.977
NULL	Cancer_Manag_Res_2012_Nov_9_4_383-395.nxml.txt.nlp	23204869	SENT225	12	12	3	3	carmustine	PC-3	PA448810	692094	0.977
NULL	Indian_J_Med_Res_2012_Dec_136(6)_907-925.nxml.txt.nlp	23391787	SENT512	29	29	43	43	primaquine	G6PD	PA451103	2539	0.977
NULL	Indian_J_Ophthalmol_2014_May_62(5)_642-644.nxml.txt.nlp	23571268	SENT8	17	17	7	7	aspirin	APS	PA448497	10603	0.977
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_29_2013_590393.nxml.txt.nlp	23737838	SENT195	14	14	22	22	resveratrol	p53		7157	0.977
NULL	J_Korean_Med_Sci_2011_Dec_29_26(12)_1563-1568.nxml.txt.nlp	22147992	SENT112	5	5	16	16	sorafenib	EGFR	PA7000	1956	0.977
NULL	Orphanet_J_Rare_Dis_2014_Aug_18_9(1)_132.nxml.txt.nlp	NULL	SENT185	6	6	21	21	cyclophosphamide	CHS	PA449165	1130	0.977
NULL	Brain_Behav_2011_Sep_1(1)_44-54.nxml.txt.nlp	22398980	SENT195	14	14	4	4	ketamine	PCP	PA450144	5547	0.977
NULL	Clin_Ophthalmol_2010_Apr_26_4_233-241.nxml.txt.nlp	20463789	SENT81	14	14	32	32	timolol	CRA	PA451690	51747;10903	0.977
NULL	Mar_Drugs_2010_May_26_8(6)_1750-1762.nxml.txt.nlp	20631867	SENT54	24	24	1	1	tramadol	zeta	PA451735	9907	0.977
NULL	Oncoscience_2014_Mar_25_1(3)_205-215.nxml.txt.nlp	25594013	SENT33	15	15	28	28	doxycycline	EFEMP1	PA449415	2202	0.977
NULL	J_Korean_Med_Sci_2007_Sep_30_22(Suppl)_S98-S103.nxml.txt.nlp	17923763	SENT23	0	0	13	13	cetuximab	EGFR	PA10040	1956	0.977
NULL	Int_J_Biol_Sci_2011_Nov_5_8(1)_1-14.nxml.txt.nlp	22211100	SENT141	3	3	33	33	evodiamine	PI3K	PA165860788	5290	0.977
NULL	Cancer_Med_2014_Apr_27_3(2)_245-251.nxml.txt.nlp	24464861	SENT71	35	35	0	0	metformin	HIF1	PA450395	3091	0.977
NULL	Mol_Brain_2014_Apr_21_7_28.nxml.txt.nlp	24751148	SENT109	4	4	13	13	minocycline	TLR4	PA450519	7099	0.977
NULL	Cancer_Cell_Int_2010_Sep_9_10_32.nxml.txt.nlp	20828393	SENT51	1	1	21	21	cisplatin	ATF3	PA449014	467	0.977
NULL	Onco_Targets_Ther_2014_Sep_9_7_1571-1582.nxml.txt.nlp	25228815	SENT130	12	12	4	4	pazopanib	VEGFR1	PA165291492	2321	0.977
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S31-S40.nxml.txt.nlp	20680106	SENT28	7	7	24	24	cetuximab	KRAS	PA10040	3845	0.977
NULL	Int_J_Mol_Sci_2014_Sep_5_15(9)_15754-15765.nxml.txt.nlp	25198898	SENT103	6	6	25	25	curcumin	NAC	PA151958596	22861	0.977
NULL	Drugs_R_D_2013_Sep_28_13(3)_191-197.nxml.txt.nlp	23982688	SENT130	7	7	12	12	warfarin	TTR	PA451906	7276	0.977
NULL	Oncotarget_2014_Oct_21_5(22)_11709-11722.nxml.txt.nlp	25365944	SENT163	15	15	2	2	metformin	JNK	PA450395	5599	0.977
NULL	Breast_Cancer_(Auckl)_2011_Apr_13_5_53-65.nxml.txt.nlp	21603258	SENT25	27	27	10	10	paclitaxel	castor	PA450761	54897	0.977
NULL	Chin_J_Cancer_2011_May_30(5)_293-302.nxml.txt.nlp	21527062	SENT67	0	0	30	30	pertuzumab	HER2		2064	0.977
NULL	Cancer_Metastasis_Rev_2014_Nov_7_33(4)_1095-1108.nxml.txt.nlp	25376898	SENT179	0	0	4	4	amiloride	NHE	PA448368	285335	0.977
NULL	Mol_Cancer_2011_Sep_7_10_109.nxml.txt.nlp	21899742	SENT219	11	11	1	1	doxorubicin	TRAIL-R2	PA449412	8795	0.977
NULL	Cases_J_2009_Jan_6_2_15.nxml.txt.nlp	19126225	SENT100	23	23	12	12	cetuximab	EGFR	PA10040	1956	0.977
NULL	Clin_Sarcoma_Res_2014_Jan_31_4_2.nxml.txt.nlp	24484617	SENT4	9	9	15	15	paclitaxel	SPARC	PA450761	6678	0.977
NULL	Core_Evid_2010_Oct_21_5_77-90.nxml.txt.nlp	21042544	SENT177	18	18	6	6	pimozide	CYP3A4	PA450965	1576	0.977
NULL	Br_J_Cancer_2012_Jan_3_106(1)_85-91.nxml.txt.nlp	22127285	SENT153	18	18	5	5	dasatinib	NRAS	PA162372878	4893	0.977
NULL	Int_J_Gen_Med_2012_Apr_13_5_317-322.nxml.txt.nlp	22536087	SENT95	0	0	19	19	liraglutide	GLP-1	PA165958364	100125288	0.977
NULL	Cancer_Med_2014_Feb_16_3(1)_111-117.nxml.txt.nlp	24403010	SENT111	20	20	2	2	fluorouracil	CRT	PA128406956	811	0.977
NULL	Mol_Cancer_2007_Sep_26_6_61.nxml.txt.nlp	17894897	SENT184	6	6	19	19	etoposide	BAX	PA449552	581	0.977
NULL	Biomed_Res_Int_2014_Jun_25_2014_203693.nxml.txt.nlp	25089265	SENT112	26	26	0	0	gefitinib	EGFR	PA131301952	1956	0.977
NULL	Breast_Cancer_Res_2014_Oct_30_16(5)_462.nxml.txt.nlp	25358638	SENT338	28	28	5	5	doxorubicin	VEGFC	PA449412	7424	0.977
NULL	Br_J_Cancer_2009_Jun_16_100(12)_1926-1936.nxml.txt.nlp	19436302	SENT129	11	11	5	5	resveratrol	PI3K		5290	0.977
NULL	Cancers_(Basel)_2011_May_3_3(2)_2255-2273.nxml.txt.nlp	24212808	SENT138	10	10	8	8	gefitinib	EGFR	PA131301952	1956	0.977
NULL	Int_J_Breast_Cancer_2011_Sep_6_2011_352182.nxml.txt.nlp	22295219	SENT144	8	8	27	27	trastuzumab	AKT	PA451743	207	0.977
NULL	J_Carcinog_2011_Nov_30_10_28.nxml.txt.nlp	22190870	SENT115	43	43	7	7	trastuzumab	p27	PA451743	5715;10534	0.977
NULL	Clinics_(Sao_Paulo)_2014_Jan_69(1)_68-74.nxml.txt.nlp	24473562	SENT13	14	14	23	23	nutlin-3	p53		7157	0.977
NULL	Anticancer_Drugs_2015_Jan_28_26(1)_46-55.nxml.txt.nlp	25099621	SENT91	17	17	3	3	cisplatin	KE-3	PA449014	6222	0.977
NULL	Br_J_Cancer_2010_Nov_9_103(10)_1627-1636.nxml.txt.nlp	20959826	SENT21	36	36	9	9	panitumumab	EGFR	PA162373091	1956	0.977
NULL	Epigenetics_2012_Nov_1_7(11)_1225-1229.nxml.txt.nlp	23069641	SENT51	21	21	30	30	cisplatin	BRCA1	PA449014	672	0.977
NULL	Pain_Res_Treat_2011_Aug_14_2011_864605.nxml.txt.nlp	22110933	SENT146	3	3	17	17	propranolol	PLP	PA451145	25824;5744	0.977
NULL	Cancer_Inform_2010_Apr_27_9_93-103.nxml.txt.nlp	20467479	SENT7	22	22	6	6	tamoxifen	CYP2D6	PA451581	1565	0.977
NULL	Acta_Neuropathol_Commun_2014_Jul_16_2(1)_81.nxml.txt.nlp	NULL	SENT150	5	5	9	9	haloperidol	p75NTR	PA449841	4804	0.977
NULL	Osteoporos_Int_2013_Oct_19_24(1)_23-57.nxml.txt.nlp	23079689	SENT551	3	3	12	12	denosumab	RANKL	PA166048634	8600	0.977
NULL	Curr_Oncol_2006_Feb_13(1)_14-26.nxml.txt.nlp	17576437	SENT339	9	9	2	2	cisplatin	HER2	PA449014	2064	0.977
NULL	Breast_Cancer_Res_2007_Dec_20_9(Suppl_2)_S13.nxml.txt.nlp	NULL	SENT51	5	5	31	31	anastrozole	ATAC	PA448432	6375	0.977
NULL	Evid_Based_Complement_Alternat_Med_2013_Mar_19_2013_184358.nxml.txt.nlp	23573117	SENT256	9	9	29	29	resveratrol	AMPK		5563	0.977
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT128	0	0	21	21	dasatinib	ABL	PA162372878	4547	0.977
NULL	Clin_Dev_Immunol_2013_Sep_11_2013_561852.nxml.txt.nlp	24106518	SENT105	0	0	9	9	alemtuzumab	CD52	PA164783958	1043	0.977
NULL	Mol_Pain_2013_May_13_9_24.nxml.txt.nlp	23668392	SENT146	34	34	12	12	capsaicin	TRPV1	PA448776	7442	0.977
NULL	Exp_Ther_Med_2013_Apr_11_5(4)_1147-1152.nxml.txt.nlp	23599738	SENT24	18	18	11	11	fentanyl	OPRM1	PA449599	4988	0.977
NULL	Br_J_Cancer_2012_Oct_9_107(8)_1268-1276.nxml.txt.nlp	22996612	SENT27	0	0	11	11	axitinib	VEGFR	PA164924493	3791	0.977
NULL	Epilepsy_Res_Treat_2012_Apr_23_2012_342928.nxml.txt.nlp	22957226	SENT144	24	24	1	1	diazepam	P80	PA449283	57599	0.977
NULL	Evid_Based_Complement_Alternat_Med_2004_Jun_1(1)_83-91.nxml.txt.nlp	15257329	SENT103	28	28	5	5	glucose	SKT	PA449773	56243	0.977
NULL	Oncologist_2010_May_28_15(5)_436-446.nxml.txt.nlp	20427383	SENT236	11	11	9	9	pazopanib	VEGFR	PA165291492	3791	0.977
NULL	Med_Sci_Monit_2013_Dec_23_19_1195-1210.nxml.txt.nlp	24362017	SENT271	21	21	5	5	cisplatin	TRPV1	PA449014	7442	0.977
NULL	Ann_Rheum_Dis_2008_Aug_20_67(8)_1121-1126.nxml.txt.nlp	18029384	SENT23	23	23	2	2	bosentan	LFA-1	PA10034	3683;3689	0.977
NULL	Cell_Death_Differ_2010_Mar_25_17(3)_398-407.nxml.txt.nlp	19779497	SENT102	24	24	11	11	etoposide	OCN	PA449552	632	0.977
NULL	J_Thyroid_Res_2011_Apr_10_2011_895923.nxml.txt.nlp	21603172	SENT186	20	20	0	0	thyroglobulin	IL-10	PA164754910	3586	0.977
NULL	J_Invest_Dermatol_2012_Jan_18_132(1)_163-169.nxml.txt.nlp	21850019	SENT107	18	18	28	28	imiquimod	CD25	PA449972	3669;3559	0.977
NULL	EPMA_J_2012_Jun_18_3(1)_6.nxml.txt.nlp	22738201	SENT97	14	14	24	24	gefitinib	EGFR	PA131301952	1956	0.977
NULL	J_Clin_Biochem_Nutr_2009_Jan_27_44(1)_79-84.nxml.txt.nlp	19177192	SENT14	7	7	14	14	curcumin	HO-1	PA151958596	3162	0.977
NULL	Oncotarget_2012_Sep_19_3(9)_1036-1048.nxml.txt.nlp	23013619	SENT46	9	9	24	24	bevacizumab	VEGFR	PA130232992	3791	0.976
NULL	Front_Oncol_2013_Sep_9_3_235.nxml.txt.nlp	24058902	SENT67	1	1	20	20	vorinostat	BIM	PA164748224	10018	0.976
NULL	Clin_Dev_Immunol_2011_Dec_26_2011_890758.nxml.txt.nlp	22235224	SENT188	0	0	19	19	ertumaxomab	HER2	PA165291442	2064	0.976
NULL	Cell_Death_Dis_2014_Jan_30_5(1)_e1030.nxml.txt.nlp	24481444	SENT18	0	0	9	9	sorafenib	Raf-1	PA7000	5894	0.976
NULL	Genome_Biol_2011_May_25_12(5)_R46.nxml.txt.nlp	21609475	SENT132	9	9	2	2	etoposide	CCND1	PA449552	595	0.976
NULL	Clin_Med_Insights_Ear_Nose_Throat_2012_Apr_3_5_1-16.nxml.txt.nlp	24179404	SENT5	0	0	10	10	cetuximab	EGFR	PA10040	1956	0.976
NULL	Arthritis_Res_Ther_2012_Nov_29_14(6)_R260.nxml.txt.nlp	23193984	SENT215	40	40	11	11	anakinra	IL-6	PA10799	3569	0.976
NULL	Br_J_Cancer_2011_Jul_26_105(3)_372-381.nxml.txt.nlp	21730979	SENT76	6	6	12	12	hydroxyurea	ATR	PA449942	390502;84168;545	0.976
NULL	eLife_2014_May_20_3_e01763.nxml.txt.nlp	24844244	SENT381	25	25	19	19	doxycycline	MELK	PA449415	9833	0.976
NULL	Indian_J_Dermatol_2013_Sep-Oct_58(5)_388-392.nxml.txt.nlp	24082187	SENT113	9	9	17	17	acitretin	LDE	PA448039	7957	0.976
NULL	Evid_Based_Complement_Alternat_Med_2012_Aug_27_2012_361516.nxml.txt.nlp	22969825	SENT99	14	14	5	5	verapamil	P-gp	PA451868	5243	0.976
NULL	J_Cell_Mol_Med_2013_Sep_11_17(9)_1160-1172.nxml.txt.nlp	23844832	SENT12	24	24	3	3	gefitinib	EGF	PA131301952	1950	0.976
NULL	Oncotarget_2014_May_27_5(19)_9049-9064.nxml.txt.nlp	24979294	SENT225	14	14	37	37	dasatinib	aromatase	PA162372878	1588	0.976
NULL	Acta_Pharmacol_Sin_2011_Oct_12_32(10)_1259-1265.nxml.txt.nlp	21909126	SENT96	8	8	1	1	fluvastatin	MCP-1	PA449688	6347	0.976
NULL	Arthritis_Res_Ther_2011_Apr_4_13(2)_R56.nxml.txt.nlp	21463515	SENT285	2	2	11	11	etanercept	p75	PA449515	7133;11168	0.976
NULL	Arch_Drug_Inf_2011_Mar_4(1)_1-9.nxml.txt.nlp	21572514	SENT169	20	20	26	26	ciprofloxacin	MRP1	PA449009	4437	0.976
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R91.nxml.txt.nlp	22541814	SENT111	4	4	15	15	thrombin	HO-1	PA451674	3162	0.976
NULL	Curr_Chem_Genomics_2010_Mar_1_4_1-8.nxml.txt.nlp	20448812	SENT94	3	3	20	20	estropipate	OATP1B1	PA165958342	10599	0.976
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_127043.nxml.txt.nlp	23227093	SENT165	11	11	19	19	lovastatin	RYR	PA450272	6261	0.976
NULL	Front_Oncol_2014_Jun_11_4_145.nxml.txt.nlp	24967214	SENT370	16	16	2	2	cyclophosphamide	CD4	PA449165	920	0.976
NULL	Aging_Cell_2013_Jun_27_12(3)_435-445.nxml.txt.nlp	23448364	SENT256	13	13	20	20	doxorubicin	p66	PA449412	6464	0.976
NULL	Arthritis_Res_Ther_2010_Apr_1_12(2)_R59.nxml.txt.nlp	20359360	SENT204	6	6	0	0	methylprednisolone	OAZ	PA450466	23090	0.976
NULL	Case_Rep_Oncol_2014_Jan_31_7(1)_97-101.nxml.txt.nlp	24575024	SENT68	7	7	30	30	erlotinib	EGFR	PA134687924	1956	0.976
NULL	Ther_Clin_Risk_Manag_2007_Mar_3(1)_29-40.nxml.txt.nlp	18360613	SENT80	3	3	11	11	azathioprine	TPMT	PA448515	7172	0.976
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_91-103.nxml.txt.nlp	17912639	SENT66	1	1	24	24	letrozole	HER2	PA450196	2064	0.976
NULL	Indian_J_Ophthalmol_2011_Jul-Aug_59(4)_338-339.nxml.txt.nlp	21666337	SENT34	3	3	11	11	bevacizumab	VEGF-A	PA130232992	7422	0.976
NULL	J_Oncol_2010_Jun_3_2010_732680.nxml.txt.nlp	20613952	SENT65	4	4	27	27	lenalidomide	IFN	PA162363968	3439	0.976
NULL	Biomed_Res_Int_2014_Jan_2_2014_126586.nxml.txt.nlp	24527434	SENT150	16	16	1	1	metformin	CD133	PA450395	8842	0.976
NULL	Parasit_Vectors_2010_Nov_17_3_106.nxml.txt.nlp	21083888	SENT247	0	0	3	3	fasudil	Rho	PA165946121	29984	0.976
NULL	Oncotarget_2012_Nov_29_4(1)_29-34.nxml.txt.nlp	23237847	SENT18	3	3	16	16	everolimus	aromatase	PA164746311	1588	0.976
NULL	Mol_Cancer_2012_Mar_23_11_14.nxml.txt.nlp	22439738	SENT222	28	28	11	11	fluorouracil	CD133	PA128406956	8842	0.976
NULL	Ann_Hematol_2014_Sep_10_93(1)_1-11.nxml.txt.nlp	24018623	SENT145	18	18	14	14	lenalidomide	SPARC	PA162363968	6678	0.976
NULL	Mol_Cancer_2010_Apr_12_9_75.nxml.txt.nlp	20385023	SENT115	0	0	14	14	gefitinib	EGFR	PA131301952	1956	0.976
NULL	Protein_Eng_Des_Sel_2011_Apr_14_24(4)_351-360.nxml.txt.nlp	21159620	SENT8	29	29	4	4	ampicillin	CD22	PA448419	933	0.976
NULL	Front_Mol_Neurosci_2012_Mar_15_5_33.nxml.txt.nlp	22435049	SENT145	10	10	27	27	haloperidol	AKT	PA449841	207	0.976
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT57	18	18	2	2	neratinib	HER2	PA165291472	2064	0.976
NULL	Breast_Cancer_Res_Treat_2013_Jan_8_137(2)_457-464.nxml.txt.nlp	23224144	SENT43	35	35	11	11	lapatinib	HER2	PA152241907	2064	0.976
NULL	Breast_Cancer_Res_2010_Jun_24_12(3)_R41.nxml.txt.nlp	20576088	SENT259	17	17	2	2	doxorubicin	PPM1D	PA449412	8493	0.976
NULL	Ann_Oncol_2013_Apr_31_24(4)_1067-1073.nxml.txt.nlp	23117073	SENT172	0	0	6	6	fosaprepitant	CYP3A4	PA165958390	1576	0.976
NULL	J_Oncol_2009_May_6_2009_567486.nxml.txt.nlp	19424511	SENT167	0	0	14	14	lapatinib	EGFR	PA152241907	1956	0.976
NULL	Adv_Urol_2012_Sep_9_2012_181964.nxml.txt.nlp	22991510	SENT106	0	0	8	8	gefitinib	EGFR	PA131301952	1956	0.976
NULL	J_Cell_Biol_2003_Dec_22_163(6)_1385-1395.nxml.txt.nlp	14676308	SENT218	9	9	1	1	thrombin	Rho	PA451674	29984	0.976
NULL	Breast_Cancer_Res_2013_Nov_27_15(6)_R113.nxml.txt.nlp	24283570	SENT337	21	21	0	0	estradiol	KLF4	PA449503	9314	0.976
NULL	Sensors_(Basel)_2013_Dec_27_14(1)_458-467.nxml.txt.nlp	24379050	SENT107	20	20	1	1	glucose	MTB	PA449773	54892;4498	0.976
NULL	Front_Neural_Circuits_2013_Sep_25_7_150.nxml.txt.nlp	24093008	SENT152	13	13	1	1	paraformaldehyde	P21	PA450790	1026;9338	0.976
NULL	Mol_Pain_2013_Jan_2_9_1.nxml.txt.nlp	23279936	SENT15	14	14	0	0	capsaicin	TRPV1	PA448776	7442	0.976
NULL	Oncoimmunology_2013_Jan_1_2(1)_e22890.nxml.txt.nlp	23483066	SENT52	3	3	11	11	vemurafenib	IFN	PA165946873	3439	0.976
NULL	Case_Rep_Psychiatry_2014_Sep_24_2014_659715.nxml.txt.nlp	25328745	SENT68	33	33	6	6	venlafaxine	CYP2D6	PA451866	1565	0.976
NULL	Cancers_(Basel)_2013_Nov_7_5(4)_1456-1468.nxml.txt.nlp	24213559	SENT9	0	0	20	20	bevacizumab	VEGF-A	PA130232992	7422	0.976
NULL	Acta_Pharmacol_Sin_2012_Jan_3_33(1)_49-56.nxml.txt.nlp	22212430	SENT90	41	41	5	5	thrombin	A10	PA451674	28870	0.976
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_127043.nxml.txt.nlp	23227093	SENT169	0	0	15	15	lovastatin	P-gp	PA450272	5243	0.976
NULL	Aging_(Albany_NY)_2012_Jul_31_4(7)_499-508.nxml.txt.nlp	22868943	SENT121	32	32	36	36	resveratrol	SIRT1		23411	0.976
NULL	Allergy_Asthma_Clin_Immunol_2010_Mar_17_6(1)_5.nxml.txt.nlp	20236545	SENT79	10	10	34	34	cyclosporine	IL-4	PA449167	3565	0.976
NULL	Basic_Clin_Neurosci_2014_Spring_5(2)_124-130.nxml.txt.nlp	25337370	SENT77	29	29	8	8	sulfanilamide	NO3	PA451545	4681	0.976
NULL	Autoimmune_Dis_2013_Aug_28_2013_613086.nxml.txt.nlp	24069534	SENT59	12	12	1	1	ustekinumab	p40	PA166048654	3921;339541;10314	0.976
NULL	Vet_Res_2013_Oct_2_44(1)_89.nxml.txt.nlp	24088531	SENT231	39	39	5	5	hemin	HO-1	PA449849	3162	0.976
NULL	Oncol_Lett_2013_Mar_28_5(3)_935-942.nxml.txt.nlp	23426424	SENT10	30	30	8	8	cisplatin	ERCC1	PA449014	2067	0.976
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_1-2.nxml.txt.nlp	17221160	SENT4	7	7	14	14	letrozole	aromatase	PA450196	1588	0.976
NULL	J_Neurochem_2007_Dec_103(6)_2268-2280.nxml.txt.nlp	17908240	SENT133	36	36	15	15	picrotoxin	GRK2	PA164777007	156	0.976
NULL	Exp_Diabetes_Res_2012_Dec_1_2012_642038.nxml.txt.nlp	22203837	SENT77	2	2	9	9	pioglitazone	SIRT1	PA450970	23411	0.976
NULL	Diabetes_2013_Jun_17_62(6)_1843-1854.nxml.txt.nlp	23349486	SENT159	18	18	2	2	pioglitazone	CCR2	PA450970	729230	0.976
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT158	9	9	0	0	trastuzumab	MUC1	PA451743	4582	0.976
NULL	BMJ_Open_2014_Feb_27_4(2)_e004071.nxml.txt.nlp	24578536	SENT25	7	7	24	24	warfarin	TTR	PA451906	7276	0.976
NULL	J_Cell_Sci_2011_Oct_1_124(19)_3344-3355.nxml.txt.nlp	21940797	SENT79	26	26	1	1	arsenite	PABP1	PA452638	26986;26980	0.976
NULL	Int_J_Mol_Imaging_2011_Oct_12_2011_694179.nxml.txt.nlp	22013519	SENT3	0	0	4	4	zolmitriptan	5-HT1B	PA451975	3351	0.976
NULL	Biomed_Res_Int_2013_Aug_6_2013_602987.nxml.txt.nlp	24027759	SENT264	20	20	9	9	cisplatin	SMF	PA449014	22993	0.976
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT177	33	33	8	8	phenprocoumon	VKORC1	PA450921	79001	0.976
NULL	Cancer_Cell_Int_2011_Aug_19_11_29.nxml.txt.nlp	21854619	SENT269	9	9	18	18	cisplatin	BRCA1	PA449014	672	0.976
NULL	J_Gynecol_Oncol_2014_Jan_8_25(1)_58-63.nxml.txt.nlp	24459582	SENT115	20	20	2	2	paclitaxel	ARID1A	PA450761	8289	0.976
NULL	AIDS_Res_Ther_2015_Jan_17_12(1)_2.nxml.txt.nlp	NULL	SENT34	32	32	3	3	zidovudine	CD4	PA451954	920	0.976
NULL	Eur_J_Endocrinol_2013_Apr_168(4)_557-564.nxml.txt.nlp	23345197	SENT170	13	13	2	2	diazoxide	ABCC8	PA449285	6833	0.976
NULL	J_Cancer_Res_Clin_Oncol_2012_Jul_10_138(7)_1113-1120.nxml.txt.nlp	22402597	SENT91	33	33	13	13	fludarabine	CD4	PA449655	920	0.976
NULL	Front_Oncol_2014_Mar_18_4_55.nxml.txt.nlp	24672775	SENT99	3	3	30	30	sorafenib	CR2	PA7000	1380	0.976
NULL	Pak_J_Med_Sci_2013_Nov-Dec_29(6)_1459-1461.nxml.txt.nlp	24550976	SENT39	15	15	25	25	protamine	ACT	PA10366	12;11332;9457;641455	0.976
NULL	Oncotarget_2013_Jul_26_4(8)_1317-1328.nxml.txt.nlp	23945331	SENT175	36	36	6	6	metformin	HER2	PA450395	2064	0.976
NULL	Br_J_Cancer_2010_Jun_8_102(12)_1699-1706.nxml.txt.nlp	20485286	SENT29	0	0	13	13	sunitinib	KIT	PA162372840	3815	0.976
NULL	Adv_Urol_2012_Apr_3_2012_248607.nxml.txt.nlp	22548055	SENT190	3	3	32	32	metformin	LKB1	PA450395	6794	0.976
NULL	Br_J_Cancer_2010_Jan_5_102(1)_97-103.nxml.txt.nlp	19904270	SENT156	13	13	0	0	vinorelbine	XIAP	PA451881	331	0.976
NULL	Acta_Pharmacol_Sin_2010_Jul_28_31(7)_867-873.nxml.txt.nlp	20581857	SENT154	31	31	6	6	docetaxel	PDCD4	PA449383	27250	0.976
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT87	22	22	8	8	nutlin-3	IBP		706;50619	0.976
NULL	J_Cell_Biol_1998_Aug_24_142(4)_923-936.nxml.txt.nlp	9722606	SENT288	3	3	34	34	fluorescein	TGN	PA164746009	7038	0.976
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT31	5	5	16	16	trastuzumab	HER2	PA451743	2064	0.976
NULL	Eur_J_Clin_Pharmacol_2007_Apr_21_63(4)_335-343.nxml.txt.nlp	17318526	SENT234	2	2	7	7	sulfamethoxazole	CYP2C8	PA451544	1558	0.976
NULL	Pain_Res_Treat_2012_May_14_2012_867067.nxml.txt.nlp	22666579	SENT27	0	0	5	5	capsaicin	TRPV1	PA448776	7442	0.976
NULL	J_Biol_2008_Dec_15_7(10)_38.nxml.txt.nlp	19090980	SENT72	39	39	7	7	artesunate	ACT	PA165111697	12;11332;9457;641455	0.976
NULL	Mol_Cancer_2008_Mar_26_7_27.nxml.txt.nlp	18366759	SENT277	13	13	36	36	etoposide	p53	PA449552	7157	0.976
NULL	Chin_J_Cancer_2012_Nov_31(11)_507-518.nxml.txt.nlp	22640626	SENT182	35	35	7	7	dasatinib	CAMK2G	PA162372878	818	0.976
NULL	Br_J_Cancer_2011_May_24_104(11)_1786-1790.nxml.txt.nlp	21559018	SENT102	19	19	10	10	decitabine	EGFR	PA164749631	1956	0.976
NULL	Chemother_Res_Pract_2012_Feb_12_2012_192362.nxml.txt.nlp	22400111	SENT81	17	17	11	11	temozolomide	CD133	PA451609	8842	0.976
NULL	Oncol_Rep_2013_Oct_22_30(4)_1535-1541.nxml.txt.nlp	23877481	SENT149	28	28	31	31	gefitinib	COX2	PA131301952	4513;5743	0.976
NULL	Br_J_Cancer_2010_May_11_102(10)_1503-1510.nxml.txt.nlp	20461093	SENT46	18	18	36	36	tamoxifen	AIB1	PA451581	8202	0.976
NULL	Diabetes_Care_2013_May_13_36(5)_1074-1082.nxml.txt.nlp	23275352	SENT216	8	8	25	25	liraglutide	ZAG	PA165958364	563	0.976
NULL	Parasit_Vectors_2013_Sep_25_6_280.nxml.txt.nlp	24294938	SENT232	0	0	25	25	permethrin	spatial	PA164743137	219793	0.976
NULL	Br_J_Pharmacol_2008_Oct_18_155(4)_596-605.nxml.txt.nlp	18852694	SENT159	14	14	21	21	fenofibrate	PI3K	PA449594	5290	0.976
NULL	Cell_Cycle_2013_Jan_15_12(2)_197-198.nxml.txt.nlp	23287464	SENT26	13	13	3	3	estradiol	AATK	PA449503	9625	0.976
NULL	Cancer_Cell_Int_2014_Jan_29_14_10.nxml.txt.nlp	24472145	SENT186	7	7	47	47	doxorubicin	HER2	PA449412	2064	0.976
NULL	Cancer_Cell_Int_2011_Aug_19_11_29.nxml.txt.nlp	21854619	SENT70	5	5	20	20	cisplatin	HDAC	PA449014	9734	0.976
NULL	Diabetes_2008_Sep_57(9)_2288-2295.nxml.txt.nlp	18535187	SENT193	0	0	14	14	pioglitazone	adiponectin	PA450970	9370	0.976
NULL	Biomed_Res_Int_2013_Nov_28_2013_791406.nxml.txt.nlp	24369536	SENT70	3	3	19	19	cisplatin	MDC	PA449014	6367	0.976
NULL	Breast_Cancer_Res_2004_May_18_6(4)_148-152.nxml.txt.nlp	15217485	SENT38	22	22	12	12	tamoxifen	aromatase	PA451581	1588	0.976
NULL	Br_J_Cancer_2009_Oct_6_101(7)_1155-1161.nxml.txt.nlp	19738614	SENT136	9	9	22	22	gemcitabine	14-3-3	PA449748	10971	0.976
NULL	Front_Neuroanat_2014_May_6_8_26.nxml.txt.nlp	24834029	SENT115	6	6	16	16	fluorescein	SP6	PA164746009	80320	0.976
NULL	Br_J_Cancer_2013_Mar_5_108(4)_983-992.nxml.txt.nlp	23361057	SENT32	31	31	13	13	methotrexate	PINK1	PA450428	65018	0.976
NULL	Diabetes_Care_2013_Apr_14_36(4)_943-949.nxml.txt.nlp	23111057	SENT77	24	24	1	1	filgrastim	CD34	PA449626	947	0.976
NULL	Front_Oncol_2013_Oct_31_3_271.nxml.txt.nlp	24199171	SENT367	23	23	12	12	gefitinib	EGFR	PA131301952	1956	0.976
NULL	Cells_2014_Apr_8_3(2)_258-287.nxml.txt.nlp	24717323	SENT330	9	9	0	0	thrombin	TRPM7	PA451674	54822	0.976
NULL	Indian_J_Endocrinol_Metab_2011_Jan-Mar_15(1)_9-17.nxml.txt.nlp	21584160	SENT111	20	20	15	15	exenatide	PPG	PA164749238	5552	0.976
NULL	Ann_Rheum_Dis_2014_Sep_3_73(9)_1616-1625.nxml.txt.nlp	24699939	SENT27	2	2	9	9	tocilizumab	IL-6	PA165292659	3569	0.976
NULL	Evid_Based_Complement_Alternat_Med_2015_Jan_6_2015_802903.nxml.txt.nlp	25632291	SENT19	3	3	8	8	berberine	CYP2D6	PA165860812	1565	0.976
NULL	Front_Neuroanat_2011_Aug_26_5_50.nxml.txt.nlp	21904525	SENT376	15	15	5	5	glibenclamide	ENSA	PA449782	2029	0.976
NULL	Nat_Commun_2014_Nov_19_5_5479.nxml.txt.nlp	25407222	SENT86	41	41	17	17	dextran	YTS	PA449261	8565	0.976
NULL	J_Oncol_2010_Aug_24_2010_654348.nxml.txt.nlp	20871846	SENT12	11	11	2	2	tamoxifen	aromatase	PA451581	1588	0.976
NULL	Oncogene_2010_Sep_16_29(37)_5193-5203.nxml.txt.nlp	20581867	SENT10	16	16	14	14	trastuzumab	HER2	PA451743	2064	0.976
NULL	Ann_Oncol_2014_Oct_23_25(10)_1941-1948.nxml.txt.nlp	25057173	SENT29	23	23	7	7	docetaxel	EGFR	PA449383	1956	0.976
NULL	Biosci_Rep_2014_Dec_12_34(6)_e00160.nxml.txt.nlp	25495645	SENT18	9	9	0	0	lipase	ANGPTL3	PA450239	27329	0.976
NULL	Mol_Cancer_2010_Oct_12_9_269.nxml.txt.nlp	20939893	SENT215	34	34	2	2	isoproterenol	STAT3	PA450121	6774	0.976
NULL	Breast_Cancer_Res_2011_Apr_15_13(2)_R44.nxml.txt.nlp	21496232	SENT11	10	10	3	3	erlotinib	HER2	PA134687924	2064	0.976
NULL	Mol_Cancer_2014_Jul_5_13_165.nxml.txt.nlp	24996221	SENT35	19	19	8	8	docetaxel	HMGB1	PA449383	3146	0.976
NULL	Adv_Hematol_2012_Mar_25_2012_302570.nxml.txt.nlp	22536253	SENT250	17	17	1	1	rituximab	Bcl-2	PA451261	596	0.976
NULL	Arch_Osteoporos_2007_Dec_29_2(1-2)_1-6.nxml.txt.nlp	NULL	SENT55	2	2	16	16	risedronate	sit	PA451255	55733	0.976
NULL	Hematol_Rep_2011_Nov_16_3(3)_e26.nxml.txt.nlp	22593817	SENT60	0	0	4	4	rituximab	CHOP	PA451261	1649	0.976
NULL	Genetics_2013_Mar_193(3)_853-864.nxml.txt.nlp	23267056	SENT115	12	12	5	5	hydroxyurea	GPN3	PA449942	51184	0.976
NULL	Cardiol_Res_Pract_2013_Jan_31_2013_128795.nxml.txt.nlp	23431496	SENT101	8	8	23	23	clopidogrel	CYP2C19	PA449053	1557	0.976
NULL	Br_J_Cancer_2013_Jan_15_108(1)_82-90.nxml.txt.nlp	23321512	SENT29	15	15	10	10	paclitaxel	TUBB3	PA450761	10381	0.976
NULL	ScientificWorldJournal_2014_Mar_23_2014_183147.nxml.txt.nlp	24790551	SENT81	4	4	15	15	aprepitant	NK1	PA164747039	11126	0.976
NULL	Breast_Cancer_Res_2011_Mar_1_13(2)_R21.nxml.txt.nlp	21362200	SENT155	31	31	10	10	estradiol	PI3K	PA449503	5290	0.976
NULL	J_Ophthalmol_2011_Oct_11_2011_753547.nxml.txt.nlp	21048997	SENT196	7	7	16	16	acetazolamide	ERG	PA448018	2078	0.976
NULL	Diabetes_2011_May_23_60(5)_1504-1511.nxml.txt.nlp	21421806	SENT52	13	13	1	1	dextran	HDL2	PA449261	57338	0.976
NULL	Core_Evid_2010_Oct_21_5_61-76.nxml.txt.nlp	21042543	SENT135	7	7	33	33	panitumumab	EGFR	PA162373091	1956	0.976
NULL	Environ_Health_Perspect_2008_Jan_5_116(1)_1-6.nxml.txt.nlp	18197291	SENT169	30	30	3	3	arsenite	ROS	PA452638	6098	0.976
NULL	Pediatr_Nephrol_2009_Jul_20_24(7)_1355-1361.nxml.txt.nlp	19301038	SENT110	29	29	3	3	sevelamer	PTH	PA164781197	5741	0.976
NULL	Cancer_2014_Aug_1_120(15)_2325-2333.nxml.txt.nlp	24737415	SENT102	16	16	21	21	imatinib	STEPP	PA10804	222659	0.976
NULL	Patient_Prefer_Adherence_2013_Mar_27_7_245-258.nxml.txt.nlp	23569364	SENT6	6	6	11	11	fulvestrant	aromatase	PA164747170	1588	0.976
NULL	F1000Prime_Rep_2014_Dec_1_6_117.nxml.txt.nlp	25580271	SENT66	35	35	3	3	gemcitabine	EGFR	PA449748	1956	0.976
NULL	Oncoscience_2014_Aug_21_1(8)_513-521.nxml.txt.nlp	25594058	SENT27	16	16	31	31	cisplatin	EGFR	PA449014	1956	0.976
NULL	Mol_Cancer_2008_Mar_26_7_27.nxml.txt.nlp	18366759	SENT317	23	23	1	1	etoposide	p53	PA449552	7157	0.976
NULL	Exp_Diabetes_Res_2011_Apr_6_2011_928523.nxml.txt.nlp	21603181	SENT155	0	0	10	10	haloperidol	DRD3	PA449841	1814	0.976
NULL	Cell_Death_Dis_2014_Jul_17_5(7)_e1333.nxml.txt.nlp	25032856	SENT235	19	19	7	7	candesartan	TLR4	PA448765	7099	0.976
NULL	Breast_Cancer_Res_2010_May_18_12(Suppl_1)_P3.nxml.txt.nlp	NULL	SENT10	17	17	9	9	tamoxifen	PDK1	PA451581	5170;5163	0.976
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT541	14	14	6	6	metformin	HIF-1	PA450395	29072	0.976
NULL	Cancers_(Basel)_2014_Mar_26_6(2)_708-722.nxml.txt.nlp	24675568	SENT109	17	17	4	4	afatinib	IL-6	PA165981154	3569	0.976
NULL	Arthritis_Res_Ther_2012_Jul_6_14(4)_R161.nxml.txt.nlp	22770118	SENT144	26	26	13	13	rituximab	CD95	PA451261	355	0.976
NULL	J_Immunother_2014_Apr_12_37(3)_180-186.nxml.txt.nlp	24598448	SENT30	0	0	23	23	sorafenib	IL-2	PA7000	3558	0.976
NULL	Cancers_(Basel)_2014_Dec_16_6(4)_2387-2403.nxml.txt.nlp	25521854	SENT124	0	0	17	17	sorafenib	VEGFR	PA7000	3791	0.976
NULL	J_Cardiothorac_Surg_2010_May_28_5_44.nxml.txt.nlp	20509873	SENT41	3	3	10	10	heparin	CO2	PA449855	4513	0.976
NULL	J_Cell_Biol_2005_Jul_4_170(1)_37-47.nxml.txt.nlp	15998798	SENT241	8	8	0	0	doxycycline	CRT	PA449415	811	0.976
NULL	Nucleic_Acids_Res_2013_Dec_14_41(22)_10334-10344.nxml.txt.nlp	24038466	SENT20	21	21	12	12	camptothecin	CtIP	PA153590860	5932	0.976
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT161	2	2	7	7	tacrolimus	RANKL	PA451578	8600	0.976
NULL	Mol_Pain_2012_Sep_24_8_73.nxml.txt.nlp	23006841	SENT203	2	2	20	20	ketoconazole	TRPV1	PA450146	7442	0.976
NULL	Cardiol_Res_Pract_2013_Jan_31_2013_128795.nxml.txt.nlp	23431496	SENT164	31	31	5	5	clopidogrel	CYP2C19	PA449053	1557	0.976
NULL	Ther_Clin_Risk_Manag_2007_Jun_3(3)_363-379.nxml.txt.nlp	18488081	SENT95	6	6	17	17	rabeprazole	CYP2C19	PA451216	1557	0.976
NULL	Oxid_Med_Cell_Longev_2012_Jun_3_2012_914273.nxml.txt.nlp	22701758	SENT200	6	6	18	18	resveratrol	SIRT1		23411	0.976
NULL	Open_Biochem_J_2011_Sep_23_5_45-51.nxml.txt.nlp	21966325	SENT109	39	39	19	19	diclofenac	p50	PA449293	958;4790	0.976
NULL	J_Antimicrob_Chemother_2011_Feb_31_66(2)_265-272.nxml.txt.nlp	21196489	SENT52	14	14	3	3	maraviroc	RTR	PA164768835	2649	0.976
NULL	EPMA_J_2010_Sep_4_1(3)_485-494.nxml.txt.nlp	23199090	SENT157	19	19	5	5	leucovorin	MTHFR	PA450198	4524	0.976
NULL	EPMA_J_2013_Jan_28_4(1)_3.nxml.txt.nlp	23356214	SENT310	22	22	33	33	cetuximab	PIK3CA	PA10040	5290	0.976
NULL	Asian_Spine_J_2014_Jun_9_8(3)_315-321.nxml.txt.nlp	24967045	SENT54	31	31	18	18	sparfloxacin	AKT	PA451472	207	0.976
NULL	Br_J_Cancer_2012_Jan_3_106(1)_18-24.nxml.txt.nlp	22108516	SENT33	24	24	5	5	irinotecan	UGT1A1	PA450085	54658	0.976
NULL	Arch_Drug_Inf_2011_Mar_4(1)_1-9.nxml.txt.nlp	21572514	SENT147	8	8	12	12	verapamil	P-gp	PA451868	5243	0.976
NULL	Oncotarget_2014_Feb_7_5(3)_775-787.nxml.txt.nlp	24519956	SENT188	26	26	0	0	dasatinib	PC3	PA162372878	57332;7832;5122	0.976
NULL	Comp_Hepatol_2004_Jan_14_3(Suppl_1)_S31.nxml.txt.nlp	14960183	SENT69	5	5	25	25	ethanol	TNF-alpha	PA448073	7124	0.976
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT158	9	9	2	2	trastuzumab	MUC4	PA451743	4585	0.976
NULL	Br_J_Pharmacol_2008_Sep_9_155(1)_127-137.nxml.txt.nlp	18536750	SENT185	29	29	3	3	piroxicam	IL-10	PA450985	3586	0.976
NULL	ScientificWorldJournal_2012_Apr_24_2012_194848.nxml.txt.nlp	22619624	SENT97	1	1	18	18	pilocarpine	DES	PA450962	1674	0.976
NULL	J_Korean_Assoc_Oral_Maxillofac_Surg_2014_Dec_26_40(6)_291-296.nxml.txt.nlp	25551094	SENT19	11	11	0	0	alendronate	OPG	PA448082	690	0.976
NULL	Br_J_Cancer_2011_Jul_26_105(3)_407-412.nxml.txt.nlp	21730976	SENT100	17	17	34	34	pha-665752	STAT3		6774	0.976
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_39-54.nxml.txt.nlp	19305787	SENT237	14	14	25	25	ethanol	NR1	PA448073	27158	0.976
NULL	Oncol_Lett_2014_Nov_14_8(5)_2086-2092.nxml.txt.nlp	25295095	SENT137	5	5	13	13	gemcitabine	LKB1	PA449748	6794	0.976
NULL	Carcinogenesis_2014_May_13_35(5)_1055-1066.nxml.txt.nlp	24419232	SENT192	31	31	0	0	metformin	AMPK	PA450395	5563	0.976
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_7-17.nxml.txt.nlp	17912633	SENT95	10	10	17	17	letrozole	ACTH	PA450196	5443	0.976
NULL	J_Hematol_Oncol_2013_Jun_3_6_38.nxml.txt.nlp	23731980	SENT154	0	0	12	12	afatinib	HER2	PA165981154	2064	0.976
NULL	Breast_Cancer_Res_2008_Mar_27_10(2)_R27.nxml.txt.nlp	18371219	SENT176	28	28	11	11	paclitaxel	PIK3CA	PA450761	5290	0.976
NULL	Br_J_Cancer_1998_Oct_78(8)_1024-1029.nxml.txt.nlp	9792145	SENT12	36	36	24	24	carboplatin	CD34	PA448803	947	0.976
NULL	Biomed_Res_Int_2014_May_15_2014_608296.nxml.txt.nlp	24949460	SENT139	23	23	5	5	novobiocin	MPN	PA164768819	83886	0.976
NULL	Case_Rep_Psychiatry_2014_Nov_4_2014_489493.nxml.txt.nlp	25530900	SENT106	0	0	6	6	ziprasidone	CYP3A4	PA451974	1576	0.976
NULL	J_Infect_Chemother_2012_Oct_28_18(5)_753-755.nxml.txt.nlp	22203121	SENT22	4	4	20	20	flutamide	EMP	PA449685	10296	0.976
NULL	Neuropsychopharmacology_2009_Sep_20_34(10)_2275-2284.nxml.txt.nlp	19458612	SENT167	31	31	17	17	citalopram	5-HT1A	PA449015	3350	0.976
NULL	Crit_Care_2011_Aug_11_15(4)_226.nxml.txt.nlp	21892977	SENT347	15	15	5	5	vasopressin	LNPEP	PA451858	4012	0.976
NULL	Breast_Cancer_(Auckl)_2009_Sep_2_3_61-75.nxml.txt.nlp	19809577	SENT117	29	29	6	6	curcumin	BRCA1	PA151958596	672	0.976
NULL	Biomed_Res_Int_2013_Jan_21_2013_581631.nxml.txt.nlp	23484133	SENT96	36	36	15	15	infliximab	IFN	PA452639	3439	0.976
NULL	Breast_Cancer_Res_2007_Dec_20_9(Suppl_2)_S19.nxml.txt.nlp	NULL	SENT33	21	21	8	8	letrozole	NRIP1	PA450196	8204	0.976
NULL	Curr_Neuropharmacol_2014_May_12(3)_219-238.nxml.txt.nlp	24851087	SENT312	16	16	3	3	clozapine	5-HT2A	PA449061	3356	0.976
NULL	Nat_Commun_2013_Sep_17_4_2464.nxml.txt.nlp	24043118	SENT121	33	33	39	39	estradiol	FGF10	PA449503	2255	0.976
NULL	Br_J_Clin_Pharmacol_2013_Aug_23_76(2)_299-315.nxml.txt.nlp	23701319	SENT230	16	16	5	5	rituximab	IL-2	PA451261	3558	0.976
NULL	Aging_(Albany_NY)_2009_Apr_21_1(4)_402-411.nxml.txt.nlp	20148189	SENT157	15	15	0	0	bleomycin	HCA2	PA448645	139081;55811;338442	0.976
NULL	Case_Rep_Infect_Dis_2011_Jun_30_2011_530568.nxml.txt.nlp	22570799	SENT11	27	27	3	3	methotrexate	TNF-alpha	PA450428	7124	0.976
NULL	Med_Sci_Monit_2012_Jan_1_18(1)_RA1-RA11.nxml.txt.nlp	22207127	SENT188	0	0	14	14	estradiol	BSP	PA449503	3381	0.976
NULL	Breast_Cancer_Res_2010_Jun_28_12(3)_R43.nxml.txt.nlp	20579400	SENT141	0	0	25	25	paclitaxel	MAPT	PA450761	4137	0.976
NULL	Biochemistry_2009_Feb_3_48(4)_800-809.nxml.txt.nlp	19132922	SENT306	8	8	25	25	penciclovir	XOR	PA450839	7498	0.976
NULL	Diabetes_2009_Apr_16_58(4)_975-983.nxml.txt.nlp	19151200	SENT114	3	3	32	32	liraglutide	LIR	PA165958364	10871	0.976
NULL	J_Pregnancy_2012_Sep_17_2012_482690.nxml.txt.nlp	23029616	SENT183	18	18	5	5	glucose	GLP-1	PA449773	100125288	0.976
NULL	Arthritis_Res_Ther_2006_Dec_28_8(1)_R18.nxml.txt.nlp	16507118	SENT75	39	39	17	17	infliximab	ACR	PA452639	49	0.976
NULL	J_Int_Soc_Sports_Nutr_2015_Jan_21_12(1)_5.nxml.txt.nlp	NULL	SENT213	11	11	28	28	curcumin	IL-6	PA151958596	3569	0.976
NULL	BMB_Rep_2014_Apr_47(4)_221-226.nxml.txt.nlp	24286312	SENT111	17	17	3	3	nutlin-3	p53		7157	0.976
NULL	Calcif_Tissue_Int_2011_Aug_3_89(2)_91-104.nxml.txt.nlp	21637997	SENT147	0	0	9	9	denosumab	RANK	PA166048634	8792	0.976
NULL	Cancer_Manag_Res_2013_Nov_21_5_387-400.nxml.txt.nlp	24294007	SENT47	2	2	25	25	panitumumab	EGFR	PA162373091	1956	0.976
NULL	Acta_Pharmacol_Sin_2009_Jul_22_30(7)_994-1000.nxml.txt.nlp	19543302	SENT53	25	25	2	2	heparin	BMP6	PA449855	654	0.976
NULL	Cell_Death_Dis_2012_Jun_21_3(6)_e327.nxml.txt.nlp	22717582	SENT187	34	34	15	15	doxorubicin	BAK	PA449412	578	0.976
NULL	Indian_J_Med_Res_2014_Aug_140(2)_209-215.nxml.txt.nlp	25297352	SENT127	24	24	5	5	carbamazepine	CLB	PA448785	171425	0.976
NULL	Nat_Genet_2011_Feb_26_43(2)_153-158.nxml.txt.nlp	21186352	SENT40	16	16	23	23	geldanamycin	Hsp90	PA152031327	3320	0.976
NULL	J_Clin_Biochem_Nutr_2011_Mar_26_48(2)_170-177.nxml.txt.nlp	21373272	SENT156	35	35	15	15	pioglitazone	CANX	PA450970	821	0.976
NULL	Int_J_Hypertens_2012_Feb_8_2012_189512.nxml.txt.nlp	22518281	SENT128	10	10	15	15	hemin	HO-1	PA449849	3162	0.976
NULL	Br_J_Clin_Pharmacol_2011_Oct_72(4)_647-657.nxml.txt.nlp	21518389	SENT217	8	8	1	1	ticagrelor	P2Y12	PA165374673	64805	0.976
NULL	Oncogene_2010_Sep_16_29(37)_5193-5203.nxml.txt.nlp	20581867	SENT114	23	23	10	10	lapatinib	PI3K	PA152241907	5290	0.976
NULL	ScientificWorldJournal_2012_Apr_1_2012_381434.nxml.txt.nlp	22545017	SENT380	5	5	14	14	aprepitant	NK-1	PA164747039	27087	0.976
NULL	Oncogene_2013_Sep_26_32(39)_10_1038_onc_2012_491.nxml.txt.nlp	23108394	SENT90	23	23	13	13	epirubicin	BRIP1	PA449476	64979;83990	0.976
NULL	Ann_Saudi_Med_2011_Jul-Aug_31(4)_417-420.nxml.txt.nlp	21293067	SENT36	23	23	7	7	didanosine	CD4	PA449301	920	0.976
NULL	J_Int_Soc_Sports_Nutr_2011_Nov_7_8(Suppl_1)_P23.nxml.txt.nlp	NULL	SENT6	15	15	24	24	creatine	FFM	PA164778930	24	0.976
NULL	Environ_Health_Perspect_2007_Jul_5_115(7)_1094-1100.nxml.txt.nlp	17637928	SENT300	23	23	9	9	etoposide	Bcl-2	PA449552	596	0.976
NULL	Clin_Ophthalmol_2010_Oct_21_4_1229-1236.nxml.txt.nlp	21060677	SENT93	34	34	0	0	tafluprost	BAK	PA165958432	578	0.976
NULL	Stroke_Res_Treat_2012_Feb_28_2012_904534.nxml.txt.nlp	22577603	SENT49	27	27	15	15	clopidogrel	ADP	PA449053	23038	0.976
NULL	Front_Oncol_2013_Sep_11_3_228.nxml.txt.nlp	24062981	SENT189	19	19	12	12	topotecan	PARP1	PA451729	142	0.976
NULL	Arthritis_Res_Ther_2014_Jul_18_16(4)_R153.nxml.txt.nlp	25037855	SENT31	0	0	17	17	adalimumab	p55	PA10004	6624;2078;8503;5718	0.976
NULL	Exp_Diabetes_Res_2012_Jul_5_2012_905683.nxml.txt.nlp	22829806	SENT24	0	0	25	25	rosiglitazone	gamma	PA451283	9913	0.976
NULL	Adv_Hematol_2012_Nov_20_2012_861060.nxml.txt.nlp	23251161	SENT61	0	0	12	12	lenalidomide	IFN	PA162363968	3439	0.976
NULL	Curr_Med_Chem_2014_Jul_21_663-688.nxml.txt.nlp	24251566	SENT354	12	12	24	24	celecoxib	spatial	PA448871	219793	0.976
NULL	Clin_Ophthalmol_2009_Jun_2_3_155-166.nxml.txt.nlp	19668560	SENT138	3	3	22	22	bevacizumab	VEGF-A	PA130232992	7422	0.976
NULL	Biomed_Res_Int_2013_Jan_16_2013_290575.nxml.txt.nlp	23484104	SENT57	0	0	31	31	tamoxifen	c-Myc	PA451581	4609	0.976
NULL	Int_J_Mol_Sci_2014_Mar_14_15(3)_4531-4549.nxml.txt.nlp	24637936	SENT128	9	9	25	25	suramin	P2X4	PA10292	5025	0.976
NULL	J_Virol_2014_Jan_88(1)_710-716.nxml.txt.nlp	24173230	SENT27	16	16	28	28	cyclosporine	CD4	PA449167	920	0.976
NULL	Diabetes_2013_Jun_17_62(6)_1913-1922.nxml.txt.nlp	23349495	SENT176	15	15	37	37	sildenafil	VASP	PA451346	7408	0.976
NULL	Oncol_Lett_2014_Oct_28_8(4)_1563-1566.nxml.txt.nlp	25202368	SENT28	0	0	13	13	gefitinib	EGFR	PA131301952	1956	0.976
NULL	J_Gen_Physiol_1997_Dec_1_110(6)_643-654.nxml.txt.nlp	9382893	SENT133	11	11	26	26	diazoxide	ADP	PA449285	23038	0.976
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT259	8	8	19	19	metformin	EGFR	PA450395	1956	0.976
NULL	Pharmaceutics_2011_Jul_13_3(3)_425-439.nxml.txt.nlp	24310588	SENT84	23	23	1	1	methylphenidate	SERS	PA450464	6301;54938	0.976
NULL	Jpn_Clin_Med_2013_Mar_6_4_7-13.nxml.txt.nlp	23966811	SENT97	21	21	37	37	esomeprazole	ESD	PA10075	2098	0.976
NULL	Oncotarget_2011_Mar_11_2(3)_135-164.nxml.txt.nlp	21411864	SENT238	0	0	32	32	sorafenib	BRAF	PA7000	673	0.976
NULL	Br_J_Cancer_2012_Mar_27_106(7)_1268-1273.nxml.txt.nlp	22415232	SENT31	0	0	19	19	tegafur	DPD	PA452620	1806	0.976
NULL	Ann_Clin_Microbiol_Antimicrob_2009_Jan_15_8_2.nxml.txt.nlp	19146672	SENT26	12	12	1	1	pyrazinamide	EMB	PA451182	133418	0.976
NULL	Curr_Cardiol_Rev_2012_Aug_8(3)_239-249.nxml.txt.nlp	22935021	SENT80	0	0	7	7	ticagrelor	P2Y12	PA165374673	64805	0.976
NULL	Pharmaceuticals_(Basel)_2013_May_23_6(6)_689-699.nxml.txt.nlp	24276256	SENT141	8	8	15	15	salmeterol	PTB	PA451300	58155	0.976
NULL	Oncotarget_2014_Jun_19_5(15)_6540-6551.nxml.txt.nlp	25153728	SENT114	33	33	18	18	paclitaxel	Bcl-2	PA450761	596	0.976
NULL	Cancer_Cell_Int_2013_Mar_4_13_21.nxml.txt.nlp	23497288	SENT176	22	22	36	36	doxorubicin	p53	PA449412	7157	0.976
NULL	Endocrinol_Diabetes_Metab_Case_Rep_2013_Nov_8_2013_130041.nxml.txt.nlp	24616771	SENT113	32	32	1	1	diazoxide	ABCC8	PA449285	6833	0.976
NULL	J_Biomed_Biotechnol_2011_Jul_6_2011_783528.nxml.txt.nlp	21785566	SENT191	14	14	4	4	metoprolol	CYP2D6	PA450480	1565	0.976
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT11	16	16	3	3	dasatinib	ABCG2	PA162372878	9429	0.976
NULL	Mol_Biol_Rep_2013_May_11_40(8)_5013-5026.nxml.txt.nlp	23666059	SENT229	20	20	5	5	resveratrol	MDM2		4193	0.976
NULL	Int_J_Mol_Sci_2014_Jun_25_15(7)_11324-11349.nxml.txt.nlp	24968272	SENT1301	9	9	16	16	methotrexate	TNF-alpha	PA450428	7124	0.976
NULL	CNS_Drugs_2014_Apr_11_28(6)_535-558.nxml.txt.nlp	24723124	SENT361	17	17	0	0	alemtuzumab	IFN	PA164783958	3439	0.976
NULL	Br_J_Cancer_2006_Dec_4_95(11)_1483-1489.nxml.txt.nlp	17106442	SENT75	11	11	15	15	gefitinib	EGFR	PA131301952	1956	0.976
NULL	Emerg_Infect_Dis_2014_Apr_20(4)_701-704.nxml.txt.nlp	24655438	SENT58	15	15	3	3	ampicillin	CT28	PA448419	51213	0.976
NULL	Acta_Physiol_(Oxf)_2008_Apr_192(4)_505-517.nxml.txt.nlp	17973950	SENT209	21	21	40	40	propranolol	LQT3	PA451145	6331	0.976
NULL	J_Obes_2011_Dec_29_2011_957268.nxml.txt.nlp	21253513	SENT27	0	0	18	18	rimonabant	adiponectin	PA152407999	9370	0.976
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT133	16	16	5	5	trastuzumab	HER2	PA451743	2064	0.976
NULL	Ann_Thorac_Med_2013_Oct-Dec_8(4)_204-208.nxml.txt.nlp	24250733	SENT26	0	0	22	22	gefitinib	EGFR	PA131301952	1956	0.976
NULL	Oncotarget_2011_Jan_25_2(1-2)_8-17.nxml.txt.nlp	21378407	SENT45	9	9	0	0	thrombin	PAR-1	PA451674	2011;2149	0.976
NULL	Leukemia_2014_Apr_14_28(4)_961-964.nxml.txt.nlp	24418991	SENT5	7	7	18	18	nilotinib	P-gp	PA165958345	5243	0.976
NULL	Philos_Trans_R_Soc_Lond_B_Biol_Sci_2008_Dec_12_363(1511)_3859-3874.nxml.txt.nlp	18829425	SENT195	13	13	31	31	l-tryptophan	PDG	PA10323	26227	0.976
NULL	Cancer_Manag_Res_2013_Jun_7_5_91-101.nxml.txt.nlp	23785245	SENT145	30	30	11	11	gefitinib	EGFR	PA131301952	1956	0.976
NULL	Indian_Dermatol_Online_J_2014_Dec_5(Suppl_2)_S76-S86.nxml.txt.nlp	25593813	SENT292	12	12	3	3	allopurinol	HLA-B	PA448320	3106	0.976
NULL	J_Lipid_Res_2014_Feb_55(2)_307-312.nxml.txt.nlp	24262094	SENT159	29	29	15	15	lipase	CLPS	PA450239	1208	0.976
NULL	Cardiol_Res_Pract_2013_Feb_19_2013_195456.nxml.txt.nlp	23533940	SENT110	24	24	11	11	clopidogrel	CYP2C19	PA449053	1557	0.976
NULL	Br_J_Cancer_2012_Jan_17_106(2)_284-289.nxml.txt.nlp	22215065	SENT44	12	12	4	4	atrasentan	IFN	PA143414738	3439	0.976
NULL	Breast_Cancer_Res_2011_Jun_29_13(3)_R70.nxml.txt.nlp	21707964	SENT184	42	42	13	13	tamoxifen	14-3-3	PA451581	10971	0.976
NULL	Cancer_Cell_Int_2008_Jan_4_8_1.nxml.txt.nlp	18177496	SENT68	18	18	38	38	gefitinib	EGFR	PA131301952	1956	0.976
NULL	J_Gynecol_Oncol_2012_Jan_9_23(1)_53-64.nxml.txt.nlp	22355468	SENT194	15	15	18	18	exemestane	aromatase	PA449563	1588	0.976
NULL	Oncogene_2010_Jul_22_29(29)_4170-4182.nxml.txt.nlp	20498638	SENT31	18	18	3	3	paclitaxel	EGFR	PA450761	1956	0.976
NULL	Diabetes_2011_Mar_21_60(3)_797-809.nxml.txt.nlp	21266330	SENT214	20	20	8	8	rosiglitazone	FATP1	PA451283	376497	0.976
NULL	Cardiol_Ther_2013_Jun_27_2(1)_1-16.nxml.txt.nlp	25135285	SENT187	6	6	0	0	metformin	GLP-1	PA450395	100125288	0.976
NULL	Curr_Genomics_2014_Jun_15(3)_217-230.nxml.txt.nlp	24955029	SENT199	9	9	43	43	oxygen	ROS	PA450744	6098	0.976
NULL	Virol_J_2010_Oct_15_7_271.nxml.txt.nlp	20950422	SENT74	12	12	4	4	collagenase	C15	PA449107	51316	0.976
NULL	Exp_Lung_Res_2013_Oct_1_39(8)_336-348.nxml.txt.nlp	23919450	SENT205	9	9	3	3	thrombin	PAR-1	PA451674	2011;2149	0.976
NULL	Oncogene_2010_Sep_23_29(38)_5299-5310.nxml.txt.nlp	20622903	SENT174	39	39	6	6	trypsin	HMGB1	PA451806	3146	0.976
NULL	Oncoimmunology_2014_May_29_3_e28925.nxml.txt.nlp	25083322	SENT109	6	6	36	36	dasatinib	CD4	PA162372878	920	0.976
NULL	Onco_Targets_Ther_2014_Dec_3_7_2227-2236.nxml.txt.nlp	25506226	SENT104	4	4	17	17	trastuzumab	HER2	PA451743	2064	0.976
NULL	Diabetes_2011_Nov_17_60(11)_2701-2709.nxml.txt.nlp	21885869	SENT203	29	29	12	12	phenylephrine	PPG	PA450935	5552	0.976
NULL	Front_Mol_Neurosci_2009_Nov_4_2_14.nxml.txt.nlp	19915732	SENT153	12	12	3	3	carrageenan	COX	PA448814	1351	0.976
NULL	Behav_Brain_Funct_2010_Aug_30_6_50.nxml.txt.nlp	20799992	SENT120	11	11	15	15	amphetamine	ADORA2A	PA448408	135	0.976
NULL	Oncotarget_2014_Oct_15_5(21)_10763-10777.nxml.txt.nlp	25333257	SENT225	0	0	10	10	tariquidar	P-gp		5243	0.976
NULL	Br_J_Cancer_2012_Oct_9_107(8)_1277-1285.nxml.txt.nlp	22990652	SENT164	1	1	23	23	paclitaxel	CYP2C8	PA450761	1558	0.976
NULL	J_Breast_Cancer_2013_Dec_31_16(4)_386-394.nxml.txt.nlp	24454460	SENT110	23	23	3	3	tamoxifen	p53	PA451581	7157	0.976
NULL	Arthritis_Res_Ther_2013_Dec_5_15(6)_R208.nxml.txt.nlp	24314202	SENT196	32	32	1	1	chymotrypsin	PPIase	PA448994	2281;2289;8468;2286;2287	0.976
NULL	Cell_Death_Differ_2010_Oct_30_17(10)_1624-1635.nxml.txt.nlp	20431602	SENT167	5	5	28	28	paclitaxel	Mcl-1	PA450761	4170	0.976
NULL	J_Immunol_Res_2014_Jul_6_2014_613136.nxml.txt.nlp	25136646	SENT95	31	31	12	12	chloroquine	HGB	PA448948	114757	0.976
NULL	EMBO_Mol_Med_2012_Aug_16_4(8)_743-760.nxml.txt.nlp	22593025	SENT193	18	18	5	5	gefitinib	EGF	PA131301952	1950	0.976
NULL	Oncotarget_2013_Nov_15_5(6)_1458-1474.nxml.txt.nlp	24681547	SENT213	20	20	4	4	celecoxib	CDH11	PA448871	1009	0.976
NULL	Int_J_Breast_Cancer_2012_Dec_31_2012_412581.nxml.txt.nlp	23346407	SENT116	6	6	42	42	atorvastatin	CO2	PA448500	4513	0.976
NULL	Nat_Genet_2013_Jul_2_45(7)_739-746.nxml.txt.nlp	23727861	SENT177	6	6	28	28	ethanol	H19	PA448073	283120	0.976
NULL	Lab_Anim_Res_2012_Jun_26_28(2)_109-114.nxml.txt.nlp	22787484	SENT6	29	29	4	4	reserpine	MKP-1	PA451236	1843	0.976
NULL	Oncotarget_2013_Nov_23_5(1)_196-210.nxml.txt.nlp	24344116	SENT212	34	34	14	14	doxorubicin	p53	PA449412	7157	0.976
NULL	J_Korean_Med_Sci_2006_Jun_21_21(3)_418-424.nxml.txt.nlp	16778382	SENT158	11	11	0	0	hemin	HO-1	PA449849	3162	0.976
NULL	Br_J_Cancer_2011_Aug_9_105(4)_498-504.nxml.txt.nlp	21792197	SENT155	20	20	6	6	cisplatin	EGFR	PA449014	1956	0.976
NULL	EPMA_J_2015_Jan_22_6(1)_1.nxml.txt.nlp	25628770	SENT159	26	26	11	11	bevacizumab	KRAS	PA130232992	3845	0.976
NULL	Oncotarget_2010_May_27_1(2)_89-103.nxml.txt.nlp	20671809	SENT260	19	19	22	22	nutlin-3	MDM2		4193	0.976
NULL	J_Oncol_2012_Apr_10_2012_931071.nxml.txt.nlp	22570654	SENT8	3	3	22	22	plerixafor	CD34	PA165958410	947	0.976
NULL	Arthritis_Res_Ther_2013_Mar_25_15(Suppl_1)_S3.nxml.txt.nlp	23566754	SENT98	5	5	27	27	rituximab	CD27	PA451261	939	0.976
NULL	Acta_Pharmacol_Sin_2009_Sep_17_30(9)_1316-1322.nxml.txt.nlp	19684609	SENT198	18	18	8	8	rosiglitazone	PTEN	PA451283	5728	0.976
NULL	EMBO_Mol_Med_2012_Sep_7_4(9)_896-909.nxml.txt.nlp	22887866	SENT240	3	3	22	22	lovastatin	SREBF1	PA450272	6720	0.976
NULL	Indian_J_Med_Res_2011_Jan_133(1)_15-26.nxml.txt.nlp	21321416	SENT230	21	21	2	2	minocycline	p38	PA450519	10598;1432;7965	0.976
NULL	Oncotarget_2011_Jan_28_3(1)_31-43.nxml.txt.nlp	22289787	SENT144	30	30	26	26	gefitinib	EGFR	PA131301952	1956	0.976
NULL	ASN_Neuro_2010_Aug_11_2(4)_e00040.nxml.txt.nlp	20711301	SENT34	0	0	19	19	novobiocin	Hsp90	PA164768819	3320	0.976
NULL	Nat_Chem_Biol_2010_Apr_28_6(4)_291-299.nxml.txt.nlp	20190765	SENT278	21	21	9	9	erlotinib	EGFR	PA134687924	1956	0.976
NULL	Pharmaceuticals_(Basel)_2013_Apr_8_6(4)_500-509.nxml.txt.nlp	24276120	SENT128	24	24	7	7	entacapone	GPR35	PA164748726	2859	0.976
NULL	Exp_Diabetes_Res_2012_Mar_15_2012_146194.nxml.txt.nlp	22474415	SENT209	8	8	24	24	valsartan	GLP-1	PA451848	100125288	0.976
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Sep_27_64(Pt_10)_o2027.nxml.txt.nlp	21201221	SENT58	17	17	12	12	ethanol	mol	PA448073	90527	0.976
NULL	Breast_Cancer_Res_2010_Mar_5_12(2)_R16.nxml.txt.nlp	20205716	SENT346	3	3	25	25	lovastatin	NDRG1	PA450272	10397	0.976
NULL	Cancer_Cell_Int_2009_Sep_10_9_25.nxml.txt.nlp	19744341	SENT153	6	6	13	13	glucosamine	STAT3	PA164747613	6774	0.976
NULL	EMBO_Mol_Med_2014_Oct_17_6(10)_1294-1311.nxml.txt.nlp	25231413	SENT144	9	9	17	17	calcein	PC3	PA132595336	57332;7832;5122	0.976
NULL	Front_Genet_2014_Nov_14_5_391.nxml.txt.nlp	25452763	SENT80	13	13	5	5	cisplatin	ERCC5	PA449014	2073	0.976
NULL	Bioinformation_2011_Sep_28_7(3)_130-133.nxml.txt.nlp	22125383	SENT48	7	7	26	26	clotrimazole	PLP1	PA449057	5354	0.976
NULL	Arthritis_Res_Ther_2006_Jul_26_8(4)_R132.nxml.txt.nlp	16872482	SENT387	15	15	8	8	pp2	MIF		4282;6280	0.976
NULL	Aging_(Albany_NY)_2009_Mar_31_1(4)_412-424.nxml.txt.nlp	20195491	SENT95	7	7	17	17	resveratrol	TXNIP		10628	0.976
NULL	Mol_Vis_2012_Nov_29_18_2839-2846.nxml.txt.nlp	23233786	SENT190	30	30	11	11	sr144528	CB2		1269	0.976
NULL	J_Exp_Clin_Cancer_Res_2009_Aug_19_28(1)_116.nxml.txt.nlp	19689822	SENT61	0	0	18	18	rituximab	CHOP	PA451261	1649	0.976
NULL	Br_J_Cancer_2014_Jan_21_110(2)_510-519.nxml.txt.nlp	24327015	SENT212	27	27	13	13	docetaxel	PLK1	PA449383	5347	0.976
NULL	J_Hematol_Oncol_2013_Jun_3_6_38.nxml.txt.nlp	23731980	SENT42	0	0	14	14	lapatinib	HER2	PA152241907	2064	0.976
NULL	Mol_Biol_Int_2014_Sep_7_2014_852748.nxml.txt.nlp	25276427	SENT154	0	0	18	18	lapatinib	HER2	PA152241907	2064	0.976
NULL	Int_J_Mol_Sci_2014_Oct_27_15(11)_19444-19457.nxml.txt.nlp	25350110	SENT150	25	25	0	0	neomycin	EAAC1	PA450608	6505	0.976
NULL	Nat_Commun_2013_4_1963.nxml.txt.nlp	23739639	SENT123	26	26	47	47	heparin	MARCO	PA449855	8685	0.976
NULL	Br_J_Cancer_1999_May_1_80(3-4)_331-337.nxml.txt.nlp	10408834	SENT9	26	26	2	2	genistein	FMLP	PA165109660	2357	0.976
NULL	Case_Rep_Transplant_2014_Jan_2_2014_548243.nxml.txt.nlp	24575309	SENT21	0	0	9	9	ranolazine	CYP3A	PA164746007	1574	0.976
NULL	J_Oncol_2010_Jan_14_2010_740472.nxml.txt.nlp	20130818	SENT142	0	0	16	16	pertuzumab	ERBB4		2066	0.976
NULL	Anc_Sci_Life_2012_Apr-Jun_31(4)_151-159.nxml.txt.nlp	23661861	SENT78	3	3	32	32	cyclophosphamide	IL-2	PA449165	3558	0.976
NULL	Arthritis_Res_Ther_2009_Nov_24_11(6)_134.nxml.txt.nlp	20017888	SENT30	21	21	8	8	rituximab	CD19	PA451261	930	0.976
NULL	Oncotarget_2012_Oct_20_3(10)_1068-1111.nxml.txt.nlp	23085539	SENT849	21	21	19	19	erlotinib	EGFR	PA134687924	1956	0.976
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT72	0	0	47	47	metformin	LKB1	PA450395	6794	0.976
NULL	Curr_Neuropharmacol_2012_Jun_10(2)_124-133.nxml.txt.nlp	23204982	SENT104	6	6	17	17	oxcarbazepine	MDR1	PA450732	5243	0.976
NULL	Br_J_Cancer_2009_Sep_15_101(6)_957-966.nxml.txt.nlp	19738618	SENT167	17	17	8	8	dexrazoxane	THBS-1	PA449259	7057	0.976
NULL	Cell_Death_Dis_2014_Jul_31_5(7)_e1358.nxml.txt.nlp	25077544	SENT40	35	35	15	15	etoposide	PC-3	PA449552	692094	0.976
NULL	Mediators_Inflamm_2010_May_18_2010_359732.nxml.txt.nlp	20508722	SENT178	5	5	19	19	hemin	JNK	PA449849	5599	0.976
NULL	Int_J_Mol_Sci_2012_Feb_1_13(2)_1512-1523.nxml.txt.nlp	22408405	SENT282	2	2	5	5	olmesartan	AT1	PA164742950	9197;185	0.976
NULL	J_Korean_Med_Sci_2007_Apr_30_22(2)_283-289.nxml.txt.nlp	17449938	SENT189	9	9	3	3	minoxidil	P21	PA450521	1026;9338	0.976
NULL	Int_J_Gen_Med_2009_Jul_30_2_91-108.nxml.txt.nlp	20360893	SENT196	23	23	2	2	methotrexate	PC-3	PA450428	692094	0.976
NULL	Case_Rep_Oncol_2010_May_7_3(2)_154-159.nxml.txt.nlp	20740189	SENT27	3	3	36	36	panitumumab	KRAS	PA162373091	3845	0.976
NULL	Core_Evid_2010_Oct_21_5_61-76.nxml.txt.nlp	21042543	SENT259	36	36	17	17	panitumumab	PI3K	PA162373091	5290	0.976
NULL	Oxid_Med_Cell_Longev_2013_Nov_28_2013_568093.nxml.txt.nlp	24379901	SENT50	1	1	8	8	resveratrol	SIRT1		23411	0.976
NULL	Biomed_Res_Int_2013_May_28_2013_919374.nxml.txt.nlp	23781510	SENT207	0	0	9	9	denosumab	RANKL	PA166048634	8600	0.976
NULL	J_Clin_Biochem_Nutr_2011_Mar_26_48(2)_170-177.nxml.txt.nlp	21373272	SENT156	35	35	17	17	pioglitazone	ERP70	PA450970	9601	0.976
NULL	Indian_J_Med_Res_2012_Apr_135(4)_500-505.nxml.txt.nlp	22664497	SENT12	17	17	12	12	estradiol	adiponectin	PA449503	9370	0.976
NULL	J_Oncol_2012_Mar_11_2012_382159.nxml.txt.nlp	22481926	SENT89	0	0	8	8	trastuzumab	HER2	PA451743	2064	0.976
NULL	J_Oral_Pathol_Med_2013_Jul_18_42(6)_499-506.nxml.txt.nlp	23331485	SENT198	20	20	18	18	indomethacin	COX	PA449982	1351	0.976
NULL	Biochemistry_2008_Dec_2_47(48)_12835-12843.nxml.txt.nlp	18991406	SENT482	11	11	26	26	thrombin	VIII	PA451674	1351	0.976
NULL	Aging_Cell_2012_Aug_11(4)_579-587.nxml.txt.nlp	22435726	SENT111	26	26	9	9	etoposide	CD28	PA449552	1493;940	0.976
NULL	Br_J_Cancer_2009_Mar_10_100(5)_758-763.nxml.txt.nlp	19259094	SENT109	43	43	32	32	decitabine	MLH1	PA164749631	4292	0.976
NULL	Braz_J_Med_Biol_Res_2013_Jun_25_46(6)_528-532.nxml.txt.nlp	23802228	SENT19	0	0	13	13	rosiglitazone	gamma	PA451283	9913	0.976
NULL	Cancer_Cell_Int_2013_Apr_15_13_35.nxml.txt.nlp	23587008	SENT101	0	0	20	20	metformin	IGFR	PA450395	3480	0.976
NULL	Clin_Psychopharmacol_Neurosci_2013_Dec_24_11(3)_132-136.nxml.txt.nlp	24465249	SENT90	2	2	14	14	perospirone	5-HT1A	PA165291546	3350	0.976
NULL	J_Physiol_2009_Feb_15_587(Pt_4)_731-744.nxml.txt.nlp	19074966	SENT11	25	25	0	0	taurine	PAT1	PA451590	10513;206358	0.976
NULL	Nucleic_Acids_Res_2010_Oct_28_38(19)_6418-6432.nxml.txt.nlp	20511593	SENT341	21	21	5	5	hydroxyurea	TREX1	PA449942	11277	0.976
NULL	Ann_Oncol_2014_Jul_14_25(7)_1333-1339.nxml.txt.nlp	24631949	SENT65	0	0	21	21	metoclopramide	NK1	PA450475	11126	0.976
NULL	Acta_Pharmacol_Sin_2012_Oct_17_33(10)_1301-1310.nxml.txt.nlp	22983390	SENT123	1	1	18	18	cisplatin	migfilin	PA449014	54751	0.976
NULL	Brain_Sci_2013_Jun_14_3(2)_941-963.nxml.txt.nlp	24961432	SENT192	34	34	6	6	ethanol	RhoE	PA448073	390	0.976
NULL	Crit_Care_2002_Mar_1_6(Suppl_1)_P34.nxml.txt.nlp	NULL	SENT7	19	19	5	5	fentanyl	COPA	PA449599	1314	0.976
NULL	Acta_Pharmacol_Sin_2011_Jul_13_32(7)_967-972.nxml.txt.nlp	21666702	SENT23	2	2	18	18	losartan	P-gp	PA450268	5243	0.976
NULL	Oncotarget_2012_May_9_3(4)_363-364.nxml.txt.nlp	22622047	SENT15	34	34	7	7	imatinib	SIRT1	PA10804	23411	0.976
NULL	Ann_Oncol_2011_Mar_8_22(3)_503-514.nxml.txt.nlp	20616198	SENT149	27	27	21	21	tamoxifen	aromatase	PA451581	1588	0.976
NULL	Exp_Ther_Med_2015_Feb_3_9(2)_377-383.nxml.txt.nlp	25574201	SENT30	16	16	4	4	curcumin	TSP-1	PA151958596	7057	0.976
NULL	Int_J_Cell_Biol_2013_Feb_12_2013_805975.nxml.txt.nlp	23476653	SENT199	13	13	23	23	temozolomide	ABCG2	PA451609	9429	0.976
NULL	Int_J_Endocrinol_Metab_2013_Jul_1_Summer_11(3)_184-190.nxml.txt.nlp	24348591	SENT28	0	0	15	15	liraglutide	GLP-1	PA165958364	100125288	0.976
NULL	J_Biomed_Biotechnol_2010_Jun_7_2010_150960.nxml.txt.nlp	20617134	SENT226	36	36	26	26	erlotinib	KRAS	PA134687924	3845	0.976
NULL	J_Hematol_Oncol_2013_Mar_27_6_23.nxml.txt.nlp	23531342	SENT71	25	25	0	0	bortezomib	MDM2	PA10252	4193	0.976
NULL	Target_Oncol_2013_Mar_30_8(1)_27-33.nxml.txt.nlp	23361373	SENT19	24	24	46	46	gefitinib	EGFR	PA131301952	1956	0.976
NULL	Oncotarget_2014_Feb_7_5(3)_775-787.nxml.txt.nlp	24519956	SENT197	27	27	0	0	dasatinib	PC3	PA162372878	57332;7832;5122	0.976
NULL	N_Am_J_Med_Sci_2011_Mar_3(3)_129-136.nxml.txt.nlp	22540078	SENT189	18	18	9	9	ciprofloxacin	SMG	PA449009	23034	0.976
NULL	Cancer_Metab_2013_Aug_14_1_18.nxml.txt.nlp	24280377	SENT157	0	0	20	20	metformin	AMPK	PA450395	5563	0.976
NULL	Protein_J_2012_Aug_5_31(6)_511-518.nxml.txt.nlp	22763563	SENT179	4	4	30	30	atorvastatin	CD36	PA448500	948	0.976
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2014_Jul_25_70(Pt_8)_2163-2174.nxml.txt.nlp	25084335	SENT23	19	19	0	0	s-adenosylmethionine	COMT	PA164754994	1312	0.976
NULL	J_Gen_Physiol_2008_Nov_132(5)_521-535.nxml.txt.nlp	18852303	SENT296	29	29	1	1	trypsin	CAP1	PA451806	10487	0.976
NULL	Breast_Cancer_Res_Treat_2012_Jun_3_133(3)_865-880.nxml.txt.nlp	22048815	SENT167	21	21	1	1	carboplatin	RAD50	PA448803	10111	0.976
NULL	Eur_J_Clin_Pharmacol_2011_May_8_67(5)_493-506.nxml.txt.nlp	21140139	SENT41	13	13	27	27	oxycodone	CYP2D6	PA450741	1565	0.976
NULL	Int_J_Biochem_Cell_Biol_2010_Jan_42(1)_113-119.nxml.txt.nlp	19800021	SENT14	42	42	16	16	curcumin	p50	PA151958596	958;4790	0.976
NULL	Clin_Pharmacol_2013_Dec_9_5_185-192.nxml.txt.nlp	24353446	SENT79	27	27	14	14	clopidogrel	ARNT	PA449053	405	0.976
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_P41.nxml.txt.nlp	NULL	SENT9	19	19	2	2	flucloxacillin	IFN	PA164781042	3439	0.976
NULL	Evid_Based_Complement_Alternat_Med_2013_Nov_5_2013_715040.nxml.txt.nlp	24302969	SENT10	23	23	2	2	gentamicin	OPG	PA449753	690	0.976
NULL	Mol_Cancer_2009_Dec_10_8_118.nxml.txt.nlp	20003259	SENT215	17	17	24	24	sorafenib	ERM	PA7000	2119	0.976
NULL	Aging_(Albany_NY)_2014_Jan_14_6(1)_70-81.nxml.txt.nlp	24429382	SENT283	11	11	5	5	etoposide	WRN	PA449552	7486	0.976
NULL	EJC_Suppl_2014_Jun_29_12(1)_5-17.nxml.txt.nlp	NULL	SENT83	15	15	5	5	tamoxifen	aromatase	PA451581	1588	0.976
NULL	Arthritis_Res_2002_Feb_4_4(Suppl_1)_40.nxml.txt.nlp	NULL	SENT4	17	17	13	13	trypsin	PAR2	PA451806	2150;55065;8856	0.976
NULL	Bioinformation_2012_Jan_6_8(1)_13-19.nxml.txt.nlp	22359429	SENT95	4	4	14	14	curcumin	MRP1	PA151958596	4437	0.976
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1522-1532.nxml.txt.nlp	21997136	SENT36	12	12	6	6	irinotecan	EGFR	PA450085	1956	0.976
NULL	JAKSTAT_2013_Jul_1_2(3)_e24574.nxml.txt.nlp	24069558	SENT49	25	25	3	3	doxycycline	HEK	PA449415	2042	0.976
NULL	Nat_Commun_2013_4_10_1038_ncomms3550.nxml.txt.nlp	24096541	SENT279	14	14	5	5	fluorescein	ADP	PA164746009	23038	0.976
NULL	Biomed_Res_Int_2014_Jun_26_2014_483501.nxml.txt.nlp	25057490	SENT138	26	26	11	11	resveratrol	Bcl-2		596	0.976
NULL	Ann_Dermatol_2011_Dec_27_23(Suppl_3)_S290-S295.nxml.txt.nlp	22346260	SENT90	9	9	19	19	dapsone	EED	PA449211	8726	0.976
NULL	Pharm_Methods_2012_Jan-Jun_3(1)_31-39.nxml.txt.nlp	23781475	SENT18	0	0	4	4	candesartan	AT1	PA448765	9197;185	0.976
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT83	29	29	7	7	trastuzumab	IL-6	PA451743	3569	0.976
NULL	Mol_Cancer_2008_Jun_5_7_50.nxml.txt.nlp	18534018	SENT149	44	44	32	32	bortezomib	HSP27	PA10252	3315	0.976
NULL	J_Antimicrob_Chemother_2009_Nov_18_64(5)_910-928.nxml.txt.nlp	19767318	SENT113	33	33	7	7	efavirenz	CCR5	PA449441	1234	0.976
NULL	Cancer_Microenviron_2009_Sep_26_2(Suppl_1)_19-204.nxml.txt.nlp	NULL	SENT3307	21	21	28	28	nelfinavir	EGFR	PA450606	1956	0.976
NULL	Oncotarget_2014_Nov_3_5(20)_10127-10139.nxml.txt.nlp	25333256	SENT144	5	5	0	0	vemurafenib	TRIM16	PA165946873	10626	0.976
NULL	Oncotarget_2012_Oct_20_3(10)_1068-1111.nxml.txt.nlp	23085539	SENT309	24	24	14	14	gemcitabine	EGFR	PA449748	1956	0.976
NULL	Biomed_Res_Int_2014_Feb_27_2014_897653.nxml.txt.nlp	24719894	SENT61	31	31	13	13	olanzapine	ADRB1	PA450688	153	0.976
NULL	Neural_Plast_2012_May_20_2012_124548.nxml.txt.nlp	22685676	SENT142	13	13	37	37	minocycline	FMRP	PA450519	2332	0.976
NULL	Ann_Thorac_Med_2015_Jan-Mar_10(1)_69-72.nxml.txt.nlp	25593612	SENT149	16	16	8	8	amiloride	HSD2	PA448368	6060	0.976
NULL	Br_J_Cancer_2003_Mar_10_88(5)_754-759.nxml.txt.nlp	12618886	SENT105	0	0	31	31	amifostine	p53	PA448365	7157	0.976
NULL	Theranostics_2013_Nov_30_3(12)_943-952.nxml.txt.nlp	24396505	SENT133	39	39	15	15	gefitinib	EGFR	PA131301952	1956	0.976
NULL	Int_J_Breast_Cancer_2012_May_9_2012_415170.nxml.txt.nlp	22649737	SENT213	33	33	11	11	trastuzumab	HER3	PA451743	2065	0.976
NULL	Indian_J_Anaesth_2009_Oct_53(5)_582-591.nxml.txt.nlp	20640109	SENT53	5	5	22	22	ticlopidine	ADP	PA451686	23038	0.976
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Apr_17_6_43-57.nxml.txt.nlp	24833916	SENT96	0	0	23	23	everolimus	aromatase	PA164746311	1588	0.976
NULL	Oncol_Lett_2014_Mar_16_7(3)_827-833.nxml.txt.nlp	24527090	SENT8	7	7	17	17	cisplatin	IFN	PA449014	3439	0.976
NULL	Eur_J_Neurosci_2014_Feb_4_39(3)_344-352.nxml.txt.nlp	24494675	SENT162	13	13	2	2	capsaicin	CB1	PA448776	1268	0.976
NULL	Basic_Clin_Pharmacol_Toxicol_2014_Dec_22_115(6)_552-559.nxml.txt.nlp	24766668	SENT216	12	12	15	15	bupropion	CYP2D6	PA448687	1565	0.976
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT247	44	44	11	11	doxorubicin	B7-H1	PA449412	29126	0.976
NULL	J_Hematol_Oncol_2008_Oct_1_1_16.nxml.txt.nlp	18828924	SENT244	0	0	11	11	pazopanib	VEGFR	PA165291492	3791	0.976
NULL	F1000Res_2013_Jul_9_2_150.nxml.txt.nlp	24627787	SENT37	17	17	14	14	clozapine	DIP	PA449061	23151;1831	0.976
NULL	Eur_J_Clin_Pharmacol_2009_Dec_16_65(12)_1211-1228.nxml.txt.nlp	19756557	SENT169	13	13	1	1	infliximab	ACT	PA452639	12;11332;9457;641455	0.976
NULL	Curr_Pain_Headache_Rep_2011_Aug_12_15(4)_271-279.nxml.txt.nlp	21479998	SENT172	0	0	9	9	buprenorphine	CYP3A4	PA448685	1576	0.976
NULL	Front_Neurol_2011_Dec_26_2_83.nxml.txt.nlp	22363312	SENT77	0	0	16	16	clopidogrel	CYP2C19	PA449053	1557	0.976
NULL	Brain_Sci_2013_Apr_26_3(2)_670-703.nxml.txt.nlp	24961420	SENT70	9	9	23	23	ethanol	p38	PA448073	10598;1432;7965	0.976
NULL	Mol_Cancer_2014_Feb_21_13_33.nxml.txt.nlp	24555688	SENT175	20	20	27	27	cisplatin	E2F5	PA449014	1875	0.976
NULL	Breast_Cancer_Res_2005_May_27_7(Suppl_1)_S16.nxml.txt.nlp	NULL	SENT5	19	19	26	26	tamoxifen	BCS	PA451581	617	0.976
NULL	Br_J_Cancer_2012_Sep_4_107(6)_947-955.nxml.txt.nlp	22892392	SENT93	12	12	6	6	lapatinib	BCAR4	PA152241907	400500	0.976
NULL	Int_J_Gen_Med_2012_May_4_5_403-411.nxml.txt.nlp	22615536	SENT16	33	33	12	12	metformin	RBP4	PA450395	5433;5950	0.976
NULL	Exp_Mol_Med_2012_May_31_44(5)_311-318.nxml.txt.nlp	22282402	SENT77	30	30	19	19	cilostazol	MCP-1	PA164746334	6347	0.976
NULL	Comb_Chem_High_Throughput_Screen_2010_Feb_13(2)_188-206.nxml.txt.nlp	20053163	SENT247	31	31	11	11	sulfamethoxazole	CYP2C19	PA451544	1557	0.976
NULL	Arthritis_Res_Ther_2009_May_19_11(3)_225.nxml.txt.nlp	19490600	SENT186	0	0	17	17	etanercept	p75	PA449515	7133;11168	0.976
NULL	Clinics_(Sao_Paulo)_2011_Aug_66(8)_1457-1462.nxml.txt.nlp	21915500	SENT104	31	31	0	0	oxygen	TNF	PA450744	7124	0.976
NULL	Pharmaceutics_2011_Oct_12_3(4)_680-705.nxml.txt.nlp	24309303	SENT114	9	9	15	15	rosiglitazone	P-gp	PA451283	5243	0.976
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT238	9	9	18	18	metformin	PTEN	PA450395	5728	0.976
NULL	Core_Evid_2011_Feb_8_6_23-29.nxml.txt.nlp	21468240	SENT47	0	0	7	7	plerixafor	CD34	PA165958410	947	0.976
NULL	Biologics_2012_Jan_5_6_13-20.nxml.txt.nlp	22291463	SENT48	0	0	20	20	bevacizumab	VEGFR1	PA130232992	2321	0.976
NULL	Sci_Rep_2014_Dec_12_4_7456.nxml.txt.nlp	25503852	SENT106	7	7	16	16	resveratrol	SIRT1		23411	0.976
NULL	Breast_Cancer_Res_2005_Jul_20_7(5)_205-211.nxml.txt.nlp	16168139	SENT108	10	10	27	27	tamoxifen	EGF	PA451581	1950	0.976
NULL	Anal_Bioanal_Chem_2010_Aug_14_397(7)_2977-2986.nxml.txt.nlp	20549493	SENT131	40	40	18	18	estradiol	P14	PA449503	11102;;6280;56259	0.976
NULL	Mol_Pain_2012_Sep_22_8_71.nxml.txt.nlp	22998838	SENT217	36	36	7	7	cisplatin	CXCR4	PA449014	7852	0.976
NULL	Mol_Pain_2014_Aug_15_10_53.nxml.txt.nlp	25127716	SENT13	0	0	26	26	paclitaxel	SDH	PA450761	1757;10993	0.976
NULL	Indian_J_Nucl_Med_2014_Apr-Jun_29(2)_65-73.nxml.txt.nlp	24761056	SENT89	4	4	26	26	erlotinib	FDG	PA134687924	23583	0.976
NULL	Oncotarget_2013_Jul_7_4(7)_1065-1074.nxml.txt.nlp	23867252	SENT163	43	43	1	1	trypsin	Hsp90	PA451806	3320	0.976
NULL	Pharmaceuticals_(Basel)_2011_Nov_11_4(11)_1503-1517.nxml.txt.nlp	NULL	SENT152	21	21	11	11	capsaicin	TRPV1	PA448776	7442	0.976
NULL	Curr_Hypertens_Rep_2011_Oct_13_13(5)_356-361.nxml.txt.nlp	21562941	SENT62	41	41	26	26	benazepril	AT1	PA448561	9197;185	0.976
NULL	Cardiol_Res_Pract_2012_Aug_7_2012_847172.nxml.txt.nlp	22919539	SENT81	5	5	8	8	simvastatin	AT1	PA451363	9197;185	0.976
NULL	Case_Rep_Genet_2014_Jan_22_2014_413743.nxml.txt.nlp	24627811	SENT65	22	22	11	11	warfarin	VKORC1	PA451906	79001	0.976
NULL	Ann_Rheum_Dis_2011_Oct_12_71(4)_541-548.nxml.txt.nlp	21994233	SENT157	39	39	1	1	methotrexate	IMPACT	PA450428	55364	0.976
NULL	Oncoimmunology_2013_May_1_2(5)_e24436.nxml.txt.nlp	23762809	SENT45	44	44	16	16	bevacizumab	IL-6	PA130232992	3569	0.976
NULL	J_Korean_Med_Sci_2011_Jul_20_26(7)_893-899.nxml.txt.nlp	21738342	SENT95	19	19	13	13	genistein	EGF	PA165109660	1950	0.976
NULL	Adv_Biomed_Res_2012_Jul_6_1_21.nxml.txt.nlp	23210080	SENT24	3	3	27	27	trastuzumab	HER-2	PA451743	2064	0.976
NULL	Indian_J_Psychiatry_2009_Jul-Sep_51(3)_222-224.nxml.txt.nlp	19881055	SENT63	5	5	12	12	paroxetine	CYP2D6	PA450801	1565	0.976
NULL	Eur_J_Immunol_2014_Jul_15_44(7)_2175-2187.nxml.txt.nlp	24668151	SENT256	30	30	5	5	neomycin	MEC1	PA450608	545	0.976
NULL	Allergy_Asthma_Immunol_Res_2014_Nov_28_6(6)_567-572.nxml.txt.nlp	25374757	SENT88	0	0	34	34	fexofenadine	p38	PA449621	10598;1432;7965	0.976
NULL	Braz_J_Med_Biol_Res_2012_Feb_17_45(3)_244-249.nxml.txt.nlp	22331137	SENT44	23	23	0	0	gentamicin	PAG	PA449753	55824	0.976
NULL	Br_J_Cancer_2011_Jul_26_105(3)_353-359.nxml.txt.nlp	21750549	SENT159	3	3	39	39	sorafenib	BRAF	PA7000	673	0.976
NULL	Oncol_Rep_2012_Apr_6_27(4)_1219-1226.nxml.txt.nlp	22159638	SENT215	18	18	7	7	cisplatin	NB-3	PA449014	27255	0.976
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT169	23	23	4	4	atorvastatin	RANKL	PA448500	8600	0.976
NULL	Diabetes_Care_2010_Jul_33(7)_1674-1685.nxml.txt.nlp	20587728	SENT287	8	8	36	36	exenatide	GLP-1	PA164749238	100125288	0.976
NULL	Arthritis_Res_Ther_2012_May_1_14(3)_R99.nxml.txt.nlp	22546542	SENT126	29	29	15	15	infliximab	IL-10	PA452639	3586	0.976
NULL	J_Inflamm_(Lond)_2008_Nov_5_5_20.nxml.txt.nlp	18986521	SENT39	13	13	0	0	l-cysteine	NAC	PA449173	22861	0.976
NULL	Case_Rep_Gastroenterol_2011_Jun_10_5(2)_336-343.nxml.txt.nlp	21712950	SENT91	22	22	3	3	voglibose	GLP-1	PA164752433	100125288	0.976
NULL	F1000Prime_Rep_2014_Aug_1_6_66.nxml.txt.nlp	25165565	SENT112	0	0	9	9	pertuzumab	HER2		2064	0.976
NULL	Diabetes_2011_Nov_17_60(11)_2691-2700.nxml.txt.nlp	21896928	SENT24	0	0	16	16	resveratrol	SIRT1		23411	0.976
NULL	Adv_Hematol_2012_May_8_2012_393864.nxml.txt.nlp	22851972	SENT34	34	34	20	20	lenalidomide	CD86	PA162363968	942	0.976
NULL	Environ_Health_Perspect_2001_May_109(5)_539-545.nxml.txt.nlp	11401768	SENT10	14	14	1	1	cholestyramine	PEAS	PA448974	116138	0.976
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_29_2013_590393.nxml.txt.nlp	23737838	SENT223	4	4	38	38	resveratrol	p53		7157	0.976
NULL	Cells_2014_Apr_29_3(2)_331-362.nxml.txt.nlp	24785347	SENT218	28	28	4	4	capsaicin	TRPV1	PA448776	7442	0.976
NULL	Chin_J_Cancer_2012_Feb_31(2)_51-57.nxml.txt.nlp	22257384	SENT117	2	2	26	26	lapatinib	MRP7	PA152241907	89845;1080	0.976
NULL	Oncotarget_2013_Dec_15_4(12)_2577-2590.nxml.txt.nlp	24342878	SENT145	28	28	3	3	cisplatin	NF-kappaB	PA449014	4790	0.976
NULL	J_Invest_Dermatol_2013_Sep_31_133(9)_2247-2254.nxml.txt.nlp	23370537	SENT214	10	10	25	25	etoposide	p53	PA449552	7157	0.976
NULL	J_Cell_Mol_Med_2014_May_14_18(5)_811-823.nxml.txt.nlp	24628949	SENT17	22	22	4	4	docetaxel	FOXM1	PA449383	2305	0.976
NULL	Clin_Exp_Gastroenterol_2012_May_14_5_49-59.nxml.txt.nlp	22649281	SENT76	4	4	19	19	esomeprazole	CYP2C19	PA10075	1557	0.976
NULL	Curr_Opin_Pharmacol_2013_Aug_13(4)_497-503.nxml.txt.nlp	23664091	SENT44	11	11	33	33	trastuzumab	HER2	PA451743	2064	0.976
NULL	Carcinogenesis_2013_Mar_7_34(3)_703-712.nxml.txt.nlp	23222814	SENT111	11	11	44	44	curcumin	p53	PA151958596	7157	0.976
NULL	Neural_Plast_2013_Jun_26_2013_605079.nxml.txt.nlp	23936678	SENT95	13	13	5	5	fluoxetine	MMP9	PA449673	4318	0.976
NULL	Orphanet_J_Rare_Dis_2014_Dec_10_9(1)_201.nxml.txt.nlp	NULL	SENT220	3	3	37	37	d-sorbitol	CMT1A	PA451455	1248	0.976
NULL	Aging_(Albany_NY)_2011_Apr_6_3(4)_444-449.nxml.txt.nlp	21483037	SENT3	7	7	0	0	resveratrol	SIRT1		23411	0.976
NULL	Oncol_Rep_2012_Apr_22_27(4)_1123-1127.nxml.txt.nlp	22200897	SENT115	16	16	2	2	hyaluronan	EMMPRIN	PA165958431	682	0.976
NULL	Int_J_Mol_Sci_2014_Sep_2_15(9)_15512-15529.nxml.txt.nlp	25184950	SENT75	17	17	3	3	resveratrol	IL-10		3586	0.976
NULL	Oncologist_2010_Mar_9_15(3)_236-245.nxml.txt.nlp	20215359	SENT67	10	10	20	20	sunitinib	IFN	PA162372840	3439	0.976
NULL	Cancer_Manag_Res_2011_May_18_3_177-189.nxml.txt.nlp	21625400	SENT41	7	7	15	15	estradiol	IL-6	PA449503	3569	0.976
NULL	Crit_Care_2007_May_24_11(3)_R61.nxml.txt.nlp	17524133	SENT166	4	4	14	14	etomidate	ACTH	PA164743987	5443	0.976
NULL	Oncol_Lett_2014_Mar_16_7(3)_827-833.nxml.txt.nlp	24527090	SENT116	7	7	16	16	cisplatin	IFN	PA449014	3439	0.976
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_19_2013_746486.nxml.txt.nlp	23861712	SENT148	24	24	0	0	irinotecan	UGT1A1	PA450085	54658	0.976
NULL	J_Vet_Med_Sci_2014_Oct_16_76(10)_1383-1387.nxml.txt.nlp	24931645	SENT6	0	0	28	28	sitagliptin	GLP-1	PA164748978	100125288	0.976
NULL	Clin_Dev_Immunol_2011_Nov_3_2011_430394.nxml.txt.nlp	22110524	SENT121	4	4	25	25	cyclophosphamide	CD25	PA449165	3669;3559	0.976
NULL	Patient_Prefer_Adherence_2013_Apr_26_7_369-377.nxml.txt.nlp	23641151	SENT1	0	0	20	20	ustekinumab	IL-23	PA166048654	51561	0.976
NULL	Nat_Med_2013_Feb_6_19(2)_217-226.nxml.txt.nlp	23291629	SENT93	15	15	40	40	forskolin	TRIP-Br2	PA146096022	9792	0.976
NULL	Biochemistry_2014_Mar_4_53(8)_1263-1274.nxml.txt.nlp	24450572	SENT64	4	4	13	13	chymotrypsin	MCO	PA448994	4178	0.976
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Feb_29_68(Pt_3)_o878-o879.nxml.txt.nlp	22412730	SENT84	11	11	43	43	coumarin	TLC	PA134521193	3933	0.976
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT784	37	37	1	1	aliskiren	OATP1B1	PA143487910	10599	0.976
NULL	J_Cell_Mol_Med_2013_Dec_6_17(12)_1588-1597.nxml.txt.nlp	24199964	SENT243	4	4	18	18	doxycycline	APT	PA449415	653639	0.976
NULL	Biomed_Res_Int_2013_Dec_31_2013_795103.nxml.txt.nlp	23710462	SENT166	35	35	9	9	fenofibrate	adiponectin	PA449594	9370	0.976
NULL	Crit_Rev_Toxicol_2013_Mar_13_43(3)_200-219.nxml.txt.nlp	23405971	SENT158	22	22	10	10	estradiol	BBP	PA449503	83941	0.976
NULL	Clin_Psychopharmacol_Neurosci_2011_Apr_30_9(1)_36-43.nxml.txt.nlp	23431025	SENT29	14	14	24	24	clozapine	NAC	PA449061	22861	0.976
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT119	11	11	35	35	gefitinib	AKT	PA131301952	207	0.976
NULL	Arthritis_Res_Ther_2012_Mar_14_14(2)_R62.nxml.txt.nlp	22417670	SENT209	1	1	17	17	chloroquine	LC3	PA448948	84557	0.976
NULL	Br_J_Cancer_2012_May_22_106(11)_1779-1789.nxml.txt.nlp	22549178	SENT30	0	0	9	9	pertuzumab	HER2		2064	0.976
NULL	J_Carcinog_2011_Dec_22_10_35.nxml.txt.nlp	22279420	SENT132	29	29	22	22	tamoxifen	HER2	PA451581	2064	0.976
NULL	Nat_Med_2012_Jul_18(7)_1118-1122.nxml.txt.nlp	22683780	SENT54	27	27	13	13	crizotinib	FGFR1	PA165946122	2260	0.976
NULL	Mol_Cancer_2013_Mar_5_12_17.nxml.txt.nlp	23497256	SENT65	10	10	5	5	sunitinib	p53	PA162372840	7157	0.976
NULL	Anal_Bioanal_Chem_2014_Jan_23_406(15)_3667-3680.nxml.txt.nlp	24452745	SENT189	4	4	22	22	ketoprofen	KET	PA450149	8626	0.976
NULL	Adv_Urol_2012_Feb_8_2012_816274.nxml.txt.nlp	22400020	SENT283	3	3	31	31	diazepam	gamma	PA449283	9913	0.976
NULL	Case_Rep_Oncol_2014_Mar_26_7(1)_204-209.nxml.txt.nlp	24803896	SENT23	18	18	13	13	trabectedin	MRCL	PA165958349	348174	0.976
NULL	Cancer_Cell_Int_2005_Jul_24_5_22.nxml.txt.nlp	16042792	SENT103	15	15	7	7	vincristine	MRP1	PA451879	4437	0.976
NULL	Case_Rep_Med_2012_Oct_30_2012_897097.nxml.txt.nlp	23197987	SENT39	0	0	21	21	ranibizumab	VEGF-A	PA164746012	7422	0.976
NULL	Nucleic_Acids_Res_2011_Dec_10_39(22)_9498-9507.nxml.txt.nlp	21835778	SENT178	8	8	0	0	camptothecin	p53	PA153590860	7157	0.976
NULL	Nat_Commun_2014_Dec_18_5_5815.nxml.txt.nlp	25519973	SENT411	27	27	3	3	tranylcypromine	E16	PA451741	8140	0.976
NULL	Br_J_Cancer_2009_Sep_15_101(6)_957-966.nxml.txt.nlp	19738618	SENT169	8	8	27	27	dexrazoxane	THBS-1	PA449259	7057	0.976
NULL	Diabetes_2009_Dec_31_58(12)_2851-2862.nxml.txt.nlp	19720788	SENT280	3	3	28	28	forskolin	GLP-1	PA146096022	100125288	0.976
NULL	Arthritis_Res_Ther_2008_Jan_30_10(1)_R14.nxml.txt.nlp	18234077	SENT191	35	35	3	3	tocilizumab	IL-6	PA165292659	3569	0.976
NULL	J_Exerc_Nutrition_Biochem_2014_Mar_25_18(1)_79-87.nxml.txt.nlp	25566442	SENT75	12	12	34	34	resveratrol	IL-6		3569	0.976
NULL	Nat_Commun_2014_Jun_4_5_4048.nxml.txt.nlp	24893992	SENT602	11	11	15	15	etoposide	PLK1	PA449552	5347	0.976
NULL	JAKSTAT_2014_Jun_12_3_e29554.nxml.txt.nlp	25105067	SENT41	7	7	3	3	propofol	STAT3	PA451141	6774	0.976
NULL	Cancers_(Basel)_2010_Jan_14_2(1)_1-19.nxml.txt.nlp	24281029	SENT41	18	18	4	4	docetaxel	HER2	PA449383	2064	0.976
NULL	J_Korean_Med_Sci_2007_Dec_20_22(6)_1055-1059.nxml.txt.nlp	18162722	SENT5	18	18	7	7	pantoprazole	ESD	PA450774	2098	0.976
NULL	Scientifica_(Cairo)_2012_Oct_14_2012_428139.nxml.txt.nlp	24278693	SENT216	15	15	27	27	verapamil	MDR1	PA451868	5243	0.976
NULL	Parasit_Vectors_2009_Sep_24_2_44.nxml.txt.nlp	19775473	SENT62	3	3	6	6	albendazole	OTC	PA164746058	5009	0.976
NULL	Mol_Cancer_2008_Sep_12_7_69.nxml.txt.nlp	18789131	SENT98	6	6	24	24	pp2	EGFR		1956	0.976
NULL	Eur_J_Clin_Microbiol_Infect_Dis_2014_May_11_33(10)_1763-1771.nxml.txt.nlp	24816901	SENT131	25	25	11	11	ivacaftor	FEV	PA165950341	54738	0.976
NULL	Int_J_Med_Sci_2015_Jan_1_12(1)_78-82.nxml.txt.nlp	25552922	SENT23	29	29	0	0	lidocaine	CYP1A2	PA450226	1544	0.975
NULL	Br_J_Cancer_2004_Mar_8_90(5)_1053-1058.nxml.txt.nlp	14997207	SENT120	2	2	12	12	marimastat	ADAM9	PA164748329	8754	0.975
NULL	Aging_(Albany_NY)_2010_Dec_14_2(12)_945-958.nxml.txt.nlp	21164223	SENT22	12	12	3	3	metformin	HER-2	PA450395	2064	0.975
NULL	Drugs_R_D_2011_Dec_27_11(4)_317-326.nxml.txt.nlp	22133387	SENT18	0	0	8	8	cetuximab	EGFR	PA10040	1956	0.975
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_11_2014_274786.nxml.txt.nlp	25505920	SENT209	13	13	4	4	cisplatin	FADD	PA449014	8772	0.975
NULL	Br_J_Cancer_2010_Sep_7_103(6)_765-771.nxml.txt.nlp	20700120	SENT157	30	30	15	15	tamoxifen	CYP2D6	PA451581	1565	0.975
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_16_2012_395912.nxml.txt.nlp	23118789	SENT151	20	20	0	0	acetaminophen	UGT1A9	PA448015	54600	0.975
NULL	Mol_Cancer_2010_Mar_25_9_68.nxml.txt.nlp	20338046	SENT163	28	28	21	21	doxorubicin	TP53	PA449412	7157	0.975
NULL	Chin_J_Cancer_2012_Jul_31(7)_319-326.nxml.txt.nlp	22257382	SENT75	0	0	15	15	cetuximab	EGFR	PA10040	1956	0.975
NULL	Br_J_Pharmacol_2014_May_171(10)_2659-2670.nxml.txt.nlp	24116661	SENT227	19	19	8	8	naringenin	TRPP1	PA151958361	5310	0.975
NULL	Appl_Clin_Genet_2013_Dec_24_7_1-13.nxml.txt.nlp	24399884	SENT248	0	0	8	8	eplerenone	CYP3A4	PA164749044	1576	0.975
NULL	Neural_Plast_2007_Jun_19_2007_52908.nxml.txt.nlp	17641734	SENT144	17	17	14	14	rimonabant	CB1	PA152407999	1268	0.975
NULL	Anal_Chem_Insights_2011_Mar_10_6_21-28.nxml.txt.nlp	21760706	SENT50	12	12	23	23	emtricitabine	API	PA10069	5345	0.975
NULL	Mol_Cells_2014_Mar_31_37(3)_234-240.nxml.txt.nlp	24642709	SENT141	22	22	4	4	cisplatin	TLR4	PA449014	7099	0.975
NULL	Braz_J_Med_Biol_Res_2013_Aug_13_46(8)_650-658.nxml.txt.nlp	23969971	SENT25	20	20	11	11	cisplatin	STAT3	PA449014	6774	0.975
NULL	Oncotarget_2013_Nov_15_5(6)_1458-1474.nxml.txt.nlp	24681547	SENT244	4	4	18	18	celecoxib	CDH11	PA448871	1009	0.975
NULL	Arthritis_Res_Ther_2011_Apr_28_13(2)_210.nxml.txt.nlp	21542894	SENT94	10	10	2	2	capsaicin	TRPV1	PA448776	7442	0.975
NULL	Cell_Oncol_(Dordr)_2011_Oct_4_34(5)_489-494.nxml.txt.nlp	21541733	SENT32	28	28	12	12	fulvestrant	aromatase	PA164747170	1588	0.975
NULL	Br_J_Cancer_2009_Jul_21_101(2)_269-277.nxml.txt.nlp	19603033	SENT124	7	7	41	41	cisplatin	XIAP	PA449014	331	0.975
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT129	44	44	36	36	trastuzumab	STAT3	PA451743	6774	0.975
NULL	Front_Genet_2014_Jun_2_5_162.nxml.txt.nlp	24917882	SENT92	15	15	20	20	vemurafenib	BRAF	PA165946873	673	0.975
NULL	Arch_Med_Sci_2011_Jun_11_7(3)_388-396.nxml.txt.nlp	22312373	SENT114	22	22	16	16	mibefradil	CYP3A	PA450492	1574	0.975
NULL	J_Cell_Mol_Med_2013_Jan_10_17(1)_30-54.nxml.txt.nlp	23301832	SENT307	42	42	28	28	gemcitabine	HIF-1	PA449748	29072	0.975
NULL	Oncotarget_2012_Oct_20_3(10)_1236-1245.nxml.txt.nlp	23100449	SENT5	11	11	0	0	doxorubicin	NGAL	PA449412	3934	0.975
NULL	Eur_J_Clin_Pharmacol_2013_Mar_11_69(3)_327-339.nxml.txt.nlp	22782539	SENT34	0	0	27	27	clopidogrel	ADP	PA449053	23038	0.975
NULL	Enzyme_Res_2010_Jun_28_2010_734182.nxml.txt.nlp	21048869	SENT144	23	23	12	12	ethanol	SSF	PA448073	56342	0.975
NULL	An_Bras_Dermatol_2014_Nov-Dec_89(6)_891-897.nxml.txt.nlp	25387493	SENT158	2	2	15	15	etanercept	LYVE-1	PA449515	10894	0.975
NULL	Subst_Abuse_Treat_Prev_Policy_2007_Oct_31_2_32.nxml.txt.nlp	17974020	SENT283	31	31	38	38	methamphetamine	NMU	PA450403	10874	0.975
NULL	Breast_Cancer_Res_2007_Jun_7_9(3)_R37.nxml.txt.nlp	17555561	SENT24	2	2	8	8	anastrozole	aromatase	PA448432	1588	0.975
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_1-20.nxml.txt.nlp	19305785	SENT201	17	17	20	20	bumetanide	NKCC1	PA448682	6558	0.975
NULL	Chin_J_Cancer_2012_Feb_31(2)_73-99.nxml.txt.nlp	22098950	SENT269	4	4	15	15	flavopiridol	P-gp	PA452627	5243	0.975
NULL	Iran_J_Pharm_Res_2014_Autumn_13(4)_1387-1392.nxml.txt.nlp	25587328	SENT79	19	19	9	9	fludarabine	Mcl-1	PA449655	4170	0.975
NULL	Curr_Pharm_Biotechnol_2012_May_13(6)_969-986.nxml.txt.nlp	22039792	SENT39	17	17	6	6	ivermectin	P-gp	PA450133	5243	0.975
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1066.nxml.txt.nlp	24556681	SENT22	12	12	34	34	ethanol	TLR4	PA448073	7099	0.975
NULL	J_Cell_Biol_1998_Nov_16_143(4)_901-910.nxml.txt.nlp	9817749	SENT10	28	28	10	10	geldanamycin	Hsp90	PA152031327	3320	0.975
NULL	FEBS_Open_Bio_2014_Oct_22_4_905-914.nxml.txt.nlp	25383314	SENT95	34	34	16	16	atropine	L-FABP	PA448505	2168	0.975
NULL	Acta_Histochem_Cytochem_2013_Dec_28_46(6)_187-197.nxml.txt.nlp	24610966	SENT139	14	14	4	4	pilocarpine	AQP5	PA450962	362	0.975
NULL	Br_J_Cancer_2009_Jan_27_100(2)_251-258.nxml.txt.nlp	19165196	SENT121	5	5	17	17	cetuximab	EGFR	PA10040	1956	0.975
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT311	41	41	14	14	metformin	HIF-1	PA450395	29072	0.975
NULL	Environ_Health_Perspect_1999_Nov_107(11)_855-860.nxml.txt.nlp	10544151	SENT8	12	12	8	8	aminoglutethimide	aromatase	PA448375	1588	0.975
NULL	Aging_(Albany_NY)_2012_Dec_6_4(11)_823-842.nxml.txt.nlp	23235539	SENT324	12	12	39	39	bleomycin	SRM	PA448645	6723;6725	0.975
NULL	Prostate_Int_2014_Sep_21_2(3)_105-113.nxml.txt.nlp	25325021	SENT154	4	4	20	20	dutasteride	SRD5A3	PA164749300	79644	0.975
NULL	J_Virol_2013_Oct_87(19)_10489-10500.nxml.txt.nlp	23885075	SENT23	6	6	28	28	heparin	EGFR	PA449855	1956	0.975
NULL	Arthritis_Res_Ther_2006_May_5_8(3)_R83.nxml.txt.nlp	16677395	SENT165	15	15	31	31	rituximab	CD25	PA451261	3669;3559	0.975
NULL	Cancers_(Basel)_2012_Nov_8_4(4)_1180-1211.nxml.txt.nlp	24213504	SENT130	0	0	19	19	cetuximab	EGFR	PA10040	1956	0.975
NULL	Ann_Oncol_2011_May_3_22(5)_1078-1087.nxml.txt.nlp	21048039	SENT131	42	42	30	30	cetuximab	KRAS	PA10040	3845	0.975
NULL	J_Biol_Chem_2012_Apr_13_287(16)_13382-13395.nxml.txt.nlp	22367194	SENT204	29	29	18	18	marimastat	TIMP2	PA164748329	7077	0.975
NULL	Cancers_(Basel)_2012_Sep_25_4(4)_969-988.nxml.txt.nlp	24213497	SENT154	23	23	8	8	fulvestrant	EGFR	PA164747170	1956	0.975
NULL	Clin_Pharmacol_2013_Apr_19_5_67-83.nxml.txt.nlp	23650452	SENT28	30	30	37	37	ticagrelor	CYP3A4	PA165374673	1576	0.975
NULL	BMB_Rep_2014_Feb_47(2)_60-68.nxml.txt.nlp	24411465	SENT135	0	0	16	16	ustekinumab	IL-23	PA166048654	51561	0.975
NULL	Antimicrob_Agents_Chemother_2013_Oct_57(10)_4882-4893.nxml.txt.nlp	23877697	SENT261	3	3	20	20	pentamidine	CARP	PA450850	27063;80013;767	0.975
NULL	Tumour_Biol_2013_Oct_9_34(5)_2617-2624.nxml.txt.nlp	23657964	SENT37	22	22	3	3	genistein	BTG3	PA165109660	10950	0.975
NULL	Cell_Biol_Int_Rep_(2010)_2012_Jun_21_19(1)_e00017.nxml.txt.nlp	23124518	SENT86	31	31	4	4	etoposide	DR5	PA449552	8795	0.975
NULL	Cell_Death_Dis_2012_Nov_15_3(11)_e422.nxml.txt.nlp	23152058	SENT89	33	33	20	20	cisplatin	ZNF143	PA449014	7702	0.975
NULL	Arthritis_Res_Ther_2012_May_1_14(3)_R99.nxml.txt.nlp	22546542	SENT120	19	19	3	3	infliximab	CD4	PA452639	920	0.975
NULL	J_Headache_Pain_2014_Sep_18_15(Suppl_1)_F28.nxml.txt.nlp	NULL	SENT6	0	0	28	28	verapamil	P-gp	PA451868	5243	0.975
NULL	Clin_Drug_Investig_2013_Aug_23_33(10)_727-736.nxml.txt.nlp	23975654	SENT184	25	25	18	18	fluoxetine	CYP2D6	PA449673	1565	0.975
NULL	Diabetol_Metab_Syndr_2014_Mar_31_6_47.nxml.txt.nlp	24684779	SENT164	11	11	24	24	pioglitazone	IL-10	PA450970	3586	0.975
NULL	J_Hematol_Oncol_2014_Apr_16_7_34.nxml.txt.nlp	24739401	SENT26	37	37	12	12	rituximab	CHOP	PA451261	1649	0.975
NULL	Indian_J_Med_Res_2012_Dec_136(6)_907-925.nxml.txt.nlp	23391787	SENT143	1	1	12	12	primaquine	G6PD	PA451103	2539	0.975
NULL	Oncotarget_2014_Aug_24_5(16)_6556-6557.nxml.txt.nlp	25179303	SENT27	20	20	6	6	celecoxib	PIK3CA	PA448871	5290	0.975
NULL	Front_Oncol_2013_Oct_22_3_268.nxml.txt.nlp	24156094	SENT98	26	26	8	8	doxorubicin	STAT3	PA449412	6774	0.975
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT81	0	0	7	7	neratinib	HER2	PA165291472	2064	0.975
NULL	J_Neuroinflammation_2011_Feb_4_8_10.nxml.txt.nlp	21294877	SENT115	28	28	10	10	capsaicin	TRPV1	PA448776	7442	0.975
NULL	Breast_Cancer_Res_2013_Oct_29_15(5)_R101.nxml.txt.nlp	24168763	SENT252	31	31	29	29	exemestane	aromatase	PA449563	1588	0.975
NULL	Front_Pharmacol_2014_May_27_5_115.nxml.txt.nlp	24904418	SENT194	19	19	27	27	hyaluronan	TLR4	PA165958431	7099	0.975
NULL	J_Cancer_2013_Nov_14_4(9)_703-715.nxml.txt.nlp	24312140	SENT223	22	22	7	7	resveratrol	BRCA1		672	0.975
NULL	Mediators_Inflamm_2010_Oct_5_2010_321061.nxml.txt.nlp	20953358	SENT166	19	19	10	10	methacholine	NOS2	PA165958382	339345;4843	0.975
NULL	Nat_Med_2010_Feb_24_16(2)_214-218.nxml.txt.nlp	20098429	SENT57	41	41	6	6	cisplatin	YWHAZ	PA449014	7534	0.975
NULL	Breast_Cancer_Res_2001_Mar_26_3(3)_180-182.nxml.txt.nlp	11305952	SENT8	33	33	46	46	anastrozole	San	PA448432	80218	0.975
NULL	Breast_Cancer_Res_Treat_2013_Jun_5_139(3)_649-655.nxml.txt.nlp	23736997	SENT27	28	28	0	0	estradiol	CYP2C19	PA449503	1557	0.975
NULL	Cancer_Growth_Metastasis_2014_Jun_2_7_9-18.nxml.txt.nlp	24926201	SENT142	33	33	36	36	tamoxifen	aromatase	PA451581	1588	0.975
NULL	J_Cancer_2013_Sep_27_4(8)_662-670.nxml.txt.nlp	24155778	SENT179	9	9	4	4	cisplatin	UCHL1	PA449014	7345	0.975
NULL	Int_J_Biol_Sci_2013_Mar_16_9(3)_303-312.nxml.txt.nlp	23569435	SENT146	17	17	1	1	panitumumab	KRAS	PA162373091	3845	0.975
NULL	Int_J_Biol_Sci_2013_Aug_27_9(8)_842-852.nxml.txt.nlp	23983617	SENT85	11	11	19	19	heparin	PPX	PA449855	5531	0.975
NULL	Arthritis_Res_Ther_2011_Apr_27_13(2)_404.nxml.txt.nlp	21542887	SENT16	17	17	1	1	infliximab	ghrelin	PA452639	51738	0.975
NULL	Clin_Epidemiol_2013_May_16_5_147-162.nxml.txt.nlp	23700373	SENT98	1	1	29	29	trastuzumab	HER2	PA451743	2064	0.975
NULL	Amino_Acids_2011_May_22_40(5)_1369-1383.nxml.txt.nlp	21424716	SENT248	23	23	4	4	creatine	CEE	PA164778930	51608	0.975
NULL	Oncoimmunology_2012_Oct_1_1(7)_1048-1060.nxml.txt.nlp	23170253	SENT57	1	1	21	21	trastuzumab	HER-2	PA451743	2064	0.975
NULL	Adv_Urol_2012_Apr_3_2012_248607.nxml.txt.nlp	22548055	SENT190	3	3	36	36	metformin	CAMKK2	PA450395	10645	0.975
NULL	J_Cell_Mol_Med_2013_Oct_2_17(10)_1218-1235.nxml.txt.nlp	23998913	SENT60	0	0	24	24	imatinib	KIT	PA10804	3815	0.975
NULL	Int_J_Breast_Cancer_2011_Sep_6_2011_352182.nxml.txt.nlp	22295219	SENT144	31	31	18	18	trastuzumab	PI3K	PA451743	5290	0.975
NULL	Pharmaceuticals_(Basel)_2014_Apr_10_7(4)_433-452.nxml.txt.nlp	24727459	SENT236	2	2	8	8	ethanol	CYP3A	PA448073	1574	0.975
NULL	Mol_Cancer_2013_Oct_24_12_128.nxml.txt.nlp	24156782	SENT226	4	4	0	0	cetuximab	EGFR	PA10040	1956	0.975
NULL	J_Biomed_Sci_2012_Oct_30_19(1)_92.nxml.txt.nlp	23110561	SENT210	19	19	14	14	geldanamycin	Hsp90	PA152031327	3320	0.975
NULL	Mol_Cancer_2014_Jul_2_13_163.nxml.txt.nlp	24990559	SENT212	21	21	5	5	hyaluronan	CD44	PA165958431	960	0.975
NULL	Aliment_Pharmacol_Ther_2012_Apr_22_35(7)_745-767.nxml.txt.nlp	22356640	SENT163	0	0	11	11	tegaserod	5-HT4	PA130413154	3360	0.975
NULL	Diabetes_2008_Sep_57(9)_2470-2479.nxml.txt.nlp	18511847	SENT112	31	31	5	5	pioglitazone	adiponectin	PA450970	9370	0.975
NULL	J_Mol_Signal_2006_Dec_6_1_8.nxml.txt.nlp	17224083	SENT65	10	10	32	32	thrombin	LARG	PA451674	23365	0.975
NULL	Ann_Oncol_2011_Aug_27_22(8)_1736-1747.nxml.txt.nlp	21709140	SENT205	1	1	9	9	tamoxifen	slim	PA451581	23008	0.975
NULL	Environ_Health_Perspect_2011_Apr_16_119(4)_534-541.nxml.txt.nlp	21081300	SENT107	24	24	4	4	genistein	PGD2	PA165109660	27306	0.975
NULL	Clin_Psychopharmacol_Neurosci_2013_Dec_24_11(3)_144-151.nxml.txt.nlp	24465251	SENT101	28	28	6	6	clozapine	IL-10	PA449061	3586	0.975
NULL	Avicenna_J_Med_2011_Oct-Dec_1(2)_52-54.nxml.txt.nlp	23210009	SENT40	0	0	3	3	erlotinib	EGFR	PA134687924	1956	0.975
NULL	Eur_J_Clin_Pharmacol_2012_Jan_8_68(1)_29-37.nxml.txt.nlp	21739267	SENT17	0	0	22	22	aripiprazole	5-HT1A	PA10026	3350	0.975
NULL	Oncol_Lett_2013_Feb_7_5(2)_411-416.nxml.txt.nlp	23420500	SENT49	8	8	19	19	cetuximab	HIF-1	PA10040	29072	0.975
NULL	Cancer_Cell_Int_2013_Jan_15_13_3.nxml.txt.nlp	23320839	SENT101	22	22	15	15	gemcitabine	MRP3	PA449748	8714	0.975
NULL	Int_J_Breast_Cancer_2013_Jun_24_2013_137414.nxml.txt.nlp	23864953	SENT89	4	4	37	37	lapatinib	HER2	PA152241907	2064	0.975
NULL	Biochem_Res_Int_2012_Aug_15_2012_940405.nxml.txt.nlp	22928112	SENT115	27	27	40	40	erlotinib	EGFR	PA134687924	1956	0.975
NULL	Br_J_Cancer_2010_Sep_7_103(6)_796-801.nxml.txt.nlp	20823888	SENT133	3	3	23	23	lapatinib	EGFR	PA152241907	1956	0.975
NULL	Indian_J_Hum_Genet_2014_Apr-Jun_20(2)_175-184.nxml.txt.nlp	25400347	SENT13	23	23	14	14	clopidogrel	CYP2C19	PA449053	1557	0.975
NULL	Daru_2011_19(5)_326-331.nxml.txt.nlp	22615677	SENT93	8	8	27	27	cisplatin	Bcl-2	PA449014	596	0.975
NULL	Ann_Rheum_Dis_2014_Jun_5_73(6)_1144-1150.nxml.txt.nlp	23644670	SENT153	27	27	41	41	rituximab	CD31	PA451261	5175	0.975
NULL	J_Invest_Dermatol_2013_Sep_31_133(9)_2247-2254.nxml.txt.nlp	23370537	SENT154	6	6	2	2	chloroquine	IL-2	PA448948	3558	0.975
NULL	Patient_Prefer_Adherence_2014_Apr_8_8_463-471.nxml.txt.nlp	24748775	SENT107	34	34	15	15	denosumab	BMD	PA166048634	1756;7439	0.975
NULL	Br_J_Cancer_2013_Mar_5_108(4)_748-754.nxml.txt.nlp	23361058	SENT37	2	2	8	8	vorinostat	RAD50	PA164748224	10111	0.975
NULL	Curr_Cardiol_Rev_2011_Nov_7(4)_214-220.nxml.txt.nlp	22758622	SENT60	5	5	11	11	doxorubicin	p38	PA449412	10598;1432;7965	0.975
NULL	Sci_Rep_2014_Dec_16_4_7500.nxml.txt.nlp	25511254	SENT42	6	6	11	11	hyperforin	TRPC6	PA165985514	7225	0.975
NULL	Br_J_Cancer_2012_Sep_25_107(7)_1093-1099.nxml.txt.nlp	22935583	SENT27	2	2	15	15	everolimus	S6K1	PA164746311	6198	0.975
NULL	Adolesc_Health_Med_Ther_2014_Mar_26_5_35-48.nxml.txt.nlp	24729739	SENT127	7	7	15	15	etanercept	ACR	PA449515	49	0.975
NULL	Br_J_Cancer_2010_Oct_26_103(9)_1380-1390.nxml.txt.nlp	20877355	SENT182	40	40	4	4	vincristine	TRAIL	PA451879	8743	0.975
NULL	Biochemistry_2008_Jul_29_47(30)_7963-7974.nxml.txt.nlp	18590276	SENT608	11	11	26	26	thrombin	VIII	PA451674	1351	0.975
NULL	AIDS_Res_Treat_2011_Jun_7_2011_354908.nxml.txt.nlp	21716719	SENT219	11	11	19	19	cidofovir	OAT1	PA448997	9356	0.975
NULL	Br_J_Cancer_2010_Aug_24_103(5)_715-726.nxml.txt.nlp	20664600	SENT172	7	7	5	5	fluoxetine	CaCC	PA449673	1179	0.975
NULL	Clin_Ophthalmol_2012_Dec_13_6_1-4.nxml.txt.nlp	22259229	SENT70	16	16	30	30	travoprost	BAK	PA164781371	578	0.975
NULL	Open_Access_J_Urol_2011_May_10_3_69-82.nxml.txt.nlp	24198638	SENT63	15	15	7	7	sorafenib	CYP3A4	PA7000	1576	0.975
NULL	Oncotarget_2011_Mar_7_2(3)_122-134.nxml.txt.nlp	21399234	SENT143	0	0	17	17	sorafenib	Raf-1	PA7000	5894	0.975
NULL	Arthritis_Res_Ther_2004_Feb_24_6(Suppl_1)_24.nxml.txt.nlp	NULL	SENT15	12	12	6	6	infliximab	OPG	PA452639	690	0.975
NULL	Support_Care_Cancer_2012_May_1_20(5)_941-949.nxml.txt.nlp	21533811	SENT30	31	31	5	5	granisetron	HEC	PA449809	10403	0.975
NULL	Br_J_Cancer_2010_May_11_102(10)_1456-1460.nxml.txt.nlp	20461090	SENT86	11	11	23	23	temsirolimus	IFN	PA164746890	3439	0.975
NULL	J_Physiol_2008_Dec_1_586(Pt_23)_5743-5755.nxml.txt.nlp	18936079	SENT161	22	22	6	6	nifedipine	P2X1	PA450631	5023	0.975
NULL	Curr_Opin_Pharmacol_2012_Jun_12(3)_335-339.nxml.txt.nlp	22560920	SENT68	23	23	5	5	simvastatin	EGF	PA451363	1950	0.975
NULL	Case_Rep_Transplant_2011_Jan_5_2011_210178.nxml.txt.nlp	23213600	SENT39	15	15	21	21	nevirapine	CYP3A	PA450616	1574	0.975
NULL	J_Biomed_Biotechnol_2011_Jan_24_2011_250860.nxml.txt.nlp	21318107	SENT162	4	4	27	27	lenalidomide	IFN	PA162363968	3439	0.975
NULL	Br_J_Haematol_2014_Mar_13_164(1)_811-821.nxml.txt.nlp	24328678	SENT22	41	41	24	24	lenalidomide	IKZF3	PA162363968	22806	0.975
NULL	Oncotarget_2014_Oct_9_5(20)_9564-9576.nxml.txt.nlp	25333255	SENT147	12	12	24	24	dasatinib	JAK2	PA162372878	3717	0.975
NULL	Breast_Cancer_Res_2012_Apr_26_14(2)_R69.nxml.txt.nlp	22537934	SENT198	14	14	7	7	tamoxifen	RAD21	PA451581	5885	0.975
NULL	Case_Rep_Dermatol_2011_Oct_11_3(3)_223-227.nxml.txt.nlp	22135629	SENT5	0	0	7	7	trastuzumab	HER2	PA451743	2064	0.975
NULL	Arthritis_Res_Ther_2012_Apr_18_14(2)_R80.nxml.txt.nlp	22513098	SENT205	0	0	24	24	hydroxychloroquine	TLR9	PA164777036	54106	0.975
NULL	Cell_Biol_Int_Rep_(2010)_2012_Jun_21_19(1)_e00017.nxml.txt.nlp	23124518	SENT90	8	8	48	48	etoposide	TRAIL	PA449552	8743	0.975
NULL	Br_J_Cancer_2013_Mar_5_108(4)_748-754.nxml.txt.nlp	23361058	SENT37	2	2	29	29	vorinostat	53BP1	PA164748224	7158	0.975
NULL	Br_J_Cancer_2009_Jun_2_100(11)_1739-1745.nxml.txt.nlp	19436299	SENT140	12	12	20	20	everolimus	FDG	PA164746311	23583	0.975
NULL	Nat_Genet_2011_Jun_5_43(7)_621-629.nxml.txt.nlp	21642992	SENT102	44	44	16	16	doxorubicin	p53	PA449412	7157	0.975
NULL	Basic_Res_Cardiol_2014_Jan_30_109(2)_402.nxml.txt.nlp	24477916	SENT280	28	28	8	8	diazoxide	SUR1	PA449285	6833	0.975
NULL	Cancer_Cell_Int_2005_Aug_23_5_27.nxml.txt.nlp	16117829	SENT202	12	12	3	3	doxycycline	p53	PA449415	7157	0.975
NULL	Cent_European_J_Urol_2013_Dec_19_66(4)_394-404.nxml.txt.nlp	24757527	SENT143	0	0	16	16	sunitinib	VEGFR	PA162372840	3791	0.975
NULL	Oncotarget_2013_Aug_30_4(10)_1698-1711.nxml.txt.nlp	24091605	SENT175	3	3	26	26	gefitinib	TIC	PA131301952	23550	0.975
NULL	Indian_J_Med_Paediatr_Oncol_2014_Jan-Mar_35(1)_109-110.nxml.txt.nlp	25006299	SENT19	16	16	11	11	gefitinib	EGFR	PA131301952	1956	0.975
NULL	Environ_Health_Perspect_2008_Apr_16_116(4)_426-433.nxml.txt.nlp	18414622	SENT150	1	1	11	11	resveratrol	NMU		10874	0.975
NULL	J_Cell_Biol_2001_May_28_153(5)_1023-1034.nxml.txt.nlp	11381087	SENT197	28	28	3	3	doxycycline	Met	PA449415	79811	0.975
NULL	Indian_J_Med_Res_2014_Jan_139(1)_76-82.nxml.txt.nlp	24604041	SENT120	6	6	34	34	albendazole	STH	PA164746058	246744	0.975
NULL	Indian_J_Med_Res_2012_Aug_136(2)_249-259.nxml.txt.nlp	22960892	SENT137	43	43	30	30	irinotecan	UGT1A1	PA450085	54658	0.975
NULL	Cancer_Immunol_Immunother_2013_Aug_27_62(10)_1637-1648.nxml.txt.nlp	23982484	SENT239	0	0	9	9	lenalidomide	STAT3	PA162363968	6774	0.975
NULL	J_Hematol_Oncol_2012_Apr_25_5(Suppl_1)_A1.nxml.txt.nlp	22738713	SENT20	0	0	15	15	pertuzumab	EGFR		1956	0.975
NULL	Nat_Chem_Biol_2010_Apr_28_6(4)_291-299.nxml.txt.nlp	20190765	SENT145	26	26	6	6	dasatinib	EGFR	PA162372878	1956	0.975
NULL	Onco_Targets_Ther_2014_Sep_23_7_1653-1661.nxml.txt.nlp	25285015	SENT117	32	32	11	11	sn-38	UGT1A1		54658	0.975
NULL	Diabetes_Care_2012_Feb_16_35(2)_327-333.nxml.txt.nlp	22179958	SENT80	37	37	5	5	metformin	B12	PA450395	7126;4709	0.975
NULL	Gene_Ther_2010_Apr_25_17(4)_550-559.nxml.txt.nlp	20182517	SENT95	23	23	6	6	etoposide	bcl-xL	PA449552	598	0.975
NULL	J_Cell_Biol_2001_Apr_2_153(1)_207-220.nxml.txt.nlp	11285286	SENT150	19	19	5	5	carbachol	DGK	PA448784	8526;1607	0.975
NULL	Front_Pharmacol_2014_Dec_23_5_286.nxml.txt.nlp	25566078	SENT57	20	20	42	42	lapatinib	FOXM1	PA152241907	2305	0.975
NULL	Int_J_Mol_Sci_2014_Jun_18_15(6)_11013-11029.nxml.txt.nlp	24945311	SENT149	7	7	16	16	celecoxib	STAT3	PA448871	6774	0.975
NULL	J_Inherit_Metab_Dis_2011_Apr_3_34(2)_367-376.nxml.txt.nlp	21290187	SENT204	2	2	16	16	galactose	GALT	PA449725	2592	0.975
NULL	Oncotarget_2013_Dec_4_5(2)_351-362.nxml.txt.nlp	24504051	SENT88	17	17	7	7	olaparib	ERG		2078	0.975
NULL	Dermatoendocrinol_2013_Apr_1_5(2)_239-251.nxml.txt.nlp	24194964	SENT209	38	38	3	3	vemurafenib	HIF-1	PA165946873	29072	0.975
NULL	Int_J_Breast_Cancer_2011_Feb_24_2011_967419.nxml.txt.nlp	22332018	SENT142	30	30	0	0	cisplatin	BRCA1	PA449014	672	0.975
NULL	FEBS_Open_Bio_2014_Jul_5_4_659-671.nxml.txt.nlp	25161875	SENT777	13	13	9	9	etoposide	XIAP	PA449552	331	0.975
NULL	Nucleic_Acids_Res_2005_Jun_8_33(10)_3283-3291.nxml.txt.nlp	15944449	SENT14	6	6	21	21	melphalan	XRCC3	PA450354	7517	0.975
NULL	Pharmacogn_Rev_2012_Jul-Dec_6(12)_132-140.nxml.txt.nlp	23055639	SENT221	26	26	15	15	glibenclamide	STZ	PA449782	6484	0.975
NULL	Oncotarget_2013_Jul_26_4(8)_1317-1328.nxml.txt.nlp	23945331	SENT15	26	26	10	10	trastuzumab	aromatase	PA451743	1588	0.975
NULL	Mol_Cells_2014_Dec_31_37(12)_899a-906.nxml.txt.nlp	25431425	SENT136	26	26	8	8	curcumin	EP2	PA151958596	5732;10407	0.975
NULL	Biochemistry_2014_Jan_28_53(3)_505-517.nxml.txt.nlp	24383758	SENT35	2	2	29	29	thrombin	San	PA451674	80218	0.975
NULL	Crit_Care_2001_Jun_26_5(Suppl_3)_P62.nxml.txt.nlp	NULL	SENT9	35	35	4	4	ceftazidime	MRB	PA448861	54538	0.975
NULL	Br_J_Clin_Pharmacol_2013_Aug_23_76(2)_299-315.nxml.txt.nlp	23701319	SENT245	15	15	26	26	alemtuzumab	CD4	PA164783958	920	0.975
NULL	Ann_Thorac_Med_2013_Oct-Dec_8(4)_204-208.nxml.txt.nlp	24250733	SENT142	4	4	16	16	erlotinib	EGFR	PA134687924	1956	0.975
NULL	Oncol_Lett_2014_Mar_19_7(3)_674-678.nxml.txt.nlp	24527071	SENT134	13	13	5	5	cisplatin	AKR1C2	PA449014	1646	0.975
NULL	Breast_Cancer_Res_2001_Nov_8_3(1)_66-75.nxml.txt.nlp	11250748	SENT104	2	2	26	26	tamoxifen	NMU	PA451581	10874	0.975
NULL	Cancer_Metab_2013_Jan_23_1_3.nxml.txt.nlp	24280005	SENT557	18	18	9	9	doxycycline	SREBP1	PA449415	6720	0.975
NULL	Bioinformation_2008_Jun_27_2(9)_384-391.nxml.txt.nlp	18795111	SENT16	2	2	16	16	methotrexate	DHFR	PA450428	1719	0.975
NULL	Int_J_Chron_Obstruct_Pulmon_Dis_2007_Jun_2(2)_121-129.nxml.txt.nlp	18044684	SENT100	3	3	35	35	roflumilast	IL-8	PA165948052	3576	0.975
NULL	Acta_Neuropathol_Commun_2013_May_20_1_17.nxml.txt.nlp	24252689	SENT58	20	20	0	0	celecoxib	ICAM1	PA448871	3383	0.975
NULL	Br_J_Cancer_2010_Jul_13_103(2)_186-195.nxml.txt.nlp	20588277	SENT105	4	4	11	11	nutlin-3	p53		7157	0.975
NULL	Front_Physiol_2013_Jul_17_4_157.nxml.txt.nlp	23882218	SENT162	25	25	2	2	oxygen	TEM	PA450744	64102	0.975
NULL	Br_J_Cancer_2009_Oct_6_101(7)_1162-1167.nxml.txt.nlp	19724276	SENT45	0	0	32	32	gemcitabine	Gem	PA449748	51053	0.975
NULL	Arch_Toxicol_2014_Sep_3_88(10)_1855-1879.nxml.txt.nlp	25182421	SENT277	22	22	44	44	metyrapone	TRPA1	PA450486	8989	0.975
NULL	Cancer_Metab_2013_Dec_5_1_22.nxml.txt.nlp	24304688	SENT271	29	29	12	12	tamoxifen	ERBB2	PA451581	2064	0.975
NULL	Pharmaceutics_2012_Jan_31_4(1)_93-103.nxml.txt.nlp	24300182	SENT23	16	16	0	0	piroxicam	PDF	PA450985	64146;9518	0.975
NULL	Breast_Cancer_Res_2010_May_18_12(Suppl_1)_P35.nxml.txt.nlp	NULL	SENT9	10	10	15	15	paclitaxel	MAD2	PA450761	4085;4601	0.975
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT282	22	22	5	5	trastuzumab	HER2	PA451743	2064	0.975
NULL	J_Cell_Biol_2002_Jun_24_157(7)_1151-1160.nxml.txt.nlp	12082077	SENT147	18	18	26	26	trypsin	COX	PA451806	1351	0.975
NULL	J_Hematol_Oncol_2013_Feb_18_6_18.nxml.txt.nlp	23415012	SENT34	6	6	29	29	cytarabine	Mcl-1	PA449177	4170	0.975
NULL	Oncogene_2014_Feb_6_33(6)_713-723.nxml.txt.nlp	23435429	SENT64	29	29	4	4	etoposide	BRCA1	PA449552	672	0.975
NULL	Ann_Med_2014_Nov_21_46(7)_475-489.nxml.txt.nlp	25045928	SENT162	33	33	12	12	clopidogrel	CYP2C19	PA449053	1557	0.975
NULL	Br_J_Cancer_2010_Jan_5_102(1)_134-143.nxml.txt.nlp	19920829	SENT182	32	32	17	17	rituximab	IL-2	PA451261	3558	0.975
NULL	Br_J_Cancer_2010_May_11_102(10)_1456-1460.nxml.txt.nlp	20461090	SENT87	11	11	20	20	temsirolimus	IFN	PA164746890	3439	0.975
NULL	Allergy_Asthma_Immunol_Res_2013_Sep_27_5(5)_258-276.nxml.txt.nlp	24003382	SENT54	14	14	3	3	montelukast	CYSLTR1	PA450546	10800	0.975
NULL	Clin_Interv_Aging_2009_May_14_4_179-186.nxml.txt.nlp	19503779	SENT55	0	0	5	5	entacapone	COMT	PA164748726	1312	0.975
NULL	Br_J_Cancer_2013_Jul_23_109(2)_351-359.nxml.txt.nlp	23799854	SENT171	16	16	12	12	paclitaxel	BLT2	PA450761	56413	0.975
NULL	Part_Fibre_Toxicol_2013_Aug_13_10_39.nxml.txt.nlp	23937860	SENT29	47	47	12	12	anakinra	IL-8	PA10799	3576	0.975
NULL	Indian_J_Med_Res_2011_Dec_134(6)_904-911.nxml.txt.nlp	22310822	SENT104	0	0	26	26	stavudine	CD4	PA451494	920	0.975
NULL	Front_Immunol_2014_Apr_22_5_184.nxml.txt.nlp	24795726	SENT173	18	18	9	9	imatinib	KIR2DS1	PA10804	3806	0.975
NULL	Mol_Biol_Cell_2012_May_15_23(10)_1812-1825.nxml.txt.nlp	22438585	SENT245	10	10	3	3	dextran	PI3K	PA449261	5290	0.975
NULL	J_Hematol_Oncol_2013_Feb_18_6_18.nxml.txt.nlp	23415012	SENT34	6	6	26	26	cytarabine	Bcl-2	PA449177	596	0.975
NULL	Arthritis_Res_Ther_2012_May_1_14(3)_R99.nxml.txt.nlp	22546542	SENT13	18	18	22	22	infliximab	IL-17	PA452639	3605	0.975
NULL	Biologics_2013_Feb_25_7_47-60.nxml.txt.nlp	23459471	SENT9	23	23	5	5	vorinostat	HDAC	PA164748224	9734	0.975
NULL	Br_J_Cancer_2012_Nov_20_107(11)_1853-1863.nxml.txt.nlp	23169338	SENT207	26	26	13	13	cisplatin	p53	PA449014	7157	0.975
NULL	Indian_J_Dermatol_2010_Apr-Jun_55(2)_161-170.nxml.txt.nlp	20606887	SENT42	20	20	13	13	ustekinumab	IL-23	PA166048654	51561	0.975
NULL	Indian_J_Endocrinol_Metab_2011_Oct_15(Suppl4)_S374-S379.nxml.txt.nlp	22145142	SENT92	17	17	10	10	lisinopril	ABCD2	PA450242	225	0.975
NULL	Cogn_Neurodyn_2012_Apr_13_6(2)_169-183.nxml.txt.nlp	22511913	SENT352	48	48	11	11	sevoflurane	MST	PA451341	55154;4357;4294	0.975
NULL	Blood_Cancer_J_2012_Jan_13_2(1)_e50.nxml.txt.nlp	22829234	SENT126	16	16	1	1	melphalan	CD138	PA450354	6382	0.975
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT167	46	46	38	38	trastuzumab	AKT	PA451743	207	0.975
NULL	Br_J_Cancer_2004_Mar_22_90(6)_1285-1292.nxml.txt.nlp	15026814	SENT188	18	18	10	10	doxorubicin	p53	PA449412	7157	0.975
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT88	0	0	18	18	efavirenz	CYP2C19	PA449441	1557	0.975
NULL	Acta_Pharmacol_Sin_2012_Dec_22_33(12)_1511-1517.nxml.txt.nlp	23085741	SENT183	32	32	22	22	zileuton	CysLT1	PA451955	10800	0.975
NULL	J_Thyroid_Res_2011_Apr_10_2011_895923.nxml.txt.nlp	21603172	SENT68	41	41	21	21	thyroglobulin	San	PA164754910	80218	0.975
NULL	Ann_Rheum_Dis_2008_Aug_29_67(8)_1096-1103.nxml.txt.nlp	18055472	SENT122	13	13	4	4	infliximab	ACR	PA452639	49	0.975
NULL	Cancers_(Basel)_2014_Apr_23_6(2)_958-968.nxml.txt.nlp	24762632	SENT71	26	26	9	9	paclitaxel	STAT3	PA450761	6774	0.975
NULL	EMBO_Mol_Med_2012_Jul_11_4(7)_603-616.nxml.txt.nlp	22407764	SENT71	10	10	1	1	doxycycline	BRG1	PA449415	6597	0.975
NULL	Arthritis_Res_Ther_2014_Apr_11_16(2)_R93.nxml.txt.nlp	24725461	SENT31	35	35	2	2	estradiol	CYP19A1	PA449503	1588	0.975
NULL	J_Cell_Mol_Med_2013_Jan_11_17(1)_134-146.nxml.txt.nlp	23305490	SENT298	28	28	4	4	quinidine	TWIK-2	PA451209	9424	0.975
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT57	11	11	2	2	neratinib	HER2	PA165291472	2064	0.975
NULL	Br_J_Pharmacol_2013_Jun_27_169(4)_933-948.nxml.txt.nlp	23517055	SENT11	39	39	22	22	bepridil	NCX	PA164754755	3196	0.975
NULL	Indian_J_Dermatol_2009_Jan-Mar_54(1)_7-12.nxml.txt.nlp	20049260	SENT37	0	0	10	10	efalizumab	LFA-1	PA164748817	3683;3689	0.975
NULL	Am_J_Case_Rep_2014_Apr_14_15_152-154.nxml.txt.nlp	24753783	SENT64	10	10	20	20	liraglutide	GLP-1	PA165958364	100125288	0.975
NULL	J_Cell_Biol_1998_Jan_26_140(2)_335-345.nxml.txt.nlp	9442109	SENT170	12	12	8	8	chloroquine	NHE	PA448948	285335	0.975
NULL	Breast_Cancer_Res_Treat_2012_Jul_5_134(2)_693-700.nxml.txt.nlp	22562123	SENT29	16	16	0	0	tamoxifen	CYP2D6	PA451581	1565	0.975
NULL	Bioinformation_2013_Jan_18_9(2)_89-93.nxml.txt.nlp	23390352	SENT64	8	8	13	13	pioglitazone	gamma	PA450970	9913	0.975
NULL	Cancers_(Basel)_2014_Mar_6_6(1)_494-525.nxml.txt.nlp	24662938	SENT21	2	2	26	26	auranofin	STAT3	PA448510	6774	0.975
NULL	Evid_Based_Complement_Alternat_Med_2014_May_8_2014_364819.nxml.txt.nlp	24899907	SENT197	3	3	11	11	tacrolimus	FKBP52	PA451578	2288	0.975
NULL	JRSM_Cardiovasc_Dis_2012_Sep_24_1(6)_cvd_2012_012015.nxml.txt.nlp	24175073	SENT108	22	22	7	7	clopidogrel	CYP2C19	PA449053	1557	0.975
NULL	Clin_Endosc_2011_Sep_30_44(1)_22-26.nxml.txt.nlp	22741108	SENT31	24	24	9	9	midazolam	ESD	PA450496	2098	0.975
NULL	Indian_J_Pharmacol_2012_Sep-Oct_44(5)_624-628.nxml.txt.nlp	23112426	SENT135	13	13	21	21	pravastatin	P-gp	PA451089	5243	0.975
NULL	Arthritis_Res_Ther_2010_Aug_26_12(4)_138.nxml.txt.nlp	20815919	SENT9	45	45	5	5	methylprednisolone	CD64	PA450466	2209	0.975
NULL	Int_J_Nephrol_2010_Dec_9_2011_957164.nxml.txt.nlp	21197105	SENT149	15	15	7	7	telmisartan	DDAH	PA451605	23576	0.975
NULL	Acta_Pharmacol_Sin_2010_Jul_28_31(7)_867-873.nxml.txt.nlp	20581857	SENT130	14	14	4	4	docetaxel	PDCD4	PA449383	27250	0.975
NULL	Oncol_Rep_2013_Mar_8_29(3)_917-924.nxml.txt.nlp	23314174	SENT147	0	0	10	10	sorafenib	HCC	PA7000	84668	0.975
NULL	Dermatoendocrinol_2013_Apr_1_5(2)_252-263.nxml.txt.nlp	24194965	SENT159	10	10	39	39	metformin	B12	PA450395	7126;4709	0.975
NULL	Curr_Neuropharmacol_2014_May_12(3)_219-238.nxml.txt.nlp	24851087	SENT319	5	5	30	30	rolipram	GluN1	PA153906323	2902	0.975
NULL	Endocrinol_Diabetes_Metab_Case_Rep_2013_Nov_8_2013_130041.nxml.txt.nlp	24616771	SENT113	32	32	20	20	diazoxide	ABCC8	PA449285	6833	0.975
NULL	Cardiovasc_Diabetol_2011_Dec_22_10_115.nxml.txt.nlp	22189184	SENT128	4	4	10	10	miglitol	GLP-1	PA164776726	100125288	0.975
NULL	Br_J_Cancer_2010_Sep_7_103(6)_765-771.nxml.txt.nlp	20700120	SENT13	14	14	0	0	tamoxifen	CYP2D6	PA451581	1565	0.975
NULL	Cell_Div_2012_Mar_29_7_11.nxml.txt.nlp	22458775	SENT253	6	6	0	0	flavopiridol	CDK9	PA452627	1025	0.975
NULL	Clin_Interv_Aging_2012_Dec_30_7_1-13.nxml.txt.nlp	22291468	SENT137	2	2	8	8	dronedarone	CYP3A4	PA153619853	1576	0.975
NULL	Oncotarget_2013_Nov_19_5(2)_309-325.nxml.txt.nlp	24525395	SENT282	11	11	37	37	resveratrol	p53		7157	0.975
NULL	Breast_Cancer_Res_2004_Nov_7_6(1)_R24-R30.nxml.txt.nlp	14680497	SENT110	28	28	10	10	doxorubicin	p53	PA449412	7157	0.975
NULL	Cancers_(Basel)_2012_Sep_25_4(4)_969-988.nxml.txt.nlp	24213497	SENT197	16	16	31	31	gefitinib	EGFR	PA131301952	1956	0.975
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT40	7	7	38	38	erlotinib	AKT	PA134687924	207	0.975
NULL	J_Cell_Biol_2003_Dec_22_163(6)_1385-1395.nxml.txt.nlp	14676308	SENT260	0	0	39	39	thrombin	RhoA	PA451674	387	0.975
NULL	Oncoscience_2014_Mar_24_1(3)_196-204.nxml.txt.nlp	25594012	SENT117	9	9	4	4	trastuzumab	PIK3CA	PA451743	5290	0.975
NULL	Oncotarget_2013_Nov_24_4(12)_2430-2438.nxml.txt.nlp	24280348	SENT142	10	10	23	23	gefitinib	STAT3	PA131301952	6774	0.975
NULL	Patient_Prefer_Adherence_2013_Apr_26_7_369-377.nxml.txt.nlp	23641151	SENT1	0	0	10	10	ustekinumab	p40	PA166048654	3921;339541;10314	0.975
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S31-S40.nxml.txt.nlp	20680106	SENT49	12	12	31	31	cetuximab	KRAS	PA10040	3845	0.975
NULL	Front_Oncol_2014_Oct_21_4_285.nxml.txt.nlp	25374842	SENT677	2	2	21	21	nutlin-3	MDM2		4193	0.975
NULL	Mol_Cancer_2006_Oct_17_5_45.nxml.txt.nlp	17044934	SENT5	5	5	13	13	resveratrol	COX		1351	0.975
NULL	J_Oncol_2009_Jun_14_2009_814140.nxml.txt.nlp	19547715	SENT6	12	12	29	29	erlotinib	MRP1	PA134687924	4437	0.975
NULL	Acta_Orthop_2010_Apr_6_81(2)_263-267.nxml.txt.nlp	20148646	SENT128	4	4	21	21	taurine	ATF4	PA451590	468	0.975
NULL	Clinics_(Sao_Paulo)_2014_May_69(5)_327-334.nxml.txt.nlp	24838898	SENT41	18	18	33	33	methotrexate	P-gp	PA450428	5243	0.975
NULL	Front_Oncol_2014_Jun_12_4_144.nxml.txt.nlp	24971229	SENT461	28	28	23	23	gemcitabine	EZH2	PA449748	2146	0.975
NULL	Ann_Hematol_2014_Jul_5_93(12)_1977-1983.nxml.txt.nlp	24994538	SENT163	24	24	5	5	rituximab	TP53	PA451261	7157	0.975
NULL	Breast_Cancer_Res_2011_Jan_17_13(1)_R5.nxml.txt.nlp	21241485	SENT323	9	9	33	33	estradiol	EGF	PA449503	1950	0.975
NULL	Int_J_Mol_Imaging_2011_Oct_12_2011_694179.nxml.txt.nlp	22013519	SENT121	11	11	31	31	zolmitriptan	5-HT1D	PA451975	3352	0.975
NULL	Acta_Physiol_(Oxf)_2008_Apr_192(4)_505-517.nxml.txt.nlp	17973950	SENT209	4	4	40	40	propranolol	LQT3	PA451145	6331	0.975
NULL	Front_Oncol_2013_Sep_23_3_250.nxml.txt.nlp	24069582	SENT145	14	14	20	20	lapatinib	EGFR	PA152241907	1956	0.975
NULL	Int_J_Endocrinol_2014_Jul_1_2014_816430.nxml.txt.nlp	25097550	SENT173	0	0	8	8	pazopanib	VEGFR	PA165291492	3791	0.975
NULL	Evid_Based_Complement_Alternat_Med_2013_May_26_2013_349790.nxml.txt.nlp	23762123	SENT130	27	27	8	8	rosiglitazone	LSP1	PA451283	4046	0.975
NULL	Braz_J_Med_Biol_Res_2014_Nov_4_48(1)_13-24.nxml.txt.nlp	25493378	SENT76	31	31	4	4	cisplatin	p53	PA449014	7157	0.975
NULL	Eur_J_Med_Chem_2014_Dec_17_88_89-100.nxml.txt.nlp	25159123	SENT455	0	0	5	5	pentamidine	PRL	PA450850	5617	0.975
NULL	Oncol_Lett_2014_Nov_10_8(5)_2333-2339.nxml.txt.nlp	25295120	SENT87	17	17	24	24	sorafenib	ADM	PA7000	133	0.975
NULL	Cancer_Cell_Int_2010_Apr_29_10_12.nxml.txt.nlp	20429927	SENT187	25	25	10	10	bortezomib	HRI	PA10252	27102	0.975
NULL	J_Cell_Biol_2008_Jul_28_182(2)_367-379.nxml.txt.nlp	18644892	SENT74	4	4	28	28	pp2	PP2		4888	0.975
NULL	Acta_Pharmacol_Sin_2012_May_26_33(5)_675-681.nxml.txt.nlp	22447226	SENT17	5	5	28	28	gefitinib	PLK1	PA131301952	5347	0.975
NULL	Core_Evid_2011_Feb_8_6_23-29.nxml.txt.nlp	21468240	SENT116	0	0	10	10	plerixafor	CD34	PA165958410	947	0.975
NULL	Oncogene_2009_Dec_10_28(49)_4353-4363.nxml.txt.nlp	19826413	SENT7	33	33	10	10	paclitaxel	IRAK4	PA450761	51135	0.975
NULL	Acta_Pharmacol_Sin_2012_Dec_22_33(12)_1511-1517.nxml.txt.nlp	23085741	SENT183	19	19	15	15	pranlukast	CysLT1	PA134698661	10800	0.975
NULL	Oncotarget_2012_Sep_28_3(10)_1169-1181.nxml.txt.nlp	23045411	SENT99	32	32	10	10	doxorubicin	JIP1	PA449412	9479	0.975
NULL	Breast_Cancer_Res_Treat_2013_Jun_5_139(3)_649-655.nxml.txt.nlp	23736997	SENT119	8	8	14	14	tamoxifen	CYP2C19	PA451581	1557	0.975
NULL	Br_J_Cancer_2010_Feb_16_102(4)_658-664.nxml.txt.nlp	20104222	SENT14	3	3	16	16	sunitinib	IFN	PA162372840	3439	0.975
NULL	J_Oncol_2012_May_16_2012_450179.nxml.txt.nlp	22666248	SENT250	18	18	7	7	everolimus	PIK3CA	PA164746311	5290	0.975
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT46	4	4	17	17	neratinib	HER2	PA165291472	2064	0.975
NULL	Ther_Clin_Risk_Manag_2007_Aug_3(4)_533-542.nxml.txt.nlp	18472974	SENT143	3	3	14	14	posaconazole	CDR1	PA151958574	1038	0.975
NULL	Clin_Med_Insights_Oncol_2013_Aug_21_7_235-245.nxml.txt.nlp	24179414	SENT52	22	22	25	25	gemfibrozil	CYP2C8	PA449750	1558	0.975
NULL	Biosci_Rep_2014_Aug_6_34(4)_e00131.nxml.txt.nlp	24975826	SENT91	3	3	31	31	probenecid	TRPM8	PA451106	79054	0.975
NULL	Oncologist_2010_Mar_3_15(3)_216-235.nxml.txt.nlp	20200040	SENT259	6	6	18	18	trastuzumab	HER-2	PA451743	2064	0.975
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_19_2013_746486.nxml.txt.nlp	23861712	SENT147	16	16	0	0	irinotecan	UGT1A1	PA450085	54658	0.975
NULL	J_Clin_Biochem_Nutr_2011_Sep_3_49(2)_70-78.nxml.txt.nlp	21980221	SENT201	8	8	32	32	cisplatin	NAC	PA449014	22861	0.975
NULL	Oncol_Lett_2014_Sep_19_8(3)_1269-1274.nxml.txt.nlp	25120704	SENT104	11	11	18	18	cisplatin	Met	PA449014	79811	0.975
NULL	An_Bras_Dermatol_2014_Mar-Apr_89(2)_266-273.nxml.txt.nlp	24770503	SENT46	0	0	8	8	thalidomide	ENL	PA451644	4298	0.975
NULL	Tuberc_Respir_Dis_(Seoul)_2014_Sep_30_77(3)_105-110.nxml.txt.nlp	25309604	SENT32	6	6	39	39	warfarin	CYP2C9	PA451906	1559	0.975
NULL	Toxins_(Basel)_2010_May_28_2(6)_1207-1224.nxml.txt.nlp	22069634	SENT122	7	7	19	19	curcumin	TCF-4	PA151958596	6934	0.975
NULL	Mol_Cancer_2011_Sep_7_10_109.nxml.txt.nlp	21899742	SENT296	0	0	16	16	etoposide	TRAIL-R2	PA449552	8795	0.975
NULL	Cancer_Inform_2012_Apr_19_11_87-111.nxml.txt.nlp	22553414	SENT217	1	1	6	6	gefitinib	FOXM1	PA131301952	2305	0.975
NULL	Clin_Pharmacol_2011_Jun_22_3_13-25.nxml.txt.nlp	22287853	SENT184	10	10	28	28	ketoconazole	CYP3A4	PA450146	1576	0.975
NULL	Nucleic_Acids_Res_2011_Oct_9_39(19)_8355-8365.nxml.txt.nlp	21745816	SENT176	14	14	23	23	doxycycline	USP7	PA449415	7874	0.975
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1224-1233.nxml.txt.nlp	22353810	SENT95	11	11	2	2	doxorubicin	MRP-1	PA449412	928	0.975
NULL	Front_Neurosci_2015_Jan_15_8_426.nxml.txt.nlp	25642160	SENT202	19	19	22	22	bupropion	CHRNA5	PA448687	1138	0.975
NULL	Nat_Neurosci_2014_Jul_25_17(7)_943-952.nxml.txt.nlp	24859199	SENT436	34	34	7	7	doxycycline	DCX	PA449415	1641	0.975
NULL	Case_Rep_Med_2012_May_28_2012_757696.nxml.txt.nlp	22685471	SENT55	3	3	10	10	lorazepam	CHS	PA450267	1130	0.975
NULL	Leukemia_2014_Jun_25_28(6)_1280-1288.nxml.txt.nlp	24270737	SENT121	7	7	32	32	decitabine	DAC	PA164749631	13	0.975
NULL	Emerg_Infect_Dis_2011_Mar_17(3)_556-558.nxml.txt.nlp	21392461	SENT45	30	30	4	4	clarithromycin	RGM	PA449028	56963	0.975
NULL	Nat_Commun_2014_Mar_25_5_3496.nxml.txt.nlp	24667209	SENT102	33	33	1	1	doxycycline	CN1	PA449415	84618;84735	0.975
NULL	Cancer_Med_2013_Aug_2_2(4)_571-582.nxml.txt.nlp	24156030	SENT37	0	0	11	11	curcumin	IL-6	PA151958596	3569	0.975
NULL	Pharmaceuticals_(Basel)_2011_Nov_10_4(11)_1488-1502.nxml.txt.nlp	NULL	SENT198	27	27	1	1	trastuzumab	PTEN	PA451743	5728	0.975
NULL	Oncotarget_2013_Oct_19_4(11)_2045-2056.nxml.txt.nlp	24185104	SENT3	17	17	5	5	cisplatin	14-3-3	PA449014	10971	0.975
NULL	Br_J_Cancer_1999_Nov_81(6)_942-951.nxml.txt.nlp	10576649	SENT8	33	33	8	8	doxorubicin	P-gp	PA449412	5243	0.975
NULL	Br_J_Cancer_2010_Dec_7_103(12)_1858-1869.nxml.txt.nlp	21063399	SENT241	41	41	5	5	doxorubicin	p53	PA449412	7157	0.975
NULL	Mol_Cancer_2014_Jun_16_13_152.nxml.txt.nlp	24935000	SENT245	34	34	5	5	vincristine	p27	PA451879	5715;10534	0.975
NULL	J_Clin_Biochem_Nutr_2008_Mar_1_42(2)_78-88.nxml.txt.nlp	18385824	SENT135	7	7	24	24	hemin	HO-1	PA449849	3162	0.975
NULL	Scientifica_(Cairo)_2012_Oct_14_2012_428139.nxml.txt.nlp	24278693	SENT233	2	2	10	10	bortezomib	CTR1	PA10252	1317	0.975
NULL	Biochem_Res_Int_2012_May_17_2012_973723.nxml.txt.nlp	22666593	SENT103	26	26	7	7	atorvastatin	MYOCD	PA448500	93649	0.975
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1129-1136.nxml.txt.nlp	20234368	SENT13	7	7	20	20	imiquimod	CD4	PA449972	920	0.975
NULL	Oncotarget_2013_Nov_26_4(12)_2502-2511.nxml.txt.nlp	24318446	SENT99	13	13	8	8	doxycycline	PHGDH	PA449415	26227	0.975
NULL	Br_J_Cancer_2012_Apr_24_106(9)_1543-1550.nxml.txt.nlp	22531721	SENT164	29	29	4	4	rituximab	CD55	PA451261	1604	0.975
NULL	Eur_J_Clin_Pharmacol_2012_Sep_15_68(9)_1267-1274.nxml.txt.nlp	22418828	SENT108	3	3	14	14	pantoprazole	CYP2C19	PA450774	1557	0.975
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_75-89.nxml.txt.nlp	17912638	SENT60	3	3	18	18	anastrozole	ATAC	PA448432	6375	0.975
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT50	37	37	28	28	anastrozole	HER2	PA448432	2064	0.975
NULL	Cancer_Cell_Int_2013_Sep_23_13_94.nxml.txt.nlp	24059699	SENT147	16	16	0	0	bevacizumab	VEGFR2	PA130232992	3791	0.975
NULL	Front_Endocrinol_(Lausanne)_2013_May_10_4_52.nxml.txt.nlp	23675368	SENT508	28	28	20	20	resveratrol	AMPK		5563	0.975
NULL	Chin_J_Cancer_2011_Oct_30(10)_701-711.nxml.txt.nlp	21959047	SENT128	35	35	3	3	cetuximab	EGFR	PA10040	1956	0.975
NULL	Breast_Cancer_Res_2008_Feb_1_10(1)_R10.nxml.txt.nlp	18241344	SENT187	43	43	18	18	cisplatin	CD44	PA449014	960	0.975
NULL	Clin_Pharmacol_2010_Apr_27_2_77-82.nxml.txt.nlp	22291489	SENT42	0	0	17	17	cosyntropin	ACTH	PA164749052	5443	0.975
NULL	Acta_Pharmacol_Sin_2009_Sep_24_30(9)_1330-1336.nxml.txt.nlp	19701234	SENT21	5	5	11	11	ilaprazole	CYP2C9	PA165947499	1559	0.975
NULL	Acta_Pharmacol_Sin_2010_Jul_21_31(7)_855-860.nxml.txt.nlp	20562904	SENT12	15	15	36	36	fluconazole	CDR1	PA449653	1038	0.975
NULL	Int_J_Breast_Cancer_2011_Jul_12_2011_232435.nxml.txt.nlp	22295213	SENT30	6	6	12	12	tamoxifen	aromatase	PA451581	1588	0.975
NULL	J_Oncol_2009_Jun_14_2009_814140.nxml.txt.nlp	19547715	SENT6	8	8	26	26	gemcitabine	MDR1	PA449748	5243	0.975
NULL	Oncotarget_2013_Oct_19_4(11)_2045-2056.nxml.txt.nlp	24185104	SENT28	22	22	8	8	cisplatin	RhoGDI2	PA449014	397	0.975
NULL	Carcinogenesis_2013_Mar_7_34(3)_703-712.nxml.txt.nlp	23222814	SENT111	11	11	39	39	curcumin	p53	PA151958596	7157	0.975
NULL	Acta_Histochem_Cytochem_2010_May_1_43(2)_33-44.nxml.txt.nlp	20514290	SENT171	14	14	3	3	oxygen	HIF-1	PA450744	29072	0.975
NULL	Leukemia_2014_May_29_28(5)_1129-1131.nxml.txt.nlp	24166296	SENT42	5	5	17	17	lenalidomide	CRBN	PA162363968	51185	0.975
NULL	Environ_Health_Perspect_2005_Nov_14_113(11)_1600-1606.nxml.txt.nlp	16263518	SENT62	17	17	6	6	estradiol	HSD2	PA449503	6060	0.975
NULL	J_Clin_Biochem_Nutr_2009_Sep_28_45(2)_125-130.nxml.txt.nlp	19794918	SENT88	17	17	4	4	lansoprazole	HO-1	PA450180	3162	0.975
NULL	Clin_Interv_Aging_2009_May_14_4_179-186.nxml.txt.nlp	19503779	SENT91	9	9	4	4	cimetidine	CYP1A2	PA449001	1544	0.975
NULL	FEBS_Open_Bio_2014_Oct_22_4_898-904.nxml.txt.nlp	25383313	SENT174	5	5	13	13	nifedipine	AMPK	PA450631	5563	0.975
NULL	Br_J_Cancer_2010_Oct_12_103(8)_1192-1200.nxml.txt.nlp	20877358	SENT190	32	32	15	15	etoposide	BRCA2	PA449552	675	0.975
NULL	Clinics_(Sao_Paulo)_2012_May_67(5)_419-424.nxml.txt.nlp	22666783	SENT38	18	18	0	0	erlotinib	KRAS	PA134687924	3845	0.975
NULL	Cardiovasc_Diabetol_2013_Mar_18_12_46.nxml.txt.nlp	23497197	SENT117	16	16	8	8	metformin	adiponectin	PA450395	9370	0.975
NULL	Indian_J_Endocrinol_Metab_2013_Jul-Aug_17(4)_636-646.nxml.txt.nlp	23961479	SENT146	20	20	4	4	ketoconazole	CYP2C9	PA450146	1559	0.975
NULL	Oncotarget_2012_Oct_20_3(10)_1068-1111.nxml.txt.nlp	23085539	SENT32	1	1	13	13	sorafenib	BRAF	PA7000	673	0.975
NULL	Ann_Med_Surg_(Lond)_2014_Jun_19_3(3)_60-64.nxml.txt.nlp	25568788	SENT90	20	20	27	27	tegaserod	5-HT4	PA130413154	3360	0.975
NULL	Interdiscip_Perspect_Infect_Dis_2014_Mar_20_2014_625670.nxml.txt.nlp	24778646	SENT20	32	32	40	40	ritonavir	CCR5	PA451260	1234	0.975
NULL	ASN_Neuro_2012_Dec_6_4(7)_e00102.nxml.txt.nlp	23240583	SENT29	13	13	0	0	novobiocin	Hsp90	PA164768819	3320	0.975
NULL	J_Korean_Med_Sci_2013_Apr_27_28(4)_527-533.nxml.txt.nlp	23580227	SENT108	16	16	10	10	genistein	TRAIL	PA165109660	8743	0.975
NULL	Acta_Pharmacol_Sin_2010_Nov_11_31(11)_1407-1408.nxml.txt.nlp	20935670	SENT15	4	4	9	9	imatinib	GSAP	PA10804	54103	0.975
NULL	Br_J_Cancer_2011_Aug_23_105(5)_649-657.nxml.txt.nlp	21811251	SENT131	3	3	19	19	gefitinib	IGF1R	PA131301952	3480	0.975
NULL	Clin_Mol_Allergy_2004_Mar_16_2_4.nxml.txt.nlp	15023231	SENT63	20	20	5	5	erythromycin	RANTES	PA449493	6352	0.975
NULL	J_Oncol_2009_Nov_12_2009_457418.nxml.txt.nlp	19920864	SENT20	3	3	44	44	gemcitabine	ERCC1	PA449748	2067	0.975
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT331	17	17	2	2	cisplatin	p53	PA449014	7157	0.975
NULL	Oncol_Lett_2013_Mar_8_5(3)_805-812.nxml.txt.nlp	23426281	SENT149	14	14	21	21	gemcitabine	B7-H3	PA449748	80381	0.975
NULL	FEBS_Open_Bio_2014_Mar_18_4_315-320.nxml.txt.nlp	24918044	SENT105	6	6	32	32	paraformaldehyde	AQP11	PA450790	282679	0.975
NULL	Mol_Cells_2014_Sep_30_37(9)_699-704.nxml.txt.nlp	25245523	SENT118	24	24	5	5	cyclophosphamide	MTA1	PA449165	9112	0.975
NULL	Br_J_Cancer_2012_Jun_5_106(12)_1997-2003.nxml.txt.nlp	22596232	SENT14	14	14	6	6	sorafenib	CD133	PA7000	8842	0.975
NULL	Cell_Death_Dis_2010_May_13_1(5)_e41.nxml.txt.nlp	21364648	SENT88	14	14	25	25	etoposide	p65	PA449552	5970	0.975
NULL	J_Cell_Biol_1992_Feb_1_116(3)_817-825.nxml.txt.nlp	1730778	SENT16	16	16	29	29	heparin	CD44	PA449855	960	0.975
NULL	Chin_J_Cancer_2011_Oct_30(10)_655-668.nxml.txt.nlp	21959043	SENT205	0	0	19	19	dasatinib	EGFR	PA162372878	1956	0.975
NULL	Int_J_Breast_Cancer_2011_Sep_8_2011_595092.nxml.txt.nlp	22295229	SENT88	16	16	27	27	fulvestrant	aromatase	PA164747170	1588	0.975
NULL	Clin_Med_Insights_Oncol_2011_Oct_31_5_333-342.nxml.txt.nlp	22084622	SENT125	3	3	29	29	pazopanib	IL-6	PA165291492	3569	0.975
NULL	Eur_J_Neurosci_2009_Apr_29(8)_1604-1614.nxml.txt.nlp	19419423	SENT206	12	12	27	27	ketanserin	5-HT2C	PA131053734	3358	0.975
NULL	Clin_Interv_Aging_2012_Sep_3_7_331-338.nxml.txt.nlp	22977302	SENT126	0	0	10	10	denosumab	RANKL	PA166048634	8600	0.975
NULL	Biomed_Res_Int_2014_Apr_28_2014_153867.nxml.txt.nlp	24877058	SENT60	1	1	36	36	ethanol	ALDH2	PA448073	217	0.975
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT105	35	35	12	12	metformin	p53	PA450395	7157	0.975
NULL	BMB_Rep_2014_Apr_47(4)_221-226.nxml.txt.nlp	24286312	SENT45	19	19	6	6	nutlin-3	p53		7157	0.975
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT49	0	0	12	12	neratinib	HER2	PA165291472	2064	0.975
NULL	Asian-Australas_J_Anim_Sci_2014_Dec_27(12)_1783-1793.nxml.txt.nlp	25358373	SENT239	30	30	7	7	capsaicin	PPARG	PA448776	5468	0.975
NULL	J_Gen_Physiol_2009_Apr_133(4)_421-438.nxml.txt.nlp	19289574	SENT483	23	23	3	3	forskolin	SLC26A9	PA146096022	115019	0.975
NULL	Chemother_Res_Pract_2011_Sep_21_2011_839742.nxml.txt.nlp	22295206	SENT90	25	25	3	3	gefitinib	EGFR	PA131301952	1956	0.975
NULL	Cell_Death_Dis_2012_Jul_19_3(7)_e351.nxml.txt.nlp	22825469	SENT133	6	6	22	22	sorafenib	MCL1	PA7000	4170	0.975
NULL	Nucleic_Acids_Res_2012_Jul_30_40(13)_6319-6337.nxml.txt.nlp	22467215	SENT345	22	22	2	2	cisplatin	Bcl-2	PA449014	596	0.975
NULL	Breast_Cancer_Res_2004_Jun_29_6(5)_R488-R498.nxml.txt.nlp	15318931	SENT175	28	28	12	12	estradiol	UGT2B15	PA449503	7366	0.975
NULL	Arthritis_Res_Ther_2005_May_27_7(5)_R915-R926.nxml.txt.nlp	16207333	SENT144	9	9	12	12	curcumin	AP-1	PA151958596	2353;3727;2354;3725	0.975
NULL	Neural_Plast_2013_Jun_19_2013_537265.nxml.txt.nlp	23862076	SENT112	22	22	4	4	mianserin	5-HT6	PA134687937	3362	0.975
NULL	Oncotarget_2012_Sep_28_3(10)_1169-1181.nxml.txt.nlp	23045411	SENT91	9	9	24	24	doxorubicin	JIP1	PA449412	9479	0.975
NULL	Exp_Lung_Res_2013_Oct_1_39(8)_336-348.nxml.txt.nlp	23919450	SENT29	14	14	3	3	thrombin	PAR-1	PA451674	2011;2149	0.975
NULL	J_Obes_2011_Sep_19_2011_984245.nxml.txt.nlp	20885921	SENT170	0	0	15	15	sitagliptin	GLP-1	PA164748978	100125288	0.975
NULL	Biol_Open_2013_Aug_14_2(10)_1013-1021.nxml.txt.nlp	24167711	SENT181	25	25	12	12	ethanol	EVL	PA448073	51466	0.975
NULL	J_Carcinog_2011_Nov_30_10_28.nxml.txt.nlp	22190870	SENT104	18	18	8	8	trastuzumab	PIK3CA	PA451743	5290	0.975
NULL	Diabetes_Care_2013_Aug_17_36(Suppl_2)_S245-S252.nxml.txt.nlp	23882053	SENT62	37	37	26	26	sitagliptin	GLP-1	PA164748978	100125288	0.975
NULL	Nat_Chem_Biol_2010_Apr_28_6(4)_291-299.nxml.txt.nlp	20190765	SENT104	8	8	18	18	dasatinib	EGFR	PA162372878	1956	0.975
NULL	Cancer_Cell_2013_Aug_12_24(2)_167-181.nxml.txt.nlp	23948297	SENT62	20	20	3	3	bortezomib	p16INK4a	PA10252	1029	0.975
NULL	Biomed_Res_Int_2013_Jul_1_2013_964743.nxml.txt.nlp	23936861	SENT198	28	28	3	3	gefitinib	VEGFR	PA131301952	3791	0.975
NULL	J_Korean_Med_Sci_1994_Dec_9(6)_482-489.nxml.txt.nlp	7786445	SENT10	21	21	2	2	theophylline	CYP2D6	PA451647	1565	0.975
NULL	Bioinformation_2012_Dec_19_8(25)_1265-1270.nxml.txt.nlp	23275732	SENT15	31	31	0	0	oxygen	UROS	PA450744	7390	0.975
NULL	Diabetes_Care_2009_Apr_32(4)_531-540.nxml.txt.nlp	19336638	SENT16	0	0	11	11	ticlopidine	ADP	PA451686	23038	0.975
NULL	Oncogene_2013_Sep_26_32(39)_10_1038_onc_2012_491.nxml.txt.nlp	23108394	SENT246	14	14	4	4	epirubicin	FOXM1	PA449476	2305	0.975
NULL	J_Res_Med_Sci_2011_Feb_16(2)_219-223.nxml.txt.nlp	22091235	SENT73	7	7	16	16	voriconazole	MOF	PA10233	84148	0.975
NULL	Int_J_Mol_Sci_2014_Jun_26_15(7)_11416-11434.nxml.txt.nlp	24972137	SENT156	1	1	15	15	sitagliptin	AMPK	PA164748978	5563	0.975
NULL	Iran_J_Basic_Med_Sci_2012_Mar-Apr_15(2)_709-718.nxml.txt.nlp	23493500	SENT31	15	15	18	18	naproxen	COX	PA450595	1351	0.975
NULL	Br_J_Cancer_2010_Mar_16_102(6)_1003-1009.nxml.txt.nlp	20179710	SENT27	0	0	33	33	doxorubicin	SLC22A16	PA449412	85413	0.975
NULL	Int_J_Chron_Obstruct_Pulmon_Dis_2006_Dec_1(4)_373-379.nxml.txt.nlp	18044094	SENT41	8	8	29	29	cilomilast	PDE4D	PA165948031	5144	0.975
NULL	Cancer_Manag_Res_2012_Aug_8_4_243-252.nxml.txt.nlp	22904646	SENT26	6	6	11	11	vemurafenib	LOX	PA165946873	4015	0.975
NULL	Nat_Med_2013_Mar_3_19(3)_295-304.nxml.txt.nlp	23377280	SENT135	1	1	16	16	erlotinib	EGFR	PA134687924	1956	0.975
NULL	Arthritis_Res_Ther_2011_May_25_13(Suppl_1)_S2.nxml.txt.nlp	21624181	SENT237	17	17	2	2	infliximab	IMPACT	PA452639	55364	0.975
NULL	J_Thromb_Thrombolysis_2013_Jul_17_36(1)_31-41.nxml.txt.nlp	23073747	SENT142	0	0	19	19	eptifibatide	LTA	PA449483	4049	0.975
NULL	Breast_Cancer_Res_2014_Sep_9_16(5)_433.nxml.txt.nlp	25212966	SENT161	6	6	20	20	aprotinin	ILEI	PA448472	10447	0.975
NULL	J_Headache_Pain_2008_Feb_24_9(1)_13-18.nxml.txt.nlp	18217199	SENT110	0	0	4	4	metoprolol	CYP2D6	PA450480	1565	0.975
NULL	Breast_Cancer_(Auckl)_2011_Oct_9_5_209-226.nxml.txt.nlp	22084574	SENT2	0	0	7	7	exemestane	aromatase	PA449563	1588	0.975
NULL	BioData_Min_2008_Jul_17_1_2.nxml.txt.nlp	18822146	SENT126	19	19	11	11	ethanol	MTHFR	PA448073	4524	0.975
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1717-1723.nxml.txt.nlp	19844230	SENT95	11	11	4	4	pazopanib	TAO2	PA165291492	9344	0.975
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1542-1553.nxml.txt.nlp	21970874	SENT132	28	28	13	13	carboplatin	DHFR	PA448803	1719	0.975
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT232	4	4	19	19	resveratrol	TRAIL		8743	0.975
NULL	Breast_Cancer_Res_2007_Jul_5_9(4)_R41.nxml.txt.nlp	17612393	SENT11	16	16	6	6	celecoxib	Bcl-2	PA448871	596	0.975
NULL	Kidney_Int_Suppl_(2011)_2013_Dec_27_3(5)_451-456.nxml.txt.nlp	25019029	SENT81	29	29	8	8	cinacalcet	PTH	PA164776671	5741	0.975
NULL	Anal_Chem_Insights_2013_Sep_10_8_83-97.nxml.txt.nlp	24115834	SENT65	11	11	5	5	ethanol	SERS	PA448073	6301;54938	0.975
NULL	Chemother_Res_Pract_2011_Sep_25_2011_730360.nxml.txt.nlp	22295205	SENT227	0	0	12	12	pertuzumab	HER3		2065	0.975
NULL	Hum_Genomics_2009_Dec_1_4(2)_91-106.nxml.txt.nlp	20038497	SENT66	2	2	16	16	galantamine	CYP3A4	PA449726	1576	0.975
NULL	Mol_Cancer_2010_Jun_7_9_139.nxml.txt.nlp	20529262	SENT105	36	36	41	41	cetuximab	EGFR	PA10040	1956	0.975
NULL	Evid_Based_Complement_Alternat_Med_2014_May_5_2014_730678.nxml.txt.nlp	24883070	SENT25	16	16	22	22	tamoxifen	aromatase	PA451581	1588	0.975
NULL	Cancers_(Basel)_2010_May_28_2(2)_1027-1039.nxml.txt.nlp	24281105	SENT42	29	29	4	4	bevacizumab	VEGFR2	PA130232992	3791	0.975
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT175	8	8	3	3	tacrolimus	OPG	PA451578	690	0.975
NULL	J_RNAi_Gene_Silencing_2009_Mar_9_5(1)_321-330.nxml.txt.nlp	19771229	SENT8	13	13	20	20	gemcitabine	RRM2	PA449748	6241	0.975
NULL	J_Gynecol_Oncol_2013_Jul_4_24(3)_273-279.nxml.txt.nlp	23875078	SENT94	3	3	7	7	paclitaxel	COX	PA450761	1351	0.975
NULL	Clin_Pharmacol_2011_Jun_22_3_13-25.nxml.txt.nlp	22287853	SENT182	5	5	42	42	saxagliptin	CYP3A4	PA165958362	1576	0.975
NULL	Ital_J_Pediatr_2011_May_14_37_21.nxml.txt.nlp	21569539	SENT16	18	18	6	6	carbamazepine	NAG	PA448785	51594;4669	0.975
NULL	Oncol_Lett_2014_May_11_7(5)_1401-1408.nxml.txt.nlp	24765145	SENT174	27	27	3	3	paclitaxel	PI3K	PA450761	5290	0.975
NULL	Acta_Pharmacol_Sin_2014_Jun_5_35(6)_716-726.nxml.txt.nlp	24793311	SENT149	3	3	18	18	atorvastatin	PSD-95	PA448500	1742	0.975
NULL	Breast_Cancer_Res_2005_May_24_7(5)_R589-R597.nxml.txt.nlp	16168102	SENT138	43	43	20	20	doxorubicin	HER2	PA449412	2064	0.975
NULL	Ther_Clin_Risk_Manag_2007_Aug_3(4)_543-552.nxml.txt.nlp	18472975	SENT69	17	17	9	9	thalidomide	HD3	PA451644	8841	0.975
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1651-1657.nxml.txt.nlp	19904273	SENT181	3	3	18	18	olaparib	BRCA1		672	0.975
NULL	Acta_Vet_Scand_2008_Nov_27_50(1)_47.nxml.txt.nlp	19038035	SENT17	3	3	7	7	paclitaxel	CYP2C8	PA450761	1558	0.975
NULL	FEBS_Open_Bio_2013_Sep_17_3_394-397.nxml.txt.nlp	24251101	SENT57	31	31	28	28	geldanamycin	Hsp90	PA152031327	3320	0.975
NULL	Curr_Neuropharmacol_2009_Sep_7(3)_180-194.nxml.txt.nlp	20190960	SENT73	10	10	28	28	baclofen	NPY	PA448533	4852	0.975
NULL	ScientificWorldJournal_2013_Jun_19_2013_174392.nxml.txt.nlp	23853530	SENT147	21	21	3	3	doxazosin	PC-3	PA449407	692094	0.975
NULL	Hum_Genet_2014_Nov_19_133(4)_463-469.nxml.txt.nlp	24241281	SENT73	14	14	2	2	methotrexate	DHFR	PA450428	1719	0.975
NULL	J_Adv_Pract_Oncol_2014_Jan_1_Jan-Feb_5(1)_47-50.nxml.txt.nlp	25032033	SENT46	22	22	4	4	cabozantinib	CYP3A4	PA165906891	1576	0.975
NULL	Ann_Clin_Microbiol_Antimicrob_2011_Jul_21_10_30.nxml.txt.nlp	21774834	SENT37	32	32	13	13	ceftriaxone	IFN	PA448866	3439	0.975
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1018.nxml.txt.nlp	24457962	SENT62	21	21	0	0	cetuximab	EGFR	PA10040	1956	0.975
NULL	Acta_Pharmacol_Sin_2010_Sep_2_31(9)_1172-1180.nxml.txt.nlp	20676117	SENT135	9	9	7	7	bsi-201	PARP1		142	0.975
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT126	24	24	4	4	sulindac	survivin	PA451565	332	0.975
NULL	Br_J_Cancer_2012_May_22_106(11)_1728-1734.nxml.txt.nlp	22531637	SENT129	8	8	21	21	paclitaxel	CYP3A4	PA450761	1576	0.975
NULL	Cardiol_Res_Pract_2012_Mar_20_2012_656247.nxml.txt.nlp	22536531	SENT91	16	16	29	29	fenofibrate	DDAH	PA449594	23576	0.975
NULL	ScientificWorldJournal_2012_Jun_18_2012_373709.nxml.txt.nlp	22761550	SENT37	40	40	27	27	methoxyflurane	NALCN	PA450434	259232	0.975
NULL	J_Carcinog_2013_Dec_31_12_22.nxml.txt.nlp	24574860	SENT372	2	2	14	14	cabozantinib	VEGFR2	PA165906891	3791	0.975
NULL	BMB_Rep_2013_Jan_46(1)_59-64.nxml.txt.nlp	23351386	SENT61	7	7	11	11	auranofin	STAT3	PA448510	6774	0.975
NULL	J_Vet_Med_Sci_2014_Jun_15_76(6)_813-817.nxml.txt.nlp	24531829	SENT93	7	7	17	17	chloroquine	DPT	PA448948	1805	0.975
NULL	Crit_Care_2003_Jul_16_7(5)_374-384.nxml.txt.nlp	12974970	SENT179	12	12	18	18	fenoldopam	DA1	PA164784034	28495;7169	0.975
NULL	Genome_Biol_2000_Jun_9_1(1)_reviews105_1-reviews105_4.nxml.txt.nlp	11104524	SENT47	9	9	26	26	tetracycline	p53	PA451640	7157	0.975
NULL	Br_J_Haematol_2008_Aug_28_142(4)_505-514.nxml.txt.nlp	18510682	SENT120	4	4	17	17	alemtuzumab	CD52	PA164783958	1043	0.975
NULL	Lipids_Health_Dis_2011_Feb_28_10_38.nxml.txt.nlp	21352602	SENT77	5	5	34	34	atorvastatin	PCSK9	PA448500	255738	0.975
NULL	Mediators_Inflamm_2011_Jun_28_2011_949072.nxml.txt.nlp	21772670	SENT142	12	12	27	27	estradiol	IFN	PA449503	3439	0.975
NULL	Breast_Cancer_Res_2008_Dec_4_10(6)_R103.nxml.txt.nlp	19055788	SENT151	11	11	28	28	tamoxifen	CDH1	PA451581	51343;999	0.975
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1522-1532.nxml.txt.nlp	21997136	SENT199	31	31	12	12	irinotecan	EGFR	PA450085	1956	0.975
NULL	Pharmacogn_Mag_2014_Aug_10(Suppl_3)_S645-S654.nxml.txt.nlp	25298686	SENT204	3	3	17	17	berberine	AMPK	PA165860812	5563	0.975
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT286	21	21	8	8	neratinib	HER2	PA165291472	2064	0.975
NULL	Cancers_(Basel)_2014_Nov_25_6(4)_2313-2329.nxml.txt.nlp	25534569	SENT30	0	0	9	9	crizotinib	Met	PA165946122	79811	0.975
NULL	Commun_Integr_Biol_2013_Jan_1_6(1)_e22278.nxml.txt.nlp	23802033	SENT30	10	10	43	43	verapamil	Dicer	PA451868	23405	0.975
NULL	Br_J_Cancer_2012_Jan_31_106(3)_496-507.nxml.txt.nlp	22240799	SENT211	17	17	23	23	cisplatin	GADD34	PA449014	23645	0.975
NULL	Cardiovasc_Diabetol_2013_May_4_12_73.nxml.txt.nlp	23642288	SENT25	8	8	22	22	voglibose	GLP-1	PA164752433	100125288	0.975
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT198	18	18	12	12	tacrolimus	SOCS3	PA451578	9021	0.975
NULL	Curr_Med_Chem_2012_Sep_19(26)_4399-4413.nxml.txt.nlp	22830345	SENT238	2	2	6	6	ketoconazole	CYP3A4	PA450146	1576	0.975
NULL	Biologics_2010_Feb_4_4_19-31.nxml.txt.nlp	20161982	SENT192	0	0	19	19	sorafenib	KIT	PA7000	3815	0.975
NULL	J_Hematol_Oncol_2008_Aug_11_1_11.nxml.txt.nlp	18694493	SENT69	0	0	16	16	axitinib	VEGFR	PA164924493	3791	0.975
NULL	Case_Rep_Oncol_2011_Feb_5_4(1)_55-59.nxml.txt.nlp	21691569	SENT66	0	0	7	7	sunitinib	VEGFR	PA162372840	3791	0.975
NULL	Acta_Pharmacol_Sin_2014_Jun_5_35(6)_716-726.nxml.txt.nlp	24793311	SENT207	25	25	7	7	atorvastatin	p38	PA448500	10598;1432;7965	0.975
NULL	Surg_Neurol_Int_2014_Aug_28_5(Suppl_7)_S373-S375.nxml.txt.nlp	25289164	SENT36	17	17	24	24	denosumab	RANK	PA166048634	8792	0.975
NULL	J_Mol_Signal_2010_May_10_5_4.nxml.txt.nlp	20459745	SENT86	21	21	11	11	cisplatin	p53	PA449014	7157	0.975
NULL	Comp_Hepatol_2005_Feb_8_4_2.nxml.txt.nlp	15701172	SENT98	26	26	24	24	ketoconazole	CYP3A4	PA450146	1576	0.975
NULL	Oncol_Lett_2013_Mar_11_5(3)_1010-1016.nxml.txt.nlp	23426784	SENT139	5	5	29	29	midazolam	TRPM7	PA450496	54822	0.975
NULL	Clin_Ophthalmol_2014_Feb_5_8_369-373.nxml.txt.nlp	24523577	SENT29	35	35	14	14	etoposide	TRPM1	PA449552	4308	0.975
NULL	Front_Endocrinol_(Lausanne)_2013_Nov_11_4_166.nxml.txt.nlp	24273531	SENT244	9	9	4	4	losartan	AT1	PA450268	9197;185	0.975
NULL	Int_J_Chron_Obstruct_Pulmon_Dis_2006_Mar_1(1)_15-29.nxml.txt.nlp	18046899	SENT201	8	8	19	19	theophylline	HDAC2	PA451647	3066	0.975
NULL	Arthritis_Res_Ther_2005_Jul_13_7(5)_R1072-R1081.nxml.txt.nlp	16207324	SENT150	10	10	2	2	cyclophosphamide	ATD	PA449165	465	0.975
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2011_Sep_13_4_47-62.nxml.txt.nlp	22879794	SENT345	0	0	17	17	liraglutide	GLP-1	PA165958364	100125288	0.975
NULL	Oncotarget_2012_May_18_3(5)_525-534.nxml.txt.nlp	22619113	SENT119	5	5	21	21	fludarabine	IL-4	PA449655	3565	0.975
NULL	Arthritis_Res_Ther_2012_Jan_30_14(1)_201.nxml.txt.nlp	22293240	SENT114	5	5	33	33	glucosamine	IL-10	PA164747613	3586	0.975
NULL	Br_J_Pharmacol_2014_May_171(10)_2659-2670.nxml.txt.nlp	24116661	SENT170	29	29	12	12	naringenin	TRPP2	PA151958361	5311	0.975
NULL	Eur_J_Clin_Pharmacol_2011_May_8_67(5)_493-506.nxml.txt.nlp	21140139	SENT30	9	9	16	16	oxycodone	CYP3A4	PA450741	1576	0.975
NULL	Cancer_Cell_Int_2008_Mar_18_8_3.nxml.txt.nlp	18348720	SENT75	3	3	16	16	gefitinib	EGF	PA131301952	1950	0.975
NULL	EMBO_Mol_Med_2012_Jun_13_4(6)_515-527.nxml.txt.nlp	22416035	SENT83	33	33	13	13	olaparib	p53		7157	0.975
NULL	Br_J_Cancer_2010_May_11_102(10)_1503-1510.nxml.txt.nlp	20461093	SENT46	18	18	40	40	tamoxifen	AKT	PA451581	207	0.975
NULL	Biosensors_(Basel)_2013_Jun_28_3(3)_238-258.nxml.txt.nlp	25506422	SENT262	33	33	9	9	etoposide	p53	PA449552	7157	0.975
NULL	J_Cancer_2012_Jul_6_3_310-321.nxml.txt.nlp	22866165	SENT217	6	6	29	29	estradiol	CYP1A1	PA449503	1543	0.975
NULL	Cases_J_2009_Jul_29_2_6449.nxml.txt.nlp	19829805	SENT53	0	0	16	16	cabergoline	PRL	PA448708	5617	0.975
NULL	J_Cell_Mol_Med_2013_Oct_2_17(10)_1218-1235.nxml.txt.nlp	23998913	SENT317	26	26	8	8	imatinib	PDGFRA	PA10804	5156	0.975
NULL	Br_J_Cancer_2009_Jul_21_101(2)_269-277.nxml.txt.nlp	19603033	SENT114	0	0	11	11	cisplatin	XIAP	PA449014	331	0.975
NULL	J_Cell_Biol_1983_Mar_1_96(3)_633-638.nxml.txt.nlp	6833374	SENT5	12	12	34	34	chymotrypsin	MP26	PA448994	4284	0.975
NULL	Breast_Cancer_Res_2014_Dec_6_16(6)_491.nxml.txt.nlp	25479686	SENT209	22	22	40	40	bortezomib	GATA3	PA10252	2625	0.975
NULL	Front_Oncol_2014_Apr_9_4_75.nxml.txt.nlp	24782986	SENT150	24	24	11	11	paclitaxel	JAK2	PA450761	3717	0.975
NULL	Oncol_Lett_2014_May_18_7(5)_1632-1638.nxml.txt.nlp	24765191	SENT21	25	25	11	11	tamoxifen	HER-2	PA451581	2064	0.975
NULL	Br_J_Cancer_2011_Aug_23_105(5)_649-657.nxml.txt.nlp	21811251	SENT131	3	3	16	16	gefitinib	EGFR	PA131301952	1956	0.975
NULL	Nucleic_Acids_Res_2013_Apr_1_41(6)_3734-3747.nxml.txt.nlp	23376929	SENT89	2	2	13	13	colchicine	FISH	PA449092	9644	0.975
NULL	Br_J_Pharmacol_2012_Apr_165(8)_2611-2619.nxml.txt.nlp	21718301	SENT214	27	27	21	21	rimonabant	GPR55	PA152407999	9290	0.975
NULL	Oncotarget_2014_Aug_29_5(19)_8947-8958.nxml.txt.nlp	25333254	SENT189	7	7	17	17	plerixafor	FLT3	PA165958410	2322	0.975
NULL	Acta_Pharmacol_Sin_2009_Oct_21_30(10)_1392-1398.nxml.txt.nlp	19767766	SENT91	0	0	40	40	atorvastatin	NAC	PA448500	22861	0.975
NULL	Oncotarget_2013_Nov_15_4(11)_1866-1867.nxml.txt.nlp	24272818	SENT36	22	22	7	7	docetaxel	PIK3CA	PA449383	5290	0.975
NULL	Front_Genet_2012_Nov_5_3_236.nxml.txt.nlp	23133441	SENT26	9	9	30	30	nelfinavir	ABCB1	PA450606	5243	0.975
NULL	Front_Oncol_2014_Jun_13_4_141.nxml.txt.nlp	24982846	SENT36	10	10	30	30	imatinib	BRAF	PA10804	673	0.975
NULL	Cancers_(Basel)_2011_May_9_3(2)_2286-2301.nxml.txt.nlp	24212810	SENT176	10	10	8	8	gefitinib	EGFR	PA131301952	1956	0.975
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT1577	9	9	30	30	tamoxifen	MRP2	PA451581	100130958;57626;1244	0.975
NULL	J_Lipids_2011_Jan_26_2011_208457.nxml.txt.nlp	21490797	SENT59	0	0	8	8	ethanol	CO2	PA448073	4513	0.975
NULL	Oncogene_2014_Feb_6_33(6)_713-723.nxml.txt.nlp	23435429	SENT205	32	32	8	8	camptothecin	BRCA1	PA153590860	672	0.975
NULL	Front_Neurosci_2014_Jun_3_8_128.nxml.txt.nlp	24917782	SENT11	24	24	3	3	ethanol	MC4R	PA448073	4160	0.975
NULL	JAKSTAT_2014_Jun_12_3_e29554.nxml.txt.nlp	25105067	SENT99	32	32	12	12	propofol	p65	PA451141	5970	0.975
NULL	Oncogene_2014_Feb_6_33(6)_713-723.nxml.txt.nlp	23435429	SENT84	39	39	12	12	etoposide	p65	PA449552	5970	0.975
NULL	Cell_Death_Dis_2013_Jun_27_4(6)_e694.nxml.txt.nlp	23807223	SENT77	17	17	31	31	chloroquine	HMGB1	PA448948	3146	0.975
NULL	Breast_Cancer_Res_2011_Mar_11_13(2)_R30.nxml.txt.nlp	21396117	SENT268	5	5	20	20	erlotinib	EGFR	PA134687924	1956	0.975
NULL	Clin_Med_Insights_Oncol_2012_Jan_5_6_53-66.nxml.txt.nlp	22253555	SENT45	0	0	14	14	vemurafenib	BRAF	PA165946873	673	0.975
NULL	Arch_Plast_Surg_2012_Sep_12_39(5)_540-545.nxml.txt.nlp	23094252	SENT56	13	13	27	27	remifentanil	TCI	PA451232	6947	0.975
NULL	J_Cell_Biol_1998_Jan_26_140(2)_335-345.nxml.txt.nlp	9442109	SENT195	1	1	40	40	chloroquine	NHE	PA448948	285335	0.975
NULL	Indian_J_Nephrol_2011_Oct-Dec_21(4)_258-263.nxml.txt.nlp	22022086	SENT62	44	44	5	5	azathioprine	IL-2	PA448515	3558	0.975
NULL	Eur_J_Clin_Pharmacol_2011_May_2_67(Suppl_1)_87-107.nxml.txt.nlp	21287160	SENT179	31	31	4	4	irinotecan	UGT1A1	PA450085	54658	0.975
NULL	Arthritis_Res_Ther_2008_Jan_18_10(1)_R8.nxml.txt.nlp	18205921	SENT223	7	7	36	36	hyaluronan	MRP5	PA165958431	10057	0.975
NULL	J_Immunother_Cancer_2014_Jul_15_2_24.nxml.txt.nlp	25089198	SENT80	2	2	23	23	vemurafenib	CD4	PA165946873	920	0.975
NULL	Indian_J_Med_Res_2012_Aug_136(2)_249-259.nxml.txt.nlp	22960892	SENT137	43	43	26	26	irinotecan	UGT1A1	PA450085	54658	0.975
NULL	Cell_Commun_Signal_2013_Feb_20_11_13.nxml.txt.nlp	23425659	SENT37	8	8	14	14	flunitrazepam	IL-8	PA164781320	3576	0.975
NULL	Oncotarget_2013_Jul_7_4(7)_1065-1074.nxml.txt.nlp	23867252	SENT64	3	3	1	1	geldanamycin	Hsp90	PA152031327	3320	0.975
NULL	Int_Semin_Surg_Oncol_2008_Apr_28_5_9.nxml.txt.nlp	18442393	SENT72	15	15	5	5	tamoxifen	HER2	PA451581	2064	0.975
NULL	J_Invest_Dermatol_2012_May_16_132(5)_1435-1442.nxml.txt.nlp	22336948	SENT228	32	32	15	15	doxycycline	TLSP	PA449415	11012	0.975
NULL	Cancer_Med_2013_Dec_31_2(6)_826-835.nxml.txt.nlp	24403256	SENT141	7	7	10	10	nutlin-3	HDM2		4193	0.975
NULL	J_Cell_Biol_2002_May_28_157(5)_761-770.nxml.txt.nlp	12034770	SENT306	28	28	1	1	doxycycline	TFF1	PA449415	7031	0.975
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_55-78.nxml.txt.nlp	19305788	SENT462	31	31	15	15	memantine	NR1	PA10364	27158	0.975
NULL	Oncogene_2014_Jun_26_33(26)_3422-3431.nxml.txt.nlp	23912457	SENT171	5	5	27	27	trastuzumab	AKT	PA451743	207	0.975
NULL	Br_J_Cancer_2013_May_14_108(9)_1807-1809.nxml.txt.nlp	23612454	SENT66	19	19	7	7	trastuzumab	PIK3CA	PA451743	5290	0.975
NULL	Br_J_Cancer_2011_May_10_104(10)_1628-1640.nxml.txt.nlp	21505453	SENT45	16	16	4	4	pp2	TRK		4914;7170	0.975
NULL	Acta_Pharmacol_Sin_2011_Jan_6_32(1)_133-138.nxml.txt.nlp	21131997	SENT45	36	36	22	22	heparin	ACT	PA449855	12;11332;9457;641455	0.975
NULL	Cancer_Cell_Int_2008_Jan_4_8_1.nxml.txt.nlp	18177496	SENT79	19	19	12	12	gefitinib	c-Myc	PA131301952	4609	0.975
NULL	Br_J_Cancer_2013_Feb_5_108(2)_469-476.nxml.txt.nlp	23169292	SENT27	27	27	11	11	erlotinib	EGFR	PA134687924	1956	0.975
NULL	Nat_Med_2013_Oct_8_19(10)_1345-1350.nxml.txt.nlp	24013701	SENT172	27	27	7	7	fluorescein	FDG	PA164746009	23583	0.975
NULL	Int_J_Cell_Biol_2014_Jan_22_2014_709828.nxml.txt.nlp	24578708	SENT92	8	8	19	19	choline	DAG	PA448976	1605	0.975
NULL	FEBS_Open_Bio_2014_Oct_22_4_905-914.nxml.txt.nlp	25383314	SENT102	23	23	4	4	atropine	L-FABP	PA448505	2168	0.975
NULL	Oncol_Lett_2014_Jan_29_7(1)_183-188.nxml.txt.nlp	24348845	SENT132	14	14	3	3	paclitaxel	PDCD4	PA450761	27250	0.975
NULL	Expert_Rev_Mol_Med_2010_Apr_12_e12.nxml.txt.nlp	20398440	SENT369	0	0	14	14	metformin	AMPK	PA450395	5563	0.975
NULL	Int_J_Biochem_Cell_Biol_2013_Feb_45(2)_283-291.nxml.txt.nlp	23085378	SENT118	2	2	12	12	anastrozole	aromatase	PA448432	1588	0.975
NULL	Cancer_Cell_Int_2011_Aug_19_11_29.nxml.txt.nlp	21854619	SENT274	13	13	31	31	cisplatin	BRCA1	PA449014	672	0.975
NULL	Breast_Cancer_Res_2004_Oct_6_6(6)_269-274.nxml.txt.nlp	15535858	SENT98	33	33	9	9	tamoxifen	HER2	PA451581	2064	0.975
NULL	Chem_Rev_2012_May_9_112(5)_2593-2603.nxml.txt.nlp	22335786	SENT139	19	19	1	1	l-histidine	ATX	PA449882	5168;23049	0.975
NULL	Clin_Interv_Aging_2014_Dec_30_10_105-115.nxml.txt.nlp	25565793	SENT120	4	4	41	41	denosumab	CTX	PA166048634	1593	0.975
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT338	3	3	16	16	resveratrol	TRAIL		8743	0.975
NULL	Clin_Sci_(Lond)_2011_Nov_1_121(Pt_10)_449-458.nxml.txt.nlp	21671887	SENT149	32	32	5	5	simvastatin	AMPK	PA451363	5563	0.975
NULL	Int_Semin_Surg_Oncol_2008_Apr_28_5_9.nxml.txt.nlp	18442393	SENT71	16	16	6	6	tamoxifen	HER-2	PA451581	2064	0.975
NULL	Nat_Commun_2013_Sep_20_4_2444.nxml.txt.nlp	24051492	SENT51	15	15	8	8	nutlin-3	p53		7157	0.975
NULL	Diabetologia_2010_Jan_6_53(1)_1-6.nxml.txt.nlp	19894028	SENT99	23	23	11	11	sitagliptin	HIP	PA164748978	6767;6159;64399;5068	0.975
NULL	J_Korean_Med_Sci_2007_Feb_28_22(1)_26-29.nxml.txt.nlp	17297247	SENT70	15	15	19	19	pyrazinamide	DST	PA451182	667	0.975
NULL	Biomed_Res_Int_2014_Jan_27_2014_696107.nxml.txt.nlp	24587987	SENT219	7	7	11	11	ebselen	NAC	PA161660841	22861	0.975
NULL	Exp_Ther_Med_2013_Dec_15_6(6)_1565-1569.nxml.txt.nlp	24255692	SENT95	10	10	3	3	simvastatin	adiponectin	PA451363	9370	0.975
NULL	Hematol_Rep_2011_Oct_28_3(3_Suppl)_e5.nxml.txt.nlp	22586513	SENT37	44	44	24	24	rituximab	PRIMA	PA451261	145270	0.975
NULL	Cancer_Cell_Int_2006_Oct_2_6_22.nxml.txt.nlp	17014709	SENT148	8	8	25	25	imatinib	PDGFA	PA10804	5154	0.975
NULL	Med_Sci_Monit_2013_Oct_31_19_916-926.nxml.txt.nlp	24172537	SENT113	31	31	2	2	chlorambucil	BRCA2	PA448926	675	0.975
NULL	Mol_Brain_2014_Apr_5_7_27.nxml.txt.nlp	24708859	SENT217	36	36	12	12	capsaicin	TRPV1	PA448776	7442	0.975
NULL	Clin_Pharmacokinet_2014_Sep_3_53(1)_1-16.nxml.txt.nlp	23999929	SENT338	20	20	27	27	rivaroxaban	CLCR	PA165958360	11330	0.975
NULL	Neuro_Oncol_2011_Jan_25_13(1)_70-83.nxml.txt.nlp	20978004	SENT258	30	30	40	40	etoposide	ABCB1	PA449552	5243	0.975
NULL	Mol_Cancer_2013_Mar_5_12_17.nxml.txt.nlp	23497256	SENT233	24	24	13	13	imatinib	HDM2	PA10804	4193	0.975
NULL	Oncol_Lett_2014_Aug_19_8(2)_809-812.nxml.txt.nlp	25009658	SENT19	5	5	22	22	metformin	AMPK	PA450395	5563	0.975
NULL	Acta_Pharmacol_Sin_2014_Jan_16_35(1)_24-32.nxml.txt.nlp	24335837	SENT174	3	3	29	29	paroxetine	Bcl-2	PA450801	596	0.975
NULL	Arthritis_Res_Ther_2014_Apr_28_16(2)_R104.nxml.txt.nlp	24774748	SENT14	23	23	4	4	cyclophosphamide	CD4	PA449165	920	0.975
NULL	J_Oncol_2011_Dec_23_2011_591427.nxml.txt.nlp	21253528	SENT96	27	27	16	16	paclitaxel	AKT2	PA450761	208	0.975
NULL	Adolesc_Health_Med_Ther_2012_Jun_20_3_85-93.nxml.txt.nlp	24600289	SENT65	20	20	1	1	methotrexate	ACR	PA450428	49	0.975
NULL	Eur_J_Clin_Pharmacol_2010_Nov_29_66(11)_1131-1136.nxml.txt.nlp	20669013	SENT131	10	10	3	3	voriconazole	CYP3A4	PA10233	1576	0.975
NULL	Open_Biol_2014_May_4(5)_140051.nxml.txt.nlp	24806840	SENT117	33	33	11	11	ethanol	PINK1	PA448073	65018	0.975
NULL	BMJ_2009_Feb_25_338_b438.nxml.txt.nlp	19244302	SENT47	30	30	10	10	letrozole	aromatase	PA450196	1588	0.975
NULL	Diabetes_2009_Jan_58(1)_243-249.nxml.txt.nlp	18840785	SENT29	22	22	4	4	glucose	GLP-1	PA449773	100125288	0.975
NULL	J_Cell_Biol_1998_Jan_26_140(2)_335-345.nxml.txt.nlp	9442109	SENT220	14	14	5	5	chloroquine	NHE	PA448948	285335	0.975
NULL	Int_J_Endocrinol_2010_May_26_2010_906163.nxml.txt.nlp	20585352	SENT34	0	0	27	27	cinacalcet	PTH	PA164776671	5741	0.975
NULL	BMB_Rep_2013_Jan_46(1)_59-64.nxml.txt.nlp	23351386	SENT4	12	12	25	25	auranofin	STAT3	PA448510	6774	0.975
NULL	Int_J_Trichology_2014_Jan-Mar_6(1)_23-24.nxml.txt.nlp	25114450	SENT34	26	26	22	22	gefitinib	EGFR	PA131301952	1956	0.975
NULL	Arthritis_Res_Ther_2013_Oct_2_15(5)_R141.nxml.txt.nlp	24286116	SENT61	24	24	3	3	infliximab	IL-6	PA452639	3569	0.975
NULL	Exp_Brain_Res_2014_Jun_27_232(8)_2637-2644.nxml.txt.nlp	24969614	SENT141	10	10	4	4	palonosetron	NK1	PA10352	11126	0.975
NULL	Acta_Pharmacol_Sin_2010_Jul_28_31(7)_867-873.nxml.txt.nlp	20581857	SENT154	31	31	22	22	docetaxel	PDCD4	PA449383	27250	0.975
NULL	Cancer_Med_2013_Feb_3_2(1)_40-49.nxml.txt.nlp	24133626	SENT7	26	26	11	11	cilostazol	PDE3B	PA164746334	5140	0.975
NULL	J_Hematol_Oncol_2014_Aug_1_7_52.nxml.txt.nlp	25085632	SENT162	13	13	5	5	sunitinib	KRAS	PA162372840	3845	0.975
NULL	Evid_Based_Complement_Alternat_Med_2012_May_7_2012_242810.nxml.txt.nlp	22645625	SENT46	23	23	7	7	paclitaxel	CYP3A4	PA450761	1576	0.975
NULL	F1000Res_2013_Mar_5_2_74.nxml.txt.nlp	24358880	SENT17	34	34	24	24	capsaicin	TRPV1	PA448776	7442	0.975
NULL	Br_J_Cancer_2010_Jan_5_102(1)_162-164.nxml.txt.nlp	19953097	SENT8	30	30	0	0	cetuximab	PTEN	PA10040	5728	0.975
NULL	Int_J_Mol_Sci_2014_Sep_9_15(9)_15791-15805.nxml.txt.nlp	25207595	SENT313	5	5	15	15	diethylstilbestrol	EZH2	PA449307	2146	0.975
NULL	Target_Oncol_2009_Sep_16_4(3)_235-252.nxml.txt.nlp	19756916	SENT208	16	16	0	0	gefitinib	HER3	PA131301952	2065	0.974
NULL	Aging_(Albany_NY)_2010_Dec_14_2(12)_945-958.nxml.txt.nlp	21164223	SENT156	2	2	21	21	metformin	HER-2	PA450395	2064	0.974
NULL	Cancer_Med_2014_Jun_14_3(3)_580-591.nxml.txt.nlp	24574330	SENT41	11	11	29	29	bevacizumab	VEGF-D	PA130232992	2277	0.974
NULL	Drugs_R_D_2010_Nov_25_10(4)_213-217.nxml.txt.nlp	21171667	SENT9	0	0	37	37	azathioprine	bcl-xL	PA448515	598	0.974
NULL	J_Biol_Chem_2013_Aug_16_288(33)_24020-24034.nxml.txt.nlp	23814048	SENT24	5	5	36	36	estradiol	aromatase	PA449503	1588	0.974
NULL	Clin_Ophthalmol_2007_Dec_1(4)_519-525.nxml.txt.nlp	19668531	SENT102	0	0	20	20	moxifloxacin	BAK	PA450555	578	0.974
NULL	Oncogene_2014_Aug_21_33(34)_4316-4329.nxml.txt.nlp	24362530	SENT124	15	15	6	6	epirubicin	FOXM1	PA449476	2305	0.974
NULL	J_Cell_Mol_Med_2014_May_14_18(5)_811-823.nxml.txt.nlp	24628949	SENT262	34	34	4	4	docetaxel	FOXM1	PA449383	2305	0.974
NULL	Case_Reports_Immunol_2014_Jul_23_2014_804761.nxml.txt.nlp	25379310	SENT112	24	24	4	4	praziquantel	IL-17	PA164764583	3605	0.974
NULL	J_Oncol_2011_Sep_15_2011_528353.nxml.txt.nlp	21941546	SENT336	33	33	13	13	genistein	COX	PA165109660	1351	0.974
NULL	Front_Neurosci_2011_Jan_14_4_207.nxml.txt.nlp	21258618	SENT140	18	18	7	7	ethanol	AC7	PA448073	113	0.974
NULL	Int_J_Endocrinol_2013_May_2_2013_501851.nxml.txt.nlp	23737774	SENT106	23	23	38	38	diethylstilbestrol	PI3K	PA449307	5290	0.974
NULL	Protein_J_2012_Aug_5_31(6)_511-518.nxml.txt.nlp	22763563	SENT179	4	4	32	32	atorvastatin	MSR1	PA448500	4481	0.974
NULL	Oncotarget_2013_Nov_7_4(12)_2550-2566.nxml.txt.nlp	24334291	SENT114	11	11	28	28	dasatinib	AMPK	PA162372878	5563	0.974
NULL	Basic_Clin_Pharmacol_Toxicol_2013_Feb_5_112(2)_132-137.nxml.txt.nlp	22900583	SENT168	0	0	6	6	prasugrel	CYP3A	PA154410481	1574	0.974
NULL	BioData_Min_2014_Aug_1_7_14.nxml.txt.nlp	25120583	SENT24	6	6	20	20	maraviroc	CCR5	PA164768835	1234	0.974
NULL	Cancer_Med_2013_Dec_27_2(6)_751-762.nxml.txt.nlp	24403249	SENT278	22	22	8	8	paclitaxel	CD44	PA450761	960	0.974
NULL	Arthritis_Res_Ther_2003_Sep_3_5(6)_R317-R328.nxml.txt.nlp	14680506	SENT112	7	7	1	1	rolipram	IL-10	PA153906323	3586	0.974
NULL	Dement_Geriatr_Cogn_Dis_Extra_2014_Nov_15_4(3)_450-456.nxml.txt.nlp	25538729	SENT19	27	27	15	15	donepezil	APOE	PA449394	348	0.974
NULL	J_Biomed_Biotechnol_2011_Feb_23_2011_631268.nxml.txt.nlp	21528007	SENT32	38	38	6	6	fluorescein	TP53	PA164746009	7157	0.974
NULL	An_Bras_Dermatol_2013_May-Jun_88(3)_355-360.nxml.txt.nlp	23793207	SENT106	10	10	25	25	thrombin	PAR-1	PA451674	2011;2149	0.974
NULL	J_Adv_Pract_Oncol_2013_Jul_1_Jul-Aug_4(4)_238-250.nxml.txt.nlp	25032004	SENT50	17	17	28	28	imatinib	KIT	PA10804	3815	0.974
NULL	Mol_Cancer_2014_Jul_5_13_165.nxml.txt.nlp	24996221	SENT133	26	26	44	44	docetaxel	HMGB1	PA449383	3146	0.974
NULL	Acta_Neuropathol_Commun_2014_Oct_21_2(1)_149.nxml.txt.nlp	NULL	SENT182	25	25	9	9	riluzole	gamma	PA451251	9913	0.974
NULL	Oncotarget_2014_Jun_13_5(20)_9689-9702.nxml.txt.nlp	25356753	SENT247	42	42	9	9	paraformaldehyde	CO2	PA450790	4513	0.974
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT222	3	3	10	10	panitumumab	KRAS	PA162373091	3845	0.974
NULL	Semin_Immunopathol_2012_Jan_4_34(1)_93-106.nxml.txt.nlp	21845431	SENT4	7	7	2	2	thrombin	PAR-1	PA451674	2011;2149	0.974
NULL	J_Mol_Med_(Berl)_2014_Jan_10_92(5)_497-507.nxml.txt.nlp	24408111	SENT179	24	24	6	6	pioglitazone	HIF-1	PA450970	29072	0.974
NULL	Clin_Ophthalmol_2014_Aug_4_8_1447-1458.nxml.txt.nlp	25120351	SENT166	4	4	30	30	cyclosporine	IL-17A	PA449167	3605	0.974
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT188	10	10	16	16	erlotinib	HER2	PA134687924	2064	0.974
NULL	Oncoscience_2014_Oct_5_1(10)_624-633.nxml.txt.nlp	25593992	SENT114	35	35	10	10	doxycycline	PCTAIRE1	PA449415	5127	0.974
NULL	Acta_Neuropathol_Commun_2013_May_20_1_17.nxml.txt.nlp	24252689	SENT58	20	20	2	2	celecoxib	CRK	PA448871	1398	0.974
NULL	Acta_Otolaryngol_2010_Nov_30_130(11)_1278-1286.nxml.txt.nlp	20586674	SENT9	24	24	5	5	methimazole	TRPM8	PA450422	79054	0.974
NULL	Oncol_Lett_2013_Apr_22_5(4)_1093-1100.nxml.txt.nlp	23599746	SENT69	12	12	26	26	vinblastine	P-gp	PA451877	5243	0.974
NULL	Clin_Ophthalmol_2009_Jun_2_3_155-166.nxml.txt.nlp	19668560	SENT138	11	11	22	22	bevacizumab	VEGF-A	PA130232992	7422	0.974
NULL	Aging_(Albany_NY)_2014_Aug_13_6(8)_661-674.nxml.txt.nlp	25239871	SENT172	0	0	9	9	resveratrol	p65		5970	0.974
NULL	Indian_J_Endocrinol_Metab_2012_Dec_16(Suppl_2)_S245-S247.nxml.txt.nlp	23565390	SENT56	4	4	11	11	repaglinide	PPG	PA451234	5552	0.974
NULL	Cancer_Cell_Int_2012_Aug_1_12_35.nxml.txt.nlp	22853623	SENT112	10	10	1	1	cisplatin	survivin	PA449014	332	0.974
NULL	J_Cell_Physiol_2007_Jun_211(3)_569-576.nxml.txt.nlp	17299780	SENT93	8	8	5	5	propranolol	PAP-1	PA451145	6100	0.974
NULL	Curr_Oncol_2009_Sep_16(5)_48-57.nxml.txt.nlp	19862361	SENT141	21	21	5	5	docetaxel	B27	PA449383	56246	0.974
NULL	Biomed_Res_Int_2014_Feb_4_2014_975927.nxml.txt.nlp	24689066	SENT133	0	0	21	21	denosumab	RANKL	PA166048634	8600	0.974
NULL	Cell_Res_2013_Jul_21_23(7)_915-930.nxml.txt.nlp	23689279	SENT104	6	6	28	28	ethanol	ALDH2	PA448073	217	0.974
NULL	Cell_Commun_Signal_2006_Aug_8_4_6.nxml.txt.nlp	16895594	SENT34	10	10	22	22	ampicillin	CCN3	PA448419	4856	0.974
NULL	Exp_Cell_Res_2011_Apr_15_317(7)_1028-1039.nxml.txt.nlp	21237154	SENT138	13	13	17	17	staurosporine	JIP1	PA165109623	9479	0.974
NULL	Cell_Death_Dis_2014_Mar_13_5(3)_e1113.nxml.txt.nlp	24625972	SENT85	14	14	0	0	bleomycin	BI-1	PA448645	7009	0.974
NULL	Clin_Ophthalmol_2014_Jun_24_8_1187-1198.nxml.txt.nlp	25028531	SENT65	3	3	18	18	ranibizumab	VEGF-A	PA164746012	7422	0.974
NULL	Oncotarget_2013_Dec_14_5(4)_970-977.nxml.txt.nlp	24448468	SENT28	17	17	23	23	paclitaxel	LZTS1	PA450761	11178	0.974
NULL	Ann_Lab_Med_2014_Jul_19_34(4)_332-335.nxml.txt.nlp	24982842	SENT12	29	29	4	4	thrombin	FXI	PA451674	2160	0.974
NULL	Cancer_Growth_Metastasis_2013_Nov_27_6_61-80.nxml.txt.nlp	24665208	SENT121	0	0	16	16	denosumab	RANKL	PA166048634	8600	0.974
NULL	Mol_Cancer_2009_Jun_9_8_37.nxml.txt.nlp	19508729	SENT61	13	13	30	30	gemcitabine	HO-1	PA449748	3162	0.974
NULL	Comp_Hepatol_2004_Jan_14_3(Suppl_1)_S37.nxml.txt.nlp	14960189	SENT84	18	18	11	11	thalidomide	TNF-alpha	PA451644	7124	0.974
NULL	Chemother_Res_Pract_2011_Sep_25_2011_730360.nxml.txt.nlp	22295205	SENT227	0	0	10	10	pertuzumab	EGFR		1956	0.974
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT168	3	3	10	10	cisplatin	p53	PA449014	7157	0.974
NULL	Nat_Commun_2012_Dec_11_3_1271.nxml.txt.nlp	23232401	SENT151	19	19	9	9	trastuzumab	HRG	PA451743	3084;3273	0.974
NULL	Breast_Cancer_(Auckl)_2012_Mar_7_6_67-77.nxml.txt.nlp	22438669	SENT168	29	29	14	14	capecitabine	HER2	PA448771	2064	0.974
NULL	J_Gen_Physiol_2013_Jan_141(1)_119-132.nxml.txt.nlp	23277478	SENT286	19	19	17	17	bumetanide	NKCC1	PA448682	6558	0.974
NULL	BMB_Rep_2014_Apr_47(4)_221-226.nxml.txt.nlp	24286312	SENT58	34	34	21	21	nutlin-3	Bcl-2		596	0.974
NULL	Mol_Biol_Cell_2012_Mar_15_23(6)_996-1009.nxml.txt.nlp	22278744	SENT207	16	16	27	27	forskolin	14-3-3	PA146096022	10971	0.974
NULL	Mol_Biol_Cell_2014_Mar_15_25(6)_739-752.nxml.txt.nlp	24430869	SENT142	13	13	36	36	pp2	EGFR		1956	0.974
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT18	13	13	9	9	heparin	FGF1	PA449855	2246	0.974
NULL	Diagn_Pathol_2007_Dec_19_2_49.nxml.txt.nlp	18093326	SENT76	0	0	10	10	cyclosporine	CHOP	PA449167	1649	0.974
NULL	J_Cell_Biol_2005_May_23_169(4)_681-691.nxml.txt.nlp	15911882	SENT69	32	32	24	24	aprotinin	MMP3	PA448472	4314	0.974
NULL	Cancer_Cell_Int_2011_Aug_19_11_29.nxml.txt.nlp	21854619	SENT135	22	22	0	0	cisplatin	BRCA1	PA449014	672	0.974
NULL	Breast_Cancer_Res_2005_Jul_20_7(5)_205-211.nxml.txt.nlp	16168139	SENT119	31	31	17	17	tamoxifen	HER2	PA451581	2064	0.974
NULL	Indian_J_Pharmacol_2008_Mar-Apr_40(2)_84-86.nxml.txt.nlp	21279172	SENT91	15	15	22	22	lidocaine	CYP3A4	PA450226	1576	0.974
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT110	16	16	30	30	perifosine	TRAIL	PA165291471	8743	0.974
NULL	Oncotarget_2011_Apr_20_2(4)_274-276.nxml.txt.nlp	21512204	SENT13	3	3	18	18	nutlin-3	p53		7157	0.974
NULL	Eur_J_Clin_Pharmacol_2010_Nov_29_66(11)_1131-1136.nxml.txt.nlp	20669013	SENT139	26	26	24	24	erythromycin	CYP3A4	PA449493	1576	0.974
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1066.nxml.txt.nlp	24556681	SENT34	16	16	36	36	ethanol	TLR4	PA448073	7099	0.974
NULL	Oxid_Med_Cell_Longev_2012_Aug_9_2012_680304.nxml.txt.nlp	22928083	SENT153	19	19	28	28	ethanol	CLS	PA448073	1210	0.974
NULL	Exp_Brain_Res_2014_Jun_27_232(8)_2637-2644.nxml.txt.nlp	24969614	SENT22	7	7	25	25	palonosetron	NK1	PA10352	11126	0.974
NULL	Front_Aging_Neurosci_2014_Sep_11_6_218.nxml.txt.nlp	25309423	SENT98	1	1	9	9	resveratrol	SIRT1		23411	0.974
NULL	Oncotarget_2011_Mar_23_2(3)_165-177.nxml.txt.nlp	21444946	SENT133	20	20	11	11	gemcitabine	EGFR	PA449748	1956	0.974
NULL	Mol_Cancer_2014_Jun_24_13_157.nxml.txt.nlp	24958351	SENT170	23	23	15	15	trastuzumab	AKT	PA451743	207	0.974
NULL	Br_J_Cancer_2009_Mar_10_100(5)_758-763.nxml.txt.nlp	19259094	SENT134	29	29	3	3	belinostat	MLH1		4292	0.974
NULL	Mol_Vis_2012_Jun_22_18_1696-1700.nxml.txt.nlp	22773907	SENT97	29	29	36	36	colchicine	MTHFR	PA449092	4524	0.974
NULL	Case_Rep_Gastroenterol_2011_Jun_10_5(2)_336-343.nxml.txt.nlp	21712950	SENT88	0	0	26	26	voglibose	GLP-1	PA164752433	100125288	0.974
NULL	Arthritis_Res_Ther_2008_Nov_14_10(6)_227.nxml.txt.nlp	19040771	SENT104	27	27	0	0	rituximab	CD4	PA451261	920	0.974
NULL	Oxid_Med_Cell_Longev_2012_Sep_16_2012_740849.nxml.txt.nlp	23029600	SENT218	17	17	0	0	doxycycline	UCP2	PA449415	7351	0.974
NULL	Emerg_Infect_Dis_2013_Jan_19(1)_129-132.nxml.txt.nlp	23260390	SENT9	0	0	45	45	linezolid	L22	PA450233	6146	0.974
NULL	Eur_J_Clin_Pharmacol_2011_May_9_67(5)_477-482.nxml.txt.nlp	21305273	SENT101	9	9	30	30	atropine	ADRB1	PA448505	153	0.974
NULL	Curr_Neuropharmacol_2008_Jun_6(2)_151-163.nxml.txt.nlp	19305794	SENT258	21	21	6	6	capsaicin	TRPV1	PA448776	7442	0.974
NULL	J_Oncol_2014_Jan_2_2014_695325.nxml.txt.nlp	24550987	SENT154	42	42	0	0	bortezomib	U87	PA10252	677775;641648	0.974
NULL	Eur_J_Med_Res_2009_Dec_7_14(Suppl_4)_71-77.nxml.txt.nlp	20156730	SENT84	5	5	41	41	tobramycin	PARI	PA451704	55010	0.974
NULL	Basic_Clin_Pharmacol_Toxicol_2013_Feb_5_112(2)_132-137.nxml.txt.nlp	22900583	SENT155	7	7	20	20	ketoconazole	CYP3A4	PA450146	1576	0.974
NULL	Cell_Death_Differ_2010_May_13_17(5)_774-786.nxml.txt.nlp	19911006	SENT321	4	4	11	11	doxycycline	AATF	PA449415	26574	0.974
NULL	Front_Oncol_2013_Nov_15_3_281.nxml.txt.nlp	24298448	SENT84	23	23	15	15	cetuximab	BRAF	PA10040	673	0.974
NULL	Basic_Clin_Pharmacol_Toxicol_2013_Feb_5_112(2)_132-137.nxml.txt.nlp	22900583	SENT23	22	22	39	39	ketoconazole	CYP3A	PA450146	1574	0.974
NULL	J_Skin_Cancer_2012_Oct_22_2012_706452.nxml.txt.nlp	23133758	SENT179	16	16	32	32	dacarbazine	BRAF	PA449197	673	0.974
NULL	Acta_Pharmacol_Sin_2013_Oct_7_34(10)_1349-1358.nxml.txt.nlp	23892274	SENT269	19	19	12	12	ritonavir	P-gp	PA451260	5243	0.974
NULL	Br_J_Cancer_2002_Dec_2_87(12)_1411-1416.nxml.txt.nlp	12454770	SENT158	38	38	15	15	tamoxifen	AIB1	PA451581	8202	0.974
NULL	Acta_Histochem_Cytochem_2013_Dec_28_46(6)_187-197.nxml.txt.nlp	24610966	SENT140	17	17	7	7	pilocarpine	AQP5	PA450962	362	0.974
NULL	Oncogene_2014_Jun_5_33(23)_3033-3042.nxml.txt.nlp	23851504	SENT102	10	10	1	1	doxycycline	AIB1	PA449415	8202	0.974
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_127043.nxml.txt.nlp	23227093	SENT165	11	11	1	1	lovastatin	RYR	PA450272	6261	0.974
NULL	Nat_Commun_2013_4_10_1038_ncomms3472.nxml.txt.nlp	24045463	SENT205	5	5	0	0	propranolol	FDG	PA451145	23583	0.974
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT80	16	16	0	0	resveratrol	TRAIL		8743	0.974
NULL	Arthritis_Res_Ther_2004_Feb_24_6(Suppl_1)_24.nxml.txt.nlp	NULL	SENT7	36	36	0	0	infliximab	OPG	PA452639	690	0.974
NULL	Cardiovasc_Res_2010_Mar_1_85(4)_825-835.nxml.txt.nlp	19840952	SENT113	17	17	7	7	staurosporine	CX3CL1	PA165109623	6376	0.974
NULL	Cancer_Cell_Int_2011_Nov_2_11_39.nxml.txt.nlp	22047021	SENT419	10	10	29	29	hydroxyurea	REV3	PA449942	5980	0.974
NULL	Cancer_Cell_Int_2004_Aug_17_4_5.nxml.txt.nlp	15315711	SENT52	16	16	4	4	genistein	PC3	PA165109660	57332;7832;5122	0.974
NULL	Int_J_Med_Sci_2013_Mar_13_10(5)_515-521.nxml.txt.nlp	23532682	SENT126	2	2	18	18	nimesulide	DAI	PA137179528	81030	0.974
NULL	Appl_Clin_Genet_2014_Jan_16_7_15-32.nxml.txt.nlp	24520200	SENT102	6	6	22	22	clopidogrel	P2Y12	PA449053	64805	0.974
NULL	AIDS_Res_Treat_2011_Jul_25_2011_743597.nxml.txt.nlp	21804938	SENT23	27	27	7	7	abacavir	CD4	PA448004	920	0.974
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_650809.nxml.txt.nlp	23258995	SENT170	0	0	6	6	vasopressin	AQP2	PA451858	359	0.974
NULL	Oncol_Lett_2013_Feb_5_5(2)_427-434.nxml.txt.nlp	23420099	SENT166	15	15	4	4	cisplatin	RRM1	PA449014	6240	0.974
NULL	Bone_Joint_Res_2014_Mar_1_3(3)_51-59.nxml.txt.nlp	24615710	SENT15	13	13	3	3	resveratrol	SIRT1		23411	0.974
NULL	Biosci_Rep_2013_Nov_25_33(6)_e00081.nxml.txt.nlp	24070327	SENT841	8	8	1	1	imatinib	XIAP	PA10804	331	0.974
NULL	Cancers_(Basel)_2011_Aug_15_3(3)_3331-3352.nxml.txt.nlp	24212957	SENT242	11	11	29	29	bevacizumab	CD133	PA130232992	8842	0.974
NULL	Oncotarget_2014_Feb_1_5(6)_1576-1594.nxml.txt.nlp	24742531	SENT282	24	24	5	5	sunitinib	NGAL	PA162372840	3934	0.974
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT61	5	5	20	20	curcumin	TRAIL	PA151958596	8743	0.974
NULL	Acta_Pharmacol_Sin_2012_May_16_33(5)_682-690.nxml.txt.nlp	22504904	SENT128	19	19	33	33	celecoxib	IL-6	PA448871	3569	0.974
NULL	Br_J_Cancer_2013_May_14_108(9)_1807-1809.nxml.txt.nlp	23612454	SENT20	13	13	5	5	trastuzumab	PI3K	PA451743	5290	0.974
NULL	Mol_Cancer_2010_Aug_20_9_220.nxml.txt.nlp	20727180	SENT35	16	16	21	21	nicotine	p53	PA450626	7157	0.974
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT255	15	15	4	4	tacrolimus	RANKL	PA451578	8600	0.974
NULL	Mol_Cancer_2010_Aug_16_9_217.nxml.txt.nlp	20712901	SENT85	8	8	20	20	curcumin	STAT3	PA151958596	6774	0.974
NULL	Int_J_Cell_Biol_2014_Feb_6_2014_572097.nxml.txt.nlp	24648844	SENT241	5	5	16	16	doxorubicin	AKR1B1	PA449412	231	0.974
NULL	Oncogene_2013_Sep_26_32(39)_10_1038_onc_2012_491.nxml.txt.nlp	23108394	SENT136	33	33	15	15	epirubicin	FOXM1	PA449476	2305	0.974
NULL	Indian_J_Med_Res_2011_May_133(5)_529-534.nxml.txt.nlp	21623039	SENT29	17	17	0	0	isoniazid	DST	PA450112	667	0.974
NULL	BMB_Rep_2014_Jun_47(6)_342-347.nxml.txt.nlp	24286324	SENT242	2	2	10	10	paclitaxel	JNK	PA450761	5599	0.974
NULL	Eur_J_Pharm_Sci_2012_Jul_16_46(4)_244-258.nxml.txt.nlp	22085636	SENT329	39	39	18	18	pertuzumab	PI3K		5290	0.974
NULL	Cardiovasc_Ther_2012_Aug_17_30(4)_e174-e182.nxml.txt.nlp	21883999	SENT98	10	10	13	13	ketoconazole	CYP3A	PA450146	1574	0.974
NULL	Br_J_Cancer_2011_Jun_7_104(12)_1848-1853.nxml.txt.nlp	21610704	SENT129	46	46	6	6	panitumumab	REL	PA162373091	5966	0.974
NULL	Oncol_Rep_2013_Apr_23_29(4)_1268-1274.nxml.txt.nlp	23354756	SENT89	3	3	13	13	paclitaxel	SLC25A43	PA450761	203427	0.974
NULL	Mol_Cancer_2013_Sep_11_12_104.nxml.txt.nlp	24025152	SENT116	35	35	17	17	gemcitabine	STAT3	PA449748	6774	0.974
NULL	Cancer_Med_2014_Jun_19_3(3)_555-564.nxml.txt.nlp	24648042	SENT136	11	11	33	33	ofatumumab	NOTCH1	PA165291493	4851	0.974
NULL	Braz_J_Med_Biol_Res_2013_Mar_15_46(3)_299-305.nxml.txt.nlp	23532269	SENT129	27	27	4	4	propofol	CD14	PA451141	929	0.974
NULL	Biomed_Res_Int_2014_Jun_3_2014_656370.nxml.txt.nlp	24995318	SENT87	11	11	43	43	olanzapine	FGA	PA450688	2243	0.974
NULL	AIDS_Res_Ther_2013_May_1_10_10.nxml.txt.nlp	23634877	SENT6	17	17	29	29	lovastatin	CCR5	PA450272	1234	0.974
NULL	Case_Rep_Transplant_2011_Jan_5_2011_210178.nxml.txt.nlp	23213600	SENT10	15	15	2	2	lansoprazole	CYP2C19	PA450180	1557	0.974
NULL	Structure_2012_May_9_20-540(5-7)_841-849.nxml.txt.nlp	22579251	SENT86	29	29	16	16	bucindolol	EL2	PA165945764	6708	0.974
NULL	J_Mol_Signal_2008_Dec_2_3_19.nxml.txt.nlp	19055733	SENT51	3	3	22	22	isoproterenol	AKAP12	PA450121	9590	0.974
NULL	Diabetes_2009_Jan_58(1)_104-115.nxml.txt.nlp	18835938	SENT166	32	32	37	37	pioglitazone	MCP-1	PA450970	6347	0.974
NULL	J_Cell_Biol_1998_Aug_24_142(4)_923-936.nxml.txt.nlp	9722606	SENT284	3	3	26	26	fluorescein	TGN	PA164746009	7038	0.974
NULL	Eur_J_Clin_Pharmacol_2007_Apr_21_63(4)_335-343.nxml.txt.nlp	17318526	SENT23	0	0	6	6	sulfamethoxazole	CYP2C9	PA451544	1559	0.974
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_May_12_66(Pt_6)_o1324-o1325.nxml.txt.nlp	21579416	SENT66	39	39	6	6	ethanol	mol	PA448073	90527	0.974
NULL	Ann_Clin_Transl_Neurol_2014_Dec_21_1(12)_996-1005.nxml.txt.nlp	25574474	SENT117	0	0	21	21	riluzole	P-gp	PA451251	5243	0.974
NULL	Int_J_Emerg_Med_2010_May_26_3(2)_81-84.nxml.txt.nlp	20606815	SENT92	23	23	11	11	ritonavir	CYP2D6	PA451260	1565	0.974
NULL	Aging_(Albany_NY)_2013_Jan_29_5(1)_3-17.nxml.txt.nlp	23363843	SENT233	24	24	2	2	etoposide	p53	PA449552	7157	0.974
NULL	Cholesterol_2010_Oct_31_2010_271504.nxml.txt.nlp	21490912	SENT177	7	7	20	20	raltegravir	CCR5		1234	0.974
NULL	Oncogene_2009_Apr_2_28(13)_1616-1625.nxml.txt.nlp	19219073	SENT100	8	8	23	23	nutlin-3	MDM2		4193	0.974
NULL	Oncogene_2013_Sep_26_32(39)_10_1038_onc_2012_491.nxml.txt.nlp	23108394	SENT120	19	19	9	9	epirubicin	FOXM1	PA449476	2305	0.974
NULL	J_Neuroinflammation_2011_Feb_4_8_10.nxml.txt.nlp	21294877	SENT22	0	0	9	9	capsaicin	TAC1	PA448776	6863	0.974
NULL	Br_J_Cancer_2012_Jan_3_106(1)_32-38.nxml.txt.nlp	22108523	SENT168	10	10	5	5	trastuzumab	HER2	PA451743	2064	0.974
NULL	J_Korean_Med_Sci_2013_May_2_28(5)_700-708.nxml.txt.nlp	23678261	SENT123	3	3	19	19	losartan	NCX	PA450268	3196	0.974
NULL	J_Hematol_Oncol_2011_Jan_21_4_5.nxml.txt.nlp	21255411	SENT174	12	12	7	7	paclitaxel	EGFR	PA450761	1956	0.974
NULL	Int_J_Alzheimers_Dis_2010_Jul_20_2010_825918.nxml.txt.nlp	20798900	SENT60	12	12	28	28	carbachol	PS1	PA448784	5663	0.974
NULL	Adv_Pharmacol_Sci_2014_Jan_15_2014_132034.nxml.txt.nlp	24527029	SENT109	36	36	11	11	olanzapine	CYP2D6	PA450688	1565	0.974
NULL	Cell_Cycle_2012_Nov_1_11(21)_3983-3996.nxml.txt.nlp	22987153	SENT61	8	8	20	20	cisplatin	RPA2	PA449014	6118;84172	0.974
NULL	J_Cell_Biol_2001_Aug_6_154(3)_599-610.nxml.txt.nlp	11481345	SENT172	10	10	40	40	tetracycline	ARNO	PA451640	9266	0.974
NULL	Adolesc_Health_Med_Ther_2013_Aug_27_4_79-87.nxml.txt.nlp	24600298	SENT46	4	4	24	24	raltegravir	UGT1A1		54658	0.974
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT107	32	32	5	5	atorvastatin	IL-6	PA448500	3569	0.974
NULL	Br_J_Cancer_2013_Dec_10_109(12)_3067-3072.nxml.txt.nlp	24263065	SENT43	28	28	14	14	irinotecan	KRAS	PA450085	3845	0.974
NULL	Crit_Care_2008_Mar_13_12(Suppl_2)_P21.nxml.txt.nlp	NULL	SENT10	18	18	5	5	fluconazole	MICA	PA449653	100507436	0.974
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_103-111.nxml.txt.nlp	23864843	SENT52	20	20	22	22	tamoxifen	aromatase	PA451581	1588	0.974
NULL	J_Hematol_Oncol_2012_May_17_5_24.nxml.txt.nlp	22594538	SENT71	19	19	24	24	vorinostat	gamma	PA164748224	9913	0.974
NULL	Mol_Biol_Evol_2010_Oct_9_27(10)_2344-2351.nxml.txt.nlp	20457586	SENT136	29	29	17	17	trypsin	DBL	PA451806	4168	0.974
NULL	Biochim_Biophys_Acta_2014_Apr_1841(4)_588-594.nxml.txt.nlp	24440819	SENT430	6	6	23	23	lipase	G0S2	PA450239	50486	0.974
NULL	Curr_Chem_Genomics_2010_Mar_1_4_1-8.nxml.txt.nlp	20448812	SENT100	18	18	28	28	methotrexate	OATP1B1	PA450428	10599	0.974
NULL	Mol_Cancer_2014_Jul_8_13_168.nxml.txt.nlp	25005754	SENT24	8	8	22	22	panitumumab	KRAS	PA162373091	3845	0.974
NULL	Biomed_Res_Int_2014_Jun_3_2014_656370.nxml.txt.nlp	24995318	SENT100	0	0	5	5	sulpiride	FGA	PA164745485	2243	0.974
NULL	Breast_Cancer_Res_2012_Feb_13_14(1)_R28.nxml.txt.nlp	22330809	SENT155	14	14	4	4	trastuzumab	PIK3CA	PA451743	5290	0.974
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1427-1436.nxml.txt.nlp	24096601	SENT24	0	0	20	20	erlotinib	EGFR	PA134687924	1956	0.974
NULL	Breast_Cancer_Res_2012_Jul_6_14(4)_R102.nxml.txt.nlp	22770227	SENT36	8	8	6	6	anastrozole	aromatase	PA448432	1588	0.974
NULL	J_Hematol_Oncol_2013_Nov_5_6_83.nxml.txt.nlp	24283248	SENT8	6	6	33	33	nutlin-3	TP53		7157	0.974
NULL	Br_J_Pharmacol_2010_Sep_161(2)_288-307.nxml.txt.nlp	20735416	SENT245	23	23	7	7	halothane	TASK	PA449845	3777	0.974
NULL	Clin_Ophthalmol_2008_Jun_2(2)_355-368.nxml.txt.nlp	19668727	SENT182	0	0	21	21	nepafenac	CYP2C9	PA165958407	1559	0.974
NULL	J_Cell_Mol_Med_2013_Sep_11_17(9)_1160-1172.nxml.txt.nlp	23844832	SENT38	24	24	3	3	gefitinib	EGF	PA131301952	1950	0.974
NULL	Br_J_Cancer_2013_Feb_19_108(3)_557-563.nxml.txt.nlp	23361053	SENT46	31	31	16	16	tamoxifen	PAK1	PA451581	5585;5058	0.974
NULL	J_Mol_Signal_2008_Dec_1_3_18.nxml.txt.nlp	19046439	SENT169	8	8	14	14	metformin	AMPK	PA450395	5563	0.974
NULL	Oncoimmunology_2014_Jan_1_3_e27359.nxml.txt.nlp	24653963	SENT31	0	0	6	6	doxorubicin	TH1	PA449412	51497	0.974
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_7-17.nxml.txt.nlp	17912633	SENT67	0	0	7	7	letrozole	aromatase	PA450196	1588	0.974
NULL	Exp_Ther_Med_2014_Sep_14_8(3)_836-840.nxml.txt.nlp	25120610	SENT86	16	16	10	10	fasudil	ROCK2	PA165946121	9475	0.974
NULL	Oncotarget_2010_Nov_19_1(7)_472-482.nxml.txt.nlp	21317446	SENT75	21	21	29	29	fludarabine	TP53	PA449655	7157	0.974
NULL	Contemp_Oncol_(Pozn)_2012_Nov_20_16(5)_401-406.nxml.txt.nlp	23788917	SENT150	4	4	25	25	afatinib	EGFR	PA165981154	1956	0.974
NULL	Br_J_Cancer_1999_Mar_79(7-8)_1104-1110.nxml.txt.nlp	10098743	SENT7	33	33	6	6	cisplatin	JNK	PA449014	5599	0.974
NULL	J_Biol_Chem_2009_Apr_3_284(14)_9558-9565.nxml.txt.nlp	19202191	SENT178	34	34	2	2	camptothecin	CtIP	PA153590860	5932	0.974
NULL	Breast_Cancer_Res_2007_Mar_2_9(2)_205.nxml.txt.nlp	NULL	SENT27	6	6	18	18	lapatinib	EGFR	PA152241907	1956	0.974
NULL	Oncogenesis_2014_Dec_15_3(12)_e133.nxml.txt.nlp	25500906	SENT299	8	8	2	2	trastuzumab	PI3K	PA451743	5290	0.974
NULL	J_Neuroinflammation_2010_Sep_7_7_51.nxml.txt.nlp	20822529	SENT22	0	0	18	18	hemin	HO-1	PA449849	3162	0.974
NULL	Indian_J_Med_Paediatr_Oncol_2014_Apr-Jun_35(2)_140-142.nxml.txt.nlp	25197175	SENT32	18	18	6	6	bevacizumab	KRAS	PA130232992	3845	0.974
NULL	ScientificWorldJournal_2012_Nov_7_2012_976740.nxml.txt.nlp	23251109	SENT133	30	30	7	7	piroxicam	Bcl-2	PA450985	596	0.974
NULL	Acta_Otolaryngol_2010_Nov_30_130(11)_1278-1286.nxml.txt.nlp	20586674	SENT244	24	24	5	5	methimazole	TRPM8	PA450422	79054	0.974
NULL	J_Cell_Biol_2001_Apr_2_153(1)_207-220.nxml.txt.nlp	11285286	SENT176	7	7	16	16	carbachol	DGK	PA448784	8526;1607	0.974
NULL	Iran_J_Pharm_Res_2013_Winter_12(Suppl)_169-174.nxml.txt.nlp	24250685	SENT31	0	0	21	21	clopidogrel	ADP	PA449053	23038	0.974
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT305	18	18	16	16	rolipram	PDE	PA153906323	501	0.974
NULL	Pharmaceutics_2011_Nov_18_3(4)_865-913.nxml.txt.nlp	24309312	SENT470	0	0	4	4	theophylline	CYP1A2	PA451647	1544	0.974
NULL	Br_J_Cancer_2010_Jun_8_102(12)_1699-1706.nxml.txt.nlp	20485286	SENT147	0	0	6	6	ifosfamide	CYP3A	PA449964	1574	0.974
NULL	Br_J_Cancer_2012_Jul_24_107(3)_516-526.nxml.txt.nlp	22782351	SENT279	20	20	2	2	tamoxifen	TIGAR	PA451581	57103	0.974
NULL	Cell_Commun_Signal_2011_May_20_9_14.nxml.txt.nlp	21599982	SENT24	7	7	25	25	pp2	PP1		5540;5464	0.974
NULL	Front_Neurol_2012_Aug_1_3_120.nxml.txt.nlp	23015798	SENT68	10	10	3	3	ethanol	CB1	PA448073	1268	0.974
NULL	Oncogene_2010_Jun_3_29(22)_3208-3216.nxml.txt.nlp	20383201	SENT253	12	12	29	29	dasatinib	EGF	PA162372878	1950	0.974
NULL	Cancers_(Basel)_2013_Jan_21_5(1)_64-91.nxml.txt.nlp	24216699	SENT308	0	0	16	16	telatinib	KIT	PA165980595	3815	0.974
NULL	Acta_Neuropathol_2012_Jun_27_123(6)_807-823.nxml.txt.nlp	22539017	SENT90	20	20	7	7	tetracycline	TDP-43	PA451640	23435	0.974
NULL	Aging_(Albany_NY)_2012_Apr_16_4(4)_247-255.nxml.txt.nlp	22511639	SENT83	34	34	3	3	metformin	CH1	PA450395	51430	0.974
NULL	Oncotarget_2011_Mar_27_2(3)_209-221.nxml.txt.nlp	21444945	SENT226	24	24	15	15	bortezomib	p53	PA10252	7157	0.974
NULL	Core_Evid_2009_Jun_15_4_83-92.nxml.txt.nlp	20694067	SENT72	0	0	7	7	conivaptan	CYP3A4	PA164742939	1576	0.974
NULL	Sci_Rep_2014_Dec_3_4_7298.nxml.txt.nlp	25466238	SENT64	19	19	3	3	chloroquine	UCHL1	PA448948	7345	0.974
NULL	Cell_Death_Dis_2012_Nov_15_3(11)_e422.nxml.txt.nlp	23152058	SENT327	11	11	6	6	cisplatin	GPX1	PA449014	2876	0.974
NULL	Curr_Gerontol_Geriatr_Res_2010_Jun_20_2010_348174.nxml.txt.nlp	20672050	SENT153	19	19	11	11	erlotinib	EGFR	PA134687924	1956	0.974
NULL	Front_Neurol_2011_Jul_4_2_36.nxml.txt.nlp	21772826	SENT69	31	31	14	14	clopidogrel	CYP2C19	PA449053	1557	0.974
NULL	Clin_Med_Oncol_2008_Mar_27_2_275-287.nxml.txt.nlp	21892289	SENT257	15	15	0	0	rituximab	CD19	PA451261	930	0.974
NULL	Arthritis_Rheum_2013_Jan_65(1)_28-38.nxml.txt.nlp	23169319	SENT63	14	14	30	30	adalimumab	ACR	PA10004	49	0.974
NULL	Breast_Cancer_Res_Treat_2014_Apr_9_145(1)_73-82.nxml.txt.nlp	24715380	SENT144	27	27	11	11	tamoxifen	CXCL10	PA451581	3627	0.974
NULL	Oncotarget_2013_Nov_24_4(12)_2186-2207.nxml.txt.nlp	24327604	SENT39	5	5	31	31	trastuzumab	PTEN	PA451743	5728	0.974
NULL	Crit_Care_2008_Jan_22_12(1)_204.nxml.txt.nlp	18279532	SENT157	5	5	23	23	voriconazole	CYP2C19	PA10233	1557	0.974
NULL	Mol_Vis_2010_Sep_2_16_1781-1790.nxml.txt.nlp	20824160	SENT240	24	24	15	15	forskolin	p38	PA146096022	10598;1432;7965	0.974
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S202-S209.nxml.txt.nlp	21525456	SENT145	2	2	4	4	exenatide	GLP-1	PA164749238	100125288	0.974
NULL	Amino_Acids_2011_Jul_21_41(2)_257-269.nxml.txt.nlp	20652610	SENT240	5	5	13	13	trypsin	ADP	PA451806	23038	0.974
NULL	J_Cancer_2012_Aug_24_3_354-361.nxml.txt.nlp	22962562	SENT88	11	11	1	1	fludarabine	p53	PA449655	7157	0.974
NULL	Int_J_Surg_Case_Rep_2014_Sep_22_5(11)_783-786.nxml.txt.nlp	25290381	SENT4	0	0	4	4	denosumab	RANKL	PA166048634	8600	0.974
NULL	Cancers_(Basel)_2014_Apr_4_6(2)_796-812.nxml.txt.nlp	24713998	SENT155	20	20	1	1	erlotinib	NGAL	PA134687924	3934	0.974
NULL	J_Cell_Biol_2008_Jul_14_182(1)_197-213.nxml.txt.nlp	18625847	SENT200	8	8	1	1	nutlin-3	BRCA1		672	0.974
NULL	J_Mol_Signal_2008_Dec_2_3_19.nxml.txt.nlp	19055733	SENT51	3	3	18	18	isoproterenol	AKAP5	PA450121	9495	0.974
NULL	Front_Zool_2011_Nov_29_8_31.nxml.txt.nlp	22126599	SENT129	3	3	9	9	pp2	PP1		5540;5464	0.974
NULL	Semin_Immunol_2011_Feb_23(1)_28-41.nxml.txt.nlp	21295490	SENT252	21	21	7	7	alefacept	IL-23	PA164748040	51561	0.974
NULL	Biol_Proced_Online_2003_Feb_17_5_43-52.nxml.txt.nlp	12734557	SENT127	2	2	6	6	bupivacaine	IFNA6	PA135057240	3443	0.974
NULL	J_Korean_Med_Sci_2010_Apr_19_25(4)_557-563.nxml.txt.nlp	20357998	SENT8	35	35	15	15	cisplatin	IL-6	PA449014	3569	0.974
NULL	Patient_Prefer_Adherence_2011_Dec_23_6_1-9.nxml.txt.nlp	22272064	SENT36	32	32	24	24	lisinopril	ACE	PA450242	1636	0.974
NULL	Oncotarget_2010_Jun_7_1(2)_156-160.nxml.txt.nlp	21297225	SENT21	26	26	20	20	dasatinib	CD38	PA162372878	952	0.974
NULL	Biomed_Imaging_Interv_J_2006_Jul_1_2(3)_e23.nxml.txt.nlp	21614238	SENT14	24	24	40	40	trastuzumab	HER-2	PA451743	2064	0.974
NULL	Clin_Interv_Aging_2015_Jan_14_10_269-275.nxml.txt.nlp	25609939	SENT77	8	8	4	4	sertraline	CYP2D6	PA451333	1565	0.974
NULL	Arthritis_Res_Ther_2006_Nov_16_8(6)_R173.nxml.txt.nlp	17109745	SENT32	31	31	16	16	glucosamine	p65	PA164747613	5970	0.974
NULL	Clin_Interv_Aging_2014_Apr_8_9_593-601.nxml.txt.nlp	24748777	SENT70	0	0	18	18	denosumab	RANKL	PA166048634	8600	0.974
NULL	Emerg_Infect_Dis_2011_Jan_17(1)_143-144.nxml.txt.nlp	21192883	SENT7	32	32	40	40	imipenem	Dakar	PA449968	22900	0.974
NULL	Int_J_Med_Sci_2015_Jan_1_12(1)_78-82.nxml.txt.nlp	25552922	SENT23	31	31	0	0	theophylline	CYP1A2	PA451647	1544	0.974
NULL	Cell_Death_Dis_2010_Oct_21_1(10)_e86.nxml.txt.nlp	21368859	SENT74	28	28	20	20	doxorubicin	Mcl-1	PA449412	4170	0.974
NULL	J_Oncol_2010_Jan_3_2010_149362.nxml.txt.nlp	20069122	SENT101	36	36	5	5	lapatinib	EGFR	PA152241907	1956	0.974
NULL	Arthritis_Res_Ther_2009_Oct_6_11(5)_128.nxml.txt.nlp	19818166	SENT20	28	28	10	10	methotrexate	CD27	PA450428	939	0.974
NULL	Breast_Cancer_Res_2004_Aug_5_6(5)_R601-R607.nxml.txt.nlp	15318941	SENT131	16	16	28	28	vincristine	p27	PA451879	5715;10534	0.974
NULL	Open_Cardiovasc_Med_J_2010_Jul_20_4_151-156.nxml.txt.nlp	20922049	SENT55	32	32	37	37	heparin	ACT	PA449855	12;11332;9457;641455	0.974
NULL	South_Asian_J_Cancer_2014_Jul-Sep_3(3)_154-158.nxml.txt.nlp	25136521	SENT30	9	9	25	25	cyclophosphamide	CYP2C9	PA449165	1559	0.974
NULL	Cell_Commun_Signal_2013_Dec_23_11_100.nxml.txt.nlp	24364863	SENT289	13	13	20	20	erlotinib	EGF	PA134687924	1950	0.974
NULL	Br_J_Cancer_2013_Dec_10_109(12)_3067-3072.nxml.txt.nlp	24263065	SENT33	32	32	9	9	irinotecan	KRAS	PA450085	3845	0.974
NULL	Indian_J_Pharmacol_2012_Sep-Oct_44(5)_624-628.nxml.txt.nlp	23112426	SENT101	4	4	32	32	pravastatin	P-gp	PA451089	5243	0.974
NULL	Mol_Cancer_2013_May_24_12_47.nxml.txt.nlp	23705854	SENT253	4	4	12	12	celecoxib	MRP1	PA448871	4437	0.974
NULL	Diabetes_Metab_J_2013_Oct_17_37(5)_315-325.nxml.txt.nlp	24199159	SENT192	0	0	14	14	resveratrol	SIRT1		23411	0.974
NULL	Nucleic_Acids_Res_2013_Apr_12_41(7)_4000-4014.nxml.txt.nlp	23408857	SENT77	17	17	2	2	doxycycline	ZNF143	PA449415	7702	0.974
NULL	Biomed_Res_Int_2014_Feb_23_2014_168949.nxml.txt.nlp	24707474	SENT19	43	43	18	18	trastuzumab	EGFR	PA451743	1956	0.974
NULL	J_Hematol_Oncol_2012_Sep_18_5_57.nxml.txt.nlp	22989009	SENT94	15	15	6	6	nutlin-3	p53		7157	0.974
NULL	Clin_Pharmacol_2013_Dec_9_5_185-192.nxml.txt.nlp	24353446	SENT9	17	17	34	34	clopidogrel	ARNT	PA449053	405	0.974
NULL	Nat_Genet_2010_Mar_31_42(3)_245-249.nxml.txt.nlp	20118933	SENT57	4	4	20	20	camptothecin	PNKP	PA153590860	11284	0.974
NULL	Indian_J_Endocrinol_Metab_2012_Mar_16(Suppl1)_S110-S113.nxml.txt.nlp	22701828	SENT35	3	3	10	10	metformin	GLP-1	PA450395	100125288	0.974
NULL	Cell_Commun_Signal_2014_Sep_25_12(1)_61.nxml.txt.nlp	NULL	SENT60	23	23	8	8	doxycycline	PC-3	PA449415	692094	0.974
NULL	Infect_Drug_Resist_2010_Mar_11_3_45-51.nxml.txt.nlp	21694893	SENT115	3	3	16	16	posaconazole	CYP3A4	PA151958574	1576	0.974
NULL	Front_Aging_Neurosci_2015_Jan_6_6_342.nxml.txt.nlp	25610395	SENT167	12	12	4	4	imatinib	GSAP	PA10804	54103	0.974
NULL	J_Hematol_Oncol_2009_Apr_22_2_18.nxml.txt.nlp	19386128	SENT21	0	0	16	16	trastuzumab	HER2	PA451743	2064	0.974
NULL	Acta_Pharmacol_Sin_2011_Nov_10_32(11)_1402-1410.nxml.txt.nlp	21986579	SENT157	32	32	23	23	curcumin	CDK4	PA151958596	1019	0.974
NULL	Oncoscience_2014_Mar_12_1(2)_158-166.nxml.txt.nlp	25594008	SENT121	36	36	28	28	dasatinib	PTRF	PA162372878	284119	0.974
NULL	Acta_Pharmacol_Sin_2014_Jan_9_35(1)_1-10.nxml.txt.nlp	24317012	SENT44	34	34	7	7	pemetrexed	SLC19A1	PA10810	6573	0.974
NULL	J_Cell_Biol_2008_Jan_28_180(2)_417-426.nxml.txt.nlp	18227283	SENT95	32	32	30	30	letrozole	aromatase	PA450196	1588	0.974
NULL	Br_J_Cancer_2014_Aug_12_111(4)_640-645.nxml.txt.nlp	24642617	SENT69	3	3	27	27	vemurafenib	BRAF	PA165946873	673	0.974
NULL	Front_Psychiatry_2014_May_19_5_47.nxml.txt.nlp	24904434	SENT65	7	7	19	19	clozapine	5-HT2A	PA449061	3356	0.974
NULL	Curr_Neuropharmacol_2012_Mar_10(1)_72-79.nxml.txt.nlp	22942880	SENT85	17	17	36	36	irinotecan	p53	PA450085	7157	0.974
NULL	Front_Oncol_2014_Mar_25_4_54.nxml.txt.nlp	24724051	SENT421	3	3	26	26	dasatinib	LYN	PA162372878	4067	0.974
NULL	Cancer_Cell_Int_2008_Jan_4_8_1.nxml.txt.nlp	18177496	SENT5	0	0	33	33	gefitinib	EGFR	PA131301952	1956	0.974
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT118	11	11	27	27	dasatinib	ABCB1	PA162372878	5243	0.974
NULL	Cell_Commun_Signal_2014_Sep_25_12(1)_61.nxml.txt.nlp	NULL	SENT169	11	11	3	3	doxycycline	PC-3	PA449415	692094	0.974
NULL	Tuberc_Respir_Dis_(Seoul)_2014_Feb_27_76(2)_66-74.nxml.txt.nlp	24624215	SENT192	2	2	7	7	vancomycin	HCAP	PA451850	117159;9126	0.974
NULL	Chin_J_Cancer_2012_Jun_31(6)_306-314.nxml.txt.nlp	22640627	SENT142	40	40	14	14	rituximab	CD10	PA451261	4311	0.974
NULL	Mol_Cell_Biochem_2012_Apr_3_363(1-2)_135-145.nxml.txt.nlp	22139302	SENT156	5	5	3	3	curcumin	survivin	PA151958596	332	0.974
NULL	Pharmaceutics_2011_Feb_7_3(1)_53-72.nxml.txt.nlp	24310425	SENT218	3	3	7	7	cisapride	CYP3A4	PA449011	1576	0.974
NULL	Indian_J_Pharm_Sci_2014_Jul-Aug_76(4)_281-286.nxml.txt.nlp	25284925	SENT5	10	10	20	20	clopidogrel	CYP2C19	PA449053	1557	0.974
NULL	Onco_Targets_Ther_2014_Mar_20_7_457-467.nxml.txt.nlp	24672248	SENT91	29	29	13	13	imatinib	PDGFRA	PA10804	5156	0.974
NULL	Mucosal_Immunol_2014_Mar_24_7(2)_335-347.nxml.txt.nlp	23881354	SENT329	7	7	1	1	galantamine	CD11c	PA449726	3687	0.974
NULL	Crit_Care_2008_Mar_13_12(Suppl_2)_P272.nxml.txt.nlp	NULL	SENT12	20	20	3	3	etomidate	RAI	PA164743987	10848;6050	0.974
NULL	Case_Rep_Surg_2013_Dec_22_2013_583856.nxml.txt.nlp	24455386	SENT55	14	14	4	4	imatinib	PDGFRA	PA10804	5156	0.974
NULL	Br_J_Cancer_2011_Jan_4_104(1)_91-100.nxml.txt.nlp	21139584	SENT156	9	9	15	15	bortezomib	Hsp90	PA10252	3320	0.974
NULL	Breast_Cancer_Res_2011_Nov_16_13(Suppl_2)_O11.nxml.txt.nlp	NULL	SENT15	0	0	12	12	neratinib	HER2	PA165291472	2064	0.974
NULL	Arthritis_Res_Ther_2010_Apr_29_12(2)_R73.nxml.txt.nlp	20429888	SENT287	8	8	27	27	bortezomib	SP1	PA10252	6667	0.974
NULL	Arthritis_Res_Ther_2010_Oct_7_12(5)_R184.nxml.txt.nlp	20929536	SENT116	8	8	22	22	methotrexate	CD4	PA450428	920	0.974
NULL	South_Asian_J_Cancer_2014_Jul-Sep_3(3)_182-184.nxml.txt.nlp	25136528	SENT82	14	14	0	0	itraconazole	CYP3A4	PA450132	1576	0.974
NULL	Exp_Diabetes_Res_2011_Jun_23_2011_898913.nxml.txt.nlp	21747834	SENT178	20	20	7	7	liraglutide	GLP-1	PA165958364	100125288	0.974
NULL	Biologics_2014_Feb_15_8_67-81.nxml.txt.nlp	24600203	SENT147	0	0	40	40	basiliximab	CD25	PA164747126	3669;3559	0.974
NULL	Oncotarget_2013_Nov_7_4(12)_2550-2566.nxml.txt.nlp	24334291	SENT119	27	27	11	11	dasatinib	AMPK	PA162372878	5563	0.974
NULL	Diabetes_Care_2013_Aug_17_36(Suppl_2)_S180-S189.nxml.txt.nlp	23882044	SENT56	21	21	8	8	metformin	GLP-1	PA450395	100125288	0.974
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT174	11	11	25	25	tacrolimus	IL-6	PA451578	3569	0.974
NULL	Child_Adolesc_Psychiatry_Ment_Health_2013_Aug_15_7_31.nxml.txt.nlp	23947389	SENT101	0	0	10	10	metformin	IMPACT	PA450395	55364	0.974
NULL	Nat_Med_2010_Feb_24_16(2)_214-218.nxml.txt.nlp	20098429	SENT57	39	39	6	6	paclitaxel	YWHAZ	PA450761	7534	0.974
NULL	Case_Rep_Psychiatry_2012_Oct_9_2012_642752.nxml.txt.nlp	23094178	SENT66	17	17	39	39	agomelatine	CYP3A4	PA165958363	1576	0.974
NULL	Breast_Cancer_Res_2007_Nov_26_9(6)_R82.nxml.txt.nlp	18036263	SENT157	25	25	5	5	trypsin	BRCA1	PA451806	672	0.974
NULL	Oncotarget_2011_Mar_10_2(3)_186-196.nxml.txt.nlp	21406729	SENT171	10	10	17	17	orlistat	FASN	PA164776864	2194	0.974
NULL	Mol_Cell_Proteomics_2014_Jan_18_13(1)_145-156.nxml.txt.nlp	24142993	SENT119	21	21	7	7	trypsin	DVL2	PA451806	1856	0.974
NULL	Leukemia_2013_Feb_14_27(2)_362-369.nxml.txt.nlp	22955330	SENT43	8	8	17	17	filgrastim	CD34	PA449626	947	0.974
NULL	Clin_Sarcoma_Res_2014_Oct_1_4_14.nxml.txt.nlp	25302110	SENT26	0	0	18	18	pazopanib	VEGFR	PA165291492	3791	0.974
NULL	Clinics_(Sao_Paulo)_2012_Feb_67(2)_191-192.nxml.txt.nlp	22358247	SENT29	10	10	21	21	paroxetine	5-HT1A	PA450801	3350	0.974
NULL	Arch_Drug_Inf_2008_Sep_1(2)_50-55.nxml.txt.nlp	19915714	SENT42	2	2	35	35	naltrexone	CYP3A4	PA450588	1576	0.974
NULL	Anticancer_Agents_Med_Chem_2012_Feb_12(2)_163-171.nxml.txt.nlp	22043994	SENT184	8	8	21	21	cetuximab	BRAF	PA10040	673	0.974
NULL	Behav_Brain_Funct_2005_Apr_22_1_2.nxml.txt.nlp	15916700	SENT157	0	0	6	6	guanfacine	spatial	PA449825	219793	0.974
NULL	Ann_Rheum_Dis_2013_Aug_23_72(8)_1362-1366.nxml.txt.nlp	23345600	SENT26	32	32	13	13	methotrexate	IL-6	PA450428	3569	0.974
NULL	Front_Microbiol_2014_Mar_14_5_99.nxml.txt.nlp	24672516	SENT94	14	14	5	5	voriconazole	NF-kappaB	PA10233	4790	0.974
NULL	Biologics_2009_Jul_13_3_51-56.nxml.txt.nlp	19707395	SENT110	31	31	8	8	basiliximab	CD25	PA164747126	3669;3559	0.974
NULL	Oncogene_2010_Sep_2_29(35)_4905-4913.nxml.txt.nlp	20581869	SENT43	12	12	0	0	cisplatin	PEO1	PA449014	56652	0.974
NULL	Mol_Cancer_2007_Sep_26_6_61.nxml.txt.nlp	17894897	SENT184	6	6	13	13	etoposide	p53	PA449552	7157	0.974
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT295	6	6	8	8	metformin	HIF-1	PA450395	29072	0.974
NULL	Breast_Cancer_Res_2007_Oct_26_9(5)_112.nxml.txt.nlp	17980056	SENT91	15	15	43	43	lapatinib	aromatase	PA152241907	1588	0.974
NULL	BMB_Rep_2014_May_47(5)_274-279.nxml.txt.nlp	24286313	SENT123	19	19	7	7	bortezomib	CD52	PA10252	1043	0.974
NULL	Pharmaceutics_2011_Oct_12_3(4)_680-705.nxml.txt.nlp	24309303	SENT96	22	22	33	33	gefitinib	OCT3	PA131301952	5460;6581	0.974
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT192	0	0	4	4	quinidine	CYP3A4	PA451209	1576	0.974
NULL	J_Cell_Biol_2005_Nov_21_171(4)_729-738.nxml.txt.nlp	16286510	SENT170	35	35	3	3	heparin	FGF2	PA449855	2247;2258	0.974
NULL	Neural_Plast_2013_Aug_18_2013_753656.nxml.txt.nlp	24024042	SENT66	5	5	34	34	minocycline	p38	PA450519	10598;1432;7965	0.974
NULL	Clin_Pediatr_Endocrinol_2008_Aug_8_17(3)_71-74.nxml.txt.nlp	24790366	SENT84	6	6	17	17	mitotane	p53	PA164746157	7157	0.974
NULL	Acta_Psychiatr_Scand_2012_Sep_126(3)_186-197.nxml.txt.nlp	22404233	SENT220	2	2	11	11	quetiapine	BPAD	PA451201	4095	0.974
NULL	Cell_Death_Dis_2012_Nov_15_3(11)_e422.nxml.txt.nlp	23152058	SENT29	16	16	2	2	cisplatin	ZNF143	PA449014	7702	0.974
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT29	29	29	11	11	cyclophosphamide	HER2	PA449165	2064	0.974
NULL	Br_J_Cancer_2011_Oct_25_105(9)_1273-1278.nxml.txt.nlp	21959871	SENT47	16	16	25	25	trastuzumab	HER2	PA451743	2064	0.974
NULL	Br_J_Cancer_1998_Aug_78(3)_375-381.nxml.txt.nlp	9703286	SENT15	33	33	9	9	cisplatin	TP53	PA449014	7157	0.974
NULL	Oncotarget_2014_Mar_14_5(10)_3029-3038.nxml.txt.nlp	24912489	SENT18	0	0	8	8	anastrozole	aromatase	PA448432	1588	0.974
NULL	Exp_Ther_Med_2014_Dec_30_8(6)_1707-1712.nxml.txt.nlp	25371719	SENT111	0	0	11	11	artemisinin	p38	PA165111696	10598;1432;7965	0.974
NULL	Cerebrospinal_Fluid_Res_2008_Oct_16_5_15.nxml.txt.nlp	18925964	SENT51	29	29	11	11	pentobarbital	CO2	PA450859	4513	0.974
NULL	Pharmaceutics_2011_Oct_12_3(4)_680-705.nxml.txt.nlp	24309303	SENT114	11	11	15	15	metformin	P-gp	PA450395	5243	0.974
NULL	Nucleic_Acids_Res_2010_Oct_22_38(19)_6502-6512.nxml.txt.nlp	20571088	SENT259	5	5	33	33	galactose	GAL	PA449725	51083	0.974
NULL	Eur_J_Med_Res_2009_Nov_24_14(Suppl_3)_36-42.nxml.txt.nlp	19959415	SENT106	41	41	22	22	boceprevir	CYP3A	PA165948902	1574	0.974
NULL	Breast_Cancer_Res_2010_Jun_28_12(3)_R44.nxml.txt.nlp	20584310	SENT55	13	13	8	8	doxycycline	ERBB2	PA449415	2064	0.974
NULL	Acta_Pharmacol_Sin_2011_Jan_6_32(1)_133-138.nxml.txt.nlp	21131997	SENT51	9	9	2	2	heparin	HSI	PA449855	57016	0.974
NULL	Diabetes_2013_May_16_62(5)_1537-1546.nxml.txt.nlp	23321073	SENT92	37	37	4	4	fluorescein	CD4	PA164746009	920	0.974
NULL	Case_Rep_Transplant_2012_Aug_30_2012_672923.nxml.txt.nlp	23259137	SENT46	44	44	16	16	thioguanine	CD19	PA451663	930	0.974
NULL	F1000Prime_Rep_2014_Dec_1_6_117.nxml.txt.nlp	25580271	SENT66	33	33	3	3	cisplatin	EGFR	PA449014	1956	0.974
NULL	Int_J_Endocrinol_Metab_2013_Jul_1_Summer_11(3)_184-190.nxml.txt.nlp	24348591	SENT132	4	4	29	29	liraglutide	INS-1	PA165958364	2305	0.974
NULL	J_Clin_Biochem_Nutr_2009_Sep_28_45(2)_125-130.nxml.txt.nlp	19794918	SENT80	3	3	9	9	lansoprazole	HO-1	PA450180	3162	0.974
NULL	Aphasiology_2012_Feb_14_28(2)_155-170.nxml.txt.nlp	25076804	SENT310	17	17	20	20	tolcapone	COMT	PA451720	1312	0.974
NULL	Biomed_Res_Int_2014_Apr_28_2014_549742.nxml.txt.nlp	24877113	SENT132	6	6	0	0	bevacizumab	BMP4	PA130232992	652	0.974
NULL	J_Cell_Mol_Med_2013_Oct_16_17(10)_1261-1270.nxml.txt.nlp	23855452	SENT12	21	21	13	13	gemcitabine	CHK2	PA449748	11200	0.974
NULL	Br_J_Pharmacol_2011_May_163(1)_141-172.nxml.txt.nlp	21265830	SENT200	18	18	31	31	azathioprine	NAC	PA448515	22861	0.974
NULL	Acta_Pharmacol_Sin_2009_Sep_17_30(9)_1316-1322.nxml.txt.nlp	19684609	SENT126	15	15	7	7	rosiglitazone	PTEN	PA451283	5728	0.974
NULL	Breast_Cancer_Res_2008_Jul_22_10(4)_210.nxml.txt.nlp	18671830	SENT258	7	7	31	31	lapatinib	CD44	PA152241907	960	0.974
NULL	Acta_Pharmacol_Sin_2011_May_18_32(5)_591-600.nxml.txt.nlp	21499286	SENT187	22	22	4	4	bezafibrate	AMPK	PA162364313	5563	0.974
NULL	Oncotarget_2011_May_16_2(5)_418-421.nxml.txt.nlp	21789791	SENT32	2	2	21	21	bortezomib	Bcl-2	PA10252	596	0.974
NULL	Ann_Dermatol_2011_Dec_27_23(Suppl_3)_S290-S295.nxml.txt.nlp	22346260	SENT91	17	17	29	29	dapsone	EED	PA449211	8726	0.974
NULL	Biol_Open_2012_May_21_1(7)_629-639.nxml.txt.nlp	23125914	SENT61	28	28	10	10	doxycycline	PITX1	PA449415	5307	0.974
NULL	Mol_Neurodegener_2011_Aug_8_6_57.nxml.txt.nlp	21819629	SENT238	1	1	7	7	arsenite	JNK	PA452638	5599	0.974
NULL	Mol_Cancer_2009_Dec_23_8_129.nxml.txt.nlp	20030852	SENT35	10	10	21	21	curcumin	ABCA1	PA151958596	19	0.974
NULL	Scientifica_(Cairo)_2012_Dec_16_2012_402783.nxml.txt.nlp	24278688	SENT171	27	27	2	2	thrombin	C5a	PA451674	727	0.974
NULL	J_Invest_Dermatol_2014_Jul_6_134(7)_1811-1816.nxml.txt.nlp	24599174	SENT33	13	13	0	0	tazarotene	TIG3	PA164746821	5920	0.974
NULL	Exp_Diabetes_Res_2011_Jun_22_2011_279530.nxml.txt.nlp	21747825	SENT51	21	21	4	4	acarbose	GLP-1	PA448010	100125288	0.974
NULL	J_Cell_Biol_2000_Feb_7_148(3)_399-404.nxml.txt.nlp	10662767	SENT64	20	20	38	38	staurosporine	p120ctn	PA165109623	1500	0.974
NULL	Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.nxml.txt.nlp	24736980	SENT222	4	4	9	9	rosuvastatin	OATP1B1	PA134308647	10599	0.974
NULL	Curr_Neuropharmacol_2012_Sep_10(3)_212-218.nxml.txt.nlp	23449551	SENT152	28	28	4	4	rimonabant	CB1	PA152407999	1268	0.974
NULL	Bone_Joint_Res_2014_Mar_1_3(3)_51-59.nxml.txt.nlp	24615710	SENT21	8	8	0	0	resveratrol	SIRT1		23411	0.974
NULL	Open_Cardiovasc_Med_J_2012_Mar_22_6_28-32.nxml.txt.nlp	22481984	SENT91	0	0	38	38	fluvastatin	DAN	PA449688	5073;4681	0.974
NULL	Cell_Death_Dis_2012_Mar_15_3(3)_e283.nxml.txt.nlp	22419112	SENT45	24	24	8	8	etoposide	CSIG	PA449552	26156	0.974
NULL	J_Biol_Chem_2009_Apr_3_284(14)_9558-9565.nxml.txt.nlp	19202191	SENT178	34	34	16	16	camptothecin	CtIP	PA153590860	5932	0.974
NULL	EMBO_Mol_Med_2013_Jul_13_5(7)_983-998.nxml.txt.nlp	23666744	SENT301	18	18	5	5	vincristine	TUBGCP4	PA451879	27229	0.974
NULL	Hum_Genomics_2008_Sep_1_3(1)_7-16.nxml.txt.nlp	19129086	SENT170	19	19	7	7	rosiglitazone	OATP1B1	PA451283	10599	0.974
NULL	Mol_Cancer_2010_Dec_20_9_316.nxml.txt.nlp	21172016	SENT151	40	40	9	9	heparin	CCL21	PA449855	6366	0.974
NULL	Oncotarget_2014_Feb_7_5(3)_775-787.nxml.txt.nlp	24519956	SENT110	11	11	0	0	dasatinib	PC3	PA162372878	57332;7832;5122	0.974
NULL	Front_Immunol_2012_May_4_3_103.nxml.txt.nlp	22566975	SENT623	14	14	0	0	cyclophosphamide	CD4	PA449165	920	0.974
NULL	Anat_Cell_Biol_2012_Jun_30_45(2)_73-78.nxml.txt.nlp	22822460	SENT85	5	5	26	26	gefitinib	HIF-1	PA131301952	29072	0.974
NULL	Front_Mol_Neurosci_2012_May_7_5_60.nxml.txt.nlp	22586367	SENT140	6	6	25	25	ivermectin	P2X4	PA450133	5025	0.974
NULL	Eur_J_Clin_Pharmacol_2007_Apr_21_63(4)_335-343.nxml.txt.nlp	17318526	SENT234	37	37	42	42	sulfamethoxazole	CYP2C8	PA451544	1558	0.974
NULL	Br_J_Cancer_2011_Oct_25_105(9)_1273-1278.nxml.txt.nlp	21959871	SENT23	0	0	15	15	trastuzumab	HER2	PA451743	2064	0.974
NULL	J_Med_Case_Rep_2013_Oct_2_7_232.nxml.txt.nlp	24088343	SENT92	0	0	32	32	hydroxychloroquine	VWF	PA164777036	7450	0.974
NULL	Endocrinology_2012_Jul_5_153(7)_3190-3198.nxml.txt.nlp	22669896	SENT168	10	10	23	23	genistein	PI3K	PA165109660	5290	0.974
NULL	Int_J_Appl_Basic_Med_Res_2013_Jan-Jun_3(1)_19-21.nxml.txt.nlp	23776835	SENT5	0	0	6	6	ticagrelor	ADP	PA165374673	23038	0.974
NULL	Comp_Hepatol_2004_Jan_14_3(Suppl_1)_S31.nxml.txt.nlp	14960183	SENT88	5	5	10	10	ethanol	TNF-alpha	PA448073	7124	0.974
NULL	Mol_Vis_2012_May_11_18_1260-1270.nxml.txt.nlp	22665973	SENT14	3	3	12	12	topotecan	HIF-1	PA451729	29072	0.974
NULL	Case_Rep_Neurol_Med_2013_Feb_27_2013_735419.nxml.txt.nlp	23533858	SENT37	26	26	4	4	clopidogrel	NF1	PA449053	4763	0.974
NULL	Breast_Cancer_Res_2011_Mar_1_13(2)_R21.nxml.txt.nlp	21362200	SENT287	0	0	18	18	estradiol	PI3K	PA449503	5290	0.974
NULL	Int_J_Mol_Sci_2014_Nov_10_15(11)_20607-20637.nxml.txt.nlp	25391045	SENT294	11	11	36	36	simvastatin	PI3K	PA451363	5290	0.974
NULL	Cancer_Metab_2013_Mar_21_1_12.nxml.txt.nlp	24280230	SENT237	27	27	4	4	urea	ASL	PA451831	435	0.974
NULL	Breast_Cancer_Res_2004_Nov_7_6(1)_39-52.nxml.txt.nlp	14680484	SENT157	25	25	12	12	tamoxifen	N-CoR	PA451581	9611	0.974
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_3_2012_908562.nxml.txt.nlp	23082087	SENT179	2	2	11	11	hesperidin	IL-4	PA449867	3565	0.974
NULL	Ann_Hematol_2014_Sep_10_93(1)_1-11.nxml.txt.nlp	24018623	SENT369	21	21	36	36	lenalidomide	SPARC	PA162363968	6678	0.974
NULL	Exp_Ther_Med_2012_Sep_29_4(3)_524-532.nxml.txt.nlp	23181130	SENT131	6	6	40	40	mk-571	MRP4		10257	0.974
NULL	Oncotarget_2014_Feb_7_5(3)_775-787.nxml.txt.nlp	24519956	SENT232	13	13	3	3	dasatinib	PC3	PA162372878	57332;7832;5122	0.974
NULL	Int_Clin_Psychopharmacol_2014_Jul_26_29(4)_206-211.nxml.txt.nlp	24374906	SENT74	5	5	9	9	doxepin	CYP2C9	PA449409	1559	0.974
NULL	Eur_J_Clin_Pharmacol_2012_Sep_15_68(9)_1267-1274.nxml.txt.nlp	22418828	SENT138	24	24	11	11	pantoprazole	CYP2C19	PA450774	1557	0.974
NULL	Ann_Dermatol_2014_Jun_12_26(3)_363-373.nxml.txt.nlp	24966637	SENT184	29	29	15	15	imiquimod	MT1-MMP	PA449972	4323	0.974
NULL	J_Asthma_Allergy_2010_Aug_13_3_33-42.nxml.txt.nlp	21437038	SENT94	8	8	23	23	salmeterol	DPI	PA451300	1832	0.974
NULL	Arch_Med_Sci_2013_Aug_30_9(4)_724-730.nxml.txt.nlp	24049536	SENT95	5	5	1	1	genistein	PTH	PA165109660	5741	0.974
NULL	Cell_Death_Dis_2010_Oct_21_1(10)_e86.nxml.txt.nlp	21368859	SENT235	15	15	21	21	doxorubicin	TRAIL	PA449412	8743	0.974
NULL	Arthritis_Res_Ther_2010_Aug_25_12(4)_R163.nxml.txt.nlp	20738860	SENT246	26	26	5	5	ns-398	COX2		4513;5743	0.974
NULL	J_Hematol_Oncol_2008_Oct_1_1_16.nxml.txt.nlp	18828924	SENT266	0	0	16	16	axitinib	VEGFR	PA164924493	3791	0.974
NULL	Lancet_2011_Jun_9_377(9784)_2181-2192.nxml.txt.nlp	21663949	SENT125	23	23	2	2	simvastatin	SHARP	PA451363	23013	0.974
NULL	Cancers_(Basel)_2011_Sep_13_3(3)_3506-3524.nxml.txt.nlp	24212966	SENT101	32	32	28	28	gefitinib	EGFR	PA131301952	1956	0.974
NULL	Indian_J_Med_Paediatr_Oncol_2013_Oct-Dec_34(4)_292-298.nxml.txt.nlp	24604960	SENT46	3	3	18	18	rituximab	CHOP	PA451261	1649	0.974
NULL	AIDS_Res_Ther_2013_May_1_10_10.nxml.txt.nlp	23634877	SENT6	17	17	31	31	lovastatin	CXCR4	PA450272	7852	0.974
NULL	Breast_Cancer_Res_2007_Jul_5_9(4)_R41.nxml.txt.nlp	17612393	SENT4	0	0	13	13	celecoxib	Bcl-2	PA448871	596	0.974
NULL	Am_J_Cardiovasc_Drugs_2013_Jun_20_13(5)_331-342.nxml.txt.nlp	23784266	SENT183	14	14	33	33	dronedarone	P-gp	PA153619853	5243	0.974
NULL	Int_J_Biol_Sci_2014_Jun_10_10(7)_654-663.nxml.txt.nlp	25013375	SENT113	5	5	25	25	ritonavir	AKT	PA451260	207	0.974
NULL	Pharmaceuticals_(Basel)_2014_Nov_25_7(12)_1028-1048.nxml.txt.nlp	25429645	SENT92	0	0	17	17	celecoxib	IFN	PA448871	3439	0.974
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_75-89.nxml.txt.nlp	17912638	SENT231	25	25	5	5	tamoxifen	ATAC	PA451581	6375	0.974
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT1690	4	4	16	16	ritonavir	CYP3A4	PA451260	1576	0.974
NULL	Curr_Chem_Genomics_2010_Mar_1_4_1-8.nxml.txt.nlp	20448812	SENT94	17	17	38	38	repaglinide	OATP1B3	PA451234	28234	0.974
NULL	Springerplus_2013_Dec_7_2_659.nxml.txt.nlp	24353977	SENT76	4	4	12	12	ketotifen	MSU	PA450152	593	0.974
NULL	Diabetes_2011_Nov_17_60(11)_2691-2700.nxml.txt.nlp	21896928	SENT179	41	41	23	23	resveratrol	SIRT1		23411	0.974
NULL	Clin_Dev_Immunol_2013_May_22_2013_701305.nxml.txt.nlp	23762095	SENT78	33	33	23	23	vincristine	MCL1	PA451879	4170	0.974
NULL	J_Cachexia_Sarcopenia_Muscle_2011_Dec_8_2(4)_209-261.nxml.txt.nlp	22476871	SENT2518	0	0	8	8	tocilizumab	IL-6	PA165292659	3569	0.974
NULL	Oncol_Lett_2014_Jul_25_8(1)_313-316.nxml.txt.nlp	24959268	SENT67	8	8	29	29	sulindac	PC-3	PA451565	692094	0.974
NULL	Curr_Pharm_Des_2008_Oct_14(28)_2983-2998.nxml.txt.nlp	18991714	SENT79	2	2	8	8	erlotinib	EGFR	PA134687924	1956	0.974
NULL	Exp_Transl_Stroke_Med_2011_Sep_12_3_8.nxml.txt.nlp	21910904	SENT65	25	25	0	0	nadh	AMPK	PA164755085	5563	0.974
NULL	Oncotarget_2013_Feb_26_4(2)_298-309.nxml.txt.nlp	23593653	SENT147	19	19	7	7	decitabine	DNMT1	PA164749631	1786	0.974
NULL	Acta_Pharmacol_Sin_2009_Aug_13_30(8)_1186-1194.nxml.txt.nlp	19597523	SENT28	38	38	10	10	sildenafil	GMP	PA451346	22978	0.974
NULL	Cell_Death_Dis_2014_Feb_13_5(2)_e1055.nxml.txt.nlp	24525731	SENT71	8	8	4	4	cisplatin	XRCC1	PA449014	7515	0.974
NULL	Br_J_Cancer_2012_Nov_6_107(10)_1737-1744.nxml.txt.nlp	23037715	SENT64	31	31	6	6	chlorpromazine	PC-3	PA448964	692094	0.974
NULL	J_Biol_2009_Apr_15_8(3)_30.nxml.txt.nlp	19435483	SENT9	0	0	18	18	imatinib	KIT	PA10804	3815	0.974
NULL	Nat_Commun_2013_Sep_20_4_2444.nxml.txt.nlp	24051492	SENT43	9	9	2	2	nutlin-3	p53		7157	0.974
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_P42.nxml.txt.nlp	NULL	SENT17	17	17	5	5	amoxicillin	IL13	PA448406	3596	0.974
NULL	Mol_Brain_2014_Aug_21_7_59.nxml.txt.nlp	25139109	SENT42	19	19	4	4	chloroquine	TLR4	PA448948	7099	0.974
NULL	J_Oncol_2009_May_6_2009_567486.nxml.txt.nlp	19424511	SENT75	12	12	34	34	cetuximab	KRAS	PA10040	3845	0.974
NULL	Arthritis_Res_Ther_2008_Oct_15_10(Suppl_1)_S5.nxml.txt.nlp	19007425	SENT220	0	0	13	13	abatacept	CTLA4	PA164747080	1493	0.974
NULL	Nat_Chem_Biol_2013_Feb_9_9(2)_112-118.nxml.txt.nlp	23222885	SENT377	11	11	28	28	geldanamycin	Hsp25	PA152031327	3315	0.974
NULL	J_Vet_Med_Sci_2014_Sep_9_76(9)_1291-1295.nxml.txt.nlp	24909969	SENT21	0	0	9	9	azithromycin	ATV	PA448519	4683	0.974
NULL	J_Hematol_Oncol_2008_Oct_1_1_16.nxml.txt.nlp	18828924	SENT370	31	31	12	12	tamoxifen	VEGFR	PA451581	3791	0.974
NULL	Virol_J_2010_Jan_22_7_16.nxml.txt.nlp	20096105	SENT151	26	26	8	8	doxorubicin	MDR1	PA449412	5243	0.974
NULL	Cancer_Microenviron_2009_Sep_26_2(Suppl_1)_19-204.nxml.txt.nlp	NULL	SENT5697	4	4	0	0	thrombin	PAR-1	PA451674	2011;2149	0.974
NULL	Cell_Death_Dis_2012_Nov_15_3(11)_e422.nxml.txt.nlp	23152058	SENT126	18	18	3	3	cisplatin	ZNF143	PA449014	7702	0.974
NULL	Exp_Ther_Med_2013_Nov_13_6(5)_1317-1321.nxml.txt.nlp	24223665	SENT106	18	18	3	3	curcumin	CD133	PA151958596	8842	0.974
NULL	Arthritis_Res_Ther_2006_Jul_21_8(4)_R130.nxml.txt.nlp	16859540	SENT262	5	5	28	28	atorvastatin	CD59	PA448500	966	0.974
NULL	Braz_J_Med_Biol_Res_2014_Sep_5_47(11)_929-939.nxml.txt.nlp	25296354	SENT15	20	20	2	2	afatinib	EGFR	PA165981154	1956	0.974
NULL	Hum_Reprod_2008_Oct_16_23(10)_2273-2281.nxml.txt.nlp	18635530	SENT165	1	1	14	14	etoposide	CTB	PA449552	9468	0.974
NULL	Breast_Cancer_Res_2011_Mar_10_13(2)_R27.nxml.txt.nlp	21392396	SENT26	26	26	9	9	tamoxifen	CYP2D6	PA451581	1565	0.974
NULL	Breast_Cancer_Res_2007_Jun_7_9(3)_R37.nxml.txt.nlp	17555561	SENT167	2	2	11	11	letrozole	aromatase	PA450196	1588	0.974
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT102	0	0	8	8	neratinib	EGFR	PA165291472	1956	0.974
NULL	Diagn_Pathol_2006_Aug_15_1_19.nxml.txt.nlp	16911776	SENT140	30	30	13	13	gefitinib	EGFR	PA131301952	1956	0.974
NULL	Oncoimmunology_2013_Jan_1_2(1)_e22890.nxml.txt.nlp	23483066	SENT46	16	16	23	23	vemurafenib	IFN	PA165946873	3439	0.974
NULL	Cell_Commun_Signal_2013_Nov_5_11_83.nxml.txt.nlp	24192293	SENT57	6	6	12	12	doxycycline	IL-6	PA449415	3569	0.974
NULL	Eur_J_Pharmacol_2011_Mar_5_654(2)_155-159.nxml.txt.nlp	21172341	SENT71	5	5	15	15	staurosporine	P2X1	PA165109623	5023	0.974
NULL	Front_Cell_Neurosci_2015_Jan_15_8_459.nxml.txt.nlp	25642166	SENT71	27	27	6	6	hemin	HO-1	PA449849	3162	0.974
NULL	J_Gen_Physiol_2000_Jun_1_115(6)_685-696.nxml.txt.nlp	10828243	SENT193	8	8	14	14	genistein	OLF	PA165109660	83857	0.974
NULL	Evid_Based_Complement_Alternat_Med_2011_Mar_14_2011_635058.nxml.txt.nlp	21437195	SENT248	10	10	2	2	genistein	IFN	PA165109660	3439	0.974
NULL	Biosci_Rep_2012_Dec_13_33(1)_e00007.nxml.txt.nlp	23095119	SENT206	5	5	30	30	orlistat	AMPK	PA164776864	5563	0.974
NULL	Cardiovasc_Diabetol_2010_Sep_23_9_57.nxml.txt.nlp	20863381	SENT21	0	0	9	9	pioglitazone	DM2	PA450970	28508	0.974
NULL	Clin_Dev_Immunol_2011_Oct_20_2011_947858.nxml.txt.nlp	22046194	SENT132	4	4	27	27	doxorubicin	AKT	PA449412	207	0.974
NULL	Br_J_Cancer_2013_Feb_5_108(2)_469-476.nxml.txt.nlp	23169292	SENT126	27	27	7	7	cetuximab	EGFR	PA10040	1956	0.974
NULL	J_Immunol_Res_2014_Jan_19_2014_103780.nxml.txt.nlp	24741572	SENT128	6	6	28	28	salmeterol	JNK	PA451300	5599	0.974
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT102	8	8	27	27	chloroquine	BMPR-II	PA448948	659	0.974
NULL	Toxins_(Basel)_2010_Mar_31_2(4)_517-551.nxml.txt.nlp	22069598	SENT225	7	7	23	23	genistein	CD19	PA165109660	930	0.974
NULL	Acta_Pharmacol_Sin_2012_Dec_22_33(12)_1511-1517.nxml.txt.nlp	23085741	SENT183	19	19	22	22	pranlukast	CysLT1	PA134698661	10800	0.974
NULL	Clinics_(Sao_Paulo)_2012_May_67(5)_419-424.nxml.txt.nlp	22666783	SENT38	16	16	22	22	gefitinib	KRAS	PA131301952	3845	0.974
NULL	Ther_Clin_Risk_Manag_2006_Jun_2(2)_129-158.nxml.txt.nlp	18360588	SENT213	5	5	11	11	vinblastine	CYP3A4	PA451877	1576	0.974
NULL	BMB_Rep_2014_Jan_47(1)_33-38.nxml.txt.nlp	24209634	SENT117	38	38	15	15	cisplatin	CXCR4	PA449014	7852	0.974
NULL	Evid_Based_Complement_Alternat_Med_2012_Dec_17_2012_857123.nxml.txt.nlp	23365602	SENT100	8	8	2	2	capsaicin	TRPV1	PA448776	7442	0.974
NULL	Crit_Care_2011_Jan_17_15(1)_R23.nxml.txt.nlp	21241489	SENT200	7	7	21	21	enoxaparin	PPIC	PA449463	5480	0.974
NULL	EMBO_Mol_Med_2011_Apr_3(4)_183-185.nxml.txt.nlp	21394915	SENT32	15	15	3	3	estradiol	ZNF703	PA449503	80139	0.974
NULL	Oncol_Lett_2013_Apr_28_5(4)_1149-1154.nxml.txt.nlp	23599754	SENT132	27	27	9	9	cisplatin	Dicer	PA449014	23405	0.974
NULL	Asian_Spine_J_2014_Jun_9_8(3)_315-321.nxml.txt.nlp	24967045	SENT54	33	33	18	18	ethionamide	AKT	PA164768738	207	0.974
NULL	Case_Rep_Oncol_2013_Sep_10_6(3)_450-455.nxml.txt.nlp	24163659	SENT67	23	23	8	8	paclitaxel	HER2	PA450761	2064	0.974
NULL	AIDS_Res_Treat_2012_Jul_5_2012_874083.nxml.txt.nlp	22829999	SENT133	13	13	24	24	ethambutol	EMB	PA164784021	133418	0.974
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT143	10	10	0	0	metformin	PTEN	PA450395	5728	0.974
NULL	Clin_Pharmacol_2013_Dec_9_5_185-192.nxml.txt.nlp	24353446	SENT75	43	43	9	9	clopidogrel	CYP3A4	PA449053	1576	0.974
NULL	Ther_Clin_Risk_Manag_2006_Dec_2(4)_337-346.nxml.txt.nlp	18360646	SENT205	7	7	37	37	brimonidine	BAK	PA448665	578	0.974
NULL	Nat_Med_2010_Feb_24_16(2)_214-218.nxml.txt.nlp	20098429	SENT62	28	28	5	5	epirubicin	YWHAZ	PA449476	7534	0.974
NULL	Acta_Pharmacol_Sin_2009_Apr_3_30(4)_478-484.nxml.txt.nlp	19343062	SENT92	0	0	4	4	cyclosporine	CYP3A4	PA449167	1576	0.974
NULL	Diabetes_Care_2013_Aug_17_36(Suppl_2)_S245-S252.nxml.txt.nlp	23882053	SENT62	29	29	26	26	exenatide	GLP-1	PA164749238	100125288	0.974
NULL	Springerplus_2014_Sep_17_3_535.nxml.txt.nlp	25279326	SENT151	13	13	11	11	anastrozole	aromatase	PA448432	1588	0.974
NULL	Oncotarget_2014_Oct_11_5(20)_10070-10083.nxml.txt.nlp	25301722	SENT226	15	15	2	2	gefitinib	EGFR	PA131301952	1956	0.974
NULL	Acta_Pharmacol_Sin_2014_Jun_4_35(6)_752-757.nxml.txt.nlp	24902786	SENT94	14	14	21	21	letrozole	STZ	PA450196	6484	0.974
NULL	Front_Integr_Neurosci_2011_Oct_14_5_63.nxml.txt.nlp	22016725	SENT338	11	11	37	37	estradiol	NCM	PA449503	57703	0.974
NULL	Int_J_Mol_Imaging_2011_Oct_26_2011_874585.nxml.txt.nlp	21490735	SENT188	26	26	16	16	tamoxifen	FDG	PA451581	23583	0.974
NULL	Diabetes_2013_Mar_14_62(3)_789-800.nxml.txt.nlp	22966074	SENT160	16	16	38	38	doxycycline	GLP-1	PA449415	100125288	0.974
NULL	Mol_Brain_2014_Jan_24_7_6.nxml.txt.nlp	24456563	SENT228	30	30	10	10	l-glutamine	CO2	PA10090	4513	0.974
NULL	Nat_Med_2010_Feb_24_16(2)_214-218.nxml.txt.nlp	20098429	SENT57	39	39	4	4	paclitaxel	LAPTM4B	PA450761	55353	0.974
NULL	Breast_Cancer_Res_2012_Jul_19_14(4)_R109.nxml.txt.nlp	22812567	SENT292	7	7	13	13	gemcitabine	CHK1	PA449748	1111	0.974
NULL	Cardiovasc_Diabetol_2005_Oct_5_4_16.nxml.txt.nlp	16207378	SENT221	0	0	20	20	glucosamine	perlecan	PA164747613	3339	0.974
NULL	Exp_Mol_Med_2013_Apr_19_45(4)_e19.nxml.txt.nlp	23598593	SENT32	0	0	18	18	colchicine	Tech	PA449092	57449	0.974
NULL	Arthritis_Res_Ther_2011_Feb_4_13(1)_R14.nxml.txt.nlp	21294864	SENT115	38	38	6	6	indomethacin	IL-17	PA449982	3605	0.974
NULL	EMBO_Mol_Med_2012_Sep_7_4(9)_896-909.nxml.txt.nlp	22887866	SENT238	4	4	33	33	lovastatin	c-Myc	PA450272	4609	0.974
NULL	Clin_Epidemiol_2014_Nov_20_6_423-432.nxml.txt.nlp	25429239	SENT78	31	31	17	17	crizotinib	KIT	PA165946122	3815	0.974
NULL	Diabetol_Metab_Syndr_2014_Mar_31_6_48.nxml.txt.nlp	24684803	SENT86	0	0	20	20	mitiglinide	STEP	PA164748124	84867	0.974
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT133	18	18	8	8	trastuzumab	VEGF-A	PA451743	7422	0.974
NULL	Cancer_Med_2013_Feb_3_2(1)_40-49.nxml.txt.nlp	24133626	SENT19	30	30	7	7	cilostazol	PDE3B	PA164746334	5140	0.974
NULL	Endocrinol_Diabetes_Metab_Case_Rep_2014_Mar_1_2014_140001.nxml.txt.nlp	24683487	SENT120	11	11	30	30	bromocriptine	ACTH	PA448671	5443	0.974
NULL	Korean_Circ_J_2014_Mar_12_44(2)_113-117.nxml.txt.nlp	24653741	SENT57	12	12	0	0	clopidogrel	DES	PA449053	1674	0.974
NULL	Br_J_Cancer_2013_Feb_19_108(3)_668-675.nxml.txt.nlp	23348520	SENT26	20	20	24	24	cetuximab	EGFR	PA10040	1956	0.974
NULL	J_Biol_Chem_2008_Jun_13_283(24)_16293-16298.nxml.txt.nlp	18397880	SENT113	24	24	12	12	curcumin	p300	PA151958596	2033	0.974
NULL	Diabetes_2011_Jun_21_60(6)_1705-1715.nxml.txt.nlp	21521872	SENT201	27	27	3	3	doxycycline	MAFA	PA449415	10219;389692	0.974
NULL	Diabetes_Care_2010_Apr_12_33(4)_861-868.nxml.txt.nlp	20067962	SENT133	34	34	6	6	hyaluronan	TLR2	PA165958431	7097	0.974
NULL	Br_J_Cancer_2012_Jan_3_106(1)_18-24.nxml.txt.nlp	22108516	SENT140	29	29	13	13	bevacizumab	BRAF	PA130232992	673	0.974
NULL	Breast_Cancer_Res_2007_Dec_20_9(Suppl_2)_S24.nxml.txt.nlp	NULL	SENT20	36	36	11	11	tamoxifen	aromatase	PA451581	1588	0.974
NULL	Ital_J_Pediatr_2014_Feb_13_40_17.nxml.txt.nlp	24524345	SENT89	30	30	12	12	cyclosporine	CHP	PA449167	11261	0.974
NULL	Breast_Cancer_Res_2013_Sep_30_15(5)_R91.nxml.txt.nlp	24074261	SENT146	29	29	6	6	trypsin	F12	PA451806	2161	0.974
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT53	17	17	1	1	nelfinavir	SLK	PA450606	9748;2534	0.974
NULL	Biologics_2009_Jul_13_3_77-97.nxml.txt.nlp	19707398	SENT361	0	0	20	20	daclizumab	IL-2	PA164764446	3558	0.974
NULL	Mol_Biol_Cell_2013_Aug_15_24(16)_2582-2592.nxml.txt.nlp	23783032	SENT112	16	16	9	9	bortezomib	FANCL	PA10252	55120	0.974
NULL	Thorax_2013_Sep_24_68(9)_835-845.nxml.txt.nlp	23709760	SENT146	8	8	2	2	metformin	GM-CSF	PA450395	1437	0.974
NULL	Trials_2014_Nov_6_15(1)_434.nxml.txt.nlp	NULL	SENT203	28	28	12	12	rifampin	Bravo	PA451250	4897	0.974
NULL	Diabetes_Obes_Metab_2011_Nov_13(11)_982-989.nxml.txt.nlp	21615670	SENT176	11	11	29	29	sitagliptin	PPG	PA164748978	5552	0.974
NULL	Iran_Red_Crescent_Med_J_2014_Aug_5_16(8)_e6915.nxml.txt.nlp	25389496	SENT122	13	13	5	5	simvastatin	adiponectin	PA451363	9370	0.974
NULL	Clin_Med_Insights_Oncol_2013_Jun_20_7_137-149.nxml.txt.nlp	23843723	SENT238	27	27	20	20	dacarbazine	BRAF	PA449197	673	0.974
NULL	Diabetes_Care_2011_Dec_14_34(12)_e176-e181.nxml.txt.nlp	22110173	SENT17	38	38	20	20	metformin	TCF7L2	PA450395	6934	0.974
NULL	Clin_Pediatr_Endocrinol_2011_Jul_7_20(3)_65-71.nxml.txt.nlp	23926398	SENT101	12	12	20	20	zoledronate	HHM	PA10235	5744	0.974
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_2_2014_789142.nxml.txt.nlp	25530790	SENT18	3	3	7	7	clopidogrel	P2Y12	PA449053	64805	0.974
NULL	Oncogene_2010_May_20_29(20)_2983-2995.nxml.txt.nlp	20208560	SENT3	19	19	0	0	fulvestrant	FOXM1	PA164747170	2305	0.974
NULL	Int_J_Biol_Sci_2012_Sep_6_8(8)_1109-1120.nxml.txt.nlp	22991499	SENT35	0	0	4	4	l-arginine	ARG	PA448478	473;27	0.974
NULL	Br_J_Pharmacol_2012_Apr_165(8)_2611-2619.nxml.txt.nlp	21718301	SENT214	27	27	14	14	rimonabant	GPR55	PA152407999	9290	0.974
NULL	Cardiovasc_J_Afr_2010_Oct_21(5)_280-285.nxml.txt.nlp	20972517	SENT84	11	11	20	20	naringin	AMPK	PA151958360	5563	0.974
NULL	Arthritis_Res_Ther_2012_Apr_30_14(2)_R96.nxml.txt.nlp	22546471	SENT135	10	10	36	36	methotrexate	IL-6	PA450428	3569	0.974
NULL	Nanoscale_Res_Lett_2012_Feb_20_7(1)_142.nxml.txt.nlp	22348621	SENT28	27	27	7	7	ethanol	FTO	PA448073	79068	0.974
NULL	Eur_Heart_J_2012_Mar_33(6)_705-713.nxml.txt.nlp	22422912	SENT148	6	6	37	37	simvastatin	FDG	PA451363	23583	0.974
NULL	Int_J_Mol_Sci_2014_Sep_29_15(10)_17411-17441.nxml.txt.nlp	25268615	SENT216	12	12	30	30	cisplatin	CD147	PA449014	682	0.974
NULL	Cancers_(Basel)_2009_Dec_15_1(1)_23-28.nxml.txt.nlp	20535236	SENT99	28	28	6	6	cisplatin	TRX	PA449014	7295	0.974
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT332	8	8	34	34	forskolin	IL-6	PA146096022	3569	0.974
NULL	Br_J_Cancer_2004_May_17_90(10)_2050-2051.nxml.txt.nlp	15138493	SENT20	0	0	9	9	irinotecan	CYP3A4	PA450085	1576	0.974
NULL	Arch_Plast_Surg_2014_Jan_13_41(1)_85-88.nxml.txt.nlp	24511501	SENT24	7	7	34	34	lidocaine	CO2	PA450226	4513	0.974
NULL	Br_J_Cancer_2012_Dec_4_107(12)_1950-1955.nxml.txt.nlp	23169295	SENT18	18	18	1	1	oxaliplatin	ERCC1	PA131285527	2067	0.974
NULL	Sci_Rep_2014_Dec_17_4_7461.nxml.txt.nlp	25514838	SENT9	7	7	14	14	cisplatin	STAT3	PA449014	6774	0.974
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT203	16	16	6	6	metformin	CA9	PA450395	768	0.974
NULL	Indian_J_Psychiatry_2011_Oct-Dec_53(4)_283-286.nxml.txt.nlp	22303034	SENT67	30	30	43	43	fluoxetine	spatial	PA449673	219793	0.974
NULL	Case_Rep_Gastroenterol_2012_May_3_6(2)_223-231.nxml.txt.nlp	22679409	SENT28	15	15	26	26	lipase	DIP	PA450239	23151;1831	0.973
NULL	J_Biol_2006_Apr_27_5(3)_7.nxml.txt.nlp	16643674	SENT200	28	28	15	15	cyclosporine	GDA	PA449167	8034;9615	0.973
NULL	Br_J_Cancer_2012_Oct_9_107(8)_1277-1285.nxml.txt.nlp	22990652	SENT164	1	1	5	5	paclitaxel	CYP2C8	PA450761	1558	0.973
NULL	J_Korean_Med_Sci_2007_Apr_30_22(2)_283-289.nxml.txt.nlp	17449938	SENT102	20	20	6	6	minoxidil	Bcl-2	PA450521	596	0.973
NULL	J_Cell_Biol_2000_Jan_10_148(1)_59-72.nxml.txt.nlp	10629218	SENT219	31	31	1	1	staurosporine	p21Cip1/Waf1	PA165109623	1026	0.973
NULL	Oxid_Med_Cell_Longev_2013_Nov_28_2013_568093.nxml.txt.nlp	24379901	SENT54	8	8	40	40	resveratrol	AMPK		5563	0.973
NULL	Clinics_(Sao_Paulo)_2009_Apr_64(4)_373-374.nxml.txt.nlp	19488598	SENT34	14	14	6	6	ketoconazole	DPT	PA450146	1805	0.973
NULL	Cardiol_Res_Pract_2011_May_10_2011_816897.nxml.txt.nlp	21629798	SENT143	0	0	5	5	dasatinib	CYP3A4	PA162372878	1576	0.973
NULL	Cases_J_2009_Jun_17_2_7394.nxml.txt.nlp	19829950	SENT42	13	13	32	32	lamotrigine	PTH	PA450164	5741	0.973
NULL	Front_Endocrinol_(Lausanne)_2011_Dec_21_2_84.nxml.txt.nlp	22654830	SENT40	7	7	26	26	rosiglitazone	CGI-58	PA451283	51099	0.973
NULL	J_Mol_Med_(Berl)_2012_Oct_20_90(10)_1223-1231.nxml.txt.nlp	22527886	SENT23	6	6	3	3	montelukast	CysLT1	PA450546	10800	0.973
NULL	J_Oncol_2012_Dec_7_2012_192464.nxml.txt.nlp	22187555	SENT251	4	4	15	15	curcumin	EGFR	PA151958596	1956	0.973
NULL	Cell_Commun_Signal_2013_Nov_4_11_82.nxml.txt.nlp	24188565	SENT15	30	30	4	4	gentamicin	N-WASP	PA449753	8976	0.973
NULL	Cell_Death_Dis_2012_Nov_29_3(11)_e436.nxml.txt.nlp	23190608	SENT80	27	27	6	6	bortezomib	CD138	PA10252	6382	0.973
NULL	Br_J_Pharmacol_2014_May_171(10)_2659-2670.nxml.txt.nlp	24116661	SENT17	13	13	27	27	naringenin	TRPP2	PA151958361	5311	0.973
NULL	Mol_Cells_2014_Dec_31_37(12)_888a-898.nxml.txt.nlp	25518923	SENT31	16	16	10	10	gemcitabine	KRAS	PA449748	3845	0.973
NULL	Part_Fibre_Toxicol_2013_Aug_13_10_39.nxml.txt.nlp	23937860	SENT29	47	47	19	19	anakinra	IL-6	PA10799	3569	0.973
NULL	Oncotarget_2013_Apr_10_4(4)_622-635.nxml.txt.nlp	23599172	SENT169	8	8	20	20	lapatinib	EGF	PA152241907	1950	0.973
NULL	Hum_Genomics_2004_May_1_1(4)_300-306.nxml.txt.nlp	15588489	SENT128	22	22	0	0	fluoxetine	CYP2D6	PA449673	1565	0.973
NULL	Acta_Pharmacol_Sin_2010_Mar_22_31(3)_329-340.nxml.txt.nlp	20173759	SENT26	32	32	7	7	ethanol	PI3K	PA448073	5290	0.973
NULL	Environ_Health_Perspect_2009_Feb_8_117(2)_175-180.nxml.txt.nlp	19270784	SENT103	12	12	2	2	vinblastine	BPA	PA451877	667	0.973
NULL	Chin_J_Cancer_2012_Feb_31(2)_73-99.nxml.txt.nlp	22098950	SENT267	0	0	20	20	flavopiridol	CDK3	PA452627	1018	0.973
NULL	Diabetes_2013_May_16_62(5)_1697-1708.nxml.txt.nlp	23364453	SENT274	0	0	12	12	exenatide	GLP-1	PA164749238	100125288	0.973
NULL	J_Res_Pharm_Pract_2013_Jan-Mar_2(1)_34-39.nxml.txt.nlp	24991602	SENT100	6	6	30	30	glucosamine	COX	PA164747613	1351	0.973
NULL	Acta_Pharmacol_Sin_2013_Jun_8_34(6)_830-836.nxml.txt.nlp	23564080	SENT22	26	26	4	4	simvastatin	HMGB1	PA451363	3146	0.973
NULL	Cell_Cycle_2012_Jul_1_11(13)_2538-2544.nxml.txt.nlp	22713238	SENT38	10	10	27	27	etoposide	RNF168	PA449552	165918	0.973
NULL	J_Gen_Physiol_2009_Oct_134(4)_323-337.nxml.txt.nlp	19786585	SENT325	17	17	1	1	dantrolene	ClC-1	PA449208	1180	0.973
NULL	Br_J_Cancer_2012_Jan_3_106(1)_148-156.nxml.txt.nlp	22045191	SENT186	19	19	15	15	erlotinib	EGFR	PA134687924	1956	0.973
NULL	Endocrinol_Metab_(Seoul)_2013_Mar_25_28(1)_55-60.nxml.txt.nlp	24396652	SENT102	33	33	18	18	methimazole	HLA-DRB1	PA450422	3123	0.973
NULL	Aging_Cell_2007_Aug_6(4)_577-591.nxml.txt.nlp	17578512	SENT76	13	13	9	9	doxycycline	HDAC1	PA449415	3065	0.973
NULL	J_Cancer_2013_Sep_10_4(8)_614-625.nxml.txt.nlp	24155773	SENT270	28	28	20	20	doxorubicin	CRM1	PA449412	7514	0.973
NULL	Bioinformation_2012_Jan_6_8(1)_13-19.nxml.txt.nlp	22359429	SENT135	10	10	16	16	calcein	MRP1	PA132595336	4437	0.973
NULL	Clinicoecon_Outcomes_Res_2014_Oct_17_6_451-461.nxml.txt.nlp	25378939	SENT28	2	2	21	21	linezolid	HAP	PA450233	5915;10313	0.973
NULL	Cancers_(Basel)_2011_Mar_7_3(1)_1158-1181.nxml.txt.nlp	24212658	SENT255	16	16	44	44	doxorubicin	HSF1	PA449412	3297	0.973
NULL	J_Thorac_Oncol_2014_Sep_22_9(9)_1345-1353.nxml.txt.nlp	25122430	SENT149	1	1	27	27	gefitinib	EGFR	PA131301952	1956	0.973
NULL	Archaea_2013_Mar_21_2013_456318.nxml.txt.nlp	23585730	SENT90	19	19	5	5	trypsin	PH1	PA451806	189	0.973
NULL	J_Physiol_2009_Feb_15_587(Pt_4)_731-744.nxml.txt.nlp	19074966	SENT98	21	21	11	11	taurine	PAT1	PA451590	10513;206358	0.973
NULL	Cells_2014_May_23_3(2)_517-545.nxml.txt.nlp	24861977	SENT1	24	24	6	6	capsaicin	TRPV1	PA448776	7442	0.973
NULL	J_Biol_Chem_2012_Dec_21_287(52)_43482-43491.nxml.txt.nlp	23135270	SENT164	18	18	8	8	trypsin	PCSK9	PA451806	255738	0.973
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT119	22	22	33	33	dasatinib	ABCB1	PA162372878	5243	0.973
NULL	Acta_Pharmacol_Sin_2010_Jul_28_31(7)_775-783.nxml.txt.nlp	20581849	SENT112	15	15	27	27	diazepam	EPM	PA449283	2054	0.973
NULL	Diabetes_Care_2011_Apr_21_34(4)_845-851.nxml.txt.nlp	21330640	SENT134	9	9	3	3	ramipril	DREAM	PA451223	30818	0.973
NULL	Mol_Cancer_2009_Nov_10_8_99.nxml.txt.nlp	19903356	SENT12	18	18	4	4	imatinib	IGFBP3	PA10804	3486	0.973
NULL	Front_Pharmacol_2014_Oct_27_5_228.nxml.txt.nlp	25452728	SENT203	21	21	8	8	ethanol	p190RhoGAP	PA448073	2909	0.973
NULL	Cancers_(Basel)_2011_Aug_15_3(3)_3331-3352.nxml.txt.nlp	24212957	SENT259	22	22	20	20	letrozole	aromatase	PA450196	1588	0.973
NULL	Cancers_(Basel)_2014_Sep_30_6(4)_2035-2048.nxml.txt.nlp	25271833	SENT124	21	21	31	31	gefitinib	IL-2	PA131301952	3558	0.973
NULL	Indian_J_Med_Paediatr_Oncol_2014_Oct-Dec_35(4)_244-248.nxml.txt.nlp	25538399	SENT87	17	17	2	2	imatinib	PDGFRA	PA10804	5156	0.973
NULL	Breast_Cancer_Res_2014_May_7_16(3)_207.nxml.txt.nlp	25223380	SENT156	28	28	26	26	letrozole	aromatase	PA450196	1588	0.973
NULL	Front_Psychiatry_2014_Jul_31_5_92.nxml.txt.nlp	25132823	SENT91	7	7	12	12	sr144528	CB2		1269	0.973
NULL	J_Hematol_Oncol_2012_May_17_5_24.nxml.txt.nlp	22594538	SENT162	19	19	10	10	methotrexate	FPGS	PA450428	2356	0.973
NULL	Environ_Health_Perspect_2011_Aug_22_119(8)_1053-1061.nxml.txt.nlp	21697028	SENT320	6	6	16	16	diethylstilbestrol	EZH2	PA449307	2146	0.973
NULL	Cancers_(Basel)_2014_Jul_8_6(3)_1487-1499.nxml.txt.nlp	25006835	SENT522	7	7	18	18	cisplatin	FAK	PA449014	5747	0.973
NULL	Oncotarget_2014_Oct_21_5(22)_11252-11268.nxml.txt.nlp	25361004	SENT255	13	13	2	2	metformin	CLIC1	PA450395	1192	0.973
NULL	Arthritis_Res_Ther_2006_Jul_21_8(4)_R130.nxml.txt.nlp	16859540	SENT5	15	15	4	4	atorvastatin	CD59	PA448500	966	0.973
NULL	Br_J_Cancer_2010_Nov_9_103(10)_1627-1636.nxml.txt.nlp	20959826	SENT185	39	39	29	29	cetuximab	NRAS	PA10040	4893	0.973
NULL	J_Inflamm_(Lond)_2008_Dec_4_5_22.nxml.txt.nlp	19055838	SENT8	16	16	3	3	carrageenan	p38	PA448814	10598;1432;7965	0.973
NULL	Arch_Drug_Inf_2011_Mar_4(1)_1-9.nxml.txt.nlp	21572514	SENT147	2	2	12	12	cyclosporine	P-gp	PA449167	5243	0.973
NULL	BMB_Rep_2013_Jun_46(6)_295-304.nxml.txt.nlp	23790972	SENT201	19	19	5	5	forskolin	CB1	PA146096022	1268	0.973
NULL	J_Histochem_Cytochem_2012_Oct_60(10)_749-760.nxml.txt.nlp	22821669	SENT238	19	19	8	8	hyaluronan	TSG-6	PA165958431	7130	0.973
NULL	Nucleic_Acids_Res_2012_Jun_22_40(11)_4861-4878.nxml.txt.nlp	22362753	SENT235	14	14	5	5	trypsin	NPM3	PA451806	10360	0.973
NULL	Cancer_Microenviron_2009_Sep_26_2(Suppl_1)_19-204.nxml.txt.nlp	NULL	SENT2561	22	22	9	9	estradiol	ENL	PA449503	4298	0.973
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Aug_30_64(Pt_9)_o1863.nxml.txt.nlp	21201832	SENT56	17	17	12	12	ethanol	mol	PA448073	90527	0.973
NULL	Acta_Pharmacol_Sin_2012_Aug_9_33(8)_1069-1079.nxml.txt.nlp	22773077	SENT11	12	12	10	10	verapamil	P-gp	PA451868	5243	0.973
NULL	Oncogene_2013_Sep_12_32(37)_4355-4365.nxml.txt.nlp	23108409	SENT51	35	35	6	6	hyaluronan	HAS2	PA165958431	3037	0.973
NULL	Front_Endocrinol_(Lausanne)_2013_Sep_4_4_116.nxml.txt.nlp	24027559	SENT38	7	7	22	22	estradiol	SULT2A1	PA449503	6822	0.973
NULL	Comp_Hepatol_2004_Jan_14_3(Suppl_1)_S37.nxml.txt.nlp	14960189	SENT69	24	24	7	7	ethanol	CD14	PA448073	929	0.973
NULL	Int_J_Breast_Cancer_2012_May_9_2012_415170.nxml.txt.nlp	22649737	SENT44	3	3	31	31	trastuzumab	PTEN	PA451743	5728	0.973
NULL	Mediators_Inflamm_1998_7(6)_391-396.nxml.txt.nlp	9927231	SENT5	6	6	23	23	forskolin	GM-CSF	PA146096022	1437	0.973
NULL	Breast_Cancer_Res_2008_Dec_18_10(Suppl_4)_S17.nxml.txt.nlp	19128430	SENT3	20	20	23	23	tamoxifen	aromatase	PA451581	1588	0.973
NULL	Ther_Clin_Risk_Manag_2007_Jun_3(3)_467-474.nxml.txt.nlp	18488080	SENT52	6	6	0	0	entacapone	COMT	PA164748726	1312	0.973
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT1288	15	15	8	8	imatinib	CD34	PA10804	947	0.973
NULL	Breast_Cancer_Res_2007_Mar_2_9(2)_205.nxml.txt.nlp	NULL	SENT26	37	37	4	4	gefitinib	HER-2	PA131301952	2064	0.973
NULL	J_Autom_Methods_Manag_Chem_2010_Oct_13_2010_913207.nxml.txt.nlp	20981343	SENT86	3	3	27	27	gentamicin	mol	PA449753	90527	0.973
NULL	Case_Rep_Endocrinol_2012_Sep_23_2012_231912.nxml.txt.nlp	23050172	SENT13	3	3	23	23	thyroglobulin	RAI	PA164754910	10848;6050	0.973
NULL	Bioessays_2014_Nov_25_36(11)_1062-1071.nxml.txt.nlp	25156960	SENT158	23	23	4	4	ethanol	ANP32A	PA448073	8125	0.973
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_39-54.nxml.txt.nlp	19305787	SENT237	14	14	27	27	ethanol	DARPP-32	PA448073	84152	0.973
NULL	J_Res_Pharm_Pract_2013_Oct-Dec_2(4)_156-161.nxml.txt.nlp	24991625	SENT17	17	17	9	9	imatinib	ANOVA	PA10804	4858	0.973
NULL	Int_J_Breast_Cancer_2012_May_9_2012_415170.nxml.txt.nlp	22649737	SENT150	0	0	48	48	neratinib	HER2	PA165291472	2064	0.973
NULL	Adv_Hematol_2012_Mar_8_2012_856341.nxml.txt.nlp	22496694	SENT199	20	20	3	3	enoxaparin	STARS	PA449463	137735	0.973
NULL	Ann_Dermatol_2011_Dec_27_23(Suppl_3)_S360-S363.nxml.txt.nlp	22346278	SENT36	0	0	28	28	imatinib	CML	PA10804	613	0.973
NULL	Cell_Death_Dis_2013_Sep_19_4(9)_e810.nxml.txt.nlp	24052078	SENT16	8	8	37	37	erlotinib	EGFR	PA134687924	1956	0.973
NULL	Oncogene_2014_Mar_6_33(10)_1316-1324.nxml.txt.nlp	23474758	SENT90	7	7	20	20	etoposide	AXL	PA449552	558	0.973
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT82	9	9	6	6	pertuzumab	HER2		2064	0.973
NULL	Diabetes_2011_Jun_21_60(6)_1770-1778.nxml.txt.nlp	21562078	SENT196	19	19	4	4	metformin	AMPK	PA450395	5563	0.973
NULL	J_Biol_Chem_2011_Oct_7_286(40)_34998-35006.nxml.txt.nlp	21757733	SENT40	7	7	16	16	lipase	PLIN1	PA450239	5346	0.973
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT102	3	3	23	23	tenofovir	Ray	PA10204	26751	0.973
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1542-1553.nxml.txt.nlp	21970874	SENT226	27	27	13	13	carboplatin	EGFR	PA448803	1956	0.973
NULL	Ann_Oncol_2013_Aug_12_24(8)_1994-1999.nxml.txt.nlp	23670096	SENT129	28	28	4	4	tamoxifen	AIB1	PA451581	8202	0.973
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1137-1144.nxml.txt.nlp	20234366	SENT121	17	17	6	6	cetuximab	BRAF	PA10040	673	0.973
NULL	Cell_Death_Dis_2014_Jan_30_5(1)_e1030.nxml.txt.nlp	24481444	SENT127	7	7	25	25	sorafenib	PUMA	PA7000	27113	0.973
NULL	Neural_Dev_2009_Nov_2_4_40.nxml.txt.nlp	19883498	SENT277	17	17	5	5	ketamine	E12	PA450144	64100	0.973
NULL	Reprod_Biol_Endocrinol_2003_Jun_12_1_47.nxml.txt.nlp	12816542	SENT169	14	14	18	18	estradiol	CDC47	PA449503	4176	0.973
NULL	Eur_Heart_J_2013_Dec_1_34(45)_3515-3524.nxml.txt.nlp	23594590	SENT85	22	22	11	11	eplerenone	p40phox	PA164749044	4689	0.973
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT784	32	32	1	1	fexofenadine	OATP1B1	PA449621	10599	0.973
NULL	Clin_Pharmacol_2013_Dec_9_5_185-192.nxml.txt.nlp	24353446	SENT75	4	4	46	46	clopidogrel	CYP3A4	PA449053	1576	0.973
NULL	Nat_Med_2013_Mar_3_19(3)_368-371.nxml.txt.nlp	23377281	SENT55	3	3	15	15	nelarabine	NT5C2	PA164752425	22978	0.973
NULL	Iran_Red_Crescent_Med_J_2014_Sep_5_16(9)_e20153.nxml.txt.nlp	25593732	SENT101	6	6	20	20	desflurane	CYP2E1	PA164749136	1571	0.973
NULL	Nucleic_Acids_Res_2005_Jun_8_33(10)_3283-3291.nxml.txt.nlp	15944449	SENT118	23	23	14	14	sjg-136	ERCC1		2067	0.973
NULL	Osteoporos_Int_2012_Jan_3_23(1)_327-337.nxml.txt.nlp	21892677	SENT187	27	27	25	25	denosumab	RANKL	PA166048634	8600	0.973
NULL	Acta_Neuropathol_Commun_2013_Jul_17_1_39.nxml.txt.nlp	24252174	SENT55	23	23	38	38	erlotinib	Erb	PA134687924	2100	0.973
NULL	Iran_J_Pharm_Res_2013_Winter_12(1)_175-184.nxml.txt.nlp	24250586	SENT110	1	1	17	17	diclofenac	COX	PA449293	1351	0.973
NULL	Curr_Health_Sci_J_2010_Mar_24_Jan-Mar_36(1)_42-49.nxml.txt.nlp	24778826	SENT33	10	10	14	14	nimesulide	BCS	PA137179528	617	0.973
NULL	Clin_Med_Case_Rep_2009_Apr_9_2_27-30.nxml.txt.nlp	24179369	SENT42	7	7	16	16	cyclosporine	CD4	PA449167	920	0.973
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Feb_29_68(Pt_3)_o878-o879.nxml.txt.nlp	22412730	SENT84	20	20	43	43	potassium	TLC	PA451047	3933	0.973
NULL	Drugs_R_D_2013_Jun_5_13(2)_153-157.nxml.txt.nlp	23737454	SENT30	5	5	15	15	prasugrel	P2Y12	PA154410481	64805	0.973
NULL	Exp_Neurobiol_2013_Mar_31_22(1)_51-57.nxml.txt.nlp	23585723	SENT17	31	31	4	4	capsaicin	TRPV1	PA448776	7442	0.973
NULL	Child_Adolesc_Psychiatry_Ment_Health_2013_Aug_15_7_31.nxml.txt.nlp	23947389	SENT93	0	0	6	6	sibutramine	IMPACT	PA451344	55364	0.973
NULL	Diabetologia_2010_Dec_25_53(12)_2646-2655.nxml.txt.nlp	20865240	SENT140	13	13	33	33	sulodexide	DM2	PA164746343	28508	0.973
NULL	Core_Evid_2010_Oct_21_5_61-76.nxml.txt.nlp	21042543	SENT189	6	6	31	31	cetuximab	EGFR	PA10040	1956	0.973
NULL	J_Cell_Sci_2012_Sep_15_125(18)_4297-4305.nxml.txt.nlp	22718348	SENT313	13	13	1	1	geldanamycin	Hsp90	PA152031327	3320	0.973
NULL	Cancer_Imaging_2011_Mar_1_11(1)_1-8.nxml.txt.nlp	21362586	SENT71	30	30	2	2	paclitaxel	P-gp	PA450761	5243	0.973
NULL	Oncol_Rep_2012_Apr_30_27(4)_923-928.nxml.txt.nlp	22209766	SENT92	7	7	1	1	erlotinib	EGFR	PA134687924	1956	0.973
NULL	Cancer_Cell_Int_2013_Feb_12_13_14.nxml.txt.nlp	23402310	SENT183	36	36	1	1	celecoxib	Bcl-2	PA448871	596	0.973
NULL	Cell_Commun_Signal_2013_Nov_5_11_83.nxml.txt.nlp	24192293	SENT91	16	16	30	30	doxycycline	IL-6	PA449415	3569	0.973
NULL	J_Gynecol_Oncol_2013_Jul_4_24(3)_265-272.nxml.txt.nlp	23875077	SENT152	0	0	14	14	thrombin	ZEB1	PA451674	6935	0.973
NULL	J_Headache_Pain_2013_Mar_12_14(1)_25.nxml.txt.nlp	23566208	SENT29	27	27	7	7	topiramate	LEP	PA451728	3952	0.973
NULL	Int_J_Biol_Sci_2012_Sep_6_8(8)_1109-1120.nxml.txt.nlp	22991499	SENT158	5	5	31	31	l-arginine	IFN	PA448478	3439	0.973
NULL	J_Cancer_2013_Nov_23_4(9)_736-754.nxml.txt.nlp	24312144	SENT93	13	13	23	23	erlotinib	EGFR	PA134687924	1956	0.973
NULL	Breast_Cancer_Res_2004_Aug_5_6(5)_R601-R607.nxml.txt.nlp	15318941	SENT131	16	16	10	10	vincristine	p27	PA451879	5715;10534	0.973
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT4005	21	21	31	31	collagenase	ECM	PA449107	22915	0.973
NULL	Front_Pharmacol_2014_May_5_5_94.nxml.txt.nlp	24847266	SENT270	4	4	15	15	probucol	HO-1	PA451107	3162	0.973
NULL	J_Antimicrob_Chemother_2011_Jun_25_66(6)_1332-1339.nxml.txt.nlp	21441248	SENT6	0	0	4	4	nevirapine	CYP2B6	PA450616	1555	0.973
NULL	Core_Evid_2011_Feb_8_6_23-29.nxml.txt.nlp	21468240	SENT30	0	0	11	11	plerixafor	CXCR4	PA165958410	7852	0.973
NULL	Carcinogenesis_2012_Mar_12_33(3)_581-586.nxml.txt.nlp	22166496	SENT34	17	17	1	1	cisplatin	ERCC1	PA449014	2067	0.973
NULL	Mol_Brain_2013_Nov_13_6_47.nxml.txt.nlp	24284042	SENT288	3	3	31	31	trypsin	Alix	PA451806	10015	0.973
NULL	Oncogene_2013_Sep_26_32(39)_10_1038_onc_2012_491.nxml.txt.nlp	23108394	SENT103	27	27	10	10	epirubicin	FOXM1	PA449476	2305	0.973
NULL	Cardiol_Res_Pract_2011_May_10_2011_816897.nxml.txt.nlp	21629798	SENT100	0	0	9	9	sunitinib	CYP3A4	PA162372840	1576	0.973
NULL	J_Hematol_Oncol_2009_Jan_21_2_2.nxml.txt.nlp	19159467	SENT269	17	17	0	0	bevacizumab	VEGF-A	PA130232992	7422	0.973
NULL	Open_Access_J_Urol_2010_Mar_12_2_35-40.nxml.txt.nlp	24198612	SENT72	5	5	22	22	sorafenib	FLT3	PA7000	2322	0.973
NULL	Neural_Regen_Res_2013_Jul_15_8(20)_1853-1862.nxml.txt.nlp	25206494	SENT168	25	25	9	9	ethanol	JNK	PA448073	5599	0.973
NULL	BMB_Rep_2014_Nov_47(11)_649-654.nxml.txt.nlp	25301019	SENT5	5	5	23	23	l-alanine	p38	PA448055	10598;1432;7965	0.973
NULL	J_Oncol_2009_Jul_14_2009_896407.nxml.txt.nlp	19636423	SENT222	21	21	11	11	cetuximab	EGFR	PA10040	1956	0.973
NULL	Oxid_Med_Cell_Longev_2014_Apr_30_2014_149627.nxml.txt.nlp	24876909	SENT221	0	0	8	8	ethanol	Hsp90	PA448073	3320	0.973
NULL	Genome_Biol_2004_Jun_24_5(7)_332.nxml.txt.nlp	15239827	SENT46	4	4	17	17	celecoxib	LKB1	PA448871	6794	0.973
NULL	Oncol_Lett_2013_Mar_11_5(3)_1010-1016.nxml.txt.nlp	23426784	SENT179	3	3	9	9	midazolam	TRPM7	PA450496	54822	0.973
NULL	Acta_Pharmacol_Sin_2011_Sep_15_32(9)_1148-1158.nxml.txt.nlp	21841814	SENT29	15	15	12	12	rimonabant	CB1	PA152407999	1268	0.973
NULL	Nat_Commun_2014_Aug_6_5_4602.nxml.txt.nlp	25098764	SENT652	10	10	4	4	trypsin	TRAF2	PA451806	7186	0.973
NULL	Ann_Surg_Oncol_2011_Oct_17_18(11)_3072-3078.nxml.txt.nlp	21847700	SENT97	21	21	32	32	trastuzumab	HER2	PA451743	2064	0.973
NULL	Clin_Mol_Allergy_2007_Jan_25_5_1.nxml.txt.nlp	17254346	SENT216	26	26	8	8	curcumin	OAT	PA151958596	4942	0.973
NULL	Patient_Prefer_Adherence_2011_Dec_23_6_1-9.nxml.txt.nlp	22272064	SENT36	32	32	20	20	lisinopril	ACE	PA450242	1636	0.973
NULL	Exp_Diabetes_Res_2012_Nov_1_2012_892706.nxml.txt.nlp	23197976	SENT186	34	34	4	4	vildagliptin	HIF-1	PA165958346	29072	0.973
NULL	Br_J_Cancer_2013_Jun_25_108(12)_2485-2494.nxml.txt.nlp	23695022	SENT165	0	0	12	12	propranolol	HIF-1	PA451145	29072	0.973
NULL	Oncoimmunology_2014_Jan_17_3_e27574.nxml.txt.nlp	24800167	SENT21	10	10	46	46	cyclophosphamide	IL-23	PA449165	51561	0.973
NULL	Case_Rep_Hematol_2014_Dec_7_2014_208597.nxml.txt.nlp	25544909	SENT103	7	7	17	17	cyclophosphamide	VIII	PA449165	1351	0.973
NULL	Mol_Cancer_2009_Nov_10_8_99.nxml.txt.nlp	19903356	SENT112	9	9	5	5	imatinib	IGFBP3	PA10804	3486	0.973
NULL	Int_J_Biol_Sci_2011_Nov_5_8(1)_1-14.nxml.txt.nlp	22211100	SENT190	7	7	25	25	evodiamine	PTEN	PA165860788	5728	0.973
NULL	Diabetes_Metab_Syndr_Obes_2010_Oct_27_3_363-372.nxml.txt.nlp	21437106	SENT51	4	4	11	11	sitagliptin	GLP-1	PA164748978	100125288	0.973
NULL	Br_J_Pharmacol_2012_Apr_165(8)_2611-2619.nxml.txt.nlp	21718301	SENT182	29	29	4	4	rimonabant	GPR55	PA152407999	9290	0.973
NULL	Oncogene_2014_Jul_24_33(30)_3927-3938.nxml.txt.nlp	23995784	SENT252	32	32	14	14	doxycycline	FOXO1	PA449415	2308	0.973
NULL	Oxid_Med_Cell_Longev_2012_May_30_2012_452902.nxml.txt.nlp	22701146	SENT184	19	19	11	11	doxorubicin	OCTN2	PA449412	6584	0.973
NULL	Indian_J_Pharmacol_2012_Sep-Oct_44(5)_624-628.nxml.txt.nlp	23112426	SENT22	17	17	23	23	nimodipine	P-gp	PA450633	5243	0.973
NULL	Ann_Indian_Acad_Neurol_2011_Jan-Mar_14(1)_50-52.nxml.txt.nlp	21655207	SENT17	14	14	8	8	modafinil	KLS	PA450530	6199	0.973
NULL	Diabetes_Care_2010_Nov_33(11)_2484-2485.nxml.txt.nlp	20980428	SENT38	0	0	7	7	ranibizumab	VEGF-A	PA164746012	7422	0.973
NULL	Arthritis_Res_Ther_2012_Nov_30_14(6)_225.nxml.txt.nlp	23198865	SENT212	0	0	17	17	teriparatide	PTH	PA451620	5741	0.973
NULL	Curr_Neuropharmacol_2007_Dec_5(4)_224-231.nxml.txt.nlp	19305739	SENT191	0	0	5	5	metoclopramide	5-HT4	PA450475	3360	0.973
NULL	Evid_Based_Complement_Alternat_Med_2012_May_22_2012_539475.nxml.txt.nlp	22675383	SENT187	0	0	5	5	indomethacin	COX	PA449982	1351	0.973
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT120	29	29	36	36	pp2	PP2		4888	0.973
NULL	J_Cell_Mol_Med_2014_Aug_6_18(8)_1519-1539.nxml.txt.nlp	25100284	SENT21	0	0	15	15	gefitinib	EGFR	PA131301952	1956	0.973
NULL	Arthritis_Res_Ther_2009_Aug_28_11(4)_R131.nxml.txt.nlp	19715572	SENT132	9	9	26	26	rituximab	CD19	PA451261	930	0.973
NULL	Front_Chem_2014_Dec_23_2_113.nxml.txt.nlp	25566531	SENT160	27	27	14	14	curcumin	GSTT1	PA151958596	2952	0.973
NULL	Nat_Med_2010_Feb_24_16(2)_214-218.nxml.txt.nlp	20098429	SENT57	41	41	4	4	cisplatin	LAPTM4B	PA449014	55353	0.973
NULL	Biomed_Res_Int_2014_Feb_27_2014_897653.nxml.txt.nlp	24719894	SENT61	33	33	13	13	risperidone	ADRB1	PA451257	153	0.973
NULL	Exp_Hematol_Oncol_2013_Sep_5_2_24.nxml.txt.nlp	24007855	SENT33	30	30	3	3	imatinib	JAK2	PA10804	3717	0.973
NULL	Clin_Ophthalmol_2008_Jun_2(2)_377-388.nxml.txt.nlp	19668729	SENT172	0	0	25	25	vatalanib	VEGFR1	PA7001	2321	0.973
NULL	Cardiovasc_Diabetol_2013_Mar_23_12_48.nxml.txt.nlp	23522121	SENT190	13	13	3	3	metformin	NNT	PA450395	23530	0.973
NULL	Diabetes_Care_2010_Jul_31_33(7)_1607-1609.nxml.txt.nlp	20357375	SENT53	6	6	37	37	sitagliptin	CD34	PA164748978	947	0.973
NULL	Int_J_Biol_Sci_2013_Mar_7_9(3)_279-288.nxml.txt.nlp	23493630	SENT51	12	12	22	22	tocilizumab	CD4	PA165292659	920	0.973
NULL	Ecancermedicalscience_2009_Oct_29_3_157.nxml.txt.nlp	22276018	SENT71	6	6	35	35	tamoxifen	EGFR	PA451581	1956	0.973
NULL	Mol_Cancer_2010_Nov_2_9_289.nxml.txt.nlp	21044322	SENT149	32	32	19	19	docetaxel	RGS17	PA449383	26575	0.973
NULL	Cancer_Med_2013_Feb_3_2(1)_76-85.nxml.txt.nlp	24133630	SENT199	19	19	17	17	vemurafenib	BRAF	PA165946873	673	0.973
NULL	J_Cell_Biol_2005_Nov_21_171(4)_651-661.nxml.txt.nlp	16301331	SENT93	24	24	3	3	flutamide	Cbl-b	PA449685	868	0.973
NULL	Ann_Med_2011_Nov_5_43(7)_531-544.nxml.txt.nlp	21815879	SENT60	0	0	16	16	ticlopidine	ADP	PA451686	23038	0.973
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT10	7	7	14	14	perifosine	JNK	PA165291471	5599	0.973
NULL	Sci_Rep_2014_Dec_12_4_7465.nxml.txt.nlp	25501874	SENT201	12	12	6	6	tetracycline	EPAS1	PA451640	2034	0.973
NULL	Bioinformation_2011_Sep_28_7(3)_130-133.nxml.txt.nlp	22125383	SENT48	13	13	26	26	tioconazole	PLP1	PA164746156	5354	0.973
NULL	Cell_Oncol_(Dordr)_2011_Oct_4_34(5)_489-494.nxml.txt.nlp	21541733	SENT33	44	44	7	7	tamoxifen	ESR1	PA451581	2099	0.973
NULL	Br_J_Pharmacol_2014_Feb_24_171(1)_1019-1032.nxml.txt.nlp	24251620	SENT177	21	21	3	3	nimodipine	TRPM3	PA450633	80036	0.973
NULL	J_Cell_Mol_Med_2013_Dec_6_17(12)_1588-1597.nxml.txt.nlp	24199964	SENT166	23	23	35	35	doxycycline	APT	PA449415	653639	0.973
NULL	Breast_Cancer_Res_2011_Mar_11_13(2)_R30.nxml.txt.nlp	21396117	SENT317	19	19	17	17	gefitinib	EGF	PA131301952	1950	0.973
NULL	Acta_Pharmacol_Sin_2012_May_26_33(5)_675-681.nxml.txt.nlp	22447226	SENT17	5	5	26	26	gefitinib	SKP2	PA131301952	6502	0.973
NULL	Mol_Cancer_2008_Nov_24_7_87.nxml.txt.nlp	19025616	SENT297	22	22	2	2	cyclophosphamide	ALDH3A1	PA449165	218	0.973
NULL	Oncotarget_2014_Oct_18_5(22)_11564-11575.nxml.txt.nlp	25344919	SENT44	11	11	41	41	paclitaxel	P14	PA450761	11102;;6280;56259	0.973
NULL	Psychiatry_Investig_2011_Dec_8_8(4)_372-376.nxml.txt.nlp	22216049	SENT63	26	26	12	12	clozapine	c-fos	PA449061	2353	0.973
NULL	Breast_Cancer_Res_2009_Jun_29_11(3)_R41.nxml.txt.nlp	19563669	SENT154	12	12	16	16	gefitinib	EGFR	PA131301952	1956	0.973
NULL	Oncol_Rep_2012_Apr_30_27(4)_923-928.nxml.txt.nlp	22209766	SENT139	5	5	25	25	erlotinib	PI3K	PA134687924	5290	0.973
NULL	Indian_J_Endocrinol_Metab_2013_Jul-Aug_17(4)_636-646.nxml.txt.nlp	23961479	SENT153	1	1	10	10	fluvastatin	CYP2C9	PA449688	1559	0.973
NULL	Cancers_(Basel)_2012_Jun_18_4(2)_581-600.nxml.txt.nlp	24213326	SENT706	14	14	2	2	cyclophosphamide	CD25	PA449165	3669;3559	0.973
NULL	Exp_Brain_Res_2014_Jun_27_232(8)_2637-2644.nxml.txt.nlp	24969614	SENT140	24	24	10	10	ondansetron	NK1	PA450705	11126	0.973
NULL	Cardiol_Res_Pract_2012_Jun_19_2012_584236.nxml.txt.nlp	22779023	SENT66	18	18	4	4	heparin	ACT	PA449855	12;11332;9457;641455	0.973
NULL	J_Breast_Cancer_2014_Sep_30_17(3)_189-199.nxml.txt.nlp	25320616	SENT103	7	7	19	19	tamoxifen	aromatase	PA451581	1588	0.973
NULL	Biomed_Res_Int_2014_Feb_6_2014_323594.nxml.txt.nlp	24689036	SENT87	44	44	0	0	raloxifene	PC3	PA451221	57332;7832;5122	0.973
NULL	Exp_Ther_Med_2012_Sep_15_4(3)_381-386.nxml.txt.nlp	23181103	SENT24	0	0	39	39	sorafenib	SHARP	PA7000	23013	0.973
NULL	BMJ_2010_Feb_8_340_c693.nxml.txt.nlp	20142325	SENT150	2	2	8	8	paroxetine	CYP2D6	PA450801	1565	0.973
NULL	Breast_Cancer_Res_2012_Aug_8_14(4)_R116.nxml.txt.nlp	22873525	SENT240	5	5	19	19	trastuzumab	HER2	PA451743	2064	0.973
NULL	Front_Genet_2014_Aug_7_5_224.nxml.txt.nlp	25147554	SENT196	7	7	20	20	ethanol	MDM2	PA448073	4193	0.973
NULL	Int_J_Breast_Cancer_2011_Jul_3_2011_912102.nxml.txt.nlp	22295238	SENT21	13	13	26	26	fulvestrant	aromatase	PA164747170	1588	0.973
NULL	Cell_Commun_Signal_2013_Jul_4_11_47.nxml.txt.nlp	23826796	SENT172	15	15	3	3	forskolin	CC2D1A	PA146096022	54862	0.973
NULL	Anat_Cell_Biol_2011_Sep_29_44(3)_169-175.nxml.txt.nlp	22025968	SENT75	34	34	6	6	ethanol	CLU	PA448073	1191	0.973
NULL	Br_J_Cancer_2003_Jun_16_88(12)_1963-1970.nxml.txt.nlp	12799644	SENT110	24	24	6	6	gemcitabine	MRP1	PA449748	4437	0.973
NULL	J_Mol_Signal_2008_Dec_1_3_18.nxml.txt.nlp	19046439	SENT169	8	8	18	18	metformin	LKB1	PA450395	6794	0.973
NULL	Case_Rep_Med_2009_Sep_8_2009_307894.nxml.txt.nlp	19746202	SENT61	6	6	16	16	trastuzumab	HER2	PA451743	2064	0.973
NULL	Breast_Cancer_Res_Treat_2007_Oct_27_105(Suppl_1)_19-29.nxml.txt.nlp	17333340	SENT184	2	2	6	6	letrozole	aromatase	PA450196	1588	0.973
NULL	Indian_J_Nephrol_2013_Nov-Dec_23(6)_413-414.nxml.txt.nlp	24339517	SENT16	25	25	21	21	cyclosporine	IL2RA	PA449167	3559	0.973
NULL	Acta_Neuropathol_Commun_2014_May_30_2_57.nxml.txt.nlp	24887326	SENT186	21	21	13	13	etoposide	MED1	PA449552	5469;8930	0.973
NULL	Mol_Cancer_2010_Mar_25_9_68.nxml.txt.nlp	20338046	SENT16	23	23	9	9	doxorubicin	ABCB1	PA449412	5243	0.973
NULL	Scientifica_(Cairo)_2012_Nov_25_2012_473829.nxml.txt.nlp	24278698	SENT238	21	21	5	5	cisplatin	ATP7B	PA449014	540	0.973
NULL	Hum_Genomics_2009_Jan_1_3(2)_128-142.nxml.txt.nlp	19164090	SENT248	20	20	8	8	methotrexate	CD44	PA450428	960	0.973
NULL	Apoptosis_2014_Apr_23_19(7)_1055-1068.nxml.txt.nlp	24756955	SENT166	16	16	29	29	nutlin-3	p53		7157	0.973
NULL	Int_J_Cell_Biol_2014_Nov_17_2014_280638.nxml.txt.nlp	25477962	SENT272	10	10	1	1	paclitaxel	CDK2	PA450761	1017	0.973
NULL	Clin_Ophthalmol_2012_May_30_6_837-844.nxml.txt.nlp	22701085	SENT76	31	31	13	13	ranibizumab	VEGF-A	PA164746012	7422	0.973
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1145.nxml.txt.nlp	24675463	SENT97	12	12	26	26	erlotinib	ERK1	PA134687924	5595	0.973
NULL	J_Obes_2011_Feb_8_2011_636181.nxml.txt.nlp	21331293	SENT192	0	0	6	6	exenatide	GLP-1	PA164749238	100125288	0.973
NULL	Diabetes_Care_2008_Jul_31(7)_1427-1432.nxml.txt.nlp	18390799	SENT16	11	11	0	0	metformin	RBP4	PA450395	5433;5950	0.973
NULL	Hum_Genomics_2008_Sep_1_3(1)_7-16.nxml.txt.nlp	19129086	SENT171	22	22	2	2	pravastatin	SLCO1B1	PA451089	10599	0.973
NULL	Br_J_Anaesth_2014_Jul_22_113(1)_157-167.nxml.txt.nlp	24154701	SENT266	5	5	17	17	sevoflurane	TREK-1	PA451341	3776	0.973
NULL	Br_J_Cancer_2009_Oct_6_101(7)_1155-1161.nxml.txt.nlp	19738614	SENT107	14	14	3	3	gemcitabine	MUC4	PA449748	4585	0.973
NULL	Case_Rep_Oncol_Med_2012_Nov_6_2012_164082.nxml.txt.nlp	23198199	SENT70	6	6	14	14	rituximab	ACTH	PA451261	5443	0.973
NULL	Breast_Cancer_Res_2012_Apr_4_14(2)_R57.nxml.txt.nlp	22475046	SENT21	5	5	3	3	anastrozole	aromatase	PA448432	1588	0.973
NULL	Cell_Death_Dis_2014_Mar_13_5(3)_e1118.nxml.txt.nlp	24625977	SENT80	40	40	5	5	etoposide	UBXN2A	PA449552	165324	0.973
NULL	J_Cell_Biol_1998_Jan_26_140(2)_283-293.nxml.txt.nlp	9442104	SENT188	24	24	12	12	galactose	CLN1	PA449725	5538	0.973
NULL	J_Carcinog_2011_Dec_22_10_35.nxml.txt.nlp	22279420	SENT132	29	29	4	4	tamoxifen	AIB1	PA451581	8202	0.973
NULL	Anticancer_Agents_Med_Chem_2010_Oct_10(8)_617-624.nxml.txt.nlp	21182469	SENT56	23	23	3	3	tamoxifen	ABCC11	PA451581	85320	0.973
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1137-1144.nxml.txt.nlp	20234366	SENT31	40	40	32	32	cetuximab	KRAS	PA10040	3845	0.973
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT55	14	14	25	25	curcumin	TRAIL	PA151958596	8743	0.973
NULL	Antiviral_Res_2009_May_82(2)_A99-A109.nxml.txt.nlp	19176219	SENT180	7	7	13	13	zalcitabine	OCT2	PA451950	6582;5452	0.973
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2011_Mar_14_4_13-24.nxml.txt.nlp	22879790	SENT73	15	15	0	0	liraglutide	PPG	PA165958364	5552	0.973
NULL	Ann_Med_2014_Nov_21_46(7)_475-489.nxml.txt.nlp	25045928	SENT450	18	18	12	12	clopidogrel	P2Y12	PA449053	64805	0.973
NULL	Blood_Res_2013_Sep_25_48(3)_171-177.nxml.txt.nlp	24086936	SENT135	3	3	9	9	bortezomib	CHOP	PA10252	1649	0.973
NULL	Br_J_Cancer_2004_Mar_5_90(Suppl_1)_S7-S10.nxml.txt.nlp	15094758	SENT94	14	14	19	19	fulvestrant	CYP3A4	PA164747170	1576	0.973
NULL	Adv_Urol_2011_Oct_20_2011_854792.nxml.txt.nlp	22046183	SENT157	32	32	23	23	estradiol	aromatase	PA449503	1588	0.973
NULL	Cent_European_J_Urol_2011_Dec_9_64(4)_256-257.nxml.txt.nlp	24578906	SENT13	24	24	2	2	doxazosin	CD133	PA449407	8842	0.973
NULL	Oncogene_2009_Dec_3_28(48)_4237-4248.nxml.txt.nlp	19734937	SENT119	34	34	19	19	thrombin	PAR-1	PA451674	2011;2149	0.973
NULL	Mol_Cancer_2010_Apr_21_9_83.nxml.txt.nlp	20409325	SENT191	10	10	31	31	paclitaxel	AKT	PA450761	207	0.973
NULL	Endocr_Relat_Cancer_2014_Apr_21(2)_311-326.nxml.txt.nlp	24478054	SENT165	28	28	11	11	denosumab	SYP	PA166048634	6855	0.973
NULL	World_Allergy_Organ_J_2012_Feb_17_5(Suppl_2)_S137a.nxml.txt.nlp	NULL	SENT20	13	13	0	0	benzydamine	DPT	PA134687812	1805	0.973
NULL	Neuropsychopharmacology_2009_Nov_5_34(12)_2560-2573.nxml.txt.nlp	19657330	SENT100	5	5	26	26	ethanol	ANOVA	PA448073	4858	0.973
NULL	Mol_Cancer_2012_Aug_8_11_53.nxml.txt.nlp	22871047	SENT115	9	9	2	2	paclitaxel	ES2	PA450761	8220	0.973
NULL	Indian_J_Pharm_Sci_2008_Mar-Apr_70(2)_251-255.nxml.txt.nlp	20046726	SENT10	2	2	10	10	fluoxetine	TLC	PA449673	3933	0.973
NULL	Int_J_Biol_Sci_2014_Nov_26_10(10)_1193-1202.nxml.txt.nlp	25516717	SENT138	15	15	8	8	hydroxyurea	CHK1	PA449942	1111	0.973
NULL	Anemia_2012_Aug_12_2012_297641.nxml.txt.nlp	22924125	SENT103	12	12	5	5	deferasirox	EOS	PA164760843	260429	0.973
NULL	Clinics_(Sao_Paulo)_2011_Dec_66(12)_2151-2157.nxml.txt.nlp	22189743	SENT53	1	1	42	42	icodextrin	AQP1	PA164743096	358	0.973
NULL	J_Cell_Mol_Med_2014_Mar_10_18(3)_514-529.nxml.txt.nlp	24410795	SENT233	27	27	36	36	resveratrol	SIRT1		23411	0.973
NULL	Cancer_Res_Treat_2013_Sep_30_45(3)_172-177.nxml.txt.nlp	24155675	SENT112	0	0	18	18	aprepitant	NK-1	PA164747039	27087	0.973
NULL	Oncotarget_2014_Nov_3_5(20)_10127-10139.nxml.txt.nlp	25333256	SENT201	7	7	19	19	vemurafenib	TRIM16	PA165946873	10626	0.973
NULL	J_Med_Case_Reports_2011_Sep_19_5_465.nxml.txt.nlp	21929779	SENT69	24	24	6	6	lopinavir	CD4	PA450264	920	0.973
NULL	Arch_Med_Sci_2011_Oct_8_7(5)_864-869.nxml.txt.nlp	22291833	SENT32	21	21	1	1	sparteine	CYP2D6	PA452610	1565	0.973
NULL	Breast_Cancer_Res_2011_Feb_3_13(1)_R16.nxml.txt.nlp	21291529	SENT116	12	12	4	4	epirubicin	PHD3	PA449476	112399	0.973
NULL	Br_J_Cancer_2010_Jan_5_102(1)_104-114.nxml.txt.nlp	20051961	SENT161	17	17	9	9	tamoxifen	PDK1	PA451581	5170;5163	0.973
NULL	Br_J_Cancer_2010_Jul_27_103(3)_401-410.nxml.txt.nlp	20628393	SENT150	14	14	7	7	trastuzumab	C35	PA451743	84299	0.973
NULL	Sensors_(Basel)_2012_Dec_28_13(1)_484-499.nxml.txt.nlp	23275084	SENT4	7	7	25	25	fluorescein	HEMA	PA164746009	2157	0.973
NULL	Int_J_Endocrinol_2011_Mar_6_2011_415719.nxml.txt.nlp	21461394	SENT123	48	48	34	34	cinacalcet	MEN1	PA164776671	4221	0.973
NULL	Int_J_Mol_Sci_2013_Aug_14_14(8)_16732-16801.nxml.txt.nlp	23949635	SENT195	9	9	40	40	estradiol	StAR	PA449503	6770	0.973
NULL	J_Cell_Mol_Med_2014_Oct_11_18(10)_2031-2043.nxml.txt.nlp	25109475	SENT141	0	0	21	21	valsartan	LKB1	PA451848	6794	0.973
NULL	Oncogene_2013_Sep_26_32(39)_10_1038_onc_2012_491.nxml.txt.nlp	23108394	SENT78	28	28	7	7	epirubicin	BRIP1	PA449476	64979;83990	0.973
NULL	Ann_Hematol_2014_Apr_1_93(8)_1371-1380.nxml.txt.nlp	24687382	SENT32	7	7	37	37	lenalidomide	IKZF3	PA162363968	22806	0.973
NULL	Mol_Cancer_2010_May_20_9_115.nxml.txt.nlp	20487546	SENT254	1	1	9	9	fludarabine	SULF2	PA449655	55959	0.973
NULL	Diabetes_2011_Jul_20_60(7)_1990-1999.nxml.txt.nlp	21617181	SENT125	21	21	19	19	geldanamycin	Hsp90	PA152031327	3320	0.973
NULL	Biomed_Res_Int_2013_Aug_6_2013_602987.nxml.txt.nlp	24027759	SENT308	26	26	6	6	doxorubicin	SMF	PA449412	22993	0.973
NULL	Biomed_Res_Int_2014_Aug_6_2014_967826.nxml.txt.nlp	25165721	SENT165	3	3	8	8	cisplatin	p38	PA449014	10598;1432;7965	0.973
NULL	Diabetes_Care_2010_Apr_12_33(4)_826-832.nxml.txt.nlp	20067954	SENT33	0	0	12	12	daclizumab	CD25	PA164764446	3669;3559	0.973
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT596	41	41	4	4	metformin	OCT1	PA450395	5451;6580	0.973
NULL	Diabetes_2011_Jan_7_60(1)_157-167.nxml.txt.nlp	20929977	SENT38	26	26	8	8	resveratrol	SIRT1		23411	0.973
NULL	Patient_Prefer_Adherence_2011_Dec_23_6_1-9.nxml.txt.nlp	22272064	SENT11	17	17	2	2	telmisartan	ACE	PA451605	1636	0.973
NULL	Small_GTPases_2012_Jan_1_3(1)_34-39.nxml.txt.nlp	22714415	SENT8	18	18	32	32	cetuximab	KRAS	PA10040	3845	0.973
NULL	Front_Genet_2014_Jul_25_5_242.nxml.txt.nlp	25120559	SENT293	5	5	15	15	dextran	NLRP3	PA449261	114548	0.973
NULL	Oncotarget_2012_Sep_28_3(10)_1169-1181.nxml.txt.nlp	23045411	SENT185	30	30	15	15	doxorubicin	p53	PA449412	7157	0.973
NULL	Drugs_2014_Oct_10_74(17)_2015-2032.nxml.txt.nlp	25300410	SENT60	1	1	10	10	verapamil	P-gp	PA451868	5243	0.973
NULL	Oncotarget_2014_Aug_27_5(17)_7328-7341.nxml.txt.nlp	25193862	SENT134	31	31	4	4	dasatinib	EGFR	PA162372878	1956	0.973
NULL	J_Cell_Mol_Med_2014_Aug_1_18(8)_1599-1611.nxml.txt.nlp	24889822	SENT189	15	15	4	4	resveratrol	SIRT1		23411	0.973
NULL	Mol_Cancer_2009_Nov_24_8_109.nxml.txt.nlp	19930708	SENT208	15	15	8	8	exemestane	aromatase	PA449563	1588	0.973
NULL	Clin_Drug_Investig_2012_Dec_13_32(8)_e1-e15.nxml.txt.nlp	22712629	SENT24	11	11	14	14	quinidine	CYP2D6	PA451209	1565	0.973
NULL	Arthritis_Res_Ther_2013_Mar_25_15(Suppl_1)_S3.nxml.txt.nlp	23566754	SENT98	5	5	19	19	rituximab	CD27	PA451261	939	0.973
NULL	Int_J_Inflam_2011_Sep_18_2011_535241.nxml.txt.nlp	21941677	SENT166	8	8	0	0	hyaluronan	CD44	PA165958431	960	0.973
NULL	Mol_Cancer_2010_May_30_9_131.nxml.txt.nlp	20509970	SENT76	9	9	14	14	colchicine	C11	PA449092	1109	0.973
NULL	Mol_Cell_Biochem_2015_Oct_8_398(1-2)_165-173.nxml.txt.nlp	25292312	SENT188	5	5	26	26	bortezomib	BIK	PA10252	638	0.973
NULL	Scientifica_(Cairo)_2013_Dec_10_2013_691251.nxml.txt.nlp	24386592	SENT194	9	9	19	19	epirubicin	SIRT6	PA449476	51548	0.973
NULL	Arthritis_Res_Ther_2006_May_5_8(3)_R83.nxml.txt.nlp	16677395	SENT165	15	15	29	29	rituximab	CD4	PA451261	920	0.973
NULL	Clin_Interv_Aging_2013_Jul_16_8_889-897.nxml.txt.nlp	23898224	SENT20	38	38	23	23	gemcitabine	SIRT1	PA449748	23411	0.973
NULL	Breast_Cancer_Res_2011_Jun_21_13(3)_R66.nxml.txt.nlp	21693010	SENT127	9	9	31	31	sunitinib	VEGF-D	PA162372840	2277	0.973
NULL	Comput_Math_Methods_Med_2014_Oct_13_2014_867289.nxml.txt.nlp	25371703	SENT16	6	6	24	24	vorinostat	HDAC	PA164748224	9734	0.973
NULL	Biochem_Res_Int_2010_Aug_4_2010_549572.nxml.txt.nlp	21188077	SENT150	27	27	14	14	l-valine	TAT	PA451843	6898	0.973
NULL	Drugs_R_D_2014_Jun_6_14(2)_113-123.nxml.txt.nlp	24797400	SENT236	11	11	3	3	dabigatran	P-gp		5243	0.973
NULL	Acta_Pharmacol_Sin_2014_Jun_4_35(6)_792-805.nxml.txt.nlp	24902787	SENT208	0	0	7	7	paroxetine	CYP2D6	PA450801	1565	0.973
NULL	Anat_Cell_Biol_2011_Mar_31_44(1)_14-24.nxml.txt.nlp	21519545	SENT109	38	38	15	15	cyclophosphamide	CK8	PA449165	3856	0.973
NULL	Arthritis_Res_Ther_2008_Mar_17_10(2)_R33.nxml.txt.nlp	18346273	SENT19	14	14	1	1	infliximab	HMGB1	PA452639	3146	0.973
NULL	Exp_Cell_Res_2009_Nov_15_315(19)_3433-3441.nxml.txt.nlp	19716819	SENT187	38	38	9	9	hyaluronidase	CD44	PA164745713	960	0.973
NULL	F1000Res_2014_Aug_19_3_198.nxml.txt.nlp	25400908	SENT291	0	0	18	18	pertuzumab	HER2		2064	0.973
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT473	30	30	0	0	iloperidone	PRL	PA161199368	5617	0.973
NULL	Sci_Rep_2015_Jan_6_5_7642.nxml.txt.nlp	25560837	SENT137	15	15	6	6	sr144528	CB2		1269	0.973
NULL	Curr_Rheumatol_Rep_2011_Jun_2_13(3)_233-240.nxml.txt.nlp	21365209	SENT142	23	23	0	0	ibandronate	Men	PA10270	8178	0.973
NULL	Biochem_Res_Int_2011_Nov_30_2011_850924.nxml.txt.nlp	21151514	SENT163	3	3	23	23	l-cysteine	NifS	PA449173	9054	0.973
NULL	Int_J_Biol_Sci_2011_Nov_5_8(1)_1-14.nxml.txt.nlp	22211100	SENT178	24	24	8	8	gemcitabine	PI3K	PA449748	5290	0.973
NULL	Eur_J_Clin_Pharmacol_2014_Oct_8_70(1)_37-45.nxml.txt.nlp	24100471	SENT203	0	0	27	27	rosuvastatin	OAT3	PA134308647	9376	0.973
NULL	JAKSTAT_2013_Jul_1_2(3)_e24574.nxml.txt.nlp	24069558	SENT150	20	20	3	3	doxycycline	HEK	PA449415	2042	0.973
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_May_12_68(Pt_6)_o1668.nxml.txt.nlp	22719463	SENT67	7	7	15	15	ethanol	mol	PA448073	90527	0.973
NULL	Cancer_Cell_Int_2013_Mar_4_13_21.nxml.txt.nlp	23497288	SENT66	4	4	15	15	doxorubicin	EWS	PA449412	2130	0.973
NULL	Int_J_Chron_Obstruct_Pulmon_Dis_2007_Jun_2(2)_121-129.nxml.txt.nlp	18044684	SENT56	23	23	8	8	roflumilast	IL-8	PA165948052	3576	0.973
NULL	Biologics_2009_Oct_12_3_469-474.nxml.txt.nlp	19851472	SENT80	42	42	20	20	mometasone	IFN	PA450541	3439	0.973
NULL	Front_Oncol_2014_May_16_4_108.nxml.txt.nlp	24904824	SENT62	35	35	22	22	sirolimus	IL-7	PA451365	3574	0.973
NULL	Br_J_Cancer_2014_May_27_110(11)_2716-2727.nxml.txt.nlp	24800946	SENT28	31	31	6	6	cetuximab	EREG	PA10040	2069	0.973
NULL	Adv_Ther_2014_Jan_30_31(2)_202-216.nxml.txt.nlp	24477354	SENT30	18	18	2	2	liraglutide	GLP-1	PA165958364	100125288	0.973
NULL	Acta_Pharmacol_Sin_2014_Aug_21_35(8)_1082-1092.nxml.txt.nlp	25047514	SENT145	11	11	25	25	letrozole	aromatase	PA450196	1588	0.973
NULL	J_Oncol_2013_Apr_29_2013_854121.nxml.txt.nlp	23737784	SENT22	14	14	29	29	trastuzumab	HER2	PA451743	2064	0.973
NULL	Curr_Oncol_2009_Jul_16(Suppl_2)_S1-S13.nxml.txt.nlp	19672416	SENT72	14	14	23	23	exemestane	aromatase	PA449563	1588	0.973
NULL	J_Invest_Dermatol_2012_Jan_18_132(1)_163-169.nxml.txt.nlp	21850019	SENT51	31	31	10	10	imiquimod	CD4	PA449972	920	0.973
NULL	Oncotarget_2013_Nov_24_4(12)_2430-2438.nxml.txt.nlp	24280348	SENT78	40	40	18	18	gefitinib	STAT3	PA131301952	6774	0.973
NULL	Epilepsia_2012_Jun_21_53(Suppl_1)_18-25.nxml.txt.nlp	22612805	SENT41	19	19	15	15	bumetanide	NKCC1	PA448682	6558	0.973
NULL	Ann_Oncol_2011_Mar_8_22(3)_503-514.nxml.txt.nlp	20616198	SENT91	9	9	5	5	tamoxifen	aromatase	PA451581	1588	0.973
NULL	Breast_Cancer_Res_Treat_2007_Oct_27_105(Suppl_1)_19-29.nxml.txt.nlp	17333340	SENT40	8	8	6	6	letrozole	aromatase	PA450196	1588	0.973
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT161	5	5	13	13	ranibizumab	VEGF-A	PA164746012	7422	0.973
NULL	Pharmaceutics_2011_Apr_14_3(2)_171-185.nxml.txt.nlp	24310494	SENT168	16	16	4	4	vincristine	CD19	PA451879	930	0.973
NULL	Clin_Ophthalmol_2008_Jun_2(2)_377-388.nxml.txt.nlp	19668729	SENT172	0	0	30	30	vatalanib	VEGFR2	PA7001	3791	0.973
NULL	Breast_Cancer_Res_2010_Jul_26_12(4)_R55.nxml.txt.nlp	20659323	SENT167	19	19	10	10	doxycycline	MYB	PA449415	4602	0.973
NULL	Front_Behav_Neurosci_2014_Dec_23_8_444.nxml.txt.nlp	25566009	SENT32	8	8	26	26	memantine	spatial	PA10364	219793	0.973
NULL	Ann_Rheum_Dis_2009_Oct_17_68(10)_1580-1584.nxml.txt.nlp	19019888	SENT129	23	23	12	12	tocilizumab	ACR	PA165292659	49	0.973
NULL	Oncotarget_2014_Oct_11_5(20)_10070-10083.nxml.txt.nlp	25301722	SENT181	18	18	6	6	gefitinib	EGFR	PA131301952	1956	0.973
NULL	Mol_Cancer_2013_Mar_5_12_17.nxml.txt.nlp	23497256	SENT157	20	20	4	4	sunitinib	p53	PA162372840	7157	0.973
NULL	Oncogene_2009_Apr_2_28(13)_1616-1625.nxml.txt.nlp	19219073	SENT98	14	14	6	6	nutlin-3	p53		7157	0.973
NULL	Oncotarget_2014_Jun_26_5(14)_5510-5522.nxml.txt.nlp	24980816	SENT232	14	14	8	8	doxycycline	BSP	PA449415	3381	0.973
NULL	ScientificWorldJournal_2014_Jul_23_2014_854093.nxml.txt.nlp	25147870	SENT10	2	2	13	13	copper	gamma	PA449114	9913	0.973
NULL	Cell_Cycle_2012_Jul_1_11(13)_2538-2544.nxml.txt.nlp	22713238	SENT47	12	12	25	25	etoposide	RNF168	PA449552	165918	0.973
NULL	Curr_Pharm_Biotechnol_2012_May_13(6)_969-986.nxml.txt.nlp	22039792	SENT260	3	3	8	8	cimetidine	P-gp	PA449001	5243	0.973
NULL	Oncotarget_2012_May_18_3(5)_525-534.nxml.txt.nlp	22619113	SENT39	21	21	29	29	fludarabine	IL-4	PA449655	3565	0.973
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_P42.nxml.txt.nlp	NULL	SENT17	17	17	7	7	amoxicillin	FasL	PA448406	356	0.973
NULL	Exp_Ther_Med_2014_Nov_29_8(5)_1473-1478.nxml.txt.nlp	25289044	SENT180	10	10	20	20	heparin	AZU	PA449855	566	0.973
NULL	Breast_Cancer_Res_Treat_2013_Apr_12_138(2)_427-435.nxml.txt.nlp	23479422	SENT238	7	7	18	18	paclitaxel	HER2	PA450761	2064	0.973
NULL	J_Neurol_Sci_2012_Nov_15_322(1-2)_92-95.nxml.txt.nlp	22819352	SENT119	17	17	0	0	ethanol	MCP-1	PA448073	6347	0.973
NULL	Cancer_Med_2014_Feb_10_3(1)_134-142.nxml.txt.nlp	24407937	SENT199	13	13	21	21	trastuzumab	HER2	PA451743	2064	0.973
NULL	Breast_Cancer_Res_2010_Oct_22_12(Suppl_2)_S1.nxml.txt.nlp	21050422	SENT170	0	0	6	6	neratinib	HER2	PA165291472	2064	0.973
NULL	J_Hematol_Oncol_2009_Jan_21_2_2.nxml.txt.nlp	19159467	SENT57	41	41	5	5	erlotinib	EGFR	PA134687924	1956	0.973
NULL	Arch_Orthop_Trauma_Surg_2009_Nov_7_129(11)_1495-1504.nxml.txt.nlp	18989686	SENT101	15	15	8	8	vancomycin	VISA	PA451850	57506	0.973
NULL	Evid_Based_Complement_Alternat_Med_2012_Feb_16_2012_430262.nxml.txt.nlp	22454664	SENT123	8	8	18	18	clopidogrel	CYP2C19	PA449053	1557	0.973
NULL	J_Cell_Biol_2008_Jul_28_182(2)_381-393.nxml.txt.nlp	18663145	SENT360	28	28	0	0	l-glutamine	THP1	PA10090	2736	0.973
NULL	Front_Immunol_2012_Jan_11_2_95.nxml.txt.nlp	22566884	SENT198	16	16	10	10	pp2	PAG		55824	0.973
NULL	Biomed_Res_Int_2014_Apr_10_2014_580852.nxml.txt.nlp	24812624	SENT31	2	2	12	12	resveratrol	PTEN		5728	0.973
NULL	Oncotarget_2011_Aug_30_2(8)_610-626.nxml.txt.nlp	21881167	SENT142	40	40	12	12	doxorubicin	Raf-1	PA449412	5894	0.973
NULL	Oncogene_2014_Apr_24_33(17)_2169-2178.nxml.txt.nlp	23728349	SENT70	25	25	9	9	imatinib	CD19	PA10804	930	0.973
NULL	Biologics_2012_Sep_25_6_337-345.nxml.txt.nlp	23055691	SENT104	24	24	11	11	pemetrexed	EGFR	PA10810	1956	0.973
NULL	J_Hum_Genet_2013_Jun_16_58(6)_353-361.nxml.txt.nlp	23677058	SENT166	29	29	18	18	cytarabine	RRM2	PA449177	6241	0.973
NULL	Breast_Cancer_(Auckl)_2011_Oct_9_5_209-226.nxml.txt.nlp	22084574	SENT205	6	6	15	15	exemestane	aromatase	PA449563	1588	0.973
NULL	Cancer_Metastasis_Rev_2010_Dec_10_29(4)_581-594.nxml.txt.nlp	20830503	SENT26	20	20	13	13	letrozole	aromatase	PA450196	1588	0.973
NULL	J_Hematol_Oncol_2008_Aug_14_1_12.nxml.txt.nlp	18702822	SENT166	18	18	4	4	trastuzumab	TOP2A	PA451743	7153	0.973
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1449-1456.nxml.txt.nlp	24077631	SENT109	21	21	25	25	tolbutamide	CYP2C9	PA451718	1559	0.973
NULL	Oncologist_2011_Feb_25_16(2)_155-164.nxml.txt.nlp	21266401	SENT158	25	25	3	3	trastuzumab	HER-2	PA451743	2064	0.973
NULL	Hum_Genomics_2004_May_1_1(4)_300-306.nxml.txt.nlp	15588489	SENT148	0	0	11	11	midazolam	CYP3A4	PA450496	1576	0.973
NULL	Front_Immunol_2013_Nov_7_4_360.nxml.txt.nlp	24223576	SENT167	3	3	10	10	imiquimod	TLR7	PA449972	51284	0.973
NULL	Drugs_Context_2012_Nov_19_2012_212242.nxml.txt.nlp	24432031	SENT229	0	0	13	13	bevacizumab	VEGF-A	PA130232992	7422	0.973
NULL	Open_Med_Chem_J_2011_Sep_9_5_82-92.nxml.txt.nlp	21966329	SENT132	5	5	13	13	sitagliptin	GLP-1	PA164748978	100125288	0.973
NULL	Oncotarget_2010_Oct_25_1(7)_497-514.nxml.txt.nlp	21165163	SENT134	21	21	7	7	erlotinib	SRC-3	PA134687924	8202	0.973
NULL	Gastric_Cancer_2013_Jul_12_16(3)_345-354.nxml.txt.nlp	22968820	SENT106	30	30	6	6	oxaliplatin	BRCA1	PA131285527	672	0.973
NULL	Clin_J_Gastroenterol_2012_Oct_22_5(6)_407-412.nxml.txt.nlp	24672586	SENT17	0	0	32	32	sorafenib	SHARP	PA7000	23013	0.973
NULL	Clin_Interv_Aging_2014_Aug_28_9_1437-1452.nxml.txt.nlp	25210448	SENT60	30	30	0	0	tamoxifen	SRC1	PA451581	8648	0.973
NULL	Curr_Neuropharmacol_2010_Mar_8(1)_2-9.nxml.txt.nlp	20808541	SENT196	7	7	12	12	propofol	gamma	PA451141	9913	0.973
NULL	Cancer_Cell_Int_2010_Apr_29_10_12.nxml.txt.nlp	20429927	SENT207	16	16	9	9	bortezomib	HRI	PA10252	27102	0.973
NULL	Patient_Prefer_Adherence_2013_Mar_27_7_245-258.nxml.txt.nlp	23569364	SENT22	0	0	16	16	exemestane	aromatase	PA449563	1588	0.973
NULL	Cancer_Cell_Int_2012_Aug_1_12_35.nxml.txt.nlp	22853623	SENT167	0	0	9	9	cisplatin	survivin	PA449014	332	0.973
NULL	Sensors_(Basel)_2013_Aug_16_13(8)_10711-10724.nxml.txt.nlp	23959236	SENT158	11	11	16	16	ethanol	GOX	PA448073	54363	0.973
NULL	Exp_Ther_Med_2014_Sep_14_8(3)_836-840.nxml.txt.nlp	25120610	SENT86	16	16	8	8	fasudil	ROCK1	PA165946121	6093	0.973
NULL	Breast_Cancer_Res_Treat_2012_Jun_18_133(3)_937-947.nxml.txt.nlp	22094936	SENT96	43	43	7	7	tamoxifen	EZH2	PA451581	2146	0.973
NULL	Nat_Commun_2014_Nov_25_5_5548.nxml.txt.nlp	25420520	SENT620	32	32	18	18	doxycycline	ERG	PA449415	2078	0.973
NULL	Mol_Cell_Biochem_2014_Oct_9_385(1-2)_265-275.nxml.txt.nlp	24104452	SENT186	14	14	1	1	bortezomib	U87	PA10252	677775;641648	0.973
NULL	Oncol_Lett_2014_Mar_15_7(3)_805-806.nxml.txt.nlp	24527088	SENT52	8	8	32	32	erlotinib	EGFR	PA134687924	1956	0.973
NULL	Br_J_Pharmacol_2014_Jan_23_171(2)_523-535.nxml.txt.nlp	24372553	SENT137	10	10	12	12	metformin	SIRT1	PA450395	23411	0.973
NULL	Curr_Oncol_2009_Jul_16(Suppl_2)_S1-S13.nxml.txt.nlp	19672416	SENT258	20	20	1	1	tamoxifen	ATAC	PA451581	6375	0.973
NULL	Mol_Biol_Rep_2013_May_11_40(8)_5013-5026.nxml.txt.nlp	23666059	SENT146	8	8	33	33	resveratrol	PLK1		5347	0.973
NULL	Eur_J_Haematol_2009_May_82(5)_339-349.nxml.txt.nlp	19187276	SENT9	7	7	22	22	rivaroxaban	TKR	PA165958360	8277	0.973
NULL	Diabetes_Obes_Metab_2011_Nov_13(11)_982-989.nxml.txt.nlp	21615670	SENT146	24	24	3	3	sitagliptin	PPG	PA164748978	5552	0.973
NULL	Cancers_(Basel)_2010_May_28_2(2)_1027-1039.nxml.txt.nlp	24281105	SENT51	34	34	18	18	bevacizumab	IL-8	PA130232992	3576	0.973
NULL	Breast_Cancer_Res_2011_Oct_14_13(5)_316.nxml.txt.nlp	22017807	SENT35	39	39	11	11	tamoxifen	Oct4	PA451581	5460	0.973
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_16_2014_926087.nxml.txt.nlp	25478000	SENT222	5	5	1	1	fenofibrate	PCSK9	PA449594	255738	0.973
NULL	ScientificWorldJournal_2014_Feb_5_2014_912640.nxml.txt.nlp	24688447	SENT129	20	20	3	3	celecoxib	COX	PA448871	1351	0.973
NULL	J_Cell_Biol_1998_Aug_24_142(4)_923-936.nxml.txt.nlp	9722606	SENT288	3	3	24	24	fluorescein	TGN	PA164746009	7038	0.973
NULL	Bioinformatics_2012_Sep_15_28(18)_i589-i595.nxml.txt.nlp	22962486	SENT25	23	23	19	19	maraviroc	CCR5	PA164768835	1234	0.973
NULL	Br_J_Cancer_1996_Dec_74(11)_1821-1827.nxml.txt.nlp	8956800	SENT16	2	2	36	36	filgrastim	CD34	PA449626	947	0.973
NULL	J_Cell_Mol_Med_2013_May_20_17(5)_648-656.nxml.txt.nlp	23601074	SENT181	22	22	2	2	gefitinib	KRAS	PA131301952	3845	0.973
NULL	Arthritis_Res_Ther_2013_Oct_17_15(5)_R154.nxml.txt.nlp	24286344	SENT309	27	27	14	14	ivermectin	P2X4	PA450133	5025	0.973
NULL	Case_Rep_Oncol_Med_2013_Jul_30_2013_496351.nxml.txt.nlp	23984138	SENT51	39	39	6	6	denosumab	RANKL	PA166048634	8600	0.973
NULL	Evid_Based_Complement_Alternat_Med_2011_Mar_13_2011_913898.nxml.txt.nlp	21785639	SENT5	0	0	7	7	nifedipine	CYP3A4	PA450631	1576	0.973
NULL	J_Anaesthesiol_Clin_Pharmacol_2011_Jul-Sep_27(3)_307-314.nxml.txt.nlp	21897498	SENT72	4	4	15	15	oxycodone	P600	PA450741	3596	0.973
NULL	Br_J_Cancer_2010_Mar_16_102(6)_1061-1067.nxml.txt.nlp	20160719	SENT127	11	11	4	4	resveratrol	DBC1		57805;1620	0.973
NULL	Breast_Cancer_Res_2007_Aug_8_9(4)_R50.nxml.txt.nlp	17686159	SENT277	25	25	1	1	gefitinib	HRG	PA131301952	3084;3273	0.973
NULL	Cancers_(Basel)_2010_Dec_30_3(1)_106-125.nxml.txt.nlp	24212609	SENT114	15	15	0	0	doxycycline	MRP5	PA449415	10057	0.973
NULL	JAKSTAT_2012_Apr_1_1(2)_55-64.nxml.txt.nlp	24058751	SENT141	5	5	19	19	flavopiridol	STAT3	PA452627	6774	0.973
NULL	Nat_Commun_2011_Jul_5_2_380.nxml.txt.nlp	21730960	SENT60	15	15	40	40	pentazocine	PGRMC1	PA164744326	10857	0.973
NULL	Br_J_Cancer_2012_Aug_7_107(4)_592-597.nxml.txt.nlp	22805325	SENT139	15	15	19	19	ketoconazole	CYP3A4	PA450146	1576	0.973
NULL	J_Headache_Pain_2008_Feb_24_9(1)_13-18.nxml.txt.nlp	18217199	SENT122	0	0	11	11	amitriptyline	CYP1A2	PA448385	1544	0.973
NULL	Biomed_Res_Int_2014_Feb_27_2014_897653.nxml.txt.nlp	24719894	SENT61	33	33	17	17	risperidone	HTR2A	PA451257	3356	0.973
NULL	Oncol_Lett_2013_Jun_4_5(6)_1915-1920.nxml.txt.nlp	23833666	SENT5	10	10	20	20	cetuximab	EGFR	PA10040	1956	0.973
NULL	Sci_Rep_2014_Dec_16_4_7500.nxml.txt.nlp	25511254	SENT25	5	5	35	35	hyperforin	TRPC6	PA165985514	7225	0.973
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_39-54.nxml.txt.nlp	19305787	SENT197	11	11	26	26	ethanol	NR1	PA448073	27158	0.973
NULL	Clin_Psychopharmacol_Neurosci_2012_Apr_30_10(1)_25-33.nxml.txt.nlp	23429852	SENT97	18	18	12	12	haloperidol	SNAP-25	PA449841	6616	0.973
NULL	Crit_Care_2010_Jul_19_14(4)_179.nxml.txt.nlp	20670385	SENT17	5	5	15	15	vasopressin	ACTH	PA451858	5443	0.973
NULL	Curr_Pharm_Des_2011_Dec_17(35)_3846-3853.nxml.txt.nlp	21933140	SENT38	30	30	47	47	nadh	PDH	PA164755085	54704	0.973
NULL	Sci_Rep_2014_Dec_3_4_7298.nxml.txt.nlp	25466238	SENT65	18	18	8	8	chloroquine	UCHL1	PA448948	7345	0.973
NULL	Drugs_Context_2012_Dec_11_2012_212244.nxml.txt.nlp	24432033	SENT41	16	16	6	6	gemcitabine	EGFR	PA449748	1956	0.973
NULL	Trials_2014_May_1_15_151.nxml.txt.nlp	24885437	SENT131	0	0	6	6	ticagrelor	P2Y12	PA165374673	64805	0.973
NULL	Nat_Med_2011_Dec_4_18(1)_111-119.nxml.txt.nlp	22138751	SENT273	32	32	14	14	doxycycline	WT1	PA449415	7490	0.973
NULL	Crit_Care_2008_Dec_17_12(6)_R159.nxml.txt.nlp	19091080	SENT14	23	23	1	1	rolipram	CD14	PA153906323	929	0.973
NULL	Acta_Oncol_2014_Oct_9_53(10)_1347-1355.nxml.txt.nlp	24909504	SENT147	2	2	26	26	cyclophosphamide	TP53	PA449165	7157	0.973
NULL	Arthritis_Res_Ther_2009_Apr_23_11(2)_R57.nxml.txt.nlp	19389237	SENT12	46	46	29	29	adalimumab	IL-18	PA10004	3606	0.973
NULL	Mol_Biol_Int_2014_Nov_20_2014_686984.nxml.txt.nlp	25505994	SENT158	16	16	0	0	etoposide	4E-BP1	PA449552	1978	0.973
NULL	Exp_Ther_Med_2013_Dec_15_6(6)_1565-1569.nxml.txt.nlp	24255692	SENT5	4	4	18	18	atorvastatin	adiponectin	PA448500	9370	0.973
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT79	5	5	16	16	resveratrol	TRAIL		8743	0.973
NULL	Cardiol_Res_Pract_2011_May_10_2011_816897.nxml.txt.nlp	21629798	SENT112	0	0	7	7	nilotinib	CYP3A4	PA165958345	1576	0.973
NULL	J_Cancer_2012_Mar_12_3_137-144.nxml.txt.nlp	22481979	SENT31	24	24	6	6	fluorouracil	HER2	PA128406956	2064	0.973
NULL	Pharmaceuticals_(Basel)_2013_Apr_17_6(4)_557-578.nxml.txt.nlp	24276125	SENT179	0	0	10	10	vemurafenib	BRAF	PA165946873	673	0.973
NULL	J_Gynecol_Oncol_2013_Jul_4_24(3)_273-279.nxml.txt.nlp	23875078	SENT122	8	8	25	25	indomethacin	P-gp	PA449982	5243	0.973
NULL	EMBO_Mol_Med_2013_Dec_8_5(12)_1821-1834.nxml.txt.nlp	24293316	SENT162	10	10	19	19	doxorubicin	p53	PA449412	7157	0.973
NULL	Int_J_Mol_Sci_2014_Oct_8_15(10)_17974-17999.nxml.txt.nlp	25299695	SENT116	19	19	3	3	curcumin	HO-1	PA151958596	3162	0.973
NULL	Onco_Targets_Ther_2014_Jun_6_7_925-935.nxml.txt.nlp	24944516	SENT151	15	15	2	2	sorafenib	CXCR4	PA7000	7852	0.973
NULL	Mol_Cancer_2010_Aug_23_9_222.nxml.txt.nlp	20731837	SENT185	29	29	5	5	gefitinib	EGFR	PA131301952	1956	0.973
NULL	Arthritis_Res_Ther_2010_Dec_17_12(6)_221.nxml.txt.nlp	21205283	SENT128	18	18	1	1	adalimumab	ACR	PA10004	49	0.973
NULL	Acta_Neuropathol_2010_Nov_17_120(5)_567-584.nxml.txt.nlp	20714900	SENT268	12	12	22	22	temozolomide	MSH6	PA451609	2956	0.973
NULL	Exp_Hematol_Oncol_2013_Apr_10_2_11.nxml.txt.nlp	23574711	SENT137	13	13	4	4	l-arginine	OTC	PA448478	5009	0.973
NULL	J_Cell_Biol_1999_Dec_27_147(7)_1481-1492.nxml.txt.nlp	10613906	SENT640	26	26	6	6	paraformaldehyde	AKAP18	PA450790	9465	0.973
NULL	Mol_Cancer_2010_Nov_2_9_289.nxml.txt.nlp	21044322	SENT211	13	13	29	29	cisplatin	RGS10	PA449014	6001	0.973
NULL	Mol_Cancer_2009_Nov_24_8_109.nxml.txt.nlp	19930708	SENT155	19	19	14	14	anastrozole	aromatase	PA448432	1588	0.973
NULL	Virol_J_2010_Oct_20_7_279.nxml.txt.nlp	20961433	SENT162	13	13	1	1	trypsin	VLP	PA451806	391104	0.973
NULL	Breast_Cancer_(Dove_Med_Press)_2014_May_2_6_59-71.nxml.txt.nlp	24833917	SENT37	20	20	32	32	tamoxifen	aromatase	PA451581	1588	0.973
NULL	Arthritis_Res_Ther_2013_Apr_17_15(2)_R51.nxml.txt.nlp	23594962	SENT15	22	22	6	6	fenofibrate	IL-6	PA449594	3569	0.973
NULL	Dement_Geriatr_Cogn_Dis_Extra_2014_Nov_15_4(3)_450-456.nxml.txt.nlp	25538729	SENT12	16	16	6	6	donepezil	CYP2D6	PA449394	1565	0.973
NULL	Oncol_Rep_2013_Oct_24_30(4)_1587-1592.nxml.txt.nlp	23900512	SENT132	31	31	17	17	tranylcypromine	NOXA	PA451741	5366	0.973
NULL	Drugs_R_D_2010_Nov_25_10(4)_219-224.nxml.txt.nlp	21171668	SENT87	0	0	18	18	clopidogrel	CYP3A4	PA449053	1576	0.973
NULL	Biomed_Res_Int_2013_Nov_28_2013_789184.nxml.txt.nlp	24369535	SENT114	0	0	14	14	imatinib	CYP3A4	PA10804	1576	0.973
NULL	J_Mol_Signal_2010_May_10_5_4.nxml.txt.nlp	20459745	SENT14	16	16	2	2	cisplatin	p53	PA449014	7157	0.973
NULL	Multidiscip_Respir_Med_2012_Dec_11_7(1)_52.nxml.txt.nlp	23232076	SENT22	14	14	6	6	gefitinib	EGFR	PA131301952	1956	0.973
NULL	Br_J_Cancer_2013_Jun_11_108(11)_2272-2280.nxml.txt.nlp	23681187	SENT215	4	4	34	34	celecoxib	COX2	PA448871	4513;5743	0.973
NULL	Nat_Med_2010_Jun_9_16(6)_662-664.nxml.txt.nlp	20473307	SENT55	46	46	25	25	ganciclovir	EGFR	PA449733	1956	0.973
NULL	Nat_Chem_Biol_2010_Apr_28_6(4)_291-299.nxml.txt.nlp	20190765	SENT285	12	12	5	5	dasatinib	EGFR	PA162372878	1956	0.973
NULL	Int_J_Biol_Sci_2014_May_14_10(5)_566-575.nxml.txt.nlp	24910535	SENT141	35	35	13	13	nadh	BRCA1	PA164755085	672	0.973
NULL	Breast_Cancer_Res_2007_Aug_8_9(4)_R50.nxml.txt.nlp	17686159	SENT248	16	16	10	10	gefitinib	HRG	PA131301952	3084;3273	0.973
NULL	Alcohol_Res_2012_34(3)_339-344.nxml.txt.nlp	23134050	SENT27	22	22	1	1	ethanol	ADH4	PA448073	127	0.973
NULL	Alcohol_Res_2012_34(3)_339-344.nxml.txt.nlp	23134050	SENT35	22	22	3	3	ethanol	ADH7	PA448073	131	0.973
NULL	Int_J_Breast_Cancer_2012_Oct_25_2012_829315.nxml.txt.nlp	22295252	SENT75	0	0	8	8	olaparib	PARP1		142	0.973
NULL	Nat_Med_2014_Apr_16_20(4)_385-397.nxml.txt.nlp	24633305	SENT438	33	33	31	31	triciribine	AKT	PA165958661	207	0.973
NULL	Am_J_Transplant_2010_Jan_10(1)_69-80.nxml.txt.nlp	19889125	SENT115	26	26	31	31	fludarabine	STAT1	PA449655	6772	0.973
NULL	Clinics_(Sao_Paulo)_2012_Apr_67(4)_335-340.nxml.txt.nlp	22522758	SENT113	19	19	10	10	citalopram	HTR1B	PA449015	3351	0.973
NULL	Arthritis_Res_Ther_2014_Sep_26_16(5)_429.nxml.txt.nlp	25606593	SENT106	2	2	16	16	anakinra	ADAMTS5	PA10799	11096	0.973
NULL	Biologics_2014_Dec_4_8_281-291.nxml.txt.nlp	25506209	SENT74	0	0	32	32	sunitinib	RET	PA162372840	5979	0.973
NULL	Tumour_Biol_2014_Mar_19_35(3)_2211-2218.nxml.txt.nlp	24142530	SENT30	2	2	23	23	deferoxamine	APAF-1	PA164746490	317	0.973
NULL	Mol_Cell_Biochem_2015_Oct_8_398(1-2)_165-173.nxml.txt.nlp	25292312	SENT188	5	5	19	19	bortezomib	PUMA	PA10252	27113	0.973
NULL	Br_J_Cancer_2012_Feb_14_106(4)_673-677.nxml.txt.nlp	22240778	SENT25	0	0	21	21	lapatinib	HER2	PA152241907	2064	0.973
NULL	Eur_J_Cell_Biol_2012_Aug_91(8)_614-628.nxml.txt.nlp	22555292	SENT63	13	13	4	4	thrombin	Nesprin-1	PA451674	23345	0.973
NULL	Mol_Cancer_2010_May_27_9_124.nxml.txt.nlp	20504375	SENT106	3	3	10	10	doxycycline	HOXB13	PA449415	10481	0.973
NULL	J_Oncol_2010_Feb_22_2010_891059.nxml.txt.nlp	20182637	SENT5	19	19	4	4	cisplatin	BRCA1	PA449014	672	0.973
NULL	Arthritis_Res_Ther_2013_Jul_9_15(4)_R73.nxml.txt.nlp	23837669	SENT303	40	40	4	4	colchicine	MSU	PA449092	593	0.973
NULL	J_Biol_Chem_2013_Oct_11_288(41)_29642-29653.nxml.txt.nlp	24005673	SENT726	19	19	3	3	hyaluronan	TSG-6	PA165958431	7130	0.973
NULL	Acta_Pharmacol_Sin_2009_Nov_12_30(11)_1566-1572.nxml.txt.nlp	19820718	SENT145	0	0	5	5	omeprazole	CYP2C19	PA450704	1557	0.973
NULL	Acta_Pharmacol_Sin_2014_Jun_4_35(6)_752-757.nxml.txt.nlp	24902786	SENT91	23	23	10	10	letrozole	STZ	PA450196	6484	0.973
NULL	J_Biol_Chem_2013_Nov_22_288(47)_34217-34229.nxml.txt.nlp	24106270	SENT327	13	13	5	5	thrombin	RhoG	PA451674	391	0.973
NULL	Breast_Cancer_Res_2005_Nov_11_7(6)_255-257.nxml.txt.nlp	16457700	SENT34	32	32	20	20	tamoxifen	aromatase	PA451581	1588	0.973
NULL	Evid_Based_Complement_Alternat_Med_2004_Jun_1(1)_17-27.nxml.txt.nlp	15257322	SENT52	4	4	31	31	methylcholanthrene	IFN	PA165816878	3439	0.973
NULL	Mol_Cancer_2012_Mar_21_11_13.nxml.txt.nlp	22436134	SENT156	18	18	32	32	doxorubicin	HuR	PA449412	1994	0.973
NULL	Open_Biol_2014_Dec_4(12)_140178.nxml.txt.nlp	25520185	SENT168	6	6	9	9	erlotinib	RIP2	PA134687924	8767;64283	0.973
NULL	Breast_Cancer_Res_2011_Jun_29_13(3)_R70.nxml.txt.nlp	21707964	SENT230	26	26	7	7	tamoxifen	14-3-3	PA451581	10971	0.973
NULL	Mediators_Inflamm_2011_Feb_6_2011_971502.nxml.txt.nlp	21437210	SENT179	3	3	23	23	urokinase	COX1	PA451836	4512;5742	0.973
NULL	Arthritis_Res_Ther_2011_Jun_20_13(3)_R94.nxml.txt.nlp	21689401	SENT86	32	32	17	17	etanercept	GDA	PA449515	8034;9615	0.973
NULL	Onco_Targets_Ther_2014_May_28_7_841-852.nxml.txt.nlp	24920926	SENT94	21	21	4	4	erlotinib	EGFR	PA134687924	1956	0.973
NULL	Diagn_Pathol_2014_Jul_10_9_143.nxml.txt.nlp	25012722	SENT126	31	31	18	18	cisplatin	PDCD4	PA449014	27250	0.973
NULL	J_Immunol_Res_2014_Mar_13_2014_734068.nxml.txt.nlp	24741620	SENT126	12	12	31	31	hydrocortisone	HLA-G	PA449905	3135	0.973
NULL	J_Oncol_2009_Jan_17_2009_581939.nxml.txt.nlp	20145720	SENT58	13	13	7	7	cisplatin	p53	PA449014	7157	0.973
NULL	Biochemistry_2009_Jun_9_48(22)_4871-4880.nxml.txt.nlp	19364131	SENT212	7	7	20	20	papain	ATP7B	PA450778	540	0.973
NULL	Oncol_Lett_2014_Mar_19_7(3)_797-798.nxml.txt.nlp	24520296	SENT58	40	40	13	13	irinotecan	OATP1	PA450085	4945;53919	0.973
NULL	Exp_Ther_Med_2013_Jan_1_5(1)_338-342.nxml.txt.nlp	23251295	SENT94	13	13	26	26	everolimus	HK2	PA164746311	3796;3099;29911;3741	0.973
NULL	BMJ_Open_2014_Feb_13_4(2)_e003960.nxml.txt.nlp	24525389	SENT123	33	33	12	12	warfarin	OAT	PA451906	4942	0.973
NULL	Nat_Med_2010_Sep_22_16(9)_998-1000.nxml.txt.nlp	20729864	SENT36	5	5	28	28	sorafenib	LRRK2	PA7000	120892	0.973
NULL	Adv_Hematol_2014_Apr_3_2014_864058.nxml.txt.nlp	24803933	SENT323	16	16	10	10	thalidomide	DEPTOR	PA451644	64798	0.973
NULL	Mol_Cancer_2010_Nov_2_9_289.nxml.txt.nlp	21044322	SENT10	8	8	14	14	docetaxel	RGS17	PA449383	26575	0.973
NULL	Acta_Pharmacol_Sin_2011_Feb_4_32(2)_259-269.nxml.txt.nlp	21293479	SENT177	31	31	4	4	sn-38	UGT1A10		54575	0.973
NULL	Oncotarget_2012_Dec_18_3(12)_1615-1628.nxml.txt.nlp	23271044	SENT206	21	21	3	3	clofarabine	ERK	PA164754863	5594	0.973
NULL	Cancer_Med_2014_Apr_27_3(2)_293-299.nxml.txt.nlp	24464780	SENT34	26	26	20	20	capecitabine	TYMS	PA448771	7298	0.973
NULL	Aging_(Albany_NY)_2012_Jul_22_4(7)_480-498.nxml.txt.nlp	22837425	SENT29	33	33	16	16	metformin	B12	PA450395	7126;4709	0.973
NULL	Drug_Saf_2014_Feb_19_37(4)_201-211.nxml.txt.nlp	24550106	SENT116	8	8	39	39	omeprazole	CYP2C19	PA450704	1557	0.973
NULL	Cancers_(Basel)_2014_Mar_6_6(1)_494-525.nxml.txt.nlp	24662938	SENT163	11	11	7	7	afatinib	EGFR	PA165981154	1956	0.973
NULL	Curr_Oncol_2009_Jan_16(1)_16-26.nxml.txt.nlp	19229368	SENT57	7	7	14	14	cetuximab	KRAS	PA10040	3845	0.973
NULL	EMBO_Mol_Med_2012_Jun_13_4(6)_515-527.nxml.txt.nlp	22416035	SENT276	14	14	18	18	olaparib	p53		7157	0.973
NULL	JRSM_Cardiovasc_Dis_2012_Sep_24_1(6)_cvd_2012_012015.nxml.txt.nlp	24175073	SENT35	24	24	3	3	clopidogrel	CYP2C19	PA449053	1557	0.973
NULL	Eur_J_Med_Res_2010_Nov_25_15(11)_461-467.nxml.txt.nlp	21159570	SENT168	7	7	23	23	rosuvastatin	MMP9	PA134308647	4318	0.973
NULL	Clin_Med_Insights_Oncol_2012_Jan_11_6_75-84.nxml.txt.nlp	22346367	SENT136	6	6	27	27	pegvisomant	ACTH	PA164749630	5443	0.973
NULL	Nucleic_Acids_Res_2014_Jan_1_42(1)_643-660.nxml.txt.nlp	24097436	SENT188	36	36	15	15	doxycycline	RRP6	PA449415	5394	0.973
NULL	Iran_Red_Crescent_Med_J_2014_Feb_7_16(2)_e15277.nxml.txt.nlp	24719748	SENT50	24	24	0	0	clopidogrel	ADP	PA449053	23038	0.973
NULL	Infect_Ecol_Epidemiol_2013_Aug_30_3_10_3402_iee_v3i0_19839.nxml.txt.nlp	24003364	SENT209	0	0	22	22	ribavirin	IFN	PA451241	3439	0.973
NULL	Cell_Cycle_2012_Nov_1_11(21)_3983-3996.nxml.txt.nlp	22987153	SENT169	12	12	3	3	cisplatin	FANCD2	PA449014	2177	0.973
NULL	Lab_Invest_2011_Jun_28_91(6)_955-967.nxml.txt.nlp	21445059	SENT43	30	30	17	17	sirolimus	DES	PA451365	1674	0.973
NULL	Mol_Brain_2014_Aug_21_7_59.nxml.txt.nlp	25139109	SENT42	24	24	4	4	imiquimod	TLR4	PA449972	7099	0.973
NULL	Diabetes_2011_Jul_20_60(7)_1990-1999.nxml.txt.nlp	21617181	SENT216	7	7	39	39	geldanamycin	Hsp90	PA152031327	3320	0.973
NULL	Acta_Pharmacol_Sin_2010_Mar_22_31(3)_329-340.nxml.txt.nlp	20173759	SENT148	11	11	2	2	ethanol	AMPK	PA448073	5563	0.973
NULL	Curr_Chem_Genomics_2008_May_23_1_54-64.nxml.txt.nlp	20161828	SENT136	8	8	6	6	staurosporine	AKT	PA165109623	207	0.973
NULL	J_Exp_Clin_Cancer_Res_2009_Jul_10_28(1)_99.nxml.txt.nlp	19591692	SENT6	13	13	34	34	imatinib	ABCB1	PA10804	5243	0.973
NULL	Asian_Spine_J_2014_Jun_9_8(3)_315-321.nxml.txt.nlp	24967045	SENT54	29	29	18	18	ciprofloxacin	AKT	PA449009	207	0.973
NULL	Mol_Cancer_2010_Jun_25_9_166.nxml.txt.nlp	20579378	SENT233	15	15	0	0	gefitinib	DUSP4	PA131301952	1846	0.973
NULL	Arch_Med_Sci_2012_May_9_8(2)_375-388.nxml.txt.nlp	22662015	SENT256	32	32	28	28	cimetidine	CYP2C19	PA449001	1557	0.973
NULL	Oncologist_2010_Dec_8_15(12)_1285-1293.nxml.txt.nlp	21147872	SENT163	3	3	21	21	sorafenib	RAI	PA7000	10848;6050	0.973
NULL	EJC_Suppl_2014_Jun_29_12(1)_41-53.nxml.txt.nlp	NULL	SENT62	2	2	27	27	tamoxifen	aromatase	PA451581	1588	0.973
NULL	Hum_Genomics_Proteomics_2010_Aug_3_2010_159761.nxml.txt.nlp	20981231	SENT254	13	13	21	21	lithium	NTRK2	PA450243	4915	0.973
NULL	Nat_Med_2010_Jun_23_16(6)_671-677.nxml.txt.nlp	20495567	SENT211	14	14	26	26	sorafenib	JNK	PA7000	5599	0.973
NULL	Exp_Neurobiol_2013_Mar_31_22(1)_51-57.nxml.txt.nlp	23585723	SENT22	16	16	7	7	capsaicin	TRPV1	PA448776	7442	0.973
NULL	eLife_2013_Nov_5_2_e00969.nxml.txt.nlp	24192036	SENT108	21	21	2	2	vemurafenib	BAX	PA165946873	581	0.973
NULL	Oncogene_2010_Jul_8_29(27)_3896-3907.nxml.txt.nlp	20453888	SENT141	2	2	25	25	trastuzumab	p27	PA451743	5715;10534	0.973
NULL	Mol_Cancer_2012_Jun_18_11_41.nxml.txt.nlp	22709873	SENT4	17	17	7	7	capecitabine	HER2	PA448771	2064	0.973
NULL	Breast_Cancer_Res_2007_May_30_9(3)_R34.nxml.txt.nlp	17537232	SENT51	13	13	36	36	tamoxifen	aromatase	PA451581	1588	0.973
NULL	Neural_Regen_Res_2014_Mar_15_9(6)_622-629.nxml.txt.nlp	25206865	SENT13	38	38	23	23	vasopressin	c-Jun	PA451858	3725	0.973
NULL	Br_J_Clin_Pharmacol_2012_Apr_7_73(4)_518-535.nxml.txt.nlp	22053916	SENT178	0	0	21	21	pitavastatin	MCP-1	PA142650384	6347	0.973
NULL	Core_Evid_2010_Oct_21_5_61-76.nxml.txt.nlp	21042543	SENT253	21	21	11	11	panitumumab	PTEN	PA162373091	5728	0.973
NULL	Arch_Med_Sci_2014_Feb_24_10(1)_191-194.nxml.txt.nlp	24701233	SENT52	31	31	8	8	hydroxyurea	MPN	PA449942	83886	0.973
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT250	28	28	12	12	lapatinib	HRG	PA152241907	3084;3273	0.973
NULL	J_Young_Pharm_2010_Oct-Dec_2(4)_428-429.nxml.txt.nlp	21264109	SENT23	4	4	9	9	metformin	B12	PA450395	7126;4709	0.973
NULL	J_Oncol_2010_May_4_2010_373491.nxml.txt.nlp	20454582	SENT134	40	40	32	32	temozolomide	TRG	PA451609	6965	0.973
NULL	Arch_Drug_Inf_2011_Mar_4(1)_1-9.nxml.txt.nlp	21572514	SENT179	18	18	3	3	vinblastine	P-gp	PA451877	5243	0.973
NULL	Cancers_(Basel)_2010_Jul_12_2(3)_1453-1491.nxml.txt.nlp	24281168	SENT160	3	3	20	20	cetuximab	KRAS	PA10040	3845	0.973
NULL	Am_J_Trop_Med_Hyg_2012_Mar_1_86(3)_489-495.nxml.txt.nlp	22403324	SENT177	19	19	38	38	ritonavir	P-gp	PA451260	5243	0.973
NULL	Patient_Prefer_Adherence_2011_Jul_19_5_369-374.nxml.txt.nlp	21845036	SENT52	0	0	5	5	miconazole	CYP3A4	PA450494	1576	0.973
NULL	Front_Genet_2013_Aug_30_4_166.nxml.txt.nlp	24009623	SENT234	26	26	6	6	everolimus	PHLDA1	PA164746311	22822	0.973
NULL	J_Hematol_Oncol_2012_Apr_25_5(Suppl_1)_A1.nxml.txt.nlp	22738713	SENT20	0	0	17	17	pertuzumab	HER3		2065	0.973
NULL	Amino_Acids_2012_May_25_42(5)_1529-1539.nxml.txt.nlp	21437784	SENT144	30	30	8	8	taurine	Bcl-2	PA451590	596	0.973
NULL	Cancer_Med_2014_Jun_29_3(3)_526-536.nxml.txt.nlp	24687970	SENT30	11	11	2	2	trastuzumab	HER2	PA451743	2064	0.973
NULL	J_Exp_Med_1998_Jun_1_187(11)_1885-1892.nxml.txt.nlp	9607928	SENT123	19	19	0	0	thalidomide	IL-4	PA451644	3565	0.973
NULL	Br_J_Cancer_2013_Jul_23_109(2)_351-359.nxml.txt.nlp	23799854	SENT122	21	21	16	16	paclitaxel	BLT2	PA450761	56413	0.973
NULL	Int_J_Gen_Med_2012_Jun_18_5_535-540.nxml.txt.nlp	22807641	SENT7	15	15	5	5	pitavastatin	adiponectin	PA142650384	9370	0.973
NULL	Iran_J_Pharm_Res_2013_Winter_12(1)_175-184.nxml.txt.nlp	24250586	SENT110	1	1	5	5	diclofenac	COX	PA449293	1351	0.973
NULL	Breast_Cancer_Res_2010_Jun_28_12(3)_R43.nxml.txt.nlp	20579400	SENT102	31	31	5	5	docetaxel	MAPT	PA449383	4137	0.973
NULL	Breast_Cancer_(Auckl)_2012_Nov_19_6_191-207.nxml.txt.nlp	23226023	SENT97	8	8	26	26	trastuzumab	HER2	PA451743	2064	0.973
NULL	Am_J_Cardiovasc_Drugs_2013_Jun_20_13(5)_331-342.nxml.txt.nlp	23784266	SENT17	5	5	3	3	quinidine	P-gp	PA451209	5243	0.973
NULL	Anal_Bioanal_Chem_2010_Oct_22_398(4)_1771-1780.nxml.txt.nlp	20730527	SENT127	6	6	18	18	phenylbutazone	p38	PA450932	10598;1432;7965	0.973
NULL	J_Cancer_2013_Sep_10_4(8)_614-625.nxml.txt.nlp	24155773	SENT168	22	22	14	14	doxorubicin	CRM1	PA449412	7514	0.973
NULL	Oncotarget_2013_May_1_4(5)_705-714.nxml.txt.nlp	23670029	SENT238	6	6	16	16	cisplatin	p53	PA449014	7157	0.973
NULL	Crit_Care_2004_May_25_8(4)_234-242.nxml.txt.nlp	15312205	SENT153	25	25	15	15	oxprenolol	THP1	PA10284	2736	0.973
NULL	Pain_2012_Apr_153(4)_775-783.nxml.txt.nlp	22325744	SENT164	6	6	25	25	naloxone	ANOVA	PA450586	4858	0.973
NULL	Br_J_Pharmacol_2013_Jun_27_169(4)_736-747.nxml.txt.nlp	23489111	SENT140	11	11	4	4	topotecan	5-HT3A	PA451729	3359	0.973
NULL	Cell_Death_Dis_2014_Jul_3_5(7)_e1311.nxml.txt.nlp	24991763	SENT19	24	24	12	12	ketamine	BAX	PA450144	581	0.973
NULL	Biomed_Opt_Express_2012_Aug_1_3(9)_1978-1992.nxml.txt.nlp	23024894	SENT213	11	11	23	23	isoflurane	PCL	PA450106	9033;2324	0.973
NULL	Sci_Rep_2014_Dec_16_4_7500.nxml.txt.nlp	25511254	SENT25	24	24	35	35	hyperforin	TRPC6	PA165985514	7225	0.973
NULL	J_Adv_Pract_Oncol_2014_May_1_May-Jun_5(3)_193-202.nxml.txt.nlp	25089218	SENT103	13	13	0	0	denosumab	RANKL	PA166048634	8600	0.973
NULL	Breast_Cancer_Res_2005_Jan_28_7(3)_R284-R290.nxml.txt.nlp	15987423	SENT6	21	21	10	10	tamoxifen	SULT1A1	PA451581	6817	0.973
NULL	J_Cell_Biol_2008_Jul_28_182(2)_233-239.nxml.txt.nlp	18644891	SENT80	24	24	4	4	staurosporine	MICB	PA165109623	4277	0.973
NULL	Biochim_Biophys_Acta_2013_Jun_1833(6)_1443-1453.nxml.txt.nlp	23485397	SENT65	34	34	1	1	trypsin	HIPK2	PA451806	28996	0.973
NULL	Int_J_Biomed_Sci_2007_Sep_3(3)_194-198.nxml.txt.nlp	23675043	SENT99	10	10	17	17	genistein	WAF1	PA165109660	1026	0.973
NULL	J_Korean_Med_Sci_2013_Feb_29_28(2)_308-314.nxml.txt.nlp	23399960	SENT114	14	14	6	6	gabapentin	IL-10	PA449720	3586	0.973
NULL	J_Hematol_Oncol_2008_Oct_23_1_19.nxml.txt.nlp	18947412	SENT115	40	40	0	0	alemtuzumab	CD34	PA164783958	947	0.973
NULL	Exp_Ther_Med_2013_Jan_1_5(1)_338-342.nxml.txt.nlp	23251295	SENT92	29	29	5	5	everolimus	HK2	PA164746311	3796;3099;29911;3741	0.973
NULL	Front_Genet_2013_Dec_16_4_281.nxml.txt.nlp	24379827	SENT376	23	23	7	7	nifedipine	CACNA1F	PA450631	778	0.973
NULL	Epilepsia_2012_Jun_21_53(Suppl_1)_18-25.nxml.txt.nlp	22612805	SENT41	9	9	15	15	bumetanide	NKCC1	PA448682	6558	0.972
NULL	Indian_J_Pharmacol_2012_Nov-Dec_44(6)_759-764.nxml.txt.nlp	23248408	SENT97	15	15	19	19	sitagliptin	ANOVA	PA164748978	4858	0.972
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1137-1144.nxml.txt.nlp	20234366	SENT59	20	20	0	0	cetuximab	MKP-1	PA10040	1843	0.972
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT59	36	36	14	14	adalimumab	CD36	PA10004	948	0.972
NULL	Biomed_Res_Int_2014_Jun_25_2014_203693.nxml.txt.nlp	25089265	SENT120	28	28	3	3	sunitinib	VEGFR	PA162372840	3791	0.972
NULL	Breast_Cancer_Res_2005_Nov_23_7(1)_R119-R129.nxml.txt.nlp	15642160	SENT176	17	17	0	0	tamoxifen	HER-2	PA451581	2064	0.972
NULL	Ann_Oncol_2011_Mar_8_22(3)_503-514.nxml.txt.nlp	20616198	SENT77	10	10	18	18	anastrozole	aromatase	PA448432	1588	0.972
NULL	Mol_Cancer_2010_Apr_12_9_75.nxml.txt.nlp	20385023	SENT213	7	7	0	0	gefitinib	ABCG2	PA131301952	9429	0.972
NULL	JAKSTAT_2013_Jul_1_2(3)_e24574.nxml.txt.nlp	24069558	SENT79	20	20	3	3	doxycycline	HEK	PA449415	2042	0.972
NULL	Int_J_Mol_Sci_2014_Oct_16_15(10)_18677-18692.nxml.txt.nlp	25325535	SENT214	2	2	10	10	metformin	AMPK	PA450395	5563	0.972
NULL	Oncologist_2010_Mar_9_15(3)_236-245.nxml.txt.nlp	20215359	SENT116	2	2	45	45	temsirolimus	IFN	PA164746890	3439	0.972
NULL	Mol_Med_Rep_2015_Jan_16_11(1)_189-195.nxml.txt.nlp	25323748	SENT88	32	32	7	7	cisplatin	p62	PA449014	8878;10657;23636	0.972
NULL	Ann_Hematol_2010_Sep_13_89(9)_861-871.nxml.txt.nlp	20387067	SENT215	27	27	16	16	dasatinib	CD34	PA162372878	947	0.972
NULL	Oncotarget_2012_May_4_3(4)_395-398.nxml.txt.nlp	22565037	SENT41	27	27	15	15	metformin	CD44	PA450395	960	0.972
NULL	Diabetes_2011_Jun_21_60(6)_1705-1715.nxml.txt.nlp	21521872	SENT139	8	8	21	21	doxycycline	STZ	PA449415	6484	0.972
NULL	Chemother_Res_Pract_2012_Aug_29_2012_817297.nxml.txt.nlp	22970367	SENT122	18	18	10	10	erlotinib	AXL	PA134687924	558	0.972
NULL	Front_Genet_2013_Aug_30_4_166.nxml.txt.nlp	24009623	SENT234	26	26	13	13	everolimus	MGLL	PA164746311	11343	0.972
NULL	Arthritis_Res_Ther_2009_Apr_23_11(2)_R57.nxml.txt.nlp	19389237	SENT252	43	43	17	17	adalimumab	MKI67	PA10004	4288	0.972
NULL	Evid_Based_Complement_Alternat_Med_2014_Dec_24_2014_596920.nxml.txt.nlp	25610477	SENT263	9	9	17	17	sucralfate	IL-4	PA451524	3565	0.972
NULL	Cancer_Med_2014_Apr_7_3(2)_362-375.nxml.txt.nlp	24515916	SENT263	39	39	9	9	zoledronate	IFN	PA10235	3439	0.972
NULL	Br_J_Cancer_2006_Dec_4_95(11)_1483-1489.nxml.txt.nlp	17106442	SENT115	5	5	13	13	gefitinib	EGFR	PA131301952	1956	0.972
NULL	Mol_Pain_2014_Apr_18_10_27.nxml.txt.nlp	24742127	SENT8	37	37	26	26	paclitaxel	CB1	PA450761	1268	0.972
NULL	Mol_Cancer_2014_Jul_5_13_165.nxml.txt.nlp	24996221	SENT212	23	23	7	7	docetaxel	HMGB1	PA449383	3146	0.972
NULL	Scientifica_(Cairo)_2013_Dec_12_2013_635203.nxml.txt.nlp	24416617	SENT441	10	10	17	17	imatinib	KIT	PA10804	3815	0.972
NULL	Front_Microbiol_2013_Aug_19_4_241.nxml.txt.nlp	23966991	SENT236	2	2	9	9	ceftriaxone	EAAT2	PA448866	6506	0.972
NULL	Lab_Invest_2011_Sep_23_91(9)_1396-1409.nxml.txt.nlp	21606925	SENT287	14	14	21	21	genistein	PP2	PA165109660	4888	0.972
NULL	Mol_Cancer_2010_Oct_12_9_269.nxml.txt.nlp	20939893	SENT137	28	28	6	6	isoproterenol	AP-1	PA450121	2353;3727;2354;3725	0.972
NULL	Scientifica_(Cairo)_2012_Sep_10_2012_482423.nxml.txt.nlp	24278703	SENT59	16	16	2	2	simvastatin	SHARP	PA451363	23013	0.972
NULL	J_Carcinog_2013_Dec_31_12_22.nxml.txt.nlp	24574860	SENT81	15	15	23	23	afatinib	HER2	PA165981154	2064	0.972
NULL	Br_J_Cancer_2010_Oct_12_103(8)_1139-1143.nxml.txt.nlp	20877357	SENT93	9	9	27	27	gefitinib	EGF	PA131301952	1950	0.972
NULL	Curr_Rheumatol_Rep_2011_Jun_2_13(3)_233-240.nxml.txt.nlp	21365209	SENT142	5	5	0	0	ibandronate	Men	PA10270	8178	0.972
NULL	Arthritis_Res_Ther_2012_Sep_24_14(5)_R200.nxml.txt.nlp	23006144	SENT129	25	25	8	8	alefacept	IL-20	PA164748040	27190;50604	0.972
NULL	EMBO_Mol_Med_2010_Jan_2(1)_3-5.nxml.txt.nlp	20043280	SENT22	43	43	4	4	trastuzumab	ERBB2	PA451743	2064	0.972
NULL	Nat_Genet_2011_Feb_26_43(2)_117-120.nxml.txt.nlp	21186350	SENT91	25	25	6	6	metformin	ATM	PA450395	472	0.972
NULL	Oncotarget_2012_Nov_14_3(12)_1557-1565.nxml.txt.nlp	23238683	SENT107	17	17	26	26	ponatinib	CRKL	PA165980594	1399	0.972
NULL	Comp_Hepatol_2004_Jan_14_3(Suppl_1)_S31.nxml.txt.nlp	14960183	SENT83	2	2	10	10	ethanol	TNF-alpha	PA448073	7124	0.972
NULL	Front_Behav_Neurosci_2010_Apr_5_4_14.nxml.txt.nlp	20407577	SENT311	13	13	3	3	doxycycline	NAC1	PA449415	112939;6323	0.972
NULL	Nucleic_Acids_Res_2005_Mar_22_33(5)_e51.nxml.txt.nlp	15784609	SENT462	25	25	5	5	doxycycline	E12	PA449415	64100	0.972
NULL	Br_J_Cancer_2004_May_17_90(10)_1989-1994.nxml.txt.nlp	15138483	SENT131	0	0	31	31	hydroquinone	p53	PA449924	7157	0.972
NULL	Cancers_(Basel)_2010_Jan_14_2(1)_1-19.nxml.txt.nlp	24281029	SENT41	23	23	4	4	capecitabine	HER2	PA448771	2064	0.972
NULL	Arthritis_Res_Ther_2006_Feb_3_8(2)_R43.nxml.txt.nlp	16507142	SENT55	6	6	28	28	heparin	CXCL12	PA449855	6387	0.972
NULL	Mol_Vis_2012_Jun_22_18_1696-1700.nxml.txt.nlp	22773907	SENT86	12	12	15	15	colchicine	MTHFR	PA449092	4524	0.972
NULL	Clin_Sci_(Lond)_2013_Feb_1_124(Pt_3)_153-164.nxml.txt.nlp	23075334	SENT669	12	12	1	1	resveratrol	SIRT1		23411	0.972
NULL	Acta_Pharmacol_Sin_2011_Nov_10_32(11)_1402-1410.nxml.txt.nlp	21986579	SENT203	40	40	20	20	curcumin	CDK4	PA151958596	1019	0.972
NULL	Core_Evid_2009_Jun_15_4_131-147.nxml.txt.nlp	20694070	SENT257	0	0	7	7	atazanavir	UGT1A1	PA10251	54658	0.972
NULL	Curr_Pathobiol_Rep_2014_Oct_17_2(4)_257-267.nxml.txt.nlp	25401052	SENT185	3	3	19	19	curcumin	NAC	PA151958596	22861	0.972
NULL	Hum_Genomics_2010_Apr_1_4(4)_238-249.nxml.txt.nlp	20511137	SENT57	7	7	14	14	sn-38	UGT1A1		54658	0.972
NULL	Front_Neurol_2014_Feb_18_5_17.nxml.txt.nlp	24600432	SENT41	13	13	21	21	levetiracetam	IL-1B	PA450206	3553	0.972
NULL	Biologics_2009_Sep_15_3_429-441.nxml.txt.nlp	19774210	SENT24	4	4	45	45	bevacizumab	IFL	PA130232992	3439	0.972
NULL	Trials_2013_May_4_14_125.nxml.txt.nlp	23782591	SENT183	6	6	34	34	galantamine	CYP3A4	PA449726	1576	0.972
NULL	Biosci_Rep_2012_Dec_20_33(1)_e00011.nxml.txt.nlp	23137297	SENT250	3	3	16	16	heparin	RPSA	PA449855	3921	0.972
NULL	Drug_Target_Insights_2013_Aug_19_7_27-34.nxml.txt.nlp	24023511	SENT34	22	22	2	2	tariquidar	P-gp		5243	0.972
NULL	Curr_Oncol_2009_Jul_16(Suppl_2)_S14-S23.nxml.txt.nlp	19672417	SENT160	32	32	5	5	anastrozole	ATAC	PA448432	6375	0.972
NULL	Clin_Ophthalmol_2014_Apr_28_8_807-812.nxml.txt.nlp	24812486	SENT29	41	41	13	13	ranibizumab	CRT	PA164746012	811	0.972
NULL	Front_Oncol_2013_Apr_29_3_92.nxml.txt.nlp	23641361	SENT67	27	27	23	23	bevacizumab	NF1	PA130232992	4763	0.972
NULL	J_Oral_Pathol_Med_2013_Jul_18_42(6)_499-506.nxml.txt.nlp	23331485	SENT198	22	22	18	18	celecoxib	COX	PA448871	1351	0.972
NULL	Patient_Prefer_Adherence_2013_Jul_3_7_633-641.nxml.txt.nlp	23861580	SENT200	21	21	43	43	acetazolamide	CO2	PA448018	4513	0.972
NULL	Br_J_Cancer_2009_Oct_6_101(7)_1155-1161.nxml.txt.nlp	19738614	SENT136	9	9	0	0	gemcitabine	MUC4	PA449748	4585	0.972
NULL	Nucleic_Acids_Res_2012_Jun_10_40(11)_4804-4815.nxml.txt.nlp	22328728	SENT235	5	5	23	23	hemin	SIRT1	PA449849	23411	0.972
NULL	Nat_Chem_Biol_2010_Apr_28_6(4)_291-299.nxml.txt.nlp	20190765	SENT145	26	26	19	19	dasatinib	EGFR	PA162372878	1956	0.972
NULL	J_Biol_Chem_2013_Nov_22_288(47)_34217-34229.nxml.txt.nlp	24106270	SENT219	3	3	7	7	thrombin	RhoG	PA451674	391	0.972
NULL	Ann_Rehabil_Med_2013_Dec_23_37(6)_839-847.nxml.txt.nlp	24466519	SENT138	0	0	8	8	diazepam	gamma	PA449283	9913	0.972
NULL	Ital_J_Pediatr_2012_Mar_30_38_11.nxml.txt.nlp	22464080	SENT13	11	11	24	24	oxatomide	CYP2D6	PA163522137	1565	0.972
NULL	Int_J_Gen_Med_2012_Nov_9_5_935-942.nxml.txt.nlp	23204857	SENT52	41	41	10	10	pentobarbital	AIDA	PA450859	64853	0.972
NULL	Biochemistry_2008_Sep_9_47(36)_9394-9404.nxml.txt.nlp	18702525	SENT107	5	5	20	20	dextran	IscU	PA449261	23479	0.972
NULL	Acta_Pharmacol_Sin_2012_Nov_4_33(11)_1379-1386.nxml.txt.nlp	22659626	SENT36	13	13	19	19	exenatide	STZ	PA164749238	6484	0.972
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1018.nxml.txt.nlp	24457962	SENT62	45	45	0	0	lapatinib	EGFR	PA152241907	1956	0.972
NULL	Front_Neurosci_2011_Feb_22_5_20.nxml.txt.nlp	21373362	SENT189	30	30	8	8	cyclophosphamide	IL-6	PA449165	3569	0.972
NULL	Br_J_Cancer_2010_Feb_2_102(3)_457-461.nxml.txt.nlp	20010942	SENT127	8	8	3	3	gefitinib	RANKL	PA131301952	8600	0.972
NULL	Cancer_Cell_Int_2010_Apr_29_10_12.nxml.txt.nlp	20429927	SENT96	23	23	3	3	bortezomib	HRI	PA10252	27102	0.972
NULL	Eur_Arch_Psychiatry_Clin_Neurosci_2010_Nov_14_260(Suppl_2)_81-89.nxml.txt.nlp	20945070	SENT129	16	16	12	12	clozapine	STX1A	PA449061	6804	0.972
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Sep_30_66(Pt_10)_o2686.nxml.txt.nlp	21587654	SENT54	9	9	33	33	benzaldehyde	mol	PA448571	90527	0.972
NULL	Clin_Med_Oncol_2008_Jun_11_2_469-470.nxml.txt.nlp	21892319	SENT22	0	0	23	23	trastuzumab	HER2	PA451743	2064	0.972
NULL	J_Inflamm_(Lond)_2008_Jul_29_5_11.nxml.txt.nlp	18664275	SENT16	6	6	15	15	ciprofloxacin	IL-8	PA449009	3576	0.972
NULL	Breast_Cancer_Res_2004_Aug_5_6(5)_R601-R607.nxml.txt.nlp	15318941	SENT137	14	14	2	2	docetaxel	p27	PA449383	5715;10534	0.972
NULL	Int_J_Breast_Cancer_2012_Oct_4_2012_439023.nxml.txt.nlp	23091732	SENT85	15	15	7	7	doxorubicin	CEA	PA449412	5670;1087	0.972
NULL	Aging_(Albany_NY)_2009_Jun_3_1(6)_515-528.nxml.txt.nlp	20157535	SENT18	7	7	16	16	resveratrol	SIRT1		23411	0.972
NULL	Crit_Care_2010_Apr_19_14(2)_R70.nxml.txt.nlp	20403177	SENT296	23	23	8	8	thrombin	RhoA	PA451674	387	0.972
NULL	J_Mol_Signal_2008_Dec_1_3_18.nxml.txt.nlp	19046439	SENT162	22	22	12	12	metformin	AMPK	PA450395	5563	0.972
NULL	Front_Oncol_2014_Apr_14_4_64.nxml.txt.nlp	24782981	SENT142	10	10	8	8	exemestane	aromatase	PA449563	1588	0.972
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2654-2664.nxml.txt.nlp	24136149	SENT140	20	20	5	5	doxorubicin	DNA-PKcs	PA449412	5591	0.972
NULL	Biomed_Res_Int_2014_May_4_2014_171892.nxml.txt.nlp	24883302	SENT134	0	0	17	17	sorafenib	BRAF	PA7000	673	0.972
NULL	Biomed_Res_Int_2013_Aug_19_2013_143202.nxml.txt.nlp	24024181	SENT102	17	17	9	9	cisplatin	CD133	PA449014	8842	0.972
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT35	1	1	6	6	warfarin	CYP2C9	PA451906	1559	0.972
NULL	J_Adv_Pract_Oncol_2012_Nov_1_Nov-Dec_3(6)_391-394.nxml.txt.nlp	25031970	SENT15	0	0	33	33	pertuzumab	EGFR		1956	0.972
NULL	Oncotarget_2014_Mar_14_5(10)_3029-3038.nxml.txt.nlp	24912489	SENT25	13	13	7	7	everolimus	aromatase	PA164746311	1588	0.972
NULL	Arch_Med_Sci_2011_Jun_11_7(3)_388-396.nxml.txt.nlp	22312373	SENT114	20	20	16	16	itraconazole	CYP3A	PA450132	1574	0.972
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT107	26	26	5	5	neratinib	HER2	PA165291472	2064	0.972
NULL	Sci_Rep_2015_Jan_6_5_7641.nxml.txt.nlp	25560734	SENT98	29	29	20	20	tamoxifen	CLTC	PA451581	1213	0.972
NULL	Ann_Hematol_2011_May_12_90(5)_557-568.nxml.txt.nlp	20938660	SENT207	23	23	11	11	plerixafor	CD34	PA165958410	947	0.972
NULL	Int_Semin_Surg_Oncol_2008_Apr_28_5_9.nxml.txt.nlp	18442393	SENT90	22	22	12	12	tamoxifen	aromatase	PA451581	1588	0.972
NULL	Cell_Cycle_2012_Nov_1_11(21)_4069-4078.nxml.txt.nlp	23095523	SENT144	18	18	4	4	imatinib	PERK	PA10804	9451	0.972
NULL	Evid_Based_Complement_Alternat_Med_2011_Feb_14_2011_248231.nxml.txt.nlp	19233878	SENT184	22	22	3	3	rosiglitazone	p85	PA451283	5296;5295;54776;23368	0.972
NULL	J_Biol_Chem_2013_Oct_11_288(41)_29692-29702.nxml.txt.nlp	24005668	SENT82	2	2	12	12	nadh	NO3	PA164755085	4681	0.972
NULL	Clin_Med_Insights_Cardiol_2010_Dec_1_4_117-128.nxml.txt.nlp	21151850	SENT119	28	28	13	13	clopidogrel	CYP3A5	PA449053	1577	0.972
NULL	Braz_J_Med_Biol_Res_2013_Aug_13_46(8)_650-658.nxml.txt.nlp	23969971	SENT31	1	1	19	19	oxaliplatin	STAT3	PA131285527	6774	0.972
NULL	Pain_Res_Treat_2012_Dec_8_2012_817347.nxml.txt.nlp	22191025	SENT120	23	23	30	30	amiloride	TRPV1	PA448368	7442	0.972
NULL	Brief_Bioinform_2014_Jul_31_15(4)_648-659.nxml.txt.nlp	23376192	SENT221	0	0	6	6	warfarin	CYP1A1	PA451906	1543	0.972
NULL	Int_J_Mol_Sci_2013_Apr_9_14(4)_7716-7741.nxml.txt.nlp	23571495	SENT201	31	31	15	15	atorvastatin	HDL2	PA448500	57338	0.972
NULL	Biomed_Res_Int_2013_Aug_19_2013_143202.nxml.txt.nlp	24024181	SENT102	17	17	34	34	cisplatin	MRP4	PA449014	10257	0.972
NULL	Lab_Invest_2014_May_10_94(5)_536-544.nxml.txt.nlp	24614194	SENT247	21	21	25	25	captopril	CD11b	PA448780	3684	0.972
NULL	J_Cell_Biol_1988_Feb_1_106(2)_395-401.nxml.txt.nlp	3276717	SENT10	29	29	5	5	valinomycin	EGF	PA151917011	1950	0.972
NULL	Front_Behav_Neurosci_2010_Apr_5_4_14.nxml.txt.nlp	20407577	SENT63	20	20	10	10	cocaine	hole	PA449072	80757	0.972
NULL	Cardiovasc_Diabetol_2010_Nov_16_9_76.nxml.txt.nlp	21080957	SENT23	0	0	36	36	exenatide	GLP-1	PA164749238	100125288	0.972
NULL	Breast_Cancer_Res_2005_Nov_21_7(6)_R1153-R1158.nxml.txt.nlp	16457695	SENT90	0	0	18	18	tamoxifen	EGFR	PA451581	1956	0.972
NULL	Br_J_Cancer_1988_Apr_57(4)_385-389.nxml.txt.nlp	3390373	SENT12	23	23	1	1	indomethacin	TNF-alpha	PA449982	7124	0.972
NULL	Diabetes_Metab_Syndr_Obes_2013_Sep_2_6_317-325.nxml.txt.nlp	24039439	SENT120	6	6	21	21	voglibose	GLP-1	PA164752433	100125288	0.972
NULL	Cell_Death_Dis_2014_Jul_3_5(7)_e1313.nxml.txt.nlp	24991765	SENT31	25	25	7	7	staurosporine	parkin	PA165109623	5071	0.972
NULL	Acta_Pharmacol_Sin_2013_Jan_5_34(1)_24-32.nxml.txt.nlp	23123646	SENT179	21	21	5	5	glibenclamide	SUR1	PA449782	6833	0.972
NULL	Br_J_Cancer_2014_Jan_21_110(2)_304-312.nxml.txt.nlp	24300978	SENT192	28	28	1	1	gemcitabine	NT5C2	PA449748	22978	0.972
NULL	Case_Rep_Oncol_2012_Jul_24_5(2)_394-399.nxml.txt.nlp	23525369	SENT68	14	14	0	0	trastuzumab	HER2	PA451743	2064	0.972
NULL	Arthritis_Res_Ther_2013_Jul_11_15(4)_R74.nxml.txt.nlp	23845159	SENT223	31	31	5	5	trypsin	CCL2	PA451806	6347	0.972
NULL	Adv_Appl_Bioinforma_Chem_2008_Oct_30_1_85-98.nxml.txt.nlp	21918608	SENT80	4	4	27	27	bortezomib	SPARC	PA10252	6678	0.972
NULL	Biosci_Microbiota_Food_Health_2014_Jan_30_33(1)_47-51.nxml.txt.nlp	24936382	SENT51	14	14	2	2	mitomycin	CD4	PA450524	920	0.972
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S18-S30.nxml.txt.nlp	20680104	SENT196	5	5	18	18	panitumumab	IFL	PA162373091	3439	0.972
NULL	F1000Res_2013_Mar_5_2_74.nxml.txt.nlp	24358880	SENT162	18	18	5	5	capsaicin	TRPV1	PA448776	7442	0.972
NULL	Mol_Cancer_2012_Mar_25_11_16.nxml.txt.nlp	22443473	SENT423	11	11	19	19	imatinib	CD34	PA10804	947	0.972
NULL	BMJ_2011_Aug_4_343_d4588.nxml.txt.nlp	21816733	SENT71	13	13	34	34	clopidogrel	CYP2C19	PA449053	1557	0.972
NULL	J_Hematol_Oncol_2013_Nov_5_6_83.nxml.txt.nlp	24283248	SENT117	39	39	13	13	nutlin-3	TP53		7157	0.972
NULL	Eur_J_Med_Res_2009_Nov_24_14(Suppl_3)_36-42.nxml.txt.nlp	19959415	SENT111	1	1	9	9	gs-9350	CYP3A		1574	0.972
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT134	12	12	44	44	pp2	CD19		930	0.972
NULL	Pain_Res_Treat_2013_Jan_30_2013_217864.nxml.txt.nlp	23431433	SENT94	7	7	37	37	amiloride	NHE	PA448368	285335	0.972
NULL	J_Cell_Biol_2001_Oct_15_155(2)_207-216.nxml.txt.nlp	11591730	SENT104	25	25	5	5	camptothecin	p53	PA153590860	7157	0.972
NULL	Mol_Cancer_2009_Jun_9_8_37.nxml.txt.nlp	19508729	SENT120	2	2	18	18	gemcitabine	HO-1	PA449748	3162	0.972
NULL	J_Med_Chem_2014_Jan_23_57(2)_449-461.nxml.txt.nlp	24387105	SENT143	27	27	14	14	cyclophosphamide	ALDH1A1	PA449165	216	0.972
NULL	Oncol_Lett_2013_Feb_9_5(2)_552-558.nxml.txt.nlp	23420128	SENT31	11	11	5	5	imatinib	KIT	PA10804	3815	0.972
NULL	Comp_Hepatol_2003_Jan_31_2_3.nxml.txt.nlp	12622871	SENT451	13	13	19	19	troglitazone	PPARgamma	PA451799	5468	0.972
NULL	J_Oncol_2012_Jun_4_2012_928127.nxml.txt.nlp	22701483	SENT166	21	21	8	8	trastuzumab	CD24	PA451743	100133941	0.972
NULL	Exp_Transl_Stroke_Med_2012_Oct_30_4_21.nxml.txt.nlp	23110876	SENT106	39	39	20	20	eplerenone	IL-17	PA164749044	3605	0.972
NULL	Oncologist_2010_Feb_15_15(2)_122-129.nxml.txt.nlp	20156908	SENT131	7	7	5	5	letrozole	aromatase	PA450196	1588	0.972
NULL	Indian_J_Nucl_Med_2011_Jul-Sep_26(Suppl1)_S37-S49.nxml.txt.nlp	NULL	SENT631	3	3	19	19	cinnarizine	gamma	PA164749342	9913	0.972
NULL	Int_J_Breast_Cancer_2012_May_9_2012_415170.nxml.txt.nlp	22649737	SENT44	3	3	36	36	trastuzumab	PI3K	PA451743	5290	0.972
NULL	Int_J_Mol_Sci_2012_Apr_16_13(4)_4831-4838.nxml.txt.nlp	22606012	SENT51	17	17	25	25	curcumin	JNK	PA151958596	5599	0.972
NULL	Proteome_Sci_2003_Jun_12_1_4.nxml.txt.nlp	12818002	SENT86	18	18	5	5	chymotrypsin	PEBP	PA448994	5037	0.972
NULL	Med_Sci_Monit_2013_Oct_31_19_916-926.nxml.txt.nlp	24172537	SENT113	29	29	2	2	cisplatin	BRCA2	PA449014	675	0.972
NULL	Int_J_Chron_Obstruct_Pulmon_Dis_2006_Dec_1(4)_345-354.nxml.txt.nlp	18044091	SENT107	40	40	9	9	salmeterol	NNT	PA451300	23530	0.972
NULL	Oncotarget_2011_Mar_23_2(3)_165-177.nxml.txt.nlp	21444946	SENT182	7	7	12	12	cetuximab	KRAS	PA10040	3845	0.972
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT332	8	8	12	12	forskolin	PDE	PA146096022	501	0.972
NULL	J_Immunol_Res_2014_May_15_2014_175265.nxml.txt.nlp	24949488	SENT259	0	0	27	27	cyclophosphamide	CHS	PA449165	1130	0.972
NULL	Oncotarget_2014_Feb_7_5(3)_775-787.nxml.txt.nlp	24519956	SENT110	28	28	0	0	dasatinib	PC3	PA162372878	57332;7832;5122	0.972
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT160	11	11	1	1	doxorubicin	SLK	PA449412	9748;2534	0.972
NULL	Tuberc_Respir_Dis_(Seoul)_2013_Jan_31_74(1)_37-40.nxml.txt.nlp	23390452	SENT27	0	0	12	12	erlotinib	EGFR	PA134687924	1956	0.972
NULL	Arthritis_Res_Ther_2010_Oct_28_12(5)_219.nxml.txt.nlp	21062511	SENT135	29	29	39	39	infliximab	IFN	PA452639	3439	0.972
NULL	Oncotarget_2011_Nov_9_2(11)_850-861.nxml.txt.nlp	22081665	SENT178	14	14	4	4	daunorubicin	DNMT3A	PA449212	1788	0.972
NULL	J_Signal_Transduct_2011_Apr_4_2011_865819.nxml.txt.nlp	21776389	SENT237	0	0	23	23	saracatinib	EGFR		1956	0.972
NULL	Aging_(Albany_NY)_2013_Aug_11_5(8)_592-598.nxml.txt.nlp	23934728	SENT28	28	28	1	1	oxygen	MTOR	PA450744	2475	0.972
NULL	Clin_Ophthalmol_2010_Nov_3_4_1253-1261.nxml.txt.nlp	21151330	SENT52	1	1	18	18	latanoprost	BAK	PA164774763	578	0.972
NULL	Nat_Methods_2012_Feb_19_9(4)_396-402.nxml.txt.nlp	22343342	SENT206	18	18	5	5	isoflurane	TRPV1	PA450106	7442	0.972
NULL	J_Hematol_Oncol_2009_Feb_23_2_9.nxml.txt.nlp	19236713	SENT71	43	43	31	31	bevacizumab	KRAS	PA130232992	3845	0.972
NULL	Nat_Genet_2013_Jul_2_45(7)_747-755.nxml.txt.nlp	23727860	SENT244	8	8	14	14	bicalutamide	XIAP	PA164746255	331	0.972
NULL	Ann_Med_Health_Sci_Res_2013_Apr-Jun_3(2)_282-284.nxml.txt.nlp	23919207	SENT70	9	9	4	4	isoniazid	RGM	PA450112	56963	0.972
NULL	Eur_J_Clin_Microbiol_Infect_Dis_2012_Jul_26_31(7)_1647-1652.nxml.txt.nlp	22278291	SENT25	23	23	13	13	fluconazole	ARTEMIS	PA449653	64421	0.972
NULL	Eur_J_Med_Res_2009_Nov_24_14(Suppl_3)_36-42.nxml.txt.nlp	19959415	SENT110	0	0	17	17	elvitegravir	CYP3A	PA165291498	1574	0.972
NULL	Target_Oncol_2013_Mar_30_8(1)_27-33.nxml.txt.nlp	23361373	SENT37	16	16	41	41	gefitinib	EGFR	PA131301952	1956	0.972
NULL	J_Adv_Pract_Oncol_2014_May_1_May-Jun_5(3)_205-210.nxml.txt.nlp	25089219	SENT94	33	33	14	14	capecitabine	DPD	PA448771	1806	0.972
NULL	Nucleic_Acids_Res_2010_Oct_4_38(19)_6375-6388.nxml.txt.nlp	20525792	SENT270	0	0	15	15	doxycycline	YY1	PA449415	7528	0.972
NULL	Contemp_Oncol_(Pozn)_2012_Jul_6_16(3)_223-229.nxml.txt.nlp	23788884	SENT73	5	5	9	9	metformin	LKB1	PA450395	6794	0.972
NULL	Mol_Vis_2014_May_13_20_649-660.nxml.txt.nlp	24868139	SENT38	0	0	34	34	ranibizumab	VEGF-A	PA164746012	7422	0.972
NULL	Indian_J_Med_Res_2013_Oct_138(4)_461-491.nxml.txt.nlp	24434254	SENT484	0	0	15	15	simvastatin	CYP3A4	PA451363	1576	0.972
NULL	Cancer_Cell_Int_2008_Jan_4_8_1.nxml.txt.nlp	18177496	SENT41	22	22	3	3	gefitinib	EWS	PA131301952	2130	0.972
NULL	Cell_Death_Dis_2012_Jun_21_3(6)_e325.nxml.txt.nlp	22717580	SENT122	3	3	30	30	tamoxifen	STOP	PA451581	4135	0.972
NULL	Adolesc_Health_Med_Ther_2013_Aug_27_4_79-87.nxml.txt.nlp	24600298	SENT46	30	30	24	24	raltegravir	UGT1A1		54658	0.972
NULL	Acta_Pharmacol_Sin_2012_May_26_33(5)_675-681.nxml.txt.nlp	22447226	SENT17	5	5	21	21	gefitinib	survivin	PA131301952	332	0.972
NULL	Arch_Med_Sci_2011_Jun_11_7(3)_388-396.nxml.txt.nlp	22312373	SENT158	9	9	18	18	simvastatin	CYP3A	PA451363	1574	0.972
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT67	18	18	1	1	gefitinib	PI3K	PA131301952	5290	0.972
NULL	Acta_Pharmacol_Sin_2014_Aug_30_35(8)_1045-1054.nxml.txt.nlp	24976155	SENT13	32	32	3	3	resveratrol	STAT3		6774	0.972
NULL	Cancer_Metastasis_Rev_2014_Dec_28_33(1)_161-171.nxml.txt.nlp	24375389	SENT279	12	12	3	3	docetaxel	CHFR	PA449383	55743	0.972
NULL	Cancer_Cell_Int_2009_Feb_17_9_4.nxml.txt.nlp	19222856	SENT195	20	20	3	3	cisplatin	p53	PA449014	7157	0.972
NULL	Mol_Cancer_2012_Apr_19_11_22.nxml.txt.nlp	22515704	SENT22	19	19	17	17	vemurafenib	BRAF	PA165946873	673	0.972
NULL	Br_J_Cancer_2009_Jul_21_101(2)_263-268.nxml.txt.nlp	19603032	SENT146	45	45	21	21	dasatinib	PC-3	PA162372878	692094	0.972
NULL	Mol_Cancer_2010_May_26_9_121.nxml.txt.nlp	20500904	SENT68	18	18	10	10	gefitinib	EGF	PA131301952	1950	0.972
NULL	Toxins_(Basel)_2010_Mar_31_2(4)_517-551.nxml.txt.nlp	22069598	SENT126	11	11	31	31	curcumin	Bcl-2	PA151958596	596	0.972
NULL	Tuberc_Res_Treat_2014_Apr_16_2014_753492.nxml.txt.nlp	24834351	SENT7	14	14	0	0	isoniazid	DST	PA450112	667	0.972
NULL	J_Korean_Med_Sci_2007_Jun_30_22(3)_393-399.nxml.txt.nlp	17596643	SENT19	10	10	5	5	gefitinib	EGFR	PA131301952	1956	0.972
NULL	Breast_Cancer_Res_Treat_2013_Jun_7_139(2)_411-419.nxml.txt.nlp	23649189	SENT20	0	0	12	12	bevacizumab	VEGF-A	PA130232992	7422	0.972
NULL	Eur_J_Clin_Pharmacol_2010_Nov_29_66(11)_1131-1136.nxml.txt.nlp	20669013	SENT133	41	41	1	1	erythromycin	CYP2C19	PA449493	1557	0.972
NULL	Breast_Cancer_Res_2011_Nov_30_13(6)_R123.nxml.txt.nlp	22129105	SENT198	41	41	4	4	trastuzumab	IL-6	PA451743	3569	0.972
NULL	Eur_J_Clin_Pharmacol_2012_Jan_7_68(1)_55-64.nxml.txt.nlp	21735164	SENT311	4	4	11	11	oxycodone	CYP2D6	PA450741	1565	0.972
NULL	Clin_Exp_Metastasis_2014_Sep_17_31(1)_135-147.nxml.txt.nlp	24043563	SENT189	21	21	4	4	paclitaxel	KLK4	PA450761	9622	0.972
NULL	Commun_Integr_Biol_2013_Sep_1_6(5)_e25446.nxml.txt.nlp	24265857	SENT89	7	7	0	0	heparin	FGF1	PA449855	2246	0.972
NULL	Biol_Cell_2014_Feb_8_106(2)_45-56.nxml.txt.nlp	24313290	SENT82	8	8	13	13	phenylephrine	NKCC1	PA450935	6558	0.972
NULL	Dermatoendocrinol_2012_Jul_1_4(3)_320-323.nxml.txt.nlp	23467502	SENT69	2	2	19	19	ustekinumab	IL-23	PA166048654	51561	0.972
NULL	Ann_Hematol_2014_Apr_1_93(8)_1371-1380.nxml.txt.nlp	24687382	SENT27	3	3	16	16	thalidomide	CRBN	PA451644	51185	0.972
NULL	Cardiovasc_Psychiatry_Neurol_2010_Jul_8_2010_801295.nxml.txt.nlp	20671945	SENT17	25	25	2	2	naloxone	S100B	PA450586	6285	0.972
NULL	Med_Sci_Monit_2013_Feb_7_19_95-101.nxml.txt.nlp	23396358	SENT114	0	0	18	18	glucose	FDG	PA449773	23583	0.972
NULL	Breast_Cancer_Res_2012_May_2_14(3)_R70.nxml.txt.nlp	22551440	SENT259	29	29	20	20	docetaxel	p53	PA449383	7157	0.972
NULL	Int_J_Breast_Cancer_2011_Jul_12_2011_232435.nxml.txt.nlp	22295213	SENT144	9	9	0	0	tamoxifen	PAK1	PA451581	5585;5058	0.972
NULL	Mol_Cancer_2010_Jun_24_9_164.nxml.txt.nlp	20576107	SENT195	29	29	5	5	etoposide	Bcl-2	PA449552	596	0.972
NULL	Nat_Commun_2013_Oct_25_4_2667.nxml.txt.nlp	24157709	SENT68	3	3	15	15	nutlin-3	p53		7157	0.972
NULL	Nat_Genet_2011_Jan_12_43(1)_27-33.nxml.txt.nlp	21151129	SENT109	22	22	4	4	tamoxifen	FOXA1	PA451581	3169	0.972
NULL	Ann_Neurosci_2011_Apr_18(2)_48-55.nxml.txt.nlp	25205921	SENT118	7	7	2	2	forskolin	SOD1	PA146096022	6647	0.972
NULL	Arthritis_Res_Ther_2009_May_21_11(3)_R76.nxml.txt.nlp	19460157	SENT50	12	12	19	19	etanercept	ACR	PA449515	49	0.972
NULL	J_Cancer_2013_Sep_27_4(8)_662-670.nxml.txt.nlp	24155778	SENT144	22	22	2	2	cisplatin	UCHL1	PA449014	7345	0.972
NULL	Bioinformation_2008_Dec_31_3(5)_198-204.nxml.txt.nlp	19255634	SENT101	27	27	42	42	diltiazem	CYP2B	PA449334	1554;1556	0.972
NULL	J_Cell_Biol_2001_Apr_2_153(1)_207-220.nxml.txt.nlp	11285286	SENT115	5	5	15	15	carbachol	CD69	PA448784	969	0.972
NULL	Exp_Diabetes_Res_2012_Oct_15_2012_465282.nxml.txt.nlp	23118742	SENT105	3	3	9	9	metformin	FGF21	PA450395	26291	0.972
NULL	Contemp_Oncol_(Pozn)_2013_Apr_29_17(2)_128-133.nxml.txt.nlp	23788978	SENT44	26	26	35	35	oxymorphone	CYP3A4	PA450748	1576	0.972
NULL	Biomed_Res_Int_2014_Mar_6_2014_757461.nxml.txt.nlp	24734243	SENT91	12	12	38	38	estradiol	MCH	PA449503	5367	0.972
NULL	Front_Hum_Neurosci_2010_Nov_2_4_187.nxml.txt.nlp	21103019	SENT31	40	40	5	5	carbachol	gamma	PA448784	9913	0.972
NULL	Oncologist_2010_Mar_9_15(3)_236-245.nxml.txt.nlp	20215359	SENT87	4	4	17	17	bevacizumab	IFN	PA130232992	3439	0.972
NULL	Oxid_Med_Cell_Longev_2014_Apr_30_2014_149627.nxml.txt.nlp	24876909	SENT221	0	0	17	17	ethanol	CYP2E1	PA448073	1571	0.972
NULL	Pharmaceuticals_(Basel)_2013_Jan_28_6(2)_124-160.nxml.txt.nlp	24275945	SENT357	4	4	2	2	probenecid	OAT	PA451106	4942	0.972
NULL	Case_Rep_Oncol_2012_Oct_10_5(3)_546-553.nxml.txt.nlp	23139670	SENT118	10	10	43	43	pemetrexed	EGFR	PA10810	1956	0.972
NULL	Curr_Neuropharmacol_2013_Dec_11(6)_652-663.nxml.txt.nlp	24396340	SENT198	1	1	4	4	lidocaine	TRPV1	PA450226	7442	0.972
NULL	EJNMMI_Res_2011_Nov_10_1_25.nxml.txt.nlp	22214344	SENT213	26	26	24	24	entacapone	COMT	PA164748726	1312	0.972
NULL	Mol_Cancer_2010_May_28_9_130.nxml.txt.nlp	20509890	SENT95	19	19	10	10	etoposide	TGFBI	PA449552	7045	0.972
NULL	Exp_Ther_Med_2013_Oct_2_6(4)_1062-1066.nxml.txt.nlp	24137317	SENT32	0	0	17	17	erlotinib	EGFR	PA134687924	1956	0.972
NULL	Pharmaceuticals_(Basel)_2012_Nov_20_5(11)_1236-1264.nxml.txt.nlp	24281308	SENT230	4	4	35	35	everolimus	EGFR	PA164746311	1956	0.972
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S279-S284.nxml.txt.nlp	21525469	SENT136	29	29	5	5	liraglutide	GLP-1	PA165958364	100125288	0.972
NULL	Springerplus_2013_Dec_7_2_659.nxml.txt.nlp	24353977	SENT205	4	4	15	15	ketotifen	MSU	PA450152	593	0.972
NULL	J_Hematol_Oncol_2009_Jan_21_2_2.nxml.txt.nlp	19159467	SENT148	23	23	8	8	gefitinib	EGFR	PA131301952	1956	0.972
NULL	Int_J_Gen_Med_2013_Dec_4_6_877-895.nxml.txt.nlp	24403842	SENT63	0	0	29	29	liraglutide	PPG	PA165958364	5552	0.972
NULL	Basic_Clin_Pharmacol_Toxicol_2013_Feb_5_112(2)_132-137.nxml.txt.nlp	22900583	SENT155	35	35	43	43	ketoconazole	CYP3A4	PA450146	1576	0.972
NULL	J_Neurosci_Rural_Pract_2010_Jul-Dec_1(2)_63-66.nxml.txt.nlp	21808505	SENT24	27	27	12	12	stavudine	gamma	PA451494	9913	0.972
NULL	Clin_Exp_Gastroenterol_2011_Dec_12_4_291-296.nxml.txt.nlp	22235173	SENT95	2	2	29	29	hesperidin	ghrelin	PA449867	51738	0.972
NULL	Acta_Neuropathol_2015_Oct_17_129_115-131.nxml.txt.nlp	25322816	SENT187	12	12	5	5	bevacizumab	HIF1	PA130232992	3091	0.972
NULL	Acta_Pharmacol_Sin_2013_Sep_5_34(9)_1192-1200.nxml.txt.nlp	23685957	SENT205	25	25	8	8	curcumin	AKT	PA151958596	207	0.972
NULL	J_Cancer_Res_Clin_Oncol_2015_Aug_3_141_61-68.nxml.txt.nlp	25086987	SENT21	11	11	30	30	afatinib	EGFR	PA165981154	1956	0.972
NULL	Gastric_Cancer_2014_Apr_7_17(1)_1-12.nxml.txt.nlp	23563986	SENT168	0	0	9	9	pertuzumab	HER2		2064	0.972
NULL	Croat_Med_J_2013_Apr_54(2)_171-179.nxml.txt.nlp	23630144	SENT45	0	0	19	19	taurine	STZ	PA451590	6484	0.972
NULL	J_Gen_Physiol_2000_Jun_1_115(6)_685-696.nxml.txt.nlp	10828243	SENT123	30	30	16	16	genistein	OLF	PA165109660	83857	0.972
NULL	Mol_Cancer_2008_Jun_5_7_50.nxml.txt.nlp	18534018	SENT86	14	14	0	0	bortezomib	HSP27	PA10252	3315	0.972
NULL	J_Asthma_Allergy_2008_Sep_19_1_19-29.nxml.txt.nlp	21436982	SENT74	0	0	17	17	probenecid	OAT3	PA451106	9376	0.972
NULL	J_Neurosci_Rural_Pract_2010_Jul-Dec_1(2)_63-66.nxml.txt.nlp	21808505	SENT24	29	29	12	12	lamivudine	gamma	PA450163	9913	0.972
NULL	Ann_Rheum_Dis_2008_Aug_29_67(8)_1096-1103.nxml.txt.nlp	18055472	SENT191	27	27	9	9	abatacept	ACR	PA164747080	49	0.972
NULL	Alcohol_Res_Health_2007_30(1)_38-47.nxml.txt.nlp	17718399	SENT173	8	8	27	27	ethanol	CYP2E1	PA448073	1571	0.972
NULL	Virol_J_2010_Jun_30_7_145.nxml.txt.nlp	20591155	SENT91	16	16	10	10	amantadine	H10	PA448360	3005	0.972
NULL	Mol_Biol_Cell_2012_Nov_1_23(21)_4212-4225.nxml.txt.nlp	22956765	SENT174	25	25	6	6	thrombin	SHP2	PA451674	5781	0.972
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Sep_19_65(Pt_10)_o2496.nxml.txt.nlp	21577946	SENT67	6	6	28	28	isoniazid	mol	PA450112	90527	0.972
NULL	Clin_Med_Insights_Oncol_2012_Dec_6_6_407-421.nxml.txt.nlp	23239933	SENT120	37	37	1	1	gefitinib	EGFR	PA131301952	1956	0.972
NULL	Oncologist_2010_Sep_26_15(9)_944-953.nxml.txt.nlp	20798196	SENT41	24	24	15	15	capecitabine	HER-2	PA448771	2064	0.972
NULL	Mol_Cancer_2010_Aug_4_9_208.nxml.txt.nlp	20684776	SENT51	29	29	14	14	doxorubicin	CDK2	PA449412	1017	0.972
NULL	Front_Oncol_2013_Sep_9_3_235.nxml.txt.nlp	24058902	SENT191	13	13	2	2	gefitinib	EGFR	PA131301952	1956	0.972
NULL	Arthritis_Res_Ther_2006_Dec_16_8(1)_R15.nxml.txt.nlp	16507115	SENT170	26	26	1	1	methotrexate	CD62L	PA450428	6402	0.972
NULL	BMJ_Open_2013_Sep_3_3(9)_e003201.nxml.txt.nlp	24002982	SENT209	10	10	17	17	voglibose	GLP-1	PA164752433	100125288	0.972
NULL	Clin_Ophthalmol_2010_Nov_22_4_1331-1346.nxml.txt.nlp	21139674	SENT57	0	0	13	13	dorzolamide	CYP2E1	PA164748765	1571	0.972
NULL	J_Clin_Biochem_Nutr_2007_Jan_27_40(1)_13-23.nxml.txt.nlp	18437209	SENT563	18	18	2	2	trypsin	IL-8	PA451806	3576	0.972
NULL	Oncotarget_2012_May_18_3(5)_525-534.nxml.txt.nlp	22619113	SENT27	21	21	9	9	fludarabine	Hsp90	PA449655	3320	0.972
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_P8.nxml.txt.nlp	NULL	SENT14	11	11	17	17	methylprednisolone	DPT	PA450466	1805	0.972
NULL	Br_J_Pharmacol_2014_Jun_15_171(11)_2705-2725.nxml.txt.nlp	24467436	SENT293	14	14	10	10	isoniazid	NAT	PA450112	6046	0.972
NULL	J_Gen_Physiol_1997_Dec_1_110(6)_643-654.nxml.txt.nlp	9382893	SENT157	39	39	26	26	trypsin	SUR1	PA451806	6833	0.972
NULL	Cancer_Imaging_2008_Nov_25_8(1)_199-205.nxml.txt.nlp	19028612	SENT125	21	21	37	37	sunitinib	VEGFR	PA162372840	3791	0.972
NULL	Osteoporos_Int_2013_May_4_24(10)_2659-2670.nxml.txt.nlp	23644877	SENT274	0	0	3	3	metformin	AMPK	PA450395	5563	0.972
NULL	Indian_J_Pharm_Sci_2014_May-Jun_76(3)_203-210.nxml.txt.nlp	25035531	SENT166	11	11	24	24	pindolol	5-HT1A	PA450966	3350	0.972
NULL	Database_(Oxford)_2014_Dec_23_2014_bau124.nxml.txt.nlp	25539768	SENT128	6	6	16	16	cetuximab	EGFR	PA10040	1956	0.972
NULL	J_Int_Soc_Sports_Nutr_2009_Aug_5_6_16.nxml.txt.nlp	19656392	SENT281	0	0	25	25	creatine	p38	PA164778930	10598;1432;7965	0.972
NULL	Int_J_Endocrinol_2013_Nov_13_2013_686315.nxml.txt.nlp	24324494	SENT71	24	24	38	38	glimepiride	CYP2C9	PA449761	1559	0.972
NULL	Arthritis_Res_Ther_2009_Nov_4_11(6)_R165.nxml.txt.nlp	19889203	SENT339	17	17	5	5	resveratrol	p65		5970	0.972
NULL	Br_J_Cancer_2013_May_28_108(10)_2039-2044.nxml.txt.nlp	23652306	SENT88	17	17	28	28	carboplatin	SRC3	PA448803	8202	0.972
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT221	16	16	29	29	capsaicin	MDM2	PA448776	4193	0.972
NULL	J_Mol_Signal_2008_Dec_1_3_18.nxml.txt.nlp	19046439	SENT184	37	37	20	20	metformin	p53	PA450395	7157	0.972
NULL	Br_J_Cancer_2009_Mar_24_100(6)_971-978.nxml.txt.nlp	19240722	SENT135	11	11	6	6	bevacizumab	VEGF-A	PA130232992	7422	0.972
NULL	Adv_Urol_2012_Oct_26_2012_812398.nxml.txt.nlp	22110495	SENT48	15	15	9	9	cisplatin	ERCC1	PA449014	2067	0.972
NULL	Oncotarget_2014_Oct_21_5(22)_11252-11268.nxml.txt.nlp	25361004	SENT181	24	24	2	2	metformin	CLIC1	PA450395	1192	0.972
NULL	Eur_J_Clin_Pharmacol_2012_Jan_8_68(1)_29-37.nxml.txt.nlp	21739267	SENT9	2	2	39	39	fluvoxamine	CYP2D6	PA449690	1565	0.972
NULL	Biomed_Res_Int_2013_Jul_16_2013_687658.nxml.txt.nlp	23956997	SENT153	0	0	10	10	trypsin	PH1	PA451806	189	0.972
NULL	Acta_Pharmacol_Sin_2013_Jan_3_34(1)_119-128.nxml.txt.nlp	23202804	SENT138	0	0	5	5	rimonabant	CB1	PA152407999	1268	0.972
NULL	Mol_Cancer_2007_Sep_26_6_61.nxml.txt.nlp	17894897	SENT98	30	30	7	7	etoposide	HIF-1	PA449552	29072	0.972
NULL	Diabetes_2009_Jun_31_58(6)_1434-1439.nxml.txt.nlp	19336679	SENT151	41	41	15	15	metformin	SLC22A1	PA450395	6580	0.972
NULL	Case_Rep_Oncol_2012_Dec_6_5(3)_651-656.nxml.txt.nlp	23275781	SENT107	6	6	16	16	sunitinib	FDG	PA162372840	23583	0.972
NULL	Sci_Rep_2015_Jan_6_5_7641.nxml.txt.nlp	25560734	SENT98	29	29	4	4	tamoxifen	CLTC	PA451581	1213	0.972
NULL	Breast_Cancer_(Dove_Med_Press)_2014_May_2_6_59-71.nxml.txt.nlp	24833917	SENT131	23	23	1	1	exemestane	aromatase	PA449563	1588	0.972
NULL	Mol_Biol_Cell_2013_Sep_1_24(17)_2633-2644.nxml.txt.nlp	23864717	SENT334	4	4	16	16	busulfan	SMAP2	PA448691	64744;64094	0.972
NULL	Breast_Cancer_Res_2014_May_28_16(3)_R53.nxml.txt.nlp	24886537	SENT267	11	11	5	5	tamoxifen	VAV3	PA451581	10451	0.972
NULL	Acta_Pharmacol_Sin_2009_Oct_21_30(10)_1392-1398.nxml.txt.nlp	19767766	SENT185	3	3	15	15	atorvastatin	NAC	PA448500	22861	0.972
NULL	Mol_Syst_Biol_2010_Dec_21_6_453.nxml.txt.nlp	21179025	SENT189	22	22	17	17	sorafenib	VEGFR	PA7000	3791	0.972
NULL	Breast_Cancer_Res_2005_Dec_7_7(1)_R156-R163.nxml.txt.nlp	15642164	SENT194	24	24	19	19	letrozole	aromatase	PA450196	1588	0.972
NULL	Int_J_Endocrinol_Metab_2013_Dec_21_Winter_11(1)_57-61.nxml.txt.nlp	23853622	SENT122	18	18	7	7	bromocriptine	PRL	PA448671	5617	0.972
NULL	Clin_Genet_2014_Feb_9_86(1)_1-11.nxml.txt.nlp	24665880	SENT148	5	5	23	23	ranibizumab	VEGFA	PA164746012	7422	0.972
NULL	Curr_Neuropharmacol_2009_Mar_7(1)_37-49.nxml.txt.nlp	19721816	SENT187	12	12	47	47	capsaicin	ghrelin	PA448776	51738	0.972
NULL	Curr_Cardiol_Rev_2010_Nov_6(4)_309-324.nxml.txt.nlp	22043207	SENT187	1	1	10	10	rosiglitazone	CD36	PA451283	948	0.972
NULL	Breast_Cancer_Res_2010_Jun_24_12(3)_R41.nxml.txt.nlp	20576088	SENT137	9	9	0	0	erlotinib	EGFR	PA134687924	1956	0.972
NULL	Aging_(Albany_NY)_2009_Jun_3_1(6)_515-528.nxml.txt.nlp	20157535	SENT9	26	26	32	32	resveratrol	S6K1		6198	0.972
NULL	Br_J_Cancer_2012_Jan_3_106(1)_148-156.nxml.txt.nlp	22045191	SENT169	32	32	24	24	erlotinib	ZEB1	PA134687924	6935	0.972
NULL	Oncogenesis_2014_Dec_15_3(12)_e133.nxml.txt.nlp	25500906	SENT108	27	27	3	3	trastuzumab	HER3	PA451743	2065	0.972
NULL	Case_Rep_Oncol_Med_2013_Mar_14_2013_793418.nxml.txt.nlp	23573438	SENT25	0	0	4	4	anastrozole	aromatase	PA448432	1588	0.972
NULL	Br_J_Cancer_2011_Jun_7_104(12)_1848-1853.nxml.txt.nlp	21610704	SENT124	11	11	17	17	panitumumab	REL	PA162373091	5966	0.972
NULL	Drugs_Context_2012_Dec_11_2012_212244.nxml.txt.nlp	24432033	SENT7	7	7	3	3	gemcitabine	EGFR	PA449748	1956	0.972
NULL	Neuro_Oncol_2011_Jan_25_13(1)_70-83.nxml.txt.nlp	20978004	SENT260	28	28	3	3	etoposide	CD133	PA449552	8842	0.972
NULL	Oncol_Lett_2014_Aug_19_8(2)_809-812.nxml.txt.nlp	25009658	SENT69	0	0	4	4	metformin	AMPK	PA450395	5563	0.972
NULL	Mediators_Inflamm_2002_Feb_11(1)_17-22.nxml.txt.nlp	11926591	SENT5	24	24	5	5	genistein	COX	PA165109660	1351	0.972
NULL	Cell_Cycle_2012_Dec_15_11(24)_4661-4672.nxml.txt.nlp	23187802	SENT124	30	30	15	15	doxorubicin	p53	PA449412	7157	0.972
NULL	BMB_Rep_2014_Jul_47(7)_376-381.nxml.txt.nlp	24286332	SENT65	14	14	4	4	thrombin	PPG	PA451674	5552	0.972
NULL	Ann_Oncol_2014_Oct_23_25(10)_1941-1948.nxml.txt.nlp	25057173	SENT108	2	2	22	22	docetaxel	EGFR	PA449383	1956	0.972
NULL	Eur_J_Clin_Pharmacol_2009_Dec_8_65(12)_1245-1251.nxml.txt.nlp	19669131	SENT159	11	11	21	21	pramipexole	DRD3	PA164742949	1814	0.972
NULL	Int_J_Breast_Cancer_2011_Jul_12_2011_232435.nxml.txt.nlp	22295213	SENT107	36	36	21	21	tamoxifen	CDK7	PA451581	1022	0.972
NULL	Oncotarget_2013_Jun_4_4(5)_772-784.nxml.txt.nlp	23800712	SENT23	2	2	26	26	erlotinib	EGFR	PA134687924	1956	0.972
NULL	Oncogene_2014_Jun_26_33(26)_3422-3431.nxml.txt.nlp	23912457	SENT19	0	0	10	10	trastuzumab	PI3K	PA451743	5290	0.972
NULL	Int_J_Cell_Biol_2014_Jan_22_2014_709828.nxml.txt.nlp	24578708	SENT76	0	0	45	45	choline	CDw92	PA448976	23446	0.972
NULL	Exp_Ther_Med_2013_Nov_6_6(5)_1089-1095.nxml.txt.nlp	24223627	SENT42	21	21	14	14	trastuzumab	HER2	PA451743	2064	0.972
NULL	Oncotarget_2011_Mar_23_2(3)_165-177.nxml.txt.nlp	21444946	SENT60	21	21	26	26	gefitinib	EGFR	PA131301952	1956	0.972
NULL	Breast_Cancer_(Auckl)_2011_Jan_13_5_1-14.nxml.txt.nlp	21494397	SENT48	13	13	5	5	ketoconazole	CYP3A4	PA450146	1576	0.972
NULL	Arthritis_Res_Ther_2003_Sep_3_5(6)_R317-R328.nxml.txt.nlp	14680506	SENT208	7	7	28	28	rolipram	IL-10	PA153906323	3586	0.972
NULL	Biomed_Res_Int_2014_Feb_27_2014_897653.nxml.txt.nlp	24719894	SENT61	33	33	22	22	risperidone	PTGS2	PA451257	5743	0.972
NULL	Front_Public_Health_2013_Nov_14_1_50.nxml.txt.nlp	24350219	SENT200	15	15	0	0	hydrocortisone	IL-6	PA449905	3569	0.972
NULL	Exp_Diabetes_Res_2012_Oct_15_2012_465282.nxml.txt.nlp	23118742	SENT5	17	17	0	0	metformin	FGF21	PA450395	26291	0.972
NULL	Neural_Plast_2007_Jan_1_2007_30585.nxml.txt.nlp	25148070	SENT3530	27	27	14	14	nortriptyline	gamma	PA450657	9913	0.972
NULL	Curr_Neuropharmacol_2007_Dec_5(4)_232-243.nxml.txt.nlp	19305740	SENT181	0	0	11	11	minocycline	IL-6	PA450519	3569	0.972
NULL	Curr_Cardiol_Rev_2011_Nov_7(4)_221-233.nxml.txt.nlp	22758623	SENT159	2	2	10	10	temsirolimus	FKBP-12	PA164746890	2280	0.972
NULL	Cancers_(Basel)_2010_Jan_14_2(1)_1-19.nxml.txt.nlp	24281029	SENT41	16	16	4	4	paclitaxel	HER2	PA450761	2064	0.972
NULL	Acta_Pharmacol_Sin_2011_Nov_19_32(11)_1387-1396.nxml.txt.nlp	21927014	SENT91	17	17	28	28	oxaliplatin	ANOVA	PA131285527	4858	0.972
NULL	Acta_Pharmacol_Sin_2014_Aug_30_35(8)_1045-1054.nxml.txt.nlp	24976155	SENT35	16	16	7	7	resveratrol	STAT3		6774	0.972
NULL	Exp_Ther_Med_2012_Oct_3_4(4)_594-604.nxml.txt.nlp	23170111	SENT100	31	31	15	15	propranolol	SAPK	PA451145	5601	0.972
NULL	Allergy_Asthma_Immunol_Res_2012_Mar_16_4(2)_104-106.nxml.txt.nlp	22379606	SENT46	30	30	7	7	capsaicin	GM-CSF	PA448776	1437	0.972
NULL	Cancer_Manag_Res_2011_Aug_10_3_273-285.nxml.txt.nlp	21931501	SENT144	4	4	8	8	pazopanib	IFN	PA165291492	3439	0.972
NULL	Breast_Cancer_Res_2010_Dec_16_12(6)_215.nxml.txt.nlp	21176175	SENT56	0	0	6	6	denosumab	RANKL	PA166048634	8600	0.972
NULL	Ann_Dermatol_2014_Jun_12_26(3)_363-373.nxml.txt.nlp	24966637	SENT221	23	23	2	2	imiquimod	MT1-MMP	PA449972	4323	0.972
NULL	Tuberc_Respir_Dis_(Seoul)_2014_Feb_27_76(2)_66-74.nxml.txt.nlp	24624215	SENT36	29	29	4	4	vancomycin	HCAP	PA451850	117159;9126	0.972
NULL	Indian_J_Endocrinol_Metab_2013_Jul-Aug_17(4)_636-646.nxml.txt.nlp	23961479	SENT151	13	13	22	22	ritonavir	CYP3A4	PA451260	1576	0.972
NULL	Eur_J_Endocrinol_2011_Jan_164(1)_69-74.nxml.txt.nlp	20961967	SENT75	14	14	1	1	metformin	adiponectin	PA450395	9370	0.972
NULL	Diabetes_Care_2012_Dec_14_35(12)_e84.nxml.txt.nlp	23173145	SENT3	0	0	13	13	metformin	B12	PA450395	7126;4709	0.972
NULL	Allergy_Asthma_Clin_Immunol_2011_Aug_25_7(1)_13.nxml.txt.nlp	21867553	SENT221	21	21	28	28	ketoconazole	CYP3A4	PA450146	1576	0.972
NULL	Int_J_Environ_Res_Public_Health_2010_Apr_25_7(4)_1285-1301.nxml.txt.nlp	20617031	SENT123	15	15	5	5	ethanol	ALDH2	PA448073	217	0.972
NULL	Case_Rep_Med_2009_Aug_9_2009_378287.nxml.txt.nlp	19721707	SENT41	2	2	14	14	tadalafil	CYP3A4	PA10333	1576	0.972
NULL	Drug_Saf_2014_Feb_19_37(4)_201-211.nxml.txt.nlp	24550106	SENT163	9	9	1	1	rabeprazole	CYP2C19	PA451216	1557	0.972
NULL	Mol_Cancer_2014_Jun_19_13_154.nxml.txt.nlp	24941944	SENT55	35	35	9	9	temozolomide	BRAF	PA451609	673	0.972
NULL	Int_J_Biomed_Imaging_2013_Feb_26_2013_230487.nxml.txt.nlp	23533377	SENT148	0	0	16	16	trastuzumab	HER2	PA451743	2064	0.972
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Dec_11_70(Pt_1)_o31.nxml.txt.nlp	24526978	SENT73	8	8	3	3	benzaldehyde	mol	PA448571	90527	0.972
NULL	Curr_Oncol_2009_May_16(Suppl_1)_S52-S59.nxml.txt.nlp	19478903	SENT146	5	5	1	1	verapamil	CYP3A4	PA451868	1576	0.972
NULL	Open_Neurol_J_2013_May_31_7_23-31.nxml.txt.nlp	23894259	SENT69	3	3	23	23	olanzapine	5-HT2C	PA450688	3358	0.972
NULL	Asian-Australas_J_Anim_Sci_2014_Dec_27(12)_1783-1793.nxml.txt.nlp	25358373	SENT239	30	30	11	11	capsaicin	FABP4	PA448776	2167	0.972
NULL	N_Am_J_Med_Sci_2012_Dec_4(12)_648-650.nxml.txt.nlp	23272308	SENT20	32	32	2	2	tazobactam	CRA	PA164764504	51747;10903	0.972
NULL	Breast_Cancer_Res_Treat_2014_Sep_25_148(1)_81-90.nxml.txt.nlp	25253174	SENT185	7	7	20	20	metformin	adiponectin	PA450395	9370	0.972
NULL	Nucleic_Acids_Res_2008_Feb_20_36(3)_998-1008.nxml.txt.nlp	18096616	SENT7	10	10	17	17	heparin	PKR	PA449855	5610	0.972
NULL	Oncol_Rep_2013_Mar_8_29(3)_917-924.nxml.txt.nlp	23314174	SENT187	21	21	10	10	sorafenib	CD24	PA7000	100133941	0.972
NULL	Cancers_(Basel)_2010_Jul_12_2(3)_1453-1491.nxml.txt.nlp	24281168	SENT160	5	5	20	20	irinotecan	KRAS	PA450085	3845	0.972
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT5	3	3	11	11	neratinib	HER2	PA165291472	2064	0.972
NULL	JAKSTAT_2012_Oct_1_1(4)_292-299.nxml.txt.nlp	24058786	SENT155	19	19	33	33	pyrimethamine	STAT3	PA451193	6774	0.972
NULL	Cell_Commun_Signal_2003_Nov_24_1_5.nxml.txt.nlp	14636425	SENT10	19	19	11	11	heparin	CCN5	PA449855	8839	0.972
NULL	Br_J_Cancer_2012_Apr_10_106(8)_1367-1373.nxml.txt.nlp	22454081	SENT20	11	11	20	20	trastuzumab	HER2	PA451743	2064	0.972
NULL	J_Korean_Med_Sci_2010_Apr_19_25(4)_557-563.nxml.txt.nlp	20357998	SENT8	35	35	20	20	cisplatin	IFN	PA449014	3439	0.972
NULL	Case_Rep_Neurol_Med_2013_Feb_27_2013_735419.nxml.txt.nlp	23533858	SENT37	26	26	7	7	clopidogrel	MTHFR	PA449053	4524	0.972
NULL	Biomed_Res_Int_2013_Dec_22_2013_835850.nxml.txt.nlp	24455731	SENT83	6	6	18	18	protamine	ACT	PA10366	12;11332;9457;641455	0.972
NULL	ScientificWorldJournal_2013_Apr_18_2013_767482.nxml.txt.nlp	23710148	SENT385	4	4	33	33	phenol	CYP3A4	PA450913	1576	0.972
NULL	Mol_Cancer_2007_Nov_17_6_73.nxml.txt.nlp	18021420	SENT45	39	39	27	27	bortezomib	Mcl-1	PA10252	4170	0.972
NULL	Exp_Hematol_Oncol_2014_Jun_4_3_15.nxml.txt.nlp	24926417	SENT102	6	6	25	25	azathioprine	VWF	PA448515	7450	0.972
NULL	Mol_Cell_2013_Mar_7_49(5)_922-933.nxml.txt.nlp	23375502	SENT135	25	25	0	0	etoposide	FMN2	PA449552	56776	0.972
NULL	J_Biol_Chem_2009_Jan_2_284(1)_77-84.nxml.txt.nlp	18854318	SENT162	42	42	13	13	forskolin	AMPK	PA146096022	5563	0.972
NULL	Drug_Target_Insights_2012_Aug_6_6_19-39.nxml.txt.nlp	22915839	SENT7	0	0	18	18	doxorubicin	Hsp90	PA449412	3320	0.972
NULL	J_Vet_Med_Sci_2014_Oct_19_76(10)_1339-1345.nxml.txt.nlp	24942113	SENT117	15	15	18	18	losartan	AT1	PA450268	9197;185	0.972
NULL	J_Headache_Pain_2008_Feb_24_9(1)_13-18.nxml.txt.nlp	18217199	SENT119	4	4	8	8	flunarizine	CYP2D	PA164776636	1565	0.972
NULL	Open_Access_J_Urol_2011_May_10_3_69-82.nxml.txt.nlp	24198638	SENT216	7	7	32	32	sorafenib	FACT	PA7000	11198	0.972
NULL	Eur_J_Clin_Pharmacol_2011_May_8_67(5)_493-506.nxml.txt.nlp	21140139	SENT209	11	11	2	2	oxycodone	CYP3A4	PA450741	1576	0.972
NULL	Basic_Clin_Neurosci_2014_Spring_5(2)_124-130.nxml.txt.nlp	25337370	SENT203	12	12	1	1	berberine	p55	PA165860812	6624;2078;8503;5718	0.972
NULL	Open_Access_J_Urol_2011_May_10_3_69-82.nxml.txt.nlp	24198638	SENT45	0	0	26	26	sorafenib	UGT1A9	PA7000	54600	0.972
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_75-89.nxml.txt.nlp	17912638	SENT72	20	20	42	42	tamoxifen	ATAC	PA451581	6375	0.972
NULL	Biologics_2009_Sep_15_3_419-428.nxml.txt.nlp	19774209	SENT170	37	37	20	20	everolimus	PTEN	PA164746311	5728	0.972
NULL	Brain_Sci_2013_Jun_14_3(2)_941-963.nxml.txt.nlp	24961432	SENT132	14	14	36	36	ethanol	TLR4	PA448073	7099	0.972
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT180	10	10	2	2	curcumin	TRAIL	PA151958596	8743	0.972
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT241	2	2	9	9	indinavir	UGT1A1	PA449977	54658	0.972
NULL	Cancer_Imaging_2013_Jul_22_13(3)_306-313.nxml.txt.nlp	23876444	SENT189	30	30	8	8	vemurafenib	BRAF	PA165946873	673	0.972
NULL	J_Clin_Neonatol_2012_Oct-Dec_1(4)_178-179.nxml.txt.nlp	24027723	SENT37	7	7	18	18	fluconazole	NNT	PA449653	23530	0.972
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT195	17	17	33	33	bevacizumab	PlGF-2	PA130232992	5228	0.972
NULL	Front_Oncol_2013_Aug_5_3_195.nxml.txt.nlp	23936763	SENT53	28	28	14	14	dasatinib	DDR2	PA162372878	4921	0.972
NULL	Eur_J_Clin_Pharmacol_2014_Aug_23_70(10)_1173-1179.nxml.txt.nlp	25146692	SENT186	0	0	5	5	elvitegravir	CYP3A4	PA165291498	1576	0.972
NULL	Nucl_Recept_Signal_2009_Jan_16_7_e001.nxml.txt.nlp	19240808	SENT412	0	0	10	10	paclitaxel	MDR1	PA450761	5243	0.972
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1699-1708.nxml.txt.nlp	19861960	SENT159	43	43	29	29	dasatinib	HER2	PA162372878	2064	0.972
NULL	Cancer_Cell_Int_2011_Nov_17_11_40.nxml.txt.nlp	22088142	SENT154	30	30	8	8	gemcitabine	MRP1	PA449748	4437	0.972
NULL	Diabetes_Care_2009_Sep_29_32(9)_1620-1625.nxml.txt.nlp	19564453	SENT156	5	5	9	9	metformin	AMPK	PA450395	5563	0.972
NULL	Breast_Cancer_Res_Treat_2012_Jun_18_133(3)_937-947.nxml.txt.nlp	22094936	SENT109	41	41	10	10	tamoxifen	CCNE1	PA451581	898	0.972
NULL	Int_J_Nephrol_2011_Apr_18_2011_732746.nxml.txt.nlp	21603106	SENT114	7	7	22	22	furosemide	AVP	PA449719	114548;551	0.972
NULL	Int_J_Womens_Health_2010_Aug_9_1_11-20.nxml.txt.nlp	21072271	SENT70	35	35	1	1	tamoxifen	STAR	PA451581	6770;2984	0.972
NULL	J_Korean_Med_Sci_2005_Jun_30_20(3)_456-460.nxml.txt.nlp	15953869	SENT110	30	30	2	2	lipase	HSL	PA450239	3991	0.972
NULL	Oncotarget_2012_May_19_3(5)_535-545.nxml.txt.nlp	22619121	SENT12	4	4	23	23	camptothecin	B-MYB	PA153590860	4605	0.972
NULL	Aging_(Albany_NY)_2012_Jul_22_4(7)_480-498.nxml.txt.nlp	22837425	SENT96	27	27	7	7	metformin	AMPK	PA450395	5563	0.972
NULL	Biomed_Res_Int_2013_Oct_27_2013_467869.nxml.txt.nlp	24282816	SENT167	15	15	24	24	boceprevir	SOC	PA165948902	91544	0.972
NULL	Cancer_Immunol_Immunother_2011_Jun_25_60(6)_793-808.nxml.txt.nlp	21350947	SENT264	11	11	30	30	temsirolimus	IFN	PA164746890	3439	0.972
NULL	Cancer_Imaging_2011_Mar_1_11(1)_1-8.nxml.txt.nlp	21362586	SENT140	12	12	23	23	tariquidar	P-gp		5243	0.972
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT173	12	12	4	4	cisplatin	AMPK	PA449014	5563	0.972
NULL	Crit_Care_2010_Aug_11_14(4)_R153.nxml.txt.nlp	20701787	SENT156	2	2	15	15	exenatide	GLP-1	PA164749238	100125288	0.972
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT121	4	4	0	0	cisplatin	IBP	PA449014	706;50619	0.972
NULL	Br_J_Cancer_2011_Dec_6_105(12)_1920-1926.nxml.txt.nlp	22095222	SENT107	33	33	6	6	trastuzumab	PTEN	PA451743	5728	0.972
NULL	J_Oncol_2009_Jun_14_2009_814140.nxml.txt.nlp	19547715	SENT6	6	6	26	26	carboplatin	MDR1	PA448803	5243	0.972
NULL	Br_J_Cancer_2010_Mar_2_102(5)_867-872.nxml.txt.nlp	20145619	SENT63	17	17	5	5	lapatinib	IL-2	PA152241907	3558	0.972
NULL	Mol_Cancer_2010_Mar_2_9_47.nxml.txt.nlp	20196847	SENT196	18	18	6	6	paclitaxel	SFN	PA450761	25996;2810	0.972
NULL	Acta_Neuropathol_Commun_2014_Apr_8_2_41.nxml.txt.nlp	24713450	SENT140	18	18	30	30	vemurafenib	BRAF	PA165946873	673	0.972
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT131	12	12	8	8	cisplatin	GSTP1	PA449014	2950	0.972
NULL	Cell_Cycle_2014_Jan_1_13(1)_90-95.nxml.txt.nlp	24196441	SENT5	17	17	5	5	camptothecin	CtIP	PA153590860	5932	0.972
NULL	Nucleic_Acids_Res_2011_Dec_10_39(22)_9498-9507.nxml.txt.nlp	21835778	SENT178	14	14	0	0	nutlin-3	p53		7157	0.972
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT335	31	31	2	2	methotrexate	MSH2	PA450428	4436	0.972
NULL	Indian_J_Med_Res_2014_Apr_139(4)_572-578.nxml.txt.nlp	24927344	SENT22	28	28	4	4	warfarin	GGCX	PA451906	2677	0.972
NULL	Mol_Cancer_2009_Apr_16_8_24.nxml.txt.nlp	19371427	SENT216	11	11	2	2	cisplatin	CHK1	PA449014	1111	0.972
NULL	Biochem_Res_Int_2012_Aug_23_2012_135723.nxml.txt.nlp	21904679	SENT30	9	9	30	30	lipase	DAG	PA450239	1605	0.972
NULL	Br_J_Cancer_2009_Jul_7_101(1)_55-63.nxml.txt.nlp	19491903	SENT8	8	8	14	14	doxorubicin	DTD	PA449412	1728	0.972
NULL	Arthritis_Res_Ther_2009_Jun_30_11(3)_234.nxml.txt.nlp	19591653	SENT73	0	0	16	16	abatacept	B7-1	PA164747080	941	0.972
NULL	Cell_Death_Dis_2013_Jul_18_4(7)_e730.nxml.txt.nlp	23868063	SENT275	6	6	12	12	bortezomib	PES	PA10252	23481	0.972
NULL	Cell_Cycle_2012_Nov_1_11(21)_4069-4078.nxml.txt.nlp	23095523	SENT6	29	29	16	16	imatinib	CD34	PA10804	947	0.972
NULL	Br_J_Cancer_2010_Oct_26_103(9)_1325-1330.nxml.txt.nlp	20940720	SENT162	11	11	29	29	paclitaxel	EGFR	PA450761	1956	0.972
NULL	Acta_Pharmacol_Sin_2010_Mar_8_31(3)_382-386.nxml.txt.nlp	20140004	SENT10	7	7	35	35	pitavastatin	SLCO1B1	PA142650384	10599	0.972
NULL	Oncogene_2013_Sep_12_32(37)_4355-4365.nxml.txt.nlp	23108409	SENT72	17	17	22	22	hyaluronan	HAS2	PA165958431	3037	0.972
NULL	Oncologist_2011_Mar_21_16(3)_264-275.nxml.txt.nlp	21339259	SENT187	4	4	25	25	docetaxel	CYP1B1	PA449383	1545	0.972
NULL	Onco_Targets_Ther_2014_Mar_20_7_447-456.nxml.txt.nlp	24672247	SENT147	4	4	9	9	oxaliplatin	AKT	PA131285527	207	0.972
NULL	Br_J_Cancer_2011_Jun_7_104(12)_1848-1853.nxml.txt.nlp	21610704	SENT129	33	33	6	6	panitumumab	REL	PA162373091	5966	0.972
NULL	Exp_Mol_Med_2012_Aug_31_44(8)_473-482.nxml.txt.nlp	22627808	SENT107	0	0	22	22	lapatinib	HER2	PA152241907	2064	0.972
NULL	J_Cell_Mol_Med_2013_Dec_6_17(12)_1588-1597.nxml.txt.nlp	24199964	SENT229	6	6	30	30	doxycycline	APT	PA449415	653639	0.972
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT116	7	7	23	23	atorvastatin	IL-6	PA448500	3569	0.972
NULL	Biologics_2012_Dec_17_6_429-464.nxml.txt.nlp	23269860	SENT267	9	9	37	37	etanercept	NMA	PA449515	25805	0.972
NULL	J_Cell_Mol_Med_2014_Mar_10_18(3)_514-529.nxml.txt.nlp	24410795	SENT234	29	29	38	38	resveratrol	SIRT1		23411	0.972
NULL	Curr_Cardiol_Rev_2011_Nov_7(4)_221-233.nxml.txt.nlp	22758623	SENT181	12	12	21	21	tamoxifen	aromatase	PA451581	1588	0.972
NULL	Ann_Oncol_2010_Oct_19_21(10)_1952-1960.nxml.txt.nlp	20305037	SENT146	9	9	14	14	cetuximab	EGFR	PA10040	1956	0.972
NULL	Cardiovasc_Diabetol_2013_Nov_12_12_169.nxml.txt.nlp	24215514	SENT9	10	10	19	19	aliskiren	AT1	PA143487910	9197;185	0.972
NULL	Front_Genet_2014_Sep_25_5_331.nxml.txt.nlp	25309582	SENT286	15	15	8	8	alemtuzumab	CD52	PA164783958	1043	0.972
NULL	Case_Rep_Endocrinol_2013_Dec_12_2013_782068.nxml.txt.nlp	24416602	SENT75	3	3	13	13	metyrapone	ACTH	PA450486	5443	0.972
NULL	Breast_Cancer_Res_2004_Nov_7_6(1)_R24-R30.nxml.txt.nlp	14680497	SENT110	28	28	8	8	doxorubicin	HER2	PA449412	2064	0.972
NULL	Oncogene_2014_Oct_9_33(41)_4941-4951.nxml.txt.nlp	24681952	SENT180	14	14	0	0	metformin	WNT5A	PA450395	7474	0.972
NULL	Mol_Cancer_2008_Jun_3_7_47.nxml.txt.nlp	18519000	SENT67	10	10	16	16	gefitinib	EGF	PA131301952	1950	0.972
NULL	Breast_Cancer_(Dove_Med_Press)_2014_May_2_6_59-71.nxml.txt.nlp	24833917	SENT131	18	18	38	38	anastrozole	aromatase	PA448432	1588	0.972
NULL	Mol_Biol_Cell_2012_Oct_15_23(20)_4097-4108.nxml.txt.nlp	22918955	SENT233	33	33	23	23	tetracycline	MMP3	PA451640	4314	0.972
NULL	Oncol_Lett_2014_May_26_7(5)_1345-1351.nxml.txt.nlp	24765136	SENT106	23	23	31	31	bevacizumab	VEGF-A	PA130232992	7422	0.972
NULL	Aging_(Albany_NY)_2013_Feb_21_5(2)_94-95.nxml.txt.nlp	23518473	SENT21	2	2	25	25	resveratrol	SIRT1		23411	0.972
NULL	Front_Neurol_2014_Sep_11_5_173.nxml.txt.nlp	25309501	SENT27	0	0	44	44	hyaluronan	HAS2	PA165958431	3037	0.972
NULL	Nucleic_Acids_Res_2011_Sep_7_39(17)_7465-7476.nxml.txt.nlp	21653549	SENT243	13	13	21	21	camptothecin	DEK	PA153590860	7913	0.972
NULL	Chem_Cent_J_2013_Feb_7_7_27.nxml.txt.nlp	23391345	SENT71	39	39	1	1	ethanol	PF6	PA448073	200162	0.972
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1986-2011.nxml.txt.nlp	25268165	SENT191	25	25	10	10	cisplatin	STAT3	PA449014	6774	0.972
NULL	Front_Neurol_2011_Dec_29_2_85.nxml.txt.nlp	22232615	SENT64	13	13	9	9	selegiline	MAOB	PA451316	4129	0.972
NULL	Arthritis_Res_Ther_2012_Jul_27_14(4)_R175.nxml.txt.nlp	22838733	SENT156	15	15	4	4	adalimumab	CD11c	PA10004	3687	0.972
NULL	Breast_Cancer_Res_2012_Jul_19_14(4)_R108.nxml.txt.nlp	22812534	SENT197	32	32	10	10	pargyline	aromatase	PA450797	1588	0.972
NULL	Oncotarget_2011_Dec_20_2(12)_1094-1108.nxml.txt.nlp	22190353	SENT56	22	22	4	4	gemcitabine	p53	PA449748	7157	0.972
NULL	Onco_Targets_Ther_2014_Jul_1_7_1185-1193.nxml.txt.nlp	25061320	SENT114	28	28	8	8	gefitinib	EGFR	PA131301952	1956	0.972
NULL	Reprod_Biol_Endocrinol_2003_Oct_7_1_66.nxml.txt.nlp	14609433	SENT258	2	2	26	26	cisplatin	p53	PA449014	7157	0.972
NULL	FASEB_J_2008_Nov_22(11)_4005-4010.nxml.txt.nlp	18753249	SENT13	24	24	0	0	rofecoxib	COX	PA451268	1351	0.972
NULL	Multidiscip_Respir_Med_2012_Aug_29_7(1)_26.nxml.txt.nlp	22958272	SENT17	0	0	9	9	paroxetine	CYP2D6	PA450801	1565	0.972
NULL	Case_Rep_Oncol_2013_Dec_12_6(3)_602-608.nxml.txt.nlp	24474924	SENT22	0	0	11	11	erlotinib	EGFR	PA134687924	1956	0.972
NULL	Br_J_Cancer_2012_Jan_3_106(1)_18-24.nxml.txt.nlp	22108516	SENT140	29	29	11	11	bevacizumab	KRAS	PA130232992	3845	0.972
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT155	23	23	9	9	cisplatin	p53	PA449014	7157	0.972
NULL	Int_J_Endocrinol_Metab_2013_Jul_1_Summer_11(3)_184-190.nxml.txt.nlp	24348591	SENT155	10	10	2	2	liraglutide	INS-1	PA165958364	2305	0.972
NULL	Gut_Liver_2011_Jun_24_5(2)_171-180.nxml.txt.nlp	21814597	SENT119	41	41	31	31	imatinib	KIT	PA10804	3815	0.972
NULL	Curr_Pharm_Biotechnol_2012_May_13(6)_969-986.nxml.txt.nlp	22039792	SENT81	5	5	11	11	acepromazine	MDR1	PA164783999	5243	0.972
NULL	Case_Rep_Oncol_2013_Nov_6_6(3)_555-560.nxml.txt.nlp	24348393	SENT45	18	18	21	21	everolimus	aromatase	PA164746311	1588	0.972
NULL	Cancer_Immunol_Immunother_2011_Jan_21_60(1)_75-85.nxml.txt.nlp	20857100	SENT165	40	40	12	12	fludarabine	IL-4	PA449655	3565	0.972
NULL	Br_J_Cancer_2009_Jul_21_101(2)_269-277.nxml.txt.nlp	19603033	SENT138	27	27	7	7	cisplatin	MLH1	PA449014	4292	0.972
NULL	Ther_Clin_Risk_Manag_2007_Jun_3(3)_363-379.nxml.txt.nlp	18488081	SENT97	27	27	11	11	lansoprazole	CYP2C19	PA450180	1557	0.972
NULL	Clin_Med_Insights_Oncol_2012_Jun_11_6_253-262.nxml.txt.nlp	22745566	SENT81	8	8	29	29	erlotinib	EGFR	PA134687924	1956	0.972
NULL	Sensors_(Basel)_2012_Nov_22_12(12)_16037-16045.nxml.txt.nlp	23443365	SENT92	30	30	18	18	rituximab	FGFR3	PA451261	2261	0.972
NULL	Mol_Cancer_2010_Aug_20_9_220.nxml.txt.nlp	20727180	SENT35	16	16	28	28	nicotine	p53	PA450626	7157	0.972
NULL	Epigenetics_2012_Nov_1_7(11)_1225-1229.nxml.txt.nlp	23069641	SENT55	4	4	10	10	cisplatin	BRCA1	PA449014	672	0.972
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT283	4	4	15	15	chloroquine	BMP9	PA448948	2658	0.972
NULL	Breast_Cancer_Res_2007_Jul_5_9(4)_R41.nxml.txt.nlp	17612393	SENT155	17	17	7	7	celecoxib	Bcl-2	PA448871	596	0.972
NULL	J_Korean_Med_Sci_2014_Jan_26_29(1)_110-116.nxml.txt.nlp	24431914	SENT112	29	29	4	4	plerixafor	CD34	PA165958410	947	0.972
NULL	Clin_Med_Insights_Oncol_2013_Aug_21_7_221-234.nxml.txt.nlp	24179413	SENT61	21	21	29	29	erlotinib	PIK3CA	PA134687924	5290	0.972
NULL	Breast_Cancer_Res_2012_Jun_19_14(3)_311.nxml.txt.nlp	22713135	SENT34	5	5	16	16	letrozole	PIK3CA	PA450196	5290	0.972
NULL	J_Exp_Clin_Cancer_Res_2009_Jul_10_28(1)_99.nxml.txt.nlp	19591692	SENT22	3	3	17	17	imatinib	ABCG2	PA10804	9429	0.972
NULL	Pharmaceuticals_(Basel)_2011_Oct_25_4(11)_1400-1422.nxml.txt.nlp	NULL	SENT63	40	40	4	4	imatinib	Hsp90	PA10804	3320	0.972
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT246	5	5	17	17	chloroquine	BMPR-II	PA448948	659	0.972
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_75-89.nxml.txt.nlp	17912638	SENT21	34	34	2	2	tamoxifen	aromatase	PA451581	1588	0.972
NULL	Front_Immunol_2013_Sep_26_4_292.nxml.txt.nlp	24133490	SENT245	24	24	10	10	cyclophosphamide	CD4	PA449165	920	0.972
NULL	Mol_Cancer_2014_Jul_17_13_174.nxml.txt.nlp	25033833	SENT28	31	31	10	10	bevacizumab	HER2	PA130232992	2064	0.972
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1021.nxml.txt.nlp	24457965	SENT243	41	41	24	24	cisplatin	JNK	PA449014	5599	0.972
NULL	J_Cell_Biol_2001_Oct_15_155(2)_207-216.nxml.txt.nlp	11591730	SENT60	25	25	11	11	camptothecin	p53	PA153590860	7157	0.972
NULL	Breast_Cancer_Res_2002_Aug_27_4(6)_213-217.nxml.txt.nlp	12473165	SENT28	23	23	1	1	tamoxifen	ATAC	PA451581	6375	0.972
NULL	Diabetes_2009_Apr_16_58(4)_975-983.nxml.txt.nlp	19151200	SENT114	3	3	38	38	liraglutide	LIR	PA165958364	10871	0.972
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jul_7_68(Pt_8)_o2392-o2393.nxml.txt.nlp	22904850	SENT72	22	22	39	39	ethanol	mol	PA448073	90527	0.972
NULL	Oxid_Med_Cell_Longev_2010_Nov-Dec_3(6)_361-373.nxml.txt.nlp	21311214	SENT135	8	8	26	26	rosiglitazone	AMPK	PA451283	5563	0.972
NULL	J_Hematol_Oncol_2012_Jul_27_5_42.nxml.txt.nlp	22839530	SENT13	24	24	5	5	vincristine	SRSF1	PA451879	6426	0.972
NULL	Mol_Cancer_2010_Jun_7_9_139.nxml.txt.nlp	20529262	SENT105	20	20	41	41	cetuximab	EGFR	PA10040	1956	0.972
NULL	Asia_Pac_Allergy_2014_Jul_29_4(3)_156-163.nxml.txt.nlp	25097851	SENT143	14	14	31	31	hydroxyzine	EMB	PA449943	133418	0.972
NULL	Front_Immunol_2013_Sep_26_4_292.nxml.txt.nlp	24133490	SENT245	24	24	12	12	cyclophosphamide	CD25	PA449165	3669;3559	0.972
NULL	Breast_Cancer_Res_2005_Nov_19_7(1)_18-20.nxml.txt.nlp	15642177	SENT55	8	8	13	13	tamoxifen	aromatase	PA451581	1588	0.972
NULL	Hum_Genomics_Proteomics_2010_Sep_13_2010_754919.nxml.txt.nlp	20981234	SENT92	27	27	0	0	warfarin	CYP3A4	PA451906	1576	0.972
NULL	Int_J_Surg_Oncol_2012_May_17_2012_406830.nxml.txt.nlp	22675625	SENT177	17	17	34	34	capecitabine	LARC	PA448771	6364	0.972
NULL	Indian_J_Pharmacol_2012_Sep-Oct_44(5)_624-628.nxml.txt.nlp	23112426	SENT135	13	13	6	6	pravastatin	P-gp	PA451089	5243	0.972
NULL	Indian_J_Med_Res_2014_Aug_140(2)_227-230.nxml.txt.nlp	25297355	SENT21	0	0	16	16	dexketoprofen	COX	PA166049175	1351	0.972
NULL	Environ_Health_Perspect_2010_Jan_118(1)_A34a.nxml.txt.nlp	20061221	SENT10	0	0	42	42	oseltamivir	STP	PA450721	9322	0.972
NULL	Brain_Res_2011_Mar_25_1382(C)_29-36.nxml.txt.nlp	21276431	SENT110	1	1	7	7	ketanserin	5-HT2A	PA131053734	3356	0.972
NULL	J_Clin_Biochem_Nutr_2009_Jan_27_44(1)_28-40.nxml.txt.nlp	19177185	SENT81	1	1	20	20	hemin	HO-1	PA449849	3162	0.972
NULL	Lipids_Health_Dis_2011_Feb_28_10_38.nxml.txt.nlp	21352602	SENT90	22	22	36	36	simvastatin	PCSK9	PA451363	255738	0.972
NULL	Acta_Orthop_2009_Dec_4_80(6)_693-703.nxml.txt.nlp	19968600	SENT251	0	0	6	6	minocycline	ACR	PA450519	49	0.972
NULL	Viruses_2014_Sep_17_6(9)_3438-3449.nxml.txt.nlp	25256392	SENT137	13	13	4	4	oseltamivir	N10	PA450721	3164	0.972
NULL	Am_J_Trop_Med_Hyg_2012_Mar_1_86(3)_489-495.nxml.txt.nlp	22403324	SENT177	19	19	10	10	ritonavir	CYP2D6	PA451260	1565	0.972
NULL	Br_J_Cancer_2010_Nov_2_103(11)_1637-1643.nxml.txt.nlp	21045832	SENT178	10	10	8	8	sorafenib	VEGFR	PA7000	3791	0.972
NULL	Patient_Prefer_Adherence_2010_Mar_24_4_61-68.nxml.txt.nlp	20361006	SENT22	0	0	6	6	liraglutide	GLP-1	PA165958364	100125288	0.972
NULL	J_Breast_Cancer_2012_Sep_28_15(3)_273-282.nxml.txt.nlp	23091539	SENT165	10	10	42	42	doxycycline	TRAIL	PA449415	8743	0.972
NULL	Endocrine_2012_Dec_14_42(3)_622-636.nxml.txt.nlp	22695986	SENT287	33	33	15	15	forskolin	PTH	PA146096022	5741	0.972
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1059-1066.nxml.txt.nlp	21364577	SENT73	14	14	5	5	letrozole	BCS	PA450196	617	0.972
NULL	Curr_Med_Chem_2011_Jun_18(18)_2686-2714.nxml.txt.nlp	21649578	SENT653	28	28	19	19	erlotinib	PI3K	PA134687924	5290	0.972
NULL	Cell_Cycle_2013_May_1_12(9)_1331-1332.nxml.txt.nlp	23588071	SENT12	11	11	28	28	doxorubicin	HIF-1	PA449412	29072	0.972
NULL	J_Gastroenterol_2013_Feb_23_48(12)_1373-1383.nxml.txt.nlp	23435670	SENT73	36	36	20	20	entecavir	LAM	PA164784025	7249;7248	0.972
NULL	Nat_Commun_2014_Dec_18_5_5815.nxml.txt.nlp	25519973	SENT428	22	22	0	0	tranylcypromine	E16	PA451741	8140	0.972
NULL	Clin_Med_Insights_Cardiol_2011_Oct_6_5_103-119.nxml.txt.nlp	22084608	SENT39	0	0	5	5	dronedarone	CYP3A4	PA153619853	1576	0.972
NULL	Int_J_Mol_Sci_2012_Aug_13_13(8)_10091-10112.nxml.txt.nlp	22949849	SENT4	35	35	10	10	ethanol	PPL	PA448073	5493	0.972
NULL	Acta_Pharmacol_Sin_2010_Apr_8_31(4)_461-469.nxml.txt.nlp	20208553	SENT126	11	11	17	17	ethanol	adiponectin	PA448073	9370	0.972
NULL	Clin_Interv_Aging_2008_Sep_3(3)_421-430.nxml.txt.nlp	18982913	SENT114	5	5	9	9	buprenorphine	CYP3A4	PA448685	1576	0.972
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT40	37	37	9	9	glucose	PP2	PA449773	4888	0.972
NULL	Curr_Chem_Genomics_2010_Mar_19_4_9-18.nxml.txt.nlp	20502647	SENT112	21	21	4	4	doxycycline	MYOD	PA449415	4654	0.972
NULL	Indian_J_Med_Res_2012_Apr_135(4)_456-458.nxml.txt.nlp	22664491	SENT30	0	0	24	24	chloroquine	ACT	PA448948	12;11332;9457;641455	0.972
NULL	Cell_Death_Dis_2014_Jul_10_5(7)_e1321.nxml.txt.nlp	25010987	SENT331	41	41	20	20	staurosporine	HuR	PA165109623	1994	0.972
NULL	Leukemia_2014_Sep_30_28(9)_1918-1922.nxml.txt.nlp	24791858	SENT26	25	25	6	6	imatinib	JAK2	PA10804	3717	0.972
NULL	Comput_Math_Methods_Med_2013_Mar_20_2013_802512.nxml.txt.nlp	23573174	SENT39	5	5	34	34	doxycycline	MYC	PA449415	4609	0.972
NULL	Aging_(Albany_NY)_2012_Dec_6_4(11)_823-842.nxml.txt.nlp	23235539	SENT338	15	15	5	5	bleomycin	HCA2	PA448645	139081;55811;338442	0.972
NULL	Cerebrospinal_Fluid_Res_2010_Aug_13_7_13.nxml.txt.nlp	20707896	SENT4	7	7	27	27	vasopressin	FGF2	PA451858	2247;2258	0.972
NULL	Cancer_Med_2013_Jun_25_2(3)_277-285.nxml.txt.nlp	23930204	SENT31	33	33	10	10	irinotecan	PTEN	PA450085	5728	0.972
NULL	Sci_Rep_2014_Dec_3_4_7298.nxml.txt.nlp	25466238	SENT60	25	25	3	3	chloroquine	UCHL1	PA448948	7345	0.972
NULL	Appetite_2013_Dec_1_71(100)_75-80.nxml.txt.nlp	23920064	SENT97	2	2	40	40	cocaine	FMI	PA449072	10076	0.972
NULL	J_Cell_Mol_Med_2014_Jan_4_18(1)_38-48.nxml.txt.nlp	24188742	SENT141	30	30	21	21	etoposide	PAX3	PA449552	5077	0.972
NULL	Breast_Cancer_Res_2012_Jul_6_14(4)_R102.nxml.txt.nlp	22770227	SENT72	37	37	41	41	tamoxifen	aromatase	PA451581	1588	0.972
NULL	Arthritis_Res_Ther_2006_Nov_16_8(6)_R173.nxml.txt.nlp	17109745	SENT32	31	31	14	14	glucosamine	p50	PA164747613	958;4790	0.972
NULL	Mol_Cancer_2010_May_20_9_115.nxml.txt.nlp	20487546	SENT228	21	21	6	6	fludarabine	MYC	PA449655	4609	0.972
NULL	Oncotarget_2010_Nov_24_1(7)_583-595.nxml.txt.nlp	21317454	SENT172	11	11	1	1	hydroxyurea	p53	PA449942	7157	0.972
NULL	Mol_Cancer_2014_Jun_30_13_160.nxml.txt.nlp	24976026	SENT153	30	30	7	7	bortezomib	AGR2	PA10252	10551	0.972
NULL	J_Cell_Mol_Med_2013_Sep_11_17(9)_1160-1172.nxml.txt.nlp	23844832	SENT38	26	26	3	3	erlotinib	EGF	PA134687924	1950	0.972
NULL	Front_Endocrinol_(Lausanne)_2013_Jul_29_4_94.nxml.txt.nlp	23908645	SENT126	10	10	28	28	estradiol	UGT2B17	PA449503	7367	0.972
NULL	Clin_Med_Insights_Oncol_2013_Oct_29_7_269-277.nxml.txt.nlp	24250243	SENT30	0	0	22	22	axitinib	VEGFR	PA164924493	3791	0.972
NULL	Cell_Commun_Signal_2011_May_15_9_13.nxml.txt.nlp	21569639	SENT289	0	0	6	6	quinacrine	p53	PA164745551	7157	0.972
NULL	Breast_Cancer_Res_2012_Dec_5_14(6)_R153.nxml.txt.nlp	23216744	SENT142	13	13	28	28	fulvestrant	p53	PA164747170	7157	0.972
NULL	Hum_Reprod_Update_2008_Sep_26_Nov-Dec_14(6)_605-621.nxml.txt.nlp	18820005	SENT247	12	12	5	5	anastrozole	aromatase	PA448432	1588	0.972
NULL	Carcinogenesis_2014_May_13_35(5)_1055-1066.nxml.txt.nlp	24419232	SENT312	17	17	10	10	metformin	CYP1B1	PA450395	1545	0.972
NULL	Evid_Based_Complement_Alternat_Med_2012_Aug_26_2012_487380.nxml.txt.nlp	22966242	SENT189	3	3	10	10	indomethacin	COX	PA449982	1351	0.972
NULL	Br_J_Cancer_2011_Sep_27_105(7)_1030-1038.nxml.txt.nlp	21863025	SENT110	34	34	5	5	saracatinib	COPA		1314	0.972
NULL	Mol_Clin_Oncol_2013_Jul_27_1(4)_711-715.nxml.txt.nlp	24649233	SENT118	15	15	5	5	gefitinib	EGFR	PA131301952	1956	0.972
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Sep_25_66(Pt_10)_o2615.nxml.txt.nlp	21587590	SENT55	15	15	21	21	letrozole	aromatase	PA450196	1588	0.972
NULL	Int_J_Cell_Biol_2012_Mar_27_2012_189794.nxml.txt.nlp	22536246	SENT101	7	7	32	32	staurosporine	Vps34	PA165109623	5289	0.972
NULL	J_Vet_Med_Sci_2014_May_13_76(5)_629-636.nxml.txt.nlp	24419976	SENT154	26	26	9	9	meloxicam	EP2	PA450353	5732;10407	0.972
NULL	Oncogenesis_2014_Mar_3_3(3)_e90.nxml.txt.nlp	24590311	SENT61	25	25	0	0	imatinib	CD34	PA10804	947	0.972
NULL	J_Oncol_2010_Dec_28_2010_414676.nxml.txt.nlp	20066160	SENT88	15	15	21	21	oxaliplatin	aromatase	PA131285527	1588	0.972
NULL	Mol_Cancer_2014_Jun_23_13_156.nxml.txt.nlp	24953832	SENT337	34	34	29	29	estradiol	HOTAIR	PA449503	100124700	0.972
NULL	Oxid_Med_Cell_Longev_2012_Jul_5_2012_718976.nxml.txt.nlp	22829960	SENT87	27	27	9	9	vasopressin	SON	PA451858	6651	0.972
NULL	Int_J_Mol_Sci_2013_Apr_15_14(4)_8213-8227.nxml.txt.nlp	23591839	SENT144	0	0	10	10	metformin	AMPK	PA450395	5563	0.972
NULL	Mol_Brain_2014_Jun_16_7_47.nxml.txt.nlp	24935250	SENT30	12	12	8	8	gabapentin	AC1	PA449720	107	0.972
NULL	Arch_Drug_Inf_2009_Mar_2(1)_1-7.nxml.txt.nlp	19381337	SENT59	19	19	35	35	ritonavir	CYP3A	PA451260	1574	0.972
NULL	AIDS_Res_Ther_2013_May_1_10_10.nxml.txt.nlp	23634877	SENT148	3	3	18	18	lovastatin	CXCR4	PA450272	7852	0.972
NULL	Breast_Cancer_Res_2000_Sep_6_2(6)_444-454.nxml.txt.nlp	11056692	SENT97	1	1	12	12	ethanol	TAZ	PA448073	25937;6901	0.972
NULL	Lipids_Health_Dis_2011_Feb_28_10_38.nxml.txt.nlp	21352602	SENT111	9	9	42	42	ezetimibe	SREBP2	PA10816	6721	0.972
NULL	Reprod_Biol_Endocrinol_2003_Oct_7_1_71.nxml.txt.nlp	14577832	SENT115	34	34	6	6	cisplatin	JNK1	PA449014	5599	0.972
NULL	Acta_Pharmacol_Sin_2012_May_26_33(5)_675-681.nxml.txt.nlp	22447226	SENT17	5	5	34	34	gefitinib	CDC25B	PA131301952	994	0.972
NULL	Cell_Death_Dis_2012_Mar_15_3(3)_e286.nxml.txt.nlp	22419115	SENT67	0	0	23	23	cisplatin	p53	PA449014	7157	0.972
NULL	Clin_Ophthalmol_2011_Mar_23_5_397-402.nxml.txt.nlp	21499563	SENT37	14	14	0	0	oxybuprocaine	TES	PA164764617	26136	0.971
NULL	Onco_Targets_Ther_2014_Jul_31_7_1367-1373.nxml.txt.nlp	25114575	SENT77	11	11	16	16	trastuzumab	aromatase	PA451743	1588	0.971
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_21-38.nxml.txt.nlp	19305786	SENT308	2	2	11	11	menthol	TRPV3	PA164776605	162514	0.971
NULL	Arq_Bras_Cardiol_2013_Nov_101(5)_379-387.nxml.txt.nlp	24100691	SENT33	26	26	4	4	everolimus	DES	PA164746311	1674	0.971
NULL	Acta_Pharmacol_Sin_2011_Jul_9_32(7)_879-887.nxml.txt.nlp	21552292	SENT166	23	23	17	17	metformin	AKT	PA450395	207	0.971
NULL	Cancer_Immunol_Immunother_2013_Aug_27_62(10)_1637-1648.nxml.txt.nlp	23982484	SENT249	3	3	36	36	lenalidomide	GM-CSF	PA162363968	1437	0.971
NULL	Oncol_Lett_2014_Oct_28_8(4)_1563-1566.nxml.txt.nlp	25202368	SENT102	0	0	5	5	gefitinib	EGFR	PA131301952	1956	0.971
NULL	J_Korean_Med_Sci_2012_Sep_22_27(9)_1037-1043.nxml.txt.nlp	22969249	SENT97	19	19	3	3	paricalcitol	CDK2	PA450798	1017	0.971
NULL	Clin_Epigenetics_2011_Dec_5_3(1)_9.nxml.txt.nlp	22414300	SENT146	13	13	2	2	decitabine	BNIP3	PA164749631	664	0.971
NULL	EMBO_Mol_Med_2012_Mar_4(3)_218-233.nxml.txt.nlp	22294553	SENT217	5	5	30	30	erlotinib	GLI1	PA134687924	2735	0.971
NULL	Cancers_(Basel)_2014_Aug_12_6(3)_1631-1669.nxml.txt.nlp	25119536	SENT86	10	10	34	34	hydroxyurea	IFN	PA449942	3439	0.971
NULL	Cancer_Med_2013_Feb_3_2(1)_76-85.nxml.txt.nlp	24133630	SENT196	8	8	18	18	vemurafenib	P-gp	PA165946873	5243	0.971
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1066.nxml.txt.nlp	24556681	SENT25	9	9	19	19	ethanol	TLR4	PA448073	7099	0.971
NULL	Breast_Cancer_Res_2014_Sep_11_16(5)_430.nxml.txt.nlp	25212826	SENT168	26	26	6	6	fulvestrant	PTEN	PA164747170	5728	0.971
NULL	Indian_J_Med_Res_2011_Jan_133(1)_50-56.nxml.txt.nlp	21321419	SENT14	26	26	9	9	lamivudine	HAI	PA450163	6692;6768	0.971
NULL	Anal_Bioanal_Chem_2014_Jan_23_406(15)_3667-3680.nxml.txt.nlp	24452745	SENT189	4	4	31	31	ketoprofen	KET	PA450149	8626	0.971
NULL	Diabetes_Metab_Syndr_Obes_2014_Mar_18_7_107-120.nxml.txt.nlp	24672252	SENT194	31	31	44	44	liraglutide	GLP-1	PA165958364	100125288	0.971
NULL	Clin_Med_Insights_Circ_Respir_Pulm_Med_2011_Aug_31_5_37-47.nxml.txt.nlp	21912491	SENT104	22	22	27	27	clarithromycin	IL-8	PA449028	3576	0.971
NULL	Clin_Ophthalmol_2014_Mar_2_8_343-346.nxml.txt.nlp	24591809	SENT43	5	5	16	16	ranibizumab	PED	PA164746012	8682	0.971
NULL	Exp_Mol_Med_2012_May_31_44(5)_311-318.nxml.txt.nlp	22282402	SENT79	15	15	39	39	cilostazol	MCP-1	PA164746334	6347	0.971
NULL	Br_J_Pharmacol_2008_Dec_25_155(7)_1056-1065.nxml.txt.nlp	18724386	SENT258	2	2	8	8	diazoxide	GLP-1	PA449285	100125288	0.971
NULL	Cells_2014_Apr_4_3(2)_199-235.nxml.txt.nlp	24709958	SENT2489	4	4	11	11	gefitinib	ERBB3	PA131301952	2065	0.971
NULL	Oncol_Lett_2014_Nov_14_8(5)_2086-2092.nxml.txt.nlp	25295095	SENT132	29	29	16	16	gemcitabine	CHK1	PA449748	1111	0.971
NULL	Crit_Care_2008_Mar_13_12(Suppl_2)_P272.nxml.txt.nlp	NULL	SENT20	3	3	7	7	etomidate	RAI	PA164743987	10848;6050	0.971
NULL	Oxid_Med_Cell_Longev_2013_Jun_2_2013_793525.nxml.txt.nlp	23819014	SENT142	0	0	32	32	resveratrol	ROS		6098	0.971
NULL	Acta_Pharmacol_Sin_2014_Sep_25_35(9)_1199-1206.nxml.txt.nlp	25152024	SENT92	5	5	28	28	cisplatin	Bcl-2	PA449014	596	0.971
NULL	Ther_Clin_Risk_Manag_2007_Aug_3(4)_675-684.nxml.txt.nlp	18472990	SENT81	8	8	16	16	vancomycin	MIC1	PA451850	29919;9518	0.971
NULL	Cancers_(Basel)_2013_Nov_26_5(4)_1601-1618.nxml.txt.nlp	24287743	SENT167	16	16	4	4	cetuximab	Met	PA10040	79811	0.971
NULL	Pharmaceuticals_(Basel)_2013_Aug_2_6(8)_915-928.nxml.txt.nlp	24276376	SENT182	2	2	19	19	thrombin	PAR1	PA451674	79581;2149	0.971
NULL	Br_J_Cancer_2010_Nov_2_103(11)_1637-1643.nxml.txt.nlp	21045832	SENT74	6	6	12	12	sirolimus	CYP3A4	PA451365	1576	0.971
NULL	J_Community_Hosp_Intern_Med_Perspect_2012_Oct_15_2(3)_10_3402_jchimp_v2i3_19081.nxml.txt.nlp	23882374	SENT65	0	0	33	33	exenatide	GLP-1	PA164749238	100125288	0.971
NULL	Nat_Med_2012_Mar_4_18(4)_547-554.nxml.txt.nlp	22388091	SENT245	28	28	21	21	methacholine	IL-17A	PA165958382	3605	0.971
NULL	Cancer_Med_2014_Aug_7_3(4)_796-811.nxml.txt.nlp	24802970	SENT302	25	25	9	9	amiloride	CD49f	PA448368	3655	0.971
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_105-115.nxml.txt.nlp	17912640	SENT122	8	8	14	14	trastuzumab	HER2	PA451743	2064	0.971
NULL	Pain_Res_Treat_2010_Mar_4_2010_705874.nxml.txt.nlp	22110916	SENT189	38	38	3	3	gabapentin	EPM	PA449720	2054	0.971
NULL	Case_Rep_Med_2014_Mar_31_2014_801805.nxml.txt.nlp	24799913	SENT38	0	0	13	13	colistin	TMP	PA164760862	2012	0.971
NULL	Mol_Cells_2014_Nov_30_37(11)_812-818.nxml.txt.nlp	25377255	SENT9	26	26	5	5	doxorubicin	PARP-1	PA449412	25976	0.971
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT52	14	14	25	25	curcumin	TRAIL	PA151958596	8743	0.971
NULL	Eur_J_Pediatr_2014_Jan_4_173(6)_793-798.nxml.txt.nlp	24390060	SENT132	5	5	15	15	dobutamine	SBF	PA449381	7702	0.971
NULL	Arthritis_Res_Ther_2011_Mar_16_13(2)_R44.nxml.txt.nlp	21410959	SENT176	22	22	4	4	glucosamine	IFN	PA164747613	3439	0.971
NULL	Case_Rep_Endocrinol_2013_Dec_12_2013_782068.nxml.txt.nlp	24416602	SENT10	3	3	13	13	metyrapone	ACTH	PA450486	5443	0.971
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1144-1150.nxml.txt.nlp	21386843	SENT23	0	0	6	6	sorafenib	Raf-1	PA7000	5894	0.971
NULL	J_Hematol_Oncol_2009_Aug_12_2_36.nxml.txt.nlp	19674465	SENT103	21	21	39	39	lenalidomide	IL-2	PA162363968	3558	0.971
NULL	Oncotarget_2012_Sep_28_3(10)_1169-1181.nxml.txt.nlp	23045411	SENT132	19	19	8	8	doxorubicin	JIP1	PA449412	9479	0.971
NULL	Clin_Interv_Aging_2014_Apr_8_9_593-601.nxml.txt.nlp	24748777	SENT123	0	0	24	24	denosumab	sit	PA166048634	55733	0.971
NULL	Mol_Cancer_2010_Apr_29_9_95.nxml.txt.nlp	20429933	SENT56	24	24	12	12	cisplatin	p53	PA449014	7157	0.971
NULL	Front_Oncol_2012_Oct_4_2_123.nxml.txt.nlp	23061041	SENT89	24	24	10	10	tamoxifen	aromatase	PA451581	1588	0.971
NULL	Cancer_Biol_Med_2012_Mar_9(1)_18-22.nxml.txt.nlp	23691449	SENT78	19	19	8	8	erlotinib	KRAS	PA134687924	3845	0.971
NULL	Nat_Commun_2013_Aug_15_4_2130.nxml.txt.nlp	23945651	SENT178	7	7	13	13	etoposide	ATG5	PA449552	9474	0.971
NULL	J_Invest_Dermatol_2014_May_25_134(5)_1230-1237.nxml.txt.nlp	24352036	SENT200	27	27	32	32	curcumin	JNK	PA151958596	5599	0.971
NULL	Nucleic_Acids_Res_2012_Jul_19_40(13)_5910-5925.nxml.txt.nlp	22434882	SENT344	4	4	21	21	etoposide	p53	PA449552	7157	0.971
NULL	Mol_Cell_Proteomics_2014_May_17_13(5)_1273-1285.nxml.txt.nlp	24637012	SENT149	34	34	3	3	trypsin	5-HT2A	PA451806	3356	0.971
NULL	Cancers_(Basel)_2011_Apr_8_3(2)_1899-1928.nxml.txt.nlp	24212788	SENT254	23	23	9	9	bevacizumab	NRP1	PA130232992	8829	0.971
NULL	Mol_Cytogenet_2014_Jan_21_7(Suppl_1)_P100.nxml.txt.nlp	NULL	SENT18	38	38	23	23	metformin	STK11	PA450395	6794	0.971
NULL	Nat_Chem_Biol_2014_Feb_1_10(2)_127-132.nxml.txt.nlp	24292070	SENT126	10	10	38	38	nitrile	EGFR	PA450636	1956	0.971
NULL	Anal_Chem_Insights_2009_Apr_7_4_1-9.nxml.txt.nlp	19652757	SENT99	39	39	23	23	citalopram	mol	PA449015	90527	0.971
NULL	Mol_Cancer_2014_Jun_30_13_160.nxml.txt.nlp	24976026	SENT156	30	30	7	7	bortezomib	AGR2	PA10252	10551	0.971
NULL	Mol_Cancer_2009_Aug_25_8_66.nxml.txt.nlp	19706164	SENT71	4	4	24	24	celecoxib	p53	PA448871	7157	0.971
NULL	ISRN_Cardiol_2012_Jun_27_2012_692761.nxml.txt.nlp	22792485	SENT124	31	31	7	7	omeprazole	CYP2C19	PA450704	1557	0.971
NULL	Mucosal_Immunol_2013_Nov_10_6(6)_1179-1190.nxml.txt.nlp	23571504	SENT59	9	9	21	21	auranofin	GRX	PA448510	2745	0.971
NULL	Br_J_Cancer_2012_Nov_20_107(11)_1844-1852.nxml.txt.nlp	23169337	SENT217	35	35	27	27	bortezomib	SP1	PA10252	6667	0.971
NULL	Int_J_Biol_Sci_2012_Mar_7_8(4)_470-485.nxml.txt.nlp	22419892	SENT262	14	14	5	5	tamoxifen	SRC-3	PA451581	8202	0.971
NULL	Adv_Hematol_2012_May_8_2012_393864.nxml.txt.nlp	22851972	SENT34	34	34	18	18	lenalidomide	CD80	PA162363968	941	0.971
NULL	Apoptosis_2014_Aug_26_19(11)_1603-1615.nxml.txt.nlp	25156145	SENT191	10	10	2	2	mitomycin	JNK	PA450524	5599	0.971
NULL	Oncoscience_2014_Oct_22_1(10)_614-623.nxml.txt.nlp	25593991	SENT92	0	0	18	18	trastuzumab	HER2	PA451743	2064	0.971
NULL	J_Hematol_Oncol_2013_Jul_9_6_49.nxml.txt.nlp	23837843	SENT281	30	30	28	28	verapamil	P-gp	PA451868	5243	0.971
NULL	J_Invest_Dermatol_2012_Sep_17_132(9)_2184-2191.nxml.txt.nlp	22592158	SENT180	10	10	26	26	calcein	CO2	PA132595336	4513	0.971
NULL	Breast_Cancer_Res_Treat_2013_May_12_139(1)_107-113.nxml.txt.nlp	23580070	SENT5	14	14	32	32	trastuzumab	Hsp90	PA451743	3320	0.971
NULL	Cancer_Cell_Int_2011_Aug_19_11_29.nxml.txt.nlp	21854619	SENT137	37	37	10	10	cisplatin	BRCA1	PA449014	672	0.971
NULL	Cancer_Med_2013_Feb_3_2(1)_40-49.nxml.txt.nlp	24133626	SENT116	21	21	9	9	cilostazol	PDE3B	PA164746334	5140	0.971
NULL	Indian_J_Med_Paediatr_Oncol_2014_Apr-Jun_35(2)_140-142.nxml.txt.nlp	25197175	SENT64	23	23	18	18	bevacizumab	EGFR	PA130232992	1956	0.971
NULL	Cell_Div_2012_Mar_29_7_11.nxml.txt.nlp	22458775	SENT4	0	0	10	10	flavopiridol	CDK9	PA452627	1025	0.971
NULL	Acta_Pharmacol_Sin_2010_Oct_16_31(10)_1293-1302.nxml.txt.nlp	20711222	SENT128	21	21	10	10	ethanol	KLF4	PA448073	9314	0.971
NULL	Acta_Pharmacol_Sin_2009_Sep_24_30(9)_1323-1329.nxml.txt.nlp	19701237	SENT28	23	23	4	4	erythromycin	CYP3A	PA449493	1574	0.971
NULL	N_Am_J_Med_Sci_2011_Jan_3(1)_1-12.nxml.txt.nlp	22540056	SENT187	35	35	16	16	gemcitabine	KRAS	PA449748	3845	0.971
NULL	Int_J_Endocrinol_2011_Aug_21_2011_742719.nxml.txt.nlp	21869886	SENT168	12	12	10	10	cangrelor	P2Y12	PA165945763	64805	0.971
NULL	Crit_Care_2008_Jul_10_12(4)_218.nxml.txt.nlp	18638356	SENT224	5	5	16	16	flutamide	aromatase	PA449685	1588	0.971
NULL	Indian_J_Pharmacol_2014_Mar-Apr_46(2)_230-231.nxml.txt.nlp	24741201	SENT18	19	19	7	7	zidovudine	CD4	PA451954	920	0.971
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_29_2013_590393.nxml.txt.nlp	23737838	SENT196	11	11	18	18	resveratrol	p53		7157	0.971
NULL	Nucleic_Acids_Res_2013_Nov_16_41(20)_9349-9360.nxml.txt.nlp	23956219	SENT184	10	10	30	30	cisplatin	RMI1	PA449014	80010	0.971
NULL	Front_Pharmacol_2014_Mar_27_5_52.nxml.txt.nlp	24723889	SENT638	7	7	13	13	resveratrol	SIRT1		23411	0.971
NULL	Breast_Cancer_Res_Treat_2012_Jul_24_134(1)_13-20.nxml.txt.nlp	22198412	SENT29	0	0	18	18	lapatinib	HER2	PA152241907	2064	0.971
NULL	Br_J_Clin_Pharmacol_2010_Sep_70(3)_320-334.nxml.txt.nlp	20716230	SENT159	30	30	11	11	fluconazole	CYP2C9	PA449653	1559	0.971
NULL	Arthritis_Res_Ther_2012_Sep_24_14(5)_R200.nxml.txt.nlp	23006144	SENT145	10	10	1	1	alefacept	IL-20	PA164748040	27190;50604	0.971
NULL	Acta_Pharmacol_Sin_2009_Jul_22_30(7)_956-964.nxml.txt.nlp	19543298	SENT132	9	9	0	0	simvastatin	SLCO1B1	PA451363	10599	0.971
NULL	Chemother_Res_Pract_2012_Dec_20_2012_743193.nxml.txt.nlp	23320171	SENT33	0	0	13	13	trastuzumab	HER2	PA451743	2064	0.971
NULL	Evid_Based_Complement_Alternat_Med_2011_May_24_2011_841564.nxml.txt.nlp	21716682	SENT117	32	32	12	12	epirubicin	p38	PA449476	10598;1432;7965	0.971
NULL	Br_J_Cancer_2012_Jun_5_106(12)_1997-2003.nxml.txt.nlp	22596232	SENT147	19	19	6	6	sorafenib	JNK	PA7000	5599	0.971
NULL	Mol_Vis_2014_Mar_30_20_441-457.nxml.txt.nlp	24715760	SENT49	10	10	5	5	geldanamycin	Hsp90	PA152031327	3320	0.971
NULL	Indian_J_Pharmacol_2008_Oct_40(Suppl_2)_S211-S221.nxml.txt.nlp	21593975	SENT38	5	5	12	12	rosiglitazone	gamma	PA451283	9913	0.971
NULL	Cardiovasc_Ther_2009_27(4)_259-274.nxml.txt.nlp	19604248	SENT94	4	4	26	26	ticagrelor	ADP	PA165374673	23038	0.971
NULL	Arthritis_Res_Ther_2010_Apr_14_12(2)_R67.nxml.txt.nlp	20398273	SENT73	9	9	22	22	abatacept	CDP	PA164747080	1523	0.971
NULL	Case_Rep_Nephrol_Urol_2013_Dec_14_3(2)_139-146.nxml.txt.nlp	24570684	SENT98	0	0	24	24	eculizumab	C5b	PA164776637	727	0.971
NULL	J_Gen_Physiol_2008_Oct_132(4)_397-405.nxml.txt.nlp	18794377	SENT159	36	36	20	20	nifedipine	NCX	PA450631	3196	0.971
NULL	Int_J_Endocrinol_2013_Jul_31_2013_632461.nxml.txt.nlp	23983688	SENT617	11	11	21	21	cetuximab	KRAS	PA10040	3845	0.971
NULL	Indian_J_Med_Res_2012_Sep_136(3)_391-403.nxml.txt.nlp	23041732	SENT168	27	27	45	45	oxaliplatin	HCC	PA131285527	84668	0.971
NULL	J_Immunother_Cancer_2013_May_29_1_4.nxml.txt.nlp	NULL	SENT282	0	0	11	11	cetuximab	EGFR	PA10040	1956	0.971
NULL	Indian_J_Ophthalmol_2014_May_62(5)_642-644.nxml.txt.nlp	23571268	SENT87	22	22	1	1	hydroxychloroquine	APS	PA164777036	10603	0.971
NULL	Alzheimers_Res_Ther_2011_Jun_20_3(3)_22.nxml.txt.nlp	21689411	SENT159	13	13	0	0	donepezil	SHF	PA449394	90525	0.971
NULL	Mol_Clin_Oncol_2013_Sep_24_1(5)_918-924.nxml.txt.nlp	24649271	SENT128	17	17	9	9	gemcitabine	EGFR	PA449748	1956	0.971
NULL	Ann_Oncol_2013_Aug_12_24(8)_1994-1999.nxml.txt.nlp	23670096	SENT26	18	18	6	6	tamoxifen	AIB1	PA451581	8202	0.971
NULL	Open_Med_Chem_J_2008_Aug_6_2_75-80.nxml.txt.nlp	19662147	SENT89	3	3	26	26	tacrine	ETM	PA451576	2112	0.971
NULL	Crit_Care_2011_Nov_20_15(6)_R275.nxml.txt.nlp	22099212	SENT179	0	0	38	38	bivalirudin	ACT	PA10032	12;11332;9457;641455	0.971
NULL	Allergy_Asthma_Clin_Immunol_2010_Mar_17_6(1)_5.nxml.txt.nlp	20236545	SENT79	10	10	36	36	cyclosporine	IL-5	PA449167	3567	0.971
NULL	Iran_J_Basic_Med_Sci_2012_Nov-Dec_15(6)_1202-1209.nxml.txt.nlp	23653852	SENT166	10	10	34	34	metformin	VEGF-A	PA450395	7422	0.971
NULL	Exp_Diabetes_Res_2011_Jun_27_2011_947138.nxml.txt.nlp	21754922	SENT91	24	24	3	3	atropine	STZ	PA448505	6484	0.971
NULL	Chem_Rev_2014_Jun_11_114(11)_5753-5774.nxml.txt.nlp	24758331	SENT404	40	40	25	25	flavopiridol	P-gp	PA452627	5243	0.971
NULL	Evid_Based_Complement_Alternat_Med_2013_May_26_2013_161628.nxml.txt.nlp	23781255	SENT256	15	15	2	2	sunitinib	STAT3	PA162372840	6774	0.971
NULL	Exp_Ther_Med_2013_Nov_13_6(5)_1317-1321.nxml.txt.nlp	24223665	SENT106	14	14	3	3	curcumin	CD133	PA151958596	8842	0.971
NULL	Nat_Chem_Biol_2013_Feb_9_9(2)_112-118.nxml.txt.nlp	23222885	SENT377	11	11	26	26	geldanamycin	Hsp40	PA152031327	3337	0.971
NULL	Curr_Oncol_2006_Feb_13(1)_2-7.nxml.txt.nlp	17576435	SENT20	13	13	8	8	tamoxifen	HER2	PA451581	2064	0.971
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT398	39	39	25	25	heparin	FGF2	PA449855	2247;2258	0.971
NULL	Br_J_Cancer_2010_Mar_2_102(5)_815-826.nxml.txt.nlp	20145614	SENT154	11	11	26	26	trastuzumab	HER2	PA451743	2064	0.971
NULL	Open_Biochem_J_2011_Sep_23_5_45-51.nxml.txt.nlp	21966325	SENT8	5	5	14	14	indomethacin	PERK	PA449982	9451	0.971
NULL	Int_J_Breast_Cancer_2011_Feb_24_2011_967419.nxml.txt.nlp	22332018	SENT142	36	36	0	0	carboplatin	BRCA1	PA448803	672	0.971
NULL	J_Cell_Mol_Med_2014_Nov_12_18(11)_2135-2146.nxml.txt.nlp	25216213	SENT188	19	19	1	1	phenylephrine	mAKAP	PA450935	9472	0.971
NULL	Oncoscience_2013_Dec_11_1(1)_30-38.nxml.txt.nlp	25593982	SENT166	32	32	23	23	glucose	Met	PA449773	79811	0.971
NULL	Sci_Rep_2014_Dec_3_4_7294.nxml.txt.nlp	25465236	SENT59	14	14	2	2	staurosporine	TYK2	PA165109623	7297	0.971
NULL	Arthritis_Res_Ther_2009_Oct_14_11(5)_246.nxml.txt.nlp	19849823	SENT208	4	4	17	17	estradiol	IL-2	PA449503	3558	0.971
NULL	Br_J_Cancer_2010_Sep_28_103(7)_1008-1018.nxml.txt.nlp	20736947	SENT149	38	38	27	27	docetaxel	CD147	PA449383	682	0.971
NULL	Spermatogenesis_2013_Apr_1_3(2)_e24194.nxml.txt.nlp	23885303	SENT117	9	9	44	44	staurosporine	STS	PA165109623	412	0.971
NULL	Mol_Cancer_2014_Jun_19_13_154.nxml.txt.nlp	24941944	SENT160	24	24	12	12	methotrexate	NRAS	PA450428	4893	0.971
NULL	Open_Orthop_J_2008_Oct_24_2_137-144.nxml.txt.nlp	19478889	SENT36	12	12	0	0	heparin	PTN	PA449855	5764	0.971
NULL	Nat_Chem_Biol_2010_Apr_28_6(4)_291-299.nxml.txt.nlp	20190765	SENT278	16	16	9	9	dasatinib	EGFR	PA162372878	1956	0.971
NULL	J_Oncol_2009_Jun_14_2009_814140.nxml.txt.nlp	19547715	SENT21	5	5	15	15	etoposide	MDR1	PA449552	5243	0.971
NULL	Theranostics_2013_Sep_4_3(9)_719-728.nxml.txt.nlp	24019856	SENT167	36	36	0	0	hyaluronan	CD44	PA165958431	960	0.971
NULL	Mol_Cancer_2014_Jun_24_13_157.nxml.txt.nlp	24958351	SENT169	12	12	5	5	lapatinib	EGFR	PA152241907	1956	0.971
NULL	Diabetes_2009_Jul_14_58(7)_1715-1720.nxml.txt.nlp	19366866	SENT31	34	34	9	9	tolbutamide	INS-1	PA451718	2305	0.971
NULL	Front_Immunol_2014_Apr_1_5_131.nxml.txt.nlp	24744755	SENT279	9	9	21	21	imiquimod	IFN	PA449972	3439	0.971
NULL	Allergy_Asthma_Immunol_Res_2010_Apr_24_2(2)_65-76.nxml.txt.nlp	20358020	SENT131	29	29	15	15	astemizole	CYP3A4	PA448498	1576	0.971
NULL	Nat_Biotechnol_2013_Jul_30_31(7)_630-637.nxml.txt.nlp	23811600	SENT390	11	11	17	17	crizotinib	ABL1	PA165946122	25	0.971
NULL	Nat_Med_2013_Dec_10_19(12)_10_1038_nm_3385.nxml.txt.nlp	24216752	SENT143	28	28	4	4	thrombin	AKT3	PA451674	10000	0.971
NULL	Mol_Cancer_2009_Apr_22_8_26.nxml.txt.nlp	19386116	SENT185	28	28	2	2	cisplatin	AKT	PA449014	207	0.971
NULL	Adv_Appl_Bioinforma_Chem_2008_Oct_30_1_85-98.nxml.txt.nlp	21918608	SENT70	19	19	7	7	bortezomib	SPARC	PA10252	6678	0.971
NULL	Nucleic_Acids_Res_2010_Oct_28_38(19)_6418-6432.nxml.txt.nlp	20511593	SENT175	41	41	4	4	collagenase	AP-1	PA449107	2353;3727;2354;3725	0.971
NULL	J_Cell_Mol_Med_2014_Aug_6_18(8)_1519-1539.nxml.txt.nlp	25100284	SENT211	36	36	27	27	gefitinib	EGFR	PA131301952	1956	0.971
NULL	Oncogenesis_2014_Dec_15_3(12)_e133.nxml.txt.nlp	25500906	SENT115	15	15	6	6	trastuzumab	PI3K	PA451743	5290	0.971
NULL	J_Korean_Med_Sci_2013_Aug_31_28(8)_1238-1243.nxml.txt.nlp	23960454	SENT137	33	33	9	9	amiloride	ASIC3	PA448368	9311	0.971
NULL	Curr_Oncol_2009_Jul_16(Suppl_2)_S14-S23.nxml.txt.nlp	19672417	SENT17	25	25	15	15	letrozole	aromatase	PA450196	1588	0.971
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT67	5	5	0	0	trastuzumab	STAT3	PA451743	6774	0.971
NULL	Comp_Hepatol_2004_Jan_14_3(Suppl_1)_S37.nxml.txt.nlp	14960189	SENT106	14	14	6	6	thalidomide	TNF-alpha	PA451644	7124	0.971
NULL	Cancers_(Basel)_2011_Apr_18_3(2)_2014-2031.nxml.txt.nlp	24212794	SENT772	3	3	18	18	cetuximab	KRAS	PA10040	3845	0.971
NULL	Arch_Drug_Inf_2008_Dec_1(3)_79-88.nxml.txt.nlp	19639028	SENT182	0	0	4	4	tegaserod	5-HT4	PA130413154	3360	0.971
NULL	J_Cell_Mol_Med_2013_Oct_23_17(10)_1207-1217.nxml.txt.nlp	24106980	SENT138	16	16	1	1	docetaxel	KRAS	PA449383	3845	0.971
NULL	Mol_Cancer_2012_May_14_11_34.nxml.txt.nlp	22583868	SENT270	14	14	5	5	arsenite	JNK1	PA452638	5599	0.971
NULL	Exp_Ther_Med_2013_Mar_8_5(3)_707-710.nxml.txt.nlp	23404433	SENT8	11	11	18	18	cisplatin	Bcl-2	PA449014	596	0.971
NULL	Clin_Microbiol_Infect_2014_Jun_21_20(6)_536-541.nxml.txt.nlp	24107197	SENT12	21	21	3	3	isoniazid	DST	PA450112	667	0.971
NULL	Mol_Cancer_2009_Aug_25_8_66.nxml.txt.nlp	19706164	SENT48	15	15	23	23	celecoxib	p53	PA448871	7157	0.971
NULL	Mol_Cancer_2012_Mar_21_11_13.nxml.txt.nlp	22436134	SENT257	13	13	5	5	tamoxifen	HuR	PA451581	1994	0.971
NULL	Cardiol_Res_Pract_2011_May_10_2011_816897.nxml.txt.nlp	21629798	SENT131	8	8	3	3	ketoconazole	CYP3A4	PA450146	1576	0.971
NULL	Cancer_Res_Treat_2014_Jan_15_46(1)_55-64.nxml.txt.nlp	24520224	SENT145	17	17	9	9	irinotecan	TRAP1	PA450085	9392;10131	0.971
NULL	Clin_Med_Insights_Oncol_2013_Aug_21_7_235-245.nxml.txt.nlp	24179414	SENT52	29	29	25	25	itraconazole	CYP2C8	PA450132	1558	0.971
NULL	J_Hematol_Oncol_2013_Dec_17_6_93.nxml.txt.nlp	24341609	SENT112	0	0	19	19	gefitinib	EGFR	PA131301952	1956	0.971
NULL	Breast_Cancer_Res_2009_Jul_30_11(4)_R56.nxml.txt.nlp	19643025	SENT115	0	0	20	20	celecoxib	IL-17	PA448871	3605	0.971
NULL	Diabetes_2011_Nov_17_60(11)_2691-2700.nxml.txt.nlp	21896928	SENT248	6	6	23	23	resveratrol	SIRT1		23411	0.971
NULL	Diabetes_2013_May_16_62(5)_1689-1696.nxml.txt.nlp	23274908	SENT40	11	11	20	20	diazoxide	ABCC8	PA449285	6833	0.971
NULL	Cell_Death_Dis_2013_Jun_13_4(6)_e665.nxml.txt.nlp	23764846	SENT46	29	29	3	3	sorafenib	BLM	PA7000	641	0.971
NULL	Br_J_Cancer_2012_Jun_5_106(12)_1997-2003.nxml.txt.nlp	22596232	SENT151	26	26	14	14	sorafenib	JNK	PA7000	5599	0.971
NULL	Arthritis_Res_Ther_2004_Feb_24_6(Suppl_1)_24.nxml.txt.nlp	NULL	SENT7	36	36	4	4	infliximab	CD31	PA452639	5175	0.971
NULL	Int_J_Nanomedicine_2007_Mar_2(1)_13-18.nxml.txt.nlp	17722507	SENT102	0	0	8	8	aprepitant	CYP3A4	PA164747039	1576	0.971
NULL	Arch_Toxicol_2014_Nov_5_88(12)_2135-2190.nxml.txt.nlp	25370008	SENT788	16	16	6	6	dapsone	FMO3	PA449211	2328	0.971
NULL	J_Cell_Mol_Med_2013_Oct_23_17(10)_1207-1217.nxml.txt.nlp	24106980	SENT136	17	17	20	20	paclitaxel	STAT3	PA450761	6774	0.971
NULL	Oncotarget_2014_Oct_16_5(20)_9546-9563.nxml.txt.nlp	25337673	SENT110	5	5	31	31	erlotinib	AXL	PA134687924	558	0.971
NULL	Neural_Plast_2014_May_12_2014_563160.nxml.txt.nlp	24900924	SENT223	8	8	31	31	resveratrol	SIRT1		23411	0.971
NULL	Ann_Oncol_2011_Mar_8_22(3)_503-514.nxml.txt.nlp	20616198	SENT184	6	6	32	32	exemestane	aromatase	PA449563	1588	0.971
NULL	Basic_Clin_Pharmacol_Toxicol_2013_Feb_5_112(2)_132-137.nxml.txt.nlp	22900583	SENT155	9	9	20	20	ritonavir	CYP3A4	PA451260	1576	0.971
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT137	9	9	28	28	neratinib	HER2	PA165291472	2064	0.971
NULL	Biosci_Rep_2013_Nov_25_33(6)_e00081.nxml.txt.nlp	24070327	SENT68	29	29	22	22	imatinib	OCT1	PA10804	5451;6580	0.971
NULL	Br_J_Cancer_2009_Jul_21_101(2)_238-243.nxml.txt.nlp	19568242	SENT17	4	4	10	10	sunitinib	IFN	PA162372840	3439	0.971
NULL	Nucleic_Acids_Res_2010_Oct_21_38(18)_6148-6158.nxml.txt.nlp	20494979	SENT264	17	17	4	4	paclitaxel	HLJ1	PA450761	11080	0.971
NULL	Oncotarget_2013_Aug_21_4(9)_1484-1495.nxml.txt.nlp	23986086	SENT165	24	24	11	11	metformin	HER2	PA450395	2064	0.971
NULL	Fibrogenesis_Tissue_Repair_2012_Apr_13_5_5.nxml.txt.nlp	22502865	SENT95	34	34	2	2	troglitazone	CCN2	PA451799	1490	0.971
NULL	Mol_Cancer_2014_Jan_13_13_7.nxml.txt.nlp	24418169	SENT47	11	11	37	37	sorafenib	STAT3	PA7000	6774	0.971
NULL	EMBO_Mol_Med_2013_Jan_29_5(1)_137-148.nxml.txt.nlp	23197407	SENT111	17	17	7	7	propranolol	TR3	PA451145	8718;3164;10587	0.971
NULL	Ann_Indian_Acad_Neurol_2009_Apr-Jun_12(2)_89-98.nxml.txt.nlp	20142853	SENT193	24	24	9	9	phenytoin	MRP2	PA450947	100130958;57626;1244	0.971
NULL	Int_J_Mol_Sci_2014_Jun_5_15(6)_10034-10051.nxml.txt.nlp	24905404	SENT145	22	22	4	4	cisplatin	Bcl-2	PA449014	596	0.971
NULL	J_Gastroenterol_2014_Jun_19_49(6)_1001-1010.nxml.txt.nlp	23780559	SENT190	6	6	15	15	clonidine	HCN	PA449051	378938	0.971
NULL	J_Mol_Signal_2011_Jul_20_6_7.nxml.txt.nlp	21774804	SENT50	41	41	22	22	dasatinib	p53	PA162372878	7157	0.971
NULL	Evid_Based_Complement_Alternat_Med_2012_May_9_2012_928234.nxml.txt.nlp	22649479	SENT101	3	3	14	14	atorvastatin	CO2	PA448500	4513	0.971
NULL	Oxid_Med_Cell_Longev_2013_Apr_21_2013_412576.nxml.txt.nlp	23710286	SENT107	32	32	4	4	curcumin	NRF2	PA151958596	2551;4780	0.971
NULL	J_Biomed_Biotechnol_2011_Dec_6_2011_974701.nxml.txt.nlp	21188174	SENT83	2	2	8	8	urea	IL10	PA451831	3586	0.971
NULL	Open_Access_J_Urol_2011_May_10_3_69-82.nxml.txt.nlp	24198638	SENT67	3	3	31	31	sorafenib	UGT1A1	PA7000	54658	0.971
NULL	Curr_Cardiol_Rev_2009_Aug_5(3)_166-176.nxml.txt.nlp	20676275	SENT228	5	5	34	34	fluoxetine	HERG	PA449673	3757	0.971
NULL	Onco_Targets_Ther_2014_Nov_17_7_2111-2120.nxml.txt.nlp	25484594	SENT7	29	29	2	2	epirubicin	TLE3	PA449476	7090	0.971
NULL	Nat_Chem_Biol_2010_Apr_28_6(4)_291-299.nxml.txt.nlp	20190765	SENT189	30	30	8	8	dasatinib	EGFR	PA162372878	1956	0.971
NULL	Oncogene_2013_Nov_28_32(48)_5439-5448.nxml.txt.nlp	23563182	SENT180	2	2	9	9	vincristine	Mcl-1	PA451879	4170	0.971
NULL	Breast_Cancer_Res_Treat_2013_Jun_5_139(3)_649-655.nxml.txt.nlp	23736997	SENT119	8	8	25	25	tamoxifen	CYP2C19	PA451581	1557	0.971
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT90	38	38	7	7	metformin	EGFR	PA450395	1956	0.971
NULL	Int_J_Surg_Oncol_2011_Aug_8_2011_374012.nxml.txt.nlp	22312502	SENT162	10	10	32	32	tamoxifen	BRCA2	PA451581	675	0.971
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT15	23	23	2	2	sulindac	AKT	PA451565	207	0.971
NULL	Patient_Prefer_Adherence_2011_Dec_23_6_1-9.nxml.txt.nlp	22272064	SENT58	26	26	12	12	telmisartan	ACE	PA451605	1636	0.971
NULL	Pharmaceuticals_(Basel)_2012_Aug_10_5(8)_802-836.nxml.txt.nlp	24280676	SENT294	16	16	22	22	sulindac	MRP2	PA451565	100130958;57626;1244	0.971
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT236	15	15	10	10	doxorubicin	B7-H1	PA449412	29126	0.971
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT167	46	46	34	34	trastuzumab	HER2	PA451743	2064	0.971
NULL	Cancers_(Basel)_2010_Dec_16_2(4)_2138-2152.nxml.txt.nlp	24281221	SENT170	9	9	3	3	metformin	AMPK	PA450395	5563	0.971
NULL	Front_Immunol_2012_Jun_11_3_144.nxml.txt.nlp	22701453	SENT195	6	6	21	21	imiquimod	TLR7	PA449972	51284	0.971
NULL	Cancer_Med_2014_Apr_7_3(2)_362-375.nxml.txt.nlp	24515916	SENT283	19	19	1	1	zoledronate	IL-6	PA10235	3569	0.971
NULL	Anticancer_Drugs_2015_Jan_28_26(1)_46-55.nxml.txt.nlp	25099621	SENT91	35	35	3	3	doxorubicin	KE-3	PA449412	6222	0.971
NULL	Mol_Biol_Cell_2012_Nov_1_23(21)_4212-4225.nxml.txt.nlp	22956765	SENT251	8	8	22	22	thrombin	cadherin	PA451674	1015	0.971
NULL	Clin_Pharmacol_2013_Apr_19_5_67-83.nxml.txt.nlp	23650452	SENT28	0	0	11	11	ticagrelor	CYP3A5	PA165374673	1577	0.971
NULL	Oncotarget_2013_Nov_22_5(4)_933-943.nxml.txt.nlp	24659749	SENT56	20	20	10	10	nutlin-3	NOXA		5366	0.971
NULL	Cancers_(Basel)_2011_Mar_3_3(1)_1042-1080.nxml.txt.nlp	24212653	SENT427	10	10	24	24	trastuzumab	EGFR	PA451743	1956	0.971
NULL	Oncoimmunology_2014_Jan_1_3_e27359.nxml.txt.nlp	24653963	SENT31	0	0	16	16	doxorubicin	CD4	PA449412	920	0.971
NULL	J_Lipid_Res_2015_Jan_56(1)_109-121.nxml.txt.nlp	25421061	SENT296	25	25	12	12	forskolin	CGI-58	PA146096022	51099	0.971
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT297	15	15	21	21	resveratrol	SIRT1		23411	0.971
NULL	Nucleic_Acids_Res_2014_Jan_1_42(1)_643-660.nxml.txt.nlp	24097436	SENT188	36	36	18	18	doxycycline	DIS3	PA449415	22894	0.971
NULL	Int_J_Inflam_2011_Oct_30_2011_642612.nxml.txt.nlp	22121495	SENT61	6	6	25	25	metformin	FABP4	PA450395	2167	0.971
NULL	Breast_Cancer_Res_Treat_2014_Dec_19_143(2)_351-358.nxml.txt.nlp	24352574	SENT66	0	0	9	9	filgrastim	2-21	PA449626	54097	0.971
NULL	J_Biomed_Sci_2013_Jul_5_20(1)_47.nxml.txt.nlp	23829868	SENT61	31	31	9	9	heparin	VEGF-A	PA449855	7422	0.971
NULL	South_Asian_J_Cancer_2014_Jul-Sep_3(3)_182-184.nxml.txt.nlp	25136528	SENT82	20	20	0	0	nelfinavir	CYP3A4	PA450606	1576	0.971
NULL	Vet_Res_2013_Oct_2_44(1)_89.nxml.txt.nlp	24088531	SENT237	21	21	1	1	hemin	HO-1	PA449849	3162	0.971
NULL	J_Clin_Biochem_Nutr_2007_Jan_27_40(1)_13-23.nxml.txt.nlp	18437209	SENT575	5	5	32	32	trypsin	PAR2	PA451806	2150;55065;8856	0.971
NULL	Curr_Gerontol_Geriatr_Res_2010_Jun_8_2010_915296.nxml.txt.nlp	20631897	SENT177	8	8	25	25	amiodarone	CYP3A4	PA448383	1576	0.971
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT158	0	0	4	4	elvitegravir	CYP3A4	PA165291498	1576	0.971
NULL	Int_J_Gen_Med_2012_Jun_18_5_535-540.nxml.txt.nlp	22807641	SENT8	17	17	14	14	pitavastatin	adiponectin	PA142650384	9370	0.971
NULL	Cancer_Immunol_Immunother_2012_Jul_23_61(7)_1101-1111.nxml.txt.nlp	22193989	SENT123	15	15	10	10	oxaliplatin	CD83	PA131285527	9308	0.971
NULL	Curr_Neuropharmacol_2007_Dec_5(4)_232-243.nxml.txt.nlp	19305740	SENT73	17	17	12	12	naproxen	COX2	PA450595	4513;5743	0.971
NULL	JAKSTAT_2014_Jun_12_3_e29510.nxml.txt.nlp	25105066	SENT38	24	24	6	6	pilocarpine	STAT3	PA450962	6774	0.971
NULL	Biomed_Res_Int_2014_Jan_2_2014_682010.nxml.txt.nlp	24524084	SENT87	35	35	17	17	imatinib	IL-2	PA10804	3558	0.971
NULL	Int_J_Biol_Sci_2011_Nov_5_8(1)_1-14.nxml.txt.nlp	22211100	SENT178	22	22	8	8	evodiamine	PI3K	PA165860788	5290	0.971
NULL	Oncogene_2009_Dec_3_28(48)_4237-4248.nxml.txt.nlp	19734937	SENT59	9	9	31	31	thrombin	PAR-1	PA451674	2011;2149	0.971
NULL	Front_Genet_2014_Oct_31_5_379.nxml.txt.nlp	25400658	SENT356	7	7	3	3	doxorubicin	UCA1	PA449412	652995	0.971
NULL	EMBO_Mol_Med_2011_Aug_3(8)_451-464.nxml.txt.nlp	21656687	SENT17	12	12	0	0	trypsin	SPINK1	PA451806	6690	0.971
NULL	Ann_Oncol_2014_Oct_23_25(10)_1941-1948.nxml.txt.nlp	25057173	SENT87	17	17	1	1	docetaxel	EGFR	PA449383	1956	0.971
NULL	J_Cell_Biol_2008_Jul_28_182(2)_327-340.nxml.txt.nlp	18644889	SENT98	21	21	3	3	estradiol	CRM1	PA449503	7514	0.971
NULL	Biosci_Rep_2014_Jan_17_34(1)_e00090.nxml.txt.nlp	24262079	SENT84	31	31	29	29	lapatinib	HER2	PA152241907	2064	0.971
NULL	EMBO_Mol_Med_2013_Mar_21_5(3)_332-343.nxml.txt.nlp	23427196	SENT182	0	0	9	9	mupirocin	ARS	PA164764568	6012;57152	0.971
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT297	15	15	5	5	resveratrol	SIRT1		23411	0.971
NULL	Nat_Genet_2011_Feb_26_43(2)_117-120.nxml.txt.nlp	21186350	SENT77	13	13	21	21	metformin	ATM	PA450395	472	0.971
NULL	Biomed_Res_Int_2014_Apr_23_2014_502542.nxml.txt.nlp	24864249	SENT103	14	14	18	18	rimonabant	CB1	PA152407999	1268	0.971
NULL	Breast_Cancer_Res_2011_Jan_11_13(1)_R3.nxml.txt.nlp	21223569	SENT162	6	6	28	28	etoposide	p53	PA449552	7157	0.971
NULL	Clin_Interv_Aging_2014_Aug_28_9_1437-1452.nxml.txt.nlp	25210448	SENT60	30	30	47	47	tamoxifen	SRC1	PA451581	8648	0.971
NULL	Front_Immunol_2012_Jan_24_3_3.nxml.txt.nlp	22566889	SENT103	13	13	7	7	rituximab	Bcl-2	PA451261	596	0.971
NULL	Cancer_Med_2014_Oct_10_3(5)_1353-1358.nxml.txt.nlp	25044922	SENT19	0	0	46	46	sunitinib	IFN	PA162372840	3439	0.971
NULL	Breast_Cancer_Res_2008_Jul_24_10(4)_211.nxml.txt.nlp	18671839	SENT215	0	0	19	19	trastuzumab	HER2	PA451743	2064	0.971
NULL	Indian_J_Pharm_Sci_2014_Mar-Apr_76(2)_125-131.nxml.txt.nlp	24843185	SENT10	16	16	2	2	resveratrol	S100B		6285	0.971
NULL	BMJ_Open_2015_Jan_6_5(1)_e006251.nxml.txt.nlp	25564143	SENT157	13	13	20	20	simvastatin	CYP3A4	PA451363	1576	0.971
NULL	Front_Chem_2014_Mar_14_2_12.nxml.txt.nlp	24790981	SENT140	12	12	3	3	curcumin	P19	PA151958596	51561	0.971
NULL	Br_J_Clin_Pharmacol_2013_Aug_23_76(2)_299-315.nxml.txt.nlp	23701319	SENT230	20	20	5	5	infliximab	IL-2	PA452639	3558	0.971
NULL	Int_J_Womens_Health_2012_Sep_3_4_455-469.nxml.txt.nlp	23071416	SENT87	8	8	1	1	alendronate	NNT	PA448082	23530	0.971
NULL	Ecancermedicalscience_2010_Oct_7_4_192.nxml.txt.nlp	22276040	SENT30	16	16	0	0	trastuzumab	PTEN	PA451743	5728	0.971
NULL	Breast_Cancer_Res_2005_Apr_12_7(4)_R570-R579.nxml.txt.nlp	15987464	SENT118	11	11	2	2	gefitinib	EGFR	PA131301952	1956	0.971
NULL	Mol_Pain_2013_Jun_10_9_27.nxml.txt.nlp	23758830	SENT67	21	21	9	9	tetracaine	ASIC3	PA451638	9311	0.971
NULL	Indian_J_Endocrinol_Metab_2013_Jul-Aug_17(4)_636-646.nxml.txt.nlp	23961479	SENT151	9	9	22	22	indinavir	CYP3A4	PA449977	1576	0.971
NULL	J_Cell_Sci_2011_Oct_1_124(19)_3344-3355.nxml.txt.nlp	21940797	SENT80	26	26	6	6	arsenite	G3BP	PA452638	10146	0.971
NULL	Tuberc_Respir_Dis_(Seoul)_2013_Nov_29_75(5)_188-198.nxml.txt.nlp	24348666	SENT204	3	3	41	41	erlotinib	EGFR	PA134687924	1956	0.971
NULL	Acta_Neuropathol_Commun_2013_Aug_9_1_49.nxml.txt.nlp	24252504	SENT102	20	20	10	10	arsenite	TDP-43	PA452638	23435	0.971
NULL	Int_J_Surg_Oncol_2012_Jun_24_2012_868645.nxml.txt.nlp	22778942	SENT76	0	0	14	14	pertuzumab	HER2		2064	0.971
NULL	Oncoimmunology_2013_Sep_1_2(9)_e25636.nxml.txt.nlp	24319636	SENT31	11	11	20	20	gemcitabine	IFN	PA449748	3439	0.971
NULL	Breast_Cancer_Res_Treat_2013_Aug_20_141(1)_43-53.nxml.txt.nlp	23959396	SENT191	38	38	18	18	trastuzumab	HER3	PA451743	2065	0.971
NULL	J_Korean_Med_Sci_2013_Feb_29_28(2)_308-314.nxml.txt.nlp	23399960	SENT13	4	4	11	11	gabapentin	IL-10	PA449720	3586	0.971
NULL	Cancer_Cell_Int_2006_Nov_3_6_24.nxml.txt.nlp	17081316	SENT208	16	16	7	7	doxorubicin	MDR1	PA449412	5243	0.971
NULL	Braz_J_Med_Biol_Res_2012_Feb_17_45(3)_244-249.nxml.txt.nlp	22331137	SENT134	39	39	4	4	gentamicin	PAG	PA449753	55824	0.971
NULL	Pharmaceutics_2010_Jun_2_2(2)_258-274.nxml.txt.nlp	NULL	SENT28	3	3	14	14	risperidone	CYP2D6	PA451257	1565	0.971
NULL	Int_J_Mol_Sci_2014_Mar_12_15(3)_4356-4392.nxml.txt.nlp	24625663	SENT278	41	41	9	9	etoposide	NEU3	PA449552	10825	0.971
NULL	Breast_Cancer_Res_2009_Sep_29_11(5)_209.nxml.txt.nlp	19818165	SENT119	32	32	22	22	tamoxifen	EGFR	PA451581	1956	0.971
NULL	Mol_Cancer_2012_Apr_5_11_20.nxml.txt.nlp	22480225	SENT336	11	11	2	2	temozolomide	HSP27	PA451609	3315	0.971
NULL	Neural_Dev_2012_Feb_27_7_9.nxml.txt.nlp	22369234	SENT287	12	12	5	5	isoflurane	P14	PA450106	11102;;6280;56259	0.971
NULL	Br_J_Cancer_2012_Dec_4_107(12)_1950-1955.nxml.txt.nlp	23169295	SENT19	21	21	5	5	oxaliplatin	DPD	PA131285527	1806	0.971
NULL	Gut_Liver_2013_Sep_14_7(5)_585-593.nxml.txt.nlp	24073317	SENT74	15	15	27	27	ribavirin	IFN	PA451241	3439	0.971
NULL	Breast_Cancer_Res_2012_Aug_13_14(4)_109.nxml.txt.nlp	22889086	SENT23	8	8	20	20	tamoxifen	aromatase	PA451581	1588	0.971
NULL	Environ_Health_Perspect_2005_Jun_14_113(6)_801-807.nxml.txt.nlp	15929907	SENT182	23	23	0	0	heparin	PF4	PA449855	5196	0.971
NULL	Int_J_Med_Sci_2015_Jan_1_12(1)_78-82.nxml.txt.nlp	25552922	SENT30	21	21	8	8	dextromethorphan	CYP2D6	PA449273	1565	0.971
NULL	Braz_J_Med_Biol_Res_2014_Nov_4_48(1)_13-24.nxml.txt.nlp	25493378	SENT87	3	3	10	10	cisplatin	ERCC1	PA449014	2067	0.971
NULL	Breast_Cancer_Res_Treat_2013_Jun_30_139(2)_441-451.nxml.txt.nlp	23715630	SENT2	5	5	1	1	anastrozole	aromatase	PA448432	1588	0.971
NULL	Chem_Rev_2011_Oct_12_111(10)_5899-5921.nxml.txt.nlp	21923193	SENT559	5	5	13	13	flurbiprofen	COX	PA449683	1351	0.971
NULL	J_Biomed_Sci_2013_Jul_2_20(1)_46.nxml.txt.nlp	23815815	SENT13	6	6	14	14	indomethacin	EPAC	PA449982	10411	0.971
NULL	Indian_J_Pharmacol_2008_Jan-Feb_40(1)_32-36.nxml.txt.nlp	21264159	SENT76	15	15	37	37	diazepam	EPM	PA449283	2054	0.971
NULL	J_Headache_Pain_2014_Sep_18_15(Suppl_1)_F28.nxml.txt.nlp	NULL	SENT19	5	5	26	26	telmisartan	P-gp	PA451605	5243	0.971
NULL	Acta_Pharmacol_Sin_2009_May_5_30(5)_545-552.nxml.txt.nlp	19417733	SENT161	10	10	1	1	lovastatin	AMPK	PA450272	5563	0.971
NULL	Oncotarget_2012_Aug_19_3(8)_890-903.nxml.txt.nlp	23097685	SENT151	0	0	21	21	etodolac	VEGF-D	PA449550	2277	0.971
NULL	Arthritis_Res_Ther_2012_Dec_3_14(6)_R262.nxml.txt.nlp	23206933	SENT212	2	2	25	25	tocilizumab	IL-6	PA165292659	3569	0.971
NULL	Hematol_Rep_2011_Oct_28_3(3_Suppl)_e3.nxml.txt.nlp	22586511	SENT26	2	2	32	32	doxorubicin	CHOP	PA449412	1649	0.971
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1137-1144.nxml.txt.nlp	20234366	SENT165	38	38	6	6	cetuximab	MKP-1	PA10040	1843	0.971
NULL	Hum_Mol_Genet_2013_Nov_15_22(22)_4616-4626.nxml.txt.nlp	23814041	SENT173	19	19	7	7	simvastatin	neuroserpin	PA451363	5274	0.971
NULL	Breast_Cancer_Res_2014_Nov_29_16(6)_488.nxml.txt.nlp	25432519	SENT60	4	4	16	16	trastuzumab	HER2	PA451743	2064	0.971
NULL	Indian_J_Nephrol_2009_Apr_19(2)_77-79.nxml.txt.nlp	20368930	SENT54	26	26	9	9	tacrolimus	CD4	PA451578	920	0.971
NULL	Brain_Behav_2013_Mar_6_3(2)_114-133.nxml.txt.nlp	23533150	SENT169	6	6	27	27	ethanol	Hsp40	PA448073	3337	0.971
NULL	FEBS_Open_Bio_2014_Jun_7_4_554-559.nxml.txt.nlp	25009769	SENT109	5	5	1	1	trypsin	HYAL1	PA451806	3373	0.971
NULL	Sci_Rep_2014_Dec_8_4_7336.nxml.txt.nlp	25482724	SENT53	20	20	1	1	imatinib	KIT	PA10804	3815	0.971
NULL	J_Biomed_Sci_2013_Jun_25_20(1)_41.nxml.txt.nlp	23800047	SENT90	34	34	19	19	trypsin	EGF	PA451806	1950	0.971
NULL	Oncogene_2010_Jun_3_29(22)_3208-3216.nxml.txt.nlp	20383201	SENT85	1	1	17	17	dasatinib	EGF	PA162372878	1950	0.971
NULL	Cancers_(Basel)_2010_Dec_9_2(4)_2058-2083.nxml.txt.nlp	24281218	SENT329	21	21	19	19	erlotinib	EGFR	PA134687924	1956	0.971
NULL	Asian_J_Androl_2015_Aug_15_Jan-Feb_17(1)_143-148.nxml.txt.nlp	25155105	SENT123	16	16	7	7	udenafil	GAQ	PA164776753	2776	0.971
NULL	Clin_Infect_Dis_2011_Jan_1_52(1)_31-40.nxml.txt.nlp	21148517	SENT32	5	5	11	11	linezolid	HAP	PA450233	5915;10313	0.971
NULL	Emerg_Infect_Dis_2011_Apr_17(4)_741-742.nxml.txt.nlp	21470476	SENT44	11	11	24	24	rituximab	B19	PA451261	59271	0.971
NULL	J_Skin_Cancer_2014_Jul_21_2014_284582.nxml.txt.nlp	25136458	SENT87	22	22	12	12	carboplatin	CRT	PA448803	811	0.971
NULL	Mucosal_Immunol_2013_Jan_4_6(1)_136-145.nxml.txt.nlp	22763408	SENT201	8	8	18	18	dextran	NLRP3	PA449261	114548	0.971
NULL	Dermatoendocrinol_2013_Apr_1_5(2)_239-251.nxml.txt.nlp	24194964	SENT196	6	6	31	31	vemurafenib	HIF-1	PA165946873	29072	0.971
NULL	Oncotarget_2014_Jun_7_5(14)_5257-5271.nxml.txt.nlp	24913448	SENT18	25	25	4	4	nilotinib	CRKL	PA165958345	1399	0.971
NULL	Indian_J_Pharmacol_2013_Mar-Apr_45(2)_121-125.nxml.txt.nlp	23716885	SENT146	11	11	25	25	aripiprazole	CYP3A4	PA10026	1576	0.971
NULL	Diabetologia_2010_Jun_27_53(6)_1142-1150.nxml.txt.nlp	20349036	SENT158	26	26	3	3	spermine	AMPK	PA164781199	5563	0.971
NULL	J_Clin_Exp_Pathol_2012_May_17_Suppl_4_7327.nxml.txt.nlp	25379357	SENT136	4	4	30	30	metformin	S6K1	PA450395	6198	0.971
NULL	Acta_Pharmacol_Sin_2010_Oct_27_31(10)_1389-1394.nxml.txt.nlp	20871620	SENT179	24	24	10	10	carbachol	JNK	PA448784	5599	0.971
NULL	Mol_Cancer_2008_Jun_5_7_50.nxml.txt.nlp	18534018	SENT126	20	20	3	3	bortezomib	p53	PA10252	7157	0.971
NULL	J_Res_Med_Sci_2012_Nov_17(11)_1015-1019.nxml.txt.nlp	23833574	SENT89	11	11	19	19	rosiglitazone	gamma	PA451283	9913	0.971
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1420-1426.nxml.txt.nlp	24056704	SENT128	5	5	18	18	ketoconazole	CYP3A	PA450146	1574	0.971
NULL	Ann_Pediatr_Endocrinol_Metab_2013_Sep_30_18(3)_128-134.nxml.txt.nlp	24904866	SENT89	29	29	20	20	hydrocortisone	ACTH	PA449905	5443	0.971
NULL	Mol_Cancer_2009_Aug_28_8_68.nxml.txt.nlp	19715609	SENT284	25	25	13	13	docetaxel	PIM1	PA449383	5292;9361	0.971
NULL	Cancer_Immunol_Immunother_2013_Aug_27_62(10)_1637-1648.nxml.txt.nlp	23982484	SENT133	19	19	11	11	lenalidomide	IL-6	PA162363968	3569	0.971
NULL	Br_J_Cancer_2013_Feb_5_108(2)_319-326.nxml.txt.nlp	23322198	SENT20	4	4	21	21	pazopanib	VEGFR2	PA165291492	3791	0.971
NULL	Curr_Heart_Fail_Rep_2012_Sep_19_9(3)_200-210.nxml.txt.nlp	22711313	SENT65	28	28	1	1	l-arginine	DHFR	PA448478	1719	0.971
NULL	Br_J_Cancer_2009_Nov_3_101(9)_1529-1536.nxml.txt.nlp	19809429	SENT53	35	35	11	11	cyclophosphamide	NAC	PA449165	22861	0.971
NULL	Neural_Plast_2013_Jun_19_2013_537265.nxml.txt.nlp	23862076	SENT112	17	17	4	4	amitriptyline	5-HT6	PA448385	3362	0.971
NULL	Springerplus_2014_Sep_17_3_535.nxml.txt.nlp	25279326	SENT150	15	15	9	9	tamoxifen	aromatase	PA451581	1588	0.971
NULL	Nat_Commun_2013_Sep_4_4_2338.nxml.txt.nlp	24005565	SENT49	14	14	1	1	cisplatin	HELQ	PA449014	113510	0.971
NULL	Clin_Sci_(Lond)_2011_Nov_1_121(Pt_10)_449-458.nxml.txt.nlp	21671887	SENT204	20	20	32	32	simvastatin	AMPK	PA451363	5563	0.971
NULL	Basic_Clin_Pharmacol_Toxicol_2013_Feb_5_112(2)_132-137.nxml.txt.nlp	22900583	SENT23	22	22	32	32	ketoconazole	CYP3A	PA450146	1574	0.971
NULL	Biochem_Biophys_Res_Commun_2008_Mar_7_367(2)_271-276.nxml.txt.nlp	18164684	SENT297	23	23	15	15	doxycycline	p53	PA449415	7157	0.971
NULL	Environ_Health_Perspect_2012_Jul_18_120(7)_990-996.nxml.txt.nlp	22510978	SENT219	23	23	33	33	diethylstilbestrol	EZH2	PA449307	2146	0.971
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1033-1038.nxml.txt.nlp	22374460	SENT171	31	31	10	10	capecitabine	HER2	PA448771	2064	0.971
NULL	Acta_Pharmacol_Sin_2012_Aug_23_33(8)_1095-1100.nxml.txt.nlp	22820908	SENT112	25	25	16	16	verapamil	CYP3A4	PA451868	1576	0.971
NULL	Acta_Naturae_2011_Jul-Sep_3(3)_12-28.nxml.txt.nlp	22649690	SENT312	25	25	11	11	elvitegravir	CD4	PA165291498	920	0.971
NULL	Biomed_Res_Int_2013_Jul_23_2013_485103.nxml.txt.nlp	23971037	SENT65	46	46	16	16	anakinra	IL1RN	PA10799	3557	0.971
NULL	J_Invest_Dermatol_2013_Sep_31_133(9)_2247-2254.nxml.txt.nlp	23370537	SENT105	18	18	11	11	chloroquine	PUMA	PA448948	27113	0.971
NULL	Cancers_(Basel)_2014_Dec_16_6(4)_2387-2403.nxml.txt.nlp	25521854	SENT129	0	0	7	7	sunitinib	VEGFR	PA162372840	3791	0.971
NULL	Open_Med_Chem_J_2011_Sep_9_5_82-92.nxml.txt.nlp	21966329	SENT303	7	7	14	14	saxagliptin	DPP4	PA165958362	1803	0.971
NULL	Int_J_Mol_Sci_2012_Sep_20_13(9)_11974-11999.nxml.txt.nlp	23109895	SENT1001	5	5	0	0	cisplatin	FATS	PA449014	118611	0.971
NULL	Breast_Cancer_Res_2011_May_26_13(3)_209.nxml.txt.nlp	21635709	SENT231	19	19	17	17	letrozole	aromatase	PA450196	1588	0.971
NULL	Br_J_Pharmacol_2013_Jun_27_169(4)_736-747.nxml.txt.nlp	23489111	SENT169	2	2	22	22	quinine	5-HT3A	PA451213	3359	0.971
NULL	Br_J_Cancer_2013_May_28_108(10)_1985-1993.nxml.txt.nlp	23632474	SENT33	0	0	16	16	neratinib	EGFR	PA165291472	1956	0.971
NULL	J_Antimicrob_Chemother_2012_May_8_67(5)_1217-1223.nxml.txt.nlp	22316571	SENT32	2	2	6	6	ritonavir	CYP3A4	PA451260	1576	0.971
NULL	Evid_Based_Complement_Alternat_Med_2012_Feb_16_2012_430262.nxml.txt.nlp	22454664	SENT28	13	13	23	23	clopidogrel	CYP2C19	PA449053	1557	0.971
NULL	Breast_Cancer_Res_2007_Mar_2_9(2)_205.nxml.txt.nlp	NULL	SENT26	18	18	4	4	ekb-569	HER-2		2064	0.971
NULL	Acta_Pharmacol_Sin_2010_Oct_13_31(10)_1350-1358.nxml.txt.nlp	20835264	SENT147	0	0	31	31	simvastatin	gamma	PA451363	9913	0.971
NULL	Acta_Pharmacol_Sin_2012_May_16_33(5)_682-690.nxml.txt.nlp	22504904	SENT167	12	12	38	38	celecoxib	IL-6	PA448871	3569	0.971
NULL	Cell_Death_Differ_2009_Aug_20_16(8)_1135-1145.nxml.txt.nlp	19300452	SENT177	22	22	7	7	doxycycline	PUMA	PA449415	27113	0.971
NULL	Bioinformation_2012_Jan_6_8(1)_13-19.nxml.txt.nlp	22359429	SENT165	19	19	32	32	curcumin	MRP1	PA151958596	4437	0.971
NULL	J_Exp_Med_1998_Jun_1_187(11)_1885-1892.nxml.txt.nlp	9607928	SENT135	8	8	23	23	thalidomide	CD4	PA451644	920	0.971
NULL	Acta_Pharmacol_Sin_2014_Jan_9_35(1)_1-10.nxml.txt.nlp	24317012	SENT23	26	26	0	0	paclitaxel	OATP1B1	PA450761	10599	0.971
NULL	Br_J_Haematol_2014_Mar_13_164(1)_811-821.nxml.txt.nlp	24328678	SENT147	11	11	30	30	lenalidomide	Aiolos	PA162363968	22806	0.971
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT124	26	26	15	15	vemurafenib	ABCG2	PA165946873	9429	0.971
NULL	Diabetes_Metab_J_2012_Jun_14_36(3)_167-180.nxml.txt.nlp	22737656	SENT154	1	1	26	26	etretinate	CD25	PA449554	3669;3559	0.971
NULL	Oncotarget_2013_Nov_15_4(11)_1866-1867.nxml.txt.nlp	24272818	SENT29	13	13	21	21	trastuzumab	PIK3CA	PA451743	5290	0.971
NULL	Oncotarget_2012_May_19_3(5)_535-545.nxml.txt.nlp	22619121	SENT12	4	4	19	19	camptothecin	MYCN	PA153590860	4613	0.971
NULL	Nucleic_Acids_Res_2005_Jun_8_33(10)_3283-3291.nxml.txt.nlp	15944449	SENT14	6	6	19	19	melphalan	XRCC2	PA450354	7516	0.971
NULL	Br_J_Cancer_2013_Jul_9_109(1)_68-75.nxml.txt.nlp	23807173	SENT111	23	23	31	31	cisplatin	ERCC1	PA449014	2067	0.971
NULL	Br_J_Cancer_2013_Mar_5_108(4)_771-774.nxml.txt.nlp	23412099	SENT88	10	10	20	20	docetaxel	EGFR	PA449383	1956	0.971
NULL	Mol_Cancer_2010_May_20_9_115.nxml.txt.nlp	20487546	SENT228	21	21	8	8	fludarabine	SULF2	PA449655	55959	0.971
NULL	Br_J_Cancer_2012_Sep_4_107(6)_947-955.nxml.txt.nlp	22892392	SENT200	11	11	2	2	tamoxifen	ERBB2	PA451581	2064	0.971
NULL	Breast_Cancer_Res_2008_Mar_27_10(2)_R27.nxml.txt.nlp	18371219	SENT23	21	21	5	5	doxorubicin	PIK3CA	PA449412	5290	0.971
NULL	Int_J_Breast_Cancer_2013_Jun_24_2013_137414.nxml.txt.nlp	23864953	SENT89	4	4	26	26	lapatinib	HER2	PA152241907	2064	0.971
NULL	Br_J_Pharmacol_2014_Jan_23_171(2)_523-535.nxml.txt.nlp	24372553	SENT53	24	24	2	2	metformin	SIRT1	PA450395	23411	0.971
NULL	Int_J_Breast_Cancer_2013_Jun_24_2013_137414.nxml.txt.nlp	23864953	SENT88	33	33	36	36	tamoxifen	aromatase	PA451581	1588	0.971
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_75-89.nxml.txt.nlp	17912638	SENT196	17	17	2	2	tamoxifen	ATAC	PA451581	6375	0.971
NULL	Curr_Neuropharmacol_2007_Dec_5(4)_278-288.nxml.txt.nlp	19305744	SENT261	11	11	28	28	nicardipine	SMF	PA450620	22993	0.971
NULL	Acta_Neuropathol_2009_Sep_14_118(3)_329-347.nxml.txt.nlp	19597829	SENT417	35	35	5	5	bortezomib	HDM2	PA10252	4193	0.971
NULL	Br_J_Cancer_2010_Nov_26_103(11)_1644-1648.nxml.txt.nlp	20978506	SENT98	15	15	4	4	erlotinib	EGFR	PA134687924	1956	0.971
NULL	Indian_J_Nephrol_2009_Jul_19(3)_126a.nxml.txt.nlp	20436737	SENT10	2	2	16	16	nevirapine	CD4	PA450616	920	0.971
NULL	Arthritis_Res_Ther_2006_Dec_28_8(1)_R18.nxml.txt.nlp	16507118	SENT75	39	39	10	10	infliximab	ACR	PA452639	49	0.971
NULL	Br_J_Cancer_1992_Feb_65(2)_183-188.nxml.txt.nlp	1739614	SENT12	3	3	29	29	novobiocin	gamma	PA164768819	9913	0.971
NULL	Oncotarget_2014_Jun_6_5(13)_4935-4944.nxml.txt.nlp	24952732	SENT95	6	6	35	35	doxazosin	HIF-1	PA449407	29072	0.971
NULL	Cardiovasc_Res_2012_Mar_15_93(4)_674-681.nxml.txt.nlp	22166712	SENT129	27	27	3	3	ketoconazole	CYP3A	PA450146	1574	0.971
NULL	EMBO_J_2008_Sep_17_27(18)_2400-2410.nxml.txt.nlp	18756267	SENT135	1	1	23	23	camptothecin	EXO1	PA153590860	9156	0.971
NULL	Acta_Pharmacol_Sin_2011_Jun_3_32(6)_817-823.nxml.txt.nlp	21642950	SENT115	0	0	23	23	propofol	minK	PA451141	3753	0.971
NULL	Osteoporos_Int_2008_Apr_12_19(4)_399-428.nxml.txt.nlp	18266020	SENT246	29	29	39	39	teriparatide	PTH	PA451620	5741	0.971
NULL	Chemother_Res_Pract_2011_Dec_1_2011_715469.nxml.txt.nlp	22312557	SENT122	10	10	23	23	cisplatin	p53	PA449014	7157	0.971
NULL	Angiogenesis_2010_Dec_7_13(4)_305-315.nxml.txt.nlp	20927579	SENT187	6	6	28	28	resveratrol	THBS1		7057	0.971
NULL	Lancet_2011_Jun_9_377(9784)_2181-2192.nxml.txt.nlp	21663949	SENT210	13	13	1	1	simvastatin	SHARP	PA451363	23013	0.971
NULL	Breast_Cancer_Res_2011_Jan_26_13(1)_R10.nxml.txt.nlp	21269472	SENT242	13	13	0	0	tamoxifen	PPARGC1B	PA451581	133522	0.971
NULL	Nat_Neurosci_2013_Dec_20_16(12)_10_1038_nn_3553.nxml.txt.nlp	24141309	SENT112	7	7	22	22	tamoxifen	Math1	PA451581	474	0.971
NULL	Commun_Integr_Biol_2012_May_1_5(3)_248-254.nxml.txt.nlp	22896785	SENT100	8	8	19	19	picrotoxin	CA1	PA164777007	759	0.971
NULL	Case_Rep_Oncol_2012_Oct_10_5(3)_546-553.nxml.txt.nlp	23139670	SENT118	12	12	43	43	bevacizumab	EGFR	PA130232992	1956	0.971
NULL	Mol_Cancer_2014_Jun_4_13_141.nxml.txt.nlp	24894453	SENT59	11	11	6	6	cetuximab	EGFR	PA10040	1956	0.971
NULL	J_Biol_Chem_2011_Oct_7_286(40)_34998-35006.nxml.txt.nlp	21757733	SENT34	4	4	30	30	lipase	ATGL	PA450239	57104	0.971
NULL	Aging_(Albany_NY)_2011_Dec_8_3(11)_1098-1109.nxml.txt.nlp	22156377	SENT96	0	0	10	10	resveratrol	SIRT1		23411	0.971
NULL	Cells_2014_Apr_8_3(2)_258-287.nxml.txt.nlp	24717323	SENT282	37	37	3	3	forskolin	TRPV1	PA146096022	7442	0.971
NULL	JAKSTAT_2013_Jul_1_2(3)_e24574.nxml.txt.nlp	24069558	SENT226	14	14	0	0	doxycycline	HEK	PA449415	2042	0.971
NULL	Breast_Cancer_Res_2012_Feb_14_14(1)_R30.nxml.txt.nlp	22333315	SENT242	7	7	23	23	indomethacin	CXCR3	PA449982	2833	0.971
NULL	Cell_Death_Differ_2010_May_13_17(5)_774-786.nxml.txt.nlp	19911006	SENT313	4	4	11	11	doxycycline	AATF	PA449415	26574	0.971
NULL	Mol_Cancer_2010_Nov_25_9_305.nxml.txt.nlp	21108789	SENT117	9	9	29	29	decitabine	TRAIL	PA164749631	8743	0.971
NULL	J_Mol_Signal_2011_Aug_10_6_8.nxml.txt.nlp	21831305	SENT114	18	18	3	3	isoproterenol	AKAP5	PA450121	9495	0.971
NULL	Int_J_Appl_Basic_Med_Res_2013_Jul-Dec_3(2)_117-121.nxml.txt.nlp	24083147	SENT128	20	20	1	1	clopidogrel	ADP	PA449053	23038	0.971
NULL	Exp_Ther_Med_2014_Mar_19_7(3)_669-674.nxml.txt.nlp	24520265	SENT133	8	8	23	23	thalidomide	JNK	PA451644	5599	0.971
NULL	Infect_Dis_Rep_2009_Dec_1_1(1)_e5.nxml.txt.nlp	24470883	SENT21	12	12	30	30	zidovudine	CD4	PA451954	920	0.971
NULL	Cancer_Manag_Res_2013_Nov_21_5_387-400.nxml.txt.nlp	24294007	SENT82	27	27	8	8	cetuximab	KRAS	PA10040	3845	0.971
NULL	Biochem_Res_Int_2012_Mar_20_2012_951539.nxml.txt.nlp	22482055	SENT262	5	5	20	20	imatinib	JNK	PA10804	5599	0.971
NULL	Onco_Targets_Ther_2014_Jun_11_7_969-983.nxml.txt.nlp	24959084	SENT115	13	13	4	4	clarithromycin	CYP3A4	PA449028	1576	0.971
NULL	Biosci_Rep_2012_Aug_1_32(Pt_4)_361-374.nxml.txt.nlp	22762204	SENT156	26	26	3	3	saracatinib	PTEN		5728	0.971
NULL	Curr_Neuropharmacol_2013_Dec_11(6)_592-597.nxml.txt.nlp	24396335	SENT86	4	4	0	0	trypsin	PAR2	PA451806	2150;55065;8856	0.971
NULL	Mol_Cancer_2013_Nov_11_12_134.nxml.txt.nlp	24215614	SENT162	29	29	27	27	exemestane	aromatase	PA449563	1588	0.971
NULL	Dement_Geriatr_Cogn_Dis_Extra_2011_Jun_29_1(1)_180-189.nxml.txt.nlp	22163243	SENT23	18	18	5	5	rivastigmine	PS2	PA451262	5664	0.971
NULL	Acta_Pharmacol_Sin_2014_Aug_21_35(8)_1082-1092.nxml.txt.nlp	25047514	SENT191	0	0	8	8	letrozole	aromatase	PA450196	1588	0.971
NULL	Kidney_Int_Suppl_(2011)_2012_Mar_29_2(1)_37-68.nxml.txt.nlp	25018919	SENT678	6	6	0	0	l-cysteine	NAC	PA449173	22861	0.971
NULL	Oncotarget_2012_Aug_10_3(8)_744-758.nxml.txt.nlp	22889873	SENT232	40	40	23	23	cetuximab	EGFR	PA10040	1956	0.971
NULL	Eur_J_Med_Res_2010_Mar_30_15(3)_97-101.nxml.txt.nlp	20452893	SENT91	37	37	2	2	ribavirin	CCR5	PA451241	1234	0.971
NULL	EMBO_Mol_Med_2011_May_3(5)_258-265.nxml.txt.nlp	21425469	SENT16	13	13	1	1	creatine	DMD	PA164778930	1756	0.971
NULL	Mol_Cell_Biochem_2014_Oct_9_385(1-2)_265-275.nxml.txt.nlp	24104452	SENT231	9	9	20	20	bortezomib	U87	PA10252	677775;641648	0.971
NULL	Case_Rep_Oncol_2011_Sep_6_4(3)_445-451.nxml.txt.nlp	22087096	SENT18	0	0	11	11	gefitinib	EGFR	PA131301952	1956	0.971
NULL	Int_J_Cell_Biol_2013_Nov_17_2013_769536.nxml.txt.nlp	24348564	SENT17	11	11	2	2	estradiol	HSD1	PA449503	26871	0.971
NULL	Case_Rep_Nephrol_2014_Aug_12_2014_823093.nxml.txt.nlp	25197587	SENT17	0	0	15	15	tocilizumab	IL-6	PA165292659	3569	0.971
NULL	Drug_Saf_2014_Feb_19_37(4)_201-211.nxml.txt.nlp	24550106	SENT152	2	2	27	27	dexlansoprazole	CYP2C19	PA166110257	1557	0.971
NULL	Indian_J_Med_Res_2011_Oct_134(4)_410-412.nxml.txt.nlp	22089600	SENT12	21	21	4	4	s-adenosylmethionine	B12	PA164754994	7126;4709	0.971
NULL	J_Carcinog_Mutagen_2013_May_27_Suppl_14_S14-004.nxml.txt.nlp	25328816	SENT108	35	35	5	5	docetaxel	XIAP	PA449383	331	0.971
NULL	Oncogene_2014_Aug_21_33(34)_4316-4329.nxml.txt.nlp	24362530	SENT61	16	16	3	3	paclitaxel	FOXM1	PA450761	2305	0.971
NULL	J_Korean_Med_Sci_2013_Sep_28_28(9)_1307-1315.nxml.txt.nlp	24015035	SENT73	13	13	38	38	heparin	TFI	PA449855	7035	0.971
NULL	Mol_Cancer_2012_Dec_12_11_91.nxml.txt.nlp	23234355	SENT60	32	32	6	6	gefitinib	HER2	PA131301952	2064	0.971
NULL	Clin_Sci_(Lond)_2012_May_1_122(Pt_9)_421-428.nxml.txt.nlp	22092038	SENT189	11	11	1	1	doxycycline	AP-1	PA449415	2353;3727;2354;3725	0.971
NULL	Oncogene_2014_Sep_18_33(38)_4664-4674.nxml.txt.nlp	24096486	SENT11	29	29	4	4	erlotinib	EGF	PA134687924	1950	0.971
NULL	Cancer_Microenviron_2013_Jan_22_6(3)_231-240.nxml.txt.nlp	23335094	SENT62	10	10	3	3	simvastatin	PC-3	PA451363	692094	0.971
NULL	J_Mol_Signal_2010_May_10_5_4.nxml.txt.nlp	20459745	SENT86	21	21	6	6	cisplatin	p53	PA449014	7157	0.971
NULL	J_Med_Internet_Res_2013_Jul_12_15(7)_e138.nxml.txt.nlp	23853350	SENT188	31	31	3	3	warfarin	TTR	PA451906	7276	0.971
NULL	Pharmaceuticals_(Basel)_2012_Aug_10_5(8)_802-836.nxml.txt.nlp	24280676	SENT90	34	34	23	23	ribavirin	CNT2	PA451241	9153	0.971
NULL	CNS_Neurosci_Ther_2010_Jun_16(3)_e1-e17.nxml.txt.nlp	20406250	SENT184	27	27	11	11	bupropion	5-HT1A	PA448687	3350	0.971
NULL	J_Med_Case_Reports_2011_Dec_21_5_593.nxml.txt.nlp	22188652	SENT52	31	31	14	14	erlotinib	CYP2D6	PA134687924	1565	0.971
NULL	J_Hematol_Oncol_2013_Jul_18_6_53.nxml.txt.nlp	23866964	SENT99	10	10	28	28	temsirolimus	MYC	PA164746890	4609	0.971
NULL	Mol_Cell_Proteomics_2012_Nov_10_11(11)_1289-1305.nxml.txt.nlp	22888148	SENT312	25	25	13	13	chloroquine	LC3	PA448948	84557	0.971
NULL	Int_J_Biol_Sci_2011_May_9_7(5)_575-587.nxml.txt.nlp	21614150	SENT83	11	11	17	17	resveratrol	SIRT1		23411	0.971
NULL	Breast_Cancer_Res_2004_Aug_5_6(5)_R601-R607.nxml.txt.nlp	15318941	SENT13	14	14	7	7	docetaxel	p27	PA449383	5715;10534	0.971
NULL	J_Radiat_Res_2014_May_28_55(3)_432-442.nxml.txt.nlp	24375278	SENT189	9	9	28	28	metformin	AMPK	PA450395	5563	0.971
NULL	Case_Rep_Neurol_2011_Jan_11_3(1)_1-6.nxml.txt.nlp	21327178	SENT60	0	0	14	14	stavudine	gamma	PA451494	9913	0.971
NULL	Onco_Targets_Ther_2014_Mar_24_7_491-500.nxml.txt.nlp	24711706	SENT85	21	21	14	14	capecitabine	EGFR	PA448771	1956	0.971
NULL	Mol_Cancer_2010_Jun_27_9_168.nxml.txt.nlp	20579391	SENT66	10	10	8	8	erlotinib	EGFR	PA134687924	1956	0.971
NULL	Acta_Pharmacol_Sin_2012_Dec_29_33(12)_1518-1524.nxml.txt.nlp	23103625	SENT146	27	27	1	1	telmisartan	ACE2	PA451605	59272	0.971
NULL	Indian_J_Endocrinol_Metab_2011_Apr-Jun_15(2)_75-90.nxml.txt.nlp	21731863	SENT206	13	13	1	1	metformin	B12	PA450395	7126;4709	0.971
NULL	Cell_Death_Dis_2014_Jan_16_5(1)_e1000.nxml.txt.nlp	24434508	SENT55	20	20	3	3	teniposide	p53	PA451611	7157	0.971
NULL	Korean_J_Anesthesiol_2013_Mar_19_64(3)_212-217.nxml.txt.nlp	23560185	SENT33	27	27	6	6	ondansetron	NK1	PA450705	11126	0.971
NULL	Neuropsychopharmacology_2009_Jul_25_34(8)_1968-1978.nxml.txt.nlp	19322168	SENT258	10	10	25	25	clozapine	PI3K	PA449061	5290	0.971
NULL	Asian_J_Androl_2014_Apr_11_Jul-Aug_16(4)_505-510.nxml.txt.nlp	24759577	SENT89	5	5	27	27	finasteride	aromatase	PA449627	1588	0.971
NULL	Oncol_Lett_2013_Feb_28_5(2)_699-701.nxml.txt.nlp	23420084	SENT63	0	0	39	39	sunitinib	FLT3	PA162372840	2322	0.971
NULL	Br_J_Cancer_2013_Sep_3_109(5)_1279-1286.nxml.txt.nlp	23949154	SENT132	24	24	2	2	flutamide	LPCAT1	PA449685	79888	0.971
NULL	Exp_Diabetes_Res_2012_Oct_15_2012_465282.nxml.txt.nlp	23118742	SENT110	16	16	0	0	metformin	FGF21	PA450395	26291	0.971
NULL	Indian_J_Psychiatry_2009_Jul-Sep_51(3)_222-224.nxml.txt.nlp	19881055	SENT16	0	0	4	4	tamoxifen	CYP3A4	PA451581	1576	0.971
NULL	Clin_Sarcoma_Res_2013_Mar_7_3_3.nxml.txt.nlp	23497641	SENT169	18	18	3	3	imatinib	EGFR	PA10804	1956	0.971
NULL	BMJ_2009_Feb_25_338_b438.nxml.txt.nlp	19244302	SENT47	35	35	10	10	tamoxifen	aromatase	PA451581	1588	0.971
NULL	Cancer_Cell_Int_2014_Jul_2_14_59.nxml.txt.nlp	25120382	SENT91	18	18	27	27	metformin	RTCA	PA450395	8634	0.971
NULL	Pan_Afr_Med_J_2014_May_2_18_9.nxml.txt.nlp	25360193	SENT62	10	10	4	4	carbamazepine	HLA-B	PA448785	3106	0.971
NULL	J_Hematol_Oncol_2009_Jan_21_2_2.nxml.txt.nlp	19159467	SENT174	12	12	4	4	gefitinib	EGFR	PA131301952	1956	0.971
NULL	J_Biomed_Biotechnol_2010_Jun_7_2010_150960.nxml.txt.nlp	20617134	SENT224	28	28	14	14	paclitaxel	KRAS	PA450761	3845	0.971
NULL	Cancers_(Basel)_2011_Aug_19_3(3)_3370-3393.nxml.txt.nlp	24212958	SENT193	38	38	16	16	trastuzumab	CD16a	PA451743	2214	0.971
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT147	12	12	38	38	sitagliptin	HIP	PA164748978	6767;6159;64399;5068	0.971
NULL	Drugs_R_D_2011_Jun_27_11(2)_113-126.nxml.txt.nlp	21679004	SENT106	1	1	6	6	axitinib	CYP3A4	PA164924493	1576	0.971
NULL	Clin_Pediatr_Endocrinol_2007_Aug_8_16(3)_75-80.nxml.txt.nlp	24790349	SENT4	11	11	6	6	octreotide	PHHI	PA450678	6833	0.971
NULL	J_Mol_Signal_2012_Aug_16_7_12.nxml.txt.nlp	22898329	SENT20	0	0	11	11	cetuximab	EGF	PA10040	1950	0.971
NULL	Oncotarget_2013_Nov_4_5(1)_161-172.nxml.txt.nlp	24389287	SENT105	14	14	2	2	propranolol	p53	PA451145	7157	0.971
NULL	J_Infect_Dis_2012_Apr_15_205(8)_1278-1286.nxml.txt.nlp	22396598	SENT66	23	23	9	9	proguanil	DHODH	PA451124	1723	0.971
NULL	Breast_Cancer_Res_2012_Jan_19_14(1)_201.nxml.txt.nlp	22277572	SENT48	13	13	8	8	letrozole	AKT	PA450196	207	0.971
NULL	Mol_Biol_Cell_2013_Jul_1_24(13)_2134-2145.nxml.txt.nlp	23657817	SENT182	23	23	2	2	pp2	EGF		1950	0.971
NULL	J_Immunol_Res_2014_Apr_30_2014_857143.nxml.txt.nlp	24877157	SENT323	3	3	9	9	cyclosporine	IL-2	PA449167	3558	0.971
NULL	Mol_Cancer_2007_Sep_18_6_56.nxml.txt.nlp	17877814	SENT7	8	8	28	28	erlotinib	EGFR	PA134687924	1956	0.971
NULL	Clin_Med_Cardiol_2009_Sep_3_3_77-91.nxml.txt.nlp	20508768	SENT285	28	28	22	22	clopidogrel	ADP	PA449053	23038	0.971
NULL	J_Biol_Chem_2010_Aug_20_285(34)_25928-25940.nxml.txt.nlp	20547488	SENT300	11	11	27	27	cisplatin	JNK1	PA449014	5599	0.971
NULL	Br_J_Cancer_2006_Dec_4_95(11)_1483-1489.nxml.txt.nlp	17106442	SENT115	5	5	23	23	gefitinib	EGFR	PA131301952	1956	0.971
NULL	Tumour_Biol_2014_Aug_12_35(8)_7807-7819.nxml.txt.nlp	24817012	SENT377	15	15	6	6	cisplatin	ERCC1	PA449014	2067	0.971
NULL	Int_J_Biol_Sci_2013_May_15_9(5)_472-479.nxml.txt.nlp	23781140	SENT151	12	12	4	4	fluorouracil	CD133	PA128406956	8842	0.971
NULL	Hum_Genomics_2015_Jan_7_9(1)_1.nxml.txt.nlp	25563503	SENT337	29	29	19	19	abacavir	HLA-B	PA448004	3106	0.971
NULL	J_Oncol_2011_Jun_12_2011_542358.nxml.txt.nlp	21772843	SENT364	40	40	3	3	doxorubicin	p53	PA449412	7157	0.971
NULL	Front_Endocrinol_(Lausanne)_2013_Nov_11_4_166.nxml.txt.nlp	24273531	SENT244	9	9	41	41	losartan	AT2	PA450268	186	0.971
NULL	Oncogene_2010_Jun_10_29(23)_3335-3348.nxml.txt.nlp	20383197	SENT195	8	8	27	27	cetuximab	EGFR	PA10040	1956	0.971
NULL	Arthritis_Res_Ther_2014_Sep_26_16(5)_429.nxml.txt.nlp	25606593	SENT106	0	0	20	20	tocilizumab	IL-6	PA165292659	3569	0.971
NULL	Curr_Med_Chem_2012_Sep_19(26)_4399-4413.nxml.txt.nlp	22830345	SENT237	21	21	19	19	ketoconazole	CYP3A4	PA450146	1576	0.971
NULL	Arthritis_Res_Ther_2014_May_16_16(3)_R113.nxml.txt.nlp	24886859	SENT17	2	2	11	11	tranylcypromine	LSD1	PA451741	23028	0.971
NULL	Nat_Commun_2014_Dec_8_5_5736.nxml.txt.nlp	25484020	SENT245	6	6	34	34	exemestane	mol	PA449563	90527	0.971
NULL	Int_Semin_Surg_Oncol_2008_Apr_28_5_9.nxml.txt.nlp	18442393	SENT91	33	33	7	7	tamoxifen	HER-2	PA451581	2064	0.971
NULL	Clin_Exp_Gastroenterol_2012_May_14_5_49-59.nxml.txt.nlp	22649281	SENT8	9	9	20	20	esomeprazole	CYP2C19	PA10075	1557	0.971
NULL	J_Invest_Dermatol_2012_Nov_14_132(11)_2601-2609.nxml.txt.nlp	22696056	SENT194	17	17	8	8	guanabenz	IL6	PA164774903	3569	0.971
NULL	Br_J_Cancer_1998_May_77(10)_1562-1567.nxml.txt.nlp	9635829	SENT16	13	13	5	5	cisplatin	Bcl-2	PA449014	596	0.971
NULL	Br_J_Cancer_2010_Jul_13_103(2)_265-274.nxml.txt.nlp	20551953	SENT339	19	19	5	5	cisplatin	DUSP16	PA449014	80824	0.971
NULL	Cell_Commun_Signal_2011_May_15_9_13.nxml.txt.nlp	21569639	SENT318	27	27	17	17	quinacrine	p65	PA164745551	5970	0.971
NULL	Int_J_Endocrinol_Metab_2013_Jul_1_Summer_11(3)_184-190.nxml.txt.nlp	24348591	SENT119	5	5	0	0	liraglutide	INS-1	PA165958364	2305	0.971
NULL	Pharmaceuticals_(Basel)_2014_Mar_5_7(3)_311-338.nxml.txt.nlp	24603603	SENT266	2	2	25	25	cetuximab	EGFR	PA10040	1956	0.971
NULL	J_Cancer_2013_Jan_11_4(2)_117-132.nxml.txt.nlp	23386910	SENT112	0	0	25	25	afatinib	HER-2	PA165981154	2064	0.971
NULL	Arthritis_Res_Ther_2013_Nov_6_15(6)_124.nxml.txt.nlp	24229459	SENT6	5	5	10	10	pioglitazone	IL-6	PA450970	3569	0.971
NULL	Protein_Cell_2014_Aug_22_5(8)_643-647.nxml.txt.nlp	25048702	SENT15	6	6	14	14	chymotrypsin	LAMP1	PA448994	3916	0.971
NULL	Chin_J_Cancer_2012_Feb_31(2)_58-72.nxml.txt.nlp	22098952	SENT239	12	12	6	6	vinorelbine	MRP7	PA451881	89845;1080	0.971
NULL	Acta_Pharmacol_Sin_2010_Jul_21_31(7)_855-860.nxml.txt.nlp	20562904	SENT12	20	20	36	36	fluconazole	CDR1	PA449653	1038	0.971
NULL	Oncotarget_2013_Apr_13_4(4)_502-530.nxml.txt.nlp	23594434	SENT383	0	0	12	12	ketoconazole	CYP3A4	PA450146	1576	0.971
NULL	Nat_Commun_2011_Oct_25_2_513.nxml.txt.nlp	22027593	SENT166	16	16	10	10	nutlin-3	p53		7157	0.971
NULL	Br_J_Cancer_2010_Dec_7_103(12)_1765-1772.nxml.txt.nlp	21139621	SENT114	18	18	28	28	cetuximab	EGFR	PA10040	1956	0.971
NULL	Ann_Hematol_2014_Sep_10_93(1)_1-11.nxml.txt.nlp	24018623	SENT146	28	28	12	12	lenalidomide	CD34	PA162363968	947	0.971
NULL	Breast_Cancer_Res_2010_Sep_29_12(5)_209.nxml.txt.nlp	21067536	SENT246	0	0	36	36	trastuzumab	HER2	PA451743	2064	0.971
NULL	Mol_Cancer_2010_Dec_20_9_317.nxml.txt.nlp	21172025	SENT34	9	9	19	19	tamoxifen	HER2	PA451581	2064	0.971
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_33-43.nxml.txt.nlp	17912634	SENT155	30	30	24	24	letrozole	HER2	PA450196	2064	0.971
NULL	Acta_Pharmacol_Sin_2011_Nov_10_32(11)_1402-1410.nxml.txt.nlp	21986579	SENT157	32	32	21	21	curcumin	CDK2	PA151958596	1017	0.971
NULL	Basic_Res_Cardiol_2010_Nov_15_105(6)_795-804.nxml.txt.nlp	20711735	SENT23	21	21	0	0	cyclosporine	PKG	PA449167	5592	0.971
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT2405	0	0	6	6	amiodarone	CYP3A4	PA448383	1576	0.971
NULL	Stroke_Res_Treat_2009_Dec_20_2010_386389.nxml.txt.nlp	20700422	SENT199	19	19	9	9	ebselen	c-Jun	PA161660841	3725	0.971
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2013_Dec_8_6_75-79.nxml.txt.nlp	24348081	SENT20	0	0	33	33	colesevelam	TGR5	PA449095	151306	0.971
NULL	Cancer_Immunol_Immunother_2013_Aug_27_62(10)_1637-1648.nxml.txt.nlp	23982484	SENT131	14	14	5	5	lenalidomide	IFN	PA162363968	3439	0.971
NULL	Breast_Cancer_Res_2012_Jun_19_14(3)_311.nxml.txt.nlp	22713135	SENT3	33	33	31	31	exemestane	aromatase	PA449563	1588	0.971
NULL	Mar_Drugs_2014_Jun_27_12(7)_3818-3837.nxml.txt.nlp	24979269	SENT209	10	10	33	33	calcein	MRP1	PA132595336	4437	0.971
NULL	J_Gen_Physiol_2009_Jun_133(6)_623-625.nxml.txt.nlp	19468076	SENT28	2	2	8	8	caffeine	TRPA1	PA448710	8989	0.971
NULL	Ann_Surg_Treat_Res_2014_Feb_22_86(2)_68-75.nxml.txt.nlp	24761411	SENT138	20	20	3	3	oxaliplatin	survivin	PA131285527	332	0.971
NULL	Iran_Red_Crescent_Med_J_2012_Jul_30_14(7)_442-446.nxml.txt.nlp	22997561	SENT12	28	28	2	2	sugar	HBM	PA451529	3042;4041	0.971
NULL	Cell_Death_Dis_2013_Sep_5_4(9)_e791.nxml.txt.nlp	24008735	SENT248	16	16	5	5	gemcitabine	PUMA	PA449748	27113	0.971
NULL	Arthritis_Res_Ther_2010_Jul_15_12(4)_R142.nxml.txt.nlp	20633267	SENT168	15	15	4	4	adalimumab	IFN	PA10004	3439	0.971
NULL	Ann_Pediatr_Cardiol_2013_Jan-Jun_6(1)_59-64.nxml.txt.nlp	23626438	SENT22	2	2	15	15	clopidogrel	P2Y12	PA449053	64805	0.971
NULL	Int_J_Breast_Cancer_2011_Jul_12_2011_232435.nxml.txt.nlp	22295213	SENT243	23	23	15	15	tamoxifen	LOX	PA451581	4015	0.971
NULL	Anal_Bioanal_Chem_2008_Mar_25_391(7)_2385-2393.nxml.txt.nlp	18363049	SENT114	16	16	11	11	fluorescein	FDG	PA164746009	23583	0.971
NULL	Nature_2012_Jan_11_481(7382)_463-468.nxml.txt.nlp	22237023	SENT82	14	14	5	5	forskolin	UCP1	PA146096022	7350	0.971
NULL	Clin_Interv_Aging_2014_Nov_18_9_1963-1980.nxml.txt.nlp	25429208	SENT141	1	1	13	13	metformin	DPP4	PA450395	1803	0.971
NULL	Oncotarget_2011_Jan_28_3(1)_31-43.nxml.txt.nlp	22289787	SENT144	35	35	26	26	cisplatin	EGFR	PA449014	1956	0.971
NULL	J_Inherit_Metab_Dis_2013_Mar_13_36(2)_363-371.nxml.txt.nlp	22971959	SENT83	4	4	30	30	gentamicin	ARSB	PA449753	411	0.971
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_79-85.nxml.txt.nlp	23864840	SENT30	17	17	31	31	docetaxel	EGFR	PA449383	1956	0.971
NULL	Acta_Pharmacol_Sin_2010_Jul_28_31(7)_867-873.nxml.txt.nlp	20581857	SENT144	1	1	25	25	docetaxel	MRP1	PA449383	4437	0.971
NULL	Psychol_Res_Behav_Manag_2010_Dec_6_3_109-118.nxml.txt.nlp	22110334	SENT114	34	34	39	39	paroxetine	CYP2D6	PA450801	1565	0.971
NULL	EJNMMI_Res_2011_Aug_17_1_15.nxml.txt.nlp	22214307	SENT27	27	27	5	5	trastuzumab	HER2	PA451743	2064	0.971
NULL	Scientifica_(Cairo)_2012_Nov_25_2012_473829.nxml.txt.nlp	24278698	SENT350	12	12	21	21	cisplatin	MATE1	PA449014	55244	0.971
NULL	Environ_Health_Perspect_2011_Mar_10_119(3)_357-363.nxml.txt.nlp	21362589	SENT167	39	39	3	3	picrotoxin	RDX	PA164777007	5962	0.971
NULL	J_Inflamm_(Lond)_2008_Dec_5_5_23.nxml.txt.nlp	19061493	SENT191	18	18	8	8	hemin	HO-1	PA449849	3162	0.971
NULL	Cancers_(Basel)_2013_May_10_5(2)_529-549.nxml.txt.nlp	24216990	SENT222	10	10	16	16	sorafenib	TKR	PA7000	8277	0.971
NULL	Arthritis_Res_Ther_2014_Jul_18_16(4)_R153.nxml.txt.nlp	25037855	SENT199	6	6	15	15	adalimumab	CD14	PA10004	929	0.971
NULL	Patient_Prefer_Adherence_2013_Jun_19_7_531-542.nxml.txt.nlp	23814462	SENT209	5	5	13	13	nevirapine	CD4	PA450616	920	0.971
NULL	Cancers_(Basel)_2014_Jul_8_6(3)_1487-1499.nxml.txt.nlp	25006835	SENT86	21	21	12	12	cisplatin	MKP-1	PA449014	1843	0.971
NULL	Mol_Cancer_2014_Apr_29_13_96.nxml.txt.nlp	24779681	SENT216	7	7	13	13	tamoxifen	EGFR	PA451581	1956	0.971
NULL	Breast_Cancer_Res_2006_Nov_27_8(6)_R66.nxml.txt.nlp	17129383	SENT199	21	21	6	6	paclitaxel	p53	PA450761	7157	0.971
NULL	J_Cardiothorac_Surg_2012_Sep_27_7_97.nxml.txt.nlp	23013706	SENT166	9	9	1	1	warfarin	CYP4F2	PA451906	8529	0.971
NULL	Oncotarget_2013_Apr_23_4(6)_816-829.nxml.txt.nlp	23615731	SENT124	22	22	15	15	doxycycline	HSF1	PA449415	3297	0.971
NULL	Oncogenesis_2014_Dec_15_3(12)_e133.nxml.txt.nlp	25500906	SENT294	12	12	6	6	trastuzumab	HER2	PA451743	2064	0.971
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT29	23	23	11	11	doxorubicin	HER2	PA449412	2064	0.971
NULL	Cell_Death_Dis_2013_Jun_27_4(6)_e694.nxml.txt.nlp	23807223	SENT41	35	35	15	15	chloroquine	IL-6	PA448948	3569	0.97
NULL	Chonnam_Med_J_2013_Apr_25_49(1)_31-37.nxml.txt.nlp	23678475	SENT90	10	10	23	23	pravastatin	adiponectin	PA451089	9370	0.97
NULL	Front_Oncol_2013_Apr_23_3_86.nxml.txt.nlp	23630663	SENT457	24	24	16	16	gefitinib	EGFR	PA131301952	1956	0.97
NULL	Nat_Commun_2011_Oct_25_2_513.nxml.txt.nlp	22027593	SENT627	28	28	19	19	doxorubicin	RBM38	PA449412	55544	0.97
NULL	Brief_Funct_Genomics_2013_Jan_14_12(1)_46-57.nxml.txt.nlp	23242178	SENT195	10	10	0	0	hyaluronan	CD44	PA165958431	960	0.97
NULL	Int_J_Mol_Sci_2012_Sep_26_13(10)_12268-12286.nxml.txt.nlp	23202898	SENT138	41	41	29	29	trastuzumab	gamma	PA451743	9913	0.97
NULL	J_Biomed_Sci_2012_Nov_21_19(1)_99.nxml.txt.nlp	23170833	SENT173	12	12	33	33	atorvastatin	CXCR4	PA448500	7852	0.97
NULL	Clin_Interv_Aging_2008_Sep_3(3)_491-501.nxml.txt.nlp	18982919	SENT34	0	0	28	28	aripiprazole	5-HT1A	PA10026	3350	0.97
NULL	Mol_Cancer_2010_May_18_9_110.nxml.txt.nlp	20482802	SENT194	10	10	18	18	bortezomib	PSMB5	PA10252	5693	0.97
NULL	J_Nucl_Cardiol_2012_Dec_17_19(6)_1211-1225.nxml.txt.nlp	23073913	SENT104	32	32	7	7	simvastatin	FDG	PA451363	23583	0.97
NULL	Breast_Cancer_Res_2007_Jun_4_9(3)_207.nxml.txt.nlp	17561991	SENT13	0	0	16	16	trastuzumab	ECD	PA451743	7979;11319	0.97
NULL	Eur_J_Clin_Pharmacol_2013_Mar_11_69(3)_327-339.nxml.txt.nlp	22782539	SENT274	5	5	21	21	clopidogrel	P-gp	PA449053	5243	0.97
NULL	Ann_Oncol_2014_Apr_26_25(4)_801-807.nxml.txt.nlp	24577117	SENT107	24	24	9	9	cetuximab	p16	PA10040	1029	0.97
NULL	Nat_Commun_2013_Nov_29_4_2869.nxml.txt.nlp	24287629	SENT152	7	7	0	0	collagenase	EDL	PA449107	9388	0.97
NULL	Oncoimmunology_2012_Oct_1_1(7)_1038-1047.nxml.txt.nlp	23170252	SENT61	15	15	1	1	cyclophosphamide	IL-10	PA449165	3586	0.97
NULL	Brain_Sci_2013_Jun_19_3(2)_964-991.nxml.txt.nlp	24961433	SENT83	8	8	1	1	ethanol	ngn1	PA448073	4762	0.97
NULL	Arch_Med_Sci_2010_Mar_1_6(1)_19-23.nxml.txt.nlp	22371715	SENT122	0	0	3	3	tocilizumab	IL-6	PA165292659	3569	0.97
NULL	Arch_Med_Sci_2012_May_9_8(2)_375-388.nxml.txt.nlp	22662015	SENT256	36	36	28	28	erythromycin	CYP2C19	PA449493	1557	0.97
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT261	5	5	19	19	methotrexate	MLH1	PA450428	4292	0.97
NULL	Indian_J_Med_Res_2010_Dec_132(6)_676-682.nxml.txt.nlp	21245614	SENT6	0	0	10	10	zinc	p53	PA451956	7157	0.97
NULL	Indian_J_Dermatol_2014_Jan-Feb_59(1)_94-95.nxml.txt.nlp	24470672	SENT38	19	19	6	6	thalidomide	ENL	PA451644	4298	0.97
NULL	Biol_Open_2013_Aug_6_2(10)_1022-1031.nxml.txt.nlp	24167712	SENT269	0	0	15	15	doxycycline	PLK1	PA449415	5347	0.97
NULL	Clin_Mol_Allergy_2007_Jan_25_5_1.nxml.txt.nlp	17254346	SENT190	33	33	10	10	curcumin	IFN	PA151958596	3439	0.97
NULL	Ann_Oncol_2011_Dec_17_22(12)_2610-2615.nxml.txt.nlp	21415234	SENT189	36	36	20	20	lapatinib	HER2	PA152241907	2064	0.97
NULL	Breast_Cancer_Res_2014_Sep_11_16(5)_430.nxml.txt.nlp	25212826	SENT24	29	29	31	31	tamoxifen	aromatase	PA451581	1588	0.97
NULL	J_Adv_Pharm_Technol_Res_2011_Jul-Sep_2(3)_163-169.nxml.txt.nlp	22171313	SENT49	0	0	8	8	domperidone	Helios	PA134711056	22807	0.97
NULL	Biochemistry_2010_Oct_5_49(39)_8520-8534.nxml.txt.nlp	20722419	SENT599	11	11	26	26	thrombin	VIII	PA451674	1351	0.97
NULL	Mol_Biol_Cell_2012_Sep_1_23(17)_3473-3484.nxml.txt.nlp	22787275	SENT97	4	4	15	15	doxorubicin	ABCC1	PA449412	4363	0.97
NULL	Eur_J_Clin_Pharmacol_2010_Nov_29_66(11)_1131-1136.nxml.txt.nlp	20669013	SENT131	8	8	3	3	voriconazole	CYP3A4	PA10233	1576	0.97
NULL	Breast_Cancer_Res_2007_Dec_17_9(6)_115.nxml.txt.nlp	18190722	SENT4	6	6	8	8	tamoxifen	aromatase	PA451581	1588	0.97
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1522-1532.nxml.txt.nlp	21997136	SENT171	15	15	9	9	irinotecan	EGFR	PA450085	1956	0.97
NULL	J_Headache_Pain_2013_Mar_12_14(1)_25.nxml.txt.nlp	23566208	SENT29	31	31	7	7	gabapentin	LEP	PA449720	3952	0.97
NULL	Core_Evid_2009_Jun_15_4_83-92.nxml.txt.nlp	20694067	SENT73	18	18	14	14	ketoconazole	CYP3A4	PA450146	1576	0.97
NULL	Cancer_Cell_Int_2013_Jun_26_13_63.nxml.txt.nlp	23800022	SENT155	10	10	16	16	genistein	MDM2	PA165109660	4193	0.97
NULL	Breast_Cancer_Res_2008_Mar_29_10(2)_R28.nxml.txt.nlp	18373870	SENT129	23	23	3	3	estradiol	HSPC111	PA449503	51491	0.97
NULL	Onco_Targets_Ther_2014_Jul_31_7_1367-1373.nxml.txt.nlp	25114575	SENT77	20	20	9	9	anastrozole	HER-2	PA448432	2064	0.97
NULL	Clin_Pharmacol_2012_Feb_20_4_13-20.nxml.txt.nlp	22427735	SENT14	11	11	0	0	clopidogrel	CYP2C19	PA449053	1557	0.97
NULL	J_Immunol_Res_2014_Mar_24_2014_320674.nxml.txt.nlp	24741588	SENT182	1	1	18	18	desmopressin	FVIII	PA449237	2157	0.97
NULL	Bonekey_Rep_2014_Feb_5_3_495.nxml.txt.nlp	24605212	SENT128	0	0	8	8	alfacalcidol	CYP27A1	PA164746469	1593	0.97
NULL	Mediators_Inflamm_1996_Oct_5(5)_346-357.nxml.txt.nlp	18475729	SENT8	31	31	10	10	heparin	C5a	PA449855	727	0.97
NULL	Diabetes_2011_Jul_20_60(7)_1872-1881.nxml.txt.nlp	21602511	SENT276	11	11	23	23	metformin	AMPK	PA450395	5563	0.97
NULL	Indian_J_Pharmacol_2014_Jan-Feb_46(1)_3-12.nxml.txt.nlp	24550577	SENT221	0	0	5	5	vismodegib	CYP2C9		1559	0.97
NULL	Oncol_Rep_2013_Jan_1_29(1)_13-20.nxml.txt.nlp	23128605	SENT37	8	8	14	14	trastuzumab	HER2	PA451743	2064	0.97
NULL	Eur_Arch_Otorhinolaryngol_2013_Mar_13_270(4)_1397-1404.nxml.txt.nlp	23404469	SENT7	23	23	34	34	dasatinib	Bcl-2	PA162372878	596	0.97
NULL	Front_Genet_2012_Oct_26_3_213.nxml.txt.nlp	23112805	SENT111	35	35	38	38	furafylline	CYP1A2	PA452614	1544	0.97
NULL	Clin_Dev_Immunol_2013_Sep_12_2013_569751.nxml.txt.nlp	24151518	SENT24	15	15	2	2	ustekinumab	IL-23	PA166048654	51561	0.97
NULL	J_Antimicrob_Chemother_2012_May_8_67(5)_1217-1223.nxml.txt.nlp	22316571	SENT31	0	0	8	8	lumefantrine	CYP3A4	PA165111722	1576	0.97
NULL	Eur_J_Clin_Pharmacol_2014_May_27_70(8)_975-981.nxml.txt.nlp	24858823	SENT106	8	8	21	21	ciprofloxacin	P-gp	PA449009	5243	0.97
NULL	Acta_Neuropathol_Commun_2013_Sep_16_1_61.nxml.txt.nlp	24252310	SENT216	33	33	5	5	iron	HNE	PA450087	1991	0.97
NULL	Neuropsychopharmacology_2012_Feb_2_37(3)_641-650.nxml.txt.nlp	22048466	SENT133	23	23	0	0	bupropion	CYP2B6	PA448687	1555	0.97
NULL	Mol_Biol_Cell_2012_Jun_1_23(11)_2017-2027.nxml.txt.nlp	22496424	SENT114	29	29	41	41	warfarin	PRDX4	PA451906	10549	0.97
NULL	Front_Oncol_2013_Aug_5_3_195.nxml.txt.nlp	23936763	SENT108	18	18	7	7	gefitinib	AKT	PA131301952	207	0.97
NULL	Front_Oncol_2014_Sep_23_4_264.nxml.txt.nlp	25295231	SENT177	21	21	10	10	lenalidomide	TP53	PA162363968	7157	0.97
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT13	30	30	15	15	pp2	ERK		5594	0.97
NULL	Diabetes_Metab_Syndr_Obes_2014_Mar_18_7_107-120.nxml.txt.nlp	24672252	SENT50	32	32	7	7	liraglutide	GLP-1	PA165958364	100125288	0.97
NULL	Br_J_Cancer_2009_Jan_27_100(2)_251-258.nxml.txt.nlp	19165196	SENT20	0	0	11	11	cetuximab	EGFR	PA10040	1956	0.97
NULL	Biomed_Res_Int_2014_May_4_2014_171892.nxml.txt.nlp	24883302	SENT134	0	0	24	24	sorafenib	KIT	PA7000	3815	0.97
NULL	Eur_J_Clin_Pharmacol_2012_Jan_7_68(1)_55-64.nxml.txt.nlp	21735164	SENT205	10	10	21	21	oxycodone	CYP2D6	PA450741	1565	0.97
NULL	Breast_Cancer_Res_2014_May_22_16(3)_R49.nxml.txt.nlp	24887419	SENT228	21	21	24	24	letrozole	aromatase	PA450196	1588	0.97
NULL	Oncol_Lett_2013_Mar_11_5(3)_1010-1016.nxml.txt.nlp	23426784	SENT183	18	18	7	7	midazolam	TRPM7	PA450496	54822	0.97
NULL	Curr_Oncol_2009_Jul_16(Suppl_2)_S1-S13.nxml.txt.nlp	19672416	SENT20	14	14	7	7	anastrozole	aromatase	PA448432	1588	0.97
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT129	14	14	36	36	trastuzumab	STAT3	PA451743	6774	0.97
NULL	Eur_J_Clin_Pharmacol_2012_Sep_15_68(9)_1267-1274.nxml.txt.nlp	22418828	SENT187	17	17	8	8	pantoprazole	CYP2C19	PA450774	1557	0.97
NULL	Eur_J_Clin_Pharmacol_2012_Sep_15_68(9)_1267-1274.nxml.txt.nlp	22418828	SENT180	15	15	4	4	pantoprazole	CYP2C19	PA450774	1557	0.97
NULL	Cancer_Med_2013_Feb_3_2(1)_40-49.nxml.txt.nlp	24133626	SENT134	21	21	9	9	cilostazol	PDE3B	PA164746334	5140	0.97
NULL	EMBO_Mol_Med_2013_Jul_5_5(7)_1035-1050.nxml.txt.nlp	23740718	SENT327	16	16	28	28	ceftriaxone	SMN2	PA448866	6607	0.97
NULL	Cell_Res_2009_Aug_19(8)_950-961.nxml.txt.nlp	19546888	SENT23	37	37	7	7	hydrocortisone	c-Cbl	PA449905	867	0.97
NULL	Clinics_(Sao_Paulo)_2013_May_68(5)_694-701.nxml.txt.nlp	23778405	SENT155	10	10	28	28	curcumin	P-gp	PA151958596	5243	0.97
NULL	Oncotarget_2013_Nov_26_4(12)_2502-2511.nxml.txt.nlp	24318446	SENT99	13	13	23	23	doxycycline	PHGDH	PA449415	26227	0.97
NULL	Arthritis_Res_2001_Jan_26_3(Suppl_A)_L013.nxml.txt.nlp	NULL	SENT16	30	30	8	8	simvastatin	ADM	PA451363	133	0.97
NULL	Leukemia_2014_May_29_28(5)_1129-1131.nxml.txt.nlp	24166296	SENT42	5	5	37	37	lenalidomide	CRBN	PA162363968	51185	0.97
NULL	Int_J_Gen_Med_2009_Jul_30_2_91-108.nxml.txt.nlp	20360893	SENT196	33	33	2	2	cisplatin	PC-3	PA449014	692094	0.97
NULL	Int_J_Vasc_Med_2013_Mar_31_2013_543141.nxml.txt.nlp	23606968	SENT240	14	14	10	10	etanercept	IL-17	PA449515	3605	0.97
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R91.nxml.txt.nlp	22541814	SENT145	41	41	9	9	thrombin	HO-1	PA451674	3162	0.97
NULL	Exp_Cell_Res_2011_Apr_15_317(7)_1028-1039.nxml.txt.nlp	21237154	SENT122	29	29	35	35	staurosporine	TRAIL	PA165109623	8743	0.97
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1150.nxml.txt.nlp	24675468	SENT100	4	4	12	12	metformin	adiponectin	PA450395	9370	0.97
NULL	Oncotarget_2013_Apr_23_4(6)_816-829.nxml.txt.nlp	23615731	SENT224	6	6	22	22	quinacrine	HSF1	PA164745551	3297	0.97
NULL	Curr_Neuropharmacol_2011_Dec_9(4)_530-552.nxml.txt.nlp	22654714	SENT703	6	6	10	10	fluoxetine	p11	PA449673	118460	0.97
NULL	Front_Endocrinol_(Lausanne)_2011_Mar_3_2_6.nxml.txt.nlp	21633718	SENT132	12	12	4	4	tetracycline	GPCR	PA451640	151306;165140	0.97
NULL	ISRN_Otolaryngol_2014_Feb_13_2014_859621.nxml.txt.nlp	24693453	SENT32	0	0	35	35	sunitinib	KIT	PA162372840	3815	0.97
NULL	J_Biomed_Biotechnol_2011_Jul_6_2011_783528.nxml.txt.nlp	21785566	SENT150	1	1	9	9	saquinavir	P-gp	PA451305	5243	0.97
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT255	24	24	4	4	tacrolimus	RANKL	PA451578	8600	0.97
NULL	Int_J_Mol_Sci_2014_Mar_18_15(3)_4747-4779.nxml.txt.nlp	24646914	SENT352	26	26	3	3	sorafenib	CXCR4	PA7000	7852	0.97
NULL	J_Int_AIDS_Soc_2012_Nov_11_15(6Suppl_4)_18154.nxml.txt.nlp	NULL	SENT4	17	17	0	0	maraviroc	CCR5	PA164768835	1234	0.97
NULL	Arthritis_Res_Ther_2012_Mar_14_14(2)_R62.nxml.txt.nlp	22417670	SENT360	1	1	17	17	chloroquine	LC3	PA448948	84557	0.97
NULL	Sarcoma_1999_Sep_3(2)_79-84.nxml.txt.nlp	18521267	SENT11	20	20	25	25	doxorubicin	mol	PA449412	90527	0.97
NULL	Cases_J_2009_Jul_30_2_7134.nxml.txt.nlp	19829918	SENT105	29	29	6	6	levodopa	LCE	PA450213	79071	0.97
NULL	Oncotarget_2011_Sep_9_2(9)_658-668.nxml.txt.nlp	21911919	SENT88	19	19	10	10	cytarabine	HO-1	PA449177	3162	0.97
NULL	Mol_Cancer_2007_Oct_22_6_66.nxml.txt.nlp	17953743	SENT199	3	3	31	31	cisplatin	FasL	PA449014	356	0.97
NULL	Eur_J_Pharm_Sci_2012_Jul_16_46(4)_244-258.nxml.txt.nlp	22085636	SENT329	39	39	20	20	pertuzumab	PDK1		5170;5163	0.97
NULL	Behav_Brain_Funct_2014_Oct_2_10(1)_35.nxml.txt.nlp	NULL	SENT17	16	16	1	1	risperidone	FTO	PA451257	79068	0.97
NULL	Inflamm_Res_2010_Sep_26_59(9)_699-709.nxml.txt.nlp	20339899	SENT29	31	31	26	26	thrombin	PAR4	PA451674	9002;5074	0.97
NULL	J_RNAi_Gene_Silencing_2010_May_29_6(1)_386-400.nxml.txt.nlp	20628499	SENT9	4	4	25	25	flavopiridol	Dicer	PA452627	23405	0.97
NULL	Indian_J_Nephrol_2013_May-Jun_23(3)_222-225.nxml.txt.nlp	23814425	SENT33	25	25	12	12	cyclosporine	SPK	PA449167	55872;8189	0.97
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Feb_15_5_3.nxml.txt.nlp	16480505	SENT187	1	1	5	5	rosiglitazone	CYP2C8	PA451283	1558	0.97
NULL	Oncogene_2010_Oct_7_29(40)_5500-5510.nxml.txt.nlp	20661224	SENT228	5	5	12	12	gefitinib	ERBB3	PA131301952	2065	0.97
NULL	Cancer_Cell_Int_2011_Dec_29_11_44.nxml.txt.nlp	22206574	SENT146	0	0	6	6	sunitinib	VEGFR	PA162372840	3791	0.97
NULL	Mol_Cancer_2009_Dec_10_8_118.nxml.txt.nlp	20003259	SENT16	15	15	26	26	sorafenib	MMP2	PA7000	4313	0.97
NULL	Adv_Hematol_2014_Dec_8_2014_735751.nxml.txt.nlp	25548568	SENT14	0	0	8	8	ethanol	CO2	PA448073	4513	0.97
NULL	Front_Pharmacol_2014_Oct_27_5_233.nxml.txt.nlp	25386143	SENT198	32	32	4	4	ustekinumab	IL-23	PA166048654	51561	0.97
NULL	Indian_J_Hum_Genet_2014_Apr-Jun_20(2)_175-184.nxml.txt.nlp	25400347	SENT12	9	9	26	26	warfarin	CYP2C9	PA451906	1559	0.97
NULL	J_Cancer_Prev_2014_Mar_19(1)_39-46.nxml.txt.nlp	25337571	SENT119	4	4	13	13	ethanol	p53	PA448073	7157	0.97
NULL	Breast_Cancer_Res_2013_Nov_8_15(6)_R107.nxml.txt.nlp	24207099	SENT180	29	29	16	16	etoposide	p53	PA449552	7157	0.97
NULL	Acta_Pharmacol_Sin_2009_Jul_8_30(7)_1060-1064.nxml.txt.nlp	19543299	SENT72	3	3	18	18	piroxicam	San	PA450985	80218	0.97
NULL	Acta_Pharmacol_Sin_2014_Jan_9_35(1)_1-10.nxml.txt.nlp	24317012	SENT23	22	22	9	9	flavopiridol	SLCO1B3	PA452627	28234	0.97
NULL	Br_J_Cancer_2010_Jul_13_103(2)_165-170.nxml.txt.nlp	20588273	SENT99	23	23	0	0	imatinib	PDGFRA	PA10804	5156	0.97
NULL	Ann_Coloproctol_2014_Jun_23_30(3)_122-131.nxml.txt.nlp	24999463	SENT154	17	17	26	26	imatinib	PDGFRA	PA10804	5156	0.97
NULL	Mol_Cancer_2009_Aug_25_8_66.nxml.txt.nlp	19706164	SENT82	7	7	19	19	celecoxib	p53	PA448871	7157	0.97
NULL	J_Infect_Dis_2013_Feb_15_207(4)_656-660.nxml.txt.nlp	23186785	SENT68	7	7	0	0	chloroquine	C10	PA448948	113246	0.97
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT187	16	16	6	6	erlotinib	CYP3A	PA134687924	1574	0.97
NULL	Oncogenesis_2014_Dec_15_3(12)_e133.nxml.txt.nlp	25500906	SENT110	15	15	23	23	trastuzumab	HER3	PA451743	2065	0.97
NULL	Acta_Pharmacol_Sin_2011_Apr_28_32(4)_441-448.nxml.txt.nlp	21441944	SENT32	9	9	3	3	isoproterenol	CASQ2	PA450121	845	0.97
NULL	J_Biol_Chem_2013_Mar_22_288(12)_8279-8288.nxml.txt.nlp	23400816	SENT742	20	20	5	5	fenofibrate	PCSK9	PA449594	255738	0.97
NULL	Acta_Pharmacol_Sin_2012_Dec_22_33(12)_1511-1517.nxml.txt.nlp	23085741	SENT115	4	4	15	15	pranlukast	CysLT1	PA134698661	10800	0.97
NULL	Exp_Mol_Med_2012_Sep_30_44(9)_545-553.nxml.txt.nlp	22809901	SENT70	44	44	7	7	quetiapine	PRDM16	PA451201	63976	0.97
NULL	Front_Oncol_2014_Apr_10_4_74.nxml.txt.nlp	24782985	SENT328	9	9	17	17	paclitaxel	HMGB1	PA450761	3146	0.97
NULL	Int_J_Environ_Res_Public_Health_2012_Aug_14_9(8)_2875-2893.nxml.txt.nlp	23066403	SENT235	8	8	27	27	genistein	PP2	PA165109660	4888	0.97
NULL	Int_J_Mol_Imaging_2012_Oct_17_2012_189254.nxml.txt.nlp	23119157	SENT150	38	38	7	7	ezetimibe	FAST	PA10816	10922	0.97
NULL	Br_J_Cancer_2001_Jun_84(11)_1551-1555.nxml.txt.nlp	11384107	SENT4	3	3	17	17	cisplatin	p53	PA449014	7157	0.97
NULL	Braz_J_Med_Biol_Res_2014_Mar_21_47(4)_273-278.nxml.txt.nlp	24676475	SENT25	21	21	6	6	doxorubicin	MDR1	PA449412	5243	0.97
NULL	Curr_Med_Chem_2013_Apr_20(10)_1241-1285.nxml.txt.nlp	23409712	SENT790	10	10	19	19	felbamate	CA1	PA449590	759	0.97
NULL	Acta_Pharmacol_Sin_2009_Sep_17_30(9)_1211-1219.nxml.txt.nlp	19684611	SENT148	8	8	17	17	scopolamine	spatial	PA451308	219793	0.97
NULL	J_Cell_Biol_2004_Jun_7_165(5)_653-662.nxml.txt.nlp	15173192	SENT184	6	6	4	4	amiloride	NHE	PA448368	285335	0.97
NULL	Br_J_Cancer_2004_Mar_22_90(6)_1285-1292.nxml.txt.nlp	15026814	SENT133	21	21	6	6	doxorubicin	p53	PA449412	7157	0.97
NULL	Cancer_2014_Apr_8_120(8)_1145-1154.nxml.txt.nlp	24501009	SENT228	23	23	15	15	gefitinib	EGFR	PA131301952	1956	0.97
NULL	Diabetes_Metab_Syndr_Obes_2009_Jun_12_2_83-90.nxml.txt.nlp	21437121	SENT22	17	17	12	12	sitagliptin	GLP-1	PA164748978	100125288	0.97
NULL	Bioconjug_Chem_2013_Apr_17_24(4)_712-723.nxml.txt.nlp	23488616	SENT184	8	8	6	6	indomethacin	COX	PA449982	1351	0.97
NULL	Open_AIDS_J_2011_Apr_22_5_44-50.nxml.txt.nlp	21643422	SENT44	31	31	18	18	zidovudine	ATV	PA451954	4683	0.97
NULL	Int_J_Gen_Med_2012_Jun_18_5_535-540.nxml.txt.nlp	22807641	SENT8	34	34	14	14	pitavastatin	adiponectin	PA142650384	9370	0.97
NULL	Scientifica_(Cairo)_2013_May_7_2013_392584.nxml.txt.nlp	24278774	SENT197	0	0	12	12	thrombin	C5a	PA451674	727	0.97
NULL	J_Clin_Biochem_Nutr_2007_Jan_27_40(1)_13-23.nxml.txt.nlp	18437209	SENT575	37	37	19	19	trypsin	p38	PA451806	10598;1432;7965	0.97
NULL	Exp_Diabetes_Res_2012_Dec_12_2012_716404.nxml.txt.nlp	22194737	SENT267	3	3	16	16	metformin	AMPK	PA450395	5563	0.97
NULL	Cancer_Cell_Int_2014_Jan_29_14_10.nxml.txt.nlp	24472145	SENT197	27	27	15	15	cisplatin	HER-2	PA449014	2064	0.97
NULL	J_Biol_Chem_2013_Dec_6_288(49)_35387-35395.nxml.txt.nlp	24142790	SENT164	43	43	18	18	meclizine	PCYT2	PA450338	5833	0.97
NULL	Clin_Med_Insights_Oncol_2013_May_20_7_87-102.nxml.txt.nlp	23761989	SENT174	0	0	8	8	gefitinib	EGFR	PA131301952	1956	0.97
NULL	Adv_Urol_2012_Apr_3_2012_248607.nxml.txt.nlp	22548055	SENT190	3	3	29	29	metformin	AMPK	PA450395	5563	0.97
NULL	EMBO_J_2010_Sep_15_29(18)_3170-3183.nxml.txt.nlp	20676059	SENT131	8	8	30	30	fluoxetine	P15	PA449673	1030;29107	0.97
NULL	Clin_Psychopharmacol_Neurosci_2013_Dec_24_11(3)_144-151.nxml.txt.nlp	24465251	SENT101	14	14	6	6	haloperidol	IL-10	PA449841	3586	0.97
NULL	Breast_Cancer_Res_Treat_2014_Sep_24_148(2)_455-462.nxml.txt.nlp	25248409	SENT22	4	4	10	10	trastuzumab	HER2	PA451743	2064	0.97
NULL	Mol_Brain_2014_Apr_21_7_28.nxml.txt.nlp	24751148	SENT163	4	4	13	13	minocycline	TLR4	PA450519	7099	0.97
NULL	ScientificWorldJournal_2014_Jul_23_2014_854093.nxml.txt.nlp	25147870	SENT124	2	2	12	12	berberine	gamma	PA165860812	9913	0.97
NULL	J_Cell_Mol_Med_2014_Jan_4_18(1)_38-48.nxml.txt.nlp	24188742	SENT143	30	30	21	21	etoposide	PAX3	PA449552	5077	0.97
NULL	Evid_Based_Complement_Alternat_Med_2013_May_28_2013_629750.nxml.txt.nlp	23781265	SENT197	4	4	18	18	capsaicin	GADD153	PA448776	1649	0.97
NULL	Cases_J_2009_Nov_20_2_9071.nxml.txt.nlp	20062708	SENT62	0	0	15	15	fluconazole	CYP1A2	PA449653	1544	0.97
NULL	Arch_Drug_Inf_2008_Sep_1(2)_50-55.nxml.txt.nlp	19915714	SENT42	27	27	35	35	naltrexone	CYP3A4	PA450588	1576	0.97
NULL	Cell_Death_Differ_2009_Aug_20_16(8)_1135-1145.nxml.txt.nlp	19300452	SENT283	21	21	4	4	doxycycline	PUMA	PA449415	27113	0.97
NULL	Eplasty_2009_Jul_1_9_e27.nxml.txt.nlp	19649159	SENT51	2	2	29	29	thrombin	FVIII	PA451674	2157	0.97
NULL	Drugs_(Abingdon_Engl)_2014_Dec_19_21(6)_470-475.nxml.txt.nlp	25552821	SENT60	27	27	32	32	diazepam	OST	PA449283	1650;23263	0.97
NULL	Cancer_Med_2013_Feb_3_2(1)_99-107.nxml.txt.nlp	24133632	SENT163	4	4	11	11	metformin	AMPK	PA450395	5563	0.97
NULL	Exp_Mol_Med_2012_Sep_30_44(9)_545-553.nxml.txt.nlp	22809901	SENT70	42	42	7	7	clozapine	PRDM16	PA449061	63976	0.97
NULL	Br_J_Cancer_2011_Jul_12_105(2)_255-262.nxml.txt.nlp	21694725	SENT111	38	38	11	11	irinotecan	KRAS	PA450085	3845	0.97
NULL	Clin_Pharmacol_2010_Sep_6_2_155-162.nxml.txt.nlp	22291500	SENT166	9	9	34	34	clopidogrel	CYP2C19	PA449053	1557	0.97
NULL	Br_J_Cancer_2012_Jan_3_106(1)_18-24.nxml.txt.nlp	22108516	SENT32	6	6	30	30	camptothecin	UGT1A1	PA153590860	54658	0.97
NULL	Oxid_Med_Cell_Longev_2013_Jun_2_2013_793525.nxml.txt.nlp	23819014	SENT253	16	16	5	5	resveratrol	SGBS		2719	0.97
NULL	Ann_Clin_Transl_Neurol_2014_Dec_18_1(12)_1006-1023.nxml.txt.nlp	25574475	SENT138	28	28	3	3	ketamine	ERG	PA450144	2078	0.97
NULL	Cancers_(Basel)_2014_Apr_3_6(2)_771-795.nxml.txt.nlp	24704793	SENT253	9	9	21	21	resveratrol	BRCA1		672	0.97
NULL	Arthritis_Res_Ther_2013_Oct_2_15(5)_R141.nxml.txt.nlp	24286116	SENT188	20	20	6	6	tocilizumab	IL-6	PA165292659	3569	0.97
NULL	Int_J_Mol_Sci_2013_Apr_22_14(4)_8638-8683.nxml.txt.nlp	23609496	SENT237	5	5	22	22	meloxicam	IL-2	PA450353	3558	0.97
NULL	J_Hematol_Oncol_2009_Aug_12_2_36.nxml.txt.nlp	19674465	SENT152	16	16	3	3	lenalidomide	SPARC	PA162363968	6678	0.97
NULL	Front_Oncol_2013_Nov_18_3_282.nxml.txt.nlp	24303367	SENT239	9	9	3	3	cisplatin	PARP	PA449014	142	0.97
NULL	Curr_Pharm_Biotechnol_2012_May_13(6)_969-986.nxml.txt.nlp	22039792	SENT16	21	21	30	30	vinblastine	P-gp	PA451877	5243	0.97
NULL	Cancers_(Basel)_2014_Oct_24_6(4)_2187-2223.nxml.txt.nlp	25347122	SENT327	35	35	22	22	bevacizumab	CD31	PA130232992	5175	0.97
NULL	Mol_Cell_Biol_2014_Oct_34(19)_3754-3764.nxml.txt.nlp	25071155	SENT266	21	21	15	15	cisplatin	WWP1	PA449014	11059	0.97
NULL	Open_Med_Inform_J_2010_Dec_3_4_225-232.nxml.txt.nlp	21603285	SENT28	25	25	14	14	nelfinavir	AAT	PA450606	5265	0.97
NULL	Int_J_Breast_Cancer_2011_Sep_6_2011_352182.nxml.txt.nlp	22295219	SENT144	31	31	14	14	trastuzumab	AKT	PA451743	207	0.97
NULL	Oncol_Lett_2014_Jan_29_7(1)_121-124.nxml.txt.nlp	24348832	SENT106	21	21	8	8	cisplatin	p53	PA449014	7157	0.97
NULL	Oncol_Lett_2014_Jun_8_7(6)_2035-2040.nxml.txt.nlp	24932285	SENT3	8	8	28	28	irinotecan	UGT1A1	PA450085	54658	0.97
NULL	Aging_(Albany_NY)_2012_Jul_22_4(7)_480-498.nxml.txt.nlp	22837425	SENT170	24	24	3	3	pemetrexed	AMPK	PA10810	5563	0.97
NULL	Drug_Target_Insights_2013_Aug_19_7_27-34.nxml.txt.nlp	24023511	SENT65	4	4	12	12	paclitaxel	P-gp	PA450761	5243	0.97
NULL	Cancer_Cell_Int_2012_Jul_4_12_19.nxml.txt.nlp	22631225	SENT196	13	13	31	31	heparin	PPIA	PA449855	5478	0.97
NULL	Front_Oncol_2013_Nov_18_3_282.nxml.txt.nlp	24303367	SENT224	6	6	38	38	metformin	TSC2	PA450395	7249	0.97
NULL	Ther_Clin_Risk_Manag_2007_Mar_3(1)_71-97.nxml.txt.nlp	18360617	SENT127	14	14	6	6	caspofungin	CDR1	PA164743013	1038	0.97
NULL	Oncotarget_2014_Feb_7_5(3)_775-787.nxml.txt.nlp	24519956	SENT219	34	34	0	0	docetaxel	PC3	PA449383	57332;7832;5122	0.97
NULL	Int_J_Chron_Obstruct_Pulmon_Dis_2006_Dec_1(4)_373-379.nxml.txt.nlp	18044094	SENT41	8	8	18	18	cilomilast	PDE4B	PA165948031	5142	0.97
NULL	Biomed_Res_Int_2013_Mar_28_2013_154073.nxml.txt.nlp	23607088	SENT14	0	0	35	35	clopidogrel	ADP	PA449053	23038	0.97
NULL	Ann_Neurosci_2011_Apr_18(2)_48-55.nxml.txt.nlp	25205921	SENT142	27	27	21	21	forskolin	SOD1	PA146096022	6647	0.97
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT67	30	30	2	2	metformin	p53	PA450395	7157	0.97
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT111	24	24	33	33	atorvastatin	IL-6	PA448500	3569	0.97
NULL	Exp_Ther_Med_2014_Dec_3_8(6)_1825-1830.nxml.txt.nlp	25371739	SENT95	17	17	33	33	sulfamethoxazole	DHFR	PA451544	1719	0.97
NULL	Nat_Commun_2014_Nov_19_5_5479.nxml.txt.nlp	25407222	SENT34	16	16	44	44	dextran	YTS	PA449261	8565	0.97
NULL	Oncoscience_2014_Oct_22_1(10)_614-623.nxml.txt.nlp	25593991	SENT91	3	3	33	33	vemurafenib	BRAF	PA165946873	673	0.97
NULL	Cancer_Med_2013_Jun_23_2(3)_296-304.nxml.txt.nlp	23930206	SENT30	38	38	23	23	erlotinib	EGFR	PA134687924	1956	0.97
NULL	Int_J_Mol_Sci_2014_Oct_8_15(10)_17974-17999.nxml.txt.nlp	25299695	SENT324	8	8	0	0	curcumin	HO-1	PA151958596	3162	0.97
NULL	Oncoscience_2014_Mar_6_1(2)_180-182.nxml.txt.nlp	25594009	SENT12	12	12	19	19	trastuzumab	HER2	PA451743	2064	0.97
NULL	J_Biomed_Biotechnol_2010_Sep_22_2010_108159.nxml.txt.nlp	20885932	SENT30	0	0	16	16	reteplase	EGF	PA164743728	1950	0.97
NULL	J_Clin_Biochem_Nutr_2011_Mar_26_48(2)_170-177.nxml.txt.nlp	21373272	SENT156	35	35	22	22	pioglitazone	PSMB4	PA450970	5692	0.97
NULL	BMB_Rep_2013_Feb_46(2)_92-96.nxml.txt.nlp	23433111	SENT32	14	14	9	9	etoposide	BRCA1	PA449552	672	0.97
NULL	Oncol_Lett_2014_Nov_12_8(5)_2203-2208.nxml.txt.nlp	25295109	SENT82	12	12	32	32	celecoxib	GLI1	PA448871	2735	0.97
NULL	Indian_J_Med_Paediatr_Oncol_2014_Apr-Jun_35(2)_176-180.nxml.txt.nlp	25197183	SENT84	45	45	22	22	bevacizumab	KRAS	PA130232992	3845	0.97
NULL	Oncol_Rep_2013_Jan_26_29(1)_297-305.nxml.txt.nlp	23129017	SENT77	27	27	30	30	doxycycline	TRA16	PA449415	126382	0.97
NULL	Curr_Chem_Genomics_2008_Feb_25_1_43-53.nxml.txt.nlp	20161827	SENT29	3	3	30	30	sorafenib	FLT3	PA7000	2322	0.97
NULL	Breast_Cancer_Res_2005_Jan_12_7(2)_48-51.nxml.txt.nlp	15743510	SENT42	20	20	12	12	exemestane	aromatase	PA449563	1588	0.97
NULL	Br_J_Pharmacol_2010_Sep_161(2)_288-307.nxml.txt.nlp	20735416	SENT245	25	25	14	14	isoflurane	TREK-1	PA450106	3776	0.97
NULL	Tuberc_Respir_Dis_(Seoul)_2013_Nov_29_75(5)_188-198.nxml.txt.nlp	24348666	SENT54	17	17	2	2	erlotinib	PTEN	PA134687924	5728	0.97
NULL	Arthritis_Res_Ther_2005_Dec_1_7(1)_R149-R155.nxml.txt.nlp	15642135	SENT9	21	21	3	3	infliximab	IL-6	PA452639	3569	0.97
NULL	Neuropsychopharmacology_2012_Feb_2_37(3)_641-650.nxml.txt.nlp	22048466	SENT132	14	14	9	9	bupropion	CYP2B6	PA448687	1555	0.97
NULL	Oncotarget_2014_Nov_4_5(19)_8906-8923.nxml.txt.nlp	25275298	SENT232	24	24	12	12	cetuximab	PIK3CA	PA10040	5290	0.97
NULL	Oncol_Rep_2014_Apr_28_31(4)_1605-1612.nxml.txt.nlp	24481648	SENT125	0	0	13	13	ponatinib	P-gp	PA165980594	5243	0.97
NULL	J_Oncol_2009_Jun_14_2009_814140.nxml.txt.nlp	19547715	SENT6	8	8	29	29	gemcitabine	MRP1	PA449748	4437	0.97
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1200.nxml.txt.nlp	NULL	SENT8	3	3	12	12	resveratrol	AMPK		5563	0.97
NULL	Chromatographia_2009_Jun_26_69(Suppl_2)_167-173.nxml.txt.nlp	19554204	SENT133	2	2	25	25	hesperetin	MS2	PA164742902	101	0.97
NULL	J_Oncol_2012_Sep_26_2012_540791.nxml.txt.nlp	21961001	SENT189	0	0	12	12	pazopanib	VEGFR	PA165291492	3791	0.97
NULL	Acta_Pharmacol_Sin_2010_Jul_28_31(7)_867-873.nxml.txt.nlp	20581857	SENT144	1	1	36	36	docetaxel	PC3	PA449383	57332;7832;5122	0.97
NULL	Mol_Pain_2013_Nov_28_9_60.nxml.txt.nlp	24283218	SENT266	37	37	2	2	capsaicin	TRPV1	PA448776	7442	0.97
NULL	Arch_Med_Sci_2013_Feb_21_9(1)_151-158.nxml.txt.nlp	23515030	SENT126	2	2	19	19	lipase	SN2	PA450239	92745	0.97
NULL	Mol_Cells_2014_Mar_31_37(3)_234-240.nxml.txt.nlp	24642709	SENT159	16	16	4	4	capsaicin	HO-1	PA448776	3162	0.97
NULL	J_Obes_2011_Dec_15_2011_928165.nxml.txt.nlp	21197151	SENT198	0	0	14	14	liraglutide	GLP-1	PA165958364	100125288	0.97
NULL	Sci_Rep_2014_Dec_17_4_7461.nxml.txt.nlp	25514838	SENT214	8	8	2	2	cisplatin	STAT3	PA449014	6774	0.97
NULL	Oncogene_2010_Sep_23_29(38)_5299-5310.nxml.txt.nlp	20622903	SENT174	39	39	12	12	trypsin	HMGB1	PA451806	3146	0.97
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT40	7	7	36	36	erlotinib	EGFR	PA134687924	1956	0.97
NULL	EMBO_Mol_Med_2013_Aug_5_5(8)_1213-1226.nxml.txt.nlp	23918228	SENT379	0	0	10	10	cetuximab	EGFR	PA10040	1956	0.97
NULL	Cancer_Inform_2013_Nov_25_12_203-219.nxml.txt.nlp	24327800	SENT114	7	7	0	0	hyaluronan	HAPLN1	PA165958431	1404	0.97
NULL	Behav_Genet_2012_Jul_17_42(4)_509-527.nxml.txt.nlp	22426781	SENT384	26	26	16	16	l-glutamine	B27	PA10090	56246	0.97
NULL	F1000Res_2014_Jul_30_3_103.nxml.txt.nlp	25285204	SENT205	29	29	4	4	thrombin	VWF	PA451674	7450	0.97
NULL	J_Radiat_Res_2014_Mar_1_55(2)_359-363.nxml.txt.nlp	24187329	SENT45	0	0	4	4	rituximab	CHOP	PA451261	1649	0.97
NULL	Indian_J_Pharmacol_2008_Oct_40(Suppl_2)_S112-S142.nxml.txt.nlp	21593965	SENT1772	15	15	40	40	ethanol	NPY	PA448073	4852	0.97
NULL	Core_Evid_2010_Jul_27_5_11-22.nxml.txt.nlp	20694136	SENT6	0	0	11	11	ustekinumab	IL-23	PA166048654	51561	0.97
NULL	Mol_Cancer_2008_Jun_5_7_50.nxml.txt.nlp	18534018	SENT149	44	44	8	8	bortezomib	ATF3	PA10252	467	0.97
NULL	Oncotarget_2012_Sep_28_3(10)_1169-1181.nxml.txt.nlp	23045411	SENT93	10	10	1	1	doxorubicin	JIP1	PA449412	9479	0.97
NULL	Comp_Hepatol_2004_Jan_14_3(Suppl_1)_S21.nxml.txt.nlp	14960173	SENT52	31	31	12	12	simvastatin	RhoA	PA451363	387	0.97
NULL	Cancers_(Basel)_2010_Dec_23_3(1)_17-42.nxml.txt.nlp	24212604	SENT928	22	22	12	12	carboplatin	PPX	PA448803	5531	0.97
NULL	Evid_Based_Complement_Alternat_Med_2011_Mar_1_2011_207034.nxml.txt.nlp	21423686	SENT113	8	8	23	23	clopidogrel	CYP2C19	PA449053	1557	0.97
NULL	J_Obes_2013_Jun_4_2013_874981.nxml.txt.nlp	23862058	SENT139	5	5	17	17	betaine	BSP	PA448603	3381	0.97
NULL	Clin_Interv_Aging_2010_May_25_5_149-156.nxml.txt.nlp	20517484	SENT133	22	22	5	5	rasagiline	CYP1A2	PA164764584	1544	0.97
NULL	J_Invest_Dermatol_2012_Oct_24_132(10)_2440-2450.nxml.txt.nlp	22622430	SENT97	12	12	4	4	paclitaxel	ABCB1	PA450761	5243	0.97
NULL	Braz_J_Med_Biol_Res_2013_Aug_10_46(7)_634-642.nxml.txt.nlp	23903680	SENT204	18	18	25	25	gemcitabine	BNIP3	PA449748	664	0.97
NULL	J_Korean_Med_Sci_2007_Apr_30_22(2)_283-289.nxml.txt.nlp	17449938	SENT113	12	12	3	3	minoxidil	P21	PA450521	1026;9338	0.97
NULL	Case_Rep_Rheumatol_2013_Nov_12_2013_792526.nxml.txt.nlp	24324911	SENT8	0	0	12	12	rituximab	TNF-alpha	PA451261	7124	0.97
NULL	Clin_Med_Insights_Oncol_2012_Feb_28_6_125-135.nxml.txt.nlp	22408376	SENT66	5	5	29	29	panitumumab	KRAS	PA162373091	3845	0.97
NULL	Arthritis_Res_Ther_2006_Jul_21_8(4)_R130.nxml.txt.nlp	16859540	SENT102	20	20	13	13	atorvastatin	CD59	PA448500	966	0.97
NULL	Int_J_Vasc_Med_2012_Dec_6_2012_293641.nxml.txt.nlp	22187650	SENT313	22	22	29	29	simvastatin	Rho	PA451363	29984	0.97
NULL	Front_Psychol_2011_Sep_15_2_233.nxml.txt.nlp	21954390	SENT298	19	19	23	23	lorazepam	PES	PA450267	23481	0.97
NULL	Front_Oncol_2013_Nov_15_3_281.nxml.txt.nlp	24298448	SENT85	33	33	11	11	leucovorin	BRAF	PA450198	673	0.97
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Oct_31_65(Pt_11)_o2963.nxml.txt.nlp	21578534	SENT47	3	3	35	35	benzaldehyde	mol	PA448571	90527	0.97
NULL	Nat_Med_2013_Dec_10_19(12)_10_1038_nm_3385.nxml.txt.nlp	24216752	SENT109	2	2	13	13	thrombin	PAR1	PA451674	79581;2149	0.97
NULL	Orphanet_J_Rare_Dis_2014_Dec_10_9(1)_200.nxml.txt.nlp	NULL	SENT94	5	5	29	29	pamidronate	HCS	PA450767	3141;54205	0.97
NULL	Mol_Cancer_2009_Apr_16_8_24.nxml.txt.nlp	19371427	SENT294	22	22	6	6	cisplatin	CHK1	PA449014	1111	0.97
NULL	Braz_J_Med_Biol_Res_2014_Jan_10_47(1)_60-69.nxml.txt.nlp	24519092	SENT218	14	14	24	24	doxorubicin	YWHAZ	PA449412	7534	0.97
NULL	Ann_Hematol_2011_Feb_17_90(2)_173-183.nxml.txt.nlp	20714724	SENT142	6	6	28	28	resveratrol	ZAP-70		7535	0.97
NULL	Oncotarget_2013_Jul_18_4(10)_1582-1591.nxml.txt.nlp	24123600	SENT126	42	42	8	8	imatinib	MXR	PA10804	9429	0.97
NULL	J_Adv_Pract_Oncol_2013_Jul_1_Jul-Aug_4(4)_263-268.nxml.txt.nlp	25032007	SENT34	1	1	5	5	imatinib	CYP3A4	PA10804	1576	0.97
NULL	Mol_Cancer_2009_Apr_16_8_24.nxml.txt.nlp	19371427	SENT233	11	11	28	28	cisplatin	CHK1	PA449014	1111	0.97
NULL	Oncotarget_2010_Oct_30_1(7)_639-650.nxml.txt.nlp	21317459	SENT51	22	22	18	18	nutlin-3	p53		7157	0.97
NULL	Cell_Death_Dis_2010_Oct_21_1(10)_e86.nxml.txt.nlp	21368859	SENT35	7	7	16	16	doxorubicin	Mcl-1	PA449412	4170	0.97
NULL	Br_J_Cancer_2013_Sep_3_109(5)_1214-1222.nxml.txt.nlp	23922104	SENT162	20	20	27	27	doxorubicin	TP53	PA449412	7157	0.97
NULL	Iran_Red_Crescent_Med_J_2014_Aug_5_16(8)_e6915.nxml.txt.nlp	25389496	SENT120	0	0	28	28	simvastatin	adiponectin	PA451363	9370	0.97
NULL	Aging_(Albany_NY)_2009_Jun_3_1(6)_515-528.nxml.txt.nlp	20157535	SENT147	27	27	12	12	resveratrol	S6K1		6198	0.97
NULL	Front_Oncol_2014_Jun_30_4_165.nxml.txt.nlp	25072020	SENT42	0	0	22	22	cetuximab	EGFR	PA10040	1956	0.97
NULL	Springerplus_2013_Feb_15_2_52.nxml.txt.nlp	23476897	SENT4	1	1	22	22	tamoxifen	CYP2D6	PA451581	1565	0.97
NULL	Cardiovasc_Ther_2012_Aug_17_30(4)_e174-e182.nxml.txt.nlp	21883999	SENT98	5	5	13	13	prasugrel	CYP3A	PA154410481	1574	0.97
NULL	Brain_2013_Jul_24_136(7)_2279-2297.nxml.txt.nlp	23801741	SENT50	11	11	1	1	tamoxifen	NRG1	PA451581	3084	0.97
NULL	J_Mol_Signal_2014_Aug_1_9_7.nxml.txt.nlp	25093037	SENT88	10	10	2	2	tamoxifen	PAK1	PA451581	5585;5058	0.97
NULL	Oxid_Med_Cell_Longev_2013_Jun_2_2013_793525.nxml.txt.nlp	23819014	SENT250	20	20	3	3	resveratrol	AMPK		5563	0.97
NULL	Appl_Clin_Genet_2010_Oct_29_3_85-101.nxml.txt.nlp	23776354	SENT127	14	14	6	6	imatinib	PDGFRA	PA10804	5156	0.97
NULL	Exp_Transl_Stroke_Med_2012_Oct_30_4_21.nxml.txt.nlp	23110876	SENT106	39	39	27	27	eplerenone	CD4	PA164749044	920	0.97
NULL	Oncotarget_2012_Oct_20_3(10)_1236-1245.nxml.txt.nlp	23100449	SENT103	30	30	15	15	doxorubicin	NGAL	PA449412	3934	0.97
NULL	Exp_Ther_Med_2014_Sep_14_8(3)_836-840.nxml.txt.nlp	25120610	SENT91	14	14	4	4	fasudil	RhoA	PA165946121	387	0.97
NULL	Cell_Death_Dis_2013_Jun_13_4(6)_e665.nxml.txt.nlp	23764846	SENT86	18	18	11	11	sorafenib	FSP1	PA7000	6275;51062	0.97
NULL	Orphanet_J_Rare_Dis_2008_Jul_7_3_18.nxml.txt.nlp	18606002	SENT350	34	34	3	3	mexiletine	SCN5A	PA450488	6331	0.97
NULL	Mol_Biol_Cell_2012_May_1_23(9)_1628-1635.nxml.txt.nlp	22398723	SENT112	23	23	9	9	ethanol	QKI	PA448073	9444	0.97
NULL	ACS_Med_Chem_Lett_2014_May_14_5(7)_736-741.nxml.txt.nlp	25057340	SENT87	15	15	38	38	sulindac	AKT	PA451565	207	0.97
NULL	Breast_Cancer_Res_2010_May_10_12(3)_R26.nxml.txt.nlp	20459744	SENT137	16	16	5	5	docetaxel	CYP3A4	PA449383	1576	0.97
NULL	J_Physiol_2009_Feb_15_587(Pt_4)_731-744.nxml.txt.nlp	19074966	SENT153	4	4	36	36	taurine	PAT1	PA451590	10513;206358	0.97
NULL	Cell_Death_Dis_2014_Mar_20_5(3)_e1138.nxml.txt.nlp	24651441	SENT42	40	40	4	4	paclitaxel	P-gp	PA450761	5243	0.97
NULL	J_Clin_Biochem_Nutr_2009_Sep_28_45(2)_125-130.nxml.txt.nlp	19794918	SENT506	13	13	3	3	lansoprazole	HO-1	PA450180	3162	0.97
NULL	N_Am_J_Med_Sci_2013_Mar_5(3)_202-206.nxml.txt.nlp	23626956	SENT80	31	31	4	4	irinotecan	EGFR	PA450085	1956	0.97
NULL	J_Hematol_Oncol_2013_Jun_3_6_38.nxml.txt.nlp	23731980	SENT23	18	18	12	12	trastuzumab	HER2	PA451743	2064	0.97
NULL	Acta_Neuropathol_Commun_2014_Jan_2_2_3.nxml.txt.nlp	24383546	SENT266	0	0	11	11	resveratrol	SIRT1		23411	0.97
NULL	Pharmaceuticals_(Basel)_2013_Aug_2_6(8)_915-928.nxml.txt.nlp	24276376	SENT63	4	4	23	23	thrombin	GPCR	PA451674	151306;165140	0.97
NULL	Br_J_Cancer_2010_Jul_13_103(2)_186-195.nxml.txt.nlp	20588277	SENT7	13	13	0	0	nutlin-3	p53		7157	0.97
NULL	Cancer_Res_Treat_2013_Mar_31_45(1)_55-62.nxml.txt.nlp	23613671	SENT137	18	18	6	6	irinotecan	KRAS	PA450085	3845	0.97
NULL	Emerg_Infect_Dis_2007_Jul_13(7)_1001-1007.nxml.txt.nlp	18214171	SENT41	39	39	8	8	nevirapine	CD4	PA450616	920	0.97
NULL	Arthritis_Res_Ther_2005_May_27_7(5)_R915-R926.nxml.txt.nlp	16207333	SENT272	26	26	29	29	curcumin	AP-1	PA151958596	2353;3727;2354;3725	0.97
NULL	Endocrinol_Metab_(Seoul)_2013_Dec_12_28(4)_262-274.nxml.txt.nlp	24396690	SENT61	0	0	9	9	exenatide	GLP-1	PA164749238	100125288	0.97
NULL	Ann_Rheum_Dis_2011_Mar_6_70(6)_909-920.nxml.txt.nlp	21378402	SENT167	2	2	21	21	rituximab	CDAI	PA451261	146059	0.97
NULL	Mol_Cancer_2010_Aug_16_9_217.nxml.txt.nlp	20712901	SENT85	39	39	20	20	curcumin	STAT3	PA151958596	6774	0.97
NULL	Oncoimmunology_2013_Jun_1_2(6)_e24677.nxml.txt.nlp	23894722	SENT133	20	20	9	9	cetuximab	CD107a	PA10040	3916	0.97
NULL	Oncol_Rep_2014_Apr_28_31(4)_1605-1612.nxml.txt.nlp	24481648	SENT125	0	0	18	18	ponatinib	P-gp	PA165980594	5243	0.97
NULL	Breast_Cancer_(Auckl)_2009_Apr_7_3_23-34.nxml.txt.nlp	21556247	SENT124	12	12	20	20	celecoxib	AKT	PA448871	207	0.97
NULL	Diabetes_2011_Jan_4_60(1)_119-126.nxml.txt.nlp	20921208	SENT224	12	12	4	4	glucose	TRPM2	PA449773	7226	0.97
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT122	5	5	31	31	pp2	PP2		4888	0.97
NULL	Curr_Cardiol_Rev_2012_Aug_8(3)_181-191.nxml.txt.nlp	22920489	SENT113	16	16	2	2	ticagrelor	ADP	PA165374673	23038	0.97
NULL	J_Hematol_Oncol_2011_Sep_9_4_35.nxml.txt.nlp	21906310	SENT231	23	23	12	12	trastuzumab	HER2	PA451743	2064	0.97
NULL	J_Parasitol_Res_2012_Dec_25_2012_394981.nxml.txt.nlp	23320145	SENT156	28	28	5	5	collagenase	IFN	PA449107	3439	0.97
NULL	EJC_Suppl_2013_Sep_5_11(2)_92-96.nxml.txt.nlp	NULL	SENT95	32	32	23	23	vemurafenib	BRAF	PA165946873	673	0.97
NULL	Cell_Biol_Int_Rep_(2010)_2012_Jun_21_19(1)_e00017.nxml.txt.nlp	23124518	SENT93	8	8	16	16	etoposide	TRAIL	PA449552	8743	0.97
NULL	Clin_Med_Insights_Oncol_2011_Sep_21_5_265-314.nxml.txt.nlp	22084619	SENT119	18	18	0	0	glucose	HIF-1	PA449773	29072	0.97
NULL	Acta_Pharmacol_Sin_2013_Feb_12_34(2)_255-261.nxml.txt.nlp	23147557	SENT14	18	18	11	11	pioglitazone	PTPRD	PA450970	5789	0.97
NULL	Cancers_(Basel)_2012_Oct_29_4(4)_1146-1160.nxml.txt.nlp	24213502	SENT81	9	9	25	25	anastrozole	aromatase	PA448432	1588	0.97
NULL	Cancer_Cell_Int_2012_Dec_21_12_54.nxml.txt.nlp	23256568	SENT34	4	4	27	27	geldanamycin	Hsp90	PA152031327	3320	0.97
NULL	Oncogene_2014_Sep_11_33(37)_4579-4588.nxml.txt.nlp	24662835	SENT119	5	5	28	28	tamoxifen	MAGEA2	PA451581	4101;266740	0.97
NULL	J_Biol_Chem_2009_Jan_2_284(1)_77-84.nxml.txt.nlp	18854318	SENT165	27	27	4	4	forskolin	MO25	PA146096022	51719	0.97
NULL	J_Biol_Chem_2013_Mar_29_288(13)_9035-9048.nxml.txt.nlp	23362266	SENT287	7	7	16	16	tamoxifen	EP4	PA451581	5734	0.97
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_P110.nxml.txt.nlp	NULL	SENT5	19	19	0	0	sulfamethoxazole	CD4	PA451544	920	0.97
NULL	Int_J_Med_Chem_2012_Dec_13_2012_530392.nxml.txt.nlp	25379286	SENT301	46	46	12	12	ethanol	mol	PA448073	90527	0.97
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1717-1723.nxml.txt.nlp	19844230	SENT95	13	13	4	4	sorafenib	TAO2	PA7000	9344	0.97
NULL	Mol_Cancer_2014_Jul_5_13_165.nxml.txt.nlp	24996221	SENT105	18	18	2	2	docetaxel	HMGB1	PA449383	3146	0.97
NULL	Gut_Liver_2013_Sep_14_7(5)_576-584.nxml.txt.nlp	24073316	SENT65	3	3	8	8	cisplatin	NAC	PA449014	22861	0.97
NULL	Cancers_(Basel)_2012_Nov_8_4(4)_1180-1211.nxml.txt.nlp	24213504	SENT50	0	0	19	19	gefitinib	EGFR	PA131301952	1956	0.97
NULL	Mol_Cancer_2006_Oct_6_5_43.nxml.txt.nlp	17026740	SENT371	15	15	6	6	irinotecan	EGFR	PA450085	1956	0.97
NULL	J_Gen_Physiol_1997_Aug_1_110(2)_185-200.nxml.txt.nlp	9236211	SENT237	31	31	8	8	methazolamide	NO3	PA450413	4681	0.97
NULL	Sci_Rep_2014_Dec_4_4_7310.nxml.txt.nlp	25472472	SENT124	24	24	3	3	decitabine	CD34	PA164749631	947	0.97
NULL	Indian_J_Dermatol_2010_Apr-Jun_55(2)_161-170.nxml.txt.nlp	20606887	SENT260	0	0	25	25	ustekinumab	p40	PA166048654	3921;339541;10314	0.97
NULL	J_Thromb_Haemost_2007_May_1_5(5)_910-917.nxml.txt.nlp	17362227	SENT118	37	37	5	5	cangrelor	P2X1	PA165945763	5023	0.97
NULL	Biologics_2012_Jan_5_6_13-20.nxml.txt.nlp	22291463	SENT48	0	0	22	22	bevacizumab	VEGFR2	PA130232992	3791	0.97
NULL	Contemp_Oncol_(Pozn)_2012_Feb_29_16(1)_86-89.nxml.txt.nlp	23788860	SENT70	4	4	17	17	trastuzumab	HER2	PA451743	2064	0.97
NULL	Acta_Pharmacol_Sin_2010_Mar_22_31(3)_329-340.nxml.txt.nlp	20173759	SENT176	13	13	22	22	ethanol	AMPK	PA448073	5563	0.97
NULL	Breast_Cancer_Res_2007_Mar_2_9(2)_205.nxml.txt.nlp	NULL	SENT27	6	6	20	20	lapatinib	HER-2	PA152241907	2064	0.97
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R91.nxml.txt.nlp	22541814	SENT223	0	0	14	14	thrombin	PAR4	PA451674	9002;5074	0.97
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT107	27	27	19	19	chloroquine	BMPR-II	PA448948	659	0.97
NULL	Int_J_Endocrinol_2014_Jun_25_2014_534904.nxml.txt.nlp	25053942	SENT59	20	20	0	0	amiodarone	AIT	PA448383	160728	0.97
NULL	Oxid_Med_Cell_Longev_2013_Nov_28_2013_568093.nxml.txt.nlp	24379901	SENT50	1	1	14	14	resveratrol	AMPK		5563	0.97
NULL	Exp_Neurobiol_2013_Mar_31_22(1)_45-50.nxml.txt.nlp	23585722	SENT127	22	22	11	11	fluoxetine	EPO	PA449673	7076;8288;2056	0.97
NULL	FEBS_Open_Bio_2013_Jul_4_3_279-284.nxml.txt.nlp	23905010	SENT117	24	24	7	7	olmesartan	MMP13	PA164742950	4322	0.97
NULL	Braz_J_Med_Biol_Res_2014_Sep_5_47(11)_929-939.nxml.txt.nlp	25296354	SENT102	3	3	29	29	gefitinib	EGFR	PA131301952	1956	0.97
NULL	J_Exp_Med_1998_Jun_1_187(11)_1779-1788.nxml.txt.nlp	9607919	SENT163	23	23	14	14	methacholine	PAFR	PA165958382	64582	0.97
NULL	Curr_Chem_Genomics_2010_Mar_1_4_1-8.nxml.txt.nlp	20448812	SENT9	5	5	11	11	piperazine	OATP1B1	PA450977	10599	0.97
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_79-96.nxml.txt.nlp	19305789	SENT49	12	12	2	2	capsaicin	TRPV1	PA448776	7442	0.97
NULL	Adv_Ther_2013_Nov_28_30(12)_1067-1085.nxml.txt.nlp	24287690	SENT60	1	1	23	23	metformin	GLP-1	PA450395	100125288	0.97
NULL	Breast_Cancer_Res_2005_May_13_7(4)_R522-R534.nxml.txt.nlp	15987459	SENT174	5	5	22	22	calcein	CBX	PA132595336	10951	0.97
NULL	Oncotarget_2014_Nov_8_5(21)_10280-10292.nxml.txt.nlp	25373733	SENT200	5	5	11	11	temsirolimus	HIF-1	PA164746890	29072	0.97
NULL	Patient_Prefer_Adherence_2013_May_7_7_391-400.nxml.txt.nlp	23687442	SENT70	7	7	46	46	fosaprepitant	HEC	PA165958390	10403	0.97
NULL	Mol_Cancer_2014_Jul_5_13_165.nxml.txt.nlp	24996221	SENT95	24	24	47	47	docetaxel	HMGB1	PA449383	3146	0.97
NULL	Cell_Biol_Int_Rep_(2010)_2012_Jun_21_19(1)_e00017.nxml.txt.nlp	23124518	SENT133	5	5	25	25	etoposide	TRAIL-R2	PA449552	8795	0.97
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT260	43	43	21	21	atorvastatin	PTEN	PA448500	5728	0.97
NULL	Oncol_Lett_2013_Apr_22_5(4)_1093-1100.nxml.txt.nlp	23599746	SENT69	10	10	26	26	vincristine	P-gp	PA451879	5243	0.97
NULL	Cardiovasc_Drugs_Ther_2013_Jul_26_27(6)_521-530.nxml.txt.nlp	23887740	SENT156	22	22	11	11	clopidogrel	CD41	PA449053	3674	0.97
NULL	Case_Rep_Psychiatry_2013_May_16_2013_913248.nxml.txt.nlp	23762722	SENT53	0	0	22	22	ziprasidone	5-HT2A	PA451974	3356	0.97
NULL	Arch_Med_Sci_2011_Apr_17_7(2)_230-234.nxml.txt.nlp	22291761	SENT6	21	21	9	9	curcumin	SMN2	PA151958596	6607	0.97
NULL	Oncol_Rep_2013_Mar_8_29(3)_917-924.nxml.txt.nlp	23314174	SENT177	2	2	7	7	sorafenib	CD44	PA7000	960	0.97
NULL	Acta_Pharmacol_Sin_2011_Oct_15_32(10)_1303-1308.nxml.txt.nlp	21841812	SENT128	13	13	35	35	losartan	CYP2C9	PA450268	1559	0.97
NULL	AAPS_J_2014_Jun_11_16(5)_1029-1037.nxml.txt.nlp	24917180	SENT173	3	3	28	28	quinidine	P-gp	PA451209	5243	0.97
NULL	Curr_Med_Chem_2014_May_21(14)_1595-1606.nxml.txt.nlp	23992330	SENT197	12	12	28	28	crizotinib	EML4	PA165946122	27436	0.97
NULL	Cell_Death_Dis_2012_Jun_7_3(6)_e319.nxml.txt.nlp	22673193	SENT43	13	13	4	4	cisplatin	survivin	PA449014	332	0.97
NULL	Cell_Mol_Life_Sci_2011_Nov_2_68(21)_3573-3587.nxml.txt.nlp	21365278	SENT297	37	37	19	19	iloprost	EP4	PA164746843	5734	0.97
NULL	Breast_Cancer_Res_2012_Mar_15_14(2)_R47.nxml.txt.nlp	22420423	SENT219	14	14	41	41	doxorubicin	TP53	PA449412	7157	0.97
NULL	Br_J_Cancer_2009_Jan_27_100(2)_334-343.nxml.txt.nlp	19142186	SENT142	14	14	5	5	gefitinib	Hsp90	PA131301952	3320	0.97
NULL	J_Invest_Dermatol_2012_Oct_24_132(10)_2440-2450.nxml.txt.nlp	22622430	SENT108	13	13	6	6	temozolomide	IL-8	PA451609	3576	0.97
NULL	Crit_Care_2011_Aug_11_15(4)_226.nxml.txt.nlp	21892977	SENT80	0	0	9	9	vasopressin	LNPEP	PA451858	4012	0.97
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Oct_20_66(Pt_11)_o2865.nxml.txt.nlp	21589047	SENT66	21	21	4	4	ethanol	mol	PA448073	90527	0.97
NULL	Br_J_Cancer_2012_Dec_4_107(12)_1950-1955.nxml.txt.nlp	23169295	SENT98	19	19	2	2	oxaliplatin	ERCC1	PA131285527	2067	0.97
NULL	Antiviral_Res_2009_May_82(2)_A99-A109.nxml.txt.nlp	19176219	SENT178	10	10	19	19	ritonavir	OCT1	PA451260	5451;6580	0.97
NULL	Curr_Neuropharmacol_2009_Sep_7(3)_217-227.nxml.txt.nlp	20190963	SENT95	32	32	20	20	dpcpx	CA1		759	0.97
NULL	Mol_Biol_Cell_2014_Jan_15_25(2)_257-266.nxml.txt.nlp	24227885	SENT158	26	26	18	18	vinblastine	TAT1	PA451877	117247	0.97
NULL	Oncotarget_2011_May_16_2(5)_418-421.nxml.txt.nlp	21789791	SENT32	2	2	25	25	bortezomib	Mcl-1	PA10252	4170	0.97
NULL	Int_J_Biol_Sci_2014_Jan_11_10(2)_142-148.nxml.txt.nlp	24520212	SENT119	10	10	1	1	cisplatin	WWOX	PA449014	51741	0.97
NULL	Cell_Death_Dis_2014_Jan_30_5(1)_e1038.nxml.txt.nlp	24481452	SENT230	12	12	21	21	raloxifene	ARNT	PA451221	405	0.97
NULL	J_Biol_Chem_2013_Aug_23_288(34)_24799-24808.nxml.txt.nlp	23836892	SENT184	4	4	25	25	s-adenosylmethionine	NDUFAF5	PA164754994	79133	0.97
NULL	J_Am_Heart_Assoc_2013_Aug_23_2(4)_e000318.nxml.txt.nlp	23926118	SENT110	30	30	19	19	isoproterenol	AC3	PA450121	109	0.97
NULL	Indian_J_Anaesth_2011_Mar-Apr_55(2)_104-110.nxml.txt.nlp	21712863	SENT57	0	0	34	34	ropivacaine	CYP3A4	PA451271	1576	0.97
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1098-1105.nxml.txt.nlp	21386838	SENT158	27	27	23	23	cisplatin	DTD	PA449014	1728	0.97
NULL	Front_Neurosci_2014_Dec_16_8_416.nxml.txt.nlp	25565946	SENT161	40	40	13	13	fluoxetine	IL-6	PA449673	3569	0.97
NULL	EMBO_Mol_Med_2012_Mar_4(3)_218-233.nxml.txt.nlp	22294553	SENT210	17	17	15	15	erlotinib	EGFR	PA134687924	1956	0.97
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Dec_21_68(Pt_1)_o193.nxml.txt.nlp	22259476	SENT6	27	27	1	1	phenol	mol	PA450913	90527	0.97
NULL	Int_J_Crit_Illn_Inj_Sci_2012_May-Aug_2(2)_82-97.nxml.txt.nlp	22837896	SENT150	9	9	30	30	fluconazole	CD4	PA449653	920	0.97
NULL	Biologics_2013_Oct_10_7_211-221.nxml.txt.nlp	24143074	SENT52	0	0	5	5	everolimus	CYP3A4	PA164746311	1576	0.97
NULL	Genome_Med_2010_Sep_15_2(9)_66.nxml.txt.nlp	20854646	SENT28	22	22	0	0	tramadol	CYP2D6	PA451735	1565	0.97
NULL	Oncotarget_2014_Jun_27_5(13)_4694-4708.nxml.txt.nlp	25051361	SENT279	16	16	0	0	fludarabine	MEC1	PA449655	545	0.97
NULL	Breast_Cancer_Res_2007_Jul_22_9(4)_R45.nxml.txt.nlp	17659092	SENT109	4	4	21	21	doxorubicin	FDG	PA449412	23583	0.97
NULL	Arch_Med_Sci_2013_Apr_20_9(2)_361-367.nxml.txt.nlp	23671450	SENT167	4	4	11	11	budesonide	HIF-1	PA448681	29072	0.97
NULL	Clin_Interv_Aging_2010_Dec_3_5_403-416.nxml.txt.nlp	21152242	SENT160	16	16	2	2	telmisartan	ACE	PA451605	1636	0.97
NULL	Breast_Cancer_Res_2004_Oct_21_6(1)_13-21.nxml.txt.nlp	14680481	SENT106	20	20	3	3	lovastatin	p27	PA450272	5715;10534	0.97
NULL	Crit_Care_2013_Mar_19_17(Suppl_2)_P435.nxml.txt.nlp	NULL	SENT10	22	22	28	28	esomeprazole	mol	PA10075	90527	0.97
NULL	Int_Dairy_J_2010_Apr_20(4)_236-242.nxml.txt.nlp	20204054	SENT60	25	25	12	12	tolbutamide	GLP-1	PA451718	100125288	0.97
NULL	Med_Sci_Monit_2013_Oct_21_19_875-882.nxml.txt.nlp	24145180	SENT92	21	21	0	0	bevacizumab	CXCL8	PA130232992	3576	0.97
NULL	Br_J_Cancer_2012_Jan_3_106(1)_32-38.nxml.txt.nlp	22108523	SENT170	10	10	5	5	trastuzumab	HER2	PA451743	2064	0.97
NULL	Int_J_Breast_Cancer_2012_May_9_2012_415170.nxml.txt.nlp	22649737	SENT92	0	0	7	7	lapatinib	EGFR	PA152241907	1956	0.97
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Feb_15_5_3.nxml.txt.nlp	16480505	SENT189	0	0	7	7	warfarin	CYP2C9	PA451906	1559	0.97
NULL	Acta_Pharmacol_Sin_2014_Aug_7_35(8)_1015-1022.nxml.txt.nlp	24998256	SENT164	0	0	21	21	ethanol	ALDH2	PA448073	217	0.97
NULL	Oncoscience_2014_Sep_16_1(9)_567-573.nxml.txt.nlp	25594066	SENT27	10	10	17	17	vismodegib	SMO		6608;54498	0.97
NULL	Breast_Cancer_Res_2005_Dec_7_7(1)_R156-R163.nxml.txt.nlp	15642164	SENT194	24	24	13	13	letrozole	aromatase	PA450196	1588	0.97
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT185	1	1	23	23	atorvastatin	TRAP	PA448500	959;54;57410	0.97
NULL	Nucleic_Acids_Res_2013_Feb_19_41(3)_1684-1697.nxml.txt.nlp	23258707	SENT36	39	39	0	0	cisplatin	TNR	PA449014	7143	0.97
NULL	Clin_Ophthalmol_2014_Oct_10_8_2091-2093.nxml.txt.nlp	25336911	SENT13	6	6	30	30	l-carnitine	castor	PA450154	54897	0.97
NULL	Iran_J_Basic_Med_Sci_2012_Mar-Apr_15(2)_709-718.nxml.txt.nlp	23493500	SENT31	8	8	18	18	rofecoxib	COX	PA451268	1351	0.97
NULL	Ann_Dermatol_2014_Feb_17_26(1)_137-138.nxml.txt.nlp	24648709	SENT21	2	2	19	19	ustekinumab	IL-23	PA166048654	51561	0.97
NULL	Int_J_Gen_Med_2009_Jul_30_2_129-140.nxml.txt.nlp	20360896	SENT163	29	29	45	45	tamoxifen	IMPACT	PA451581	55364	0.97
NULL	Clin_Pediatr_Endocrinol_2014_Apr_22_23(2)_27-34.nxml.txt.nlp	24790384	SENT45	3	3	14	14	hydrocortisone	ACTH	PA449905	5443	0.97
NULL	BMB_Rep_2014_May_47(5)_274-279.nxml.txt.nlp	24286313	SENT62	27	27	4	4	bortezomib	p65	PA10252	5970	0.97
NULL	Br_J_Pharmacol_2012_Apr_165(7)_2191-2202.nxml.txt.nlp	21958009	SENT16	23	23	1	1	phenylephrine	5-HT2A	PA450935	3356	0.97
NULL	Oncol_Lett_2013_Jul_14_6(1)_69-74.nxml.txt.nlp	23946779	SENT20	0	0	12	12	axitinib	VEGFR	PA164924493	3791	0.97
NULL	Oncotarget_2014_Feb_7_5(3)_775-787.nxml.txt.nlp	24519956	SENT110	22	22	0	0	docetaxel	PC3	PA449383	57332;7832;5122	0.97
NULL	Oncogene_2014_Jul_24_33(30)_3959-3969.nxml.txt.nlp	24096481	SENT25	29	29	10	10	nutlin-3	MDM2		4193	0.97
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT272	10	10	4	4	chloroquine	BMPR-II	PA448948	659	0.97
NULL	Oncogene_2014_Jul_24_33(30)_3927-3938.nxml.txt.nlp	23995784	SENT269	7	7	17	17	doxycycline	FOXO1	PA449415	2308	0.97
NULL	Cancer_Manag_Res_2014_May_23_6_225-252.nxml.txt.nlp	24904222	SENT333	27	27	30	30	tamoxifen	aromatase	PA451581	1588	0.97
NULL	Oncotarget_2014_Jun_30_5(14)_5637-5650.nxml.txt.nlp	25026298	SENT244	11	11	2	2	tamoxifen	HDAC3	PA451581	8841	0.97
NULL	Biosci_Rep_2013_Aug_14_33(4)_e00057.nxml.txt.nlp	23837802	SENT120	13	13	25	25	cisplatin	IL6	PA449014	3569	0.97
NULL	Cell_Death_Dis_2014_Feb_27_5(2)_e1088.nxml.txt.nlp	24577086	SENT119	19	19	4	4	metformin	Bcl-2	PA450395	596	0.97
NULL	J_Clin_Biochem_Nutr_2009_Jan_27_44(1)_79-84.nxml.txt.nlp	19177192	SENT89	2	2	17	17	curcumin	HO-1	PA151958596	3162	0.97
NULL	J_Cell_Mol_Med_2014_Oct_11_18(10)_2031-2043.nxml.txt.nlp	25109475	SENT232	31	31	16	16	valsartan	TLR-4	PA451848	7099	0.97
NULL	Int_Clin_Psychopharmacol_2014_Nov_3_29(6)_351-356.nxml.txt.nlp	24978955	SENT35	0	0	7	7	vilazodone	5-HT1A	PA165958365	3350	0.97
NULL	Indian_J_Med_Res_2014_Aug_140(2)_209-215.nxml.txt.nlp	25297352	SENT127	17	17	5	5	phenytoin	CLB	PA450947	171425	0.97
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S349-S354.nxml.txt.nlp	21525481	SENT119	15	15	3	3	liraglutide	GLP-1	PA165958364	100125288	0.97
NULL	Indian_J_Anaesth_2014_Sep-Oct_58(5)_565-572.nxml.txt.nlp	25535418	SENT125	32	32	7	7	aprotinin	ACT	PA448472	12;11332;9457;641455	0.97
NULL	J_Cell_Biol_2005_Jul_4_170(1)_37-47.nxml.txt.nlp	15998798	SENT248	8	8	2	2	doxycycline	CRT	PA449415	811	0.97
NULL	Indian_J_Med_Res_2011_May_133(5)_529-534.nxml.txt.nlp	21623039	SENT29	30	30	0	0	ofloxacin	DST	PA450684	667	0.97
NULL	Cell_Cycle_2012_Dec_1_11(23)_4300.nxml.txt.nlp	23159861	SENT10	33	33	19	19	imatinib	CML	PA10804	613	0.97
NULL	Oncol_Lett_2013_Dec_18_6(6)_1539-1542.nxml.txt.nlp	24260043	SENT84	0	0	9	9	doxorubicin	NDRG1	PA449412	10397	0.97
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT241	6	6	24	24	perifosine	JNK	PA165291471	5599	0.97
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT122	37	37	8	8	capsaicin	p53	PA448776	7157	0.97
NULL	Adolesc_Health_Med_Ther_2014_Mar_26_5_35-48.nxml.txt.nlp	24729739	SENT36	18	18	7	7	methotrexate	TNF-alpha	PA450428	7124	0.97
NULL	Acta_Pharmacol_Sin_2009_Sep_24_30(9)_1323-1329.nxml.txt.nlp	19701237	SENT44	6	6	23	23	clarithromycin	CYP3A	PA449028	1574	0.97
NULL	J_Cell_Biol_1993_May_2_121(4)_775-783.nxml.txt.nlp	8491771	SENT3	27	27	7	7	trypsin	gamma	PA451806	9913	0.97
NULL	Oncol_Lett_2013_Mar_28_5(3)_935-942.nxml.txt.nlp	23426424	SENT13	29	29	6	6	cisplatin	ERCC1	PA449014	2067	0.97
NULL	Mol_Cancer_2013_Oct_24_12_128.nxml.txt.nlp	24156782	SENT226	4	4	18	18	cetuximab	EGFR	PA10040	1956	0.97
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1123-1128.nxml.txt.nlp	20354531	SENT119	14	14	1	1	mitomycin	ACT	PA450524	12;11332;9457;641455	0.97
NULL	Acta_Naturae_2012_Jan-Mar_4(1)_82-85.nxml.txt.nlp	22708067	SENT38	4	4	20	20	gefitinib	EGFR	PA131301952	1956	0.97
NULL	Aging_(Albany_NY)_2012_Dec_6_4(11)_823-842.nxml.txt.nlp	23235539	SENT334	17	17	9	9	bleomycin	HCA2	PA448645	139081;55811;338442	0.97
NULL	J_Hematol_Oncol_2013_Jan_4_6_1.nxml.txt.nlp	23286345	SENT21	13	13	4	4	trastuzumab	HER2	PA451743	2064	0.97
NULL	Clin_Dev_Immunol_2011_Mar_22_2011_790460.nxml.txt.nlp	21603161	SENT421	24	24	7	7	thalidomide	OED	PA451644	4961	0.97
NULL	Br_J_Cancer_2013_Sep_3_109(5)_1214-1222.nxml.txt.nlp	23922104	SENT130	21	21	9	9	dasatinib	MDM2	PA162372878	4193	0.97
NULL	Breast_Cancer_Res_2009_Sep_21_11(5)_R71.nxml.txt.nlp	19772563	SENT59	11	11	14	14	tamoxifen	aromatase	PA451581	1588	0.97
NULL	Behav_Brain_Funct_2012_Feb_28_8_11.nxml.txt.nlp	22369141	SENT37	15	15	6	6	olanzapine	GHRL	PA450688	51738	0.97
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_297-299.nxml.txt.nlp	20049732	SENT51	0	0	30	30	methotrexate	MSH2	PA450428	4436	0.97
NULL	South_Asian_J_Cancer_2014_Jul-Sep_3(3)_182-184.nxml.txt.nlp	25136528	SENT82	16	16	9	9	ritonavir	CYP3A4	PA451260	1576	0.97
NULL	Int_J_Environ_Res_Public_Health_2011_Jul_30_8(7)_2747-2757.nxml.txt.nlp	21845156	SENT37	31	31	4	4	trypsin	PRSS1	PA451806	5644	0.97
NULL	Mol_Cancer_2014_Jan_13_13_7.nxml.txt.nlp	24418169	SENT211	13	13	7	7	sorafenib	STAT3	PA7000	6774	0.97
NULL	J_Geriatr_Cardiol_2014_Sep_11(3)_200-205.nxml.txt.nlp	25278967	SENT143	29	29	1	1	clopidogrel	ADP	PA449053	23038	0.97
NULL	Front_Behav_Neurosci_2014_Dec_16_8_437.nxml.txt.nlp	25566005	SENT17	18	18	8	8	nicotine	TRPM8	PA450626	79054	0.97
NULL	Clin_Med_Insights_Cardiol_2012_Feb_1_6_17-33.nxml.txt.nlp	22442638	SENT66	14	14	0	0	rosuvastatin	CYP2C9	PA134308647	1559	0.97
NULL	Oncotarget_2014_Feb_25_5(5)_1304-1314.nxml.txt.nlp	24675421	SENT130	19	19	30	30	cisplatin	MKK4	PA449014	6416	0.97
NULL	Cancers_(Basel)_2013_Jul_4_5(3)_838-856.nxml.txt.nlp	24202322	SENT149	0	0	10	10	nutlin-3	p53		7157	0.97
NULL	Diabetes_2013_Jun_17_62(6)_1843-1854.nxml.txt.nlp	23349486	SENT237	7	7	37	37	pioglitazone	IL-6	PA450970	3569	0.97
NULL	Cell_Commun_Signal_2013_Nov_11_11_86.nxml.txt.nlp	24215724	SENT18	5	5	32	32	thrombin	PAR1	PA451674	79581;2149	0.97
NULL	Chem_Rev_2012_May_9_112(5)_2593-2603.nxml.txt.nlp	22335786	SENT52	13	13	0	0	choline	ATX	PA448976	5168;23049	0.97
NULL	Oncotarget_2014_Jun_8_5(13)_5040-5053.nxml.txt.nlp	24970815	SENT113	26	26	4	4	cisplatin	LOX	PA449014	4015	0.97
NULL	Oncogene_2014_Feb_6_33(6)_713-723.nxml.txt.nlp	23435429	SENT82	28	28	0	0	etoposide	BRCA1	PA449552	672	0.97
NULL	J_Neuroinflammation_2011_Feb_4_8_10.nxml.txt.nlp	21294877	SENT169	5	5	18	18	capsaicin	NK1	PA448776	11126	0.97
NULL	Korean_Circ_J_2013_May_31_43(5)_287-292.nxml.txt.nlp	23755073	SENT81	28	28	1	1	rivaroxaban	VKORC1	PA165958360	79001	0.97
NULL	Oxid_Med_Cell_Longev_2012_May_30_2012_452902.nxml.txt.nlp	22701146	SENT182	24	24	3	3	verapamil	OCTN2	PA451868	6584	0.97
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT229	7	7	23	23	erlotinib	PI3K	PA134687924	5290	0.97
NULL	Br_J_Pharmacol_2014_Feb_24_171(1)_1019-1032.nxml.txt.nlp	24251620	SENT177	19	19	6	6	nitrendipine	TRPA1	PA146096020	8989	0.97
NULL	Int_J_Surg_Oncol_2012_May_17_2012_406830.nxml.txt.nlp	22675625	SENT33	0	0	18	18	bevacizumab	VEGF-A	PA130232992	7422	0.97
NULL	Oxid_Med_Cell_Longev_2013_May_14_2013_957947.nxml.txt.nlp	23766864	SENT159	20	20	13	13	napqi	CYP2E1		1571	0.97
NULL	Support_Care_Cancer_2011_Mar_16_19(3)_353-361.nxml.txt.nlp	20157746	SENT39	21	21	1	1	cytarabine	CTX	PA449177	1593	0.97
NULL	Cell_Cycle_2012_Nov_1_11(21)_3917-3918.nxml.txt.nlp	23032263	SENT13	15	15	45	45	hydroxyurea	CDK1	PA449942	983	0.97
NULL	Cells_2014_Apr_4_3(2)_199-235.nxml.txt.nlp	24709958	SENT336	18	18	12	12	gefitinib	PTEN	PA131301952	5728	0.97
NULL	Pharmaceuticals_(Basel)_2011_Nov_10_4(11)_1488-1502.nxml.txt.nlp	NULL	SENT290	13	13	0	0	tanespimycin	Hsp90	PA165291490	3320	0.97
NULL	Br_J_Haematol_2014_Mar_6_164(6)_759-766.nxml.txt.nlp	24387053	SENT123	22	22	0	0	rituximab	ADAMTS13	PA451261	11093	0.97
NULL	Hum_Reprod_2012_Jun_3_27(6)_1829-1839.nxml.txt.nlp	22473395	SENT35	5	5	11	11	estradiol	AMH	PA449503	268	0.97
NULL	Indian_J_Med_Res_2010_Dec_132(6)_676-682.nxml.txt.nlp	21245614	SENT94	32	32	2	2	zinc	p53	PA451956	7157	0.97
NULL	Clin_Sci_(Lond)_2011_Nov_1_121(Pt_10)_449-458.nxml.txt.nlp	21671887	SENT195	7	7	34	34	simvastatin	AMPK	PA451363	5563	0.97
NULL	Korean_Circ_J_2013_Aug_31_43(8)_541-549.nxml.txt.nlp	24044013	SENT60	19	19	6	6	ticagrelor	CYP2C19	PA165374673	1557	0.97
NULL	Arthritis_Res_Ther_2011_Sep_21_13(5)_239.nxml.txt.nlp	21955617	SENT96	0	0	9	9	celecoxib	JNK	PA448871	5599	0.97
NULL	Acta_Neuropathol_Commun_2014_May_30_2_57.nxml.txt.nlp	24887326	SENT77	26	26	24	24	verapamil	ABCB1	PA451868	5243	0.97
NULL	Mol_Cancer_2007_Jan_19_6_9.nxml.txt.nlp	17233922	SENT114	29	29	8	8	cisplatin	CROP	PA449014	51747	0.97
NULL	J_Oncol_2011_Dec_15_2011_852970.nxml.txt.nlp	21209724	SENT224	0	0	19	19	nutlin-3	p53		7157	0.97
NULL	Child_Adolesc_Psychiatry_Ment_Health_2013_Aug_15_7_31.nxml.txt.nlp	23947389	SENT353	28	28	16	16	iloperidone	IMPACT	PA161199368	55364	0.97
NULL	Hum_Mol_Genet_2012_Feb_1_21(3)_511-525.nxml.txt.nlp	22012985	SENT140	23	23	16	16	dantrolene	LRRK2	PA449208	120892	0.97
NULL	EJC_Suppl_2013_Sep_5_11(2)_254-256.nxml.txt.nlp	NULL	SENT29	0	0	10	10	denosumab	RANKL	PA166048634	8600	0.97
NULL	Pharmaceuticals_(Basel)_2011_Oct_25_4(11)_1400-1422.nxml.txt.nlp	NULL	SENT212	21	21	17	17	imatinib	Hsp90	PA10804	3320	0.97
NULL	Pain_2014_Nov_155(11)_2243-2252.nxml.txt.nlp	24978826	SENT175	33	33	2	2	propofol	IL10	PA451141	3586	0.97
NULL	Breast_Cancer_Res_2014_Dec_6_16(6)_491.nxml.txt.nlp	25479686	SENT221	28	28	5	5	bortezomib	GATA3	PA10252	2625	0.97
NULL	Clin_Pharmacokinet_2014_Sep_3_53(1)_1-16.nxml.txt.nlp	23999929	SENT87	0	0	12	12	rivaroxaban	CYP2J2	PA165958360	1573	0.97
NULL	Exp_Ther_Med_2014_Jun_28_7(6)_1653-1658.nxml.txt.nlp	24926361	SENT33	9	9	33	33	curcumin	CO2	PA151958596	4513	0.97
NULL	Pharmaceuticals_(Basel)_2012_Nov_20_5(11)_1236-1264.nxml.txt.nlp	24281308	SENT196	16	16	14	14	gefitinib	EGFR	PA131301952	1956	0.97
NULL	Breast_Cancer_Res_2010_Jun_28_12(3)_R43.nxml.txt.nlp	20579400	SENT95	11	11	0	0	docetaxel	MTS	PA449383	1678	0.97
NULL	EJC_Suppl_2013_Sep_5_11(2)_92-96.nxml.txt.nlp	NULL	SENT8	3	3	1	1	vemurafenib	BRAF	PA165946873	673	0.97
NULL	J_Gen_Physiol_1993_Mar_1_101(3)_337-353.nxml.txt.nlp	8386216	SENT7	29	29	16	16	forskolin	gamma	PA146096022	9913	0.97
NULL	Aging_(Albany_NY)_2010_Sep_18_2(9)_535-537.nxml.txt.nlp	20876940	SENT31	6	6	18	18	doxorubicin	CDKN1A	PA449412	1026	0.97
NULL	Respir_Med_Case_Rep_2013_Jul_17_10_10-12.nxml.txt.nlp	NULL	SENT19	26	26	8	8	erlotinib	EGFR	PA134687924	1956	0.97
NULL	Nucleic_Acids_Res_2010_Oct_21_38(18)_6148-6158.nxml.txt.nlp	20494979	SENT264	19	19	4	4	staurosporine	HLJ1	PA165109623	11080	0.97
NULL	Ann_Hematol_2014_Sep_10_93(1)_1-11.nxml.txt.nlp	24018623	SENT131	22	22	7	7	lenalidomide	CDC25C	PA162363968	995	0.97
NULL	Mol_Cancer_2008_Jan_25_7_14.nxml.txt.nlp	18221502	SENT233	28	28	2	2	thioguanine	PSAT1	PA451663	29968	0.97
NULL	Cardiol_Res_Pract_2013_Feb_19_2013_195456.nxml.txt.nlp	23533940	SENT132	0	0	7	7	ticagrelor	CYP3A4	PA165374673	1576	0.97
NULL	Semin_Immunol_2011_Feb_23(1)_28-41.nxml.txt.nlp	21295490	SENT238	26	26	10	10	infliximab	DDC	PA452639	1644	0.969
NULL	J_Biomed_Sci_2013_Jul_2_20(1)_46.nxml.txt.nlp	23815815	SENT98	11	11	19	19	phenylephrine	EPAC	PA450935	10411	0.969
NULL	J_Cancer_2013_Sep_27_4(8)_662-670.nxml.txt.nlp	24155778	SENT144	22	22	13	13	cisplatin	UCHL1	PA449014	7345	0.969
NULL	Breast_Cancer_Res_2007_Aug_8_9(4)_R50.nxml.txt.nlp	17686159	SENT248	16	16	36	36	gefitinib	AKT	PA131301952	207	0.969
NULL	Drugs_Context_2012_Nov_19_2012_212242.nxml.txt.nlp	24432031	SENT173	0	0	20	20	sorafenib	VEGFR	PA7000	3791	0.969
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1651-1657.nxml.txt.nlp	19904273	SENT157	6	6	13	13	olaparib	BRCA1		672	0.969
NULL	Acta_Pharmacol_Sin_2011_May_25_32(5)_655-663.nxml.txt.nlp	21516133	SENT198	7	7	12	12	genistein	CYP1A2	PA165109660	1544	0.969
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_P42.nxml.txt.nlp	NULL	SENT17	17	17	3	3	amoxicillin	IFN	PA448406	3439	0.969
NULL	Nat_Med_2012_May_18(5)_783-790.nxml.txt.nlp	22466704	SENT80	14	14	3	3	etoposide	HDAC4	PA449552	9759	0.969
NULL	Breast_Cancer_Res_2011_Apr_26_13(2)_R47.nxml.txt.nlp	21521526	SENT179	14	14	4	4	topotecan	HIF-1	PA451729	29072	0.969
NULL	Crit_Care_2006_Jul_19_10(4)_R106.nxml.txt.nlp	16859510	SENT104	35	35	1	1	methylprednisolone	OLB	PA450466	26681	0.969
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1224-1233.nxml.txt.nlp	22353810	SENT165	10	10	29	29	doxorubicin	MRP-1	PA449412	928	0.969
NULL	Br_J_Pharmacol_2008_Sep_9_155(1)_127-137.nxml.txt.nlp	18536750	SENT190	13	13	0	0	piroxicam	IL-6	PA450985	3569	0.969
NULL	Cell_Death_Differ_2010_Apr_16_17(4)_666-676.nxml.txt.nlp	19834494	SENT311	27	27	18	18	oxaliplatin	RAGE	PA131285527	177	0.969
NULL	Front_Neurosci_2012_Feb_8_6_10.nxml.txt.nlp	22347156	SENT297	17	17	7	7	allopregnanolone	PMP22	PA142320763	5376;5827	0.969
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1059-1066.nxml.txt.nlp	21364577	SENT4	1	1	7	7	exemestane	aromatase	PA449563	1588	0.969
NULL	Mol_Cancer_2006_Oct_17_5_45.nxml.txt.nlp	17044934	SENT91	2	2	37	37	indomethacin	COX	PA449982	1351	0.969
NULL	Diabetes_Care_2009_Aug_9_32(8)_1485-1490.nxml.txt.nlp	19509012	SENT84	7	7	22	22	valsartan	ANOVA	PA451848	4858	0.969
NULL	J_Thromb_Haemost_2007_May_1_5(5)_910-917.nxml.txt.nlp	17362227	SENT107	9	9	2	2	thrombin	P2X1	PA451674	5023	0.969
NULL	Breast_Cancer_Res_2012_Feb_9_14(1)_R27.nxml.txt.nlp	22321971	SENT37	21	21	23	23	tamoxifen	aromatase	PA451581	1588	0.969
NULL	Exp_Ther_Med_2012_Oct_16_4(4)_705-710.nxml.txt.nlp	23170130	SENT55	25	25	31	31	verapamil	P-gp	PA451868	5243	0.969
NULL	Cell_Cycle_2013_Sep_15_12(18)_3013-3024.nxml.txt.nlp	23974104	SENT134	5	5	18	18	disulfiram	CD44	PA449376	960	0.969
NULL	Front_Oncol_2013_Sep_17_3_240.nxml.txt.nlp	24062990	SENT186	0	0	15	15	everolimus	PTEN	PA164746311	5728	0.969
NULL	Indian_J_Dermatol_2013_Jan-Feb_58(1)_61-64.nxml.txt.nlp	23372216	SENT99	4	4	10	10	paroxetine	CYP1A2	PA450801	1544	0.969
NULL	Cancers_(Basel)_2012_Jun_5_4(2)_549-565.nxml.txt.nlp	24213324	SENT16	13	13	1	1	sorafenib	SHARP	PA7000	23013	0.969
NULL	Chem_Rev_2014_Jun_11_114(11)_5753-5774.nxml.txt.nlp	24758331	SENT212	31	31	2	2	verapamil	P-gp	PA451868	5243	0.969
NULL	Hum_Genomics_2008_Sep_1_3(1)_7-16.nxml.txt.nlp	19129086	SENT182	40	40	18	18	rosiglitazone	CYP2C8	PA451283	1558	0.969
NULL	Genome_Biol_2008_May_9_9(5)_221.nxml.txt.nlp	18492217	SENT47	16	16	32	32	cisplatin	p53	PA449014	7157	0.969
NULL	Gut_Liver_2013_Sep_14_7(5)_585-593.nxml.txt.nlp	24073317	SENT165	7	7	18	18	ribavirin	IFN	PA451241	3439	0.969
NULL	Int_J_Biomed_Sci_2007_Dec_3(4)_251-257.nxml.txt.nlp	23675050	SENT158	16	16	2	2	cabergoline	PRL	PA448708	5617	0.969
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_13_2014_849783.nxml.txt.nlp	25477998	SENT123	5	5	12	12	isoproterenol	IL-6	PA450121	3569	0.969
NULL	Br_J_Cancer_2012_Nov_20_107(11)_1853-1863.nxml.txt.nlp	23169338	SENT207	26	26	7	7	cisplatin	TP53	PA449014	7157	0.969
NULL	Mol_Cancer_2012_Jul_25_11_46.nxml.txt.nlp	22830422	SENT133	7	7	20	20	rolipram	AKT	PA153906323	207	0.969
NULL	Endocrinol_Metab_(Seoul)_2013_Dec_12_28(4)_275-279.nxml.txt.nlp	24396691	SENT52	3	3	9	9	methimazole	ATD	PA450422	465	0.969
NULL	J_Clin_Neonatol_2012_Oct-Dec_1(4)_178-179.nxml.txt.nlp	24027723	SENT42	5	5	11	11	nystatin	NNT	PA450666	23530	0.969
NULL	J_Indian_Assoc_Pediatr_Surg_2012_Jul-Sep_17(3)_99-103.nxml.txt.nlp	22869973	SENT89	13	13	9	9	diazoxide	PHHI	PA449285	6833	0.969
NULL	Oncotarget_2014_Nov_11_5(22)_10963-10964.nxml.txt.nlp	25460503	SENT15	29	29	15	15	trastuzumab	ADAM17	PA451743	6868	0.969
NULL	J_Antimicrob_Chemother_2013_Jan_30_68(1)_17-22.nxml.txt.nlp	22941900	SENT59	5	5	16	16	oxytetracycline	BSAC	PA450757	57591	0.969
NULL	Oncotarget_2012_Oct_20_3(10)_1068-1111.nxml.txt.nlp	23085539	SENT128	0	0	9	9	vemurafenib	BRAF	PA165946873	673	0.969
NULL	Adv_Hematol_2012_Feb_16_2012_535709.nxml.txt.nlp	22400031	SENT81	1	1	11	11	imatinib	JAK2	PA10804	3717	0.969
NULL	Int_J_Mol_Sci_2014_Mar_7_15(3)_4126-4141.nxml.txt.nlp	24608925	SENT100	23	23	5	5	ethanol	CYP2E1	PA448073	1571	0.969
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_75-89.nxml.txt.nlp	17912638	SENT217	26	26	7	7	tamoxifen	ATAC	PA451581	6375	0.969
NULL	Breast_Cancer_Res_2007_Oct_26_9(5)_112.nxml.txt.nlp	17980056	SENT79	8	8	25	25	anastrozole	HER2	PA448432	2064	0.969
NULL	Curr_Neuropharmacol_2014_Jul_12(4)_308-323.nxml.txt.nlp	25342939	SENT292	12	12	27	27	bumetanide	NKCC1	PA448682	6558	0.969
NULL	Ther_Clin_Risk_Manag_2007_Dec_3(6)_975-981.nxml.txt.nlp	18516312	SENT23	8	8	0	0	sildenafil	Men	PA451346	8178	0.969
NULL	Int_J_Biomed_Sci_2014_Sep_10(3)_146-157.nxml.txt.nlp	25324695	SENT157	30	30	20	20	bleomycin	CD44	PA448645	960	0.969
NULL	Eur_J_Cancer_2014_Sep_50(14)_2367-2374.nxml.txt.nlp	25027307	SENT136	6	6	27	27	tamoxifen	aromatase	PA451581	1588	0.969
NULL	Arch_Drug_Inf_2011_Mar_4(1)_1-9.nxml.txt.nlp	21572514	SENT47	3	3	12	12	ciprofloxacin	MRP2	PA449009	100130958;57626;1244	0.969
NULL	Oncogene_2010_Nov_18_29(46)_6115-6124.nxml.txt.nlp	20729912	SENT105	0	0	13	13	doxorubicin	ABCG1	PA449412	9619	0.969
NULL	J_Oncol_2013_Feb_17_2013_872957.nxml.txt.nlp	23476648	SENT210	16	16	6	6	cisplatin	p27	PA449014	5715;10534	0.969
NULL	Clin_Psychopharmacol_Neurosci_2011_Dec_31_9(3)_134-136.nxml.txt.nlp	23429759	SENT51	0	0	9	9	aripiprazole	5-HT1A	PA10026	3350	0.969
NULL	Cardiovasc_Diabetol_2011_Dec_1_10_109.nxml.txt.nlp	22132774	SENT157	20	20	4	4	liraglutide	GLP-1	PA165958364	100125288	0.969
NULL	Int_J_Breast_Cancer_2011_Feb_24_2011_967419.nxml.txt.nlp	22332018	SENT237	7	7	11	11	tamoxifen	MRP1	PA451581	4437	0.969
NULL	Pharmaceuticals_(Basel)_2011_Nov_10_4(11)_1488-1502.nxml.txt.nlp	NULL	SENT277	6	6	18	18	tanespimycin	HER-2	PA165291490	2064	0.969
NULL	CNS_Spectr_2014_Apr_1_19(2)_121-133.nxml.txt.nlp	23903233	SENT123	34	34	7	7	scopolamine	5-HT1B	PA451308	3351	0.969
NULL	Acta_Naturae_2013_Apr-Jun_5(2)_19-39.nxml.txt.nlp	23819034	SENT205	8	8	4	4	thrombin	FVIII	PA451674	2157	0.969
NULL	Front_Immunol_2013_Oct_31_4_351.nxml.txt.nlp	24198817	SENT401	32	32	21	21	canakinumab	PSTPIP1	PA165958358	9051	0.969
NULL	Oncotarget_2012_Sep_28_3(10)_1169-1181.nxml.txt.nlp	23045411	SENT91	9	9	20	20	doxorubicin	JIP1	PA449412	9479	0.969
NULL	Oncoscience_2014_Oct_22_1(10)_614-623.nxml.txt.nlp	25593991	SENT97	14	14	10	10	erlotinib	EGFR	PA134687924	1956	0.969
NULL	Br_J_Cancer_2012_Apr_10_106(8)_1367-1373.nxml.txt.nlp	22454081	SENT143	43	43	34	34	trastuzumab	PIK3CA	PA451743	5290	0.969
NULL	Mol_Biol_Cell_2014_Jan_15_25(2)_290-301.nxml.txt.nlp	24258026	SENT29	3	3	10	10	lipase	ATGL	PA450239	57104	0.969
NULL	Int_J_Surg_Oncol_2012_Jun_12_2012_862879.nxml.txt.nlp	22778941	SENT146	4	4	14	14	cisplatin	BIN1	PA449014	274	0.969
NULL	Mol_Vis_2007_Feb_2_13_164-173.nxml.txt.nlp	17293780	SENT252	26	26	2	2	collagenase	CRISP3	PA449107	10321	0.969
NULL	Springerplus_2014_Sep_17_3_535.nxml.txt.nlp	25279326	SENT156	20	20	27	27	tamoxifen	aromatase	PA451581	1588	0.969
NULL	J_Biol_Chem_2008_May_30_283(22)_15122-15126.nxml.txt.nlp	18381285	SENT121	0	0	5	5	capsaicin	TRPV1	PA448776	7442	0.969
NULL	Cell_Death_Dis_2010_Feb_4_1(2)_e23.nxml.txt.nlp	21364631	SENT29	35	35	44	44	curcumin	AP-1	PA151958596	2353;3727;2354;3725	0.969
NULL	Hum_Genomics_2009_Dec_1_4(2)_91-106.nxml.txt.nlp	20038497	SENT120	46	46	20	20	donepezil	CHRNA7	PA449394	1139	0.969
NULL	Curr_Pain_Headache_Rep_2011_Aug_12_15(4)_271-279.nxml.txt.nlp	21479998	SENT149	0	0	22	22	oxycodone	CYP2D6	PA450741	1565	0.969
NULL	Oncotarget_2012_Aug_9_3(8)_774-782.nxml.txt.nlp	22885298	SENT69	3	3	40	40	tetracycline	IDH1	PA451640	3417	0.969
NULL	Cancers_(Basel)_2014_Sep_5_6(3)_1769-1792.nxml.txt.nlp	25198391	SENT52	16	16	3	3	irinotecan	UGT1A1	PA450085	54658	0.969
NULL	F1000Res_2014_Jul_1_3_149.nxml.txt.nlp	25352980	SENT114	4	4	24	24	galactose	GAL4	PA449725	3960	0.969
NULL	Scientifica_(Cairo)_2013_Feb_7_2013_249101.nxml.txt.nlp	24278770	SENT274	3	3	17	17	daclizumab	CD56	PA164764446	4684	0.969
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT126	19	19	11	11	adalimumab	CD36	PA10004	948	0.969
NULL	Subst_Abuse_Rehabil_2013_Nov_6_4_75-82.nxml.txt.nlp	24648790	SENT28	0	0	5	5	dextromethorphan	CYP2D6	PA449273	1565	0.969
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT179	5	5	32	32	adalimumab	CD36	PA10004	948	0.969
NULL	Diabetes_2009_Dec_31_58(12)_2851-2862.nxml.txt.nlp	19720788	SENT277	4	4	9	9	forskolin	XBP1	PA146096022	7494	0.969
NULL	Nat_Commun_2014_Apr_1_5_3550.nxml.txt.nlp	24686499	SENT84	14	14	29	29	forskolin	DRP1	PA146096022	8562;10059;7402	0.969
NULL	Braz_J_Microbiol_2008_Jun_1_Apr-Jun_39(2)_219-225.nxml.txt.nlp	24031205	SENT65	9	9	21	21	fluconazole	CDR1	PA449653	1038	0.969
NULL	Anesthesiol_Res_Pract_2013_Sep_23_2013_297141.nxml.txt.nlp	24174934	SENT350	30	30	24	24	capsaicin	TRPV1	PA448776	7442	0.969
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT477	29	29	18	18	iloperidone	PRL	PA161199368	5617	0.969
NULL	Br_J_Cancer_2010_Aug_24_103(5)_676-684.nxml.txt.nlp	20664585	SENT199	23	23	15	15	cisplatin	CD70	PA449014	970	0.969
NULL	Asian-Australas_J_Anim_Sci_2014_Dec_27(12)_1783-1793.nxml.txt.nlp	25358373	SENT239	30	30	9	9	capsaicin	CEBPA	PA448776	1050	0.969
NULL	Biosensors_(Basel)_2012_Sep_10_2(3)_318-340.nxml.txt.nlp	25585933	SENT302	37	37	22	22	bleomycin	p53	PA448645	7157	0.969
NULL	Cancer_Cell_Int_2012_Jun_6_12_22.nxml.txt.nlp	22672528	SENT168	16	16	4	4	fludarabine	DR4	PA449655	8797	0.969
NULL	J_Invest_Dermatol_2012_Sep_10_132(9)_2255-2262.nxml.txt.nlp	22572817	SENT83	12	12	31	31	forskolin	MC1R	PA146096022	4157	0.969
NULL	Biomed_Res_Int_2013_Jan_21_2013_581631.nxml.txt.nlp	23484133	SENT190	18	18	10	10	infliximab	IL23R	PA452639	149233	0.969
NULL	Exp_Ther_Med_2013_Oct_25_6(4)_1022-1028.nxml.txt.nlp	24137309	SENT93	34	34	10	10	acetone	p53	PA448025	7157	0.969
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_127043.nxml.txt.nlp	23227093	SENT151	7	7	12	12	nifedipine	CYP3A4	PA450631	1576	0.969
NULL	Mol_Cancer_2009_Dec_23_8_129.nxml.txt.nlp	20030852	SENT216	8	8	19	19	curcumin	ABCA1	PA151958596	19	0.969
NULL	Avicenna_J_Phytomed_2014_Jul-Aug_4(4)_276-286.nxml.txt.nlp	25068142	SENT107	36	36	8	8	lamotrigine	HEG	PA450164	57493	0.969
NULL	Curr_Biol_2012_Mar_6_22(5)_397-402.nxml.txt.nlp	22305751	SENT34	24	24	7	7	physostigmine	spatial	PA450957	219793	0.969
NULL	Oncologist_2010_Mar_3_15(3)_216-235.nxml.txt.nlp	20200040	SENT157	6	6	13	13	neratinib	HER-2	PA165291472	2064	0.969
NULL	Ther_Clin_Risk_Manag_2006_Mar_2(1)_77-86.nxml.txt.nlp	18360583	SENT113	10	10	28	28	raloxifene	PTH	PA451221	5741	0.969
NULL	Clin_Epigenetics_2011_Jun_27_2(2)_171-185.nxml.txt.nlp	21949547	SENT89	5	5	21	21	cisplatin	p38	PA449014	10598;1432;7965	0.969
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT180	25	25	2	2	curcumin	TRAIL	PA151958596	8743	0.969
NULL	Clin_Epidemiol_2014_Nov_20_6_423-432.nxml.txt.nlp	25429239	SENT78	31	31	21	21	crizotinib	EGFR	PA165946122	1956	0.969
NULL	J_Infect_Dis_2014_Aug_15_210(4)_656-666.nxml.txt.nlp	24634497	SENT163	12	12	3	3	zileuton	TLR2	PA451955	7097	0.969
NULL	Harm_Reduct_J_2010_Jul_19_7_17.nxml.txt.nlp	20642849	SENT42	16	16	0	0	buprenorphine	OST	PA448685	1650;23263	0.969
NULL	Indian_J_Nephrol_2008_Oct_18(4)_175-182.nxml.txt.nlp	20142933	SENT196	0	0	33	33	trypsin	TTR	PA451806	7276	0.969
NULL	Biomed_Res_Int_2014_Aug_7_2014_482396.nxml.txt.nlp	25177692	SENT215	10	10	14	14	marimastat	ADAM9	PA164748329	8754	0.969
NULL	Case_Rep_Pediatr_2013_May_16_2013_207907.nxml.txt.nlp	23762715	SENT64	0	0	10	10	clonidine	ACTH	PA449051	5443	0.969
NULL	Adipocyte_2013_Jan_1_2(1)_28-32.nxml.txt.nlp	23700549	SENT51	15	15	7	7	valsartan	IL-6	PA451848	3569	0.969
NULL	South_Asian_J_Cancer_2014_Jul-Sep_3(3)_182-184.nxml.txt.nlp	25136528	SENT82	12	12	0	0	ketoconazole	CYP3A4	PA450146	1576	0.969
NULL	Cell_Mol_Life_Sci_2011_Nov_2_68(21)_3573-3587.nxml.txt.nlp	21365278	SENT41	30	30	17	17	iloprost	EP4	PA164746843	5734	0.969
NULL	Oncogene_2014_Aug_21_33(34)_4316-4329.nxml.txt.nlp	24362530	SENT46	27	27	17	17	epirubicin	SUMO1	PA449476	7341	0.969
NULL	Oncol_Lett_2013_Mar_28_5(3)_935-942.nxml.txt.nlp	23426424	SENT118	33	33	2	2	cisplatin	ERCC1	PA449014	2067	0.969
NULL	ARYA_Atheroscler_2011_Summer_7(2)_78-86.nxml.txt.nlp	22577451	SENT89	24	24	15	15	choline	CRP	PA448976	1401;140913	0.969
NULL	Indian_J_Pharm_Sci_2013_Nov-Dec_75(6)_635-641.nxml.txt.nlp	24591737	SENT21	8	8	21	21	atorvastatin	CA1	PA448500	759	0.969
NULL	Acta_Pharmacol_Sin_2009_Nov_5_30(11)_1522-1528.nxml.txt.nlp	19890360	SENT78	18	18	7	7	fenoterol	TLR4	PA10079	7099	0.969
NULL	J_Med_Life_2011_Feb_15_4(1)_11-20.nxml.txt.nlp	21505570	SENT190	7	7	2	2	sulindac	COX	PA451565	1351	0.969
NULL	Pain_Res_Treat_2012_Apr_24_2012_265605.nxml.txt.nlp	22619712	SENT143	8	8	10	10	diclofenac	ASIC3	PA449293	9311	0.969
NULL	Exp_Diabetes_Res_2012_Mar_15_2012_146194.nxml.txt.nlp	22474415	SENT227	7	7	2	2	valsartan	GLP-1	PA451848	100125288	0.969
NULL	Oncol_Rep_2013_Oct_22_30(4)_1535-1541.nxml.txt.nlp	23877481	SENT149	19	19	31	31	plerixafor	COX2	PA165958410	4513;5743	0.969
NULL	Oncol_Lett_2013_Dec_4_6(6)_1665-1672.nxml.txt.nlp	24273604	SENT118	4	4	17	17	chloroquine	TLR9	PA448948	54106	0.969
NULL	Cancer_Cell_2013_Jul_8_24(1)_15-29.nxml.txt.nlp	23845441	SENT782	10	10	17	17	gefitinib	PI3K	PA131301952	5290	0.969
NULL	Cent_European_J_Urol_2013_Dec_19_66(4)_394-404.nxml.txt.nlp	24757527	SENT143	0	0	20	20	sunitinib	KIT	PA162372840	3815	0.969
NULL	Cell_Death_Dis_2014_Apr_24_5(4)_e1197.nxml.txt.nlp	24763054	SENT25	13	13	5	5	doxorubicin	ARC	PA449412	8996;23237	0.969
NULL	Adv_Hematol_2012_Jul_24_2012_513702.nxml.txt.nlp	22888354	SENT31	5	5	16	16	lenalidomide	CD28	PA162363968	1493;940	0.969
NULL	Front_Endocrinol_(Lausanne)_2014_Aug_4_5_131.nxml.txt.nlp	25136332	SENT151	30	30	10	10	naltrexone	MC4R	PA450588	4160	0.969
NULL	J_Int_Soc_Sports_Nutr_2015_Jan_21_12(1)_5.nxml.txt.nlp	NULL	SENT42	6	6	11	11	curcumin	IL-6	PA151958596	3569	0.969
NULL	Surg_Neurol_Int_2014_May_8_5_64.nxml.txt.nlp	24991467	SENT225	0	0	7	7	perifosine	AKT	PA165291471	207	0.969
NULL	J_Adv_Pract_Oncol_2013_Jul_1_Jul-Aug_4(4)_263-268.nxml.txt.nlp	25032007	SENT48	4	4	9	9	voriconazole	CYP3A4	PA10233	1576	0.969
NULL	Breast_Cancer_Res_2011_Jan_26_13(1)_R10.nxml.txt.nlp	21269472	SENT225	21	21	0	0	estradiol	PPARGC1B	PA449503	133522	0.969
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1717-1723.nxml.txt.nlp	19844230	SENT95	18	18	4	4	sunitinib	TAO2	PA162372840	9344	0.969
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT15	13	13	0	0	adalimumab	CD36	PA10004	948	0.969
NULL	Int_J_Gen_Med_2009_Jul_30_2_129-140.nxml.txt.nlp	20360896	SENT79	34	34	8	8	anastrozole	aromatase	PA448432	1588	0.969
NULL	Cardiol_Res_Pract_2013_Feb_19_2013_195456.nxml.txt.nlp	23533940	SENT114	28	28	20	20	clopidogrel	CYP2C19	PA449053	1557	0.969
NULL	Nat_Chem_Biol_2009_Apr_26_5(4)_236-243.nxml.txt.nlp	19172146	SENT321	20	20	18	18	indomethacin	COX	PA449982	1351	0.969
NULL	Environ_Health_Perspect_2005_Oct_14_113(10)_1330-1335.nxml.txt.nlp	16203242	SENT157	26	26	29	29	arsenite	MLC	PA452638	23209	0.969
NULL	J_Adv_Pract_Oncol_2012_Nov_1_Nov-Dec_3(6)_391-394.nxml.txt.nlp	25031970	SENT15	0	0	25	25	pertuzumab	HER2		2064	0.969
NULL	Virol_J_2010_Jun_8_7_120.nxml.txt.nlp	20529349	SENT93	17	17	0	0	paraformaldehyde	DEF	PA450790	27042	0.969
NULL	Int_J_Med_Sci_2015_Jan_5_12(2)_135-140.nxml.txt.nlp	25589889	SENT35	9	9	27	27	aripiprazole	NMS	PA10026	129521	0.969
NULL	Oncotarget_2013_Feb_27_4(2)_329-345.nxml.txt.nlp	23593654	SENT185	20	20	8	8	paclitaxel	RSK	PA450761	6195;6196;6197	0.969
NULL	Adv_Urol_2012_Feb_13_2012_364919.nxml.txt.nlp	22400017	SENT275	21	21	3	3	gemcitabine	ERCC1	PA449748	2067	0.969
NULL	Bonekey_Rep_2014_Feb_5_3_495.nxml.txt.nlp	24605212	SENT389	3	3	24	24	alfacalcidol	CYP27A1	PA164746469	1593	0.969
NULL	Sci_Rep_2015_Jan_6_5_7641.nxml.txt.nlp	25560734	SENT27	25	25	19	19	tamoxifen	14-3-3	PA451581	10971	0.969
NULL	Mol_Biol_Cell_2012_Oct_15_23(20)_3936-3947.nxml.txt.nlp	22933571	SENT113	38	38	18	18	galactose	GAL7	PA449725	3963;653499	0.969
NULL	Br_J_Cancer_2013_Feb_19_108(3)_557-563.nxml.txt.nlp	23361053	SENT29	10	10	6	6	tamoxifen	PAK1	PA451581	5585;5058	0.969
NULL	Endocrinol_Metab_(Seoul)_2014_Sep_25_29(3)_379-387.nxml.txt.nlp	25309798	SENT39	3	3	20	20	resveratrol	SIRT1		23411	0.969
NULL	Eur_J_Clin_Pharmacol_2012_Sep_15_68(9)_1267-1274.nxml.txt.nlp	22418828	SENT96	44	44	4	4	pantoprazole	CYP2C19	PA450774	1557	0.969
NULL	J_Headache_Pain_2013_Mar_12_14(1)_25.nxml.txt.nlp	23566208	SENT29	29	29	7	7	amitriptyline	LEP	PA448385	3952	0.969
NULL	J_Oncol_2013_Feb_28_2013_897025.nxml.txt.nlp	23533410	SENT268	5	5	9	9	temsirolimus	MVD	PA164746890	4597	0.969
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1137-1144.nxml.txt.nlp	20234366	SENT140	36	36	10	10	cetuximab	MKP-1	PA10040	1843	0.969
NULL	Cancers_(Basel)_2011_Aug_9_3(3)_3189-3205.nxml.txt.nlp	24212952	SENT125	7	7	31	31	hyaluronan	CD44	PA165958431	960	0.969
NULL	Br_J_Cancer_2012_Nov_6_107(10)_1714-1721.nxml.txt.nlp	23073173	SENT211	18	18	12	12	docetaxel	RUNX2	PA449383	860	0.969
NULL	Breast_Cancer_Res_2007_May_19_9(3)_R31.nxml.txt.nlp	17511881	SENT152	12	12	20	20	trastuzumab	HER2	PA451743	2064	0.969
NULL	Indian_J_Anaesth_2014_Sep-Oct_58(5)_565-572.nxml.txt.nlp	25535418	SENT121	8	8	1	1	heparin	ACT	PA449855	12;11332;9457;641455	0.969
NULL	Endocrinol_Metab_(Seoul)_2014_Sep_25_29(3)_211-216.nxml.txt.nlp	25309777	SENT84	2	2	15	15	pazopanib	RET	PA165291492	5979	0.969
NULL	Atherosclerosis_2011_Nov_219(1)_109-115.nxml.txt.nlp	21820657	SENT143	0	0	6	6	probucol	CETP	PA451107	1071	0.969
NULL	Indian_J_Med_Res_2014_Apr_139(4)_572-578.nxml.txt.nlp	24927344	SENT4	21	21	0	0	warfarin	CYP4F2	PA451906	8529	0.969
NULL	Acta_Pharmacol_Sin_2013_Oct_7_34(10)_1317-1324.nxml.txt.nlp	23933652	SENT176	7	7	23	23	rosiglitazone	p65	PA451283	5970	0.969
NULL	J_Thorac_Oncol_2014_Feb_23_9(2)_231-238.nxml.txt.nlp	24419421	SENT190	14	14	37	37	carboplatin	EGFR	PA448803	1956	0.969
NULL	Mol_Med_Rep_2015_Jan_16_11(1)_91-98.nxml.txt.nlp	25322694	SENT102	14	14	39	39	cisplatin	LC3	PA449014	84557	0.969
NULL	Oncotarget_2013_Nov_15_4(11)_1866-1867.nxml.txt.nlp	24272818	SENT3	8	8	22	22	trastuzumab	HER2	PA451743	2064	0.969
NULL	Diabetes_Care_2011_Sep_19_34(9)_2072-2077.nxml.txt.nlp	21788633	SENT145	13	13	22	22	vildagliptin	GLP-1	PA165958346	100125288	0.969
NULL	Ann_Gen_Psychiatry_2009_Jul_27_8_16.nxml.txt.nlp	19635147	SENT80	1	1	7	7	aripiprazole	CYP3A4	PA10026	1576	0.969
NULL	ScientificWorldJournal_2013_Jun_19_2013_174392.nxml.txt.nlp	23853530	SENT101	29	29	21	21	doxazosin	c-FLIP	PA449407	8837	0.969
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jan_9_66(Pt_2)_o301.nxml.txt.nlp	21579734	SENT59	14	14	20	20	letrozole	aromatase	PA450196	1588	0.969
NULL	Cancer_Manag_Res_2013_Nov_21_5_387-400.nxml.txt.nlp	24294007	SENT80	22	22	8	8	cetuximab	KRAS	PA10040	3845	0.969
NULL	Arthritis_Res_Ther_2011_Feb_10_13(1)_R26.nxml.txt.nlp	21329504	SENT175	19	19	23	23	minocycline	TNF	PA450519	7124	0.969
NULL	Front_Behav_Neurosci_2011_Sep_8_5_56.nxml.txt.nlp	21927600	SENT232	9	9	1	1	nicotine	DARPP-32	PA450626	84152	0.969
NULL	Mol_Cell_Biochem_2014_Jul_26_396(1-2)_221-228.nxml.txt.nlp	25063218	SENT160	8	8	31	31	resveratrol	AP-1		2353;3727;2354;3725	0.969
NULL	Biosci_Rep_2013_Nov_25_33(6)_e00081.nxml.txt.nlp	24070327	SENT61	16	16	8	8	imatinib	OCT1	PA10804	5451;6580	0.969
NULL	Exp_Hematol_2012_Feb_40(2)_97-106.nxml.txt.nlp	22085453	SENT141	6	6	14	14	sitagliptin	DPPIV	PA164748978	2191;1803	0.969
NULL	Indian_J_Pharmacol_2008_Oct_40(Suppl_2)_S97-S112.nxml.txt.nlp	21593984	SENT594	15	15	26	26	minocycline	COX	PA450519	1351	0.969
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT135	32	32	14	14	erlotinib	AMPK	PA134687924	5563	0.969
NULL	Case_Rep_Oncol_2012_Mar_16_5(1)_114-118.nxml.txt.nlp	22666198	SENT7	43	43	28	28	doxorubicin	CD56	PA449412	4684	0.969
NULL	Case_Rep_Psychiatry_2012_Aug_15_2012_592784.nxml.txt.nlp	22934219	SENT89	5	5	32	32	clozapine	IL-6	PA449061	3569	0.969
NULL	Br_J_Haematol_2014_Feb_16_164(4)_586-596.nxml.txt.nlp	24236640	SENT170	19	19	10	10	carboplatin	EPO	PA448803	7076;8288;2056	0.969
NULL	Chin_J_Cancer_2011_May_30(5)_293-302.nxml.txt.nlp	21527062	SENT67	0	0	36	36	pertuzumab	HER3		2065	0.969
NULL	Br_J_Cancer_2013_Mar_5_108(4)_983-992.nxml.txt.nlp	23361057	SENT149	0	0	20	20	cytarabine	POLB	PA449177	5423	0.969
NULL	Pharmaceuticals_(Basel)_2011_Jan_28_4(2)_366-381.nxml.txt.nlp	NULL	SENT188	7	7	14	14	naltrexone	ACTH	PA450588	5443	0.969
NULL	Br_J_Cancer_2009_Mar_10_100(5)_758-763.nxml.txt.nlp	19259094	SENT140	13	13	3	3	belinostat	MLH1		4292	0.969
NULL	Mol_Cancer_2013_Nov_20_12_144.nxml.txt.nlp	24257371	SENT211	33	33	4	4	cisplatin	PRL	PA449014	5617	0.969
NULL	Br_J_Cancer_2012_Feb_14_106(4)_719-726.nxml.txt.nlp	22240798	SENT175	19	19	10	10	trastuzumab	PI3K	PA451743	5290	0.969
NULL	Cell_Death_Dis_2012_Jun_7_3(6)_e319.nxml.txt.nlp	22673193	SENT81	17	17	26	26	cisplatin	p53	PA449014	7157	0.969
NULL	Nat_Genet_2011_Feb_26_43(2)_117-120.nxml.txt.nlp	21186350	SENT25	26	26	3	3	metformin	ATM	PA450395	472	0.969
NULL	Cell_Oncol_(Dordr)_2011_Oct_4_34(5)_489-494.nxml.txt.nlp	21541733	SENT3	36	36	11	11	tamoxifen	ESR1	PA451581	2099	0.969
NULL	Iran_J_Microbiol_2013_Sep_5(3)_263-267.nxml.txt.nlp	24475334	SENT50	17	17	9	9	ethanol	PIF	PA448073	117159	0.969
NULL	Int_J_Mol_Sci_2014_Jun_25_15(7)_11220-11233.nxml.txt.nlp	24968265	SENT75	10	10	26	26	temsirolimus	REST	PA164746890	5978	0.969
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT134	23	23	44	44	pp2	CD19		930	0.969
NULL	Oxid_Med_Cell_Longev_2011_Aug_17_2011_450317.nxml.txt.nlp	21904643	SENT131	3	3	34	34	l-leucine	DAN	PA450197	5073;4681	0.969
NULL	Mol_Cancer_2003_Jan_7_2_6.nxml.txt.nlp	12605713	SENT110	20	20	12	12	cisplatin	Bcl-2	PA449014	596	0.969
NULL	Oncotarget_2011_Dec_31_2(12)_1314-1321.nxml.txt.nlp	22248929	SENT58	17	17	7	7	lapatinib	HER2	PA152241907	2064	0.969
NULL	Scientifica_(Cairo)_2012_Nov_25_2012_473829.nxml.txt.nlp	24278698	SENT219	26	26	4	4	cisplatin	ATP7B	PA449014	540	0.969
NULL	Oncogene_2010_Jul_15_29(28)_4090-4100.nxml.txt.nlp	20473326	SENT158	11	11	18	18	nutlin-3	p53		7157	0.969
NULL	Cancer_Cell_Int_2013_Feb_12_13_14.nxml.txt.nlp	23402310	SENT113	4	4	10	10	celecoxib	p65	PA448871	5970	0.969
NULL	Osteoarthritis_Cartilage_2010_Apr_18(4)_555-562.nxml.txt.nlp	20060953	SENT414	22	22	3	3	clenbuterol	MNX	PA164745640	3892	0.969
NULL	Ann_Oncol_2011_Mar_8_22(3)_503-514.nxml.txt.nlp	20616198	SENT118	16	16	9	9	letrozole	aromatase	PA450196	1588	0.969
NULL	J_Gen_Physiol_2010_Apr_135(4)_333-353.nxml.txt.nlp	20231374	SENT362	15	15	32	32	pp2	P2X4		5025	0.969
NULL	Crit_Care_2012_Jul_26_16(4)_228.nxml.txt.nlp	22839302	SENT53	4	4	16	16	ticlopidine	P2Y12	PA451686	64805	0.969
NULL	Indian_J_Pharmacol_2009_Aug_41(4)_167-172.nxml.txt.nlp	20523867	SENT133	25	25	18	18	acetaminophen	BCRP	PA448015	9429	0.969
NULL	Comb_Chem_High_Throughput_Screen_2010_Feb_13(2)_188-206.nxml.txt.nlp	20053163	SENT247	27	27	9	9	phenytoin	CYP2C9	PA450947	1559	0.969
NULL	Int_Arch_Med_2010_Nov_11_3_31.nxml.txt.nlp	21070670	SENT32	30	30	22	22	cyclophosphamide	ACR	PA449165	49	0.969
NULL	Cancer_Cell_Int_2010_Apr_29_10_12.nxml.txt.nlp	20429927	SENT191	12	12	5	5	arsenite	Hsp90	PA452638	3320	0.969
NULL	J_Biol_Eng_2010_Nov_29_4_15.nxml.txt.nlp	21114841	SENT101	0	0	11	11	doxorubicin	P105	PA449412	57410	0.969
NULL	Int_J_Surg_Oncol_2012_May_17_2012_406830.nxml.txt.nlp	22675625	SENT177	11	11	34	34	erlotinib	LARC	PA134687924	6364	0.969
NULL	Ann_Oncol_2011_Mar_8_22(3)_503-514.nxml.txt.nlp	20616198	SENT184	13	13	32	32	letrozole	aromatase	PA450196	1588	0.969
NULL	Curr_Med_Chem_2012_Aug_19(22)_3763-3778.nxml.txt.nlp	22680930	SENT58	22	22	9	9	celecoxib	5-LOX	PA448871	240	0.969
NULL	Mol_Cancer_2008_May_21_7_42.nxml.txt.nlp	18492291	SENT22	0	0	9	9	gefitinib	EGFR	PA131301952	1956	0.969
NULL	Cell_Death_Differ_2010_Oct_30_17(10)_1624-1635.nxml.txt.nlp	20431602	SENT54	15	15	33	33	paclitaxel	Mcl-1	PA450761	4170	0.969
NULL	Oncotarget_2012_May_29_3(5)_581-585.nxml.txt.nlp	22653910	SENT50	36	36	18	18	resveratrol	P-gp		5243	0.969
NULL	Cell_Res_2013_Jul_21_23(7)_915-930.nxml.txt.nlp	23689279	SENT8	1	1	31	31	ethanol	ALDH2	PA448073	217	0.969
NULL	Clin_Sci_(Lond)_2009_Nov_16_118(Pt_4)_269-279.nxml.txt.nlp	19698082	SENT207	3	3	28	28	ramipril	ACE2	PA451223	59272	0.969
NULL	Diabetes_Metab_J_2013_Oct_17_37(5)_301-314.nxml.txt.nlp	24199158	SENT119	3	3	14	14	simvastatin	PDK4	PA451363	5166	0.969
NULL	Croat_Med_J_2012_Jun_53(3)_224-233.nxml.txt.nlp	22661135	SENT68	0	0	17	17	bromocriptine	PRL	PA448671	5617	0.969
NULL	Nucl_Recept_Signal_2009_Jan_16_7_e001.nxml.txt.nlp	19240808	SENT412	0	0	8	8	paclitaxel	CYP3A4	PA450761	1576	0.969
NULL	Clin_Med_Insights_Oncol_2012_May_16_6_205-217.nxml.txt.nlp	22654526	SENT197	7	7	21	21	vorinostat	CXCR4	PA164748224	7852	0.969
NULL	Int_Semin_Surg_Oncol_2008_Apr_28_5_9.nxml.txt.nlp	18442393	SENT70	24	24	4	4	tamoxifen	HER-2	PA451581	2064	0.969
NULL	Clinics_(Sao_Paulo)_2013_May_68(5)_694-701.nxml.txt.nlp	23778405	SENT183	18	18	10	10	curcumin	survivin	PA151958596	332	0.969
NULL	Front_Pharmacol_2014_May_13_5_89.nxml.txt.nlp	24860504	SENT393	3	3	17	17	resveratrol	gamma		9913	0.969
NULL	Cancer_Cell_Int_2010_Sep_9_10_32.nxml.txt.nlp	20828393	SENT164	24	24	7	7	cisplatin	p38	PA449014	10598;1432;7965	0.969
NULL	Onco_Targets_Ther_2014_May_28_7_841-852.nxml.txt.nlp	24920926	SENT67	3	3	35	35	gefitinib	DELTA	PA131301952	7528;5694	0.969
NULL	Ann_Hematol_2011_Feb_17_90(2)_173-183.nxml.txt.nlp	20714724	SENT142	6	6	36	36	resveratrol	CD38		952	0.969
NULL	Fibrogenesis_Tissue_Repair_2010_Aug_5_3_13.nxml.txt.nlp	20687922	SENT60	6	6	12	12	bevacizumab	VEGF-A	PA130232992	7422	0.969
NULL	Acta_Pharmacol_Sin_2010_Jan_5_31(1)_93-101.nxml.txt.nlp	20048748	SENT34	17	17	9	9	cisplatin	DAPK	PA449014	1612	0.969
NULL	Case_Rep_Gastrointest_Med_2012_Oct_21_2012_480135.nxml.txt.nlp	23198186	SENT86	14	14	21	21	sorafenib	VEGFR	PA7000	3791	0.969
NULL	Front_Aging_Neurosci_2014_Nov_27_6_322.nxml.txt.nlp	25505884	SENT462	0	0	20	20	dipyridamole	CA1	PA449367	759	0.969
NULL	Clin_Interv_Aging_2008_Sep_3(3)_421-430.nxml.txt.nlp	18982913	SENT81	0	0	12	12	buprenorphine	CYP3A4	PA448685	1576	0.969
NULL	Indian_J_Endocrinol_Metab_2013_Jul-Aug_17(4)_636-646.nxml.txt.nlp	23961479	SENT138	0	0	9	9	lovastatin	CYP3A4	PA450272	1576	0.969
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT253	24	24	14	14	cetuximab	BRAF	PA10040	673	0.969
NULL	Adv_Biomed_Res_2014_Jan_9_3_1.nxml.txt.nlp	24592358	SENT242	3	3	29	29	estradiol	CD86	PA449503	942	0.969
NULL	Tanaffos_2013_12(2)_16-21.nxml.txt.nlp	25191457	SENT114	21	21	35	35	pantoprazole	HAP	PA450774	5915;10313	0.969
NULL	Biomed_Res_Int_2014_Jun_25_2014_203693.nxml.txt.nlp	25089265	SENT120	13	13	3	3	bevacizumab	VEGFR	PA130232992	3791	0.969
NULL	Chin_J_Cancer_2012_Mar_31(3)_150-158.nxml.txt.nlp	22360854	SENT126	7	7	13	13	cisplatin	ABCG2	PA449014	9429	0.969
NULL	Mol_Biol_Cell_2014_Jun_1_25(11)_1782-1792.nxml.txt.nlp	24719457	SENT206	7	7	27	27	nicotine	p53	PA450626	7157	0.969
NULL	Diabetes_Care_2012_Feb_16_35(2)_327-333.nxml.txt.nlp	22179958	SENT10	22	22	1	1	metformin	B12	PA450395	7126;4709	0.969
NULL	Br_J_Cancer_2013_Feb_5_108(2)_469-476.nxml.txt.nlp	23169292	SENT128	31	31	5	5	erlotinib	KRAS	PA134687924	3845	0.969
NULL	Case_Rep_Gastroenterol_2010_Feb_6_4(1)_57-65.nxml.txt.nlp	21103229	SENT107	36	36	26	26	propofol	CYP2B6	PA451141	1555	0.969
NULL	Biotechnol_Res_Int_2011_Jul_14_2011_478925.nxml.txt.nlp	21804944	SENT31	31	31	19	19	benzaldehyde	mol	PA448571	90527	0.969
NULL	J_Hum_Genet_2013_Jun_16_58(6)_353-361.nxml.txt.nlp	23677058	SENT168	15	15	27	27	cytarabine	RRM2	PA449177	6241	0.969
NULL	Leukemia_2014_Mar_13_28(3)_600-608.nxml.txt.nlp	24240203	SENT135	18	18	7	7	nutlin-3	MDM2		4193	0.969
NULL	Oncotarget_2014_Jun_6_5(13)_4935-4944.nxml.txt.nlp	24952732	SENT95	6	6	22	22	doxazosin	PDK1	PA449407	5170;5163	0.969
NULL	Br_J_Cancer_2011_Jul_26_105(3)_372-381.nxml.txt.nlp	21730979	SENT163	26	26	2	2	temozolomide	ATR	PA451609	390502;84168;545	0.969
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT174	14	14	43	43	metformin	HIF-1	PA450395	29072	0.969
NULL	Eur_J_Clin_Pharmacol_2012_Sep_15_68(9)_1267-1274.nxml.txt.nlp	22418828	SENT166	27	27	3	3	pantoprazole	CYP2C19	PA450774	1557	0.969
NULL	Int_J_Mol_Sci_2014_Oct_8_15(10)_17974-17999.nxml.txt.nlp	25299695	SENT103	11	11	5	5	curcumin	HO-2	PA151958596	3163	0.969
NULL	Int_J_Vasc_Med_2012_Aug_22_2012_201027.nxml.txt.nlp	21876813	SENT282	2	2	7	7	pioglitazone	CYP3A4	PA450970	1576	0.969
NULL	Oncotarget_2014_Aug_24_5(16)_6556-6557.nxml.txt.nlp	25179303	SENT31	14	14	6	6	resveratrol	COX		1351	0.969
NULL	Front_Microbiol_2014_May_16_5_237.nxml.txt.nlp	24904551	SENT47	11	11	18	18	ethanol	CO2	PA448073	4513	0.969
NULL	Oncotarget_2013_Nov_24_4(12)_2430-2438.nxml.txt.nlp	24280348	SENT77	7	7	14	14	gefitinib	STAT3	PA131301952	6774	0.969
NULL	Breast_Cancer_Res_2009_Jun_29_11(3)_R41.nxml.txt.nlp	19563669	SENT185	15	15	7	7	gefitinib	XIAP	PA131301952	331	0.969
NULL	Pharmaceuticals_(Basel)_2014_Apr_14_7(4)_453-463.nxml.txt.nlp	24736104	SENT24	14	14	41	41	diclofenac	GIT	PA449293	5034	0.969
NULL	JAKSTAT_2013_Jul_1_2(3)_e24574.nxml.txt.nlp	24069558	SENT49	25	25	4	4	doxycycline	JAK2	PA449415	3717	0.969
NULL	Mol_Cancer_2012_Aug_22_11_59.nxml.txt.nlp	22913813	SENT157	33	33	31	31	geldanamycin	Hsp90	PA152031327	3320	0.969
NULL	Mol_Cancer_2010_May_20_9_115.nxml.txt.nlp	20487546	SENT206	22	22	2	2	fludarabine	MYC	PA449655	4609	0.969
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT122	16	16	5	5	curcumin	TRAIL	PA151958596	8743	0.969
NULL	Physiol_Rep_2014_Sep_28_2(9)_e12160.nxml.txt.nlp	25263209	SENT167	21	21	9	9	capsaicin	TRPV1	PA448776	7442	0.969
NULL	Int_J_Biomed_Sci_2014_Sep_10(3)_217-220.nxml.txt.nlp	25324704	SENT28	18	18	36	36	amiodarone	APT	PA448383	653639	0.969
NULL	Nat_Chem_Biol_2010_Apr_28_6(4)_291-299.nxml.txt.nlp	20190765	SENT179	24	24	34	34	dasatinib	EGFR	PA162372878	1956	0.969
NULL	Anal_Chem_2014_Mar_18_86(6)_2867-2870.nxml.txt.nlp	24579851	SENT63	1	1	11	11	hemin	GAPDH	PA449849	2597	0.969
NULL	Pharmaceuticals_(Basel)_2013_Nov_11_6(11)_1429-1450.nxml.txt.nlp	24287465	SENT283	20	20	12	12	vemurafenib	SMO	PA165946873	6608;54498	0.969
NULL	Evid_Based_Complement_Alternat_Med_2011_Mar_1_2011_207034.nxml.txt.nlp	21423686	SENT1	16	16	21	21	clopidogrel	CYP2C19	PA449053	1557	0.969
NULL	Int_J_Nanomedicine_2012_Oct_25_7_5565-5575.nxml.txt.nlp	23118538	SENT4	0	0	19	19	fenofibrate	CO2	PA449594	4513	0.969
NULL	Ther_Clin_Risk_Manag_2005_Dec_1(4)_299-306.nxml.txt.nlp	18360572	SENT84	1	1	25	25	terbinafine	CYP3A4	PA451614	1576	0.969
NULL	J_Gastroenterol_2013_Jan_27_48(1)_22-30.nxml.txt.nlp	23104468	SENT115	29	29	7	7	ribavirin	RVR	PA451241	9975	0.969
NULL	Case_Rep_Oncol_2010_Jun_30_4(2)_327-335.nxml.txt.nlp	21738504	SENT16	32	32	6	6	epirubicin	HCC	PA449476	84668	0.969
NULL	Br_J_Cancer_2011_Jul_26_105(3)_420-427.nxml.txt.nlp	21730982	SENT192	20	20	31	31	paclitaxel	EGFR	PA450761	1956	0.969
NULL	Oncotarget_2014_Oct_23_5(21)_10816-10829.nxml.txt.nlp	25333261	SENT146	27	27	9	9	doxorubicin	p53	PA449412	7157	0.969
NULL	J_Mol_Signal_2008_Dec_1_3_18.nxml.txt.nlp	19046439	SENT128	36	36	18	18	metformin	CDK2	PA450395	1017	0.969
NULL	J_Bras_Pneumol_2014_May-Jun_40(3)_313-318.nxml.txt.nlp	25029655	SENT16	26	26	14	14	venlafaxine	CYP2D6	PA451866	1565	0.969
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_75-89.nxml.txt.nlp	17912638	SENT21	16	16	2	2	tamoxifen	aromatase	PA451581	1588	0.969
NULL	Br_J_Cancer_2010_Mar_2_102(5)_815-826.nxml.txt.nlp	20145614	SENT231	26	26	2	2	fluorescein	CD44	PA164746009	960	0.969
NULL	Nat_Med_2011_May_1_17(5)_604-609.nxml.txt.nlp	21532597	SENT92	4	4	37	37	daclizumab	CD25	PA164764446	3669;3559	0.969
NULL	Br_J_Cancer_2010_Jan_5_102(1)_134-143.nxml.txt.nlp	19920829	SENT108	9	9	40	40	pertuzumab	IL-2		3558	0.969
NULL	Breast_Cancer_Res_2011_Feb_3_13(1)_R16.nxml.txt.nlp	21291529	SENT116	12	12	2	2	epirubicin	PHD2	PA449476	54583	0.969
NULL	Clin_Exp_Otorhinolaryngol_2011_Jun_31_4(2)_77-82.nxml.txt.nlp	21716954	SENT184	5	5	25	25	minocycline	Bcl-2	PA450519	596	0.969
NULL	Nat_Neurosci_2012_Sep_5_15(9)_1245-1254.nxml.txt.nlp	22864611	SENT52	24	24	10	10	risperidone	mGlu2	PA451257	2912	0.969
NULL	EJC_Suppl_2013_Sep_5_11(2)_299-300.nxml.txt.nlp	NULL	SENT29	18	18	12	12	tamoxifen	aromatase	PA451581	1588	0.969
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1145.nxml.txt.nlp	24675463	SENT338	21	21	4	4	cetuximab	U87	PA10040	677775;641648	0.969
NULL	Cell_Commun_Signal_2013_Oct_1_11_73.nxml.txt.nlp	24083678	SENT245	6	6	28	28	sulindac	ICAM1	PA451565	3383	0.969
NULL	Oncotarget_2013_Jul_26_4(8)_1317-1328.nxml.txt.nlp	23945331	SENT15	26	26	16	16	trastuzumab	HER2	PA451743	2064	0.969
NULL	Int_J_Surg_Oncol_2012_Jun_12_2012_862879.nxml.txt.nlp	22778941	SENT36	4	4	12	12	cisplatin	p53	PA449014	7157	0.969
NULL	Diabetes_2011_Jun_21_60(6)_1770-1778.nxml.txt.nlp	21562078	SENT287	6	6	14	14	metformin	AMPK	PA450395	5563	0.969
NULL	Br_J_Cancer_2009_Oct_20_101(8)_1290-1297.nxml.txt.nlp	19755992	SENT162	7	7	18	18	cisplatin	p53	PA449014	7157	0.969
NULL	Springerplus_2013_Dec_6_2_658.nxml.txt.nlp	24349960	SENT88	29	29	4	4	heparin	OPG	PA449855	690	0.969
NULL	Am_J_Cardiovasc_Drugs_2013_Jun_20_13(5)_331-342.nxml.txt.nlp	23784266	SENT183	10	10	21	21	verapamil	P-gp	PA451868	5243	0.969
NULL	Br_J_Cancer_2011_Nov_22_105(11)_1654-1662.nxml.txt.nlp	22045187	SENT152	31	31	23	23	irinotecan	MTHFR	PA450085	4524	0.969
NULL	Biologics_2012_Oct_25_6_371-378.nxml.txt.nlp	23118526	SENT54	9	9	24	24	tocilizumab	IL-6	PA165292659	3569	0.969
NULL	J_Ophthalmol_2011_Oct_20_2011_252549.nxml.txt.nlp	22046503	SENT111	9	9	19	19	ranibizumab	ARMS2	PA164746012	387715	0.969
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT102	0	0	10	10	neratinib	HER2	PA165291472	2064	0.969
NULL	Oncotarget_2011_Dec_31_2(12)_1314-1321.nxml.txt.nlp	22248929	SENT78	9	9	7	7	lapatinib	HER2	PA152241907	2064	0.969
NULL	Nucleic_Acids_Res_2013_Dec_4_41(22)_10124-10134.nxml.txt.nlp	24005039	SENT140	14	14	4	4	ethanol	CYC1	PA448073	1537	0.969
NULL	Oncotarget_2014_Jun_8_5(13)_5040-5053.nxml.txt.nlp	24970815	SENT249	27	27	19	19	vemurafenib	EGFR	PA165946873	1956	0.969
NULL	Arthritis_Res_Ther_2006_May_5_8(3)_R83.nxml.txt.nlp	16677395	SENT107	31	31	11	11	rituximab	CD4	PA451261	920	0.969
NULL	Oncotarget_2013_Nov_24_4(12)_2430-2438.nxml.txt.nlp	24280348	SENT38	23	23	38	38	gefitinib	EGFR	PA131301952	1956	0.969
NULL	Biomed_Res_Int_2014_Jan_29_2014_862851.nxml.txt.nlp	24605338	SENT26	0	0	7	7	ustekinumab	p40	PA166048654	3921;339541;10314	0.969
NULL	Case_Rep_Anesthesiol_2012_Sep_3_2012_349046.nxml.txt.nlp	22973525	SENT33	2	2	14	14	heparin	ACT	PA449855	12;11332;9457;641455	0.969
NULL	J_Hematol_Oncol_2009_Feb_23_2_10.nxml.txt.nlp	19236716	SENT106	0	0	3	3	dasatinib	CYP3A4	PA162372878	1576	0.969
NULL	J_Hematol_Oncol_2009_Jan_21_2_2.nxml.txt.nlp	19159467	SENT287	0	0	14	14	bevacizumab	VEGF-A	PA130232992	7422	0.969
NULL	Hum_Genomics_2005_Jun_1_2(2)_138-143.nxml.txt.nlp	16004729	SENT98	23	23	1	1	ethanol	ALDH2	PA448073	217	0.969
NULL	J_Cell_Sci_2014_Mar_15_127(6)_1263-1278.nxml.txt.nlp	24424030	SENT393	11	11	6	6	doxycycline	TDP-43	PA449415	23435	0.969
NULL	Adolesc_Health_Med_Ther_2010_Dec_23_2_1-8.nxml.txt.nlp	24600270	SENT31	0	0	18	18	infliximab	TNF-alpha	PA452639	7124	0.969
NULL	J_Adv_Pract_Oncol_2013_May_1_May-Jun_4(3)_176-181.nxml.txt.nlp	25031998	SENT112	5	5	15	15	tamoxifen	aromatase	PA451581	1588	0.969
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_75-89.nxml.txt.nlp	17912638	SENT1	12	12	2	2	exemestane	aromatase	PA449563	1588	0.969
NULL	Acta_Pharmacol_Sin_2014_Jan_9_35(1)_1-10.nxml.txt.nlp	24317012	SENT23	22	22	2	2	flavopiridol	OATP1B3	PA452627	28234	0.969
NULL	Int_J_Mol_Sci_2014_Sep_5_15(9)_15754-15765.nxml.txt.nlp	25198898	SENT5	5	5	32	32	curcumin	JNK	PA151958596	5599	0.969
NULL	Cases_J_2009_Jul_30_2_7134.nxml.txt.nlp	19829918	SENT20	4	4	18	18	levodopa	COMT	PA450213	1312	0.969
NULL	Leukemia_2014_Aug_4_28(8)_1573-1585.nxml.txt.nlp	24496300	SENT218	6	6	1	1	clarithromycin	P-gp	PA449028	5243	0.969
NULL	J_Cell_Mol_Med_2014_Dec_6_18(12)_2331-2339.nxml.txt.nlp	25284457	SENT132	10	10	21	21	curcumin	TLR2	PA151958596	7097	0.969
NULL	Acta_Pharmacol_Sin_2011_Oct_15_32(10)_1233-1238.nxml.txt.nlp	21841815	SENT76	9	9	0	0	naloxone	CTX	PA450586	1593	0.969
NULL	Int_J_Mol_Sci_2014_Oct_6_15(10)_17886-17900.nxml.txt.nlp	25290095	SENT222	8	8	36	36	resveratrol	SIRT1		23411	0.969
NULL	Drug_Des_Devel_Ther_2014_Oct_31_8_2121-2128.nxml.txt.nlp	25382970	SENT81	31	31	10	10	curcumin	TTR	PA151958596	7276	0.969
NULL	Nature_2012_Aug_16_488(7411)_384-388.nxml.txt.nlp	22820255	SENT285	7	7	15	15	doxycycline	CD4	PA449415	920	0.969
NULL	Cancer_Immunol_Immunother_2011_Jul_24_60(7)_943-951.nxml.txt.nlp	21431918	SENT155	29	29	20	20	doxorubicin	CD34	PA449412	947	0.969
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT123	21	21	29	29	pp2	RAR		10966;5914	0.969
NULL	Drugs_R_D_2013_Jun_5_13(2)_153-157.nxml.txt.nlp	23737454	SENT30	3	3	15	15	clopidogrel	P2Y12	PA449053	64805	0.969
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT116	11	11	23	23	celecoxib	IL-6	PA448871	3569	0.969
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT41	1	1	16	16	capsaicin	MDM2	PA448776	4193	0.969
NULL	J_Thromb_Haemost_2013_Jan_11(1)_132-141.nxml.txt.nlp	23205847	SENT140	8	8	3	3	thrombin	FVIII	PA451674	2157	0.969
NULL	Cancer_Imaging_2008_Sep_10_8(1)_159-162.nxml.txt.nlp	18818134	SENT33	17	17	2	2	levothyroxine	WBS	PA450221	2006	0.969
NULL	Environ_Health_Perspect_2012_Jun_22_120(6)_904-909.nxml.txt.nlp	22357172	SENT170	36	36	14	14	estradiol	PCB	PA449503	5091	0.969
NULL	Mol_Vis_2011_Feb_1_17_332-340.nxml.txt.nlp	21297899	SENT145	2	2	8	8	telmisartan	DPI	PA451605	1832	0.969
NULL	J_Clin_Imaging_Sci_2013_Oct_29_3(Suppl_1)_10.nxml.txt.nlp	24516773	SENT84	24	24	31	31	imatinib	KIT	PA10804	3815	0.969
NULL	Breast_Cancer_Res_2005_May_24_7(5)_R589-R597.nxml.txt.nlp	16168102	SENT138	43	43	22	22	doxorubicin	HER3	PA449412	2065	0.969
NULL	Front_Neurol_2011_Dec_16_2_72.nxml.txt.nlp	22203815	SENT52	18	18	0	0	protamine	VSOP	PA10366	84329	0.969
NULL	J_Oncol_2012_Aug_8_2012_608406.nxml.txt.nlp	22927846	SENT161	5	5	25	25	dacarbazine	CXCL9	PA449197	4283	0.969
NULL	Breast_Cancer_Res_Treat_2014_Apr_9_145(1)_73-82.nxml.txt.nlp	24715380	SENT82	7	7	0	0	tamoxifen	CXCL10	PA451581	3627	0.969
NULL	Neural_Regen_Res_2013_Mar_25_8(9)_825-832.nxml.txt.nlp	25206730	SENT106	34	34	9	9	isoflurane	P2X7	PA450106	5027	0.969
NULL	Pharmaceutics_2011_Nov_18_3(4)_865-913.nxml.txt.nlp	24309312	SENT172	0	0	15	15	rifaximin	CYP3A4	PA164752443	1576	0.969
NULL	Curr_Oncol_2010_Feb_17(1)_81-86.nxml.txt.nlp	20179808	SENT116	6	6	12	12	venlafaxine	CYP2D6	PA451866	1565	0.969
NULL	J_Clin_Exp_Pathol_2012_May_17_Suppl_4_7327.nxml.txt.nlp	25379357	SENT137	3	3	15	15	metformin	AMPK	PA450395	5563	0.969
NULL	Int_J_Nanomedicine_2008_Sep_3(3)_359-372.nxml.txt.nlp	18990945	SENT235	1	1	23	23	camptothecin	CDP	PA153590860	1523	0.969
NULL	Cancer_Cell_Int_2005_Jul_24_5_22.nxml.txt.nlp	16042792	SENT168	8	8	19	19	vincristine	NAC	PA451879	22861	0.969
NULL	Clin_Med_Insights_Oncol_2012_Feb_28_6_125-135.nxml.txt.nlp	22408376	SENT57	8	8	23	23	panitumumab	KRAS	PA162373091	3845	0.969
NULL	Curr_HIV_Res_2014_May_12(3)_174-188.nxml.txt.nlp	24862327	SENT147	25	25	8	8	hemin	MCP-1	PA449849	6347	0.969
NULL	Case_Rep_Neurol_2014_Mar_29_6(1)_101-108.nxml.txt.nlp	24761147	SENT108	7	7	29	29	vincristine	IVL	PA451879	3713	0.969
NULL	Br_J_Cancer_2010_Jun_29_103(1)_61-72.nxml.txt.nlp	20588279	SENT35	11	11	39	39	trastuzumab	AKT	PA451743	207	0.969
NULL	Apoptosis_2012_Sep_30_17(9)_989-997.nxml.txt.nlp	22460505	SENT150	3	3	17	17	thioridazine	PI3K	PA451666	5290	0.969
NULL	J_Adv_Pract_Oncol_2012_Nov_1_Nov-Dec_3(6)_391-394.nxml.txt.nlp	25031970	SENT64	36	36	10	10	trastuzumab	HER2	PA451743	2064	0.969
NULL	J_Biomed_Sci_2014_Feb_3_21(1)_10.nxml.txt.nlp	24490900	SENT186	20	20	2	2	alendronate	M-CSF	PA448082	1435	0.969
NULL	Cell_Commun_Signal_2013_Nov_11_11_86.nxml.txt.nlp	24215724	SENT520	33	33	2	2	paclitaxel	PAR2	PA450761	2150;55065;8856	0.969
NULL	Oncotarget_2013_Nov_24_4(12)_2430-2438.nxml.txt.nlp	24280348	SENT29	15	15	5	5	gefitinib	STAT3	PA131301952	6774	0.969
NULL	Toxins_(Basel)_2010_Nov_10_2(11)_2699-2737.nxml.txt.nlp	22069572	SENT363	26	26	11	11	cetuximab	EGFR	PA10040	1956	0.969
NULL	Ther_Clin_Risk_Manag_2007_Mar_3(1)_71-97.nxml.txt.nlp	18360617	SENT270	1	1	11	11	micafungin	CYP3A	PA164781026	1574	0.969
NULL	Genetics_2015_Jan_13_199(1)_247-262.nxml.txt.nlp	25398792	SENT348	19	19	11	11	galactose	GAL	PA449725	51083	0.969
NULL	Eukaryot_Cell_2014_Aug_13(8)_1077-1084.nxml.txt.nlp	24951438	SENT197	14	14	28	28	doxycycline	ACT1	PA449415	10758	0.969
NULL	Cell_Res_2013_Oct_27_23(10)_1163-1171.nxml.txt.nlp	23979020	SENT42	29	29	35	35	doxycycline	MSI1	PA449415	4440	0.969
NULL	Acta_Histochem_Cytochem_2012_Apr_26_45(2)_139-146.nxml.txt.nlp	22685356	SENT324	11	11	0	0	forskolin	AQP2	PA146096022	359	0.969
NULL	Nucleic_Acids_Res_2013_May_5_41(10)_5210-5222.nxml.txt.nlp	23563151	SENT236	9	9	20	20	arsenite	GADD45	PA452638	1647	0.969
NULL	Breast_Cancer_Res_2011_Jan_28_13(1)_R11.nxml.txt.nlp	21276249	SENT273	33	33	19	19	tamoxifen	aromatase	PA451581	1588	0.969
NULL	J_Aging_Res_2012_Apr_23_2012_753949.nxml.txt.nlp	22619720	SENT112	16	16	6	6	amobarbital	ADP	PA448401	23038	0.969
NULL	Surg_Neurol_Int_2013_May_2_4(Suppl_4)_S245-S255.nxml.txt.nlp	23717796	SENT278	8	8	2	2	erlotinib	EGFR	PA134687924	1956	0.969
NULL	Oncol_Lett_2013_Mar_8_5(3)_805-812.nxml.txt.nlp	23426281	SENT187	8	8	20	20	gemcitabine	survivin	PA449748	332	0.969
NULL	Indian_J_Med_Res_2014_Apr_139(4)_572-578.nxml.txt.nlp	24927344	SENT4	21	21	6	6	warfarin	GGCX	PA451906	2677	0.969
NULL	Acta_Neuropathol_Commun_2013_May_20_1_17.nxml.txt.nlp	24252689	SENT58	22	22	6	6	fluvastatin	IQGAP1	PA449688	8826	0.969
NULL	Clin_Pharmacol_2013_Apr_19_5_67-83.nxml.txt.nlp	23650452	SENT76	3	3	32	32	clopidogrel	CYP2C19	PA449053	1557	0.969
NULL	Br_J_Cancer_2013_Jan_15_108(1)_115-120.nxml.txt.nlp	23175150	SENT4	16	16	9	9	oxaliplatin	KRAS	PA131285527	3845	0.969
NULL	Mol_Cancer_2012_Jul_12_11_45.nxml.txt.nlp	22788833	SENT94	6	6	23	23	cisplatin	EGFR	PA449014	1956	0.969
NULL	Clin_Epigenetics_2011_Dec_5_3(1)_8.nxml.txt.nlp	22414275	SENT183	26	26	14	14	ribavirin	ESR1	PA451241	2099	0.969
NULL	Breast_Cancer_Res_2012_May_23_14(3)_R82.nxml.txt.nlp	22621306	SENT50	29	29	18	18	trastuzumab	HER2	PA451743	2064	0.969
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_55-66.nxml.txt.nlp	17912636	SENT117	7	7	24	24	letrozole	HER2	PA450196	2064	0.969
NULL	Acta_Pharmacol_Sin_2011_Oct_15_32(10)_1303-1308.nxml.txt.nlp	21841812	SENT135	20	20	2	2	phenytoin	CYP2C9	PA450947	1559	0.969
NULL	Scientifica_(Cairo)_2012_Nov_25_2012_473829.nxml.txt.nlp	24278698	SENT314	9	9	18	18	cisplatin	OCT1	PA449014	5451;6580	0.969
NULL	Core_Evid_2010_Oct_21_5_23-37.nxml.txt.nlp	21042540	SENT177	28	28	20	20	metformin	PPG	PA450395	5552	0.969
NULL	J_Cancer_2014_Jul_4_5(7)_559-571.nxml.txt.nlp	25057307	SENT208	33	33	7	7	trastuzumab	HER2	PA451743	2064	0.969
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT199	32	32	41	41	cetuximab	KRAS	PA10040	3845	0.969
NULL	Clin_Endocrinol_(Oxf)_2014_Jan_1_81(2)_289-293.nxml.txt.nlp	24735400	SENT69	24	24	15	15	metyrapone	ACTH	PA450486	5443	0.969
NULL	Arch_Drug_Inf_2011_Mar_4(1)_1-9.nxml.txt.nlp	21572514	SENT32	9	9	14	14	ciprofloxacin	P-gp	PA449009	5243	0.969
NULL	Mol_Vis_2012_May_1_18_1115-1122.nxml.txt.nlp	22605923	SENT113	36	36	8	8	estradiol	IL-6	PA449503	3569	0.969
NULL	Toxins_(Basel)_2010_Sep_20_2(9)_2289-2332.nxml.txt.nlp	22069686	SENT179	0	0	9	9	hyperforin	CYP3A4	PA165985514	1576	0.969
NULL	Anal_Chem_Insights_2007_Nov_14_2_93-106.nxml.txt.nlp	19662183	SENT154	32	32	20	20	imatinib	Yes	PA10804	7525	0.969
NULL	J_Adv_Pract_Oncol_2012_Nov_1_Nov-Dec_3(6)_391-394.nxml.txt.nlp	25031970	SENT64	36	36	29	29	trastuzumab	HER2	PA451743	2064	0.969
NULL	Mol_Cancer_2010_Nov_25_9_305.nxml.txt.nlp	21108789	SENT117	9	9	19	19	decitabine	TRAIL	PA164749631	8743	0.969
NULL	Br_J_Pharmacol_2010_Sep_161(2)_288-307.nxml.txt.nlp	20735416	SENT245	32	32	28	28	halothane	TASK	PA449845	3777	0.969
NULL	Protein_Eng_Des_Sel_2009_Jul_10_22(7)_421-430.nxml.txt.nlp	19515728	SENT166	4	4	12	12	urea	p53	PA451831	7157	0.969
NULL	Case_Rep_Ophthalmol_2014_Jul_30_5(2)_231-238.nxml.txt.nlp	25232335	SENT80	0	0	33	33	ranibizumab	VEGF-A	PA164746012	7422	0.969
NULL	Acta_Pharmacol_Sin_2012_Oct_3_33(10)_1311-1318.nxml.txt.nlp	22941289	SENT123	4	4	15	15	sorafenib	VEGFR2	PA7000	3791	0.969
NULL	Gut_Liver_2012_Oct_18_6(4)_464-470.nxml.txt.nlp	23170151	SENT135	31	31	44	44	propofol	ESD	PA451141	2098	0.969
NULL	Oncogene_2013_Sep_26_32(39)_10_1038_onc_2012_491.nxml.txt.nlp	23108394	SENT103	41	41	10	10	epirubicin	FOXM1	PA449476	2305	0.969
NULL	Reprod_Biol_Endocrinol_2003_Oct_9_1_74.nxml.txt.nlp	14613550	SENT13	8	8	6	6	indomethacin	COX	PA449982	1351	0.969
NULL	Br_J_Cancer_2011_Jul_26_105(3)_452-459.nxml.txt.nlp	21750557	SENT83	7	7	4	4	rofecoxib	COX2	PA451268	4513;5743	0.969
NULL	Environ_Sci_Pollut_Res_Int_2012_Jun_2_19(5)_1605-1611.nxml.txt.nlp	22134861	SENT156	0	0	11	11	nitrogen	NO3	PA450643	4681	0.969
NULL	Br_J_Cancer_2011_Mar_1_104(5)_750-755.nxml.txt.nlp	21326243	SENT123	37	37	25	25	olaparib	MPG		4350	0.969
NULL	Leukemia_2013_Jan_11_27(1)_32-40.nxml.txt.nlp	22781593	SENT112	1	1	40	40	dasatinib	FGFR1	PA162372878	2260	0.969
NULL	J_Hematol_Oncol_2012_Sep_18_5_57.nxml.txt.nlp	22989009	SENT225	2	2	11	11	nutlin-3	HDM2		4193	0.969
NULL	Antimicrob_Agents_Chemother_2014_Oct_58(10)_6032-6043.nxml.txt.nlp	25070106	SENT202	14	14	25	25	staurosporine	ADP	PA165109623	23038	0.969
NULL	Arch_Drug_Inf_2008_Sep_1(2)_56-62.nxml.txt.nlp	19915709	SENT51	2	2	35	35	naltrexone	CYP3A4	PA450588	1576	0.969
NULL	Clin_Interv_Aging_2012_Dec_30_7_1-13.nxml.txt.nlp	22291468	SENT267	3	3	15	15	dronedarone	CYP3A4	PA153619853	1576	0.969
NULL	Breast_Cancer_Res_2013_Oct_29_15(5)_R101.nxml.txt.nlp	24168763	SENT252	45	45	29	29	paclitaxel	aromatase	PA450761	1588	0.969
NULL	J_Korean_Neurosurg_Soc_2014_Jun_30_55(6)_313-320.nxml.txt.nlp	25237426	SENT56	6	6	16	16	heparin	ACT	PA449855	12;11332;9457;641455	0.969
NULL	Angiogenesis_2010_Dec_7_13(4)_305-315.nxml.txt.nlp	20927579	SENT149	9	9	25	25	resveratrol	p53		7157	0.969
NULL	Drugs_2014_Oct_10_74(17)_2015-2032.nxml.txt.nlp	25300410	SENT61	7	7	1	1	clarithromycin	P-gp	PA449028	5243	0.969
NULL	Curr_Mol_Med_2011_Apr_11(3)_246-254.nxml.txt.nlp	21375489	SENT163	11	11	1	1	minocycline	SOD1	PA450519	6647	0.969
NULL	Ann_Clin_Transl_Neurol_2014_Dec_21_1(12)_996-1005.nxml.txt.nlp	25574474	SENT199	37	37	18	18	riluzole	P-gp	PA451251	5243	0.969
NULL	Indian_J_Med_Paediatr_Oncol_2014_Apr-Jun_35(2)_140-142.nxml.txt.nlp	25197175	SENT61	24	24	15	15	cetuximab	NRAS	PA10040	4893	0.969
NULL	Clin_Exp_Reprod_Med_2013_Jun_30_40(2)_67-75.nxml.txt.nlp	23875162	SENT157	1	1	13	13	estradiol	aromatase	PA449503	1588	0.969
NULL	Cancers_(Basel)_2013_Jul_4_5(3)_838-856.nxml.txt.nlp	24202322	SENT149	0	0	18	18	nutlin-3	MDM2		4193	0.969
NULL	Breast_Cancer_Res_2013_Oct_18_15(5)_R97.nxml.txt.nlp	24135425	SENT20	32	32	20	20	trastuzumab	HER2	PA451743	2064	0.969
NULL	Int_J_Mol_Sci_2010_May_5_11(5)_2039-2055.nxml.txt.nlp	20559500	SENT89	5	5	12	12	imipramine	Bcl-2	PA449969	596	0.969
NULL	Exp_Hematol_Oncol_2012_Apr_18_1_6.nxml.txt.nlp	23211007	SENT90	8	8	22	22	filgrastim	CD34	PA449626	947	0.969
NULL	Ann_Oncol_2011_Mar_8_22(3)_503-514.nxml.txt.nlp	20616198	SENT24	33	33	9	9	aminoglutethimide	aromatase	PA448375	1588	0.969
NULL	Cancer_Microenviron_2013_Jan_22_6(3)_231-240.nxml.txt.nlp	23335094	SENT124	15	15	24	24	simvastatin	PC-3	PA451363	692094	0.969
NULL	J_Neurovirol_2011_Feb_19_17(1)_63-69.nxml.txt.nlp	21246320	SENT9	18	18	7	7	memantine	IP-10	PA10364	3627	0.969
NULL	Exp_Hematol_2012_Feb_40(2)_97-106.nxml.txt.nlp	22085453	SENT327	29	29	0	0	sitagliptin	DPPIV	PA164748978	2191;1803	0.969
NULL	Exp_Ther_Med_2013_Feb_13_5(2)_581-585.nxml.txt.nlp	23403473	SENT89	4	4	13	13	etanercept	HMGB1	PA449515	3146	0.969
NULL	Arthritis_Res_Ther_2005_Mar_16_7(Suppl_2)_S4-S14.nxml.txt.nlp	15833146	SENT225	5	5	13	13	cyclosporine	IFN	PA449167	3439	0.969
NULL	J_Mol_Signal_2011_Jul_20_6_7.nxml.txt.nlp	21774804	SENT6	12	12	26	26	dasatinib	CD44	PA162372878	960	0.969
NULL	J_Oncol_2012_Mar_11_2012_382159.nxml.txt.nlp	22481926	SENT78	0	0	42	42	sorafenib	VEGFR	PA7000	3791	0.969
NULL	Acta_Pharmacol_Sin_2012_Aug_25_33(8)_1004-1012.nxml.txt.nlp	22728710	SENT29	12	12	0	0	napqi	CYP2E1		1571	0.969
NULL	Acta_Pharmacol_Sin_2013_Apr_18_34(4)_555-560.nxml.txt.nlp	23503472	SENT8	8	8	33	33	cyclosporine	NR1I2	PA449167	8856	0.969
NULL	Oncologist_2010_May_28_15(5)_436-446.nxml.txt.nlp	20427383	SENT139	0	0	20	20	sorafenib	VEGFR	PA7000	3791	0.969
NULL	Br_J_Haematol_2014_Jan_28_164(2)_233-244.nxml.txt.nlp	24206017	SENT14	15	15	4	4	thalidomide	CRBN	PA451644	51185	0.969
NULL	Oncol_Lett_2013_Dec_4_6(6)_1665-1672.nxml.txt.nlp	24273604	SENT138	7	7	36	36	chloroquine	p53	PA448948	7157	0.969
NULL	Mol_Cancer_2010_Nov_8_9_291.nxml.txt.nlp	21059223	SENT186	15	15	5	5	doxorubicin	ABCB1	PA449412	5243	0.969
NULL	Oncoscience_2014_Mar_6_1(2)_180-182.nxml.txt.nlp	25594009	SENT2	12	12	19	19	trastuzumab	HER2	PA451743	2064	0.969
NULL	Nat_Commun_2014_Jun_30_5_4209.nxml.txt.nlp	24979243	SENT184	19	19	11	11	trypsin	CO2	PA451806	4513	0.969
NULL	ScientificWorldJournal_2012_Apr_1_2012_381434.nxml.txt.nlp	22545017	SENT364	10	10	36	36	cyclophosphamide	NK-1	PA449165	27087	0.969
NULL	Indian_J_Anaesth_2011_Nov-Dec_55(6)_567-572.nxml.txt.nlp	22223899	SENT154	27	27	0	0	ephedrine	NAC	PA449466	22861	0.969
NULL	Oncol_Rep_2014_Sep_2_32(3)_887-892.nxml.txt.nlp	24994673	SENT107	22	22	14	14	leucovorin	DPD	PA450198	1806	0.969
NULL	Oncotarget_2013_Nov_24_4(12)_2430-2438.nxml.txt.nlp	24280348	SENT115	10	10	18	18	gefitinib	STAT3	PA131301952	6774	0.969
NULL	Alcohol_Res_2013_35(1)_47-55.nxml.txt.nlp	24313164	SENT111	36	36	29	29	ethanol	HDAC3	PA448073	8841	0.969
NULL	Neuro_Oncol_2010_Apr_27_12(4)_389-400.nxml.txt.nlp	20308316	SENT70	36	36	25	25	chloroquine	p53	PA448948	7157	0.969
NULL	Br_J_Clin_Pharmacol_2010_Sep_70(3)_320-334.nxml.txt.nlp	20716230	SENT159	3	3	13	13	losartan	CYP3A4	PA450268	1576	0.969
NULL	Mol_Cell_Biochem_2012_Apr_3_363(1-2)_135-145.nxml.txt.nlp	22139302	SENT220	27	27	25	25	curcumin	survivin	PA151958596	332	0.969
NULL	Mol_Cells_2014_Mar_31_37(3)_234-240.nxml.txt.nlp	24642709	SENT155	17	17	6	6	cisplatin	HO-1	PA449014	3162	0.969
NULL	Br_J_Cancer_2013_Feb_19_108(3)_668-675.nxml.txt.nlp	23348520	SENT9	22	22	3	3	cetuximab	HER2	PA10040	2064	0.969
NULL	Arthritis_Res_Ther_2014_Jul_18_16(4)_R153.nxml.txt.nlp	25037855	SENT31	0	0	19	19	adalimumab	p75	PA10004	7133;11168	0.969
NULL	Mol_Vis_2014_Dec_19_20_1680-1694.nxml.txt.nlp	25558172	SENT233	23	23	15	15	ranibizumab	ARMS2	PA164746012	387715	0.969
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT117	6	6	10	10	erlotinib	CYP2C8	PA134687924	1558	0.969
NULL	Mol_Vis_2011_Feb_1_17_332-340.nxml.txt.nlp	21297899	SENT130	2	2	8	8	benazepril	NAC	PA448561	22861	0.969
NULL	Exp_Ther_Med_2013_Nov_13_6(5)_1317-1321.nxml.txt.nlp	24223665	SENT15	9	9	0	0	cisplatin	CD133	PA449014	8842	0.969
NULL	Br_J_Cancer_2009_Jul_21_101(2)_269-277.nxml.txt.nlp	19603033	SENT107	31	31	8	8	cisplatin	MLH1	PA449014	4292	0.969
NULL	J_Adv_Pract_Oncol_2012_Jul_1_Jul-Aug_3(4)_267-272.nxml.txt.nlp	25031955	SENT37	0	0	5	5	crizotinib	CYP3A4	PA165946122	1576	0.969
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1013.nxml.txt.nlp	24457957	SENT75	22	22	1	1	bortezomib	NOXA	PA10252	5366	0.969
NULL	Nat_Commun_2014_Aug_6_5_4619.nxml.txt.nlp	25099074	SENT65	23	23	31	31	colchicine	ML7	PA449092	8034	0.969
NULL	Int_J_Gen_Med_2011_Jul_20_4_539-545.nxml.txt.nlp	21845063	SENT94	32	32	15	15	miglitol	adiponectin	PA164776726	9370	0.969
NULL	Acta_Pharmacol_Sin_2014_Jun_5_35(6)_716-726.nxml.txt.nlp	24793311	SENT194	11	11	28	28	atorvastatin	IL-6	PA448500	3569	0.969
NULL	Br_J_Clin_Pharmacol_2011_Oct_72(4)_647-657.nxml.txt.nlp	21518389	SENT146	13	13	25	25	cangrelor	P2Y12	PA165945763	64805	0.969
NULL	Core_Evid_2011_Feb_8_6_23-29.nxml.txt.nlp	21468240	SENT52	17	17	30	30	plerixafor	CD34	PA165958410	947	0.969
NULL	Adv_Hematol_2012_Aug_2_2012_842945.nxml.txt.nlp	22919394	SENT156	24	24	41	41	lenalidomide	CRBN	PA162363968	51185	0.969
NULL	Breast_Cancer_(Auckl)_2011_Jul_27_5_175-199.nxml.txt.nlp	21863131	SENT410	14	14	10	10	everolimus	EGFR	PA164746311	1956	0.969
NULL	Mol_Biol_Rep_2013_May_11_40(8)_5013-5026.nxml.txt.nlp	23666059	SENT163	15	15	25	25	resveratrol	p53		7157	0.969
NULL	Br_J_Cancer_2012_Sep_25_107(7)_1044-1050.nxml.txt.nlp	22910317	SENT28	19	19	5	5	vatalanib	LDHA	PA7001	3939	0.969
NULL	Oncotarget_2013_Aug_15_4(9)_1438-1448.nxml.txt.nlp	23988457	SENT84	10	10	2	2	daunorubicin	RINF	PA449212	51523	0.969
NULL	Breast_Cancer_Res_2010_Aug_23_12(4)_R64.nxml.txt.nlp	20731819	SENT206	25	25	12	12	tamoxifen	CYP2D6	PA451581	1565	0.969
NULL	Cardiol_Res_Pract_2013_Jan_31_2013_128795.nxml.txt.nlp	23431496	SENT129	12	12	6	6	ticagrelor	P2Y12	PA165374673	64805	0.969
NULL	Oncotarget_2012_Sep_28_3(10)_1169-1181.nxml.txt.nlp	23045411	SENT106	27	27	21	21	doxorubicin	JIP1	PA449412	9479	0.969
NULL	Drug_Healthc_Patient_Saf_2012_Nov_29_4_173-180.nxml.txt.nlp	23236256	SENT68	13	13	17	17	amisulpride	FGA	PA162565877	2243	0.969
NULL	Clin_Dev_Immunol_2011_Nov_3_2011_430394.nxml.txt.nlp	22110524	SENT121	4	4	23	23	cyclophosphamide	CD4	PA449165	920	0.969
NULL	Arthritis_Res_Ther_2009_Aug_28_11(4)_R131.nxml.txt.nlp	19715572	SENT101	6	6	23	23	rituximab	CD19	PA451261	930	0.969
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R91.nxml.txt.nlp	22541814	SENT129	14	14	37	37	thrombin	HO-1	PA451674	3162	0.969
NULL	Ann_Oncol_2010_Feb_21(2)_217-222.nxml.txt.nlp	20110292	SENT152	15	15	2	2	erlotinib	PSPH	PA134687924	5723	0.969
NULL	Breast_Cancer_Res_2002_Apr_4_4(3)_85-89.nxml.txt.nlp	12052249	SENT40	41	41	6	6	tamoxifen	CYP3A4	PA451581	1576	0.969
NULL	Eur_J_Cancer_2014_Sep_50(14)_2367-2374.nxml.txt.nlp	25027307	SENT127	14	14	39	39	estradiol	AMH	PA449503	268	0.969
NULL	J_Hematol_Oncol_2014_Aug_1_7_54.nxml.txt.nlp	25084809	SENT118	1	1	14	14	thrombin	C5a	PA451674	727	0.969
NULL	Cancer_Immunol_Immunother_2015_Oct_7_64_61-73.nxml.txt.nlp	25287778	SENT195	20	20	3	3	lenalidomide	IL-2	PA162363968	3558	0.969
NULL	J_Neurovirol_2013_Feb_24_19(1)_89-101.nxml.txt.nlp	23341224	SENT101	19	19	27	27	paraformaldehyde	MAP2	PA450790	4133;10988	0.969
NULL	Drugs_2014_Oct_10_74(17)_2015-2032.nxml.txt.nlp	25300410	SENT61	3	3	1	1	erythromycin	P-gp	PA449493	5243	0.969
NULL	Curr_Neuropharmacol_2010_Jun_8(2)_122-127.nxml.txt.nlp	21119883	SENT46	26	26	19	19	capsaicin	TRPV1	PA448776	7442	0.969
NULL	Clin_Ophthalmol_2012_Sep_21_6_1547-1552.nxml.txt.nlp	23055677	SENT97	22	22	0	0	bimatoprost	SPK	PA164748867	55872;8189	0.969
NULL	J_Biomed_Biotechnol_2010_Mar_2_2010_793843.nxml.txt.nlp	20204133	SENT112	1	1	13	13	trypsin	PAR-1	PA451806	2011;2149	0.969
NULL	Biomed_Res_Int_2013_Oct_27_2013_725410.nxml.txt.nlp	24282820	SENT63	0	0	8	8	pazopanib	VEGFR	PA165291492	3791	0.969
NULL	Exp_Ther_Med_2014_Nov_29_8(5)_1473-1478.nxml.txt.nlp	25289044	SENT14	23	23	7	7	heparin	AZU	PA449855	566	0.969
NULL	EPMA_J_2011_Jun_20_2(2)_141-147.nxml.txt.nlp	23199143	SENT120	16	16	29	29	panitumumab	KRAS	PA162373091	3845	0.969
NULL	J_Am_Heart_Assoc_2013_Apr_24_2(2)_e000131.nxml.txt.nlp	23537811	SENT37	10	10	6	6	prasugrel	P2Y12	PA154410481	64805	0.969
NULL	Curr_HIV_Res_2013_Jul_11(5)_378-387.nxml.txt.nlp	24191939	SENT329	5	5	36	36	palivizumab	CD4	PA164748781	920	0.969
NULL	Br_J_Cancer_2013_May_14_108(9)_1807-1809.nxml.txt.nlp	23612454	SENT7	16	16	0	0	trastuzumab	PIK3CA	PA451743	5290	0.969
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT282	18	18	3	3	nutlin-3	DR4		8797	0.969
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT191	35	35	8	8	pp2	STZ		6484	0.969
NULL	Clinics_(Sao_Paulo)_2012_Apr_67(Suppl_1)_119-123.nxml.txt.nlp	22584716	SENT82	28	28	22	22	temozolomide	MEN1	PA451609	4221	0.969
NULL	Evid_Based_Complement_Alternat_Med_2013_May_22_2013_921012.nxml.txt.nlp	23762167	SENT177	15	15	22	22	metformin	AMPK	PA450395	5563	0.969
NULL	Clin_Med_Pathol_2008_Jul_28_1_83-91.nxml.txt.nlp	21876656	SENT168	16	16	1	1	sitagliptin	GLP-1	PA164748978	100125288	0.969
NULL	Cancer_Med_2014_Jun_19_3(3)_555-564.nxml.txt.nlp	24648042	SENT132	28	28	5	5	fludarabine	NOTCH1	PA449655	4851	0.969
NULL	Exp_Ther_Med_2013_Dec_26_6(6)_1359-1364.nxml.txt.nlp	24255662	SENT169	23	23	4	4	dexmedetomidine	TLR4	PA449256	7099	0.969
NULL	Braz_J_Med_Biol_Res_2012_Mar_2_45(3)_250-255.nxml.txt.nlp	22370705	SENT14	10	10	3	3	atropine	ADM	PA448505	133	0.969
NULL	Indian_J_Med_Paediatr_Oncol_2014_Jan-Mar_35(1)_109-110.nxml.txt.nlp	25006299	SENT8	6	6	1	1	erlotinib	EGFR	PA134687924	1956	0.969
NULL	Diabetes_2009_Jan_58(1)_174-184.nxml.txt.nlp	18984736	SENT186	9	9	14	14	tranilast	TRPV2	PA131890628	51393	0.969
NULL	CNS_Spectr_2014_Apr_1_19(2)_121-133.nxml.txt.nlp	23903233	SENT199	3	3	35	35	vilazodone	5-HT1B	PA165958365	3351	0.969
NULL	Br_J_Cancer_2014_Oct_14_111(8)_1552-1561.nxml.txt.nlp	25117814	SENT139	7	7	23	23	doxorubicin	AKT	PA449412	207	0.969
NULL	Br_J_Cancer_2011_Nov_22_105(11)_1635-1639.nxml.txt.nlp	22033275	SENT47	8	8	22	22	bevacizumab	IFN	PA130232992	3439	0.969
NULL	Open_Biochem_J_2011_Sep_23_5_45-51.nxml.txt.nlp	21966325	SENT187	21	21	37	37	diclofenac	XBP1	PA449293	7494	0.969
NULL	J_Int_Soc_Sports_Nutr_2010_Aug_22_7_28.nxml.txt.nlp	20727213	SENT150	5	5	13	13	l-glutamine	IL-6	PA10090	3569	0.969
NULL	Cardiovasc_Res_2012_Dec_1_96(3)_552-560.nxml.txt.nlp	22918977	SENT266	15	15	6	6	losartan	JAM-A	PA450268	50848	0.969
NULL	Acta_Otolaryngol_2010_Nov_30_130(11)_1278-1286.nxml.txt.nlp	20586674	SENT235	4	4	0	0	capsaicin	TRPV1	PA448776	7442	0.969
NULL	Biomed_Res_Int_2014_Feb_6_2014_323594.nxml.txt.nlp	24689036	SENT277	18	18	7	7	raloxifene	OATP1B1	PA451221	10599	0.969
NULL	Breast_Cancer_Res_2005_Jan_28_7(3)_R284-R290.nxml.txt.nlp	15987423	SENT6	21	21	4	4	tamoxifen	CYP2D6	PA451581	1565	0.969
NULL	Anat_Cell_Biol_2013_Jun_30_46(2)_113-121.nxml.txt.nlp	23869258	SENT126	20	20	3	3	hyaluronan	CD44	PA165958431	960	0.969
NULL	J_Thyroid_Res_2011_Apr_10_2011_895923.nxml.txt.nlp	21603172	SENT161	14	14	8	8	thyroglobulin	CD4	PA164754910	920	0.969
NULL	Front_Oncol_2014_Mar_6_4_40.nxml.txt.nlp	24639951	SENT410	13	13	17	17	cisplatin	P-gp	PA449014	5243	0.969
NULL	Clin_Sci_(Lond)_2013_Apr_1_124(Pt_8)_543-552.nxml.txt.nlp	23130652	SENT118	41	41	35	35	enalapril	STZ	PA449456	6484	0.969
NULL	J_Adv_Pharm_Technol_Res_2014_Jul-Sep_5(3)_129-133.nxml.txt.nlp	25126534	SENT46	7	7	29	29	perindopril	COX	PA450877	1351	0.969
NULL	Oncotarget_2013_Nov_7_4(12)_2550-2566.nxml.txt.nlp	24334291	SENT119	27	27	6	6	dasatinib	LKB1	PA162372878	6794	0.969
NULL	Nat_Genet_2011_Jun_5_43(7)_621-629.nxml.txt.nlp	21642992	SENT103	21	21	8	8	doxorubicin	CDKN1A	PA449412	1026	0.969
NULL	Mol_Imaging_Radionucl_Ther_2013_Aug_1_22(2)_49-55.nxml.txt.nlp	24003397	SENT28	20	20	27	27	octreotide	ACTH	PA450678	5443	0.969
NULL	Ann_Intensive_Care_2011_Sep_19_1_38.nxml.txt.nlp	21929821	SENT4	32	32	0	0	glucose	STAR	PA449773	6770;2984	0.969
NULL	Clin_Sci_(Lond)_2013_Apr_1_124(Pt_8)_543-552.nxml.txt.nlp	23130652	SENT150	16	16	10	10	enalapril	STZ	PA449456	6484	0.969
NULL	Acta_Pharmacol_Sin_2011_Apr_28_32(4)_487-494.nxml.txt.nlp	21441943	SENT146	20	20	15	15	atropine	NK1	PA448505	11126	0.969
NULL	Mol_Cancer_2013_Sep_11_12_104.nxml.txt.nlp	24025152	SENT198	9	9	7	7	gefitinib	EGFR	PA131301952	1956	0.969
NULL	Eur_J_Neurosci_2007_Mar_1_25(6)_1619-1630.nxml.txt.nlp	17408433	SENT212	16	16	33	33	dextran	CB1	PA449261	1268	0.969
NULL	Clin_Exp_Gastroenterol_2011_Jul_15_4_163-172.nxml.txt.nlp	21904462	SENT89	41	41	27	27	adalimumab	OLC	PA10004	26679	0.969
NULL	Curr_Gerontol_Geriatr_Res_2010_Jun_20_2010_348174.nxml.txt.nlp	20672050	SENT153	17	17	11	11	gefitinib	EGFR	PA131301952	1956	0.968
NULL	Breast_Cancer_Res_2012_Jul_19_14(4)_R108.nxml.txt.nlp	22812534	SENT369	7	7	5	5	letrozole	aromatase	PA450196	1588	0.968
NULL	Patient_Prefer_Adherence_2009_Nov_3_3_51-59.nxml.txt.nlp	19936145	SENT253	6	6	3	3	entacapone	COMT	PA164748726	1312	0.968
NULL	Cancer_Metab_2013_Aug_14_1_18.nxml.txt.nlp	24280377	SENT289	4	4	25	25	metformin	4E-BP1	PA450395	1978	0.968
NULL	Exp_Ther_Med_2013_Nov_13_6(5)_1317-1321.nxml.txt.nlp	24223665	SENT103	7	7	0	0	cisplatin	CD133	PA449014	8842	0.968
NULL	Oncoscience_2013_Dec_11_1(1)_30-38.nxml.txt.nlp	25593982	SENT166	8	8	23	23	oxygen	Met	PA450744	79811	0.968
NULL	Mol_Cancer_2007_Oct_22_6_66.nxml.txt.nlp	17953743	SENT150	29	29	18	18	cisplatin	Mcl-1	PA449014	4170	0.968
NULL	Arthritis_Res_Ther_2009_Aug_28_11(4)_R131.nxml.txt.nlp	19715572	SENT101	6	6	25	25	rituximab	CD27	PA451261	939	0.968
NULL	Br_J_Cancer_1980_Jul_42(1)_85-94.nxml.txt.nlp	7426332	SENT8	7	7	34	34	warfarin	B12	PA451906	7126;4709	0.968
NULL	Gut_Liver_2012_Apr_17_6(2)_210-217.nxml.txt.nlp	22570750	SENT154	6	6	21	21	diclofenac	cPLA2	PA449293	10524	0.968
NULL	Biologics_2014_Dec_4_8_281-291.nxml.txt.nlp	25506209	SENT74	0	0	29	29	sunitinib	FLT3	PA162372840	2322	0.968
NULL	Cancer_Immunol_Immunother_2011_Jan_21_60(1)_75-85.nxml.txt.nlp	20857100	SENT225	5	5	18	18	fludarabine	IFN	PA449655	3439	0.968
NULL	Ann_Dermatol_2011_Dec_27_23(Suppl_3)_S350-S353.nxml.txt.nlp	22346276	SENT13	0	0	17	17	erlotinib	EGFR	PA134687924	1956	0.968
NULL	Adv_Hematol_2012_Jun_14_2012_523842.nxml.txt.nlp	22761620	SENT42	2	2	32	32	lenalidomide	CDK2	PA162363968	1017	0.968
NULL	Clin_Pharmacokinet_2014_Sep_3_53(1)_1-16.nxml.txt.nlp	23999929	SENT288	14	14	24	24	clarithromycin	CYP3A4	PA449028	1576	0.968
NULL	Mol_Cancer_2010_Jun_24_9_164.nxml.txt.nlp	20576107	SENT144	10	10	14	14	etoposide	p53	PA449552	7157	0.968
NULL	Front_Synaptic_Neurosci_2014_May_30_6_12.nxml.txt.nlp	24910611	SENT151	25	25	4	4	l-serine	asc-1	PA451330	56301	0.968
NULL	Carcinogenesis_2013_Nov_10_34(11)_2580-2586.nxml.txt.nlp	23843037	SENT398	9	9	15	15	troglitazone	PPARgamma	PA451799	5468	0.968
NULL	Core_Evid_2011_Feb_8_6_23-29.nxml.txt.nlp	21468240	SENT24	7	7	34	34	plerixafor	CD34	PA165958410	947	0.968
NULL	Mol_Immunol_2009_Mar_46(6)_1229-1239.nxml.txt.nlp	19135256	SENT174	7	7	27	27	trypsin	CD205	PA451806	4065	0.968
NULL	Breast_Cancer_Res_2012_Aug_14_14(4)_R117.nxml.txt.nlp	22889108	SENT266	22	22	9	9	epirubicin	TP53	PA449476	7157	0.968
NULL	Biochemistry_2008_Nov_4_47(44)_11446-11456.nxml.txt.nlp	18842000	SENT165	8	8	0	0	trypsin	BARD1	PA451806	580	0.968
NULL	Clin_Exp_Gastroenterol_2012_Jan_12_5_1-10.nxml.txt.nlp	22346361	SENT69	15	15	13	13	ketoconazole	CYP3A4	PA450146	1576	0.968
NULL	Cell_Death_Differ_2010_Oct_30_17(10)_1624-1635.nxml.txt.nlp	20431602	SENT81	18	18	8	8	paclitaxel	Bcl-2	PA450761	596	0.968
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT29	25	25	11	11	epirubicin	HER2	PA449476	2064	0.968
NULL	Exp_Hematol_Oncol_2014_Mar_11_3_7.nxml.txt.nlp	24618035	SENT158	11	11	4	4	imatinib	CXCL12	PA10804	6387	0.968
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_39-54.nxml.txt.nlp	19305787	SENT577	18	18	5	5	ethanol	NR1	PA448073	27158	0.968
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Oct_31_66(Pt_11)_o2999.nxml.txt.nlp	21589160	SENT65	36	36	6	6	ethanol	mol	PA448073	90527	0.968
NULL	Br_J_Cancer_2012_Jun_5_106(12)_1997-2003.nxml.txt.nlp	22596232	SENT205	2	2	7	7	sorafenib	JNK	PA7000	5599	0.968
NULL	J_Gen_Physiol_2010_Jan_135(1)_3-13.nxml.txt.nlp	20038523	SENT287	5	5	29	29	bumetanide	ANOVA	PA448682	4858	0.968
NULL	J_Cell_Mol_Med_2015_Jan_14_19(1)_53-61.nxml.txt.nlp	25311234	SENT51	24	24	6	6	isoflurane	APLN	PA450106	8862	0.968
NULL	Br_J_Cancer_2012_Feb_14_106(4)_748-755.nxml.txt.nlp	22240781	SENT184	27	27	8	8	cetuximab	KRAS	PA10040	3845	0.968
NULL	Arthritis_Res_Ther_2007_Mar_5_9(2)_205.nxml.txt.nlp	17349064	SENT55	6	6	14	14	hyaluronan	TLR4	PA165958431	7099	0.968
NULL	Br_J_Cancer_2013_May_14_108(9)_1862-1869.nxml.txt.nlp	23579219	SENT119	13	13	2	2	cetuximab	ISX	PA10040	91464	0.968
NULL	Cancer_Cell_Int_2011_Mar_25_11_7.nxml.txt.nlp	21439058	SENT159	21	21	3	3	daunorubicin	ILK	PA449212	3611	0.968
NULL	Gastric_Cancer_2013_Jul_12_16(3)_345-354.nxml.txt.nlp	22968820	SENT142	4	4	39	39	oxaliplatin	FANCJ	PA131285527	83990	0.968
NULL	Gastric_Cancer_2013_Jul_12_16(3)_345-354.nxml.txt.nlp	22968820	SENT205	26	26	30	30	oxaliplatin	FANCJ	PA131285527	83990	0.968
NULL	Br_J_Cancer_2004_Mar_8_90(5)_944-949.nxml.txt.nlp	14997187	SENT68	11	11	15	15	fulvestrant	aromatase	PA164747170	1588	0.968
NULL	Diabetes_Care_2009_Nov_32(Suppl_2)_S373-S377.nxml.txt.nlp	19875584	SENT73	3	3	23	23	fenofibrate	HDL2	PA449594	57338	0.968
NULL	Oncotarget_2014_Oct_18_5(22)_11641-11652.nxml.txt.nlp	25361002	SENT208	4	4	19	19	cisplatin	ERCC1	PA449014	2067	0.968
NULL	Arthritis_Res_Ther_2008_Oct_15_10(Suppl_1)_S5.nxml.txt.nlp	19007425	SENT65	5	5	14	14	abatacept	ACR	PA164747080	49	0.968
NULL	Biomed_Res_Int_2014_Jan_29_2014_196249.nxml.txt.nlp	24605321	SENT203	5	5	19	19	bortezomib	PUMA	PA10252	27113	0.968
NULL	Toxins_(Basel)_2010_Mar_31_2(4)_517-551.nxml.txt.nlp	22069598	SENT195	30	30	1	1	genistein	PTEN	PA165109660	5728	0.968
NULL	J_Korean_Med_Sci_2007_Jun_30_22(3)_557-559.nxml.txt.nlp	17596671	SENT80	14	14	0	0	warfarin	CYP2C9	PA451906	1559	0.968
NULL	Breast_Cancer_Res_2010_Jun_28_12(3)_R43.nxml.txt.nlp	20579400	SENT161	12	12	4	4	tamoxifen	MAPT	PA451581	4137	0.968
NULL	Oncol_Lett_2013_Sep_12_6(3)_860-864.nxml.txt.nlp	24137426	SENT29	28	28	17	17	ketoconazole	CYP1A1	PA450146	1543	0.968
NULL	J_Clin_Biochem_Nutr_2007_Nov_30_41(3)_154-159.nxml.txt.nlp	18299709	SENT344	18	18	5	5	sn-38	ATP7A		538	0.968
NULL	Cell_Commun_Signal_2014_Nov_7_12(1)_73.nxml.txt.nlp	NULL	SENT203	14	14	6	6	tamoxifen	THOC5	PA451581	8563	0.968
NULL	Int_J_Mol_Sci_2010_Nov_15_11(11)_4539-4555.nxml.txt.nlp	21151455	SENT3	19	19	27	27	naringenin	mol	PA151958361	90527	0.968
NULL	J_Cell_Mol_Med_2013_May_12_17(5)_636-647.nxml.txt.nlp	23577651	SENT100	1	1	12	12	thrombin	ADP	PA451674	23038	0.968
NULL	Gut_Liver_2012_Oct_18_6(4)_464-470.nxml.txt.nlp	23170151	SENT105	5	5	42	42	propofol	ESD	PA451141	2098	0.968
NULL	Cardiovasc_Diabetol_2013_May_4_12_73.nxml.txt.nlp	23642288	SENT172	3	3	21	21	acarbose	GLP-1	PA448010	100125288	0.968
NULL	Crit_Rev_Toxicol_2013_Feb_25_43(2)_119-153.nxml.txt.nlp	23346981	SENT271	35	35	27	27	phenol	CYP2E1	PA450913	1571	0.968
NULL	Brain_Sci_2013_Jun_14_3(2)_941-963.nxml.txt.nlp	24961432	SENT192	34	34	14	14	ethanol	IRAK	PA448073	3654	0.968
NULL	Indian_J_Pharmacol_2009_Aug_41(4)_167-172.nxml.txt.nlp	20523867	SENT139	1	1	13	13	imatinib	CYP3A4	PA10804	1576	0.968
NULL	Cancer_Cell_Int_2012_Jul_4_12_19.nxml.txt.nlp	22631225	SENT181	34	34	4	4	heparin	IL-8	PA449855	3576	0.968
NULL	Int_J_Breast_Cancer_2011_Sep_8_2011_595092.nxml.txt.nlp	22295229	SENT88	34	34	27	27	letrozole	aromatase	PA450196	1588	0.968
NULL	Oncotarget_2014_Oct_11_5(20)_10070-10083.nxml.txt.nlp	25301722	SENT176	20	20	10	10	cetuximab	EGFR	PA10040	1956	0.968
NULL	Br_J_Cancer_2010_Nov_9_103(10)_1548-1553.nxml.txt.nlp	20924376	SENT26	0	0	19	19	paclitaxel	castor	PA450761	54897	0.968
NULL	Oncotarget_2012_Sep_11_3(9)_1026-1035.nxml.txt.nlp	22976441	SENT89	42	42	9	9	etoposide	ATM	PA449552	472	0.968
NULL	Arthritis_Rheumatol_2014_Jun_27_66(6)_1574-1582.nxml.txt.nlp	24577881	SENT154	14	14	0	0	hydralazine	CD4	PA449894	920	0.968
NULL	J_Biol_Chem_2009_Apr_3_284(14)_9558-9565.nxml.txt.nlp	19202191	SENT71	13	13	7	7	camptothecin	CtIP	PA153590860	5932	0.968
NULL	Oxid_Med_Cell_Longev_2012_May_28_2012_632959.nxml.txt.nlp	22690272	SENT129	15	15	1	1	genistein	ROS	PA165109660	6098	0.968
NULL	J_Thromb_Haemost_2014_May_22_12(5)_748-760.nxml.txt.nlp	24612393	SENT19	16	16	11	11	thrombin	TSC2	PA451674	7249	0.968
NULL	Adv_Biomed_Res_2014_Sep_8_3_189.nxml.txt.nlp	25298958	SENT90	37	37	11	11	amoxicillin	NAC	PA448406	22861	0.968
NULL	Front_Genet_2012_Oct_26_3_213.nxml.txt.nlp	23112805	SENT255	2	2	6	6	furafylline	CYP1A2	PA452614	1544	0.968
NULL	Hum_Genomics_2011_Oct_1_5(6)_577-622.nxml.txt.nlp	22155605	SENT619	13	13	33	33	tamoxifen	CYP2D6	PA451581	1565	0.968
NULL	Endocrinol_Diabetes_Metab_Case_Rep_2014_Sep_1_2014_140072.nxml.txt.nlp	25332771	SENT54	0	0	21	21	sitagliptin	DPP4	PA164748978	1803	0.968
NULL	Clin_Pract_2012_Feb_15_2(2)_e31.nxml.txt.nlp	24765430	SENT35	26	26	1	1	lamivudine	CD4	PA450163	920	0.968
NULL	Genet_Mol_Biol_2010_Dec_1_Oct-Dec_33(4)_686-695.nxml.txt.nlp	21637578	SENT60	22	22	13	13	ampicillin	UGDH	PA448419	7358	0.968
NULL	Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.nxml.txt.nlp	24736980	SENT7	8	8	19	19	rosuvastatin	OATP1B1	PA134308647	10599	0.968
NULL	Br_J_Cancer_2010_Oct_12_103(8)_1192-1200.nxml.txt.nlp	20877358	SENT190	27	27	15	15	mitomycin	BRCA2	PA450524	675	0.968
NULL	Oncotarget_2013_Aug_21_4(9)_1484-1495.nxml.txt.nlp	23986086	SENT166	33	33	6	6	metformin	PIK3CA	PA450395	5290	0.968
NULL	Front_Endocrinol_(Lausanne)_2013_Sep_4_4_116.nxml.txt.nlp	24027559	SENT38	7	7	19	19	estradiol	SULT1E1	PA449503	6783	0.968
NULL	Gene_Regul_Syst_Bio_2014_Mar_4_8_63-73.nxml.txt.nlp	24634581	SENT78	15	15	4	4	minocycline	BNIP3	PA450519	664	0.968
NULL	Clin_Med_Insights_Cardiol_2010_Dec_1_4_117-128.nxml.txt.nlp	21151850	SENT195	30	30	0	0	cilostazol	CYP2C19	PA164746334	1557	0.968
NULL	Br_J_Cancer_2009_Jul_21_101(2)_238-243.nxml.txt.nlp	19568242	SENT115	16	16	33	33	bevacizumab	IFN	PA130232992	3439	0.968
NULL	Biosci_Rep_2014_Dec_8_34(6)_e00156.nxml.txt.nlp	25307539	SENT316	15	15	1	1	diethylstilbestrol	HOXA10	PA449307	3206	0.968
NULL	Diabetes_Metab_Syndr_Obes_2010_Jul_20_3_263-273.nxml.txt.nlp	21437094	SENT52	0	0	7	7	exenatide	GLP-1	PA164749238	100125288	0.968
NULL	Curr_Cardiol_Rev_2009_Aug_5(3)_166-176.nxml.txt.nlp	20676275	SENT201	0	0	4	4	domperidone	CYP3A4	PA134711056	1576	0.968
NULL	J_Neurovirol_2013_Jun_4_19(4)_351-358.nxml.txt.nlp	23733308	SENT72	4	4	19	19	mefloquine	SOC	PA450348	91544	0.968
NULL	Am_J_Case_Rep_2014_Mar_21_15_119-122.nxml.txt.nlp	24696753	SENT87	34	34	11	11	hydroxychloroquine	DPP4	PA164777036	1803	0.968
NULL	Cancer_Manag_Res_2011_May_10_3_157-175.nxml.txt.nlp	21625399	SENT136	7	7	32	32	tolbutamide	CYP2C9	PA451718	1559	0.968
NULL	Blood_Cancer_J_2014_Aug_22_4(8)_e240.nxml.txt.nlp	25148222	SENT210	0	0	17	17	pimozide	SYK	PA450965	6850	0.968
NULL	Cancer_Cell_Int_2009_Sep_10_9_25.nxml.txt.nlp	19744341	SENT173	20	20	16	16	glucosamine	survivin	PA164747613	332	0.968
NULL	Blood_Cancer_J_2012_Jan_13_2(1)_e50.nxml.txt.nlp	22829234	SENT126	18	18	1	1	bortezomib	CD138	PA10252	6382	0.968
NULL	Onco_Targets_Ther_2014_Jul_1_7_1185-1193.nxml.txt.nlp	25061320	SENT114	30	30	22	22	erlotinib	EGFR	PA134687924	1956	0.968
NULL	Eur_J_Clin_Pharmacol_2008_Feb_26_64(2)_133-157.nxml.txt.nlp	18224312	SENT53	32	32	8	8	debrisoquine	CYP2D6	PA452616	1565	0.968
NULL	Scientifica_(Cairo)_2013_Dec_30_2013_637629.nxml.txt.nlp	24490108	SENT340	24	24	8	8	doxorubicin	PSMD14	PA449412	10213	0.968
NULL	J_Biol_Chem_2013_Dec_6_288(49)_35387-35395.nxml.txt.nlp	24142790	SENT151	0	0	6	6	meclizine	PCYT2	PA450338	5833	0.968
NULL	Case_Rep_Transplant_2012_Aug_30_2012_672923.nxml.txt.nlp	23259137	SENT46	41	41	16	16	asparaginase	CD19	PA448492	930	0.968
NULL	Mar_Drugs_2010_May_26_8(6)_1750-1762.nxml.txt.nlp	20631867	SENT54	15	15	1	1	clarithromycin	zeta	PA449028	9907	0.968
NULL	Case_Rep_Oncol_2013_Dec_12_6(3)_602-608.nxml.txt.nlp	24474924	SENT23	3	3	14	14	erlotinib	CYP3A4	PA134687924	1576	0.968
NULL	Oncotarget_2012_May_4_3(4)_371-394.nxml.txt.nlp	22564882	SENT270	21	21	5	5	etoposide	PI3K	PA449552	5290	0.968
NULL	Cancer_Immunol_Immunother_2011_Jan_21_60(1)_75-85.nxml.txt.nlp	20857100	SENT154	33	33	3	3	fludarabine	CD4	PA449655	920	0.968
NULL	J_Skin_Cancer_2012_Oct_22_2012_706452.nxml.txt.nlp	23133758	SENT179	36	36	32	32	vemurafenib	BRAF	PA165946873	673	0.968
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT86	28	28	16	16	cisplatin	ERCC1	PA449014	2067	0.968
NULL	Clinics_2008_Jun_63(3)_381-388.nxml.txt.nlp	18568250	SENT54	21	21	8	8	ketamine	CEE	PA450144	51608	0.968
NULL	J_Vet_Med_Sci_2014_Feb_8_76(2)_173-182.nxml.txt.nlp	24107430	SENT14	5	5	33	33	yohimbine	AVP	PA451946	114548;551	0.968
NULL	Acta_Pharmacol_Sin_2010_Dec_22_31(12)_1576-1582.nxml.txt.nlp	21102485	SENT136	26	26	42	42	ethanol	PI3K	PA448073	5290	0.968
NULL	Carcinogenesis_2014_May_13_35(5)_1055-1066.nxml.txt.nlp	24419232	SENT177	11	11	20	20	metformin	CCL2	PA450395	6347	0.968
NULL	EPMA_J_2011_Jun_20_2(2)_141-147.nxml.txt.nlp	23199143	SENT120	18	18	29	29	cetuximab	KRAS	PA10040	3845	0.968
NULL	Int_J_Surg_Oncol_2012_Jun_12_2012_862879.nxml.txt.nlp	22778941	SENT111	35	35	5	5	cisplatin	c-Myc	PA449014	4609	0.968
NULL	Carcinogenesis_2014_May_13_35(5)_1055-1066.nxml.txt.nlp	24419232	SENT327	24	24	7	7	metformin	AMPK	PA450395	5563	0.968
NULL	Br_J_Cancer_1998_Oct_78(8)_1024-1029.nxml.txt.nlp	9792145	SENT12	38	38	24	24	doxorubicin	CD34	PA449412	947	0.968
NULL	Aging_Cell_2012_Aug_11(4)_579-587.nxml.txt.nlp	22435726	SENT10	7	7	20	20	etoposide	CD28	PA449552	1493;940	0.968
NULL	Int_J_Gen_Med_2012_Jun_18_5_535-540.nxml.txt.nlp	22807641	SENT81	20	20	17	17	pitavastatin	adiponectin	PA142650384	9370	0.968
NULL	Mol_Med_Rep_2015_Jan_22_11(1)_83-90.nxml.txt.nlp	25338529	SENT143	8	8	21	21	octreotide	HO-1	PA450678	3162	0.968
NULL	BMB_Rep_2013_Aug_46(8)_410-415.nxml.txt.nlp	23977989	SENT107	35	35	19	19	curcumin	HO-1	PA151958596	3162	0.968
NULL	Oncotarget_2014_Aug_12_5(20)_9710-9726.nxml.txt.nlp	25339152	SENT213	8	8	21	21	pp2	DGK		8526;1607	0.968
NULL	Nat_Med_2010_Nov_24_16(11)_1299-1304.nxml.txt.nlp	20972434	SENT32	9	9	36	36	colchicine	ASM	PA449092	6609;283120	0.968
NULL	Mol_Cancer_2009_Dec_23_8_129.nxml.txt.nlp	20030852	SENT237	24	24	14	14	curcumin	ABCA1	PA151958596	19	0.968
NULL	J_Invest_Dermatol_2012_Nov_14_132(11)_2601-2609.nxml.txt.nlp	22696056	SENT194	17	17	3	3	guanabenz	PERK	PA164774903	9451	0.968
NULL	Clin_Med_Insights_Oncol_2012_May_16_6_205-217.nxml.txt.nlp	22654526	SENT158	15	15	22	22	decitabine	FLT3	PA164749631	2322	0.968
NULL	J_Immunol_Res_2014_Jul_16_2014_696812.nxml.txt.nlp	25133198	SENT124	26	26	10	10	rifaximin	TLR4	PA164752443	7099	0.968
NULL	Cell_Death_Dis_2014_Mar_13_5(3)_e1112.nxml.txt.nlp	24625971	SENT66	25	25	10	10	curcumin	JNK	PA151958596	5599	0.968
NULL	Oncol_Rep_2014_Aug_16_32(2)_523-529.nxml.txt.nlp	24939415	SENT119	1	1	22	22	bevacizumab	CD74	PA130232992	972	0.968
NULL	Contemp_Oncol_(Pozn)_2012_Jan_4_16(6)_582-585.nxml.txt.nlp	23788948	SENT5	15	15	9	9	trastuzumab	HER2	PA451743	2064	0.968
NULL	Pharmaceuticals_(Basel)_2011_Nov_11_4(11)_1503-1517.nxml.txt.nlp	NULL	SENT116	6	6	33	33	capsaicin	TRPV1	PA448776	7442	0.968
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Oct_28_65(Pt_11)_o2899.nxml.txt.nlp	21578481	SENT63	6	6	28	28	isoniazid	mol	PA450112	90527	0.968
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT206	23	23	8	8	perifosine	DR4	PA165291471	8797	0.968
NULL	Oncol_Lett_2013_Jun_16_5(6)_1854-1858.nxml.txt.nlp	23833655	SENT31	14	14	0	0	paclitaxel	COL4A3BP	PA450761	10087	0.968
NULL	Front_Oncol_2014_Apr_22_4_86.nxml.txt.nlp	24795863	SENT375	32	32	13	13	etoposide	DNA-PKcs	PA449552	5591	0.968
NULL	Orphanet_J_Rare_Dis_2007_Jan_4_2_1.nxml.txt.nlp	17204147	SENT88	15	15	0	0	trypsin	SPINK1	PA451806	6690	0.968
NULL	Mol_Cancer_2014_Jun_12_13_148.nxml.txt.nlp	24924916	SENT37	28	28	14	14	geldanamycin	Hsp90	PA152031327	3320	0.968
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_91-103.nxml.txt.nlp	17912639	SENT71	27	27	33	33	lapatinib	HER2	PA152241907	2064	0.968
NULL	Breast_Cancer_Res_2013_Nov_29_15(6)_R114.nxml.txt.nlp	24289103	SENT318	21	21	9	9	tamoxifen	EGFR	PA451581	1956	0.968
NULL	Cancer_Cell_Int_2012_Jun_18_12_28.nxml.txt.nlp	22709531	SENT70	43	43	9	9	imatinib	p120ctn	PA10804	1500	0.968
NULL	Biologics_2009_Jul_13_3_289-301.nxml.txt.nlp	19707416	SENT213	0	0	24	24	everolimus	HER2	PA164746311	2064	0.968
NULL	Cancer_Cell_Int_2010_Apr_29_10_12.nxml.txt.nlp	20429927	SENT138	11	11	1	1	bortezomib	HRI	PA10252	27102	0.968
NULL	Clin_Drug_Investig_2013_Aug_23_33(10)_727-736.nxml.txt.nlp	23975654	SENT172	12	12	22	22	paroxetine	CYP2D6	PA450801	1565	0.968
NULL	Acta_Pharmacol_Sin_2010_Feb_5_31(2)_137-144.nxml.txt.nlp	20139896	SENT115	16	16	14	14	zileuton	5-LOX	PA451955	240	0.968
NULL	Nat_Med_2012_Jul_18(7)_1118-1122.nxml.txt.nlp	22683780	SENT49	5	5	36	36	crizotinib	MET	PA165946122	4233	0.968
NULL	Cancers_(Basel)_2013_Nov_26_5(4)_1601-1618.nxml.txt.nlp	24287743	SENT122	12	12	33	33	gefitinib	EGFR	PA131301952	1956	0.968
NULL	Chem_Rev_2014_Jun_11_114(11)_5753-5774.nxml.txt.nlp	24758331	SENT78	0	0	8	8	tariquidar	P-gp		5243	0.968
NULL	Breast_Cancer_Res_2007_Jan_23_9(1)_R7.nxml.txt.nlp	17244352	SENT152	20	20	0	0	tamoxifen	SULT1A1	PA451581	6817	0.968
NULL	Cell_Mol_Life_Sci_2011_Oct_5_68(19)_3175-3199.nxml.txt.nlp	21818551	SENT544	19	19	7	7	paclitaxel	IL-2	PA450761	3558	0.968
NULL	J_Hematol_Oncol_2012_Sep_18_5_57.nxml.txt.nlp	22989009	SENT254	5	5	10	10	nutlin-3	p53		7157	0.968
NULL	Front_Plant_Sci_2012_Mar_19_3_54.nxml.txt.nlp	22639652	SENT134	18	18	1	1	propranolol	DGK	PA451145	8526;1607	0.968
NULL	J_Korean_Med_Sci_2014_Jul_11_29(7)_965-972.nxml.txt.nlp	25045229	SENT14	14	14	20	20	metformin	B12	PA450395	7126;4709	0.968
NULL	Biologics_2014_Dec_4_8_281-291.nxml.txt.nlp	25506209	SENT58	0	0	27	27	sorafenib	BRAF	PA7000	673	0.968
NULL	J_Invest_Dermatol_2014_Feb_10_134(2)_319-325.nxml.txt.nlp	24108405	SENT125	25	25	15	15	vemurafenib	BRAF	PA165946873	673	0.968
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Aug_17_67(Pt_9)_o2351.nxml.txt.nlp	22058967	SENT78	32	32	7	7	ethanol	mol	PA448073	90527	0.968
NULL	Oncotarget_2013_Feb_17_4(1)_7-8.nxml.txt.nlp	23448894	SENT1	19	19	22	22	imatinib	ABL1	PA10804	25	0.968
NULL	Oncol_Lett_2014_May_11_7(5)_1401-1408.nxml.txt.nlp	24765145	SENT137	13	13	7	7	paclitaxel	PI3K	PA450761	5290	0.968
NULL	Int_Arch_Med_2008_Aug_12_1_15.nxml.txt.nlp	18700023	SENT50	21	21	4	4	midazolam	RIG	PA450496	148252;27122;6209	0.968
NULL	Curr_HIV_Res_2014_May_12(3)_174-188.nxml.txt.nlp	24862327	SENT178	17	17	6	6	hemin	HO-1	PA449849	3162	0.968
NULL	Indian_J_Nephrol_2013_Nov-Dec_23(6)_413-414.nxml.txt.nlp	24339517	SENT33	12	12	0	0	cyclosporine	IL2RA	PA449167	3559	0.968
NULL	Int_J_Endocrinol_2014_Jun_25_2014_534904.nxml.txt.nlp	25053942	SENT128	17	17	6	6	amiodarone	AIT	PA448383	160728	0.968
NULL	Oncotarget_2012_Nov_16_3(11)_1439-1454.nxml.txt.nlp	23183822	SENT111	34	34	6	6	paraformaldehyde	U87	PA450790	677775;641648	0.968
NULL	Front_Pharmacol_2014_Dec_10_5_271.nxml.txt.nlp	25540621	SENT124	8	8	33	33	hesperetin	ghrelin	PA164742902	51738	0.968
NULL	Mol_Vis_2007_Jul_12_13_1130-1137.nxml.txt.nlp	17653058	SENT25	4	4	12	12	ketamine	IL-6	PA450144	3569	0.968
NULL	J_Cell_Mol_Med_2014_May_14_18(5)_811-823.nxml.txt.nlp	24628949	SENT118	31	31	11	11	docetaxel	FOXM1	PA449383	2305	0.968
NULL	Environ_Health_Perspect_2011_Mar_10_119(3)_357-363.nxml.txt.nlp	21362589	SENT147	13	13	37	37	picrotoxin	RDX	PA164777007	5962	0.968
NULL	Bioinformation_2012_Jan_6_8(1)_13-19.nxml.txt.nlp	22359429	SENT169	20	20	6	6	curcumin	MRP1	PA151958596	4437	0.968
NULL	J_Thorac_Oncol_2014_Oct_23_9(10)_1443-1448.nxml.txt.nlp	25521397	SENT105	23	23	27	27	erlotinib	EGFR	PA134687924	1956	0.968
NULL	Breast_Cancer_Res_2012_May_14_14(3)_R77.nxml.txt.nlp	22583478	SENT52	5	5	25	25	estradiol	c-Myc	PA449503	4609	0.968
NULL	EMBO_Mol_Med_2013_Jul_30_5(7)_932-948.nxml.txt.nlp	23723167	SENT94	2	2	27	27	pilocarpine	MMP13	PA450962	4322	0.968
NULL	Front_Neurosci_2014_Jan_10_7_270.nxml.txt.nlp	24454277	SENT57	36	36	14	14	ethanol	SIRT1	PA448073	23411	0.968
NULL	J_Cell_Biol_1998_Jun_29_141(7)_1685-1695.nxml.txt.nlp	9647659	SENT22	5	5	38	38	thrombin	PAC1	PA451674	8624;1316;117	0.968
NULL	Oncol_Lett_2013_Feb_7_5(2)_411-416.nxml.txt.nlp	23420500	SENT49	8	8	21	21	cetuximab	Bcl-2	PA10040	596	0.968
NULL	Mol_Biol_Cell_2012_Oct_1_23(19)_3851-3862.nxml.txt.nlp	22875990	SENT80	6	6	0	0	l-leucine	GDH	PA450197	51084;2746	0.968
NULL	Indian_J_Pharm_Sci_2009_Nov-Dec_71(6)_622-629.nxml.txt.nlp	20376214	SENT183	4	4	13	13	captopril	B10	PA448780	5169	0.968
NULL	Mol_Cancer_2009_Aug_25_8_66.nxml.txt.nlp	19706164	SENT12	4	4	22	22	celecoxib	p53	PA448871	7157	0.968
NULL	Adv_Hematol_2012_Mar_8_2012_856341.nxml.txt.nlp	22496694	SENT86	0	0	19	19	rivaroxaban	TKR	PA165958360	8277	0.968
NULL	Evid_Based_Complement_Alternat_Med_2012_May_7_2012_242810.nxml.txt.nlp	22645625	SENT27	17	17	5	5	rifampin	CYP3A4	PA451250	1576	0.968
NULL	Breast_Cancer_Res_2012_Jan_17_14(1)_R12.nxml.txt.nlp	22251451	SENT290	30	30	14	14	tamoxifen	GPER	PA451581	2852	0.968
NULL	Arthritis_Res_Ther_2008_Apr_18_10(2)_206.nxml.txt.nlp	18466633	SENT147	6	6	24	24	amoxicillin	IL-17	PA448406	3605	0.968
NULL	JAKSTAT_2013_Jul_1_2(3)_e24574.nxml.txt.nlp	24069558	SENT49	25	25	6	6	doxycycline	HEK	PA449415	2042	0.968
NULL	Eur_J_Clin_Pharmacol_2008_Feb_26_64(2)_133-157.nxml.txt.nlp	18224312	SENT53	34	34	8	8	sparteine	CYP2D6	PA452610	1565	0.968
NULL	J_Cancer_Epidemiol_2012_Oct_24_2012_294730.nxml.txt.nlp	23150730	SENT241	22	22	3	3	irinotecan	UGT1A1	PA450085	54658	0.968
NULL	Onco_Targets_Ther_2014_Oct_4_7_1817-1828.nxml.txt.nlp	25336973	SENT82	13	13	0	0	oxaliplatin	ERCC1	PA131285527	2067	0.968
NULL	Indian_J_Pharmacol_2013_Mar-Apr_45(2)_155-158.nxml.txt.nlp	23716892	SENT118	3	3	16	16	voriconazole	CYP3A4	PA10233	1576	0.968
NULL	Biosci_Microflora_2011_Nov_17_30(4)_135-140.nxml.txt.nlp	25045319	SENT27	38	38	9	9	genistein	flower	PA165109660	11094	0.968
NULL	Front_Oncol_2014_Jun_27_4_157.nxml.txt.nlp	25019058	SENT122	13	13	29	29	erlotinib	EGFR	PA134687924	1956	0.968
NULL	Nature_2009_Apr_2_458(7238)_591-596.nxml.txt.nlp	19234442	SENT198	13	13	4	4	etoposide	Fe65	PA449552	322	0.968
NULL	Eur_J_Clin_Pharmacol_2010_Aug_21_66(8)_811-812.nxml.txt.nlp	20407763	SENT43	0	0	5	5	proguanil	CYP2C19	PA451124	1557	0.968
NULL	J_Biol_2008_Dec_15_7(10)_38.nxml.txt.nlp	19090980	SENT72	37	37	7	7	artemether	ACT	PA165111698	12;11332;9457;641455	0.968
NULL	Clin_Med_Insights_Arthritis_Musculoskelet_Disord_2012_Mar_5_5_27-42.nxml.txt.nlp	22438671	SENT235	5	5	30	30	tocilizumab	IL-6	PA165292659	3569	0.968
NULL	Am_J_Physiol_Endocrinol_Metab_2010_Feb_17_298(2)_E278-E286.nxml.txt.nlp	19920213	SENT114	10	10	1	1	pioglitazone	adiponectin	PA450970	9370	0.968
NULL	Mol_Cell_Biochem_2012_Apr_3_363(1-2)_135-145.nxml.txt.nlp	22139302	SENT178	7	7	5	5	curcumin	survivin	PA151958596	332	0.968
NULL	Br_J_Cancer_1996_Oct_74(8)_1286-1291.nxml.txt.nlp	8883419	SENT10	3	3	20	20	anastrozole	aromatase	PA448432	1588	0.968
NULL	Endocr_Connect_2012_Dec_5_2(1)_32-37.nxml.txt.nlp	23781316	SENT51	0	0	14	14	levothyroxine	RAI	PA450221	10848;6050	0.968
NULL	Aging_(Albany_NY)_2012_Mar_12_4(3)_146-158.nxml.txt.nlp	22436213	SENT47	7	7	19	19	resveratrol	SIRT1		23411	0.968
NULL	Breast_Cancer_Res_2007_Mar_2_9(2)_205.nxml.txt.nlp	NULL	SENT117	29	29	9	9	trastuzumab	HER-2	PA451743	2064	0.968
NULL	Lipids_Health_Dis_2011_Feb_28_10_38.nxml.txt.nlp	21352602	SENT77	5	5	14	14	atorvastatin	PCSK9	PA448500	255738	0.968
NULL	Biomed_Res_Int_2014_Jan_29_2014_196249.nxml.txt.nlp	24605321	SENT203	5	5	26	26	bortezomib	BIK	PA10252	638	0.968
NULL	Mol_Cancer_2002_Nov_12_1_6.nxml.txt.nlp	12495447	SENT144	15	15	0	0	galactose	Rho	PA449725	29984	0.968
NULL	Clin_Ophthalmol_2014_Feb_5_8_369-373.nxml.txt.nlp	24523577	SENT29	33	33	14	14	cisplatin	TRPM1	PA449014	4308	0.968
NULL	Adolesc_Health_Med_Ther_2014_Sep_26_5_171-182.nxml.txt.nlp	25298741	SENT210	16	16	9	9	benztropine	IMPACT	PA448591	55364	0.968
NULL	Int_J_Endocrinol_2010_Feb_10_2010_625852.nxml.txt.nlp	20169119	SENT129	21	21	4	4	paricalcitol	PTH	PA450798	5741	0.968
NULL	Breast_Cancer_Res_Treat_2013_Jan_8_137(2)_457-464.nxml.txt.nlp	23224144	SENT43	39	39	11	11	trastuzumab	HER2	PA451743	2064	0.968
NULL	Int_J_Fertil_Steril_2014_Mar_9_Apr-Jun_8(1)_51-58.nxml.txt.nlp	24696769	SENT70	14	14	0	0	simvastatin	PON3	PA451363	5446	0.968
NULL	Protein_Cell_2014_Feb_11_5(2)_124-140.nxml.txt.nlp	24515614	SENT41	13	13	0	0	bortezomib	DSS1	PA10252	7979	0.968
NULL	Curr_Gerontol_Geriatr_Res_2010_Jun_20_2010_348174.nxml.txt.nlp	20672050	SENT57	38	38	18	18	gefitinib	EGFR	PA131301952	1956	0.968
NULL	Int_J_Biol_Sci_2014_Jun_10_10(7)_654-663.nxml.txt.nlp	25013375	SENT210	0	0	8	8	itraconazole	SMO	PA450132	6608;54498	0.968
NULL	Int_J_Hypertens_2012_Nov_21_2012_474870.nxml.txt.nlp	23227311	SENT183	42	42	10	10	vasopressin	AT1	PA451858	9197;185	0.968
NULL	eLife_2014_May_6_3_e02482.nxml.txt.nlp	24843002	SENT221	13	13	7	7	etoposide	SETD2	PA449552	29072	0.968
NULL	Clinics_(Sao_Paulo)_2011_Aug_66(8)_1457-1462.nxml.txt.nlp	21915500	SENT101	6	6	16	16	rosuvastatin	IL-6	PA134308647	3569	0.968
NULL	Amino_Acids_2012_Oct_10_43(4)_1751-1759.nxml.txt.nlp	22407485	SENT175	17	17	33	33	carrageenan	ghrelin	PA448814	51738	0.968
NULL	Indian_J_Endocrinol_Metab_2013_Jul-Aug_17(4)_636-646.nxml.txt.nlp	23961479	SENT151	11	11	22	22	nelfinavir	CYP3A4	PA450606	1576	0.968
NULL	ScientificWorldJournal_2013_Sep_26_2013_608415.nxml.txt.nlp	24191141	SENT137	24	24	8	8	ritonavir	APOE	PA451260	348	0.968
NULL	Diabetes_Metab_Syndr_Obes_2014_Mar_18_7_107-120.nxml.txt.nlp	24672252	SENT194	31	31	35	35	liraglutide	GLP-1	PA165958364	100125288	0.968
NULL	Indian_J_Psychol_Med_2013_Jan-Mar_35(1)_23-28.nxml.txt.nlp	23833338	SENT91	26	26	15	15	baclofen	CAGE	PA448533	168400	0.968
NULL	Bioinformation_2012_Dec_19_8(25)_1249-1254.nxml.txt.nlp	23275729	SENT9	3	3	23	23	curcumin	VEGFR	PA151958596	3791	0.968
NULL	Onco_Targets_Ther_2014_Jul_31_7_1367-1373.nxml.txt.nlp	25114575	SENT19	0	0	16	16	lapatinib	EGFR	PA152241907	1956	0.968
NULL	Clin_Sci_(Lond)_2010_Mar_9_118(Pt_11)_681-689.nxml.txt.nlp	20088827	SENT31	0	0	7	7	losartan	AT1	PA450268	9197;185	0.968
NULL	Indian_J_Pharm_Sci_2008_Jan-Feb_70(1)_105-108.nxml.txt.nlp	20390093	SENT23	22	22	17	17	isoniazid	mol	PA450112	90527	0.968
NULL	JAKSTAT_2013_Jul_1_2(3)_e24812.nxml.txt.nlp	24069562	SENT59	23	23	8	8	pp2	STAT3		6774	0.968
NULL	Breast_Cancer_Res_2011_Mar_1_13(2)_R21.nxml.txt.nlp	21362200	SENT70	17	17	19	19	estradiol	PI3K	PA449503	5290	0.968
NULL	Indian_J_Anaesth_2010_Mar-Apr_54(2)_127-131.nxml.txt.nlp	20661350	SENT126	4	4	15	15	nimodipine	ANOVA	PA450633	4858	0.968
NULL	Ann_Indian_Acad_Neurol_2009_Oct-Dec_12(4)_221-225.nxml.txt.nlp	20182568	SENT114	0	0	19	19	abatacept	CTLA4	PA164747080	1493	0.968
NULL	Cell_Death_Dis_2013_Sep_5_4(9)_e791.nxml.txt.nlp	24008735	SENT82	43	43	36	36	gemcitabine	PUMA	PA449748	27113	0.968
NULL	Oncotarget_2012_May_4_3(4)_395-398.nxml.txt.nlp	22565037	SENT9	24	24	11	11	trastuzumab	CD24	PA451743	100133941	0.968
NULL	Breast_Cancer_Res_2012_Apr_4_14(2)_R57.nxml.txt.nlp	22475046	SENT3	23	23	0	0	tamoxifen	CCND1	PA451581	595	0.968
NULL	Genetics_2013_Jan_193(1)_1-50.nxml.txt.nlp	23275493	SENT260	33	33	9	9	choline	DAG	PA448976	1605	0.968
NULL	Ann_Indian_Acad_Neurol_2009_Apr-Jun_12(2)_89-98.nxml.txt.nlp	20142853	SENT193	19	19	9	9	carbamazepine	MRP2	PA448785	100130958;57626;1244	0.968
NULL	BMB_Rep_2014_Oct_47(10)_575-580.nxml.txt.nlp	24499675	SENT102	0	0	24	24	arsenite	ROS	PA452638	6098	0.968
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT288	5	5	22	22	resveratrol	TRAIL		8743	0.968
NULL	Cancer_Res_Treat_2012_Mar_31_44(1)_63-68.nxml.txt.nlp	22500163	SENT128	17	17	6	6	gefitinib	EGFR	PA131301952	1956	0.968
NULL	Breast_Cancer_(Auckl)_2012_Nov_19_6_191-207.nxml.txt.nlp	23226023	SENT84	1	1	12	12	lapatinib	HER2	PA152241907	2064	0.968
NULL	Cancers_(Basel)_2010_Dec_30_3(1)_106-125.nxml.txt.nlp	24212609	SENT21	3	3	32	32	gemcitabine	CNT3	PA449748	64078	0.968
NULL	Biol_Open_2014_Sep_12_3(10)_937-946.nxml.txt.nlp	25217618	SENT181	20	20	11	11	niclosamide	SOST	PA165958408	50964	0.968
NULL	Cancer_Med_2013_Feb_3_2(1)_40-49.nxml.txt.nlp	24133626	SENT137	8	8	17	17	cilostazol	PDE3B	PA164746334	5140	0.968
NULL	Acta_Pharmacol_Sin_2010_Nov_18_31(11)_1447-1453.nxml.txt.nlp	20953204	SENT146	36	36	20	20	rimonabant	IL-6	PA152407999	3569	0.968
NULL	Infection_2007_Jun_35(3)_186-189.nxml.txt.nlp	17565462	SENT24	12	12	32	32	ritonavir	CD4	PA451260	920	0.968
NULL	Orphanet_J_Rare_Dis_2013_Feb_12_8_23.nxml.txt.nlp	23398819	SENT194	16	16	4	4	l-carnitine	BTHS	PA450154	6901	0.968
NULL	J_Korean_Med_Sci_2008_Aug_25_23(4)_685-690.nxml.txt.nlp	18756058	SENT98	30	30	5	5	olanzapine	ghrelin	PA450688	51738	0.968
NULL	Int_J_Biol_Sci_2014_Nov_26_10(10)_1193-1202.nxml.txt.nlp	25516717	SENT138	15	15	3	3	hydroxyurea	SIRT1	PA449942	23411	0.968
NULL	Arthritis_Res_Ther_2011_Mar_16_13(2)_R44.nxml.txt.nlp	21410959	SENT251	4	4	15	15	glucosamine	RANTES	PA164747613	6352	0.968
NULL	J_Korean_Med_Sci_2010_Jun_24_25(6)_829-834.nxml.txt.nlp	20514301	SENT8	39	39	8	8	papain	IL-25	PA450778	64806;56005	0.968
NULL	Arthritis_Res_Ther_2013_Sep_27_15(5)_R138.nxml.txt.nlp	24289726	SENT26	34	34	42	42	tocilizumab	IL-6	PA165292659	3569	0.968
NULL	Nat_Commun_2013_Nov_26_4_2825.nxml.txt.nlp	24281397	SENT51	15	15	0	0	bezafibrate	LSR	PA162364313	51599	0.968
NULL	Cell_Commun_Signal_2013_Oct_1_11_73.nxml.txt.nlp	24083678	SENT25	28	28	12	12	sulindac	COX	PA451565	1351	0.968
NULL	Breast_Cancer_Res_2009_May_29_11(3)_206.nxml.txt.nlp	19519952	SENT36	5	5	23	23	estradiol	PI3K	PA449503	5290	0.968
NULL	Thorax_2012_Oct_12_67(10)_891-900.nxml.txt.nlp	22693178	SENT135	7	7	16	16	capsaicin	TRPA1	PA448776	8989	0.968
NULL	Oncotarget_2013_Aug_21_4(9)_1484-1495.nxml.txt.nlp	23986086	SENT101	10	10	3	3	metformin	PIK3CA	PA450395	5290	0.968
NULL	Arthritis_Res_Ther_2010_Aug_26_12(4)_138.nxml.txt.nlp	20815919	SENT9	45	45	36	36	methylprednisolone	CD64	PA450466	2209	0.968
NULL	Diabetes_Care_2010_Jul_33(7)_1674-1685.nxml.txt.nlp	20587728	SENT287	30	30	36	36	liraglutide	GLP-1	PA165958364	100125288	0.968
NULL	Autoimmune_Dis_2011_Mar_15_2011_961702.nxml.txt.nlp	21547093	SENT53	35	35	15	15	methylprednisolone	IL-4	PA450466	3565	0.968
NULL	Exp_Mol_Med_2012_May_31_44(5)_311-318.nxml.txt.nlp	22282402	SENT77	36	36	1	1	cilostazol	MCP-1	PA164746334	6347	0.968
NULL	Ther_Clin_Risk_Manag_2007_Jun_3(2)_245-258.nxml.txt.nlp	18360633	SENT57	1	1	18	18	etanercept	p55	PA449515	6624;2078;8503;5718	0.968
NULL	Int_J_Mol_Sci_2012_Sep_26_13(10)_12287-12314.nxml.txt.nlp	23202899	SENT333	24	24	16	16	dasatinib	EGFR	PA162372878	1956	0.968
NULL	BMB_Rep_2014_May_47(5)_274-279.nxml.txt.nlp	24286313	SENT74	14	14	27	27	bortezomib	p65	PA10252	5970	0.968
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1126-1134.nxml.txt.nlp	21364592	SENT132	39	39	11	11	capecitabine	ERCC1	PA448771	2067	0.968
NULL	Acta_Pharmacol_Sin_2013_Jul_5_34(7)_893-900.nxml.txt.nlp	23685954	SENT65	15	15	30	30	l-glutamine	CO2	PA10090	4513	0.968
NULL	Int_J_Med_Sci_2015_Jan_1_12(1)_63-71.nxml.txt.nlp	25552920	SENT101	24	24	17	17	berberine	PC-3	PA165860812	692094	0.968
NULL	Cancers_(Basel)_2014_Apr_4_6(2)_796-812.nxml.txt.nlp	24713998	SENT172	30	30	16	16	imatinib	NGAL	PA10804	3934	0.968
NULL	Oncogenesis_2012_Apr_2_1(4)_e5.nxml.txt.nlp	23552603	SENT242	25	25	17	17	ns-398	BIM		10018	0.968
NULL	Endocr_Relat_Cancer_2014_Apr_21(2)_175-187.nxml.txt.nlp	24280133	SENT117	22	22	4	4	doxycycline	PC3	PA449415	57332;7832;5122	0.968
NULL	Exp_Ther_Med_2014_Mar_10_7(3)_640-648.nxml.txt.nlp	24520260	SENT118	11	11	18	18	resveratrol	p38		10598;1432;7965	0.968
NULL	Arthritis_Res_Ther_2011_Feb_28_13(1)_205.nxml.txt.nlp	21371351	SENT64	15	15	4	4	etanercept	TNF	PA449515	7124	0.968
NULL	Neural_Regen_Res_2014_May_15_9(10)_1055-1062.nxml.txt.nlp	25206759	SENT218	25	25	4	4	furosemide	NKCC1	PA449719	6558	0.968
NULL	Psychiatry_Investig_2013_Dec_16_10(4)_425-427.nxml.txt.nlp	24474994	SENT41	0	0	7	7	ziprasidone	CYP3A4	PA451974	1576	0.968
NULL	Nucleic_Acids_Res_2014_Jan_1_42(1)_643-660.nxml.txt.nlp	24097436	SENT188	36	36	6	6	doxycycline	TRF4	PA449415	11044	0.968
NULL	Cell_Death_Dis_2014_Feb_27_5(2)_e1088.nxml.txt.nlp	24577086	SENT12	20	20	16	16	metformin	Bcl-2	PA450395	596	0.968
NULL	Mol_Cancer_2009_Dec_23_8_129.nxml.txt.nlp	20030852	SENT216	8	8	29	29	curcumin	p65	PA151958596	5970	0.968
NULL	J_Cardiovasc_Dis_Res_2010_Oct-Dec_1(4)_165-170.nxml.txt.nlp	21264179	SENT58	3	3	22	22	thrombin	RhoA	PA451674	387	0.968
NULL	Indian_J_Pharmacol_2009_Aug_41(4)_167-172.nxml.txt.nlp	20523867	SENT139	1	1	19	19	imatinib	CYP2C9	PA10804	1559	0.968
NULL	EMBO_Mol_Med_2012_Jun_13_4(6)_515-527.nxml.txt.nlp	22416035	SENT144	41	41	22	22	olaparib	p53		7157	0.968
NULL	Front_Immunol_2013_Oct_8_4_289.nxml.txt.nlp	24115947	SENT348	19	19	29	29	dextran	NLRP3	PA449261	114548	0.968
NULL	J_Mol_Signal_2014_Aug_8_9_8.nxml.txt.nlp	25237386	SENT200	27	27	5	5	sc-560	PTGS2		5743	0.968
NULL	J_Hematol_Oncol_2013_Jun_3_6_38.nxml.txt.nlp	23731980	SENT175	6	6	19	19	afatinib	HER2	PA165981154	2064	0.968
NULL	Oncotarget_2012_Nov_17_3(12)_1600-1614.nxml.txt.nlp	23307622	SENT98	34	34	46	46	trastuzumab	ATG12	PA451743	9140	0.968
NULL	Br_J_Cancer_2010_Jun_29_103(1)_1-5.nxml.txt.nlp	20461086	SENT3	14	14	7	7	oxygen	PHD2	PA450744	54583	0.968
NULL	Br_J_Cancer_2014_Dec_9_111(12)_2379-2380.nxml.txt.nlp	24619075	SENT12	28	28	1	1	irinotecan	KRAS	PA450085	3845	0.968
NULL	Breast_Cancer_Res_2011_Apr_14_13(2)_R43.nxml.txt.nlp	21492444	SENT211	23	23	6	6	doxycycline	PTEN	PA449415	5728	0.968
NULL	Mol_Cancer_2010_Oct_12_9_269.nxml.txt.nlp	20939893	SENT215	34	34	4	4	isoproterenol	c-Jun	PA450121	3725	0.968
NULL	Front_Microbiol_2014_Mar_14_5_99.nxml.txt.nlp	24672516	SENT82	30	30	16	16	caspofungin	TLR4	PA164743013	7099	0.968
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_75-89.nxml.txt.nlp	17912638	SENT1	15	15	2	2	tamoxifen	aromatase	PA451581	1588	0.968
NULL	Orphanet_J_Rare_Dis_2010_Dec_16_5_39.nxml.txt.nlp	21162721	SENT76	17	17	5	5	lamotrigine	HLA-B	PA450164	3106	0.968
NULL	Acta_Pharmacol_Sin_2009_Oct_21_30(10)_1392-1398.nxml.txt.nlp	19767766	SENT185	3	3	9	9	atorvastatin	DPI	PA448500	1832	0.968
NULL	Nucleic_Acids_Res_2011_Sep_7_39(17)_7465-7476.nxml.txt.nlp	21653549	SENT148	23	23	5	5	etoposide	DEK	PA449552	7913	0.968
NULL	J_Cell_Biol_2002_Sep_16_158(6)_1067-1078.nxml.txt.nlp	12235124	SENT74	4	4	12	12	galactose	TCF4	PA449725	6925	0.968
NULL	Environ_Health_Perspect_2005_Oct_14_113(10)_1330-1335.nxml.txt.nlp	16203242	SENT112	5	5	25	25	arsenite	MLC	PA452638	23209	0.968
NULL	Oncotarget_2013_Nov_23_5(1)_196-210.nxml.txt.nlp	24344116	SENT148	16	16	3	3	doxorubicin	p53	PA449412	7157	0.968
NULL	J_Physiol_2011_Mar_1_589(Pt_5)_1081-1093.nxml.txt.nlp	21224236	SENT12	29	29	23	23	nifedipine	GLP-1	PA450631	100125288	0.968
NULL	JAKSTAT_2013_Jul_1_2(3)_e24574.nxml.txt.nlp	24069558	SENT150	20	20	4	4	doxycycline	JAK2	PA449415	3717	0.968
NULL	Curr_Neuropharmacol_2014_Jul_12(4)_365-379.nxml.txt.nlp	25342944	SENT174	9	9	0	0	fluoxetine	GluK4	PA449673	2900	0.968
NULL	Genome_Med_2009_Oct_27_1(10)_99.nxml.txt.nlp	19863774	SENT93	34	34	13	13	gemcitabine	p53	PA449748	7157	0.968
NULL	Oncotarget_2013_Apr_13_4(4)_502-530.nxml.txt.nlp	23594434	SENT429	15	15	2	2	nelfinavir	AKT	PA450606	207	0.968
NULL	Breast_Cancer_Res_2008_Dec_18_10(Suppl_4)_S25.nxml.txt.nlp	19128439	SENT27	12	12	23	23	tamoxifen	aromatase	PA451581	1588	0.968
NULL	J_Lipid_Res_2013_May_54(5)_1410-1420.nxml.txt.nlp	23419260	SENT143	9	9	34	34	tetracycline	IDOL	PA451640	29116	0.968
NULL	Biochemistry_2010_Jan_26_49(3)_623-634.nxml.txt.nlp	19921809	SENT63	37	37	16	16	fluorescein	PSK	PA164746009	9344	0.968
NULL	Adv_Biomed_Res_2012_Aug_28_1_66.nxml.txt.nlp	23459777	SENT121	23	23	1	1	celecoxib	NNT	PA448871	23530	0.968
NULL	CNS_Neurosci_Ther_2010_Jun_16(3)_e1-e17.nxml.txt.nlp	20406250	SENT207	37	37	8	8	fluoxetine	5-HT2A	PA449673	3356	0.968
NULL	ScientificWorldJournal_2014_Nov_26_2014_546192.nxml.txt.nlp	25525621	SENT81	30	30	15	15	taurine	PC1	PA451590	5122	0.968
NULL	Diabetes_Care_2009_Apr_32(4)_531-540.nxml.txt.nlp	19336638	SENT23	5	5	9	9	clopidogrel	ADP	PA449053	23038	0.968
NULL	Front_Neurol_2014_Feb_4_5_13.nxml.txt.nlp	24550886	SENT78	12	12	2	2	cyclophosphamide	ABRA	PA449165	137735	0.968
NULL	J_Mol_Signal_2008_Dec_1_3_18.nxml.txt.nlp	19046439	SENT96	0	0	22	22	metformin	AMPK	PA450395	5563	0.968
NULL	J_Radiat_Res_2014_Nov_16_55(6)_1171-1177.nxml.txt.nlp	25129557	SENT174	5	5	10	10	capecitabine	CRT	PA448771	811	0.968
NULL	J_Korean_Med_Sci_2002_Feb_17(1)_129-132.nxml.txt.nlp	11850603	SENT7	4	4	23	23	cyclophosphamide	CD34	PA449165	947	0.968
NULL	Oncol_Rep_2012_Apr_30_27(4)_923-928.nxml.txt.nlp	22209766	SENT156	27	27	17	17	erlotinib	EGFR	PA134687924	1956	0.968
NULL	Br_J_Cancer_2010_Mar_16_102(6)_1003-1009.nxml.txt.nlp	20179710	SENT35	30	30	17	17	cyclophosphamide	NHS	PA449165	4810	0.968
NULL	Mol_Cancer_2010_Dec_20_9_316.nxml.txt.nlp	21172016	SENT159	9	9	4	4	heparin	CCL21	PA449855	6366	0.968
NULL	Mol_Cancer_2010_Jun_27_9_168.nxml.txt.nlp	20579391	SENT41	3	3	22	22	nilotinib	CML	PA165958345	613	0.968
NULL	Br_J_Cancer_2012_May_8_106(10)_1587-1590.nxml.txt.nlp	22568998	SENT13	6	6	21	21	sunitinib	IFN	PA162372840	3439	0.968
NULL	Ann_Rheum_Dis_2013_Apr_11_72(4)_583-589.nxml.txt.nlp	23144446	SENT9	0	0	30	30	tocilizumab	IL-6	PA165292659	3569	0.968
NULL	Mol_Cancer_2012_Aug_8_11_53.nxml.txt.nlp	22871047	SENT241	18	18	7	7	cisplatin	HIN-1	PA449014	92304	0.968
NULL	Bioinformatics_2013_Mar_15_29(6)_671-677.nxml.txt.nlp	23341502	SENT37	3	3	24	24	imatinib	ABL1	PA10804	25	0.968
NULL	Genome_Announc_2013_May_30_1(3)_e00257-13.nxml.txt.nlp	23723394	SENT24	18	18	11	11	l-methionine	B12	PA450423	7126;4709	0.968
NULL	Mol_Cancer_2009_Nov_10_8_99.nxml.txt.nlp	19903356	SENT34	17	17	3	3	imatinib	IGFBP3	PA10804	3486	0.968
NULL	Biochimie_2010_Nov_92(11)_1546-1567.nxml.txt.nlp	20615447	SENT206	17	17	8	8	heparin	KLK14	PA449855	43847	0.968
NULL	Mol_Cancer_2014_Apr_29_13_96.nxml.txt.nlp	24779681	SENT212	15	15	34	34	tamoxifen	HER-2	PA451581	2064	0.968
NULL	Cell_Cycle_2012_Jul_15_11(14)_2591.nxml.txt.nlp	22751433	SENT18	21	21	5	5	doxorubicin	p53	PA449412	7157	0.968
NULL	Diabetes_Obes_Metab_2010_Jul_12(7)_604-612.nxml.txt.nlp	20590735	SENT29	0	0	26	26	liraglutide	GLP-1	PA165958364	100125288	0.968
NULL	Nucleic_Acids_Res_2013_Dec_30_41(22)_10268-10282.nxml.txt.nlp	23997120	SENT349	16	16	39	39	olaparib	TRF1		7013	0.968
NULL	Breast_Cancer_(Auckl)_2009_Sep_2_3_61-75.nxml.txt.nlp	19809577	SENT271	10	10	35	35	ethanol	survivin	PA448073	332	0.968
NULL	Front_Endocrinol_(Lausanne)_2011_Nov_10_2_72.nxml.txt.nlp	22649383	SENT83	4	4	19	19	pentobarbital	StAR	PA450859	6770	0.968
NULL	J_Antimicrob_Chemother_2014_Dec_20_69(12)_3329-3334.nxml.txt.nlp	25147095	SENT31	0	0	20	20	nevirapine	CYP3A4	PA450616	1576	0.968
NULL	Surg_Neurol_Int_2013_May_2_4(Suppl_4)_S265-S288.nxml.txt.nlp	23717798	SENT478	1	1	26	26	trastuzumab	HER-2	PA451743	2064	0.968
NULL	Oncotarget_2014_Aug_19_5(18)_8737-8749.nxml.txt.nlp	25228590	SENT170	21	21	10	10	crizotinib	PI3K	PA165946122	5290	0.968
NULL	Aging_(Albany_NY)_2009_Oct_13_1(10)_842-844.nxml.txt.nlp	20157556	SENT20	1	1	9	9	nutlin-3	p53		7157	0.968
NULL	Eur_J_Med_Res_2011_Nov_10_16(11)_491-494.nxml.txt.nlp	22027642	SENT11	0	0	18	18	sunitinib	KIT	PA162372840	3815	0.968
NULL	J_Korean_Med_Sci_2013_Feb_29_28(2)_308-314.nxml.txt.nlp	23399960	SENT31	9	9	20	20	gabapentin	IL-10	PA449720	3586	0.968
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_P108.nxml.txt.nlp	NULL	SENT10	22	22	2	2	piperacillin	CD4	PA450975	920	0.968
NULL	eLife_2013_Nov_5_2_e00969.nxml.txt.nlp	24192036	SENT109	6	6	14	14	vemurafenib	JNK	PA165946873	5599	0.968
NULL	Case_Rep_Oncol_2014_Sep_27_7(3)_681-684.nxml.txt.nlp	25408663	SENT3	0	0	31	31	crizotinib	ALK	PA165946122	238	0.968
NULL	Eur_J_Neurosci_2014_Apr_8_39(7)_1068-1073.nxml.txt.nlp	24712987	SENT50	13	13	23	23	tamoxifen	DISC1	PA451581	27185	0.968
NULL	Biomed_Res_Int_2014_May_18_2014_756078.nxml.txt.nlp	24949467	SENT144	36	36	10	10	bevacizumab	IL-10	PA130232992	3586	0.968
NULL	Oncol_Rep_2012_Apr_30_27(4)_923-928.nxml.txt.nlp	22209766	SENT114	13	13	1	1	erlotinib	EGFR	PA134687924	1956	0.968
NULL	Nat_Med_2010_Sep_22_16(9)_998-1000.nxml.txt.nlp	20729864	SENT30	16	16	39	39	sorafenib	LRRK1	PA7000	79705	0.968
NULL	ACS_Nano_2014_Mar_25_8(3)_2018-2032.nxml.txt.nlp	24555414	SENT256	0	0	27	27	ethanol	mol	PA448073	90527	0.968
NULL	Breast_Cancer_Res_Treat_2013_Jun_30_139(2)_441-451.nxml.txt.nlp	23715630	SENT2	3	3	1	1	exemestane	aromatase	PA449563	1588	0.968
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_7-17.nxml.txt.nlp	17912633	SENT92	13	13	38	38	letrozole	aromatase	PA450196	1588	0.968
NULL	Biomed_Res_Int_2013_Nov_28_2013_789184.nxml.txt.nlp	24369535	SENT15	8	8	10	10	imatinib	CYP3A4	PA10804	1576	0.968
NULL	J_Biomed_Biotechnol_2011_Dec_6_2011_856985.nxml.txt.nlp	21188173	SENT179	12	12	29	29	vorinostat	EGFR	PA164748224	1956	0.968
NULL	Biochem_Res_Int_2012_Jul_1_2012_832059.nxml.txt.nlp	22811914	SENT3	8	8	19	19	doxorubicin	PC3	PA449412	57332;7832;5122	0.968
NULL	Clin_Dev_Immunol_2011_Oct_20_2011_947858.nxml.txt.nlp	22046194	SENT132	4	4	20	20	doxorubicin	PD-L1	PA449412	29126	0.968
NULL	Oxid_Med_Cell_Longev_2013_Apr_21_2013_412576.nxml.txt.nlp	23710286	SENT106	14	14	5	5	curcumin	NRF1	PA151958596	4899;4779	0.968
NULL	Cancer_Cell_2007_Dec_11_12(6)_514-527.nxml.txt.nlp	18068629	SENT176	16	16	29	29	etoposide	AKT	PA449552	207	0.968
NULL	Front_Oncol_2013_Apr_29_3_92.nxml.txt.nlp	23641361	SENT148	3	3	27	27	bevacizumab	IL-2	PA130232992	3558	0.968
NULL	Nat_Commun_2013_Sep_17_4_2464.nxml.txt.nlp	24043118	SENT43	8	8	3	3	estradiol	FGFR2	PA449503	2263	0.968
NULL	Biochim_Biophys_Acta_2014_Jul_1842(7)_959-970.nxml.txt.nlp	24594481	SENT58	4	4	16	16	lipase	FGF21	PA450239	26291	0.968
NULL	Cancers_(Basel)_2014_Jul_8_6(3)_1487-1499.nxml.txt.nlp	25006835	SENT79	19	19	6	6	cisplatin	AMPK	PA449014	5563	0.968
NULL	Acta_Pharmacol_Sin_2014_Jun_5_35(6)_727-737.nxml.txt.nlp	24793312	SENT135	46	46	10	10	telmisartan	B27	PA451605	56246	0.968
NULL	Br_J_Cancer_2012_Jan_3_106(1)_18-24.nxml.txt.nlp	22108516	SENT97	15	15	9	9	irinotecan	XRCC1	PA450085	7515	0.968
NULL	Mol_Cancer_2010_Apr_29_9_95.nxml.txt.nlp	20429933	SENT139	16	16	32	32	etoposide	LC3	PA449552	84557	0.968
NULL	Genome_Biol_2003_Jun_30_4(7)_220.nxml.txt.nlp	12844351	SENT46	20	20	3	3	l-arginine	T1R1	PA448478	80835	0.968
NULL	Nat_Methods_2012_Feb_19_9(4)_396-402.nxml.txt.nlp	22343342	SENT78	23	23	4	4	capsaicin	TRPV1	PA448776	7442	0.968
NULL	Exp_Ther_Med_2014_Sep_14_8(3)_836-840.nxml.txt.nlp	25120610	SENT91	14	14	6	6	fasudil	ROCK1	PA165946121	6093	0.968
NULL	Int_J_Biochem_Cell_Biol_2013_Feb_45(2)_283-291.nxml.txt.nlp	23085378	SENT174	20	20	23	23	anastrozole	aromatase	PA448432	1588	0.968
NULL	J_Korean_Med_Sci_2007_Dec_20_22(6)_1055-1059.nxml.txt.nlp	18162722	SENT137	3	3	16	16	pantoprazole	ESD	PA450774	2098	0.968
NULL	Protein_Cell_2014_Sep_5_5(11)_816-826.nxml.txt.nlp	25185441	SENT131	17	17	4	4	temozolomide	PARP-1	PA451609	25976	0.968
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT197	29	29	6	6	irinotecan	KRAS	PA450085	3845	0.968
NULL	Breast_Cancer_Res_2011_Nov_1_13(6)_226.nxml.txt.nlp	22078097	SENT209	6	6	22	22	docetaxel	CD44	PA449383	960	0.968
NULL	Mol_Cancer_2013_Sep_11_12_104.nxml.txt.nlp	24025152	SENT237	12	12	7	7	gemcitabine	STAT3	PA449748	6774	0.968
NULL	Front_Neurol_2013_Oct_7_4_153.nxml.txt.nlp	24109474	SENT197	0	0	15	15	levetiracetam	HDAC1	PA450206	3065	0.968
NULL	Front_Integr_Neurosci_2012_Feb_27_6_8.nxml.txt.nlp	22375107	SENT23	27	27	11	11	lidocaine	spatial	PA450226	219793	0.968
NULL	Am_J_Trop_Med_Hyg_2012_Aug_1_87(2)_231-241.nxml.txt.nlp	22855752	SENT16	43	43	0	0	artemisinin	ACT	PA165111696	12;11332;9457;641455	0.968
NULL	F1000Res_2013_Mar_5_2_74.nxml.txt.nlp	24358880	SENT151	8	8	0	0	capsaicin	TRPV1	PA448776	7442	0.968
NULL	Front_Genet_2012_Oct_26_3_213.nxml.txt.nlp	23112805	SENT111	35	35	5	5	furafylline	CYP1A2	PA452614	1544	0.968
NULL	Mol_Cancer_2014_Feb_5_13_24.nxml.txt.nlp	24495306	SENT297	32	32	12	12	collagenase	ADAM17	PA449107	6868	0.968
NULL	Behav_Brain_Funct_2012_Mar_9_8_12.nxml.txt.nlp	22404856	SENT91	26	26	4	4	haloperidol	NR4A1	PA449841	3164	0.968
NULL	Neural_Plast_2007_Jan_1_2007_30585.nxml.txt.nlp	25148070	SENT2881	3	3	21	21	forskolin	AC5	PA146096022	111	0.968
NULL	Br_J_Cancer_2004_Mar_22_90(6)_1285-1292.nxml.txt.nlp	15026814	SENT128	7	7	12	12	cisplatin	p53	PA449014	7157	0.968
NULL	Curr_Oncol_2009_May_16(Suppl_1)_S52-S59.nxml.txt.nlp	19478903	SENT72	0	0	4	4	temsirolimus	CYP3A4	PA164746890	1576	0.968
NULL	Case_Rep_Oncol_2014_Jul_23_7(2)_503-508.nxml.txt.nlp	25232318	SENT63	26	26	3	3	crizotinib	KRAS	PA165946122	3845	0.968
NULL	BMJ_2009_Feb_25_338_b438.nxml.txt.nlp	19244302	SENT47	27	27	10	10	tamoxifen	aromatase	PA451581	1588	0.968
NULL	Clin_Pract_2012_Feb_15_2(2)_e31.nxml.txt.nlp	24765430	SENT35	19	19	1	1	zidovudine	CD4	PA451954	920	0.968
NULL	Oncotarget_2014_Oct_21_5(22)_11180-11192.nxml.txt.nlp	25361003	SENT130	33	33	19	19	doxycycline	NTRK1	PA449415	4914	0.968
NULL	Cancer_Metastasis_Rev_2013_Jun_6_32(1-2)_179-188.nxml.txt.nlp	23129208	SENT124	2	2	12	12	lapatinib	HER2	PA152241907	2064	0.968
NULL	Clin_Mol_Allergy_2007_Jan_25_5_1.nxml.txt.nlp	17254346	SENT190	33	33	7	7	curcumin	IL-13	PA151958596	3596	0.968
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT85	9	9	18	18	methotrexate	MSH2	PA450428	4436	0.968
NULL	Thorax_2010_Jul_13_65(7)_654-658.nxml.txt.nlp	20627927	SENT45	6	6	29	29	tobramycin	NAG	PA451704	51594;4669	0.968
NULL	Diabetes_2008_Oct_57(10)_2801-2808.nxml.txt.nlp	18633115	SENT112	23	23	13	13	sulfasalazine	p65	PA451547	5970	0.968
NULL	Protein_Cell_2014_Mar_29_5(3)_214-223.nxml.txt.nlp	24474193	SENT19	11	11	2	2	paclitaxel	CLIP-170	PA450761	6249	0.968
NULL	Clin_Interv_Aging_2010_Nov_19_5_345-354.nxml.txt.nlp	21228900	SENT6	5	5	14	14	denosumab	RANKL	PA166048634	8600	0.968
NULL	Clin_Sci_(Lond)_2012_Jun_122(11)_535-543.nxml.txt.nlp	22233532	SENT125	6	6	22	22	valsartan	TLR4	PA451848	7099	0.968
NULL	Hum_Genomics_2011_May_1_5(4)_265-282.nxml.txt.nlp	21712189	SENT21	32	32	24	24	irinotecan	UGT1A1	PA450085	54658	0.968
NULL	Oncotarget_2014_Nov_4_5(19)_8906-8923.nxml.txt.nlp	25275298	SENT193	10	10	3	3	doxycycline	SMAD4	PA449415	4089	0.968
NULL	Mol_Syst_Biol_2010_Jun_8_6_375.nxml.txt.nlp	20531405	SENT197	9	9	14	14	simvastatin	OSC	PA451363	4047	0.968
NULL	Exp_Diabetes_Res_2012_May_28_2012_924168.nxml.txt.nlp	22693487	SENT17	0	0	4	4	exenatide	GLP-1	PA164749238	100125288	0.968
NULL	Diabetes_Metab_Syndr_Obes_2014_May_23_7_169-183.nxml.txt.nlp	24920930	SENT112	29	29	11	11	clopidogrel	P2Y12	PA449053	64805	0.968
NULL	ISRN_Otolaryngol_2011_Dec_7_2011_931813.nxml.txt.nlp	23724261	SENT139	0	0	7	7	nutlin-3	MDM2		4193	0.968
NULL	Mol_Cancer_2012_Mar_21_11_13.nxml.txt.nlp	22436134	SENT54	28	28	8	8	cisplatin	HuR	PA449014	1994	0.968
NULL	Arthritis_Res_Ther_2013_Oct_2_15(5)_R141.nxml.txt.nlp	24286116	SENT152	5	5	26	26	tocilizumab	IL-6	PA165292659	3569	0.968
NULL	CNS_Neurosci_Ther_2010_Jun_16(3)_e1-e17.nxml.txt.nlp	20406250	SENT207	43	43	8	8	risperidone	5-HT2A	PA451257	3356	0.968
NULL	Allergy_Asthma_Immunol_Res_2013_Sep_7_5(5)_329-336.nxml.txt.nlp	24003391	SENT83	35	35	33	33	indomethacin	COX	PA449982	1351	0.968
NULL	J_Korean_Neurosurg_Soc_2013_Oct_31_54(4)_329-335.nxml.txt.nlp	24294457	SENT184	22	22	47	47	trastuzumab	HER-2	PA451743	2064	0.968
NULL	Adv_Prev_Med_2012_Sep_20_2012_507571.nxml.txt.nlp	21991452	SENT185	0	0	12	12	hydroxocobalamin	B12	PA164768689	7126;4709	0.968
NULL	Crit_Care_2007_Aug_14_11(4)_R87.nxml.txt.nlp	17697359	SENT178	39	39	23	23	dextran	IL-6	PA449261	3569	0.968
NULL	Neuro_Oncol_2010_Apr_27_12(4)_389-400.nxml.txt.nlp	20308316	SENT117	29	29	1	1	chloroquine	p53	PA448948	7157	0.968
NULL	Hum_Genomics_2004_May_1_1(4)_300-306.nxml.txt.nlp	15588489	SENT128	24	24	0	0	imipramine	CYP2D6	PA449969	1565	0.968
NULL	Chin_J_Cancer_2011_Oct_30(10)_655-668.nxml.txt.nlp	21959043	SENT205	0	0	11	11	dasatinib	KIT	PA162372878	3815	0.968
NULL	J_Cell_Mol_Med_2014_May_14_18(5)_811-823.nxml.txt.nlp	24628949	SENT99	34	34	22	22	docetaxel	FOXM1	PA449383	2305	0.968
NULL	Breast_Cancer_Res_2007_Jun_4_9(3)_207.nxml.txt.nlp	17561991	SENT171	47	47	30	30	trastuzumab	HER-2	PA451743	2064	0.968
NULL	Indian_J_Med_Res_2012_Aug_136(2)_249-259.nxml.txt.nlp	22960892	SENT31	15	15	2	2	irinotecan	UGT1A1	PA450085	54658	0.968
NULL	J_Clin_Biochem_Nutr_2007_Jul_27_41(1)_32-42.nxml.txt.nlp	18392098	SENT162	18	18	6	6	curcumin	PARP	PA151958596	142	0.968
NULL	Biol_Proced_Online_2004_Oct_25_6_250-256.nxml.txt.nlp	15514699	SENT176	13	13	3	3	flavopiridol	survivin	PA452627	332	0.968
NULL	Oncol_Lett_2014_Nov_14_8(5)_2086-2092.nxml.txt.nlp	25295095	SENT5	1	1	32	32	gemcitabine	LKB1	PA449748	6794	0.968
NULL	Core_Evid_2008_Jun_3(1)_45-54.nxml.txt.nlp	20694083	SENT228	27	27	5	5	tegaserod	5-HT4	PA130413154	3360	0.968
NULL	Evid_Based_Complement_Alternat_Med_2013_Nov_5_2013_715040.nxml.txt.nlp	24302969	SENT74	19	19	15	15	gentamicin	OPG	PA449753	690	0.968
NULL	Oncotarget_2012_Nov_17_4(1)_18-28.nxml.txt.nlp	23248157	SENT63	20	20	5	5	pargyline	U87	PA450797	677775;641648	0.968
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT270	15	15	23	23	resveratrol	TRAIL		8743	0.968
NULL	Oncotarget_2014_Sep_2_5(19)_9308-9321.nxml.txt.nlp	25301721	SENT71	25	25	5	5	rolipram	MRP4	PA153906323	10257	0.968
NULL	Ann_Clin_Microbiol_Antimicrob_2011_Jul_21_10_30.nxml.txt.nlp	21774834	SENT37	34	34	13	13	cefotiam	IFN	PA164749298	3439	0.968
NULL	Indian_J_Pharmacol_2013_Jan-Feb_45(1)_54-60.nxml.txt.nlp	23543867	SENT172	11	11	1	1	terlipressin	NAC	PA164781020	22861	0.968
NULL	Diabetes_Metab_J_2013_Feb_15_37(1)_72-80.nxml.txt.nlp	23439802	SENT25	0	0	17	17	vildagliptin	GLP-1	PA165958346	100125288	0.968
NULL	Cancers_(Basel)_2014_Jan_15_6(1)_143-152.nxml.txt.nlp	24434543	SENT80	9	9	17	17	lapatinib	HER2	PA152241907	2064	0.968
NULL	Mol_Biol_Cell_2012_Nov_1_23(21)_4212-4225.nxml.txt.nlp	22956765	SENT39	6	6	12	12	thrombin	SHP2	PA451674	5781	0.968
NULL	Oncogene_2013_Sep_26_32(39)_10_1038_onc_2012_491.nxml.txt.nlp	23108394	SENT78	28	28	16	16	epirubicin	FOXM1	PA449476	2305	0.968
NULL	Case_Rep_Oncol_Med_2013_Jul_30_2013_496351.nxml.txt.nlp	23984138	SENT7	5	5	3	3	denosumab	RANKL	PA166048634	8600	0.968
NULL	Cancer_Cell_Int_2014_Jun_11_14_49.nxml.txt.nlp	24991192	SENT97	27	27	20	20	berberine	AMPK	PA165860812	5563	0.968
NULL	Case_Rep_Neurol_Med_2012_Oct_9_2012_745430.nxml.txt.nlp	23091751	SENT72	31	31	22	22	fluoxetine	OAT	PA449673	4942	0.968
NULL	Br_J_Cancer_2009_Jul_21_101(2)_269-277.nxml.txt.nlp	19603033	SENT152	8	8	27	27	cisplatin	XIAP	PA449014	331	0.968
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1196-1204.nxml.txt.nlp	22315058	SENT152	22	22	32	32	gefitinib	HSC3	PA131301952	150353	0.968
NULL	Comb_Chem_High_Throughput_Screen_2010_Feb_13(2)_188-206.nxml.txt.nlp	20053163	SENT247	38	38	11	11	fluconazole	CYP2C19	PA449653	1557	0.968
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT143	13	13	25	25	curcumin	TRAIL	PA151958596	8743	0.968
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT13	30	30	17	17	pp2	EGFR		1956	0.968
NULL	Evid_Based_Complement_Alternat_Med_2014_May_5_2014_730678.nxml.txt.nlp	24883070	SENT138	27	27	13	13	epirubicin	CXCR7	PA449476	57007	0.968
NULL	Breast_Cancer_Res_2007_May_30_9(3)_R34.nxml.txt.nlp	17537232	SENT51	16	16	36	36	tamoxifen	aromatase	PA451581	1588	0.968
NULL	Mol_Cancer_2008_Mar_26_7_27.nxml.txt.nlp	18366759	SENT317	23	23	12	12	etoposide	GPX1	PA449552	2876	0.968
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1033-1038.nxml.txt.nlp	22374460	SENT106	33	33	22	22	capecitabine	HER2	PA448771	2064	0.968
NULL	Clin_Sci_(Lond)_2013_Feb_1_124(Pt_3)_153-164.nxml.txt.nlp	23075334	SENT261	14	14	19	19	resveratrol	SIRT1		23411	0.968
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Apr_8_65(Pt_5)_o1006-o1007.nxml.txt.nlp	21583831	SENT58	14	14	20	20	letrozole	aromatase	PA450196	1588	0.968
NULL	Eur_J_Neurosci_2008_Apr_1_27(7)_1722-1730.nxml.txt.nlp	18380669	SENT183	4	4	1	1	sr144528	CB2		1269	0.968
NULL	J_Korean_Med_Sci_2014_Jul_11_29(7)_965-972.nxml.txt.nlp	25045229	SENT25	33	33	18	18	metformin	B12	PA450395	7126;4709	0.968
NULL	Curr_Cardiol_Rev_2009_Aug_5(3)_166-176.nxml.txt.nlp	20676275	SENT156	23	23	12	12	sotalol	KCNH2	PA451457	3757	0.968
NULL	Br_J_Cancer_2004_May_17_90(10)_2050-2051.nxml.txt.nlp	15138493	SENT21	10	10	3	3	phenytoin	CYP3A4	PA450947	1576	0.968
NULL	Clin_Med_Insights_Oncol_2012_Dec_6_6_407-421.nxml.txt.nlp	23239933	SENT26	18	18	4	4	gefitinib	EGFR	PA131301952	1956	0.968
NULL	Oncotarget_2013_Nov_4_5(1)_161-172.nxml.txt.nlp	24389287	SENT177	29	29	36	36	propranolol	p53	PA451145	7157	0.968
NULL	Arch_Med_Sci_2010_Apr_30_6(2)_201-207.nxml.txt.nlp	22371748	SENT121	10	10	35	35	omeprazole	IL-8	PA450704	3576	0.968
NULL	J_Cell_Mol_Med_2014_Mar_10_18(3)_514-529.nxml.txt.nlp	24410795	SENT276	12	12	21	21	resveratrol	SIRT1		23411	0.968
NULL	Clin_Sarcoma_Res_2014_Jul_29_4_7.nxml.txt.nlp	25089183	SENT52	14	14	33	33	sunitinib	KIT	PA162372840	3815	0.968
NULL	Evid_Based_Complement_Alternat_Med_2011_Feb_14_2011_650263.nxml.txt.nlp	21799686	SENT167	32	32	11	11	atropine	IRS1	PA448505	3667	0.968
NULL	Arthritis_Res_Ther_2004_Jun_21_6(Suppl_2)_S3-S11.nxml.txt.nlp	15228615	SENT38	0	0	13	13	etanercept	p75	PA449515	7133;11168	0.968
NULL	Br_J_Cancer_2011_Jul_26_105(3)_366-371.nxml.txt.nlp	21750556	SENT97	25	25	3	3	trastuzumab	T-bet	PA451743	30009	0.968
NULL	Cancers_(Basel)_2011_Aug_15_3(3)_3331-3352.nxml.txt.nlp	24212957	SENT264	16	16	32	32	erlotinib	VEGFR	PA134687924	3791	0.968
NULL	J_Cell_Mol_Med_2014_Sep_3_18(9)_1840-1850.nxml.txt.nlp	24894955	SENT44	9	9	30	30	ethanol	DMT1	PA448073	4891;1761	0.968
NULL	Br_J_Haematol_2014_Jan_28_164(2)_233-244.nxml.txt.nlp	24206017	SENT18	25	25	1	1	thalidomide	CRBN	PA451644	51185	0.968
NULL	Arthritis_Res_Ther_2012_May_22_14(3)_R121.nxml.txt.nlp	22616846	SENT10	34	34	6	6	methotrexate	COX	PA450428	1351	0.968
NULL	Reprod_Biol_Endocrinol_2003_Oct_9_1_74.nxml.txt.nlp	14613550	SENT199	10	10	29	29	ns-398	COX		1351	0.968
NULL	Br_J_Clin_Pharmacol_2013_Apr_10_75(4)_979-989.nxml.txt.nlp	22882281	SENT31	0	0	29	29	exenatide	GLP-1	PA164749238	100125288	0.968
NULL	Oncotarget_2014_Nov_2_5(21)_10222-10236.nxml.txt.nlp	25400118	SENT100	11	11	2	2	trastuzumab	HER3	PA451743	2065	0.968
NULL	Biomed_Res_Int_2014_Apr_28_2014_153867.nxml.txt.nlp	24877058	SENT304	24	24	17	17	cisplatin	ERCC1	PA449014	2067	0.968
NULL	Cancer_Cell_Int_2011_Aug_19_11_29.nxml.txt.nlp	21854619	SENT221	29	29	17	17	cisplatin	HDAC	PA449014	9734	0.968
NULL	J_Cell_Biol_2002_May_13_157(4)_579-589.nxml.txt.nlp	11994314	SENT116	32	32	16	16	paraformaldehyde	spatial	PA450790	219793	0.968
NULL	Br_J_Cancer_2011_Aug_9_105(4)_523-533.nxml.txt.nlp	21792199	SENT162	0	0	10	10	erlotinib	AKT	PA134687924	207	0.968
NULL	Acta_Pharmacol_Sin_2013_Oct_7_34(10)_1359-1366.nxml.txt.nlp	23933653	SENT136	16	16	9	9	retigabine	KCNQ2	PA144997862	3785	0.968
NULL	Br_J_Cancer_2009_Oct_20_101(8)_1290-1297.nxml.txt.nlp	19755992	SENT11	22	22	9	9	oxaliplatin	HIF-1	PA131285527	29072	0.968
NULL	Mol_Cell_Biochem_2012_Apr_3_363(1-2)_135-145.nxml.txt.nlp	22139302	SENT250	30	30	28	28	curcumin	survivin	PA151958596	332	0.968
NULL	Calcif_Tissue_Int_2010_Aug_15_87(2)_99-107.nxml.txt.nlp	20473488	SENT121	32	32	3	3	forskolin	PTH	PA146096022	5741	0.968
NULL	Mol_Cancer_2013_Nov_11_12_134.nxml.txt.nlp	24215614	SENT162	45	45	27	27	paclitaxel	aromatase	PA450761	1588	0.968
NULL	Acta_Pharmacol_Sin_2012_May_16_33(5)_682-690.nxml.txt.nlp	22504904	SENT196	7	7	16	16	celecoxib	STAT3	PA448871	6774	0.968
NULL	Cell_Death_Dis_2013_Sep_5_4(9)_e789.nxml.txt.nlp	24008733	SENT8	31	31	18	18	minocycline	IL-6	PA450519	3569	0.968
NULL	Crit_Care_2011_Nov_30_15(6)_235.nxml.txt.nlp	22216838	SENT127	23	23	30	30	hyaluronan	NLRP3	PA165958431	114548	0.968
NULL	Braz_J_Med_Biol_Res_2013_Aug_13_46(8)_650-658.nxml.txt.nlp	23969971	SENT191	7	7	35	35	cisplatin	STAT3	PA449014	6774	0.968
NULL	Gut_2013_Apr_14_62(4)_540-549.nxml.txt.nlp	22798500	SENT176	27	27	5	5	cetuximab	EREG	PA10040	2069	0.968
NULL	Cancer_Cell_Int_2013_Apr_10_13_33.nxml.txt.nlp	23574945	SENT156	23	23	8	8	cisplatin	p53	PA449014	7157	0.968
NULL	J_Cell_Biol_1997_Jul_28_138(2)_255-270.nxml.txt.nlp	9230069	SENT378	37	37	5	5	ethanol	CRY2	PA448073	1408	0.968
NULL	J_Hematol_Oncol_2013_Jul_18_6_53.nxml.txt.nlp	23866964	SENT83	19	19	7	7	temsirolimus	HDAC1	PA164746890	3065	0.968
NULL	Eur_J_Clin_Pharmacol_2013_Mar_11_69(3)_327-339.nxml.txt.nlp	22782539	SENT271	10	10	4	4	amiodarone	P-gp	PA448383	5243	0.968
NULL	Core_Evid_2009_Jun_15_4_131-147.nxml.txt.nlp	20694070	SENT256	0	0	5	5	raltegravir	UGT1A1		54658	0.968
NULL	Indian_J_Radiol_Imaging_2010_Aug_20(3)_188-191.nxml.txt.nlp	21042441	SENT62	3	3	12	12	iron	PKAN	PA450087	80025	0.968
NULL	Diabetes_2011_Nov_17_60(11)_2691-2700.nxml.txt.nlp	21896928	SENT350	13	13	19	19	resveratrol	SIRT1		23411	0.968
NULL	Carcinogenesis_2013_Feb_3_34(2)_351-360.nxml.txt.nlp	23125222	SENT49	12	12	20	20	curcumin	NAC	PA151958596	22861	0.968
NULL	J_Oncol_2012_Jun_4_2012_928127.nxml.txt.nlp	22701483	SENT166	30	30	8	8	metformin	CD24	PA450395	100133941	0.968
NULL	Mol_Cancer_2008_May_19_7_40.nxml.txt.nlp	18489772	SENT42	11	11	1	1	bortezomib	PIR	PA10252	8544	0.968
NULL	Emerg_Infect_Dis_2014_Jul_20(7)_1236-1238.nxml.txt.nlp	24960586	SENT44	13	13	20	20	sulfamethoxazole	ST11	PA451544	8466	0.968
NULL	J_Cell_Mol_Med_2013_Sep_11_17(9)_1160-1172.nxml.txt.nlp	23844832	SENT12	24	24	22	22	gefitinib	EGFR	PA131301952	1956	0.968
NULL	Br_J_Pharmacol_2012_Jan_165(2)_390-400.nxml.txt.nlp	21671897	SENT31	0	0	13	13	suramin	P2X4	PA10292	5025	0.968
NULL	EPMA_J_2013_Jan_28_4(1)_3.nxml.txt.nlp	23356214	SENT311	31	31	9	9	cetuximab	PIK3CA	PA10040	5290	0.968
NULL	Core_Evid_2011_Mar_17_6_31-42.nxml.txt.nlp	21468241	SENT260	16	16	10	10	clopidogrel	P2Y12	PA449053	64805	0.968
NULL	Breast_Cancer_Res_2007_Jul_5_9(4)_R41.nxml.txt.nlp	17612393	SENT163	4	4	22	22	celecoxib	Bcl-2	PA448871	596	0.968
NULL	Breast_Cancer_Res_Treat_2014_Nov_24_143(1)_125-133.nxml.txt.nlp	24272078	SENT133	2	2	24	24	everolimus	aromatase	PA164746311	1588	0.968
NULL	Adv_Hematol_2012_Mar_8_2012_856341.nxml.txt.nlp	22496694	SENT206	18	18	3	3	enoxaparin	STARS	PA449463	137735	0.968
NULL	Case_Rep_Transplant_2013_Jun_13_2013_375263.nxml.txt.nlp	23844312	SENT92	25	25	4	4	tacrolimus	CYP3A4	PA451578	1576	0.968
NULL	Oncotarget_2012_Aug_9_3(8)_774-782.nxml.txt.nlp	22885298	SENT69	3	3	21	21	tetracycline	IDH1	PA451640	3417	0.968
NULL	J_Neurosci_Methods_2009_Oct_15_183(2)_107-113.nxml.txt.nlp	19524611	SENT378	19	19	6	6	carbachol	gamma	PA448784	9913	0.968
NULL	Aging_Cell_2012_Aug_11(4)_579-587.nxml.txt.nlp	22435726	SENT109	2	2	24	24	etoposide	CD28	PA449552	1493;940	0.968
NULL	Am_J_Cardiovasc_Drugs_2013_Jun_20_13(5)_331-342.nxml.txt.nlp	23784266	SENT183	30	30	33	33	atorvastatin	P-gp	PA448500	5243	0.968
NULL	Cancer_Cell_Int_2014_Jun_16_14_53.nxml.txt.nlp	24966801	SENT261	4	4	16	16	metformin	p53	PA450395	7157	0.968
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1563-1573.nxml.txt.nlp	22015557	SENT171	9	9	28	28	sunitinib	c-Myc	PA162372840	4609	0.968
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT163	3	3	14	14	atorvastatin	CD14	PA448500	929	0.968
NULL	Acta_Pharmacol_Sin_2010_Sep_2_31(9)_1172-1180.nxml.txt.nlp	20676117	SENT102	0	0	10	10	bsi-201	PARP1		142	0.968
NULL	Indian_J_Ophthalmol_2010_Jan-Feb_58(1)_45-54.nxml.txt.nlp	20029145	SENT163	0	0	8	8	etanercept	p75	PA449515	7133;11168	0.968
NULL	Oncotarget_2012_May_19_3(5)_535-545.nxml.txt.nlp	22619121	SENT9	17	17	8	8	camptothecin	MYCN	PA153590860	4613	0.968
NULL	Structure_2013_Sep_3_21(9)_1648-1658.nxml.txt.nlp	23932590	SENT111	22	22	0	0	mitomycin	FAAP24	PA450524	91442	0.968
NULL	Oncotarget_2014_Jun_8_5(17)_7446-7457.nxml.txt.nlp	25277184	SENT96	30	30	5	5	cisplatin	TRIM8	PA449014	81603	0.968
NULL	Oncotarget_2014_Jun_7_5(14)_5257-5271.nxml.txt.nlp	24913448	SENT92	8	8	3	3	nilotinib	LASP1	PA165958345	3927	0.968
NULL	Oxid_Med_Cell_Longev_2012_Aug_9_2012_680304.nxml.txt.nlp	22928083	SENT7	0	0	8	8	ethanol	CLS	PA448073	1210	0.968
NULL	Front_Endocrinol_(Lausanne)_2014_Oct_9_5_166.nxml.txt.nlp	25346724	SENT201	26	26	15	15	resveratrol	SIRT1		23411	0.968
NULL	J_Infect_Dis_2013_Sep_1_208(5)_801-812.nxml.txt.nlp	23766527	SENT193	1	1	8	8	primaquine	G6PD	PA451103	2539	0.968
NULL	J_Biol_Chem_2008_Oct_31_283(44)_29841-29846.nxml.txt.nlp	18765669	SENT34	1	1	20	20	suramin	P2X1	PA10292	5023	0.968
NULL	J_Biol_Chem_2011_Sep_30_286(39)_34271-34285.nxml.txt.nlp	21784845	SENT221	28	28	17	17	marimastat	CCL2	PA164748329	6347	0.968
NULL	Br_J_Cancer_2012_Dec_4_107(12)_1950-1955.nxml.txt.nlp	23169295	SENT18	18	18	3	3	oxaliplatin	DPD	PA131285527	1806	0.968
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT129	14	14	9	9	trastuzumab	STAT3	PA451743	6774	0.968
NULL	J_Emerg_Trauma_Shock_2012_Oct-Dec_5(4)_279-284.nxml.txt.nlp	23248494	SENT65	6	6	23	23	ketamine	OST	PA450144	1650;23263	0.968
NULL	Oncol_Lett_2014_May_25_7(5)_1711-1717.nxml.txt.nlp	24765206	SENT123	10	10	21	21	genistein	FOXM1	PA165109660	2305	0.968
NULL	F1000_Med_Rep_2009_Nov_26_1_90.nxml.txt.nlp	20948687	SENT22	9	9	18	18	sorafenib	IFN	PA7000	3439	0.968
NULL	Cell_Microbiol_2014_Jun_21_16(6)_797-815.nxml.txt.nlp	24552180	SENT260	6	6	26	26	lovastatin	HMGCR	PA450272	3156	0.968
NULL	Channels_(Austin)_2010_Jan_1_4(1)_22-41.nxml.txt.nlp	19934650	SENT11	0	0	6	6	quinidine	Slo3	PA451209	157855	0.968
NULL	Cancers_(Basel)_2012_Jun_5_4(2)_549-565.nxml.txt.nlp	24213324	SENT11	28	28	8	8	sorafenib	Raf-1	PA7000	5894	0.968
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT158	19	19	2	2	trastuzumab	MUC4	PA451743	4585	0.968
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT667	10	10	25	25	acetaminophen	CYP1A2	PA448015	1544	0.968
NULL	Front_Genet_2014_Sep_10_5_317.nxml.txt.nlp	25309576	SENT156	17	17	20	20	tranylcypromine	LSD1	PA451741	23028	0.968
NULL	Clin_Interv_Aging_2013_Aug_19_8_1089-1095.nxml.txt.nlp	23983461	SENT33	11	11	19	19	minocycline	STZ	PA450519	6484	0.968
NULL	Antiviral_Res_2009_May_82(2)_A99-A109.nxml.txt.nlp	19176219	SENT180	7	7	11	11	zalcitabine	OCT1	PA451950	5451;6580	0.968
NULL	Protein_Cell_2014_Jun_22_5(11)_805-815.nxml.txt.nlp	24952721	SENT118	40	40	0	0	crizotinib	MED12	PA165946122	9968	0.968
NULL	Curr_Chem_Genomics_2010_Mar_19_4_9-18.nxml.txt.nlp	20502647	SENT151	12	12	24	24	triciribine	DM1	PA165958661	338023;1760;28509	0.968
NULL	Oncogene_2010_Sep_16_29(37)_5135-5145.nxml.txt.nlp	20622897	SENT9	22	22	14	14	cetuximab	STAT3	PA10040	6774	0.968
NULL	J_Immunother_Cancer_2013_Nov_7_1(Suppl_1)_P234.nxml.txt.nlp	NULL	SENT6	6	6	32	32	mitoxantrone	CT26	PA450526	168400	0.968
NULL	Cancers_(Basel)_2013_May_27_5(2)_617-638.nxml.txt.nlp	24216994	SENT140	5	5	0	0	curcumin	PC3	PA151958596	57332;7832;5122	0.968
NULL	Int_J_Biol_Sci_2014_Jun_5_10(6)_614-619.nxml.txt.nlp	24948874	SENT120	18	18	3	3	paclitaxel	FOXO1	PA450761	2308	0.968
NULL	Oncoimmunology_2012_Aug_1_1(5)_618-629.nxml.txt.nlp	22934254	SENT295	24	24	4	4	dasatinib	p38	PA162372878	10598;1432;7965	0.968
NULL	Case_Rep_Med_2011_May_10_2011_107928.nxml.txt.nlp	21629846	SENT45	0	0	28	28	ustekinumab	IL-23	PA166048654	51561	0.968
NULL	J_Histochem_Cytochem_2014_Nov_62(11)_802-812.nxml.txt.nlp	25124006	SENT38	2	2	8	8	l-isoleucine	GDH	PA164750430	51084;2746	0.968
NULL	Clinics_(Sao_Paulo)_2014_Jan_69(Suppl_1)_8-16.nxml.txt.nlp	24860853	SENT157	4	4	35	35	eculizumab	CFHR1	PA164776637	3078	0.968
NULL	Springerplus_2015_Jan_23_4_29.nxml.txt.nlp	25628986	SENT18	1	1	11	11	dapsone	G6PD	PA449211	2539	0.968
NULL	Oncotarget_2014_Aug_27_5(19)_9214-9226.nxml.txt.nlp	25313137	SENT231	16	16	33	33	l-glutamine	CO2	PA10090	4513	0.968
NULL	Genome_Biol_2008_Mar_11_9(3)_R53.nxml.txt.nlp	18334025	SENT420	14	14	3	3	quinacrine	TP53	PA164745551	7157	0.968
NULL	Front_Endocrinol_(Lausanne)_2011_Aug_25_2_25.nxml.txt.nlp	22649368	SENT96	16	16	6	6	cosyntropin	ACTH	PA164749052	5443	0.968
NULL	Oncotarget_2013_Nov_7_4(12)_2550-2566.nxml.txt.nlp	24334291	SENT108	13	13	7	7	dasatinib	TIGAR	PA162372878	57103	0.968
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_650809.nxml.txt.nlp	23258995	SENT170	28	28	6	6	vasopressin	AQP2	PA451858	359	0.968
NULL	Hum_Mol_Genet_2008_Jul_15_17(14)_2101-2107.nxml.txt.nlp	18413323	SENT113	10	10	3	3	ezetimibe	NPC1L1	PA10816	29881	0.968
NULL	Bone_Marrow_Transplant_2011_Apr_28_46(4)_539-544.nxml.txt.nlp	20581880	SENT3	6	6	34	34	fludarabine	NRM	PA449655	11270	0.968
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT303	1	1	23	23	lapatinib	HER2	PA152241907	2064	0.968
NULL	Iran_J_Pharm_Res_2013_Winter_12(Suppl)_37-46.nxml.txt.nlp	24250670	SENT43	7	7	18	18	etoposide	P-gp	PA449552	5243	0.968
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT100	0	0	9	9	afatinib	EGFR	PA165981154	1956	0.968
NULL	J_Mol_Signal_2011_Jul_20_6_7.nxml.txt.nlp	21774804	SENT6	14	14	28	28	curcumin	CD133	PA151958596	8842	0.968
NULL	Arthritis_Res_Ther_2003_Dec_11_5(1)_32-45.nxml.txt.nlp	12716446	SENT174	0	0	17	17	indomethacin	gamma	PA449982	9913	0.968
NULL	Saudi_J_Anaesth_2013_Apr-Jun_7(2)_151-154.nxml.txt.nlp	23956714	SENT21	8	8	14	14	theophylline	NAC	PA451647	22861	0.968
NULL	Breast_Cancer_Res_2007_Oct_1_9(5)_R64.nxml.txt.nlp	17908324	SENT141	14	14	4	4	fluorescein	HER2	PA164746009	2064	0.968
NULL	Breast_Cancer_Res_2011_Jun_14_13(3)_R63.nxml.txt.nlp	21679465	SENT32	16	16	9	9	trastuzumab	HER2	PA451743	2064	0.968
NULL	Angiogenesis_2011_Sep_31_14(3)_245-253.nxml.txt.nlp	21452059	SENT23	8	8	13	13	topotecan	HIF-1	PA451729	29072	0.968
NULL	Ann_Gen_Psychiatry_2010_Dec_10_9_39.nxml.txt.nlp	21143969	SENT62	0	0	32	32	fluoxetine	5-HT2C	PA449673	3358	0.968
NULL	J_Breast_Cancer_2011_Sep_29_14(3)_167-174.nxml.txt.nlp	22031796	SENT144	2	2	11	11	tanespimycin	HER2	PA165291490	2064	0.968
NULL	Nat_Chem_Biol_2010_Apr_28_6(4)_291-299.nxml.txt.nlp	20190765	SENT128	44	44	9	9	dasatinib	EGFR	PA162372878	1956	0.968
NULL	Acta_Pharmacol_Sin_2011_Jan_6_32(1)_133-138.nxml.txt.nlp	21131997	SENT40	8	8	24	24	heparin	ACT	PA449855	12;11332;9457;641455	0.968
NULL	J_Biol_Chem_2013_Feb_1_288(5)_3312-3321.nxml.txt.nlp	23255604	SENT210	3	3	25	25	mitomycin	IP6K1	PA450524	9807	0.968
NULL	Front_Cell_Neurosci_2015_Jan_15_8_459.nxml.txt.nlp	25642166	SENT71	27	27	17	17	hemin	HO-1	PA449849	3162	0.968
NULL	J_Mammary_Gland_Biol_Neoplasia_2010_Mar_27_15(1)_5-17.nxml.txt.nlp	20101446	SENT366	12	12	8	8	tamoxifen	HuR	PA451581	1994	0.968
NULL	Breast_Cancer_Res_2012_Jul_12_14(4)_R104.nxml.txt.nlp	22788954	SENT194	13	13	3	3	gefitinib	Met	PA131301952	79811	0.968
NULL	Asian-Australas_J_Anim_Sci_2014_Dec_27(12)_1783-1793.nxml.txt.nlp	25358373	SENT136	8	8	1	1	capsaicin	BAX	PA448776	581	0.968
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT197	11	11	23	23	adalimumab	DPI	PA10004	1832	0.968
NULL	Clin_Med_Insights_Womens_Health_2013_Jan_22_6_1-11.nxml.txt.nlp	24665209	SENT50	43	43	30	30	tamoxifen	aromatase	PA451581	1588	0.968
NULL	Arthritis_Res_Ther_2014_Apr_3_16(2)_R86.nxml.txt.nlp	24708674	SENT246	25	25	5	5	bosentan	Fli1	PA10034	2314	0.968
NULL	Mol_Cancer_2014_Jan_15_13_8.nxml.txt.nlp	24423412	SENT13	14	14	4	4	cisplatin	CD44	PA449014	960	0.968
NULL	Biomed_Res_Int_2013_Aug_4_2013_152909.nxml.txt.nlp	23984319	SENT106	19	19	31	31	temozolomide	MSH2	PA451609	4436	0.968
NULL	Biomed_Res_Int_2013_Jul_25_2013_295132.nxml.txt.nlp	23984335	SENT385	3	3	26	26	simvastatin	IL-17	PA451363	3605	0.968
NULL	Indian_J_Med_Res_2011_Dec_134(6)_878-897.nxml.txt.nlp	22310820	SENT281	6	6	15	15	pyrimethamine	CT93	PA451193	125972	0.968
NULL	Diabetes_2011_Mar_21_60(3)_993-999.nxml.txt.nlp	21282368	SENT215	21	21	12	12	isoproterenol	VAP-1	PA450121	8639	0.968
NULL	Front_Neuroenergetics_2013_Mar_27_5_2.nxml.txt.nlp	23543638	SENT178	24	24	8	8	exenatide	GLP-1	PA164749238	100125288	0.968
NULL	Mol_Cancer_2010_Apr_23_9_87.nxml.txt.nlp	20416058	SENT147	26	26	19	19	doxorubicin	TRAIL	PA449412	8743	0.968
NULL	Diabetes_Obes_Metab_2011_Nov_13(11)_982-989.nxml.txt.nlp	21615670	SENT107	18	18	7	7	exenatide	GLP-1	PA164749238	100125288	0.968
NULL	Crit_Care_2009_Jul_6_13(4)_R108.nxml.txt.nlp	19580651	SENT225	4	4	23	23	heparin	C5a	PA449855	727	0.968
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1449-1456.nxml.txt.nlp	24077631	SENT120	30	30	8	8	tolbutamide	CYP2C9	PA451718	1559	0.968
NULL	J_Gastroenterol_2013_Feb_23_48(12)_1373-1383.nxml.txt.nlp	23435670	SENT73	6	6	25	25	lamivudine	LAM	PA450163	7249;7248	0.968
NULL	Front_Behav_Neurosci_2015_Jan_15_8_453.nxml.txt.nlp	25642174	SENT137	12	12	24	24	clozapine	5-HT1A	PA449061	3350	0.968
NULL	Oncol_Lett_2013_Apr_4_5(4)_1165-1170.nxml.txt.nlp	23599757	SENT35	11	11	4	4	pemetrexed	SLC19A1	PA10810	6573	0.968
NULL	Breast_Cancer_Res_2013_Oct_1_15(5)_R92.nxml.txt.nlp	24286369	SENT397	21	21	14	14	paclitaxel	HER2	PA450761	2064	0.968
NULL	Breast_Cancer_Res_2011_Jan_11_13(1)_R3.nxml.txt.nlp	21223569	SENT236	15	15	5	5	doxycycline	p53	PA449415	7157	0.968
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT36	13	13	16	16	pemetrexed	UNG	PA10810	7374	0.968
NULL	Ann_Oncol_2013_Apr_31_24(4)_1067-1073.nxml.txt.nlp	23117073	SENT173	7	7	22	22	aprepitant	CYP3A4	PA164747039	1576	0.968
NULL	Inflamm_Res_2010_Sep_26_59(9)_699-709.nxml.txt.nlp	20339899	SENT29	23	23	19	19	thrombin	PAR3	PA451674	56288;2151	0.968
NULL	Hum_Genomics_Proteomics_2009_Jun_24_2009_453634.nxml.txt.nlp	20981323	SENT8	2	2	11	11	thalidomide	CCL5	PA451644	6352	0.968
NULL	Braz_J_Med_Biol_Res_2014_Sep_12_47(12)_1075-1084.nxml.txt.nlp	25387675	SENT48	2	2	9	9	paraformaldehyde	Tech	PA450790	57449	0.968
NULL	Cell_Death_Dis_2014_Feb_13_5(2)_e1055.nxml.txt.nlp	24525731	SENT8	0	0	29	29	irinotecan	XRCC1	PA450085	7515	0.967
NULL	Cardiol_Res_Pract_2013_Feb_19_2013_195456.nxml.txt.nlp	23533940	SENT57	0	0	9	9	ticagrelor	P2Y12	PA165374673	64805	0.967
NULL	Comp_Hepatol_2011_Sep_12_10_9.nxml.txt.nlp	21910861	SENT165	15	15	3	3	azathioprine	AIC	PA448515	192	0.967
NULL	Oncoscience_2014_Aug_7_1(8)_540-549.nxml.txt.nlp	25594061	SENT27	8	8	18	18	bevacizumab	EGFR	PA130232992	1956	0.967
NULL	Int_J_Endocrinol_2014_Feb_13_2014_329456.nxml.txt.nlp	24688539	SENT225	3	3	8	8	tadalafil	IL-8	PA10333	3576	0.967
NULL	Breast_Cancer_Res_2011_Feb_3_13(1)_R16.nxml.txt.nlp	21291529	SENT10	10	10	4	4	epirubicin	PHD3	PA449476	112399	0.967
NULL	Cancers_(Basel)_2013_Nov_26_5(4)_1601-1618.nxml.txt.nlp	24287743	SENT122	12	12	27	27	gefitinib	Met	PA131301952	79811	0.967
NULL	Mol_Cancer_2014_Jul_5_13_165.nxml.txt.nlp	24996221	SENT328	24	24	47	47	docetaxel	HMGB1	PA449383	3146	0.967
NULL	Biomed_Res_Int_2014_Jun_2_2014_946492.nxml.txt.nlp	24991574	SENT152	2	2	18	18	olmesartan	ATRAP	PA164742950	57085	0.967
NULL	Clin_Ophthalmol_2008_Mar_2(1)_1-14.nxml.txt.nlp	19668384	SENT32	16	16	12	12	bevacizumab	VEGF-A	PA130232992	7422	0.967
NULL	Br_J_Pharmacol_2014_Feb_24_171(1)_1019-1032.nxml.txt.nlp	24251620	SENT177	21	21	6	6	nimodipine	TRPA1	PA450633	8989	0.967
NULL	Br_J_Cancer_2011_Mar_15_104(6)_1020-1026.nxml.txt.nlp	21364579	SENT27	2	2	44	44	panitumumab	KRAS	PA162373091	3845	0.967
NULL	Libyan_J_Med_2008_Mar_1_3(1)_42-48.nxml.txt.nlp	21499481	SENT72	2	2	7	7	lumefantrine	ACT	PA165111722	12;11332;9457;641455	0.967
NULL	Ther_Clin_Risk_Manag_2006_Mar_2(1)_87-98.nxml.txt.nlp	18360584	SENT184	16	16	12	12	erlotinib	EGFR	PA134687924	1956	0.967
NULL	Evid_Based_Complement_Alternat_Med_2011_Feb_14_2011_248231.nxml.txt.nlp	19233878	SENT213	23	23	4	4	rosiglitazone	DBT	PA451283	1629	0.967
NULL	Exp_Ther_Med_2014_Sep_14_8(3)_836-840.nxml.txt.nlp	25120610	SENT91	14	14	8	8	fasudil	ROCK2	PA165946121	9475	0.967
NULL	Breast_Cancer_Res_Treat_2007_Oct_27_105(Suppl_1)_19-29.nxml.txt.nlp	17333340	SENT30	19	19	7	7	tamoxifen	aromatase	PA451581	1588	0.967
NULL	Acta_Pharmacol_Sin_2010_Aug_5_31(8)_938-943.nxml.txt.nlp	20686519	SENT132	18	18	1	1	reserpine	GML	PA451236	2765	0.967
NULL	Aging_(Albany_NY)_2010_Oct_31_2(10)_669-677.nxml.txt.nlp	21076179	SENT59	33	33	3	3	vorinostat	GCN2	PA164748224	440275	0.967
NULL	Br_J_Cancer_2011_Jan_4_104(1)_91-100.nxml.txt.nlp	21139584	SENT99	1	1	9	9	coumarin	Hsp90	PA134521193	3320	0.967
NULL	J_Mol_Med_(Berl)_2014_May_10_92(7)_709-722.nxml.txt.nlp	24811491	SENT105	13	13	23	23	cetuximab	PIK3CA	PA10040	5290	0.967
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT146	21	21	6	6	trastuzumab	STAT3	PA451743	6774	0.967
NULL	BMJ_Open_2013_Sep_7_3(9)_e003138.nxml.txt.nlp	24022390	SENT69	6	6	8	8	tamoxifen	aromatase	PA451581	1588	0.967
NULL	Breast_Cancer_Res_2000_Mar_12_2(Suppl_1)_P2_02.nxml.txt.nlp	NULL	SENT2	7	7	27	27	estradiol	EGFR	PA449503	1956	0.967
NULL	Cell_Commun_Signal_2014_Nov_25_12(1)_55.nxml.txt.nlp	NULL	SENT96	21	21	9	9	vanillin	SF-1	PA451852	2516	0.967
NULL	EMBO_Mol_Med_2013_May_15_5(5)_751-761.nxml.txt.nlp	23505126	SENT78	13	13	35	35	trypsin	Vel	PA451806	388588	0.967
NULL	Colorectal_Dis_2012_Feb_14(2)_e31-e47.nxml.txt.nlp	21848897	SENT41	27	27	7	7	irinotecan	KRAS	PA450085	3845	0.967
NULL	Hum_Genomics_2008_Sep_1_3(1)_7-16.nxml.txt.nlp	19129086	SENT186	32	32	8	8	rosiglitazone	CYP2C8	PA451283	1558	0.967
NULL	J_Invest_Dermatol_2014_Jun_17_134(6)_1589-1598.nxml.txt.nlp	24499735	SENT34	22	22	3	3	lipase	GPIHBP1	PA450239	338328	0.967
NULL	Asian-Australas_J_Anim_Sci_2014_Dec_27(12)_1783-1793.nxml.txt.nlp	25358373	SENT192	10	10	27	27	capsaicin	CEBPA	PA448776	1050	0.967
NULL	Ther_Clin_Risk_Manag_2005_Dec_1(4)_299-306.nxml.txt.nlp	18360572	SENT84	1	1	23	23	terbinafine	CYP1A2	PA451614	1544	0.967
NULL	ACS_Chem_Biol_2010_Sep_17_5(9)_863-873.nxml.txt.nlp	20849068	SENT303	10	10	16	16	resveratrol	SIRT1		23411	0.967
NULL	J_Mol_Signal_2009_Sep_2_4_6.nxml.txt.nlp	19725972	SENT74	3	3	30	30	ethanol	RCAN1	PA448073	1827	0.967
NULL	Oncotarget_2014_Oct_21_5(22)_11709-11722.nxml.txt.nlp	25365944	SENT200	21	21	14	14	metformin	p53	PA450395	7157	0.967
NULL	An_Bras_Dermatol_2014_Mar-Apr_89(2)_266-273.nxml.txt.nlp	24770503	SENT6	0	0	11	11	thalidomide	ENL	PA451644	4298	0.967
NULL	Int_J_Biol_Sci_2011_Nov_5_8(1)_1-14.nxml.txt.nlp	22211100	SENT170	6	6	25	25	gemcitabine	Bcl-2	PA449748	596	0.967
NULL	Diabetes_Care_2009_Nov_32(Suppl_2)_S223-S231.nxml.txt.nlp	19875556	SENT164	15	15	4	4	liraglutide	GLP-1	PA165958364	100125288	0.967
NULL	Arch_Pharm_Res_2014_Nov_1_37(5)_588-599.nxml.txt.nlp	24178744	SENT18	27	27	4	4	liraglutide	GLP-1	PA165958364	100125288	0.967
NULL	J_Oncol_2012_Sep_5_2012_128608.nxml.txt.nlp	21904549	SENT114	6	6	30	30	bevacizumab	VEGFR2	PA130232992	3791	0.967
NULL	Front_Pharmacol_2014_Dec_23_5_286.nxml.txt.nlp	25566078	SENT57	18	18	42	42	doxorubicin	FOXM1	PA449412	2305	0.967
NULL	Arthritis_Res_Ther_2003_Oct_2_5(Suppl_4)_S17-S21.nxml.txt.nlp	15180893	SENT54	3	3	37	37	rituximab	ACR	PA451261	49	0.967
NULL	Breast_Cancer_Res_2010_Jul_22_12(4)_R53.nxml.txt.nlp	20649975	SENT161	13	13	6	6	estradiol	HOXB13	PA449503	10481	0.967
NULL	Acta_Pharmacol_Sin_2010_Jan_5_31(1)_93-101.nxml.txt.nlp	20048748	SENT143	13	13	2	2	cisplatin	DAPK	PA449014	1612	0.967
NULL	J_Oncol_2010_Aug_24_2010_398564.nxml.txt.nlp	20862373	SENT74	0	0	7	7	axitinib	VEGFR	PA164924493	3791	0.967
NULL	Arthritis_Res_Ther_2006_Dec_28_8(1)_R18.nxml.txt.nlp	16507118	SENT150	14	14	0	0	infliximab	IL-15	PA452639	3600	0.967
NULL	Front_Endocrinol_(Lausanne)_2013_Sep_13_4_122.nxml.txt.nlp	24062725	SENT46	5	5	23	23	forskolin	PRL	PA146096022	5617	0.967
NULL	Neuropsychopharmacology_2012_Feb_2_37(3)_641-650.nxml.txt.nlp	22048466	SENT114	4	4	46	46	varenicline	HTR3B	PA164781343	9177	0.967
NULL	Nat_Commun_2013_Sep_20_4_2443.nxml.txt.nlp	24051437	SENT182	16	16	18	18	tamoxifen	aromatase	PA451581	1588	0.967
NULL	Cancer_Growth_Metastasis_2014_Aug_10_7_33-42.nxml.txt.nlp	25187738	SENT182	0	0	18	18	denosumab	RANKL	PA166048634	8600	0.967
NULL	Oncotarget_2014_Feb_7_5(3)_775-787.nxml.txt.nlp	24519956	SENT104	30	30	10	10	dasatinib	PC3	PA162372878	57332;7832;5122	0.967
NULL	J_Immunol_Res_2014_May_25_2014_608930.nxml.txt.nlp	24971371	SENT88	10	10	39	39	zafirlukast	IL-8	PA451949	3576	0.967
NULL	Eur_J_Med_Res_2011_Feb_24_16(2)_63-66.nxml.txt.nlp	21463983	SENT123	31	31	36	36	tobramycin	PARI	PA451704	55010	0.967
NULL	J_Cancer_2012_Mar_12_3_137-144.nxml.txt.nlp	22481979	SENT21	14	14	0	0	trastuzumab	HER2	PA451743	2064	0.967
NULL	Asian_J_Androl_2014_Apr_25_Sep-Oct_16(5)_761-766.nxml.txt.nlp	24799635	SENT129	28	28	12	12	fructose	DAN	PA449716	5073;4681	0.967
NULL	Curr_Oncol_2009_Jul_16(Suppl_2)_S1-S13.nxml.txt.nlp	19672416	SENT20	16	16	7	7	exemestane	aromatase	PA449563	1588	0.967
NULL	Cardiovasc_Res_2012_Mar_15_93(4)_674-681.nxml.txt.nlp	22166712	SENT129	27	27	25	25	ketoconazole	CYP3A	PA450146	1574	0.967
NULL	Cell_Death_Dis_2014_Jul_17_5(7)_e1333.nxml.txt.nlp	25032856	SENT255	14	14	33	33	candesartan	TLR4	PA448765	7099	0.967
NULL	Clinics_(Sao_Paulo)_2012_Apr_67(Suppl_1)_125-129.nxml.txt.nlp	22584717	SENT61	0	0	28	28	sorafenib	VEGFR	PA7000	3791	0.967
NULL	Clinicoecon_Outcomes_Res_2014_Oct_17_6_451-461.nxml.txt.nlp	25378939	SENT29	26	26	4	4	linezolid	HAP	PA450233	5915;10313	0.967
NULL	J_Clin_Biochem_Nutr_2007_Jan_27_40(1)_13-23.nxml.txt.nlp	18437209	SENT575	37	37	0	0	trypsin	PAR2	PA451806	2150;55065;8856	0.967
NULL	J_Carcinog_2014_Feb_20_13_4.nxml.txt.nlp	24737952	SENT39	0	0	12	12	panitumumab	EGFR	PA162373091	1956	0.967
NULL	Chin_J_Cancer_2012_Feb_31(2)_73-99.nxml.txt.nlp	22098950	SENT117	22	22	29	29	imatinib	CD34	PA10804	947	0.967
NULL	Cell_Cycle_2013_Sep_15_12(18)_3037-3051.nxml.txt.nlp	23974101	SENT173	20	20	14	14	camptothecin	HDAC2	PA153590860	3066	0.967
NULL	Breast_Cancer_Res_2011_Feb_3_13(1)_R16.nxml.txt.nlp	21291529	SENT116	12	12	0	0	epirubicin	PHD1	PA449476	112398	0.967
NULL	Mol_Vis_2012_Oct_5_18_2454-2467.nxml.txt.nlp	23077404	SENT188	13	13	8	8	bevacizumab	VEGF-A	PA130232992	7422	0.967
NULL	Oncogene_2013_Sep_12_32(37)_4355-4365.nxml.txt.nlp	23108409	SENT35	43	43	20	20	hyaluronan	HAS3	PA165958431	3038	0.967
NULL	Oncogenesis_2014_Dec_15_3(12)_e133.nxml.txt.nlp	25500906	SENT106	19	19	2	2	trastuzumab	HER2	PA451743	2064	0.967
NULL	Br_J_Cancer_2011_Jul_26_105(3)_420-427.nxml.txt.nlp	21730982	SENT218	7	7	18	18	cetuximab	EGFR	PA10040	1956	0.967
NULL	Ann_Intensive_Care_2012_Jul_2_2_22.nxml.txt.nlp	22747633	SENT182	2	2	36	36	vancomycin	TDD	PA451850	6994	0.967
NULL	J_Exp_Clin_Cancer_Res_2009_Jul_10_28(1)_99.nxml.txt.nlp	19591692	SENT29	15	15	13	13	valspodar	ABCB1		5243	0.967
NULL	Acta_Histochem_Cytochem_2007_Feb_27_40(1)_9-17.nxml.txt.nlp	17375204	SENT6	21	21	5	5	geldanamycin	p38	PA152031327	10598;1432;7965	0.967
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_75-89.nxml.txt.nlp	17912638	SENT121	16	16	2	2	tamoxifen	ATAC	PA451581	6375	0.967
NULL	Br_J_Cancer_2012_Apr_24_106(9)_1469-1474.nxml.txt.nlp	22460270	SENT74	5	5	15	15	sunitinib	ANOVA	PA162372840	4858	0.967
NULL	Exp_Diabetes_Res_2012_Nov_1_2012_972679.nxml.txt.nlp	22110483	SENT70	4	4	14	14	resveratrol	HO-1		3162	0.967
NULL	Nat_Commun_2013_Apr_9_4_1684.nxml.txt.nlp	23575688	SENT139	3	3	12	12	rolipram	PDE4B	PA153906323	5142	0.967
NULL	Cancers_(Basel)_2013_Jan_21_5(1)_64-91.nxml.txt.nlp	24216699	SENT308	0	0	12	12	telatinib	VEGFR	PA165980595	3791	0.967
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT105	40	40	26	26	imatinib	ABCB1	PA10804	5243	0.967
NULL	J_Biol_Chem_2013_Dec_6_288(49)_35387-35395.nxml.txt.nlp	24142790	SENT164	43	43	20	20	meclizine	CDP	PA450338	1523	0.967
NULL	J_Cell_Biol_2000_Feb_21_148(4)_665-678.nxml.txt.nlp	10684249	SENT42	13	13	6	6	collagenase	ST2	PA449107	9173;6761	0.967
NULL	Oncotarget_2014_Mar_13_5(4)_1101-1110.nxml.txt.nlp	24658355	SENT167	41	41	16	16	tamoxifen	MKP-2	PA451581	1846	0.967
NULL	Oncotarget_2012_Sep_28_3(10)_1169-1181.nxml.txt.nlp	23045411	SENT187	13	13	6	6	doxorubicin	p53	PA449412	7157	0.967
NULL	Eur_J_Haematol_2013_Feb_22_90(2)_89-98.nxml.txt.nlp	23181448	SENT123	2	2	9	9	imatinib	KIT	PA10804	3815	0.967
NULL	Ann_Med_Health_Sci_Res_2013_Apr-Jun_3(2)_282-284.nxml.txt.nlp	23919207	SENT70	36	36	4	4	cefoxitin	RGM	PA448856	56963	0.967
NULL	Acta_Histochem_Cytochem_2013_Dec_28_46(6)_187-197.nxml.txt.nlp	24610966	SENT140	13	13	7	7	pilocarpine	AQP5	PA450962	362	0.967
NULL	Cardiol_Res_Pract_2013_Feb_19_2013_195456.nxml.txt.nlp	23533940	SENT77	0	0	6	6	cangrelor	P2Y12	PA165945763	64805	0.967
NULL	Cancer_Cell_Int_2011_Dec_29_11_44.nxml.txt.nlp	22206574	SENT145	0	0	10	10	sorafenib	c-Raf	PA7000	5894	0.967
NULL	Oncogene_2014_Jun_26_33(26)_3422-3431.nxml.txt.nlp	23912457	SENT16	4	4	28	28	trastuzumab	p27	PA451743	5715;10534	0.967
NULL	Core_Evid_2007_Nov_30_2(2)_81-88.nxml.txt.nlp	21221177	SENT175	16	16	20	20	panitumumab	IFL	PA162373091	3439	0.967
NULL	Front_Neurosci_2013_Jun_13_7_99.nxml.txt.nlp	23781168	SENT55	31	31	7	7	colchicine	PGRMC1	PA449092	10857	0.967
NULL	J_Immunother_Cancer_2013_Jun_27_1_9.nxml.txt.nlp	NULL	SENT194	27	27	6	6	doxorubicin	GM-CSF	PA449412	1437	0.967
NULL	Diabetes_Metab_J_2012_Aug_20_36(4)_293-299.nxml.txt.nlp	22950061	SENT121	9	9	38	38	metformin	POMC	PA450395	5443	0.967
NULL	J_Carcinog_2012_Dec_31_11_20.nxml.txt.nlp	23346013	SENT53	5	5	20	20	gefitinib	EGFR	PA131301952	1956	0.967
NULL	Tumour_Biol_2014_Aug_12_35(8)_7807-7819.nxml.txt.nlp	24817012	SENT377	15	15	8	8	cisplatin	ERCC2	PA449014	2068	0.967
NULL	EPMA_J_2013_Jan_28_4(1)_3.nxml.txt.nlp	23356214	SENT328	27	27	23	23	cetuximab	PTEN	PA10040	5728	0.967
NULL	Aging_(Albany_NY)_2009_Jun_29_1(6)_511-514.nxml.txt.nlp	20157534	SENT64	6	6	19	19	resveratrol	AMPK		5563	0.967
NULL	Cardiovasc_Diabetol_2008_Aug_11_7_24.nxml.txt.nlp	18694484	SENT57	41	41	5	5	exenatide	Ray	PA164749238	26751	0.967
NULL	Cancer_Med_2013_Dec_31_2(6)_826-835.nxml.txt.nlp	24403256	SENT168	7	7	14	14	daunorubicin	p53	PA449212	7157	0.967
NULL	Oncotarget_2011_Apr_27_2(4)_284-286.nxml.txt.nlp	21525531	SENT22	26	26	8	8	bortezomib	HDAC6	PA10252	10013	0.967
NULL	Br_J_Cancer_2012_Nov_6_107(10)_1714-1721.nxml.txt.nlp	23073173	SENT217	17	17	11	11	docetaxel	RUNX2	PA449383	860	0.967
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT188	18	18	13	13	atorvastatin	M-CSF	PA448500	1435	0.967
NULL	Child_Adolesc_Psychiatry_Ment_Health_2011_Nov_4_5_35.nxml.txt.nlp	22054243	SENT150	24	24	1	1	atomoxetine	NNT	PA134688071	23530	0.967
NULL	Diabetes_Care_2010_Jul_31_33(7)_1544-1548.nxml.txt.nlp	20357370	SENT94	22	22	7	7	metformin	AMPK	PA450395	5563	0.967
NULL	Oncol_Lett_2014_Nov_14_8(5)_2086-2092.nxml.txt.nlp	25295095	SENT8	15	15	4	4	gemcitabine	LKB1	PA449748	6794	0.967
NULL	Mol_Cancer_2014_Jun_19_13_154.nxml.txt.nlp	24941944	SENT55	28	28	9	9	dacarbazine	BRAF	PA449197	673	0.967
NULL	Breast_Cancer_Res_2014_May_28_16(3)_R53.nxml.txt.nlp	24886537	SENT316	22	22	8	8	erlotinib	VAV3	PA134687924	10451	0.967
NULL	Osteoarthritis_Cartilage_2010_Apr_18(4)_555-562.nxml.txt.nlp	20060953	SENT141	13	13	7	7	clenbuterol	MNX	PA164745640	3892	0.967
NULL	Pharmaceuticals_(Basel)_2013_Mar_26_6(4)_469-479.nxml.txt.nlp	24276118	SENT149	19	19	8	8	ethanol	DARPP-32	PA448073	84152	0.967
NULL	Mol_Cancer_2013_Sep_11_12_104.nxml.txt.nlp	24025152	SENT212	25	25	36	36	gemcitabine	STAT3	PA449748	6774	0.967
NULL	Lab_Invest_2012_Jun_26_92(6)_827-841.nxml.txt.nlp	22449800	SENT12	4	4	27	27	curcumin	gamma	PA151958596	9913	0.967
NULL	Comput_Struct_Biotechnol_J_2013_Jun_26_7_e201304003.nxml.txt.nlp	24688733	SENT350	11	11	20	20	s-adenosylmethionine	B12	PA164754994	7126;4709	0.967
NULL	Oncotarget_2013_Nov_24_4(12)_2430-2438.nxml.txt.nlp	24280348	SENT1	32	32	7	7	erlotinib	EGFR	PA134687924	1956	0.967
NULL	Clin_Pharmacol_2013_Dec_9_5_185-192.nxml.txt.nlp	24353446	SENT20	18	18	46	46	clopidogrel	CYP3A4	PA449053	1576	0.967
NULL	Nat_Med_2012_Jul_18(7)_1118-1122.nxml.txt.nlp	22683780	SENT42	11	11	19	19	crizotinib	MET	PA165946122	4233	0.967
NULL	Drug_Target_Insights_2007_Mar_6_2_71-81.nxml.txt.nlp	21901064	SENT160	29	29	4	4	doxorubicin	P-gp	PA449412	5243	0.967
NULL	Br_J_Cancer_2010_Sep_7_103(6)_889-898.nxml.txt.nlp	20664599	SENT12	10	10	30	30	paclitaxel	AKT	PA450761	207	0.967
NULL	Curr_Neuropharmacol_2012_Mar_10(1)_72-79.nxml.txt.nlp	22942880	SENT85	10	10	36	36	dacarbazine	p53	PA449197	7157	0.967
NULL	Asian_J_Androl_2015_Aug_15_Jan-Feb_17(1)_143-148.nxml.txt.nlp	25155105	SENT123	25	25	7	7	udenafil	GAQ	PA164776753	2776	0.967
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1449-1456.nxml.txt.nlp	24077631	SENT120	30	30	20	20	tolbutamide	CYP2C9	PA451718	1559	0.967
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_16_2012_395912.nxml.txt.nlp	23118789	SENT151	18	18	0	0	propofol	UGT1A9	PA451141	54600	0.967
NULL	J_Asthma_Allergy_2014_Feb_27_7_11-21.nxml.txt.nlp	24600237	SENT195	47	47	18	18	tiotropium	ADRB2	PA164769056	154	0.967
NULL	Arthritis_Res_Ther_2006_May_5_8(3)_R83.nxml.txt.nlp	16677395	SENT41	9	9	19	19	rituximab	CD40L	PA451261	959	0.967
NULL	Br_J_Cancer_2010_Dec_7_103(12)_1765-1772.nxml.txt.nlp	21139621	SENT108	16	16	33	33	cetuximab	EGFR	PA10040	1956	0.967
NULL	Curr_Neuropharmacol_2009_Jun_7(2)_142-149.nxml.txt.nlp	19949573	SENT117	12	12	17	17	oxytetracycline	P-gp	PA450757	5243	0.967
NULL	Nat_Biotechnol_2013_Jul_30_31(7)_630-637.nxml.txt.nlp	23811600	SENT123	2	2	16	16	ponatinib	FLT3	PA165980594	2322	0.967
NULL	Cancer_Cell_Int_2008_Mar_18_8_3.nxml.txt.nlp	18348720	SENT75	9	9	21	21	lapatinib	EGFR	PA152241907	1956	0.967
NULL	Hum_Genomics_2008_Sep_1_3(1)_7-16.nxml.txt.nlp	19129086	SENT152	33	33	7	7	rosiglitazone	CYP2C8	PA451283	1558	0.967
NULL	Cancer_Cell_Int_2014_Jan_29_14_10.nxml.txt.nlp	24472145	SENT197	29	29	15	15	paclitaxel	HER-2	PA450761	2064	0.967
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT63	37	37	20	20	trastuzumab	STAT3	PA451743	6774	0.967
NULL	Korean_Circ_J_2013_Aug_31_43(8)_541-549.nxml.txt.nlp	24044013	SENT80	23	23	10	10	ticagrelor	CYP2C19	PA165374673	1557	0.967
NULL	Patient_Prefer_Adherence_2010_Mar_24_4_61-68.nxml.txt.nlp	20361006	SENT28	0	0	13	13	liraglutide	GLP-1	PA165958364	100125288	0.967
NULL	Acta_Pharmacol_Sin_2009_Mar_5_30(3)_307-313.nxml.txt.nlp	19262554	SENT29	0	0	11	11	losartan	CYP3A4	PA450268	1576	0.967
NULL	J_Oncol_2012_Jul_8_2012_537861.nxml.txt.nlp	22973309	SENT259	26	26	8	8	temozolomide	CD133	PA451609	8842	0.967
NULL	J_Headache_Pain_2012_Nov_16_13(8)_677-684.nxml.txt.nlp	23070400	SENT115	0	0	8	8	nabilone	DAI	PA164746998	81030	0.967
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT178	16	16	0	0	cisplatin	CHK2	PA449014	11200	0.967
NULL	Arthritis_Res_Ther_2005_Sep_22_7(6)_R1325-R1337.nxml.txt.nlp	16277686	SENT136	26	26	19	19	rosiglitazone	adiponectin	PA451283	9370	0.967
NULL	Acta_Vet_Scand_2014_May_20_56(1)_33.nxml.txt.nlp	24884817	SENT201	4	4	34	34	isoflurane	IL-6	PA450106	3569	0.967
NULL	Biomed_Res_Int_2013_Oct_27_2013_467869.nxml.txt.nlp	24282816	SENT167	13	13	24	24	telaprevir	SOC	PA165958354	91544	0.967
NULL	ScientificWorldJournal_2014_Mar_3_2014_781857.nxml.txt.nlp	24729754	SENT97	6	6	14	14	clopidogrel	P2Y12	PA449053	64805	0.967
NULL	Drugs_R_D_2010_Nov_25_10(4)_219-224.nxml.txt.nlp	21171668	SENT21	15	15	32	32	clopidogrel	DES	PA449053	1674	0.967
NULL	Front_Behav_Neurosci_2014_Sep_3_8_303.nxml.txt.nlp	25232310	SENT27	21	21	0	0	cocaine	DAT	PA449072	6531	0.967
NULL	Front_Psychol_2013_Jan_7_3_601.nxml.txt.nlp	23308072	SENT180	7	7	0	0	estradiol	DYX1C1	PA449503	161582	0.967
NULL	Breast_Cancer_Res_2008_Jul_8_10(4)_R56.nxml.txt.nlp	18611244	SENT241	19	19	32	32	letrozole	PI3K	PA450196	5290	0.967
NULL	Front_Mol_Neurosci_2012_Jun_6_5_69.nxml.txt.nlp	22685426	SENT41	26	26	14	14	etoposide	c-Jun	PA449552	3725	0.967
NULL	J_Med_Chem_2014_Jan_23_57(2)_449-461.nxml.txt.nlp	24387105	SENT147	0	0	11	11	benzaldehyde	ALDH1A1	PA448571	216	0.967
NULL	Acta_Pharmacol_Sin_2009_Jul_22_30(7)_956-964.nxml.txt.nlp	19543298	SENT11	5	5	30	30	simvastatin	SLC22A1	PA451363	6580	0.967
NULL	Indian_J_Dermatol_2014_Nov-Dec_59(6)_630b.nxml.txt.nlp	25484410	SENT28	11	11	41	41	isotretinoin	B12	PA450128	7126;4709	0.967
NULL	Diabetes_Obes_Metab_2011_Apr_13(4)_348-356.nxml.txt.nlp	21205128	SENT21	0	0	23	23	liraglutide	GLP-1	PA165958364	100125288	0.967
NULL	Diabetes_2011_Nov_17_60(11)_2691-2700.nxml.txt.nlp	21896928	SENT260	22	22	14	14	resveratrol	SIRT1		23411	0.967
NULL	Exp_Diabetes_Res_2012_Oct_15_2012_465282.nxml.txt.nlp	23118742	SENT108	5	5	11	11	metformin	FGF21	PA450395	26291	0.967
NULL	Oncotarget_2014_Aug_29_5(19)_8947-8958.nxml.txt.nlp	25333254	SENT147	19	19	4	4	plerixafor	CXCR7	PA165958410	57007	0.967
NULL	Oncotarget_2014_Jun_26_5(14)_5559-5569.nxml.txt.nlp	24980819	SENT106	23	23	5	5	vemurafenib	p53	PA165946873	7157	0.967
NULL	Mol_Cancer_2009_Apr_16_8_24.nxml.txt.nlp	19371427	SENT218	12	12	9	9	cisplatin	CHK1	PA449014	1111	0.967
NULL	Exp_Ther_Med_2014_Sep_20_8(3)_968-972.nxml.txt.nlp	25120631	SENT78	19	19	8	8	naringin	ADP	PA151958360	23038	0.967
NULL	Braz_J_Med_Biol_Res_2013_Mar_15_46(3)_299-305.nxml.txt.nlp	23532269	SENT175	8	8	33	33	propofol	CD14	PA451141	929	0.967
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT50	0	0	12	12	resveratrol	IL-6		3569	0.967
NULL	Br_J_Cancer_2006_Dec_4_95(11)_1483-1489.nxml.txt.nlp	17106442	SENT25	23	23	10	10	gefitinib	EGFR	PA131301952	1956	0.967
NULL	Mol_Cancer_2010_Mar_25_9_68.nxml.txt.nlp	20338046	SENT188	14	14	10	10	doxorubicin	GSTP1	PA449412	2950	0.967
NULL	Br_J_Cancer_2011_Jul_12_105(2)_212-220.nxml.txt.nlp	21694723	SENT190	4	4	12	12	curcumin	STAT3	PA151958596	6774	0.967
NULL	Biomed_Res_Int_2013_Jul_31_2013_692071.nxml.txt.nlp	23984399	SENT200	2	2	6	6	gefitinib	OCT1	PA131301952	5451;6580	0.967
NULL	J_Hum_Genet_2013_Jun_16_58(6)_353-361.nxml.txt.nlp	23677058	SENT168	15	15	25	25	cytarabine	RRM1	PA449177	6240	0.967
NULL	Oncotarget_2013_Nov_24_4(12)_2430-2438.nxml.txt.nlp	24280348	SENT113	7	7	0	0	gefitinib	STAT3	PA131301952	6774	0.967
NULL	Diabetes_Metab_J_2012_Feb_17_36(1)_29-36.nxml.txt.nlp	22363919	SENT36	24	24	6	6	fenofibrate	FGF21	PA449594	26291	0.967
NULL	Int_J_Mol_Sci_2014_Jun_25_15(7)_11220-11233.nxml.txt.nlp	24968265	SENT75	10	10	19	19	temsirolimus	REST	PA164746890	5978	0.967
NULL	Eur_J_Med_Res_2010_Aug_20_15(8)_337-344.nxml.txt.nlp	20947470	SENT114	6	6	20	20	methotrexate	DDP	PA450428	1678	0.967
NULL	Infect_Drug_Resist_2010_Apr_26_3_15-23.nxml.txt.nlp	21694890	SENT27	0	0	21	21	tipranavir	UGT	PA163522473	7361;7355	0.967
NULL	J_Oral_Pathol_Med_2013_Jul_18_42(6)_499-506.nxml.txt.nlp	23331485	SENT14	4	4	2	2	indomethacin	COX	PA449982	1351	0.967
NULL	Front_Neurosci_2014_Jan_10_7_270.nxml.txt.nlp	24454277	SENT159	1	1	14	14	resveratrol	SIRT1		23411	0.967
NULL	Breast_Cancer_Res_2006_Jul_3_8(3)_211.nxml.txt.nlp	16834766	SENT215	17	17	3	3	daunorubicin	CD34	PA449212	947	0.967
NULL	Biologics_2009_Jul_13_3_289-301.nxml.txt.nlp	19707416	SENT120	30	30	11	11	capecitabine	HER2	PA448771	2064	0.967
NULL	Diabetes_Metab_J_2012_Jun_14_36(3)_167-180.nxml.txt.nlp	22737656	SENT154	1	1	24	24	etretinate	CD4	PA449554	920	0.967
NULL	Breast_Cancer_Res_2005_Apr_12_7(4)_R570-R579.nxml.txt.nlp	15987464	SENT118	30	30	2	2	gefitinib	EGFR	PA131301952	1956	0.967
NULL	Front_Genet_2014_Nov_14_5_391.nxml.txt.nlp	25452763	SENT44	27	27	11	11	cisplatin	REV3L	PA449014	5980	0.967
NULL	Mol_Cytogenet_2013_Mar_6_6_11.nxml.txt.nlp	23497671	SENT67	19	19	0	0	chymotrypsin	ENTK	PA448994	5651	0.967
NULL	Blood_Res_2014_Sep_25_49(3)_148-153.nxml.txt.nlp	25325033	SENT47	29	29	15	15	vincristine	B2M	PA451879	567	0.967
NULL	J_Neurophysiol_2013_May_1_109(9)_2393-2403.nxml.txt.nlp	23427303	SENT225	23	23	0	0	capsaicin	TRPA1	PA448776	8989	0.967
NULL	Diabetes_Metab_Syndr_Obes_2009_Jul_31_2_135-144.nxml.txt.nlp	21437127	SENT132	0	0	3	3	exenatide	GLP-1	PA164749238	100125288	0.967
NULL	Breast_Cancer_Res_2011_Jan_17_13(1)_R5.nxml.txt.nlp	21241485	SENT323	28	28	4	4	tamoxifen	NGF	PA451581	4803	0.967
NULL	EMBO_Mol_Med_2013_Jul_5_5(7)_1035-1050.nxml.txt.nlp	23740718	SENT327	10	10	28	28	riluzole	SMN2	PA451251	6607	0.967
NULL	Biomed_Res_Int_2014_Feb_27_2014_897653.nxml.txt.nlp	24719894	SENT61	31	31	22	22	olanzapine	PTGS2	PA450688	5743	0.967
NULL	Eur_J_Clin_Pharmacol_2012_Jan_8_68(1)_29-37.nxml.txt.nlp	21739267	SENT9	2	2	7	7	fluvoxamine	CYP3A4	PA449690	1576	0.967
NULL	Endocrinol_Diabetes_Metab_Case_Rep_2014_Dec_1_2014_140083.nxml.txt.nlp	25535576	SENT100	1	1	33	33	ketoconazole	ACTH	PA450146	5443	0.967
NULL	Arthritis_Res_Ther_2009_Aug_17_11(4)_R123.nxml.txt.nlp	19686595	SENT203	15	15	3	3	rituximab	CD27	PA451261	939	0.967
NULL	Int_J_Surg_Case_Rep_2014_Sep_22_5(11)_783-786.nxml.txt.nlp	25290381	SENT20	0	0	5	5	denosumab	RANKL	PA166048634	8600	0.967
NULL	Oncotarget_2014_Nov_6_5(22)_11038-11053.nxml.txt.nlp	25402820	SENT171	40	40	30	30	gemcitabine	IL-8	PA449748	3576	0.967
NULL	J_Cardiothorac_Surg_2009_Jun_18_4_25.nxml.txt.nlp	19538741	SENT54	4	4	13	13	heparin	ACT	PA449855	12;11332;9457;641455	0.967
NULL	Br_J_Cancer_2001_Jan_1_84(1)_42-47.nxml.txt.nlp	11139311	SENT2	9	9	20	20	paclitaxel	P-gp	PA450761	5243	0.967
NULL	Eur_J_Clin_Pharmacol_2013_Mar_5_69(3)_467-475.nxml.txt.nlp	22864379	SENT29	34	34	4	4	coumarin	VKORC1	PA134521193	79001	0.967
NULL	Endocrinology_2011_Feb_5_152(2)_405-413.nxml.txt.nlp	21209017	SENT26	5	5	13	13	l-glutamine	GLP-1	PA10090	100125288	0.967
NULL	Breast_Cancer_Res_2006_Nov_30_8(6)_216.nxml.txt.nlp	17164010	SENT190	9	9	7	7	anastrozole	aromatase	PA448432	1588	0.967
NULL	J_Antimicrob_Chemother_2009_Nov_18_64(5)_910-928.nxml.txt.nlp	19767318	SENT108	0	0	6	6	maraviroc	CXCR4	PA164768835	7852	0.967
NULL	Br_J_Cancer_2011_Mar_15_104(6)_893-898.nxml.txt.nlp	21364594	SENT110	0	0	24	24	cetuximab	KRAS	PA10040	3845	0.967
NULL	Oncologist_2010_Mar_3_15(3)_216-235.nxml.txt.nlp	20200040	SENT109	7	7	2	2	trastuzumab	HER-2	PA451743	2064	0.967
NULL	Channels_(Austin)_2012_Mar_1_6(2)_124-132.nxml.txt.nlp	22627148	SENT95	41	41	27	27	capsaicin	TRPV1	PA448776	7442	0.967
NULL	Case_Rep_Transplant_2012_Aug_30_2012_672923.nxml.txt.nlp	23259137	SENT83	5	5	14	14	voriconazole	IPA	PA10233	3160	0.967
NULL	Patient_Prefer_Adherence_2013_May_7_7_391-400.nxml.txt.nlp	23687442	SENT33	3	3	39	39	fosaprepitant	HEC	PA165958390	10403	0.967
NULL	Brain_Sci_2013_Jun_14_3(2)_941-963.nxml.txt.nlp	24961432	SENT155	21	21	16	16	ethanol	NR1	PA448073	27158	0.967
NULL	J_Headache_Pain_2014_Sep_18_15(Suppl_1)_F28.nxml.txt.nlp	NULL	SENT8	12	12	23	23	telmisartan	P-gp	PA451605	5243	0.967
NULL	Oncol_Rep_2013_Jun_22_29(6)_2479-2485.nxml.txt.nlp	23525656	SENT24	23	23	17	17	vincristine	MRP7	PA451879	89845;1080	0.967
NULL	Br_J_Cancer_2004_Mar_5_90(Suppl_1)_S7-S10.nxml.txt.nlp	15094758	SENT96	7	7	26	26	fulvestrant	CYP3A4	PA164747170	1576	0.967
NULL	Oncotarget_2011_Jun_7_2(6)_491-496.nxml.txt.nlp	21653999	SENT18	12	12	6	6	tamoxifen	PAK1	PA451581	5585;5058	0.967
NULL	Exp_Diabetes_Res_2012_Feb_23_2012_709893.nxml.txt.nlp	22611375	SENT13	6	6	1	1	exenatide	GLP-1	PA164749238	100125288	0.967
NULL	Trials_2014_Dec_3_15(1)_474.nxml.txt.nlp	NULL	SENT139	28	28	15	15	sorafenib	SHARP	PA7000	23013	0.967
NULL	Biomed_Res_Int_2014_Jan_20_2014_948427.nxml.txt.nlp	24563867	SENT7	21	21	0	0	buspirone	STZ	PA448689	6484	0.967
NULL	Lab_Invest_2010_Mar_11_90(3)_383-390.nxml.txt.nlp	20065942	SENT186	16	16	9	9	zidovudine	TMPK	PA451954	1841	0.967
NULL	Arch_Drug_Inf_2011_Mar_4(1)_1-9.nxml.txt.nlp	21572514	SENT156	7	7	0	0	vinblastine	P-gp	PA451877	5243	0.967
NULL	Br_J_Cancer_2013_Mar_19_108(5)_1079-1091.nxml.txt.nlp	23449353	SENT133	1	1	30	30	docetaxel	MIC-1	PA449383	29919;9518	0.967
NULL	Curr_HIV_Res_2014_May_12(3)_174-188.nxml.txt.nlp	24862327	SENT162	0	0	23	23	curcumin	HO-1	PA151958596	3162	0.967
NULL	J_Oncol_2010_Jan_3_2010_149362.nxml.txt.nlp	20069122	SENT63	0	0	12	12	pazopanib	VEGFR	PA165291492	3791	0.967
NULL	Cancers_(Basel)_2014_Jul_8_6(3)_1487-1499.nxml.txt.nlp	25006835	SENT31	19	19	7	7	cisplatin	JNK	PA449014	5599	0.967
NULL	Br_J_Cancer_2002_Feb_1_86(3)_402-408.nxml.txt.nlp	11875707	SENT118	21	21	6	6	tamoxifen	p53	PA451581	7157	0.967
NULL	Evid_Based_Complement_Alternat_Med_2004_Jun_1(1)_17-27.nxml.txt.nlp	15257322	SENT52	4	4	36	36	methylcholanthrene	IFN	PA165816878	3439	0.967
NULL	Breast_Cancer_(Auckl)_2009_Sep_2_3_61-75.nxml.txt.nlp	19809577	SENT151	16	16	1	1	curcumin	BRCA1	PA151958596	672	0.967
NULL	Sci_Rep_2014_Nov_28_4_7237.nxml.txt.nlp	25429875	SENT108	41	41	30	30	hesperidin	p38	PA449867	10598;1432;7965	0.967
NULL	Oncotarget_2013_Dec_12_5(1)_249-257.nxml.txt.nlp	24371149	SENT22	25	25	6	6	tamoxifen	14-3-3	PA451581	10971	0.967
NULL	Biomed_Res_Int_2013_Mar_17_2013_783131.nxml.txt.nlp	23586059	SENT82	22	22	16	16	paclitaxel	GDI2	PA450761	2665	0.967
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT48	0	0	42	42	pertuzumab	HER-2		2064	0.967
NULL	Infect_Dis_Obstet_Gynecol_2012_Nov_29_2012_543916.nxml.txt.nlp	23251074	SENT37	10	10	38	38	nevirapine	CD4	PA450616	920	0.967
NULL	Int_J_Breast_Cancer_2012_Nov_9_2012_716564.nxml.txt.nlp	22295250	SENT131	0	0	10	10	imiquimod	MPL	PA449972	4352	0.967
NULL	Cent_European_J_Urol_2013_Dec_19_66(4)_394-404.nxml.txt.nlp	24757527	SENT146	30	30	6	6	sunitinib	CA9	PA162372840	768	0.967
NULL	J_Immunol_Res_2014_May_12_2014_897249.nxml.txt.nlp	24901013	SENT58	5	5	18	18	natalizumab	CD4	PA164747191	920	0.967
NULL	Curr_Oncol_2006_Oct_13(5)_147-159.nxml.txt.nlp	22792012	SENT39	27	27	14	14	tamoxifen	CYP2D6	PA451581	1565	0.967
NULL	Breast_Cancer_Res_2007_Oct_26_9(5)_306.nxml.txt.nlp	17980055	SENT35	19	19	10	10	tamoxifen	Bcl-2	PA451581	596	0.967
NULL	Exp_Anim_2014_Apr_26_63(2)_257-267.nxml.txt.nlp	24770651	SENT102	29	29	14	14	perindopril	apelin	PA450877	8862	0.967
NULL	Arthritis_Res_Ther_2012_May_1_14(3)_R99.nxml.txt.nlp	22546542	SENT149	24	24	0	0	infliximab	CD4	PA452639	920	0.967
NULL	Allergy_Asthma_Clin_Immunol_2013_Oct_3_9(1)_39.nxml.txt.nlp	24219860	SENT7	7	7	24	24	rituximab	BAFF	PA451261	10673	0.967
NULL	Front_Oncol_2014_Aug_11_4_204.nxml.txt.nlp	25157335	SENT285	21	21	28	28	gefitinib	ERBB3	PA131301952	2065	0.967
NULL	J_Adv_Pract_Oncol_2014_May_1_May-Jun_5(3)_193-202.nxml.txt.nlp	25089218	SENT366	7	7	1	1	bortezomib	AKT	PA10252	207	0.967
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S349-S354.nxml.txt.nlp	21525481	SENT119	20	20	3	3	exenatide	GLP-1	PA164749238	100125288	0.967
NULL	Evid_Based_Complement_Alternat_Med_2015_Jan_6_2015_736431.nxml.txt.nlp	25632290	SENT117	17	17	8	8	curcumin	CYP3A	PA151958596	1574	0.967
NULL	Oncoscience_2014_Oct_22_1(10)_614-623.nxml.txt.nlp	25593991	SENT92	7	7	32	32	trastuzumab	KIT	PA451743	3815	0.967
NULL	Curr_Hematol_Malig_Rep_2014_Jun_18_9(3)_212-216.nxml.txt.nlp	24939521	SENT155	3	3	33	33	doxorubicin	HD7	PA449412	9734	0.967
NULL	Arthritis_Res_Ther_2004_Sep_13_6(Suppl_3)_16.nxml.txt.nlp	NULL	SENT10	24	24	2	2	staurosporine	CCL3	PA165109623	6348	0.967
NULL	Oncotarget_2013_Feb_27_4(2)_329-345.nxml.txt.nlp	23593654	SENT178	12	12	29	29	paclitaxel	CD44	PA450761	960	0.967
NULL	Trials_2013_May_4_14_125.nxml.txt.nlp	23782591	SENT183	6	6	32	32	galantamine	CYP2D6	PA449726	1565	0.967
NULL	Clin_Pharmacol_2010_Jun_24_2_131-134.nxml.txt.nlp	22291496	SENT79	0	0	3	3	liraglutide	GLP-1	PA165958364	100125288	0.967
NULL	Blood_Res_2014_Mar_24_49(1)_69-72.nxml.txt.nlp	24724072	SENT16	35	35	33	33	exemestane	aromatase	PA449563	1588	0.967
NULL	Oncotarget_2011_Dec_21_2(12)_1134-1144.nxml.txt.nlp	22193779	SENT132	23	23	5	5	gefitinib	PC3	PA131301952	57332;7832;5122	0.967
NULL	Ann_Rheum_Dis_2012_Sep_71(9)_1510-1516.nxml.txt.nlp	22440821	SENT11	30	30	3	3	adalimumab	adiponectin	PA10004	9370	0.967
NULL	Br_J_Cancer_1998_Aug_78(3)_375-381.nxml.txt.nlp	9703286	SENT15	31	31	9	9	cyclophosphamide	TP53	PA449165	7157	0.967
NULL	Nucleic_Acids_Res_2011_Dec_31_39(22)_9536-9548.nxml.txt.nlp	21880590	SENT229	16	16	27	27	etoposide	BRCA1	PA449552	672	0.967
NULL	Eplasty_2014_Jun_17_14_e22.nxml.txt.nlp	24966996	SENT29	5	5	28	28	trypsin	gamma	PA451806	9913	0.967
NULL	J_Exp_Bot_2012_Apr_20_63(7)_2449-2464.nxml.txt.nlp	22268155	SENT73	0	0	16	16	phenol	mol	PA450913	90527	0.967
NULL	Eur_J_Clin_Pharmacol_2012_Jan_8_68(1)_29-37.nxml.txt.nlp	21739267	SENT31	16	16	28	28	quinidine	CYP3A4	PA451209	1576	0.967
NULL	Clin_Epigenetics_2010_Sep_18_1(3-4)_101-116.nxml.txt.nlp	21258631	SENT260	4	4	19	19	resveratrol	SIRT1		23411	0.967
NULL	Adv_Hematol_2012_Jan_18_2012_195484.nxml.txt.nlp	22312366	SENT22	5	5	30	30	cyclophosphamide	CHOP	PA449165	1649	0.967
NULL	Biomed_Res_Int_2014_Jan_15_2014_859871.nxml.txt.nlp	24527460	SENT18	29	29	41	41	cetuximab	EGFR	PA10040	1956	0.967
NULL	Oxid_Med_Cell_Longev_2013_Mar_5_2013_264935.nxml.txt.nlp	23533686	SENT205	16	16	28	28	hemin	HO-1	PA449849	3162	0.967
NULL	Braz_J_Med_Biol_Res_2012_Mar_9_45(4)_357-365.nxml.txt.nlp	22392189	SENT129	9	9	12	12	capsaicin	TRPV1	PA448776	7442	0.967
NULL	Environ_Health_Perspect_2005_Aug_15_113(8)_1009-1014.nxml.txt.nlp	16079071	SENT14	10	10	6	6	captopril	p38	PA448780	10598;1432;7965	0.967
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT249	17	17	2	2	dasatinib	PP1	PA162372878	5540;5464	0.967
NULL	EJC_Suppl_2013_Sep_5_11(2)_3-22.nxml.txt.nlp	NULL	SENT316	26	26	3	3	goserelin	aromatase	PA164747674	1588	0.967
NULL	Case_Rep_Oncol_2014_Mar_19_7(1)_210-216.nxml.txt.nlp	24803897	SENT7	14	14	4	4	capecitabine	HER2	PA448771	2064	0.967
NULL	F1000_Biol_Rep_2011_Nov_1_3_23.nxml.txt.nlp	22065982	SENT140	8	8	37	37	benzbromarone	URAT1	PA134852920	116085	0.967
NULL	Curr_Genomics_2014_Jun_15(3)_190-202.nxml.txt.nlp	24955027	SENT178	42	42	24	24	sunitinib	RAI	PA162372840	10848;6050	0.967
NULL	Oxid_Med_Cell_Longev_2011_Sep_21_2011_253529.nxml.txt.nlp	21949898	SENT18	3	3	31	31	dactinomycin	TRAIL	PA151917012	8743	0.967
NULL	Int_J_Gen_Med_2009_Dec_29_2_209-217.nxml.txt.nlp	20360906	SENT139	20	20	28	28	cabergoline	PRL	PA448708	5617	0.967
NULL	Hum_Mol_Genet_2010_Feb_15_19(4)_623-633.nxml.txt.nlp	19955119	SENT265	0	0	28	28	phenol	FKRP	PA450913	79147	0.967
NULL	J_Mol_Signal_2010_May_10_5_4.nxml.txt.nlp	20459745	SENT57	21	21	26	26	cisplatin	p53	PA449014	7157	0.967
NULL	Cell_Death_Dis_2013_Oct_3_4(10)_e827.nxml.txt.nlp	24091670	SENT37	10	10	31	31	nilotinib	CD34	PA165958345	947	0.967
NULL	Ann_Rheum_Dis_2008_Nov_14_67(11)_1516-1523.nxml.txt.nlp	18625622	SENT213	36	36	0	0	methotrexate	ACR	PA450428	49	0.967
NULL	Oncol_Rep_2014_Jul_15_32(1)_45-49.nxml.txt.nlp	24841138	SENT10	8	8	0	0	pp2	MT1-MMP		4323	0.967
NULL	BMB_Rep_2014_Jun_47(6)_299-310.nxml.txt.nlp	24856830	SENT169	20	20	37	37	olaparib	BRCA2		675	0.967
NULL	Oncogene_2014_Jun_26_33(26)_3422-3431.nxml.txt.nlp	23912457	SENT20	10	10	0	0	trastuzumab	PTEN	PA451743	5728	0.967
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1046.nxml.txt.nlp	24503538	SENT84	26	26	18	18	oxaliplatin	FGFR4	PA131285527	2264	0.967
NULL	Croat_Med_J_2013_Apr_54(2)_171-179.nxml.txt.nlp	23630144	SENT9	0	0	11	11	taurine	STZ	PA451590	6484	0.967
NULL	Cancer_Metab_2014_Nov_3_2(1)_20.nxml.txt.nlp	NULL	SENT303	22	22	6	6	erlotinib	PDK4	PA134687924	5166	0.967
NULL	Diabetes_Care_2010_Jan_21_33(1)_156-161.nxml.txt.nlp	19846797	SENT175	12	12	18	18	metformin	B12	PA450395	7126;4709	0.967
NULL	J_Adv_Pharm_Technol_Res_2012_Jul-Sep_3(3)_147-159.nxml.txt.nlp	23057001	SENT437	4	4	16	16	saquinavir	zeta	PA451305	9907	0.967
NULL	Cancer_Cell_Int_2008_Mar_18_8_3.nxml.txt.nlp	18348720	SENT36	10	10	6	6	lapatinib	EGFR	PA152241907	1956	0.967
NULL	Anticancer_Agents_Med_Chem_2012_Feb_12(2)_163-171.nxml.txt.nlp	22043994	SENT143	23	23	8	8	panitumumab	KRAS	PA162373091	3845	0.967
NULL	Oncotarget_2014_Nov_3_5(20)_10127-10139.nxml.txt.nlp	25333256	SENT148	35	35	5	5	vemurafenib	TRIM16	PA165946873	10626	0.967
NULL	Biosci_Rep_2012_Aug_1_32(Pt_4)_361-374.nxml.txt.nlp	22762204	SENT147	26	26	19	19	erlotinib	EGFR	PA134687924	1956	0.967
NULL	J_Mol_Signal_2010_May_10_5_4.nxml.txt.nlp	20459745	SENT86	21	21	14	14	cisplatin	p53	PA449014	7157	0.967
NULL	Cholesterol_2012_Oct_17_2012_292598.nxml.txt.nlp	23119149	SENT159	4	4	13	13	vismodegib	SMO		6608;54498	0.967
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1196-1204.nxml.txt.nlp	22315058	SENT146	18	18	14	14	lapatinib	HER2	PA152241907	2064	0.967
NULL	Open_Biochem_J_2007_Jun_15_1_1-6.nxml.txt.nlp	18949066	SENT61	24	24	3	3	ng-monomethyl-l-arginine	CPX		1371;10682;1377	0.967
NULL	Eur_J_Immunol_2012_Nov_18_42(11)_3049-3061.nxml.txt.nlp	22806397	SENT100	10	10	19	19	imiquimod	CD127	PA449972	3575	0.967
NULL	Cancers_(Basel)_2012_Sep_25_4(4)_969-988.nxml.txt.nlp	24213497	SENT175	6	6	15	15	gefitinib	aromatase	PA131301952	1588	0.967
NULL	Endocrinol_Diabetes_Metab_Case_Rep_2014_Mar_1_2014_140001.nxml.txt.nlp	24683487	SENT38	24	24	2	2	bromocriptine	ACTH	PA448671	5443	0.967
NULL	Acta_Neuropathol_Commun_2013_May_20_1_17.nxml.txt.nlp	24252689	SENT58	22	22	0	0	fluvastatin	ICAM1	PA449688	3383	0.967
NULL	Breast_Cancer_Res_2009_Jun_23_11(Suppl_1)_P29.nxml.txt.nlp	NULL	SENT7	6	6	12	12	tamoxifen	aromatase	PA451581	1588	0.967
NULL	Int_J_Mol_Imaging_2011_Oct_12_2011_694179.nxml.txt.nlp	22013519	SENT13	0	0	3	3	zolmitriptan	5-HT1B	PA451975	3351	0.967
NULL	Acta_Pharmacol_Sin_2009_Nov_5_30(11)_1522-1528.nxml.txt.nlp	19890360	SENT8	19	19	2	2	fenoterol	CD14	PA10079	929	0.967
NULL	Nat_Commun_2014_Nov_19_5_5479.nxml.txt.nlp	25407222	SENT227	24	24	0	0	dextran	YTS	PA449261	8565	0.967
NULL	Br_J_Cancer_2010_Sep_7_103(6)_765-771.nxml.txt.nlp	20700120	SENT7	5	5	25	25	tamoxifen	CYP2D6	PA451581	1565	0.967
NULL	Ann_Hematol_2013_Apr_13_92(4)_481-486.nxml.txt.nlp	23238896	SENT3	35	35	31	31	doxorubicin	CHOP	PA449412	1649	0.967
NULL	Toxins_(Basel)_2010_Mar_31_2(4)_517-551.nxml.txt.nlp	22069598	SENT374	2	2	16	16	resveratrol	survivin		332	0.967
NULL	Clin_Med_Insights_Arthritis_Musculoskelet_Disord_2013_Aug_8_6_35-43.nxml.txt.nlp	23997576	SENT24	20	20	2	2	celecoxib	COX	PA448871	1351	0.967
NULL	Nat_Chem_Biol_2010_Apr_28_6(4)_291-299.nxml.txt.nlp	20190765	SENT53	40	40	16	16	dasatinib	DDR1	PA162372878	780	0.967
NULL	Indian_J_Med_Res_2014_Jan_139(1)_27-65.nxml.txt.nlp	24604039	SENT56	29	29	3	3	theophylline	CYP1A2	PA451647	1544	0.967
NULL	Nucleic_Acids_Res_2013_Nov_22_41(21)_9719-9731.nxml.txt.nlp	23969417	SENT44	16	16	0	0	hydroxyurea	53BP1	PA449942	7158	0.967
NULL	Int_J_Mol_Imaging_2011_Oct_26_2011_874585.nxml.txt.nlp	21490735	SENT173	23	23	44	44	colchicine	FDG	PA449092	23583	0.967
NULL	EMBO_Mol_Med_2012_Mar_4(3)_218-233.nxml.txt.nlp	22294553	SENT45	26	26	13	13	tamoxifen	EGFR	PA451581	1956	0.967
NULL	Proteome_Sci_2009_May_28_7_20.nxml.txt.nlp	19476632	SENT186	28	28	2	2	galactose	IDH3A	PA449725	3419	0.967
NULL	J_Korean_Med_Sci_2012_Sep_22_27(9)_1037-1043.nxml.txt.nlp	22969249	SENT129	4	4	19	19	paricalcitol	CDK2	PA450798	1017	0.967
NULL	J_Obes_2011_Sep_30_2011_431985.nxml.txt.nlp	20953366	SENT247	12	12	7	7	sitagliptin	GLP-1	PA164748978	100125288	0.967
NULL	Oncogene_2014_Oct_23_33(43)_5109-5120.nxml.txt.nlp	24858043	SENT81	32	32	25	25	pp2	MCT-1		28985	0.967
NULL	Ann_Indian_Acad_Neurol_2009_Oct-Dec_12(4)_264-272.nxml.txt.nlp	20182574	SENT113	0	0	12	12	methylprednisolone	LFA-1	PA450466	3683;3689	0.967
NULL	Oncotarget_2014_Feb_7_5(3)_775-787.nxml.txt.nlp	24519956	SENT188	35	35	0	0	docetaxel	PC3	PA449383	57332;7832;5122	0.967
NULL	ScientificWorldJournal_2013_Apr_18_2013_978394.nxml.txt.nlp	23710154	SENT108	6	6	30	30	fluorouracil	IFL	PA128406956	3439	0.967
NULL	Arthritis_Res_Ther_2013_Oct_2_15(5)_R141.nxml.txt.nlp	24286116	SENT152	13	13	26	26	infliximab	IL-6	PA452639	3569	0.967
NULL	Cases_J_2009_Apr_20_2_6644.nxml.txt.nlp	20181174	SENT79	48	48	7	7	tazobactam	CRP	PA164764504	1401;140913	0.967
NULL	Oncotarget_2014_Jun_7_5(14)_5257-5271.nxml.txt.nlp	24913448	SENT92	8	8	1	1	nilotinib	CRKL	PA165958345	1399	0.967
NULL	Patient_Prefer_Adherence_2013_Apr_26_7_369-377.nxml.txt.nlp	23641151	SENT41	19	19	33	33	ustekinumab	IL-23	PA166048654	51561	0.967
NULL	Oncoimmunology_2012_Jul_1_1(4)_493-506.nxml.txt.nlp	22754768	SENT78	22	22	2	2	sargramostim	GM-CSF	PA164748631	1437	0.967
NULL	Behav_Brain_Funct_2010_Mar_22_6_19.nxml.txt.nlp	20307280	SENT216	30	30	1	1	ethanol	CB1	PA448073	1268	0.967
NULL	Cell_Death_Differ_2010_Oct_30_17(10)_1624-1635.nxml.txt.nlp	20431602	SENT56	37	37	16	16	paclitaxel	Mcl-1	PA450761	4170	0.967
NULL	Autophagy_2012_Jul_1_8(7)_1045-1057.nxml.txt.nlp	22647547	SENT178	29	29	5	5	gentamicin	MIR30B	PA449753	407030	0.967
NULL	Acta_Naturae_2011_Oct-Dec_3(4)_83-93.nxml.txt.nlp	22649707	SENT106	30	30	12	12	fluorouracil	TLR2	PA128406956	7097	0.967
NULL	Curr_Opin_Pharmacol_2012_Dec_12(6)_653-658.nxml.txt.nlp	23063456	SENT83	23	23	12	12	dextran	CB2	PA449261	1269	0.967
NULL	Br_J_Haematol_2009_Nov_2_147(3)_396-410.nxml.txt.nlp	19758122	SENT9	31	31	18	18	dasatinib	TP53	PA162372878	7157	0.967
NULL	Diabetologia_2010_Dec_19_53(12)_2621-2628.nxml.txt.nlp	20853098	SENT268	4	4	15	15	mannitol	HLA-DQB1	PA450320	3119	0.967
NULL	J_Med_Case_Rep_2013_Oct_8_7_238.nxml.txt.nlp	24103078	SENT61	0	0	24	24	thrombin	VIII	PA451674	1351	0.967
NULL	Cancer_Manag_Res_2013_Nov_21_5_387-400.nxml.txt.nlp	24294007	SENT38	36	36	4	4	panitumumab	EGFR	PA162373091	1956	0.967
NULL	Acta_Pharmacol_Sin_2010_Nov_18_31(11)_1447-1453.nxml.txt.nlp	20953204	SENT127	12	12	15	15	rimonabant	CB1	PA152407999	1268	0.967
NULL	Indian_J_Endocrinol_Metab_2012_Dec_16(Suppl_2)_S195-S198.nxml.txt.nlp	23565377	SENT38	16	16	0	0	paclitaxel	PRL	PA450761	5617	0.967
NULL	Lipids_Health_Dis_2011_Feb_28_10_38.nxml.txt.nlp	21352602	SENT77	5	5	22	22	atorvastatin	PCSK9	PA448500	255738	0.967
NULL	Breast_Cancer_Res_Treat_2013_Jun_5_139(3)_649-655.nxml.txt.nlp	23736997	SENT27	14	14	0	0	tamoxifen	CYP2C19	PA451581	1557	0.967
NULL	Front_Physiol_2010_Jul_15_1_14.nxml.txt.nlp	21423357	SENT68	17	17	3	3	selegiline	CYP2D6	PA451316	1565	0.967
NULL	Mol_Biol_Cell_2013_Jun_1_24(11)_1801-1811.nxml.txt.nlp	23552691	SENT205	27	27	13	13	phenformin	AMPK	PA1000	5563	0.967
NULL	Front_Genet_2013_Aug_29_4_163.nxml.txt.nlp	24009622	SENT74	11	11	33	33	ethanol	ABCG2	PA448073	9429	0.967
NULL	Comp_Hepatol_2005_Feb_8_4_2.nxml.txt.nlp	15701172	SENT259	7	7	23	23	ketoconazole	CYP3A4	PA450146	1576	0.967
NULL	Cancer_Med_2014_Apr_7_3(2)_362-375.nxml.txt.nlp	24515916	SENT177	10	10	3	3	zoledronate	IFN	PA10235	3439	0.967
NULL	Nature_2007_Jan_25_445(7126)_437-441.nxml.txt.nlp	17206155	SENT33	30	30	36	36	gefitinib	EGFR	PA131301952	1956	0.967
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_127043.nxml.txt.nlp	23227093	SENT28	6	6	22	22	lovastatin	RYR	PA450272	6261	0.967
NULL	Biologics_2009_Jul_13_3_77-97.nxml.txt.nlp	19707398	SENT259	6	6	23	23	infliximab	ACT	PA452639	12;11332;9457;641455	0.967
NULL	Br_J_Cancer_2012_Feb_28_106(5)_916-922.nxml.txt.nlp	22333602	SENT152	16	16	22	22	doxorubicin	HER2	PA449412	2064	0.967
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1542-1553.nxml.txt.nlp	21970874	SENT226	25	25	13	13	pemetrexed	EGFR	PA10810	1956	0.967
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT35	36	36	6	6	phenprocoumon	CYP2C9	PA450921	1559	0.967
NULL	Indian_J_Anaesth_2009_Aug_53(4)_434-441.nxml.txt.nlp	20640205	SENT154	5	5	17	17	acetazolamide	STP	PA448018	9322	0.967
NULL	Cancers_(Basel)_2014_Mar_6_6(1)_494-525.nxml.txt.nlp	24662938	SENT163	11	11	17	17	afatinib	IL-6	PA165981154	3569	0.967
NULL	Scientifica_(Cairo)_2013_Dec_12_2013_635203.nxml.txt.nlp	24416617	SENT407	18	18	11	11	vemurafenib	BRAF	PA165946873	673	0.967
NULL	Curr_Pharm_Biotechnol_2012_May_13(6)_969-986.nxml.txt.nlp	22039792	SENT56	27	27	10	10	ivermectin	P-gp	PA450133	5243	0.967
NULL	Clin_Sci_(Lond)_2013_May_1_124(Pt_9)_567-578.nxml.txt.nlp	23113760	SENT321	18	18	4	4	camptothecin	RRM2	PA153590860	6241	0.967
NULL	J_Korean_Med_Sci_2008_Aug_25_23(4)_685-690.nxml.txt.nlp	18756058	SENT98	16	16	5	5	olanzapine	ghrelin	PA450688	51738	0.967
NULL	Breast_Cancer_Res_2002_Aug_27_4(6)_213-217.nxml.txt.nlp	12473165	SENT86	10	10	29	29	tamoxifen	aromatase	PA451581	1588	0.967
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT318	25	25	6	6	chloroquine	FGF1	PA448948	2246	0.967
NULL	Mol_Cytogenet_2010_Nov_15_3_23.nxml.txt.nlp	21078186	SENT224	32	32	17	17	lenalidomide	RPS14	PA162363968	6208	0.967
NULL	N_Am_J_Med_Sci_2011_Oct_3(10)_441-450.nxml.txt.nlp	22363081	SENT229	28	28	6	6	gemcitabine	DPD	PA449748	1806	0.967
NULL	Basic_Clin_Pharmacol_Toxicol_2013_Feb_5_112(2)_132-137.nxml.txt.nlp	22900583	SENT148	17	17	22	22	prasugrel	CYP3A4	PA154410481	1576	0.967
NULL	Breast_Cancer_Res_2009_Sep_18_11(5)_R70.nxml.txt.nlp	19761616	SENT55	18	18	9	9	tetracycline	MUC4	PA451640	4585	0.967
NULL	J_Oncol_2012_Aug_8_2012_608406.nxml.txt.nlp	22927846	SENT161	5	5	30	30	dacarbazine	CCL5	PA449197	6352	0.967
NULL	Cancer_Med_2012_Aug_15_1(1)_28-38.nxml.txt.nlp	23342251	SENT228	7	7	22	22	trastuzumab	ERBB2	PA451743	2064	0.967
NULL	Breast_Cancer_Res_2004_Jul_29_6(5)_204-210.nxml.txt.nlp	15318926	SENT48	15	15	2	2	erlotinib	EGFR	PA134687924	1956	0.967
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_39-54.nxml.txt.nlp	19305787	SENT323	40	40	22	22	ethanol	PP1	PA448073	5540;5464	0.967
NULL	Oncotarget_2014_Feb_7_5(3)_775-787.nxml.txt.nlp	24519956	SENT197	36	36	0	0	docetaxel	PC3	PA449383	57332;7832;5122	0.967
NULL	Acta_Pharmacol_Sin_2011_Jun_23_32(6)_765-780.nxml.txt.nlp	21602835	SENT320	0	0	19	19	diazoxide	SCHAD	PA449285	3033	0.967
NULL	Oncotarget_2013_Jul_26_4(8)_1317-1328.nxml.txt.nlp	23945331	SENT15	26	26	33	33	trastuzumab	HER2	PA451743	2064	0.967
NULL	Br_J_Pharmacol_2013_Mar_25_168(6)_1445-1455.nxml.txt.nlp	23121507	SENT284	6	6	11	11	diethylstilbestrol	TRPC5	PA449307	7224	0.967
NULL	J_Immunol_Res_2014_Mar_13_2014_734068.nxml.txt.nlp	24741620	SENT126	12	12	0	0	hydrocortisone	HLA-G	PA449905	3135	0.967
NULL	J_Biol_Chem_2009_Aug_21_284(34)_22926-22937.nxml.txt.nlp	19520847	SENT399	1	1	20	20	amrinone	ADP	PA164746803	23038	0.967
NULL	Oncotarget_2014_Aug_19_5(18)_8737-8749.nxml.txt.nlp	25228590	SENT8	20	20	10	10	crizotinib	PI3K	PA165946122	5290	0.967
NULL	Pharmaceuticals_(Basel)_2014_May_14_7(5)_621-633.nxml.txt.nlp	24830987	SENT53	36	36	8	8	ethanol	FDG	PA448073	23583	0.967
NULL	Arthritis_Res_Ther_2011_May_25_13(Suppl_1)_S2.nxml.txt.nlp	21624181	SENT347	12	12	4	4	infliximab	IMPACT	PA452639	55364	0.967
NULL	Adv_Hematol_2012_Aug_2_2012_842945.nxml.txt.nlp	22919394	SENT180	13	13	2	2	lenalidomide	CRBN	PA162363968	51185	0.967
NULL	Cell_Death_Dis_2013_Sep_5_4(9)_e791.nxml.txt.nlp	24008735	SENT82	43	43	4	4	gemcitabine	PUMA	PA449748	27113	0.967
NULL	J_Hematol_Oncol_2014_Aug_1_7_52.nxml.txt.nlp	25085632	SENT148	20	20	15	15	sunitinib	PTEN	PA162372840	5728	0.967
NULL	Front_Pharmacol_2014_Nov_21_5_257.nxml.txt.nlp	25484865	SENT105	8	8	20	20	verapamil	P-gp	PA451868	5243	0.967
NULL	Iran_J_Pharm_Res_2013_Winter_12(1)_141-146.nxml.txt.nlp	24250582	SENT8	15	15	25	25	rifampin	NAC	PA451250	22861	0.967
NULL	Clin_Pharmacokinet_2014_Sep_3_53(1)_1-16.nxml.txt.nlp	23999929	SENT284	22	22	20	20	fluconazole	CYP3A4	PA449653	1576	0.967
NULL	EJC_Suppl_2013_Sep_5_11(2)_299-300.nxml.txt.nlp	NULL	SENT27	3	3	17	17	tamoxifen	aromatase	PA451581	1588	0.967
NULL	Mar_Drugs_2014_May_27_12(6)_3231-3244.nxml.txt.nlp	24879546	SENT107	0	0	25	25	curcumin	p300	PA151958596	2033	0.967
NULL	J_Med_Life_2011_Feb_15_4(1)_11-20.nxml.txt.nlp	21505570	SENT72	7	7	36	36	sulindac	COX2	PA451565	4513;5743	0.967
NULL	Mol_Cancer_2007_Sep_26_6_61.nxml.txt.nlp	17894897	SENT98	30	30	11	11	etoposide	HIF-1	PA449552	29072	0.967
NULL	Oncotarget_2012_Sep_28_3(10)_1169-1181.nxml.txt.nlp	23045411	SENT34	40	40	3	3	doxorubicin	MAPK8IP1	PA449412	9479	0.967
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT148	26	26	15	15	trastuzumab	STAT3	PA451743	6774	0.967
NULL	Cancer_Imaging_2011_Mar_1_11(1)_1-8.nxml.txt.nlp	21362586	SENT97	12	12	7	7	verapamil	P-gp	PA451868	5243	0.967
NULL	Br_J_Cancer_2010_Sep_7_103(6)_889-898.nxml.txt.nlp	20664599	SENT164	28	28	6	6	paclitaxel	HER-2	PA450761	2064	0.967
NULL	Ther_Clin_Risk_Manag_2007_Jun_3(3)_361-362.nxml.txt.nlp	18488067	SENT30	0	0	34	34	alefacept	CD2	PA164748040	914	0.967
NULL	Int_J_Breast_Cancer_2012_Jan_24_2012_385978.nxml.txt.nlp	22461984	SENT85	29	29	20	20	cisplatin	BRCA1	PA449014	672	0.967
NULL	Diabetes_Metab_Syndr_Obes_2014_Mar_18_7_107-120.nxml.txt.nlp	24672252	SENT38	0	0	4	4	liraglutide	GLP-1	PA165958364	100125288	0.967
NULL	Breast_Cancer_Res_Treat_2013_Jul_5_140(1)_63-71.nxml.txt.nlp	23828499	SENT52	21	21	1	1	carboplatin	HER2	PA448803	2064	0.967
NULL	Breast_Cancer_Res_2010_Oct_22_12(Suppl_2)_S1.nxml.txt.nlp	21050422	SENT279	0	0	22	22	bevacizumab	TRN	PA130232992	3842	0.967
NULL	Arthritis_Res_Ther_2014_Aug_30_16(4)_419.nxml.txt.nlp	25175678	SENT171	20	20	36	36	glibenclamide	NLRP3	PA449782	114548	0.967
NULL	Breast_Cancer_Res_2012_Jan_17_14(1)_R12.nxml.txt.nlp	22251451	SENT284	5	5	33	33	genistein	GPER	PA165109660	2852	0.967
NULL	Cancers_(Basel)_2012_Oct_29_4(4)_1146-1160.nxml.txt.nlp	24213502	SENT81	20	20	25	25	exemestane	aromatase	PA449563	1588	0.967
NULL	Mol_Cancer_2008_May_21_7_42.nxml.txt.nlp	18492291	SENT5	6	6	28	28	gefitinib	EGF	PA131301952	1950	0.967
NULL	Diabetes_Metab_J_2013_Aug_14_37(4)_240-248.nxml.txt.nlp	23991401	SENT6	6	6	0	0	ezetimibe	NPC1L1	PA10816	29881	0.967
NULL	Cell_Cycle_2013_Dec_15_12(24)_3759-3769.nxml.txt.nlp	24107633	SENT10	2	2	25	25	metformin	HER2	PA450395	2064	0.967
NULL	Acta_Neuropathol_Commun_2013_May_20_1_17.nxml.txt.nlp	24252689	SENT58	22	22	4	4	fluvastatin	CD36	PA449688	948	0.967
NULL	Oncotarget_2011_Dec_24_2(12)_896-917.nxml.txt.nlp	22203527	SENT207	0	0	7	7	metformin	CD44	PA450395	960	0.967
NULL	Adv_Biomed_Res_2014_Nov_29_3_234.nxml.txt.nlp	25538920	SENT74	32	32	2	2	propofol	ANOVA	PA451141	4858	0.967
NULL	Oxid_Med_Cell_Longev_2013_Apr_21_2013_412576.nxml.txt.nlp	23710286	SENT91	8	8	21	21	curcumin	ANOVA	PA151958596	4858	0.967
NULL	Cell_Mol_Life_Sci_2012_Mar_2_69(6)_963-979.nxml.txt.nlp	21964925	SENT398	24	24	12	12	imiquimod	TLR3	PA449972	7098	0.967
NULL	J_Hematol_Oncol_2009_Aug_12_2_36.nxml.txt.nlp	19674465	SENT133	14	14	3	3	lenalidomide	CD34	PA162363968	947	0.967
NULL	Front_Chem_2014_Dec_23_2_113.nxml.txt.nlp	25566531	SENT160	34	34	18	18	curcumin	AREG	PA151958596	374	0.967
NULL	F1000Prime_Rep_2014_Apr_1_6_21.nxml.txt.nlp	24765526	SENT53	23	23	20	20	tocilizumab	IL-6	PA165292659	3569	0.967
NULL	Indian_J_Endocrinol_Metab_2013_Mar-Apr_17(2)_332-335.nxml.txt.nlp	23776915	SENT101	3	3	26	26	methimazole	NIS	PA450422	6528	0.967
NULL	Br_J_Cancer_2011_Jul_26_105(3)_403-406.nxml.txt.nlp	21730978	SENT34	0	0	21	21	cetuximab	KRAS	PA10040	3845	0.967
NULL	Br_J_Cancer_2012_Jan_3_106(1)_107-115.nxml.txt.nlp	22116303	SENT130	0	0	33	33	vorinostat	AKT	PA164748224	207	0.967
NULL	Bioinformation_2012_Jan_6_8(1)_13-19.nxml.txt.nlp	22359429	SENT131	5	5	20	20	curcumin	MRP1	PA151958596	4437	0.967
NULL	Int_J_Mol_Sci_2014_Mar_10_15(3)_4201-4220.nxml.txt.nlp	24619193	SENT20	25	25	11	11	vinblastine	IFN	PA451877	3439	0.967
NULL	Breast_Cancer_Res_2002_Jul_30_4(5)_205.nxml.txt.nlp	12238488	SENT20	0	0	14	14	geldanamycin	Hsp90	PA152031327	3320	0.967
NULL	Breast_Cancer_Res_Treat_2013_Jul_5_140(1)_63-71.nxml.txt.nlp	23828499	SENT192	41	41	16	16	paclitaxel	HER2	PA450761	2064	0.967
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_29_2013_590393.nxml.txt.nlp	23737838	SENT223	25	25	38	38	resveratrol	p53		7157	0.967
NULL	Blood_Cancer_J_2012_Oct_19_2(10)_e95.nxml.txt.nlp	23085780	SENT117	23	23	33	33	dasatinib	PAH	PA162372878	5053	0.967
NULL	Sci_Rep_2014_Dec_12_4_7456.nxml.txt.nlp	25503852	SENT51	0	0	18	18	resveratrol	SIRT1		23411	0.967
NULL	Oncogene_2014_Oct_9_33(41)_4941-4951.nxml.txt.nlp	24681952	SENT99	14	14	7	7	metformin	WNT5A	PA450395	7474	0.967
NULL	Nat_Commun_2012_Dec_4_3_1238.nxml.txt.nlp	23212367	SENT168	29	29	4	4	phenylephrine	TRPC6	PA450935	7225	0.967
NULL	Arthritis_Res_Ther_2005_Feb_17_7(Suppl_1)_P81.nxml.txt.nlp	NULL	SENT5	30	30	2	2	infliximab	RANKL	PA452639	8600	0.967
NULL	Br_J_Ophthalmol_2014_Jun_98(Suppl_1)_i11-i16.nxml.txt.nlp	24836865	SENT21	0	0	14	14	ranibizumab	VEGF-A	PA164746012	7422	0.967
NULL	Int_J_Vasc_Med_2012_Aug_22_2012_201027.nxml.txt.nlp	21876813	SENT259	21	21	9	9	rosuvastatin	CYP3A4	PA134308647	1576	0.967
NULL	Cancer_Cell_Int_2009_Sep_10_9_25.nxml.txt.nlp	19744341	SENT19	3	3	40	40	glucosamine	HBP	PA164747613	3069;50865;7884;566	0.967
NULL	Mol_Cells_2014_Nov_30_37(11)_812-818.nxml.txt.nlp	25377255	SENT9	11	11	5	5	doxorubicin	PARP-1	PA449412	25976	0.967
NULL	Biol_Proced_Online_1999_Oct_4_2_1-38.nxml.txt.nlp	12734586	SENT323	1	1	6	6	galactose	GAL4	PA449725	3960	0.967
NULL	J_Adv_Pract_Oncol_2012_May_1_May-Jun_3(3)_138-150.nxml.txt.nlp	25031940	SENT362	13	13	39	39	cetuximab	EGFR	PA10040	1956	0.967
NULL	Alcohol_Res_2012_34(3)_339-344.nxml.txt.nlp	23134050	SENT35	12	12	3	3	ethanol	ADH7	PA448073	131	0.967
NULL	N_Am_J_Med_Sci_2012_Dec_4(12)_648-650.nxml.txt.nlp	23272308	SENT20	8	8	2	2	amikacin	CRA	PA164744372	51747;10903	0.967
NULL	Oncotarget_2014_Oct_18_5(22)_11604-11619.nxml.txt.nlp	25344099	SENT181	33	33	13	13	cisplatin	p53	PA449014	7157	0.967
NULL	Indian_J_Pharmacol_2008_Oct_40(Suppl_2)_S150-S160.nxml.txt.nlp	21593968	SENT61	11	11	17	17	pioglitazone	gamma	PA450970	9913	0.967
NULL	Hum_Genomics_2009_Jan_1_3(2)_128-142.nxml.txt.nlp	19164090	SENT186	17	17	7	7	carboplatin	CD44	PA448803	960	0.967
NULL	J_Korean_Med_Sci_2012_Sep_22_27(9)_1037-1043.nxml.txt.nlp	22969249	SENT97	19	19	5	5	paricalcitol	CDK4	PA450798	1019	0.967
NULL	Clinics_(Sao_Paulo)_2014_Jan_69(1)_68-74.nxml.txt.nlp	24473562	SENT116	7	7	25	25	nutlin-3	SOCS-1		8651	0.967
NULL	Oncoimmunology_2014_Apr_25_3_e28518.nxml.txt.nlp	25071979	SENT119	14	14	20	20	oxaliplatin	CRT	PA131285527	811	0.967
NULL	Indian_J_Pharmacol_2014_May-Jun_46(3)_292-297.nxml.txt.nlp	24987176	SENT13	4	4	12	12	udenafil	DES	PA164776753	1674	0.967
NULL	Oncol_Lett_2013_Mar_8_5(3)_805-812.nxml.txt.nlp	23426281	SENT7	28	28	2	2	gemcitabine	B7-H3	PA449748	80381	0.967
NULL	J_Cancer_2013_Sep_27_4(8)_662-670.nxml.txt.nlp	24155778	SENT180	23	23	5	5	carboplatin	UCHL1	PA448803	7345	0.967
NULL	Ann_Rheum_Dis_2008_Oct_1_68(6)_930-937.nxml.txt.nlp	18829616	SENT14	4	4	12	12	adalimumab	ACR	PA10004	49	0.967
NULL	Oncogenesis_2012_Apr_2_1(4)_e5.nxml.txt.nlp	23552603	SENT241	21	21	3	3	celecoxib	Bcl-2	PA448871	596	0.967
NULL	Oncol_Rep_2013_Jan_1_29(1)_13-20.nxml.txt.nlp	23128605	SENT168	0	0	10	10	lapatinib	HER2	PA152241907	2064	0.967
NULL	Eur_J_Clin_Pharmacol_2014_Oct_8_70(1)_37-45.nxml.txt.nlp	24100471	SENT204	0	0	7	7	rosuvastatin	OATP1B1	PA134308647	10599	0.967
NULL	Hum_Reprod_Update_2008_Sep_26_Nov-Dec_14(6)_605-621.nxml.txt.nlp	18820005	SENT247	12	12	31	31	anastrozole	Casper	PA448432	8837	0.967
NULL	Oxid_Med_Cell_Longev_2013_Nov_10_2013_680414.nxml.txt.nlp	24319532	SENT137	4	4	33	33	minocycline	PARP-1	PA450519	25976	0.967
NULL	Mol_Cancer_2014_Jun_27_13_159.nxml.txt.nlp	24972933	SENT184	18	18	0	0	fludarabine	DCK	PA449655	1633	0.967
NULL	Braz_J_Med_Biol_Res_2012_Feb_17_45(3)_244-249.nxml.txt.nlp	22331137	SENT95	23	23	0	0	gentamicin	PAG	PA449753	55824	0.967
NULL	Breast_Cancer_Res_2012_Jun_7_14(3)_R89.nxml.txt.nlp	22676470	SENT293	30	30	15	15	lapatinib	HER2	PA152241907	2064	0.967
NULL	EMBO_Mol_Med_2013_Dec_8_5(12)_1821-1834.nxml.txt.nlp	24293316	SENT96	25	25	8	8	doxorubicin	UNC5B	PA449412	219699	0.967
NULL	Cell_Death_Dis_2010_Oct_21_1(10)_e86.nxml.txt.nlp	21368859	SENT60	4	4	23	23	doxorubicin	JNK	PA449412	5599	0.967
NULL	Mol_Brain_2013_Sep_23_6_41.nxml.txt.nlp	24059452	SENT42	33	33	12	12	vasopressin	CD38	PA451858	952	0.967
NULL	Breast_Cancer_(Auckl)_2009_Sep_2_3_61-75.nxml.txt.nlp	19809577	SENT104	6	6	26	26	curcumin	BRCA1	PA151958596	672	0.967
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Dec_17_3(12)_e152.nxml.txt.nlp	25518025	SENT31	20	20	9	9	oxymorphone	CYP3A4	PA450748	1576	0.967
NULL	Biosci_Rep_2013_Oct_31_33(5)_e00078.nxml.txt.nlp	24073800	SENT199	15	15	6	6	capsaicin	TRPV1	PA448776	7442	0.967
NULL	Indian_J_Dermatol_2014_May-Jun_59(3)_316e.nxml.txt.nlp	24891683	SENT64	0	0	11	11	methotrexate	IL-2	PA450428	3558	0.967
NULL	Breast_Cancer_Res_2007_Oct_19_9(5)_111.nxml.txt.nlp	17983482	SENT68	31	31	9	9	gefitinib	HER3	PA131301952	2065	0.967
NULL	Biologics_2013_Apr_26_7_91-101.nxml.txt.nlp	23671386	SENT110	7	7	18	18	crizotinib	KIT	PA165946122	3815	0.967
NULL	Breast_Cancer_Res_2011_Mar_11_13(2)_R29.nxml.txt.nlp	21396094	SENT163	21	21	1	1	fulvestrant	HRG	PA164747170	3084;3273	0.967
NULL	AIDS_Res_Ther_2012_Mar_12_9_7.nxml.txt.nlp	22409770	SENT161	26	26	10	10	vorinostat	CD4	PA164748224	920	0.967
NULL	Cardiovasc_Diabetol_2010_Oct_18_9_64.nxml.txt.nlp	20955583	SENT135	26	26	17	17	losartan	CD36	PA450268	948	0.967
NULL	Front_Pharmacol_2014_May_13_5_89.nxml.txt.nlp	24860504	SENT16	16	16	24	24	resveratrol	SIRT1		23411	0.967
NULL	Ann_Rheum_Dis_2014_Jul_1_73(7)_1405-1413.nxml.txt.nlp	23727633	SENT151	24	24	3	3	resveratrol	p53		7157	0.967
NULL	Clin_Med_Insights_Oncol_2012_Aug_16_6_287-303.nxml.txt.nlp	22933844	SENT86	0	0	9	9	denosumab	RANKL	PA166048634	8600	0.967
NULL	Leukemia_2014_Aug_4_28(8)_1573-1585.nxml.txt.nlp	24496300	SENT218	8	8	1	1	itraconazole	P-gp	PA450132	5243	0.967
NULL	Chem_Rev_2014_Jun_11_114(11)_5753-5774.nxml.txt.nlp	24758331	SENT46	12	12	29	29	vinblastine	MRP1	PA451877	4437	0.967
NULL	Case_Rep_Oncol_2011_Nov_22_4(3)_534-541.nxml.txt.nlp	22187539	SENT30	28	28	15	15	paclitaxel	GEM	PA450761	2669	0.967
NULL	Breast_Cancer_Res_2003_Oct_7_5(1)_8-15.nxml.txt.nlp	12559039	SENT137	8	8	26	26	trastuzumab	AKT	PA451743	207	0.967
NULL	Crit_Care_2011_Jul_12_15(4)_R166.nxml.txt.nlp	21749676	SENT127	4	4	25	25	levosimendan	CD62L	PA164749138	6402	0.967
NULL	J_Headache_Pain_2007_Apr_11_8(2)_83-89.nxml.txt.nlp	17497262	SENT7	9	9	6	6	ketanserin	5-HT2A	PA131053734	3356	0.967
NULL	Lancet_2011_Jun_9_377(9784)_2181-2192.nxml.txt.nlp	21663949	SENT125	25	25	2	2	ezetimibe	SHARP	PA10816	23013	0.967
NULL	Breast_Cancer_Res_2002_Jan_14_4(2)_65-69.nxml.txt.nlp	11879566	SENT63	24	24	8	8	estradiol	aromatase	PA449503	1588	0.967
NULL	Cell_Death_Differ_2010_Oct_30_17(10)_1624-1635.nxml.txt.nlp	20431602	SENT70	12	12	4	4	paclitaxel	Mcl-1	PA450761	4170	0.967
NULL	Oncoimmunology_2012_Oct_1_1(7)_1038-1047.nxml.txt.nlp	23170252	SENT61	35	35	1	1	cyclophosphamide	IL-10	PA449165	3586	0.967
NULL	Clinics_(Sao_Paulo)_2012_May_67(5)_419-424.nxml.txt.nlp	22666783	SENT38	16	16	5	5	gefitinib	EGFR	PA131301952	1956	0.967
NULL	Eur_J_Neurosci_2007_Sep_26(6)_1657-1669.nxml.txt.nlp	17880399	SENT363	8	8	36	36	chlorpromazine	DAO	PA448964	26;1610	0.967
NULL	Cells_2012_Jul_6_1(3)_284-312.nxml.txt.nlp	24710477	SENT302	5	5	20	20	lapatinib	Mcl-1	PA152241907	4170	0.967
NULL	J_Oncol_2010_Dec_28_2010_414676.nxml.txt.nlp	20066160	SENT88	11	11	21	21	paclitaxel	aromatase	PA450761	1588	0.967
NULL	Ann_Oncol_2011_Mar_8_22(3)_503-514.nxml.txt.nlp	20616198	SENT135	17	17	13	13	tamoxifen	aromatase	PA451581	1588	0.967
NULL	Diabetes_Care_2008_Jul_31(7)_1427-1432.nxml.txt.nlp	18390799	SENT163	5	5	1	1	pioglitazone	RBP4	PA450970	5433;5950	0.967
NULL	Gene_Ther_2010_Jan_27_17(1)_117-131.nxml.txt.nlp	19710705	SENT285	31	31	1	1	cyclopentolate	ERG	PA164743019	2078	0.967
NULL	Neuropsychopharmacology_2009_Jul_25_34(8)_1968-1978.nxml.txt.nlp	19322168	SENT258	45	45	2	2	clozapine	PI3K	PA449061	5290	0.967
NULL	Ann_Clin_Transl_Neurol_2014_Dec_21_1(12)_996-1005.nxml.txt.nlp	25574474	SENT114	24	24	0	0	riluzole	P-gp	PA451251	5243	0.967
NULL	Oncol_Rep_2012_Oct_6_28(4)_1301-1308.nxml.txt.nlp	22895640	SENT262	0	0	12	12	camptothecin	CD44	PA153590860	960	0.967
NULL	J_Hematol_Oncol_2014_Apr_16_7_34.nxml.txt.nlp	24739401	SENT26	37	37	27	27	rituximab	CHOP	PA451261	1649	0.967
NULL	Br_J_Cancer_2010_Sep_28_103(7)_1008-1018.nxml.txt.nlp	20736947	SENT109	27	27	9	9	ethanol	MCT1	PA448073	6566	0.967
NULL	Br_J_Cancer_2010_Oct_26_103(9)_1335-1342.nxml.txt.nlp	20978512	SENT22	17	17	1	1	trastuzumab	HER-2	PA451743	2064	0.967
NULL	CNS_Neurosci_Ther_2010_Jun_16(3)_e1-e17.nxml.txt.nlp	20406250	SENT207	39	39	8	8	escitalopram	5-HT2A	PA10074	3356	0.967
NULL	Cell_Death_Differ_2010_Oct_19_17(10)_1566-1576.nxml.txt.nlp	20300112	SENT68	8	8	12	12	etoposide	p53	PA449552	7157	0.967
NULL	Colorectal_Dis_2012_Feb_14(2)_e31-e47.nxml.txt.nlp	21848897	SENT41	13	13	31	31	cetuximab	KRAS	PA10040	3845	0.967
NULL	Cancers_(Basel)_2014_Apr_9_6(2)_829-859.nxml.txt.nlp	24722453	SENT200	5	5	15	15	curcumin	JAK1	PA151958596	3716	0.967
NULL	Oncotarget_2011_Dec_20_2(12)_1094-1108.nxml.txt.nlp	22190353	SENT56	27	27	4	4	doxorubicin	p53	PA449412	7157	0.967
NULL	Diabetes_2013_Oct_17_62(10)_3500-3513.nxml.txt.nlp	23884882	SENT287	7	7	18	18	resveratrol	SIRT1		23411	0.967
NULL	Curr_Pain_Headache_Rep_2011_Aug_12_15(4)_271-279.nxml.txt.nlp	21479998	SENT100	6	6	14	14	clarithromycin	CYP3A4	PA449028	1576	0.967
NULL	J_Ginseng_Res_2011_Sep_35(3)_339-343.nxml.txt.nlp	23717078	SENT3	9	9	19	19	ginseng	PAH	PA164781150	5053	0.967
NULL	Int_J_Mol_Sci_2012_Aug_15_13(8)_10143-10153.nxml.txt.nlp	22949852	SENT312	4	4	14	14	diethylstilbestrol	EZH2	PA449307	2146	0.967
NULL	J_Am_Heart_Assoc_2013_Dec_19_2(6)_e000355.nxml.txt.nlp	24190878	SENT158	7	7	0	0	isoproterenol	HK2	PA450121	3796;3099;29911;3741	0.966
NULL	F1000_Biol_Rep_2012_Mar_1_4_5.nxml.txt.nlp	22403588	SENT45	16	16	35	35	telaprevir	IFN	PA165958354	3439	0.966
NULL	Mol_Syst_Biol_2010_Jun_8_6_375.nxml.txt.nlp	20531405	SENT187	7	7	14	14	simvastatin	HMGCR	PA451363	3156	0.966
NULL	Physiol_Rep_2014_Aug_28_2(8)_e12124.nxml.txt.nlp	25168873	SENT65	24	24	8	8	creatine	ADP	PA164778930	23038	0.966
NULL	Curr_Clin_Pharmacol_2008_Sep_3(3)_198-203.nxml.txt.nlp	18781906	SENT35	4	4	12	12	phenytoin	CYP3A4	PA450947	1576	0.966
NULL	Braz_J_Med_Biol_Res_2012_Sep_21_45(12)_1240-1243.nxml.txt.nlp	22983178	SENT101	27	27	6	6	diclofenac	CB1	PA449293	1268	0.966
NULL	J_Cancer_Prev_2014_Mar_19(1)_7-13.nxml.txt.nlp	25337567	SENT111	4	4	18	18	evodiamine	p38	PA165860788	10598;1432;7965	0.966
NULL	Mol_Cancer_2008_Nov_24_7_87.nxml.txt.nlp	19025616	SENT30	27	27	3	3	etoposide	ALDH3A1	PA449552	218	0.966
NULL	Front_Behav_Neurosci_2012_Sep_18_6_61.nxml.txt.nlp	23049505	SENT30	5	5	22	22	donepezil	spatial	PA449394	219793	0.966
NULL	J_Cancer_2013_Jan_11_4(2)_117-132.nxml.txt.nlp	23386910	SENT23	2	2	20	20	pertuzumab	HER2		2064	0.966
NULL	Front_Oncol_2014_Jun_16_4_146.nxml.txt.nlp	24982847	SENT278	24	24	14	14	docetaxel	RANKL	PA449383	8600	0.966
NULL	Acta_Neuropathol_Commun_2013_Jul_17_1_39.nxml.txt.nlp	24252174	SENT7	20	20	25	25	erlotinib	Erb	PA134687924	2100	0.966
NULL	Biologics_2009_Oct_12_3_443-457.nxml.txt.nlp	19851470	SENT43	0	0	19	19	etanercept	p75	PA449515	7133;11168	0.966
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1137-1144.nxml.txt.nlp	20234366	SENT121	10	10	6	6	cetuximab	BRAF	PA10040	673	0.966
NULL	J_Oncol_2010_Jan_14_2010_740472.nxml.txt.nlp	20130818	SENT122	21	21	7	7	tamoxifen	AGO	PA451581	55294	0.966
NULL	J_Biomed_Biotechnol_2010_Mar_28_2010_178614.nxml.txt.nlp	20368797	SENT195	19	19	2	2	phenylephrine	S100A1	PA450935	6271	0.966
NULL	Oncotarget_2013_Aug_24_4(10)_1618-1631.nxml.txt.nlp	24113128	SENT133	6	6	17	17	sorafenib	p53	PA7000	7157	0.966
NULL	Arthritis_Res_Ther_2004_Feb_24_6(Suppl_1)_72.nxml.txt.nlp	NULL	SENT5	36	36	31	31	infliximab	IL-10	PA452639	3586	0.966
NULL	Genome_Announc_2014_Jul_10_2(4)_e00688-14.nxml.txt.nlp	25013145	SENT4	3	3	42	42	vancomycin	VISA	PA451850	57506	0.966
NULL	Aging_(Albany_NY)_2009_Sep_25_1(10)_845-854.nxml.txt.nlp	20157557	SENT164	24	24	6	6	doxorubicin	p53	PA449412	7157	0.966
NULL	Exp_Ther_Med_2013_Nov_13_6(5)_1317-1321.nxml.txt.nlp	24223665	SENT142	18	18	5	5	cisplatin	CD133	PA449014	8842	0.966
NULL	Ther_Clin_Risk_Manag_2006_Dec_2(4)_435-445.nxml.txt.nlp	18360654	SENT147	8	8	4	4	erlotinib	EGFR	PA134687924	1956	0.966
NULL	Allergy_2014_Feb_14_69(2)_137-149.nxml.txt.nlp	24117861	SENT193	23	23	16	16	cetuximab	EGFR	PA10040	1956	0.966
NULL	Cancer_Causes_Control_2009_Nov_4_20(9)_1617-1622.nxml.txt.nlp	19653109	SENT88	0	0	42	42	metformin	HER2	PA450395	2064	0.966
NULL	Multidiscip_Respir_Med_2013_May_30_8(1)_35.nxml.txt.nlp	23721656	SENT24	23	23	2	2	bleomycin	IL-4	PA448645	3565	0.966
NULL	Biomed_Res_Int_2013_Nov_28_2013_791406.nxml.txt.nlp	24369536	SENT70	5	5	19	19	sunitinib	MDC	PA162372840	6367	0.966
NULL	J_Gen_Physiol_2009_Oct_134(4)_323-337.nxml.txt.nlp	19786585	SENT228	25	25	16	16	dantrolene	ClC-1	PA449208	1180	0.966
NULL	J_Clin_Exp_Pathol_2012_May_17_Suppl_4_7327.nxml.txt.nlp	25379357	SENT41	15	15	31	31	resveratrol	SIRT1		23411	0.966
NULL	Cardiovasc_Diabetol_2013_Nov_11_12_168.nxml.txt.nlp	24215469	SENT155	27	27	5	5	vasopressin	AVP	PA451858	114548;551	0.966
NULL	F1000Res_2013_Mar_5_2_74.nxml.txt.nlp	24358880	SENT175	11	11	0	0	benzaldehyde	TRPV1	PA448571	7442	0.966
NULL	Clin_Interv_Aging_2010_Dec_3_5_403-416.nxml.txt.nlp	21152242	SENT160	32	32	2	2	ramipril	ACE	PA451223	1636	0.966
NULL	Nat_Commun_2013_Aug_15_4_2130.nxml.txt.nlp	23945651	SENT130	25	25	6	6	etoposide	ATG5	PA449552	9474	0.966
NULL	J_Inherit_Metab_Dis_2010_Oct_3_33(5)_625-632.nxml.txt.nlp	20814828	SENT89	5	5	11	11	simvastatin	RhoA	PA451363	387	0.966
NULL	Curr_Neuropharmacol_2013_Mar_11(2)_160-170.nxml.txt.nlp	23997751	SENT102	13	13	3	3	mianserin	5-HT2C	PA134687937	3358	0.966
NULL	Biosci_Rep_2012_Aug_1_32(Pt_4)_361-374.nxml.txt.nlp	22762204	SENT1496	14	14	2	2	etoposide	p33ING1b	PA449552	3621	0.966
NULL	Int_J_Endocrinol_2014_Jun_25_2014_534904.nxml.txt.nlp	25053942	SENT12	19	19	29	29	amiodarone	AIT	PA448383	160728	0.966
NULL	Crit_Care_2002_Mar_1_6(Suppl_1)_P34.nxml.txt.nlp	NULL	SENT7	17	17	5	5	propofol	COPA	PA451141	1314	0.966
NULL	Cancer_Inform_2012_Apr_19_11_87-111.nxml.txt.nlp	22553414	SENT217	1	1	13	13	gefitinib	MELK	PA131301952	9833	0.966
NULL	Korean_Circ_J_2014_Mar_12_44(2)_82-88.nxml.txt.nlp	24653737	SENT38	24	24	32	32	clopidogrel	P2Y12	PA449053	64805	0.966
NULL	Nat_Med_2014_Apr_16_20(4)_385-397.nxml.txt.nlp	24633305	SENT438	33	33	17	17	triciribine	PI3K	PA165958661	5290	0.966
NULL	Pharmaceuticals_(Basel)_2013_Aug_21_6(8)_988-1038.nxml.txt.nlp	24276379	SENT499	21	21	15	15	irinotecan	CD166	PA450085	214	0.966
NULL	Arthritis_Res_Ther_2011_Feb_4_13(1)_R14.nxml.txt.nlp	21294864	SENT115	38	38	29	29	indomethacin	IL-6	PA449982	3569	0.966
NULL	Oncol_Rep_2013_Jun_22_29(6)_2479-2485.nxml.txt.nlp	23525656	SENT24	23	23	13	13	vincristine	MRP7	PA451879	89845;1080	0.966
NULL	Anal_Bioanal_Chem_2011_Jan_3_399(2)_527-539.nxml.txt.nlp	20814668	SENT141	17	17	4	4	heparin	NIR	PA449855	26155	0.966
NULL	J_Cell_Biol_1998_Jul_13_142(1)_101-115.nxml.txt.nlp	9660866	SENT144	26	26	2	2	dextran	RhoA	PA449261	387	0.966
NULL	J_Oncol_2012_Oct_9_2012_261750.nxml.txt.nlp	22007214	SENT55	21	21	3	3	bevacizumab	VEGF-A	PA130232992	7422	0.966
NULL	Cancer_Cell_Int_2008_Mar_18_8_3.nxml.txt.nlp	18348720	SENT123	19	19	4	4	lapatinib	EGF	PA152241907	1950	0.966
NULL	Indian_J_Med_Res_2012_Sep_136(3)_391-403.nxml.txt.nlp	23041732	SENT168	25	25	45	45	cisplatin	HCC	PA449014	84668	0.966
NULL	Nat_Commun_2014_Dec_18_5_5815.nxml.txt.nlp	25519973	SENT485	12	12	1	1	tranylcypromine	LSD1	PA451741	23028	0.966
NULL	Clin_Dev_Immunol_2011_Dec_26_2011_890758.nxml.txt.nlp	22235224	SENT157	4	4	24	24	cetuximab	EGFR	PA10040	1956	0.966
NULL	Oncotarget_2014_Oct_22_5(20)_9530-9531.nxml.txt.nlp	25393980	SENT22	10	10	17	17	ustekinumab	p40	PA166048654	3921;339541;10314	0.966
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT307	29	29	22	22	pp2	PP2		4888	0.966
NULL	J_Cell_Biol_2000_Feb_21_148(4)_665-678.nxml.txt.nlp	10684249	SENT55	13	13	6	6	collagenase	ST2	PA449107	9173;6761	0.966
NULL	Ther_Clin_Risk_Manag_2007_Mar_3(1)_71-97.nxml.txt.nlp	18360617	SENT270	1	1	17	17	micafungin	CYP3A	PA164781026	1574	0.966
NULL	J_Invest_Dermatol_2014_Apr_8_134(4)_902-909.nxml.txt.nlp	24213370	SENT53	24	24	11	11	mitomycin	PKD1	PA450524	5310	0.966
NULL	Mol_Cancer_2014_Jun_4_13_141.nxml.txt.nlp	24894453	SENT11	23	23	5	5	cetuximab	EGFR	PA10040	1956	0.966
NULL	Int_J_Endocrinol_2012_Apr_10_2012_268957.nxml.txt.nlp	22550484	SENT596	33	33	12	12	pegvisomant	UGT1A1	PA164749630	54658	0.966
NULL	Emerg_Infect_Dis_2003_Jul_9(7)_864-867.nxml.txt.nlp	12890330	SENT7	0	0	14	14	trimethoprim	DHPS	PA451788	1725	0.966
NULL	Korean_J_Anesthesiol_2013_Dec_26_65(6)_501-507.nxml.txt.nlp	24427455	SENT132	42	42	14	14	neostigmine	NMB	PA450611	10457;4828	0.966
NULL	Arthritis_Res_Ther_2004_Sep_23_6(6)_R535-R543.nxml.txt.nlp	15535831	SENT66	21	21	0	0	infliximab	ACL	PA452639	47	0.966
NULL	J_Exp_Clin_Cancer_Res_2010_Aug_11_29(1)_110.nxml.txt.nlp	20701792	SENT29	33	33	4	4	etoposide	CSE1L	PA449552	1434	0.966
NULL	Acta_Pharmacol_Sin_2014_Jan_9_35(1)_1-10.nxml.txt.nlp	24317012	SENT23	26	26	9	9	paclitaxel	SLCO1B3	PA450761	28234	0.966
NULL	J_Biol_Chem_2008_Oct_31_283(44)_29841-29846.nxml.txt.nlp	18765669	SENT34	1	1	14	14	suramin	P2X1	PA10292	5023	0.966
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT72	0	0	28	28	metformin	LKB1	PA450395	6794	0.966
NULL	Cell_Death_Dis_2014_Feb_13_5(2)_e1055.nxml.txt.nlp	24525731	SENT69	11	11	20	20	irinotecan	XRCC1	PA450085	7515	0.966
NULL	Cancers_(Basel)_2011_May_3_3(2)_2255-2273.nxml.txt.nlp	24212808	SENT141	4	4	25	25	gefitinib	AAP	PA131301952	5345	0.966
NULL	Acta_Diabetol_2012_Aug_11_49(4)_277-289.nxml.txt.nlp	21833779	SENT134	17	17	26	26	carbachol	EGF	PA448784	1950	0.966
NULL	Iran_J_Pharm_Res_2014_Autumn_13(4)_1393-1401.nxml.txt.nlp	25587329	SENT6	12	12	3	3	celecoxib	ABCG2	PA448871	9429	0.966
NULL	J_Exp_Med_1969_May_1_129(5)_1109-1130.nxml.txt.nlp	5778786	SENT10	4	4	0	0	trypsin	C3b	PA451806	718	0.966
NULL	AIDS_2013_Nov_28_27(18)_F21-F28.nxml.txt.nlp	24051706	SENT115	4	4	20	20	maraviroc	CCL2	PA164768835	6347	0.966
NULL	Curr_Clin_Pharmacol_2013_May_8(2)_135-155.nxml.txt.nlp	23062036	SENT400	8	8	6	6	exemestane	aromatase	PA449563	1588	0.966
NULL	Cancers_(Basel)_2013_Nov_26_5(4)_1601-1618.nxml.txt.nlp	24287743	SENT193	0	0	12	12	cabozantinib	Met	PA165906891	79811	0.966
NULL	Oncotarget_2011_Sep_9_2(9)_658-668.nxml.txt.nlp	21911919	SENT111	18	18	10	10	daunorubicin	HO-1	PA449212	3162	0.966
NULL	Breast_Cancer_Res_2011_Oct_12_13(5)_220.nxml.txt.nlp	22018398	SENT49	32	32	16	16	trastuzumab	EPO	PA451743	7076;8288;2056	0.966
NULL	Cancer_Immunol_Immunother_2011_Jan_21_60(1)_75-85.nxml.txt.nlp	20857100	SENT224	36	36	9	9	fludarabine	IFN	PA449655	3439	0.966
NULL	Eur_J_Med_Res_2009_Nov_24_14(Suppl_3)_36-42.nxml.txt.nlp	19959415	SENT106	43	43	22	22	telaprevir	CYP3A	PA165958354	1574	0.966
NULL	Cancer_Cell_Int_2008_Mar_18_8_3.nxml.txt.nlp	18348720	SENT11	23	23	9	9	gefitinib	SMO	PA131301952	6608;54498	0.966
NULL	J_Gen_Physiol_1997_Dec_1_110(6)_643-654.nxml.txt.nlp	9382893	SENT156	18	18	13	13	trypsin	SUR1	PA451806	6833	0.966
NULL	Breast_Cancer_Res_2008_Apr_9_10(Suppl_1)_S1.nxml.txt.nlp	19091005	SENT140	15	15	7	7	trastuzumab	HER2	PA451743	2064	0.966
NULL	Eur_J_Clin_Pharmacol_2014_Oct_8_70(1)_37-45.nxml.txt.nlp	24100471	SENT195	2	2	10	10	omeprazole	CYP3A4	PA450704	1576	0.966
NULL	Front_Oncol_2013_Oct_22_3_268.nxml.txt.nlp	24156094	SENT98	26	26	41	41	doxorubicin	STAT3	PA449412	6774	0.966
NULL	Mol_Cancer_2012_Aug_8_11_53.nxml.txt.nlp	22871047	SENT13	24	24	1	1	paclitaxel	HIN-1	PA450761	92304	0.966
NULL	Exp_Ther_Med_2015_Feb_3_9(2)_585-590.nxml.txt.nlp	25574239	SENT129	26	26	3	3	indomethacin	COX	PA449982	1351	0.966
NULL	J_Hematol_Oncol_2013_Mar_27_6_23.nxml.txt.nlp	23531342	SENT70	5	5	18	18	geldanamycin	p53	PA152031327	7157	0.966
NULL	Cell_Commun_Signal_2012_Sep_3_10_26.nxml.txt.nlp	22943670	SENT44	8	8	1	1	hyaluronan	CD44	PA165958431	960	0.966
NULL	Oncoimmunology_2013_Apr_1_2(4)_e24117.nxml.txt.nlp	23734336	SENT88	10	10	4	4	curcumin	IL-6	PA151958596	3569	0.966
NULL	eLife_2013_Nov_5_2_e00969.nxml.txt.nlp	24192036	SENT410	2	2	42	42	vemurafenib	San	PA165946873	80218	0.966
NULL	Oncogene_2013_Sep_5_32(36)_4252-4263.nxml.txt.nlp	23045288	SENT83	8	8	13	13	idarubicin	CD49f	PA449961	3655	0.966
NULL	Iran_Red_Crescent_Med_J_2014_Aug_5_16(8)_e6915.nxml.txt.nlp	25389496	SENT130	26	26	11	11	simvastatin	adiponectin	PA451363	9370	0.966
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jan_11_68(Pt_2)_o315.nxml.txt.nlp	22346950	SENT63	36	36	6	6	ethanol	mol	PA448073	90527	0.966
NULL	J_Oncol_2009_Mar_24_2009_491985.nxml.txt.nlp	19325924	SENT150	23	23	1	1	genistein	CXCR4	PA165109660	7852	0.966
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1149.nxml.txt.nlp	24675467	SENT102	24	24	3	3	trastuzumab	HER2	PA451743	2064	0.966
NULL	Orphanet_J_Rare_Dis_2007_Jan_8_2_3.nxml.txt.nlp	17210076	SENT321	35	35	5	5	anagrelide	IFN	PA164742986	3439	0.966
NULL	Pharmaceutics_2011_Aug_10_3(3)_474-484.nxml.txt.nlp	24310591	SENT109	3	3	22	22	cyanocobalamin	B12	PA451892	7126;4709	0.966
NULL	Br_J_Cancer_2010_Mar_2_102(5)_815-826.nxml.txt.nlp	20145614	SENT194	18	18	5	5	letrozole	HER2	PA450196	2064	0.966
NULL	J_Oncol_2013_Apr_29_2013_854121.nxml.txt.nlp	23737784	SENT116	1	1	19	19	lapatinib	PTEN	PA152241907	5728	0.966
NULL	Oncoimmunology_2013_Oct_1_2(10)_e27025.nxml.txt.nlp	24353914	SENT176	27	27	20	20	docetaxel	ICOS	PA449383	29851;1493	0.966
NULL	Int_J_Mol_Sci_2014_May_8_15(5)_8106-8121.nxml.txt.nlp	24815071	SENT55	28	28	16	16	atorvastatin	LC3	PA448500	84557	0.966
NULL	Breast_Cancer_Res_2010_Dec_17_12(6)_216.nxml.txt.nlp	21172067	SENT77	24	24	3	3	tamoxifen	aromatase	PA451581	1588	0.966
NULL	Oncoscience_2014_Mar_24_1(3)_196-204.nxml.txt.nlp	25594012	SENT120	13	13	7	7	gefitinib	HER3	PA131301952	2065	0.966
NULL	Prostate_Int_2014_Sep_21_2(3)_105-113.nxml.txt.nlp	25325021	SENT147	20	20	9	9	finasteride	SRD5A1	PA449627	6715	0.966
NULL	Emerg_Infect_Dis_2012_Aug_18(8)_1290-1297.nxml.txt.nlp	22840274	SENT154	10	10	19	19	ciprofloxacin	GISP	PA449009	83998	0.966
NULL	Oncotarget_2014_Jun_26_5(14)_5559-5569.nxml.txt.nlp	24980819	SENT184	10	10	34	34	vemurafenib	p53	PA165946873	7157	0.966
NULL	Front_Oncol_2014_Mar_6_4_40.nxml.txt.nlp	24639951	SENT544	4	4	17	17	lapatinib	BAK	PA152241907	578	0.966
NULL	Oncol_Lett_2014_Jun_8_7(6)_1761-1766.nxml.txt.nlp	24932229	SENT84	35	35	27	27	cetuximab	KRAS	PA10040	3845	0.966
NULL	J_Cell_Mol_Med_2014_Mar_10_18(3)_514-529.nxml.txt.nlp	24410795	SENT301	22	22	31	31	resveratrol	SIRT1		23411	0.966
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Jan_10_6_1-13.nxml.txt.nlp	24648765	SENT80	7	7	35	35	perifosine	MDR1	PA165291471	5243	0.966
NULL	Clin_Med_Insights_Oncol_2013_Jun_20_7_137-149.nxml.txt.nlp	23843723	SENT238	22	22	20	20	vemurafenib	BRAF	PA165946873	673	0.966
NULL	Case_Rep_Rheumatol_2014_Nov_11_2014_536856.nxml.txt.nlp	25436167	SENT8	5	5	8	8	infliximab	TNF	PA452639	7124	0.966
NULL	Biomed_Res_Int_2013_Jul_25_2013_295132.nxml.txt.nlp	23984335	SENT339	0	0	27	27	ustekinumab	IL-23	PA166048654	51561	0.966
NULL	J_Gen_Physiol_2004_Aug_124(2)_125-137.nxml.txt.nlp	15277574	SENT274	13	13	4	4	amiloride	CFTR	PA448368	1080	0.966
NULL	Diabetes_Metab_J_2012_Aug_20_36(4)_293-299.nxml.txt.nlp	22950061	SENT121	11	11	28	28	metformin	AMPK	PA450395	5563	0.966
NULL	J_Korean_Med_Sci_2010_Aug_21_25(8)_1222-1227.nxml.txt.nlp	20676337	SENT66	39	39	30	30	propofol	LPA	PA451141	4018	0.966
NULL	Mol_Cancer_2010_Jun_24_9_164.nxml.txt.nlp	20576107	SENT102	8	8	17	17	etoposide	Mcl-1	PA449552	4170	0.966
NULL	Anal_Bioanal_Chem_2014_Jan_23_406(15)_3667-3680.nxml.txt.nlp	24452745	SENT189	4	4	34	34	ketoprofen	KET	PA450149	8626	0.966
NULL	Oncoimmunology_2012_Jul_1_1(4)_493-506.nxml.txt.nlp	22754768	SENT50	3	3	25	25	maraviroc	CCR5	PA164768835	1234	0.966
NULL	Front_Cell_Neurosci_2013_Aug_29_7_130.nxml.txt.nlp	24009554	SENT163	30	30	2	2	pilocarpine	NPY	PA450962	4852	0.966
NULL	Cancer_Metab_2013_Feb_4_1_7.nxml.txt.nlp	24280108	SENT90	12	12	3	3	doxycycline	MYC	PA449415	4609	0.966
NULL	Br_J_Cancer_2013_May_14_108(9)_1862-1869.nxml.txt.nlp	23579219	SENT124	5	5	18	18	bevacizumab	ANXA11	PA130232992	311	0.966
NULL	Cardiovasc_Res_2009_May_1_82(2)_296-302.nxml.txt.nlp	19088082	SENT84	4	4	23	23	desipramine	nSMase	PA449233	6610	0.966
NULL	Ther_Clin_Risk_Manag_2007_Jun_3(3)_467-474.nxml.txt.nlp	18488080	SENT52	4	4	0	0	tolcapone	COMT	PA451720	1312	0.966
NULL	Cancer_Res_Treat_2014_Jul_15_46(3)_243-249.nxml.txt.nlp	25038759	SENT111	1	1	12	12	capecitabine	CRT	PA448771	811	0.966
NULL	Nat_Biotechnol_2009_Apr_29_27(4)_387-394.nxml.txt.nlp	19329999	SENT126	28	28	20	20	omeprazole	RBBP9	PA450704	10741	0.966
NULL	Mol_Cancer_2010_May_28_9_130.nxml.txt.nlp	20509890	SENT67	21	21	4	4	etoposide	TGFBI	PA449552	7045	0.966
NULL	Cases_J_2009_Apr_20_2_6644.nxml.txt.nlp	20181174	SENT79	46	46	7	7	piperacillin	CRP	PA450975	1401;140913	0.966
NULL	Hum_Genomics_2009_Jan_1_3(2)_101-102.nxml.txt.nlp	19164086	SENT18	14	14	6	6	carboplatin	CD44	PA448803	960	0.966
NULL	Clin_Mol_Hepatol_2014_Sep_25_20(3)_283-290.nxml.txt.nlp	25320732	SENT95	37	37	2	2	propranolol	EVL	PA451145	51466	0.966
NULL	Infect_Dis_Obstet_Gynecol_2014_Sep_25_2014_961375.nxml.txt.nlp	25328370	SENT198	24	24	0	0	atazanavir	ATV	PA10251	4683	0.966
NULL	Ann_Lab_Med_2015_Jan_8_35(1)_15-21.nxml.txt.nlp	25553275	SENT60	18	18	0	0	thrombin	Lag	PA451674	3925	0.966
NULL	Front_Behav_Neurosci_2014_Dec_16_8_437.nxml.txt.nlp	25566005	SENT195	7	7	13	13	menthol	TRPM8	PA164776605	79054	0.966
NULL	Cancer_Manag_Res_2012_Mar_12_4_75-89.nxml.txt.nlp	22457602	SENT169	11	11	19	19	lenalidomide	CD4	PA162363968	920	0.966
NULL	Clin_Ophthalmol_2008_Mar_2(1)_1-14.nxml.txt.nlp	19668384	SENT35	0	0	14	14	ranibizumab	MB1	PA164746012	5693	0.966
NULL	Mol_Cancer_2010_Jun_25_9_166.nxml.txt.nlp	20579378	SENT188	10	10	0	0	gefitinib	DUSP6	PA131301952	1848	0.966
NULL	Nat_Chem_Biol_2013_Feb_2_9(2)_97-104.nxml.txt.nlp	23201900	SENT154	21	21	0	0	diazepam	TSPO	PA449283	706	0.966
NULL	Arthritis_Res_Ther_2014_May_16_16(3)_R113.nxml.txt.nlp	24886859	SENT12	13	13	3	3	pargyline	LSD1	PA450797	23028	0.966
NULL	ScientificWorldJournal_2013_Dec_30_2013_565813.nxml.txt.nlp	24489506	SENT192	16	16	31	31	resveratrol	Q10		27161	0.966
NULL	J_Oncol_2010_May_11_2010_659231.nxml.txt.nlp	20467564	SENT54	15	15	7	7	doxycycline	Ang2	PA449415	285	0.966
NULL	Br_J_Cancer_2010_Sep_28_103(7)_1008-1018.nxml.txt.nlp	20736947	SENT109	27	27	7	7	ethanol	MDR1	PA448073	5243	0.966
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1449-1456.nxml.txt.nlp	24077631	SENT120	30	30	11	11	tolbutamide	CYP2C9	PA451718	1559	0.966
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Aug_26_65(Pt_9)_o2234.nxml.txt.nlp	21577633	SENT71	41	41	13	13	ethanol	mol	PA448073	90527	0.966
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1145.nxml.txt.nlp	24675463	SENT338	27	27	4	4	omalizumab	U87	PA164752253	677775;641648	0.966
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT127	4	4	22	22	adalimumab	CD36	PA10004	948	0.966
NULL	Br_J_Cancer_2009_Jun_2_100(11)_1697-1703.nxml.txt.nlp	19384299	SENT61	10	10	24	24	cyclophosphamide	GITR	PA449165	8784	0.966
NULL	Ann_Rheum_Dis_2008_Aug_20_67(8)_1121-1126.nxml.txt.nlp	18029384	SENT107	28	28	23	23	bosentan	LFA-1	PA10034	3683;3689	0.966
NULL	J_Korean_Med_Sci_2010_May_16_25(5)_716-722.nxml.txt.nlp	20436707	SENT11	3	3	20	20	ezetimibe	DES	PA10816	1674	0.966
NULL	Oncotarget_2014_Jun_19_5(15)_6540-6551.nxml.txt.nlp	25153728	SENT114	28	28	6	6	paclitaxel	p53	PA450761	7157	0.966
NULL	Breast_Cancer_Res_2005_May_27_7(Suppl_1)_S16.nxml.txt.nlp	NULL	SENT4	13	13	6	6	tamoxifen	aromatase	PA451581	1588	0.966
NULL	Oncotarget_2014_Oct_23_5(21)_10816-10829.nxml.txt.nlp	25333261	SENT151	3	3	11	11	doxorubicin	p53	PA449412	7157	0.966
NULL	Lipids_Health_Dis_2011_Feb_28_10_38.nxml.txt.nlp	21352602	SENT145	21	21	28	28	fenofibrate	PCSK9	PA449594	255738	0.966
NULL	AMB_Express_2012_Apr_26_2_25.nxml.txt.nlp	22537922	SENT17	15	15	6	6	isoniazid	INA	PA450112	9118	0.966
NULL	Diabetes_2011_Nov_17_60(11)_2730-2739.nxml.txt.nlp	21926273	SENT76	15	15	23	23	resveratrol	SIRT1		23411	0.966
NULL	Int_J_Gen_Med_2012_Apr_13_5_317-322.nxml.txt.nlp	22536087	SENT113	38	38	15	15	liraglutide	PPG	PA165958364	5552	0.966
NULL	Environ_Health_Perspect_2006_Sep_23_114(9)_1401-1406.nxml.txt.nlp	16966095	SENT150	27	27	10	10	arsenite	p53	PA452638	7157	0.966
NULL	Cell_Cycle_2013_Feb_1_12(3)_409-416.nxml.txt.nlp	23324337	SENT84	28	28	25	25	nutlin-3	p53		7157	0.966
NULL	F1000Res_2013_Mar_5_2_74.nxml.txt.nlp	24358880	SENT163	7	7	4	4	capsaicin	TRPV1	PA448776	7442	0.966
NULL	Evid_Based_Complement_Alternat_Med_2015_Jan_6_2015_802903.nxml.txt.nlp	25632291	SENT104	15	15	26	26	berberine	CYP3A4	PA165860812	1576	0.966
NULL	Acta_Naturae_2011_Apr-Jun_3(2)_22-33.nxml.txt.nlp	22649682	SENT306	5	5	15	15	s-adenosylmethionine	S12	PA164754994	3351;6206;5713;6268	0.966
NULL	J_Cell_Mol_Med_2013_Oct_23_17(10)_1207-1217.nxml.txt.nlp	24106980	SENT161	14	14	22	22	paclitaxel	CD44	PA450761	960	0.966
NULL	Clin_Med_Insights_Oncol_2013_May_20_7_87-102.nxml.txt.nlp	23761989	SENT195	7	7	0	0	lapatinib	CYP3A4	PA152241907	1576	0.966
NULL	Drugs_Aging_2014_May_6_31(6)_413-424.nxml.txt.nlp	24797286	SENT139	18	18	2	2	alendronate	CTX	PA448082	1593	0.966
NULL	Cardiovasc_Diabetol_2006_Dec_4_5_26.nxml.txt.nlp	17144912	SENT68	34	34	5	5	dobutamine	ANOVA	PA449381	4858	0.966
NULL	Oncol_Rep_2012_Apr_30_27(4)_923-928.nxml.txt.nlp	22209766	SENT157	35	35	12	12	erlotinib	EGFR	PA134687924	1956	0.966
NULL	J_Mol_Med_(Berl)_2014_May_10_92(7)_709-722.nxml.txt.nlp	24811491	SENT296	5	5	12	12	gefitinib	ERBB3	PA131301952	2065	0.966
NULL	Evid_Based_Complement_Alternat_Med_2011_Aug_11_2011_307121.nxml.txt.nlp	19383840	SENT116	11	11	27	27	naproxen	IFN	PA450595	3439	0.966
NULL	J_Hematol_Oncol_2011_Jun_14_4_29.nxml.txt.nlp	21672194	SENT7	29	29	25	25	sunitinib	VEGFR	PA162372840	3791	0.966
NULL	Ann_Gastroenterol_2014_27(4)_313-319.nxml.txt.nlp	25331779	SENT143	25	25	36	36	infliximab	POR	PA452639	5447	0.966
NULL	J_Exp_Med_1998_Jun_1_187(11)_1885-1892.nxml.txt.nlp	9607928	SENT106	17	17	4	4	thalidomide	CD4	PA451644	920	0.966
NULL	J_Cereb_Blood_Flow_Metab_2014_Oct_23_34(10)_1688-1694.nxml.txt.nlp	25052553	SENT113	14	14	5	5	losartan	SMAD1	PA450268	2617;4086	0.966
NULL	Nucleic_Acids_Res_2012_Jan_9_40(1)_11-26.nxml.txt.nlp	21908410	SENT306	4	4	20	20	pentamidine	MBNL1	PA450850	4154	0.966
NULL	Eur_J_Med_Chem_2014_Dec_17_88_89-100.nxml.txt.nlp	25159123	SENT256	26	26	14	14	entacapone	PRL-3	PA164748726	11156	0.966
NULL	Front_Cell_Neurosci_2013_Dec_5_7_243.nxml.txt.nlp	24367290	SENT123	28	28	12	12	resveratrol	SOD1		6647	0.966
NULL	Biomed_Imaging_Interv_J_2008_Jul_1_4(3)_e40.nxml.txt.nlp	21611006	SENT137	0	0	26	26	lapatinib	HER2	PA152241907	2064	0.966
NULL	Indian_J_Psychol_Med_2012_Apr-Jun_34(2)_140-143.nxml.txt.nlp	23162189	SENT27	5	5	11	11	dextromethorphan	spatial	PA449273	219793	0.966
NULL	Aging_Cell_2012_Aug_11(4)_579-587.nxml.txt.nlp	22435726	SENT90	32	32	20	20	etoposide	CD28	PA449552	1493;940	0.966
NULL	Front_Pharmacol_2014_May_28_5_121.nxml.txt.nlp	24904423	SENT62	24	24	18	18	trastuzumab	HER2	PA451743	2064	0.966
NULL	Cardiovasc_Diabetol_2013_May_30_12(Suppl_1)_S2.nxml.txt.nlp	23819752	SENT129	3	3	10	10	simvastatin	CYP3A4	PA451363	1576	0.966
NULL	Indian_J_Med_Res_2014_Feb_139(2)_216-225.nxml.txt.nlp	24718395	SENT127	18	18	7	7	gabapentin	PMPS	PA449720	5377	0.966
NULL	Environ_Health_Perspect_2005_Oct_15_113(10)_1410-1413.nxml.txt.nlp	16203256	SENT34	10	10	29	29	hydroquinone	IL-2	PA449924	3558	0.966
NULL	Int_J_Breast_Cancer_2012_Feb_26_2012_761917.nxml.txt.nlp	22482061	SENT128	25	25	5	5	trastuzumab	CDK2	PA451743	1017	0.966
NULL	Int_J_Biol_Sci_2006_Jun_10_2(4)_179-185.nxml.txt.nlp	16810332	SENT139	31	31	10	10	tamoxifen	BRCA1	PA451581	672	0.966
NULL	Int_J_Surg_Oncol_2012_May_17_2012_406830.nxml.txt.nlp	22675625	SENT177	9	9	34	34	bevacizumab	LARC	PA130232992	6364	0.966
NULL	Eur_J_Haematol_2013_Feb_22_90(2)_89-98.nxml.txt.nlp	23181448	SENT131	14	14	36	36	imatinib	KIT	PA10804	3815	0.966
NULL	Eur_J_Haematol_2013_Feb_22_90(2)_89-98.nxml.txt.nlp	23181448	SENT131	14	14	24	24	imatinib	KIT	PA10804	3815	0.966
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S225-S230.nxml.txt.nlp	21525460	SENT130	14	14	29	29	glucose	GLP-1	PA449773	100125288	0.966
NULL	Curr_Med_Chem_2014_May_21(14)_1595-1606.nxml.txt.nlp	23992330	SENT143	36	36	12	12	lapatinib	PI3K	PA152241907	5290	0.966
NULL	Oncotarget_2014_Jun_29_5(12)_4567-4578.nxml.txt.nlp	24994120	SENT147	2	2	14	14	doxorubicin	PC3	PA449412	57332;7832;5122	0.966
NULL	Arthritis_Res_Ther_2013_Jul_9_15(4)_R73.nxml.txt.nlp	23837669	SENT251	3	3	11	11	colchicine	MSU	PA449092	593	0.966
NULL	Cancer_Cell_Int_2013_Feb_12_13_14.nxml.txt.nlp	23402310	SENT149	22	22	12	12	celecoxib	CDK2	PA448871	1017	0.966
NULL	JRSM_Cardiovasc_Dis_2012_Sep_24_1(6)_cvd_2012_012015.nxml.txt.nlp	24175073	SENT21	15	15	5	5	clopidogrel	CYP2C19	PA449053	1557	0.966
NULL	Indian_J_Anaesth_2009_Aug_53(4)_467-474.nxml.txt.nlp	20640210	SENT72	4	4	19	19	propofol	ANOVA	PA451141	4858	0.966
NULL	J_Med_Case_Reports_2011_Dec_21_5_593.nxml.txt.nlp	22188652	SENT36	0	0	20	20	erlotinib	EGFR	PA134687924	1956	0.966
NULL	Oncotarget_2014_Sep_2_5(19)_9308-9321.nxml.txt.nlp	25301721	SENT71	27	27	15	15	probenecid	MRP4	PA451106	10257	0.966
NULL	Pharmaceuticals_(Basel)_2012_Nov_20_5(11)_1236-1264.nxml.txt.nlp	24281308	SENT74	14	14	21	21	gefitinib	PI3K	PA131301952	5290	0.966
NULL	J_Oncol_2010_Dec_28_2010_414676.nxml.txt.nlp	20066160	SENT121	0	0	28	28	pertuzumab	PI3		5266	0.966
NULL	Ann_Oncol_2011_Mar_8_22(3)_503-514.nxml.txt.nlp	20616198	SENT293	6	6	15	15	exemestane	aromatase	PA449563	1588	0.966
NULL	Case_Rep_Med_2009_Aug_9_2009_378287.nxml.txt.nlp	19721707	SENT48	8	8	19	19	tadalafil	CYP3A	PA10333	1574	0.966
NULL	J_Cardiothorac_Surg_2013_Apr_2_8_59.nxml.txt.nlp	23547910	SENT65	2	2	14	14	heparin	ACT	PA449855	12;11332;9457;641455	0.966
NULL	Arthritis_Res_Ther_2005_Dec_1_7(1)_R149-R155.nxml.txt.nlp	15642135	SENT9	21	21	5	5	infliximab	OPG	PA452639	690	0.966
NULL	Breast_Cancer_Res_2005_May_24_7(5)_R589-R597.nxml.txt.nlp	16168102	SENT138	43	43	5	5	doxorubicin	HER3	PA449412	2065	0.966
NULL	ScientificWorldJournal_2012_Apr_19_2012_804730.nxml.txt.nlp	22606063	SENT114	9	9	26	26	tafluprost	BAK	PA165958432	578	0.966
NULL	Cancer_Med_2014_Oct_18_3(5)_1294-1301.nxml.txt.nlp	24941936	SENT29	3	3	21	21	cetuximab	KRAS	PA10040	3845	0.966
NULL	Ann_Neurosci_2011_Apr_18(2)_48-55.nxml.txt.nlp	25205921	SENT116	35	35	3	3	forskolin	SOD1	PA146096022	6647	0.966
NULL	J_Hematol_Oncol_2008_Oct_23_1_19.nxml.txt.nlp	18947412	SENT101	18	18	34	34	alemtuzumab	CD34	PA164783958	947	0.966
NULL	J_Cardiothorac_Surg_2014_Feb_17_9_35.nxml.txt.nlp	24533613	SENT18	6	6	15	15	heparin	ACT	PA449855	12;11332;9457;641455	0.966
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1224-1233.nxml.txt.nlp	22353810	SENT198	2	2	17	17	doxorubicin	MRP-1	PA449412	928	0.966
NULL	Mol_Neurodegener_2011_Jun_22_6_43.nxml.txt.nlp	21696630	SENT225	31	31	21	21	desmopressin	PKD1	PA449237	5310	0.966
NULL	Diabetes_2009_Jun_31_58(6)_1434-1439.nxml.txt.nlp	19336679	SENT154	22	22	15	15	metformin	SLC22A2	PA450395	6582	0.966
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT207	4	4	32	32	adalimumab	CD36	PA10004	948	0.966
NULL	J_Cell_Biol_1997_Jun_16_137(6)_1445-1457.nxml.txt.nlp	9182674	SENT72	14	14	5	5	hydroxyurea	EGF	PA449942	1950	0.966
NULL	Clin_Pharmacol_2011_Jun_22_3_13-25.nxml.txt.nlp	22287853	SENT16	3	3	19	19	saxagliptin	CYP3A4	PA165958362	1576	0.966
NULL	J_Oncol_2010_Dec_28_2010_414676.nxml.txt.nlp	20066160	SENT88	17	17	21	21	vinorelbine	aromatase	PA451881	1588	0.966
NULL	Cancers_(Basel)_2014_Oct_24_6(4)_2187-2223.nxml.txt.nlp	25347122	SENT119	28	28	2	2	cisplatin	BRCA2	PA449014	675	0.966
NULL	Mol_Vis_2011_Feb_24_17_591-597.nxml.txt.nlp	21386928	SENT116	32	32	7	7	fluorescein	FRMD7	PA164746009	90167	0.966
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT142	13	13	25	25	curcumin	TRAIL	PA151958596	8743	0.966
NULL	Breast_Cancer_Res_2010_Jun_24_12(3)_R41.nxml.txt.nlp	20576088	SENT136	12	12	7	7	paclitaxel	EGFR	PA450761	1956	0.966
NULL	Clin_Med_Insights_Oncol_2012_Dec_6_6_407-421.nxml.txt.nlp	23239933	SENT54	2	2	34	34	gefitinib	EGFR	PA131301952	1956	0.966
NULL	Cancer_Med_2014_Jun_25_3(3)_674-680.nxml.txt.nlp	24668895	SENT26	4	4	15	15	cetuximab	EGFR	PA10040	1956	0.966
NULL	Oncologist_2010_Mar_9_15(3)_236-245.nxml.txt.nlp	20215359	SENT79	0	0	17	17	bevacizumab	IFN	PA130232992	3439	0.966
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S272-S275.nxml.txt.nlp	21525467	SENT70	0	0	7	7	liraglutide	GLP-1	PA165958364	100125288	0.966
NULL	Ann_Oncol_2011_Mar_8_22(3)_503-514.nxml.txt.nlp	20616198	SENT86	19	19	16	16	tamoxifen	aromatase	PA451581	1588	0.966
NULL	Nat_Commun_2014_Dec_8_5_5736.nxml.txt.nlp	25484020	SENT164	11	11	29	29	letrozole	TRPA1	PA450196	8989	0.966
NULL	Mol_Cancer_2014_Jul_5_13_165.nxml.txt.nlp	24996221	SENT144	21	21	12	12	docetaxel	HMGB1	PA449383	3146	0.966
NULL	Mol_Cancer_2007_Oct_22_6_66.nxml.txt.nlp	17953743	SENT89	6	6	27	27	cisplatin	TRAIL	PA449014	8743	0.966
NULL	Oncotarget_2012_Dec_17_4(1)_48-63.nxml.txt.nlp	23295955	SENT223	19	19	2	2	methotrexate	MTHFD2	PA450428	10797	0.966
NULL	Drug_Saf_2014_Feb_19_37(4)_201-211.nxml.txt.nlp	24550106	SENT86	7	7	12	12	clopidogrel	CYP2C19	PA449053	1557	0.966
NULL	Aging_(Albany_NY)_2011_Apr_6_3(4)_444-449.nxml.txt.nlp	21483037	SENT55	12	12	20	20	resveratrol	SIRT1		23411	0.966
NULL	Curr_Neuropharmacol_2013_Jul_11(4)_338-378.nxml.txt.nlp	24381528	SENT571	4	4	25	25	curcumin	p53	PA151958596	7157	0.966
NULL	Front_Oncol_2013_Nov_18_3_282.nxml.txt.nlp	24303367	SENT239	9	9	16	16	cisplatin	PARP	PA449014	142	0.966
NULL	Front_Endocrinol_(Lausanne)_2014_Feb_25_5_22.nxml.txt.nlp	24611062	SENT291	28	28	16	16	estradiol	PAK1	PA449503	5585;5058	0.966
NULL	J_Cancer_Res_Clin_Oncol_2012_Mar_31_138(3)_537-544.nxml.txt.nlp	22209975	SENT5	12	12	19	19	tanespimycin	Hsp90	PA165291490	3320	0.966
NULL	Reprod_Biol_Endocrinol_2013_Nov_26_11_109.nxml.txt.nlp	24279306	SENT188	36	36	0	0	hyaluronan	PTX3	PA165958431	5806	0.966
NULL	Arthritis_Res_Ther_2007_Jun_29_9(Suppl_1)_S3.nxml.txt.nlp	17634142	SENT94	0	0	26	26	denosumab	RANKL	PA166048634	8600	0.966
NULL	Breast_Cancer_Res_2008_Feb_28_10(1)_R20.nxml.txt.nlp	18307763	SENT108	9	9	45	45	trastuzumab	HER2	PA451743	2064	0.966
NULL	J_Cell_Biol_2002_Jun_24_157(7)_1151-1160.nxml.txt.nlp	12082077	SENT100	35	35	3	3	trypsin	COX	PA451806	1351	0.966
NULL	Oncogene_2009_Jan_29_28(4)_479-491.nxml.txt.nlp	18978811	SENT252	18	18	6	6	doxycycline	DPPIV	PA449415	2191;1803	0.966
NULL	Eur_J_Clin_Pharmacol_2011_May_2_67(Suppl_1)_87-107.nxml.txt.nlp	21287160	SENT115	0	0	5	5	aprepitant	CYP3A4	PA164747039	1576	0.966
NULL	Br_J_Cancer_2012_Jun_5_106(12)_1997-2003.nxml.txt.nlp	22596232	SENT135	17	17	11	11	sorafenib	JNK	PA7000	5599	0.966
NULL	Acta_Pharmacol_Sin_2013_Apr_18_34(4)_555-560.nxml.txt.nlp	23503472	SENT17	13	13	7	7	cyclosporine	NFKB1	PA449167	4790	0.966
NULL	Int_J_Biol_Sci_2013_Mar_7_9(3)_279-288.nxml.txt.nlp	23493630	SENT14	0	0	7	7	tocilizumab	IL-6	PA165292659	3569	0.966
NULL	Int_J_Breast_Cancer_2012_May_9_2012_415170.nxml.txt.nlp	22649737	SENT70	10	10	3	3	trastuzumab	IGF1R	PA451743	3480	0.966
NULL	J_Cell_Biol_2007_Apr_23_177(2)_265-275.nxml.txt.nlp	17452530	SENT348	37	37	14	14	imiquimod	TLR7	PA449972	51284	0.966
NULL	Nucleic_Acids_Res_2012_Jun_22_40(11)_4861-4878.nxml.txt.nlp	22362753	SENT245	27	27	5	5	trypsin	NPM3	PA451806	10360	0.966
NULL	Cell_Death_Dis_2013_Jan_31_4(1)_e480.nxml.txt.nlp	23370280	SENT119	7	7	35	35	cisplatin	WWOX	PA449014	51741	0.966
NULL	Ther_Clin_Risk_Manag_2007_Jun_3(2)_245-258.nxml.txt.nlp	18360633	SENT40	38	38	18	18	etanercept	TNF-alpha	PA449515	7124	0.966
NULL	Ther_Clin_Risk_Manag_2006_Sep_2(3)_235-249.nxml.txt.nlp	18360599	SENT332	30	30	9	9	alendronate	PTH	PA448082	5741	0.966
NULL	Nucleic_Acids_Res_2011_Dec_31_39(22)_9536-9548.nxml.txt.nlp	21880590	SENT172	26	26	17	17	etoposide	BRCA1	PA449552	672	0.966
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1449-1456.nxml.txt.nlp	24077631	SENT120	30	30	14	14	tolbutamide	CYP2C9	PA451718	1559	0.966
NULL	Calcif_Tissue_Int_2010_Dec_16_87(6)_485-492.nxml.txt.nlp	20953593	SENT52	6	6	10	10	teriparatide	PTH	PA451620	5741	0.966
NULL	Indian_J_Pharmacol_2008_Jun_40(3)_95-102.nxml.txt.nlp	20040934	SENT129	5	5	26	26	efalizumab	LFA-1	PA164748817	3683;3689	0.966
NULL	Oncogene_2014_Jan_23_33(4)_421-428.nxml.txt.nlp	23318437	SENT118	36	36	12	12	etoposide	MDM2	PA449552	4193	0.966
NULL	Breast_Cancer_Res_2010_Jul_20_12(4)_R52.nxml.txt.nlp	20646288	SENT127	33	33	28	28	letrozole	HTRA1	PA450196	5654	0.966
NULL	Br_J_Cancer_2012_May_22_106(11)_1779-1789.nxml.txt.nlp	22549178	SENT23	0	0	6	6	trastuzumab	HER2	PA451743	2064	0.966
NULL	Int_J_Biol_Sci_2011_Sep_8_7(8)_1077-1092.nxml.txt.nlp	21927577	SENT134	16	16	7	7	telmisartan	p47phox	PA451605	653361	0.966
NULL	Pharmaceutics_2011_Nov_18_3(4)_865-913.nxml.txt.nlp	24309312	SENT79	3	3	24	24	amprenavir	CYP3A4	PA448422	1576	0.966
NULL	Acta_Pharmacol_Sin_2014_Jun_4_35(6)_752-757.nxml.txt.nlp	24902786	SENT88	3	3	25	25	letrozole	castor	PA450196	54897	0.966
NULL	Oncol_Rep_2015_Feb_11_33(2)_526-532.nxml.txt.nlp	25501339	SENT98	19	19	3	3	gefitinib	p53	PA131301952	7157	0.966
NULL	Breast_Cancer_Res_2014_Sep_9_16(5)_433.nxml.txt.nlp	25212966	SENT161	6	6	41	41	aprotinin	ILEI	PA448472	10447	0.966
NULL	Ecancermedicalscience_2009_Sep_24_3_153.nxml.txt.nlp	22276017	SENT56	31	31	24	24	oxaliplatin	ERCC1	PA131285527	2067	0.966
NULL	Arthritis_Res_Ther_2012_Feb_9_14(Suppl_1)_O37.nxml.txt.nlp	NULL	SENT7	10	10	17	17	tocilizumab	IL-6	PA165292659	3569	0.966
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT119	22	22	31	31	dasatinib	ABCG2	PA162372878	9429	0.966
NULL	Support_Care_Cancer_2009_Sep_10_17(9)_1187-1193.nxml.txt.nlp	19205754	SENT7	6	6	22	22	dolasetron	CYP2D6	PA449390	1565	0.966
NULL	ScientificWorldJournal_2013_Dec_24_2013_196541.nxml.txt.nlp	24453810	SENT108	7	7	24	24	trastuzumab	HER2	PA451743	2064	0.966
NULL	Br_J_Cancer_1995_Feb_71(2)_294-299.nxml.txt.nlp	7841043	SENT8	14	14	23	23	tamoxifen	P-gp	PA451581	5243	0.966
NULL	Oncotarget_2011_Dec_31_2(12)_1314-1321.nxml.txt.nlp	22248929	SENT140	36	36	2	2	lapatinib	HER3	PA152241907	2065	0.966
NULL	Cell_Death_Dis_2010_Oct_21_1(10)_e86.nxml.txt.nlp	21368859	SENT69	21	21	23	23	doxorubicin	TRAIL	PA449412	8743	0.966
NULL	Breast_Cancer_Res_2010_Nov_16_12(6)_R96.nxml.txt.nlp	21080941	SENT142	18	18	12	12	lapatinib	HER2	PA152241907	2064	0.966
NULL	Br_J_Cancer_2012_Jan_31_106(3)_496-507.nxml.txt.nlp	22240799	SENT211	7	7	23	23	cisplatin	GADD34	PA449014	23645	0.966
NULL	Nat_Neurosci_2012_Sep_5_15(9)_1245-1254.nxml.txt.nlp	22864611	SENT86	33	33	17	17	clozapine	HDAC2	PA449061	3066	0.966
NULL	Drug_Des_Devel_Ther_2014_Oct_31_8_2121-2128.nxml.txt.nlp	25382970	SENT83	6	6	20	20	curcumin	TTR	PA151958596	7276	0.966
NULL	Cancer_Cell_Int_2011_Aug_19_11_29.nxml.txt.nlp	21854619	SENT216	23	23	17	17	cisplatin	HDAC	PA449014	9734	0.966
NULL	Cell_Death_Dis_2013_Jul_11_4(7)_e719.nxml.txt.nlp	23846221	SENT64	11	11	22	22	cisplatin	TRAIL	PA449014	8743	0.966
NULL	J_Gerontol_A_Biol_Sci_Med_Sci_2014_Jun_8_69(Suppl_1)_S21-S27.nxml.txt.nlp	24833582	SENT278	8	8	14	14	resveratrol	SIRT1		23411	0.966
NULL	Clin_J_Gastroenterol_2013_Apr_14_6(2)_188-192.nxml.txt.nlp	23606919	SENT35	9	9	0	0	sorafenib	IFN	PA7000	3439	0.966
NULL	Acta_Pharmacol_Sin_2010_Mar_22_31(3)_329-340.nxml.txt.nlp	20173759	SENT226	8	8	0	0	ethanol	AMPK	PA448073	5563	0.966
NULL	Psychiatry_Investig_2011_Jun_25_8(2)_161-168.nxml.txt.nlp	21852994	SENT113	22	22	13	13	fluoxetine	Bcl-2	PA449673	596	0.966
NULL	Gene_Regul_Syst_Bio_2014_Mar_4_8_63-73.nxml.txt.nlp	24634581	SENT138	19	19	13	13	minocycline	MT1-MMP	PA450519	4323	0.966
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT118	9	9	25	25	nilotinib	ABCG2	PA165958345	9429	0.966
NULL	Cell_Cycle_2013_Dec_15_12(24)_3791-3803.nxml.txt.nlp	24107631	SENT177	21	21	7	7	doxorubicin	YB-1	PA449412	4904	0.966
NULL	Aging_Cell_2009_Apr_8(2)_113-127.nxml.txt.nlp	19239417	SENT111	12	12	4	4	resveratrol	AMPK		5563	0.966
NULL	Cancers_(Basel)_2011_Sep_13_3(3)_3506-3524.nxml.txt.nlp	24212966	SENT104	14	14	19	19	carboplatin	EGFR	PA448803	1956	0.966
NULL	Adv_Hematol_2010_Dec_2_2010_424786.nxml.txt.nlp	21188274	SENT99	16	16	20	20	alemtuzumab	CHOP	PA164783958	1649	0.966
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT233	14	14	6	6	capsaicin	p53	PA448776	7157	0.966
NULL	Cancers_(Basel)_2014_Aug_12_6(3)_1631-1669.nxml.txt.nlp	25119536	SENT425	3	3	16	16	bortezomib	THPO	PA10252	7066	0.966
NULL	Open_Biol_2014_Nov_4(11)_140180.nxml.txt.nlp	25392452	SENT224	18	18	6	6	imatinib	LEF1	PA10804	51176	0.966
NULL	Hum_Genomics_2009_Dec_1_4(2)_91-106.nxml.txt.nlp	20038497	SENT72	0	0	15	15	galantamine	CYP2D6	PA449726	1565	0.966
NULL	Br_J_Cancer_2010_Sep_28_103(7)_1008-1018.nxml.txt.nlp	20736947	SENT109	27	27	11	11	ethanol	MCT4	PA448073	9122;9123	0.966
NULL	Evid_Based_Complement_Alternat_Med_2013_Dec_12_2013_324618.nxml.txt.nlp	24416065	SENT37	20	20	0	0	diazepam	ATV	PA449283	4683	0.966
NULL	Acta_Pharmacol_Sin_2009_Sep_24_30(9)_1262-1275.nxml.txt.nlp	19701231	SENT222	14	14	4	4	lovastatin	HIST1H2BG	PA450272	8339	0.966
NULL	Ann_Hematol_2010_Sep_13_89(9)_861-871.nxml.txt.nlp	20387067	SENT75	30	30	48	48	dasatinib	TPO	PA162372878	7066;7173	0.966
NULL	Arthritis_Res_Ther_2006_Dec_16_8(1)_R15.nxml.txt.nlp	16507115	SENT170	26	26	9	9	methotrexate	CD19	PA450428	930	0.966
NULL	Mol_Imaging_Radionucl_Ther_2011_Dec_1_20(3)_114-116.nxml.txt.nlp	23486704	SENT29	19	19	5	5	metformin	FDG	PA450395	23583	0.966
NULL	Biol_Cell_2014_Feb_8_106(2)_45-56.nxml.txt.nlp	24313290	SENT82	8	8	0	0	phenylephrine	SPAK	PA450935	27347	0.966
NULL	Scientifica_(Cairo)_2012_Nov_25_2012_473829.nxml.txt.nlp	24278698	SENT314	9	9	20	20	cisplatin	OCT2	PA449014	6582;5452	0.966
NULL	Nature_2012_Dec_20_492(7429)_387-392.nxml.txt.nlp	23222541	SENT5	21	21	3	3	thrombin	PAR1	PA451674	79581;2149	0.966
NULL	J_Young_Pharm_2010_Apr-Jun_2(2)_196-200.nxml.txt.nlp	21264125	SENT127	7	7	9	9	rosuvastatin	CYP2C9	PA134308647	1559	0.966
NULL	Br_J_Cancer_2009_Jan_13_100(1)_145-152.nxml.txt.nlp	19050706	SENT15	28	28	16	16	erlotinib	EGFR	PA134687924	1956	0.966
NULL	Mol_Biol_Cell_2014_May_1_25(9)_1411-1420.nxml.txt.nlp	24623724	SENT282	0	0	8	8	doxycycline	ATF6	PA449415	22926	0.966
NULL	Basic_Clin_Neurosci_2013_Autumn_4(4)_323-328.nxml.txt.nlp	25337364	SENT4	0	0	30	30	colchicine	CA1	PA449092	759	0.966
NULL	Commun_Integr_Biol_2012_May_1_5(3)_248-254.nxml.txt.nlp	22896785	SENT100	8	8	21	21	picrotoxin	CA3	PA164777007	761	0.966
NULL	Lancet_2012_Mar_31_379(9822)_1205-1213.nxml.txt.nlp	22421339	SENT34	19	19	27	27	tocilizumab	IL6R	PA165292659	3570	0.966
NULL	Indian_J_Pharmacol_2013_Nov-Dec_45(6)_597-602.nxml.txt.nlp	24347768	SENT23	22	22	3	3	daunorubicin	P-gp	PA449212	5243	0.966
NULL	Daru_2012_Oct_4_20(1)_45.nxml.txt.nlp	23351300	SENT36	24	24	39	39	indomethacin	API	PA449982	5345	0.966
NULL	Mol_Cancer_2009_Mar_5_8_14.nxml.txt.nlp	19265551	SENT62	5	5	0	0	camptothecin	p53	PA153590860	7157	0.966
NULL	Exp_Ther_Med_2013_Nov_13_6(5)_1317-1321.nxml.txt.nlp	24223665	SENT4	5	5	19	19	curcumin	CD133	PA151958596	8842	0.966
NULL	Mol_Cancer_2010_Nov_2_9_289.nxml.txt.nlp	21044322	SENT10	5	5	12	12	vincristine	RGS10	PA451879	6001	0.966
NULL	J_Exerc_Nutrition_Biochem_2014_Sep_17_18(3)_267-275.nxml.txt.nlp	25566463	SENT9	4	4	42	42	creatine	IL-6	PA164778930	3569	0.966
NULL	Br_J_Cancer_2012_Aug_21_107(5)_793-799.nxml.txt.nlp	22850551	SENT114	18	18	5	5	lapatinib	EGFR	PA152241907	1956	0.966
NULL	Breast_Cancer_Res_2011_Sep_29_13(5)_219.nxml.txt.nlp	22017761	SENT79	1	1	11	11	tamoxifen	aromatase	PA451581	1588	0.966
NULL	Int_J_Gen_Med_2009_Jul_30_2_91-108.nxml.txt.nlp	20360893	SENT196	13	13	2	2	vinblastine	PC-3	PA451877	692094	0.966
NULL	Comp_Hepatol_2004_Jan_14_3(Suppl_1)_S31.nxml.txt.nlp	14960183	SENT18	15	15	1	1	ethanol	TNF-alpha	PA448073	7124	0.966
NULL	Acta_Pharmacol_Sin_2012_Jul_18_33(7)_861-872.nxml.txt.nlp	22705730	SENT150	7	7	19	19	atorvastatin	4E-BP1	PA448500	1978	0.966
NULL	FEBS_Open_Bio_2013_Sep_17_3_394-397.nxml.txt.nlp	24251101	SENT39	0	0	18	18	geldanamycin	San	PA152031327	80218	0.966
NULL	Indian_J_Pharmacol_2008_Jun_40(3)_95-102.nxml.txt.nlp	20040934	SENT170	11	11	15	15	cyclosporine	IL-2	PA449167	3558	0.966
NULL	Ther_Clin_Risk_Manag_2006_Sep_2(3)_235-249.nxml.txt.nlp	18360599	SENT340	36	36	10	10	alendronate	PTH	PA448082	5741	0.966
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1013.nxml.txt.nlp	24457957	SENT98	24	24	3	3	orlistat	NOXA	PA164776864	5366	0.966
NULL	Environ_Health_Perspect_2009_Feb_28_117(2)_223-230.nxml.txt.nlp	19270792	SENT166	46	46	35	35	estradiol	HD3	PA449503	8841	0.966
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT148	10	10	15	15	raltegravir	UGT1A1		54658	0.966
NULL	Oncol_Lett_2014_May_4_7(5)_1352-1362.nxml.txt.nlp	24765137	SENT142	15	15	29	29	cisplatin	p53	PA449014	7157	0.966
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT2407	11	11	0	0	ethanol	CYP2E1	PA448073	1571	0.966
NULL	Br_J_Cancer_2011_Apr_12_104(8)_1342-1348.nxml.txt.nlp	21427727	SENT24	7	7	15	15	trastuzumab	HER2	PA451743	2064	0.966
NULL	Crit_Care_2011_Nov_30_15(6)_R289.nxml.txt.nlp	22129171	SENT64	3	3	15	15	dipyridamole	ANOVA	PA449367	4858	0.966
NULL	Ann_Hematol_2012_Jul_10_91(7)_1097-1105.nxml.txt.nlp	22318468	SENT19	12	12	0	0	l-cysteine	NAC	PA449173	22861	0.966
NULL	Sci_Rep_2014_Dec_12_4_7467.nxml.txt.nlp	25502280	SENT120	21	21	41	41	taurine	spatial	PA451590	219793	0.966
NULL	Exp_Diabetes_Res_2011_Apr_6_2011_928523.nxml.txt.nlp	21603181	SENT42	12	12	15	15	bromocriptine	DRD2	PA448671	1813	0.966
NULL	Nucleic_Acids_Res_2006_Jul_26_34(13)_e92.nxml.txt.nlp	16870721	SENT312	19	19	12	12	ganciclovir	p53	PA449733	7157	0.966
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Apr_16_67(Pt_5)_o1144.nxml.txt.nlp	21754452	SENT56	7	7	16	16	hydroquinone	K10	PA449924	3858	0.966
NULL	Case_Rep_Oncol_2012_Oct_10_5(3)_546-553.nxml.txt.nlp	23139670	SENT15	10	10	41	41	pemetrexed	EGFR	PA10810	1956	0.966
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1449-1456.nxml.txt.nlp	24077631	SENT117	27	27	1	1	tolbutamide	CYP2C9	PA451718	1559	0.966
NULL	Int_J_Mol_Sci_2014_Sep_30_15(10)_17733-17750.nxml.txt.nlp	25272228	SENT141	5	5	0	0	oxygen	ROS	PA450744	6098	0.966
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT121	32	32	41	41	pp2	PP2		4888	0.966
NULL	Clinics_(Sao_Paulo)_2013_Feb_68(Suppl_1)_75-79.nxml.txt.nlp	23503956	SENT86	14	14	4	4	anastrozole	aromatase	PA448432	1588	0.966
NULL	Environ_Health_Perspect_2012_Jan_22_120(1)_62-67.nxml.txt.nlp	21859636	SENT26	11	11	18	18	phenol	CYP2E1	PA450913	1571	0.966
NULL	Breast_Cancer_Res_Treat_2014_Dec_21_143(3)_459-467.nxml.txt.nlp	24362951	SENT19	3	3	27	27	everolimus	HER2	PA164746311	2064	0.966
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT345	2	2	32	32	risperidone	PRL	PA451257	5617	0.966
NULL	FEBS_Open_Bio_2012_Jul_20_2_179-186.nxml.txt.nlp	23650597	SENT141	38	38	30	30	imiquimod	MxA	PA449972	4599	0.966
NULL	Arthritis_Res_Ther_2012_Dec_3_14(6)_R262.nxml.txt.nlp	23206933	SENT23	2	2	10	10	tocilizumab	IL-6	PA165292659	3569	0.966
NULL	Diabetes_Care_2009_Nov_32(Suppl_2)_S223-S231.nxml.txt.nlp	19875556	SENT164	23	23	4	4	exenatide	GLP-1	PA164749238	100125288	0.966
NULL	Oncotarget_2014_Dec_4_5(22)_11365-11380.nxml.txt.nlp	25426548	SENT31	14	14	18	18	nutlin-3	p53		7157	0.966
NULL	J_Breast_Cancer_2013_Jun_28_16(2)_133-137.nxml.txt.nlp	23843843	SENT33	18	18	12	12	curcumin	maspin	PA151958596	5268	0.966
NULL	Indian_J_Pharm_Sci_2014_May-Jun_76(3)_188-197.nxml.txt.nlp	25035529	SENT209	1	1	14	14	berberine	p38	PA165860812	10598;1432;7965	0.966
NULL	Mol_Cancer_2004_May_4_3_14.nxml.txt.nlp	15125777	SENT36	19	19	7	7	cisplatin	CHK2	PA449014	11200	0.966
NULL	Support_Care_Cancer_2011_Oct_8_19(10)_1505-1510.nxml.txt.nlp	20694798	SENT30	5	5	27	27	palonosetron	HEC	PA10352	10403	0.966
NULL	Oncogene_2010_Jul_8_29(27)_3896-3907.nxml.txt.nlp	20453888	SENT156	17	17	9	9	trastuzumab	CDK1	PA451743	983	0.966
NULL	Front_Plant_Sci_2011_Jun_6_2_18.nxml.txt.nlp	22645527	SENT62	19	19	0	0	trypsin	MP17	PA451806	3982	0.966
NULL	Arthritis_Res_Ther_2006_May_5_8(3)_R83.nxml.txt.nlp	16677395	SENT165	15	15	43	43	rituximab	CD25	PA451261	3669;3559	0.966
NULL	Front_Genet_2014_May_6_5_118.nxml.txt.nlp	24834073	SENT60	35	35	16	16	l-glutamine	CO2	PA10090	4513	0.966
NULL	Indian_J_Pharmacol_2013_Mar-Apr_45(2)_155-158.nxml.txt.nlp	23716892	SENT117	11	11	23	23	voriconazole	CYP3A4	PA10233	1576	0.966
NULL	Oncogene_2013_Sep_26_32(39)_10_1038_onc_2012_491.nxml.txt.nlp	23108394	SENT136	33	33	17	17	epirubicin	BRIP1	PA449476	64979;83990	0.966
NULL	BMJ_2013_Aug_21_347_f4877.nxml.txt.nlp	23965506	SENT172	34	34	9	9	trazodone	5-HT2A	PA451744	3356	0.966
NULL	J_Cancer_2013_Nov_21_4(9)_727-735.nxml.txt.nlp	24312143	SENT59	32	32	8	8	trypsin	SRPK1	PA451806	6732	0.966
NULL	Cancers_(Basel)_2010_Feb_23_2(1)_88-113.nxml.txt.nlp	24281034	SENT178	10	10	30	30	gefitinib	EGFR	PA131301952	1956	0.966
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT56	15	15	1	1	nelfinavir	SLK	PA450606	9748;2534	0.966
NULL	Case_Rep_Transplant_2011_Jan_5_2011_210178.nxml.txt.nlp	23213600	SENT68	14	14	0	0	tacrolimus	CYP3A4	PA451578	1576	0.966
NULL	Mol_Cancer_2009_Nov_19_8_108.nxml.txt.nlp	19925669	SENT25	8	8	19	19	doxorubicin	CRT	PA449412	811	0.966
NULL	Mol_Cancer_2012_May_14_11_34.nxml.txt.nlp	22583868	SENT270	14	14	2	2	arsenite	JNK2	PA452638	5601	0.966
NULL	Breast_Cancer_Res_2001_Nov_8_3(1)_66-75.nxml.txt.nlp	11250748	SENT174	21	21	6	6	tamoxifen	NMU	PA451581	10874	0.966
NULL	Mol_Cancer_2012_Apr_5_11_20.nxml.txt.nlp	22480225	SENT362	15	15	4	4	temozolomide	HSP27	PA451609	3315	0.966
NULL	Arthritis_Res_Ther_2010_Apr_29_12(2)_R73.nxml.txt.nlp	20429888	SENT287	8	8	33	33	bortezomib	COL1A2	PA10252	1278	0.966
NULL	Oncotarget_2014_Jun_1_5(13)_4868-4880.nxml.txt.nlp	24947902	SENT71	7	7	27	27	afatinib	HER2	PA165981154	2064	0.966
NULL	Diabetes_2008_Oct_57(10)_2801-2808.nxml.txt.nlp	18633115	SENT198	16	16	40	40	sulfasalazine	NFkappaB	PA451547	4790	0.966
NULL	Arthritis_Res_Ther_2014_Oct_30_16(5)_474.nxml.txt.nlp	25359291	SENT6	40	40	1	1	methotrexate	OX40	PA450428	7293	0.966
NULL	Mol_Cancer_2009_Dec_23_8_129.nxml.txt.nlp	20030852	SENT216	8	8	33	33	curcumin	survivin	PA151958596	332	0.966
NULL	Mol_Cancer_2013_May_1_12_34.nxml.txt.nlp	23634843	SENT4	6	6	40	40	estradiol	aromatase	PA449503	1588	0.966
NULL	Int_J_Genomics_2013_Nov_4_2013_464720.nxml.txt.nlp	24364026	SENT145	8	8	2	2	cisplatin	ERCC1	PA449014	2067	0.966
NULL	Clin_Med_Insights_Arthritis_Musculoskelet_Disord_2013_Aug_8_6_35-43.nxml.txt.nlp	23997576	SENT24	22	22	2	2	etoricoxib	COX	PA164776853	1351	0.966
NULL	Indian_J_Psychiatry_2014_Jan_56(Suppl_1)_S63-S96.nxml.txt.nlp	NULL	SENT818	19	19	36	36	clozapine	OGC	PA449061	8402	0.966
NULL	Acta_Histochem_Cytochem_2012_Oct_31_45(5)_251-259.nxml.txt.nlp	23209334	SENT32	12	12	21	21	vasopressin	AQP2	PA451858	359	0.966
NULL	Front_Oncol_2014_Mar_25_4_54.nxml.txt.nlp	24724051	SENT329	13	13	17	17	imatinib	CD34	PA10804	947	0.966
NULL	J_Immunol_Res_2014_Apr_30_2014_857143.nxml.txt.nlp	24877157	SENT318	0	0	9	9	cyclosporine	IL-2	PA449167	3558	0.966
NULL	Front_Neurosci_2014_Jun_3_8_128.nxml.txt.nlp	24917782	SENT63	3	3	21	21	ethanol	POMC	PA448073	5443	0.966
NULL	Clin_Epigenetics_2011_Jun_14_2(2)_151-169.nxml.txt.nlp	22704335	SENT298	0	0	13	13	procainamide	GSTP1	PA451108	2950	0.966
NULL	Crit_Care_2011_Aug_11_15(4)_226.nxml.txt.nlp	21892977	SENT59	6	6	39	39	vasopressin	P2Y1	PA451858	5028	0.966
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT68	22	22	7	7	vinblastine	ABCC10	PA451877	89845	0.966
NULL	Oncogene_2013_Sep_12_32(37)_4355-4365.nxml.txt.nlp	23108409	SENT35	43	43	18	18	hyaluronan	HAS1	PA165958431	3036	0.966
NULL	Int_J_Vasc_Med_2013_Mar_31_2013_543141.nxml.txt.nlp	23606968	SENT128	14	14	9	9	etanercept	IL-17	PA449515	3605	0.966
NULL	JAKSTAT_2013_Jul_1_2(3)_e24574.nxml.txt.nlp	24069558	SENT226	14	14	3	3	doxycycline	HEK	PA449415	2042	0.966
NULL	AAPS_J_2012_Jan_4_14(1)_87-96.nxml.txt.nlp	22215264	SENT26	22	22	6	6	tariquidar	P-gp		5243	0.966
NULL	Behav_Brain_Funct_2014_Oct_2_10(1)_35.nxml.txt.nlp	NULL	SENT134	15	15	4	4	risperidone	FTO	PA451257	79068	0.966
NULL	Oncologist_2010_Feb_15_15(2)_122-129.nxml.txt.nlp	20156908	SENT24	9	9	6	6	tamoxifen	aromatase	PA451581	1588	0.966
NULL	Mol_Med_Rep_2015_Jan_16_11(1)_189-195.nxml.txt.nlp	25323748	SENT161	8	8	28	28	cisplatin	CHOP	PA449014	1649	0.966
NULL	Can_J_Infect_Dis_Med_Microbiol_2014_Nov-Dec_25(6)_327-343.nxml.txt.nlp	25587296	SENT378	0	0	8	8	itraconazole	CYP3A4	PA450132	1576	0.966
NULL	Environ_Health_Perspect_2005_Aug_15_113(8)_1009-1014.nxml.txt.nlp	16079071	SENT122	13	13	8	8	captopril	p38	PA448780	10598;1432;7965	0.966
NULL	Mol_Cancer_2008_Jan_25_7_14.nxml.txt.nlp	18221502	SENT225	3	3	25	25	oxaliplatin	PSAT1	PA131285527	29968	0.966
NULL	Biomed_Res_Int_2014_May_29_2014_768758.nxml.txt.nlp	24971349	SENT73	14	14	3	3	docetaxel	CXCR4	PA449383	7852	0.966
NULL	J_Clin_Exp_Pathol_2012_May_17_Suppl_4_7327.nxml.txt.nlp	25379357	SENT136	4	4	32	32	metformin	4E-BP1	PA450395	1978	0.966
NULL	Oncoscience_2014_Oct_22_1(10)_614-623.nxml.txt.nlp	25593991	SENT95	36	36	19	19	cetuximab	KRAS	PA10040	3845	0.966
NULL	Tuberc_Respir_Dis_(Seoul)_2014_Nov_28_77(5)_227-229.nxml.txt.nlp	25473412	SENT59	32	32	4	4	amikacin	RGM	PA164744372	56963	0.966
NULL	Neuropsychopharmacology_2012_Feb_2_37(3)_641-650.nxml.txt.nlp	22048466	SENT114	4	4	44	44	varenicline	HTR3A	PA164781343	3359	0.966
NULL	Front_Genet_2012_Nov_22_3_249.nxml.txt.nlp	23189085	SENT725	8	8	2	2	imatinib	ERCC1	PA10804	2067	0.966
NULL	Breast_Cancer_Res_2004_Nov_7_6(1)_39-52.nxml.txt.nlp	14680484	SENT135	20	20	4	4	letrozole	aromatase	PA450196	1588	0.966
NULL	Breast_Cancer_(Auckl)_2012_Mar_7_6_67-77.nxml.txt.nlp	22438669	SENT168	3	3	14	14	lapatinib	HER2	PA152241907	2064	0.966
NULL	Case_Rep_Rheumatol_2011_Dec_15_2011_185657.nxml.txt.nlp	22937439	SENT69	7	7	16	16	etanercept	IL-6	PA449515	3569	0.966
NULL	JAKSTAT_2013_Jan_1_2(1)_e23011.nxml.txt.nlp	24058792	SENT25	5	5	18	18	imiquimod	TLR9	PA449972	54106	0.966
NULL	Int_J_Endocrinol_Metab_2013_Jul_1_Summer_11(3)_184-190.nxml.txt.nlp	24348591	SENT98	8	8	0	0	liraglutide	INS-1	PA165958364	2305	0.966
NULL	Hum_Genomics_2009_Jan_1_3(2)_128-142.nxml.txt.nlp	19164090	SENT212	21	21	5	5	carboplatin	CD44	PA448803	960	0.966
NULL	Cancers_(Basel)_2014_Apr_8_6(2)_813-828.nxml.txt.nlp	24717239	SENT168	7	7	5	5	erlotinib	EGFR	PA134687924	1956	0.966
NULL	Indian_J_Ophthalmol_2011_Sep-Oct_59(5)_403a.nxml.txt.nlp	21836356	SENT17	28	28	11	11	nifedipine	P-gp	PA450631	5243	0.966
NULL	J_Cell_Biol_2000_Jan_10_148(1)_173-188.nxml.txt.nlp	10629227	SENT185	18	18	26	26	estradiol	AP-1	PA449503	2353;3727;2354;3725	0.966
NULL	Oncol_Lett_2014_Jul_25_8(1)_313-316.nxml.txt.nlp	24959268	SENT78	21	21	27	27	sulindac	JNK1	PA451565	5599	0.966
NULL	Indian_J_Psychol_Med_2009_Jan-Jun_31(1)_3-10.nxml.txt.nlp	21938084	SENT177	13	13	22	22	paroxetine	5-HT2A	PA450801	3356	0.966
NULL	Breast_Cancer_Res_Treat_2014_Jan_9_143(3)_493-505.nxml.txt.nlp	24402830	SENT166	10	10	17	17	capecitabine	aromatase	PA448771	1588	0.966
NULL	Ann_Hematol_2014_Apr_1_93(8)_1371-1380.nxml.txt.nlp	24687382	SENT192	26	26	11	11	lenalidomide	CRBN	PA162363968	51185	0.966
NULL	Hum_Genomics_2008_Sep_1_3(1)_7-16.nxml.txt.nlp	19129086	SENT172	8	8	12	12	rosiglitazone	OATP1B1	PA451283	10599	0.966
NULL	Neuropsychopharmacology_2009_Dec_19_34(13)_2710-2720.nxml.txt.nlp	19693002	SENT203	15	15	4	4	haloperidol	NAC	PA449841	22861	0.966
NULL	Pharmaceutics_2011_Oct_12_3(4)_680-705.nxml.txt.nlp	24309303	SENT102	7	7	9	9	sitagliptin	OCT1	PA164748978	5451;6580	0.966
NULL	Anticancer_Agents_Med_Chem_2012_Feb_12(2)_163-171.nxml.txt.nlp	22043994	SENT185	13	13	2	2	cetuximab	BRAF	PA10040	673	0.966
NULL	Indian_J_Psychol_Med_2009_Jan-Jun_31(1)_3-10.nxml.txt.nlp	21938084	SENT177	15	15	22	22	fluvoxamine	5-HT2A	PA449690	3356	0.966
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT39	11	11	3	3	pemetrexed	UNG	PA10810	7374	0.966
NULL	Ann_Indian_Acad_Neurol_2009_Oct-Dec_12(4)_273-282.nxml.txt.nlp	20182575	SENT291	0	0	13	13	methotrexate	CCR4	PA450428	25819;57472;1233	0.966
NULL	Mol_Pain_2013_Feb_19_9_5.nxml.txt.nlp	23421753	SENT185	23	23	12	12	capsaicin	GCH1	PA448776	2643	0.966
NULL	Pharmaceuticals_(Basel)_2012_Jun_4_5(6)_553-590.nxml.txt.nlp	24281662	SENT290	5	5	30	30	levodopa	GCH1	PA450213	2643	0.966
NULL	J_Biomed_Sci_2014_Feb_3_21(1)_10.nxml.txt.nlp	24490900	SENT210	2	2	32	32	alendronate	RANKL	PA448082	8600	0.966
NULL	Clinics_(Sao_Paulo)_2011_Dec_66(12)_2179-2181.nxml.txt.nlp	22189748	SENT13	5	5	15	15	zidovudine	CD4	PA451954	920	0.966
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_May_8_66(Pt_6)_o1294.nxml.txt.nlp	21579391	SENT56	16	16	22	22	letrozole	aromatase	PA450196	1588	0.966
NULL	Oncol_Rep_2015_Feb_11_33(2)_526-532.nxml.txt.nlp	25501339	SENT34	4	4	8	8	gefitinib	p53	PA131301952	7157	0.966
NULL	Open_Cardiovasc_Med_J_2014_Feb_7_8_12-17.nxml.txt.nlp	24653785	SENT108	28	28	18	18	atorvastatin	CYP3A5	PA448500	1577	0.966
NULL	Proteome_Sci_2005_May_31_3_4.nxml.txt.nlp	15927046	SENT129	19	19	13	13	nadh	PDH	PA164755085	54704	0.966
NULL	Patient_Prefer_Adherence_2010_Sep_7_4_313-324.nxml.txt.nlp	20859458	SENT48	32	32	9	9	exenatide	AMIGO	PA164749238	57463	0.966
NULL	Front_Oncol_2014_Sep_29_4_256.nxml.txt.nlp	25325013	SENT101	34	34	11	11	gemcitabine	EGFR	PA449748	1956	0.966
NULL	Pharmaceuticals_(Basel)_2013_Aug_2_6(8)_915-928.nxml.txt.nlp	24276376	SENT72	37	37	18	18	clopidogrel	PAR-1	PA449053	2011;2149	0.966
NULL	Cancer_Metab_2013_Feb_4_1_7.nxml.txt.nlp	24280108	SENT176	17	17	29	29	galactose	NAC	PA449725	22861	0.966
NULL	Front_Endocrinol_(Lausanne)_2014_Apr_15_5_54.nxml.txt.nlp	24782832	SENT105	20	20	29	29	capsaicin	TRPV1	PA448776	7442	0.966
NULL	Br_J_Cancer_2010_Sep_28_103(7)_1008-1018.nxml.txt.nlp	20736947	SENT11	10	10	1	1	docetaxel	CD147	PA449383	682	0.966
NULL	Sci_Rep_2014_Dec_15_4_7490.nxml.txt.nlp	25502402	SENT277	16	16	9	9	cetuximab	EGFR	PA10040	1956	0.966
NULL	Arch_Drug_Inf_2008_Dec_1(3)_79-88.nxml.txt.nlp	19639028	SENT4	0	0	7	7	tegaserod	5-HT4	PA130413154	3360	0.966
NULL	Int_J_Breast_Cancer_2013_Jan_16_2013_872743.nxml.txt.nlp	23401782	SENT299	29	29	17	17	olaparib	BRCA2		675	0.966
NULL	J_Hematol_Oncol_2009_Apr_22_2_18.nxml.txt.nlp	19386128	SENT174	27	27	6	6	panitumumab	KRAS	PA162373091	3845	0.966
NULL	Case_Rep_Oncol_2014_Jan_16_7(1)_52-57.nxml.txt.nlp	24575017	SENT56	13	13	2	2	lapatinib	EGFR	PA152241907	1956	0.966
NULL	Environ_Health_Perspect_2007_Dec_8_115(Suppl_1)_77-83.nxml.txt.nlp	18174954	SENT72	9	9	0	0	propylthiouracil	TPO	PA451156	7066;7173	0.966
NULL	Cancer_Cell_Int_2014_Jul_2_14_59.nxml.txt.nlp	25120382	SENT197	20	20	29	29	metformin	RTCA	PA450395	8634	0.966
NULL	Acta_Pharmacol_Sin_2012_Jan_3_33(1)_49-56.nxml.txt.nlp	22212430	SENT89	10	10	6	6	thrombin	A10	PA451674	28870	0.966
NULL	Pharmaceuticals_(Basel)_2011_Jan_28_4(2)_366-381.nxml.txt.nlp	NULL	SENT180	17	17	0	0	naltrexone	POMC	PA450588	5443	0.966
NULL	Pharmaceuticals_(Basel)_2014_Sep_17_7(9)_943-953.nxml.txt.nlp	25232798	SENT23	7	7	21	21	docetaxel	HER2	PA449383	2064	0.966
NULL	J_Immune_Based_Ther_Vaccines_2011_Oct_24_9_7.nxml.txt.nlp	22024351	SENT22	2	2	17	17	gefitinib	EGFR	PA131301952	1956	0.966
NULL	J_Headache_Pain_2013_Apr_10_14(1)_33.nxml.txt.nlp	23574808	SENT150	0	0	21	21	capsaicin	TRPV1	PA448776	7442	0.966
NULL	Gut_Liver_2011_Jun_24_5(2)_117-132.nxml.txt.nlp	21814590	SENT159	43	43	4	4	ribavirin	IFN	PA451241	3439	0.966
NULL	Br_J_Cancer_2013_Jul_23_109(2)_502-511.nxml.txt.nlp	23799850	SENT129	9	9	26	26	gemcitabine	PSN1	PA449748	51251	0.966
NULL	Stroke_Res_Treat_2010_Dec_28_2011_534362.nxml.txt.nlp	21234312	SENT88	3	3	28	28	heparin	AIS	PA449855	367	0.966
NULL	Pharmaceuticals_(Basel)_2013_Mar_26_6(4)_469-479.nxml.txt.nlp	24276118	SENT190	3	3	14	14	diazepam	AT1	PA449283	9197;185	0.966
NULL	Braz_J_Med_Biol_Res_2014_Sep_5_47(11)_929-939.nxml.txt.nlp	25296354	SENT163	38	38	29	29	gefitinib	EGFR	PA131301952	1956	0.966
NULL	Acta_Pharmacol_Sin_2009_Jul_22_30(7)_956-964.nxml.txt.nlp	19543298	SENT165	18	18	6	6	simvastatin	ABCB1	PA451363	5243	0.966
NULL	Front_Neurosci_2014_Nov_10_8_364.nxml.txt.nlp	25426018	SENT242	1	1	11	11	fluorescein	Casper	PA164746009	8837	0.966
NULL	Diabetes_2009_Jan_58(1)_243-249.nxml.txt.nlp	18840785	SENT119	21	21	6	6	glucose	GLP-1	PA449773	100125288	0.966
NULL	J_Mol_Signal_2009_Sep_2_4_6.nxml.txt.nlp	19725972	SENT74	3	3	15	15	ethanol	RCAN1	PA448073	1827	0.966
NULL	J_Carcinog_2013_Dec_31_12_22.nxml.txt.nlp	24574860	SENT220	15	15	6	6	dasatinib	BRAF	PA162372878	673	0.966
NULL	Int_J_Mol_Imaging_2011_Oct_26_2011_874585.nxml.txt.nlp	21490735	SENT176	31	31	19	19	doxorubicin	FDG	PA449412	23583	0.966
NULL	Clin_Exp_Otorhinolaryngol_2012_Sep_27_5(3)_117-121.nxml.txt.nlp	22977707	SENT6	26	26	11	11	kanamycin	KCC2	PA450137	57468	0.966
NULL	Indian_J_Pharmacol_2008_Oct_40(Suppl_2)_S112-S142.nxml.txt.nlp	21593965	SENT456	0	0	17	17	perindopril	STZ	PA450877	6484	0.966
NULL	Diabetes_Care_2009_Nov_32(Suppl_2)_S322-S325.nxml.txt.nlp	19875573	SENT97	2	2	6	6	exenatide	GLP-1	PA164749238	100125288	0.966
NULL	Oncotarget_2013_Jul_7_4(7)_1065-1074.nxml.txt.nlp	23867252	SENT163	43	43	9	9	trypsin	Hsp90	PA451806	3320	0.966
NULL	Mol_Vis_2012_Oct_5_18_2454-2467.nxml.txt.nlp	23077404	SENT136	13	13	4	4	bevacizumab	VEGF-A	PA130232992	7422	0.966
NULL	Alzheimers_Res_Ther_2013_Apr_22_5(2)_15.nxml.txt.nlp	23607787	SENT147	10	10	2	2	donepezil	5-HT6	PA449394	3362	0.966
NULL	J_Am_Heart_Assoc_2013_Apr_24_2(2)_e000128.nxml.txt.nlp	23584809	SENT114	6	6	20	20	nitroprusside	EPO	PA451406	7076;8288;2056	0.966
NULL	Cell_Cycle_2013_Dec_15_12(24)_3791-3803.nxml.txt.nlp	24107631	SENT5	26	26	11	11	doxorubicin	YB-1	PA449412	4904	0.966
NULL	Cancer_Cell_Int_2005_Oct_4_5_30.nxml.txt.nlp	16202168	SENT57	32	32	3	3	talinolol	MDR1	PA146123005	5243	0.966
NULL	Hum_Reprod_2012_Jun_3_27(6)_1829-1839.nxml.txt.nlp	22473395	SENT35	5	5	34	34	estradiol	AMH	PA449503	268	0.966
NULL	J_Oncol_2010_Dec_28_2010_414676.nxml.txt.nlp	20066160	SENT89	7	7	13	13	docetaxel	VEGFR	PA449383	3791	0.966
NULL	Breast_Cancer_Res_2012_May_2_14(3)_R70.nxml.txt.nlp	22551440	SENT42	18	18	9	9	docetaxel	p53	PA449383	7157	0.966
NULL	Acta_Pharmacol_Sin_2013_Feb_12_34(2)_255-261.nxml.txt.nlp	23147557	SENT126	1	1	26	26	pioglitazone	CYP2C8	PA450970	1558	0.966
NULL	Ther_Clin_Risk_Manag_2006_Sep_2(3)_235-249.nxml.txt.nlp	18360599	SENT341	33	33	23	23	alendronate	PTH	PA448082	5741	0.966
NULL	Arthritis_Res_Ther_2006_Jan_10_8(1)_203.nxml.txt.nlp	16542467	SENT162	10	10	33	33	hydralazine	TLR9	PA449894	54106	0.966
NULL	Arthritis_Res_Ther_2004_Feb_24_6(Suppl_1)_24.nxml.txt.nlp	NULL	SENT7	36	36	2	2	infliximab	OPGL	PA452639	8600	0.966
NULL	Cell_Death_Differ_2010_May_13_17(5)_774-786.nxml.txt.nlp	19911006	SENT309	4	4	11	11	doxycycline	AATF	PA449415	26574	0.966
NULL	Indian_J_Pharm_Sci_2011_Sep-Oct_73(5)_510-516.nxml.txt.nlp	22923863	SENT21	2	2	12	12	venlafaxine	CYP2D6	PA451866	1565	0.966
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT129	44	44	9	9	trastuzumab	STAT3	PA451743	6774	0.966
NULL	Breast_Cancer_Res_2011_Mar_30_13(2)_R34.nxml.txt.nlp	21450081	SENT22	7	7	9	9	tamoxifen	aromatase	PA451581	1588	0.966
NULL	Patient_Prefer_Adherence_2008_Feb_2_2_167-175.nxml.txt.nlp	19920959	SENT45	12	12	32	32	clopidogrel	DES	PA449053	1674	0.966
NULL	Exp_Ther_Med_2013_Mar_21_5(3)_987-991.nxml.txt.nlp	23407636	SENT144	31	31	7	7	losartan	CXCR2	PA450268	3579	0.966
NULL	Oncoscience_2014_Oct_22_1(10)_614-623.nxml.txt.nlp	25593991	SENT92	4	4	18	18	lapatinib	HER2	PA152241907	2064	0.966
NULL	Neural_Dev_2011_Mar_18_6_8.nxml.txt.nlp	21418557	SENT110	16	16	30	30	carbachol	ANOVA	PA448784	4858	0.966
NULL	Clin_Med_Insights_Oncol_2012_Dec_20_7_1-12.nxml.txt.nlp	23362372	SENT34	0	0	17	17	cabazitaxel	CYP3A	PA165958401	1574	0.966
NULL	Oncol_Lett_2013_Jul_29_6(1)_118-124.nxml.txt.nlp	23946788	SENT9	18	18	10	10	tamoxifen	HER-2	PA451581	2064	0.966
NULL	Evid_Based_Complement_Alternat_Med_2012_Dec_20_2012_908601.nxml.txt.nlp	23326293	SENT274	26	26	18	18	oxaliplatin	EMT	PA131285527	3702;6581	0.966
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S18-S30.nxml.txt.nlp	20680104	SENT30	30	30	18	18	capecitabine	EGFR	PA448771	1956	0.966
NULL	Oncogene_2014_Jun_26_33(26)_3422-3431.nxml.txt.nlp	23912457	SENT19	0	0	28	28	trastuzumab	PIK3CA	PA451743	5290	0.966
NULL	Sensors_(Basel)_2012_Dec_28_13(1)_500-515.nxml.txt.nlp	23275085	SENT134	4	4	21	21	isoflurane	ARC	PA450106	8996;23237	0.966
NULL	Crit_Care_2010_Aug_3_14(4)_R148.nxml.txt.nlp	20682059	SENT33	13	13	1	1	aprotinin	BART	PA448472	7809;23568	0.966
NULL	Mol_Biol_Cell_2013_Sep_15_24(18)_2849-2860.nxml.txt.nlp	23885123	SENT265	25	25	13	13	dextran	JAM-A	PA449261	50848	0.966
NULL	Evid_Based_Complement_Alternat_Med_2014_Dec_11_2014_429256.nxml.txt.nlp	25580151	SENT76	23	23	10	10	indomethacin	COX	PA449982	1351	0.966
NULL	Indian_J_Med_Res_2011_Jan_133(1)_15-26.nxml.txt.nlp	21321416	SENT230	21	21	7	7	minocycline	p38	PA450519	10598;1432;7965	0.966
NULL	Oncotarget_2013_Nov_23_5(1)_196-210.nxml.txt.nlp	24344116	SENT150	22	22	9	9	doxorubicin	TNFAIP3	PA449412	7128	0.966
NULL	Nat_Commun_2013_Sep_20_4_2444.nxml.txt.nlp	24051492	SENT189	3	3	30	30	nutlin-3	PER2		8864	0.966
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT131	4	4	19	19	adalimumab	CD36	PA10004	948	0.966
NULL	Arthritis_Res_Ther_2008_Jan_7_10(1)_R1.nxml.txt.nlp	18179697	SENT178	12	12	17	17	oxaliplatin	HMGB1	PA131285527	3146	0.966
NULL	Acta_Orthop_2010_Apr_6_81(2)_263-267.nxml.txt.nlp	20148646	SENT152	21	21	10	10	taurine	LIR	PA451590	10871	0.966
NULL	Oncotarget_2014_Aug_29_5(19)_8947-8958.nxml.txt.nlp	25333254	SENT214	3	3	18	18	plerixafor	CD49d	PA165958410	3676	0.966
NULL	J_Immunol_Res_2014_Feb_5_2014_632307.nxml.txt.nlp	24741610	SENT41	0	0	14	14	bevacizumab	VEGF-A	PA130232992	7422	0.966
NULL	Exp_Cell_Res_2009_Nov_15_315(19)_3433-3441.nxml.txt.nlp	19716819	SENT444	12	12	17	17	hyaluronan	TNF-alpha	PA165958431	7124	0.966
NULL	Oncogene_2010_Jun_17_29(24)_3532-3544.nxml.txt.nlp	20418907	SENT112	4	4	17	17	geldanamycin	Hsp90	PA152031327	3320	0.966
NULL	Front_Neurol_2014_Mar_24_5_31.nxml.txt.nlp	24715886	SENT258	3	3	13	13	flumazenil	FDG	PA449659	23583	0.966
NULL	Biomed_Res_Int_2014_Apr_27_2014_180428.nxml.txt.nlp	24877063	SENT262	9	9	20	20	vincristine	TRPV4	PA451879	59341	0.966
NULL	Mol_Med_Rep_2015_Jan_16_11(1)_91-98.nxml.txt.nlp	25322694	SENT163	11	11	44	44	cisplatin	LC3	PA449014	84557	0.966
NULL	BMB_Rep_2013_Aug_46(8)_410-415.nxml.txt.nlp	23977989	SENT54	33	33	14	14	curcumin	HO-1	PA151958596	3162	0.966
NULL	Oncol_Lett_2013_Feb_7_5(2)_440-446.nxml.txt.nlp	23420122	SENT12	39	39	19	19	gemcitabine	EGFR	PA449748	1956	0.966
NULL	Saudi_J_Anaesth_2013_Apr-Jun_7(2)_151-154.nxml.txt.nlp	23956714	SENT103	8	8	14	14	theophylline	NAC	PA451647	22861	0.966
NULL	Adv_Hematol_2012_Jul_24_2012_513702.nxml.txt.nlp	22888354	SENT54	20	20	11	11	thalidomide	CRBN	PA451644	51185	0.966
NULL	Oncotarget_2013_Jul_28_4(9)_1365-1372.nxml.txt.nlp	23965755	SENT85	23	23	6	6	doxorubicin	U87	PA449412	677775;641648	0.966
NULL	Reprod_Biol_Endocrinol_2003_Aug_6_1_54.nxml.txt.nlp	12932297	SENT14	5	5	0	0	hyaluronidase	SPAM1	PA164745713	6677	0.966
NULL	Case_Rep_Med_2010_Aug_23_2010_278427.nxml.txt.nlp	20827440	SENT13	18	18	24	24	ceftriaxone	CD4	PA448866	920	0.966
NULL	Front_Behav_Neurosci_2014_Oct_30_8_366.nxml.txt.nlp	25400560	SENT280	7	7	25	25	ceftriaxone	p65	PA448866	5970	0.966
NULL	Oncotarget_2013_Nov_26_4(12)_2502-2511.nxml.txt.nlp	24318446	SENT110	13	13	8	8	doxycycline	PHGDH	PA449415	26227	0.966
NULL	Front_Pharmacol_2014_Sep_2_5_205.nxml.txt.nlp	25228882	SENT180	0	0	6	6	infliximab	TNF-alpha	PA452639	7124	0.966
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_105-115.nxml.txt.nlp	17912640	SENT54	2	2	7	7	erlotinib	EGFR	PA134687924	1956	0.966
NULL	Front_Endocrinol_(Lausanne)_2013_Sep_2_4_111.nxml.txt.nlp	24065951	SENT17	12	12	0	0	estradiol	CLOCK	PA449503	9575	0.966
NULL	Oncogenesis_2014_Dec_15_3(12)_e133.nxml.txt.nlp	25500906	SENT114	16	16	12	12	trastuzumab	HER2	PA451743	2064	0.966
NULL	Breast_Cancer_Res_2004_Oct_24_6(1)_R8-R17.nxml.txt.nlp	14680495	SENT134	3	3	17	17	tamoxifen	BRCA2	PA451581	675	0.966
NULL	Breast_Cancer_Res_2004_Nov_25_6(1)_E8.nxml.txt.nlp	14680493	SENT45	2	2	23	23	tamoxifen	STAR	PA451581	6770;2984	0.966
NULL	Biologics_2009_Jul_13_3_77-97.nxml.txt.nlp	19707398	SENT259	6	6	26	26	infliximab	ACT	PA452639	12;11332;9457;641455	0.966
NULL	Clin_Sci_(Lond)_2012_May_1_122(Pt_9)_421-428.nxml.txt.nlp	22092038	SENT31	1	1	19	19	tetracycline	c-Jun	PA451640	3725	0.966
NULL	Indian_J_Endocrinol_Metab_2012_Dec_16(Suppl_2)_S474-S476.nxml.txt.nlp	23565471	SENT66	27	27	18	18	glimepiride	PPG	PA449761	5552	0.966
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT256	3	3	33	33	sitagliptin	GLP-1	PA164748978	100125288	0.966
NULL	Lab_Invest_2014_May_10_94(5)_503-516.nxml.txt.nlp	24614199	SENT316	34	34	24	24	curcumin	RAGE	PA151958596	177	0.966
NULL	Nucleic_Acids_Res_2005_Jun_9_33(10)_3323-3330.nxml.txt.nlp	15947132	SENT43	31	31	8	8	cisplatin	MSH2	PA449014	4436	0.965
NULL	J_Biomed_Biotechnol_2010_Jun_7_2010_150960.nxml.txt.nlp	20617134	SENT226	16	16	26	26	carboplatin	KRAS	PA448803	3845	0.965
NULL	Int_J_Mol_Sci_2014_Mar_12_15(3)_4356-4392.nxml.txt.nlp	24625663	SENT278	41	41	20	20	etoposide	BAX	PA449552	581	0.965
NULL	Br_J_Cancer_2013_Feb_19_108(3)_557-563.nxml.txt.nlp	23361053	SENT194	18	18	11	11	tamoxifen	PAK1	PA451581	5585;5058	0.965
NULL	Oncotarget_2014_Mar_14_5(10)_3029-3038.nxml.txt.nlp	24912489	SENT102	30	30	16	16	anastrozole	aromatase	PA448432	1588	0.965
NULL	Acta_Pharmacol_Sin_2012_May_26_33(5)_675-681.nxml.txt.nlp	22447226	SENT109	39	39	10	10	gefitinib	survivin	PA131301952	332	0.965
NULL	Br_J_Ophthalmol_2010_May_94(5)_639-642.nxml.txt.nlp	20447966	SENT67	33	33	39	39	rimexolone	MYOC	PA164752251	4653	0.965
NULL	Cancers_(Basel)_2010_Aug_18_2(3)_1576-1596.nxml.txt.nlp	24281174	SENT223	5	5	31	31	etoposide	CD34	PA449552	947	0.965
NULL	Diabetes_2009_Mar_58(3)_579-589.nxml.txt.nlp	19074989	SENT99	10	10	3	3	rosiglitazone	ANGPTL4	PA451283	51129	0.965
NULL	Arthritis_Res_Ther_2006_Jan_10_8(1)_203.nxml.txt.nlp	16542467	SENT162	12	12	33	33	procainamide	TLR9	PA451108	54106	0.965
NULL	Acta_Pharmacol_Sin_2012_Jun_14_33(6)_832-838.nxml.txt.nlp	22580740	SENT13	6	6	32	32	doxorubicin	DDP	PA449412	1678	0.965
NULL	Cancer_Metab_2014_May_28_2(Suppl_1)_P65.nxml.txt.nlp	NULL	SENT21	8	8	16	16	resveratrol	SIRT1		23411	0.965
NULL	Ther_Clin_Risk_Manag_2007_Jun_3(2)_245-258.nxml.txt.nlp	18360633	SENT40	38	38	9	9	etanercept	TNF-alpha	PA449515	7124	0.965
NULL	Br_J_Pharmacol_2014_Jun_15_171(11)_2705-2725.nxml.txt.nlp	24467436	SENT49	27	27	35	35	hydralazine	C4B	PA449894	720;721	0.965
NULL	Int_J_Nanomedicine_2012_Oct_25_7_5565-5575.nxml.txt.nlp	23118538	SENT27	15	15	5	5	fenofibrate	CO2	PA449594	4513	0.965
NULL	Diabetes_2013_Nov_18_62(11)_3751-3759.nxml.txt.nlp	23897951	SENT128	23	23	9	9	rosiglitazone	FRS2	PA451283	10818	0.965
NULL	F1000Res_2014_Jul_1_3_149.nxml.txt.nlp	25352980	SENT109	25	25	7	7	galactose	GAL4	PA449725	3960	0.965
NULL	Diabetes_2008_Oct_57(10)_2784-2793.nxml.txt.nlp	18599521	SENT13	0	0	24	24	simvastatin	Rho	PA451363	29984	0.965
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT122	31	31	5	5	pp2	PP2		4888	0.965
NULL	Pharmaceuticals_(Basel)_2012_Aug_30_5(9)_890-898.nxml.txt.nlp	24280696	SENT82	17	17	8	8	fludarabine	Hsp90	PA449655	3320	0.965
NULL	Curr_Neuropharmacol_2012_Mar_10(1)_72-79.nxml.txt.nlp	22942880	SENT85	12	12	36	36	paclitaxel	p53	PA450761	7157	0.965
NULL	J_Cell_Biol_1998_Jan_26_140(2)_335-345.nxml.txt.nlp	9442109	SENT339	12	12	2	2	chloroquine	NHE	PA448948	285335	0.965
NULL	Br_J_Cancer_2013_May_28_108(10)_2013-2020.nxml.txt.nlp	23632482	SENT149	43	43	10	10	paclitaxel	CENP-A	PA450761	1058	0.965
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S31-S40.nxml.txt.nlp	20680106	SENT49	12	12	24	24	cetuximab	KRAS	PA10040	3845	0.965
NULL	Int_J_Breast_Cancer_2011_Jul_12_2011_232435.nxml.txt.nlp	22295213	SENT243	23	23	11	11	tamoxifen	TIMP3	PA451581	7078	0.965
NULL	Islets_2013_Sep_1_5(5)_201-206.nxml.txt.nlp	24275157	SENT74	24	24	5	5	glucosamine	HBP	PA164747613	3069;50865;7884;566	0.965
NULL	Aging_(Albany_NY)_2012_Apr_30_4(5)_320-329.nxml.txt.nlp	22589237	SENT31	0	0	13	13	metformin	OCT1	PA450395	5451;6580	0.965
NULL	Cancers_(Basel)_2014_Oct_24_6(4)_2187-2223.nxml.txt.nlp	25347122	SENT177	33	33	3	3	gefitinib	EGFR	PA131301952	1956	0.965
NULL	Nucleic_Acids_Res_2011_Dec_10_39(22)_9498-9507.nxml.txt.nlp	21835778	SENT180	3	3	6	6	nutlin-3	PUMA		27113	0.965
NULL	Indian_J_Med_Res_2012_Aug_136(2)_249-259.nxml.txt.nlp	22960892	SENT27	0	0	5	5	sn-38	UGT1A1		54658	0.965
NULL	Am_J_Cardiovasc_Drugs_2013_Jun_20_13(5)_331-342.nxml.txt.nlp	23784266	SENT183	17	17	33	33	amiodarone	P-gp	PA448383	5243	0.965
NULL	Indian_J_Pharmacol_2014_Jan-Feb_46(1)_3-12.nxml.txt.nlp	24550577	SENT221	0	0	7	7	vismodegib	CYP3A4		1576	0.965
NULL	Oncol_Lett_2013_Dec_4_6(6)_1665-1672.nxml.txt.nlp	24273604	SENT145	16	16	18	18	chloroquine	TLR9	PA448948	54106	0.965
NULL	Acta_Pharmacol_Sin_2011_Jun_23_32(6)_711-715.nxml.txt.nlp	21602841	SENT97	19	19	0	0	vasopressin	AQP2	PA451858	359	0.965
NULL	Eur_J_Med_Res_2011_Feb_24_16(2)_63-66.nxml.txt.nlp	21463983	SENT123	13	13	36	36	tobramycin	PARI	PA451704	55010	0.965
NULL	Eur_J_Clin_Pharmacol_2014_Oct_8_70(1)_37-45.nxml.txt.nlp	24100471	SENT15	6	6	38	38	pioglitazone	OATP1B1	PA450970	10599	0.965
NULL	Environ_Health_Perspect_2005_Aug_15_113(8)_1009-1014.nxml.txt.nlp	16079071	SENT13	31	31	27	27	losartan	p38	PA450268	10598;1432;7965	0.965
NULL	Nat_Med_2013_Mar_3_19(3)_295-304.nxml.txt.nlp	23377280	SENT66	24	24	27	27	erlotinib	EGFR	PA134687924	1956	0.965
NULL	Eur_Respir_J_2014_Jul_23_44(1)_23-63.nxml.txt.nlp	24659544	SENT373	5	5	21	21	ethambutol	DST	PA164784021	667	0.965
NULL	Br_J_Cancer_2004_Mar_22_90(6)_1285-1292.nxml.txt.nlp	15026814	SENT197	23	23	7	7	doxorubicin	p53	PA449412	7157	0.965
NULL	Lancet_2011_Jun_18_377(9783)_2103-2114.nxml.txt.nlp	21641636	SENT113	23	23	7	7	cetuximab	KRAS	PA10040	3845	0.965
NULL	Acta_Pharmacol_Sin_2012_Dec_22_33(12)_1511-1517.nxml.txt.nlp	23085741	SENT180	2	2	9	9	pranlukast	CysLT1	PA134698661	10800	0.965
NULL	J_Biomed_Sci_2014_Apr_9_21(1)_29.nxml.txt.nlp	24712823	SENT153	20	20	4	4	genistein	IL-4	PA165109660	3565	0.965
NULL	Oncotarget_2013_Apr_15_4(4)_636-646.nxml.txt.nlp	23592437	SENT66	18	18	8	8	decitabine	OIP5	PA164749631	11339	0.965
NULL	Sci_Rep_2015_Jan_6_5_7642.nxml.txt.nlp	25560837	SENT891	16	16	12	12	rimonabant	CB1	PA152407999	1268	0.965
NULL	J_Adv_Pract_Oncol_2012_Jan_1_Jan-Feb_3(1)_23-33.nxml.txt.nlp	25031924	SENT121	7	7	10	10	tamoxifen	aromatase	PA451581	1588	0.965
NULL	Clin_Dev_Immunol_2013_Oct_10_2013_746068.nxml.txt.nlp	24223607	SENT168	3	3	9	9	minocycline	CD68	PA450519	968	0.965
NULL	Acta_Pharmacol_Sin_2013_Mar_11_34(3)_403-413.nxml.txt.nlp	23396374	SENT231	0	0	18	18	curcumin	IL-6	PA151958596	3569	0.965
NULL	J_Oncol_2009_Mar_24_2009_491985.nxml.txt.nlp	19325924	SENT51	21	21	9	9	genistein	CXCL12	PA165109660	6387	0.965
NULL	J_Adv_Pract_Oncol_2012_Jul_1_Jul-Aug_3(4)_267-272.nxml.txt.nlp	25031955	SENT18	3	3	31	31	erlotinib	EGFR	PA134687924	1956	0.965
NULL	Breast_Cancer_Res_2007_Dec_20_9(Suppl_2)_S16.nxml.txt.nlp	NULL	SENT48	17	17	19	19	tamoxifen	aromatase	PA451581	1588	0.965
NULL	Oncogene_2010_Sep_23_29(38)_5286-5298.nxml.txt.nlp	20603611	SENT8	32	32	30	30	pha-665752	Met		79811	0.965
NULL	J_Carcinog_2011_Nov_30_10_28.nxml.txt.nlp	22190870	SENT167	26	26	10	10	paclitaxel	San	PA450761	80218	0.965
NULL	Database_(Oxford)_2014_Dec_23_2014_bau124.nxml.txt.nlp	25539768	SENT320	6	6	15	15	metformin	EGFR	PA450395	1956	0.965
NULL	J_Cell_Biol_1998_May_4_141(3)_839-847.nxml.txt.nlp	9566981	SENT1	17	17	10	10	guanidine	osteoadherin	PA164781028	4958	0.965
NULL	Clinics_(Sao_Paulo)_2013_Jun_68(6)_766-771.nxml.txt.nlp	23778483	SENT117	32	32	1	1	chloroquine	IL-6	PA448948	3569	0.965
NULL	Br_J_Cancer_2012_Jul_10_107(2)_360-369.nxml.txt.nlp	22713663	SENT157	2	2	11	11	bevacizumab	DDP	PA130232992	1678	0.965
NULL	Oncol_Lett_2013_Feb_19_5(2)_583-587.nxml.txt.nlp	23420689	SENT77	18	18	38	38	cisplatin	CO2	PA449014	4513	0.965
NULL	Hematol_Rep_2012_Sep_4_4(3)_e16.nxml.txt.nlp	23087805	SENT57	8	8	0	0	verapamil	P-gp	PA451868	5243	0.965
NULL	Apoptosis_2013_Jun_7_18(6)_664-680.nxml.txt.nlp	23468121	SENT9	3	3	16	16	staurosporine	PDCD2	PA165109623	5134	0.965
NULL	Crit_Care_2011_Jun_24_15(3)_R153.nxml.txt.nlp	21702944	SENT214	3	3	11	11	dexmedetomidine	TLR-4	PA449256	7099	0.965
NULL	Oncotarget_2014_Aug_12_5(20)_9710-9726.nxml.txt.nlp	25339152	SENT234	24	24	13	13	pp2	DGK		8526;1607	0.965
NULL	Breast_Cancer_Res_2008_May_13_10(Suppl_2)_O3.nxml.txt.nlp	NULL	SENT21	10	10	19	19	tamoxifen	c-src	PA451581	6714	0.965
NULL	Springerplus_2015_Jan_23_4_29.nxml.txt.nlp	25628986	SENT68	17	17	35	35	dapsone	G6PD	PA449211	2539	0.965
NULL	Oncol_Rep_2012_Oct_13_28(4)_1146-1152.nxml.txt.nlp	22797812	SENT52	25	25	2	2	irinotecan	WRN	PA450085	7486	0.965
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_39-54.nxml.txt.nlp	19305787	SENT234	2	2	19	19	ethanol	DARPP-32	PA448073	84152	0.965
NULL	Cell_J_2013_Feb_20_Winter_14(4)_292-297.nxml.txt.nlp	23577309	SENT67	17	17	37	37	chlorpromazine	gamma	PA448964	9913	0.965
NULL	Indian_J_Nucl_Med_2010_Apr-Jun_25(2)_64-66.nxml.txt.nlp	21188067	SENT68	17	17	36	36	clonazepam	FDG	PA449050	23583	0.965
NULL	Oncol_Lett_2014_May_11_7(5)_1401-1408.nxml.txt.nlp	24765145	SENT137	35	35	7	7	paclitaxel	PI3K	PA450761	5290	0.965
NULL	Mol_Cells_2014_Dec_31_37(12)_888a-898.nxml.txt.nlp	25518923	SENT32	16	16	9	9	gemcitabine	KRAS	PA449748	3845	0.965
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_29_2012_109796.nxml.txt.nlp	22110543	SENT94	37	37	0	0	lipase	NPY	PA450239	4852	0.965
NULL	Oncogene_2013_Sep_26_32(39)_10_1038_onc_2012_491.nxml.txt.nlp	23108394	SENT103	27	27	33	33	epirubicin	FOXM1	PA449476	2305	0.965
NULL	Iran_J_Pharm_Res_2014_Autumn_13(4)_1393-1401.nxml.txt.nlp	25587329	SENT11	25	25	7	7	celecoxib	ABCG2	PA448871	9429	0.965
NULL	Int_J_Mol_Sci_2014_Oct_27_15(11)_19417-19443.nxml.txt.nlp	25350109	SENT135	16	16	42	42	nadh	p47phox	PA164755085	653361	0.965
NULL	Oncol_Lett_2014_Jul_8_8(1)_47-54.nxml.txt.nlp	24959217	SENT32	5	5	0	0	vemurafenib	BRAF	PA165946873	673	0.965
NULL	Reprod_Biol_Endocrinol_2013_Feb_26_11_15.nxml.txt.nlp	23442442	SENT143	25	25	14	14	l-arginine	BCL2	PA448478	596	0.965
NULL	J_Oncol_2010_Jan_13_2010_314326.nxml.txt.nlp	20111741	SENT172	10	10	3	3	bevacizumab	TED	PA130232992	27112	0.965
NULL	Front_Oncol_2014_Mar_3_4_34.nxml.txt.nlp	24624361	SENT274	15	15	40	40	vorinostat	BRCA1	PA164748224	672	0.965
NULL	Diabetes_Care_2010_Jun_23_33(6)_1294-1296.nxml.txt.nlp	20332358	SENT72	20	20	0	0	exenatide	GLP-1	PA164749238	100125288	0.965
NULL	Eur_J_Clin_Pharmacol_2012_Sep_15_68(9)_1267-1274.nxml.txt.nlp	22418828	SENT95	29	29	2	2	pantoprazole	CYP2C19	PA450774	1557	0.965
NULL	Breast_Cancer_Res_2006_Nov_30_8(6)_216.nxml.txt.nlp	17164010	SENT191	10	10	1	1	anastrozole	IMPACT	PA448432	55364	0.965
NULL	Br_J_Cancer_2009_Mar_10_100(5)_758-763.nxml.txt.nlp	19259094	SENT129	9	9	12	12	decitabine	HDAC	PA164749631	9734	0.965
NULL	Ann_Lab_Med_2012_Jul_20_32(4)_264-269.nxml.txt.nlp	22779067	SENT104	39	39	3	3	rifampin	DST	PA451250	667	0.965
NULL	Evid_Based_Complement_Alternat_Med_2004_Jun_1(1)_83-91.nxml.txt.nlp	15257329	SENT103	28	28	8	8	glucose	SKT	PA449773	56243	0.965
NULL	Nat_Commun_2014_Dec_18_5_5815.nxml.txt.nlp	25519973	SENT73	13	13	9	9	tranylcypromine	ATN1	PA451741	1822	0.965
NULL	Br_J_Cancer_2009_May_5_100(9)_1425-1433.nxml.txt.nlp	19401701	SENT164	17	17	25	25	curcumin	EGFR	PA151958596	1956	0.965
NULL	Biol_Open_2012_Jun_28_1(8)_789-801.nxml.txt.nlp	23213472	SENT155	22	22	5	5	tetracycline	PER1	PA451640	93210;5187	0.965
NULL	Mol_Cancer_2010_Nov_2_9_289.nxml.txt.nlp	21044322	SENT149	30	30	19	19	vincristine	RGS17	PA451879	26575	0.965
NULL	J_Lipid_Res_2012_May_53(5)_1000-1011.nxml.txt.nlp	22368281	SENT776	16	16	7	7	simvastatin	ABCB1	PA451363	5243	0.965
NULL	Subst_Abuse_Treat_Prev_Policy_2009_Apr_17_4_6.nxml.txt.nlp	19374740	SENT149	0	0	9	9	buprenorphine	OST	PA448685	1650;23263	0.965
NULL	Neural_Regen_Res_2012_Oct_5_7(28)_2227-2239.nxml.txt.nlp	25538744	SENT193	22	22	6	6	estradiol	spatial	PA449503	219793	0.965
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT30	2	2	36	36	metformin	LKB1	PA450395	6794	0.965
NULL	Br_J_Cancer_2009_Jul_7_101(1)_38-47.nxml.txt.nlp	19513066	SENT131	24	24	3	3	dasatinib	p27	PA162372878	5715;10534	0.965
NULL	Mol_Cancer_2014_Jan_13_13_7.nxml.txt.nlp	24418169	SENT177	28	28	7	7	sorafenib	SHP-1	PA7000	5777	0.965
NULL	Breast_Cancer_(Auckl)_2011_Jan_13_5_1-14.nxml.txt.nlp	21494397	SENT52	22	22	9	9	rifampin	CYP3A4	PA451250	1576	0.965
NULL	Acta_Oncol_2014_Oct_9_53(10)_1347-1355.nxml.txt.nlp	24909504	SENT191	20	20	7	7	epirubicin	TP53	PA449476	7157	0.965
NULL	Clin_Pharmacol_2010_Jun_22_2_105-110.nxml.txt.nlp	22291493	SENT7	22	22	9	9	sibutramine	ADIPOQ	PA451344	9370	0.965
NULL	Int_J_Surg_Oncol_2012_May_16_2012_863034.nxml.txt.nlp	22666572	SENT152	2	2	19	19	cetuximab	KRAS	PA10040	3845	0.965
NULL	Drugs_R_D_2011_Jun_27_11(2)_113-126.nxml.txt.nlp	21679004	SENT103	21	21	13	13	axitinib	CYP3A4	PA164924493	1576	0.965
NULL	South_Asian_J_Cancer_2014_Jul-Sep_3(3)_182-184.nxml.txt.nlp	25136528	SENT82	20	20	9	9	nelfinavir	CYP3A4	PA450606	1576	0.965
NULL	Mol_Cancer_2014_Jan_13_13_7.nxml.txt.nlp	24418169	SENT234	14	14	5	5	sorafenib	STAT3	PA7000	6774	0.965
NULL	Acta_Pharmacol_Sin_2014_Jan_9_35(1)_1-10.nxml.txt.nlp	24317012	SENT145	29	29	18	18	epirubicin	NQO1	PA449476	1728	0.965
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT160	20	20	8	8	metformin	AKT	PA450395	207	0.965
NULL	J_Hematol_Oncol_2012_Sep_18_5_57.nxml.txt.nlp	22989009	SENT225	2	2	24	24	nutlin-3	p53		7157	0.965
NULL	Breast_Cancer_(Auckl)_2009_Sep_2_3_61-75.nxml.txt.nlp	19809577	SENT110	18	18	13	13	curcumin	BRCA1	PA151958596	672	0.965
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT121	4	4	13	13	sulindac	AKT	PA451565	207	0.965
NULL	Br_J_Cancer_2010_May_11_102(10)_1483-1490.nxml.txt.nlp	20407444	SENT42	19	19	2	2	doxorubicin	IFN	PA449412	3439	0.965
NULL	Mol_Syst_Biol_2009_Jul_28_5_288.nxml.txt.nlp	19638969	SENT218	3	3	6	6	resveratrol	COX		1351	0.965
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT139	4	4	29	29	resveratrol	Bcl-2		596	0.965
NULL	Oncogene_2010_May_20_29(20)_2983-2995.nxml.txt.nlp	20208560	SENT137	24	24	9	9	tamoxifen	FOXM1	PA451581	2305	0.965
NULL	Biomed_Res_Int_2014_Apr_24_2014_459736.nxml.txt.nlp	24864245	SENT262	0	0	12	12	heparin	TP2	PA449855	7015;7142	0.965
NULL	Oncotarget_2014_Mar_14_5(10)_3029-3038.nxml.txt.nlp	24912489	SENT159	13	13	11	11	anastrozole	aromatase	PA448432	1588	0.965
NULL	J_Inflamm_(Lond)_2008_Dec_5_5_23.nxml.txt.nlp	19061493	SENT30	0	0	26	26	hemin	HO-1	PA449849	3162	0.965
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT124	26	26	13	13	vemurafenib	ABCG2	PA165946873	9429	0.965
NULL	JAKSTAT_2013_Jul_1_2(3)_e24574.nxml.txt.nlp	24069558	SENT79	20	20	4	4	doxycycline	JAK2	PA449415	3717	0.965
NULL	Arthritis_Res_Ther_2012_Sep_24_14(5)_R200.nxml.txt.nlp	23006144	SENT168	10	10	14	14	alefacept	IL-20	PA164748040	27190;50604	0.965
NULL	Biomed_Res_Int_2014_Jan_27_2014_696107.nxml.txt.nlp	24587987	SENT223	10	10	16	16	ebselen	NAC	PA161660841	22861	0.965
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT213	9	9	0	0	sitagliptin	PDX-1	PA164748978	3651	0.965
NULL	Open_Access_J_Urol_2010_Mar_12_2_35-40.nxml.txt.nlp	24198612	SENT39	2	2	15	15	pazopanib	VEGFR2	PA165291492	3791	0.965
NULL	Mol_Pain_2013_Jun_10_9_27.nxml.txt.nlp	23758830	SENT218	8	8	21	21	tetracaine	ASIC3	PA451638	9311	0.965
NULL	Adv_Hematol_2012_Mar_26_2012_932658.nxml.txt.nlp	22548067	SENT77	16	16	38	38	methotrexate	CHOP	PA450428	1649	0.965
NULL	Oncotarget_2013_Nov_19_5(1)_95-102.nxml.txt.nlp	24395633	SENT86	3	3	8	8	vorinostat	SIRT1	PA164748224	23411	0.965
NULL	J_Oncol_2013_Apr_29_2013_854121.nxml.txt.nlp	23737784	SENT42	29	29	20	20	capecitabine	HER2	PA448771	2064	0.965
NULL	Br_J_Cancer_2010_May_11_102(10)_1456-1460.nxml.txt.nlp	20461090	SENT83	9	9	19	19	temsirolimus	IFN	PA164746890	3439	0.965
NULL	Cell_Cycle_2013_Sep_15_12(18)_3013-3024.nxml.txt.nlp	23974104	SENT134	11	11	18	18	doxorubicin	CD44	PA449412	960	0.965
NULL	J_Oncol_2012_Jun_4_2012_928127.nxml.txt.nlp	22701483	SENT166	21	21	6	6	trastuzumab	CD44	PA451743	960	0.965
NULL	Front_Behav_Neurosci_2011_Sep_21_5_60.nxml.txt.nlp	22007163	SENT129	30	30	27	27	rimonabant	CB1	PA152407999	1268	0.965
NULL	J_Adv_Pract_Oncol_2012_Jul_1_Jul-Aug_3(4)_267-272.nxml.txt.nlp	25031955	SENT99	13	13	4	4	crizotinib	CYP3A	PA165946122	1574	0.965
NULL	Asian_J_Androl_2014_Feb_25_May-Jun_16(3)_401-406.nxml.txt.nlp	24589464	SENT16	10	10	23	23	olaparib	BRCA2		675	0.965
NULL	Onco_Targets_Ther_2014_Oct_4_7_1817-1828.nxml.txt.nlp	25336973	SENT147	0	0	14	14	cetuximab	KRAS	PA10040	3845	0.965
NULL	J_Cancer_2011_May_1_2_232-261.nxml.txt.nlp	21552384	SENT121	3	3	12	12	exemestane	HER2	PA449563	2064	0.965
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_29_2013_590393.nxml.txt.nlp	23737838	SENT221	9	9	16	16	resveratrol	p53		7157	0.965
NULL	Endocrine_2012_Dec_14_42(3)_622-636.nxml.txt.nlp	22695986	SENT5	5	5	26	26	forskolin	PTH	PA146096022	5741	0.965
NULL	Mol_Med_Rep_2014_Oct_23_10(4)_1717-1724.nxml.txt.nlp	25069516	SENT108	16	16	10	10	resveratrol	PC-3		692094	0.965
NULL	Crit_Care_2006_Dec_7_10(6)_239.nxml.txt.nlp	17169139	SENT72	0	0	6	6	thrombin	PAR1	PA451674	79581;2149	0.965
NULL	Breast_Cancer_Res_2010_Dec_20_12(Suppl_4)_S15.nxml.txt.nlp	21172077	SENT16	22	22	13	13	tamoxifen	aromatase	PA451581	1588	0.965
NULL	Int_J_Med_Sci_2013_Jun_14_10(8)_995-1002.nxml.txt.nlp	23801886	SENT14	13	13	0	0	doxycycline	ILK	PA449415	3611	0.965
NULL	Br_J_Cancer_1995_Oct_72(4)_1007-1012.nxml.txt.nlp	7547212	SENT0	11	11	16	16	exemestane	aromatase	PA449563	1588	0.965
NULL	Ann_Med_2011_Nov_5_43(7)_531-544.nxml.txt.nlp	21815879	SENT168	2	2	16	16	ticagrelor	CYP3A4	PA165374673	1576	0.965
NULL	Cell_Death_Dis_2011_Aug_11_2(8)_e190.nxml.txt.nlp	21833028	SENT125	9	9	35	35	lovastatin	CDC25A	PA450272	993	0.965
NULL	Arthritis_Res_Ther_2009_Jan_26_11(1)_R12.nxml.txt.nlp	19171052	SENT319	17	17	30	30	dipyridamole	ACTH	PA449367	5443	0.965
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT90	5	5	26	26	curcumin	DR4	PA151958596	8797	0.965
NULL	ScientificWorldJournal_2014_Mar_2_2014_794078.nxml.txt.nlp	24723825	SENT20	9	9	22	22	clopidogrel	DES	PA449053	1674	0.965
NULL	AIDS_Res_Ther_2013_May_1_10_10.nxml.txt.nlp	23634877	SENT149	25	25	6	6	atorvastatin	CCL5	PA448500	6352	0.965
NULL	Br_J_Cancer_2012_May_22_106(11)_1728-1734.nxml.txt.nlp	22531637	SENT129	23	23	21	21	ketoconazole	CYP3A4	PA450146	1576	0.965
NULL	Mol_Biol_Cell_2013_Jul_15_24(14)_2186-2200.nxml.txt.nlp	23699397	SENT90	21	21	7	7	staurosporine	TRAIL	PA165109623	8743	0.965
NULL	Mol_Vis_2012_Apr_11_18_901-908.nxml.txt.nlp	22539869	SENT8	26	26	6	6	curcumin	HO-1	PA151958596	3162	0.965
NULL	Mol_Cell_Proteomics_2012_Feb_6_11(2)_M111_015222.nxml.txt.nlp	22147731	SENT334	16	16	8	8	cetuximab	TOMM20	PA10040	9804	0.965
NULL	J_Gastroenterol_2014_Mar_26_49(1)_46-56.nxml.txt.nlp	23525980	SENT171	0	0	30	30	sorafenib	SHARP	PA7000	23013	0.965
NULL	Mol_Cancer_2010_Nov_8_9_291.nxml.txt.nlp	21059223	SENT147	10	10	33	33	paclitaxel	Bcl-2	PA450761	596	0.965
NULL	Oncogene_2014_Mar_20_33(12)_1495-1505.nxml.txt.nlp	23604115	SENT195	0	0	31	31	nilotinib	RAD51	PA165958345	5888	0.965
NULL	J_Korean_Med_Sci_2010_Jun_24_25(6)_846-852.nxml.txt.nlp	20514304	SENT150	23	23	9	9	carboplatin	GSTP1	PA448803	2950	0.965
NULL	Mol_Cancer_2008_Jun_5_7_50.nxml.txt.nlp	18534018	SENT126	20	20	9	9	bortezomib	Mcl-1	PA10252	4170	0.965
NULL	Int_J_Breast_Cancer_2012_May_9_2012_415170.nxml.txt.nlp	22649737	SENT71	20	20	28	28	trastuzumab	IGF1R	PA451743	3480	0.965
NULL	Pharmaceuticals_(Basel)_2013_Aug_21_6(8)_988-1038.nxml.txt.nlp	24276379	SENT2132	25	25	4	4	fluorouracil	UGT1A1	PA128406956	54658	0.965
NULL	Curr_Pain_Headache_Rep_2011_Aug_12_15(4)_271-279.nxml.txt.nlp	21479998	SENT149	0	0	10	10	oxycodone	CYP3A4	PA450741	1576	0.965
NULL	J_Hematol_Oncol_2013_Jan_4_6_1.nxml.txt.nlp	23286345	SENT120	35	35	14	14	doxorubicin	FCGR3A	PA449412	2214	0.965
NULL	Cardiovasc_Diabetol_2013_May_4_12_73.nxml.txt.nlp	23642288	SENT133	20	20	11	11	acarbose	GLP-1	PA448010	100125288	0.965
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_16_2012_395912.nxml.txt.nlp	23118789	SENT148	29	29	0	0	ketoprofen	UGT1A3	PA450149	54659	0.965
NULL	J_Mov_Disord_2011_May_30_4(1)_46-48.nxml.txt.nlp	24868392	SENT44	0	0	22	22	pramipexole	AVP	PA164742949	114548;551	0.965
NULL	J_Hematol_Oncol_2013_Jan_15_6_5.nxml.txt.nlp	23320987	SENT118	11	11	36	36	heparin	PI-PLC	PA449855	2923	0.965
NULL	Ann_Lab_Med_2012_Jul_20_32(4)_264-269.nxml.txt.nlp	22779067	SENT43	33	33	7	7	rifampin	DST	PA451250	667	0.965
NULL	Clin_Med_Oncol_2008_Mar_27_2_275-287.nxml.txt.nlp	21892289	SENT275	35	35	7	7	rituximab	CD19	PA451261	930	0.965
NULL	J_Breast_Cancer_2012_Jun_28_15(2)_203-210.nxml.txt.nlp	22807938	SENT116	24	24	45	45	trastuzumab	NACT	PA451743	284111	0.965
NULL	J_Biol_Chem_2010_Aug_20_285(34)_25913-25927.nxml.txt.nlp	20452970	SENT114	38	38	6	6	iloprost	cPLA2	PA164746843	10524	0.965
NULL	Cholesterol_2011_Jan_20_2011_176802.nxml.txt.nlp	21512589	SENT92	27	27	7	7	allopregnanolone	NPC1	PA142320763	4864	0.965
NULL	Ann_Med_Health_Sci_Res_2013_Apr-Jun_3(2)_238-244.nxml.txt.nlp	23919197	SENT126	4	4	12	12	micafungin	NAC	PA164781026	22861	0.965
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_315-322.nxml.txt.nlp	20049735	SENT57	6	6	15	15	cisplatin	PTEN	PA449014	5728	0.965
NULL	Mol_Cancer_2014_Aug_16_13(1)_193.nxml.txt.nlp	NULL	SENT99	7	7	0	0	cisplatin	RKIP	PA449014	5037	0.965
NULL	Mol_Cancer_2009_Nov_24_8_109.nxml.txt.nlp	19930708	SENT101	30	30	1	1	exemestane	aromatase	PA449563	1588	0.965
NULL	Front_Behav_Neurosci_2014_Dec_16_8_437.nxml.txt.nlp	25566005	SENT17	36	36	8	8	menthol	TRPM8	PA164776605	79054	0.965
NULL	Ann_Neurosci_2011_Apr_18(2)_48-55.nxml.txt.nlp	25205921	SENT142	12	12	6	6	forskolin	SOD1	PA146096022	6647	0.965
NULL	Chem_Cent_J_2012_May_11_6_41.nxml.txt.nlp	22578215	SENT61	3	3	21	21	naringin	castor	PA151958360	54897	0.965
NULL	J_Immunol_Res_2014_May_12_2014_897249.nxml.txt.nlp	24901013	SENT125	29	29	5	5	natalizumab	CD49d	PA164747191	3676	0.965
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT459	12	12	1	1	clozapine	PRL	PA449061	5617	0.965
NULL	Cardiovasc_Diabetol_2013_Nov_12_12_169.nxml.txt.nlp	24215514	SENT307	6	6	27	27	valsartan	AT2	PA451848	186	0.965
NULL	Oncol_Lett_2013_Sep_12_6(3)_860-864.nxml.txt.nlp	24137426	SENT85	37	37	41	41	ketoconazole	CYP3A4	PA450146	1576	0.965
NULL	Cell_Death_Dis_2014_Jan_16_5(1)_e1000.nxml.txt.nlp	24434508	SENT59	33	33	21	21	etoposide	p53	PA449552	7157	0.965
NULL	J_Oncol_2010_Jun_3_2010_732680.nxml.txt.nlp	20613952	SENT63	0	0	7	7	lenalidomide	IL-10	PA162363968	3586	0.965
NULL	Lab_Invest_2012_Jul_30_92(7)_1071-1083.nxml.txt.nlp	22546867	SENT341	17	17	32	32	hydrocortisone	GAPDH	PA449905	2597	0.965
NULL	Multidiscip_Respir_Med_2012_Nov_23_7(1)_48.nxml.txt.nlp	23174134	SENT67	14	14	4	4	imatinib	DLST	PA10804	1743	0.965
NULL	Biomed_Res_Int_2014_Apr_23_2014_408683.nxml.txt.nlp	24864240	SENT137	35	35	28	28	cisplatin	p53	PA449014	7157	0.965
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1522-1532.nxml.txt.nlp	21997136	SENT169	8	8	11	11	irinotecan	EGFR	PA450085	1956	0.965
NULL	Paediatr_Drugs_2013_Apr_20_15(2)_119-131.nxml.txt.nlp	23512128	SENT315	12	12	4	4	omeprazole	CYP2C19	PA450704	1557	0.965
NULL	Breast_Cancer_Res_Treat_2012_Jul_28_134(1)_267-276.nxml.txt.nlp	22453754	SENT31	1	1	16	16	tamoxifen	aromatase	PA451581	1588	0.965
NULL	Oncogene_2014_Sep_18_33(38)_4685-4696.nxml.txt.nlp	24121268	SENT310	18	18	6	6	bortezomib	p53	PA10252	7157	0.965
NULL	J_Hematol_Oncol_2013_Jul_18_6_53.nxml.txt.nlp	23866964	SENT36	10	10	8	8	temsirolimus	MTOR	PA164746890	2475	0.965
NULL	Indian_J_Endocrinol_Metab_2013_Dec_17(Suppl_3)_S674-S679.nxml.txt.nlp	24910836	SENT153	9	9	27	27	acarbose	PPG	PA448010	5552	0.965
NULL	Mol_Biol_Cell_2013_Sep_1_24(17)_2727-2738.nxml.txt.nlp	23864707	SENT370	12	12	18	18	fluorescein	giantin	PA164746009	2804	0.965
NULL	Drugs_R_D_2013_Jun_5_13(2)_153-157.nxml.txt.nlp	23737454	SENT153	13	13	8	8	clopidogrel	P2Y12	PA449053	64805	0.965
NULL	Clin_Epigenetics_2010_Sep_18_1(3-4)_101-116.nxml.txt.nlp	21258631	SENT258	25	25	9	9	resveratrol	DNMT1		1786	0.965
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_O5.nxml.txt.nlp	NULL	SENT14	7	7	41	41	vancomycin	IL-4	PA451850	3565	0.965
NULL	Cell_Commun_Signal_2009_Oct_27_7_25.nxml.txt.nlp	19860902	SENT180	0	0	17	17	dipyridamole	NFATc	PA449367	4772	0.965
NULL	eLife_2014_Aug_13_3_e03756.nxml.txt.nlp	25122624	SENT167	18	18	3	3	nitrogen	SNAP-25	PA450643	6616	0.965
NULL	Indian_J_Sex_Transm_Dis_2013_Jul-Dec_34(2)_126-128.nxml.txt.nlp	24339465	SENT17	23	23	3	3	nevirapine	CD4	PA450616	920	0.965
NULL	Parasit_Vectors_2011_Dec_13_4_232.nxml.txt.nlp	22166365	SENT91	7	7	24	24	praziquantel	STH	PA164764583	246744	0.965
NULL	Front_Oncol_2014_Sep_23_4_264.nxml.txt.nlp	25295231	SENT101	11	11	28	28	lenalidomide	p53	PA162363968	7157	0.965
NULL	J_Cell_Biol_1998_Jan_26_140(2)_335-345.nxml.txt.nlp	9442109	SENT237	7	7	24	24	chloroquine	NHE	PA448948	285335	0.965
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jul_11_65(Pt_8)_o1836.nxml.txt.nlp	21583537	SENT68	21	21	4	4	ethanol	mol	PA448073	90527	0.965
NULL	Cancer_Med_2014_Jun_19_3(3)_555-564.nxml.txt.nlp	24648042	SENT132	23	23	5	5	chlorambucil	NOTCH1	PA448926	4851	0.965
NULL	Int_J_Biol_Sci_2014_Jun_10_10(7)_654-663.nxml.txt.nlp	25013375	SENT110	0	0	9	9	nelfinavir	CDK2	PA450606	1017	0.965
NULL	J_Oncol_2009_Mar_24_2009_491985.nxml.txt.nlp	19325924	SENT128	25	25	1	1	genistein	CXCR4	PA165109660	7852	0.965
NULL	Breast_Cancer_(Auckl)_2009_Sep_2_3_61-75.nxml.txt.nlp	19809577	SENT148	0	0	23	23	curcumin	STAT3	PA151958596	6774	0.965
NULL	J_Cell_Biol_2000_Jul_10_150(1)_213-224.nxml.txt.nlp	10893269	SENT113	33	33	8	8	amiloride	NHE	PA448368	285335	0.965
NULL	Exp_Ther_Med_2013_Nov_13_6(5)_1317-1321.nxml.txt.nlp	24223665	SENT84	5	5	0	0	curcumin	ABCG2	PA151958596	9429	0.965
NULL	Asian_J_Androl_2015_Oct_24_Jan-Feb_17(1)_61-67.nxml.txt.nlp	25370206	SENT10	20	20	1	1	tadalafil	SEP2	PA10333	23176;23157	0.965
NULL	Acta_Pharmacol_Sin_2009_Sep_24_30(9)_1262-1275.nxml.txt.nlp	19701231	SENT168	27	27	2	2	lovastatin	INSIG2	PA450272	51141	0.965
NULL	Br_J_Cancer_2009_Nov_3_101(9)_1529-1536.nxml.txt.nlp	19809429	SENT53	26	26	11	11	methotrexate	NAC	PA450428	22861	0.965
NULL	J_Inflamm_(Lond)_2008_Dec_4_5_22.nxml.txt.nlp	19055838	SENT27	11	11	20	20	etanercept	p38	PA449515	10598;1432;7965	0.965
NULL	Int_J_Mol_Sci_2014_Mar_5_15(3)_3970-3988.nxml.txt.nlp	24603537	SENT2	22	22	0	0	curcumin	MCH	PA151958596	5367	0.965
NULL	Am_J_Cardiovasc_Drugs_2013_Jun_20_13(5)_331-342.nxml.txt.nlp	23784266	SENT183	30	30	21	21	atorvastatin	P-gp	PA448500	5243	0.965
NULL	Oncol_Lett_2014_Jan_12_7(1)_17-22.nxml.txt.nlp	24348813	SENT116	9	9	11	11	curcumin	COX	PA151958596	1351	0.965
NULL	Diabetes_2011_Jun_21_60(6)_1770-1778.nxml.txt.nlp	21562078	SENT147	16	16	7	7	metformin	AMPK	PA450395	5563	0.965
NULL	JRSM_Cardiovasc_Dis_2012_Sep_24_1(6)_cvd_2012_012015.nxml.txt.nlp	24175073	SENT12	45	45	6	6	clopidogrel	P2Y12	PA449053	64805	0.965
NULL	Nat_Med_2010_Nov_24_16(11)_1299-1304.nxml.txt.nlp	20972434	SENT189	21	21	34	34	forskolin	VASP	PA146096022	7408	0.965
NULL	Indian_J_Pharmacol_2013_May-Jun_45(3)_274-277.nxml.txt.nlp	23833372	SENT2	0	0	27	27	colchicine	CA1	PA449092	759	0.965
NULL	Ann_Rheum_Dis_2014_Jul_1_73(7)_1405-1413.nxml.txt.nlp	23727633	SENT127	4	4	20	20	ethanol	p53	PA448073	7157	0.965
NULL	Clin_Sci_(Lond)_2012_Oct_1_123(Pt_8)_473-486.nxml.txt.nlp	22757958	SENT144	3	3	6	6	glucosamine	OGA	PA164747613	10724	0.965
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT9	5	5	31	31	curcumin	TRAIL	PA151958596	8743	0.965
NULL	Biomed_Res_Int_2013_Sep_9_2013_239354.nxml.txt.nlp	24089667	SENT29	0	0	18	18	gefitinib	EGFR	PA131301952	1956	0.965
NULL	Braz_J_Microbiol_2011_Dec_1_Oct-Dec_42(4)_1300-1307.nxml.txt.nlp	24031756	SENT114	9	9	14	14	fluconazole	CDR1	PA449653	1038	0.965
NULL	Breast_Cancer_Res_2007_Dec_17_9(6)_115.nxml.txt.nlp	18190722	SENT51	4	4	26	26	exemestane	aromatase	PA449563	1588	0.965
NULL	JAKSTAT_2013_Jan_1_2(1)_e22882.nxml.txt.nlp	24058788	SENT123	33	33	35	35	doxorubicin	EGFR	PA449412	1956	0.965
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_67-74.nxml.txt.nlp	17912637	SENT209	5	5	3	3	letrozole	aromatase	PA450196	1588	0.965
NULL	Br_J_Cancer_2010_Jan_5_102(1)_134-143.nxml.txt.nlp	19920829	SENT182	32	32	6	6	rituximab	IL-2	PA451261	3558	0.965
NULL	Breast_Cancer_Res_Treat_2014_Oct_22_148(2)_315-325.nxml.txt.nlp	25338319	SENT16	24	24	0	0	trastuzumab	HER2	PA451743	2064	0.965
NULL	Nat_Cell_Biol_2014_Mar_9_16(3)_245-254.nxml.txt.nlp	24509793	SENT14	17	17	5	5	lapatinib	HER2	PA152241907	2064	0.965
NULL	Diabetes_Care_2010_Jul_33(7)_1691-1692.nxml.txt.nlp	20587731	SENT30	24	24	5	5	liraglutide	GLP-1	PA165958364	100125288	0.965
NULL	Oncogene_2010_Sep_16_29(37)_5193-5203.nxml.txt.nlp	20581867	SENT236	5	5	12	12	gefitinib	ERBB3	PA131301952	2065	0.965
NULL	Arch_Drug_Inf_2009_Mar_2(1)_1-7.nxml.txt.nlp	19381337	SENT59	19	19	27	27	ritonavir	CYP3A	PA451260	1574	0.965
NULL	Adolesc_Health_Med_Ther_2013_Aug_27_4_79-87.nxml.txt.nlp	24600298	SENT35	27	27	4	4	raltegravir	UGT1A1		54658	0.965
NULL	Acta_Pharmacol_Sin_2013_Oct_7_34(10)_1349-1358.nxml.txt.nlp	23892274	SENT10	3	3	1	1	verapamil	P-gp	PA451868	5243	0.965
NULL	EMBO_Mol_Med_2013_Apr_25_5(4)_548-562.nxml.txt.nlp	23526803	SENT349	27	27	33	33	heparin	EGF	PA449855	1950	0.965
NULL	J_Cell_Biol_2002_Nov_25_159(4)_637-648.nxml.txt.nlp	12438416	SENT53	6	6	35	35	staurosporine	GM130	PA165109623	2801	0.965
NULL	Diabetes_Metab_J_2012_Oct_18_36(5)_336-344.nxml.txt.nlp	23130317	SENT92	2	2	9	9	metformin	B12	PA450395	7126;4709	0.965
NULL	J_Adv_Pract_Oncol_2012_Jan_1_Jan-Feb_3(1)_49-54.nxml.txt.nlp	25031928	SENT37	0	0	20	20	plerixafor	CXCR4	PA165958410	7852	0.965
NULL	Front_Cell_Neurosci_2013_Dec_6_7_245.nxml.txt.nlp	24367291	SENT54	6	6	26	26	naproxen	P2X3	PA450595	5024	0.965
NULL	Mol_Cancer_2010_Aug_23_9_222.nxml.txt.nlp	20731837	SENT206	18	18	14	14	gefitinib	ATM	PA131301952	472	0.965
NULL	Endocrinol_Metab_(Seoul)_2014_Sep_25_29(3)_388-393.nxml.txt.nlp	25309799	SENT84	1	1	18	18	sorafenib	AKT	PA7000	207	0.965
NULL	Breast_Cancer_Res_Treat_2007_Oct_27_105(Suppl_1)_19-29.nxml.txt.nlp	17333340	SENT25	4	4	2	2	letrozole	aromatase	PA450196	1588	0.965
NULL	Front_Endocrinol_(Lausanne)_2014_Oct_27_5_163.nxml.txt.nlp	25386163	SENT279	10	10	22	22	maprotiline	ghrelin	PA450322	51738	0.965
NULL	Biochemistry_2014_Mar_4_53(8)_1263-1274.nxml.txt.nlp	24450572	SENT64	1	1	13	13	trypsin	MCO	PA451806	4178	0.965
NULL	Braz_J_Med_Biol_Res_2013_Mar_15_46(3)_299-305.nxml.txt.nlp	23532269	SENT129	27	27	6	6	propofol	TLR4	PA451141	7099	0.965
NULL	Pharmaceuticals_(Basel)_2012_Aug_30_5(9)_890-898.nxml.txt.nlp	24280696	SENT80	25	25	23	23	vemurafenib	BRAF	PA165946873	673	0.965
NULL	J_Biomed_Biotechnol_2010_Jun_7_2010_150960.nxml.txt.nlp	20617134	SENT200	30	30	9	9	panitumumab	KRAS	PA162373091	3845	0.965
NULL	Endocrinology_2011_Feb_5_152(2)_405-413.nxml.txt.nlp	21209017	SENT200	6	6	15	15	l-glutamine	GLP-1	PA10090	100125288	0.965
NULL	Oncogene_2010_Sep_16_29(37)_5135-5145.nxml.txt.nlp	20622897	SENT103	11	11	4	4	cetuximab	STAT3	PA10040	6774	0.965
NULL	J_Biomed_Sci_2014_Feb_3_21(1)_10.nxml.txt.nlp	24490900	SENT257	27	27	12	12	alendronate	RANKL	PA448082	8600	0.965
NULL	ScientificWorldJournal_2014_May_19_2014_567148.nxml.txt.nlp	24971383	SENT159	5	5	20	20	doxorubicin	Bcl-2	PA449412	596	0.965
NULL	J_Cell_Biol_2002_Sep_16_158(6)_1133-1144.nxml.txt.nlp	12235127	SENT27	27	27	15	15	hyaluronan	CD44	PA165958431	960	0.965
NULL	Infect_Drug_Resist_2010_Oct_13_3_103-114.nxml.txt.nlp	21694899	SENT44	0	0	8	8	raltegravir	UGT1A1		54658	0.965
NULL	Breast_Cancer_Res_2009_Jun_23_11(Suppl_1)_S21.nxml.txt.nlp	NULL	SENT12	28	28	5	5	paclitaxel	SPARC	PA450761	6678	0.965
NULL	Lab_Anim_Res_2013_Jun_24_29(2)_84-95.nxml.txt.nlp	23825481	SENT211	11	11	1	1	nifedipine	INS-1	PA450631	2305	0.965
NULL	Breast_Cancer_Res_2005_Jul_20_7(5)_205-211.nxml.txt.nlp	16168139	SENT108	10	10	25	25	tamoxifen	HER2	PA451581	2064	0.965
NULL	Arthritis_Res_Ther_2011_Apr_27_13(2)_111.nxml.txt.nlp	21542890	SENT25	11	11	20	20	methotrexate	CD11c	PA450428	3687	0.965
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1013.nxml.txt.nlp	24457957	SENT27	46	46	14	14	cisplatin	NOXA	PA449014	5366	0.965
NULL	Indian_J_Endocrinol_Metab_2013_Jul-Aug_17(4)_568-579.nxml.txt.nlp	23961471	SENT98	9	9	0	0	vasopressin	ACTH	PA451858	5443	0.965
NULL	Acta_Pharmacol_Sin_2011_Jun_23_32(6)_765-780.nxml.txt.nlp	21602835	SENT103	23	23	4	4	diazoxide	SUR1	PA449285	6833	0.965
NULL	J_Cancer_2013_Nov_23_4(9)_736-754.nxml.txt.nlp	24312144	SENT90	0	0	14	14	afatinib	EGFR	PA165981154	1956	0.965
NULL	Onco_Targets_Ther_2014_Jun_11_7_969-983.nxml.txt.nlp	24959084	SENT115	11	11	4	4	voriconazole	CYP3A4	PA10233	1576	0.965
NULL	Cancers_(Basel)_2011_Aug_10_3(3)_3242-3278.nxml.txt.nlp	24212955	SENT642	5	5	0	0	gefitinib	HER2	PA131301952	2064	0.965
NULL	Curr_Neuropharmacol_2013_Sep_11(5)_521-534.nxml.txt.nlp	24403876	SENT436	31	31	12	12	methamphetamine	5-HT2A	PA450403	3356	0.965
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT173	11	11	18	18	nutlin-3	DR5		8795	0.965
NULL	Oncotarget_2013_Nov_7_4(12)_2550-2566.nxml.txt.nlp	24334291	SENT110	26	26	2	2	dasatinib	UCP2	PA162372878	7351	0.965
NULL	Mol_Cancer_2008_Mar_26_7_27.nxml.txt.nlp	18366759	SENT111	18	18	3	3	etoposide	p53	PA449552	7157	0.965
NULL	J_Lipid_Res_2013_May_54(5)_1275-1282.nxml.txt.nlp	23471027	SENT114	0	0	26	26	phenformin	AMPK	PA1000	5563	0.965
NULL	Breast_Cancer_Res_2011_Oct_12_13(5)_220.nxml.txt.nlp	22018398	SENT197	24	24	14	14	paclitaxel	STAT3	PA450761	6774	0.965
NULL	Diabetes_2011_Nov_17_60(11)_2810-2819.nxml.txt.nlp	21911750	SENT224	0	0	16	16	metformin	AMPK	PA450395	5563	0.965
NULL	Cancer_Med_2013_Oct_19_2(5)_646-653.nxml.txt.nlp	24403230	SENT182	16	16	9	9	cisplatin	JNK	PA449014	5599	0.965
NULL	J_Oncol_2013_Apr_29_2013_854121.nxml.txt.nlp	23737784	SENT116	1	1	33	33	lapatinib	PTEN	PA152241907	5728	0.965
NULL	Cancers_(Basel)_2010_Apr_9_2(2)_397-419.nxml.txt.nlp	24281076	SENT943	7	7	17	17	resveratrol	p53		7157	0.965
NULL	Nat_Commun_2014_Nov_25_5_5548.nxml.txt.nlp	25420520	SENT620	32	32	38	38	doxycycline	ERG	PA449415	2078	0.965
NULL	Nucleic_Acids_Res_2011_Dec_31_39(22)_9536-9548.nxml.txt.nlp	21880590	SENT229	16	16	34	34	etoposide	BRCA1	PA449552	672	0.965
NULL	J_Hematol_Oncol_2013_Oct_12_6_78.nxml.txt.nlp	24283803	SENT16	32	32	10	10	daunorubicin	p53	PA449212	7157	0.965
NULL	Cardiovasc_Res_2014_Mar_1_101(3)_513-521.nxml.txt.nlp	24323316	SENT134	9	9	4	4	maraviroc	CCL5	PA164768835	6352	0.965
NULL	Br_J_Cancer_2010_Sep_7_103(6)_765-771.nxml.txt.nlp	20700120	SENT82	35	35	5	5	tamoxifen	CYP2D6	PA451581	1565	0.965
NULL	Nat_Commun_2014_Nov_25_5_5582.nxml.txt.nlp	25420773	SENT650	16	16	9	9	erlotinib	PHD3	PA134687924	112399	0.965
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT240	14	14	4	4	pemetrexed	UNG	PA10810	7374	0.965
NULL	Breast_Cancer_Res_2012_Feb_14_14(1)_R30.nxml.txt.nlp	22333315	SENT242	17	17	23	23	celecoxib	CXCR3	PA448871	2833	0.965
NULL	Nucleic_Acids_Res_2005_Jun_8_33(10)_3283-3291.nxml.txt.nlp	15944449	SENT156	32	32	11	11	mechlorethamine	XRCC2	PA450336	7516	0.965
NULL	Oncogene_2014_Jul_17_33(29)_3784-3793.nxml.txt.nlp	24013225	SENT330	32	32	7	7	clodronate	EGF	PA10239	1950	0.965
NULL	Cardiovasc_Diabetol_2006_Sep_26_5_20.nxml.txt.nlp	17002798	SENT44	0	0	13	13	fenofibrate	CAD	PA449594	1677;790	0.965
NULL	Ann_Oncol_2014_Jun_31_25(6)_1116-1121.nxml.txt.nlp	24685829	SENT133	38	38	8	8	capecitabine	HER2	PA448771	2064	0.965
NULL	Biotechnol_Res_Int_2014_Jul_24_2014_319397.nxml.txt.nlp	25170426	SENT120	25	25	12	12	fluoxetine	mol	PA449673	90527	0.965
NULL	Breast_Cancer_Res_2011_Mar_11_13(2)_R30.nxml.txt.nlp	21396117	SENT270	13	13	31	31	erlotinib	EGFR	PA134687924	1956	0.965
NULL	Cell_Death_Dis_2014_Mar_13_5(3)_e1113.nxml.txt.nlp	24625972	SENT83	12	12	0	0	bleomycin	BI-1	PA448645	7009	0.965
NULL	Chem_Cent_J_2012_May_11_6_41.nxml.txt.nlp	22578215	SENT76	13	13	27	27	naringin	APT	PA151958360	653639	0.965
NULL	Indian_J_Med_Res_2013_Nov_138(5)_632-647.nxml.txt.nlp	24434318	SENT168	3	3	30	30	l-tryptophan	IFN	PA10323	3439	0.965
NULL	Open_Cardiovasc_Med_J_2010_Feb_23_4_71-77.nxml.txt.nlp	20360979	SENT40	21	21	5	5	thrombin	TFPI	PA451674	7035	0.965
NULL	J_Oncol_2010_Nov_19_2010_568938.nxml.txt.nlp	20037743	SENT211	16	16	25	25	erlotinib	EGFR	PA134687924	1956	0.965
NULL	Evid_Based_Complement_Alternat_Med_2004_Sep_1(2)_207-209.nxml.txt.nlp	15480447	SENT43	7	7	1	1	cisplatin	HER-2	PA449014	2064	0.965
NULL	Arthritis_Res_Ther_2006_Nov_1_8(6)_R166.nxml.txt.nlp	17078892	SENT373	12	12	22	22	etanercept	CD4	PA449515	920	0.965
NULL	Neural_Regen_Res_2014_May_15_9(10)_1055-1062.nxml.txt.nlp	25206759	SENT224	12	12	24	24	furosemide	NKCC1	PA449719	6558	0.965
NULL	J_Hematol_Oncol_2013_Oct_12_6_78.nxml.txt.nlp	24283803	SENT187	21	21	25	25	daunorubicin	STAT3	PA449212	6774	0.965
NULL	Biosci_Rep_2012_Aug_1_32(Pt_4)_361-374.nxml.txt.nlp	22762204	SENT164	35	35	3	3	irinotecan	BRCA1	PA450085	672	0.965
NULL	Biosci_Rep_2012_Dec_20_33(1)_e00011.nxml.txt.nlp	23137297	SENT149	24	24	7	7	heparin	RPSA	PA449855	3921	0.965
NULL	Indian_J_Dermatol_2010_Jan-Mar_55(1)_20-24.nxml.txt.nlp	20418971	SENT26	16	16	6	6	estradiol	aromatase	PA449503	1588	0.965
NULL	Curr_Biol_2012_Mar_6_22(5)_397-402.nxml.txt.nlp	22305751	SENT42	24	24	4	4	physostigmine	gamma	PA450957	9913	0.965
NULL	Arthritis_Res_Ther_2009_Feb_23_11(1)_216.nxml.txt.nlp	19291269	SENT158	32	32	18	18	anakinra	ACR	PA10799	49	0.965
NULL	South_Asian_J_Cancer_2014_Jul-Sep_3(3)_182-184.nxml.txt.nlp	25136528	SENT82	14	14	9	9	itraconazole	CYP3A4	PA450132	1576	0.965
NULL	J_Hematol_Oncol_2013_Jan_4_6_1.nxml.txt.nlp	23286345	SENT148	25	25	12	12	cetuximab	KRAS	PA10040	3845	0.965
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_23_2013_941093.nxml.txt.nlp	23864901	SENT299	21	21	26	26	omeprazole	CYP3A4	PA450704	1576	0.965
NULL	Ann_Rheum_Dis_2011_Oct_12_71(4)_541-548.nxml.txt.nlp	21994233	SENT157	35	35	1	1	infliximab	IMPACT	PA452639	55364	0.965
NULL	Case_Rep_Dermatol_2012_Sep_16_4(3)_256-260.nxml.txt.nlp	23275770	SENT61	0	0	6	6	pyridostigmine	Q10	PA451185	27161	0.965
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT220	22	22	5	5	chloroquine	BMPR-II	PA448948	659	0.965
NULL	Orphanet_J_Rare_Dis_2014_Dec_10_9(1)_201.nxml.txt.nlp	NULL	SENT162	28	28	8	8	ketamine	CMT1A	PA450144	1248	0.965
NULL	Arthritis_Res_Ther_2014_Jan_15_16(1)_R10.nxml.txt.nlp	24423138	SENT110	21	21	31	31	collagenase	TRPV1	PA449107	7442	0.965
NULL	Onco_Targets_Ther_2014_May_16_7_761-770.nxml.txt.nlp	24876785	SENT192	23	23	11	11	erlotinib	EGFR	PA134687924	1956	0.965
NULL	Breast_Cancer_Res_Treat_2013_Apr_12_138(2)_427-435.nxml.txt.nlp	23479422	SENT27	6	6	11	11	lapatinib	HER2	PA152241907	2064	0.965
NULL	Indian_J_Nephrol_2011_Jan-Mar_21(1)_56-58.nxml.txt.nlp	21655173	SENT87	2	2	7	7	rituximab	CHOP	PA451261	1649	0.965
NULL	Exp_Mol_Med_2012_Sep_30_44(9)_545-553.nxml.txt.nlp	22809901	SENT102	13	13	3	3	ciprofloxacin	CYP1A2	PA449009	1544	0.965
NULL	J_Neuroinflammation_2010_Sep_7_7_51.nxml.txt.nlp	20822529	SENT101	14	14	29	29	hemin	HO-2	PA449849	3163	0.965
NULL	Pharmaceutics_2011_Oct_12_3(4)_680-705.nxml.txt.nlp	24309303	SENT112	9	9	1	1	glibenclamide	P-gp	PA449782	5243	0.965
NULL	Br_J_Cancer_2012_Aug_7_107(4)_592-597.nxml.txt.nlp	22805325	SENT138	0	0	9	9	imatinib	CYP2C9	PA10804	1559	0.965
NULL	J_Breast_Cancer_2011_Mar_31_14(1)_20-27.nxml.txt.nlp	21847390	SENT196	18	18	4	4	estradiol	CLDN6	PA449503	9074	0.965
NULL	Case_Rep_Oncol_2013_Mar_29_6(1)_189-196.nxml.txt.nlp	23626560	SENT4	14	14	24	24	gefitinib	EGFR	PA131301952	1956	0.965
NULL	Oncotarget_2013_Nov_23_5(1)_196-210.nxml.txt.nlp	24344116	SENT190	24	24	7	7	doxorubicin	p65	PA449412	5970	0.965
NULL	Exp_Neurobiol_2013_Mar_31_22(1)_45-50.nxml.txt.nlp	23585722	SENT113	11	11	5	5	fluoxetine	EPO	PA449673	7076;8288;2056	0.965
NULL	Exp_Hematol_Oncol_2014_Jan_11_3_2.nxml.txt.nlp	24410791	SENT16	2	2	7	7	erlotinib	EGFR	PA134687924	1956	0.965
NULL	Mol_Cancer_2014_Jul_5_13_165.nxml.txt.nlp	24996221	SENT105	18	18	5	5	docetaxel	HMGB1	PA449383	3146	0.965
NULL	Hematol_Rep_2013_Apr_4_5(1)_21-25.nxml.txt.nlp	23888242	SENT104	0	0	17	17	amifostine	HCST	PA448365	10870	0.965
NULL	Mol_Cell_Endocrinol_2011_Mar_15_335(1)_2-13.nxml.txt.nlp	20398732	SENT1321	14	14	7	7	metformin	HSD1	PA450395	26871	0.965
NULL	Bioinform_Biol_Insights_2014_Apr_16_8_83-91.nxml.txt.nlp	24812497	SENT99	24	24	7	7	vanillin	FBA	PA451852	26273	0.965
NULL	Mol_Cancer_2014_Jan_15_13_8.nxml.txt.nlp	24423412	SENT101	11	11	0	0	cisplatin	CD44	PA449014	960	0.965
NULL	Braz_J_Med_Biol_Res_2012_Feb_17_45(3)_244-249.nxml.txt.nlp	22331137	SENT134	19	19	41	41	gentamicin	PAG	PA449753	55824	0.965
NULL	Acta_Pharmacol_Sin_2010_Jul_21_31(7)_855-860.nxml.txt.nlp	20562904	SENT12	15	15	38	38	fluconazole	CDR2	PA449653	1039	0.965
NULL	Breast_Cancer_Res_2008_Dec_18_10(Suppl_4)_S26.nxml.txt.nlp	19128440	SENT14	19	19	43	43	tamoxifen	ATAC	PA451581	6375	0.965
NULL	Acta_Pharmacol_Sin_2009_Oct_21_30(10)_1392-1398.nxml.txt.nlp	19767766	SENT128	0	0	34	34	atorvastatin	p22	PA448500	11331;11261;1778	0.965
NULL	Breast_Cancer_Res_2005_Jan_26_7(2)_R256-R266.nxml.txt.nlp	15743506	SENT29	36	36	22	22	cyclophosphamide	HER-2	PA449165	2064	0.965
NULL	Evid_Based_Complement_Alternat_Med_2011_Feb_20_2011_541209.nxml.txt.nlp	21799681	SENT85	4	4	29	29	curcumin	p34	PA151958596	902;79719	0.965
NULL	Br_J_Clin_Pharmacol_2013_Aug_23_76(2)_299-315.nxml.txt.nlp	23701319	SENT230	14	14	5	5	alemtuzumab	IL-2	PA164783958	3558	0.965
NULL	Biomed_Res_Int_2014_Jun_25_2014_203693.nxml.txt.nlp	25089265	SENT112	24	24	0	0	erlotinib	EGFR	PA134687924	1956	0.965
NULL	Onco_Targets_Ther_2014_Sep_18_7_1625-1630.nxml.txt.nlp	25258543	SENT99	16	16	3	3	paclitaxel	PVT1	PA450761	5820	0.965
NULL	Exp_Ther_Med_2014_Nov_29_8(5)_1473-1478.nxml.txt.nlp	25289044	SENT178	24	24	37	37	heparin	AZU	PA449855	566	0.965
NULL	Nucl_Recept_Signal_2009_Jan_16_7_e001.nxml.txt.nlp	19240808	SENT410	35	35	8	8	cisplatin	SXR	PA449014	8856	0.965
NULL	Clin_Dev_Immunol_2011_Dec_26_2011_890758.nxml.txt.nlp	22235224	SENT332	23	23	3	3	cetuximab	EGFR	PA10040	1956	0.965
NULL	Clin_Pharmacokinet_2014_Sep_3_53(1)_1-16.nxml.txt.nlp	23999929	SENT342	26	26	7	7	rivaroxaban	P-gp	PA165958360	5243	0.965
NULL	Br_J_Cancer_2010_Jul_13_103(2)_265-274.nxml.txt.nlp	20551953	SENT210	9	9	4	4	cisplatin	DUSP16	PA449014	80824	0.965
NULL	J_Cancer_2013_Sep_10_4(8)_614-625.nxml.txt.nlp	24155773	SENT207	33	33	15	15	doxorubicin	CRM1	PA449412	7514	0.965
NULL	EPMA_J_2010_Sep_20_1(3)_421-437.nxml.txt.nlp	23199086	SENT228	29	29	12	12	cyclophosphamide	MTSS1	PA449165	9788	0.965
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Jul_23_3(7)_e126.nxml.txt.nlp	25054314	SENT60	13	13	18	18	docetaxel	OATP1B3	PA449383	28234	0.965
NULL	Cancer_Med_2014_Dec_13_3(6)_1579-1594.nxml.txt.nlp	25124282	SENT233	14	14	28	28	cisplatin	DNA-PKcs	PA449014	5591	0.965
NULL	Endocr_Relat_Cancer_2014_Apr_21(2)_175-187.nxml.txt.nlp	24280133	SENT280	36	36	7	7	doxycycline	SOCS2	PA449415	8835	0.965
NULL	Biosci_Rep_2012_Dec_20_33(1)_e00011.nxml.txt.nlp	23137297	SENT251	12	12	28	28	heparin	RPSA	PA449855	3921	0.965
NULL	Br_J_Haematol_2014_Mar_13_164(1)_811-821.nxml.txt.nlp	24328678	SENT220	4	4	19	19	lenalidomide	IL2	PA162363968	3558	0.965
NULL	Oncotarget_2013_Jul_18_4(10)_1582-1591.nxml.txt.nlp	24123600	SENT139	33	33	6	6	imatinib	SLC22A1	PA10804	6580	0.965
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT86	28	28	10	10	cisplatin	ERCC1	PA449014	2067	0.965
NULL	Mol_Cancer_2006_Oct_17_5_45.nxml.txt.nlp	17044934	SENT154	7	7	12	12	resveratrol	COX		1351	0.965
NULL	JAKSTAT_2013_Jan_1_2(1)_e22925.nxml.txt.nlp	24058789	SENT107	17	17	3	3	carbachol	JAK2	PA448784	3717	0.965
NULL	J_Carcinog_2011_Dec_8_10_32.nxml.txt.nlp	22279417	SENT117	40	40	2	2	trastuzumab	EPO	PA451743	7076;8288;2056	0.965
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_May_12_66(Pt_6)_o1324-o1325.nxml.txt.nlp	21579416	SENT66	43	43	6	6	ethanol	mol	PA448073	90527	0.965
NULL	Chemother_Res_Pract_2012_Dec_20_2012_743193.nxml.txt.nlp	23320171	SENT51	6	6	19	19	trastuzumab	HER2	PA451743	2064	0.965
NULL	J_Inflamm_(Lond)_2006_May_4_3_8.nxml.txt.nlp	16674821	SENT134	5	5	11	11	pp2	SKI-1		8720	0.965
NULL	J_Thromb_Thrombolysis_2013_Jul_17_36(1)_31-41.nxml.txt.nlp	23073747	SENT158	16	16	10	10	abciximab	ADP	PA448006	23038	0.965
NULL	Acta_Orthop_2010_Dec_26_81(6)_748-755.nxml.txt.nlp	21067431	SENT146	27	27	3	3	sc-560	COX		1351	0.965
NULL	Ann_Med_2014_Nov_21_46(7)_475-489.nxml.txt.nlp	25045928	SENT452	15	15	7	7	ticagrelor	CYP2C19	PA165374673	1557	0.965
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT273	27	27	7	7	lapatinib	HRG	PA152241907	3084;3273	0.965
NULL	Exp_Hematol_2012_Feb_40(2)_97-106.nxml.txt.nlp	22085453	SENT142	12	12	3	3	sitagliptin	DPPIV	PA164748978	2191;1803	0.965
NULL	J_Cell_Biol_2005_Nov_21_171(4)_729-738.nxml.txt.nlp	16286510	SENT160	14	14	8	8	heparin	MMP7	PA449855	4316	0.965
NULL	Lab_Invest_2013_Aug_3_93(8)_868-879.nxml.txt.nlp	23732814	SENT233	24	24	14	14	hemin	HO-1	PA449849	3162	0.965
NULL	Breast_Cancer_Res_2008_Dec_18_10(Suppl_4)_S20.nxml.txt.nlp	19128434	SENT20	31	31	41	41	exemestane	aromatase	PA449563	1588	0.965
NULL	FEBS_Open_Bio_2014_Sep_6_4_777-787.nxml.txt.nlp	25349782	SENT142	29	29	0	0	napqi	RIPK3		11035	0.965
NULL	Biosci_Rep_2012_Aug_1_32(Pt_4)_361-374.nxml.txt.nlp	22762204	SENT116	8	8	33	33	melphalan	p16INK4a	PA450354	1029	0.965
NULL	Int_J_Mol_Sci_2014_Sep_30_15(10)_17686-17704.nxml.txt.nlp	25272226	SENT73	5	5	7	7	cetuximab	EGFR	PA10040	1956	0.965
NULL	Mol_Cancer_2007_Sep_26_6_61.nxml.txt.nlp	17894897	SENT193	26	26	5	5	etoposide	BIRC5	PA449552	332	0.965
NULL	Eur_J_Pediatr_2012_Sep_29_171(9)_1339-1348.nxml.txt.nlp	22543566	SENT103	18	18	7	7	icatibant	C1-INH	PA164749185	710	0.965
NULL	Oncol_Lett_2013_Mar_11_5(3)_1010-1016.nxml.txt.nlp	23426784	SENT126	15	15	4	4	midazolam	TRPM7	PA450496	54822	0.965
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT61	27	27	2	2	neratinib	HER2	PA165291472	2064	0.965
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT331	17	17	0	0	cisplatin	IBP	PA449014	706;50619	0.965
NULL	Cell_Death_Dis_2010_Oct_21_1(10)_e86.nxml.txt.nlp	21368859	SENT216	25	25	10	10	doxorubicin	JNK	PA449412	5599	0.965
NULL	J_Biol_Chem_2009_Jan_2_284(1)_77-84.nxml.txt.nlp	18854318	SENT162	42	42	19	19	forskolin	BRSK1	PA146096022	84446	0.965
NULL	J_Cell_Mol_Med_2013_Jan_10_17(1)_30-54.nxml.txt.nlp	23301832	SENT307	21	21	28	28	gemcitabine	HIF-1	PA449748	29072	0.965
NULL	Exp_Hematol_Oncol_2013_Aug_8_2_21.nxml.txt.nlp	23927414	SENT94	12	12	16	16	enoxaparin	HARE	PA449463	55576	0.965
NULL	Crit_Care_2008_Jul_2_12(4)_163.nxml.txt.nlp	18620550	SENT10	17	17	32	32	hydrocortisone	RAI	PA449905	10848;6050	0.965
NULL	Breast_Cancer_Res_2011_Jan_24_13(1)_401.nxml.txt.nlp	21349137	SENT15	9	9	16	16	lapatinib	AMPK	PA152241907	5563	0.965
NULL	Breast_Cancer_Res_2009_Jun_23_11(3)_R39.nxml.txt.nlp	19549321	SENT153	35	35	9	9	vincristine	CK19	PA451879	3880	0.965
NULL	Oncotarget_2013_Nov_24_4(12)_2430-2438.nxml.txt.nlp	24280348	SENT1	30	30	7	7	gefitinib	EGFR	PA131301952	1956	0.965
NULL	J_Cardiothorac_Surg_2014_Dec_18_9(1)_196.nxml.txt.nlp	NULL	SENT92	7	7	23	23	heparin	ACT	PA449855	12;11332;9457;641455	0.965
NULL	Clin_Ophthalmol_2011_Dec_30_5_23-25.nxml.txt.nlp	21311653	SENT46	10	10	20	20	tocilizumab	IL-6	PA165292659	3569	0.965
NULL	Breast_Cancer_Res_2013_Nov_29_15(6)_R114.nxml.txt.nlp	24289103	SENT299	19	19	10	10	tamoxifen	EGFR	PA451581	1956	0.965
NULL	Oncotarget_2012_Oct_20_3(10)_1068-1111.nxml.txt.nlp	23085539	SENT122	0	0	32	32	sorafenib	BRAF	PA7000	673	0.965
NULL	Cell_Commun_Signal_2013_Oct_1_11_73.nxml.txt.nlp	24083678	SENT126	22	22	9	9	sulindac	ICAM1	PA451565	3383	0.965
NULL	Cancer_Cell_Int_2011_Aug_19_11_29.nxml.txt.nlp	21854619	SENT28	14	14	2	2	platinum	BRCA1	PA150595617	672	0.965
NULL	Arthritis_Res_Ther_2014_Apr_3_16(2)_R86.nxml.txt.nlp	24708674	SENT246	25	25	8	8	bosentan	Fli1	PA10034	2314	0.965
NULL	Nat_Commun_2014_Dec_8_5_5736.nxml.txt.nlp	25484020	SENT245	16	16	34	34	letrozole	mol	PA450196	90527	0.965
NULL	J_Cardiothorac_Surg_2013_Apr_2_8_59.nxml.txt.nlp	23547910	SENT61	14	14	28	28	heparin	ACT	PA449855	12;11332;9457;641455	0.965
NULL	Nucl_Recept_Signal_2009_Jan_16_7_e001.nxml.txt.nlp	19240808	SENT412	0	0	22	22	paclitaxel	MDR1	PA450761	5243	0.965
NULL	Indian_J_Pharmacol_2008_Oct_40(Suppl_2)_S178-S211.nxml.txt.nlp	21593974	SENT293	1	1	12	12	metformin	NAC	PA450395	22861	0.965
NULL	Ann_Surg_Treat_Res_2014_Feb_22_86(2)_68-75.nxml.txt.nlp	24761411	SENT231	14	14	6	6	oxaliplatin	Bcl-2	PA131285527	596	0.965
NULL	Int_J_Endocrinol_2014_Jun_25_2014_534904.nxml.txt.nlp	25053942	SENT91	15	15	24	24	amiodarone	AIT	PA448383	160728	0.965
NULL	Pharmaceuticals_(Basel)_2013_Apr_17_6(4)_557-578.nxml.txt.nlp	24276125	SENT57	0	0	26	26	ustekinumab	IL-23	PA166048654	51561	0.965
NULL	Adv_Hematol_2012_Feb_12_2012_701704.nxml.txt.nlp	22400032	SENT111	1	1	31	31	rituximab	TLR9	PA451261	54106	0.965
NULL	Mol_Cancer_2014_Aug_16_13(1)_193.nxml.txt.nlp	NULL	SENT108	7	7	0	0	cisplatin	RKIP	PA449014	5037	0.965
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1137-1144.nxml.txt.nlp	20234366	SENT188	21	21	12	12	cetuximab	MKP-1	PA10040	1843	0.965
NULL	Biol_Open_2014_Sep_12_3(10)_937-946.nxml.txt.nlp	25217618	SENT181	20	20	13	13	niclosamide	DKK1	PA165958408	22943	0.965
NULL	Int_J_Mol_Sci_2014_Nov_7_15(11)_20500-20517.nxml.txt.nlp	25387078	SENT125	23	23	40	40	vorinostat	c-FLIP	PA164748224	8837	0.965
NULL	Hum_Genomics_2009_Dec_1_4(2)_91-106.nxml.txt.nlp	20038497	SENT183	9	9	26	26	donepezil	CYP2D6	PA449394	1565	0.965
NULL	J_Hum_Genet_2013_Jun_16_58(6)_353-361.nxml.txt.nlp	23677058	SENT120	18	18	0	0	etoposide	ABCC3	PA449552	8714	0.965
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT10	6	6	18	18	gefitinib	AKT	PA131301952	207	0.965
NULL	Front_Aging_Neurosci_2010_Feb_3_2_2.nxml.txt.nlp	20552042	SENT130	2	2	30	30	isoproterenol	CA1	PA450121	759	0.965
NULL	Br_J_Cancer_2012_Nov_6_107(10)_1714-1721.nxml.txt.nlp	23073173	SENT157	18	18	13	13	docetaxel	RUNX2	PA449383	860	0.965
NULL	Sci_Rep_2014_Dec_12_4_7467.nxml.txt.nlp	25502280	SENT101	5	5	13	13	taurine	spatial	PA451590	219793	0.965
NULL	Breast_Cancer_Res_Treat_2014_Nov_24_143(1)_125-133.nxml.txt.nlp	24272078	SENT8	6	6	31	31	exemestane	aromatase	PA449563	1588	0.965
NULL	Exp_Ther_Med_2015_Feb_8_9(2)_341-344.nxml.txt.nlp	25574195	SENT86	16	16	2	2	hydroquinone	OTC	PA449924	5009	0.965
NULL	Br_J_Cancer_2014_Jan_21_110(2)_384-391.nxml.txt.nlp	24346286	SENT133	17	17	7	7	trastuzumab	HER3	PA451743	2065	0.965
NULL	J_Oncol_2013_Aug_20_2013_732047.nxml.txt.nlp	24027583	SENT170	4	4	18	18	bevacizumab	HER2	PA130232992	2064	0.965
NULL	Br_J_Cancer_2013_Mar_19_108(5)_997-1003.nxml.txt.nlp	23385734	SENT146	6	6	16	16	tocilizumab	IL-6	PA165292659	3569	0.965
NULL	Cells_2014_Jun_11_3(2)_616-626.nxml.txt.nlp	24921186	SENT63	10	10	25	25	capsaicin	TRPV1	PA448776	7442	0.965
NULL	Oncoimmunology_2012_Nov_1_1(8)_1422-1424.nxml.txt.nlp	23243615	SENT22	19	19	12	12	letrozole	aromatase	PA450196	1588	0.965
NULL	Ann_Oncol_2011_Mar_8_22(3)_503-514.nxml.txt.nlp	20616198	SENT210	6	6	21	21	anastrozole	aromatase	PA448432	1588	0.965
NULL	Crit_Care_2008_Mar_13_12(Suppl_2)_P262.nxml.txt.nlp	NULL	SENT18	6	6	37	37	dobutamine	PAWP	PA449381	164684	0.965
NULL	Acta_Pharmacol_Sin_2010_May_12_31(5)_531-539.nxml.txt.nlp	20383168	SENT98	13	13	4	4	trypsin	F12	PA451806	2161	0.965
NULL	Breast_Cancer_Res_2007_Feb_6_9(1)_R17.nxml.txt.nlp	17280616	SENT28	10	10	2	2	trastuzumab	aromatase	PA451743	1588	0.965
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT221	16	16	27	27	capsaicin	p53	PA448776	7157	0.965
NULL	Cancers_(Basel)_2011_Aug_5_3(3)_3114-3142.nxml.txt.nlp	24212948	SENT144	23	23	2	2	cetuximab	GEM	PA10040	2669	0.965
NULL	J_Immunother_Cancer_2013_May_29_1_4.nxml.txt.nlp	NULL	SENT280	3	3	15	15	imatinib	B7-H6	PA10804	374383	0.965
NULL	J_Biomed_Biotechnol_2010_Jun_7_2010_150960.nxml.txt.nlp	20617134	SENT224	21	21	14	14	cisplatin	KRAS	PA449014	3845	0.965
NULL	Mol_Vis_2012_Apr_11_18_901-908.nxml.txt.nlp	22539869	SENT156	6	6	2	2	curcumin	p38	PA151958596	10598;1432;7965	0.965
NULL	Cardiol_Res_Pract_2011_Jul_2_2011_615087.nxml.txt.nlp	21747989	SENT79	5	5	11	11	heparin	ACT	PA449855	12;11332;9457;641455	0.965
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT147	12	12	23	23	sitagliptin	HIP	PA164748978	6767;6159;64399;5068	0.965
NULL	J_Aging_Res_2012_Jul_19_2012_194821.nxml.txt.nlp	22888430	SENT313	3	3	12	12	resveratrol	SIRT1		23411	0.965
NULL	Pharmaceuticals_(Basel)_2013_Aug_2_6(8)_915-928.nxml.txt.nlp	24276376	SENT186	18	18	26	26	aspirin	PAR-1	PA448497	2011;2149	0.965
NULL	Front_Aging_Neurosci_2014_Sep_22_6_246.nxml.txt.nlp	25295003	SENT1433	11	11	0	0	resveratrol	SIRT1		23411	0.965
NULL	J_Int_Soc_Sports_Nutr_2012_Jun_12_9_25.nxml.txt.nlp	22691230	SENT118	6	6	20	20	creatine	ANOVA	PA164778930	4858	0.965
NULL	Arthritis_Res_Ther_2003_Feb_24_5(Suppl_1)_47.nxml.txt.nlp	NULL	SENT15	14	14	4	4	methotrexate	IFN	PA450428	3439	0.965
NULL	Int_J_Cell_Biol_2013_Mar_19_2013_834684.nxml.txt.nlp	23573093	SENT82	21	21	12	12	metformin	aromatase	PA450395	1588	0.965
NULL	Thorax_2012_Mar_28_67(3)_229-237.nxml.txt.nlp	21957094	SENT92	0	0	39	39	carbachol	ACL	PA448784	47	0.965
NULL	Nat_Commun_2013_Aug_15_4_2130.nxml.txt.nlp	23945651	SENT42	13	13	3	3	cisplatin	ATG5	PA449014	9474	0.965
NULL	Clin_Mol_Hepatol_2014_Sep_25_20(3)_283-290.nxml.txt.nlp	25320732	SENT115	12	12	4	4	propranolol	EVL	PA451145	51466	0.965
NULL	Patient_Prefer_Adherence_2011_Dec_23_6_1-9.nxml.txt.nlp	22272064	SENT3	6	6	26	26	telmisartan	ACE	PA451605	1636	0.965
NULL	Oncotarget_2013_Nov_22_5(4)_933-943.nxml.txt.nlp	24659749	SENT107	14	14	6	6	nutlin-3	AML2		864	0.965
NULL	ScientificWorldJournal_2012_Jul_31_2012_475675.nxml.txt.nlp	22919323	SENT56	19	19	8	8	capsaicin	AMPK	PA448776	5563	0.965
NULL	Mol_Cancer_2009_Nov_10_8_99.nxml.txt.nlp	19903356	SENT112	35	35	26	26	imatinib	IGFBP3	PA10804	3486	0.965
NULL	Spermatogenesis_2013_Apr_1_3(2)_e24194.nxml.txt.nlp	23885303	SENT117	9	9	47	47	staurosporine	PARP	PA165109623	142	0.965
NULL	Cell_Death_Dis_2012_Jun_7_3(6)_e319.nxml.txt.nlp	22673193	SENT8	8	8	20	20	cisplatin	Mcl-1	PA449014	4170	0.965
NULL	Front_Oncol_2013_Aug_12_3_189.nxml.txt.nlp	23964346	SENT11	35	35	24	24	vemurafenib	BRAF	PA165946873	673	0.965
NULL	J_Biol_Chem_2013_Feb_8_288(6)_3918-3928.nxml.txt.nlp	23239877	SENT23	0	0	17	17	thrombin	PAR4	PA451674	9002;5074	0.965
NULL	Clin_Sarcoma_Res_2014_Sep_24_4_13.nxml.txt.nlp	25276340	SENT8	23	23	4	4	pazopanib	FDG	PA165291492	23583	0.965
NULL	AIDS_Res_Treat_2012_Mar_21_2012_186987.nxml.txt.nlp	22536495	SENT184	11	11	1	1	darunavir	TYPE	PA163522472	6445	0.965
NULL	Oncoscience_2014_Jan_30_1(1)_57-68.nxml.txt.nlp	25593988	SENT215	15	15	33	33	imatinib	c-FLIP	PA10804	8837	0.965
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1044.nxml.txt.nlp	24503536	SENT133	15	15	3	3	cisplatin	XIAP	PA449014	331	0.965
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1046.nxml.txt.nlp	24503538	SENT83	20	20	5	5	doxorubicin	FGFR4	PA449412	2264	0.965
NULL	Behav_Brain_Funct_2014_Jun_16_10_21.nxml.txt.nlp	24934302	SENT8	22	22	10	10	rosiglitazone	gamma	PA451283	9913	0.965
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT190	0	0	8	8	pp2	STZ		6484	0.965
NULL	J_Biol_Chem_2012_Apr_27_287(18)_14644-14658.nxml.txt.nlp	22375002	SENT366	14	14	20	20	forskolin	CC2D1A	PA146096022	54862	0.965
NULL	J_Exp_Clin_Cancer_Res_2009_Nov_24_28(1)_144.nxml.txt.nlp	19930704	SENT121	22	22	3	3	doxorubicin	P-gp	PA449412	5243	0.965
NULL	Oncogene_2009_Dec_3_28(48)_4237-4248.nxml.txt.nlp	19734937	SENT130	0	0	20	20	thrombin	PAR-1	PA451674	2011;2149	0.965
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1137-1144.nxml.txt.nlp	20234366	SENT134	32	32	6	6	cetuximab	MKP-1	PA10040	1843	0.965
NULL	Cancer_Cell_Int_2005_Jul_24_5_22.nxml.txt.nlp	16042792	SENT30	19	19	38	38	vincristine	MRP1	PA451879	4437	0.965
NULL	Int_Semin_Surg_Oncol_2006_Sep_14_3_29.nxml.txt.nlp	16972993	SENT190	21	21	3	3	tamoxifen	aromatase	PA451581	1588	0.965
NULL	Cancer_Manag_Res_2012_Jul_26_4_195-205.nxml.txt.nlp	22904641	SENT12	9	9	24	24	amiloride	NHE	PA448368	285335	0.965
NULL	EMBO_Mol_Med_2013_Aug_1_5(8)_1196-1212.nxml.txt.nlp	23818228	SENT327	8	8	31	31	isoflurane	hole	PA450106	80757	0.965
NULL	Clin_Med_Oncol_2008_Feb_9_2_47-61.nxml.txt.nlp	21892266	SENT257	15	15	38	38	chloroquine	EGFR	PA448948	1956	0.965
NULL	Mol_Cancer_2008_Jan_25_7_14.nxml.txt.nlp	18221502	SENT159	19	19	3	3	oxaliplatin	PSAT1	PA131285527	29968	0.965
NULL	Aging_Cell_2009_Apr_8(2)_113-127.nxml.txt.nlp	19239417	SENT113	27	27	19	19	resveratrol	AMPK		5563	0.965
NULL	Acta_Crystallogr_Sect_F_Struct_Biol_Cryst_Commun_2010_Jul_31_66(Pt_10)_1317-1325.nxml.txt.nlp	20944228	SENT23	32	32	5	5	l-tyrosine	PDH	PA451822	54704	0.965
NULL	J_Cell_Sci_2012_May_15_125(10)_2446-2456.nxml.txt.nlp	22357953	SENT97	34	34	8	8	l-methionine	G3BP2	PA450423	9908	0.965
NULL	Support_Care_Cancer_2009_Sep_10_17(9)_1177-1185.nxml.txt.nlp	19205755	SENT26	16	16	7	7	ondansetron	NK-1	PA450705	27087	0.965
NULL	Oncol_Rep_2013_Jan_26_29(1)_297-305.nxml.txt.nlp	23129017	SENT77	27	27	16	16	doxycycline	TR2	PA449415	80834;114112;8764	0.965
NULL	Clin_Exp_Otorhinolaryngol_2011_Jun_31_4(2)_77-82.nxml.txt.nlp	21716954	SENT40	12	12	25	25	gentamicin	p38	PA449753	10598;1432;7965	0.965
NULL	N_Am_J_Med_Sci_2011_Apr_3(4)_167-175.nxml.txt.nlp	22540086	SENT199	6	6	12	12	erlotinib	EGFR	PA134687924	1956	0.965
NULL	Exp_Hematol_Oncol_2013_Dec_6_2_32.nxml.txt.nlp	24314093	SENT108	30	30	2	2	everolimus	NNT	PA164746311	23530	0.965
NULL	Cancer_Cell_Int_2013_Mar_4_13_21.nxml.txt.nlp	23497288	SENT14	20	20	33	33	doxorubicin	p53	PA449412	7157	0.965
NULL	J_Anaesthesiol_Clin_Pharmacol_2012_Oct-Dec_28(4)_444-450.nxml.txt.nlp	23225921	SENT169	10	10	0	0	prilocaine	Met	PA451101	79811	0.965
NULL	Springerplus_2014_Sep_11_3_516.nxml.txt.nlp	25279308	SENT33	43	43	4	4	ethanol	SHF	PA448073	90525	0.965
NULL	Anal_Bioanal_Chem_2010_Oct_22_398(4)_1771-1780.nxml.txt.nlp	20730527	SENT127	8	8	18	18	celecoxib	p38	PA448871	10598;1432;7965	0.965
NULL	J_Adv_Pharm_Technol_Res_2014_Oct-Dec_5(4)_185-190.nxml.txt.nlp	25364697	SENT16	14	14	22	22	metoprolol	CYP2D6	PA450480	1565	0.965
NULL	Front_Oncol_2014_Mar_3_4_34.nxml.txt.nlp	24624361	SENT220	27	27	10	10	flavopiridol	CDK2	PA452627	1017	0.965
NULL	Exp_Ther_Med_2014_Apr_7_7(4)_827-834.nxml.txt.nlp	24660031	SENT243	23	23	0	0	mitomycin	CD4	PA450524	920	0.965
NULL	EMBO_Mol_Med_2011_May_3(5)_258-265.nxml.txt.nlp	21425469	SENT4	2	2	21	21	creatine	DMD	PA164778930	1756	0.965
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1449-1456.nxml.txt.nlp	24077631	SENT120	30	30	5	5	tolbutamide	CYP2C9	PA451718	1559	0.965
NULL	Cell_Death_Differ_2010_Apr_16_17(4)_666-676.nxml.txt.nlp	19834494	SENT56	31	31	3	3	gemcitabine	RAGE	PA449748	177	0.965
NULL	Ther_Clin_Risk_Manag_2006_Mar_2(1)_87-98.nxml.txt.nlp	18360584	SENT153	4	4	28	28	sorafenib	RDT	PA7000	6598	0.965
NULL	Oncotarget_2012_May_29_3(5)_581-585.nxml.txt.nlp	22653910	SENT50	10	10	38	38	genistein	P-gp	PA165109660	5243	0.965
NULL	Breast_Cancer_Res_2007_Dec_8_9(6)_R85.nxml.txt.nlp	18067675	SENT225	9	9	45	45	vasopressin	RGS2	PA451858	5997	0.965
NULL	Oncogene_2014_Feb_6_33(6)_734-744.nxml.txt.nlp	23376847	SENT116	28	28	1	1	tetracycline	SUV39H1	PA451640	6839	0.965
NULL	Ann_Indian_Acad_Neurol_2009_Oct-Dec_12(4)_273-282.nxml.txt.nlp	20182575	SENT291	0	0	11	11	methotrexate	CXCR3	PA450428	2833	0.965
NULL	J_Obes_2011_Sep_19_2011_984245.nxml.txt.nlp	20885921	SENT145	3	3	14	14	exenatide	GLP-1	PA164749238	100125288	0.965
NULL	Cell_Death_Dis_2014_Apr_17_5(4)_e1188.nxml.txt.nlp	24743743	SENT344	13	13	7	7	dantrolene	IRE1	PA449208	2081	0.965
NULL	Oncotarget_2011_Sep_9_2(9)_658-668.nxml.txt.nlp	21911919	SENT5	33	33	4	4	daunorubicin	HO-1	PA449212	3162	0.965
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_91-103.nxml.txt.nlp	17912639	SENT101	0	0	5	5	letrozole	HER2	PA450196	2064	0.965
NULL	Target_Oncol_2013_Jun_27_8(2)_127-136.nxml.txt.nlp	23625191	SENT19	22	22	4	4	bevacizumab	KRAS	PA130232992	3845	0.965
NULL	Br_J_Cancer_2013_May_28_108(10)_2039-2044.nxml.txt.nlp	23652306	SENT77	40	40	2	2	carboplatin	SRC3	PA448803	8202	0.965
NULL	FEBS_Open_Bio_2012_Jul_20_2_179-186.nxml.txt.nlp	23650597	SENT102	11	11	3	3	imiquimod	MxA	PA449972	4599	0.965
NULL	J_Biomed_Biotechnol_2010_Jun_7_2010_150960.nxml.txt.nlp	20617134	SENT218	26	26	5	5	panitumumab	KRAS	PA162373091	3845	0.965
NULL	Crit_Care_2010_Apr_19_14(2)_R70.nxml.txt.nlp	20403177	SENT312	28	28	34	34	thrombin	cPLA2	PA451674	10524	0.965
NULL	J_Cell_Biol_2005_May_23_169(4)_681-691.nxml.txt.nlp	15911882	SENT61	6	6	19	19	heparin	MMP9	PA449855	4318	0.965
NULL	Cells_2014_Apr_4_3(2)_199-235.nxml.txt.nlp	24709958	SENT331	16	16	3	3	cetuximab	EGFR	PA10040	1956	0.965
NULL	Mucosal_Immunol_2014_Mar_24_7(2)_335-347.nxml.txt.nlp	23881354	SENT335	5	5	15	15	galantamine	CD11c	PA449726	3687	0.965
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT135	28	28	14	14	metformin	AMPK	PA450395	5563	0.965
NULL	J_Oncol_2009_Jun_22_2009_849051.nxml.txt.nlp	19584908	SENT31	0	0	14	14	panitumumab	EGFR	PA162373091	1956	0.965
NULL	Arthritis_Res_Ther_2004_Feb_24_6(Suppl_1)_24.nxml.txt.nlp	NULL	SENT15	12	12	4	4	infliximab	OPGL	PA452639	8600	0.965
NULL	Br_J_Cancer_2012_Jan_3_106(1)_107-115.nxml.txt.nlp	22116303	SENT39	0	0	4	4	cisplatin	DBL	PA449014	4168	0.965
NULL	Front_Oncol_2014_Mar_3_4_34.nxml.txt.nlp	24624361	SENT260	19	19	7	7	olaparib	PI3K		5290	0.965
NULL	BMB_Rep_2014_May_47(5)_292-297.nxml.txt.nlp	24286321	SENT61	13	13	3	3	ranibizumab	Rpn2	PA164746012	5707	0.965
NULL	Adv_Hematol_2009_Jun_22_2009_251915.nxml.txt.nlp	19946423	SENT8	29	29	4	4	hemin	HRI	PA449849	27102	0.965
NULL	Acta_Pharmacol_Sin_2009_Sep_24_30(9)_1262-1275.nxml.txt.nlp	19701231	SENT229	24	24	14	14	lovastatin	MAD2L1	PA450272	4085	0.965
NULL	Clin_Exp_Gastroenterol_2012_May_14_5_49-59.nxml.txt.nlp	22649281	SENT75	0	0	18	18	esomeprazole	CYP2C19	PA10075	1557	0.965
NULL	Comp_Hepatol_2005_Feb_8_4_2.nxml.txt.nlp	15701172	SENT76	12	12	3	3	ketoconazole	CYP3A	PA450146	1574	0.965
NULL	Arthritis_Res_Ther_2010_Apr_29_12(2)_R73.nxml.txt.nlp	20429888	SENT252	25	25	21	21	bortezomib	COL1A2	PA10252	1278	0.965
NULL	Apoptosis_2012_Sep_30_17(9)_989-997.nxml.txt.nlp	22460505	SENT150	3	3	20	20	thioridazine	PI3K	PA451666	5290	0.965
NULL	Curr_Oncol_2006_Feb_13(1)_8-13.nxml.txt.nlp	17576436	SENT115	2	2	31	31	trastuzumab	aromatase	PA451743	1588	0.965
NULL	Curr_Neuropharmacol_2007_Dec_5(4)_232-243.nxml.txt.nlp	19305740	SENT73	17	17	23	23	naproxen	COX	PA450595	1351	0.965
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Mar_24_68(Pt_4)_o1180.nxml.txt.nlp	22606121	SENT63	36	36	10	10	ethanol	mol	PA448073	90527	0.965
NULL	J_Viral_Hepat_2012_Feb_19(2)_e112-e119.nxml.txt.nlp	22239508	SENT175	17	17	7	7	telaprevir	solo	PA165958354	55701	0.965
NULL	Cancer_Res_Treat_2013_Mar_31_45(1)_55-62.nxml.txt.nlp	23613671	SENT10	15	15	3	3	irinotecan	KRAS	PA450085	3845	0.965
NULL	J_Int_Soc_Sports_Nutr_2010_Jan_22_7_3.nxml.txt.nlp	20205750	SENT8	0	0	12	12	betaine	mol	PA448603	90527	0.965
NULL	Br_J_Cancer_2013_Feb_5_108(2)_334-341.nxml.txt.nlp	23257893	SENT203	32	32	6	6	sorafenib	NOXA	PA7000	5366	0.965
NULL	Nucleic_Acids_Res_2005_Jun_8_33(10)_3283-3291.nxml.txt.nlp	15944449	SENT156	34	34	11	11	cisplatin	XRCC2	PA449014	7516	0.965
NULL	Oncotarget_2011_Jun_15_2(6)_518-524.nxml.txt.nlp	21680956	SENT87	12	12	3	3	imatinib	STAT3	PA10804	6774	0.965
NULL	Mol_Cancer_2012_Dec_12_11_91.nxml.txt.nlp	23234355	SENT192	7	7	3	3	gefitinib	EGFR	PA131301952	1956	0.965
NULL	Cell_Res_2009_Aug_19(8)_950-961.nxml.txt.nlp	19546888	SENT23	37	37	26	26	hydrocortisone	c-Cbl	PA449905	867	0.965
NULL	Nat_Commun_2014_Nov_19_5_5479.nxml.txt.nlp	25407222	SENT99	40	40	0	0	dextran	YTS	PA449261	8565	0.965
NULL	Cancer_Cell_Int_2013_Sep_23_13_94.nxml.txt.nlp	24059699	SENT191	19	19	0	0	bevacizumab	VEGFA	PA130232992	7422	0.965
NULL	Mol_Cells_2014_Dec_31_37(12)_899a-906.nxml.txt.nlp	25431425	SENT135	35	35	20	20	curcumin	EP2	PA151958596	5732;10407	0.965
NULL	Br_J_Cancer_2011_Jun_28_105(1)_53-57.nxml.txt.nlp	21654688	SENT29	0	0	27	27	irinotecan	UGT1A1	PA450085	54658	0.965
NULL	Ann_Oncol_2014_May_6_25(5)_959-967.nxml.txt.nlp	24504448	SENT157	27	27	15	15	vemurafenib	BRAF	PA165946873	673	0.965
NULL	EMBO_Mol_Med_2014_Oct_17_6(10)_1294-1311.nxml.txt.nlp	25231413	SENT448	11	11	32	32	calcein	CO2	PA132595336	4513	0.965
NULL	Mol_Vis_2011_Dec_24_17_3384-3391.nxml.txt.nlp	22219634	SENT114	20	20	2	2	mannitol	TLR2	PA450320	7097	0.965
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_145-149.nxml.txt.nlp	23864848	SENT10	5	5	16	16	gemcitabine	HHM	PA449748	5744	0.965
NULL	Oncotarget_2012_Oct_20_3(10)_1068-1111.nxml.txt.nlp	23085539	SENT73	26	26	12	12	sorafenib	BRAF	PA7000	673	0.965
NULL	Breast_Cancer_Res_Treat_2014_Nov_11_148(3)_563-570.nxml.txt.nlp	25385180	SENT173	17	17	13	13	cetuximab	EGFR	PA10040	1956	0.965
NULL	Exp_Mol_Med_2012_Aug_31_44(8)_473-482.nxml.txt.nlp	22627808	SENT110	5	5	28	28	lapatinib	HER2	PA152241907	2064	0.965
NULL	Diabetes_Care_2008_Jul_31(7)_1427-1432.nxml.txt.nlp	18390799	SENT154	14	14	41	41	metformin	RBP4	PA450395	5433;5950	0.965
NULL	Front_Oncol_2014_Sep_15_4_244.nxml.txt.nlp	25309870	SENT86	0	0	25	25	afatinib	HER2	PA165981154	2064	0.965
NULL	J_Korean_Med_Sci_2007_Jun_30_22(3)_557-559.nxml.txt.nlp	17596671	SENT4	7	7	18	18	warfarin	CYP2C9	PA451906	1559	0.965
NULL	Nat_Commun_2014_Dec_8_5_5736.nxml.txt.nlp	25484020	SENT164	9	9	21	21	exemestane	PAR2	PA449563	2150;55065;8856	0.965
NULL	Int_J_Mol_Sci_2014_Oct_8_15(10)_17974-17999.nxml.txt.nlp	25299695	SENT306	13	13	0	0	curcumin	HO-1	PA151958596	3162	0.965
NULL	Ann_Dermatol_2014_Feb_17_26(1)_141-143.nxml.txt.nlp	24648711	SENT29	16	16	25	25	tacrolimus	LDE	PA451578	7957	0.965
NULL	Hum_Genomics_2010_Apr_1_4(4)_238-249.nxml.txt.nlp	20511137	SENT86	3	3	20	20	raltegravir	UGT1A1		54658	0.965
NULL	Breast_Cancer_Res_2011_Jan_11_13(1)_R3.nxml.txt.nlp	21223569	SENT162	6	6	17	17	etoposide	p53	PA449552	7157	0.965
NULL	EJC_Suppl_2013_Sep_5_11(2)_92-96.nxml.txt.nlp	NULL	SENT187	22	22	20	20	vemurafenib	BRAF	PA165946873	673	0.965
NULL	Drug_Healthc_Patient_Saf_2012_Nov_29_4_173-180.nxml.txt.nlp	23236256	SENT66	43	43	48	48	risperidone	FGA	PA451257	2243	0.965
NULL	Neuro_Oncol_2010_Apr_27_12(4)_389-400.nxml.txt.nlp	20308316	SENT78	6	6	32	32	chloroquine	p53	PA448948	7157	0.965
NULL	Br_J_Cancer_2012_Feb_28_106(5)_876-882.nxml.txt.nlp	22333597	SENT102	6	6	15	15	everolimus	4E-BP1	PA164746311	1978	0.965
NULL	Arthritis_Res_Ther_2009_Aug_17_11(4)_R123.nxml.txt.nlp	19686595	SENT11	16	16	4	4	rituximab	CD27	PA451261	939	0.965
NULL	Biochem_Res_Int_2012_Mar_20_2012_951539.nxml.txt.nlp	22482055	SENT172	9	9	5	5	doxorubicin	p38	PA449412	10598;1432;7965	0.965
NULL	Diabetes_Care_2013_Jul_12_36(7)_1913-1918.nxml.txt.nlp	23359361	SENT31	32	32	1	1	sitagliptin	GLP-1	PA164748978	100125288	0.965
NULL	J_Invest_Dermatol_2012_May_16_132(5)_1435-1442.nxml.txt.nlp	22336948	SENT9	3	3	26	26	doxycycline	TLSP	PA449415	11012	0.965
NULL	Breast_Cancer_Res_2000_Mar_12_2(Suppl_1)_S_32.nxml.txt.nlp	NULL	SENT6	40	40	18	18	tamoxifen	PS2	PA451581	5664	0.965
NULL	Chin_J_Cancer_2011_Sep_30(9)_645-654.nxml.txt.nlp	21880186	SENT176	22	22	12	12	cisplatin	NACT	PA449014	284111	0.965
NULL	Lab_Invest_2014_May_10_94(5)_503-516.nxml.txt.nlp	24614199	SENT56	0	0	17	17	curcumin	PI3K	PA151958596	5290	0.965
NULL	Biomed_Res_Int_2013_Sep_4_2013_419176.nxml.txt.nlp	24093097	SENT45	0	0	6	6	axitinib	VEGFR	PA164924493	3791	0.965
NULL	Mol_Cancer_2009_Apr_22_8_26.nxml.txt.nlp	19386116	SENT14	16	16	8	8	ritonavir	AKT	PA451260	207	0.965
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Apr_17_6_43-57.nxml.txt.nlp	24833916	SENT300	16	16	29	29	exemestane	PI3K	PA449563	5290	0.965
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT253	30	30	20	20	heparin	FGF1	PA449855	2246	0.965
NULL	Cardiol_Res_Pract_2013_Feb_19_2013_195456.nxml.txt.nlp	23533940	SENT120	18	18	5	5	clopidogrel	ABCB1	PA449053	5243	0.965
NULL	Diabetes_Care_2011_Jul_17_34(7)_1610-1616.nxml.txt.nlp	21709297	SENT98	2	2	13	13	nadh	AAT	PA164755085	5265	0.965
NULL	Br_J_Cancer_2009_Oct_6_101(7)_1155-1161.nxml.txt.nlp	19738614	SENT189	13	13	8	8	gemcitabine	14-3-3	PA449748	10971	0.964
NULL	Mol_Cell_Proteomics_2014_May_17_13(5)_1273-1285.nxml.txt.nlp	24637012	SENT141	30	30	9	9	ergotamine	5-HT2A	PA164747651	3356	0.964
NULL	Front_Oncol_2014_Apr_9_4_75.nxml.txt.nlp	24782986	SENT150	24	24	13	13	paclitaxel	STAT3	PA450761	6774	0.964
NULL	Evid_Based_Complement_Alternat_Med_2011_Feb_14_2011_650263.nxml.txt.nlp	21799686	SENT145	20	20	6	6	atropine	IRS1	PA448505	3667	0.964
NULL	Interdiscip_Toxicol_2011_Jun_4(2)_78-84.nxml.txt.nlp	21753903	SENT24	13	13	0	0	ethanol	CYP2E1	PA448073	1571	0.964
NULL	Oncotarget_2011_Mar_23_2(3)_165-177.nxml.txt.nlp	21444946	SENT169	12	12	16	16	erlotinib	KRAS	PA134687924	3845	0.964
NULL	Oncotarget_2013_Jun_3_4(6)_875-883.nxml.txt.nlp	23900261	SENT108	22	22	1	1	estradiol	RB1	PA449503	5925	0.964
NULL	Brain_Sci_2013_Jul_31_3(3)_1153-1181.nxml.txt.nlp	24587895	SENT109	26	26	37	37	ketamine	NR1	PA450144	27158	0.964
NULL	Cardiovasc_Res_2010_Oct_1_88(1)_51-57.nxml.txt.nlp	20558439	SENT50	17	17	0	0	ethanol	ALDH2	PA448073	217	0.964
NULL	Front_Immunol_2013_Nov_18_4_382.nxml.txt.nlp	24302925	SENT177	26	26	8	8	imatinib	AKT	PA10804	207	0.964
NULL	Oncotarget_2012_Oct_20_3(10)_1068-1111.nxml.txt.nlp	23085539	SENT377	4	4	21	21	sorafenib	Raf-1	PA7000	5894	0.964
NULL	Theranostics_2013_Jan_15_3(1)_40-46.nxml.txt.nlp	23382785	SENT36	32	32	11	11	methotrexate	CXCL12	PA450428	6387	0.964
NULL	Evid_Based_Complement_Alternat_Med_2012_Dec_30_2012_508902.nxml.txt.nlp	23346204	SENT180	18	18	3	3	mesalazine	EGF	PA450384	1950	0.964
NULL	J_Hematol_Oncol_2010_Apr_23_3_17.nxml.txt.nlp	20416083	SENT128	21	21	14	14	idarubicin	FLT3	PA449961	2322	0.964
NULL	Mol_Vis_2012_Oct_5_18_2454-2467.nxml.txt.nlp	23077404	SENT214	17	17	25	25	bevacizumab	VEGF-A	PA130232992	7422	0.964
NULL	Br_J_Cancer_2009_Mar_10_100(5)_758-763.nxml.txt.nlp	19259094	SENT103	19	19	8	8	decitabine	HDAC	PA164749631	9734	0.964
NULL	Onco_Targets_Ther_2014_Sep_9_7_1571-1582.nxml.txt.nlp	25228815	SENT109	10	10	22	22	sunitinib	VEGFR2	PA162372840	3791	0.964
NULL	Acta_Histochem_Cytochem_2011_Apr_28_44(2)_113-118.nxml.txt.nlp	21614172	SENT342	18	18	6	6	everolimus	HIF-1	PA164746311	29072	0.964
NULL	Evid_Based_Complement_Alternat_Med_2013_Oct_28_2013_989670.nxml.txt.nlp	24288572	SENT49	1	1	36	36	ethanol	TLN	PA448073	7087	0.964
NULL	Int_J_Mol_Sci_2012_Aug_24_13(9)_10697-10721.nxml.txt.nlp	23109817	SENT133	11	11	30	30	arsenite	JNK	PA452638	5599	0.964
NULL	Breast_Cancer_Res_2006_Nov_6_8(6)_215.nxml.txt.nlp	17096862	SENT101	0	0	28	28	lapatinib	EGFR	PA152241907	1956	0.964
NULL	EMBO_Mol_Med_2012_Oct_2_4(10)_1043-1056.nxml.txt.nlp	23027611	SENT112	32	32	13	13	scopolamine	5-HT6	PA451308	3362	0.964
NULL	Mol_Vis_2012_Jun_22_18_1696-1700.nxml.txt.nlp	22773907	SENT91	26	26	16	16	colchicine	MEFV	PA449092	4210	0.964
NULL	J_Cell_Mol_Med_2013_Feb_5_17(2)_293-302.nxml.txt.nlp	23379308	SENT100	7	7	28	28	carbachol	PS1	PA448784	5663	0.964
NULL	Adolesc_Health_Med_Ther_2014_Nov_27_5_211-221.nxml.txt.nlp	25473324	SENT52	0	0	10	10	aripiprazole	CYP2D6	PA10026	1565	0.964
NULL	Glob_Health_Action_2014_May_22_7_10_3402_gha_v7_24303.nxml.txt.nlp	24857613	SENT212	35	35	10	10	amoxicillin	PTB	PA448406	58155	0.964
NULL	Breast_Cancer_Res_Treat_2012_Dec_26_136(3)_907-909.nxml.txt.nlp	23099437	SENT4	21	21	0	0	tamoxifen	HOXB13	PA451581	10481	0.964
NULL	Arch_Drug_Inf_2008_Jul_1(1)_14-22.nxml.txt.nlp	20157364	SENT18	16	16	7	7	pravastatin	MCP-1	PA451089	6347	0.964
NULL	Arthritis_Res_Ther_2007_Jun_29_9(Suppl_1)_S3.nxml.txt.nlp	17634142	SENT94	0	0	21	21	denosumab	RANKL	PA166048634	8600	0.964
NULL	Emerg_Infect_Dis_2011_Apr_17(4)_754-756.nxml.txt.nlp	21470484	SENT4	4	4	16	16	tocilizumab	IL-6	PA165292659	3569	0.964
NULL	Mol_Cancer_2004_May_4_3_14.nxml.txt.nlp	15125777	SENT146	37	37	24	24	cisplatin	CHK2	PA449014	11200	0.964
NULL	Breast_Cancer_(Auckl)_2014_Oct_15_8_145-155.nxml.txt.nlp	25368521	SENT57	20	20	12	12	trastuzumab	HER2	PA451743	2064	0.964
NULL	J_Neuroinflammation_2011_Feb_4_8_10.nxml.txt.nlp	21294877	SENT156	15	15	36	36	capsaicin	TRPV1	PA448776	7442	0.964
NULL	Arthritis_Res_Ther_2008_Mar_17_10(2)_R33.nxml.txt.nlp	18346273	SENT123	17	17	2	2	infliximab	CD163	PA452639	9332	0.964
NULL	Oncogenesis_2012_Apr_2_1(4)_e5.nxml.txt.nlp	23552603	SENT242	25	25	11	11	ns-398	MCL1		4170	0.964
NULL	J_Biol_Chem_2008_May_23_283(21)_14845-14856.nxml.txt.nlp	18356157	SENT232	17	17	6	6	paraformaldehyde	SNAP45	PA450790	6618	0.964
NULL	Mol_Pain_2013_Jul_31_9_38.nxml.txt.nlp	23898828	SENT11	27	27	14	14	losartan	p38	PA450268	10598;1432;7965	0.964
NULL	J_Cancer_Epidemiol_2012_Apr_12_2012_529357.nxml.txt.nlp	22570656	SENT20	44	44	25	25	aprepitant	HEC	PA164747039	10403	0.964
NULL	J_Cancer_2011_May_1_2_232-261.nxml.txt.nlp	21552384	SENT97	24	24	31	31	tamoxifen	aromatase	PA451581	1588	0.964
NULL	Curr_Neuropharmacol_2007_Dec_5(4)_232-243.nxml.txt.nlp	19305740	SENT454	10	10	6	6	indomethacin	gamma	PA449982	9913	0.964
NULL	Oxid_Med_Cell_Longev_2013_Jun_2_2013_793525.nxml.txt.nlp	23819014	SENT247	18	18	8	8	resveratrol	SIRT1		23411	0.964
NULL	Diabetes_Care_2009_Apr_32(4)_531-540.nxml.txt.nlp	19336638	SENT18	7	7	28	28	ticlopidine	P2Y12	PA451686	64805	0.964
NULL	Cardiovasc_Diabetol_2005_Oct_5_4_16.nxml.txt.nlp	16207378	SENT210	4	4	11	11	glucosamine	perlecan	PA164747613	3339	0.964
NULL	Front_Microbiol_2013_Aug_19_4_241.nxml.txt.nlp	23966991	SENT297	3	3	26	26	rifampin	PPARgamma	PA451250	5468	0.964
NULL	AIDS_Res_Ther_2013_Jun_7_10_15.nxml.txt.nlp	23758814	SENT2	7	7	2	2	maraviroc	CCR5	PA164768835	1234	0.964
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jan_11_68(Pt_2)_o314.nxml.txt.nlp	22346949	SENT58	36	36	15	15	ethanol	mol	PA448073	90527	0.964
NULL	Oncotarget_2014_Aug_27_5(17)_7328-7341.nxml.txt.nlp	25193862	SENT215	37	37	3	3	dasatinib	EPHB1	PA162372878	2047	0.964
NULL	Int_Clin_Psychopharmacol_2014_Jul_26_29(4)_185-196.nxml.txt.nlp	24424469	SENT10	0	0	11	11	paroxetine	CYP2D6	PA450801	1565	0.964
NULL	Diabetes_2013_Oct_17_62(10)_3305-3306.nxml.txt.nlp	NULL	SENT56	35	35	44	44	resveratrol	SIRT1		23411	0.964
NULL	Oncogene_2014_Aug_21_33(34)_4316-4329.nxml.txt.nlp	24362530	SENT48	20	20	4	4	epirubicin	FOXM1	PA449476	2305	0.964
NULL	Biomed_Imaging_Interv_J_2008_Jul_1_4(3)_e40.nxml.txt.nlp	21611006	SENT142	1	1	36	36	trastuzumab	HER2	PA451743	2064	0.964
NULL	Pharmaceuticals_(Basel)_2012_Nov_20_5(11)_1236-1264.nxml.txt.nlp	24281308	SENT230	4	4	7	7	everolimus	EGFR	PA164746311	1956	0.964
NULL	J_Invest_Dermatol_2012_Oct_24_132(10)_2440-2450.nxml.txt.nlp	22622430	SENT8	9	9	21	21	temozolomide	IL-8	PA451609	3576	0.964
NULL	Inflammopharmacology_2013_Aug_6_21(5)_339-363.nxml.txt.nlp	23918298	SENT248	0	0	22	22	denosumab	RANKL	PA166048634	8600	0.964
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT3	38	38	31	31	lapatinib	HER2	PA152241907	2064	0.964
NULL	Reprod_Biol_Endocrinol_2003_Oct_9_1_74.nxml.txt.nlp	14613550	SENT199	8	8	29	29	indomethacin	COX	PA449982	1351	0.964
NULL	Acta_Histochem_Cytochem_2012_Apr_26_45(2)_139-146.nxml.txt.nlp	22685356	SENT34	15	15	2	2	forskolin	AQP2	PA146096022	359	0.964
NULL	Mol_Cell_Proteomics_2014_Jan_18_13(1)_145-156.nxml.txt.nlp	24142993	SENT119	21	21	2	2	trypsin	DVL2	PA451806	1856	0.964
NULL	Acta_Histochem_Cytochem_2012_Apr_26_45(2)_139-146.nxml.txt.nlp	22685356	SENT4	23	23	4	4	forskolin	AQP2	PA146096022	359	0.964
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT167	46	46	24	24	trastuzumab	MUC4	PA451743	4585	0.964
NULL	Oncogene_2010_Sep_16_29(37)_5193-5203.nxml.txt.nlp	20581867	SENT169	37	37	13	13	lapatinib	HRG	PA152241907	3084;3273	0.964
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT116	24	24	11	11	neratinib	HER2	PA165291472	2064	0.964
NULL	Cell_Death_Dis_2011_Aug_11_2(8)_e191.nxml.txt.nlp	21833029	SENT163	36	36	0	0	oxaliplatin	CT26	PA131285527	168400	0.964
NULL	Neural_Plast_2007_Jun_19_2007_52908.nxml.txt.nlp	17641734	SENT246	18	18	6	6	desipramine	CB1	PA449233	1268	0.964
NULL	Diabetes_2008_Sep_57(9)_2272-2279.nxml.txt.nlp	18519799	SENT10	5	5	17	17	rosiglitazone	PDK2	PA451283	5164	0.964
NULL	Indian_J_Dermatol_2013_Jan-Feb_58(1)_61-64.nxml.txt.nlp	23372216	SENT98	2	2	17	17	itraconazole	CYP3A4	PA450132	1576	0.964
NULL	Chem_Rev_2012_May_9_112(5)_2593-2603.nxml.txt.nlp	22335786	SENT69	1	1	19	19	fluorescein	ATX	PA164746009	5168;23049	0.964
NULL	Front_Endocrinol_(Lausanne)_2014_Feb_25_5_22.nxml.txt.nlp	24611062	SENT94	20	20	2	2	estradiol	PTEN	PA449503	5728	0.964
NULL	Ann_Thorac_Med_2011_Oct-Dec_6(4)_221-226.nxml.txt.nlp	21977068	SENT127	9	9	17	17	doxycycline	IL-6	PA449415	3569	0.964
NULL	Mol_Cancer_2010_Apr_12_9_75.nxml.txt.nlp	20385023	SENT219	13	13	24	24	imatinib	c-ABL	PA10804	25	0.964
NULL	Diabetes_Care_2012_Dec_14_35(12)_2631-2639.nxml.txt.nlp	22912426	SENT207	4	4	11	11	pioglitazone	IL-10	PA450970	3586	0.964
NULL	Br_J_Cancer_2013_Jul_23_109(2)_351-359.nxml.txt.nlp	23799854	SENT14	18	18	29	29	paclitaxel	BLT2	PA450761	56413	0.964
NULL	Clin_Ophthalmol_2008_Jun_2(2)_355-368.nxml.txt.nlp	19668727	SENT182	0	0	23	23	nepafenac	CYP2C19	PA165958407	1557	0.964
NULL	Oncogene_2010_Nov_18_29(46)_6115-6124.nxml.txt.nlp	20729912	SENT105	0	0	9	9	doxorubicin	ABCB1	PA449412	5243	0.964
NULL	Environ_Health_Perspect_2005_Aug_15_113(8)_1009-1014.nxml.txt.nlp	16079071	SENT36	33	33	25	25	losartan	SRM	PA450268	6723;6725	0.964
NULL	Cancer_Cell_Int_2011_Aug_19_11_29.nxml.txt.nlp	21854619	SENT135	22	22	14	14	cisplatin	HDAC	PA449014	9734	0.964
NULL	Cancer_Cell_Int_2005_Aug_23_5_27.nxml.txt.nlp	16117829	SENT160	14	14	4	4	doxycycline	p53	PA449415	7157	0.964
NULL	Clin_Med_Insights_Oncol_2012_Mar_12_6_137-147.nxml.txt.nlp	22550402	SENT36	0	0	11	11	erlotinib	CYP3A4	PA134687924	1576	0.964
NULL	Mol_Cancer_2014_Jan_15_13_9.nxml.txt.nlp	24428911	SENT119	12	12	4	4	gefitinib	EGFR	PA131301952	1956	0.964
NULL	Int_J_Endocrinol_2013_Jun_16_2013_290734.nxml.txt.nlp	23843787	SENT111	16	16	6	6	pioglitazone	CTX	PA450970	1593	0.964
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT10	0	0	18	18	atorvastatin	AKT	PA448500	207	0.964
NULL	Biosensors_(Basel)_2013_Jun_28_3(3)_238-258.nxml.txt.nlp	25506422	SENT248	16	16	21	21	etoposide	p53	PA449552	7157	0.964
NULL	Mol_Biol_Cell_2012_Nov_1_23(21)_4212-4225.nxml.txt.nlp	22956765	SENT80	3	3	25	25	thrombin	SHP2	PA451674	5781	0.964
NULL	J_Clin_Biochem_Nutr_2010_May_20_46(3)_187-194.nxml.txt.nlp	20490313	SENT74	17	17	0	0	vasopressin	ANG	PA451858	283	0.964
NULL	Drugs_R_D_2010_Sep_27_10(3)_165-178.nxml.txt.nlp	20945947	SENT60	0	0	15	15	ridaforolimus	KRAS	PA165291475	3845	0.964
NULL	Core_Evid_2012_Dec_11_7_131-143.nxml.txt.nlp	23271985	SENT225	10	10	14	14	vancomycin	HAP	PA451850	5915;10313	0.964
NULL	Cancer_Manag_Res_2013_Jul_31_5_187-195.nxml.txt.nlp	23986650	SENT61	24	24	10	10	lapatinib	CD44	PA152241907	960	0.964
NULL	Oncotarget_2013_Dec_18_5(3)_634-648.nxml.txt.nlp	24504138	SENT142	32	32	12	12	bortezomib	p65	PA10252	5970	0.964
NULL	Nature_2008_Nov_13_456(7219)_269-273.nxml.txt.nlp	18849969	SENT73	17	17	20	20	staurosporine	SIK2	PA165109623	23235	0.964
NULL	Breast_Cancer_Res_Treat_2013_May_12_139(1)_107-113.nxml.txt.nlp	23580070	SENT195	4	4	16	16	tanespimycin	HER-2	PA165291490	2064	0.964
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Dec_23_68(Pt_1)_o246.nxml.txt.nlp	22259528	SENT67	21	21	4	4	ethanol	mol	PA448073	90527	0.964
NULL	J_Ind_Microbiol_Biotechnol_2013_Jul_30_40(10)_1153-1160.nxml.txt.nlp	23896974	SENT29	31	31	2	2	ethanol	GPD2	PA448073	2820	0.964
NULL	Indian_J_Med_Paediatr_Oncol_2013_Apr-Jun_34(2)_101-103.nxml.txt.nlp	24049297	SENT23	18	18	35	35	doxorubicin	FDG	PA449412	23583	0.964
NULL	Oncogene_2014_Feb_6_33(6)_713-723.nxml.txt.nlp	23435429	SENT82	28	28	18	18	etoposide	BRCA1	PA449552	672	0.964
NULL	Infect_Ecol_Epidemiol_2013_Feb_22_3_10_3402_iee_v3i0_19946.nxml.txt.nlp	23440849	SENT86	14	14	6	6	benzocaine	CO2	PA448576	4513	0.964
NULL	Carcinogenesis_2014_May_13_35(5)_1055-1066.nxml.txt.nlp	24419232	SENT183	15	15	0	0	metformin	CYP1B1	PA450395	1545	0.964
NULL	Biochem_Biophys_Res_Commun_2009_May_22_383(1)_63-67.nxml.txt.nlp	19332024	SENT107	28	28	3	3	lipase	CES1	PA450239	1066	0.964
NULL	Pain_2011_Aug_152(8)_1899-1908.nxml.txt.nlp	21600693	SENT124	23	23	16	16	capsaicin	ADP	PA448776	23038	0.964
NULL	Indian_J_Dermatol_2009_Apr-Jun_54(2)_100-109.nxml.txt.nlp	20101303	SENT208	32	32	0	0	alefacept	CD4	PA164748040	920	0.964
NULL	Arch_Orthop_Trauma_Surg_2009_Oct_2_129(10)_1427-1432.nxml.txt.nlp	18677494	SENT114	2	2	30	30	rofecoxib	COX	PA451268	1351	0.964
NULL	Mol_Cancer_2014_Aug_22_13(1)_195.nxml.txt.nlp	NULL	SENT109	10	10	3	3	cisplatin	TBL1XR1	PA449014	79718	0.964
NULL	Mol_Cancer_2014_Jun_20_13_155.nxml.txt.nlp	24950741	SENT155	20	20	6	6	bortezomib	StAR	PA10252	6770	0.964
NULL	Front_Physiol_2011_Apr_12_2_13.nxml.txt.nlp	21559063	SENT748	34	34	17	17	ranolazine	PDH	PA164746007	54704	0.964
NULL	Br_J_Cancer_2003_Jun_16_88(12)_1963-1970.nxml.txt.nlp	12799644	SENT225	12	12	3	3	gemcitabine	MRP1	PA449748	4437	0.964
NULL	Neural_Dev_2011_Feb_1_6_4.nxml.txt.nlp	21284844	SENT191	10	10	21	21	bumetanide	NKCC1	PA448682	6558	0.964
NULL	Case_Rep_Hematol_2013_Sep_26_2013_521785.nxml.txt.nlp	24191205	SENT9	23	23	5	5	cyclophosphamide	VIII	PA449165	1351	0.964
NULL	Ann_Clin_Transl_Neurol_2014_Dec_21_1(12)_996-1005.nxml.txt.nlp	25574474	SENT117	0	0	3	3	riluzole	P-gp	PA451251	5243	0.964
NULL	J_Oncol_2011_Oct_25_2011_316243.nxml.txt.nlp	20981261	SENT145	7	7	9	9	tamoxifen	aromatase	PA451581	1588	0.964
NULL	Int_J_Mol_Sci_2012_Feb_22_13(2)_2387-2404.nxml.txt.nlp	22408460	SENT17	13	13	5	5	gefitinib	KDR	PA131301952	3791	0.964
NULL	Int_J_Environ_Res_Public_Health_2012_May_4_9(5)_1630-1648.nxml.txt.nlp	22754462	SENT9	39	39	13	13	malathion	CYP1A1	PA164748092	1543	0.964
NULL	Mucosal_Immunol_2011_Nov_6_4(6)_648-657.nxml.txt.nlp	21734653	SENT94	25	25	6	6	azithromycin	HEC	PA448519	10403	0.964
NULL	Br_J_Cancer_2013_Dec_10_109(12)_3057-3066.nxml.txt.nlp	24196786	SENT49	2	2	16	16	trastuzumab	HER-2	PA451743	2064	0.964
NULL	J_Adv_Pract_Oncol_2013_Jul_1_Jul-Aug_4(4)_263-268.nxml.txt.nlp	25032007	SENT47	16	16	4	4	voriconazole	CYP3A4	PA10233	1576	0.964
NULL	J_Exp_Med_1998_Jun_1_187(11)_1885-1892.nxml.txt.nlp	9607928	SENT213	5	5	18	18	thalidomide	CD4	PA451644	920	0.964
NULL	Cell_Death_Dis_2014_Feb_13_5(2)_e1055.nxml.txt.nlp	24525731	SENT74	14	14	8	8	cisplatin	XRCC1	PA449014	7515	0.964
NULL	Mol_Cancer_2010_May_28_9_130.nxml.txt.nlp	20509890	SENT11	9	9	4	4	etoposide	TGFBI	PA449552	7045	0.964
NULL	Mol_Cancer_2008_Jun_3_7_47.nxml.txt.nlp	18519000	SENT81	4	4	32	32	gefitinib	EGFR	PA131301952	1956	0.964
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Dec_9_6_191-203.nxml.txt.nlp	25525387	SENT158	34	34	37	37	tamoxifen	aromatase	PA451581	1588	0.964
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S244-S250.nxml.txt.nlp	21525463	SENT29	6	6	12	12	colesevelam	GLP-1	PA449095	100125288	0.964
NULL	Biologics_2014_Apr_7_8_141-153.nxml.txt.nlp	24741293	SENT199	10	10	22	22	etanercept	IL-6	PA449515	3569	0.964
NULL	Adv_Hematol_2011_Apr_10_2011_960137.nxml.txt.nlp	21547266	SENT70	4	4	26	26	rituximab	NHL	PA451261	51750	0.964
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT89	17	17	8	8	methotrexate	MSH2	PA450428	4436	0.964
NULL	Biomed_Res_Int_2013_Mar_28_2013_154073.nxml.txt.nlp	23607088	SENT94	40	40	25	25	clopidogrel	P2Y12	PA449053	64805	0.964
NULL	J_Adv_Pharm_Technol_Res_2012_Oct-Dec_3(4)_202-209.nxml.txt.nlp	23378940	SENT168	28	28	5	5	fosaprepitant	CYP3A4	PA165958390	1576	0.964
NULL	Drugs_2009_Mar_17_69(5)_549-565.nxml.txt.nlp	19368417	SENT13	27	27	15	15	formoterol	DPI	PA134687907	1832	0.964
NULL	Biomed_Res_Int_2014_Jun_25_2014_203693.nxml.txt.nlp	25089265	SENT205	9	9	27	27	sorafenib	survivin	PA7000	332	0.964
NULL	Case_Rep_Oncol_Med_2013_Sep_26_2013_234391.nxml.txt.nlp	24191208	SENT6	21	21	8	8	lapatinib	HER-2	PA152241907	2064	0.964
NULL	Oncol_Lett_2013_Mar_7_5(3)_857-861.nxml.txt.nlp	23426781	SENT105	23	23	30	30	cisplatin	PI3K	PA449014	5290	0.964
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2011_Mar_14_4_13-24.nxml.txt.nlp	22879790	SENT138	10	10	28	28	liraglutide	PPG	PA165958364	5552	0.964
NULL	Acta_Pharmacol_Sin_2014_Jun_5_35(6)_727-737.nxml.txt.nlp	24793312	SENT139	15	15	6	6	telmisartan	B27	PA451605	56246	0.964
NULL	Clin_Drug_Investig_2013_Aug_23_33(10)_727-736.nxml.txt.nlp	23975654	SENT80	16	16	6	6	ketoconazole	CYP2C19	PA450146	1557	0.964
NULL	Oncotarget_2011_Dec_20_2(12)_1075-1093.nxml.txt.nlp	22185818	SENT123	29	29	23	23	tamoxifen	ANXA2	PA451581	302	0.964
NULL	Br_J_Cancer_2011_Jan_4_104(1)_91-100.nxml.txt.nlp	21139584	SENT156	9	9	5	5	bortezomib	Hsp90	PA10252	3320	0.964
NULL	Alcohol_Res_Health_2010_33(1-2)_76-86.nxml.txt.nlp	23579938	SENT75	5	5	17	17	resveratrol	SIRT7		51547	0.964
NULL	ScientificWorldJournal_2013_Apr_18_2013_978394.nxml.txt.nlp	23710154	SENT108	8	8	30	30	leucovorin	IFL	PA450198	3439	0.964
NULL	Oncol_Lett_2013_Mar_8_5(3)_805-812.nxml.txt.nlp	23426281	SENT164	4	4	9	9	gemcitabine	B7-H3	PA449748	80381	0.964
NULL	Biologics_2014_Dec_4_8_281-291.nxml.txt.nlp	25506209	SENT58	0	0	11	11	sorafenib	RET	PA7000	5979	0.964
NULL	Curr_Opin_Obstet_Gynecol_2014_Aug_3_26(4)_226-236.nxml.txt.nlp	24978853	SENT35	23	23	5	5	estradiol	AMH	PA449503	268	0.964
NULL	Allergy_2014_Feb_14_69(2)_137-149.nxml.txt.nlp	24117861	SENT193	23	23	18	18	cetuximab	HER-2	PA10040	2064	0.964
NULL	Ann_Oncol_2014_Apr_26_25(4)_801-807.nxml.txt.nlp	24577117	SENT114	28	28	40	40	cetuximab	p16	PA10040	1029	0.964
NULL	Niger_Med_J_2012_Jul-Sep_53(3)_109-115.nxml.txt.nlp	23293407	SENT176	27	27	0	0	demeclocycline	AQP2	PA164745513	359	0.964
NULL	Breast_Cancer_Res_2011_Mar_1_13(2)_R21.nxml.txt.nlp	21362200	SENT275	32	32	30	30	letrozole	aromatase	PA450196	1588	0.964
NULL	J_Adv_Pract_Oncol_2014_May_1_May-Jun_5(3)_211-215.nxml.txt.nlp	25089220	SENT17	0	0	13	13	vemurafenib	BRAF	PA165946873	673	0.964
NULL	Nature_2012_Jan_11_481(7382)_463-468.nxml.txt.nlp	22237023	SENT83	18	18	1	1	forskolin	ANOVA	PA146096022	4858	0.964
NULL	Int_J_Biol_Sci_2011_Nov_5_8(1)_1-14.nxml.txt.nlp	22211100	SENT141	5	5	33	33	evodiamine	PI3K	PA165860788	5290	0.964
NULL	Ann_Surg_Oncol_2012_Aug_7_19(8)_2685-2692.nxml.txt.nlp	22396006	SENT57	16	16	7	7	docetaxel	CRT	PA449383	811	0.964
NULL	J_Hematol_Oncol_2013_Jun_3_6_38.nxml.txt.nlp	23731980	SENT175	0	0	22	22	neratinib	HER3	PA165291472	2065	0.964
NULL	Oncotarget_2013_Nov_23_5(1)_196-210.nxml.txt.nlp	24344116	SENT122	10	10	15	15	doxorubicin	p53	PA449412	7157	0.964
NULL	Clin_Pharmacol_2011_Jun_22_3_13-25.nxml.txt.nlp	22287853	SENT190	38	38	5	5	saxagliptin	CYP3A4	PA165958362	1576	0.964
NULL	Nucleic_Acids_Res_2005_Jun_8_33(10)_3283-3291.nxml.txt.nlp	15944449	SENT118	26	26	14	14	melphalan	ERCC1	PA450354	2067	0.964
NULL	Cancers_(Basel)_2010_Dec_22_2(4)_2153-2170.nxml.txt.nlp	21390244	SENT336	11	11	0	0	gefitinib	EGFR	PA131301952	1956	0.964
NULL	Mol_Cancer_2008_Mar_26_7_27.nxml.txt.nlp	18366759	SENT80	7	7	39	39	etoposide	MCL1	PA449552	4170	0.964
NULL	Antiviral_Res_2009_May_82(2)_A99-A109.nxml.txt.nlp	19176219	SENT116	26	26	7	7	nevirapine	MRP-1	PA450616	928	0.964
NULL	Acta_Pharmacol_Sin_2011_May_25_32(5)_565-572.nxml.txt.nlp	21516132	SENT30	23	23	11	11	imiquimod	TLR7	PA449972	51284	0.964
NULL	Adipocyte_2013_Jan_1_2(1)_47-49.nxml.txt.nlp	23700552	SENT36	19	19	16	16	rimonabant	CB1	PA152407999	1268	0.964
NULL	Onco_Targets_Ther_2014_Oct_4_7_1817-1828.nxml.txt.nlp	25336973	SENT115	9	9	38	38	capecitabine	IFL	PA448771	3439	0.964
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT51	12	12	25	25	curcumin	TRAIL	PA151958596	8743	0.964
NULL	EPMA_J_2010_Mar_13_1(1)_138-163.nxml.txt.nlp	23199048	SENT309	0	0	19	19	sitagliptin	GLP-1	PA164748978	100125288	0.964
NULL	Exp_Brain_Res_2014_Jun_27_232(8)_2637-2644.nxml.txt.nlp	24969614	SENT169	39	39	30	30	palonosetron	NK1	PA10352	11126	0.964
NULL	Oncotarget_2011_Sep_9_2(9)_658-668.nxml.txt.nlp	21911919	SENT98	25	25	4	4	cytarabine	NAC	PA449177	22861	0.964
NULL	Cell_Death_Dis_2014_Jul_3_5(7)_e1316.nxml.txt.nlp	24991768	SENT204	6	6	0	0	pemetrexed	ATF3	PA10810	467	0.964
NULL	Eur_J_Endocrinol_2010_May_162(5)_987-992.nxml.txt.nlp	20164212	SENT16	11	11	3	3	diazoxide	HNF4A	PA449285	3172	0.964
NULL	Br_J_Cancer_2013_Feb_5_108(2)_334-341.nxml.txt.nlp	23257893	SENT151	0	0	14	14	cisplatin	NOXA	PA449014	5366	0.964
NULL	Cancer_Manag_Res_2011_Sep_9_3_301-309.nxml.txt.nlp	21931504	SENT168	17	17	2	2	spermine	CXCR4	PA164781199	7852	0.964
NULL	Evid_Based_Complement_Alternat_Med_2013_May_23_2013_632121.nxml.txt.nlp	23762150	SENT8	19	19	3	3	resveratrol	MITF		4286	0.964
NULL	Evid_Based_Complement_Alternat_Med_2013_May_28_2013_629750.nxml.txt.nlp	23781265	SENT148	12	12	2	2	capsaicin	GADD153	PA448776	1649	0.964
NULL	Brain_2013_May_4_136(5)_1462-1475.nxml.txt.nlp	23460667	SENT277	22	22	7	7	bevacizumab	CD31	PA130232992	5175	0.964
NULL	Int_J_Surg_Oncol_2012_May_17_2012_406830.nxml.txt.nlp	22675625	SENT85	12	12	19	19	cetuximab	KRAS	PA10040	3845	0.964
NULL	Cardiol_Res_Pract_2013_Feb_21_2013_127270.nxml.txt.nlp	23509665	SENT127	13	13	30	30	ticagrelor	NNT	PA165374673	23530	0.964
NULL	Cardiovasc_Ther_2012_Aug_17_30(4)_e174-e182.nxml.txt.nlp	21883999	SENT120	17	17	31	31	prasugrel	P2Y12	PA154410481	64805	0.964
NULL	Front_Neurosci_2011_Jan_14_4_207.nxml.txt.nlp	21258618	SENT159	38	38	13	13	ethanol	HET	PA448073	6294	0.964
NULL	Cancer_Med_2013_Dec_31_2(6)_826-835.nxml.txt.nlp	24403256	SENT9	17	17	15	15	nutlin-3	HDM2		4193	0.964
NULL	Arthritis_Res_Ther_2013_Dec_2_15(6)_R203.nxml.txt.nlp	24289091	SENT117	9	9	25	25	methotrexate	COX2	PA450428	4513;5743	0.964
NULL	Oncotarget_2013_Dec_15_4(12)_2577-2590.nxml.txt.nlp	24342878	SENT145	30	30	3	3	paclitaxel	NF-kappaB	PA450761	4790	0.964
NULL	Br_J_Clin_Pharmacol_2014_Nov_20_78(5)_1043-1049.nxml.txt.nlp	24838177	SENT37	0	0	17	17	boceprevir	CYP3A4	PA165948902	1576	0.964
NULL	Clin_Mol_Allergy_2007_Jan_25_5_1.nxml.txt.nlp	17254346	SENT216	19	19	8	8	curcumin	OAT	PA151958596	4942	0.964
NULL	Anticancer_Agents_Med_Chem_2012_Feb_12(2)_163-171.nxml.txt.nlp	22043994	SENT25	17	17	7	7	cetuximab	BRAF	PA10040	673	0.964
NULL	Gene_Regul_Syst_Bio_2014_Mar_4_8_63-73.nxml.txt.nlp	24634581	SENT121	2	2	36	36	minocycline	MT1-MMP	PA450519	4323	0.964
NULL	Arthritis_Res_Ther_2014_Apr_28_16(2)_R104.nxml.txt.nlp	24774748	SENT149	39	39	11	11	cyclophosphamide	CD4	PA449165	920	0.964
NULL	Eur_J_Neurosci_2014_Jul_27_40(1)_2311-2319.nxml.txt.nlp	24674448	SENT204	11	11	27	27	dexmedetomidine	CYP3A	PA449256	1574	0.964
NULL	Int_J_Gen_Med_2009_Jul_30_2_91-108.nxml.txt.nlp	20360893	SENT196	38	38	2	2	cyclophosphamide	PC-3	PA449165	692094	0.964
NULL	J_Vet_Med_Sci_2014_Oct_19_76(10)_1339-1345.nxml.txt.nlp	24942113	SENT117	2	2	18	18	losartan	AT1	PA450268	9197;185	0.964
NULL	J_Cell_Biol_2000_Jan_10_148(1)_59-72.nxml.txt.nlp	10629218	SENT289	9	9	0	0	staurosporine	p21Cip1/Waf1	PA165109623	1026	0.964
NULL	J_Cancer_Prev_2013_Jun_18(2)_186-191.nxml.txt.nlp	25337545	SENT71	24	24	2	2	curcumin	STAT3	PA151958596	6774	0.964
NULL	Biologics_2010_Aug_9_4_173-185.nxml.txt.nlp	20714355	SENT130	5	5	21	21	cisplatin	EGFR	PA449014	1956	0.964
NULL	CNS_Neurosci_Ther_2010_Jun_16(3)_e1-e17.nxml.txt.nlp	20406250	SENT77	1	1	12	12	escitalopram	5-HT1A	PA10074	3350	0.964
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT138	7	7	11	11	tamoxifen	AF1	PA451581	1946	0.964
NULL	Cancer_Cell_Int_2011_Nov_17_11_40.nxml.txt.nlp	22088142	SENT180	20	20	11	11	gemcitabine	EGFR	PA449748	1956	0.964
NULL	Neural_Regen_Res_2014_May_15_9(10)_1055-1062.nxml.txt.nlp	25206759	SENT218	33	33	6	6	bumetanide	KCC2	PA448682	57468	0.964
NULL	J_Hematol_Oncol_2012_Apr_25_5(Suppl_1)_A4.nxml.txt.nlp	NULL	SENT11	27	27	16	16	decitabine	TET2	PA164749631	54790	0.964
NULL	J_Hematol_Oncol_2011_Dec_21_4_53.nxml.txt.nlp	22189016	SENT70	14	14	7	7	clarithromycin	P-gp	PA449028	5243	0.964
NULL	Braz_J_Med_Biol_Res_2013_Mar_15_46(3)_299-305.nxml.txt.nlp	23532269	SENT11	24	24	1	1	propofol	CD14	PA451141	929	0.964
NULL	Clin_Pharmacol_2010_Jun_22_2_105-110.nxml.txt.nlp	22291493	SENT15	26	26	14	14	sibutramine	ADIPOQ	PA451344	9370	0.964
NULL	Chin_J_Cancer_2012_Feb_31(2)_51-57.nxml.txt.nlp	22257384	SENT113	0	0	15	15	imatinib	MRP1	PA10804	4437	0.964
NULL	Cell_Death_Differ_2010_Oct_30_17(10)_1655-1664.nxml.txt.nlp	20431598	SENT228	37	37	1	1	etoposide	CD4	PA449552	920	0.964
NULL	J_Cell_Mol_Med_2013_Sep_24_17(9)_1065-1087.nxml.txt.nlp	24151975	SENT248	0	0	28	28	palifermin	CD4	PA164744014	920	0.964
NULL	Front_Oncol_2014_Apr_9_4_75.nxml.txt.nlp	24782986	SENT276	19	19	44	44	paclitaxel	CD117	PA450761	3815	0.964
NULL	Oncogenesis_2014_Dec_15_3(12)_e133.nxml.txt.nlp	25500906	SENT304	12	12	2	2	trastuzumab	MPZL1	PA451743	9019	0.964
NULL	Br_J_Cancer_2009_Oct_6_101(7)_1168-1174.nxml.txt.nlp	19724277	SENT148	11	11	32	32	bortezomib	HIF-1	PA10252	29072	0.964
NULL	Clin_Pediatr_Endocrinol_2014_Apr_22_23(2)_27-34.nxml.txt.nlp	24790384	SENT107	3	3	29	29	hydrocortisone	ACTH	PA449905	5443	0.964
NULL	J_Inflamm_(Lond)_2008_Apr_27_5_5.nxml.txt.nlp	18439312	SENT168	27	27	9	9	genistein	AREG	PA165109660	374	0.964
NULL	Br_J_Cancer_2012_Jan_3_106(1)_85-91.nxml.txt.nlp	22127285	SENT23	6	6	4	4	vemurafenib	BRAF	PA165946873	673	0.964
NULL	Br_J_Cancer_2013_May_28_108(10)_2070-2078.nxml.txt.nlp	23591200	SENT167	23	23	19	19	genistein	NF-kappaB	PA165109660	4790	0.964
NULL	Bioinformation_2012_Jan_6_8(1)_13-19.nxml.txt.nlp	22359429	SENT138	35	35	28	28	calcein	MRP1	PA132595336	4437	0.964
NULL	Cell_Cycle_2013_Jan_15_12(2)_201.nxml.txt.nlp	23287470	SENT11	4	4	0	0	doxorubicin	NCF2	PA449412	4688	0.964
NULL	Acta_Pharmacol_Sin_2011_Feb_4_32(2)_223-229.nxml.txt.nlp	21293474	SENT180	16	16	26	26	isoproterenol	ETB	PA450121	1910	0.964
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1717-1723.nxml.txt.nlp	19844230	SENT95	18	18	2	2	sunitinib	DDR2	PA162372840	4921	0.964
NULL	Mol_Cancer_2007_Apr_23_6_31.nxml.txt.nlp	17451600	SENT126	23	23	7	7	daunorubicin	p52	PA449212	11168;4791	0.964
NULL	Appl_Clin_Genet_2010_Oct_29_3_85-101.nxml.txt.nlp	23776354	SENT193	29	29	39	39	imatinib	KIT	PA10804	3815	0.964
NULL	Br_J_Pharmacol_2014_Feb_24_171(1)_1019-1032.nxml.txt.nlp	24251620	SENT177	19	19	3	3	nitrendipine	TRPM3	PA146096020	80036	0.964
NULL	Breast_Cancer_Res_2005_Dec_7_7(1)_R156-R163.nxml.txt.nlp	15642164	SENT160	21	21	17	17	letrozole	aromatase	PA450196	1588	0.964
NULL	Oncotarget_2011_Mar_27_2(3)_209-221.nxml.txt.nlp	21444945	SENT32	13	13	18	18	cisplatin	HSF1	PA449014	3297	0.964
NULL	Pharmaceuticals_(Basel)_2013_Nov_11_6(11)_1407-1428.nxml.txt.nlp	24287464	SENT998	22	22	7	7	erlotinib	Hsp90	PA134687924	3320	0.964
NULL	Mol_Cancer_2009_Jun_23_8_39.nxml.txt.nlp	19549337	SENT233	36	36	14	14	resveratrol	TRAIL		8743	0.964
NULL	ScientificWorldJournal_2013_Apr_18_2013_767482.nxml.txt.nlp	23710148	SENT385	4	4	31	31	phenol	CYP1A2	PA450913	1544	0.964
NULL	Oncotarget_2014_Oct_23_5(21)_10816-10829.nxml.txt.nlp	25333261	SENT146	27	27	13	13	doxorubicin	MTDH	PA449412	92140	0.964
NULL	Biomed_Res_Int_2013_Aug_4_2013_152909.nxml.txt.nlp	23984319	SENT97	29	29	4	4	methotrexate	MSH2	PA450428	4436	0.964
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2011_Mar_14_4_13-24.nxml.txt.nlp	22879790	SENT11	2	2	4	4	liraglutide	GLP-1	PA165958364	100125288	0.964
NULL	Br_J_Pharmacol_2012_Dec_29_167(8)_1712-1722.nxml.txt.nlp	22862290	SENT125	12	12	0	0	carbachol	TRPC3	PA448784	7222	0.964
NULL	Br_J_Cancer_2012_Apr_10_106(8)_1367-1373.nxml.txt.nlp	22454081	SENT136	23	23	4	4	trastuzumab	PTEN	PA451743	5728	0.964
NULL	Lab_Invest_2014_May_10_94(5)_503-516.nxml.txt.nlp	24614199	SENT251	26	26	14	14	curcumin	RAGE	PA151958596	177	0.964
NULL	Cardiol_Res_Pract_2011_Jul_2_2011_615087.nxml.txt.nlp	21747989	SENT51	0	0	12	12	heparin	ACT	PA449855	12;11332;9457;641455	0.964
NULL	Mol_Brain_2013_Nov_13_6_47.nxml.txt.nlp	24284042	SENT288	3	3	24	24	trypsin	CD81	PA451806	975	0.964
NULL	Pharmaceutics_2011_Oct_12_3(4)_680-705.nxml.txt.nlp	24309303	SENT91	36	36	15	15	metformin	OCT2	PA450395	6582;5452	0.964
NULL	Br_J_Cancer_2011_Mar_15_104(6)_1020-1026.nxml.txt.nlp	21364579	SENT20	0	0	19	19	cetuximab	EGFR	PA10040	1956	0.964
NULL	Cancer_Immunol_Immunother_2013_Jul_20_62(9)_1533-1545.nxml.txt.nlp	23873089	SENT102	31	31	9	9	paclitaxel	CD69	PA450761	969	0.964
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT132	9	9	15	15	trastuzumab	STAT3	PA451743	6774	0.964
NULL	Exp_Ther_Med_2013_Nov_6_6(5)_1089-1095.nxml.txt.nlp	24223627	SENT44	19	19	8	8	tamoxifen	aromatase	PA451581	1588	0.964
NULL	Ann_Oncol_2011_Mar_8_22(3)_503-514.nxml.txt.nlp	20616198	SENT372	18	18	16	16	letrozole	aromatase	PA450196	1588	0.964
NULL	Pharmaceuticals_(Basel)_2013_Nov_25_6(12)_1475-1506.nxml.txt.nlp	24287492	SENT353	12	12	7	7	erlotinib	EGFR	PA134687924	1956	0.964
NULL	Biologics_2009_Jul_13_3_289-301.nxml.txt.nlp	19707416	SENT83	20	20	7	7	trastuzumab	HER2	PA451743	2064	0.964
NULL	J_Hematol_Oncol_2009_Feb_23_2_10.nxml.txt.nlp	19236716	SENT96	3	3	10	10	dasatinib	CYP3A4	PA162372878	1576	0.964
NULL	Cancer_Manag_Res_2011_Sep_9_3_301-309.nxml.txt.nlp	21931504	SENT168	15	15	2	2	dextran	CXCR4	PA449261	7852	0.964
NULL	Oncotarget_2014_Oct_16_5(20)_9546-9563.nxml.txt.nlp	25337673	SENT133	11	11	2	2	cisplatin	AXL	PA449014	558	0.964
NULL	Indian_J_Pharmacol_2013_Mar-Apr_45(2)_155-158.nxml.txt.nlp	23716892	SENT116	31	31	37	37	pioglitazone	CYP2C8	PA450970	1558	0.964
NULL	Endocrinol_Metab_(Seoul)_2014_Sep_25_29(3)_356-362.nxml.txt.nlp	25309795	SENT102	9	9	5	5	hemin	HO-1	PA449849	3162	0.964
NULL	Arthritis_Res_Ther_2014_Apr_3_16(2)_R86.nxml.txt.nlp	24708674	SENT276	38	38	15	15	imatinib	Fli1	PA10804	2314	0.964
NULL	Diabetes_Care_2013_May_13_36(5)_1368-1376.nxml.txt.nlp	23275363	SENT24	11	11	15	15	exenatide	GLP-1	PA164749238	100125288	0.964
NULL	Clin_Mol_Hepatol_2014_Sep_25_20(3)_283-290.nxml.txt.nlp	25320732	SENT116	18	18	1	1	propranolol	EVL	PA451145	51466	0.964
NULL	Breast_Cancer_(Auckl)_2012_Mar_7_6_67-77.nxml.txt.nlp	22438669	SENT46	0	0	19	19	lapatinib	CYP3A4	PA152241907	1576	0.964
NULL	J_Thorac_Oncol_2014_Jun_30_9(6)_775-783.nxml.txt.nlp	24828661	SENT142	1	1	12	12	crizotinib	Met	PA165946122	79811	0.964
NULL	Case_Rep_Oncol_2010_Jun_8_3(2)_182-188.nxml.txt.nlp	20740194	SENT62	0	0	5	5	phenprocoumon	CYP3A4	PA450921	1576	0.964
NULL	Allergy_Asthma_Immunol_Res_2014_Nov_19_6(6)_548-557.nxml.txt.nlp	25374755	SENT121	26	26	19	19	lovastatin	MUC5AC	PA450272	4586	0.964
NULL	J_Hematol_Oncol_2012_Jul_11_5_16.nxml.txt.nlp	22534171	SENT224	13	13	11	11	erlotinib	EGFR	PA134687924	1956	0.964
NULL	Cell_Death_Dis_2012_Jun_21_3(6)_e327.nxml.txt.nlp	22717582	SENT187	34	34	11	11	doxorubicin	BAX	PA449412	581	0.964
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Jul_21_9_20.nxml.txt.nlp	20663145	SENT94	27	27	3	3	clindamycin	AAP	PA449035	5345	0.964
NULL	Pharmaceuticals_(Basel)_2012_Sep_12_5(9)_1008-1020.nxml.txt.nlp	24280702	SENT653	4	4	16	16	tanespimycin	HER-2	PA165291490	2064	0.964
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1542-1553.nxml.txt.nlp	21970874	SENT132	28	28	4	4	carboplatin	ERCC1	PA448803	2067	0.964
NULL	Pharm_Pract_(Granada)_2011_Mar_15_Jan-Mar_9(1)_1-10.nxml.txt.nlp	25132883	SENT121	9	9	34	34	rivaroxaban	SPAF	PA165958360	166378	0.964
NULL	J_Korean_Med_Sci_2009_Oct_23_24(5)_979-981.nxml.txt.nlp	19795005	SENT35	28	28	9	9	hydrocortisone	ACTH	PA449905	5443	0.964
NULL	eLife_2014_May_6_3_e02482.nxml.txt.nlp	24843002	SENT219	12	12	3	3	etoposide	SETD2	PA449552	29072	0.964
NULL	Braz_J_Med_Biol_Res_2012_Jul_20_45(10)_935-941.nxml.txt.nlp	22801415	SENT155	15	15	5	5	pioglitazone	ghrelin	PA450970	51738	0.964
NULL	Anticancer_Drugs_2015_Jan_28_26(1)_46-55.nxml.txt.nlp	25099621	SENT92	36	36	5	5	paclitaxel	KE-3	PA450761	6222	0.964
NULL	Oncol_Rep_2013_Mar_8_29(3)_917-924.nxml.txt.nlp	23314174	SENT124	2	2	6	6	sorafenib	HIF-1	PA7000	29072	0.964
NULL	Crit_Care_2005_Sep_3_9(1)_23-24.nxml.txt.nlp	15693976	SENT14	11	11	31	31	dantrolene	CHS	PA449208	1130	0.964
NULL	Aging_(Albany_NY)_2010_Oct_31_2(10)_669-677.nxml.txt.nlp	21076179	SENT59	33	33	7	7	vorinostat	PERK	PA164748224	9451	0.964
NULL	Cell_Commun_Signal_2013_Nov_11_11_86.nxml.txt.nlp	24215724	SENT524	15	15	23	23	ketamine	PAR1	PA450144	79581;2149	0.964
NULL	Cancers_(Basel)_2011_May_3_3(2)_2255-2273.nxml.txt.nlp	24212808	SENT146	4	4	20	20	gefitinib	AAP	PA131301952	5345	0.964
NULL	Oncoimmunology_2013_Mar_1_2(3)_e23205.nxml.txt.nlp	23802072	SENT39	41	41	10	10	rituximab	IL-2	PA451261	3558	0.964
NULL	Ann_Rheum_Dis_2010_Oct_27_70(2)_299-304.nxml.txt.nlp	20980704	SENT75	17	17	7	7	infliximab	FCGR3A	PA452639	2214	0.964
NULL	Indian_J_Urol_2009_Oct-Dec_25(4)_427-436.nxml.txt.nlp	19955664	SENT110	15	15	24	24	bevacizumab	EGFR	PA130232992	1956	0.964
NULL	Arthritis_Res_Ther_2012_Apr_30_14(2)_R96.nxml.txt.nlp	22546471	SENT232	34	34	24	24	methotrexate	IL-6	PA450428	3569	0.964
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT127	14	14	3	3	doxorubicin	SLK	PA449412	9748;2534	0.964
NULL	Br_J_Cancer_2011_Mar_1_104(5)_750-755.nxml.txt.nlp	21326243	SENT123	39	39	25	25	dacarbazine	MPG	PA449197	4350	0.964
NULL	Breast_Cancer_Res_2007_Mar_2_9(2)_205.nxml.txt.nlp	NULL	SENT27	6	6	33	33	lapatinib	SLK	PA152241907	9748;2534	0.964
NULL	Evid_Based_Complement_Alternat_Med_2014_May_8_2014_364819.nxml.txt.nlp	24899907	SENT169	10	10	30	30	tacrolimus	FKBP52	PA451578	2288	0.964
NULL	J_Mol_Signal_2006_Dec_6_1_8.nxml.txt.nlp	17224083	SENT65	10	10	20	20	thrombin	Rho	PA451674	29984	0.964
NULL	Cell_Death_Dis_2014_Apr_24_5(4)_e1197.nxml.txt.nlp	24763054	SENT103	21	21	1	1	cisplatin	RUNX3	PA449014	864	0.964
NULL	Cell_Commun_Signal_2014_Mar_23_12_19.nxml.txt.nlp	24656144	SENT302	2	2	8	8	minocycline	MMP9	PA450519	4318	0.964
NULL	Core_Evid_2010_Oct_21_5_77-90.nxml.txt.nlp	21042544	SENT177	20	20	6	6	terfenadine	CYP3A4	PA451619	1576	0.964
NULL	Br_J_Cancer_2013_Sep_3_109(5)_1214-1222.nxml.txt.nlp	23922104	SENT162	20	20	10	10	doxorubicin	TP53	PA449412	7157	0.964
NULL	Nucleic_Acids_Res_2005_Oct_19_33(18)_5819-5828.nxml.txt.nlp	16237123	SENT98	9	9	36	36	cisplatin	HMGB1	PA449014	3146	0.964
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT75	12	12	25	25	erlotinib	EGFR	PA134687924	1956	0.964
NULL	Cent_European_J_Urol_2013_Aug_13_66(2)_150-151.nxml.txt.nlp	24579015	SENT29	1	1	19	19	resveratrol	ski		55733	0.964
NULL	Oncotarget_2010_Oct_9_1(6)_387-395.nxml.txt.nlp	21311095	SENT138	9	9	30	30	irinotecan	CD166	PA450085	214	0.964
NULL	Arch_Drug_Inf_2011_Mar_4(1)_1-9.nxml.txt.nlp	21572514	SENT143	4	4	7	7	ciprofloxacin	P-gp	PA449009	5243	0.964
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT118	14	14	20	20	paclitaxel	HER2	PA450761	2064	0.964
NULL	Clin_Ophthalmol_2008_Jun_2(2)_355-368.nxml.txt.nlp	19668727	SENT182	0	0	25	25	nepafenac	CYP2D6	PA165958407	1565	0.964
NULL	Clin_Ophthalmol_2014_Jun_26_8_1213-1219.nxml.txt.nlp	25061267	SENT18	3	3	13	13	proparacaine	PRK	PA164776849	1263	0.964
NULL	Oncogene_2014_Sep_18_33(38)_4664-4674.nxml.txt.nlp	24096486	SENT10	16	16	3	3	erlotinib	EGF	PA134687924	1950	0.964
NULL	Orphanet_J_Rare_Dis_2014_Apr_29_9_66.nxml.txt.nlp	24775865	SENT86	40	40	9	9	paraformaldehyde	ALPL	PA450790	249	0.964
NULL	Oncol_Rep_2013_Mar_8_29(3)_917-924.nxml.txt.nlp	23314174	SENT125	36	36	22	22	sorafenib	HIF-1	PA7000	29072	0.964
NULL	Onco_Targets_Ther_2014_Dec_16_8_7-14.nxml.txt.nlp	25565860	SENT95	16	16	29	29	cetuximab	EGFR	PA10040	1956	0.964
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT195	3	3	14	14	methotrexate	MSH2	PA450428	4436	0.964
NULL	J_Korean_Med_Sci_2009_Jan_29_24(Suppl_1)_S170-S175.nxml.txt.nlp	19194548	SENT84	3	3	43	43	cisplatin	EPO	PA449014	7076;8288;2056	0.964
NULL	Cancer_Res_Treat_2012_Mar_31_44(1)_50-56.nxml.txt.nlp	22500161	SENT133	12	12	0	0	trastuzumab	HER2	PA451743	2064	0.964
NULL	Curr_Clin_Pharmacol_2008_Sep_3(3)_198-203.nxml.txt.nlp	18781906	SENT119	5	5	20	20	lamotrigine	CYP3A4	PA450164	1576	0.964
NULL	Mol_Clin_Oncol_2013_Sep_24_1(5)_918-924.nxml.txt.nlp	24649271	SENT155	2	2	12	12	gemcitabine	EGFR	PA449748	1956	0.964
NULL	Oncotarget_2014_Oct_29_5(21)_10901-10915.nxml.txt.nlp	25337721	SENT3	28	28	7	7	temozolomide	BRCC3	PA451609	79184;55789	0.964
NULL	J_Hematol_Oncol_2009_Apr_22_2_18.nxml.txt.nlp	19386128	SENT151	31	31	14	14	bevacizumab	KRAS	PA130232992	3845	0.964
NULL	Front_Oncol_2014_Mar_3_4_34.nxml.txt.nlp	24624361	SENT218	13	13	6	6	cisplatin	CDK1	PA449014	983	0.964
NULL	Cancers_(Basel)_2011_Apr_1_3(2)_1844-1860.nxml.txt.nlp	24212785	SENT98	27	27	17	17	cetuximab	PTEN	PA10040	5728	0.964
NULL	Dement_Geriatr_Cogn_Dis_Extra_2014_Nov_15_4(3)_450-456.nxml.txt.nlp	25538729	SENT94	20	20	13	13	donepezil	APOE	PA449394	348	0.964
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT68	18	18	7	7	paclitaxel	ABCC10	PA450761	89845	0.964
NULL	Lipids_Health_Dis_2011_Aug_4_10_129.nxml.txt.nlp	21813022	SENT20	36	36	5	5	lipase	FAAH	PA450239	79152;2166	0.964
NULL	Aging_Cell_2010_Dec_9(6)_1084-1097.nxml.txt.nlp	20883526	SENT226	9	9	32	32	collagenase	CO2	PA449107	4513	0.964
NULL	J_Adv_Pract_Oncol_2012_Jan_1_Jan-Feb_3(1)_49-54.nxml.txt.nlp	25031928	SENT40	16	16	32	32	plerixafor	CD34	PA165958410	947	0.964
NULL	Mol_Cancer_2008_Jun_30_7_60.nxml.txt.nlp	18590557	SENT71	16	16	3	3	doxorubicin	TRAIL	PA449412	8743	0.964
NULL	Diabetes_2013_Oct_17_62(10)_e19-e22.nxml.txt.nlp	24065800	SENT50	4	4	25	25	lipase	GLP-1	PA450239	100125288	0.964
NULL	Arthritis_Res_Ther_2006_Nov_1_8(6)_R166.nxml.txt.nlp	17078892	SENT61	6	6	23	23	etanercept	CD4	PA449515	920	0.964
NULL	Oncologist_2010_Sep_26_15(9)_944-953.nxml.txt.nlp	20798196	SENT30	26	26	21	21	letrozole	aromatase	PA450196	1588	0.964
NULL	Eur_J_Med_Res_2011_Apr_28_16(4)_139-144.nxml.txt.nlp	21486727	SENT157	20	20	28	28	posaconazole	NNT	PA151958574	23530	0.964
NULL	Br_J_Cancer_2012_Aug_21_107(5)_793-799.nxml.txt.nlp	22850551	SENT104	33	33	26	26	erlotinib	EGFR	PA134687924	1956	0.964
NULL	Breast_Cancer_Res_2012_Aug_16_14(4)_R119.nxml.txt.nlp	22898337	SENT138	29	29	11	11	trastuzumab	HER2	PA451743	2064	0.964
NULL	Oncogene_2013_Sep_26_32(39)_10_1038_onc_2012_491.nxml.txt.nlp	23108394	SENT78	28	28	5	5	epirubicin	FOXM1	PA449476	2305	0.964
NULL	Breast_Cancer_Res_2008_Apr_29_10(2)_206.nxml.txt.nlp	18492214	SENT125	17	17	9	9	estradiol	aromatase	PA449503	1588	0.964
NULL	Oncotarget_2014_Mar_14_5(10)_3029-3038.nxml.txt.nlp	24912489	SENT23	7	7	5	5	letrozole	aromatase	PA450196	1588	0.964
NULL	BMB_Rep_2014_Mar_47(3)_167-172.nxml.txt.nlp	24499665	SENT86	0	0	4	4	nutlin-3	MDM2		4193	0.964
NULL	Breast_Cancer_Res_Treat_2013_Aug_20_141(1)_43-53.nxml.txt.nlp	23959396	SENT27	44	44	16	16	pertuzumab	HER2		2064	0.964
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Jul_23_3(7)_e126.nxml.txt.nlp	25054314	SENT60	13	13	21	21	docetaxel	MRP2	PA449383	100130958;57626;1244	0.964
NULL	Reprod_Biol_Endocrinol_2004_Aug_4_2_59.nxml.txt.nlp	15294019	SENT118	17	17	29	29	forskolin	EGF	PA146096022	1950	0.964
NULL	J_Res_Med_Sci_2011_May_16(5)_611-620.nxml.txt.nlp	22091283	SENT44	9	9	23	23	propofol	DES	PA451141	1674	0.964
NULL	Front_Physiol_2015_Jan_5_5_501.nxml.txt.nlp	25601838	SENT179	21	21	12	12	thrombin	IL-6	PA451674	3569	0.964
NULL	J_Korean_Neurosurg_Soc_2014_Oct_31_56(4)_344-347.nxml.txt.nlp	25371786	SENT32	12	12	8	8	aspirin	APT	PA448497	653639	0.964
NULL	Front_Oncol_2014_Sep_23_4_264.nxml.txt.nlp	25295231	SENT71	6	6	2	2	nutlin-3	CD34		947	0.964
NULL	Nat_Commun_2013_Sep_20_4_2444.nxml.txt.nlp	24051492	SENT146	10	10	17	17	nutlin-3	p53		7157	0.964
NULL	Nucleic_Acids_Res_2011_Sep_25_39(17)_7576-7585.nxml.txt.nlp	21705779	SENT179	28	28	8	8	doxycycline	KHSRP	PA449415	8570	0.964
NULL	J_Cell_Biol_2002_Jun_24_157(7)_1151-1160.nxml.txt.nlp	12082077	SENT100	35	35	6	6	trypsin	COX	PA451806	1351	0.964
NULL	Arthritis_Res_Ther_2014_Sep_26_16(5)_429.nxml.txt.nlp	25606593	SENT106	2	2	14	14	anakinra	ADAMTS4	PA10799	9507	0.964
NULL	Breast_Cancer_Res_2011_Feb_23_13(1)_203.nxml.txt.nlp	21392408	SENT6	35	35	21	21	tamoxifen	aromatase	PA451581	1588	0.964
NULL	Diabetes_Metab_Syndr_Obes_2013_Sep_2_6_317-325.nxml.txt.nlp	24039439	SENT56	14	14	26	26	mitiglinide	GLP-1	PA164748124	100125288	0.964
NULL	Ecancermedicalscience_2010_Apr_30_4_ed6.nxml.txt.nlp	24966881	SENT8	33	33	4	4	trastuzumab	PTEN	PA451743	5728	0.964
NULL	Breast_Cancer_2013_Mar_1_20(4)_302-309.nxml.txt.nlp	23456736	SENT165	34	34	13	13	tamoxifen	aromatase	PA451581	1588	0.964
NULL	Eur_J_Haematol_2014_Feb_25_92(2)_127-136.nxml.txt.nlp	24118452	SENT68	12	12	3	3	anagrelide	CRT	PA164742986	811	0.964
NULL	Front_Zool_2013_Feb_21_10_8.nxml.txt.nlp	23433033	SENT98	8	8	14	14	flutamide	aromatase	PA449685	1588	0.964
NULL	Acta_Pharmacol_Sin_2010_Sep_2_31(9)_1172-1180.nxml.txt.nlp	20676117	SENT182	6	6	30	30	bsi-201	PARP1		142	0.964
NULL	AIDS_Res_Ther_2014_Oct_7_11(1)_33.nxml.txt.nlp	NULL	SENT34	8	8	5	5	raltegravir	CCR5		1234	0.964
NULL	Diabetes_Metab_Syndr_Obes_2010_Mar_29_3_31-41.nxml.txt.nlp	21437074	SENT157	10	10	2	2	exenatide	GLP-1	PA164749238	100125288	0.964
NULL	Oncotarget_2012_Oct_20_3(10)_1068-1111.nxml.txt.nlp	23085539	SENT900	4	4	31	31	vemurafenib	BRAF	PA165946873	673	0.964
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT116	6	6	11	11	sulindac	AKT	PA451565	207	0.964
NULL	Cell_Cycle_2013_Sep_1_12(17)_2899-2913.nxml.txt.nlp	23966157	SENT128	10	10	1	1	cisplatin	EMMPRIN	PA449014	682	0.964
NULL	Int_Semin_Surg_Oncol_2008_Apr_28_5_9.nxml.txt.nlp	18442393	SENT72	27	27	18	18	tamoxifen	HER2	PA451581	2064	0.964
NULL	Nucleic_Acids_Res_2005_Jun_8_33(10)_3283-3291.nxml.txt.nlp	15944449	SENT156	32	32	13	13	mechlorethamine	XRCC3	PA450336	7517	0.964
NULL	Target_Oncol_2013_Mar_30_8(1)_27-33.nxml.txt.nlp	23361373	SENT59	12	12	20	20	gefitinib	EGFR	PA131301952	1956	0.964
NULL	J_Infect_Dis_2014_Oct_1_210(7)_1029-1041.nxml.txt.nlp	24706936	SENT192	14	14	2	2	dextran	p40	PA449261	3921;339541;10314	0.964
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT145	11	11	0	0	lapatinib	HER3	PA152241907	2065	0.964
NULL	Br_J_Cancer_2012_Jan_3_106(1)_85-91.nxml.txt.nlp	22127285	SENT153	18	18	3	3	dasatinib	BRAF	PA162372878	673	0.964
NULL	Evid_Based_Complement_Alternat_Med_2013_Mar_26_2013_625892.nxml.txt.nlp	23589719	SENT181	37	37	18	18	probenecid	GLP-1	PA451106	100125288	0.964
NULL	J_Inherit_Metab_Dis_2012_Jan_10_35(1)_141-149.nxml.txt.nlp	21556832	SENT15	0	0	27	27	creatine	CRTR	PA164778930	6535	0.964
NULL	Int_J_Mol_Sci_2014_Oct_8_15(10)_17974-17999.nxml.txt.nlp	25299695	SENT117	6	6	14	14	curcumin	HO-2	PA151958596	3163	0.964
NULL	Eur_J_Neurosci_2008_Apr_1_27(7)_1722-1730.nxml.txt.nlp	18380669	SENT198	28	28	25	25	sr144528	CB2		1269	0.964
NULL	J_Mol_Signal_2014_Mar_6_9_1.nxml.txt.nlp	24597858	SENT105	13	13	30	30	metoprolol	GRK5	PA450480	2869	0.964
NULL	Indian_J_Pharmacol_2013_Nov-Dec_45(6)_597-602.nxml.txt.nlp	24347768	SENT23	46	46	3	3	docetaxel	P-gp	PA449383	5243	0.964
NULL	Int_J_Endocrinol_2014_Mar_17_2014_878670.nxml.txt.nlp	24744785	SENT345	0	0	9	9	sildenafil	CYP2C9	PA451346	1559	0.964
NULL	J_Hematol_Oncol_2008_Oct_1_1_16.nxml.txt.nlp	18828924	SENT66	4	4	23	23	lapatinib	HER2	PA152241907	2064	0.964
NULL	Acta_Pharmacol_Sin_2014_Oct_25_35(10)_1293-1301.nxml.txt.nlp	25152022	SENT114	8	8	16	16	enalapril	NLRP3	PA449456	114548	0.964
NULL	Cell_Commun_Signal_2013_Dec_20_11_97.nxml.txt.nlp	24359404	SENT256	25	25	0	0	imatinib	PDGF-A	PA10804	5154	0.964
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT152	13	13	26	26	simvastatin	survivin	PA451363	332	0.964
NULL	Cell_Oncol_(Dordr)_2011_Oct_4_34(5)_489-494.nxml.txt.nlp	21541733	SENT33	44	44	10	10	tamoxifen	ESR1	PA451581	2099	0.964
NULL	Core_Evid_2009_Jun_15_4_131-147.nxml.txt.nlp	20694070	SENT240	16	16	32	32	raltegravir	CD4		920	0.964
NULL	Diabetol_Metab_Syndr_2014_Sep_24_6(1)_103.nxml.txt.nlp	NULL	SENT122	15	15	30	30	sitagliptin	GLP-1	PA164748978	100125288	0.964
NULL	Cancer_Med_2013_Oct_18_2(5)_595-610.nxml.txt.nlp	24403226	SENT373	16	16	6	6	gefitinib	ZEB1	PA131301952	6935	0.964
NULL	Breast_Cancer_Res_2002_Jul_24_4(6)_R12.nxml.txt.nlp	12473173	SENT28	9	9	2	2	estradiol	BRCA1	PA449503	672	0.964
NULL	Environ_Health_Perspect_2006_Sep_23_114(9)_1401-1406.nxml.txt.nlp	16966095	SENT139	41	41	5	5	tetracycline	p53	PA451640	7157	0.964
NULL	Respir_Med_Case_Rep_2013_Sep_7_10_34-36.nxml.txt.nlp	NULL	SENT28	10	10	12	12	erlotinib	EGFR	PA134687924	1956	0.964
NULL	Mol_Cancer_2012_Sep_21_11_72.nxml.txt.nlp	22995644	SENT9	16	16	6	6	imatinib	PRL-3	PA10804	11156	0.964
NULL	Breast_Cancer_Res_2006_Jul_3_8(3)_211.nxml.txt.nlp	16834766	SENT215	17	17	5	5	daunorubicin	CD38	PA449212	952	0.964
NULL	Nature_2008_Oct_23_455(7216)_1076-1081.nxml.txt.nlp	18948948	SENT94	27	27	9	9	staurosporine	BAX	PA165109623	581	0.964
NULL	Adv_Hematol_2012_Jul_24_2012_513702.nxml.txt.nlp	22888354	SENT78	0	0	22	22	lenalidomide	IL-6	PA162363968	3569	0.964
NULL	Cancer_Med_2014_Feb_10_3(1)_134-142.nxml.txt.nlp	24407937	SENT194	20	20	12	12	trastuzumab	NNT	PA451743	23530	0.964
NULL	Int_J_Hypertens_2012_Feb_8_2012_189512.nxml.txt.nlp	22518281	SENT166	11	11	24	24	hemin	HO-1	PA449849	3162	0.964
NULL	Pharmaceuticals_(Basel)_2013_Apr_3_6(4)_480-499.nxml.txt.nlp	24276119	SENT183	9	9	24	24	acamprosate	mGlu5	PA10344	2915	0.964
NULL	Br_J_Pharmacol_2013_Jun_27_169(4)_736-747.nxml.txt.nlp	23489111	SENT167	0	0	6	6	quinine	5-HT3A	PA451213	3359	0.964
NULL	Cell_Commun_Signal_2009_Aug_13_7_19.nxml.txt.nlp	19678929	SENT47	7	7	20	20	panitumumab	KRAS	PA162373091	3845	0.964
NULL	Acta_Otolaryngol_2010_Nov_30_130(11)_1278-1286.nxml.txt.nlp	20586674	SENT125	15	15	8	8	methimazole	TRPV1	PA450422	7442	0.964
NULL	J_Gynecol_Oncol_2014_Apr_9_25(2)_130-135.nxml.txt.nlp	24761217	SENT26	1	1	15	15	paclitaxel	castor	PA450761	54897	0.964
NULL	Biologics_2009_Jul_13_3_289-301.nxml.txt.nlp	19707416	SENT220	0	0	8	8	lapatinib	HER2	PA152241907	2064	0.964
NULL	Breast_Cancer_Res_2012_May_18_14(3)_R78.nxml.txt.nlp	22608253	SENT24	17	17	27	27	tamoxifen	aromatase	PA451581	1588	0.964
NULL	Arthritis_Res_Ther_2009_Aug_28_11(4)_R131.nxml.txt.nlp	19715572	SENT119	5	5	26	26	rituximab	CD4	PA451261	920	0.964
NULL	Mol_Biol_Int_2014_Sep_7_2014_852748.nxml.txt.nlp	25276427	SENT182	0	0	11	11	neratinib	EGFR	PA165291472	1956	0.964
NULL	Cancer_Cell_Int_2013_Nov_1_13_108.nxml.txt.nlp	24176221	SENT164	12	12	1	1	cisplatin	PI3K	PA449014	5290	0.964
NULL	Case_Rep_Hematol_2013_Sep_30_2013_628513.nxml.txt.nlp	24198984	SENT94	18	18	3	3	vincristine	FVIII	PA451879	2157	0.964
NULL	Oncotarget_2014_Jun_27_5(13)_4694-4708.nxml.txt.nlp	25051361	SENT320	8	8	4	4	fludarabine	p27	PA449655	5715;10534	0.964
NULL	Br_J_Cancer_2010_Nov_2_103(11)_1680-1691.nxml.txt.nlp	21045833	SENT255	18	18	35	35	vorinostat	GADD45	PA164748224	1647	0.964
NULL	Arthritis_Res_Ther_2007_Jun_29_9(Suppl_1)_S3.nxml.txt.nlp	17634142	SENT94	0	0	28	28	denosumab	RANK	PA166048634	8792	0.964
NULL	Mol_Biol_Rep_2012_May_20_39(5)_5253-5267.nxml.txt.nlp	22183301	SENT176	7	7	18	18	gliclazide	NAC	PA10892	22861	0.964
NULL	Breast_Cancer_Res_2005_Aug_5_7(5)_212-214.nxml.txt.nlp	16168140	SENT13	30	30	15	15	trastuzumab	HER2	PA451743	2064	0.964
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT9	3	3	14	14	resveratrol	FADD		8772	0.964
NULL	Biosci_Rep_2012_Aug_1_32(Pt_4)_413-422.nxml.txt.nlp	22668349	SENT378	4	4	11	11	gefitinib	ERBB3	PA131301952	2065	0.964
NULL	Front_Neurosci_2012_May_30_6_77.nxml.txt.nlp	22661925	SENT335	9	9	44	44	ethanol	NALP3	PA448073	114548	0.964
NULL	J_Cell_Mol_Med_2013_Nov_9_17(11)_1484-1493.nxml.txt.nlp	24015932	SENT196	30	30	9	9	berberine	c-Myc	PA165860812	4609	0.964
NULL	Onco_Targets_Ther_2014_Sep_9_7_1571-1582.nxml.txt.nlp	25228815	SENT166	11	11	1	1	sunitinib	VEGFR2	PA162372840	3791	0.964
NULL	J_Young_Pharm_2010_Jul-Sep_2(3)_326-331.nxml.txt.nlp	21042495	SENT127	8	8	15	15	simvastatin	CYP3A4	PA451363	1576	0.964
NULL	Oncotarget_2014_May_27_5(19)_9049-9064.nxml.txt.nlp	24979294	SENT225	16	16	37	37	fulvestrant	aromatase	PA164747170	1588	0.964
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1033-1038.nxml.txt.nlp	22374460	SENT159	20	20	8	8	capecitabine	HER2	PA448771	2064	0.964
NULL	Evid_Based_Complement_Alternat_Med_2012_May_27_2012_272710.nxml.txt.nlp	22685484	SENT126	18	18	2	2	genistein	flower	PA165109660	11094	0.964
NULL	Cell_Cycle_2012_Jun_15_11(12)_2229.nxml.txt.nlp	22672903	SENT45	14	14	12	12	flavopiridol	CDK9	PA452627	1025	0.964
NULL	Br_J_Clin_Pharmacol_2012_Apr_7_73(4)_518-535.nxml.txt.nlp	22053916	SENT63	8	8	16	16	rosuvastatin	CYP3A4	PA134308647	1576	0.964
NULL	Neuro_Oncol_2010_Apr_27_12(4)_389-400.nxml.txt.nlp	20308316	SENT120	6	6	1	1	chloroquine	p53	PA448948	7157	0.964
NULL	Clin_Ophthalmol_2014_Sep_26_8_1967-1985.nxml.txt.nlp	25328381	SENT252	45	45	23	23	latanoprost	BAK	PA164774763	578	0.964
NULL	Oncotarget_2011_Dec_20_2(12)_1075-1093.nxml.txt.nlp	22185818	SENT123	29	29	11	11	tamoxifen	ANXA2	PA451581	302	0.964
NULL	Med_Sci_Monit_2013_Oct_31_19_916-926.nxml.txt.nlp	24172537	SENT113	34	34	4	4	melphalan	FANCC	PA450354	2176	0.964
NULL	J_Exp_Med_2000_May_15_191(10)_1755-1764.nxml.txt.nlp	10811868	SENT90	21	21	8	8	neomycin	CCR4	PA450608	25819;57472;1233	0.964
NULL	J_Breast_Cancer_2014_Dec_26_17(4)_332-338.nxml.txt.nlp	25548580	SENT107	23	23	0	0	capsaicin	TRPV1	PA448776	7442	0.964
NULL	Arthritis_Res_Ther_2005_Apr_4_7(4)_R756-R768.nxml.txt.nlp	15987477	SENT202	11	11	1	1	hyaluronidase	PH-20	PA164745713	6677	0.964
NULL	Oncotarget_2013_Nov_24_4(12)_2186-2207.nxml.txt.nlp	24327604	SENT39	5	5	37	37	trastuzumab	PI3K	PA451743	5290	0.964
NULL	Oncol_Lett_2013_Feb_9_5(2)_552-558.nxml.txt.nlp	23420128	SENT108	4	4	9	9	imatinib	KIT	PA10804	3815	0.964
NULL	Allergy_Asthma_Clin_Immunol_2005_Sep_15_1(3)_101-116.nxml.txt.nlp	20529221	SENT240	26	26	4	4	desloratadine	PACT	PA164776964	8575;5930	0.964
NULL	Contemp_Oncol_(Pozn)_2013_Apr_29_17(2)_137-143.nxml.txt.nlp	23788980	SENT186	20	20	41	41	bromocriptine	PRL	PA448671	5617	0.964
NULL	Eur_J_Med_Res_2011_Apr_28_16(4)_139-144.nxml.txt.nlp	21486727	SENT157	22	22	28	28	fluconazole	NNT	PA449653	23530	0.964
NULL	Front_Neurosci_2014_Jan_31_8_6.nxml.txt.nlp	24550768	SENT77	4	4	16	16	capsaicin	TRPV1	PA448776	7442	0.964
NULL	Int_J_Nanomedicine_2010_Apr_7_5_203-211.nxml.txt.nlp	20463936	SENT103	13	13	4	4	glutaraldehyde	CD133	PA449777	8842	0.964
NULL	Arthritis_Res_Ther_2014_Feb_11_16(1)_R51.nxml.txt.nlp	24517398	SENT210	6	6	19	19	rituximab	BAFF	PA451261	10673	0.964
NULL	Mol_Cancer_2009_Nov_10_8_99.nxml.txt.nlp	19903356	SENT66	26	26	12	12	imatinib	IGFBP3	PA10804	3486	0.964
NULL	Oncotarget_2013_Nov_23_5(1)_196-210.nxml.txt.nlp	24344116	SENT141	23	23	9	9	doxorubicin	TNFAIP3	PA449412	7128	0.964
NULL	Dement_Geriatr_Cogn_Dis_Extra_2014_Nov_15_4(3)_450-456.nxml.txt.nlp	25538729	SENT94	20	20	15	15	donepezil	CYP2D6	PA449394	1565	0.964
NULL	Mol_Vis_2014_Dec_19_20_1680-1694.nxml.txt.nlp	25558172	SENT28	30	30	14	14	bevacizumab	HTRA1	PA130232992	5654	0.964
NULL	Mol_Cancer_2008_Jan_25_7_14.nxml.txt.nlp	18221502	SENT37	18	18	5	5	oxaliplatin	PSAT1	PA131285527	29968	0.964
NULL	J_Neuroinflammation_2010_Sep_7_7_51.nxml.txt.nlp	20822529	SENT101	3	3	29	29	hemin	HO-2	PA449849	3163	0.964
NULL	Cancers_(Basel)_2014_Jul_7_6(3)_1441-1463.nxml.txt.nlp	25003395	SENT250	9	9	16	16	trastuzumab	HER2	PA451743	2064	0.964
NULL	Reprod_Biol_Endocrinol_2003_Oct_7_1_66.nxml.txt.nlp	14609433	SENT258	2	2	7	7	cisplatin	p53	PA449014	7157	0.964
NULL	J_Physiol_2011_Feb_1_589(Pt_3)_755-766.nxml.txt.nlp	21173081	SENT262	5	5	22	22	vasopressin	ACTH	PA451858	5443	0.964
NULL	Orthop_Rev_(Pavia)_2014_Sep_18_6(3)_5405.nxml.txt.nlp	25317308	SENT60	21	21	25	25	codeine	PRN	PA449088	64428	0.964
NULL	J_Breast_Cancer_2013_Jun_28_16(2)_220-228.nxml.txt.nlp	23843857	SENT196	2	2	17	17	tamoxifen	aromatase	PA451581	1588	0.964
NULL	Cancers_(Basel)_2013_Jul_4_5(3)_838-856.nxml.txt.nlp	24202322	SENT149	0	0	16	16	nutlin-3	p53		7157	0.964
NULL	Asian_J_Androl_2014_Jan_17_Mar-Apr_16(2)_274-279.nxml.txt.nlp	24457841	SENT114	25	25	16	16	finasteride	PC3	PA449627	57332;7832;5122	0.964
NULL	Pharmaceutics_2011_Nov_18_3(4)_865-913.nxml.txt.nlp	24309312	SENT50	5	5	18	18	clarithromycin	CYP3A4	PA449028	1576	0.964
NULL	Breast_Cancer_(Auckl)_2011_Apr_13_5_53-65.nxml.txt.nlp	21603258	SENT128	0	0	6	6	trastuzumab	HER2	PA451743	2064	0.964
NULL	Breast_Cancer_Res_2010_Apr_30_12(2)_203.nxml.txt.nlp	20459590	SENT269	14	14	9	9	cisplatin	BRCA2	PA449014	675	0.964
NULL	Clin_Interv_Aging_2015_Jan_14_10_269-275.nxml.txt.nlp	25609939	SENT100	31	31	15	15	donepezil	CYP2D6	PA449394	1565	0.964
NULL	Onco_Targets_Ther_2014_Sep_9_7_1571-1582.nxml.txt.nlp	25228815	SENT165	30	30	17	17	sunitinib	VEGFR1	PA162372840	2321	0.964
NULL	Breast_Cancer_Res_Treat_2013_Apr_12_138(2)_427-435.nxml.txt.nlp	23479422	SENT21	0	0	12	12	trastuzumab	HER2	PA451743	2064	0.964
NULL	Open_AIDS_J_2010_May_14_4_103-104.nxml.txt.nlp	20648218	SENT10	4	4	37	37	methamphetamine	CD4	PA450403	920	0.964
NULL	Alzheimers_Res_Ther_2013_May_14_5(3)_25.nxml.txt.nlp	23673233	SENT15	8	8	28	28	scopolamine	spatial	PA451308	219793	0.964
NULL	Cancer_Cell_Int_2009_Sep_10_9_25.nxml.txt.nlp	19744341	SENT173	20	20	14	14	glucosamine	p27	PA164747613	5715;10534	0.964
NULL	J_Gynecol_Oncol_2013_Jan_8_24(1)_66-82.nxml.txt.nlp	23346316	SENT245	19	19	15	15	letrozole	aromatase	PA450196	1588	0.964
NULL	Br_J_Cancer_2011_Aug_23_105(5)_649-657.nxml.txt.nlp	21811251	SENT118	4	4	15	15	gefitinib	AKT	PA131301952	207	0.964
NULL	Ann_Oncol_2014_Oct_23_25(10)_1941-1948.nxml.txt.nlp	25057173	SENT14	27	27	10	10	docetaxel	EGFR	PA449383	1956	0.964
NULL	Breast_Cancer_Res_2013_Nov_29_15(6)_R114.nxml.txt.nlp	24289103	SENT332	6	6	20	20	pp2	EGFR		1956	0.964
NULL	Indian_J_Psychiatry_2007_Jan-Mar_49(1)_19-25.nxml.txt.nlp	20640061	SENT82	0	0	11	11	disulfiram	CAD	PA449376	1677;790	0.964
NULL	Breast_Cancer_Res_2010_Jun_24_12(3)_R41.nxml.txt.nlp	20576088	SENT167	15	15	4	4	paclitaxel	PPM1D	PA450761	8493	0.964
NULL	Cancer_Cell_2007_Dec_11_12(6)_514-527.nxml.txt.nlp	18068629	SENT147	22	22	3	3	paclitaxel	TGFBI	PA450761	7045	0.964
NULL	Mol_Biol_Cell_2014_May_1_25(9)_1411-1420.nxml.txt.nlp	24623724	SENT99	36	36	8	8	doxycycline	IRE1	PA449415	2081	0.964
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2012_Nov_14_1(11)_e14.nxml.txt.nlp	23835796	SENT86	41	41	26	26	denosumab	BSAP	PA166048634	5079	0.964
NULL	Chem_Cent_J_2013_Jun_8_7_98.nxml.txt.nlp	23759021	SENT156	7	7	30	30	meropenem	spatial	PA164764445	219793	0.964
NULL	Mol_Cancer_2014_Jun_5_13_143.nxml.txt.nlp	24898067	SENT49	2	2	17	17	trastuzumab	HER-2	PA451743	2064	0.964
NULL	Onco_Targets_Ther_2014_Jul_31_7_1367-1373.nxml.txt.nlp	25114575	SENT77	20	20	16	16	anastrozole	aromatase	PA448432	1588	0.964
NULL	Breast_Cancer_Res_2010_Jul_20_12(4)_R52.nxml.txt.nlp	20646288	SENT127	33	33	26	26	letrozole	COLEC12	PA450196	81035	0.964
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT188	5	5	16	16	lapatinib	HER2	PA152241907	2064	0.964
NULL	Biosci_Rep_2012_Aug_1_32(Pt_4)_361-374.nxml.txt.nlp	22762204	SENT204	24	24	3	3	methotrexate	p53	PA450428	7157	0.964
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT9	4	4	17	17	trastuzumab	HER2	PA451743	2064	0.964
NULL	Patient_Prefer_Adherence_2013_Mar_27_7_245-258.nxml.txt.nlp	23569364	SENT160	18	18	31	31	tamoxifen	aromatase	PA451581	1588	0.964
NULL	Diabetes_Metab_J_2012_Aug_20_36(4)_293-299.nxml.txt.nlp	22950061	SENT121	9	9	32	32	metformin	PI3K	PA450395	5290	0.964
NULL	Ecancermedicalscience_2009_Sep_24_3_153.nxml.txt.nlp	22276017	SENT60	21	21	5	5	oxaliplatin	ERCC1	PA131285527	2067	0.964
NULL	Oncol_Rep_2015_Feb_11_33(2)_526-532.nxml.txt.nlp	25501339	SENT13	15	15	3	3	gefitinib	p53	PA131301952	7157	0.964
NULL	F1000Res_2013_Jul_8_2_148.nxml.txt.nlp	24358859	SENT89	46	46	6	6	papain	E16	PA450778	8140	0.964
NULL	F1000Res_2013_Mar_5_2_74.nxml.txt.nlp	24358880	SENT230	1	1	6	6	capsaicin	TRPV1	PA448776	7442	0.964
NULL	Case_Reports_Hepatol_2013_May_14_2013_406901.nxml.txt.nlp	25431703	SENT14	0	0	20	20	adalimumab	TNF-alpha	PA10004	7124	0.964
NULL	Brain_Pathol_2010_Jan_20(1)_17-27.nxml.txt.nlp	19371355	SENT209	27	27	15	15	cisplatin	Bcl-2	PA449014	596	0.964
NULL	Oncoscience_2014_Jan_30_1(1)_57-68.nxml.txt.nlp	25593988	SENT215	19	19	33	33	ponatinib	c-FLIP	PA165980594	8837	0.964
NULL	Diabetes_2011_Jun_21_60(6)_1705-1715.nxml.txt.nlp	21521872	SENT123	12	12	31	31	doxycycline	STZ	PA449415	6484	0.964
NULL	Breast_Cancer_Res_2010_Jul_6_12(4)_R46.nxml.txt.nlp	20604919	SENT158	31	31	11	11	cetuximab	EGFR	PA10040	1956	0.964
NULL	Eur_J_Haematol_2009_May_82(5)_339-349.nxml.txt.nlp	19187276	SENT120	10	10	40	40	rivaroxaban	TKR	PA165958360	8277	0.964
NULL	Addict_Sci_Clin_Pract_2010_Dec_5(2)_17-29.nxml.txt.nlp	22002450	SENT129	4	4	12	12	bupropion	CYP2A6	PA448687	1548	0.964
NULL	Psychiatr_Genet_2013_Aug_28_23(4)_153-162.nxml.txt.nlp	23811784	SENT156	7	7	13	13	clozapine	5-HT2A	PA449061	3356	0.964
NULL	Cell_Death_Dis_2014_Feb_13_5(2)_e1057.nxml.txt.nlp	24525733	SENT107	7	7	16	16	staurosporine	BAX	PA165109623	581	0.964
NULL	Oncol_Lett_2013_Sep_12_6(3)_860-864.nxml.txt.nlp	24137426	SENT29	28	28	32	32	ketoconazole	CYP3A4	PA450146	1576	0.964
NULL	Cell_J_2013_Feb_20_Winter_14(4)_292-297.nxml.txt.nlp	23577309	SENT67	11	11	37	37	ketamine	gamma	PA450144	9913	0.964
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT137	3	3	33	33	maraviroc	CYP3A	PA164768835	1574	0.964
NULL	Arthritis_Res_Ther_2006_Nov_8_8(6)_R167.nxml.txt.nlp	17092341	SENT165	31	31	8	8	rituximab	BAFF	PA451261	10673	0.963
NULL	Oncotarget_2014_Oct_23_5(21)_10816-10829.nxml.txt.nlp	25333261	SENT147	22	22	18	18	doxorubicin	p53	PA449412	7157	0.963
NULL	J_Immunother_2014_Apr_12_37(3)_180-186.nxml.txt.nlp	24598448	SENT16	4	4	27	27	sorafenib	IL-2	PA7000	3558	0.963
NULL	AAPS_J_2011_Jun_1_13(3)_405-416.nxml.txt.nlp	21630127	SENT251	9	9	2	2	tocilizumab	IL-6	PA165292659	3569	0.963
NULL	Oncogene_2013_Oct_17_32(42)_5058-5065.nxml.txt.nlp	23160381	SENT81	41	41	29	29	docetaxel	p38	PA449383	10598;1432;7965	0.963
NULL	Nat_Neurosci_2012_Sep_5_15(9)_1245-1254.nxml.txt.nlp	22864611	SENT107	20	20	9	9	clozapine	mGlu3	PA449061	2913	0.963
NULL	Iran_J_Pharm_Res_2014_Winter_13(Suppl)_1-2.nxml.txt.nlp	24711823	SENT23	4	4	27	27	curcumin	Bcl-2	PA151958596	596	0.963
NULL	Biomed_Res_Int_2014_Apr_15_2014_175721.nxml.txt.nlp	24822180	SENT176	26	26	24	24	nutlin-3	MDM2		4193	0.963
NULL	Front_Endocrinol_(Lausanne)_2011_Dec_8_2_91.nxml.txt.nlp	22649391	SENT50	7	7	3	3	indomethacin	COX	PA449982	1351	0.963
NULL	Br_J_Cancer_2004_May_17_90(10)_2032-2041.nxml.txt.nlp	15138490	SENT149	24	24	2	2	trastuzumab	HER-2	PA451743	2064	0.963
NULL	J_Korean_Med_Sci_2008_Aug_25_23(4)_657-661.nxml.txt.nlp	18756053	SENT16	31	31	9	9	estradiol	AMH	PA449503	268	0.963
NULL	Breast_Cancer_Res_2009_Mar_19_11(2)_204.nxml.txt.nlp	19344489	SENT240	33	33	21	21	doxorubicin	HER2	PA449412	2064	0.963
NULL	Br_J_Cancer_2009_Jul_21_101(2)_269-277.nxml.txt.nlp	19603033	SENT129	21	21	1	1	cisplatin	XIAP	PA449014	331	0.963
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT177	26	26	13	13	methotrexate	RANKL	PA450428	8600	0.963
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1420-1426.nxml.txt.nlp	24056704	SENT136	7	7	13	13	verapamil	CYP3A	PA451868	1574	0.963
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT166	12	12	32	32	cisplatin	p53	PA449014	7157	0.963
NULL	Diabetes_Care_2011_Jun_20_34(6)_1369-1371.nxml.txt.nlp	21515844	SENT75	3	3	9	9	pioglitazone	gamma	PA450970	9913	0.963
NULL	Oncotarget_2014_Aug_27_5(19)_9227-9238.nxml.txt.nlp	25193861	SENT173	10	10	6	6	cisplatin	TP53	PA449014	7157	0.963
NULL	Curr_Hepat_Rep_2010_May_21_9(2)_75-90.nxml.txt.nlp	20461127	SENT362	4	4	26	26	entecavir	LAM	PA164784025	7249;7248	0.963
NULL	Biochemistry_2013_Mar_12_52(10)_1788-1801.nxml.txt.nlp	24449932	SENT101	5	5	32	32	thyroglobulin	B12	PA164754910	7126;4709	0.963
NULL	J_Hematol_Oncol_2013_Oct_12_6_78.nxml.txt.nlp	24283803	SENT46	14	14	19	19	daunorubicin	p53	PA449212	7157	0.963
NULL	FEBS_Open_Bio_2013_Oct_23_3_490-495.nxml.txt.nlp	24282676	SENT130	24	24	29	29	resveratrol	HIF-1		29072	0.963
NULL	Diabetes_Care_2009_Aug_12_32(8)_1428-1430.nxml.txt.nlp	19435956	SENT61	10	10	20	20	glibenclamide	KCNJ11	PA449782	3767	0.963
NULL	Cancers_(Basel)_2012_Jul_10_4(3)_658-672.nxml.txt.nlp	24213460	SENT26	15	15	5	5	irinotecan	DRG1	PA450085	4733;10397	0.963
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Apr_18_65(Pt_5)_o1065.nxml.txt.nlp	21583881	SENT57	4	4	33	33	ethanol	mol	PA448073	90527	0.963
NULL	J_Biol_Chem_2013_Jun_7_288(23)_16282-16294.nxml.txt.nlp	23632023	SENT271	3	3	12	12	collagenase	PAR-1	PA449107	2011;2149	0.963
NULL	Balkan_J_Med_Genet_2011_Jun_25_14(1)_25-30.nxml.txt.nlp	24052699	SENT71	32	32	11	11	phenytoin	RLIP76	PA450947	10928	0.963
NULL	Biomed_Res_Int_2014_Feb_23_2014_168949.nxml.txt.nlp	24707474	SENT30	35	35	2	2	gefitinib	EGFR	PA131301952	1956	0.963
NULL	Drugs_R_D_2011_Mar_27_11(1)_37-51.nxml.txt.nlp	21410294	SENT244	10	10	4	4	itraconazole	CYP3A4	PA450132	1576	0.963
NULL	Int_J_Cell_Biol_2012_May_17_2012_908724.nxml.txt.nlp	22675362	SENT70	18	18	3	3	vorinostat	SMN2	PA164748224	6607	0.963
NULL	Aging_(Albany_NY)_2010_Oct_12_2(11)_775-784.nxml.txt.nlp	20966530	SENT190	32	32	5	5	aprotinin	ACTH	PA448472	5443	0.963
NULL	Hum_Genomics_Proteomics_2010_Sep_13_2010_754919.nxml.txt.nlp	20981234	SENT92	27	27	2	2	warfarin	CYP2C9	PA451906	1559	0.963
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Oct_14_6_159-168.nxml.txt.nlp	25339848	SENT131	0	0	10	10	trastuzumab	GM-CSF	PA451743	1437	0.963
NULL	Arthritis_Res_Ther_2011_Oct_26_13(5)_R177.nxml.txt.nlp	22029963	SENT25	0	0	18	18	abatacept	CD28	PA164747080	1493;940	0.963
NULL	Br_J_Cancer_2011_Jan_4_104(1)_91-100.nxml.txt.nlp	21139584	SENT100	17	17	8	8	geldanamycin	Hsp90	PA152031327	3320	0.963
NULL	J_Hematol_Oncol_2012_Dec_13_5_75.nxml.txt.nlp	23237230	SENT159	20	20	13	13	rasburicase	G6PD	PA10176	2539	0.963
NULL	J_Immunother_Cancer_2014_Nov_6_2(Suppl_3)_P130.nxml.txt.nlp	NULL	SENT3	34	34	18	18	cyclophosphamide	survivin	PA449165	332	0.963
NULL	J_Korean_Med_Sci_2011_Dec_29_26(12)_1634-1637.nxml.txt.nlp	22148003	SENT79	0	0	28	28	candesartan	CYP2C9	PA448765	1559	0.963
NULL	Oxid_Med_Cell_Longev_2013_Jun_2_2013_793525.nxml.txt.nlp	23819014	SENT187	9	9	16	16	resveratrol	AMPK		5563	0.963
NULL	Mol_Cell_Biochem_2014_Jan_3_389(1-2)_177-185.nxml.txt.nlp	24385108	SENT205	5	5	23	23	bortezomib	NOXA	PA10252	5366	0.963
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT190	5	5	14	14	procainamide	CYP2D6	PA451108	1565	0.963
NULL	Arch_Drug_Inf_2008_Sep_1(2)_50-55.nxml.txt.nlp	19915714	SENT42	16	16	21	21	fentanyl	CYP3A4	PA449599	1576	0.963
NULL	Epigenetics_2012_Nov_1_7(11)_1217-1218.nxml.txt.nlp	23089629	SENT10	23	23	0	0	cisplatin	BRCA1	PA449014	672	0.963
NULL	J_Korean_Med_Sci_2013_Sep_28_28(9)_1307-1315.nxml.txt.nlp	24015035	SENT73	6	6	38	38	clopidogrel	TFI	PA449053	7035	0.963
NULL	J_Cell_Biol_2005_Nov_21_171(4)_729-738.nxml.txt.nlp	16286510	SENT215	22	22	1	1	heparin	syndecan	PA449855	6382	0.963
NULL	ISRN_Otolaryngol_2012_Nov_14_2012_797619.nxml.txt.nlp	23762619	SENT168	23	23	9	9	doxycycline	BRAK	PA449415	9547	0.963
NULL	Cardiol_Res_Pract_2013_Feb_21_2013_127270.nxml.txt.nlp	23509665	SENT22	13	13	16	16	clopidogrel	P2Y12	PA449053	64805	0.963
NULL	J_Mol_Med_(Berl)_2013_Aug_17_91(11)_1257-1271.nxml.txt.nlp	23955016	SENT51	0	0	30	30	thrombin	ADP	PA451674	23038	0.963
NULL	Pharmaceuticals_(Basel)_2013_Aug_21_6(8)_988-1038.nxml.txt.nlp	24276379	SENT2132	25	25	6	6	fluorouracil	UGT1A7	PA128406956	54577	0.963
NULL	Cancer_Cell_Int_2013_Feb_12_13_14.nxml.txt.nlp	23402310	SENT149	22	22	14	14	celecoxib	CDK4	PA448871	1019	0.963
NULL	Cell_Death_Dis_2014_Feb_13_5(2)_e1055.nxml.txt.nlp	24525731	SENT8	20	20	29	29	cisplatin	XRCC1	PA449014	7515	0.963
NULL	Breast_Cancer_Res_2010_Oct_22_12(Suppl_2)_S1.nxml.txt.nlp	21050422	SENT170	0	0	8	8	neratinib	EGFR	PA165291472	1956	0.963
NULL	Indian_J_Ophthalmol_2007_Nov-Dec_55(6)_421-425.nxml.txt.nlp	17951897	SENT65	5	5	35	35	ranibizumab	VEGF-A	PA164746012	7422	0.963
NULL	J_Hematol_Oncol_2010_Mar_13_3_10.nxml.txt.nlp	20226083	SENT29	16	16	6	6	gemcitabine	RRM1	PA449748	6240	0.963
NULL	Biol_Direct_2008_Apr_29_3_17.nxml.txt.nlp	18445273	SENT250	24	24	37	37	paclitaxel	14-3-3	PA450761	10971	0.963
NULL	Mol_Biol_Cell_2012_Jun_1_23(11)_2017-2027.nxml.txt.nlp	22496424	SENT209	18	18	8	8	warfarin	PRDX4	PA451906	10549	0.963
NULL	Breast_Cancer_Res_2012_May_2_14(3)_R70.nxml.txt.nlp	22551440	SENT209	17	17	24	24	docetaxel	p53	PA449383	7157	0.963
NULL	Mol_Cancer_2014_Jul_5_13_165.nxml.txt.nlp	24996221	SENT220	38	38	8	8	docetaxel	HMGB1	PA449383	3146	0.963
NULL	Mol_Cancer_2009_Dec_3_8_115.nxml.txt.nlp	19958544	SENT143	9	9	15	15	nutlin-3	MDM2		4193	0.963
NULL	Exp_Brain_Res_2014_Jun_27_232(8)_2637-2644.nxml.txt.nlp	24969614	SENT80	19	19	9	9	palonosetron	NK1	PA10352	11126	0.963
NULL	Br_J_Cancer_2011_Jul_26_105(3)_452-459.nxml.txt.nlp	21750557	SENT43	12	12	4	4	etoricoxib	COX2	PA164776853	4513;5743	0.963
NULL	Case_Rep_Med_2012_Jul_19_2012_706243.nxml.txt.nlp	22851978	SENT72	0	0	7	7	levetiracetam	GIT	PA450206	5034	0.963
NULL	Nucleic_Acids_Res_2014_Jan_1_42(1)_643-660.nxml.txt.nlp	24097436	SENT188	36	36	31	31	doxycycline	DIS3	PA449415	22894	0.963
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT124	26	26	11	11	vemurafenib	ABCB1	PA165946873	5243	0.963
NULL	BMB_Rep_2014_May_47(5)_274-279.nxml.txt.nlp	24286313	SENT113	12	12	2	2	bortezomib	CD138	PA10252	6382	0.963
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT16	18	18	42	42	capsaicin	p53	PA448776	7157	0.963
NULL	BMB_Rep_2014_Sep_47(9)_506-511.nxml.txt.nlp	24393528	SENT108	22	22	9	9	propranolol	BSP	PA451145	3381	0.963
NULL	Curr_Neuropharmacol_2014_Jul_12(4)_365-379.nxml.txt.nlp	25342944	SENT453	39	39	17	17	fluoxetine	5-HT2C	PA449673	3358	0.963
NULL	Basic_Clin_Neurosci_2013_Autumn_4(4)_323-328.nxml.txt.nlp	25337364	SENT98	1	1	14	14	colchicine	CA1	PA449092	759	0.963
NULL	Support_Care_Cancer_2012_May_1_20(5)_941-949.nxml.txt.nlp	21533811	SENT17	0	0	32	32	palonosetron	HEC	PA10352	10403	0.963
NULL	Int_J_Mol_Imaging_2011_Oct_12_2011_694179.nxml.txt.nlp	22013519	SENT122	5	5	22	22	zolmitriptan	5-HT1D	PA451975	3352	0.963
NULL	J_Epilepsy_Res_2014_Dec_31_4(2)_39-44.nxml.txt.nlp	25625087	SENT62	0	0	11	11	levetiracetam	SV2A	PA450206	9900	0.963
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT268	0	0	27	27	tenofovir	SLC22A8	PA10204	9376	0.963
NULL	Case_Rep_Oncol_2013_Mar_29_6(1)_189-196.nxml.txt.nlp	23626560	SENT4	37	37	6	6	erlotinib	EGFR	PA134687924	1956	0.963
NULL	Arthritis_Res_2002_May_9_4(Suppl_3)_S177-S182.nxml.txt.nlp	12110137	SENT105	11	11	17	17	rolipram	IL-10	PA153906323	3586	0.963
NULL	Surg_Neurol_Int_2014_May_8_5_64.nxml.txt.nlp	24991467	SENT165	8	8	19	19	erlotinib	EGFR	PA134687924	1956	0.963
NULL	Neural_Plast_2007_Dec_11_2007_73079.nxml.txt.nlp	NULL	SENT1259	10	10	20	20	desipramine	5-HT1A	PA449233	3350	0.963
NULL	Mol_Cancer_2007_Oct_11_6_63.nxml.txt.nlp	17931419	SENT141	22	22	10	10	cetuximab	HIF-1	PA10040	29072	0.963
NULL	Ann_Surg_Oncol_2014_Feb_13_21(5)_1575-1582.nxml.txt.nlp	24522992	SENT37	1	1	15	15	trastuzumab	HER2	PA451743	2064	0.963
NULL	J_Lipid_Res_2012_May_53(5)_1000-1011.nxml.txt.nlp	22368281	SENT13	14	14	5	5	pravastatin	LPA	PA451089	4018	0.963
NULL	Mol_Cancer_2010_Aug_23_9_222.nxml.txt.nlp	20731837	SENT80	14	14	7	7	gefitinib	ATM	PA131301952	472	0.963
NULL	J_Neuroinflammation_2010_Sep_7_7_51.nxml.txt.nlp	20822529	SENT109	6	6	35	35	hemin	HO-2	PA449849	3163	0.963
NULL	Contemp_Oncol_(Pozn)_2012_Nov_20_16(5)_363-370.nxml.txt.nlp	23788912	SENT302	22	22	14	14	dacarbazine	BRAF	PA449197	673	0.963
NULL	Eur_J_Endocrinol_2010_May_162(5)_987-992.nxml.txt.nlp	20164212	SENT123	20	20	4	4	diazoxide	HNF4A	PA449285	3172	0.963
NULL	Eur_J_Clin_Pharmacol_2010_Nov_29_66(11)_1131-1136.nxml.txt.nlp	20669013	SENT136	23	23	6	6	erythromycin	CYP2C19	PA449493	1557	0.963
NULL	Cancer_Cell_Int_2011_Aug_19_11_29.nxml.txt.nlp	21854619	SENT34	37	37	4	4	platinum	HDAC	PA150595617	9734	0.963
NULL	Eur_J_Clin_Microbiol_Infect_Dis_2014_Feb_23_33(6)_879-910.nxml.txt.nlp	24563274	SENT161	25	25	14	14	cefotaxime	19A	PA448852	57823	0.963
NULL	Cell_Death_Differ_2010_Oct_30_17(10)_1624-1635.nxml.txt.nlp	20431602	SENT375	18	18	32	32	paclitaxel	Bcl-2	PA450761	596	0.963
NULL	J_Breast_Cancer_2013_Mar_31_16(1)_23-31.nxml.txt.nlp	23593078	SENT103	39	39	21	21	decitabine	SLIT2	PA164749631	9353	0.963
NULL	Ecancermedicalscience_2008_Feb_18_2_75.nxml.txt.nlp	22275966	SENT156	30	30	7	7	cisplatin	NSCL	PA449014	4807	0.963
NULL	Orphanet_J_Rare_Dis_2013_Sep_8_8_137.nxml.txt.nlp	24011030	SENT361	9	9	7	7	vemurafenib	BRAF	PA165946873	673	0.963
NULL	Oncotarget_2014_Oct_11_5(20)_10070-10083.nxml.txt.nlp	25301722	SENT169	20	20	33	33	gefitinib	EGF	PA131301952	1950	0.963
NULL	Angiogenesis_2012_Sep_27_15(3)_361-376.nxml.txt.nlp	22451299	SENT111	3	3	28	28	resveratrol	HHS		2591	0.963
NULL	Ann_Rheum_Dis_2013_Aug_21_72(8)_1287-1294.nxml.txt.nlp	22915624	SENT249	30	30	11	11	methotrexate	MRI	PA450428	78996	0.963
NULL	Clin_Ophthalmol_2009_Jun_2_3_189-194.nxml.txt.nlp	19668564	SENT97	2	2	15	15	latanoprost	BAK	PA164774763	578	0.963
NULL	Oncoimmunology_2013_Aug_1_2(8)_e25238.nxml.txt.nlp	24083080	SENT67	45	45	10	10	doxorubicin	TLR8	PA449412	51311	0.963
NULL	Clin_Med_Insights_Oncol_2012_Feb_28_6_125-135.nxml.txt.nlp	22408376	SENT104	14	14	8	8	panitumumab	BRAF	PA162373091	673	0.963
NULL	Int_Clin_Psychopharmacol_2014_Nov_3_29(6)_351-356.nxml.txt.nlp	24978955	SENT30	5	5	9	9	buspirone	5-HT1A	PA448689	3350	0.963
NULL	Indian_J_Dermatol_2014_Sep-Oct_59(5)_425-441.nxml.txt.nlp	25284845	SENT181	10	10	0	0	etanercept	TNF-alpha	PA449515	7124	0.963
NULL	Mol_Cancer_2014_Jun_12_13_148.nxml.txt.nlp	24924916	SENT37	28	28	31	31	geldanamycin	Hsp90	PA152031327	3320	0.963
NULL	ARYA_Atheroscler_2011_Summer_7(2)_78-86.nxml.txt.nlp	22577451	SENT11	8	8	38	38	choline	IL-6	PA448976	3569	0.963
NULL	J_Cell_Biol_1997_Jul_28_138(2)_239-253.nxml.txt.nlp	9230068	SENT389	5	5	24	24	chloramphenicol	TRBP	PA448927	23054;6896	0.963
NULL	Infect_Drug_Resist_2011_Mar_2_4_77-86.nxml.txt.nlp	21694911	SENT69	2	2	15	15	tigecycline	CABP	PA164746412	6277	0.963
NULL	J_Hematol_Oncol_2014_Apr_28_7_37.nxml.txt.nlp	24775308	SENT141	9	9	0	0	imatinib	JAK2	PA10804	3717	0.963
NULL	Oncoscience_2014_Aug_7_1(8)_540-549.nxml.txt.nlp	25594061	SENT27	6	6	18	18	cetuximab	EGFR	PA10040	1956	0.963
NULL	Gut_Liver_2011_Jun_24_5(2)_160-164.nxml.txt.nlp	21814595	SENT107	10	10	43	43	midazolam	ESD	PA450496	2098	0.963
NULL	Environ_Health_Perspect_2005_Oct_14_113(10)_1330-1335.nxml.txt.nlp	16203242	SENT112	5	5	12	12	arsenite	MLC	PA452638	23209	0.963
NULL	Breast_Cancer_Res_2007_Mar_2_9(2)_205.nxml.txt.nlp	NULL	SENT27	6	6	31	31	lapatinib	STK10	PA152241907	6793	0.963
NULL	Breast_Cancer_Res_2014_Sep_12_16(5)_436.nxml.txt.nlp	25213081	SENT161	21	21	0	0	tamoxifen	FOXM1	PA451581	2305	0.963
NULL	Breast_Cancer_Res_2011_Jan_24_13(1)_401.nxml.txt.nlp	21349137	SENT17	5	5	20	20	erlotinib	AMPK	PA134687924	5563	0.963
NULL	Br_J_Pharmacol_2014_Feb_24_171(1)_1019-1032.nxml.txt.nlp	24251620	SENT177	14	14	6	6	nifedipine	TRPA1	PA450631	8989	0.963
NULL	Endocrinol_Metab_(Seoul)_2013_Dec_12_28(4)_262-274.nxml.txt.nlp	24396690	SENT89	0	0	3	3	liraglutide	GLP-1	PA165958364	100125288	0.963
NULL	Cancers_(Basel)_2013_Jul_4_5(3)_838-856.nxml.txt.nlp	24202322	SENT204	12	12	20	20	camptothecin	p53	PA153590860	7157	0.963
NULL	Bioanal_Rev_2012_Mar_17_4(1)_1-30.nxml.txt.nlp	22389661	SENT444	18	18	11	11	thalidomide	THM	PA451644	7063	0.963
NULL	Breast_Cancer_Res_Treat_2013_Jul_5_140(1)_63-71.nxml.txt.nlp	23828499	SENT192	39	39	31	31	carboplatin	HER2	PA448803	2064	0.963
NULL	Br_J_Cancer_2012_Nov_6_107(10)_1714-1721.nxml.txt.nlp	23073173	SENT10	12	12	21	21	bicalutamide	RUNX2	PA164746255	860	0.963
NULL	Eur_J_Clin_Pharmacol_2014_Oct_8_70(12)_1433-1441.nxml.txt.nlp	25291992	SENT10	15	15	36	36	olanzapine	B12	PA450688	7126;4709	0.963
NULL	Clinics_(Sao_Paulo)_2011_May_66(5)_753-757.nxml.txt.nlp	21789376	SENT86	6	6	14	14	nifedipine	Bcl-2	PA450631	596	0.963
NULL	Mol_Cancer_2007_Apr_2_6_25.nxml.txt.nlp	17407558	SENT179	25	25	12	12	cetuximab	EGFR	PA10040	1956	0.963
NULL	Indian_J_Pharm_Sci_2014_Mar-Apr_76(2)_166-169.nxml.txt.nlp	24843191	SENT30	18	18	6	6	nebivolol	HEC	PA151958426	10403	0.963
NULL	Mol_Cancer_2014_Jun_24_13_157.nxml.txt.nlp	24958351	SENT23	25	25	37	37	lapatinib	HER2	PA152241907	2064	0.963
NULL	Oncotarget_2010_May_1_1(1)_48-58.nxml.txt.nlp	21293053	SENT116	15	15	6	6	cisplatin	ID4	PA449014	3400	0.963
NULL	Br_J_Cancer_2012_May_22_106(11)_1722-1727.nxml.txt.nlp	22568966	SENT29	12	12	23	23	cetuximab	KRAS	PA10040	3845	0.963
NULL	Nucleic_Acids_Res_2007_Jul_18_35(13)_4453-4463.nxml.txt.nlp	17576667	SENT94	32	32	15	15	phenol	CPSF30	PA450913	10898	0.963
NULL	Trials_2014_Aug_15_15(1)_324.nxml.txt.nlp	NULL	SENT144	23	23	31	31	everolimus	CD4	PA164746311	920	0.963
NULL	Br_J_Cancer_2013_Jun_11_108(11)_2272-2280.nxml.txt.nlp	23681187	SENT113	16	16	20	20	celecoxib	COX2	PA448871	4513;5743	0.963
NULL	Arch_Drug_Inf_2008_Sep_1(2)_50-55.nxml.txt.nlp	19915714	SENT42	4	4	21	21	fentanyl	CYP3A4	PA449599	1576	0.963
NULL	Int_J_Biomed_Sci_2014_Sep_10(3)_146-157.nxml.txt.nlp	25324695	SENT25	11	11	0	0	hyaluronan	LFA-1	PA165958431	3683;3689	0.963
NULL	Cancers_(Basel)_2014_Aug_12_6(3)_1631-1669.nxml.txt.nlp	25119536	SENT426	0	0	19	19	bortezomib	THPO	PA10252	7066	0.963
NULL	Acta_Pharmacol_Sin_2011_Aug_18_32(8)_1078-1084.nxml.txt.nlp	21765448	SENT120	15	15	8	8	iptakalim	KCNJ11	PA165949694	3767	0.963
NULL	Anat_Cell_Biol_2011_Sep_29_44(3)_194-203.nxml.txt.nlp	22025971	SENT176	4	4	21	21	berberine	AMPK	PA165860812	5563	0.963
NULL	Breast_Cancer_Res_2012_Mar_14_14(2)_R45.nxml.txt.nlp	22417809	SENT267	37	37	25	25	tamoxifen	MARCKS	PA451581	4082	0.963
NULL	Acta_Pharmacol_Sin_2012_Dec_22_33(12)_1511-1517.nxml.txt.nlp	23085741	SENT114	10	10	7	7	pranlukast	CysLT1	PA134698661	10800	0.963
NULL	Pharmaceutics_2011_Nov_18_3(4)_865-913.nxml.txt.nlp	24309312	SENT158	12	12	29	29	maraviroc	CYP3A4	PA164768835	1576	0.963
NULL	Cardiovasc_Diabetol_2010_Oct_18_9_64.nxml.txt.nlp	20955583	SENT67	3	3	7	7	telmisartan	PPARgamma	PA451605	5468	0.963
NULL	Crit_Care_2010_Apr_19_14(2)_R70.nxml.txt.nlp	20403177	SENT314	14	14	11	11	thrombin	cPLA2	PA451674	10524	0.963
NULL	J_RNAi_Gene_Silencing_2006_Feb_28_2(1)_136-145.nxml.txt.nlp	19771215	SENT183	21	21	0	0	doxorubicin	Bcl-2	PA449412	596	0.963
NULL	J_Breast_Cancer_2012_Mar_28_15(1)_71-78.nxml.txt.nlp	22493631	SENT125	0	0	25	25	trastuzumab	HER2	PA451743	2064	0.963
NULL	Gut_Liver_2011_Jun_24_5(2)_160-164.nxml.txt.nlp	21814595	SENT106	3	3	33	33	meperidine	ESD	PA450369	2098	0.963
NULL	Acta_Pharmacol_Sin_2010_Jan_5_31(1)_93-101.nxml.txt.nlp	20048748	SENT132	32	32	20	20	cisplatin	DAPK	PA449014	1612	0.963
NULL	Int_J_Mol_Sci_2014_Sep_18_15(9)_16544-16576.nxml.txt.nlp	25238417	SENT106	24	24	4	4	hyaluronan	AOX1	PA165958431	316	0.963
NULL	Case_Rep_Oncol_2012_Dec_6_5(3)_651-656.nxml.txt.nlp	23275781	SENT32	19	19	4	4	sunitinib	KIT	PA162372840	3815	0.963
NULL	Asian_J_Androl_2014_Jan_20_Mar-Apr_16(2)_223-231.nxml.txt.nlp	24407187	SENT43	22	22	17	17	estradiol	aromatase	PA449503	1588	0.963
NULL	Ann_Hematol_2014_Sep_10_93(1)_1-11.nxml.txt.nlp	24018623	SENT159	17	17	5	5	lenalidomide	CD34	PA162363968	947	0.963
NULL	Breast_Cancer_(Auckl)_2011_Jan_13_5_1-14.nxml.txt.nlp	21494397	SENT48	35	35	5	5	delavirdine	CYP3A4	PA449223	1576	0.963
NULL	Biosci_Rep_2014_Aug_6_34(4)_e00131.nxml.txt.nlp	24975826	SENT147	13	13	0	0	pp2	TRPA1		8989	0.963
NULL	Ann_Oncol_2009_Aug_17_20(8)_1319-1329.nxml.txt.nlp	19535820	SENT226	36	36	8	8	tamoxifen	aromatase	PA451581	1588	0.963
NULL	Arthritis_Res_Ther_2005_Oct_26_7(6)_253-269.nxml.txt.nlp	16277701	SENT313	16	16	7	7	etanercept	DPPIV	PA449515	2191;1803	0.963
NULL	Arch_Drug_Inf_2011_Mar_4(1)_1-9.nxml.txt.nlp	21572514	SENT152	2	2	4	4	indomethacin	MRP1	PA449982	4437	0.963
NULL	Exp_Ther_Med_2012_Sep_7_4(3)_452-458.nxml.txt.nlp	23181117	SENT6	22	22	10	10	cisplatin	HCC	PA449014	84668	0.963
NULL	Sci_Rep_2015_Jan_6_5_7642.nxml.txt.nlp	25560837	SENT891	27	27	12	12	sr144528	CB1		1268	0.963
NULL	Nucleic_Acids_Res_2012_Jun_22_40(11)_4861-4878.nxml.txt.nlp	22362753	SENT235	14	14	1	1	trypsin	NPM1	PA451806	4869	0.963
NULL	AIDS_Res_Ther_2013_Jun_7_10_15.nxml.txt.nlp	23758814	SENT22	4	4	0	0	maraviroc	CCR5	PA164768835	1234	0.963
NULL	Mol_Syst_Biol_2010_Jun_8_6_375.nxml.txt.nlp	20531405	SENT47	7	7	14	14	simvastatin	HMGCR	PA451363	3156	0.963
NULL	Ann_Pediatr_Endocrinol_Metab_2014_Jun_30_19(2)_57-68.nxml.txt.nlp	25077087	SENT168	16	16	4	4	diazoxide	GCK	PA449285	5871;2645	0.963
NULL	Mol_Cell_Proteomics_2012_Feb_6_11(2)_M111_015222.nxml.txt.nlp	22147731	SENT339	9	9	0	0	cetuximab	JUN	PA10040	3725	0.963
NULL	Oncoimmunology_2014_Jan_1_3_e27414.nxml.txt.nlp	24701376	SENT40	18	18	10	10	vorinostat	IFN	PA164748224	3439	0.963
NULL	Sensors_(Basel)_2012_Dec_3_12(12)_16614-16627.nxml.txt.nlp	23208557	SENT118	20	20	4	4	irinotecan	UGT1A1	PA450085	54658	0.963
NULL	Br_J_Cancer_2004_May_4_90(9)_1733-1739.nxml.txt.nlp	15150604	SENT17	11	11	16	16	tamoxifen	aromatase	PA451581	1588	0.963
NULL	Clin_Pharmacol_2013_Apr_19_5_67-83.nxml.txt.nlp	23650452	SENT224	9	9	14	14	ticagrelor	P2Y12	PA165374673	64805	0.963
NULL	Cancer_Med_2014_Jun_27_3(3)_613-622.nxml.txt.nlp	24574362	SENT180	34	34	22	22	trastuzumab	EGFR	PA451743	1956	0.963
NULL	Indian_J_Endocrinol_Metab_2014_Mar-Apr_18(2)_138-141.nxml.txt.nlp	24741507	SENT89	0	0	14	14	acarbose	GLP1	PA448010	100125288;2641	0.963
NULL	Nat_Genet_2010_Mar_31_42(3)_245-249.nxml.txt.nlp	20118933	SENT58	15	15	41	41	camptothecin	PNKP	PA153590860	11284	0.963
NULL	Hum_Genomics_2010_Apr_1_4(4)_238-249.nxml.txt.nlp	20511137	SENT75	10	10	0	0	raloxifene	UGT1A1	PA451221	54658	0.963
NULL	Springerplus_2015_Jan_23_4_29.nxml.txt.nlp	25628986	SENT65	26	26	8	8	dapsone	G6PD	PA449211	2539	0.963
NULL	Physiol_Rep_2014_Oct_10_2(10)_e12177.nxml.txt.nlp	25303952	SENT254	8	8	10	10	estradiol	CD16	PA449503	2215;2214	0.963
NULL	Drug_Des_Devel_Ther_2014_Sep_26_8_1595-1611.nxml.txt.nlp	25302015	SENT128	36	36	22	22	erlotinib	EGFR	PA134687924	1956	0.963
NULL	Springerplus_2015_Jan_14_4_19.nxml.txt.nlp	25625039	SENT250	0	0	26	26	pha-665752	SP8		221833	0.963
NULL	Case_Rep_Dermatol_2013_Jan_22_5(1)_21-26.nxml.txt.nlp	23466824	SENT54	19	19	24	24	sulfapyridine	COX	PA164779050	1351	0.963
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT50	12	12	25	25	curcumin	TRAIL	PA151958596	8743	0.963
NULL	J_Inflamm_(Lond)_2006_May_4_3_8.nxml.txt.nlp	16674821	SENT151	10	10	3	3	pp2	PI3K		5290	0.963
NULL	Sci_Rep_2014_Dec_4_4_7310.nxml.txt.nlp	25472472	SENT207	27	27	2	2	decitabine	CD34	PA164749631	947	0.963
NULL	Ann_Hematol_2010_Nov_25_89(11)_1115-1124.nxml.txt.nlp	20499237	SENT162	21	21	13	13	simvastatin	CD5	PA451363	921	0.963
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT287	26	26	11	11	bevacizumab	VEGFR1	PA130232992	2321	0.963
NULL	Diabetes_Metab_J_2012_Feb_17_36(1)_29-36.nxml.txt.nlp	22363919	SENT125	8	8	14	14	bezafibrate	FGF21	PA162364313	26291	0.963
NULL	Clin_Pharmacol_2011_Jun_22_3_13-25.nxml.txt.nlp	22287853	SENT190	26	26	5	5	saxagliptin	CYP3A4	PA165958362	1576	0.963
NULL	Exp_Diabetes_Res_2012_May_14_2012_470851.nxml.txt.nlp	22666230	SENT203	30	30	4	4	exenatide	GLP-1	PA164749238	100125288	0.963
NULL	Front_Physiol_2011_Jun_30_2_33.nxml.txt.nlp	21747769	SENT264	3	3	14	14	berberine	KCNQ1	PA165860812	3784	0.963
NULL	Biomed_Res_Int_2013_Jul_31_2013_692071.nxml.txt.nlp	23984399	SENT183	8	8	19	19	mitoxantrone	OCT1	PA450526	5451;6580	0.963
NULL	Open_Virol_J_2010_Jun_18_4_109-122.nxml.txt.nlp	20811580	SENT177	1	1	25	25	neomycin	AAVS1	PA450608	17	0.963
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT87	5	5	26	26	curcumin	DR4	PA151958596	8797	0.963
NULL	J_Int_Soc_Sports_Nutr_2008_Aug_12_5_12.nxml.txt.nlp	18700016	SENT34	19	19	25	25	estradiol	aromatase	PA449503	1588	0.963
NULL	Biosci_Rep_2012_Aug_1_32(Pt_4)_361-374.nxml.txt.nlp	22762204	SENT147	26	26	4	4	erlotinib	PTEN	PA134687924	5728	0.963
NULL	Acta_Pharmacol_Sin_2014_Jan_9_35(1)_1-10.nxml.txt.nlp	24317012	SENT23	22	22	0	0	flavopiridol	OATP1B1	PA452627	10599	0.963
NULL	Mol_Cancer_2010_Jun_25_9_166.nxml.txt.nlp	20579378	SENT12	27	27	25	25	gefitinib	EGFR	PA131301952	1956	0.963
NULL	Indian_J_Med_Res_2013_Mar_137(3)_527-532.nxml.txt.nlp	23640560	SENT90	38	38	22	22	cisplatin	PARP-1	PA449014	25976	0.963
NULL	Biologics_2012_Apr_12_6_89-99.nxml.txt.nlp	22532777	SENT3	14	14	11	11	denosumab	RANKL	PA166048634	8600	0.963
NULL	Oncotarget_2013_Oct_19_4(11)_2045-2056.nxml.txt.nlp	24185104	SENT6	35	35	21	21	cisplatin	14-3-3	PA449014	10971	0.963
NULL	Oncotarget_2011_Mar_23_2(3)_165-177.nxml.txt.nlp	21444946	SENT133	16	16	11	11	erlotinib	EGFR	PA134687924	1956	0.963
NULL	Cancer_Immunol_Immunother_2013_Aug_27_62(10)_1637-1648.nxml.txt.nlp	23982484	SENT228	28	28	1	1	lenalidomide	IL-6	PA162363968	3569	0.963
NULL	Oncotarget_2013_Nov_23_4(12)_2451-2461.nxml.txt.nlp	24353195	SENT79	13	13	3	3	everolimus	EZH2	PA164746311	2146	0.963
NULL	J_Gen_Physiol_2009_Oct_134(4)_309-322.nxml.txt.nlp	19786584	SENT13	2	2	27	27	glibenclamide	ClC-1	PA449782	1180	0.963
NULL	Pharmaceutics_2011_Nov_18_3(4)_865-913.nxml.txt.nlp	24309312	SENT158	1	1	29	29	maraviroc	CYP3A4	PA164768835	1576	0.963
NULL	Breast_Cancer_Res_2006_Jul_25_8(4)_R48.nxml.txt.nlp	16869955	SENT105	33	33	16	16	tamoxifen	p53	PA451581	7157	0.963
NULL	J_Oncol_2010_Dec_15_2010_821717.nxml.txt.nlp	20049172	SENT163	16	16	4	4	paclitaxel	TUBB3	PA450761	10381	0.963
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT238	11	11	18	18	phenformin	PTEN	PA1000	5728	0.963
NULL	Oncol_Rep_2013_Jan_26_29(1)_297-305.nxml.txt.nlp	23129017	SENT77	27	27	36	36	doxycycline	TR2	PA449415	80834;114112;8764	0.963
NULL	Front_Endocrinol_(Lausanne)_2013_Mar_18_4_23.nxml.txt.nlp	23515889	SENT232	20	20	13	13	estradiol	NPW	PA449503	283869	0.963
NULL	Arthritis_Res_Ther_2009_Feb_23_11(1)_216.nxml.txt.nlp	19291269	SENT222	0	0	22	22	tocilizumab	IL-6	PA165292659	3569	0.963
NULL	EMBO_Mol_Med_2013_Aug_5_5(8)_1213-1226.nxml.txt.nlp	23918228	SENT315	17	17	11	11	neomycin	EGFR	PA450608	1956	0.963
NULL	Core_Evid_2010_Oct_21_5_23-37.nxml.txt.nlp	21042540	SENT229	7	7	14	14	saxagliptin	DPP4	PA165958362	1803	0.963
NULL	Oncotarget_2013_Nov_23_5(1)_196-210.nxml.txt.nlp	24344116	SENT212	34	34	7	7	doxorubicin	p53	PA449412	7157	0.963
NULL	Breast_Cancer_Res_2008_Dec_4_10(6)_R103.nxml.txt.nlp	19055788	SENT11	7	7	29	29	tamoxifen	aromatase	PA451581	1588	0.963
NULL	J_Mol_Signal_2011_Jul_20_6_7.nxml.txt.nlp	21774804	SENT6	12	12	30	30	dasatinib	CD166	PA162372878	214	0.963
NULL	Br_J_Pharmacol_2011_Nov_164(5)_1522-1533.nxml.txt.nlp	21557728	SENT221	31	31	9	9	cangrelor	ADP	PA165945763	23038	0.963
NULL	Indian_J_Radiol_Imaging_2008_Aug_18(3)_256-263.nxml.txt.nlp	19774171	SENT30	36	36	13	13	clopidogrel	ACT	PA449053	12;11332;9457;641455	0.963
NULL	Eur_J_Clin_Pharmacol_2010_Nov_29_66(11)_1131-1136.nxml.txt.nlp	20669013	SENT107	2	2	9	9	erythromycin	CYP2C19	PA449493	1557	0.963
NULL	Allergy_Asthma_Immunol_Res_2010_Apr_24_2(2)_65-76.nxml.txt.nlp	20358020	SENT131	31	31	15	15	ketoconazole	CYP3A4	PA450146	1576	0.963
NULL	Oncotarget_2014_Oct_16_5(20)_9546-9563.nxml.txt.nlp	25337673	SENT117	10	10	4	4	erlotinib	AXL	PA134687924	558	0.963
NULL	J_Hematol_Oncol_2009_Jan_21_2_2.nxml.txt.nlp	19159467	SENT70	28	28	3	3	gefitinib	EGFR	PA131301952	1956	0.963
NULL	Cell_Commun_Signal_2013_Nov_11_11_86.nxml.txt.nlp	24215724	SENT501	27	27	4	4	thrombin	PAR1	PA451674	79581;2149	0.963
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Nov_30_67(Pt_12)_o3457.nxml.txt.nlp	22199935	SENT64	0	0	27	27	coumarin	MEK1	PA134521193	5604	0.963
NULL	Curr_Neuropharmacol_2010_Jun_8(2)_122-127.nxml.txt.nlp	21119883	SENT46	10	10	0	0	capsaicin	AQP1	PA448776	358	0.963
NULL	Hum_Mol_Genet_2013_Nov_15_22(22)_4616-4626.nxml.txt.nlp	23814041	SENT39	2	2	19	19	doxycycline	neuroserpin	PA449415	5274	0.963
NULL	Oncol_Lett_2014_May_4_7(5)_1352-1362.nxml.txt.nlp	24765137	SENT143	29	29	22	22	cisplatin	p53	PA449014	7157	0.963
NULL	Hum_Mol_Genet_2013_Nov_15_22(22)_4602-4615.nxml.txt.nlp	23814040	SENT13	2	2	9	9	l-cysteine	TRMU	PA449173	55687	0.963
NULL	Mol_Cancer_2012_Dec_12_11_91.nxml.txt.nlp	23234355	SENT14	0	0	8	8	erlotinib	HER2	PA134687924	2064	0.963
NULL	Lab_Invest_2011_Apr_14_91(4)_598-608.nxml.txt.nlp	21321535	SENT132	19	19	3	3	sorafenib	CD11b	PA7000	3684	0.963
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jun_18_67(Pt_7)_o1733.nxml.txt.nlp	21837122	SENT68	23	23	9	9	benzaldehyde	mol	PA448571	90527	0.963
NULL	Hum_Genomics_2011_May_1_5(4)_265-282.nxml.txt.nlp	21712189	SENT125	23	23	4	4	nevirapine	ABCB1	PA450616	5243	0.963
NULL	Biomed_Res_Int_2013_Dec_4_2013_685308.nxml.txt.nlp	23509762	SENT213	7	7	17	17	doxorubicin	HIF-1	PA449412	29072	0.963
NULL	Int_J_Biol_Sci_2012_Feb_9_8(3)_310-327.nxml.txt.nlp	22355267	SENT131	11	11	33	33	simvastatin	PCSK9	PA451363	255738	0.963
NULL	Oncotarget_2014_Dec_4_5(22)_11365-11380.nxml.txt.nlp	25426548	SENT62	9	9	15	15	nutlin-3	p53		7157	0.963
NULL	J_Biol_Chem_2009_Feb_13_284(7)_4705-4712.nxml.txt.nlp	19074433	SENT190	11	11	31	31	s-adenosylmethionine	viperin	PA164754994	91543	0.963
NULL	Biologics_2009_Jul_13_3_77-97.nxml.txt.nlp	19707398	SENT282	22	22	8	8	infliximab	CDAI	PA452639	146059	0.963
NULL	Acta_Pharmacol_Sin_2014_Aug_30_35(8)_1045-1054.nxml.txt.nlp	24976155	SENT145	12	12	26	26	resveratrol	STAT3		6774	0.963
NULL	Hum_Mol_Genet_2013_Nov_15_22(22)_4602-4615.nxml.txt.nlp	23814040	SENT13	2	2	29	29	l-cysteine	TRMU	PA449173	55687	0.963
NULL	Indian_J_Pharmacol_2008_Oct_40(Suppl_2)_S97-S112.nxml.txt.nlp	21593984	SENT312	22	22	4	4	phenylephrine	STZ	PA450935	6484	0.963
NULL	Clin_Interv_Aging_2014_Apr_8_9_593-601.nxml.txt.nlp	24748777	SENT121	0	0	32	32	denosumab	CTX	PA166048634	1593	0.963
NULL	Front_Physiol_2011_Jun_30_2_33.nxml.txt.nlp	21747769	SENT19	4	4	30	30	berberine	p38	PA165860812	10598;1432;7965	0.963
NULL	Ann_Gastroenterol_2014_27(4)_313-319.nxml.txt.nlp	25331779	SENT143	25	25	45	45	infliximab	POR	PA452639	5447	0.963
NULL	Int_J_Gen_Med_2012_Jun_18_5_535-540.nxml.txt.nlp	22807641	SENT81	35	35	17	17	pitavastatin	adiponectin	PA142650384	9370	0.963
NULL	J_Hum_Genet_2013_Jun_16_58(6)_353-361.nxml.txt.nlp	23677058	SENT120	21	21	0	0	etoposide	ABCC3	PA449552	8714	0.963
NULL	Evid_Based_Complement_Alternat_Med_2014_Jan_8_2014_976364.nxml.txt.nlp	24527057	SENT16	34	34	27	27	oseltamivir	p38	PA450721	10598;1432;7965	0.963
NULL	J_Cell_Biol_2000_Aug_7_150(3)_657-666.nxml.txt.nlp	10931875	SENT55	19	19	5	5	trypsin	E16	PA451806	8140	0.963
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Oct_20_66(Pt_11)_o2865.nxml.txt.nlp	21589047	SENT66	21	21	12	12	ethanol	mol	PA448073	90527	0.963
NULL	Oncologist_2010_Apr_15(4)_372-381.nxml.txt.nlp	20413642	SENT156	6	6	25	25	cetuximab	EGFR	PA10040	1956	0.963
NULL	Oncotarget_2013_Dec_28_5(6)_1475-1490.nxml.txt.nlp	24721996	SENT146	2	2	13	13	rosiglitazone	PTEN	PA451283	5728	0.963
NULL	J_Oncol_2010_Dec_28_2010_414676.nxml.txt.nlp	20066160	SENT88	13	13	21	21	topotecan	aromatase	PA451729	1588	0.963
NULL	Pharmaceuticals_(Basel)_2013_Aug_21_6(8)_988-1038.nxml.txt.nlp	24276379	SENT291	21	21	12	12	cetuximab	EGFR	PA10040	1956	0.963
NULL	Am_J_Trop_Med_Hyg_2012_Aug_1_87(2)_231-241.nxml.txt.nlp	22855752	SENT16	28	28	0	0	mefloquine	ACT	PA450348	12;11332;9457;641455	0.963
NULL	Oncol_Rep_2013_Apr_5_29(4)_1671-1677.nxml.txt.nlp	23404329	SENT165	19	19	3	3	curcumin	MIA	PA151958596	8190	0.963
NULL	Exp_Mol_Med_2012_Jul_31_44(7)_448-456.nxml.txt.nlp	22581380	SENT117	20	20	0	0	ethanol	NAC	PA448073	22861	0.963
NULL	Tumour_Biol_2014_Jan_13_35(1)_257-264.nxml.txt.nlp	24222327	SENT127	34	34	18	18	artemisinin	mol	PA165111696	90527	0.963
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT327	3	3	9	9	ranibizumab	VEGF-A	PA164746012	7422	0.963
NULL	Int_J_Mol_Sci_2014_Nov_21_15(11)_21433-21454.nxml.txt.nlp	25421240	SENT99	4	4	41	41	pp2	EGF		1950	0.963
NULL	Int_J_Med_Sci_2013_Mar_19_10(5)_599-606.nxml.txt.nlp	23569422	SENT56	5	5	28	28	propofol	HO-1	PA451141	3162	0.963
NULL	Biologics_2013_May_3_7_103-113.nxml.txt.nlp	23662043	SENT85	5	5	36	36	icatibant	C1-INH	PA164749185	710	0.963
NULL	Front_Neurosci_2014_Aug_14_8_252.nxml.txt.nlp	25177267	SENT144	0	0	11	11	fasudil	EPHA4	PA165946121	2043	0.963
NULL	J_Cancer_2013_Sep_27_4(8)_662-670.nxml.txt.nlp	24155778	SENT180	34	34	5	5	carboplatin	UCHL1	PA448803	7345	0.963
NULL	Protein_Cell_2014_Feb_29_5(2)_113-123.nxml.txt.nlp	24474196	SENT125	11	11	35	35	metformin	CYP2B	PA450395	1554;1556	0.963
NULL	Arthritis_Res_Ther_2010_Apr_29_12(2)_R73.nxml.txt.nlp	20429888	SENT170	0	0	7	7	bortezomib	c-Jun	PA10252	3725	0.963
NULL	Oncol_Lett_2013_Feb_5_5(2)_427-434.nxml.txt.nlp	23420099	SENT166	17	17	8	8	carboplatin	ERCC2	PA448803	2068	0.963
NULL	Orphanet_J_Rare_Dis_2014_Sep_2_9(1)_130.nxml.txt.nlp	NULL	SENT228	11	11	1	1	cyanocobalamin	B12	PA451892	7126;4709	0.963
NULL	Arthritis_Res_Ther_2012_Nov_30_14(6)_225.nxml.txt.nlp	23198865	SENT212	0	0	5	5	teriparatide	PTH	PA451620	5741	0.963
NULL	J_Hematol_Oncol_2012_Apr_25_5(Suppl_1)_A4.nxml.txt.nlp	NULL	SENT11	27	27	11	11	decitabine	DNMT3A	PA164749631	1788	0.963
NULL	Mol_Cancer_2013_Sep_11_12_104.nxml.txt.nlp	24025152	SENT316	26	26	14	14	gemcitabine	STAT3	PA449748	6774	0.963
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_75-89.nxml.txt.nlp	17912638	SENT1	9	9	2	2	anastrozole	aromatase	PA448432	1588	0.963
NULL	Patient_Prefer_Adherence_2009_Nov_3_3_51-59.nxml.txt.nlp	19936145	SENT127	5	5	3	3	tolcapone	COMT	PA451720	1312	0.963
NULL	Oxid_Med_Cell_Longev_2013_Apr_21_2013_412576.nxml.txt.nlp	23710286	SENT90	11	11	24	24	curcumin	ANOVA	PA151958596	4858	0.963
NULL	Oncogene_2013_Sep_12_32(37)_4355-4365.nxml.txt.nlp	23108409	SENT72	4	4	22	22	hyaluronan	HAS2	PA165958431	3037	0.963
NULL	Breast_Cancer_Res_2010_Oct_28_12(5)_212.nxml.txt.nlp	21067532	SENT100	17	17	2	2	estradiol	aromatase	PA449503	1588	0.963
NULL	Acta_Pharmacol_Sin_2012_Dec_5_33(12)_1502-1510.nxml.txt.nlp	23123644	SENT131	2	2	12	12	losartan	RhoA	PA450268	387	0.963
NULL	Breast_Cancer_Res_2010_Jul_22_12(4)_R53.nxml.txt.nlp	20649975	SENT15	10	10	2	2	tamoxifen	HOXB13	PA451581	10481	0.963
NULL	Clin_Med_Insights_Oncol_2011_Sep_21_5_265-314.nxml.txt.nlp	22084619	SENT510	18	18	3	3	sugar	NKR-P1	PA451529	3820	0.963
NULL	Clin_Pharmacol_2010_Apr_27_2_77-82.nxml.txt.nlp	22291489	SENT47	4	4	12	12	cosyntropin	ACTH	PA164749052	5443	0.963
NULL	Breast_Cancer_Res_2009_Jun_23_11(Suppl_1)_S15.nxml.txt.nlp	NULL	SENT4	13	13	4	4	tamoxifen	aromatase	PA451581	1588	0.963
NULL	Breast_Cancer_Res_2011_Aug_16_13(4)_218.nxml.txt.nlp	21884642	SENT9	17	17	20	20	lapatinib	aromatase	PA152241907	1588	0.963
NULL	Ophthalmol_Eye_Dis_2011_Jan_12_3_13-19.nxml.txt.nlp	23861619	SENT50	5	5	13	13	tafluprost	EP3	PA165958432	5733	0.963
NULL	J_Korean_Med_Sci_2011_Dec_29_26(12)_1563-1568.nxml.txt.nlp	22147992	SENT112	7	7	16	16	ekb-569	EGFR		1956	0.963
NULL	Clin_Exp_Otorhinolaryngol_2011_Mar_17_4(1)_18-23.nxml.txt.nlp	21461058	SENT93	14	14	1	1	bumetanide	KCC2	PA448682	57468	0.963
NULL	Breast_Cancer_Res_2010_Jun_22_12(3)_R40.nxml.txt.nlp	20569503	SENT161	8	8	0	0	tamoxifen	PI3K	PA451581	5290	0.963
NULL	Ann_Med_2011_Nov_5_43(7)_531-544.nxml.txt.nlp	21815879	SENT80	33	33	12	12	clopidogrel	CYP2C19	PA449053	1557	0.963
NULL	Open_Med_Chem_J_2010_Sep_3_4_57-61.nxml.txt.nlp	21249167	SENT53	12	12	5	5	hydrochlorothiazide	NCCT	PA449899	6559	0.963
NULL	Acta_Pharmacol_Sin_2012_Jul_18_33(7)_861-872.nxml.txt.nlp	22705730	SENT118	25	25	41	41	atorvastatin	PI3K	PA448500	5290	0.963
NULL	J_Res_Med_Sci_2011_May_16(5)_611-620.nxml.txt.nlp	22091283	SENT6	4	4	18	18	propofol	DES	PA451141	1674	0.963
NULL	J_Hematol_Oncol_2011_Apr_1_4_13.nxml.txt.nlp	21453545	SENT183	14	14	29	29	geldanamycin	Hsp90	PA152031327	3320	0.963
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Dec_17_3(12)_e152.nxml.txt.nlp	25518025	SENT72	20	20	14	14	ketoconazole	CYP2D6	PA450146	1565	0.963
NULL	Alcohol_Res_Health_2008_31(3)_243-246.nxml.txt.nlp	23584867	SENT56	4	4	22	22	oxygen	MRI	PA450744	78996	0.963
NULL	Clin_Sarcoma_Res_2014_Jul_29_4_7.nxml.txt.nlp	25089183	SENT23	0	0	24	24	pazopanib	VEGFR	PA165291492	3791	0.963
NULL	Int_J_Womens_Health_2010_Aug_9_1_11-20.nxml.txt.nlp	21072271	SENT70	30	30	1	1	raloxifene	STAR	PA451221	6770;2984	0.963
NULL	Breast_Cancer_(Auckl)_2011_Jan_13_5_1-14.nxml.txt.nlp	21494397	SENT48	38	38	5	5	voriconazole	CYP3A4	PA10233	1576	0.963
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2008_May_1_64(Pt_5)_525-531.nxml.txt.nlp	18453688	SENT25	35	35	1	1	mitoxantrone	vRNA	PA450526	56664	0.963
NULL	J_Oncol_2012_Jul_14_2012_193436.nxml.txt.nlp	21804824	SENT51	0	0	10	10	bevacizumab	VEGF-A	PA130232992	7422	0.963
NULL	Hum_Mol_Genet_2013_Jul_1_22(13)_2676-2688.nxml.txt.nlp	23474818	SENT159	16	16	7	7	arsenite	FUS	PA452638	2521	0.963
NULL	J_Cardiovasc_Med_(Hagerstown)_2014_Dec_7_15(12)_873-879.nxml.txt.nlp	25304034	SENT107	33	33	6	6	warfarin	NMA	PA451906	25805	0.963
NULL	Br_J_Cancer_2012_Jan_17_106(2)_348-357.nxml.txt.nlp	22146521	SENT117	6	6	20	20	gemcitabine	TP53	PA449748	7157	0.963
NULL	Case_Rep_Nephrol_Urol_2013_Apr_10_3(1)_40-45.nxml.txt.nlp	23626597	SENT67	0	0	23	23	bevacizumab	GTS	PA130232992	2973	0.963
NULL	Exp_Ther_Med_2014_Nov_29_8(5)_1473-1478.nxml.txt.nlp	25289044	SENT187	5	5	21	21	heparin	AZU	PA449855	566	0.963
NULL	Oncotarget_2012_Dec_31_3(12)_1653-1668.nxml.txt.nlp	23391506	SENT170	15	15	8	8	docetaxel	U87	PA449383	677775;641648	0.963
NULL	Cancer_Cell_Int_2014_Jun_11_14_49.nxml.txt.nlp	24991192	SENT6	3	3	22	22	berberine	AMPK	PA165860812	5563	0.963
NULL	J_Thromb_Thrombolysis_2011_Nov_26_32(4)_459-466.nxml.txt.nlp	21706290	SENT121	0	0	7	7	cangrelor	P2Y12	PA165945763	64805	0.963
NULL	Hum_Genomics_2009_Jan_1_3(2)_128-142.nxml.txt.nlp	19164090	SENT11	16	16	7	7	carboplatin	CD44	PA448803	960	0.963
NULL	Diabetes_2009_Aug_28_58(8)_1816-1825.nxml.txt.nlp	19401425	SENT178	22	22	29	29	diazoxide	GLP-1	PA449285	100125288	0.963
NULL	Br_J_Cancer_2006_Feb_13_94(3)_407-426.nxml.txt.nlp	16434996	SENT185	14	14	22	22	genistein	BRCA1	PA165109660	672	0.963
NULL	Eur_J_Neurosci_2008_Apr_1_27(7)_1722-1730.nxml.txt.nlp	18380669	SENT189	21	21	28	28	sr144528	CB1		1268	0.963
NULL	Mol_Cancer_2010_Mar_25_9_68.nxml.txt.nlp	20338046	SENT163	28	28	18	18	doxorubicin	ERBB2	PA449412	2064	0.963
NULL	Mol_Cancer_2010_Aug_23_9_222.nxml.txt.nlp	20731837	SENT77	8	8	1	1	gefitinib	ATM	PA131301952	472	0.963
NULL	Cancer_Immunol_Immunother_2013_Feb_26_62(2)_309-320.nxml.txt.nlp	22923191	SENT269	5	5	1	1	cetuximab	EGFR	PA10040	1956	0.963
NULL	Clin_Exp_Otorhinolaryngol_2011_Jun_31_4(2)_77-82.nxml.txt.nlp	21716954	SENT155	16	16	8	8	tetracycline	PARP-1	PA451640	25976	0.963
NULL	Arthritis_Res_Ther_2013_Oct_2_15(5)_R141.nxml.txt.nlp	24286116	SENT15	36	36	11	11	infliximab	IL-6	PA452639	3569	0.963
NULL	Int_J_Biol_Sci_2013_Aug_27_9(8)_842-852.nxml.txt.nlp	23983617	SENT214	40	40	0	0	heparin	PPX	PA449855	5531	0.963
NULL	Mol_Clin_Oncol_2013_Sep_24_1(5)_918-924.nxml.txt.nlp	24649271	SENT92	7	7	22	22	gemcitabine	EGFR	PA449748	1956	0.963
NULL	Pharmaceuticals_(Basel)_2013_Aug_6_6(8)_929-959.nxml.txt.nlp	24276377	SENT979	14	14	2	2	oxaliplatin	CXCR2	PA131285527	3579	0.963
NULL	Br_J_Cancer_2009_Mar_24_100(6)_950-958.nxml.txt.nlp	19293809	SENT145	11	11	17	17	cetuximab	EGFR	PA10040	1956	0.963
NULL	Int_J_Surg_Oncol_2012_Aug_27_2012_180574.nxml.txt.nlp	22970358	SENT27	33	33	14	14	tamoxifen	aromatase	PA451581	1588	0.963
NULL	Acta_Pharmacol_Sin_2014_Sep_4_35(9)_1157-1166.nxml.txt.nlp	25088002	SENT13	2	2	7	7	curcumin	JAK2	PA151958596	3717	0.963
NULL	Int_J_Mol_Sci_2014_Mar_20_15(3)_4965-4976.nxml.txt.nlp	24658440	SENT5	12	12	26	26	cyclosporine	P-gp	PA449167	5243	0.963
NULL	Eur_J_Pediatr_2014_Nov_20_173(12)_1639-1642.nxml.txt.nlp	24253372	SENT95	2	2	8	8	levomepromazine	CYP2D6	PA134687942	1565	0.963
NULL	Springerplus_2014_Sep_17_3_535.nxml.txt.nlp	25279326	SENT153	29	29	5	5	exemestane	aromatase	PA449563	1588	0.963
NULL	Breast_Cancer_Res_2006_Nov_6_8(6)_215.nxml.txt.nlp	17096862	SENT47	35	35	11	11	trastuzumab	MUC4	PA451743	4585	0.963
NULL	Cancer_Res_Treat_2012_Jun_30_44(2)_74-84.nxml.txt.nlp	22802745	SENT96	0	0	4	4	erlotinib	EGFR	PA134687924	1956	0.963
NULL	Breast_Cancer_Res_2005_Jan_26_7(2)_R256-R266.nxml.txt.nlp	15743506	SENT29	36	36	10	10	cyclophosphamide	HER-2	PA449165	2064	0.963
NULL	Eur_J_Clin_Microbiol_Infect_Dis_2012_Apr_29_31(4)_571-574.nxml.txt.nlp	21796345	SENT23	15	15	29	29	lamivudine	IFN	PA450163	3439	0.963
NULL	Aging_(Albany_NY)_2009_Jun_22_1(6)_529-541.nxml.txt.nlp	20157536	SENT176	43	43	6	6	resveratrol	ANOVA		4858	0.963
NULL	Oncotarget_2012_May_4_3(4)_395-398.nxml.txt.nlp	22565037	SENT28	20	20	9	9	metformin	CD44	PA450395	960	0.963
NULL	Cell_Biol_Int_Rep_(2010)_2012_Jun_21_19(1)_e00017.nxml.txt.nlp	23124518	SENT101	21	21	5	5	etoposide	TRAIL	PA449552	8743	0.963
NULL	Front_Immunol_2013_Oct_31_4_351.nxml.txt.nlp	24198817	SENT141	25	25	5	5	etanercept	p55	PA449515	6624;2078;8503;5718	0.963
NULL	EMBO_Mol_Med_2013_Feb_11_5(2)_264-279.nxml.txt.nlp	23307470	SENT15	31	31	33	33	tamoxifen	aromatase	PA451581	1588	0.963
NULL	EMBO_Mol_Med_2010_May_2(5)_172-187.nxml.txt.nlp	20432503	SENT297	18	18	16	16	indomethacin	COX	PA449982	1351	0.963
NULL	Indian_J_Med_Res_2012_Dec_136(6)_907-925.nxml.txt.nlp	23391787	SENT513	20	20	6	6	primaquine	ACT	PA451103	12;11332;9457;641455	0.963
NULL	J_Breast_Cancer_2013_Mar_31_16(1)_23-31.nxml.txt.nlp	23593078	SENT136	15	15	28	28	curcumin	HDAC1	PA151958596	3065	0.963
NULL	Anesthesiol_Res_Pract_2014_Feb_11_2014_848051.nxml.txt.nlp	24672542	SENT21	20	20	4	4	rocuronium	NMB	PA164754992	10457;4828	0.963
NULL	Nat_Chem_Biol_2010_Feb_6(2)_117-124.nxml.txt.nlp	20081827	SENT203	16	16	1	1	heparin	p110	PA449855	9733	0.963
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT10	9	9	33	33	doxorubicin	ABCB1	PA449412	5243	0.963
NULL	Drugs_2014_Nov_12_74(18)_2129-2139.nxml.txt.nlp	25389048	SENT64	27	27	5	5	adalimumab	BRIGHT	PA10004	1820	0.963
NULL	Mol_Syst_Biol_2009_Jul_28_5_288.nxml.txt.nlp	19638969	SENT179	31	31	6	6	resveratrol	HuR		1994	0.963
NULL	Br_J_Clin_Pharmacol_2011_Oct_72(4)_647-657.nxml.txt.nlp	21518389	SENT144	7	7	13	13	cangrelor	P2Y12	PA165945763	64805	0.963
NULL	Acta_Pharmacol_Sin_2010_Nov_18_31(11)_1447-1453.nxml.txt.nlp	20953204	SENT105	11	11	3	3	rimonabant	CB1	PA152407999	1268	0.963
NULL	Oncotarget_2014_Sep_3_5(19)_9362-9381.nxml.txt.nlp	25313139	SENT87	10	10	22	22	orlistat	PC-3	PA164776864	692094	0.963
NULL	Br_J_Cancer_2013_Oct_15_109(8)_2131-2141.nxml.txt.nlp	24052043	SENT155	11	11	25	25	docetaxel	PC-3	PA449383	692094	0.963
NULL	Indian_J_Endocrinol_Metab_2015_Jan-Feb_19(1)_30-38.nxml.txt.nlp	25593823	SENT104	16	16	10	10	pioglitazone	adiponectin	PA450970	9370	0.963
NULL	J_Cell_Biol_2001_Aug_6_154(3)_659-666.nxml.txt.nlp	11489922	SENT194	9	9	38	38	warfarin	MGP	PA451906	4256	0.963
NULL	Oncotarget_2013_Dec_4_5(2)_351-362.nxml.txt.nlp	24504051	SENT92	3	3	22	22	nilotinib	ERG	PA165958345	2078	0.963
NULL	Anesthesiol_Res_Pract_2011_Oct_27_2011_317410.nxml.txt.nlp	22110498	SENT10	29	29	5	5	propofol	IL-8	PA451141	3576	0.963
NULL	Mar_Drugs_2009_Jun_11_7(2)_210-248.nxml.txt.nlp	19597582	SENT239	33	33	20	20	sn-38	ABCG2		9429	0.963
NULL	Acta_Pharmacol_Sin_2013_Feb_12_34(2)_255-261.nxml.txt.nlp	23147557	SENT114	14	14	3	3	pioglitazone	PTPRD	PA450970	5789	0.963
NULL	Oncotarget_2014_Mar_12_5(5)_1363-1381.nxml.txt.nlp	24658058	SENT279	5	5	12	12	doxorubicin	HIF-1	PA449412	29072	0.963
NULL	Mol_Cancer_2007_Oct_11_6_63.nxml.txt.nlp	17931419	SENT81	20	20	12	12	cetuximab	EGFR	PA10040	1956	0.963
NULL	Clin_Med_Oncol_2008_Mar_19_2_221-222.nxml.txt.nlp	21892282	SENT21	17	17	8	8	erlotinib	PTEN	PA134687924	5728	0.963
NULL	Indian_J_Med_Paediatr_Oncol_2014_Apr-Jun_35(2)_140-142.nxml.txt.nlp	25197175	SENT48	2	2	10	10	cetuximab	BEST	PA10040	7439	0.963
NULL	Clin_Ophthalmol_2012_Nov_28_6_1977-1980.nxml.txt.nlp	23226003	SENT64	19	19	14	14	levofloxacin	SCL	PA450214	6886;3855;51540	0.963
NULL	Acta_Neuropathol_2012_Mar_16_123(3)_369-380.nxml.txt.nlp	22083253	SENT82	4	4	21	21	carboplatin	NF1	PA448803	4763	0.963
NULL	Bioinformation_2012_Jan_6_8(1)_13-19.nxml.txt.nlp	22359429	SENT175	23	23	2	2	indomethacin	MRP1	PA449982	4437	0.963
NULL	Arthritis_Res_Ther_2007_Oct_10_9(5)_R105.nxml.txt.nlp	17927818	SENT160	4	4	29	29	pp2	PP2		4888	0.963
NULL	Diabetes_2013_May_16_62(5)_1689-1696.nxml.txt.nlp	23274908	SENT217	11	11	26	26	diazoxide	KCNJ11	PA449285	3767	0.963
NULL	Cell_Death_Dis_2010_May_13_1(5)_e41.nxml.txt.nlp	21364648	SENT82	24	24	9	9	etoposide	p65	PA449552	5970	0.963
NULL	Br_J_Cancer_2009_Jul_21_101(2)_238-243.nxml.txt.nlp	19568242	SENT108	20	20	31	31	sunitinib	IFN	PA162372840	3439	0.963
NULL	F1000Res_2013_Mar_5_2_74.nxml.txt.nlp	24358880	SENT269	28	28	22	22	benzaldehyde	TRPV1	PA448571	7442	0.963
NULL	JSLS_2001_Apr-Jun_5(2)_183-185.nxml.txt.nlp	11394434	SENT23	28	28	3	3	lipase	CO2	PA450239	4513	0.963
NULL	Drugs_R_D_2013_Jun_5_13(2)_153-157.nxml.txt.nlp	23737454	SENT152	17	17	11	11	clopidogrel	P2Y12	PA449053	64805	0.963
NULL	Clin_Mol_Allergy_2007_Jan_25_5_1.nxml.txt.nlp	17254346	SENT14	2	2	32	32	curcumin	OAT	PA151958596	4942	0.963
NULL	Front_Aging_Neurosci_2014_Sep_11_6_218.nxml.txt.nlp	25309423	SENT199	4	4	14	14	resveratrol	TLR4		7099	0.963
NULL	Br_J_Cancer_1999_Jan_24_79(1)_119-130.nxml.txt.nlp	10408703	SENT9	11	11	5	5	indomethacin	CD86	PA449982	942	0.963
NULL	Biosci_Rep_2014_Apr_15_34(2)_e00105.nxml.txt.nlp	24617546	SENT125	30	30	5	5	metformin	AMPK	PA450395	5563	0.963
NULL	Bioimpacts_2014_Feb_27_4(1)_21-27.nxml.txt.nlp	24790895	SENT122	16	16	25	25	isoproterenol	ANOVA	PA450121	4858	0.963
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_May_30_64(Pt_6)_o1169.nxml.txt.nlp	21202676	SENT59	24	24	31	31	ethanol	CS2	PA448073	64084	0.963
NULL	Diabetes_2013_Mar_14_62(3)_953-964.nxml.txt.nlp	23223176	SENT135	42	42	8	8	paroxetine	ROS	PA450801	6098	0.963
NULL	Blood_Cancer_J_2014_Jun_27_4(6)_e221.nxml.txt.nlp	24972150	SENT16	11	11	22	22	carboplatin	NPM1	PA448803	4869	0.963
NULL	Cell_Cycle_2013_Dec_1_12(23)_3673-3680.nxml.txt.nlp	24091726	SENT92	18	18	41	41	cisplatin	PER2	PA449014	8864	0.963
NULL	J_Neuroinflammation_2010_Sep_7_7_51.nxml.txt.nlp	20822529	SENT200	24	24	1	1	hemin	HO-1	PA449849	3162	0.963
NULL	Mol_Cells_2014_Mar_31_37(3)_234-240.nxml.txt.nlp	24642709	SENT111	42	42	10	10	cisplatin	NOX4	PA449014	50507	0.963
NULL	Nucleic_Acids_Res_2012_Jun_22_40(11)_4861-4878.nxml.txt.nlp	22362753	SENT246	13	13	4	4	trypsin	NPM2	PA451806	10361	0.963
NULL	Oncotarget_2011_Dec_31_2(12)_1314-1321.nxml.txt.nlp	22248929	SENT62	36	36	2	2	lapatinib	HER3	PA152241907	2065	0.963
NULL	J_Hematol_Oncol_2013_Jun_3_6_38.nxml.txt.nlp	23731980	SENT154	0	0	15	15	afatinib	HER3	PA165981154	2065	0.963
NULL	J_Physiol_2009_Feb_15_587(Pt_4)_731-744.nxml.txt.nlp	19074966	SENT11	17	17	0	0	taurine	PAT1	PA451590	10513;206358	0.963
NULL	Cells_2014_Apr_4_3(2)_199-235.nxml.txt.nlp	24709958	SENT328	17	17	15	15	erlotinib	EGFR	PA134687924	1956	0.963
NULL	Case_Rep_Dermatol_2014_Sep_11_6(3)_218-221.nxml.txt.nlp	25408649	SENT29	32	32	17	17	rituximab	IL-6	PA451261	3569	0.963
NULL	Front_Physiol_2010_Nov_2_1_145.nxml.txt.nlp	21423385	SENT221	12	12	10	10	celecoxib	COX2	PA448871	4513;5743	0.963
NULL	Colorectal_Dis_2012_Feb_14(2)_e31-e47.nxml.txt.nlp	21848897	SENT126	8	8	33	33	bevacizumab	KRAS	PA130232992	3845	0.963
NULL	Cardiovasc_Diabetol_2013_Nov_12_12_169.nxml.txt.nlp	24215514	SENT301	10	10	7	7	valsartan	AT1	PA451848	9197;185	0.963
NULL	Cardiovasc_Diabetol_2006_Dec_4_5_26.nxml.txt.nlp	17144912	SENT9	34	34	5	5	dobutamine	ANOVA	PA449381	4858	0.963
NULL	Open_Biol_2013_Nov_3(11)_130130.nxml.txt.nlp	24258275	SENT188	12	12	2	2	etoposide	p53	PA449552	7157	0.963
NULL	Neural_Regen_Res_2014_Mar_1_9(5)_540-548.nxml.txt.nlp	25206852	SENT38	25	25	43	43	choline	HSP27	PA448976	3315	0.963
NULL	Eur_J_Endocrinol_2011_Dec_165(6)_987-991.nxml.txt.nlp	21951701	SENT51	8	8	1	1	hydrocortisone	ACTH	PA449905	5443	0.963
NULL	Oncotarget_2014_Jun_8_5(13)_5040-5053.nxml.txt.nlp	24970815	SENT48	4	4	25	25	cisplatin	LOX	PA449014	4015	0.963
NULL	Int_J_Mol_Sci_2014_Mar_5_15(3)_3970-3988.nxml.txt.nlp	24603537	SENT2	22	22	16	16	curcumin	MCH	PA151958596	5367	0.963
NULL	Arthritis_Res_Ther_2009_Apr_23_11(2)_R57.nxml.txt.nlp	19389237	SENT12	46	46	26	26	adalimumab	CXCL11	PA10004	6373	0.963
NULL	J_Hematol_Oncol_2010_Sep_9_3_30.nxml.txt.nlp	20828385	SENT67	20	20	0	0	temsirolimus	VEGF-A	PA164746890	7422	0.963
NULL	Br_J_Cancer_2012_May_22_106(11)_1826-1832.nxml.txt.nlp	22549179	SENT8	25	25	13	13	cetuximab	KRAS	PA10040	3845	0.963
NULL	Curr_Neuropharmacol_2013_Dec_11(6)_652-663.nxml.txt.nlp	24396340	SENT78	12	12	2	2	oxaliplatin	TRPA1	PA131285527	8989	0.963
NULL	Ann_Hematol_2010_Sep_13_89(9)_861-871.nxml.txt.nlp	20387067	SENT102	30	30	15	15	dasatinib	CD34	PA162372878	947	0.963
NULL	Int_J_Breast_Cancer_2011_Feb_24_2011_967419.nxml.txt.nlp	22332018	SENT236	5	5	12	12	cyclophosphamide	MRP1	PA449165	4437	0.963
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2006_Dec_13_63(Pt_1)_80-93.nxml.txt.nlp	17164530	SENT161	25	25	1	1	imatinib	KDR	PA10804	3791	0.963
NULL	Cancer_Cell_Int_2013_Apr_30_13_38.nxml.txt.nlp	23631593	SENT30	16	16	0	0	heparin	EGFR	PA449855	1956	0.963
NULL	Cancers_(Basel)_2010_Dec_9_2(4)_2058-2083.nxml.txt.nlp	24281218	SENT317	3	3	32	32	gemcitabine	EGFR	PA449748	1956	0.963
NULL	J_Cell_Biol_2005_Nov_7_171(3)_505-516.nxml.txt.nlp	16275754	SENT296	13	13	6	6	pp2	HRG		3084;3273	0.963
NULL	Evid_Based_Complement_Alternat_Med_2014_Sep_11_2014_895272.nxml.txt.nlp	25295069	SENT199	15	15	4	4	curcumin	AMPK	PA151958596	5563	0.963
NULL	Exp_Neurobiol_2014_Dec_12_23(4)_365-371.nxml.txt.nlp	25548536	SENT53	24	24	9	9	paraformaldehyde	CO2	PA450790	4513	0.963
NULL	Semin_Immunopathol_2014_Jul_24_36(4)_461-478.nxml.txt.nlp	25056155	SENT299	0	0	4	4	alemtuzumab	CD52	PA164783958	1043	0.963
NULL	Aging_(Albany_NY)_2012_Jul_31_4(7)_499-508.nxml.txt.nlp	22868943	SENT121	0	0	6	6	resveratrol	SIRT1		23411	0.963
NULL	Diabetes_Metab_Syndr_Obes_2010_Jul_20_3_263-273.nxml.txt.nlp	21437094	SENT108	0	0	7	7	liraglutide	GLP-1	PA165958364	100125288	0.963
NULL	Core_Evid_2009_Jun_15_4_131-147.nxml.txt.nlp	20694070	SENT311	3	3	30	30	raltegravir	CD4		920	0.963
NULL	Int_J_Mol_Sci_2014_Jun_3_15(6)_9924-9944.nxml.txt.nlp	24897026	SENT181	28	28	4	4	ethanol	AMPK	PA448073	5563	0.963
NULL	Curr_Rev_Musculoskelet_Med_2009_Mar_10_2(1)_56-64.nxml.txt.nlp	19468919	SENT86	11	11	0	0	heparin	OPG	PA449855	690	0.963
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1137-1144.nxml.txt.nlp	20234366	SENT205	33	33	7	7	cetuximab	MKP-1	PA10040	1843	0.963
NULL	Breast_Cancer_Res_2012_Jun_19_14(3)_209.nxml.txt.nlp	22713170	SENT115	0	0	17	17	neratinib	HER2	PA165291472	2064	0.963
NULL	Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.nxml.txt.nlp	24736980	SENT189	8	8	20	20	rosuvastatin	OATP1B1	PA134308647	10599	0.963
NULL	Eur_J_Haematol_2014_Feb_25_92(2)_127-136.nxml.txt.nlp	24118452	SENT27	0	0	7	7	anagrelide	IFN	PA164742986	3439	0.963
NULL	Breast_Cancer_Res_2007_Jul_5_9(4)_R41.nxml.txt.nlp	17612393	SENT37	8	8	13	13	ns-398	Bcl-2		596	0.963
NULL	Hum_Mol_Genet_2012_Aug_1_21(15)_3374-3386.nxml.txt.nlp	22547224	SENT144	13	13	0	0	nadh	DISC1	PA164755085	27185	0.963
NULL	Breast_Cancer_Res_Treat_2012_Aug_5_134(3)_1149-1159.nxml.txt.nlp	22763464	SENT5	0	0	11	11	afatinib	HER2	PA165981154	2064	0.963
NULL	Nucleic_Acids_Res_2012_Jun_22_40(11)_4861-4878.nxml.txt.nlp	22362753	SENT246	13	13	2	2	trypsin	NPM1	PA451806	4869	0.963
NULL	Front_Endocrinol_(Lausanne)_2014_Jan_16_5_1.nxml.txt.nlp	24474947	SENT63	20	20	37	37	estradiol	GPER	PA449503	2852	0.963
NULL	Nucleic_Acids_Res_2012_Jun_22_40(11)_4861-4878.nxml.txt.nlp	22362753	SENT254	21	21	11	11	trypsin	NPM	PA451806	4869	0.963
NULL	Case_Rep_Genet_2014_Jan_22_2014_413743.nxml.txt.nlp	24627811	SENT64	11	11	27	27	warfarin	CYP2C9	PA451906	1559	0.963
NULL	J_Hematol_Oncol_2011_Aug_15_4_34.nxml.txt.nlp	21843362	SENT20	13	13	28	28	doxorubicin	CHOP	PA449412	1649	0.963
NULL	Br_J_Cancer_2009_Oct_20_101(8)_1261-1268.nxml.txt.nlp	19773760	SENT36	0	0	20	20	cetuximab	EGFR	PA10040	1956	0.963
NULL	Gynecol_Oncol_Case_Rep_2013_Mar_6_5_16-18.nxml.txt.nlp	24371685	SENT31	10	10	14	14	estradiol	NAC	PA449503	22861	0.963
NULL	J_Med_Case_Reports_2011_Mar_28_5_117.nxml.txt.nlp	21443773	SENT127	9	9	19	19	sitagliptin	GLP-1	PA164748978	100125288	0.963
NULL	Breast_Cancer_Res_2004_May_7_6(4)_R352-R365.nxml.txt.nlp	15217502	SENT228	23	23	5	5	estradiol	CYP1A2	PA449503	1544	0.963
NULL	Mol_Cancer_2012_Oct_22_11_80.nxml.txt.nlp	23088607	SENT101	25	25	17	17	fulvestrant	PI3K	PA164747170	5290	0.963
NULL	Neural_Regen_Res_2013_Mar_25_8(9)_825-832.nxml.txt.nlp	25206730	SENT101	26	26	13	13	isoflurane	P2X7	PA450106	5027	0.963
NULL	Chin_J_Cancer_2011_May_30(5)_293-302.nxml.txt.nlp	21527062	SENT54	0	0	27	27	trastuzumab	HER2	PA451743	2064	0.963
NULL	Front_Oncol_2014_Mar_25_4_54.nxml.txt.nlp	24724051	SENT261	8	8	22	22	imatinib	ABL1	PA10804	25	0.963
NULL	Alcohol_Res_Health_2011_33(4)_380-388.nxml.txt.nlp	23580022	SENT59	8	8	18	18	buprenorphine	CRA	PA448685	51747;10903	0.963
NULL	Int_J_Mol_Imaging_2011_Oct_26_2011_874585.nxml.txt.nlp	21490735	SENT171	22	22	15	15	docetaxel	FDG	PA449383	23583	0.963
NULL	JAKSTAT_2012_Oct_1_1(4)_292-299.nxml.txt.nlp	24058786	SENT155	19	19	38	38	pyrimethamine	STAT3	PA451193	6774	0.963
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT161	10	10	23	23	didanosine	CD4	PA449301	920	0.963
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT50	0	0	30	30	resveratrol	p65		5970	0.963
NULL	Cancer_Cell_Int_2011_Nov_17_11_40.nxml.txt.nlp	22088142	SENT154	30	30	11	11	gemcitabine	MRP2	PA449748	100130958;57626;1244	0.963
NULL	Ann_Gastroenterol_2014_27(1)_53-59.nxml.txt.nlp	24714782	SENT135	10	10	32	32	omeprazole	CYP1A2	PA450704	1544	0.963
NULL	Br_J_Cancer_2010_Mar_2_102(5)_852-861.nxml.txt.nlp	20145622	SENT56	0	0	32	32	methotrexate	CD16	PA450428	2215;2214	0.963
NULL	J_Cell_Mol_Med_2014_Oct_11_18(10)_2031-2043.nxml.txt.nlp	25109475	SENT149	26	26	5	5	valsartan	AMPK	PA451848	5563	0.963
NULL	Int_J_Mol_Sci_2012_Dec_3_13(12)_16373-16386.nxml.txt.nlp	23208375	SENT148	22	22	4	4	doxorubicin	DDB2	PA449412	1643	0.963
NULL	J_Exp_Med_1998_Jun_1_187(11)_1885-1892.nxml.txt.nlp	9607928	SENT204	7	7	37	37	thalidomide	IL-2	PA451644	3558	0.963
NULL	Biomed_Res_Int_2014_Feb_27_2014_897653.nxml.txt.nlp	24719894	SENT61	31	31	19	19	olanzapine	MTHFR	PA450688	4524	0.963
NULL	Pharmaceuticals_(Basel)_2013_Oct_11_6(10)_1287-1303.nxml.txt.nlp	24275850	SENT60	4	4	13	13	glibenclamide	NeuN	PA449782	146713	0.963
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT238	9	9	21	21	metformin	LKB1	PA450395	6794	0.963
NULL	Chem_Res_Toxicol_2011_Aug_15_24(8)_1275-1282.nxml.txt.nlp	21749116	SENT37	6	6	14	14	geldanamycin	Hsp90	PA152031327	3320	0.963
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT121	27	27	11	11	doxorubicin	B7-H1	PA449412	29126	0.963
NULL	Evid_Based_Complement_Alternat_Med_2015_Jan_6_2015_736431.nxml.txt.nlp	25632290	SENT117	17	17	10	10	curcumin	P-gp	PA151958596	5243	0.963
NULL	J_Int_Soc_Sports_Nutr_2007_Oct_19_4_13.nxml.txt.nlp	17949492	SENT184	32	32	9	9	estradiol	aromatase	PA449503	1588	0.963
NULL	Cancers_(Basel)_2012_Feb_21_4(1)_165-183.nxml.txt.nlp	24213234	SENT188	14	14	7	7	sorafenib	SHARP	PA7000	23013	0.963
NULL	Exp_Cell_Res_2013_Apr_1_319(6)_800-809.nxml.txt.nlp	23247073	SENT205	14	14	8	8	curcumin	AKT	PA151958596	207	0.963
NULL	Oncotarget_2011_Jun_7_2(6)_491-496.nxml.txt.nlp	21653999	SENT61	28	28	4	4	tamoxifen	PAK1	PA451581	5585;5058	0.963
NULL	Int_J_Biol_Sci_2013_Apr_22_9(4)_350-360.nxml.txt.nlp	23630447	SENT140	3	3	12	12	doxorubicin	MDR1	PA449412	5243	0.963
NULL	Cancer_Cell_Int_2009_Sep_10_9_25.nxml.txt.nlp	19744341	SENT128	4	4	18	18	glucosamine	STAT3	PA164747613	6774	0.963
NULL	Blood_Cancer_J_2014_Feb_28_4(2)_e187.nxml.txt.nlp	24583533	SENT33	19	19	6	6	azacitidine	GFM	PA451996	85476	0.963
NULL	Cancer_Res_Treat_2013_Sep_30_45(3)_178-185.nxml.txt.nlp	24155676	SENT87	11	11	27	27	gefitinib	EGFR	PA131301952	1956	0.963
NULL	J_Hematol_Oncol_2013_Jun_3_6_38.nxml.txt.nlp	23731980	SENT172	24	24	4	4	vinorelbine	HER2	PA451881	2064	0.963
NULL	Front_Oncol_2013_Nov_15_3_281.nxml.txt.nlp	24298448	SENT181	31	31	14	14	oxaliplatin	BRAF	PA131285527	673	0.963
NULL	Mol_Biol_Cell_2014_Jun_1_25(11)_1782-1792.nxml.txt.nlp	24719457	SENT112	7	7	2	2	nicotine	p53	PA450626	7157	0.963
NULL	Ann_Oncol_2013_Sep_4_24(9)_2206-2223.nxml.txt.nlp	23917950	SENT111	11	11	19	19	tamoxifen	aromatase	PA451581	1588	0.963
NULL	J_Antimicrob_Chemother_2011_Feb_31_66(2)_265-272.nxml.txt.nlp	21196489	SENT24	0	0	4	4	maraviroc	CCR5	PA164768835	1234	0.963
NULL	Drugs_2009_Mar_17_69(5)_549-565.nxml.txt.nlp	19368417	SENT43	18	18	27	27	budesonide	DPI	PA448681	1832	0.963
NULL	JRSM_Short_Rep_2012_Apr_27_3(4)_26.nxml.txt.nlp	22715427	SENT59	0	0	18	18	trastuzumab	HER2	PA451743	2064	0.963
NULL	Diabetes_Care_2011_Apr_21_34(4)_789-794.nxml.txt.nlp	21447659	SENT55	22	22	33	33	bromocriptine	CYP3A4	PA448671	1576	0.963
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT3264	0	0	10	10	flucloxacillin	HLA-B	PA164781042	3106	0.963
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT295	6	6	35	35	metformin	AMPK	PA450395	5563	0.963
NULL	Nat_Commun_2013_Oct_7_4_2564.nxml.txt.nlp	24096827	SENT50	23	23	14	14	thrombin	ADP	PA451674	23038	0.963
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1699-1708.nxml.txt.nlp	19861960	SENT159	21	21	12	12	dasatinib	STAT3	PA162372878	6774	0.963
NULL	Mol_Brain_2013_May_4_6_22.nxml.txt.nlp	23641686	SENT29	21	21	7	7	phencyclidine	NR2D	PA128406980	2906	0.963
NULL	Chem_Rev_2012_May_9_112(5)_2593-2603.nxml.txt.nlp	22335786	SENT83	0	0	18	18	l-histidine	ATX	PA449882	5168;23049	0.963
NULL	ISRN_Cardiol_2012_Jun_27_2012_692761.nxml.txt.nlp	22792485	SENT101	0	0	18	18	clopidogrel	CYP2C19	PA449053	1557	0.963
NULL	BMJ_Open_2014_Feb_27_4(2)_e004071.nxml.txt.nlp	24578536	SENT66	33	33	8	8	warfarin	TTR	PA451906	7276	0.963
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1196-1204.nxml.txt.nlp	22315058	SENT141	44	44	3	3	gefitinib	EGFR	PA131301952	1956	0.963
NULL	Nat_Commun_2013_Aug_15_4_2130.nxml.txt.nlp	23945651	SENT739	13	13	9	9	etoposide	ATG5	PA449552	9474	0.963
NULL	J_Cell_Biol_2000_Jul_24_150(2)_335-348.nxml.txt.nlp	10908576	SENT212	32	32	17	17	camptothecin	p53	PA153590860	7157	0.963
NULL	EMBO_Mol_Med_2012_Jun_13_4(6)_515-527.nxml.txt.nlp	22416035	SENT102	0	0	15	15	olaparib	p53		7157	0.963
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT209	8	8	42	42	ranibizumab	VEGFR2	PA164746012	3791	0.963
NULL	J_Hematol_Oncol_2011_Feb_7_4_6.nxml.txt.nlp	21299849	SENT156	20	20	7	7	imatinib	RPS6	PA10804	6194	0.963
NULL	Mol_Clin_Oncol_2013_Jul_27_1(4)_711-715.nxml.txt.nlp	24649233	SENT119	8	8	24	24	gefitinib	EGFR	PA131301952	1956	0.963
NULL	Cardiovasc_Drugs_Ther_2010_Dec_13_24(5-6)_391-399.nxml.txt.nlp	20640495	SENT197	25	25	5	5	atorvastatin	COX2	PA448500	4513;5743	0.963
NULL	Br_J_Cancer_2013_Feb_19_108(3)_557-563.nxml.txt.nlp	23361053	SENT46	31	31	3	3	tamoxifen	PAK1	PA451581	5585;5058	0.963
NULL	Breast_Cancer_(Auckl)_2009_Sep_2_3_61-75.nxml.txt.nlp	19809577	SENT242	10	10	41	41	curcumin	p65	PA151958596	5970	0.963
NULL	Case_Rep_Oncol_2010_Apr_22_3(2)_98-105.nxml.txt.nlp	20740181	SENT21	28	28	17	17	erlotinib	EGFR	PA134687924	1956	0.963
NULL	Int_J_Biomed_Sci_2008_Dec_4(4)_260-265.nxml.txt.nlp	19568323	SENT81	27	27	14	14	forskolin	aromatase	PA146096022	1588	0.963
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_P51.nxml.txt.nlp	NULL	SENT11	7	7	2	2	allopurinol	HLA-B	PA448320	3106	0.963
NULL	Nat_Commun_2012_Dec_4_3_1248.nxml.txt.nlp	23212377	SENT86	12	12	4	4	nadh	NADK	PA164755085	65220	0.963
NULL	Front_Cell_Neurosci_2013_Dec_5_7_243.nxml.txt.nlp	24367290	SENT123	28	28	22	22	resveratrol	SIRT1		23411	0.963
NULL	J_Occup_Med_Toxicol_2008_Feb_27_3(Suppl_1)_S6.nxml.txt.nlp	18315837	SENT84	2	2	13	13	theophylline	IL-2	PA451647	3558	0.963
NULL	Front_Synaptic_Neurosci_2014_May_30_6_12.nxml.txt.nlp	24910611	SENT151	27	27	4	4	l-threonine	asc-1	PA451673	56301	0.963
NULL	Bone_Marrow_Transplant_2011_Jul_11_46(7)_943-949.nxml.txt.nlp	20935680	SENT107	13	13	28	28	plerixafor	CD34	PA165958410	947	0.963
NULL	Nat_Med_2014_Jun_4_20(6)_607-615.nxml.txt.nlp	24793239	SENT100	2	2	24	24	indomethacin	FasL	PA449982	356	0.963
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT178	6	6	0	0	tacrolimus	OPG	PA451578	690	0.963
NULL	Avicenna_J_Phytomed_2013_Summer_3(3)_201-204.nxml.txt.nlp	25050275	SENT4	30	30	5	5	ketoconazole	CYP3A4	PA450146	1576	0.963
NULL	Oncotarget_2012_Jan_28_3(1)_22-30.nxml.txt.nlp	22289880	SENT88	28	28	10	10	rituximab	CD19	PA451261	930	0.963
NULL	Nucleic_Acids_Res_2005_Jun_8_33(10)_3283-3291.nxml.txt.nlp	15944449	SENT156	34	34	9	9	cisplatin	ERCC1	PA449014	2067	0.963
NULL	Mol_Cancer_2014_Apr_16_13_83.nxml.txt.nlp	24735930	SENT19	4	4	0	0	vemurafenib	BRAF	PA165946873	673	0.963
NULL	Chem_Rev_2014_Jun_11_114(11)_5753-5774.nxml.txt.nlp	24758331	SENT215	15	15	6	6	verapamil	P-gp	PA451868	5243	0.963
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_297-299.nxml.txt.nlp	20049732	SENT52	0	0	35	35	methotrexate	MSH2	PA450428	4436	0.963
NULL	Environ_Health_2009_Apr_23_8_20.nxml.txt.nlp	19389254	SENT46	15	15	5	5	estradiol	aromatase	PA449503	1588	0.963
NULL	eLife_2013_Nov_5_2_e00969.nxml.txt.nlp	24192036	SENT414	6	6	24	24	vemurafenib	ASK1	PA165946873	4217	0.963
NULL	Biomed_Res_Int_2013_Jan_8_2013_252158.nxml.txt.nlp	23509696	SENT119	27	27	10	10	pioglitazone	adiponectin	PA450970	9370	0.963
NULL	Endosc_Ultrasound_2013_Oct-Dec_2(4)_181-189.nxml.txt.nlp	24949393	SENT73	8	8	21	21	paclitaxel	sit	PA450761	55733	0.963
NULL	Cancers_(Basel)_2012_Sep_25_4(4)_969-988.nxml.txt.nlp	24213497	SENT154	25	25	28	28	gefitinib	EGFR	PA131301952	1956	0.963
NULL	Exp_Hematol_Oncol_2014_Dec_17_3(1)_30.nxml.txt.nlp	NULL	SENT43	7	7	0	0	thrombin	PAR-1	PA451674	2011;2149	0.963
NULL	Int_J_Mol_Sci_2014_Sep_23_15(9)_16936-16948.nxml.txt.nlp	25250911	SENT137	26	26	15	15	trypsin	CO2	PA451806	4513	0.963
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT253	26	26	3	3	lapatinib	HRG	PA152241907	3084;3273	0.963
NULL	Diabetes_Metab_Syndr_Obes_2010_Jul_20_3_263-273.nxml.txt.nlp	21437094	SENT6	6	6	0	0	exenatide	GLP-1	PA164749238	100125288	0.963
NULL	J_Invest_Dermatol_2012_Nov_21_132(11)_2642-2651.nxml.txt.nlp	22718118	SENT52	29	29	4	4	collagenase	CD11c	PA449107	3687	0.963
NULL	Mol_Cells_2014_Mar_31_37(3)_234-240.nxml.txt.nlp	24642709	SENT155	17	17	26	26	cisplatin	HO-1	PA449014	3162	0.963
NULL	Breast_Cancer_Res_2007_Jun_4_9(3)_207.nxml.txt.nlp	17561991	SENT170	37	37	17	17	trastuzumab	HER-2	PA451743	2064	0.963
NULL	J_Med_Case_Reports_2011_Jul_19_5_318.nxml.txt.nlp	21771301	SENT86	8	8	20	20	ketoconazole	ACTH	PA450146	5443	0.963
NULL	Oncotarget_2012_May_4_3(4)_371-394.nxml.txt.nlp	22564882	SENT297	5	5	43	43	nutlin-3	p53		7157	0.963
NULL	Cancer_Cell_Int_2013_Mar_4_13_21.nxml.txt.nlp	23497288	SENT91	7	7	2	2	doxorubicin	EWS	PA449412	2130	0.963
NULL	Breast_Cancer_(Auckl)_2009_Sep_2_3_61-75.nxml.txt.nlp	19809577	SENT87	19	19	1	1	curcumin	BRCA1	PA151958596	672	0.963
NULL	Oncologist_2010_Apr_15(4)_360-371.nxml.txt.nlp	20413641	SENT209	0	0	5	5	palifermin	KGF	PA164744014	2252	0.963
NULL	Oncotarget_2014_Oct_18_5(22)_11604-11619.nxml.txt.nlp	25344099	SENT11	7	7	2	2	cisplatin	RYBP	PA449014	23429	0.963
NULL	Allergy_Rhinol_(Providence)_2014_Jan_31_Spring_5(1)_e2-e8.nxml.txt.nlp	24612853	SENT115	18	18	35	35	clarithromycin	IL-8	PA449028	3576	0.963
NULL	Aging_(Albany_NY)_2009_Feb_5_1(2)_219-233.nxml.txt.nlp	20157511	SENT43	21	21	7	7	galactose	WRN	PA449725	7486	0.963
NULL	Pharmaceuticals_(Basel)_2012_Feb_2_5(2)_114-132.nxml.txt.nlp	24288084	SENT60	0	0	4	4	capsaicin	TRPV1	PA448776	7442	0.963
NULL	Diabetes_2013_Jun_17_62(6)_1843-1854.nxml.txt.nlp	23349486	SENT235	5	5	37	37	pioglitazone	MCP-1	PA450970	6347	0.963
NULL	Exp_Ther_Med_2014_Aug_4_8(2)_657-661.nxml.txt.nlp	25009636	SENT108	22	22	3	3	propofol	CCL2	PA451141	6347	0.962
NULL	Acta_Pharmacol_Sin_2009_Jul_22_30(7)_956-964.nxml.txt.nlp	19543298	SENT11	5	5	28	28	simvastatin	ABCC2	PA451363	1244	0.962
NULL	Case_Rep_Oncol_2013_Mar_29_6(1)_189-196.nxml.txt.nlp	23626560	SENT16	3	3	21	21	gefitinib	EGFR	PA131301952	1956	0.962
NULL	Int_J_Alzheimer_Dis_2009_Jul_14_2009_257403.nxml.txt.nlp	20721293	SENT90	41	41	4	4	forskolin	HCN	PA146096022	378938	0.962
NULL	J_Biol_Chem_2008_Oct_31_283(44)_29841-29846.nxml.txt.nlp	18765669	SENT198	11	11	32	32	suramin	P2X1	PA10292	5023	0.962
NULL	EMBO_Mol_Med_2013_Aug_1_5(8)_1263-1277.nxml.txt.nlp	23818182	SENT56	15	15	36	36	naloxone	GIRK2	PA450586	3763	0.962
NULL	Comput_Math_Methods_Med_2012_Dec_19_2012_473572.nxml.txt.nlp	23365616	SENT108	13	13	6	6	anastrozole	aromatase	PA448432	1588	0.962
NULL	Oncotarget_2012_Sep_11_3(9)_1026-1035.nxml.txt.nlp	22976441	SENT89	42	42	19	19	etoposide	CKI	PA449552	1119	0.962
NULL	Neural_Regen_Res_2013_Mar_25_8(9)_825-832.nxml.txt.nlp	25206730	SENT95	14	14	3	3	isoflurane	P2X7	PA450106	5027	0.962
NULL	Clin_Exp_Otorhinolaryngol_2012_Sep_27_5(3)_117-121.nxml.txt.nlp	22977707	SENT94	19	19	14	14	kanamycin	KCC2	PA450137	57468	0.962
NULL	Cancer_Cell_Int_2013_Mar_13_13_25.nxml.txt.nlp	23497375	SENT139	30	30	35	35	bortezomib	p38	PA10252	10598;1432;7965	0.962
NULL	Ann_Thorac_Med_2014_Apr-Jun_9(2)_124-126.nxml.txt.nlp	24791177	SENT76	2	2	13	13	sirolimus	LAM	PA451365	7249;7248	0.962
NULL	Korean_Circ_J_2014_Mar_12_44(2)_97-104.nxml.txt.nlp	24653739	SENT123	10	10	3	3	bosentan	IL-6	PA10034	3569	0.962
NULL	Arch_Drug_Inf_2011_Mar_4(1)_1-9.nxml.txt.nlp	21572514	SENT10	9	9	22	22	ciprofloxacin	MDR1	PA449009	5243	0.962
NULL	Clin_Interv_Aging_2008_Mar_3(1)_45-50.nxml.txt.nlp	18488877	SENT59	16	16	1	1	raloxifene	STAR	PA451221	6770;2984	0.962
NULL	Oncotarget_2014_Mar_16_5(12)_4087-4102.nxml.txt.nlp	24961479	SENT188	6	6	2	2	hemin	PC3	PA449849	57332;7832;5122	0.962
NULL	Cancer_Imaging_2008_Nov_25_8(1)_199-205.nxml.txt.nlp	19028612	SENT137	22	22	20	20	erlotinib	EGFR	PA134687924	1956	0.962
NULL	Cancer_Cell_Int_2009_Sep_10_9_25.nxml.txt.nlp	19744341	SENT181	11	11	22	22	glucosamine	STAT3	PA164747613	6774	0.962
NULL	Curr_HIV_Res_2014_May_12(3)_174-188.nxml.txt.nlp	24862327	SENT127	1	1	17	17	ethanol	AP-1	PA448073	2353;3727;2354;3725	0.962
NULL	Int_J_Mol_Sci_2014_Mar_5_15(3)_3970-3988.nxml.txt.nlp	24603537	SENT245	28	28	22	22	curcumin	MCH	PA151958596	5367	0.962
NULL	Int_J_Biochem_Cell_Biol_2013_Feb_45(2)_283-291.nxml.txt.nlp	23085378	SENT174	4	4	23	23	finasteride	aromatase	PA449627	1588	0.962
NULL	Clin_Med_Insights_Oncol_2013_Jun_3_7_103-122.nxml.txt.nlp	23843721	SENT134	15	15	3	3	trastuzumab	PTEN	PA451743	5728	0.962
NULL	Ann_Hematol_2014_Mar_18_93(8)_1335-1344.nxml.txt.nlp	24638841	SENT163	4	4	23	23	rituximab	CLB	PA451261	171425	0.962
NULL	Mol_Biol_Cell_2012_Sep_1_23(17)_3473-3484.nxml.txt.nlp	22787275	SENT188	33	33	12	12	doxorubicin	ABCC1	PA449412	4363	0.962
NULL	Atten_Defic_Hyperact_Disord_2009_Dec_23_1(2)_201-210.nxml.txt.nlp	20234828	SENT24	5	5	20	20	atomoxetine	CYP2D6	PA134688071	1565	0.962
NULL	Mol_Cancer_2010_Apr_29_9_95.nxml.txt.nlp	20429933	SENT65	13	13	25	25	cisplatin	p53	PA449014	7157	0.962
NULL	Cancers_(Basel)_2013_Apr_3_5(2)_334-356.nxml.txt.nlp	24216980	SENT55	6	6	0	0	doxycycline	ZEB1	PA449415	6935	0.962
NULL	Oncoimmunology_2014_Apr_25_3_e28518.nxml.txt.nlp	25071979	SENT161	11	11	3	3	paclitaxel	SF2	PA450761	6426	0.962
NULL	Anat_Cell_Biol_2010_Sep_30_43(3)_194-200.nxml.txt.nlp	21212859	SENT13	11	11	6	6	ethanol	PLP	PA448073	25824;5744	0.962
NULL	J_Adv_Pharm_Technol_Res_2013_Jul-Sep_4(3)_151-159.nxml.txt.nlp	24083203	SENT35	8	8	12	12	mannitol	Lobe	PA450320	84335	0.962
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1137-1144.nxml.txt.nlp	20234366	SENT59	11	11	0	0	cetuximab	MKP-1	PA10040	1843	0.962
NULL	J_Hematol_Oncol_2012_Sep_18_5_57.nxml.txt.nlp	22989009	SENT191	18	18	0	0	nutlin-3	HDM2		4193	0.962
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_12_2012_160726.nxml.txt.nlp	23243430	SENT190	5	5	18	18	losartan	c-Jun	PA450268	3725	0.962
NULL	Int_J_Endocrinol_2014_Apr_13_2014_390121.nxml.txt.nlp	24829575	SENT73	18	18	10	10	ampicillin	TPO	PA448419	7066;7173	0.962
NULL	Nucleic_Acids_Res_2011_Mar_22_39(4)_1398-1407.nxml.txt.nlp	20972214	SENT79	8	8	17	17	chloramphenicol	GATC	PA448927	283459	0.962
NULL	Hematol_Rep_2011_Oct_27_3(3)_e20.nxml.txt.nlp	22593812	SENT58	2	2	16	16	eltrombopag	TPO	PA165981594	7066;7173	0.962
NULL	J_Hematol_Oncol_2013_Jun_3_6_38.nxml.txt.nlp	23731980	SENT175	6	6	22	22	afatinib	HER3	PA165981154	2065	0.962
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jan_9_66(Pt_2)_o301.nxml.txt.nlp	21579734	SENT59	12	12	20	20	anastrozole	aromatase	PA448432	1588	0.962
NULL	J_Bras_Pneumol_2014_Jul-Aug_40(4)_429-442.nxml.txt.nlp	25210967	SENT201	29	29	21	21	pemetrexed	CSF1R	PA10810	1436	0.962
NULL	Breast_Cancer_Res_2002_Mar_20_4(3)_R3.nxml.txt.nlp	12052255	SENT130	17	17	2	2	cytarabine	DCTD	PA449177	1635	0.962
NULL	Cancer_Manag_Res_2013_Nov_19_5_377-385.nxml.txt.nlp	24399885	SENT46	32	32	23	23	cetuximab	KRAS	PA10040	3845	0.962
NULL	Drugs_Aging_2014_May_6_31(6)_413-424.nxml.txt.nlp	24797286	SENT139	16	16	2	2	denosumab	CTX	PA166048634	1593	0.962
NULL	Front_Physiol_2013_Dec_24_4_386.nxml.txt.nlp	24399968	SENT333	17	17	12	12	carbamazepine	SUR1	PA448785	6833	0.962
NULL	Curr_Gerontol_Geriatr_Res_2010_May_4_2010_420139.nxml.txt.nlp	20454643	SENT89	35	35	4	4	estradiol	AMPK	PA449503	5563	0.962
NULL	Cells_2014_Sep_12_3(3)_914-938.nxml.txt.nlp	25222270	SENT85	4	4	9	9	capsaicin	TRPM1	PA448776	4308	0.962
NULL	Oncotarget_2013_Nov_15_5(6)_1458-1474.nxml.txt.nlp	24681547	SENT128	0	0	9	9	celecoxib	CDH11	PA448871	1009	0.962
NULL	Oncotarget_2012_Nov_5_3(10)_1054-1056.nxml.txt.nlp	23175477	SENT29	10	10	26	26	tanespimycin	CD34	PA165291490	947	0.962
NULL	Front_Genet_2012_Nov_5_3_236.nxml.txt.nlp	23133441	SENT16	13	13	2	2	efavirenz	ABCB1	PA449441	5243	0.962
NULL	Breast_Cancer_Res_2012_May_14_14(3)_R77.nxml.txt.nlp	22583478	SENT52	5	5	30	30	estradiol	E2F2	PA449503	1870	0.962
NULL	Aging_(Albany_NY)_2011_Mar_10_3(3)_192-222.nxml.txt.nlp	21422497	SENT513	6	6	10	10	doxorubicin	p53	PA449412	7157	0.962
NULL	Mol_Cancer_2013_Sep_11_12_104.nxml.txt.nlp	24025152	SENT8	16	16	19	19	gemcitabine	EGFR	PA449748	1956	0.962
NULL	Breast_Cancer_Res_Treat_2012_Jun_15_133(3)_1057-1065.nxml.txt.nlp	22418700	SENT33	6	6	23	23	afatinib	HER2	PA165981154	2064	0.962
NULL	Mol_Cancer_2012_Apr_26_11_26.nxml.txt.nlp	22537224	SENT14	23	23	10	10	cisplatin	CHK1	PA449014	1111	0.962
NULL	CNS_Spectr_2014_Apr_1_19(2)_121-133.nxml.txt.nlp	23903233	SENT103	13	13	4	4	scopolamine	5-HT1A	PA451308	3350	0.962
NULL	BMJ_Open_2013_Oct_14_3(10)_e003912.nxml.txt.nlp	24127058	SENT165	11	11	19	19	vancomycin	HAP	PA451850	5915;10313	0.962
NULL	J_Hum_Genet_2013_Jun_23_58(6)_339-345.nxml.txt.nlp	23697979	SENT24	3	3	15	15	clopidogrel	P2Y12	PA449053	64805	0.962
NULL	Hum_Genomics_2011_May_1_5(4)_265-282.nxml.txt.nlp	21712189	SENT153	4	4	20	20	nevirapine	CYP2B6	PA450616	1555	0.962
NULL	Gene_Regul_Syst_Bio_2014_Mar_4_8_63-73.nxml.txt.nlp	24634581	SENT119	23	23	7	7	minocycline	STAT3	PA450519	6774	0.962
NULL	Mol_Cell_Biochem_2015_Oct_8_398(1-2)_165-173.nxml.txt.nlp	25292312	SENT188	5	5	21	21	bortezomib	BIM	PA10252	10018	0.962
NULL	Breast_Cancer_Res_2012_Mar_20_14(2)_R53.nxml.txt.nlp	22433433	SENT222	18	18	0	0	cisplatin	CCNE1	PA449014	898	0.962
NULL	Acta_Pharmacol_Sin_2012_Dec_29_33(12)_1518-1524.nxml.txt.nlp	23103625	SENT127	23	23	9	9	telmisartan	ACE	PA451605	1636	0.962
NULL	Front_Immunol_2013_Oct_7_4_325.nxml.txt.nlp	24109484	SENT57	24	24	7	7	colchicine	NKp30	PA449092	259197	0.962
NULL	Cell_Cycle_2013_Apr_1_12(7)_1020.nxml.txt.nlp	23511169	SENT28	12	12	6	6	bortezomib	p53	PA10252	7157	0.962
NULL	Front_Oncol_2014_Apr_9_4_75.nxml.txt.nlp	24782986	SENT264	17	17	11	11	paclitaxel	CD34	PA450761	947	0.962
NULL	Oncotarget_2013_Apr_13_4(4)_502-530.nxml.txt.nlp	23594434	SENT382	10	10	0	0	aprepitant	CYP3A4	PA164747039	1576	0.962
NULL	Br_J_Cancer_2009_May_19_100(10)_1540-1548.nxml.txt.nlp	19384300	SENT103	26	26	6	6	trypsin	TATI	PA451806	6690	0.962
NULL	Nat_Med_2013_Mar_3_19(3)_295-304.nxml.txt.nlp	23377280	SENT136	5	5	21	21	erlotinib	EGFR	PA134687924	1956	0.962
NULL	Orphanet_J_Rare_Dis_2007_Jan_4_2_1.nxml.txt.nlp	17204147	SENT157	20	20	41	41	trypsin	PRSS1	PA451806	5644	0.962
NULL	Oncotarget_2013_Nov_22_5(4)_933-943.nxml.txt.nlp	24659749	SENT108	42	42	6	6	nutlin-3	p53		7157	0.962
NULL	Int_J_Emerg_Med_2010_May_26_3(2)_81-84.nxml.txt.nlp	20606815	SENT90	9	9	16	16	lopinavir	CYP3A4	PA450264	1576	0.962
NULL	Oncoimmunology_2013_May_1_2(5)_e23850.nxml.txt.nlp	23762785	SENT37	6	6	34	34	denosumab	RANKL	PA166048634	8600	0.962
NULL	Cell_Death_Dis_2014_Jul_3_5(7)_e1316.nxml.txt.nlp	24991768	SENT70	10	10	4	4	pemetrexed	Mcl-1	PA10810	4170	0.962
NULL	J_Invest_Dermatol_2011_Nov_14_131(11)_2323-2324.nxml.txt.nlp	21753782	SENT18	0	0	10	10	abatacept	CTLA4	PA164747080	1493	0.962
NULL	Oncotarget_2013_Jul_7_4(7)_1065-1074.nxml.txt.nlp	23867252	SENT163	43	43	7	7	trypsin	Hsp90	PA451806	3320	0.962
NULL	Biosci_Rep_2014_Apr_15_34(2)_e00105.nxml.txt.nlp	24617546	SENT96	32	32	9	9	sorafenib	AMPK	PA7000	5563	0.962
NULL	J_Autoimmune_Dis_2005_Mar_15_2_2.nxml.txt.nlp	15769293	SENT22	22	22	0	0	thyroglobulin	TPO	PA164754910	7066;7173	0.962
NULL	Oncoimmunology_2012_Aug_1_1(5)_618-629.nxml.txt.nlp	22934254	SENT192	35	35	27	27	nilotinib	CD19	PA165958345	930	0.962
NULL	J_Skin_Cancer_2011_Nov_17_2011_423239.nxml.txt.nlp	22175026	SENT158	32	32	5	5	vemurafenib	CRAF	PA165946873	5894	0.962
NULL	Cancer_Manag_Res_2014_Feb_3_6_63-75.nxml.txt.nlp	24520205	SENT187	0	0	13	13	erlotinib	EGF	PA134687924	1950	0.962
NULL	Cancer_Cell_Int_2009_Mar_3_9_6.nxml.txt.nlp	19257877	SENT165	19	19	9	9	trypsin	CO2	PA451806	4513	0.962
NULL	Oncol_Lett_2013_Mar_19_5(3)_923-928.nxml.txt.nlp	23426648	SENT146	5	5	8	8	sc-560	COX		1351	0.962
NULL	FEBS_Open_Bio_2013_May_10_3_225-230.nxml.txt.nlp	23772398	SENT141	24	24	6	6	cisplatin	CD9	PA449014	928	0.962
NULL	Int_J_Breast_Cancer_2013_Jan_16_2013_872743.nxml.txt.nlp	23401782	SENT48	12	12	6	6	tamoxifen	PAK1	PA451581	5585;5058	0.962
NULL	Br_J_Cancer_2012_Feb_14_106(4)_719-726.nxml.txt.nlp	22240798	SENT177	24	24	19	19	erlotinib	EGFR	PA134687924	1956	0.962
NULL	Arthritis_Res_Ther_2012_Apr_30_14(2)_R96.nxml.txt.nlp	22546471	SENT135	10	10	29	29	methotrexate	IL-6	PA450428	3569	0.962
NULL	J_Cell_Biol_1998_Nov_30_143(5)_1317-1328.nxml.txt.nlp	9832559	SENT119	26	26	11	11	trypsin	EGF	PA451806	1950	0.962
NULL	Arthritis_Res_Ther_2005_Feb_17_7(Suppl_1)_P40.nxml.txt.nlp	NULL	SENT4	5	5	1	1	hemin	HO-1	PA449849	3162	0.962
NULL	Cancer_Imaging_2013_Jul_22_13(3)_306-313.nxml.txt.nlp	23876444	SENT189	30	30	12	12	vemurafenib	BRAF	PA165946873	673	0.962
NULL	Contemp_Oncol_(Pozn)_2012_Nov_20_16(5)_401-406.nxml.txt.nlp	23788917	SENT36	9	9	30	30	erlotinib	EGFR	PA134687924	1956	0.962
NULL	Eur_J_Haematol_2008_Feb_80(2)_93-106.nxml.txt.nlp	18081719	SENT363	24	24	3	3	iron	MRI	PA450087	78996	0.962
NULL	Acta_Pharmacol_Sin_2009_Sep_24_30(9)_1262-1275.nxml.txt.nlp	19701231	SENT226	39	39	12	12	lovastatin	LMNB2	PA450272	84823	0.962
NULL	Antiviral_Res_2009_May_82(2)_A99-A109.nxml.txt.nlp	19176219	SENT178	10	10	21	21	ritonavir	OCT2	PA451260	6582;5452	0.962
NULL	Arthritis_Res_Ther_2004_Sep_13_6(Suppl_3)_63.nxml.txt.nlp	NULL	SENT15	9	9	15	15	etanercept	IL-6	PA449515	3569	0.962
NULL	J_Neurosci_Methods_2008_Jul_30_172(2-4)_143-157.nxml.txt.nlp	18550176	SENT183	0	0	10	10	pilocarpine	CA1	PA450962	759	0.962
NULL	Leukemia_2013_Feb_3_27(2)_315-324.nxml.txt.nlp	22751450	SENT206	3	3	41	41	sorafenib	Mcl-1	PA7000	4170	0.962
NULL	Br_J_Cancer_2010_Sep_28_103(7)_1008-1018.nxml.txt.nlp	20736947	SENT212	19	19	6	6	docetaxel	CD147	PA449383	682	0.962
NULL	Mol_Cancer_2014_Feb_5_13_24.nxml.txt.nlp	24495306	SENT297	32	32	5	5	collagenase	ADAM17	PA449107	6868	0.962
NULL	Gut_2013_Apr_14_62(4)_540-549.nxml.txt.nlp	22798500	SENT269	13	13	17	17	cetuximab	KRAS	PA10040	3845	0.962
NULL	Oncotarget_2013_Nov_24_4(12)_2430-2438.nxml.txt.nlp	24280348	SENT151	33	33	24	24	gefitinib	EGFR	PA131301952	1956	0.962
NULL	Oncogene_2014_Feb_6_33(6)_713-723.nxml.txt.nlp	23435429	SENT54	31	31	2	2	cisplatin	BRCA1	PA449014	672	0.962
NULL	Exp_Ther_Med_2013_May_15_5(5)_1327-1331.nxml.txt.nlp	23737873	SENT22	8	8	0	0	vasopressin	AQP2	PA451858	359	0.962
NULL	J_Hematol_Oncol_2012_Jun_18_5_31.nxml.txt.nlp	22709792	SENT120	0	0	3	3	trastuzumab	HER2	PA451743	2064	0.962
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1699-1708.nxml.txt.nlp	19861960	SENT159	21	21	5	5	dasatinib	HER2	PA162372878	2064	0.962
NULL	ACS_Med_Chem_Lett_2011_May_16_2(7)_549-554.nxml.txt.nlp	21765967	SENT24	17	17	24	24	maraviroc	CCR5	PA164768835	1234	0.962
NULL	Basic_Res_Cardiol_2015_Jan_20_110_4.nxml.txt.nlp	25600226	SENT315	8	8	4	4	fenofibrate	PCSK9	PA449594	255738	0.962
NULL	Breast_Cancer_(Auckl)_2012_Mar_7_6_67-77.nxml.txt.nlp	22438669	SENT34	3	3	12	12	lapatinib	HER2	PA152241907	2064	0.962
NULL	J_Immunol_Res_2014_Apr_30_2014_857143.nxml.txt.nlp	24877157	SENT323	5	5	9	9	tacrolimus	IL-2	PA451578	3558	0.962
NULL	Oncoscience_2014_Mar_24_1(3)_196-204.nxml.txt.nlp	25594012	SENT118	26	26	17	17	gefitinib	HER3	PA131301952	2065	0.962
NULL	J_Oncol_2010_Dec_28_2010_414676.nxml.txt.nlp	20066160	SENT89	9	9	13	13	paclitaxel	VEGFR	PA450761	3791	0.962
NULL	Oncotarget_2011_Sep_9_2(9)_658-668.nxml.txt.nlp	21911919	SENT82	19	19	4	4	daunorubicin	HO-1	PA449212	3162	0.962
NULL	Orthop_Rev_(Pavia)_2014_Sep_18_6(3)_5405.nxml.txt.nlp	25317308	SENT60	14	14	25	25	acetaminophen	PRN	PA448015	64428	0.962
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT195	11	11	33	33	ranibizumab	PlGF-2	PA164746012	5228	0.962
NULL	Curr_Chem_Genomics_2010_Mar_1_4_1-8.nxml.txt.nlp	20448812	SENT28	24	24	12	12	methotrexate	OATP1B1	PA450428	10599	0.962
NULL	Case_Rep_Med_2013_Aug_4_2013_373981.nxml.txt.nlp	23983708	SENT83	16	16	4	4	imatinib	KIT	PA10804	3815	0.962
NULL	Ann_Gen_Psychiatry_2009_Jul_27_8_16.nxml.txt.nlp	19635147	SENT80	1	1	5	5	aripiprazole	CYP2D6	PA10026	1565	0.962
NULL	Acta_Pharmacol_Sin_2009_Jul_8_30(7)_1060-1064.nxml.txt.nlp	19543299	SENT72	0	0	18	18	meloxicam	San	PA450353	80218	0.962
NULL	Int_J_Mol_Sci_2014_Sep_1_15(9)_15358-15376.nxml.txt.nlp	25257519	SENT49	11	11	24	24	tobramycin	NAG	PA451704	51594;4669	0.962
NULL	Arch_Gynecol_Obstet_2012_May_30_285(5)_1447-1453.nxml.txt.nlp	22127553	SENT9	15	15	0	0	carboplatin	TEC	PA448803	7006	0.962
NULL	J_Gastroenterol_2013_Jan_27_48(1)_22-30.nxml.txt.nlp	23104468	SENT169	8	8	12	12	ribavirin	SOC	PA451241	91544	0.962
NULL	Core_Evid_2007_Nov_30_2(2)_81-88.nxml.txt.nlp	21221177	SENT234	10	10	30	30	irinotecan	EGFR	PA450085	1956	0.962
NULL	Breast_Cancer_Res_Treat_2007_Oct_27_105(Suppl_1)_19-29.nxml.txt.nlp	17333340	SENT25	9	9	2	2	exemestane	aromatase	PA449563	1588	0.962
NULL	J_Hematol_Oncol_2011_Jan_21_4_5.nxml.txt.nlp	21255411	SENT166	22	22	2	2	paclitaxel	EGFR	PA450761	1956	0.962
NULL	Br_J_Cancer_2009_Jun_2_100(11)_1704-1719.nxml.txt.nlp	19436303	SENT100	6	6	19	19	cetuximab	HER2	PA10040	2064	0.962
NULL	Front_Oncol_2013_Aug_5_3_195.nxml.txt.nlp	23936763	SENT59	0	0	20	20	dasatinib	DDR2	PA162372878	4921	0.962
NULL	Neuro_Oncol_2010_Apr_27_12(4)_389-400.nxml.txt.nlp	20308316	SENT117	13	13	1	1	chloroquine	p53	PA448948	7157	0.962
NULL	Biomed_Res_Int_2014_Jun_24_2014_282657.nxml.txt.nlp	25050334	SENT8	22	22	7	7	resveratrol	GPX1		2876	0.962
NULL	ScientificWorldJournal_2013_Dec_30_2013_565813.nxml.txt.nlp	24489506	SENT52	16	16	3	3	ethanol	Q10	PA448073	27161	0.962
NULL	Hum_Genomics_2010_Apr_1_4(4)_238-249.nxml.txt.nlp	20511137	SENT37	21	21	6	6	etoposide	UGT1A1	PA449552	54658	0.962
NULL	Oncotarget_2013_Jul_30_5(3)_599-612.nxml.txt.nlp	24583601	SENT344	16	16	6	6	cisplatin	CD133	PA449014	8842	0.962
NULL	Gut_Liver_2012_Apr_17_6(2)_210-217.nxml.txt.nlp	22570750	SENT154	39	39	21	21	diclofenac	cPLA2	PA449293	10524	0.962
NULL	Diabetes_2009_Jun_31_58(6)_1434-1439.nxml.txt.nlp	19336679	SENT4	0	0	19	19	metformin	SLC22A1	PA450395	6580	0.962
NULL	Breast_Cancer_Res_2012_May_4_14(3)_R72.nxml.txt.nlp	22559056	SENT6	33	33	3	3	tamoxifen	CENP-A	PA451581	1058	0.962
NULL	Arthritis_Res_Ther_2006_May_5_8(3)_R83.nxml.txt.nlp	16677395	SENT159	12	12	25	25	rituximab	CD4	PA451261	920	0.962
NULL	Clin_Neuroradiol_2013_Sep_8_23(3)_225-229.nxml.txt.nlp	22960936	SENT51	8	8	22	22	heparin	ACT	PA449855	12;11332;9457;641455	0.962
NULL	Eur_J_Clin_Pharmacol_2012_Jan_7_68(1)_55-64.nxml.txt.nlp	21735164	SENT26	2	2	11	11	oxymorphone	CYP3A4	PA450748	1576	0.962
NULL	Biomed_Res_Int_2013_Dec_31_2013_795103.nxml.txt.nlp	23710462	SENT166	35	35	30	30	fenofibrate	adiponectin	PA449594	9370	0.962
NULL	Onco_Targets_Ther_2014_Jun_19_7_1025-1032.nxml.txt.nlp	24971016	SENT93	3	3	13	13	bevacizumab	VEGFR	PA130232992	3791	0.962
NULL	Eur_J_Clin_Pharmacol_2011_Dec_23_67(12)_1231-1241.nxml.txt.nlp	21698374	SENT286	15	15	6	6	simvastatin	ABCB1	PA451363	5243	0.962
NULL	Oncol_Lett_2013_Aug_17_6(2)_295-305.nxml.txt.nlp	24137320	SENT176	13	13	1	1	tamoxifen	14-3-3	PA451581	10971	0.962
NULL	ARYA_Atheroscler_2011_Summer_7(2)_78-86.nxml.txt.nlp	22577451	SENT11	8	8	40	40	choline	TNF	PA448976	7124	0.962
NULL	Biosci_Rep_2013_Sep_17_33(5)_e00070.nxml.txt.nlp	23883094	SENT105	19	19	3	3	bicalutamide	PC3	PA164746255	57332;7832;5122	0.962
NULL	Breast_Cancer_Res_2008_Mar_27_10(2)_R26.nxml.txt.nlp	18371194	SENT113	23	23	10	10	cisplatin	BRCA1	PA449014	672	0.962
NULL	Front_Immunol_2012_Jan_24_3_3.nxml.txt.nlp	22566889	SENT114	17	17	5	5	rituximab	TLR9	PA451261	54106	0.962
NULL	Indian_J_Med_Res_2011_May_133(5)_467-470.nxml.txt.nlp	21623029	SENT39	11	11	23	23	minocycline	CD4	PA450519	920	0.962
NULL	Exp_Ther_Med_2014_Apr_13_7(4)_799-803.nxml.txt.nlp	24669235	SENT16	3	3	33	33	vildagliptin	PPG	PA165958346	5552	0.962
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT126	26	26	4	4	simvastatin	survivin	PA451363	332	0.962
NULL	Basic_Clin_Pharmacol_Toxicol_2013_Feb_5_112(2)_132-137.nxml.txt.nlp	22900583	SENT12	11	11	25	25	ritonavir	CYP3A4	PA451260	1576	0.962
NULL	Biologics_2009_Sep_15_3_419-428.nxml.txt.nlp	19774209	SENT173	30	30	35	35	erlotinib	EGFR	PA134687924	1956	0.962
NULL	Ann_Oncol_2010_Feb_21(2)_217-222.nxml.txt.nlp	20110292	SENT158	24	24	13	13	erlotinib	RAPGEF5	PA134687924	9771	0.962
NULL	Iran_J_Psychiatry_2010_Winter_5(1)_11-17.nxml.txt.nlp	22952484	SENT157	11	11	28	28	ranitidine	OAT	PA451224	4942	0.962
NULL	J_Hematol_Oncol_2010_Oct_27_3_42.nxml.txt.nlp	20979652	SENT121	11	11	1	1	olaparib	PARP1		142	0.962
NULL	Biomed_Res_Int_2014_Feb_19_2014_627510.nxml.txt.nlp	24701578	SENT192	37	37	7	7	docetaxel	ABCB1	PA449383	5243	0.962
NULL	Oncotarget_2013_Nov_20_5(1)_173-184.nxml.txt.nlp	24368422	SENT67	8	8	26	26	chloroquine	LC3	PA448948	84557	0.962
NULL	Oncotarget_2014_Aug_27_5(19)_9227-9238.nxml.txt.nlp	25193861	SENT120	29	29	8	8	cisplatin	p53	PA449014	7157	0.962
NULL	Oncol_Lett_2013_Mar_8_5(3)_805-812.nxml.txt.nlp	23426281	SENT126	15	15	24	24	gemcitabine	B7-H3	PA449748	80381	0.962
NULL	Clin_Pharmacokinet_2014_Sep_3_53(1)_1-16.nxml.txt.nlp	23999929	SENT288	14	14	28	28	clarithromycin	P-gp	PA449028	5243	0.962
NULL	Arthritis_Res_Ther_2008_Mar_17_10(2)_R33.nxml.txt.nlp	18346273	SENT118	5	5	8	8	infliximab	HMGB1	PA452639	3146	0.962
NULL	Acta_Pharmacol_Sin_2013_Feb_31_34(2)_231-238.nxml.txt.nlp	23274414	SENT191	21	21	9	9	amiloride	Bcl-2	PA448368	596	0.962
NULL	Br_J_Cancer_2014_Mar_4_110(5)_1221-1227.nxml.txt.nlp	24496456	SENT55	22	22	8	8	cetuximab	EGFR	PA10040	1956	0.962
NULL	Int_J_Breast_Cancer_2011_Sep_6_2011_352182.nxml.txt.nlp	22295219	SENT40	0	0	27	27	trastuzumab	HER2	PA451743	2064	0.962
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT196	43	43	4	4	cetuximab	KRAS	PA10040	3845	0.962
NULL	ScientificWorldJournal_2012_Nov_7_2012_976740.nxml.txt.nlp	23251109	SENT111	8	8	12	12	piroxicam	COX	PA450985	1351	0.962
NULL	Indian_J_Pharmacol_2013_May-Jun_45(3)_252-257.nxml.txt.nlp	23833368	SENT71	10	10	2	2	ranitidine	B12	PA451224	7126;4709	0.962
NULL	Daru_2011_19(2)_138-144.nxml.txt.nlp	22615650	SENT113	29	29	9	9	heparin	FGF20	PA449855	26281	0.962
NULL	Pharmaceuticals_(Basel)_2012_Aug_17_5(8)_837-852.nxml.txt.nlp	24280677	SENT133	5	5	31	31	capsaicin	TRPV1	PA448776	7442	0.962
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT186	2	2	5	5	erlotinib	EGFR	PA134687924	1956	0.962
NULL	J_Cachexia_Sarcopenia_Muscle_2010_Sep_26_1(1)_9-21.nxml.txt.nlp	21475693	SENT81	25	25	28	28	losartan	AT1	PA450268	9197;185	0.962
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT113	3	3	10	10	cisplatin	MLH1	PA449014	4292	0.962
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT229	9	9	21	21	metformin	EGFR	PA450395	1956	0.962
NULL	Br_J_Cancer_2013_Jul_9_109(1)_68-75.nxml.txt.nlp	23807173	SENT185	28	28	1	1	cisplatin	ERCC1	PA449014	2067	0.962
NULL	Mol_Cancer_2014_Feb_24_13_35.nxml.txt.nlp	24565101	SENT99	3	3	39	39	doxorubicin	c-IAP2	PA449412	330	0.962
NULL	Breast_Cancer_Res_2012_Feb_13_14(1)_R28.nxml.txt.nlp	22330809	SENT153	23	23	12	12	trastuzumab	PTEN	PA451743	5728	0.962
NULL	Virol_J_2011_Nov_28_8_523.nxml.txt.nlp	22122911	SENT6	25	25	13	13	heparin	RANTES	PA449855	6352	0.962
NULL	Front_Aging_Neurosci_2009_Dec_9_1_4.nxml.txt.nlp	20552055	SENT210	2	2	22	22	resveratrol	SIRT1		23411	0.962
NULL	J_Invest_Dermatol_2012_Jan_18_132(1)_163-169.nxml.txt.nlp	21850019	SENT68	11	11	28	28	imiquimod	HLA-A	PA449972	3105	0.962
NULL	Pharmaceuticals_(Basel)_2012_Feb_2_5(2)_114-132.nxml.txt.nlp	24288084	SENT166	13	13	42	42	capsaicin	TRPV1	PA448776	7442	0.962
NULL	Cell_Death_Differ_2010_Apr_16_17(4)_666-676.nxml.txt.nlp	19834494	SENT317	10	10	3	3	oxaliplatin	RAGE	PA131285527	177	0.962
NULL	Acta_Neuropathol_2012_Feb_19_123(2)_247-258.nxml.txt.nlp	22009304	SENT47	0	0	13	13	tamoxifen	flower	PA451581	11094	0.962
NULL	Acta_Pharmacol_Sin_2012_Feb_3_33(2)_194-200.nxml.txt.nlp	22301859	SENT31	0	0	4	4	liraglutide	GLP-1	PA165958364	100125288	0.962
NULL	J_Cell_Mol_Med_2013_Dec_6_17(12)_1588-1597.nxml.txt.nlp	24199964	SENT227	8	8	24	24	doxycycline	APT	PA449415	653639	0.962
NULL	Mediators_Inflamm_1996_Oct_5(5)_346-357.nxml.txt.nlp	18475729	SENT8	31	31	8	8	heparin	FMLP	PA449855	2357	0.962
NULL	J_Cardiothorac_Surg_2009_Jun_18_4_25.nxml.txt.nlp	19538741	SENT55	5	5	23	23	heparin	ACT	PA449855	12;11332;9457;641455	0.962
NULL	Breast_Cancer_Res_2011_Feb_3_13(1)_R16.nxml.txt.nlp	21291529	SENT145	27	27	38	38	tamoxifen	PHD1	PA451581	112398	0.962
NULL	Acta_Pharmacol_Sin_2010_Jan_5_31(1)_93-101.nxml.txt.nlp	20048748	SENT146	7	7	28	28	cisplatin	DAPK	PA449014	1612	0.962
NULL	Oncogene_2009_Jan_15_28(2)_157-169.nxml.txt.nlp	18931700	SENT235	9	9	21	21	tanespimycin	HER-2	PA165291490	2064	0.962
NULL	Front_Neural_Circuits_2014_Aug_5_8_93.nxml.txt.nlp	25140130	SENT133	6	6	11	11	bromocriptine	spatial	PA448671	219793	0.962
NULL	Cancers_(Basel)_2013_Nov_26_5(4)_1601-1618.nxml.txt.nlp	24287743	SENT193	0	0	14	14	cabozantinib	VEGFR2	PA165906891	3791	0.962
NULL	Support_Care_Cancer_2011_Mar_16_19(3)_353-361.nxml.txt.nlp	20157746	SENT39	15	15	1	1	cisplatin	CTX	PA449014	1593	0.962
NULL	J_Inflamm_(Lond)_2008_Jul_29_5_11.nxml.txt.nlp	18664275	SENT17	4	4	11	11	clarithromycin	IL-8	PA449028	3576	0.962
NULL	J_Gerontol_A_Biol_Sci_Med_Sci_2014_Jun_8_69(Suppl_1)_S21-S27.nxml.txt.nlp	24833582	SENT43	0	0	5	5	metformin	AMPK	PA450395	5563	0.962
NULL	Clin_Interv_Aging_2012_Sep_3_7_331-338.nxml.txt.nlp	22977302	SENT96	8	8	16	16	denosumab	RANKL	PA166048634	8600	0.962
NULL	Hum_Genomics_2010_Apr_1_4(4)_238-249.nxml.txt.nlp	20511137	SENT60	19	19	13	13	irinotecan	UGT1A1	PA450085	54658	0.962
NULL	Breast_Cancer_Res_2011_Mar_11_13(2)_R30.nxml.txt.nlp	21396117	SENT251	21	21	9	9	erlotinib	p53	PA134687924	7157	0.962
NULL	J_Hematol_Oncol_2011_Jan_21_4_5.nxml.txt.nlp	21255411	SENT167	4	4	19	19	paclitaxel	EGFR	PA450761	1956	0.962
NULL	Mol_Cancer_2010_Nov_2_9_289.nxml.txt.nlp	21044322	SENT141	14	14	4	4	cisplatin	RGS17	PA449014	26575	0.962
NULL	Diabetes_Metab_Syndr_Obes_2010_Dec_6_3_421-429.nxml.txt.nlp	21437112	SENT3	0	0	19	19	curcumin	COX	PA151958596	1351	0.962
NULL	Neuro_Oncol_2010_Apr_27_12(4)_389-400.nxml.txt.nlp	20308316	SENT175	32	32	13	13	chloroquine	p53	PA448948	7157	0.962
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT80	8	8	19	19	etravirine	CYP3A4	PA166014703	1576	0.962
NULL	Cancer_Cell_Int_2008_Mar_18_8_3.nxml.txt.nlp	18348720	SENT11	25	25	9	9	lapatinib	SMO	PA152241907	6608;54498	0.962
NULL	Endocrinol_Diabetes_Metab_Case_Rep_2014_Mar_1_2014_140001.nxml.txt.nlp	24683487	SENT6	3	3	18	18	bromocriptine	ACTH	PA448671	5443	0.962
NULL	Indian_J_Med_Res_2011_May_133(5)_529-534.nxml.txt.nlp	21623039	SENT29	28	28	0	0	kanamycin	DST	PA450137	667	0.962
NULL	Onco_Targets_Ther_2014_Dec_4_7_2249-2255.nxml.txt.nlp	25587220	SENT119	28	28	15	15	diethylstilbestrol	P-gp	PA449307	5243	0.962
NULL	Indian_J_Med_Res_2012_Mar_135(3)_312-317.nxml.txt.nlp	22561616	SENT81	19	19	6	6	trastuzumab	HER-2	PA451743	2064	0.962
NULL	Oxid_Med_Cell_Longev_2011_Sep_21_2011_253529.nxml.txt.nlp	21949898	SENT18	3	3	33	33	dactinomycin	TNF-alpha	PA151917012	7124	0.962
NULL	Indian_J_Anaesth_2009_Oct_53(5)_582-591.nxml.txt.nlp	20640109	SENT38	7	7	39	39	sirolimus	p27	PA451365	5715;10534	0.962
NULL	Cell_Death_Dis_2013_Sep_19_4(9)_e807.nxml.txt.nlp	24052075	SENT75	20	20	9	9	doxorubicin	p63	PA449412	8626	0.962
NULL	Avicenna_J_Phytomed_2014_Jul-Aug_4(4)_276-286.nxml.txt.nlp	25068142	SENT113	33	33	8	8	lamotrigine	HEG	PA450164	57493	0.962
NULL	Blood_Cancer_J_2012_Oct_12_2(10)_e93.nxml.txt.nlp	23064741	SENT134	5	5	30	30	etoposide	CHOP	PA449552	1649	0.962
NULL	Braz_J_Med_Biol_Res_2014_Mar_3_47(3)_245-251.nxml.txt.nlp	24554037	SENT108	0	0	7	7	atorvastatin	IFN	PA448500	3439	0.962
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1013.nxml.txt.nlp	24457957	SENT93	4	4	8	8	orlistat	NOXA	PA164776864	5366	0.962
NULL	Breast_Cancer_Res_2007_May_30_9(3)_R34.nxml.txt.nlp	17537232	SENT172	31	31	10	10	tamoxifen	TP53	PA451581	7157	0.962
NULL	Nat_Med_2012_Jul_18(7)_1118-1122.nxml.txt.nlp	22683780	SENT49	5	5	16	16	crizotinib	MET	PA165946122	4233	0.962
NULL	Br_J_Cancer_2010_Oct_26_103(9)_1331-1334.nxml.txt.nlp	20877352	SENT49	15	15	1	1	trastuzumab	GM-CSF	PA451743	1437	0.962
NULL	Nat_Prod_Bioprospect_2012_Mar_8_2(2)_59-64.nxml.txt.nlp	NULL	SENT9	14	14	30	30	calcein	P-gp	PA132595336	5243	0.962
NULL	Indian_J_Dermatol_2010_Apr-Jun_55(2)_161-170.nxml.txt.nlp	20606887	SENT260	0	0	18	18	ustekinumab	IL-23	PA166048654	51561	0.962
NULL	Mol_Cancer_2014_Aug_22_13(1)_195.nxml.txt.nlp	NULL	SENT110	11	11	3	3	cisplatin	TBL1XR1	PA449014	79718	0.962
NULL	Cardiovasc_Drugs_Ther_2014_Aug_28_28(5)_477-488.nxml.txt.nlp	25163464	SENT83	0	0	10	10	vasopressin	ACTH	PA451858	5443	0.962
NULL	Biosci_Rep_2012_Aug_1_32(Pt_4)_361-374.nxml.txt.nlp	22762204	SENT146	10	10	18	18	trastuzumab	PTEN	PA451743	5728	0.962
NULL	Clin_Med_Insights_Oncol_2013_May_20_7_87-102.nxml.txt.nlp	23761989	SENT107	0	0	23	23	sorafenib	VEGFR	PA7000	3791	0.962
NULL	Cell_Death_Dis_2013_Jul_11_4(7)_e718.nxml.txt.nlp	23846220	SENT153	6	6	19	19	auranofin	p53	PA448510	7157	0.962
NULL	Pharmaceuticals_(Basel)_2013_Aug_21_6(8)_988-1038.nxml.txt.nlp	24276379	SENT263	22	22	8	8	irinotecan	UGT1A1	PA450085	54658	0.962
NULL	Front_Oncol_2014_Oct_21_4_285.nxml.txt.nlp	25374842	SENT257	24	24	13	13	cisplatin	RITA	PA449014	55422;84934	0.962
NULL	Nat_Med_2011_Aug_7_17(9)_1116-1120.nxml.txt.nlp	21822287	SENT171	35	35	17	17	doxycycline	c-Myc	PA449415	4609	0.962
NULL	Biomed_Res_Int_2014_Jan_12_2014_276918.nxml.txt.nlp	24524073	SENT98	11	11	35	35	citalopram	CYP2C19	PA449015	1557	0.962
NULL	Breast_Cancer_Res_Treat_2013_Oct_8_141(3)_437-446.nxml.txt.nlp	24101324	SENT171	17	17	22	22	trastuzumab	PIK3CA	PA451743	5290	0.962
NULL	Clin_Dev_Immunol_2011_Mar_28_2011_370872.nxml.txt.nlp	21461372	SENT104	5	5	12	12	doxycycline	IL-6	PA449415	3569	0.962
NULL	Nat_Med_2011_May_1_17(5)_604-609.nxml.txt.nlp	21532597	SENT228	37	37	16	16	daclizumab	CD4	PA164764446	920	0.962
NULL	Clin_Kidney_J_2012_Oct_5(5)_434-437.nxml.txt.nlp	23986860	SENT71	27	27	16	16	valganciclovir	SPK	PA10227	55872;8189	0.962
NULL	Cancer_Immunol_Immunother_2011_Jan_21_60(1)_75-85.nxml.txt.nlp	20857100	SENT165	40	40	14	14	fludarabine	IL-6	PA449655	3569	0.962
NULL	Int_J_Cell_Biol_2014_Feb_6_2014_572097.nxml.txt.nlp	24648844	SENT241	7	7	0	0	cisplatin	AKR1B1	PA449014	231	0.962
NULL	Front_Neuroeng_2013_Feb_25_6_1.nxml.txt.nlp	23443302	SENT70	4	4	21	21	propofol	gamma	PA451141	9913	0.962
NULL	Arch_Drug_Inf_2011_Mar_4(1)_1-9.nxml.txt.nlp	21572514	SENT156	7	7	16	16	vinblastine	PEPT1	PA451877	6564	0.962
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Apr_18_65(Pt_5)_o1066.nxml.txt.nlp	21583882	SENT55	4	4	33	33	ethanol	mol	PA448073	90527	0.962
NULL	Nucleic_Acids_Res_2011_Dec_31_39(22)_9536-9548.nxml.txt.nlp	21880590	SENT224	23	23	36	36	paclitaxel	STAT1	PA450761	6772	0.962
NULL	J_Hematol_Oncol_2010_May_2_3_18.nxml.txt.nlp	20433767	SENT178	17	17	13	13	carboplatin	EGFR	PA448803	1956	0.962
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT81	10	10	3	3	imatinib	ABCG2	PA10804	9429	0.962
NULL	Hum_Genomics_2008_Sep_1_3(1)_7-16.nxml.txt.nlp	19129086	SENT26	6	6	29	29	rosiglitazone	CYP2C9	PA451283	1559	0.962
NULL	Cell_Death_Dis_2014_Feb_13_5(2)_e1055.nxml.txt.nlp	24525731	SENT74	16	16	8	8	irinotecan	XRCC1	PA450085	7515	0.962
NULL	J_Cell_Mol_Med_2013_Jan_11_17(1)_134-146.nxml.txt.nlp	23305490	SENT298	26	26	4	4	bupivacaine	TWIK-2	PA135057240	9424	0.962
NULL	Evid_Based_Complement_Alternat_Med_2013_Mar_26_2013_625892.nxml.txt.nlp	23589719	SENT103	4	4	42	42	probenecid	GLP-1	PA451106	100125288	0.962
NULL	J_Exp_Med_2000_Jun_5_191(11)_1987-1998.nxml.txt.nlp	10839813	SENT389	11	11	6	6	cyclosporine	CD28	PA449167	1493;940	0.962
NULL	Aging_(Albany_NY)_2014_Oct_30_6(10)_788-819.nxml.txt.nlp	25411230	SENT244	0	0	12	12	levodopa	COMT	PA450213	1312	0.962
NULL	Oncotarget_2012_Oct_20_3(10)_1236-1245.nxml.txt.nlp	23100449	SENT5	13	13	0	0	docetaxel	NGAL	PA449383	3934	0.962
NULL	Nat_Commun_2010_Jun_1_1(3)_1-9.nxml.txt.nlp	20975695	SENT79	20	20	2	2	tamoxifen	E12	PA451581	64100	0.962
NULL	Clin_Med_Oncol_2008_Mar_27_2_275-287.nxml.txt.nlp	21892289	SENT264	9	9	28	28	rituximab	CD138	PA451261	6382	0.962
NULL	Clin_Ophthalmol_2014_Jun_3_8_1057-1064.nxml.txt.nlp	24940042	SENT35	0	0	43	43	bevacizumab	CST	PA130232992	9514	0.962
NULL	Oncotarget_2014_Sep_3_5(19)_9362-9381.nxml.txt.nlp	25313139	SENT73	9	9	26	26	metformin	AMPK	PA450395	5563	0.962
NULL	Diabetes_2013_Sep_15_62(9)_3019-3021.nxml.txt.nlp	23970522	SENT20	29	29	1	1	chymotrypsin	CTRB1	PA448994	1504	0.962
NULL	Diabetes_Care_2011_Jul_17_34(7)_e115-e120.nxml.txt.nlp	21709286	SENT111	12	12	1	1	metformin	AMPK	PA450395	5563	0.962
NULL	Acta_Pharmacol_Sin_2013_Sep_5_34(9)_1237-1242.nxml.txt.nlp	23770984	SENT38	0	0	7	7	sulfaphenazole	DAI	PA130231310	81030	0.962
NULL	Cancer_Med_2014_Jun_19_3(3)_555-564.nxml.txt.nlp	24648042	SENT132	25	25	5	5	fludarabine	NOTCH1	PA449655	4851	0.962
NULL	Environ_Health_Perspect_2008_Mar_11_116(3)_297-302.nxml.txt.nlp	18335094	SENT140	8	8	36	36	lindane	OTC	PA164754914	5009	0.962
NULL	Cancers_(Basel)_2010_May_7_2(2)_794-808.nxml.txt.nlp	24281094	SENT154	16	16	14	14	erlotinib	EGFR	PA134687924	1956	0.962
NULL	Cell_Death_Differ_2010_Apr_16_17(4)_666-676.nxml.txt.nlp	19834494	SENT286	7	7	23	23	oxaliplatin	p53	PA131285527	7157	0.962
NULL	Br_J_Pharmacol_2011_Feb_162(4)_989-999.nxml.txt.nlp	21054342	SENT220	10	10	43	43	ketoconazole	CYP2C8	PA450146	1558	0.962
NULL	Ann_Pediatr_Endocrinol_Metab_2014_Jun_30_19(2)_57-68.nxml.txt.nlp	25077087	SENT168	16	16	6	6	diazoxide	SLC16A1	PA449285	6566	0.962
NULL	J_Biol_Chem_2009_Apr_3_284(14)_9558-9565.nxml.txt.nlp	19202191	SENT43	30	30	16	16	camptothecin	CtIP	PA153590860	5932	0.962
NULL	Scientifica_(Cairo)_2013_Feb_3_2013_125705.nxml.txt.nlp	24278766	SENT270	8	8	23	23	saquinavir	RANKL	PA451305	8600	0.962
NULL	Nucleic_Acids_Res_2013_Feb_19_41(3)_e50.nxml.txt.nlp	23258702	SENT187	41	41	24	24	cetuximab	KRAS	PA10040	3845	0.962
NULL	Mol_Cancer_2014_Jun_13_13_149.nxml.txt.nlp	24925061	SENT95	7	7	17	17	metformin	PDK1	PA450395	5170;5163	0.962
NULL	Clin_Med_Insights_Oncol_2011_Jun_23_5_185-199.nxml.txt.nlp	21792346	SENT184	23	23	11	11	dasatinib	BTK	PA162372878	695	0.962
NULL	Cell_Death_Dis_2012_Jul_19_3(7)_e351.nxml.txt.nlp	22825469	SENT11	17	17	26	26	sorafenib	MCL1	PA7000	4170	0.962
NULL	Ther_Clin_Risk_Manag_2007_Dec_3(6)_1009-1020.nxml.txt.nlp	18516316	SENT59	0	0	9	9	palonosetron	CYP2D6	PA10352	1565	0.962
NULL	Acta_Pharmacol_Sin_2010_Nov_18_31(11)_1447-1453.nxml.txt.nlp	20953204	SENT40	3	3	10	10	rimonabant	CB1	PA152407999	1268	0.962
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT168	17	17	8	8	chloroquine	BMP9	PA448948	2658	0.962
NULL	J_Inherit_Metab_Dis_2012_Nov_24_35(6)_1137-1145.nxml.txt.nlp	22447153	SENT211	19	19	9	9	fenofibrate	ALDRP	PA449594	225	0.962
NULL	Clin_Ophthalmol_2009_Jun_2_3_291-295.nxml.txt.nlp	19668581	SENT7	13	13	9	9	travoprost	BAK	PA164781371	578	0.962
NULL	Br_J_Cancer_2009_Mar_10_100(5)_758-763.nxml.txt.nlp	19259094	SENT106	10	10	2	2	decitabine	MLH1	PA164749631	4292	0.962
NULL	Cancers_(Basel)_2010_Aug_19_2(3)_1629-1641.nxml.txt.nlp	24281178	SENT117	5	5	14	14	gemcitabine	CD133	PA449748	8842	0.962
NULL	Biomed_Res_Int_2013_Aug_6_2013_909613.nxml.txt.nlp	24027765	SENT334	36	36	1	1	metronidazole	IL-10	PA450484	3586	0.962
NULL	Indian_J_Med_Res_2014_Jan_139(1)_117-124.nxml.txt.nlp	24604047	SENT131	3	3	18	18	fluvastatin	p38	PA449688	10598;1432;7965	0.962
NULL	J_Exp_Med_2000_Mar_6_191(5)_859-870.nxml.txt.nlp	10704466	SENT170	20	20	12	12	arsenite	p38	PA452638	10598;1432;7965	0.962
NULL	J_Gastroenterol_Hepatol_2014_Dec_18_29(12)_1996-2005.nxml.txt.nlp	24910341	SENT10	10	10	27	27	ribavirin	IL28B	PA451241	282617	0.962
NULL	Acta_Pharmacol_Sin_2014_Jun_4_35(6)_752-757.nxml.txt.nlp	24902786	SENT94	12	12	8	8	flutamide	STZ	PA449685	6484	0.962
NULL	Drugs_2014_Jul_18_74(11)_1209-1231.nxml.txt.nlp	25034361	SENT293	24	24	10	10	enoxaparin	STARS	PA449463	137735	0.962
NULL	Br_J_Haematol_2014_Jan_28_164(2)_233-244.nxml.txt.nlp	24206017	SENT195	3	3	16	16	lenalidomide	CRBN	PA162363968	51185	0.962
NULL	J_Thromb_Thrombolysis_2011_Nov_26_32(4)_459-466.nxml.txt.nlp	21706290	SENT35	26	26	10	10	clopidogrel	CYP2C19	PA449053	1557	0.962
NULL	Biologics_2014_Apr_23_8_183-192.nxml.txt.nlp	24790411	SENT107	0	0	18	18	afatinib	EGFR	PA165981154	1956	0.962
NULL	Int_J_Breast_Cancer_2012_Oct_25_2012_829315.nxml.txt.nlp	22295252	SENT79	8	8	17	17	olaparib	BRCA1		672	0.962
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT307	22	22	29	29	pp2	PP2		4888	0.962
NULL	Indian_J_Pharmacol_2008_Jun_40(3)_95-102.nxml.txt.nlp	20040934	SENT167	0	0	13	13	basiliximab	IL-2	PA164747126	3558	0.962
NULL	Oncotarget_2014_Jun_26_5(14)_5559-5569.nxml.txt.nlp	24980819	SENT47	16	16	1	1	vemurafenib	BRAF	PA165946873	673	0.962
NULL	Oncogenesis_2014_Dec_15_3(12)_e133.nxml.txt.nlp	25500906	SENT91	15	15	11	11	trastuzumab	HER2	PA451743	2064	0.962
NULL	J_Carcinog_2014_Feb_20_13_4.nxml.txt.nlp	24737952	SENT241	0	0	6	6	brivanib	EGFR	PA164924492	1956	0.962
NULL	Pediatr_Nephrol_2008_Feb_28_23(2)_195-207.nxml.txt.nlp	18046581	SENT189	2	2	7	7	paricalcitol	PTH	PA450798	5741	0.962
NULL	Oncotarget_2014_Mar_26_5(21)_10342-10355.nxml.txt.nlp	25431950	SENT118	4	4	0	0	doxycycline	EZH2	PA449415	2146	0.962
NULL	Oncoimmunology_2012_Oct_1_1(7)_1004-1016.nxml.txt.nlp	23170249	SENT174	25	25	19	19	paclitaxel	HER-2	PA450761	2064	0.962
NULL	Lancet_2009_May_16_373(9676)_1681-1692.nxml.txt.nlp	19447249	SENT175	8	8	21	21	docetaxel	HER2	PA449383	2064	0.962
NULL	Biomed_Res_Int_2013_Jul_21_2013_723129.nxml.txt.nlp	23971044	SENT110	12	12	6	6	voriconazole	IPA	PA10233	3160	0.962
NULL	Ann_Oncol_2014_Jul_5_25(7)_1328-1333.nxml.txt.nlp	24603643	SENT61	0	0	20	20	metoclopramide	NK1	PA450475	11126	0.962
NULL	JAKSTAT_2013_Jan_1_2(1)_e23011.nxml.txt.nlp	24058792	SENT25	5	5	16	16	imiquimod	TLR3	PA449972	7098	0.962
NULL	Anal_Bioanal_Chem_2014_Jan_23_406(15)_3667-3680.nxml.txt.nlp	24452745	SENT189	4	4	38	38	ketoprofen	KET	PA450149	8626	0.962
NULL	Braz_J_Med_Biol_Res_2014_May_9_47(6)_478-482.nxml.txt.nlp	24770568	SENT19	30	30	6	6	cisplatin	CD133	PA449014	8842	0.962
NULL	Int_J_Hypertens_2012_Dec_4_2012_789671.nxml.txt.nlp	23304452	SENT171	6	6	18	18	vasopressin	IRAP	PA451858	3557	0.962
NULL	Nat_Biotechnol_2011_Jul_17_29(8)_757-761.nxml.txt.nlp	21765402	SENT148	30	30	3	3	ampicillin	NIR	PA448419	26155	0.962
NULL	Arthritis_Res_Ther_2011_Feb_11_13(1)_R21.nxml.txt.nlp	21314928	SENT126	28	28	14	14	methotrexate	CD4	PA450428	920	0.962
NULL	Toxins_(Basel)_2010_Mar_31_2(4)_517-551.nxml.txt.nlp	22069598	SENT729	9	9	20	20	curcumin	EGFR	PA151958596	1956	0.962
NULL	Int_J_Mol_Sci_2012_Aug_13_13(8)_10091-10112.nxml.txt.nlp	22949849	SENT169	9	9	22	22	ethanol	PPL	PA448073	5493	0.962
NULL	Cell_Cycle_2012_Nov_1_11(21)_3983-3996.nxml.txt.nlp	22987153	SENT208	6	6	18	18	cisplatin	DNA-PKcs	PA449014	5591	0.962
NULL	Mol_Pain_2012_Sep_24_8_73.nxml.txt.nlp	23006841	SENT220	4	4	10	10	ketoconazole	TRPV1	PA450146	7442	0.962
NULL	J_Korean_Med_Sci_2001_Apr_16(2)_135-139.nxml.txt.nlp	11306736	SENT13	10	10	4	4	etoposide	p53	PA449552	7157	0.962
NULL	Mol_Cancer_2013_Mar_5_12_17.nxml.txt.nlp	23497256	SENT279	15	15	44	44	doxorubicin	p53	PA449412	7157	0.962
NULL	Anemia_2012_May_24_2012_481583.nxml.txt.nlp	22693661	SENT61	19	19	3	3	curcumin	FANCD2	PA151958596	2177	0.962
NULL	Open_Cardiovasc_Med_J_2014_Feb_7_8_12-17.nxml.txt.nlp	24653785	SENT108	33	33	18	18	clarithromycin	CYP3A5	PA449028	1577	0.962
NULL	Curr_Oncol_2009_Jul_16(Suppl_2)_S1-S13.nxml.txt.nlp	19672416	SENT72	0	0	11	11	anastrozole	aromatase	PA448432	1588	0.962
NULL	Diabetes_2011_Jun_21_60(6)_1797-1804.nxml.txt.nlp	21536946	SENT187	2	2	19	19	diazoxide	SUR1	PA449285	6833	0.962
NULL	Oncotarget_2014_Oct_18_5(21)_10206-10221.nxml.txt.nlp	25344914	SENT123	7	7	4	4	vemurafenib	EGFR	PA165946873	1956	0.962
NULL	Oncoimmunology_2012_Jul_1_1(4)_493-506.nxml.txt.nlp	22754768	SENT148	26	26	11	11	paclitaxel	CD40	PA450761	958	0.962
NULL	Biosci_Rep_2012_Aug_1_32(Pt_4)_361-374.nxml.txt.nlp	22762204	SENT116	8	8	2	2	melphalan	p16INK4a	PA450354	1029	0.962
NULL	Clin_Interv_Aging_2013_Jul_16_8_889-897.nxml.txt.nlp	23898224	SENT69	11	11	35	35	gemcitabine	PARP-1	PA449748	25976	0.962
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_16_2012_395912.nxml.txt.nlp	23118789	SENT148	37	37	0	0	candesartan	UGT1A3	PA448765	54659	0.962
NULL	J_Gen_Physiol_2009_Apr_133(4)_421-438.nxml.txt.nlp	19289574	SENT428	22	22	10	10	forskolin	SLC26A9	PA146096022	115019	0.962
NULL	Hum_Genomics_2009_Jan_1_3(2)_121-127.nxml.txt.nlp	19164089	SENT84	15	15	4	4	ethanol	ADH4	PA448073	127	0.962
NULL	Breast_Cancer_Res_2004_Oct_24_6(1)_R8-R17.nxml.txt.nlp	14680495	SENT134	3	3	23	23	tamoxifen	BRCA1	PA451581	672	0.962
NULL	Clin_Epigenetics_2011_Dec_5_3(1)_8.nxml.txt.nlp	22414275	SENT144	31	31	10	10	ribavirin	ESR1	PA451241	2099	0.962
NULL	Acta_Pharmacol_Sin_2014_Sep_25_35(9)_1199-1206.nxml.txt.nlp	25152024	SENT89	8	8	26	26	cisplatin	mig-2	PA449014	10979	0.962
NULL	Arch_Drug_Inf_2011_Mar_4(1)_1-9.nxml.txt.nlp	21572514	SENT179	16	16	3	3	ketoconazole	P-gp	PA450146	5243	0.962
NULL	J_Inflamm_(Lond)_2005_Oct_31_2_14.nxml.txt.nlp	16259633	SENT338	24	24	7	7	staurosporine	M-CSF	PA165109623	1435	0.962
NULL	Front_Neurosci_2012_Mar_26_6_33.nxml.txt.nlp	22470316	SENT452	13	13	22	22	rosiglitazone	gamma	PA451283	9913	0.962
NULL	Oncotarget_2012_Oct_20_3(10)_1236-1245.nxml.txt.nlp	23100449	SENT102	18	18	8	8	doxorubicin	NGAL	PA449412	3934	0.962
NULL	Cancer_Cell_Int_2013_Jan_15_13_3.nxml.txt.nlp	23320839	SENT132	5	5	17	17	imatinib	ABCG1	PA10804	9619	0.962
NULL	Onco_Targets_Ther_2014_Jun_12_7_1015-1023.nxml.txt.nlp	24959088	SENT97	4	4	16	16	paclitaxel	TLR4	PA450761	7099	0.962
NULL	Evid_Based_Complement_Alternat_Med_2013_May_26_2013_349790.nxml.txt.nlp	23762123	SENT130	27	27	6	6	rosiglitazone	TLSP	PA451283	11012	0.962
NULL	Int_J_Med_Sci_2013_Mar_19_10(5)_599-606.nxml.txt.nlp	23569422	SENT74	20	20	9	9	propofol	HO-1	PA451141	3162	0.962
NULL	J_Clin_Biochem_Nutr_2009_Jan_27_44(1)_79-84.nxml.txt.nlp	19177192	SENT14	11	11	28	28	curcumin	HO-1	PA151958596	3162	0.962
NULL	Br_J_Cancer_1996_Oct_74(8)_1286-1291.nxml.txt.nlp	8883419	SENT0	10	10	19	19	anastrozole	aromatase	PA448432	1588	0.962
NULL	Indian_J_Pharmacol_2013_Mar-Apr_45(2)_155-158.nxml.txt.nlp	23716892	SENT116	31	31	45	45	pioglitazone	CYP2C9	PA450970	1559	0.962
NULL	J_Cell_Biol_2008_Jul_14_182(1)_197-213.nxml.txt.nlp	18625847	SENT171	17	17	40	40	nutlin-3	p53		7157	0.962
NULL	Front_Mol_Neurosci_2012_Nov_12_5_99.nxml.txt.nlp	23162427	SENT273	1	1	15	15	cocaine	CBP	PA449072	55824;1387	0.962
NULL	J_Anaesthesiol_Clin_Pharmacol_2012_Jan-Mar_28(1)_106-110.nxml.txt.nlp	22345956	SENT35	30	30	6	6	argatroban	ACT	PA164745516	12;11332;9457;641455	0.962
NULL	J_Hematol_Oncol_2013_Jun_3_6_38.nxml.txt.nlp	23731980	SENT144	23	23	32	32	pazopanib	HER2	PA165291492	2064	0.962
NULL	Diabetes_Care_2013_Jul_12_36(7)_2098-2106.nxml.txt.nlp	23695817	SENT297	11	11	17	17	pioglitazone	gamma	PA450970	9913	0.962
NULL	Arthritis_Res_Ther_2009_Nov_4_11(6)_R165.nxml.txt.nlp	19889203	SENT355	4	4	25	25	resveratrol	Bcl-2		596	0.962
NULL	Acta_Pharmacol_Sin_2012_May_16_33(5)_682-690.nxml.txt.nlp	22504904	SENT119	43	43	35	35	celecoxib	STAT3	PA448871	6774	0.962
NULL	Breast_Cancer_Res_Treat_2012_Jul_31_134(1)_199-205.nxml.txt.nlp	22290080	SENT17	16	16	3	3	estradiol	EGF	PA449503	1950	0.962
NULL	Front_Physiol_2011_Jun_30_2_33.nxml.txt.nlp	21747769	SENT260	6	6	16	16	berberine	EGF	PA165860812	1950	0.962
NULL	Int_J_Surg_Oncol_2011_Aug_8_2011_374012.nxml.txt.nlp	22312502	SENT168	18	18	14	14	tamoxifen	BRCA2	PA451581	675	0.962
NULL	Br_J_Pharmacol_2014_May_171(10)_2659-2670.nxml.txt.nlp	24116661	SENT171	20	20	7	7	naringenin	TRPP2	PA151958361	5311	0.962
NULL	J_Neurol_2011_Jul_2_258(7)_1207-1222.nxml.txt.nlp	21461686	SENT129	14	14	22	22	acetazolamide	CACNA1A	PA448018	773	0.962
NULL	Front_Genet_2014_Jun_4_5_167.nxml.txt.nlp	24926315	SENT29	10	10	23	23	nevirapine	CYP2B6	PA450616	1555	0.962
NULL	Clin_Ophthalmol_2008_Jun_2(2)_377-388.nxml.txt.nlp	19668729	SENT172	0	0	36	36	vatalanib	VEGFR3	PA7001	2324	0.962
NULL	Oncotarget_2014_Dec_4_5(22)_11365-11380.nxml.txt.nlp	25426548	SENT69	5	5	10	10	nutlin-3	p53		7157	0.962
NULL	Acta_Pharmacol_Sin_2013_Mar_11_34(3)_403-413.nxml.txt.nlp	23396374	SENT231	0	0	16	16	curcumin	RANKL	PA151958596	8600	0.962
NULL	J_Cell_Mol_Med_2013_Sep_11_17(9)_1160-1172.nxml.txt.nlp	23844832	SENT174	26	26	1	1	gefitinib	BMP9	PA131301952	2658	0.962
NULL	Indian_J_Med_Paediatr_Oncol_2014_Apr-Jun_35(2)_176-180.nxml.txt.nlp	25197183	SENT35	39	39	4	4	lapatinib	HER-2	PA152241907	2064	0.962
NULL	Indian_J_Med_Res_2014_Jan_139(1)_117-124.nxml.txt.nlp	24604047	SENT136	3	3	14	14	fluvastatin	p38	PA449688	10598;1432;7965	0.962
NULL	Cancer_Imaging_2011_Mar_1_11(1)_1-8.nxml.txt.nlp	21362586	SENT71	25	25	2	2	daunorubicin	P-gp	PA449212	5243	0.962
NULL	Int_J_Nanomedicine_2007_Mar_2(1)_25-32.nxml.txt.nlp	17722509	SENT28	4	4	25	25	cyclosporine	castor	PA449167	54897	0.962
NULL	J_Mol_Signal_2011_Aug_10_6_8.nxml.txt.nlp	21831305	SENT114	18	18	5	5	isoproterenol	AKAP12	PA450121	9590	0.962
NULL	Cancers_(Basel)_2014_Oct_24_6(4)_2187-2223.nxml.txt.nlp	25347122	SENT86	9	9	2	2	docetaxel	BRCA1	PA449383	672	0.962
NULL	J_Pain_Res_2014_Sep_11_7_547-554.nxml.txt.nlp	25246806	SENT122	4	4	33	33	capsaicin	TRPV1	PA448776	7442	0.962
NULL	Oncotarget_2011_Apr_19_2(4)_336-346.nxml.txt.nlp	21505228	SENT162	7	7	21	21	imatinib	BRAF	PA10804	673	0.962
NULL	Alzheimers_Res_Ther_2011_Jul_20_3(4)_23.nxml.txt.nlp	21774798	SENT244	6	6	13	13	tacrine	APOE	PA451576	348	0.962
NULL	Evid_Based_Complement_Alternat_Med_2012_Sep_18_2012_674101.nxml.txt.nlp	23028394	SENT159	3	3	28	28	donepezil	CA3	PA449394	761	0.962
NULL	Front_Neural_Circuits_2013_Aug_1_7_129.nxml.txt.nlp	23914157	SENT220	21	21	31	31	ethanol	CEA	PA448073	5670;1087	0.962
NULL	Br_J_Cancer_2010_Jun_8_102(12)_1707-1716.nxml.txt.nlp	20461078	SENT143	24	24	13	13	bortezomib	TRAIL	PA10252	8743	0.962
NULL	Br_J_Pharmacol_2012_Jan_165(2)_390-400.nxml.txt.nlp	21671897	SENT45	11	11	46	46	suramin	P2X2	PA10292	22953	0.962
NULL	Braz_J_Med_Biol_Res_2013_Aug_13_46(8)_650-658.nxml.txt.nlp	23969971	SENT156	25	25	2	2	cisplatin	STAT3	PA449014	6774	0.962
NULL	Breast_Cancer_Res_Treat_2013_Aug_20_141(1)_43-53.nxml.txt.nlp	23959396	SENT31	46	46	11	11	trastuzumab	HER2	PA451743	2064	0.962
NULL	Onco_Targets_Ther_2014_Jun_13_7_1043-1050.nxml.txt.nlp	24966686	SENT65	0	0	44	44	lenalidomide	PMF	PA162363968	5542	0.962
NULL	Clin_Mol_Hepatol_2014_Sep_25_20(3)_267-273.nxml.txt.nlp	25320730	SENT71	23	23	14	14	telbivudine	LAM	PA164760861	7249;7248	0.962
NULL	Diabetes_Metab_J_2013_Aug_14_37(4)_240-248.nxml.txt.nlp	23991401	SENT48	15	15	3	3	ezetimibe	NPC1L1	PA10816	29881	0.962
NULL	Evid_Based_Complement_Alternat_Med_2014_May_8_2014_364819.nxml.txt.nlp	24899907	SENT8	22	22	46	46	tacrolimus	FKBP52	PA451578	2288	0.962
NULL	Oncoimmunology_2013_Jun_1_2(6)_e24677.nxml.txt.nlp	23894722	SENT147	40	40	21	21	cetuximab	TLR3	PA10040	7098	0.962
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT3238	0	0	19	19	sulfamethoxazole	APC	PA451544	324	0.962
NULL	Biomed_Res_Int_2014_Aug_6_2014_967826.nxml.txt.nlp	25165721	SENT81	0	0	14	14	cisplatin	p53	PA449014	7157	0.962
NULL	Patient_Prefer_Adherence_2011_Dec_23_6_1-9.nxml.txt.nlp	22272064	SENT36	28	28	20	20	enalapril	ACE	PA449456	1636	0.962
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_6_2014_270930.nxml.txt.nlp	25431606	SENT203	5	5	11	11	curcumin	JNK	PA151958596	5599	0.962
NULL	Pharmaceutics_2011_Jul_11_3(3)_354-378.nxml.txt.nlp	24310585	SENT68	31	31	7	7	bevacizumab	NIR	PA130232992	26155	0.962
NULL	Mol_Cancer_2012_Jul_25_11_47.nxml.txt.nlp	22830443	SENT31	3	3	23	23	panitumumab	EGFR	PA162373091	1956	0.962
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT147	7	7	15	15	doxorubicin	ABCB1	PA449412	5243	0.962
NULL	Evid_Based_Complement_Alternat_Med_2011_Aug_11_2011_237941.nxml.txt.nlp	19887507	SENT138	3	3	13	13	metformin	STZ	PA450395	6484	0.962
NULL	Oncol_Rep_2013_Apr_6_29(4)_1285-1292.nxml.txt.nlp	23404427	SENT57	1	1	5	5	cisplatin	GEM	PA449014	2669	0.962
NULL	Br_J_Cancer_2009_Mar_24_100(6)_932-940.nxml.txt.nlp	19240717	SENT90	15	15	9	9	formaldehyde	CO2	PA449703	4513	0.962
NULL	Cardiol_Res_Pract_2013_Jan_31_2013_128795.nxml.txt.nlp	23431496	SENT59	26	26	4	4	clopidogrel	P2Y12	PA449053	64805	0.962
NULL	Theranostics_2014_Feb_12_4(4)_432-444.nxml.txt.nlp	24578726	SENT92	25	25	38	38	methotrexate	FUS	PA450428	2521	0.962
NULL	Eur_J_Endocrinol_2010_Dec_163(6)_919-924.nxml.txt.nlp	20844025	SENT82	39	39	5	5	cyclophosphamide	POR	PA449165	5447	0.962
NULL	South_Asian_J_Cancer_2014_Jul-Sep_3(3)_182-184.nxml.txt.nlp	25136528	SENT82	22	22	9	9	saquinavir	CYP3A4	PA451305	1576	0.962
NULL	Cell_Death_Differ_2010_Oct_30_17(10)_1624-1635.nxml.txt.nlp	20431602	SENT375	18	18	36	36	paclitaxel	Mcl-1	PA450761	4170	0.962
NULL	Biomed_Res_Int_2013_Aug_5_2013_462589.nxml.txt.nlp	23998124	SENT119	41	41	7	7	bleomycin	BLM	PA448645	641	0.962
NULL	Oncotarget_2012_Jan_28_3(1)_78-83.nxml.txt.nlp	22289679	SENT77	7	7	0	0	doxorubicin	Raf-1	PA449412	5894	0.962
NULL	Mol_Brain_2014_Apr_24_7_32.nxml.txt.nlp	24758222	SENT98	10	10	17	17	metyrapone	CORT	PA450486	1325	0.962
NULL	Oncotarget_2012_Dec_17_4(1)_48-63.nxml.txt.nlp	23295955	SENT184	32	32	3	3	cisplatin	MTHFD2	PA449014	10797	0.962
NULL	J_Thromb_Haemost_2013_Jan_11(1)_132-141.nxml.txt.nlp	23205847	SENT119	15	15	0	0	thrombin	FVIII	PA451674	2157	0.962
NULL	J_Exp_Clin_Cancer_Res_2009_Aug_19_28(1)_116.nxml.txt.nlp	19689822	SENT106	29	29	12	12	rituximab	CHOP	PA451261	1649	0.962
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT7	7	7	0	0	metformin	HIP	PA450395	6767;6159;64399;5068	0.962
NULL	Breast_Cancer_Res_2002_Sep_10_4(6)_218-221.nxml.txt.nlp	12473166	SENT61	19	19	1	1	tamoxifen	STAR	PA451581	6770;2984	0.962
NULL	J_Radiat_Res_2014_Nov_16_55(6)_1171-1177.nxml.txt.nlp	25129557	SENT199	7	7	16	16	capecitabine	LARC	PA448771	6364	0.962
NULL	J_Headache_Pain_2010_Oct_7_11(5)_379-389.nxml.txt.nlp	20607582	SENT409	12	12	3	3	sumatriptan	5-HT1B	PA451566	3351	0.962
NULL	Mol_Syst_Biol_2010_Jul_13_6_387.nxml.txt.nlp	20631681	SENT230	3	3	14	14	nadh	ADP	PA164755085	23038	0.962
NULL	Diabetes_2013_Jun_17_62(6)_1990-1995.nxml.txt.nlp	23378611	SENT104	10	10	21	21	rosiglitazone	RUNX2	PA451283	860	0.962
NULL	Ann_Hematol_2014_Sep_12_93(1)_13-32.nxml.txt.nlp	24026426	SENT357	1	1	27	27	voriconazole	BII	PA10233	777	0.962
NULL	Hum_Mol_Genet_2013_Nov_15_22(22)_4616-4626.nxml.txt.nlp	23814041	SENT153	2	2	14	14	simvastatin	neuroserpin	PA451363	5274	0.962
NULL	Breast_Cancer_Res_2004_May_7_6(4)_R352-R365.nxml.txt.nlp	15217502	SENT173	7	7	0	0	estradiol	CYP1A2	PA449503	1544	0.962
NULL	Clin_Med_Insights_Cardiol_2011_Oct_6_5_103-119.nxml.txt.nlp	22084608	SENT41	10	10	6	6	verapamil	CYP3A4	PA451868	1576	0.962
NULL	eLife_2013_Nov_5_2_e00969.nxml.txt.nlp	24192036	SENT165	11	11	2	2	vemurafenib	MKK4	PA165946873	6416	0.962
NULL	Cell_Biol_Toxicol_2012_Feb_25_28(1)_1-9.nxml.txt.nlp	21866320	SENT11	10	10	19	19	disulfiram	DDC	PA449376	1644	0.962
NULL	Arthritis_Res_Ther_2013_Oct_17_15(5)_R154.nxml.txt.nlp	24286344	SENT14	22	22	19	19	probenecid	ANK	PA451106	56172	0.962
NULL	Int_J_Environ_Res_Public_Health_2012_May_4_9(5)_1630-1648.nxml.txt.nlp	22754462	SENT208	11	11	1	1	malathion	CYP1A1	PA164748092	1543	0.962
NULL	Blood_Cancer_J_2012_Jan_13_2(1)_e50.nxml.txt.nlp	22829234	SENT126	22	22	1	1	lenalidomide	CD138	PA162363968	6382	0.962
NULL	Nucleic_Acids_Res_2006_Jul_4_34(11)_3299-3308.nxml.txt.nlp	16820530	SENT167	37	37	22	22	ethanol	APOBEC-1	PA448073	339	0.962
NULL	Am_J_Cardiovasc_Drugs_2013_Jun_20_13(5)_331-342.nxml.txt.nlp	23784266	SENT221	25	25	21	21	dabigatran	P-gp		5243	0.962
NULL	ACS_Med_Chem_Lett_2011_May_16_2(7)_549-554.nxml.txt.nlp	21765967	SENT80	12	12	42	42	dextran	CCR5	PA449261	1234	0.962
NULL	Clin_Med_Insights_Ear_Nose_Throat_2012_Apr_3_5_1-16.nxml.txt.nlp	24179404	SENT203	21	21	11	11	cetuximab	STAT3	PA10040	6774	0.962
NULL	Mol_Pain_2012_Sep_22_8_71.nxml.txt.nlp	22998838	SENT124	20	20	7	7	paclitaxel	CB2	PA450761	1269	0.962
NULL	Carcinogenesis_2012_Nov_8_33(11)_2007-2017.nxml.txt.nlp	22822097	SENT226	24	24	17	17	doxorubicin	p53	PA449412	7157	0.962
NULL	Cell_Death_Dis_2013_Jun_13_4(6)_e665.nxml.txt.nlp	23764846	SENT86	22	22	11	11	sorafenib	FSP1	PA7000	6275;51062	0.962
NULL	Cancer_Med_2013_Feb_3_2(1)_76-85.nxml.txt.nlp	24133630	SENT49	9	9	16	16	vemurafenib	PI3K	PA165946873	5290	0.962
NULL	Eur_J_Clin_Pharmacol_2014_Oct_8_70(1)_37-45.nxml.txt.nlp	24100471	SENT201	4	4	12	12	pioglitazone	CYP2C8	PA450970	1558	0.962
NULL	J_Young_Pharm_2010_Jan-Mar_2(1)_54-58.nxml.txt.nlp	21331192	SENT23	32	32	17	17	trypsin	PAR-1	PA451806	2011;2149	0.962
NULL	J_Ophthalmic_Inflamm_Infect_2012_May_14_2(4)_231-233.nxml.txt.nlp	22581347	SENT61	13	13	9	9	adalimumab	TNF	PA10004	7124	0.962
NULL	Mol_Cancer_2008_Sep_12_7_69.nxml.txt.nlp	18789131	SENT99	12	12	6	6	pp2	EGFR		1956	0.962
NULL	Mol_Vis_2011_Dec_24_17_3384-3391.nxml.txt.nlp	22219634	SENT121	24	24	7	7	mannitol	TLR2	PA450320	7097	0.962
NULL	Oncol_Rep_2012_Nov_31_28(5)_1544-1550.nxml.txt.nlp	22940844	SENT147	19	19	8	8	amifostine	p53	PA448365	7157	0.962
NULL	Oncotarget_2014_Dec_4_5(22)_11365-11380.nxml.txt.nlp	25426548	SENT31	14	14	0	0	nutlin-3	TP53		7157	0.962
NULL	Int_J_Biol_Sci_2013_Mar_7_9(3)_279-288.nxml.txt.nlp	23493630	SENT50	12	12	23	23	tocilizumab	IL-17	PA165292659	3605	0.962
NULL	Ann_Gen_Psychiatry_2010_Apr_22_9(Suppl_1)_S83.nxml.txt.nlp	NULL	SENT7	30	30	18	18	carbamazepine	AC5	PA448785	111	0.962
NULL	J_Biomed_Biotechnol_2010_May_31_2010_548749.nxml.txt.nlp	20589074	SENT195	10	10	35	35	carrageenan	TLR4	PA448814	7099	0.962
NULL	Br_J_Cancer_2013_Feb_19_108(3)_557-563.nxml.txt.nlp	23361053	SENT175	27	27	17	17	tamoxifen	PAK1	PA451581	5585;5058	0.962
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT190	5	5	17	17	curcumin	p16	PA151958596	1029	0.962
NULL	Cancers_(Basel)_2014_Jun_27_6(3)_1382-1393.nxml.txt.nlp	24978439	SENT428	13	13	0	0	tanespimycin	Hsp90	PA165291490	3320	0.962
NULL	Breast_Cancer_Res_2003_Jan_13_5(2)_R30-R36.nxml.txt.nlp	12631396	SENT124	10	10	14	14	tamoxifen	HER-2	PA451581	2064	0.962
NULL	Breast_Cancer_(Auckl)_2012_Mar_7_6_67-77.nxml.txt.nlp	22438669	SENT6	25	25	17	17	trastuzumab	HER2	PA451743	2064	0.962
NULL	Braz_J_Med_Biol_Res_2014_Mar_21_47(4)_273-278.nxml.txt.nlp	24676475	SENT25	21	21	4	4	doxorubicin	P-gp	PA449412	5243	0.962
NULL	Case_Rep_Crit_Care_2014_Jun_24_2014_650916.nxml.txt.nlp	25057417	SENT53	17	17	3	3	iron	MRI	PA450087	78996	0.962
NULL	Endocrinol_Metab_(Seoul)_2013_Dec_12_28(4)_262-274.nxml.txt.nlp	24396690	SENT48	19	19	4	4	exenatide	GLP-1	PA164749238	100125288	0.962
NULL	Exp_Mol_Med_2012_Nov_30_44(11)_665-673.nxml.txt.nlp	23114424	SENT104	19	19	5	5	taurine	adiponectin	PA451590	9370	0.962
NULL	J_Neuroinflammation_2010_Sep_7_7_51.nxml.txt.nlp	20822529	SENT124	12	12	3	3	hemin	HO-1	PA449849	3162	0.962
NULL	Cancer_Immunol_Immunother_2013_Aug_27_62(10)_1637-1648.nxml.txt.nlp	23982484	SENT152	15	15	9	9	lenalidomide	STAT3	PA162363968	6774	0.962
NULL	J_Carcinog_2013_Dec_31_12_22.nxml.txt.nlp	24574860	SENT191	12	12	8	8	dasatinib	DDR2	PA162372878	4921	0.962
NULL	Nucl_Recept_Signal_2009_Jan_16_7_e001.nxml.txt.nlp	19240808	SENT416	1	1	9	9	estradiol	SXR	PA449503	8856	0.962
NULL	FEBS_Open_Bio_2014_Oct_12_4_879-885.nxml.txt.nlp	25379385	SENT121	6	6	2	2	trypsin	ECM1	PA451806	1893	0.962
NULL	Adolesc_Health_Med_Ther_2014_Mar_26_5_35-48.nxml.txt.nlp	24729739	SENT45	15	15	2	2	methotrexate	TNF-alpha	PA450428	7124	0.962
NULL	J_Immunother_Cancer_2013_May_29_1_4.nxml.txt.nlp	NULL	SENT280	3	3	12	12	imatinib	NKp30	PA10804	259197	0.962
NULL	Eur_J_Clin_Pharmacol_2014_Oct_8_70(1)_37-45.nxml.txt.nlp	24100471	SENT195	2	2	12	12	omeprazole	CYP2C19	PA450704	1557	0.962
NULL	Mol_Cancer_2014_Jun_30_13_160.nxml.txt.nlp	24976026	SENT9	21	21	3	3	bortezomib	AGR2	PA10252	10551	0.962
NULL	Biomed_Res_Int_2014_Feb_6_2014_323594.nxml.txt.nlp	24689036	SENT277	18	18	9	9	raloxifene	OATP1B3	PA451221	28234	0.962
NULL	Diabetol_Metab_Syndr_2014_Oct_15_6(1)_110.nxml.txt.nlp	NULL	SENT134	10	10	21	21	metformin	GLP-1	PA450395	100125288	0.962
NULL	Cancers_(Basel)_2014_Mar_26_6(2)_708-722.nxml.txt.nlp	24675568	SENT64	18	18	7	7	crizotinib	STAT3	PA165946122	6774	0.962
NULL	Br_J_Cancer_2010_Jun_8_102(12)_1717-1723.nxml.txt.nlp	20485285	SENT136	7	7	18	18	staurosporine	SMAC	PA165109623	56616	0.962
NULL	Acta_Pharmacol_Sin_2012_May_4_33(5)_710-716.nxml.txt.nlp	22555373	SENT118	13	13	23	23	diazepam	DOM	PA449283	6663	0.962
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Dec_23_68(Pt_1)_o246.nxml.txt.nlp	22259528	SENT67	21	21	12	12	ethanol	mol	PA448073	90527	0.962
NULL	Case_Rep_Nephrol_Urol_2012_Apr_11_2(1)_20-24.nxml.txt.nlp	23197951	SENT69	15	15	3	3	colchicine	NAC	PA449092	22861	0.962
NULL	Asian-Australas_J_Anim_Sci_2014_Dec_27(12)_1783-1793.nxml.txt.nlp	25358373	SENT192	10	10	31	31	capsaicin	PPARG	PA448776	5468	0.962
NULL	Breast_Cancer_Res_2011_Mar_1_13(2)_R21.nxml.txt.nlp	21362200	SENT70	9	9	19	19	fulvestrant	PI3K	PA164747170	5290	0.962
NULL	Oncol_Lett_2014_May_28_7(5)_1581-1585.nxml.txt.nlp	24765180	SENT20	11	11	0	0	cisplatin	LPA	PA449014	4018	0.962
NULL	Oncogene_2010_Sep_16_29(37)_5193-5203.nxml.txt.nlp	20581867	SENT10	18	18	14	14	lapatinib	HER2	PA152241907	2064	0.962
NULL	Anal_Bioanal_Chem_2010_Aug_14_397(7)_2977-2986.nxml.txt.nlp	20549493	SENT131	40	40	21	21	estradiol	P15	PA449503	1030;29107	0.961
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jan_11_68(Pt_2)_o314.nxml.txt.nlp	22346949	SENT58	36	36	6	6	ethanol	mol	PA448073	90527	0.961
NULL	J_Oncol_2013_Apr_29_2013_854121.nxml.txt.nlp	23737784	SENT153	29	29	20	20	lapatinib	HER2	PA152241907	2064	0.961
NULL	Oncogenesis_2012_Apr_2_1(4)_e5.nxml.txt.nlp	23552603	SENT234	22	22	3	3	ns-398	Bcl-2		596	0.961
NULL	Clin_Ophthalmol_2010_Apr_26_4_233-241.nxml.txt.nlp	20463789	SENT81	12	12	32	32	dorzolamide	CRA	PA164748765	51747;10903	0.961
NULL	Cell_Commun_Signal_2014_Sep_25_12(1)_61.nxml.txt.nlp	NULL	SENT57	21	21	3	3	doxycycline	PC-3	PA449415	692094	0.961
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT111	14	14	2	2	doxorubicin	p53	PA449412	7157	0.961
NULL	Cancer_Manag_Res_2013_Jul_31_5_187-195.nxml.txt.nlp	23986650	SENT61	41	41	10	10	carboplatin	CD44	PA448803	960	0.961
NULL	Diabetes_2011_Nov_17_60(11)_2691-2700.nxml.txt.nlp	21896928	SENT31	20	20	5	5	resveratrol	SIRT1		23411	0.961
NULL	J_Adv_Pharm_Technol_Res_2014_Apr-Jun_5(2)_78-83.nxml.txt.nlp	24959416	SENT57	0	0	8	8	glimepiride	MSN	PA449761	4478	0.961
NULL	Cancer_Res_Treat_2012_Mar_31_44(1)_1-10.nxml.txt.nlp	22500155	SENT29	8	8	12	12	imatinib	EGFR	PA10804	1956	0.961
NULL	Case_Rep_Obstet_Gynecol_2014_Jun_29_2014_518398.nxml.txt.nlp	25093134	SENT73	2	2	13	13	genistein	aromatase	PA165109660	1588	0.961
NULL	Cell_Death_Dis_2014_Jan_9_5(1)_e991.nxml.txt.nlp	24407244	SENT13	13	13	31	31	cisplatin	Bcl-2	PA449014	596	0.961
NULL	Nat_Commun_2013_Apr_23_4_1758.nxml.txt.nlp	23612299	SENT64	2	2	21	21	isoproterenol	SOD1	PA450121	6647	0.961
NULL	Cardiovasc_Diabetol_2010_May_25_9_21.nxml.txt.nlp	20500877	SENT164	5	5	10	10	metoprolol	adiponectin	PA450480	9370	0.961
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT234	8	8	18	18	chloroquine	BMP9	PA448948	2658	0.961
NULL	Indian_J_Endocrinol_Metab_2012_Dec_16(Suppl_2)_S474-S476.nxml.txt.nlp	23565471	SENT66	36	36	18	18	sitagliptin	PPG	PA164748978	5552	0.961
NULL	Breast_Cancer_Res_2012_Apr_26_14(2)_R69.nxml.txt.nlp	22537934	SENT197	30	30	1	1	tamoxifen	RAD21	PA451581	5885	0.961
NULL	J_Hematol_Oncol_2009_Feb_23_2_10.nxml.txt.nlp	19236716	SENT107	15	15	25	25	ketoconazole	CYP3A4	PA450146	1576	0.961
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT171	22	22	0	0	phenprocoumon	VKORC1	PA450921	79001	0.961
NULL	J_Hematol_Oncol_2012_Sep_16_5_55.nxml.txt.nlp	22980425	SENT49	39	39	8	8	chlorambucil	CD52	PA448926	1043	0.961
NULL	Daru_2013_Dec_19_21(1)_67.nxml.txt.nlp	24355111	SENT151	3	3	12	12	modafinil	EPM	PA450530	2054	0.961
NULL	Diabetes_2009_Aug_28_58(8)_1816-1825.nxml.txt.nlp	19401425	SENT178	24	24	29	29	nimodipine	GLP-1	PA450633	100125288	0.961
NULL	Indian_J_Med_Res_2012_Aug_136(2)_242-248.nxml.txt.nlp	22960891	SENT114	3	3	15	15	carbimazole	ghrelin	PA164742970	51738	0.961
NULL	Onco_Targets_Ther_2014_Sep_23_7_1653-1661.nxml.txt.nlp	25285015	SENT108	33	33	25	25	irinotecan	UGT1A1	PA450085	54658	0.961
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT14	23	23	12	12	tacrolimus	SOCS1	PA451578	8651	0.961
NULL	Biomed_Res_Int_2014_Jan_29_2014_862851.nxml.txt.nlp	24605338	SENT26	0	0	13	13	ustekinumab	IL-23	PA166048654	51561	0.961
NULL	Acta_Neuropathol_Commun_2013_May_20_1_17.nxml.txt.nlp	24252689	SENT179	31	31	11	11	celecoxib	CRK	PA448871	1398	0.961
NULL	J_Mol_Signal_2012_Aug_16_7_12.nxml.txt.nlp	22898329	SENT259	0	0	10	10	sorafenib	BIM	PA7000	10018	0.961
NULL	J_Thorac_Oncol_2014_Jun_30_9(6)_775-783.nxml.txt.nlp	24828661	SENT157	6	6	13	13	crizotinib	EGFR	PA165946122	1956	0.961
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT41	38	38	23	23	pertuzumab	HER2		2064	0.961
NULL	Clin_Ophthalmol_2010_Apr_26_4_349-358.nxml.txt.nlp	20463804	SENT168	8	8	26	26	latanoprost	C-1	PA164774763	5203	0.961
NULL	Cardiovasc_Ther_2009_27(4)_259-274.nxml.txt.nlp	19604248	SENT50	1	1	25	25	ticagrelor	ADP	PA165374673	23038	0.961
NULL	Clin_Med_Insights_Oncol_2011_Oct_31_5_333-342.nxml.txt.nlp	22084622	SENT125	3	3	31	31	pazopanib	IL-8	PA165291492	3576	0.961
NULL	Breast_Cancer_Res_2010_Jun_28_12(3)_R43.nxml.txt.nlp	20579400	SENT160	31	31	18	18	tamoxifen	MAPT	PA451581	4137	0.961
NULL	Mol_Cancer_2009_Jun_8_8_34.nxml.txt.nlp	19500427	SENT69	11	11	1	1	gemcitabine	p53	PA449748	7157	0.961
NULL	J_Gerontol_A_Biol_Sci_Med_Sci_2014_Jun_8_69(Suppl_1)_S21-S27.nxml.txt.nlp	24833582	SENT107	8	8	29	29	metformin	AMPK	PA450395	5563	0.961
NULL	J_Invest_Dermatol_2014_Jan_25_134(1)_268-271.nxml.txt.nlp	23812303	SENT47	0	0	12	12	adalimumab	p40	PA10004	3921;339541;10314	0.961
NULL	Breast_Cancer_Res_2008_Aug_5_10(4)_R68.nxml.txt.nlp	18681966	SENT221	7	7	17	17	doxorubicin	PRLR	PA449412	5618	0.961
NULL	Gut_Liver_2013_Jan_11_7(1)_120-125.nxml.txt.nlp	23423322	SENT15	30	30	21	21	sulindac	AFAP	PA451565	60312	0.961
NULL	J_Geriatr_Cardiol_2014_Jun_11(2)_151-157.nxml.txt.nlp	25009566	SENT118	5	5	18	18	cilostazol	CDP	PA164746334	1523	0.961
NULL	Aging_(Albany_NY)_2012_Jul_22_4(7)_480-498.nxml.txt.nlp	22837425	SENT28	25	25	15	15	metformin	B12	PA450395	7126;4709	0.961
NULL	F1000Res_2013_Mar_5_2_74.nxml.txt.nlp	24358880	SENT234	0	0	9	9	capsaicin	TRPV1	PA448776	7442	0.961
NULL	Acta_Pharmacol_Sin_2014_Jun_5_35(6)_727-737.nxml.txt.nlp	24793312	SENT15	9	9	17	17	pioglitazone	B27	PA450970	56246	0.961
NULL	Nucleic_Acids_Res_2011_Mar_4_39(5)_1843-1854.nxml.txt.nlp	21051342	SENT301	19	19	7	7	carbenicillin	IFN	PA448788	3439	0.961
NULL	Oncogenesis_2014_Dec_15_3(12)_e133.nxml.txt.nlp	25500906	SENT85	15	15	11	11	trastuzumab	HER2	PA451743	2064	0.961
NULL	Clin_Med_Insights_Cardiol_2011_Oct_6_5_103-119.nxml.txt.nlp	22084608	SENT41	0	0	6	6	dronedarone	CYP3A4	PA153619853	1576	0.961
NULL	J_Oncol_2011_Sep_29_2011_232037.nxml.txt.nlp	21977030	SENT130	18	18	2	2	bortezomib	Hsp90	PA10252	3320	0.961
NULL	Oncotarget_2013_Jun_4_4(5)_772-784.nxml.txt.nlp	23800712	SENT125	47	47	4	4	dasatinib	EGFR	PA162372878	1956	0.961
NULL	Arch_Drug_Inf_2009_Mar_2(1)_1-7.nxml.txt.nlp	19381337	SENT25	0	0	24	24	saquinavir	CYP3A4	PA451305	1576	0.961
NULL	Antimicrob_Agents_Chemother_2014_Oct_58(10)_5900-5908.nxml.txt.nlp	25070091	SENT295	2	2	19	19	metoprolol	CYP3A4	PA450480	1576	0.961
NULL	Nat_Med_2013_Sep_11_19(9)_1153-1156.nxml.txt.nlp	23933983	SENT50	18	18	6	6	estradiol	FGF21	PA449503	26291	0.961
NULL	Am_J_Case_Rep_2014_Nov_3_15_480-484.nxml.txt.nlp	25380070	SENT55	4	4	19	19	crizotinib	CEA	PA165946122	5670;1087	0.961
NULL	Antiviral_Res_2009_May_82(2)_A99-A109.nxml.txt.nlp	19176219	SENT116	35	35	7	7	lamivudine	MRP-1	PA450163	928	0.961
NULL	Front_Oncol_2013_Sep_9_3_235.nxml.txt.nlp	24058902	SENT120	21	21	12	12	pargyline	LSD1	PA450797	23028	0.961
NULL	Dis_Markers_2010_Jun_29_28(5)_307-313.nxml.txt.nlp	20592455	SENT13	26	26	12	12	atorvastatin	CAD	PA448500	1677;790	0.961
NULL	Biochim_Biophys_Acta_2013_Jul_1832(7)_905-910.nxml.txt.nlp	23032152	SENT56	11	11	3	3	fenfluramine	5-HT2B	PA449592	3357	0.961
NULL	Cardiovasc_Drugs_Ther_2013_Jul_26_27(6)_521-530.nxml.txt.nlp	23887740	SENT167	39	39	19	19	clopidogrel	CD41	PA449053	3674	0.961
NULL	Exp_Ther_Med_2013_Mar_21_5(3)_987-991.nxml.txt.nlp	23407636	SENT144	31	31	12	12	losartan	CXCR1	PA450268	3577	0.961
NULL	Breast_Cancer_Res_Treat_2012_Jun_18_133(3)_937-947.nxml.txt.nlp	22094936	SENT148	47	47	12	12	tamoxifen	E2F1	PA451581	1869	0.961
NULL	Br_J_Cancer_2013_May_28_108(10)_1957-1963.nxml.txt.nlp	23640393	SENT25	5	5	17	17	vincristine	NACT	PA451879	284111	0.961
NULL	Oncol_Lett_2014_Oct_22_8(4)_1603-1607.nxml.txt.nlp	25202376	SENT86	4	4	16	16	cisplatin	ERCC1	PA449014	2067	0.961
NULL	Front_Neuroeng_2013_Feb_25_6_1.nxml.txt.nlp	23443302	SENT70	4	4	27	27	propofol	gamma	PA451141	9913	0.961
NULL	Ther_Clin_Risk_Manag_2005_Dec_1(4)_299-306.nxml.txt.nlp	18360572	SENT84	1	1	21	21	terbinafine	CYP2C9	PA451614	1559	0.961
NULL	Blood_Res_2014_Dec_23_49(4)_279-280.nxml.txt.nlp	25548764	SENT23	4	4	31	31	lenalidomide	CD86	PA162363968	942	0.961
NULL	Mol_Vis_2014_Dec_19_20_1680-1694.nxml.txt.nlp	25558172	SENT28	30	30	17	17	bevacizumab	APOE	PA130232992	348	0.961
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1522-1532.nxml.txt.nlp	21997136	SENT212	30	30	8	8	irinotecan	EGFR	PA450085	1956	0.961
NULL	Mol_Cancer_2010_Aug_23_9_222.nxml.txt.nlp	20731837	SENT124	10	10	20	20	gefitinib	ATM	PA131301952	472	0.961
NULL	Neuropsychopharmacology_2009_Jul_11_34(8)_1946-1957.nxml.txt.nlp	19279569	SENT100	2	2	20	20	cocaine	DOR	PA449072	58476	0.961
NULL	Nat_Commun_2012_Dec_4_3_1248.nxml.txt.nlp	23212377	SENT571	29	29	36	36	nadh	NADK	PA164755085	65220	0.961
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1137-1144.nxml.txt.nlp	20234366	SENT168	34	34	14	14	cetuximab	MKP-2	PA10040	1846	0.961
NULL	Exp_Ther_Med_2014_Sep_4_8(3)_851-855.nxml.txt.nlp	25120613	SENT72	24	24	6	6	darunavir	IRS1	PA163522472	3667	0.961
NULL	Br_J_Cancer_2010_Nov_9_103(10)_1627-1636.nxml.txt.nlp	20959826	SENT185	22	22	29	29	cetuximab	NRAS	PA10040	4893	0.961
NULL	Case_Rep_Oncol_2014_Sep_25_7(3)_669-672.nxml.txt.nlp	25408661	SENT7	0	0	5	5	ifosfamide	CYP3A4	PA449964	1576	0.961
NULL	Oncotarget_2013_Nov_7_4(12)_2550-2566.nxml.txt.nlp	24334291	SENT114	34	34	28	28	chloroquine	AMPK	PA448948	5563	0.961
NULL	Tuberc_Respir_Dis_(Seoul)_2014_Mar_29_76(3)_114-119.nxml.txt.nlp	24734098	SENT102	19	19	3	3	paclitaxel	Bcl-2	PA450761	596	0.961
NULL	Sci_Rep_2015_Jan_6_5_7642.nxml.txt.nlp	25560837	SENT891	16	16	23	23	rimonabant	CB2	PA152407999	1269	0.961
NULL	Int_J_Mol_Sci_2014_Mar_5_15(3)_3970-3988.nxml.txt.nlp	24603537	SENT245	28	28	0	0	curcumin	MCH	PA151958596	5367	0.961
NULL	Commun_Integr_Biol_2013_Sep_1_6(5)_e25446.nxml.txt.nlp	24265857	SENT114	10	10	4	4	heparin	FGF1	PA449855	2246	0.961
NULL	Cancer_Cell_Int_2010_Jul_8_10_23.nxml.txt.nlp	20615241	SENT73	38	38	14	14	perifosine	BAR	PA165291471	154;51283	0.961
NULL	Nat_Commun_2014_Dec_19_5_5812.nxml.txt.nlp	25524025	SENT518	25	25	3	3	doxorubicin	p53	PA449412	7157	0.961
NULL	Clin_Sci_(Lond)_2013_Apr_1_124(Pt_8)_543-552.nxml.txt.nlp	23130652	SENT214	20	20	14	14	enalapril	STZ	PA449456	6484	0.961
NULL	Front_Genet_2012_Nov_5_3_236.nxml.txt.nlp	23133441	SENT26	5	5	30	30	efavirenz	ABCB1	PA449441	5243	0.961
NULL	N_Am_J_Med_Sci_2011_Oct_3(10)_441-450.nxml.txt.nlp	22363081	SENT132	16	16	13	13	erlotinib	EGFR	PA134687924	1956	0.961
NULL	Cell_Death_Dis_2014_Mar_6_5(3)_e1104.nxml.txt.nlp	24603332	SENT96	10	10	14	14	sorafenib	BRAF	PA7000	673	0.961
NULL	Case_Rep_Rheumatol_2011_Dec_15_2011_185657.nxml.txt.nlp	22937439	SENT57	21	21	0	0	etanercept	TNF-alpha	PA449515	7124	0.961
NULL	Front_Cell_Neurosci_2014_Feb_6_8_27.nxml.txt.nlp	24567703	SENT330	36	36	14	14	carbachol	KCC2	PA448784	57468	0.961
NULL	J_Korean_Med_Sci_2010_Nov_26_25(11)_1683-1687.nxml.txt.nlp	21060764	SENT57	11	11	0	0	thyroglobulin	P63	PA164754910	10970	0.961
NULL	Diabetes_Care_2013_Aug_11_36(8)_2408-2414.nxml.txt.nlp	23536583	SENT111	25	25	31	31	pioglitazone	adiponectin	PA450970	9370	0.961
NULL	J_Cell_Mol_Med_2013_Sep_11_17(9)_1160-1172.nxml.txt.nlp	23844832	SENT12	26	26	3	3	erlotinib	EGF	PA134687924	1950	0.961
NULL	J_Adv_Pharm_Technol_Res_2014_Oct-Dec_5(4)_185-190.nxml.txt.nlp	25364697	SENT162	10	10	6	6	metoprolol	CYP3A4	PA450480	1576	0.961
NULL	Patient_Prefer_Adherence_2011_Dec_23_6_1-9.nxml.txt.nlp	22272064	SENT102	14	14	17	17	telmisartan	ACE	PA451605	1636	0.961
NULL	JRSM_Cardiovasc_Dis_2012_Sep_24_1(6)_cvd_2012_012015.nxml.txt.nlp	24175073	SENT3	16	16	35	35	clopidogrel	HPR	PA449053	3250	0.961
NULL	J_Korean_Med_Sci_2013_Oct_25_28(10)_1555-1558.nxml.txt.nlp	24133367	SENT19	16	16	25	25	gefitinib	EGFR	PA131301952	1956	0.961
NULL	Acta_Pharmacol_Sin_2009_Dec_4_30(12)_1601-1606.nxml.txt.nlp	19960006	SENT188	4	4	10	10	suramin	DPI	PA10292	1832	0.961
NULL	J_Oncol_2014_Mar_26_2014_625060.nxml.txt.nlp	24795759	SENT139	8	8	28	28	ibandronate	aromatase	PA10270	1588	0.961
NULL	Front_Oncol_2013_Aug_5_3_195.nxml.txt.nlp	23936763	SENT53	28	28	20	20	dasatinib	DDR2	PA162372878	4921	0.961
NULL	Arch_Med_Sci_2013_Apr_20_9(2)_332-339.nxml.txt.nlp	23671446	SENT157	9	9	40	40	midazolam	p38	PA450496	10598;1432;7965	0.961
NULL	Nat_Chem_Biol_2010_Apr_28_6(4)_291-299.nxml.txt.nlp	20190765	SENT132	24	24	16	16	dasatinib	EGFR	PA162372878	1956	0.961
NULL	Depress_Res_Treat_2012_Dec_18_2012_752563.nxml.txt.nlp	23320155	SENT147	12	12	5	5	perifosine	AKT	PA165291471	207	0.961
NULL	Biomed_Res_Int_2014_Feb_10_2014_305610.nxml.txt.nlp	24683545	SENT72	29	29	38	38	chlorpromazine	ANOVA	PA448964	4858	0.961
NULL	Mol_Med_Rep_2014_Oct_23_10(4)_1717-1724.nxml.txt.nlp	25069516	SENT6	30	30	15	15	resveratrol	PC-3		692094	0.961
NULL	Crit_Care_2007_Aug_14_11(4)_R87.nxml.txt.nlp	17697359	SENT178	39	39	14	14	dextran	IL-6	PA449261	3569	0.961
NULL	Iran_J_Public_Health_2012_Jun_30_41(6)_65-71.nxml.txt.nlp	23113195	SENT87	0	0	18	18	methotrexate	DHFR	PA450428	1719	0.961
NULL	Hum_Genomics_2008_Sep_1_3(1)_7-16.nxml.txt.nlp	19129086	SENT157	25	25	13	13	rosiglitazone	CYP2C8	PA451283	1558	0.961
NULL	Acta_Pharmacol_Sin_2013_Jun_20_34(6)_732-740.nxml.txt.nlp	23685952	SENT135	10	10	2	2	verapamil	P-gp	PA451868	5243	0.961
NULL	Indian_J_Psychiatry_2014_Oct-Dec_56(4)_359-364.nxml.txt.nlp	25568476	SENT138	5	5	12	12	clozapine	5-HT2A	PA449061	3356	0.961
NULL	Contemp_Oncol_(Pozn)_2012_Nov_20_16(5)_416-419.nxml.txt.nlp	23788920	SENT128	4	4	12	12	heparin	CRT	PA449855	811	0.961
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Aug_21_69(Pt_9)_m510-m511.nxml.txt.nlp	24427002	SENT10	2	2	14	14	nitrile	mol	PA450636	90527	0.961
NULL	Clin_Psychopharmacol_Neurosci_2011_Apr_30_9(1)_36-43.nxml.txt.nlp	23431025	SENT103	8	8	40	40	haloperidol	FLI	PA449841	2314	0.961
NULL	Pharm_Methods_2011_Jul-Sep_2(3)_173-177.nxml.txt.nlp	23781451	SENT25	15	15	9	9	ticlopidine	ADP	PA451686	23038	0.961
NULL	Ann_Oncol_2010_Feb_21(2)_217-222.nxml.txt.nlp	20110292	SENT142	25	25	7	7	erlotinib	EGFR	PA134687924	1956	0.961
NULL	Indian_J_Pharmacol_2008_Oct_40(Suppl_2)_S91-S97.nxml.txt.nlp	21593983	SENT298	10	10	0	0	piperaquine	CYP3A4	PA166104279	1576	0.961
NULL	Br_J_Clin_Pharmacol_2011_Oct_72(4)_647-657.nxml.txt.nlp	21518389	SENT142	8	8	15	15	cangrelor	P2Y12	PA165945763	64805	0.961
NULL	J_Exp_Med_1998_Jun_1_187(11)_1885-1892.nxml.txt.nlp	9607928	SENT172	24	24	8	8	thalidomide	ENL	PA451644	4298	0.961
NULL	Breast_Cancer_Res_2011_Aug_31_13(4)_R84.nxml.txt.nlp	21884573	SENT239	7	7	40	40	lapatinib	HER2	PA152241907	2064	0.961
NULL	Cell_Death_Dis_2014_Apr_17_5(4)_e1185.nxml.txt.nlp	24743740	SENT84	4	4	15	15	temsirolimus	Met	PA164746890	79811	0.961
NULL	Oncol_Rep_2012_Apr_30_27(4)_923-928.nxml.txt.nlp	22209766	SENT25	20	20	14	14	erlotinib	EGFR	PA134687924	1956	0.961
NULL	Oncotarget_2014_Mar_16_5(12)_4087-4102.nxml.txt.nlp	24961479	SENT112	17	17	13	13	hemin	PC3	PA449849	57332;7832;5122	0.961
NULL	Cell_Biol_Int_Rep_(2010)_2012_Jun_21_19(1)_e00017.nxml.txt.nlp	23124518	SENT72	5	5	11	11	etoposide	TRAIL	PA449552	8743	0.961
NULL	Breast_Cancer_Res_2006_Nov_30_8(6)_216.nxml.txt.nlp	17164010	SENT193	27	27	12	12	tamoxifen	aromatase	PA451581	1588	0.961
NULL	Oncotarget_2011_Dec_31_2(12)_1314-1321.nxml.txt.nlp	22248929	SENT140	36	36	28	28	lapatinib	HER3	PA152241907	2065	0.961
NULL	Arthritis_Res_Ther_2007_Jun_29_9(Suppl_1)_S3.nxml.txt.nlp	17634142	SENT127	26	26	4	4	alendronate	CTX	PA448082	1593	0.961
NULL	Mol_Vis_2011_Aug_25_17_2297-2310.nxml.txt.nlp	21921981	SENT216	9	9	0	0	estradiol	HSD17B1	PA449503	3292	0.961
NULL	Oncogene_2010_Jan_7_29(1)_81-92.nxml.txt.nlp	19784067	SENT102	20	20	1	1	cisplatin	MITF	PA449014	4286	0.961
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_17_2013_514719.nxml.txt.nlp	23843876	SENT163	30	30	6	6	cisplatin	LC3	PA449014	84557	0.961
NULL	Oncotarget_2010_Nov_19_1(7)_596-605.nxml.txt.nlp	21317455	SENT59	28	28	17	17	sunitinib	IGF1	PA162372840	3479	0.961
NULL	Br_J_Cancer_2010_Jun_29_103(1)_52-60.nxml.txt.nlp	20531411	SENT137	8	8	32	32	gemcitabine	MTD	PA449748	4493	0.961
NULL	Clin_Med_Insights_Oncol_2012_Feb_28_6_125-135.nxml.txt.nlp	22408376	SENT225	10	10	18	18	bevacizumab	KRAS	PA130232992	3845	0.961
NULL	Mol_Pain_2013_Jun_10_9_27.nxml.txt.nlp	23758830	SENT168	3	3	7	7	tetracaine	ASIC3	PA451638	9311	0.961
NULL	J_Vet_Med_Sci_2013_Nov_21_75(11)_1507-1510.nxml.txt.nlp	23800973	SENT26	6	6	2	2	trypsin	CK19	PA451806	3880	0.961
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT401	14	14	18	18	dasatinib	Bcl-2	PA162372878	596	0.961
NULL	ScientificWorldJournal_2012_Nov_7_2012_680189.nxml.txt.nlp	23213294	SENT56	38	38	1	1	ethanol	SDH	PA448073	1757;10993	0.961
NULL	Oxid_Med_Cell_Longev_2013_Nov_28_2013_568093.nxml.txt.nlp	24379901	SENT54	8	8	22	22	resveratrol	SIRT1		23411	0.961
NULL	BMB_Rep_2014_Nov_47(11)_649-654.nxml.txt.nlp	25301019	SENT161	17	17	39	39	l-alanine	IL-10	PA448055	3586	0.961
NULL	Oncotarget_2012_May_18_3(5)_525-534.nxml.txt.nlp	22619113	SENT45	12	12	1	1	fludarabine	Hsp90	PA449655	3320	0.961
NULL	Oncol_Lett_2013_Sep_12_6(3)_860-864.nxml.txt.nlp	24137426	SENT29	28	28	25	25	ketoconazole	CYP1A2	PA450146	1544	0.961
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT305	10	10	16	16	forskolin	PDE	PA146096022	501	0.961
NULL	Front_Neurol_2014_Feb_18_5_17.nxml.txt.nlp	24600432	SENT107	10	10	30	30	levetiracetam	CD80	PA450206	941	0.961
NULL	Biomed_Res_Int_2014_Jun_26_2014_483501.nxml.txt.nlp	25057490	SENT145	2	2	12	12	resveratrol	p53		7157	0.961
NULL	Lab_Invest_2012_Mar_12_92(3)_420-436.nxml.txt.nlp	22157717	SENT307	19	19	3	3	carbachol	CD133	PA448784	8842	0.961
NULL	Breast_Cancer_Res_2006_Nov_27_8(6)_R66.nxml.txt.nlp	17129383	SENT144	5	5	16	16	paclitaxel	p53	PA450761	7157	0.961
NULL	Pharmaceuticals_(Basel)_2012_Nov_20_5(11)_1236-1264.nxml.txt.nlp	24281308	SENT1568	2	2	20	20	everolimus	EGFR	PA164746311	1956	0.961
NULL	Oncogene_2009_Feb_5_28(5)_742-751.nxml.txt.nlp	19043454	SENT122	23	23	0	0	etoposide	TOP2A	PA449552	7153	0.961
NULL	Br_J_Cancer_2010_Oct_26_103(9)_1380-1390.nxml.txt.nlp	20877355	SENT180	10	10	1	1	etoposide	TRAIL	PA449552	8743	0.961
NULL	Cancer_Med_2014_Oct_18_3(5)_1294-1301.nxml.txt.nlp	24941936	SENT176	14	14	10	10	cetuximab	KRAS	PA10040	3845	0.961
NULL	Indian_J_Pharmacol_2013_Mar-Apr_45(2)_121-125.nxml.txt.nlp	23716885	SENT11	10	10	16	16	fluvoxamine	CYP3A4	PA449690	1576	0.961
NULL	Clin_Infect_Dis_2011_Nov_15_53(10)_977-984.nxml.txt.nlp	22002979	SENT46	16	16	5	5	primaquine	G6PD	PA451103	2539	0.961
NULL	Mol_Cancer_2012_Nov_20_11_85.nxml.txt.nlp	23167739	SENT8	17	17	34	34	everolimus	AKT	PA164746311	207	0.961
NULL	Exp_Neurol_2012_Jun_235(2)_528-538.nxml.txt.nlp	22417924	SENT140	29	29	12	12	rosiglitazone	ANOVA	PA451283	4858	0.961
NULL	Cancers_(Basel)_2013_May_27_5(2)_617-638.nxml.txt.nlp	24216994	SENT168	8	8	4	4	curcumin	PC3	PA151958596	57332;7832;5122	0.961
NULL	Breast_Cancer_Res_2007_Jun_15_9(3)_R38.nxml.txt.nlp	17573968	SENT152	33	33	9	9	fulvestrant	BMI1	PA164747170	648	0.961
NULL	Front_Oncol_2013_Aug_12_3_206.nxml.txt.nlp	23964347	SENT23	29	29	4	4	cisplatin	BRCA1	PA449014	672	0.961
NULL	Patient_Prefer_Adherence_2013_Apr_26_7_369-377.nxml.txt.nlp	23641151	SENT41	19	19	23	23	ustekinumab	p40	PA166048654	3921;339541;10314	0.961
NULL	J_Gynecol_Oncol_2013_Jul_4_24(3)_273-279.nxml.txt.nlp	23875078	SENT108	3	3	11	11	paclitaxel	MDR1	PA450761	5243	0.961
NULL	Arthritis_Res_Ther_2011_Feb_28_13(1)_205.nxml.txt.nlp	21371351	SENT171	34	34	2	2	rituximab	BAFF	PA451261	10673	0.961
NULL	Hum_Mol_Genet_2013_Jul_1_22(13)_2676-2688.nxml.txt.nlp	23474818	SENT153	20	20	6	6	arsenite	FUS	PA452638	2521	0.961
NULL	Ann_Rheum_Dis_2009_Jul_4_68(7)_1220-1227.nxml.txt.nlp	18772191	SENT108	22	22	3	3	abatacept	CD68	PA164747080	968	0.961
NULL	Diabetes_Care_2012_Jan_13_35(Suppl_1)_S11-S63.nxml.txt.nlp	22187469	SENT1913	13	13	7	7	ramipril	DREAM	PA451223	30818	0.961
NULL	Oncol_Rep_2014_Aug_12_32(2)_469-474.nxml.txt.nlp	24926795	SENT29	2	2	11	11	cisplatin	CTR1	PA449014	1317	0.961
NULL	Ann_Surg_Oncol_2010_Apr_20_17(4)_1168-1176.nxml.txt.nlp	19936839	SENT76	7	7	14	14	cetuximab	KRAS	PA10040	3845	0.961
NULL	Braz_J_Microbiol_2008_Jun_1_Apr-Jun_39(2)_219-225.nxml.txt.nlp	24031205	SENT65	9	9	23	23	fluconazole	CDR2	PA449653	1039	0.961
NULL	Cell_Cycle_2013_Dec_15_12(24)_3791-3803.nxml.txt.nlp	24107631	SENT161	20	20	8	8	etoposide	YB-1	PA449552	4904	0.961
NULL	Expert_Rev_Endocrinol_Metab_2014_Jul_9_9(4)_397-409.nxml.txt.nlp	25264451	SENT319	1	1	31	31	estradiol	aromatase	PA449503	1588	0.961
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT87	18	18	8	8	metformin	AKT	PA450395	207	0.961
NULL	Eur_J_Clin_Pharmacol_2014_Oct_8_70(1)_37-45.nxml.txt.nlp	24100471	SENT200	6	6	12	12	ketoconazole	CYP3A4	PA450146	1576	0.961
NULL	Acta_Physiol_(Oxf)_2012_Feb_204(2)_227-237.nxml.txt.nlp	21624095	SENT192	4	4	9	9	propofol	TRPC5	PA451141	7224	0.961
NULL	Curr_Med_Chem_2014_Feb_21(4)_417-436.nxml.txt.nlp	24164197	SENT271	11	11	13	13	tamoxifen	aromatase	PA451581	1588	0.961
NULL	Front_Neurosci_2014_Dec_5_8_398.nxml.txt.nlp	25538552	SENT123	26	26	31	31	glucose	gamma	PA449773	9913	0.961
NULL	Breast_Cancer_Res_2009_Jun_23_11(Suppl_1)_S16.nxml.txt.nlp	NULL	SENT15	20	20	25	25	denosumab	RANK	PA166048634	8792	0.961
NULL	Cell_Death_Dis_2014_Jul_17_5(7)_e1333.nxml.txt.nlp	25032856	SENT34	3	3	28	28	candesartan	EAAC1	PA448765	6505	0.961
NULL	Oncol_Lett_2013_Jun_29_5(6)_1943-1947.nxml.txt.nlp	23833672	SENT111	29	29	35	35	celecoxib	mol	PA448871	90527	0.961
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2587-2596.nxml.txt.nlp	24129237	SENT183	10	10	6	6	paclitaxel	NOTCH1	PA450761	4851	0.961
NULL	J_Immunother_2014_Apr_12_37(3)_180-186.nxml.txt.nlp	24598448	SENT8	20	20	1	1	sorafenib	IL-2	PA7000	3558	0.961
NULL	J_Oncol_2011_Sep_29_2011_232037.nxml.txt.nlp	21977030	SENT25	13	13	27	27	bortezomib	Hsp90	PA10252	3320	0.961
NULL	Physiol_Rep_2014_Sep_28_2(9)_e12160.nxml.txt.nlp	25263209	SENT91	5	5	12	12	capsaicin	TRPV1	PA448776	7442	0.961
NULL	Nat_Med_2013_Oct_8_19(10)_1313-1317.nxml.txt.nlp	24013700	SENT147	17	17	0	0	ribavirin	IFN	PA451241	3439	0.961
NULL	Drugs_R_D_2010_Nov_25_10(4)_219-224.nxml.txt.nlp	21171668	SENT14	10	10	23	23	clopidogrel	DES	PA449053	1674	0.961
NULL	Mol_Cancer_2012_Apr_26_11_26.nxml.txt.nlp	22537224	SENT176	20	20	4	4	cisplatin	CHK1	PA449014	1111	0.961
NULL	Front_Genet_2014_Nov_4_5_383.nxml.txt.nlp	25408701	SENT48	36	36	6	6	gefitinib	NRF2	PA131301952	2551;4780	0.961
NULL	Front_Behav_Neurosci_2014_Sep_24_8_317.nxml.txt.nlp	25309368	SENT80	36	36	20	20	isoflurane	EGR1	PA450106	1958	0.961
NULL	Eur_J_Neurol_2012_Nov_19_19(11)_1470-1476.nxml.txt.nlp	22607270	SENT34	10	10	17	17	mexiletine	DM1	PA450488	338023;1760;28509	0.961
NULL	Exp_Ther_Med_2014_Aug_4_8(2)_657-661.nxml.txt.nlp	25009636	SENT91	5	5	15	15	propofol	CCL2	PA451141	6347	0.961
NULL	Ann_Rheum_Dis_2014_May_13_73(5)_810-816.nxml.txt.nlp	24525910	SENT27	0	0	19	19	tocilizumab	IL-6	PA165292659	3569	0.961
NULL	J_Hematol_Oncol_2013_Nov_22_6_88.nxml.txt.nlp	24261963	SENT327	13	13	29	29	erlotinib	PI3K	PA134687924	5290	0.961
NULL	Breast_Cancer_Res_2004_Oct_6_6(6)_262-268.nxml.txt.nlp	15535857	SENT74	11	11	13	13	tamoxifen	aromatase	PA451581	1588	0.961
NULL	J_Young_Pharm_2010_Oct-Dec_2(4)_428-429.nxml.txt.nlp	21264109	SENT23	4	4	12	12	metformin	B12	PA450395	7126;4709	0.961
NULL	Bioinformation_2012_Jan_6_8(1)_13-19.nxml.txt.nlp	22359429	SENT142	33	33	14	14	curcumin	MRP1	PA151958596	4437	0.961
NULL	Acta_Pharmacol_Sin_2012_Aug_23_33(8)_1095-1100.nxml.txt.nlp	22820908	SENT108	6	6	47	47	clarithromycin	CYP3A4	PA449028	1576	0.961
NULL	Ann_Gastroenterol_2013_26(3)_276.nxml.txt.nlp	24714314	SENT19	6	6	33	33	capsaicin	TRPV1	PA448776	7442	0.961
NULL	Tuberc_Respir_Dis_(Seoul)_2012_Aug_31_73(2)_93-99.nxml.txt.nlp	23166541	SENT42	31	31	43	43	budesonide	DPI	PA448681	1832	0.961
NULL	Breast_Cancer_Res_2005_Nov_16_7(1)_R82-R92.nxml.txt.nlp	15642172	SENT37	31	31	12	12	tamoxifen	BCAR1	PA451581	9564	0.961
NULL	Mol_Syst_Biol_2010_Dec_21_6_453.nxml.txt.nlp	21179025	SENT189	22	22	7	7	sorafenib	HIF1	PA7000	3091	0.961
NULL	Contemp_Oncol_(Pozn)_2012_Jul_6_16(3)_197-200.nxml.txt.nlp	23788878	SENT149	22	22	20	20	vemurafenib	BRAF	PA165946873	673	0.961
NULL	Biosci_Rep_2013_Nov_25_33(6)_e00081.nxml.txt.nlp	24070327	SENT255	27	27	13	13	imatinib	MCM7	PA10804	4176	0.961
NULL	Cancers_(Basel)_2013_Jan_21_5(1)_64-91.nxml.txt.nlp	24216699	SENT151	16	16	0	0	lapatinib	HER2	PA152241907	2064	0.961
NULL	Gut_2011_Sep_8_60(9)_1284-1293.nxml.txt.nlp	21303914	SENT230	18	18	6	6	ribavirin	IL28B	PA451241	282617	0.961
NULL	Indian_J_Nephrol_2010_Jul_20(3)_146-151.nxml.txt.nlp	21072155	SENT95	8	8	12	12	tacrolimus	CYP3A5	PA451578	1577	0.961
NULL	Mol_Cancer_2013_Sep_11_12_104.nxml.txt.nlp	24025152	SENT69	18	18	2	2	gemcitabine	EGFR	PA449748	1956	0.961
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1150.nxml.txt.nlp	24675468	SENT53	20	20	28	28	ethanol	Bcl-2	PA448073	596	0.961
NULL	Scientifica_(Cairo)_2012_Nov_25_2012_578257.nxml.txt.nlp	24278717	SENT32	29	29	0	0	alprostadil	Men	PA448334	8178	0.961
NULL	Acta_Pharmacol_Sin_2013_Feb_12_34(2)_255-261.nxml.txt.nlp	23147557	SENT120	6	6	1	1	pioglitazone	PTPRD	PA450970	5789	0.961
NULL	J_Oncol_2011_Dec_5_2011_465343.nxml.txt.nlp	21188169	SENT175	8	8	24	24	gemcitabine	CD133	PA449748	8842	0.961
NULL	Cells_2014_May_23_3(2)_517-545.nxml.txt.nlp	24861977	SENT159	19	19	11	11	cisplatin	TRPV1	PA449014	7442	0.961
NULL	EJC_Suppl_2013_Sep_5_11(2)_296-298.nxml.txt.nlp	NULL	SENT37	0	0	25	25	pemetrexed	B12	PA10810	7126;4709	0.961
NULL	J_Cell_Biol_2004_Jul_5_166(1)_97-109.nxml.txt.nlp	15240572	SENT355	3	3	19	19	geldanamycin	PP1	PA152031327	5540;5464	0.961
NULL	Acta_Pharmacol_Sin_2012_May_16_33(5)_682-690.nxml.txt.nlp	22504904	SENT155	2	2	11	11	celecoxib	PI3K	PA448871	5290	0.961
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT112	13	13	7	7	trastuzumab	PTEN	PA451743	5728	0.961
NULL	Arthritis_Res_Ther_2003_Oct_2_5(Suppl_4)_S17-S21.nxml.txt.nlp	15180893	SENT50	15	15	4	4	rituximab	ACR	PA451261	49	0.961
NULL	Hematol_Rep_2011_Oct_28_3(3_Suppl)_e3.nxml.txt.nlp	22586511	SENT26	25	25	32	32	cyclophosphamide	CHOP	PA449165	1649	0.961
NULL	Ther_Clin_Risk_Manag_2006_Mar_2(1)_59-75.nxml.txt.nlp	18360582	SENT90	10	10	37	37	telithromycin	CYP3A4	PA10202	1576	0.961
NULL	Diabetes_Care_2013_Dec_13_36(12)_4083-4090.nxml.txt.nlp	24130353	SENT205	10	10	2	2	sitagliptin	DPP4	PA164748978	1803	0.961
NULL	Pain_2014_Nov_155(11)_2243-2252.nxml.txt.nlp	24978826	SENT175	33	33	7	7	propofol	IL4	PA451141	3565	0.961
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jul_22_65(Pt_8)_o1937.nxml.txt.nlp	21583619	SENT64	0	0	10	10	abacavir	Hua	PA448004	1994	0.961
NULL	J_Clin_Biochem_Nutr_2007_Jan_27_40(1)_13-23.nxml.txt.nlp	18437209	SENT142	22	22	18	18	trypsin	PAR2	PA451806	2150;55065;8856	0.961
NULL	J_Korean_Med_Sci_2014_Jul_11_29(7)_965-972.nxml.txt.nlp	25045229	SENT33	27	27	8	8	metformin	B12	PA450395	7126;4709	0.961
NULL	Case_Rep_Rheumatol_2012_Dec_23_2012_724013.nxml.txt.nlp	23320239	SENT38	0	0	17	17	etanercept	IFN	PA449515	3439	0.961
NULL	J_RNAi_Gene_Silencing_2009_Mar_9_5(1)_321-330.nxml.txt.nlp	19771229	SENT161	43	43	0	0	gemcitabine	RRM1	PA449748	6240	0.961
NULL	Clinicoecon_Outcomes_Res_2014_Oct_17_6_451-461.nxml.txt.nlp	25378939	SENT127	28	28	13	13	linezolid	HAP	PA450233	5915;10313	0.961
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT167	46	46	22	22	trastuzumab	MUC1	PA451743	4582	0.961
NULL	Oncoimmunology_2012_Oct_1_1(7)_1004-1016.nxml.txt.nlp	23170249	SENT178	8	8	18	18	paclitaxel	HER-2	PA450761	2064	0.961
NULL	Diabetes_2013_Jun_17_62(6)_1843-1854.nxml.txt.nlp	23349486	SENT158	18	18	2	2	pioglitazone	MCP-1	PA450970	6347	0.961
NULL	Oxid_Med_Cell_Longev_2008_Oct-Dec_1(1)_39-45.nxml.txt.nlp	19794907	SENT51	7	7	42	42	taurine	MCH	PA451590	5367	0.961
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT282	18	18	5	5	nutlin-3	DR5		8795	0.961
NULL	Ann_Dermatol_2014_Apr_30_26(2)_236-240.nxml.txt.nlp	24882980	SENT85	0	0	12	12	amikacin	RGM	PA164744372	56963	0.961
NULL	Front_Oncol_2014_Mar_25_4_54.nxml.txt.nlp	24724051	SENT421	3	3	30	30	dasatinib	AXL	PA162372878	558	0.961
NULL	Oncotarget_2013_Feb_24_4(2)_231-241.nxml.txt.nlp	23548208	SENT20	30	30	5	5	cetuximab	EGFR	PA10040	1956	0.961
NULL	Alcohol_Res_Health_2007_30(1)_38-47.nxml.txt.nlp	17718399	SENT60	13	13	21	21	ethanol	CYP2E1	PA448073	1571	0.961
NULL	Mol_Cancer_2007_Oct_11_6_63.nxml.txt.nlp	17931419	SENT114	19	19	25	25	cetuximab	HIF-1	PA10040	29072	0.961
NULL	Pharmaceutics_2011_Oct_12_3(4)_680-705.nxml.txt.nlp	24309303	SENT55	36	36	6	6	pioglitazone	OATP1B1	PA450970	10599	0.961
NULL	Gynecol_Oncol_Case_Rep_2013_Jul_1_6_7-9.nxml.txt.nlp	24371706	SENT12	0	0	15	15	bevacizumab	VEGF-A	PA130232992	7422	0.961
NULL	Br_J_Cancer_1999_Feb_79(3-4)_509-514.nxml.txt.nlp	10027321	SENT4	7	7	31	31	marimastat	CEA	PA164748329	5670;1087	0.961
NULL	J_Oncol_2012_Nov_10_2012_358472.nxml.txt.nlp	22131994	SENT89	2	2	11	11	sunitinib	VEGFR2	PA162372840	3791	0.961
NULL	Int_J_Gen_Med_2012_Sep_10_5_753-758.nxml.txt.nlp	23049268	SENT85	14	14	24	24	telmisartan	adiponectin	PA451605	9370	0.961
NULL	Arthritis_Res_Ther_2003_Sep_12_5(Suppl_3)_55.nxml.txt.nlp	NULL	SENT7	19	19	3	3	rosiglitazone	ARC	PA451283	8996;23237	0.961
NULL	Pharmaceuticals_(Basel)_2012_Aug_10_5(8)_802-836.nxml.txt.nlp	24280676	SENT294	42	42	22	22	phenylbutazone	MRP2	PA450932	100130958;57626;1244	0.961
NULL	Emerg_Infect_Dis_2007_Jul_13(7)_1001-1007.nxml.txt.nlp	18214171	SENT41	20	20	8	8	nevirapine	CD4	PA450616	920	0.961
NULL	Aging_(Albany_NY)_2009_Oct_13_1(10)_842-844.nxml.txt.nlp	20157556	SENT20	1	1	20	20	nutlin-3	p53		7157	0.961
NULL	Case_Rep_Rheumatol_2012_Dec_24_2012_270315.nxml.txt.nlp	23424706	SENT53	0	0	6	6	tocilizumab	IL-6	PA165292659	3569	0.961
NULL	Core_Evid_2009_Jun_15_4_83-92.nxml.txt.nlp	20694067	SENT73	20	20	14	14	itraconazole	CYP3A4	PA450132	1576	0.961
NULL	AIDS_Res_Treat_2012_Feb_20_2012_105980.nxml.txt.nlp	22454762	SENT135	10	10	17	17	efavirenz	CYP2B6	PA449441	1555	0.961
NULL	AIDS_Res_Treat_2013_Sep_17_2013_231956.nxml.txt.nlp	24159383	SENT139	10	10	4	4	buprenorphine	OAT	PA448685	4942	0.961
NULL	Trials_2013_May_4_14_125.nxml.txt.nlp	23782591	SENT183	6	6	37	37	galantamine	CYP3A5	PA449726	1577	0.961
NULL	Cell_Death_Differ_2010_Apr_16_17(4)_666-676.nxml.txt.nlp	19834494	SENT251	37	37	0	0	gemcitabine	RAGE	PA449748	177	0.961
NULL	Breast_Cancer_Res_2010_Aug_23_12(4)_R64.nxml.txt.nlp	20731819	SENT56	26	26	30	30	tamoxifen	aromatase	PA451581	1588	0.961
NULL	Cancer_Metab_2014_May_28_2(Suppl_1)_P65.nxml.txt.nlp	NULL	SENT21	8	8	14	14	resveratrol	NAMPT		10135	0.961
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT53	22	22	1	1	ritonavir	SLK	PA451260	9748;2534	0.961
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S31-S40.nxml.txt.nlp	20680106	SENT67	3	3	23	23	panitumumab	KRAS	PA162373091	3845	0.961
NULL	Clin_Med_Insights_Cardiol_2010_Dec_1_4_117-128.nxml.txt.nlp	21151850	SENT27	2	2	17	17	clopidogrel	ABCB1	PA449053	5243	0.961
NULL	Oncotarget_2012_May_18_3(5)_525-534.nxml.txt.nlp	22619113	SENT101	24	24	6	6	fludarabine	BIRC5	PA449655	332	0.961
NULL	Crit_Care_2011_Aug_11_15(4)_226.nxml.txt.nlp	21892977	SENT80	0	0	11	11	vasopressin	IRAP	PA451858	3557	0.961
NULL	Autoimmune_Dis_2012_Dec_5_2012_815753.nxml.txt.nlp	23251792	SENT13	0	0	25	25	hyaluronan	CD44	PA165958431	960	0.961
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jan_11_68(Pt_2)_o315.nxml.txt.nlp	22346950	SENT63	36	36	15	15	ethanol	mol	PA448073	90527	0.961
NULL	Oncotarget_2013_Nov_23_5(1)_196-210.nxml.txt.nlp	24344116	SENT128	6	6	35	35	doxorubicin	p53	PA449412	7157	0.961
NULL	Br_J_Cancer_2013_Jul_23_109(2)_502-511.nxml.txt.nlp	23799850	SENT171	7	7	19	19	gemcitabine	SMARCC1	PA449748	6599	0.961
NULL	Oncol_Lett_2014_Nov_14_8(5)_2086-2092.nxml.txt.nlp	25295095	SENT10	19	19	5	5	gemcitabine	LKB1	PA449748	6794	0.961
NULL	Breast_Cancer_Res_2004_Jun_18_6(4)_179-180.nxml.txt.nlp	NULL	SENT25	30	30	10	10	tamoxifen	STAR	PA451581	6770;2984	0.961
NULL	Acta_Neuropathol_2012_Aug_18_124(2)_273-283.nxml.txt.nlp	22526018	SENT204	24	24	7	7	salbutamol	RYR1	PA448068	6261	0.961
NULL	Front_Behav_Neurosci_2013_Apr_17_7_29.nxml.txt.nlp	23616753	SENT117	29	29	12	12	ethanol	CO2	PA448073	4513	0.961
NULL	Case_Rep_Dermatol_2014_Sep_11_6(3)_218-221.nxml.txt.nlp	25408649	SENT29	32	32	19	19	rituximab	IL-8	PA451261	3576	0.961
NULL	Oncotarget_2011_May_16_2(5)_378-392.nxml.txt.nlp	21623005	SENT193	15	15	28	28	oxaliplatin	p53	PA131285527	7157	0.961
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1051.nxml.txt.nlp	24503543	SENT46	22	22	41	41	thioridazine	FYN	PA451666	2534	0.961
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2654-2664.nxml.txt.nlp	24136149	SENT138	3	3	10	10	doxorubicin	DNA-PKcs	PA449412	5591	0.961
NULL	Clin_Exp_Reprod_Med_2013_Jun_30_40(2)_67-75.nxml.txt.nlp	23875162	SENT168	13	13	3	3	rosiglitazone	aromatase	PA451283	1588	0.961
NULL	Cancers_(Basel)_2011_Apr_1_3(2)_1844-1860.nxml.txt.nlp	24212785	SENT453	19	19	2	2	oxaliplatin	BRAF	PA131285527	673	0.961
NULL	Diabetes_2009_Feb_58(2)_329-336.nxml.txt.nlp	19171749	SENT13	36	36	26	26	imatinib	CHOP	PA10804	1649	0.961
NULL	Biol_Proced_Online_2004_Oct_25_6_250-256.nxml.txt.nlp	15514699	SENT179	3	3	5	5	flavopiridol	survivin	PA452627	332	0.961
NULL	Case_Rep_Med_2013_Dec_4_2013_250716.nxml.txt.nlp	24368917	SENT21	0	0	21	21	ethanol	CYP1A2	PA448073	1544	0.961
NULL	Oncol_Rep_2012_Nov_31_28(5)_1544-1550.nxml.txt.nlp	22940844	SENT147	19	19	15	15	amifostine	p53	PA448365	7157	0.961
NULL	Arthritis_Res_Ther_2009_Jan_26_11(1)_R12.nxml.txt.nlp	19171052	SENT322	29	29	11	11	dipyridamole	ACTH	PA449367	5443	0.961
NULL	Mol_Cancer_2013_Sep_11_12_104.nxml.txt.nlp	24025152	SENT212	12	12	36	36	gemcitabine	STAT3	PA449748	6774	0.961
NULL	Br_J_Cancer_2011_Aug_23_105(5)_649-657.nxml.txt.nlp	21811251	SENT26	7	7	15	15	gefitinib	IGF1R	PA131301952	3480	0.961
NULL	Environ_Health_Perspect_2005_Oct_14_113(10)_1330-1335.nxml.txt.nlp	16203242	SENT21	31	31	11	11	arsenite	MLC	PA452638	23209	0.961
NULL	Curr_Med_Chem_2014_May_21(14)_1595-1606.nxml.txt.nlp	23992330	SENT175	19	19	37	37	sunitinib	IL-8	PA162372840	3576	0.961
NULL	Int_J_Gen_Med_2011_Mar_15_4_211-219.nxml.txt.nlp	21475632	SENT30	31	31	27	27	fenofibrate	HPD	PA449594	3242	0.961
NULL	J_Cell_Biol_2002_Sep_16_158(6)_1133-1144.nxml.txt.nlp	12235127	SENT327	10	10	2	2	hyaluronan	CD44	PA165958431	960	0.961
NULL	Pharmaceutics_2011_Jul_13_3(3)_425-439.nxml.txt.nlp	24310588	SENT84	18	18	1	1	diazepam	SERS	PA449283	6301;54938	0.961
NULL	Diabetes_2009_Jan_58(1)_104-115.nxml.txt.nlp	18835938	SENT166	32	32	21	21	pioglitazone	MCP-2	PA450970	6355	0.961
NULL	J_Skin_Cancer_2011_Oct_11_2011_521947.nxml.txt.nlp	22007305	SENT207	16	16	12	12	imatinib	KIT	PA10804	3815	0.961
NULL	Diabetes_2011_Jul_20_60(7)_1990-1999.nxml.txt.nlp	21617181	SENT187	27	27	25	25	geldanamycin	Hsp90	PA152031327	3320	0.961
NULL	Chem_Cent_J_2013_Sep_12_7_153.nxml.txt.nlp	24028654	SENT339	4	4	12	12	nimesulide	5-LOX	PA137179528	240	0.961
NULL	Ann_Intensive_Care_2011_Jul_19_1_26.nxml.txt.nlp	21906376	SENT87	6	6	16	16	vancomycin	SAPS	PA451850	8935	0.961
NULL	Oncol_Rep_2013_Apr_6_29(4)_1285-1292.nxml.txt.nlp	23404427	SENT136	0	0	7	7	cisplatin	GEM	PA449014	2669	0.961
NULL	Front_Endocrinol_(Lausanne)_2013_May_10_4_52.nxml.txt.nlp	23675368	SENT508	28	28	22	22	resveratrol	SIRT1		23411	0.961
NULL	J_Cell_Mol_Med_2014_Nov_28_18(11)_2213-2224.nxml.txt.nlp	25164131	SENT241	33	33	28	28	infliximab	IFN	PA452639	3439	0.961
NULL	Arthritis_Res_Ther_2013_Jul_9_15(4)_R73.nxml.txt.nlp	23837669	SENT16	4	4	10	10	colchicine	MICL	PA449092	160364	0.961
NULL	Acta_Neuropathol_Commun_2014_May_30_2_57.nxml.txt.nlp	24887326	SENT180	20	20	4	4	vardenafil	MED1	PA10229	5469;8930	0.961
NULL	Br_J_Cancer_2009_Mar_10_100(5)_758-763.nxml.txt.nlp	19259094	SENT99	11	11	20	20	decitabine	HDAC	PA164749631	9734	0.961
NULL	J_Res_Med_Sci_2010_Nov-Dec_15(6)_331-343.nxml.txt.nlp	21526106	SENT160	4	4	11	11	l-arginine	HDEL	PA448478	10945	0.961
NULL	J_Geriatr_Cardiol_2013_Dec_10(4)_330-335.nxml.txt.nlp	24454325	SENT87	15	15	7	7	clopidogrel	DES	PA449053	1674	0.961
NULL	Oncotarget_2010_Nov_19_1(7)_596-605.nxml.txt.nlp	21317455	SENT59	28	28	13	13	sunitinib	EGF	PA162372840	1950	0.961
NULL	Front_Genet_2013_Dec_16_4_281.nxml.txt.nlp	24379827	SENT376	27	27	7	7	verapamil	CACNA1F	PA451868	778	0.961
NULL	Breast_Cancer_(Auckl)_2011_Oct_9_5_209-226.nxml.txt.nlp	22084574	SENT21	0	0	11	11	exemestane	aromatase	PA449563	1588	0.961
NULL	Breast_Cancer_Res_2013_Oct_3_15(5)_R93.nxml.txt.nlp	24088226	SENT20	16	16	9	9	tamoxifen	CYP2D6	PA451581	1565	0.961
NULL	Front_Neuroendocrinol_2014_Aug_35(3)_370-384.nxml.txt.nlp	24607323	SENT325	19	19	5	5	estradiol	aromatase	PA449503	1588	0.961
NULL	Ann_Lab_Med_2014_Jan_6_34(1)_43-50.nxml.txt.nlp	24422195	SENT38	26	26	16	16	thrombin	PRP	PA451674	7001;5621	0.961
NULL	J_Antimicrob_Chemother_2014_Jul_14_69(7)_1945-1953.nxml.txt.nlp	24633206	SENT199	33	33	8	8	clarithromycin	RGM	PA449028	56963	0.961
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Apr_25_68(Pt_5)_m664.nxml.txt.nlp	22590148	SENT74	41	41	15	15	ethanol	mol	PA448073	90527	0.961
NULL	J_Biol_Chem_2013_Jul_19_288(29)_21412-21421.nxml.txt.nlp	23740251	SENT106	0	0	18	18	suramin	P2X1	PA10292	5023	0.961
NULL	Trials_2013_May_4_14_125.nxml.txt.nlp	23782591	SENT183	4	4	34	34	donepezil	CYP3A4	PA449394	1576	0.961
NULL	Oncologist_2010_Apr_15(4)_372-381.nxml.txt.nlp	20413642	SENT147	2	2	16	16	erlotinib	EGFR	PA134687924	1956	0.961
NULL	Cardiol_Res_Pract_2013_Feb_21_2013_127270.nxml.txt.nlp	23509665	SENT128	11	11	28	28	ticagrelor	NNT	PA165374673	23530	0.961
NULL	Mol_Vis_2011_Dec_24_17_3384-3391.nxml.txt.nlp	22219634	SENT121	24	24	9	9	mannitol	TLR4	PA450320	7099	0.961
NULL	Sensors_(Basel)_2013_Dec_27_14(1)_458-467.nxml.txt.nlp	24379050	SENT105	28	28	16	16	glucose	SPR	PA449773	6697;6869	0.961
NULL	Chin_J_Cancer_2012_Feb_31(2)_58-72.nxml.txt.nlp	22098952	SENT114	17	17	11	11	cisplatin	MRP1	PA449014	4437	0.961
NULL	Pain_Res_Treat_2012_Oct_24_2012_153060.nxml.txt.nlp	23150819	SENT81	36	36	23	23	tamoxifen	aromatase	PA451581	1588	0.961
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Nov_13_64(Pt_12)_o2334.nxml.txt.nlp	21581309	SENT3	10	10	25	25	piperazine	mol	PA450977	90527	0.961
NULL	Oxid_Med_Cell_Longev_2012_May_28_2012_386527.nxml.txt.nlp	22690271	SENT178	7	7	13	13	resveratrol	HO-1		3162	0.961
NULL	Arthritis_Res_Ther_2009_Feb_23_11(1)_216.nxml.txt.nlp	19291269	SENT158	32	32	10	10	anakinra	ACR	PA10799	49	0.961
NULL	Breast_Cancer_Res_2011_Mar_11_13(2)_R30.nxml.txt.nlp	21396117	SENT228	3	3	25	25	erlotinib	p53	PA134687924	7157	0.961
NULL	Nat_Commun_2013_Oct_25_4_2667.nxml.txt.nlp	24157709	SENT68	3	3	27	27	nutlin-3	p53		7157	0.961
NULL	J_Biomed_Biotechnol_2011_Jan_24_2011_250860.nxml.txt.nlp	21318107	SENT164	0	0	14	14	lenalidomide	IL-8	PA162363968	3576	0.961
NULL	Curr_Control_Trials_Cardiovasc_Med_2001_Oct_16_2(6)_271-277.nxml.txt.nlp	11806813	SENT58	19	19	24	24	amlodipine	IL-6	PA448388	3569	0.961
NULL	Mol_Cancer_2010_Jun_24_9_164.nxml.txt.nlp	20576107	SENT173	0	0	5	5	etoposide	p53	PA449552	7157	0.961
NULL	Breast_Cancer_Res_2003_Oct_7_5(1)_8-15.nxml.txt.nlp	12559039	SENT163	0	0	19	19	geldanamycin	EGFR	PA152031327	1956	0.961
NULL	Nanoscale_Res_Lett_2012_Jul_17_7(1)_401.nxml.txt.nlp	22804871	SENT31	14	14	5	5	ethanol	ITO	PA448073	3160	0.961
NULL	J_Cell_Biol_2004_Jan_5_164(1)_145-155.nxml.txt.nlp	14709546	SENT308	3	3	8	8	ethanol	CO2	PA448073	4513	0.961
NULL	J_Gen_Physiol_1997_Dec_1_110(6)_643-654.nxml.txt.nlp	9382893	SENT225	24	24	11	11	diazoxide	SUR1	PA449285	6833	0.961
NULL	Arthritis_Res_Ther_2010_Jun_3_12(3)_R109.nxml.txt.nlp	20525258	SENT108	9	9	19	19	pentoxifylline	gamma	PA450864	9913	0.961
NULL	Acta_Pharmacol_Sin_2014_Jan_9_35(1)_1-10.nxml.txt.nlp	24317012	SENT23	26	26	2	2	paclitaxel	OATP1B3	PA450761	28234	0.961
NULL	Hum_Genomics_2008_Sep_1_3(1)_7-16.nxml.txt.nlp	19129086	SENT164	1	1	21	21	rosiglitazone	CYP3A4	PA451283	1576	0.961
NULL	Br_J_Cancer_2009_Jul_7_101(1)_38-47.nxml.txt.nlp	19513066	SENT171	25	25	3	3	dasatinib	N-WASP	PA162372878	8976	0.961
NULL	Acta_Pharmacol_Sin_2014_Jun_5_35(6)_716-726.nxml.txt.nlp	24793311	SENT185	20	20	12	12	atorvastatin	PSD-95	PA448500	1742	0.961
NULL	Indian_J_Anaesth_2014_Sep-Oct_58(5)_515-523.nxml.txt.nlp	25535411	SENT128	4	4	21	21	thrombin	VIII	PA451674	1351	0.961
NULL	Oncotarget_2013_Nov_23_5(1)_196-210.nxml.txt.nlp	24344116	SENT120	17	17	5	5	doxorubicin	p53	PA449412	7157	0.961
NULL	J_Hum_Genet_2013_Jun_16_58(6)_353-361.nxml.txt.nlp	23677058	SENT166	29	29	16	16	cytarabine	RRM1	PA449177	6240	0.961
NULL	J_Carcinog_2011_Nov_30_10_28.nxml.txt.nlp	22190870	SENT223	36	36	6	6	trastuzumab	PTEN	PA451743	5728	0.961
NULL	Balkan_J_Med_Genet_2011_Jun_25_14(1)_25-30.nxml.txt.nlp	24052699	SENT81	12	12	25	25	lamotrigine	ABCC2	PA450164	1244	0.961
NULL	Clin_Med_Insights_Oncol_2012_Nov_20_6_381-393.nxml.txt.nlp	23226079	SENT137	20	20	15	15	ritonavir	CYP3A4	PA451260	1576	0.961
NULL	Nat_Med_2010_Jun_23_16(6)_671-677.nxml.txt.nlp	20495567	SENT54	12	12	4	4	sorafenib	CREB3L2	PA7000	64764	0.961
NULL	J_Korean_Med_Sci_2009_Oct_23_24(5)_782-788.nxml.txt.nlp	19794971	SENT121	3	3	13	13	bosentan	ETB	PA10034	1910	0.961
NULL	Open_Biochem_J_2011_Sep_23_5_45-51.nxml.txt.nlp	21966325	SENT119	19	19	32	32	indomethacin	XBP1	PA449982	7494	0.961
NULL	Nanoscale_Res_Lett_2014_Apr_1_9(1)_156.nxml.txt.nlp	24685243	SENT18	0	0	4	4	paclitaxel	BCS	PA450761	617	0.961
NULL	J_Korean_Med_Sci_2007_Dec_20_22(6)_1055-1059.nxml.txt.nlp	18162722	SENT131	12	12	35	35	famotidine	ESD	PA449586	2098	0.961
NULL	Clin_Pharmacokinet_2014_Jan_16_53(3)_213-225.nxml.txt.nlp	24430725	SENT193	35	35	16	16	verapamil	P-gp	PA451868	5243	0.961
NULL	Int_J_Biol_Sci_2013_Apr_22_9(4)_350-360.nxml.txt.nlp	23630447	SENT43	10	10	17	17	trastuzumab	HER2	PA451743	2064	0.961
NULL	Indian_J_Anaesth_2011_Nov-Dec_55(6)_567-572.nxml.txt.nlp	22223899	SENT19	12	12	2	2	isoflurane	NAC	PA450106	22861	0.961
NULL	Mol_Cells_2014_Sep_30_37(9)_664-671.nxml.txt.nlp	25234467	SENT271	10	10	6	6	cisplatin	KRAS	PA449014	3845	0.961
NULL	Eur_J_Clin_Pharmacol_2012_Sep_15_68(9)_1267-1274.nxml.txt.nlp	22418828	SENT203	11	11	3	3	omeprazole	CYP2C19	PA450704	1557	0.961
NULL	Cancers_(Basel)_2014_Apr_8_6(2)_813-828.nxml.txt.nlp	24717239	SENT169	5	5	12	12	erlotinib	HIF-1	PA134687924	29072	0.961
NULL	Clin_Interv_Aging_2009_May_14_4_165-177.nxml.txt.nlp	19503778	SENT59	5	5	38	38	enoxaparin	NNT	PA449463	23530	0.961
NULL	Brain_Sci_2013_Jun_14_3(2)_941-963.nxml.txt.nlp	24961432	SENT1087	15	15	0	0	ethanol	RhoA	PA448073	387	0.961
NULL	Br_J_Cancer_2012_Jun_5_106(12)_1945-1952.nxml.txt.nlp	22588555	SENT147	26	26	8	8	sorafenib	Bcl-2	PA7000	596	0.961
NULL	Cell_Death_Dis_2010_May_13_1(5)_e41.nxml.txt.nlp	21364648	SENT7	31	31	25	25	etoposide	p65	PA449552	5970	0.961
NULL	Springerplus_2014_Oct_24_3_628.nxml.txt.nlp	25392798	SENT111	16	16	22	22	ezetimibe	NPC1L1	PA10816	29881	0.961
NULL	Oncotarget_2012_May_9_3(4)_363-364.nxml.txt.nlp	22622047	SENT17	45	45	14	14	camptothecin	SIRT1	PA153590860	23411	0.961
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT798	21	21	4	4	metformin	SLC22A1	PA450395	6580	0.961
NULL	Br_J_Cancer_2003_Mar_10_88(5)_754-759.nxml.txt.nlp	12618886	SENT166	19	19	7	7	amifostine	p53	PA448365	7157	0.961
NULL	Nat_Med_2013_Mar_10_19(3)_313-321.nxml.txt.nlp	23396211	SENT42	0	0	8	8	amlexanox	TBK1	PA164745310	29110	0.961
NULL	J_Antimicrob_Chemother_2011_Feb_31_66(2)_265-272.nxml.txt.nlp	21196489	SENT14	8	8	25	25	maraviroc	CXCR4	PA164768835	7852	0.961
NULL	Br_J_Cancer_2010_Mar_2_102(5)_852-861.nxml.txt.nlp	20145622	SENT56	0	0	28	28	methotrexate	CD64	PA450428	2209	0.961
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT87	6	6	20	20	resveratrol	TNF		7124	0.961
NULL	Cancer_Immunol_Immunother_2012_Jul_23_61(7)_1101-1111.nxml.txt.nlp	22193989	SENT107	5	5	15	15	oxaliplatin	IFN	PA131285527	3439	0.961
NULL	Curr_Neuropharmacol_2012_Mar_10(1)_72-79.nxml.txt.nlp	22942880	SENT85	17	17	30	30	irinotecan	GSTP1	PA450085	2950	0.961
NULL	Neuropsychopharmacology_2009_Sep_20_34(10)_2275-2284.nxml.txt.nlp	19458612	SENT185	12	12	16	16	citalopram	STAR	PA449015	6770;2984	0.961
NULL	Cancer_Gene_Ther_2013_Jan_9_20(1)_10_1038_cgt_2012_75.nxml.txt.nlp	23138870	SENT102	34	34	28	28	vincristine	PC3	PA451879	57332;7832;5122	0.961
NULL	Autophagy_2012_May_1_8(5)_853-855.nxml.txt.nlp	22617440	SENT67	16	16	6	6	imatinib	BECN1	PA10804	8678	0.961
NULL	Arthritis_Res_Ther_2010_Apr_29_12(2)_R73.nxml.txt.nlp	20429888	SENT252	25	25	15	15	bortezomib	SP1	PA10252	6667	0.961
NULL	Breast_Cancer_Res_2013_Oct_31_15(5)_317.nxml.txt.nlp	24172207	SENT8	3	3	5	5	tamoxifen	aromatase	PA451581	1588	0.961
NULL	Ann_Dermatol_2014_Feb_17_26(1)_137-138.nxml.txt.nlp	24648709	SENT21	2	2	14	14	ustekinumab	p40	PA166048654	3921;339541;10314	0.961
NULL	J_Immunol_Res_2014_Jan_29_2014_828732.nxml.txt.nlp	24741626	SENT18	11	11	29	29	rituximab	CAMR	PA451261	3028	0.961
NULL	Drugs_2014_Oct_10_74(17)_2015-2032.nxml.txt.nlp	25300410	SENT61	9	9	1	1	ketoconazole	P-gp	PA450146	5243	0.961
NULL	Mol_Pain_2013_Jun_10_9_27.nxml.txt.nlp	23758830	SENT109	7	7	19	19	tetracaine	ASIC1	PA451638	41	0.961
NULL	Indian_J_Pharm_Sci_2011_May-Jun_73(3)_328-332.nxml.txt.nlp	22457562	SENT15	21	21	2	2	loperamide	castor	PA450262	54897	0.961
NULL	Neural_Regen_Res_2013_Mar_25_8(9)_825-832.nxml.txt.nlp	25206730	SENT104	6	6	29	29	isoflurane	P2X7	PA450106	5027	0.961
NULL	Arthritis_Res_Ther_2008_Apr_16_10(2)_R43.nxml.txt.nlp	18416822	SENT227	5	5	2	2	sr144528	CB2		1269	0.961
NULL	Curr_Opin_Immunol_2012_Aug_24(4)_459-466.nxml.txt.nlp	22795966	SENT81	5	5	25	25	praziquantel	IL-10	PA164764583	3586	0.961
NULL	Int_J_Mol_Sci_2014_Mar_28_15(4)_5412-5425.nxml.txt.nlp	24686514	SENT41	21	21	3	3	eltrombopag	TPO	PA165981594	7066;7173	0.961
NULL	Endocr_Relat_Cancer_2014_Apr_21(2)_311-326.nxml.txt.nlp	24478054	SENT165	28	28	9	9	denosumab	FOXA2	PA166048634	3170	0.961
NULL	FEBS_Open_Bio_2014_Jul_3_4_602-610.nxml.txt.nlp	25161868	SENT88	21	21	3	3	rosiglitazone	FABP4	PA451283	2167	0.961
NULL	Br_J_Cancer_2011_Jun_28_105(1)_118-123.nxml.txt.nlp	21654685	SENT123	17	17	9	9	dasatinib	S100beta	PA162372878	6285	0.961
NULL	Clin_Endosc_2013_Nov_19_46(6)_643-646.nxml.txt.nlp	24340258	SENT68	0	0	14	14	triamcinolone	ESD	PA451749	2098	0.961
NULL	Mol_Cell_Biochem_2014_Oct_9_385(1-2)_265-275.nxml.txt.nlp	24104452	SENT197	19	19	1	1	bortezomib	U87	PA10252	677775;641648	0.961
NULL	Behav_Brain_Funct_2008_Aug_15_4_37.nxml.txt.nlp	18702828	SENT101	16	16	4	4	methamphetamine	FZD3	PA450403	7976;8326	0.961
NULL	Curr_Cardiol_Rev_2011_Nov_7(4)_221-233.nxml.txt.nlp	22758623	SENT149	9	9	15	15	temsirolimus	FKBP-12	PA164746890	2280	0.961
NULL	Cancers_(Basel)_2011_Aug_15_3(3)_3331-3352.nxml.txt.nlp	24212957	SENT259	17	17	20	20	tamoxifen	aromatase	PA451581	1588	0.961
NULL	Biologics_2010_Sep_13_4_263-271.nxml.txt.nlp	20859453	SENT78	13	13	5	5	abatacept	CTLA4	PA164747080	1493	0.961
NULL	Exp_Mol_Med_2013_Aug_16_45(8)_e36.nxml.txt.nlp	23949442	SENT38	21	21	32	32	doxycycline	LRRK2	PA449415	120892	0.961
NULL	J_Oncol_2011_Dec_15_2011_852970.nxml.txt.nlp	21209724	SENT224	0	0	11	11	nutlin-3	p53		7157	0.961
NULL	Cancers_(Basel)_2011_Nov_23_3(4)_4170-4190.nxml.txt.nlp	24213132	SENT173	3	3	22	22	flavopiridol	XIAP	PA452627	331	0.961
NULL	J_Hematol_Oncol_2008_Oct_23_1_19.nxml.txt.nlp	18947412	SENT57	16	16	7	7	alemtuzumab	CD34	PA164783958	947	0.961
NULL	Ann_Lab_Med_2013_May_17_33(3)_229-232.nxml.txt.nlp	23667855	SENT18	25	25	3	3	hydroxyurea	MPN	PA449942	83886	0.961
NULL	Nucleic_Acids_Res_2006_Jul_5_34(11)_3399-3407.nxml.txt.nlp	16822860	SENT113	19	19	11	11	doxycycline	TFIIIC110	PA449415	2976	0.961
NULL	Front_Behav_Neurosci_2014_Dec_16_8_437.nxml.txt.nlp	25566005	SENT16	4	4	15	15	menthol	TRPM8	PA164776605	79054	0.961
NULL	Evid_Based_Complement_Alternat_Med_2014_Jan_8_2014_976364.nxml.txt.nlp	24527057	SENT16	34	34	30	30	oseltamivir	JNK	PA450721	5599	0.961
NULL	Br_J_Cancer_2012_Jan_3_106(1)_6-13.nxml.txt.nlp	22215104	SENT130	19	19	2	2	trastuzumab	HER2	PA451743	2064	0.961
NULL	Breast_Cancer_Res_2005_May_27_7(Suppl_1)_S16.nxml.txt.nlp	NULL	SENT4	8	8	27	27	letrozole	BCS	PA450196	617	0.961
NULL	Indian_J_Occup_Environ_Med_2012_Sep-Dec_16(3)_101-107.nxml.txt.nlp	23776317	SENT136	6	6	11	11	hemin	HO-1	PA449849	3162	0.961
NULL	Breast_Cancer_Res_2012_Jan_17_14(1)_R12.nxml.txt.nlp	22251451	SENT36	34	34	0	0	fulvestrant	GPER	PA164747170	2852	0.961
NULL	Mol_Cancer_2010_Apr_15_9_77.nxml.txt.nlp	20398291	SENT119	3	3	10	10	geldanamycin	survivin	PA152031327	332	0.961
NULL	Case_Rep_Dermatol_2014_Feb_12_6(1)_37-42.nxml.txt.nlp	24707248	SENT56	21	21	7	7	methotrexate	CHOP	PA450428	1649	0.961
NULL	Mucosal_Immunol_2014_Jan_12_7(1)_10_1038_mi_2013_36.nxml.txt.nlp	23757303	SENT53	33	33	9	9	mitomycin	CD4	PA450524	920	0.961
NULL	J_Cell_Biol_1998_Jan_26_140(2)_335-345.nxml.txt.nlp	9442109	SENT210	14	14	2	2	chloroquine	NHE	PA448948	285335	0.961
NULL	Exp_Diabetes_Res_2007_Jun_28_2007_52487.nxml.txt.nlp	17713597	SENT56	0	0	17	17	pegaptanib	VEGF-A	PA164771236	7422	0.961
NULL	Gut_2008_Jul_4_57(7)_923-929.nxml.txt.nlp	18252749	SENT23	9	9	0	0	capsaicin	TRPV1	PA448776	7442	0.961
NULL	J_Hematol_Oncol_2008_Aug_11_1_11.nxml.txt.nlp	18694493	SENT76	0	0	10	10	pazopanib	VEGFR	PA165291492	3791	0.961
NULL	Biologics_2012_Oct_25_6_371-378.nxml.txt.nlp	23118526	SENT54	9	9	17	17	tocilizumab	IL-6	PA165292659	3569	0.961
NULL	N_Am_J_Med_Sci_2010_Oct_2(10)_491-495.nxml.txt.nlp	22558553	SENT103	2	2	16	16	napqi	CYP1A2		1544	0.961
NULL	J_Biol_Chem_2009_Jan_16_284(3)_1772-1780.nxml.txt.nlp	19015261	SENT171	34	34	11	11	doxycycline	KEN	PA449415	5116	0.961
NULL	Cell_Death_Dis_2013_Jun_27_4(6)_e696.nxml.txt.nlp	23807225	SENT168	0	0	16	16	doxycycline	PI3K	PA449415	5290	0.961
NULL	Cardiol_Res_Pract_2013_Feb_21_2013_127270.nxml.txt.nlp	23509665	SENT66	11	11	31	31	prasugrel	NNT	PA154410481	23530	0.961
NULL	Cancers_(Basel)_2013_Nov_26_5(4)_1601-1618.nxml.txt.nlp	24287743	SENT202	0	0	14	14	crizotinib	Met	PA165946122	79811	0.961
NULL	Oncotarget_2013_Jul_21_4(8)_1253-1265.nxml.txt.nlp	23896512	SENT29	7	7	26	26	gefitinib	EGFR	PA131301952	1956	0.961
NULL	Indian_J_Pharmacol_2014_Sep-Oct_46(5)_549-550.nxml.txt.nlp	25298588	SENT19	8	8	22	22	warfarin	CYP2C9	PA451906	1559	0.961
NULL	Ann_Surg_Treat_Res_2014_Apr_25_86(4)_220-225.nxml.txt.nlp	24783183	SENT6	32	32	10	10	imatinib	KIT	PA10804	3815	0.961
NULL	Ann_Oncol_2013_Aug_12_24(8)_1994-1999.nxml.txt.nlp	23670096	SENT112	15	15	4	4	tamoxifen	AIB1	PA451581	8202	0.961
NULL	Int_J_Chron_Obstruct_Pulmon_Dis_2008_Jun_3(2)_217-229.nxml.txt.nlp	18686731	SENT194	26	26	18	18	methacholine	IL-5	PA165958382	3567	0.961
NULL	Nat_Commun_2014_5_3361.nxml.txt.nlp	24553445	SENT138	11	11	18	18	vorinostat	Hsp90	PA164748224	3320	0.961
NULL	J_Oncol_2012_Feb_6_2012_737981.nxml.txt.nlp	22481932	SENT142	31	31	6	6	carboplatin	ABCB1	PA448803	5243	0.961
NULL	Cancer_Metastasis_Rev_2014_Dec_28_33(1)_161-171.nxml.txt.nlp	24375389	SENT168	30	30	6	6	cisplatin	CHFR	PA449014	55743	0.961
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT190	5	5	12	12	procainamide	CYP3A4	PA451108	1576	0.961
NULL	Front_Pharmacol_2014_Oct_6_5_224.nxml.txt.nlp	25339904	SENT133	5	5	22	22	erlotinib	EGFR	PA134687924	1956	0.961
NULL	Oncotarget_2014_Oct_21_5(22)_11252-11268.nxml.txt.nlp	25361004	SENT235	35	35	29	29	metformin	CLIC1	PA450395	1192	0.961
NULL	Scientifica_(Cairo)_2013_Apr_17_2013_217513.nxml.txt.nlp	24278769	SENT234	16	16	3	3	geldanamycin	Hsp90	PA152031327	3320	0.961
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT82	10	10	22	22	cisplatin	XPA	PA449014	7507	0.961
NULL	Clin_Interv_Aging_2012_Sep_17_7_363-372.nxml.txt.nlp	23049248	SENT57	0	0	26	26	denosumab	RANKL	PA166048634	8600	0.961
NULL	Int_J_Mol_Sci_2014_Sep_29_15(10)_17411-17441.nxml.txt.nlp	25268615	SENT182	19	19	6	6	estradiol	CD147	PA449503	682	0.961
NULL	Biomed_Res_Int_2014_Apr_14_2014_209163.nxml.txt.nlp	24822183	SENT58	0	0	10	10	staurosporine	ZO-1	PA165109623	7082	0.961
NULL	Arthritis_Res_Ther_2009_Aug_27_11(4)_R130.nxml.txt.nlp	19709444	SENT117	21	21	2	2	nitroprusside	Bcl-2	PA451406	596	0.961
NULL	Toxins_(Basel)_2010_Oct_26_2(11)_2490-2518.nxml.txt.nlp	22069563	SENT186	28	28	14	14	cisplatin	p38	PA449014	10598;1432;7965	0.961
NULL	Arthritis_Res_Ther_2012_Aug_15_14(4)_R186.nxml.txt.nlp	22894827	SENT150	14	14	5	5	etanercept	ACTH	PA449515	5443	0.961
NULL	Cancer_Med_2013_Jun_2_2(3)_286-295.nxml.txt.nlp	23930205	SENT32	14	14	26	26	doxorubicin	EGFR	PA449412	1956	0.961
NULL	Cardiovasc_Diabetol_2013_Nov_12_12_169.nxml.txt.nlp	24215514	SENT307	6	6	13	13	valsartan	AT2	PA451848	186	0.961
NULL	Oxid_Med_Cell_Longev_2013_Nov_28_2013_568093.nxml.txt.nlp	24379901	SENT55	7	7	22	22	resveratrol	AMPK		5563	0.961
NULL	Neuro_Oncol_2010_Apr_27_12(4)_389-400.nxml.txt.nlp	20308316	SENT108	4	4	28	28	chloroquine	p53	PA448948	7157	0.961
NULL	J_Gen_Physiol_2000_Jun_1_115(6)_685-696.nxml.txt.nlp	10828243	SENT117	4	4	19	19	genistein	OLF	PA165109660	83857	0.961
NULL	Acta_Pharmacol_Sin_2014_Sep_25_35(9)_1199-1206.nxml.txt.nlp	25152024	SENT33	18	18	7	7	cisplatin	mig-2	PA449014	10979	0.961
NULL	Eur_J_Immunol_2013_Dec_9_43(12)_3183-3196.nxml.txt.nlp	24030559	SENT107	35	35	3	3	mitomycin	CD4	PA450524	920	0.961
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT122	23	23	14	14	pp2	PP2		4888	0.961
NULL	Clin_Med_Insights_Oncol_2013_May_20_7_87-102.nxml.txt.nlp	23761989	SENT192	0	0	19	19	lapatinib	EGFR	PA152241907	1956	0.961
NULL	Cell_Death_Dis_2012_Jun_21_3(6)_e330.nxml.txt.nlp	22717585	SENT328	19	19	0	0	simvastatin	ATG5	PA451363	9474	0.961
NULL	Oncoimmunology_2013_Jun_1_2(6)_e24677.nxml.txt.nlp	23894722	SENT108	43	43	2	2	cetuximab	HLA-A	PA10040	3105	0.961
NULL	Breast_Cancer_Res_2011_Jan_17_13(1)_R5.nxml.txt.nlp	21241485	SENT323	9	9	35	35	estradiol	NGF	PA449503	4803	0.961
NULL	Eur_J_Clin_Pharmacol_2014_Oct_8_70(1)_37-45.nxml.txt.nlp	24100471	SENT15	8	8	38	38	omeprazole	OATP1B1	PA450704	10599	0.961
NULL	Br_J_Cancer_2012_Aug_7_107(4)_592-597.nxml.txt.nlp	22805325	SENT138	0	0	7	7	imatinib	CYP2D6	PA10804	1565	0.961
NULL	Cancers_(Basel)_2012_May_8_4(2)_523-530.nxml.txt.nlp	24213322	SENT19	22	22	9	9	erlotinib	EGFR	PA134687924	1956	0.961
NULL	J_Cell_Mol_Med_2014_May_14_18(5)_811-823.nxml.txt.nlp	24628949	SENT266	10	10	4	4	docetaxel	FOXM1	PA449383	2305	0.961
NULL	Front_Synaptic_Neurosci_2010_Feb_22_2_1.nxml.txt.nlp	21423487	SENT106	31	31	16	16	picrotoxin	CA3	PA164777007	761	0.961
NULL	Diabetes_Metab_Syndr_Obes_2009_May_18_2_37-49.nxml.txt.nlp	20148188	SENT86	0	0	3	3	liraglutide	GLP-1	PA165958364	100125288	0.961
NULL	Hum_Genomics_2010_Apr_1_4(4)_238-249.nxml.txt.nlp	20511137	SENT85	0	0	14	14	raltegravir	UGT1A1		54658	0.961
NULL	Pak_J_Med_Sci_2013_Jan-Mar_29(1)_97-102.nxml.txt.nlp	24353516	SENT5	2	2	11	11	clopidogrel	ADP	PA449053	23038	0.961
NULL	F1000_Med_Rep_2012_Feb_1_4_4.nxml.txt.nlp	22312414	SENT171	8	8	22	22	vancomycin	VISA	PA451850	57506	0.961
NULL	Eur_J_Endocrinol_2014_Mar_170(3)_451-459.nxml.txt.nlp	24362411	SENT35	0	0	17	17	liraglutide	GLP1	PA165958364	100125288;2641	0.961
NULL	Breast_Cancer_Res_2005_Jul_20_7(5)_205-211.nxml.txt.nlp	16168139	SENT123	18	18	6	6	tamoxifen	EGF	PA451581	1950	0.961
NULL	Mol_Vis_2011_Aug_11_17_2157-2170.nxml.txt.nlp	21850191	SENT224	17	17	7	7	tacrolimus	Bp50	PA451578	958	0.961
NULL	Evid_Based_Complement_Alternat_Med_2013_Aug_22_2013_423164.nxml.txt.nlp	24027594	SENT238	16	16	26	26	berberine	AP-1	PA165860812	2353;3727;2354;3725	0.961
NULL	Cell_Cycle_2012_Aug_15_11(16)_3067-3078.nxml.txt.nlp	22871739	SENT116	41	41	4	4	cisplatin	E2F1	PA449014	1869	0.961
NULL	Br_J_Cancer_2009_May_5_100(9)_1425-1433.nxml.txt.nlp	19401701	SENT75	4	4	10	10	curcumin	ANOVA	PA151958596	4858	0.961
NULL	Cell_Death_Dis_2014_Feb_13_5(2)_e1055.nxml.txt.nlp	24525731	SENT136	8	8	12	12	irinotecan	XRCC1	PA450085	7515	0.961
NULL	Case_Rep_Transplant_2014_Jan_2_2014_548243.nxml.txt.nlp	24575309	SENT25	0	0	5	5	sirolimus	CYP3A4	PA451365	1576	0.961
NULL	Diabetol_Metab_Syndr_2014_May_18_6_56.nxml.txt.nlp	24860622	SENT165	8	8	26	26	amlodipine	adiponectin	PA448388	9370	0.961
NULL	Mol_Biol_Rep_2013_Jul_11_40(7)_4211-4217.nxml.txt.nlp	23666051	SENT119	2	2	11	11	montelukast	OATP2B1	PA450546	11309	0.961
NULL	J_Adv_Pract_Oncol_2013_Sep_1_Sep-Oct_4(5)_348-352.nxml.txt.nlp	25032013	SENT15	12	12	28	28	cetuximab	KRAS	PA10040	3845	0.961
NULL	Eur_J_Clin_Pharmacol_2011_May_8_67(5)_493-506.nxml.txt.nlp	21140139	SENT258	0	0	7	7	oxymorphone	CYP2D6	PA450748	1565	0.961
NULL	Trials_2014_May_1_15_151.nxml.txt.nlp	24885437	SENT22	0	0	6	6	ticagrelor	P2Y12	PA165374673	64805	0.961
NULL	Arch_Med_Sci_2012_May_9_8(2)_227-235.nxml.txt.nlp	22661994	SENT3	0	0	24	24	trastuzumab	HER2	PA451743	2064	0.961
NULL	Cancers_(Basel)_2013_Aug_14_5(3)_1020-1048.nxml.txt.nlp	24202332	SENT310	4	4	25	25	bromocriptine	zeta	PA448671	9907	0.961
NULL	Case_Rep_Oncol_2013_May_14_6(2)_263-268.nxml.txt.nlp	23741221	SENT22	8	8	1	1	erlotinib	EGFR	PA134687924	1956	0.961
NULL	Cancer_Med_2013_Aug_2_2(4)_571-582.nxml.txt.nlp	24156030	SENT232	0	0	8	8	curcumin	IL-6	PA151958596	3569	0.961
NULL	Aging_(Albany_NY)_2011_Jan_18_3(1)_33-43.nxml.txt.nlp	21248371	SENT123	20	20	13	13	zinc	HIF-1	PA451956	29072	0.961
NULL	Exp_Ther_Med_2014_Nov_17_8(5)_1484-1488.nxml.txt.nlp	25289046	SENT53	10	10	18	18	cisplatin	ECRG2	PA449014	84651	0.961
NULL	Sensors_(Basel)_2012_Apr_20_12(4)_5170-5194.nxml.txt.nlp	22666081	SENT113	4	4	30	30	ethanol	IPA	PA448073	3160	0.961
NULL	Cancers_(Basel)_2010_Sep_17_2(3)_1717-1730.nxml.txt.nlp	24281184	SENT148	12	12	9	9	capecitabine	DPD	PA448771	1806	0.961
NULL	Nat_Chem_Biol_2009_Apr_8_5(4)_251-257.nxml.txt.nlp	19270684	SENT29	18	18	0	0	s-adenosylmethionine	MTAP	PA164754994	4507	0.961
NULL	Arthritis_Res_Ther_2005_Jan_12_7(2)_R256-R267.nxml.txt.nlp	15743472	SENT100	25	25	1	1	levamisole	CCR7	PA450205	1236	0.961
NULL	Cancer_Res_Treat_2011_Dec_27_43(4)_212-216.nxml.txt.nlp	22247705	SENT39	24	24	47	47	docetaxel	EGFR	PA449383	1956	0.961
NULL	Indian_J_Pharm_Sci_2013_Jan-Feb_75(1)_31-35.nxml.txt.nlp	23901158	SENT49	23	23	5	5	cefpodoxime	DCX	PA164746385	1641	0.961
NULL	Ther_Clin_Risk_Manag_2006_Mar_2(1)_77-86.nxml.txt.nlp	18360583	SENT110	10	10	30	30	alendronate	PTH	PA448082	5741	0.961
NULL	Ther_Clin_Risk_Manag_2005_Dec_1(4)_299-306.nxml.txt.nlp	18360572	SENT76	22	22	4	4	itraconazole	CYP3A4	PA450132	1576	0.961
NULL	Oncotarget_2013_Jun_4_4(5)_772-784.nxml.txt.nlp	23800712	SENT125	45	45	4	4	erlotinib	EGFR	PA134687924	1956	0.961
NULL	F1000Prime_Rep_2014_Dec_1_6_117.nxml.txt.nlp	25580271	SENT66	17	17	3	3	cisplatin	EGFR	PA449014	1956	0.961
NULL	Breast_Cancer_Res_2004_Oct_6_6(6)_269-274.nxml.txt.nlp	15535858	SENT81	8	8	21	21	tamoxifen	pS2	PA451581	7031	0.961
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT117	4	4	15	15	resveratrol	TRAIL		8743	0.961
NULL	Int_J_Gen_Med_2009_Jul_30_2_91-108.nxml.txt.nlp	20360893	SENT196	28	28	2	2	etoposide	PC-3	PA449552	692094	0.961
NULL	Front_Hum_Neurosci_2013_Apr_9_7_136.nxml.txt.nlp	23576977	SENT26	8	8	12	12	propofol	spatial	PA451141	219793	0.961
NULL	Chin_J_Cancer_2011_Oct_30(10)_701-711.nxml.txt.nlp	21959047	SENT35	20	20	1	1	cetuximab	EGFR	PA10040	1956	0.961
NULL	Br_J_Cancer_2009_Jul_21_101(2)_269-277.nxml.txt.nlp	19603033	SENT152	8	8	22	22	cisplatin	XIAP	PA449014	331	0.961
NULL	Oncotarget_2013_Apr_13_4(4)_502-530.nxml.txt.nlp	23594434	SENT511	18	18	25	25	disulfiram	IL-18	PA449376	3606	0.961
NULL	J_Cancer_2013_Sep_27_4(8)_662-670.nxml.txt.nlp	24155778	SENT203	19	19	2	2	cisplatin	UCHL1	PA449014	7345	0.961
NULL	J_Headache_Pain_2009_Apr_27_10(2)_105-110.nxml.txt.nlp	19172228	SENT108	5	5	8	8	indomethacin	COX	PA449982	1351	0.961
NULL	Eur_J_Clin_Pharmacol_2012_May_21_68(5)_553-560.nxml.txt.nlp	22189672	SENT197	9	9	35	35	alprazolam	CYP2D6	PA448333	1565	0.961
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT120	29	29	7	7	pp2	PP2		4888	0.961
NULL	Cancer_Res_Treat_2014_Jan_15_46(1)_55-64.nxml.txt.nlp	24520224	SENT166	9	9	2	2	irinotecan	ERCC1	PA450085	2067	0.961
NULL	Pharmaceuticals_(Basel)_2013_Nov_11_6(11)_1429-1450.nxml.txt.nlp	24287465	SENT278	32	32	36	36	vismodegib	SMO		6608;54498	0.961
NULL	Mol_Cell_Proteomics_2013_Aug_14_12(8)_2313-2323.nxml.txt.nlp	23674616	SENT202	29	29	5	5	levamisole	ALPL	PA450205	249	0.961
NULL	Autoimmune_Dis_2013_Aug_28_2013_613086.nxml.txt.nlp	24069534	SENT144	5	5	19	19	ustekinumab	p40	PA166048654	3921;339541;10314	0.961
NULL	Indian_J_Dermatol_2010_Apr-Jun_55(2)_157-160.nxml.txt.nlp	20606886	SENT74	20	20	9	9	cyclosporine	ZAP70	PA449167	7535	0.961
NULL	F1000_Med_Rep_2009_Dec_15_1_96.nxml.txt.nlp	20948681	SENT68	0	0	6	6	denosumab	RANKL	PA166048634	8600	0.961
NULL	Biomed_Res_Int_2014_Feb_6_2014_323594.nxml.txt.nlp	24689036	SENT195	10	10	21	21	raloxifene	PC3	PA451221	57332;7832;5122	0.961
NULL	Sci_Rep_2014_Dec_15_4_7490.nxml.txt.nlp	25502402	SENT7	0	0	15	15	cetuximab	EGFR	PA10040	1956	0.961
NULL	Cancer_2014_Jan_15_120(2)_229-237.nxml.txt.nlp	24122122	SENT84	30	30	7	7	sorafenib	SHARP	PA7000	23013	0.961
NULL	Oncotarget_2011_Dec_31_2(12)_1314-1321.nxml.txt.nlp	22248929	SENT62	36	36	28	28	lapatinib	HER3	PA152241907	2065	0.961
NULL	Onco_Targets_Ther_2014_Sep_23_7_1653-1661.nxml.txt.nlp	25285015	SENT117	32	32	7	7	sn-38	UGT1A1		54658	0.961
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Feb_24_68(Pt_3)_o792-o793.nxml.txt.nlp	22412664	SENT11	17	17	4	4	deferasirox	mol	PA164760843	90527	0.961
NULL	Cardiovasc_Diabetol_2005_Oct_5_4_16.nxml.txt.nlp	16207378	SENT163	4	4	22	22	glucosamine	perlecan	PA164747613	3339	0.961
NULL	Evid_Based_Complement_Alternat_Med_2012_Feb_16_2012_430262.nxml.txt.nlp	22454664	SENT109	27	27	0	0	diazepam	CYP2C19	PA449283	1557	0.961
NULL	Acta_Pharmacol_Sin_2013_Sep_5_34(9)_1192-1200.nxml.txt.nlp	23685957	SENT133	15	15	5	5	curcumin	AP-2	PA151958596	7020	0.961
NULL	Breast_Cancer_Res_Treat_2012_Aug_5_134(3)_1149-1159.nxml.txt.nlp	22763464	SENT200	4	4	21	21	cetuximab	EGFR	PA10040	1956	0.961
NULL	Cells_2014_Sep_12_3(3)_914-938.nxml.txt.nlp	25222270	SENT85	18	18	32	32	capsaicin	TRPM1	PA448776	4308	0.961
NULL	Mol_Cancer_2010_Aug_20_9_220.nxml.txt.nlp	20727180	SENT217	20	20	2	2	nicotine	p53	PA450626	7157	0.961
NULL	Eur_J_Med_Res_2009_Dec_7_14(Suppl_4)_32-37.nxml.txt.nlp	20156721	SENT71	16	16	22	22	ketanserin	ANOVA	PA131053734	4858	0.961
NULL	Ther_Clin_Risk_Manag_2005_Mar_1(1)_3-13.nxml.txt.nlp	18360537	SENT61	24	24	12	12	diltiazem	CYP3A4	PA449334	1576	0.961
NULL	Curr_Health_Sci_J_2010_Mar_24_Jan-Mar_36(1)_42-49.nxml.txt.nlp	24778826	SENT4	10	10	14	14	nimesulide	BCS	PA137179528	617	0.961
NULL	Cancer_Med_2013_Dec_31_2(6)_826-835.nxml.txt.nlp	24403256	SENT181	17	17	15	15	nutlin-3	HDM2		4193	0.961
NULL	J_Cardiothorac_Surg_2012_Sep_27_7_97.nxml.txt.nlp	23013706	SENT163	29	29	4	4	warfarin	CYP4F2	PA451906	8529	0.961
NULL	Biomed_Res_Int_2014_Apr_13_2014_738625.nxml.txt.nlp	24822215	SENT164	26	26	6	6	montelukast	IL-13	PA450546	3596	0.961
NULL	Oncogene_2014_Jul_3_33(27)_3571-3582.nxml.txt.nlp	23934191	SENT159	18	18	5	5	bevacizumab	LIMK	PA130232992	3984	0.961
NULL	J_Lipid_Res_2012_Aug_53(8)_1459-1471.nxml.txt.nlp	22628619	SENT321	21	21	17	17	celecoxib	DEGS1	PA448871	8560	0.961
NULL	Acta_Neuropathol_Commun_2014_May_30_2_57.nxml.txt.nlp	24887326	SENT77	34	34	2	2	vardenafil	ABCB1	PA10229	5243	0.961
NULL	Blood_Res_2013_Mar_25_48(1)_35-39.nxml.txt.nlp	23589793	SENT80	15	15	23	23	bortezomib	CD4	PA10252	920	0.961
NULL	Comput_Struct_Biotechnol_J_2012_Oct_31_3_e201210005.nxml.txt.nlp	24688665	SENT144	28	28	3	3	ethanol	PDH	PA448073	54704	0.961
NULL	EMBO_Mol_Med_2011_May_3(5)_266-278.nxml.txt.nlp	21438154	SENT125	36	36	10	10	oxaliplatin	TRPA1	PA131285527	8989	0.961
NULL	J_Cell_Biol_2002_Jun_10_157(6)_1017-1028.nxml.txt.nlp	12058017	SENT156	28	28	10	10	lovastatin	HAC1	PA450272	10612	0.961
NULL	Indian_J_Endocrinol_Metab_2013_Jul-Aug_17(4)_636-646.nxml.txt.nlp	23961479	SENT247	4	4	21	21	atorvastatin	SGS	PA448500	2200	0.961
NULL	Arch_Med_Sci_2013_Jun_20_9(3)_472-478.nxml.txt.nlp	23847669	SENT29	11	11	6	6	letrozole	aromatase	PA450196	1588	0.961
NULL	Braz_J_Med_Biol_Res_2014_Feb_17_47(2)_101-109.nxml.txt.nlp	24519125	SENT130	7	7	22	22	phentolamine	IL-6	PA450926	3569	0.961
NULL	Open_Ophthalmol_J_2013_Feb_1_7_4-10.nxml.txt.nlp	23459241	SENT112	0	0	43	43	ranibizumab	VEGF-A	PA164746012	7422	0.961
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT268	0	0	19	19	tenofovir	SLC22A6	PA10204	9356	0.96
NULL	Breast_Cancer_Res_2013_Sep_26_15(5)_211.nxml.txt.nlp	24090167	SENT141	35	35	4	4	tamoxifen	CCND1	PA451581	595	0.96
NULL	J_RNAi_Gene_Silencing_2009_Mar_9_5(1)_321-330.nxml.txt.nlp	19771229	SENT229	18	18	2	2	gemcitabine	RRM1	PA449748	6240	0.96
NULL	Oncotarget_2014_Oct_16_5(22)_11442-11451.nxml.txt.nlp	25347345	SENT87	10	10	2	2	oxaliplatin	CT26	PA131285527	168400	0.96
NULL	Cough_2006_Mar_30_2_2.nxml.txt.nlp	16623933	SENT151	5	5	12	12	capsaicin	TRPV1	PA448776	7442	0.96
NULL	Sci_Rep_2014_Dec_15_4_7490.nxml.txt.nlp	25502402	SENT26	14	14	1	1	cetuximab	EGFR	PA10040	1956	0.96
NULL	BMB_Rep_2013_Feb_46(2)_92-96.nxml.txt.nlp	23433111	SENT40	11	11	2	2	etoposide	BRCA1	PA449552	672	0.96
NULL	J_Cell_Biol_2005_Jul_4_170(1)_49-59.nxml.txt.nlp	15983061	SENT145	48	48	31	31	forskolin	MITF	PA146096022	4286	0.96
NULL	Clin_Transl_Allergy_2013_Sep_2_3_29.nxml.txt.nlp	24004581	SENT190	5	5	31	31	omalizumab	IL-8	PA164752253	3576	0.96
NULL	Curr_Pharm_Biotechnol_2012_May_13(6)_969-986.nxml.txt.nlp	22039792	SENT177	28	28	12	12	ivermectin	P-gp	PA450133	5243	0.96
NULL	Front_Oncol_2014_Sep_3_4_221.nxml.txt.nlp	25232533	SENT196	12	12	44	44	anastrozole	aromatase	PA448432	1588	0.96
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT269	5	5	17	17	tacrolimus	SOCS3	PA451578	9021	0.96
NULL	Cardiovasc_Drugs_Ther_2012_Oct_12_26(5)_417-426.nxml.txt.nlp	22968678	SENT47	3	3	17	17	metformin	AMPK	PA450395	5563	0.96
NULL	Indian_J_Pharmacol_2014_Mar-Apr_46(2)_230-231.nxml.txt.nlp	24741201	SENT18	21	21	7	7	lamivudine	CD4	PA450163	920	0.96
NULL	Eur_J_Clin_Pharmacol_2012_Jan_7_68(1)_55-64.nxml.txt.nlp	21735164	SENT19	27	27	0	0	oxycodone	CYP2D6	PA450741	1565	0.96
NULL	J_Clin_Biochem_Nutr_2009_Jan_27_44(1)_79-84.nxml.txt.nlp	19177192	SENT84	22	22	13	13	curcumin	HO-1	PA151958596	3162	0.96
NULL	Pharmaceuticals_(Basel)_2012_Nov_20_5(11)_1236-1264.nxml.txt.nlp	24281308	SENT183	18	18	16	16	ekb-569	EGFR		1956	0.96
NULL	Arthritis_Rheum_2011_Oct_63(10)_2854-2864.nxml.txt.nlp	21618201	SENT61	13	13	24	24	abatacept	ACR	PA164747080	49	0.96
NULL	Exp_Brain_Res_2014_Jun_27_232(8)_2637-2644.nxml.txt.nlp	24969614	SENT148	7	7	23	23	palonosetron	NK1	PA10352	11126	0.96
NULL	Mol_Cell_Proteomics_2012_Jan_3_11(1)_M111_011445.nxml.txt.nlp	22338125	SENT215	9	9	21	21	trypsin	MS2	PA451806	101	0.96
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT127	9	9	0	0	curcumin	PC-3	PA151958596	692094	0.96
NULL	Br_J_Cancer_2010_Jan_19_102(2)_268-275.nxml.txt.nlp	20010948	SENT7	41	41	7	7	sorafenib	CD133	PA7000	8842	0.96
NULL	Arthritis_Res_Ther_2009_Nov_4_11(6)_R165.nxml.txt.nlp	19889203	SENT355	4	4	29	29	resveratrol	TRAF1		7185	0.96
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S279-S284.nxml.txt.nlp	21525469	SENT53	0	0	3	3	liraglutide	GLP-1	PA165958364	100125288	0.96
NULL	Extremophiles_2009_Nov_23_13(6)_885-894.nxml.txt.nlp	19701714	SENT133	29	29	33	33	ethanol	mol	PA448073	90527	0.96
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_16_2014_926087.nxml.txt.nlp	25478000	SENT222	7	7	1	1	atorvastatin	PCSK9	PA448500	255738	0.96
NULL	Tuberc_Res_Treat_2014_Apr_16_2014_753492.nxml.txt.nlp	24834351	SENT7	24	24	0	0	ethambutol	DST	PA164784021	667	0.96
NULL	Br_J_Cancer_2011_Mar_1_104(5)_750-755.nxml.txt.nlp	21326243	SENT141	37	37	18	18	dacarbazine	PARP-1	PA449197	25976	0.96
NULL	J_Oncol_2009_Nov_12_2009_457418.nxml.txt.nlp	19920864	SENT78	5	5	21	21	paclitaxel	p53	PA450761	7157	0.96
NULL	Breast_Cancer_Res_2002_Jun_21_4(5)_R9.nxml.txt.nlp	12223126	SENT116	4	4	38	38	tamoxifen	FasL	PA451581	356	0.96
NULL	Clin_Drug_Investig_2013_Apr_20_33(4)_243-254.nxml.txt.nlp	23512639	SENT41	0	0	20	20	venlafaxine	CYP2D6	PA451866	1565	0.96
NULL	Case_Rep_Med_2011_Jul_31_2011_145856.nxml.txt.nlp	21811505	SENT17	9	9	34	34	vasopressin	AVP	PA451858	114548;551	0.96
NULL	J_Indian_Assoc_Pediatr_Surg_2012_Apr-Jun_17(2)_84-86.nxml.txt.nlp	22529558	SENT83	10	10	40	40	doxorubicin	FDG	PA449412	23583	0.96
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT319	20	20	3	3	cisplatin	DR5	PA449014	8795	0.96
NULL	Eur_J_Neurosci_2014_Jul_27_40(1)_2311-2319.nxml.txt.nlp	24674448	SENT204	11	11	23	23	dexmedetomidine	CYP2D	PA449256	1565	0.96
NULL	Acta_Pharmacol_Sin_2013_Jan_5_34(1)_24-32.nxml.txt.nlp	23123646	SENT56	17	17	0	0	glibenclamide	SUR1	PA449782	6833	0.96
NULL	Exp_Anim_2014_Aug_22_63(3)_289-296.nxml.txt.nlp	25077758	SENT183	11	11	6	6	rituximab	LPL	PA451261	4023	0.96
NULL	Acta_Histochem_Cytochem_2012_Apr_26_45(2)_139-146.nxml.txt.nlp	22685356	SENT107	21	21	26	26	forskolin	AQP2	PA146096022	359	0.96
NULL	Oncoimmunology_2012_Aug_1_1(5)_726-734.nxml.txt.nlp	22934264	SENT63	39	39	42	42	imiquimod	TLR7	PA449972	51284	0.96
NULL	Br_J_Pharmacol_2014_May_171(10)_2659-2670.nxml.txt.nlp	24116661	SENT17	23	23	27	27	naringenin	TRPP2	PA151958361	5311	0.96
NULL	Breast_Cancer_Res_2007_Oct_26_9(5)_R74.nxml.txt.nlp	17963511	SENT30	35	35	15	15	trastuzumab	HER2	PA451743	2064	0.96
NULL	Front_Immunol_2012_Jul_20_3_212.nxml.txt.nlp	22833744	SENT141	18	18	31	31	cyclophosphamide	CTX	PA449165	1593	0.96
NULL	Br_J_Cancer_1977_Feb_35(2)_179-189.nxml.txt.nlp	319818	SENT6	21	21	0	0	ethanol	CEA	PA448073	5670;1087	0.96
NULL	Front_Zool_2011_Nov_29_8_31.nxml.txt.nlp	22126599	SENT129	33	33	9	9	pp2	PP1		5540;5464	0.96
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT110	3	3	30	30	perifosine	TRAIL	PA165291471	8743	0.96
NULL	Indian_J_Med_Res_2013_Oct_138(4)_461-491.nxml.txt.nlp	24434254	SENT449	37	37	30	30	pravastatin	2A9	PA451089	6277	0.96
NULL	Behav_Brain_Funct_2012_Feb_28_8_11.nxml.txt.nlp	22369141	SENT37	15	15	9	9	olanzapine	GHRL	PA450688	51738	0.96
NULL	Indian_J_Pharmacol_2008_Oct_40(Suppl_2)_S66-S91.nxml.txt.nlp	21593982	SENT818	31	31	8	8	proguanil	CYP2C19	PA451124	1557	0.96
NULL	Br_J_Cancer_2012_Jun_5_106(12)_1997-2003.nxml.txt.nlp	22596232	SENT145	20	20	13	13	sorafenib	CD31	PA7000	5175	0.96
NULL	Pharm_Methods_2011_Jul-Sep_2(3)_173-177.nxml.txt.nlp	23781451	SENT35	0	0	8	8	prasugrel	MSN	PA154410481	4478	0.96
NULL	Clin_Med_Insights_Cardiol_2011_Oct_6_5_103-119.nxml.txt.nlp	22084608	SENT40	0	0	22	22	dronedarone	CYP3A4	PA153619853	1576	0.96
NULL	AIDS_Res_Treat_2011_Jul_25_2011_743597.nxml.txt.nlp	21804938	SENT23	29	29	7	7	lamivudine	CD4	PA450163	920	0.96
NULL	Nat_Commun_2013_Sep_17_4_2464.nxml.txt.nlp	24043118	SENT43	1	1	19	19	estradiol	FGFR2	PA449503	2263	0.96
NULL	Indian_J_Psychiatry_2003_Jul-Sep_45(3)_151-154.nxml.txt.nlp	21206845	SENT8	12	12	45	45	olanzapine	DAI	PA450688	81030	0.96
NULL	Exp_Ther_Med_2013_Aug_22_6(2)_419-422.nxml.txt.nlp	24137201	SENT86	0	0	43	43	diclofenac	PGF	PA449293	5228	0.96
NULL	Clin_Endosc_2014_Mar_31_47(2)_141-150.nxml.txt.nlp	24765596	SENT66	19	19	2	2	propofol	ACLS	PA451141	46;2737	0.96
NULL	Mol_Biol_Cell_2014_Jan_1_25(1)_76-86.nxml.txt.nlp	24173717	SENT41	21	21	0	0	paclitaxel	TUBB6	PA450761	84617	0.96
NULL	Br_J_Cancer_2010_Sep_28_103(7)_1008-1018.nxml.txt.nlp	20736947	SENT146	8	8	2	2	docetaxel	CD147	PA449383	682	0.96
NULL	Hum_Mol_Genet_2013_Nov_15_22(22)_4616-4626.nxml.txt.nlp	23814041	SENT142	4	4	27	27	doxycycline	SREBP2	PA449415	6721	0.96
NULL	Cancer_Res_Treat_2012_Mar_31_44(1)_1-10.nxml.txt.nlp	22500155	SENT29	8	8	18	18	imatinib	BRAF	PA10804	673	0.96
NULL	J_Clin_Exp_Pathol_2012_May_17_Suppl_4_7327.nxml.txt.nlp	25379357	SENT143	6	6	26	26	metformin	SIRT1	PA450395	23411	0.96
NULL	Front_Neurol_2012_Aug_1_3_120.nxml.txt.nlp	23015798	SENT103	3	3	24	24	isoflurane	RhoA	PA450106	387	0.96
NULL	Br_J_Pharmacol_2008_Sep_9_155(1)_127-137.nxml.txt.nlp	18536750	SENT197	36	36	31	31	piroxicam	IL-10	PA450985	3586	0.96
NULL	Breast_Cancer_(Auckl)_2009_Sep_2_3_61-75.nxml.txt.nlp	19809577	SENT268	7	7	38	38	ethanol	PARP	PA448073	142	0.96
NULL	Arch_Drug_Inf_2008_Jul_1(1)_14-22.nxml.txt.nlp	20157364	SENT165	16	16	7	7	pravastatin	MCP-1	PA451089	6347	0.96
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1059-1066.nxml.txt.nlp	21364577	SENT51	8	8	19	19	letrozole	aromatase	PA450196	1588	0.96
NULL	Clin_Med_Insights_Oncol_2012_Jun_7_6_243-252.nxml.txt.nlp	22723734	SENT159	14	14	10	10	erlotinib	EGFR	PA134687924	1956	0.96
NULL	Br_J_Cancer_2011_Feb_15_104(4)_559-563.nxml.txt.nlp	21285992	SENT61	13	13	15	15	tamoxifen	aromatase	PA451581	1588	0.96
NULL	Alzheimers_Res_Ther_2012_Mar_1_4(2)_7.nxml.txt.nlp	22380508	SENT124	26	26	6	6	resveratrol	B12		7126;4709	0.96
NULL	J_Biomed_Sci_2014_Apr_29_21(1)_35.nxml.txt.nlp	24780003	SENT36	0	0	4	4	bevacizumab	NIRF	PA130232992	27190;115426	0.96
NULL	Case_Rep_Endocrinol_2015_Jan_5_2015_268714.nxml.txt.nlp	25628901	SENT67	6	6	21	21	thyroglobulin	TTF-1	PA164754910	7080	0.96
NULL	Cancer_Manag_Res_2014_Jun_20_6_279-289.nxml.txt.nlp	25018651	SENT94	7	7	19	19	vemurafenib	BRAF	PA165946873	673	0.96
NULL	Biosci_Rep_2014_Dec_12_34(6)_e00160.nxml.txt.nlp	25495645	SENT170	21	21	4	4	rosiglitazone	ANGPTL3	PA451283	27329	0.96
NULL	Genetics_2013_Jan_193(1)_1-50.nxml.txt.nlp	23275493	SENT410	23	23	3	3	lipase	ATGL	PA450239	57104	0.96
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT385	29	29	37	37	quetiapine	PRL	PA451201	5617	0.96
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT188	7	7	14	14	gefitinib	EGFR	PA131301952	1956	0.96
NULL	J_Skin_Cancer_2011_Nov_17_2011_423239.nxml.txt.nlp	22175026	SENT88	8	8	29	29	sorafenib	BRAF	PA7000	673	0.96
NULL	Int_J_Environ_Res_Public_Health_2011_Mar_1_8(3)_683-697.nxml.txt.nlp	21556173	SENT68	0	0	25	25	sunitinib	C-Kit	PA162372840	3815	0.96
NULL	J_Biol_Chem_2013_Dec_6_288(49)_35387-35395.nxml.txt.nlp	24142790	SENT258	13	13	20	20	meclizine	PCYT2	PA450338	5833	0.96
NULL	Breast_Cancer_Res_Treat_2012_Jun_15_133(3)_1057-1065.nxml.txt.nlp	22418700	SENT34	2	2	33	33	afatinib	HER2	PA165981154	2064	0.96
NULL	Arthritis_Res_Ther_2009_Nov_9_11(6)_R167.nxml.txt.nlp	19900268	SENT36	27	27	2	2	infliximab	IL-17	PA452639	3605	0.96
NULL	Viruses_2013_Mar_21_5(3)_902-927.nxml.txt.nlp	23518577	SENT255	6	6	26	26	vorinostat	7SK	PA164748224	125050	0.96
NULL	Front_Oncol_2013_Sep_9_3_235.nxml.txt.nlp	24058902	SENT61	23	23	15	15	erlotinib	EGFR	PA134687924	1956	0.96
NULL	Breast_Cancer_Res_2011_Jan_17_13(1)_R5.nxml.txt.nlp	21241485	SENT323	28	28	6	6	tamoxifen	EGF	PA451581	1950	0.96
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT42	0	0	20	20	bevacizumab	VEGF-A	PA130232992	7422	0.96
NULL	Biomed_Res_Int_2013_Aug_6_2013_602987.nxml.txt.nlp	24027759	SENT274	12	12	18	18	paclitaxel	SMF	PA450761	22993	0.96
NULL	Case_Rep_Oncol_Med_2013_Jan_28_2013_154674.nxml.txt.nlp	23424693	SENT4	37	37	20	20	trastuzumab	HER2	PA451743	2064	0.96
NULL	Hematol_Rep_2014_Feb_5_6(1)_5159.nxml.txt.nlp	24711918	SENT45	15	15	12	12	anastrozole	aromatase	PA448432	1588	0.96
NULL	Br_J_Cancer_2003_Mar_10_88(5)_754-759.nxml.txt.nlp	12618886	SENT69	20	20	9	9	amifostine	p53	PA448365	7157	0.96
NULL	Br_J_Cancer_2013_Apr_16_108(7)_1408-1414.nxml.txt.nlp	23511562	SENT44	27	27	21	21	tamoxifen	aromatase	PA451581	1588	0.96
NULL	Indian_J_Occup_Environ_Med_2012_Sep-Dec_16(3)_101-107.nxml.txt.nlp	23776317	SENT136	6	6	22	22	hemin	HO-1	PA449849	3162	0.96
NULL	J_Breast_Cancer_2013_Jun_28_16(2)_220-228.nxml.txt.nlp	23843857	SENT120	20	20	23	23	tamoxifen	aromatase	PA451581	1588	0.96
NULL	Core_Evid_2009_Jun_15_4_83-92.nxml.txt.nlp	20694067	SENT73	22	22	14	14	clarithromycin	CYP3A4	PA449028	1576	0.96
NULL	J_Gastrointest_Cancer_2013_Aug_7_44(4)_385-392.nxml.txt.nlp	23921604	SENT149	25	25	14	14	imatinib	BSC	PA10804	6558	0.96
NULL	Adv_Hematol_2012_Feb_28_2012_843085.nxml.txt.nlp	22505939	SENT102	12	12	5	5	perifosine	AKT	PA165291471	207	0.96
NULL	Front_Pharmacol_2014_May_9_5_98.nxml.txt.nlp	24847268	SENT78	11	11	25	25	pseudoephedrine	ANOVA	PA451170	4858	0.96
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_16_2012_395912.nxml.txt.nlp	23118789	SENT75	29	29	1	1	phenylbutazone	UGT	PA450932	7361;7355	0.96
NULL	Eur_J_Immunol_2013_Apr_13_43(4)_889-896.nxml.txt.nlp	23310952	SENT36	8	8	14	14	metformin	AMPK	PA450395	5563	0.96
NULL	Acta_Pharmacol_Sin_2009_Dec_4_30(12)_1585-1593.nxml.txt.nlp	19960004	SENT68	30	30	14	14	prazosin	mol	PA451093	90527	0.96
NULL	Anal_Bioanal_Chem_2012_Mar_29_402(7)_2267-2274.nxml.txt.nlp	22038587	SENT30	0	0	19	19	creatine	spatial	PA164778930	219793	0.96
NULL	Cell_Cycle_2012_Dec_1_11(23)_4300.nxml.txt.nlp	23159861	SENT10	33	33	28	28	imatinib	CML	PA10804	613	0.96
NULL	Br_J_Cancer_2013_Jan_15_108(1)_170-178.nxml.txt.nlp	23321518	SENT191	28	28	19	19	bortezomib	PDK1	PA10252	5170;5163	0.96
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT373	7	7	29	29	acetaminophen	TLR9	PA448015	54106	0.96
NULL	Cancer_Med_2013_Jun_25_2(3)_277-285.nxml.txt.nlp	23930204	SENT51	7	7	3	3	bevacizumab	PTEN	PA130232992	5728	0.96
NULL	Ann_Gen_Psychiatry_2010_Apr_22_9(Suppl_1)_S83.nxml.txt.nlp	NULL	SENT4	14	14	0	0	forskolin	AC5	PA146096022	111	0.96
NULL	Chin_J_Cancer_2012_Feb_31(2)_58-72.nxml.txt.nlp	22098952	SENT222	39	39	25	25	teniposide	MRP6	PA451611	368;6283	0.96
NULL	AIDS_Res_Ther_2013_Jun_7_10_15.nxml.txt.nlp	23758814	SENT2	7	7	27	27	maraviroc	CCR5	PA164768835	1234	0.96
NULL	Arch_Med_Sci_2014_Aug_29_10(4)_684-691.nxml.txt.nlp	25276151	SENT157	18	18	41	41	dobutamine	CRT	PA449381	811	0.96
NULL	J_Lipid_Res_2013_Feb_54(2)_425-435.nxml.txt.nlp	23220585	SENT165	18	18	3	3	tyloxapol	ATGL	PA164743726	57104	0.96
NULL	Ann_Surg_Oncol_2010_Apr_20_17(4)_1168-1176.nxml.txt.nlp	19936839	SENT104	23	23	9	9	bevacizumab	KRAS	PA130232992	3845	0.96
NULL	Oncol_Lett_2014_Nov_12_8(5)_2203-2208.nxml.txt.nlp	25295109	SENT111	37	37	12	12	celecoxib	PTCH1	PA448871	5727	0.96
NULL	Cancer_Cell_Int_2014_Jun_11_14_49.nxml.txt.nlp	24991192	SENT73	33	33	21	21	berberine	AMPK	PA165860812	5563	0.96
NULL	Cancer_Immunol_Immunother_2011_Jun_25_60(6)_793-808.nxml.txt.nlp	21350947	SENT207	18	18	30	30	sorafenib	IFN	PA7000	3439	0.96
NULL	Leukemia_2013_Apr_14_27(4)_803-812.nxml.txt.nlp	23238589	SENT153	14	14	38	38	imatinib	IFN	PA10804	3439	0.96
NULL	Curr_Neuropharmacol_2013_Jul_11(4)_338-378.nxml.txt.nlp	24381528	SENT576	14	14	36	36	curcumin	Bcl-2	PA151958596	596	0.96
NULL	Ann_Rheum_Dis_2010_Jan_17_69(1)_88-96.nxml.txt.nlp	19297346	SENT95	19	19	9	9	methotrexate	ACR	PA450428	49	0.96
NULL	Cell_Death_Dis_2010_Nov_18_1(11)_e102.nxml.txt.nlp	21368867	SENT147	18	18	11	11	gentamicin	CLIMP-63	PA449753	10970	0.96
NULL	Nucleic_Acids_Res_2012_Jul_30_40(13)_6319-6337.nxml.txt.nlp	22467215	SENT273	21	21	7	7	cisplatin	Bcl-2	PA449014	596	0.96
NULL	Ann_Saudi_Med_2011_Jul-Aug_31(4)_402-406.nxml.txt.nlp	21727749	SENT4	12	12	10	10	vildagliptin	DPP4	PA165958346	1803	0.96
NULL	J_Biomed_Biotechnol_2010_Mar_15_2010_527850.nxml.txt.nlp	20300436	SENT151	45	45	18	18	pioglitazone	AS160	PA450970	9882	0.96
NULL	Breast_Cancer_Res_2005_May_27_7(Suppl_1)_S16.nxml.txt.nlp	NULL	SENT6	16	16	8	8	tamoxifen	aromatase	PA451581	1588	0.96
NULL	Front_Endocrinol_(Lausanne)_2014_Oct_22_5_182.nxml.txt.nlp	25379037	SENT199	26	26	40	40	estradiol	aromatase	PA449503	1588	0.96
NULL	Nat_Commun_2013_Oct_15_4_2602.nxml.txt.nlp	24129506	SENT160	11	11	0	0	coumarin	S28	PA134521193	6234	0.96
NULL	Biomed_Res_Int_2014_Jan_29_2014_196249.nxml.txt.nlp	24605321	SENT203	5	5	21	21	bortezomib	BIM	PA10252	10018	0.96
NULL	Ann_Oncol_2011_Aug_27_22(8)_1736-1747.nxml.txt.nlp	21709140	SENT97	3	3	30	30	cisplatin	BRCA1	PA449014	672	0.96
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT166	27	27	18	18	cisplatin	p53	PA449014	7157	0.96
NULL	Neural_Plast_2000_7(4)_245-259.nxml.txt.nlp	11486485	SENT1	0	0	4	4	taurine	Pegasus	PA451590	64376	0.96
NULL	Sci_Rep_2014_Dec_4_4_7310.nxml.txt.nlp	25472472	SENT120	14	14	4	4	decitabine	CD34	PA164749631	947	0.96
NULL	eLife_2014_May_23_3_e02758.nxml.txt.nlp	24859756	SENT564	7	7	17	17	nadh	ADP	PA164755085	23038	0.96
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT40	23	23	4	4	pertuzumab	HER-2		2064	0.96
NULL	JRSM_Cardiovasc_Dis_2012_Sep_24_1(6)_cvd_2012_012015.nxml.txt.nlp	24175073	SENT37	20	20	6	6	clopidogrel	CYP2C19	PA449053	1557	0.96
NULL	Chemother_Res_Pract_2012_Aug_29_2012_817297.nxml.txt.nlp	22970367	SENT137	8	8	0	0	cetuximab	EGFR	PA10040	1956	0.96
NULL	Breast_Cancer_Res_Treat_2012_Jun_18_133(3)_937-947.nxml.txt.nlp	22094936	SENT148	47	47	14	14	tamoxifen	CCNB1	PA451581	891	0.96
NULL	Int_J_Nanomedicine_2009_Apr_20_4_99-105.nxml.txt.nlp	19516888	SENT95	8	8	31	31	paclitaxel	castor	PA450761	54897	0.96
NULL	Pharmaceuticals_(Basel)_2012_Jul_25_5(8)_779-801.nxml.txt.nlp	24280675	SENT79	2	2	0	0	geldanamycin	Hsp90	PA152031327	3320	0.96
NULL	Int_J_Gen_Med_2009_Jul_30_2_129-140.nxml.txt.nlp	20360896	SENT80	6	6	3	3	tamoxifen	aromatase	PA451581	1588	0.96
NULL	J_Mol_Signal_2006_Nov_29_1_4.nxml.txt.nlp	17224080	SENT237	42	42	24	24	forskolin	PTPBR7	PA146096022	5801	0.96
NULL	Eplasty_2009_Aug_20_9_e34.nxml.txt.nlp	19768118	SENT31	10	10	28	28	fluorescein	TRAM	PA164746009	23471;353376	0.96
NULL	J_RNAi_Gene_Silencing_2009_Mar_9_5(1)_321-330.nxml.txt.nlp	19771229	SENT229	18	18	4	4	gemcitabine	RRM2	PA449748	6241	0.96
NULL	Drugs_R_D_2013_Dec_30_13(4)_281-288.nxml.txt.nlp	24170256	SENT91	18	18	7	7	risperidone	FAST	PA451257	10922	0.96
NULL	Gene_Ther_2010_May_18_17(5)_634-642.nxml.txt.nlp	20164856	SENT93	46	46	0	0	paraformaldehyde	CD4	PA450790	920	0.96
NULL	J_Breast_Cancer_2013_Dec_31_16(4)_395-403.nxml.txt.nlp	24454461	SENT158	34	34	9	9	docetaxel	aromatase	PA449383	1588	0.96
NULL	Diabetes_2009_Dec_9_58(12)_2828-2834.nxml.txt.nlp	19741164	SENT24	11	11	4	4	glucose	SIRT1	PA449773	23411	0.96
NULL	Indian_J_Dermatol_2011_Mar-Apr_56(2)_137-144.nxml.txt.nlp	21716938	SENT106	24	24	11	11	abacavir	HLA-B	PA448004	3106	0.96
NULL	Brain_Sci_2014_May_6_4(2)_356-375.nxml.txt.nlp	24961766	SENT195	6	6	27	27	propofol	G18	PA451141	1154;63940	0.96
NULL	Int_Neurourol_J_2014_Sep_24_18(3)_115-125.nxml.txt.nlp	25279238	SENT140	31	31	10	10	berberine	Bcl-2	PA165860812	596	0.96
NULL	Cell_Death_Differ_2009_Aug_20_16(8)_1135-1145.nxml.txt.nlp	19300452	SENT219	20	20	2	2	doxycycline	PUMA	PA449415	27113	0.96
NULL	Environ_Health_Perspect_2007_Sep_12_115(9)_1298-1305.nxml.txt.nlp	17805419	SENT201	25	25	7	7	estradiol	OAT2	PA449503	10864	0.96
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_16_2012_395912.nxml.txt.nlp	23118789	SENT148	35	35	0	0	losartan	UGT1A3	PA450268	54659	0.96
NULL	Oncotarget_2012_Nov_17_3(12)_1600-1614.nxml.txt.nlp	23307622	SENT6	19	19	9	9	trastuzumab	ATG12	PA451743	9140	0.96
NULL	Oncol_Lett_2014_Nov_14_8(5)_2086-2092.nxml.txt.nlp	25295095	SENT149	17	17	1	1	gemcitabine	LKB1	PA449748	6794	0.96
NULL	Indian_J_Med_Res_2013_Mar_137(3)_527-532.nxml.txt.nlp	23640560	SENT118	20	20	1	1	doxorubicin	PARP-1	PA449412	25976	0.96
NULL	Mol_Cell_Proteomics_2012_Feb_13_11(2)_M111_013904.nxml.txt.nlp	21997733	SENT196	12	12	0	0	hyaluronan	ITIH1	PA165958431	3697	0.96
NULL	Mol_Cell_Proteomics_2012_Mar_13_11(3)_M111_014654.nxml.txt.nlp	22167270	SENT34	27	27	5	5	geldanamycin	Hsp90	PA152031327	3320	0.96
NULL	Toxins_(Basel)_2010_Sep_20_2(9)_2289-2332.nxml.txt.nlp	22069686	SENT179	0	0	11	11	hyperforin	CYP2C9	PA165985514	1559	0.96
NULL	Int_J_Cell_Biol_2014_Sep_17_2014_272689.nxml.txt.nlp	25313309	SENT232	15	15	8	8	cisplatin	p38	PA449014	10598;1432;7965	0.96
NULL	Onco_Targets_Ther_2014_Nov_10_7_2075-2084.nxml.txt.nlp	25419145	SENT122	12	12	25	25	gefitinib	EGFR	PA131301952	1956	0.96
NULL	Mol_Cancer_2010_May_28_9_130.nxml.txt.nlp	20509890	SENT67	23	23	4	4	cisplatin	TGFBI	PA449014	7045	0.96
NULL	Oncogene_2014_Jul_24_33(30)_3959-3969.nxml.txt.nlp	24096481	SENT25	29	29	38	38	nutlin-3	p53		7157	0.96
NULL	Nucleic_Acids_Res_2011_Nov_18_39(20)_8881-8890.nxml.txt.nlp	21768123	SENT25	3	3	19	19	pentamidine	MBNL1	PA450850	4154	0.96
NULL	Front_Syst_Neurosci_2014_Jun_11_8_107.nxml.txt.nlp	24999320	SENT24	2	2	23	23	methylphenidate	spatial	PA450464	219793	0.96
NULL	Oncoimmunology_2012_Oct_1_1(7)_1048-1060.nxml.txt.nlp	23170253	SENT57	11	11	21	21	pertuzumab	HER-2		2064	0.96
NULL	Inflamm_Res_2010_Sep_26_59(9)_699-709.nxml.txt.nlp	20339899	SENT29	7	7	3	3	thrombin	PAR1	PA451674	79581;2149	0.96
NULL	Cancer_Cell_Int_2007_Sep_10_7_14.nxml.txt.nlp	17845729	SENT212	25	25	5	5	decitabine	GADD45A	PA164749631	1647	0.96
NULL	Crit_Care_2006_Mar_21_10(Suppl_1)_P249.nxml.txt.nlp	NULL	SENT14	19	19	0	0	glucose	NGF	PA449773	4803	0.96
NULL	Ann_Hematol_2010_Nov_25_89(11)_1115-1124.nxml.txt.nlp	20499237	SENT118	19	19	2	2	simvastatin	CD19	PA451363	930	0.96
NULL	Br_J_Cancer_2012_Jan_3_106(1)_92-98.nxml.txt.nlp	22134504	SENT78	8	8	25	25	paraformaldehyde	IFN	PA450790	3439	0.96
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Jan_9_64(Pt_2)_o411.nxml.txt.nlp	21201439	SENT60	18	18	9	9	ethanol	mol	PA448073	90527	0.96
NULL	Can_J_Infect_Dis_Med_Microbiol_2014_Nov-Dec_25(6)_327-343.nxml.txt.nlp	25587296	SENT385	0	0	8	8	voriconazole	CYP2C19	PA10233	1557	0.96
NULL	Epigenetics_2012_Nov_1_7(11)_1225-1229.nxml.txt.nlp	23069641	SENT66	13	13	0	0	cisplatin	BRCA1	PA449014	672	0.96
NULL	Biologics_2010_Aug_9_4_173-185.nxml.txt.nlp	20714355	SENT160	15	15	12	12	cetuximab	EGFR	PA10040	1956	0.96
NULL	Nat_Commun_2013_Apr_9_4_1684.nxml.txt.nlp	23575688	SENT14	5	5	26	26	rolipram	CYLD	PA153906323	1540	0.96
NULL	AAPS_J_2012_Jan_4_14(1)_87-96.nxml.txt.nlp	22215264	SENT25	0	0	22	22	quinidine	P-gp	PA451209	5243	0.96
NULL	Cardiol_Res_Pract_2011_May_10_2011_816897.nxml.txt.nlp	21629798	SENT117	10	10	4	4	voriconazole	CYP3A4	PA10233	1576	0.96
NULL	Mar_Drugs_2014_Sep_25_12(9)_4984-5020.nxml.txt.nlp	25257786	SENT123	31	31	0	0	thrombin	SP2	PA451674	6668	0.96
NULL	J_Cereb_Blood_Flow_Metab_2014_Aug_14_34(8)_1315-1320.nxml.txt.nlp	24824914	SENT45	34	34	2	2	isoflurane	FDG	PA450106	23583	0.96
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT173	8	8	16	16	metformin	PTEN	PA450395	5728	0.96
NULL	Case_Rep_Rheumatol_2014_Nov_11_2014_536856.nxml.txt.nlp	25436167	SENT12	4	4	12	12	infliximab	CPDD	PA452639	882	0.96
NULL	Indian_J_Pharm_Sci_2014_May-Jun_76(3)_203-210.nxml.txt.nlp	25035531	SENT165	35	35	15	15	fluoxetine	5-HT1A	PA449673	3350	0.96
NULL	FEBS_J_2012_May_279(10)_1857-1870.nxml.txt.nlp	22420714	SENT9	3	3	10	10	capsaicin	TRPV1	PA448776	7442	0.96
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT154	3	3	21	21	dasatinib	PP2	PA162372878	4888	0.96
NULL	Onco_Targets_Ther_2014_Oct_4_7_1817-1828.nxml.txt.nlp	25336973	SENT115	0	0	38	38	bevacizumab	IFL	PA130232992	3439	0.96
NULL	Br_J_Cancer_2012_Sep_25_107(7)_1009-1016.nxml.txt.nlp	22948724	SENT51	14	14	4	4	sunitinib	HIF1	PA162372840	3091	0.96
NULL	Curr_Mol_Med_2014_Jun_14(5)_603-615.nxml.txt.nlp	24894176	SENT201	27	27	0	0	etoposide	BI-1	PA449552	7009	0.96
NULL	Ital_J_Pediatr_2010_Feb_8_36_15.nxml.txt.nlp	20181122	SENT270	14	14	21	21	topiramate	ACTH	PA451728	5443	0.96
NULL	Asia_Pac_Allergy_2013_Oct_31_3(4)_231-240.nxml.txt.nlp	24260728	SENT119	18	18	11	11	theophylline	CYP1A2	PA451647	1544	0.96
NULL	Patient_Prefer_Adherence_2011_Dec_23_6_1-9.nxml.txt.nlp	22272064	SENT64	11	11	14	14	telmisartan	ACE	PA451605	1636	0.96
NULL	Breast_Cancer_(Auckl)_2011_Jul_27_5_175-199.nxml.txt.nlp	21863131	SENT410	7	7	10	10	erlotinib	EGFR	PA134687924	1956	0.96
NULL	J_Thyroid_Res_2011_Aug_2_2011_102636.nxml.txt.nlp	21826256	SENT124	0	0	14	14	sunitinib	VEGFR	PA162372840	3791	0.96
NULL	Cell_Death_Dis_2013_Sep_5_4(9)_e792.nxml.txt.nlp	24008736	SENT6	25	25	15	15	methotrexate	FOR	PA450428	51741	0.96
NULL	Mol_Cancer_2010_Aug_23_9_222.nxml.txt.nlp	20731837	SENT175	0	0	25	25	gefitinib	ATM	PA131301952	472	0.96
NULL	Breast_Cancer_Res_2011_Nov_1_13(6)_224.nxml.txt.nlp	22114931	SENT131	16	16	14	14	everolimus	TORC1	PA164746311	23373	0.96
NULL	Clin_Pharmacol_2012_Feb_20_4_13-20.nxml.txt.nlp	22427735	SENT98	10	10	32	32	clopidogrel	P2Y12	PA449053	64805	0.96
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT260	43	43	14	14	atorvastatin	PIK3CA	PA448500	5290	0.96
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT360	19	19	11	11	ziprasidone	PRL	PA451974	5617	0.96
NULL	Biomed_Res_Int_2013_Nov_26_2013_343808.nxml.txt.nlp	24371820	SENT43	10	10	3	3	verapamil	DCK	PA451868	1633	0.96
NULL	Front_Genet_2012_Nov_12_3_235.nxml.txt.nlp	23162568	SENT149	14	14	26	26	methamphetamine	CYP2D6	PA450403	1565	0.96
NULL	Can_J_Infect_Dis_Med_Microbiol_2014_Nov-Dec_25(6)_327-343.nxml.txt.nlp	25587296	SENT385	0	0	10	10	voriconazole	CYP3A4	PA10233	1576	0.96
NULL	EMBO_Mol_Med_2013_Dec_8_5(12)_1821-1834.nxml.txt.nlp	24293316	SENT113	10	10	27	27	doxorubicin	UNC5B	PA449412	219699	0.96
NULL	Cent_European_J_Urol_2013_Aug_13_66(2)_200-201.nxml.txt.nlp	24579028	SENT31	2	2	8	8	ketoconazole	TRPV1	PA450146	7442	0.96
NULL	Onco_Targets_Ther_2014_Oct_20_7_1933-1944.nxml.txt.nlp	25364264	SENT94	5	5	8	8	erlotinib	EGFR	PA134687924	1956	0.96
NULL	ScientificWorldJournal_2012_Apr_26_2012_358102.nxml.txt.nlp	22645419	SENT182	22	22	11	11	captopril	AT2	PA448780	186	0.96
NULL	Arch_Osteoporos_2013_Oct_11_8(1-2)_136.nxml.txt.nlp	24113837	SENT3131	0	0	9	9	teriparatide	PTH	PA451620	5741	0.96
NULL	Br_J_Cancer_2013_May_28_108(10)_2039-2044.nxml.txt.nlp	23652306	SENT88	17	17	6	6	carboplatin	SRC3	PA448803	8202	0.96
NULL	Front_Mol_Neurosci_2013_Apr_10_6_7.nxml.txt.nlp	23596389	SENT422	43	43	11	11	furosemide	KCC2	PA449719	57468	0.96
NULL	Iran_J_Pharm_Res_2014_Spring_13(2)_683-693.nxml.txt.nlp	25237365	SENT14	28	28	19	19	tranilast	CXCR4	PA131890628	7852	0.96
NULL	Mol_Cancer_2010_Nov_25_9_305.nxml.txt.nlp	21108789	SENT107	8	8	14	14	decitabine	p53	PA164749631	7157	0.96
NULL	Cells_2014_Apr_8_3(2)_258-287.nxml.txt.nlp	24717323	SENT298	14	14	7	7	pp2	TRPV1		7442	0.96
NULL	Curr_Neuropharmacol_2011_Dec_9(4)_530-552.nxml.txt.nlp	22654714	SENT703	6	6	12	12	fluoxetine	S100A10	PA449673	6281	0.96
NULL	J_Headache_Pain_2011_Aug_25_12(4)_399-403.nxml.txt.nlp	21437713	SENT28	1	1	6	6	naratriptan	OTC	PA450597	5009	0.96
NULL	Front_Behav_Neurosci_2014_Nov_5_8_388.nxml.txt.nlp	25414651	SENT220	33	33	5	5	ketamine	NAC	PA450144	22861	0.96
NULL	Evid_Based_Complement_Alternat_Med_2014_Jan_8_2014_976364.nxml.txt.nlp	24527057	SENT16	34	34	15	15	oseltamivir	IFN	PA450721	3439	0.96
NULL	Diabetes_Metab_Syndr_Obes_2010_Jul_20_3_263-273.nxml.txt.nlp	21437094	SENT162	16	16	5	5	liraglutide	GLP-1	PA165958364	100125288	0.96
NULL	Breast_Cancer_Res_2010_Jul_22_12(4)_R53.nxml.txt.nlp	20649975	SENT164	12	12	5	5	tamoxifen	HOXB13	PA451581	10481	0.96
NULL	Front_Genet_2014_Jul_22_5_239.nxml.txt.nlp	25101118	SENT232	6	6	14	14	minocycline	MMP9	PA450519	4318	0.96
NULL	Exp_Ther_Med_2014_Feb_4_7(2)_478-482.nxml.txt.nlp	24396429	SENT118	15	15	1	1	glucose	HO-1	PA449773	3162	0.96
NULL	Adv_Urol_2013_Oct_31_2013_401750.nxml.txt.nlp	24288526	SENT135	23	23	8	8	rosuvastatin	p53	PA134308647	7157	0.96
NULL	Oncogene_2010_Mar_11_29(10)_1509-1518.nxml.txt.nlp	19946334	SENT53	11	11	25	25	bortezomib	p53	PA10252	7157	0.96
NULL	ScientificWorldJournal_2014_Mar_13_2014_604685.nxml.txt.nlp	24757426	SENT141	0	0	11	11	resveratrol	SIRT1		23411	0.96
NULL	Br_J_Cancer_2010_Oct_12_103(8)_1201-1208.nxml.txt.nlp	20877360	SENT206	12	12	23	23	etoposide	IL-6	PA449552	3569	0.96
NULL	Arthritis_Care_Res_(Hoboken)_2014_Nov_24_66(11)_1653-1661.nxml.txt.nlp	24942540	SENT37	0	0	14	14	tocilizumab	IL-6	PA165292659	3569	0.96
NULL	Cardiovasc_Diabetol_2013_Oct_17_12_150.nxml.txt.nlp	24134550	SENT16	19	19	4	4	metformin	activin	PA450395	83729	0.96
NULL	Antimicrob_Agents_Chemother_2014_Nov_10_59(1)_490-497.nxml.txt.nlp	25385107	SENT199	5	5	25	25	proguanil	ATV	PA451124	4683	0.96
NULL	BMB_Rep_2013_Nov_46(11)_544-549.nxml.txt.nlp	24152910	SENT56	18	18	36	36	thrombin	HMGB1	PA451674	3146	0.96
NULL	Korean_Circ_J_2013_Oct_30_43(10)_699-701.nxml.txt.nlp	24255655	SENT7	24	24	18	18	amiodarone	APT	PA448383	653639	0.96
NULL	Arch_Drug_Inf_2011_Mar_4(1)_1-9.nxml.txt.nlp	21572514	SENT193	6	6	12	12	ciprofloxacin	P-gp	PA449009	5243	0.96
NULL	Int_Neurourol_J_2014_Sep_24_18(3)_115-125.nxml.txt.nlp	25279238	SENT116	30	30	11	11	berberine	CA1	PA165860812	759	0.96
NULL	Adv_Hematol_2012_Jun_19_2012_851674.nxml.txt.nlp	22778745	SENT157	13	13	9	9	celecoxib	COX	PA448871	1351	0.96
NULL	Reprod_Biol_Endocrinol_2003_Oct_7_1_71.nxml.txt.nlp	14577832	SENT115	20	20	6	6	cisplatin	JNK1	PA449014	5599	0.96
NULL	Nat_Neurosci_2012_Sep_5_15(9)_1245-1254.nxml.txt.nlp	22864611	SENT107	20	20	7	7	clozapine	mGlu2	PA449061	2912	0.96
NULL	Br_J_Haematol_2014_Mar_13_164(1)_811-821.nxml.txt.nlp	24328678	SENT142	6	6	24	24	lenalidomide	CRBN	PA162363968	51185	0.96
NULL	Mol_Cancer_2008_Mar_26_7_27.nxml.txt.nlp	18366759	SENT317	23	23	14	14	etoposide	BAX	PA449552	581	0.96
NULL	Gut_Liver_2013_Jan_5_7(1)_35-40.nxml.txt.nlp	23423603	SENT40	20	20	12	12	imatinib	KIT	PA10804	3815	0.96
NULL	Psychiatr_Genet_2013_Aug_28_23(4)_153-162.nxml.txt.nlp	23811784	SENT156	7	7	26	26	clozapine	GALR2	PA449061	8811	0.96
NULL	Clin_Sci_(Lond)_2013_Apr_1_124(Pt_8)_543-552.nxml.txt.nlp	23130652	SENT5	0	0	10	10	enalapril	STZ	PA449456	6484	0.96
NULL	Exp_Ther_Med_2013_May_15_5(5)_1327-1331.nxml.txt.nlp	23737873	SENT27	7	7	17	17	imidapril	AQP2	PA452640	359	0.96
NULL	Acta_Neuropathol_Commun_2014_May_30_2_57.nxml.txt.nlp	24887326	SENT189	4	4	14	14	etoposide	ABCB1	PA449552	5243	0.96
NULL	Oncotarget_2011_Mar_19_2(3)_239-244.nxml.txt.nlp	21608150	SENT52	21	21	18	18	sorafenib	Mcl-1	PA7000	4170	0.96
NULL	Clin_Epigenetics_2011_Jun_14_2(2)_151-169.nxml.txt.nlp	22704335	SENT287	14	14	32	32	bicalutamide	PC3	PA164746255	57332;7832;5122	0.96
NULL	Chem_Res_Toxicol_2012_Nov_19_25(11)_2333-2339.nxml.txt.nlp	22917110	SENT27	7	7	12	12	arsenite	TERT	PA452638	7015	0.96
NULL	Cell_Death_Differ_2010_Mar_25_17(3)_398-407.nxml.txt.nlp	19779497	SENT98	5	5	20	20	etoposide	OCN	PA449552	632	0.96
NULL	Arthritis_Res_Ther_2014_Jul_24_16(4)_R157.nxml.txt.nlp	25059342	SENT118	11	11	0	0	bleomycin	IL-6	PA448645	3569	0.96
NULL	Eur_J_Endocrinol_2010_May_162(5)_987-992.nxml.txt.nlp	20164212	SENT2	14	14	5	5	diazoxide	HNF4A	PA449285	3172	0.96
NULL	Front_Immunol_2013_Nov_18_4_387.nxml.txt.nlp	24302927	SENT258	25	25	15	15	cblb502	TLR5		7100	0.96
NULL	Acta_Vet_Scand_2003_Sep_30_44(3)_121-129.nxml.txt.nlp	15074625	SENT118	12	12	20	20	gentamicin	TMP	PA449753	2012	0.96
NULL	Breast_Cancer_Res_2010_Jul_22_12(4)_R53.nxml.txt.nlp	20649975	SENT2	17	17	1	1	tamoxifen	HOXB13	PA451581	10481	0.96
NULL	Oncol_Lett_2013_Apr_28_5(4)_1149-1154.nxml.txt.nlp	23599754	SENT121	20	20	2	2	cisplatin	Dicer	PA449014	23405	0.96
NULL	Psychol_Res_Behav_Manag_2010_Dec_6_3_109-118.nxml.txt.nlp	22110334	SENT114	0	0	13	13	fluvoxamine	CYP2C19	PA449690	1557	0.96
NULL	Eur_J_Med_Res_2010_Nov_30_15(12)_533-543.nxml.txt.nlp	21163728	SENT139	5	5	18	18	linezolid	ABCB1	PA450233	5243	0.96
NULL	Clin_Pharmacol_2013_Apr_19_5_67-83.nxml.txt.nlp	23650452	SENT325	7	7	5	5	ticagrelor	P2Y12	PA165374673	64805	0.96
NULL	Cancer_Immunol_Immunother_2012_Oct_8_61(10)_1713-1720.nxml.txt.nlp	22399057	SENT92	17	17	13	13	plerixafor	CXCL12	PA165958410	6387	0.96
NULL	Aging_(Albany_NY)_2009_Sep_25_1(10)_845-854.nxml.txt.nlp	20157557	SENT164	18	18	6	6	doxorubicin	p53	PA449412	7157	0.96
NULL	Iran_J_Pharm_Res_2013_Winter_12(Suppl)_37-46.nxml.txt.nlp	24250670	SENT123	0	0	21	21	verapamil	P-gp	PA451868	5243	0.96
NULL	Curr_Immunol_Rev_2013_Nov_9(4)_214-221.nxml.txt.nlp	24876829	SENT94	9	9	21	21	papain	IL-2	PA450778	3558	0.96
NULL	Br_J_Cancer_2013_Sep_3_109(5)_1214-1222.nxml.txt.nlp	23922104	SENT130	21	21	4	4	dasatinib	p53	PA162372878	7157	0.96
NULL	Oncol_Rep_2013_Apr_23_29(4)_1268-1274.nxml.txt.nlp	23354756	SENT174	6	6	21	21	paclitaxel	SLC25A43	PA450761	203427	0.96
NULL	Mol_Brain_2013_Oct_21_6_44.nxml.txt.nlp	24144318	SENT106	8	8	14	14	pioglitazone	APOE	PA450970	348	0.96
NULL	Cancer_Imaging_2011_Mar_1_11(1)_1-8.nxml.txt.nlp	21362586	SENT72	20	20	38	38	loperamide	P-gp	PA450262	5243	0.96
NULL	Nucleic_Acids_Res_2005_Jun_8_33(10)_3283-3291.nxml.txt.nlp	15944449	SENT156	34	34	13	13	cisplatin	XRCC3	PA449014	7517	0.96
NULL	Int_J_Breast_Cancer_2011_Jul_12_2011_232435.nxml.txt.nlp	22295213	SENT243	23	23	13	13	tamoxifen	FN1	PA451581	2335	0.96
NULL	Cancer_Cell_Int_2007_Mar_28_7_3.nxml.txt.nlp	17391526	SENT15	0	0	17	17	forskolin	JNK	PA146096022	5599	0.96
NULL	Neuro_Oncol_2010_Apr_27_12(4)_389-400.nxml.txt.nlp	20308316	SENT123	29	29	6	6	chloroquine	p53	PA448948	7157	0.96
NULL	Oncotarget_2014_Nov_2_5(21)_10222-10236.nxml.txt.nlp	25400118	SENT100	13	13	2	2	neratinib	HER3	PA165291472	2065	0.96
NULL	Core_Evid_2010_Oct_21_5_61-76.nxml.txt.nlp	21042543	SENT253	21	21	6	6	panitumumab	PIK3CA	PA162373091	5290	0.96
NULL	Lab_Invest_2014_May_10_94(5)_503-516.nxml.txt.nlp	24614199	SENT56	0	0	12	12	curcumin	JAK2	PA151958596	3717	0.96
NULL	Mol_Cell_Proteomics_2014_May_17_13(5)_1273-1285.nxml.txt.nlp	24637012	SENT134	34	34	28	28	lisuride	5-HT2A	PA164749019	3356	0.96
NULL	Oncol_Rep_2014_Mar_30_31(3)_1043-1050.nxml.txt.nlp	24378760	SENT36	7	7	1	1	doxycycline	p53	PA449415	7157	0.96
NULL	Exp_Ther_Med_2014_Mar_2_7(3)_635-639.nxml.txt.nlp	24520259	SENT84	10	10	6	6	doxorubicin	P-gp	PA449412	5243	0.96
NULL	Cardiovasc_Diabetol_2008_Aug_11_7_24.nxml.txt.nlp	18694484	SENT39	0	0	45	45	exenatide	GLP-1	PA164749238	100125288	0.96
NULL	Cancer_Cell_Int_2011_Aug_19_11_29.nxml.txt.nlp	21854619	SENT161	12	12	26	26	cisplatin	BRCA1	PA449014	672	0.96
NULL	Clin_Drug_Investig_2013_Aug_23_33(10)_727-736.nxml.txt.nlp	23975654	SENT184	27	27	18	18	paroxetine	CYP2D6	PA450801	1565	0.96
NULL	Oncotarget_2014_Jun_6_5(12)_4516-4528.nxml.txt.nlp	24980831	SENT8	14	14	10	10	temozolomide	JNK	PA451609	5599	0.96
NULL	Acta_Neuropathol_2009_Sep_14_118(3)_329-347.nxml.txt.nlp	19597829	SENT417	35	35	10	10	bortezomib	p53	PA10252	7157	0.96
NULL	Exp_Ther_Med_2013_May_15_5(5)_1327-1331.nxml.txt.nlp	23737873	SENT148	9	9	3	3	imidapril	AQP2	PA452640	359	0.96
NULL	Thorax_2014_Jun_10_69(6)_558-564.nxml.txt.nlp	24613990	SENT8	36	36	43	43	methacholine	GSTM1	PA165958382	2944	0.96
NULL	Exp_Brain_Res_2014_Jun_27_232(8)_2637-2644.nxml.txt.nlp	24969614	SENT7	9	9	14	14	palonosetron	NK1	PA10352	11126	0.96
NULL	Eur_J_Endocrinol_2011_Jan_164(1)_69-74.nxml.txt.nlp	20961967	SENT14	33	33	12	12	metformin	OPG	PA450395	690	0.96
NULL	An_Bras_Dermatol_2013_Nov-Dec_88(6_Suppl_1)_93-96.nxml.txt.nlp	24346890	SENT61	2	2	12	12	clofazimine	ENL	PA164748759	4298	0.96
NULL	Clin_Ophthalmol_2008_Jun_2(2)_355-368.nxml.txt.nlp	19668727	SENT182	0	0	27	27	nepafenac	CYP2E1	PA165958407	1571	0.96
NULL	Front_Genet_2012_Oct_31_3_224.nxml.txt.nlp	23118737	SENT51	4	4	10	10	resveratrol	SIRT1		23411	0.96
NULL	Breast_Cancer_Res_Treat_2007_Oct_27_105(Suppl_1)_19-29.nxml.txt.nlp	17333340	SENT181	29	29	25	25	tamoxifen	aromatase	PA451581	1588	0.96
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_33-43.nxml.txt.nlp	17912634	SENT197	4	4	16	16	letrozole	HER2	PA450196	2064	0.96
NULL	Cell_Cycle_2012_Dec_15_11(24)_4661-4672.nxml.txt.nlp	23187802	SENT255	1	1	10	10	doxorubicin	p130	PA449412	5934	0.96
NULL	Front_Psychiatry_2014_Jul_31_5_92.nxml.txt.nlp	25132823	SENT360	12	12	34	34	naloxone	CB1	PA450586	1268	0.96
NULL	Cell_Cycle_2013_Jun_1_12(11)_1679-1687.nxml.txt.nlp	23656790	SENT21	35	35	33	33	olaparib	PARP1		142	0.96
NULL	Oncogene_2009_Dec_3_28(48)_4237-4248.nxml.txt.nlp	19734937	SENT80	8	8	11	11	thrombin	PAR-1	PA451674	2011;2149	0.96
NULL	J_Cell_Biol_1988_Dec_1_107(6)_2293-2305.nxml.txt.nlp	2461949	SENT18	13	13	6	6	heparin	p30	PA449855	201161	0.96
NULL	Front_Neurosci_2014_Dec_8_8_388.nxml.txt.nlp	25538545	SENT154	28	28	4	4	estradiol	5-HT2A	PA449503	3356	0.96
NULL	Antimicrob_Agents_Chemother_2014_Nov_10_59(1)_505-513.nxml.txt.nlp	25385096	SENT33	0	0	19	19	artesunate	CYP2A6	PA165111697	1548	0.96
NULL	Int_Neurourol_J_2014_Sep_24_18(3)_115-125.nxml.txt.nlp	25279238	SENT124	29	29	10	10	berberine	CA1	PA165860812	759	0.96
NULL	Cell_Commun_Signal_2004_Jun_30_2_6.nxml.txt.nlp	15228623	SENT10	33	33	10	10	verapamil	TTN	PA451868	7273	0.96
NULL	Acta_Pharmacol_Sin_2013_Sep_5_34(9)_1192-1200.nxml.txt.nlp	23685957	SENT252	24	24	39	39	curcumin	AP-2	PA151958596	7020	0.96
NULL	Arthritis_Res_Ther_2009_Aug_17_11(4)_R123.nxml.txt.nlp	19686595	SENT177	30	30	4	4	rituximab	CD38	PA451261	952	0.96
NULL	Int_J_Breast_Cancer_2011_Sep_6_2011_352182.nxml.txt.nlp	22295219	SENT145	22	22	14	14	trastuzumab	PIK3CA	PA451743	5290	0.96
NULL	Bone_Marrow_Res_2012_Oct_18_2012_180391.nxml.txt.nlp	23119165	SENT98	27	27	29	29	alemtuzumab	CD34	PA164783958	947	0.96
NULL	Contemp_Oncol_(Pozn)_2012_May_29_16(2)_170-175.nxml.txt.nlp	23788872	SENT139	0	0	11	11	erlotinib	EGFR	PA134687924	1956	0.96
NULL	J_Antimicrob_Chemother_2013_Jan_30_68(1)_17-22.nxml.txt.nlp	22941900	SENT59	11	11	16	16	tigecycline	BSAC	PA164746412	57591	0.96
NULL	Acta_Pharmacol_Sin_2011_Oct_12_32(10)_1259-1265.nxml.txt.nlp	21909126	SENT96	10	10	1	1	losartan	MCP-1	PA450268	6347	0.96
NULL	Oncotarget_2013_Nov_23_5(1)_196-210.nxml.txt.nlp	24344116	SENT150	22	22	15	15	doxorubicin	p53	PA449412	7157	0.96
NULL	Chin_J_Cancer_2012_Feb_31(2)_58-72.nxml.txt.nlp	22098952	SENT240	16	16	4	4	paclitaxel	MRP7	PA450761	89845;1080	0.96
NULL	Cases_J_2009_Sep_11_2_6773.nxml.txt.nlp	20181177	SENT71	8	8	25	25	azithromycin	CD4	PA448519	920	0.96
NULL	Clin_Interv_Aging_2010_Dec_3_5_395-402.nxml.txt.nlp	21152241	SENT42	14	14	12	12	verapamil	P-gp	PA451868	5243	0.96
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT335	31	31	23	23	methotrexate	MSH2	PA450428	4436	0.96
NULL	Mol_Vis_2007_Jul_9_13_1083-1093.nxml.txt.nlp	17653053	SENT252	7	7	14	14	minocycline	p38	PA450519	10598;1432;7965	0.96
NULL	Oncotarget_2014_Jun_7_5(14)_5257-5271.nxml.txt.nlp	24913448	SENT100	20	20	6	6	nilotinib	LASP1	PA165958345	3927	0.96
NULL	J_Cancer_2013_Nov_23_4(9)_736-754.nxml.txt.nlp	24312144	SENT129	22	22	27	27	erlotinib	EGFR	PA134687924	1956	0.96
NULL	Open_Cardiovasc_Med_J_2010_Jun_17_4_135-145.nxml.txt.nlp	20700394	SENT317	1	1	12	12	bivalirudin	PF4	PA10032	5196	0.96
NULL	J_Cancer_2014_Jan_5_5(2)_86-97.nxml.txt.nlp	24494026	SENT94	5	5	16	16	cisplatin	EGFR	PA449014	1956	0.96
NULL	Cardiovasc_Diabetol_2013_Nov_12_12_169.nxml.txt.nlp	24215514	SENT17	13	13	4	4	aliskiren	ANG	PA143487910	283	0.96
NULL	Br_J_Cancer_2006_Dec_4_95(11)_1483-1489.nxml.txt.nlp	17106442	SENT5	23	23	5	5	gefitinib	EGFR	PA131301952	1956	0.96
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT116	42	42	6	6	raltitrexed	UNG	PA131625240	7374	0.96
NULL	Basic_Res_Cardiol_2015_Jan_20_110_4.nxml.txt.nlp	25600226	SENT137	15	15	8	8	atorvastatin	PCSK9	PA448500	255738	0.96
NULL	Breast_Cancer_(Dove_Med_Press)_2014_May_2_6_59-71.nxml.txt.nlp	24833917	SENT37	39	39	32	32	exemestane	aromatase	PA449563	1588	0.96
NULL	ISRN_Nutr_2013_Aug_28_2013_403792.nxml.txt.nlp	24967258	SENT83	33	33	14	14	lipase	SREBP1	PA450239	6720	0.96
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT24	9	9	4	4	trastuzumab	STAT3	PA451743	6774	0.96
NULL	Epilepsia_2012_Jun_21_53(Suppl_1)_18-25.nxml.txt.nlp	22612805	SENT41	28	28	15	15	furosemide	NKCC1	PA449719	6558	0.96
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT137	14	14	45	45	paclitaxel	SLK	PA450761	9748;2534	0.96
NULL	Oncol_Lett_2013_Apr_1_5(4)_1331-1334.nxml.txt.nlp	23599789	SENT18	0	0	11	11	cetuximab	EGFR	PA10040	1956	0.96
NULL	Clin_Pharmacokinet_2014_Sep_3_53(1)_1-16.nxml.txt.nlp	23999929	SENT333	12	12	28	28	rivaroxaban	CLCR	PA165958360	11330	0.96
NULL	Eur_J_Med_Res_2010_Apr_8_15(4)_145-151.nxml.txt.nlp	20554495	SENT38	31	31	21	21	abacavir	HLA-B	PA448004	3106	0.96
NULL	Arthritis_Res_Ther_2010_Sep_8_12(5)_R167.nxml.txt.nlp	20825639	SENT186	29	29	9	9	resveratrol	AP-1		2353;3727;2354;3725	0.96
NULL	Br_J_Cancer_2013_Feb_5_108(2)_334-341.nxml.txt.nlp	23257893	SENT16	20	20	8	8	sorafenib	NOXA	PA7000	5366	0.96
NULL	Oncotarget_2011_Sep_9_2(9)_658-668.nxml.txt.nlp	21911919	SENT59	17	17	8	8	daunorubicin	HO-1	PA449212	3162	0.96
NULL	Pharmaceutics_2011_Nov_18_3(4)_865-913.nxml.txt.nlp	24309312	SENT532	1	1	10	10	nafcillin	CYP3A4	PA450576	1576	0.96
NULL	Clin_Med_Insights_Oncol_2013_Aug_21_7_221-234.nxml.txt.nlp	24179413	SENT63	0	0	16	16	afatinib	EGFR	PA165981154	1956	0.96
NULL	Cell_Commun_Signal_2010_Sep_22_8_27.nxml.txt.nlp	20860841	SENT212	1	1	14	14	cisplatin	CHK2	PA449014	11200	0.96
NULL	Sci_Rep_2014_Dec_23_4_7593.nxml.txt.nlp	25534349	SENT98	22	22	4	4	atorvastatin	PC-3	PA448500	692094	0.96
NULL	Br_J_Pharmacol_2014_Jan_23_171(2)_523-535.nxml.txt.nlp	24372553	SENT209	41	41	43	43	metformin	SIRT1	PA450395	23411	0.96
NULL	Front_Oncol_2011_Aug_22_1_22.nxml.txt.nlp	22666659	SENT134	0	0	7	7	cetuximab	EGF	PA10040	1950	0.96
NULL	Acta_Pharmacol_Sin_2012_May_16_33(5)_682-690.nxml.txt.nlp	22504904	SENT169	9	9	34	34	celecoxib	Mcl-1	PA448871	4170	0.96
NULL	Biochem_Res_Int_2012_Mar_20_2012_951539.nxml.txt.nlp	22482055	SENT172	9	9	3	3	doxorubicin	JNK	PA449412	5599	0.96
NULL	Mol_Cancer_2010_Nov_8_9_291.nxml.txt.nlp	21059223	SENT8	30	30	5	5	paclitaxel	ZNF217	PA450761	7764	0.96
NULL	Drug_Saf_2013_Jul_26_36(7)_533-546.nxml.txt.nlp	23620169	SENT169	0	0	7	7	propranolol	API	PA451145	5345	0.96
NULL	J_Biomed_Biotechnol_2004_Jun_30_2004(2)_106-112.nxml.txt.nlp	15240921	SENT85	14	14	0	0	vasopressin	SAGE	PA451858	55511	0.96
NULL	Clin_Sci_(Lond)_2013_Apr_1_124(Pt_8)_543-552.nxml.txt.nlp	23130652	SENT101	26	26	10	10	enalapril	STZ	PA449456	6484	0.96
NULL	Mol_Biol_Cell_2014_Jan_1_25(1)_76-86.nxml.txt.nlp	24173717	SENT199	15	15	7	7	paclitaxel	TUBB6	PA450761	84617	0.96
NULL	J_Cardiothorac_Surg_2014_Dec_18_9(1)_196.nxml.txt.nlp	NULL	SENT92	9	9	23	23	protamine	ACT	PA10366	12;11332;9457;641455	0.96
NULL	Curr_Cardiol_Rev_2009_Aug_5(3)_166-176.nxml.txt.nlp	20676275	SENT156	25	25	12	12	ibutilide	KCNH2	PA449958	3757	0.96
NULL	Nat_Med_2011_May_1_17(5)_604-609.nxml.txt.nlp	21532597	SENT124	27	27	17	17	daclizumab	CD25	PA164764446	3669;3559	0.96
NULL	Iran_Red_Crescent_Med_J_2012_Jan_1_14(1)_53-55.nxml.txt.nlp	22737557	SENT32	16	16	37	37	rifampin	PTB	PA451250	58155	0.96
NULL	J_Biol_Chem_2013_Jul_19_288(29)_21412-21421.nxml.txt.nlp	23740251	SENT106	0	0	20	20	suramin	P2X2	PA10292	22953	0.96
NULL	Cancer_Res_Treat_2011_Dec_27_43(4)_212-216.nxml.txt.nlp	22247705	SENT39	22	22	47	47	irinotecan	EGFR	PA450085	1956	0.96
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT147	28	28	23	23	sitagliptin	HIP	PA164748978	6767;6159;64399;5068	0.96
NULL	Cancer_Sci_2012_Nov_17_103(11)_1907-1912.nxml.txt.nlp	22809142	SENT92	26	26	3	3	tanespimycin	Hsp90	PA165291490	3320	0.96
NULL	Breast_Cancer_Res_Treat_2013_May_12_139(1)_107-113.nxml.txt.nlp	23580070	SENT24	38	38	20	20	trastuzumab	PI3	PA451743	5266	0.96
NULL	Breast_Cancer_Res_2007_Dec_18_9(6)_R88.nxml.txt.nlp	18088411	SENT44	21	21	0	0	oxygen	NIR	PA450744	26155	0.96
NULL	AIDS_Res_Treat_2012_Mar_21_2012_186987.nxml.txt.nlp	22536495	SENT134	5	5	14	14	darunavir	SLCO1B1	PA163522472	10599	0.96
NULL	Nucleic_Acids_Res_2012_Jul_19_40(13)_5910-5925.nxml.txt.nlp	22434882	SENT311	39	39	15	15	curcumin	p300	PA151958596	2033	0.96
NULL	Acta_Pharmacol_Sin_2012_May_4_33(5)_710-716.nxml.txt.nlp	22555373	SENT118	13	13	19	19	diazepam	DOM	PA449283	6663	0.96
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT56	13	13	1	1	indinavir	SLK	PA449977	9748;2534	0.96
NULL	J_Cancer_2013_Apr_29_4(4)_330-335.nxml.txt.nlp	23678369	SENT73	17	17	11	11	bevacizumab	p53	PA130232992	7157	0.96
NULL	Indian_J_Endocrinol_Metab_2011_Sep_15(Suppl3)_S172-S179.nxml.txt.nlp	22029021	SENT206	8	8	4	4	letrozole	aromatase	PA450196	1588	0.96
NULL	Adolesc_Health_Med_Ther_2012_Jun_20_3_85-93.nxml.txt.nlp	24600289	SENT31	0	0	14	14	adalimumab	TNF	PA10004	7124	0.96
NULL	Mol_Cancer_2009_Dec_23_8_129.nxml.txt.nlp	20030852	SENT250	10	10	20	20	curcumin	ABCA1	PA151958596	19	0.96
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT173	18	18	0	0	sitagliptin	HIP	PA164748978	6767;6159;64399;5068	0.96
NULL	Indian_J_Hum_Genet_2014_Apr-Jun_20(2)_175-184.nxml.txt.nlp	25400347	SENT137	30	30	11	11	warfarin	CYP2C9	PA451906	1559	0.96
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jul_24_66(Pt_8)_o2092.nxml.txt.nlp	21588387	SENT52	0	0	25	25	rocuronium	Tuba	PA164754992	23268	0.96
NULL	Breast_Cancer_Res_2010_Jun_28_12(3)_R43.nxml.txt.nlp	20579400	SENT116	45	45	5	5	doxorubicin	MAPT	PA449412	4137	0.96
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT89	19	19	2	2	cisplatin	p53	PA449014	7157	0.96
NULL	Cancer_Cell_Int_2006_Aug_9_6_20.nxml.txt.nlp	16899133	SENT58	21	21	43	43	genistein	p27	PA165109660	5715;10534	0.96
NULL	Case_Rep_Dermatol_2011_Jun_30_3(2)_130-136.nxml.txt.nlp	21743808	SENT60	18	18	12	12	adapalene	EGFR	PA448047	1956	0.96
NULL	Front_Behav_Neurosci_2011_Sep_21_5_60.nxml.txt.nlp	22007163	SENT129	30	30	17	17	rimonabant	CB1	PA152407999	1268	0.96
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1013.nxml.txt.nlp	24457957	SENT116	36	36	14	14	bortezomib	NOXA	PA10252	5366	0.96
NULL	Chin_J_Cancer_2012_Feb_31(2)_73-99.nxml.txt.nlp	22098950	SENT169	5	5	12	12	elacridar	P-gp		5243	0.96
NULL	Breast_Cancer_Res_2010_Oct_28_12(5)_212.nxml.txt.nlp	21067532	SENT134	7	7	27	27	estradiol	aromatase	PA449503	1588	0.96
NULL	ScientificWorldJournal_2012_Mar_12_2012_417809.nxml.txt.nlp	22536140	SENT38	37	37	17	17	neomycin	c-Myc	PA450608	4609	0.96
NULL	J_Thyroid_Res_2011_Aug_2_2011_102636.nxml.txt.nlp	21826256	SENT94	9	9	1	1	sorafenib	BRAF	PA7000	673	0.96
NULL	Br_J_Cancer_2011_Nov_22_105(11)_1654-1662.nxml.txt.nlp	22045187	SENT162	10	10	3	3	capecitabine	MTHFR	PA448771	4524	0.96
NULL	Nat_Commun_2014_Dec_8_5_5736.nxml.txt.nlp	25484020	SENT143	8	8	12	12	capsaicin	TRPV1	PA448776	7442	0.96
NULL	ScientificWorldJournal_2012_Apr_26_2012_358102.nxml.txt.nlp	22645419	SENT192	21	21	3	3	captopril	AT1	PA448780	9197;185	0.96
NULL	J_Mammary_Gland_Biol_Neoplasia_2010_Mar_27_15(1)_5-17.nxml.txt.nlp	20101446	SENT180	9	9	3	3	tamoxifen	HuR	PA451581	1994	0.96
NULL	Case_Rep_Transplant_2013_Jun_13_2013_375263.nxml.txt.nlp	23844312	SENT94	1	1	5	5	rifampin	CYP3A4	PA451250	1576	0.96
NULL	Front_Oncol_2014_Sep_29_4_256.nxml.txt.nlp	25325013	SENT62	12	12	33	33	afatinib	EGFR	PA165981154	1956	0.96
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT80	8	8	17	17	etravirine	CYP2B6	PA166014703	1555	0.96
NULL	Iran_J_Pharm_Res_2013_Winter_12(1)_175-184.nxml.txt.nlp	24250586	SENT126	1	1	15	15	diclofenac	COX2	PA449293	4513;5743	0.96
NULL	J_Physiol_2011_Mar_1_589(Pt_5)_1081-1093.nxml.txt.nlp	21224236	SENT139	13	13	1	1	diazoxide	GLP-1	PA449285	100125288	0.96
NULL	Libyan_J_Med_2006_Jul_28_1(1)_42-59.nxml.txt.nlp	21526020	SENT196	20	20	5	5	cetuximab	EGFR	PA10040	1956	0.96
NULL	Clin_Dev_Immunol_2013_Sep_26_2013_982163.nxml.txt.nlp	24187567	SENT140	12	12	0	0	tacrolimus	CYP3A5	PA451578	1577	0.96
NULL	Mol_Cell_Biochem_2012_Apr_3_363(1-2)_135-145.nxml.txt.nlp	22139302	SENT176	3	3	1	1	curcumin	survivin	PA151958596	332	0.96
NULL	Breast_Cancer_Res_2011_Feb_8_13(1)_202.nxml.txt.nlp	21392411	SENT162	7	7	31	31	metformin	CD44	PA450395	960	0.96
NULL	Atten_Defic_Hyperact_Disord_2011_Dec_15_3(4)_351-358.nxml.txt.nlp	22002672	SENT2	44	44	8	8	methylphenidate	spatial	PA450464	219793	0.96
NULL	Breast_Cancer_Res_2010_Jun_24_12(3)_R41.nxml.txt.nlp	20576088	SENT137	9	9	12	12	erlotinib	EGFR	PA134687924	1956	0.96
NULL	Acta_Pharmacol_Sin_2010_Nov_18_31(11)_1447-1453.nxml.txt.nlp	20953204	SENT129	20	20	3	3	rimonabant	CB1	PA152407999	1268	0.96
NULL	Pharmaceuticals_(Basel)_2013_Apr_17_6(4)_557-578.nxml.txt.nlp	24276125	SENT246	0	0	31	31	alefacept	CD58	PA164748040	965	0.96
NULL	Mol_Pain_2014_Aug_15_10_53.nxml.txt.nlp	25127716	SENT120	27	27	14	14	paclitaxel	CCL3	PA450761	6348	0.96
NULL	Open_Virol_J_2012_Dec_28_6_257-263.nxml.txt.nlp	23341861	SENT28	8	8	36	36	imiquimod	CXCR3	PA449972	2833	0.96
NULL	Int_J_Biol_Sci_2012_Sep_6_8(8)_1109-1120.nxml.txt.nlp	22991499	SENT57	23	23	13	13	l-arginine	IFN	PA448478	3439	0.96
NULL	Br_J_Clin_Pharmacol_2011_Oct_72(4)_647-657.nxml.txt.nlp	21518389	SENT182	27	27	12	12	ticagrelor	P2Y12	PA165374673	64805	0.96
NULL	Biomed_Res_Int_2014_Jun_2_2014_946492.nxml.txt.nlp	24991574	SENT147	2	2	13	13	olmesartan	adiponectin	PA164742950	9370	0.96
NULL	Acta_Neuropathol_Commun_2013_May_20_1_17.nxml.txt.nlp	24252689	SENT58	20	20	8	8	celecoxib	COX2	PA448871	4513;5743	0.96
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT68	20	20	7	7	vincristine	ABCC10	PA451879	89845	0.96
NULL	J_Korean_Med_Sci_2008_Aug_25_23(4)_657-661.nxml.txt.nlp	18756053	SENT74	20	20	11	11	estradiol	AMH	PA449503	268	0.96
NULL	Biol_Proced_Online_2003_Feb_17_5_43-52.nxml.txt.nlp	12734557	SENT174	7	7	20	20	bupivacaine	IFNA6	PA135057240	3443	0.96
NULL	EMBO_Mol_Med_2012_Jul_18_4(7)_557-560.nxml.txt.nlp	22610822	SENT37	9	9	29	29	resveratrol	SIRT1		23411	0.96
NULL	Oxid_Med_Cell_Longev_2010_Nov-Dec_3(6)_392-403.nxml.txt.nlp	21307645	SENT224	0	0	12	12	curcumin	IL-18	PA151958596	3606	0.96
NULL	Mol_Cancer_2010_Jun_25_9_165.nxml.txt.nlp	20576164	SENT32	8	8	32	32	curcumin	STAT3	PA151958596	6774	0.96
NULL	Mol_Biol_Cell_2012_Sep_1_23(17)_3473-3484.nxml.txt.nlp	22787275	SENT156	30	30	0	0	doxorubicin	ABCC1	PA449412	4363	0.96
NULL	Cell_Cycle_2012_Dec_15_11(24)_4661-4672.nxml.txt.nlp	23187802	SENT186	7	7	3	3	doxorubicin	p130	PA449412	5934	0.96
NULL	J_Korean_Med_Sci_2009_Jun_12_24(3)_448-452.nxml.txt.nlp	19543508	SENT10	8	8	4	4	gefitinib	EGFR	PA131301952	1956	0.96
NULL	Mol_Vis_2011_Dec_27_17_3415-3422.nxml.txt.nlp	22219637	SENT160	16	16	6	6	estradiol	p38	PA449503	10598;1432;7965	0.96
NULL	Oncol_Lett_2014_Nov_14_8(5)_2086-2092.nxml.txt.nlp	25295095	SENT6	11	11	4	4	gemcitabine	LKB1	PA449748	6794	0.96
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT120	36	36	29	29	pp2	PP2		4888	0.96
NULL	Chemother_Res_Pract_2011_Feb_27_2011_175054.nxml.txt.nlp	22295203	SENT60	24	24	2	2	cisplatin	MBT	PA449014	5657	0.96
NULL	Alcohol_Res_Health_2007_30(1)_38-47.nxml.txt.nlp	17718399	SENT60	13	13	19	19	ethanol	ADH	PA448073	551	0.96
NULL	Mol_Biol_Cell_2014_Jan_1_25(1)_145-159.nxml.txt.nlp	24196833	SENT249	8	8	2	2	valinomycin	LC3	PA151917011	84557	0.96
NULL	Acta_Pharmacol_Sin_2012_Dec_17_33(12)_1441-1458.nxml.txt.nlp	22983389	SENT266	7	7	11	11	trastuzumab	HER-2	PA451743	2064	0.96
NULL	Indian_J_Med_Res_2011_May_133(5)_529-534.nxml.txt.nlp	21623039	SENT29	32	32	0	0	ethionamide	DST	PA164768738	667	0.96
NULL	Endocrinology_2013_May_22_154(5)_1690-1700.nxml.txt.nlp	23525216	SENT243	31	31	9	9	etoposide	PRKCD	PA449552	5580	0.96
NULL	Cancer_Manag_Res_2013_Jun_7_5_91-101.nxml.txt.nlp	23785245	SENT146	4	4	23	23	gefitinib	EGFR	PA131301952	1956	0.96
NULL	Aging_(Albany_NY)_2010_Dec_20_2(12)_959-968.nxml.txt.nlp	21191146	SENT69	16	16	6	6	cisplatin	LKB1	PA449014	6794	0.96
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT316	19	19	12	12	bortezomib	STAT3	PA10252	6774	0.96
NULL	Ann_Hematol_2014_Apr_1_93(8)_1371-1380.nxml.txt.nlp	24687382	SENT20	30	30	5	5	lenalidomide	CRBN	PA162363968	51185	0.96
NULL	Iran_J_Pharm_Res_2014_Autumn_13(4)_1393-1401.nxml.txt.nlp	25587329	SENT137	17	17	28	28	celecoxib	ABCG2	PA448871	9429	0.96
NULL	Breast_Cancer_Res_2014_May_5_16(3)_R45.nxml.txt.nlp	24887236	SENT286	28	28	11	11	lapatinib	EGFR	PA152241907	1956	0.96
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1224-1233.nxml.txt.nlp	22353810	SENT295	8	8	20	20	doxorubicin	MRP-1	PA449412	928	0.96
NULL	Acta_Neuropathol_Commun_2013_Aug_9_1_49.nxml.txt.nlp	24252504	SENT39	6	6	20	20	arsenite	TDP-43	PA452638	23435	0.96
NULL	Breast_Cancer_Res_2010_Jun_28_12(3)_R43.nxml.txt.nlp	20579400	SENT102	31	31	11	11	docetaxel	MTS	PA449383	1678	0.96
NULL	Cancer_Cell_Int_2012_Jun_18_12_28.nxml.txt.nlp	22709531	SENT146	17	17	4	4	imatinib	kaiso	PA10804	10009	0.96
NULL	J_Mol_Signal_2010_Feb_23_5_2.nxml.txt.nlp	20178605	SENT29	6	6	25	25	sorafenib	VEGFR	PA7000	3791	0.96
NULL	Am_J_Pathol_2011_Mar_178(3)_1245-1256.nxml.txt.nlp	21356375	SENT582	11	11	17	17	indomethacin	COX	PA449982	1351	0.96
NULL	Ecancermedicalscience_2008_Feb_18_2_75.nxml.txt.nlp	22275966	SENT152	15	15	29	29	cisplatin	ERCC1	PA449014	2067	0.96
NULL	Case_Rep_Oncol_Med_2014_Sep_14_2014_532924.nxml.txt.nlp	25298899	SENT63	16	16	3	3	methotrexate	NAC	PA450428	22861	0.96
NULL	Br_J_Cancer_2000_Apr_6_82(7)_1327-1331.nxml.txt.nlp	10755409	SENT4	7	7	19	19	doxorubicin	MDR1	PA449412	5243	0.96
NULL	Br_J_Pharmacol_2014_May_171(10)_2659-2670.nxml.txt.nlp	24116661	SENT198	24	24	3	3	naringenin	TRPP2	PA151958361	5311	0.96
NULL	Cancer_Med_2014_Dec_13_3(6)_1579-1594.nxml.txt.nlp	25124282	SENT233	22	22	5	5	cisplatin	DNA-PKcs	PA449014	5591	0.96
NULL	Clin_Pharmacol_2013_Dec_9_5_185-192.nxml.txt.nlp	24353446	SENT20	18	18	26	26	clopidogrel	CYP3A4	PA449053	1576	0.96
NULL	Front_Pharmacol_2014_Nov_26_5_258.nxml.txt.nlp	25505415	SENT30	11	11	20	20	rosuvastatin	OATP1B1	PA134308647	10599	0.96
NULL	Psychiatry_Investig_2010_Dec_30_7(4)_236-242.nxml.txt.nlp	21253406	SENT59	14	14	47	47	citalopram	BDNF	PA449015	627	0.96
NULL	Br_J_Cancer_2013_Mar_19_108(5)_1071-1078.nxml.txt.nlp	23412102	SENT142	21	21	1	1	fentanyl	CYP3A4	PA449599	1576	0.96
NULL	Gene_Ther_2010_May_18_17(5)_634-642.nxml.txt.nlp	20164856	SENT93	9	9	0	0	fluorescein	CD4	PA164746009	920	0.96
NULL	Patient_Prefer_Adherence_2011_Dec_23_6_1-9.nxml.txt.nlp	22272064	SENT36	28	28	24	24	enalapril	ACE	PA449456	1636	0.96
NULL	Oncotarget_2014_Sep_10_5(19)_8924-8936.nxml.txt.nlp	25238040	SENT78	21	21	28	28	decitabine	p53	PA164749631	7157	0.96
NULL	JRSM_Short_Rep_2012_Apr_27_3(4)_26.nxml.txt.nlp	22715427	SENT62	11	11	9	9	letrozole	aromatase	PA450196	1588	0.96
NULL	Evid_Based_Complement_Alternat_Med_2011_Jan_20_2011_751671.nxml.txt.nlp	21318106	SENT142	8	8	34	34	verapamil	P-gp	PA451868	5243	0.96
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT37	34	34	6	6	tamoxifen	TFF3	PA451581	7033	0.96
NULL	Cancer_Med_2012_Oct_1_1(2)_114-127.nxml.txt.nlp	23342262	SENT33	2	2	17	17	sirolimus	AKT	PA451365	207	0.96
NULL	Nat_Commun_2013_Aug_15_4_2130.nxml.txt.nlp	23945651	SENT46	21	21	12	12	cisplatin	LC3	PA449014	84557	0.96
NULL	Mol_Cancer_2010_Jun_25_9_165.nxml.txt.nlp	20576164	SENT25	0	0	44	44	curcumin	STAT3	PA151958596	6774	0.96
NULL	Gene_Ther_2011_Dec_12_18(12)_1150-1156.nxml.txt.nlp	21562591	SENT139	13	13	0	0	isoflurane	RAG1	PA450106	5896	0.96
NULL	Br_J_Cancer_2013_Oct_15_109(8)_2131-2141.nxml.txt.nlp	24052043	SENT155	33	33	25	25	docetaxel	PC-3	PA449383	692094	0.96
NULL	Arthritis_Res_Ther_2013_Oct_2_15(5)_R141.nxml.txt.nlp	24286116	SENT15	32	32	11	11	tocilizumab	IL-6	PA165292659	3569	0.96
NULL	Br_J_Cancer_2009_Jul_21_101(2)_269-277.nxml.txt.nlp	19603033	SENT7	13	13	4	4	cisplatin	MLH1	PA449014	4292	0.96
NULL	Acta_Pharmacol_Sin_2014_Jun_5_35(6)_716-726.nxml.txt.nlp	24793311	SENT14	6	6	35	35	atorvastatin	PSD-95	PA448500	1742	0.96
NULL	Case_Rep_Oncol_2012_Sep_21_5(3)_627-632.nxml.txt.nlp	23275777	SENT75	1	1	8	8	sunitinib	CYP3A4	PA162372840	1576	0.96
NULL	Arthritis_Res_Ther_2009_Aug_28_11(4)_R131.nxml.txt.nlp	19715572	SENT162	17	17	20	20	rituximab	CD4	PA451261	920	0.96
NULL	Indian_J_Pharmacol_2013_Jan-Feb_45(1)_54-60.nxml.txt.nlp	23543867	SENT172	21	21	1	1	terlipressin	NAC	PA164781020	22861	0.96
NULL	Cardiovasc_Drugs_Ther_2010_Apr_20_24(2)_139-149.nxml.txt.nlp	20490905	SENT325	13	13	16	16	aliskiren	AT1	PA143487910	9197;185	0.96
NULL	Pharmaceutics_2011_Apr_14_3(2)_171-185.nxml.txt.nlp	24310494	SENT167	17	17	4	4	doxorubicin	CD22	PA449412	933	0.96
NULL	J_Biol_Chem_2012_Apr_27_287(18)_14644-14658.nxml.txt.nlp	22375002	SENT364	12	12	17	17	forskolin	CC2D1A	PA146096022	54862	0.96
NULL	Cancers_(Basel)_2010_Jul_14_2(3)_1492-1512.nxml.txt.nlp	24281169	SENT311	14	14	1	1	doxycycline	SOD2	PA449415	6648	0.96
NULL	Springerplus_2014_Sep_9_3_510.nxml.txt.nlp	25279302	SENT36	4	4	21	21	creatine	CKM	PA164778930	1158	0.96
NULL	Br_J_Cancer_2011_May_10_104(10)_1558-1563.nxml.txt.nlp	21522148	SENT3	31	31	23	23	tamoxifen	aromatase	PA451581	1588	0.96
NULL	Front_Endocrinol_(Lausanne)_2011_Dec_21_2_84.nxml.txt.nlp	22654830	SENT40	7	7	22	22	rosiglitazone	ATGL	PA451283	57104	0.96
NULL	Oncol_Lett_2013_Oct_26_6(4)_1063-1067.nxml.txt.nlp	24137465	SENT99	16	16	27	27	afatinib	HER2	PA165981154	2064	0.96
NULL	Breast_Cancer_Res_2004_Aug_5_6(5)_R601-R607.nxml.txt.nlp	15318941	SENT36	22	22	4	4	cisplatin	p27	PA449014	5715;10534	0.96
NULL	Oncotarget_2014_Aug_19_5(18)_8729-8736.nxml.txt.nlp	25238266	SENT116	1	1	35	35	l-methionine	San	PA450423	80218	0.96
NULL	Clin_Endosc_2011_Sep_30_44(1)_22-26.nxml.txt.nlp	22741108	SENT6	15	15	32	32	midazolam	ESD	PA450496	2098	0.96
NULL	Breast_Cancer_Res_2004_Aug_5_6(5)_R601-R607.nxml.txt.nlp	15318941	SENT134	0	0	8	8	docetaxel	p27	PA449383	5715;10534	0.96
NULL	Arch_Drug_Inf_2008_Jul_1(1)_14-22.nxml.txt.nlp	20157364	SENT18	16	16	3	3	pravastatin	IL-6	PA451089	3569	0.96
NULL	Ann_Gastroenterol_2012_25(3)_207-217.nxml.txt.nlp	24713803	SENT235	0	0	3	3	exenatide	GLP-1	PA164749238	100125288	0.96
NULL	J_Korean_Med_Sci_2014_Jul_11_29(7)_965-972.nxml.txt.nlp	25045229	SENT119	33	33	12	12	metformin	B12	PA450395	7126;4709	0.96
NULL	Eur_J_Med_Res_2009_Nov_24_14(Suppl_3)_17-21.nxml.txt.nlp	19959412	SENT35	27	27	0	0	raltegravir	UGT1A1		54658	0.96
NULL	Clinicoecon_Outcomes_Res_2014_Oct_17_6_451-461.nxml.txt.nlp	25378939	SENT139	13	13	21	21	linezolid	HAP	PA450233	5915;10313	0.96
NULL	Int_J_Gen_Med_2011_May_3_4_345-357.nxml.txt.nlp	21674027	SENT186	17	17	10	10	pioglitazone	PI3	PA450970	5266	0.96
NULL	Mediators_Inflamm_2002_Feb_11(1)_17-22.nxml.txt.nlp	11926591	SENT5	32	32	5	5	staurosporine	COX	PA165109623	1351	0.96
NULL	Breast_Cancer_Res_2004_Oct_6_6(6)_269-274.nxml.txt.nlp	15535858	SENT54	30	30	13	13	letrozole	HER2	PA450196	2064	0.96
NULL	J_Cell_Mol_Med_2014_Mar_10_18(3)_514-529.nxml.txt.nlp	24410795	SENT219	20	20	29	29	resveratrol	SIRT1		23411	0.96
NULL	Br_J_Cancer_2004_Mar_22_90(6)_1285-1292.nxml.txt.nlp	15026814	SENT188	28	28	10	10	cisplatin	p53	PA449014	7157	0.96
NULL	N_Am_J_Med_Sci_2012_Dec_4(12)_648-650.nxml.txt.nlp	23272308	SENT20	23	23	2	2	ciprofloxacin	CRA	PA449009	51747;10903	0.96
NULL	Oncol_Lett_2013_Feb_7_5(2)_440-446.nxml.txt.nlp	23420122	SENT121	30	30	25	25	sorafenib	Bcl-2	PA7000	596	0.96
NULL	Curr_Med_Chem_2014_May_21(14)_1595-1606.nxml.txt.nlp	23992330	SENT145	26	26	17	17	dasatinib	EGFR	PA162372878	1956	0.96
NULL	Chem_Rev_2014_Jun_11_114(11)_5753-5774.nxml.txt.nlp	24758331	SENT195	11	11	35	35	verapamil	P-gp	PA451868	5243	0.96
NULL	Oncologist_2010_Mar_3_15(3)_216-235.nxml.txt.nlp	20200040	SENT157	29	29	13	13	trastuzumab	HER-2	PA451743	2064	0.96
NULL	J_Cell_Biol_2004_Jun_7_165(5)_653-662.nxml.txt.nlp	15173192	SENT178	19	19	35	35	amiloride	GAD1	PA448368	2571	0.96
NULL	J_Cancer_2013_Nov_23_4(9)_736-754.nxml.txt.nlp	24312144	SENT54	15	15	0	0	erlotinib	EGFR	PA134687924	1956	0.96
NULL	Korean_J_Anesthesiol_2013_Dec_26_65(6)_501-507.nxml.txt.nlp	24427455	SENT25	0	0	16	16	neostigmine	NMB	PA450611	10457;4828	0.96
NULL	Gut_2011_May_29_60(5)_638-647.nxml.txt.nlp	21115544	SENT278	13	13	17	17	tegaserod	5-HT4	PA130413154	3360	0.96
NULL	Acta_Pharmacol_Sin_2010_Mar_8_31(3)_382-386.nxml.txt.nlp	20140004	SENT10	7	7	30	30	pitavastatin	SLCO1B1	PA142650384	10599	0.96
NULL	Breast_Cancer_Res_2009_Jan_27_11(1)_R5.nxml.txt.nlp	19173736	SENT218	34	34	8	8	tamoxifen	CD68	PA451581	968	0.96
NULL	Pediatr_Nephrol_2009_Jul_20_24(7)_1355-1361.nxml.txt.nlp	19301038	SENT79	28	28	4	4	sevelamer	PTH	PA164781197	5741	0.96
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT264	28	28	5	5	lapatinib	HER3	PA152241907	2065	0.96
NULL	Cancers_(Basel)_2014_May_16_6(2)_1180-1194.nxml.txt.nlp	24840048	SENT128	0	0	23	23	cabozantinib	VEGFR2	PA165906891	3791	0.96
NULL	Pharmaceutics_2011_Nov_18_3(4)_865-913.nxml.txt.nlp	24309312	SENT174	35	35	6	6	triazolam	CYP3A4	PA451753	1576	0.96
NULL	Oncotarget_2011_Mar_10_2(3)_186-196.nxml.txt.nlp	21406729	SENT171	10	10	5	5	orlistat	SREBP1	PA164776864	6720	0.96
NULL	Br_J_Cancer_2011_Dec_6_105(12)_1850-1855.nxml.txt.nlp	22095231	SENT103	31	31	22	22	erlotinib	EGFR	PA134687924	1956	0.96
NULL	Brain_Behav_2014_Jan_27_4(1)_51-59.nxml.txt.nlp	24653954	SENT18	9	9	32	32	estradiol	EPM	PA449503	2054	0.96
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT85	37	37	12	12	trastuzumab	IL-10	PA451743	3586	0.96
NULL	Biomed_Res_Int_2013_Jan_21_2013_581631.nxml.txt.nlp	23484133	SENT81	18	18	0	0	infliximab	GM-CSF	PA452639	1437	0.96
NULL	J_Immunol_Res_2014_Oct_12_2014_570685.nxml.txt.nlp	25371908	SENT156	20	20	9	9	levofloxacin	IL-6	PA450214	3569	0.96
NULL	Br_J_Pharmacol_2010_Sep_161(2)_288-307.nxml.txt.nlp	20735416	SENT245	34	34	28	28	isoflurane	TASK	PA450106	3777	0.96
NULL	Oncol_Rep_2013_Mar_8_29(3)_917-924.nxml.txt.nlp	23314174	SENT124	2	2	12	12	sorafenib	CD44	PA7000	960	0.96
NULL	Br_J_Cancer_2013_May_14_108(9)_1807-1809.nxml.txt.nlp	23612454	SENT45	38	38	12	12	trastuzumab	PIK3CA	PA451743	5290	0.96
NULL	Breast_Cancer_Res_2008_Feb_1_10(1)_R10.nxml.txt.nlp	18241344	SENT187	43	43	32	32	cisplatin	CD24	PA449014	100133941	0.96
NULL	Stroke_Res_Treat_2011_Nov_10_2011_212485.nxml.txt.nlp	22135769	SENT150	18	18	38	38	ticagrelor	CYP2C19	PA165374673	1557	0.96
NULL	Br_J_Cancer_2012_Jul_10_107(2)_360-369.nxml.txt.nlp	22713663	SENT119	16	16	8	8	bevacizumab	DDP	PA130232992	1678	0.96
NULL	Acta_Vet_Scand_2007_Jul_2_49(1)_17.nxml.txt.nlp	17605810	SENT102	16	16	4	4	nadh	SOD1	PA164755085	6647	0.96
NULL	Cancer_Metab_2013_Feb_4_1_7.nxml.txt.nlp	24280108	SENT159	20	20	4	4	glucose	ROS	PA449773	6098	0.96
NULL	J_Inherit_Metab_Dis_2010_Oct_3_33(5)_625-632.nxml.txt.nlp	20814828	SENT72	20	20	38	38	simvastatin	RhoA	PA451363	387	0.96
NULL	Arch_Drug_Inf_2011_Mar_4(1)_1-9.nxml.txt.nlp	21572514	SENT47	3	3	8	8	ciprofloxacin	P-gp	PA449009	5243	0.96
NULL	Anat_Cell_Biol_2010_Sep_30_43(3)_194-200.nxml.txt.nlp	21212859	SENT15	17	17	0	0	ethanol	PLP	PA448073	25824;5744	0.96
NULL	Breast_Cancer_(Auckl)_2012_Mar_7_6_67-77.nxml.txt.nlp	22438669	SENT160	24	24	7	7	capecitabine	HER2	PA448771	2064	0.96
NULL	Curr_Neuropharmacol_2010_Sep_8(3)_287-304.nxml.txt.nlp	21358978	SENT33	24	24	3	3	lamotrigine	NK-1	PA450164	27087	0.96
NULL	Cell_Cycle_2014_Jan_15_13(2)_303-314.nxml.txt.nlp	24247149	SENT168	14	14	25	25	gemcitabine	p53	PA449748	7157	0.96
NULL	Ann_Gen_Psychiatry_2014_Jun_13_13_17.nxml.txt.nlp	25053968	SENT125	10	10	5	5	escitalopram	IL-11	PA10074	3589	0.959
NULL	Aging_(Albany_NY)_2012_Jul_31_4(7)_499-508.nxml.txt.nlp	22868943	SENT127	0	0	9	9	resveratrol	SIRT1		23411	0.959
NULL	Clinics_(Sao_Paulo)_2012_May_67(5)_419-424.nxml.txt.nlp	22666783	SENT38	18	18	22	22	erlotinib	KRAS	PA134687924	3845	0.959
NULL	Breast_Cancer_Res_2014_Dec_19_16(6)_499.nxml.txt.nlp	25522654	SENT206	11	11	33	33	estradiol	aromatase	PA449503	1588	0.959
NULL	Breast_Cancer_(Auckl)_2011_Oct_9_5_209-226.nxml.txt.nlp	22084574	SENT203	7	7	15	15	exemestane	aromatase	PA449563	1588	0.959
NULL	J_Cell_Biol_2004_Jul_5_166(1)_133-143.nxml.txt.nlp	15226308	SENT112	18	18	0	0	hydrocortisone	BRCA1	PA449905	672	0.959
NULL	Cardiol_Res_Pract_2014_Nov_20_2014_784018.nxml.txt.nlp	25506463	SENT143	0	0	11	11	protamine	ACT	PA10366	12;11332;9457;641455	0.959
NULL	Case_Rep_Oncol_Med_2014_Jul_17_2014_162534.nxml.txt.nlp	25136467	SENT59	0	0	13	13	lapatinib	EGFR	PA152241907	1956	0.959
NULL	Acta_Pharmacol_Sin_2010_Feb_5_31(2)_137-144.nxml.txt.nlp	20139896	SENT110	12	12	21	21	zileuton	p38	PA451955	10598;1432;7965	0.959
NULL	J_Int_AIDS_Soc_2012_Mar_14_15_15.nxml.txt.nlp	22417404	SENT53	24	24	6	6	fluconazole	CD4	PA449653	920	0.959
NULL	Breast_Cancer_Res_2007_Mar_2_9(2)_205.nxml.txt.nlp	NULL	SENT88	1	1	21	21	lapatinib	aromatase	PA152241907	1588	0.959
NULL	Hum_Reprod_2008_Oct_16_23(10)_2273-2281.nxml.txt.nlp	18635530	SENT155	7	7	10	10	etoposide	p53	PA449552	7157	0.959
NULL	Cancer_Metastasis_Rev_2014_Dec_28_33(1)_161-171.nxml.txt.nlp	24375389	SENT168	28	28	6	6	etoposide	CHFR	PA449552	55743	0.959
NULL	Oncol_Rep_2012_Sep_26_28(3)_777-784.nxml.txt.nlp	22751903	SENT139	4	4	8	8	celecoxib	MVD	PA448871	4597	0.959
NULL	Int_J_Mol_Sci_2014_Oct_6_15(10)_17886-17900.nxml.txt.nlp	25290095	SENT11	5	5	35	35	resveratrol	SIRT1		23411	0.959
NULL	Clin_Ophthalmol_2009_Jun_2_3_199-210.nxml.txt.nlp	19668566	SENT84	40	40	9	9	ketorolac	COX	PA450150	1351	0.959
NULL	Trials_2014_Nov_6_15(1)_434.nxml.txt.nlp	NULL	SENT203	30	30	12	12	isoniazid	Bravo	PA450112	4897	0.959
NULL	Biochem_Biophys_Res_Commun_2009_Aug_14_386(1)_111-117.nxml.txt.nlp	19501051	SENT289	1	1	8	8	disopyramide	HERG	PA449373	3757	0.959
NULL	Cell_Death_Differ_2010_May_13_17(5)_774-786.nxml.txt.nlp	19911006	SENT326	4	4	11	11	doxycycline	AATF	PA449415	26574	0.959
NULL	Arthritis_Res_Ther_2011_Sep_16_13(Suppl_2)_O16.nxml.txt.nlp	NULL	SENT6	4	4	1	1	tocilizumab	IL-6	PA165292659	3569	0.959
NULL	J_Antimicrob_Chemother_2014_Jul_14_69(7)_1945-1953.nxml.txt.nlp	24633206	SENT93	9	9	22	22	tigecycline	RGM	PA164746412	56963	0.959
NULL	Crit_Care_2002_Mar_1_6(Suppl_1)_P220.nxml.txt.nlp	NULL	SENT8	16	16	3	3	hydrocortisone	ACTH	PA449905	5443	0.959
NULL	Nucleic_Acids_Res_2005_Jun_8_33(10)_3283-3291.nxml.txt.nlp	15944449	SENT434	30	30	22	22	melphalan	XRCC3	PA450354	7517	0.959
NULL	Cell_Cycle_2012_Sep_1_11(17)_3143-3144.nxml.txt.nlp	22894901	SENT16	17	17	8	8	etoposide	TOP2B	PA449552	7155	0.959
NULL	Leukemia_2014_Mar_12_28(3)_577-588.nxml.txt.nlp	24080946	SENT272	0	0	10	10	resveratrol	SIRT1		23411	0.959
NULL	Eur_J_Haematol_2014_Feb_25_92(2)_127-136.nxml.txt.nlp	24118452	SENT18	15	15	7	7	anagrelide	CRT	PA164742986	811	0.959
NULL	Cancer_Cell_Int_2013_May_15_13_42.nxml.txt.nlp	23672670	SENT196	37	37	6	6	paclitaxel	PIDD	PA450761	55367	0.959
NULL	Cancers_(Basel)_2014_Jan_15_6(1)_143-152.nxml.txt.nlp	24434543	SENT80	7	7	28	28	trastuzumab	HER2	PA451743	2064	0.959
NULL	Arch_Drug_Inf_2011_Mar_4(1)_1-9.nxml.txt.nlp	21572514	SENT47	3	3	10	10	ciprofloxacin	MRP1	PA449009	4437	0.959
NULL	Eur_J_Endocrinol_2014_Mar_170(3)_451-459.nxml.txt.nlp	24362411	SENT35	0	0	4	4	liraglutide	GLP1	PA165958364	100125288;2641	0.959
NULL	Curr_Pharm_Biotechnol_2012_May_13(6)_969-986.nxml.txt.nlp	22039792	SENT16	23	23	30	30	doxorubicin	P-gp	PA449412	5243	0.959
NULL	Mol_Immunol_2009_Mar_46(6)_1229-1239.nxml.txt.nlp	19135256	SENT105	15	15	1	1	trypsin	DC2	PA451806	58505	0.959
NULL	J_Cell_Biol_2002_Nov_25_159(4)_637-648.nxml.txt.nlp	12438416	SENT53	11	11	35	35	etoposide	GM130	PA449552	2801	0.959
NULL	Br_J_Cancer_2010_Jan_19_102(2)_268-275.nxml.txt.nlp	20010948	SENT7	43	43	7	7	erlotinib	CD133	PA134687924	8842	0.959
NULL	Arthritis_Res_Ther_2009_Aug_17_11(4)_R123.nxml.txt.nlp	19686595	SENT173	33	33	22	22	rituximab	CD38	PA451261	952	0.959
NULL	Exp_Diabetes_Res_2011_Jun_4_2011_489708.nxml.txt.nlp	21747829	SENT136	28	28	8	8	aliskiren	GLP-1	PA143487910	100125288	0.959
NULL	J_Gastroenterol_2013_Feb_23_48(12)_1373-1383.nxml.txt.nlp	23435670	SENT73	36	36	8	8	entecavir	LAM	PA164784025	7249;7248	0.959
NULL	Breast_Cancer_Res_2005_May_27_7(Suppl_1)_S29.nxml.txt.nlp	NULL	SENT6	15	15	13	13	letrozole	aromatase	PA450196	1588	0.959
NULL	Eur_J_Clin_Pharmacol_2014_Mar_22_70(6)_685-693.nxml.txt.nlp	24658827	SENT4	0	0	13	13	tacrolimus	CYP3A4	PA451578	1576	0.959
NULL	Oncol_Lett_2014_Sep_19_8(3)_1269-1274.nxml.txt.nlp	25120704	SENT27	14	14	5	5	cisplatin	Met	PA449014	79811	0.959
NULL	Aging_(Albany_NY)_2010_Sep_18_2(9)_535-537.nxml.txt.nlp	20876940	SENT27	21	21	8	8	doxorubicin	CDKN1A	PA449412	1026	0.959
NULL	Curr_Oncol_2009_May_16(Suppl_1)_S52-S59.nxml.txt.nlp	19478903	SENT73	14	14	3	3	temsirolimus	CYP3A4	PA164746890	1576	0.959
NULL	Oncotarget_2013_Nov_4_5(1)_161-172.nxml.txt.nlp	24389287	SENT37	19	19	2	2	propranolol	MYCN	PA451145	4613	0.959
NULL	Eur_J_Clin_Pharmacol_2012_Jan_7_68(1)_55-64.nxml.txt.nlp	21735164	SENT25	0	0	8	8	oxycodone	CYP3A4	PA450741	1576	0.959
NULL	Daru_2011_19(6)_433-439.nxml.txt.nlp	23008689	SENT107	6	6	17	17	ethanol	IPA	PA448073	3160	0.959
NULL	Oncoscience_2014_Jun_19_1(7)_478-479.nxml.txt.nlp	25594047	SENT21	5	5	24	24	paclitaxel	P-gp	PA450761	5243	0.959
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT207	4	4	16	16	adalimumab	DPI	PA10004	1832	0.959
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT192	10	10	3	3	tacrolimus	SOCS1	PA451578	8651	0.959
NULL	Crit_Care_2008_Dec_17_12(6)_R159.nxml.txt.nlp	19091080	SENT14	21	21	1	1	forskolin	CD14	PA146096022	929	0.959
NULL	Biomed_Res_Int_2014_Apr_15_2014_232817.nxml.txt.nlp	24822185	SENT70	29	29	14	14	cisplatin	ALK7	PA449014	130399	0.959
NULL	Curr_Med_Chem_2009_Aug_16(23)_3041-3053.nxml.txt.nlp	19689281	SENT171	27	27	12	12	napqi	IL10		3586	0.959
NULL	Int_J_Gen_Med_2012_Nov_9_5_935-942.nxml.txt.nlp	23204857	SENT77	41	41	10	10	pentobarbital	AIDA	PA450859	64853	0.959
NULL	J_Med_Chem_2014_Feb_13_57(3)_677-685.nxml.txt.nlp	24428777	SENT122	21	21	5	5	geldanamycin	AKT	PA152031327	207	0.959
NULL	J_Adv_Pract_Oncol_2012_Sep_1_Sep-Oct_3(5)_343-344.nxml.txt.nlp	25031965	SENT57	10	10	15	15	capecitabine	DPD	PA448771	1806	0.959
NULL	Oncotarget_2013_Jun_4_4(5)_772-784.nxml.txt.nlp	23800712	SENT131	45	45	14	14	erlotinib	EGFR	PA134687924	1956	0.959
NULL	Ecancermedicalscience_2008_Feb_18_2_75.nxml.txt.nlp	22275966	SENT152	32	32	7	7	cisplatin	ERCC1	PA449014	2067	0.959
NULL	Scand_J_Infect_Dis_2012_Dec_9_44(12)_997-1000.nxml.txt.nlp	22776013	SENT28	23	23	1	1	lamivudine	CD4	PA450163	920	0.959
NULL	Case_Rep_Dermatol_2011_Oct_11_3(3)_223-227.nxml.txt.nlp	22135629	SENT67	9	9	26	26	trastuzumab	HER2	PA451743	2064	0.959
NULL	Oncotarget_2014_Sep_10_5(20)_9877-9888.nxml.txt.nlp	25245676	SENT170	33	33	23	23	cetuximab	EGFR	PA10040	1956	0.959
NULL	Pharmaceuticals_(Basel)_2012_Aug_10_5(8)_802-836.nxml.txt.nlp	24280676	SENT40	0	0	9	9	gemcitabine	CNT1	PA449748	9154	0.959
NULL	Acta_Pharmacol_Sin_2012_Aug_9_33(8)_1069-1079.nxml.txt.nlp	22773077	SENT11	23	23	10	10	cyclosporine	P-gp	PA449167	5243	0.959
NULL	Br_J_Cancer_2013_Mar_19_108(5)_1079-1091.nxml.txt.nlp	23449353	SENT173	18	18	9	9	docetaxel	MIC-1	PA449383	29919;9518	0.959
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT784	37	37	3	3	aliskiren	OATP1B3	PA143487910	28234	0.959
NULL	Neuroscience_2011_Aug_25_189(1-2)_316-329.nxml.txt.nlp	21616128	SENT399	7	7	17	17	pilocarpine	CA2	PA450962	760	0.959
NULL	Inflammopharmacology_2013_Aug_6_21(5)_339-363.nxml.txt.nlp	23918298	SENT248	0	0	13	13	denosumab	RANKL	PA166048634	8600	0.959
NULL	Ann_Oncol_2014_May_6_25(5)_959-967.nxml.txt.nlp	24504448	SENT12	8	8	4	4	vemurafenib	BRAF	PA165946873	673	0.959
NULL	Nucleic_Acids_Res_2012_Jan_9_40(1)_11-26.nxml.txt.nlp	21908410	SENT306	6	6	20	20	neomycin	MBNL1	PA450608	4154	0.959
NULL	Indian_J_Dermatol_2013_Nov-Dec_58(6)_485-486.nxml.txt.nlp	24249905	SENT37	20	20	18	18	anastrozole	aromatase	PA448432	1588	0.959
NULL	Cell_Commun_Signal_2004_Jun_30_2_6.nxml.txt.nlp	15228623	SENT10	17	17	10	10	flunarizine	TTN	PA164776636	7273	0.959
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Jan_10_6_1-13.nxml.txt.nlp	24648765	SENT29	0	0	37	37	tamoxifen	CYP3A4	PA451581	1576	0.959
NULL	Cancers_(Basel)_2014_Jul_22_6(3)_1540-1552.nxml.txt.nlp	25055117	SENT226	4	4	0	0	crizotinib	Met	PA165946122	79811	0.959
NULL	Arthritis_Res_Ther_2009_Oct_14_11(5)_251.nxml.txt.nlp	19849819	SENT297	6	6	1	1	alendronate	PTH	PA448082	5741	0.959
NULL	Oxid_Med_Cell_Longev_2013_Jun_11_2013_870472.nxml.txt.nlp	23840921	SENT34	3	3	12	12	chloroquine	HO-1	PA448948	3162	0.959
NULL	Front_Cell_Neurosci_2013_Dec_18_7_250.nxml.txt.nlp	24391538	SENT451	17	17	5	5	suramin	CA3	PA10292	761	0.959
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1699-1708.nxml.txt.nlp	19861960	SENT159	43	43	34	34	dasatinib	STAT3	PA162372878	6774	0.959
NULL	Indian_J_Anaesth_2014_Mar-Apr_58(2)_154-159.nxml.txt.nlp	24963179	SENT72	23	23	30	30	fentanyl	ANOVA	PA449599	4858	0.959
NULL	Acta_Pharmacol_Sin_2009_Sep_24_30(9)_1262-1275.nxml.txt.nlp	19701231	SENT222	14	14	0	0	lovastatin	HIST1H2AC	PA450272	8334	0.959
NULL	Asian_Spine_J_2008_Dec_31_2(2)_109-113.nxml.txt.nlp	20404966	SENT67	6	6	25	25	gefitinib	RANKL	PA131301952	8600	0.959
NULL	Oncotarget_2014_Jun_1_5(13)_4855-4867.nxml.txt.nlp	24952592	SENT82	26	26	16	16	platinum	HGF	PA150595617	3569;6654;3082	0.959
NULL	Aging_(Albany_NY)_2012_Jul_22_4(7)_480-498.nxml.txt.nlp	22837425	SENT159	3	3	9	9	metformin	AMPK	PA450395	5563	0.959
NULL	J_Hematol_Oncol_2013_Jan_17_6_8.nxml.txt.nlp	23327547	SENT26	7	7	27	27	sulindac	JNK1	PA451565	5599	0.959
NULL	Clin_Med_Insights_Womens_Health_2013_Jan_22_6_1-11.nxml.txt.nlp	24665209	SENT43	7	7	5	5	anastrozole	aromatase	PA448432	1588	0.959
NULL	Exp_Ther_Med_2014_Mar_10_7(3)_640-648.nxml.txt.nlp	24520260	SENT150	19	19	9	9	resveratrol	p53		7157	0.959
NULL	Acta_Pharmacol_Sin_2014_Jun_5_35(6)_727-737.nxml.txt.nlp	24793312	SENT15	9	9	39	39	pioglitazone	B27	PA450970	56246	0.959
NULL	Mol_Imaging_Biol_2010_Oct_1_12(5)_539-546.nxml.txt.nlp	19949980	SENT78	30	30	2	2	l-glutamine	IL2	PA10090	3558	0.959
NULL	Br_J_Clin_Pharmacol_2013_Aug_23_76(2)_299-315.nxml.txt.nlp	23701319	SENT125	21	21	5	5	daclizumab	IL-8	PA164764446	3576	0.959
NULL	J_Cell_Biol_2005_May_23_169(4)_681-691.nxml.txt.nlp	15911882	SENT80	14	14	5	5	heparin	MMP9	PA449855	4318	0.959
NULL	Oncotarget_2012_Jan_28_3(1)_22-30.nxml.txt.nlp	22289880	SENT92	8	8	3	3	rituximab	CXCL10	PA451261	3627	0.959
NULL	J_Oncol_2013_Aug_20_2013_732047.nxml.txt.nlp	24027583	SENT109	32	32	4	4	paclitaxel	HER2	PA450761	2064	0.959
NULL	Brief_Funct_Genomics_2013_Jan_14_12(1)_46-57.nxml.txt.nlp	23242178	SENT195	10	10	2	2	hyaluronan	RHAMM	PA165958431	3161	0.959
NULL	Nature_2012_Aug_16_488(7411)_384-388.nxml.txt.nlp	22820255	SENT97	21	21	3	3	doxycycline	CD4	PA449415	920	0.959
NULL	Arthritis_Res_Ther_2004_Jun_21_6(Suppl_2)_S31-S35.nxml.txt.nlp	15228619	SENT96	17	17	5	5	methotrexate	ACR	PA450428	49	0.959
NULL	Front_Genet_2012_Nov_5_3_236.nxml.txt.nlp	23133441	SENT122	25	25	11	11	efavirenz	ABCB1	PA449441	5243	0.959
NULL	Oncogene_2013_Sep_26_32(39)_10_1038_onc_2012_491.nxml.txt.nlp	23108394	SENT120	19	19	23	23	epirubicin	FOXM1	PA449476	2305	0.959
NULL	Diabetes_Care_2010_Apr_12_33(4)_861-868.nxml.txt.nlp	20067962	SENT133	34	34	8	8	hyaluronan	TLR4	PA165958431	7099	0.959
NULL	Arthritis_Rheum_2013_Sep_26_65(9)_2290-2300.nxml.txt.nlp	23740547	SENT204	26	26	12	12	doxycycline	DIP	PA449415	23151;1831	0.959
NULL	Eur_J_Clin_Pharmacol_2013_Mar_11_69(3)_327-339.nxml.txt.nlp	22782539	SENT283	16	16	5	5	dabigatran	CYP2C19		1557	0.959
NULL	Oncotarget_2013_Dec_17_5(1)_67-77.nxml.txt.nlp	24393766	SENT167	8	8	23	23	curcumin	merlin	PA151958596	4771	0.959
NULL	Oxid_Med_Cell_Longev_2013_Apr_21_2013_412576.nxml.txt.nlp	23710286	SENT106	14	14	29	29	curcumin	NRF1	PA151958596	4899;4779	0.959
NULL	J_Viral_Hepat_2007_Nov_14(11)_788-796.nxml.txt.nlp	17927615	SENT30	19	19	9	9	ribavirin	IFN	PA451241	3439	0.959
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT240	14	14	9	9	pemetrexed	UNG	PA10810	7374	0.959
NULL	Open_Cardiovasc_Med_J_2010_Jul_20_4_151-156.nxml.txt.nlp	20922049	SENT55	3	3	23	23	heparin	ACT	PA449855	12;11332;9457;641455	0.959
NULL	Mediators_Inflamm_2010_Jun_2_2010_682879.nxml.txt.nlp	20592757	SENT184	19	19	9	9	l-arginine	MCP-1	PA448478	6347	0.959
NULL	Aging_(Albany_NY)_2009_Jun_3_1(6)_515-528.nxml.txt.nlp	20157535	SENT95	25	25	9	9	resveratrol	SIRT1		23411	0.959
NULL	Mol_Cancer_2010_Apr_15_9_77.nxml.txt.nlp	20398291	SENT84	8	8	20	20	geldanamycin	p53	PA152031327	7157	0.959
NULL	Br_J_Cancer_2004_Mar_5_90(Suppl_1)_S11-S14.nxml.txt.nlp	15094759	SENT6	10	10	13	13	fulvestrant	aromatase	PA164747170	1588	0.959
NULL	Cardiol_Res_Pract_2012_Apr_22_2012_181394.nxml.txt.nlp	22577589	SENT176	16	16	0	0	thrombin	ATIII	PA451674	462	0.959
NULL	Cell_Death_Differ_2010_Oct_30_17(10)_1624-1635.nxml.txt.nlp	20431602	SENT45	20	20	8	8	paclitaxel	Mcl-1	PA450761	4170	0.959
NULL	Curr_Pharm_Biotechnol_2012_May_13(6)_969-986.nxml.txt.nlp	22039792	SENT81	7	7	34	34	butorphanol	MDR1	PA164745398	5243	0.959
NULL	J_Thromb_Haemost_2014_May_22_12(5)_748-760.nxml.txt.nlp	24612393	SENT127	6	6	25	25	thrombin	PI3	PA451674	5266	0.959
NULL	Int_J_Mol_Sci_2014_Jun_25_15(7)_11220-11233.nxml.txt.nlp	24968265	SENT133	5	5	15	15	temsirolimus	REST	PA164746890	5978	0.959
NULL	Mol_Biol_Cell_2013_Jul_1_24(13)_2098-2111.nxml.txt.nlp	23676662	SENT67	11	11	31	31	tetracycline	BiP	PA451640	3309	0.959
NULL	Cell_Div_2012_Dec_26_7_26.nxml.txt.nlp	23268747	SENT75	0	0	17	17	bortezomib	p27	PA10252	5715;10534	0.959
NULL	Br_J_Pharmacol_2013_Apr_25_168(8)_1868-1877.nxml.txt.nlp	23194305	SENT213	4	4	22	22	bortezomib	ALDH2	PA10252	217	0.959
NULL	Acta_Pharmacol_Sin_2013_Jan_17_34(1)_157-166.nxml.txt.nlp	23247593	SENT252	36	36	25	25	berberine	Set9	PA165860812	80854	0.959
NULL	Evid_Based_Complement_Alternat_Med_2014_Jul_8_2014_537014.nxml.txt.nlp	25114706	SENT23	0	0	17	17	resveratrol	SIRT1		23411	0.959
NULL	Exp_Ther_Med_2013_Nov_13_6(5)_1317-1321.nxml.txt.nlp	24223665	SENT112	21	21	4	4	cisplatin	ABCG2	PA449014	9429	0.959
NULL	BMJ_Open_2014_Sep_4_4(9)_e005423.nxml.txt.nlp	25190618	SENT127	24	24	14	14	iloperidone	HTR2C	PA161199368	3358	0.959
NULL	Oncogene_2010_Sep_16_29(37)_5135-5145.nxml.txt.nlp	20622897	SENT10	19	19	4	4	cetuximab	EGF	PA10040	1950	0.959
NULL	Antiviral_Res_2009_May_82(2)_A99-A109.nxml.txt.nlp	19176219	SENT178	12	12	21	21	saquinavir	OCT2	PA451305	6582;5452	0.959
NULL	Br_J_Cancer_2012_Dec_4_107(12)_1950-1955.nxml.txt.nlp	23169295	SENT95	3	3	11	11	oxaliplatin	ERCC1	PA131285527	2067	0.959
NULL	Eur_J_Clin_Pharmacol_2011_May_8_67(5)_493-506.nxml.txt.nlp	21140139	SENT33	0	0	7	7	oxymorphone	CYP3A4	PA450748	1576	0.959
NULL	J_Oncol_2009_Mar_24_2009_491985.nxml.txt.nlp	19325924	SENT85	22	22	2	2	genistein	CXCL12	PA165109660	6387	0.959
NULL	Clin_Med_Insights_Oncol_2013_Jul_4_7_159-163.nxml.txt.nlp	23885182	SENT86	20	20	46	46	doxorubicin	CHOP	PA449412	1649	0.959
NULL	J_Biomed_Sci_2012_Nov_21_19(1)_99.nxml.txt.nlp	23170833	SENT185	25	25	10	10	atorvastatin	CXCR4	PA448500	7852	0.959
NULL	Drug_Target_Insights_2006_Oct_26_1_13-17.nxml.txt.nlp	21901054	SENT38	15	15	2	2	fluoxetine	5-HT1A	PA449673	3350	0.959
NULL	Br_J_Cancer_2010_Feb_16_102(4)_645-650.nxml.txt.nlp	20087347	SENT25	9	9	15	15	goserelin	aromatase	PA164747674	1588	0.959
NULL	Oncotarget_2014_Mar_14_5(10)_3029-3038.nxml.txt.nlp	24912489	SENT81	30	30	20	20	anastrozole	aromatase	PA448432	1588	0.959
NULL	Endocr_Relat_Cancer_2014_Apr_21(2)_311-326.nxml.txt.nlp	24478054	SENT141	24	24	2	2	denosumab	RANKL	PA166048634	8600	0.959
NULL	Clin_Sci_(Lond)_2009_Nov_16_118(Pt_4)_269-279.nxml.txt.nlp	19698082	SENT98	0	0	8	8	ramipril	ACE2	PA451223	59272	0.959
NULL	Mol_Cell_Proteomics_2014_Aug_19_13(8)_2017-2030.nxml.txt.nlp	24947669	SENT317	7	7	32	32	heparin	14-3-3	PA449855	10971	0.959
NULL	Toxins_(Basel)_2010_Oct_26_2(11)_2490-2518.nxml.txt.nlp	22069563	SENT216	6	6	11	11	cisplatin	TLR4	PA449014	7099	0.959
NULL	Mol_Neurobiol_2010_Jun_2_41(2-3)_392-409.nxml.txt.nlp	20437209	SENT299	26	26	0	0	curcumin	5-LOX	PA151958596	240	0.959
NULL	Lab_Invest_2010_Nov_28_90(11)_1573-1581.nxml.txt.nlp	20585312	SENT89	9	9	39	39	telmisartan	AT2	PA451605	186	0.959
NULL	Hum_Mol_Genet_2008_Aug_1_17(15)_2293-2309.nxml.txt.nlp	18424448	SENT205	25	25	4	4	estradiol	ESR1	PA449503	2099	0.959
NULL	Oncoimmunology_2012_Jul_1_1(4)_493-506.nxml.txt.nlp	22754768	SENT148	24	24	16	16	carboplatin	CD40L	PA448803	959	0.959
NULL	Arthritis_Res_Ther_2006_Feb_3_8(2)_R43.nxml.txt.nlp	16507142	SENT169	25	25	11	11	fluorescein	CXCL12	PA164746009	6387	0.959
NULL	Diabetes_2011_Nov_17_60(11)_2691-2700.nxml.txt.nlp	21896928	SENT147	0	0	7	7	resveratrol	SIRT1		23411	0.959
NULL	Cell_Death_Dis_2014_Apr_24_5(4)_e1197.nxml.txt.nlp	24763054	SENT91	38	38	3	3	doxorubicin	RUNX3	PA449412	864	0.959
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jun_30_66(Pt_7)_o1881.nxml.txt.nlp	21588075	SENT60	6	6	26	26	isoniazid	mol	PA450112	90527	0.959
NULL	Diabetes_Care_2010_Nov_33(11)_2484-2485.nxml.txt.nlp	20980428	SENT36	25	25	8	8	bevacizumab	VEGF-A	PA130232992	7422	0.959
NULL	Nat_Commun_2014_Nov_24_5_5514.nxml.txt.nlp	25417698	SENT767	15	15	7	7	curcumin	LC3	PA151958596	84557	0.959
NULL	Eur_J_Neurosci_2007_Mar_1_25(6)_1619-1630.nxml.txt.nlp	17408433	SENT187	20	20	41	41	dextran	CB1	PA449261	1268	0.959
NULL	Cancer_Cell_Int_2005_Oct_4_5_30.nxml.txt.nlp	16202168	SENT57	26	26	3	3	fexofenadine	MDR1	PA449621	5243	0.959
NULL	Exp_Cell_Res_2011_Apr_15_317(7)_1028-1039.nxml.txt.nlp	21237154	SENT216	31	31	16	16	staurosporine	JIP1	PA165109623	9479	0.959
NULL	Cell_Death_Dis_2010_Oct_21_1(10)_e86.nxml.txt.nlp	21368859	SENT35	7	7	27	27	doxorubicin	SMAC	PA449412	56616	0.959
NULL	Drug_Healthc_Patient_Saf_2012_Jun_6_4_39-54.nxml.txt.nlp	22792008	SENT201	23	23	13	13	lorazepam	UGT	PA450267	7361;7355	0.959
NULL	EMBO_J_2008_Mar_19_27(6)_852-864.nxml.txt.nlp	18309296	SENT318	12	12	6	6	nutlin-3	p53		7157	0.959
NULL	Cancer_Res_Treat_2014_Jan_15_46(1)_48-54.nxml.txt.nlp	24520223	SENT56	17	17	5	5	bevacizumab	KRAS	PA130232992	3845	0.959
NULL	J_Vis_Exp_2014_Jun_28_(88)_51278.nxml.txt.nlp	24998179	SENT255	10	10	24	24	cyclosporine	P-gp	PA449167	5243	0.959
NULL	Neuro_Oncol_2011_Jan_25_13(1)_70-83.nxml.txt.nlp	20978004	SENT258	30	30	38	38	etoposide	CD133	PA449552	8842	0.959
NULL	Mol_Cancer_2009_Nov_10_8_99.nxml.txt.nlp	19903356	SENT150	25	25	6	6	imatinib	IGFBP3	PA10804	3486	0.959
NULL	Biomed_Res_Int_2014_Mar_6_2014_712893.nxml.txt.nlp	24734240	SENT153	15	15	2	2	ethanol	JNK	PA448073	5599	0.959
NULL	Diabetologia_2009_Oct_14_52(10)_2046-2055.nxml.txt.nlp	19688338	SENT36	0	0	5	5	liraglutide	GLP-1	PA165958364	100125288	0.959
NULL	Breast_Cancer_Res_Treat_2013_Sep_1_141(2)_243-248.nxml.txt.nlp	23996142	SENT111	19	19	17	17	letrozole	aromatase	PA450196	1588	0.959
NULL	Mol_Cancer_2014_Apr_17_13_85.nxml.txt.nlp	24741998	SENT57	40	40	13	13	rituximab	CD40L	PA451261	959	0.959
NULL	Cells_2014_Apr_8_3(2)_258-287.nxml.txt.nlp	24717323	SENT229	12	12	4	4	capsaicin	TRPV1	PA448776	7442	0.959
NULL	Exp_Ther_Med_2014_Nov_29_8(5)_1473-1478.nxml.txt.nlp	25289044	SENT141	13	13	0	0	heparin	AZU	PA449855	566	0.959
NULL	Oxid_Med_Cell_Longev_2013_Jun_2_2013_793525.nxml.txt.nlp	23819014	SENT250	20	20	9	9	resveratrol	AMPK		5563	0.959
NULL	Cancer_Med_2014_Dec_13_3(6)_1579-1594.nxml.txt.nlp	25124282	SENT24	22	22	10	10	temozolomide	PARP-1	PA451609	25976	0.959
NULL	Clin_Med_Insights_Oncol_2013_Jun_20_7_137-149.nxml.txt.nlp	23843723	SENT125	42	42	14	14	paclitaxel	BRAF	PA450761	673	0.959
NULL	Breast_Cancer_Res_2006_Nov_6_8(6)_215.nxml.txt.nlp	17096862	SENT101	0	0	30	30	lapatinib	HER2	PA152241907	2064	0.959
NULL	Breast_Cancer_(Auckl)_2011_Jan_13_5_1-14.nxml.txt.nlp	21494397	SENT52	20	20	9	9	carbamazepine	CYP3A4	PA448785	1576	0.959
NULL	Appl_Clin_Genet_2013_Dec_24_7_1-13.nxml.txt.nlp	24399884	SENT248	0	0	15	15	eplerenone	CYP3A4	PA164749044	1576	0.959
NULL	Arthritis_Res_Ther_2009_Jul_23_11(4)_236.nxml.txt.nlp	19664185	SENT33	4	4	29	29	etoricoxib	COX2	PA164776853	4513;5743	0.959
NULL	Mol_Cancer_2010_Nov_13_9_293.nxml.txt.nlp	21073737	SENT131	7	7	24	24	choline	KRAS	PA448976	3845	0.959
NULL	Case_Rep_Neurol_Med_2014_Mar_5_2014_164826.nxml.txt.nlp	24716014	SENT53	0	0	13	13	fluconazole	CD4	PA449653	920	0.959
NULL	Arthritis_Res_Ther_2004_Sep_13_6(Suppl_3)_63.nxml.txt.nlp	NULL	SENT15	7	7	15	15	adalimumab	IL-6	PA10004	3569	0.959
NULL	Front_Pharmacol_2014_Nov_28_5_255.nxml.txt.nlp	25506327	SENT645	5	5	9	9	maraviroc	CCR5	PA164768835	1234	0.959
NULL	Br_J_Cancer_2010_Jan_19_102(2)_294-300.nxml.txt.nlp	19953095	SENT163	9	9	31	31	tamoxifen	ESR1	PA451581	2099	0.959
NULL	Scientifica_(Cairo)_2012_Oct_9_2012_821549.nxml.txt.nlp	24278743	SENT338	9	9	0	0	risperidone	5-HT2A	PA451257	3356	0.959
NULL	Acta_Pharmacol_Sin_2014_Oct_25_35(10)_1293-1301.nxml.txt.nlp	25152022	SENT189	28	28	8	8	enalapril	NLRP3	PA449456	114548	0.959
NULL	Indian_J_Pharmacol_2008_Oct_40(Suppl_2)_S211-S221.nxml.txt.nlp	21593975	SENT42	0	0	8	8	rosiglitazone	gamma	PA451283	9913	0.959
NULL	Eur_J_Clin_Pharmacol_2013_Mar_11_69(3)_327-339.nxml.txt.nlp	22782539	SENT271	12	12	4	4	verapamil	P-gp	PA451868	5243	0.959
NULL	Acta_Pharmacol_Sin_2010_Mar_22_31(3)_329-340.nxml.txt.nlp	20173759	SENT232	16	16	5	5	ethanol	AMPK	PA448073	5563	0.959
NULL	Indian_J_Pharmacol_2008_Mar-Apr_40(2)_84-86.nxml.txt.nlp	21279172	SENT91	15	15	28	28	lidocaine	CYP3A4	PA450226	1576	0.959
NULL	Int_J_Mol_Sci_2014_Sep_5_15(9)_15754-15765.nxml.txt.nlp	25198898	SENT5	5	5	38	38	curcumin	JNK	PA151958596	5599	0.959
NULL	Arthritis_Res_Ther_2006_Jul_21_8(4)_R130.nxml.txt.nlp	16859540	SENT273	29	29	45	45	atorvastatin	CD59	PA448500	966	0.959
NULL	J_Biol_2003_Sep_24_2(4)_28.nxml.txt.nlp	14511394	SENT13	8	8	37	37	phenformin	LKB1	PA1000	6794	0.959
NULL	J_Cell_Biol_2004_Feb_2_164(3)_441-449.nxml.txt.nlp	14744997	SENT212	4	4	0	0	heparin	HMGB1	PA449855	3146	0.959
NULL	Int_J_Biol_Sci_2012_Sep_6_8(8)_1109-1120.nxml.txt.nlp	22991499	SENT159	6	6	24	24	l-arginine	IFN	PA448478	3439	0.959
NULL	Mol_Cell_Biochem_2015_Oct_8_398(1-2)_165-173.nxml.txt.nlp	25292312	SENT188	5	5	23	23	bortezomib	NOXA	PA10252	5366	0.959
NULL	Korean_J_Anesthesiol_2013_Dec_26_65(6_Suppl)_S62-S64.nxml.txt.nlp	24478876	SENT23	6	6	24	24	heparin	ACT	PA449855	12;11332;9457;641455	0.959
NULL	Avicenna_J_Phytomed_2014_Jul-Aug_4(4)_276-286.nxml.txt.nlp	25068142	SENT109	39	39	10	10	lamotrigine	HEG	PA450164	57493	0.959
NULL	Oncogene_2010_Sep_16_29(37)_5135-5145.nxml.txt.nlp	20622897	SENT76	5	5	21	21	cetuximab	STAT3	PA10040	6774	0.959
NULL	J_Headache_Pain_2013_Apr_10_14(1)_33.nxml.txt.nlp	23574808	SENT167	7	7	15	15	capsaicin	TRPV1	PA448776	7442	0.959
NULL	Scientifica_(Cairo)_2012_Oct_9_2012_821549.nxml.txt.nlp	24278743	SENT338	13	13	0	0	clozapine	5-HT2A	PA449061	3356	0.959
NULL	Arthritis_Res_Ther_2013_Sep_10_15(5)_R110.nxml.txt.nlp	24020899	SENT113	2	2	11	11	pioglitazone	IL-6	PA450970	3569	0.959
NULL	J_Immunotoxicol_2013_Jan_11_10(1)_75-82.nxml.txt.nlp	22967038	SENT102	12	12	36	36	rituximab	IFN	PA451261	3439	0.959
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Aug_21_69(Pt_9)_m510-m511.nxml.txt.nlp	24427002	SENT10	2	2	23	23	nitrile	mol	PA450636	90527	0.959
NULL	Orphanet_J_Rare_Dis_2014_Mar_19_9_38.nxml.txt.nlp	24646194	SENT336	0	0	11	11	vincristine	HNPP	PA451879	5376	0.959
NULL	Trials_2012_Sep_8_13_160.nxml.txt.nlp	22958580	SENT5	18	18	12	12	succinylcholine	LSR	PA451522	51599	0.959
NULL	Breast_Cancer_Res_2007_Jun_4_9(3)_207.nxml.txt.nlp	17561991	SENT12	11	11	4	4	trastuzumab	HER-2	PA451743	2064	0.959
NULL	Br_J_Cancer_2009_Mar_10_100(5)_758-763.nxml.txt.nlp	19259094	SENT72	8	8	2	2	decitabine	MLH1	PA164749631	4292	0.959
NULL	Korean_J_Anesthesiol_2013_Jan_21_64(1)_47-53.nxml.txt.nlp	23372886	SENT26	18	18	2	2	bupivacaine	IGK	PA135057240	50802	0.959
NULL	Cancers_(Basel)_2011_Aug_19_3(3)_3370-3393.nxml.txt.nlp	24212958	SENT193	40	40	16	16	cetuximab	CD16a	PA10040	2214	0.959
NULL	Cell_Death_Dis_2012_Jul_19_3(7)_e353.nxml.txt.nlp	22825471	SENT124	22	22	11	11	camptothecin	ATF3	PA153590860	467	0.959
NULL	Cell_Cycle_2012_Nov_1_11(21)_3983-3996.nxml.txt.nlp	22987153	SENT167	12	12	3	3	cisplatin	DNA2	PA449014	1763	0.959
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_39-54.nxml.txt.nlp	19305787	SENT184	28	28	13	13	ethanol	NR1	PA448073	27158	0.959
NULL	Br_J_Pharmacol_2014_Jan_23_171(2)_523-535.nxml.txt.nlp	24372553	SENT101	10	10	22	22	metformin	SIRT1	PA450395	23411	0.959
NULL	Indian_J_Med_Res_2011_May_133(5)_529-534.nxml.txt.nlp	21623039	SENT29	13	13	0	0	ethambutol	DST	PA164784021	667	0.959
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT122	14	14	23	23	pp2	PP2		4888	0.959
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Feb_15_5_3.nxml.txt.nlp	16480505	SENT105	0	0	17	17	rifabutin	CYP3A4	PA451249	1576	0.959
NULL	Oncotarget_2012_Dec_30_3(12)_1505-1521.nxml.txt.nlp	23455493	SENT278	3	3	20	20	metformin	p53	PA450395	7157	0.959
NULL	Pharmaceuticals_(Basel)_2012_Aug_10_5(8)_802-836.nxml.txt.nlp	24280676	SENT90	34	34	8	8	ribavirin	CNT1	PA451241	9154	0.959
NULL	Breast_Cancer_(Auckl)_2009_Aug_17_3_47-60.nxml.txt.nlp	21556249	SENT48	8	8	24	24	tamoxifen	AF-1	PA451581	3460;5710	0.959
NULL	Oncol_Rep_2013_Jun_22_29(6)_2479-2485.nxml.txt.nlp	23525656	SENT125	6	6	25	25	erlotinib	MRP7	PA134687924	89845;1080	0.959
NULL	Br_J_Cancer_2010_Mar_16_102(6)_995-1002.nxml.txt.nlp	20179708	SENT22	33	33	21	21	trastuzumab	EGFR	PA451743	1956	0.959
NULL	J_Cell_Biol_1998_Jan_26_140(2)_335-345.nxml.txt.nlp	9442109	SENT210	25	25	2	2	chloroquine	NHE	PA448948	285335	0.959
NULL	Mol_Cancer_2009_Dec_23_8_129.nxml.txt.nlp	20030852	SENT148	12	12	32	32	curcumin	CXCL1	PA151958596	2919	0.959
NULL	Gut_2013_Sep_7_62(9)_1340-1346.nxml.txt.nlp	23135762	SENT160	17	17	6	6	ribavirin	IL28B	PA451241	282617	0.959
NULL	Clin_Mol_Allergy_2007_Jan_25_5_1.nxml.txt.nlp	17254346	SENT190	33	33	5	5	curcumin	IL-5	PA151958596	3567	0.959
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT244	5	5	12	12	pp2	AKT		207	0.959
NULL	Int_J_Environ_Res_Public_Health_2010_Apr_29_7(4)_1392-1431.nxml.txt.nlp	20617037	SENT260	43	43	26	26	ethanol	CRF2	PA448073	1395	0.959
NULL	Indian_J_Anaesth_2011_Mar-Apr_55(2)_160-162.nxml.txt.nlp	21712873	SENT74	11	11	21	21	propofol	MMD	PA451141	23531	0.959
NULL	Mediators_Inflamm_2010_Nov_29_2010_143026.nxml.txt.nlp	21127728	SENT24	5	5	17	17	lamivudine	CD4	PA450163	920	0.959
NULL	Mol_Pain_2013_Feb_15_9_3.nxml.txt.nlp	23413875	SENT210	12	12	19	19	resveratrol	TRPA1		8989	0.959
NULL	Clin_Sci_(Lond)_2013_Feb_1_124(Pt_3)_153-164.nxml.txt.nlp	23075334	SENT261	14	14	10	10	resveratrol	SIRT1		23411	0.959
NULL	Cancer_Med_2014_Feb_10_3(1)_134-142.nxml.txt.nlp	24407937	SENT182	13	13	5	5	tamoxifen	aromatase	PA451581	1588	0.959
NULL	Br_J_Cancer_2014_Jan_21_110(2)_330-340.nxml.txt.nlp	24281000	SENT193	11	11	0	0	doxorubicin	CHKA	PA449412	1119	0.959
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT352	11	11	15	15	heparin	FGF1	PA449855	2246	0.959
NULL	Nucleic_Acids_Res_2012_Sep_8_40(16)_8059-8071.nxml.txt.nlp	22684629	SENT238	7	7	20	20	forskolin	U2AF65	PA146096022	11338	0.959
NULL	Ann_Gen_Psychiatry_2013_Aug_13_12_26.nxml.txt.nlp	23941527	SENT152	12	12	0	0	venlafaxine	NMA	PA451866	25805	0.959
NULL	AIDS_Res_Ther_2014_May_21_11_14.nxml.txt.nlp	24904682	SENT23	13	13	9	9	maraviroc	CCR5	PA164768835	1234	0.959
NULL	Clin_Drug_Investig_2014_Nov_9_34(2)_107-115.nxml.txt.nlp	24214232	SENT36	0	0	11	11	cinacalcet	PTH	PA164776671	5741	0.959
NULL	Mol_Vis_2012_Nov_29_18_2839-2846.nxml.txt.nlp	23233786	SENT13	10	10	12	12	geldanamycin	CB2	PA152031327	1269	0.959
NULL	Breast_Cancer_(Auckl)_2011_Jan_13_5_1-14.nxml.txt.nlp	21494397	SENT100	13	13	33	33	ixabepilone	p53		7157	0.959
NULL	Int_J_Endocrinol_2010_Mar_2_2010_621687.nxml.txt.nlp	20204178	SENT124	17	17	26	26	paricalcitol	PTH	PA450798	5741	0.959
NULL	Curr_Neuropharmacol_2013_Dec_11(6)_652-663.nxml.txt.nlp	24396340	SENT171	20	20	9	9	capsaicin	TRPV1	PA448776	7442	0.959
NULL	Mol_Biol_Cell_2014_Jan_1_25(1)_76-86.nxml.txt.nlp	24173717	SENT17	8	8	1	1	paclitaxel	TUBB6	PA450761	84617	0.959
NULL	Biol_Open_2012_Oct_4_1(12)_1215-1225.nxml.txt.nlp	23259056	SENT171	14	14	29	29	l-leucine	LAMP2	PA450197	3920	0.959
NULL	Ann_Rheum_Dis_2008_Apr_20_67(4)_511-517.nxml.txt.nlp	17644552	SENT147	4	4	27	27	infliximab	IL-6	PA452639	3569	0.959
NULL	Oncotarget_2013_Jul_18_4(10)_1582-1591.nxml.txt.nlp	24123600	SENT139	15	15	30	30	imatinib	SLC22A1	PA10804	6580	0.959
NULL	J_Hematol_Oncol_2012_May_15_5_23.nxml.txt.nlp	22587422	SENT89	7	7	13	13	dasatinib	ALL	PA162372878	613	0.959
NULL	Infection_2007_Jun_35(3)_186-189.nxml.txt.nlp	17565462	SENT24	9	9	32	32	indinavir	CD4	PA449977	920	0.959
NULL	Diabetes_2013_Mar_14_62(3)_669-671.nxml.txt.nlp	23431005	SENT18	28	28	5	5	clopidogrel	P2Y12	PA449053	64805	0.959
NULL	EMBO_Mol_Med_2013_May_15_5(5)_751-761.nxml.txt.nlp	23505126	SENT180	11	11	2	2	trypsin	SMIM1	PA451806	388588	0.959
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_4_2012_127373.nxml.txt.nlp	23227094	SENT6	18	18	1	1	vincristine	CD50	PA451879	3385	0.959
NULL	Clin_Med_Insights_Oncol_2012_Nov_20_6_381-393.nxml.txt.nlp	23226079	SENT137	24	24	15	15	erythromycin	CYP3A4	PA449493	1576	0.959
NULL	Curr_Mol_Med_2014_Jun_14(5)_603-615.nxml.txt.nlp	24894176	SENT201	29	29	0	0	staurosporine	BI-1	PA165109623	7009	0.959
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2011_Aug_23_4_39-45.nxml.txt.nlp	22879793	SENT17	0	0	18	18	ribavirin	IFN	PA451241	3439	0.959
NULL	Cancer_Cell_Int_2011_Nov_17_11_40.nxml.txt.nlp	22088142	SENT87	16	16	9	9	gemcitabine	MRP2	PA449748	100130958;57626;1244	0.959
NULL	Diabetes_Obes_Metab_2010_May_12(5)_437-441.nxml.txt.nlp	20415692	SENT35	12	12	22	22	metformin	GLA	PA450395	9027;2717	0.959
NULL	Front_Oncol_2014_Apr_30_4_88.nxml.txt.nlp	24818101	SENT43	34	34	8	8	camptothecin	STAT1	PA153590860	6772	0.959
NULL	Int_J_Biol_Sci_2011_May_5_7(5)_567-574.nxml.txt.nlp	21552422	SENT164	16	16	4	4	etoposide	FCAS	PA449552	114548	0.959
NULL	Pharm_Pract_(Granada)_2011_Mar_15_Jan-Mar_9(1)_1-10.nxml.txt.nlp	25132883	SENT167	26	26	45	45	dabigatran	SPAF		166378	0.959
NULL	Chin_J_Cancer_2011_Oct_30(10)_731-738.nxml.txt.nlp	21959050	SENT7	22	22	9	9	cyclosporine	CHOP	PA449167	1649	0.959
NULL	Curr_Neuropharmacol_2013_Dec_11(6)_652-663.nxml.txt.nlp	24396340	SENT172	7	7	32	32	capsaicin	TRPV1	PA448776	7442	0.959
NULL	Allergy_Asthma_Clin_Immunol_2010_Mar_17_6(1)_5.nxml.txt.nlp	20236545	SENT79	12	12	34	34	azathioprine	IL-4	PA448515	3565	0.959
NULL	J_Headache_Pain_2014_Sep_18_15(Suppl_1)_F28.nxml.txt.nlp	NULL	SENT19	5	5	37	37	telmisartan	P-gp	PA451605	5243	0.959
NULL	J_Mol_Med_(Berl)_2014_Jan_10_92(5)_497-507.nxml.txt.nlp	24408111	SENT223	9	9	36	36	pioglitazone	HIF-1	PA450970	29072	0.959
NULL	Oncogene_2014_Feb_6_33(6)_713-723.nxml.txt.nlp	23435429	SENT54	11	11	2	2	etoposide	BRCA1	PA449552	672	0.959
NULL	Brain_2014_Apr_27_137(4)_1145-1155.nxml.txt.nlp	24578545	SENT236	10	10	25	25	citalopram	MRI	PA449015	78996	0.959
NULL	Br_J_Cancer_2010_Jan_5_102(1)_97-103.nxml.txt.nlp	19904270	SENT156	15	15	0	0	etoposide	XIAP	PA449552	331	0.959
NULL	Open_Cardiovasc_Med_J_2012_Dec_28_6_147-155.nxml.txt.nlp	23346258	SENT196	2	2	21	21	rimonabant	adiponectin	PA152407999	9370	0.959
NULL	Oncotarget_2014_Aug_19_5(18)_8737-8749.nxml.txt.nlp	25228590	SENT174	13	13	37	37	crizotinib	MYCN	PA165946122	4613	0.959
NULL	Mol_Biol_Cell_2012_Sep_15_23(18)_3499-3510.nxml.txt.nlp	22833567	SENT218	10	10	19	19	arsenite	WDR62	PA452638	284403	0.959
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_75-89.nxml.txt.nlp	17912638	SENT21	9	9	2	2	anastrozole	aromatase	PA448432	1588	0.959
NULL	Nucleic_Acids_Res_2005_Jun_8_33(10)_3283-3291.nxml.txt.nlp	15944449	SENT156	32	32	9	9	mechlorethamine	ERCC1	PA450336	2067	0.959
NULL	Acta_Pharmacol_Sin_2010_Dec_3_31(12)_1635-1642.nxml.txt.nlp	21127497	SENT135	0	0	8	8	fluconazole	UGT	PA449653	7361;7355	0.959
NULL	Alcohol_Res_2013_35(1)_57-67.nxml.txt.nlp	24313165	SENT191	15	15	4	4	ethanol	TLR4	PA448073	7099	0.959
NULL	Mol_Immunol_2009_Mar_46(6)_1229-1239.nxml.txt.nlp	19135256	SENT629	15	15	3	3	trypsin	DC2	PA451806	58505	0.959
NULL	Breast_Cancer_Res_2011_Feb_23_13(1)_203.nxml.txt.nlp	21392408	SENT153	34	34	16	16	tamoxifen	aromatase	PA451581	1588	0.959
NULL	Commun_Integr_Biol_2013_Sep_1_6(5)_e25145.nxml.txt.nlp	24255740	SENT59	27	27	36	36	neomycin	DAG	PA450608	1605	0.959
NULL	Arthritis_Res_Ther_2006_Jul_21_8(4)_R130.nxml.txt.nlp	16859540	SENT169	12	12	35	35	lovastatin	CD59	PA450272	966	0.959
NULL	Mol_Cancer_2012_Jun_18_11_41.nxml.txt.nlp	22709873	SENT4	17	17	9	9	capecitabine	EGFR	PA448771	1956	0.959
NULL	Cardiovasc_Drugs_Ther_2010_Dec_13_24(5-6)_391-399.nxml.txt.nlp	20640495	SENT4	0	0	28	28	dipyridamole	COX2	PA449367	4513;5743	0.959
NULL	Europace_2009_Nov_11(Suppl_5)_v58-v65.nxml.txt.nlp	19861392	SENT125	3	3	45	45	hydralazine	CRT	PA449894	811	0.959
NULL	Cancers_(Basel)_2014_Mar_6_6(1)_494-525.nxml.txt.nlp	24662938	SENT18	3	3	13	13	pyrimethamine	STAT3	PA451193	6774	0.959
NULL	J_Hematol_Oncol_2008_Oct_23_1_19.nxml.txt.nlp	18947412	SENT184	7	7	24	24	alemtuzumab	CD34	PA164783958	947	0.959
NULL	Acta_Pharmacol_Sin_2010_Jun_4_31(6)_709-717.nxml.txt.nlp	20523342	SENT13	24	24	1	1	repaglinide	IGF2BP2	PA451234	10644	0.959
NULL	Biomed_Res_Int_2014_Jan_29_2014_232870.nxml.txt.nlp	24592384	SENT131	32	32	26	26	tamoxifen	HEXIM1	PA451581	10614	0.959
NULL	Diabetes_2011_Nov_17_60(11)_2691-2700.nxml.txt.nlp	21896928	SENT148	8	8	1	1	resveratrol	SIRT1		23411	0.959
NULL	Mol_Cell_Biochem_2014_Jul_26_396(1-2)_221-228.nxml.txt.nlp	25063218	SENT99	36	36	14	14	resveratrol	EGFR		1956	0.959
NULL	Breast_Cancer_Res_2007_Dec_17_9(6)_R87.nxml.txt.nlp	18086299	SENT16	4	4	28	28	trastuzumab	HER-2	PA451743	2064	0.959
NULL	Ther_Clin_Risk_Manag_2006_Sep_2(3)_235-249.nxml.txt.nlp	18360599	SENT226	11	11	22	22	alendronate	BSAP	PA448082	5079	0.959
NULL	Breast_Cancer_Res_2005_Dec_7_7(1)_R156-R163.nxml.txt.nlp	15642164	SENT105	7	7	14	14	letrozole	aromatase	PA450196	1588	0.959
NULL	Br_J_Haematol_2014_Mar_13_164(1)_811-821.nxml.txt.nlp	24328678	SENT6	35	35	11	11	lenalidomide	IKZF1	PA162363968	10320	0.959
NULL	Front_Neurosci_2014_Dec_5_8_398.nxml.txt.nlp	25538552	SENT127	2	2	16	16	glucose	gamma	PA449773	9913	0.959
NULL	Biomed_Res_Int_2013_Jan_21_2013_581631.nxml.txt.nlp	23484133	SENT96	36	36	31	31	infliximab	IFN	PA452639	3439	0.959
NULL	Front_Neurol_2012_Aug_1_3_120.nxml.txt.nlp	23015798	SENT67	13	13	1	1	ethanol	CB1	PA448073	1268	0.959
NULL	J_Cell_Mol_Med_2013_Sep_24_17(9)_1065-1087.nxml.txt.nlp	24151975	SENT250	0	0	14	14	palifermin	CD34	PA164744014	947	0.959
NULL	Mol_Cancer_2009_Jun_23_8_39.nxml.txt.nlp	19549337	SENT53	37	37	6	6	l-glutamine	PC-3	PA10090	692094	0.959
NULL	J_Neurosci_Rural_Pract_2010_Jul-Dec_1(2)_63-66.nxml.txt.nlp	21808505	SENT24	25	25	12	12	didanosine	gamma	PA449301	9913	0.959
NULL	J_Hematol_Oncol_2013_Nov_5_6_83.nxml.txt.nlp	24283248	SENT8	6	6	36	36	nutlin-3	CDKN1A		1026	0.959
NULL	Breast_Cancer_Res_2011_Feb_3_13(1)_R16.nxml.txt.nlp	21291529	SENT145	27	27	1	1	tamoxifen	PHD1	PA451581	112398	0.959
NULL	Neural_Dev_2011_Mar_18_6_8.nxml.txt.nlp	21418557	SENT110	16	16	42	42	carbachol	P14	PA448784	11102;;6280;56259	0.959
NULL	Breast_Cancer_Res_2014_Jul_29_16(4)_412.nxml.txt.nlp	25410383	SENT138	0	0	11	11	decitabine	CTR1	PA164749631	1317	0.959
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT200	27	27	14	14	ketoconazole	CYP3A4	PA450146	1576	0.959
NULL	Indian_J_Dermatol_2013_Nov-Dec_58(6)_485-486.nxml.txt.nlp	24249905	SENT37	10	10	18	18	paclitaxel	aromatase	PA450761	1588	0.959
NULL	J_Oncol_2009_Mar_24_2009_491985.nxml.txt.nlp	19325924	SENT99	5	5	32	32	genistein	CXCL12	PA165109660	6387	0.959
NULL	Cancer_Med_2012_Oct_16_1(2)_207-217.nxml.txt.nlp	23342270	SENT204	40	40	32	32	saracatinib	PIK3CA		5290	0.959
NULL	Nucleic_Acids_Res_2006_Jul_4_34(11)_3299-3308.nxml.txt.nlp	16820530	SENT41	25	25	13	13	ethanol	APOBEC-1	PA448073	339	0.959
NULL	Blood_Res_2014_Dec_23_49(4)_253-258.nxml.txt.nlp	25548759	SENT75	5	5	26	26	cyclophosphamide	CHOP	PA449165	1649	0.959
NULL	Brain_Sci_2013_Jan_30_3(1)_123-142.nxml.txt.nlp	24961310	SENT159	14	14	32	32	capsaicin	TRPV1	PA448776	7442	0.959
NULL	Cancer_Immunol_Immunother_2011_Jun_25_60(6)_793-808.nxml.txt.nlp	21350947	SENT264	11	11	20	20	temsirolimus	IFN	PA164746890	3439	0.959
NULL	J_Oncol_2010_Dec_15_2010_821717.nxml.txt.nlp	20049172	SENT44	18	18	9	9	paclitaxel	TUBB3	PA450761	10381	0.959
NULL	Breast_Cancer_Res_2007_Aug_8_9(4)_R50.nxml.txt.nlp	17686159	SENT265	7	7	29	29	trastuzumab	HRG	PA451743	3084;3273	0.959
NULL	Br_J_Cancer_2011_Jun_7_104(12)_1828-1835.nxml.txt.nlp	21559012	SENT117	34	34	17	17	tamoxifen	aromatase	PA451581	1588	0.959
NULL	Int_J_Biol_Sci_2014_Sep_6_10(9)_1007-1017.nxml.txt.nlp	25210499	SENT92	22	22	33	33	tamoxifen	p63	PA451581	8626	0.959
NULL	Cardiovasc_Diabetol_2011_Feb_1_10_14.nxml.txt.nlp	21284833	SENT174	29	29	13	13	glucose	CAD	PA449773	1677;790	0.959
NULL	Br_J_Pharmacol_2014_May_171(10)_2659-2670.nxml.txt.nlp	24116661	SENT14	24	24	13	13	naringenin	TRPP2	PA151958361	5311	0.959
NULL	J_Mol_Med_(Berl)_2014_May_10_92(7)_709-722.nxml.txt.nlp	24811491	SENT127	16	16	30	30	cetuximab	HER2	PA10040	2064	0.959
NULL	Int_J_Biol_Sci_2014_Jun_21_10(7)_702-714.nxml.txt.nlp	25013379	SENT162	22	22	6	6	gefitinib	ADAM17	PA131301952	6868	0.959
NULL	Ther_Clin_Risk_Manag_2006_Dec_2(4)_337-346.nxml.txt.nlp	18360646	SENT205	9	9	37	37	timolol	BAK	PA451690	578	0.959
NULL	Int_J_Breast_Cancer_2012_Dec_9_2012_849592.nxml.txt.nlp	23304528	SENT27	12	12	4	4	tamoxifen	aromatase	PA451581	1588	0.959
NULL	J_Cell_Biol_2008_Jul_28_182(2)_233-239.nxml.txt.nlp	18644891	SENT95	16	16	4	4	staurosporine	MICB	PA165109623	4277	0.959
NULL	Cancer_Inform_2013_Feb_13_12_31-51.nxml.txt.nlp	23470717	SENT189	29	29	47	47	cisplatin	securin	PA449014	9232	0.959
NULL	Cancer_Res_Treat_2014_Jan_15_46(1)_55-64.nxml.txt.nlp	24520224	SENT33	26	26	13	13	oxaliplatin	ERCC1	PA131285527	2067	0.959
NULL	Cell_Death_Dis_2014_Mar_13_5(3)_e1118.nxml.txt.nlp	24625977	SENT290	13	13	2	2	etoposide	UBXN2A	PA449552	165324	0.959
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Nov_27_66(Pt_12)_o3337.nxml.txt.nlp	21589611	SENT46	3	3	34	34	benzaldehyde	mol	PA448571	90527	0.959
NULL	Biomed_Res_Int_2014_May_4_2014_351252.nxml.txt.nlp	24877084	SENT183	38	38	13	13	bevacizumab	FTM	PA130232992	23322	0.959
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1420-1426.nxml.txt.nlp	24056704	SENT122	18	18	30	30	ketoconazole	CYP3A	PA450146	1574	0.959
NULL	Int_J_Med_Sci_2015_Jan_5_12(2)_135-140.nxml.txt.nlp	25589889	SENT77	22	22	3	3	aripiprazole	NMS	PA10026	129521	0.959
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT263	3	3	19	19	tacrolimus	IL-6	PA451578	3569	0.959
NULL	J_Hematol_Oncol_2008_Oct_1_1_16.nxml.txt.nlp	18828924	SENT32	0	0	19	19	lapatinib	EGFR	PA152241907	1956	0.959
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT159	0	0	11	11	lapatinib	EGFR	PA152241907	1956	0.959
NULL	Evid_Based_Complement_Alternat_Med_2014_May_8_2014_364819.nxml.txt.nlp	24899907	SENT173	16	16	32	32	tacrolimus	FKBP52	PA451578	2288	0.959
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_P113.nxml.txt.nlp	NULL	SENT14	7	7	27	27	piperacillin	CD27	PA450975	939	0.959
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT127	10	10	7	7	simvastatin	RANKL	PA451363	8600	0.959
NULL	Br_J_Cancer_2000_Jul_3_83(3)_366-374.nxml.txt.nlp	10917553	SENT8	28	28	35	35	calcein	MDR1	PA132595336	5243	0.959
NULL	eLife_2014_Aug_1_3_e02725.nxml.txt.nlp	25085081	SENT750	28	28	9	9	oxaliplatin	KRAS	PA131285527	3845	0.959
NULL	Front_Oncol_2011_Jun_28_1_12.nxml.txt.nlp	22649753	SENT125	22	22	32	32	trastuzumab	HER2	PA451743	2064	0.959
NULL	Mol_Cancer_2012_Jun_26_11_43.nxml.txt.nlp	22731636	SENT242	17	17	29	29	pp2	PP2		4888	0.959
NULL	Int_J_Nanomedicine_2012_Sep_13_7_4917-4926.nxml.txt.nlp	23028220	SENT224	35	35	22	22	calcein	mol	PA132595336	90527	0.959
NULL	Ann_Med_2011_Nov_5_43(7)_531-544.nxml.txt.nlp	21815879	SENT24	30	30	4	4	thrombin	P2Y12	PA451674	64805	0.959
NULL	Am_J_Case_Rep_2014_Apr_14_15_152-154.nxml.txt.nlp	24753783	SENT62	32	32	17	17	metformin	DPP4	PA450395	1803	0.959
NULL	Acta_Pharmacol_Sin_2009_Apr_9_30(4)_451-457.nxml.txt.nlp	19270722	SENT154	8	8	21	21	imatinib	P-gp	PA10804	5243	0.959
NULL	Arthritis_Res_Ther_2014_Apr_16_16(2)_R96.nxml.txt.nlp	24742125	SENT241	27	27	12	12	fluorescein	IL-10	PA164746009	3586	0.959
NULL	J_Immune_Based_Ther_Vaccines_2005_Sep_2_3_6.nxml.txt.nlp	16138929	SENT222	0	0	11	11	daclizumab	IL-2	PA164764446	3558	0.959
NULL	Br_J_Cancer_2012_May_22_106(11)_1779-1789.nxml.txt.nlp	22549178	SENT30	0	0	3	3	pertuzumab	HER2		2064	0.959
NULL	Mol_Cancer_2010_Apr_23_9_87.nxml.txt.nlp	20416058	SENT179	12	12	18	18	doxorubicin	TRAIL	PA449412	8743	0.959
NULL	J_Exp_Med_1995_Aug_1_182(2)_431-437.nxml.txt.nlp	7543138	SENT1	12	12	0	0	hyaluronan	CD44	PA165958431	960	0.959
NULL	Nat_Commun_2014_Aug_4_5_4535.nxml.txt.nlp	25088745	SENT122	15	15	5	5	metformin	CRTC2	PA450395	200186	0.959
NULL	Cell_Death_Dis_2010_Feb_4_1(2)_e23.nxml.txt.nlp	21364631	SENT56	19	19	32	32	desipramine	MKK4	PA449233	6416	0.959
NULL	eLife_2014_Apr_30_3_e02208.nxml.txt.nlp	24842996	SENT748	12	12	5	5	trypsin	Spc110	PA451806	26059	0.959
NULL	Oncogenesis_2012_Apr_2_1(4)_e5.nxml.txt.nlp	23552603	SENT84	5	5	13	13	celecoxib	IL-8	PA448871	3576	0.959
NULL	Int_J_Mol_Sci_2014_Jun_25_15(7)_11220-11233.nxml.txt.nlp	24968265	SENT134	5	5	15	15	sunitinib	REST	PA162372840	5978	0.959
NULL	Clin_Med_Insights_Oncol_2012_Feb_28_6_125-135.nxml.txt.nlp	22408376	SENT92	8	8	13	13	panitumumab	KRAS	PA162373091	3845	0.959
NULL	Biomed_Res_Int_2014_May_4_2014_171892.nxml.txt.nlp	24883302	SENT134	0	0	11	11	sorafenib	CRAF	PA7000	5894	0.959
NULL	J_Hematol_Oncol_2010_May_2_3_18.nxml.txt.nlp	20433767	SENT123	21	21	11	11	cisplatin	EGFR	PA449014	1956	0.959
NULL	Oncogene_2014_Sep_18_33(38)_4685-4696.nxml.txt.nlp	24121268	SENT310	18	18	1	1	bortezomib	p53	PA10252	7157	0.959
NULL	Front_Oncol_2014_Nov_3_4_299.nxml.txt.nlp	25405100	SENT277	3	3	6	6	trastuzumab	HER2	PA451743	2064	0.959
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT243	26	26	12	12	sitagliptin	GLP-1	PA164748978	100125288	0.959
NULL	Clin_Med_Insights_Oncol_2012_Mar_12_6_137-147.nxml.txt.nlp	22550402	SENT102	30	30	14	14	erlotinib	EGFR	PA134687924	1956	0.959
NULL	Exp_Diabetes_Res_2012_Mar_15_2012_146194.nxml.txt.nlp	22474415	SENT11	6	6	16	16	valsartan	GLP-1	PA451848	100125288	0.959
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT83	29	29	10	10	trastuzumab	STAT3	PA451743	6774	0.959
NULL	Gut_Liver_2011_Jun_24_5(2)_117-132.nxml.txt.nlp	21814590	SENT159	36	36	4	4	ribavirin	IFN	PA451241	3439	0.959
NULL	Front_Aging_Neurosci_2014_Sep_11_6_218.nxml.txt.nlp	25309423	SENT235	0	0	5	5	resveratrol	HO-1		3162	0.959
NULL	F1000Res_2013_Oct_8_2_173.nxml.txt.nlp	24555085	SENT19	15	15	0	0	ketoconazole	CYP3A5	PA450146	1577	0.959
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT173	18	18	10	10	sitagliptin	HIP	PA164748978	6767;6159;64399;5068	0.959
NULL	J_Med_Chem_2014_Feb_13_57(3)_1063-1078.nxml.txt.nlp	24450337	SENT660	7	7	13	13	resveratrol	SIRT1		23411	0.959
NULL	J_Autoimmune_Dis_2008_Jul_14_5_3.nxml.txt.nlp	18625050	SENT36	9	9	0	0	cyclophosphamide	C-ANCA	PA449165	5657	0.959
NULL	Oncogene_2009_Feb_5_28(5)_674-685.nxml.txt.nlp	19015634	SENT219	26	26	3	3	ethanol	FANCD2	PA448073	2177	0.959
NULL	Front_Oncol_2013_Nov_18_3_282.nxml.txt.nlp	24303367	SENT593	20	20	12	12	gemcitabine	HMGA1	PA449748	3159	0.959
NULL	Biologics_2012_Dec_17_6_429-464.nxml.txt.nlp	23269860	SENT159	20	20	4	4	etanercept	NMA	PA449515	25805	0.959
NULL	Interdiscip_Toxicol_2008_Sep_1(2)_150-154.nxml.txt.nlp	21218105	SENT76	38	38	13	13	furafylline	CYP2B	PA452614	1554;1556	0.959
NULL	Case_Rep_Rheumatol_2014_Nov_11_2014_536856.nxml.txt.nlp	25436167	SENT24	18	18	7	7	infliximab	TNF	PA452639	7124	0.959
NULL	Cancer_Cell_Int_2005_Aug_23_5_27.nxml.txt.nlp	16117829	SENT206	25	25	14	14	doxycycline	p53	PA449415	7157	0.959
NULL	Ann_Oncol_2012_Dec_2_23(12)_3007-3016.nxml.txt.nlp	22865781	SENT171	32	32	20	20	trastuzumab	IGF1R	PA451743	3480	0.959
NULL	Mol_Cancer_2010_Dec_2_9_309.nxml.txt.nlp	21122157	SENT400	24	24	11	11	paclitaxel	IL-6	PA450761	3569	0.959
NULL	Front_Genet_2012_Nov_5_3_236.nxml.txt.nlp	23133441	SENT129	14	14	8	8	efavirenz	ABCB1	PA449441	5243	0.959
NULL	Eur_J_Clin_Pharmacol_2012_Jan_7_68(1)_55-64.nxml.txt.nlp	21735164	SENT25	0	0	15	15	oxycodone	CYP2D6	PA450741	1565	0.959
NULL	EMBO_Mol_Med_2013_Mar_18_5(3)_344-352.nxml.txt.nlp	23417962	SENT127	12	12	27	27	resveratrol	HTT		3064	0.959
NULL	J_Hepatol_2010_Dec_53(6)_1101-1107.nxml.txt.nlp	20801540	SENT125	12	12	6	6	deferasirox	ACP	PA164760843	4706	0.959
NULL	Front_Physiol_2011_Dec_13_2_100.nxml.txt.nlp	22319499	SENT119	21	21	4	4	nadh	GDH	PA164755085	51084;2746	0.959
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Dec_17_3(12)_e152.nxml.txt.nlp	25518025	SENT72	16	16	14	14	paroxetine	CYP2D6	PA450801	1565	0.959
NULL	Mol_Cancer_2014_Jun_4_13_141.nxml.txt.nlp	24894453	SENT22	13	13	1	1	gefitinib	EGFR	PA131301952	1956	0.959
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT36	13	13	25	25	pemetrexed	UNG	PA10810	7374	0.959
NULL	J_Ophthalmic_Inflamm_Infect_2012_May_14_2(4)_231-233.nxml.txt.nlp	22581347	SENT61	13	13	27	27	adalimumab	TNF	PA10004	7124	0.959
NULL	Evid_Based_Complement_Alternat_Med_2012_Dec_19_2012_703034.nxml.txt.nlp	22216058	SENT102	30	30	0	0	ethanol	U87	PA448073	677775;641648	0.959
NULL	Biomed_Res_Int_2013_May_8_2013_703130.nxml.txt.nlp	23738330	SENT130	5	5	33	33	lipase	SP75	PA450239	6674	0.959
NULL	Arthritis_Res_Ther_2005_Feb_18_7(3)_R476-R484.nxml.txt.nlp	15899034	SENT103	10	10	27	27	thrombin	Rho	PA451674	29984	0.959
NULL	Reprod_Biol_Endocrinol_2013_Jun_19_11_53.nxml.txt.nlp	23782518	SENT72	3	3	27	27	cisplatin	ABCG2	PA449014	9429	0.959
NULL	Osteoporos_Int_2013_Jan_10_24(1)_227-235.nxml.txt.nlp	22776860	SENT33	0	0	21	21	denosumab	RANK	PA166048634	8792	0.959
NULL	Oncotarget_2013_Jul_26_4(8)_1317-1328.nxml.txt.nlp	23945331	SENT15	8	8	16	16	tamoxifen	HER2	PA451581	2064	0.959
NULL	Oncotarget_2014_Aug_16_5(18)_8637-8650.nxml.txt.nlp	25226617	SENT30	37	37	24	24	dasatinib	JAK2	PA162372878	3717	0.959
NULL	Arch_Med_Sci_2011_Apr_17_7(2)_230-234.nxml.txt.nlp	22291761	SENT105	30	30	11	11	curcumin	AKT	PA151958596	207	0.959
NULL	Front_Neurosci_2010_Jun_17_4_35.nxml.txt.nlp	20661455	SENT93	5	5	22	22	pindolol	5-HT1A	PA450966	3350	0.959
NULL	Front_Oncol_2014_Jun_18_4_159.nxml.txt.nlp	24995161	SENT126	7	7	34	34	indomethacin	PGD2	PA449982	27306	0.959
NULL	Br_J_Cancer_2011_Nov_22_105(11)_1654-1662.nxml.txt.nlp	22045187	SENT172	5	5	21	21	irinotecan	TYMS	PA450085	7298	0.959
NULL	Br_J_Cancer_2013_Oct_15_109(8)_2155-2166.nxml.txt.nlp	24045666	SENT145	3	3	6	6	erlotinib	EGFR	PA134687924	1956	0.959
NULL	Front_Oncol_2013_Nov_18_3_282.nxml.txt.nlp	24303367	SENT239	5	5	3	3	olaparib	PARP		142	0.959
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT117	5	5	13	13	ranibizumab	VEGFR2	PA164746012	3791	0.959
NULL	Mol_Cancer_2010_Jun_27_9_168.nxml.txt.nlp	20579391	SENT41	5	5	22	22	dasatinib	CML	PA162372878	613	0.959
NULL	Cancer_Inform_2008_Jun_10_6_315-355.nxml.txt.nlp	19259415	SENT356	18	18	3	3	cisplatin	GAS1	PA449014	2619	0.959
NULL	Clin_Endosc_2011_Sep_30_44(1)_22-26.nxml.txt.nlp	22741108	SENT112	6	6	30	30	propofol	ESD	PA451141	2098	0.959
NULL	Acta_Physiol_(Oxf)_2008_Apr_192(4)_505-517.nxml.txt.nlp	17973950	SENT152	17	17	22	22	propranolol	PES	PA451145	23481	0.959
NULL	Aging_(Albany_NY)_2009_Oct_13_1(10)_842-844.nxml.txt.nlp	20157556	SENT33	12	12	42	42	nutlin-3	p53		7157	0.959
NULL	F1000Prime_Rep_2013_Jul_1_5_23.nxml.txt.nlp	23864930	SENT58	44	44	18	18	methysergide	LTF	PA164743265	4057	0.959
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT101	11	11	28	28	chloroquine	BMPR-II	PA448948	659	0.959
NULL	J_Hematol_Oncol_2012_Apr_25_5(Suppl_1)_A1.nxml.txt.nlp	22738713	SENT10	20	20	7	7	trastuzumab	HER2	PA451743	2064	0.959
NULL	J_Inflamm_(Lond)_2008_Nov_5_5_20.nxml.txt.nlp	18986521	SENT174	38	38	11	11	bleomycin	p47phox	PA448645	653361	0.959
NULL	BMB_Rep_2013_Jan_46(1)_59-64.nxml.txt.nlp	23351386	SENT62	34	34	10	10	auranofin	STAT3	PA448510	6774	0.959
NULL	Arch_Drug_Inf_2009_Mar_2(1)_8-16.nxml.txt.nlp	19381336	SENT6	19	19	22	22	ritonavir	CYP3A4	PA451260	1576	0.959
NULL	Nat_Commun_2013_4_2996.nxml.txt.nlp	24356649	SENT58	23	23	33	33	tetracycline	MDM2	PA451640	4193	0.959
NULL	Br_J_Cancer_2004_Mar_22_90(6)_1285-1292.nxml.txt.nlp	15026814	SENT110	7	7	12	12	doxorubicin	p53	PA449412	7157	0.959
NULL	Acta_Naturae_2010_Oct-Dec_2(4)_31-35.nxml.txt.nlp	22649661	SENT124	0	0	9	9	cisplatin	BRCA1	PA449014	672	0.959
NULL	Front_Neurosci_2013_Oct_7_7_179.nxml.txt.nlp	24109427	SENT143	2	2	15	15	capsaicin	TRPV1	PA448776	7442	0.959
NULL	FASEB_J_2009_Feb_23(2)_575-585.nxml.txt.nlp	18957574	SENT332	23	23	0	0	nitrogen	L10	PA450643	6134	0.959
NULL	Acta_Pharmacol_Sin_2014_Oct_25_35(10)_1293-1301.nxml.txt.nlp	25152022	SENT107	6	6	25	25	enalapril	NLRP3	PA449456	114548	0.959
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT416	10	10	2	2	cetuximab	BRAF	PA10040	673	0.959
NULL	Eur_J_Immunol_2012_Nov_18_42(11)_3049-3061.nxml.txt.nlp	22806397	SENT183	28	28	14	14	imiquimod	CCR7	PA449972	1236	0.959
NULL	Mol_Cancer_2007_Sep_24_6_59.nxml.txt.nlp	17888187	SENT61	6	6	19	19	raloxifene	c-Myc	PA451221	4609	0.959
NULL	Mol_Cancer_2010_May_18_9_110.nxml.txt.nlp	20482802	SENT191	24	24	7	7	bortezomib	MDR1	PA10252	5243	0.959
NULL	J_Mol_Med_(Berl)_2014_Jan_10_92(5)_497-507.nxml.txt.nlp	24408111	SENT152	18	18	8	8	pioglitazone	HIF-1	PA450970	29072	0.959
NULL	Br_J_Cancer_2013_Mar_5_108(4)_983-992.nxml.txt.nlp	23361057	SENT122	7	7	13	13	cytarabine	MLH1	PA449177	4292	0.959
NULL	Mol_Cancer_2010_May_27_9_124.nxml.txt.nlp	20504375	SENT100	14	14	10	10	doxycycline	HOXB13	PA449415	10481	0.959
NULL	Arthritis_Res_Ther_2014_Nov_24_16(6)_487.nxml.txt.nlp	25418464	SENT100	11	11	22	22	calcein	CO2	PA132595336	4513	0.959
NULL	J_Histochem_Cytochem_2014_Nov_62(11)_802-812.nxml.txt.nlp	25124006	SENT38	4	4	8	8	l-valine	GDH	PA451843	51084;2746	0.959
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT303	1	1	13	13	paliperidone	PRL	PA163518919	5617	0.959
NULL	Breast_Cancer_Res_2004_Oct_28_6(1)_E1.nxml.txt.nlp	14680487	SENT34	19	19	15	15	exemestane	aromatase	PA449563	1588	0.959
NULL	Oncogene_2013_Sep_12_32(37)_4355-4365.nxml.txt.nlp	23108409	SENT88	20	20	8	8	hyaluronan	HAS2	PA165958431	3037	0.959
NULL	Patient_Prefer_Adherence_2010_Mar_24_4_61-68.nxml.txt.nlp	20361006	SENT6	0	0	5	5	liraglutide	GLP-1	PA165958364	100125288	0.959
NULL	Diabetes_Care_2013_Feb_17_36(2)_245-250.nxml.txt.nlp	23086138	SENT89	34	34	1	1	glimepiride	GLP-1	PA449761	100125288	0.959
NULL	Breast_Cancer_Res_2008_Jul_24_10(4)_211.nxml.txt.nlp	18671839	SENT78	25	25	7	7	bortezomib	HER2	PA10252	2064	0.959
NULL	Clin_Exp_Reprod_Med_2013_Jun_30_40(2)_67-75.nxml.txt.nlp	23875162	SENT122	9	9	3	3	rosiglitazone	aromatase	PA451283	1588	0.959
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT47	4	4	10	10	curcumin	PC-3	PA151958596	692094	0.959
NULL	J_Cancer_2013_Sep_27_4(8)_662-670.nxml.txt.nlp	24155778	SENT200	23	23	11	11	cisplatin	XIAP	PA449014	331	0.959
NULL	Front_Neurol_2014_Feb_18_5_17.nxml.txt.nlp	24600432	SENT111	14	14	29	29	levetiracetam	CD178	PA450206	356	0.959
NULL	Indian_J_Ophthalmol_2007_Nov-Dec_55(6)_421-425.nxml.txt.nlp	17951897	SENT49	0	0	25	25	ranibizumab	VEGF-A	PA164746012	7422	0.959
NULL	J_Oncol_2012_Nov_10_2012_358472.nxml.txt.nlp	22131994	SENT84	28	28	18	18	paclitaxel	CD31	PA450761	5175	0.959
NULL	Breast_Cancer_Res_2014_Sep_11_16(5)_430.nxml.txt.nlp	25212826	SENT168	20	20	6	6	tamoxifen	PTEN	PA451581	5728	0.959
NULL	Dermatoendocrinol_2012_Jul_1_4(3)_320-323.nxml.txt.nlp	23467502	SENT69	2	2	14	14	ustekinumab	p40	PA166048654	3921;339541;10314	0.959
NULL	Ann_Dermatol_2014_Dec_26_26(6)_706-712.nxml.txt.nlp	25473222	SENT31	33	33	15	15	isotretinoin	EPO	PA450128	7076;8288;2056	0.959
NULL	Oncotarget_2013_Apr_13_4(4)_502-530.nxml.txt.nlp	23594434	SENT394	8	8	0	0	artesunate	CYP3A4	PA165111697	1576	0.959
NULL	Colorectal_Dis_2012_Feb_14(2)_e31-e47.nxml.txt.nlp	21848897	SENT150	9	9	31	31	cetuximab	KRAS	PA10040	3845	0.959
NULL	Adv_Urol_2012_Oct_26_2012_812398.nxml.txt.nlp	22110495	SENT6	28	28	17	17	cisplatin	ERCC1	PA449014	2067	0.959
NULL	J_Exp_Med_2003_Aug_4_198(3)_411-421.nxml.txt.nlp	12900517	SENT217	16	16	3	3	rosiglitazone	IL-5	PA451283	3567	0.959
NULL	Cell_Death_Dis_2012_Nov_15_3(11)_e422.nxml.txt.nlp	23152058	SENT272	20	20	3	3	doxycycline	ZNF143	PA449415	7702	0.959
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_33-43.nxml.txt.nlp	17912634	SENT2	27	27	18	18	tamoxifen	aromatase	PA451581	1588	0.959
NULL	Curr_Cardiol_Rev_2010_May_6(2)_82-90.nxml.txt.nlp	21532773	SENT49	10	10	2	2	l-arginine	DDAH	PA448478	23576	0.959
NULL	J_Carcinog_2012_Oct_27_11_16.nxml.txt.nlp	23230393	SENT56	8	8	20	20	lapatinib	aromatase	PA152241907	1588	0.959
NULL	J_Biol_Chem_2012_Apr_20_287(17)_13868-13876.nxml.txt.nlp	22389490	SENT70	12	12	1	1	capsaicin	TRPV1	PA448776	7442	0.959
NULL	Br_J_Pharmacol_2008_Oct_18_155(4)_596-605.nxml.txt.nlp	18852694	SENT297	11	11	18	18	fenofibrate	PI3K	PA449594	5290	0.959
NULL	Reprod_Biol_Endocrinol_2013_Feb_26_11_15.nxml.txt.nlp	23442442	SENT143	25	25	16	16	l-arginine	BAX	PA448478	581	0.959
NULL	J_Hematol_Oncol_2011_Jun_14_4_29.nxml.txt.nlp	21672194	SENT136	0	0	11	11	sorafenib	VEGFR	PA7000	3791	0.959
NULL	J_Inflamm_(Lond)_2007_Jun_13_4_13.nxml.txt.nlp	17567894	SENT130	8	8	20	20	pentobarbital	GM-CSF	PA450859	1437	0.959
NULL	Oncol_Rep_2013_Jun_22_29(6)_2479-2485.nxml.txt.nlp	23525656	SENT165	14	14	32	32	vincristine	MRP7	PA451879	89845;1080	0.959
NULL	Nat_Med_2010_Feb_24_16(2)_214-218.nxml.txt.nlp	20098429	SENT62	28	28	3	3	epirubicin	LAPTM4B	PA449476	55353	0.959
NULL	Mol_Cancer_2009_Dec_10_8_118.nxml.txt.nlp	20003259	SENT218	13	13	4	4	sorafenib	ERM	PA7000	2119	0.959
NULL	Oncol_Lett_2014_Mar_14_7(3)_663-668.nxml.txt.nlp	24527070	SENT96	19	19	4	4	trastuzumab	NAC	PA451743	22861	0.959
NULL	J_Mov_Disord_2009_May_30_2(1)_33-36.nxml.txt.nlp	24868350	SENT64	35	35	11	11	levodopa	B12	PA450213	7126;4709	0.959
NULL	Breast_Cancer_Res_2012_Jun_19_14(3)_209.nxml.txt.nlp	22713170	SENT48	24	24	15	15	trastuzumab	HER2	PA451743	2064	0.959
NULL	Indian_J_Med_Paediatr_Oncol_2013_Apr-Jun_34(2)_101-103.nxml.txt.nlp	24049297	SENT23	16	16	35	35	vincristine	FDG	PA451879	23583	0.959
NULL	Arthritis_Res_Ther_2009_Aug_3_11(4)_238.nxml.txt.nlp	19678909	SENT72	0	0	19	19	hydroquinone	IFN	PA449924	3439	0.959
NULL	Case_Rep_Oncol_2011_Aug_18_4(2)_385-391.nxml.txt.nlp	21941487	SENT67	37	37	13	13	sorafenib	EGFR	PA7000	1956	0.959
NULL	Br_J_Cancer_2010_Jul_13_103(2)_265-274.nxml.txt.nlp	20551953	SENT204	5	5	0	0	cisplatin	JNK	PA449014	5599	0.959
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT120	17	17	9	9	cisplatin	MDM2	PA449014	4193	0.959
NULL	Br_J_Cancer_2013_Feb_19_108(3)_668-675.nxml.txt.nlp	23348520	SENT114	17	17	3	3	cetuximab	HER2	PA10040	2064	0.959
NULL	Orphanet_J_Rare_Dis_2013_Sep_8_8_137.nxml.txt.nlp	24011030	SENT361	9	9	30	30	vemurafenib	BRAF	PA165946873	673	0.959
NULL	Breast_Cancer_Res_2013_Oct_18_15(5)_R97.nxml.txt.nlp	24135425	SENT92	6	6	25	25	letrozole	PIK3CA	PA450196	5290	0.959
NULL	Arch_Med_Sci_2013_Jun_20_9(3)_472-478.nxml.txt.nlp	23847669	SENT29	18	18	6	6	exemestane	aromatase	PA449563	1588	0.959
NULL	Blood_Cancer_J_2013_Dec_6_3(12)_e167.nxml.txt.nlp	24317089	SENT129	2	2	23	23	lovastatin	GADD153	PA450272	1649	0.959
NULL	Korean_J_Anesthesiol_2013_Dec_26_65(6)_501-507.nxml.txt.nlp	24427455	SENT51	30	30	42	42	neostigmine	NMB	PA450611	10457;4828	0.959
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Aug_18_66(Pt_9)_m1098-m1099.nxml.txt.nlp	21588511	SENT70	15	15	10	10	chloroquine	NO3	PA448948	4681	0.959
NULL	Acta_Pharmacol_Sin_2011_Feb_4_32(2)_223-229.nxml.txt.nlp	21293474	SENT32	12	12	2	2	isoproterenol	FKBP12	PA450121	2280	0.959
NULL	Arthritis_Res_Ther_2010_Apr_29_12(2)_R73.nxml.txt.nlp	20429888	SENT336	3	3	8	8	curcumin	p300	PA151958596	2033	0.959
NULL	Mol_Cancer_2012_Jun_18_11_41.nxml.txt.nlp	22709873	SENT70	42	42	18	18	lapatinib	ERBB3	PA152241907	2065	0.959
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2010_Aug_3_3_43-51.nxml.txt.nlp	22879786	SENT85	16	16	8	8	pioglitazone	CYP2C8	PA450970	1558	0.959
NULL	Oncogene_2009_Dec_3_28(48)_4237-4248.nxml.txt.nlp	19734937	SENT86	6	6	17	17	thrombin	PAR-1	PA451674	2011;2149	0.959
NULL	Lancet_2011_Jun_18_377(9783)_2103-2114.nxml.txt.nlp	21641636	SENT21	12	12	31	31	cetuximab	KRAS	PA10040	3845	0.959
NULL	Oncotarget_2013_Apr_13_4(4)_502-530.nxml.txt.nlp	23594434	SENT299	15	15	3	3	sertraline	AKT	PA451333	207	0.959
NULL	J_Headache_Pain_2008_Feb_24_9(1)_13-18.nxml.txt.nlp	18217199	SENT129	0	0	14	14	amitriptyline	CYP2D6	PA448385	1565	0.959
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1224-1233.nxml.txt.nlp	22353810	SENT153	2	2	23	23	etoposide	MRP-1	PA449552	928	0.959
NULL	J_Oral_Pathol_Med_2013_Jul_18_42(6)_499-506.nxml.txt.nlp	23331485	SENT100	27	27	5	5	celecoxib	COX	PA448871	1351	0.959
NULL	J_Occup_Med_Toxicol_2008_Feb_27_3(Suppl_1)_S6.nxml.txt.nlp	18315837	SENT82	15	15	22	22	theophylline	CD4	PA451647	920	0.959
NULL	Cancer_Immunol_Immunother_2013_Aug_27_62(10)_1637-1648.nxml.txt.nlp	23982484	SENT182	9	9	28	28	lenalidomide	IL-2	PA162363968	3558	0.959
NULL	Reprod_Biol_Endocrinol_2013_Feb_26_11_15.nxml.txt.nlp	23442442	SENT140	5	5	28	28	l-arginine	BAX	PA448478	581	0.959
NULL	Breast_Cancer_Res_2006_Nov_6_8(6)_215.nxml.txt.nlp	17096862	SENT36	11	11	25	25	trastuzumab	HER2	PA451743	2064	0.959
NULL	Niger_Med_J_2013_Mar-Apr_54(2)_100-106.nxml.txt.nlp	23798795	SENT12	14	14	1	1	indomethacin	HEC	PA449982	10403	0.958
NULL	Biologics_2009_Sep_15_3_429-441.nxml.txt.nlp	19774210	SENT24	4	4	40	40	bevacizumab	IFL	PA130232992	3439	0.958
NULL	Arthritis_Res_Ther_2005_Apr_4_7(3)_R666-R676.nxml.txt.nlp	15899052	SENT30	12	12	29	29	etanercept	p55	PA449515	6624;2078;8503;5718	0.958
NULL	Oncotarget_2011_May_16_2(5)_418-421.nxml.txt.nlp	21789791	SENT36	27	27	5	5	bortezomib	XIAP	PA10252	331	0.958
NULL	J_Cell_Biol_1998_Apr_6_141(1)_175-185.nxml.txt.nlp	9531557	SENT48	33	33	0	0	ethanol	LPA	PA448073	4018	0.958
NULL	Indian_J_Med_Res_2011_Nov_134(5)_688-695.nxml.txt.nlp	22199109	SENT35	0	0	4	4	vancomycin	API	PA451850	5345	0.958
NULL	Cardiol_Res_Pract_2013_Feb_21_2013_127270.nxml.txt.nlp	23509665	SENT173	39	39	23	23	ticagrelor	ADP	PA165374673	23038	0.958
NULL	Mol_Cancer_2014_Apr_16_13_83.nxml.txt.nlp	24735930	SENT39	27	27	25	25	vemurafenib	BRAF	PA165946873	673	0.958
NULL	Exp_Ther_Med_2014_Apr_13_7(4)_923-928.nxml.txt.nlp	24669252	SENT12	21	21	7	7	estradiol	PRL	PA449503	5617	0.958
NULL	Mol_Cancer_2012_Dec_12_11_91.nxml.txt.nlp	23234355	SENT14	0	0	6	6	erlotinib	EGFR	PA134687924	1956	0.958
NULL	J_Thromb_Thrombolysis_2011_Nov_26_32(4)_459-466.nxml.txt.nlp	21706290	SENT81	37	37	7	7	clopidogrel	CYP2C19	PA449053	1557	0.958
NULL	Br_J_Cancer_2003_Mar_10_88(5)_754-759.nxml.txt.nlp	12618886	SENT79	23	23	10	10	amifostine	p53	PA448365	7157	0.958
NULL	Cancer_Res_Treat_2012_Sep_30_44(3)_195-201.nxml.txt.nlp	23091446	SENT16	24	24	10	10	etoposide	MKP-1	PA449552	1843	0.958
NULL	Acta_Pharmacol_Sin_2012_Jan_28_33(1)_66-74.nxml.txt.nlp	22120966	SENT37	4	4	22	22	genistein	RANKL	PA165109660	8600	0.958
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_12_2012_160726.nxml.txt.nlp	23243430	SENT153	25	25	28	28	losartan	c-Jun	PA450268	3725	0.958
NULL	Cough_2009_Nov_20_5_9.nxml.txt.nlp	19930579	SENT23	6	6	17	17	capsaicin	TRPV1	PA448776	7442	0.958
NULL	Angiogenesis_2012_Sep_27_15(3)_361-376.nxml.txt.nlp	22451299	SENT128	3	3	28	28	resveratrol	HHS		2591	0.958
NULL	J_Oncol_2012_Aug_7_2012_803294.nxml.txt.nlp	22919383	SENT127	7	7	39	39	resveratrol	Bcl-2		596	0.958
NULL	Drugs_R_D_2014_Jun_6_14(2)_113-123.nxml.txt.nlp	24797400	SENT30	11	11	4	4	dabigatran	CES1		1066	0.958
NULL	Clin_Pharmacokinet_2014_Sep_3_53(1)_1-16.nxml.txt.nlp	23999929	SENT342	21	21	13	13	dabigatran	P-gp		5243	0.958
NULL	Clinics_(Sao_Paulo)_2013_May_68(5)_628-631.nxml.txt.nlp	23778422	SENT31	3	3	20	20	cyclophosphamide	CTX	PA449165	1593	0.958
NULL	Br_J_Cancer_2010_Jan_19_102(2)_268-275.nxml.txt.nlp	20010948	SENT7	43	43	1	1	erlotinib	VEGFR2	PA134687924	3791	0.958
NULL	Curr_Neuropharmacol_2014_Jul_12(4)_308-323.nxml.txt.nlp	25342939	SENT224	23	23	16	16	nifedipine	NKCC1	PA450631	6558	0.958
NULL	Basic_Res_Cardiol_2015_Jan_20_110_4.nxml.txt.nlp	25600226	SENT315	10	10	4	4	atorvastatin	PCSK9	PA448500	255738	0.958
NULL	Support_Care_Cancer_2009_Sep_10_17(9)_1187-1193.nxml.txt.nlp	19205754	SENT88	21	21	42	42	dolasetron	CYP2D6	PA449390	1565	0.958
NULL	Mol_Cancer_2007_Oct_11_6_63.nxml.txt.nlp	17931419	SENT108	44	44	35	35	cetuximab	STAT3	PA10040	6774	0.958
NULL	JRSM_Cardiovasc_Dis_2012_Sep_24_1(6)_cvd_2012_012015.nxml.txt.nlp	24175073	SENT144	41	41	17	17	clopidogrel	CYP2C19	PA449053	1557	0.958
NULL	Oncotarget_2011_Nov_9_2(11)_850-861.nxml.txt.nlp	22081665	SENT180	14	14	5	5	doxorubicin	DNMT3A	PA449412	1788	0.958
NULL	Oncotarget_2012_Oct_20_3(10)_1236-1245.nxml.txt.nlp	23100449	SENT106	15	15	1	1	doxorubicin	NGAL	PA449412	3934	0.958
NULL	Cardiol_Ther_2013_Jun_27_2(1)_1-16.nxml.txt.nlp	25135285	SENT169	15	15	25	25	metformin	GLP-1	PA450395	100125288	0.958
NULL	Toxins_(Basel)_2011_Jul_14_3(7)_848-883.nxml.txt.nlp	22069744	SENT293	6	6	16	16	trastuzumab	DM1	PA451743	338023;1760;28509	0.958
NULL	J_Geriatr_Cardiol_2013_Mar_10(1)_21-27.nxml.txt.nlp	23610570	SENT58	28	28	35	35	dipyridamole	CD62P	PA449367	6403	0.958
NULL	Stroke_Res_Treat_2011_Nov_10_2011_212485.nxml.txt.nlp	22135769	SENT151	2	2	11	11	ticagrelor	CYP2C19	PA165374673	1557	0.958
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Dec_3_68(Pt_1)_o12.nxml.txt.nlp	22259407	SENT54	0	0	14	14	urea	CXCR3	PA451831	2833	0.958
NULL	Eur_J_Clin_Pharmacol_2013_Mar_5_69(3)_467-475.nxml.txt.nlp	22864379	SENT29	25	25	15	15	warfarin	VKORC1	PA451906	79001	0.958
NULL	Int_J_Cell_Biol_2013_May_16_2013_639401.nxml.txt.nlp	23762063	SENT292	3	3	7	7	curcumin	HIF-1	PA151958596	29072	0.958
NULL	Ann_Oncol_2012_Dec_2_23(12)_3007-3016.nxml.txt.nlp	22865781	SENT111	28	28	16	16	everolimus	PTEN	PA164746311	5728	0.958
NULL	Nat_Med_2011_May_1_17(5)_604-609.nxml.txt.nlp	21532597	SENT228	37	37	8	8	daclizumab	IFN	PA164764446	3439	0.958
NULL	Oncoscience_2014_Jul_29_1(8)_504-512.nxml.txt.nlp	25594057	SENT100	29	29	21	21	erlotinib	EGFR	PA134687924	1956	0.958
NULL	J_Biol_Chem_2011_Sep_30_286(39)_34271-34285.nxml.txt.nlp	21784845	SENT221	28	28	5	5	marimastat	CCL2	PA164748329	6347	0.958
NULL	Oncol_Lett_2013_Apr_7_5(4)_1382-1384.nxml.txt.nlp	23599798	SENT56	0	0	11	11	temsirolimus	San	PA164746890	80218	0.958
NULL	Mol_Biol_Rep_2013_Sep_28_40(10)_5573-5585.nxml.txt.nlp	24078156	SENT43	4	4	19	19	iron	IRP1	PA450087	48	0.958
NULL	Allergy_Asthma_Clin_Immunol_2011_Nov_14_7(Suppl_2)_A37.nxml.txt.nlp	NULL	SENT13	18	18	0	0	ceftazidime	IFN	PA448861	3439	0.958
NULL	Ther_Clin_Risk_Manag_2006_Jun_2(2)_129-158.nxml.txt.nlp	18360588	SENT126	7	7	12	12	quinidine	CYP3A4	PA451209	1576	0.958
NULL	Contemp_Oncol_(Pozn)_2012_Nov_20_16(5)_401-406.nxml.txt.nlp	23788917	SENT151	7	7	20	20	afatinib	HER2	PA165981154	2064	0.958
NULL	Cases_J_2009_Jul_30_2_7134.nxml.txt.nlp	19829918	SENT21	17	17	5	5	levodopa	LCE	PA450213	79071	0.958
NULL	J_Immunother_Cancer_2014_Nov_6_2(Suppl_3)_P77.nxml.txt.nlp	NULL	SENT7	0	0	11	11	vemurafenib	IL-2	PA165946873	3558	0.958
NULL	Korean_Circ_J_2013_Jun_30_43(6)_400-407.nxml.txt.nlp	23882289	SENT108	11	11	7	7	doxorubicin	Bcl-2	PA449412	596	0.958
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT605	8	8	16	16	paliperidone	PRL	PA163518919	5617	0.958
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S202-S209.nxml.txt.nlp	21525456	SENT159	14	14	29	29	exenatide	GLP-1	PA164749238	100125288	0.958
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_127043.nxml.txt.nlp	23227093	SENT191	5	5	10	10	lovastatin	CYP2C8	PA450272	1558	0.958
NULL	Curr_Neuropharmacol_2008_Sep_6(3)_215-234.nxml.txt.nlp	19506722	SENT139	19	19	5	5	fluoxetine	c-fos	PA449673	2353	0.958
NULL	Pharmaceutics_2011_Aug_24_3(3)_510-524.nxml.txt.nlp	24310594	SENT199	8	8	33	33	trastuzumab	ANOVA	PA451743	4858	0.958
NULL	J_Korean_Med_Sci_2011_Feb_24_26(2)_214-221.nxml.txt.nlp	21286012	SENT30	6	6	20	20	gefitinib	EGFR	PA131301952	1956	0.958
NULL	Adolesc_Health_Med_Ther_2014_Mar_26_5_35-48.nxml.txt.nlp	24729739	SENT36	20	20	7	7	sulfasalazine	TNF-alpha	PA451547	7124	0.958
NULL	Clin_Psychopharmacol_Neurosci_2013_Dec_24_11(3)_132-136.nxml.txt.nlp	24465249	SENT8	5	5	17	17	perospirone	5-HT1A	PA165291546	3350	0.958
NULL	Toxins_(Basel)_2010_Mar_31_2(4)_517-551.nxml.txt.nlp	22069598	SENT226	0	0	6	6	genistein	EGF	PA165109660	1950	0.958
NULL	Ann_Oncol_2013_Aug_12_24(8)_1994-1999.nxml.txt.nlp	23670096	SENT126	9	9	3	3	tamoxifen	AIB1	PA451581	8202	0.958
NULL	Lab_Invest_2013_Mar_7_93(3)_354-364.nxml.txt.nlp	23295648	SENT5	4	4	23	23	berberine	DAXX	PA165860812	1616	0.958
NULL	Chin_J_Cancer_2012_Nov_31(11)_507-518.nxml.txt.nlp	22640626	SENT176	27	27	22	22	dasatinib	DDR1	PA162372878	780	0.958
NULL	Cancer_Metab_2014_Nov_3_2(1)_20.nxml.txt.nlp	NULL	SENT9	24	24	2	2	erlotinib	PDK4	PA134687924	5166	0.958
NULL	Int_J_Environ_Res_Public_Health_2010_Apr_4_7(4)_1540-1557.nxml.txt.nlp	20617045	SENT140	22	22	15	15	ethanol	APOE	PA448073	348	0.958
NULL	Acta_Pharmacol_Sin_2009_Oct_5_30(10)_1428-1435.nxml.txt.nlp	19801997	SENT150	7	7	34	34	artemisinin	IFN	PA165111696	3439	0.958
NULL	Arch_Med_Sci_2013_Apr_20_9(2)_332-339.nxml.txt.nlp	23671446	SENT129	42	42	13	13	midazolam	JNK	PA450496	5599	0.958
NULL	Cancer_Cell_Int_2009_Sep_10_9_25.nxml.txt.nlp	19744341	SENT140	18	18	2	2	glucosamine	survivin	PA164747613	332	0.958
NULL	Mol_Cancer_2010_Jun_24_9_164.nxml.txt.nlp	20576107	SENT195	31	31	5	5	vinblastine	Bcl-2	PA451877	596	0.958
NULL	Indian_J_Pharm_Sci_2011_Sep-Oct_73(5)_510-516.nxml.txt.nlp	22923863	SENT160	3	3	16	16	venlafaxine	GLP	PA451866	342096	0.958
NULL	Drug_Healthc_Patient_Saf_2012_Nov_29_4_173-180.nxml.txt.nlp	23236256	SENT68	10	10	17	17	sertindole	FGA	PA164784002	2243	0.958
NULL	BMB_Rep_2013_Feb_46(2)_92-96.nxml.txt.nlp	23433111	SENT21	22	22	8	8	etoposide	BRCA1	PA449552	672	0.958
NULL	Dement_Geriatr_Cogn_Dis_Extra_2014_Nov_15_4(3)_450-456.nxml.txt.nlp	25538729	SENT33	13	13	24	24	donepezil	APOE	PA449394	348	0.958
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT31	32	32	5	5	metformin	GLP-1	PA450395	100125288	0.958
NULL	J_Biomed_Sci_2012_Nov_21_19(1)_99.nxml.txt.nlp	23170833	SENT125	10	10	2	2	atorvastatin	STAT3	PA448500	6774	0.958
NULL	J_Invest_Dermatol_2012_Oct_24_132(10)_2440-2450.nxml.txt.nlp	22622430	SENT97	12	12	6	6	paclitaxel	ABCB5	PA450761	340273	0.958
NULL	Breast_Cancer_(Auckl)_2012_Feb_20_6_47-66.nxml.txt.nlp	22399860	SENT172	4	4	16	16	tamoxifen	TNFAIP3	PA451581	7128	0.958
NULL	Oncol_Lett_2014_May_18_7(5)_1632-1638.nxml.txt.nlp	24765191	SENT18	10	10	3	3	tamoxifen	aromatase	PA451581	1588	0.958
NULL	Mol_Biol_Cell_2012_Sep_1_23(17)_3473-3484.nxml.txt.nlp	22787275	SENT219	0	0	5	5	doxorubicin	ABCC1	PA449412	4363	0.958
NULL	J_Carcinog_2013_Dec_31_12_22.nxml.txt.nlp	24574860	SENT198	14	14	8	8	sunitinib	KIT	PA162372840	3815	0.958
NULL	Drugs_R_D_2011_Jun_27_11(2)_101-111.nxml.txt.nlp	21679003	SENT60	18	18	16	16	panitumumab	EGFR	PA162373091	1956	0.958
NULL	Arch_Drug_Inf_2008_Sep_1(2)_56-62.nxml.txt.nlp	19915709	SENT51	16	16	21	21	fentanyl	CYP3A4	PA449599	1576	0.958
NULL	J_Exp_Med_1998_Jun_1_187(11)_1885-1892.nxml.txt.nlp	9607928	SENT114	39	39	22	22	thalidomide	CD4	PA451644	920	0.958
NULL	Arthritis_Res_Ther_2006_Dec_28_8(1)_R18.nxml.txt.nlp	16507118	SENT75	39	39	3	3	infliximab	ACR	PA452639	49	0.958
NULL	Breast_Cancer_Res_2002_Jun_21_4(5)_R9.nxml.txt.nlp	12223126	SENT146	35	35	18	18	tamoxifen	FasL	PA451581	356	0.958
NULL	Eur_Arch_Psychiatry_Clin_Neurosci_2010_Sep_9_260(6)_499-506.nxml.txt.nlp	19997739	SENT132	20	20	13	13	escitalopram	DPYSL2	PA10074	1808	0.958
NULL	Br_J_Pharmacol_2011_Nov_164(5)_1522-1533.nxml.txt.nlp	21557728	SENT221	31	31	29	29	cangrelor	P2Y12	PA165945763	64805	0.958
NULL	Exp_Hematol_Oncol_2012_Jul_20_1_18.nxml.txt.nlp	23210897	SENT25	18	18	1	1	cisplatin	E2F1	PA449014	1869	0.958
NULL	Oncotarget_2011_May_16_2(5)_418-421.nxml.txt.nlp	21789791	SENT32	2	2	17	17	bortezomib	Bcl-2	PA10252	596	0.958
NULL	Cancer_Res_Treat_2012_Jun_30_44(2)_74-84.nxml.txt.nlp	22802745	SENT75	34	34	24	24	gefitinib	EGFR	PA131301952	1956	0.958
NULL	Int_J_Biol_Sci_2011_Sep_8_7(8)_1077-1092.nxml.txt.nlp	21927577	SENT162	8	8	21	21	captopril	NF-kappaB	PA448780	4790	0.958
NULL	Diabetes_2013_Jun_20_62(6)_1904-1912.nxml.txt.nlp	23349487	SENT157	14	14	38	38	forskolin	EP3	PA146096022	5733	0.958
NULL	ScientificWorldJournal_2013_Jun_19_2013_174392.nxml.txt.nlp	23853530	SENT27	0	0	21	21	doxazosin	PC-3	PA449407	692094	0.958
NULL	Oncol_Lett_2013_Mar_28_5(3)_835-839.nxml.txt.nlp	23443531	SENT101	4	4	0	0	paclitaxel	SXR	PA450761	8856	0.958
NULL	J_Am_Heart_Assoc_2013_Aug_23_2(4)_e000318.nxml.txt.nlp	23926118	SENT110	30	30	15	15	isoproterenol	AC3	PA450121	109	0.958
NULL	Diabetes_2011_Nov_17_60(11)_2928-2938.nxml.txt.nlp	21885868	SENT150	24	24	13	13	curcumin	IL-6	PA151958596	3569	0.958
NULL	Breast_Cancer_Res_2011_Apr_15_13(2)_R44.nxml.txt.nlp	21496232	SENT27	29	29	10	10	trastuzumab	HER2	PA451743	2064	0.958
NULL	Apoptosis_2013_Aug_23_18(11)_1306-1318.nxml.txt.nlp	23975731	SENT103	26	26	5	5	hydrocortisone	CD34	PA449905	947	0.958
NULL	Epigenetics_2012_Nov_1_7(11)_1225-1229.nxml.txt.nlp	23069641	SENT55	4	4	16	16	cisplatin	BRCA1	PA449014	672	0.958
NULL	Chemother_Res_Pract_2011_Sep_25_2011_730360.nxml.txt.nlp	22295205	SENT112	21	21	12	12	trastuzumab	HER2	PA451743	2064	0.958
NULL	Br_J_Pharmacol_2012_Jan_165(2)_380-389.nxml.txt.nlp	21585347	SENT115	19	19	4	4	rosiglitazone	ATGL	PA451283	57104	0.958
NULL	Nat_Commun_2013_Apr_23_4_1758.nxml.txt.nlp	23612299	SENT146	23	23	12	12	isoproterenol	SOD1	PA450121	6647	0.958
NULL	Cardiovasc_Diabetol_2011_Dec_22_10_115.nxml.txt.nlp	22189184	SENT134	24	24	21	21	sitagliptin	GLP-1	PA164748978	100125288	0.958
NULL	Clinics_(Sao_Paulo)_2012_Apr_67(4)_335-340.nxml.txt.nlp	22522758	SENT162	28	28	3	3	citalopram	5-HT1D	PA449015	3352	0.958
NULL	Evid_Based_Complement_Alternat_Med_2014_Oct_29_2014_594354.nxml.txt.nlp	25530784	SENT57	3	3	19	19	trifluoperazine	UGT1A4	PA451771	54657	0.958
NULL	Nucleic_Acids_Res_2007_Jan_7_35(2)_e9.nxml.txt.nlp	17158148	SENT128	17	17	6	6	cisplatin	RAD18	PA449014	56852	0.958
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R189.nxml.txt.nlp	22901830	SENT112	5	5	19	19	allopurinol	ANOVA	PA448320	4858	0.958
NULL	Biomed_Res_Int_2014_Jun_26_2014_483501.nxml.txt.nlp	25057490	SENT135	11	11	3	3	resveratrol	p53		7157	0.958
NULL	Crit_Care_2000_Oct_13_4(Suppl_2)_S21-S25.nxml.txt.nlp	11255595	SENT86	16	16	26	26	furosemide	STP	PA449719	9322	0.958
NULL	Front_Oncol_2014_Nov_18_4_322.nxml.txt.nlp	25478323	SENT27	6	6	12	12	bevacizumab	VEGF-A	PA130232992	7422	0.958
NULL	J_Obes_2011_Jan_17_2011_893629.nxml.txt.nlp	21318056	SENT90	7	7	20	20	quetiapine	5-HT2C	PA451201	3358	0.958
NULL	Indian_J_Pharmacol_2012_Sep-Oct_44(5)_624-628.nxml.txt.nlp	23112426	SENT136	9	9	12	12	simvastatin	CYP3A4	PA451363	1576	0.958
NULL	Mol_Cancer_2010_Nov_2_9_289.nxml.txt.nlp	21044322	SENT149	32	32	17	17	docetaxel	RGS10	PA449383	6001	0.958
NULL	Clin_Med_Insights_Oncol_2012_Dec_6_6_407-421.nxml.txt.nlp	23239933	SENT132	47	47	24	24	gefitinib	CTL1	PA131301952	23446	0.958
NULL	Nat_Genet_2011_Feb_26_43(2)_117-120.nxml.txt.nlp	21186350	SENT77	32	32	3	3	metformin	ATM	PA450395	472	0.958
NULL	Mol_Cancer_2013_Sep_11_12_104.nxml.txt.nlp	24025152	SENT40	10	10	3	3	gemcitabine	EGFR	PA449748	1956	0.958
NULL	J_Adv_Pharm_Technol_Res_2012_Oct-Dec_3(4)_202-209.nxml.txt.nlp	23378940	SENT86	7	7	28	28	ondansetron	GIT	PA450705	5034	0.958
NULL	Br_J_Cancer_2013_Jul_9_109(1)_100-108.nxml.txt.nlp	23756858	SENT24	24	24	17	17	anastrozole	aromatase	PA448432	1588	0.958
NULL	Blood_Cancer_J_2013_Mar_1_3(3)_e103.nxml.txt.nlp	23454896	SENT94	5	5	13	13	nelfinavir	ATF6	PA450606	22926	0.958
NULL	Clin_Exp_Metastasis_2014_Sep_17_31(1)_135-147.nxml.txt.nlp	24043563	SENT188	16	16	8	8	paclitaxel	KLK7	PA450761	5650	0.958
NULL	Diabetes_Obes_Metab_2011_Nov_13(11)_982-989.nxml.txt.nlp	21615670	SENT176	3	3	29	29	exenatide	PPG	PA164749238	5552	0.958
NULL	J_Carcinog_2012_Oct_27_11_16.nxml.txt.nlp	23230393	SENT56	17	17	20	20	letrozole	aromatase	PA450196	1588	0.958
NULL	Indian_J_Med_Res_2012_Apr_135(4)_494-499.nxml.txt.nlp	22664496	SENT110	12	12	0	0	chloroquine	ACT	PA448948	12;11332;9457;641455	0.958
NULL	Oncol_Lett_2014_Jul_25_8(1)_313-316.nxml.txt.nlp	24959268	SENT7	21	21	13	13	sulindac	PC-3	PA451565	692094	0.958
NULL	Environ_Sci_Technol_2014_Oct_21_48(20)_12454-12463.nxml.txt.nlp	25232892	SENT61	4	4	8	8	vanillin	SN2	PA451852	92745	0.958
NULL	Comp_Hepatol_2004_Jan_14_3(Suppl_1)_S31.nxml.txt.nlp	14960183	SENT63	7	7	14	14	ethanol	TNF-alpha	PA448073	7124	0.958
NULL	Oncotarget_2013_Jul_26_4(8)_1317-1328.nxml.txt.nlp	23945331	SENT175	10	10	6	6	trastuzumab	HER2	PA451743	2064	0.958
NULL	Br_J_Cancer_2013_Mar_5_108(4)_924-931.nxml.txt.nlp	23403819	SENT10	9	9	26	26	vemurafenib	BRAF	PA165946873	673	0.958
NULL	Evid_Based_Complement_Alternat_Med_2011_Mar_9_2011_750230.nxml.txt.nlp	21423639	SENT17	12	12	18	18	bevacizumab	VEGFR	PA130232992	3791	0.958
NULL	Clin_Exp_Otorhinolaryngol_2008_Mar_20_1(1)_41-45.nxml.txt.nlp	19434261	SENT13	3	3	27	27	thyroglobulin	RAI	PA164754910	10848;6050	0.958
NULL	Acta_Pharmacol_Sin_2014_Aug_30_35(8)_1045-1054.nxml.txt.nlp	24976155	SENT128	6	6	13	13	resveratrol	STAT3		6774	0.958
NULL	Int_J_Mol_Sci_2010_May_19_11(5)_2188-2199.nxml.txt.nlp	20559509	SENT206	4	4	10	10	troglitazone	gamma	PA451799	9913	0.958
NULL	Oncotarget_2013_Apr_23_4(6)_816-829.nxml.txt.nlp	23615731	SENT94	16	16	0	0	doxycycline	HSF1	PA449415	3297	0.958
NULL	Oncol_Lett_2014_Mar_19_7(3)_674-678.nxml.txt.nlp	24527071	SENT17	16	16	7	7	cisplatin	AKR1C2	PA449014	1646	0.958
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT159	17	17	31	31	nutlin-3	p53		7157	0.958
NULL	Mol_Cell_Proteomics_2012_Feb_6_11(2)_M111_015222.nxml.txt.nlp	22147731	SENT408	19	19	3	3	cetuximab	EGFR	PA10040	1956	0.958
NULL	Breast_Cancer_Res_2010_Oct_14_12(5)_R84.nxml.txt.nlp	20946630	SENT306	15	15	13	13	geldanamycin	Hsp90	PA152031327	3320	0.958
NULL	Case_Rep_Med_2012_Dec_3_2012_163173.nxml.txt.nlp	23326270	SENT7	0	0	24	24	bezafibrate	CPT2	PA162364313	1376	0.958
NULL	Crit_Care_2011_Feb_3_15(1)_R49.nxml.txt.nlp	21291554	SENT170	29	29	3	3	cefepime	CLCR	PA164754876	11330	0.958
NULL	Br_J_Cancer_2010_Jun_29_103(1)_61-72.nxml.txt.nlp	20588279	SENT212	0	0	20	20	trastuzumab	PTEN	PA451743	5728	0.958
NULL	Clin_Pharmacol_2012_Feb_20_4_13-20.nxml.txt.nlp	22427735	SENT74	26	26	34	34	clopidogrel	PON1	PA449053	5444	0.958
NULL	J_Gastrointest_Cancer_2013_Aug_7_44(4)_385-392.nxml.txt.nlp	23921604	SENT25	19	19	26	26	imatinib	CML	PA10804	613	0.958
NULL	Case_Rep_Med_2011_Aug_22_2011_262674.nxml.txt.nlp	21869893	SENT71	7	7	15	15	bevacizumab	VEGF-A	PA130232992	7422	0.958
NULL	J_Hematol_Oncol_2010_Oct_27_3_42.nxml.txt.nlp	20979652	SENT141	14	14	25	25	gemcitabine	PARP1	PA449748	142	0.958
NULL	Clin_Exp_Gastroenterol_2012_May_14_5_49-59.nxml.txt.nlp	22649281	SENT2	4	4	13	13	esomeprazole	CYP2C19	PA10075	1557	0.958
NULL	Breast_Cancer_Res_2010_Dec_1_12(6)_R105.nxml.txt.nlp	21122106	SENT237	26	26	5	5	tamoxifen	HER-2	PA451581	2064	0.958
NULL	Oncotarget_2012_Jul_7_3(6)_629-639.nxml.txt.nlp	22776759	SENT80	9	9	0	0	staurosporine	LIMK1	PA165109623	3984	0.958
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S31-S40.nxml.txt.nlp	20680106	SENT67	3	3	11	11	panitumumab	EGFR	PA162373091	1956	0.958
NULL	Clin_Interv_Aging_2010_Nov_19_5_345-354.nxml.txt.nlp	21228900	SENT123	0	0	15	15	denosumab	RANKL	PA166048634	8600	0.958
NULL	Breast_Cancer_Res_2010_May_10_12(3)_R26.nxml.txt.nlp	20459744	SENT42	19	19	5	5	tamoxifen	CYP2D6	PA451581	1565	0.958
NULL	Arthritis_Res_Ther_2007_Jun_29_9(Suppl_1)_S3.nxml.txt.nlp	17634142	SENT155	7	7	22	22	denosumab	aromatase	PA166048634	1588	0.958
NULL	Oncogenesis_2012_Apr_2_1(4)_e5.nxml.txt.nlp	23552603	SENT241	23	23	3	3	ns-398	Bcl-2		596	0.958
NULL	Front_Genet_2012_Nov_12_3_235.nxml.txt.nlp	23162568	SENT170	3	3	7	7	bupropion	CYP2D6	PA448687	1565	0.958
NULL	Oncogenesis_2014_Dec_15_3(12)_e133.nxml.txt.nlp	25500906	SENT64	26	26	21	21	trastuzumab	HER2	PA451743	2064	0.958
NULL	Arthritis_Res_Ther_2014_Jul_18_16(4)_R153.nxml.txt.nlp	25037855	SENT121	25	25	4	4	adalimumab	CD14	PA10004	929	0.958
NULL	Anemia_2011_Mar_3_2011_740235.nxml.txt.nlp	21490765	SENT191	0	0	5	5	montelukast	OATP2B1	PA450546	11309	0.958
NULL	Breast_Cancer_Res_2007_Jul_5_9(4)_R41.nxml.txt.nlp	17612393	SENT185	6	6	21	21	celecoxib	Bcl-2	PA448871	596	0.958
NULL	Oncol_Lett_2014_Mar_19_7(3)_674-678.nxml.txt.nlp	24527071	SENT15	11	11	3	3	cisplatin	AKR1C2	PA449014	1646	0.958
NULL	Acta_Pharmacol_Sin_2012_Oct_17_33(10)_1301-1310.nxml.txt.nlp	22983390	SENT149	10	10	25	25	cisplatin	migfilin	PA449014	54751	0.958
NULL	J_Carcinog_2011_Dec_8_10_33.nxml.txt.nlp	22279418	SENT131	39	39	23	23	estradiol	aromatase	PA449503	1588	0.958
NULL	Curr_Cardiol_Rev_2011_Nov_7(4)_221-233.nxml.txt.nlp	22758623	SENT159	31	31	10	10	temsirolimus	FKBP-12	PA164746890	2280	0.958
NULL	Br_J_Cancer_2009_Jan_27_100(2)_366-369.nxml.txt.nlp	19165200	SENT53	26	26	16	16	bortezomib	Apo2	PA10252	8797	0.958
NULL	Hum_Genomics_2013_Apr_5_7(1)_10.nxml.txt.nlp	23561625	SENT151	8	8	11	11	flavopiridol	CDK7	PA452627	1022	0.958
NULL	Case_Rep_Oncol_2012_Jan_7_5(1)_1-8.nxml.txt.nlp	22379470	SENT59	0	0	13	13	cinacalcet	PTH	PA164776671	5741	0.958
NULL	J_Oncol_2010_Nov_19_2010_568938.nxml.txt.nlp	20037743	SENT211	16	16	9	9	erlotinib	EGFR	PA134687924	1956	0.958
NULL	Cancer_Cell_Int_2011_Aug_19_11_29.nxml.txt.nlp	21854619	SENT163	17	17	2	2	cisplatin	HDAC	PA449014	9734	0.958
NULL	Mol_Med_Rep_2015_Feb_5_11(2)_805-814.nxml.txt.nlp	25373883	SENT237	13	13	3	3	colchicine	APE	PA449092	55704;328	0.958
NULL	Diabetes_Care_2012_Apr_13_35(4)_731-737.nxml.txt.nlp	22442396	SENT80	5	5	0	0	metformin	Men	PA450395	8178	0.958
NULL	Oncotarget_2013_Aug_21_4(9)_1484-1495.nxml.txt.nlp	23986086	SENT166	18	18	16	16	cetuximab	EGFR	PA10040	1956	0.958
NULL	Mol_Biol_Cell_2013_Jul_1_24(13)_2134-2145.nxml.txt.nlp	23657817	SENT140	4	4	32	32	pp2	ILK		3611	0.958
NULL	Case_Rep_Dermatol_2013_Jan_22_5(1)_21-26.nxml.txt.nlp	23466824	SENT54	8	8	24	24	indomethacin	COX	PA449982	1351	0.958
NULL	Mol_Cancer_2008_Mar_6_7_24.nxml.txt.nlp	18325101	SENT20	20	20	38	38	cisplatin	FANCD2	PA449014	2177	0.958
NULL	Front_Neurosci_2013_Dec_20_7_256.nxml.txt.nlp	24391536	SENT115	21	21	11	11	lipase	DAG	PA450239	1605	0.958
NULL	Indian_J_Pharm_Sci_2008_Sep-Oct_70(5)_591-595.nxml.txt.nlp	21394254	SENT79	10	10	33	33	potassium	NEB	PA451047	4703	0.958
NULL	Core_Evid_2010_Oct_21_5_61-76.nxml.txt.nlp	21042543	SENT303	32	32	10	10	panitumumab	EGFR	PA162373091	1956	0.958
NULL	Front_Neurosci_2011_Dec_19_5_137.nxml.txt.nlp	22194715	SENT146	8	8	2	2	estradiol	aromatase	PA449503	1588	0.958
NULL	Acta_Psychiatr_Scand_2012_Sep_126(3)_186-197.nxml.txt.nlp	22404233	SENT220	0	0	11	11	olanzapine	BPAD	PA450688	4095	0.958
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT107	5	5	24	24	curcumin	IL-8	PA151958596	3576	0.958
NULL	Nat_Commun_2013_Sep_20_4_2444.nxml.txt.nlp	24051492	SENT388	26	26	35	35	nutlin-3	CT9		676	0.958
NULL	Acta_Pharmacol_Sin_2010_Mar_22_31(3)_329-340.nxml.txt.nlp	20173759	SENT150	10	10	21	21	ethanol	AMPK	PA448073	5563	0.958
NULL	Nucleic_Acids_Res_2010_Oct_21_38(18)_6148-6158.nxml.txt.nlp	20494979	SENT266	24	24	5	5	staurosporine	HLJ1	PA165109623	11080	0.958
NULL	Mol_Biol_Cell_2012_Jul_15_23(14)_2658-2670.nxml.txt.nlp	22621899	SENT229	7	7	0	0	doxycycline	AURKA	PA449415	6790	0.958
NULL	Oncotarget_2013_Aug_21_4(9)_1484-1495.nxml.txt.nlp	23986086	SENT168	32	32	19	19	metformin	p53	PA450395	7157	0.958
NULL	J_Invest_Dermatol_2014_Apr_11_134(4)_1083-1090.nxml.txt.nlp	24335898	SENT57	9	9	12	12	nutlin-3	MDM2		4193	0.958
NULL	Cardiovasc_Diabetol_2005_Oct_5_4_16.nxml.txt.nlp	16207378	SENT223	14	14	30	30	glucosamine	perlecan	PA164747613	3339	0.958
NULL	Curr_Neuropharmacol_2013_Dec_11(6)_652-663.nxml.txt.nlp	24396340	SENT36	12	12	0	0	capsaicin	TRPV1	PA448776	7442	0.958
NULL	Infection_2013_Sep_14_41(Suppl_2)_91-115.nxml.txt.nlp	24037688	SENT523	34	34	22	22	azithromycin	CD4	PA448519	920	0.958
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1044.nxml.txt.nlp	24503536	SENT359	20	20	7	7	cisplatin	XIAP	PA449014	331	0.958
NULL	Mol_Biol_Cell_2012_Nov_15_23(22)_4444-4455.nxml.txt.nlp	22993210	SENT142	27	27	10	10	forskolin	MyRIP	PA146096022	25924	0.958
NULL	Oncogene_2014_Feb_6_33(6)_713-723.nxml.txt.nlp	23435429	SENT73	11	11	3	3	etoposide	p50	PA449552	958;4790	0.958
NULL	Int_J_Nanomedicine_2012_May_7_7_2307-2314.nxml.txt.nlp	22661887	SENT162	11	11	0	0	gemcitabine	F10	PA449748	2159	0.958
NULL	Atherosclerosis_2014_Nov_237(1)_287-300.nxml.txt.nlp	25299963	SENT193	6	6	19	19	metformin	adiponectin	PA450395	9370	0.958
NULL	Diabetes_2011_May_23_60(5)_1566-1576.nxml.txt.nlp	21464444	SENT389	9	9	26	26	lipase	IL-6	PA450239	3569	0.958
NULL	Eur_J_Clin_Pharmacol_2012_Sep_15_68(9)_1267-1274.nxml.txt.nlp	22418828	SENT19	11	11	4	4	pantoprazole	CYP2C19	PA450774	1557	0.958
NULL	J_Cell_Biol_1988_Feb_1_106(2)_385-393.nxml.txt.nlp	2448313	SENT6	34	34	1	1	trypsin	CG1	PA451806	11097;10046;3895	0.958
NULL	Case_Rep_Psychiatry_2013_May_16_2013_913248.nxml.txt.nlp	23762722	SENT53	0	0	32	32	ziprasidone	5-HT1A	PA451974	3350	0.958
NULL	Oncogene_2014_Jul_24_33(30)_3959-3969.nxml.txt.nlp	24096481	SENT25	29	29	12	12	nutlin-3	PIG3		64975;9540	0.958
NULL	Int_J_Nanomedicine_2012_Nov_29_7_5915-5927.nxml.txt.nlp	23226697	SENT102	20	20	27	27	heparin	FGF1	PA449855	2246	0.958
NULL	Clin_Proteomics_2014_Jun_2_11(1)_23.nxml.txt.nlp	24982608	SENT177	8	8	25	25	trypsin	LRG1	PA451806	116844	0.958
NULL	Mol_Cancer_2010_Apr_23_9_87.nxml.txt.nlp	20416058	SENT280	34	34	4	4	doxorubicin	TRAIL	PA449412	8743	0.958
NULL	Breast_Cancer_Res_Treat_2014_Sep_19_147(3)_599-607.nxml.txt.nlp	25234842	SENT3	2	2	28	28	trastuzumab	HER2	PA451743	2064	0.958
NULL	Carcinogenesis_2014_May_13_35(5)_1055-1066.nxml.txt.nlp	24419232	SENT319	16	16	5	5	metformin	CYP1B1	PA450395	1545	0.958
NULL	Biologics_2010_Feb_4_4_19-31.nxml.txt.nlp	20161982	SENT202	0	0	14	14	nilotinib	KIT	PA165958345	3815	0.958
NULL	J_Cancer_2013_Nov_23_4(9)_736-754.nxml.txt.nlp	24312144	SENT54	17	17	0	0	afatinib	EGFR	PA165981154	1956	0.958
NULL	Core_Evid_2009_Jun_15_4_25-36.nxml.txt.nlp	20694062	SENT172	26	26	11	11	febuxostat	FACT	PA165958521	11198	0.958
NULL	Indian_J_Urol_2007_Apr-Jun_23(2)_91-96.nxml.txt.nlp	19675781	SENT175	33	33	25	25	finasteride	NNT	PA449627	23530	0.958
NULL	Diabetes_Care_2012_Feb_16_35(2)_327-333.nxml.txt.nlp	22179958	SENT47	2	2	17	17	metformin	B12	PA450395	7126;4709	0.958
NULL	Oncoimmunology_2012_May_1_1(3)_372-374.nxml.txt.nlp	22737619	SENT15	36	36	11	11	lenalidomide	CD4	PA162363968	920	0.958
NULL	Nucleic_Acids_Res_2005_Jun_8_33(10)_3283-3291.nxml.txt.nlp	15944449	SENT118	26	26	16	16	melphalan	XRCC3	PA450354	7517	0.958
NULL	Evid_Based_Complement_Alternat_Med_2012_Dec_27_2012_472821.nxml.txt.nlp	23346202	SENT139	28	28	33	33	indomethacin	COX	PA449982	1351	0.958
NULL	Mediators_Inflamm_2010_Jun_21_2010_194896.nxml.txt.nlp	20652055	SENT39	0	0	39	39	berberine	mol	PA165860812	90527	0.958
NULL	Indian_J_Med_Res_2012_Mar_135(3)_359-364.nxml.txt.nlp	22561623	SENT111	0	0	15	15	cefotetan	FOX-1	PA164784033	54715	0.958
NULL	Onco_Targets_Ther_2014_Sep_19_7_1631-1639.nxml.txt.nlp	25278770	SENT70	12	12	22	22	temozolomide	GNA11	PA451609	2767	0.958
NULL	Nat_Methods_2012_Feb_19_9(4)_396-402.nxml.txt.nlp	22343342	SENT118	0	0	6	6	capsaicin	TRPV1	PA448776	7442	0.958
NULL	Oncotarget_2013_Oct_27_4(11)_2080-2095.nxml.txt.nlp	24231268	SENT216	40	40	21	21	nutlin-3	p53		7157	0.958
NULL	Exp_Cell_Res_2009_Nov_15_315(19)_3433-3441.nxml.txt.nlp	19716819	SENT188	8	8	33	33	hyaluronidase	CD44	PA164745713	960	0.958
NULL	Biomed_Res_Int_2014_Apr_28_2014_549742.nxml.txt.nlp	24877113	SENT87	20	20	26	26	vincristine	BMP4	PA451879	652	0.958
NULL	Leukemia_2013_Jan_11_27(1)_32-40.nxml.txt.nlp	22781593	SENT37	4	4	28	28	ponatinib	FGFR1	PA165980594	2260	0.958
NULL	Drugs_2014_Oct_10_74(17)_2015-2032.nxml.txt.nlp	25300410	SENT61	5	5	1	1	azithromycin	P-gp	PA448519	5243	0.958
NULL	Depress_Res_Treat_2011_Jul_18_2011_529638.nxml.txt.nlp	21789279	SENT78	24	24	38	38	lithium	ST2	PA450243	9173;6761	0.958
NULL	Neural_Plast_2014_Mar_17_2014_123026.nxml.txt.nlp	24757568	SENT168	0	0	15	15	estradiol	CA1	PA449503	759	0.958
NULL	Nucleic_Acids_Res_2010_Oct_22_38(19)_6502-6512.nxml.txt.nlp	20571088	SENT114	25	25	40	40	galactose	SMC6	PA449725	79677	0.958
NULL	Core_Evid_2011_Feb_8_6_23-29.nxml.txt.nlp	21468240	SENT117	3	3	15	15	plerixafor	CD34	PA165958410	947	0.958
NULL	Breast_Cancer_Res_2010_Oct_14_12(5)_R84.nxml.txt.nlp	20946630	SENT270	14	14	0	0	choline	SLC44A1	PA448976	23446	0.958
NULL	Breast_Cancer_Res_2011_Dec_16_13(6)_R131.nxml.txt.nlp	22177475	SENT188	18	18	4	4	trastuzumab	HER2	PA451743	2064	0.958
NULL	Acta_Pharmacol_Sin_2013_Jun_8_34(6)_830-836.nxml.txt.nlp	23564080	SENT143	16	16	7	7	simvastatin	HMGB1	PA451363	3146	0.958
NULL	FEBS_Open_Bio_2014_Oct_22_4_898-904.nxml.txt.nlp	25383313	SENT174	5	5	20	20	nifedipine	LKB1	PA450631	6794	0.958
NULL	Ann_Oncol_2010_Feb_21(2)_217-222.nxml.txt.nlp	20110292	SENT142	25	25	11	11	erlotinib	RAPGEF5	PA134687924	9771	0.958
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT123	0	0	5	5	tanespimycin	HER2	PA165291490	2064	0.958
NULL	Breast_Cancer_Res_2006_Nov_6_8(6)_215.nxml.txt.nlp	17096862	SENT104	27	27	4	4	lapatinib	HER2	PA152241907	2064	0.958
NULL	J_Oncol_2011_Mar_30_2011_456743.nxml.txt.nlp	21541211	SENT111	26	26	8	8	cisplatin	PI3K	PA449014	5290	0.958
NULL	Med_Sci_Monit_2014_Apr_11_20_594-600.nxml.txt.nlp	24721823	SENT149	24	24	7	7	atorvastatin	PON1	PA448500	5444	0.958
NULL	Oncotarget_2014_Jun_8_5(13)_5040-5053.nxml.txt.nlp	24970815	SENT112	3	3	12	12	cisplatin	AKT	PA449014	207	0.958
NULL	Ann_Surg_Oncol_2010_Jan_20_17(1)_14-17.nxml.txt.nlp	19841980	SENT77	36	36	21	21	trastuzumab	PI3	PA451743	5266	0.958
NULL	Curr_Oncol_2009_Jul_16(Suppl_2)_S14-S23.nxml.txt.nlp	19672417	SENT120	2	2	15	15	tamoxifen	CYP2D6	PA451581	1565	0.958
NULL	ISRN_Oxidative_Med_2013_2013_831596.nxml.txt.nlp	25506596	SENT45	0	0	27	27	hemin	TLR4	PA449849	7099	0.958
NULL	Br_J_Cancer_2009_Jul_21_101(2)_269-277.nxml.txt.nlp	19603033	SENT22	3	3	15	15	cisplatin	XIAP	PA449014	331	0.958
NULL	Cancer_Metastasis_Rev_2011_Dec_20_30(3-4)_465-480.nxml.txt.nlp	22012553	SENT435	7	7	16	16	berberine	EP4	PA165860812	5734	0.958
NULL	Core_Evid_2011_Sep_8_6_67-79.nxml.txt.nlp	22022289	SENT23	0	0	8	8	exenatide	GLP-1	PA164749238	100125288	0.958
NULL	Breast_Cancer_(Auckl)_2012_Mar_7_6_67-77.nxml.txt.nlp	22438669	SENT145	5	5	22	22	lapatinib	VEGFR	PA152241907	3791	0.958
NULL	Oncol_Rep_2013_Sep_1_30(3)_1045-1052.nxml.txt.nlp	23817662	SENT154	21	21	3	3	afatinib	EGFR	PA165981154	1956	0.958
NULL	Br_J_Cancer_2012_Jan_17_106(2)_284-289.nxml.txt.nlp	22215065	SENT45	0	0	10	10	atrasentan	IFN	PA143414738	3439	0.958
NULL	J_Cell_Biol_1997_Nov_3_139(3)_639-649.nxml.txt.nlp	9348281	SENT51	27	27	5	5	neomycin	A20	PA450608	7128;28935	0.958
NULL	Osteopath_Med_Prim_Care_2010_Aug_11_4_5.nxml.txt.nlp	20701768	SENT135	0	0	13	13	cilostazol	PAD	PA164746334	79665;23569	0.958
NULL	Exp_Neurobiol_2013_Mar_31_22(1)_51-57.nxml.txt.nlp	23585723	SENT6	26	26	12	12	capsaicin	TRPV1	PA448776	7442	0.958
NULL	Nat_Neurosci_2014_Jan_8_17(1)_114-120.nxml.txt.nlp	24316890	SENT182	8	8	17	17	vanillin	OR10G4	PA451852	390264	0.958
NULL	Breast_Cancer_Res_2014_Sep_9_16(5)_433.nxml.txt.nlp	25212966	SENT8	24	24	16	16	aprotinin	ILEI	PA448472	10447	0.958
NULL	Breast_Cancer_Res_2010_May_18_12(Suppl_1)_P48.nxml.txt.nlp	NULL	SENT4	25	25	20	20	tamoxifen	CYP2D6	PA451581	1565	0.958
NULL	Cancer_Cell_Int_2006_Aug_9_6_20.nxml.txt.nlp	16899133	SENT54	22	22	42	42	tamoxifen	p27	PA451581	5715;10534	0.958
NULL	Biologics_2009_Sep_15_3_419-428.nxml.txt.nlp	19774209	SENT4	6	6	4	4	erlotinib	EGFR	PA134687924	1956	0.958
NULL	Cancer_Med_2013_Feb_3_2(1)_40-49.nxml.txt.nlp	24133626	SENT223	23	23	7	7	cisplatin	gamma	PA449014	9913	0.958
NULL	Clin_Sarcoma_Res_2013_Mar_7_3_3.nxml.txt.nlp	23497641	SENT176	34	34	36	36	imatinib	EGFR	PA10804	1956	0.958
NULL	Springerplus_2014_Sep_9_3_510.nxml.txt.nlp	25279302	SENT34	3	3	27	27	creatine	GAMT	PA164778930	2593	0.958
NULL	Breast_Cancer_(Auckl)_2012_Feb_20_6_47-66.nxml.txt.nlp	22399860	SENT172	4	4	14	14	tamoxifen	MYC	PA451581	4609	0.958
NULL	Biomed_Res_Int_2013_Feb_28_2013_749078.nxml.txt.nlp	23555095	SENT109	0	0	11	11	trypsin	CD102	PA451806	3384	0.958
NULL	Exp_Diabetes_Res_2011_Apr_26_2011_215764.nxml.txt.nlp	21584276	SENT11	40	40	4	4	exenatide	GLP-1	PA164749238	100125288	0.958
NULL	Cancer_Cell_Int_2008_Mar_18_8_3.nxml.txt.nlp	18348720	SENT75	9	9	16	16	lapatinib	EGF	PA152241907	1950	0.958
NULL	Ophthalmol_Eye_Dis_2011_Mar_16_3_1-6.nxml.txt.nlp	23861617	SENT36	13	13	1	1	tetracaine	PTK	PA451638	2185	0.958
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Dec_17_3(12)_e152.nxml.txt.nlp	25518025	SENT72	20	20	18	18	ketoconazole	CYP3A	PA450146	1574	0.958
NULL	Oncotarget_2014_Dec_4_5(22)_11365-11380.nxml.txt.nlp	25426548	SENT115	11	11	19	19	nutlin-3	p53		7157	0.958
NULL	Indian_J_Endocrinol_Metab_2011_Jan-Mar_15(1)_9-17.nxml.txt.nlp	21584160	SENT63	0	0	3	3	liraglutide	GLP-1	PA165958364	100125288	0.958
NULL	Arthritis_Res_Ther_2003_May_29_5(4)_180-191.nxml.txt.nlp	12823849	SENT220	0	0	13	13	alemtuzumab	CD52	PA164783958	1043	0.958
NULL	Int_J_Breast_Cancer_2011_Feb_14_2011_618757.nxml.txt.nlp	22332014	SENT150	39	39	6	6	anastrozole	ATAC	PA448432	6375	0.958
NULL	J_Invest_Dermatol_2012_Oct_24_132(10)_2440-2450.nxml.txt.nlp	22622430	SENT78	17	17	10	10	temozolomide	IL-8	PA451609	3576	0.958
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT50	0	0	24	24	resveratrol	SIRT1		23411	0.958
NULL	Acta_Pharmacol_Sin_2010_Jun_4_31(6)_709-717.nxml.txt.nlp	20523342	SENT78	31	31	5	5	repaglinide	ANOVA	PA451234	4858	0.958
NULL	Environ_Health_Perspect_2005_Jul_3_113(7)_840-848.nxml.txt.nlp	16002370	SENT327	10	10	0	0	nicotine	CYP2A6	PA450626	1548	0.958
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_650809.nxml.txt.nlp	23258995	SENT245	5	5	20	20	forskolin	AQP2	PA146096022	359	0.958
NULL	Clin_Sci_(Lond)_2013_May_1_124(Pt_9)_567-578.nxml.txt.nlp	23113760	SENT632	10	10	2	2	cetuximab	BRAF	PA10040	673	0.958
NULL	Arch_Med_Sci_2013_Feb_21_9(1)_151-158.nxml.txt.nlp	23515030	SENT132	19	19	31	31	lipase	SN2	PA450239	92745	0.958
NULL	Cancer_Manag_Res_2013_Oct_8_5_337-347.nxml.txt.nlp	24204170	SENT40	6	6	9	9	sorafenib	EGFR	PA7000	1956	0.958
NULL	Endocrinology_2012_Jul_3_153(7)_3236-3248.nxml.txt.nlp	22555437	SENT31	38	38	8	8	metformin	HSD1	PA450395	26871	0.958
NULL	Ann_Hematol_2010_Sep_13_89(9)_861-871.nxml.txt.nlp	20387067	SENT102	7	7	15	15	dasatinib	CD34	PA162372878	947	0.958
NULL	Nat_Commun_2013_Sep_17_4_2464.nxml.txt.nlp	24043118	SENT120	12	12	24	24	estradiol	FGF10	PA449503	2255	0.958
NULL	Indian_J_Endocrinol_Metab_2011_Jan-Mar_15(1)_9-17.nxml.txt.nlp	21584160	SENT68	0	0	4	4	liraglutide	GLP-1	PA165958364	100125288	0.958
NULL	Int_J_Endocrinol_2010_Feb_10_2010_625852.nxml.txt.nlp	20169119	SENT159	19	19	5	5	cinacalcet	PTH	PA164776671	5741	0.958
NULL	Arch_Drug_Inf_2011_Mar_4(1)_1-9.nxml.txt.nlp	21572514	SENT31	14	14	27	27	ciprofloxacin	P-gp	PA449009	5243	0.958
NULL	Ann_Oncol_2013_Apr_31_24(4)_1067-1073.nxml.txt.nlp	23117073	SENT48	6	6	26	26	fosaprepitant	CYP3A4	PA165958390	1576	0.958
NULL	N_Am_J_Med_Sci_2013_Jul_5(7)_432-437.nxml.txt.nlp	24020054	SENT63	10	10	20	20	vinblastine	CHOP	PA451877	1649	0.958
NULL	J_Clin_Biochem_Nutr_2009_Jul_30_45(1)_9-13.nxml.txt.nlp	19590701	SENT41	24	24	14	14	lansoprazole	HO-1	PA450180	3162	0.958
NULL	Indian_J_Pharm_Sci_2008_Jan-Feb_70(1)_102-105.nxml.txt.nlp	20390092	SENT75	6	6	0	0	domperidone	LAN	PA134711056	9993	0.958
NULL	EJNMMI_Res_2011_Jun_7_1_1.nxml.txt.nlp	21845232	SENT33	0	0	30	30	panitumumab	EGFR	PA162373091	1956	0.958
NULL	Indian_J_Nephrol_2009_Jul_19(3)_119-121.nxml.txt.nlp	20436733	SENT59	6	6	15	15	cyclosporine	CYP3A	PA449167	1574	0.958
NULL	N_Am_J_Med_Sci_2010_Oct_2(10)_491-495.nxml.txt.nlp	22558553	SENT106	20	20	8	8	napqi	CYP2E1		1571	0.958
NULL	J_Biol_Chem_2013_Feb_8_288(6)_3918-3928.nxml.txt.nlp	23239877	SENT112	34	34	19	19	thrombin	PAR1	PA451674	79581;2149	0.958
NULL	J_Inflamm_(Lond)_2005_Oct_31_2_14.nxml.txt.nlp	16259633	SENT338	24	24	4	4	staurosporine	IFN	PA165109623	3439	0.958
NULL	J_Korean_Med_Sci_2010_May_16_25(5)_772-775.nxml.txt.nlp	20436716	SENT66	5	5	37	37	glycopyrrolate	CLS	PA164754882	1210	0.958
NULL	Mol_Cancer_2014_Jun_3_13_139.nxml.txt.nlp	24894297	SENT127	10	10	23	23	cisplatin	HES1	PA449014	3280;8209	0.958
NULL	Cell_Death_Dis_2012_Mar_1_3(3)_e275.nxml.txt.nlp	22378068	SENT66	18	18	3	3	doxorubicin	AMPK	PA449412	5563	0.958
NULL	Cancer_Med_2014_Oct_25_3(5)_1099-1111.nxml.txt.nlp	24961511	SENT368	15	15	5	5	cisplatin	CD133	PA449014	8842	0.958
NULL	Mol_Cancer_2010_Nov_2_9_289.nxml.txt.nlp	21044322	SENT149	32	32	6	6	docetaxel	RGS2	PA449383	5997	0.958
NULL	Acta_Pharmacol_Sin_2010_Jul_28_31(7)_867-873.nxml.txt.nlp	20581857	SENT91	6	6	0	0	docetaxel	PC3	PA449383	57332;7832;5122	0.958
NULL	Mol_Cancer_2010_Dec_31_9_320.nxml.txt.nlp	21194429	SENT307	19	19	0	0	bevacizumab	VEGF-A	PA130232992	7422	0.958
NULL	Diabetes_Care_2012_Jan_9_35(1)_4-11.nxml.txt.nlp	22040840	SENT103	0	0	21	21	exenatide	adiponectin	PA164749238	9370	0.958
NULL	Comb_Chem_High_Throughput_Screen_2010_Feb_13(2)_188-206.nxml.txt.nlp	20053163	SENT244	16	16	21	21	itraconazole	CYP3A4	PA450132	1576	0.958
NULL	Genetics_2014_Mar_7_196(3)_711-727.nxml.txt.nlp	24398420	SENT156	22	22	5	5	ethanol	C17	PA448073	54360	0.958
NULL	J_Korean_Med_Sci_2010_Apr_19_25(4)_557-563.nxml.txt.nlp	20357998	SENT106	5	5	21	21	cisplatin	IL-10	PA449014	3586	0.958
NULL	Case_Rep_Transplant_2014_Jan_2_2014_548243.nxml.txt.nlp	24575309	SENT69	26	26	4	4	tacrolimus	CYP3A	PA451578	1574	0.958
NULL	Int_Neurourol_J_2014_Sep_24_18(3)_115-125.nxml.txt.nlp	25279238	SENT118	30	30	11	11	berberine	CA1	PA165860812	759	0.958
NULL	Oncol_Lett_2014_Sep_19_8(3)_1320-1322.nxml.txt.nlp	25120716	SENT3	16	16	28	28	gefitinib	EGFR	PA131301952	1956	0.958
NULL	J_Adv_Pharm_Technol_Res_2013_Jul-Sep_4(3)_151-159.nxml.txt.nlp	24083203	SENT188	23	23	8	8	clobazam	F18	PA10888	10046	0.958
NULL	Endocrinol_Diabetes_Metab_Case_Rep_2014_Mar_1_2014_140001.nxml.txt.nlp	24683487	SENT10	17	17	6	6	metyrapone	ACTH	PA450486	5443	0.958
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT248	16	16	7	7	phenprocoumon	CYP2C9	PA450921	1559	0.958
NULL	Eur_J_Clin_Pharmacol_2012_Sep_15_68(9)_1267-1274.nxml.txt.nlp	22418828	SENT183	13	13	20	20	pantoprazole	CYP2C19	PA450774	1557	0.958
NULL	Basic_Clin_Pharmacol_Toxicol_2013_Feb_5_112(2)_132-137.nxml.txt.nlp	22900583	SENT155	26	26	20	20	ritonavir	CYP3A4	PA451260	1576	0.958
NULL	Ann_Oncol_2013_Apr_31_24(4)_1067-1073.nxml.txt.nlp	23117073	SENT48	0	0	26	26	aprepitant	CYP3A4	PA164747039	1576	0.958
NULL	Cells_2014_Jun_11_3(2)_616-626.nxml.txt.nlp	24921186	SENT63	10	10	21	21	capsaicin	TRPA1	PA448776	8989	0.958
NULL	Cancer_Med_2013_Dec_31_2(6)_950-963.nxml.txt.nlp	24403269	SENT374	30	30	15	15	cisplatin	RAB25	PA449014	57111	0.958
NULL	J_Headache_Pain_2012_Mar_27_13(2)_103-111.nxml.txt.nlp	22200764	SENT71	22	22	0	0	capsaicin	TRPV1	PA448776	7442	0.958
NULL	Cell_Commun_Signal_2004_Jun_30_2_6.nxml.txt.nlp	15228623	SENT10	31	31	10	10	nifedipine	TTN	PA450631	7273	0.958
NULL	Mol_Cancer_2007_Oct_11_6_63.nxml.txt.nlp	17931419	SENT82	6	6	45	45	cetuximab	EGFR	PA10040	1956	0.958
NULL	Med_Sci_Monit_2013_Oct_31_19_916-926.nxml.txt.nlp	24172537	SENT113	23	23	7	7	mitomycin	FANCG	PA450524	2189	0.958
NULL	Case_Rep_Genet_2014_Jan_22_2014_413743.nxml.txt.nlp	24627811	SENT75	29	29	19	19	warfarin	CYP2C9	PA451906	1559	0.958
NULL	Int_J_Biol_Sci_2014_Feb_6_10(2)_212-224.nxml.txt.nlp	24550689	SENT273	6	6	0	0	temozolomide	MDC	PA451609	6367	0.958
NULL	eLife_2014_May_20_3_e01763.nxml.txt.nlp	24844244	SENT497	20	20	35	35	doxycycline	MELK	PA449415	9833	0.958
NULL	Case_Rep_Hematol_2013_Jun_11_2013_680459.nxml.txt.nlp	23840983	SENT12	19	19	1	1	hydroxocobalamin	B12	PA164768689	7126;4709	0.958
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Dec_17_3(12)_e152.nxml.txt.nlp	25518025	SENT125	24	24	8	8	oxycodone	CYP3A	PA450741	1574	0.958
NULL	Front_Genet_2014_Aug_27_5_281.nxml.txt.nlp	25221567	SENT231	26	26	12	12	methotrexate	OATP1B1	PA450428	10599	0.958
NULL	Mol_Cell_Biochem_2014_Jan_3_389(1-2)_177-185.nxml.txt.nlp	24385108	SENT205	5	5	19	19	bortezomib	PUMA	PA10252	27113	0.958
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1059-1066.nxml.txt.nlp	21364577	SENT131	14	14	2	2	anastrozole	ATAC	PA448432	6375	0.958
NULL	Hum_Genomics_2008_Sep_1_3(1)_7-16.nxml.txt.nlp	19129086	SENT30	14	14	6	6	rosiglitazone	CYP2C8	PA451283	1558	0.958
NULL	Br_J_Cancer_2009_Oct_6_101(7)_1168-1174.nxml.txt.nlp	19724277	SENT148	11	11	39	39	bortezomib	p300	PA10252	2033	0.958
NULL	AIDS_Res_Ther_2013_May_1_10_10.nxml.txt.nlp	23634877	SENT148	5	5	20	20	atorvastatin	CCR5	PA448500	1234	0.958
NULL	Daru_2012_Oct_4_20(1)_45.nxml.txt.nlp	23351300	SENT36	22	22	39	39	norfloxacin	API	PA450654	5345	0.958
NULL	Cell_Death_Dis_2014_Apr_17_5(4)_e1185.nxml.txt.nlp	24743740	SENT128	4	4	0	0	pha-665752	Met		79811	0.958
NULL	J_Gen_Physiol_1960_Mar_1_43(4)_753-758.nxml.txt.nlp	14433991	SENT1	45	45	8	8	dextran	gamma	PA449261	9913	0.958
NULL	Patient_Prefer_Adherence_2011_Dec_23_6_1-9.nxml.txt.nlp	22272064	SENT21	25	25	28	28	telmisartan	ACE	PA451605	1636	0.958
NULL	EMBO_Mol_Med_2013_Aug_4_5(8)_1247-1262.nxml.txt.nlp	23737459	SENT9	9	9	25	25	nilotinib	parkin	PA165958345	5071	0.958
NULL	Curr_Neuropharmacol_2014_Jul_12(4)_365-379.nxml.txt.nlp	25342944	SENT160	29	29	8	8	fluoxetine	GluK4	PA449673	2900	0.958
NULL	Orphanet_J_Rare_Dis_2014_Dec_10_9(1)_200.nxml.txt.nlp	NULL	SENT95	0	0	13	13	teriparatide	HCS	PA451620	3141;54205	0.958
NULL	Int_J_Breast_Cancer_2012_May_9_2012_415170.nxml.txt.nlp	22649737	SENT12	3	3	19	19	trastuzumab	HER2	PA451743	2064	0.958
NULL	Breast_Cancer_Res_2005_May_24_7(5)_R589-R597.nxml.txt.nlp	16168102	SENT109	36	36	20	20	doxorubicin	FAK	PA449412	5747	0.958
NULL	Int_J_Cell_Biol_2012_Sep_9_2012_683897.nxml.txt.nlp	22991514	SENT58	16	16	30	30	oxygen	ROS	PA450744	6098	0.958
NULL	Oncotarget_2011_Sep_9_2(9)_658-668.nxml.txt.nlp	21911919	SENT82	17	17	4	4	cytarabine	HO-1	PA449177	3162	0.958
NULL	Case_Rep_Ophthalmol_2010_Aug_18_1(1)_36-41.nxml.txt.nlp	21369348	SENT45	11	11	2	2	bevacizumab	hole	PA130232992	80757	0.958
NULL	Oncol_Lett_2013_Mar_28_5(3)_935-942.nxml.txt.nlp	23426424	SENT142	38	38	30	30	cisplatin	ERCC1	PA449014	2067	0.958
NULL	Indian_J_Pharmacol_2008_Oct_40(Suppl_2)_S178-S211.nxml.txt.nlp	21593974	SENT292	12	12	26	26	metformin	NAC	PA450395	22861	0.958
NULL	Cancers_(Basel)_2011_Sep_13_3(3)_3506-3524.nxml.txt.nlp	24212966	SENT101	35	35	28	28	docetaxel	EGFR	PA449383	1956	0.958
NULL	Case_Rep_Gastroenterol_2011_Oct_4_5(3)_583-589.nxml.txt.nlp	22110419	SENT60	31	31	14	14	imatinib	KIT	PA10804	3815	0.958
NULL	Cell_Commun_Signal_2013_Oct_1_11_73.nxml.txt.nlp	24083678	SENT25	4	4	12	12	sulindac	COX	PA451565	1351	0.958
NULL	J_Am_Heart_Assoc_2013_Dec_19_2(6)_e000355.nxml.txt.nlp	24190878	SENT185	23	23	11	11	phenylephrine	HK2	PA450935	3796;3099;29911;3741	0.958
NULL	Arthritis_Res_Ther_2011_Apr_14_13(2)_R61.nxml.txt.nlp	21492463	SENT266	6	6	9	9	imatinib	TKR	PA10804	8277	0.958
NULL	Biogerontology_2014_Nov_16_15(1)_47-64.nxml.txt.nlp	24243065	SENT366	0	0	8	8	doxorubicin	TRF1	PA449412	7013	0.958
NULL	J_Korean_Med_Sci_2010_Jun_24_25(6)_829-834.nxml.txt.nlp	20514301	SENT137	15	15	8	8	papain	p38	PA450778	10598;1432;7965	0.958
NULL	Braz_J_Med_Biol_Res_2013_Aug_13_46(8)_650-658.nxml.txt.nlp	23969971	SENT10	37	37	44	44	oxaliplatin	STAT3	PA131285527	6774	0.958
NULL	Exp_Mol_Med_2012_May_31_44(5)_311-318.nxml.txt.nlp	22282402	SENT45	14	14	4	4	cilostazol	MCP-1	PA164746334	6347	0.958
NULL	Braz_J_Microbiol_2014_Aug_29_45(2)_677-687.nxml.txt.nlp	25242958	SENT93	3	3	13	13	lipase	mol	PA450239	90527	0.958
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S272-S275.nxml.txt.nlp	21525467	SENT108	13	13	10	10	liraglutide	GLP-1	PA165958364	100125288	0.958
NULL	Mol_Cancer_2010_Nov_25_9_305.nxml.txt.nlp	21108789	SENT95	9	9	1	1	cisplatin	MLH1	PA449014	4292	0.958
NULL	J_Cell_Biol_1998_Jan_26_140(2)_335-345.nxml.txt.nlp	9442109	SENT157	12	12	31	31	chloroquine	NHE	PA448948	285335	0.958
NULL	Front_Neurosci_2013_Jan_31_7_3.nxml.txt.nlp	23386808	SENT178	25	25	16	16	capsaicin	TRPV1	PA448776	7442	0.958
NULL	Acta_Pharmacol_Sin_2014_Jun_5_35(6)_727-737.nxml.txt.nlp	24793312	SENT135	46	46	34	34	telmisartan	AT1	PA451605	9197;185	0.958
NULL	Clin_Med_Pathol_2008_Jul_28_1_83-91.nxml.txt.nlp	21876656	SENT168	11	11	1	1	vildagliptin	GLP-1	PA165958346	100125288	0.958
NULL	Front_Pharmacol_2014_Dec_23_5_286.nxml.txt.nlp	25566078	SENT57	27	27	42	42	cisplatin	FOXM1	PA449014	2305	0.958
NULL	Oncogene_2010_Mar_18_29(11)_1691-1701.nxml.txt.nlp	20023700	SENT54	24	24	6	6	bicalutamide	KLK2	PA164746255	3817	0.958
NULL	Cell_Commun_Signal_2004_Aug_6_2_8.nxml.txt.nlp	15296508	SENT52	13	13	32	32	genistein	JAK1	PA165109660	3716	0.958
NULL	J_Cell_Mol_Med_2014_May_20_18(5)_844-851.nxml.txt.nlp	24444371	SENT120	13	13	5	5	mannitol	MAD2B	PA450320	10459	0.958
NULL	Mol_Cancer_2010_Apr_15_9_77.nxml.txt.nlp	20398291	SENT49	28	28	43	43	geldanamycin	survivin	PA152031327	332	0.958
NULL	Br_J_Cancer_2014_Aug_12_111(4)_646-650.nxml.txt.nlp	24755886	SENT47	4	4	26	26	trabectedin	TRAIL	PA165958349	8743	0.958
NULL	Exp_Lung_Res_2013_Oct_1_39(8)_336-348.nxml.txt.nlp	23919450	SENT127	4	4	8	8	thrombin	PAR-1	PA451674	2011;2149	0.958
NULL	Front_Endocrinol_(Lausanne)_2013_Nov_11_4_166.nxml.txt.nlp	24273531	SENT236	20	20	3	3	candesartan	ANG	PA448765	283	0.958
NULL	Br_J_Cancer_2010_Jan_5_102(1)_1-7.nxml.txt.nlp	19935796	SENT132	21	21	30	30	orlistat	PI3K	PA164776864	5290	0.958
NULL	Springerplus_2014_Sep_17_3_535.nxml.txt.nlp	25279326	SENT153	29	29	13	13	exemestane	aromatase	PA449563	1588	0.958
NULL	Sci_Rep_2015_Jan_6_5_7641.nxml.txt.nlp	25560734	SENT16	30	30	32	32	tamoxifen	aromatase	PA451581	1588	0.958
NULL	J_Exp_Med_1998_Jun_1_187(11)_1885-1892.nxml.txt.nlp	9607928	SENT105	7	7	22	22	thalidomide	CD4	PA451644	920	0.958
NULL	Front_Oncol_2014_Apr_9_4_75.nxml.txt.nlp	24782986	SENT213	4	4	18	18	paclitaxel	IL-6	PA450761	3569	0.958
NULL	Infect_Drug_Resist_2011_Mar_2_4_77-86.nxml.txt.nlp	21694911	SENT69	24	24	15	15	tigecycline	CABP	PA164746412	6277	0.958
NULL	Mol_Cancer_2009_May_15_8_28.nxml.txt.nlp	19445670	SENT46	13	13	4	4	doxorubicin	XIAP	PA449412	331	0.958
NULL	J_Hematol_Oncol_2009_Aug_12_2_36.nxml.txt.nlp	19674465	SENT94	13	13	30	30	thalidomide	CD56	PA451644	4684	0.958
NULL	Virulence_2014_Jan_1_5(1)_36-44.nxml.txt.nlp	23774844	SENT139	19	19	3	3	trypsin	PAR1	PA451806	79581;2149	0.958
NULL	Mol_Cancer_2009_Nov_24_8_109.nxml.txt.nlp	19930708	SENT190	6	6	15	15	exemestane	EGFR	PA449563	1956	0.958
NULL	Cerebrospinal_Fluid_Res_2010_Aug_13_7_13.nxml.txt.nlp	20707896	SENT87	5	5	15	15	vasopressin	AVP	PA451858	114548;551	0.958
NULL	Exp_Ther_Med_2013_Apr_5_5(4)_1259-1263.nxml.txt.nlp	23596498	SENT101	6	6	1	1	capsaicin	TRPV1	PA448776	7442	0.958
NULL	J_Hematol_Oncol_2011_Dec_21_4_53.nxml.txt.nlp	22189016	SENT70	12	12	7	7	quinidine	P-gp	PA451209	5243	0.958
NULL	J_Mol_Signal_2012_May_31_7_5.nxml.txt.nlp	22651821	SENT66	21	21	8	8	neomycin	SSTR3	PA450608	6753	0.958
NULL	Small_GTPases_2012_Jan_1_3(1)_34-39.nxml.txt.nlp	22714415	SENT8	18	18	9	9	cetuximab	KRAS	PA10040	3845	0.958
NULL	Curr_Neuropharmacol_2007_Dec_5(4)_278-288.nxml.txt.nlp	19305744	SENT261	11	11	19	19	nicardipine	SMF	PA450620	22993	0.958
NULL	Behav_Brain_Funct_2007_Jan_11_3_3.nxml.txt.nlp	17217544	SENT61	18	18	32	32	nortriptyline	IPT	PA450657	54802	0.958
NULL	Int_J_Mol_Sci_2014_Jun_25_15(7)_11220-11233.nxml.txt.nlp	24968265	SENT93	38	38	29	29	sunitinib	REST	PA162372840	5978	0.958
NULL	J_Cancer_2013_Sep_27_4(8)_662-670.nxml.txt.nlp	24155778	SENT200	23	23	15	15	cisplatin	UCHL1	PA449014	7345	0.958
NULL	Clin_Pharmacol_2010_Apr_27_2_77-82.nxml.txt.nlp	22291489	SENT112	0	0	6	6	cosyntropin	ACTH	PA164749052	5443	0.958
NULL	Mol_Med_Rep_2015_Jan_16_11(1)_189-195.nxml.txt.nlp	25323748	SENT154	8	8	30	30	cisplatin	p62	PA449014	8878;10657;23636	0.958
NULL	Oncotarget_2011_May_16_2(5)_378-392.nxml.txt.nlp	21623005	SENT206	15	15	20	20	oxaliplatin	EGR1	PA131285527	1958	0.958
NULL	Int_J_Biol_Sci_2011_Sep_8_7(8)_1077-1092.nxml.txt.nlp	21927577	SENT134	16	16	9	9	telmisartan	p67phox	PA451605	4688	0.958
NULL	Cancer_Inform_2014_Jan_21_13_21-45.nxml.txt.nlp	24526833	SENT97	33	33	14	14	l-glutamine	CO2	PA10090	4513	0.958
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT204	8	8	17	17	phenprocoumon	CYP2C9	PA450921	1559	0.958
NULL	Breast_Cancer_Res_2007_Aug_8_9(4)_R50.nxml.txt.nlp	17686159	SENT265	9	9	29	29	gefitinib	HRG	PA131301952	3084;3273	0.958
NULL	Clin_Exp_Otorhinolaryngol_2011_Jun_31_4(2)_77-82.nxml.txt.nlp	21716954	SENT185	8	8	0	0	minocycline	Bcl-2	PA450519	596	0.958
NULL	Mol_Cancer_2014_Jan_15_13_8.nxml.txt.nlp	24423412	SENT89	11	11	0	0	cisplatin	CD44	PA449014	960	0.958
NULL	Libyan_J_Med_2006_Jul_28_1(1)_42-59.nxml.txt.nlp	21526020	SENT196	16	16	5	5	irinotecan	EGFR	PA450085	1956	0.958
NULL	J_Gen_Physiol_2009_Oct_134(4)_323-337.nxml.txt.nlp	19786585	SENT322	25	25	7	7	creatine	ClC-1	PA164778930	1180	0.958
NULL	Br_J_Cancer_2012_Jun_5_106(12)_1997-2003.nxml.txt.nlp	22596232	SENT16	20	20	9	9	sorafenib	CD133	PA7000	8842	0.958
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Apr_17_6_43-57.nxml.txt.nlp	24833916	SENT145	6	6	24	24	everolimus	PI3K	PA164746311	5290	0.958
NULL	Lipids_Health_Dis_2011_Jan_18_10_8.nxml.txt.nlp	21241519	SENT107	31	31	26	26	simvastatin	SR-BI	PA451363	949	0.958
NULL	Arthritis_Res_Ther_2012_May_1_14(3)_R99.nxml.txt.nlp	22546542	SENT8	7	7	33	33	infliximab	gamma	PA452639	9913	0.958
NULL	Nucleic_Acids_Res_2012_Jun_22_40(11)_4861-4878.nxml.txt.nlp	22362753	SENT235	14	14	3	3	trypsin	NPM2	PA451806	10361	0.958
NULL	Acta_Histochem_Cytochem_2013_Dec_28_46(6)_187-197.nxml.txt.nlp	24610966	SENT5	31	31	1	1	pilocarpine	AQP5	PA450962	362	0.958
NULL	Breast_Cancer_Res_2010_Aug_23_12(4)_208.nxml.txt.nlp	20804567	SENT153	9	9	7	7	gefitinib	EGFR	PA131301952	1956	0.958
NULL	Korean_Circ_J_2013_Aug_31_43(8)_541-549.nxml.txt.nlp	24044013	SENT26	9	9	4	4	prasugrel	P2Y12	PA154410481	64805	0.958
NULL	Acta_Pharmacol_Sin_2012_Oct_17_33(10)_1301-1310.nxml.txt.nlp	22983390	SENT205	30	30	11	11	cisplatin	Bcl-2	PA449014	596	0.958
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_13_2012_636848.nxml.txt.nlp	23258994	SENT192	37	37	6	6	capsaicin	TRPV1	PA448776	7442	0.958
NULL	Int_J_Endocrinol_2013_Nov_27_2013_592576.nxml.txt.nlp	24369464	SENT124	12	12	8	8	atorvastatin	SCAP	PA448500	22937	0.958
NULL	Biologics_2013_Apr_15_7_77-90.nxml.txt.nlp	23723688	SENT105	10	10	17	17	cetuximab	CRT	PA10040	811	0.958
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT212	15	15	7	7	perifosine	DR4	PA165291471	8797	0.958
NULL	Clin_Pharmacol_2011_Jun_22_3_13-25.nxml.txt.nlp	22287853	SENT127	11	11	0	0	saxagliptin	ANOVA	PA165958362	4858	0.958
NULL	Acta_Pharmacol_Sin_2014_Jun_4_35(6)_752-757.nxml.txt.nlp	24902786	SENT91	25	25	10	10	tamoxifen	STZ	PA451581	6484	0.958
NULL	Int_J_Endocrinol_Metab_2013_Dec_21_Winter_11(1)_57-61.nxml.txt.nlp	23853622	SENT136	15	15	2	2	bromocriptine	PRL	PA448671	5617	0.958
NULL	Scientifica_(Cairo)_2012_Nov_25_2012_473829.nxml.txt.nlp	24278698	SENT306	20	20	11	11	cisplatin	OCT2	PA449014	6582;5452	0.958
NULL	Diabetes_2009_Jan_58(1)_243-249.nxml.txt.nlp	18840785	SENT118	26	26	12	12	glucose	GLP-1	PA449773	100125288	0.958
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_9_2013_486047.nxml.txt.nlp	23662138	SENT122	21	21	18	18	glibenclamide	SDH	PA449782	1757;10993	0.958
NULL	Acta_Pharmacol_Sin_2012_Jan_12_33(1)_27-33.nxml.txt.nlp	22158109	SENT38	11	11	31	31	propofol	AMPK	PA451141	5563	0.958
NULL	J_Cell_Mol_Med_2014_Mar_10_18(3)_514-529.nxml.txt.nlp	24410795	SENT259	30	30	39	39	resveratrol	SIRT1		23411	0.958
NULL	Acta_Pharmacol_Sin_2012_Mar_27_33(3)_342-350.nxml.txt.nlp	22367283	SENT193	35	35	31	31	trypsin	PAR2	PA451806	2150;55065;8856	0.958
NULL	Clinics_(Sao_Paulo)_2011_Aug_66(8)_1457-1462.nxml.txt.nlp	21915500	SENT101	6	6	18	18	rosuvastatin	TNF	PA134308647	7124	0.958
NULL	Daru_2013_Dec_20_21(1)_78.nxml.txt.nlp	24359941	SENT11	18	18	8	8	gentamicin	EPO	PA449753	7076;8288;2056	0.958
NULL	Cell_Commun_Signal_2013_Oct_1_11_73.nxml.txt.nlp	24083678	SENT245	6	6	26	26	sulindac	A20	PA451565	7128;28935	0.958
NULL	Ann_Indian_Acad_Neurol_2014_Jan-Mar_17(1)_106-107.nxml.txt.nlp	24753674	SENT58	8	8	18	18	hydroxyurea	JAK2	PA449942	3717	0.958
NULL	J_Exp_Clin_Cancer_Res_2010_Apr_30_29(1)_41.nxml.txt.nlp	20433702	SENT195	24	24	30	30	doxorubicin	PC3	PA449412	57332;7832;5122	0.958
NULL	Mol_Cancer_2010_Aug_16_9_217.nxml.txt.nlp	20712901	SENT85	8	8	23	23	curcumin	IL-6	PA151958596	3569	0.958
NULL	Br_J_Cancer_2012_Aug_7_107(4)_707-712.nxml.txt.nlp	22828609	SENT184	20	20	0	0	celecoxib	OSC	PA448871	4047	0.958
NULL	Br_J_Cancer_2011_Dec_6_105(12)_1920-1926.nxml.txt.nlp	22095222	SENT107	33	33	8	8	trastuzumab	PIK3CA	PA451743	5290	0.958
NULL	Indian_J_Pharmacol_2014_Nov-Dec_46(6)_590-595.nxml.txt.nlp	25538328	SENT81	46	46	15	15	colchicine	IL-6	PA449092	3569	0.958
NULL	J_Headache_Pain_2011_Aug_25_12(4)_399-403.nxml.txt.nlp	21437713	SENT101	0	0	4	4	naratriptan	OTC	PA450597	5009	0.958
NULL	J_Mol_Psychiatry_2013_Nov_4_1(1)_19.nxml.txt.nlp	25408910	SENT101	24	24	7	7	olanzapine	DRD5	PA450688	1816	0.958
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Aug_27_6_145-150.nxml.txt.nlp	25249759	SENT25	4	4	14	14	tamoxifen	aromatase	PA451581	1588	0.958
NULL	J_Hematol_Oncol_2009_Apr_22_2_18.nxml.txt.nlp	19386128	SENT127	20	20	13	13	panitumumab	KRAS	PA162373091	3845	0.958
NULL	Br_J_Cancer_2012_Jun_5_106(12)_1901-1906.nxml.txt.nlp	22596239	SENT48	7	7	2	2	imatinib	CXCR4	PA10804	7852	0.958
NULL	Onco_Targets_Ther_2014_Sep_19_7_1631-1639.nxml.txt.nlp	25278770	SENT70	12	12	20	20	temozolomide	GNAQ	PA451609	2776	0.958
NULL	Oncol_Lett_2013_Sep_12_6(3)_860-864.nxml.txt.nlp	24137426	SENT85	37	37	32	32	ketoconazole	CYP1A2	PA450146	1544	0.958
NULL	Oncoimmunology_2014_Jan_17_3_e27574.nxml.txt.nlp	24800167	SENT4	24	24	11	11	cyclophosphamide	CD4	PA449165	920	0.958
NULL	J_Cancer_2013_Sep_10_4(8)_614-625.nxml.txt.nlp	24155773	SENT18	14	14	3	3	doxorubicin	CRM1	PA449412	7514	0.958
NULL	Curr_Neuropharmacol_2010_Dec_8(4)_382-393.nxml.txt.nlp	21629445	SENT149	30	30	11	11	haloperidol	RAB12	PA449841	201475	0.958
NULL	Breast_Cancer_Res_2010_Jun_28_12(3)_R43.nxml.txt.nlp	20579400	SENT102	33	33	5	5	vinorelbine	MAPT	PA451881	4137	0.958
NULL	Eur_J_Haematol_2013_Feb_22_90(2)_89-98.nxml.txt.nlp	23181448	SENT124	2	2	27	27	imatinib	KIT	PA10804	3815	0.958
NULL	Diabetes_2011_Nov_17_60(11)_2928-2938.nxml.txt.nlp	21885868	SENT150	24	24	18	18	curcumin	IL-6	PA151958596	3569	0.958
NULL	Acta_Orthop_2014_Feb_25_85(1)_1.nxml.txt.nlp	24171676	SENT18	7	7	0	0	denosumab	RANKL	PA166048634	8600	0.958
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT222	6	6	34	34	metformin	EGFR	PA450395	1956	0.958
NULL	Int_J_Mol_Sci_2012_Dec_5_13(12)_16514-16543.nxml.txt.nlp	23443116	SENT259	4	4	42	42	l-carnitine	CO2	PA450154	4513	0.958
NULL	Basic_Res_Cardiol_2012_Mar_11_107(2)_245.nxml.txt.nlp	22234702	SENT165	13	13	0	0	isoproterenol	PTIP	PA450121	22976	0.958
NULL	Nucl_Recept_Signal_2009_Jan_16_7_e001.nxml.txt.nlp	19240808	SENT416	1	1	6	6	estradiol	CYP3A4	PA449503	1576	0.958
NULL	Nature_2009_Apr_2_458(7238)_591-596.nxml.txt.nlp	19234442	SENT198	13	13	7	7	etoposide	JNK1	PA449552	5599	0.958
NULL	Front_Oncol_2014_Sep_29_4_256.nxml.txt.nlp	25325013	SENT101	32	32	11	11	pemetrexed	EGFR	PA10810	1956	0.958
NULL	Acta_Pharmacol_Sin_2009_Feb_5_30(2)_228-234.nxml.txt.nlp	19122672	SENT103	4	4	13	13	isoflurane	HO-1	PA450106	3162	0.958
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Apr_17_6_43-57.nxml.txt.nlp	24833916	SENT97	18	18	29	29	exemestane	aromatase	PA449563	1588	0.958
NULL	EMBO_Mol_Med_2013_Apr_25_5(4)_548-562.nxml.txt.nlp	23526803	SENT349	27	27	41	41	heparin	FGF2	PA449855	2247;2258	0.958
NULL	Ophthalmol_Eye_Dis_2011_Jan_12_3_13-19.nxml.txt.nlp	23861619	SENT61	10	10	15	15	tafluprost	EP3	PA165958432	5733	0.958
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT229	13	13	8	8	doxorubicin	B7-H1	PA449412	29126	0.957
NULL	Mol_Biol_Cell_2012_Jul_15_23(14)_2658-2670.nxml.txt.nlp	22621899	SENT181	13	13	24	24	doxycycline	AURKA	PA449415	6790	0.957
NULL	J_Oncol_2012_Mar_11_2012_382159.nxml.txt.nlp	22481926	SENT90	37	37	16	16	carboplatin	HER2	PA448803	2064	0.957
NULL	Breast_Cancer_Res_2012_Jul_20_14(4)_R110.nxml.txt.nlp	22817698	SENT153	14	14	12	12	olaparib	PARP		142	0.957
NULL	Cancers_(Basel)_2013_Jul_24_5(3)_901-918.nxml.txt.nlp	24202326	SENT7	22	22	34	34	melphalan	CDC7	PA450354	8317	0.957
NULL	Int_J_Breast_Cancer_2011_Jul_12_2011_232435.nxml.txt.nlp	22295213	SENT243	23	23	18	18	tamoxifen	SPARC	PA451581	6678	0.957
NULL	Ann_Oncol_2010_Feb_21(2)_217-222.nxml.txt.nlp	20110292	SENT146	39	39	10	10	erlotinib	PSPH	PA134687924	5723	0.957
NULL	Int_J_Mol_Sci_2012_Feb_1_13(2)_1512-1523.nxml.txt.nlp	22408405	SENT149	9	9	28	28	olmesartan	LOX-1	PA164742950	4973	0.957
NULL	Oncotarget_2013_Dec_18_5(2)_375-385.nxml.txt.nlp	24495868	SENT129	16	16	6	6	fludarabine	MCL1	PA449655	4170	0.957
NULL	Open_Biomed_Eng_J_2011_Jan_19_5_1-7.nxml.txt.nlp	21625374	SENT155	13	13	36	36	metformin	EGI	PA450395	1957	0.957
NULL	Mol_Cancer_2007_Apr_2_6_26.nxml.txt.nlp	17407576	SENT99	29	29	7	7	cisplatin	p53	PA449014	7157	0.957
NULL	Diabetes_Care_2013_Apr_14_36(4)_943-949.nxml.txt.nlp	23111057	SENT50	17	17	31	31	filgrastim	CD34	PA449626	947	0.957
NULL	Appl_Microbiol_Biotechnol_2014_Feb_18_98(8)_3829-3840.nxml.txt.nlp	24535257	SENT178	8	8	17	17	ethanol	CAT-1	PA448073	6541	0.957
NULL	Cell_Commun_Signal_2013_Oct_1_11_73.nxml.txt.nlp	24083678	SENT227	5	5	18	18	sulindac	A20	PA451565	7128;28935	0.957
NULL	J_Signal_Transduct_2011_Jun_7_2011_982879.nxml.txt.nlp	21776391	SENT152	11	11	4	4	cetuximab	STAT3	PA10040	6774	0.957
NULL	Diagn_Pathol_2014_Aug_9_9(1)_153.nxml.txt.nlp	NULL	SENT221	11	11	3	3	cetuximab	BRAF	PA10040	673	0.957
NULL	Case_Rep_Nephrol_Urol_2013_Jun_11_3(1)_74-86.nxml.txt.nlp	24167516	SENT100	6	6	20	20	sevelamer	PTH	PA164781197	5741	0.957
NULL	Acta_Pharmacol_Sin_2013_Jun_8_34(6)_830-836.nxml.txt.nlp	23564080	SENT121	22	22	13	13	simvastatin	RAGE	PA451363	177	0.957
NULL	Indian_J_Med_Res_2012_Aug_136(2)_242-248.nxml.txt.nlp	22960891	SENT114	3	3	13	13	carbimazole	adiponectin	PA164742970	9370	0.957
NULL	Indian_J_Med_Res_2011_Sep_134(3)_295-301.nxml.txt.nlp	21985811	SENT109	22	22	17	17	phenytoin	CYP2C19	PA450947	1557	0.957
NULL	Oncol_Lett_2013_Mar_8_5(3)_805-812.nxml.txt.nlp	23426281	SENT198	43	43	30	30	gemcitabine	B7-H3	PA449748	80381	0.957
NULL	Front_Immunol_2012_Jan_24_3_3.nxml.txt.nlp	22566889	SENT123	22	22	4	4	rituximab	CD55	PA451261	1604	0.957
NULL	Anal_Chem_Insights_2009_Apr_7_4_1-9.nxml.txt.nlp	19652757	SENT99	20	20	23	23	citalopram	mol	PA449015	90527	0.957
NULL	Mol_Cancer_2004_May_4_3_14.nxml.txt.nlp	15125777	SENT156	8	8	3	3	cisplatin	CHK2	PA449014	11200	0.957
NULL	Front_Neurol_2014_Jul_7_5_119.nxml.txt.nlp	25071707	SENT26	2	2	12	12	thrombin	VCAM1	PA451674	7412	0.957
NULL	Onco_Targets_Ther_2014_Dec_4_7_2249-2255.nxml.txt.nlp	25587220	SENT55	6	6	14	14	diethylstilbestrol	ABCG2	PA449307	9429	0.957
NULL	Chin_J_Cancer_2012_Feb_31(2)_110-118.nxml.txt.nlp	22098951	SENT168	13	13	24	24	imatinib	P-gp	PA10804	5243	0.957
NULL	Br_J_Cancer_2011_Aug_23_105(5)_687-693.nxml.txt.nlp	21829193	SENT49	11	11	32	32	paraformaldehyde	LSR	PA450790	51599	0.957
NULL	Breast_Cancer_Res_2007_Feb_6_9(1)_R17.nxml.txt.nlp	17280616	SENT27	21	21	18	18	trastuzumab	aromatase	PA451743	1588	0.957
NULL	Br_J_Cancer_2013_Jul_9_109(1)_68-75.nxml.txt.nlp	23807173	SENT12	19	19	12	12	cisplatin	ERCC1	PA449014	2067	0.957
NULL	Iran_Red_Crescent_Med_J_2014_Jan_5_16(1)_e6727.nxml.txt.nlp	24719712	SENT55	8	8	1	1	thrombin	VIII	PA451674	1351	0.957
NULL	Acta_Pharmacol_Sin_2009_Apr_3_30(4)_478-484.nxml.txt.nlp	19343062	SENT125	2	2	8	8	cyclosporine	P-gp	PA449167	5243	0.957
NULL	ISRN_Oxidative_Med_2013_2013_831596.nxml.txt.nlp	25506596	SENT284	17	17	3	3	hemin	p65	PA449849	5970	0.957
NULL	BioDrugs_2013_Jun_7_27(6)_591-603.nxml.txt.nlp	23743670	SENT102	5	5	29	29	doxorubicin	IFN	PA449412	3439	0.957
NULL	Mol_Cells_2014_Mar_31_37(3)_234-240.nxml.txt.nlp	24642709	SENT31	11	11	26	26	capsaicin	HO-1	PA448776	3162	0.957
NULL	J_Immunol_Res_2014_Jan_19_2014_103780.nxml.txt.nlp	24741572	SENT129	32	32	43	43	salmeterol	EPAC	PA451300	10411	0.957
NULL	Oxid_Med_Cell_Longev_2013_Apr_21_2013_412576.nxml.txt.nlp	23710286	SENT161	4	4	25	25	curcumin	NRF2	PA151958596	2551;4780	0.957
NULL	Oncol_Lett_2013_Feb_5_5(2)_427-434.nxml.txt.nlp	23420099	SENT166	17	17	6	6	carboplatin	ERCC1	PA448803	2067	0.957
NULL	EMBO_Mol_Med_2013_Jul_14_5(7)_999-1018.nxml.txt.nlp	23776131	SENT373	7	7	0	0	doxycycline	FBXO28	PA449415	23219	0.957
NULL	Cell_Commun_Signal_2014_Sep_25_12(1)_61.nxml.txt.nlp	NULL	SENT97	21	21	3	3	doxycycline	PC-3	PA449415	692094	0.957
NULL	Nat_Commun_2013_Sep_17_4_2464.nxml.txt.nlp	24043118	SENT42	5	5	16	16	estradiol	FGF10	PA449503	2255	0.957
NULL	Clin_Drug_Investig_2015_Dec_4_35_45-51.nxml.txt.nlp	25471740	SENT146	8	8	28	28	atorvastatin	CYP2C8	PA448500	1558	0.957
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2654-2664.nxml.txt.nlp	24136149	SENT138	3	3	8	8	doxorubicin	HSF1	PA449412	3297	0.957
NULL	Biochim_Biophys_Acta_2013_Jul_1832(7)_905-910.nxml.txt.nlp	23032152	SENT141	25	25	11	11	ketanserin	5-HT2B	PA131053734	3357	0.957
NULL	Mol_Cancer_2007_Sep_18_6_56.nxml.txt.nlp	17877814	SENT3	27	27	21	21	erlotinib	EGFR	PA134687924	1956	0.957
NULL	Pharmaceutics_2012_Dec_13_4(4)_607-640.nxml.txt.nlp	24300373	SENT431	28	28	9	9	diclofenac	CERT	PA449293	10087	0.957
NULL	Biosci_Rep_2012_Aug_1_32(Pt_4)_361-374.nxml.txt.nlp	22762204	SENT60	25	25	14	14	cisplatin	p53	PA449014	7157	0.957
NULL	Oncotarget_2012_Sep_28_3(10)_1169-1181.nxml.txt.nlp	23045411	SENT125	11	11	3	3	doxorubicin	JIP1	PA449412	9479	0.957
NULL	ScientificWorldJournal_2014_Dec_11_2014_194652.nxml.txt.nlp	25580452	SENT61	14	14	29	29	ethanol	mol	PA448073	90527	0.957
NULL	Cancers_(Basel)_2014_Oct_27_6(4)_2224-2242.nxml.txt.nlp	25349887	SENT108	8	8	1	1	gemcitabine	CDK4	PA449748	1019	0.957
NULL	Clin_Exp_Reprod_Med_2013_Jun_30_40(2)_67-75.nxml.txt.nlp	23875162	SENT185	13	13	5	5	rosiglitazone	aromatase	PA451283	1588	0.957
NULL	Aquat_Biosyst_2012_Apr_17_8_9.nxml.txt.nlp	22510370	SENT192	25	25	4	4	ethanol	PHB	PA448073	5245	0.957
NULL	Br_J_Pharmacol_2014_Jun_15_171(11)_2705-2725.nxml.txt.nlp	24467436	SENT354	9	9	30	30	balsalazide	NAT	PA448536	6046	0.957
NULL	Oncotarget_2014_Aug_19_5(18)_8737-8749.nxml.txt.nlp	25228590	SENT35	22	22	12	12	crizotinib	PI3K	PA165946122	5290	0.957
NULL	Br_J_Cancer_2003_Mar_24_88(6)_848-854.nxml.txt.nlp	12644821	SENT21	26	26	32	32	cisplatin	BAX	PA449014	581	0.957
NULL	Cardiol_Ther_2013_Jun_1_2(1)_111-124.nxml.txt.nlp	25135294	SENT123	21	21	14	14	amiodarone	P-gp	PA448383	5243	0.957
NULL	Cell_Death_Differ_2010_Mar_25_17(3)_398-407.nxml.txt.nlp	19779497	SENT100	34	34	20	20	etoposide	OCN	PA449552	632	0.957
NULL	Oncotarget_2013_Aug_29_4(10)_1673-1685.nxml.txt.nlp	24127549	SENT83	8	8	2	2	bortezomib	SIRT1	PA10252	23411	0.957
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1449-1456.nxml.txt.nlp	24077631	SENT120	30	30	17	17	tolbutamide	CYP2C9	PA451718	1559	0.957
NULL	Biologics_2013_Jan_30_7_13-32.nxml.txt.nlp	23386784	SENT120	16	16	6	6	bortezomib	JNK	PA10252	5599	0.957
NULL	Front_Neural_Circuits_2014_Aug_28_8_102.nxml.txt.nlp	25221477	SENT60	27	27	29	29	ketanserin	5-HT7	PA131053734	3363	0.957
NULL	Cancers_(Basel)_2012_Nov_29_4(4)_1252-1299.nxml.txt.nlp	24213506	SENT720	15	15	3	3	thrombin	ADAMTS18	PA451674	170692	0.957
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_75-89.nxml.txt.nlp	17912638	SENT223	12	12	8	8	anastrozole	ATAC	PA448432	6375	0.957
NULL	Br_J_Cancer_2006_Feb_13_94(3)_407-426.nxml.txt.nlp	16434996	SENT9	9	9	13	13	genistein	BRCA1	PA165109660	672	0.957
NULL	Acta_Pharmacol_Sin_2011_Jul_13_32(7)_967-972.nxml.txt.nlp	21666702	SENT131	1	1	6	6	losartan	P-gp	PA450268	5243	0.957
NULL	Oncotarget_2013_Aug_11_4(9)_1416-1426.nxml.txt.nlp	23965832	SENT42	32	32	10	10	tetracycline	FANCD2	PA451640	2177	0.957
NULL	Curr_Neuropharmacol_2012_Mar_10(1)_72-79.nxml.txt.nlp	22942880	SENT85	12	12	30	30	paclitaxel	GSTP1	PA450761	2950	0.957
NULL	AIDS_Behav_2008_Jul_9_12(4)_662-669.nxml.txt.nlp	17487577	SENT160	28	28	45	45	naltrexone	RAB	PA450588	3267	0.957
NULL	Int_J_Mol_Sci_2010_Sep_13_11(9)_3195-3208.nxml.txt.nlp	20957088	SENT125	8	8	20	20	lipase	AT2	PA450239	186	0.957
NULL	Cancers_(Basel)_2012_Oct_29_4(4)_1146-1160.nxml.txt.nlp	24213502	SENT54	25	25	4	4	tamoxifen	STAR	PA451581	6770;2984	0.957
NULL	J_Exp_Clin_Cancer_Res_2009_Jul_10_28(1)_99.nxml.txt.nlp	19591692	SENT29	15	15	20	20	valspodar	ABCG2		9429	0.957
NULL	Cell_Death_Dis_2014_Jan_30_5(1)_e1039.nxml.txt.nlp	24481453	SENT13	15	15	4	4	etoposide	CD44	PA449552	960	0.957
NULL	Breast_Cancer_Res_2006_Nov_6_8(6)_215.nxml.txt.nlp	17096862	SENT70	12	12	17	17	trastuzumab	PI3K	PA451743	5290	0.957
NULL	Blood_Res_2014_Dec_23_49(4)_279-280.nxml.txt.nlp	25548764	SENT23	4	4	36	36	lenalidomide	CD95	PA162363968	355	0.957
NULL	Br_J_Cancer_2012_Jan_3_106(1)_107-115.nxml.txt.nlp	22116303	SENT108	4	4	14	14	vorinostat	AKT	PA164748224	207	0.957
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT115	3	3	28	28	capsaicin	p53	PA448776	7157	0.957
NULL	Arthritis_Res_Ther_2009_Feb_23_11(1)_216.nxml.txt.nlp	19291269	SENT106	11	11	14	14	infliximab	ACR	PA452639	49	0.957
NULL	Clin_Ophthalmol_2013_Dec_21_7_7-14.nxml.txt.nlp	23293509	SENT97	42	42	21	21	travoprost	BAK	PA164781371	578	0.957
NULL	J_Oncol_2012_Nov_10_2012_358472.nxml.txt.nlp	22131994	SENT89	2	2	13	13	sunitinib	VEGFR3	PA162372840	2324	0.957
NULL	J_Gen_Physiol_2009_Apr_133(4)_421-438.nxml.txt.nlp	19289574	SENT293	26	26	7	7	glibenclamide	SLC26A9	PA449782	115019	0.957
NULL	Hum_Genomics_2008_Sep_1_3(1)_7-16.nxml.txt.nlp	19129086	SENT164	1	1	11	11	rosiglitazone	CYP2C8	PA451283	1558	0.957
NULL	Indian_J_Psychiatry_2010_Jan_52(Suppl1)_S120-S127.nxml.txt.nlp	21836667	SENT212	20	20	9	9	risperidone	COMT	PA451257	1312	0.957
NULL	Pharmaceuticals_(Basel)_2012_Nov_20_5(11)_1236-1264.nxml.txt.nlp	24281308	SENT778	3	3	15	15	gefitinib	PTEN	PA131301952	5728	0.957
NULL	J_Signal_Transduct_2011_Feb_24_2011_804236.nxml.txt.nlp	21637380	SENT31	32	32	11	11	trastuzumab	EGFR	PA451743	1956	0.957
NULL	Cancer_Cell_Int_2013_Feb_13_13_15.nxml.txt.nlp	23402326	SENT143	28	28	14	14	gefitinib	EGFR	PA131301952	1956	0.957
NULL	Emerg_Microbes_Infect_2013_Jul_10_2(7)_e42.nxml.txt.nlp	NULL	SENT30	32	32	6	6	paraformaldehyde	HEC	PA450790	10403	0.957
NULL	Oncotarget_2014_Oct_23_5(21)_10816-10829.nxml.txt.nlp	25333261	SENT146	27	27	30	30	doxorubicin	p53	PA449412	7157	0.957
NULL	Exp_Ther_Med_2014_Feb_25_7(2)_397-400.nxml.txt.nlp	24396413	SENT69	6	6	8	8	isoniazid	LOX	PA450112	4015	0.957
NULL	Acta_Pharmacol_Sin_2013_Sep_5_34(9)_1192-1200.nxml.txt.nlp	23685957	SENT204	19	19	12	12	curcumin	AKT	PA151958596	207	0.957
NULL	Clinics_(Sao_Paulo)_2013_May_68(5)_694-701.nxml.txt.nlp	23778405	SENT155	15	15	28	28	vinblastine	P-gp	PA451877	5243	0.957
NULL	Ecancermedicalscience_2008_Feb_18_2_75.nxml.txt.nlp	22275966	SENT152	17	17	7	7	oxaliplatin	ERCC1	PA131285527	2067	0.957
NULL	Eur_J_Neurosci_2010_Mar_31(6)_1019-1026.nxml.txt.nlp	20377616	SENT33	44	44	37	37	halothane	P28	PA449845	9446;7802;9527	0.957
NULL	Acta_Pharmacol_Sin_2012_Jan_3_33(1)_82-90.nxml.txt.nlp	22212431	SENT141	21	21	7	7	rosiglitazone	PDK4	PA451283	5166	0.957
NULL	Lipids_Health_Dis_2011_Feb_28_10_38.nxml.txt.nlp	21352602	SENT129	8	8	31	31	fenofibrate	PCSK9	PA449594	255738	0.957
NULL	Calcif_Tissue_Int_2014_Aug_21_94(2)_170-175.nxml.txt.nlp	23963633	SENT164	7	7	3	3	teriparatide	PTH	PA451620	5741	0.957
NULL	Balkan_J_Med_Genet_2011_Jun_25_14(1)_25-30.nxml.txt.nlp	24052699	SENT22	11	11	5	5	phenytoin	RLIP76	PA450947	10928	0.957
NULL	Ann_Hematol_2010_Sep_13_89(9)_861-871.nxml.txt.nlp	20387067	SENT217	6	6	13	13	dasatinib	KIT	PA162372878	3815	0.957
NULL	Breast_Cancer_(Auckl)_2011_Jan_13_5_1-14.nxml.txt.nlp	21494397	SENT198	13	13	6	6	ixabepilone	CYP3A4		1576	0.957
NULL	Case_Rep_Dermatol_2011_Jun_30_3(2)_130-136.nxml.txt.nlp	21743808	SENT15	21	21	16	16	erlotinib	EGFR	PA134687924	1956	0.957
NULL	Front_Neurol_2014_Feb_18_5_17.nxml.txt.nlp	24600432	SENT107	10	10	37	37	levetiracetam	CD86	PA450206	942	0.957
NULL	Cell_Cycle_2013_Feb_1_12(3)_409-416.nxml.txt.nlp	23324337	SENT153	31	31	17	17	nutlin-3	p63		8626	0.957
NULL	Curr_Neuropharmacol_2007_Dec_5(4)_232-243.nxml.txt.nlp	19305740	SENT116	35	35	14	14	diclofenac	COX	PA449293	1351	0.957
NULL	Acta_Pharmacol_Sin_2010_Feb_5_31(2)_137-144.nxml.txt.nlp	20139896	SENT175	23	23	5	5	zileuton	ROS	PA451955	6098	0.957
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT124	8	8	2	2	nutlin-3	DR5		8795	0.957
NULL	Breast_Cancer_Res_2011_May_26_13(3)_209.nxml.txt.nlp	21635709	SENT179	33	33	35	35	tamoxifen	aromatase	PA451581	1588	0.957
NULL	Dis_Markers_2008_Aug_22_25(1)_37-47.nxml.txt.nlp	18776590	SENT9	3	3	18	18	doxycycline	NGAL	PA449415	3934	0.957
NULL	EPMA_J_2011_Dec_22_3(1)_1.nxml.txt.nlp	22738081	SENT189	12	12	0	0	sorafenib	CAIX	PA7000	768	0.957
NULL	Virchows_Arch_2012_Feb_16_460(2)_141-149.nxml.txt.nlp	22173329	SENT247	20	20	3	3	oxaliplatin	BRAF	PA131285527	673	0.957
NULL	Eur_J_Neurosci_2014_Aug_2_40(3)_2528-2540.nxml.txt.nlp	24891292	SENT46	28	28	12	12	vasopressin	VPAC2	PA451858	7434	0.957
NULL	Orphanet_J_Rare_Dis_2011_Apr_12_6_14.nxml.txt.nlp	21486454	SENT70	23	23	7	7	minocycline	AAT	PA450519	5265	0.957
NULL	Cell_Death_Differ_2010_Apr_16_17(4)_666-676.nxml.txt.nlp	19834494	SENT313	10	10	3	3	oxaliplatin	RAGE	PA131285527	177	0.957
NULL	Chemother_Res_Pract_2012_Dec_20_2012_743193.nxml.txt.nlp	23320171	SENT80	15	15	12	12	trastuzumab	HER2	PA451743	2064	0.957
NULL	Nat_Med_2014_Jul_8_20(7)_764-768.nxml.txt.nlp	24908571	SENT77	32	32	13	13	citalopram	GRM4	PA449015	2914	0.957
NULL	Acta_Pharmacol_Sin_2009_Oct_21_30(10)_1392-1398.nxml.txt.nlp	19767766	SENT97	15	15	4	4	atorvastatin	p38	PA448500	10598;1432;7965	0.957
NULL	Biomed_Res_Int_2013_Aug_7_2013_864012.nxml.txt.nlp	23991423	SENT116	0	0	7	7	alfacalcidol	PTH	PA164746469	5741	0.957
NULL	Cancer_Med_2012_Aug_12_1(1)_68-75.nxml.txt.nlp	23342255	SENT121	24	24	27	27	gefitinib	EGFR	PA131301952	1956	0.957
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1522-1532.nxml.txt.nlp	21997136	SENT144	27	27	6	6	lapatinib	p53	PA152241907	7157	0.957
NULL	Biomed_Res_Int_2013_Jul_31_2013_692071.nxml.txt.nlp	23984399	SENT156	2	2	5	5	ganciclovir	OCT1	PA449733	5451;6580	0.957
NULL	F1000_Biol_Rep_2009_Mar_24_1_23.nxml.txt.nlp	20948663	SENT13	17	17	2	2	trimipramine	ABCB1	PA451791	5243	0.957
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1522-1532.nxml.txt.nlp	21997136	SENT214	27	27	6	6	irinotecan	ABCG2	PA450085	9429	0.957
NULL	Ecancermedicalscience_2011_Dec_1_5_237.nxml.txt.nlp	22276069	SENT31	5	5	24	24	fulvestrant	CEA	PA164747170	5670;1087	0.957
NULL	Int_J_Med_Sci_2015_Jan_1_12(1)_63-71.nxml.txt.nlp	25552920	SENT143	20	20	15	15	berberine	NODAL	PA165860812	4838	0.957
NULL	Gut_2013_Apr_14_62(4)_540-549.nxml.txt.nlp	22798500	SENT254	17	17	9	9	cetuximab	BRAF	PA10040	673	0.957
NULL	Cancers_(Basel)_2013_Jan_10_5(1)_15-26.nxml.txt.nlp	24216696	SENT97	6	6	3	3	estradiol	HIF-1	PA449503	29072	0.957
NULL	Environ_Health_Perspect_2008_Mar_26_116(3)_322-328.nxml.txt.nlp	18335098	SENT142	20	20	7	7	estradiol	PMI	PA449503	8834;5373	0.957
NULL	J_Oncol_2012_Jul_8_2012_537861.nxml.txt.nlp	22973309	SENT393	14	14	12	12	topotecan	HIF-1	PA451729	29072	0.957
NULL	Breast_Cancer_Res_2005_Jan_12_7(2)_48-51.nxml.txt.nlp	15743510	SENT42	20	20	18	18	exemestane	aromatase	PA449563	1588	0.957
NULL	Breast_Cancer_Res_2005_Apr_4_7(4)_R422-R435.nxml.txt.nlp	15987447	SENT362	11	11	3	3	celecoxib	BAX	PA448871	581	0.957
NULL	Mol_Cancer_2014_Jan_15_13_8.nxml.txt.nlp	24423412	SENT103	11	11	2	2	cisplatin	CD44	PA449014	960	0.957
NULL	Clin_Drug_Investig_2013_Aug_23_33(10)_727-736.nxml.txt.nlp	23975654	SENT80	16	16	21	21	ketoconazole	P-gp	PA450146	5243	0.957
NULL	Arthritis_Res_Ther_2011_Mar_24_13(2)_R51.nxml.txt.nlp	21435232	SENT222	16	16	41	41	etanercept	TWEAK	PA449515	8742	0.957
NULL	Cell_Host_Microbe_2014_Sep_10_16(3)_291-303.nxml.txt.nlp	25211072	SENT86	9	9	30	30	pp2	tetherin		684	0.957
NULL	Br_J_Pharmacol_2014_Jan_23_171(2)_523-535.nxml.txt.nlp	24372553	SENT185	20	20	10	10	metformin	SIRT1	PA450395	23411	0.957
NULL	Int_J_Mol_Sci_2014_Oct_27_15(11)_19417-19443.nxml.txt.nlp	25350109	SENT135	3	3	42	42	diazoxide	p47phox	PA449285	653361	0.957
NULL	Acta_Pharmacol_Sin_2009_Sep_24_30(9)_1262-1275.nxml.txt.nlp	19701231	SENT274	8	8	1	1	lovastatin	SREBP2	PA450272	6721	0.957
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Jun_27_5_15.nxml.txt.nlp	16803618	SENT138	16	16	4	4	flucloxacillin	IL-8	PA164781042	3576	0.957
NULL	Open_Access_J_Urol_2011_May_10_3_69-82.nxml.txt.nlp	24198638	SENT97	11	11	21	21	sorafenib	IFN	PA7000	3439	0.957
NULL	Cancers_(Basel)_2014_Sep_5_6(3)_1769-1792.nxml.txt.nlp	25198391	SENT643	7	7	2	2	trastuzumab	IGF1R	PA451743	3480	0.957
NULL	Cancers_(Basel)_2014_Jul_8_6(3)_1487-1499.nxml.txt.nlp	25006835	SENT99	10	10	1	1	cisplatin	STAT3	PA449014	6774	0.957
NULL	Emerg_Infect_Dis_2011_Mar_17(3)_495-497.nxml.txt.nlp	21392442	SENT18	0	0	6	6	kanamycin	DST	PA450137	667	0.957
NULL	Cardiol_Res_Pract_2011_May_10_2011_816897.nxml.txt.nlp	21629798	SENT117	8	8	4	4	ketoconazole	CYP3A4	PA450146	1576	0.957
NULL	J_Oncol_2010_Jun_20_2010_138758.nxml.txt.nlp	20634932	SENT34	42	42	7	7	vinblastine	FRG	PA451877	9855	0.957
NULL	FEBS_J_2012_May_279(10)_1857-1870.nxml.txt.nlp	22420714	SENT137	42	42	6	6	capsaicin	PKD1L3	PA448776	342372	0.957
NULL	Aging_(Albany_NY)_2011_Feb_27_3(3)_223-236.nxml.txt.nlp	21415464	SENT238	10	10	0	0	kanamycin	Bcl-2	PA450137	596	0.957
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S202-S209.nxml.txt.nlp	21525456	SENT145	2	2	12	12	exenatide	GLP-1	PA164749238	100125288	0.957
NULL	J_Inflamm_(Lond)_2005_Oct_31_2_14.nxml.txt.nlp	16259633	SENT331	21	21	7	7	staurosporine	IFN	PA165109623	3439	0.957
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT398	15	15	8	8	risperidone	PRL	PA451257	5617	0.957
NULL	Drug_Target_Insights_2012_Aug_6_6_19-39.nxml.txt.nlp	22915839	SENT261	36	36	16	16	doxorubicin	Hsp90	PA449412	3320	0.957
NULL	J_Breast_Cancer_2013_Mar_31_16(1)_23-31.nxml.txt.nlp	23593078	SENT142	19	19	8	8	curcumin	MBD2	PA151958596	8932	0.957
NULL	Ann_Dermatol_2014_Aug_31_26(4)_517-520.nxml.txt.nlp	25143685	SENT51	10	10	3	3	tazarotene	TIG3	PA164746821	5920	0.957
NULL	Cell_Cycle_2013_Dec_15_12(24)_3791-3803.nxml.txt.nlp	24107631	SENT55	31	31	23	23	doxorubicin	YB-1	PA449412	4904	0.957
NULL	Mol_Cell_Biochem_2014_Apr_22_392(1-2)_85-93.nxml.txt.nlp	24390089	SENT111	19	19	10	10	estradiol	NOTCH1	PA449503	4851	0.957
NULL	Ann_Neurosci_2014_Jul_21(3)_90-96.nxml.txt.nlp	25206072	SENT15	24	24	8	8	scopolamine	spatial	PA451308	219793	0.957
NULL	Breast_Cancer_Res_2012_Aug_31_14(4)_212.nxml.txt.nlp	22963717	SENT87	18	18	5	5	tamoxifen	NCOR1	PA451581	9611	0.957
NULL	Cardiol_Res_Pract_2011_Mar_23_2011_568095.nxml.txt.nlp	21559218	SENT97	3	3	1	1	sildenafil	PDE5A	PA451346	8654	0.957
NULL	Iran_J_Ped_Hematol_Oncol_2014_Jul_20_4(3)_118-126.nxml.txt.nlp	25254091	SENT106	19	19	5	5	doxorubicin	ABCA2	PA449412	20	0.957
NULL	J_Korean_Med_Sci_2007_Dec_20_22(6)_1055-1059.nxml.txt.nlp	18162722	SENT13	3	3	16	16	pantoprazole	ESD	PA450774	2098	0.957
NULL	Arthritis_Res_Ther_2011_Feb_4_13(1)_R14.nxml.txt.nlp	21294864	SENT200	26	26	10	10	indomethacin	IL-17	PA449982	3605	0.957
NULL	Cancer_Cell_Int_2010_Sep_9_10_32.nxml.txt.nlp	20828393	SENT126	11	11	22	22	cisplatin	ATF3	PA449014	467	0.957
NULL	Acta_Pharmacol_Sin_2014_Jun_5_35(6)_727-737.nxml.txt.nlp	24793312	SENT14	34	34	0	0	telmisartan	B27	PA451605	56246	0.957
NULL	Biologics_2009_Jul_13_3_215-224.nxml.txt.nlp	19707410	SENT42	0	0	26	26	panitumumab	EGFR	PA162373091	1956	0.957
NULL	J_Vet_Med_Sci_2014_Oct_19_76(10)_1339-1345.nxml.txt.nlp	24942113	SENT117	2	2	26	26	losartan	AT2	PA450268	186	0.957
NULL	Mol_Pain_2013_Feb_15_9_3.nxml.txt.nlp	23413875	SENT183	36	36	38	38	resveratrol	TRPA1		8989	0.957
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_33-43.nxml.txt.nlp	17912634	SENT196	10	10	15	15	letrozole	HER2	PA450196	2064	0.957
NULL	Br_J_Haematol_2014_Sep_17_166(6)_818-829.nxml.txt.nlp	24935654	SENT161	21	21	28	28	etanercept	IL6	PA449515	3569	0.957
NULL	Breast_Cancer_Res_2011_Feb_7_13(1)_R18.nxml.txt.nlp	21299862	SENT20	12	12	2	2	tamoxifen	aromatase	PA451581	1588	0.957
NULL	Int_J_Med_Sci_2013_Feb_11_10(3)_320-330.nxml.txt.nlp	23423768	SENT241	19	19	4	4	gefitinib	EGFR	PA131301952	1956	0.957
NULL	Breast_Cancer_Res_2004_May_7_6(4)_R352-R365.nxml.txt.nlp	15217502	SENT231	8	8	23	23	estradiol	CYP1A2	PA449503	1544	0.957
NULL	Breast_Cancer_Res_2007_Dec_20_9(Suppl_2)_S19.nxml.txt.nlp	NULL	SENT33	21	21	16	16	letrozole	TFF1	PA450196	7031	0.957
NULL	Amino_Acids_2014_Feb_20_46(5)_1275-1283.nxml.txt.nlp	24553827	SENT9	9	9	19	19	taurine	CDO	PA451590	50937	0.957
NULL	Acta_Neuropathol_Commun_2014_May_30_2_57.nxml.txt.nlp	24887326	SENT77	34	34	24	24	vardenafil	ABCB1	PA10229	5243	0.957
NULL	Front_Genet_2012_Nov_2_3_229.nxml.txt.nlp	23130019	SENT502	11	11	1	1	nifedipine	CYP3A4	PA450631	1576	0.957
NULL	Breast_Cancer_Res_Treat_2013_Sep_1_141(2)_243-248.nxml.txt.nlp	23996142	SENT178	12	12	5	5	tamoxifen	HER-2	PA451581	2064	0.957
NULL	Breast_Cancer_Res_2004_May_18_6(4)_148-152.nxml.txt.nlp	15217485	SENT68	19	19	14	14	tamoxifen	aromatase	PA451581	1588	0.957
NULL	Protein_Cell_2014_Jun_19_5(6)_469-479.nxml.txt.nlp	24748116	SENT168	25	25	5	5	paclitaxel	EB1	PA450761	9167;22919;10982	0.957
NULL	Br_J_Cancer_2012_Jan_3_106(1)_6-13.nxml.txt.nlp	22215104	SENT20	3	3	27	27	pertuzumab	HER2		2064	0.957
NULL	Structure_2012_May_9_20-540(5-7)_841-849.nxml.txt.nlp	22579251	SENT86	31	31	16	16	carvedilol	EL2	PA448817	6708	0.957
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT250	7	7	17	17	resveratrol	ROS		6098	0.957
NULL	Acta_Pharmacol_Sin_2012_Jan_3_33(1)_82-90.nxml.txt.nlp	22212431	SENT218	14	14	27	27	rosiglitazone	adiponectin	PA451283	9370	0.957
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Jul_21_9_20.nxml.txt.nlp	20663145	SENT69	29	29	1	1	tetracycline	LBH	PA451640	81606;221491	0.957
NULL	Breast_Cancer_(Auckl)_2014_Mar_23_8_51-56.nxml.txt.nlp	24678242	SENT8	14	14	7	7	carboplatin	BRCA1	PA448803	672	0.957
NULL	Indian_J_Endocrinol_Metab_2011_Jan-Mar_15(1)_9-17.nxml.txt.nlp	21584160	SENT111	2	2	15	15	exenatide	PPG	PA164749238	5552	0.957
NULL	J_Gen_Physiol_2009_Apr_133(4)_421-438.nxml.txt.nlp	19289574	SENT261	18	18	7	7	forskolin	SLC26A9	PA146096022	115019	0.957
NULL	Mol_Cancer_2009_Apr_22_8_26.nxml.txt.nlp	19386116	SENT202	6	6	26	26	ritonavir	AKT	PA451260	207	0.957
NULL	Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.nxml.txt.nlp	24736980	SENT179	3	3	11	11	rosuvastatin	OATP1B1	PA134308647	10599	0.957
NULL	Breast_Cancer_Res_2007_Aug_8_9(4)_R50.nxml.txt.nlp	17686159	SENT195	3	3	21	21	gefitinib	AKT	PA131301952	207	0.957
NULL	Clin_Med_Insights_Cardiol_2011_Oct_6_5_103-119.nxml.txt.nlp	22084608	SENT40	41	41	22	22	dronedarone	CYP3A4	PA153619853	1576	0.957
NULL	Mol_Cells_2014_Dec_31_37(12)_888a-898.nxml.txt.nlp	25518923	SENT217	8	8	0	0	gemcitabine	IQGAP1	PA449748	8826	0.957
NULL	Crit_Care_2000_Oct_13_4(Suppl_2)_S21-S25.nxml.txt.nlp	11255595	SENT13	8	8	18	18	furosemide	STP	PA449719	9322	0.957
NULL	J_Oncol_2012_Aug_9_2012_685213.nxml.txt.nlp	22934113	SENT173	0	0	15	15	octreotide	ACTH	PA450678	5443	0.957
NULL	Patient_Prefer_Adherence_2013_Mar_27_7_245-258.nxml.txt.nlp	23569364	SENT90	24	24	31	31	letrozole	aromatase	PA450196	1588	0.957
NULL	Acta_Oncol_2014_Oct_9_53(10)_1347-1355.nxml.txt.nlp	24909504	SENT117	14	14	1	1	doxorubicin	TP53	PA449412	7157	0.957
NULL	Anticancer_Agents_Med_Chem_2012_Feb_12(2)_163-171.nxml.txt.nlp	22043994	SENT23	31	31	2	2	panitumumab	BRAF	PA162373091	673	0.957
NULL	Cell_Death_Dis_2010_Oct_21_1(10)_e84.nxml.txt.nlp	21368857	SENT160	26	26	5	5	heparin	EGF	PA449855	1950	0.957
NULL	Oncol_Lett_2013_Jul_14_6(1)_69-74.nxml.txt.nlp	23946779	SENT20	0	0	28	28	axitinib	VEGFR	PA164924493	3791	0.957
NULL	Br_J_Cancer_2010_Jul_13_103(2)_186-195.nxml.txt.nlp	20588277	SENT105	4	4	23	23	nutlin-3	SF2		6426	0.957
NULL	Mol_Cell_Biochem_2014_Jan_3_389(1-2)_177-185.nxml.txt.nlp	24385108	SENT205	5	5	21	21	bortezomib	BIM	PA10252	10018	0.957
NULL	Environ_Health_Perspect_2005_Oct_14_113(10)_1330-1335.nxml.txt.nlp	16203242	SENT157	11	11	8	8	phenylephrine	MLC	PA450935	23209	0.957
NULL	Oncotarget_2014_Mar_14_5(10)_3029-3038.nxml.txt.nlp	24912489	SENT102	18	18	16	16	exemestane	aromatase	PA449563	1588	0.957
NULL	J_Vet_Med_Sci_2014_Jun_15_76(6)_813-817.nxml.txt.nlp	24531829	SENT145	16	16	2	2	primaquine	DPT	PA451103	1805	0.957
NULL	Oncogene_2010_Sep_23_29(38)_5299-5310.nxml.txt.nlp	20622903	SENT48	7	7	12	12	paclitaxel	p62	PA450761	8878;10657;23636	0.957
NULL	Oxid_Med_Cell_Longev_2013_Mar_5_2013_264935.nxml.txt.nlp	23533686	SENT166	10	10	21	21	hemin	HO-1	PA449849	3162	0.957
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT174	40	40	31	31	metformin	AMPK	PA450395	5563	0.957
NULL	Cancer_Med_2013_Aug_29_2(4)_478-487.nxml.txt.nlp	24156020	SENT26	5	5	27	27	gemcitabine	CD11b	PA449748	3684	0.957
NULL	Br_J_Cancer_1995_Aug_72(2)_287-292.nxml.txt.nlp	7640207	SENT2	0	0	28	28	cisplatin	GMP	PA449014	22978	0.957
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT43	25	25	34	34	ritonavir	CYP3A4	PA451260	1576	0.957
NULL	Arthritis_Res_Ther_2012_Apr_18_14(2)_R80.nxml.txt.nlp	22513098	SENT153	12	12	2	2	hydroxychloroquine	TLR9	PA164777036	54106	0.957
NULL	Semin_Immunol_2011_Feb_23(1)_28-41.nxml.txt.nlp	21295490	SENT243	1	1	18	18	ustekinumab	IL-23	PA166048654	51561	0.957
NULL	J_Headache_Pain_2013_Mar_12_14(1)_25.nxml.txt.nlp	23566208	SENT29	33	33	7	7	cinnarizine	LEP	PA164749342	3952	0.957
NULL	Clin_Sci_(Lond)_2009_Nov_16_118(Pt_4)_269-279.nxml.txt.nlp	19698082	SENT98	0	0	21	21	ramipril	ACE2	PA451223	59272	0.957
NULL	Oncogene_2013_Nov_28_32(48)_5439-5448.nxml.txt.nlp	23563182	SENT180	0	0	19	19	etoposide	Mcl-1	PA449552	4170	0.957
NULL	J_Biol_Chem_2012_Apr_27_287(18)_14644-14658.nxml.txt.nlp	22375002	SENT155	18	18	11	11	forskolin	CC2D1A	PA146096022	54862	0.957
NULL	Clin_Med_Insights_Oncol_2012_May_16_6_205-217.nxml.txt.nlp	22654526	SENT197	7	7	39	39	vorinostat	CXCL12	PA164748224	6387	0.957
NULL	Environ_Health_Perspect_2012_Jul_25_120(7)_984-989.nxml.txt.nlp	22763116	SENT26	3	3	12	12	ether	BPA	PA449525	667	0.957
NULL	Breast_Cancer_Res_2012_Mar_9_14(2)_R41.nxml.txt.nlp	22405131	SENT122	33	33	5	5	estradiol	IL-17RA	PA449503	23765	0.957
NULL	Nat_Med_2012_Mar_25_18(4)_538-546.nxml.txt.nlp	22447074	SENT51	5	5	24	24	papain	CD4	PA450778	920	0.957
NULL	Front_Oncol_2014_Oct_21_4_285.nxml.txt.nlp	25374842	SENT690	27	27	25	25	nutlin-3	MDM2		4193	0.957
NULL	Front_Neurosci_2012_May_30_6_77.nxml.txt.nlp	22661925	SENT155	6	6	0	0	ethanol	DCX	PA448073	1641	0.957
NULL	Clin_Pharmacol_2011_Jun_22_3_13-25.nxml.txt.nlp	22287853	SENT208	3	3	19	19	saxagliptin	CYP3A4	PA165958362	1576	0.957
NULL	Oncotarget_2013_Nov_23_5(1)_196-210.nxml.txt.nlp	24344116	SENT119	23	23	7	7	doxorubicin	p53	PA449412	7157	0.957
NULL	Cardiovasc_Diabetol_2013_Mar_4_12_42.nxml.txt.nlp	23452502	SENT220	2	2	5	5	liraglutide	GLP1	PA165958364	100125288;2641	0.957
NULL	Breast_Cancer_Res_2007_Jul_5_9(4)_R41.nxml.txt.nlp	17612393	SENT153	7	7	0	0	celecoxib	Bcl-2	PA448871	596	0.957
NULL	Mol_Pain_2013_Feb_15_9_3.nxml.txt.nlp	23413875	SENT31	9	9	5	5	capsaicin	TRPV1	PA448776	7442	0.957
NULL	Cell_Death_Dis_2014_Feb_13_5(2)_e1055.nxml.txt.nlp	24525731	SENT96	6	6	9	9	irinotecan	TXNL1	PA450085	9352	0.957
NULL	Chin_J_Cancer_2011_Jan_30(1)_5-12.nxml.txt.nlp	21192840	SENT110	1	1	8	8	gefitinib	ABCG2	PA131301952	9429	0.957
NULL	Biologics_2012_Sep_25_6_337-345.nxml.txt.nlp	23055691	SENT104	22	22	11	11	cisplatin	EGFR	PA449014	1956	0.957
NULL	Ther_Clin_Risk_Manag_2007_Dec_3(6)_1009-1020.nxml.txt.nlp	18516316	SENT94	17	17	4	4	dacarbazine	HEC	PA449197	10403	0.957
NULL	J_Cancer_Prev_2013_Sep_18(3)_227-234.nxml.txt.nlp	25337550	SENT68	9	9	2	2	cisplatin	EZH2	PA449014	2146	0.957
NULL	Eur_J_Clin_Pharmacol_2011_May_8_67(5)_493-506.nxml.txt.nlp	21140139	SENT208	24	24	2	2	oxycodone	CYP3A4	PA450741	1576	0.957
NULL	J_Oral_Pathol_Med_2013_Jul_18_42(6)_499-506.nxml.txt.nlp	23331485	SENT198	22	22	32	32	celecoxib	IL-6	PA448871	3569	0.957
NULL	Acta_Pharmacol_Sin_2009_Feb_5_30(2)_228-234.nxml.txt.nlp	19122672	SENT31	13	13	5	5	isoflurane	HO-1	PA450106	3162	0.957
NULL	Oncol_Rep_2012_Apr_30_27(4)_923-928.nxml.txt.nlp	22209766	SENT26	12	12	2	2	erlotinib	EGFR	PA134687924	1956	0.957
NULL	Arch_Drug_Inf_2008_Sep_1(2)_56-62.nxml.txt.nlp	19915709	SENT51	27	27	35	35	naltrexone	CYP3A4	PA450588	1576	0.957
NULL	J_Lipid_Res_2014_Dec_55(12)_2479-2490.nxml.txt.nlp	25325755	SENT207	21	21	14	14	indomethacin	aP2	PA449982	2167	0.957
NULL	Proteome_Sci_2010_Apr_13_8_22.nxml.txt.nlp	20388209	SENT8	25	25	0	0	trypsin	PARP-1	PA451806	25976	0.957
NULL	Nat_Commun_2014_Nov_25_5_5582.nxml.txt.nlp	25420773	SENT111	13	13	7	7	erlotinib	PHD3	PA134687924	112399	0.957
NULL	Front_Cell_Neurosci_2015_Jan_15_8_459.nxml.txt.nlp	25642166	SENT81	39	39	12	12	hemin	HO-1	PA449849	3162	0.957
NULL	J_Hematol_Oncol_2008_Oct_23_1_19.nxml.txt.nlp	18947412	SENT56	19	19	2	2	alemtuzumab	CD34	PA164783958	947	0.957
NULL	Acta_Pharmacol_Sin_2012_Oct_17_33(10)_1301-1310.nxml.txt.nlp	22983390	SENT187	37	37	19	19	cisplatin	migfilin	PA449014	54751	0.957
NULL	Br_J_Cancer_2004_Mar_22_90(6)_1285-1292.nxml.txt.nlp	15026814	SENT109	1	1	6	6	doxorubicin	p53	PA449412	7157	0.957
NULL	Br_J_Cancer_2012_Feb_14_106(4)_685-692.nxml.txt.nlp	22294184	SENT172	34	34	20	20	lovastatin	p53	PA450272	7157	0.957
NULL	Cancers_(Basel)_2011_Aug_9_3(3)_3189-3205.nxml.txt.nlp	24212952	SENT79	0	0	16	16	hyaluronan	HAS2	PA165958431	3037	0.957
NULL	Br_J_Cancer_2011_May_24_104(11)_1786-1790.nxml.txt.nlp	21559018	SENT102	12	12	10	10	gefitinib	EGFR	PA131301952	1956	0.957
NULL	Front_Endocrinol_(Lausanne)_2013_Nov_11_4_165.nxml.txt.nlp	24273530	SENT99	0	0	5	5	tiagabine	GAT1	PA451682	6529	0.957
NULL	Int_J_Cell_Biol_2012_Sep_9_2012_683897.nxml.txt.nlp	22991514	SENT58	16	16	20	20	oxygen	CO2	PA450744	4513	0.957
NULL	Nucleic_Acids_Res_2011_Mar_4_39(5)_1843-1854.nxml.txt.nlp	21051342	SENT277	19	19	7	7	carbenicillin	IFN	PA448788	3439	0.957
NULL	Oncol_Lett_2013_Aug_25_6(2)_480-486.nxml.txt.nlp	24137351	SENT26	0	0	23	23	sorafenib	RET	PA7000	5979	0.957
NULL	Br_J_Cancer_2010_Nov_2_103(11)_1680-1691.nxml.txt.nlp	21045833	SENT171	5	5	18	18	vorinostat	LCK	PA164748224	3932	0.957
NULL	Brain_Sci_2012_Oct_1_2(4)_434-482.nxml.txt.nlp	24961256	SENT82	26	26	20	20	citalopram	5-HTT	PA449015	6532	0.957
NULL	F1000Res_2014_Aug_19_3_198.nxml.txt.nlp	25400908	SENT282	15	15	25	25	trastuzumab	HER2	PA451743	2064	0.957
NULL	Facts_Views_Vis_Obgyn_2011_3(2)_109-120.nxml.txt.nlp	24753856	SENT144	18	18	34	34	medroxyprogesterone	CEE	PA450344	51608	0.957
NULL	FEBS_J_2009_Oct_276(19)_5571-5578.nxml.txt.nlp	19702827	SENT38	15	15	8	8	gefitinib	EGFR	PA131301952	1956	0.957
NULL	Oncotarget_2014_Sep_2_5(19)_9308-9321.nxml.txt.nlp	25301721	SENT243	34	34	14	14	forskolin	CD38	PA146096022	952	0.957
NULL	Oncotarget_2013_Jun_4_4(5)_772-784.nxml.txt.nlp	23800712	SENT131	47	47	14	14	dasatinib	EGFR	PA162372878	1956	0.957
NULL	Oncotarget_2014_Jun_18_5(14)_5428-5438.nxml.txt.nlp	24980817	SENT66	40	40	12	12	cetuximab	EGFR	PA10040	1956	0.957
NULL	Lab_Invest_2010_Mar_11_90(3)_383-390.nxml.txt.nlp	20065942	SENT10	22	22	8	8	zidovudine	TMPK	PA451954	1841	0.957
NULL	ISRN_Otolaryngol_2012_Nov_14_2012_797619.nxml.txt.nlp	23762619	SENT80	12	12	26	26	gefitinib	EGF	PA131301952	1950	0.957
NULL	Cancers_(Basel)_2010_May_28_2(2)_1027-1039.nxml.txt.nlp	24281105	SENT42	29	29	6	6	bevacizumab	VEGFR3	PA130232992	2324	0.957
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT154	18	18	27	27	atorvastatin	OPG	PA448500	690	0.957
NULL	Arthritis_Res_Ther_2014_Aug_30_16(4)_419.nxml.txt.nlp	25175678	SENT171	20	20	2	2	glibenclamide	NLRP3	PA449782	114548	0.957
NULL	J_Cell_Mol_Med_2014_Mar_25_18(3)_492-502.nxml.txt.nlp	24460759	SENT272	13	13	9	9	gemcitabine	IFN	PA449748	3439	0.957
NULL	Cancer_Cell_Int_2011_Nov_2_11_39.nxml.txt.nlp	22047021	SENT415	10	10	4	4	cisplatin	REV3	PA449014	5980	0.957
NULL	Breast_Cancer_(Auckl)_2012_Mar_7_6_67-77.nxml.txt.nlp	22438669	SENT145	13	13	22	22	pazopanib	VEGFR	PA165291492	3791	0.957
NULL	Autoimmune_Dis_2013_Jul_10_2013_728529.nxml.txt.nlp	23936634	SENT168	11	11	17	17	adalimumab	p38	PA10004	10598;1432;7965	0.957
NULL	Breast_Cancer_Res_2011_May_26_13(3)_209.nxml.txt.nlp	21635709	SENT203	21	21	5	5	tamoxifen	aromatase	PA451581	1588	0.957
NULL	Curr_Gerontol_Geriatr_Res_2010_May_4_2010_420139.nxml.txt.nlp	20454643	SENT89	35	35	21	21	estradiol	AMPK	PA449503	5563	0.957
NULL	Biomed_Res_Int_2014_Jan_29_2014_458592.nxml.txt.nlp	24592391	SENT82	8	8	19	19	curcumin	HO-1	PA151958596	3162	0.957
NULL	J_Hematol_Oncol_2008_Oct_1_1_16.nxml.txt.nlp	18828924	SENT56	17	17	36	36	paclitaxel	HER2	PA450761	2064	0.957
NULL	Oncogene_2010_Jul_22_29(29)_4170-4182.nxml.txt.nlp	20498638	SENT118	8	8	24	24	paclitaxel	EMT	PA450761	3702;6581	0.957
NULL	Evid_Based_Complement_Alternat_Med_2011_Feb_13_2011_248481.nxml.txt.nlp	19861508	SENT72	21	21	1	1	phenol	5-HT4	PA450913	3360	0.957
NULL	Ther_Clin_Risk_Manag_2007_Aug_3(4)_665-673.nxml.txt.nlp	18472989	SENT25	0	0	27	27	trastuzumab	HER-2	PA451743	2064	0.957
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_1-20.nxml.txt.nlp	19305785	SENT182	4	4	9	9	estradiol	KCC2	PA449503	57468	0.957
NULL	Scientifica_(Cairo)_2012_Nov_25_2012_473829.nxml.txt.nlp	24278698	SENT229	8	8	17	17	cisplatin	ATP7A	PA449014	538	0.957
NULL	Mol_Cancer_2009_Jun_8_8_34.nxml.txt.nlp	19500427	SENT7	26	26	17	17	gemcitabine	p53	PA449748	7157	0.957
NULL	Evid_Based_Complement_Alternat_Med_2012_Aug_25_2012_946867.nxml.txt.nlp	21876716	SENT121	2	2	32	32	oseltamivir	TRAIL	PA450721	8743	0.957
NULL	Mol_Biol_Cell_2012_Nov_1_23(21)_4212-4225.nxml.txt.nlp	22956765	SENT192	31	31	23	23	thrombin	SHP2	PA451674	5781	0.957
NULL	Br_J_Cancer_2012_Feb_14_106(4)_646-650.nxml.txt.nlp	22240794	SENT67	3	3	28	28	sunitinib	IFN	PA162372840	3439	0.957
NULL	Indian_J_Med_Paediatr_Oncol_2014_Apr-Jun_35(2)_176-180.nxml.txt.nlp	25197183	SENT84	38	38	22	22	cetuximab	KRAS	PA10040	3845	0.957
NULL	Exp_Ther_Med_2013_Oct_20_6(4)_899-903.nxml.txt.nlp	24137286	SENT10	46	46	28	28	rosuvastatin	p38	PA134308647	10598;1432;7965	0.957
NULL	Biochimie_2012_Aug_94(8)_1749-1753.nxml.txt.nlp	22522093	SENT120	15	15	35	35	fluorescein	PNKP	PA164746009	11284	0.957
NULL	Open_Biol_2014_Jul_4(7)_140071.nxml.txt.nlp	25030607	SENT54	22	22	12	12	acenocoumarol	CYP2C9	PA452632	1559	0.957
NULL	Breast_Cancer_Res_2012_Mar_19_14(2)_R51.nxml.txt.nlp	22429463	SENT41	29	29	31	31	tamoxifen	aromatase	PA451581	1588	0.957
NULL	Front_Neurol_2011_Aug_5_2_48.nxml.txt.nlp	21886636	SENT143	36	36	10	10	vasopressin	AQP2	PA451858	359	0.957
NULL	Oncotarget_2014_Aug_19_5(18)_8737-8749.nxml.txt.nlp	25228590	SENT80	24	24	2	2	crizotinib	MYCN	PA165946122	4613	0.957
NULL	eLife_2013_Oct_29_2_e01236.nxml.txt.nlp	24171104	SENT421	13	13	3	3	bortezomib	SRM	PA10252	6723;6725	0.957
NULL	Mol_Cancer_2010_May_26_9_121.nxml.txt.nlp	20500904	SENT68	18	18	12	12	gefitinib	HRG1	PA131301952	55652	0.957
NULL	Onco_Targets_Ther_2014_Jun_11_7_969-983.nxml.txt.nlp	24959084	SENT115	15	15	4	4	atazanavir	CYP3A4	PA10251	1576	0.957
NULL	J_Med_Case_Rep_2013_Oct_29_7_247.nxml.txt.nlp	24168730	SENT59	17	17	34	34	levothyroxine	RAI	PA450221	10848;6050	0.957
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1059-1066.nxml.txt.nlp	21364577	SENT46	13	13	25	25	letrozole	aromatase	PA450196	1588	0.957
NULL	Arthritis_Res_Ther_2010_Aug_23_12(4)_213.nxml.txt.nlp	20735863	SENT127	12	12	7	7	bleomycin	LPA1	PA448645	1902	0.957
NULL	Int_J_Mol_Sci_2014_Oct_8_15(10)_17974-17999.nxml.txt.nlp	25299695	SENT114	12	12	3	3	curcumin	HO-1	PA151958596	3162	0.957
NULL	J_Immunother_Cancer_2014_Jan_27_2_2.nxml.txt.nlp	24829759	SENT137	30	30	18	18	sorafenib	IL-21	PA7000	59067;50616;27189	0.957
NULL	Biosci_Rep_2013_Sep_4_33(5)_e00064.nxml.txt.nlp	23889169	SENT61	15	15	6	6	thrombin	PAR1	PA451674	79581;2149	0.957
NULL	Clin_Interv_Aging_2013_Jan_18_8_47-59.nxml.txt.nlp	23355775	SENT113	19	19	7	7	simvastatin	CYP3A4	PA451363	1576	0.957
NULL	Br_J_Cancer_2009_Oct_6_101(7)_1155-1161.nxml.txt.nlp	19738614	SENT142	17	17	8	8	gemcitabine	HER2	PA449748	2064	0.957
NULL	Pain_2014_Nov_155(11)_2243-2252.nxml.txt.nlp	24978826	SENT175	33	33	4	4	propofol	PTGER2	PA451141	5732	0.957
NULL	F1000Prime_Rep_2014_Dec_1_6_117.nxml.txt.nlp	25580271	SENT5	9	9	20	20	afatinib	EGFR	PA165981154	1956	0.957
NULL	J_Cancer_2013_Nov_14_4(9)_703-715.nxml.txt.nlp	24312140	SENT223	24	24	7	7	genistein	BRCA1	PA165109660	672	0.957
NULL	Breast_Cancer_Res_2012_Aug_24_14(4)_R121.nxml.txt.nlp	22920668	SENT296	10	10	8	8	lapatinib	ERBB2	PA152241907	2064	0.957
NULL	J_Cell_Biol_1998_Jan_26_140(2)_335-345.nxml.txt.nlp	9442109	SENT187	28	28	9	9	amiloride	NHE	PA448368	285335	0.957
NULL	Korean_Circ_J_2013_Aug_31_43(8)_541-549.nxml.txt.nlp	24044013	SENT80	41	41	26	26	clopidogrel	CYP2C19	PA449053	1557	0.957
NULL	Int_J_Endocrinol_2013_Nov_13_2013_686315.nxml.txt.nlp	24324494	SENT7	15	15	0	0	metformin	SLC22A1	PA450395	6580	0.957
NULL	Indian_J_Pharmacol_2014_Jan-Feb_46(1)_3-12.nxml.txt.nlp	24550577	SENT222	5	5	16	16	vismodegib	P-gp		5243	0.957
NULL	Indian_J_Ophthalmol_2014_Jun_62(6)_671-674.nxml.txt.nlp	25005192	SENT89	34	34	15	15	candesartan	CRA	PA448765	51747;10903	0.957
NULL	Clin_Mol_Hepatol_2014_Jun_30_20(2)_89-136.nxml.txt.nlp	25032178	SENT311	27	27	17	17	ribavirin	RVR	PA451241	9975	0.957
NULL	Biosci_Rep_2012_Aug_1_32(Pt_4)_361-374.nxml.txt.nlp	22762204	SENT1496	14	14	7	7	etoposide	p53	PA449552	7157	0.957
NULL	Int_J_Genomics_2013_Oct_7_2013_480534.nxml.txt.nlp	24222893	SENT30	30	30	21	21	estradiol	HOTAIR	PA449503	100124700	0.957
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_24_2012_673132.nxml.txt.nlp	23133498	SENT113	0	0	5	5	ciprofloxacin	P-gp	PA449009	5243	0.957
NULL	Genome_Biol_2011_Nov_11_12(11)_233.nxml.txt.nlp	22078297	SENT54	9	9	1	1	sugar	TIMP1	PA451529	7076	0.957
NULL	Curr_Neuropharmacol_2009_Sep_7(3)_246-256.nxml.txt.nlp	20190966	SENT186	4	4	28	28	cisplatin	p53	PA449014	7157	0.957
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_12_2012_160726.nxml.txt.nlp	23243430	SENT153	25	25	0	0	losartan	c-Jun	PA450268	3725	0.957
NULL	Diabetes_Obes_Metab_2011_Nov_13(11)_982-989.nxml.txt.nlp	21615670	SENT105	15	15	4	4	exenatide	PPG	PA164749238	5552	0.957
NULL	J_Hematol_Oncol_2013_Feb_17_6_17.nxml.txt.nlp	23414938	SENT159	3	3	23	23	prasugrel	CD40L	PA154410481	959	0.957
NULL	Arthritis_Res_Ther_2012_Sep_24_14(5)_R200.nxml.txt.nlp	23006144	SENT160	3	3	9	9	alefacept	IL-20	PA164748040	27190;50604	0.957
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT139	4	4	27	27	resveratrol	PUMA		27113	0.957
NULL	Breast_Cancer_Res_2011_Sep_13_13(5)_R87.nxml.txt.nlp	21914172	SENT193	39	39	15	15	neratinib	HER2	PA165291472	2064	0.957
NULL	Open_Med_Chem_J_2011_Sep_9_5_82-92.nxml.txt.nlp	21966329	SENT75	0	0	9	9	liraglutide	GLP-1	PA165958364	100125288	0.957
NULL	Pharmaceuticals_(Basel)_2012_Jan_5_5(1)_79-93.nxml.txt.nlp	24288044	SENT14	15	15	7	7	trastuzumab	HER2	PA451743	2064	0.957
NULL	Cancers_(Basel)_2011_Apr_1_3(2)_1844-1860.nxml.txt.nlp	24212785	SENT453	19	19	0	0	oxaliplatin	KRAS	PA131285527	3845	0.957
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Dec_18_67(Pt_1)_o193.nxml.txt.nlp	21522695	SENT62	4	4	21	21	nitrile	mol	PA450636	90527	0.957
NULL	Biologics_2014_Apr_23_8_183-192.nxml.txt.nlp	24790411	SENT25	0	0	33	33	afatinib	HER2	PA165981154	2064	0.957
NULL	Biomed_Res_Int_2013_Aug_4_2013_152909.nxml.txt.nlp	23984319	SENT97	34	34	24	24	cytarabine	MSH2	PA449177	4436	0.957
NULL	Chem_Rev_2011_Oct_12_111(10)_6387-6422.nxml.txt.nlp	21942574	SENT261	30	30	12	12	cycloserine	PLP	PA164764600	25824;5744	0.957
NULL	J_Geriatr_Cardiol_2013_Jun_10(2)_151-158.nxml.txt.nlp	23888175	SENT229	4	4	14	14	rosuvastatin	ACE2	PA134308647	59272	0.957
NULL	Cancer_Cell_Int_2005_Oct_4_5_30.nxml.txt.nlp	16202168	SENT57	30	30	3	3	cyclosporine	MDR1	PA449167	5243	0.957
NULL	Mol_Cancer_2014_Jun_20_13_155.nxml.txt.nlp	24950741	SENT156	13	13	1	1	bortezomib	StAR	PA10252	6770	0.957
NULL	Breast_Cancer_Res_2007_Jul_5_9(4)_R41.nxml.txt.nlp	17612393	SENT37	8	8	30	30	ns-398	Bcl-2		596	0.957
NULL	Mol_Biol_Rep_2011_Jun_18_38(5)_3339-3349.nxml.txt.nlp	21086176	SENT108	4	4	20	20	novobiocin	Hsp90	PA164768819	3320	0.957
NULL	Epilepsia_2011_Mar_26_52(3)_531-540.nxml.txt.nlp	21269296	SENT187	9	9	21	21	nifedipine	spatial	PA450631	219793	0.957
NULL	Br_J_Cancer_2013_Jan_15_108(1)_72-81.nxml.txt.nlp	23257894	SENT162	20	20	9	9	sorafenib	FDG	PA7000	23583	0.957
NULL	Curr_Neuropharmacol_2011_Dec_9(4)_530-552.nxml.txt.nlp	22654714	SENT143	9	9	24	24	ketamine	BDNF	PA450144	627	0.957
NULL	Cell_Commun_Signal_2004_Jun_30_2_6.nxml.txt.nlp	15228623	SENT10	15	15	10	10	mibefradil	TTN	PA450492	7273	0.957
NULL	Nucleic_Acids_Res_2011_Sep_19_39(16)_6932-6943.nxml.txt.nlp	21596782	SENT113	16	16	1	1	estradiol	DBC1	PA449503	57805;1620	0.957
NULL	Curr_Oncol_2009_Jul_16(Suppl_2)_S1-S13.nxml.txt.nlp	19672416	SENT7	10	10	2	2	tamoxifen	aromatase	PA451581	1588	0.957
NULL	Genome_Med_2010_Jun_14_2(6)_37.nxml.txt.nlp	20546595	SENT242	41	41	15	15	tamoxifen	ERBB2	PA451581	2064	0.957
NULL	Breast_Cancer_Res_2012_Feb_8_14(1)_R26.nxml.txt.nlp	22316048	SENT34	17	17	10	10	trastuzumab	HER-2	PA451743	2064	0.957
NULL	Clinics_(Sao_Paulo)_2012_Jul_67(7)_827-830.nxml.txt.nlp	22892930	SENT22	6	6	28	28	midazolam	IL-10	PA450496	3586	0.957
NULL	Clin_Transl_Allergy_2013_Sep_2_3_29.nxml.txt.nlp	24004581	SENT190	5	5	29	29	omalizumab	IL-5	PA164752253	3567	0.957
NULL	Oncotarget_2014_Mar_14_5(10)_3029-3038.nxml.txt.nlp	24912489	SENT159	18	18	11	11	everolimus	aromatase	PA164746311	1588	0.957
NULL	Cancer_Cell_Int_2012_Jun_21_12_32.nxml.txt.nlp	22720671	SENT47	38	38	9	9	paraformaldehyde	KDR	PA450790	3791	0.957
NULL	Front_Immunol_2012_Jan_12_2_98.nxml.txt.nlp	22566887	SENT2248	7	7	16	16	celecoxib	NFkappaB	PA448871	4790	0.957
NULL	Acta_Pharmacol_Sin_2013_Feb_12_34(2)_255-261.nxml.txt.nlp	23147557	SENT127	21	21	14	14	pioglitazone	PTPRD	PA450970	5789	0.957
NULL	Cancer_Imaging_2011_Mar_1_11(1)_1-8.nxml.txt.nlp	21362586	SENT71	15	15	2	2	colchicine	P-gp	PA449092	5243	0.957
NULL	Oncotarget_2014_Aug_4_5(17)_7776-7787.nxml.txt.nlp	25277200	SENT119	7	7	32	32	cisplatin	ANXA4	PA449014	307	0.957
NULL	BMB_Rep_2014_Apr_47(4)_221-226.nxml.txt.nlp	24286312	SENT109	20	20	4	4	nutlin-3	p53		7157	0.957
NULL	Indian_J_Crit_Care_Med_2010_Oct-Dec_14(4)_188-195.nxml.txt.nlp	21572750	SENT86	0	0	5	5	clopidogrel	ADP	PA449053	23038	0.957
NULL	J_Cell_Mol_Med_2014_May_14_18(5)_811-823.nxml.txt.nlp	24628949	SENT216	11	11	36	36	docetaxel	FOXM1	PA449383	2305	0.957
NULL	Daru_2012_Nov_30_20(1)_82.nxml.txt.nlp	23351311	SENT153	3	3	36	36	sn-38	p53		7157	0.957
NULL	Clin_Med_Insights_Oncol_2011_Sep_21_5_315-323.nxml.txt.nlp	22084620	SENT231	3	3	11	11	gemcitabine	IFN	PA449748	3439	0.957
NULL	Eur_J_Med_Res_2009_Nov_24_14(Suppl_3)_17-21.nxml.txt.nlp	19959412	SENT12	0	0	17	17	raltegravir	UGT		7361;7355	0.957
NULL	Breast_Cancer_Res_2010_Sep_29_12(5)_209.nxml.txt.nlp	21067536	SENT177	0	0	12	12	axitinib	VEGFR1	PA164924493	2321	0.957
NULL	J_Hematol_Oncol_2013_Jul_8_6_48.nxml.txt.nlp	23829943	SENT133	23	23	14	14	ridaforolimus	CYP3A4	PA165291475	1576	0.957
NULL	Acta_Neuropathol_Commun_2013_May_9_1_10.nxml.txt.nlp	24252471	SENT160	13	13	2	2	cyclophosphamide	ALDH1A1	PA449165	216	0.957
NULL	Arch_Med_Sci_2012_May_9_8(2)_375-388.nxml.txt.nlp	22662015	SENT256	38	38	28	28	ketoconazole	CYP2C19	PA450146	1557	0.957
NULL	J_Mol_Signal_2009_Sep_2_4_6.nxml.txt.nlp	19725972	SENT99	15	15	29	29	ethanol	PI3	PA448073	5266	0.957
NULL	Cell_Death_Differ_2010_Oct_30_17(10)_1624-1635.nxml.txt.nlp	20431602	SENT54	15	15	28	28	paclitaxel	BimL	PA450761	10018	0.957
NULL	Br_J_Cancer_2012_Apr_24_106(9)_1481-1485.nxml.txt.nlp	22472884	SENT171	6	6	15	15	cisplatin	TRAIL	PA449014	8743	0.957
NULL	Arthritis_Res_Ther_2014_Jul_24_16(4)_R157.nxml.txt.nlp	25059342	SENT121	11	11	3	3	bleomycin	IL-6	PA448645	3569	0.957
NULL	Ann_Oncol_2013_Sep_4_24(9)_2206-2223.nxml.txt.nlp	23917950	SENT249	12	12	5	5	tamoxifen	aromatase	PA451581	1588	0.957
NULL	J_Res_Med_Sci_2011_Aug_16(8)_1062-1069.nxml.txt.nlp	22279483	SENT35	9	9	0	0	gabapentin	Sancho	PA449720	91151	0.957
NULL	ARYA_Atheroscler_2011_Summer_7(2)_78-86.nxml.txt.nlp	22577451	SENT11	28	28	36	36	betaine	CRP	PA448603	1401;140913	0.957
NULL	Case_Rep_Dermatol_2012_Sep_16_4(3)_256-260.nxml.txt.nlp	23275770	SENT61	0	0	9	9	pyridostigmine	Q10	PA451185	27161	0.957
NULL	Med_Sci_Monit_2013_Oct_31_19_916-926.nxml.txt.nlp	24172537	SENT113	34	34	2	2	melphalan	BRCA2	PA450354	675	0.957
NULL	Front_Oncol_2013_Oct_29_3_269.nxml.txt.nlp	24195060	SENT40	22	22	5	5	cisplatin	THBS1	PA449014	7057	0.957
NULL	Front_Neurosci_2014_Nov_10_8_364.nxml.txt.nlp	25426018	SENT95	21	21	0	0	fluorescein	Casper	PA164746009	8837	0.957
NULL	Oncogene_2010_Sep_2_29(35)_4905-4913.nxml.txt.nlp	20581869	SENT122	9	9	18	18	cisplatin	BRCA2	PA449014	675	0.957
NULL	Indian_J_Endocrinol_Metab_2012_Dec_16(Suppl_3)_S569-S576.nxml.txt.nlp	23565492	SENT62	12	12	1	1	lipase	NPY	PA450239	4852	0.957
NULL	Ann_Hematol_2014_Apr_1_93(8)_1371-1380.nxml.txt.nlp	24687382	SENT2	22	22	2	2	thalidomide	CRBN	PA451644	51185	0.957
NULL	Neural_Regen_Res_2014_May_15_9(10)_1055-1062.nxml.txt.nlp	25206759	SENT218	33	33	4	4	bumetanide	NKCC1	PA448682	6558	0.957
NULL	Mol_Cell_Proteomics_2014_May_17_13(5)_1273-1285.nxml.txt.nlp	24637012	SENT196	40	40	9	9	lisuride	5-HT2A	PA164749019	3356	0.957
NULL	Ann_Surg_Oncol_2010_Apr_20_17(4)_1168-1176.nxml.txt.nlp	19936839	SENT112	19	19	4	4	cetuximab	KRAS	PA10040	3845	0.957
NULL	Br_J_Cancer_2011_Jul_12_105(2)_255-262.nxml.txt.nlp	21694725	SENT167	4	4	16	16	cetuximab	EGFR	PA10040	1956	0.957
NULL	Br_J_Cancer_2012_May_8_106(10)_1587-1590.nxml.txt.nlp	22568998	SENT15	3	3	18	18	sunitinib	IFN	PA162372840	3439	0.957
NULL	J_Mol_Med_(Berl)_2012_Oct_20_90(10)_1223-1231.nxml.txt.nlp	22527886	SENT9	22	22	19	19	mk-571	CysLT1		10800	0.957
NULL	Cell_Death_Dis_2010_May_13_1(5)_e41.nxml.txt.nlp	21364648	SENT55	8	8	20	20	etoposide	p65	PA449552	5970	0.957
NULL	Breast_Cancer_Res_2011_Jun_9_13(3)_R57.nxml.txt.nlp	21658222	SENT25	8	8	12	12	tamoxifen	UGT2B7	PA451581	7364	0.957
NULL	Cancer_Cell_Int_2012_Jun_21_12_32.nxml.txt.nlp	22720671	SENT47	38	38	11	11	paraformaldehyde	CD31	PA450790	5175	0.957
NULL	Environ_Health_Perspect_1998_Jan_106(1)_23-26.nxml.txt.nlp	9417770	SENT7	19	19	45	45	genistein	mol	PA165109660	90527	0.957
NULL	Mol_Cancer_2010_Aug_23_9_222.nxml.txt.nlp	20731837	SENT13	4	4	10	10	gefitinib	ATM	PA131301952	472	0.957
NULL	Front_Behav_Neurosci_2011_Sep_13_5_57.nxml.txt.nlp	21949506	SENT78	0	0	16	16	rimonabant	CB1	PA152407999	1268	0.957
NULL	Surg_Neurol_Int_2013_Sep_6_4_114.nxml.txt.nlp	24083050	SENT215	12	12	27	27	prasugrel	PED	PA154410481	8682	0.957
NULL	J_Hematol_Oncol_2008_Oct_1_1_16.nxml.txt.nlp	18828924	SENT227	37	37	30	30	trastuzumab	HER2	PA451743	2064	0.957
NULL	Int_J_Gen_Med_2009_Jul_30_2_129-140.nxml.txt.nlp	20360896	SENT9	9	9	4	4	anastrozole	aromatase	PA448432	1588	0.957
NULL	Biomed_Res_Int_2013_Jul_30_2013_754946.nxml.txt.nlp	23984405	SENT113	37	37	4	4	mannitol	CYTB	PA450320	4519	0.957
NULL	Front_Chem_2014_Mar_14_2_12.nxml.txt.nlp	24790981	SENT152	15	15	6	6	curcumin	p300	PA151958596	2033	0.957
NULL	Brain_2013_May_4_136(5)_1462-1475.nxml.txt.nlp	23460667	SENT265	28	28	21	21	bevacizumab	CD44	PA130232992	960	0.957
NULL	Front_Mol_Neurosci_2012_Jun_6_5_69.nxml.txt.nlp	22685426	SENT41	26	26	2	2	etoposide	c-Jun	PA449552	3725	0.957
NULL	EMBO_J_2008_Sep_17_27(18)_2400-2410.nxml.txt.nlp	18756267	SENT134	17	17	10	10	camptothecin	EXO1	PA153590860	9156	0.957
NULL	Indian_J_Anaesth_2012_Mar-Apr_56(2)_129-134.nxml.txt.nlp	22701202	SENT113	17	17	32	32	bupivacaine	CEA	PA135057240	5670;1087	0.957
NULL	Br_J_Cancer_2013_Feb_19_108(3)_557-563.nxml.txt.nlp	23361053	SENT192	10	10	4	4	tamoxifen	PAK1	PA451581	5585;5058	0.957
NULL	Clin_Drug_Investig_2013_Jun_20_33(6)_419-427.nxml.txt.nlp	23605507	SENT4	22	22	6	6	ciprofloxacin	DPI	PA449009	1832	0.957
NULL	Biosci_Rep_2014_Dec_12_34(6)_e00162.nxml.txt.nlp	25385088	SENT172	33	33	6	6	chymotrypsin	XPA	PA448994	7507	0.957
NULL	Clin_Interv_Aging_2010_Dec_3_5_403-416.nxml.txt.nlp	21152242	SENT131	31	31	3	3	telmisartan	ACE	PA451605	1636	0.957
NULL	Mol_Brain_2014_Jan_24_7_6.nxml.txt.nlp	24456563	SENT174	17	17	9	9	suramin	ADP	PA10292	23038	0.957
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT249	17	17	9	9	dasatinib	AKT	PA162372878	207	0.957
NULL	Clin_Pharmacokinet_2014_Sep_3_53(1)_1-16.nxml.txt.nlp	23999929	SENT120	26	26	9	9	rivaroxaban	CLCR	PA165958360	11330	0.957
NULL	Breast_Cancer_Res_2007_Jun_4_9(3)_207.nxml.txt.nlp	17561991	SENT39	13	13	1	1	trastuzumab	FISH	PA451743	9644	0.957
NULL	Mol_Cancer_2009_Nov_24_8_109.nxml.txt.nlp	19930708	SENT180	28	28	9	9	exemestane	aromatase	PA449563	1588	0.957
NULL	Chem_Cent_J_2012_Jul_18_6_68.nxml.txt.nlp	22809051	SENT56	35	35	1	1	ethanol	PF6	PA448073	200162	0.957
NULL	Oncotarget_2014_Feb_25_5(5)_1304-1314.nxml.txt.nlp	24675421	SENT112	22	22	30	30	cisplatin	JNK1	PA449014	5599	0.957
NULL	Nat_Neurosci_2012_Sep_5_15(9)_1245-1254.nxml.txt.nlp	22864611	SENT519	19	19	5	5	clozapine	HDAC2	PA449061	3066	0.957
NULL	Indian_J_Pharmacol_2008_Jan-Feb_40(1)_10-14.nxml.txt.nlp	21264154	SENT112	28	28	14	14	vildagliptin	GLP-1	PA165958346	100125288	0.957
NULL	Korean_Circ_J_2013_May_31_43(5)_343-346.nxml.txt.nlp	23755082	SENT5	17	17	25	25	clopidogrel	DES	PA449053	1674	0.957
NULL	Int_J_Mol_Cell_Med_2012_Summer_1(3)_145-152.nxml.txt.nlp	24551770	SENT34	34	34	22	22	memantine	Bcl-2	PA10364	596	0.957
NULL	Nat_Chem_Biol_2013_May_24_9(5)_326-332.nxml.txt.nlp	23524984	SENT72	27	27	34	34	tamoxifen	AF1	PA451581	1946	0.957
NULL	Oncotarget_2014_Aug_19_5(18)_8737-8749.nxml.txt.nlp	25228590	SENT157	28	28	10	10	crizotinib	MYCN	PA165946122	4613	0.957
NULL	Biomed_Res_Int_2013_Dec_31_2013_273498.nxml.txt.nlp	23484100	SENT39	34	34	1	1	genistein	OTC	PA165109660	5009	0.957
NULL	Drug_Target_Insights_2006_Oct_23_1_5-10.nxml.txt.nlp	21901053	SENT124	20	20	1	1	thrombin	INCA	PA451674	440068	0.957
NULL	Comp_Hepatol_2005_Feb_8_4_2.nxml.txt.nlp	15701172	SENT115	5	5	13	13	ketoconazole	CYP3A	PA450146	1574	0.957
NULL	Infect_Dis_Obstet_Gynecol_2008_May_29_2008_493508.nxml.txt.nlp	18528520	SENT135	25	25	16	16	tetracycline	CDR1	PA451640	1038	0.957
NULL	Br_J_Cancer_2011_Jan_4_104(1)_91-100.nxml.txt.nlp	21139584	SENT65	18	18	25	25	geldanamycin	San	PA152031327	80218	0.957
NULL	Toxins_(Basel)_2010_Oct_28_2(11)_2584-2592.nxml.txt.nlp	22069565	SENT55	20	20	10	10	warfarin	CYP2C9	PA451906	1559	0.957
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_3_2014_639856.nxml.txt.nlp	25530785	SENT488	10	10	33	33	ethanol	GAPDH	PA448073	2597	0.957
NULL	Viruses_2014_Mar_21_6(3)_1395-1409.nxml.txt.nlp	24662607	SENT38	34	34	32	32	maraviroc	CCR5	PA164768835	1234	0.957
NULL	J_Cancer_Res_Clin_Oncol_2015_Aug_3_141_61-68.nxml.txt.nlp	25086987	SENT21	2	2	30	30	gefitinib	EGFR	PA131301952	1956	0.957
NULL	Pharmaceuticals_(Basel)_2012_Aug_10_5(8)_802-836.nxml.txt.nlp	24280676	SENT294	18	18	22	22	tolmetin	MRP2	PA451721	100130958;57626;1244	0.957
NULL	Br_J_Cancer_2012_Feb_28_106(5)_867-875.nxml.txt.nlp	22333600	SENT19	24	24	20	20	gefitinib	EGFR	PA131301952	1956	0.957
NULL	Biomed_Res_Int_2014_Jun_26_2014_161346.nxml.txt.nlp	25054130	SENT11	3	3	22	22	curcumin	NOX2	PA151958596	1536	0.957
NULL	Breast_Cancer_Res_Treat_2012_Jun_18_133(3)_937-947.nxml.txt.nlp	22094936	SENT109	41	41	13	13	tamoxifen	CDC2	PA451581	5424	0.957
NULL	Front_Chem_2014_Dec_23_2_113.nxml.txt.nlp	25566531	SENT160	34	34	14	14	curcumin	GSTT1	PA151958596	2952	0.957
NULL	Oncogene_2010_Sep_9_29(36)_5048-5060.nxml.txt.nlp	20639907	SENT269	35	35	42	42	cisplatin	TRAIL	PA449014	8743	0.957
NULL	Crit_Care_2011_Oct_26_15(5)_R257.nxml.txt.nlp	22030215	SENT206	6	6	29	29	dexmedetomidine	SAPS	PA449256	8935	0.957
NULL	Breast_Cancer_Res_Treat_2012_Aug_29_135(1)_241-252.nxml.txt.nlp	22872523	SENT202	25	25	23	23	sunitinib	VEGFR	PA162372840	3791	0.957
NULL	Pharmaceuticals_(Basel)_2012_Aug_30_5(9)_890-898.nxml.txt.nlp	24280696	SENT70	34	34	20	20	cisplatin	Hsp90	PA449014	3320	0.957
NULL	Breast_Cancer_Res_Treat_2013_Jun_30_139(2)_441-451.nxml.txt.nlp	23715630	SENT256	11	11	14	14	letrozole	aromatase	PA450196	1588	0.957
NULL	Oncol_Rep_2014_Apr_28_31(4)_1605-1612.nxml.txt.nlp	24481648	SENT9	4	4	20	20	ponatinib	P-gp	PA165980594	5243	0.957
NULL	Mol_Cancer_2013_Mar_5_12_17.nxml.txt.nlp	23497256	SENT156	24	24	20	20	sunitinib	p53	PA162372840	7157	0.957
NULL	Sensors_(Basel)_2010_May_19_10(5)_5031-5053.nxml.txt.nlp	22399922	SENT167	0	0	6	6	troglitazone	PPARG	PA451799	5468	0.957
NULL	Oxid_Med_Cell_Longev_2013_Apr_21_2013_412576.nxml.txt.nlp	23710286	SENT126	12	12	23	23	curcumin	NRF2	PA151958596	2551;4780	0.957
NULL	Blood_Res_2014_Sep_25_49(3)_162-169.nxml.txt.nlp	25325035	SENT22	5	5	25	25	rituximab	CHOP	PA451261	1649	0.957
NULL	Med_Sci_Monit_2013_Oct_31_19_916-926.nxml.txt.nlp	24172537	SENT113	29	29	7	7	cisplatin	FANCG	PA449014	2189	0.957
NULL	Braz_J_Microbiol_2012_Jun_1_Jan-Mar_43(1)_187-200.nxml.txt.nlp	24031817	SENT162	22	22	5	5	nitrogen	C15	PA450643	51316	0.957
NULL	J_Korean_Assoc_Oral_Maxillofac_Surg_2014_Dec_26_40(6)_291-296.nxml.txt.nlp	25551094	SENT122	16	16	11	11	alendronate	RANKL	PA448082	8600	0.957
NULL	Fibrogenesis_Tissue_Repair_2011_Aug_2_4_18.nxml.txt.nlp	21810214	SENT149	6	6	26	26	bleomycin	IL-13	PA448645	3596	0.957
NULL	Arthritis_Res_2002_May_24_4(Suppl_2)_S34-S40.nxml.txt.nlp	12110156	SENT3	18	18	11	11	infliximab	p75	PA452639	7133;11168	0.957
NULL	Cancer_Cell_Int_2013_Feb_12_13_14.nxml.txt.nlp	23402310	SENT129	7	7	28	28	celecoxib	p65	PA448871	5970	0.957
NULL	Mol_Cancer_2012_Mar_21_11_13.nxml.txt.nlp	22436134	SENT241	36	36	9	9	staurosporine	HuR	PA165109623	1994	0.957
NULL	Sci_Rep_2014_Nov_28_4_7237.nxml.txt.nlp	25429875	SENT123	34	34	41	41	hesperidin	JNK	PA449867	5599	0.957
NULL	Mol_Cancer_2010_Aug_16_9_217.nxml.txt.nlp	20712901	SENT5	15	15	4	4	curcumin	STAT3	PA151958596	6774	0.957
NULL	Breast_Cancer_Res_Treat_2014_Apr_9_145(1)_73-82.nxml.txt.nlp	24715380	SENT84	23	23	4	4	tamoxifen	CXCL10	PA451581	3627	0.957
NULL	Breast_Cancer_Res_2012_Jan_19_14(1)_201.nxml.txt.nlp	22277572	SENT243	19	19	17	17	letrozole	aromatase	PA450196	1588	0.957
NULL	Br_J_Cancer_2006_Dec_4_95(11)_1504-1513.nxml.txt.nlp	17088902	SENT174	3	3	24	24	gefitinib	HER2	PA131301952	2064	0.957
NULL	Mol_Cancer_2014_Apr_29_13_96.nxml.txt.nlp	24779681	SENT218	39	39	23	23	tamoxifen	EGFR	PA451581	1956	0.957
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT7	14	14	0	0	adalimumab	CD36	PA10004	948	0.957
NULL	Antimicrob_Agents_Chemother_2014_Nov_10_59(1)_505-513.nxml.txt.nlp	25385096	SENT22	4	4	16	16	artesunate	ACT	PA165111697	12;11332;9457;641455	0.957
NULL	Clin_Mol_Hepatol_2014_Jun_30_20(2)_89-136.nxml.txt.nlp	25032178	SENT334	10	10	18	18	telaprevir	CYP2C	PA165958354	1562	0.957
NULL	J_Mov_Disord_2010_Oct_30_3(2)_54-56.nxml.txt.nlp	24868384	SENT44	0	0	22	22	pramipexole	AVP	PA164742949	114548;551	0.957
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R91.nxml.txt.nlp	22541814	SENT220	5	5	15	15	thrombin	HO-1	PA451674	3162	0.957
NULL	Cancers_(Basel)_2011_Apr_18_3(2)_2014-2031.nxml.txt.nlp	24212794	SENT772	5	5	18	18	panitumumab	KRAS	PA162373091	3845	0.957
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1563-1573.nxml.txt.nlp	22015557	SENT167	8	8	24	24	sunitinib	Xin	PA162372840	165904	0.957
NULL	Br_J_Cancer_2013_Jul_23_109(2)_502-511.nxml.txt.nlp	23799850	SENT142	5	5	8	8	gemcitabine	SMARCC1	PA449748	6599	0.957
NULL	Patient_Prefer_Adherence_2013_Mar_27_7_245-258.nxml.txt.nlp	23569364	SENT1	40	40	4	4	tamoxifen	aromatase	PA451581	1588	0.957
NULL	Front_Neurosci_2013_Dec_20_7_256.nxml.txt.nlp	24391536	SENT162	3	3	19	19	rimonabant	NPY	PA152407999	4852	0.957
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Mar_26_3(3)_e107.nxml.txt.nlp	24670388	SENT89	0	0	5	5	midazolam	CYP3A	PA450496	1574	0.957
NULL	Exp_Hematol_Oncol_2014_Nov_7_3(1)_26.nxml.txt.nlp	NULL	SENT120	25	25	14	14	erlotinib	KRAS	PA134687924	3845	0.957
NULL	Case_Rep_Oncol_Med_2014_Sep_14_2014_532924.nxml.txt.nlp	25298899	SENT63	18	18	3	3	fluorouracil	NAC	PA128406956	22861	0.957
NULL	Mol_Syst_Biol_2010_Dec_21_6_453.nxml.txt.nlp	21179025	SENT189	24	24	17	17	sunitinib	VEGFR	PA162372840	3791	0.957
NULL	Oncol_Lett_2013_Sep_15_6(3)_705-708.nxml.txt.nlp	24137394	SENT138	32	32	20	20	gefitinib	EGFR	PA131301952	1956	0.957
NULL	Mol_Vis_2012_Nov_29_18_2839-2846.nxml.txt.nlp	23233786	SENT129	5	5	9	9	geldanamycin	Hsp90	PA152031327	3320	0.957
NULL	Mol_Cancer_2012_Apr_26_11_26.nxml.txt.nlp	22537224	SENT125	16	16	3	3	cisplatin	CHK1	PA449014	1111	0.957
NULL	Front_Oncol_2014_Jun_27_4_157.nxml.txt.nlp	25019058	SENT75	16	16	26	26	cisplatin	EGFR	PA449014	1956	0.957
NULL	Oncotarget_2013_Aug_15_4(9)_1438-1448.nxml.txt.nlp	23988457	SENT115	8	8	27	27	lenalidomide	RINF	PA162363968	51523	0.957
NULL	Cancer_Immunol_Immunother_2011_Jun_25_60(6)_793-808.nxml.txt.nlp	21350947	SENT224	32	32	37	37	sorafenib	IFN	PA7000	3439	0.957
NULL	Food_Nutr_Res_2011_Jul_20_55_10_3402_fnr_v55i0_5961.nxml.txt.nlp	21799667	SENT100	20	20	3	3	ethanol	GLP-1	PA448073	100125288	0.957
NULL	Acta_Neuropathol_Commun_2013_May_20_1_17.nxml.txt.nlp	24252689	SENT58	22	22	8	8	fluvastatin	COX2	PA449688	4513;5743	0.957
NULL	J_Mol_Signal_2011_Jul_20_6_7.nxml.txt.nlp	21774804	SENT6	14	14	26	26	curcumin	CD44	PA151958596	960	0.957
NULL	Oncotarget_2012_Mar_31_3(3)_236-260.nxml.txt.nlp	22470194	SENT296	11	11	7	7	perifosine	PI3K	PA165291471	5290	0.957
NULL	Environ_Health_Perspect_2006_Sep_23_114(9)_1401-1406.nxml.txt.nlp	16966095	SENT48	31	31	25	25	arsenite	p53	PA452638	7157	0.957
NULL	Diabetes_Care_2010_Jul_31_33(7)_1544-1548.nxml.txt.nlp	20357370	SENT94	22	22	5	5	metformin	STK11	PA450395	6794	0.957
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT163	2	2	26	26	tenofovir	Ray	PA10204	26751	0.956
NULL	Br_J_Cancer_2012_Jun_5_106(12)_1997-2003.nxml.txt.nlp	22596232	SENT151	26	26	20	20	sorafenib	CD133	PA7000	8842	0.956
NULL	Nucleic_Acids_Res_2013_May_5_41(10)_5210-5222.nxml.txt.nlp	23563151	SENT258	35	35	13	13	arsenite	GADD45	PA452638	1647	0.956
NULL	Diabetes_Care_2009_Oct_8_32(10)_1796-1801.nxml.txt.nlp	19587369	SENT184	11	11	5	5	ramipril	DREAM	PA451223	30818	0.956
NULL	Diabetes_Care_2008_Sep_31(9)_1736-1737.nxml.txt.nlp	18556340	SENT78	7	7	40	40	glucose	KCNJ11	PA449773	3767	0.956
NULL	J_Immunother_Cancer_2014_Mar_12_2(Suppl_2)_I7.nxml.txt.nlp	NULL	SENT14	22	22	37	37	gemcitabine	gamma	PA449748	9913	0.956
NULL	Evid_Based_Complement_Alternat_Med_2011_Jan_4_2011_392627.nxml.txt.nlp	19542183	SENT129	13	13	36	36	phenylephrine	mol	PA450935	90527	0.956
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT87	5	5	24	24	curcumin	DcR2	PA151958596	8793	0.956
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT241	9	9	22	22	sitagliptin	GLP-1	PA164748978	100125288	0.956
NULL	Open_Biol_2014_Feb_4(2)_130210.nxml.txt.nlp	24554596	SENT155	17	17	9	9	trypsin	BMPR1A	PA451806	657	0.956
NULL	Mediators_Inflamm_1996_Oct_5(5)_346-357.nxml.txt.nlp	18475729	SENT8	31	31	15	15	heparin	IL-8	PA449855	3576	0.956
NULL	Breast_Cancer_Res_Treat_2013_May_12_139(1)_107-113.nxml.txt.nlp	23580070	SENT24	38	38	5	5	trastuzumab	Hsp90	PA451743	3320	0.956
NULL	Mol_Cancer_2010_May_19_9_111.nxml.txt.nlp	20482821	SENT21	29	29	23	23	tamoxifen	BEX2	PA451581	84707	0.956
NULL	Daru_2012_Oct_4_20(1)_45.nxml.txt.nlp	23351300	SENT36	32	32	39	39	itraconazole	API	PA450132	5345	0.956
NULL	Curr_Cardiol_Rev_2012_Aug_8(3)_239-249.nxml.txt.nlp	22935021	SENT53	7	7	22	22	pantoprazole	CYP2C19	PA450774	1557	0.956
NULL	Cancer_2014_Aug_1_120(15)_2343-2351.nxml.txt.nlp	24752945	SENT8	17	17	3	3	cisplatin	ERCC1	PA449014	2067	0.956
NULL	J_Oncol_2013_Aug_20_2013_732047.nxml.txt.nlp	24027583	SENT109	30	30	4	4	everolimus	HER2	PA164746311	2064	0.956
NULL	Am_J_Case_Rep_2014_Nov_3_15_480-484.nxml.txt.nlp	25380070	SENT77	7	7	26	26	crizotinib	CEA	PA165946122	5670;1087	0.956
NULL	Pharmaceutics_2011_Nov_18_3(4)_865-913.nxml.txt.nlp	24309312	SENT238	15	15	20	20	nelfinavir	P-gp	PA450606	5243	0.956
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_79-85.nxml.txt.nlp	23864840	SENT28	20	20	5	5	gemcitabine	EGFR	PA449748	1956	0.956
NULL	Br_J_Cancer_1990_May_61(5)_659-662.nxml.txt.nlp	2337503	SENT13	25	25	11	11	galactose	CPG2	PA449725	23345	0.956
NULL	Small_GTPases_2012_Jan_1_3(1)_34-39.nxml.txt.nlp	22714415	SENT8	22	22	32	32	cetuximab	KRAS	PA10040	3845	0.956
NULL	Calcif_Tissue_Int_2010_Aug_15_87(2)_99-107.nxml.txt.nlp	20473488	SENT121	32	32	5	5	forskolin	SOST	PA146096022	50964	0.956
NULL	Breast_Cancer_Res_2013_Nov_29_15(6)_R114.nxml.txt.nlp	24289103	SENT347	25	25	6	6	tamoxifen	EGFR	PA451581	1956	0.956
NULL	Front_Bioeng_Biotechnol_2013_Aug_27_1_4.nxml.txt.nlp	25023946	SENT182	31	31	4	4	metronidazole	NRP	PA450484	8829;4673;10133	0.956
NULL	Breast_Cancer_(Auckl)_2012_Feb_20_6_47-66.nxml.txt.nlp	22399860	SENT172	4	4	10	10	tamoxifen	BAP1	PA451581	8314;9223;6045	0.956
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1542-1553.nxml.txt.nlp	21970874	SENT132	30	30	17	17	pemetrexed	FPGS	PA10810	2356	0.956
NULL	Front_Neurosci_2014_Apr_8_8_63.nxml.txt.nlp	24782698	SENT75	11	11	34	34	fluoxetine	5-HT1A	PA449673	3350	0.956
NULL	Mol_Cancer_2007_Oct_22_6_66.nxml.txt.nlp	17953743	SENT260	12	12	35	35	cisplatin	survivin	PA449014	332	0.956
NULL	Evid_Based_Complement_Alternat_Med_2013_May_28_2013_629750.nxml.txt.nlp	23781265	SENT199	16	16	8	8	capsaicin	GADD153	PA448776	1649	0.956
NULL	Curr_Med_Chem_2014_May_21(14)_1595-1606.nxml.txt.nlp	23992330	SENT145	45	45	17	17	dasatinib	EGFR	PA162372878	1956	0.956
NULL	Cardiovasc_Ther_2009_27(4)_259-274.nxml.txt.nlp	19604248	SENT94	20	20	26	26	clopidogrel	ADP	PA449053	23038	0.956
NULL	Angiogenesis_2008_Sep_7_11(3)_235-243.nxml.txt.nlp	18324477	SENT0	15	15	22	22	verteporfin	CAM	PA451871	889	0.956
NULL	F1000Prime_Rep_2014_Dec_1_6_117.nxml.txt.nlp	25580271	SENT66	19	19	3	3	pemetrexed	EGFR	PA10810	1956	0.956
NULL	Breast_Cancer_Res_2014_Sep_12_16(5)_436.nxml.txt.nlp	25213081	SENT161	4	4	0	0	tamoxifen	FOXM1	PA451581	2305	0.956
NULL	Tuberc_Respir_Dis_(Seoul)_2014_Feb_27_76(2)_66-74.nxml.txt.nlp	24624215	SENT36	27	27	4	4	linezolid	HCAP	PA450233	117159;9126	0.956
NULL	Br_J_Cancer_2006_Dec_4_95(11)_1483-1489.nxml.txt.nlp	17106442	SENT136	9	9	20	20	gefitinib	EGFR	PA131301952	1956	0.956
NULL	Cell_Death_Dis_2014_Feb_13_5(2)_e1055.nxml.txt.nlp	24525731	SENT115	13	13	19	19	irinotecan	TXNL1	PA450085	9352	0.956
NULL	Biomed_Res_Int_2013_Jan_21_2013_581631.nxml.txt.nlp	23484133	SENT211	29	29	19	19	infliximab	IL-15	PA452639	3600	0.956
NULL	Breast_Cancer_Res_2009_Oct_28_11(5)_211.nxml.txt.nlp	19889200	SENT231	18	18	5	5	tamoxifen	HER2	PA451581	2064	0.956
NULL	Mol_Cancer_2008_Nov_24_7_87.nxml.txt.nlp	19025616	SENT297	22	22	0	0	cyclophosphamide	ALDH1A1	PA449165	216	0.956
NULL	Oncogene_2010_Sep_16_29(37)_5135-5145.nxml.txt.nlp	20622897	SENT77	10	10	15	15	cetuximab	STAT3	PA10040	6774	0.956
NULL	Indian_J_Ophthalmol_2012_Jan-Feb_60(1)_5-14.nxml.txt.nlp	22218239	SENT259	10	10	17	17	nepafenac	PRK	PA165958407	1263	0.956
NULL	Evid_Based_Complement_Alternat_Med_2015_Jan_6_2015_802903.nxml.txt.nlp	25632291	SENT104	15	15	29	29	berberine	CYP1A2	PA165860812	1544	0.956
NULL	Oncol_Lett_2014_May_4_7(5)_1352-1362.nxml.txt.nlp	24765137	SENT142	34	34	11	11	cisplatin	p53	PA449014	7157	0.956
NULL	Hum_Genomics_2010_Apr_1_4(4)_238-249.nxml.txt.nlp	20511137	SENT75	10	10	21	21	raloxifene	UGT1A1	PA451221	54658	0.956
NULL	Acta_Pharmacol_Sin_2013_Apr_18_34(4)_555-560.nxml.txt.nlp	23503472	SENT8	8	8	27	27	cyclosporine	NFKB1	PA449167	4790	0.956
NULL	Breast_Cancer_Res_2009_Oct_28_11(5)_211.nxml.txt.nlp	19889200	SENT152	10	10	18	18	anastrozole	ATAC	PA448432	6375	0.956
NULL	Cancers_(Basel)_2012_Nov_8_4(4)_1180-1211.nxml.txt.nlp	24213504	SENT50	2	2	19	19	erlotinib	EGFR	PA134687924	1956	0.956
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R91.nxml.txt.nlp	22541814	SENT245	2	2	14	14	thrombin	HO-1	PA451674	3162	0.956
NULL	J_Gastrointest_Cancer_2014_May_7_45(3)_262-267.nxml.txt.nlp	24802226	SENT38	1	1	16	16	imatinib	KIT	PA10804	3815	0.956
NULL	Drugs_Context_2012_Nov_19_2012_212242.nxml.txt.nlp	24432031	SENT202	1	1	37	37	vemurafenib	BRAF	PA165946873	673	0.956
NULL	Patient_Prefer_Adherence_2011_Dec_23_6_1-9.nxml.txt.nlp	22272064	SENT77	22	22	25	25	telmisartan	ACE	PA451605	1636	0.956
NULL	Mol_Cancer_2004_Nov_17_3_31.nxml.txt.nlp	15548330	SENT140	0	0	12	12	etoposide	PC-3	PA449552	692094	0.956
NULL	Cancer_Cell_Int_2012_Jun_6_12_22.nxml.txt.nlp	22672528	SENT168	16	16	7	7	fludarabine	DR5	PA449655	8795	0.956
NULL	Mol_Cancer_2004_May_4_3_14.nxml.txt.nlp	15125777	SENT146	37	37	5	5	cisplatin	CHK2	PA449014	11200	0.956
NULL	J_Breast_Cancer_2013_Sep_30_16(3)_274-284.nxml.txt.nlp	24155756	SENT50	0	0	17	17	trastuzumab	HER2	PA451743	2064	0.956
NULL	Clin_Cosmet_Investig_Dermatol_2013_Mar_14_6_75-80.nxml.txt.nlp	23515267	SENT84	5	5	13	13	etanercept	IL-23	PA449515	51561	0.956
NULL	J_Exp_Bot_2012_Apr_20_63(7)_2449-2464.nxml.txt.nlp	22268155	SENT73	0	0	32	32	phenol	mol	PA450913	90527	0.956
NULL	Eur_Heart_J_2013_Jul_21_34(28)_2132-2140.nxml.txt.nlp	23782649	SENT65	1	1	14	14	heparin	ACT	PA449855	12;11332;9457;641455	0.956
NULL	Biomed_Res_Int_2013_Jul_17_2013_549359.nxml.txt.nlp	23956990	SENT162	19	19	13	13	gemcitabine	EGFR	PA449748	1956	0.956
NULL	J_Adv_Pharm_Technol_Res_2013_Jul-Sep_4(3)_151-159.nxml.txt.nlp	24083203	SENT188	23	23	6	6	clobazam	F10	PA10888	2159	0.956
NULL	Clin_Pharmacokinet_2014_Jul_24_53(1)_73-87.nxml.txt.nlp	23881596	SENT256	18	18	28	28	rosuvastatin	OATP1B3	PA134308647	28234	0.956
NULL	Cell_Commun_Signal_2013_Apr_17_11_27.nxml.txt.nlp	23594441	SENT222	5	5	13	13	doxorubicin	TRAIL	PA449412	8743	0.956
NULL	Braz_J_Microbiol_2010_Sep_1_Jul-Sep_41(3)_574-580.nxml.txt.nlp	24031531	SENT38	0	0	19	19	verapamil	Gen	PA451868	348654	0.956
NULL	J_Biomed_Biotechnol_2010_Nov_25_2010_238080.nxml.txt.nlp	20011065	SENT108	5	5	38	38	forskolin	NHERF	PA146096022	9368	0.956
NULL	Basic_Res_Cardiol_2014_May_22_109(4)_416.nxml.txt.nlp	24847907	SENT169	3	3	20	20	diazoxide	GAPDH	PA449285	2597	0.956
NULL	Br_J_Cancer_2009_May_19_100(10)_1540-1548.nxml.txt.nlp	19384300	SENT103	8	8	20	20	trypsin	TATI	PA451806	6690	0.956
NULL	Clinics_(Sao_Paulo)_2014_Jan_69(1)_68-74.nxml.txt.nlp	24473562	SENT108	23	23	5	5	nutlin-3	SOCS-1		8651	0.956
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT15	16	16	5	5	capsaicin	p53	PA448776	7157	0.956
NULL	Diabetes_2009_Apr_2_58(4)_954-964.nxml.txt.nlp	19188429	SENT47	25	25	6	6	perindopril	STZ	PA450877	6484	0.956
NULL	Pharmaceutics_2010_Oct_14_2(4)_321-338.nxml.txt.nlp	NULL	SENT142	3	3	17	17	cefepime	ANOVA	PA164754876	4858	0.956
NULL	Ann_Hematol_2010_Sep_13_89(9)_861-871.nxml.txt.nlp	20387067	SENT222	12	12	20	20	dasatinib	IL-3	PA162372878	3562	0.956
NULL	Chin_J_Cancer_2012_Mar_31(3)_150-158.nxml.txt.nlp	22360854	SENT126	23	23	13	13	cisplatin	ABCG2	PA449014	9429	0.956
NULL	AAPS_J_2011_Dec_22_14(1)_68-78.nxml.txt.nlp	22189899	SENT179	8	8	5	5	ketoconazole	CYP3A4	PA450146	1576	0.956
NULL	J_Parasitol_Res_2013_Apr_3_2013_429736.nxml.txt.nlp	23691276	SENT177	0	0	17	17	curcumin	IL-10	PA151958596	3586	0.956
NULL	Indian_J_Pharmacol_2009_Aug_41(4)_167-172.nxml.txt.nlp	20523867	SENT139	38	38	15	15	acetaminophen	CYP3A5	PA448015	1577	0.956
NULL	Evid_Based_Complement_Alternat_Med_2011_Feb_14_2011_248231.nxml.txt.nlp	19233878	SENT238	5	5	13	13	rosiglitazone	AS160	PA451283	9882	0.956
NULL	Indian_J_Anaesth_2014_Sep-Oct_58(5)_573-580.nxml.txt.nlp	25535419	SENT164	13	13	4	4	heparin	ACT	PA449855	12;11332;9457;641455	0.956
NULL	ARYA_Atheroscler_2011_Summer_7(2)_78-86.nxml.txt.nlp	22577451	SENT11	28	28	38	38	betaine	IL-6	PA448603	3569	0.956
NULL	J_Exp_Med_1998_Jun_1_187(11)_1885-1892.nxml.txt.nlp	9607928	SENT197	5	5	19	19	thalidomide	CD4	PA451644	920	0.956
NULL	J_Hum_Genet_2013_Jun_23_58(6)_339-345.nxml.txt.nlp	23697979	SENT72	25	25	7	7	clopidogrel	CYP2C19	PA449053	1557	0.956
NULL	Inflamm_Res_2010_Sep_26_59(9)_699-709.nxml.txt.nlp	20339899	SENT29	7	7	19	19	thrombin	PAR3	PA451674	56288;2151	0.956
NULL	Ecancermedicalscience_2009_Oct_29_3_157.nxml.txt.nlp	22276018	SENT416	12	12	1	1	tamoxifen	ATAC	PA451581	6375	0.956
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_May_8_66(Pt_6)_o1294.nxml.txt.nlp	21579391	SENT56	14	14	22	22	anastrozole	aromatase	PA448432	1588	0.956
NULL	Int_J_Biol_Sci_2012_Feb_9_8(3)_310-327.nxml.txt.nlp	22355267	SENT156	18	18	36	36	simvastatin	PCSK9	PA451363	255738	0.956
NULL	J_Cardiothorac_Surg_2013_Apr_4_8_63.nxml.txt.nlp	23557204	SENT165	18	18	0	0	glucose	FDG	PA449773	23583	0.956
NULL	Fibrogenesis_Tissue_Repair_2012_Jun_6_5(Suppl_1)_S13.nxml.txt.nlp	23259677	SENT41	29	29	20	20	pravastatin	Rho	PA451089	29984	0.956
NULL	Behav_Brain_Funct_2014_Feb_13_10_5.nxml.txt.nlp	24524628	SENT132	9	9	12	12	capsaicin	TRPV1	PA448776	7442	0.956
NULL	Cell_Death_Dis_2012_Jun_21_3(6)_e330.nxml.txt.nlp	22717585	SENT312	11	11	23	23	simvastatin	Bcl-2	PA451363	596	0.956
NULL	ScientificWorldJournal_2012_Jun_18_2012_373709.nxml.txt.nlp	22761550	SENT106	24	24	17	17	halothane	NALCN	PA449845	259232	0.956
NULL	Cancers_(Basel)_2014_Jul_22_6(3)_1540-1552.nxml.txt.nlp	25055117	SENT349	8	8	4	4	crizotinib	Met	PA165946122	79811	0.956
NULL	EMBO_Mol_Med_2013_Jan_29_5(1)_137-148.nxml.txt.nlp	23197407	SENT298	2	2	15	15	propranolol	TR3	PA451145	8718;3164;10587	0.956
NULL	Int_J_Mol_Sci_2014_Oct_6_15(10)_17886-17900.nxml.txt.nlp	25290095	SENT41	4	4	34	34	resveratrol	SIRT1		23411	0.956
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT14	23	23	18	18	tacrolimus	SOCS3	PA451578	9021	0.956
NULL	ARYA_Atheroscler_2011_Summer_7(2)_78-86.nxml.txt.nlp	22577451	SENT11	10	10	38	38	betaine	IL-6	PA448603	3569	0.956
NULL	Oncoimmunology_2013_Oct_1_2(10)_e27025.nxml.txt.nlp	24353914	SENT164	3	3	21	21	tamoxifen	CD4	PA451581	920	0.956
NULL	Case_Rep_Transplant_2014_Jan_2_2014_548243.nxml.txt.nlp	24575309	SENT69	24	24	4	4	sirolimus	CYP3A	PA451365	1574	0.956
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_79-96.nxml.txt.nlp	19305789	SENT129	15	15	22	22	evodiamine	TRPV1	PA165860788	7442	0.956
NULL	Cancer_Cell_Int_2013_Jun_17_13_61.nxml.txt.nlp	23773282	SENT390	5	5	22	22	hesperetin	FADD	PA164742902	8772	0.956
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_9_2013_486047.nxml.txt.nlp	23662138	SENT122	21	21	35	35	glibenclamide	SDH	PA449782	1757;10993	0.956
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT70	9	9	5	5	vinorelbine	ABCC10	PA451881	89845	0.956
NULL	J_Oncol_2013_Apr_29_2013_854121.nxml.txt.nlp	23737784	SENT42	29	29	18	18	capecitabine	EGFR	PA448771	1956	0.956
NULL	Mol_Cancer_2010_Aug_16_9_217.nxml.txt.nlp	20712901	SENT93	41	41	20	20	curcumin	U87	PA151958596	677775;641648	0.956
NULL	Br_J_Cancer_2011_Mar_1_104(5)_856-862.nxml.txt.nlp	21285991	SENT154	26	26	34	34	irinotecan	KRAS	PA450085	3845	0.956
NULL	Adv_Biomed_Res_2014_Jan_9_3_1.nxml.txt.nlp	24592358	SENT116	5	5	16	16	estradiol	TLR3	PA449503	7098	0.956
NULL	Br_J_Cancer_2013_May_14_108(9)_1862-1869.nxml.txt.nlp	23579219	SENT136	5	5	21	21	cetuximab	KRAS	PA10040	3845	0.956
NULL	J_Mol_Signal_2014_Aug_1_9_7.nxml.txt.nlp	25093037	SENT88	10	10	24	24	tamoxifen	PAK1	PA451581	5585;5058	0.956
NULL	Mol_Cancer_2014_Jan_15_13_9.nxml.txt.nlp	24428911	SENT114	24	24	8	8	gefitinib	EGFR	PA131301952	1956	0.956
NULL	Cell_Oncol_(Dordr)_2014_Nov_20_37(6)_421-428.nxml.txt.nlp	25410120	SENT35	34	34	12	12	doxorubicin	P-gp	PA449412	5243	0.956
NULL	Mol_Vis_2012_Nov_12_18_2673-2686.nxml.txt.nlp	23170060	SENT401	13	13	0	0	taurine	Gen	PA451590	348654	0.956
NULL	Oncotarget_2012_Sep_28_3(10)_1169-1181.nxml.txt.nlp	23045411	SENT83	19	19	11	11	doxorubicin	JIP1	PA449412	9479	0.956
NULL	Arthritis_Res_Ther_2009_Jan_26_11(1)_R12.nxml.txt.nlp	19171052	SENT337	0	0	33	33	dipyridamole	POMC	PA449367	5443	0.956
NULL	Clin_Cosmet_Investig_Dermatol_2014_Sep_2_7_243-249.nxml.txt.nlp	25214798	SENT36	34	34	0	0	ustekinumab	ACR	PA166048654	49	0.956
NULL	Orphanet_J_Rare_Dis_2013_Feb_12_8_23.nxml.txt.nlp	23398819	SENT193	17	17	8	8	l-carnitine	BTHS	PA450154	6901	0.956
NULL	ScientificWorldJournal_2012_Apr_26_2012_358102.nxml.txt.nlp	22645419	SENT192	21	21	11	11	captopril	AT2	PA448780	186	0.956
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT957	0	0	11	11	chlorothiazide	OAT3	PA448953	9376	0.956
NULL	Cardiovasc_Res_2011_Apr_1_90(1)_140-147.nxml.txt.nlp	21071431	SENT87	0	0	26	26	resveratrol	ROS		6098	0.956
NULL	Neuro_Oncol_2010_Aug_14_12(8)_882-889.nxml.txt.nlp	20472883	SENT51	10	10	35	35	erlotinib	EGFR	PA134687924	1956	0.956
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT176	21	21	13	13	neratinib	HER2	PA165291472	2064	0.956
NULL	Br_J_Cancer_2012_Oct_9_107(8)_1233-1238.nxml.txt.nlp	22955852	SENT32	18	18	2	2	docetaxel	RPN2	PA449383	6185	0.956
NULL	Daru_2012_Sep_3_20(1)_24.nxml.txt.nlp	23351176	SENT6	9	9	28	28	itopride	EPO	PA152432599	7076;8288;2056	0.956
NULL	Ann_Hematol_2010_Sep_13_89(9)_861-871.nxml.txt.nlp	20387067	SENT177	14	14	18	18	dasatinib	KIT	PA162372878	3815	0.956
NULL	Cancers_(Basel)_2014_Mar_13_6(1)_595-624.nxml.txt.nlp	24633084	SENT222	14	14	22	22	pertuzumab	HER2		2064	0.956
NULL	Nat_Med_2013_Mar_10_19(3)_313-321.nxml.txt.nlp	23396211	SENT363	0	0	8	8	amlexanox	TBK1	PA164745310	29110	0.956
NULL	Biomed_Res_Int_2014_Jan_15_2014_859871.nxml.txt.nlp	24527460	SENT126	0	0	7	7	metformin	CD44	PA450395	960	0.956
NULL	Mol_Cell_Biochem_2015_Oct_8_398(1-2)_165-173.nxml.txt.nlp	25292312	SENT112	27	27	19	19	bortezomib	HIF-1	PA10252	29072	0.956
NULL	Asian-Australas_J_Anim_Sci_2014_Dec_27(12)_1783-1793.nxml.txt.nlp	25358373	SENT43	0	0	19	19	capsaicin	CEBPA	PA448776	1050	0.956
NULL	Oncotarget_2011_May_16_2(5)_418-421.nxml.txt.nlp	21789791	SENT19	21	21	31	31	bortezomib	TRAIL	PA10252	8743	0.956
NULL	Niger_J_Surg_2014_Jan-Jun_20(1)_9-15.nxml.txt.nlp	24665195	SENT223	3	3	9	9	denosumab	RANKL	PA166048634	8600	0.956
NULL	J_Korean_Med_Sci_2010_May_16_25(5)_716-722.nxml.txt.nlp	20436707	SENT103	8	8	25	25	ezetimibe	DES	PA10816	1674	0.956
NULL	Indian_J_Med_Res_2014_Jan_139(1)_117-124.nxml.txt.nlp	24604047	SENT160	0	0	27	27	fluvastatin	PI3K	PA449688	5290	0.956
NULL	Oncotarget_2014_Jun_1_5(13)_4868-4880.nxml.txt.nlp	24947902	SENT71	7	7	19	19	afatinib	HER2	PA165981154	2064	0.956
NULL	Br_J_Cancer_2009_Sep_15_101(6)_957-966.nxml.txt.nlp	19738618	SENT148	39	39	5	5	dexrazoxane	THBS-1	PA449259	7057	0.956
NULL	Case_Rep_Oncol_2013_Jul_20_6(2)_382-386.nxml.txt.nlp	23904849	SENT51	24	24	5	5	panitumumab	ERBB2	PA162373091	2064	0.956
NULL	Genome_Med_2010_Nov_30_2(11)_85.nxml.txt.nlp	21122163	SENT211	18	18	3	3	imatinib	IFNG	PA10804	3458	0.956
NULL	Cancer_Cell_Int_2011_Nov_2_11_39.nxml.txt.nlp	22047021	SENT416	21	21	12	12	cisplatin	REV3	PA449014	5980	0.956
NULL	Evid_Based_Complement_Alternat_Med_2012_May_7_2012_242810.nxml.txt.nlp	22645625	SENT27	32	32	5	5	hyperforin	CYP3A4	PA165985514	1576	0.956
NULL	Open_Access_J_Urol_2010_Mar_12_2_35-40.nxml.txt.nlp	24198612	SENT72	18	18	22	22	pazopanib	FLT3	PA165291492	2322	0.956
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT48	29	29	42	42	trastuzumab	HER-2	PA451743	2064	0.956
NULL	Nucleic_Acids_Res_2005_Jun_8_33(10)_3283-3291.nxml.txt.nlp	15944449	SENT434	30	30	9	9	melphalan	XPB	PA450354	2071	0.956
NULL	Cancer_Biol_Med_2012_Mar_9(1)_18-22.nxml.txt.nlp	23691449	SENT63	13	13	4	4	erlotinib	EGFR	PA134687924	1956	0.956
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT107	26	26	20	20	neratinib	HER2	PA165291472	2064	0.956
NULL	Cancer_Immunol_Immunother_2012_Aug_5_61(8)_1349-1353.nxml.txt.nlp	22310930	SENT24	37	37	40	40	vemurafenib	BRAF	PA165946873	673	0.956
NULL	Mol_Cancer_2010_Aug_23_9_222.nxml.txt.nlp	20731837	SENT13	30	30	10	10	gefitinib	ATM	PA131301952	472	0.956
NULL	Arthritis_Res_Ther_2006_Jul_3_8(4)_216.nxml.txt.nlp	16879719	SENT107	35	35	7	7	methotrexate	ACR	PA450428	49	0.956
NULL	Diabetes_Care_2011_Sep_19_34(9)_2072-2077.nxml.txt.nlp	21788633	SENT145	13	13	2	2	vildagliptin	GLP-1	PA165958346	100125288	0.956
NULL	Int_J_Mol_Sci_2014_May_12_15(5)_8335-8351.nxml.txt.nlp	24823879	SENT156	10	10	6	6	doxorubicin	P-gp	PA449412	5243	0.956
NULL	Braz_J_Med_Biol_Res_2013_Jun_25_46(6)_528-532.nxml.txt.nlp	23802228	SENT102	17	17	5	5	rosiglitazone	PON1	PA451283	5444	0.956
NULL	Hum_Genomics_2004_May_1_1(4)_300-306.nxml.txt.nlp	15588489	SENT128	32	32	0	0	risperidone	CYP2D6	PA451257	1565	0.956
NULL	Mol_Cancer_2012_Aug_22_11_59.nxml.txt.nlp	22913813	SENT157	28	28	31	31	bortezomib	Hsp90	PA10252	3320	0.956
NULL	Br_J_Cancer_2004_Mar_22_90(6)_1293-1294.nxml.txt.nlp	15026815	SENT49	23	23	11	11	forskolin	Raf-1	PA146096022	5894	0.956
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_14_2012_617085.nxml.txt.nlp	23097677	SENT182	21	21	1	1	doxorubicin	ABCG2	PA449412	9429	0.956
NULL	Indian_J_Psychiatry_2012_Jan-Mar_54(1)_59-63.nxml.txt.nlp	22556440	SENT114	10	10	36	36	olanzapine	LGA	PA450688	27165	0.956
NULL	Cell_Death_Dis_2013_Jun_27_4(6)_e694.nxml.txt.nlp	23807223	SENT90	10	10	6	6	chloroquine	JNK	PA448948	5599	0.956
NULL	Core_Evid_2007_Nov_30_2(2)_81-88.nxml.txt.nlp	21221177	SENT89	0	0	11	11	cetuximab	EGFR	PA10040	1956	0.956
NULL	Inflamm_Res_2010_Sep_26_59(9)_699-709.nxml.txt.nlp	20339899	SENT29	13	13	26	26	trypsin	PAR4	PA451806	9002;5074	0.956
NULL	Indian_J_Psychiatry_2012_Oct-Dec_54(4)_394.nxml.txt.nlp	23372255	SENT11	11	11	37	37	raloxifene	B12	PA451221	7126;4709	0.956
NULL	Cent_European_J_Urol_2013_Dec_19_66(4)_394-404.nxml.txt.nlp	24757527	SENT146	30	30	10	10	sunitinib	CD34	PA162372840	947	0.956
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Apr_8_65(Pt_5)_o1006-o1007.nxml.txt.nlp	21583831	SENT58	12	12	20	20	anastrozole	aromatase	PA448432	1588	0.956
NULL	Nucleic_Acids_Res_2013_Nov_27_41(21)_9786-9799.nxml.txt.nlp	23982513	SENT207	17	17	26	26	arsenite	TIAR	PA452638	7073	0.956
NULL	Acta_Pharmacol_Sin_2014_Jun_4_35(6)_792-805.nxml.txt.nlp	24902787	SENT257	1	1	24	24	sertraline	S6K1	PA451333	6198	0.956
NULL	Cell_Death_Dis_2013_Oct_3_4(10)_e834.nxml.txt.nlp	24091677	SENT71	40	40	25	25	vinblastine	Mcl-1	PA451877	4170	0.956
NULL	Biomed_Res_Int_2013_Jan_1_2013_384734.nxml.txt.nlp	23484114	SENT70	18	18	5	5	thioguanine	FGF2	PA451663	2247;2258	0.956
NULL	Br_J_Cancer_2000_Jun_82(11)_1851-1859.nxml.txt.nlp	10839301	SENT7	38	38	32	32	topotecan	CD95	PA451729	355	0.956
NULL	Eur_J_Neurosci_2007_Mar_1_25(6)_1619-1630.nxml.txt.nlp	17408433	SENT189	36	36	4	4	dextran	CB1	PA449261	1268	0.956
NULL	ACS_Chem_Biol_2011_Feb_18_6(2)_169-175.nxml.txt.nlp	20886892	SENT34	33	33	5	5	indomethacin	PC2	PA449982	5126;5311;8535	0.956
NULL	J_Gynecol_Oncol_2013_Jan_8_24(1)_83-91.nxml.txt.nlp	23346317	SENT73	42	42	18	18	paclitaxel	AGO	PA450761	55294	0.956
NULL	Arthritis_Res_Ther_2005_Jul_13_7(5)_R1072-R1081.nxml.txt.nlp	16207324	SENT125	11	11	2	2	iodine	ATD	PA450049	465	0.956
NULL	Brain_Sci_2013_Apr_26_3(2)_670-703.nxml.txt.nlp	24961420	SENT70	9	9	15	15	ethanol	JNK	PA448073	5599	0.956
NULL	Mol_Cancer_2010_May_20_9_115.nxml.txt.nlp	20487546	SENT206	22	22	4	4	fludarabine	SULF2	PA449655	55959	0.956
NULL	Oncotarget_2013_Nov_24_4(12)_2186-2207.nxml.txt.nlp	24327604	SENT208	14	14	3	3	bortezomib	IL-6	PA10252	3569	0.956
NULL	Trials_2014_Jun_5_15_207.nxml.txt.nlp	24899137	SENT249	6	6	19	19	metformin	B12	PA450395	7126;4709	0.956
NULL	Nat_Commun_2011_Feb_8_2_190.nxml.txt.nlp	21304519	SENT209	31	31	29	29	indomethacin	COX	PA449982	1351	0.956
NULL	Front_Mol_Neurosci_2012_Sep_6_5_91.nxml.txt.nlp	22973190	SENT466	3	3	13	13	ethanol	CRF1	PA448073	1394	0.956
NULL	Oncotarget_2013_Dec_18_5(2)_375-385.nxml.txt.nlp	24495868	SENT6	22	22	13	13	fludarabine	XIAP	PA449655	331	0.956
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1986-2011.nxml.txt.nlp	25268165	SENT1466	7	7	10	10	pyrimethamine	STAT3	PA451193	6774	0.956
NULL	J_Thromb_Thrombolysis_2011_Nov_26_32(4)_459-466.nxml.txt.nlp	21706290	SENT72	13	13	6	6	clopidogrel	CYP2C19	PA449053	1557	0.956
NULL	AIDS_Res_Treat_2012_Mar_21_2012_186987.nxml.txt.nlp	22536495	SENT134	29	29	14	14	darunavir	SLCO1B1	PA163522472	10599	0.956
NULL	Nat_Med_2013_Dec_10_19(12)_10_1038_nm_3385.nxml.txt.nlp	24216752	SENT38	28	28	6	6	thrombin	PAR4	PA451674	9002;5074	0.956
NULL	Mol_Cancer_2006_Oct_6_5_43.nxml.txt.nlp	17026740	SENT366	7	7	17	17	bevacizumab	EGFR	PA130232992	1956	0.956
NULL	Mol_Pain_2013_Sep_8_9_46.nxml.txt.nlp	24010880	SENT130	19	19	31	31	capsaicin	GluN1	PA448776	2902	0.956
NULL	Indian_J_Pharmacol_2012_Sep-Oct_44(5)_624-628.nxml.txt.nlp	23112426	SENT21	4	4	17	17	nimodipine	CYP3A4	PA450633	1576	0.956
NULL	Adv_Hematol_2010_Dec_30_2010_627401.nxml.txt.nlp	21234094	SENT114	27	27	21	21	leucovorin	SMILE	PA450198	160418	0.956
NULL	J_Bras_Pneumol_2013_Jan-Feb_39(1)_5-15.nxml.txt.nlp	23503480	SENT218	19	19	1	1	doxycycline	LAM	PA449415	7249;7248	0.956
NULL	Eur_Heart_J_2013_Dec_1_34(45)_3515-3524.nxml.txt.nlp	23594590	SENT85	22	22	13	13	eplerenone	Rac-1	PA164749044	5879	0.956
NULL	Mol_Cancer_2012_Mar_21_11_13.nxml.txt.nlp	22436134	SENT258	11	11	6	6	gemcitabine	HuR	PA449748	1994	0.956
NULL	Br_J_Cancer_2013_Jul_23_109(2)_502-511.nxml.txt.nlp	23799850	SENT197	15	15	8	8	gemcitabine	SMARCC1	PA449748	6599	0.956
NULL	Hum_Genomics_2009_Jan_1_3(2)_121-127.nxml.txt.nlp	19164089	SENT112	22	22	3	3	ethanol	ALDH2	PA448073	217	0.956
NULL	Tuberc_Respir_Dis_(Seoul)_2013_Nov_29_75(5)_188-198.nxml.txt.nlp	24348666	SENT81	5	5	11	11	afatinib	EGFR	PA165981154	1956	0.956
NULL	Cell_Death_Dis_2012_Mar_1_3(3)_e275.nxml.txt.nlp	22378068	SENT66	18	18	0	0	doxorubicin	AMPK	PA449412	5563	0.956
NULL	Front_Physiol_2013_Nov_14_4_323.nxml.txt.nlp	24294204	SENT200	17	17	29	29	carvedilol	CYP2D6	PA448817	1565	0.956
NULL	J_Oncol_2010_Apr_8_2010_785934.nxml.txt.nlp	20396391	SENT29	0	0	34	34	pemetrexed	DHFR	PA10810	1719	0.956
NULL	J_Cell_Sci_2014_Nov_1_127(21)_4728-4739.nxml.txt.nlp	25179605	SENT260	22	22	43	43	bortezomib	SGTA	PA10252	6449	0.956
NULL	Acta_Pharmacol_Sin_2009_May_6_30(5)_589-596.nxml.txt.nlp	19349964	SENT139	25	25	33	33	thrombin	VWF	PA451674	7450	0.956
NULL	Breast_Cancer_Res_Treat_2014_Sep_25_148(1)_81-90.nxml.txt.nlp	25253174	SENT131	4	4	33	33	metformin	HER2	PA450395	2064	0.956
NULL	Int_J_Mol_Sci_2014_Mar_6_15(3)_4049-4059.nxml.txt.nlp	24663080	SENT32	16	16	5	5	dexmedetomidine	IL-6	PA449256	3569	0.956
NULL	J_Hematol_Oncol_2010_Apr_7_3_13.nxml.txt.nlp	20374647	SENT155	21	21	17	17	bortezomib	MARCKS	PA10252	4082	0.956
NULL	Cell_Commun_Signal_2009_Aug_13_7_19.nxml.txt.nlp	19678929	SENT47	7	7	29	29	panitumumab	KRAS	PA162373091	3845	0.956
NULL	Ann_Pediatr_Cardiol_2008_Jan-Jun_1(1)_18-26.nxml.txt.nlp	20300233	SENT180	31	31	19	19	mexiletine	LQT3	PA450488	6331	0.956
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2014_Jul_25_70(Pt_8)_2163-2174.nxml.txt.nlp	25084335	SENT478	5	5	11	11	tolcapone	COMT	PA451720	1312	0.956
NULL	Iran_J_Reprod_Med_2012_Nov_10(6)_531-536.nxml.txt.nlp	25246922	SENT101	9	9	6	6	letrozole	aromatase	PA450196	1588	0.956
NULL	Clinics_(Sao_Paulo)_2012_Jul_67(7)_821-826.nxml.txt.nlp	22892929	SENT96	22	22	3	3	phenylephrine	S100B	PA450935	6285	0.956
NULL	Onco_Targets_Ther_2014_Dec_4_7_2249-2255.nxml.txt.nlp	25587220	SENT119	28	28	32	32	diethylstilbestrol	MRP1	PA449307	4437	0.956
NULL	Oncotarget_2013_Jan_14_4(1)_118-127.nxml.txt.nlp	23435217	SENT131	15	15	6	6	bevacizumab	PIK3CA	PA130232992	5290	0.956
NULL	Acta_Pharmacol_Sin_2013_Feb_31_34(2)_191-198.nxml.txt.nlp	23274413	SENT93	24	24	16	16	etoposide	IL-7	PA449552	3574	0.956
NULL	Diabetes_Metab_J_2013_Aug_14_37(4)_240-248.nxml.txt.nlp	23991401	SENT104	20	20	7	7	ezetimibe	NPC1L1	PA10816	29881	0.956
NULL	Biomed_Res_Int_2014_Jan_20_2014_948427.nxml.txt.nlp	24563867	SENT5	14	14	0	0	buspirone	STZ	PA448689	6484	0.956
NULL	Exp_Ther_Med_2014_Apr_13_7(4)_799-803.nxml.txt.nlp	24669235	SENT69	0	0	13	13	metformin	GLP-1	PA450395	100125288	0.956
NULL	Mol_Cancer_2014_Jul_5_13_165.nxml.txt.nlp	24996221	SENT188	24	24	19	19	docetaxel	HMGB1	PA449383	3146	0.956
NULL	Int_J_Cell_Biol_2014_Feb_6_2014_572097.nxml.txt.nlp	24648844	SENT241	7	7	16	16	cisplatin	AKR1B1	PA449014	231	0.956
NULL	Cancer_Cell_Int_2014_Jul_2_14_59.nxml.txt.nlp	25120382	SENT196	20	20	29	29	metformin	RTCA	PA450395	8634	0.956
NULL	Breast_Cancer_Res_2010_Jun_4_12(3)_R32.nxml.txt.nlp	20525379	SENT26	2	2	27	27	estradiol	c-Myc	PA449503	4609	0.956
NULL	J_Cell_Biol_2003_Sep_29_162(7)_1197-1209.nxml.txt.nlp	14517203	SENT228	17	17	3	3	bleomycin	NBS1	PA448645	55655	0.956
NULL	Arthritis_Res_Ther_2011_Apr_15_13(2)_R64.nxml.txt.nlp	21496249	SENT87	29	29	3	3	trypsin	CD166	PA451806	214	0.956
NULL	Cancer_Med_2013_Jun_25_2(3)_277-285.nxml.txt.nlp	23930204	SENT112	20	20	5	5	capecitabine	PTEN	PA448771	5728	0.956
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT12	14	14	2	2	atorvastatin	OPG	PA448500	690	0.956
NULL	BMJ_2011_Jul_26_343_d4366.nxml.txt.nlp	21791491	SENT271	40	40	30	30	hydrochlorothiazide	ACE	PA449899	1636	0.956
NULL	J_Med_Life_2011_Feb_15_4(1)_11-20.nxml.txt.nlp	21505570	SENT208	17	17	12	12	indomethacin	FAAH	PA449982	79152;2166	0.956
NULL	Front_Microbiol_2012_Mar_19_3_92.nxml.txt.nlp	22461781	SENT1497	3	3	1	1	geldanamycin	Hsp90	PA152031327	3320	0.956
NULL	Oncogene_2009_Apr_23_28(16)_1864-1874.nxml.txt.nlp	19305426	SENT6	22	22	13	13	etoposide	Bcl-2	PA449552	596	0.956
NULL	Emerg_Infect_Dis_2011_Jul_17(7)_1289-1292.nxml.txt.nlp	21762590	SENT15	16	16	30	30	gentamicin	API	PA449753	5345	0.956
NULL	Clin_Med_Insights_Oncol_2012_Dec_6_6_407-421.nxml.txt.nlp	23239933	SENT29	44	44	14	14	gefitinib	EGFR	PA131301952	1956	0.956
NULL	Biomed_Res_Int_2013_Dec_5_2013_642848.nxml.txt.nlp	24381940	SENT136	0	0	5	5	telmisartan	AT1	PA451605	9197;185	0.956
NULL	Oncogene_2010_Nov_18_29(46)_6115-6124.nxml.txt.nlp	20729912	SENT10	16	16	30	30	doxorubicin	ABCB5	PA449412	340273	0.956
NULL	J_Biol_2006_Nov_30_5(7)_22.nxml.txt.nlp	17125495	SENT50	3	3	31	31	cisplatin	NRP	PA449014	8829;4673;10133	0.956
NULL	Br_J_Cancer_2010_Feb_2_102(3)_541-552.nxml.txt.nlp	20087344	SENT159	31	31	9	9	paclitaxel	NRP1	PA450761	8829	0.956
NULL	Br_J_Cancer_2013_Mar_5_108(4)_887-900.nxml.txt.nlp	23462807	SENT126	18	18	27	27	sunitinib	NR1I2	PA162372840	8856	0.956
NULL	Oncoimmunology_2012_Sep_1_1(6)_810-821.nxml.txt.nlp	23162748	SENT18	9	9	23	23	trastuzumab	HER2	PA451743	2064	0.956
NULL	Front_Oncol_2013_Sep_11_3_229.nxml.txt.nlp	24062982	SENT55	42	42	39	39	vemurafenib	BRAF	PA165946873	673	0.956
NULL	Mol_Cancer_2012_Sep_14_11_69.nxml.txt.nlp	22978347	SENT42	18	18	16	16	letrozole	aromatase	PA450196	1588	0.956
NULL	Br_J_Clin_Pharmacol_2011_Oct_72(4)_647-657.nxml.txt.nlp	21518389	SENT92	2	2	15	15	clopidogrel	P2Y12	PA449053	64805	0.956
NULL	Acta_Pharmacol_Sin_2013_Jan_17_34(1)_157-166.nxml.txt.nlp	23247593	SENT201	16	16	11	11	berberine	Set9	PA165860812	80854	0.956
NULL	Drug_Saf_2014_Feb_19_37(4)_201-211.nxml.txt.nlp	24550106	SENT148	11	11	3	3	lansoprazole	CYP2C19	PA450180	1557	0.956
NULL	Gut_Liver_2013_Sep_14_7(5)_585-593.nxml.txt.nlp	24073317	SENT127	29	29	11	11	ribavirin	IL28B	PA451241	282617	0.956
NULL	Nat_Commun_2013_4_1963.nxml.txt.nlp	23739639	SENT123	34	34	47	47	dextran	MARCO	PA449261	8685	0.956
NULL	Ecancermedicalscience_2008_Feb_18_2_75.nxml.txt.nlp	22275966	SENT156	26	26	7	7	erlotinib	NSCL	PA134687924	4807	0.956
NULL	Can_J_Infect_Dis_Med_Microbiol_2014_Nov-Dec_25(6)_327-343.nxml.txt.nlp	25587296	SENT114	0	0	18	18	voriconazole	CYP3A4	PA10233	1576	0.956
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT87	5	5	22	22	curcumin	DcR1	PA151958596	8794	0.956
NULL	Oncotarget_2010_Oct_30_1(7)_639-650.nxml.txt.nlp	21317459	SENT42	15	15	28	28	nutlin-3	p53		7157	0.956
NULL	J_Infect_Dis_2012_Apr_15_205(8)_1278-1286.nxml.txt.nlp	22396598	SENT155	20	20	16	16	artemisinin	DHODH	PA165111696	1723	0.956
NULL	Biologics_2013_Apr_15_7_77-90.nxml.txt.nlp	23723688	SENT9	0	0	9	9	cetuximab	CRT	PA10040	811	0.956
NULL	Exp_Ther_Med_2013_Feb_13_5(2)_581-585.nxml.txt.nlp	23403473	SENT89	4	4	27	27	etanercept	HMGB1	PA449515	3146	0.956
NULL	Orphanet_J_Rare_Dis_2014_Oct_11_9(1)_150.nxml.txt.nlp	NULL	SENT3	16	16	0	0	glucosamine	GNE	PA164747613	10020	0.956
NULL	Trials_2012_Dec_13_13_239.nxml.txt.nlp	23237631	SENT199	33	33	11	11	amiodarone	CYP4F2	PA448383	8529	0.956
NULL	Chemother_Res_Pract_2011_Sep_25_2011_730360.nxml.txt.nlp	22295205	SENT226	0	0	10	10	pertuzumab	HER2		2064	0.956
NULL	Int_J_Biomed_Sci_2014_Sep_10(3)_217-220.nxml.txt.nlp	25324704	SENT26	33	33	27	27	amiodarone	APT	PA448383	653639	0.956
NULL	Breast_Cancer_Res_2011_Mar_11_13(2)_R30.nxml.txt.nlp	21396117	SENT326	47	47	28	28	gefitinib	EGFR	PA131301952	1956	0.956
NULL	Br_J_Cancer_2004_Mar_8_90(5)_944-949.nxml.txt.nlp	14997187	SENT50	33	33	18	18	tamoxifen	aromatase	PA451581	1588	0.956
NULL	Open_Biochem_J_2014_Nov_1_8_74-82.nxml.txt.nlp	25400709	SENT168	16	16	7	7	curcumin	AKT	PA151958596	207	0.956
NULL	Br_J_Cancer_1996_Jul_74(1)_78-85.nxml.txt.nlp	8679463	SENT12	35	35	2	2	cyclophosphamide	Bcl-2	PA449165	596	0.956
NULL	J_Res_Pharm_Pract_2013_Oct-Dec_2(4)_156-161.nxml.txt.nlp	24991625	SENT126	22	22	36	36	imatinib	IFN	PA10804	3439	0.956
NULL	Br_J_Clin_Pharmacol_2014_Nov_20_78(5)_1043-1049.nxml.txt.nlp	24838177	SENT163	28	28	26	26	atazanavir	UGT1A1	PA10251	54658	0.956
NULL	Breast_Cancer_Res_2009_Oct_28_11(5)_211.nxml.txt.nlp	19889200	SENT150	23	23	7	7	anastrozole	PTH	PA448432	5741	0.956
NULL	Front_Physiol_2013_May_15_4_103.nxml.txt.nlp	23720630	SENT142	15	15	3	3	l-carnitine	Q10	PA450154	27161	0.956
NULL	Mol_Biol_Cell_2014_Jan_1_25(1)_145-159.nxml.txt.nlp	24196833	SENT450	30	30	7	7	paraformaldehyde	Fis1	PA450790	51024	0.956
NULL	Nat_Commun_2013_Apr_16_4_1706.nxml.txt.nlp	23591873	SENT226	29	29	9	9	paraformaldehyde	CXCL12	PA450790	6387	0.956
NULL	Exp_Diabetes_Res_2012_May_28_2012_924168.nxml.txt.nlp	22693487	SENT21	0	0	4	4	liraglutide	GLP-1	PA165958364	100125288	0.956
NULL	Arthritis_Res_Ther_2011_Jun_20_13(3)_R94.nxml.txt.nlp	21689401	SENT86	30	30	17	17	infliximab	GDA	PA452639	8034;9615	0.956
NULL	Asia_Pac_Allergy_2013_Oct_31_3(4)_231-240.nxml.txt.nlp	24260728	SENT6	0	0	12	12	theophylline	CYP2E1	PA451647	1571	0.956
NULL	J_Thromb_Haemost_2014_Jun_10_12(6)_987-998.nxml.txt.nlp	24655807	SENT18	8	8	27	27	calcein	P2X1	PA132595336	5023	0.956
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_3_2012_856029.nxml.txt.nlp	23091559	SENT385	11	11	0	0	paclitaxel	PC-3	PA450761	692094	0.956
NULL	Anesthesiol_Res_Pract_2011_Jul_12_2011_124898.nxml.txt.nlp	21776253	SENT100	8	8	0	0	capsaicin	TRPV1	PA448776	7442	0.956
NULL	Br_J_Cancer_1999_Nov_81(6)_942-951.nxml.txt.nlp	10576649	SENT8	24	24	8	8	verapamil	P-gp	PA451868	5243	0.956
NULL	Croat_Med_J_2012_Jun_53(3)_214-223.nxml.txt.nlp	22661134	SENT95	28	28	14	14	yohimbine	ACTH	PA451946	5443	0.956
NULL	Cardiovasc_Diabetol_2013_May_4_12_73.nxml.txt.nlp	23642288	SENT140	19	19	41	41	acarbose	GLP-1	PA448010	100125288	0.956
NULL	Ann_Rheum_Dis_2012_Sep_71(9)_1510-1516.nxml.txt.nlp	22440821	SENT99	18	18	2	2	adalimumab	adiponectin	PA10004	9370	0.956
NULL	J_Biol_Eng_2009_Oct_16_3_18.nxml.txt.nlp	19835592	SENT62	3	3	11	11	tetracycline	CPZ	PA451640	8532	0.956
NULL	Mol_Syst_Biol_2010_Jul_27_6_392.nxml.txt.nlp	20664638	SENT338	23	23	20	20	rimonabant	CB1	PA152407999	1268	0.956
NULL	Support_Care_Cancer_2014_Oct_19_22(2)_469-477.nxml.txt.nlp	24141698	SENT36	17	17	30	30	cyclophosphamide	HEC	PA449165	10403	0.956
NULL	Chin_J_Cancer_2012_Feb_31(2)_100-109.nxml.txt.nlp	22237039	SENT94	7	7	31	31	paclitaxel	Bcl-2	PA450761	596	0.956
NULL	Front_Oncol_2013_Aug_5_3_201.nxml.txt.nlp	23936765	SENT283	0	0	3	3	staurosporine	RSK1	PA165109623	6195	0.956
NULL	Ecancermedicalscience_2009_Sep_24_3_153.nxml.txt.nlp	22276017	SENT60	21	21	16	16	oxaliplatin	ERCC1	PA131285527	2067	0.956
NULL	Curr_Neuropharmacol_2012_Jun_10(2)_97-123.nxml.txt.nlp	23204981	SENT199	9	9	14	14	reboxetine	IL-6	PA144614921	3569	0.956
NULL	Breast_Cancer_Res_2011_Jan_28_13(1)_R11.nxml.txt.nlp	21276249	SENT326	9	9	7	7	anastrozole	aromatase	PA448432	1588	0.956
NULL	Int_J_Mol_Sci_2012_Sep_6_13(9)_11102-11129.nxml.txt.nlp	23109841	SENT76	37	37	8	8	methotrexate	EPO	PA450428	7076;8288;2056	0.956
NULL	Sensors_(Basel)_2010_Jan_12_10(1)_526-543.nxml.txt.nlp	22315554	SENT771	12	12	26	26	benzphetamine	2B4	PA448586	51744	0.956
NULL	Breast_Cancer_Res_2004_Nov_7_6(1)_39-52.nxml.txt.nlp	14680484	SENT160	32	32	15	15	tamoxifen	N-CoR	PA451581	9611	0.956
NULL	Emerg_Infect_Dis_2013_Jan_19(1)_21-28.nxml.txt.nlp	23260763	SENT147	14	14	6	6	pentamidine	DHPS	PA450850	1725	0.956
NULL	J_Occup_Med_Toxicol_2008_Feb_27_3(Suppl_1)_S6.nxml.txt.nlp	18315837	SENT80	3	3	10	10	theophylline	CD4	PA451647	920	0.956
NULL	J_Cell_Biol_2000_Aug_7_150(3)_475-488.nxml.txt.nlp	10931861	SENT163	7	7	18	18	trypsin	GM130	PA451806	2801	0.956
NULL	Front_Oncol_2014_Sep_23_4_264.nxml.txt.nlp	25295231	SENT245	28	28	18	18	azacitidine	TP53	PA451996	7157	0.956
NULL	Br_J_Cancer_2013_May_14_108(9)_1862-1869.nxml.txt.nlp	23579219	SENT136	5	5	29	29	cetuximab	KRAS	PA10040	3845	0.956
NULL	Clin_Pediatr_Endocrinol_2004_Jul_7_13(1)_37-46.nxml.txt.nlp	24790296	SENT154	11	11	15	15	thyroglobulin	TPO	PA164754910	7066;7173	0.956
NULL	Breast_Cancer_Res_2007_Dec_18_9(6)_216.nxml.txt.nlp	18190723	SENT7	0	0	20	20	bevacizumab	VEGF-A	PA130232992	7422	0.956
NULL	J_Neuroinflammation_2011_Feb_4_8_10.nxml.txt.nlp	21294877	SENT18	17	17	32	32	capsaicin	TAC1	PA448776	6863	0.956
NULL	Can_J_Infect_Dis_Med_Microbiol_2014_May-Jun_25(3)_155-158.nxml.txt.nlp	25285112	SENT87	33	33	17	17	cefuroxime	TMP	PA448868	2012	0.956
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT118	5	5	0	0	cisplatin	IBP	PA449014	706;50619	0.956
NULL	J_Cell_Biol_2004_Apr_26_165(2)_167-173.nxml.txt.nlp	15096522	SENT115	29	29	16	16	trypsin	DHFR	PA451806	1719	0.956
NULL	Exp_Diabetes_Res_2010_Feb_17_2010_686734.nxml.txt.nlp	21403818	SENT129	7	7	4	4	pimozide	5-HT7	PA450965	3363	0.956
NULL	J_Gynecol_Oncol_2013_Jul_4_24(3)_273-279.nxml.txt.nlp	23875078	SENT118	9	9	2	2	paclitaxel	COX	PA450761	1351	0.956
NULL	J_Cancer_2014_Jan_28_5(3)_173-181.nxml.txt.nlp	24563672	SENT46	8	8	11	11	letrozole	aromatase	PA450196	1588	0.956
NULL	Mol_Brain_2013_May_1_6_21.nxml.txt.nlp	23634821	SENT29	30	30	8	8	pilocarpine	CA1	PA450962	759	0.956
NULL	BMB_Rep_2014_Jul_47(7)_376-381.nxml.txt.nlp	24286332	SENT3	29	29	6	6	thrombin	PPG	PA451674	5552	0.956
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Jul_13_69(Pt_8)_o1242.nxml.txt.nlp	24109332	SENT55	0	0	42	42	indomethacin	COX	PA449982	1351	0.956
NULL	Ther_Clin_Risk_Manag_2006_Dec_2(4)_389-400.nxml.txt.nlp	18360651	SENT163	3	3	21	21	infliximab	IMPACT	PA452639	55364	0.956
NULL	Mol_Cancer_2010_Jun_25_9_166.nxml.txt.nlp	20579378	SENT214	29	29	16	16	gefitinib	p53	PA131301952	7157	0.956
NULL	Br_J_Cancer_2012_May_8_106(10)_1587-1590.nxml.txt.nlp	22568998	SENT26	32	32	10	10	sunitinib	IFN	PA162372840	3439	0.956
NULL	Int_J_Mol_Sci_2012_Feb_10_13(2)_1886-1918.nxml.txt.nlp	22408430	SENT250	21	21	1	1	sorafenib	PI3K	PA7000	5290	0.956
NULL	Ann_Rheum_Dis_2014_Jun_6_73(6)_1052-1059.nxml.txt.nlp	23831963	SENT160	2	2	14	14	hydroxychloroquine	IFN	PA164777036	3439	0.956
NULL	Cancers_(Basel)_2011_May_3_3(2)_2255-2273.nxml.txt.nlp	24212808	SENT106	26	26	16	16	cetuximab	HER-2	PA10040	2064	0.956
NULL	Open_Access_J_Urol_2011_May_10_3_69-82.nxml.txt.nlp	24198638	SENT69	14	14	2	2	sorafenib	CYP3A4	PA7000	1576	0.956
NULL	Osteoporos_Int_2011_Jun_12_22(6)_1935-1946.nxml.txt.nlp	20938767	SENT175	15	15	17	17	teriparatide	PTH	PA451620	5741	0.956
NULL	Acta_Pharmacol_Sin_2011_Jul_9_32(7)_879-887.nxml.txt.nlp	21552292	SENT111	11	11	37	37	metformin	AMPK	PA450395	5563	0.956
NULL	Hum_Mol_Genet_2013_Nov_15_22(22)_4602-4615.nxml.txt.nlp	23814040	SENT144	4	4	21	21	l-cysteine	COX	PA449173	1351	0.956
NULL	Core_Evid_2010_Oct_21_5_77-90.nxml.txt.nlp	21042544	SENT45	6	6	3	3	aprepitant	NK1	PA164747039	11126	0.956
NULL	Mol_Cancer_2013_Mar_2_12_16.nxml.txt.nlp	23452820	SENT127	33	33	13	13	chloroquine	Bcl-2	PA448948	596	0.956
NULL	J_Gynecol_Oncol_2013_Jan_8_24(1)_66-82.nxml.txt.nlp	23346316	SENT270	5	5	24	24	exemestane	aromatase	PA449563	1588	0.956
NULL	Endocrinol_Diabetes_Metab_Case_Rep_2014_Mar_1_2014_140001.nxml.txt.nlp	24683487	SENT18	17	17	6	6	metyrapone	ACTH	PA450486	5443	0.956
NULL	J_Cell_Biol_1998_Nov_16_143(4)_973-990.nxml.txt.nlp	9817755	SENT325	27	27	34	34	chloroquine	TGN	PA448948	7038	0.956
NULL	Curr_Hepat_Rep_2010_May_21_9(2)_75-90.nxml.txt.nlp	20461127	SENT253	27	27	20	20	telbivudine	LAM	PA164760861	7249;7248	0.956
NULL	Oncotarget_2011_Mar_28_2(3)_109-112.nxml.txt.nlp	21487160	SENT36	13	13	6	6	paclitaxel	p53	PA450761	7157	0.956
NULL	Blood_Res_2014_Sep_25_49(3)_148-153.nxml.txt.nlp	25325033	SENT47	31	31	15	15	doxorubicin	B2M	PA449412	567	0.956
NULL	Cancer_Med_2014_Jun_29_3(3)_526-536.nxml.txt.nlp	24687970	SENT30	24	24	2	2	lapatinib	HER2	PA152241907	2064	0.956
NULL	Neural_Plast_2007_Sep_19_2007_26496.nxml.txt.nlp	18301726	SENT113	2	2	26	26	fluoxetine	TIEG1	PA449673	7071	0.956
NULL	Anat_Cell_Biol_2010_Sep_30_43(3)_194-200.nxml.txt.nlp	21212859	SENT86	21	21	9	9	ethanol	PLP	PA448073	25824;5744	0.956
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT162	0	0	10	10	metformin	ADP	PA450395	23038	0.956
NULL	J_Interv_Card_Electrophysiol_2013_Apr_14_37(3)_223-231.nxml.txt.nlp	23585240	SENT76	30	30	12	12	protamine	ACT	PA10366	12;11332;9457;641455	0.956
NULL	Cell_Death_Differ_2010_Oct_30_17(10)_1624-1635.nxml.txt.nlp	20431602	SENT107	32	32	22	22	paclitaxel	Bcl-2	PA450761	596	0.956
NULL	Indian_J_Med_Res_2014_Feb_139(2)_205-215.nxml.txt.nlp	24718394	SENT105	8	8	37	37	artemisinin	ACT	PA165111696	12;11332;9457;641455	0.956
NULL	Sci_Rep_2014_Nov_28_4_7237.nxml.txt.nlp	25429875	SENT121	12	12	38	38	hesperidin	JNK	PA449867	5599	0.956
NULL	Blood_Cancer_J_2013_Mar_1_3(3)_e103.nxml.txt.nlp	23454896	SENT149	37	37	10	10	lopinavir	AKT	PA450264	207	0.956
NULL	Arthritis_Res_Ther_2013_Dec_3_15(6)_R205.nxml.txt.nlp	24295447	SENT173	12	12	25	25	infliximab	OPG	PA452639	690	0.956
NULL	Int_J_Mol_Sci_2013_Apr_10_14(4)_7742-7756.nxml.txt.nlp	23574936	SENT161	22	22	2	2	paclitaxel	CERT	PA450761	10087	0.956
NULL	Mol_Cancer_2013_Sep_11_12_104.nxml.txt.nlp	24025152	SENT149	13	13	0	0	gemcitabine	STAT3	PA449748	6774	0.956
NULL	Braz_J_Med_Biol_Res_2014_Sep_5_47(11)_929-939.nxml.txt.nlp	25296354	SENT171	25	25	2	2	gefitinib	EGFR	PA131301952	1956	0.956
NULL	Front_Immunol_2013_Oct_4_4_312.nxml.txt.nlp	24109479	SENT183	7	7	11	11	maraviroc	CCR5	PA164768835	1234	0.956
NULL	Cardiovasc_Diabetol_2013_Mar_18_12_46.nxml.txt.nlp	23497197	SENT18	7	7	31	31	metformin	adiponectin	PA450395	9370	0.956
NULL	Chin_J_Cancer_2012_Jun_31(6)_306-314.nxml.txt.nlp	22640627	SENT161	11	11	29	29	rituximab	Bcl-2	PA451261	596	0.956
NULL	Emerg_Infect_Dis_2011_Mar_17(3)_432-440.nxml.txt.nlp	21392434	SENT117	10	10	34	34	isoniazid	DST	PA450112	667	0.956
NULL	Front_Physiol_2014_Dec_11_5_479.nxml.txt.nlp	25566082	SENT100	24	24	38	38	vasopressin	UCP1	PA451858	7350	0.956
NULL	Oncotarget_2014_Sep_9_5(20)_9811-9822.nxml.txt.nlp	25238146	SENT24	4	4	15	15	bevacizumab	VEGF-A	PA130232992	7422	0.956
NULL	Diabetes_Care_2009_Apr_32(4)_531-540.nxml.txt.nlp	19336638	SENT18	7	7	27	27	ticlopidine	ADP	PA451686	23038	0.956
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_O5.nxml.txt.nlp	NULL	SENT14	7	7	33	33	vancomycin	IFN	PA451850	3439	0.956
NULL	Clin_Med_Insights_Case_Rep_2011_Dec_4_4_73-77.nxml.txt.nlp	22174593	SENT69	9	9	1	1	warfarin	VKORC1	PA451906	79001	0.956
NULL	Ann_Oncol_2011_Mar_8_22(3)_503-514.nxml.txt.nlp	20616198	SENT210	15	15	4	4	letrozole	aromatase	PA450196	1588	0.956
NULL	J_Immunother_Cancer_2014_Jan_27_2_2.nxml.txt.nlp	24829759	SENT169	9	9	40	40	sorafenib	IFN	PA7000	3439	0.956
NULL	Int_J_Inflam_2010_Nov_25_2010_910283.nxml.txt.nlp	21151692	SENT135	15	15	0	0	trypsin	HD-5	PA451806	1670	0.956
NULL	Clin_Interv_Aging_2012_Dec_30_7_1-13.nxml.txt.nlp	22291468	SENT137	13	13	8	8	verapamil	CYP3A4	PA451868	1576	0.956
NULL	Mol_Pain_2013_May_20_9_25.nxml.txt.nlp	23688027	SENT188	9	9	0	0	capsaicin	TRPV1	PA448776	7442	0.956
NULL	Cell_Death_Dis_2014_Feb_13_5(2)_e1055.nxml.txt.nlp	24525731	SENT123	46	46	2	2	cisplatin	XRCC1	PA449014	7515	0.956
NULL	J_Cell_Biol_1988_Feb_1_106(2)_385-393.nxml.txt.nlp	2448313	SENT6	36	36	1	1	chymotrypsin	CG1	PA448994	11097;10046;3895	0.956
NULL	Acta_Pharmacol_Sin_2011_Aug_11_32(8)_999-1008.nxml.txt.nlp	21743486	SENT153	4	4	9	9	fasudil	JNK	PA165946121	5599	0.956
NULL	J_Ind_Microbiol_Biotechnol_2013_Jul_30_40(10)_1153-1160.nxml.txt.nlp	23896974	SENT29	31	31	1	1	ethanol	GPD1	PA448073	2819	0.956
NULL	ScientificWorldJournal_2013_Dec_31_2013_837573.nxml.txt.nlp	24501586	SENT156	8	8	19	19	pamidronate	PTH	PA450767	5741	0.956
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT6	45	45	7	7	tacrolimus	STAT3	PA451578	6774	0.956
NULL	Acta_Pharmacol_Sin_2009_Sep_24_30(9)_1262-1275.nxml.txt.nlp	19701231	SENT229	24	24	12	12	lovastatin	PLK4	PA450272	10733	0.956
NULL	Neural_Plast_2007_Sep_19_2007_26496.nxml.txt.nlp	18301726	SENT106	15	15	8	8	fluoxetine	TIEG1	PA449673	7071	0.956
NULL	Cardiol_Ther_2013_Dec_6_2(2)_135-149.nxml.txt.nlp	25135392	SENT160	1	1	10	10	warfarin	SPAF	PA451906	166378	0.956
NULL	Oncotarget_2012_Nov_8_3(11)_1472-1482.nxml.txt.nlp	23178531	SENT6	1	1	27	27	iron	IRP1	PA450087	48	0.956
NULL	Environ_Health_Perspect_2005_Aug_15_113(8)_1009-1014.nxml.txt.nlp	16079071	SENT117	14	14	10	10	losartan	p38	PA450268	10598;1432;7965	0.956
NULL	EMBO_Mol_Med_2012_Dec_15_4(12)_1276-1293.nxml.txt.nlp	23065753	SENT187	18	18	0	0	cisplatin	HK-1	PA449014	255061	0.956
NULL	Mol_Cancer_2012_Apr_26_11_24.nxml.txt.nlp	22537161	SENT138	28	28	41	41	pp2	MUC4		4585	0.956
NULL	Oncoimmunology_2012_Dec_1_1(9)_1661-1663.nxml.txt.nlp	23264929	SENT26	20	20	5	5	imiquimod	IFN	PA449972	3439	0.956
NULL	Neural_Regen_Res_2013_Mar_25_8(9)_825-832.nxml.txt.nlp	25206730	SENT9	11	11	4	4	isoflurane	P2X7	PA450106	5027	0.956
NULL	Br_J_Cancer_2012_Nov_20_107(11)_1815-1819.nxml.txt.nlp	23099804	SENT21	15	15	11	11	tamoxifen	aromatase	PA451581	1588	0.956
NULL	AAPS_J_2014_Jan_8_16(2)_226-239.nxml.txt.nlp	24399240	SENT211	5	5	8	8	sotalol	BCS	PA451457	617	0.956
NULL	Oncotarget_2014_Sep_16_5(20)_9980-9991.nxml.txt.nlp	25296971	SENT143	31	31	17	17	oxaliplatin	E2F1	PA131285527	1869	0.956
NULL	Front_Cell_Neurosci_2014_Jul_18_8_185.nxml.txt.nlp	25100946	SENT381	16	16	0	0	pp2	Isl-1		3670	0.956
NULL	Pharmaceuticals_(Basel)_2012_Aug_10_5(8)_802-836.nxml.txt.nlp	24280676	SENT90	34	34	16	16	ribavirin	CNT1	PA451241	9154	0.956
NULL	Cell_Commun_Signal_2013_Apr_16_11_25.nxml.txt.nlp	23590831	SENT63	20	20	8	8	etoposide	USP34	PA449552	9736	0.956
NULL	Diabetes_Obes_Metab_2010_Aug_12(8)_700-708.nxml.txt.nlp	20590747	SENT189	17	17	4	4	vildagliptin	PPG	PA165958346	5552	0.956
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT121	20	20	3	3	dasatinib	ABCG2	PA162372878	9429	0.956
NULL	Cardiovasc_Diabetol_2013_May_30_12(Suppl_1)_S2.nxml.txt.nlp	23819752	SENT129	1	1	10	10	lovastatin	CYP3A4	PA450272	1576	0.956
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT68	24	24	7	7	cytarabine	ABCC10	PA449177	89845	0.956
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1699-1708.nxml.txt.nlp	19861960	SENT191	24	24	13	13	dasatinib	Yes	PA162372878	7525	0.956
NULL	Cancers_(Basel)_2011_Oct_13_3(4)_3856-3893.nxml.txt.nlp	24213115	SENT86	35	35	8	8	bevacizumab	IFN	PA130232992	3439	0.956
NULL	Int_J_Nanomedicine_2012_Sep_13_7_4917-4926.nxml.txt.nlp	23028220	SENT224	35	35	7	7	calcein	mol	PA132595336	90527	0.956
NULL	Anal_Chem_2014_Feb_4_86(3)_1845-1852.nxml.txt.nlp	24383576	SENT8	40	40	14	14	taurine	HCN	PA451590	378938	0.956
NULL	Oncotarget_2014_May_27_5(19)_9049-9064.nxml.txt.nlp	24979294	SENT23	11	11	21	21	dasatinib	IGF1R	PA162372878	3480	0.956
NULL	Indian_J_Endocrinol_Metab_2015_Jan-Feb_19(1)_30-38.nxml.txt.nlp	25593823	SENT97	13	13	19	19	pioglitazone	adiponectin	PA450970	9370	0.956
NULL	Case_Rep_Med_2010_Jun_17_2010_472389.nxml.txt.nlp	20589221	SENT10	17	17	28	28	tetracaine	BCHE	PA451638	590	0.956
NULL	Front_Neurosci_2014_Jan_10_7_270.nxml.txt.nlp	24454277	SENT57	27	27	14	14	ethanol	SIRT1	PA448073	23411	0.956
NULL	Acta_Neuropathol_Commun_2013_May_20_1_17.nxml.txt.nlp	24252689	SENT58	20	20	4	4	celecoxib	CD36	PA448871	948	0.956
NULL	Breast_Cancer_Res_2000_Mar_12_2(Suppl_1)_P2_03.nxml.txt.nlp	NULL	SENT5	22	22	7	7	estradiol	HES-1	PA449503	3280	0.956
NULL	Br_J_Cancer_2012_Apr_10_106(8)_1367-1373.nxml.txt.nlp	22454081	SENT16	4	4	18	18	trastuzumab	EGFR	PA451743	1956	0.956
NULL	Ann_Rheum_Dis_2013_Apr_21_72(4)_482-492.nxml.txt.nlp	23172750	SENT215	4	4	16	16	isoniazid	IL-6	PA450112	3569	0.956
NULL	Cardiol_Res_Pract_2013_Feb_19_2013_195456.nxml.txt.nlp	23533940	SENT32	7	7	13	13	ticlopidine	P2Y12	PA451686	64805	0.956
NULL	Front_Neurosci_2014_Dec_8_8_388.nxml.txt.nlp	25538545	SENT154	28	28	16	16	estradiol	aromatase	PA449503	1588	0.956
NULL	Nucleic_Acids_Res_2005_Jun_8_33(10)_3283-3291.nxml.txt.nlp	15944449	SENT118	23	23	16	16	sjg-136	XRCC3		7517	0.956
NULL	Front_Neurosci_2010_Jun_17_4_35.nxml.txt.nlp	20661455	SENT100	31	31	15	15	forskolin	5-HT1A	PA146096022	3350	0.956
NULL	J_Radiat_Res_2012_Jul_12_53(4)_551-557.nxml.txt.nlp	22843620	SENT135	23	23	30	30	genistein	P2X7	PA165109660	5027	0.956
NULL	Thorax_2014_Jun_10_69(6)_558-564.nxml.txt.nlp	24613990	SENT8	36	36	45	45	methacholine	GSTT1	PA165958382	2952	0.956
NULL	J_Immunother_Cancer_2014_Nov_6_2(Suppl_3)_P210.nxml.txt.nlp	NULL	SENT5	0	0	16	16	curcumin	STAT3	PA151958596	6774	0.956
NULL	Diabetes_Metab_J_2012_Aug_20_36(4)_293-299.nxml.txt.nlp	22950061	SENT121	9	9	40	40	metformin	NPY	PA450395	4852	0.956
NULL	Front_Mol_Neurosci_2014_Nov_4_7_83.nxml.txt.nlp	25414638	SENT319	9	9	2	2	estradiol	AKT	PA449503	207	0.956
NULL	Cancer_Immunol_Immunother_2013_Aug_27_62(10)_1637-1648.nxml.txt.nlp	23982484	SENT238	6	6	18	18	lenalidomide	STAT3	PA162363968	6774	0.956
NULL	FASEB_J_2011_Apr_25(4)_1133-1144.nxml.txt.nlp	21163859	SENT272	0	0	17	17	imipramine	ASM	PA449969	6609;283120	0.956
NULL	Cerebrospinal_Fluid_Res_2010_Aug_13_7_13.nxml.txt.nlp	20707896	SENT4	7	7	33	33	vasopressin	AVP	PA451858	114548;551	0.956
NULL	Cancer_Immunol_Immunother_2014_Sep_4_63(12)_1297-1306.nxml.txt.nlp	25186613	SENT232	14	14	1	1	ns-398	COX		1351	0.956
NULL	Oncologist_2010_May_28_15(5)_436-446.nxml.txt.nlp	20427383	SENT168	0	0	15	15	pazopanib	KIT	PA165291492	3815	0.956
NULL	Oncol_Lett_2014_Mar_19_7(3)_674-678.nxml.txt.nlp	24527071	SENT7	19	19	26	26	cisplatin	AKR1C2	PA449014	1646	0.956
NULL	J_Cancer_2012_Jul_6_3_310-321.nxml.txt.nlp	22866165	SENT217	15	15	29	29	estradiol	CYP1A1	PA449503	1543	0.956
NULL	Cancer_Cell_Int_2011_Dec_29_11_44.nxml.txt.nlp	22206574	SENT175	18	18	20	20	sorafenib	c-Raf	PA7000	5894	0.956
NULL	Colorectal_Dis_2012_Feb_14(2)_e31-e47.nxml.txt.nlp	21848897	SENT136	4	4	18	18	cetuximab	KRAS	PA10040	3845	0.956
NULL	Acta_Pharmacol_Sin_2010_Jul_28_31(7)_798-804.nxml.txt.nlp	20581852	SENT7	28	28	19	19	phenylephrine	AMPK	PA450935	5563	0.956
NULL	Oncotarget_2014_Jun_7_5(13)_4990-5001.nxml.txt.nlp	24970801	SENT24	0	0	29	29	everolimus	AKT	PA164746311	207	0.956
NULL	Front_Neurol_2014_May_20_5_78.nxml.txt.nlp	24904522	SENT60	30	30	8	8	apomorphine	5-HT1A	PA164781163	3350	0.956
NULL	Mol_Cancer_2007_Oct_11_6_63.nxml.txt.nlp	17931419	SENT82	6	6	42	42	cetuximab	EGFR	PA10040	1956	0.956
NULL	J_Breast_Cancer_2013_Dec_31_16(4)_386-394.nxml.txt.nlp	24454460	SENT110	17	17	3	3	letrozole	p53	PA450196	7157	0.956
NULL	Biosci_Rep_2013_Nov_25_33(6)_e00081.nxml.txt.nlp	24070327	SENT255	27	27	15	15	imatinib	LRPPRC	PA10804	10128	0.956
NULL	Front_Neurol_2014_Sep_11_5_173.nxml.txt.nlp	25309501	SENT27	0	0	42	42	hyaluronan	HAS1	PA165958431	3036	0.956
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S31-S40.nxml.txt.nlp	20680106	SENT40	11	11	20	20	panitumumab	KRAS	PA162373091	3845	0.956
NULL	Mol_Cytogenet_2010_Oct_19_3_20.nxml.txt.nlp	20959006	SENT233	20	20	6	6	doxorubicin	p53	PA449412	7157	0.956
NULL	Cell_Death_Dis_2010_Oct_21_1(10)_e86.nxml.txt.nlp	21368859	SENT62	22	22	9	9	doxorubicin	JNK	PA449412	5599	0.956
NULL	Br_J_Cancer_2013_Sep_3_109(5)_1214-1222.nxml.txt.nlp	23922104	SENT172	17	17	9	9	nutlin-3	p53		7157	0.956
NULL	Case_Rep_Oncol_2014_Jan_31_7(1)_97-101.nxml.txt.nlp	24575024	SENT60	40	40	43	43	topotecan	EGFR	PA451729	1956	0.956
NULL	Br_J_Clin_Pharmacol_2013_Aug_23_76(2)_299-315.nxml.txt.nlp	23701319	SENT240	8	8	13	13	daclizumab	IL-2	PA164764446	3558	0.956
NULL	Environ_Health_Perspect_2005_Aug_15_113(8)_1009-1014.nxml.txt.nlp	16079071	SENT102	16	16	10	10	losartan	p38	PA450268	10598;1432;7965	0.956
NULL	Evid_Based_Complement_Alternat_Med_2014_May_21_2014_707908.nxml.txt.nlp	25628748	SENT33	10	10	3	3	ethanol	flower	PA448073	11094	0.956
NULL	Oncotarget_2012_Aug_10_3(8)_744-758.nxml.txt.nlp	22889873	SENT97	30	30	21	21	erlotinib	AKT	PA134687924	207	0.956
NULL	Eur_J_Haematol_2014_Feb_25_92(2)_127-136.nxml.txt.nlp	24118452	SENT212	15	15	7	7	anagrelide	CRT	PA164742986	811	0.956
NULL	Mol_Brain_2014_Mar_5_7_15.nxml.txt.nlp	24594013	SENT328	34	34	17	17	l-glutamine	CO2	PA10090	4513	0.956
NULL	Cell_Death_Dis_2013_Sep_19_4(9)_e807.nxml.txt.nlp	24052075	SENT63	13	13	21	21	doxorubicin	p53	PA449412	7157	0.956
NULL	Front_Behav_Neurosci_2014_Dec_16_8_437.nxml.txt.nlp	25566005	SENT498	3	3	7	7	nicotine	CRF1	PA450626	1394	0.956
NULL	Biologics_2010_Aug_9_4_187-197.nxml.txt.nlp	20714356	SENT83	9	9	19	19	sunitinib	IFN	PA162372840	3439	0.956
NULL	Cardiovasc_Psychiatry_Neurol_2009_Sep_9_2009_969752.nxml.txt.nlp	20029636	SENT100	11	11	9	9	entacapone	COMT	PA164748726	1312	0.956
NULL	Nucleic_Acids_Res_2010_Oct_22_38(19)_6502-6512.nxml.txt.nlp	20571088	SENT264	7	7	20	20	galactose	SMC6	PA449725	79677	0.956
NULL	Int_J_Biol_Sci_2013_Mar_7_9(3)_279-288.nxml.txt.nlp	23493630	SENT114	40	40	14	14	tocilizumab	CD14	PA165292659	929	0.956
NULL	Gene_Regul_Syst_Bio_2014_Mar_4_8_63-73.nxml.txt.nlp	24634581	SENT9	0	0	15	15	minocycline	STAT3	PA450519	6774	0.956
NULL	Acta_Histochem_Cytochem_2010_May_1_43(2)_61-68.nxml.txt.nlp	20514293	SENT67	19	19	1	1	hyaluronan	CD44	PA165958431	960	0.956
NULL	Br_J_Clin_Pharmacol_2010_Dec_70(6)_807-814.nxml.txt.nlp	21175436	SENT26	0	0	5	5	liraglutide	GLP-1	PA165958364	100125288	0.956
NULL	Front_Mol_Neurosci_2012_Nov_12_5_99.nxml.txt.nlp	23162427	SENT265	29	29	5	5	cocaine	SIRT2	PA449072	22933	0.956
NULL	Biomed_Res_Int_2013_Sep_5_2013_929531.nxml.txt.nlp	24083250	SENT59	13	13	0	0	hyaluronan	HYAL2	PA165958431	8692	0.956
NULL	Breast_Cancer_(Auckl)_2009_Sep_2_3_61-75.nxml.txt.nlp	19809577	SENT130	18	18	3	3	curcumin	PARP	PA151958596	142	0.956
NULL	Core_Evid_2009_Jun_15_4_159-170.nxml.txt.nlp	20694072	SENT26	0	0	5	5	etanercept	p75	PA449515	7133;11168	0.956
NULL	Cell_Rep_2012_Feb_23_1(2)_99-109.nxml.txt.nlp	22832160	SENT94	18	18	30	30	doxycycline	Oct4	PA449415	5460	0.956
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT64	4	4	7	7	neratinib	HER2	PA165291472	2064	0.956
NULL	J_Lipid_Res_2015_Jan_56(1)_109-121.nxml.txt.nlp	25421061	SENT229	24	24	2	2	chymotrypsin	CGI-58	PA448994	51099	0.956
NULL	BMB_Rep_2014_Sep_47(9)_500-505.nxml.txt.nlp	24393525	SENT294	14	14	2	2	cisplatin	PER1	PA449014	93210;5187	0.956
NULL	eLife_2013_Oct_29_2_e01222.nxml.txt.nlp	24171103	SENT481	29	29	1	1	doxycycline	LBH	PA449415	81606;221491	0.956
NULL	Breast_Cancer_Res_2007_Dec_20_9(Suppl_2)_S19.nxml.txt.nlp	NULL	SENT33	21	21	14	14	letrozole	MYB	PA450196	4602	0.956
NULL	Neural_Plast_2013_Dec_26_2013_424651.nxml.txt.nlp	24455309	SENT16	16	16	1	1	hydroxocobalamin	B12	PA164768689	7126;4709	0.956
NULL	Case_Rep_Rheumatol_2011_Dec_15_2011_185657.nxml.txt.nlp	22937439	SENT57	34	34	0	0	etanercept	TNF-alpha	PA449515	7124	0.956
NULL	Cell_Death_Dis_2014_Mar_13_5(3)_e1113.nxml.txt.nlp	24625972	SENT112	43	43	17	17	bleomycin	BI-1	PA448645	7009	0.956
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Jul_21_9_20.nxml.txt.nlp	20663145	SENT84	11	11	16	16	tetracycline	LBH	PA451640	81606;221491	0.956
NULL	Case_Rep_Oncol_2014_Jul_23_7(2)_503-508.nxml.txt.nlp	25232318	SENT49	20	20	11	11	gefitinib	EGFR	PA131301952	1956	0.956
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1059-1066.nxml.txt.nlp	21364577	SENT125	17	17	7	7	anastrozole	ATAC	PA448432	6375	0.955
NULL	Breast_Cancer_Res_2007_Dec_17_9(6)_115.nxml.txt.nlp	18190722	SENT51	2	2	26	26	tamoxifen	aromatase	PA451581	1588	0.955
NULL	Evid_Based_Complement_Alternat_Med_2011_Mar_1_2011_207034.nxml.txt.nlp	21423686	SENT149	18	18	23	23	clopidogrel	CYP2C19	PA449053	1557	0.955
NULL	Oncotarget_2014_Jun_9_5(13)_5076-5086.nxml.txt.nlp	24970803	SENT27	26	26	4	4	temozolomide	PARP-1	PA451609	25976	0.955
NULL	Oncotarget_2013_Aug_9_4(9)_1332-1333.nxml.txt.nlp	23934763	SENT9	22	22	11	11	ponatinib	ABL1	PA165980594	25	0.955
NULL	Front_Neurosci_2013_Jan_31_7_3.nxml.txt.nlp	23386808	SENT15	21	21	26	26	capsaicin	TRPV4	PA448776	59341	0.955
NULL	EMBO_Mol_Med_2012_Aug_16_4(8)_743-760.nxml.txt.nlp	22593025	SENT200	13	13	6	6	docetaxel	EGFR	PA449383	1956	0.955
NULL	Oncotarget_2014_Nov_3_5(20)_10127-10139.nxml.txt.nlp	25333256	SENT156	19	19	3	3	vemurafenib	TRIM16	PA165946873	10626	0.955
NULL	Iran_J_Neurol_2013_12(4)_129-135.nxml.txt.nlp	24250922	SENT35	5	5	19	19	thrombin	B-50	PA451674	2596	0.955
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT91	26	26	5	5	pp2	PP2		4888	0.955
NULL	Blood_Cancer_J_2014_Aug_1_4(8)_e232.nxml.txt.nlp	25083816	SENT95	17	17	8	8	pioglitazone	HMGCR	PA450970	3156	0.955
NULL	Mol_Cancer_2010_May_26_9_121.nxml.txt.nlp	20500904	SENT101	19	19	39	39	doxycycline	HRG1	PA449415	55652	0.955
NULL	Br_J_Cancer_1999_Mar_79(7-8)_1104-1110.nxml.txt.nlp	10098743	SENT10	28	28	21	21	cisplatin	JNK	PA449014	5599	0.955
NULL	Breast_Cancer_(Auckl)_2012_Feb_20_6_47-66.nxml.txt.nlp	22399860	SENT172	4	4	12	12	tamoxifen	NAE1	PA451581	8883	0.955
NULL	Ayu_2011_Oct-Dec_32(4)_451-457.nxml.txt.nlp	22661835	SENT195	3	3	27	27	sildenafil	GMP	PA451346	22978	0.955
NULL	Arthritis_Res_Ther_2009_Oct_8_11(5)_R151.nxml.txt.nlp	19814819	SENT70	22	22	15	15	ethanol	CO2	PA448073	4513	0.955
NULL	Open_Biol_2014_Feb_4(2)_130217.nxml.txt.nlp	24522884	SENT279	16	16	5	5	thalidomide	CUL4A	PA451644	8451	0.955
NULL	J_Hematol_Oncol_2013_Jul_18_6_53.nxml.txt.nlp	23866964	SENT65	5	5	0	0	temsirolimus	MTOR	PA164746890	2475	0.955
NULL	Cell_Host_Microbe_2014_Sep_10_16(3)_291-303.nxml.txt.nlp	25211072	SENT554	31	31	36	36	genistein	PP2	PA165109660	4888	0.955
NULL	Oncoscience_2014_Jun_6_1(6)_423-426.nxml.txt.nlp	25594040	SENT30	23	23	6	6	imatinib	PI3K	PA10804	5290	0.955
NULL	Mol_Biol_Cell_2013_Jul_15_24(14)_2186-2200.nxml.txt.nlp	23699397	SENT263	45	45	28	28	staurosporine	TRAIL	PA165109623	8743	0.955
NULL	Breast_Cancer_Res_2004_Aug_5_6(5)_R601-R607.nxml.txt.nlp	15318941	SENT160	22	22	6	6	docetaxel	p27	PA449383	5715;10534	0.955
NULL	Cancer_Cell_Int_2013_May_15_13_42.nxml.txt.nlp	23672670	SENT185	14	14	0	0	paclitaxel	PIDD	PA450761	55367	0.955
NULL	Curr_Control_Trials_Cardiovasc_Med_2001_May_31_2(3)_129-140.nxml.txt.nlp	11806786	SENT89	10	10	26	26	enoxaparin	NICE-4	PA449463	9898	0.955
NULL	Br_J_Ophthalmol_2014_Aug_2_98(8)_1023-1027.nxml.txt.nlp	24695688	SENT30	2	2	13	13	tacrolimus	castor	PA451578	54897	0.955
NULL	Acta_Pharmacol_Sin_2009_Jul_22_30(7)_956-964.nxml.txt.nlp	19543298	SENT169	9	9	34	34	simvastatin	NPC1L1	PA451363	29881	0.955
NULL	Diabetes_Care_2011_Sep_19_34(9)_2108-2112.nxml.txt.nlp	21788628	SENT157	16	16	10	10	ramipril	DREAM	PA451223	30818	0.955
NULL	Breast_Cancer_Res_2010_Mar_5_12(2)_R16.nxml.txt.nlp	20205716	SENT300	16	16	6	6	lovastatin	RhoA	PA450272	387	0.955
NULL	Indian_J_Pharmacol_2013_Mar-Apr_45(2)_155-158.nxml.txt.nlp	23716892	SENT117	11	11	19	19	voriconazole	CYP2C19	PA10233	1557	0.955
NULL	Am_J_Trop_Med_Hyg_2012_Aug_1_87(2)_231-241.nxml.txt.nlp	22855752	SENT16	5	5	0	0	artemisinin	ACT	PA165111696	12;11332;9457;641455	0.955
NULL	J_Cell_Biol_2005_May_23_169(4)_681-691.nxml.txt.nlp	15911882	SENT80	14	14	7	7	heparin	MMP3	PA449855	4314	0.955
NULL	Br_J_Cancer_2011_Jan_4_104(1)_91-100.nxml.txt.nlp	21139584	SENT65	18	18	1	1	geldanamycin	Hsp90	PA152031327	3320	0.955
NULL	Chemother_Res_Pract_2012_Apr_11_2012_283181.nxml.txt.nlp	22567280	SENT287	20	20	2	2	hyaluronan	CD44	PA165958431	960	0.955
NULL	Br_J_Cancer_1990_Jan_61(1)_32-38.nxml.txt.nlp	2153395	SENT0	27	27	11	11	tamoxifen	pNR-2	PA451581	7031	0.955
NULL	Cancer_Med_2014_Dec_1_3(6)_1493-1501.nxml.txt.nlp	25081631	SENT33	12	12	10	10	erlotinib	EGFR	PA134687924	1956	0.955
NULL	Biomed_Res_Int_2013_Aug_7_2013_546318.nxml.txt.nlp	23986907	SENT98	0	0	31	31	gefitinib	BAX	PA131301952	581	0.955
NULL	Aging_(Albany_NY)_2010_Dec_31_2(12)_924-935.nxml.txt.nlp	21212465	SENT215	0	0	17	17	etoposide	p53	PA449552	7157	0.955
NULL	J_Korean_Med_Sci_2001_Apr_16(2)_135-139.nxml.txt.nlp	11306736	SENT13	10	10	29	29	etoposide	ADP	PA449552	23038	0.955
NULL	Cancer_Cell_Int_2010_Sep_9_10_32.nxml.txt.nlp	20828393	SENT133	13	13	1	1	cisplatin	ATF3	PA449014	467	0.955
NULL	Breast_Cancer_Res_2013_Nov_29_15(6)_R114.nxml.txt.nlp	24289103	SENT269	16	16	7	7	tamoxifen	EGFR	PA451581	1956	0.955
NULL	Nucl_Recept_Signal_2012_Feb_27_10_e003.nxml.txt.nlp	22438793	SENT232	10	10	3	3	estradiol	RALDH3	PA449503	220	0.955
NULL	Indian_J_Endocrinol_Metab_2012_Mar_16(Suppl1)_S79-S82.nxml.txt.nlp	22701852	SENT84	9	9	17	17	metformin	B12	PA450395	7126;4709	0.955
NULL	Br_J_Cancer_2011_Mar_15_104(6)_941-947.nxml.txt.nlp	21407223	SENT152	6	6	26	26	sorafenib	survivin	PA7000	332	0.955
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT117	3	3	11	11	bevacizumab	VEGFR1	PA130232992	2321	0.955
NULL	Br_J_Cancer_2006_Dec_4_95(11)_1504-1513.nxml.txt.nlp	17088902	SENT6	11	11	19	19	gefitinib	EGFR	PA131301952	1956	0.955
NULL	Cell_Death_Dis_2011_Aug_11_2(8)_e190.nxml.txt.nlp	21833028	SENT408	30	30	20	20	doxorubicin	JNK	PA449412	5599	0.955
NULL	Ther_Clin_Risk_Manag_2006_Mar_2(1)_115-125.nxml.txt.nlp	18360586	SENT171	3	3	19	19	buprenorphine	CYP3A4	PA448685	1576	0.955
NULL	Breast_Cancer_Res_2006_Jun_28_8(3)_R33.nxml.txt.nlp	16805920	SENT215	2	2	14	14	estradiol	EGFR	PA449503	1956	0.955
NULL	ScientificWorldJournal_2012_Jul_31_2012_475675.nxml.txt.nlp	22919323	SENT36	41	41	3	3	metformin	AMPK	PA450395	5563	0.955
NULL	Arthritis_Res_Ther_2014_Mar_11_16(2)_R65.nxml.txt.nlp	24612997	SENT200	7	7	0	0	valsartan	CCL18	PA451848	6362	0.955
NULL	Ann_Gen_Psychiatry_2008_Dec_23_7_27.nxml.txt.nlp	19105845	SENT139	21	21	29	29	bupropion	CD50	PA448687	3385	0.955
NULL	Oncogene_2013_Sep_26_32(39)_10_1038_onc_2012_491.nxml.txt.nlp	23108394	SENT237	31	31	15	15	epirubicin	FOXM1	PA449476	2305	0.955
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Mar_2_69(Pt_4)_o464-o465.nxml.txt.nlp	23634024	SENT11	31	31	6	6	ethanol	mol	PA448073	90527	0.955
NULL	AIDS_Res_Ther_2013_May_1_10_10.nxml.txt.nlp	23634877	SENT23	4	4	35	35	maraviroc	CXCR4	PA164768835	7852	0.955
NULL	Ann_Hematol_2010_Sep_13_89(9)_861-871.nxml.txt.nlp	20387067	SENT196	18	18	3	3	dasatinib	CD34	PA162372878	947	0.955
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_75-89.nxml.txt.nlp	17912638	SENT60	5	5	18	18	tamoxifen	ATAC	PA451581	6375	0.955
NULL	Diabetes_Care_2013_Aug_17_36(Suppl_2)_S139-S144.nxml.txt.nlp	23882038	SENT88	14	14	22	22	liraglutide	GLP-1	PA165958364	100125288	0.955
NULL	Child_Adolesc_Psychiatry_Ment_Health_2012_Jun_22_6_25.nxml.txt.nlp	22726236	SENT100	2	2	25	25	s-adenosylmethionine	MTHFR	PA164754994	4524	0.955
NULL	Front_Neurosci_2011_Jul_26_5_92.nxml.txt.nlp	21845173	SENT117	20	20	1	1	ketorolac	PAG	PA450150	55824	0.955
NULL	Front_Genet_2015_Jan_9_5_441.nxml.txt.nlp	25620975	SENT66	33	33	22	22	camptothecin	WRN	PA153590860	7486	0.955
NULL	Oncol_Lett_2013_Apr_28_5(4)_1305-1310.nxml.txt.nlp	23599784	SENT21	10	10	3	3	letrozole	aromatase	PA450196	1588	0.955
NULL	Ophthalmol_Eye_Dis_2011_Mar_16_3_1-6.nxml.txt.nlp	23861617	SENT36	11	11	1	1	proparacaine	PTK	PA164776849	2185	0.955
NULL	J_Biol_Chem_2013_Dec_6_288(49)_35387-35395.nxml.txt.nlp	24142790	SENT223	25	25	19	19	meclizine	PCYT2	PA450338	5833	0.955
NULL	Epigenetics_2012_Nov_1_7(11)_1225-1229.nxml.txt.nlp	23069641	SENT55	4	4	22	22	cisplatin	BRCA1	PA449014	672	0.955
NULL	Front_Immunol_2013_Nov_18_4_382.nxml.txt.nlp	24302925	SENT83	0	0	5	5	sunitinib	VEGFR	PA162372840	3791	0.955
NULL	Nucleic_Acids_Res_2010_Oct_21_38(18)_6148-6158.nxml.txt.nlp	20494979	SENT266	22	22	5	5	paclitaxel	HLJ1	PA450761	11080	0.955
NULL	Cardiovasc_Res_2011_Feb_15_89(3)_560-565.nxml.txt.nlp	20889759	SENT120	8	8	36	36	nitroprusside	ANOVA	PA451406	4858	0.955
NULL	Br_J_Cancer_2012_Nov_6_107(10)_1714-1721.nxml.txt.nlp	23073173	SENT96	1	1	32	32	bicalutamide	RUNX2	PA164746255	860	0.955
NULL	J_Hepatol_2013_Jan_58(1)_155-168.nxml.txt.nlp	22885388	SENT93	4	4	18	18	estradiol	MRP2	PA449503	100130958;57626;1244	0.955
NULL	J_Cell_Mol_Med_2014_Oct_11_18(10)_2031-2043.nxml.txt.nlp	25109475	SENT149	26	26	7	7	valsartan	LKB1	PA451848	6794	0.955
NULL	Exp_Ther_Med_2015_Jan_10_9(1)_267-271.nxml.txt.nlp	25452814	SENT26	29	29	15	15	clopidogrel	P-gp	PA449053	5243	0.955
NULL	Crit_Care_2008_Feb_2_12(1)_R11.nxml.txt.nlp	18252006	SENT172	0	0	19	19	vasopressin	ACTH	PA451858	5443	0.955
NULL	Breast_Cancer_Res_2007_Dec_20_9(Suppl_2)_S19.nxml.txt.nlp	NULL	SENT33	21	21	10	10	letrozole	STC2	PA450196	8614	0.955
NULL	Crit_Care_2003_Jun_26_7(6)_427-434.nxml.txt.nlp	14624682	SENT180	0	0	16	16	vasopressin	SON	PA451858	6651	0.955
NULL	Cancer_Cell_Int_2010_Jan_11_10_1.nxml.txt.nlp	20142996	SENT152	29	29	32	32	erlotinib	EGFR	PA134687924	1956	0.955
NULL	Nucleic_Acids_Res_2005_Oct_27_33(18)_6024-6033.nxml.txt.nlp	16254079	SENT230	11	11	2	2	bicalutamide	HDAC2	PA164746255	3066	0.955
NULL	Nat_Commun_2013_Aug_15_4_2130.nxml.txt.nlp	23945651	SENT46	19	19	12	12	etoposide	LC3	PA449552	84557	0.955
NULL	Front_Genet_2014_Aug_15_5_263.nxml.txt.nlp	25177341	SENT176	12	12	9	9	lapatinib	EGFR	PA152241907	1956	0.955
NULL	Neural_Regen_Res_2013_Jul_15_8(20)_1853-1862.nxml.txt.nlp	25206494	SENT178	30	30	5	5	ethanol	p53	PA448073	7157	0.955
NULL	Oxid_Med_Cell_Longev_2012_Aug_13_2012_741468.nxml.txt.nlp	22928085	SENT318	13	13	6	6	resveratrol	SIRT1		23411	0.955
NULL	Br_J_Cancer_2009_Oct_20_101(8)_1253-1260.nxml.txt.nlp	19755984	SENT8	42	42	38	38	letrozole	aromatase	PA450196	1588	0.955
NULL	Pharmaceuticals_(Basel)_2013_Apr_17_6(4)_557-578.nxml.txt.nlp	24276125	SENT57	0	0	16	16	ustekinumab	p40	PA166048654	3921;339541;10314	0.955
NULL	Eur_J_Endocrinol_2011_Jan_164(1)_69-74.nxml.txt.nlp	20961967	SENT4	13	13	5	5	pioglitazone	OPG	PA450970	690	0.955
NULL	Breast_Cancer_Res_2005_Jul_18_7(5)_187-189.nxml.txt.nlp	16168136	SENT16	34	34	19	19	tamoxifen	AKT	PA451581	207	0.955
NULL	ScientificWorldJournal_2014_Mar_17_2014_709801.nxml.txt.nlp	24778598	SENT61	1	1	10	10	rocuronium	NMT	PA164754992	4836	0.955
NULL	Indian_Dermatol_Online_J_2013_Jul-Sep_4(3)_246-249.nxml.txt.nlp	23984250	SENT38	43	43	26	26	capecitabine	EGFR	PA448771	1956	0.955
NULL	Br_J_Cancer_2010_Nov_2_103(11)_1671-1679.nxml.txt.nlp	21045835	SENT205	22	22	35	35	gemcitabine	CXCL12	PA449748	6387	0.955
NULL	Cancers_(Basel)_2010_Dec_30_3(1)_106-125.nxml.txt.nlp	24212609	SENT50	23	23	4	4	gemcitabine	MUC4	PA449748	4585	0.955
NULL	Hum_Genomics_2008_Sep_1_3(1)_7-16.nxml.txt.nlp	19129086	SENT30	14	14	34	34	rosiglitazone	CYP2C8	PA451283	1558	0.955
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT167	46	46	4	4	trastuzumab	STAT3	PA451743	6774	0.955
NULL	Case_Rep_Med_2009_Aug_9_2009_378287.nxml.txt.nlp	19721707	SENT49	29	29	25	25	tadalafil	CYP3A4	PA10333	1576	0.955
NULL	Mol_Cancer_2008_Mar_6_7_24.nxml.txt.nlp	18325101	SENT160	17	17	7	7	cisplatin	FANCD2	PA449014	2177	0.955
NULL	Int_J_Breast_Cancer_2011_Jul_3_2011_912102.nxml.txt.nlp	22295238	SENT21	32	32	26	26	letrozole	aromatase	PA450196	1588	0.955
NULL	Gut_Liver_2011_Jun_24_5(2)_160-164.nxml.txt.nlp	21814595	SENT106	1	1	33	33	midazolam	ESD	PA450496	2098	0.955
NULL	Drug_Des_Devel_Ther_2014_Oct_14_8_1839-1849.nxml.txt.nlp	25342883	SENT42	0	0	6	6	paclitaxel	Tech	PA450761	57449	0.955
NULL	Cancer_Cell_Int_2011_Jun_1_11_15.nxml.txt.nlp	21631944	SENT193	18	18	11	11	etoposide	MICA	PA449552	100507436	0.955
NULL	Arch_Med_Sci_2014_Aug_29_10(4)_684-691.nxml.txt.nlp	25276151	SENT163	7	7	24	24	dobutamine	CRT	PA449381	811	0.955
NULL	Cancer_Metastasis_Rev_2010_Dec_10_29(4)_581-594.nxml.txt.nlp	20830503	SENT26	23	23	13	13	exemestane	aromatase	PA449563	1588	0.955
NULL	Exp_Diabetes_Res_2012_Oct_15_2012_465282.nxml.txt.nlp	23118742	SENT8	31	31	8	8	metformin	AMPK	PA450395	5563	0.955
NULL	Cerebrospinal_Fluid_Res_2006_Dec_21_3_13.nxml.txt.nlp	17184532	SENT163	1	1	20	20	verapamil	FRG	PA451868	9855	0.955
NULL	Case_Rep_Oncol_2014_Sep_25_7(3)_669-672.nxml.txt.nlp	25408661	SENT62	4	4	8	8	aprepitant	CYP3A4	PA164747039	1576	0.955
NULL	Braz_J_Med_Biol_Res_2014_Oct_14_47(12)_1068-1074.nxml.txt.nlp	25387674	SENT53	16	16	32	32	carbachol	HCS	PA448784	3141;54205	0.955
NULL	Acta_Pharmacol_Sin_2014_Aug_30_35(8)_1045-1054.nxml.txt.nlp	24976155	SENT130	2	2	23	23	resveratrol	STAT3		6774	0.955
NULL	Acta_Pharmacol_Sin_2014_Jun_4_35(6)_846-852.nxml.txt.nlp	24902791	SENT3	0	0	15	15	lapatinib	HER2	PA152241907	2064	0.955
NULL	Oncogene_2014_Aug_21_33(34)_4316-4329.nxml.txt.nlp	24362530	SENT48	20	20	9	9	epirubicin	SUMO1	PA449476	7341	0.955
NULL	Front_Oncol_2013_Sep_23_3_250.nxml.txt.nlp	24069582	SENT114	3	3	22	22	letrozole	aromatase	PA450196	1588	0.955
NULL	J_Biol_Chem_2010_Aug_20_285(34)_25928-25940.nxml.txt.nlp	20547488	SENT30	17	17	31	31	cisplatin	p38	PA449014	10598;1432;7965	0.955
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT341	20	20	10	10	risperidone	PRL	PA451257	5617	0.955
NULL	Oncoimmunology_2012_Dec_1_1(9)_1658-1660.nxml.txt.nlp	23264928	SENT57	10	10	42	42	thalidomide	CD28	PA451644	1493;940	0.955
NULL	Int_J_Surg_Oncol_2011_Aug_8_2011_374012.nxml.txt.nlp	22312502	SENT162	10	10	17	17	tamoxifen	BRCA1	PA451581	672	0.955
NULL	Anat_Cell_Biol_2011_Sep_29_44(3)_169-175.nxml.txt.nlp	22025968	SENT56	14	14	2	2	ethanol	CLU	PA448073	1191	0.955
NULL	Hum_Genomics_2010_Apr_1_4(4)_238-249.nxml.txt.nlp	20511137	SENT121	23	23	10	10	etoposide	UGT1A1	PA449552	54658	0.955
NULL	Ann_Med_Health_Sci_Res_2013_Apr-Jun_3(2)_238-244.nxml.txt.nlp	23919197	SENT94	16	16	7	7	fluconazole	NAC	PA449653	22861	0.955
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT90	38	38	11	11	metformin	AKT	PA450395	207	0.955
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Apr_18_65(Pt_5)_o1065.nxml.txt.nlp	21583881	SENT57	4	4	39	39	ethanol	mol	PA448073	90527	0.955
NULL	J_Gynecol_Oncol_2013_Jul_4_24(3)_273-279.nxml.txt.nlp	23875078	SENT156	12	12	17	17	paclitaxel	COX	PA450761	1351	0.955
NULL	J_Cell_Mol_Med_2013_Jan_10_17(1)_30-54.nxml.txt.nlp	23301832	SENT229	9	9	18	18	docetaxel	CD133	PA449383	8842	0.955
NULL	Orphanet_J_Rare_Dis_2007_Jan_8_2_3.nxml.txt.nlp	17210076	SENT211	7	7	0	0	ticlopidine	ADP	PA451686	23038	0.955
NULL	Curr_HIV_Res_2014_May_12(3)_174-188.nxml.txt.nlp	24862327	SENT147	25	25	31	31	hemin	HO-1	PA449849	3162	0.955
NULL	Front_Pharmacol_2014_Oct_6_5_224.nxml.txt.nlp	25339904	SENT121	2	2	37	37	erlotinib	EGFR	PA134687924	1956	0.955
NULL	Breast_Cancer_Res_2005_Jul_29_7(5)_E6.nxml.txt.nlp	16168100	SENT9	35	35	12	12	tamoxifen	CYP2D6	PA451581	1565	0.955
NULL	Acta_Pharmacol_Sin_2012_May_16_33(5)_682-690.nxml.txt.nlp	22504904	SENT115	3	3	19	19	celecoxib	STAT3	PA448871	6774	0.955
NULL	Pharmaceuticals_(Basel)_2013_Apr_26_6(5)_579-603.nxml.txt.nlp	24276168	SENT245	6	6	19	19	methotrexate	DHFR	PA450428	1719	0.955
NULL	Ann_Indian_Acad_Neurol_2010_Jul-Sep_13(3)_207-210.nxml.txt.nlp	21085534	SENT96	3	3	0	0	infliximab	TNF	PA452639	7124	0.955
NULL	Cancer_Cell_Int_2012_Dec_19_12_53.nxml.txt.nlp	23249419	SENT150	13	13	38	38	celecoxib	STAT3	PA448871	6774	0.955
NULL	Neuropsychopharmacology_2009_Jul_25_34(8)_1968-1978.nxml.txt.nlp	19322168	SENT258	22	22	2	2	clozapine	PI3K	PA449061	5290	0.955
NULL	BMB_Rep_2013_Jan_46(1)_59-64.nxml.txt.nlp	23351386	SENT104	18	18	13	13	auranofin	STAT3	PA448510	6774	0.955
NULL	Cancers_(Basel)_2014_Mar_25_6(2)_684-707.nxml.txt.nlp	24670368	SENT177	16	16	29	29	lapatinib	HER2	PA152241907	2064	0.955
NULL	Nat_Biotechnol_2013_Jul_30_31(7)_630-637.nxml.txt.nlp	23811600	SENT390	21	21	17	17	ponatinib	ABL1	PA165980594	25	0.955
NULL	Scientifica_(Cairo)_2012_Nov_25_2012_473829.nxml.txt.nlp	24278698	SENT380	19	19	7	7	cisplatin	MATE1	PA449014	55244	0.955
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT1261	4	4	18	18	sunitinib	ABCG2	PA162372840	9429	0.955
NULL	Br_J_Clin_Pharmacol_2011_Oct_72(4)_647-657.nxml.txt.nlp	21518389	SENT217	6	6	1	1	prasugrel	P2Y12	PA154410481	64805	0.955
NULL	Adv_Hematol_2012_Jul_24_2012_513702.nxml.txt.nlp	22888354	SENT152	0	0	20	20	lenalidomide	B7-1	PA162363968	941	0.955
NULL	Pharmaceutics_2010_Jun_2_2(2)_258-274.nxml.txt.nlp	NULL	SENT23	6	6	29	29	risperidone	P-gp	PA451257	5243	0.955
NULL	Oncotarget_2012_Jan_28_3(1)_84-97.nxml.txt.nlp	22289741	SENT214	30	30	4	4	acetazolamide	CAIX	PA448018	768	0.955
NULL	FASEB_J_2009_Feb_23(2)_575-585.nxml.txt.nlp	18957574	SENT332	23	23	2	2	nitrogen	L11	PA450643	90861;6135	0.955
NULL	Arthritis_Res_Ther_2014_Mar_7_16(2)_R63.nxml.txt.nlp	24602182	SENT62	0	0	38	38	pegloticase	mol	PA165963961	90527	0.955
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2014_Jun_29_70(Pt_7)_1922-1933.nxml.txt.nlp	25004969	SENT5	13	13	10	10	cycloserine	PLP	PA164764600	25824;5744	0.955
NULL	Pharmaceuticals_(Basel)_2013_Aug_21_6(8)_988-1038.nxml.txt.nlp	24276379	SENT2699	9	9	1	1	cetuximab	BRAF	PA10040	673	0.955
NULL	Scientifica_(Cairo)_2013_Dec_12_2013_635203.nxml.txt.nlp	24416617	SENT441	10	10	23	23	imatinib	KIT	PA10804	3815	0.955
NULL	Oncotarget_2013_Jul_21_4(8)_1266-1279.nxml.txt.nlp	23907540	SENT155	10	10	19	19	doxycycline	PTEN	PA449415	5728	0.955
NULL	Oncol_Lett_2013_Mar_28_5(3)_935-942.nxml.txt.nlp	23426424	SENT115	11	11	2	2	cisplatin	ERCC1	PA449014	2067	0.955
NULL	J_Oncol_2012_Apr_23_2012_901956.nxml.txt.nlp	22619676	SENT159	9	9	4	4	docetaxel	eIF3a	PA449383	8661	0.955
NULL	Protein_Cell_2014_Jun_19_5(6)_469-479.nxml.txt.nlp	24748116	SENT161	25	25	8	8	paclitaxel	EB1	PA450761	9167;22919;10982	0.955
NULL	Oncotarget_2011_Jun_7_2(6)_491-496.nxml.txt.nlp	21653999	SENT61	28	28	18	18	tamoxifen	PAK1	PA451581	5585;5058	0.955
NULL	Colorectal_Dis_2012_Feb_14(2)_e31-e47.nxml.txt.nlp	21848897	SENT126	18	18	33	33	panitumumab	KRAS	PA162373091	3845	0.955
NULL	J_Med_Chem_2014_Jan_23_57(2)_449-461.nxml.txt.nlp	24387105	SENT147	0	0	8	8	benzaldehyde	ALDH3A1	PA448571	218	0.955
NULL	EMBO_Mol_Med_2012_Jul_20_4(7)_633-646.nxml.txt.nlp	22517678	SENT174	22	22	0	0	cyclosporine	NAC	PA449167	22861	0.955
NULL	J_Biol_Chem_2013_Nov_22_288(47)_34217-34229.nxml.txt.nlp	24106270	SENT271	26	26	21	21	thrombin	RhoG	PA451674	391	0.955
NULL	J_Oral_Pathol_Med_2013_Jul_18_42(6)_499-506.nxml.txt.nlp	23331485	SENT39	9	9	6	6	celecoxib	COX	PA448871	1351	0.955
NULL	Oncotarget_2014_Oct_16_5(20)_9546-9563.nxml.txt.nlp	25337673	SENT105	35	35	29	29	gefitinib	AXL	PA131301952	558	0.955
NULL	Endocr_Connect_2012_Jun_8_1(1)_1-12.nxml.txt.nlp	23781298	SENT133	9	9	21	21	fenofibrate	adiponectin	PA449594	9370	0.955
NULL	Br_J_Cancer_2012_Nov_20_107(11)_1844-1852.nxml.txt.nlp	23169337	SENT230	16	16	10	10	bortezomib	AKT	PA10252	207	0.955
NULL	Ann_Oncol_2011_May_3_22(5)_1078-1087.nxml.txt.nlp	21048039	SENT137	31	31	14	14	cetuximab	EGFR	PA10040	1956	0.955
NULL	Br_J_Cancer_2012_Sep_4_107(6)_956-960.nxml.txt.nlp	22892393	SENT113	16	16	8	8	trastuzumab	HER2	PA451743	2064	0.955
NULL	Aging_(Albany_NY)_2009_Jun_22_1(6)_529-541.nxml.txt.nlp	20157536	SENT176	45	45	6	6	ethanol	ANOVA	PA448073	4858	0.955
NULL	Arthritis_Res_Ther_2003_Feb_24_5(Suppl_1)_47.nxml.txt.nlp	NULL	SENT15	14	14	7	7	methotrexate	IL-6	PA450428	3569	0.955
NULL	Fibrogenesis_Tissue_Repair_2012_Jul_23_5_11.nxml.txt.nlp	22824096	SENT302	18	18	8	8	bleomycin	NOX4	PA448645	50507	0.955
NULL	Front_Behav_Neurosci_2012_Nov_9_6_75.nxml.txt.nlp	23162448	SENT621	25	25	8	8	ethanol	mGlu5	PA448073	2915	0.955
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT144	41	41	18	18	methotrexate	MSH2	PA450428	4436	0.955
NULL	Br_J_Cancer_2000_Jul_3_83(3)_366-374.nxml.txt.nlp	10917553	SENT8	7	7	35	35	calcein	MDR1	PA132595336	5243	0.955
NULL	Comp_Hepatol_2005_Feb_8_4_2.nxml.txt.nlp	15701172	SENT110	0	0	10	10	ketoconazole	CYP3A	PA450146	1574	0.955
NULL	Diabetes_Obes_Metab_2011_Nov_13(11)_982-989.nxml.txt.nlp	21615670	SENT177	4	4	26	26	exenatide	GLP-1	PA164749238	100125288	0.955
NULL	Nat_Med_2011_Aug_28_17(9)_1094-1100.nxml.txt.nlp	21873989	SENT107	16	16	4	4	imatinib	KIT	PA10804	3815	0.955
NULL	Ann_Surg_Oncol_2012_Apr_27_19(4)_1185-1191.nxml.txt.nlp	22031063	SENT20	13	13	16	16	tamoxifen	aromatase	PA451581	1588	0.955
NULL	Acta_Pharmacol_Sin_2013_Sep_5_34(9)_1192-1200.nxml.txt.nlp	23685957	SENT199	9	9	14	14	curcumin	AP-2	PA151958596	7020	0.955
NULL	Diabetes_Care_2009_Sep_15_32(9)_1656-1662.nxml.txt.nlp	19528367	SENT50	16	16	40	40	rosiglitazone	U100	PA451283	692149	0.955
NULL	Iran_Red_Crescent_Med_J_2014_Feb_7_16(2)_e15277.nxml.txt.nlp	24719748	SENT51	19	19	4	4	clopidogrel	ADP	PA449053	23038	0.955
NULL	Cell_Commun_Signal_2013_Jul_4_11_47.nxml.txt.nlp	23826796	SENT96	31	31	21	21	rolipram	CC2D1A	PA153906323	54862	0.955
NULL	J_Biol_Chem_2012_Apr_27_287(18)_14644-14658.nxml.txt.nlp	22375002	SENT230	9	9	2	2	forskolin	CC2D1A	PA146096022	54862	0.955
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT82	19	19	7	7	capecitabine	HER2	PA448771	2064	0.955
NULL	Anticancer_Drugs_2015_Jan_28_26(1)_46-55.nxml.txt.nlp	25099621	SENT92	30	30	5	5	methotrexate	KE-3	PA450428	6222	0.955
NULL	J_Mol_Signal_2008_Mar_31_3_8.nxml.txt.nlp	18377662	SENT63	30	30	3	3	pp2	PP2		4888	0.955
NULL	J_Adv_Pharm_Technol_Res_2012_Oct-Dec_3(4)_202-209.nxml.txt.nlp	23378940	SENT166	4	4	9	9	aprepitant	CYP2C9	PA164747039	1559	0.955
NULL	Nat_Med_2010_Nov_24_16(11)_1299-1304.nxml.txt.nlp	20972434	SENT32	9	9	12	12	colchicine	TAS2R4	PA449092	50832	0.955
NULL	AMIA_Jt_Summits_Transl_Sci_Proc_2012_Mar_19_2012_19-24.nxml.txt.nlp	22779042	SENT13	15	15	10	10	warfarin	CYP2C9	PA451906	1559	0.955
NULL	Cancer_Res_Treat_2012_Sep_30_44(3)_195-201.nxml.txt.nlp	23091446	SENT99	10	10	4	4	irinotecan	MKP-1	PA450085	1843	0.955
NULL	Oncotarget_2014_Oct_21_5(22)_11709-11722.nxml.txt.nlp	25365944	SENT92	27	27	16	16	metformin	AKT	PA450395	207	0.955
NULL	Oncotarget_2012_May_9_3(4)_363-364.nxml.txt.nlp	22622047	SENT16	29	29	10	10	imatinib	SIRT1	PA10804	23411	0.955
NULL	Curr_Gerontol_Geriatr_Res_2010_Jun_20_2010_348174.nxml.txt.nlp	20672050	SENT115	8	8	4	4	erlotinib	EGFR	PA134687924	1956	0.955
NULL	J_Inflamm_(Lond)_2005_Apr_20_2_3.nxml.txt.nlp	15840176	SENT220	6	6	21	21	collagenase	AP-1	PA449107	2353;3727;2354;3725	0.955
NULL	Nat_Commun_2013_Sep_20_4_2443.nxml.txt.nlp	24051437	SENT8	20	20	31	31	tamoxifen	BIG3	PA451581	57221	0.955
NULL	Int_J_Environ_Res_Public_Health_2010_Apr_29_7(4)_1392-1431.nxml.txt.nlp	20617037	SENT260	43	43	21	21	ethanol	CRF1	PA448073	1394	0.955
NULL	Front_Chem_2014_Oct_8_2_85.nxml.txt.nlp	25340049	SENT65	0	0	10	10	heparin	mol	PA449855	90527	0.955
NULL	Diabetes_2013_Sep_15_62(9)_3019-3021.nxml.txt.nlp	23970522	SENT20	29	29	3	3	chymotrypsin	CTRB2	PA448994	440387	0.955
NULL	Arthritis_Res_Ther_2013_Jul_11_15(4)_R74.nxml.txt.nlp	23845159	SENT228	29	29	3	3	trypsin	CCL2	PA451806	6347	0.955
NULL	Clin_Dev_Immunol_2013_May_22_2013_701305.nxml.txt.nlp	23762095	SENT75	5	5	9	9	vinblastine	MCL1	PA451877	4170	0.955
NULL	Oncotarget_2013_Dec_5_5(1)_49-66.nxml.txt.nlp	24393708	SENT280	8	8	2	2	everolimus	KRAS	PA164746311	3845	0.955
NULL	Mol_Biol_Cell_2012_Jun_15_23(12)_2302-2318.nxml.txt.nlp	22553350	SENT345	17	17	2	2	doxycycline	MARK2	PA449415	2011	0.955
NULL	Biomed_Res_Int_2014_Jun_24_2014_282657.nxml.txt.nlp	25050334	SENT8	22	22	5	5	resveratrol	SOD2		6648	0.955
NULL	J_Thromb_Thrombolysis_2012_Feb_20_33(2)_143-153.nxml.txt.nlp	22183178	SENT30	0	0	25	25	clopidogrel	P2Y12	PA449053	64805	0.955
NULL	Biosci_Rep_2012_Dec_13_33(1)_e00007.nxml.txt.nlp	23095119	SENT206	5	5	19	19	orlistat	NEFA	PA164776864	4925	0.955
NULL	Arthritis_Res_Ther_2007_Oct_19_9(Suppl_3)_P20.nxml.txt.nlp	NULL	SENT18	14	14	5	5	infliximab	p38	PA452639	10598;1432;7965	0.955
NULL	Front_Genet_2014_Mar_10_5_46.nxml.txt.nlp	24653733	SENT52	38	38	19	19	paraformaldehyde	CO2	PA450790	4513	0.955
NULL	Br_J_Cancer_2012_Jun_26_107(1)_108-115.nxml.txt.nlp	22627319	SENT133	37	37	11	11	etoposide	TOP2B	PA449552	7155	0.955
NULL	Nat_Med_2011_Aug_28_17(9)_1094-1100.nxml.txt.nlp	21873989	SENT39	22	22	6	6	imatinib	IL-6	PA10804	3569	0.955
NULL	Mol_Cancer_2010_Nov_22_9_298.nxml.txt.nlp	21092190	SENT116	2	2	25	25	gemcitabine	SRM	PA449748	6723;6725	0.955
NULL	Case_Rep_Hematol_2013_Sep_30_2013_628513.nxml.txt.nlp	24198984	SENT91	1	1	14	14	rituximab	FVIII	PA451261	2157	0.955
NULL	Br_J_Pharmacol_2008_Dec_25_155(7)_1056-1065.nxml.txt.nlp	18724386	SENT254	39	39	10	10	diazoxide	GLP-1	PA449285	100125288	0.955
NULL	Allergy_2014_Jul_29_69(7)_817-827.nxml.txt.nlp	24773466	SENT209	2	2	18	18	imatinib	IL-13	PA10804	3596	0.955
NULL	Breast_Cancer_Res_2013_Oct_18_15(5)_R97.nxml.txt.nlp	24135425	SENT20	6	6	20	20	tamoxifen	HER2	PA451581	2064	0.955
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT261	5	5	15	15	methotrexate	MSH2	PA450428	4436	0.955
NULL	J_Exp_Med_1998_Jun_15_187(12)_1995-2007.nxml.txt.nlp	9625759	SENT29	5	5	0	0	trypsin	Bcl-2	PA451806	596	0.955
NULL	Mol_Clin_Oncol_2013_Sep_23_1(5)_887-893.nxml.txt.nlp	24649266	SENT120	13	13	3	3	gefitinib	EGFR	PA131301952	1956	0.955
NULL	Tuberc_Respir_Dis_(Seoul)_2014_Sep_30_77(3)_105-110.nxml.txt.nlp	25309604	SENT32	6	6	35	35	warfarin	CYP2C9	PA451906	1559	0.955
NULL	Support_Care_Cancer_2012_May_1_20(5)_941-949.nxml.txt.nlp	21533811	SENT30	25	25	18	18	palonosetron	HEC	PA10352	10403	0.955
NULL	Oncogene_2010_May_20_29(20)_2983-2995.nxml.txt.nlp	20208560	SENT3	13	13	0	0	tamoxifen	FOXM1	PA451581	2305	0.955
NULL	Eur_J_Clin_Pharmacol_2011_May_8_67(5)_493-506.nxml.txt.nlp	21140139	SENT205	9	9	0	0	oxycodone	Men	PA450741	8178	0.955
NULL	Autophagy_2013_Mar_1_9(3)_317-327.nxml.txt.nlp	23242206	SENT177	20	20	0	0	l-glutamine	CD34	PA10090	947	0.955
NULL	Oncogene_2010_Jul_8_29(27)_3896-3907.nxml.txt.nlp	20453888	SENT91	16	16	8	8	trastuzumab	HER2	PA451743	2064	0.955
NULL	Emerg_Infect_Dis_2015_Jan_21(1)_40-47.nxml.txt.nlp	25530077	SENT142	21	21	5	5	meropenem	API	PA164764445	5345	0.955
NULL	Cancer_Inform_2012_Apr_19_11_87-111.nxml.txt.nlp	22553414	SENT217	1	1	11	11	gefitinib	FOXC1	PA131301952	2296	0.955
NULL	Br_J_Cancer_2012_Jul_10_107(2)_230-233.nxml.txt.nlp	22735900	SENT47	10	10	4	4	fluoxetine	CYP2D6	PA449673	1565	0.955
NULL	Acta_Pharmacol_Sin_2012_May_16_33(5)_682-690.nxml.txt.nlp	22504904	SENT42	14	14	35	35	celecoxib	STAT3	PA448871	6774	0.955
NULL	J_Invest_Dermatol_2012_Sep_19_132(9)_2198-2205.nxml.txt.nlp	22513780	SENT193	27	27	4	4	isotretinoin	TLR-4	PA450128	7099	0.955
NULL	Diabetes_Care_2013_Aug_17_36(Suppl_2)_S245-S252.nxml.txt.nlp	23882053	SENT9	30	30	10	10	sitagliptin	GLP-1	PA164748978	100125288	0.955
NULL	Oncol_Lett_2014_Mar_19_7(3)_674-678.nxml.txt.nlp	24527071	SENT128	9	9	16	16	cisplatin	DDH	PA449014	1645	0.955
NULL	Ann_Oncol_2011_Mar_8_22(3)_503-514.nxml.txt.nlp	20616198	SENT210	8	8	21	21	letrozole	aromatase	PA450196	1588	0.955
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT342	15	15	6	6	risperidone	PRL	PA451257	5617	0.955
NULL	Acta_Pharmacol_Sin_2014_Sep_4_35(9)_1157-1166.nxml.txt.nlp	25088002	SENT169	2	2	12	12	curcumin	STAT3	PA151958596	6774	0.955
NULL	Clin_Psychopharmacol_Neurosci_2011_Apr_30_9(1)_36-43.nxml.txt.nlp	23431025	SENT95	32	32	25	25	clozapine	NAC	PA449061	22861	0.955
NULL	J_Hum_Genet_2013_Jun_2_58(6)_306-312.nxml.txt.nlp	23635953	SENT15	27	27	19	19	exemestane	aromatase	PA449563	1588	0.955
NULL	Nat_Commun_2013_Apr_9_4_1684.nxml.txt.nlp	23575688	SENT67	4	4	24	24	rolipram	CYLD	PA153906323	1540	0.955
NULL	Biosci_Rep_2012_Dec_20_33(1)_e00011.nxml.txt.nlp	23137297	SENT267	13	13	19	19	heparin	RPSA	PA449855	3921	0.955
NULL	Eur_J_Clin_Pharmacol_2007_Apr_21_63(4)_335-343.nxml.txt.nlp	17318526	SENT234	37	37	44	44	sulfamethoxazole	CYP2C9	PA451544	1559	0.955
NULL	Breast_Cancer_Res_2007_Aug_8_9(4)_R50.nxml.txt.nlp	17686159	SENT239	0	0	5	5	gefitinib	EGFR	PA131301952	1956	0.955
NULL	Br_J_Cancer_2013_May_14_108(9)_1862-1869.nxml.txt.nlp	23579219	SENT12	7	7	34	34	bevacizumab	ANXA11	PA130232992	311	0.955
NULL	Br_J_Cancer_2009_Jun_2_100(11)_1739-1745.nxml.txt.nlp	19436299	SENT24	25	25	8	8	temsirolimus	FDG	PA164746890	23583	0.955
NULL	Clin_Ophthalmol_2014_Sep_26_8_1967-1985.nxml.txt.nlp	25328381	SENT252	10	10	23	23	latanoprost	BAK	PA164774763	578	0.955
NULL	Ann_Med_2011_Nov_5_43(7)_531-544.nxml.txt.nlp	21815879	SENT157	0	0	15	15	cangrelor	P2Y12	PA165945763	64805	0.955
NULL	Pak_J_Med_Sci_2014_Mar-Apr_30(2)_449-451.nxml.txt.nlp	24772161	SENT58	2	2	21	21	cyclophosphamide	CTX	PA449165	1593	0.955
NULL	Leukemia_2013_Jan_11_27(1)_32-40.nxml.txt.nlp	22781593	SENT9	17	17	13	13	ponatinib	FGFR1	PA165980594	2260	0.955
NULL	Environ_Health_Perspect_2006_Sep_23_114(9)_1401-1406.nxml.txt.nlp	16966095	SENT48	31	31	20	20	arsenite	p53	PA452638	7157	0.955
NULL	J_Mol_Signal_2008_Dec_1_3_18.nxml.txt.nlp	19046439	SENT175	17	17	22	22	metformin	CDK2	PA450395	1017	0.955
NULL	Anesth_Pain_Med_2014_Sep_9_4(4)_e14221.nxml.txt.nlp	25599022	SENT123	18	18	7	7	cisplatin	LPO	PA449014	4025	0.955
NULL	J_Vis_Exp_2014_Mar_28_(85)_51300.nxml.txt.nlp	24747269	SENT333	27	27	7	7	thrombin	Rho	PA451674	29984	0.955
NULL	Oncotarget_2014_Aug_8_5(17)_7936-7944.nxml.txt.nlp	25277205	SENT63	9	9	12	12	vemurafenib	AKT	PA165946873	207	0.955
NULL	Br_J_Cancer_2010_May_11_102(10)_1456-1460.nxml.txt.nlp	20461090	SENT129	0	0	13	13	temsirolimus	IFN	PA164746890	3439	0.955
NULL	Case_Rep_Neurol_Med_2013_Jul_1_2013_451206.nxml.txt.nlp	23936696	SENT46	0	0	15	15	ranolazine	CYP2D	PA164746007	1565	0.955
NULL	Breast_Cancer_Res_Treat_2014_Apr_9_145(1)_73-82.nxml.txt.nlp	24715380	SENT120	7	7	28	28	tamoxifen	CXCL10	PA451581	3627	0.955
NULL	Mol_Biol_Cell_2013_Jul_15_24(14)_2186-2200.nxml.txt.nlp	23699397	SENT245	37	37	1	1	staurosporine	TRAIL	PA165109623	8743	0.955
NULL	Adolesc_Health_Med_Ther_2014_Mar_14_5_25-34.nxml.txt.nlp	24729738	SENT125	0	0	10	10	ustekinumab	IL-23	PA166048654	51561	0.955
NULL	Oncogene_2014_Feb_6_33(6)_713-723.nxml.txt.nlp	23435429	SENT108	13	13	32	32	camptothecin	BRCA1	PA153590860	672	0.955
NULL	Indian_J_Ophthalmol_2007_Nov-Dec_55(6)_482-483.nxml.txt.nlp	17951917	SENT16	29	29	6	6	ciprofloxacin	API	PA449009	5345	0.955
NULL	Cardiovasc_J_Afr_2013_Apr_24(3)_58-65.nxml.txt.nlp	23736127	SENT82	22	22	16	16	candesartan	AT1	PA448765	9197;185	0.955
NULL	Br_J_Cancer_2012_Sep_4_107(6)_947-955.nxml.txt.nlp	22892392	SENT203	12	12	5	5	tamoxifen	ERBB2	PA451581	2064	0.955
NULL	J_Hematol_Oncol_2014_Aug_1_7_52.nxml.txt.nlp	25085632	SENT189	17	17	12	12	sunitinib	PTEN	PA162372840	5728	0.955
NULL	J_Hematol_Oncol_2013_Jan_4_6_1.nxml.txt.nlp	23286345	SENT169	19	19	10	10	cetuximab	FCGR2A	PA10040	2212	0.955
NULL	Front_Neurol_2014_Sep_11_5_173.nxml.txt.nlp	25309501	SENT27	0	0	47	47	hyaluronan	HAS3	PA165958431	3038	0.955
NULL	Breast_Cancer_(Auckl)_2011_Jan_13_5_1-14.nxml.txt.nlp	21494397	SENT52	37	37	9	9	ixabepilone	CYP3A4		1576	0.955
NULL	Adv_Ther_2013_Nov_22_30(12)_1031-1032.nxml.txt.nlp	24263555	SENT13	20	20	0	0	metformin	GLP-1	PA450395	100125288	0.955
NULL	Front_Endocrinol_(Lausanne)_2015_Jan_9_5_235.nxml.txt.nlp	25620956	SENT87	12	12	36	36	glucosamine	p65	PA164747613	5970	0.955
NULL	J_Cardiovasc_Thorac_Res_2014_Jun_30_6(2)_97-100.nxml.txt.nlp	25031824	SENT72	2	2	21	21	heparin	ACT	PA449855	12;11332;9457;641455	0.955
NULL	Cell_Death_Differ_2009_Aug_20_16(8)_1135-1145.nxml.txt.nlp	19300452	SENT197	13	13	16	16	doxycycline	PUMA	PA449415	27113	0.955
NULL	Front_Neurol_2014_Feb_18_5_17.nxml.txt.nlp	24600432	SENT93	8	8	20	20	levetiracetam	C17	PA450206	54360	0.955
NULL	Eur_J_Clin_Pharmacol_2012_Jan_8_68(1)_29-37.nxml.txt.nlp	21739267	SENT26	4	4	13	13	paroxetine	CYP2D6	PA450801	1565	0.955
NULL	J_Gen_Physiol_2003_Jul_122(1)_45-61.nxml.txt.nlp	12835470	SENT63	15	15	4	4	capsaicin	VR1	PA448776	56664	0.955
NULL	Acta_Pharmacol_Sin_2012_May_16_33(5)_682-690.nxml.txt.nlp	22504904	SENT124	5	5	7	7	celecoxib	STAT3	PA448871	6774	0.955
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S279-S284.nxml.txt.nlp	21525469	SENT37	17	17	1	1	exenatide	GLP-1	PA164749238	100125288	0.955
NULL	Int_J_Breast_Cancer_2013_Dec_5_2013_354579.nxml.txt.nlp	24383004	SENT72	26	26	14	14	tamoxifen	aromatase	PA451581	1588	0.955
NULL	Dement_Geriatr_Cogn_Dis_Extra_2014_Nov_15_4(3)_450-456.nxml.txt.nlp	25538729	SENT92	39	39	33	33	donepezil	APOE	PA449394	348	0.955
NULL	Cell_Death_Dis_2012_Mar_15_3(3)_e285.nxml.txt.nlp	22419114	SENT48	17	17	6	6	cisplatin	MLH1	PA449014	4292	0.955
NULL	Ann_Hematol_2014_Sep_12_93(1)_13-32.nxml.txt.nlp	24026426	SENT299	0	0	15	15	voriconazole	BII	PA10233	777	0.955
NULL	Blood_Res_2013_Jun_25_48(2)_72-73.nxml.txt.nlp	23826573	SENT11	0	0	16	16	plerixafor	CXCR4	PA165958410	7852	0.955
NULL	J_Lipids_2011_Jan_13_2011_565316.nxml.txt.nlp	21490804	SENT72	4	4	2	2	celecoxib	COX2	PA448871	4513;5743	0.955
NULL	Front_Oncol_2013_Sep_11_3_228.nxml.txt.nlp	24062981	SENT191	34	34	27	27	camptothecin	PARP1	PA153590860	142	0.955
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT120	7	7	29	29	pp2	PP2		4888	0.955
NULL	J_Oncol_2009_May_6_2009_567486.nxml.txt.nlp	19424511	SENT73	19	19	11	11	cetuximab	KRAS	PA10040	3845	0.955
NULL	Mol_Cancer_2010_Jun_25_9_165.nxml.txt.nlp	20576164	SENT210	3	3	14	14	curcumin	STAT1	PA151958596	6772	0.955
NULL	Mol_Cell_Biochem_2012_Apr_3_363(1-2)_135-145.nxml.txt.nlp	22139302	SENT250	30	30	34	34	curcumin	survivin	PA151958596	332	0.955
NULL	Diabetes_Care_2012_Jan_9_35(1)_131-136.nxml.txt.nlp	22040838	SENT159	23	23	2	2	metformin	FFM	PA450395	24	0.955
NULL	Biomed_Res_Int_2013_Jul_31_2013_692071.nxml.txt.nlp	23984399	SENT122	14	14	6	6	guanidine	OCT1	PA164781028	5451;6580	0.955
NULL	Cancer_Med_2013_Jun_25_2(3)_277-285.nxml.txt.nlp	23930204	SENT104	20	20	5	5	capecitabine	PTEN	PA448771	5728	0.955
NULL	Front_Neurosci_2015_Jan_13_8_448.nxml.txt.nlp	25628528	SENT277	8	8	0	0	capsaicin	5-HT7	PA448776	3363	0.955
NULL	Mol_Cancer_2008_Oct_23_7_82.nxml.txt.nlp	18947424	SENT548	0	0	12	12	fluvastatin	CYP3A4	PA449688	1576	0.955
NULL	Int_J_Nephrol_2011_Jun_28_2011_593291.nxml.txt.nlp	21755059	SENT188	9	9	4	4	ribavirin	IFN	PA451241	3439	0.955
NULL	Front_Immunol_2012_Mar_21_3_57.nxml.txt.nlp	22566938	SENT1366	0	0	9	9	vasopressin	IRAP	PA451858	3557	0.955
NULL	Cell_Commun_Signal_2013_Oct_3_11_75.nxml.txt.nlp	24090133	SENT167	24	24	0	0	heparin	CCN2	PA449855	1490	0.955
NULL	Angiogenesis_2012_Sep_27_15(3)_361-376.nxml.txt.nlp	22451299	SENT213	3	3	22	22	resveratrol	ROS		6098	0.955
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT241	8	8	0	0	pemetrexed	UNG	PA10810	7374	0.955
NULL	Comb_Chem_High_Throughput_Screen_2010_Feb_13(2)_188-206.nxml.txt.nlp	20053163	SENT247	33	33	9	9	losartan	CYP2C9	PA450268	1559	0.955
NULL	Mol_Cancer_2014_Jun_24_13_157.nxml.txt.nlp	24958351	SENT23	25	25	39	39	lapatinib	EGFR	PA152241907	1956	0.955
NULL	Oncol_Rep_2013_Apr_23_29(4)_1268-1274.nxml.txt.nlp	23354756	SENT146	0	0	10	10	trastuzumab	CDK2	PA451743	1017	0.955
NULL	Open_Cardiovasc_Med_J_2010_Oct_21_4_198-205.nxml.txt.nlp	21331307	SENT115	18	18	13	13	diclofenac	COX	PA449293	1351	0.955
NULL	Cardiovasc_Diabetol_2013_Mar_23_12_48.nxml.txt.nlp	23522121	SENT40	34	34	10	10	metformin	GLP-1	PA450395	100125288	0.955
NULL	Eur_J_Clin_Pharmacol_2009_Dec_8_65(12)_1245-1251.nxml.txt.nlp	19669131	SENT159	11	11	13	13	pramipexole	DRD2	PA164742949	1813	0.955
NULL	Cancer_Manag_Res_2012_Nov_9_4_383-395.nxml.txt.nlp	23204869	SENT98	9	9	13	13	carmustine	PC-3	PA448810	692094	0.955
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT287	15	15	5	5	chloroquine	BMPR-II	PA448948	659	0.955
NULL	Br_J_Cancer_2003_Mar_10_88(5)_754-759.nxml.txt.nlp	12618886	SENT157	24	24	12	12	amifostine	p53	PA448365	7157	0.955
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Nov_27_66(Pt_12)_o3315.nxml.txt.nlp	21589592	SENT3	27	27	1	1	piperazine	mol	PA450977	90527	0.955
NULL	Oncotarget_2013_Nov_22_5(4)_933-943.nxml.txt.nlp	24659749	SENT107	14	14	8	8	nutlin-3	AML3		860	0.955
NULL	Br_J_Cancer_2012_Apr_10_106(8)_1367-1373.nxml.txt.nlp	22454081	SENT16	4	4	20	20	trastuzumab	IGF1R	PA451743	3480	0.955
NULL	Neuropsychopharmacology_2009_Apr_2_34(5)_1135-1148.nxml.txt.nlp	18596687	SENT199	6	6	37	37	betaxolol	CRF	PA448611	1392;10882	0.955
NULL	J_Carcinog_2014_Feb_20_13_4.nxml.txt.nlp	24737952	SENT40	0	0	7	7	panitumumab	EGFR	PA162373091	1956	0.955
NULL	Curr_Pain_Headache_Rep_2011_Aug_12_15(4)_271-279.nxml.txt.nlp	21479998	SENT162	9	9	3	3	oxycodone	CYP2D6	PA450741	1565	0.955
NULL	Cell_Res_2013_Oct_27_23(10)_1163-1171.nxml.txt.nlp	23979020	SENT42	29	29	8	8	doxycycline	MSI1	PA449415	4440	0.955
NULL	Mol_Cancer_2010_Apr_21_9_83.nxml.txt.nlp	20409325	SENT94	32	32	6	6	doxycycline	MYCN	PA449415	4613	0.955
NULL	Indian_J_Ophthalmol_2011_Sep-Oct_59(5)_403a.nxml.txt.nlp	21836356	SENT18	41	41	14	14	nifedipine	CYP3A	PA450631	1574	0.955
NULL	J_Clin_Biochem_Nutr_2009_Jan_27_44(1)_28-40.nxml.txt.nlp	19177185	SENT81	1	1	32	32	hemin	HO-1	PA449849	3162	0.955
NULL	Mol_Syst_Biol_2011_Apr_26_7_486.nxml.txt.nlp	21525872	SENT513	11	11	30	30	gefitinib	NR2E1	PA131301952	7101	0.955
NULL	Cancer_Cell_Int_2014_Jun_16_14_53.nxml.txt.nlp	24966801	SENT192	16	16	6	6	metformin	LC3	PA450395	84557	0.955
NULL	Allergy_Asthma_Clin_Immunol_2009_Oct_22_5(1)_4.nxml.txt.nlp	20016776	SENT218	0	0	4	4	pitrakinra	IL-4	PA165983754	3565	0.955
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S258-S263.nxml.txt.nlp	21525465	SENT10	12	12	6	6	exenatide	GLP-1	PA164749238	100125288	0.955
NULL	Environ_Health_Perspect_2006_Sep_23_114(9)_1401-1406.nxml.txt.nlp	16966095	SENT52	16	16	5	5	arsenite	p53	PA452638	7157	0.955
NULL	Br_J_Cancer_2013_Dec_10_109(12)_2965-2972.nxml.txt.nlp	24149178	SENT32	35	35	15	15	cyclophosphamide	HER2	PA449165	2064	0.955
NULL	Sci_Rep_2014_Nov_28_4_7237.nxml.txt.nlp	25429875	SENT125	4	4	14	14	hesperidin	p38	PA449867	10598;1432;7965	0.955
NULL	Arch_Med_Sci_2014_Feb_24_10(1)_154-160.nxml.txt.nlp	24701228	SENT133	20	20	13	13	thrombin	MCP-1	PA451674	6347	0.955
NULL	Exp_Hematol_Oncol_2012_Dec_10_1_39.nxml.txt.nlp	23227903	SENT162	3	3	32	32	clofarabine	MTHFR	PA164754863	4524	0.955
NULL	Trials_2013_Sep_24_14_311.nxml.txt.nlp	24063608	SENT62	0	0	10	10	piperaquine	IPT	PA166104279	54802	0.955
NULL	Carcinogenesis_2014_May_13_35(5)_1055-1066.nxml.txt.nlp	24419232	SENT188	5	5	1	1	metformin	AMPK	PA450395	5563	0.955
NULL	Br_J_Pharmacol_2011_Apr_162(8)_1832-1842.nxml.txt.nlp	21232033	SENT156	5	5	26	26	resveratrol	SIRT1		23411	0.955
NULL	Front_Neuroanat_2014_Oct_2_8_110.nxml.txt.nlp	25324733	SENT107	22	22	5	5	ethanol	PSD-95	PA448073	1742	0.955
NULL	Br_J_Cancer_2011_Jul_12_105(2)_212-220.nxml.txt.nlp	21694723	SENT39	4	4	6	6	curcumin	STAT3	PA151958596	6774	0.955
NULL	Exp_Mol_Med_2012_Sep_30_44(9)_536-544.nxml.txt.nlp	22771771	SENT28	16	16	28	28	celecoxib	COX	PA448871	1351	0.955
NULL	Cell_Death_Dis_2010_May_13_1(5)_e41.nxml.txt.nlp	21364648	SENT146	26	26	13	13	etoposide	p65	PA449552	5970	0.955
NULL	Clin_Transl_Allergy_2013_Sep_2_3_29.nxml.txt.nlp	24004581	SENT190	5	5	33	33	omalizumab	IL-13	PA164752253	3596	0.955
NULL	J_Geriatr_Cardiol_2013_Mar_10(1)_21-27.nxml.txt.nlp	23610570	SENT58	28	28	40	40	dipyridamole	PAC-1	PA449367	1844	0.955
NULL	Oncologist_2010_May_28_15(5)_436-446.nxml.txt.nlp	20427383	SENT147	0	0	13	13	vatalanib	VEGFR	PA7001	3791	0.955
NULL	Anat_Cell_Biol_2011_Mar_31_44(1)_14-24.nxml.txt.nlp	21519545	SENT99	30	30	6	6	cyclophosphamide	CK8	PA449165	3856	0.955
NULL	Neuro_Oncol_2010_Aug_14_12(8)_882-889.nxml.txt.nlp	20472883	SENT51	10	10	4	4	erlotinib	EGFR	PA134687924	1956	0.955
NULL	EMBO_Mol_Med_2011_Aug_3(8)_451-464.nxml.txt.nlp	21656687	SENT131	43	43	5	5	etoposide	SPINK1	PA449552	6690	0.955
NULL	Anal_Chem_Insights_2014_Mar_2_9_1-7.nxml.txt.nlp	24634579	SENT43	40	40	20	20	ethanol	SLB	PA448073	26160	0.955
NULL	J_Am_Heart_Assoc_2013_Dec_19_2(6)_e000433.nxml.txt.nlp	24275630	SENT106	33	33	9	9	lipase	DAG	PA450239	1605	0.955
NULL	Clin_Pharmacokinet_2014_Sep_3_53(1)_1-16.nxml.txt.nlp	23999929	SENT278	7	7	18	18	erythromycin	P-gp	PA449493	5243	0.955
NULL	Mol_Brain_2014_Jan_24_7_6.nxml.txt.nlp	24456563	SENT93	7	7	28	28	suramin	P2X7	PA10292	5027	0.955
NULL	Front_Behav_Neurosci_2011_Oct_13_5_67.nxml.txt.nlp	22016727	SENT156	9	9	27	27	rimonabant	CB1	PA152407999	1268	0.955
NULL	Cancer_Metastasis_Rev_2010_Dec_10_29(4)_581-594.nxml.txt.nlp	20830503	SENT26	18	18	13	13	anastrozole	aromatase	PA448432	1588	0.955
NULL	J_Oncol_2012_Nov_1_2012_707156.nxml.txt.nlp	23193402	SENT81	2	2	22	22	levothyroxine	RAI	PA450221	10848;6050	0.955
NULL	Case_Rep_Oncol_Med_2014_Sep_14_2014_532924.nxml.txt.nlp	25298899	SENT63	20	20	3	3	paclitaxel	NAC	PA450761	22861	0.955
NULL	Front_Neurosci_2011_Jan_14_4_207.nxml.txt.nlp	21258618	SENT30	1	1	14	14	ethanol	CRF1	PA448073	1394	0.955
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT122	31	31	17	17	pp2	LYN		4067	0.955
NULL	Hum_Mol_Genet_2013_Nov_15_22(22)_4602-4615.nxml.txt.nlp	23814040	SENT144	31	31	40	40	l-cysteine	TRMU	PA449173	55687	0.955
NULL	J_Biol_Chem_2013_Feb_1_288(5)_3312-3321.nxml.txt.nlp	23255604	SENT200	3	3	27	27	mitomycin	IP6K1	PA450524	9807	0.955
NULL	J_Gen_Physiol_1995_Dec_1_106(6)_1193-1209.nxml.txt.nlp	8786356	SENT0	22	22	1	1	lidocaine	Gen	PA450226	348654	0.955
NULL	Arthritis_Res_Ther_2012_Aug_15_14(4)_R186.nxml.txt.nlp	22894827	SENT77	3	3	13	13	etanercept	IL-6	PA449515	3569	0.955
NULL	ScientificWorldJournal_2014_May_13_2014_701329.nxml.txt.nlp	24959618	SENT47	1	1	6	6	rocuronium	NMT	PA164754992	4836	0.955
NULL	Ther_Clin_Risk_Manag_2006_Sep_2(3)_297-301.nxml.txt.nlp	18360604	SENT52	3	3	16	16	paricalcitol	PTH	PA450798	5741	0.955
NULL	Oncol_Lett_2014_May_26_7(5)_1345-1351.nxml.txt.nlp	24765136	SENT205	7	7	17	17	ethanol	AMPK	PA448073	5563	0.955
NULL	Cancer_Manag_Res_2013_Jan_17_5_15-20.nxml.txt.nlp	23378782	SENT38	5	5	13	13	erlotinib	EGFR	PA134687924	1956	0.955
NULL	Int_J_Environ_Res_Public_Health_2010_Apr_30_7(4)_1448-1466.nxml.txt.nlp	20617039	SENT78	17	17	10	10	ethanol	NR1	PA448073	27158	0.955
NULL	Pharmaceutics_2011_Oct_12_3(4)_680-705.nxml.txt.nlp	24309303	SENT103	23	23	36	36	sitagliptin	AMPK	PA164748978	5563	0.955
NULL	J_Cancer_2014_Jan_5_5(2)_86-97.nxml.txt.nlp	24494026	SENT194	10	10	6	6	carboplatin	WEE1	PA448803	7465	0.955
NULL	Br_J_Haematol_2009_Nov_2_147(3)_396-410.nxml.txt.nlp	19758122	SENT11	30	30	9	9	chlorambucil	p53	PA448926	7157	0.955
NULL	Arthritis_Res_Ther_2003_Oct_2_5(Suppl_4)_S17-S21.nxml.txt.nlp	15180893	SENT54	9	9	37	37	rituximab	ACR	PA451261	49	0.955
NULL	Indian_J_Pharm_Sci_2014_May-Jun_76(3)_203-210.nxml.txt.nlp	25035531	SENT171	18	18	9	9	pindolol	5-HT1A	PA450966	3350	0.955
NULL	Arch_Drug_Inf_2008_Dec_1(3)_79-88.nxml.txt.nlp	19639028	SENT34	0	0	9	9	tegaserod	5-HT4	PA130413154	3360	0.955
NULL	Br_J_Cancer_2012_Nov_20_107(11)_1844-1852.nxml.txt.nlp	23169337	SENT162	13	13	0	0	bortezomib	SP1	PA10252	6667	0.955
NULL	Mol_Cancer_2014_Jun_3_13_139.nxml.txt.nlp	24894297	SENT128	18	18	24	24	cisplatin	HES1	PA449014	3280;8209	0.955
NULL	Ann_Hematol_2010_Sep_13_89(9)_861-871.nxml.txt.nlp	20387067	SENT194	23	23	16	16	dasatinib	GM-CSF	PA162372878	1437	0.955
NULL	Int_J_Biol_Sci_2013_Mar_7_9(3)_279-288.nxml.txt.nlp	23493630	SENT122	33	33	15	15	tocilizumab	CD4	PA165292659	920	0.955
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Apr_7_9_12.nxml.txt.nlp	20374640	SENT63	14	14	28	28	ampicillin	K12	PA448419	6398;3859	0.955
NULL	J_Exp_Med_2000_Mar_6_191(5)_859-870.nxml.txt.nlp	10704466	SENT166	21	21	11	11	arsenite	p38	PA452638	10598;1432;7965	0.955
NULL	Oncol_Lett_2014_Oct_22_8(4)_1603-1607.nxml.txt.nlp	25202376	SENT86	4	4	14	14	cisplatin	BRCA1	PA449014	672	0.955
NULL	Mediators_Inflamm_2011_Feb_21_2011_670613.nxml.txt.nlp	21403895	SENT147	10	10	16	16	phenytoin	P-gp	PA450947	5243	0.955
NULL	J_Obes_2011_Feb_8_2011_636181.nxml.txt.nlp	21331293	SENT213	0	0	7	7	liraglutide	GLP-1	PA165958364	100125288	0.955
NULL	Br_J_Cancer_2002_Jan_21_86(2)_218-221.nxml.txt.nlp	11870509	SENT30	30	30	11	11	tamoxifen	BRCA1	PA451581	672	0.955
NULL	Physiol_Rep_2014_Aug_28_2(8)_e12143.nxml.txt.nlp	25168879	SENT19	22	22	36	36	staurosporine	COX	PA165109623	1351	0.955
NULL	Osteoporos_Int_2013_Oct_19_24(1)_23-57.nxml.txt.nlp	23079689	SENT508	30	30	40	40	teriparatide	PTH	PA451620	5741	0.955
NULL	Curr_Neuropharmacol_2013_Jul_11(4)_338-378.nxml.txt.nlp	24381528	SENT579	5	5	7	7	curcumin	JNK	PA151958596	5599	0.955
NULL	Front_Neural_Circuits_2014_Jun_17_8_65.nxml.txt.nlp	24987336	SENT112	26	26	23	23	furosemide	KCC2	PA449719	57468	0.955
NULL	Diabetes_2011_May_23_60(5)_1582-1589.nxml.txt.nlp	21411513	SENT265	29	29	20	20	alprazolam	ACTH	PA448333	5443	0.955
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1135-1143.nxml.txt.nlp	21364580	SENT29	9	9	6	6	trastuzumab	ERBB2	PA451743	2064	0.955
NULL	Breast_Cancer_Res_2012_Mar_19_14(2)_205.nxml.txt.nlp	22429313	SENT72	0	0	16	16	exemestane	aromatase	PA449563	1588	0.955
NULL	Cancer_Cell_Int_2010_Oct_23_10_39.nxml.txt.nlp	20969791	SENT14	3	3	21	21	cetuximab	EGFR	PA10040	1956	0.955
NULL	Br_J_Cancer_1996_May_73(9)_1063-1068.nxml.txt.nlp	8624264	SENT12	12	12	10	10	reserpine	P-gp	PA451236	5243	0.955
NULL	Colorectal_Dis_2012_Feb_14(2)_e31-e47.nxml.txt.nlp	21848897	SENT126	16	16	33	33	cetuximab	KRAS	PA10040	3845	0.955
NULL	Ann_Dermatol_2014_Aug_31_26(4)_517-520.nxml.txt.nlp	25143685	SENT38	41	41	22	22	tazarotene	p53	PA164746821	7157	0.955
NULL	Clin_Pharmacol_2011_Jun_22_3_13-25.nxml.txt.nlp	22287853	SENT119	11	11	0	0	saxagliptin	ANOVA	PA165958362	4858	0.955
NULL	J_Korean_Med_Sci_2013_Feb_29_28(2)_308-314.nxml.txt.nlp	23399960	SENT151	3	3	20	20	gabapentin	IL-10	PA449720	3586	0.955
NULL	Evid_Based_Complement_Alternat_Med_2014_Jul_23_2014_273878.nxml.txt.nlp	25152760	SENT146	5	5	19	19	estradiol	CYP1A1	PA449503	1543	0.955
NULL	Front_Behav_Neurosci_2011_Sep_13_5_57.nxml.txt.nlp	21949506	SENT167	23	23	12	12	rimonabant	FAAH	PA152407999	79152;2166	0.955
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Sep_25_66(Pt_10)_o2615.nxml.txt.nlp	21587590	SENT55	13	13	21	21	anastrozole	aromatase	PA448432	1588	0.955
NULL	Int_J_Endocrinol_2010_Feb_10_2010_625852.nxml.txt.nlp	20169119	SENT123	28	28	4	4	cinacalcet	PTH	PA164776671	5741	0.955
NULL	Diabetes_Care_2009_Jan_32(1)_84-90.nxml.txt.nlp	18931095	SENT30	0	0	4	4	liraglutide	GLP-1	PA165958364	100125288	0.955
NULL	Cancers_(Basel)_2014_May_16_6(2)_1180-1194.nxml.txt.nlp	24840048	SENT67	20	20	7	7	imatinib	KIT	PA10804	3815	0.955
NULL	Clin_Med_Insights_Oncol_2013_Jun_3_7_103-122.nxml.txt.nlp	23843721	SENT199	11	11	2	2	hydroxyurea	CHK2	PA449942	11200	0.955
NULL	Indian_J_Endocrinol_Metab_2013_Jul-Aug_17(4)_636-646.nxml.txt.nlp	23961479	SENT247	6	6	21	21	simvastatin	SGS	PA451363	2200	0.955
NULL	Nucleic_Acids_Res_2005_Jun_8_33(10)_3283-3291.nxml.txt.nlp	15944449	SENT116	21	21	11	11	sjg-136	ERCC1		2067	0.955
NULL	Nat_Med_2014_Jun_11_20(6)_599-606.nxml.txt.nlp	24813251	SENT82	17	17	25	25	imatinib	YAP1	PA10804	10413	0.955
NULL	Breast_Cancer_Res_2011_Jun_14_13(3)_R63.nxml.txt.nlp	21679465	SENT28	14	14	17	17	tamoxifen	aromatase	PA451581	1588	0.955
NULL	Mol_Cell_Proteomics_2012_Feb_6_11(2)_M111_015222.nxml.txt.nlp	22147731	SENT321	11	11	3	3	cetuximab	EGFR	PA10040	1956	0.955
NULL	Breast_Cancer_Res_2010_Jul_26_12(4)_R55.nxml.txt.nlp	20659323	SENT255	14	14	7	7	fulvestrant	MYB	PA164747170	4602	0.955
NULL	Hum_Genomics_2011_May_1_5(4)_265-282.nxml.txt.nlp	21712189	SENT125	21	21	4	4	efavirenz	ABCB1	PA449441	5243	0.955
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S202-S209.nxml.txt.nlp	21525456	SENT145	0	0	4	4	liraglutide	GLP-1	PA165958364	100125288	0.955
NULL	Exp_Ther_Med_2014_May_4_7(5)_1285-1290.nxml.txt.nlp	24940426	SENT21	3	3	23	23	metformin	LKB1	PA450395	6794	0.955
NULL	Adv_Hematol_2012_Apr_18_2012_403648.nxml.txt.nlp	22570659	SENT140	26	26	9	9	rituximab	CD4	PA451261	920	0.955
NULL	Mol_Biol_Cell_2012_Jun_1_23(11)_2017-2027.nxml.txt.nlp	22496424	SENT114	29	29	37	37	warfarin	PRDX4	PA451906	10549	0.955
NULL	Biomed_Res_Int_2013_Jul_31_2013_692071.nxml.txt.nlp	23984399	SENT162	18	18	6	6	tramadol	OCT1	PA451735	5451;6580	0.955
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT220	10	10	16	16	atorvastatin	RANK	PA448500	8792	0.955
NULL	Cell_Death_Dis_2014_Feb_27_5(2)_e1088.nxml.txt.nlp	24577086	SENT127	7	7	19	19	metformin	Bcl-2	PA450395	596	0.955
NULL	Acta_Pharmacol_Sin_2012_Aug_23_33(8)_1095-1100.nxml.txt.nlp	22820908	SENT110	2	2	10	10	omeprazole	CYP3A	PA450704	1574	0.955
NULL	Mol_Cancer_2014_Jan_28_13_17.nxml.txt.nlp	24472312	SENT35	7	7	23	23	ponatinib	KIT	PA165980594	3815	0.955
NULL	Diabetes_Care_2013_Aug_17_36(Suppl_2)_S245-S252.nxml.txt.nlp	23882053	SENT9	15	15	10	10	exenatide	GLP-1	PA164749238	100125288	0.955
NULL	Crit_Care_2011_Jun_24_15(3)_R153.nxml.txt.nlp	21702944	SENT214	3	3	21	21	dexmedetomidine	HMGB1	PA449256	3146	0.955
NULL	Exp_Ther_Med_2013_Nov_13_6(5)_1317-1321.nxml.txt.nlp	24223665	SENT112	21	21	6	6	cisplatin	CD133	PA449014	8842	0.955
NULL	Br_J_Cancer_2013_Mar_5_108(4)_748-754.nxml.txt.nlp	23361058	SENT50	10	10	21	21	vorinostat	53BP1	PA164748224	7158	0.955
NULL	Braz_J_Med_Biol_Res_2014_Sep_5_47(11)_929-939.nxml.txt.nlp	25296354	SENT171	30	30	2	2	afatinib	EGFR	PA165981154	1956	0.955
NULL	Mol_Cancer_2010_Nov_8_9_291.nxml.txt.nlp	21059223	SENT10	12	12	2	2	paclitaxel	ZNF217	PA450761	7764	0.955
NULL	Nucleic_Acids_Res_2010_Oct_4_38(19)_6375-6388.nxml.txt.nlp	20525792	SENT156	0	0	14	14	doxycycline	YY1	PA449415	7528	0.955
NULL	Psychiatry_Investig_2012_Dec_12_9(4)_422-424.nxml.txt.nlp	23251210	SENT14	5	5	7	7	terbinafine	CYP2D6	PA451614	1565	0.955
NULL	Adolesc_Health_Med_Ther_2014_Mar_26_5_35-48.nxml.txt.nlp	24729739	SENT33	16	16	3	3	tocilizumab	TNF-alpha	PA165292659	7124	0.955
NULL	Cancer_Immunol_Immunother_2013_Jul_20_62(9)_1533-1545.nxml.txt.nlp	23873089	SENT102	31	31	15	15	paclitaxel	CD69	PA450761	969	0.955
NULL	Br_J_Cancer_2011_Mar_15_104(6)_957-967.nxml.txt.nlp	21364585	SENT93	10	10	25	25	doxorubicin	CD138	PA449412	6382	0.955
NULL	Clin_Sci_(Lond)_2009_Nov_16_118(Pt_4)_269-279.nxml.txt.nlp	19698082	SENT174	14	14	11	11	ramipril	ACE2	PA451223	59272	0.955
NULL	Mol_Vis_2007_Jul_9_13_1083-1093.nxml.txt.nlp	17653053	SENT17	7	7	14	14	minocycline	p38	PA450519	10598;1432;7965	0.955
NULL	Clin_Epigenetics_2010_Nov_9_1(3-4)_117-136.nxml.txt.nlp	21258646	SENT197	20	20	8	8	vorinostat	STAT3	PA164748224	6774	0.955
NULL	Cardiol_Ther_2013_Jun_1_2(1)_111-124.nxml.txt.nlp	25135294	SENT122	17	17	22	22	dabigatran	P-gp		5243	0.955
NULL	Biomed_Res_Int_2013_Sep_5_2013_929531.nxml.txt.nlp	24083250	SENT59	13	13	32	32	hyaluronan	HYAL2	PA165958431	8692	0.955
NULL	J_Gen_Physiol_2000_Jun_1_115(6)_685-696.nxml.txt.nlp	10828243	SENT120	17	17	3	3	genistein	OLF	PA165109660	83857	0.955
NULL	Leukemia_2014_Mar_13_28(3)_600-608.nxml.txt.nlp	24240203	SENT126	0	0	16	16	nutlin-3	p53		7157	0.955
NULL	J_Mol_Med_(Berl)_2014_Jan_10_92(5)_497-507.nxml.txt.nlp	24408111	SENT223	17	17	36	36	pioglitazone	HIF-1	PA450970	29072	0.955
NULL	Case_Rep_Oncol_2014_Sep_25_7(3)_669-672.nxml.txt.nlp	25408661	SENT10	3	3	8	8	aprepitant	CYP3A4	PA164747039	1576	0.955
NULL	Patient_Prefer_Adherence_2011_Dec_23_6_1-9.nxml.txt.nlp	22272064	SENT99	4	4	19	19	telmisartan	ACE	PA451605	1636	0.955
NULL	Cancer_Cell_2007_Dec_11_12(6)_514-527.nxml.txt.nlp	18068629	SENT111	14	14	4	4	paclitaxel	TGFBI	PA450761	7045	0.955
NULL	Cancer_Med_2013_Jun_25_2(3)_277-285.nxml.txt.nlp	23930204	SENT8	22	22	14	14	bevacizumab	PTEN	PA130232992	5728	0.955
NULL	Cancer_Med_2013_Jun_25_2(3)_277-285.nxml.txt.nlp	23930204	SENT159	16	16	1	1	capecitabine	PTEN	PA448771	5728	0.955
NULL	Ann_Gastroenterol_2014_27(1)_79-81.nxml.txt.nlp	24714420	SENT17	35	35	29	29	warfarin	MTHFR	PA451906	4524	0.955
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_315-322.nxml.txt.nlp	20049735	SENT57	6	6	11	11	cisplatin	PTEN	PA449014	5728	0.955
NULL	Cell_Death_Dis_2013_Oct_3_4(10)_e828.nxml.txt.nlp	24091671	SENT86	6	6	28	28	cetuximab	CD44	PA10040	960	0.955
NULL	Br_J_Haematol_2009_Nov_2_147(3)_396-410.nxml.txt.nlp	19758122	SENT12	11	11	27	27	chlorambucil	p53	PA448926	7157	0.955
NULL	Open_Virol_J_2009_Apr_1_3_21-25.nxml.txt.nlp	19572053	SENT104	20	20	26	26	pp2	CXCR4		7852	0.955
NULL	Front_Aging_Neurosci_2014_Sep_11_6_218.nxml.txt.nlp	25309423	SENT215	3	3	40	40	resveratrol	HO-1		3162	0.955
NULL	Front_Oncol_2013_Apr_23_3_86.nxml.txt.nlp	23630663	SENT149	18	18	7	7	neratinib	ERBB2	PA165291472	2064	0.955
NULL	Arthritis_Res_Ther_2006_Dec_14_8(1)_102.nxml.txt.nlp	16542465	SENT29	35	35	14	14	infliximab	ACR	PA452639	49	0.955
NULL	Oncotarget_2014_Nov_11_5(22)_11490-11500.nxml.txt.nlp	25359780	SENT59	14	14	3	3	docetaxel	PC3	PA449383	57332;7832;5122	0.955
NULL	Biomed_Res_Int_2013_Jun_6_2013_928271.nxml.txt.nlp	23841099	SENT21	0	0	6	6	ticagrelor	P2Y12	PA165374673	64805	0.955
NULL	Biologics_2010_Aug_9_4_187-197.nxml.txt.nlp	20714356	SENT152	9	9	27	27	pazopanib	HER2	PA165291492	2064	0.955
NULL	Br_J_Cancer_2011_Jul_12_105(2)_246-254.nxml.txt.nlp	21712828	SENT31	11	11	1	1	panitumumab	EGFR	PA162373091	1956	0.954
NULL	Nat_Commun_2013_Aug_15_4_2130.nxml.txt.nlp	23945651	SENT130	25	25	15	15	etoposide	survivin	PA449552	332	0.954
NULL	Ann_Oncol_2011_Mar_8_22(3)_503-514.nxml.txt.nlp	20616198	SENT300	2	2	11	11	anastrozole	aromatase	PA448432	1588	0.954
NULL	Front_Genet_2012_Nov_12_3_235.nxml.txt.nlp	23162568	SENT137	3	3	7	7	ritonavir	CYP2D6	PA451260	1565	0.954
NULL	Case_Rep_Hematol_2013_Jul_7_2013_896394.nxml.txt.nlp	23936694	SENT23	24	24	36	36	docetaxel	aromatase	PA449383	1588	0.954
NULL	Case_Rep_Med_2013_Jun_12_2013_167267.nxml.txt.nlp	23840216	SENT52	25	25	11	11	vasopressin	ACTH	PA451858	5443	0.954
NULL	ScientificWorldJournal_2012_Apr_26_2012_358102.nxml.txt.nlp	22645419	SENT146	16	16	10	10	captopril	AT2	PA448780	186	0.954
NULL	Clin_Neuropathol_2013_May_2_May-Jun_32(3)_148-158.nxml.txt.nlp	23618424	SENT211	18	18	10	10	temozolomide	IDH2	PA451609	3418	0.954
NULL	Diabetes_Care_2013_Jul_12_36(7)_2118-2125.nxml.txt.nlp	23645885	SENT50	6	6	26	26	exenatide	GLP-1	PA164749238	100125288	0.954
NULL	Front_Synaptic_Neurosci_2011_Nov_3_3_6.nxml.txt.nlp	22065958	SENT264	10	10	28	28	isoproterenol	ANOVA	PA450121	4858	0.954
NULL	Eur_Respir_J_2014_Jul_23_44(1)_23-63.nxml.txt.nlp	24659544	SENT93	27	27	44	44	isoniazid	DST	PA450112	667	0.954
NULL	J_Oncol_2010_Jun_24_2010_412985.nxml.txt.nlp	20628489	SENT26	4	4	2	2	geldanamycin	Hsp90	PA152031327	3320	0.954
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT293	6	6	13	13	erlotinib	EGFR	PA134687924	1956	0.954
NULL	Hum_Genomics_2004_May_1_1(4)_300-306.nxml.txt.nlp	15588489	SENT99	12	12	23	23	debrisoquine	CYP2D6	PA452616	1565	0.954
NULL	Eur_Heart_J_2013_Dec_1_34(45)_3515-3524.nxml.txt.nlp	23594590	SENT156	14	14	12	12	indomethacin	COX	PA449982	1351	0.954
NULL	Breast_Cancer_Res_2010_Jul_22_12(4)_R53.nxml.txt.nlp	20649975	SENT4	18	18	13	13	tamoxifen	HOXB13	PA451581	10481	0.954
NULL	Cell_Res_2011_Mar_11_21(3)_530-545.nxml.txt.nlp	21221130	SENT102	12	12	7	7	thrombin	PAC-1	PA451674	1844	0.954
NULL	Diabetes_Care_2012_Feb_16_35(2)_327-333.nxml.txt.nlp	22179958	SENT143	47	47	7	7	metformin	B12	PA450395	7126;4709	0.954
NULL	J_Gen_Physiol_2008_Nov_132(5)_521-535.nxml.txt.nlp	18852303	SENT352	28	28	0	0	trypsin	CAP2	PA451806	5271;10486	0.954
NULL	ScientificWorldJournal_2014_Mar_24_2014_694326.nxml.txt.nlp	24782665	SENT39	8	8	16	16	metformin	FDG	PA450395	23583	0.954
NULL	Int_J_Nanomedicine_2007_Jun_2(2)_143-161.nxml.txt.nlp	17722543	SENT120	0	0	10	10	sirolimus	DES	PA451365	1674	0.954
NULL	J_Cancer_2013_Sep_27_4(8)_662-670.nxml.txt.nlp	24155778	SENT200	23	23	9	9	cisplatin	AEN	PA449014	64782	0.954
NULL	Viruses_2014_Apr_14_6(4)_1715-1758.nxml.txt.nlp	24736215	SENT2902	23	23	21	21	maraviroc	CCR5	PA164768835	1234	0.954
NULL	Cancer_Med_2014_Jun_19_3(3)_555-564.nxml.txt.nlp	24648042	SENT132	23	23	3	3	chlorambucil	SF3B1	PA448926	23451	0.954
NULL	Mol_Vis_2012_May_1_18_1115-1122.nxml.txt.nlp	22605923	SENT116	24	24	14	14	estradiol	p38	PA449503	10598;1432;7965	0.954
NULL	Clin_Pharmacol_2013_Dec_9_5_185-192.nxml.txt.nlp	24353446	SENT77	46	46	37	37	clopidogrel	CYP3A4	PA449053	1576	0.954
NULL	Breast_Cancer_Res_2005_Apr_12_7(4)_R570-R579.nxml.txt.nlp	15987464	SENT106	6	6	0	0	gefitinib	EGFR	PA131301952	1956	0.954
NULL	Oxid_Med_Cell_Longev_2013_Jun_2_2013_793525.nxml.txt.nlp	23819014	SENT245	14	14	5	5	resveratrol	SGBS		2719	0.954
NULL	Mol_Cancer_2014_Apr_29_13_96.nxml.txt.nlp	24779681	SENT216	7	7	15	15	tamoxifen	HER-2	PA451581	2064	0.954
NULL	Multidiscip_Respir_Med_2011_Oct_31_6(5)_313-317.nxml.txt.nlp	22958860	SENT62	10	10	20	20	sirolimus	LAM	PA451365	7249;7248	0.954
NULL	Oncol_Rep_2012_Apr_30_27(4)_923-928.nxml.txt.nlp	22209766	SENT92	16	16	1	1	erlotinib	EGFR	PA134687924	1956	0.954
NULL	Mol_Cancer_2013_May_24_12_47.nxml.txt.nlp	23705854	SENT16	11	11	15	15	celecoxib	P-gp	PA448871	5243	0.954
NULL	Arch_Med_Sci_2012_May_9_8(2)_375-388.nxml.txt.nlp	22662015	SENT256	40	40	28	28	lansoprazole	CYP2C19	PA450180	1557	0.954
NULL	Braz_J_Med_Biol_Res_2014_Aug_15_47(10)_826-833.nxml.txt.nlp	25140811	SENT33	29	29	36	36	phenylephrine	AMPK	PA450935	5563	0.954
NULL	Drugs_R_D_2010_Nov_25_10(4)_219-224.nxml.txt.nlp	21171668	SENT10	12	12	32	32	clopidogrel	DES	PA449053	1674	0.954
NULL	Diabetes_2013_Mar_14_62(3)_953-964.nxml.txt.nlp	23223176	SENT193	26	26	36	36	glucose	PRX	PA449773	9588;57716	0.954
NULL	Pharmaceuticals_(Basel)_2012_Sep_10_5(9)_944-962.nxml.txt.nlp	24280699	SENT396	13	13	21	21	geldanamycin	Hsp90	PA152031327	3320	0.954
NULL	Ann_Rheum_Dis_2008_Nov_14_67(11)_1516-1523.nxml.txt.nlp	18625622	SENT7	21	21	9	9	tocilizumab	TNF	PA165292659	7124	0.954
NULL	Nature_2008_Oct_23_455(7216)_1076-1081.nxml.txt.nlp	18948948	SENT125	12	12	0	0	staurosporine	BAX	PA165109623	581	0.954
NULL	Cell_Commun_Signal_2013_Oct_1_11_73.nxml.txt.nlp	24083678	SENT245	6	6	24	24	sulindac	IL-8	PA451565	3576	0.954
NULL	Mediators_Inflamm_1998_7(6)_391-396.nxml.txt.nlp	9927231	SENT3	13	13	3	3	forskolin	GM-CSF	PA146096022	1437	0.954
NULL	Int_J_Med_Sci_2015_Jan_1_12(2)_92-99.nxml.txt.nlp	25589885	SENT162	5	5	12	12	panitumumab	EGFR	PA162373091	1956	0.954
NULL	Cancer_Med_2014_Oct_3_3(5)_1322-1335.nxml.txt.nlp	24989836	SENT138	2	2	39	39	vorinostat	PC3	PA164748224	57332;7832;5122	0.954
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_16_2012_395912.nxml.txt.nlp	23118789	SENT150	9	9	0	0	sn-38	UGT1A7		54577	0.954
NULL	Front_Aging_Neurosci_2010_Mar_19_2_11.nxml.txt.nlp	20552049	SENT311	2	2	35	35	sulindac	GluN2B	PA451565	2904	0.954
NULL	Ann_Rheum_Dis_2008_Jul_22_68(8)_1303-1309.nxml.txt.nlp	18647851	SENT142	19	19	3	3	adalimumab	MMP13	PA10004	4322	0.954
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT137	7	7	28	28	trastuzumab	HER2	PA451743	2064	0.954
NULL	Chin_J_Cancer_2011_May_30(5)_293-302.nxml.txt.nlp	21527062	SENT67	0	0	25	25	pertuzumab	HER2		2064	0.954
NULL	EMBO_Mol_Med_2012_Jun_13_4(6)_515-527.nxml.txt.nlp	22416035	SENT223	29	29	17	17	olaparib	p53		7157	0.954
NULL	Infect_Dis_Rep_2013_Jun_6_5(Suppl_1)_e5.nxml.txt.nlp	24470969	SENT93	14	14	19	19	elvitegravir	CCR5	PA165291498	1234	0.954
NULL	Front_Behav_Neurosci_2014_May_6_8_147.nxml.txt.nlp	24834033	SENT70	35	35	23	23	fluoxetine	CFD	PA449673	1675	0.954
NULL	Br_J_Cancer_2010_Sep_7_103(6)_765-771.nxml.txt.nlp	20700120	SENT148	17	17	20	20	tamoxifen	aromatase	PA451581	1588	0.954
NULL	J_Cancer_2013_Sep_27_4(8)_662-670.nxml.txt.nlp	24155778	SENT180	23	23	13	13	carboplatin	UCHL1	PA448803	7345	0.954
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1709-1716.nxml.txt.nlp	19844235	SENT227	6	6	25	25	gemcitabine	B7-H3	PA449748	80381	0.954
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1137-1144.nxml.txt.nlp	20234366	SENT138	6	6	0	0	cetuximab	MKP-1	PA10040	1843	0.954
NULL	Diabetes_Obes_Metab_2011_Apr_13(4)_348-356.nxml.txt.nlp	21205128	SENT93	20	20	3	3	glimepiride	PPG	PA449761	5552	0.954
NULL	Oncogene_2009_Jan_15_28(2)_279-288.nxml.txt.nlp	18836480	SENT66	38	38	8	8	pp2	PP2		4888	0.954
NULL	J_Adv_Pract_Oncol_2012_Sep_1_Sep-Oct_3(5)_289-298.nxml.txt.nlp	25031958	SENT68	4	4	10	10	letrozole	aromatase	PA450196	1588	0.954
NULL	Oncol_Lett_2013_Mar_2_5(3)_877-883.nxml.txt.nlp	23426065	SENT31	5	5	24	24	verapamil	EGF	PA451868	1950	0.954
NULL	Br_J_Cancer_2009_Mar_24_100(6)_941-949.nxml.txt.nlp	19240716	SENT142	21	21	17	17	gefitinib	Met	PA131301952	79811	0.954
NULL	Int_J_Biol_Sci_2013_Mar_7_9(3)_279-288.nxml.txt.nlp	23493630	SENT114	40	40	29	29	tocilizumab	CD4	PA165292659	920	0.954
NULL	Nat_Med_2011_Aug_28_17(9)_1094-1100.nxml.txt.nlp	21873989	SENT39	22	22	13	13	imatinib	IL-10	PA10804	3586	0.954
NULL	Ther_Clin_Risk_Manag_2006_Sep_2(3)_297-301.nxml.txt.nlp	18360604	SENT81	8	8	14	14	paricalcitol	PTH	PA450798	5741	0.954
NULL	Eur_J_Pharmacol_2013_Sep_15_716(1-3)_188-202.nxml.txt.nlp	23500200	SENT41	16	16	5	5	carbamazepine	PEPD	PA448785	5184	0.954
NULL	Acta_Neuropathol_2012_Mar_16_123(3)_369-380.nxml.txt.nlp	22083253	SENT82	6	6	21	21	vincristine	NF1	PA451879	4763	0.954
NULL	Autophagy_2012_May_1_8(5)_853-855.nxml.txt.nlp	22617440	SENT66	6	6	2	2	imatinib	MIR30A	PA10804	407029	0.954
NULL	J_Invest_Dermatol_2013_Jul_13_133(7)_1742-1751.nxml.txt.nlp	23407402	SENT10	8	8	0	0	etanercept	TREM-1	PA449515	54210	0.954
NULL	Crit_Care_2004_Oct_27_8(6)_R474-R482.nxml.txt.nlp	15566594	SENT133	16	16	4	4	ns-398	IL-6		3569	0.954
NULL	Breast_Cancer_Res_Treat_2014_Apr_9_145(1)_73-82.nxml.txt.nlp	24715380	SENT123	14	14	8	8	tamoxifen	CXCR3	PA451581	2833	0.954
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT211	8	8	2	2	chloroquine	BMPR-II	PA448948	659	0.954
NULL	Biochem_Res_Int_2012_Aug_15_2012_940405.nxml.txt.nlp	22928112	SENT194	13	13	28	28	lapatinib	AKT	PA152241907	207	0.954
NULL	Clin_Drug_Investig_2015_Dec_4_35_45-51.nxml.txt.nlp	25471740	SENT146	8	8	30	30	atorvastatin	CYP2C9	PA448500	1559	0.954
NULL	Breast_Cancer_Res_2010_Jul_22_12(4)_R53.nxml.txt.nlp	20649975	SENT165	23	23	21	21	letrozole	aromatase	PA450196	1588	0.954
NULL	Nucleic_Acids_Res_2005_May_24_33(9)_2962-2979.nxml.txt.nlp	15914670	SENT266	3	3	13	13	heparin	HuR	PA449855	1994	0.954
NULL	Mol_Cancer_2008_Jan_25_7_14.nxml.txt.nlp	18221502	SENT233	26	26	18	18	mercaptopurine	PSAT1	PA450379	29968	0.954
NULL	Evid_Based_Complement_Alternat_Med_2012_Dec_20_2012_908601.nxml.txt.nlp	23326293	SENT163	3	3	15	15	oxaliplatin	EMT	PA131285527	3702;6581	0.954
NULL	Exp_Ther_Med_2014_Nov_29_8(5)_1473-1478.nxml.txt.nlp	25289044	SENT190	2	2	18	18	heparin	AZU	PA449855	566	0.954
NULL	Br_J_Ophthalmol_2010_May_94(5)_639-642.nxml.txt.nlp	20447966	SENT67	10	10	39	39	fluorometholone	MYOC	PA164781355	4653	0.954
NULL	Arthritis_Res_Ther_2009_Feb_23_11(1)_216.nxml.txt.nlp	19291269	SENT158	32	32	14	14	anakinra	ACR	PA10799	49	0.954
NULL	Breast_Cancer_Res_2007_Aug_8_9(4)_R50.nxml.txt.nlp	17686159	SENT236	12	12	22	22	gefitinib	EGFR	PA131301952	1956	0.954
NULL	Oncotarget_2011_Mar_23_2(3)_165-177.nxml.txt.nlp	21444946	SENT63	30	30	0	0	docetaxel	EGFR	PA449383	1956	0.954
NULL	J_Mol_Signal_2010_May_10_5_4.nxml.txt.nlp	20459745	SENT87	8	8	0	0	cisplatin	p53	PA449014	7157	0.954
NULL	Breast_Cancer_Res_2011_Apr_1_13(2)_R35.nxml.txt.nlp	21457545	SENT212	24	24	40	40	gefitinib	KRAS	PA131301952	3845	0.954
NULL	Trials_2013_Sep_23_14_307.nxml.txt.nlp	24059911	SENT279	25	25	3	3	clindamycin	ACT	PA449035	12;11332;9457;641455	0.954
NULL	Oncogene_2013_Sep_26_32(39)_10_1038_onc_2012_491.nxml.txt.nlp	23108394	SENT99	24	24	3	3	epirubicin	BRIP1	PA449476	64979;83990	0.954
NULL	Evid_Based_Complement_Alternat_Med_2012_Dec_20_2012_908601.nxml.txt.nlp	23326293	SENT6	15	15	7	7	oxaliplatin	HCC	PA131285527	84668	0.954
NULL	Int_J_Med_Sci_2013_Mar_19_10(5)_599-606.nxml.txt.nlp	23569422	SENT74	4	4	9	9	propofol	HO-1	PA451141	3162	0.954
NULL	Allergy_Asthma_Immunol_Res_2014_Jul_27_6(4)_288-295.nxml.txt.nlp	24991451	SENT74	12	12	2	2	montelukast	IL-5	PA450546	3567	0.954
NULL	Int_J_Mol_Sci_2014_Sep_11_15(9)_15994-16011.nxml.txt.nlp	25216334	SENT38	28	28	23	23	sorafenib	VEGFR	PA7000	3791	0.954
NULL	Int_J_Mol_Sci_2014_Sep_15_15(9)_16284-16301.nxml.txt.nlp	25226537	SENT308	11	11	20	20	doxorubicin	HER-2	PA449412	2064	0.954
NULL	Mol_Cancer_2009_Dec_10_8_118.nxml.txt.nlp	20003259	SENT102	10	10	5	5	sorafenib	ERM	PA7000	2119	0.954
NULL	Can_J_Infect_Dis_Med_Microbiol_2014_Nov-Dec_25(6)_327-343.nxml.txt.nlp	25587296	SENT304	4	4	9	9	cyclosporine	CYP3A4	PA449167	1576	0.954
NULL	Oncotarget_2011_May_13_2(5)_401-406.nxml.txt.nlp	21576761	SENT75	23	23	4	4	lapatinib	HER2	PA152241907	2064	0.954
NULL	Eur_J_Clin_Pharmacol_2014_Oct_8_70(1)_37-45.nxml.txt.nlp	24100471	SENT198	6	6	18	18	gemfibrozil	CYP2C8	PA449750	1558	0.954
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT248	13	13	28	28	perifosine	AKT	PA165291471	207	0.954
NULL	Indian_J_Psychiatry_2007_Jan-Mar_49(1)_26-33.nxml.txt.nlp	20640062	SENT196	9	9	45	45	topiramate	gamma	PA451728	9913	0.954
NULL	Apoptosis_2013_Jun_7_18(6)_664-680.nxml.txt.nlp	23468121	SENT315	10	10	3	3	staurosporine	PDCD2	PA165109623	5134	0.954
NULL	Nat_Commun_2013_Sep_4_4_2338.nxml.txt.nlp	24005565	SENT125	15	15	8	8	cisplatin	RAD51D	PA449014	5892	0.954
NULL	Breast_Cancer_Res_2014_May_28_16(3)_R53.nxml.txt.nlp	24886537	SENT22	12	12	3	3	tamoxifen	VAV3	PA451581	10451	0.954
NULL	J_Mol_Med_(Berl)_2014_Jun_1_92(8)_797-810.nxml.txt.nlp	24880953	SENT188	9	9	3	3	cyclosporine	CD55	PA449167	1604	0.954
NULL	J_Korean_Med_Sci_1994_Dec_9(6)_482-489.nxml.txt.nlp	7786445	SENT10	23	23	2	2	metoprolol	CYP2D6	PA450480	1565	0.954
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_24_2012_673132.nxml.txt.nlp	23133498	SENT121	7	7	19	19	ciprofloxacin	P-gp	PA449009	5243	0.954
NULL	Psychiatry_Investig_2008_Mar_31_5(1)_36-40.nxml.txt.nlp	20046406	SENT92	8	8	1	1	s-adenosylmethionine	B12	PA164754994	7126;4709	0.954
NULL	Biomed_Res_Int_2014_Jan_23_2014_312647.nxml.txt.nlp	24587984	SENT134	5	5	35	35	infliximab	ABCG1	PA452639	9619	0.954
NULL	Breast_Cancer_Res_2010_Jun_28_12(3)_R43.nxml.txt.nlp	20579400	SENT95	13	13	0	0	vinorelbine	MTS	PA451881	1678	0.954
NULL	Int_J_Cell_Biol_2013_May_20_2013_647975.nxml.txt.nlp	23762064	SENT96	32	32	8	8	nadh	GAPDH	PA164755085	2597	0.954
NULL	Nucleic_Acids_Res_2005_Jun_8_33(10)_3283-3291.nxml.txt.nlp	15944449	SENT129	9	9	26	26	mechlorethamine	ERCC1	PA450336	2067	0.954
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT9	22	22	4	4	imatinib	ABCB1	PA10804	5243	0.954
NULL	J_Mol_Signal_2014_Aug_8_9_8.nxml.txt.nlp	25237386	SENT200	29	29	5	5	ns-398	PTGS2		5743	0.954
NULL	J_Geriatr_Cardiol_2012_Jun_9(2)_209-210.nxml.txt.nlp	23097648	SENT9	18	18	8	8	warfarin	CYP4F2	PA451906	8529	0.954
NULL	Proteome_Sci_2003_Jun_12_1_4.nxml.txt.nlp	12818002	SENT86	14	14	5	5	thrombin	PEBP	PA451674	5037	0.954
NULL	Br_J_Cancer_2009_Oct_6_101(7)_1155-1161.nxml.txt.nlp	19738614	SENT128	15	15	3	3	gemcitabine	MUC1	PA449748	4582	0.954
NULL	J_Cardiothorac_Surg_2014_May_9_9_81.nxml.txt.nlp	24885948	SENT172	37	37	14	14	sorafenib	c-fos	PA7000	2353	0.954
NULL	Cancer_Med_2013_Oct_10_2(5)_636-645.nxml.txt.nlp	24403229	SENT55	9	9	30	30	mitomycin	IFN	PA450524	3439	0.954
NULL	Front_Immunol_2013_Nov_7_4_360.nxml.txt.nlp	24223576	SENT163	15	15	0	0	imiquimod	TLR7	PA449972	51284	0.954
NULL	Korean_Circ_J_2014_Mar_12_44(2)_97-104.nxml.txt.nlp	24653739	SENT150	16	16	3	3	bosentan	IL-6	PA10034	3569	0.954
NULL	Oncoimmunology_2013_Sep_1_2(9)_e25770.nxml.txt.nlp	24327936	SENT37	30	30	41	41	doxorubicin	CRT	PA449412	811	0.954
NULL	Case_Rep_Rheumatol_2014_Nov_6_2014_429698.nxml.txt.nlp	25431725	SENT65	38	38	9	9	sulfasalazine	ILBP	PA451547	2172	0.954
NULL	Braz_J_Med_Biol_Res_2014_Sep_5_47(11)_929-939.nxml.txt.nlp	25296354	SENT156	12	12	32	32	afatinib	EGFR	PA165981154	1956	0.954
NULL	Mol_Cell_Biochem_2012_Apr_3_363(1-2)_135-145.nxml.txt.nlp	22139302	SENT220	27	27	31	31	curcumin	survivin	PA151958596	332	0.954
NULL	Br_J_Cancer_2013_Jul_23_109(2)_351-359.nxml.txt.nlp	23799854	SENT14	18	18	3	3	paclitaxel	BLT2	PA450761	56413	0.954
NULL	Clin_Epidemiol_2014_Oct_24_6_379-393.nxml.txt.nlp	25368531	SENT145	21	21	0	0	infliximab	TNF	PA452639	7124	0.954
NULL	Cancers_(Basel)_2010_Dec_30_3(1)_106-125.nxml.txt.nlp	24212609	SENT98	11	11	3	3	gemcitabine	MRP5	PA449748	10057	0.954
NULL	Kidney_Int_Suppl_(2011)_2013_Dec_27_3(4)_392-409.nxml.txt.nlp	NULL	SENT165	10	10	18	18	paricalcitol	PTH	PA450798	5741	0.954
NULL	Exp_Ther_Med_2013_May_15_5(5)_1327-1331.nxml.txt.nlp	23737873	SENT22	8	8	16	16	vasopressin	AVP	PA451858	114548;551	0.954
NULL	Nat_Commun_2012_Feb_21_3_682.nxml.txt.nlp	22353713	SENT464	32	32	10	10	galactose	GAL	PA449725	51083	0.954
NULL	Eur_J_Haematol_2014_Feb_25_92(2)_127-136.nxml.txt.nlp	24118452	SENT27	16	16	7	7	anagrelide	IFN	PA164742986	3439	0.954
NULL	Oncotarget_2011_Apr_20_2(4)_274-276.nxml.txt.nlp	21512204	SENT30	12	12	9	9	nutlin-3	p53		7157	0.954
NULL	Ther_Clin_Risk_Manag_2006_Mar_2(1)_87-98.nxml.txt.nlp	18360584	SENT119	2	2	21	21	sorafenib	MVD	PA7000	4597	0.954
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT120	11	11	2	2	doxorubicin	SLK	PA449412	9748;2534	0.954
NULL	Clin_Med_Insights_Oncol_2013_Jun_20_7_137-149.nxml.txt.nlp	23843723	SENT125	40	40	14	14	dacarbazine	BRAF	PA449197	673	0.954
NULL	J_Oncol_2013_Apr_29_2013_854121.nxml.txt.nlp	23737784	SENT63	0	0	18	18	pertuzumab	HER2		2064	0.954
NULL	Arthritis_Res_Ther_2005_Mar_16_7(Suppl_2)_S4-S14.nxml.txt.nlp	15833146	SENT225	5	5	25	25	cyclosporine	IL-10	PA449167	3586	0.954
NULL	Breast_Cancer_(Dove_Med_Press)_2014_May_2_6_59-71.nxml.txt.nlp	24833917	SENT131	20	20	38	38	letrozole	aromatase	PA450196	1588	0.954
NULL	Ther_Clin_Risk_Manag_2007_Jun_3(3)_401-410.nxml.txt.nlp	18488071	SENT49	0	0	17	17	tramadol	ACR	PA451735	49	0.954
NULL	ScientificWorldJournal_2013_Dec_31_2013_837573.nxml.txt.nlp	24501586	SENT157	16	16	36	36	pamidronate	PTH	PA450767	5741	0.954
NULL	Breast_Cancer_Res_Treat_2012_Jun_18_133(3)_937-947.nxml.txt.nlp	22094936	SENT185	12	12	36	36	tamoxifen	CDC2	PA451581	5424	0.954
NULL	Cancer_Metab_2013_Jan_23_1_3.nxml.txt.nlp	24280005	SENT396	17	17	4	4	doxycycline	SREBP2	PA449415	6721	0.954
NULL	J_Cell_Biol_2000_Jul_10_150(1)_13-26.nxml.txt.nlp	10893252	SENT252	20	20	33	33	nitrogen	ESI	PA450643	5266	0.954
NULL	Cell_Mol_Life_Sci_2012_Oct_6_69(20)_3481-3492.nxml.txt.nlp	22669259	SENT60	18	18	10	10	thrombin	PAR1	PA451674	79581;2149	0.954
NULL	J_Ophthalmol_2010_Jun_22_2010_170393.nxml.txt.nlp	20652047	SENT135	19	19	5	5	telmisartan	RAGE	PA451605	177	0.954
NULL	J_Hematol_Oncol_2013_Jan_17_6_8.nxml.txt.nlp	23327547	SENT131	4	4	21	21	sulindac	p53	PA451565	7157	0.954
NULL	Surg_Today_2014_Mar_20_44(12)_2378-2381.nxml.txt.nlp	24643265	SENT16	12	12	4	4	estradiol	HHT	PA449503	94	0.954
NULL	Acta_Pharmacol_Sin_2009_May_6_30(5)_576-581.nxml.txt.nlp	19349965	SENT107	5	5	23	23	genistein	Bcl-2	PA165109660	596	0.954
NULL	Hum_Genomics_2011_May_1_5(4)_265-282.nxml.txt.nlp	21712189	SENT153	2	2	20	20	efavirenz	CYP2B6	PA449441	1555	0.954
NULL	Arthritis_Res_Ther_2008_Apr_16_10(2)_R43.nxml.txt.nlp	18416822	SENT240	8	8	20	20	sr144528	p44		10561;2966	0.954
NULL	Breast_Cancer_Res_2011_Sep_13_13(5)_R87.nxml.txt.nlp	21914172	SENT193	37	37	32	32	lapatinib	HER2	PA152241907	2064	0.954
NULL	J_Biol_Chem_2012_Aug_3_287(32)_27095-27105.nxml.txt.nlp	22665491	SENT82	31	31	11	11	gentamicin	CO2	PA449753	4513	0.954
NULL	J_Neuroinflammation_2010_Sep_7_7_51.nxml.txt.nlp	20822529	SENT123	8	8	3	3	hemin	HO-2	PA449849	3163	0.954
NULL	Arthritis_Res_Ther_2004_Sep_23_6(6)_R535-R543.nxml.txt.nlp	15535831	SENT54	20	20	8	8	infliximab	TPO	PA452639	7066;7173	0.954
NULL	Cell_Death_Dis_2011_Aug_11_2(8)_e191.nxml.txt.nlp	21833029	SENT12	32	32	4	4	oxaliplatin	CT26	PA131285527	168400	0.954
NULL	J_Gen_Physiol_2000_Mar_1_115(3)_229-240.nxml.txt.nlp	10694252	SENT225	0	0	10	10	dofetilide	HERG	PA449389	3757	0.954
NULL	Clin_Interv_Aging_2015_Jan_14_10_269-275.nxml.txt.nlp	25609939	SENT32	14	14	24	24	donepezil	CYP2D6	PA449394	1565	0.954
NULL	Case_Rep_Oncol_2010_Jun_30_4(2)_327-335.nxml.txt.nlp	21738504	SENT5	23	23	8	8	epirubicin	HCC	PA449476	84668	0.954
NULL	Int_J_Mol_Sci_2012_Dec_3_13(12)_16373-16386.nxml.txt.nlp	23208375	SENT148	20	20	4	4	cisplatin	DDB2	PA449014	1643	0.954
NULL	Ann_Oncol_2012_Dec_2_23(12)_3007-3016.nxml.txt.nlp	22865781	SENT103	10	10	19	19	trastuzumab	PTEN	PA451743	5728	0.954
NULL	Front_Chem_2014_Dec_23_2_113.nxml.txt.nlp	25566531	SENT160	27	27	12	12	curcumin	ACOX1	PA151958596	51	0.954
NULL	Semin_Immunopathol_2013_May_10_35(3)_351-373.nxml.txt.nlp	23572207	SENT372	10	10	5	5	bortezomib	XBP1	PA10252	7494	0.954
NULL	Clin_Ophthalmol_2014_Mar_2_8_343-346.nxml.txt.nlp	24591809	SENT28	5	5	16	16	ranibizumab	PED	PA164746012	8682	0.954
NULL	F1000Prime_Rep_2013_Jul_1_5_23.nxml.txt.nlp	23864930	SENT58	44	44	3	3	methysergide	LTF	PA164743265	4057	0.954
NULL	Biologics_2010_Feb_4_4_19-31.nxml.txt.nlp	20161982	SENT110	11	11	42	42	imatinib	KIT	PA10804	3815	0.954
NULL	Oncol_Rep_2012_Nov_31_28(5)_1544-1550.nxml.txt.nlp	22940844	SENT147	19	19	34	34	amifostine	p53	PA448365	7157	0.954
NULL	Mol_Biol_Rep_2012_May_20_39(5)_5253-5267.nxml.txt.nlp	22183301	SENT120	18	18	12	12	gliclazide	NAC	PA10892	22861	0.954
NULL	Breast_Cancer_Res_2010_Apr_30_12(2)_203.nxml.txt.nlp	20459590	SENT52	23	23	9	9	etoposide	BRCA1	PA449552	672	0.954
NULL	Oxid_Med_Cell_Longev_2013_Mar_7_2013_297512.nxml.txt.nlp	23533687	SENT126	0	0	29	29	ethanol	ADP	PA448073	23038	0.954
NULL	Biologics_2012_Jun_20_6_147-154.nxml.txt.nlp	22807625	SENT44	26	26	6	6	trastuzumab	EGFR	PA451743	1956	0.954
NULL	Addict_Biol_2011_Jan_16(1)_82-91.nxml.txt.nlp	20579004	SENT83	4	4	10	10	naltrexone	ghrelin	PA450588	51738	0.954
NULL	Support_Care_Cancer_2013_May_26_21(5)_1453-1460.nxml.txt.nlp	23354552	SENT4	0	0	45	45	palonosetron	HEC	PA10352	10403	0.954
NULL	Front_Oncol_2014_Mar_3_4_34.nxml.txt.nlp	24624361	SENT260	19	19	11	11	olaparib	BRCA1		672	0.954
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1420-1426.nxml.txt.nlp	24056704	SENT54	9	9	6	6	ketoconazole	CYP3A	PA450146	1574	0.954
NULL	Eukaryot_Cell_2014_Aug_13(8)_1077-1084.nxml.txt.nlp	24951438	SENT120	14	14	29	29	doxycycline	ACT1	PA449415	10758	0.954
NULL	F1000_Biol_Rep_2009_Mar_24_1_23.nxml.txt.nlp	20948663	SENT13	19	19	2	2	venlafaxine	ABCB1	PA451866	5243	0.954
NULL	Pharmaceuticals_(Basel)_2013_Nov_11_6(11)_1429-1450.nxml.txt.nlp	24287465	SENT163	44	44	42	42	vemurafenib	BRAF	PA165946873	673	0.954
NULL	Lab_Invest_2011_Oct_27_91(10)_1480-1490.nxml.txt.nlp	21709671	SENT127	28	28	16	16	fluorescein	MYB	PA164746009	4602	0.954
NULL	Cell_Cycle_2014_Jan_1_13(1)_90-95.nxml.txt.nlp	24196441	SENT5	17	17	7	7	camptothecin	P21	PA153590860	1026;9338	0.954
NULL	Cell_Death_Dis_2012_Nov_29_3(11)_e434.nxml.txt.nlp	23190606	SENT52	29	29	25	25	geldanamycin	Hsp90	PA152031327	3320	0.954
NULL	Ther_Clin_Risk_Manag_2005_Dec_1(4)_299-306.nxml.txt.nlp	18360572	SENT11	7	7	15	15	terbinafine	CYP2D6	PA451614	1565	0.954
NULL	Br_J_Cancer_1998_Jun_77(12)_2267-2273.nxml.txt.nlp	9649144	SENT17	40	40	3	3	epirubicin	p53	PA449476	7157	0.954
NULL	Mol_Cancer_2013_Mar_5_12_17.nxml.txt.nlp	23497256	SENT233	15	15	13	13	nutlin-3	HDM2		4193	0.954
NULL	Mol_Cancer_2010_Aug_4_9_208.nxml.txt.nlp	20684776	SENT51	29	29	12	12	doxorubicin	CDK1	PA449412	983	0.954
NULL	Int_J_Vasc_Med_2012_Jan_4_2012_657025.nxml.txt.nlp	22347626	SENT24	20	20	23	23	pitavastatin	PTX3	PA142650384	5806	0.954
NULL	Br_J_Cancer_2012_May_22_106(11)_1826-1832.nxml.txt.nlp	22549179	SENT8	27	27	13	13	panitumumab	KRAS	PA162373091	3845	0.954
NULL	Nat_Commun_2014_5_3361.nxml.txt.nlp	24553445	SENT101	8	8	20	20	olaparib	BRCA1		672	0.954
NULL	Br_J_Cancer_2011_Jun_7_104(12)_1828-1835.nxml.txt.nlp	21559012	SENT167	15	15	10	10	tamoxifen	EGFR	PA451581	1956	0.954
NULL	Eur_J_Clin_Pharmacol_2012_Jan_8_68(1)_29-37.nxml.txt.nlp	21739267	SENT6	3	3	14	14	aripiprazole	CYP2D6	PA10026	1565	0.954
NULL	Scientifica_(Cairo)_2012_Dec_17_2012_502378.nxml.txt.nlp	24278706	SENT132	0	0	17	17	rivaroxaban	CYP3A4	PA165958360	1576	0.954
NULL	Eur_J_Clin_Pharmacol_2012_Sep_15_68(9)_1267-1274.nxml.txt.nlp	22418828	SENT168	26	26	16	16	pantoprazole	CYP2C19	PA450774	1557	0.954
NULL	Br_J_Cancer_2012_Apr_24_106(9)_1543-1550.nxml.txt.nlp	22531721	SENT172	18	18	26	26	trastuzumab	CD55	PA451743	1604	0.954
NULL	J_Vet_Med_Sci_2014_Aug_15_76(8)_1119-1127.nxml.txt.nlp	24829081	SENT27	8	8	0	0	thrombin	PAR-1	PA451674	2011;2149	0.954
NULL	Cholesterol_2011_Feb_22_2011_503028.nxml.txt.nlp	21490773	SENT112	5	5	21	21	methotrexate	ABCA1	PA450428	19	0.954
NULL	Neural_Plast_2007_Dec_11_2007_73079.nxml.txt.nlp	NULL	SENT1259	38	38	20	20	desipramine	5-HT1A	PA449233	3350	0.954
NULL	Breast_Cancer_Res_2008_Apr_1_10(2)_R30.nxml.txt.nlp	18380893	SENT49	22	22	9	9	doxorubicin	p53	PA449412	7157	0.954
NULL	J_Carcinog_2013_Mar_18_12_7.nxml.txt.nlp	23599689	SENT123	19	19	5	5	crizotinib	ROS1	PA165946122	6098	0.954
NULL	Eur_J_Haematol_2013_Feb_22_90(2)_89-98.nxml.txt.nlp	23181448	SENT125	25	25	13	13	imatinib	ASM	PA10804	6609;283120	0.954
NULL	EJC_Suppl_2013_Sep_5_11(2)_307-309.nxml.txt.nlp	NULL	SENT50	6	6	30	30	neratinib	EGFR	PA165291472	1956	0.954
NULL	Iran_J_Pediatr_2011_Jun_21(2)_244-248.nxml.txt.nlp	23056796	SENT110	12	12	21	21	colchicine	MEFV	PA449092	4210	0.954
NULL	Br_J_Haematol_2009_Nov_2_147(3)_396-410.nxml.txt.nlp	19758122	SENT42	2	2	28	28	dasatinib	TP53	PA162372878	7157	0.954
NULL	Front_Oncol_2014_Jun_12_4_144.nxml.txt.nlp	24971229	SENT162	25	25	2	2	cisplatin	HOTAIR	PA449014	100124700	0.954
NULL	EMBO_Mol_Med_2012_Sep_7_4(9)_896-909.nxml.txt.nlp	22887866	SENT251	9	9	12	12	metformin	c-Myc	PA450395	4609	0.954
NULL	Crit_Care_2010_Jul_30_14(4)_R143.nxml.txt.nlp	20673352	SENT172	22	22	7	7	simvastatin	IL-6	PA451363	3569	0.954
NULL	Diabetes_Metab_Syndr_Obes_2014_Mar_18_7_107-120.nxml.txt.nlp	24672252	SENT50	17	17	7	7	exenatide	GLP-1	PA164749238	100125288	0.954
NULL	Acta_Pharmacol_Sin_2010_Jun_4_31(6)_741-745.nxml.txt.nlp	20523344	SENT104	9	9	17	17	gemcitabine	p65	PA449748	5970	0.954
NULL	Pharmaceuticals_(Basel)_2014_Sep_17_7(9)_943-953.nxml.txt.nlp	25232798	SENT120	20	20	9	9	trastuzumab	HER2	PA451743	2064	0.954
NULL	Int_J_Nanomedicine_2012_May_7_7_2307-2314.nxml.txt.nlp	22661887	SENT174	13	13	2	2	gemcitabine	F10	PA449748	2159	0.954
NULL	Cancers_(Basel)_2013_Jun_5_5(2)_676-713.nxml.txt.nlp	24216997	SENT359	23	23	7	7	decitabine	SPARC	PA164749631	6678	0.954
NULL	Oncoimmunology_2012_Mar_1_1(2)_214-216.nxml.txt.nlp	22720246	SENT20	6	6	29	29	imatinib	BAFF	PA10804	10673	0.954
NULL	Ann_Dermatol_2014_Jun_12_26(3)_363-373.nxml.txt.nlp	24966637	SENT132	15	15	7	7	imiquimod	MT1-MMP	PA449972	4323	0.954
NULL	J_Hematol_Oncol_2012_Oct_2_5_60.nxml.txt.nlp	23031422	SENT17	3	3	26	26	vemurafenib	BRAF	PA165946873	673	0.954
NULL	Indian_J_Med_Paediatr_Oncol_2013_Apr-Jun_34(2)_101-103.nxml.txt.nlp	24049297	SENT23	26	26	35	35	methotrexate	FDG	PA450428	23583	0.954
NULL	Indian_J_Med_Res_2014_Apr_139(4)_572-578.nxml.txt.nlp	24927344	SENT78	29	29	14	14	acenocoumarol	CYP4F2	PA452632	8529	0.954
NULL	Pharmaceuticals_(Basel)_2012_Feb_2_5(2)_114-132.nxml.txt.nlp	24288084	SENT65	18	18	4	4	carrageenan	TRPV1	PA448814	7442	0.954
NULL	Curr_Neuropharmacol_2013_Dec_11(6)_592-597.nxml.txt.nlp	24396335	SENT90	4	4	0	0	thrombin	PAR1	PA451674	79581;2149	0.954
NULL	Diabetes_Metab_Syndr_Obes_2010_Mar_29_3_31-41.nxml.txt.nlp	21437074	SENT21	15	15	10	10	exenatide	GLP-1	PA164749238	100125288	0.954
NULL	An_Bras_Dermatol_2014_Mar-Apr_89(2)_266-273.nxml.txt.nlp	24770503	SENT144	26	26	13	13	thalidomide	ENL	PA451644	4298	0.954
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT238	11	11	21	21	phenformin	LKB1	PA1000	6794	0.954
NULL	Evid_Based_Complement_Alternat_Med_2011_Feb_13_2011_248481.nxml.txt.nlp	19861508	SENT150	2	2	21	21	hesperidin	5-HT4	PA449867	3360	0.954
NULL	Acta_Pharmacol_Sin_2012_Jun_6_33(6)_798-808.nxml.txt.nlp	22669117	SENT59	7	7	35	35	heparin	San	PA449855	80218	0.954
NULL	Diabetes_Care_2010_Jul_31_33(7)_1544-1548.nxml.txt.nlp	20357370	SENT95	11	11	5	5	metformin	STK11	PA450395	6794	0.954
NULL	J_Cancer_2013_Nov_23_4(9)_736-754.nxml.txt.nlp	24312144	SENT136	5	5	9	9	everolimus	EGFR	PA164746311	1956	0.954
NULL	Br_J_Cancer_2013_Feb_19_108(3)_668-675.nxml.txt.nlp	23348520	SENT114	17	17	11	11	cetuximab	KRAS	PA10040	3845	0.954
NULL	Oncol_Lett_2014_Mar_19_7(3)_674-678.nxml.txt.nlp	24527071	SENT130	12	12	4	4	cisplatin	AKR1C2	PA449014	1646	0.954
NULL	Ann_Lab_Med_2012_Jul_20_32(4)_264-269.nxml.txt.nlp	22779067	SENT43	31	31	7	7	isoniazid	DST	PA450112	667	0.954
NULL	Cancer_Immunol_Immunother_2015_Oct_7_64_61-73.nxml.txt.nlp	25287778	SENT218	18	18	11	11	lenalidomide	IL-2	PA162363968	3558	0.954
NULL	Ann_Gen_Psychiatry_2013_Aug_13_12_26.nxml.txt.nlp	23941527	SENT146	11	11	23	23	fluoxetine	NMA	PA449673	25805	0.954
NULL	Cancers_(Basel)_2010_Feb_23_2(1)_88-113.nxml.txt.nlp	24281034	SENT193	0	0	22	22	olaparib	PARP2		10038	0.954
NULL	Br_J_Pharmacol_2014_Jun_15_171(11)_2705-2725.nxml.txt.nlp	24467436	SENT19	28	28	0	0	balsalazide	NAT	PA448536	6046	0.954
NULL	Core_Evid_2011_Mar_17_6_31-42.nxml.txt.nlp	21468241	SENT22	4	4	20	20	clopidogrel	P2Y12	PA449053	64805	0.954
NULL	Indian_J_Nephrol_2012_Mar-Apr_22(2)_139-142.nxml.txt.nlp	22787319	SENT111	17	17	24	24	cyclosporine	MRP2	PA449167	100130958;57626;1244	0.954
NULL	Mol_Cancer_2012_Dec_12_11_91.nxml.txt.nlp	23234355	SENT184	11	11	7	7	erlotinib	EGFR	PA134687924	1956	0.954
NULL	EMBO_Mol_Med_2011_May_3(5)_266-278.nxml.txt.nlp	21438154	SENT244	25	25	14	14	oxaliplatin	HCN1	PA131285527	348980	0.954
NULL	Biosci_Rep_2012_Aug_1_32(Pt_4)_361-374.nxml.txt.nlp	22762204	SENT1128	20	20	2	2	gefitinib	PTEN	PA131301952	5728	0.954
NULL	Ann_Oncol_2010_Mar_28_21(3)_498-505.nxml.txt.nlp	19717534	SENT217	6	6	11	11	exemestane	aromatase	PA449563	1588	0.954
NULL	J_Invest_Dermatol_2013_May_10_133(5)_1302-1310.nxml.txt.nlp	23303459	SENT103	15	15	5	5	bleomycin	p300	PA448645	2033	0.954
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R91.nxml.txt.nlp	22541814	SENT252	3	3	31	31	thrombin	HO-1	PA451674	3162	0.954
NULL	J_Orthop_Surg_2007_May_21_2_9.nxml.txt.nlp	17511887	SENT119	20	20	2	2	alendronate	DPD	PA448082	1806	0.954
NULL	J_Neuroinflammation_2010_Sep_7_7_51.nxml.txt.nlp	20822529	SENT15	9	9	26	26	hemin	HO-1	PA449849	3162	0.954
NULL	Virol_J_2010_Dec_3_7_354.nxml.txt.nlp	21129188	SENT52	33	33	10	10	raltegravir	p24		11261;140767	0.954
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2675-2684.nxml.txt.nlp	24129246	SENT198	37	37	19	19	etoposide	KSR1	PA449552	8844	0.954
NULL	Biomed_Res_Int_2013_Jan_21_2013_581631.nxml.txt.nlp	23484133	SENT190	18	18	26	26	infliximab	IL23R	PA452639	149233	0.954
NULL	Int_J_Gen_Med_2011_Jul_20_4_539-545.nxml.txt.nlp	21845063	SENT71	22	22	19	19	miglitol	adiponectin	PA164776726	9370	0.954
NULL	Angiogenesis_2009_Dec_21_12(4)_303-311.nxml.txt.nlp	19544080	SENT39	3	3	20	20	oxygen	CO2	PA450744	4513	0.954
NULL	Adv_Hematol_2012_Sep_14_2012_524308.nxml.txt.nlp	21941553	SENT251	20	20	31	31	chlorambucil	BAX	PA448926	581	0.954
NULL	Crit_Care_2002_Mar_1_6(Suppl_1)_P34.nxml.txt.nlp	NULL	SENT7	21	21	5	5	mivacurium	COPA	PA450528	1314	0.954
NULL	Br_J_Cancer_2010_Oct_12_103(8)_1192-1200.nxml.txt.nlp	20877358	SENT190	29	29	15	15	doxorubicin	BRCA2	PA449412	675	0.954
NULL	Ann_Dermatol_2014_Dec_26_26(6)_681-687.nxml.txt.nlp	25473218	SENT57	8	8	0	0	ethanol	SOD1	PA448073	6647	0.954
NULL	Clin_Sci_(Lond)_2011_Nov_1_121(Pt_10)_449-458.nxml.txt.nlp	21671887	SENT144	0	0	21	21	simvastatin	AMPK	PA451363	5563	0.954
NULL	Br_J_Cancer_2012_Nov_20_107(11)_1840-1843.nxml.txt.nlp	23099805	SENT93	0	0	5	5	methotrexate	DHFR	PA450428	1719	0.954
NULL	Cancers_(Basel)_2011_Apr_13_3(2)_1957-1974.nxml.txt.nlp	24212791	SENT149	0	0	11	11	cetuximab	KRAS	PA10040	3845	0.954
NULL	Oncol_Lett_2014_May_18_7(5)_1632-1638.nxml.txt.nlp	24765191	SENT121	9	9	17	17	trastuzumab	HER-2	PA451743	2064	0.954
NULL	Clin_Med_Oncol_2008_Mar_27_2_275-287.nxml.txt.nlp	21892289	SENT104	34	34	15	15	rituximab	CD19	PA451261	930	0.954
NULL	Nucleic_Acids_Res_2013_Apr_17_41(7)_4129-4143.nxml.txt.nlp	23420868	SENT283	25	25	9	9	hemin	CD71	PA449849	7037	0.954
NULL	Diabetes_2009_Mar_58(3)_579-589.nxml.txt.nlp	19074989	SENT134	12	12	0	0	lipase	ANGPTL4	PA450239	51129	0.954
NULL	Breast_Cancer_Res_2014_Sep_11_16(5)_430.nxml.txt.nlp	25212826	SENT318	13	13	11	11	exemestane	aromatase	PA449563	1588	0.954
NULL	Mol_Vis_2012_Jun_22_18_1696-1700.nxml.txt.nlp	22773907	SENT60	9	9	12	12	colchicine	MTHFR	PA449092	4524	0.954
NULL	Crit_Care_2004_Mar_15_8(Suppl_1)_P250.nxml.txt.nlp	NULL	SENT5	1	1	7	7	glucose	ABL	PA449773	4547	0.954
NULL	Nat_Commun_2013_Aug_15_4_2130.nxml.txt.nlp	23945651	SENT137	1	1	20	20	etoposide	survivin	PA449552	332	0.954
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_13_2013_468537.nxml.txt.nlp	23956772	SENT23	14	14	26	26	curcumin	p53	PA151958596	7157	0.954
NULL	Br_J_Cancer_2014_Oct_14_111(8)_1552-1561.nxml.txt.nlp	25117814	SENT192	20	20	14	14	cisplatin	XIAP	PA449014	331	0.954
NULL	Blood_Press_Monit_2014_Jun_9_19(3)_164-169.nxml.txt.nlp	24710336	SENT149	25	25	19	19	enalapril	AT1	PA449456	9197;185	0.954
NULL	Toxins_(Basel)_2011_Jun_10_3(6)_551-565.nxml.txt.nlp	22069725	SENT231	18	18	1	1	choline	PTMA	PA448976	5757	0.954
NULL	Cardiovasc_Res_2011_Apr_1_90(1)_140-147.nxml.txt.nlp	21071431	SENT87	0	0	12	12	resveratrol	ROS		6098	0.954
NULL	Mol_Cancer_2010_Apr_23_9_87.nxml.txt.nlp	20416058	SENT159	27	27	17	17	doxorubicin	TRAIL	PA449412	8743	0.954
NULL	Oxid_Med_Cell_Longev_2013_Jul_9_2013_574029.nxml.txt.nlp	23936610	SENT124	28	28	15	15	resveratrol	CO2		4513	0.954
NULL	Pharmaceuticals_(Basel)_2014_Mar_5_7(3)_311-338.nxml.txt.nlp	24603603	SENT265	22	22	27	27	cetuximab	EGFR	PA10040	1956	0.954
NULL	Indian_J_Endocrinol_Metab_2012_Mar_16(Suppl1)_S12-S19.nxml.txt.nlp	22701831	SENT44	13	13	8	8	estradiol	aromatase	PA449503	1588	0.954
NULL	Stroke_Res_Treat_2011_Nov_10_2011_212485.nxml.txt.nlp	22135769	SENT47	20	20	0	0	hydrochlorothiazide	GRK2	PA449899	156	0.954
NULL	Onco_Targets_Ther_2014_Oct_21_7_1945-1954.nxml.txt.nlp	25364265	SENT24	4	4	21	21	sorafenib	HCC	PA7000	84668	0.954
NULL	AIDS_Res_Treat_2014_Nov_9_2014_724958.nxml.txt.nlp	25431661	SENT185	6	6	14	14	nevirapine	CD4	PA450616	920	0.954
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT161	3	3	23	23	tenofovir	CD4	PA10204	920	0.954
NULL	Biofactors_2014_May_6_40(3)_277-283.nxml.txt.nlp	24353111	SENT78	3	3	17	17	choline	PEMT	PA448976	10400	0.954
NULL	Nat_Commun_2013_Apr_23_4_1758.nxml.txt.nlp	23612299	SENT80	0	0	13	13	isoproterenol	SOD1	PA450121	6647	0.954
NULL	Cancer_Cell_Int_2009_Feb_17_9_4.nxml.txt.nlp	19222856	SENT195	44	44	14	14	cisplatin	p53	PA449014	7157	0.954
NULL	Diabetes_Care_2011_Jul_17_34(7)_e115-e120.nxml.txt.nlp	21709286	SENT88	27	27	0	0	berberine	AMPK	PA165860812	5563	0.954
NULL	Daru_2012_Oct_15_20(1)_55.nxml.txt.nlp	23352178	SENT49	3	3	8	8	quetiapine	CYP1A2	PA451201	1544	0.954
NULL	Breast_Cancer_Res_2009_Oct_15_11(5)_110.nxml.txt.nlp	19849815	SENT43	26	26	2	2	trastuzumab	HER2	PA451743	2064	0.954
NULL	Adv_Urol_2012_Oct_26_2012_812398.nxml.txt.nlp	22110495	SENT50	14	14	4	4	cisplatin	ERCC1	PA449014	2067	0.954
NULL	Clinics_(Sao_Paulo)_2013_Oct_68(10)_1325-1332.nxml.txt.nlp	24212839	SENT41	25	25	5	5	ribavirin	IL28B	PA451241	282617	0.954
NULL	Exp_Ther_Med_2013_Oct_20_6(4)_899-903.nxml.txt.nlp	24137286	SENT95	31	31	22	22	rosuvastatin	p38	PA134308647	10598;1432;7965	0.954
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT639	4	4	10	10	phenobarbital	CAR	PA450911	1525;6687;9970	0.954
NULL	Oncogene_2014_Aug_28_33(35)_4407-4417.nxml.txt.nlp	24469038	SENT242	26	26	4	4	cisplatin	14-3-3	PA449014	10971	0.954
NULL	Br_J_Cancer_2010_Jun_29_103(1)_61-72.nxml.txt.nlp	20588279	SENT309	3	3	23	23	trastuzumab	EGF	PA451743	1950	0.954
NULL	Int_J_Cell_Biol_2014_Jan_22_2014_709828.nxml.txt.nlp	24578708	SENT76	0	0	37	37	choline	CTL1	PA448976	23446	0.954
NULL	J_Cardiothorac_Surg_2012_Sep_27_7_97.nxml.txt.nlp	23013706	SENT136	30	30	14	14	warfarin	CYP4F2	PA451906	8529	0.954
NULL	Acta_Pharmacol_Sin_2009_Sep_24_30(9)_1323-1329.nxml.txt.nlp	19701237	SENT121	17	17	13	13	clarithromycin	CYP3A	PA449028	1574	0.954
NULL	J_Mol_Signal_2014_Mar_6_9_1.nxml.txt.nlp	24597858	SENT107	3	3	12	12	carvedilol	EGFR	PA448817	1956	0.954
NULL	J_Exp_Clin_Cancer_Res_2009_Jun_6_28(1)_76.nxml.txt.nlp	19500405	SENT240	6	6	24	24	gemcitabine	p53	PA449748	7157	0.954
NULL	Cell_Death_Differ_2010_Oct_30_17(10)_1624-1635.nxml.txt.nlp	20431602	SENT107	32	32	24	24	paclitaxel	Bcl-2	PA450761	596	0.954
NULL	Int_J_Mol_Sci_2014_Sep_5_15(9)_15754-15765.nxml.txt.nlp	25198898	SENT5	5	5	34	34	curcumin	MKK4	PA151958596	6416	0.954
NULL	Oncotarget_2013_Nov_23_5(1)_196-210.nxml.txt.nlp	24344116	SENT152	12	12	4	4	doxorubicin	p53	PA449412	7157	0.954
NULL	Cancer_Cell_Int_2014_Jun_16_14_53.nxml.txt.nlp	24966801	SENT61	8	8	37	37	l-glutamine	CO2	PA10090	4513	0.954
NULL	Scientifica_(Cairo)_2012_Nov_25_2012_478631.nxml.txt.nlp	24278700	SENT271	19	19	3	3	ribavirin	SOC	PA451241	91544	0.954
NULL	J_Young_Pharm_2010_Apr-Jun_2(2)_196-200.nxml.txt.nlp	21264125	SENT123	4	4	6	6	glimepiride	CYP2C9	PA449761	1559	0.954
NULL	Indian_J_Med_Res_2012_Aug_136(2)_249-259.nxml.txt.nlp	22960892	SENT137	43	43	8	8	irinotecan	UGT1A1	PA450085	54658	0.954
NULL	Structure_2012_May_9_20-540(5-7)_841-849.nxml.txt.nlp	22579251	SENT86	5	5	40	40	formoterol	EL2	PA134687907	6708	0.954
NULL	Arthritis_Res_2001_Dec_19_3(2)_77-79.nxml.txt.nlp	11178113	SENT42	8	8	3	3	probenecid	ANK	PA451106	56172	0.954
NULL	Indian_J_Med_Res_2014_Jan_139(1)_117-124.nxml.txt.nlp	24604047	SENT107	18	18	4	4	fluvastatin	Rho	PA449688	29984	0.954
NULL	Arthritis_Res_Ther_2014_Apr_15_16(2)_R95.nxml.txt.nlp	24735586	SENT201	34	34	14	14	methotrexate	CD27	PA450428	939	0.954
NULL	Ann_Rheum_Dis_2008_Aug_20_67(8)_1121-1126.nxml.txt.nlp	18029384	SENT117	46	46	21	21	bosentan	LFA-1	PA10034	3683;3689	0.954
NULL	Mol_Imaging_Biol_2013_Apr_11_15(2)_136-147.nxml.txt.nlp	22886728	SENT223	6	6	13	13	orlistat	AKT	PA164776864	207	0.954
NULL	Mol_Cancer_2008_Sep_12_7_70.nxml.txt.nlp	18789133	SENT67	13	13	28	28	belinostat	HDAC2		3066	0.954
NULL	Diabetes_Metab_Syndr_Obes_2010_Aug_24_3_297-299.nxml.txt.nlp	21437098	SENT35	12	12	19	19	sitagliptin	GLP-1	PA164748978	100125288	0.954
NULL	Epigenetics_2012_Nov_1_7(11)_1225-1229.nxml.txt.nlp	23069641	SENT6	26	26	3	3	cisplatin	BRCA1	PA449014	672	0.954
NULL	Mol_Clin_Oncol_2013_Sep_24_1(5)_918-924.nxml.txt.nlp	24649271	SENT155	2	2	15	15	gemcitabine	EGFR	PA449748	1956	0.954
NULL	Mol_Cancer_2009_Nov_19_8_108.nxml.txt.nlp	19925669	SENT103	5	5	10	10	doxorubicin	MRP3	PA449412	8714	0.954
NULL	Mol_Cancer_2011_Sep_7_10_109.nxml.txt.nlp	21899742	SENT219	9	9	1	1	etoposide	TRAIL-R2	PA449552	8795	0.954
NULL	Support_Care_Cancer_2012_May_1_20(5)_941-949.nxml.txt.nlp	21533811	SENT30	25	25	5	5	palonosetron	HEC	PA10352	10403	0.954
NULL	Ann_Trop_Med_Parasitol_2010_Sep_104(6)_455-464.nxml.txt.nlp	20863434	SENT437	11	11	19	19	rituximab	C3b	PA451261	718	0.954
NULL	Cancer_Cell_Int_2007_Jun_8_7_11.nxml.txt.nlp	17559657	SENT30	31	31	17	17	estradiol	CD133	PA449503	8842	0.954
NULL	J_Radiat_Res_2014_Nov_16_55(6)_1171-1177.nxml.txt.nlp	25129557	SENT169	10	10	5	5	bevacizumab	CRT	PA130232992	811	0.954
NULL	Curr_Opin_Lipidol_2014_Oct_4_25(5)_387-393.nxml.txt.nlp	25110901	SENT71	13	13	3	3	berberine	HNF1	PA165860812	6927	0.954
NULL	J_Hematol_Oncol_2013_Jan_15_6_5.nxml.txt.nlp	23320987	SENT114	25	25	0	0	heparin	PI-PLC	PA449855	2923	0.954
NULL	Int_J_Mol_Imaging_2011_Oct_26_2011_874585.nxml.txt.nlp	21490735	SENT150	13	13	4	4	tamoxifen	FDG	PA451581	23583	0.954
NULL	Arthritis_Res_Ther_2003_Oct_28_5(1)_8-11.nxml.txt.nlp	12716442	SENT53	22	22	5	5	naproxen	Ray	PA450595	26751	0.954
NULL	Adv_Hematol_2010_Dec_21_2010_320624.nxml.txt.nlp	21253465	SENT25	6	6	2	2	doxorubicin	CHOP	PA449412	1649	0.954
NULL	Oncotarget_2014_Jun_1_5(13)_4868-4880.nxml.txt.nlp	24947902	SENT315	25	25	6	6	afatinib	HER2	PA165981154	2064	0.954
NULL	Clinics_(Sao_Paulo)_2014_Feb_69(2)_134-144.nxml.txt.nlp	24519205	SENT131	5	5	29	29	thrombin	CO2	PA451674	4513	0.954
NULL	Crit_Care_2011_Mar_11_15(Suppl_1)_P360.nxml.txt.nlp	NULL	SENT13	5	5	18	18	ketamine	CB1	PA450144	1268	0.954
NULL	J_Neurol_Sci_2012_Nov_15_322(1-2)_92-95.nxml.txt.nlp	22819352	SENT118	4	4	17	17	ethanol	MCP-1	PA448073	6347	0.954
NULL	Breast_Cancer_Res_Treat_2013_Jun_5_139(3)_649-655.nxml.txt.nlp	23736997	SENT160	37	37	15	15	tamoxifen	aromatase	PA451581	1588	0.954
NULL	Int_J_Mol_Imaging_2011_Oct_26_2011_874585.nxml.txt.nlp	21490735	SENT149	43	43	28	28	doxorubicin	FDG	PA449412	23583	0.954
NULL	Arch_Drug_Inf_2011_Mar_4(1)_1-9.nxml.txt.nlp	21572514	SENT152	0	0	6	6	sulfinpyrazone	MRP2	PA451550	100130958;57626;1244	0.954
NULL	J_Health_Popul_Nutr_2007_Jun_25(2)_179-188.nxml.txt.nlp	17985819	SENT69	27	27	5	5	ceftriaxone	Spn	PA448866	84687	0.954
NULL	Diabetes_2011_Jul_20_60(7)_1872-1881.nxml.txt.nlp	21602511	SENT270	12	12	27	27	metformin	AMPK	PA450395	5563	0.954
NULL	J_Biomed_Sci_2013_Jul_2_20(1)_46.nxml.txt.nlp	23815815	SENT225	23	23	8	8	indomethacin	EPAC	PA449982	10411	0.954
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT447	15	15	24	24	olanzapine	PRL	PA450688	5617	0.954
NULL	Biomed_Res_Int_2014_Jan_29_2014_196249.nxml.txt.nlp	24605321	SENT203	5	5	23	23	bortezomib	NOXA	PA10252	5366	0.954
NULL	Mol_Cancer_2010_Nov_8_9_291.nxml.txt.nlp	21059223	SENT177	15	15	21	21	paclitaxel	ZNF217	PA450761	7764	0.954
NULL	Med_Sci_Monit_2013_Oct_31_19_916-926.nxml.txt.nlp	24172537	SENT175	7	7	1	1	erlotinib	EGFR	PA134687924	1956	0.954
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT196	4	4	23	23	metformin	EGFR	PA450395	1956	0.954
NULL	Biomed_Res_Int_2014_Jun_26_2014_161346.nxml.txt.nlp	25054130	SENT42	5	5	17	17	curcumin	STZ	PA151958596	6484	0.954
NULL	Diabetol_Metab_Syndr_2014_Sep_8_6(1)_95.nxml.txt.nlp	NULL	SENT164	3	3	21	21	liraglutide	GLP-1	PA165958364	100125288	0.954
NULL	Cancers_(Basel)_2014_Mar_6_6(1)_494-525.nxml.txt.nlp	24662938	SENT207	15	15	11	11	gefitinib	EGFR	PA131301952	1956	0.954
NULL	ScientificWorldJournal_2013_Aug_19_2013_157527.nxml.txt.nlp	24089600	SENT60	27	27	5	5	ethanol	TPC	PA448073	8030;60386	0.954
NULL	Clin_Pharmacokinet_2014_Jul_24_53(1)_73-87.nxml.txt.nlp	23881596	SENT256	18	18	26	26	rosuvastatin	OATP1B1	PA134308647	10599	0.954
NULL	Drugs_Aging_2012_Nov_5_29(11)_863-869.nxml.txt.nlp	23038608	SENT123	11	11	1	1	tramadol	NNT	PA451735	23530	0.954
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT26	3	3	34	34	imatinib	BCRP	PA10804	9429	0.954
NULL	Curr_Neuropharmacol_2012_Mar_10(1)_53-63.nxml.txt.nlp	22942878	SENT236	21	21	6	6	naloxone	AVP	PA450586	114548;551	0.954
NULL	J_Gynecol_Oncol_2013_Jul_4_24(3)_273-279.nxml.txt.nlp	23875078	SENT97	12	12	15	15	paclitaxel	COX	PA450761	1351	0.954
NULL	Front_Neurosci_2014_Jun_24_8_176.nxml.txt.nlp	25009459	SENT15	26	26	5	5	ivermectin	P2X4	PA450133	5025	0.954
NULL	Eur_J_Haematol_2014_Feb_25_92(2)_127-136.nxml.txt.nlp	24118452	SENT63	21	21	8	8	anagrelide	CRT	PA164742986	811	0.954
NULL	Ann_N_Y_Acad_Sci_2012_Oct_10_1271(1)_58-67.nxml.txt.nlp	23050965	SENT207	5	5	43	43	resveratrol	p38		10598;1432;7965	0.954
NULL	Cardiol_Res_Pract_2012_Apr_22_2012_181394.nxml.txt.nlp	22577589	SENT216	8	8	16	16	atorvastatin	IL-6	PA448500	3569	0.954
NULL	Oxid_Med_Cell_Longev_2012_Jun_3_2012_914273.nxml.txt.nlp	22701758	SENT164	3	3	37	37	resveratrol	HO-1		3162	0.954
NULL	Front_Cell_Neurosci_2013_Dec_25_7_263.nxml.txt.nlp	24399930	SENT43	38	38	21	21	carbachol	CA1	PA448784	759	0.954
NULL	Front_Aging_Neurosci_2010_Oct_25_2_142.nxml.txt.nlp	21152343	SENT86	23	23	2	2	triflusal	COX1	PA165958430	4512;5742	0.954
NULL	J_Hematol_Oncol_2008_Oct_23_1_19.nxml.txt.nlp	18947412	SENT111	14	14	32	32	alemtuzumab	CD34	PA164783958	947	0.954
NULL	Indian_J_Urol_2008_Jul-Sep_24(3)_289-294.nxml.txt.nlp	19468456	SENT79	27	27	8	8	tetracycline	AVP	PA451640	114548;551	0.954
NULL	Cancer_Cell_2007_Dec_11_12(6)_514-527.nxml.txt.nlp	18068629	SENT30	12	12	0	0	paclitaxel	TGFBI	PA450761	7045	0.954
NULL	Mol_Cancer_2010_Jun_24_9_164.nxml.txt.nlp	20576107	SENT173	0	0	10	10	etoposide	p53	PA449552	7157	0.954
NULL	Curr_Oncol_2009_Jul_16(Suppl_2)_S14-S23.nxml.txt.nlp	19672417	SENT17	8	8	15	15	tamoxifen	aromatase	PA451581	1588	0.954
NULL	Br_J_Cancer_2011_Mar_15_104(6)_957-967.nxml.txt.nlp	21364585	SENT91	19	19	0	0	doxorubicin	CD138	PA449412	6382	0.954
NULL	Indian_J_Ophthalmol_2007_Nov-Dec_55(6)_482-483.nxml.txt.nlp	17951917	SENT16	25	25	6	6	amikacin	API	PA164744372	5345	0.954
NULL	J_Int_AIDS_Soc_2012_Oct_22_15(Suppl_3)_10_7448_IAS_15_5_18440.nxml.txt.nlp	NULL	SENT2567	1	1	13	13	raltegravir	LSR		51599	0.954
NULL	Bioeng_Bugs_2012_May_1_3(3)_147-156.nxml.txt.nlp	22572786	SENT144	22	22	14	14	ethanol	CO2	PA448073	4513	0.954
NULL	Mol_Cancer_2009_Nov_10_8_99.nxml.txt.nlp	19903356	SENT81	21	21	31	31	imatinib	IGFBP3	PA10804	3486	0.954
NULL	Chin_J_Cancer_2011_May_30(5)_287-292.nxml.txt.nlp	21527061	SENT64	24	24	7	7	paclitaxel	EGFR	PA450761	1956	0.954
NULL	Oncogene_2013_Oct_24_32(43)_5176-5185.nxml.txt.nlp	23208500	SENT136	24	24	12	12	cisplatin	p53	PA449014	7157	0.954
NULL	Arthritis_Res_Ther_2014_Apr_11_16(2)_R93.nxml.txt.nlp	24725461	SENT214	21	21	19	19	letrozole	aromatase	PA450196	1588	0.954
NULL	J_Antimicrob_Chemother_2014_Jul_14_69(7)_1945-1953.nxml.txt.nlp	24633206	SENT195	29	29	11	11	tigecycline	RGM	PA164746412	56963	0.954
NULL	EPMA_J_2010_Jun_29_1(2)_343-361.nxml.txt.nlp	23199069	SENT98	23	23	36	36	rasagiline	GDNF	PA164764584	2668	0.954
NULL	J_Oncol_2011_Dec_15_2011_852970.nxml.txt.nlp	21209724	SENT205	10	10	6	6	temozolomide	p53	PA451609	7157	0.954
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT486	13	13	1	1	phenobarbital	CAR	PA450911	1525;6687;9970	0.954
NULL	Environ_Health_Perspect_2006_Sep_23_114(9)_1401-1406.nxml.txt.nlp	16966095	SENT199	7	7	23	23	arsenite	p53	PA452638	7157	0.954
NULL	Fibrogenesis_Tissue_Repair_2012_Apr_13_5_5.nxml.txt.nlp	22502865	SENT95	13	13	2	2	troglitazone	CCN2	PA451799	1490	0.954
NULL	Open_Virol_J_2011_Jun_1_5_60-69.nxml.txt.nlp	21760870	SENT174	14	14	5	5	cyclophosphamide	IL-10	PA449165	3586	0.954
NULL	Nat_Commun_2014_5_3361.nxml.txt.nlp	24553445	SENT101	8	8	0	0	olaparib	BRCA1		672	0.954
NULL	Front_Endocrinol_(Lausanne)_2014_Aug_18_5_129.nxml.txt.nlp	25183960	SENT104	36	36	45	45	cabergoline	DRD2	PA448708	1813	0.954
NULL	Aging_(Albany_NY)_2012_Jul_21_4(7)_462-479.nxml.txt.nlp	22820736	SENT367	34	34	8	8	chymotrypsin	Set9	PA448994	80854	0.954
NULL	Curr_Neuropharmacol_2008_Jun_6(2)_151-163.nxml.txt.nlp	19305794	SENT43	8	8	18	18	capsaicin	TRPV1	PA448776	7442	0.954
NULL	Mol_Cancer_2009_Aug_25_8_66.nxml.txt.nlp	19706164	SENT55	7	7	11	11	celecoxib	p53	PA448871	7157	0.954
NULL	Clin_Ophthalmol_2008_Mar_2(1)_1-14.nxml.txt.nlp	19668384	SENT241	16	16	10	10	bevacizumab	VEGF-A	PA130232992	7422	0.954
NULL	Oncogene_2014_Aug_21_33(34)_4316-4329.nxml.txt.nlp	24362530	SENT52	7	7	2	2	epirubicin	SUMO1	PA449476	7341	0.954
NULL	Adv_Appl_Bioinforma_Chem_2008_Oct_30_1_85-98.nxml.txt.nlp	21918608	SENT78	24	24	2	2	bortezomib	SPARC	PA10252	6678	0.954
NULL	Arch_Med_Sci_2011_Aug_2_7(4)_713-719.nxml.txt.nlp	22291810	SENT106	17	17	4	4	methotrexate	IL-18	PA450428	3606	0.954
NULL	Mol_Cancer_2012_Mar_21_11_13.nxml.txt.nlp	22436134	SENT17	15	15	20	20	doxorubicin	HuR	PA449412	1994	0.954
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Oct_30_66(Pt_11)_o2981.nxml.txt.nlp	21589147	SENT60	36	36	6	6	ethanol	mol	PA448073	90527	0.954
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT168	16	16	35	35	sulindac	AKT	PA451565	207	0.954
NULL	Oncotarget_2013_Dec_28_5(6)_1475-1490.nxml.txt.nlp	24721996	SENT177	23	23	14	14	celecoxib	CD133	PA448871	8842	0.954
NULL	Arch_Med_Sci_2013_Aug_30_9(4)_739-744.nxml.txt.nlp	24049538	SENT122	25	25	3	3	candesartan	PC-3	PA448765	692094	0.954
NULL	J_Mol_Med_(Berl)_2014_May_10_92(7)_709-722.nxml.txt.nlp	24811491	SENT74	41	41	5	5	panitumumab	KRAS	PA162373091	3845	0.954
NULL	Mol_Cancer_2009_Nov_24_8_109.nxml.txt.nlp	19930708	SENT45	17	17	8	8	anastrozole	aromatase	PA448432	1588	0.954
NULL	J_Biol_Chem_2013_Apr_26_288(17)_11865-11876.nxml.txt.nlp	23449983	SENT287	29	29	4	4	vanillin	CXCL12	PA451852	6387	0.954
NULL	Indian_J_Pharm_Sci_2013_Sep-Oct_75(5)_610-614.nxml.txt.nlp	24403665	SENT83	17	17	9	9	glibenclamide	MESD	PA449782	23184	0.954
NULL	Core_Evid_2009_Jun_15_4_131-147.nxml.txt.nlp	20694070	SENT265	5	5	18	18	tenofovir	UGT1A1	PA10204	54658	0.954
NULL	Evid_Based_Complement_Alternat_Med_2014_May_18_2014_156276.nxml.txt.nlp	24963318	SENT109	4	4	17	17	hesperidin	SOD1	PA449867	6647	0.954
NULL	Br_J_Cancer_2006_Dec_4_95(11)_1483-1489.nxml.txt.nlp	17106442	SENT33	16	16	19	19	gefitinib	EGFR	PA131301952	1956	0.954
NULL	Orphanet_J_Rare_Dis_2007_Jan_8_2_3.nxml.txt.nlp	17210076	SENT321	3	3	43	43	anagrelide	IFN	PA164742986	3439	0.954
NULL	Biochem_Res_Int_2012_Feb_9_2012_592806.nxml.txt.nlp	22400117	SENT21	3	3	15	15	nadh	tNOX	PA164755085	10495	0.954
NULL	Oncotarget_2013_Jun_29_4(9)_1338-1348.nxml.txt.nlp	23907514	SENT66	3	3	35	35	doxorubicin	PSMB3	PA449412	5691	0.954
NULL	Adv_Virol_2012_Jul_19_2012_267483.nxml.txt.nlp	22851970	SENT140	12	12	33	33	telaprevir	IFN	PA165958354	3439	0.954
NULL	Nat_Commun_2014_Dec_8_5_5736.nxml.txt.nlp	25484020	SENT164	9	9	29	29	exemestane	TRPA1	PA449563	8989	0.954
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2675-2684.nxml.txt.nlp	24129246	SENT237	26	26	35	35	etoposide	p53	PA449552	7157	0.954
NULL	Cardiovasc_Diabetol_2013_Nov_12_12_169.nxml.txt.nlp	24215514	SENT263	21	21	6	6	valsartan	AT2	PA451848	186	0.954
NULL	Br_J_Cancer_2010_Mar_16_102(6)_1003-1009.nxml.txt.nlp	20179710	SENT4	0	0	7	7	doxorubicin	SLC22A16	PA449412	85413	0.954
NULL	Exp_Ther_Med_2014_Feb_4_7(2)_478-482.nxml.txt.nlp	24396429	SENT10	26	26	0	0	glucose	HO-1	PA449773	3162	0.954
NULL	Breast_Cancer_Res_2005_Jan_28_7(3)_R284-R290.nxml.txt.nlp	15987423	SENT142	21	21	17	17	tamoxifen	CYP2D6	PA451581	1565	0.954
NULL	Curr_Med_Chem_2008_Jun_15(13)_1274-1287.nxml.txt.nlp	18537607	SENT406	24	24	10	10	azacitidine	p15	PA451996	10923;10573	0.954
NULL	Neuroscience_2009_Jun_30_161(2-3)_572-577.nxml.txt.nlp	19327387	SENT8	25	25	4	4	capsaicin	NAPE-PLD	PA448776	222236	0.954
NULL	Osteoarthritis_Cartilage_2010_Apr_18(4)_555-562.nxml.txt.nlp	20060953	SENT142	7	7	27	27	clenbuterol	MNX	PA164745640	3892	0.954
NULL	Oncogene_2010_Sep_16_29(37)_5135-5145.nxml.txt.nlp	20622897	SENT10	19	19	10	10	cetuximab	STAT3	PA10040	6774	0.954
NULL	Cancer_Microenviron_2009_Sep_26_2(Suppl_1)_19-204.nxml.txt.nlp	NULL	SENT5866	10	10	0	0	hyaluronan	CD44	PA165958431	960	0.954
NULL	Br_J_Cancer_2010_Sep_7_103(6)_759-764.nxml.txt.nlp	20700118	SENT19	21	21	2	2	tamoxifen	IMPACT	PA451581	55364	0.954
NULL	Br_J_Cancer_2009_Jul_7_101(1)_71-79.nxml.txt.nlp	19491901	SENT18	3	3	15	15	trastuzumab	HER-2	PA451743	2064	0.954
NULL	J_Invest_Dermatol_2012_Sep_10_132(9)_2255-2262.nxml.txt.nlp	22572817	SENT7	3	3	31	31	forskolin	MC1R	PA146096022	4157	0.954
NULL	Cell_Commun_Signal_2009_Aug_13_7_19.nxml.txt.nlp	19678929	SENT70	3	3	29	29	cetuximab	KRAS	PA10040	3845	0.954
NULL	Oncotarget_2013_Jul_14_4(8)_1185-1198.nxml.txt.nlp	23852390	SENT197	27	27	17	17	cisplatin	TRAIL	PA449014	8743	0.954
NULL	J_Biol_Chem_2013_Jan_25_288(4)_2721-2733.nxml.txt.nlp	23209292	SENT123	30	30	5	5	heparin	FGF1	PA449855	2246	0.954
NULL	Front_Physiol_2015_Jan_5_5_501.nxml.txt.nlp	25601838	SENT179	21	21	2	2	thrombin	IL-6	PA451674	3569	0.954
NULL	EPMA_J_2011_Dec_22_3(1)_1.nxml.txt.nlp	22738081	SENT190	17	17	4	4	sunitinib	NGAL	PA162372840	3934	0.954
NULL	Sci_Rep_2014_Dec_3_4_7294.nxml.txt.nlp	25465236	SENT61	32	32	12	12	axitinib	TYK2	PA164924493	7297	0.954
NULL	Environ_Health_Perspect_2008_Jan_5_116(1)_1-6.nxml.txt.nlp	18197291	SENT201	3	3	34	34	arsenite	CPM	PA452638	1368	0.954
NULL	Brain_Sci_2013_Jun_14_3(2)_941-963.nxml.txt.nlp	24961432	SENT181	4	4	11	11	ethanol	RhoA	PA448073	387	0.954
NULL	Open_Biol_2014_Jan_4(1)_130138.nxml.txt.nlp	24403013	SENT294	29	29	5	5	etoposide	PP1	PA449552	5540;5464	0.954
NULL	Front_Behav_Neurosci_2014_Dec_16_8_437.nxml.txt.nlp	25566005	SENT17	27	27	8	8	nicotine	TRPM8	PA450626	79054	0.954
NULL	Br_J_Cancer_1995_May_71(5)_907-913.nxml.txt.nlp	7734314	SENT16	38	38	16	16	camptothecin	MDR1	PA153590860	5243	0.954
NULL	Leukemia_2013_Jan_11_27(1)_32-40.nxml.txt.nlp	22781593	SENT37	4	4	16	16	ponatinib	FGFR1	PA165980594	2260	0.954
NULL	Mol_Cytogenet_2010_Oct_19_3_20.nxml.txt.nlp	20959006	SENT233	20	20	4	4	doxorubicin	p53	PA449412	7157	0.954
NULL	Curr_Mol_Med_2012_Jan_12(1)_96-110.nxml.txt.nlp	22082486	SENT159	10	10	26	26	paclitaxel	ERBB2	PA450761	2064	0.954
NULL	Clin_Interv_Aging_2012_Dec_30_7_1-13.nxml.txt.nlp	22291468	SENT136	42	42	19	19	dronedarone	CYP3A4	PA153619853	1576	0.954
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_75-89.nxml.txt.nlp	17912638	SENT200	15	15	5	5	anastrozole	ATAC	PA448432	6375	0.954
NULL	Front_Oncol_2013_Nov_14_3_279.nxml.txt.nlp	24294592	SENT102	25	25	11	11	oxaliplatin	MSH3	PA131285527	4437	0.954
NULL	Oncotarget_2014_Aug_16_5(17)_7342-7356.nxml.txt.nlp	25277177	SENT210	23	23	7	7	gefitinib	IDH1	PA131301952	3417	0.954
NULL	Onco_Targets_Ther_2014_Jul_12_7_1273-1284.nxml.txt.nlp	25050069	SENT36	0	0	18	18	trabectedin	CYP2C19	PA165958349	1557	0.954
NULL	Breast_Cancer_Res_2004_Jul_29_6(5)_204-210.nxml.txt.nlp	15318926	SENT102	12	12	7	7	gefitinib	EGFR	PA131301952	1956	0.954
NULL	Br_J_Cancer_1990_May_61(5)_702-708.nxml.txt.nlp	2337507	SENT6	0	0	34	34	methotrexate	PC3	PA450428	57332;7832;5122	0.954
NULL	Oncoimmunology_2012_Dec_1_1(9)_1476-1483.nxml.txt.nlp	23264894	SENT203	19	19	2	2	oxaliplatin	BRAF	PA131285527	673	0.954
NULL	EMBO_Mol_Med_2013_Aug_5_5(8)_1213-1226.nxml.txt.nlp	23918228	SENT138	22	22	5	5	cetuximab	EGFR	PA10040	1956	0.954
NULL	J_Korean_Med_Sci_2010_Aug_21_25(8)_1222-1227.nxml.txt.nlp	20676337	SENT28	0	0	14	14	aminophylline	LPA	PA164781029	4018	0.954
NULL	Front_Physiol_2013_Dec_24_4_386.nxml.txt.nlp	24399968	SENT195	13	13	41	41	repaglinide	SUR1	PA451234	6833	0.954
NULL	J_Inherit_Metab_Dis_2013_Mar_13_36(2)_363-371.nxml.txt.nlp	22971959	SENT93	2	2	25	25	gentamicin	ARSB	PA449753	411	0.954
NULL	Int_J_Alzheimers_Dis_2010_Dec_8_2011_741974.nxml.txt.nlp	21197086	SENT176	1	1	26	26	ramelteon	BZP	PA164744896	6935	0.954
NULL	Breast_Cancer_Res_2013_Oct_1_15(5)_R92.nxml.txt.nlp	24286369	SENT116	10	10	28	28	exemestane	aromatase	PA449563	1588	0.954
NULL	Curr_Pharm_Biotechnol_2012_May_13(6)_969-986.nxml.txt.nlp	22039792	SENT81	7	7	11	11	butorphanol	MDR1	PA164745398	5243	0.954
NULL	Front_Behav_Neurosci_2011_Sep_8_5_56.nxml.txt.nlp	21927600	SENT237	29	29	33	33	fluoxetine	DARPP-32	PA449673	84152	0.954
NULL	Clin_Ophthalmol_2012_Oct_30_6_1749-1753.nxml.txt.nlp	23152652	SENT55	6	6	18	18	bimatoprost	ANOVA	PA164748867	4858	0.954
NULL	Clin_Exp_Metastasis_2013_May_15_30(7)_867-876.nxml.txt.nlp	23673558	SENT29	16	16	14	14	vemurafenib	BRAF	PA165946873	673	0.954
NULL	Breast_Cancer_Res_2010_Oct_14_12(5)_R84.nxml.txt.nlp	20946630	SENT276	29	29	5	5	choline	SLC44A1	PA448976	23446	0.954
NULL	Front_Cell_Neurosci_2013_Aug_29_7_130.nxml.txt.nlp	24009554	SENT155	25	25	6	6	pilocarpine	NPY	PA450962	4852	0.954
NULL	Breast_Cancer_Res_2010_Jun_28_12(3)_R43.nxml.txt.nlp	20579400	SENT129	18	18	5	5	vinorelbine	MAPT	PA451881	4137	0.954
NULL	Int_J_Surg_Oncol_2012_May_17_2012_406830.nxml.txt.nlp	22675625	SENT166	0	0	7	7	panitumumab	CRT	PA162373091	811	0.954
NULL	J_Immunother_2014_Feb_21_37(2)_105-114.nxml.txt.nlp	24509173	SENT167	9	9	4	4	gemcitabine	WT1	PA449748	7490	0.954
NULL	Front_Neural_Circuits_2014_Aug_28_8_102.nxml.txt.nlp	25221477	SENT60	27	27	24	24	ketanserin	5-HT2A	PA131053734	3356	0.954
NULL	Extremophiles_2009_Nov_23_13(6)_885-894.nxml.txt.nlp	19701714	SENT138	23	23	8	8	ethanol	mol	PA448073	90527	0.954
NULL	Front_Neurosci_2012_May_30_6_77.nxml.txt.nlp	22661925	SENT258	0	0	37	37	rolipram	DCX	PA153906323	1641	0.954
NULL	Indian_J_Med_Res_2012_Sep_136(3)_391-403.nxml.txt.nlp	23041732	SENT168	23	23	45	45	capecitabine	HCC	PA448771	84668	0.954
NULL	Curr_Med_Chem_2011_Jun_18(18)_2686-2714.nxml.txt.nlp	21649578	SENT608	20	20	16	16	paclitaxel	PI3K	PA450761	5290	0.954
NULL	Breast_Cancer_Res_2005_Apr_6_7(3)_119-130.nxml.txt.nlp	15987442	SENT237	5	5	14	14	fulvestrant	aromatase	PA164747170	1588	0.954
NULL	Indian_J_Pharmacol_2013_Nov-Dec_45(6)_597-602.nxml.txt.nlp	24347768	SENT23	44	44	3	3	paclitaxel	P-gp	PA450761	5243	0.954
NULL	J_Hematol_Oncol_2009_Feb_23_2_9.nxml.txt.nlp	19236713	SENT310	0	0	12	12	sorafenib	VEGFR	PA7000	3791	0.954
NULL	Acta_Pharmacol_Sin_2011_Nov_10_32(11)_1402-1410.nxml.txt.nlp	21986579	SENT163	39	39	14	14	curcumin	p27	PA151958596	5715;10534	0.953
NULL	Braz_J_Med_Biol_Res_2014_Oct_24_48(1)_65-76.nxml.txt.nlp	25493385	SENT151	15	15	31	31	phenylephrine	AT1	PA450935	9197;185	0.953
NULL	Mol_Cancer_2008_Jun_30_7_60.nxml.txt.nlp	18590557	SENT71	18	18	3	3	paclitaxel	TRAIL	PA450761	8743	0.953
NULL	Case_Rep_Med_2012_Jun_19_2012_680431.nxml.txt.nlp	22778751	SENT92	22	22	18	18	vincristine	CHOP	PA451879	1649	0.953
NULL	Case_Rep_Endocrinol_2013_Dec_22_2013_675298.nxml.txt.nlp	24455332	SENT185	16	16	1	1	cisplatin	ACTH	PA449014	5443	0.953
NULL	Core_Evid_2010_Oct_22_5_91-105.nxml.txt.nlp	21468365	SENT67	4	4	19	19	simvastatin	CYP3A4	PA451363	1576	0.953
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT50	14	14	2	2	nutlin-3	p53		7157	0.953
NULL	J_Exp_Med_1998_Jun_1_187(11)_1885-1892.nxml.txt.nlp	9607928	SENT121	30	30	21	21	thalidomide	IL-2	PA451644	3558	0.953
NULL	Cancers_(Basel)_2014_Jul_8_6(3)_1487-1499.nxml.txt.nlp	25006835	SENT80	0	0	5	5	cisplatin	JNK	PA449014	5599	0.953
NULL	Chemother_Res_Pract_2011_Dec_1_2011_715469.nxml.txt.nlp	22312557	SENT114	20	20	6	6	cisplatin	p53	PA449014	7157	0.953
NULL	Acta_Pharmacol_Sin_2011_May_18_32(5)_591-600.nxml.txt.nlp	21499286	SENT214	7	7	37	37	bezafibrate	AMPK	PA162364313	5563	0.953
NULL	Nat_Med_2013_Feb_6_19(2)_217-226.nxml.txt.nlp	23291629	SENT92	22	22	41	41	isoproterenol	HSL	PA450121	3991	0.953
NULL	Arthritis_Res_2002_Mar_27_4(3)_220-225.nxml.txt.nlp	12010574	SENT51	6	6	0	0	fluorescein	PR-3	PA164746009	5657	0.953
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Aug_27_67(Pt_9)_o2403.nxml.txt.nlp	22058995	SENT66	38	38	3	3	ethanol	mol	PA448073	90527	0.953
NULL	Acta_Pharmacol_Sin_2011_May_18_32(5)_591-600.nxml.txt.nlp	21499286	SENT138	6	6	10	10	bezafibrate	AMPK	PA162364313	5563	0.953
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_75-89.nxml.txt.nlp	17912638	SENT196	14	14	2	2	anastrozole	ATAC	PA448432	6375	0.953
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_9_2013_486047.nxml.txt.nlp	23662138	SENT122	41	41	3	3	glibenclamide	SDH	PA449782	1757;10993	0.953
NULL	Eur_J_Neurosci_2007_Aug_26(4)_935-942.nxml.txt.nlp	17714187	SENT98	2	2	12	12	capsaicin	TRPV1	PA448776	7442	0.953
NULL	Mol_Pain_2014_Aug_15_10_53.nxml.txt.nlp	25127716	SENT132	9	9	20	20	paclitaxel	SDH	PA450761	1757;10993	0.953
NULL	Oncoimmunology_2013_Jan_1_2(1)_e22840.nxml.txt.nlp	23482926	SENT171	22	22	14	14	erlotinib	EGFR	PA134687924	1956	0.953
NULL	J_Thromb_Haemost_2011_Oct_9(10)_2050-2056.nxml.txt.nlp	21794076	SENT99	19	19	5	5	prasugrel	ADP	PA154410481	23038	0.953
NULL	Front_Aging_Neurosci_2014_Sep_11_6_218.nxml.txt.nlp	25309423	SENT219	16	16	38	38	resveratrol	p53		7157	0.953
NULL	Acta_Neuropathol_2012_Dec_11_124(6)_763-775.nxml.txt.nlp	23143192	SENT373	3	3	14	14	bevacizumab	CXCL6	PA130232992	6372	0.953
NULL	F1000_Med_Rep_2012_Jun_1_4_12.nxml.txt.nlp	22719795	SENT58	0	0	11	11	rifapentine	CYP3A	PA164783809	1574	0.953
NULL	Exp_Hematol_Oncol_2014_Jun_4_3_15.nxml.txt.nlp	24926417	SENT23	6	6	14	14	desmopressin	VIII	PA449237	1351	0.953
NULL	Pharmaceutics_2011_Nov_18_3(4)_865-913.nxml.txt.nlp	24309312	SENT532	5	5	10	10	nifedipine	CYP3A4	PA450631	1576	0.953
NULL	Breast_Cancer_Res_2012_Jun_19_14(3)_209.nxml.txt.nlp	22713170	SENT48	3	3	15	15	lapatinib	HER2	PA152241907	2064	0.953
NULL	Br_J_Cancer_2014_Nov_25_111(11)_2039-2045.nxml.txt.nlp	25412233	SENT123	4	4	13	13	tranylcypromine	CD11b	PA451741	3684	0.953
NULL	Lipids_Health_Dis_2011_Jan_18_10_8.nxml.txt.nlp	21241519	SENT117	24	24	17	17	simvastatin	ABCA1	PA451363	19	0.953
NULL	Mol_Neurodegener_2011_Jun_22_6_43.nxml.txt.nlp	21696630	SENT225	31	31	11	11	desmopressin	PKD1	PA449237	5310	0.953
NULL	Acta_Neuropathol_Commun_2014_May_30_2_57.nxml.txt.nlp	24887326	SENT274	3	3	16	16	vardenafil	ABCB1	PA10229	5243	0.953
NULL	Br_J_Cancer_2004_Mar_22_90(6)_1285-1292.nxml.txt.nlp	15026814	SENT154	36	36	11	11	cisplatin	p53	PA449014	7157	0.953
NULL	Evid_Based_Complement_Alternat_Med_2014_Jan_8_2014_976364.nxml.txt.nlp	24527057	SENT16	34	34	23	23	oseltamivir	TLR7	PA450721	51284	0.953
NULL	Oncologist_2010_Mar_3_15(3)_216-235.nxml.txt.nlp	20200040	SENT120	11	11	4	4	trastuzumab	HER-2	PA451743	2064	0.953
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT289	2	2	12	12	bevacizumab	VEGF-A	PA130232992	7422	0.953
NULL	Nat_Neurosci_2012_Sep_5_15(9)_1245-1254.nxml.txt.nlp	22864611	SENT519	19	19	12	12	clozapine	mGlu3	PA449061	2913	0.953
NULL	Tuberc_Respir_Dis_(Seoul)_2013_Nov_29_75(5)_188-198.nxml.txt.nlp	24348666	SENT43	7	7	13	13	pertuzumab	HER2		2064	0.953
NULL	Cancers_(Basel)_2010_May_26_2(2)_970-988.nxml.txt.nlp	24281102	SENT172	25	25	28	28	sunitinib	VEGFR1	PA162372840	2321	0.953
NULL	Leukemia_2013_Feb_3_27(2)_315-324.nxml.txt.nlp	22751450	SENT91	27	27	36	36	sorafenib	Mcl-1	PA7000	4170	0.953
NULL	Mol_Pain_2013_Jan_2_9_1.nxml.txt.nlp	23279936	SENT145	20	20	32	32	doxycycline	TRPV1	PA449415	7442	0.953
NULL	Pediatr_Nephrol_2009_Jul_20_24(7)_1355-1361.nxml.txt.nlp	19301038	SENT83	25	25	4	4	sevelamer	PTH	PA164781197	5741	0.953
NULL	Cancer_Cell_2007_Dec_11_12(6)_514-527.nxml.txt.nlp	18068629	SENT46	6	6	22	22	paclitaxel	ANOVA	PA450761	4858	0.953
NULL	J_Mol_Signal_2013_Oct_1_8_10.nxml.txt.nlp	24083380	SENT75	47	47	1	1	forskolin	ANOVA	PA146096022	4858	0.953
NULL	Hum_Genomics_2008_Sep_1_3(1)_7-16.nxml.txt.nlp	19129086	SENT166	5	5	9	9	pioglitazone	CYP2C8	PA450970	1558	0.953
NULL	Mol_Cancer_2012_Oct_22_11_80.nxml.txt.nlp	23088607	SENT114	11	11	17	17	fulvestrant	HIF-1	PA164747170	29072	0.953
NULL	J_Korean_Med_Sci_1990_Dec_5(4)_185-188.nxml.txt.nlp	1966034	SENT15	21	21	11	11	methacholine	TDI	PA165958382	100038246	0.953
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT239	4	4	31	31	perifosine	JNK	PA165291471	5599	0.953
NULL	Asian_Spine_J_2014_Jun_9_8(3)_315-321.nxml.txt.nlp	24967045	SENT54	27	27	18	18	kanamycin	AKT	PA450137	207	0.953
NULL	J_Biol_Chem_2013_Mar_22_288(12)_8332-8341.nxml.txt.nlp	23362253	SENT163	19	19	4	4	tetracycline	MYCN	PA451640	4613	0.953
NULL	Cancers_(Basel)_2010_Jan_14_2(1)_1-19.nxml.txt.nlp	24281029	SENT41	20	20	4	4	vinorelbine	HER2	PA451881	2064	0.953
NULL	Ann_Gen_Psychiatry_2013_Jan_24_12_1.nxml.txt.nlp	23347694	SENT384	15	15	20	20	ziprasidone	CYP3A4	PA451974	1576	0.953
NULL	Cancer_Causes_Control_2009_Nov_4_20(9)_1617-1622.nxml.txt.nlp	19653109	SENT110	0	0	14	14	metformin	PC-3	PA450395	692094	0.953
NULL	Cancer_2014_Apr_8_120(8)_1145-1154.nxml.txt.nlp	24501009	SENT228	23	23	17	17	gefitinib	ERBB2	PA131301952	2064	0.953
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT136	0	0	19	19	capsaicin	p53	PA448776	7157	0.953
NULL	Nucleic_Acids_Res_2011_Mar_20_39(6)_2234-2248.nxml.txt.nlp	21097889	SENT24	11	11	40	40	fluorouracil	p53	PA128406956	7157	0.953
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_33-43.nxml.txt.nlp	17912634	SENT83	12	12	5	5	tamoxifen	HER2	PA451581	2064	0.953
NULL	Open_Cardiovasc_Med_J_2011_Feb_24_5_49-63.nxml.txt.nlp	21643501	SENT207	0	0	15	15	ezetimibe	CYP3A4	PA10816	1576	0.953
NULL	J_Hematol_Oncol_2011_Apr_20_4_17.nxml.txt.nlp	21507255	SENT237	38	38	18	18	cisplatin	HDAC	PA449014	9734	0.953
NULL	Ann_Med_Health_Sci_Res_2014_Mar-Apr_4(Suppl_1)_S25-S28.nxml.txt.nlp	25031901	SENT84	7	7	24	24	rituximab	CAD	PA451261	1677;790	0.953
NULL	Arthritis_Res_Ther_2006_Feb_3_8(2)_R43.nxml.txt.nlp	16507142	SENT55	6	6	21	21	heparin	CXCR4	PA449855	7852	0.953
NULL	Cancers_(Basel)_2014_Sep_5_6(3)_1769-1792.nxml.txt.nlp	25198391	SENT84	9	9	4	4	trastuzumab	IGF1R	PA451743	3480	0.953
NULL	Med_Sci_Monit_2013_Nov_29_19_1080-1088.nxml.txt.nlp	24287619	SENT138	16	16	3	3	estradiol	ANOVA	PA449503	4858	0.953
NULL	Oncol_Rep_2012_Oct_6_28(4)_1301-1308.nxml.txt.nlp	22895640	SENT262	0	0	14	14	camptothecin	CD133	PA153590860	8842	0.953
NULL	Front_Physiol_2012_Oct_5_3_398.nxml.txt.nlp	23060821	SENT227	3	3	6	6	capsaicin	TRPV1	PA448776	7442	0.953
NULL	Lab_Anim_Res_2012_Jun_26_28(2)_109-114.nxml.txt.nlp	22787484	SENT31	6	6	17	17	reserpine	CO2	PA451236	4513	0.953
NULL	Pharmaceuticals_(Basel)_2013_Mar_26_6(4)_469-479.nxml.txt.nlp	24276118	SENT190	1	1	14	14	ethanol	AT1	PA448073	9197;185	0.953
NULL	Cancer_Manag_Res_2013_Oct_8_5_337-347.nxml.txt.nlp	24204170	SENT66	34	34	15	15	sorafenib	VEGFR2	PA7000	3791	0.953
NULL	Daru_2012_Nov_30_20(1)_82.nxml.txt.nlp	23351311	SENT153	3	3	29	29	sn-38	p53		7157	0.953
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT394	5	5	13	13	gw2016	EGF		1950	0.953
NULL	Br_J_Cancer_2012_Apr_10_106(8)_1367-1373.nxml.txt.nlp	22454081	SENT143	43	43	25	25	trastuzumab	PI3K	PA451743	5290	0.953
NULL	Cancer_Cell_Int_2005_Jul_7_5_20.nxml.txt.nlp	16001980	SENT11	31	31	24	24	doxorubicin	P-gp	PA449412	5243	0.953
NULL	Oncogene_2014_Sep_18_33(38)_4664-4674.nxml.txt.nlp	24096486	SENT10	16	16	22	22	erlotinib	PI3K	PA134687924	5290	0.953
NULL	J_Immunol_Res_2014_Jul_16_2014_696812.nxml.txt.nlp	25133198	SENT190	1	1	10	10	rifaximin	TLR2	PA164752443	7097	0.953
NULL	Br_J_Cancer_2013_May_28_108(10)_2013-2020.nxml.txt.nlp	23632482	SENT65	7	7	19	19	ethanol	San	PA448073	80218	0.953
NULL	Br_J_Cancer_2009_Sep_15_101(6)_957-966.nxml.txt.nlp	19738618	SENT148	12	12	34	34	dexrazoxane	THBS-1	PA449259	7057	0.953
NULL	Oncogene_2010_May_20_29(20)_2983-2995.nxml.txt.nlp	20208560	SENT137	24	24	14	14	tamoxifen	FOXM1	PA451581	2305	0.953
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT230	10	10	22	22	sn-38	ABCG2		9429	0.953
NULL	Pharm_Pract_(Granada)_2011_Mar_15_Jan-Mar_9(1)_1-10.nxml.txt.nlp	25132883	SENT135	3	3	22	22	warfarin	SPAF	PA451906	166378	0.953
NULL	Onco_Targets_Ther_2014_Jun_11_7_969-983.nxml.txt.nlp	24959084	SENT115	29	29	4	4	rifampin	CYP3A4	PA451250	1576	0.953
NULL	Cancers_(Basel)_2014_Jul_8_6(3)_1487-1499.nxml.txt.nlp	25006835	SENT31	19	19	12	12	cisplatin	p38	PA449014	10598;1432;7965	0.953
NULL	Breast_Cancer_Res_2008_Dec_4_10(6)_R103.nxml.txt.nlp	19055788	SENT11	9	9	29	29	fulvestrant	aromatase	PA164747170	1588	0.953
NULL	Channels_(Austin)_2010_Jan_1_4(1)_22-41.nxml.txt.nlp	19934650	SENT38	7	7	12	12	quinidine	Slo3	PA451209	157855	0.953
NULL	Ann_Surg_Oncol_2010_Jan_20_17(1)_14-17.nxml.txt.nlp	19841980	SENT78	43	43	34	34	lapatinib	PI3K	PA152241907	5290	0.953
NULL	J_Hematol_Oncol_2013_Jan_17_6_8.nxml.txt.nlp	23327547	SENT26	7	7	21	21	sulindac	p53	PA451565	7157	0.953
NULL	Mol_Cancer_2013_Oct_8_12_119.nxml.txt.nlp	24103454	SENT212	16	16	7	7	doxorubicin	TOP1	PA449412	7150	0.953
NULL	Mol_Cancer_2013_Oct_8_12_119.nxml.txt.nlp	24103454	SENT34	18	18	22	22	etoposide	TOP2A	PA449552	7153	0.953
NULL	Clin_Interv_Aging_2012_Sep_3_7_331-338.nxml.txt.nlp	22977302	SENT39	8	8	33	33	denosumab	aromatase	PA166048634	1588	0.953
NULL	Ann_Thorac_Med_2012_Jul-Sep_7(3)_157-161.nxml.txt.nlp	22924075	SENT36	6	6	16	16	iloprost	U22	PA164746843	9304	0.953
NULL	Oncol_Lett_2013_Feb_7_5(2)_440-446.nxml.txt.nlp	23420122	SENT122	21	21	8	8	gemcitabine	Bcl-2	PA449748	596	0.953
NULL	Mol_Vis_2012_Apr_11_18_901-908.nxml.txt.nlp	22539869	SENT170	44	44	27	27	curcumin	p38	PA151958596	10598;1432;7965	0.953
NULL	Oncogene_2009_Feb_5_28(5)_674-685.nxml.txt.nlp	19015634	SENT102	20	20	5	5	hydroxyurea	FANCD2	PA449942	2177	0.953
NULL	Acta_Pharmacol_Sin_2010_May_12_31(5)_578-584.nxml.txt.nlp	20383171	SENT117	2	2	28	28	berberine	c-Jun	PA165860812	3725	0.953
NULL	Cancer_Cell_Int_2008_Jan_4_8_1.nxml.txt.nlp	18177496	SENT68	32	32	7	7	gefitinib	EWS	PA131301952	2130	0.953
NULL	Oncotarget_2011_Mar_23_2(3)_165-177.nxml.txt.nlp	21444946	SENT174	18	18	5	5	gefitinib	KRAS	PA131301952	3845	0.953
NULL	Ann_Oncol_2014_Jul_14_25(7)_1333-1339.nxml.txt.nlp	24631949	SENT34	30	30	15	15	palonosetron	NK1	PA10352	11126	0.953
NULL	Exp_Diabetes_Res_2011_Apr_6_2011_928523.nxml.txt.nlp	21603181	SENT217	26	26	13	13	bromocriptine	NEFA	PA448671	4925	0.953
NULL	Breast_Cancer_(Auckl)_2009_Apr_7_3_23-34.nxml.txt.nlp	21556247	SENT101	6	6	14	14	celecoxib	AKT	PA448871	207	0.953
NULL	Onco_Targets_Ther_2014_May_28_7_841-852.nxml.txt.nlp	24920926	SENT63	13	13	6	6	gefitinib	EGFR	PA131301952	1956	0.953
NULL	Gastric_Cancer_2013_Jul_12_16(3)_345-354.nxml.txt.nlp	22968820	SENT137	8	8	0	0	oxaliplatin	MLH1	PA131285527	4292	0.953
NULL	J_Korean_Med_Sci_2013_May_2_28(5)_700-708.nxml.txt.nlp	23678261	SENT174	9	9	17	17	losartan	NCX	PA450268	3196	0.953
NULL	Eur_Arch_Psychiatry_Clin_Neurosci_2012_Oct_28_262(7)_549-556.nxml.txt.nlp	22454242	SENT19	23	23	5	5	haloperidol	DAOA	PA449841	267012	0.953
NULL	Oncotarget_2014_Mar_14_5(10)_3029-3038.nxml.txt.nlp	24912489	SENT25	9	9	7	7	anastrozole	aromatase	PA448432	1588	0.953
NULL	Oncogene_2014_Jul_24_33(30)_3959-3969.nxml.txt.nlp	24096481	SENT25	29	29	4	4	nutlin-3	p53		7157	0.953
NULL	Can_J_Infect_Dis_Med_Microbiol_2014_Sep-Oct_25(5)_271-276.nxml.txt.nlp	25371690	SENT149	0	0	13	13	voriconazole	CYP3A4	PA10233	1576	0.953
NULL	Front_Neurosci_2011_Feb_2_5_12.nxml.txt.nlp	21344007	SENT306	13	13	4	4	capsaicin	NR1	PA448776	27158	0.953
NULL	Cardiol_Res_Pract_2012_Mar_20_2012_656247.nxml.txt.nlp	22536531	SENT91	10	10	29	29	pravastatin	DDAH	PA451089	23576	0.953
NULL	Mol_Biol_Evol_2011_Aug_4_28(8)_2379-2391.nxml.txt.nlp	21378103	SENT189	14	14	1	1	nadh	PDH	PA164755085	54704	0.953
NULL	Iran_J_Pharm_Res_2015_Winter_14(1)_321-328.nxml.txt.nlp	25561938	SENT68	19	19	9	9	forskolin	VASP	PA146096022	7408	0.953
NULL	Curr_Neuropharmacol_2012_Mar_10(1)_72-79.nxml.txt.nlp	22942880	SENT85	14	14	36	36	vincristine	p53	PA451879	7157	0.953
NULL	Breast_Cancer_Res_2011_Dec_16_13(6)_R131.nxml.txt.nlp	22177475	SENT30	29	29	22	22	trastuzumab	HER2	PA451743	2064	0.953
NULL	Indian_J_Med_Res_2010_Dec_132(6)_676-682.nxml.txt.nlp	21245614	SENT48	0	0	15	15	zinc	p53	PA451956	7157	0.953
NULL	Cell_Commun_Signal_2014_Nov_7_12(1)_73.nxml.txt.nlp	NULL	SENT296	14	14	4	4	tamoxifen	THOC5	PA451581	8563	0.953
NULL	J_Cancer_2014_Jan_1_5(1)_25-30.nxml.txt.nlp	24396495	SENT151	17	17	8	8	sorafenib	CA125	PA7000	4077;94025	0.953
NULL	Nat_Neurosci_2012_Sep_5_15(9)_1245-1254.nxml.txt.nlp	22864611	SENT508	18	18	4	4	clozapine	mGlu2	PA449061	2912	0.953
NULL	Exp_Ther_Med_2013_Feb_13_5(2)_581-585.nxml.txt.nlp	23403473	SENT93	27	27	29	29	etanercept	HMGB1	PA449515	3146	0.953
NULL	Case_Rep_Med_2009_Aug_31_2009_420152.nxml.txt.nlp	19730751	SENT43	7	7	45	45	thrombin	VIII	PA451674	1351	0.953
NULL	Eur_J_Clin_Pharmacol_2011_May_8_67(5)_493-506.nxml.txt.nlp	21140139	SENT154	23	23	10	10	paroxetine	CYP2D6	PA450801	1565	0.953
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT104	28	28	12	12	doxorubicin	B7-H1	PA449412	29126	0.953
NULL	Mol_Brain_2014_Apr_21_7_28.nxml.txt.nlp	24751148	SENT163	4	4	21	21	minocycline	TLR4	PA450519	7099	0.953
NULL	Aging_(Albany_NY)_2011_Jan_18_3(1)_33-43.nxml.txt.nlp	21248371	SENT143	22	22	20	20	zinc	HIF-1	PA451956	29072	0.953
NULL	Cancer_Cell_Int_2005_Oct_4_5_30.nxml.txt.nlp	16202168	SENT57	34	34	3	3	loperamide	MDR1	PA450262	5243	0.953
NULL	AMIA_Jt_Summits_Transl_Sci_Proc_2012_Mar_19_2012_19-24.nxml.txt.nlp	22779042	SENT100	19	19	32	32	warfarin	TTR	PA451906	7276	0.953
NULL	Oncogene_2014_Jul_24_33(30)_3959-3969.nxml.txt.nlp	24096481	SENT24	13	13	27	27	nutlin-3	p53		7157	0.953
NULL	HSR_Proc_Intensive_Care_Cardiovasc_Anesth_2010_2(3)_161-175.nxml.txt.nlp	23441054	SENT287	15	15	33	33	amrinone	IL-6	PA164746803	3569	0.953
NULL	Mol_Cancer_2014_Feb_20_13_32.nxml.txt.nlp	24555657	SENT185	11	11	4	4	cisplatin	p53	PA449014	7157	0.953
NULL	Clin_Med_Insights_Oncol_2013_Jun_3_7_103-122.nxml.txt.nlp	23843721	SENT199	11	11	22	22	hydroxyurea	CHK2	PA449942	11200	0.953
NULL	Oncotarget_2014_Jun_22_5(13)_4581-4602.nxml.txt.nlp	25015035	SENT400	16	16	9	9	doxorubicin	p53	PA449412	7157	0.953
NULL	Environ_Health_Perspect_2005_Nov_14_113(11)_1600-1606.nxml.txt.nlp	16263518	SENT62	17	17	2	2	estradiol	HSD1	PA449503	26871	0.953
NULL	Breast_Cancer_Res_2014_Jul_24_16(4)_411.nxml.txt.nlp	25056669	SENT192	10	10	25	25	tamoxifen	CD49f	PA451581	3655	0.953
NULL	J_Ophthalmic_Inflamm_Infect_2012_May_14_2(4)_231-233.nxml.txt.nlp	22581347	SENT61	31	31	27	27	infliximab	TNF	PA452639	7124	0.953
NULL	Oncol_Lett_2013_Feb_27_5(2)_435-439.nxml.txt.nlp	23420613	SENT16	4	4	8	8	gefitinib	EGFR	PA131301952	1956	0.953
NULL	Breast_Cancer_Res_2010_Oct_22_12(Suppl_2)_S3.nxml.txt.nlp	21050424	SENT120	9	9	18	18	sorafenib	San	PA7000	80218	0.953
NULL	Chemother_Res_Pract_2012_Aug_29_2012_817297.nxml.txt.nlp	22970367	SENT21	15	15	27	27	erlotinib	EGFR	PA134687924	1956	0.953
NULL	Structure_2013_Jun_4_21(6)_986-996.nxml.txt.nlp	23665168	SENT213	23	23	18	18	nadh	ADP	PA164755085	23038	0.953
NULL	Mol_Biol_Cell_2012_Jun_1_23(11)_2017-2027.nxml.txt.nlp	22496424	SENT213	39	39	15	15	warfarin	PRDX4	PA451906	10549	0.953
NULL	Indian_J_Pharm_Sci_2013_Jan-Feb_75(1)_31-35.nxml.txt.nlp	23901158	SENT75	23	23	5	5	cefpodoxime	DCX	PA164746385	1641	0.953
NULL	J_Biol_Chem_2013_Jun_28_288(26)_18789-18802.nxml.txt.nlp	23625922	SENT155	4	4	17	17	thrombin	C5a	PA451674	727	0.953
NULL	Br_J_Cancer_2004_Mar_22_90(6)_1285-1292.nxml.txt.nlp	15026814	SENT127	1	1	6	6	cisplatin	p53	PA449014	7157	0.953
NULL	Int_J_Appl_Basic_Med_Res_2013_Jul-Dec_3(2)_117-121.nxml.txt.nlp	24083147	SENT64	5	5	0	0	clopidogrel	ADP	PA449053	23038	0.953
NULL	Springerplus_2013_Dec_18_2_679.nxml.txt.nlp	24386625	SENT86	16	16	25	25	dacarbazine	BRAF	PA449197	673	0.953
NULL	Breast_Cancer_Res_2011_Nov_1_13(6)_224.nxml.txt.nlp	22114931	SENT126	31	31	23	23	trastuzumab	PTEN	PA451743	5728	0.953
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT258	40	40	13	13	gefitinib	PIK3CA	PA131301952	5290	0.953
NULL	Front_Neurosci_2015_Jan_15_8_426.nxml.txt.nlp	25642160	SENT202	19	19	27	27	bupropion	CHRNB4	PA448687	1143	0.953
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT185	33	33	6	6	cisplatin	p53	PA449014	7157	0.953
NULL	J_Immunother_Cancer_2013_Nov_7_1(Suppl_1)_P91.nxml.txt.nlp	NULL	SENT10	15	15	2	2	docetaxel	CEA	PA449383	5670;1087	0.953
NULL	J_Cell_Mol_Med_2014_Nov_11_18(11)_2275-2286.nxml.txt.nlp	25208472	SENT235	7	7	17	17	cisplatin	p53	PA449014	7157	0.953
NULL	Gut_2008_Jan_1_58(1)_41-48.nxml.txt.nlp	18829978	SENT151	3	3	24	24	mannitol	IL10	PA450320	3586	0.953
NULL	Oncotarget_2012_Sep_28_3(10)_1169-1181.nxml.txt.nlp	23045411	SENT125	11	11	6	6	doxorubicin	JNK	PA449412	5599	0.953
NULL	Mol_Cancer_2009_Oct_24_8_91.nxml.txt.nlp	19852844	SENT40	20	20	32	32	cisplatin	TUSC2	PA449014	11334	0.953
NULL	ScientificWorldJournal_2013_Sep_26_2013_608415.nxml.txt.nlp	24191141	SENT137	24	24	10	10	ritonavir	APOC3	PA451260	345	0.953
NULL	J_Inherit_Metab_Dis_2012_Jan_10_35(1)_141-149.nxml.txt.nlp	21556832	SENT133	25	25	11	11	creatine	CRTR	PA164778930	6535	0.953
NULL	Front_Oncol_2014_Aug_11_4_204.nxml.txt.nlp	25157335	SENT107	28	28	18	18	erlotinib	KRAS	PA134687924	3845	0.953
NULL	Breast_Cancer_(Auckl)_2011_Jan_13_5_1-14.nxml.txt.nlp	21494397	SENT198	21	21	27	27	capecitabine	CYP3A4	PA448771	1576	0.953
NULL	Environ_Health_Perspect_2008_Mar_11_116(3)_297-302.nxml.txt.nlp	18335094	SENT77	2	2	11	11	lindane	San	PA164754914	80218	0.953
NULL	Oncotarget_2014_Aug_19_5(18)_8737-8749.nxml.txt.nlp	25228590	SENT147	3	3	19	19	crizotinib	MYCN	PA165946122	4613	0.953
NULL	Acta_Pharmacol_Sin_2014_Oct_25_35(10)_1293-1301.nxml.txt.nlp	25152022	SENT170	21	21	0	0	enalapril	NLRP3	PA449456	114548	0.953
NULL	Orphanet_J_Rare_Dis_2011_Apr_12_6_14.nxml.txt.nlp	21486454	SENT70	25	25	7	7	cloxacillin	AAT	PA449059	5265	0.953
NULL	Oncotarget_2013_Aug_21_4(9)_1484-1495.nxml.txt.nlp	23986086	SENT168	32	32	25	25	metformin	p53	PA450395	7157	0.953
NULL	Eur_J_Clin_Microbiol_Infect_Dis_2012_Apr_29_31(4)_571-574.nxml.txt.nlp	21796345	SENT23	15	15	36	36	lamivudine	IFN	PA450163	3439	0.953
NULL	Diabetes_2011_Nov_17_60(11)_2691-2700.nxml.txt.nlp	21896928	SENT156	9	9	3	3	resveratrol	SIRT1		23411	0.953
NULL	J_Immunother_2014_Apr_12_37(3)_180-186.nxml.txt.nlp	24598448	SENT61	0	0	10	10	sorafenib	IL-2	PA7000	3558	0.953
NULL	Med_Sci_Monit_2014_Aug_4_20_1369-1375.nxml.txt.nlp	25087904	SENT136	19	19	0	0	oxaliplatin	MLNR	PA131285527	2862	0.953
NULL	Cell_Death_Differ_2010_Oct_30_17(10)_1624-1635.nxml.txt.nlp	20431602	SENT41	25	25	19	19	paclitaxel	Bcl-2	PA450761	596	0.953
NULL	Sensors_(Basel)_2012_May_11_12(5)_6269-6281.nxml.txt.nlp	22778641	SENT94	10	10	1	1	glutaraldehyde	LOX	PA449777	4015	0.953
NULL	F1000_Biol_Rep_2009_Nov_26_1_87.nxml.txt.nlp	20948603	SENT57	15	15	4	4	vasopressin	SP-D	PA451858	6441	0.953
NULL	J_Cell_Mol_Med_2014_May_14_18(5)_811-823.nxml.txt.nlp	24628949	SENT266	10	10	17	17	docetaxel	FOXM1	PA449383	2305	0.953
NULL	J_Mol_Signal_2011_May_16_6_4.nxml.txt.nlp	21575178	SENT170	17	17	6	6	forskolin	HSP27	PA146096022	3315	0.953
NULL	J_Biomed_Biotechnol_2010_Nov_1_2010_617521.nxml.txt.nlp	19888437	SENT86	4	4	9	9	lovastatin	P-gp	PA450272	5243	0.953
NULL	J_Hum_Genet_2013_Jun_16_58(6)_353-361.nxml.txt.nlp	23677058	SENT157	2	2	13	13	cytarabine	SLC28A3	PA449177	64078	0.953
NULL	Cell_Commun_Signal_2009_Aug_27_7_20.nxml.txt.nlp	19712465	SENT298	23	23	31	31	carbachol	PYK2	PA448784	2185	0.953
NULL	Arthritis_Res_Ther_2013_Dec_19_15(6)_R218.nxml.txt.nlp	24351550	SENT22	37	37	14	14	methotrexate	AMPK	PA450428	5563	0.953
NULL	Pharmaceutics_2011_Nov_18_3(4)_865-913.nxml.txt.nlp	24309312	SENT172	8	8	15	15	midazolam	CYP3A4	PA450496	1576	0.953
NULL	Mol_Cancer_2014_Jun_9_13_146.nxml.txt.nlp	24913494	SENT217	40	40	31	31	metformin	MID1	PA450395	4281	0.953
NULL	Acta_Pharmacol_Sin_2009_Jul_22_30(7)_956-964.nxml.txt.nlp	19543298	SENT165	18	18	10	10	simvastatin	SLC22A1	PA451363	6580	0.953
NULL	Drugs_R_D_2014_Sep_31_14(3)_177-184.nxml.txt.nlp	25079671	SENT27	14	14	10	10	miglitol	MCP-1	PA164776726	6347	0.953
NULL	Biomed_Res_Int_2013_Jan_8_2013_252158.nxml.txt.nlp	23509696	SENT72	15	15	0	0	valsartan	CD34	PA451848	947	0.953
NULL	J_Epilepsy_Res_2014_Jun_30_4(1)_7-13.nxml.txt.nlp	24977124	SENT64	26	26	16	16	pilocarpine	CA1	PA450962	759	0.953
NULL	Front_Immunol_2012_Jan_12_2_98.nxml.txt.nlp	22566887	SENT255	0	0	29	29	celecoxib	Bcl-2	PA448871	596	0.953
NULL	Br_J_Cancer_2010_Jun_29_103(1)_1-5.nxml.txt.nlp	20461086	SENT46	14	14	7	7	oxygen	PHD2	PA450744	54583	0.953
NULL	J_Clin_Biochem_Nutr_2007_Jan_27_40(1)_13-23.nxml.txt.nlp	18437209	SENT142	16	16	6	6	thrombin	PAR1	PA451674	79581;2149	0.953
NULL	Oncotarget_2011_Dec_21_2(12)_1134-1144.nxml.txt.nlp	22193779	SENT9	24	24	20	20	gefitinib	EGFR	PA131301952	1956	0.953
NULL	J_Infect_Dis_2013_Feb_15_207(4)_656-660.nxml.txt.nlp	23186785	SENT67	8	8	0	0	atovaquone	C10	PA448502	113246	0.953
NULL	Oncotarget_2014_Oct_16_5(20)_9546-9563.nxml.txt.nlp	25337673	SENT190	25	25	4	4	gefitinib	AXL	PA131301952	558	0.953
NULL	Indian_J_Med_Res_2012_May_135(5)_703-730.nxml.txt.nlp	22771605	SENT344	8	8	1	1	isoniazid	DST	PA450112	667	0.953
NULL	Biomed_Res_Int_2013_Dec_30_2013_720579.nxml.txt.nlp	23533998	SENT126	12	12	4	4	ethanol	PS1	PA448073	5663	0.953
NULL	Support_Care_Cancer_2009_Sep_10_17(9)_1187-1193.nxml.txt.nlp	19205754	SENT73	11	11	23	23	dolasetron	CYP2D6	PA449390	1565	0.953
NULL	Core_Evid_2007_Nov_30_2(2)_121-129.nxml.txt.nlp	21221180	SENT106	6	6	20	20	rituximab	EFS	PA451261	10278	0.953
NULL	JAKSTAT_2013_Oct_1_2(4)_e25434.nxml.txt.nlp	24416648	SENT84	4	4	9	9	glucosamine	STAT3	PA164747613	6774	0.953
NULL	Breast_Cancer_Res_2007_Nov_2_9(6)_R76.nxml.txt.nlp	17980029	SENT275	32	32	6	6	docetaxel	PRDX2	PA449383	7001	0.953
NULL	Bioinformation_2012_Jan_20_8(2)_81-86.nxml.txt.nlp	22359440	SENT3	0	0	19	19	bosentan	ETB	PA10034	1910	0.953
NULL	Asian-Australas_J_Anim_Sci_2014_May_27(5)_717-725.nxml.txt.nlp	25050007	SENT103	32	32	1	1	creatine	PROC	PA164778930	5624	0.953
NULL	J_Oncol_2012_Aug_9_2012_685213.nxml.txt.nlp	22934113	SENT137	17	17	22	22	cabergoline	PRL	PA448708	5617	0.953
NULL	Oncotarget_2013_Nov_19_5(2)_309-325.nxml.txt.nlp	24525395	SENT311	23	23	18	18	bortezomib	Mcl-1	PA10252	4170	0.953
NULL	Clinics_(Sao_Paulo)_2013_May_68(5)_694-701.nxml.txt.nlp	23778405	SENT176	18	18	12	12	curcumin	P-gp	PA151958596	5243	0.953
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT89	21	21	14	14	resveratrol	TNF		7124	0.953
NULL	J_Hematol_Oncol_2014_Aug_1_7_54.nxml.txt.nlp	25084809	SENT118	1	1	16	16	thrombin	C5b	PA451674	727	0.953
NULL	Arch_Drug_Inf_2011_Mar_4(1)_1-9.nxml.txt.nlp	21572514	SENT156	26	26	0	0	ciprofloxacin	P-gp	PA449009	5243	0.953
NULL	Pharmaceuticals_(Basel)_2011_Nov_11_4(11)_1503-1517.nxml.txt.nlp	NULL	SENT41	0	0	15	15	capsaicin	TRPV1	PA448776	7442	0.953
NULL	Mol_Vis_2011_Dec_24_17_3384-3391.nxml.txt.nlp	22219634	SENT114	20	20	4	4	mannitol	TLR4	PA450320	7099	0.953
NULL	J_Cancer_2013_Jan_11_4(2)_117-132.nxml.txt.nlp	23386910	SENT268	10	10	43	43	ridaforolimus	aromatase	PA165291475	1588	0.953
NULL	Diabetes_2011_Nov_17_60(11)_2691-2700.nxml.txt.nlp	21896928	SENT250	17	17	2	2	resveratrol	SIRT1		23411	0.953
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Jan_8_3(1)_e89.nxml.txt.nlp	24402116	SENT15	8	8	23	23	tocilizumab	IL-6	PA165292659	3569	0.953
NULL	Mol_Cancer_2014_Jun_4_13_141.nxml.txt.nlp	24894453	SENT95	18	18	31	31	cetuximab	EGFR	PA10040	1956	0.953
NULL	Lipids_Health_Dis_2011_Feb_28_10_38.nxml.txt.nlp	21352602	SENT10	24	24	10	10	ezetimibe	PCSK9	PA10816	255738	0.953
NULL	Diabetes_Metab_Syndr_Obes_2014_Jun_24_7_229-239.nxml.txt.nlp	25018644	SENT41	32	32	35	35	exenatide	GLP-1	PA164749238	100125288	0.953
NULL	Oncogenesis_2014_Dec_15_3(12)_e133.nxml.txt.nlp	25500906	SENT304	12	12	4	4	trastuzumab	MYO3A	PA451743	53904	0.953
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT193	20	20	8	8	methotrexate	MSH2	PA450428	4436	0.953
NULL	Acta_Pharmacol_Sin_2014_Sep_25_35(9)_1199-1206.nxml.txt.nlp	25152024	SENT104	5	5	46	46	cisplatin	ERK5	PA449014	5598	0.953
NULL	Br_J_Cancer_2009_Oct_6_101(7)_1155-1161.nxml.txt.nlp	19738614	SENT116	19	19	8	8	gemcitabine	HER2	PA449748	2064	0.953
NULL	Oncol_Lett_2014_Nov_14_8(5)_2086-2092.nxml.txt.nlp	25295095	SENT132	29	29	22	22	gemcitabine	CHK2	PA449748	11200	0.953
NULL	Bioinformation_2012_Jan_6_8(1)_13-19.nxml.txt.nlp	22359429	SENT138	35	35	6	6	calcein	MRP1	PA132595336	4437	0.953
NULL	Oncoimmunology_2014_Jun_3_3_e29030.nxml.txt.nlp	25083328	SENT43	23	23	8	8	rituximab	IL-18	PA451261	3606	0.953
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT199	20	20	41	41	cetuximab	KRAS	PA10040	3845	0.953
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Dec_17_3(12)_e152.nxml.txt.nlp	25518025	SENT67	29	29	19	19	oxymorphone	CYP2D6	PA450748	1565	0.953
NULL	Iran_Red_Crescent_Med_J_2013_Dec_5_15(12)_e12260.nxml.txt.nlp	24693388	SENT68	32	32	11	11	warfarin	FIX	PA451906	2158	0.953
NULL	Int_J_Nanomedicine_2009_Nov_23_4_251-259.nxml.txt.nlp	20011242	SENT163	7	7	28	28	paclitaxel	survivin	PA450761	332	0.953
NULL	Oncotarget_2014_Oct_15_5(21)_10763-10777.nxml.txt.nlp	25333257	SENT154	41	41	18	18	sn-38	P-gp		5243	0.953
NULL	J_Korean_Med_Sci_2014_Aug_30_29(8)_1042-1053.nxml.txt.nlp	25120312	SENT161	12	12	3	3	triciribine	JNK	PA165958661	5599	0.953
NULL	Ecancermedicalscience_2011_Dec_1_5_237.nxml.txt.nlp	22276069	SENT34	22	22	8	8	letrozole	CEA	PA450196	5670;1087	0.953
NULL	Comput_Struct_Biotechnol_J_2013_Jan_18_3_e201210019.nxml.txt.nlp	24688679	SENT50	33	33	5	5	nadh	EMP	PA164755085	10296	0.953
NULL	Indian_J_Endocrinol_Metab_2013_Nov-Dec_17(6)_996-1004.nxml.txt.nlp	24381874	SENT114	13	13	21	21	bromocriptine	PRL	PA448671	5617	0.953
NULL	Cardiovasc_Diabetol_2011_Dec_1_10_109.nxml.txt.nlp	22132774	SENT29	0	0	16	16	liraglutide	GLP-1	PA165958364	100125288	0.953
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT784	32	32	3	3	fexofenadine	OATP1B3	PA449621	28234	0.953
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Dec_18_67(Pt_1)_o184-o185.nxml.txt.nlp	21522689	SENT67	43	43	17	17	ethanol	mol	PA448073	90527	0.953
NULL	Int_J_Mol_Sci_2012_Feb_1_13(2)_1512-1523.nxml.txt.nlp	22408405	SENT134	11	11	24	24	olmesartan	LOX-1	PA164742950	4973	0.953
NULL	Diabetes_2011_Mar_21_60(3)_757-765.nxml.txt.nlp	21282370	SENT174	5	5	23	23	isoproterenol	PTRF	PA450121	284119	0.953
NULL	Diabetes_2008_Sep_57(9)_2272-2279.nxml.txt.nlp	18519799	SENT10	5	5	15	15	rosiglitazone	PDK4	PA451283	5166	0.953
NULL	Oncotarget_2013_Jul_18_4(10)_1582-1591.nxml.txt.nlp	24123600	SENT21	13	13	28	28	imatinib	ABCG1	PA10804	9619	0.953
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT15	16	16	10	10	capsaicin	p53	PA448776	7157	0.953
NULL	Eur_J_Clin_Pharmacol_2012_Jan_8_68(1)_29-37.nxml.txt.nlp	21739267	SENT12	16	16	31	31	aripiprazole	CYP2D6	PA10026	1565	0.953
NULL	Arthritis_Res_Ther_2008_Jun_5_10(3)_R66.nxml.txt.nlp	18534002	SENT204	28	28	6	6	tocilizumab	IL-6	PA165292659	3569	0.953
NULL	Bioinformation_2012_Jan_6_8(1)_13-19.nxml.txt.nlp	22359429	SENT7	2	2	34	34	curcumin	MRP1	PA151958596	4437	0.953
NULL	Mol_Cancer_2012_Apr_5_11_20.nxml.txt.nlp	22480225	SENT609	19	19	14	14	temozolomide	HSP27	PA451609	3315	0.953
NULL	Acta_Pharmacol_Sin_2011_Jan_6_32(1)_133-138.nxml.txt.nlp	21131997	SENT8	6	6	16	16	heparin	ACT	PA449855	12;11332;9457;641455	0.953
NULL	Breast_Cancer_Res_2010_Nov_16_12(6)_R96.nxml.txt.nlp	21080941	SENT6	0	0	17	17	lapatinib	HER2	PA152241907	2064	0.953
NULL	Arthritis_Res_Ther_2014_Jan_14_16(1)_R9.nxml.txt.nlp	24423102	SENT9	26	26	2	2	methotrexate	TLR3	PA450428	7098	0.953
NULL	Braz_J_Med_Biol_Res_2014_Mar_21_47(4)_273-278.nxml.txt.nlp	24676475	SENT73	17	17	3	3	doxorubicin	CIAPIN1	PA449412	57019	0.953
NULL	Chin_J_Cancer_2012_Feb_31(2)_73-99.nxml.txt.nlp	22098950	SENT232	9	9	38	38	gefitinib	P-gp	PA131301952	5243	0.953
NULL	J_Adv_Pract_Oncol_2012_Nov_1_Nov-Dec_3(6)_391-394.nxml.txt.nlp	25031970	SENT15	0	0	18	18	pertuzumab	HER2		2064	0.953
NULL	Health_Econ_Rev_2013_May_16_3_15.nxml.txt.nlp	23680096	SENT150	31	31	4	4	gefitinib	EGFR	PA131301952	1956	0.953
NULL	J_Hematol_Oncol_2011_Apr_20_4_16.nxml.txt.nlp	21504625	SENT211	0	0	19	19	bsi-201	PARP-1		25976	0.953
NULL	Hum_Genomics_2008_Sep_1_3(1)_7-16.nxml.txt.nlp	19129086	SENT154	32	32	18	18	rosiglitazone	SLCO1B1	PA451283	10599	0.953
NULL	Acta_Pharmacol_Sin_2010_Mar_8_31(3)_382-386.nxml.txt.nlp	20140004	SENT72	39	39	25	25	pravastatin	CYP7A1	PA451089	1581	0.953
NULL	Nat_Commun_2012_Jan_31_3_649.nxml.txt.nlp	22337127	SENT378	16	16	5	5	thrombin	RhoA	PA451674	387	0.953
NULL	Ann_Oncol_2013_Aug_12_24(8)_1994-1999.nxml.txt.nlp	23670096	SENT106	18	18	1	1	tamoxifen	AIB1	PA451581	8202	0.953
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT52	3	3	31	31	ranibizumab	VEGFR1	PA164746012	2321	0.953
NULL	J_Gynecol_Oncol_2014_Apr_9_25(2)_130-135.nxml.txt.nlp	24761217	SENT139	8	8	18	18	paclitaxel	P-gp	PA450761	5243	0.953
NULL	Mol_Cancer_2008_Jun_30_7_60.nxml.txt.nlp	18590557	SENT71	14	14	3	3	tamoxifen	TRAIL	PA451581	8743	0.953
NULL	Oncotarget_2013_Nov_24_4(12)_2186-2207.nxml.txt.nlp	24327604	SENT137	22	22	12	12	bortezomib	RITA	PA10252	55422;84934	0.953
NULL	Eur_J_Clin_Pharmacol_2012_Jan_8_68(1)_29-37.nxml.txt.nlp	21739267	SENT31	16	16	18	18	quinidine	CYP2D6	PA451209	1565	0.953
NULL	Asian-Australas_J_Anim_Sci_2014_Apr_27(4)_561-566.nxml.txt.nlp	25049988	SENT63	16	16	6	6	kanamycin	ISG15	PA450137	9636	0.953
NULL	J_Cell_Mol_Med_2014_Oct_11_18(10)_2031-2043.nxml.txt.nlp	25109475	SENT275	24	24	8	8	valsartan	TLR-4	PA451848	7099	0.953
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT15	25	25	2	2	simvastatin	AKT	PA451363	207	0.953
NULL	Korean_J_Anesthesiol_2013_Dec_26_65(6)_501-507.nxml.txt.nlp	24427455	SENT51	5	5	42	42	rocuronium	NMB	PA164754992	10457;4828	0.953
NULL	Diabetes_Care_2010_Jul_22_33(7)_1604-1606.nxml.txt.nlp	20413521	SENT19	14	14	7	7	desmopressin	AVP	PA449237	114548;551	0.953
NULL	J_Ind_Microbiol_Biotechnol_2013_Jul_30_40(10)_1153-1160.nxml.txt.nlp	23896974	SENT31	28	28	23	23	ethanol	CO2	PA448073	4513	0.953
NULL	Gut_Liver_2011_Sep_18_5(3)_253-266.nxml.txt.nlp	21927652	SENT65	17	17	23	23	tegaserod	5-HT4	PA130413154	3360	0.953
NULL	Curr_Cardiol_Rev_2012_Aug_8(3)_177-180.nxml.txt.nlp	22920485	SENT58	40	40	28	28	prasugrel	P2Y12	PA154410481	64805	0.953
NULL	Indian_J_Endocrinol_Metab_2011_Sep_15(Suppl3)_S172-S179.nxml.txt.nlp	22029021	SENT223	8	8	2	2	ketoconazole	aromatase	PA450146	1588	0.953
NULL	Breast_Cancer_Res_Treat_2012_Aug_5_134(3)_1149-1159.nxml.txt.nlp	22763464	SENT200	4	4	18	18	cetuximab	PTEN	PA10040	5728	0.953
NULL	Iran_J_Pharm_Res_2013_Summer_12(3)_457-469.nxml.txt.nlp	24250652	SENT182	21	21	28	28	allopregnanolone	CA1	PA142320763	759	0.953
NULL	Cell_Cycle_2013_Mar_15_12(6)_868.nxml.txt.nlp	23442795	SENT28	20	20	12	12	bortezomib	p53	PA10252	7157	0.953
NULL	Clin_Interv_Aging_2012_Jul_12_7_249-255.nxml.txt.nlp	22866002	SENT35	0	0	6	6	gabapentin	gamma	PA449720	9913	0.953
NULL	Acta_Pharmacol_Sin_2010_Jun_4_31(6)_709-717.nxml.txt.nlp	20523342	SENT110	15	15	22	22	repaglinide	PPG	PA451234	5552	0.953
NULL	Indian_J_Pharmacol_2013_Nov-Dec_45(6)_597-602.nxml.txt.nlp	24347768	SENT23	30	30	3	3	vincristine	P-gp	PA451879	5243	0.953
NULL	Cell_Death_Differ_2009_Aug_20_16(8)_1135-1145.nxml.txt.nlp	19300452	SENT201	13	13	16	16	doxycycline	PUMA	PA449415	27113	0.953
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT251	17	17	10	10	lapatinib	EGFR	PA152241907	1956	0.953
NULL	Nucleic_Acids_Res_2011_Sep_7_39(17)_7465-7476.nxml.txt.nlp	21653549	SENT243	15	15	21	21	etoposide	DEK	PA449552	7913	0.953
NULL	J_Hematol_Oncol_2013_Jan_17_6_8.nxml.txt.nlp	23327547	SENT131	4	4	23	23	sulindac	JNK1	PA451565	5599	0.953
NULL	Acta_Pharmacol_Sin_2013_Sep_5_34(9)_1192-1200.nxml.txt.nlp	23685957	SENT177	6	6	9	9	curcumin	AP-2	PA151958596	7020	0.953
NULL	Reprod_Biol_Endocrinol_2003_Oct_7_1_66.nxml.txt.nlp	14609433	SENT130	22	22	13	13	paclitaxel	PI3K	PA450761	5290	0.953
NULL	Mol_Cancer_2009_Nov_19_8_108.nxml.txt.nlp	19925669	SENT154	37	37	13	13	mitomycin	CTRL	PA450524	1506	0.953
NULL	Gynecol_Oncol_Case_Rep_2013_Jun_12_6_34-35.nxml.txt.nlp	24371715	SENT14	0	0	13	13	aprepitant	NK1	PA164747039	11126	0.953
NULL	Anat_Cell_Biol_2011_Sep_29_44(3)_194-203.nxml.txt.nlp	22025971	SENT6	5	5	11	11	resveratrol	AMPK		5563	0.953
NULL	Int_J_Breast_Cancer_2011_Jul_3_2011_912102.nxml.txt.nlp	22295238	SENT21	34	34	26	26	exemestane	aromatase	PA449563	1588	0.953
NULL	Br_J_Cancer_2009_Mar_10_100(5)_758-763.nxml.txt.nlp	19259094	SENT139	18	18	3	3	decitabine	MLH1	PA164749631	4292	0.953
NULL	Breast_Cancer_Res_2004_Aug_5_6(5)_R601-R607.nxml.txt.nlp	15318941	SENT138	11	11	6	6	docetaxel	p27	PA449383	5715;10534	0.953
NULL	Cancer_Res_Treat_2012_Sep_30_44(3)_195-201.nxml.txt.nlp	23091446	SENT106	4	4	21	21	etoposide	MKP-1	PA449552	1843	0.953
NULL	Vet_Res_2013_Oct_2_44(1)_89.nxml.txt.nlp	24088531	SENT5	33	33	5	5	hemin	HO-1	PA449849	3162	0.953
NULL	Cancer_Manag_Res_2013_Jan_17_5_15-20.nxml.txt.nlp	23378782	SENT38	5	5	19	19	erlotinib	Met	PA134687924	79811	0.953
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT521	2	2	8	8	risperidone	PRL	PA451257	5617	0.953
NULL	J_Exp_Med_2003_Aug_4_198(3)_505-512.nxml.txt.nlp	12900524	SENT118	10	10	5	5	dextran	CCL21	PA449261	6366	0.953
NULL	Pain_Res_Treat_2012_Apr_23_2012_295926.nxml.txt.nlp	22577544	SENT60	26	26	45	45	diclofenac	ARC	PA449293	8996;23237	0.953
NULL	Int_J_Mol_Sci_2014_Mar_24_15(3)_5140-5162.nxml.txt.nlp	24663085	SENT103	16	16	31	31	cyclophosphamide	LP1	PA449165	6176	0.953
NULL	Niger_Med_J_2013_Mar-Apr_54(2)_79-86.nxml.txt.nlp	23798791	SENT120	29	29	10	10	tamoxifen	PTEN	PA451581	5728	0.953
NULL	Oncol_Lett_2014_Oct_30_8(4)_1447-1454.nxml.txt.nlp	25202348	SENT100	31	31	15	15	everolimus	UBC	PA164746311	7316	0.953
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT92	1	1	19	19	methotrexate	MLH1	PA450428	4292	0.953
NULL	Br_J_Cancer_2013_Jan_15_108(1)_82-90.nxml.txt.nlp	23321512	SENT28	22	22	10	10	paclitaxel	TUBB3	PA450761	10381	0.953
NULL	Oncotarget_2012_Feb_2_3(1)_58-66.nxml.txt.nlp	22308267	SENT93	22	22	27	27	doxycycline	MYC	PA449415	4609	0.953
NULL	Korean_Circ_J_2013_Jun_30_43(6)_400-407.nxml.txt.nlp	23882289	SENT87	12	12	8	8	doxorubicin	survivin	PA449412	332	0.953
NULL	Breast_Cancer_Res_2010_Apr_30_12(2)_203.nxml.txt.nlp	20459590	SENT269	14	14	7	7	cisplatin	BRCA1	PA449014	672	0.953
NULL	Breast_Cancer_Res_2007_Feb_28_9(1)_204.nxml.txt.nlp	17338830	SENT134	5	5	11	11	bromocriptine	PRL	PA448671	5617	0.953
NULL	Multidiscip_Respir_Med_2012_Jun_11_7(1)_4.nxml.txt.nlp	22958344	SENT140	16	16	10	10	rituximab	GM-CSF	PA451261	1437	0.953
NULL	Int_J_Mol_Sci_2014_Jun_26_15(7)_11416-11434.nxml.txt.nlp	24972137	SENT224	6	6	26	26	sitagliptin	GLP-1	PA164748978	100125288	0.953
NULL	CNS_Neurosci_Ther_2010_Jun_16(3)_e1-e17.nxml.txt.nlp	20406250	SENT202	20	20	25	25	mirtazapine	5-HT2A	PA450522	3356	0.953
NULL	Front_Endocrinol_(Lausanne)_2011_Dec_6_2_93.nxml.txt.nlp	22654833	SENT1372	22	22	6	6	cisplatin	gamma	PA449014	9913	0.953
NULL	Int_J_Med_Sci_2013_Mar_20_10(5)_607-616.nxml.txt.nlp	23569423	SENT81	16	16	20	20	losartan	AT1	PA450268	9197;185	0.953
NULL	Ann_Oncol_2012_Dec_2_23(12)_3007-3016.nxml.txt.nlp	22865781	SENT45	18	18	22	22	trastuzumab	HER2	PA451743	2064	0.953
NULL	Curr_Cardiol_Rev_2009_Aug_5(3)_196-202.nxml.txt.nlp	20676278	SENT34	3	3	23	23	hyaluronan	TLR4	PA165958431	7099	0.953
NULL	Ann_Rheum_Dis_2013_Aug_21_72(8)_1287-1294.nxml.txt.nlp	22915624	SENT17	22	22	1	1	abatacept	MRI	PA164747080	78996	0.953
NULL	Mol_Cancer_2014_Feb_24_13_35.nxml.txt.nlp	24565101	SENT99	3	3	37	37	doxorubicin	c-IAP1	PA449412	329	0.953
NULL	Database_(Oxford)_2014_Dec_23_2014_bau124.nxml.txt.nlp	25539768	SENT130	0	0	7	7	cetuximab	EGFR	PA10040	1956	0.953
NULL	Cancer_Res_Treat_2013_Mar_31_45(1)_55-62.nxml.txt.nlp	23613671	SENT18	12	12	0	0	irinotecan	KRAS	PA450085	3845	0.953
NULL	Leukemia_2014_Mar_12_28(3)_577-588.nxml.txt.nlp	24080946	SENT272	2	2	10	10	suramin	SIRT1	PA10292	23411	0.953
NULL	Br_J_Pharmacol_2014_Oct_26_171(20)_4785-4796.nxml.txt.nlp	25074741	SENT244	16	16	4	4	guanfacine	spatial	PA449825	219793	0.953
NULL	Breast_Cancer_Res_2007_Dec_20_9(Suppl_2)_S19.nxml.txt.nlp	NULL	SENT33	21	21	12	12	letrozole	CCND1	PA450196	595	0.953
NULL	Mol_Brain_2013_Feb_12_6_8.nxml.txt.nlp	23402298	SENT169	27	27	11	11	remifentanil	CACNA2D2	PA451232	9254	0.953
NULL	Mol_Cancer_2014_Jan_7_13_4.nxml.txt.nlp	24393163	SENT208	24	24	34	34	imatinib	JNK1	PA10804	5599	0.953
NULL	Exp_Ther_Med_2014_Sep_20_8(3)_968-972.nxml.txt.nlp	25120631	SENT85	15	15	3	3	naringin	PF4	PA151958360	5196	0.953
NULL	Front_Neurol_2013_Sep_3_4_122.nxml.txt.nlp	24027553	SENT315	13	13	11	11	geldanamycin	Hsp90	PA152031327	3320	0.953
NULL	Case_Rep_Neurol_Med_2013_Jul_1_2013_451206.nxml.txt.nlp	23936696	SENT46	0	0	5	5	ranolazine	CYP3A	PA164746007	1574	0.953
NULL	Mol_Cancer_2008_Jun_5_7_50.nxml.txt.nlp	18534018	SENT84	13	13	24	24	bortezomib	HSP	PA10252	7190	0.953
NULL	J_Korean_Med_Sci_2010_Jun_24_25(6)_829-834.nxml.txt.nlp	20514301	SENT137	15	15	5	5	papain	JNK	PA450778	5599	0.953
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S31-S40.nxml.txt.nlp	20680106	SENT190	10	10	2	2	cetuximab	BRAF	PA10040	673	0.953
NULL	Br_J_Cancer_2003_Mar_24_88(6)_848-854.nxml.txt.nlp	12644821	SENT21	26	26	34	34	cisplatin	MEK1	PA449014	5604	0.953
NULL	Indian_J_Endocrinol_Metab_2012_May-Jun_16(3)_343-348.nxml.txt.nlp	22629497	SENT32	0	0	7	7	teriparatide	PTH	PA451620	5741	0.953
NULL	Breast_Cancer_Res_Treat_2014_Sep_25_148(1)_81-90.nxml.txt.nlp	25253174	SENT167	3	3	12	12	metformin	HER2	PA450395	2064	0.953
NULL	Front_Neurosci_2012_Jan_19_5_136.nxml.txt.nlp	22294977	SENT230	13	13	4	4	diazepam	TSPO	PA449283	706	0.953
NULL	Cell_Death_Differ_2010_Oct_30_17(10)_1624-1635.nxml.txt.nlp	20431602	SENT357	8	8	26	26	paclitaxel	Mcl-1	PA450761	4170	0.953
NULL	Breast_Cancer_Res_2011_Nov_7_13(6)_R112.nxml.txt.nlp	22060274	SENT3	41	41	2	2	tamoxifen	ARTN	PA451581	9048	0.953
NULL	Cell_Cycle_2012_Nov_1_11(21)_4069-4078.nxml.txt.nlp	23095523	SENT153	18	18	30	30	imatinib	PERK	PA10804	9451	0.953
NULL	Hum_Genomics_2008_Sep_1_3(1)_7-16.nxml.txt.nlp	19129086	SENT186	32	32	18	18	rosiglitazone	SLCO1B1	PA451283	10599	0.953
NULL	Chemother_Res_Pract_2012_Dec_20_2012_743193.nxml.txt.nlp	23320171	SENT110	0	0	9	9	trastuzumab	HER2	PA451743	2064	0.953
NULL	ARYA_Atheroscler_2011_Summer_7(2)_78-86.nxml.txt.nlp	22577451	SENT11	8	8	36	36	choline	CRP	PA448976	1401;140913	0.953
NULL	Mol_Cancer_2013_Mar_5_12_17.nxml.txt.nlp	23497256	SENT198	32	32	22	22	sunitinib	HDMX	PA162372840	4194;4193	0.953
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT282	30	30	6	6	pemetrexed	UNG	PA10810	7374	0.953
NULL	Oncotarget_2011_Dec_31_2(12)_1314-1321.nxml.txt.nlp	22248929	SENT41	10	10	8	8	everolimus	TORC1	PA164746311	23373	0.953
NULL	Biomed_Res_Int_2014_Jan_27_2014_683123.nxml.txt.nlp	24592395	SENT273	26	26	12	12	estradiol	cPLA2	PA449503	10524	0.953
NULL	Nat_Chem_Biol_2010_Apr_28_6(4)_291-299.nxml.txt.nlp	20190765	SENT129	3	3	33	33	dasatinib	EGFR	PA162372878	1956	0.953
NULL	Br_J_Cancer_2010_Jun_29_103(1)_61-72.nxml.txt.nlp	20588279	SENT253	6	6	10	10	trastuzumab	HER-2	PA451743	2064	0.953
NULL	Cancers_(Basel)_2011_Apr_1_3(2)_1844-1860.nxml.txt.nlp	24212785	SENT93	21	21	6	6	cetuximab	KRAS	PA10040	3845	0.953
NULL	Eur_J_Med_Res_2012_Feb_23_17(1)_4.nxml.txt.nlp	22472354	SENT19	25	25	18	18	erlotinib	EGFR	PA134687924	1956	0.953
NULL	Br_J_Cancer_2013_Mar_19_108(5)_1052-1060.nxml.txt.nlp	23422754	SENT156	48	48	9	9	bevacizumab	VEGF-A	PA130232992	7422	0.953
NULL	Clin_Interv_Aging_2012_Sep_3_7_331-338.nxml.txt.nlp	22977302	SENT48	7	7	15	15	denosumab	aromatase	PA166048634	1588	0.953
NULL	J_Cell_Mol_Med_2013_May_12_17(5)_636-647.nxml.txt.nlp	23577651	SENT72	7	7	19	19	quinacrine	HIP8	PA164745551	4102	0.953
NULL	Chin_J_Cancer_2012_Nov_31(11)_541-548.nxml.txt.nlp	23114088	SENT120	9	9	32	32	paclitaxel	SPARC	PA450761	6678	0.953
NULL	Acta_Pharmacol_Sin_2010_Jan_5_31(1)_93-101.nxml.txt.nlp	20048748	SENT108	23	23	15	15	cisplatin	DAPK	PA449014	1612	0.953
NULL	Oncotarget_2012_Feb_22_3(2)_203-211.nxml.txt.nlp	22361516	SENT138	24	24	30	30	temsirolimus	PI3	PA164746890	5266	0.953
NULL	J_Korean_Med_Sci_2010_Aug_21_25(8)_1222-1227.nxml.txt.nlp	20676337	SENT66	3	3	30	30	propofol	LPA	PA451141	4018	0.953
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Dec_17_3(12)_e152.nxml.txt.nlp	25518025	SENT31	5	5	22	22	oxycodone	CYP2D6	PA450741	1565	0.953
NULL	J_Inherit_Metab_Dis_2012_Nov_24_35(6)_1137-1145.nxml.txt.nlp	22447153	SENT210	5	5	10	10	fenofibrate	ALDRP	PA449594	225	0.953
NULL	Int_J_Mol_Sci_2012_Aug_21_13(8)_10461-10477.nxml.txt.nlp	22949874	SENT122	24	24	22	22	letrozole	aromatase	PA450196	1588	0.953
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT203	5	5	38	38	adalimumab	CD36	PA10004	948	0.953
NULL	J_Breast_Cancer_2011_Jun_18_14(2)_140-146.nxml.txt.nlp	21847410	SENT156	9	9	40	40	capecitabine	HER2	PA448771	2064	0.953
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT163	13	13	2	2	perifosine	JNK	PA165291471	5599	0.953
NULL	Indian_J_Pharmacol_2013_Mar-Apr_45(2)_155-158.nxml.txt.nlp	23716892	SENT116	31	31	39	39	pioglitazone	CYP3A4	PA450970	1576	0.953
NULL	Braz_J_Med_Biol_Res_2014_Sep_5_47(11)_929-939.nxml.txt.nlp	25296354	SENT114	17	17	35	35	gefitinib	EGFR	PA131301952	1956	0.953
NULL	Cancer_Med_2013_Aug_28_2(4)_468-477.nxml.txt.nlp	24156019	SENT7	15	15	0	0	docetaxel	Men	PA449383	8178	0.953
NULL	Cancer_Manag_Res_2013_Jun_27_5_133-146.nxml.txt.nlp	23869177	SENT124	11	11	22	22	trastuzumab	EGFR	PA451743	1956	0.953
NULL	Cancers_(Basel)_2014_Jan_15_6(1)_143-152.nxml.txt.nlp	24434543	SENT80	7	7	22	22	trastuzumab	HER2	PA451743	2064	0.953
NULL	Oncotarget_2014_Aug_19_5(18)_8737-8749.nxml.txt.nlp	25228590	SENT6	3	3	10	10	crizotinib	RPS6	PA165946122	6194	0.953
NULL	Arch_Med_Sci_2014_Oct_27_10(5)_920-932.nxml.txt.nlp	25395943	SENT173	23	23	12	12	salmeterol	CYP3A4	PA451300	1576	0.953
NULL	J_Lipid_Res_2015_Jan_56(1)_109-121.nxml.txt.nlp	25421061	SENT101	20	20	3	3	trypsin	CGI-58	PA451806	51099	0.953
NULL	Curr_Colorectal_Cancer_Rep_2014_Jan_12_10(1)_45-54.nxml.txt.nlp	24659930	SENT104	15	15	17	17	curcumin	HER2	PA151958596	2064	0.953
NULL	Arq_Bras_Cardiol_2013_Oct_101(4)_304-310.nxml.txt.nlp	24008655	SENT82	7	7	17	17	carvedilol	mol	PA448817	90527	0.953
NULL	Clin_Psychopharmacol_Neurosci_2012_Dec_20_10(3)_168-179.nxml.txt.nlp	23430396	SENT157	4	4	19	19	iptakalim	IPT	PA165949694	54802	0.953
NULL	Emerg_Infect_Dis_2003_Jul_9(7)_864-867.nxml.txt.nlp	12890330	SENT70	25	25	6	6	dapsone	DHPS	PA449211	1725	0.953
NULL	Indian_J_Med_Res_2013_Oct_138(4)_461-491.nxml.txt.nlp	24434254	SENT449	10	10	30	30	simvastatin	2A9	PA451363	6277	0.953
NULL	Nature_2008_Oct_23_455(7216)_1076-1081.nxml.txt.nlp	18948948	SENT94	27	27	23	23	staurosporine	BAX	PA165109623	581	0.953
NULL	Int_J_Nanomedicine_2012_Sep_13_7_4917-4926.nxml.txt.nlp	23028220	SENT217	24	24	10	10	calcein	mol	PA132595336	90527	0.953
NULL	Int_J_Mol_Sci_2014_Nov_25_15(12)_21703-21722.nxml.txt.nlp	25429431	SENT105	22	22	8	8	curcumin	Mcl-1	PA151958596	4170	0.953
NULL	Leukemia_2014_Feb_8_28(2)_407-410.nxml.txt.nlp	23979520	SENT22	18	18	24	24	bortezomib	BCL2	PA10252	596	0.953
NULL	Med_Sci_Monit_2013_Dec_23_19_1195-1210.nxml.txt.nlp	24362017	SENT271	40	40	5	5	cisplatin	TRPV1	PA449014	7442	0.953
NULL	Front_Immunol_2014_Aug_22_5_406.nxml.txt.nlp	25202312	SENT174	0	0	14	14	eculizumab	ABO	PA164776637	28	0.953
NULL	Oncoimmunology_2013_Jan_1_2(1)_e22890.nxml.txt.nlp	23483066	SENT58	6	6	20	20	vemurafenib	NLRC5	PA165946873	84166	0.953
NULL	J_Cell_Biol_1993_Nov_1_123(3)_749-758.nxml.txt.nlp	7693717	SENT2	6	6	22	22	hyaluronan	RHAMM	PA165958431	3161	0.953
NULL	Physiol_Rep_2014_Sep_11_2(9)_e12144.nxml.txt.nlp	25214522	SENT148	6	6	18	18	resveratrol	RVR		9975	0.953
NULL	Br_J_Cancer_2013_Jun_25_108(12)_2464-2469.nxml.txt.nlp	23695016	SENT7	8	8	21	21	paclitaxel	CRT	PA450761	811	0.953
NULL	Patient_Prefer_Adherence_2010_Mar_24_4_61-68.nxml.txt.nlp	20361006	SENT28	0	0	4	4	liraglutide	GLP-1	PA165958364	100125288	0.953
NULL	Mol_Vis_2012_Oct_5_18_2454-2467.nxml.txt.nlp	23077404	SENT152	13	13	21	21	bevacizumab	VEGF-A	PA130232992	7422	0.953
NULL	Case_Rep_Endocrinol_2013_Mar_4_2013_706989.nxml.txt.nlp	23533838	SENT70	1	1	24	24	hydrocortisone	ACTH	PA449905	5443	0.953
NULL	Indian_J_Med_Res_2012_Jul_136(1)_3-6.nxml.txt.nlp	22885256	SENT69	8	8	31	31	boceprevir	IFN	PA165948902	3439	0.953
NULL	Clin_Dev_Immunol_2013_Oct_3_2013_349067.nxml.txt.nlp	24198842	SENT121	11	11	3	3	paraformaldehyde	CD34	PA450790	947	0.953
NULL	Drugs_R_D_2014_Jun_2_14(2)_63-71.nxml.txt.nlp	24691742	SENT38	18	18	47	47	moxifloxacin	E14	PA450555	4863	0.953
NULL	Oncotarget_2014_Apr_30_5(22)_11193-11208.nxml.txt.nlp	25008202	SENT179	27	27	10	10	bortezomib	CD138	PA10252	6382	0.953
NULL	Nat_Commun_2014_Nov_19_5_5479.nxml.txt.nlp	25407222	SENT252	23	23	0	0	dextran	YTS	PA449261	8565	0.953
NULL	Ann_Oncol_2013_Sep_4_24(9)_2206-2223.nxml.txt.nlp	23917950	SENT250	29	29	40	40	tamoxifen	aromatase	PA451581	1588	0.953
NULL	Cancer_Cell_Int_2013_Oct_11_13_97.nxml.txt.nlp	24119761	SENT153	6	6	27	27	trastuzumab	EGF	PA451743	1950	0.953
NULL	Cell_Death_Dis_2012_Mar_15_3(3)_e286.nxml.txt.nlp	22419115	SENT64	11	11	23	23	cisplatin	p53	PA449014	7157	0.953
NULL	J_Mammary_Gland_Biol_Neoplasia_2010_Mar_27_15(1)_5-17.nxml.txt.nlp	20101446	SENT178	13	13	3	3	tamoxifen	HuR	PA451581	1994	0.953
NULL	Mol_Cancer_2013_Sep_11_12_104.nxml.txt.nlp	24025152	SENT134	9	9	2	2	gemcitabine	STAT3	PA449748	6774	0.953
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT114	16	16	9	9	adalimumab	CD36	PA10004	948	0.953
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1013.nxml.txt.nlp	24457957	SENT316	5	5	10	10	orlistat	NOXA	PA164776864	5366	0.953
NULL	Br_J_Pharmacol_2008_Nov_11_155(6)_896-905.nxml.txt.nlp	18695641	SENT150	0	0	28	28	genistein	OPG	PA165109660	690	0.953
NULL	J_Breast_Cancer_2012_Jun_28_15(2)_203-210.nxml.txt.nlp	22807938	SENT131	8	8	15	15	trastuzumab	HER2	PA451743	2064	0.953
NULL	Cancer_Biol_Med_2012_Mar_9(1)_18-22.nxml.txt.nlp	23691449	SENT54	3	3	29	29	gefitinib	EGFR	PA131301952	1956	0.953
NULL	Crit_Care_2011_Nov_20_15(6)_R275.nxml.txt.nlp	22099212	SENT60	9	9	17	17	bivalirudin	ACT	PA10032	12;11332;9457;641455	0.953
NULL	Ann_Med_Health_Sci_Res_2012_Jul-Dec_2(2)_191-198.nxml.txt.nlp	23439914	SENT165	13	13	1	1	simvastatin	P-gp	PA451363	5243	0.953
NULL	Cancers_(Basel)_2012_Oct_29_4(4)_1146-1160.nxml.txt.nlp	24213502	SENT53	41	41	16	16	tamoxifen	STAR	PA451581	6770;2984	0.953
NULL	Arch_Drug_Inf_2011_Mar_4(1)_1-9.nxml.txt.nlp	21572514	SENT16	16	16	1	1	ciprofloxacin	P-gp	PA449009	5243	0.953
NULL	Breast_Cancer_Res_2005_Jan_26_7(2)_R256-R266.nxml.txt.nlp	15743506	SENT27	10	10	3	3	tamoxifen	HER-2	PA451581	2064	0.953
NULL	J_Cell_Biol_2002_Jun_24_157(7)_1267-1278.nxml.txt.nlp	12082084	SENT236	22	22	25	25	thrombin	AC6	PA451674	112	0.953
NULL	Breast_Cancer_Res_2012_Apr_26_14(2)_R69.nxml.txt.nlp	22537934	SENT198	14	14	2	2	tamoxifen	RAD21	PA451581	5885	0.953
NULL	J_Antimicrob_Chemother_2014_Jul_14_69(7)_1945-1953.nxml.txt.nlp	24633206	SENT60	0	0	16	16	tigecycline	RGM	PA164746412	56963	0.953
NULL	Ann_Dermatol_2014_Aug_31_26(4)_517-520.nxml.txt.nlp	25143685	SENT39	22	22	2	2	tazarotene	TIG3	PA164746821	5920	0.953
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT219	22	22	6	6	nutlin-3	DR5		8795	0.953
NULL	Pharmaceuticals_(Basel)_2012_Aug_10_5(8)_802-836.nxml.txt.nlp	24280676	SENT90	34	34	30	30	ribavirin	CNT1	PA451241	9154	0.953
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1420-1426.nxml.txt.nlp	24056704	SENT136	3	3	13	13	itraconazole	CYP3A	PA450132	1574	0.953
NULL	J_Int_Soc_Sports_Nutr_2014_May_12_11_20.nxml.txt.nlp	24864135	SENT323	28	28	13	13	creatine	CEE	PA164778930	51608	0.953
NULL	Ann_Surg_Treat_Res_2014_Dec_28_87(6)_331-335.nxml.txt.nlp	25485242	SENT73	0	0	29	29	sulindac	FAP	PA451565	2191	0.953
NULL	Oncotarget_2013_Nov_24_4(12)_2186-2207.nxml.txt.nlp	24327604	SENT164	31	31	3	3	bortezomib	HSP27	PA10252	3315	0.953
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT535	11	11	5	5	amisulpride	PRL	PA162565877	5617	0.953
NULL	Indian_J_Pharm_Sci_2014_May-Jun_76(3)_203-210.nxml.txt.nlp	25035531	SENT165	23	23	15	15	fluoxetine	5-HT1A	PA449673	3350	0.953
NULL	Oncotarget_2010_Oct_15_1(7)_515-529.nxml.txt.nlp	21317448	SENT74	11	11	4	4	gemcitabine	BTC	PA449748	685	0.953
NULL	Mol_Cancer_2009_Nov_10_8_99.nxml.txt.nlp	19903356	SENT85	15	15	8	8	imatinib	IGFBP3	PA10804	3486	0.953
NULL	Mol_Brain_2014_Apr_5_7_27.nxml.txt.nlp	24708859	SENT231	9	9	6	6	capsaicin	TRPV1	PA448776	7442	0.953
NULL	F1000Res_2013_Oct_3_2_202.nxml.txt.nlp	24795806	SENT131	7	7	10	10	panitumumab	EGFR	PA162373091	1956	0.953
NULL	Cancer_Cell_Int_2011_Mar_25_11_7.nxml.txt.nlp	21439058	SENT150	19	19	27	27	mitoxantrone	PI3K	PA450526	5290	0.953
NULL	Adv_Bioinformatics_2012_Jun_6_2012_582765.nxml.txt.nlp	22719757	SENT128	34	34	27	27	thrombin	AKT	PA451674	207	0.953
NULL	Diabetes_2011_Jul_20_60(7)_1990-1999.nxml.txt.nlp	21617181	SENT216	7	7	21	21	geldanamycin	STAT3	PA152031327	6774	0.953
NULL	Oncol_Rep_2013_Aug_23_30(2)_560-566.nxml.txt.nlp	23708493	SENT85	16	16	0	0	paraformaldehyde	U87	PA450790	677775;641648	0.953
NULL	Int_J_Breast_Cancer_2012_May_9_2012_415170.nxml.txt.nlp	22649737	SENT77	13	13	35	35	trastuzumab	MUC1	PA451743	4582	0.953
NULL	Cancer_Immunol_Immunother_2012_Oct_8_61(10)_1713-1720.nxml.txt.nlp	22399057	SENT6	41	41	38	38	plerixafor	CXCR4	PA165958410	7852	0.953
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Aug_26_65(Pt_9)_o2234.nxml.txt.nlp	21577633	SENT71	41	41	23	23	ethanol	mol	PA448073	90527	0.953
NULL	Clin_Exp_Gastroenterol_2011_Sep_14_4_213-220.nxml.txt.nlp	22016582	SENT79	10	10	28	28	dexlansoprazole	CYP2C19	PA166110257	1557	0.953
NULL	Patient_Prefer_Adherence_2009_Nov_3_3_105-111.nxml.txt.nlp	19936152	SENT126	1	1	30	30	tadalafil	CYP3A4	PA10333	1576	0.953
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_16_2013_146142.nxml.txt.nlp	23843863	SENT99	6	6	31	31	ns-398	SAA1		6288	0.953
NULL	Drugs_R_D_2010_Sep_27_10(3)_203-210.nxml.txt.nlp	20945949	SENT142	6	6	41	41	boceprevir	RVR	PA165948902	9975	0.953
NULL	Cancer_Med_2013_Feb_3_2(1)_76-85.nxml.txt.nlp	24133630	SENT8	3	3	1	1	vemurafenib	BRAF	PA165946873	673	0.953
NULL	BMJ_Open_2014_Feb_27_4(2)_e004071.nxml.txt.nlp	24578536	SENT197	9	9	24	24	warfarin	TTR	PA451906	7276	0.953
NULL	EMBO_Mol_Med_2011_May_3(5)_266-278.nxml.txt.nlp	21438154	SENT157	5	5	21	21	oxaliplatin	HCN	PA131285527	378938	0.953
NULL	Breast_Cancer_Res_2005_Jun_17_7(Suppl_2)_S_13.nxml.txt.nlp	NULL	SENT8	23	23	18	18	exemestane	aromatase	PA449563	1588	0.953
NULL	J_Cell_Biol_1998_Jan_26_140(2)_335-345.nxml.txt.nlp	9442109	SENT215	17	17	24	24	chloroquine	NHE	PA448948	285335	0.953
NULL	Exp_Ther_Med_2014_Oct_24_8(4)_1092-1096.nxml.txt.nlp	25187802	SENT73	6	6	34	34	carvedilol	TLR4	PA448817	7099	0.953
NULL	Adv_Hematol_2012_Aug_2_2012_842945.nxml.txt.nlp	22919394	SENT161	14	14	9	9	lenalidomide	CRBN	PA162363968	51185	0.953
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT115	11	11	36	36	sulindac	XIAP	PA451565	331	0.953
NULL	Nucleic_Acids_Res_2013_May_3_41(9)_4976-4987.nxml.txt.nlp	23558749	SENT101	16	16	7	7	doxorubicin	p53	PA449412	7157	0.953
NULL	Acta_Pharmacol_Sin_2013_Apr_11_34(4)_473-479.nxml.txt.nlp	23474709	SENT121	10	10	25	25	probenecid	MRP1	PA451106	4437	0.953
NULL	Exp_Lung_Res_2013_Oct_1_39(8)_336-348.nxml.txt.nlp	23919450	SENT103	15	15	10	10	argatroban	PAR-1	PA164745516	2011;2149	0.953
NULL	Arthritis_Res_Ther_2007_Sep_23_9(5)_R96.nxml.txt.nlp	17888176	SENT213	31	31	17	17	etanercept	OPG	PA449515	690	0.953
NULL	Cell_Death_Differ_2010_Apr_16_17(4)_666-676.nxml.txt.nlp	19834494	SENT94	18	18	9	9	oxaliplatin	p53	PA131285527	7157	0.953
NULL	Arthritis_Res_Ther_2008_Dec_10_10(6)_R141.nxml.txt.nlp	19068145	SENT34	20	20	25	25	tocilizumab	IL-6	PA165292659	3569	0.953
NULL	Eur_J_Clin_Pharmacol_2011_May_2_67(Suppl_1)_87-107.nxml.txt.nlp	21287160	SENT343	12	12	9	9	aprepitant	NK-1	PA164747039	27087	0.953
NULL	Cell_Commun_Signal_2009_Aug_27_7_20.nxml.txt.nlp	19712465	SENT288	7	7	20	20	thrombin	EGFR	PA451674	1956	0.953
NULL	Exp_Ther_Med_2014_Jul_8_8(1)_165-168.nxml.txt.nlp	24944616	SENT55	22	22	41	41	fluorescein	CD25	PA164746009	3669;3559	0.953
NULL	J_Mol_Med_2008_Jul_2_86(7)_747-759.nxml.txt.nlp	18246321	SENT467	29	29	27	27	curcumin	NF-kappaB	PA151958596	4790	0.953
NULL	Mol_Pain_2014_Aug_15_10_53.nxml.txt.nlp	25127716	SENT85	5	5	18	18	paclitaxel	SDH	PA450761	1757;10993	0.953
NULL	Acta_Pharmacol_Sin_2012_Dec_22_33(12)_1511-1517.nxml.txt.nlp	23085741	SENT146	7	7	4	4	pranlukast	CysLT1	PA134698661	10800	0.952
NULL	F1000Res_2014_Aug_19_3_198.nxml.txt.nlp	25400908	SENT185	10	10	23	23	trastuzumab	HER2	PA451743	2064	0.952
NULL	Psychiatr_Genet_2013_Aug_28_23(4)_153-162.nxml.txt.nlp	23811784	SENT197	15	15	5	5	clozapine	SSTR3	PA449061	6753	0.952
NULL	Aging_(Albany_NY)_2012_Mar_12_4(3)_146-158.nxml.txt.nlp	22436213	SENT63	12	12	4	4	resveratrol	AMPK		5563	0.952
NULL	Curr_Med_Chem_2012_Sep_19(26)_4399-4413.nxml.txt.nlp	22830345	SENT237	23	23	19	19	erythromycin	CYP3A4	PA449493	1576	0.952
NULL	Cell_Death_Differ_2010_Oct_30_17(10)_1655-1664.nxml.txt.nlp	20431598	SENT61	36	36	12	12	etoposide	CD4	PA449552	920	0.952
NULL	J_Cell_Mol_Med_2014_Dec_22_18(12)_2519-2529.nxml.txt.nlp	25338520	SENT206	0	0	22	22	tamoxifen	AP-1	PA451581	2353;3727;2354;3725	0.952
NULL	Nucleic_Acids_Res_2011_Jun_9_39(11)_4640-4652.nxml.txt.nlp	21310710	SENT292	4	4	8	8	camptothecin	BCL2	PA153590860	596	0.952
NULL	Trials_2012_Sep_8_13_160.nxml.txt.nlp	22958580	SENT47	26	26	8	8	succinylcholine	LSR	PA451522	51599	0.952
NULL	Biol_Open_2014_Sep_4_3(9)_871-879.nxml.txt.nlp	25190058	SENT244	37	37	4	4	neomycin	CBX7	PA450608	23492	0.952
NULL	Bioinformation_2013_Jul_12_9(12)_633-638.nxml.txt.nlp	23904741	SENT24	18	18	45	45	genistein	TWEAK	PA165109660	8742	0.952
NULL	Oncol_Lett_2014_Sep_19_8(3)_1320-1322.nxml.txt.nlp	25120716	SENT4	7	7	2	2	gefitinib	EGFR	PA131301952	1956	0.952
NULL	Cerebrospinal_Fluid_Res_2010_Sep_22_7_15.nxml.txt.nlp	20860832	SENT253	14	14	30	30	acetazolamide	AQP4	PA448018	361	0.952
NULL	J_Antimicrob_Chemother_2009_Nov_18_64(5)_910-928.nxml.txt.nlp	19767318	SENT225	36	36	27	27	efavirenz	CYP3A4	PA449441	1576	0.952
NULL	J_Am_Heart_Assoc_2013_Dec_19_2(6)_e000439.nxml.txt.nlp	24334905	SENT231	6	6	9	9	doxorubicin	AMPK	PA449412	5563	0.952
NULL	Drug_Des_Devel_Ther_2014_Sep_26_8_1595-1611.nxml.txt.nlp	25302015	SENT192	0	0	11	11	afatinib	EGFR	PA165981154	1956	0.952
NULL	Int_J_Endocrinol_2010_Feb_10_2010_625852.nxml.txt.nlp	20169119	SENT129	21	21	30	30	paricalcitol	PTH	PA450798	5741	0.952
NULL	Acta_Naturae_2011_Jul-Sep_3(3)_12-28.nxml.txt.nlp	22649690	SENT307	3	3	10	10	elvitegravir	CYP3A4	PA165291498	1576	0.952
NULL	JAKSTAT_2013_Apr_1_2(2)_e23092.nxml.txt.nlp	24058802	SENT85	15	15	7	7	lipase	STAT1	PA450239	6772	0.952
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1196-1204.nxml.txt.nlp	22315058	SENT18	13	13	18	18	gefitinib	EGFR	PA131301952	1956	0.952
NULL	Breast_Cancer_Res_2005_Nov_11_7(6)_255-257.nxml.txt.nlp	16457700	SENT10	8	8	30	30	tamoxifen	aromatase	PA451581	1588	0.952
NULL	Br_J_Cancer_2014_Aug_12_111(4)_696-707.nxml.txt.nlp	24937672	SENT172	9	9	17	17	docetaxel	ABCC10	PA449383	89845	0.952
NULL	Cancer_Med_2013_Feb_3_2(1)_86-98.nxml.txt.nlp	24133631	SENT181	3	3	27	27	sorafenib	SHARP	PA7000	23013	0.952
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT145	47	47	22	22	trastuzumab	STAT3	PA451743	6774	0.952
NULL	J_Invest_Dermatol_2012_Sep_10_132(9)_2255-2262.nxml.txt.nlp	22572817	SENT60	12	12	20	20	forskolin	MC1R	PA146096022	4157	0.952
NULL	Aging_(Albany_NY)_2009_Dec_29_2(1)_63-68.nxml.txt.nlp	20228936	SENT29	30	30	17	17	nadh	CYB5R3	PA164755085	1727	0.952
NULL	Clin_Pharmacokinet_2014_Sep_3_53(1)_1-16.nxml.txt.nlp	23999929	SENT129	5	5	14	14	rivaroxaban	CLCR	PA165958360	11330	0.952
NULL	Biomed_Res_Int_2013_Jun_6_2013_928271.nxml.txt.nlp	23841099	SENT19	17	17	2	2	clopidogrel	P2Y12	PA449053	64805	0.952
NULL	J_Hematol_Oncol_2013_Jun_3_6_38.nxml.txt.nlp	23731980	SENT184	20	20	5	5	neratinib	HER2	PA165291472	2064	0.952
NULL	Int_J_Gen_Med_2012_Jun_18_5_535-540.nxml.txt.nlp	22807641	SENT81	7	7	39	39	pitavastatin	adiponectin	PA142650384	9370	0.952
NULL	Drug_Des_Devel_Ther_2014_Oct_6_8_1723-1731.nxml.txt.nlp	25336916	SENT134	5	5	40	40	valsartan	CLCR	PA451848	11330	0.952
NULL	Breast_Cancer_Res_2012_Jun_7_14(3)_R89.nxml.txt.nlp	22676470	SENT298	36	36	25	25	lapatinib	HER2	PA152241907	2064	0.952
NULL	J_Automat_Chem_1998_20(1)_23-26.nxml.txt.nlp	18924818	SENT2	7	7	27	27	l-carnitine	DTNB	PA450154	1838	0.952
NULL	J_Korean_Med_Sci_2010_Sep_12_25(9)_1330-1335.nxml.txt.nlp	20808677	SENT119	7	7	0	0	trypsin	PAR2	PA451806	2150;55065;8856	0.952
NULL	Mol_Cancer_2014_Aug_22_13(1)_195.nxml.txt.nlp	NULL	SENT96	9	9	3	3	cisplatin	TBL1XR1	PA449014	79718	0.952
NULL	Neural_Regen_Res_2013_Mar_25_8(9)_825-832.nxml.txt.nlp	25206730	SENT106	34	34	22	22	isoflurane	P2X7	PA450106	5027	0.952
NULL	Nucleic_Acids_Res_2005_Oct_27_33(18)_6024-6033.nxml.txt.nlp	16254079	SENT504	11	11	33	33	bicalutamide	HDAC2	PA164746255	3066	0.952
NULL	J_Cell_Biol_2008_Jul_14_182(1)_197-213.nxml.txt.nlp	18625847	SENT187	26	26	8	8	nutlin-3	BRCA1		672	0.952
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT88	0	0	26	26	efavirenz	CYP2B6	PA449441	1555	0.952
NULL	Braz_J_Med_Biol_Res_2013_Mar_15_46(3)_299-305.nxml.txt.nlp	23532269	SENT11	24	24	3	3	propofol	TLR4	PA451141	7099	0.952
NULL	Infect_Dis_Obstet_Gynecol_2006_Mar_7_2006_61265.nxml.txt.nlp	17093354	SENT67	0	0	19	19	imiquimod	TH1	PA449972	51497	0.952
NULL	J_Hematol_Oncol_2013_Jan_17_6_8.nxml.txt.nlp	23327547	SENT131	4	4	19	19	sulindac	p27	PA451565	5715;10534	0.952
NULL	Evid_Based_Complement_Alternat_Med_2011_Feb_14_2011_650263.nxml.txt.nlp	21799686	SENT167	32	32	13	13	atropine	AKT2	PA448505	208	0.952
NULL	Semin_Immunopathol_2013_May_10_35(3)_351-373.nxml.txt.nlp	23572207	SENT371	13	13	18	18	bortezomib	XBP1	PA10252	7494	0.952
NULL	Thorax_2010_Jul_13_65(7)_654-658.nxml.txt.nlp	20627927	SENT47	18	18	27	27	tobramycin	NAG	PA451704	51594;4669	0.952
NULL	Tuberc_Respir_Dis_(Seoul)_2013_Nov_29_75(5)_188-198.nxml.txt.nlp	24348666	SENT167	0	0	28	28	crizotinib	EGFR	PA165946122	1956	0.952
NULL	FEBS_J_2009_Oct_276(19)_5571-5578.nxml.txt.nlp	19702827	SENT49	36	36	14	14	gefitinib	EGF	PA131301952	1950	0.952
NULL	EMBO_Mol_Med_2011_Nov_3(11)_623-636.nxml.txt.nlp	21953712	SENT190	7	7	37	37	trastuzumab	HER2	PA451743	2064	0.952
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1717-1723.nxml.txt.nlp	19844230	SENT95	13	13	2	2	sorafenib	DDR2	PA7000	4921	0.952
NULL	Blood_Cancer_J_2012_May_25_2(5)_e73.nxml.txt.nlp	22829975	SENT171	44	44	6	6	hydrocortisone	CD73	PA449905	4907	0.952
NULL	Indian_J_Pharmacol_2008_Oct_40(Suppl_2)_S66-S91.nxml.txt.nlp	21593982	SENT818	18	18	8	8	proguanil	CYP2C19	PA451124	1557	0.952
NULL	Arthritis_Res_Ther_2006_Jul_28_8(Suppl_2)_S5.nxml.txt.nlp	16899109	SENT88	5	5	2	2	tocilizumab	IL-6	PA165292659	3569	0.952
NULL	Patient_Prefer_Adherence_2011_Jul_19_5_369-374.nxml.txt.nlp	21845036	SENT52	0	0	7	7	miconazole	CYP2C9	PA450494	1559	0.952
NULL	Int_J_Endocrinol_2014_Jan_16_2014_412354.nxml.txt.nlp	24550985	SENT98	11	11	20	20	buserelin	CB1	PA10253	1268	0.952
NULL	Cancer_Biol_Med_2013_Dec_10(4)_192-205.nxml.txt.nlp	24349829	SENT173	13	13	21	21	gefitinib	EGFR	PA131301952	1956	0.952
NULL	Arthritis_Res_Ther_2014_May_16_16(3)_R113.nxml.txt.nlp	24886859	SENT17	4	4	11	11	pargyline	LSD1	PA450797	23028	0.952
NULL	Diabetes_2013_May_16_62(5)_1697-1708.nxml.txt.nlp	23364453	SENT307	10	10	8	8	fasudil	Rho	PA165946121	29984	0.952
NULL	Oncotarget_2013_Nov_23_5(1)_196-210.nxml.txt.nlp	24344116	SENT69	18	18	29	29	doxorubicin	IL8	PA449412	3576	0.952
NULL	J_Carcinog_2013_Aug_8_12_16.nxml.txt.nlp	24082825	SENT90	4	4	0	0	metformin	AMPK	PA450395	5563	0.952
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT32	12	12	17	17	metformin	HIF-1	PA450395	29072	0.952
NULL	Clin_Interv_Aging_2015_Jan_6_10_157-174.nxml.txt.nlp	25609933	SENT56	21	21	13	13	tamoxifen	aromatase	PA451581	1588	0.952
NULL	Onco_Targets_Ther_2014_Sep_23_7_1653-1661.nxml.txt.nlp	25285015	SENT117	32	32	4	4	sn-38	UGT1A1		54658	0.952
NULL	Arch_Med_Sci_2013_Apr_20_9(2)_361-367.nxml.txt.nlp	23671450	SENT165	6	6	19	19	budesonide	HIF-1	PA448681	29072	0.952
NULL	Pharmaceuticals_(Basel)_2013_Nov_11_6(11)_1429-1450.nxml.txt.nlp	24287465	SENT264	18	18	13	13	vemurafenib	SMO	PA165946873	6608;54498	0.952
NULL	Mol_Biol_Cell_2014_Apr_1_25(7)_965-976.nxml.txt.nlp	24478450	SENT39	38	38	20	20	chloramphenicol	COX	PA448927	1351	0.952
NULL	Crit_Care_2009_Jul_10_13(4)_R113.nxml.txt.nlp	19591694	SENT214	1	1	11	11	vasopressin	San	PA451858	80218	0.952
NULL	Front_Genet_2012_Nov_5_3_236.nxml.txt.nlp	23133441	SENT26	12	12	24	24	ritonavir	P-gp	PA451260	5243	0.952
NULL	Ther_Clin_Risk_Manag_2006_Sep_2(3)_303-308.nxml.txt.nlp	18360605	SENT47	11	11	20	20	frovatriptan	5-HT1B	PA164754891	3351	0.952
NULL	Mol_Vis_2012_May_11_18_1260-1270.nxml.txt.nlp	22665973	SENT182	22	22	34	34	topotecan	HIF-1	PA451729	29072	0.952
NULL	Br_J_Pharmacol_2014_Jan_23_171(2)_523-535.nxml.txt.nlp	24372553	SENT163	25	25	13	13	metformin	SIRT1	PA450395	23411	0.952
NULL	Aging_Cell_2009_Apr_8(2)_113-127.nxml.txt.nlp	19239417	SENT182	24	24	12	12	resveratrol	AMPK		5563	0.952
NULL	Eur_J_Clin_Pharmacol_2014_May_21_70(8)_915-920.nxml.txt.nlp	24839948	SENT92	39	39	16	16	ketoconazole	CYP3A4	PA450146	1576	0.952
NULL	Br_J_Cancer_2010_Feb_16_102(4)_658-664.nxml.txt.nlp	20104222	SENT119	18	18	46	46	sunitinib	IFN	PA162372840	3439	0.952
NULL	J_Obes_2010_Jan_14_2010_970865.nxml.txt.nlp	20798864	SENT131	18	18	22	22	berberine	AMPK	PA165860812	5563	0.952
NULL	Oncogene_2009_Feb_5_28(5)_674-685.nxml.txt.nlp	19015634	SENT219	26	26	5	5	ethanol	53BP1	PA448073	7158	0.952
NULL	Oncoimmunology_2013_Jan_1_2(1)_e23033.nxml.txt.nlp	23483678	SENT14	16	16	1	1	paclitaxel	CD40	PA450761	958	0.952
NULL	Exp_Ther_Med_2013_Nov_13_6(5)_1317-1321.nxml.txt.nlp	24223665	SENT106	14	14	24	24	curcumin	CD133	PA151958596	8842	0.952
NULL	J_Young_Pharm_2010_Jul-Sep_2(3)_326-331.nxml.txt.nlp	21042495	SENT129	39	39	18	18	atorvastatin	CYP3A4	PA448500	1576	0.952
NULL	Evid_Based_Complement_Alternat_Med_2014_Sep_3_2014_809083.nxml.txt.nlp	25276218	SENT167	3	3	25	25	berberine	PI3K	PA165860812	5290	0.952
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2008_Jun_1_64(Pt_6)_611-619.nxml.txt.nlp	18560148	SENT191	10	10	29	29	heparin	CXCR3	PA449855	2833	0.952
NULL	Ther_Clin_Risk_Manag_2005_Dec_1(4)_299-306.nxml.txt.nlp	18360572	SENT10	0	0	10	10	terbinafine	CYP3A4	PA451614	1576	0.952
NULL	Cell_Death_Dis_2014_Jan_30_5(1)_e1030.nxml.txt.nlp	24481444	SENT125	9	9	2	2	sorafenib	Mcl-1	PA7000	4170	0.952
NULL	Arthritis_Res_Ther_2013_Feb_20_15(1)_R31.nxml.txt.nlp	23421940	SENT16	19	19	5	5	nitroprusside	STAT3	PA451406	6774	0.952
NULL	Adv_Hematol_2012_Jan_18_2012_195484.nxml.txt.nlp	22312366	SENT22	7	7	30	30	doxorubicin	CHOP	PA449412	1649	0.952
NULL	Breast_Cancer_Res_2009_Jul_15_11(4)_207.nxml.txt.nlp	19664181	SENT99	0	0	23	23	lapatinib	HER2	PA152241907	2064	0.952
NULL	Mol_Cancer_2014_Jul_8_13_168.nxml.txt.nlp	25005754	SENT24	10	10	22	22	cetuximab	KRAS	PA10040	3845	0.952
NULL	Br_J_Cancer_2012_May_8_106(10)_1618-1625.nxml.txt.nlp	22531635	SENT117	47	47	45	45	anastrozole	aromatase	PA448432	1588	0.952
NULL	J_Mol_Signal_2012_Sep_8_7_15.nxml.txt.nlp	22958338	SENT121	30	30	9	9	pp2	PSD-95		1742	0.952
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_127043.nxml.txt.nlp	23227093	SENT205	15	15	5	5	lovastatin	RYR	PA450272	6261	0.952
NULL	Br_J_Cancer_2012_Sep_4_107(6)_947-955.nxml.txt.nlp	22892392	SENT172	14	14	6	6	lapatinib	BCAR4	PA152241907	400500	0.952
NULL	Cancer_Metastasis_Rev_2010_Sep_24_29(3)_465-482.nxml.txt.nlp	20730632	SENT295	31	31	16	16	genistein	CXCR4	PA165109660	7852	0.952
NULL	Oncotarget_2014_Jun_7_5(14)_5257-5271.nxml.txt.nlp	24913448	SENT147	21	21	29	29	nilotinib	CRKL	PA165958345	1399	0.952
NULL	Biosci_Rep_2012_Dec_1_32(Pt_6)_511-519.nxml.txt.nlp	NULL	SENT88	5	5	11	11	pitavastatin	Rho	PA142650384	29984	0.952
NULL	Oncol_Rep_2013_Jun_22_29(6)_2479-2485.nxml.txt.nlp	23525656	SENT31	6	6	19	19	dasatinib	KIT	PA162372878	3815	0.952
NULL	Anat_Cell_Biol_2010_Sep_30_43(3)_194-200.nxml.txt.nlp	21212859	SENT111	24	24	10	10	ethanol	PLP	PA448073	25824;5744	0.952
NULL	Mol_Cancer_2013_Mar_5_12_17.nxml.txt.nlp	23497256	SENT223	28	28	5	5	sunitinib	p53	PA162372840	7157	0.952
NULL	Osteoporos_Int_2013_May_7_24(10)_2729-2732.nxml.txt.nlp	23649801	SENT94	8	8	11	11	teriparatide	PTH	PA451620	5741	0.952
NULL	Oncoimmunology_2013_Aug_1_2(8)_e25123.nxml.txt.nlp	24083076	SENT2	3	3	23	23	everolimus	TLR9	PA164746311	54106	0.952
NULL	Breast_Cancer_Res_2011_Jan_24_13(1)_401.nxml.txt.nlp	21349137	SENT17	2	2	20	20	cetuximab	AMPK	PA10040	5563	0.952
NULL	Arthritis_Res_Ther_2011_Feb_11_13(1)_R21.nxml.txt.nlp	21314928	SENT207	39	39	13	13	rituximab	CD4	PA451261	920	0.952
NULL	Mol_Cancer_2002_Nov_14_1_7.nxml.txt.nlp	12473178	SENT106	28	28	6	6	bicalutamide	ARA70	PA164746255	8031	0.952
NULL	Alcohol_Res_Health_2011_34(1)_106-120.nxml.txt.nlp	23580048	SENT143	15	15	22	22	ethanol	CA1	PA448073	759	0.952
NULL	Br_J_Cancer_2012_Nov_6_107(10)_1714-1721.nxml.txt.nlp	23073173	SENT111	32	32	23	23	docetaxel	RUNX2	PA449383	860	0.952
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT121	8	8	23	23	glucose	EGFR	PA449773	1956	0.952
NULL	Pharmaceuticals_(Basel)_2012_Nov_20_5(11)_1236-1264.nxml.txt.nlp	24281308	SENT990	22	22	13	13	erlotinib	PI3K	PA134687924	5290	0.952
NULL	Cancer_Cell_Int_2013_Jan_15_13_3.nxml.txt.nlp	23320839	SENT135	13	13	9	9	sorafenib	EGFR	PA7000	1956	0.952
NULL	Breast_Cancer_Res_2007_Dec_20_9(Suppl_2)_S19.nxml.txt.nlp	NULL	SENT9	18	18	40	40	tamoxifen	aromatase	PA451581	1588	0.952
NULL	FEBS_Open_Bio_2014_Jan_6_4_77-89.nxml.txt.nlp	24490132	SENT183	12	12	18	18	ebselen	NAC	PA161660841	22861	0.952
NULL	Int_J_Womens_Health_2012_Oct_10_4_543-549.nxml.txt.nlp	23091400	SENT63	39	39	20	20	drospirenone	aromatase	PA164749409	1588	0.952
NULL	J_Neuroinflammation_2010_Sep_7_7_51.nxml.txt.nlp	20822529	SENT13	21	21	7	7	hemin	HO-1	PA449849	3162	0.952
NULL	Case_Rep_Oncol_2012_Aug_9_5(2)_428-433.nxml.txt.nlp	22949905	SENT69	16	16	9	9	cetuximab	KRAS	PA10040	3845	0.952
NULL	Cell_Death_Dis_2014_Jul_17_5(7)_e1333.nxml.txt.nlp	25032856	SENT50	15	15	4	4	candesartan	TLR4	PA448765	7099	0.952
NULL	Acta_Pharmacol_Sin_2012_Jul_18_33(7)_861-872.nxml.txt.nlp	22705730	SENT176	6	6	17	17	pravastatin	RhoA	PA451089	387	0.952
NULL	Bioinformation_2012_Jan_6_8(1)_13-19.nxml.txt.nlp	22359429	SENT87	25	25	10	10	curcumin	MRP1	PA151958596	4437	0.952
NULL	ScientificWorldJournal_2013_Mar_3_2013_951343.nxml.txt.nlp	23533367	SENT92	16	16	33	33	pentobarbital	FDG	PA450859	23583	0.952
NULL	Oncotarget_2011_Mar_27_2(3)_209-221.nxml.txt.nlp	21444945	SENT135	7	7	14	14	bortezomib	p53	PA10252	7157	0.952
NULL	Br_J_Cancer_2011_Jul_26_105(3)_372-381.nxml.txt.nlp	21730979	SENT13	22	22	12	12	temozolomide	p53	PA451609	7157	0.952
NULL	J_Cell_Biol_2000_Jul_10_150(1)_155-164.nxml.txt.nlp	10893264	SENT75	18	18	20	20	etoposide	CD95	PA449552	355	0.952
NULL	Breast_Cancer_Res_2007_Jun_7_9(3)_R37.nxml.txt.nlp	17555561	SENT24	0	0	8	8	letrozole	aromatase	PA450196	1588	0.952
NULL	Mol_Cancer_2010_Aug_27_9_226.nxml.txt.nlp	20799951	SENT149	27	27	0	0	fluorouracil	PRAME	PA128406956	23532	0.952
NULL	Patient_Prefer_Adherence_2013_Jul_4_7_653-666.nxml.txt.nlp	23869169	SENT4	0	0	20	20	tocilizumab	IL-6	PA165292659	3569	0.952
NULL	Oncol_Lett_2014_May_11_7(5)_1401-1408.nxml.txt.nlp	24765145	SENT120	11	11	32	32	paclitaxel	HIF-1	PA450761	29072	0.952
NULL	J_Inherit_Metab_Dis_2010_Oct_3_33(5)_625-632.nxml.txt.nlp	20814828	SENT120	27	27	4	4	simvastatin	RhoA	PA451363	387	0.952
NULL	Evid_Based_Complement_Alternat_Med_2011_Feb_14_2011_429843.nxml.txt.nlp	21869897	SENT54	5	5	25	25	ethanol	PC6	PA448073	5125	0.952
NULL	ARYA_Atheroscler_2011_Summer_7(2)_78-86.nxml.txt.nlp	22577451	SENT11	28	28	40	40	betaine	TNF	PA448603	7124	0.952
NULL	Mol_Cancer_2009_Nov_10_8_99.nxml.txt.nlp	19903356	SENT88	33	33	23	23	imatinib	IGFBP3	PA10804	3486	0.952
NULL	Acta_Pharmacol_Sin_2011_Oct_15_32(10)_1233-1238.nxml.txt.nlp	21841815	SENT10	2	2	16	16	naloxone	CTX	PA450586	1593	0.952
NULL	Oncotarget_2014_Oct_21_5(22)_11252-11268.nxml.txt.nlp	25361004	SENT238	19	19	7	7	metformin	CLIC1	PA450395	1192	0.952
NULL	Nat_Chem_Biol_2009_Apr_26_5(4)_236-243.nxml.txt.nlp	19172146	SENT321	11	11	18	18	nimesulide	COX	PA137179528	1351	0.952
NULL	Ann_Med_2014_Nov_21_46(7)_475-489.nxml.txt.nlp	25045928	SENT148	30	30	4	4	thrombin	P2Y12	PA451674	64805	0.952
NULL	Br_J_Cancer_2012_Feb_14_106(4)_719-726.nxml.txt.nlp	22240798	SENT177	22	22	11	11	gefitinib	PTEN	PA131301952	5728	0.952
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT156	8	8	30	30	capsaicin	p53	PA448776	7157	0.952
NULL	Diabetes_Care_2011_Jul_17_34(7)_1601-1604.nxml.txt.nlp	21709296	SENT80	13	13	7	7	ramipril	DREAM	PA451223	30818	0.952
NULL	J_Biol_Chem_2010_Apr_23_285(17)_12979-12989.nxml.txt.nlp	20189985	SENT102	5	5	27	27	forskolin	PTH	PA146096022	5741	0.952
NULL	Nucleic_Acids_Res_2012_Jun_22_40(11)_4861-4878.nxml.txt.nlp	22362753	SENT246	13	13	6	6	trypsin	NPM3	PA451806	10360	0.952
NULL	Arch_Drug_Inf_2008_Jul_1(1)_14-22.nxml.txt.nlp	20157364	SENT165	16	16	3	3	pravastatin	IL-6	PA451089	3569	0.952
NULL	J_Cell_Mol_Med_2013_Feb_10_17(2)_233-241.nxml.txt.nlp	23301673	SENT49	0	0	40	40	cisplatin	San	PA449014	80218	0.952
NULL	Diabetes_Care_2010_Feb_33(2)_453-455.nxml.txt.nlp	20103562	SENT61	15	15	4	4	sitagliptin	HIP	PA164748978	6767;6159;64399;5068	0.952
NULL	Pharmaceuticals_(Basel)_2014_Jan_9_7(1)_46-57.nxml.txt.nlp	24451403	SENT140	23	23	40	40	ritonavir	AKT	PA451260	207	0.952
NULL	Pharmaceuticals_(Basel)_2012_Feb_2_5(2)_114-132.nxml.txt.nlp	24288084	SENT166	39	39	4	4	capsaicin	TRPV1	PA448776	7442	0.952
NULL	Oncotarget_2010_Oct_15_1(7)_515-529.nxml.txt.nlp	21317448	SENT104	25	25	7	7	irinotecan	IFL	PA450085	3439	0.952
NULL	Oncotarget_2013_Dec_2_4(12)_2523-2531.nxml.txt.nlp	24344114	SENT70	5	5	24	24	paraformaldehyde	RP53	PA450790	145226	0.952
NULL	Arch_Toxicol_2011_Feb_12_85(2)_79-117.nxml.txt.nlp	21225242	SENT752	3	3	27	27	bufuralol	CYP2D6	PA166110256	1565	0.952
NULL	Arthritis_Res_Ther_2005_Feb_17_7(Suppl_1)_P77.nxml.txt.nlp	NULL	SENT11	33	33	9	9	hydrocortisone	IL-6	PA449905	3569	0.952
NULL	Int_J_Nephrol_2010_Dec_9_2011_957164.nxml.txt.nlp	21197105	SENT171	4	4	13	13	pravastatin	SLCO4C1	PA451089	353189	0.952
NULL	JAKSTAT_2013_Jul_1_2(3)_e24812.nxml.txt.nlp	24069562	SENT59	23	23	4	4	pp2	HL-1		55600	0.952
NULL	Curr_Gerontol_Geriatr_Res_2010_Mar_3_2010_927503.nxml.txt.nlp	20204184	SENT62	0	0	10	10	cyclophosphamide	FVIII	PA449165	2157	0.952
NULL	Breast_Cancer_Res_2005_Jan_12_7(2)_48-51.nxml.txt.nlp	15743510	SENT42	14	14	12	12	anastrozole	aromatase	PA448432	1588	0.952
NULL	Diabetes_Care_2012_Dec_14_35(12)_2665-2673.nxml.txt.nlp	23173135	SENT242	8	8	22	22	metformin	HER2	PA450395	2064	0.952
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT50	15	15	22	22	chloroquine	BMPR-II	PA448948	659	0.952
NULL	Amyloid_2014_Sep_11_21(3)_175-184.nxml.txt.nlp	24918964	SENT100	18	18	6	6	anakinra	TTR	PA10799	7276	0.952
NULL	Oncoimmunology_2012_Oct_1_1(7)_1048-1060.nxml.txt.nlp	23170253	SENT25	13	13	20	20	pertuzumab	HER-2		2064	0.952
NULL	J_Bras_Pneumol_2013_Jan-Feb_39(1)_5-15.nxml.txt.nlp	23503480	SENT230	15	15	37	37	doxycycline	LAM	PA449415	7249;7248	0.952
NULL	Curr_Neuropharmacol_2009_Sep_7(3)_160-179.nxml.txt.nlp	20190959	SENT258	38	38	32	32	dpcpx	CA3		761	0.952
NULL	Protein_J_2012_Aug_5_31(6)_511-518.nxml.txt.nlp	22763563	SENT136	3	3	7	7	atorvastatin	CD36	PA448500	948	0.952
NULL	J_Radiat_Res_2014_Jul_11_55(4)_613-628.nxml.txt.nlp	24522270	SENT55	0	0	18	18	curcumin	p300	PA151958596	2033	0.952
NULL	Breast_Cancer_Res_2002_Aug_27_4(6)_213-217.nxml.txt.nlp	12473165	SENT92	26	26	7	7	anastrozole	ATAC	PA448432	6375	0.952
NULL	Oncotarget_2013_Nov_24_4(12)_2186-2207.nxml.txt.nlp	24327604	SENT190	16	16	3	3	melphalan	KLF4	PA450354	9314	0.952
NULL	J_Invest_Dermatol_2012_Oct_24_132(10)_2440-2450.nxml.txt.nlp	22622430	SENT7	17	17	22	22	paclitaxel	ABCB1	PA450761	5243	0.952
NULL	Mol_Cancer_2013_Sep_23_12_107.nxml.txt.nlp	24053443	SENT261	5	5	12	12	erlotinib	EGFR	PA134687924	1956	0.952
NULL	Oncotarget_2013_Nov_4_5(1)_161-172.nxml.txt.nlp	24389287	SENT127	17	17	6	6	propranolol	p53	PA451145	7157	0.952
NULL	Oncotarget_2013_Oct_19_4(11)_2045-2056.nxml.txt.nlp	24185104	SENT144	31	31	8	8	cisplatin	14-3-3	PA449014	10971	0.952
NULL	Br_J_Cancer_2011_Nov_22_105(11)_1676-1683.nxml.txt.nlp	22033271	SENT31	11	11	17	17	tamoxifen	aromatase	PA451581	1588	0.952
NULL	Eur_J_Clin_Pharmacol_2010_Nov_29_66(11)_1131-1136.nxml.txt.nlp	20669013	SENT133	44	44	1	1	voriconazole	CYP2C19	PA10233	1557	0.952
NULL	Br_J_Cancer_2012_Jan_3_106(1)_107-115.nxml.txt.nlp	22116303	SENT122	7	7	14	14	vorinostat	PI3K	PA164748224	5290	0.952
NULL	Biologics_2012_Sep_25_6_337-345.nxml.txt.nlp	23055691	SENT181	8	8	5	5	afatinib	EGFR	PA165981154	1956	0.952
NULL	Br_J_Cancer_2013_Jul_9_109(1)_68-75.nxml.txt.nlp	23807173	SENT193	9	9	21	21	cisplatin	ERCC1	PA449014	2067	0.952
NULL	Eur_Respir_J_2012_Nov_26_40(5)_1106-1114.nxml.txt.nlp	23060624	SENT164	19	19	10	10	tiotropium	TDI	PA164769056	100038246	0.952
NULL	Open_Biochem_J_2013_Sep_4_7_73-81.nxml.txt.nlp	24062859	SENT26	38	38	22	22	gemcitabine	HMGA1	PA449748	3159	0.952
NULL	Behav_Brain_Funct_2011_Oct_5_7_41.nxml.txt.nlp	21974752	SENT303	13	13	19	19	fluoxetine	EPM	PA449673	2054	0.952
NULL	Front_Neurosci_2011_Jan_14_4_207.nxml.txt.nlp	21258618	SENT164	6	6	19	19	ethanol	AC7	PA448073	113	0.952
NULL	J_Adv_Pract_Oncol_2012_Jul_1_Jul-Aug_3(4)_267-272.nxml.txt.nlp	25031955	SENT37	0	0	7	7	crizotinib	CYP3A5	PA165946122	1577	0.952
NULL	J_Oncol_2012_Feb_16_2012_204946.nxml.txt.nlp	22481918	SENT240	14	14	23	23	bevacizumab	VEGF-A	PA130232992	7422	0.952
NULL	Evid_Based_Complement_Alternat_Med_2012_May_7_2012_970635.nxml.txt.nlp	22611438	SENT34	8	8	0	0	ezetimibe	NPC1L1	PA10816	29881	0.952
NULL	Ann_Lab_Med_2014_Jan_6_34(1)_60-63.nxml.txt.nlp	24422198	SENT79	10	10	4	4	imatinib	c-Jun	PA10804	3725	0.952
NULL	Mol_Cancer_2010_Apr_23_9_87.nxml.txt.nlp	20416058	SENT188	14	14	8	8	doxorubicin	TRAIL	PA449412	8743	0.952
NULL	Br_J_Cancer_2009_Sep_15_101(6)_957-966.nxml.txt.nlp	19738618	SENT197	7	7	36	36	dexrazoxane	THBS-1	PA449259	7057	0.952
NULL	J_Gen_Physiol_2000_Jun_1_115(6)_685-696.nxml.txt.nlp	10828243	SENT116	21	21	3	3	genistein	OLF	PA165109660	83857	0.952
NULL	Am_J_Trop_Med_Hyg_2012_Mar_1_86(3)_489-495.nxml.txt.nlp	22403324	SENT177	19	19	36	36	ritonavir	CYP2D6	PA451260	1565	0.952
NULL	Ann_Rheum_Dis_2008_Nov_14_67(11)_1516-1523.nxml.txt.nlp	18625622	SENT133	43	43	15	15	methotrexate	AST	PA450428	26503	0.952
NULL	BMJ_2010_Feb_8_340_c693.nxml.txt.nlp	20142325	SENT85	19	19	23	23	paroxetine	CYP2D6	PA450801	1565	0.952
NULL	Clin_Epigenetics_2010_Sep_18_1(3-4)_101-116.nxml.txt.nlp	21258631	SENT247	4	4	20	20	curcumin	HDAC2	PA151958596	3066	0.952
NULL	Diabetes_2013_Nov_18_62(11)_3751-3759.nxml.txt.nlp	23897951	SENT126	9	9	0	0	rosiglitazone	FRS2	PA451283	10818	0.952
NULL	Angiogenesis_2011_Sep_31_14(3)_245-253.nxml.txt.nlp	21452059	SENT162	16	16	18	18	topotecan	HIF-1	PA451729	29072	0.952
NULL	Nucleic_Acids_Res_2013_Nov_27_41(21)_9786-9799.nxml.txt.nlp	23982513	SENT222	25	25	7	7	arsenite	PTB4	PA452638	5725	0.952
NULL	Oncol_Rep_2013_May_27_29(5)_1707-1713.nxml.txt.nlp	23446822	SENT5	35	35	24	24	tamoxifen	aromatase	PA451581	1588	0.952
NULL	Acta_Pharmacol_Sin_2011_Oct_15_32(10)_1233-1238.nxml.txt.nlp	21841815	SENT119	8	8	23	23	mecamylamine	CTX	PA450334	1593	0.952
NULL	Br_J_Cancer_2012_Jun_26_107(1)_43-52.nxml.txt.nlp	22644306	SENT112	14	14	36	36	tamoxifen	CXCR4	PA451581	7852	0.952
NULL	Breast_Cancer_Res_2010_Jun_28_12(3)_R43.nxml.txt.nlp	20579400	SENT95	16	16	0	0	doxorubicin	MTS	PA449412	1678	0.952
NULL	Curr_Oncol_2009_Jul_16(Suppl_2)_S14-S23.nxml.txt.nlp	19672417	SENT152	19	19	2	2	tamoxifen	ATAC	PA451581	6375	0.952
NULL	J_Biol_Chem_2013_Nov_22_288(47)_34217-34229.nxml.txt.nlp	24106270	SENT262	11	11	4	4	thrombin	RhoG	PA451674	391	0.952
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT107	32	32	6	6	lapatinib	survivin	PA152241907	332	0.952
NULL	Cancers_(Basel)_2010_May_7_2(2)_794-808.nxml.txt.nlp	24281094	SENT154	20	20	14	14	bevacizumab	EGFR	PA130232992	1956	0.952
NULL	Hum_Mol_Genet_2008_Jul_15_17(14)_2101-2107.nxml.txt.nlp	18413323	SENT25	32	32	26	26	ezetimibe	NPC1L1	PA10816	29881	0.952
NULL	Arthritis_Res_Ther_2008_Oct_17_10(Suppl_2)_S2.nxml.txt.nlp	19007427	SENT76	13	13	31	31	nitroprusside	Bcl-2	PA451406	596	0.952
NULL	J_Gen_Physiol_2013_Aug_142(2)_137-155.nxml.txt.nlp	23858003	SENT438	19	19	30	30	forskolin	TREK-1	PA146096022	3776	0.952
NULL	Eur_J_Clin_Pharmacol_2010_Feb_17_66(2)_165-170.nxml.txt.nlp	19838691	SENT18	5	5	26	26	midazolam	CYP3A4	PA450496	1576	0.952
NULL	Cell_Death_Dis_2010_Oct_21_1(10)_e86.nxml.txt.nlp	21368859	SENT199	11	11	19	19	doxorubicin	TRAIL	PA449412	8743	0.952
NULL	Ther_Clin_Risk_Manag_2006_Mar_2(1)_59-75.nxml.txt.nlp	18360582	SENT243	9	9	5	5	pimozide	CYP3A4	PA450965	1576	0.952
NULL	Cancer_Med_2014_Jun_28_3(3)_719-730.nxml.txt.nlp	24683044	SENT296	5	5	8	8	metformin	AMPK	PA450395	5563	0.952
NULL	Curr_Neuropharmacol_2013_Mar_11(2)_160-170.nxml.txt.nlp	23997751	SENT102	40	40	3	3	pilocarpine	5-HT2C	PA450962	3358	0.952
NULL	Acta_Pharmacol_Sin_2012_Jan_3_33(1)_49-56.nxml.txt.nlp	22212430	SENT83	14	14	3	3	thrombin	A10	PA451674	28870	0.952
NULL	Iran_Red_Crescent_Med_J_2014_Sep_5_16(9)_e20153.nxml.txt.nlp	25593732	SENT12	6	6	18	18	desflurane	CYP2E1	PA164749136	1571	0.952
NULL	J_Am_Heart_Assoc_2013_Aug_23_2(4)_e000318.nxml.txt.nlp	23926118	SENT54	21	21	8	8	isoproterenol	AC3	PA450121	109	0.952
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT192	20	20	14	14	propafenone	CYP2D6	PA451131	1565	0.952
NULL	Pharmaceuticals_(Basel)_2014_Jan_9_7(1)_46-57.nxml.txt.nlp	24451403	SENT140	23	23	47	47	ritonavir	PI3K	PA451260	5290	0.952
NULL	Onco_Targets_Ther_2014_Oct_4_7_1817-1828.nxml.txt.nlp	25336973	SENT115	34	34	38	38	bevacizumab	IFL	PA130232992	3439	0.952
NULL	Biologics_2012_Dec_17_6_429-464.nxml.txt.nlp	23269860	SENT12	1	1	15	15	etanercept	ACR	PA449515	49	0.952
NULL	Mol_Biol_Int_2012_May_24_2012_705948.nxml.txt.nlp	22693671	SENT203	26	26	5	5	cisplatin	RASSF2	PA449014	9770	0.952
NULL	Front_Synaptic_Neurosci_2013_Sep_18_5_6.nxml.txt.nlp	24065916	SENT103	10	10	33	33	amphetamine	DCC	PA448408	1630	0.952
NULL	Breast_Cancer_Res_2005_Jul_20_7(5)_205-211.nxml.txt.nlp	16168139	SENT123	11	11	6	6	gefitinib	EGF	PA131301952	1950	0.952
NULL	Saudi_J_Anaesth_2014_Apr-Jun_8(2)_209-214.nxml.txt.nlp	24843334	SENT128	4	4	18	18	mephentermine	C15	PA164745533	51316	0.952
NULL	Oncotarget_2012_Nov_17_3(12)_1600-1614.nxml.txt.nlp	23307622	SENT79	8	8	19	19	erlotinib	ATG12	PA134687924	9140	0.952
NULL	Biomed_Res_Int_2013_Jul_25_2013_295132.nxml.txt.nlp	23984335	SENT339	0	0	21	21	ustekinumab	IL-23	PA166048654	51561	0.952
NULL	Oncotarget_2010_May_1_1(1)_6-8.nxml.txt.nlp	21293050	SENT52	5	5	15	15	bortezomib	KIT	PA10252	3815	0.952
NULL	Nucleic_Acids_Res_2010_Oct_4_38(19)_6375-6388.nxml.txt.nlp	20525792	SENT272	30	30	19	19	doxycycline	YY1	PA449415	7528	0.952
NULL	eLife_2014_May_6_3_e02482.nxml.txt.nlp	24843002	SENT182	32	32	20	20	etoposide	SETD2	PA449552	29072	0.952
NULL	Angew_Chem_Int_Ed_Engl_2013_Jan_2_52(1)_325-330.nxml.txt.nlp	23080482	SENT83	26	26	8	8	thrombin	ACPP	PA451674	55	0.952
NULL	Reprod_Biol_Endocrinol_2013_Feb_26_11_15.nxml.txt.nlp	23442442	SENT140	5	5	26	26	l-arginine	BCL2	PA448478	596	0.952
NULL	Cell_Death_Dis_2014_Jul_17_5(7)_e1333.nxml.txt.nlp	25032856	SENT9	12	12	19	19	candesartan	EAAC1	PA448765	6505	0.952
NULL	Br_J_Cancer_1996_Jul_74(1)_78-85.nxml.txt.nlp	8679463	SENT12	33	33	2	2	doxorubicin	Bcl-2	PA449412	596	0.952
NULL	Int_J_Mol_Sci_2014_Mar_20_15(3)_4965-4976.nxml.txt.nlp	24658440	SENT35	13	13	22	22	verapamil	P-gp	PA451868	5243	0.952
NULL	Diabetes_Care_2010_Nov_33(11)_2399-2405.nxml.txt.nlp	20980427	SENT19	8	8	1	1	ranibizumab	CRT	PA164746012	811	0.952
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1013.nxml.txt.nlp	24457957	SENT116	36	36	24	24	bortezomib	NOXA	PA10252	5366	0.952
NULL	Database_(Oxford)_2014_Dec_23_2014_bau124.nxml.txt.nlp	25539768	SENT128	4	4	16	16	erlotinib	EGFR	PA134687924	1956	0.952
NULL	Genome_Biol_2003_Aug_29_4(9)_117.nxml.txt.nlp	12952525	SENT46	32	32	12	12	trypsin	ICAT	PA451806	56998	0.952
NULL	J_Biol_Chem_2010_Aug_20_285(34)_25913-25927.nxml.txt.nlp	20452970	SENT208	2	2	31	31	iloprost	EP3	PA164746843	5733	0.952
NULL	Oncotarget_2012_Nov_17_3(12)_1600-1614.nxml.txt.nlp	23307622	SENT83	36	36	7	7	vinorelbine	ATG12	PA451881	9140	0.952
NULL	Breast_Cancer_Res_2011_Jan_17_13(1)_R5.nxml.txt.nlp	21241485	SENT307	17	17	9	9	estradiol	Brn-3b	PA449503	5458	0.952
NULL	Clin_Epidemiol_2014_May_13_6_169-182.nxml.txt.nlp	24872723	SENT107	20	20	36	36	fluconazole	CD4	PA449653	920	0.952
NULL	J_Radiat_Res_2014_Nov_16_55(6)_1171-1177.nxml.txt.nlp	25129557	SENT48	9	9	30	30	bevacizumab	LARC	PA130232992	6364	0.952
NULL	Acta_Pharmacol_Sin_2012_May_26_33(5)_675-681.nxml.txt.nlp	22447226	SENT129	11	11	41	41	gefitinib	survivin	PA131301952	332	0.952
NULL	Br_J_Pharmacol_2012_Jan_165(2)_390-400.nxml.txt.nlp	21671897	SENT233	9	9	2	2	suramin	P2X1	PA10292	5023	0.952
NULL	Mol_Cancer_2009_Nov_24_8_109.nxml.txt.nlp	19930708	SENT4	12	12	10	10	exemestane	aromatase	PA449563	1588	0.952
NULL	Br_J_Cancer_2010_Jun_29_103(1)_61-72.nxml.txt.nlp	20588279	SENT273	18	18	6	6	trastuzumab	RhoB	PA451743	388	0.952
NULL	Biomed_Res_Int_2013_Nov_4_2013_517237.nxml.txt.nlp	24294611	SENT100	14	14	6	6	topotecan	AP-1	PA451729	2353;3727;2354;3725	0.952
NULL	Br_J_Cancer_2010_Jun_29_103(1)_61-72.nxml.txt.nlp	20588279	SENT272	8	8	31	31	trastuzumab	RhoB	PA451743	388	0.952
NULL	Br_J_Cancer_2009_Jul_7_101(1)_55-63.nxml.txt.nlp	19491903	SENT128	30	30	38	38	cisplatin	DTD	PA449014	1728	0.952
NULL	Acta_Pharmacol_Sin_2010_Nov_18_31(11)_1447-1453.nxml.txt.nlp	20953204	SENT85	27	27	15	15	rimonabant	IL-6	PA152407999	3569	0.952
NULL	Arthritis_Res_Ther_2009_Aug_28_11(4)_R131.nxml.txt.nlp	19715572	SENT119	5	5	28	28	rituximab	CD25	PA451261	3669;3559	0.952
NULL	Oncotarget_2011_Mar_23_2(3)_165-177.nxml.txt.nlp	21444946	SENT33	5	5	21	21	cetuximab	EGFR	PA10040	1956	0.952
NULL	Onco_Targets_Ther_2014_Jun_11_7_969-983.nxml.txt.nlp	24959084	SENT115	9	9	4	4	itraconazole	CYP3A4	PA450132	1576	0.952
NULL	Clin_Psychopharmacol_Neurosci_2012_Apr_30_10(1)_25-33.nxml.txt.nlp	23429852	SENT98	22	22	14	14	haloperidol	SNAP-25	PA449841	6616	0.952
NULL	EMBO_Mol_Med_2012_Jun_13_4(6)_515-527.nxml.txt.nlp	22416035	SENT100	12	12	3	3	olaparib	p53		7157	0.952
NULL	Oncologist_2010_May_28_15(5)_436-446.nxml.txt.nlp	20427383	SENT130	13	13	31	31	erlotinib	EGFR	PA134687924	1956	0.952
NULL	Lab_Anim_Res_2014_Mar_24_30(1)_35-43.nxml.txt.nlp	24707303	SENT36	4	4	12	12	loperamide	CO2	PA450262	4513	0.952
NULL	Arthritis_Res_Ther_2011_Feb_8_13(1)_R17.nxml.txt.nlp	21303509	SENT214	7	7	20	20	leflunomide	FSTL1	PA450192	11167	0.952
NULL	Br_J_Cancer_2013_May_14_108(9)_1807-1809.nxml.txt.nlp	23612454	SENT45	18	18	32	32	trastuzumab	PIK3CA	PA451743	5290	0.952
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_55-78.nxml.txt.nlp	19305788	SENT205	0	0	16	16	memantine	spatial	PA10364	219793	0.952
NULL	Arthritis_Res_Ther_2010_Oct_28_12(5)_219.nxml.txt.nlp	21062511	SENT143	11	11	26	26	etanercept	IFN	PA449515	3439	0.952
NULL	Breast_Cancer_Res_2009_Oct_28_11(5)_211.nxml.txt.nlp	19889200	SENT142	21	21	2	2	tamoxifen	ATAC	PA451581	6375	0.952
NULL	Clin_Ophthalmol_2011_Oct_31_5_1567-1574.nxml.txt.nlp	22125403	SENT134	5	5	18	18	clarithromycin	MUC5AC	PA449028	4586	0.952
NULL	Oncotarget_2012_Jul_13_3(6)_601-607.nxml.txt.nlp	22802145	SENT82	3	3	11	11	nutlin-3	p53		7157	0.952
NULL	Mol_Vis_2012_Nov_29_18_2839-2846.nxml.txt.nlp	23233786	SENT9	0	0	14	14	geldanamycin	Hsp90	PA152031327	3320	0.952
NULL	Breast_Cancer_Res_Treat_2012_Jun_18_133(3)_937-947.nxml.txt.nlp	22094936	SENT109	41	41	8	8	tamoxifen	EZH2	PA451581	2146	0.952
NULL	Int_J_Surg_Oncol_2012_May_17_2012_406830.nxml.txt.nlp	22675625	SENT42	16	16	7	7	bevacizumab	PIGF	PA130232992	5281	0.952
NULL	Mol_Cell_Proteomics_2012_Feb_6_11(2)_M111_015222.nxml.txt.nlp	22147731	SENT963	6	6	4	4	gefitinib	EGFR	PA131301952	1956	0.952
NULL	J_Hematol_Oncol_2013_Feb_18_6_18.nxml.txt.nlp	23415012	SENT175	32	32	21	21	perifosine	PRAP	PA165291471	51478	0.952
NULL	Breast_Cancer_Res_2001_Dec_22_3(2)_118-121.nxml.txt.nlp	11250758	SENT33	6	6	17	17	tamoxifen	pS2	PA451581	7031	0.952
NULL	Cardiovasc_Res_2011_Apr_1_90(1)_105-112.nxml.txt.nlp	21123217	SENT193	44	44	35	35	fluoxetine	Bcl-2	PA449673	596	0.952
NULL	Acta_Pharmacol_Sin_2009_Sep_17_30(9)_1316-1322.nxml.txt.nlp	19684609	SENT205	20	20	10	10	rosiglitazone	PTEN	PA451283	5728	0.952
NULL	Oncologist_2010_Jul_24_15(7)_665-672.nxml.txt.nlp	20576644	SENT105	17	17	27	27	trastuzumab	HER-2	PA451743	2064	0.952
NULL	J_Biol_Chem_2010_Aug_20_285(34)_26406-26416.nxml.txt.nlp	20530490	SENT37	37	37	33	33	artemisinin	SERCA1	PA165111696	487	0.952
NULL	Int_J_Mol_Sci_2014_Mar_12_15(3)_4356-4392.nxml.txt.nlp	24625663	SENT122	28	28	3	3	paclitaxel	CERT	PA450761	10087	0.952
NULL	Hematol_Rep_2011_Oct_10_3(2)_e16.nxml.txt.nlp	22184537	SENT71	12	12	17	17	warfarin	CYP2C9	PA451906	1559	0.952
NULL	Case_Rep_Med_2010_Jun_17_2010_472389.nxml.txt.nlp	20589221	SENT10	14	14	28	28	chloroprocaine	BCHE	PA448946	590	0.952
NULL	Case_Rep_Med_2012_Dec_3_2012_163173.nxml.txt.nlp	23326270	SENT20	16	16	11	11	fenofibrate	CPT2	PA449594	1376	0.952
NULL	Arthritis_Res_Ther_2014_Jan_29_16(1)_R31.nxml.txt.nlp	24472667	SENT218	3	3	17	17	resveratrol	Bcl-2		596	0.952
NULL	Breast_Cancer_Res_2010_Oct_28_12(5)_212.nxml.txt.nlp	21067532	SENT134	29	29	27	27	letrozole	aromatase	PA450196	1588	0.952
NULL	Indian_J_Ophthalmol_2011_Sep-Oct_59(5)_403a.nxml.txt.nlp	21836356	SENT17	28	28	36	36	nifedipine	P-gp	PA450631	5243	0.952
NULL	Anesth_Essays_Res_2010_Jul-Dec_4(2)_96-101.nxml.txt.nlp	NULL	SENT51	0	0	17	17	heparin	ACT	PA449855	12;11332;9457;641455	0.952
NULL	Arthritis_Res_Ther_2012_Jan_30_14(1)_201.nxml.txt.nlp	22293240	SENT108	7	7	20	20	glucosamine	JNK	PA164747613	5599	0.952
NULL	Pharmaceuticals_(Basel)_2012_Aug_10_5(8)_802-836.nxml.txt.nlp	24280676	SENT90	27	27	37	37	gemcitabine	CNT2	PA449748	9153	0.952
NULL	Nat_Med_2010_Sep_22_16(9)_998-1000.nxml.txt.nlp	20729864	SENT36	5	5	16	16	sorafenib	LRRK2	PA7000	120892	0.952
NULL	Indian_J_Ophthalmol_2007_Nov-Dec_55(6)_482-483.nxml.txt.nlp	17951917	SENT16	27	27	6	6	ceftazidime	API	PA448861	5345	0.952
NULL	Oncol_Rep_2013_Oct_22_30(4)_1535-1541.nxml.txt.nlp	23877481	SENT149	13	13	17	17	bevacizumab	CXCR4	PA130232992	7852	0.952
NULL	Br_J_Cancer_2006_Dec_4_95(11)_1483-1489.nxml.txt.nlp	17106442	SENT145	38	38	8	8	platinum	TTP	PA150595617	7538;11093	0.952
NULL	Clin_Pharmacol_2013_Apr_19_5_67-83.nxml.txt.nlp	23650452	SENT206	3	3	12	12	ticagrelor	P2Y12	PA165374673	64805	0.952
NULL	An_Bras_Dermatol_2014_Mar-Apr_89(2)_266-273.nxml.txt.nlp	24770503	SENT58	13	13	9	9	thalidomide	ENL	PA451644	4298	0.952
NULL	Front_Mol_Neurosci_2013_Mar_21_6_5.nxml.txt.nlp	23518818	SENT216	4	4	39	39	capsaicin	TRPV1	PA448776	7442	0.952
NULL	Exp_Ther_Med_2014_Feb_25_7(2)_397-400.nxml.txt.nlp	24396413	SENT70	7	7	16	16	isoniazid	LOX	PA450112	4015	0.952
NULL	Arthritis_Rheumatol_2014_Jun_27_66(6)_1574-1582.nxml.txt.nlp	24577881	SENT34	25	25	6	6	hydralazine	ERK	PA449894	5594	0.952
NULL	Mol_Cancer_2007_Oct_11_6_63.nxml.txt.nlp	17931419	SENT13	32	32	7	7	gefitinib	EGFR	PA131301952	1956	0.952
NULL	J_Immigr_Minor_Health_2010_Aug_16_12(4)_544-550.nxml.txt.nlp	19085104	SENT112	34	34	5	5	isoniazid	San	PA450112	80218	0.952
NULL	Indian_J_Med_Res_2011_Sep_134(3)_295-301.nxml.txt.nlp	21985811	SENT28	38	38	7	7	phenytoin	CYP2C9	PA450947	1559	0.952
NULL	Curr_Chem_Genomics_2010_Mar_1_4_1-8.nxml.txt.nlp	20448812	SENT28	32	32	12	12	methotrexate	OATP1B1	PA450428	10599	0.952
NULL	Mol_Cancer_2007_Oct_11_6_63.nxml.txt.nlp	17931419	SENT30	27	27	12	12	cetuximab	HIF-1	PA10040	29072	0.952
NULL	Br_J_Cancer_2014_Oct_14_111(8)_1552-1561.nxml.txt.nlp	25117814	SENT192	20	20	8	8	cisplatin	XIAP	PA449014	331	0.952
NULL	J_Cardiothorac_Surg_2011_Nov_21_6_154.nxml.txt.nlp	22104114	SENT21	20	20	26	26	heparin	ACT	PA449855	12;11332;9457;641455	0.952
NULL	BMJ_Open_2014_Oct_29_4(10)_e006344.nxml.txt.nlp	25354826	SENT51	6	6	22	22	protamine	ACT	PA10366	12;11332;9457;641455	0.952
NULL	Scientifica_(Cairo)_2012_Oct_9_2012_821549.nxml.txt.nlp	24278743	SENT201	10	10	0	0	mirtazapine	5-HT2C	PA450522	3358	0.952
NULL	J_Hematol_Oncol_2013_Jun_3_6_38.nxml.txt.nlp	23731980	SENT62	29	29	33	33	trastuzumab	HER2	PA451743	2064	0.952
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT220	10	10	14	14	atorvastatin	OPG	PA448500	690	0.952
NULL	J_Cell_Biol_2002_Nov_25_159(4)_637-648.nxml.txt.nlp	12438416	SENT72	19	19	10	10	staurosporine	p115	PA165109623	8615;393	0.952
NULL	Cancer_Immunol_Immunother_2012_Jul_23_61(7)_1101-1111.nxml.txt.nlp	22193989	SENT111	21	21	33	33	oxaliplatin	RANTES	PA131285527	6352	0.952
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT37	40	40	6	6	tamoxifen	TFF3	PA451581	7033	0.952
NULL	Mol_Cells_2014_Sep_30_37(9)_664-671.nxml.txt.nlp	25234467	SENT10	14	14	5	5	cisplatin	miR-217	PA449014	406999	0.952
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT88	0	0	24	24	efavirenz	CYP3A4	PA449441	1576	0.952
NULL	Biomed_Res_Int_2013_Dec_22_2013_835850.nxml.txt.nlp	24455731	SENT78	7	7	24	24	heparin	ACT	PA449855	12;11332;9457;641455	0.952
NULL	Cell_Logist_2012_Apr_1_2(2)_117-125.nxml.txt.nlp	23162743	SENT105	4	4	13	13	berberine	spatial	PA165860812	219793	0.952
NULL	Cancer_Med_2013_Dec_31_2(6)_950-963.nxml.txt.nlp	24403269	SENT314	35	35	18	18	cisplatin	RAB25	PA449014	57111	0.952
NULL	Oncotarget_2013_Nov_24_4(12)_2186-2207.nxml.txt.nlp	24327604	SENT152	24	24	10	10	bortezomib	TRAF3	PA10252	7187	0.952
NULL	Arthritis_Res_Ther_2006_Nov_16_8(6)_R173.nxml.txt.nlp	17109745	SENT32	27	27	14	14	glucosamine	p50	PA164747613	958;4790	0.952
NULL	J_Biol_Chem_2012_Apr_13_287(16)_12952-12965.nxml.txt.nlp	22371491	SENT63	21	21	10	10	labetalol	CCL2	PA164743150	6347	0.952
NULL	Arthritis_Res_Ther_2012_Apr_18_14(2)_R80.nxml.txt.nlp	22513098	SENT153	17	17	2	2	azathioprine	TLR9	PA448515	54106	0.952
NULL	J_Invest_Dermatol_2013_Sep_31_133(9)_2247-2254.nxml.txt.nlp	23370537	SENT105	18	18	9	9	chloroquine	p53	PA448948	7157	0.952
NULL	Contemp_Clin_Dent_2013_Jan-Mar_4(1)_1.nxml.txt.nlp	23853443	SENT19	6	6	21	21	vemurafenib	BRAF	PA165946873	673	0.952
NULL	Iran_J_Pharm_Res_2014_Winter_13(Suppl)_35-42.nxml.txt.nlp	24711827	SENT189	16	16	0	0	indomethacin	ADP	PA449982	23038	0.952
NULL	J_Cardiothorac_Surg_2014_Jun_19_9_105.nxml.txt.nlp	24942178	SENT52	5	5	12	12	heparin	ACT	PA449855	12;11332;9457;641455	0.952
NULL	Oncogene_2009_Dec_10_28(49)_4353-4363.nxml.txt.nlp	19826413	SENT7	33	33	25	25	paclitaxel	TLR4	PA450761	7099	0.952
NULL	Br_J_Cancer_2011_Mar_15_104(6)_1020-1026.nxml.txt.nlp	21364579	SENT27	0	0	44	44	cetuximab	KRAS	PA10040	3845	0.952
NULL	Autoimmune_Dis_2012_Dec_11_2012_502813.nxml.txt.nlp	23304456	SENT195	30	30	40	40	doxorubicin	HSP27	PA449412	3315	0.952
NULL	Curr_Oncol_2009_Jul_16(Suppl_2)_S1-S13.nxml.txt.nlp	19672416	SENT20	19	19	7	7	letrozole	aromatase	PA450196	1588	0.952
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT109	31	31	20	20	pp2	EGFR		1956	0.952
NULL	Crit_Care_2010_Oct_13_14(5)_R181.nxml.txt.nlp	20942931	SENT222	14	14	1	1	cisplatin	IL-6	PA449014	3569	0.952
NULL	J_Carcinog_2011_Sep_21_10_23.nxml.txt.nlp	22013393	SENT136	17	17	15	15	ketorolac	COX	PA450150	1351	0.952
NULL	BMJ_2011_Aug_4_343_d4588.nxml.txt.nlp	21816733	SENT389	9	9	1	1	imipramine	CYP2C19	PA449969	1557	0.952
NULL	Acta_Pharmacol_Sin_2011_Oct_15_32(10)_1233-1238.nxml.txt.nlp	21841815	SENT84	6	6	17	17	mecamylamine	CTX	PA450334	1593	0.952
NULL	J_Hematol_Oncol_2012_Jul_27_5_42.nxml.txt.nlp	22839530	SENT166	27	27	7	7	cytarabine	PRMT1	PA449177	3276	0.952
NULL	Arthritis_Res_Ther_2010_Sep_8_12(5)_R167.nxml.txt.nlp	20825639	SENT241	22	22	8	8	resveratrol	AP-1		2353;3727;2354;3725	0.952
NULL	J_Headache_Pain_2008_Feb_24_9(1)_13-18.nxml.txt.nlp	18217199	SENT129	0	0	10	10	amitriptyline	CYP3A4	PA448385	1576	0.952
NULL	Exp_Cell_Res_2009_Nov_15_315(19)_3433-3441.nxml.txt.nlp	19716819	SENT34	4	4	24	24	hyaluronidase	CD44	PA164745713	960	0.952
NULL	J_Thromb_Thrombolysis_2012_Feb_20_33(2)_143-153.nxml.txt.nlp	22183178	SENT7	26	26	13	13	ticagrelor	P2Y12	PA165374673	64805	0.952
NULL	J_Inflamm_(Lond)_2008_Jul_29_5_11.nxml.txt.nlp	18664275	SENT115	7	7	20	20	levofloxacin	IFN	PA450214	3439	0.952
NULL	Acta_Pharmacol_Sin_2013_Jan_17_34(1)_157-166.nxml.txt.nlp	23247593	SENT17	5	5	13	13	berberine	Set9	PA165860812	80854	0.952
NULL	Br_J_Cancer_1996_Apr_73(7)_849-855.nxml.txt.nlp	8611394	SENT11	13	13	5	5	calcein	P-gp	PA132595336	5243	0.952
NULL	Mol_Cancer_2014_Jul_5_13_165.nxml.txt.nlp	24996221	SENT104	22	22	27	27	docetaxel	HMGB1	PA449383	3146	0.952
NULL	Eur_J_Med_Res_2011_Feb_24_16(2)_71-75.nxml.txt.nlp	21463985	SENT122	22	22	10	10	dacarbazine	HAI	PA449197	6692;6768	0.952
NULL	Diabetes_2013_Jun_17_62(6)_2095-2105.nxml.txt.nlp	23349482	SENT32	4	4	18	18	fenofibrate	DAG	PA449594	1605	0.952
NULL	Infect_Dis_Ther_2014_Dec_24_3(2)_83-102.nxml.txt.nlp	25134686	SENT222	9	9	29	29	rifampin	CYP3A4	PA451250	1576	0.952
NULL	J_Neuroinflammation_2011_Feb_4_8_10.nxml.txt.nlp	21294877	SENT22	0	0	22	22	capsaicin	NK1	PA448776	11126	0.952
NULL	Behav_Brain_Funct_2011_Oct_5_7_41.nxml.txt.nlp	21974752	SENT286	8	8	20	20	fluvoxamine	EPM	PA449690	2054	0.952
NULL	J_Clin_Exp_Pathol_2012_May_17_Suppl_4_7327.nxml.txt.nlp	25379357	SENT28	26	26	7	7	resveratrol	AMPK		5563	0.952
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT42	0	0	9	9	ritonavir	CYP3A4	PA451260	1576	0.952
NULL	Oncoscience_2014_Jun_1_1(5)_310-325.nxml.txt.nlp	25594026	SENT178	28	28	32	32	cisplatin	CXCR4	PA449014	7852	0.952
NULL	Oncologist_2010_Mar_9_15(3)_236-245.nxml.txt.nlp	20215359	SENT116	39	39	12	12	temsirolimus	IFN	PA164746890	3439	0.952
NULL	J_Exp_Clin_Cancer_Res_2009_Jul_10_28(1)_99.nxml.txt.nlp	19591692	SENT122	28	28	9	9	tariquidar	ABCB1		5243	0.952
NULL	Cell_Death_Dis_2014_Jan_9_5(1)_e986.nxml.txt.nlp	24407239	SENT138	12	12	19	19	fludarabine	STAT1	PA449655	6772	0.952
NULL	EMBO_Mol_Med_2011_May_3(5)_266-278.nxml.txt.nlp	21438154	SENT24	7	7	30	30	oxaliplatin	TRPM8	PA131285527	79054	0.952
NULL	Clin_Med_Insights_Oncol_2012_Feb_28_6_125-135.nxml.txt.nlp	22408376	SENT28	0	0	15	15	panitumumab	EGFR	PA162373091	1956	0.952
NULL	Pharmaceuticals_(Basel)_2012_Oct_25_5(11)_1160-1176.nxml.txt.nlp	24281306	SENT185	19	19	12	12	indomethacin	ANG	PA449982	283	0.952
NULL	Int_J_Biol_Sci_2013_Mar_7_9(3)_279-288.nxml.txt.nlp	23493630	SENT122	33	33	12	12	tocilizumab	CD4	PA165292659	920	0.952
NULL	Breast_Cancer_Res_2011_Feb_3_13(1)_R16.nxml.txt.nlp	21291529	SENT10	10	10	2	2	epirubicin	PHD2	PA449476	54583	0.952
NULL	Hum_Genomics_2008_Sep_1_3(1)_7-16.nxml.txt.nlp	19129086	SENT164	1	1	19	19	rosiglitazone	CYP2C9	PA451283	1559	0.952
NULL	Oncotarget_2012_Dec_30_3(12)_1522-1532.nxml.txt.nlp	23455653	SENT42	6	6	12	12	everolimus	PI3K	PA164746311	5290	0.952
NULL	Anat_Cell_Biol_2011_Sep_29_44(3)_194-203.nxml.txt.nlp	22025971	SENT157	9	9	19	19	berberine	AMPK	PA165860812	5563	0.952
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Feb_15_5_3.nxml.txt.nlp	16480505	SENT187	1	1	7	7	rosiglitazone	CYP2C9	PA451283	1559	0.952
NULL	Br_J_Cancer_2012_Jun_26_107(1)_129-136.nxml.txt.nlp	22644295	SENT199	21	21	39	39	ethanol	p38	PA448073	10598;1432;7965	0.952
NULL	Nat_Commun_2013_Oct_7_4_2564.nxml.txt.nlp	24096827	SENT55	22	22	13	13	thrombin	ADP	PA451674	23038	0.952
NULL	Anal_Bioanal_Chem_2010_Oct_22_398(4)_1771-1780.nxml.txt.nlp	20730527	SENT127	4	4	18	18	warfarin	p38	PA451906	10598;1432;7965	0.952
NULL	Biochemistry_2008_Sep_9_47(36)_9394-9404.nxml.txt.nlp	18702525	SENT107	5	5	17	17	dextran	IscU	PA449261	23479	0.952
NULL	Oncogene_2010_Sep_9_29(36)_5032-5047.nxml.txt.nlp	20603614	SENT91	28	28	12	12	chloroquine	ARRDC3	PA448948	57561	0.952
NULL	Cancer_Cell_Int_2014_Jan_23_14_6.nxml.txt.nlp	24456610	SENT212	10	10	5	5	resveratrol	p53		7157	0.952
NULL	Acta_Pharmacol_Sin_2009_Sep_24_30(9)_1262-1275.nxml.txt.nlp	19701231	SENT131	13	13	3	3	lovastatin	TGFBR3	PA450272	7049	0.952
NULL	Ther_Clin_Risk_Manag_2007_Aug_3(4)_533-542.nxml.txt.nlp	18472974	SENT143	3	3	16	16	posaconazole	CDR2	PA151958574	1039	0.952
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1063.nxml.txt.nlp	24556678	SENT70	7	7	29	29	thioridazine	Mcl-1	PA451666	4170	0.952
NULL	Braz_J_Med_Biol_Res_2014_Mar_3_47(3)_245-251.nxml.txt.nlp	24554037	SENT147	4	4	6	6	atorvastatin	IFN	PA448500	3439	0.952
NULL	Cancer_Biol_Med_2013_Mar_10(1)_36-42.nxml.txt.nlp	23691443	SENT168	2	2	13	13	rituximab	CTX	PA451261	1593	0.952
NULL	Case_Rep_Med_2012_May_9_2012_698513.nxml.txt.nlp	22649458	SENT98	10	10	16	16	ritonavir	CYP3A4	PA451260	1576	0.952
NULL	Cardiol_Res_Pract_2014_Nov_20_2014_784018.nxml.txt.nlp	25506463	SENT156	0	0	19	19	protamine	ACT	PA10366	12;11332;9457;641455	0.952
NULL	J_Cell_Biol_2008_Jan_28_180(2)_417-426.nxml.txt.nlp	18227283	SENT63	23	23	21	21	letrozole	aromatase	PA450196	1588	0.952
NULL	Mol_Biol_Cell_2013_Feb_15_24(4)_495-509.nxml.txt.nlp	23408788	SENT159	29	29	3	3	pp2	PP2		4888	0.952
NULL	Ann_Oncol_2012_Dec_2_23(12)_3007-3016.nxml.txt.nlp	22865781	SENT45	18	18	36	36	trastuzumab	HER2	PA451743	2064	0.952
NULL	Exp_Hematol_Oncol_2013_Jan_10_2_2.nxml.txt.nlp	23305345	SENT22	27	27	0	0	rituximab	BTZ	PA451261	22794	0.952
NULL	Hum_Genomics_2009_Jan_1_3(2)_121-127.nxml.txt.nlp	19164089	SENT86	39	39	3	3	ethanol	ALDH2	PA448073	217	0.952
NULL	Oncol_Lett_2014_Mar_19_7(3)_674-678.nxml.txt.nlp	24527071	SENT129	20	20	7	7	cisplatin	AKR1C2	PA449014	1646	0.952
NULL	Crit_Care_1999_Nov_8_3(6)_R107-R111.nxml.txt.nlp	NULL	SENT53	18	18	7	7	propranolol	IL-10	PA451145	3586	0.952
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jul_15_65(Pt_8)_o1857.nxml.txt.nlp	21583555	SENT49	15	15	8	8	benzaldehyde	mol	PA448571	90527	0.952
NULL	Exp_Lung_Res_2013_Oct_1_39(8)_336-348.nxml.txt.nlp	23919450	SENT92	6	6	9	9	argatroban	PAR-1	PA164745516	2011;2149	0.952
NULL	J_Neuroinflammation_2011_Feb_4_8_10.nxml.txt.nlp	21294877	SENT156	15	15	7	7	capsaicin	TRPV1	PA448776	7442	0.952
NULL	Nucleic_Acids_Res_2013_Dec_30_41(22)_10268-10282.nxml.txt.nlp	23997120	SENT349	16	16	12	12	olaparib	TRF1		7013	0.952
NULL	Oncogene_2014_Aug_28_33(35)_4396-4406.nxml.txt.nlp	24531714	SENT57	26	26	24	24	nutlin-3	MDM2		4193	0.952
NULL	Front_Neurol_2011_Dec_26_2_83.nxml.txt.nlp	22363312	SENT105	23	23	26	26	clopidogrel	P2Y12	PA449053	64805	0.952
NULL	Oncotarget_2010_Oct_25_1(7)_497-514.nxml.txt.nlp	21165163	SENT266	42	42	23	23	docetaxel	EGFR	PA449383	1956	0.952
NULL	Exp_Ther_Med_2014_Mar_10_7(3)_640-648.nxml.txt.nlp	24520260	SENT149	8	8	14	14	resveratrol	JNK		5599	0.952
NULL	ScientificWorldJournal_2013_Sep_21_2013_208309.nxml.txt.nlp	24170980	SENT27	11	11	21	21	lenalidomide	MRP8	PA162363968	6833;6279;85320	0.952
NULL	J_Oncol_2009_Jun_14_2009_814140.nxml.txt.nlp	19547715	SENT21	30	30	15	15	paclitaxel	MDR1	PA450761	5243	0.952
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jan_11_68(Pt_2)_o324-o325.nxml.txt.nlp	22346958	SENT70	36	36	6	6	ethanol	mol	PA448073	90527	0.952
NULL	Br_J_Cancer_2010_Jan_19_102(2)_361-368.nxml.txt.nlp	20010949	SENT215	19	19	8	8	paclitaxel	PSMB7	PA450761	5695	0.952
NULL	Indian_J_Dermatol_2008_53(3)_125-128.nxml.txt.nlp	19882010	SENT73	2	2	35	35	ketoconazole	ANOVA	PA450146	4858	0.952
NULL	Exp_Ther_Med_2013_May_15_5(5)_1327-1331.nxml.txt.nlp	23737873	SENT131	28	28	22	22	imidapril	AQP2	PA452640	359	0.952
NULL	Int_J_Endocrinol_Metab_2013_Jul_1_Summer_11(3)_184-190.nxml.txt.nlp	24348591	SENT28	0	0	4	4	liraglutide	GLP-1	PA165958364	100125288	0.952
NULL	Ann_Hematol_2010_Sep_13_89(9)_861-871.nxml.txt.nlp	20387067	SENT225	19	19	22	22	dasatinib	KIT	PA162372878	3815	0.952
NULL	Cancer_Cell_Int_2009_Sep_10_9_25.nxml.txt.nlp	19744341	SENT124	5	5	35	35	glucosamine	STAT3	PA164747613	6774	0.952
NULL	Oncotarget_2014_Oct_18_5(21)_10206-10221.nxml.txt.nlp	25344914	SENT2	2	2	0	0	vemurafenib	BRAF	PA165946873	673	0.952
NULL	Nucleic_Acids_Res_2012_Sep_30_40(17)_8743-8758.nxml.txt.nlp	22753105	SENT73	36	36	5	5	nadh	ADP	PA164755085	23038	0.952
NULL	Chemother_Res_Pract_2012_Dec_20_2012_743193.nxml.txt.nlp	23320171	SENT119	20	20	12	12	letrozole	HER2	PA450196	2064	0.952
NULL	Cell_Cycle_2013_Feb_15_12(4)_625-634.nxml.txt.nlp	23324396	SENT59	16	16	4	4	doxycycline	p53	PA449415	7157	0.952
NULL	Ann_Rheum_Dis_2008_Nov_14_67(11)_1516-1523.nxml.txt.nlp	18625622	SENT18	2	2	23	23	methotrexate	TNF	PA450428	7124	0.952
NULL	Ther_Clin_Risk_Manag_2006_Mar_2(1)_45-57.nxml.txt.nlp	18360581	SENT48	0	0	6	6	etoricoxib	CYP3A	PA164776853	1574	0.952
NULL	Nat_Commun_2011_Oct_25_2_513.nxml.txt.nlp	22027593	SENT629	30	30	22	22	nutlin-3	RBM38		55544	0.952
NULL	Oncotarget_2014_Oct_21_5(22)_11252-11268.nxml.txt.nlp	25361004	SENT256	8	8	12	12	metformin	CLIC1	PA450395	1192	0.952
NULL	Case_Rep_Oncol_Med_2013_Sep_26_2013_234391.nxml.txt.nlp	24191208	SENT6	23	23	8	8	capecitabine	HER-2	PA448771	2064	0.952
NULL	Cells_2014_Feb_19_3(1)_112-128.nxml.txt.nlp	24709905	SENT100	5	5	19	19	doxorubicin	TRPV2	PA449412	51393	0.952
NULL	Pharmaceuticals_(Basel)_2013_Aug_21_6(8)_988-1038.nxml.txt.nlp	24276379	SENT291	14	14	12	12	erlotinib	EGFR	PA134687924	1956	0.952
NULL	Mol_Biol_Int_2014_Sep_7_2014_852748.nxml.txt.nlp	25276427	SENT123	36	36	25	25	trastuzumab	HER2	PA451743	2064	0.952
NULL	AIDS_Res_Ther_2013_Sep_3_10_22.nxml.txt.nlp	24004690	SENT42	7	7	17	17	tenofovir	CD4	PA10204	920	0.952
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Dec_17_65(Pt_1)_m86.nxml.txt.nlp	21581549	SENT5	9	9	1	1	copper	mol	PA449114	90527	0.952
NULL	J_Hematol_Oncol_2009_Apr_28_2_19.nxml.txt.nlp	19400935	SENT103	7	7	15	15	bortezomib	IL-6	PA10252	3569	0.952
NULL	Aging_(Albany_NY)_2012_Mar_4_4(3)_144-145.nxml.txt.nlp	22388573	SENT14	7	7	24	24	resveratrol	AMPK		5563	0.952
NULL	Clinicoecon_Outcomes_Res_2014_Oct_17_6_451-461.nxml.txt.nlp	25378939	SENT142	2	2	33	33	vancomycin	HAP	PA451850	5915;10313	0.952
NULL	Indian_J_Pharmacol_2009_Dec_41(6)_262-267.nxml.txt.nlp	20407557	SENT154	6	6	23	23	ezetimibe	STZ	PA10816	6484	0.952
NULL	Vet_Res_Forum_2013_Winter_4(1)_19-24.nxml.txt.nlp	25593681	SENT103	17	17	6	6	diclofenac	B12	PA449293	7126;4709	0.952
NULL	Cell_Death_Dis_2010_Nov_18_1(11)_e102.nxml.txt.nlp	21368867	SENT89	4	4	22	22	gentamicin	CLIMP-63	PA449753	10970	0.952
NULL	J_Mol_Signal_2010_Jun_11_5_6.nxml.txt.nlp	20540776	SENT4	20	20	24	24	etoposide	gamma	PA449552	9913	0.952
NULL	Mol_Pain_2013_May_13_9_24.nxml.txt.nlp	23668392	SENT145	24	24	4	4	capsaicin	TRPV1	PA448776	7442	0.952
NULL	Arch_Osteoporos_2013_Oct_11_8(1-2)_136.nxml.txt.nlp	24113837	SENT3131	0	0	21	21	teriparatide	PTH	PA451620	5741	0.952
NULL	Cancers_(Basel)_2013_Oct_23_5(4)_1306-1331.nxml.txt.nlp	24202447	SENT117	10	10	29	29	temozolomide	Bcl-2	PA451609	596	0.952
NULL	Cancer_Metab_2014_Nov_3_2(1)_20.nxml.txt.nlp	NULL	SENT102	31	31	22	22	erlotinib	EGFR	PA134687924	1956	0.952
NULL	J_Oncol_2011_Jun_12_2011_542358.nxml.txt.nlp	21772843	SENT367	20	20	10	10	gefitinib	EGFR	PA131301952	1956	0.952
NULL	Indian_J_Pharmacol_2009_Aug_41(4)_167-172.nxml.txt.nlp	20523867	SENT137	24	24	9	9	acetaminophen	CYP2E1	PA448015	1571	0.952
NULL	J_Cell_Biol_2002_Sep_16_158(6)_1133-1144.nxml.txt.nlp	12235127	SENT7	34	34	2	2	hyaluronan	FLG	PA165958431	2260;2312	0.952
NULL	Cancer_Immunol_Immunother_2015_Oct_7_64_61-73.nxml.txt.nlp	25287778	SENT250	22	22	10	10	lenalidomide	LFA-1	PA162363968	3683;3689	0.952
NULL	Gene_Regul_Syst_Bio_2014_Mar_4_8_63-73.nxml.txt.nlp	24634581	SENT10	8	8	20	20	minocycline	MT1-MMP	PA450519	4323	0.952
NULL	Chem_Rev_2013_Oct_9_113(10)_7769-7792.nxml.txt.nlp	23808632	SENT166	17	17	23	23	arsenite	ArsB	PA452638	57152	0.952
NULL	Mol_Cancer_2013_Oct_7_12_116.nxml.txt.nlp	24098916	SENT155	0	0	21	21	benzaldehyde	mol	PA448571	90527	0.952
NULL	Cancer_Cell_Int_2013_Jun_17_13_61.nxml.txt.nlp	23773282	SENT230	6	6	16	16	bortezomib	TRAIL	PA10252	8743	0.952
NULL	Crit_Care_2008_Aug_4_12(4)_R100.nxml.txt.nlp	18680601	SENT165	22	22	17	17	bacitracin	IL-6	PA448531	3569	0.952
NULL	Mol_Vis_2012_Nov_29_18_2839-2846.nxml.txt.nlp	23233786	SENT192	8	8	19	19	geldanamycin	CB2	PA152031327	1269	0.952
NULL	Curr_Neuropharmacol_2009_Sep_7(3)_195-206.nxml.txt.nlp	20190961	SENT181	5	5	12	12	clozapine	c-fos	PA449061	2353	0.952
NULL	Exp_Ther_Med_2014_Mar_19_7(3)_669-674.nxml.txt.nlp	24520265	SENT147	0	0	21	21	thalidomide	JNK	PA451644	5599	0.952
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT90	5	5	29	29	curcumin	DR5	PA151958596	8795	0.952
NULL	Int_J_Nanomedicine_2012_Nov_20_7_5781-5792.nxml.txt.nlp	23185118	SENT70	24	24	9	9	etoposide	CO2	PA449552	4513	0.952
NULL	Int_J_Nanomedicine_2012_Sep_13_7_4917-4926.nxml.txt.nlp	23028220	SENT236	18	18	7	7	calcein	mol	PA132595336	90527	0.952
NULL	Breast_Cancer_Res_2008_Dec_18_10(Suppl_4)_S25.nxml.txt.nlp	19128439	SENT27	31	31	23	23	gefitinib	aromatase	PA131301952	1588	0.952
NULL	Leukemia_2014_Apr_14_28(4)_961-964.nxml.txt.nlp	24418991	SENT38	0	0	15	15	nilotinib	P-gp	PA165958345	5243	0.952
NULL	Cell_Rep_2012_Feb_23_1(2)_99-109.nxml.txt.nlp	22832160	SENT51	21	21	4	4	tetracycline	Oct4	PA451640	5460	0.952
NULL	Front_Oncol_2014_Aug_11_4_204.nxml.txt.nlp	25157335	SENT150	12	12	23	23	docetaxel	KRAS	PA449383	3845	0.952
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1522-1532.nxml.txt.nlp	21997136	SENT152	15	15	11	11	lapatinib	EGFR	PA152241907	1956	0.952
NULL	Viruses_2014_Apr_23_6(4)_1861-1875.nxml.txt.nlp	24762393	SENT172	25	25	8	8	paraformaldehyde	CO2	PA450790	4513	0.952
NULL	Onco_Targets_Ther_2014_Dec_4_7_2249-2255.nxml.txt.nlp	25587220	SENT55	22	22	30	30	verapamil	P-gp	PA451868	5243	0.952
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT84	22	22	2	2	methotrexate	MSH2	PA450428	4436	0.952
NULL	Diabetes_Metab_J_2013_Feb_15_37(1)_72-80.nxml.txt.nlp	23439802	SENT97	6	6	28	28	vildagliptin	PPG	PA165958346	5552	0.952
NULL	Int_J_Nanomedicine_2007_Mar_2(1)_13-18.nxml.txt.nlp	17722507	SENT61	26	26	7	7	ondansetron	NK1	PA450705	11126	0.952
NULL	Br_J_Cancer_2012_May_22_106(11)_1779-1789.nxml.txt.nlp	22549178	SENT215	10	10	20	20	trastuzumab	HER2	PA451743	2064	0.952
NULL	Arthritis_Res_Ther_2011_Mar_24_13(2)_R51.nxml.txt.nlp	21435232	SENT34	29	29	20	20	etanercept	TWEAK	PA449515	8742	0.952
NULL	J_Headache_Pain_2008_Feb_24_9(1)_13-18.nxml.txt.nlp	18217199	SENT102	0	0	8	8	propranolol	CYP1A2	PA451145	1544	0.952
NULL	Eur_J_Clin_Pharmacol_2011_May_9_67(5)_477-482.nxml.txt.nlp	21305273	SENT24	0	0	17	17	dobutamine	DSE	PA449381	29940	0.952
NULL	Clin_Med_Insights_Case_Rep_2014_Nov_19_7_131-134.nxml.txt.nlp	25452706	SENT94	39	39	7	7	ranolazine	CYP3A	PA164746007	1574	0.952
NULL	Mol_Vis_2011_Feb_24_17_591-597.nxml.txt.nlp	21386928	SENT116	32	32	9	9	fluorescein	FRMD7	PA164746009	90167	0.952
NULL	Ann_Hematol_2010_Nov_25_89(11)_1115-1124.nxml.txt.nlp	20499237	SENT100	15	15	2	2	simvastatin	CD19	PA451363	930	0.952
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT1406	17	17	1	1	probenecid	MRP2	PA451106	100130958;57626;1244	0.952
NULL	J_Oncol_2011_Jun_13_2011_125467.nxml.txt.nlp	21772841	SENT91	29	29	17	17	cetuximab	KRAS	PA10040	3845	0.952
NULL	Arthritis_Res_Ther_2005_Apr_4_7(4)_R756-R768.nxml.txt.nlp	15987477	SENT25	6	6	23	23	hyaluronidase	PH-20	PA164745713	6677	0.952
NULL	Eur_J_Clin_Pharmacol_2007_Apr_21_63(4)_335-343.nxml.txt.nlp	17318526	SENT234	2	2	9	9	sulfamethoxazole	CYP2C9	PA451544	1559	0.952
NULL	J_Hematol_Oncol_2013_Jan_15_6_5.nxml.txt.nlp	23320987	SENT121	10	10	20	20	heparin	PI-PLC	PA449855	2923	0.952
NULL	J_Cell_Mol_Med_2014_Feb_5_18(2)_263-273.nxml.txt.nlp	24304472	SENT10	37	37	2	2	prazosin	p38	PA451093	10598;1432;7965	0.952
NULL	Arch_Med_Sci_2011_Dec_31_7(6)_977-983.nxml.txt.nlp	22328880	SENT126	3	3	24	24	heparin	ACT	PA449855	12;11332;9457;641455	0.952
NULL	Exp_Diabetes_Res_2011_Apr_26_2011_215764.nxml.txt.nlp	21584276	SENT11	42	42	4	4	liraglutide	GLP-1	PA165958364	100125288	0.952
NULL	Cancers_(Basel)_2014_Apr_9_6(2)_829-859.nxml.txt.nlp	24722453	SENT251	7	7	21	21	sorafenib	JAK2	PA7000	3717	0.952
NULL	Cell_Div_2012_Dec_26_7_26.nxml.txt.nlp	23268747	SENT109	0	0	25	25	bortezomib	HIF-1	PA10252	29072	0.952
NULL	Indian_Dermatol_Online_J_2011_Jul-Dec_2(2)_111-119.nxml.txt.nlp	23130241	SENT215	27	27	44	44	methotrexate	FAE	PA450428	2178	0.952
NULL	Environ_Health_Perspect_2005_Jun_25_113(6)_716-720.nxml.txt.nlp	15929894	SENT153	31	31	15	15	lindane	aromatase	PA164754914	1588	0.952
NULL	Arthritis_Res_Ther_2013_Oct_2_15(5)_R141.nxml.txt.nlp	24286116	SENT178	11	11	5	5	tocilizumab	IL-6	PA165292659	3569	0.952
NULL	Oncotarget_2013_Nov_19_5(2)_309-325.nxml.txt.nlp	24525395	SENT301	9	9	32	32	flavopiridol	Bcl-2	PA452627	596	0.951
NULL	Can_J_Infect_Dis_Med_Microbiol_2014_Nov-Dec_25(6)_327-343.nxml.txt.nlp	25587296	SENT181	22	22	9	9	itraconazole	CYP3A4	PA450132	1576	0.951
NULL	Brain_2013_Jul_24_136(7)_2279-2297.nxml.txt.nlp	23801741	SENT315	8	8	20	20	tamoxifen	NRG1	PA451581	3084	0.951
NULL	Ann_Med_2014_Nov_21_46(7)_475-489.nxml.txt.nlp	25045928	SENT172	2	2	16	16	ticagrelor	CYP3A4	PA165374673	1576	0.951
NULL	Breast_Cancer_Res_2012_May_2_14(3)_R70.nxml.txt.nlp	22551440	SENT19	10	10	0	0	docetaxel	p53	PA449383	7157	0.951
NULL	Br_J_Cancer_2010_Jun_29_103(1)_61-72.nxml.txt.nlp	20588279	SENT212	0	0	24	24	trastuzumab	RhoB	PA451743	388	0.951
NULL	J_Korean_Med_Sci_2007_Jun_30_22(3)_557-559.nxml.txt.nlp	17596671	SENT50	10	10	5	5	warfarin	CYP2C9	PA451906	1559	0.951
NULL	Int_J_Breast_Cancer_2013_Dec_5_2013_354579.nxml.txt.nlp	24383004	SENT64	22	22	9	9	methotrexate	NAC	PA450428	22861	0.951
NULL	Int_J_Chron_Obstruct_Pulmon_Dis_2006_Dec_1(4)_409-423.nxml.txt.nlp	18044097	SENT245	5	5	23	23	cilomilast	PDE4D	PA165948031	5144	0.951
NULL	Support_Care_Cancer_2009_Sep_10_17(9)_1177-1185.nxml.txt.nlp	19205755	SENT33	19	19	37	37	ondansetron	HEC	PA450705	10403	0.951
NULL	J_Gen_Physiol_2012_Jun_139(6)_407-414.nxml.txt.nlp	22641635	SENT123	8	8	17	17	nadh	PDH	PA164755085	54704	0.951
NULL	Nat_Chem_Biol_2010_Apr_28_6(4)_291-299.nxml.txt.nlp	20190765	SENT128	44	44	37	37	dasatinib	EGFR	PA162372878	1956	0.951
NULL	Nat_Med_2013_Dec_10_19(12)_10_1038_nm_3385.nxml.txt.nlp	24216752	SENT109	2	2	15	15	thrombin	PAR4	PA451674	9002;5074	0.951
NULL	J_Asthma_Allergy_2014_Feb_27_7_11-21.nxml.txt.nlp	24600237	SENT285	0	0	22	22	tiotropium	FEV	PA164769056	54738	0.951
NULL	J_Oncol_2014_Sep_24_2014_767652.nxml.txt.nlp	25328521	SENT27	20	20	6	6	cisplatin	NK1	PA449014	11126	0.951
NULL	Mol_Cancer_2009_Aug_25_8_66.nxml.txt.nlp	19706164	SENT98	13	13	25	25	celecoxib	FBS	PA448871	64319;26269	0.951
NULL	Oncotarget_2011_Dec_24_2(12)_896-917.nxml.txt.nlp	22203527	SENT207	20	20	7	7	doxorubicin	CD44	PA449412	960	0.951
NULL	Br_J_Cancer_2013_Jul_23_109(2)_502-511.nxml.txt.nlp	23799850	SENT239	13	13	9	9	gemcitabine	SMARCC1	PA449748	6599	0.951
NULL	J_Neuroinflammation_2011_Feb_4_8_10.nxml.txt.nlp	21294877	SENT8	15	15	5	5	capsaicin	NK1	PA448776	11126	0.951
NULL	Tuberc_Respir_Dis_(Seoul)_2014_Mar_29_76(3)_114-119.nxml.txt.nlp	24734098	SENT128	11	11	31	31	erlotinib	EGFR	PA134687924	1956	0.951
NULL	Oncol_Rep_2014_Sep_2_32(3)_887-892.nxml.txt.nlp	24994673	SENT107	26	26	14	14	oxaliplatin	DPD	PA131285527	1806	0.951
NULL	Acta_Pharmacol_Sin_2014_Aug_30_35(8)_1045-1054.nxml.txt.nlp	24976155	SENT167	2	2	9	9	resveratrol	STAT3		6774	0.951
NULL	J_Hematol_Oncol_2010_Oct_31_3_43.nxml.txt.nlp	21034513	SENT145	20	20	4	4	oxaliplatin	p53	PA131285527	7157	0.951
NULL	Mol_Imaging_Radionucl_Ther_2014_Jun_5_23(2)_54-59.nxml.txt.nlp	24963446	SENT54	9	9	0	0	levothyroxine	WBS	PA450221	2006	0.951
NULL	J_Neurodev_Disord_2009_Jun_9_1(2)_158-171.nxml.txt.nlp	19960097	SENT52	7	7	26	26	risperidone	5-HT2A	PA451257	3356	0.951
NULL	Clin_Sarcoma_Res_2013_May_13_3_8.nxml.txt.nlp	23668619	SENT75	4	4	20	20	imatinib	CSF1R	PA10804	1436	0.951
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT107	32	32	24	24	atorvastatin	IL-6	PA448500	3569	0.951
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Nov_29_64(Pt_12)_o2496.nxml.txt.nlp	21581457	SENT73	37	37	29	29	ethanol	mol	PA448073	90527	0.951
NULL	Comput_Struct_Biotechnol_J_2013_Jan_16_3_e201210018.nxml.txt.nlp	24688678	SENT121	11	11	29	29	nadh	PHB	PA164755085	5245	0.951
NULL	Clin_Med_Pathol_2008_Jul_28_1_83-91.nxml.txt.nlp	21876656	SENT168	11	11	4	4	vildagliptin	DPPIV	PA165958346	2191;1803	0.951
NULL	Genome_Med_2009_Sep_4_1(9)_83.nxml.txt.nlp	19732436	SENT305	14	14	3	3	doxorubicin	EEF1A1	PA449412	1915	0.951
NULL	Oncotarget_2013_Nov_20_5(1)_173-184.nxml.txt.nlp	24368422	SENT36	1	1	23	23	chloroquine	LC3	PA448948	84557	0.951
NULL	Acta_Pharmacol_Sin_2013_Apr_18_34(4)_555-560.nxml.txt.nlp	23503472	SENT25	0	0	12	12	cyclosporine	CYP3A5	PA449167	1577	0.951
NULL	Crit_Care_2005_Aug_11_9(1)_86-91.nxml.txt.nlp	15693989	SENT61	9	9	22	22	dantrolene	CHS	PA449208	1130	0.951
NULL	Br_J_Cancer_2010_Jun_29_103(1)_52-60.nxml.txt.nlp	20531411	SENT176	8	8	16	16	gemcitabine	MTD	PA449748	4493	0.951
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT154	3	3	19	19	dasatinib	PP1	PA162372878	5540;5464	0.951
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_16_2013_146142.nxml.txt.nlp	23843863	SENT13	15	15	19	19	ns-398	COX2		4513;5743	0.951
NULL	Arthritis_Res_Ther_2006_Nov_8_8(6)_R167.nxml.txt.nlp	17092341	SENT67	14	14	3	3	rituximab	BAFF	PA451261	10673	0.951
NULL	Cell_Death_Dis_2014_Mar_13_5(3)_e1112.nxml.txt.nlp	24625971	SENT86	23	23	14	14	curcumin	ATF4	PA151958596	468	0.951
NULL	Endocrine_2012_Dec_14_42(3)_622-636.nxml.txt.nlp	22695986	SENT318	9	9	20	20	forskolin	PTH1R	PA146096022	5745	0.951
NULL	J_Gen_Physiol_2008_Nov_132(5)_521-535.nxml.txt.nlp	18852303	SENT323	26	26	18	18	trypsin	CAP2	PA451806	5271;10486	0.951
NULL	Br_J_Clin_Pharmacol_2012_Apr_7_73(4)_518-535.nxml.txt.nlp	22053916	SENT60	13	13	23	23	lovastatin	CYP3A4	PA450272	1576	0.951
NULL	Environ_Health_Perspect_2005_Aug_15_113(8)_1009-1014.nxml.txt.nlp	16079071	SENT154	1	1	4	4	losartan	p38	PA450268	10598;1432;7965	0.951
NULL	Arthritis_Rheumatol_2014_Jun_27_66(6)_1574-1582.nxml.txt.nlp	24577881	SENT166	14	14	8	8	hydralazine	CD4	PA449894	920	0.951
NULL	Arch_Drug_Inf_2009_Sep_2(3)_41-50.nxml.txt.nlp	19915711	SENT12	14	14	5	5	atenolol	FGFBP2	PA448499	83888	0.951
NULL	Mol_Vis_2012_May_1_18_1115-1122.nxml.txt.nlp	22605923	SENT108	20	20	4	4	estradiol	IL-6	PA449503	3569	0.951
NULL	Breast_Cancer_Res_2010_Dec_20_12(Suppl_4)_S23.nxml.txt.nlp	21172086	SENT33	4	4	10	10	lapatinib	HER-2	PA152241907	2064	0.951
NULL	Behav_Genet_2008_Jul_7_38(4)_396-406.nxml.txt.nlp	18461434	SENT192	21	21	1	1	glucose	GLUT8	PA449773	29988;154091	0.951
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_13_2013_468537.nxml.txt.nlp	23956772	SENT141	2	2	27	27	paclitaxel	PUMA	PA450761	27113	0.951
NULL	Mol_Cells_2014_Mar_31_37(3)_234-240.nxml.txt.nlp	24642709	SENT129	16	16	19	19	capsaicin	HO-1	PA448776	3162	0.951
NULL	Exp_Ther_Med_2014_Aug_4_8(2)_657-661.nxml.txt.nlp	25009636	SENT9	17	17	2	2	propofol	CCL2	PA451141	6347	0.951
NULL	Case_Rep_Hematol_2013_Oct_9_2013_458303.nxml.txt.nlp	24224106	SENT58	22	22	6	6	imatinib	PDGFRA	PA10804	5156	0.951
NULL	Diabetologia_2009_Oct_14_52(10)_2046-2055.nxml.txt.nlp	19688338	SENT36	0	0	21	21	liraglutide	GLP-1	PA165958364	100125288	0.951
NULL	Breast_Cancer_Res_2005_Dec_17_7(1)_41-42.nxml.txt.nlp	15642182	SENT33	25	25	14	14	paclitaxel	HER2	PA450761	2064	0.951
NULL	Case_Rep_Oncol_Med_2012_Dec_26_2012_390702.nxml.txt.nlp	23326741	SENT59	0	0	34	34	axitinib	CD117	PA164924493	3815	0.951
NULL	J_Cell_Biol_2003_Dec_8_163(5)_1099-1109.nxml.txt.nlp	14662748	SENT162	32	32	3	3	forskolin	AQP2	PA146096022	359	0.951
NULL	Oncol_Lett_2013_Oct_26_6(4)_1063-1067.nxml.txt.nlp	24137465	SENT99	18	18	27	27	sirolimus	HER2	PA451365	2064	0.951
NULL	Br_J_Pharmacol_2012_Apr_165(7)_2191-2202.nxml.txt.nlp	21958009	SENT168	12	12	6	6	ketanserin	5-HT2A	PA131053734	3356	0.951
NULL	Basic_Clin_Neurosci_2014_Winter_5(1)_66-73.nxml.txt.nlp	25436086	SENT110	0	0	6	6	lidocaine	LHA	PA450226	1081	0.951
NULL	Eur_J_Clin_Pharmacol_2013_Mar_11_69(3)_327-339.nxml.txt.nlp	22782539	SENT30	6	6	14	14	dabigatran	P-gp		5243	0.951
NULL	Acta_Neuropathol_2015_Oct_17_129_81-96.nxml.txt.nlp	25322817	SENT271	9	9	0	0	capsaicin	TRPV1	PA448776	7442	0.951
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2675-2684.nxml.txt.nlp	24129246	SENT205	7	7	39	39	etoposide	p53	PA449552	7157	0.951
NULL	Diagn_Pathol_2007_Dec_19_2_49.nxml.txt.nlp	18093326	SENT76	14	14	10	10	doxorubicin	CHOP	PA449412	1649	0.951
NULL	Oncogene_2009_Feb_5_28(5)_674-685.nxml.txt.nlp	19015634	SENT210	7	7	0	0	mitomycin	FANCA	PA450524	2175	0.951
NULL	Acta_Neuropathol_2008_Jul_19_116(1)_119-124.nxml.txt.nlp	18283468	SENT48	4	4	13	13	chlorpromazine	B12	PA448964	7126;4709	0.951
NULL	Oncol_Rep_2014_Mar_14_31(3)_1035-1042.nxml.txt.nlp	24424445	SENT167	9	9	2	2	cisplatin	ABCG2	PA449014	9429	0.951
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1420-1426.nxml.txt.nlp	24056704	SENT36	6	6	17	17	ketoconazole	CYP3A4	PA450146	1576	0.951
NULL	J_Int_AIDS_Soc_2011_Mar_8_14_11.nxml.txt.nlp	21385405	SENT30	18	18	27	27	nevirapine	CD4	PA450616	920	0.951
NULL	Oxid_Med_Cell_Longev_2012_Aug_22_2012_534705.nxml.txt.nlp	22966415	SENT291	2	2	13	13	riluzole	GLAST	PA451251	6507	0.951
NULL	Adv_Urol_2012_Oct_26_2012_812398.nxml.txt.nlp	22110495	SENT111	40	40	22	22	cisplatin	ERCC1	PA449014	2067	0.951
NULL	Nucleic_Acids_Res_2013_Dec_30_41(22)_10268-10282.nxml.txt.nlp	23997120	SENT216	12	12	7	7	olaparib	TRF1		7013	0.951
NULL	Breast_Cancer_Res_Treat_2012_Jun_15_133(3)_1057-1065.nxml.txt.nlp	22418700	SENT161	4	4	22	22	afatinib	HER2	PA165981154	2064	0.951
NULL	Gut_Liver_2013_Sep_14_7(5)_585-593.nxml.txt.nlp	24073317	SENT26	14	14	31	31	ribavirin	IFN	PA451241	3439	0.951
NULL	Mol_Cell_Biochem_2014_Oct_9_385(1-2)_265-275.nxml.txt.nlp	24104452	SENT231	29	29	20	20	bortezomib	U87	PA10252	677775;641648	0.951
NULL	Breast_Cancer_(Auckl)_2014_Jul_29_8_109-118.nxml.txt.nlp	25125981	SENT97	16	16	25	25	vinorelbine	HER2	PA451881	2064	0.951
NULL	Protein_Cell_2014_Feb_11_5(2)_124-140.nxml.txt.nlp	24515614	SENT285	23	23	3	3	bortezomib	DSS1	PA10252	7979	0.951
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT188	7	7	16	16	gefitinib	HER2	PA131301952	2064	0.951
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_29_2013_590393.nxml.txt.nlp	23737838	SENT8	3	3	21	21	resveratrol	p53		7157	0.951
NULL	J_Cell_Biol_1986_Sep_1_103(3)_1109-1119.nxml.txt.nlp	3528169	SENT8	42	42	3	3	hyaluronidase	STBM	PA164745713	57216	0.951
NULL	Cancers_(Basel)_2011_Sep_13_3(3)_3506-3524.nxml.txt.nlp	24212966	SENT86	23	23	4	4	docetaxel	EGFR	PA449383	1956	0.951
NULL	Drugs_2012_Sep_6_72(9)_e1-e25.nxml.txt.nlp	22686620	SENT514	6	6	10	10	maraviroc	CCR5	PA164768835	1234	0.951
NULL	Drugs_R_D_2014_Dec_30_14(4)_241-251.nxml.txt.nlp	25265895	SENT223	0	0	13	13	propranolol	CYP2C19	PA451145	1557	0.951
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_145-149.nxml.txt.nlp	23864848	SENT10	7	7	16	16	cisplatin	HHM	PA449014	5744	0.951
NULL	Acta_Pharmacol_Sin_2013_Sep_5_34(9)_1229-1236.nxml.txt.nlp	23892269	SENT32	5	5	10	10	ketoconazole	CYP3A	PA450146	1574	0.951
NULL	Acta_Pharmacol_Sin_2011_Jul_9_32(7)_879-887.nxml.txt.nlp	21552292	SENT142	6	6	10	10	metformin	AMPK	PA450395	5563	0.951
NULL	Int_J_Biomed_Imaging_2013_Feb_26_2013_230487.nxml.txt.nlp	23533377	SENT153	1	1	9	9	pertuzumab	HER2		2064	0.951
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Feb_15_5_3.nxml.txt.nlp	16480505	SENT176	0	0	5	5	cyclosporine	CYP3A4	PA449167	1576	0.951
NULL	Front_Oncol_2014_Apr_9_4_75.nxml.txt.nlp	24782986	SENT183	13	13	5	5	paclitaxel	Oct4	PA450761	5460	0.951
NULL	Int_J_Mol_Sci_2012_Sep_5_13(9)_11012-11026.nxml.txt.nlp	23109835	SENT140	25	25	11	11	cisplatin	DDB2	PA449014	1643	0.951
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jul_16_67(Pt_8)_o2069.nxml.txt.nlp	22091093	SENT52	15	15	39	39	benzaldehyde	mol	PA448571	90527	0.951
NULL	Oncoimmunology_2013_Dec_1_2(12)_e26662.nxml.txt.nlp	24498551	SENT90	18	18	12	12	gemcitabine	LAK	PA449748	10123	0.951
NULL	Arthritis_Res_Ther_2009_Nov_13_11(6)_R172.nxml.txt.nlp	19912653	SENT186	7	7	2	2	simvastatin	IVD	PA451363	3712	0.951
NULL	Clin_Ophthalmol_2014_Sep_1_8_1681-1687.nxml.txt.nlp	25214761	SENT21	43	43	28	28	brimonidine	BAK	PA448665	578	0.951
NULL	AIDS_Res_Treat_2014_Nov_9_2014_724958.nxml.txt.nlp	25431661	SENT185	4	4	14	14	efavirenz	CD4	PA449441	920	0.951
NULL	Oncotarget_2014_Nov_8_5(21)_10280-10292.nxml.txt.nlp	25373733	SENT196	10	10	8	8	bortezomib	HIF-1	PA10252	29072	0.951
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Aug_27_67(Pt_9)_o2403.nxml.txt.nlp	22058995	SENT66	38	38	9	9	ethanol	mol	PA448073	90527	0.951
NULL	Blood_Cancer_J_2013_Aug_2_3(8)_e130.nxml.txt.nlp	23912610	SENT27	0	0	7	7	tacrolimus	WT1	PA451578	7490	0.951
NULL	Oncogene_2014_Aug_21_33(34)_4316-4329.nxml.txt.nlp	24362530	SENT46	27	27	0	0	epirubicin	FOXM1	PA449476	2305	0.951
NULL	Mol_Cytogenet_2013_Mar_6_6_11.nxml.txt.nlp	23497671	SENT67	17	17	0	0	trypsin	ENTK	PA451806	5651	0.951
NULL	Exp_Diabetes_Res_2012_Oct_15_2012_465282.nxml.txt.nlp	23118742	SENT97	13	13	27	27	metformin	AMPK	PA450395	5563	0.951
NULL	Br_J_Pharmacol_2011_Nov_164(5)_1522-1533.nxml.txt.nlp	21557728	SENT143	8	8	3	3	cangrelor	ADP	PA165945763	23038	0.951
NULL	Evid_Based_Complement_Alternat_Med_2011_Feb_14_2011_248231.nxml.txt.nlp	19233878	SENT267	34	34	24	24	rosiglitazone	DBT	PA451283	1629	0.951
NULL	Ann_Dermatol_2014_Aug_31_26(4)_517-520.nxml.txt.nlp	25143685	SENT50	23	23	5	5	tazarotene	TIG3	PA164746821	5920	0.951
NULL	J_Vet_Med_Sci_2014_Apr_12_76(4)_509-516.nxml.txt.nlp	24334855	SENT9	12	12	24	24	fluorescein	LAMP	PA164746009	4045;27074	0.951
NULL	J_Bras_Pneumol_2013_Jan-Feb_39(1)_5-15.nxml.txt.nlp	23503480	SENT223	33	33	18	18	doxycycline	LAM	PA449415	7249;7248	0.951
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_91-103.nxml.txt.nlp	17912639	SENT102	16	16	5	5	tamoxifen	HER2	PA451581	2064	0.951
NULL	Br_J_Cancer_2012_Oct_9_107(8)_1249-1256.nxml.txt.nlp	22955858	SENT144	18	18	9	9	tamoxifen	aromatase	PA451581	1588	0.951
NULL	Clin_Med_Insights_Cardiol_2011_Oct_6_5_103-119.nxml.txt.nlp	22084608	SENT40	0	0	34	34	dronedarone	CYP3A4	PA153619853	1576	0.951
NULL	Cancers_(Basel)_2014_Aug_12_6(3)_1631-1669.nxml.txt.nlp	25119536	SENT328	2	2	18	18	nilotinib	p38	PA165958345	10598;1432;7965	0.951
NULL	J_Gynecol_Oncol_2013_Jan_8_24(1)_66-82.nxml.txt.nlp	23346316	SENT245	21	21	15	15	anastrozole	aromatase	PA448432	1588	0.951
NULL	Tumour_Biol_2012_Jun_21_33(3)_607-615.nxml.txt.nlp	22270450	SENT41	20	20	18	18	afatinib	HER2	PA165981154	2064	0.951
NULL	J_Korean_Med_Sci_2007_Apr_30_22(2)_283-289.nxml.txt.nlp	17449938	SENT113	21	21	3	3	minoxidil	P21	PA450521	1026;9338	0.951
NULL	Aging_(Albany_NY)_2009_Feb_18_1(3)_335-349.nxml.txt.nlp	20195489	SENT199	2	2	40	40	etoposide	p65	PA449552	5970	0.951
NULL	J_Korean_Med_Sci_2006_Jun_21_21(3)_460-468.nxml.txt.nlp	16778390	SENT156	13	13	25	25	tamoxifen	p52	PA451581	11168;4791	0.951
NULL	Nat_Med_2012_Jul_18(7)_1118-1122.nxml.txt.nlp	22683780	SENT64	41	41	36	36	crizotinib	HGF	PA165946122	3569;6654;3082	0.951
NULL	Protein_Cell_2014_Oct_8_5(10)_750-760.nxml.txt.nlp	25000876	SENT105	22	22	11	11	hydroxyurea	MMS19	PA449942	64210	0.951
NULL	Evid_Based_Complement_Alternat_Med_2011_Mar_1_2011_207034.nxml.txt.nlp	21423686	SENT115	28	28	5	5	clopidogrel	CYP2C19	PA449053	1557	0.951
NULL	J_Thorac_Oncol_2015_Jan_29_10(1)_156-163.nxml.txt.nlp	25247337	SENT297	6	6	16	16	gefitinib	EGF	PA131301952	1950	0.951
NULL	Core_Evid_2008_Jun_3(1)_31-43.nxml.txt.nlp	20694082	SENT286	1	1	9	9	conivaptan	CYP3A4	PA164742939	1576	0.951
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT134	20	20	6	6	erlotinib	AMPK	PA134687924	5563	0.951
NULL	Oncotarget_2011_Dec_21_2(12)_1134-1144.nxml.txt.nlp	22193779	SENT132	15	15	5	5	gefitinib	PC3	PA131301952	57332;7832;5122	0.951
NULL	Ann_Oncol_2014_Oct_23_25(10)_1941-1948.nxml.txt.nlp	25057173	SENT14	27	27	14	14	docetaxel	EGFR	PA449383	1956	0.951
NULL	Cancer_Cell_Int_2009_Jun_10_9_16.nxml.txt.nlp	19508737	SENT337	7	7	38	38	vinblastine	p53	PA451877	7157	0.951
NULL	Cancer_Med_2012_Oct_16_1(2)_207-217.nxml.txt.nlp	23342270	SENT204	40	40	6	6	saracatinib	LRRC19		64922	0.951
NULL	Cancer_Cell_Int_2014_Jun_11_14_49.nxml.txt.nlp	24991192	SENT76	19	19	3	3	berberine	AMPK	PA165860812	5563	0.951
NULL	Breast_Cancer_Res_2014_May_28_16(3)_R53.nxml.txt.nlp	24886537	SENT305	26	26	15	15	erlotinib	VAV3	PA134687924	10451	0.951
NULL	Breast_Cancer_Res_2010_Jul_22_12(4)_R53.nxml.txt.nlp	20649975	SENT28	24	24	7	7	tamoxifen	HOXB13	PA451581	10481	0.951
NULL	J_Health_Popul_Nutr_2007_Jun_25(2)_179-188.nxml.txt.nlp	17985819	SENT69	25	25	5	5	chloramphenicol	Spn	PA448927	84687	0.951
NULL	Emerg_Microbes_Infect_2014_Sep_3_3(9)_e62.nxml.txt.nlp	NULL	SENT114	12	12	0	0	suramin	CYP1A2	PA10292	1544	0.951
NULL	J_Immunother_Cancer_2013_Jul_15_1_10.nxml.txt.nlp	24829747	SENT42	7	7	26	26	sildenafil	NOS2	PA451346	339345;4843	0.951
NULL	Int_J_Trichology_2014_Jan-Mar_6(1)_23-24.nxml.txt.nlp	25114450	SENT34	28	28	22	22	erlotinib	EGFR	PA134687924	1956	0.951
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT285	28	28	6	6	pp2	Bcl-2		596	0.951
NULL	Case_Rep_Oncol_2014_Jun_18_7(2)_393-400.nxml.txt.nlp	25076890	SENT79	23	23	9	9	erlotinib	EGFR	PA134687924	1956	0.951
NULL	Oncoimmunology_2013_Jan_1_2(1)_e22840.nxml.txt.nlp	23482926	SENT171	22	22	35	35	erlotinib	EGFR	PA134687924	1956	0.951
NULL	Diabetes_Care_2012_Feb_16_35(2)_327-333.nxml.txt.nlp	22179958	SENT80	18	18	31	31	metformin	B12	PA450395	7126;4709	0.951
NULL	Evid_Based_Complement_Alternat_Med_2011_Jan_20_2011_751671.nxml.txt.nlp	21318106	SENT139	6	6	33	33	tacrolimus	CYP3A4	PA451578	1576	0.951
NULL	Int_Semin_Surg_Oncol_2008_Apr_28_5_9.nxml.txt.nlp	18442393	SENT92	33	33	12	12	tamoxifen	aromatase	PA451581	1588	0.951
NULL	Arch_Drug_Inf_2008_Sep_1(2)_56-62.nxml.txt.nlp	19915709	SENT51	4	4	21	21	fentanyl	CYP3A4	PA449599	1576	0.951
NULL	Dement_Geriatr_Cogn_Dis_Extra_2014_Nov_15_4(3)_450-456.nxml.txt.nlp	25538729	SENT100	27	27	40	40	donepezil	CYP2D6	PA449394	1565	0.951
NULL	Nat_Biotechnol_2013_Jul_30_31(7)_630-637.nxml.txt.nlp	23811600	SENT200	5	5	16	16	crizotinib	ABL1	PA165946122	25	0.951
NULL	Breast_Cancer_Res_2007_May_19_9(3)_R31.nxml.txt.nlp	17511881	SENT32	17	17	4	4	trastuzumab	HER2	PA451743	2064	0.951
NULL	Breast_Cancer_Res_2011_Jan_11_13(1)_R3.nxml.txt.nlp	21223569	SENT185	18	18	9	9	etoposide	p53	PA449552	7157	0.951
NULL	J_Carcinog_2014_Nov_27_13_13.nxml.txt.nlp	25525412	SENT113	6	6	18	18	cetuximab	KRAS	PA10040	3845	0.951
NULL	J_Headache_Pain_2010_Apr_30_11(2)_157-160.nxml.txt.nlp	20119679	SENT44	4	4	16	16	indomethacin	COX	PA449982	1351	0.951
NULL	Br_J_Cancer_2004_Mar_5_90(Suppl_1)_S2-S6.nxml.txt.nlp	15094757	SENT65	18	18	23	23	tamoxifen	AF1	PA451581	1946	0.951
NULL	Int_J_Biomed_Imaging_2013_Feb_26_2013_230487.nxml.txt.nlp	23533377	SENT151	1	1	18	18	trastuzumab	HER2	PA451743	2064	0.951
NULL	Pharmaceutics_2011_Aug_24_3(3)_510-524.nxml.txt.nlp	24310594	SENT35	0	0	21	21	trastuzumab	HER2	PA451743	2064	0.951
NULL	Tuberc_Respir_Dis_(Seoul)_2013_Jul_31_75(1)_9-17.nxml.txt.nlp	23946753	SENT124	7	7	39	39	erlotinib	Bcl-2	PA134687924	596	0.951
NULL	Br_J_Clin_Pharmacol_2013_Aug_23_76(2)_299-315.nxml.txt.nlp	23701319	SENT176	30	30	1	1	rituximab	CD4	PA451261	920	0.951
NULL	J_Hematop_2009_Feb_28_2(2)_113-119.nxml.txt.nlp	19669197	SENT182	8	8	2	2	flavopiridol	Bcl-2	PA452627	596	0.951
NULL	Case_Rep_Rheumatol_2014_Nov_11_2014_536856.nxml.txt.nlp	25436167	SENT23	0	0	3	3	infliximab	TNF	PA452639	7124	0.951
NULL	Breast_Cancer_Res_2012_Apr_4_14(2)_R57.nxml.txt.nlp	22475046	SENT39	14	14	4	4	tamoxifen	CCND1	PA451581	595	0.951
NULL	J_Invest_Dermatol_2012_Jan_18_132(1)_163-169.nxml.txt.nlp	21850019	SENT78	9	9	33	33	imiquimod	IL-2	PA449972	3558	0.951
NULL	Br_J_Pharmacol_2008_Oct_18_155(4)_596-605.nxml.txt.nlp	18852694	SENT224	2	2	11	11	fenofibrate	PCSK9	PA449594	255738	0.951
NULL	Am_J_Cardiovasc_Drugs_2013_Jun_20_13(5)_331-342.nxml.txt.nlp	23784266	SENT17	7	7	3	3	verapamil	P-gp	PA451868	5243	0.951
NULL	Br_J_Cancer_2010_Jan_19_102(2)_403-413.nxml.txt.nlp	19997104	SENT75	1	1	6	6	ethanol	CO2	PA448073	4513	0.951
NULL	Int_J_Gen_Med_2010_Nov_19_3_379-382.nxml.txt.nlp	21189835	SENT57	6	6	12	12	atorvastatin	JBS	PA448500	3719	0.951
NULL	Arthritis_Res_Ther_2009_Aug_28_11(4)_R131.nxml.txt.nlp	19715572	SENT97	3	3	12	12	rituximab	CD27	PA451261	939	0.951
NULL	Am_J_Cardiovasc_Drugs_2013_Jun_20_13(5)_331-342.nxml.txt.nlp	23784266	SENT226	26	26	24	24	quinidine	P-gp	PA451209	5243	0.951
NULL	Cardiovasc_Drugs_Ther_2014_Aug_28_28(5)_477-488.nxml.txt.nlp	25163464	SENT29	1	1	26	26	vasopressin	ACTH	PA451858	5443	0.951
NULL	Br_J_Cancer_2011_Apr_12_104(8)_1278-1287.nxml.txt.nlp	21487429	SENT248	23	23	11	11	cisplatin	p53	PA449014	7157	0.951
NULL	Arthritis_Res_Ther_2012_Sep_24_14(5)_R200.nxml.txt.nlp	23006144	SENT20	7	7	30	30	alefacept	IL-20	PA164748040	27190;50604	0.951
NULL	Ann_Gen_Psychiatry_2014_Apr_1_13_10.nxml.txt.nlp	24690136	SENT174	0	0	14	14	aripiprazole	5-HT2A	PA10026	3356	0.951
NULL	Diabetes_2009_Dec_31_58(12)_2851-2862.nxml.txt.nlp	19720788	SENT223	27	27	6	6	forskolin	Bcl-2	PA146096022	596	0.951
NULL	J_Thorac_Oncol_2014_Feb_23_9(2)_189-194.nxml.txt.nlp	24419415	SENT23	5	5	34	34	gefitinib	EGFR	PA131301952	1956	0.951
NULL	Cancers_(Basel)_2014_Jul_8_6(3)_1487-1499.nxml.txt.nlp	25006835	SENT54	11	11	2	2	cisplatin	p53	PA449014	7157	0.951
NULL	Mol_Cancer_2009_Dec_23_8_129.nxml.txt.nlp	20030852	SENT152	11	11	31	31	curcumin	CXCL1	PA151958596	2919	0.951
NULL	Br_J_Cancer_2009_Jul_21_101(2)_269-277.nxml.txt.nlp	19603033	SENT79	5	5	0	0	cisplatin	MLH1	PA449014	4292	0.951
NULL	J_Neuroinflammation_2010_Sep_7_7_51.nxml.txt.nlp	20822529	SENT101	3	3	27	27	hemin	HO-1	PA449849	3162	0.951
NULL	Clin_Ophthalmol_2014_Jun_3_8_1057-1064.nxml.txt.nlp	24940042	SENT8	1	1	32	32	bevacizumab	CST	PA130232992	9514	0.951
NULL	Front_Immunol_2013_Mar_27_4_76.nxml.txt.nlp	23543707	SENT122	7	7	20	20	cetuximab	KRAS	PA10040	3845	0.951
NULL	Dement_Geriatr_Cogn_Dis_Extra_2014_Nov_15_4(3)_450-456.nxml.txt.nlp	25538729	SENT30	5	5	9	9	donepezil	APOE	PA449394	348	0.951
NULL	Acta_Pharmacol_Sin_2011_May_18_32(5)_591-600.nxml.txt.nlp	21499286	SENT247	8	8	20	20	bezafibrate	AMPK	PA162364313	5563	0.951
NULL	Arthritis_Res_Ther_2006_Dec_28_8(1)_R18.nxml.txt.nlp	16507118	SENT160	29	29	10	10	infliximab	IL-15	PA452639	3600	0.951
NULL	Br_J_Cancer_2012_Jan_3_106(1)_18-24.nxml.txt.nlp	22108516	SENT108	16	16	6	6	irinotecan	TDP1	PA450085	55775	0.951
NULL	Cancer_Manag_Res_2013_Nov_21_5_387-400.nxml.txt.nlp	24294007	SENT38	34	34	4	4	cetuximab	EGFR	PA10040	1956	0.951
NULL	Acta_Pharmacol_Sin_2009_Sep_24_30(9)_1262-1275.nxml.txt.nlp	19701231	SENT222	14	14	2	2	lovastatin	HIST1H2BD	PA450272	3017	0.951
NULL	Infect_Dis_Ther_2013_Dec_2_2(2)_123-144.nxml.txt.nlp	25134476	SENT262	38	38	9	9	nevirapine	CYP3A4	PA450616	1576	0.951
NULL	Am_J_Trop_Med_Hyg_2012_Aug_1_87(2)_231-241.nxml.txt.nlp	22855752	SENT16	30	30	0	0	piperaquine	ACT	PA166104279	12;11332;9457;641455	0.951
NULL	Nucleic_Acids_Res_2013_Oct_17_41(18)_8601-8614.nxml.txt.nlp	23863842	SENT213	17	17	36	36	tamoxifen	JAG1	PA451581	182	0.951
NULL	Ther_Clin_Risk_Manag_2006_Mar_2(1)_19-24.nxml.txt.nlp	18360578	SENT35	10	10	6	6	itraconazole	CYP3A4	PA450132	1576	0.951
NULL	Mol_Biol_Cell_2014_Jan_1_25(1)_145-159.nxml.txt.nlp	24196833	SENT250	18	18	5	5	valinomycin	p62	PA151917011	8878;10657;23636	0.951
NULL	Adv_Urol_2012_Oct_26_2012_812398.nxml.txt.nlp	22110495	SENT98	26	26	9	9	gemcitabine	ERCC1	PA449748	2067	0.951
NULL	Can_J_Infect_Dis_Med_Microbiol_2014_Nov-Dec_25(6)_327-343.nxml.txt.nlp	25587296	SENT114	0	0	14	14	voriconazole	CYP2C19	PA10233	1557	0.951
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT130	17	17	11	11	resveratrol	IL-6		3569	0.951
NULL	Int_Neurourol_J_2014_Sep_24_18(3)_115-125.nxml.txt.nlp	25279238	SENT122	29	29	10	10	berberine	CA1	PA165860812	759	0.951
NULL	Mol_Cancer_2014_Jun_19_13_154.nxml.txt.nlp	24941944	SENT160	24	24	10	10	methotrexate	BRAF	PA450428	673	0.951
NULL	Cell_Death_Differ_2010_Oct_30_17(10)_1624-1635.nxml.txt.nlp	20431602	SENT280	8	8	28	28	paclitaxel	Mcl-1	PA450761	4170	0.951
NULL	Mol_Cancer_2010_Apr_12_9_75.nxml.txt.nlp	20385023	SENT188	7	7	22	22	imatinib	AKT	PA10804	207	0.951
NULL	Oncotarget_2012_Jan_28_3(1)_78-83.nxml.txt.nlp	22289679	SENT2	12	12	5	5	paclitaxel	PLK2	PA450761	10769	0.951
NULL	Nucl_Recept_Signal_2009_Jan_16_7_e001.nxml.txt.nlp	19240808	SENT403	6	6	26	26	tamoxifen	SXR	PA451581	8856	0.951
NULL	J_Hematol_Oncol_2009_Feb_23_2_10.nxml.txt.nlp	19236716	SENT113	23	23	6	6	dasatinib	CYP3A4	PA162372878	1576	0.951
NULL	Front_Neurosci_2014_Dec_16_8_416.nxml.txt.nlp	25565946	SENT161	40	40	30	30	fluoxetine	IL-6	PA449673	3569	0.951
NULL	Vet_Res_Forum_2013_Winter_4(1)_19-24.nxml.txt.nlp	25593681	SENT43	21	21	14	14	diclofenac	B12	PA449293	7126;4709	0.951
NULL	Arch_Drug_Inf_2008_Dec_1(3)_97-106.nxml.txt.nlp	19639031	SENT33	2	2	10	10	sn-38	UGT1A1		54658	0.951
NULL	Mol_Cancer_2006_Oct_17_5_45.nxml.txt.nlp	17044934	SENT13	9	9	1	1	resveratrol	COX		1351	0.951
NULL	Mol_Cancer_2009_May_15_8_28.nxml.txt.nlp	19445670	SENT73	38	38	30	30	doxorubicin	XIAP	PA449412	331	0.951
NULL	Adv_Hematol_2010_Dec_21_2010_320624.nxml.txt.nlp	21253465	SENT25	8	8	2	2	vincristine	CHOP	PA451879	1649	0.951
NULL	J_Vis_Exp_2014_Mar_28_(85)_51300.nxml.txt.nlp	24747269	SENT286	12	12	2	2	thrombin	Rho	PA451674	29984	0.951
NULL	Curr_Neuropharmacol_2013_Jul_11(4)_338-378.nxml.txt.nlp	24381528	SENT576	14	14	28	28	curcumin	Bcl-2	PA151958596	596	0.951
NULL	Mol_Cancer_2009_Aug_25_8_66.nxml.txt.nlp	19706164	SENT125	13	13	25	25	celecoxib	FBS	PA448871	64319;26269	0.951
NULL	Pharmaceutics_2011_Oct_12_3(4)_680-705.nxml.txt.nlp	24309303	SENT69	22	22	1	1	glibenclamide	OATP2B1	PA449782	11309	0.951
NULL	Clin_Cosmet_Investig_Dermatol_2013_Mar_14_6_75-80.nxml.txt.nlp	23515267	SENT84	0	0	13	13	infliximab	IL-23	PA452639	51561	0.951
NULL	Br_J_Cancer_2013_Jul_23_109(2)_351-359.nxml.txt.nlp	23799854	SENT146	26	26	5	5	paclitaxel	MDR1	PA450761	5243	0.951
NULL	Diabetes_Care_2012_Jun_11_35(6)_1364-1379.nxml.txt.nlp	22517736	SENT560	24	24	35	35	metformin	Met	PA450395	79811	0.951
NULL	Ann_Rheum_Dis_2009_Oct_17_68(10)_1580-1584.nxml.txt.nlp	19019888	SENT129	23	23	0	0	tocilizumab	ACR	PA165292659	49	0.951
NULL	Drugs_R_D_2011_Jun_27_11(2)_101-111.nxml.txt.nlp	21679003	SENT264	11	11	3	3	cetuximab	BRAF	PA10040	673	0.951
NULL	Clin_Pharmacokinet_2014_Jan_16_53(3)_213-225.nxml.txt.nlp	24430725	SENT190	43	43	7	7	verapamil	P-gp	PA451868	5243	0.951
NULL	Clin_Interv_Aging_2014_Apr_8_9_593-601.nxml.txt.nlp	24748777	SENT9	0	0	24	24	denosumab	RANKL	PA166048634	8600	0.951
NULL	Stroke_Res_Treat_2011_Jan_20_2011_712903.nxml.txt.nlp	21331163	SENT301	4	4	14	14	collagenase	MMP9	PA449107	4318	0.951
NULL	Clin_Med_Insights_Oncol_2012_Feb_28_6_125-135.nxml.txt.nlp	22408376	SENT28	0	0	18	18	panitumumab	EGFR	PA162373091	1956	0.951
NULL	J_Pain_Res_2014_Jan_20_7_71-79.nxml.txt.nlp	24470772	SENT93	27	27	0	0	capsaicin	TRPV1	PA448776	7442	0.951
NULL	Br_J_Cancer_2010_Jan_19_102(2)_268-275.nxml.txt.nlp	20010948	SENT142	10	10	26	26	sorafenib	CD133	PA7000	8842	0.951
NULL	Acta_Pharmacol_Sin_2012_May_4_33(5)_644-651.nxml.txt.nlp	22555371	SENT128	23	23	11	11	irbesartan	eNOS	PA450084	4846	0.951
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT162	13	13	9	9	sitagliptin	HIP	PA164748978	6767;6159;64399;5068	0.951
NULL	J_Cancer_2013_Nov_14_4(9)_703-715.nxml.txt.nlp	24312140	SENT223	26	26	7	7	curcumin	BRCA1	PA151958596	672	0.951
NULL	Mol_Cancer_2012_Jul_12_11_45.nxml.txt.nlp	22788833	SENT107	3	3	17	17	cisplatin	EGFR	PA449014	1956	0.951
NULL	Clin_Psychopharmacol_Neurosci_2012_Apr_30_10(1)_25-33.nxml.txt.nlp	23429852	SENT97	21	21	12	12	haloperidol	SNAP-25	PA449841	6616	0.951
NULL	Breast_Cancer_Res_2002_Apr_4_4(3)_85-89.nxml.txt.nlp	12052249	SENT40	19	19	4	4	tamoxifen	SULT1A1	PA451581	6817	0.951
NULL	AIDS_Res_Treat_2012_May_20_2012_953678.nxml.txt.nlp	22666564	SENT121	34	34	13	13	naloxone	CCR5	PA450586	1234	0.951
NULL	Br_J_Pharmacol_2012_Oct_167(3)_505-514.nxml.txt.nlp	22506619	SENT159	44	44	42	42	indomethacin	COX	PA449982	1351	0.951
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT53	38	38	18	18	pertuzumab	HER3		2065	0.951
NULL	Clin_Exp_Otorhinolaryngol_2012_Sep_27_5(3)_117-121.nxml.txt.nlp	22977707	SENT12	39	39	9	9	kanamycin	NKCC1	PA450137	6558	0.951
NULL	Hum_Genomics_2009_Dec_1_4(2)_91-106.nxml.txt.nlp	20038497	SENT66	2	2	13	13	galantamine	CYP2D6	PA449726	1565	0.951
NULL	Br_J_Cancer_2013_Feb_5_108(2)_461-468.nxml.txt.nlp	23149842	SENT155	20	20	12	12	cisplatin	BRCA2	PA449014	675	0.951
NULL	Leukemia_2014_Aug_4_28(8)_1573-1585.nxml.txt.nlp	24496300	SENT218	10	10	1	1	ketoconazole	P-gp	PA450146	5243	0.951
NULL	J_Biol_Chem_2013_Jan_4_288(1)_561-569.nxml.txt.nlp	23139420	SENT54	3	3	18	18	doxycycline	GCH1	PA449415	2643	0.951
NULL	Oncotarget_2014_Oct_21_5(22)_11180-11192.nxml.txt.nlp	25361003	SENT111	10	10	33	33	tetracycline	NTRK1	PA451640	4914	0.951
NULL	Open_Biochem_J_2011_Sep_23_5_45-51.nxml.txt.nlp	21966325	SENT200	19	19	5	5	indomethacin	CHOP	PA449982	1649	0.951
NULL	JRSM_Cardiovasc_Dis_2012_Sep_24_1(6)_cvd_2012_012015.nxml.txt.nlp	24175073	SENT145	27	27	15	15	clopidogrel	CYP2C19	PA449053	1557	0.951
NULL	Breast_Cancer_Res_2012_Feb_14_14(1)_R30.nxml.txt.nlp	22333315	SENT242	17	17	3	3	celecoxib	COX	PA448871	1351	0.951
NULL	J_Infect_Dis_2012_Apr_15_205(8)_1278-1286.nxml.txt.nlp	22396598	SENT159	17	17	6	6	proguanil	DHODH	PA451124	1723	0.951
NULL	Br_J_Pharmacol_2010_Sep_161(2)_241-270.nxml.txt.nlp	20735414	SENT258	11	11	24	24	choline	LPA	PA448976	4018	0.951
NULL	Curr_Clin_Pharmacol_2008_Sep_3(3)_198-203.nxml.txt.nlp	18781906	SENT119	3	3	20	20	levetiracetam	CYP3A4	PA450206	1576	0.951
NULL	Acta_Pharmacol_Sin_2009_Feb_26_30(2)_175-183.nxml.txt.nlp	19169269	SENT9	3	3	22	22	iptakalim	P54	PA165949694	2289;4841	0.951
NULL	Arthritis_Res_2001_Jan_26_3(Suppl_A)_P094.nxml.txt.nlp	NULL	SENT11	28	28	20	20	pamidronate	OPG	PA450767	690	0.951
NULL	Biotechnol_Res_Int_2013_Dec_1_2013_253286.nxml.txt.nlp	24363937	SENT100	7	7	3	3	phosphorus	DAP	PA450954	23549;3375;1611	0.951
NULL	Clin_Ophthalmol_2008_Jun_2(2)_339-346.nxml.txt.nlp	19668725	SENT127	8	8	26	26	pegaptanib	VEGF-A	PA164771236	7422	0.951
NULL	Chem_Rev_2014_Jun_11_114(11)_5753-5774.nxml.txt.nlp	24758331	SENT212	31	31	15	15	verapamil	P-gp	PA451868	5243	0.951
NULL	Diabetes_Metab_J_2012_Oct_18_36(5)_328-335.nxml.txt.nlp	23130316	SENT137	28	28	8	8	rosiglitazone	PDK4	PA451283	5166	0.951
NULL	Mol_Cancer_2014_Jul_5_13_165.nxml.txt.nlp	24996221	SENT81	26	26	16	16	docetaxel	HMGB1	PA449383	3146	0.951
NULL	Oncol_Lett_2013_Feb_5_5(2)_424-426.nxml.txt.nlp	23420786	SENT67	15	15	26	26	dacarbazine	BRAF	PA449197	673	0.951
NULL	Cell_Death_Dis_2014_Jan_30_5(1)_e1030.nxml.txt.nlp	24481444	SENT111	28	28	14	14	sorafenib	Bcl-2	PA7000	596	0.951
NULL	Front_Oncol_2013_Oct_9_3_261.nxml.txt.nlp	24130964	SENT213	11	11	20	20	vorinostat	EGFR	PA164748224	1956	0.951
NULL	Reprod_Biol_Endocrinol_2003_Oct_9_1_74.nxml.txt.nlp	14613550	SENT13	10	10	6	6	diclofenac	COX	PA449293	1351	0.951
NULL	Diabetes_Metab_Syndr_Obes_2009_Jul_21_2_117-126.nxml.txt.nlp	21437125	SENT161	14	14	5	5	vildagliptin	DPP4	PA165958346	1803	0.951
NULL	Curr_Opin_Lipidol_2014_Oct_4_25(5)_387-393.nxml.txt.nlp	25110901	SENT101	16	16	5	5	berberine	PCSK9	PA165860812	255738	0.951
NULL	Target_Oncol_2013_Jun_27_8(2)_127-136.nxml.txt.nlp	23625191	SENT126	9	9	43	43	panitumumab	KRAS	PA162373091	3845	0.951
NULL	Diabetol_Metab_Syndr_2014_Mar_31_6_47.nxml.txt.nlp	24684779	SENT105	5	5	17	17	pioglitazone	CD68	PA450970	968	0.951
NULL	Cell_Death_Dis_2014_Jan_16_5(1)_e1000.nxml.txt.nlp	24434508	SENT179	34	34	6	6	collagenase	p53	PA449107	7157	0.951
NULL	Chin_J_Cancer_2012_Jun_31(6)_266-280.nxml.txt.nlp	22313597	SENT282	12	12	7	7	exemestane	IGFBP5	PA449563	3488	0.951
NULL	J_Hematol_Oncol_2014_Aug_1_7_52.nxml.txt.nlp	25085632	SENT166	14	14	9	9	sunitinib	PTEN	PA162372840	5728	0.951
NULL	Exp_Ther_Med_2014_Nov_29_8(5)_1473-1478.nxml.txt.nlp	25289044	SENT95	16	16	8	8	heparin	AZU	PA449855	566	0.951
NULL	Iran_Red_Crescent_Med_J_2014_Sep_5_16(9)_e20153.nxml.txt.nlp	25593732	SENT62	8	8	39	39	halothane	CYP2A6	PA449845	1548	0.951
NULL	Cardiol_Res_Pract_2013_Feb_19_2013_195456.nxml.txt.nlp	23533940	SENT131	4	4	22	22	prasugrel	CYP3A4	PA154410481	1576	0.951
NULL	Exp_Mol_Med_2012_Oct_31_44(10)_622-632.nxml.txt.nlp	23095254	SENT116	18	18	13	13	glucose	SOCS-3	PA449773	9021	0.951
NULL	Cell_Death_Dis_2013_Jul_11_4(7)_e719.nxml.txt.nlp	23846221	SENT70	16	16	23	23	cisplatin	XIAP	PA449014	331	0.951
NULL	Acta_Pharmacol_Sin_2012_Feb_3_33(2)_173-181.nxml.txt.nlp	22301857	SENT17	0	0	3	3	liraglutide	GLP-1	PA165958364	100125288	0.951
NULL	Acta_Pharmacol_Sin_2010_Feb_5_31(2)_137-144.nxml.txt.nlp	20139896	SENT138	3	3	15	15	zileuton	5-LOX	PA451955	240	0.951
NULL	Curr_Cardiol_Rev_2009_Nov_5(4)_268-272.nxml.txt.nlp	21037843	SENT92	7	7	0	0	dobutamine	MRI	PA449381	78996	0.951
NULL	Ther_Clin_Risk_Manag_2007_Mar_3(1)_107-118.nxml.txt.nlp	18360619	SENT4	6	6	10	10	tegaserod	5-HT4	PA130413154	3360	0.951
NULL	Clin_Endocrinol_(Oxf)_2009_Aug_71(2)_171-175.nxml.txt.nlp	19170705	SENT149	33	33	8	8	fludrocortisone	MC2R	PA164743961	4158	0.951
NULL	Breast_Cancer_Res_2005_Aug_5_7(5)_212-214.nxml.txt.nlp	16168140	SENT13	30	30	4	4	trastuzumab	PI3K	PA451743	5290	0.951
NULL	Exp_Ther_Med_2014_Nov_22_8(5)_1559-1564.nxml.txt.nlp	25289059	SENT19	16	16	7	7	geldanamycin	Hsp90	PA152031327	3320	0.951
NULL	Clin_Med_Insights_Oncol_2013_Aug_21_7_221-234.nxml.txt.nlp	24179413	SENT61	21	21	27	27	erlotinib	KRAS	PA134687924	3845	0.951
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_105-115.nxml.txt.nlp	17912640	SENT264	42	42	16	16	letrozole	AMH	PA450196	268	0.951
NULL	J_Thyroid_Res_2011_Aug_2_2011_102636.nxml.txt.nlp	21826256	SENT187	0	0	5	5	axitinib	VEGFR	PA164924493	3791	0.951
NULL	Diabetes_Care_2010_Jun_23_33(6)_1300-1303.nxml.txt.nlp	20332351	SENT111	24	24	36	36	metformin	Met	PA450395	79811	0.951
NULL	Mol_Cancer_2009_Dec_23_8_129.nxml.txt.nlp	20030852	SENT151	16	16	27	27	curcumin	CXCL1	PA151958596	2919	0.951
NULL	Breast_Cancer_Res_Treat_2012_Jul_5_134(2)_693-700.nxml.txt.nlp	22562123	SENT204	42	42	15	15	tamoxifen	CYP2C19	PA451581	1557	0.951
NULL	Environ_Health_Perspect_2008_Jan_5_116(1)_1-6.nxml.txt.nlp	18197291	SENT205	30	30	19	19	arsenite	p85	PA452638	5296;5295;54776;23368	0.951
NULL	Clin_Drug_Investig_2013_Aug_23_33(10)_727-736.nxml.txt.nlp	23975654	SENT181	2	2	21	21	bupropion	CYP2D6	PA448687	1565	0.951
NULL	Front_Immunol_2013_May_31_4_129.nxml.txt.nlp	23755052	SENT99	17	17	27	27	anakinra	IL-17A	PA10799	3605	0.951
NULL	Mol_Cells_2014_Mar_31_37(3)_234-240.nxml.txt.nlp	24642709	SENT31	19	19	26	26	capsaicin	HO-1	PA448776	3162	0.951
NULL	Oncogenesis_2014_Dec_15_3(12)_e133.nxml.txt.nlp	25500906	SENT82	16	16	9	9	trastuzumab	PI3K	PA451743	5290	0.951
NULL	Br_J_Cancer_2009_Sep_15_101(6)_957-966.nxml.txt.nlp	19738618	SENT184	14	14	0	0	heparin	THBS-1	PA449855	7057	0.951
NULL	Br_J_Haematol_2014_Sep_17_166(6)_818-829.nxml.txt.nlp	24935654	SENT161	25	25	28	28	tocilizumab	IL6	PA165292659	3569	0.951
NULL	JAKSTAT_2013_Jul_1_2(3)_e24574.nxml.txt.nlp	24069558	SENT219	44	44	1	1	streptomycin	HEK	PA451512	2042	0.951
NULL	Mol_Syst_Biol_2011_Apr_26_7_486.nxml.txt.nlp	21525872	SENT513	11	11	28	28	gefitinib	SOCS2	PA131301952	8835	0.951
NULL	Breast_Cancer_Res_Treat_2012_Jun_18_133(3)_937-947.nxml.txt.nlp	22094936	SENT38	25	25	12	12	tamoxifen	EZH2	PA451581	2146	0.951
NULL	Oncogene_2014_Jun_26_33(26)_3422-3431.nxml.txt.nlp	23912457	SENT75	33	33	26	26	trastuzumab	HER2	PA451743	2064	0.951
NULL	Oncotarget_2013_Apr_13_4(4)_502-530.nxml.txt.nlp	23594434	SENT393	4	4	12	12	ketoconazole	CYP3A4	PA450146	1576	0.951
NULL	Pediatr_Nephrol_2009_Jul_20_24(7)_1355-1361.nxml.txt.nlp	19301038	SENT88	23	23	1	1	sevelamer	PTH	PA164781197	5741	0.951
NULL	Leukemia_2013_Feb_3_27(2)_315-324.nxml.txt.nlp	22751450	SENT10	0	0	14	14	sorafenib	Mcl-1	PA7000	4170	0.951
NULL	Onco_Targets_Ther_2014_Oct_4_7_1817-1828.nxml.txt.nlp	25336973	SENT115	34	34	13	13	bevacizumab	IFL	PA130232992	3439	0.951
NULL	Br_J_Pharmacol_2008_Dec_25_155(7)_1056-1065.nxml.txt.nlp	18724386	SENT128	16	16	0	0	nitrendipine	GLP-1	PA146096020	100125288	0.951
NULL	Hum_Immunol_2013_Nov_74(11)_1459-1462.nxml.txt.nlp	23777935	SENT81	33	33	39	39	cyclosporine	CD40	PA449167	958	0.951
NULL	Anat_Cell_Biol_2011_Mar_31_44(1)_14-24.nxml.txt.nlp	21519545	SENT109	38	38	24	24	cyclophosphamide	CK8	PA449165	3856	0.951
NULL	Cardiovasc_Drugs_Ther_2011_Jun_12_25(3)_223-232.nxml.txt.nlp	21562974	SENT50	3	3	22	22	esmolol	AKT	PA449500	207	0.951
NULL	Oncol_Lett_2013_Mar_19_5(3)_923-928.nxml.txt.nlp	23426648	SENT146	5	5	16	16	sc-560	MVD		4597	0.951
NULL	Aging_(Albany_NY)_2009_Sep_10_1(9)_803-817.nxml.txt.nlp	20157568	SENT38	25	25	34	34	doxycycline	TTP	PA449415	7538;11093	0.951
NULL	J_Inherit_Metab_Dis_2010_Oct_3_33(5)_625-632.nxml.txt.nlp	20814828	SENT106	26	26	15	15	simvastatin	RhoA	PA451363	387	0.951
NULL	J_Hematol_Oncol_2013_Mar_27_6_23.nxml.txt.nlp	23531342	SENT98	19	19	25	25	doxorubicin	JNK	PA449412	5599	0.951
NULL	Br_J_Cancer_2009_Oct_6_101(7)_1155-1161.nxml.txt.nlp	19738614	SENT130	20	20	10	10	gemcitabine	MUC4	PA449748	4585	0.951
NULL	Case_Rep_Med_2014_Mar_31_2014_801805.nxml.txt.nlp	24799913	SENT38	9	9	13	13	pentamidine	TMP	PA450850	2012	0.951
NULL	J_Int_AIDS_Soc_2012_Oct_22_15(Suppl_3)_10_7448_IAS_15_5_18440.nxml.txt.nlp	NULL	SENT2545	0	0	14	14	saquinavir	LSR	PA451305	51599	0.951
NULL	Emerg_Infect_Dis_2007_Jul_13(7)_1024-1030.nxml.txt.nlp	18214174	SENT91	15	15	4	4	linezolid	LSE	PA450233	54414	0.951
NULL	Mol_Cancer_2009_Jun_9_8_37.nxml.txt.nlp	19508729	SENT74	38	38	2	2	gemcitabine	HO-1	PA449748	3162	0.951
NULL	Oncotarget_2013_Apr_15_4(4)_636-646.nxml.txt.nlp	23592437	SENT66	18	18	6	6	decitabine	CTCFL	PA164749631	140690	0.951
NULL	J_Inflamm_(Lond)_2008_Jul_29_5_11.nxml.txt.nlp	18664275	SENT95	7	7	19	19	ciprofloxacin	IL-8	PA449009	3576	0.951
NULL	Cancer_Res_Treat_2013_Mar_31_45(1)_55-62.nxml.txt.nlp	23613671	SENT14	19	19	45	45	irinotecan	KRAS	PA450085	3845	0.951
NULL	Arthritis_Res_Ther_2012_Jan_30_14(1)_201.nxml.txt.nlp	22293240	SENT114	5	5	22	22	glucosamine	IL-6	PA164747613	3569	0.951
NULL	Adv_Urol_2012_Oct_26_2012_812398.nxml.txt.nlp	22110495	SENT103	10	10	3	3	cisplatin	ERCC1	PA449014	2067	0.951
NULL	Breast_Cancer_Res_Treat_2012_Jun_15_133(3)_1057-1065.nxml.txt.nlp	22418700	SENT32	0	0	37	37	afatinib	HER2	PA165981154	2064	0.951
NULL	J_Oncol_2010_Apr_11_2010_251231.nxml.txt.nlp	20414333	SENT191	0	0	10	10	erlotinib	EGFR	PA134687924	1956	0.951
NULL	Exp_Mol_Med_2012_Sep_30_44(9)_536-544.nxml.txt.nlp	22771771	SENT7	22	22	11	11	celecoxib	COX	PA448871	1351	0.951
NULL	BMJ_2013_Sep_17_347_f5307.nxml.txt.nlp	24046285	SENT125	10	10	28	28	prasugrel	CYP3A4	PA154410481	1576	0.951
NULL	Lipids_Health_Dis_2011_Feb_28_10_38.nxml.txt.nlp	21352602	SENT83	17	17	7	7	atorvastatin	PCSK9	PA448500	255738	0.951
NULL	Indian_J_Endocrinol_Metab_2012_Nov-Dec_16(6)_910-917.nxml.txt.nlp	23226635	SENT266	39	39	29	29	estradiol	SARM	PA449503	23098	0.951
NULL	Arthritis_Res_Ther_2004_Feb_24_6(Suppl_1)_24.nxml.txt.nlp	NULL	SENT15	23	23	6	6	etanercept	OPG	PA449515	690	0.951
NULL	Int_J_Environ_Res_Public_Health_2011_May_19_8(5)_1613-1630.nxml.txt.nlp	21655141	SENT397	10	10	8	8	itraconazole	CYP3A4	PA450132	1576	0.951
NULL	Curr_Neuropharmacol_2011_Dec_9(4)_530-552.nxml.txt.nlp	22654714	SENT228	9	9	1	1	fluoxetine	p11	PA449673	118460	0.951
NULL	Iran_J_Pharm_Res_2013_Winter_12(Suppl)_71-76.nxml.txt.nlp	24250674	SENT31	10	10	15	15	fluoxetine	CYP2D6	PA449673	1565	0.951
NULL	Leukemia_2013_Feb_31_27(2)_278-285.nxml.txt.nlp	22907049	SENT35	9	9	3	3	sunitinib	KIT	PA162372840	3815	0.951
NULL	J_Hematol_Oncol_2011_Jan_21_4_5.nxml.txt.nlp	21255411	SENT20	7	7	21	21	paclitaxel	EGFR	PA450761	1956	0.951
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT74	12	12	5	5	metformin	p53	PA450395	7157	0.951
NULL	N_Am_J_Med_Sci_2011_Oct_3(10)_441-450.nxml.txt.nlp	22363081	SENT107	29	29	9	9	gemcitabine	EGFR	PA449748	1956	0.951
NULL	Mol_Cancer_2014_Apr_28_13_92.nxml.txt.nlp	24775712	SENT228	32	32	13	13	trastuzumab	HER2	PA451743	2064	0.951
NULL	Breast_Cancer_Res_2005_Jun_17_7(Suppl_2)_S_13.nxml.txt.nlp	NULL	SENT16	34	34	32	32	letrozole	aromatase	PA450196	1588	0.951
NULL	Colorectal_Dis_2012_Feb_14(2)_e31-e47.nxml.txt.nlp	21848897	SENT136	31	31	18	18	oxaliplatin	KRAS	PA131285527	3845	0.951
NULL	Br_J_Pharmacol_2014_Apr_28_171(8)_1798-1817.nxml.txt.nlp	24116962	SENT227	14	14	36	36	bezafibrate	YY1	PA162364313	7528	0.951
NULL	Exp_Ther_Med_2013_Dec_27_6(6)_1431-1436.nxml.txt.nlp	24250723	SENT137	29	29	1	1	dextromethorphan	spatial	PA449273	219793	0.951
NULL	Scientifica_(Cairo)_2012_Sep_3_2012_757890.nxml.txt.nlp	24278738	SENT115	10	10	1	1	curcumin	p53	PA151958596	7157	0.951
NULL	Biomed_Res_Int_2014_Apr_29_2014_186864.nxml.txt.nlp	24877064	SENT142	8	8	33	33	curcumin	CD4	PA151958596	920	0.951
NULL	Int_Clin_Psychopharmacol_2014_Jul_26_29(4)_206-211.nxml.txt.nlp	24374906	SENT73	1	1	10	10	doxepin	CYP2C19	PA449409	1557	0.951
NULL	Infect_Drug_Resist_2010_Apr_26_3_15-23.nxml.txt.nlp	21694890	SENT27	7	7	21	21	ritonavir	UGT	PA451260	7361;7355	0.951
NULL	Acta_Pharmacol_Sin_2013_Sep_5_34(9)_1208-1216.nxml.txt.nlp	23852087	SENT175	13	13	6	6	disulfiram	HIF-1	PA449376	29072	0.951
NULL	J_Headache_Pain_2013_Apr_10_14(1)_33.nxml.txt.nlp	23574808	SENT4	19	19	3	3	capsaicin	CO2	PA448776	4513	0.951
NULL	Acta_Pharmacol_Sin_2010_Feb_5_31(2)_137-144.nxml.txt.nlp	20139896	SENT5	8	8	6	6	zileuton	5-LOX	PA451955	240	0.951
NULL	Mol_Cell_Proteomics_2014_May_17_13(5)_1273-1285.nxml.txt.nlp	24637012	SENT196	40	40	12	12	lisuride	5-HT2A	PA164749019	3356	0.951
NULL	Psychiatry_Investig_2012_Dec_12_9(4)_422-424.nxml.txt.nlp	23251210	SENT14	20	20	7	7	terbinafine	CYP2D6	PA451614	1565	0.951
NULL	Mol_Cancer_2004_Nov_17_3_31.nxml.txt.nlp	15548330	SENT131	9	9	35	35	etoposide	PC-3	PA449552	692094	0.951
NULL	Cell_Host_Microbe_2009_Mar_19_5(3-3)_225-233.nxml.txt.nlp	19286132	SENT496	18	18	24	24	gentamicin	ANOVA	PA449753	4858	0.951
NULL	Diabetes_Metab_J_2012_Jun_14_36(3)_199-206.nxml.txt.nlp	22737659	SENT133	11	11	30	30	tacrolimus	NFATc	PA451578	4772	0.951
NULL	Adipocyte_2012_Jul_1_1(3)_182-187.nxml.txt.nlp	23700531	SENT46	26	26	20	20	lipase	CGI-58	PA450239	51099	0.951
NULL	J_Cell_Biol_2005_Nov_7_171(3)_505-516.nxml.txt.nlp	16275754	SENT134	17	17	28	28	pp2	MEK1		5604	0.951
NULL	Leukemia_2014_Apr_14_28(4)_961-964.nxml.txt.nlp	24418991	SENT18	0	0	28	28	nilotinib	P-gp	PA165958345	5243	0.951
NULL	Mol_Pain_2013_Feb_15_9_3.nxml.txt.nlp	23413875	SENT183	22	22	38	38	resveratrol	TRPA1		8989	0.951
NULL	J_Inflamm_(Lond)_2008_Jul_29_5_11.nxml.txt.nlp	18664275	SENT96	4	4	15	15	clarithromycin	IL-8	PA449028	3576	0.951
NULL	Br_J_Pharmacol_2014_Apr_28_171(8)_1890-1906.nxml.txt.nlp	24328763	SENT349	18	18	3	3	phenylephrine	MFN2	PA450935	9927	0.951
NULL	Orphanet_J_Rare_Dis_2006_Aug_9_1_30.nxml.txt.nlp	16899117	SENT92	36	36	3	3	levodopa	FTDP-17	PA450213	4137	0.951
NULL	Mol_Cancer_2009_Aug_25_8_66.nxml.txt.nlp	19706164	SENT78	4	4	10	10	celecoxib	p53	PA448871	7157	0.951
NULL	ScientificWorldJournal_2013_Oct_22_2013_686304.nxml.txt.nlp	24250273	SENT94	13	13	16	16	liraglutide	GLP-1	PA165958364	100125288	0.951
NULL	Ann_Oncol_2014_Jun_31_25(6)_1116-1121.nxml.txt.nlp	24685829	SENT133	38	38	15	15	capecitabine	EGFR	PA448771	1956	0.951
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT262	3	3	25	25	tacrolimus	IL-6	PA451578	3569	0.951
NULL	Nat_Commun_2014_5_3321.nxml.txt.nlp	24531236	SENT255	11	11	28	28	ethanol	CO2	PA448073	4513	0.951
NULL	Clin_Med_Insights_Oncol_2012_Nov_20_6_381-393.nxml.txt.nlp	23226079	SENT137	22	22	15	15	itraconazole	CYP3A4	PA450132	1576	0.951
NULL	Front_Neuroanat_2014_Oct_20_8_116.nxml.txt.nlp	25368556	SENT277	12	12	15	15	minocycline	MMP9	PA450519	4318	0.951
NULL	Breast_Cancer_Res_2007_Aug_10_9(4)_R52.nxml.txt.nlp	17692126	SENT5	15	15	13	13	anastrozole	aromatase	PA448432	1588	0.951
NULL	Clin_Ophthalmol_2014_May_23_8_1031-1038.nxml.txt.nlp	24920879	SENT106	43	43	20	20	travoprost	BAK	PA164781371	578	0.951
NULL	Mol_Cancer_2009_Jun_23_8_39.nxml.txt.nlp	19549337	SENT233	36	36	21	21	resveratrol	TRAIL		8743	0.951
NULL	Arthritis_Res_Ther_2012_Sep_24_14(5)_R200.nxml.txt.nlp	23006144	SENT156	11	11	6	6	alefacept	IL-20	PA164748040	27190;50604	0.951
NULL	J_Hematol_Oncol_2010_Mar_13_3_10.nxml.txt.nlp	20226083	SENT118	0	0	6	6	gemcitabine	RRM1	PA449748	6240	0.951
NULL	Diabetes_Care_2009_Sep_29_32(9)_1620-1625.nxml.txt.nlp	19564453	SENT162	5	5	9	9	metformin	AMPK	PA450395	5563	0.951
NULL	Cell_Death_Dis_2010_Mar_18_1(3)_e31.nxml.txt.nlp	21364639	SENT333	24	24	3	3	staurosporine	PI3K	PA165109623	5290	0.951
NULL	Acta_Orthop_2011_Apr_5_82(2)_211-216.nxml.txt.nlp	21434784	SENT181	1	1	34	34	doxorubicin	VIII	PA449412	1351	0.951
NULL	Clin_Pharmacokinet_2014_Jan_16_53(3)_213-225.nxml.txt.nlp	24430725	SENT193	8	8	16	16	verapamil	P-gp	PA451868	5243	0.951
NULL	Protein_Cell_2014_Jun_19_5(6)_469-479.nxml.txt.nlp	24748116	SENT56	18	18	7	7	vinblastine	EB1	PA451877	9167;22919;10982	0.951
NULL	J_Cancer_2013_Sep_27_4(8)_662-670.nxml.txt.nlp	24155778	SENT148	8	8	3	3	cisplatin	UCHL1	PA449014	7345	0.951
NULL	Exp_Ther_Med_2014_Nov_29_8(5)_1473-1478.nxml.txt.nlp	25289044	SENT128	15	15	10	10	heparin	AZU	PA449855	566	0.951
NULL	AAPS_J_2013_Aug_20_15(4)_1119-1127.nxml.txt.nlp	23959685	SENT162	4	4	28	28	lidocaine	CPE	PA450226	1363	0.951
NULL	J_Thromb_Thrombolysis_2013_Jul_17_36(1)_31-41.nxml.txt.nlp	23073747	SENT142	8	8	19	19	bivalirudin	LTA	PA10032	4049	0.951
NULL	Breast_Cancer_Res_2011_Mar_11_13(2)_R30.nxml.txt.nlp	21396117	SENT317	21	21	17	17	erlotinib	EGF	PA134687924	1950	0.951
NULL	Cell_Death_Dis_2013_Jul_11_4(7)_e719.nxml.txt.nlp	23846221	SENT64	24	24	9	9	cisplatin	TRAIL	PA449014	8743	0.951
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT106	10	10	1	1	curcumin	TRAIL	PA151958596	8743	0.951
NULL	Br_J_Cancer_2013_Dec_10_109(12)_3067-3072.nxml.txt.nlp	24263065	SENT38	23	23	10	10	irinotecan	KRAS	PA450085	3845	0.951
NULL	Nature_2012_Aug_16_488(7411)_394-398.nxml.txt.nlp	22810587	SENT63	4	4	15	15	isoproterenol	apelin	PA450121	8862	0.951
NULL	Arthritis_Res_Ther_2010_Feb_9_12(1)_R21.nxml.txt.nlp	20144213	SENT60	31	31	1	1	naproxen	5-LOX	PA450595	240	0.951
NULL	Front_Neural_Circuits_2013_Oct_2_7_155.nxml.txt.nlp	24106462	SENT186	43	43	15	15	haloperidol	gamma	PA449841	9913	0.951
NULL	Biologics_2012_Dec_17_6_429-464.nxml.txt.nlp	23269860	SENT197	20	20	4	4	etanercept	NMA	PA449515	25805	0.951
NULL	Arthritis_Res_Ther_2012_Dec_3_14(6)_R262.nxml.txt.nlp	23206933	SENT139	6	6	3	3	tocilizumab	IL-6	PA165292659	3569	0.951
NULL	Curr_Genomics_2013_Nov_14(7)_441-452.nxml.txt.nlp	24396276	SENT103	26	26	17	17	cisplatin	ATP7A	PA449014	538	0.951
NULL	Front_Oncol_2013_Apr_23_3_86.nxml.txt.nlp	23630663	SENT131	5	5	15	15	trastuzumab	MUC4	PA451743	4585	0.951
NULL	Clin_Epigenetics_2011_Dec_5_3(1)_8.nxml.txt.nlp	22414275	SENT102	6	6	18	18	ribavirin	ESR1	PA451241	2099	0.951
NULL	Oncotarget_2014_Nov_8_5(21)_10280-10292.nxml.txt.nlp	25373733	SENT3	3	3	21	21	bortezomib	HIF-1	PA10252	29072	0.951
NULL	Cancer_Cell_Int_2011_Mar_25_11_7.nxml.txt.nlp	21439058	SENT217	40	40	30	30	simvastatin	NAC	PA451363	22861	0.951
NULL	Oncotarget_2013_Nov_19_5(2)_309-325.nxml.txt.nlp	24525395	SENT180	9	9	29	29	cyclophosphamide	p53	PA449165	7157	0.951
NULL	Br_J_Cancer_2013_Mar_19_108(5)_1052-1060.nxml.txt.nlp	23422754	SENT33	5	5	0	0	bevacizumab	VEGF-A	PA130232992	7422	0.951
NULL	Iran_J_Public_Health_2013_Feb_1_42(2)_145-148.nxml.txt.nlp	23515429	SENT76	32	32	0	0	naltrexone	NMT	PA450588	4836	0.951
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT616	13	13	39	39	risperidone	PRL	PA451257	5617	0.951
NULL	Exp_Anim_2014_Apr_26_63(2)_257-267.nxml.txt.nlp	24770651	SENT161	34	34	9	9	olmesartan	APJ	PA164742950	187	0.951
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT199	13	13	4	4	metformin	p53	PA450395	7157	0.951
NULL	Clin_Infect_Dis_2014_Apr_1_58(7)_928-936.nxml.txt.nlp	24399087	SENT163	0	0	7	7	efavirenz	API	PA449441	5345	0.951
NULL	J_Korean_Med_Sci_2008_Aug_25_23(4)_598-603.nxml.txt.nlp	18756044	SENT111	7	7	28	28	gemcitabine	CRT	PA449748	811	0.951
NULL	Oncogene_2014_Mar_6_33(10)_1316-1324.nxml.txt.nlp	23474758	SENT175	30	30	1	1	etoposide	AXL	PA449552	558	0.951
NULL	Mol_Pain_2012_Sep_22_8_71.nxml.txt.nlp	22998838	SENT132	43	43	30	30	paclitaxel	CB1	PA450761	1268	0.951
NULL	Cancer_Cell_Int_2012_Dec_15_12_52.nxml.txt.nlp	23241263	SENT79	23	23	4	4	imatinib	WT1	PA10804	7490	0.951
NULL	Diabetes_2013_Jun_17_62(6)_1843-1854.nxml.txt.nlp	23349486	SENT158	18	18	10	10	pioglitazone	CD44	PA450970	960	0.951
NULL	J_Cell_Mol_Med_2013_May_20_17(5)_648-656.nxml.txt.nlp	23601074	SENT167	28	28	10	10	erlotinib	EGFR	PA134687924	1956	0.951
NULL	Scientifica_(Cairo)_2012_Dec_20_2012_106576.nxml.txt.nlp	24278664	SENT194	40	40	7	7	fenfluramine	BMPR-II	PA449592	659	0.951
NULL	Ther_Clin_Risk_Manag_2006_Jun_2(2)_207-212.nxml.txt.nlp	18360594	SENT99	13	13	31	31	rituximab	ACR	PA451261	49	0.951
NULL	Clin_Interv_Aging_2009_May_14_4_109-113.nxml.txt.nlp	19503773	SENT98	5	5	8	8	tolcapone	COMT	PA451720	1312	0.951
NULL	J_Mol_Signal_2008_Mar_31_3_8.nxml.txt.nlp	18377662	SENT63	30	30	15	15	pp2	SHP-1		5777	0.951
NULL	J_Cancer_Res_Clin_Oncol_2011_Aug_28_137(8)_1203-1211.nxml.txt.nlp	21626008	SENT151	11	11	2	2	gefitinib	EGFR	PA131301952	1956	0.951
NULL	Oxid_Med_Cell_Longev_2013_Nov_28_2013_568093.nxml.txt.nlp	24379901	SENT50	23	23	8	8	resveratrol	SIRT1		23411	0.951
NULL	Allergy_2014_Jun_16_69(6)_741-751.nxml.txt.nlp	24735481	SENT210	9	9	3	3	papain	TLR4	PA450778	7099	0.951
NULL	J_Oncol_2010_Jan_3_2010_149362.nxml.txt.nlp	20069122	SENT101	20	20	5	5	pertuzumab	EGFR		1956	0.951
NULL	Curr_Chem_Genomics_2010_Mar_1_4_1-8.nxml.txt.nlp	20448812	SENT9	0	0	22	22	estropipate	OATP1B3	PA165958342	28234	0.951
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT10	14	14	1	1	dasatinib	ABCG2	PA162372878	9429	0.951
NULL	Oncotarget_2014_Aug_29_5(19)_8947-8958.nxml.txt.nlp	25333254	SENT37	5	5	16	16	plerixafor	CXCR4	PA165958410	7852	0.951
NULL	Clin_Exp_Reprod_Med_2013_Jun_30_40(2)_67-75.nxml.txt.nlp	23875162	SENT157	9	9	13	13	estradiol	aromatase	PA449503	1588	0.951
NULL	Oncotarget_2014_Oct_15_5(21)_10763-10777.nxml.txt.nlp	25333257	SENT154	41	41	10	10	sn-38	P-gp		5243	0.951
NULL	Acta_Naturae_2011_Oct-Dec_3(4)_12-29.nxml.txt.nlp	22649701	SENT369	18	18	27	27	docetaxel	A10	PA449383	28870	0.951
NULL	Crit_Care_2010_Nov_5_14(6)_R200.nxml.txt.nlp	21054850	SENT181	1	1	15	15	vasopressin	AVP	PA451858	114548;551	0.951
NULL	Clin_Ophthalmol_2010_Oct_21_4_1165-1171.nxml.txt.nlp	21060666	SENT122	1	1	7	7	travoprost	BAK	PA164781371	578	0.951
NULL	Mol_Biol_Cell_2013_Sep_15_24(18)_2849-2860.nxml.txt.nlp	23885123	SENT179	16	16	8	8	dextran	JAM-A	PA449261	50848	0.951
NULL	Cancers_(Basel)_2011_Apr_1_3(2)_1844-1860.nxml.txt.nlp	24212785	SENT93	21	21	4	4	cetuximab	PTEN	PA10040	5728	0.951
NULL	ScientificWorldJournal_2013_Jun_19_2013_174392.nxml.txt.nlp	23853530	SENT104	30	30	16	16	doxazosin	c-FLIP	PA449407	8837	0.951
NULL	J_Indian_Assoc_Pediatr_Surg_2012_Apr-Jun_17(2)_84-86.nxml.txt.nlp	22529558	SENT83	6	6	40	40	rituximab	FDG	PA451261	23583	0.951
NULL	J_Biomed_Sci_2014_Feb_3_21(1)_10.nxml.txt.nlp	24490900	SENT186	20	20	0	0	alendronate	RANKL	PA448082	8600	0.951
NULL	Evid_Based_Complement_Alternat_Med_2012_Sep_4_2012_485042.nxml.txt.nlp	22988474	SENT126	11	11	26	26	doxorubicin	P-gp	PA449412	5243	0.951
NULL	BMB_Rep_2014_Jul_47(7)_376-381.nxml.txt.nlp	24286332	SENT53	11	11	22	22	heparin	PPG	PA449855	5552	0.951
NULL	Exp_Ther_Med_2014_Jun_28_7(6)_1653-1658.nxml.txt.nlp	24926361	SENT121	5	5	20	20	curcumin	p65	PA151958596	5970	0.951
NULL	Biochem_Res_Int_2012_Aug_23_2012_135723.nxml.txt.nlp	21904679	SENT104	17	17	3	3	lipase	LIPA	PA450239	3988;10648	0.951
NULL	Breast_Cancer_Res_2005_Jul_20_7(5)_205-211.nxml.txt.nlp	16168139	SENT112	7	7	10	10	tamoxifen	aromatase	PA451581	1588	0.951
NULL	Mol_Clin_Oncol_2013_Sep_24_1(5)_918-924.nxml.txt.nlp	24649271	SENT129	3	3	10	10	gemcitabine	EGFR	PA449748	1956	0.951
NULL	Oncogene_2010_Sep_23_29(38)_5299-5310.nxml.txt.nlp	20622903	SENT48	7	7	22	22	paclitaxel	HMGB1	PA450761	3146	0.951
NULL	Am_J_Case_Rep_2014_Feb_24_15_85-89.nxml.txt.nlp	24587856	SENT88	3	3	6	6	exemestane	aromatase	PA449563	1588	0.951
NULL	Cell_Death_Dis_2014_Jul_3_5(7)_e1316.nxml.txt.nlp	24991768	SENT28	4	4	38	38	pemetrexed	Mcl-1	PA10810	4170	0.951
NULL	Br_J_Cancer_2013_May_14_108(9)_1807-1809.nxml.txt.nlp	23612454	SENT59	11	11	6	6	trastuzumab	PIK3CA	PA451743	5290	0.951
NULL	Oncotarget_2014_Oct_18_5(22)_11641-11652.nxml.txt.nlp	25361002	SENT82	19	19	31	31	cisplatin	NAC	PA449014	22861	0.951
NULL	Biochem_Res_Int_2012_Mar_4_2012_875742.nxml.txt.nlp	22500233	SENT203	22	22	0	0	collagenase	MMP13	PA449107	4322	0.951
NULL	Drug_Target_Insights_2013_Aug_19_7_27-34.nxml.txt.nlp	24023511	SENT86	7	7	11	11	tariquidar	P-gp		5243	0.951
NULL	Breast_Cancer_Res_2011_Feb_3_13(1)_R16.nxml.txt.nlp	21291529	SENT10	10	10	0	0	epirubicin	PHD1	PA449476	112398	0.951
NULL	Infect_Dis_Ther_2014_Jun_29_3(1)_45-53.nxml.txt.nlp	25134811	SENT100	21	21	2	2	ciprofloxacin	SOC	PA449009	91544	0.951
NULL	Cell_Death_Differ_2010_Oct_30_17(10)_1624-1635.nxml.txt.nlp	20431602	SENT264	8	8	33	33	paclitaxel	Mcl-1	PA450761	4170	0.951
NULL	Cell_Commun_Signal_2013_Oct_1_11_73.nxml.txt.nlp	24083678	SENT44	9	9	0	0	sulindac	IL-8	PA451565	3576	0.951
NULL	Breast_Cancer_Res_2005_May_27_7(Suppl_1)_S19.nxml.txt.nlp	NULL	SENT8	14	14	23	23	tamoxifen	ATAC	PA451581	6375	0.951
NULL	Breast_Cancer_Res_2010_Dec_20_12(Suppl_4)_S17.nxml.txt.nlp	21172079	SENT36	34	34	10	10	estradiol	TCL1A	PA449503	8115	0.951
NULL	ScientificWorldJournal_2012_Jul_31_2012_475675.nxml.txt.nlp	22919323	SENT56	14	14	8	8	genistein	AMPK	PA165109660	5563	0.95
NULL	Oncogenesis_2014_Nov_17_3(11)_e127.nxml.txt.nlp	25402609	SENT140	6	6	25	25	flavopiridol	ALOX5	PA452627	240	0.95
NULL	Infect_Drug_Resist_2010_Mar_11_3_45-51.nxml.txt.nlp	21694893	SENT113	28	28	3	3	voriconazole	CYP3A4	PA10233	1576	0.95
NULL	J_Hematol_Oncol_2008_Aug_11_1_11.nxml.txt.nlp	18694493	SENT38	14	14	18	18	sorafenib	IFN	PA7000	3439	0.95
NULL	Cancer_Inform_2007_May_1_3_125-139.nxml.txt.nlp	19455240	SENT122	8	8	27	27	indomethacin	COX	PA449982	1351	0.95
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT23	21	21	11	11	heparin	FGF2	PA449855	2247;2258	0.95
NULL	Curr_Neuropharmacol_2010_Jun_8(2)_97-104.nxml.txt.nlp	21119880	SENT44	16	16	9	9	arsenite	AQP9	PA452638	366;364	0.95
NULL	Nucleic_Acids_Res_2012_Jun_22_40(11)_4861-4878.nxml.txt.nlp	22362753	SENT208	1	1	16	16	glutaraldehyde	NPM1	PA449777	4869	0.95
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT282	18	18	7	7	nutlin-3	DcR2		8793	0.95
NULL	Int_J_Genomics_2013_Nov_4_2013_464720.nxml.txt.nlp	24364026	SENT228	6	6	4	4	olaparib	PARP-1		25976	0.95
NULL	Br_J_Cancer_2012_Jun_5_106(12)_1997-2003.nxml.txt.nlp	22596232	SENT174	15	15	2	2	sorafenib	JNK	PA7000	5599	0.95
NULL	Mol_Cancer_2009_Aug_25_8_66.nxml.txt.nlp	19706164	SENT196	12	12	30	30	celecoxib	p53	PA448871	7157	0.95
NULL	Breast_Cancer_Res_2009_Sep_29_11(5)_209.nxml.txt.nlp	19818165	SENT119	5	5	22	22	trastuzumab	EGFR	PA451743	1956	0.95
NULL	Curr_Oncol_2010_Feb_17(1)_81-86.nxml.txt.nlp	20179808	SENT57	30	30	43	43	tamoxifen	aromatase	PA451581	1588	0.95
NULL	Oxid_Med_Cell_Longev_2013_Jun_6_2013_891748.nxml.txt.nlp	23840922	SENT88	4	4	15	15	resveratrol	SIRT1		23411	0.95
NULL	Mol_Cancer_2008_Jun_5_7_50.nxml.txt.nlp	18534018	SENT84	29	29	24	24	bortezomib	HSP	PA10252	7190	0.95
NULL	Nano_Rev_2010_Nov_8_1_10_3402_nano_v1i0_5705.nxml.txt.nlp	22110857	SENT14	42	42	0	0	doxorubicin	PK1	PA449412	84432	0.95
NULL	J_Clin_Exp_Pathol_2012_May_17_Suppl_4_7327.nxml.txt.nlp	25379357	SENT25	15	15	25	25	resveratrol	SIRT1		23411	0.95
NULL	Ethiop_J_Health_Sci_2011_Nov_21(3)_195-201.nxml.txt.nlp	22435000	SENT97	24	24	37	37	l-arginine	IL-6	PA448478	3569	0.95
NULL	Cancers_(Basel)_2013_Jul_25_5(3)_919-942.nxml.txt.nlp	24202327	SENT164	17	17	12	12	ketoconazole	CYP3A4	PA450146	1576	0.95
NULL	Int_J_Inflam_2011_Apr_6_2011_807279.nxml.txt.nlp	21603133	SENT153	31	31	9	9	glucosamine	ghrelin	PA164747613	51738	0.95
NULL	Nat_Neurosci_2014_Jul_25_17(7)_943-952.nxml.txt.nlp	24859199	SENT318	2	2	9	9	doxycycline	ANOVA	PA449415	4858	0.95
NULL	Evid_Based_Complement_Alternat_Med_2013_May_28_2013_629750.nxml.txt.nlp	23781265	SENT249	9	9	32	32	capsaicin	GADD153	PA448776	1649	0.95
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT10	40	40	21	21	cisplatin	p53	PA449014	7157	0.95
NULL	BMB_Rep_2013_May_46(5)_252-257.nxml.txt.nlp	23710635	SENT53	12	12	2	2	collagenase	MVD	PA449107	4597	0.95
NULL	Br_J_Cancer_2010_Mar_16_102(6)_1003-1009.nxml.txt.nlp	20179710	SENT114	1	1	18	18	doxorubicin	ABCB1	PA449412	5243	0.95
NULL	Breast_Cancer_Res_Treat_2013_Aug_20_141(1)_43-53.nxml.txt.nlp	23959396	SENT27	44	44	23	23	pertuzumab	HER3		2065	0.95
NULL	Arthritis_Res_Ther_2011_Feb_16_13(1)_R25.nxml.txt.nlp	21324169	SENT140	46	46	1	1	abatacept	TNF	PA164747080	7124	0.95
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT167	21	21	6	6	tacrolimus	IL-6	PA451578	3569	0.95
NULL	Carcinogenesis_2010_Jan_27_31(1)_2-8.nxml.txt.nlp	19861649	SENT104	25	25	21	21	gefitinib	EGFR	PA131301952	1956	0.95
NULL	Breast_Cancer_Res_2010_Jun_22_12(3)_R39.nxml.txt.nlp	20569502	SENT215	8	8	1	1	tamoxifen	IMPACT	PA451581	55364	0.95
NULL	Biologics_2012_Jul_13_6_221-231.nxml.txt.nlp	22904614	SENT184	20	20	1	1	cetuximab	EGFR	PA10040	1956	0.95
NULL	Open_Med_Chem_J_2012_May_17_6_1-14.nxml.txt.nlp	22876271	SENT43	25	25	9	9	sr144528	CB2		1269	0.95
NULL	Int_J_Fertil_Steril_2014_Jul_8_Jul-Sep_8(2)_119-128.nxml.txt.nlp	25083175	SENT12	4	4	0	0	metformin	MTF	PA450395	4500	0.95
NULL	Mol_Cancer_2010_May_18_9_110.nxml.txt.nlp	20482802	SENT191	24	24	9	9	bortezomib	MRP1	PA10252	4437	0.95
NULL	Int_J_Mol_Sci_2014_May_8_15(5)_8106-8121.nxml.txt.nlp	24815071	SENT56	24	24	4	4	atorvastatin	LC3	PA448500	84557	0.95
NULL	Exp_Diabetes_Res_2011_May_22_2011_376509.nxml.txt.nlp	21716694	SENT148	13	13	7	7	sitagliptin	HIP	PA164748978	6767;6159;64399;5068	0.95
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT52	13	13	23	23	trastuzumab	STAT3	PA451743	6774	0.95
NULL	J_Oncol_2009_Jun_14_2009_814140.nxml.txt.nlp	19547715	SENT6	6	6	29	29	carboplatin	MRP1	PA448803	4437	0.95
NULL	Mol_Cancer_2008_Mar_26_7_27.nxml.txt.nlp	18366759	SENT278	16	16	8	8	etoposide	HIF-1	PA449552	29072	0.95
NULL	Nucleic_Acids_Res_2012_Jun_10_40(11)_4804-4815.nxml.txt.nlp	22328728	SENT217	21	21	2	2	hemin	SIRT1	PA449849	23411	0.95
NULL	Acta_Pharmacol_Sin_2013_Apr_25_34(4)_455-463.nxml.txt.nlp	23524568	SENT181	35	35	16	16	pioglitazone	RAGE	PA450970	177	0.95
NULL	Arthritis_Res_Ther_2014_Jan_24_16(1)_R23.nxml.txt.nlp	24460726	SENT242	12	12	6	6	doxorubicin	STAT1	PA449412	6772	0.95
NULL	Crit_Care_2008_Dec_17_12(6)_R159.nxml.txt.nlp	19091080	SENT120	22	22	30	30	rolipram	CD14	PA153906323	929	0.95
NULL	Mol_Biol_Rep_2013_May_11_40(8)_5013-5026.nxml.txt.nlp	23666059	SENT202	7	7	25	25	resveratrol	CHK2		11200	0.95
NULL	Mol_Biol_Rep_2012_May_20_39(5)_5253-5267.nxml.txt.nlp	22183301	SENT66	16	16	3	3	gliclazide	NAC	PA10892	22861	0.95
NULL	J_Cell_Biol_1977_Jul_1_74(1)_204-225.nxml.txt.nlp	406264	SENT8	14	14	27	27	guanidine	mol	PA164781028	90527	0.95
NULL	Adv_Appl_Bioinforma_Chem_2008_Oct_30_1_85-98.nxml.txt.nlp	21918608	SENT80	39	39	27	27	bortezomib	SPARC	PA10252	6678	0.95
NULL	Int_J_Mol_Sci_2012_Apr_23_13(4)_5060-5073.nxml.txt.nlp	22606030	SENT128	1	1	6	6	artemisinin	CO2	PA165111696	4513	0.95
NULL	Can_J_Infect_Dis_Med_Microbiol_2014_Nov-Dec_25(6)_327-343.nxml.txt.nlp	25587296	SENT75	0	0	10	10	itraconazole	P-gp	PA450132	5243	0.95
NULL	Curr_Neuropharmacol_2013_Dec_11(6)_652-663.nxml.txt.nlp	24396340	SENT333	9	9	17	17	oxaliplatin	TRPA1	PA131285527	8989	0.95
NULL	J_Exp_Clin_Cancer_Res_2009_Sep_23_28(1)_131.nxml.txt.nlp	19775450	SENT37	4	4	31	31	olanzapine	HEC	PA450688	10403	0.95
NULL	Prostate_Int_2014_Sep_21_2(3)_105-113.nxml.txt.nlp	25325021	SENT154	4	4	9	9	dutasteride	SRD5A1	PA164749300	6715	0.95
NULL	Arthritis_Res_Ther_2013_Jul_9_15(4)_R73.nxml.txt.nlp	23837669	SENT303	40	40	22	22	colchicine	MICL	PA449092	160364	0.95
NULL	Oncotarget_2012_May_29_3(5)_581-585.nxml.txt.nlp	22653910	SENT49	10	10	22	22	resveratrol	P-gp		5243	0.95
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT73	9	9	14	14	gefitinib	AKT	PA131301952	207	0.95
NULL	Diabetes_Care_2012_Dec_14_35(12)_2650-2664.nxml.txt.nlp	23100048	SENT262	0	0	24	24	metformin	hole	PA450395	80757	0.95
NULL	Cancer_Immunol_Immunother_2012_Jul_23_61(7)_1101-1111.nxml.txt.nlp	22193989	SENT111	21	21	27	27	oxaliplatin	IL-6	PA131285527	3569	0.95
NULL	Front_Immunol_2012_Jan_24_3_3.nxml.txt.nlp	22566889	SENT109	9	9	28	28	rituximab	IL-2	PA451261	3558	0.95
NULL	Int_J_Cell_Biol_2013_Sep_12_2013_153634.nxml.txt.nlp	24159334	SENT140	7	7	14	14	camptothecin	MDM2	PA153590860	4193	0.95
NULL	Front_Oncol_2014_Sep_23_4_264.nxml.txt.nlp	25295231	SENT175	25	25	21	21	lenalidomide	p53	PA162363968	7157	0.95
NULL	Acta_Pharmacol_Sin_2013_Sep_5_34(9)_1208-1216.nxml.txt.nlp	23852087	SENT121	18	18	11	11	disulfiram	HIF-1	PA449376	29072	0.95
NULL	Nat_Med_2011_May_1_17(5)_604-609.nxml.txt.nlp	21532597	SENT9	0	0	15	15	daclizumab	IL-2	PA164764446	3558	0.95
NULL	Br_J_Cancer_2011_Dec_6_105(12)_1920-1926.nxml.txt.nlp	22095222	SENT24	40	40	23	23	gefitinib	EGFR	PA131301952	1956	0.95
NULL	Cell_Biol_Int_Rep_(2010)_2012_Jun_21_19(1)_e00017.nxml.txt.nlp	23124518	SENT137	36	36	5	5	etoposide	TRAIL-R2	PA449552	8795	0.95
NULL	Biosci_Rep_2012_Dec_20_33(1)_e00011.nxml.txt.nlp	23137297	SENT252	0	0	27	27	heparin	RPSA	PA449855	3921	0.95
NULL	Diabetes_Care_2008_Oct_31(10)_2062-2069.nxml.txt.nlp	18820229	SENT129	8	8	2	2	acarbose	STOP	PA448010	4135	0.95
NULL	Breast_Cancer_Res_2014_May_5_16(3)_R45.nxml.txt.nlp	24887236	SENT292	32	32	10	10	cetuximab	EGFR	PA10040	1956	0.95
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT385	10	10	21	21	heparin	FGF1	PA449855	2246	0.95
NULL	Oncogene_2013_Sep_26_32(39)_10_1038_onc_2012_491.nxml.txt.nlp	23108394	SENT136	33	33	3	3	epirubicin	FOXM1	PA449476	2305	0.95
NULL	Br_J_Pharmacol_2012_Apr_165(7)_2191-2202.nxml.txt.nlp	21958009	SENT119	9	9	5	5	ketanserin	5-HT2A	PA131053734	3356	0.95
NULL	J_Skin_Cancer_2011_Nov_17_2011_423239.nxml.txt.nlp	22175026	SENT152	20	20	15	15	vemurafenib	BRAF	PA165946873	673	0.95
NULL	Oncogene_2010_Jun_3_29(22)_3208-3216.nxml.txt.nlp	20383201	SENT233	8	8	19	19	dasatinib	EGF	PA162372878	1950	0.95
NULL	J_Korean_Med_Sci_2011_Dec_29_26(12)_1563-1568.nxml.txt.nlp	22147992	SENT118	4	4	15	15	ekb-569	AKT		207	0.95
NULL	Br_J_Cancer_2009_Jul_21_101(2)_327-334.nxml.txt.nlp	19568240	SENT217	36	36	8	8	pp2	PP2		4888	0.95
NULL	Br_J_Pharmacol_2014_Jun_15_171(11)_2705-2725.nxml.txt.nlp	24467436	SENT82	10	10	18	18	isoniazid	NAT1	PA450112	9;1982	0.95
NULL	Core_Evid_2007_Nov_30_2(2)_121-129.nxml.txt.nlp	21221180	SENT195	3	3	21	21	rituximab	PRIMA	PA451261	145270	0.95
NULL	Oncol_Lett_2013_Mar_11_5(3)_1010-1016.nxml.txt.nlp	23426784	SENT105	24	24	5	5	midazolam	TRPM7	PA450496	54822	0.95
NULL	N_Am_J_Med_Sci_2011_Jan_3(1)_1-12.nxml.txt.nlp	22540056	SENT55	46	46	27	27	gemcitabine	HuR	PA449748	1994	0.95
NULL	Oncotarget_2012_Sep_21_3(9)_909-910.nxml.txt.nlp	23006984	SENT16	0	0	4	4	fasudil	Rho	PA165946121	29984	0.95
NULL	Oncotarget_2012_May_18_3(5)_525-534.nxml.txt.nlp	22619113	SENT99	16	16	19	19	fludarabine	MCL1	PA449655	4170	0.95
NULL	J_Oncol_2011_Oct_12_2011_941876.nxml.txt.nlp	20981352	SENT155	21	21	31	31	gemcitabine	CD44	PA449748	960	0.95
NULL	J_Breast_Cancer_2012_Sep_28_15(3)_273-282.nxml.txt.nlp	23091539	SENT205	15	15	3	3	doxycycline	TRAIL	PA449415	8743	0.95
NULL	BMB_Rep_2013_Aug_46(8)_410-415.nxml.txt.nlp	23977989	SENT30	26	26	8	8	curcumin	HO-1	PA151958596	3162	0.95
NULL	Int_J_Mol_Sci_2014_Sep_26_15(10)_17204-17220.nxml.txt.nlp	25264738	SENT138	32	32	11	11	sildenafil	HO-1	PA451346	3162	0.95
NULL	Acta_Histochem_Cytochem_2012_Apr_26_45(2)_139-146.nxml.txt.nlp	22685356	SENT16	3	3	16	16	vasopressin	AQP2	PA451858	359	0.95
NULL	Cell_Cycle_2012_Aug_15_11(16)_3067-3078.nxml.txt.nlp	22871739	SENT123	22	22	16	16	cisplatin	E2F1	PA449014	1869	0.95
NULL	Exp_Ther_Med_2013_Jun_2_5(6)_1701-1709.nxml.txt.nlp	23837058	SENT235	31	31	22	22	cisplatin	AP-1	PA449014	2353;3727;2354;3725	0.95
NULL	Blood_Res_2014_Sep_25_49(3)_192-195.nxml.txt.nlp	25325040	SENT54	0	0	10	10	bevacizumab	VEGF-A	PA130232992	7422	0.95
NULL	EPMA_J_2011_Sep_24_2(Suppl_1)_103-118.nxml.txt.nlp	NULL	SENT144	11	11	27	27	oxaliplatin	GSTP1	PA131285527	2950	0.95
NULL	Biomed_Res_Int_2013_Jul_31_2013_692071.nxml.txt.nlp	23984399	SENT213	8	8	4	4	ondansetron	OCT1	PA450705	5451;6580	0.95
NULL	Apoptosis_2012_Sep_30_17(9)_989-997.nxml.txt.nlp	22460505	SENT150	3	3	6	6	thioridazine	PI3K	PA451666	5290	0.95
NULL	Exp_Ther_Med_2015_Jan_11_9(1)_17-24.nxml.txt.nlp	25452770	SENT142	34	34	3	3	erlotinib	HER-2	PA134687924	2064	0.95
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1986-2011.nxml.txt.nlp	25268165	SENT140	6	6	2	2	panitumumab	STAT3	PA162373091	6774	0.95
NULL	Int_J_Endocrinol_Metab_2013_Jul_1_Summer_11(3)_184-190.nxml.txt.nlp	24348591	SENT157	18	18	9	9	liraglutide	INS-1	PA165958364	2305	0.95
NULL	Br_J_Cancer_2011_Sep_6_105(6)_778-786.nxml.txt.nlp	21847128	SENT70	16	16	2	2	zoledronate	IL-2	PA10235	3558	0.95
NULL	J_Breast_Cancer_2012_Sep_28_15(3)_273-282.nxml.txt.nlp	23091539	SENT243	16	16	4	4	doxycycline	TRAIL	PA449415	8743	0.95
NULL	Braz_J_Med_Biol_Res_2012_Jul_27_45(10)_948-954.nxml.txt.nlp	22832600	SENT108	16	16	11	11	fluoxetine	5-HT4	PA449673	3360	0.95
NULL	Adv_Hematol_2009_Dec_22_2009_924301.nxml.txt.nlp	20049174	SENT30	11	11	1	1	fluorescein	ETV6	PA164746009	2120	0.95
NULL	Exp_Diabetes_Res_2012_Oct_26_2012_820989.nxml.txt.nlp	22110480	SENT136	11	11	4	4	rosiglitazone	LYRM1	PA451283	57149	0.95
NULL	Arch_Toxicol_2014_Nov_5_88(12)_2135-2190.nxml.txt.nlp	25370008	SENT790	3	3	17	17	sulfamethoxazole	FMO3	PA451544	2328	0.95
NULL	J_Cell_Biol_2008_Jun_16_181(6)_1013-1026.nxml.txt.nlp	18541700	SENT112	13	13	25	25	heparin	RhoA	PA449855	387	0.95
NULL	Drugs_R_D_2011_Mar_27_11(1)_37-51.nxml.txt.nlp	21410294	SENT258	18	18	16	16	itraconazole	CYP3A4	PA450132	1576	0.95
NULL	Ann_Rheum_Dis_2014_Dec_21_73(12)_2160-2167.nxml.txt.nlp	23965844	SENT206	43	43	16	16	etanercept	TNFRSF1A	PA449515	7132	0.95
NULL	Mol_Cancer_2009_Nov_10_8_99.nxml.txt.nlp	19903356	SENT80	7	7	17	17	imatinib	ANOVA	PA10804	4858	0.95
NULL	Breast_Cancer_Res_2007_Aug_8_9(4)_R50.nxml.txt.nlp	17686159	SENT147	31	31	20	20	gefitinib	EGFR	PA131301952	1956	0.95
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT109	31	31	14	14	pp2	EGFR		1956	0.95
NULL	Oncologist_2010_Jan_19_15(1)_3-5.nxml.txt.nlp	20086166	SENT28	19	19	9	9	cisplatin	EGFR	PA449014	1956	0.95
NULL	Clin_Pharmacol_2013_Apr_19_5_67-83.nxml.txt.nlp	23650452	SENT28	0	0	8	8	ticagrelor	CYP3A4	PA165374673	1576	0.95
NULL	Acta_Pharmacol_Sin_2013_Feb_31_34(2)_191-198.nxml.txt.nlp	23274413	SENT93	24	24	11	11	etoposide	IFN	PA449552	3439	0.95
NULL	Allergy_Asthma_Immunol_Res_2010_Apr_24_2(2)_65-76.nxml.txt.nlp	20358020	SENT131	9	9	15	15	pranlukast	CYP3A4	PA134698661	1576	0.95
NULL	Lipids_Health_Dis_2011_Jan_18_10_8.nxml.txt.nlp	21241519	SENT107	31	31	24	24	simvastatin	ABCG1	PA451363	9619	0.95
NULL	Crit_Care_2004_Oct_27_8(6)_R474-R482.nxml.txt.nlp	15566594	SENT36	29	29	12	12	piroxicam	PGD2	PA450985	27306	0.95
NULL	Case_Rep_Pulmonol_2014_Jul_15_2014_837612.nxml.txt.nlp	25126437	SENT6	4	4	22	22	tadalafil	PTPA	PA10333	5524	0.95
NULL	Anesthesiol_Res_Pract_2013_Sep_23_2013_297141.nxml.txt.nlp	24174934	SENT135	18	18	6	6	prilocaine	mol	PA451101	90527	0.95
NULL	Drug_Saf_2014_Feb_19_37(4)_201-211.nxml.txt.nlp	24550106	SENT152	11	11	27	27	diazepam	CYP2C19	PA449283	1557	0.95
NULL	J_Oncol_2012_Jun_4_2012_928127.nxml.txt.nlp	22701483	SENT101	11	11	31	31	metformin	HER-2	PA450395	2064	0.95
NULL	Mol_Cells_2014_Nov_30_37(11)_812-818.nxml.txt.nlp	25377255	SENT9	11	11	3	3	doxorubicin	PARP-1	PA449412	25976	0.95
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT10	4	4	2	2	erlotinib	CYP3A	PA134687924	1574	0.95
NULL	J_Gen_Physiol_2004_Aug_124(2)_125-137.nxml.txt.nlp	15277574	SENT302	7	7	20	20	glibenclamide	CFTR	PA449782	1080	0.95
NULL	Nat_Med_2013_Mar_10_19(3)_313-321.nxml.txt.nlp	23396211	SENT369	17	17	3	3	amlexanox	TBK1	PA164745310	29110	0.95
NULL	Eur_J_Clin_Pharmacol_2013_Mar_11_69(3)_327-339.nxml.txt.nlp	22782539	SENT271	14	14	4	4	ketoconazole	P-gp	PA450146	5243	0.95
NULL	AIDS_Res_Treat_2014_Feb_25_2014_636584.nxml.txt.nlp	24715982	SENT64	7	7	2	2	etravirine	DUET	PA166014703	8997	0.95
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT261	15	15	7	7	resveratrol	NAC		22861	0.95
NULL	Br_J_Cancer_2013_Jan_15_108(1)_115-120.nxml.txt.nlp	23175150	SENT10	13	13	18	18	bevacizumab	KRAS	PA130232992	3845	0.95
NULL	J_Cell_Mol_Med_2013_Mar_23_17(3)_325-336.nxml.txt.nlp	23521716	SENT255	2	2	11	11	cetuximab	EGFR	PA10040	1956	0.95
NULL	Diabetes_2009_Jul_7_58(7)_1550-1557.nxml.txt.nlp	19351711	SENT64	1	1	23	23	trypsin	CD133	PA451806	8842	0.95
NULL	Front_Chem_2014_Dec_23_2_113.nxml.txt.nlp	25566531	SENT160	27	27	21	21	curcumin	IL-8	PA151958596	3576	0.95
NULL	Asia_Pac_Allergy_2014_Jan_31_4(1)_3-13.nxml.txt.nlp	24527404	SENT60	15	15	26	26	capsaicin	TRPV1	PA448776	7442	0.95
NULL	Br_J_Cancer_2013_Feb_19_108(3)_579-586.nxml.txt.nlp	23370212	SENT113	10	10	15	15	cisplatin	DNMT3A	PA449014	1788	0.95
NULL	Breast_Cancer_Res_2011_Oct_12_13(5)_220.nxml.txt.nlp	22018398	SENT49	32	32	25	25	trastuzumab	JAK2	PA451743	3717	0.95
NULL	J_Cancer_2011_May_1_2_232-261.nxml.txt.nlp	21552384	SENT99	7	7	9	9	tamoxifen	aromatase	PA451581	1588	0.95
NULL	Allergy_Asthma_Immunol_Res_2014_Nov_19_6(6)_548-557.nxml.txt.nlp	25374755	SENT127	21	21	0	0	lovastatin	IL-6	PA450272	3569	0.95
NULL	Mol_Cancer_2007_Nov_17_6_73.nxml.txt.nlp	18021420	SENT45	16	16	6	6	bortezomib	Mcl-1	PA10252	4170	0.95
NULL	Core_Evid_2010_Oct_21_5_61-76.nxml.txt.nlp	21042543	SENT1	0	0	14	14	panitumumab	EGFR	PA162373091	1956	0.95
NULL	Ann_Gen_Psychiatry_2013_Aug_13_12_26.nxml.txt.nlp	23941527	SENT152	7	7	0	0	fluoxetine	NMA	PA449673	25805	0.95
NULL	Oncol_Lett_2014_Mar_27_7(3)_820-826.nxml.txt.nlp	24520300	SENT7	40	40	3	3	cyclophosphamide	U14	PA449165	85388;26822	0.95
NULL	Chemother_Res_Pract_2011_Dec_1_2011_715469.nxml.txt.nlp	22312557	SENT98	4	4	16	16	cisplatin	p53	PA449014	7157	0.95
NULL	Clin_Exp_Gastroenterol_2012_Jan_12_5_1-10.nxml.txt.nlp	22346361	SENT69	15	15	11	11	ketoconazole	P-gp	PA450146	5243	0.95
NULL	J_Exerc_Nutrition_Biochem_2014_Mar_11_18(1)_1-7.nxml.txt.nlp	25566433	SENT19	18	18	0	0	metformin	SIRT1	PA450395	23411	0.95
NULL	Int_J_Nephrol_2011_Apr_26_2011_245823.nxml.txt.nlp	21603155	SENT125	0	0	30	30	ribavirin	IFN	PA451241	3439	0.95
NULL	Br_J_Cancer_2012_Feb_14_106(4)_719-726.nxml.txt.nlp	22240798	SENT165	3	3	13	13	trastuzumab	EGFR	PA451743	1956	0.95
NULL	Cancer_Metab_2013_Jan_23_1_3.nxml.txt.nlp	24280005	SENT557	18	18	3	3	doxycycline	U87	PA449415	677775;641648	0.95
NULL	Front_Chem_2014_Mar_14_2_12.nxml.txt.nlp	24790981	SENT118	14	14	2	2	curcumin	GATA4	PA151958596	2626	0.95
NULL	Exp_Ther_Med_2014_Nov_29_8(5)_1473-1478.nxml.txt.nlp	25289044	SENT105	18	18	4	4	heparin	AZU	PA449855	566	0.95
NULL	Oxid_Med_Cell_Longev_2013_Apr_21_2013_412576.nxml.txt.nlp	23710286	SENT9	15	15	33	33	curcumin	NRF2	PA151958596	2551;4780	0.95
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_7_2013_219472.nxml.txt.nlp	23662119	SENT141	9	9	22	22	cisplatin	HER2	PA449014	2064	0.95
NULL	Cancer_Cell_Int_2014_Jun_11_14_49.nxml.txt.nlp	24991192	SENT76	34	34	24	24	berberine	AMPK	PA165860812	5563	0.95
NULL	Eur_J_Clin_Pharmacol_2010_Nov_29_66(11)_1131-1136.nxml.txt.nlp	20669013	SENT135	22	22	3	3	erythromycin	CYP2C19	PA449493	1557	0.95
NULL	Oncotarget_2013_Aug_21_4(9)_1484-1495.nxml.txt.nlp	23986086	SENT32	24	24	11	11	metformin	PIK3CA	PA450395	5290	0.95
NULL	Diabetes_2013_Sep_15_62(9)_3224-3231.nxml.txt.nlp	23545707	SENT159	40	40	8	8	losartan	ACR	PA450268	49	0.95
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT200	19	19	10	10	methotrexate	MSH2	PA450428	4436	0.95
NULL	Oncotarget_2012_May_18_3(5)_525-534.nxml.txt.nlp	22619113	SENT101	24	24	4	4	fludarabine	CFLAR	PA449655	8837	0.95
NULL	Chem_Rev_2012_May_9_112(5)_2593-2603.nxml.txt.nlp	22335786	SENT68	26	26	4	4	fluorescein	ATX	PA164746009	5168;23049	0.95
NULL	Nat_Chem_Biol_2010_Apr_28_6(4)_291-299.nxml.txt.nlp	20190765	SENT77	30	30	3	3	dasatinib	EGFR	PA162372878	1956	0.95
NULL	Nucleic_Acids_Res_2013_May_3_41(10)_e107.nxml.txt.nlp	23558748	SENT334	10	10	1	1	doxycycline	Bsr	PA449415	79104	0.95
NULL	Clin_Exp_Otorhinolaryngol_2011_Jun_31_4(2)_77-82.nxml.txt.nlp	21716954	SENT202	9	9	23	23	minocycline	PARP-1	PA450519	25976	0.95
NULL	Brain_Res_2011_Mar_25_1382(C)_29-36.nxml.txt.nlp	21276431	SENT111	11	11	24	24	ketanserin	5-HT2C	PA131053734	3358	0.95
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1047.nxml.txt.nlp	24503539	SENT59	11	11	3	3	tamoxifen	SIRT3	PA451581	23410	0.95
NULL	Contemp_Oncol_(Pozn)_2012_Jan_4_16(6)_480-484.nxml.txt.nlp	23788933	SENT132	29	29	16	16	crizotinib	EGFR	PA165946122	1956	0.95
NULL	J_Invest_Dermatol_2012_Nov_14_132(11)_2601-2609.nxml.txt.nlp	22696056	SENT75	11	11	15	15	guanabenz	HMOX1	PA164774903	3162	0.95
NULL	Oncotarget_2014_Jun_3_5(13)_4920-4928.nxml.txt.nlp	24952482	SENT95	0	0	19	19	crizotinib	HGF	PA165946122	3569;6654;3082	0.95
NULL	Crit_Care_2004_Oct_27_8(6)_R474-R482.nxml.txt.nlp	15566594	SENT152	29	29	32	32	bosentan	COX	PA10034	1351	0.95
NULL	Aging_(Albany_NY)_2013_Jun_23_5(7)_515-530.nxml.txt.nlp	24018842	SENT198	8	8	14	14	rosiglitazone	AMPK	PA451283	5563	0.95
NULL	Br_J_Cancer_2012_Nov_6_107(10)_1714-1721.nxml.txt.nlp	23073173	SENT154	25	25	5	5	docetaxel	RUNX2	PA449383	860	0.95
NULL	Mol_Cancer_2010_Nov_8_9_291.nxml.txt.nlp	21059223	SENT196	18	18	28	28	paclitaxel	Bcl-2	PA450761	596	0.95
NULL	Pain_Res_Treat_2012_Mar_1_2012_348043.nxml.txt.nlp	22550578	SENT24	15	15	20	20	capsaicin	TRPV1	PA448776	7442	0.95
NULL	Indian_J_Hum_Genet_2014_Apr-Jun_20(2)_175-184.nxml.txt.nlp	25400347	SENT9	39	39	27	27	warfarin	SLCO1B1	PA451906	10599	0.95
NULL	Br_J_Cancer_2013_Sep_3_109(5)_1214-1222.nxml.txt.nlp	23922104	SENT175	6	6	18	18	dasatinib	TP53	PA162372878	7157	0.95
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT102	28	28	11	11	sitagliptin	HIP	PA164748978	6767;6159;64399;5068	0.95
NULL	Acta_Otolaryngol_2010_Nov_30_130(11)_1278-1286.nxml.txt.nlp	20586674	SENT231	13	13	8	8	methimazole	TRPM8	PA450422	79054	0.95
NULL	Breast_Cancer_Res_Treat_2014_Jan_9_143(3)_493-505.nxml.txt.nlp	24402830	SENT29	15	15	8	8	capecitabine	HER2	PA448771	2064	0.95
NULL	J_Adv_Pract_Oncol_2012_Mar_1_Mar-Apr_3(2)_112-116.nxml.txt.nlp	25031937	SENT31	7	7	11	11	itraconazole	CYP3A4	PA450132	1576	0.95
NULL	Int_J_Breast_Cancer_2012_May_9_2012_415170.nxml.txt.nlp	22649737	SENT161	1	1	26	26	afatinib	EGFR	PA165981154	1956	0.95
NULL	Br_J_Cancer_2011_Jul_12_105(2)_221-230.nxml.txt.nlp	21750559	SENT44	5	5	14	14	pentostatin	Mcl-1	PA450863	4170	0.95
NULL	Acta_Pharmacol_Sin_2010_Sep_16_31(9)_1075-1084.nxml.txt.nlp	20711221	SENT115	8	8	5	5	metformin	eNOS	PA450395	4846	0.95
NULL	Int_J_Endocrinol_2010_Jul_18_2010_205357.nxml.txt.nlp	20706540	SENT149	7	7	0	0	galactose	GLUT10	PA449725	81031;66035	0.95
NULL	Pharmaceuticals_(Basel)_2012_Jun_28_5(7)_674-689.nxml.txt.nlp	24281706	SENT144	3	3	7	7	trastuzumab	EEA1	PA451743	8411	0.95
NULL	Oncogene_2010_Jun_17_29(24)_3532-3544.nxml.txt.nlp	20418907	SENT333	26	26	23	23	geldanamycin	Hsp90	PA152031327	3320	0.95
NULL	Braz_J_Med_Biol_Res_2013_Aug_13_46(8)_650-658.nxml.txt.nlp	23969971	SENT14	10	10	1	1	cisplatin	STAT3	PA449014	6774	0.95
NULL	Adv_Virol_2012_Oct_29_2012_186512.nxml.txt.nlp	22312362	SENT27	30	30	9	9	azacitidine	TET2	PA451996	54790	0.95
NULL	Int_J_Nanomedicine_2012_Sep_13_7_4917-4926.nxml.txt.nlp	23028220	SENT224	35	35	16	16	calcein	mol	PA132595336	90527	0.95
NULL	Mol_Cancer_2008_Sep_12_7_70.nxml.txt.nlp	18789133	SENT71	7	7	26	26	belinostat	HDAC2		3066	0.95
NULL	Cancer_Med_2014_Jun_25_3(3)_674-680.nxml.txt.nlp	24668895	SENT186	10	10	2	2	cetuximab	BRAF	PA10040	673	0.95
NULL	Crit_Care_2007_Mar_22_11(Suppl_2)_P101.nxml.txt.nlp	NULL	SENT12	4	4	13	13	amikacin	TBC	PA164744372	23216	0.95
NULL	Exp_Ther_Med_2015_Jan_4_9(1)_49-54.nxml.txt.nlp	25452775	SENT128	7	7	2	2	buspirone	5-HT1A	PA448689	3350	0.95
NULL	Int_J_Biol_Sci_2013_Apr_22_9(4)_350-360.nxml.txt.nlp	23630447	SENT162	28	28	10	10	doxorubicin	ARC	PA449412	8996;23237	0.95
NULL	Theranostics_2013_Jan_13_3(1)_34-39.nxml.txt.nlp	23382784	SENT125	41	41	30	30	etoposide	CXCR4	PA449552	7852	0.95
NULL	Indian_J_Pharm_Sci_2013_Nov-Dec_75(6)_657-663.nxml.txt.nlp	24591740	SENT139	3	3	10	10	dextromethorphan	LPO	PA449273	4025	0.95
NULL	Arthritis_Res_Ther_2014_Oct_29_16(5)_469.nxml.txt.nlp	25606596	SENT338	42	42	31	31	abatacept	CD4	PA164747080	920	0.95
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT38	9	9	33	33	lapatinib	HRG	PA152241907	3084;3273	0.95
NULL	Case_Rep_Hematol_2013_Oct_9_2013_458303.nxml.txt.nlp	24224106	SENT58	22	22	8	8	imatinib	PDGFRB	PA10804	5159	0.95
NULL	Front_Neurosci_2014_Feb_14_8_23.nxml.txt.nlp	24592205	SENT71	2	2	13	13	capsaicin	TRPV1	PA448776	7442	0.95
NULL	Eur_J_Clin_Pharmacol_2011_May_9_67(5)_477-482.nxml.txt.nlp	21305273	SENT101	9	9	19	19	atropine	DBP	PA448505	3295;1628;2638	0.95
NULL	Breast_Cancer_Res_2010_Jan_15_12(1)_R8.nxml.txt.nlp	20078855	SENT227	9	9	24	24	paclitaxel	ERBB2	PA450761	2064	0.95
NULL	EPMA_J_2012_Sep_27_3(1)_10.nxml.txt.nlp	23016735	SENT200	22	22	1	1	warfarin	CALU	PA451906	813	0.95
NULL	J_Cell_Mol_Med_2014_May_14_18(5)_811-823.nxml.txt.nlp	24628949	SENT159	22	22	3	3	docetaxel	FOXM1	PA449383	2305	0.95
NULL	Mol_Cancer_2010_Oct_12_9_269.nxml.txt.nlp	20939893	SENT137	28	28	12	12	isoproterenol	AP-1	PA450121	2353;3727;2354;3725	0.95
NULL	Oncotarget_2013_Nov_24_4(12)_2186-2207.nxml.txt.nlp	24327604	SENT130	30	30	17	17	vincristine	p53	PA451879	7157	0.95
NULL	J_Exp_Clin_Cancer_Res_2009_Feb_15_28(1)_19.nxml.txt.nlp	19216799	SENT173	4	4	17	17	cisplatin	AEG-1	PA449014	92140	0.95
NULL	Endocrinol_Metab_(Seoul)_2014_Sep_25_29(3)_363-370.nxml.txt.nlp	25309796	SENT118	25	25	4	4	metformin	AMPK	PA450395	5563	0.95
NULL	Cardiovasc_Diabetol_2006_Dec_4_5_26.nxml.txt.nlp	17144912	SENT4	9	9	27	27	dobutamine	STZ	PA449381	6484	0.95
NULL	Breast_Cancer_Res_2011_Feb_8_13(1)_202.nxml.txt.nlp	21392411	SENT162	7	7	20	20	metformin	SNAI2	PA450395	6591	0.95
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT214	30	30	13	13	cetuximab	KRAS	PA10040	3845	0.95
NULL	Basic_Res_Cardiol_2013_Jul_28_108(4)_367.nxml.txt.nlp	23812248	SENT7	12	12	10	10	zileuton	5-LOX	PA451955	240	0.95
NULL	Nat_Med_2011_Dec_11_18(1)_74-82.nxml.txt.nlp	22157681	SENT75	10	10	14	14	gefitinib	AKT	PA131301952	207	0.95
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Jun_25_3(6)_e120.nxml.txt.nlp	24964282	SENT3	24	24	10	10	ketoconazole	CYP3A4	PA450146	1576	0.95
NULL	Mol_Cancer_2010_Aug_20_9_220.nxml.txt.nlp	20727180	SENT178	14	14	34	34	nicotine	p53	PA450626	7157	0.95
NULL	Biomed_Res_Int_2014_Jun_2_2014_946492.nxml.txt.nlp	24991574	SENT157	2	2	19	19	olmesartan	MCP-1	PA164742950	6347	0.95
NULL	COPD_2008_Jun_13_5(3)_187-200.nxml.txt.nlp	18568843	SENT158	17	17	7	7	salmeterol	NNT	PA451300	23530	0.95
NULL	J_Biol_Chem_2008_Jun_13_283(24)_16293-16298.nxml.txt.nlp	18397880	SENT158	7	7	5	5	curcumin	p300	PA151958596	2033	0.95
NULL	Int_J_Chron_Obstruct_Pulmon_Dis_2007_Dec_2(4)_517-533.nxml.txt.nlp	18268925	SENT162	7	7	17	17	cilomilast	CD68	PA165948031	968	0.95
NULL	Br_J_Haematol_2014_Jan_28_164(2)_233-244.nxml.txt.nlp	24206017	SENT21	28	28	5	5	lenalidomide	CRBN	PA162363968	51185	0.95
NULL	J_Cancer_Epidemiol_2012_Apr_12_2012_529357.nxml.txt.nlp	22570656	SENT71	38	38	5	5	aprepitant	HEC	PA164747039	10403	0.95
NULL	Drugs_R_D_2011_Jun_27_11(2)_113-126.nxml.txt.nlp	21679004	SENT106	14	14	6	6	axitinib	CYP3A4	PA164924493	1576	0.95
NULL	Semin_Nephrol_2013_Nov_33(6)_508-530.nxml.txt.nlp	24161037	SENT169	7	7	2	2	eculizumab	ADAMTS13	PA164776637	11093	0.95
NULL	Front_Comput_Neurosci_2014_Feb_6_8_11.nxml.txt.nlp	24567716	SENT32	9	9	22	22	levetiracetam	CA3	PA450206	761	0.95
NULL	Int_J_Vasc_Med_2012_Jan_4_2012_657025.nxml.txt.nlp	22347626	SENT23	18	18	4	4	pitavastatin	PTX3	PA142650384	5806	0.95
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Jul_21_9_20.nxml.txt.nlp	20663145	SENT69	10	10	1	1	clarithromycin	LBH	PA449028	81606;221491	0.95
NULL	Nat_Neurosci_2014_Jul_25_17(7)_943-952.nxml.txt.nlp	24859199	SENT145	15	15	5	5	doxycycline	DCX	PA449415	1641	0.95
NULL	J_Int_Soc_Sports_Nutr_2007_Oct_19_4_13.nxml.txt.nlp	17949492	SENT184	18	18	9	9	estradiol	aromatase	PA449503	1588	0.95
NULL	Eur_J_Neurosci_2012_Oct_36(7)_2941-2948.nxml.txt.nlp	22845676	SENT99	3	3	27	27	isoflurane	CO2	PA450106	4513	0.95
NULL	Evid_Based_Complement_Alternat_Med_2013_Aug_28_2013_516017.nxml.txt.nlp	24066014	SENT119	10	10	25	25	doxorubicin	EDH	PA449412	10804	0.95
NULL	Mol_Cancer_2009_Jun_8_8_34.nxml.txt.nlp	19500427	SENT120	13	13	35	35	gemcitabine	p53	PA449748	7157	0.95
NULL	Cell_Death_Differ_2010_Apr_16_17(4)_666-676.nxml.txt.nlp	19834494	SENT94	20	20	9	9	melphalan	p53	PA450354	7157	0.95
NULL	Indian_J_Med_Res_2010_Dec_132(6)_676-682.nxml.txt.nlp	21245614	SENT48	0	0	24	24	zinc	p53	PA451956	7157	0.95
NULL	Pharmaceutics_2010_Sep_9_2(3)_291-299.nxml.txt.nlp	NULL	SENT56	2	2	16	16	tacrolimus	MDR1	PA451578	5243	0.95
NULL	J_Am_Heart_Assoc_2013_Apr_24_2(2)_e000131.nxml.txt.nlp	23537811	SENT48	21	21	9	9	clopidogrel	CYP2C19	PA449053	1557	0.95
NULL	Br_J_Cancer_2009_Jun_2_100(11)_1704-1719.nxml.txt.nlp	19436303	SENT94	11	11	8	8	bevacizumab	EGFR	PA130232992	1956	0.95
NULL	Pain_Res_Manag_2014_Nov-Dec_19(6)_328-335.nxml.txt.nlp	25479151	SENT139	0	0	21	21	tramadol	NNT	PA451735	23530	0.95
NULL	Mol_Biol_Cell_2014_May_1_25(9)_1411-1420.nxml.txt.nlp	24623724	SENT99	36	36	15	15	doxycycline	PERK	PA449415	9451	0.95
NULL	Acta_Pharmacol_Sin_2009_Sep_24_30(9)_1262-1275.nxml.txt.nlp	19701231	SENT229	24	24	10	10	lovastatin	AURKA	PA450272	6790	0.95
NULL	Hum_Genomics_2008_Sep_1_3(1)_7-16.nxml.txt.nlp	19129086	SENT157	21	21	13	13	rosiglitazone	CYP2C8	PA451283	1558	0.95
NULL	Int_J_Endocrinol_Metab_2013_Jul_1_Summer_11(3)_184-190.nxml.txt.nlp	24348591	SENT131	14	14	3	3	liraglutide	MDC	PA165958364	6367	0.95
NULL	Addict_Sci_Clin_Pract_2010_Dec_5(2)_4-14.nxml.txt.nlp	22002448	SENT114	9	9	27	27	methamphetamine	spatial	PA450403	219793	0.95
NULL	Br_J_Cancer_2012_Jan_3_106(1)_18-24.nxml.txt.nlp	22108516	SENT109	23	23	39	39	irinotecan	TDP1	PA450085	55775	0.95
NULL	Carcinogenesis_2010_Dec_27_31(12)_2049-2057.nxml.txt.nlp	20876285	SENT93	22	22	4	4	trastuzumab	HER2	PA451743	2064	0.95
NULL	Arthritis_Res_Ther_2009_Nov_4_11(6)_R165.nxml.txt.nlp	19889203	SENT339	19	19	5	5	curcumin	p65	PA151958596	5970	0.95
NULL	Evid_Based_Complement_Alternat_Med_2011_Feb_20_2011_541209.nxml.txt.nlp	21799681	SENT85	4	4	17	17	curcumin	p53	PA151958596	7157	0.95
NULL	Mol_Cells_2014_Sep_30_37(9)_664-671.nxml.txt.nlp	25234467	SENT267	43	43	27	27	cisplatin	miR-217	PA449014	406999	0.95
NULL	Arthritis_Res_Ther_2010_Jul_19_12(4)_R148.nxml.txt.nlp	20642840	SENT126	15	15	1	1	infliximab	IL-17	PA452639	3605	0.95
NULL	Oncotarget_2011_Sep_9_2(9)_658-668.nxml.txt.nlp	21911919	SENT104	10	10	26	26	cytarabine	NAC	PA449177	22861	0.95
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Apr_18_65(Pt_5)_o1066.nxml.txt.nlp	21583882	SENT55	4	4	39	39	ethanol	mol	PA448073	90527	0.95
NULL	Basic_Res_Cardiol_2014_May_22_109(4)_416.nxml.txt.nlp	24847907	SENT169	3	3	34	34	diazoxide	GAPDH	PA449285	2597	0.95
NULL	Neural_Plast_2014_Mar_17_2014_123026.nxml.txt.nlp	24757568	SENT156	5	5	22	22	fluoxetine	CA3	PA449673	761	0.95
NULL	Acta_Pharmacol_Sin_2013_Apr_18_34(4)_555-560.nxml.txt.nlp	23503472	SENT25	0	0	10	10	cyclosporine	CYP3A4	PA449167	1576	0.95
NULL	Case_Rep_Oncol_2010_Sep_28_3(3)_339-343.nxml.txt.nlp	21537376	SENT42	7	7	13	13	sunitinib	IFN	PA162372840	3439	0.95
NULL	Br_J_Cancer_2009_Jul_21_101(2)_269-277.nxml.txt.nlp	19603033	SENT11	5	5	12	12	cisplatin	MLH1	PA449014	4292	0.95
NULL	Cell_Death_Dis_2010_Feb_4_1(2)_e23.nxml.txt.nlp	21364631	SENT29	35	35	5	5	curcumin	JNK	PA151958596	5599	0.95
NULL	Diabetes_Metab_J_2012_Aug_20_36(4)_293-299.nxml.txt.nlp	22950061	SENT112	15	15	0	0	metformin	POMC	PA450395	5443	0.95
NULL	Multidiscip_Respir_Med_2013_Sep_4_8(1)_59.nxml.txt.nlp	24135224	SENT130	15	15	25	25	voriconazole	IPA	PA10233	3160	0.95
NULL	Acta_Pharmacol_Sin_2013_Sep_5_34(9)_1208-1216.nxml.txt.nlp	23852087	SENT116	13	13	3	3	disulfiram	EPO	PA449376	7076;8288;2056	0.95
NULL	Mol_Cell_Biochem_2012_Apr_3_363(1-2)_135-145.nxml.txt.nlp	22139302	SENT250	30	30	12	12	curcumin	PI3K	PA151958596	5290	0.95
NULL	Exp_Ther_Med_2013_Apr_5_5(4)_1259-1263.nxml.txt.nlp	23596498	SENT98	12	12	23	23	capsaicin	TRPV1	PA448776	7442	0.95
NULL	Cell_Death_Dis_2014_Feb_13_5(2)_e1055.nxml.txt.nlp	24525731	SENT92	19	19	11	11	cisplatin	TXNL1	PA449014	9352	0.95
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT409	24	24	8	8	heparin	FGF1	PA449855	2246	0.95
NULL	Scientifica_(Cairo)_2013_Dec_10_2013_691251.nxml.txt.nlp	24386592	SENT194	28	28	19	19	paclitaxel	SIRT6	PA450761	51548	0.95
NULL	Oncogene_2010_Sep_16_29(37)_5135-5145.nxml.txt.nlp	20622897	SENT11	24	24	13	13	cetuximab	STAT3	PA10040	6774	0.95
NULL	J_Cell_Biol_2008_Jan_28_180(2)_417-426.nxml.txt.nlp	18227283	SENT52	11	11	9	9	letrozole	aromatase	PA450196	1588	0.95
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Sep_15_66(Pt_10)_o2566.nxml.txt.nlp	21587551	SENT4	42	42	7	7	piperazine	mol	PA450977	90527	0.95
NULL	Biomed_Res_Int_2014_Jan_20_2014_948427.nxml.txt.nlp	24563867	SENT20	0	0	5	5	buspirone	5-HT1A	PA448689	3350	0.95
NULL	Int_J_Biol_Sci_2013_Dec_17_10(1)_64-72.nxml.txt.nlp	24391452	SENT60	26	26	24	24	ketanserin	5-HT2A	PA131053734	3356	0.95
NULL	Case_Rep_Psychiatry_2014_Sep_24_2014_659715.nxml.txt.nlp	25328745	SENT67	14	14	6	6	venlafaxine	CYP2C19	PA451866	1557	0.95
NULL	Open_Access_J_Urol_2010_Mar_12_2_35-40.nxml.txt.nlp	24198612	SENT71	10	10	13	13	sorafenib	VEGFR2	PA7000	3791	0.95
NULL	Diabetes_Care_2012_Jul_12_35(7)_1446-1454.nxml.txt.nlp	22584132	SENT234	23	23	34	34	metformin	Met	PA450395	79811	0.95
NULL	Mol_Cancer_2013_Oct_8_12_119.nxml.txt.nlp	24103454	SENT221	14	14	8	8	etoposide	p53	PA449552	7157	0.95
NULL	Diabetes_Care_2013_Aug_17_36(Suppl_2)_S245-S252.nxml.txt.nlp	23882053	SENT29	19	19	15	15	sitagliptin	HIP	PA164748978	6767;6159;64399;5068	0.95
NULL	Clin_Exp_Otorhinolaryngol_2011_Dec_15_4(4)_177-183.nxml.txt.nlp	22232712	SENT133	10	10	13	13	doxycycline	MUC5B	PA449415	727897	0.95
NULL	J_Oncol_2010_Jan_5_2010_257058.nxml.txt.nlp	20069126	SENT225	5	5	15	15	metformin	AKT	PA450395	207	0.95
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT320	20	20	7	7	cetuximab	KRAS	PA10040	3845	0.95
NULL	Onco_Targets_Ther_2014_Dec_4_7_2249-2255.nxml.txt.nlp	25587220	SENT119	28	28	23	23	diethylstilbestrol	ABCG2	PA449307	9429	0.95
NULL	Breast_Cancer_Res_Treat_2013_Jan_6_137(1)_167-174.nxml.txt.nlp	23129173	SENT35	43	43	4	4	estradiol	CYP19A1	PA449503	1588	0.95
NULL	Cancer_Med_2013_Jun_25_2(3)_277-285.nxml.txt.nlp	23930204	SENT76	30	30	26	26	bevacizumab	PTEN	PA130232992	5728	0.95
NULL	Diabetes_Metab_J_2012_Oct_18_36(5)_328-335.nxml.txt.nlp	23130316	SENT137	28	28	39	39	rosiglitazone	PDK4	PA451283	5166	0.95
NULL	Front_Oncol_2014_Nov_5_4_281.nxml.txt.nlp	25414829	SENT21	28	28	1	1	erlotinib	EGFR	PA134687924	1956	0.95
NULL	J_Asthma_Allergy_2012_Nov_8_5_65-70.nxml.txt.nlp	23204847	SENT83	4	4	25	25	omalizumab	ACT	PA164752253	12;11332;9457;641455	0.95
NULL	Avicenna_J_Phytomed_2014_May-Jun_4(3)_215-224.nxml.txt.nlp	25050319	SENT76	32	32	22	22	indomethacin	MEPI	PA449982	5276	0.95
NULL	J_Biol_Chem_2010_Aug_20_285(34)_26406-26416.nxml.txt.nlp	20530490	SENT10	16	16	47	47	artemisinin	SERCA1	PA165111696	487	0.95
NULL	Oncogene_2014_Feb_6_33(6)_713-723.nxml.txt.nlp	23435429	SENT84	39	39	18	18	etoposide	BCL2	PA449552	596	0.95
NULL	Br_J_Cancer_2011_Mar_1_104(5)_750-755.nxml.txt.nlp	21326243	SENT30	21	21	27	27	dacarbazine	PARP-1	PA449197	25976	0.95
NULL	Br_J_Cancer_2010_Sep_7_103(6)_889-898.nxml.txt.nlp	20664599	SENT202	18	18	10	10	paclitaxel	HER-2	PA450761	2064	0.95
NULL	Alcohol_Res_2013_35(1)_47-55.nxml.txt.nlp	24313164	SENT52	29	29	8	8	ethanol	miR-217	PA448073	406999	0.95
NULL	Breast_Cancer_Res_2006_Nov_6_8(6)_215.nxml.txt.nlp	17096862	SENT70	12	12	34	34	trastuzumab	PTEN	PA451743	5728	0.95
NULL	Indian_J_Pharmacol_2014_Mar-Apr_46(2)_230-231.nxml.txt.nlp	24741201	SENT18	23	23	7	7	efavirenz	CD4	PA449441	920	0.95
NULL	J_Vet_Med_Sci_2014_Oct_16_76(10)_1383-1387.nxml.txt.nlp	24931645	SENT9	37	37	10	10	sitagliptin	GLP-1	PA164748978	100125288	0.95
NULL	Breast_Cancer_Res_2005_Apr_6_7(3)_119-130.nxml.txt.nlp	15987442	SENT38	37	37	31	31	tamoxifen	N-CoR	PA451581	9611	0.95
NULL	Indian_J_Med_Paediatr_Oncol_2013_Apr-Jun_34(2)_101-103.nxml.txt.nlp	24049297	SENT23	20	20	35	35	cyclophosphamide	FDG	PA449165	23583	0.95
NULL	AIDS_Res_Treat_2012_Apr_1_2012_317695.nxml.txt.nlp	22545210	SENT24	13	13	29	29	zidovudine	gamma	PA451954	9913	0.95
NULL	Nat_Cell_Biol_2014_May_6_16(5)_401-414.nxml.txt.nlp	24705551	SENT170	2	2	9	9	lindane	EMB	PA164754914	133418	0.95
NULL	Appl_Clin_Genet_2013_Jul_19_6_43-52.nxml.txt.nlp	23935381	SENT106	16	16	33	33	mitomycin	PALB2	PA450524	79728	0.95
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT50	10	10	1	1	curcumin	TRAIL	PA151958596	8743	0.95
NULL	Pharmaceuticals_(Basel)_2012_Nov_20_5(11)_1236-1264.nxml.txt.nlp	24281308	SENT1768	4	4	8	8	ridaforolimus	MTOR	PA165291475	2475	0.95
NULL	Oncogene_2010_Nov_18_29(46)_6115-6124.nxml.txt.nlp	20729912	SENT105	0	0	16	16	doxorubicin	ABCG2	PA449412	9429	0.95
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT239	38	38	34	34	liraglutide	GLP-1	PA165958364	100125288	0.95
NULL	Biomed_Res_Int_2014_Aug_6_2014_967826.nxml.txt.nlp	25165721	SENT229	21	21	4	4	cisplatin	CXCL1	PA449014	2919	0.95
NULL	Blood_Cancer_J_2012_Mar_9_2(3)_e60.nxml.txt.nlp	22829255	SENT124	8	8	4	4	flavopiridol	FLT3	PA452627	2322	0.95
NULL	Br_J_Cancer_2013_Feb_5_108(2)_469-476.nxml.txt.nlp	23169292	SENT128	16	16	5	5	erlotinib	KRAS	PA134687924	3845	0.95
NULL	Br_J_Cancer_2011_Apr_12_104(8)_1278-1287.nxml.txt.nlp	21487429	SENT170	22	22	2	2	cisplatin	p53	PA449014	7157	0.95
NULL	Appl_Microbiol_Biotechnol_2014_Feb_18_98(8)_3829-3840.nxml.txt.nlp	24535257	SENT220	34	34	12	12	ethanol	CAT-1	PA448073	6541	0.95
NULL	Oncotarget_2014_Feb_7_5(3)_775-787.nxml.txt.nlp	24519956	SENT219	25	25	0	0	dasatinib	PC3	PA162372878	57332;7832;5122	0.95
NULL	Cancer_Metastasis_Rev_2012_Jun_20_31(1-2)_143-162.nxml.txt.nlp	22101807	SENT440	3	3	17	17	meloxicam	gamma	PA450353	9913	0.95
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Jul_24_69(Pt_8)_o1301-o1302.nxml.txt.nlp	24109379	SENT68	8	8	20	20	l-arginine	C23	PA448478	4691	0.95
NULL	Cancer_Res_Treat_2014_Jul_15_46(3)_307-311.nxml.txt.nlp	25038766	SENT74	7	7	13	13	rituximab	CHOP	PA451261	1649	0.95
NULL	Aging_(Albany_NY)_2012_Jul_21_4(7)_462-479.nxml.txt.nlp	22820736	SENT367	32	32	8	8	trypsin	Set9	PA451806	80854	0.95
NULL	Br_J_Pharmacol_2014_Feb_24_171(1)_1019-1032.nxml.txt.nlp	24251620	SENT48	22	22	29	29	nitrendipine	TRPM3	PA146096020	80036	0.95
NULL	Alcohol_Res_Health_2010_33(1-2)_76-86.nxml.txt.nlp	23579938	SENT170	24	24	3	3	ethanol	ALDH2	PA448073	217	0.95
NULL	Clin_Transl_Allergy_2013_Sep_2_3_29.nxml.txt.nlp	24004581	SENT188	2	2	16	16	omalizumab	CD23	PA164752253	2208	0.95
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1522-1532.nxml.txt.nlp	21997136	SENT214	27	27	2	2	irinotecan	p53	PA450085	7157	0.95
NULL	Clin_Interv_Aging_2012_Dec_30_7_1-13.nxml.txt.nlp	22291468	SENT136	0	0	19	19	dronedarone	CYP3A4	PA153619853	1576	0.95
NULL	Oncotarget_2014_Aug_29_5(19)_8947-8958.nxml.txt.nlp	25333254	SENT4	5	5	3	3	plerixafor	CXCR4	PA165958410	7852	0.95
NULL	J_Neurosci_Rural_Pract_2010_Jul-Dec_1(2)_63-66.nxml.txt.nlp	21808505	SENT24	31	31	12	12	zidovudine	gamma	PA451954	9913	0.95
NULL	J_Inflamm_(Lond)_2007_Oct_10_4_21.nxml.txt.nlp	17925040	SENT56	1	1	10	10	heparin	ACT	PA449855	12;11332;9457;641455	0.95
NULL	Mol_Cancer_2010_Dec_2_9_309.nxml.txt.nlp	21122157	SENT401	0	0	13	13	paclitaxel	IL-6	PA450761	3569	0.95
NULL	Adv_Urol_2012_Oct_26_2012_812398.nxml.txt.nlp	22110495	SENT111	40	40	16	16	cisplatin	EGFR	PA449014	1956	0.95
NULL	J_Hematol_Oncol_2011_Mar_9_4_9.nxml.txt.nlp	21388537	SENT54	6	6	11	11	phenytoin	UGT1A1	PA450947	54658	0.95
NULL	Biomed_Res_Int_2014_Jun_2_2014_946492.nxml.txt.nlp	24991574	SENT118	10	10	27	27	olmesartan	ATRAP	PA164742950	57085	0.95
NULL	Cancer_Cell_Int_2005_Jul_24_5_22.nxml.txt.nlp	16042792	SENT116	18	18	7	7	indomethacin	MRP1	PA449982	4437	0.95
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT370	14	14	24	24	resveratrol	IL-6		3569	0.95
NULL	Tuberc_Respir_Dis_(Seoul)_2013_Mar_29_74(3)_129-133.nxml.txt.nlp	23579627	SENT59	12	12	8	8	afatinib	EGFR	PA165981154	1956	0.95
NULL	Arch_Med_Sci_2011_Jun_11_7(3)_388-396.nxml.txt.nlp	22312373	SENT26	8	8	27	27	simvastatin	CYP3A	PA451363	1574	0.95
NULL	J_Cell_Biol_2008_Jul_28_182(2)_381-393.nxml.txt.nlp	18663145	SENT213	22	22	1	1	trypsin	GIV	PA451806	55704	0.95
NULL	Environ_Health_Perspect_2011_Mar_1_119(3)_371-376.nxml.txt.nlp	21041162	SENT79	0	0	39	39	fluorescein	San	PA164746009	80218	0.95
NULL	Carcinogenesis_2013_Feb_3_34(2)_351-360.nxml.txt.nlp	23125222	SENT274	19	19	3	3	curcumin	NAC	PA151958596	22861	0.95
NULL	Bone_Joint_Res_2014_Mar_1_3(3)_51-59.nxml.txt.nlp	24615710	SENT192	33	33	6	6	resveratrol	SIRT1		23411	0.95
NULL	Breast_Cancer_Res_2006_Nov_1_8(Suppl_2)_P26.nxml.txt.nlp	NULL	SENT13	27	27	14	14	doxycycline	CYP1A1	PA449415	1543	0.95
NULL	Basic_Clin_Pharmacol_Toxicol_2013_Feb_5_112(2)_132-137.nxml.txt.nlp	22900583	SENT23	29	29	25	25	atorvastatin	CYP3A	PA448500	1574	0.95
NULL	Mar_Drugs_2014_Dec_18_12(12)_6190-6212.nxml.txt.nlp	25528960	SENT105	27	27	18	18	rosiglitazone	adiponectin	PA451283	9370	0.95
NULL	Cancers_(Basel)_2013_Nov_11_5(4)_1522-1544.nxml.txt.nlp	24351670	SENT193	16	16	25	25	cisplatin	CD9	PA449014	928	0.95
NULL	Oncotarget_2014_Nov_8_5(21)_10280-10292.nxml.txt.nlp	25373733	SENT196	4	4	8	8	bevacizumab	HIF-1	PA130232992	29072	0.95
NULL	J_Korean_Med_Sci_2010_Apr_19_25(4)_557-563.nxml.txt.nlp	20357998	SENT159	16	16	3	3	cisplatin	MCP-1	PA449014	6347	0.95
NULL	Mol_Cancer_2010_Jun_25_9_165.nxml.txt.nlp	20576164	SENT219	11	11	26	26	curcumin	IFN	PA151958596	3439	0.95
NULL	Front_Physiol_2014_Dec_22_5_482.nxml.txt.nlp	25566084	SENT289	17	17	2	2	flecainide	PKP2	PA449646	5318	0.95
NULL	Cancer_Cell_Int_2010_Sep_9_10_32.nxml.txt.nlp	20828393	SENT189	18	18	13	13	cisplatin	ATF3	PA449014	467	0.95
NULL	ScientificWorldJournal_2013_Jun_19_2013_174392.nxml.txt.nlp	23853530	SENT4	13	13	32	32	doxazosin	PC-3	PA449407	692094	0.95
NULL	Cancer_Manag_Res_2013_Jul_31_5_197-203.nxml.txt.nlp	23940421	SENT73	34	34	25	25	vismodegib	SMO		6608;54498	0.95
NULL	Cell_Death_Dis_2014_Jul_17_5(7)_e1333.nxml.txt.nlp	25032856	SENT255	14	14	5	5	candesartan	TLR4	PA448765	7099	0.95
NULL	J_Cardiothorac_Surg_2013_Mar_15_8_47.nxml.txt.nlp	23497403	SENT53	13	13	28	28	heparin	ACT	PA449855	12;11332;9457;641455	0.95
NULL	Nat_Med_2011_Aug_28_17(9)_1094-1100.nxml.txt.nlp	21873989	SENT39	22	22	11	11	imatinib	IL-17	PA10804	3605	0.95
NULL	BMJ_Open_2014_Feb_27_4(2)_e004071.nxml.txt.nlp	24578536	SENT196	19	19	2	2	warfarin	TTR	PA451906	7276	0.95
NULL	Aging_(Albany_NY)_2013_Jan_29_5(1)_3-17.nxml.txt.nlp	23363843	SENT51	32	32	15	15	etoposide	p53	PA449552	7157	0.95
NULL	Ann_Rheum_Dis_2014_Jun_19_73(6)_1000-1006.nxml.txt.nlp	24553909	SENT29	3	3	35	35	ustekinumab	IL-23	PA166048654	51561	0.95
NULL	Antiviral_Res_2009_May_82(2)_A99-A109.nxml.txt.nlp	19176219	SENT116	41	41	7	7	tenofovir	MRP-1	PA10204	928	0.95
NULL	Biomed_Res_Int_2014_Jun_25_2014_764981.nxml.txt.nlp	25057499	SENT113	29	29	5	5	crizotinib	Met	PA165946122	79811	0.95
NULL	Sci_Rep_2015_Jan_6_5_7642.nxml.txt.nlp	25560837	SENT891	27	27	23	23	sr144528	CB2		1269	0.95
NULL	Cancers_(Basel)_2014_Sep_5_6(3)_1769-1792.nxml.txt.nlp	25198391	SENT53	12	12	6	6	irinotecan	UGT1A1	PA450085	54658	0.95
NULL	Breast_Cancer_Res_2010_Mar_5_12(2)_R16.nxml.txt.nlp	20205716	SENT282	21	21	8	8	lovastatin	PTEN	PA450272	5728	0.95
NULL	Br_J_Cancer_2009_Mar_10_100(5)_758-763.nxml.txt.nlp	19259094	SENT134	29	29	22	22	belinostat	DAC		13	0.95
NULL	Clin_Med_Insights_Oncol_2013_Oct_29_7_269-277.nxml.txt.nlp	24250243	SENT113	40	40	5	5	sorafenib	VEGFR	PA7000	3791	0.95
NULL	Cancer_Immunol_Immunother_2013_Aug_27_62(10)_1637-1648.nxml.txt.nlp	23982484	SENT238	6	6	23	23	lenalidomide	IL-6	PA162363968	3569	0.95
NULL	Oncol_Lett_2013_Dec_18_6(6)_1539-1542.nxml.txt.nlp	24260043	SENT84	0	0	6	6	doxorubicin	p53	PA449412	7157	0.95
NULL	Mar_Drugs_2011_Jun_9_9(6)_1007-1023.nxml.txt.nlp	21747745	SENT189	3	3	6	6	trastuzumab	HER2	PA451743	2064	0.95
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT111	34	34	3	3	pemetrexed	UNG	PA10810	7374	0.95
NULL	Biochem_Res_Int_2012_May_17_2012_973723.nxml.txt.nlp	22666593	SENT101	22	22	3	3	phenylephrine	MYOCD	PA450935	93649	0.95
NULL	Indian_J_Pharmacol_2013_Mar-Apr_45(2)_155-158.nxml.txt.nlp	23716892	SENT116	31	31	12	12	pioglitazone	CYP2C19	PA450970	1557	0.95
NULL	J_Hematol_Oncol_2009_Apr_22_2_18.nxml.txt.nlp	19386128	SENT116	21	21	12	12	panitumumab	KRAS	PA162373091	3845	0.95
NULL	Eur_J_Histochem_2011_Mar_24_55(1)_e6.nxml.txt.nlp	21556121	SENT15	10	10	3	3	heparin	HRG	PA449855	3084;3273	0.95
NULL	Evid_Based_Complement_Alternat_Med_2011_Feb_20_2011_541209.nxml.txt.nlp	21799681	SENT85	4	4	38	38	curcumin	c-Jun	PA151958596	3725	0.95
NULL	Front_Mol_Neurosci_2012_Nov_12_5_99.nxml.txt.nlp	23162427	SENT265	29	29	3	3	cocaine	SIRT1	PA449072	23411	0.95
NULL	Int_J_Vasc_Med_2013_Mar_31_2013_543141.nxml.txt.nlp	23606968	SENT128	16	16	9	9	methylprednisolone	IL-17	PA450466	3605	0.95
NULL	Int_J_Mol_Sci_2014_Oct_23_15(10)_19265-19280.nxml.txt.nlp	25342321	SENT117	8	8	29	29	sc-560	COX		1351	0.95
NULL	EPMA_J_2010_Sep_22_1(3)_377-387.nxml.txt.nlp	23199082	SENT134	4	4	15	15	trastuzumab	HER2	PA451743	2064	0.95
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_11_2014_274786.nxml.txt.nlp	25505920	SENT245	5	5	32	32	curcumin	ERCC1	PA151958596	2067	0.95
NULL	Mol_Vis_2011_Dec_27_17_3415-3422.nxml.txt.nlp	22219637	SENT160	23	23	6	6	estradiol	p38	PA449503	10598;1432;7965	0.95
NULL	Front_Genet_2014_Nov_14_5_391.nxml.txt.nlp	25452763	SENT1023	21	21	4	4	cisplatin	MTHFR	PA449014	4524	0.95
NULL	Mol_Cancer_2010_Nov_8_9_291.nxml.txt.nlp	21059223	SENT95	5	5	0	0	paclitaxel	ZNF217	PA450761	7764	0.95
NULL	Cerebrospinal_Fluid_Res_2007_Sep_20_4_8.nxml.txt.nlp	17883837	SENT410	13	13	0	0	nitroprusside	AQP1	PA451406	358	0.95
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Dec_17_3(12)_e152.nxml.txt.nlp	25518025	SENT41	21	21	13	13	oxycodone	CYP2D6	PA450741	1565	0.95
NULL	Gut_2012_Aug_24_61(8)_1146-1153.nxml.txt.nlp	22115910	SENT109	32	32	5	5	fluorescein	CLE	PA164746009	51637	0.95
NULL	Arthritis_Res_Ther_2009_Oct_6_11(5)_128.nxml.txt.nlp	19818166	SENT20	21	21	10	10	etanercept	CD27	PA449515	939	0.95
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT181	26	26	19	19	doxorubicin	ABCB1	PA449412	5243	0.95
NULL	Nucleic_Acids_Res_2012_Apr_16_40(8)_3641-3652.nxml.txt.nlp	22180534	SENT108	13	13	5	5	tobramycin	GAL	PA451704	51083	0.95
NULL	Arthritis_Res_Ther_2014_Oct_30_16(5)_467.nxml.txt.nlp	25359150	SENT167	18	18	4	4	adalimumab	CXCL13	PA10004	10563	0.95
NULL	Breast_Cancer_Res_2011_Mar_11_13(2)_R30.nxml.txt.nlp	21396117	SENT35	12	12	15	15	erlotinib	EGFR	PA134687924	1956	0.95
NULL	Nucleic_Acids_Res_2005_Oct_27_33(18)_6024-6033.nxml.txt.nlp	16254079	SENT501	18	18	6	6	bicalutamide	HDAC2	PA164746255	3066	0.95
NULL	Anemia_2011_Dec_13_2011_945289.nxml.txt.nlp	21490768	SENT50	15	15	4	4	calcein	LIP	PA132595336	23049	0.95
NULL	Cancers_(Basel)_2010_Dec_22_2(4)_2153-2170.nxml.txt.nlp	21390244	SENT20	11	11	1	1	erlotinib	EGFR	PA134687924	1956	0.95
NULL	Ann_Med_2014_Nov_21_46(7)_475-489.nxml.txt.nlp	25045928	SENT150	31	31	22	22	cangrelor	P2Y12	PA165945763	64805	0.95
NULL	Ther_Clin_Risk_Manag_2006_Dec_2(4)_435-445.nxml.txt.nlp	18360654	SENT101	9	9	13	13	erlotinib	CA4	PA134687924	762	0.95
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT147	28	28	38	38	sitagliptin	HIP	PA164748978	6767;6159;64399;5068	0.95
NULL	Nat_Med_2011_Dec_4_18(1)_111-119.nxml.txt.nlp	22138751	SENT42	12	12	17	17	doxycycline	TERT	PA449415	7015	0.95
NULL	Hum_Genomics_2008_Sep_1_3(1)_17-23.nxml.txt.nlp	19129087	SENT122	29	29	3	3	proguanil	CYP2C19	PA451124	1557	0.95
NULL	Front_Oncol_2014_Mar_25_4_54.nxml.txt.nlp	24724051	SENT123	0	0	10	10	sirolimus	TORC1	PA451365	23373	0.95
NULL	J_Korean_Assoc_Oral_Maxillofac_Surg_2014_Dec_26_40(6)_291-296.nxml.txt.nlp	25551094	SENT99	24	24	8	8	alendronate	M-CSF	PA448082	1435	0.95
NULL	Dis_Markers_2008_Aug_22_25(1)_37-47.nxml.txt.nlp	18776590	SENT9	3	3	6	6	doxycycline	TTR	PA449415	7276	0.95
NULL	Korean_Circ_J_2013_May_31_43(5)_287-292.nxml.txt.nlp	23755073	SENT81	30	30	1	1	dabigatran	VKORC1		79001	0.95
NULL	Biosci_Rep_2012_Aug_1_32(Pt_4)_361-374.nxml.txt.nlp	22762204	SENT204	26	26	3	3	cyclophosphamide	p53	PA449165	7157	0.95
NULL	Arthritis_Res_Ther_2006_Feb_3_8(2)_R43.nxml.txt.nlp	16507142	SENT151	31	31	17	17	fluorescein	CXCL12	PA164746009	6387	0.95
NULL	Clin_Exp_Metastasis_2014_Sep_17_31(1)_135-147.nxml.txt.nlp	24043563	SENT188	16	16	6	6	paclitaxel	KLK4	PA450761	9622	0.95
NULL	Br_J_Cancer_2012_Jan_17_106(2)_348-357.nxml.txt.nlp	22146521	SENT179	22	22	6	6	gemcitabine	TP53	PA449748	7157	0.95
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1137-1144.nxml.txt.nlp	20234366	SENT145	6	6	0	0	cetuximab	MKP-1	PA10040	1843	0.95
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S177-S183.nxml.txt.nlp	21525452	SENT111	9	9	2	2	exenatide	GLP-1	PA164749238	100125288	0.95
NULL	Evid_Based_Complement_Alternat_Med_2015_Jan_6_2015_802903.nxml.txt.nlp	25632291	SENT104	15	15	24	24	berberine	CYP2D6	PA165860812	1565	0.95
NULL	Mol_Cancer_2008_Oct_23_7_82.nxml.txt.nlp	18947424	SENT547	0	0	10	10	lovastatin	CYP3A4	PA450272	1576	0.95
NULL	Cancers_(Basel)_2014_Mar_26_6(2)_708-722.nxml.txt.nlp	24675568	SENT59	15	15	1	1	paclitaxel	STAT3	PA450761	6774	0.95
NULL	J_Am_Heart_Assoc_2013_Apr_24_2(2)_e000128.nxml.txt.nlp	23584809	SENT113	6	6	11	11	nitroprusside	EPO	PA451406	7076;8288;2056	0.95
NULL	Open_AIDS_J_2011_Apr_22_5_44-50.nxml.txt.nlp	21643422	SENT44	33	33	18	18	lamivudine	ATV	PA450163	4683	0.95
NULL	Acta_Pharmacol_Sin_2011_Apr_14_32(4)_449-455.nxml.txt.nlp	21399654	SENT3	9	9	35	35	isoproterenol	adiponectin	PA450121	9370	0.95
NULL	Mol_Syst_Biol_2010_Dec_21_6_453.nxml.txt.nlp	21179025	SENT189	24	24	7	7	sunitinib	HIF1	PA162372840	3091	0.95
NULL	Evid_Based_Complement_Alternat_Med_2014_Jan_8_2014_976364.nxml.txt.nlp	24527057	SENT180	29	29	22	22	oseltamivir	IL-8	PA450721	3576	0.95
NULL	Onco_Targets_Ther_2014_May_28_7_841-852.nxml.txt.nlp	24920926	SENT73	10	10	15	15	gefitinib	EGFR	PA131301952	1956	0.95
NULL	Clin_Genet_2011_Jun_79(6)_582-587.nxml.txt.nlp	20573158	SENT37	30	30	11	11	diazoxide	ABCC8	PA449285	6833	0.95
NULL	EPMA_J_2013_Jan_28_4(1)_3.nxml.txt.nlp	23356214	SENT328	27	27	13	13	cetuximab	PTEN	PA10040	5728	0.95
NULL	Behav_Brain_Funct_2010_Oct_7_6_57.nxml.txt.nlp	20929549	SENT181	4	4	15	15	methylphenidate	SLC6A3	PA450464	6531	0.95
NULL	Nat_Biotechnol_2013_Dec_9_31(12)_10_1038_nbt_2726.nxml.txt.nlp	24108092	SENT33	5	5	9	9	decitabine	RHOXF2	PA164749631	84528	0.95
NULL	J_Hematol_Oncol_2012_Feb_14_5_3.nxml.txt.nlp	22333219	SENT169	44	44	35	35	dacarbazine	BRAF	PA449197	673	0.95
NULL	Arthritis_Res_Ther_2013_Apr_17_15(2)_R51.nxml.txt.nlp	23594962	SENT300	6	6	33	33	muraglitazar	IL-6	PA162356187	3569	0.95
NULL	J_Cancer_2013_Jan_11_4(2)_117-132.nxml.txt.nlp	23386910	SENT233	23	23	30	30	vinorelbine	HER2	PA451881	2064	0.95
NULL	Cancers_(Basel)_2013_Nov_26_5(4)_1601-1618.nxml.txt.nlp	24287743	SENT170	21	21	5	5	erlotinib	Met	PA134687924	79811	0.95
NULL	Acta_Pharmacol_Sin_2012_Jan_3_33(1)_49-56.nxml.txt.nlp	22212430	SENT104	18	18	3	3	thrombin	JNK	PA451674	5599	0.95
NULL	Iran_J_Psychiatry_2010_Winter_5(1)_11-17.nxml.txt.nlp	22952484	SENT157	5	5	28	28	pyrilamine	OAT	PA165817939	4942	0.95
NULL	Curr_Med_Chem_2013_Jan_20(3)_438-447.nxml.txt.nlp	23157636	SENT191	3	3	17	17	clozapine	FGA	PA449061	2243	0.95
NULL	AIDS_Res_Treat_2012_Nov_8_2012_595762.nxml.txt.nlp	23193464	SENT94	2	2	5	5	raltegravir	CCR5		1234	0.95
NULL	J_Ophthalmic_Inflamm_Infect_2013_Feb_11_3_32.nxml.txt.nlp	23514595	SENT34	0	0	26	26	sirolimus	FKBP-12	PA451365	2280	0.95
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_25_2013_504642.nxml.txt.nlp	23878600	SENT62	32	32	13	13	captopril	TFG	PA448780	10342	0.95
NULL	Carcinogenesis_2010_Dec_27_31(12)_2049-2057.nxml.txt.nlp	20876285	SENT178	43	43	25	25	tamoxifen	HER2	PA451581	2064	0.95
NULL	Br_J_Cancer_2012_Jan_3_106(1)_107-115.nxml.txt.nlp	22116303	SENT108	4	4	32	32	vorinostat	AKT	PA164748224	207	0.95
NULL	Mol_Cancer_2014_Jan_13_13_7.nxml.txt.nlp	24418169	SENT15	17	17	9	9	sorafenib	survivin	PA7000	332	0.95
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT179	4	4	19	19	doxorubicin	AKT	PA449412	207	0.95
NULL	Breast_Cancer_Res_2011_Oct_12_13(5)_220.nxml.txt.nlp	22018398	SENT197	24	24	32	32	paclitaxel	STAT3	PA450761	6774	0.95
NULL	Arthritis_Res_Ther_2012_Jun_27_14(3)_R155.nxml.txt.nlp	22734582	SENT94	16	16	5	5	imiquimod	IFN	PA449972	3439	0.95
NULL	Med_Sci_Monit_2014_Aug_1_20_1345-1352.nxml.txt.nlp	25080850	SENT135	26	26	8	8	rosiglitazone	AQP7	PA451283	364	0.95
NULL	Oncogene_2013_Sep_5_32(36)_4252-4263.nxml.txt.nlp	23045288	SENT83	8	8	1	1	idarubicin	CD49f	PA449961	3655	0.95
NULL	Acta_Pharmacol_Sin_2013_Jan_17_34(1)_157-166.nxml.txt.nlp	23247593	SENT252	36	36	4	4	berberine	Set9	PA165860812	80854	0.95
NULL	Clin_Epigenetics_2011_Jun_27_2(2)_171-185.nxml.txt.nlp	21949547	SENT59	23	23	11	11	doxorubicin	MRP2	PA449412	100130958;57626;1244	0.95
NULL	J_Cardiothorac_Surg_2014_Jun_19_9_105.nxml.txt.nlp	24942178	SENT61	9	9	16	16	heparin	ACT	PA449855	12;11332;9457;641455	0.95
NULL	Br_J_Cancer_2012_Nov_20_107(11)_1864-1868.nxml.txt.nlp	23093229	SENT28	0	0	16	16	cetuximab	EGFR	PA10040	1956	0.95
NULL	Eur_J_Clin_Pharmacol_2010_Nov_29_66(11)_1131-1136.nxml.txt.nlp	20669013	SENT128	6	6	10	10	voriconazole	CYP3A4	PA10233	1576	0.95
NULL	Cancer_Med_2013_Aug_2_2(4)_571-582.nxml.txt.nlp	24156030	SENT15	4	4	26	26	curcumin	IL-6	PA151958596	3569	0.95
NULL	EJNMMI_Res_2011_Jun_7_1_1.nxml.txt.nlp	21845232	SENT221	10	10	17	17	panitumumab	Ray	PA162373091	26751	0.95
NULL	Case_Rep_Oncol_2010_Apr_22_3(2)_98-105.nxml.txt.nlp	20740181	SENT5	32	32	21	21	erlotinib	EGFR	PA134687924	1956	0.95
NULL	Clin_Drug_Investig_2012_Dec_13_32(8)_e17-e24.nxml.txt.nlp	22708825	SENT37	29	29	4	4	vancomycin	NNT	PA451850	23530	0.95
NULL	Oncogene_2010_Jun_24_29(25)_3639-3649.nxml.txt.nlp	20453883	SENT84	12	12	4	4	doxycycline	HEXIM1	PA449415	10614	0.95
NULL	Cancer_Med_2014_Oct_2_3(5)_1256-1265.nxml.txt.nlp	24890382	SENT132	16	16	0	0	trastuzumab	HER2	PA451743	2064	0.95
NULL	Breast_Cancer_Res_2014_Sep_11_16(5)_430.nxml.txt.nlp	25212826	SENT484	13	13	5	5	tamoxifen	PTEN	PA451581	5728	0.95
NULL	J_Signal_Transduct_2011_Jan_5_2011_821615.nxml.txt.nlp	21637381	SENT134	10	10	32	32	estradiol	p38	PA449503	10598;1432;7965	0.95
NULL	Int_J_Nanomedicine_2012_Sep_13_7_4917-4926.nxml.txt.nlp	23028220	SENT217	24	24	14	14	calcein	mol	PA132595336	90527	0.95
NULL	Breast_Cancer_Res_2011_Nov_28_13(6)_R121.nxml.txt.nlp	22123186	SENT208	19	19	7	7	trastuzumab	HER2	PA451743	2064	0.95
NULL	Breast_Cancer_Res_2012_Jul_19_14(4)_R109.nxml.txt.nlp	22812567	SENT215	21	21	14	14	gemcitabine	CHK1	PA449748	1111	0.95
NULL	N_Am_J_Med_Sci_2012_Dec_4(12)_638-640.nxml.txt.nlp	23272306	SENT73	13	13	24	24	metformin	Met	PA450395	79811	0.949
NULL	J_Immunol_Res_2014_May_8_2014_565320.nxml.txt.nlp	24901010	SENT65	23	23	4	4	lamotrigine	HLA-B	PA450164	3106	0.949
NULL	Biol_Open_2014_Dec_12_4(1)_48-61.nxml.txt.nlp	25505152	SENT498	21	21	31	31	metformin	AMPK	PA450395	5563	0.949
NULL	Basic_Clin_Pharmacol_Toxicol_2009_Sep_105(3)_199-206.nxml.txt.nlp	19496778	SENT193	4	4	0	0	cyclosporine	PEPT1	PA449167	6564	0.949
NULL	Acta_Pharmacol_Sin_2009_Mar_5_30(3)_355-363.nxml.txt.nlp	19262559	SENT106	8	8	28	28	metrizamide	CD11c	PA164742936	3687	0.949
NULL	Arthritis_Res_Ther_2005_Dec_17_7(1)_38-41.nxml.txt.nlp	15642152	SENT78	19	19	3	3	methotrexate	IL-18	PA450428	3606	0.949
NULL	Breast_Cancer_Res_2011_Nov_1_13(6)_224.nxml.txt.nlp	22114931	SENT109	15	15	5	5	lapatinib	HER2	PA152241907	2064	0.949
NULL	Oncotarget_2014_Aug_19_5(18)_8737-8749.nxml.txt.nlp	25228590	SENT155	3	3	33	33	crizotinib	PI3K	PA165946122	5290	0.949
NULL	J_Hematol_Oncol_2009_Jan_21_2_2.nxml.txt.nlp	19159467	SENT134	13	13	24	24	gefitinib	EGFR	PA131301952	1956	0.949
NULL	Anesth_Essays_Res_2014_Jan-Apr_8(1)_9-12.nxml.txt.nlp	NULL	SENT70	23	23	7	7	palonosetron	CYP2D6	PA10352	1565	0.949
NULL	Mol_Cell_Proteomics_2012_Feb_6_11(2)_M111_015222.nxml.txt.nlp	22147731	SENT409	22	22	15	15	cetuximab	JAG1	PA10040	182	0.949
NULL	J_Geriatr_Cardiol_2012_Jun_9(2)_209-210.nxml.txt.nlp	23097648	SENT9	18	18	6	6	warfarin	VKORC1	PA451906	79001	0.949
NULL	Cancer_Med_2013_Apr_6_2(2)_234-242.nxml.txt.nlp	23634291	SENT218	6	6	17	17	bevacizumab	CXCL6	PA130232992	6372	0.949
NULL	Int_J_Biol_Sci_2013_Mar_7_9(3)_279-288.nxml.txt.nlp	23493630	SENT122	33	33	9	9	tocilizumab	CD4	PA165292659	920	0.949
NULL	Breast_Cancer_Res_Treat_2013_Jun_5_139(3)_649-655.nxml.txt.nlp	23736997	SENT17	14	14	27	27	tamoxifen	CYP2C19	PA451581	1557	0.949
NULL	Cancer_Cell_Int_2013_May_15_13_42.nxml.txt.nlp	23672670	SENT222	32	32	8	8	paclitaxel	RAIDD	PA450761	8738	0.949
NULL	Acta_Pharmacol_Sin_2010_Mar_22_31(3)_329-340.nxml.txt.nlp	20173759	SENT154	28	28	6	6	ethanol	AMPK	PA448073	5563	0.949
NULL	Arthritis_Res_Ther_2009_Aug_17_11(4)_R123.nxml.txt.nlp	19686595	SENT17	26	26	3	3	rituximab	CD27	PA451261	939	0.949
NULL	Genome_Med_2010_Aug_11_2(8)_53.nxml.txt.nlp	20701793	SENT60	5	5	25	25	sunitinib	CSF1	PA162372840	1435	0.949
NULL	Pharmaceuticals_(Basel)_2011_Jan_25_4(2)_244-272.nxml.txt.nlp	NULL	SENT975	6	6	10	10	maraviroc	CCR5	PA164768835	1234	0.949
NULL	Case_Rep_Endocrinol_2014_Feb_10_2014_479641.nxml.txt.nlp	24660072	SENT9	0	0	12	12	cinacalcet	PTH	PA164776671	5741	0.949
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT120	33	33	9	9	capsaicin	p53	PA448776	7157	0.949
NULL	Front_Neurol_2014_Apr_29_5_63.nxml.txt.nlp	24808888	SENT238	32	32	3	3	carbamazepine	ghrelin	PA448785	51738	0.949
NULL	Behav_Brain_Funct_2008_Aug_15_4_37.nxml.txt.nlp	18702828	SENT66	16	16	9	9	methamphetamine	FZD3	PA450403	7976;8326	0.949
NULL	Breast_Cancer_Res_2013_Oct_18_15(5)_R97.nxml.txt.nlp	24135425	SENT20	26	26	34	34	trastuzumab	DM1	PA451743	338023;1760;28509	0.949
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1059-1066.nxml.txt.nlp	21364577	SENT46	11	11	25	25	anastrozole	aromatase	PA448432	1588	0.949
NULL	HPB_Surg_2014_Jul_1_2014_983684.nxml.txt.nlp	25100899	SENT22	1	1	24	24	ethanol	spatial	PA448073	219793	0.949
NULL	Clin_Pharmacol_2012_Feb_20_4_13-20.nxml.txt.nlp	22427735	SENT22	28	28	10	10	clopidogrel	PON1	PA449053	5444	0.949
NULL	Oncotarget_2011_Mar_28_2(3)_222-233.nxml.txt.nlp	21447859	SENT90	10	10	25	25	paclitaxel	p53	PA450761	7157	0.949
NULL	Biomed_Res_Int_2014_Jan_12_2014_698313.nxml.txt.nlp	24524085	SENT23	27	27	6	6	tocilizumab	IL-6	PA165292659	3569	0.949
NULL	Oncogene_2014_Feb_6_33(6)_713-723.nxml.txt.nlp	23435429	SENT94	11	11	19	19	etoposide	BRCA1	PA449552	672	0.949
NULL	Afr_J_Infect_Dis_2010_4(2)_29-42.nxml.txt.nlp	23878698	SENT15	1	1	23	23	artemisinin	ACT	PA165111696	12;11332;9457;641455	0.949
NULL	Mol_Brain_2014_Aug_21_7_59.nxml.txt.nlp	25139109	SENT57	3	3	9	9	chloroquine	TLR4	PA448948	7099	0.949
NULL	FEBS_Open_Bio_2013_May_10_3_225-230.nxml.txt.nlp	23772398	SENT141	24	24	11	11	cisplatin	CD9	PA449014	928	0.949
NULL	J_Biol_2003_Sep_24_2(4)_28.nxml.txt.nlp	14511394	SENT129	13	13	30	30	phenformin	LKB1	PA1000	6794	0.949
NULL	Front_Chem_2014_Mar_14_2_12.nxml.txt.nlp	24790981	SENT498	0	0	5	5	curcumin	p300	PA151958596	2033	0.949
NULL	Cancer_Res_Treat_2014_Jan_15_46(1)_55-64.nxml.txt.nlp	24520224	SENT32	21	21	8	8	oxaliplatin	ERCC1	PA131285527	2067	0.949
NULL	J_Korean_Assoc_Oral_Maxillofac_Surg_2014_Dec_26_40(6)_291-296.nxml.txt.nlp	25551094	SENT122	16	16	8	8	alendronate	M-CSF	PA448082	1435	0.949
NULL	Calcif_Tissue_Int_2011_Aug_3_89(2)_91-104.nxml.txt.nlp	21637997	SENT240	3	3	5	5	teriparatide	PTH	PA451620	5741	0.949
NULL	Ann_Med_Health_Sci_Res_2013_Apr-Jun_3(2)_282-284.nxml.txt.nlp	23919207	SENT70	34	34	4	4	imipenem	RGM	PA449968	56963	0.949
NULL	Curr_Osteoporos_Rep_2010_Dec_1_8(4)_178-184.nxml.txt.nlp	20809203	SENT221	13	13	24	24	metformin	Met	PA450395	79811	0.949
NULL	Mol_Cancer_2010_Aug_23_9_222.nxml.txt.nlp	20731837	SENT105	23	23	16	16	gefitinib	EGFR	PA131301952	1956	0.949
NULL	Clin_Cosmet_Investig_Dermatol_2011_Apr_8_4_35-40.nxml.txt.nlp	21691565	SENT11	0	0	27	27	imiquimod	IL-6	PA449972	3569	0.949
NULL	Eukaryot_Cell_2014_Aug_13(8)_1077-1084.nxml.txt.nlp	24951438	SENT180	23	23	15	15	doxycycline	RSP5	PA449415	23327	0.949
NULL	Ann_Dermatol_2011_Oct_31_23(Suppl_2)_S169-S174.nxml.txt.nlp	22148042	SENT104	31	31	11	11	doxorubicin	CHOP	PA449412	1649	0.949
NULL	Pain_Res_Treat_2013_Jan_30_2013_217864.nxml.txt.nlp	23431433	SENT77	10	10	6	6	amiloride	NHE	PA448368	285335	0.949
NULL	Asian-Australas_J_Anim_Sci_2014_Dec_27(12)_1783-1793.nxml.txt.nlp	25358373	SENT240	13	13	7	7	capsaicin	BAX	PA448776	581	0.949
NULL	Diabetes_2011_Jul_20_60(7)_1946-1954.nxml.txt.nlp	21617177	SENT86	9	9	30	30	trypsin	San	PA451806	80218	0.949
NULL	J_Immunother_2014_Apr_12_37(3)_180-186.nxml.txt.nlp	24598448	SENT173	7	7	32	32	sorafenib	IL-2	PA7000	3558	0.949
NULL	Diabetol_Metab_Syndr_2014_Mar_31_6_47.nxml.txt.nlp	24684779	SENT148	31	31	13	13	pioglitazone	IL-6	PA450970	3569	0.949
NULL	AIDS_2013_Nov_28_27(18)_F21-F28.nxml.txt.nlp	24051706	SENT107	4	4	10	10	maraviroc	CD68	PA164768835	968	0.949
NULL	Breast_Cancer_Res_2011_Mar_1_13(2)_R21.nxml.txt.nlp	21362200	SENT296	3	3	30	30	estradiol	PI3K	PA449503	5290	0.949
NULL	Br_J_Cancer_2012_Aug_7_107(4)_626-631.nxml.txt.nlp	22805329	SENT150	12	12	22	22	cetuximab	MUT	PA10040	4594	0.949
NULL	Breast_Cancer_Res_Treat_2007_Dec_27_106(2)_161-170.nxml.txt.nlp	17260092	SENT249	3	3	37	37	tamoxifen	aromatase	PA451581	1588	0.949
NULL	Hum_Genomics_2008_Sep_1_3(1)_53-70.nxml.txt.nlp	19129090	SENT211	26	26	17	17	perifosine	PSMA2	PA165291471	5683	0.949
NULL	Clin_Mol_Allergy_2007_Jan_25_5_1.nxml.txt.nlp	17254346	SENT139	29	29	2	2	curcumin	IL-4	PA151958596	3565	0.949
NULL	CNS_Spectr_2014_Oct_3_19(5)_391-402.nxml.txt.nlp	24698103	SENT233	0	0	20	20	clozapine	5-HT2A	PA449061	3356	0.949
NULL	Mol_Cancer_2014_Jul_5_13_165.nxml.txt.nlp	24996221	SENT133	26	26	40	40	docetaxel	LC3	PA449383	84557	0.949
NULL	Cancer_Res_Treat_2014_Jan_15_46(1)_48-54.nxml.txt.nlp	24520223	SENT120	24	24	15	15	irinotecan	KRAS	PA450085	3845	0.949
NULL	Diabetes_Metab_Syndr_Obes_2014_Jan_18_7_15-24.nxml.txt.nlp	24465132	SENT50	21	21	7	7	exenatide	GLP-1	PA164749238	100125288	0.949
NULL	Br_J_Pharmacol_2014_Jan_23_171(2)_523-535.nxml.txt.nlp	24372553	SENT96	7	7	39	39	mannitol	SIRT1	PA450320	23411	0.949
NULL	Indian_J_Nephrol_2010_Jul_20(3)_146-151.nxml.txt.nlp	21072155	SENT107	3	3	8	8	tacrolimus	P-gp	PA451578	5243	0.949
NULL	Clin_Ophthalmol_2007_Sep_1(3)_209-215.nxml.txt.nlp	19668474	SENT102	8	8	17	17	octreotide	TED	PA450678	27112	0.949
NULL	Int_J_Biol_Sci_2014_Feb_6_10(2)_212-224.nxml.txt.nlp	24550689	SENT82	11	11	20	20	temozolomide	MDC	PA451609	6367	0.949
NULL	Mol_Vis_2012_Apr_11_18_901-908.nxml.txt.nlp	22539869	SENT201	16	16	3	3	curcumin	p38	PA151958596	10598;1432;7965	0.949
NULL	EMBO_J_2010_Jan_6_29(1)_68-79.nxml.txt.nlp	19927124	SENT46	7	7	24	24	tetracycline	NO66	PA451640	79697	0.949
NULL	Breast_Cancer_Res_2011_Mar_11_13(2)_R30.nxml.txt.nlp	21396117	SENT326	45	45	28	28	lapatinib	EGFR	PA152241907	1956	0.949
NULL	Part_Fibre_Toxicol_2012_Aug_6_9_31.nxml.txt.nlp	22867088	SENT69	4	4	20	20	deferoxamine	IL-8	PA164746490	3576	0.949
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT361	30	30	9	9	metformin	p53	PA450395	7157	0.949
NULL	Acta_Pharmacol_Sin_2010_Nov_18_31(11)_1447-1453.nxml.txt.nlp	20953204	SENT123	20	20	7	7	rimonabant	IL-6	PA152407999	3569	0.949
NULL	Int_J_Mol_Sci_2014_Sep_5_15(9)_15754-15765.nxml.txt.nlp	25198898	SENT5	5	5	21	21	curcumin	JNK	PA151958596	5599	0.949
NULL	Cell_Death_Differ_2010_Oct_30_17(10)_1624-1635.nxml.txt.nlp	20431602	SENT45	20	20	6	6	paclitaxel	Bcl-2	PA450761	596	0.949
NULL	Mol_Biol_Cell_2014_Apr_1_25(7)_965-976.nxml.txt.nlp	24478450	SENT39	34	34	20	20	galactose	COX	PA449725	1351	0.949
NULL	Case_Rep_Oncol_Med_2014_Sep_14_2014_532924.nxml.txt.nlp	25298899	SENT82	5	5	9	9	paclitaxel	NAC	PA450761	22861	0.949
NULL	Cancers_(Basel)_2014_Apr_16_6(2)_926-957.nxml.txt.nlp	24743778	SENT190	5	5	0	0	niclosamide	STAT3	PA165958408	6774	0.949
NULL	Mol_Biol_Cell_2013_Dec_15_24(24)_3776-3786.nxml.txt.nlp	24131995	SENT74	24	24	22	22	geldanamycin	SGK1	PA152031327	6446	0.949
NULL	Curr_Neuropharmacol_2013_Dec_11(6)_652-663.nxml.txt.nlp	24396340	SENT162	0	0	20	20	capsaicin	TRPV1	PA448776	7442	0.949
NULL	Hum_Reprod_2008_Oct_16_23(10)_2273-2281.nxml.txt.nlp	18635530	SENT165	1	1	26	26	etoposide	p53	PA449552	7157	0.949
NULL	Oxid_Med_Cell_Longev_2013_Nov_28_2013_568093.nxml.txt.nlp	24379901	SENT55	7	7	26	26	resveratrol	SIRT1		23411	0.949
NULL	Indian_J_Psychiatry_2007_Jan-Mar_49(1)_19-25.nxml.txt.nlp	20640061	SENT172	9	9	11	11	topiramate	CYP2C19	PA451728	1557	0.949
NULL	Br_J_Cancer_2011_Jul_26_105(3)_452-459.nxml.txt.nlp	21750557	SENT43	18	18	4	4	valdecoxib	COX2	PA10226	4513;5743	0.949
NULL	Cancer_Med_2013_Jun_25_2(3)_277-285.nxml.txt.nlp	23930204	SENT113	19	19	4	4	capecitabine	PTEN	PA448771	5728	0.949
NULL	Chin_J_Cancer_2011_May_30(5)_293-302.nxml.txt.nlp	21527062	SENT127	0	0	17	17	denosumab	RANKL	PA166048634	8600	0.949
NULL	Cancer_Cell_2007_Dec_11_12(6)_514-527.nxml.txt.nlp	18068629	SENT176	16	16	27	27	etoposide	PI3K	PA449552	5290	0.949
NULL	Cancer_Med_2013_Aug_2_2(4)_571-582.nxml.txt.nlp	24156030	SENT163	14	14	6	6	curcumin	IL-6	PA151958596	3569	0.949
NULL	Antimicrob_Resist_Infect_Control_2013_Jun_20_2(Suppl_1)_P8.nxml.txt.nlp	NULL	SENT15	6	6	16	16	colistin	NAC	PA164760862	22861	0.949
NULL	Front_Microbiol_2014_Mar_14_5_99.nxml.txt.nlp	24672516	SENT82	30	30	5	5	caspofungin	TLR9	PA164743013	54106	0.949
NULL	Sensors_(Basel)_2011_Oct_28_11(11)_10266-10282.nxml.txt.nlp	22346641	SENT183	5	5	11	11	oxygen	ADC	PA450744	113451	0.949
NULL	Aging_(Albany_NY)_2012_Mar_4_4(3)_144-145.nxml.txt.nlp	22388573	SENT12	34	34	38	38	resveratrol	AMPK		5563	0.949
NULL	Aging_(Albany_NY)_2012_Dec_6_4(11)_823-842.nxml.txt.nlp	23235539	SENT54	23	23	4	4	bleomycin	HCA2	PA448645	139081;55811;338442	0.949
NULL	Breast_Cancer_Res_2005_Aug_1_7(5)_R796-R807.nxml.txt.nlp	16168126	SENT24	3	3	18	18	celecoxib	HER-2	PA448871	2064	0.949
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT308	36	36	21	21	ranibizumab	VEGF-A	PA164746012	7422	0.949
NULL	Cancers_(Basel)_2012_Nov_2_4(4)_1161-1179.nxml.txt.nlp	24213503	SENT39	30	30	16	16	daunorubicin	NPM1	PA449212	4869	0.949
NULL	Oncogene_2014_Jul_24_33(30)_3959-3969.nxml.txt.nlp	24096481	SENT47	15	15	24	24	doxorubicin	p53	PA449412	7157	0.949
NULL	Diabetes_2011_Nov_17_60(11)_2691-2700.nxml.txt.nlp	21896928	SENT158	5	5	14	14	resveratrol	SIRT1		23411	0.949
NULL	Org_Med_Chem_Lett_2012_Oct_24_2_33.nxml.txt.nlp	23095284	SENT122	12	12	0	0	galactose	FN1	PA449725	2335	0.949
NULL	Cancer_Cell_Int_2008_Jan_4_8_1.nxml.txt.nlp	18177496	SENT43	20	20	1	1	gefitinib	EWS	PA131301952	2130	0.949
NULL	Cell_Death_Dis_2014_Mar_13_5(3)_e1113.nxml.txt.nlp	24625972	SENT87	20	20	28	28	bleomycin	BI-1	PA448645	7009	0.949
NULL	Ann_Med_Health_Sci_Res_2013_Apr-Jun_3(2)_282-284.nxml.txt.nlp	23919207	SENT70	11	11	4	4	ethambutol	RGM	PA164784021	56963	0.949
NULL	Protein_Cell_2014_Feb_29_5(2)_141-150.nxml.txt.nlp	24474202	SENT67	31	31	27	27	trypsin	ORF26	PA451806	57728	0.949
NULL	Nat_Med_2012_Mar_25_18(4)_538-546.nxml.txt.nlp	22447074	SENT269	25	25	10	10	papain	IL-4	PA450778	3565	0.949
NULL	Diabetes_2011_Nov_17_60(11)_2701-2709.nxml.txt.nlp	21885869	SENT115	35	35	6	6	picrotoxin	PPG	PA164777007	5552	0.949
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT218	0	0	17	17	posaconazole	UGT	PA151958574	7361;7355	0.949
NULL	Arthritis_Res_Ther_2012_Jan_30_14(1)_201.nxml.txt.nlp	22293240	SENT108	7	7	18	18	glucosamine	p38	PA164747613	10598;1432;7965	0.949
NULL	Diabetes_Obes_Metab_2010_Aug_12(8)_700-708.nxml.txt.nlp	20590747	SENT189	24	24	4	4	voglibose	PPG	PA164752433	5552	0.949
NULL	Mol_Cancer_2012_Mar_21_11_13.nxml.txt.nlp	22436134	SENT109	16	16	9	9	doxorubicin	HuR	PA449412	1994	0.949
NULL	Acta_Pharmacol_Sin_2011_Apr_14_32(4)_449-455.nxml.txt.nlp	21399654	SENT3	3	3	35	35	telmisartan	adiponectin	PA451605	9370	0.949
NULL	J_Antimicrob_Chemother_2014_Jul_14_69(7)_1945-1953.nxml.txt.nlp	24633206	SENT219	19	19	34	34	tigecycline	RGM	PA164746412	56963	0.949
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT176	22	22	2	2	doxorubicin	SLK	PA449412	9748;2534	0.949
NULL	Oncol_Rep_2013_Mar_8_29(3)_917-924.nxml.txt.nlp	23314174	SENT158	15	15	2	2	sorafenib	HIF-1	PA7000	29072	0.949
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT115	40	40	31	31	neratinib	HER2	PA165291472	2064	0.949
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT72	3	3	7	7	metformin	EGFR	PA450395	1956	0.949
NULL	Front_Neurosci_2014_Jun_3_8_128.nxml.txt.nlp	24917782	SENT91	10	10	30	30	ethanol	POMC	PA448073	5443	0.949
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_May_30_64(Pt_6)_o1169.nxml.txt.nlp	21202676	SENT59	24	24	34	34	ethanol	mol	PA448073	90527	0.949
NULL	Oncotarget_2014_Dec_4_5(22)_11365-11380.nxml.txt.nlp	25426548	SENT49	11	11	4	4	nutlin-3	p53		7157	0.949
NULL	Lab_Anim_Res_2012_Jun_26_28(2)_109-114.nxml.txt.nlp	22787484	SENT43	29	29	1	1	reserpine	ANOVA	PA451236	4858	0.949
NULL	Int_J_Mol_Sci_2014_Nov_18_15(11)_21401-21418.nxml.txt.nlp	25411802	SENT222	33	33	5	5	phenol	AMPK	PA450913	5563	0.949
NULL	Indian_J_Endocrinol_Metab_2012_Mar_16(Suppl1)_S110-S113.nxml.txt.nlp	22701828	SENT88	12	12	4	4	vildagliptin	GLP-1	PA165958346	100125288	0.949
NULL	Breast_Cancer_Res_2003_Oct_7_5(1)_8-15.nxml.txt.nlp	12559039	SENT163	0	0	14	14	geldanamycin	EGFR	PA152031327	1956	0.949
NULL	J_Ophthalmic_Inflamm_Infect_2012_Feb_4_2(3)_149-152.nxml.txt.nlp	22311604	SENT69	26	26	7	7	vancomycin	CD4	PA451850	920	0.949
NULL	Curr_Pain_Headache_Rep_2011_Aug_12_15(4)_271-279.nxml.txt.nlp	21479998	SENT162	21	21	24	24	quinidine	CYP2D6	PA451209	1565	0.949
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT326	18	18	9	9	nutlin-3	p53		7157	0.949
NULL	Oncol_Lett_2014_Mar_2_7(3)_791-796.nxml.txt.nlp	24527087	SENT111	6	6	21	21	imatinib	CD34	PA10804	947	0.949
NULL	Int_J_Mol_Sci_2012_Sep_25_13(10)_12153-12168.nxml.txt.nlp	23202889	SENT564	10	10	2	2	cetuximab	BRAF	PA10040	673	0.949
NULL	Atten_Defic_Hyperact_Disord_2009_Dec_23_1(2)_201-210.nxml.txt.nlp	20234828	SENT26	4	4	11	11	atomoxetine	CYP2D6	PA134688071	1565	0.949
NULL	Diabetes_2011_Jul_20_60(7)_1861-1871.nxml.txt.nlp	21593203	SENT297	9	9	2	2	colesevelam	GLP-1	PA449095	100125288	0.949
NULL	Cancer_Immunol_Immunother_2011_Jun_25_60(6)_793-808.nxml.txt.nlp	21350947	SENT224	32	32	7	7	sorafenib	IFN	PA7000	3439	0.949
NULL	Mol_Clin_Oncol_2013_Sep_24_1(5)_918-924.nxml.txt.nlp	24649271	SENT128	19	19	9	9	cetuximab	EGFR	PA10040	1956	0.949
NULL	Behav_Brain_Funct_2009_Jun_4_5_23.nxml.txt.nlp	19497110	SENT11	9	9	16	16	ethanol	P90	PA448073	821	0.949
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2012_Feb_20_5_13-30.nxml.txt.nlp	22879796	SENT223	17	17	9	9	fluvastatin	SLCO1B1	PA449688	10599	0.949
NULL	Environ_Health_Perspect_2008_Apr_16_116(4)_426-433.nxml.txt.nlp	18414622	SENT169	36	36	31	31	resveratrol	AP-1		2353;3727;2354;3725	0.949
NULL	Ann_Oncol_2012_Dec_2_23(12)_3007-3016.nxml.txt.nlp	22865781	SENT164	18	18	8	8	trastuzumab	HER2	PA451743	2064	0.949
NULL	Nucleic_Acids_Res_2005_Oct_19_33(18)_5819-5828.nxml.txt.nlp	16237123	SENT98	9	9	20	20	cisplatin	HMGB1	PA449014	3146	0.949
NULL	Pharmaceutics_2011_Nov_18_3(4)_865-913.nxml.txt.nlp	24309312	SENT79	3	3	8	8	amprenavir	CYP3A4	PA448422	1576	0.949
NULL	Mol_Biol_Cell_2013_Jul_1_24(13)_2134-2145.nxml.txt.nlp	23657817	SENT140	4	4	17	17	pp2	RhoA		387	0.949
NULL	Clin_Ophthalmol_2012_Aug_10_6_1287-1291.nxml.txt.nlp	22927741	SENT16	47	47	37	37	ranibizumab	hole	PA164746012	80757	0.949
NULL	Oncotarget_2013_Jul_21_4(8)_1253-1265.nxml.txt.nlp	23896512	SENT198	26	26	15	15	gefitinib	p53	PA131301952	7157	0.949
NULL	Indian_J_Crit_Care_Med_2014_Sep_18(9)_575-584.nxml.txt.nlp	25249742	SENT206	8	8	14	14	pancuronium	NMB	PA450771	10457;4828	0.949
NULL	Indian_J_Pharmacol_2014_Jan-Feb_46(1)_3-12.nxml.txt.nlp	24550577	SENT222	30	30	25	25	erythromycin	P-gp	PA449493	5243	0.949
NULL	EMBO_Mol_Med_2012_Sep_7_4(9)_896-909.nxml.txt.nlp	22887866	SENT164	29	29	6	6	lovastatin	c-Myc	PA450272	4609	0.949
NULL	EMBO_J_2009_Apr_22_28(8)_1043-1054.nxml.txt.nlp	19300439	SENT337	34	34	22	22	genistein	p38	PA165109660	10598;1432;7965	0.949
NULL	Nat_Neurosci_2012_Sep_5_15(9)_1245-1254.nxml.txt.nlp	22864611	SENT457	19	19	10	10	risperidone	mGlu2	PA451257	2912	0.949
NULL	Diabetes_Care_2013_Aug_17_36(Suppl_2)_S127-S138.nxml.txt.nlp	23882037	SENT476	22	22	34	34	metformin	Met	PA450395	79811	0.949
NULL	Br_J_Pharmacol_2014_Jan_23_171(2)_523-535.nxml.txt.nlp	24372553	SENT163	6	6	17	17	metformin	SIRT1	PA450395	23411	0.949
NULL	J_Gen_Physiol_2003_Nov_122(5)_485-500.nxml.txt.nlp	14581581	SENT12	8	8	33	33	spermine	IRK1	PA164781199	3759	0.949
NULL	Breast_Cancer_Res_Treat_2012_Jul_31_134(1)_199-205.nxml.txt.nlp	22290080	SENT160	17	17	2	2	estradiol	c-fos	PA449503	2353	0.949
NULL	Int_J_Mol_Med_2014_Sep_25_34(3)_695-704.nxml.txt.nlp	24970492	SENT106	6	6	17	17	mitomycin	MSC	PA450524	9242	0.949
NULL	Oncotarget_2014_Dec_4_5(22)_11365-11380.nxml.txt.nlp	25426548	SENT53	5	5	10	10	nutlin-3	p53		7157	0.949
NULL	Oncogene_2010_Sep_16_29(37)_5193-5203.nxml.txt.nlp	20581867	SENT121	16	16	4	4	trastuzumab	HRG	PA451743	3084;3273	0.949
NULL	Asian_J_Androl_2014_Apr_18_May-Jun_16(3)_378-386.nxml.txt.nlp	24759575	SENT106	20	20	3	3	bicalutamide	AKT	PA164746255	207	0.949
NULL	Open_Med_Chem_J_2010_May_27_4_20-36.nxml.txt.nlp	21160908	SENT237	0	0	21	21	piperazine	mGlu1	PA450977	2911	0.949
NULL	Oncologist_2010_Feb_15_15(2)_122-129.nxml.txt.nlp	20156908	SENT31	31	31	34	34	trastuzumab	aromatase	PA451743	1588	0.949
NULL	Nat_Commun_2014_5_3361.nxml.txt.nlp	24553445	SENT126	15	15	5	5	vorinostat	PI3K	PA164748224	5290	0.949
NULL	Mol_Pain_2013_Jul_31_9_38.nxml.txt.nlp	23898828	SENT148	7	7	1	1	losartan	p38	PA450268	10598;1432;7965	0.949
NULL	Breast_Cancer_Res_2012_Apr_4_14(2)_R57.nxml.txt.nlp	22475046	SENT77	19	19	2	2	tamoxifen	ATAC	PA451581	6375	0.949
NULL	Clin_Dev_Immunol_2011_Dec_6_2011_349575.nxml.txt.nlp	22190970	SENT129	9	9	1	1	ribavirin	IFN	PA451241	3439	0.949
NULL	Ann_Neurosci_2011_Apr_18(2)_48-55.nxml.txt.nlp	25205921	SENT142	12	12	21	21	forskolin	SOD1	PA146096022	6647	0.949
NULL	Pain_2014_Nov_155(11)_2243-2252.nxml.txt.nlp	24978826	SENT175	38	38	25	25	capsaicin	TRPV1	PA448776	7442	0.949
NULL	Acta_Pharmacol_Sin_2011_Jan_6_32(1)_133-138.nxml.txt.nlp	21131997	SENT48	12	12	2	2	protamine	ACT	PA10366	12;11332;9457;641455	0.949
NULL	J_Hum_Genet_2013_Jun_2_58(6)_306-312.nxml.txt.nlp	23635953	SENT15	25	25	19	19	anastrozole	aromatase	PA448432	1588	0.949
NULL	Clin_Ophthalmol_2011_Feb_11_5_167-170.nxml.txt.nlp	21383944	SENT18	11	11	1	1	ranibizumab	hole	PA164746012	80757	0.949
NULL	Oncogene_2010_Mar_11_29(10)_1509-1518.nxml.txt.nlp	19946334	SENT160	9	9	4	4	fulvestrant	aromatase	PA164747170	1588	0.949
NULL	Breast_Cancer_Res_2010_May_18_12(Suppl_1)_O5.nxml.txt.nlp	NULL	SENT5	38	38	14	14	doxorubicin	CD44	PA449412	960	0.949
NULL	Eur_J_Endocrinol_2011_Dec_165(6)_987-991.nxml.txt.nlp	21951701	SENT105	16	16	6	6	hydrocortisone	ACTH	PA449905	5443	0.949
NULL	J_Inflamm_(Lond)_2008_Apr_27_5_5.nxml.txt.nlp	18439312	SENT168	27	27	14	14	genistein	ADAM17	PA165109660	6868	0.949
NULL	BMJ_2014_Nov_11_349_g6419.nxml.txt.nlp	25389143	SENT143	20	20	9	9	bivalirudin	P2Y12	PA10032	64805	0.949
NULL	Anesth_Pain_Med_2012_Sep_13_Autumn_2(2)_52-53.nxml.txt.nlp	24223337	SENT17	0	0	6	6	pregabalin	gamma	PA164754814	9913	0.949
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT206	5	5	27	27	pp2	p38		10598;1432;7965	0.949
NULL	Biosci_Rep_2013_Jul_25_33(4)_e00052.nxml.txt.nlp	23800285	SENT206	16	16	7	7	metronidazole	NAC	PA450484	22861	0.949
NULL	Oncol_Lett_2014_May_18_7(5)_1632-1638.nxml.txt.nlp	24765191	SENT120	0	0	27	27	trastuzumab	HER-2	PA451743	2064	0.949
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT2430	17	17	15	15	napqi	CYP2E1		1571	0.949
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_May_12_66(Pt_6)_o1324-o1325.nxml.txt.nlp	21579416	SENT66	39	39	15	15	ethanol	mol	PA448073	90527	0.949
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT264	26	26	21	21	methotrexate	PMS2	PA450428	5395	0.949
NULL	EMBO_Mol_Med_2013_Dec_8_5(12)_1821-1834.nxml.txt.nlp	24293316	SENT161	4	4	10	10	doxorubicin	p53	PA449412	7157	0.949
NULL	Nat_Commun_2013_Sep_20_4_2443.nxml.txt.nlp	24051437	SENT8	20	20	33	33	tamoxifen	PHB2	PA451581	11331	0.949
NULL	Cardiovasc_Ther_2009_27(4)_259-274.nxml.txt.nlp	19604248	SENT267	21	21	4	4	clopidogrel	IPA	PA449053	3160	0.949
NULL	Biomed_Res_Int_2013_Jan_22_2013_346480.nxml.txt.nlp	23484111	SENT124	15	15	2	2	pp2	EGFR		1956	0.949
NULL	Ann_Med_Health_Sci_Res_2014_Jul-Aug_4(4)_466-471.nxml.txt.nlp	25221689	SENT153	11	11	1	1	piperaquine	CYP3A4	PA166104279	1576	0.949
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_21-38.nxml.txt.nlp	19305786	SENT141	27	27	11	11	capsaicin	VR1	PA448776	56664	0.949
NULL	Acta_Pharmacol_Sin_2010_Dec_22_31(12)_1643-1648.nxml.txt.nlp	21102481	SENT41	35	35	5	5	sorafenib	Raf-1	PA7000	5894	0.949
NULL	Clin_Exp_Reprod_Med_2013_Jun_30_40(2)_67-75.nxml.txt.nlp	23875162	SENT128	17	17	10	10	rosiglitazone	ERK1	PA451283	5595	0.949
NULL	Braz_J_Med_Biol_Res_2014_May_9_47(6)_478-482.nxml.txt.nlp	24770568	SENT19	25	25	6	6	cisplatin	CD133	PA449014	8842	0.949
NULL	Hum_Genomics_2011_Oct_1_5(6)_569-576.nxml.txt.nlp	22155604	SENT20	13	13	3	3	ethanol	ALDH2	PA448073	217	0.949
NULL	Core_Evid_2010_Oct_21_5_61-76.nxml.txt.nlp	21042543	SENT189	6	6	22	22	cetuximab	EGFR	PA10040	1956	0.949
NULL	Cell_Death_Dis_2014_Jul_17_5(7)_e1333.nxml.txt.nlp	25032856	SENT82	17	17	7	7	candesartan	TLR4	PA448765	7099	0.949
NULL	Front_Cell_Neurosci_2014_Jan_22_8_2.nxml.txt.nlp	24478627	SENT130	15	15	22	22	picrotoxin	BIM	PA164777007	10018	0.949
NULL	Breast_Cancer_Res_2010_Jul_22_12(4)_R53.nxml.txt.nlp	20649975	SENT173	11	11	4	4	tamoxifen	HOXB13	PA451581	10481	0.949
NULL	Acta_Crystallogr_Sect_F_Struct_Biol_Cryst_Commun_2009_Sep_25_65(Pt_10)_1030-1034.nxml.txt.nlp	19851015	SENT26	13	13	10	10	oxaliplatin	dUTPase	PA131285527	1854	0.949
NULL	Arthritis_Res_Ther_2010_Jan_22_12(1)_R11.nxml.txt.nlp	20096109	SENT160	28	28	11	11	infliximab	IFN	PA452639	3439	0.949
NULL	Exp_Hematol_Oncol_2012_Jun_18_1_14.nxml.txt.nlp	23210689	SENT107	36	36	21	21	imatinib	KIT	PA10804	3815	0.949
NULL	Mol_Cancer_2010_Dec_2_9_309.nxml.txt.nlp	21122157	SENT400	24	24	16	16	paclitaxel	IL-6	PA450761	3569	0.949
NULL	BMB_Rep_2013_Jan_46(1)_59-64.nxml.txt.nlp	23351386	SENT62	34	34	20	20	auranofin	STAT3	PA448510	6774	0.949
NULL	Br_J_Haematol_2014_Jan_28_164(2)_233-244.nxml.txt.nlp	24206017	SENT31	23	23	9	9	lenalidomide	CRBN	PA162363968	51185	0.949
NULL	Behav_Brain_Funct_2011_Oct_5_7_41.nxml.txt.nlp	21974752	SENT286	6	6	20	20	paroxetine	EPM	PA450801	2054	0.949
NULL	Br_J_Cancer_2012_Jan_17_106(2)_348-357.nxml.txt.nlp	22146521	SENT118	26	26	7	7	gemcitabine	TP53	PA449748	7157	0.949
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT90	5	5	24	24	curcumin	DcR2	PA151958596	8793	0.949
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT131	13	13	22	22	sulindac	AKT	PA451565	207	0.949
NULL	Ann_Oncol_2012_Dec_2_23(12)_3007-3016.nxml.txt.nlp	22865781	SENT102	22	22	13	13	lapatinib	PTEN	PA152241907	5728	0.949
NULL	F1000_Med_Rep_2009_Jan_21_1_8.nxml.txt.nlp	20948699	SENT8	0	0	20	20	clopidogrel	ADP	PA449053	23038	0.949
NULL	Oncol_Lett_2013_Mar_28_5(3)_935-942.nxml.txt.nlp	23426424	SENT142	40	40	7	7	oxaliplatin	ERCC1	PA131285527	2067	0.949
NULL	Mol_Cancer_2014_Jun_20_13_155.nxml.txt.nlp	24950741	SENT127	25	25	29	29	bortezomib	p53	PA10252	7157	0.949
NULL	Breast_Cancer_Res_2011_Apr_14_13(2)_R43.nxml.txt.nlp	21492444	SENT21	28	28	37	37	tamoxifen	aromatase	PA451581	1588	0.949
NULL	Biosci_Rep_2012_Dec_20_33(1)_e00011.nxml.txt.nlp	23137297	SENT323	13	13	25	25	heparin	RPSA	PA449855	3921	0.949
NULL	Ann_Clin_Microbiol_Antimicrob_2008_Jan_28_7_3.nxml.txt.nlp	18226256	SENT81	18	18	6	6	ritonavir	SXR	PA451260	8856	0.949
NULL	J_Invest_Dermatol_2014_Jul_134(7)_1786-1788.nxml.txt.nlp	24924756	SENT80	15	15	21	21	aprepitant	NK1R	PA164747039	6869	0.949
NULL	Breast_Cancer_Res_2012_Jun_19_14(3)_311.nxml.txt.nlp	22713135	SENT34	7	7	16	16	everolimus	PIK3CA	PA164746311	5290	0.949
NULL	Br_J_Cancer_2010_Jun_29_103(1)_61-72.nxml.txt.nlp	20588279	SENT274	26	26	0	0	trastuzumab	RhoB	PA451743	388	0.949
NULL	Br_J_Cancer_1998_Sep_78(Suppl_4)_12-15.nxml.txt.nlp	9741783	SENT6	0	0	17	17	anastrozole	aromatase	PA448432	1588	0.949
NULL	Cancers_(Basel)_2014_Sep_30_6(4)_2035-2048.nxml.txt.nlp	25271833	SENT120	12	12	4	4	gefitinib	IL-2	PA131301952	3558	0.949
NULL	Oncol_Lett_2013_Mar_28_5(3)_935-942.nxml.txt.nlp	23426424	SENT118	33	33	24	24	cisplatin	ERCC1	PA449014	2067	0.949
NULL	Nucleic_Acids_Res_2011_Nov_8_39(21)_9224-9237.nxml.txt.nlp	21824916	SENT142	23	23	4	4	trypsin	PNKP	PA451806	11284	0.949
NULL	Sci_Rep_2015_Jan_6_5_7641.nxml.txt.nlp	25560734	SENT104	32	32	15	15	tamoxifen	CLTC	PA451581	1213	0.949
NULL	Chem_Rev_2012_May_9_112(5)_2593-2603.nxml.txt.nlp	22335786	SENT139	19	19	39	39	l-histidine	ATX	PA449882	5168;23049	0.949
NULL	J_Biol_Chem_2009_Sep_25_284(39)_26447-26455.nxml.txt.nlp	19633293	SENT5	27	27	17	17	hyaluronan	TSHR	PA165958431	7253	0.949
NULL	Arthritis_Res_Ther_2005_Apr_28_7(4)_R844-R851.nxml.txt.nlp	15987486	SENT134	12	12	4	4	oxygen	p53	PA450744	7157	0.949
NULL	Ann_Oncol_2014_Oct_23_25(10)_1941-1948.nxml.txt.nlp	25057173	SENT29	23	23	1	1	docetaxel	EGFR	PA449383	1956	0.949
NULL	Clin_Interv_Aging_2013_Aug_19_8_1089-1095.nxml.txt.nlp	23983461	SENT33	1	1	19	19	minocycline	STZ	PA450519	6484	0.949
NULL	Aging_(Albany_NY)_2009_Dec_31_1(12)_988-1007.nxml.txt.nlp	20157582	SENT211	8	8	16	16	doxorubicin	CTX	PA449412	1593	0.949
NULL	BMB_Rep_2014_May_47(5)_274-279.nxml.txt.nlp	24286313	SENT80	16	16	5	5	bortezomib	CD138	PA10252	6382	0.949
NULL	Arthritis_Res_Ther_2009_Nov_4_11(6)_R165.nxml.txt.nlp	19889203	SENT354	7	7	28	28	curcumin	p65	PA151958596	5970	0.949
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_9_2013_486047.nxml.txt.nlp	23662138	SENT122	41	41	18	18	glibenclamide	SDH	PA449782	1757;10993	0.949
NULL	Scientifica_(Cairo)_2012_Dec_16_2012_402783.nxml.txt.nlp	24278688	SENT171	13	13	18	18	thrombin	C5a	PA451674	727	0.949
NULL	Eur_Heart_J_2013_Dec_1_34(45)_3515-3524.nxml.txt.nlp	23594590	SENT85	22	22	18	18	eplerenone	p40phox	PA164749044	4689	0.949
NULL	Front_Chem_2014_Mar_14_2_12.nxml.txt.nlp	24790981	SENT71	15	15	32	32	curcumin	p300	PA151958596	2033	0.949
NULL	Chem_Rev_2014_Jun_11_114(11)_5753-5774.nxml.txt.nlp	24758331	SENT121	24	24	5	5	paclitaxel	P-gp	PA450761	5243	0.949
NULL	Breast_Cancer_Res_2011_Apr_14_13(2)_R43.nxml.txt.nlp	21492444	SENT133	43	43	17	17	doxycycline	HER3	PA449415	2065	0.949
NULL	Cancers_(Basel)_2014_May_16_6(2)_1180-1194.nxml.txt.nlp	24840048	SENT429	27	27	7	7	imatinib	KIT	PA10804	3815	0.949
NULL	Oncotarget_2014_Oct_11_5(20)_10070-10083.nxml.txt.nlp	25301722	SENT225	13	13	5	5	cetuximab	EGFR	PA10040	1956	0.949
NULL	J_Hematol_Oncol_2013_Jul_18_6_53.nxml.txt.nlp	23866964	SENT99	10	10	21	21	temsirolimus	CDKN1B	PA164746890	1027	0.949
NULL	Arthritis_Res_Ther_2008_Oct_15_10(Suppl_1)_S5.nxml.txt.nlp	19007425	SENT22	0	0	17	17	abatacept	CTLA4	PA164747080	1493	0.949
NULL	Cell_Death_Dis_2013_Sep_5_4(9)_e791.nxml.txt.nlp	24008735	SENT62	3	3	9	9	gemcitabine	p53	PA449748	7157	0.949
NULL	Exp_Ther_Med_2014_Apr_21_7(4)_763-767.nxml.txt.nlp	24660026	SENT79	12	12	8	8	gefitinib	EGFR	PA131301952	1956	0.949
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT163	6	6	12	12	lapatinib	ABCB1	PA152241907	5243	0.949
NULL	J_Clin_Biochem_Nutr_2011_Mar_26_48(2)_126-133.nxml.txt.nlp	21373265	SENT135	2	2	30	30	dextran	HO-2	PA449261	3163	0.949
NULL	J_Young_Pharm_2011_Apr-Jun_3(2)_105-111.nxml.txt.nlp	21731354	SENT3	0	0	9	9	naproxen	castor	PA450595	54897	0.949
NULL	Cancer_Metastasis_Rev_2010_Dec_10_29(4)_581-594.nxml.txt.nlp	20830503	SENT71	0	0	15	15	anastrozole	aromatase	PA448432	1588	0.949
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT151	38	38	3	3	glucose	ERK	PA449773	5594	0.949
NULL	J_Neuroinflammation_2010_Nov_25_7_85.nxml.txt.nlp	21108840	SENT257	0	0	19	19	sulfasalazine	AP-1	PA451547	2353;3727;2354;3725	0.949
NULL	Nat_Commun_2014_Dec_18_5_5815.nxml.txt.nlp	25519973	SENT81	29	29	17	17	tranylcypromine	LSD1	PA451741	23028	0.949
NULL	J_Korean_Med_Sci_1994_Dec_9(6)_482-489.nxml.txt.nlp	7786445	SENT10	21	21	0	0	theophylline	CYP1A2	PA451647	1544	0.949
NULL	EMBO_Mol_Med_2011_May_3(5)_266-278.nxml.txt.nlp	21438154	SENT109	16	16	9	9	oxaliplatin	TRAAK	PA131285527	50801	0.949
NULL	Mol_Cancer_2013_Nov_5_12_133.nxml.txt.nlp	24192080	SENT21	28	28	34	34	cetuximab	EGFR	PA10040	1956	0.949
NULL	Mol_Cancer_2010_Apr_15_9_77.nxml.txt.nlp	20398291	SENT84	8	8	16	16	geldanamycin	survivin	PA152031327	332	0.949
NULL	Cardiol_Res_Pract_2011_May_10_2011_816897.nxml.txt.nlp	21629798	SENT131	10	10	3	3	ritonavir	CYP3A4	PA451260	1576	0.949
NULL	Biosci_Rep_2014_Dec_12_34(6)_e00160.nxml.txt.nlp	25495645	SENT136	14	14	6	6	rosiglitazone	ANGPTL3	PA451283	27329	0.949
NULL	Breast_Cancer_(Auckl)_2012_Mar_7_6_67-77.nxml.txt.nlp	22438669	SENT60	21	21	7	7	lapatinib	HER2	PA152241907	2064	0.949
NULL	Neural_Plast_2007_Dec_11_2007_73079.nxml.txt.nlp	NULL	SENT2996	26	26	18	18	forskolin	AC5	PA146096022	111	0.949
NULL	Emerg_Infect_Dis_2012_Sep_18(9)_1508-1511.nxml.txt.nlp	22932478	SENT71	34	34	14	14	permethrin	DDT	PA164743137	1652	0.949
NULL	Oncol_Rep_2013_Jun_22_29(6)_2479-2485.nxml.txt.nlp	23525656	SENT117	14	14	20	20	cisplatin	MRP7	PA449014	89845;1080	0.949
NULL	Clin_Ophthalmol_2010_Apr_26_4_227-231.nxml.txt.nlp	20463788	SENT17	0	0	31	31	ranibizumab	VEGF-A	PA164746012	7422	0.949
NULL	J_Immunother_Cancer_2014_Jan_27_2_2.nxml.txt.nlp	24829759	SENT89	25	25	3	3	sorafenib	IL-21	PA7000	59067;50616;27189	0.949
NULL	Clin_Ophthalmol_2010_Apr_26_4_369-374.nxml.txt.nlp	20463807	SENT15	5	5	13	13	bevacizumab	PED	PA130232992	8682	0.949
NULL	Front_Oncol_2011_Aug_22_1_22.nxml.txt.nlp	22666659	SENT154	18	18	24	24	bevacizumab	VEGFR	PA130232992	3791	0.949
NULL	J_Cell_Biol_2000_Jul_10_150(1)_213-224.nxml.txt.nlp	10893269	SENT113	37	37	8	8	amiloride	NHE	PA448368	285335	0.949
NULL	Ther_Clin_Risk_Manag_2005_Mar_1(1)_3-13.nxml.txt.nlp	18360537	SENT126	3	3	7	7	isoniazid	CYP3A4	PA450112	1576	0.949
NULL	Cancer_Manag_Res_2012_Nov_9_4_383-395.nxml.txt.nlp	23204869	SENT90	34	34	1	1	carmustine	PC-3	PA448810	692094	0.949
NULL	Fibrogenesis_Tissue_Repair_2012_Jul_23_5_11.nxml.txt.nlp	22824096	SENT392	16	16	29	29	thrombin	PAR-1	PA451674	2011;2149	0.949
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT215	28	28	3	3	metformin	PI3K	PA450395	5290	0.949
NULL	Eur_J_Neurosci_2008_Jun_27(12)_3151-3160.nxml.txt.nlp	18598259	SENT99	28	28	7	7	paraformaldehyde	TRPA1	PA450790	8989	0.949
NULL	ScientificWorldJournal_2012_Apr_26_2012_358102.nxml.txt.nlp	22645419	SENT118	17	17	14	14	losartan	AT1	PA450268	9197;185	0.949
NULL	J_Oncol_2009_Jun_14_2009_814140.nxml.txt.nlp	19547715	SENT21	30	30	10	10	paclitaxel	MRP1	PA450761	4437	0.949
NULL	Mol_Cell_Biochem_2014_Jul_26_396(1-2)_221-228.nxml.txt.nlp	25063218	SENT99	36	36	21	21	resveratrol	EGFR		1956	0.949
NULL	Cancer_Cell_Int_2012_Jul_4_12_19.nxml.txt.nlp	22631225	SENT181	34	34	45	45	heparin	PPIA	PA449855	5478	0.949
NULL	Ann_Hematol_2014_Sep_10_93(1)_1-11.nxml.txt.nlp	24018623	SENT146	28	28	8	8	lenalidomide	SPARC	PA162363968	6678	0.949
NULL	Pharmaceuticals_(Basel)_2014_Apr_10_7(4)_433-452.nxml.txt.nlp	24727459	SENT1	4	4	33	33	lopinavir	CYP3A4	PA450264	1576	0.949
NULL	Int_J_Breast_Cancer_2012_May_9_2012_415170.nxml.txt.nlp	22649737	SENT202	12	12	19	19	pazopanib	VEGFR	PA165291492	3791	0.949
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT120	5	5	27	27	gefitinib	KRAS	PA131301952	3845	0.949
NULL	Cancers_(Basel)_2014_Jul_8_6(3)_1487-1499.nxml.txt.nlp	25006835	SENT78	17	17	8	8	cisplatin	p38	PA449014	10598;1432;7965	0.949
NULL	Support_Care_Cancer_2013_Feb_8_21(2)_565-573.nxml.txt.nlp	22869054	SENT156	16	16	4	4	palonosetron	NK-1	PA10352	27087	0.949
NULL	Front_Immunol_2012_Mar_19_3_47.nxml.txt.nlp	22566929	SENT58	3	3	32	32	abatacept	CD28	PA164747080	1493;940	0.949
NULL	Oncotarget_2011_Jun_5_2(6)_448-460.nxml.txt.nlp	21646687	SENT59	36	36	6	6	tetracycline	PIM3	PA451640	415116	0.949
NULL	Mol_Biol_Cell_2012_Jun_1_23(11)_2226-2234.nxml.txt.nlp	22493319	SENT162	4	4	12	12	doxorubicin	FOXO3	PA449412	2309	0.949
NULL	J_Thromb_Haemost_2007_May_5(5)_1010-1018.nxml.txt.nlp	17355572	SENT225	35	35	17	17	thrombin	VWF	PA451674	7450	0.949
NULL	Case_Rep_Neurol_Med_2013_Jul_1_2013_451206.nxml.txt.nlp	23936696	SENT48	10	10	6	6	ketoconazole	CYP3A4	PA450146	1576	0.949
NULL	Comp_Hepatol_2004_Jan_14_3(Suppl_1)_S37.nxml.txt.nlp	14960189	SENT12	32	32	8	8	thalidomide	TNF-alpha	PA451644	7124	0.949
NULL	J_Adv_Pract_Oncol_2013_Jul_1_Jul-Aug_4(4)_263-268.nxml.txt.nlp	25032007	SENT63	34	34	31	31	tamoxifen	CYP2D6	PA451581	1565	0.949
NULL	Biomed_Res_Int_2014_May_19_2014_456037.nxml.txt.nlp	24967371	SENT166	42	42	2	2	lenalidomide	San	PA162363968	80218	0.949
NULL	Behav_Genet_2008_Jul_7_38(4)_396-406.nxml.txt.nlp	18461434	SENT178	8	8	4	4	glucose	GLUT8	PA449773	29988;154091	0.949
NULL	Oncol_Rep_2013_Oct_22_30(4)_1535-1541.nxml.txt.nlp	23877481	SENT149	33	33	31	31	etoricoxib	COX2	PA164776853	4513;5743	0.949
NULL	Cancer_Gene_Ther_2013_Jan_9_20(1)_10_1038_cgt_2012_75.nxml.txt.nlp	23138870	SENT102	38	38	28	28	paclitaxel	PC3	PA450761	57332;7832;5122	0.949
NULL	Mol_Cancer_2009_Jun_9_8_37.nxml.txt.nlp	19508729	SENT63	46	46	23	23	gemcitabine	HO-1	PA449748	3162	0.949
NULL	Aging_(Albany_NY)_2013_Feb_21_5(2)_94-95.nxml.txt.nlp	23518473	SENT13	12	12	29	29	resveratrol	p53		7157	0.949
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Nov_29_64(Pt_12)_o2487.nxml.txt.nlp	21581451	SENT57	12	12	3	3	ethanol	mol	PA448073	90527	0.949
NULL	Cancer_Cell_Int_2012_Jun_21_12_32.nxml.txt.nlp	22720671	SENT47	38	38	7	7	paraformaldehyde	CD133	PA450790	8842	0.949
NULL	Crit_Care_2006_Jan_31_10(1)_R20.nxml.txt.nlp	16469127	SENT30	0	0	9	9	terlipressin	AVP	PA164781020	114548;551	0.949
NULL	Arch_Drug_Inf_2011_Mar_4(1)_1-9.nxml.txt.nlp	21572514	SENT156	9	9	16	16	verapamil	PEPT1	PA451868	6564	0.949
NULL	Exp_Hematol_Oncol_2013_Dec_6_2_32.nxml.txt.nlp	24314093	SENT108	38	38	2	2	sunitinib	NNT	PA162372840	23530	0.949
NULL	Breast_Cancer_(Auckl)_2012_Feb_20_6_47-66.nxml.txt.nlp	22399860	SENT172	4	4	40	40	tamoxifen	ERBB2	PA451581	2064	0.949
NULL	Evid_Based_Complement_Alternat_Med_2012_Dec_11_2012_310872.nxml.txt.nlp	23304196	SENT149	17	17	24	24	raloxifene	aromatase	PA451221	1588	0.949
NULL	Ann_Clin_Transl_Neurol_2014_Dec_21_1(12)_996-1005.nxml.txt.nlp	25574474	SENT11	8	8	14	14	riluzole	P-gp	PA451251	5243	0.949
NULL	J_Biol_Chem_2009_Oct_16_284(42)_28885-28895.nxml.txt.nlp	19687008	SENT153	22	22	34	34	simvastatin	PCSK9	PA451363	255738	0.949
NULL	ARYA_Atheroscler_2011_Fall_7(3)_106-110.nxml.txt.nlp	22577456	SENT3	18	18	7	7	clopidogrel	CYP2C19	PA449053	1557	0.949
NULL	Nat_Commun_2013_Sep_27_4_2519.nxml.txt.nlp	24071738	SENT254	34	34	8	8	bortezomib	OTUB1	PA10252	55611	0.949
NULL	Clin_Mol_Allergy_2007_Jan_25_5_1.nxml.txt.nlp	17254346	SENT190	33	33	3	3	curcumin	IL-4	PA151958596	3565	0.949
NULL	Drugs_R_D_2011_Jun_27_11(2)_113-126.nxml.txt.nlp	21679004	SENT103	21	21	15	15	axitinib	CYP1A2	PA164924493	1544	0.949
NULL	Oncotarget_2012_Sep_28_3(10)_1169-1181.nxml.txt.nlp	23045411	SENT105	9	9	12	12	doxorubicin	JIP1	PA449412	9479	0.949
NULL	Oncotarget_2014_Nov_3_5(20)_10127-10139.nxml.txt.nlp	25333256	SENT147	6	6	26	26	vemurafenib	TRIM16	PA165946873	10626	0.949
NULL	Mol_Cancer_2014_Feb_20_13_31.nxml.txt.nlp	24555568	SENT35	8	8	2	2	bumetanide	NKCC1	PA448682	6558	0.949
NULL	Breast_Cancer_Res_Treat_2007_Oct_27_105(Suppl_1)_19-29.nxml.txt.nlp	17333340	SENT20	6	6	4	4	aminoglutethimide	aromatase	PA448375	1588	0.949
NULL	Arthritis_Res_Ther_2012_May_1_14(3)_R99.nxml.txt.nlp	22546542	SENT61	18	18	31	31	infliximab	IL-6	PA452639	3569	0.949
NULL	Mol_Cancer_2008_Jun_5_7_50.nxml.txt.nlp	18534018	SENT127	8	8	24	24	bortezomib	NOXA	PA10252	5366	0.949
NULL	J_Autom_Methods_Manag_Chem_2005_2005(2)_31-36.nxml.txt.nlp	18924626	SENT9	11	11	1	1	phenol	COD	PA450913	6628	0.949
NULL	Br_J_Cancer_2012_Jun_26_107(1)_129-136.nxml.txt.nlp	22644295	SENT197	23	23	42	42	ethanol	p38	PA448073	10598;1432;7965	0.949
NULL	J_Thorac_Oncol_2014_Feb_23_9(2)_189-194.nxml.txt.nlp	24419415	SENT16	8	8	41	41	gefitinib	EGFR	PA131301952	1956	0.949
NULL	Breast_Cancer_Res_2006_Jul_25_8(4)_R48.nxml.txt.nlp	16869955	SENT102	20	20	11	11	tamoxifen	p53	PA451581	7157	0.949
NULL	Curr_Gerontol_Geriatr_Res_2010_Jun_20_2010_348174.nxml.txt.nlp	20672050	SENT57	23	23	33	33	gefitinib	EGFR	PA131301952	1956	0.949
NULL	Mol_Cancer_2010_Apr_21_9_83.nxml.txt.nlp	20409325	SENT191	10	10	16	16	paclitaxel	AKT2	PA450761	208	0.949
NULL	Sci_Rep_2014_Nov_28_4_7237.nxml.txt.nlp	25429875	SENT108	41	41	16	16	hesperidin	p38	PA449867	10598;1432;7965	0.949
NULL	J_Infect_Dis_2011_Oct_1_204(7)_1104-1114.nxml.txt.nlp	21881126	SENT161	24	24	7	7	chloroquine	IFN	PA448948	3439	0.949
NULL	eLife_2014_May_20_3_e02523.nxml.txt.nlp	24844246	SENT343	11	11	37	37	sorafenib	GPX4	PA7000	2879	0.949
NULL	Arthritis_Res_Ther_2005_Jan_21_7(2)_55-61.nxml.txt.nlp	15743490	SENT129	14	14	16	16	atorvastatin	IFN	PA448500	3439	0.949
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Oct_7_65(Pt_11)_o2667.nxml.txt.nlp	21578277	SENT83	29	29	12	12	ethanol	mol	PA448073	90527	0.949
NULL	Mol_Brain_2014_Nov_18_7(1)_82.nxml.txt.nlp	NULL	SENT42	5	5	17	17	tamoxifen	p35	PA451581	3592;80761	0.949
NULL	J_Signal_Transduct_2011_Feb_24_2011_804236.nxml.txt.nlp	21637380	SENT26	42	42	30	30	trastuzumab	PTEN	PA451743	5728	0.949
NULL	Biomed_Res_Int_2013_Sep_4_2013_419176.nxml.txt.nlp	24093097	SENT90	2	2	10	10	gefitinib	IFN	PA131301952	3439	0.949
NULL	Breast_Cancer_Res_2012_Mar_9_14(2)_R41.nxml.txt.nlp	22405131	SENT122	33	33	3	3	estradiol	TCL1A	PA449503	8115	0.949
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Dec_8_67(Pt_1)_o50.nxml.txt.nlp	21522760	SENT48	3	3	33	33	benzaldehyde	mol	PA448571	90527	0.949
NULL	Mol_Cells_2014_Dec_31_37(12)_899a-906.nxml.txt.nlp	25431425	SENT135	13	13	4	4	curcumin	EP2	PA151958596	5732;10407	0.949
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT207	4	4	25	25	adalimumab	DPI	PA10004	1832	0.949
NULL	Nucleic_Acids_Res_2013_Nov_27_41(21)_9786-9799.nxml.txt.nlp	23982513	SENT277	17	17	26	26	arsenite	TIAR	PA452638	7073	0.949
NULL	Mol_Cell_Biochem_2014_Oct_9_385(1-2)_265-275.nxml.txt.nlp	24104452	SENT222	17	17	12	12	bortezomib	U87	PA10252	677775;641648	0.949
NULL	F1000_Biol_Rep_2009_Sep_8_1_70.nxml.txt.nlp	20948617	SENT8	24	24	6	6	ustekinumab	IL-6	PA166048654	3569	0.949
NULL	Clin_Ophthalmol_2014_Jun_26_8_1213-1219.nxml.txt.nlp	25061267	SENT4	2	2	27	27	proparacaine	PRK	PA164776849	1263	0.949
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT157	26	26	10	10	docetaxel	HER2	PA449383	2064	0.949
NULL	Biologics_2009_Oct_12_3_469-474.nxml.txt.nlp	19851472	SENT83	48	48	12	12	desloratadine	IL-13	PA164776964	3596	0.949
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Jul_23_3(7)_e126.nxml.txt.nlp	25054314	SENT73	8	8	17	17	docetaxel	OATP1B3	PA449383	28234	0.949
NULL	Br_J_Cancer_2011_Jan_4_104(1)_91-100.nxml.txt.nlp	21139584	SENT156	7	7	15	15	geldanamycin	Hsp90	PA152031327	3320	0.949
NULL	J_Lipid_Res_2015_Jan_56(1)_109-121.nxml.txt.nlp	25421061	SENT236	18	18	2	2	chymotrypsin	CGI-58	PA448994	51099	0.949
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT191	3	3	35	35	glucose	PP2	PA449773	4888	0.949
NULL	Cancers_(Basel)_2014_Mar_6_6(1)_494-525.nxml.txt.nlp	24662938	SENT207	23	23	11	11	imatinib	EGFR	PA10804	1956	0.949
NULL	FASEB_J_2014_Feb_28(2)_923-934.nxml.txt.nlp	24249636	SENT14	20	20	11	11	urokinase	PLAUR	PA451836	5329	0.949
NULL	Mol_Pain_2013_May_20_9_25.nxml.txt.nlp	23688027	SENT191	1	1	7	7	carrageenan	TRPV1	PA448814	7442	0.949
NULL	Br_J_Pharmacol_2014_Dec_2_171(24)_5491-5506.nxml.txt.nlp	24571448	SENT167	2	2	7	7	fasudil	Rho	PA165946121	29984	0.949
NULL	Mol_Vis_2007_Jan_24_13_57-65.nxml.txt.nlp	17277739	SENT178	7	7	17	17	heparin	FGF2	PA449855	2247;2258	0.949
NULL	Br_J_Cancer_2010_Sep_7_103(6)_889-898.nxml.txt.nlp	20664599	SENT154	21	21	6	6	paclitaxel	HER-2	PA450761	2064	0.949
NULL	J_Mol_Signal_2011_Jul_20_6_7.nxml.txt.nlp	21774804	SENT6	14	14	30	30	curcumin	CD166	PA151958596	214	0.949
NULL	EMBO_Mol_Med_2012_Apr_4(4)_298-312.nxml.txt.nlp	22331558	SENT125	29	29	5	5	etoposide	p53	PA449552	7157	0.949
NULL	Cancer_Metab_2014_May_28_2(Suppl_1)_O16.nxml.txt.nlp	NULL	SENT9	6	6	2	2	metformin	AMPK	PA450395	5563	0.949
NULL	Cardiol_Res_Pract_2011_Mar_7_2011_175363.nxml.txt.nlp	21403866	SENT72	30	30	3	3	sulfanilamide	NO3	PA451545	4681	0.949
NULL	Oxid_Med_Cell_Longev_2013_Jun_2_2013_793525.nxml.txt.nlp	23819014	SENT204	42	42	21	21	resveratrol	ROS		6098	0.949
NULL	Br_J_Cancer_2012_Feb_14_106(4)_685-692.nxml.txt.nlp	22294184	SENT131	11	11	4	4	lovastatin	JNK	PA450272	5599	0.949
NULL	Breast_Cancer_Res_Treat_2014_Apr_6_145(1)_33-44.nxml.txt.nlp	24706169	SENT30	24	24	14	14	trastuzumab	HER2	PA451743	2064	0.949
NULL	Indian_J_Med_Res_2011_Aug_134(2)_149-161.nxml.txt.nlp	21911966	SENT119	19	19	8	8	marimastat	ADAM33	PA164748329	80332	0.949
NULL	Br_J_Cancer_2012_Nov_6_107(10)_1714-1721.nxml.txt.nlp	23073173	SENT207	7	7	1	1	docetaxel	RUNX2	PA449383	860	0.949
NULL	Ann_Indian_Acad_Neurol_2009_Oct-Dec_12(4)_254-263.nxml.txt.nlp	20182573	SENT186	3	3	10	10	alemtuzumab	CD52	PA164783958	1043	0.949
NULL	Mol_Cancer_2010_Apr_15_9_77.nxml.txt.nlp	20398291	SENT89	32	32	23	23	geldanamycin	survivin	PA152031327	332	0.949
NULL	Mol_Cancer_2012_Jun_26_11_43.nxml.txt.nlp	22731636	SENT125	19	19	12	12	pp2	CD24		100133941	0.949
NULL	Eur_J_Med_Res_2009_Nov_24_14(Suppl_3)_36-42.nxml.txt.nlp	19959415	SENT106	8	8	22	22	raltegravir	CYP3A		1574	0.949
NULL	Ann_Surg_Oncol_2012_Apr_27_19(4)_1185-1191.nxml.txt.nlp	22031063	SENT20	13	13	3	3	tamoxifen	TTR	PA451581	7276	0.949
NULL	Breast_Cancer_Res_2007_Mar_2_9(2)_205.nxml.txt.nlp	NULL	SENT16	13	13	5	5	trastuzumab	HER-2	PA451743	2064	0.949
NULL	FEBS_Open_Bio_2012_Jul_20_2_179-186.nxml.txt.nlp	23650597	SENT102	11	11	38	38	imiquimod	MxA	PA449972	4599	0.949
NULL	Arthritis_Res_Ther_2010_Jun_2_12(3)_R107.nxml.txt.nlp	20525198	SENT119	17	17	1	1	rolipram	IL-6	PA153906323	3569	0.949
NULL	Diabetes_2008_Oct_57(10)_2801-2808.nxml.txt.nlp	18633115	SENT136	7	7	22	22	sulfasalazine	PARP-1	PA451547	25976	0.949
NULL	Biomed_Res_Int_2014_Feb_19_2014_627510.nxml.txt.nlp	24701578	SENT192	25	25	7	7	docetaxel	ABCB1	PA449383	5243	0.949
NULL	Cell_Cycle_2013_Oct_1_12(19)_3194-3202.nxml.txt.nlp	24013423	SENT65	18	18	3	3	arsenite	FUS	PA452638	2521	0.949
NULL	Braz_J_Microbiol_2010_Mar_1_Jan-Mar_41(1)_59-65.nxml.txt.nlp	24031464	SENT46	3	3	17	17	bacitracin	API	PA448531	5345	0.949
NULL	Case_Rep_Hematol_2014_Dec_7_2014_208597.nxml.txt.nlp	25544909	SENT103	7	7	19	19	cyclophosphamide	VWF	PA449165	7450	0.949
NULL	Cancer_Cell_Int_2013_Feb_12_13_14.nxml.txt.nlp	23402310	SENT129	7	7	33	33	celecoxib	p65	PA448871	5970	0.949
NULL	BMB_Rep_2013_Aug_46(8)_404-409.nxml.txt.nlp	23977988	SENT28	9	9	0	0	heparin	EC-SOD	PA449855	6649	0.949
NULL	Mol_Pain_2013_Jun_10_9_27.nxml.txt.nlp	23758830	SENT113	18	18	8	8	tetracaine	ASIC1	PA451638	41	0.949
NULL	Pharmaceutics_2011_Aug_24_3(3)_510-524.nxml.txt.nlp	24310594	SENT7	18	18	22	22	trastuzumab	ANOVA	PA451743	4858	0.949
NULL	Addict_Sci_Clin_Pract_2010_Dec_5(2)_4-14.nxml.txt.nlp	22002448	SENT114	9	9	31	31	methamphetamine	spatial	PA450403	219793	0.949
NULL	Addict_Sci_Clin_Pract_2010_Dec_5(2)_17-29.nxml.txt.nlp	22002450	SENT50	8	8	20	20	oxycodone	CYP2D6	PA450741	1565	0.949
NULL	Neuropsychopharmacology_2009_Dec_19_34(13)_2710-2720.nxml.txt.nlp	19693002	SENT167	3	3	25	25	clozapine	F10	PA449061	2159	0.949
NULL	Cell_Commun_Signal_2011_May_20_9_14.nxml.txt.nlp	21599982	SENT73	22	22	3	3	pp2	IL-8		3576	0.949
NULL	Br_J_Cancer_2012_Oct_9_107(8)_1277-1285.nxml.txt.nlp	22990652	SENT164	38	38	23	23	axitinib	CYP2C8	PA164924493	1558	0.949
NULL	Clin_Med_Insights_Womens_Health_2013_Jan_22_6_1-11.nxml.txt.nlp	24665209	SENT200	15	15	6	6	tamoxifen	aromatase	PA451581	1588	0.949
NULL	Ann_Surg_Oncol_2010_Apr_20_17(4)_1168-1176.nxml.txt.nlp	19936839	SENT113	9	9	26	26	cetuximab	KRAS	PA10040	3845	0.949
NULL	Bioinformation_2011_Oct_31_7(5)_246-250.nxml.txt.nlp	22125393	SENT23	7	7	1	1	valdecoxib	COX	PA10226	1351	0.949
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT174	10	10	20	20	doxorubicin	B7-H1	PA449412	29126	0.949
NULL	Mol_Med_Rep_2015_Jan_16_11(1)_91-98.nxml.txt.nlp	25322694	SENT102	14	14	42	42	cisplatin	LC3	PA449014	84557	0.949
NULL	Clin_Med_Insights_Oncol_2012_Dec_6_6_407-421.nxml.txt.nlp	23239933	SENT122	20	20	29	29	gefitinib	EGFR	PA131301952	1956	0.949
NULL	Oncologist_2010_Feb_15_15(2)_122-129.nxml.txt.nlp	20156908	SENT45	4	4	1	1	trastuzumab	aromatase	PA451743	1588	0.949
NULL	Front_Pharmacol_2014_May_13_5_89.nxml.txt.nlp	24860504	SENT38	4	4	18	18	resveratrol	SIRT1		23411	0.949
NULL	Osteoporos_Int_2008_Apr_12_19(4)_399-428.nxml.txt.nlp	18266020	SENT956	9	9	16	16	risedronate	IMPACT	PA451255	55364	0.949
NULL	Ther_Clin_Risk_Manag_2007_Aug_3(4)_665-673.nxml.txt.nlp	18472989	SENT175	37	37	34	34	lapatinib	CYP3A4	PA152241907	1576	0.949
NULL	Oncotarget_2014_Nov_2_5(21)_10222-10236.nxml.txt.nlp	25400118	SENT208	21	21	2	2	exemestane	HER3	PA449563	2065	0.949
NULL	Bioinformation_2010_Nov_1_5(5)_191-197.nxml.txt.nlp	21364796	SENT135	25	25	10	10	phenol	LAM	PA450913	7249;7248	0.949
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_127043.nxml.txt.nlp	23227093	SENT182	19	19	5	5	nifedipine	RYR	PA450631	6261	0.949
NULL	Alcohol_Res_2013_35(1)_6-16.nxml.txt.nlp	24313160	SENT125	14	14	0	0	ethanol	CYP2E1	PA448073	1571	0.949
NULL	Nat_Commun_2012_Dec_4_3_1248.nxml.txt.nlp	23212377	SENT569	31	31	5	5	nadh	NADK	PA164755085	65220	0.949
NULL	Front_Endocrinol_(Lausanne)_2011_Dec_2_2_90.nxml.txt.nlp	22654832	SENT178	19	19	0	0	estradiol	STX	PA449503	8128	0.949
NULL	Interdiscip_Toxicol_2008_Sep_1(2)_150-154.nxml.txt.nlp	21218105	SENT76	36	36	13	13	sulfaphenazole	CYP2B	PA130231310	1554;1556	0.949
NULL	Breast_Cancer_Res_2005_Jun_22_7(5)_R681-R689.nxml.txt.nlp	16168113	SENT26	0	0	23	23	paclitaxel	p53	PA450761	7157	0.949
NULL	Acta_Neuropathol_Commun_2014_May_30_2_57.nxml.txt.nlp	24887326	SENT190	8	8	11	11	vardenafil	ABCB1	PA10229	5243	0.949
NULL	BMB_Rep_2013_Jan_46(1)_59-64.nxml.txt.nlp	23351386	SENT61	7	7	21	21	auranofin	STAT3	PA448510	6774	0.949
NULL	Acta_Pharmacol_Sin_2011_Feb_4_32(2)_223-229.nxml.txt.nlp	21293474	SENT180	16	16	5	5	isoproterenol	FKBP12	PA450121	2280	0.949
NULL	Breast_Cancer_Res_2008_Dec_18_10(Suppl_4)_S24.nxml.txt.nlp	19128438	SENT47	37	37	2	2	tamoxifen	IMPACT	PA451581	55364	0.949
NULL	Iran_J_Pharm_Res_2014_Spring_13(2)_683-693.nxml.txt.nlp	25237365	SENT14	26	26	19	19	tamoxifen	CXCR4	PA451581	7852	0.949
NULL	Int_J_Mol_Sci_2014_Oct_23_15(10)_19265-19280.nxml.txt.nlp	25342321	SENT58	20	20	13	13	sc-560	CD34		947	0.949
NULL	Indian_J_Pharmacol_2008_Oct_40(Suppl_2)_S112-S142.nxml.txt.nlp	21593965	SENT1772	25	25	40	40	ethanol	NPY	PA448073	4852	0.949
NULL	Curr_Neuropharmacol_2011_Dec_9(4)_530-552.nxml.txt.nlp	22654714	SENT407	17	17	28	28	desipramine	BDNF	PA449233	627	0.949
NULL	Lab_Invest_2009_Oct_10_89(10)_1076-1083.nxml.txt.nlp	19668239	SENT118	19	19	12	12	minocycline	IFN	PA450519	3439	0.949
NULL	J_Korean_Med_Sci_2010_Aug_21_25(8)_1222-1227.nxml.txt.nlp	20676337	SENT60	0	0	10	10	propofol	LPA	PA451141	4018	0.949
NULL	Pharmaceuticals_(Basel)_2013_Aug_21_6(8)_988-1038.nxml.txt.nlp	24276379	SENT366	2	2	8	8	cetuximab	EGFR	PA10040	1956	0.949
NULL	Mol_Cancer_2006_Oct_17_5_45.nxml.txt.nlp	17044934	SENT100	24	24	14	14	resveratrol	COX		1351	0.949
NULL	Int_J_Mol_Sci_2014_Nov_13_15(11)_20800-20832.nxml.txt.nlp	25402643	SENT407	13	13	0	0	heparin	TMC	PA449855	3703	0.949
NULL	Mol_Pain_2013_Feb_15_9_3.nxml.txt.nlp	23413875	SENT201	5	5	7	7	resveratrol	TRPA1		8989	0.949
NULL	Oncotarget_2014_May_27_5(19)_9049-9064.nxml.txt.nlp	24979294	SENT19	4	4	11	11	dasatinib	SRC	PA162372878	6714	0.949
NULL	Acta_Pharmacol_Sin_2012_Jan_3_33(1)_49-56.nxml.txt.nlp	22212430	SENT23	9	9	0	0	thrombin	PAR-1	PA451674	2011;2149	0.949
NULL	Arthritis_Res_Ther_2011_Apr_27_13(2)_111.nxml.txt.nlp	21542890	SENT25	11	11	5	5	methotrexate	CD11c	PA450428	3687	0.949
NULL	Breast_Cancer_(Auckl)_2012_Mar_7_6_67-77.nxml.txt.nlp	22438669	SENT19	0	0	4	4	trastuzumab	HER2	PA451743	2064	0.949
NULL	Autoimmune_Dis_2012_Jan_19_2012_873587.nxml.txt.nlp	22312482	SENT129	3	3	1	1	infliximab	TNF	PA452639	7124	0.949
NULL	J_Invest_Dermatol_2013_Sep_25_133(9)_2212-2220.nxml.txt.nlp	23439393	SENT127	20	20	25	25	imiquimod	TRAIL	PA449972	8743	0.949
NULL	Clin_Exp_Otorhinolaryngol_2011_Dec_15_4(4)_177-183.nxml.txt.nlp	22232712	SENT128	7	7	10	10	doxycycline	MUC5B	PA449415	727897	0.949
NULL	Case_Rep_Oncol_2013_Jan_29_6(1)_72-77.nxml.txt.nlp	23466899	SENT98	20	20	9	9	gemcitabine	GTX	PA449748	84504	0.949
NULL	Patient_Prefer_Adherence_2013_Apr_26_7_369-377.nxml.txt.nlp	23641151	SENT40	0	0	29	29	ustekinumab	p40	PA166048654	3921;339541;10314	0.949
NULL	Evid_Based_Complement_Alternat_Med_2011_Feb_14_2011_248231.nxml.txt.nlp	19233878	SENT184	22	22	32	32	rosiglitazone	DBT	PA451283	1629	0.949
NULL	Indian_J_Pharmacol_2013_Nov-Dec_45(6)_597-602.nxml.txt.nlp	24347768	SENT23	39	39	3	3	teniposide	P-gp	PA451611	5243	0.949
NULL	Int_J_Breast_Cancer_2012_Dec_18_2012_502092.nxml.txt.nlp	23320178	SENT182	13	13	19	19	etodolac	CCNA2	PA449550	890	0.949
NULL	J_Hematol_Oncol_2013_Jul_18_6_53.nxml.txt.nlp	23866964	SENT99	10	10	19	19	temsirolimus	CDKN1A	PA164746890	1026	0.949
NULL	Diabetes_Metab_J_2013_Feb_15_37(1)_36-39.nxml.txt.nlp	23441298	SENT8	0	0	16	16	vildagliptin	GLP-1	PA165958346	100125288	0.949
NULL	Breast_Cancer_Res_Treat_2013_Jan_6_137(1)_167-174.nxml.txt.nlp	23129173	SENT208	16	16	14	14	letrozole	aromatase	PA450196	1588	0.949
NULL	Cardiol_Ther_2013_Jun_7_2(1)_57-68.nxml.txt.nlp	25135289	SENT58	28	28	6	6	thrombin	PAR-1	PA451674	2011;2149	0.949
NULL	Clin_Med_Insights_Oncol_2013_May_20_7_87-102.nxml.txt.nlp	23761989	SENT206	0	0	26	26	cetuximab	EGFR	PA10040	1956	0.949
NULL	Breast_Cancer_Res_Treat_2012_Jun_18_133(3)_937-947.nxml.txt.nlp	22094936	SENT227	16	16	5	5	tamoxifen	EZH2	PA451581	2146	0.949
NULL	Biomed_Res_Int_2013_Aug_6_2013_909613.nxml.txt.nlp	24027765	SENT334	24	24	45	45	hydrocortisone	EEN	PA449905	6455	0.949
NULL	J_Breast_Cancer_2011_Jun_18_14(2)_135-139.nxml.txt.nlp	21847409	SENT21	29	29	27	27	anastrozole	aromatase	PA448432	1588	0.948
NULL	Acta_Pharmacol_Sin_2010_Apr_15_31(4)_421-428.nxml.txt.nlp	20228827	SENT45	25	25	13	13	phenylephrine	mol	PA450935	90527	0.948
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1013.nxml.txt.nlp	24457957	SENT116	6	6	24	24	bortezomib	NOXA	PA10252	5366	0.948
NULL	Clin_Interv_Aging_2009_May_14_4_197-205.nxml.txt.nlp	19503782	SENT315	5	5	13	13	cytarabine	CD33	PA449177	945	0.948
NULL	Clin_Ophthalmol_2008_Dec_2(4)_821-828.nxml.txt.nlp	19668436	SENT8	24	24	7	7	nilvadipine	Rho	PA165958385	29984	0.948
NULL	Drug_Healthc_Patient_Saf_2012_Nov_29_4_173-180.nxml.txt.nlp	23236256	SENT66	40	40	48	48	olanzapine	FGA	PA450688	2243	0.948
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT109	3	3	24	24	tenofovir	CD4	PA10204	920	0.948
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT52	1	1	31	31	bevacizumab	VEGFR1	PA130232992	2321	0.948
NULL	Breast_Cancer_Res_2007_Aug_8_9(4)_R50.nxml.txt.nlp	17686159	SENT174	3	3	18	18	gefitinib	AKT	PA131301952	207	0.948
NULL	Indian_J_Ophthalmol_2007_Nov-Dec_55(6)_482-483.nxml.txt.nlp	17951917	SENT16	33	33	6	6	chloramphenicol	API	PA448927	5345	0.948
NULL	Cancer_Cell_Int_2011_Aug_19_11_29.nxml.txt.nlp	21854619	SENT207	18	18	15	15	cisplatin	HDAC	PA449014	9734	0.948
NULL	Oncologist_2010_Mar_3_15(3)_216-235.nxml.txt.nlp	20200040	SENT108	0	0	15	15	trastuzumab	HER-2	PA451743	2064	0.948
NULL	BMB_Rep_2014_Nov_47(11)_649-654.nxml.txt.nlp	25301019	SENT85	5	5	24	24	l-alanine	IL-10	PA448055	3586	0.948
NULL	Front_Oncol_2014_Jun_16_4_146.nxml.txt.nlp	24982847	SENT183	4	4	11	11	denosumab	RANKL	PA166048634	8600	0.948
NULL	N_Am_J_Med_Sci_2010_Oct_2(10)_491-495.nxml.txt.nlp	22558553	SENT103	2	2	14	14	napqi	CYP2E1		1571	0.948
NULL	Breast_Cancer_Res_2008_Jul_24_10(4)_211.nxml.txt.nlp	18671839	SENT113	33	33	18	18	docetaxel	PI3K	PA449383	5290	0.948
NULL	Comp_Funct_Genomics_2008_Jun_9_2008_634283.nxml.txt.nlp	18551189	SENT165	20	20	7	7	etoposide	RAD21	PA449552	5885	0.948
NULL	Int_J_Trichology_2014_Jul-Sep_6(3)_113-139.nxml.txt.nlp	NULL	SENT285	0	0	8	8	minoxidil	PHL	PA450521	613	0.948
NULL	Int_J_Mol_Sci_2014_Sep_30_15(10)_17686-17704.nxml.txt.nlp	25272226	SENT213	12	12	28	28	cetuximab	EGF	PA10040	1950	0.948
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1420-1426.nxml.txt.nlp	24056704	SENT125	24	24	20	20	midazolam	CYP3A	PA450496	1574	0.948
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT35	19	19	28	28	phenprocoumon	CYP3A4	PA450921	1576	0.948
NULL	Oncotarget_2011_Jun_15_2(6)_518-524.nxml.txt.nlp	21680956	SENT87	14	14	3	3	nilotinib	STAT3	PA165958345	6774	0.948
NULL	Case_Rep_Nephrol_Urol_2014_Apr_12_4(1)_75-81.nxml.txt.nlp	24847349	SENT61	32	32	0	0	amiodarone	APT	PA448383	653639	0.948
NULL	J_Gen_Physiol_2009_Oct_134(4)_309-322.nxml.txt.nlp	19786584	SENT13	2	2	43	43	glibenclamide	ClC-1	PA449782	1180	0.948
NULL	Curr_Med_Chem_2014_May_21(14)_1595-1606.nxml.txt.nlp	23992330	SENT346	19	19	6	6	everolimus	PI3K	PA164746311	5290	0.948
NULL	Cells_2014_Apr_4_3(2)_199-235.nxml.txt.nlp	24709958	SENT330	13	13	4	4	erlotinib	EGFR	PA134687924	1956	0.948
NULL	J_Exp_Clin_Cancer_Res_2009_Oct_7_28(1)_134.nxml.txt.nlp	19811659	SENT11	8	8	17	17	sunitinib	VEGFR	PA162372840	3791	0.948
NULL	Br_J_Cancer_1992_Oct_66(4)_692-697.nxml.txt.nlp	1419608	SENT8	7	7	5	5	aminoglutethimide	aromatase	PA448375	1588	0.948
NULL	Oncol_Lett_2013_Apr_22_5(4)_1093-1100.nxml.txt.nlp	23599746	SENT190	8	8	16	16	doxorubicin	MDR1	PA449412	5243	0.948
NULL	Cell_Death_Dis_2010_Oct_21_1(10)_e86.nxml.txt.nlp	21368859	SENT242	16	16	8	8	doxorubicin	TRAIL	PA449412	8743	0.948
NULL	Acta_Neuropathol_2014_Nov_9_127(2)_303-305.nxml.txt.nlp	24212601	SENT35	23	23	4	4	trypsin	RD3	PA451806	343035	0.948
NULL	J_Biomed_Biotechnol_2004_Jun_30_2004(2)_106-112.nxml.txt.nlp	15240921	SENT105	39	39	8	8	busulfan	SAGE	PA448691	55511	0.948
NULL	Cancers_(Basel)_2011_Apr_26_3(2)_2176-2194.nxml.txt.nlp	24212803	SENT107	14	14	6	6	cetuximab	KRAS	PA10040	3845	0.948
NULL	Biomed_Res_Int_2013_Jul_16_2013_953520.nxml.txt.nlp	23957013	SENT26	27	27	7	7	cyclosporine	P-gp	PA449167	5243	0.948
NULL	Pharmaceuticals_(Basel)_2012_Aug_30_5(9)_890-898.nxml.txt.nlp	24280696	SENT36	16	16	5	5	geldanamycin	Hsp90	PA152031327	3320	0.948
NULL	Adolesc_Health_Med_Ther_2014_Mar_26_5_35-48.nxml.txt.nlp	24729739	SENT45	18	18	2	2	etanercept	TNF-alpha	PA449515	7124	0.948
NULL	Case_Rep_Oncol_2013_Mar_29_6(1)_189-196.nxml.txt.nlp	23626560	SENT4	16	16	6	6	erlotinib	EGFR	PA134687924	1956	0.948
NULL	Breast_Cancer_Res_2011_Jan_21_13(1)_R9.nxml.txt.nlp	21255398	SENT207	14	14	32	32	doxorubicin	RAD21	PA449412	5885	0.948
NULL	Cancers_(Basel)_2011_Apr_1_3(2)_1844-1860.nxml.txt.nlp	24212785	SENT543	10	10	2	2	cetuximab	BRAF	PA10040	673	0.948
NULL	Chem_Rev_2013_Jul_10_113(7)_4633-4679.nxml.txt.nlp	23514336	SENT300	3	3	22	22	trypsin	GAPDH	PA451806	2597	0.948
NULL	Br_J_Cancer_2011_Jul_26_105(3)_372-381.nxml.txt.nlp	21730979	SENT13	22	22	26	26	temozolomide	p53	PA451609	7157	0.948
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT102	18	18	11	11	sitagliptin	HIP	PA164748978	6767;6159;64399;5068	0.948
NULL	Iran_J_Pharm_Res_2014_Spring_13(2)_683-693.nxml.txt.nlp	25237365	SENT9	6	6	18	18	tamoxifen	CXCR4	PA451581	7852	0.948
NULL	Indian_J_Anaesth_2014_Sep-Oct_58(5)_652-657.nxml.txt.nlp	25535431	SENT148	6	6	25	25	desmopressin	VIII	PA449237	1351	0.948
NULL	Physiol_Rep_2014_Sep_28_2(9)_e12158.nxml.txt.nlp	25263207	SENT395	28	28	4	4	forskolin	MRP4	PA146096022	10257	0.948
NULL	Open_Biol_2014_Oct_4(10)_140053.nxml.txt.nlp	25274119	SENT422	37	37	1	1	l-glutamine	37LRP	PA10090	3921	0.948
NULL	Biologics_2014_Dec_4_8_281-291.nxml.txt.nlp	25506209	SENT58	0	0	21	21	sorafenib	FLT3	PA7000	2322	0.948
NULL	Breast_Cancer_(Auckl)_2009_Sep_2_3_61-75.nxml.txt.nlp	19809577	SENT270	35	35	7	7	curcumin	PARP	PA151958596	142	0.948
NULL	Diabetes_2013_Jun_17_62(6)_1843-1854.nxml.txt.nlp	23349486	SENT159	14	14	2	2	pioglitazone	CCR2	PA450970	729230	0.948
NULL	Oxid_Med_Cell_Longev_2013_Mar_18_2013_528935.nxml.txt.nlp	23577224	SENT137	26	26	2	2	resveratrol	SIRT1		23411	0.948
NULL	Cancer_Metastasis_Rev_2010_Dec_10_29(4)_581-594.nxml.txt.nlp	20830503	SENT335	3	3	6	6	tamoxifen	aromatase	PA451581	1588	0.948
NULL	Oncotarget_2014_Sep_2_5(19)_9308-9321.nxml.txt.nlp	25301721	SENT243	41	41	14	14	mk-571	CD38		952	0.948
NULL	Indian_J_Med_Res_2013_Oct_138(4)_461-491.nxml.txt.nlp	24434254	SENT449	7	7	30	30	lovastatin	2A9	PA450272	6277	0.948
NULL	Case_Rep_Oncol_2014_Jul_23_7(2)_503-508.nxml.txt.nlp	25232318	SENT7	17	17	22	22	crizotinib	KRAS	PA165946122	3845	0.948
NULL	Cells_2014_Jun_26_3(3)_662-673.nxml.txt.nlp	24971848	SENT97	37	37	17	17	capsaicin	TRPV1	PA448776	7442	0.948
NULL	Cancer_Manag_Res_2011_Aug_10_3_273-285.nxml.txt.nlp	21931501	SENT56	6	6	22	22	pazopanib	VEGFR2	PA165291492	3791	0.948
NULL	J_Biomed_Sci_2013_Jan_25_20(1)_4.nxml.txt.nlp	23350663	SENT155	23	23	29	29	thrombin	ADP	PA451674	23038	0.948
NULL	J_Biomed_Biotechnol_2010_Oct_27_2010_948543.nxml.txt.nlp	21048930	SENT177	0	0	14	14	chlorpromazine	AP-2	PA448964	7020	0.948
NULL	Biologics_2012_Sep_25_6_337-345.nxml.txt.nlp	23055691	SENT151	17	17	35	35	erlotinib	EGFR	PA134687924	1956	0.948
NULL	AIDS_Res_Treat_2012_Mar_26_2012_948059.nxml.txt.nlp	22536498	SENT11	24	24	12	12	ribavirin	IL-28B	PA451241	282617	0.948
NULL	Cell_Cycle_2012_Nov_15_11(22)_4110.nxml.txt.nlp	23099922	SENT15	7	7	5	5	verapamil	P-gp	PA451868	5243	0.948
NULL	J_Obes_2011_Dec_15_2011_928165.nxml.txt.nlp	21197151	SENT198	0	0	3	3	liraglutide	GLP-1	PA165958364	100125288	0.948
NULL	Evid_Based_Complement_Alternat_Med_2013_May_12_2013_692549.nxml.txt.nlp	23737842	SENT178	7	7	3	3	heparin	CXCL12	PA449855	6387	0.948
NULL	Nature_2012_Dec_20_492(7429)_387-392.nxml.txt.nlp	23222541	SENT18	27	27	12	12	thrombin	PAR1	PA451674	79581;2149	0.948
NULL	Cell_Death_Dis_2010_Oct_21_1(10)_e86.nxml.txt.nlp	21368859	SENT74	28	28	17	17	doxorubicin	BimEL	PA449412	10018	0.948
NULL	Int_J_Mol_Sci_2014_Oct_15_15(10)_18574-18592.nxml.txt.nlp	25322151	SENT166	20	20	12	12	sirolimus	IL-2	PA451365	3558	0.948
NULL	J_Immunother_Cancer_2013_Nov_7_1(Suppl_1)_P29.nxml.txt.nlp	NULL	SENT5	0	0	11	11	famotidine	IL-2	PA449586	3558	0.948
NULL	Breast_Cancer_Res_2014_May_5_16(3)_R45.nxml.txt.nlp	24887236	SENT191	3	3	24	24	saracatinib	HER2		2064	0.948
NULL	J_Headache_Pain_2010_Dec_27_11(6)_477-483.nxml.txt.nlp	20978816	SENT19	14	14	34	34	indomethacin	COX	PA449982	1351	0.948
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2654-2664.nxml.txt.nlp	24136149	SENT140	9	9	15	15	doxorubicin	HSF1	PA449412	3297	0.948
NULL	Curr_Chem_Genomics_2010_Mar_1_4_1-8.nxml.txt.nlp	20448812	SENT120	9	9	47	47	bosentan	OATP1B3	PA10034	28234	0.948
NULL	Breast_Cancer_Res_2005_Jun_17_7(Suppl_2)_S_08.nxml.txt.nlp	NULL	SENT18	26	26	18	18	tamoxifen	aromatase	PA451581	1588	0.948
NULL	J_Biomed_Biotechnol_2010_Jun_7_2010_150960.nxml.txt.nlp	20617134	SENT226	20	20	26	26	erlotinib	KRAS	PA134687924	3845	0.948
NULL	Front_Neurol_2011_Dec_26_2_83.nxml.txt.nlp	22363312	SENT86	21	21	3	3	clopidogrel	CYP2C19	PA449053	1557	0.948
NULL	Avicenna_J_Phytomed_2014_May-Jun_4(3)_215-224.nxml.txt.nlp	25050319	SENT134	17	17	42	42	diazepam	MEPI	PA449283	5276	0.948
NULL	Br_J_Cancer_2010_May_11_102(10)_1456-1460.nxml.txt.nlp	20461090	SENT98	0	0	13	13	temsirolimus	IFN	PA164746890	3439	0.948
NULL	Clin_Interv_Aging_2012_Jul_12_7_235-247.nxml.txt.nlp	22866001	SENT97	46	46	20	20	atorvastatin	PTH	PA448500	5741	0.948
NULL	Cancers_(Basel)_2011_Apr_1_3(2)_1844-1860.nxml.txt.nlp	24212785	SENT93	21	21	8	8	cetuximab	BRAF	PA10040	673	0.948
NULL	J_Exp_Clin_Cancer_Res_2009_Sep_1_28(1)_123.nxml.txt.nlp	19723324	SENT110	32	32	15	15	gefitinib	PTEN	PA131301952	5728	0.948
NULL	Clin_Dev_Immunol_2013_May_22_2013_701305.nxml.txt.nlp	23762095	SENT78	8	8	23	23	vincristine	MCL1	PA451879	4170	0.948
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S279-S284.nxml.txt.nlp	21525469	SENT187	19	19	30	30	metformin	Met	PA450395	79811	0.948
NULL	Chem_Cent_J_2012_Dec_22_6_162.nxml.txt.nlp	23259549	SENT35	24	24	10	10	diclofenac	UGT2B17	PA449293	7367	0.948
NULL	Exp_Diabetes_Res_2012_Mar_15_2012_146194.nxml.txt.nlp	22474415	SENT204	4	4	14	14	valsartan	MCP-1	PA451848	6347	0.948
NULL	Diabetologia_2009_Oct_4_52(10)_2182-2189.nxml.txt.nlp	19652946	SENT103	18	18	2	2	metformin	SNARK	PA450395	81788	0.948
NULL	Cancers_(Basel)_2011_Mar_4_3(1)_1111-1128.nxml.txt.nlp	24212655	SENT95	7	7	14	14	trastuzumab	San	PA451743	80218	0.948
NULL	Neuro_Oncol_2010_Apr_27_12(4)_389-400.nxml.txt.nlp	20308316	SENT135	3	3	9	9	chloroquine	p53	PA448948	7157	0.948
NULL	Cancer_Cell_Int_2009_Feb_17_9_4.nxml.txt.nlp	19222856	SENT195	20	20	14	14	cisplatin	p53	PA449014	7157	0.948
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT105	40	40	28	28	imatinib	ABCG2	PA10804	9429	0.948
NULL	Cancers_(Basel)_2011_May_9_3(2)_2286-2301.nxml.txt.nlp	24212810	SENT184	21	21	9	9	gemcitabine	Raf-1	PA449748	5894	0.948
NULL	Breast_Cancer_2014_Feb_13_21(6)_703-714.nxml.txt.nlp	23404211	SENT166	22	22	11	11	tamoxifen	aromatase	PA451581	1588	0.948
NULL	Br_J_Cancer_2010_Oct_26_103(9)_1325-1330.nxml.txt.nlp	20940720	SENT162	9	9	29	29	carboplatin	EGFR	PA448803	1956	0.948
NULL	Aging_(Albany_NY)_2010_Dec_20_2(12)_959-968.nxml.txt.nlp	21191146	SENT129	4	4	26	26	cisplatin	Rpn13	PA449014	11047	0.948
NULL	Crit_Care_1999_Dec_23_4(Suppl_A)_4.nxml.txt.nlp	NULL	SENT9	0	0	19	19	heparin	ACT	PA449855	12;11332;9457;641455	0.948
NULL	EMBO_J_2013_May_29_32(11)_1514-1528.nxml.txt.nlp	23524851	SENT132	20	20	4	4	staurosporine	SENP3	PA165109623	26168	0.948
NULL	Nat_Med_2011_Dec_18_18(1)_120-127.nxml.txt.nlp	22179318	SENT84	13	13	0	0	hemin	HO-1	PA449849	3162	0.948
NULL	Ann_Clin_Transl_Neurol_2014_Dec_21_1(12)_996-1005.nxml.txt.nlp	25574474	SENT118	18	18	2	2	riluzole	P-gp	PA451251	5243	0.948
NULL	Nucleic_Acids_Res_2012_Jun_22_40(11)_4861-4878.nxml.txt.nlp	22362753	SENT251	0	0	27	27	trypsin	NPM1	PA451806	4869	0.948
NULL	Adv_Prev_Med_2013_Mar_31_2013_190190.nxml.txt.nlp	23606977	SENT185	2	2	10	10	nevirapine	CD4	PA450616	920	0.948
NULL	Arthritis_Res_Ther_2008_Jul_28_10(4)_R83.nxml.txt.nlp	18662393	SENT104	17	17	4	4	l-tryptophan	IFN	PA10323	3439	0.948
NULL	Oxid_Med_Cell_Longev_2013_Nov_10_2013_680414.nxml.txt.nlp	24319532	SENT184	6	6	9	9	minocycline	PARP-1	PA450519	25976	0.948
NULL	J_Hematol_Oncol_2013_Jun_3_6_38.nxml.txt.nlp	23731980	SENT71	18	18	16	16	lapatinib	HER2	PA152241907	2064	0.948
NULL	Cell_Death_Dis_2014_Jan_2_5(1)_e980.nxml.txt.nlp	24384723	SENT12	12	12	26	26	lapatinib	HSF1	PA152241907	3297	0.948
NULL	Oncol_Rep_2014_Dec_13_32(6)_2307-2318.nxml.txt.nlp	25310523	SENT33	39	39	28	28	gemcitabine	BNIP3	PA449748	664	0.948
NULL	Oncotarget_2014_Sep_10_5(19)_8924-8936.nxml.txt.nlp	25238040	SENT72	22	22	3	3	decitabine	p53	PA164749631	7157	0.948
NULL	Osteoporos_Int_2011_Jun_12_22(6)_1935-1946.nxml.txt.nlp	20938767	SENT31	20	20	23	23	teriparatide	PTH	PA451620	5741	0.948
NULL	Ann_Oncol_2009_Aug_17_20(8)_1319-1329.nxml.txt.nlp	19535820	SENT224	21	21	9	9	tamoxifen	CYP2D6	PA451581	1565	0.948
NULL	Mol_Cancer_2010_Jun_24_9_164.nxml.txt.nlp	20576107	SENT195	29	29	7	7	etoposide	Mcl-1	PA449552	4170	0.948
NULL	Adolesc_Health_Med_Ther_2014_Nov_27_5_211-221.nxml.txt.nlp	25473324	SENT52	0	0	8	8	aripiprazole	CYP3A4	PA10026	1576	0.948
NULL	ScientificWorldJournal_2012_Sep_10_2012_168953.nxml.txt.nlp	22997489	SENT114	0	0	22	22	latanoprost	PGF	PA164774763	5228	0.948
NULL	Br_J_Cancer_2012_Jan_31_106(3)_475-481.nxml.txt.nlp	22187040	SENT147	8	8	11	11	gefitinib	EGFR	PA131301952	1956	0.948
NULL	Oncol_Lett_2014_Oct_22_8(4)_1603-1607.nxml.txt.nlp	25202376	SENT85	21	21	4	4	cisplatin	BRCA1	PA449014	672	0.948
NULL	Drug_Des_Devel_Ther_2014_Oct_31_8_2121-2128.nxml.txt.nlp	25382970	SENT74	3	3	7	7	curcumin	TTR	PA151958596	7276	0.948
NULL	Cardiovasc_Diabetol_2013_May_29_12_80.nxml.txt.nlp	23718574	SENT134	4	4	14	14	mannitol	LOX-1	PA450320	4973	0.948
NULL	Biomed_Res_Int_2013_Aug_19_2013_129629.nxml.txt.nlp	24024180	SENT168	5	5	14	14	curcumin	Hes1	PA151958596	3280	0.948
NULL	Case_Rep_Ophthalmol_Med_2012_Nov_6_2012_968180.nxml.txt.nlp	23198204	SENT23	14	14	21	21	tocilizumab	IL-6	PA165292659	3569	0.948
NULL	Br_J_Cancer_2011_Apr_12_104(8)_1262-1269.nxml.txt.nlp	21407216	SENT101	11	11	18	18	cetuximab	EGFR	PA10040	1956	0.948
NULL	Br_J_Cancer_2012_Feb_14_106(4)_685-692.nxml.txt.nlp	22294184	SENT190	15	15	6	6	lovastatin	survivin	PA450272	332	0.948
NULL	Breast_Cancer_Res_2012_Nov_6_14(6)_325.nxml.txt.nlp	23131146	SENT29	28	28	19	19	cyclophosphamide	p53	PA449165	7157	0.948
NULL	Indian_J_Med_Res_2014_Apr_139(4)_572-578.nxml.txt.nlp	24927344	SENT22	28	28	16	16	warfarin	GGCX	PA451906	2677	0.948
NULL	Cardiovasc_Diabetol_2013_Oct_17_12_150.nxml.txt.nlp	24134550	SENT147	7	7	25	25	metformin	activin	PA450395	83729	0.948
NULL	J_Gen_Physiol_2009_Jun_133(6)_603-622.nxml.txt.nlp	19468075	SENT9	16	16	11	11	dorzolamide	CO2	PA164748765	4513	0.948
NULL	J_Cell_Mol_Med_2013_Sep_11_17(9)_1160-1172.nxml.txt.nlp	23844832	SENT276	28	28	24	24	erlotinib	EGFR	PA134687924	1956	0.948
NULL	J_Ophthalmol_2012_Dec_18_2012_483034.nxml.txt.nlp	22220269	SENT206	0	0	14	14	ranibizumab	MB1	PA164746012	5693	0.948
NULL	Eur_J_Clin_Pharmacol_2010_Nov_29_66(11)_1131-1136.nxml.txt.nlp	20669013	SENT130	22	22	34	34	voriconazole	CYP3A4	PA10233	1576	0.948
NULL	Curr_Cardiol_Rev_2008_Nov_4(4)_309-322.nxml.txt.nlp	20066139	SENT171	3	3	1	1	indomethacin	COX	PA449982	1351	0.948
NULL	J_Cell_Mol_Med_2014_Oct_11_18(10)_2031-2043.nxml.txt.nlp	25109475	SENT339	6	6	3	3	valsartan	AMPK	PA451848	5563	0.948
NULL	Leukemia_2013_Feb_14_27(2)_362-369.nxml.txt.nlp	22955330	SENT175	24	24	6	6	sirolimus	NRM	PA451365	11270	0.948
NULL	Cancer_Manag_Res_2014_Jan_28_6_39-51.nxml.txt.nlp	24501545	SENT134	37	37	15	15	theophylline	CYP2D6	PA451647	1565	0.948
NULL	J_Vis_Exp_2014_Jul_4_(89)_51847.nxml.txt.nlp	25045833	SENT126	25	25	0	0	theophylline	CARS	PA451647	833	0.948
NULL	Anal_Biochem_2013_Nov_1_442(1)_19-23.nxml.txt.nlp	23886887	SENT105	17	17	6	6	nadh	mol	PA164755085	90527	0.948
NULL	Oncologist_2010_Feb_15_15(2)_122-129.nxml.txt.nlp	20156908	SENT137	21	21	4	4	letrozole	HER-2	PA450196	2064	0.948
NULL	Environ_Health_Perspect_2005_Oct_14_113(10)_1330-1335.nxml.txt.nlp	16203242	SENT164	7	7	25	25	arsenite	MLC	PA452638	23209	0.948
NULL	Nat_Commun_2013_Apr_9_4_1684.nxml.txt.nlp	23575688	SENT598	14	14	21	21	rolipram	CYLD	PA153906323	1540	0.948
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT13	5	5	16	16	erlotinib	CYP3A	PA134687924	1574	0.948
NULL	Lancet_2011_Jun_9_377(9784)_2181-2192.nxml.txt.nlp	21663949	SENT124	36	36	16	16	simvastatin	SHARP	PA451363	23013	0.948
NULL	Alcohol_Res_2012_34(3)_339-344.nxml.txt.nlp	23134050	SENT31	7	7	2	2	ethanol	ADH5	PA448073	128	0.948
NULL	Cancer_Sci_2012_Nov_17_103(11)_1907-1912.nxml.txt.nlp	22809142	SENT86	19	19	9	9	bortezomib	HDAC6	PA10252	10013	0.948
NULL	Aging_(Albany_NY)_2014_May_4_6(6)_440-453.nxml.txt.nlp	25013207	SENT117	23	23	8	8	cyclosporine	VGF	PA449167	7425	0.948
NULL	Indian_J_Nucl_Med_2011_Jul-Sep_26(Suppl1)_S16-S19.nxml.txt.nlp	NULL	SENT67	16	16	4	4	thyroglobulin	FDG	PA164754910	23583	0.948
NULL	Mol_Cell_Biol_2014_Oct_34(19)_3754-3764.nxml.txt.nlp	25071155	SENT270	33	33	23	23	cisplatin	WWP1	PA449014	11059	0.948
NULL	ARYA_Atheroscler_2012_Winter_7(4)_133-137.nxml.txt.nlp	23205044	SENT34	20	20	6	6	pentoxifylline	p50	PA450864	958;4790	0.948
NULL	Sci_Rep_2014_Nov_28_4_7237.nxml.txt.nlp	25429875	SENT86	9	9	22	22	hesperidin	JNK	PA449867	5599	0.948
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Feb_5_67(Pt_3)_o573.nxml.txt.nlp	21522335	SENT67	35	35	19	19	ethanol	mol	PA448073	90527	0.948
NULL	Oncotarget_2011_Jan_25_2(1-2)_8-17.nxml.txt.nlp	21378407	SENT32	1	1	10	10	thrombin	PAR-1	PA451674	2011;2149	0.948
NULL	Nat_Commun_2014_5_3361.nxml.txt.nlp	24553445	SENT101	8	8	2	2	olaparib	PTEN		5728	0.948
NULL	J_Carcinog_2014_Feb_7_13_1.nxml.txt.nlp	24737949	SENT185	11	11	5	5	sorafenib	KIT	PA7000	3815	0.948
NULL	Nat_Commun_2013_Sep_17_4_2464.nxml.txt.nlp	24043118	SENT43	8	8	19	19	estradiol	FGFR2	PA449503	2263	0.948
NULL	Open_Cardiovasc_Med_J_2014_Feb_7_8_12-17.nxml.txt.nlp	24653785	SENT157	7	7	14	14	simvastatin	CYP3A	PA451363	1574	0.948
NULL	Clin_Epigenetics_2011_Dec_5_3(1)_8.nxml.txt.nlp	22414275	SENT77	7	7	31	31	ribavirin	ESR1	PA451241	2099	0.948
NULL	J_Biol_Chem_2009_Aug_21_284(34)_22926-22937.nxml.txt.nlp	19520847	SENT399	1	1	17	17	amrinone	ADP	PA164746803	23038	0.948
NULL	Cancer_Immunol_Immunother_2012_Oct_8_61(10)_1713-1720.nxml.txt.nlp	22399057	SENT94	31	31	16	16	plerixafor	CXCR4	PA165958410	7852	0.948
NULL	Ther_Clin_Risk_Manag_2005_Jun_1(2)_107-114.nxml.txt.nlp	18360550	SENT108	15	15	7	7	nifedipine	castor	PA450631	54897	0.948
NULL	Nat_Methods_2012_Sep_15_9(9)_917-922.nxml.txt.nlp	22796663	SENT164	37	37	14	14	forskolin	B27	PA146096022	56246	0.948
NULL	Arthritis_Res_2001_Jan_26_3(Suppl_A)_L013.nxml.txt.nlp	NULL	SENT16	26	26	8	8	fluvastatin	ADM	PA449688	133	0.948
NULL	J_Cancer_Prev_2014_Jun_19(2)_97-102.nxml.txt.nlp	25337577	SENT113	9	9	27	27	curcumin	p38	PA151958596	10598;1432;7965	0.948
NULL	J_Hematol_Oncol_2011_Dec_21_4_53.nxml.txt.nlp	22189016	SENT70	16	16	7	7	ketoconazole	P-gp	PA450146	5243	0.948
NULL	Cancers_(Basel)_2014_Jul_22_6(3)_1540-1552.nxml.txt.nlp	25055117	SENT431	17	17	0	0	gefitinib	Met	PA131301952	79811	0.948
NULL	Clin_Pharmacol_2010_Sep_6_2_155-162.nxml.txt.nlp	22291500	SENT63	13	13	26	26	clopidogrel	CYP2C19	PA449053	1557	0.948
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_2_2014_789142.nxml.txt.nlp	25530790	SENT18	3	3	6	6	clopidogrel	ADP	PA449053	23038	0.948
NULL	Nat_Med_2012_Mar_4_18(4)_547-554.nxml.txt.nlp	22388091	SENT75	0	0	15	15	atropine	IL-17A	PA448505	3605	0.948
NULL	Oncoimmunology_2012_Dec_1_1(9)_1661-1663.nxml.txt.nlp	23264929	SENT17	35	35	8	8	imiquimod	CCL2	PA449972	6347	0.948
NULL	Acta_Neuropathol_Commun_2014_Jul_16_2(1)_81.nxml.txt.nlp	NULL	SENT150	3	3	9	9	fluoxetine	p75NTR	PA449673	4804	0.948
NULL	Pharmaceutics_2011_Aug_10_3(3)_474-484.nxml.txt.nlp	24310591	SENT1	22	22	1	1	cyanocobalamin	B12	PA451892	7126;4709	0.948
NULL	Acta_Naturae_2013_Oct-Dec_5(4)_83-93.nxml.txt.nlp	24455187	SENT75	40	40	8	8	trypsin	7SL	PA451806	6029	0.948
NULL	Oxid_Med_Cell_Longev_2013_Nov_12_2013_820679.nxml.txt.nlp	24327827	SENT17	5	5	17	17	resveratrol	SIRT1		23411	0.948
NULL	Sci_Rep_2014_Dec_4_4_7315.nxml.txt.nlp	25472865	SENT26	26	26	9	9	thrombin	GT24	PA451674	1501	0.948
NULL	Biomed_Res_Int_2014_Feb_19_2014_627510.nxml.txt.nlp	24701578	SENT192	39	39	7	7	thalidomide	ABCB1	PA451644	5243	0.948
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Sep_24_3(9)_e137.nxml.txt.nlp	25250527	SENT57	0	0	9	9	oxaprozin	COX	PA450730	1351	0.948
NULL	Oncogene_2014_Sep_18_33(38)_4664-4674.nxml.txt.nlp	24096486	SENT142	0	0	41	41	erlotinib	EGF	PA134687924	1950	0.948
NULL	Iran_J_Ped_Hematol_Oncol_2014_Jul_20_4(3)_118-126.nxml.txt.nlp	25254091	SENT112	12	12	21	21	methotrexate	ABCA2	PA450428	20	0.948
NULL	Arthritis_Res_Ther_2014_Mar_11_16(2)_R65.nxml.txt.nlp	24612997	SENT199	7	7	0	0	valsartan	IL-8	PA451848	3576	0.948
NULL	Pharmaceuticals_(Basel)_2012_Aug_10_5(8)_802-836.nxml.txt.nlp	24280676	SENT294	36	36	22	22	ketoprofen	MRP2	PA450149	100130958;57626;1244	0.948
NULL	Breast_Cancer_Res_2010_Jun_4_12(3)_R32.nxml.txt.nlp	20525379	SENT312	10	10	3	3	tamoxifen	survivin	PA451581	332	0.948
NULL	Curr_Hepat_Rep_2010_May_21_9(2)_75-90.nxml.txt.nlp	20461127	SENT290	12	12	15	15	telbivudine	LAM	PA164760861	7249;7248	0.948
NULL	Arch_Trauma_Res_2012_Oct_14_Autumn_1(3)_126-130.nxml.txt.nlp	24396761	SENT40	35	35	5	5	oxygen	GCS	PA450744	2729;7357	0.948
NULL	Exp_Ther_Med_2014_Nov_29_8(5)_1473-1478.nxml.txt.nlp	25289044	SENT167	27	27	39	39	heparin	AZU	PA449855	566	0.948
NULL	Case_Rep_Med_2013_Nov_12_2013_640216.nxml.txt.nlp	24319464	SENT57	37	37	18	18	emtricitabine	CD4	PA10069	920	0.948
NULL	Open_Biochem_J_2011_Sep_23_5_45-51.nxml.txt.nlp	21966325	SENT183	8	8	2	2	diclofenac	ATF6	PA449293	22926	0.948
NULL	Br_J_Cancer_2012_Jan_3_106(1)_18-24.nxml.txt.nlp	22108516	SENT111	43	43	26	26	irinotecan	TDP1	PA450085	55775	0.948
NULL	Pharmaceutics_2011_Oct_12_3(4)_680-705.nxml.txt.nlp	24309303	SENT52	10	10	16	16	cyclosporine	CYP3A4	PA449167	1576	0.948
NULL	Indian_J_Psychiatry_2009_Jul-Sep_51(3)_222-224.nxml.txt.nlp	19881055	SENT60	0	0	4	4	tamoxifen	CYP2D6	PA451581	1565	0.948
NULL	J_Hematol_Oncol_2013_Jan_15_6_5.nxml.txt.nlp	23320987	SENT138	17	17	26	26	heparin	PI-PLC	PA449855	2923	0.948
NULL	Am_J_Cardiovasc_Drugs_2013_Jun_20_13(5)_331-342.nxml.txt.nlp	23784266	SENT223	4	4	13	13	rivaroxaban	CYP3A4	PA165958360	1576	0.948
NULL	J_Occup_Med_Toxicol_2008_Feb_27_3(Suppl_1)_S6.nxml.txt.nlp	18315837	SENT80	3	3	18	18	theophylline	IL-4	PA451647	3565	0.948
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT123	16	16	3	3	metformin	HIF-1	PA450395	29072	0.948
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT520	31	31	43	43	aripiprazole	PRL	PA10026	5617	0.948
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Feb_15_5_3.nxml.txt.nlp	16480505	SENT136	24	24	12	12	felodipine	CYP3A4	PA449591	1576	0.948
NULL	Biologics_2009_Jul_13_3_289-301.nxml.txt.nlp	19707416	SENT90	0	0	19	19	lapatinib	EGFR	PA152241907	1956	0.948
NULL	Biomed_Res_Int_2014_Jan_23_2014_312647.nxml.txt.nlp	24587984	SENT186	26	26	0	0	infliximab	ABCA1	PA452639	19	0.948
NULL	Pharm_Pract_(Granada)_2011_Mar_15_Jan-Mar_9(1)_1-10.nxml.txt.nlp	25132883	SENT121	7	7	34	34	dabigatran	SPAF		166378	0.948
NULL	Cancers_(Basel)_2013_Apr_15_5(2)_430-461.nxml.txt.nlp	24216985	SENT1372	20	20	12	12	bortezomib	HDAC6	PA10252	10013	0.948
NULL	Int_J_Environ_Res_Public_Health_2012_Aug_3_9(8)_2788-2800.nxml.txt.nlp	23066397	SENT149	38	38	0	0	cytarabine	CYP2E1	PA449177	1571	0.948
NULL	Crit_Care_2008_Aug_4_12(4)_R100.nxml.txt.nlp	18680601	SENT165	22	22	10	10	bacitracin	IL-10	PA448531	3586	0.948
NULL	Breast_Cancer_Res_2000_Mar_12_2(Suppl_1)_P2_03.nxml.txt.nlp	NULL	SENT5	22	22	11	11	estradiol	HES-1	PA449503	3280	0.948
NULL	Arthritis_Res_Ther_2014_Jul_18_16(4)_R153.nxml.txt.nlp	25037855	SENT229	20	20	6	6	adalimumab	CD14	PA10004	929	0.948
NULL	Diabetes_Care_2008_Dec_31(12)_2284-2287.nxml.txt.nlp	18768676	SENT127	37	37	24	24	pioglitazone	AS160	PA450970	9882	0.948
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2705-2713.nxml.txt.nlp	24129232	SENT135	12	12	21	21	doxorubicin	IFN	PA449412	3439	0.948
NULL	J_Biol_Chem_2008_Oct_31_283(44)_29841-29846.nxml.txt.nlp	18765669	SENT33	8	8	12	12	suramin	P2X4	PA10292	5025	0.948
NULL	Adv_Hematol_2012_Mar_26_2012_932658.nxml.txt.nlp	22548067	SENT77	14	14	38	38	vincristine	CHOP	PA451879	1649	0.948
NULL	Indian_Dermatol_Online_J_2013_Jan-Mar_4(1)_2-11.nxml.txt.nlp	23439959	SENT162	3	3	13	13	ustekinumab	p40	PA166048654	3921;339541;10314	0.948
NULL	Commun_Integr_Biol_2013_Jan_1_6(1)_e22278.nxml.txt.nlp	23802033	SENT32	28	28	13	13	nifedipine	Dicer	PA450631	23405	0.948
NULL	Br_J_Cancer_2009_Jul_7_101(1)_48-54.nxml.txt.nlp	19513067	SENT115	22	22	25	25	imatinib	aromatase	PA10804	1588	0.948
NULL	Breast_Cancer_Res_2010_Jul_8_12(4)_R47.nxml.txt.nlp	20615243	SENT31	19	19	5	5	tamoxifen	aromatase	PA451581	1588	0.948
NULL	J_Mol_Signal_2012_Aug_16_7_12.nxml.txt.nlp	22898329	SENT254	11	11	19	19	erlotinib	BIM	PA134687924	10018	0.948
NULL	Korean_Circ_J_2014_Mar_12_44(2)_97-104.nxml.txt.nlp	24653739	SENT139	11	11	4	4	bosentan	Bcl-2	PA10034	596	0.948
NULL	Front_Neurol_2014_Sep_2_5_159.nxml.txt.nlp	25228896	SENT62	22	22	7	7	morphine	GCS	PA450550	2729;7357	0.948
NULL	Drugs_R_D_2011_Mar_27_11(1)_37-51.nxml.txt.nlp	21410294	SENT17	18	18	16	16	itraconazole	CYP3A4	PA450132	1576	0.948
NULL	Breast_Cancer_Res_2011_Nov_30_13(6)_221.nxml.txt.nlp	22217398	SENT172	14	14	21	21	letrozole	PIK3CA	PA450196	5290	0.948
NULL	Mol_Biol_Cell_2012_Oct_1_23(19)_3838-3850.nxml.txt.nlp	22875993	SENT138	29	29	15	15	mesna	GDNF	PA450385	2668	0.948
NULL	Hum_Genomics_2010_Oct_1_5(1)_61-72.nxml.txt.nlp	21106490	SENT149	10	10	20	20	atorvastatin	CYP3A4	PA448500	1576	0.948
NULL	Cancer_Res_Treat_2012_Sep_30_44(3)_202-209.nxml.txt.nlp	23091447	SENT156	8	8	28	28	gefitinib	EGFR	PA131301952	1956	0.948
NULL	Front_Neurol_2015_Jan_13_5_289.nxml.txt.nlp	25628599	SENT289	9	9	25	25	nadh	p53	PA164755085	7157	0.948
NULL	Arthritis_Res_Ther_2005_Oct_18_7(6)_R1412-R1420.nxml.txt.nlp	16277694	SENT237	16	16	3	3	infliximab	CD4	PA452639	920	0.948
NULL	Ther_Clin_Risk_Manag_2007_Aug_3(4)_675-684.nxml.txt.nlp	18472990	SENT207	4	4	12	12	tigecycline	VISA	PA164746412	57506	0.948
NULL	Acta_Pharmacol_Sin_2012_Dec_5_33(12)_1502-1510.nxml.txt.nlp	23123644	SENT153	16	16	5	5	losartan	AT2	PA450268	186	0.948
NULL	Indian_J_Dermatol_2013_Jan-Feb_58(1)_61-64.nxml.txt.nlp	23372216	SENT99	2	2	10	10	fluoxetine	CYP1A2	PA449673	1544	0.948
NULL	Breast_Cancer_Res_2005_Apr_6_7(3)_119-130.nxml.txt.nlp	15987442	SENT169	3	3	18	18	fulvestrant	EGFR	PA164747170	1956	0.948
NULL	Environ_Health_Perspect_2007_Jul_5_115(7)_1094-1100.nxml.txt.nlp	17637928	SENT184	15	15	6	6	etoposide	Bcl-2	PA449552	596	0.948
NULL	Br_J_Cancer_2010_Oct_26_103(9)_1331-1334.nxml.txt.nlp	20877352	SENT75	11	11	15	15	trastuzumab	GM-CSF	PA451743	1437	0.948
NULL	Indian_J_Med_Res_2014_Apr_139(4)_572-578.nxml.txt.nlp	24927344	SENT78	29	29	20	20	acenocoumarol	GGCX	PA452632	2677	0.948
NULL	Cell_Biol_Int_Rep_(2010)_2012_Jun_21_19(1)_e00017.nxml.txt.nlp	23124518	SENT72	5	5	21	21	etoposide	TRAIL	PA449552	8743	0.948
NULL	Child_Adolesc_Psychiatry_Ment_Health_2009_Aug_24_3_21.nxml.txt.nlp	19703299	SENT240	11	11	34	34	atomoxetine	CHIP	PA134688071	10273	0.948
NULL	J_Exp_Clin_Cancer_Res_2009_Jul_10_28(1)_99.nxml.txt.nlp	19591692	SENT122	28	28	11	11	tariquidar	ABCG2		9429	0.948
NULL	Eur_Radiol_2011_Jun_3_21(6)_1188-1199.nxml.txt.nlp	21127880	SENT197	29	29	9	9	trastuzumab	HER2	PA451743	2064	0.948
NULL	Arch_Drug_Inf_2011_Mar_4(1)_1-9.nxml.txt.nlp	21572514	SENT208	8	8	20	20	ciprofloxacin	P-gp	PA449009	5243	0.948
NULL	Acta_Pharmacol_Sin_2010_Sep_16_31(9)_1075-1084.nxml.txt.nlp	20711221	SENT129	7	7	11	11	metformin	eNOS	PA450395	4846	0.948
NULL	Diabetes_2013_Sep_15_62(9)_3232-3240.nxml.txt.nlp	23835329	SENT221	9	9	2	2	olanzapine	GLP-1	PA450688	100125288	0.948
NULL	Int_J_Biol_Sci_2014_Jan_11_10(2)_142-148.nxml.txt.nlp	24520212	SENT32	11	11	0	0	estradiol	WWOX	PA449503	51741	0.948
NULL	Anat_Res_Int_2012_Feb_22_2012_457546.nxml.txt.nlp	22567309	SENT295	30	30	17	17	methimazole	DRB1	PA450422	129831	0.948
NULL	Pharmaceutics_2011_Sep_14_3(3)_615-635.nxml.txt.nlp	24310600	SENT146	3	3	18	18	elacridar	ABCG2		9429	0.948
NULL	Mol_Pain_2013_Jun_10_9_27.nxml.txt.nlp	23758830	SENT113	18	18	3	3	tetracaine	ASIC3	PA451638	9311	0.948
NULL	Arthritis_Res_2002_Feb_4_4(Suppl_1)_40.nxml.txt.nlp	NULL	SENT4	11	11	0	0	thrombin	PAR1	PA451674	79581;2149	0.948
NULL	Drugs_Context_2013_May_22_2013_212255.nxml.txt.nlp	24432042	SENT250	16	16	8	8	ranolazine	GLP-1	PA164746007	100125288	0.948
NULL	Case_Rep_Med_2011_Oct_24_2011_527569.nxml.txt.nlp	22110512	SENT35	34	34	44	44	fludarabine	CD34	PA449655	947	0.948
NULL	Semin_Immunopathol_2012_Jan_4_34(1)_93-106.nxml.txt.nlp	21845431	SENT61	6	6	15	15	thrombin	PAR-1	PA451674	2011;2149	0.948
NULL	Ann_Gen_Psychiatry_2010_Dec_10_9_39.nxml.txt.nlp	21143969	SENT62	0	0	19	19	fluoxetine	5-HT2A	PA449673	3356	0.948
NULL	Br_J_Pharmacol_2012_Jan_165(2)_390-400.nxml.txt.nlp	21671897	SENT38	3	3	24	24	suramin	P2X4	PA10292	5025	0.948
NULL	Cancer_Med_2013_Aug_30_2(4)_457-467.nxml.txt.nlp	24156018	SENT157	13	13	0	0	temozolomide	U87	PA451609	677775;641648	0.948
NULL	Oxid_Med_Cell_Longev_2014_Apr_30_2014_149627.nxml.txt.nlp	24876909	SENT112	30	30	18	18	ethanol	PER2	PA448073	8864	0.948
NULL	Tuberc_Respir_Dis_(Seoul)_2013_Nov_29_75(5)_188-198.nxml.txt.nlp	24348666	SENT43	5	5	13	13	gefitinib	HER2	PA131301952	2064	0.948
NULL	Indian_J_Endocrinol_Metab_2011_Jul-Sep_15(3)_175-181.nxml.txt.nlp	21897893	SENT150	4	4	31	31	denosumab	OPG	PA166048634	690	0.948
NULL	Evid_Based_Complement_Alternat_Med_2012_Aug_23_2012_643973.nxml.txt.nlp	22956975	SENT188	3	3	22	22	amitriptyline	GLT-1	PA448385	6506	0.948
NULL	Biomed_Res_Int_2013_Sep_4_2013_419176.nxml.txt.nlp	24093097	SENT69	24	24	39	39	sunitinib	VEGFR	PA162372840	3791	0.948
NULL	Front_Endocrinol_(Lausanne)_2013_Sep_4_4_116.nxml.txt.nlp	24027559	SENT38	7	7	17	17	estradiol	SULT1A1	PA449503	6817	0.948
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_P104.nxml.txt.nlp	NULL	SENT18	12	12	1	1	abacavir	DPT	PA448004	1805	0.948
NULL	Exp_Ther_Med_2012_Oct_3_4(4)_594-604.nxml.txt.nlp	23170111	SENT101	27	27	20	20	propranolol	p44	PA451145	10561;2966	0.948
NULL	Exp_Diabetes_Res_2012_Apr_17_2012_635472.nxml.txt.nlp	22577369	SENT112	9	9	3	3	exenatide	GLP-1	PA164749238	100125288	0.948
NULL	Mol_Cancer_2012_Jul_25_11_47.nxml.txt.nlp	22830443	SENT110	19	19	32	32	panitumumab	EGF	PA162373091	1950	0.948
NULL	Onco_Targets_Ther_2014_Sep_9_7_1571-1582.nxml.txt.nlp	25228815	SENT234	7	7	11	11	sunitinib	VEGFR1	PA162372840	2321	0.948
NULL	Mol_Biol_Int_2014_Sep_7_2014_852748.nxml.txt.nlp	25276427	SENT139	6	6	17	17	cisplatin	HER2	PA449014	2064	0.948
NULL	Clin_Interv_Aging_2012_Jul_12_7_249-255.nxml.txt.nlp	22866002	SENT4	0	0	6	6	gabapentin	gamma	PA449720	9913	0.948
NULL	Pharmaceuticals_(Basel)_2011_Nov_10_4(11)_1488-1502.nxml.txt.nlp	NULL	SENT15	4	4	16	16	trastuzumab	HER2	PA451743	2064	0.948
NULL	J_Nutr_Metab_2011_Oct_1_2011_525094.nxml.txt.nlp	21977315	SENT5	30	30	19	19	resveratrol	SIRT1		23411	0.948
NULL	Leukemia_2014_Sep_30_28(9)_1918-1922.nxml.txt.nlp	24791858	SENT53	4	4	14	14	imatinib	JAK2	PA10804	3717	0.948
NULL	Br_J_Pharmacol_2014_May_171(10)_2659-2670.nxml.txt.nlp	24116661	SENT46	14	14	3	3	naringenin	TRPP2	PA151958361	5311	0.948
NULL	Front_Oncol_2013_Sep_23_3_250.nxml.txt.nlp	24069582	SENT341	26	26	24	24	anastrozole	aromatase	PA448432	1588	0.948
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Jun_27_5_15.nxml.txt.nlp	16803618	SENT204	31	31	18	18	flucloxacillin	LTA	PA164781042	4049	0.948
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1522-1532.nxml.txt.nlp	21997136	SENT148	3	3	1	1	lapatinib	EGFR	PA152241907	1956	0.948
NULL	J_Am_Heart_Assoc_2013_Dec_19_2(6)_e000439.nxml.txt.nlp	24334905	SENT228	6	6	20	20	doxorubicin	p62	PA449412	8878;10657;23636	0.948
NULL	Mol_Cell_Biochem_2012_Apr_3_363(1-2)_135-145.nxml.txt.nlp	22139302	SENT160	26	26	24	24	curcumin	survivin	PA151958596	332	0.948
NULL	ScientificWorldJournal_2012_Apr_30_2012_253724.nxml.txt.nlp	22629124	SENT116	35	35	0	0	nadh	MPST	PA164755085	4357	0.948
NULL	F1000Res_2014_Aug_19_3_198.nxml.txt.nlp	25400908	SENT97	14	14	7	7	estradiol	aromatase	PA449503	1588	0.948
NULL	Oncol_Lett_2014_Jul_25_8(1)_313-316.nxml.txt.nlp	24959268	SENT78	13	13	27	27	sulindac	JNK1	PA451565	5599	0.948
NULL	J_Oncol_2010_Apr_11_2010_251231.nxml.txt.nlp	20414333	SENT214	3	3	10	10	2-methoxyestradiol	HIF1	PA134967247	3091	0.948
NULL	Target_Oncol_2013_Jun_27_8(2)_127-136.nxml.txt.nlp	23625191	SENT47	7	7	22	22	panitumumab	KRAS	PA162373091	3845	0.948
NULL	Br_J_Cancer_2012_May_22_106(11)_1833-1841.nxml.txt.nlp	22617157	SENT134	22	22	6	6	bevacizumab	CXCR2	PA130232992	3579	0.948
NULL	Fibrogenesis_Tissue_Repair_2012_Jul_23_5_11.nxml.txt.nlp	22824096	SENT408	15	15	6	6	thrombin	PAR-1	PA451674	2011;2149	0.948
NULL	Clin_Pharmacokinet_2014_Sep_3_53(1)_1-16.nxml.txt.nlp	23999929	SENT278	5	5	18	18	rivaroxaban	P-gp	PA165958360	5243	0.948
NULL	Psychiatry_Investig_2012_Dec_12_9(4)_422-424.nxml.txt.nlp	23251210	SENT8	5	5	7	7	terbinafine	CYP2D6	PA451614	1565	0.948
NULL	Acta_Pharmacol_Sin_2009_May_5_30(5)_646-652.nxml.txt.nlp	19417737	SENT126	24	24	6	6	midazolam	CYP3A4	PA450496	1576	0.948
NULL	Br_J_Cancer_2009_Mar_24_100(6)_870-873.nxml.txt.nlp	19293806	SENT37	38	38	27	27	gemcitabine	CDA	PA449748	978	0.948
NULL	Biomed_Res_Int_2014_Feb_6_2014_323594.nxml.txt.nlp	24689036	SENT368	18	18	0	0	raloxifene	PC3	PA451221	57332;7832;5122	0.948
NULL	Acta_Neuropathol_Commun_2014_May_30_2_57.nxml.txt.nlp	24887326	SENT185	42	42	38	38	vardenafil	ABCB1	PA10229	5243	0.948
NULL	Mol_Cancer_2014_Jan_15_13_8.nxml.txt.nlp	24423412	SENT15	19	19	35	35	cisplatin	CD44	PA449014	960	0.948
NULL	Anal_Bioanal_Chem_2011_Jan_24_399(3)_1081-1091.nxml.txt.nlp	21107826	SENT202	31	31	6	6	adalimumab	CDR1	PA10004	1038	0.948
NULL	J_Cell_Biol_1998_Apr_20_141(2)_527-538.nxml.txt.nlp	9548729	SENT268	3	3	14	14	paraformaldehyde	MB1	PA450790	5693	0.948
NULL	FEBS_Open_Bio_2014_Oct_22_4_898-904.nxml.txt.nlp	25383313	SENT184	6	6	22	22	metformin	AMPK	PA450395	5563	0.948
NULL	Clin_Endosc_2011_Sep_30_44(1)_22-26.nxml.txt.nlp	22741108	SENT31	26	26	9	9	propofol	ESD	PA451141	2098	0.948
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT143	14	14	27	27	simvastatin	survivin	PA451363	332	0.948
NULL	Breast_Cancer_Res_2012_Jul_19_14(4)_R108.nxml.txt.nlp	22812534	SENT218	9	9	28	28	pargyline	PELP1	PA450797	27043	0.948
NULL	Cancer_Manag_Res_2013_Jun_7_5_91-101.nxml.txt.nlp	23785245	SENT2	18	18	0	0	erlotinib	EGFR	PA134687924	1956	0.948
NULL	Oncoimmunology_2012_Aug_1_1(5)_618-629.nxml.txt.nlp	22934254	SENT14	9	9	4	4	nilotinib	p38	PA165958345	10598;1432;7965	0.948
NULL	Cell_Death_Dis_2014_Jan_30_5(1)_e1030.nxml.txt.nlp	24481444	SENT102	19	19	5	5	sorafenib	PUMA	PA7000	27113	0.948
NULL	Int_J_Med_Sci_2013_Mar_19_10(5)_599-606.nxml.txt.nlp	23569422	SENT69	7	7	3	3	propofol	HO-1	PA451141	3162	0.948
NULL	Cancer_Manag_Res_2013_Nov_19_5_377-385.nxml.txt.nlp	24399885	SENT46	36	36	23	23	bevacizumab	KRAS	PA130232992	3845	0.948
NULL	Cardiovasc_Diabetol_2010_Sep_23_9_57.nxml.txt.nlp	20863381	SENT22	0	0	32	32	pioglitazone	DM2	PA450970	28508	0.948
NULL	Br_J_Cancer_2013_Jul_9_109(1)_68-75.nxml.txt.nlp	23807173	SENT200	12	12	30	30	cisplatin	ERCC1	PA449014	2067	0.948
NULL	Acta_Pharmacol_Sin_2009_Nov_12_30(11)_1566-1572.nxml.txt.nlp	19820718	SENT37	22	22	15	15	omeprazole	P-gp	PA450704	5243	0.948
NULL	J_Thromb_Thrombolysis_2011_Nov_26_32(4)_459-466.nxml.txt.nlp	21706290	SENT111	23	23	17	17	clopidogrel	CYP2C19	PA449053	1557	0.948
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT164	31	31	5	5	lapatinib	HER3	PA152241907	2065	0.948
NULL	Case_Rep_Oncol_2009_Feb_16_2(1)_12-19.nxml.txt.nlp	20740139	SENT37	13	13	1	1	docetaxel	CEA	PA449383	5670;1087	0.948
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1117-1122.nxml.txt.nlp	22361631	SENT11	8	8	14	14	phenformin	AMPK	PA1000	5563	0.948
NULL	Leukemia_2014_Apr_14_28(4)_961-964.nxml.txt.nlp	24418991	SENT61	0	0	6	6	nilotinib	P-gp	PA165958345	5243	0.948
NULL	Eukaryot_Cell_2014_Aug_13(8)_1077-1084.nxml.txt.nlp	24951438	SENT193	17	17	3	3	doxycycline	RSP5	PA449415	23327	0.948
NULL	Cancers_(Basel)_2014_Oct_13_6(4)_2100-2115.nxml.txt.nlp	25314153	SENT584	4	4	0	0	trastuzumab	Met	PA451743	79811	0.948
NULL	Diabetes_Care_2009_Oct_8_32(10)_1873-1879.nxml.txt.nlp	19587362	SENT218	21	21	24	24	aliskiren	AT1	PA143487910	9197;185	0.948
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT216	23	23	14	14	cisplatin	p53	PA449014	7157	0.948
NULL	Exp_Diabetes_Res_2012_May_10_2012_460869.nxml.txt.nlp	22649445	SENT151	18	18	6	6	forskolin	EPAC	PA146096022	10411	0.948
NULL	Ann_Clin_Transl_Neurol_2014_Nov_3_1(11)_851-866.nxml.txt.nlp	25540800	SENT212	1	1	26	26	baclofen	CA1	PA448533	759	0.948
NULL	Arthritis_Res_Ther_2006_Jul_21_8(4)_R130.nxml.txt.nlp	16859540	SENT177	4	4	21	21	atorvastatin	CD59	PA448500	966	0.948
NULL	Cell_Oncol_(Dordr)_2011_Apr_11_34(2)_141-153.nxml.txt.nlp	21394647	SENT340	17	17	10	10	bortezomib	STAT3	PA10252	6774	0.948
NULL	Front_Oncol_2014_Jun_18_4_153.nxml.txt.nlp	24995158	SENT583	17	17	4	4	carboplatin	ERCC1	PA448803	2067	0.948
NULL	Int_J_Surg_Oncol_2012_Aug_27_2012_180574.nxml.txt.nlp	22970358	SENT27	17	17	14	14	anastrozole	aromatase	PA448432	1588	0.948
NULL	Br_J_Cancer_2009_Oct_6_101(7)_1155-1161.nxml.txt.nlp	19738614	SENT9	9	9	2	2	gemcitabine	MUC4	PA449748	4585	0.948
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT77	2	2	17	17	midazolam	CYP3A	PA450496	1574	0.948
NULL	Biomed_Res_Int_2013_Jul_18_2013_603782.nxml.txt.nlp	23971041	SENT138	8	8	23	23	tafluprost	BAK	PA165958432	578	0.948
NULL	Int_J_Mol_Sci_2014_Jun_25_15(7)_11220-11233.nxml.txt.nlp	24968265	SENT29	11	11	1	1	sunitinib	REST	PA162372840	5978	0.948
NULL	Cancer_Res_Treat_2014_Jan_15_46(1)_55-64.nxml.txt.nlp	24520224	SENT148	23	23	3	3	irinotecan	TRAP1	PA450085	9392;10131	0.948
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2007_Dec_6_64(Pt_1)_o198.nxml.txt.nlp	21200763	SENT59	11	11	3	3	ethanol	mol	PA448073	90527	0.948
NULL	Arthritis_Res_Ther_2014_Jul_18_16(4)_R153.nxml.txt.nlp	25037855	SENT225	5	5	9	9	adalimumab	CD14	PA10004	929	0.948
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT184	2	2	25	25	capsaicin	p53	PA448776	7157	0.948
NULL	Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.nxml.txt.nlp	24736980	SENT176	3	3	13	13	rosuvastatin	OATP1B1	PA134308647	10599	0.948
NULL	Mol_Cancer_2010_Dec_31_9_320.nxml.txt.nlp	21194429	SENT307	21	21	0	0	sunitinib	VEGF-A	PA162372840	7422	0.948
NULL	Allergy_Asthma_Immunol_Res_2014_Jul_27_6(4)_288-295.nxml.txt.nlp	24991451	SENT74	20	20	15	15	montelukast	IL-5	PA450546	3567	0.948
NULL	Breast_Cancer_Res_2007_May_14_9(3)_R29.nxml.txt.nlp	17501995	SENT136	0	0	10	10	estradiol	CD34	PA449503	947	0.948
NULL	Tuberc_Respir_Dis_(Seoul)_2013_Mar_29_74(3)_129-133.nxml.txt.nlp	23579627	SENT54	18	18	23	23	gefitinib	EGFR	PA131301952	1956	0.948
NULL	Nat_Med_2013_Mar_10_19(3)_313-321.nxml.txt.nlp	23396211	SENT48	11	11	4	4	amlexanox	TBK1	PA164745310	29110	0.948
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Jul_9_3(7)_e124.nxml.txt.nlp	25006781	SENT98	2	2	29	29	rosuvastatin	OATP1B1	PA134308647	10599	0.948
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT141	26	26	8	8	neratinib	HER2	PA165291472	2064	0.948
NULL	Cell_Death_Dis_2014_Mar_13_5(3)_e1113.nxml.txt.nlp	24625972	SENT112	43	43	24	24	bleomycin	BI-1	PA448645	7009	0.948
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT102	28	28	14	14	sitagliptin	HIP	PA164748978	6767;6159;64399;5068	0.948
NULL	Br_J_Cancer_2010_Jun_29_103(1)_1-5.nxml.txt.nlp	20461086	SENT129	4	4	18	18	oxygen	VHL	PA450744	7428	0.948
NULL	Int_J_Breast_Cancer_2013_Sep_25_2013_404396.nxml.txt.nlp	24187626	SENT64	10	10	4	4	tamoxifen	aromatase	PA451581	1588	0.948
NULL	J_Gynecol_Oncol_2013_Jul_4_24(3)_273-279.nxml.txt.nlp	23875078	SENT18	5	5	8	8	paclitaxel	COX	PA450761	1351	0.948
NULL	F1000Res_2013_Feb_28_2_65.nxml.txt.nlp	24358861	SENT261	16	16	13	13	naloxone	TLR4	PA450586	7099	0.948
NULL	Nucleic_Acids_Res_2011_Dec_31_39(22)_9536-9548.nxml.txt.nlp	21880590	SENT231	40	40	2	2	paclitaxel	BRCA1	PA450761	672	0.948
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jul_11_65(Pt_8)_o1836.nxml.txt.nlp	21583537	SENT68	21	21	12	12	ethanol	mol	PA448073	90527	0.948
NULL	Cancer_Manag_Res_2011_Sep_9_3_301-309.nxml.txt.nlp	21931504	SENT138	9	9	36	36	spermine	CXCR4	PA164781199	7852	0.948
NULL	Breast_Cancer_(Auckl)_2013_Feb_13_7_7-22.nxml.txt.nlp	23492649	SENT71	10	10	26	26	fulvestrant	aromatase	PA164747170	1588	0.948
NULL	Oncoimmunology_2013_Nov_1_2(11)_e26468.nxml.txt.nlp	24498546	SENT121	12	12	18	18	cyclophosphamide	CD4	PA449165	920	0.948
NULL	Chemother_Res_Pract_2011_Feb_27_2011_175054.nxml.txt.nlp	22295203	SENT70	12	12	1	1	cisplatin	MTD	PA449014	4493	0.948
NULL	Oncotarget_2014_Jun_5_5(21)_10382-10392.nxml.txt.nlp	25071015	SENT2	27	27	20	20	trastuzumab	HER2	PA451743	2064	0.948
NULL	Int_J_Biol_Sci_2014_Sep_21_10(10)_1108-1115.nxml.txt.nlp	25332685	SENT29	0	0	20	20	dexmedetomidine	DMT	PA449256	2039	0.948
NULL	Nucleic_Acids_Res_2012_Jun_22_40(11)_4861-4878.nxml.txt.nlp	22362753	SENT208	1	1	18	18	glutaraldehyde	NPM2	PA449777	10361	0.948
NULL	Braz_J_Microbiol_2012_Jun_1_Oct-Dec_43(4)_1499-1507.nxml.txt.nlp	24031981	SENT84	3	3	16	16	ethanol	ANOVA	PA448073	4858	0.948
NULL	Cancers_(Basel)_2014_Jul_17_6(3)_1500-1521.nxml.txt.nlp	25037020	SENT238	0	0	5	5	zileuton	5-LOX	PA451955	240	0.948
NULL	Blood_Cancer_J_2013_Mar_1_3(3)_e103.nxml.txt.nlp	23454896	SENT149	35	35	10	10	ritonavir	AKT	PA451260	207	0.948
NULL	Mol_Clin_Oncol_2013_Sep_26_1(5)_799-804.nxml.txt.nlp	24649249	SENT119	27	27	3	3	ridaforolimus	PTEN	PA165291475	5728	0.948
NULL	J_Sens_Technol_2013_Sep_3(3)_10_4236_jst_2013_33015.nxml.txt.nlp	24409399	SENT86	2	2	37	37	ketamine	DC2	PA450144	58505	0.948
NULL	Alcohol_Res_2012_34(3)_282-292.nxml.txt.nlp	23134044	SENT231	36	36	38	38	naltrexone	Ray	PA450588	26751	0.948
NULL	Behav_Brain_Funct_2006_Aug_8_2_29.nxml.txt.nlp	16893471	SENT209	5	5	24	24	capsaicin	spatial	PA448776	219793	0.948
NULL	J_Cardiothorac_Surg_2006_Nov_1_1_39.nxml.txt.nlp	17078889	SENT12	26	26	19	19	docetaxel	aromatase	PA449383	1588	0.948
NULL	Clin_Med_Insights_Oncol_2011_May_24_5_163-169.nxml.txt.nlp	21695098	SENT33	0	0	20	20	cabazitaxel	CYP2C8	PA165958401	1558	0.948
NULL	J_Hematol_Oncol_2010_May_2_3_18.nxml.txt.nlp	20433767	SENT139	17	17	1	1	cetuximab	KRAS	PA10040	3845	0.948
NULL	Environ_Health_Perspect_2006_Sep_23_114(9)_1401-1406.nxml.txt.nlp	16966095	SENT110	3	3	16	16	arsenite	p53	PA452638	7157	0.948
NULL	Cardiovasc_Diabetol_2013_Nov_12_12_169.nxml.txt.nlp	24215514	SENT264	10	10	15	15	valsartan	AT2	PA451848	186	0.948
NULL	J_Oncol_2010_Aug_24_2010_398564.nxml.txt.nlp	20862373	SENT95	4	4	20	20	gefitinib	EGF	PA131301952	1950	0.948
NULL	Pharmaceuticals_(Basel)_2012_Aug_10_5(8)_802-836.nxml.txt.nlp	24280676	SENT40	0	0	11	11	gemcitabine	CNT3	PA449748	64078	0.948
NULL	Blood_Cancer_J_2013_Jul_19_3(7)_e127.nxml.txt.nlp	23872706	SENT74	15	15	35	35	vemurafenib	BRAF	PA165946873	673	0.948
NULL	Br_J_Cancer_2006_Feb_13_94(3)_407-426.nxml.txt.nlp	16434996	SENT230	30	30	5	5	genistein	BRCA2	PA165109660	675	0.948
NULL	Exp_Neurobiol_2013_Mar_31_22(1)_51-57.nxml.txt.nlp	23585723	SENT107	9	9	1	1	capsaicin	TRPV1	PA448776	7442	0.948
NULL	Breast_Cancer_Res_2004_Mar_18_6(3)_119-127.nxml.txt.nlp	15084232	SENT42	8	8	0	0	resveratrol	CYP1B1		1545	0.948
NULL	Pharmaceuticals_(Basel)_2013_Aug_21_6(8)_988-1038.nxml.txt.nlp	24276379	SENT263	22	22	5	5	irinotecan	UGT1A1	PA450085	54658	0.948
NULL	Nat_Med_2013_Mar_10_19(3)_313-321.nxml.txt.nlp	23396211	SENT90	26	26	19	19	amlexanox	HSL	PA164745310	3991	0.948
NULL	J_Oncol_2009_Jul_14_2009_896407.nxml.txt.nlp	19636423	SENT55	14	14	31	31	gefitinib	EGFR	PA131301952	1956	0.948
NULL	BMJ_Open_2013_Nov_4_3(11)_e003995.nxml.txt.nlp	24189085	SENT382	19	19	30	30	metformin	Met	PA450395	79811	0.948
NULL	Bioinformation_2012_Jan_6_8(1)_13-19.nxml.txt.nlp	22359429	SENT138	4	4	28	28	probenecid	MRP1	PA451106	4437	0.948
NULL	Front_Microbiol_2014_Mar_14_5_99.nxml.txt.nlp	24672516	SENT81	18	18	22	22	caspofungin	TLR2	PA164743013	7097	0.948
NULL	J_Biol_Chem_2008_May_30_283(22)_15440-15450.nxml.txt.nlp	18385140	SENT186	9	9	4	4	trypsin	NDUFB6	PA451806	4712	0.948
NULL	Mol_Neurobiol_2007_Oct_10_36(2)_137-151.nxml.txt.nlp	17952658	SENT82	27	27	1	1	vasopressin	CXCL12	PA451858	6387	0.948
NULL	Oncotarget_2011_May_16_2(5)_418-421.nxml.txt.nlp	21789791	SENT27	21	21	32	32	bortezomib	TRAIL	PA10252	8743	0.948
NULL	Oncogene_2010_Oct_21_29(42)_5700-5711.nxml.txt.nlp	20676140	SENT105	9	9	17	17	doxorubicin	cIAP1	PA449412	329	0.948
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1522-1532.nxml.txt.nlp	21997136	SENT212	30	30	27	27	irinotecan	EGFR	PA450085	1956	0.948
NULL	Scientifica_(Cairo)_2012_Nov_25_2012_473829.nxml.txt.nlp	24278698	SENT391	5	5	11	11	oxaliplatin	MATE2-K	PA131285527	146802	0.948
NULL	Drug_Des_Devel_Ther_2014_Sep_30_8_1695-1708.nxml.txt.nlp	25328384	SENT168	26	26	0	0	tacrolimus	H-FABP	PA451578	2170	0.948
NULL	Protein_Sci_2010_Jul_3_19(7)_1312-1326.nxml.txt.nlp	20506237	SENT256	33	33	11	11	kanamycin	LCK	PA450137	3932	0.948
NULL	Ther_Clin_Risk_Manag_2005_Dec_1(4)_299-306.nxml.txt.nlp	18360572	SENT72	12	12	8	8	cisapride	CYP3A4	PA449011	1576	0.948
NULL	Acta_Pharmacol_Sin_2012_Dec_29_33(12)_1518-1524.nxml.txt.nlp	23103625	SENT13	4	4	22	22	telmisartan	ACE	PA451605	1636	0.948
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_55-78.nxml.txt.nlp	19305788	SENT274	5	5	40	40	memantine	NR1	PA10364	27158	0.948
NULL	J_Gen_Physiol_2009_May_133(5)_511-524.nxml.txt.nlp	19398777	SENT160	6	6	4	4	nifedipine	DHPR	PA450631	5860	0.948
NULL	J_Gynecol_Oncol_2014_Jan_8_25(1)_58-63.nxml.txt.nlp	24459582	SENT116	23	23	7	7	paclitaxel	ARID1A	PA450761	8289	0.948
NULL	Oncotarget_2014_Jun_6_5(12)_4060-4070.nxml.txt.nlp	24938183	SENT11	19	19	17	17	vemurafenib	BRAF	PA165946873	673	0.948
NULL	Indian_J_Med_Paediatr_Oncol_2014_Jul-Sep_35(3)_192-196.nxml.txt.nlp	25336788	SENT31	24	24	30	30	cetuximab	BRAF	PA10040	673	0.948
NULL	Mol_Cancer_2010_Jun_24_9_164.nxml.txt.nlp	20576107	SENT144	1	1	14	14	etoposide	p53	PA449552	7157	0.948
NULL	Curr_Neuropharmacol_2010_Sep_8(3)_287-304.nxml.txt.nlp	21358978	SENT33	22	22	3	3	riluzole	NK-1	PA451251	27087	0.948
NULL	Breast_Cancer_Res_2010_Oct_22_12(Suppl_2)_S1.nxml.txt.nlp	21050422	SENT424	16	16	6	6	bsi-201	TRN		3842	0.948
NULL	Nat_Genet_2013_Jul_2_45(7)_739-746.nxml.txt.nlp	23727861	SENT177	6	6	32	32	ethanol	DMBT1	PA448073	1755	0.948
NULL	Br_J_Cancer_1997_76(7)_935-938.nxml.txt.nlp	9328155	SENT9	28	28	5	5	chlorambucil	Bcl-2	PA448926	596	0.948
NULL	Oncol_Rep_2013_May_5_29(5)_1962-1968.nxml.txt.nlp	23467841	SENT29	29	29	1	1	chymotrypsin	SLPI	PA448994	6590	0.948
NULL	Int_J_Gen_Med_2010_Nov_19_3_379-382.nxml.txt.nlp	21189835	SENT58	8	8	15	15	simvastatin	JBS	PA451363	3719	0.948
NULL	EMBO_Mol_Med_2013_Dec_8_5(12)_1821-1834.nxml.txt.nlp	24293316	SENT80	5	5	23	23	doxorubicin	UNC5B	PA449412	219699	0.948
NULL	Br_J_Pharmacol_2014_Jan_23_171(2)_523-535.nxml.txt.nlp	24372553	SENT136	3	3	5	5	metformin	SIRT1	PA450395	23411	0.948
NULL	Clin_Med_Insights_Oncol_2013_Aug_21_7_221-234.nxml.txt.nlp	24179413	SENT63	0	0	18	18	afatinib	HER2	PA165981154	2064	0.948
NULL	Mol_Med_Rep_2015_Jan_16_11(1)_91-98.nxml.txt.nlp	25322694	SENT138	23	23	14	14	cisplatin	LC3	PA449014	84557	0.948
NULL	Oncol_Lett_2013_Mar_8_5(3)_805-812.nxml.txt.nlp	23426281	SENT245	16	16	6	6	gemcitabine	survivin	PA449748	332	0.948
NULL	Brain_2008_Nov_22_131(11)_3072-3080.nxml.txt.nlp	18945724	SENT165	7	7	21	21	rituximab	CD19	PA451261	930	0.948
NULL	Arthritis_Res_Ther_2005_Mar_1_7(3)_R545-R551.nxml.txt.nlp	15899041	SENT41	13	13	26	26	etanercept	ACR	PA449515	49	0.948
NULL	Oncotarget_2011_Jun_15_2(6)_518-524.nxml.txt.nlp	21680956	SENT101	10	10	30	30	pimozide	STAT3	PA450965	6774	0.948
NULL	J_Am_Heart_Assoc_2013_Dec_19_2(6)_e000355.nxml.txt.nlp	24190878	SENT174	9	9	15	15	isoproterenol	HK2	PA450121	3796;3099;29911;3741	0.948
NULL	Front_Behav_Neurosci_2009_Jan_27_3_1.nxml.txt.nlp	19194528	SENT179	11	11	28	28	imipramine	EPM	PA449969	2054	0.948
NULL	Stroke_Res_Treat_2011_Nov_10_2011_212485.nxml.txt.nlp	22135769	SENT47	20	20	9	9	hydrochlorothiazide	GRK5	PA449899	2869	0.948
NULL	Mol_Cell_2012_Feb_10_45(3)_371-383.nxml.txt.nlp	22325354	SENT727	20	20	12	12	olaparib	T13		29123	0.948
NULL	Case_Rep_Med_2012_Apr_11_2012_810428.nxml.txt.nlp	22567020	SENT8	9	9	2	2	tamoxifen	aromatase	PA451581	1588	0.948
NULL	Biomed_Res_Int_2013_Oct_21_2013_505864.nxml.txt.nlp	24228254	SENT306	15	15	38	38	amantadine	IL8	PA448360	3576	0.948
NULL	J_Hematol_Oncol_2013_Jan_17_6_8.nxml.txt.nlp	23327547	SENT26	7	7	23	23	sulindac	p27	PA451565	5715;10534	0.948
NULL	Cell_Death_Dis_2013_Jul_11_4(7)_e719.nxml.txt.nlp	23846221	SENT212	17	17	11	11	cisplatin	TRAIL	PA449014	8743	0.948
NULL	Mol_Pain_2012_Sep_22_8_71.nxml.txt.nlp	22998838	SENT132	43	43	18	18	paclitaxel	CB2	PA450761	1269	0.948
NULL	J_Brachial_Plex_Peripher_Nerve_Inj_2011_Aug_24_6_4.nxml.txt.nlp	21864390	SENT167	20	20	2	2	isoflurane	ANOVA	PA450106	4858	0.948
NULL	Arthritis_Res_Ther_2007_Nov_21_9(6)_R121.nxml.txt.nlp	18031579	SENT33	9	9	0	0	thrombin	PAR-1	PA451674	2011;2149	0.948
NULL	Curr_Neuropharmacol_2007_Dec_5(4)_232-243.nxml.txt.nlp	19305740	SENT100	7	7	17	17	indomethacin	COX	PA449982	1351	0.948
NULL	Biomed_Res_Int_2013_Dec_16_2013_741403.nxml.txt.nlp	24455721	SENT60	19	19	9	9	cimetidine	CYP3A4	PA449001	1576	0.948
NULL	Drug_Saf_2014_Feb_19_37(4)_201-211.nxml.txt.nlp	24550106	SENT67	0	0	16	16	ritonavir	CYP3A4	PA451260	1576	0.948
NULL	Open_Biol_2014_Jan_4(1)_130138.nxml.txt.nlp	24403013	SENT292	25	25	11	11	etoposide	PP1	PA449552	5540;5464	0.948
NULL	Tumour_Biol_2014_Aug_12_35(8)_7807-7819.nxml.txt.nlp	24817012	SENT377	17	17	4	4	carboplatin	RRM1	PA448803	6240	0.948
NULL	Cell_Death_Differ_2010_Oct_30_17(10)_1624-1635.nxml.txt.nlp	20431602	SENT52	22	22	9	9	paclitaxel	Mcl-1	PA450761	4170	0.948
NULL	Mol_Cancer_2008_Jun_5_7_50.nxml.txt.nlp	18534018	SENT143	3	3	7	7	bortezomib	p38	PA10252	10598;1432;7965	0.948
NULL	BMJ_2014_Apr_15_348_g2366.nxml.txt.nlp	24736555	SENT474	13	13	24	24	metformin	Met	PA450395	79811	0.948
NULL	Tumour_Biol_2014_Aug_12_35(8)_7807-7819.nxml.txt.nlp	24817012	SENT377	17	17	6	6	carboplatin	ERCC1	PA448803	2067	0.948
NULL	J_Nat_Sci_Biol_Med_2011_Jan-Jun_2(1)_66-70.nxml.txt.nlp	22470237	SENT104	20	20	0	0	indomethacin	AAP	PA449982	5345	0.948
NULL	Clin_Ophthalmol_2008_Jun_2(2)_355-368.nxml.txt.nlp	19668727	SENT81	11	11	34	34	amfenac	COX2	PA166049186	4513;5743	0.948
NULL	Exp_Ther_Med_2013_Apr_5_5(4)_1259-1263.nxml.txt.nlp	23596498	SENT26	26	26	10	10	propofol	TRPV1	PA451141	7442	0.948
NULL	Cancers_(Basel)_2010_Dec_22_2(4)_2153-2170.nxml.txt.nlp	21390244	SENT245	17	17	25	25	gefitinib	EGFR	PA131301952	1956	0.948
NULL	Chem_Rev_2011_Oct_12_111(10)_5899-5921.nxml.txt.nlp	21923193	SENT600	6	6	18	18	parecoxib	CB1	PA166049193	1268	0.948
NULL	Int_J_Biol_Sci_2014_Jun_10_10(7)_654-663.nxml.txt.nlp	25013375	SENT228	29	29	20	20	nitroxoline	SIRT1	PA164754993	23411	0.948
NULL	Contemp_Oncol_(Pozn)_2012_Jan_4_16(6)_582-585.nxml.txt.nlp	23788948	SENT108	8	8	15	15	capecitabine	HER2	PA448771	2064	0.948
NULL	Tuberc_Respir_Dis_(Seoul)_2013_Nov_29_75(5)_188-198.nxml.txt.nlp	24348666	SENT177	11	11	2	2	crizotinib	EGFR	PA165946122	1956	0.948
NULL	Front_Mol_Neurosci_2012_Nov_12_5_99.nxml.txt.nlp	23162427	SENT279	22	22	5	5	cocaine	HDAC	PA449072	9734	0.948
NULL	Arch_Orthop_Trauma_Surg_2009_Nov_7_129(11)_1495-1504.nxml.txt.nlp	18989686	SENT101	17	17	8	8	linezolid	VISA	PA450233	57506	0.948
NULL	Front_Neural_Circuits_2014_Nov_7_8_134.nxml.txt.nlp	25426030	SENT350	0	0	14	14	pentamidine	OCT1	PA450850	5451;6580	0.948
NULL	Case_Rep_Dermatol_2011_Jun_30_3(2)_130-136.nxml.txt.nlp	21743808	SENT62	6	6	12	12	hyaluronan	EGFR	PA165958431	1956	0.948
NULL	Mol_Cancer_2004_May_4_3_14.nxml.txt.nlp	15125777	SENT44	10	10	5	5	cisplatin	CHK2	PA449014	11200	0.948
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1067.nxml.txt.nlp	24556682	SENT102	25	25	13	13	cytarabine	CNT1	PA449177	9154	0.948
NULL	FEBS_Open_Bio_2014_Jan_6_4_77-89.nxml.txt.nlp	24490132	SENT10	5	5	7	7	ebselen	GDH	PA161660841	51084;2746	0.948
NULL	Support_Care_Cancer_2009_Sep_10_17(9)_1187-1193.nxml.txt.nlp	19205754	SENT114	6	6	13	13	dolasetron	CYP2D6	PA449390	1565	0.948
NULL	Br_J_Cancer_2006_Feb_13_94(3)_407-426.nxml.txt.nlp	16434996	SENT141	10	10	2	2	genistein	BRCA1	PA165109660	672	0.948
NULL	Int_J_Mol_Sci_2012_Dec_7_13(12)_16751-16768.nxml.txt.nlp	23222680	SENT170	23	23	12	12	pargyline	LSD2	PA450797	221656	0.948
NULL	Cancer_Cell_Int_2013_May_28_13_51.nxml.txt.nlp	23710609	SENT200	44	44	10	10	ethanol	CO2	PA448073	4513	0.948
NULL	Front_Microbiol_2014_Mar_14_5_99.nxml.txt.nlp	24672516	SENT82	30	30	3	3	caspofungin	TLR4	PA164743013	7099	0.948
NULL	Arthritis_Res_Ther_2009_Jan_30_11(1)_206.nxml.txt.nlp	19232066	SENT269	0	0	5	5	imatinib	CIA	PA10804	25842;57727	0.948
NULL	Cell_Cycle_2013_Sep_15_12(18)_3037-3051.nxml.txt.nlp	23974101	SENT171	21	21	15	15	camptothecin	HDAC1	PA153590860	3065	0.948
NULL	Front_Oncol_2014_Mar_25_4_54.nxml.txt.nlp	24724051	SENT311	13	13	3	3	imatinib	LYN	PA10804	4067	0.948
NULL	Evid_Based_Complement_Alternat_Med_2013_May_13_2013_506324.nxml.txt.nlp	23818927	SENT145	24	24	9	9	doxorubicin	STAT3	PA449412	6774	0.948
NULL	Oncogene_2014_Aug_28_33(35)_4396-4406.nxml.txt.nlp	24531714	SENT73	32	32	13	13	hydroxyurea	BAX	PA449942	581	0.948
NULL	Breast_Cancer_Res_2010_Sep_29_12(5)_209.nxml.txt.nlp	21067536	SENT167	0	0	19	19	pazopanib	VEGFR1	PA165291492	2321	0.948
NULL	Indian_J_Pharmacol_2009_Aug_41(4)_167-172.nxml.txt.nlp	20523867	SENT139	1	1	17	17	imatinib	CYP2D6	PA10804	1565	0.948
NULL	Nat_Med_2012_Mar_25_18(4)_538-546.nxml.txt.nlp	22447074	SENT269	25	25	14	14	papain	CD4	PA450778	920	0.948
NULL	Br_J_Cancer_2003_Jun_16_88(12)_1963-1970.nxml.txt.nlp	12799644	SENT201	27	27	2	2	gemcitabine	TK2	PA449748	7084	0.948
NULL	Comp_Hepatol_2004_Jan_14_3(Suppl_1)_S31.nxml.txt.nlp	14960183	SENT36	19	19	27	27	ethanol	TNF-alpha	PA448073	7124	0.948
NULL	Int_J_Inflam_2011_Oct_30_2011_642612.nxml.txt.nlp	22121495	SENT61	6	6	19	19	metformin	FOXO1	PA450395	2308	0.948
NULL	Asian-Australas_J_Anim_Sci_2014_Dec_27(12)_1783-1793.nxml.txt.nlp	25358373	SENT192	10	10	29	29	capsaicin	FABP4	PA448776	2167	0.948
NULL	Exp_Ther_Med_2013_May_15_5(5)_1327-1331.nxml.txt.nlp	23737873	SENT150	4	4	36	36	imidapril	AQP2	PA452640	359	0.948
NULL	J_Hematol_Oncol_2013_Jan_4_6_1.nxml.txt.nlp	23286345	SENT124	24	24	6	6	rituximab	FCGR2A	PA451261	2212	0.948
NULL	Acta_Pharmacol_Sin_2009_Jan_8_30(1)_1-24.nxml.txt.nlp	19060915	SENT331	27	27	4	4	sildenafil	PKG	PA451346	5592	0.948
NULL	Nat_Med_2011_Dec_11_18(1)_74-82.nxml.txt.nlp	22157681	SENT103	13	13	9	9	gefitinib	EGFR	PA131301952	1956	0.948
NULL	Clin_Interv_Aging_2012_Sep_3_7_331-338.nxml.txt.nlp	22977302	SENT17	0	0	20	20	denosumab	RANKL	PA166048634	8600	0.948
NULL	Arthritis_Res_Ther_2009_Jan_26_11(1)_R12.nxml.txt.nlp	19171052	SENT243	16	16	23	23	dipyridamole	ACTH	PA449367	5443	0.948
NULL	Br_J_Cancer_2010_Jan_5_102(1)_151-161.nxml.txt.nlp	19935791	SENT149	7	7	17	17	cetuximab	KRAS	PA10040	3845	0.948
NULL	Contemp_Oncol_(Pozn)_2012_Feb_29_16(1)_86-89.nxml.txt.nlp	23788860	SENT76	5	5	11	11	bevacizumab	DDP	PA130232992	1678	0.947
NULL	Int_J_Breast_Cancer_2011_Jul_3_2011_912102.nxml.txt.nlp	22295238	SENT196	16	16	4	4	methylcholanthrene	IFN	PA165816878	3439	0.947
NULL	Mol_Biol_Cell_2014_Mar_15_25(6)_739-752.nxml.txt.nlp	24430869	SENT319	20	20	2	2	trypsin	EGFR	PA451806	1956	0.947
NULL	Carcinogenesis_2010_Dec_15_31(12)_2031-2038.nxml.txt.nlp	20952512	SENT175	18	18	5	5	hydroxyurea	BRCA2	PA449942	675	0.947
NULL	Indian_J_Anaesth_2011_Nov-Dec_55(6)_578-583.nxml.txt.nlp	22223901	SENT117	17	17	2	2	phenylephrine	NNT	PA450935	23530	0.947
NULL	Front_Immunol_2012_Mar_12_3_44.nxml.txt.nlp	22566926	SENT153	12	12	27	27	dextran	IL-18	PA449261	3606	0.947
NULL	Oncotarget_2012_May_4_3(4)_395-398.nxml.txt.nlp	22565037	SENT25	31	31	23	23	metformin	CD24	PA450395	100133941	0.947
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT163	6	6	14	14	lapatinib	ABCG2	PA152241907	9429	0.947
NULL	J_Oncol_2012_Feb_15_2012_168303.nxml.txt.nlp	22481917	SENT83	16	16	11	11	doxorubicin	NET	PA449412	2004;6530	0.947
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_297-299.nxml.txt.nlp	20049732	SENT55	24	24	20	20	methotrexate	MSH6	PA450428	2956	0.947
NULL	Atherosclerosis_2011_Nov_219(1)_109-115.nxml.txt.nlp	21820657	SENT71	0	0	3	3	anacetrapib	CETP	PA165960688	1071	0.947
NULL	Oncotarget_2014_Aug_19_5(18)_8737-8749.nxml.txt.nlp	25228590	SENT171	8	8	21	21	crizotinib	MYCN	PA165946122	4613	0.947
NULL	Oncol_Lett_2013_Oct_26_6(4)_1063-1067.nxml.txt.nlp	24137465	SENT97	7	7	15	15	afatinib	EGFR	PA165981154	1956	0.947
NULL	Open_Access_J_Urol_2010_Mar_12_2_35-40.nxml.txt.nlp	24198612	SENT105	6	6	3	3	pazopanib	VEGFR	PA165291492	3791	0.947
NULL	Mol_Cancer_2007_Oct_22_6_66.nxml.txt.nlp	17953743	SENT99	14	14	17	17	cisplatin	TRAIL	PA449014	8743	0.947
NULL	Br_J_Pharmacol_2014_Jun_15_171(11)_2705-2725.nxml.txt.nlp	24467436	SENT24	0	0	9	9	isoniazid	NAT	PA450112	6046	0.947
NULL	J_Cell_Biol_1998_Jan_26_140(2)_335-345.nxml.txt.nlp	9442109	SENT336	15	15	1	1	chloroquine	NHE	PA448948	285335	0.947
NULL	Arthritis_Res_Ther_2005_Mar_16_7(Suppl_2)_S15-S20.nxml.txt.nlp	15833144	SENT81	8	8	24	24	abatacept	CTLA4	PA164747080	1493	0.947
NULL	Indian_J_Pharmacol_2013_Nov-Dec_45(6)_597-602.nxml.txt.nlp	24347768	SENT23	20	20	3	3	doxorubicin	P-gp	PA449412	5243	0.947
NULL	Br_J_Cancer_2010_Jan_5_102(1)_80-86.nxml.txt.nlp	19920817	SENT140	19	19	16	16	sunitinib	IFN	PA162372840	3439	0.947
NULL	Thorax_2012_Oct_12_67(10)_891-900.nxml.txt.nlp	22693178	SENT135	7	7	18	18	capsaicin	TRPV1	PA448776	7442	0.947
NULL	Clin_Ophthalmol_2012_Feb_20_6_277-282.nxml.txt.nlp	22375096	SENT29	20	20	1	1	triamcinolone	STA	PA451749	2010;2656	0.947
NULL	Curr_Pharm_Biotechnol_2011_Jan_12(1)_35-41.nxml.txt.nlp	20932261	SENT126	6	6	19	19	hyperforin	TRPC6	PA165985514	7225	0.947
NULL	Orphanet_J_Rare_Dis_2014_Sep_2_9(1)_130.nxml.txt.nlp	NULL	SENT228	9	9	1	1	hydroxocobalamin	B12	PA164768689	7126;4709	0.947
NULL	Oncol_Lett_2013_Mar_11_5(3)_1010-1016.nxml.txt.nlp	23426784	SENT150	5	5	19	19	midazolam	TRPM7	PA450496	54822	0.947
NULL	Clin_Interv_Aging_2013_Jan_31_8_103-110.nxml.txt.nlp	23386786	SENT100	5	5	13	13	atorvastatin	spatial	PA448500	219793	0.947
NULL	Colorectal_Dis_2012_Feb_14(2)_e31-e47.nxml.txt.nlp	21848897	SENT136	29	29	18	18	irinotecan	KRAS	PA450085	3845	0.947
NULL	Mol_Biol_Cell_2013_Aug_1_24(15)_2467-2476.nxml.txt.nlp	23761075	SENT225	2	2	17	17	resveratrol	SIRT1		23411	0.947
NULL	Diabetes_Obes_Metab_2012_Apr_14(4)_304-314.nxml.txt.nlp	22051096	SENT57	22	22	9	9	pramlintide	GLP-1	PA164781394	100125288	0.947
NULL	Eur_J_Cancer_2014_Sep_50(14)_2367-2374.nxml.txt.nlp	25027307	SENT135	19	19	9	9	tamoxifen	aromatase	PA451581	1588	0.947
NULL	Breast_Cancer_Res_2009_Jun_16_11(3)_R35.nxml.txt.nlp	19531217	SENT151	6	6	3	3	tamoxifen	aromatase	PA451581	1588	0.947
NULL	J_Cancer_2011_May_1_2_232-261.nxml.txt.nlp	21552384	SENT119	27	27	24	24	celecoxib	aromatase	PA448871	1588	0.947
NULL	Br_J_Cancer_2013_May_14_108(9)_1862-1869.nxml.txt.nlp	23579219	SENT86	12	12	42	42	bevacizumab	ANXA11	PA130232992	311	0.947
NULL	Breast_Cancer_Res_2012_Jul_20_14(4)_R110.nxml.txt.nlp	22817698	SENT181	10	10	20	20	cisplatin	BRCA1	PA449014	672	0.947
NULL	Adv_Urol_2014_Apr_3_2014_957013.nxml.txt.nlp	24803927	SENT126	6	6	0	0	verapamil	Men	PA451868	8178	0.947
NULL	Arthritis_Res_Ther_2014_Jan_30_16(1)_R33.nxml.txt.nlp	24476340	SENT191	6	6	4	4	denosumab	RANKL	PA166048634	8600	0.947
NULL	Bioinformation_2012_Jan_6_8(1)_13-19.nxml.txt.nlp	22359429	SENT132	20	20	16	16	curcumin	MRP1	PA151958596	4437	0.947
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT156	19	19	7	7	metformin	AMPK	PA450395	5563	0.947
NULL	Arthritis_Res_Ther_2012_Sep_24_14(5)_R200.nxml.txt.nlp	23006144	SENT42	22	22	3	3	infliximab	IL-20	PA452639	27190;50604	0.947
NULL	Front_Genet_2014_Nov_12_5_392.nxml.txt.nlp	25429298	SENT153	4	4	32	32	nilotinib	AIMP2	PA165958345	7965	0.947
NULL	Curr_Neuropharmacol_2013_Mar_11(2)_141-159.nxml.txt.nlp	23997750	SENT348	4	4	23	23	carbachol	SON	PA448784	6651	0.947
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT173	22	22	5	5	ranibizumab	PlGF-2	PA164746012	5228	0.947
NULL	J_Invest_Dermatol_2012_Oct_24_132(10)_2440-2450.nxml.txt.nlp	22622430	SENT73	6	6	10	10	paclitaxel	IL-8	PA450761	3576	0.947
NULL	J_Invest_Dermatol_2014_Feb_10_134(2)_319-325.nxml.txt.nlp	24108405	SENT131	18	18	13	13	vemurafenib	FOXD3	PA165946873	27022	0.947
NULL	Br_J_Cancer_2013_Jul_9_109(1)_100-108.nxml.txt.nlp	23756858	SENT24	22	22	17	17	letrozole	aromatase	PA450196	1588	0.947
NULL	Mol_Cancer_2010_May_21_9_116.nxml.txt.nlp	20492666	SENT198	14	14	5	5	bortezomib	RNF	PA10252	11074	0.947
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_79-96.nxml.txt.nlp	19305789	SENT38	19	19	5	5	hyperforin	TRPC6	PA165985514	7225	0.947
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT285	2	2	23	23	atorvastatin	PTEN	PA448500	5728	0.947
NULL	Curr_Hematol_Malig_Rep_2014_Jun_18_9(3)_212-216.nxml.txt.nlp	24939521	SENT155	5	5	33	33	bleomycin	HD7	PA448645	9734	0.947
NULL	Breast_Cancer_Res_Treat_2012_Jun_18_133(3)_937-947.nxml.txt.nlp	22094936	SENT201	20	20	6	6	tamoxifen	CDC2	PA451581	5424	0.947
NULL	Neural_Plast_2013_Aug_18_2013_753656.nxml.txt.nlp	24024042	SENT64	7	7	30	30	tetracycline	p38	PA451640	10598;1432;7965	0.947
NULL	Diabetes_2009_Mar_58(3)_641-651.nxml.txt.nlp	19073764	SENT20	39	39	24	24	sitagliptin	GLP-1	PA164748978	100125288	0.947
NULL	Interdiscip_Toxicol_2011_Dec_4(4)_173-183.nxml.txt.nlp	22319251	SENT120	3	3	0	0	diethylstilbestrol	Men	PA449307	8178	0.947
NULL	J_Oncol_2012_Apr_10_2012_931071.nxml.txt.nlp	22570654	SENT72	24	24	2	2	plerixafor	CD34	PA165958410	947	0.947
NULL	Med_Sci_Monit_2013_Dec_23_19_1195-1210.nxml.txt.nlp	24362017	SENT271	21	21	15	15	cisplatin	NOX3	PA449014	50508	0.947
NULL	Oncotarget_2013_Nov_22_5(4)_933-943.nxml.txt.nlp	24659749	SENT38	19	19	0	0	nutlin-3	AML2		864	0.947
NULL	Crit_Care_2011_Oct_26_15(5)_R257.nxml.txt.nlp	22030215	SENT257	4	4	34	34	dexmedetomidine	SAPS	PA449256	8935	0.947
NULL	Core_Evid_2011_Mar_17_6_31-42.nxml.txt.nlp	21468241	SENT262	14	14	6	6	ticagrelor	CYP2C19	PA165374673	1557	0.947
NULL	Ther_Clin_Risk_Manag_2006_Sep_2(3)_235-249.nxml.txt.nlp	18360599	SENT329	21	21	8	8	alendronate	PTH	PA448082	5741	0.947
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT287	26	26	13	13	bevacizumab	VEGFR2	PA130232992	3791	0.947
NULL	Int_J_Breast_Cancer_2011_Sep_6_2011_352182.nxml.txt.nlp	22295219	SENT142	28	28	35	35	trastuzumab	PTEN	PA451743	5728	0.947
NULL	Nucleic_Acids_Res_2012_Jul_16_40(Web_Server_issue)_W214-W221.nxml.txt.nlp	22600737	SENT140	9	9	4	4	staurosporine	ADP	PA165109623	23038	0.947
NULL	Cardiol_Res_Pract_2013_Feb_21_2013_127270.nxml.txt.nlp	23509665	SENT65	10	10	33	33	prasugrel	NNT	PA154410481	23530	0.947
NULL	Exp_Ther_Med_2013_Aug_20_6(2)_355-360.nxml.txt.nlp	24137188	SENT10	18	18	0	0	paclitaxel	CEA	PA450761	5670;1087	0.947
NULL	Mol_Cells_2014_Feb_28_37(2)_161-171.nxml.txt.nlp	24599001	SENT26	6	6	2	2	miglustat	NPC1	PA10140	4864	0.947
NULL	J_Korean_Med_Sci_2013_Feb_29_28(2)_308-314.nxml.txt.nlp	23399960	SENT8	16	16	4	4	gabapentin	IL-10	PA449720	3586	0.947
NULL	Crit_Care_2011_Apr_5_15(2)_R109.nxml.txt.nlp	21466684	SENT58	0	0	6	6	heparin	ACT	PA449855	12;11332;9457;641455	0.947
NULL	J_Cell_Mol_Med_2014_Dec_9_18(12)_2425-2436.nxml.txt.nlp	25297942	SENT195	21	21	8	8	cisplatin	HOTAIR	PA449014	100124700	0.947
NULL	Acta_Pharmacol_Sin_2012_May_26_33(5)_675-681.nxml.txt.nlp	22447226	SENT129	11	11	39	39	gefitinib	CDC25B	PA131301952	994	0.947
NULL	Aging_(Albany_NY)_2009_Jun_3_1(6)_515-528.nxml.txt.nlp	20157535	SENT64	16	16	4	4	resveratrol	SIRT1		23411	0.947
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT217	7	7	21	21	perifosine	JNK	PA165291471	5599	0.947
NULL	Basic_Clin_Pharmacol_Toxicol_2013_Feb_5_112(2)_132-137.nxml.txt.nlp	22900583	SENT161	0	0	10	10	ritonavir	CYP3A	PA451260	1574	0.947
NULL	Core_Evid_2010_Oct_21_5_61-76.nxml.txt.nlp	21042543	SENT254	12	12	0	0	cetuximab	PIK3CA	PA10040	5290	0.947
NULL	J_Geriatr_Cardiol_2013_Jun_10(2)_151-158.nxml.txt.nlp	23888175	SENT23	4	4	13	13	rosuvastatin	ACE2	PA134308647	59272	0.947
NULL	Arthritis_Res_Ther_2010_Jul_5_12(4)_R128.nxml.txt.nlp	20602758	SENT60	8	8	2	2	fluorescein	CD204	PA164746009	4481	0.947
NULL	Exp_Ther_Med_2015_Jan_11_9(1)_17-24.nxml.txt.nlp	25452770	SENT175	26	26	10	10	cetuximab	HER-2	PA10040	2064	0.947
NULL	Acta_Pharmacol_Sin_2014_Jun_4_35(6)_752-757.nxml.txt.nlp	24902786	SENT98	37	37	5	5	flutamide	STL2	PA449685	1301	0.947
NULL	Oncol_Rep_2013_Oct_22_30(4)_1535-1541.nxml.txt.nlp	23877481	SENT149	11	11	6	6	sunitinib	VEGFR	PA162372840	3791	0.947
NULL	Diabetes_Care_2013_Aug_17_36(Suppl_2)_S180-S189.nxml.txt.nlp	23882044	SENT139	12	12	2	2	metformin	GLP-1	PA450395	100125288	0.947
NULL	Acta_Pharmacol_Sin_2010_Jan_28_31(1)_10-18.nxml.txt.nlp	20037604	SENT128	25	25	6	6	valsartan	AT-1	PA451848	9197	0.947
NULL	EMBO_Mol_Med_2012_Oct_2_4(10)_1043-1056.nxml.txt.nlp	23027611	SENT206	37	37	14	14	phencyclidine	5-HT6	PA128406980	3362	0.947
NULL	J_Gastroenterol_2013_Feb_22_48(2)_222-237.nxml.txt.nlp	22722906	SENT271	32	32	35	35	ethanol	CYP3A4	PA448073	1576	0.947
NULL	Front_Neurosci_2013_Dec_20_7_256.nxml.txt.nlp	24391536	SENT108	3	3	9	9	rimonabant	CB1	PA152407999	1268	0.947
NULL	J_Org_Chem_2008_Jun_6_73(11)_3975-3984.nxml.txt.nlp	18459734	SENT118	0	0	25	25	docetaxel	C10	PA449383	113246	0.947
NULL	J_Immunol_Res_2014_Apr_9_2014_657625.nxml.txt.nlp	24818168	SENT47	19	19	2	2	methotrexate	HLA-G	PA450428	3135	0.947
NULL	Br_J_Pharmacol_2008_Oct_18_155(4)_596-605.nxml.txt.nlp	18852694	SENT156	8	8	6	6	fenofibrate	SREBP2	PA449594	6721	0.947
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT260	36	36	14	14	gefitinib	PIK3CA	PA131301952	5290	0.947
NULL	Br_J_Pharmacol_2010_Sep_161(2)_288-307.nxml.txt.nlp	20735416	SENT247	27	27	7	7	halothane	TREK-1	PA449845	3776	0.947
NULL	Mol_Cancer_2009_Dec_23_8_129.nxml.txt.nlp	20030852	SENT126	30	30	19	19	curcumin	p65	PA151958596	5970	0.947
NULL	Br_J_Cancer_2011_Jul_26_105(3)_452-459.nxml.txt.nlp	21750557	SENT43	14	14	4	4	lumiracoxib	COX2	PA164769031	4513;5743	0.947
NULL	J_Infect_Dis_2012_Apr_15_205(8)_1278-1286.nxml.txt.nlp	22396598	SENT160	2	2	13	13	proguanil	DHODH	PA451124	1723	0.947
NULL	Cancer_Inform_2014_Jan_21_13_21-45.nxml.txt.nlp	24526833	SENT720	15	15	3	3	fulvestrant	p67	PA164747170	945;10988	0.947
NULL	Arthritis_Res_Ther_2010_Apr_29_12(2)_R73.nxml.txt.nlp	20429888	SENT300	1	1	33	33	bortezomib	p300	PA10252	2033	0.947
NULL	Korean_J_Urol_2010_Feb_18_51(2)_139-144.nxml.txt.nlp	20414428	SENT50	26	26	17	17	fluorescein	CD83	PA164746009	9308	0.947
NULL	J_Clin_Biochem_Nutr_2010_Sep_6_47(2)_121-129.nxml.txt.nlp	20838567	SENT67	10	10	4	4	ethanol	ATX	PA448073	5168;23049	0.947
NULL	Arch_Orthop_Trauma_Surg_2009_Oct_2_129(10)_1427-1432.nxml.txt.nlp	18677494	SENT111	22	22	16	16	indomethacin	COX	PA449982	1351	0.947
NULL	Oncotarget_2011_Mar_27_2(3)_209-221.nxml.txt.nlp	21444945	SENT32	11	11	9	9	geldanamycin	Hsp90	PA152031327	3320	0.947
NULL	Indian_J_Nephrol_2009_Jul_19(3)_119-121.nxml.txt.nlp	20436733	SENT59	17	17	22	22	cyclosporine	P-gp	PA449167	5243	0.947
NULL	Case_Rep_Oncol_Med_2013_Jul_1_2013_793927.nxml.txt.nlp	23936700	SENT56	7	7	15	15	epirubicin	FDG	PA449476	23583	0.947
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_13_2012_636848.nxml.txt.nlp	23258994	SENT230	17	17	5	5	carrageenan	TRPV1	PA448814	7442	0.947
NULL	Front_Neurosci_2014_Feb_14_8_23.nxml.txt.nlp	24592205	SENT182	47	47	34	34	ethanol	TRPV1	PA448073	7442	0.947
NULL	Open_Biochem_J_2012_Dec_11_6_131-138.nxml.txt.nlp	23264832	SENT60	11	11	26	26	carbidopa	PLP	PA448794	25824;5744	0.947
NULL	F1000Prime_Rep_2013_Sep_2_5_37.nxml.txt.nlp	24049641	SENT44	25	25	15	15	doxycycline	ADAM12	PA449415	8038	0.947
NULL	Gastric_Cancer_2013_Jul_12_16(3)_345-354.nxml.txt.nlp	22968820	SENT198	14	14	4	4	oxaliplatin	FANCJ	PA131285527	83990	0.947
NULL	Thorax_2012_Sep_11_67(9)_796-803.nxml.txt.nlp	22496351	SENT93	8	8	27	27	bleomycin	TRAIL	PA448645	8743	0.947
NULL	Int_J_Mol_Sci_2014_Sep_5_15(9)_15754-15765.nxml.txt.nlp	25198898	SENT74	3	3	18	18	curcumin	NAC	PA151958596	22861	0.947
NULL	Eur_J_Med_Res_2014_Feb_18_19(1)_9.nxml.txt.nlp	24548763	SENT111	21	21	6	6	fluorescein	CD31	PA164746009	5175	0.947
NULL	Environ_Health_Perspect_2005_Aug_15_113(8)_1009-1014.nxml.txt.nlp	16079071	SENT204	2	2	14	14	losartan	p38	PA450268	10598;1432;7965	0.947
NULL	J_Cancer_2011_Mar_8_2_142-152.nxml.txt.nlp	21475719	SENT144	11	11	0	0	fluorouracil	TYMS	PA128406956	7298	0.947
NULL	Breast_Cancer_Res_2012_Jul_6_14(4)_R102.nxml.txt.nlp	22770227	SENT36	10	10	6	6	letrozole	aromatase	PA450196	1588	0.947
NULL	Clin_Sarcoma_Res_2013_May_13_3_8.nxml.txt.nlp	23668619	SENT74	0	0	14	14	imatinib	FLT3	PA10804	2322	0.947
NULL	Arthritis_Res_Ther_2014_Apr_15_16(2)_208.nxml.txt.nlp	25099015	SENT231	4	4	2	2	denosumab	RANKL	PA166048634	8600	0.947
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT166	22	22	33	33	rosiglitazone	CD36	PA451283	948	0.947
NULL	Br_J_Cancer_2013_Mar_5_108(4)_887-900.nxml.txt.nlp	23462807	SENT124	19	19	7	7	pazopanib	FGFR2	PA165291492	2263	0.947
NULL	Int_J_Breast_Cancer_2013_Jun_24_2013_137414.nxml.txt.nlp	23864953	SENT88	33	33	21	21	tamoxifen	HER2	PA451581	2064	0.947
NULL	Ann_Dermatol_2011_Dec_27_23(Suppl_3)_S290-S295.nxml.txt.nlp	22346260	SENT86	17	17	12	12	dapsone	EED	PA449211	8726	0.947
NULL	Avicenna_J_Phytomed_2014_Jul-Aug_4(4)_276-286.nxml.txt.nlp	25068142	SENT112	33	33	8	8	lamotrigine	HEG	PA450164	57493	0.947
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT93	9	9	18	18	metformin	HIP	PA450395	6767;6159;64399;5068	0.947
NULL	Oncotarget_2013_Nov_23_5(1)_196-210.nxml.txt.nlp	24344116	SENT174	24	24	5	5	doxorubicin	p53	PA449412	7157	0.947
NULL	Brain_2008_Dec_6_131(12)_3361-3379.nxml.txt.nlp	18988638	SENT87	13	13	0	0	pentobarbital	E12	PA450859	64100	0.947
NULL	J_Lipid_Res_2013_May_54(5)_1410-1420.nxml.txt.nlp	23419260	SENT178	20	20	36	36	tetracycline	IDOL	PA451640	29116	0.947
NULL	Acta_Pharmacol_Sin_2010_Jul_28_31(7)_867-873.nxml.txt.nlp	20581857	SENT154	15	15	22	22	docetaxel	PDCD4	PA449383	27250	0.947
NULL	Acta_Pharmacol_Sin_2011_Oct_15_32(10)_1233-1238.nxml.txt.nlp	21841815	SENT154	0	0	14	14	mecamylamine	CTX	PA450334	1593	0.947
NULL	Front_Oncol_2014_Mar_3_4_34.nxml.txt.nlp	24624361	SENT372	24	24	16	16	cisplatin	CCNE1	PA449014	898	0.947
NULL	Oncogene_2014_Aug_28_33(35)_4407-4417.nxml.txt.nlp	24469038	SENT57	19	19	3	3	cisplatin	p53	PA449014	7157	0.947
NULL	Chemother_Res_Pract_2012_Feb_12_2012_192362.nxml.txt.nlp	22400111	SENT80	28	28	22	22	temozolomide	CD133	PA451609	8842	0.947
NULL	Mol_Biol_Cell_2013_Dec_15_24(24)_3776-3786.nxml.txt.nlp	24131995	SENT128	18	18	21	21	geldanamycin	SGK1	PA152031327	6446	0.947
NULL	J_Cancer_2013_Sep_10_4(8)_614-625.nxml.txt.nlp	24155773	SENT132	13	13	25	25	bortezomib	CRM1	PA10252	7514	0.947
NULL	Oncotarget_2014_Feb_25_5(5)_1304-1314.nxml.txt.nlp	24675421	SENT21	19	19	13	13	cisplatin	JNK	PA449014	5599	0.947
NULL	Behav_Brain_Funct_2014_May_13_10_19.nxml.txt.nlp	24884961	SENT104	48	48	19	19	aprotinin	PAG	PA448472	55824	0.947
NULL	Acta_Pharmacol_Sin_2010_Nov_18_31(11)_1447-1453.nxml.txt.nlp	20953204	SENT73	0	0	9	9	rimonabant	IL-6	PA152407999	3569	0.947
NULL	Ann_Hematol_2010_Sep_13_89(9)_861-871.nxml.txt.nlp	20387067	SENT75	30	30	45	45	dasatinib	IL-3	PA162372878	3562	0.947
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_16_2012_395912.nxml.txt.nlp	23118789	SENT75	9	9	1	1	diclofenac	UGT	PA449293	7361;7355	0.947
NULL	Biologics_2014_Apr_7_8_141-153.nxml.txt.nlp	24741293	SENT22	7	7	5	5	tocilizumab	IL-6	PA165292659	3569	0.947
NULL	Cardiol_Ther_2013_Jun_1_2(1)_111-124.nxml.txt.nlp	25135294	SENT86	46	46	28	28	dabigatran	ACT		12;11332;9457;641455	0.947
NULL	Ann_Hematol_2011_Feb_17_90(2)_173-183.nxml.txt.nlp	20714724	SENT168	7	7	16	16	resveratrol	BAX		581	0.947
NULL	Acta_Neuropathol_Commun_2013_May_20_1_17.nxml.txt.nlp	24252689	SENT58	22	22	2	2	fluvastatin	CRK	PA449688	1398	0.947
NULL	Alzheimers_Res_Ther_2013_Nov_7_5(6)_54.nxml.txt.nlp	24229456	SENT20	0	0	21	21	bexarotene	ABCA1	PA164752250	19	0.947
NULL	J_Cell_Biol_1998_Mar_9_140(5)_975-989.nxml.txt.nlp	9490713	SENT50	14	14	5	5	methotrexate	DHFR	PA450428	1719	0.947
NULL	Br_J_Cancer_2013_Feb_19_108(3)_557-563.nxml.txt.nlp	23361053	SENT197	13	13	20	20	tamoxifen	IPA	PA451581	3160	0.947
NULL	Orphanet_J_Rare_Dis_2014_Dec_10_9(1)_201.nxml.txt.nlp	NULL	SENT199	11	11	27	27	naltrexone	CMT1A	PA450588	1248	0.947
NULL	Breast_Cancer_Res_2004_Nov_7_6(1)_39-52.nxml.txt.nlp	14680484	SENT163	15	15	7	7	tamoxifen	N-CoR	PA451581	9611	0.947
NULL	Arthritis_Res_Ther_2011_Sep_21_13(5)_239.nxml.txt.nlp	21955617	SENT51	6	6	4	4	diclofenac	COX	PA449293	1351	0.947
NULL	Indian_J_Pharmacol_2012_Nov-Dec_44(6)_704-709.nxml.txt.nlp	23248398	SENT66	23	23	43	43	tolnaftate	ANOVA	PA164752438	4858	0.947
NULL	Arthritis_Res_Ther_2003_Oct_2_5(Suppl_4)_S17-S21.nxml.txt.nlp	15180893	SENT54	34	34	17	17	rituximab	ACR	PA451261	49	0.947
NULL	Oncotarget_2014_Oct_21_5(22)_11252-11268.nxml.txt.nlp	25361004	SENT292	6	6	14	14	metformin	CLIC1	PA450395	1192	0.947
NULL	Case_Rep_Ophthalmol_2010_Aug_18_1(1)_36-41.nxml.txt.nlp	21369348	SENT46	14	14	8	8	bevacizumab	hole	PA130232992	80757	0.947
NULL	Oncotarget_2014_Oct_16_5(20)_9546-9563.nxml.txt.nlp	25337673	SENT135	9	9	21	21	nilotinib	AXL	PA165958345	558	0.947
NULL	Mol_Syst_Biol_2009_Jul_28_5_289.nxml.txt.nlp	19638970	SENT37	20	20	11	11	resveratrol	HuR		1994	0.947
NULL	Tuberc_Respir_Dis_(Seoul)_2013_Nov_29_75(5)_188-198.nxml.txt.nlp	24348666	SENT134	3	3	7	7	erlotinib	IGF1R	PA134687924	3480	0.947
NULL	Front_Behav_Neurosci_2011_Sep_28_5_64.nxml.txt.nlp	21991251	SENT80	23	23	10	10	estradiol	CB1	PA449503	1268	0.947
NULL	Oncol_Rep_2012_Dec_21_28(6)_1977-1983.nxml.txt.nlp	23007635	SENT61	13	13	38	38	fluorescein	HER-2	PA164746009	2064	0.947
NULL	Open_Access_J_Urol_2010_Mar_12_2_35-40.nxml.txt.nlp	24198612	SENT70	12	12	2	2	sunitinib	mol	PA162372840	90527	0.947
NULL	Oncogene_2009_Apr_23_28(16)_1864-1874.nxml.txt.nlp	19305426	SENT222	2	2	35	35	etoposide	ANOVA	PA449552	4858	0.947
NULL	Am_J_Trop_Med_Hyg_2012_Nov_7_87(5)_783-784.nxml.txt.nlp	23136171	SENT24	29	29	20	20	mefloquine	ACT	PA450348	12;11332;9457;641455	0.947
NULL	Breast_Cancer_Res_2010_Jun_28_12(3)_R43.nxml.txt.nlp	20579400	SENT160	23	23	18	18	tamoxifen	MAPT	PA451581	4137	0.947
NULL	Oncol_Rep_2014_Aug_12_32(2)_469-474.nxml.txt.nlp	24926795	SENT33	18	18	1	1	carboplatin	ATP7A	PA448803	538	0.947
NULL	Clin_Interv_Aging_2008_Sep_3(3)_503-509.nxml.txt.nlp	18982920	SENT147	16	16	3	3	tolterodine	STAR	PA164746757	6770;2984	0.947
NULL	Mediators_Inflamm_2001_Jun_10(3)_109-115.nxml.txt.nlp	11545247	SENT0	24	24	11	11	risperidone	IL-8	PA451257	3576	0.947
NULL	Cancer_Inform_2012_Apr_19_11_87-111.nxml.txt.nlp	22553414	SENT217	1	1	15	15	gefitinib	DEK	PA131301952	7913	0.947
NULL	Front_Synaptic_Neurosci_2014_Jun_10_6_14.nxml.txt.nlp	24959138	SENT107	21	21	3	3	l-proline	DAO	PA451125	26;1610	0.947
NULL	Evid_Based_Complement_Alternat_Med_2014_May_21_2014_564810.nxml.txt.nlp	24963324	SENT183	11	11	0	0	cisplatin	HEC	PA449014	10403	0.947
NULL	Clin_Med_Insights_Oncol_2013_Jun_3_7_103-122.nxml.txt.nlp	23843721	SENT136	9	9	2	2	trastuzumab	PTEN	PA451743	5728	0.947
NULL	Arch_Drug_Inf_2011_Mar_4(1)_1-9.nxml.txt.nlp	21572514	SENT156	9	9	0	0	verapamil	P-gp	PA451868	5243	0.947
NULL	Front_Oncol_2014_Apr_1_4_67.nxml.txt.nlp	24744992	SENT32	0	0	43	43	erlotinib	HER2	PA134687924	2064	0.947
NULL	Oncotarget_2013_Jul_21_4(8)_1253-1265.nxml.txt.nlp	23896512	SENT179	24	24	3	3	erlotinib	EGFR	PA134687924	1956	0.947
NULL	Diabetes_2013_Mar_14_62(3)_709-710.nxml.txt.nlp	23431018	SENT12	0	0	6	6	ticagrelor	P2Y12	PA165374673	64805	0.947
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT280	25	25	36	36	irinotecan	EGFR	PA450085	1956	0.947
NULL	Autoimmune_Dis_2013_Aug_28_2013_613086.nxml.txt.nlp	24069534	SENT6	23	23	38	38	adalimumab	p40	PA10004	3921;339541;10314	0.947
NULL	Drugs_2014_Jul_18_74(11)_1209-1231.nxml.txt.nlp	25034361	SENT59	3	3	1	1	quinidine	P-gp	PA451209	5243	0.947
NULL	J_Mol_Signal_2010_May_10_5_4.nxml.txt.nlp	20459745	SENT87	8	8	15	15	cisplatin	p53	PA449014	7157	0.947
NULL	Indian_J_Hum_Genet_2014_Apr-Jun_20(2)_175-184.nxml.txt.nlp	25400347	SENT9	46	46	35	35	clopidogrel	VKORC1	PA449053	79001	0.947
NULL	J_Hematol_Oncol_2009_Apr_22_2_18.nxml.txt.nlp	19386128	SENT106	27	27	14	14	cetuximab	EGFR	PA10040	1956	0.947
NULL	Evid_Based_Complement_Alternat_Med_2014_Dec_11_2014_429256.nxml.txt.nlp	25580151	SENT75	9	9	21	21	indomethacin	COX	PA449982	1351	0.947
NULL	Int_J_Biol_Sci_2013_Dec_17_10(1)_64-72.nxml.txt.nlp	24391452	SENT91	8	8	35	35	verapamil	5-HT2B	PA451868	3357	0.947
NULL	Aging_(Albany_NY)_2011_Oct_28_3(10)_1028-1038.nxml.txt.nlp	22067284	SENT46	4	4	2	2	metformin	AMPK	PA450395	5563	0.947
NULL	Mucosal_Immunol_2014_Jan_12_7(1)_10_1038_mi_2013_36.nxml.txt.nlp	23757303	SENT53	33	33	20	20	mitomycin	CD4	PA450524	920	0.947
NULL	Oncotarget_2013_Jul_31_4(10)_1572-1581.nxml.txt.nlp	24197907	SENT16	9	9	4	4	cisplatin	BRCA1	PA449014	672	0.947
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S279-S284.nxml.txt.nlp	21525469	SENT44	38	38	12	12	metformin	GLP-1	PA450395	100125288	0.947
NULL	Drugs_Context_2013_Oct_4_2013_212257.nxml.txt.nlp	24432044	SENT377	9	9	16	16	citalopram	STAR	PA449015	6770;2984	0.947
NULL	Evid_Based_Complement_Alternat_Med_2013_Aug_12_2013_982689.nxml.txt.nlp	23997806	SENT175	23	23	29	29	tolbutamide	APE	PA451718	55704;328	0.947
NULL	Ther_Clin_Risk_Manag_2006_Jun_2(2)_187-192.nxml.txt.nlp	18360592	SENT49	21	21	30	30	clozapine	5-HT2A	PA449061	3356	0.947
NULL	Nucleic_Acids_Res_2005_Aug_12_33(14)_4584-4592.nxml.txt.nlp	16100380	SENT124	29	29	14	14	paromomycin	GCN2	PA164784023	440275	0.947
NULL	Korean_J_Radiol_2010_Feb_22_Mar-Apr_11(2)_156-163.nxml.txt.nlp	20191062	SENT52	1	1	8	8	heparin	ACT	PA449855	12;11332;9457;641455	0.947
NULL	Acta_Pharmacol_Sin_2012_Aug_23_33(8)_1095-1100.nxml.txt.nlp	22820908	SENT112	23	23	29	29	clarithromycin	CYP3A	PA449028	1574	0.947
NULL	Oxid_Med_Cell_Longev_2011_Aug_4_2011_471590.nxml.txt.nlp	21904644	SENT40	14	14	4	4	probucol	CA1	PA451107	759	0.947
NULL	Acta_Pharmacol_Sin_2013_Sep_5_34(9)_1208-1216.nxml.txt.nlp	23852087	SENT116	13	13	5	5	disulfiram	CA9	PA449376	768	0.947
NULL	Cancer_Manag_Res_2014_Jan_28_6_39-51.nxml.txt.nlp	24501545	SENT137	11	11	17	17	ketoconazole	CYP3A4	PA450146	1576	0.947
NULL	Eur_Respir_J_2014_Jul_23_44(1)_23-63.nxml.txt.nlp	24659544	SENT918	0	0	16	16	ethambutol	DST	PA164784021	667	0.947
NULL	Br_J_Cancer_2011_Mar_15_104(6)_941-947.nxml.txt.nlp	21407223	SENT161	13	13	5	5	sorafenib	survivin	PA7000	332	0.947
NULL	Cancers_(Basel)_2011_May_3_3(2)_2255-2273.nxml.txt.nlp	24212808	SENT138	12	12	8	8	erlotinib	EGFR	PA134687924	1956	0.947
NULL	Oncotarget_2013_Aug_24_4(10)_1618-1631.nxml.txt.nlp	24113128	SENT205	25	25	17	17	sorafenib	p53	PA7000	7157	0.947
NULL	Cancer_Metastasis_Rev_2011_Dec_20_30(3-4)_465-480.nxml.txt.nlp	22012553	SENT435	7	7	14	14	berberine	EP2	PA165860812	5732;10407	0.947
NULL	Arch_Toxicol_2014_Nov_5_88(12)_2135-2190.nxml.txt.nlp	25370008	SENT1041	11	11	27	27	4-methylumbelliferone	UGT	PA154081778	7361;7355	0.947
NULL	Br_J_Cancer_2013_Mar_19_108(5)_1052-1060.nxml.txt.nlp	23422754	SENT156	48	48	38	38	bevacizumab	VEGF-A	PA130232992	7422	0.947
NULL	Int_J_Biol_Sci_2013_Jan_3_9(1)_94-107.nxml.txt.nlp	23355795	SENT62	31	31	14	14	fluorescein	TLR4	PA164746009	7099	0.947
NULL	Clin_Med_Insights_Oncol_2012_Dec_6_6_407-421.nxml.txt.nlp	23239933	SENT146	17	17	13	13	erlotinib	EGFR	PA134687924	1956	0.947
NULL	Cell_Commun_Signal_2010_Dec_22_8_31.nxml.txt.nlp	21176168	SENT57	27	27	11	11	etoposide	PARP-1	PA449552	25976	0.947
NULL	J_Cell_Mol_Med_2014_Nov_28_18(11)_2213-2224.nxml.txt.nlp	25164131	SENT241	33	33	17	17	infliximab	IFN	PA452639	3439	0.947
NULL	BMB_Rep_2014_Jul_47(7)_376-381.nxml.txt.nlp	24286332	SENT5	25	25	2	2	thrombin	PPG	PA451674	5552	0.947
NULL	Breast_Cancer_Res_Treat_2012_Aug_13_135(1)_49-58.nxml.txt.nlp	22527098	SENT265	11	11	4	4	lapatinib	HER2	PA152241907	2064	0.947
NULL	Cancer_Med_2013_Aug_10_2(4)_488-495.nxml.txt.nlp	24156021	SENT121	38	38	20	20	sn-38	GEM		2669	0.947
NULL	Scientifica_(Cairo)_2012_Sep_16_2012_683683.nxml.txt.nlp	24278728	SENT105	0	0	9	9	ticagrelor	P2Y12	PA165374673	64805	0.947
NULL	Orphanet_J_Rare_Dis_2011_May_28_6_32.nxml.txt.nlp	21619687	SENT244	22	22	31	31	diethylstilbestrol	HOXA10	PA449307	3206	0.947
NULL	Oncol_Lett_2014_May_11_7(5)_1401-1408.nxml.txt.nlp	24765145	SENT120	11	11	28	28	paclitaxel	PI3K	PA450761	5290	0.947
NULL	Open_Access_J_Urol_2010_Mar_12_2_35-40.nxml.txt.nlp	24198612	SENT71	6	6	13	13	pazopanib	VEGFR2	PA165291492	3791	0.947
NULL	Arthritis_Res_Ther_2012_May_1_14(3)_R99.nxml.txt.nlp	22546542	SENT105	27	27	0	0	infliximab	CD4	PA452639	920	0.947
NULL	Front_Neural_Circuits_2015_Jan_12_8_150.nxml.txt.nlp	25628540	SENT149	6	6	31	31	atropine	CA1	PA448505	759	0.947
NULL	Arthritis_Res_Ther_2013_May_29_15(3)_R64.nxml.txt.nlp	23718630	SENT9	16	16	9	9	canakinumab	NLRP3	PA165958358	114548	0.947
NULL	Mol_Cancer_2012_Mar_21_11_13.nxml.txt.nlp	22436134	SENT9	13	13	3	3	doxorubicin	HuR	PA449412	1994	0.947
NULL	Cancer_Cell_Int_2013_Jan_15_13_3.nxml.txt.nlp	23320839	SENT105	5	5	8	8	doxorubicin	MRP1	PA449412	4437	0.947
NULL	J_Korean_Med_Sci_2009_Jan_29_24(Suppl_1)_S183-S188.nxml.txt.nlp	19194550	SENT111	7	7	22	22	celecoxib	COX	PA448871	1351	0.947
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT29	30	30	37	37	celecoxib	survivin	PA448871	332	0.947
NULL	Clin_Dev_Immunol_2011_Dec_26_2011_890758.nxml.txt.nlp	22235224	SENT331	0	0	19	19	cetuximab	EGFR	PA10040	1956	0.947
NULL	Breast_Cancer_Res_2012_Apr_26_14(2)_R69.nxml.txt.nlp	22537934	SENT198	14	14	26	26	tamoxifen	RAD21	PA451581	5885	0.947
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT60	19	19	28	28	ranibizumab	VEGFR1	PA164746012	2321	0.947
NULL	Nucleic_Acids_Res_2011_Dec_31_39(22)_9536-9548.nxml.txt.nlp	21880590	SENT211	18	18	26	26	cisplatin	BRCA1	PA449014	672	0.947
NULL	Eur_J_Clin_Pharmacol_2011_May_8_67(5)_493-506.nxml.txt.nlp	21140139	SENT154	13	13	10	10	haloperidol	CYP2D6	PA449841	1565	0.947
NULL	Clin_Med_Insights_Circ_Respir_Pulm_Med_2011_Dec_7_6_1-11.nxml.txt.nlp	22259262	SENT46	1	1	33	33	salmeterol	CYP3A4	PA451300	1576	0.947
NULL	Indian_J_Med_Paediatr_Oncol_2014_Apr-Jun_35(2)_140-142.nxml.txt.nlp	25197175	SENT57	20	20	5	5	cetuximab	KRAS	PA10040	3845	0.947
NULL	Mol_Cell_Proteomics_2012_Feb_6_11(2)_M111_015222.nxml.txt.nlp	22147731	SENT206	24	24	17	17	gefitinib	EGF	PA131301952	1950	0.947
NULL	Indian_J_Pharm_Sci_2014_May-Jun_76(3)_203-210.nxml.txt.nlp	25035531	SENT171	16	16	9	9	curcumin	5-HT1A	PA151958596	3350	0.947
NULL	J_Oncol_2012_Apr_10_2012_931071.nxml.txt.nlp	22570654	SENT91	12	12	20	20	plerixafor	CD34	PA165958410	947	0.947
NULL	Comb_Chem_High_Throughput_Screen_2010_Feb_13(2)_188-206.nxml.txt.nlp	20053163	SENT247	27	27	11	11	phenytoin	CYP2C19	PA450947	1557	0.947
NULL	Front_Neurosci_2013_Jan_31_7_3.nxml.txt.nlp	23386808	SENT201	34	34	8	8	capsaicin	TRPV1	PA448776	7442	0.947
NULL	Diabetes_2011_Jan_4_60(1)_119-126.nxml.txt.nlp	20921208	SENT80	25	25	5	5	glucose	TRPM2	PA449773	7226	0.947
NULL	Cancer_Med_2014_Aug_3_3(4)_947-953.nxml.txt.nlp	24799363	SENT84	14	14	5	5	tamoxifen	aromatase	PA451581	1588	0.947
NULL	Cancer_Med_2013_Aug_2_2(4)_571-582.nxml.txt.nlp	24156030	SENT6	10	10	15	15	curcumin	IL-6	PA151958596	3569	0.947
NULL	Ther_Clin_Risk_Manag_2006_Mar_2(1)_87-98.nxml.txt.nlp	18360584	SENT96	4	4	16	16	sorafenib	BRAF	PA7000	673	0.947
NULL	Mol_Cancer_2010_Aug_23_9_222.nxml.txt.nlp	20731837	SENT191	5	5	16	16	cetuximab	EGFR	PA10040	1956	0.947
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1046.nxml.txt.nlp	24503538	SENT48	18	18	42	42	oxaliplatin	ANOVA	PA131285527	4858	0.947
NULL	Br_J_Cancer_2012_May_22_106(11)_1807-1815.nxml.txt.nlp	22531632	SENT167	23	23	13	13	nifedipine	CDK1	PA450631	983	0.947
NULL	Acta_Pharmacol_Sin_2014_Aug_21_35(8)_1082-1092.nxml.txt.nlp	25047514	SENT195	12	12	20	20	letrozole	aromatase	PA450196	1588	0.947
NULL	Clin_Med_Insights_Oncol_2012_Dec_6_6_407-421.nxml.txt.nlp	23239933	SENT29	20	20	14	14	gefitinib	EGFR	PA131301952	1956	0.947
NULL	Cancers_(Basel)_2014_Oct_21_6(4)_2137-2154.nxml.txt.nlp	25337831	SENT149	38	38	21	21	gemcitabine	MVD	PA449748	4597	0.947
NULL	Cancer_Med_2013_Dec_31_2(6)_950-963.nxml.txt.nlp	24403269	SENT262	4	4	16	16	cisplatin	RAB25	PA449014	57111	0.947
NULL	Crit_Care_2010_Oct_13_14(5)_R181.nxml.txt.nlp	20942931	SENT220	14	14	1	1	cisplatin	IL-6	PA449014	3569	0.947
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Aug_27_6_145-150.nxml.txt.nlp	25249759	SENT5	35	35	4	4	letrozole	aromatase	PA450196	1588	0.947
NULL	Breast_Cancer_Res_Treat_2012_Jun_3_133(3)_865-880.nxml.txt.nlp	22048815	SENT168	31	31	20	20	carboplatin	RAD50	PA448803	10111	0.947
NULL	Br_J_Cancer_2013_Jul_23_109(2)_342-350.nxml.txt.nlp	23807172	SENT186	0	0	21	21	sorafenib	Bcl-2	PA7000	596	0.947
NULL	Oncogene_2013_Sep_26_32(39)_10_1038_onc_2012_491.nxml.txt.nlp	23108394	SENT49	36	36	5	5	epirubicin	FOXM1	PA449476	2305	0.947
NULL	J_Neurophysiol_2013_May_1_109(9)_2393-2403.nxml.txt.nlp	23427303	SENT234	34	34	4	4	capsaicin	LEP	PA448776	3952	0.947
NULL	Autophagy_2012_May_1_8(5)_853-855.nxml.txt.nlp	22617440	SENT20	0	0	12	12	imatinib	MIR30A	PA10804	407029	0.947
NULL	Oncol_Lett_2013_Feb_9_5(2)_552-558.nxml.txt.nlp	23420128	SENT190	2	2	16	16	imatinib	KIT	PA10804	3815	0.947
NULL	Diabetes_2011_Jun_21_60(6)_1705-1715.nxml.txt.nlp	21521872	SENT125	11	11	35	35	doxycycline	STZ	PA449415	6484	0.947
NULL	Front_Endocrinol_(Lausanne)_2014_Jan_16_5_1.nxml.txt.nlp	24474947	SENT62	32	32	6	6	estradiol	GPER	PA449503	2852	0.947
NULL	J_Immunol_Res_2014_May_12_2014_897249.nxml.txt.nlp	24901013	SENT250	11	11	17	17	natalizumab	CD49d	PA164747191	3676	0.947
NULL	NMR_Biomed_2013_Oct_7_26(10)_1258-1270.nxml.txt.nlp	23564602	SENT263	26	26	24	24	erythromycin	OATP	PA449493	6579	0.947
NULL	Br_J_Cancer_2011_Jul_26_105(3)_452-459.nxml.txt.nlp	21750557	SENT43	10	10	4	4	etodolac	COX2	PA449550	4513;5743	0.947
NULL	Oxid_Med_Cell_Longev_2013_Jun_2_2013_793525.nxml.txt.nlp	23819014	SENT244	3	3	17	17	resveratrol	AMPK		5563	0.947
NULL	J_Exp_Med_1969_May_1_129(5)_1109-1130.nxml.txt.nlp	5778786	SENT10	9	9	0	0	thrombin	C3b	PA451674	718	0.947
NULL	Anemia_2012_Nov_8_2012_607436.nxml.txt.nlp	23198140	SENT163	38	38	7	7	capsaicin	TRPV1	PA448776	7442	0.947
NULL	Braz_J_Med_Biol_Res_2013_Aug_13_46(8)_650-658.nxml.txt.nlp	23969971	SENT183	18	18	4	4	cisplatin	STAT3	PA449014	6774	0.947
NULL	Diabetes_2009_Jan_58(1)_243-249.nxml.txt.nlp	18840785	SENT142	3	3	16	16	vildagliptin	GLP-1	PA165958346	100125288	0.947
NULL	Drugs_Aging_2012_Nov_5_29(11)_863-869.nxml.txt.nlp	23038608	SENT128	22	22	6	6	capsaicin	NNT	PA448776	23530	0.947
NULL	J_Gen_Physiol_2012_May_139(5)_333-348.nxml.txt.nlp	22547664	SENT35	24	24	0	0	gentamicin	GT1	PA449753	4635	0.947
NULL	Mol_Cancer_2012_Sep_11_11_66.nxml.txt.nlp	22966907	SENT574	9	9	37	37	hyaluronan	RANKL	PA165958431	8600	0.947
NULL	Case_Rep_Transplant_2011_Jan_5_2011_210178.nxml.txt.nlp	23213600	SENT68	26	26	0	0	sirolimus	CYP3A4	PA451365	1576	0.947
NULL	FEBS_Open_Bio_2014_Jul_5_4_659-671.nxml.txt.nlp	25161875	SENT335	15	15	10	10	etoposide	XIAP	PA449552	331	0.947
NULL	Diabetes_2009_Jan_58(1)_243-249.nxml.txt.nlp	18840785	SENT114	23	23	18	18	vildagliptin	GLP-1	PA165958346	100125288	0.947
NULL	Front_Neurol_2014_Feb_18_5_17.nxml.txt.nlp	24600432	SENT107	10	10	24	24	levetiracetam	CD178	PA450206	356	0.947
NULL	Oncoimmunology_2013_Dec_1_2(12)_e26961.nxml.txt.nlp	24575379	SENT12	11	11	28	28	everolimus	MTOR	PA164746311	2475	0.947
NULL	Cell_Res_2013_Aug_9_23(8)_986-993.nxml.txt.nlp	23835475	SENT38	28	28	26	26	sitagliptin	DPP4	PA164748978	1803	0.947
NULL	Br_J_Cancer_2012_Jan_17_106(2)_284-289.nxml.txt.nlp	22215065	SENT6	24	24	8	8	atrasentan	IFN	PA143414738	3439	0.947
NULL	Cell_Death_Dis_2014_Jan_16_5(1)_e1000.nxml.txt.nlp	24434508	SENT179	34	34	3	3	collagenase	p53	PA449107	7157	0.947
NULL	Arthritis_Res_Ther_2008_Sep_24_10(5)_R115.nxml.txt.nlp	18816401	SENT178	39	39	8	8	etanercept	BMP2	PA449515	650	0.947
NULL	ASN_Neuro_2012_Jun_20_4(4)_e00091.nxml.txt.nlp	22591512	SENT36	8	8	24	24	l-glutamine	CO2	PA10090	4513	0.947
NULL	Biologics_2010_Feb_4_4_19-31.nxml.txt.nlp	20161982	SENT110	31	31	42	42	imatinib	KIT	PA10804	3815	0.947
NULL	Int_J_Biomed_Sci_2005_Jun_1(1)_67-71.nxml.txt.nlp	23674956	SENT28	32	32	1	1	heparin	hole	PA449855	80757	0.947
NULL	Angiogenesis_2011_Sep_31_14(3)_245-253.nxml.txt.nlp	21452059	SENT23	5	5	13	13	camptothecin	HIF-1	PA153590860	29072	0.947
NULL	J_Thromb_Haemost_2010_Mar_8(3)_577-587.nxml.txt.nlp	20040043	SENT179	15	15	18	18	rosiglitazone	mol	PA451283	90527	0.947
NULL	Exp_Ther_Med_2013_Mar_21_5(3)_987-991.nxml.txt.nlp	23407636	SENT27	6	6	16	16	losartan	AT-1	PA450268	9197	0.947
NULL	Cancer_Med_2014_Jun_19_3(3)_555-564.nxml.txt.nlp	24648042	SENT132	28	28	3	3	fludarabine	SF3B1	PA449655	23451	0.947
NULL	Nat_Commun_2013_Sep_20_4_2444.nxml.txt.nlp	24051492	SENT168	13	13	9	9	nutlin-3	p53		7157	0.947
NULL	F1000Prime_Rep_2013_Jul_1_5_24.nxml.txt.nlp	23864931	SENT101	3	3	14	14	telaprevir	CYP3A4	PA165958354	1576	0.947
NULL	Ann_Rheum_Dis_2014_Sep_3_73(9)_1616-1625.nxml.txt.nlp	24699939	SENT206	18	18	4	4	tocilizumab	IL-6	PA165292659	3569	0.947
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT133	2	2	8	8	bevacizumab	VEGF-A	PA130232992	7422	0.947
NULL	Arthritis_Res_Ther_2012_Jan_17_14(1)_R11.nxml.txt.nlp	22251436	SENT19	0	0	14	14	maraviroc	CCR5	PA164768835	1234	0.947
NULL	Oncotarget_2014_Sep_16_5(20)_10034-10047.nxml.txt.nlp	25296981	SENT184	25	25	12	12	doxorubicin	CHK1	PA449412	1111	0.947
NULL	Front_Oncol_2014_May_27_4_125.nxml.txt.nlp	24904835	SENT356	16	16	25	25	troglitazone	gamma	PA451799	9913	0.947
NULL	Acta_Pharmacol_Sin_2010_Jul_28_31(7)_867-873.nxml.txt.nlp	20581857	SENT145	41	41	18	18	docetaxel	PC3	PA449383	57332;7832;5122	0.947
NULL	Oncotarget_2014_Oct_21_5(22)_11709-11722.nxml.txt.nlp	25365944	SENT6	26	26	18	18	metformin	RhoA	PA450395	387	0.947
NULL	Onco_Targets_Ther_2014_Mar_6_7_387-393.nxml.txt.nlp	24623981	SENT99	21	21	6	6	erlotinib	EGFR	PA134687924	1956	0.947
NULL	Br_J_Haematol_2014_Jan_28_164(2)_233-244.nxml.txt.nlp	24206017	SENT14	35	35	4	4	thalidomide	CRBN	PA451644	51185	0.947
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Jul_23_6_103-113.nxml.txt.nlp	25114588	SENT43	7	7	39	39	pertuzumab	HER2		2064	0.947
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT237	28	28	38	38	perifosine	DR5	PA165291471	8795	0.947
NULL	Br_J_Cancer_2012_Jan_3_106(1)_6-13.nxml.txt.nlp	22215104	SENT98	0	0	13	13	sunitinib	VEGFR	PA162372840	3791	0.947
NULL	Case_Rep_Hematol_2013_Sep_30_2013_628513.nxml.txt.nlp	24198984	SENT44	22	22	5	5	cyclophosphamide	VIII	PA449165	1351	0.947
NULL	Epilepsia_2012_Jun_21_53(Suppl_1)_18-25.nxml.txt.nlp	22612805	SENT41	4	4	15	15	furosemide	NKCC1	PA449719	6558	0.947
NULL	Oncologist_2011_Feb_25_16(2)_155-164.nxml.txt.nlp	21266401	SENT159	5	5	11	11	trastuzumab	HER-2	PA451743	2064	0.947
NULL	Arthritis_Res_Ther_2012_Dec_3_14(6)_R262.nxml.txt.nlp	23206933	SENT81	9	9	28	28	tocilizumab	IL-6	PA165292659	3569	0.947
NULL	Front_Genet_2012_Nov_12_3_235.nxml.txt.nlp	23162568	SENT172	3	3	7	7	ritonavir	CYP2D6	PA451260	1565	0.947
NULL	Oncotarget_2012_May_18_3(5)_525-534.nxml.txt.nlp	22619113	SENT155	4	4	11	11	fludarabine	IL-4	PA449655	3565	0.947
NULL	J_Cancer_2013_Sep_27_4(8)_662-670.nxml.txt.nlp	24155778	SENT154	13	13	3	3	cisplatin	UCHL1	PA449014	7345	0.947
NULL	Oncogene_2009_Aug_27_28(34)_3022-3032.nxml.txt.nlp	19543317	SENT160	44	44	17	17	etoposide	BMI1	PA449552	648	0.947
NULL	Basic_Res_Cardiol_2010_Nov_20_105(6)_771-785.nxml.txt.nlp	20960209	SENT170	17	17	0	0	cyclosporine	STAT3	PA449167	6774	0.947
NULL	Clin_Sci_(Lond)_2012_May_1_122(Pt_9)_421-428.nxml.txt.nlp	22092038	SENT189	11	11	4	4	doxycycline	c-Jun	PA449415	3725	0.947
NULL	AIDS_Res_Treat_2011_Jul_25_2011_743597.nxml.txt.nlp	21804938	SENT69	32	32	19	19	alemtuzumab	CD4	PA164783958	920	0.947
NULL	Mol_Vis_2011_Dec_27_17_3415-3422.nxml.txt.nlp	22219637	SENT144	13	13	6	6	estradiol	p38	PA449503	10598;1432;7965	0.947
NULL	Indian_J_Dermatol_2010_Apr-Jun_55(2)_161-170.nxml.txt.nlp	20606887	SENT34	0	0	7	7	ustekinumab	p40	PA166048654	3921;339541;10314	0.947
NULL	J_Hum_Genet_2013_Jun_23_58(6)_339-345.nxml.txt.nlp	23697979	SENT88	8	8	5	5	prasugrel	P2Y12	PA154410481	64805	0.947
NULL	Cancers_(Basel)_2014_Nov_25_6(4)_2313-2329.nxml.txt.nlp	25534569	SENT132	7	7	10	10	crizotinib	Met	PA165946122	79811	0.947
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1522-1532.nxml.txt.nlp	21997136	SENT214	27	27	22	22	irinotecan	EGFR	PA450085	1956	0.947
NULL	Front_Physiol_2013_May_15_4_103.nxml.txt.nlp	23720630	SENT127	29	29	9	9	l-carnitine	ADP	PA450154	23038	0.947
NULL	Mol_Cancer_2008_Mar_26_7_27.nxml.txt.nlp	18366759	SENT277	13	13	6	6	etoposide	p53	PA449552	7157	0.947
NULL	Oncoimmunology_2012_May_1_1(3)_372-374.nxml.txt.nlp	22737619	SENT20	23	23	12	12	lenalidomide	CD4	PA162363968	920	0.947
NULL	Pharmaceutics_2011_Feb_7_3(1)_53-72.nxml.txt.nlp	24310425	SENT176	0	0	14	14	theophylline	CYP3A4	PA451647	1576	0.947
NULL	Allergy_Asthma_Immunol_Res_2014_Mar_15_6(2)_126-130.nxml.txt.nlp	24587948	SENT28	8	8	31	31	salbutamol	TTN	PA448068	7273	0.947
NULL	Am_J_Cardiovasc_Drugs_2013_Jun_20_13(5)_331-342.nxml.txt.nlp	23784266	SENT223	27	27	13	13	clarithromycin	CYP3A4	PA449028	1576	0.947
NULL	Acta_Pharmacol_Sin_2010_Feb_5_31(2)_137-144.nxml.txt.nlp	20139896	SENT33	18	18	5	5	zileuton	5-LOX	PA451955	240	0.947
NULL	Arch_Virol_2014_Dec_24_159(6)_1365-1371.nxml.txt.nlp	24366548	SENT142	35	35	6	6	ribavirin	IFN	PA451241	3439	0.947
NULL	J_Gen_Physiol_2010_Apr_135(4)_333-353.nxml.txt.nlp	20231374	SENT427	6	6	14	14	desipramine	P2X4	PA449233	5025	0.947
NULL	Exp_Diabetes_Res_2012_May_14_2012_470851.nxml.txt.nlp	22666230	SENT203	32	32	4	4	liraglutide	GLP-1	PA165958364	100125288	0.947
NULL	J_Hematol_Oncol_2013_Jul_18_6_53.nxml.txt.nlp	23866964	SENT8	13	13	18	18	temsirolimus	HDAC1	PA164746890	3065	0.947
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT332	14	14	34	34	rolipram	IL-6	PA153906323	3569	0.947
NULL	Evid_Based_Complement_Alternat_Med_2011_Jan_9_2011_619650.nxml.txt.nlp	21799685	SENT139	6	6	10	10	ketanserin	5-HT2A	PA131053734	3356	0.947
NULL	Front_Endocrinol_(Lausanne)_2014_Aug_13_5_134.nxml.txt.nlp	25165463	SENT67	7	7	0	0	morphine	NPFF	PA450550	8620	0.947
NULL	Front_Microbiol_2012_Nov_30_3_406.nxml.txt.nlp	23226145	SENT464	1	1	41	41	bortezomib	p65	PA10252	5970	0.947
NULL	Adipocyte_2012_Jul_1_1(3)_123-131.nxml.txt.nlp	23145367	SENT24	30	30	19	19	lipase	ATGL	PA450239	57104	0.947
NULL	Br_J_Cancer_2010_Jul_13_103(2)_265-274.nxml.txt.nlp	20551953	SENT214	17	17	7	7	cisplatin	DUSP16	PA449014	80824	0.947
NULL	Br_J_Cancer_2013_Dec_10_109(12)_3067-3072.nxml.txt.nlp	24263065	SENT38	23	23	12	12	irinotecan	BRAF	PA450085	673	0.947
NULL	Sensors_(Basel)_2013_Jun_14_13(6)_7668-7679.nxml.txt.nlp	23771156	SENT130	5	5	17	17	lidocaine	mol	PA450226	90527	0.947
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT343	30	30	5	5	heparin	FGF1	PA449855	2246	0.947
NULL	Clin_Ophthalmol_2014_Jun_26_8_1213-1219.nxml.txt.nlp	25061267	SENT7	30	30	19	19	proparacaine	PRK	PA164776849	1263	0.947
NULL	Arthritis_Res_Ther_2014_Apr_11_16(2)_R93.nxml.txt.nlp	24725461	SENT64	18	18	16	16	letrozole	aromatase	PA450196	1588	0.947
NULL	Case_Rep_Transplant_2014_Jan_2_2014_548243.nxml.txt.nlp	24575309	SENT21	0	0	23	23	ranolazine	CYP2D6	PA164746007	1565	0.947
NULL	Cancer_Metab_2014_Nov_3_2(1)_20.nxml.txt.nlp	NULL	SENT102	10	10	22	22	erlotinib	EGFR	PA134687924	1956	0.947
NULL	J_Gen_Physiol_2008_Nov_132(5)_521-535.nxml.txt.nlp	18852303	SENT410	15	15	31	31	trypsin	CAP2	PA451806	5271;10486	0.947
NULL	Oncogene_2014_Feb_6_33(6)_713-723.nxml.txt.nlp	23435429	SENT77	28	28	0	0	etoposide	BRCA1	PA449552	672	0.947
NULL	Front_Endocrinol_(Lausanne)_2014_Jan_16_5_1.nxml.txt.nlp	24474947	SENT80	9	9	27	27	estradiol	aromatase	PA449503	1588	0.947
NULL	Indian_J_Ophthalmol_2007_Nov-Dec_55(6)_482-483.nxml.txt.nlp	17951917	SENT16	31	31	6	6	gatifloxacin	API	PA449738	5345	0.947
NULL	J_Hematol_Oncol_2009_Apr_22_2_18.nxml.txt.nlp	19386128	SENT106	29	29	5	5	irinotecan	KRAS	PA450085	3845	0.947
NULL	J_Gynecol_Oncol_2012_Jan_9_23(1)_53-64.nxml.txt.nlp	22355468	SENT67	21	21	9	9	olaparib	BRCA2		675	0.947
NULL	Oncotarget_2012_Sep_11_3(9)_1026-1035.nxml.txt.nlp	22976441	SENT89	42	42	13	13	etoposide	CKI	PA449552	1119	0.947
NULL	J_Gen_Physiol_2003_Jan_121(1)_3-16.nxml.txt.nlp	12508050	SENT17	9	9	28	28	nifedipine	RYR	PA450631	6261	0.947
NULL	Nat_Med_2011_Aug_28_17(9)_1094-1100.nxml.txt.nlp	21873989	SENT39	22	22	16	16	imatinib	IFN	PA10804	3439	0.947
NULL	Front_Genet_2014_Feb_26_5_40.nxml.txt.nlp	24616734	SENT316	35	35	11	11	docetaxel	CCL20	PA449383	6364	0.947
NULL	Oxid_Med_Cell_Longev_2013_Jun_2_2013_793525.nxml.txt.nlp	23819014	SENT142	28	28	32	32	resveratrol	ROS		6098	0.947
NULL	Cardiovasc_Diabetol_2013_Mar_28_12_53.nxml.txt.nlp	23537430	SENT63	21	21	5	5	metformin	DPP4	PA450395	1803	0.947
NULL	Oncol_Rep_2014_Sep_2_32(3)_887-892.nxml.txt.nlp	24994673	SENT107	22	22	2	2	leucovorin	DPD	PA450198	1806	0.947
NULL	Infect_Drug_Resist_2008_Sep_9_1_27-44.nxml.txt.nlp	21694878	SENT148	16	16	7	7	vancomycin	VISA	PA451850	57506	0.947
NULL	Emerg_Infect_Dis_2011_Mar_17(3)_495-497.nxml.txt.nlp	21392442	SENT17	11	11	1	1	rifampin	DST	PA451250	667	0.947
NULL	Indian_J_Pharm_Sci_2014_May-Jun_76(3)_203-210.nxml.txt.nlp	25035531	SENT165	3	3	15	15	pindolol	5-HT1A	PA450966	3350	0.947
NULL	Cell_Cycle_2013_Feb_15_12(4)_625-634.nxml.txt.nlp	23324396	SENT61	18	18	4	4	doxycycline	p53	PA449415	7157	0.947
NULL	Clin_Interv_Aging_2010_May_25_5_149-156.nxml.txt.nlp	20517484	SENT133	0	0	5	5	rasagiline	CYP1A2	PA164764584	1544	0.947
NULL	Oncotarget_2014_Mar_13_5(4)_1101-1110.nxml.txt.nlp	24658355	SENT34	13	13	2	2	tamoxifen	MKP-2	PA451581	1846	0.947
NULL	Sci_Rep_2014_Nov_28_4_7237.nxml.txt.nlp	25429875	SENT109	18	18	9	9	hesperidin	p38	PA449867	10598;1432;7965	0.947
NULL	J_Cancer_2013_Jan_11_4(2)_117-132.nxml.txt.nlp	23386910	SENT116	0	0	19	19	neratinib	HER2	PA165291472	2064	0.947
NULL	Oncogene_2014_Aug_21_33(34)_4316-4329.nxml.txt.nlp	24362530	SENT113	7	7	16	16	epirubicin	FOXM1	PA449476	2305	0.947
NULL	Br_J_Cancer_2011_Jul_26_105(3)_407-412.nxml.txt.nlp	21730976	SENT76	2	2	4	4	pha-665752	STAT3		6774	0.947
NULL	Exp_Anim_2014_Apr_26_63(2)_257-267.nxml.txt.nlp	24770651	SENT160	40	40	36	36	perindopril	ACE	PA450877	1636	0.947
NULL	Diabetes_Care_2010_Feb_33(2)_e20-e25.nxml.txt.nlp	20103551	SENT65	27	27	39	39	exenatide	GLP-1	PA164749238	100125288	0.947
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2010_Apr_1_66(Pt_4)_426-436.nxml.txt.nlp	20382996	SENT34	9	9	30	30	trypsin	X11	PA451806	320	0.947
NULL	Ann_Lab_Med_2012_Jul_20_32(4)_270-275.nxml.txt.nlp	22779068	SENT105	15	15	33	33	ceftazidime	FOX-1	PA448861	54715	0.947
NULL	Breast_Cancer_Res_2006_Nov_27_8(6)_R66.nxml.txt.nlp	17129383	SENT175	30	30	5	5	paclitaxel	p53	PA450761	7157	0.947
NULL	Curr_Cardiol_Rev_2008_Nov_4(4)_309-322.nxml.txt.nlp	20066139	SENT171	3	3	22	22	indomethacin	COX	PA449982	1351	0.947
NULL	J_Vet_Sci_2007_Dec_31_8(4)_341-351.nxml.txt.nlp	17993747	SENT157	6	6	20	20	echinacea	gamma	PA131550706	9913	0.947
NULL	J_Gen_Physiol_1997_Dec_1_110(6)_643-654.nxml.txt.nlp	9382893	SENT151	9	9	18	18	trypsin	SUR1	PA451806	6833	0.947
NULL	Exp_Diabetes_Res_2012_Oct_15_2012_465282.nxml.txt.nlp	23118742	SENT115	5	5	20	20	metformin	FGF21	PA450395	26291	0.947
NULL	J_Biomed_Sci_2012_Nov_21_19(1)_99.nxml.txt.nlp	23170833	SENT126	30	30	22	22	atorvastatin	STAT3	PA448500	6774	0.947
NULL	Breast_Cancer_Res_2003_Mar_27_5(3)_154-159.nxml.txt.nlp	12793897	SENT53	25	25	33	33	letrozole	aromatase	PA450196	1588	0.947
NULL	Oncol_Lett_2013_Feb_7_5(2)_440-446.nxml.txt.nlp	23420122	SENT122	18	18	8	8	sorafenib	Bcl-2	PA7000	596	0.947
NULL	N_Am_J_Med_Sci_2011_Jan_3(1)_1-12.nxml.txt.nlp	22540056	SENT187	35	35	11	11	gemcitabine	EGFR	PA449748	1956	0.947
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT126	19	19	23	23	dasatinib	LYN	PA162372878	4067	0.947
NULL	Biomed_Res_Int_2014_Feb_6_2014_323594.nxml.txt.nlp	24689036	SENT145	3	3	28	28	raloxifene	CO2	PA451221	4513	0.947
NULL	Clin_Pharmacol_2011_Jun_22_3_13-25.nxml.txt.nlp	22287853	SENT202	2	2	12	12	diltiazem	CYP3A4	PA449334	1576	0.947
NULL	J_Immunother_Cancer_2013_May_29_1_4.nxml.txt.nlp	NULL	SENT276	0	0	19	19	imatinib	IFN	PA10804	3439	0.947
NULL	Biosci_Rep_2013_Mar_7_33(2)_e00026.nxml.txt.nlp	23350699	SENT144	40	40	16	16	ethanol	Alix	PA448073	10015	0.947
NULL	Hum_Genomics_2013_Apr_5_7(1)_10.nxml.txt.nlp	23561625	SENT35	4	4	9	9	flavopiridol	CDK7	PA452627	1022	0.947
NULL	Breast_Cancer_Res_2012_Aug_13_14(4)_109.nxml.txt.nlp	22889086	SENT3	9	9	28	28	tamoxifen	aromatase	PA451581	1588	0.947
NULL	Int_J_Environ_Res_Public_Health_2011_Jul_21_8(7)_3019-3031.nxml.txt.nlp	21845171	SENT84	3	3	12	12	ethanol	adiponectin	PA448073	9370	0.947
NULL	Endocrinol_Diabetes_Metab_Case_Rep_2014_Mar_1_2014_140001.nxml.txt.nlp	24683487	SENT18	19	19	6	6	mitotane	ACTH	PA164746157	5443	0.947
NULL	Mol_Cancer_2008_Mar_26_7_27.nxml.txt.nlp	18366759	SENT160	24	24	13	13	etoposide	HIF-1	PA449552	29072	0.947
NULL	Cancer_2014_Dec_15_120(24)_3862-3865.nxml.txt.nlp	25155780	SENT16	26	26	13	13	cetuximab	EGFR	PA10040	1956	0.947
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT83	29	29	5	5	trastuzumab	EGF	PA451743	1950	0.947
NULL	Braz_J_Microbiol_2011_Dec_1_Oct-Dec_42(4)_1479-1484.nxml.txt.nlp	24031781	SENT50	6	6	17	17	lipase	mol	PA450239	90527	0.947
NULL	Curr_Cardiol_Rev_2014_May_10(2)_161-171.nxml.txt.nlp	24527681	SENT136	1	1	13	13	losartan	AGTR2	PA450268	186	0.947
NULL	Case_Rep_Psychiatry_2012_Nov_5_2012_427698.nxml.txt.nlp	23193494	SENT41	11	11	24	24	amantadine	B12	PA448360	7126;4709	0.947
NULL	Sci_Rep_2015_Jan_6_5_7641.nxml.txt.nlp	25560734	SENT27	25	25	13	13	tamoxifen	14-3-3	PA451581	10971	0.947
NULL	Breast_Cancer_Res_2008_Dec_18_10(Suppl_4)_S16.nxml.txt.nlp	19128429	SENT19	23	23	27	27	tamoxifen	aromatase	PA451581	1588	0.947
NULL	Curr_Neuropharmacol_2012_Mar_10(1)_72-79.nxml.txt.nlp	22942880	SENT85	10	10	30	30	dacarbazine	GSTP1	PA449197	2950	0.947
NULL	Curr_Oncol_2010_Feb_17(1)_81-86.nxml.txt.nlp	20179808	SENT57	47	47	43	43	tamoxifen	aromatase	PA451581	1588	0.947
NULL	Front_Endocrinol_(Lausanne)_2014_Aug_18_5_129.nxml.txt.nlp	25183960	SENT135	10	10	2	2	estradiol	GHSR	PA449503	2693	0.947
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT173	8	8	20	20	metformin	HIP	PA450395	6767;6159;64399;5068	0.947
NULL	Bone_Marrow_Transplant_2014_Feb_4_49(2)_201-205.nxml.txt.nlp	24185588	SENT29	21	21	10	10	plerixafor	CD34	PA165958410	947	0.947
NULL	Breast_Cancer_Res_Treat_2013_May_12_139(1)_107-113.nxml.txt.nlp	23580070	SENT25	10	10	28	28	tanespimycin	HER2	PA165291490	2064	0.947
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jan_11_68(Pt_2)_o340-o341.nxml.txt.nlp	22346970	SENT72	36	36	6	6	ethanol	mol	PA448073	90527	0.947
NULL	Arthritis_Res_Ther_2006_Nov_16_8(6)_R173.nxml.txt.nlp	17109745	SENT32	27	27	16	16	glucosamine	p65	PA164747613	5970	0.947
NULL	J_Mol_Signal_2011_May_16_6_4.nxml.txt.nlp	21575178	SENT134	26	26	15	15	forskolin	HSP27	PA146096022	3315	0.947
NULL	J_Hematol_Oncol_2013_Jun_3_6_38.nxml.txt.nlp	23731980	SENT122	29	29	5	5	trastuzumab	HER2	PA451743	2064	0.947
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1016.nxml.txt.nlp	24457960	SENT324	18	18	3	3	paclitaxel	PC-3	PA450761	692094	0.947
NULL	Scientifica_(Cairo)_2012_Oct_9_2012_821549.nxml.txt.nlp	24278743	SENT189	12	12	4	4	citalopram	5-HT1A	PA449015	3350	0.947
NULL	Oncotarget_2014_Feb_7_5(3)_775-787.nxml.txt.nlp	24519956	SENT151	5	5	2	2	dasatinib	PC3	PA162372878	57332;7832;5122	0.947
NULL	J_Cell_Mol_Med_2014_Sep_3_18(9)_1840-1850.nxml.txt.nlp	24894955	SENT245	25	25	3	3	ethanol	TFR1	PA448073	7037	0.947
NULL	J_Biol_Chem_2009_Sep_4_284(36)_24443-24452.nxml.txt.nlp	19561358	SENT34	14	14	4	4	mitomycin	FANCD2	PA450524	2177	0.947
NULL	Oncogene_2009_Apr_2_28(13)_1616-1625.nxml.txt.nlp	19219073	SENT124	29	29	8	8	nutlin-3	p53		7157	0.947
NULL	Onco_Targets_Ther_2014_Jul_12_7_1273-1284.nxml.txt.nlp	25050069	SENT36	0	0	31	31	trabectedin	CYP3A4	PA165958349	1576	0.947
NULL	Breast_Cancer_Res_2005_Jan_17_7(2)_R248-R255.nxml.txt.nlp	15743505	SENT202	4	4	0	0	fluorescein	ZO-1	PA164746009	7082	0.947
NULL	Oxid_Med_Cell_Longev_2013_Nov_12_2013_820679.nxml.txt.nlp	24327827	SENT17	5	5	19	19	resveratrol	AMPK		5563	0.947
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT173	24	24	5	5	bevacizumab	PlGF-2	PA130232992	5228	0.947
NULL	J_Oncol_2009_May_6_2009_567486.nxml.txt.nlp	19424511	SENT115	18	18	3	3	panitumumab	EGFR	PA162373091	1956	0.947
NULL	Breast_Cancer_Res_2013_Nov_29_15(6)_R114.nxml.txt.nlp	24289103	SENT212	4	4	15	15	ethanol	EGF	PA448073	1950	0.947
NULL	Diabetes_Care_2012_Feb_16_35(2)_327-333.nxml.txt.nlp	22179958	SENT80	18	18	5	5	metformin	B12	PA450395	7126;4709	0.947
NULL	Cardiovasc_Psychiatry_Neurol_2010_Jun_10_2010_480707.nxml.txt.nlp	20631894	SENT150	19	19	3	3	risperidone	S100B	PA451257	6285	0.947
NULL	Cardiovasc_Ther_2009_27(4)_259-274.nxml.txt.nlp	19604248	SENT26	0	0	10	10	ticagrelor	P2Y12	PA165374673	64805	0.947
NULL	Diabetes_2013_Jul_14_62(7)_2595-2604.nxml.txt.nlp	23524641	SENT143	23	23	37	37	exenatide	GLP-1	PA164749238	100125288	0.947
NULL	Biomed_Res_Int_2013_Nov_6_2013_798164.nxml.txt.nlp	24308005	SENT5	15	15	31	31	tacrolimus	CXCR5	PA451578	643	0.947
NULL	Mol_Cancer_2010_Apr_15_9_77.nxml.txt.nlp	20398291	SENT47	26	26	24	24	geldanamycin	Hsp90	PA152031327	3320	0.947
NULL	Mol_Breed_2012_Oct_8_30(3)_1237-1252.nxml.txt.nlp	23024595	SENT143	38	38	7	7	acetone	ANOVA	PA448025	4858	0.947
NULL	Jpn_Clin_Med_2014_Sep_17_5_33-41.nxml.txt.nlp	25288908	SENT56	0	0	25	25	glimepiride	GLP-1	PA449761	100125288	0.947
NULL	Nat_Commun_2010_Jun_1_1(3)_1-9.nxml.txt.nlp	20975695	SENT410	0	0	14	14	tamoxifen	E12	PA451581	64100	0.947
NULL	Breast_Cancer_Res_2004_Oct_24_6(1)_R8-R17.nxml.txt.nlp	14680495	SENT154	23	23	42	42	mitomycin	BRCA1	PA450524	672	0.947
NULL	J_Mol_Med_(Berl)_2014_Feb_20_92(3)_217-225.nxml.txt.nlp	24553779	SENT91	9	9	3	3	fasudil	MRCK	PA165946121	8476	0.947
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT93	9	9	38	38	metformin	HIP	PA450395	6767;6159;64399;5068	0.947
NULL	Mol_Cancer_2010_May_21_9_116.nxml.txt.nlp	20492666	SENT198	14	14	2	2	bortezomib	RNF	PA10252	11074	0.947
NULL	Oncol_Rep_2014_Apr_28_31(4)_1605-1612.nxml.txt.nlp	24481648	SENT95	32	32	13	13	vinblastine	MRP7	PA451877	89845;1080	0.947
NULL	Mol_Brain_2014_Apr_21_7_28.nxml.txt.nlp	24751148	SENT116	14	14	5	5	minocycline	NeuN	PA450519	146713	0.947
NULL	Br_J_Cancer_2003_Mar_24_88(6)_879-886.nxml.txt.nlp	12644825	SENT219	9	9	17	17	cisplatin	MRP1	PA449014	4437	0.947
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Apr_17_6_43-57.nxml.txt.nlp	24833916	SENT96	17	17	23	23	exemestane	aromatase	PA449563	1588	0.947
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_7-17.nxml.txt.nlp	17912633	SENT368	39	39	37	37	letrozole	aromatase	PA450196	1588	0.947
NULL	Cell_Death_Dis_2014_Feb_27_5(2)_e1088.nxml.txt.nlp	24577086	SENT14	19	19	3	3	metformin	Bcl-2	PA450395	596	0.947
NULL	Patient_Prefer_Adherence_2011_Jul_19_5_343-356.nxml.txt.nlp	21845034	SENT193	26	26	14	14	duloxetine	CYP2D6	PA10066	1565	0.947
NULL	Front_Oncol_2014_Oct_21_4_285.nxml.txt.nlp	25374842	SENT677	2	2	0	0	nutlin-3	MDM2		4193	0.947
NULL	Mol_Cancer_2006_Oct_17_5_45.nxml.txt.nlp	17044934	SENT126	36	36	23	23	resveratrol	COX		1351	0.947
NULL	Eur_J_Clin_Microbiol_Infect_Dis_2014_Feb_23_33(6)_879-910.nxml.txt.nlp	24563274	SENT161	25	25	20	20	cefotaxime	19A	PA448852	57823	0.947
NULL	Oncogene_2010_Sep_16_29(37)_5135-5145.nxml.txt.nlp	20622897	SENT103	11	11	7	7	cetuximab	HIF-1	PA10040	29072	0.947
NULL	Mol_Cancer_2009_Feb_28_8_11.nxml.txt.nlp	19250552	SENT120	32	32	15	15	hydroxyurea	RRM2	PA449942	6241	0.947
NULL	Int_J_Mol_Sci_2014_Mar_12_15(3)_4356-4392.nxml.txt.nlp	24625663	SENT278	43	43	20	20	staurosporine	BAX	PA165109623	581	0.947
NULL	Int_J_Endocrinol_Metab_2013_Dec_21_Winter_11(1)_57-61.nxml.txt.nlp	23853622	SENT122	1	1	7	7	bromocriptine	PRL	PA448671	5617	0.947
NULL	Ther_Clin_Risk_Manag_2005_Dec_1(4)_299-306.nxml.txt.nlp	18360572	SENT84	1	1	30	30	terbinafine	CYP2C19	PA451614	1557	0.947
NULL	EMBO_Mol_Med_2011_Jul_3(7)_410-427.nxml.txt.nlp	21567994	SENT178	34	34	5	5	probucol	SOD2	PA451107	6648	0.947
NULL	Br_J_Cancer_2009_Jan_13_100(1)_145-152.nxml.txt.nlp	19050706	SENT15	26	26	4	4	gefitinib	EGFR	PA131301952	1956	0.947
NULL	J_Cell_Biol_2000_Jul_10_150(1)_213-224.nxml.txt.nlp	10893269	SENT222	26	26	15	15	neomycin	AP-1	PA450608	2353;3727;2354;3725	0.947
NULL	Cancer_Manag_Res_2013_Jun_7_5_91-101.nxml.txt.nlp	23785245	SENT45	11	11	5	5	gefitinib	EGFR	PA131301952	1956	0.947
NULL	Clin_Med_Insights_Oncol_2011_Sep_21_5_265-314.nxml.txt.nlp	22084619	SENT590	20	20	3	3	sugar	NKR-P1	PA451529	3820	0.947
NULL	Front_Comput_Neurosci_2013_Oct_16_7_134.nxml.txt.nlp	24137127	SENT296	8	8	2	2	mefloquine	gamma	PA450348	9913	0.947
NULL	Genome_Biol_2003_Aug_29_4(9)_117.nxml.txt.nlp	12952525	SENT46	32	32	23	23	trypsin	ICAT	PA451806	56998	0.947
NULL	Scientifica_(Cairo)_2012_Oct_14_2012_428139.nxml.txt.nlp	24278693	SENT50	14	14	2	2	amiodarone	OATP2B1	PA448383	11309	0.947
NULL	Breast_Cancer_Res_2011_Sep_13_13(5)_R87.nxml.txt.nlp	21914172	SENT168	14	14	8	8	lapatinib	EGFR	PA152241907	1956	0.947
NULL	Multidiscip_Respir_Med_2013_Oct_5_8(1)_65.nxml.txt.nlp	24094028	SENT171	20	20	6	6	tipifarnib	CD34	PA165110778	947	0.947
NULL	Evid_Based_Complement_Alternat_Med_2014_May_18_2014_156276.nxml.txt.nlp	24963318	SENT10	4	4	17	17	hesperidin	SOD1	PA449867	6647	0.947
NULL	Indian_J_Med_Res_2012_Dec_136(6)_907-925.nxml.txt.nlp	23391787	SENT509	6	6	14	14	chloroquine	ACT	PA448948	12;11332;9457;641455	0.947
NULL	EMBO_Mol_Med_2013_Mar_12_5(3)_441-455.nxml.txt.nlp	23401241	SENT37	16	16	5	5	streptozocin	TIMP3	PA451514	7078	0.947
NULL	Br_J_Cancer_2012_Jan_3_106(1)_18-24.nxml.txt.nlp	22108516	SENT97	15	15	7	7	irinotecan	TDP1	PA450085	55775	0.947
NULL	J_Korean_Med_Sci_2009_Jun_12_24(3)_448-452.nxml.txt.nlp	19543508	SENT89	28	28	24	24	erlotinib	EGFR	PA134687924	1956	0.947
NULL	Clin_Sci_(Lond)_2009_Nov_16_118(Pt_4)_269-279.nxml.txt.nlp	19698082	SENT207	3	3	15	15	ramipril	ACE2	PA451223	59272	0.947
NULL	Environ_Health_Perspect_2005_Jun_24_113(6)_675-679.nxml.txt.nlp	15929888	SENT132	5	5	29	29	estradiol	CA1	PA449503	759	0.947
NULL	Breast_Cancer_Res_2008_Dec_5_10(6)_R104.nxml.txt.nlp	19061505	SENT225	33	33	5	5	estradiol	p54	PA449503	9295	0.947
NULL	Breast_Cancer_Res_2011_Nov_1_13(6)_224.nxml.txt.nlp	22114931	SENT127	35	35	18	18	trastuzumab	PIK3CA	PA451743	5290	0.947
NULL	Front_Neurosci_2014_Jun_3_8_128.nxml.txt.nlp	24917782	SENT166	42	42	16	16	ethanol	POMC	PA448073	5443	0.947
NULL	Drug_Target_Insights_2013_Aug_19_7_27-34.nxml.txt.nlp	24023511	SENT143	30	30	44	44	tariquidar	P-gp		5243	0.947
NULL	Adv_Ther_2014_Feb_15_31(3)_289-317.nxml.txt.nlp	24535623	SENT355	13	13	24	24	metformin	Met	PA450395	79811	0.947
NULL	Oncotarget_2010_Oct_25_1(7)_497-514.nxml.txt.nlp	21165163	SENT98	22	22	13	13	flavopiridol	EGFR	PA452627	1956	0.947
NULL	Br_J_Cancer_2011_Dec_6_105(12)_1850-1855.nxml.txt.nlp	22095231	SENT36	14	14	21	21	erlotinib	EGFR	PA134687924	1956	0.947
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT31	5	5	15	15	atorvastatin	survivin	PA448500	332	0.947
NULL	FASEB_J_2011_Apr_25(4)_1133-1144.nxml.txt.nlp	21163859	SENT343	7	7	5	5	desipramine	ASM	PA449233	6609;283120	0.947
NULL	Mol_Cell_Biochem_2015_Oct_8_398(1-2)_165-173.nxml.txt.nlp	25292312	SENT113	13	13	5	5	bortezomib	HIF-1	PA10252	29072	0.947
NULL	Arthritis_Res_Ther_2013_Apr_4_15(Suppl_1)_S4.nxml.txt.nlp	23566679	SENT120	14	14	19	19	rituximab	CD27	PA451261	939	0.947
NULL	Clin_Psychopharmacol_Neurosci_2012_Dec_20_10(3)_168-179.nxml.txt.nlp	23430396	SENT157	4	4	14	14	iptakalim	IPT	PA165949694	54802	0.947
NULL	Open_Biochem_J_2011_Sep_23_5_45-51.nxml.txt.nlp	21966325	SENT8	0	0	14	14	diclofenac	PERK	PA449293	9451	0.946
NULL	Cancer_Cell_Int_2009_Sep_10_9_25.nxml.txt.nlp	19744341	SENT195	23	23	2	2	glucosamine	STAT3	PA164747613	6774	0.946
NULL	Breast_Cancer_Res_Treat_2012_Jun_3_133(3)_865-880.nxml.txt.nlp	22048815	SENT165	14	14	3	3	carboplatin	RAD17	PA448803	5884	0.946
NULL	J_Hematol_Oncol_2009_Aug_12_2_36.nxml.txt.nlp	19674465	SENT112	0	0	21	21	thalidomide	IL-6	PA451644	3569	0.946
NULL	ARYA_Atheroscler_2011_Summer_7(2)_78-86.nxml.txt.nlp	22577451	SENT11	10	10	36	36	betaine	CRP	PA448603	1401;140913	0.946
NULL	Mol_Syst_Biol_2010_Oct_19_6_420.nxml.txt.nlp	20959818	SENT94	48	48	7	7	galactose	GAL4	PA449725	3960	0.946
NULL	Mol_Cancer_2008_Mar_26_7_27.nxml.txt.nlp	18366759	SENT145	26	26	5	5	etoposide	AP-1	PA449552	2353;3727;2354;3725	0.946
NULL	Oncogene_2010_Mar_11_29(10)_1509-1518.nxml.txt.nlp	19946334	SENT112	12	12	22	22	bortezomib	pS2	PA10252	7031	0.946
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_May_31_68(Pt_6)_o1953.nxml.txt.nlp	22719702	SENT69	14	14	4	4	ethanol	mol	PA448073	90527	0.946
NULL	Curr_Pharm_Biotechnol_2012_May_13(6)_969-986.nxml.txt.nlp	22039792	SENT83	18	18	21	21	vincristine	MDR1	PA451879	5243	0.946
NULL	Cardiovasc_Diabetol_2013_Nov_12_12_169.nxml.txt.nlp	24215514	SENT307	41	41	13	13	valsartan	AT2	PA451848	186	0.946
NULL	Front_Oncol_2014_May_16_4_107.nxml.txt.nlp	24904823	SENT210	2	2	5	5	metformin	AMPK	PA450395	5563	0.946
NULL	Front_Oncol_2013_Apr_23_3_86.nxml.txt.nlp	23630663	SENT169	18	18	28	28	lapatinib	ERBB2	PA152241907	2064	0.946
NULL	J_Oncol_2013_Aug_20_2013_732047.nxml.txt.nlp	24027583	SENT190	15	15	6	6	pertuzumab	HER2		2064	0.946
NULL	J_Am_Heart_Assoc_2013_Dec_19_2(6)_e000355.nxml.txt.nlp	24190878	SENT27	15	15	2	2	isoproterenol	HK2	PA450121	3796;3099;29911;3741	0.946
NULL	Diabetes_Care_2010_Mar_33(3)_692a.nxml.txt.nlp	NULL	SENT2	13	13	24	24	metformin	Met	PA450395	79811	0.946
NULL	FEBS_Open_Bio_2013_Jun_27_3_291-301.nxml.txt.nlp	23905012	SENT324	37	37	6	6	genistein	p27	PA165109660	5715;10534	0.946
NULL	Lab_Invest_2010_Dec_9_90(12)_1794-1804.nxml.txt.nlp	20697377	SENT47	19	19	1	1	choline	MCD	PA448976	23417;4169;4582	0.946
NULL	Indian_J_Sex_Transm_Dis_2013_Jul-Dec_34(2)_126-128.nxml.txt.nlp	24339465	SENT17	21	21	3	3	lamivudine	CD4	PA450163	920	0.946
NULL	Hum_Genomics_2009_Jan_1_3(2)_128-142.nxml.txt.nlp	19164090	SENT256	18	18	8	8	carboplatin	CD44	PA448803	960	0.946
NULL	J_Hematol_Oncol_2010_Mar_13_3_10.nxml.txt.nlp	20226083	SENT31	5	5	21	21	gemcitabine	BRCA1	PA449748	672	0.946
NULL	J_Biol_Chem_2013_Aug_23_288(34)_24799-24808.nxml.txt.nlp	23836892	SENT72	16	16	13	13	trypsin	PSST	PA451806	374291	0.946
NULL	Cancers_(Basel)_2011_Oct_26_3(4)_4024-4045.nxml.txt.nlp	24213123	SENT115	14	14	25	25	curcumin	mol	PA151958596	90527	0.946
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Dec_17_3(12)_e152.nxml.txt.nlp	25518025	SENT72	16	16	18	18	paroxetine	CYP3A	PA450801	1574	0.946
NULL	Cardiol_Res_Pract_2013_Feb_21_2013_127270.nxml.txt.nlp	23509665	SENT33	0	0	10	10	clopidogrel	P2Y12	PA449053	64805	0.946
NULL	Arthritis_Res_2002_Mar_19_4(4)_266-273.nxml.txt.nlp	12106498	SENT119	15	15	43	43	methotrexate	IL-10	PA450428	3586	0.946
NULL	Hum_Genomics_2009_Dec_1_4(2)_91-106.nxml.txt.nlp	20038497	SENT120	18	18	7	7	rivastigmine	BCHE	PA451262	590	0.946
NULL	J_Clin_Biochem_Nutr_2009_Jan_27_44(1)_79-84.nxml.txt.nlp	19177192	SENT5	2	2	31	31	curcumin	HO-1	PA151958596	3162	0.946
NULL	Curr_Chem_Genomics_2010_Mar_1_4_1-8.nxml.txt.nlp	20448812	SENT63	16	16	20	20	fluorescein	OATP1B3	PA164746009	28234	0.946
NULL	Breast_Cancer_Res_2004_Oct_6_6(6)_269-274.nxml.txt.nlp	15535858	SENT106	8	8	29	29	tamoxifen	HER2	PA451581	2064	0.946
NULL	Front_Immunol_2012_Mar_30_3_63.nxml.txt.nlp	22566944	SENT132	30	30	6	6	primaquine	Hsp90	PA451103	3320	0.946
NULL	Aging_(Albany_NY)_2009_Mar_31_1(4)_412-424.nxml.txt.nlp	20195491	SENT162	9	9	41	41	resveratrol	AMPK		5563	0.946
NULL	Oncotarget_2013_Jan_14_4(1)_118-127.nxml.txt.nlp	23435217	SENT131	13	13	6	6	erlotinib	PIK3CA	PA134687924	5290	0.946
NULL	Oncotarget_2013_Nov_24_4(12)_2430-2438.nxml.txt.nlp	24280348	SENT27	5	5	21	21	gefitinib	STAT3	PA131301952	6774	0.946
NULL	Int_J_Endocrinol_Metab_2013_Jul_1_Summer_11(3)_195-198.nxml.txt.nlp	24348593	SENT78	31	31	38	38	temozolomide	ACTH	PA451609	5443	0.946
NULL	Cancer_Cell_Int_2011_Nov_2_11_39.nxml.txt.nlp	22047021	SENT149	19	19	11	11	cisplatin	REV3	PA449014	5980	0.946
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_24_2012_673132.nxml.txt.nlp	23133498	SENT121	10	10	27	27	berberine	P-gp	PA165860812	5243	0.946
NULL	Case_Rep_Oncol_2014_May_24_7(2)_343-348.nxml.txt.nlp	24987354	SENT5	14	14	4	4	vemurafenib	BRAF	PA165946873	673	0.946
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1224-1233.nxml.txt.nlp	22353810	SENT13	6	6	24	24	doxorubicin	MRP-1	PA449412	928	0.946
NULL	Int_J_Endocrinol_Metab_2013_Jul_1_Summer_11(3)_184-190.nxml.txt.nlp	24348591	SENT157	18	18	5	5	liraglutide	LC3	PA165958364	84557	0.946
NULL	Int_J_Med_Sci_2014_Jul_29_11(10)_1015-1021.nxml.txt.nlp	25136257	SENT84	9	9	1	1	rosiglitazone	ANOVA	PA451283	4858	0.946
NULL	J_Mol_Med_(Berl)_2014_May_10_92(7)_709-722.nxml.txt.nlp	24811491	SENT247	11	11	3	3	cetuximab	BRAF	PA10040	673	0.946
NULL	Front_Immunol_2013_Nov_7_4_360.nxml.txt.nlp	24223576	SENT300	7	7	17	17	imiquimod	IRF5	PA449972	3663	0.946
NULL	Case_Rep_Oncol_2014_May_24_7(2)_343-348.nxml.txt.nlp	24987354	SENT74	5	5	33	33	vemurafenib	BRAF	PA165946873	673	0.946
NULL	Diabetes_2008_Sep_57(9)_2272-2279.nxml.txt.nlp	18519799	SENT205	0	0	32	32	rosiglitazone	PEPCK-C	PA451283	5105	0.946
NULL	EMBO_Mol_Med_2012_Jun_13_4(6)_515-527.nxml.txt.nlp	22416035	SENT227	19	19	28	28	olaparib	p53		7157	0.946
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Sep_25_66(Pt_10)_o2620.nxml.txt.nlp	21587594	SENT62	11	11	3	3	ethanol	mol	PA448073	90527	0.946
NULL	Basic_Clin_Neurosci_2014_Winter_5(1)_66-73.nxml.txt.nlp	25436086	SENT12	0	0	6	6	lidocaine	LHA	PA450226	1081	0.946
NULL	EMBO_Mol_Med_2012_Oct_2_4(10)_1043-1056.nxml.txt.nlp	23027611	SENT7	9	9	30	30	phencyclidine	5-HT6	PA128406980	3362	0.946
NULL	Eukaryot_Cell_2014_Aug_13(8)_1077-1084.nxml.txt.nlp	24951438	SENT184	13	13	3	3	doxycycline	RSP5	PA449415	23327	0.946
NULL	J_Obes_2011_Dec_15_2011_928165.nxml.txt.nlp	21197151	SENT195	2	2	10	10	exenatide	GLP-1	PA164749238	100125288	0.946
NULL	Blood_Cancer_J_2013_Sep_13_3(9)_e146.nxml.txt.nlp	24036945	SENT12	11	11	31	31	ribavirin	PI3K	PA451241	5290	0.946
NULL	J_Headache_Pain_2009_Apr_27_10(2)_105-110.nxml.txt.nlp	19172228	SENT137	6	6	9	9	sumatriptan	NK1	PA451566	11126	0.946
NULL	Pharmaceutics_2012_Jan_31_4(1)_104-129.nxml.txt.nlp	24300183	SENT309	16	16	4	4	lidocaine	SMO	PA450226	6608;54498	0.946
NULL	J_Exp_Clin_Cancer_Res_2009_Nov_24_28(1)_144.nxml.txt.nlp	19930704	SENT121	45	45	3	3	carboplatin	P-gp	PA448803	5243	0.946
NULL	Ann_Rehabil_Med_2012_Dec_28_36(6)_857-860.nxml.txt.nlp	23342320	SENT14	7	7	19	19	warfarin	CYP2C9	PA451906	1559	0.946
NULL	Pharmaceutics_2011_Aug_24_3(3)_510-524.nxml.txt.nlp	24310594	SENT4	5	5	16	16	trastuzumab	HER-2	PA451743	2064	0.946
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1149.nxml.txt.nlp	24675467	SENT122	11	11	19	19	trastuzumab	LC3	PA451743	84557	0.946
NULL	Drug_Target_Insights_2007_Jul_20_2_159-182.nxml.txt.nlp	21901072	SENT266	0	0	18	18	efavirenz	p66	PA449441	6464	0.946
NULL	Biosci_Rep_2014_Dec_12_34(6)_e00162.nxml.txt.nlp	25385088	SENT110	19	19	12	12	trypsin	XPA	PA451806	7507	0.946
NULL	Nat_Chem_Biol_2010_Apr_28_6(4)_291-299.nxml.txt.nlp	20190765	SENT111	23	23	13	13	dasatinib	LYN	PA162372878	4067	0.946
NULL	Nucleic_Acids_Res_2012_Jul_19_40(13)_5910-5925.nxml.txt.nlp	22434882	SENT344	4	4	11	11	etoposide	p53	PA449552	7157	0.946
NULL	Br_J_Pharmacol_2010_Sep_161(2)_241-270.nxml.txt.nlp	20735414	SENT275	24	24	0	0	cisplatin	ATX	PA449014	5168;23049	0.946
NULL	Indian_J_Med_Res_2012_Dec_136(6)_907-925.nxml.txt.nlp	23391787	SENT154	8	8	3	3	artemisinin	ACT	PA165111696	12;11332;9457;641455	0.946
NULL	Nucleic_Acids_Res_2011_Oct_30_39(18)_7908-7919.nxml.txt.nlp	21724609	SENT396	12	12	8	8	flavopiridol	CDK9	PA452627	1025	0.946
NULL	Oncotarget_2012_Nov_17_3(12)_1600-1614.nxml.txt.nlp	23307622	SENT147	12	12	1	1	gefitinib	EGFR	PA131301952	1956	0.946
NULL	Acta_Pharmacol_Sin_2014_Jun_4_35(6)_752-757.nxml.txt.nlp	24902786	SENT94	16	16	8	8	tamoxifen	STZ	PA451581	6484	0.946
NULL	Brain_2013_May_4_136(5)_1462-1475.nxml.txt.nlp	23460667	SENT277	22	22	11	11	bevacizumab	CD44	PA130232992	960	0.946
NULL	J_Vis_Exp_2010_Sep_11_(43)_2209.nxml.txt.nlp	22157975	SENT18	14	14	8	8	heparin	FGF2	PA449855	2247;2258	0.946
NULL	Ann_Hematol_2010_Nov_25_89(11)_1115-1124.nxml.txt.nlp	20499237	SENT162	21	21	16	16	simvastatin	CD19	PA451363	930	0.946
NULL	Front_Neurol_2011_Feb_14_1_160.nxml.txt.nlp	21359195	SENT53	16	16	10	10	warfarin	ICAD	PA451906	1676	0.946
NULL	Mol_Cancer_2010_Apr_23_9_87.nxml.txt.nlp	20416058	SENT198	0	0	12	12	doxorubicin	DR5	PA449412	8795	0.946
NULL	Oncotarget_2014_Mar_16_5(12)_4087-4102.nxml.txt.nlp	24961479	SENT188	6	6	23	23	hemin	HO-1	PA449849	3162	0.946
NULL	Int_J_Mol_Sci_2012_Feb_1_13(2)_1512-1523.nxml.txt.nlp	22408405	SENT142	10	10	7	7	olmesartan	LOX-1	PA164742950	4973	0.946
NULL	Breast_Cancer_(Auckl)_2012_Feb_20_6_47-66.nxml.txt.nlp	22399860	SENT172	4	4	18	18	tamoxifen	CLLP	PA451581	8727	0.946
NULL	Mol_Cancer_2009_Apr_16_8_24.nxml.txt.nlp	19371427	SENT43	27	27	21	21	cisplatin	CHK1	PA449014	1111	0.946
NULL	Oncogene_2010_Sep_16_29(37)_5193-5203.nxml.txt.nlp	20581867	SENT171	28	28	24	24	lapatinib	HER2	PA152241907	2064	0.946
NULL	Curr_Med_Chem_2012_Aug_19(22)_3763-3778.nxml.txt.nlp	22680930	SENT8	0	0	6	6	zileuton	5-LOX	PA451955	240	0.946
NULL	Curr_Neurol_Neurosci_Rep_2013_May_26_13(5)_347.nxml.txt.nlp	23529375	SENT65	26	26	33	33	bevacizumab	VEGF-A	PA130232992	7422	0.946
NULL	Clin_Interv_Aging_2015_Jan_6_10_157-174.nxml.txt.nlp	25609933	SENT160	37	37	42	42	exemestane	aromatase	PA449563	1588	0.946
NULL	Mol_Cancer_2013_Nov_11_12_134.nxml.txt.nlp	24215614	SENT303	38	38	7	7	trastuzumab	PI3K	PA451743	5290	0.946
NULL	Br_J_Cancer_2009_Jul_21_101(2)_350-356.nxml.txt.nlp	19513075	SENT109	30	30	16	16	fluorouracil	TP53	PA128406956	7157	0.946
NULL	Front_Neural_Circuits_2015_Jan_12_8_150.nxml.txt.nlp	25628540	SENT290	3	3	16	16	atropine	CA1	PA448505	759	0.946
NULL	Environ_Sci_Technol_2013_Oct_15_47(20)_11384-11395.nxml.txt.nlp	24006913	SENT470	5	5	3	3	letrozole	aromatase	PA450196	1588	0.946
NULL	Breast_Cancer_Res_2011_Jun_29_13(3)_R70.nxml.txt.nlp	21707964	SENT173	22	22	0	0	tamoxifen	14-3-3	PA451581	10971	0.946
NULL	Hum_Mol_Genet_2013_Nov_15_22(22)_4616-4626.nxml.txt.nlp	23814041	SENT147	18	18	12	12	doxycycline	neuroserpin	PA449415	5274	0.946
NULL	Cell_Death_Dis_2014_Apr_24_5(4)_e1197.nxml.txt.nlp	24763054	SENT178	7	7	18	18	cisplatin	RUNX3	PA449014	864	0.946
NULL	J_Cell_Mol_Med_2014_Apr_20_18(4)_709-720.nxml.txt.nlp	24444314	SENT135	4	4	8	8	losartan	AMPK	PA450268	5563	0.946
NULL	EPMA_J_2013_Jan_28_4(1)_3.nxml.txt.nlp	23356214	SENT327	26	26	11	11	cetuximab	PTEN	PA10040	5728	0.946
NULL	Ann_Rehabil_Med_2012_Aug_27_36(4)_561-564.nxml.txt.nlp	22977784	SENT48	13	13	17	17	levetiracetam	LAS	PA450206	11019	0.946
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT87	5	5	29	29	curcumin	DR5	PA151958596	8795	0.946
NULL	Front_Neurosci_2012_May_30_6_77.nxml.txt.nlp	22661925	SENT258	0	0	29	29	rolipram	DCX	PA153906323	1641	0.946
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2013_Sep_1_6_25-37.nxml.txt.nlp	24031162	SENT179	3	3	24	24	metformin	GLP-1	PA450395	100125288	0.946
NULL	J_Mol_Signal_2008_May_2_3_10.nxml.txt.nlp	18452624	SENT334	37	37	10	10	hydrocortisone	EGF	PA449905	1950	0.946
NULL	Cancer_Biol_Med_2012_Mar_9(1)_18-22.nxml.txt.nlp	23691449	SENT172	15	15	7	7	gefitinib	PIK3CA	PA131301952	5290	0.946
NULL	Crit_Care_2004_Oct_27_8(6)_R474-R482.nxml.txt.nlp	15566594	SENT152	34	34	32	32	diclofenac	COX	PA449293	1351	0.946
NULL	Diagn_Pathol_2014_Feb_26_9_42.nxml.txt.nlp	24571686	SENT30	31	31	3	3	finasteride	AKR1C3	PA449627	8644	0.946
NULL	Surg_Endosc_2013_Jun_18_27(6)_2094-2101.nxml.txt.nlp	23247745	SENT139	5	5	9	9	atorvastatin	CYP3A	PA448500	1574	0.946
NULL	Breast_Cancer_Res_2010_Jun_28_12(3)_R43.nxml.txt.nlp	20579400	SENT27	24	24	6	6	doxorubicin	MAPT	PA449412	4137	0.946
NULL	Clin_Epigenetics_2010_Nov_9_1(3-4)_117-136.nxml.txt.nlp	21258646	SENT197	20	20	6	6	vorinostat	STAT1	PA164748224	6772	0.946
NULL	Acta_Pharmacol_Sin_2009_Sep_24_30(9)_1262-1275.nxml.txt.nlp	19701231	SENT229	24	24	6	6	lovastatin	CCNB2	PA450272	9133	0.946
NULL	Cancer_Manag_Res_2013_Nov_21_5_387-400.nxml.txt.nlp	24294007	SENT192	14	14	4	4	irinotecan	DPD	PA450085	1806	0.946
NULL	Int_J_Biomed_Sci_2008_Dec_4(4)_260-265.nxml.txt.nlp	19568323	SENT81	27	27	11	11	forskolin	BRCA1	PA146096022	672	0.946
NULL	Br_J_Cancer_2000_Jun_82(11)_1851-1859.nxml.txt.nlp	10839301	SENT8	24	24	13	13	topotecan	CD95	PA451729	355	0.946
NULL	J_Gen_Physiol_2009_Jun_133(6)_623-625.nxml.txt.nlp	19468076	SENT23	3	3	9	9	menthol	TRPA1	PA164776605	8989	0.946
NULL	Cell_Cycle_2013_Feb_1_12(3)_409-416.nxml.txt.nlp	23324337	SENT153	24	24	17	17	doxycycline	p63	PA449415	8626	0.946
NULL	Exp_Ther_Med_2015_Feb_16_9(2)_289-293.nxml.txt.nlp	25574188	SENT43	12	12	6	6	cyclosporine	ABCB1	PA449167	5243	0.946
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT96	7	7	21	21	celecoxib	IL-6	PA448871	3569	0.946
NULL	Biol_Proced_Online_2003_Feb_17_5_1-12.nxml.txt.nlp	12734561	SENT221	11	11	4	4	ethanol	CYP2E1	PA448073	1571	0.946
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT486	15	15	1	1	clotrimazole	CAR	PA449057	1525;6687;9970	0.946
NULL	J_Biol_Chem_2013_Dec_6_288(49)_35387-35395.nxml.txt.nlp	24142790	SENT248	7	7	9	9	meclizine	PCYT2	PA450338	5833	0.946
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_7-17.nxml.txt.nlp	17912633	SENT300	38	38	36	36	aminoglutethimide	aromatase	PA448375	1588	0.946
NULL	Indian_J_Endocrinol_Metab_2013_Oct_17(Suppl1)_S259-S261.nxml.txt.nlp	24251180	SENT54	27	27	17	17	letrozole	CDP	PA450196	1523	0.946
NULL	EPMA_J_2012_Sep_27_3(1)_10.nxml.txt.nlp	23016735	SENT142	13	13	3	3	warfarin	CYP4F2	PA451906	8529	0.946
NULL	Breast_Cancer_Res_2010_Nov_16_12(6)_R96.nxml.txt.nlp	21080941	SENT236	8	8	16	16	lapatinib	HER2	PA152241907	2064	0.946
NULL	EMBO_Mol_Med_2012_Feb_4(2)_93-108.nxml.txt.nlp	22246988	SENT56	13	13	16	16	tetracycline	NDRG1	PA451640	10397	0.946
NULL	J_Biol_Chem_2008_May_30_283(22)_15440-15450.nxml.txt.nlp	18385140	SENT257	9	9	4	4	trypsin	NDUFB6	PA451806	4712	0.946
NULL	Chin_J_Cancer_2013_Apr_32(4)_213-223.nxml.txt.nlp	22776235	SENT129	16	16	26	26	imatinib	CD10	PA10804	4311	0.946
NULL	Arthritis_Res_Ther_2006_Jul_3_8(4)_216.nxml.txt.nlp	16879719	SENT105	33	33	9	9	cyclosporine	ACR	PA449167	49	0.946
NULL	Case_Rep_Oncol_2014_Jun_18_7(2)_393-400.nxml.txt.nlp	25076890	SENT115	18	18	14	14	erlotinib	EGFR	PA134687924	1956	0.946
NULL	Nat_Med_2010_Nov_24_16(11)_1299-1304.nxml.txt.nlp	20972434	SENT52	13	13	32	32	indomethacin	ASM	PA449982	6609;283120	0.946
NULL	Breast_Cancer_Res_2011_Apr_14_13(2)_R43.nxml.txt.nlp	21492444	SENT152	6	6	31	31	tamoxifen	SRC-3	PA451581	8202	0.946
NULL	Nucleic_Acids_Res_2012_Jan_9_40(1)_181-195.nxml.txt.nlp	21908405	SENT258	11	11	4	4	bleomycin	53BP1	PA448645	7158	0.946
NULL	Int_J_Vasc_Med_2012_Oct_22_2012_641917.nxml.txt.nlp	23133757	SENT117	10	10	1	1	thrombin	VIII	PA451674	1351	0.946
NULL	Nat_Med_2011_Dec_4_18(1)_111-119.nxml.txt.nlp	22138751	SENT134	28	28	8	8	doxycycline	WT1	PA449415	7490	0.946
NULL	Br_J_Cancer_2010_Sep_28_103(7)_1008-1018.nxml.txt.nlp	20736947	SENT47	32	32	21	21	docetaxel	CD147	PA449383	682	0.946
NULL	Breast_Cancer_Res_2011_Mar_11_13(2)_R29.nxml.txt.nlp	21396094	SENT213	22	22	34	34	gefitinib	HRG	PA131301952	3084;3273	0.946
NULL	Core_Evid_2010_Oct_21_5_61-76.nxml.txt.nlp	21042543	SENT360	17	17	6	6	cetuximab	KRAS	PA10040	3845	0.946
NULL	Br_J_Cancer_2009_Jun_2_100(11)_1697-1703.nxml.txt.nlp	19384299	SENT61	10	10	27	27	cyclophosphamide	FOXP3	PA449165	50943	0.946
NULL	Ann_Oncol_2014_Oct_18_25(10)_1871-1888.nxml.txt.nlp	25234545	SENT334	32	32	18	18	pertuzumab	HER-2		2064	0.946
NULL	Trials_2014_Aug_22_15(1)_332.nxml.txt.nlp	NULL	SENT11	15	15	29	29	simvastatin	IL8	PA451363	3576	0.946
NULL	Exp_Ther_Med_2015_Jan_5_9(1)_84-88.nxml.txt.nlp	25452780	SENT86	23	23	10	10	lipase	GLP-1	PA450239	100125288	0.946
NULL	Cancer_Cell_Int_2013_Jun_26_13_64.nxml.txt.nlp	23802572	SENT125	27	27	32	32	curcumin	Bcl-2	PA151958596	596	0.946
NULL	Cancer_Manag_Res_2012_Nov_9_4_383-395.nxml.txt.nlp	23204869	SENT7	25	25	10	10	carmustine	PC-3	PA448810	692094	0.946
NULL	Calcif_Tissue_Int_2013_Jan_13_92(1)_59-67.nxml.txt.nlp	23150144	SENT26	0	0	10	10	risedronate	BMD	PA451255	1756;7439	0.946
NULL	Oncoscience_2014_Mar_25_1(3)_205-215.nxml.txt.nlp	25594013	SENT207	16	16	30	30	doxycycline	EGF	PA449415	1950	0.946
NULL	Eur_J_Clin_Pharmacol_2012_Sep_15_68(9)_1267-1274.nxml.txt.nlp	22418828	SENT215	5	5	12	12	omeprazole	CYP2C19	PA450704	1557	0.946
NULL	Cell_Death_Dis_2012_Oct_11_3(10)_e407.nxml.txt.nlp	23059826	SENT128	21	21	43	43	l-glutamine	CO2	PA10090	4513	0.946
NULL	Front_Genet_2013_Aug_29_4_163.nxml.txt.nlp	24009622	SENT48	24	24	9	9	ethanol	ABCG2	PA448073	9429	0.946
NULL	Ann_Rheum_Dis_2014_Mar_11_73(3)_536-543.nxml.txt.nlp	23316080	SENT90	5	5	23	23	adalimumab	CDAI	PA10004	146059	0.946
NULL	J_Gen_Physiol_1997_Dec_1_110(6)_643-654.nxml.txt.nlp	9382893	SENT154	22	22	16	16	trypsin	SUR1	PA451806	6833	0.946
NULL	Breast_Cancer_Res_2004_Oct_6_6(6)_269-274.nxml.txt.nlp	15535858	SENT100	26	26	2	2	anastrozole	ATAC	PA448432	6375	0.946
NULL	Oncotarget_2013_Aug_30_4(10)_1698-1711.nxml.txt.nlp	24091605	SENT175	3	3	10	10	gefitinib	TIC	PA131301952	23550	0.946
NULL	Clin_Drug_Investig_2013_May_22_33(5)_333-342.nxml.txt.nlp	23519576	SENT32	14	14	33	33	dabigatran	E14		4863	0.946
NULL	Front_Oncol_2014_Apr_9_4_75.nxml.txt.nlp	24782986	SENT213	4	4	20	20	paclitaxel	CXCR4	PA450761	7852	0.946
NULL	Cancers_(Basel)_2014_Aug_12_6(3)_1631-1669.nxml.txt.nlp	25119536	SENT1125	26	26	11	11	hydroxyurea	JAK2	PA449942	3717	0.946
NULL	J_Mol_Signal_2012_Sep_8_7_15.nxml.txt.nlp	22958338	SENT121	30	30	24	24	pp2	DPI		1832	0.946
NULL	Eur_J_Clin_Pharmacol_2014_Oct_8_70(1)_37-45.nxml.txt.nlp	24100471	SENT15	6	6	30	30	pioglitazone	CYP2C8	PA450970	1558	0.946
NULL	Oncotarget_2014_Nov_11_5(22)_11490-11500.nxml.txt.nlp	25359780	SENT45	9	9	0	0	docetaxel	CXCR4	PA449383	7852	0.946
NULL	Allergy_Asthma_Immunol_Res_2014_Mar_15_6(2)_126-130.nxml.txt.nlp	24587948	SENT104	0	0	11	11	salbutamol	TTN	PA448068	7273	0.946
NULL	Mycorrhiza_2012_Feb_28_22(2)_149-156.nxml.txt.nlp	21626142	SENT15	4	4	22	22	hyperforin	AMF	PA165985514	2821	0.946
NULL	J_Hematol_Oncol_2013_Jul_9_6_49.nxml.txt.nlp	23837843	SENT283	26	26	2	2	mitoxantrone	ABCG2	PA450526	9429	0.946
NULL	Breast_Cancer_Res_2009_May_29_11(3)_206.nxml.txt.nlp	19519952	SENT50	19	19	9	9	tamoxifen	DES	PA451581	1674	0.946
NULL	Exp_Ther_Med_2013_Sep_10_6(3)_641-648.nxml.txt.nlp	24137240	SENT217	37	37	31	31	isoflurane	IL-6	PA450106	3569	0.946
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2654-2664.nxml.txt.nlp	24136149	SENT140	20	20	15	15	doxorubicin	HSF1	PA449412	3297	0.946
NULL	Indian_J_Endocrinol_Metab_2013_Jul-Aug_17(4)_636-646.nxml.txt.nlp	23961479	SENT138	0	0	16	16	lovastatin	CYP2C9	PA450272	1559	0.946
NULL	Mar_Drugs_2014_May_27_12(6)_3091-3115.nxml.txt.nlp	24871460	SENT91	23	23	18	18	rifaximin	CYP3A4	PA164752443	1576	0.946
NULL	An_Bras_Dermatol_2013_Nov-Dec_88(6)_937-944.nxml.txt.nlp	24474103	SENT118	0	0	10	10	itraconazole	CYP3A4	PA450132	1576	0.946
NULL	Indian_J_Anaesth_2012_Jul-Aug_56(4)_430-431.nxml.txt.nlp	23087482	SENT17	11	11	2	2	heparin	ACT	PA449855	12;11332;9457;641455	0.946
NULL	Brain_Behav_2013_Mar_6_3(2)_114-133.nxml.txt.nlp	23533150	SENT308	1	1	9	9	lipase	ARG	PA450239	473;27	0.946
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT112	11	11	9	9	erlotinib	CYP3A	PA134687924	1574	0.946
NULL	Pharmaceuticals_(Basel)_2013_Aug_21_6(8)_988-1038.nxml.txt.nlp	24276379	SENT499	21	21	13	13	irinotecan	CD44	PA450085	960	0.946
NULL	Breast_Cancer_Res_2010_Aug_9_12(4)_R62.nxml.txt.nlp	20696059	SENT241	17	17	7	7	trastuzumab	AKT	PA451743	207	0.946
NULL	Oncotarget_2011_Dec_24_2(12)_896-917.nxml.txt.nlp	22203527	SENT117	22	22	4	4	metformin	LKB1	PA450395	6794	0.946
NULL	J_Cell_Biol_2005_Jul_18_170(2)_191-200.nxml.txt.nlp	16027218	SENT114	17	17	4	4	estradiol	HIP1	PA449503	3092	0.946
NULL	Indian_Pacing_Electrophysiol_J_2011_Jul_3_11(4)_120-125.nxml.txt.nlp	21760683	SENT38	2	2	12	12	heparin	ACT	PA449855	12;11332;9457;641455	0.946
NULL	Mol_Cancer_2012_Apr_19_11_22.nxml.txt.nlp	22515704	SENT112	32	32	30	30	vemurafenib	BRAF	PA165946873	673	0.946
NULL	Oncotarget_2013_Nov_22_5(4)_933-943.nxml.txt.nlp	24659749	SENT108	42	42	27	27	nutlin-3	p53		7157	0.946
NULL	Cardiol_Ther_2013_Jun_1_2(1)_111-124.nxml.txt.nlp	25135294	SENT123	23	23	14	14	quinidine	P-gp	PA451209	5243	0.946
NULL	Mol_Cancer_2008_Apr_7_7_29.nxml.txt.nlp	18394172	SENT35	7	7	1	1	vinorelbine	BRCA1	PA451881	672	0.946
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_67-74.nxml.txt.nlp	17912637	SENT64	19	19	46	46	anastrozole	ATAC	PA448432	6375	0.946
NULL	Br_J_Cancer_2009_Sep_15_101(6)_957-966.nxml.txt.nlp	19738618	SENT133	13	13	1	1	dexrazoxane	THBS-1	PA449259	7057	0.946
NULL	Biomed_Res_Int_2013_Dec_23_2013_186563.nxml.txt.nlp	24455677	SENT35	6	6	33	33	vemurafenib	BRAF	PA165946873	673	0.946
NULL	ScientificWorldJournal_2014_Feb_5_2014_912640.nxml.txt.nlp	24688447	SENT52	34	34	21	21	ampicillin	B27	PA448419	56246	0.946
NULL	ScientificWorldJournal_2012_Apr_26_2012_358102.nxml.txt.nlp	22645419	SENT182	6	6	11	11	losartan	AT2	PA450268	186	0.946
NULL	Case_Rep_Transplant_2012_Aug_30_2012_672923.nxml.txt.nlp	23259137	SENT80	9	9	21	21	voriconazole	IPA	PA10233	3160	0.946
NULL	J_Mol_Med_2011_Jul_23_89(7)_667-676.nxml.txt.nlp	21431325	SENT25	16	16	2	2	metformin	AMPK	PA450395	5563	0.946
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT171	38	38	11	11	nutlin-3	p53		7157	0.946
NULL	Cancer_Microenviron_2009_Sep_26_2(Suppl_1)_19-204.nxml.txt.nlp	NULL	SENT3307	21	21	1	1	nelfinavir	EGFR	PA450606	1956	0.946
NULL	Acta_Pharmacol_Sin_2012_Aug_9_33(8)_1069-1079.nxml.txt.nlp	22773077	SENT11	40	40	10	10	diclofenac	P-gp	PA449293	5243	0.946
NULL	Clin_Interv_Aging_2009_May_14_4_179-186.nxml.txt.nlp	19503779	SENT91	7	7	4	4	amiodarone	CYP1A2	PA448383	1544	0.946
NULL	J_Gen_Physiol_2009_Apr_133(4)_421-438.nxml.txt.nlp	19289574	SENT255	24	24	13	13	forskolin	SLC26A9	PA146096022	115019	0.946
NULL	Brain_Behav_2014_Mar_13_4(2)_108-122.nxml.txt.nlp	24683506	SENT32	13	13	0	0	l-cysteine	NAC	PA449173	22861	0.946
NULL	Clin_Exp_Otorhinolaryngol_2011_Jun_31_4(2)_77-82.nxml.txt.nlp	21716954	SENT40	10	10	25	25	minocycline	p38	PA450519	10598;1432;7965	0.946
NULL	Allergy_Asthma_Clin_Immunol_2010_Jul_28_6(1)_18.nxml.txt.nlp	20667121	SENT23	13	13	23	23	icatibant	C1-INH	PA164749185	710	0.946
NULL	Oncogene_2013_Oct_17_32(42)_5089-5100.nxml.txt.nlp	23178492	SENT72	9	9	2	2	vorinostat	LOX	PA164748224	4015	0.946
NULL	Indian_J_Endocrinol_Metab_2012_Dec_16(Suppl_2)_S245-S247.nxml.txt.nlp	23565390	SENT58	25	25	1	1	acarbose	STOP	PA448010	4135	0.946
NULL	J_Exp_Clin_Cancer_Res_2009_Nov_24_28(1)_144.nxml.txt.nlp	19930704	SENT121	36	36	3	3	etoposide	P-gp	PA449552	5243	0.946
NULL	Hum_Reprod_Update_2008_Sep_23_Nov-Dec_14(6)_571-582.nxml.txt.nlp	18812422	SENT79	3	3	19	19	letrozole	aromatase	PA450196	1588	0.946
NULL	Biomed_Res_Int_2014_Jun_3_2014_656370.nxml.txt.nlp	24995318	SENT87	11	11	29	29	olanzapine	FGA	PA450688	2243	0.946
NULL	Blood_Res_2014_Jun_25_49(2)_107-114.nxml.txt.nlp	25025012	SENT5	17	17	21	21	rituximab	CHOP	PA451261	1649	0.946
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Jul_24_69(Pt_8)_o1301-o1302.nxml.txt.nlp	24109379	SENT85	8	8	26	26	l-arginine	C23	PA448478	4691	0.946
NULL	Biologics_2009_Jul_13_3_289-301.nxml.txt.nlp	19707416	SENT181	9	9	17	17	tanespimycin	HER2	PA165291490	2064	0.946
NULL	Ann_Surg_Oncol_2010_Apr_20_17(4)_1168-1176.nxml.txt.nlp	19936839	SENT208	10	10	2	2	cetuximab	BRAF	PA10040	673	0.946
NULL	Breast_Cancer_Res_2008_Mar_29_10(2)_R28.nxml.txt.nlp	18373870	SENT165	20	20	9	9	estradiol	c-Myc	PA449503	4609	0.946
NULL	Front_Neuroanat_2014_Mar_11_8_11.nxml.txt.nlp	24653680	SENT74	18	18	6	6	paraformaldehyde	E12	PA450790	64100	0.946
NULL	J_Gen_Physiol_2003_Mar_121(3)_181-197.nxml.txt.nlp	12601083	SENT414	8	8	3	3	tolbutamide	ADP	PA451718	23038	0.946
NULL	Nat_Neurosci_2013_Dec_20_16(12)_10_1038_nn_3553.nxml.txt.nlp	24141309	SENT174	4	4	13	13	tamoxifen	P21	PA451581	1026;9338	0.946
NULL	Acta_Pharmacol_Sin_2011_Aug_11_32(8)_999-1008.nxml.txt.nlp	21743486	SENT224	27	27	15	15	fasudil	JNK	PA165946121	5599	0.946
NULL	Database_(Oxford)_2014_Sep_15_2014_bau090.nxml.txt.nlp	25228593	SENT446	15	15	7	7	infliximab	FCGR3A	PA452639	2214	0.946
NULL	J_Oncol_2010_Jun_21_2010_430142.nxml.txt.nlp	20652056	SENT196	33	33	13	13	dasatinib	EGFR	PA162372878	1956	0.946
NULL	Int_J_Nanomedicine_2007_Jun_2(2)_143-161.nxml.txt.nlp	17722543	SENT127	0	0	11	11	paclitaxel	DES	PA450761	1674	0.946
NULL	Drugs_R_D_2010_Nov_25_10(4)_219-224.nxml.txt.nlp	21171668	SENT88	14	14	10	10	clopidogrel	CYP3A4	PA449053	1576	0.946
NULL	Diabetes_2013_Sep_15_62(9)_3232-3240.nxml.txt.nlp	23835329	SENT200	0	0	13	13	olanzapine	GLP-1	PA450688	100125288	0.946
NULL	Aust_N_Z_J_Psychiatry_2011_Sep_3_45(9)_712-725.nxml.txt.nlp	21888608	SENT285	24	24	6	6	clozapine	CYP1A2	PA449061	1544	0.946
NULL	Biomed_Res_Int_2013_Jul_1_2013_964743.nxml.txt.nlp	23936861	SENT115	0	0	20	20	axitinib	VEGFR	PA164924493	3791	0.946
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2011_Mar_14_4_13-24.nxml.txt.nlp	22879790	SENT238	15	15	26	26	metformin	Met	PA450395	79811	0.946
NULL	Cell_Death_Differ_2010_Apr_16_17(4)_666-676.nxml.txt.nlp	19834494	SENT251	27	27	0	0	melphalan	RAGE	PA450354	177	0.946
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_P113.nxml.txt.nlp	NULL	SENT14	7	7	25	25	piperacillin	CD19	PA450975	930	0.946
NULL	Ann_Gastroenterol_2012_25(2)_106-118.nxml.txt.nlp	24713845	SENT208	20	20	16	16	roxithromycin	CYP3A4	PA164750505	1576	0.946
NULL	Nat_Med_2010_Jun_23_16(6)_671-677.nxml.txt.nlp	20495567	SENT62	5	5	19	19	sorafenib	PI3K	PA7000	5290	0.946
NULL	Oxid_Med_Cell_Longev_2012_Jun_3_2012_914273.nxml.txt.nlp	22701758	SENT207	2	2	28	28	resveratrol	SIRT1		23411	0.946
NULL	Nat_Genet_2013_Jul_2_45(7)_739-746.nxml.txt.nlp	23727861	SENT177	6	6	35	35	ethanol	CXCL5	PA448073	6374	0.946
NULL	AIDS_Res_Treat_2011_Jul_25_2011_743597.nxml.txt.nlp	21804938	SENT23	25	25	7	7	stavudine	CD4	PA451494	920	0.946
NULL	Breast_Cancer_Res_2014_May_22_16(3)_R49.nxml.txt.nlp	24887419	SENT228	33	33	24	24	letrozole	aromatase	PA450196	1588	0.946
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Dec_3_65(Pt_1)_o19.nxml.txt.nlp	21581644	SENT65	14	14	29	29	ethanol	mol	PA448073	90527	0.946
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT278	31	31	43	43	neratinib	HRG	PA165291472	3084;3273	0.946
NULL	Cancer_Cell_Int_2009_Jan_2_9_1.nxml.txt.nlp	19118501	SENT25	2	2	23	23	curcumin	c-Jun	PA151958596	3725	0.946
NULL	Ther_Clin_Risk_Manag_2007_Jun_3(3)_401-410.nxml.txt.nlp	18488071	SENT119	1	1	17	17	tramadol	ACR	PA451735	49	0.946
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Jun_22_69(Pt_7)_o1137.nxml.txt.nlp	24046688	SENT69	40	40	6	6	ethanol	mol	PA448073	90527	0.946
NULL	Indian_J_Endocrinol_Metab_2013_Jul-Aug_17(4)_636-646.nxml.txt.nlp	23961479	SENT157	6	6	24	24	atorvastatin	CYP3A4	PA448500	1576	0.946
NULL	Genome_Med_2010_Aug_11_2(8)_53.nxml.txt.nlp	20701793	SENT105	29	29	5	5	temsirolimus	PTEN	PA164746890	5728	0.946
NULL	Core_Evid_2010_Oct_21_5_61-76.nxml.txt.nlp	21042543	SENT22	33	33	9	9	panitumumab	EGFR	PA162373091	1956	0.946
NULL	Breast_Cancer_Res_2014_May_23_16(3)_R50.nxml.txt.nlp	24887458	SENT24	0	0	30	30	trastuzumab	DM1	PA451743	338023;1760;28509	0.946
NULL	Br_J_Haematol_2011_Apr_153(1)_83-91.nxml.txt.nlp	21332705	SENT111	26	26	33	33	cangrelor	P2Y1	PA165945763	5028	0.946
NULL	Int_J_Antimicrob_Agents_2011_Jul_38(1)_39-45.nxml.txt.nlp	21514798	SENT58	2	2	25	25	tigecycline	BSAC	PA164746412	57591	0.946
NULL	Breast_Cancer_Res_Treat_2013_Jun_5_139(3)_649-655.nxml.txt.nlp	23736997	SENT160	37	37	32	32	tamoxifen	aromatase	PA451581	1588	0.946
NULL	Drug_Target_Insights_2007_Jul_20_2_159-182.nxml.txt.nlp	21901072	SENT266	0	0	20	20	efavirenz	p51	PA449441	8626	0.946
NULL	Genet_Sel_Evol_2014_Mar_4_46(1)_19.nxml.txt.nlp	24592996	SENT165	29	29	8	8	taurine	PCDHB6	PA451590	56130	0.946
NULL	Int_J_Biol_Sci_2015_Jan_1_11(2)_144-155.nxml.txt.nlp	25561897	SENT240	8	8	0	0	cisplatin	POLB	PA449014	5423	0.946
NULL	Iran_J_Pharm_Res_2014_Winter_13(1)_243-251.nxml.txt.nlp	24734077	SENT45	3	3	9	9	ethanol	MOX	PA448073	26002	0.946
NULL	Cancer_Metab_2014_Nov_3_2(1)_20.nxml.txt.nlp	NULL	SENT9	24	24	12	12	erlotinib	PDK4	PA134687924	5166	0.946
NULL	Acta_Pharmacol_Sin_2013_Jun_8_34(6)_830-836.nxml.txt.nlp	23564080	SENT111	4	4	24	24	simvastatin	HMGB1	PA451363	3146	0.946
NULL	J_Cell_Mol_Med_2013_Oct_23_17(10)_1207-1217.nxml.txt.nlp	24106980	SENT130	28	28	9	9	paclitaxel	YB-1	PA450761	4904	0.946
NULL	Open_Biochem_J_2011_Sep_23_5_45-51.nxml.txt.nlp	21966325	SENT191	19	19	4	4	indomethacin	JNK	PA449982	5599	0.946
NULL	Arthritis_Rheumatol_2014_Jun_27_66(6)_1574-1582.nxml.txt.nlp	24577881	SENT146	35	35	15	15	hydralazine	CD4	PA449894	920	0.946
NULL	Oncol_Lett_2013_Feb_9_5(2)_552-558.nxml.txt.nlp	23420128	SENT99	2	2	9	9	imatinib	KIT	PA10804	3815	0.946
NULL	Arthritis_Res_Ther_2011_Jun_21_13(3)_R98.nxml.txt.nlp	21693018	SENT198	0	0	14	14	tiludronate	ACL	PA451688	47	0.946
NULL	Hematol_Rep_2011_Oct_28_3(3_Suppl)_e3.nxml.txt.nlp	22586511	SENT26	4	4	32	32	cyclophosphamide	CHOP	PA449165	1649	0.946
NULL	Front_Immunol_2013_Sep_17_4_281.nxml.txt.nlp	24062747	SENT380	28	28	10	10	atorvastatin	IFN	PA448500	3439	0.946
NULL	Oncogene_2010_Nov_18_29(46)_6115-6124.nxml.txt.nlp	20729912	SENT105	0	0	11	11	doxorubicin	ABCB5	PA449412	340273	0.946
NULL	Mol_Cancer_2013_Mar_5_12_17.nxml.txt.nlp	23497256	SENT194	21	21	10	10	sunitinib	p53	PA162372840	7157	0.946
NULL	BMB_Rep_2013_Jan_46(1)_59-64.nxml.txt.nlp	23351386	SENT28	12	12	25	25	auranofin	p38	PA448510	10598;1432;7965	0.946
NULL	Oncogene_2009_Apr_2_28(13)_1616-1625.nxml.txt.nlp	19219073	SENT51	27	27	6	6	etoposide	p53	PA449552	7157	0.946
NULL	Acta_Neuropathol_Commun_2014_Sep_4_2(1)_93.nxml.txt.nlp	NULL	SENT340	27	27	21	21	ethanol	STAT3	PA448073	6774	0.946
NULL	Croat_Med_J_2011_Feb_52(1)_41-47.nxml.txt.nlp	21328719	SENT190	21	21	1	1	haloperidol	Gen	PA449841	348654	0.946
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2654-2664.nxml.txt.nlp	24136149	SENT146	29	29	7	7	doxorubicin	JNK	PA449412	5599	0.946
NULL	Blood_Cancer_J_2013_Dec_6_3(12)_e167.nxml.txt.nlp	24317089	SENT301	13	13	39	39	lovastatin	IBP	PA450272	706;50619	0.946
NULL	Breast_Cancer_Res_2009_Oct_28_11(5)_211.nxml.txt.nlp	19889200	SENT284	14	14	12	12	letrozole	aromatase	PA450196	1588	0.946
NULL	Turk_J_Haematol_2012_Mar_5_29(1)_1-9.nxml.txt.nlp	24744617	SENT52	20	20	2	2	aprepitant	NK-1	PA164747039	27087	0.946
NULL	Mol_Cell_2014_May_8_54(3)_445-459.nxml.txt.nlp	24746700	SENT501	31	31	10	10	etoposide	BACH1	PA449552	571;83990	0.946
NULL	Br_J_Cancer_2013_Jun_25_108(12)_2485-2494.nxml.txt.nlp	23695022	SENT166	27	27	12	12	gemcitabine	Bcl-2	PA449748	596	0.946
NULL	Clin_Med_Oncol_2008_Mar_27_2_275-287.nxml.txt.nlp	21892289	SENT267	32	32	5	5	rituximab	CD19	PA451261	930	0.946
NULL	Am_J_Case_Rep_2012_May_16_13_66-68.nxml.txt.nlp	23569491	SENT60	11	11	17	17	denosumab	RANK	PA166048634	8792	0.946
NULL	Biosci_Rep_2014_Dec_12_34(6)_e00162.nxml.txt.nlp	25385088	SENT110	19	19	3	3	trypsin	XPA	PA451806	7507	0.946
NULL	Arthritis_Res_Ther_2014_Jul_18_16(4)_R153.nxml.txt.nlp	25037855	SENT168	4	4	13	13	adalimumab	CD14	PA10004	929	0.946
NULL	Neural_Plast_2007_Oct_10_2007_23250.nxml.txt.nlp	NULL	SENT273	44	44	41	41	rimonabant	CB1	PA152407999	1268	0.946
NULL	Clin_Med_Insights_Oncol_2013_Aug_21_7_221-234.nxml.txt.nlp	24179413	SENT61	21	21	11	11	erlotinib	EGFR	PA134687924	1956	0.946
NULL	J_Hematol_Oncol_2009_Aug_12_2_36.nxml.txt.nlp	19674465	SENT118	20	20	4	4	lenalidomide	VEGFR	PA162363968	3791	0.946
NULL	Indian_J_Pharmacol_2009_Aug_41(4)_203-204.nxml.txt.nlp	20523876	SENT54	2	2	6	6	ketoconazole	CYP3A4	PA450146	1576	0.946
NULL	J_Breast_Cancer_2012_Mar_28_15(1)_34-42.nxml.txt.nlp	22493626	SENT106	12	12	7	7	trastuzumab	HER2	PA451743	2064	0.946
NULL	Diabetes_Care_2009_Nov_32(Suppl_2)_S223-S231.nxml.txt.nlp	19875556	SENT46	33	33	9	9	metformin	GLP-1	PA450395	100125288	0.946
NULL	Mol_Pain_2013_Jun_10_9_27.nxml.txt.nlp	23758830	SENT113	18	18	10	10	tetracaine	ASIC2a	PA451638	40	0.946
NULL	Cancer_Cell_Int_2008_Jan_4_8_1.nxml.txt.nlp	18177496	SENT68	32	32	38	38	gefitinib	EGFR	PA131301952	1956	0.946
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT270	15	15	7	7	resveratrol	NAC		22861	0.946
NULL	Ann_Saudi_Med_2011_Jul-Aug_31(4)_417-420.nxml.txt.nlp	21293067	SENT17	7	7	14	14	zidovudine	CD4	PA451954	920	0.946
NULL	Cancer_Metab_2014_May_28_2(Suppl_1)_P90.nxml.txt.nlp	NULL	SENT17	5	5	22	22	metformin	TSC2	PA450395	7249	0.946
NULL	Breast_Cancer_Res_2007_Jan_23_9(1)_R7.nxml.txt.nlp	17244352	SENT149	30	30	18	18	tamoxifen	UGT2B15	PA451581	7366	0.946
NULL	Cells_2014_May_23_3(2)_517-545.nxml.txt.nlp	24861977	SENT225	8	8	17	17	capsaicin	TRPV1	PA448776	7442	0.946
NULL	Biomed_Res_Int_2014_Jun_25_2014_203693.nxml.txt.nlp	25089265	SENT336	18	18	5	5	temsirolimus	San	PA164746890	80218	0.946
NULL	Br_J_Cancer_2012_Oct_9_107(8)_1277-1285.nxml.txt.nlp	22990652	SENT163	5	5	14	14	axitinib	CYP2C8	PA164924493	1558	0.946
NULL	Ann_Clin_Transl_Neurol_2014_Dec_21_1(12)_996-1005.nxml.txt.nlp	25574474	SENT118	12	12	2	2	riluzole	P-gp	PA451251	5243	0.946
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT7	9	9	0	0	sitagliptin	HIP	PA164748978	6767;6159;64399;5068	0.946
NULL	Indian_Dermatol_Online_J_2013_Oct-Dec_4(4)_340-343.nxml.txt.nlp	24350021	SENT111	33	33	20	20	isotretinoin	GJB4	PA450128	127534	0.946
NULL	Evid_Based_Complement_Alternat_Med_2011_Feb_14_2011_650263.nxml.txt.nlp	21799686	SENT100	24	24	3	3	atropine	STZ	PA448505	6484	0.946
NULL	Gut_Liver_2013_May_25_7(3)_323-328.nxml.txt.nlp	23710314	SENT50	0	0	4	4	protamine	BCS	PA10366	617	0.946
NULL	Acta_Pharmacol_Sin_2012_May_4_33(5)_710-716.nxml.txt.nlp	22555373	SENT154	13	13	30	30	mexiletine	DOM	PA450488	6663	0.946
NULL	J_Invest_Dermatol_2014_Apr_11_134(4)_1083-1090.nxml.txt.nlp	24335898	SENT57	9	9	19	19	nutlin-3	p53		7157	0.946
NULL	Cell_Death_Dis_2013_Sep_19_4(9)_e810.nxml.txt.nlp	24052078	SENT20	20	20	30	30	erlotinib	EGFR	PA134687924	1956	0.946
NULL	Mar_Drugs_2014_Jun_27_12(7)_3818-3837.nxml.txt.nlp	24979269	SENT47	14	14	7	7	calcein	P-gp	PA132595336	5243	0.946
NULL	Biomed_Res_Int_2014_Feb_17_2014_503784.nxml.txt.nlp	24696853	SENT151	13	13	26	26	arsenite	ArsB	PA452638	57152	0.946
NULL	J_Hematol_Oncol_2009_Oct_27_2_45.nxml.txt.nlp	19860903	SENT129	27	27	37	37	everolimus	VEGFR	PA164746311	3791	0.946
NULL	Oncogene_2010_Sep_16_29(37)_5193-5203.nxml.txt.nlp	20581867	SENT165	11	11	3	3	lapatinib	PI3K	PA152241907	5290	0.946
NULL	Exp_Mol_Med_2012_Apr_30_44(4)_281-292.nxml.txt.nlp	22228119	SENT60	26	26	16	16	genistein	activin	PA165109660	83729	0.946
NULL	Br_J_Cancer_2012_Jun_26_107(1)_116-122.nxml.txt.nlp	22596240	SENT145	35	35	15	15	imatinib	PRAME	PA10804	23532	0.946
NULL	J_Biomed_Sci_2014_Feb_3_21(1)_10.nxml.txt.nlp	24490900	SENT133	5	5	8	8	alendronate	RANKL	PA448082	8600	0.946
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1150.nxml.txt.nlp	24675468	SENT100	27	27	12	12	metformin	adiponectin	PA450395	9370	0.946
NULL	J_Med_Econ_2013_Jul_24_16(7)_917-925.nxml.txt.nlp	23663091	SENT149	13	13	33	33	aripiprazole	SOC	PA10026	91544	0.946
NULL	Acta_Pharmacol_Sin_2014_Aug_21_35(8)_1082-1092.nxml.txt.nlp	25047514	SENT173	16	16	6	6	estradiol	aromatase	PA449503	1588	0.946
NULL	Indian_J_Pharmacol_2014_Nov-Dec_46(6)_627-632.nxml.txt.nlp	25538335	SENT65	17	17	11	11	metformin	Q10	PA450395	27161	0.946
NULL	CNS_Drugs_2013_Aug_20_27(12)_1081-1092.nxml.txt.nlp	23959815	SENT30	32	32	11	11	guanfacine	ATX	PA449825	5168;23049	0.946
NULL	Br_J_Cancer_2011_Mar_1_104(5)_750-755.nxml.txt.nlp	21326243	SENT123	39	39	4	4	dacarbazine	MPG	PA449197	4350	0.946
NULL	Evid_Based_Complement_Alternat_Med_2013_May_13_2013_506324.nxml.txt.nlp	23818927	SENT190	31	31	10	10	doxorubicin	S6K1	PA449412	6198	0.946
NULL	Br_J_Clin_Pharmacol_2013_Aug_23_76(2)_299-315.nxml.txt.nlp	23701319	SENT230	16	16	7	7	rituximab	IL-17	PA451261	3605	0.946
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_24_2012_673132.nxml.txt.nlp	23133498	SENT121	7	7	27	27	ciprofloxacin	P-gp	PA449009	5243	0.946
NULL	Braz_J_Microbiol_2010_Jun_1_Apr-Jun_41(2)_333-344.nxml.txt.nlp	24031501	SENT123	27	27	4	4	ciprofloxacin	BEF	PA449009	10189	0.946
NULL	Diabetes_2013_Nov_18_62(11)_3751-3759.nxml.txt.nlp	23897951	SENT125	7	7	17	17	rosiglitazone	FRS2	PA451283	10818	0.946
NULL	Eur_J_Med_Res_2009_Nov_24_14(Suppl_3)_30-35.nxml.txt.nlp	19959414	SENT75	3	3	24	24	raltegravir	CD4		920	0.946
NULL	Br_J_Cancer_2012_Apr_10_106(8)_1367-1373.nxml.txt.nlp	22454081	SENT143	43	43	31	31	trastuzumab	PTEN	PA451743	5728	0.946
NULL	BMJ_2010_Feb_8_340_c693.nxml.txt.nlp	20142325	SENT137	18	18	26	26	fluoxetine	CYP2D6	PA449673	1565	0.946
NULL	Oncogene_2014_Feb_6_33(6)_713-723.nxml.txt.nlp	23435429	SENT77	28	28	19	19	etoposide	p50	PA449552	958;4790	0.946
NULL	Neural_Regen_Res_2014_Mar_15_9(6)_622-629.nxml.txt.nlp	25206865	SENT13	42	42	27	27	vasopressin	p38	PA451858	10598;1432;7965	0.946
NULL	J_Hematol_Oncol_2012_Jul_27_5_42.nxml.txt.nlp	22839530	SENT166	22	22	7	7	vincristine	PRMT1	PA451879	3276	0.946
NULL	Cancers_(Basel)_2013_Jan_21_5(1)_64-91.nxml.txt.nlp	24216699	SENT151	7	7	0	0	trastuzumab	HER2	PA451743	2064	0.946
NULL	J_Geriatr_Cardiol_2012_Jun_9(2)_209-210.nxml.txt.nlp	23097648	SENT11	20	20	5	5	warfarin	CYP2C9	PA451906	1559	0.946
NULL	Arch_Pharm_Res_2014_Nov_1_37(5)_588-599.nxml.txt.nlp	24178744	SENT18	14	14	4	4	exenatide	GLP-1	PA164749238	100125288	0.946
NULL	Indian_J_Pharmacol_2013_May-Jun_45(3)_252-257.nxml.txt.nlp	23833368	SENT71	12	12	2	2	chlorpheniramine	B12	PA448960	7126;4709	0.946
NULL	Oncoscience_2014_Oct_22_1(10)_614-623.nxml.txt.nlp	25593991	SENT92	2	2	18	18	pertuzumab	HER2		2064	0.946
NULL	Cancer_Manag_Res_2013_Dec_11_9_1-3.nxml.txt.nlp	24376362	SENT5	21	21	10	10	trastuzumab	HER-2	PA451743	2064	0.946
NULL	Front_Oncol_2014_Sep_15_4_248.nxml.txt.nlp	25309873	SENT215	33	33	43	43	afatinib	EGFR	PA165981154	1956	0.946
NULL	Core_Evid_2010_Oct_21_5_61-76.nxml.txt.nlp	21042543	SENT75	0	0	11	11	panitumumab	IFL	PA162373091	3439	0.946
NULL	Ann_Med_Health_Sci_Res_2012_Jul-Dec_2(2)_191-198.nxml.txt.nlp	23439914	SENT165	20	20	1	1	ketoconazole	P-gp	PA450146	5243	0.946
NULL	Oxid_Med_Cell_Longev_2013_Nov_28_2013_568093.nxml.txt.nlp	24379901	SENT50	23	23	14	14	resveratrol	AMPK		5563	0.946
NULL	Indian_J_Endocrinol_Metab_2013_May-Jun_17(3)_465-471.nxml.txt.nlp	23869304	SENT147	15	15	5	5	hydrocortisone	RAI	PA449905	10848;6050	0.946
NULL	Oncotarget_2013_Jun_4_4(5)_772-784.nxml.txt.nlp	23800712	SENT204	7	7	0	0	erlotinib	EGFR	PA134687924	1956	0.946
NULL	Mol_Brain_2014_Apr_21_7_28.nxml.txt.nlp	24751148	SENT181	29	29	18	18	minocycline	TLR4	PA450519	7099	0.946
NULL	Cancer_Med_2013_Jun_25_2(3)_277-285.nxml.txt.nlp	23930204	SENT182	40	40	8	8	cetuximab	PIK3CA	PA10040	5290	0.946
NULL	Front_Pharmacol_2014_Oct_20_5_230.nxml.txt.nlp	25368579	SENT21	13	13	20	20	berberine	IL-6	PA165860812	3569	0.946
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Jan_10_6_1-13.nxml.txt.nlp	24648765	SENT49	3	3	13	13	trastuzumab	HER2	PA451743	2064	0.946
NULL	J_Neuroinflammation_2011_Dec_21_8_177.nxml.txt.nlp	22189061	SENT51	9	9	19	19	capsaicin	TRPV1	PA448776	7442	0.946
NULL	Orphanet_J_Rare_Dis_2013_Feb_12_8_23.nxml.txt.nlp	23398819	SENT238	11	11	5	5	doxycycline	BTHS	PA449415	6901	0.946
NULL	Br_J_Cancer_2009_Jul_21_101(2)_238-243.nxml.txt.nlp	19568242	SENT19	8	8	25	25	sunitinib	IFN	PA162372840	3439	0.946
NULL	Pharmaceuticals_(Basel)_2012_Jun_28_5(7)_674-689.nxml.txt.nlp	24281706	SENT6	8	8	28	28	trastuzumab	Hsp90	PA451743	3320	0.946
NULL	Oncoimmunology_2013_Jun_1_2(6)_e24677.nxml.txt.nlp	23894722	SENT89	28	28	12	12	cetuximab	CD107a	PA10040	3916	0.946
NULL	Oncotarget_2013_Apr_15_4(4)_636-646.nxml.txt.nlp	23592437	SENT66	18	18	4	4	decitabine	ACTL8	PA164749631	81569	0.946
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT20	12	12	30	30	pp2	PP2		4888	0.946
NULL	Clin_Drug_Investig_2015_Dec_16_35_141-147.nxml.txt.nlp	25511640	SENT88	5	5	14	14	miglitol	GLP-1	PA164776726	100125288	0.946
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_3_2014_473213.nxml.txt.nlp	25538791	SENT110	5	5	0	0	ritonavir	MDR1	PA451260	5243	0.946
NULL	Breast_Cancer_Res_2010_Sep_29_12(5)_209.nxml.txt.nlp	21067536	SENT150	0	0	40	40	sunitinib	FLT3	PA162372840	2322	0.946
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT13	4	4	17	17	capsaicin	p53	PA448776	7157	0.946
NULL	Leukemia_2013_Apr_14_27(4)_803-812.nxml.txt.nlp	23238589	SENT159	30	30	34	34	nilotinib	IFN	PA165958345	3439	0.946
NULL	Br_J_Cancer_2006_Feb_13_94(3)_407-426.nxml.txt.nlp	16434996	SENT385	18	18	33	33	genistein	CHOP	PA165109660	1649	0.946
NULL	Cancers_(Basel)_2010_Mar_26_2(2)_274-304.nxml.txt.nlp	24281071	SENT1707	5	5	10	10	resveratrol	NFkappaB		4790	0.946
NULL	Int_J_Mol_Sci_2014_Sep_29_15(10)_17411-17441.nxml.txt.nlp	25268615	SENT216	24	24	30	30	cisplatin	CD147	PA449014	682	0.946
NULL	Oxid_Med_Cell_Longev_2013_Mar_5_2013_264935.nxml.txt.nlp	23533686	SENT167	9	9	22	22	hemin	HO-1	PA449849	3162	0.946
NULL	Nat_Genet_2014_Feb_12_46(2)_166-170.nxml.txt.nlp	24413734	SENT57	11	11	26	26	dasatinib	FYN	PA162372878	2534	0.946
NULL	Front_Aging_Neurosci_2010_Aug_26_2_138.nxml.txt.nlp	20838473	SENT201	10	10	13	13	diazoxide	SDH	PA449285	1757;10993	0.946
NULL	Clin_Pharmacokinet_2014_Jul_24_53(1)_73-87.nxml.txt.nlp	23881596	SENT256	18	18	30	30	rosuvastatin	OATP2B1	PA134308647	11309	0.946
NULL	Environ_Health_Perspect_2009_Nov_26_117(11)_1737-1744.nxml.txt.nlp	20049126	SENT207	18	18	11	11	arsenite	REV3	PA452638	5980	0.946
NULL	Ann_Indian_Acad_Neurol_2011_Jan-Mar_14(1)_50-52.nxml.txt.nlp	21655207	SENT7	14	14	8	8	modafinil	KLS	PA450530	6199	0.946
NULL	Anesthesiol_Res_Pract_2014_Feb_11_2014_848051.nxml.txt.nlp	24672542	SENT21	22	22	4	4	vecuronium	NMB	PA164748865	10457;4828	0.946
NULL	Front_Physiol_2011_Feb_24_2_4.nxml.txt.nlp	21483730	SENT690	10	10	8	8	itraconazole	CYP3A4	PA450132	1576	0.946
NULL	Emerg_Infect_Dis_2011_Feb_17(2)_317-319.nxml.txt.nlp	21291621	SENT21	4	4	23	23	erythromycin	CD196	PA449493	1235	0.946
NULL	Ann_Hematol_2011_Feb_17_90(2)_173-183.nxml.txt.nlp	20714724	SENT95	11	11	32	32	resveratrol	CD5		921	0.946
NULL	Biosci_Rep_2013_Nov_25_33(6)_e00081.nxml.txt.nlp	24070327	SENT68	14	14	22	22	vincristine	OCT1	PA451879	5451;6580	0.946
NULL	Eur_J_Clin_Pharmacol_2012_Jan_8_68(1)_29-37.nxml.txt.nlp	21739267	SENT31	26	26	18	18	itraconazole	CYP2D6	PA450132	1565	0.946
NULL	Br_J_Cancer_2011_Jul_26_105(3)_452-459.nxml.txt.nlp	21750557	SENT43	16	16	4	4	rofecoxib	COX2	PA451268	4513;5743	0.946
NULL	Breast_Cancer_Res_2010_Mar_5_12(2)_R16.nxml.txt.nlp	20205716	SENT318	32	32	19	19	lovastatin	E2F1	PA450272	1869	0.946
NULL	Oxid_Med_Cell_Longev_2011_Oct_15_2011_703676.nxml.txt.nlp	22013498	SENT83	19	19	6	6	resveratrol	IL-6		3569	0.946
NULL	Case_Rep_Oncol_2013_Jun_6_6(2)_311-315.nxml.txt.nlp	23898274	SENT46	13	13	6	6	propranolol	JAK2	PA451145	3717	0.946
NULL	Indian_J_Dermatol_2009_Apr-Jun_54(2)_100-109.nxml.txt.nlp	20101303	SENT185	0	0	12	12	abatacept	CTLA4	PA164747080	1493	0.946
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT58	33	33	9	9	panitumumab	HER-2	PA162373091	2064	0.946
NULL	Contemp_Clin_Dent_2014_Oct-Dec_5(4)_466-470.nxml.txt.nlp	25395761	SENT7	3	3	21	21	chlorhexidine	PLB	PA164776863	151056	0.946
NULL	Pharmaceutics_2011_Sep_14_3(3)_615-635.nxml.txt.nlp	24310600	SENT641	4	4	10	10	dasatinib	ABCB1	PA162372878	5243	0.946
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT223	5	5	22	22	metformin	HIP	PA450395	6767;6159;64399;5068	0.946
NULL	Exp_Ther_Med_2015_Jan_11_9(1)_17-24.nxml.txt.nlp	25452770	SENT15	14	14	2	2	trastuzumab	HER-2	PA451743	2064	0.946
NULL	J_Gen_Physiol_1990_Sep_1_96(3)_535-557.nxml.txt.nlp	2230711	SENT5	3	3	29	29	nifedipine	gamma	PA450631	9913	0.946
NULL	Mediators_Inflamm_1996_Oct_5(5)_346-357.nxml.txt.nlp	18475729	SENT8	24	24	10	10	dextran	C5a	PA449261	727	0.946
NULL	Oxid_Med_Cell_Longev_2013_Jun_2_2013_793525.nxml.txt.nlp	23819014	SENT225	16	16	0	0	resveratrol	SGBS		2719	0.946
NULL	Nucleic_Acids_Res_2005_Mar_23_33(6)_1804-1812.nxml.txt.nlp	15788752	SENT84	14	14	4	4	phenol	Met	PA450913	79811	0.946
NULL	Ther_Clin_Risk_Manag_2007_Jun_3(3)_411-420.nxml.txt.nlp	18488075	SENT31	19	19	2	2	alefacept	CD2	PA164748040	914	0.946
NULL	Oncotarget_2012_Jan_28_3(1)_78-83.nxml.txt.nlp	22289679	SENT3	28	28	19	19	carboplatin	PLK2	PA448803	10769	0.946
NULL	FEBS_Open_Bio_2013_Dec_30_4_96-104.nxml.txt.nlp	24490130	SENT159	8	8	15	15	cisplatin	BRCA1	PA449014	672	0.946
NULL	Arthritis_Res_2002_May_24_4(Suppl_2)_S34-S40.nxml.txt.nlp	12110156	SENT18	0	0	23	23	etanercept	p75	PA449515	7133;11168	0.946
NULL	Ann_Indian_Acad_Neurol_2014_Mar_17(Suppl_1)_S32-S36.nxml.txt.nlp	24791086	SENT117	13	13	5	5	midazolam	PTB	PA450496	58155	0.946
NULL	Cancer_Cell_Int_2010_Apr_29_10_12.nxml.txt.nlp	20429927	SENT99	20	20	7	7	bortezomib	HRI	PA10252	27102	0.946
NULL	Mol_Cancer_2010_Nov_25_9_305.nxml.txt.nlp	21108789	SENT107	8	8	17	17	decitabine	p53	PA164749631	7157	0.946
NULL	Crit_Care_2011_Jun_29_15(3)_R160.nxml.txt.nlp	21714857	SENT195	26	26	1	1	fenoldopam	NGAL	PA164784034	3934	0.946
NULL	Nat_Chem_Biol_2010_Apr_28_6(4)_291-299.nxml.txt.nlp	20190765	SENT282	16	16	6	6	dasatinib	EGFR	PA162372878	1956	0.946
NULL	Br_J_Cancer_2013_Jul_23_109(2)_502-511.nxml.txt.nlp	23799850	SENT41	16	16	8	8	gemcitabine	PSN1	PA449748	51251	0.946
NULL	Breast_Cancer_Res_2007_Jul_5_9(4)_R41.nxml.txt.nlp	17612393	SENT152	19	19	8	8	celecoxib	Bcl-2	PA448871	596	0.946
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT109	3	3	20	20	tenofovir	ABCC10	PA10204	89845	0.946
NULL	J_Oncol_2012_Aug_24_2012_281261.nxml.txt.nlp	21876693	SENT246	0	0	14	14	axitinib	VEGFR	PA164924493	3791	0.946
NULL	Int_J_Biomed_Imaging_2013_Feb_26_2013_230487.nxml.txt.nlp	23533377	SENT115	11	11	4	4	tamoxifen	FTX	PA451581	100302692	0.946
NULL	Psychol_Res_Behav_Manag_2010_Dec_6_3_109-118.nxml.txt.nlp	22110334	SENT114	32	32	39	39	fluoxetine	CYP2D6	PA449673	1565	0.946
NULL	Arch_Med_Sci_2011_Apr_17_7(2)_230-234.nxml.txt.nlp	22291761	SENT105	30	30	23	23	curcumin	LOX	PA151958596	4015	0.946
NULL	Int_J_Mol_Sci_2012_Feb_24_13(3)_2578-2589.nxml.txt.nlp	22489112	SENT64	8	8	33	33	amitriptyline	GAT3	PA448385	6538	0.946
NULL	Mar_Drugs_2014_Jun_27_12(7)_3818-3837.nxml.txt.nlp	24979269	SENT195	16	16	21	21	calcein	P-gp	PA132595336	5243	0.946
NULL	Drugs_R_D_2013_Jun_5_13(2)_145-151.nxml.txt.nlp	23737453	SENT136	10	10	13	13	simvastatin	CYP3A4	PA451363	1576	0.946
NULL	Oncotarget_2014_Jun_5_5(21)_10382-10392.nxml.txt.nlp	25071015	SENT2	27	27	3	3	trastuzumab	p53	PA451743	7157	0.946
NULL	Front_Aging_Neurosci_2010_Oct_25_2_142.nxml.txt.nlp	21152343	SENT519	15	15	21	21	pioglitazone	gamma	PA450970	9913	0.946
NULL	Ther_Clin_Risk_Manag_2006_Mar_2(1)_59-75.nxml.txt.nlp	18360582	SENT248	0	0	8	8	pravastatin	CYP3A4	PA451089	1576	0.946
NULL	Cancer_Microenviron_2009_May_6_2(1)_59-67.nxml.txt.nlp	19418243	SENT29	9	9	2	2	tetracycline	CCL21	PA451640	6366	0.946
NULL	F1000Res_2014_Jun_4_3_76.nxml.txt.nlp	25075293	SENT121	10	10	6	6	ustekinumab	TNF-alpha	PA166048654	7124	0.946
NULL	Environ_Sci_Technol_2014_Feb_4_48(3)_1964-1972.nxml.txt.nlp	24392850	SENT431	14	14	6	6	fenfluramine	5-HT2B	PA449592	3357	0.946
NULL	Mol_Brain_2014_Jun_16_7_47.nxml.txt.nlp	24935250	SENT181	4	4	31	31	gabapentin	ANOVA	PA449720	4858	0.946
NULL	Br_J_Cancer_2010_Sep_7_103(6)_889-898.nxml.txt.nlp	20664599	SENT197	12	12	3	3	paclitaxel	HER-2	PA450761	2064	0.946
NULL	Core_Evid_2012_Dec_11_7_131-143.nxml.txt.nlp	23271985	SENT225	24	24	14	14	vancomycin	HAP	PA451850	5915;10313	0.946
NULL	Indian_J_Pharm_Sci_2013_Jan-Feb_75(1)_94-98.nxml.txt.nlp	23901167	SENT61	26	26	44	44	tolbutamide	CYP2C9	PA451718	1559	0.946
NULL	Psychiatry_Investig_2009_Mar_31_6(1)_39-43.nxml.txt.nlp	20046372	SENT26	29	29	15	15	olanzapine	GNB3	PA450688	2784	0.946
NULL	Sci_Rep_2015_Jan_15_5_7768.nxml.txt.nlp	25588811	SENT251	9	9	2	2	ethanol	ITO	PA448073	3160	0.946
NULL	Evid_Based_Complement_Alternat_Med_2013_Dec_12_2013_324618.nxml.txt.nlp	24416065	SENT112	14	14	2	2	nevirapine	ATV	PA450616	4683	0.946
NULL	Oncogene_2014_Sep_18_33(38)_4664-4674.nxml.txt.nlp	24096486	SENT94	14	14	22	22	erlotinib	PI3K	PA134687924	5290	0.946
NULL	Croat_Med_J_2012_Aug_53(4)_314-320.nxml.txt.nlp	22911523	SENT113	21	21	29	29	docetaxel	HER2	PA449383	2064	0.946
NULL	Drug_Des_Devel_Ther_2014_Sep_23_8_1527-1538.nxml.txt.nlp	25284985	SENT98	41	41	3	3	celecoxib	IFN	PA448871	3439	0.946
NULL	Acta_Pharmacol_Sin_2013_Feb_31_34(2)_231-238.nxml.txt.nlp	23274414	SENT137	0	0	19	19	amiloride	Bcl-2	PA448368	596	0.946
NULL	Oxid_Med_Cell_Longev_2013_Jun_6_2013_891748.nxml.txt.nlp	23840922	SENT206	0	0	12	12	resveratrol	IL-17A		3605	0.946
NULL	Front_Oncol_2014_Mar_24_4_47.nxml.txt.nlp	24716189	SENT245	17	17	26	26	vemurafenib	BRAF	PA165946873	673	0.946
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Dec_17_3(12)_e152.nxml.txt.nlp	25518025	SENT31	18	18	9	9	oxycodone	CYP3A4	PA450741	1576	0.946
NULL	Br_J_Cancer_2010_Mar_16_102(6)_1003-1009.nxml.txt.nlp	20179710	SENT4	0	0	5	5	doxorubicin	ABCB1	PA449412	5243	0.946
NULL	J_Hematol_Oncol_2014_Apr_28_7_37.nxml.txt.nlp	24775308	SENT189	15	15	10	10	imatinib	JAK2	PA10804	3717	0.946
NULL	Int_J_Med_Sci_2015_Jan_1_12(1)_78-82.nxml.txt.nlp	25552922	SENT23	34	34	0	0	propranolol	CYP1A2	PA451145	1544	0.946
NULL	Cell_Biochem_Biophys_2013_May_14_66(1)_65-71.nxml.txt.nlp	23065501	SENT46	28	28	24	24	doxorubicin	telethonin	PA449412	8557	0.946
NULL	FEBS_J_2012_May_279(10)_1857-1870.nxml.txt.nlp	22420714	SENT9	32	32	10	10	capsaicin	TRPV1	PA448776	7442	0.946
NULL	J_Mol_Signal_2011_Jul_20_6_7.nxml.txt.nlp	21774804	SENT50	41	41	4	4	dasatinib	p53	PA162372878	7157	0.946
NULL	Eur_J_Med_Res_2011_Apr_28_16(4)_139-144.nxml.txt.nlp	21486727	SENT129	3	3	19	19	posaconazole	UGT	PA151958574	7361;7355	0.946
NULL	Arthritis_Res_Ther_2013_Jul_9_15(4)_R73.nxml.txt.nlp	23837669	SENT62	6	6	21	21	colchicine	MICL	PA449092	160364	0.946
NULL	Mol_Cancer_2008_Jan_25_7_13.nxml.txt.nlp	18218140	SENT21	33	33	9	9	estradiol	PRL	PA449503	5617	0.946
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT167	4	4	6	6	atorvastatin	TNF	PA448500	7124	0.946
NULL	Nat_Commun_2012_Dec_11_3_1271.nxml.txt.nlp	23232401	SENT184	20	20	8	8	trastuzumab	HSF1	PA451743	3297	0.946
NULL	Front_Public_Health_2013_Nov_14_1_50.nxml.txt.nlp	24350219	SENT200	15	15	2	2	hydrocortisone	IL-8	PA449905	3576	0.945
NULL	Semin_Immunol_2011_Feb_23(1)_28-41.nxml.txt.nlp	21295490	SENT237	12	12	5	5	etanercept	CD207	PA449515	50489	0.945
NULL	Clin_Ophthalmol_2009_Jun_2_3_199-210.nxml.txt.nlp	19668566	SENT185	12	12	0	0	diclofenac	Rho	PA449293	29984	0.945
NULL	Cardiovasc_J_Afr_2010_Jun_21(3)_132-136.nxml.txt.nlp	20532450	SENT94	10	10	34	34	indomethacin	EDRF	PA449982	51327	0.945
NULL	Int_J_Mol_Sci_2012_Feb_1_13(2)_1512-1523.nxml.txt.nlp	22408405	SENT62	33	33	6	6	olmesartan	LOX-1	PA164742950	4973	0.945
NULL	Genome_Med_2010_Aug_11_2(8)_53.nxml.txt.nlp	20701793	SENT118	20	20	17	17	sunitinib	VEGFR	PA162372840	3791	0.945
NULL	Oncoscience_2014_Oct_24_1(10)_665-673.nxml.txt.nlp	25593995	SENT79	21	21	3	3	doxorubicin	NANOG	PA449412	79923	0.945
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S31-S40.nxml.txt.nlp	20680106	SENT71	38	38	32	32	cetuximab	KRAS	PA10040	3845	0.945
NULL	Mol_Vis_2012_Apr_11_18_901-908.nxml.txt.nlp	22539869	SENT28	7	7	12	12	curcumin	HO-1	PA151958596	3162	0.945
NULL	Ther_Clin_Risk_Manag_2006_Dec_2(4)_435-445.nxml.txt.nlp	18360654	SENT102	14	14	18	18	erlotinib	EGFR	PA134687924	1956	0.945
NULL	Gut_Liver_2012_Apr_17_6(2)_210-217.nxml.txt.nlp	22570750	SENT17	4	4	0	0	indomethacin	cPLA2	PA449982	10524	0.945
NULL	Leukemia_2014_Mar_20_28(3)_554-565.nxml.txt.nlp	24280866	SENT207	32	32	27	27	doxycycline	IL-3	PA449415	3562	0.945
NULL	Crit_Care_2012_Jun_7_16(Suppl_2)_A25.nxml.txt.nlp	NULL	SENT94	4	4	8	8	methylprednisolone	IL-6	PA450466	3569	0.945
NULL	Indian_J_Dermatol_2013_Jan-Feb_58(1)_61-64.nxml.txt.nlp	23372216	SENT98	4	4	17	17	ketoconazole	CYP3A4	PA450146	1576	0.945
NULL	EMBO_Mol_Med_2012_Mar_4(3)_218-233.nxml.txt.nlp	22294553	SENT201	5	5	3	3	erlotinib	EGFR	PA134687924	1956	0.945
NULL	Front_Genet_2013_Aug_29_4_163.nxml.txt.nlp	24009622	SENT120	31	31	19	19	ethanol	ABCG2	PA448073	9429	0.945
NULL	Mol_Cancer_2012_Aug_8_11_53.nxml.txt.nlp	22871047	SENT296	10	10	30	30	paclitaxel	HIN-1	PA450761	92304	0.945
NULL	Org_Med_Chem_Lett_2014_Feb_28_4_1.nxml.txt.nlp	24576663	SENT65	3	3	25	25	sulfamethoxazole	mol	PA451544	90527	0.945
NULL	Open_Ophthalmol_J_2013_Feb_1_7_4-10.nxml.txt.nlp	23459241	SENT112	30	30	7	7	bevacizumab	San	PA130232992	80218	0.945
NULL	Br_J_Cancer_2013_Feb_19_108(3)_493-502.nxml.txt.nlp	23299530	SENT26	1	1	36	36	bevacizumab	VEGFR	PA130232992	3791	0.945
NULL	Breast_Cancer_Res_2012_Feb_14_14(1)_R30.nxml.txt.nlp	22333315	SENT165	15	15	5	5	celecoxib	CXCL10	PA448871	3627	0.945
NULL	Br_J_Cancer_2012_May_8_106(10)_1587-1590.nxml.txt.nlp	22568998	SENT77	37	37	7	7	sunitinib	IFN	PA162372840	3439	0.945
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT102	18	18	14	14	sitagliptin	HIP	PA164748978	6767;6159;64399;5068	0.945
NULL	Virulence_2013_Apr_1_4(3)_230-240.nxml.txt.nlp	23406779	SENT61	23	23	11	11	tetracycline	L22	PA451640	6146	0.945
NULL	Facts_Views_Vis_Obgyn_2010_2(4)_289-295.nxml.txt.nlp	25009716	SENT255	18	18	3	3	phenol	ISM1	PA450913	140862	0.945
NULL	EMBO_Mol_Med_2013_Dec_8_5(12)_1821-1834.nxml.txt.nlp	24293316	SENT186	3	3	8	8	doxorubicin	p53	PA449412	7157	0.945
NULL	Oncol_Lett_2014_Jul_15_8(1)_198-202.nxml.txt.nlp	24959245	SENT29	7	7	22	22	gentamicin	CO2	PA449753	4513	0.945
NULL	Arthritis_Res_Ther_2006_Dec_28_8(1)_R18.nxml.txt.nlp	16507118	SENT75	39	39	28	28	infliximab	ACR	PA452639	49	0.945
NULL	Mol_Imaging_Biol_2010_Oct_1_12(5)_539-546.nxml.txt.nlp	19949980	SENT43	15	15	7	7	benzaldehyde	IL2	PA448571	3558	0.945
NULL	J_Oncol_2010_May_4_2010_373491.nxml.txt.nlp	20454582	SENT134	40	40	29	29	temozolomide	TRG	PA451609	6965	0.945
NULL	Cancer_Med_2013_Aug_10_2(4)_488-495.nxml.txt.nlp	24156021	SENT117	18	18	32	32	sn-38	GEM		2669	0.945
NULL	Breast_Cancer_Res_Treat_2014_Jul_20_146(3)_627-636.nxml.txt.nlp	25038878	SENT109	23	23	25	25	tamoxifen	aromatase	PA451581	1588	0.945
NULL	Exp_Hematol_Oncol_2013_Aug_8_2_21.nxml.txt.nlp	23927414	SENT94	30	30	7	7	enoxaparin	HARE	PA449463	55576	0.945
NULL	Ann_Hematol_2010_Nov_25_89(11)_1115-1124.nxml.txt.nlp	20499237	SENT119	19	19	2	2	simvastatin	CD19	PA451363	930	0.945
NULL	Diabetes_2009_Dec_31_58(12)_2851-2862.nxml.txt.nlp	19720788	SENT143	41	41	11	11	forskolin	GADD34	PA146096022	23645	0.945
NULL	Eur_J_Clin_Pharmacol_2013_Feb_12_69(2)_209-215.nxml.txt.nlp	22688722	SENT99	24	24	13	13	duloxetine	LIM	PA10066	10611	0.945
NULL	J_Cell_Biol_2008_Jan_28_180(2)_417-426.nxml.txt.nlp	18227283	SENT173	16	16	14	14	letrozole	aromatase	PA450196	1588	0.945
NULL	J_Biol_Chem_2012_Aug_10_287(33)_28169-28179.nxml.txt.nlp	22584573	SENT289	42	42	14	14	rosiglitazone	HDX	PA451283	139324	0.945
NULL	Mol_Cancer_2010_Apr_23_9_87.nxml.txt.nlp	20416058	SENT198	0	0	25	25	doxorubicin	TRAIL	PA449412	8743	0.945
NULL	Br_J_Cancer_2012_Jun_26_107(1)_43-52.nxml.txt.nlp	22644306	SENT226	32	32	28	28	tamoxifen	CXCR4	PA451581	7852	0.945
NULL	Br_J_Haematol_2014_Mar_13_164(1)_811-821.nxml.txt.nlp	24328678	SENT6	35	35	22	22	lenalidomide	IKZF3	PA162363968	22806	0.945
NULL	Crit_Care_1999_Dec_23_4(Suppl_A)_4.nxml.txt.nlp	NULL	SENT11	15	15	7	7	heparin	ACT	PA449855	12;11332;9457;641455	0.945
NULL	N_Am_J_Med_Sci_2011_Feb_3(2)_82-84.nxml.txt.nlp	22540071	SENT14	0	0	4	4	sulfamethoxazole	CYP2C9	PA451544	1559	0.945
NULL	Ann_Oncol_2014_Apr_26_25(4)_801-807.nxml.txt.nlp	24577117	SENT7	15	15	3	3	cetuximab	p16	PA10040	1029	0.945
NULL	J_Exp_Bot_2012_Feb_3_63(3)_1479-1493.nxml.txt.nlp	22140239	SENT75	26	26	14	14	nitroprusside	flower	PA451406	11094	0.945
NULL	Curr_Oncol_2009_Jul_16(Suppl_2)_S14-S23.nxml.txt.nlp	19672417	SENT17	20	20	15	15	anastrozole	aromatase	PA448432	1588	0.945
NULL	Diabetes_Care_2010_Nov_33(11)_2399-2405.nxml.txt.nlp	20980427	SENT39	11	11	34	34	ranibizumab	CRT	PA164746012	811	0.945
NULL	Br_J_Pharmacol_2011_Jul_163(6)_1263-1275.nxml.txt.nlp	21391977	SENT9	17	17	22	22	ketoconazole	CYP3A4	PA450146	1576	0.945
NULL	Angiogenesis_2010_Dec_7_13(4)_305-315.nxml.txt.nlp	20927579	SENT133	23	23	6	6	resveratrol	TSP1		7057	0.945
NULL	Diabetes_Metab_Syndr_Obes_2010_Jul_20_3_263-273.nxml.txt.nlp	21437094	SENT109	1	1	18	18	exenatide	GLP-1	PA164749238	100125288	0.945
NULL	J_Exp_Clin_Cancer_Res_2009_Oct_7_28(1)_134.nxml.txt.nlp	19811659	SENT10	20	20	2	2	dasatinib	CD117	PA162372878	3815	0.945
NULL	Int_J_Biol_Sci_2011_Nov_5_8(1)_1-14.nxml.txt.nlp	22211100	SENT136	25	25	10	10	gemcitabine	PI3K	PA449748	5290	0.945
NULL	Indian_J_Pharmacol_2013_Mar-Apr_45(2)_155-158.nxml.txt.nlp	23716892	SENT116	31	31	10	10	pioglitazone	CYP2C9	PA450970	1559	0.945
NULL	Evid_Based_Complement_Alternat_Med_2006_Sep_5_3(3)_309-316.nxml.txt.nlp	16951715	SENT103	0	0	18	18	thyroglobulin	IFN	PA164754910	3439	0.945
NULL	Oncoscience_2014_Jun_6_1(6)_423-426.nxml.txt.nlp	25594040	SENT29	30	30	8	8	imatinib	PI3K	PA10804	5290	0.945
NULL	Front_Oncol_2011_Jun_17_1_10.nxml.txt.nlp	22655230	SENT144	11	11	8	8	irinotecan	DLL4	PA450085	54567	0.945
NULL	Drug_Des_Devel_Ther_2014_Sep_16_8_1391-1403.nxml.txt.nlp	25258509	SENT134	25	25	1	1	ethanol	ANOVA	PA448073	4858	0.945
NULL	Dermatoendocrinol_2013_Apr_1_5(2)_252-263.nxml.txt.nlp	24194965	SENT20	27	27	5	5	metformin	AMPK	PA450395	5563	0.945
NULL	eLife_2013_Nov_5_2_e00969.nxml.txt.nlp	24192036	SENT587	4	4	19	19	vemurafenib	JNK	PA165946873	5599	0.945
NULL	Front_Physiol_2013_Nov_14_4_323.nxml.txt.nlp	24294204	SENT200	35	35	8	8	carvedilol	CYP2D6	PA448817	1565	0.945
NULL	Toxins_(Basel)_2010_Mar_31_2(4)_517-551.nxml.txt.nlp	22069598	SENT374	2	2	20	20	resveratrol	Mcl-1		4170	0.945
NULL	Oncotarget_2014_Jun_30_5(14)_5591-5601.nxml.txt.nlp	25015320	SENT208	36	36	13	13	heparin	B27	PA449855	56246	0.945
NULL	Nat_Genet_2011_Feb_26_43(2)_117-120.nxml.txt.nlp	21186350	SENT2	16	16	9	9	metformin	ATM	PA450395	472	0.945
NULL	Iran_J_Pharm_Res_2013_Winter_12(Suppl)_37-46.nxml.txt.nlp	24250670	SENT43	13	13	18	18	verapamil	P-gp	PA451868	5243	0.945
NULL	Curr_Oncol_2006_Oct_13(5)_147-159.nxml.txt.nlp	22792012	SENT26	25	25	28	28	tamoxifen	aromatase	PA451581	1588	0.945
NULL	Front_Oncol_2013_Aug_12_3_206.nxml.txt.nlp	23964347	SENT23	29	29	8	8	cisplatin	BRCA2	PA449014	675	0.945
NULL	Biochemistry_2011_May_10_50(18)_3609-3620.nxml.txt.nlp	21410224	SENT17	11	11	2	2	methotrexate	DHFR	PA450428	1719	0.945
NULL	Oncogene_2010_May_20_29(20)_2983-2995.nxml.txt.nlp	20208560	SENT139	21	21	15	15	tamoxifen	FOXM1	PA451581	2305	0.945
NULL	J_Hepatol_2013_Aug_59(2)_318-326.nxml.txt.nlp	23624001	SENT150	17	17	24	24	bevacizumab	VEGF-A	PA130232992	7422	0.945
NULL	Breast_Cancer_Res_2014_May_5_16(3)_R45.nxml.txt.nlp	24887236	SENT191	5	5	24	24	lapatinib	HER2	PA152241907	2064	0.945
NULL	eLife_2014_Apr_15_3_e02238.nxml.txt.nlp	24737865	SENT460	19	19	8	8	paraformaldehyde	WISH	PA450790	51517	0.945
NULL	Br_J_Cancer_2012_Jun_5_106(12)_1997-2003.nxml.txt.nlp	22596232	SENT16	20	20	24	24	sorafenib	JNK	PA7000	5599	0.945
NULL	Cancer_Cell_Int_2009_Sep_10_9_25.nxml.txt.nlp	19744341	SENT15	16	16	24	24	glucosamine	STAT3	PA164747613	6774	0.945
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT37	8	8	31	31	ritonavir	ABCB1	PA451260	5243	0.945
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT191	3	3	11	11	procainamide	NAPA	PA451108	9476;8775	0.945
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_May_5_68(Pt_6)_o1640-o1641.nxml.txt.nlp	22719441	SENT71	11	11	27	27	ethanol	mol	PA448073	90527	0.945
NULL	J_Carcinog_2013_Dec_31_12_22.nxml.txt.nlp	24574860	SENT330	16	16	8	8	temsirolimus	EGFR	PA164746890	1956	0.945
NULL	Cell_Biol_Int_Rep_(2010)_2012_Jun_21_19(1)_e00017.nxml.txt.nlp	23124518	SENT90	8	8	17	17	etoposide	TRAIL	PA449552	8743	0.945
NULL	J_Thromb_Haemost_2010_Mar_8(3)_577-587.nxml.txt.nlp	20040043	SENT232	8	8	22	22	rosiglitazone	mol	PA451283	90527	0.945
NULL	Leukemia_2013_Jan_11_27(1)_32-40.nxml.txt.nlp	22781593	SENT174	11	11	32	32	ponatinib	FGFR1	PA165980594	2260	0.945
NULL	Br_J_Cancer_2006_Dec_4_95(11)_1483-1489.nxml.txt.nlp	17106442	SENT33	16	16	8	8	gefitinib	EGFR	PA131301952	1956	0.945
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Dec_16_66(Pt_1)_o140.nxml.txt.nlp	21580032	SENT61	11	11	3	3	ethanol	mol	PA448073	90527	0.945
NULL	Arthritis_Res_Ther_2010_Aug_23_12(4)_213.nxml.txt.nlp	20735863	SENT125	21	21	1	1	bleomycin	LPA	PA448645	4018	0.945
NULL	Oncotarget_2014_Mar_16_5(12)_4087-4102.nxml.txt.nlp	24961479	SENT133	11	11	20	20	hemin	PC3	PA449849	57332;7832;5122	0.945
NULL	Int_J_Cell_Biol_2013_Sep_3_2013_642853.nxml.txt.nlp	24082883	SENT143	0	0	9	9	camptothecin	EWS	PA153590860	2130	0.945
NULL	Int_J_Womens_Health_2012_Sep_3_4_455-469.nxml.txt.nlp	23071416	SENT87	10	10	1	1	risedronate	NNT	PA451255	23530	0.945
NULL	Int_J_Mol_Sci_2014_Mar_10_15(3)_4201-4220.nxml.txt.nlp	24619193	SENT20	25	25	5	5	vinblastine	IL-2	PA451877	3558	0.945
NULL	Mol_Vis_2012_Nov_29_18_2839-2846.nxml.txt.nlp	23233786	SENT188	17	17	26	26	geldanamycin	CB2	PA152031327	1269	0.945
NULL	Scientifica_(Cairo)_2012_Dec_17_2012_502378.nxml.txt.nlp	24278706	SENT103	31	31	24	24	verapamil	P-gp	PA451868	5243	0.945
NULL	Indian_Pacing_Electrophysiol_J_2011_Mar_25_11(2)_50-55.nxml.txt.nlp	21468249	SENT25	1	1	7	7	heparin	ACT	PA449855	12;11332;9457;641455	0.945
NULL	Mol_Med_Rep_2015_Jan_22_11(1)_83-90.nxml.txt.nlp	25338529	SENT3	12	12	30	30	octreotide	HO-1	PA450678	3162	0.945
NULL	Breast_Cancer_Res_2013_Nov_29_15(6)_R114.nxml.txt.nlp	24289103	SENT269	24	24	7	7	tamoxifen	EGFR	PA451581	1956	0.945
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_13_2014_849783.nxml.txt.nlp	25477998	SENT102	19	19	11	11	isoproterenol	Bcl-2	PA450121	596	0.945
NULL	Clin_Infect_Dis_2013_Mar_1_56(5)_694-696.nxml.txt.nlp	23175557	SENT30	6	6	30	30	primaquine	G6PD	PA451103	2539	0.945
NULL	EMBO_J_2009_Jun_17_28(12)_1679-1680.nxml.txt.nlp	19532144	SENT22	21	21	7	7	galactose	Set1	PA449725	9739	0.945
NULL	Acta_Pharmacol_Sin_2012_May_16_33(5)_682-690.nxml.txt.nlp	22504904	SENT169	9	9	36	36	celecoxib	Bcl-2	PA448871	596	0.945
NULL	Oncogene_2014_Sep_11_33(37)_4579-4588.nxml.txt.nlp	24662835	SENT78	43	43	3	3	estradiol	MAGEA2	PA449503	4101;266740	0.945
NULL	Acta_Pharmacol_Sin_2012_Aug_23_33(8)_1095-1100.nxml.txt.nlp	22820908	SENT108	36	36	47	47	lansoprazole	CYP3A4	PA450180	1576	0.945
NULL	Lab_Invest_2011_Oct_18_91(10)_1414-1426.nxml.txt.nlp	21769085	SENT146	3	3	32	32	gefitinib	EGF	PA131301952	1950	0.945
NULL	Int_J_Mol_Sci_2014_Jun_3_15(6)_9826-9843.nxml.txt.nlp	24897020	SENT298	12	12	0	0	ribavirin	IL28B	PA451241	282617	0.945
NULL	Osteoarthritis_Cartilage_2013_Sep_21(9)_1336-1345.nxml.txt.nlp	23973148	SENT17	10	10	17	17	triamcinolone	MNX	PA451749	3892	0.945
NULL	Br_J_Pharmacol_2014_Oct_26_171(20)_4785-4796.nxml.txt.nlp	25074741	SENT268	1	1	30	30	guanfacine	NK1R	PA449825	6869	0.945
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT771	1	1	9	9	vemurafenib	BRAF	PA165946873	673	0.945
NULL	J_Geriatr_Cardiol_2013_Jun_10(2)_151-158.nxml.txt.nlp	23888175	SENT229	4	4	24	24	rosuvastatin	AT1	PA134308647	9197;185	0.945
NULL	Braz_J_Med_Biol_Res_2013_Jul_2_46(6)_465-485.nxml.txt.nlp	23828584	SENT222	0	0	23	23	lisinopril	GGH	PA450242	8836	0.945
NULL	Cell_Biol_Int_Rep_(2010)_2012_Jun_21_19(1)_e00017.nxml.txt.nlp	23124518	SENT101	21	21	13	13	etoposide	Mcl-1	PA449552	4170	0.945
NULL	Pharmaceuticals_(Basel)_2012_Jul_25_5(8)_779-801.nxml.txt.nlp	24280675	SENT79	2	2	24	24	geldanamycin	HOP	PA152031327	84525;10963	0.945
NULL	Cardiol_Res_Pract_2012_Mar_20_2012_656247.nxml.txt.nlp	22536531	SENT91	0	0	29	29	nebivolol	DDAH	PA151958426	23576	0.945
NULL	EJNMMI_Res_2011_Jun_20_1_7.nxml.txt.nlp	22214546	SENT34	26	26	36	36	rituximab	CHOP	PA451261	1649	0.945
NULL	J_Hematol_Oncol_2012_May_15_5_23.nxml.txt.nlp	22587422	SENT19	17	17	13	13	dasatinib	ALL	PA162372878	613	0.945
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT12	2	2	13	13	dasatinib	PP2	PA162372878	4888	0.945
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT331	10	10	48	48	lapatinib	HER3	PA152241907	2065	0.945
NULL	Indian_J_Pharm_Sci_2013_Nov-Dec_75(6)_680-687.nxml.txt.nlp	24591743	SENT70	2	2	14	14	gemfibrozil	CYP2C8	PA449750	1558	0.945
NULL	Cancers_(Basel)_2011_Aug_15_3(3)_3331-3352.nxml.txt.nlp	24212957	SENT233	8	8	25	25	bevacizumab	CD133	PA130232992	8842	0.945
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT213	33	33	11	11	nifedipine	CYP3A	PA450631	1574	0.945
NULL	Breast_Cancer_Res_2014_Sep_9_16(5)_433.nxml.txt.nlp	25212966	SENT228	11	11	44	44	aprotinin	ILEI	PA448472	10447	0.945
NULL	Int_J_Biol_Sci_2013_Dec_17_10(1)_64-72.nxml.txt.nlp	24391452	SENT16	34	34	32	32	ketanserin	5-HT2A	PA131053734	3356	0.945
NULL	Front_Immunol_2013_Nov_7_4_360.nxml.txt.nlp	24223576	SENT184	0	0	15	15	imiquimod	IRF5	PA449972	3663	0.945
NULL	Br_J_Cancer_2010_Nov_9_103(11)_1692-1697.nxml.txt.nlp	21063402	SENT61	15	15	38	38	mitoxantrone	TRAIL	PA450526	8743	0.945
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT10	27	27	18	18	gefitinib	AKT	PA131301952	207	0.945
NULL	J_Neurol_2013_Jan_30_260(1)_93-99.nxml.txt.nlp	22752065	SENT27	0	0	9	9	clonazepam	MR-1	PA449050	25953	0.945
NULL	Br_J_Cancer_2012_Jun_5_106(12)_1926-1933.nxml.txt.nlp	22596235	SENT194	37	37	18	18	bevacizumab	MVD	PA130232992	4597	0.945
NULL	J_Hum_Genet_2013_Jun_2_58(6)_306-312.nxml.txt.nlp	23635953	SENT7	31	31	23	23	exemestane	aromatase	PA449563	1588	0.945
NULL	Breast_Cancer_Res_2011_Jun_20_13(3)_R65.nxml.txt.nlp	21689417	SENT337	10	10	15	15	trastuzumab	AKT	PA451743	207	0.945
NULL	Int_J_Endocrinol_Metab_2013_Jul_1_Summer_11(3)_184-190.nxml.txt.nlp	24348591	SENT130	30	30	11	11	liraglutide	INS-1	PA165958364	2305	0.945
NULL	Ann_Hematol_2011_Feb_17_90(2)_173-183.nxml.txt.nlp	20714724	SENT142	6	6	33	33	resveratrol	CD38		952	0.945
NULL	Nat_Med_2010_Feb_24_16(2)_214-218.nxml.txt.nlp	20098429	SENT49	10	10	0	0	doxorubicin	LAPTM4B	PA449412	55353	0.945
NULL	Cancers_(Basel)_2011_Apr_19_3(2)_2080-2105.nxml.txt.nlp	24212797	SENT136	10	10	13	13	cetuximab	KRAS	PA10040	3845	0.945
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT90	5	5	22	22	curcumin	DcR1	PA151958596	8794	0.945
NULL	Iran_J_Reprod_Med_2012_Mar_10(2)_149-154.nxml.txt.nlp	25242989	SENT37	13	13	19	19	estradiol	aromatase	PA449503	1588	0.945
NULL	Biol_Proced_Online_2002_Apr_8_3_70-78.nxml.txt.nlp	12734577	SENT136	13	13	8	8	indomethacin	mol	PA449982	90527	0.945
NULL	Int_J_Hypertens_2012_Dec_4_2012_789671.nxml.txt.nlp	23304452	SENT228	9	9	25	25	vasopressin	IRAP	PA451858	3557	0.945
NULL	Br_J_Nutr_2014_Oct_14_112(7)_1175-1184.nxml.txt.nlp	25119518	SENT230	19	19	0	0	creatine	PTI	PA164778930	5269	0.945
NULL	Hum_Genet_2015_Dec_9_134_231-245.nxml.txt.nlp	25487306	SENT208	7	7	4	4	cisplatin	CLPTM1L	PA449014	81037	0.945
NULL	Mol_Cells_2014_Nov_30_37(11)_812-818.nxml.txt.nlp	25377255	SENT9	26	26	3	3	doxorubicin	PARP-1	PA449412	25976	0.945
NULL	N_Am_J_Med_Sci_2011_Apr_3(4)_167-175.nxml.txt.nlp	22540086	SENT187	3	3	13	13	vatalanib	VEGFR	PA7001	3791	0.945
NULL	Cancer_Res_Treat_2012_Sep_30_44(3)_195-201.nxml.txt.nlp	23091446	SENT106	2	2	9	9	irinotecan	JNK	PA450085	5599	0.945
NULL	Breast_Cancer_Res_2007_Jun_15_9(3)_R38.nxml.txt.nlp	17573968	SENT152	33	33	14	14	fulvestrant	BMI1	PA164747170	648	0.945
NULL	J_Histochem_Cytochem_2013_Feb_61(2)_101-115.nxml.txt.nlp	23092791	SENT481	8	8	20	20	bevacizumab	CXCL6	PA130232992	6372	0.945
NULL	Front_Oncol_2014_Jun_13_4_141.nxml.txt.nlp	24982846	SENT36	33	33	30	30	vemurafenib	BRAF	PA165946873	673	0.945
NULL	Breast_Cancer_Res_2010_Apr_9_12(2)_202.nxml.txt.nlp	20398329	SENT149	14	14	3	3	trastuzumab	PTEN	PA451743	5728	0.945
NULL	J_Physiol_2009_Feb_15_587(Pt_4)_731-744.nxml.txt.nlp	19074966	SENT84	23	23	31	31	taurine	PAT1	PA451590	10513;206358	0.945
NULL	Breast_Cancer_Res_2014_Dec_19_16(6)_499.nxml.txt.nlp	25522654	SENT42	38	38	30	30	estradiol	aromatase	PA449503	1588	0.945
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT6	30	30	7	7	imatinib	ABCG2	PA10804	9429	0.945
NULL	Ann_Rheum_Dis_2008_Jul_26_67(7)_917-925.nxml.txt.nlp	17965121	SENT98	13	13	0	0	rituximab	CD19	PA451261	930	0.945
NULL	Mol_Cell_Proteomics_2014_Mar_20_13(3)_701-715.nxml.txt.nlp	24361865	SENT1098	8	8	3	3	daunorubicin	AKR1B10	PA449212	57016	0.945
NULL	Infect_Drug_Resist_2011_Feb_3_4_43-53.nxml.txt.nlp	21694908	SENT51	13	13	28	28	voriconazole	CYP3A4	PA10233	1576	0.945
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Aug_8_65(Pt_9)_o2077-o2078.nxml.txt.nlp	21577497	SENT73	32	32	12	12	ethanol	mol	PA448073	90527	0.945
NULL	Brain_Res_2011_Mar_25_1382(C)_29-36.nxml.txt.nlp	21276431	SENT39	0	0	20	20	ketanserin	5-HT4	PA131053734	3360	0.945
NULL	Br_J_Cancer_2010_Dec_7_103(12)_1765-1772.nxml.txt.nlp	21139621	SENT94	15	15	7	7	cetuximab	TP53	PA10040	7157	0.945
NULL	J_Int_Soc_Sports_Nutr_2009_Aug_5_6_16.nxml.txt.nlp	19656392	SENT281	0	0	36	36	creatine	MEF-2	PA164778930	50804	0.945
NULL	Biosci_Rep_2012_Aug_1_32(Pt_4)_361-374.nxml.txt.nlp	22762204	SENT142	19	19	34	34	trastuzumab	PTEN	PA451743	5728	0.945
NULL	J_Geriatr_Cardiol_2012_Jun_9(2)_209-210.nxml.txt.nlp	23097648	SENT11	20	20	7	7	warfarin	VKORC1	PA451906	79001	0.945
NULL	J_Mol_Signal_2010_Feb_18_5_1.nxml.txt.nlp	20167101	SENT123	8	8	32	32	metformin	AMPK	PA450395	5563	0.945
NULL	J_Gynecol_Oncol_2013_Jan_8_24(1)_83-91.nxml.txt.nlp	23346317	SENT73	44	44	18	18	cisplatin	AGO	PA449014	55294	0.945
NULL	Acta_Pharmacol_Sin_2014_Jan_16_35(1)_48-57.nxml.txt.nlp	24335843	SENT121	20	20	2	2	doxazosin	ANOVA	PA449407	4858	0.945
NULL	Breast_Cancer_(Auckl)_2012_Feb_20_6_47-66.nxml.txt.nlp	22399860	SENT172	4	4	24	24	tamoxifen	RARG	PA451581	5916	0.945
NULL	Ann_Hematol_2010_Nov_25_89(11)_1115-1124.nxml.txt.nlp	20499237	SENT103	14	14	5	5	simvastatin	CD19	PA451363	930	0.945
NULL	Br_J_Cancer_2010_Jan_5_102(1)_97-103.nxml.txt.nlp	19904270	SENT156	9	9	0	0	doxorubicin	XIAP	PA449412	331	0.945
NULL	Oncol_Lett_2014_Mar_15_7(3)_805-806.nxml.txt.nlp	24527088	SENT55	11	11	3	3	erlotinib	EGFR	PA134687924	1956	0.945
NULL	Oncotarget_2012_Sep_28_3(10)_1169-1181.nxml.txt.nlp	23045411	SENT34	40	40	22	22	doxorubicin	JIP1	PA449412	9479	0.945
NULL	Infect_Dis_Rep_2013_Jun_6_5(Suppl_1)_e5.nxml.txt.nlp	24470969	SENT98	8	8	13	13	enfuvirtide	CCR5	PA164744517	1234	0.945
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT404	21	21	4	4	cetuximab	KRAS	PA10040	3845	0.945
NULL	Breast_Cancer_Res_2009_Mar_19_11(2)_204.nxml.txt.nlp	19344489	SENT240	41	41	21	21	paclitaxel	HER2	PA450761	2064	0.945
NULL	Curr_Neuropharmacol_2013_Mar_11(2)_171-185.nxml.txt.nlp	23997752	SENT281	11	11	33	33	reboxetine	ERK1	PA144614921	5595	0.945
NULL	Aging_(Albany_NY)_2010_Dec_20_2(12)_959-968.nxml.txt.nlp	21191146	SENT143	13	13	24	24	cisplatin	AMPK	PA449014	5563	0.945
NULL	Clin_Ophthalmol_2009_Jun_2_3_199-210.nxml.txt.nlp	19668566	SENT84	40	40	4	4	ketorolac	COX	PA450150	1351	0.945
NULL	Tuberc_Respir_Dis_(Seoul)_2013_Nov_29_75(5)_188-198.nxml.txt.nlp	24348666	SENT177	11	11	5	5	crizotinib	EGFR	PA165946122	1956	0.945
NULL	Oncogenesis_2014_Dec_15_3(12)_e133.nxml.txt.nlp	25500906	SENT28	14	14	23	23	trastuzumab	HER2	PA451743	2064	0.945
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_May_22_66(Pt_6)_o1397.nxml.txt.nlp	21579476	SENT47	8	8	39	39	benzaldehyde	mol	PA448571	90527	0.945
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1059-1066.nxml.txt.nlp	21364577	SENT131	16	16	2	2	letrozole	ATAC	PA450196	6375	0.945
NULL	Cell_Death_Dis_2014_Feb_27_5(2)_e1088.nxml.txt.nlp	24577086	SENT80	29	29	24	24	metformin	Bcl-2	PA450395	596	0.945
NULL	FEBS_Open_Bio_2012_Jul_20_2_179-186.nxml.txt.nlp	23650597	SENT141	38	38	24	24	imiquimod	IFN	PA449972	3439	0.945
NULL	Cells_2012_Sep_28_1(4)_699-710.nxml.txt.nlp	24710526	SENT41	18	18	4	4	heparin	HMGB1	PA449855	3146	0.945
NULL	J_Thorac_Oncol_2014_Jun_30_9(6)_775-783.nxml.txt.nlp	24828661	SENT307	10	10	2	2	gefitinib	PIK3CA	PA131301952	5290	0.945
NULL	Breast_Cancer_Res_2011_Apr_14_13(2)_R43.nxml.txt.nlp	21492444	SENT152	6	6	24	24	tamoxifen	HER2	PA451581	2064	0.945
NULL	Curr_Oncol_2009_Sep_16(5)_91-110.nxml.txt.nlp	NULL	SENT891	22	22	18	18	cisplatin	BRCA1	PA449014	672	0.945
NULL	Ethiop_J_Health_Sci_2011_Nov_21(3)_175-182.nxml.txt.nlp	22434997	SENT46	6	6	34	34	mannitol	CO2	PA450320	4513	0.945
NULL	Front_Neural_Circuits_2014_Nov_7_8_134.nxml.txt.nlp	25426030	SENT350	0	0	16	16	pentamidine	OCT2	PA450850	6582;5452	0.945
NULL	Eur_J_Clin_Pharmacol_2011_May_2_67(Suppl_1)_87-107.nxml.txt.nlp	21287160	SENT82	24	24	6	6	irinotecan	UGT1A	PA450085	7361;54658	0.945
NULL	Cancer_Cell_Int_2009_Aug_18_9_23.nxml.txt.nlp	19689790	SENT197	0	0	8	8	hyperforin	TRPC6	PA165985514	7225	0.945
NULL	Acta_Pharmacol_Sin_2011_Jul_13_32(7)_967-972.nxml.txt.nlp	21666702	SENT141	8	8	44	44	losartan	P-gp	PA450268	5243	0.945
NULL	J_Inflamm_(Lond)_2006_Jul_12_3_10.nxml.txt.nlp	16834783	SENT127	0	0	12	12	mometasone	IL-8	PA450541	3576	0.945
NULL	Eur_J_Clin_Pharmacol_2011_May_9_67(5)_477-482.nxml.txt.nlp	21305273	SENT117	25	25	7	7	dobutamine	ADRB1	PA449381	153	0.945
NULL	Acta_Neuropathol_2015_Oct_17_129_115-131.nxml.txt.nlp	25322816	SENT255	14	14	10	10	bevacizumab	LDHA	PA130232992	3939	0.945
NULL	Aging_(Albany_NY)_2009_Mar_31_1(4)_412-424.nxml.txt.nlp	20195491	SENT124	11	11	35	35	resveratrol	AMPK		5563	0.945
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT312	30	30	18	18	hydrocortisone	EGF	PA449905	1950	0.945
NULL	Curr_Pharm_Des_2011_Feb_17(6)_578-590.nxml.txt.nlp	21391908	SENT178	21	21	5	5	nutlin-3	p53		7157	0.945
NULL	BMB_Rep_2014_Nov_47(11)_649-654.nxml.txt.nlp	25301019	SENT161	17	17	36	36	l-alanine	CCL2	PA448055	6347	0.945
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1137-1144.nxml.txt.nlp	20234366	SENT147	20	20	35	35	cetuximab	MKP-1	PA10040	1843	0.945
NULL	J_Cell_Mol_Med_2014_May_18_18(5)_875-884.nxml.txt.nlp	24533641	SENT246	41	41	10	10	nadh	HIF-1	PA164755085	29072	0.945
NULL	Cardiovasc_Ther_2009_27(4)_259-274.nxml.txt.nlp	19604248	SENT127	23	23	0	0	clopidogrel	IPA	PA449053	3160	0.945
NULL	Mol_Cancer_2009_Jul_3_8_43.nxml.txt.nlp	19575780	SENT138	25	25	5	5	colchicine	survivin	PA449092	332	0.945
NULL	Mar_Drugs_2014_Mar_7_12(3)_1377-1389.nxml.txt.nlp	24608973	SENT110	36	36	16	16	flavopiridol	CDK4	PA452627	1019	0.945
NULL	Adv_Virol_2011_Mar_24_2011_260561.nxml.txt.nlp	22312337	SENT103	13	13	28	28	foscarnet	OTC	PA449706	5009	0.945
NULL	Aging_(Albany_NY)_2011_Dec_12_3(11)_1063-1077.nxml.txt.nlp	22170748	SENT56	14	14	29	29	metformin	AMPK	PA450395	5563	0.945
NULL	J_Cell_Biol_2005_Nov_7_171(3)_505-516.nxml.txt.nlp	16275754	SENT131	15	15	25	25	pp2	MEK1		5604	0.945
NULL	Br_J_Cancer_2009_Oct_6_101(7)_1155-1161.nxml.txt.nlp	19738614	SENT9	24	24	2	2	gemcitabine	MUC4	PA449748	4585	0.945
NULL	Acta_Pharmacol_Sin_2010_May_12_31(5)_578-584.nxml.txt.nlp	20383171	SENT158	21	21	15	15	berberine	JNK	PA165860812	5599	0.945
NULL	Ann_Saudi_Med_2011_May-Jun_31(3)_279-283.nxml.txt.nlp	21623058	SENT23	28	28	20	20	basiliximab	IL-2	PA164747126	3558	0.945
NULL	Biologics_2009_Oct_12_3_469-474.nxml.txt.nlp	19851472	SENT98	32	32	6	6	montelukast	IL-5	PA450546	3567	0.945
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT83	3	3	10	10	metformin	AKT	PA450395	207	0.945
NULL	Tumour_Biol_2014_Aug_13_35(10)_9447-9457.nxml.txt.nlp	25117071	SENT96	11	11	19	19	clopidogrel	CD40L	PA449053	959	0.945
NULL	Clin_Ophthalmol_2014_Jun_26_8_1213-1219.nxml.txt.nlp	25061267	SENT151	8	8	16	16	tetracaine	PRK	PA451638	1263	0.945
NULL	Breast_Cancer_Res_2005_Jan_26_7(2)_R267-R273.nxml.txt.nlp	15743507	SENT28	9	9	0	0	trastuzumab	ERBB2	PA451743	2064	0.945
NULL	Cancer_Cell_Int_2013_Jun_26_13_63.nxml.txt.nlp	23800022	SENT223	27	27	9	9	genistein	MDM2	PA165109660	4193	0.945
NULL	Spermatogenesis_2013_Apr_1_3(2)_e24194.nxml.txt.nlp	23885303	SENT117	9	9	4	4	staurosporine	PARP	PA165109623	142	0.945
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT37	19	19	24	24	tamoxifen	TFF3	PA451581	7033	0.945
NULL	J_Thyroid_Res_2010_Apr_13_2010_279468.nxml.txt.nlp	21048836	SENT415	0	0	16	16	gefitinib	EGFR	PA131301952	1956	0.945
NULL	Mol_Biol_Int_2011_Jun_8_2011_571242.nxml.txt.nlp	22091408	SENT380	4	4	9	9	lovastatin	P-gp	PA450272	5243	0.945
NULL	Cells_2014_Apr_29_3(2)_331-362.nxml.txt.nlp	24785347	SENT68	0	0	33	33	capsaicin	TRPV1	PA448776	7442	0.945
NULL	Cardiovasc_Ther_2009_27(4)_259-274.nxml.txt.nlp	19604248	SENT58	28	28	0	0	ticagrelor	ADP	PA165374673	23038	0.945
NULL	Support_Care_Cancer_2011_Mar_16_19(3)_353-361.nxml.txt.nlp	20157746	SENT39	19	19	1	1	cyclophosphamide	CTX	PA449165	1593	0.945
NULL	Indian_J_Med_Res_2014_Jun_139(6)_913-920.nxml.txt.nlp	25109726	SENT63	37	37	5	5	vancomycin	C23	PA451850	4691	0.945
NULL	Oncotarget_2013_Dec_18_5(2)_375-385.nxml.txt.nlp	24495868	SENT106	20	20	8	8	fludarabine	MCL1	PA449655	4170	0.945
NULL	AIDS_Res_Ther_2013_May_1_10_10.nxml.txt.nlp	23634877	SENT148	5	5	31	31	atorvastatin	ANOVA	PA448500	4858	0.945
NULL	Environ_Health_Perspect_2005_Jun_10_113(6)_659-664.nxml.txt.nlp	15929885	SENT41	6	6	14	14	arsenite	p38	PA452638	10598;1432;7965	0.945
NULL	Open_Access_J_Urol_2010_Mar_12_2_35-40.nxml.txt.nlp	24198612	SENT71	8	8	13	13	sunitinib	VEGFR2	PA162372840	3791	0.945
NULL	Hum_Mol_Genet_2013_Feb_15_22(4)_795-803.nxml.txt.nlp	23175443	SENT218	25	25	16	16	heparin	FGF1	PA449855	2246	0.945
NULL	Patient_Prefer_Adherence_2008_Feb_2_2_233-240.nxml.txt.nlp	19920968	SENT139	0	0	18	18	paliperidone	5-HT2A	PA163518919	3356	0.945
NULL	Crit_Care_2005_Aug_25_9(Suppl_4)_S38-S45.nxml.txt.nlp	16168074	SENT135	16	16	30	30	thrombin	PAR-1	PA451674	2011;2149	0.945
NULL	Ann_Hematol_2013_Apr_13_92(4)_481-486.nxml.txt.nlp	23238896	SENT3	37	37	31	31	vincristine	CHOP	PA451879	1649	0.945
NULL	Biologics_2010_May_25_4_139-145.nxml.txt.nlp	20531970	SENT83	4	4	32	32	eltrombopag	TPO	PA165981594	7066;7173	0.945
NULL	Diabetes_Care_2011_Jun_20_34(6)_1265-1269.nxml.txt.nlp	21515846	SENT148	13	13	7	7	ramipril	DREAM	PA451223	30818	0.945
NULL	Biofactors_2014_May_6_40(3)_277-283.nxml.txt.nlp	24353111	SENT78	3	3	27	27	choline	BHMT	PA448976	635	0.945
NULL	Cardiovasc_Diabetol_2013_Jan_31_12_28.nxml.txt.nlp	23368770	SENT110	28	28	6	6	glucose	DIA	PA449773	1730;3976	0.945
NULL	Evid_Based_Complement_Alternat_Med_2011_Jun_16_2011_471074.nxml.txt.nlp	21808653	SENT216	7	7	16	16	curcumin	COX2	PA151958596	4513;5743	0.945
NULL	Diabetes_Care_2008_Oct_31(10)_1939-1944.nxml.txt.nlp	18599530	SENT162	24	24	11	11	gliclazide	ABCC8	PA10892	6833	0.945
NULL	Eur_J_Med_Res_2011_Apr_28_16(4)_159-166.nxml.txt.nlp	21486730	SENT211	20	20	7	7	caspofungin	CYP3A4	PA164743013	1576	0.945
NULL	Br_J_Pharmacol_2014_Oct_26_171(20)_4785-4796.nxml.txt.nlp	25074741	SENT205	20	20	5	5	guanfacine	TACR1	PA449825	6869	0.945
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT267	15	15	7	7	resveratrol	NAC		22861	0.945
NULL	Fibrogenesis_Tissue_Repair_2012_Jul_23_5_11.nxml.txt.nlp	22824096	SENT371	2	2	29	29	thrombin	PAR-1	PA451674	2011;2149	0.945
NULL	Nucleic_Acids_Res_2012_Jun_22_40(11)_4861-4878.nxml.txt.nlp	22362753	SENT251	0	0	29	29	trypsin	NPM2	PA451806	10361	0.945
NULL	Pharmaceuticals_(Basel)_2012_Nov_20_5(11)_1236-1264.nxml.txt.nlp	24281308	SENT148	7	7	25	25	staurosporine	PI3K	PA165109623	5290	0.945
NULL	Oxid_Med_Cell_Longev_2013_Jun_2_2013_793525.nxml.txt.nlp	23819014	SENT122	3	3	16	16	resveratrol	PI3K		5290	0.945
NULL	Arthritis_Res_Ther_2006_Apr_12_8(Suppl_1)_S3.nxml.txt.nlp	16820042	SENT21	36	36	23	23	colchicine	MSU	PA449092	593	0.945
NULL	Indian_J_Endocrinol_Metab_2012_Jul-Aug_16(4)_525-527.nxml.txt.nlp	22837910	SENT24	5	5	10	10	exenatide	GLP-1	PA164749238	100125288	0.945
NULL	Eur_J_Clin_Pharmacol_2013_Mar_5_69(3)_467-475.nxml.txt.nlp	22864379	SENT29	25	25	4	4	warfarin	VKORC1	PA451906	79001	0.945
NULL	Front_Microbiol_2014_Mar_14_5_99.nxml.txt.nlp	24672516	SENT93	10	10	3	3	voriconazole	TLR4	PA10233	7099	0.945
NULL	Biomed_Res_Int_2014_Aug_6_2014_967826.nxml.txt.nlp	25165721	SENT352	25	25	6	6	cisplatin	HO-1	PA449014	3162	0.945
NULL	J_Hematol_Oncol_2008_Aug_14_1_12.nxml.txt.nlp	18702822	SENT168	4	4	16	16	trastuzumab	TOP2A	PA451743	7153	0.945
NULL	Clinics_(Sao_Paulo)_2013_Jun_68(6)_766-771.nxml.txt.nlp	23778483	SENT24	6	6	8	8	hydroxychloroquine	IL-6	PA164777036	3569	0.945
NULL	F1000Res_2013_Oct_3_2_202.nxml.txt.nlp	24795806	SENT44	23	23	14	14	panitumumab	EGFR	PA162373091	1956	0.945
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1135-1143.nxml.txt.nlp	21364580	SENT24	14	14	20	20	trastuzumab	ERBB2	PA451743	2064	0.945
NULL	Chin_J_Cancer_2012_Feb_31(2)_58-72.nxml.txt.nlp	22098952	SENT202	17	17	3	3	sildenafil	MRP5	PA451346	10057	0.945
NULL	Mol_Cancer_2010_May_28_9_130.nxml.txt.nlp	20509890	SENT67	25	25	4	4	gemcitabine	TGFBI	PA449748	7045	0.945
NULL	Leukemia_2014_Mar_20_28(3)_554-565.nxml.txt.nlp	24280866	SENT208	39	39	34	34	doxycycline	IL-3	PA449415	3562	0.945
NULL	Alcohol_Res_2013_35(1)_97-113.nxml.txt.nlp	24313169	SENT200	12	12	0	0	ethanol	ACSS1	PA448073	84532	0.945
NULL	Front_Neurosci_2013_Jun_17_7_109.nxml.txt.nlp	23785312	SENT144	9	9	23	23	vasopressin	ACTH	PA451858	5443	0.945
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jul_1_65(Pt_8)_m846.nxml.txt.nlp	21583316	SENT61	10	10	25	25	ethanol	mol	PA448073	90527	0.945
NULL	Case_Rep_Hematol_2013_Feb_3_2013_837906.nxml.txt.nlp	23431487	SENT40	27	27	5	5	desmopressin	FVIII	PA449237	2157	0.945
NULL	Breast_Cancer_Res_2002_Jun_21_4(5)_R9.nxml.txt.nlp	12223126	SENT81	4	4	13	13	tamoxifen	FasL	PA451581	356	0.945
NULL	J_Oncol_2009_Jul_14_2009_804108.nxml.txt.nlp	19636422	SENT34	21	21	5	5	gefitinib	EGFR	PA131301952	1956	0.945
NULL	Clin_Exp_Pharmacol_2014_Jan_1_4(1)_142.nxml.txt.nlp	25105064	SENT65	13	13	2	2	capsaicin	ANOVA	PA448776	4858	0.945
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT83	3	3	8	8	metformin	EGFR	PA450395	1956	0.945
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT37	19	19	6	6	tamoxifen	TFF3	PA451581	7033	0.945
NULL	Exp_Brain_Res_2014_Jun_27_232(8)_2637-2644.nxml.txt.nlp	24969614	SENT169	39	39	2	2	palonosetron	NK1	PA10352	11126	0.945
NULL	Cent_European_J_Urol_2011_Dec_9_64(4)_256-257.nxml.txt.nlp	24578906	SENT13	24	24	13	13	doxazosin	CD133	PA449407	8842	0.945
NULL	Eur_J_Clin_Pharmacol_2014_Oct_8_70(1)_37-45.nxml.txt.nlp	24100471	SENT15	6	6	32	32	pioglitazone	CYP2C19	PA450970	1557	0.945
NULL	J_Cardiovasc_Dis_Res_2012_Oct-Dec_3(4)_319-322.nxml.txt.nlp	23233778	SENT13	3	3	9	9	clarithromycin	CYP3A4	PA449028	1576	0.945
NULL	Oncotarget_2014_Jun_9_5(13)_5076-5086.nxml.txt.nlp	24970803	SENT27	28	28	4	4	cyclophosphamide	PARP-1	PA449165	25976	0.945
NULL	J_Signal_Transduct_2011_Feb_24_2011_804236.nxml.txt.nlp	21637380	SENT26	42	42	16	16	trastuzumab	EGFR	PA451743	1956	0.945
NULL	Oncotarget_2013_Aug_29_4(10)_1673-1685.nxml.txt.nlp	24127549	SENT227	10	10	5	5	bortezomib	SIRT1	PA10252	23411	0.945
NULL	Oncotarget_2014_Oct_18_5(22)_11641-11652.nxml.txt.nlp	25361002	SENT85	29	29	8	8	cisplatin	NAC	PA449014	22861	0.945
NULL	Mol_Cancer_2013_Sep_11_12_104.nxml.txt.nlp	24025152	SENT18	27	27	22	22	gemcitabine	STAT3	PA449748	6774	0.945
NULL	Orphanet_J_Rare_Dis_2013_Sep_13_8_142.nxml.txt.nlp	24034279	SENT146	7	7	1	1	metoclopramide	AVP	PA450475	114548;551	0.945
NULL	J_Vet_Med_Sci_2014_Feb_8_76(2)_173-182.nxml.txt.nlp	24107430	SENT14	5	5	16	16	yohimbine	AVP	PA451946	114548;551	0.945
NULL	Cancer_Med_2012_Dec_26_1(3)_318-327.nxml.txt.nlp	23342281	SENT221	5	5	8	8	tamoxifen	aromatase	PA451581	1588	0.945
NULL	Oncoimmunology_2012_Oct_1_1(7)_1004-1016.nxml.txt.nlp	23170249	SENT46	13	13	5	5	paclitaxel	HER-2	PA450761	2064	0.945
NULL	Nat_Med_2010_Jun_23_16(6)_671-677.nxml.txt.nlp	20495567	SENT191	39	39	24	24	sorafenib	ATF5	PA7000	22809	0.945
NULL	Mol_Neurodegener_2011_Aug_16_6_58.nxml.txt.nlp	21846363	SENT75	10	10	7	7	candesartan	AT1	PA448765	9197;185	0.945
NULL	J_Int_AIDS_Soc_2012_Jul_27_15(2)_17396.nxml.txt.nlp	22905358	SENT117	41	41	9	9	isoniazid	IPT	PA450112	54802	0.945
NULL	Comput_Struct_Biotechnol_J_2012_Oct_31_3_e201210005.nxml.txt.nlp	24688665	SENT143	18	18	1	1	nadh	PDH	PA164755085	54704	0.945
NULL	Genome_Med_2010_Aug_11_2(8)_53.nxml.txt.nlp	20701793	SENT118	11	11	17	17	everolimus	VEGFR	PA164746311	3791	0.945
NULL	Arthritis_Res_Ther_2010_Jan_22_12(1)_R11.nxml.txt.nlp	20096109	SENT162	6	6	10	10	infliximab	IFN	PA452639	3439	0.945
NULL	J_Asthma_Allergy_2008_Sep_19_1_19-29.nxml.txt.nlp	21436982	SENT45	20	20	11	11	fexofenadine	CYP3A4	PA449621	1576	0.945
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Dec_3_65(Pt_1)_o19.nxml.txt.nlp	21581644	SENT65	14	14	9	9	ethanol	mol	PA448073	90527	0.945
NULL	J_Inherit_Metab_Dis_2010_Oct_3_33(5)_625-632.nxml.txt.nlp	20814828	SENT108	35	35	9	9	simvastatin	RhoA	PA451363	387	0.945
NULL	Indian_J_Med_Res_2012_Sep_136(3)_391-403.nxml.txt.nlp	23041732	SENT168	33	33	45	45	epirubicin	HCC	PA449476	84668	0.945
NULL	Mol_Vis_2011_Aug_11_17_2157-2170.nxml.txt.nlp	21850191	SENT204	6	6	3	3	tacrolimus	p50	PA451578	958;4790	0.945
NULL	Eur_J_Immunol_2014_Jun_10_44(6)_1759-1769.nxml.txt.nlp	24595810	SENT67	3	3	24	24	fludrocortisone	CD62L	PA164743961	6402	0.945
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT166	18	18	4	4	cisplatin	IBP	PA449014	706;50619	0.945
NULL	J_Immunol_Res_2014_Jan_19_2014_103780.nxml.txt.nlp	24741572	SENT121	3	3	19	19	salmeterol	TAK1	PA451300	7182	0.945
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT6	45	45	3	3	tacrolimus	RANKL	PA451578	8600	0.945
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1420-1426.nxml.txt.nlp	24056704	SENT3	29	29	41	41	ketoconazole	CYP3A	PA450146	1574	0.945
NULL	Biomed_Res_Int_2014_Jan_15_2014_859871.nxml.txt.nlp	24527460	SENT126	20	20	7	7	doxorubicin	CD44	PA449412	960	0.945
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Dec_17_3(12)_e152.nxml.txt.nlp	25518025	SENT41	21	21	3	3	oxycodone	CYP3A	PA450741	1574	0.945
NULL	Asian-Australas_J_Anim_Sci_2014_Dec_27(12)_1783-1793.nxml.txt.nlp	25358373	SENT43	0	0	27	27	capsaicin	PPARG	PA448776	5468	0.945
NULL	Pharmaceutics_2012_Jun_18_4(2)_314-333.nxml.txt.nlp	24300234	SENT582	8	8	2	2	lopinavir	P-gp	PA450264	5243	0.945
NULL	Front_Oncol_2014_May_1_4_80.nxml.txt.nlp	24822169	SENT315	22	22	27	27	resveratrol	DNMT1		1786	0.945
NULL	Patient_Prefer_Adherence_2010_Mar_24_4_61-68.nxml.txt.nlp	20361006	SENT71	6	6	3	3	exenatide	GLP-1	PA164749238	100125288	0.945
NULL	Cancer_Res_Treat_2014_Jan_15_46(1)_55-64.nxml.txt.nlp	24520224	SENT159	5	5	0	0	oxaliplatin	ERCC1	PA131285527	2067	0.945
NULL	Br_J_Cancer_2013_Apr_16_108(7)_1408-1414.nxml.txt.nlp	23511562	SENT36	11	11	16	16	aminoglutethimide	aromatase	PA448375	1588	0.945
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT211	2	2	23	23	curcumin	DR4	PA151958596	8797	0.945
NULL	Ann_Lab_Med_2012_Jul_20_32(4)_270-275.nxml.txt.nlp	22779068	SENT105	15	15	35	35	ceftazidime	ACC-1	PA448861	597	0.945
NULL	Br_J_Cancer_2012_Nov_6_107(10)_1745-1753.nxml.txt.nlp	23099808	SENT155	28	28	3	3	gefitinib	CEACAM3	PA131301952	1084	0.945
NULL	Cell_Death_Dis_2013_Jul_11_4(7)_e719.nxml.txt.nlp	23846221	SENT196	26	26	20	20	cisplatin	TRAIL	PA449014	8743	0.945
NULL	J_Mol_Med_(Berl)_2014_May_10_92(7)_709-722.nxml.txt.nlp	24811491	SENT127	16	16	8	8	cetuximab	HER2	PA10040	2064	0.945
NULL	Angiogenesis_2012_Sep_27_15(3)_361-376.nxml.txt.nlp	22451299	SENT322	3	3	10	10	resveratrol	TSP1		7057	0.945
NULL	Pharmaceuticals_(Basel)_2012_Aug_10_5(8)_802-836.nxml.txt.nlp	24280676	SENT90	34	34	37	37	ribavirin	CNT2	PA451241	9153	0.945
NULL	Arthritis_Res_Ther_2008_Mar_19_10(2)_R36.nxml.txt.nlp	18353171	SENT219	19	19	3	3	paraformaldehyde	CD4	PA450790	920	0.945
NULL	Mol_Pain_2014_Apr_18_10_27.nxml.txt.nlp	24742127	SENT8	37	37	20	20	paclitaxel	CD11b	PA450761	3684	0.945
NULL	Br_J_Cancer_2009_Jun_2_100(11)_1697-1703.nxml.txt.nlp	19384299	SENT88	25	25	10	10	fludarabine	CD4	PA449655	920	0.945
NULL	J_Mater_Sci_Mater_Med_2012_Jul_20_23(7)_1637-1644.nxml.txt.nlp	22528070	SENT59	3	3	20	20	ethanol	PES	PA448073	23481	0.945
NULL	Evid_Based_Complement_Alternat_Med_2013_May_16_2013_857929.nxml.txt.nlp	23762164	SENT188	7	7	19	19	doxorubicin	AKT	PA449412	207	0.945
NULL	Chin_J_Cancer_2011_May_30(5)_287-292.nxml.txt.nlp	21527061	SENT64	22	22	7	7	carboplatin	EGFR	PA448803	1956	0.945
NULL	Acta_Pharmacol_Sin_2009_Sep_24_30(9)_1262-1275.nxml.txt.nlp	19701231	SENT229	24	24	8	8	lovastatin	CDC2	PA450272	5424	0.945
NULL	Ann_N_Y_Acad_Sci_2013_Mar_28_1280(1)_19-23.nxml.txt.nlp	23551097	SENT86	15	15	11	11	letrozole	PI3K	PA450196	5290	0.945
NULL	Environ_Health_Perspect_2005_Aug_15_113(8)_1009-1014.nxml.txt.nlp	16079071	SENT13	31	31	20	20	losartan	p38	PA450268	10598;1432;7965	0.945
NULL	Cancer_Med_2014_Jun_19_3(3)_555-564.nxml.txt.nlp	24648042	SENT138	10	10	22	22	rituximab	NOTCH1	PA451261	4851	0.945
NULL	Osteoporos_Int_2014_Dec_4_25(3)_1141-1150.nxml.txt.nlp	24301537	SENT297	12	12	10	10	denosumab	RANKL	PA166048634	8600	0.945
NULL	J_Am_Heart_Assoc_2013_Aug_23_2(4)_e000318.nxml.txt.nlp	23926118	SENT54	21	21	4	4	isoproterenol	AC3	PA450121	109	0.945
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT103	2	2	19	19	trastuzumab	HER2	PA451743	2064	0.945
NULL	Case_Rep_Rheumatol_2013_Dec_17_2013_923497.nxml.txt.nlp	24455384	SENT59	7	7	23	23	etanercept	IL6	PA449515	3569	0.945
NULL	J_Oncol_2009_Mar_24_2009_491985.nxml.txt.nlp	19325924	SENT85	22	22	13	13	genistein	CXCL12	PA165109660	6387	0.945
NULL	Evid_Based_Complement_Alternat_Med_2013_Mar_28_2013_291972.nxml.txt.nlp	23606876	SENT139	12	12	7	7	ketanserin	5-HT1A	PA131053734	3350	0.945
NULL	Open_Biochem_J_2011_Sep_23_5_45-51.nxml.txt.nlp	21966325	SENT81	30	30	7	7	indomethacin	XBP1	PA449982	7494	0.945
NULL	Breast_Cancer_Res_2008_Dec_18_10(Suppl_4)_S18.nxml.txt.nlp	19128431	SENT62	37	37	35	35	letrozole	aromatase	PA450196	1588	0.945
NULL	Ann_Oncol_2011_Mar_8_22(3)_503-514.nxml.txt.nlp	20616198	SENT210	6	6	4	4	anastrozole	aromatase	PA448432	1588	0.945
NULL	Cancers_(Basel)_2014_Apr_3_6(2)_771-795.nxml.txt.nlp	24704793	SENT184	24	24	9	9	camptothecin	BRCA1	PA153590860	672	0.945
NULL	Oncotarget_2011_Sep_9_2(9)_658-668.nxml.txt.nlp	21911919	SENT59	15	15	8	8	cytarabine	HO-1	PA449177	3162	0.945
NULL	Sci_Rep_2015_Jan_6_5_7641.nxml.txt.nlp	25560734	SENT96	14	14	8	8	tamoxifen	CLTC	PA451581	1213	0.945
NULL	Atherosclerosis_2011_Nov_219(1)_109-115.nxml.txt.nlp	21820657	SENT181	11	11	7	7	probucol	CETP	PA451107	1071	0.945
NULL	Curr_Oncol_2009_May_16(Suppl_1)_S52-S59.nxml.txt.nlp	19478903	SENT51	31	31	12	12	sorafenib	CYP3A4	PA7000	1576	0.945
NULL	Br_J_Cancer_2012_Jan_3_106(1)_6-13.nxml.txt.nlp	22215104	SENT20	3	3	13	13	pertuzumab	HER2		2064	0.945
NULL	Mol_Cancer_2014_Jun_26_13_158.nxml.txt.nlp	24965046	SENT94	0	0	8	8	sorafenib	VEGFR2	PA7000	3791	0.945
NULL	Oncotarget_2013_Dec_2_4(12)_2523-2531.nxml.txt.nlp	24344114	SENT198	14	14	1	1	fluorescein	p53	PA164746009	7157	0.945
NULL	EPMA_J_2012_Sep_27_3(1)_10.nxml.txt.nlp	23016735	SENT193	19	19	5	5	warfarin	CYP2C9	PA451906	1559	0.945
NULL	Adv_Pharmacol_Sci_2014_Feb_24_2014_809438.nxml.txt.nlp	24707284	SENT149	22	22	4	4	glibenclamide	ANOVA	PA449782	4858	0.945
NULL	Br_J_Cancer_2011_May_24_104(11)_1786-1790.nxml.txt.nlp	21559018	SENT69	38	38	11	11	cetuximab	EGFR	PA10040	1956	0.945
NULL	Croat_Med_J_2013_Apr_54(2)_171-179.nxml.txt.nlp	23630144	SENT91	25	25	20	20	taurine	STZ	PA451590	6484	0.945
NULL	J_Korean_Med_Sci_2013_Jul_3_28(7)_1111-1113.nxml.txt.nlp	23853500	SENT70	25	25	19	19	naloxone	ACTH	PA450586	5443	0.945
NULL	Breast_Cancer_Res_2012_Nov_14_14(6)_R146.nxml.txt.nlp	23151593	SENT145	15	15	9	9	phenol	CO2	PA450913	4513	0.945
NULL	J_Obes_2011_Dec_15_2011_928165.nxml.txt.nlp	21197151	SENT135	0	0	10	10	fluoxetine	GIT	PA449673	5034	0.945
NULL	Curr_Neuropharmacol_2010_Dec_8(4)_359-366.nxml.txt.nlp	21629443	SENT169	25	25	10	10	carbamazepine	HLA-B	PA448785	3106	0.945
NULL	J_Allergy_(Cairo)_2011_Dec_13_2011_948406.nxml.txt.nlp	22203854	SENT384	7	7	23	23	mechlorethamine	HBE1	PA450336	3046	0.945
NULL	Clin_Ophthalmol_2011_Apr_18_5_495-502.nxml.txt.nlp	21573098	SENT114	15	15	3	3	gatifloxacin	BAK	PA449738	578	0.945
NULL	Arthritis_Res_Ther_2013_Sep_25_15(5)_118.nxml.txt.nlp	24063679	SENT26	3	3	13	13	colchicine	MICL	PA449092	160364	0.945
NULL	Br_J_Cancer_2009_Jul_21_101(2)_238-243.nxml.txt.nlp	19568242	SENT143	11	11	28	28	sunitinib	IFN	PA162372840	3439	0.945
NULL	Oncotarget_2012_Oct_8_3(10)_1112-1123.nxml.txt.nlp	23047041	SENT189	32	32	22	22	heparin	EGF	PA449855	1950	0.945
NULL	Oncotarget_2014_Aug_29_5(19)_8947-8958.nxml.txt.nlp	25333254	SENT214	3	3	9	9	plerixafor	CXCR7	PA165958410	57007	0.945
NULL	Oncol_Rep_2013_Apr_5_29(4)_1671-1677.nxml.txt.nlp	23404329	SENT165	14	14	31	31	aspirin	ACS	PA448497	55902;84680	0.945
NULL	Ther_Clin_Risk_Manag_2007_Dec_3(6)_1097-1104.nxml.txt.nlp	18516268	SENT171	7	7	28	28	didanosine	ATV	PA449301	4683	0.945
NULL	Oncol_Lett_2014_Jul_8_8(1)_47-54.nxml.txt.nlp	24959217	SENT32	5	5	16	16	vemurafenib	BRAF	PA165946873	673	0.945
NULL	Front_Oncol_2014_Apr_2_4_70.nxml.txt.nlp	24765614	SENT71	25	25	7	7	sorafenib	VEGF-A	PA7000	7422	0.945
NULL	Case_Rep_Transplant_2011_Jan_5_2011_210178.nxml.txt.nlp	23213600	SENT69	35	35	47	47	efavirenz	CYP3A4	PA449441	1576	0.945
NULL	Exp_Diabetes_Res_2012_Feb_23_2012_709893.nxml.txt.nlp	22611375	SENT159	30	30	43	43	phenol	GLP-1	PA450913	100125288	0.945
NULL	J_Clin_Biochem_Nutr_2007_Nov_30_41(3)_160-168.nxml.txt.nlp	18299710	SENT106	13	13	5	5	ecabet	IL-8	PA165958350	3576	0.945
NULL	Diabetes_2008_Sep_57(9)_2470-2479.nxml.txt.nlp	18511847	SENT112	31	31	22	22	pioglitazone	CD68	PA450970	968	0.945
NULL	Breast_Cancer_Res_2012_Feb_8_14(1)_R26.nxml.txt.nlp	22316048	SENT34	17	17	13	13	trastuzumab	HER-2	PA451743	2064	0.945
NULL	Cell_Death_Dis_2012_Nov_15_3(11)_e422.nxml.txt.nlp	23152058	SENT128	9	9	3	3	cisplatin	ZNF143	PA449014	7702	0.945
NULL	Braz_J_Med_Biol_Res_2012_Mar_2_45(3)_250-255.nxml.txt.nlp	22370705	SENT15	21	21	38	38	vasopressin	ADM	PA451858	133	0.945
NULL	Korean_J_Anesthesiol_2013_Dec_26_65(6_Suppl)_S16-S18.nxml.txt.nlp	24478855	SENT21	15	15	22	22	propofol	ANOVA	PA451141	4858	0.945
NULL	Br_J_Pharmacol_2011_Jul_163(6)_1263-1275.nxml.txt.nlp	21391977	SENT17	3	3	1	1	ketoconazole	CYP3A4	PA450146	1576	0.945
NULL	Clin_Sci_(Lond)_2011_Nov_1_121(Pt_10)_449-458.nxml.txt.nlp	21671887	SENT163	13	13	35	35	simvastatin	AMPK	PA451363	5563	0.945
NULL	Br_J_Pharmacol_2014_Feb_24_171(1)_1019-1032.nxml.txt.nlp	24251620	SENT128	2	2	7	7	nifedipine	TRPM3	PA450631	80036	0.945
NULL	Ther_Clin_Risk_Manag_2007_Aug_3(4)_533-542.nxml.txt.nlp	18472974	SENT143	38	38	14	14	fluconazole	CDR1	PA449653	1038	0.945
NULL	Mol_Cancer_2009_May_15_8_28.nxml.txt.nlp	19445670	SENT162	20	20	10	10	doxorubicin	XIAP	PA449412	331	0.945
NULL	Cancer_Med_2013_Apr_20_2(2)_130-143.nxml.txt.nlp	23634281	SENT214	7	7	20	20	rituximab	CD55	PA451261	1604	0.945
NULL	Oncoscience_2014_Oct_22_1(10)_649-664.nxml.txt.nlp	25593994	SENT219	3	3	17	17	perifosine	PC-3	PA165291471	692094	0.945
NULL	Acta_Pharmacol_Sin_2012_Aug_9_33(8)_1069-1079.nxml.txt.nlp	22773077	SENT11	43	43	10	10	indomethacin	P-gp	PA449982	5243	0.945
NULL	BMB_Rep_2014_May_47(5)_274-279.nxml.txt.nlp	24286313	SENT105	19	19	23	23	bortezomib	IL-6	PA10252	3569	0.945
NULL	Eur_J_Neurosci_2007_Sep_26(6)_1657-1669.nxml.txt.nlp	17880399	SENT272	10	10	0	0	haloperidol	DAO	PA449841	26;1610	0.945
NULL	Acta_Neuropathol_Commun_2014_Oct_21_2(1)_149.nxml.txt.nlp	NULL	SENT334	28	28	11	11	riluzole	gamma	PA451251	9913	0.945
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_3_2012_908562.nxml.txt.nlp	23082087	SENT208	6	6	16	16	rolipram	IL-6	PA153906323	3569	0.945
NULL	Breast_Cancer_Res_2012_Feb_14_14(1)_R30.nxml.txt.nlp	22333315	SENT165	23	23	5	5	celecoxib	CXCL10	PA448871	3627	0.945
NULL	Surg_Neurol_Int_2013_May_2_4(Suppl_4)_S245-S255.nxml.txt.nlp	23717796	SENT278	6	6	2	2	gefitinib	EGFR	PA131301952	1956	0.945
NULL	Iran_J_Pediatr_2012_Mar_22(1)_23-27.nxml.txt.nlp	23056855	SENT89	20	20	0	0	dapsone	MEFV	PA449211	4210	0.945
NULL	Oncogene_2010_Mar_11_29(10)_1509-1518.nxml.txt.nlp	19946334	SENT149	17	17	5	5	bortezomib	pS2	PA10252	7031	0.945
NULL	Basic_Clin_Neurosci_2014_Spring_5(2)_124-130.nxml.txt.nlp	25337370	SENT203	12	12	0	0	berberine	PI3K	PA165860812	5290	0.945
NULL	Environ_Health_Perspect_2008_Jul_26_116(7)_854-862.nxml.txt.nlp	18629305	SENT205	11	11	5	5	ebselen	NAC	PA161660841	22861	0.945
NULL	J_Biol_Chem_2009_Apr_3_284(14)_9558-9565.nxml.txt.nlp	19202191	SENT101	7	7	30	30	camptothecin	CtIP	PA153590860	5932	0.945
NULL	Front_Neurosci_2010_Jun_17_4_35.nxml.txt.nlp	20661455	SENT99	26	26	11	11	pindolol	5-HT1A	PA450966	3350	0.945
NULL	Cancers_(Basel)_2014_Aug_29_6(3)_1753-1768.nxml.txt.nlp	25256831	SENT9	4	4	23	23	bevacizumab	CEA	PA130232992	5670;1087	0.945
NULL	Environ_Health_Perspect_2005_Apr_14_113(4)_431-439.nxml.txt.nlp	15811834	SENT223	2	2	21	21	nifedipine	DES	PA450631	1674	0.945
NULL	Neuro_Oncol_2010_Apr_27_12(4)_389-400.nxml.txt.nlp	20308316	SENT110	4	4	12	12	chloroquine	p53	PA448948	7157	0.945
NULL	Bioimpacts_2014_May_28_4(2)_75-81.nxml.txt.nlp	25035850	SENT6	3	3	31	31	methacholine	gamma	PA165958382	9913	0.945
NULL	Oxid_Med_Cell_Longev_2014_Apr_30_2014_149627.nxml.txt.nlp	24876909	SENT112	30	30	16	16	ethanol	CLOCK	PA448073	9575	0.945
NULL	Cell_Cycle_2012_Dec_15_11(24)_4661-4672.nxml.txt.nlp	23187802	SENT170	15	15	1	1	doxorubicin	p107	PA449412	5933	0.945
NULL	J_Cancer_Res_Clin_Oncol_2013_Aug_7_139(10)_1667-1672.nxml.txt.nlp	23918349	SENT30	7	7	2	2	cetuximab	EGFR	PA10040	1956	0.945
NULL	Oncol_Rep_2013_Jun_22_29(6)_2479-2485.nxml.txt.nlp	23525656	SENT157	18	18	26	26	cisplatin	MRP7	PA449014	89845;1080	0.945
NULL	J_Cell_Biol_2005_Jul_4_170(1)_49-59.nxml.txt.nlp	15983061	SENT97	20	20	13	13	forskolin	HIF1	PA146096022	3091	0.945
NULL	Hum_Genomics_Proteomics_2010_Sep_13_2010_754919.nxml.txt.nlp	20981234	SENT94	30	30	16	16	warfarin	CYP2C9	PA451906	1559	0.945
NULL	J_Hum_Genet_2013_Jun_23_58(6)_339-345.nxml.txt.nlp	23697979	SENT14	18	18	4	4	prasugrel	ADP	PA154410481	23038	0.945
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Aug_13_64(Pt_9)_o1743.nxml.txt.nlp	21201725	SENT57	21	21	8	8	ethanol	mol	PA448073	90527	0.945
NULL	Br_J_Cancer_2012_Feb_14_106(4)_748-755.nxml.txt.nlp	22240781	SENT137	25	25	5	5	cetuximab	KRAS	PA10040	3845	0.945
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT1261	4	4	10	10	sunitinib	ABCB1	PA162372840	5243	0.945
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT206	5	5	18	18	pp2	EGFR		1956	0.945
NULL	Breast_Cancer_(Auckl)_2011_Sep_25_5_201-208.nxml.txt.nlp	22084573	SENT133	28	28	18	18	cisplatin	BRCA1	PA449014	672	0.945
NULL	Chin_J_Cancer_2012_Feb_31(2)_51-57.nxml.txt.nlp	22257384	SENT71	0	0	8	8	sulindac	MRP1	PA451565	4437	0.945
NULL	Ann_Rheum_Dis_2011_Oct_12_71(4)_541-548.nxml.txt.nlp	21994233	SENT157	37	37	1	1	methotrexate	IMPACT	PA450428	55364	0.945
NULL	Breast_Cancer_Res_2011_Jun_29_13(3)_R70.nxml.txt.nlp	21707964	SENT121	23	23	38	38	tamoxifen	14-3-3	PA451581	10971	0.945
NULL	J_Biol_Chem_2010_Aug_20_285(34)_25913-25927.nxml.txt.nlp	20452970	SENT197	14	14	7	7	iloprost	CYR61	PA164746843	3491	0.945
NULL	Gut_2013_Sep_7_62(9)_1340-1346.nxml.txt.nlp	23135762	SENT5	27	27	9	9	ribavirin	IL28B	PA451241	282617	0.945
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT82	11	11	24	24	atorvastatin	IL-6	PA448500	3569	0.945
NULL	Indian_J_Anaesth_2014_Sep-Oct_58(5)_652-657.nxml.txt.nlp	25535431	SENT148	6	6	27	27	desmopressin	VWF	PA449237	7450	0.945
NULL	Nucleic_Acids_Res_2011_Dec_31_39(22)_9536-9548.nxml.txt.nlp	21880590	SENT174	3	3	17	17	etoposide	BRCA1	PA449552	672	0.945
NULL	Mol_Cancer_2010_Nov_18_9_295.nxml.txt.nlp	21087507	SENT21	19	19	25	25	fulvestrant	aromatase	PA164747170	1588	0.945
NULL	Iran_J_Basic_Med_Sci_2012_Nov-Dec_15(6)_1202-1209.nxml.txt.nlp	23653852	SENT26	7	7	11	11	metformin	LKB1	PA450395	6794	0.945
NULL	Br_J_Pharmacol_2010_Sep_161(2)_288-307.nxml.txt.nlp	20735416	SENT245	25	25	9	9	isoflurane	TREK-1	PA450106	3776	0.945
NULL	Front_Neurosci_2012_Feb_21_6_26.nxml.txt.nlp	22363256	SENT137	9	9	12	12	estradiol	COX	PA449503	1351	0.945
NULL	Mol_Imaging_Biol_2009_Jul_31_11(4)_241-245.nxml.txt.nlp	19333655	SENT108	6	6	30	30	aprepitant	NK1	PA164747039	11126	0.945
NULL	Breast_Cancer_Res_2004_Mar_11_6(3)_109-118.nxml.txt.nlp	15084231	SENT90	29	29	13	13	tamoxifen	AIB1	PA451581	8202	0.945
NULL	Crit_Care_2006_Dec_7_10(6)_239.nxml.txt.nlp	17169139	SENT72	12	12	30	30	thrombin	PAR1	PA451674	79581;2149	0.945
NULL	Small_GTPases_2012_Jan_1_3(1)_34-39.nxml.txt.nlp	22714415	SENT8	22	22	9	9	cetuximab	KRAS	PA10040	3845	0.945
NULL	Br_J_Cancer_1992_Jun_65(6)_865-869.nxml.txt.nlp	1616857	SENT8	12	12	35	35	tamoxifen	EGFR	PA451581	1956	0.945
NULL	Cancer_Med_2013_Feb_3_2(1)_76-85.nxml.txt.nlp	24133630	SENT176	14	14	12	12	vemurafenib	BRAF	PA165946873	673	0.945
NULL	Acta_Pharmacol_Sin_2012_Jul_18_33(7)_861-872.nxml.txt.nlp	22705730	SENT118	10	10	32	32	atorvastatin	PTEN	PA448500	5728	0.945
NULL	J_Cell_Biol_2001_Oct_1_155(1)_27-40.nxml.txt.nlp	11581284	SENT326	25	25	6	6	gentamicin	CO2	PA449753	4513	0.945
NULL	Front_Neuroenergetics_2013_Mar_27_5_2.nxml.txt.nlp	23543638	SENT178	36	36	22	22	vildagliptin	GLP-1	PA165958346	100125288	0.945
NULL	Int_J_Mol_Sci_2014_Sep_11_15(9)_15994-16011.nxml.txt.nlp	25216334	SENT38	16	16	23	23	ranibizumab	VEGFR	PA164746012	3791	0.945
NULL	Nucleic_Acids_Res_2011_Mar_9_39(5)_1953-1965.nxml.txt.nlp	21062815	SENT131	17	17	5	5	ethanol	DMT	PA448073	2039	0.945
NULL	Clin_Exp_Otorhinolaryngol_2011_Mar_17_4(1)_18-23.nxml.txt.nlp	21461058	SENT93	12	12	1	1	furosemide	KCC2	PA449719	57468	0.945
NULL	Oncologist_2010_Sep_26_15(9)_944-953.nxml.txt.nlp	20798196	SENT23	5	5	38	38	letrozole	HER-2	PA450196	2064	0.945
NULL	Acta_Pharmacol_Sin_2014_Aug_21_35(8)_1082-1092.nxml.txt.nlp	25047514	SENT163	4	4	14	14	anastrozole	aromatase	PA448432	1588	0.945
NULL	J_Exp_Clin_Cancer_Res_2009_Jul_10_28(1)_99.nxml.txt.nlp	19591692	SENT21	20	20	2	2	imatinib	ABCB1	PA10804	5243	0.945
NULL	Neurosci_Lett_2011_Nov_14_505(2)_146-149.nxml.txt.nlp	22005578	SENT106	0	0	11	11	carbamazepine	TRPV1	PA448785	7442	0.945
NULL	Biochemistry_2009_Feb_3_48(4)_800-809.nxml.txt.nlp	19132922	SENT306	6	6	25	25	aciclovir	XOR	PA448045	7498	0.945
NULL	Cancer_Med_2013_Feb_3_2(1)_11-20.nxml.txt.nlp	24133623	SENT31	2	2	20	20	panitumumab	KRAS	PA162373091	3845	0.945
NULL	Support_Care_Cancer_2009_Sep_10_17(9)_1187-1193.nxml.txt.nlp	19205754	SENT211	42	42	32	32	granisetron	CYP1A1	PA449809	1543	0.945
NULL	Front_Endocrinol_(Lausanne)_2013_Mar_28_4_22.nxml.txt.nlp	23543285	SENT314	22	22	13	13	estradiol	ARC	PA449503	8996;23237	0.945
NULL	Clin_Med_Insights_Case_Rep_2014_Nov_19_7_131-134.nxml.txt.nlp	25452706	SENT94	39	39	17	17	ranolazine	CYP3A	PA164746007	1574	0.945
NULL	Mol_Neurodegener_2011_Aug_8_6_57.nxml.txt.nlp	21819629	SENT248	27	27	13	13	arsenite	JNK	PA452638	5599	0.945
NULL	Br_J_Cancer_2013_Aug_6_109(3)_686-693.nxml.txt.nlp	23839492	SENT23	12	12	21	21	sunitinib	IL-8	PA162372840	3576	0.945
NULL	Oncotarget_2012_May_4_3(4)_395-398.nxml.txt.nlp	22565037	SENT9	29	29	9	9	metformin	CD44	PA450395	960	0.945
NULL	Pharmaceuticals_(Basel)_2012_Feb_2_5(2)_114-132.nxml.txt.nlp	24288084	SENT166	13	13	4	4	capsaicin	TRPV1	PA448776	7442	0.945
NULL	Mol_Cell_Biochem_2014_Oct_9_385(1-2)_265-275.nxml.txt.nlp	24104452	SENT9	4	4	27	27	bortezomib	U87	PA10252	677775;641648	0.945
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT263	29	29	11	11	lapatinib	HER3	PA152241907	2065	0.945
NULL	BMB_Rep_2013_Apr_46(4)_230-235.nxml.txt.nlp	23615266	SENT85	21	21	3	3	pp2	ILK		3611	0.945
NULL	Br_J_Pharmacol_2014_Aug_17_171(15)_3651-3665.nxml.txt.nlp	24712679	SENT270	3	3	17	17	exenatide	GLP-1	PA164749238	100125288	0.945
NULL	Oncologist_2010_Jul_24_15(7)_665-672.nxml.txt.nlp	20576644	SENT30	18	18	15	15	trastuzumab	HER-2	PA451743	2064	0.945
NULL	Oncoimmunology_2013_Jan_1_2(1)_e22890.nxml.txt.nlp	23483066	SENT51	14	14	1	1	vemurafenib	IFN	PA165946873	3439	0.945
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT450	17	17	40	40	ziprasidone	PRL	PA451974	5617	0.945
NULL	Brain_2008_Jul_4_131(7)_1912-1925.nxml.txt.nlp	18524793	SENT231	43	43	15	15	pilocarpine	SFN	PA450962	25996;2810	0.945
NULL	Arthritis_Res_Ther_2005_Mar_1_7(3)_R545-R551.nxml.txt.nlp	15899041	SENT41	7	7	26	26	infliximab	ACR	PA452639	49	0.945
NULL	Open_Cardiovasc_Med_J_2014_Feb_7_8_12-17.nxml.txt.nlp	24653785	SENT108	13	13	18	18	atorvastatin	CYP3A5	PA448500	1577	0.945
NULL	Acta_Pharmacol_Sin_2011_Aug_18_32(8)_1031-1037.nxml.txt.nlp	21765446	SENT191	1	1	7	7	raloxifene	MCP-1	PA451221	6347	0.945
NULL	Mol_Cancer_2012_Dec_12_11_91.nxml.txt.nlp	23234355	SENT192	9	9	3	3	erlotinib	EGFR	PA134687924	1956	0.945
NULL	Diabetes_Care_2010_Jul_31_33(7)_1544-1548.nxml.txt.nlp	20357370	SENT18	31	31	8	8	metformin	STK11	PA450395	6794	0.944
NULL	Cent_European_J_Urol_2013_Dec_19_66(4)_394-404.nxml.txt.nlp	24757527	SENT146	30	30	8	8	sunitinib	CD31	PA162372840	5175	0.944
NULL	Alcohol_Res_Health_2007_30(1)_5-13.nxml.txt.nlp	17718394	SENT103	12	12	1	1	ethanol	ADH1B	PA448073	125	0.944
NULL	Mol_Imaging_Biol_2011_Dec_16_13(6)_1234-1240.nxml.txt.nlp	21161686	SENT21	28	28	9	9	imatinib	KIT	PA10804	3815	0.944
NULL	Drugs_2014_Jul_18_74(11)_1209-1231.nxml.txt.nlp	25034361	SENT172	16	16	11	11	quinidine	P-gp	PA451209	5243	0.944
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1495-1502.nxml.txt.nlp	21989186	SENT78	8	8	31	31	panitumumab	KRAS	PA162373091	3845	0.944
NULL	Biomed_Res_Int_2013_Jul_30_2013_754946.nxml.txt.nlp	23984405	SENT113	37	37	10	10	mannitol	B2M	PA450320	567	0.944
NULL	Int_J_Surg_Oncol_2011_Aug_22_2011_658767.nxml.txt.nlp	22312516	SENT119	15	15	19	19	erlotinib	EGFR	PA134687924	1956	0.944
NULL	Arthritis_Res_Ther_2013_Jul_9_15(4)_R73.nxml.txt.nlp	23837669	SENT251	18	18	28	28	colchicine	MICL	PA449092	160364	0.944
NULL	Br_J_Cancer_2006_Dec_4_95(11)_1483-1489.nxml.txt.nlp	17106442	SENT177	3	3	7	7	gefitinib	EGFR	PA131301952	1956	0.944
NULL	J_Anaesthesiol_Clin_Pharmacol_2012_Apr-Jun_28(2)_178-184.nxml.txt.nlp	22557739	SENT46	18	18	1	1	propofol	LDP	PA451141	10404	0.944
NULL	Breast_Cancer_Res_Treat_2014_Apr_6_145(1)_33-44.nxml.txt.nlp	24706169	SENT35	30	30	22	22	trastuzumab	HER2	PA451743	2064	0.944
NULL	Chin_J_Cancer_2012_Oct_31(10)_476-483.nxml.txt.nlp	22692073	SENT140	17	17	45	45	cisplatin	RRM1	PA449014	6240	0.944
NULL	Breast_Cancer_Res_2008_Dec_18_10(Suppl_4)_S18.nxml.txt.nlp	19128431	SENT62	37	37	26	26	letrozole	aromatase	PA450196	1588	0.944
NULL	Ecancermedicalscience_2009_Sep_24_3_153.nxml.txt.nlp	22276017	SENT73	15	15	5	5	oxaliplatin	ERCC1	PA131285527	2067	0.944
NULL	Biochemistry_2008_Nov_4_47(44)_11446-11456.nxml.txt.nlp	18842000	SENT58	14	14	1	1	trypsin	BARD1	PA451806	580	0.944
NULL	J_Adv_Pharm_Technol_Res_2014_Oct-Dec_5(4)_185-190.nxml.txt.nlp	25364697	SENT162	10	10	12	12	metoprolol	CYP2D6	PA450480	1565	0.944
NULL	Blood_Cancer_J_2012_May_25_2(5)_e73.nxml.txt.nlp	22829975	SENT171	24	24	6	6	fludarabine	CD73	PA449655	4907	0.944
NULL	Blood_Cancer_J_2012_Sep_7_2(9)_e89.nxml.txt.nlp	22961061	SENT68	22	22	44	44	lenalidomide	FGFR3	PA162363968	2261	0.944
NULL	Breast_Cancer_Res_2008_Dec_18_10(Suppl_4)_S20.nxml.txt.nlp	19128434	SENT30	35	35	25	25	gefitinib	HER2	PA131301952	2064	0.944
NULL	Acta_Pharmacol_Sin_2009_Sep_24_30(9)_1220-1226.nxml.txt.nlp	19701239	SENT181	4	4	11	11	cyclosporine	KCNQ4	PA449167	9132	0.944
NULL	Ann_Oncol_2014_Oct_18_25(10)_1871-1888.nxml.txt.nlp	25234545	SENT323	7	7	14	14	exemestane	aromatase	PA449563	1588	0.944
NULL	J_Physiol_2011_Nov_1_589(Pt_21)_5153-5165.nxml.txt.nlp	21930604	SENT68	27	27	10	10	phenylephrine	mol	PA450935	90527	0.944
NULL	J_Cancer_2012_Mar_12_3_137-144.nxml.txt.nlp	22481979	SENT31	26	26	6	6	cisplatin	HER2	PA449014	2064	0.944
NULL	Br_J_Pharmacol_2011_Aug_163(8)_1679-1690.nxml.txt.nlp	21371008	SENT149	21	21	19	19	indomethacin	COX	PA449982	1351	0.944
NULL	Nat_Med_2013_Oct_8_19(10)_1313-1317.nxml.txt.nlp	24013700	SENT15	24	24	12	12	ribavirin	IFN	PA451241	3439	0.944
NULL	Aliment_Pharmacol_Ther_2012_Apr_22_35(7)_745-767.nxml.txt.nlp	22356640	SENT19	16	16	2	2	tegaserod	5-HT4	PA130413154	3360	0.944
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_21-38.nxml.txt.nlp	19305786	SENT4	0	0	19	19	capsaicin	TRPV1	PA448776	7442	0.944
NULL	Br_J_Cancer_2013_Jul_9_109(1)_100-108.nxml.txt.nlp	23756858	SENT24	29	29	17	17	tamoxifen	aromatase	PA451581	1588	0.944
NULL	Oncotarget_2014_Aug_29_5(19)_8947-8958.nxml.txt.nlp	25333254	SENT143	21	21	44	44	plerixafor	CXCR4	PA165958410	7852	0.944
NULL	Nat_Med_2013_Mar_10_19(3)_313-321.nxml.txt.nlp	23396211	SENT369	17	17	8	8	amlexanox	IRF3	PA164745310	3661	0.944
NULL	Interdiscip_Toxicol_2008_Dec_1(3-4)_218-224.nxml.txt.nlp	21218119	SENT136	13	13	17	17	ethanol	CYP2E1	PA448073	1571	0.944
NULL	Ann_Oncol_2011_Mar_8_22(3)_503-514.nxml.txt.nlp	20616198	SENT207	28	28	34	34	diethylstilbestrol	aromatase	PA449307	1588	0.944
NULL	Biochem_Biophys_Res_Commun_2011_May_20_408(4)_511-515.nxml.txt.nlp	21513697	SENT69	6	6	17	17	nitroprusside	TLR4	PA451406	7099	0.944
NULL	Front_Endocrinol_(Lausanne)_2011_Dec_2_2_90.nxml.txt.nlp	22654832	SENT179	10	10	16	16	estradiol	STX	PA449503	8128	0.944
NULL	J_Cell_Mol_Med_2014_Aug_1_18(8)_1599-1611.nxml.txt.nlp	24889822	SENT303	26	26	7	7	resveratrol	FOXO1		2308	0.944
NULL	Clin_Ophthalmol_2011_Nov_1_5_1575-1583.nxml.txt.nlp	22125404	SENT156	9	9	16	16	latanoprost	BAK	PA164774763	578	0.944
NULL	Nat_Commun_2014_5_3361.nxml.txt.nlp	24553445	SENT73	19	19	6	6	olaparib	RAD51		5888	0.944
NULL	Mol_Brain_2013_Jan_28_6_6.nxml.txt.nlp	23356992	SENT291	12	12	4	4	picrotoxin	CA1	PA164777007	759	0.944
NULL	Front_Endocrinol_(Lausanne)_2013_Mar_12_4_26.nxml.txt.nlp	23486926	SENT762	1	1	9	9	vasopressin	ACTH	PA451858	5443	0.944
NULL	Arthritis_Res_Ther_2003_Aug_5_5(5)_214-222.nxml.txt.nlp	12932280	SENT67	23	23	12	12	alendronate	PTH	PA448082	5741	0.944
NULL	J_Immunol_Res_2014_Feb_10_2014_264723.nxml.txt.nlp	24741582	SENT8	12	12	1	1	rituximab	FCGR3A	PA451261	2214	0.944
NULL	Ann_Lab_Med_2012_Jul_20_32(4)_264-269.nxml.txt.nlp	22779067	SENT46	12	12	29	29	rifampin	DST	PA451250	667	0.944
NULL	Cancer_Cell_Int_2011_Aug_19_11_29.nxml.txt.nlp	21854619	SENT148	2	2	9	9	cisplatin	BRCA1	PA449014	672	0.944
NULL	Neural_Regen_Res_2014_Mar_15_9(6)_622-629.nxml.txt.nlp	25206865	SENT82	8	8	0	0	vasopressin	p38	PA451858	10598;1432;7965	0.944
NULL	J_Thromb_Haemost_2010_Mar_8(3)_577-587.nxml.txt.nlp	20040043	SENT117	25	25	3	3	rosiglitazone	mol	PA451283	90527	0.944
NULL	Front_Oncol_2013_Nov_27_3_290.nxml.txt.nlp	24350055	SENT89	23	23	29	29	imatinib	JNK	PA10804	5599	0.944
NULL	Aging_(Albany_NY)_2012_Jul_22_4(7)_480-498.nxml.txt.nlp	22837425	SENT30	16	16	11	11	metformin	B12	PA450395	7126;4709	0.944
NULL	Ann_Oncol_2011_Aug_27_22(8)_1736-1747.nxml.txt.nlp	21709140	SENT65	13	13	0	0	cisplatin	BRCA1	PA449014	672	0.944
NULL	Oncotarget_2011_May_16_2(5)_378-392.nxml.txt.nlp	21623005	SENT206	15	15	6	6	oxaliplatin	MDM2	PA131285527	4193	0.944
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT331	10	10	13	13	lapatinib	EGFR	PA152241907	1956	0.944
NULL	Neuropsychopharmacology_2009_Apr_2_34(5)_1135-1148.nxml.txt.nlp	18596687	SENT9	8	8	37	37	betaxolol	CRF	PA448611	1392;10882	0.944
NULL	Virol_J_2011_Nov_28_8_523.nxml.txt.nlp	22122911	SENT8	36	36	25	25	heparin	DARC	PA449855	2532	0.944
NULL	Alzheimers_Res_Ther_2013_Jan_3_5(1)_2.nxml.txt.nlp	23286718	SENT79	25	25	5	5	galantamine	ANOVA	PA449726	4858	0.944
NULL	Breast_Cancer_Res_2006_Jul_25_8(4)_R48.nxml.txt.nlp	16869955	SENT23	13	13	0	0	tamoxifen	HER2	PA451581	2064	0.944
NULL	Eur_Heart_J_2013_Aug_14_34(31)_2453-2463.nxml.txt.nlp	23713082	SENT170	3	3	8	8	eplerenone	ARTS	PA164749044	5414	0.944
NULL	J_Hematol_Oncol_2011_Apr_20_4_16.nxml.txt.nlp	21504625	SENT46	0	0	20	20	nutlin-3	p53		7157	0.944
NULL	Blood_Cancer_J_2014_Feb_14_4(2)_e184.nxml.txt.nlp	24531447	SENT83	0	0	12	12	alemtuzumab	CD52	PA164783958	1043	0.944
NULL	Iran_J_Pharm_Res_2013_Winter_12(Suppl)_37-46.nxml.txt.nlp	24250670	SENT8	3	3	7	7	verapamil	P-gp	PA451868	5243	0.944
NULL	Cell_Death_Dis_2014_Feb_13_5(2)_e1055.nxml.txt.nlp	24525731	SENT46	33	33	12	12	cisplatin	XRCC1	PA449014	7515	0.944
NULL	Arthritis_Res_Ther_2007_Oct_10_9(5)_R105.nxml.txt.nlp	17927818	SENT170	6	6	34	34	pp2	RhoA		387	0.944
NULL	Front_Synaptic_Neurosci_2014_May_30_6_12.nxml.txt.nlp	24910611	SENT138	23	23	3	3	l-asparagine	asc-1	PA164776968	56301	0.944
NULL	Brain_Behav_2012_Jan_2(1)_68-73.nxml.txt.nlp	22574275	SENT126	6	6	26	26	oxaliplatin	TRPM8	PA131285527	79054	0.944
NULL	Hum_Mol_Genet_2011_Jun_1_20(11)_2273-2284.nxml.txt.nlp	21378095	SENT133	16	16	2	2	olanzapine	GPR98	PA450688	84059	0.944
NULL	Neural_Regen_Res_2013_Mar_25_8(9)_825-832.nxml.txt.nlp	25206730	SENT9	34	34	20	20	isoflurane	P2X7	PA450106	5027	0.944
NULL	Aging_(Albany_NY)_2011_Jan_18_3(1)_33-43.nxml.txt.nlp	21248371	SENT112	26	26	12	12	zinc	HIPK2	PA451956	28996	0.944
NULL	Breast_Cancer_Res_2012_Jul_19_14(4)_R108.nxml.txt.nlp	22812534	SENT369	9	9	5	5	tamoxifen	aromatase	PA451581	1588	0.944
NULL	Int_J_Biol_Sci_2014_Feb_20_10(3)_268-277.nxml.txt.nlp	24644425	SENT114	21	21	38	38	metformin	PI3K	PA450395	5290	0.944
NULL	Breast_Cancer_Res_2008_Dec_5_10(6)_R104.nxml.txt.nlp	19061505	SENT221	6	6	19	19	estradiol	JNK	PA449503	5599	0.944
NULL	Breast_Cancer_Res_2012_Mar_20_14(2)_R53.nxml.txt.nlp	22433433	SENT349	29	29	21	21	cisplatin	CCNE1	PA449014	898	0.944
NULL	Mol_Cancer_2009_Jun_23_8_39.nxml.txt.nlp	19549337	SENT37	8	8	18	18	cisplatin	XIAP	PA449014	331	0.944
NULL	Indian_J_Endocrinol_Metab_2011_Oct_15(Suppl4)_S317-S321.nxml.txt.nlp	22145134	SENT132	27	27	3	3	vasopressin	ACTH	PA451858	5443	0.944
NULL	Ann_Hematol_2014_May_29_93(8)_1263-1277.nxml.txt.nlp	24870942	SENT277	3	3	17	17	bortezomib	EZH2	PA10252	2146	0.944
NULL	Mol_Cancer_2010_May_30_9_131.nxml.txt.nlp	20509970	SENT76	26	26	14	14	colchicine	C11	PA449092	1109	0.944
NULL	Anticancer_Agents_Med_Chem_2012_Feb_12(2)_163-171.nxml.txt.nlp	22043994	SENT23	31	31	0	0	panitumumab	KRAS	PA162373091	3845	0.944
NULL	Cell_Commun_Signal_2013_Jul_4_11_47.nxml.txt.nlp	23826796	SENT69	10	10	3	3	forskolin	CC2D1A	PA146096022	54862	0.944
NULL	Eur_J_Med_Res_2009_Nov_24_14(Suppl_3)_17-21.nxml.txt.nlp	19959412	SENT69	14	14	5	5	raltegravir	UGT1A1		54658	0.944
NULL	Indian_J_Pharmacol_2009_Aug_41(4)_167-172.nxml.txt.nlp	20523867	SENT139	38	38	13	13	acetaminophen	CYP3A4	PA448015	1576	0.944
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT120	5	5	18	18	gefitinib	PI3K	PA131301952	5290	0.944
NULL	Breast_Cancer_Res_2011_Sep_13_13(5)_R87.nxml.txt.nlp	21914172	SENT193	39	39	13	13	neratinib	EGFR	PA165291472	1956	0.944
NULL	Indian_J_Med_Res_2012_Aug_136(2)_249-259.nxml.txt.nlp	22960892	SENT7	23	23	8	8	irinotecan	UGT1A1	PA450085	54658	0.944
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1046.nxml.txt.nlp	24503538	SENT83	22	22	5	5	cyclophosphamide	FGFR4	PA449165	2264	0.944
NULL	Eur_J_Endocrinol_2010_May_162(5)_987-992.nxml.txt.nlp	20164212	SENT121	15	15	7	7	diazoxide	HNF4A	PA449285	3172	0.944
NULL	Curr_Cardiol_Rev_2010_Nov_6(4)_298-308.nxml.txt.nlp	22043206	SENT86	24	24	20	20	losartan	AT1	PA450268	9197;185	0.944
NULL	Br_J_Cancer_2010_Mar_2_102(5)_815-826.nxml.txt.nlp	20145614	SENT194	27	27	5	5	tamoxifen	HER2	PA451581	2064	0.944
NULL	J_Korean_Med_Sci_2010_Aug_21_25(8)_1222-1227.nxml.txt.nlp	20676337	SENT66	9	9	30	30	aminophylline	LPA	PA164781029	4018	0.944
NULL	Acta_Pharmacol_Sin_2014_Oct_25_35(10)_1293-1301.nxml.txt.nlp	25152022	SENT189	28	28	15	15	enalapril	IL-18	PA449456	3606	0.944
NULL	J_Adv_Pract_Oncol_2013_Jul_1_Jul-Aug_4(4)_238-250.nxml.txt.nlp	25032004	SENT160	10	10	3	3	imatinib	CYP3A4	PA10804	1576	0.944
NULL	Nat_Biotechnol_2013_Jul_30_31(7)_630-637.nxml.txt.nlp	23811600	SENT199	5	5	3	3	ponatinib	ABL1	PA165980594	25	0.944
NULL	Diabetes_2013_Jun_17_62(6)_2141-2150.nxml.txt.nlp	23378610	SENT213	22	22	12	12	betaine	BHMT	PA448603	635	0.944
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT167	4	4	27	27	atorvastatin	ERK	PA448500	5594	0.944
NULL	Nat_Commun_2014_Dec_8_5_5736.nxml.txt.nlp	25484020	SENT9	10	10	2	2	letrozole	aromatase	PA450196	1588	0.944
NULL	J_Invest_Dermatol_2012_Oct_24_132(10)_2440-2450.nxml.txt.nlp	22622430	SENT67	2	2	12	12	temozolomide	IL-8	PA451609	3576	0.944
NULL	Breast_Cancer_Res_2012_May_4_14(3)_R72.nxml.txt.nlp	22559056	SENT6	33	33	14	14	tamoxifen	CENP-A	PA451581	1058	0.944
NULL	Anal_Bioanal_Chem_2011_Jan_3_399(2)_527-539.nxml.txt.nlp	20814668	SENT56	29	29	15	15	heparin	API	PA449855	5345	0.944
NULL	Acta_Pharmacol_Sin_2009_Apr_3_30(4)_478-484.nxml.txt.nlp	19343062	SENT3	9	9	20	20	cyclosporine	CYP3A4	PA449167	1576	0.944
NULL	Mol_Vis_2012_May_1_18_1115-1122.nxml.txt.nlp	22605923	SENT185	6	6	31	31	estradiol	p38	PA449503	10598;1432;7965	0.944
NULL	Cancer_Cell_Int_2013_Sep_3_13_89.nxml.txt.nlp	24004445	SENT143	12	12	6	6	doxorubicin	CAIX	PA449412	768	0.944
NULL	eLife_2013_Oct_29_2_e01236.nxml.txt.nlp	24171104	SENT469	10	10	2	2	bortezomib	PERK	PA10252	9451	0.944
NULL	Anticancer_Agents_Med_Chem_2012_Feb_12(2)_163-171.nxml.txt.nlp	22043994	SENT157	21	21	8	8	cetuximab	KRAS	PA10040	3845	0.944
NULL	Diabetes_2011_Jan_4_60(1)_119-126.nxml.txt.nlp	20921208	SENT243	14	14	2	2	forskolin	TRPM2	PA146096022	7226	0.944
NULL	Adipocyte_2012_Oct_1_1(4)_256-258.nxml.txt.nlp	23700542	SENT34	28	28	16	16	resveratrol	AMPK		5563	0.944
NULL	ScientificWorldJournal_2014_Mar_3_2014_781857.nxml.txt.nlp	24729754	SENT97	3	3	14	14	ticlopidine	P2Y12	PA451686	64805	0.944
NULL	Behav_Brain_Funct_2007_Jan_11_3_3.nxml.txt.nlp	17217544	SENT61	16	16	32	32	fluoxetine	IPT	PA449673	54802	0.944
NULL	J_Cell_Biol_2005_Jun_20_169(6)_871-884.nxml.txt.nlp	15967811	SENT76	26	26	7	7	arsenite	G3BP	PA452638	10146	0.944
NULL	Diabetes_Care_2011_Mar_17_34(3)_730-733.nxml.txt.nlp	21289232	SENT52	2	2	26	26	pioglitazone	IL-10	PA450970	3586	0.944
NULL	J_Hematol_Oncol_2013_Jul_9_6_49.nxml.txt.nlp	23837843	SENT232	21	21	26	26	verapamil	P-gp	PA451868	5243	0.944
NULL	Cell_Death_Dis_2013_Oct_3_4(10)_e834.nxml.txt.nlp	24091677	SENT231	16	16	3	3	vinblastine	Bcl-2	PA451877	596	0.944
NULL	Curr_Rheumatol_Rep_2011_Aug_19_13(4)_353-359.nxml.txt.nlp	21503693	SENT52	10	10	22	22	abatacept	CD80	PA164747080	941	0.944
NULL	J_Biol_Chem_2008_Jun_13_283(24)_16293-16298.nxml.txt.nlp	18397880	SENT167	21	21	2	2	curcumin	p300	PA151958596	2033	0.944
NULL	Behav_Brain_Funct_2014_Feb_13_10_5.nxml.txt.nlp	24524628	SENT213	9	9	30	30	capsaicin	TRPV1	PA448776	7442	0.944
NULL	Anal_Bioanal_Chem_2010_Aug_14_397(7)_2977-2986.nxml.txt.nlp	20549493	SENT134	14	14	30	30	estradiol	NIP	PA449503	90527;10755	0.944
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_4_2013_378657.nxml.txt.nlp	23662132	SENT75	23	23	8	8	vildagliptin	GLP-1	PA165958346	100125288	0.944
NULL	Nucleic_Acids_Res_2010_Oct_28_38(19)_6418-6432.nxml.txt.nlp	20511593	SENT181	2	2	27	27	collagenase	c-Jun	PA449107	3725	0.944
NULL	Case_Rep_Transplant_2013_Jun_13_2013_375263.nxml.txt.nlp	23844312	SENT103	15	15	25	25	phenytoin	CYP3A	PA450947	1574	0.944
NULL	Acta_Histochem_Cytochem_2006_Jul_1_39(3)_61-67.nxml.txt.nlp	17327925	SENT31	22	22	3	3	cisplatin	p53	PA449014	7157	0.944
NULL	Breast_Cancer_Res_2010_Jun_28_12(3)_R43.nxml.txt.nlp	20579400	SENT15	13	13	0	0	tamoxifen	MAPT	PA451581	4137	0.944
NULL	Oncol_Lett_2013_Sep_28_6(3)_795-800.nxml.txt.nlp	24137413	SENT11	28	28	14	14	paclitaxel	P-gp	PA450761	5243	0.944
NULL	Eur_J_Clin_Pharmacol_2011_May_8_67(5)_493-506.nxml.txt.nlp	21140139	SENT225	10	10	33	33	oxymorphone	CYP2D6	PA450748	1565	0.944
NULL	Br_J_Cancer_1998_Oct_78(8)_1030-1034.nxml.txt.nlp	9792146	SENT13	6	6	22	22	cisplatin	NAG	PA449014	51594;4669	0.944
NULL	BMJ_Open_2015_Jan_15_5(1)_e007247.nxml.txt.nlp	25596202	SENT123	12	12	3	3	azithromycin	Spn	PA448519	84687	0.944
NULL	Scientifica_(Cairo)_2012_Nov_25_2012_473829.nxml.txt.nlp	24278698	SENT298	33	33	6	6	lamivudine	OCT1	PA450163	5451;6580	0.944
NULL	Curr_Colorectal_Cancer_Rep_2011_Dec_17_7(4)_253-259.nxml.txt.nlp	22131911	SENT116	14	14	4	4	cisplatin	CD133	PA449014	8842	0.944
NULL	Mol_Clin_Oncol_2013_Sep_18_1(5)_839-844.nxml.txt.nlp	24649257	SENT94	12	12	7	7	doxorubicin	NAC	PA449412	22861	0.944
NULL	Orphanet_J_Rare_Dis_2014_Dec_5_9(1)_194.nxml.txt.nlp	NULL	SENT397	19	19	9	9	desogestrel	CO2	PA449238	4513	0.944
NULL	J_Gynecol_Oncol_2013_Jul_4_24(3)_273-279.nxml.txt.nlp	23875078	SENT10	7	7	14	14	paclitaxel	COX	PA450761	1351	0.944
NULL	Case_Rep_Ophthalmol_Med_2012_Dec_18_2012_379132.nxml.txt.nlp	23320223	SENT40	31	31	34	34	gefitinib	EGFR	PA131301952	1956	0.944
NULL	ISRN_Otolaryngol_2012_Nov_14_2012_797619.nxml.txt.nlp	23762619	SENT80	22	22	10	10	gefitinib	EGF	PA131301952	1950	0.944
NULL	Clinics_(Sao_Paulo)_2010_Sep_65(9)_885-894.nxml.txt.nlp	21049217	SENT36	0	0	31	31	haloperidol	5-HT2C	PA449841	3358	0.944
NULL	Breast_Cancer_Res_2011_Mar_11_13(2)_R30.nxml.txt.nlp	21396117	SENT251	21	21	19	19	erlotinib	EGFR	PA134687924	1956	0.944
NULL	Nucleic_Acids_Res_2005_Jun_8_33(10)_3283-3291.nxml.txt.nlp	15944449	SENT156	16	16	11	11	sjg-136	XRCC2		7516	0.944
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1137-1144.nxml.txt.nlp	20234366	SENT31	4	4	32	32	cetuximab	KRAS	PA10040	3845	0.944
NULL	Eur_J_Clin_Pharmacol_2013_Feb_12_69(2)_209-215.nxml.txt.nlp	22688722	SENT162	36	36	22	22	duloxetine	LIM	PA10066	10611	0.944
NULL	Br_J_Cancer_2012_Aug_7_107(4)_592-597.nxml.txt.nlp	22805325	SENT138	0	0	5	5	imatinib	CYP3A4	PA10804	1576	0.944
NULL	J_Nutr_Metab_2011_Oct_1_2011_525094.nxml.txt.nlp	21977315	SENT5	30	30	21	21	resveratrol	SIRT4		23409	0.944
NULL	J_Clin_Biochem_Nutr_2009_Nov_28_45(3)_347-354.nxml.txt.nlp	19902027	SENT145	15	15	29	29	capsaicin	LPO	PA448776	4025	0.944
NULL	Cell_Mol_Life_Sci_2011_Nov_2_68(21)_3573-3587.nxml.txt.nlp	21365278	SENT41	30	30	5	5	iloprost	EP2	PA164746843	5732;10407	0.944
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT8	10	10	4	4	curcumin	FADD	PA151958596	8772	0.944
NULL	Br_J_Haematol_2014_Mar_13_164(1)_811-821.nxml.txt.nlp	24328678	SENT182	30	30	5	5	lenalidomide	Aiolos	PA162363968	22806	0.944
NULL	Mol_Vis_2012_Oct_5_18_2454-2467.nxml.txt.nlp	23077404	SENT139	27	27	3	3	bevacizumab	VEGF-A	PA130232992	7422	0.944
NULL	Biol_Proced_Online_2003_Feb_17_5_1-12.nxml.txt.nlp	12734561	SENT222	11	11	20	20	ethanol	CYP2E1	PA448073	1571	0.944
NULL	Indian_J_Crit_Care_Med_2010_Oct-Dec_14(4)_188-195.nxml.txt.nlp	21572750	SENT86	2	2	5	5	ticlopidine	ADP	PA451686	23038	0.944
NULL	Arthritis_Res_Ther_2009_Nov_9_11(6)_R167.nxml.txt.nlp	19900268	SENT25	9	9	21	21	tacrolimus	CD4	PA451578	920	0.944
NULL	Int_J_Mol_Sci_2014_Oct_8_15(10)_17974-17999.nxml.txt.nlp	25299695	SENT165	10	10	41	41	curcumin	HO-2	PA151958596	3163	0.944
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT144	17	17	8	8	trastuzumab	STAT3	PA451743	6774	0.944
NULL	Arthritis_Res_Ther_2013_Jul_9_15(4)_R73.nxml.txt.nlp	23837669	SENT251	3	3	16	16	colchicine	MICL	PA449092	160364	0.944
NULL	Endocrinol_Diabetes_Metab_Case_Rep_2014_Mar_1_2014_140001.nxml.txt.nlp	24683487	SENT38	16	16	2	2	octreotide	ACTH	PA450678	5443	0.944
NULL	Osteoarthritis_Cartilage_2013_Sep_21(9)_1336-1345.nxml.txt.nlp	23973148	SENT17	10	10	19	19	triamcinolone	MIA	PA451749	8190	0.944
NULL	Curr_Neuropharmacol_2008_Jun_6(2)_151-163.nxml.txt.nlp	19305794	SENT206	8	8	15	15	trypsin	TRPV1	PA451806	7442	0.944
NULL	Cancer_Cell_Int_2013_Feb_12_13_14.nxml.txt.nlp	23402310	SENT147	3	3	12	12	celecoxib	p65	PA448871	5970	0.944
NULL	J_Biol_Eng_2012_Jun_11_6_7.nxml.txt.nlp	22686441	SENT59	21	21	15	15	triamcinolone	EVA	PA451749	10205	0.944
NULL	J_Hematol_Oncol_2011_Aug_15_4_34.nxml.txt.nlp	21843362	SENT20	9	9	28	28	cyclophosphamide	CHOP	PA449165	1649	0.944
NULL	Iran_J_Basic_Med_Sci_2013_Apr_16(4)_610-614.nxml.txt.nlp	24250937	SENT32	8	8	1	1	coumarin	CYP2A6	PA134521193	1548	0.944
NULL	Mol_Cancer_2013_May_24_12_46.nxml.txt.nlp	23705826	SENT314	21	21	4	4	imatinib	KIT	PA10804	3815	0.944
NULL	Blood_Res_2014_Jun_25_49(2)_85-94.nxml.txt.nlp	25025009	SENT251	38	38	18	18	rivaroxaban	STA	PA165958360	2010;2656	0.944
NULL	J_Hematol_Oncol_2009_Feb_23_2_10.nxml.txt.nlp	19236716	SENT109	16	16	3	3	dasatinib	CYP3A4	PA162372878	1576	0.944
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT167	4	4	25	25	atorvastatin	JNK	PA448500	5599	0.944
NULL	Mediators_Inflamm_2000_9(5)_235-241.nxml.txt.nlp	11200364	SENT4	5	5	22	22	dextran	TNF-alpha	PA449261	7124	0.944
NULL	Breast_Cancer_Res_2004_Aug_5_6(5)_R601-R607.nxml.txt.nlp	15318941	SENT131	40	40	10	10	cisplatin	p27	PA449014	5715;10534	0.944
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT120	13	13	9	9	nutlin-3	MDM2		4193	0.944
NULL	Gene_Regul_Syst_Bio_2014_Mar_4_8_63-73.nxml.txt.nlp	24634581	SENT209	44	44	19	19	minocycline	MT1-MMP	PA450519	4323	0.944
NULL	Evid_Based_Complement_Alternat_Med_2013_May_26_2013_161628.nxml.txt.nlp	23781255	SENT255	10	10	0	0	sunitinib	STAT3	PA162372840	6774	0.944
NULL	Scientifica_(Cairo)_2013_Apr_17_2013_217513.nxml.txt.nlp	24278769	SENT194	16	16	8	8	estradiol	FKBP2	PA449503	2286	0.944
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2675-2684.nxml.txt.nlp	24129246	SENT186	22	22	4	4	etoposide	KSR1	PA449552	8844	0.944
NULL	Open_Virol_J_2012_Nov_30_6_135-143.nxml.txt.nlp	23264839	SENT134	24	24	14	14	maraviroc	CCR5	PA164768835	1234	0.944
NULL	Mol_Pain_2013_Jun_10_9_27.nxml.txt.nlp	23758830	SENT178	13	13	35	35	tetracaine	ASIC3	PA451638	9311	0.944
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT160	20	20	6	6	metformin	EGFR	PA450395	1956	0.944
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_209.nxml.txt.nlp	22546362	SENT54	19	19	32	32	infliximab	IFN	PA452639	3439	0.944
NULL	Infect_Dis_Rep_2010_Feb_2_2(1)_e1.nxml.txt.nlp	24470884	SENT14	5	5	33	33	tigecycline	HAP	PA164746412	5915;10313	0.944
NULL	Front_Behav_Neurosci_2013_Dec_18_7_203.nxml.txt.nlp	24385956	SENT256	8	8	16	16	memantine	spatial	PA10364	219793	0.944
NULL	Cancer_Imaging_2011_Mar_1_11(1)_1-8.nxml.txt.nlp	21362586	SENT71	36	36	2	2	loperamide	P-gp	PA450262	5243	0.944
NULL	Front_Behav_Neurosci_2009_Jan_27_3_1.nxml.txt.nlp	19194528	SENT179	9	9	28	28	fluoxetine	EPM	PA449673	2054	0.944
NULL	Cell_Commun_Signal_2003_Nov_24_1_5.nxml.txt.nlp	14636425	SENT79	21	21	10	10	heparin	CCN5	PA449855	8839	0.944
NULL	Int_J_Mol_Sci_2012_Feb_24_13(3)_2578-2589.nxml.txt.nlp	22489112	SENT64	8	8	15	15	amitriptyline	GAT1	PA448385	6529	0.944
NULL	J_Carcinog_2011_Dec_8_10_33.nxml.txt.nlp	22279418	SENT7	8	8	17	17	estradiol	aromatase	PA449503	1588	0.944
NULL	Br_J_Cancer_2010_Feb_2_102(3)_457-461.nxml.txt.nlp	20010942	SENT127	8	8	17	17	gefitinib	EGFR	PA131301952	1956	0.944
NULL	Oncol_Rep_2013_May_4_29(5)_1683-1688.nxml.txt.nlp	23467693	SENT23	11	11	2	2	staurosporine	PARG	PA165109623	8505	0.944
NULL	Ann_Surg_Treat_Res_2014_Feb_22_86(2)_68-75.nxml.txt.nlp	24761411	SENT116	8	8	20	20	resveratrol	survivin		332	0.944
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT291	15	15	18	18	paclitaxel	ABCB1	PA450761	5243	0.944
NULL	Anticancer_Agents_Med_Chem_2012_Feb_12(2)_163-171.nxml.txt.nlp	22043994	SENT154	14	14	9	9	cetuximab	KRAS	PA10040	3845	0.944
NULL	Oncotarget_2013_Nov_22_5(4)_933-943.nxml.txt.nlp	24659749	SENT113	9	9	0	0	nutlin-3	AML2		864	0.944
NULL	Br_J_Cancer_2012_Nov_20_107(11)_1844-1852.nxml.txt.nlp	23169337	SENT281	11	11	36	36	bortezomib	GAPDH	PA10252	2597	0.944
NULL	Case_Rep_Med_2010_Jun_17_2010_472389.nxml.txt.nlp	20589221	SENT10	10	10	28	28	cocaine	BCHE	PA449072	590	0.944
NULL	Environ_Health_Perspect_2010_Dec_12_118(12)_1707-1713.nxml.txt.nlp	20705543	SENT81	24	24	3	3	paclitaxel	XRCC1	PA450761	7515	0.944
NULL	AIDS_Res_Ther_2013_May_1_10_10.nxml.txt.nlp	23634877	SENT149	25	25	8	8	atorvastatin	CXCL12	PA448500	6387	0.944
NULL	Indian_J_Med_Res_2010_Dec_132(6)_676-682.nxml.txt.nlp	21245614	SENT48	0	0	35	35	zinc	AP-1	PA451956	2353;3727;2354;3725	0.944
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_28_2012_937605.nxml.txt.nlp	23304227	SENT102	7	7	18	18	resveratrol	GDNF		2668	0.944
NULL	J_Ophthalmol_2011_Dec_23_2011_292040.nxml.txt.nlp	21253505	SENT85	20	20	3	3	nilvadipine	CNTF	PA165958385	1270	0.944
NULL	Biologics_2010_Sep_28_4_273-287.nxml.txt.nlp	21116326	SENT70	8	8	18	18	bortezomib	c-Jun	PA10252	3725	0.944
NULL	Crit_Care_2009_Feb_24_13(1)_R22.nxml.txt.nlp	19239703	SENT64	16	16	2	2	vecuronium	ARM	PA164748865	80210	0.944
NULL	Aging_(Albany_NY)_2012_Apr_16_4(4)_247-255.nxml.txt.nlp	22511639	SENT78	30	30	9	9	metformin	CH1	PA450395	51430	0.944
NULL	eLife_2014_Apr_22_3_e02053.nxml.txt.nlp	24755289	SENT102	7	7	15	15	baclofen	RGS7	PA448533	6000	0.944
NULL	Clin_Infect_Dis_2013_May_1_56(9)_1330-1339.nxml.txt.nlp	23362284	SENT44	29	29	11	11	nevirapine	CD4	PA450616	920	0.944
NULL	Diabetes_Metab_Syndr_Obes_2010_Jul_20_3_263-273.nxml.txt.nlp	21437094	SENT109	1	1	6	6	exenatide	GLP-1	PA164749238	100125288	0.944
NULL	Chin_J_Cancer_2012_Feb_31(2)_73-99.nxml.txt.nlp	22098950	SENT232	29	29	38	38	gefitinib	P-gp	PA131301952	5243	0.944
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT157	7	7	20	20	curcumin	TRAIL	PA151958596	8743	0.944
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_May_12_66(Pt_6)_o1310.nxml.txt.nlp	21579405	SENT58	1	1	16	16	coumarin	mol	PA134521193	90527	0.944
NULL	Aging_(Albany_NY)_2009_Mar_31_1(4)_412-424.nxml.txt.nlp	20195491	SENT53	7	7	40	40	resveratrol	TXNIP		10628	0.944
NULL	Mol_Neurobiol_2010_Jun_2_41(2-3)_392-409.nxml.txt.nlp	20437209	SENT296	3	3	10	10	curcumin	5-LOX	PA151958596	240	0.944
NULL	Breast_Cancer_Res_2011_Mar_11_13(2)_R30.nxml.txt.nlp	21396117	SENT235	17	17	11	11	erlotinib	BRCA1	PA134687924	672	0.944
NULL	Mol_Cancer_2008_Mar_26_7_27.nxml.txt.nlp	18366759	SENT79	7	7	12	12	etoposide	MDM2	PA449552	4193	0.944
NULL	J_Cell_Biol_2005_May_23_169(4)_657-667.nxml.txt.nlp	15911880	SENT65	17	17	32	32	pp2	EGF		1950	0.944
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT3	38	38	13	13	lapatinib	EGFR	PA152241907	1956	0.944
NULL	Endocrinol_Diabetes_Metab_Case_Rep_2015_Jan_1_2015_140105.nxml.txt.nlp	25614825	SENT59	0	0	23	23	hydrocortisone	ACTH	PA449905	5443	0.944
NULL	Cell_Commun_Signal_2013_Oct_1_11_73.nxml.txt.nlp	24083678	SENT126	22	22	7	7	sulindac	A20	PA451565	7128;28935	0.944
NULL	Toxins_(Basel)_2010_May_28_2(6)_1207-1224.nxml.txt.nlp	22069634	SENT252	38	38	32	32	vinblastine	MRP1	PA451877	4437	0.944
NULL	Cell_Death_Dis_2010_Nov_18_1(11)_e102.nxml.txt.nlp	21368867	SENT137	24	24	2	2	gentamicin	CLIMP-63	PA449753	10970	0.944
NULL	Open_Biol_2014_Feb_4(2)_130217.nxml.txt.nlp	24522884	SENT539	10	10	5	5	thalidomide	CUL4A	PA451644	8451	0.944
NULL	Oncotarget_2012_Oct_20_3(10)_1068-1111.nxml.txt.nlp	23085539	SENT535	22	22	9	9	gefitinib	U87	PA131301952	677775;641648	0.944
NULL	Arthritis_Res_Ther_2013_Sep_10_15(5)_R110.nxml.txt.nlp	24020899	SENT152	19	19	3	3	pioglitazone	IL-6	PA450970	3569	0.944
NULL	Int_J_Mol_Sci_2007_May_11_8(5)_392-398.nxml.txt.nlp	NULL	SENT42	28	28	5	5	naphthol	mol	PA154081779	90527	0.944
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Dec_17_3(12)_e152.nxml.txt.nlp	25518025	SENT66	30	30	12	12	oxymorphone	CYP3A4	PA450748	1576	0.944
NULL	Br_J_Pharmacol_2014_Feb_24_171(1)_1019-1032.nxml.txt.nlp	24251620	SENT42	4	4	18	18	nifedipine	TRPM3	PA450631	80036	0.944
NULL	Anal_Bioanal_Chem_2014_Jan_23_406(15)_3667-3680.nxml.txt.nlp	24452745	SENT221	15	15	3	3	ketoprofen	KET	PA450149	8626	0.944
NULL	Front_Neurosci_2014_Jan_10_7_270.nxml.txt.nlp	24454277	SENT57	36	36	1	1	ethanol	SIRT1	PA448073	23411	0.944
NULL	J_Cell_Mol_Med_2013_Nov_9_17(11)_1484-1493.nxml.txt.nlp	24015932	SENT8	24	24	9	9	berberine	c-Myc	PA165860812	4609	0.944
NULL	Curr_Cardiol_Rev_2009_Nov_5(4)_251-262.nxml.txt.nlp	21037841	SENT166	41	41	15	15	ibutilide	spatial	PA449958	219793	0.944
NULL	Oncotarget_2012_Jul_13_3(6)_601-607.nxml.txt.nlp	22802145	SENT38	25	25	16	16	paclitaxel	p53	PA450761	7157	0.944
NULL	J_Mol_Signal_2011_Jul_20_6_7.nxml.txt.nlp	21774804	SENT50	43	43	22	22	curcumin	p53	PA151958596	7157	0.944
NULL	Int_J_Surg_Oncol_2012_Jun_12_2012_862879.nxml.txt.nlp	22778941	SENT108	29	29	6	6	cisplatin	BIN1	PA449014	274	0.944
NULL	J_Cancer_2011_May_1_2_232-261.nxml.txt.nlp	21552384	SENT100	21	21	23	23	tamoxifen	aromatase	PA451581	1588	0.944
NULL	Biologics_2013_Feb_25_7_47-60.nxml.txt.nlp	23459471	SENT77	3	3	9	9	vorinostat	CTCL	PA164748224	64061	0.944
NULL	Nucleic_Acids_Res_2012_Sep_26_40(17)_8371-8380.nxml.txt.nlp	22740648	SENT25	30	30	14	14	camptothecin	TDP1	PA153590860	55775	0.944
NULL	Int_J_Environ_Res_Public_Health_2012_Aug_3_9(8)_2788-2800.nxml.txt.nlp	23066397	SENT137	20	20	0	0	cytarabine	CYP2E1	PA449177	1571	0.944
NULL	Front_Physiol_2012_Sep_12_3_364.nxml.txt.nlp	22988445	SENT258	13	13	2	2	captopril	ACE2	PA448780	59272	0.944
NULL	Diabetes_Obes_Metab_2010_Aug_12(8)_700-708.nxml.txt.nlp	20590747	SENT181	15	15	10	10	voglibose	PPG	PA164752433	5552	0.944
NULL	Case_Rep_Med_2010_Aug_23_2010_278427.nxml.txt.nlp	20827440	SENT13	20	20	24	24	clarithromycin	CD4	PA449028	920	0.944
NULL	Support_Care_Cancer_2012_Jul_6_20(7)_1533-1540.nxml.txt.nlp	21822636	SENT59	33	33	28	28	letrozole	aromatase	PA450196	1588	0.944
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_91-103.nxml.txt.nlp	17912639	SENT497	32	32	42	42	estradiol	aromatase	PA449503	1588	0.944
NULL	Case_Rep_Med_2011_Nov_1_2011_393568.nxml.txt.nlp	22110510	SENT60	11	11	28	28	rituximab	CD19	PA451261	930	0.944
NULL	J_Med_Chem_2014_Feb_13_57(3)_539-566.nxml.txt.nlp	24025027	SENT25	29	29	25	25	raltegravir	CCR5		1234	0.944
NULL	Front_Oncol_2013_Apr_2_3_64.nxml.txt.nlp	23565502	SENT83	7	7	14	14	nutlin-3	p53		7157	0.944
NULL	J_Immunol_Res_2014_May_12_2014_897249.nxml.txt.nlp	24901013	SENT181	17	17	6	6	natalizumab	CD4	PA164747191	920	0.944
NULL	Evid_Based_Complement_Alternat_Med_2013_Mar_26_2013_625892.nxml.txt.nlp	23589719	SENT255	3	3	7	7	probenecid	GLP-1	PA451106	100125288	0.944
NULL	Arthritis_Res_Ther_2005_Dec_1_7(1)_R149-R155.nxml.txt.nlp	15642135	SENT115	19	19	5	5	infliximab	IL-6	PA452639	3569	0.944
NULL	Behav_Brain_Funct_2008_Aug_15_4_37.nxml.txt.nlp	18702828	SENT7	23	23	6	6	methamphetamine	FZD3	PA450403	7976;8326	0.944
NULL	Ann_Rheum_Dis_2014_Feb_18_73(2)_328-335.nxml.txt.nlp	23868909	SENT172	24	24	17	17	benzbromarone	ACR	PA134852920	49	0.944
NULL	Ecancermedicalscience_2009_Sep_24_3_153.nxml.txt.nlp	22276017	SENT60	21	21	7	7	oxaliplatin	XPA	PA131285527	7507	0.944
NULL	Protein_Sci_2010_Jul_3_19(7)_1312-1326.nxml.txt.nlp	20506237	SENT256	33	33	13	13	kanamycin	CK1	PA450137	1452	0.944
NULL	J_Korean_Med_Sci_2014_Jan_26_29(1)_110-116.nxml.txt.nlp	24431914	SENT112	13	13	4	4	plerixafor	CD34	PA165958410	947	0.944
NULL	Nucl_Recept_Signal_2009_Jan_16_7_e001.nxml.txt.nlp	19240808	SENT112	26	26	0	0	hyperforin	SXR	PA165985514	8856	0.944
NULL	eLife_2014_May_6_3_e02482.nxml.txt.nlp	24843002	SENT187	43	43	13	13	etoposide	SETD2	PA449552	29072	0.944
NULL	J_Invest_Dermatol_2014_Jan_25_134(1)_268-271.nxml.txt.nlp	23812303	SENT47	0	0	18	18	adalimumab	IL-23	PA10004	51561	0.944
NULL	F1000Res_2013_Mar_5_2_74.nxml.txt.nlp	24358880	SENT229	0	0	14	14	capsaicin	TRPV1	PA448776	7442	0.944
NULL	Cancer_Cell_Int_2010_Nov_24_10_47.nxml.txt.nlp	21106101	SENT6	10	10	0	0	camptothecin	PC-3	PA153590860	692094	0.944
NULL	Cell_Death_Differ_2009_Aug_20_16(8)_1135-1145.nxml.txt.nlp	19300452	SENT177	22	22	25	25	doxycycline	PUMA	PA449415	27113	0.944
NULL	Cell_Death_Dis_2013_Oct_3_4(10)_e827.nxml.txt.nlp	24091670	SENT121	22	22	45	45	nilotinib	PI3K	PA165958345	5290	0.944
NULL	ARYA_Atheroscler_2011_Summer_7(2)_78-86.nxml.txt.nlp	22577451	SENT11	26	26	38	38	choline	IL-6	PA448976	3569	0.944
NULL	Arthritis_Res_Ther_2009_Nov_4_11(6)_R165.nxml.txt.nlp	19889203	SENT355	6	6	29	29	curcumin	TRAF1	PA151958596	7185	0.944
NULL	Biomed_Res_Int_2014_Jun_3_2014_590848.nxml.txt.nlp	24995312	SENT46	2	2	13	13	lomefloxacin	RAK	PA164749165	2444	0.944
NULL	J_Cell_Mol_Med_2013_Oct_23_17(10)_1207-1217.nxml.txt.nlp	24106980	SENT80	15	15	23	23	docetaxel	PLK1	PA449383	5347	0.944
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT89	4	4	14	14	pp2	PP2		4888	0.944
NULL	Mol_Cell_2012_Feb_10_45(3)_371-383.nxml.txt.nlp	22325354	SENT203	7	7	5	5	olaparib	PARP1		142	0.944
NULL	Oncotarget_2013_Jul_18_4(10)_1582-1591.nxml.txt.nlp	24123600	SENT130	16	16	7	7	imatinib	ABCG2	PA10804	9429	0.944
NULL	Mol_Cancer_2011_Sep_30_10_125.nxml.txt.nlp	21962244	SENT23	7	7	12	12	gefitinib	AKT	PA131301952	207	0.944
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1033-1038.nxml.txt.nlp	22374460	SENT187	12	12	4	4	trastuzumab	HER2	PA451743	2064	0.944
NULL	Cancer_Res_Treat_2014_Jul_15_46(3)_243-249.nxml.txt.nlp	25038759	SENT108	1	1	9	9	capecitabine	CRT	PA448771	811	0.944
NULL	Int_J_Cell_Biol_2010_Feb_16_2010_818497.nxml.txt.nlp	20182544	SENT220	9	9	6	6	sr144528	CB2		1269	0.944
NULL	Breast_Cancer_Res_2010_May_12_12(3)_R27.nxml.txt.nlp	20462431	SENT265	8	8	36	36	trastuzumab	HER2	PA451743	2064	0.944
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT186	21	21	13	13	cidofovir	SLC22A6	PA448997	9356	0.944
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1126-1134.nxml.txt.nlp	21364592	SENT135	31	31	20	20	docetaxel	CYP2A6	PA449383	1548	0.944
NULL	Cancers_(Basel)_2011_Apr_1_3(2)_1844-1860.nxml.txt.nlp	24212785	SENT98	27	27	36	36	cetuximab	PTEN	PA10040	5728	0.944
NULL	Cell_Death_Differ_2010_Dec_28_17(12)_1867-1881.nxml.txt.nlp	20508647	SENT90	6	6	19	19	resveratrol	LC3		84557	0.944
NULL	Curr_Genomics_2014_Jun_15(3)_217-230.nxml.txt.nlp	24955029	SENT42	14	14	7	7	oxygen	ROS	PA450744	6098	0.944
NULL	Diabetes_Metab_Syndr_Obes_2009_Jun_12_2_83-90.nxml.txt.nlp	21437121	SENT23	11	11	7	7	vildagliptin	GLP-1	PA165958346	100125288	0.944
NULL	Br_J_Cancer_2009_Jul_21_101(2)_238-243.nxml.txt.nlp	19568242	SENT115	16	16	21	21	bevacizumab	IFN	PA130232992	3439	0.944
NULL	Biomed_Res_Int_2014_Jun_3_2014_656370.nxml.txt.nlp	24995318	SENT99	13	13	4	4	sulpiride	FGA	PA164745485	2243	0.944
NULL	Breast_Cancer_Res_2009_Oct_28_11(5)_211.nxml.txt.nlp	19889200	SENT142	16	16	2	2	anastrozole	ATAC	PA448432	6375	0.944
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_67-74.nxml.txt.nlp	17912637	SENT43	29	29	17	17	anastrozole	aromatase	PA448432	1588	0.944
NULL	J_Neurosci_Methods_2008_Jul_30_172(2-4)_143-157.nxml.txt.nlp	18550176	SENT327	0	0	17	17	metyrapone	CA1	PA450486	759	0.944
NULL	Curr_Neuropharmacol_2008_Sep_6(3)_215-234.nxml.txt.nlp	19506722	SENT97	4	4	13	13	desipramine	5-HT2A	PA449233	3356	0.944
NULL	Biomed_Res_Int_2013_Mar_28_2013_154073.nxml.txt.nlp	23607088	SENT98	19	19	8	8	clopidogrel	CYP2C19	PA449053	1557	0.944
NULL	J_Oncol_2010_Dec_28_2010_414676.nxml.txt.nlp	20066160	SENT89	15	15	13	13	bevacizumab	VEGFR	PA130232992	3791	0.944
NULL	Front_Aging_Neurosci_2010_Nov_5_2_146.nxml.txt.nlp	21119769	SENT312	11	11	9	9	tolcapone	COMT	PA451720	1312	0.944
NULL	FASEB_J_2009_Sep_23(9)_3179-3192.nxml.txt.nlp	19447881	SENT255	10	10	16	16	capsaicin	TRPA1	PA448776	8989	0.944
NULL	Biologics_2013_Apr_26_7_91-101.nxml.txt.nlp	23671386	SENT127	11	11	16	16	crizotinib	EGFR	PA165946122	1956	0.944
NULL	Mol_Cancer_2009_Aug_25_8_66.nxml.txt.nlp	19706164	SENT175	6	6	33	33	celecoxib	p53	PA448871	7157	0.944
NULL	Cardiovasc_Res_2012_Dec_1_96(3)_552-560.nxml.txt.nlp	22918977	SENT191	6	6	0	0	losartan	JAM-A	PA450268	50848	0.944
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT65	10	10	4	4	trastuzumab	STAT3	PA451743	6774	0.944
NULL	Oncotarget_2013_Jul_21_4(8)_1266-1279.nxml.txt.nlp	23907540	SENT152	2	2	4	4	doxycycline	PTEN	PA449415	5728	0.944
NULL	Arthritis_Res_Ther_2007_Jun_29_9(Suppl_1)_S7.nxml.txt.nlp	17634146	SENT38	0	0	13	13	denosumab	RANKL	PA166048634	8600	0.944
NULL	Breast_Cancer_Res_2006_Nov_6_8(6)_215.nxml.txt.nlp	17096862	SENT121	23	23	6	6	trastuzumab	HER2	PA451743	2064	0.944
NULL	eLife_2013_Nov_5_2_e00969.nxml.txt.nlp	24192036	SENT238	30	30	19	19	vemurafenib	JNK	PA165946873	5599	0.944
NULL	Open_Cardiovasc_Med_J_2010_Jun_17_4_135-145.nxml.txt.nlp	20700394	SENT163	7	7	14	14	bivalirudin	END	PA10032	2022	0.944
NULL	Br_J_Cancer_2010_Sep_28_103(7)_1008-1018.nxml.txt.nlp	20736947	SENT147	26	26	19	19	docetaxel	CD147	PA449383	682	0.944
NULL	Evid_Based_Complement_Alternat_Med_2011_Feb_14_2011_248231.nxml.txt.nlp	19233878	SENT278	31	31	21	21	rosiglitazone	DBT	PA451283	1629	0.944
NULL	Drugs_R_D_2014_Jun_6_14(2)_113-123.nxml.txt.nlp	24797400	SENT235	1	1	6	6	phenytoin	P-gp	PA450947	5243	0.944
NULL	Biology_(Basel)_2012_Dec_31_2(1)_40-63.nxml.txt.nlp	24832651	SENT153	34	34	21	21	mitomycin	PALB2	PA450524	79728	0.944
NULL	Cardiol_Ther_2013_Jun_1_2(1)_111-124.nxml.txt.nlp	25135294	SENT120	0	0	11	11	dabigatran	P-gp		5243	0.944
NULL	Eur_J_Clin_Pharmacol_2009_Dec_8_65(12)_1245-1251.nxml.txt.nlp	19669131	SENT159	9	9	21	21	ropinirole	DRD3	PA164749035	1814	0.944
NULL	Cell_Death_Dis_2010_Oct_21_1(10)_e86.nxml.txt.nlp	21368859	SENT121	5	5	25	25	doxorubicin	TRAIL	PA449412	8743	0.944
NULL	J_Oncol_2009_Jul_14_2009_804108.nxml.txt.nlp	19636422	SENT34	30	30	5	5	panitumumab	EGFR	PA162373091	1956	0.944
NULL	Chem_Rev_2014_Jun_11_114(11)_5753-5774.nxml.txt.nlp	24758331	SENT195	11	11	9	9	verapamil	P-gp	PA451868	5243	0.944
NULL	Breast_Cancer_Res_2014_Sep_12_16(5)_436.nxml.txt.nlp	25213081	SENT244	6	6	3	3	tamoxifen	MEK1	PA451581	5604	0.944
NULL	Nucleic_Acids_Res_2005_Aug_12_33(14)_4584-4592.nxml.txt.nlp	16100380	SENT110	34	34	16	16	paromomycin	GCN2	PA164784023	440275	0.944
NULL	Anesth_Essays_Res_2011_Jan-Jun_5(1)_33-38.nxml.txt.nlp	NULL	SENT159	21	21	8	8	fentanyl	NNT	PA449599	23530	0.944
NULL	Ann_Oncol_2011_Mar_8_22(3)_503-514.nxml.txt.nlp	20616198	SENT5	25	25	15	15	letrozole	aromatase	PA450196	1588	0.944
NULL	Exp_Mol_Med_2012_Sep_30_44(9)_536-544.nxml.txt.nlp	22771771	SENT56	6	6	30	30	ns-398	p53		7157	0.944
NULL	Aging_(Albany_NY)_2014_Jan_14_6(1)_70-81.nxml.txt.nlp	24429382	SENT6	22	22	5	5	bleomycin	WRN	PA448645	7486	0.944
NULL	Arthritis_Res_Ther_2005_Feb_17_7(Suppl_1)_P77.nxml.txt.nlp	NULL	SENT11	33	33	18	18	hydrocortisone	IL-6	PA449905	3569	0.944
NULL	Cell_Biol_Int_Rep_(2010)_2012_Jun_21_19(1)_e00017.nxml.txt.nlp	23124518	SENT42	13	13	27	27	etoposide	TRAIL	PA449552	8743	0.944
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT167	0	0	7	7	diclofenac	ABCC4	PA449293	10257	0.944
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Feb_23_67(Pt_3)_o682-o683.nxml.txt.nlp	21522429	SENT75	19	19	2	2	ethanol	mol	PA448073	90527	0.944
NULL	Proteome_Sci_2003_Jun_12_1_4.nxml.txt.nlp	12818002	SENT86	21	21	5	5	trypsin	PEBP	PA451806	5037	0.944
NULL	Indian_J_Endocrinol_Metab_2013_Jul-Aug_17(4)_759-762.nxml.txt.nlp	23961503	SENT31	27	27	14	14	vasopressin	ACTH	PA451858	5443	0.944
NULL	EPMA_J_2012_Sep_27_3(1)_10.nxml.txt.nlp	23016735	SENT112	22	22	5	5	warfarin	CYP2C9	PA451906	1559	0.944
NULL	J_Hematol_Oncol_2011_Jan_21_4_5.nxml.txt.nlp	21255411	SENT50	19	19	15	15	erlotinib	EGFR	PA134687924	1956	0.944
NULL	Int_J_Womens_Health_2012_Sep_3_4_455-469.nxml.txt.nlp	23071416	SENT87	13	13	1	1	zoledronate	NNT	PA10235	23530	0.944
NULL	Mol_Cancer_2014_Apr_17_13_85.nxml.txt.nlp	24741998	SENT39	8	8	27	27	rituximab	FasL	PA451261	356	0.944
NULL	Clin_Pharmacol_2011_Jun_22_3_13-25.nxml.txt.nlp	22287853	SENT188	0	0	10	10	simvastatin	OATP1B1	PA451363	10599	0.944
NULL	J_Biomed_Biotechnol_2010_Mar_9_2010_525180.nxml.txt.nlp	20300455	SENT30	13	13	1	1	valspodar	P-gp		5243	0.944
NULL	Apoptosis_2014_Apr_23_19(7)_1055-1068.nxml.txt.nlp	24756955	SENT152	17	17	2	2	cisplatin	RITA	PA449014	55422;84934	0.944
NULL	Breast_Cancer_Res_Treat_2013_Aug_20_141(1)_43-53.nxml.txt.nlp	23959396	SENT192	14	14	39	39	trastuzumab	HER3	PA451743	2065	0.944
NULL	Emerg_Infect_Dis_2013_Mar_19(3)_449-455.nxml.txt.nlp	23622714	SENT45	22	22	1	1	ethionamide	DST	PA164768738	667	0.944
NULL	Breast_Cancer_Res_2010_Oct_20_12(5)_315.nxml.txt.nlp	21062517	SENT13	10	10	5	5	trastuzumab	PI3K	PA451743	5290	0.944
NULL	Mol_Cancer_2012_Oct_22_11_80.nxml.txt.nlp	23088607	SENT72	17	17	20	20	estradiol	HIF-1	PA449503	29072	0.944
NULL	J_Gen_Physiol_1997_Feb_1_109(2)_229-243.nxml.txt.nlp	9041451	SENT15	2	2	34	34	spermine	IRK1	PA164781199	3759	0.944
NULL	Breast_Cancer_Res_2011_Jan_11_13(1)_R3.nxml.txt.nlp	21223569	SENT162	6	6	14	14	etoposide	p53	PA449552	7157	0.944
NULL	Mol_Cancer_2007_Apr_2_6_24.nxml.txt.nlp	17407548	SENT355	22	22	6	6	troglitazone	FBXW8	PA451799	26259	0.944
NULL	J_Hematol_Oncol_2013_Jul_18_6_53.nxml.txt.nlp	23866964	SENT227	8	8	11	11	temsirolimus	HDAC1	PA164746890	3065	0.944
NULL	J_Antimicrob_Chemother_2008_Nov_13_62(5)_1086-1093.nxml.txt.nlp	18703526	SENT86	7	7	17	17	cefotaxime	CTX	PA448852	1593	0.944
NULL	Mol_Syst_Biol_2009_Jul_28_5_288.nxml.txt.nlp	19638969	SENT229	11	11	39	39	resveratrol	HuR		1994	0.944
NULL	Arthritis_Res_Ther_2008_Mar_17_10(2)_R33.nxml.txt.nlp	18346273	SENT180	16	16	21	21	infliximab	HMGB1	PA452639	3146	0.944
NULL	Oncologist_2010_Mar_9_15(3)_236-245.nxml.txt.nlp	20215359	SENT78	0	0	22	22	bevacizumab	VEGF-A	PA130232992	7422	0.944
NULL	J_Neurodev_Disord_2014_Jul_30_6(1)_31.nxml.txt.nlp	25642984	SENT147	18	18	5	5	memantine	ERP	PA10364	2004	0.944
NULL	Korean_Circ_J_2013_Jun_30_43(6)_400-407.nxml.txt.nlp	23882289	SENT13	16	16	1	1	doxorubicin	survivin	PA449412	332	0.944
NULL	Int_J_Gen_Med_2010_Oct_5_3_305-311.nxml.txt.nlp	21042569	SENT95	40	40	10	10	eltrombopag	TPO	PA165981594	7066;7173	0.944
NULL	J_Cell_Mol_Med_2013_Dec_6_17(12)_1588-1597.nxml.txt.nlp	24199964	SENT65	15	15	28	28	doxycycline	APT	PA449415	653639	0.944
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_13_2012_636848.nxml.txt.nlp	23258994	SENT168	11	11	6	6	carrageenan	TRPV4	PA448814	59341	0.944
NULL	Curr_Pharm_Biotechnol_2012_May_13(6)_969-986.nxml.txt.nlp	22039792	SENT83	18	18	29	29	vincristine	MDR1	PA451879	5243	0.944
NULL	Drug_Healthc_Patient_Saf_2012_Nov_29_4_173-180.nxml.txt.nlp	23236256	SENT66	36	36	48	48	clozapine	FGA	PA449061	2243	0.944
NULL	Arthritis_Res_Ther_2011_Mar_29_13(2)_R55.nxml.txt.nlp	21447156	SENT109	31	31	5	5	hyaluronan	OP-1	PA165958431	655	0.944
NULL	J_Oncol_2010_Apr_11_2010_251231.nxml.txt.nlp	20414333	SENT194	0	0	10	10	gefitinib	EGFR	PA131301952	1956	0.944
NULL	J_Cell_Biol_2008_Jan_28_180(2)_389-402.nxml.txt.nlp	18209100	SENT274	15	15	2	2	tetracycline	VPS4B	PA451640	9525	0.944
NULL	Curr_Neuropharmacol_2008_Sep_6(3)_215-234.nxml.txt.nlp	19506722	SENT395	18	18	7	7	paroxetine	5-HT1A	PA450801	3350	0.944
NULL	J_Oncol_2013_Apr_29_2013_854121.nxml.txt.nlp	23737784	SENT118	16	16	3	3	lapatinib	PTEN	PA152241907	5728	0.944
NULL	J_Biol_Chem_2009_Apr_3_284(14)_9558-9565.nxml.txt.nlp	19202191	SENT70	20	20	14	14	camptothecin	CtIP	PA153590860	5932	0.944
NULL	J_Med_Case_Reports_2008_May_19_2_167.nxml.txt.nlp	18489739	SENT19	27	27	4	4	vincristine	PPL	PA451879	5493	0.944
NULL	Clin_Cosmet_Investig_Dermatol_2014_Apr_17_7_119-132.nxml.txt.nlp	24790463	SENT178	6	6	0	0	adalimumab	TNF-alpha	PA10004	7124	0.944
NULL	Int_J_Mol_Sci_2014_Oct_27_15(11)_19417-19443.nxml.txt.nlp	25350109	SENT174	2	2	43	43	nadh	p47phox	PA164755085	653361	0.944
NULL	Diabetes_Care_2013_Jan_10_36(Suppl_1)_S11-S66.nxml.txt.nlp	23264422	SENT1932	13	13	7	7	ramipril	DREAM	PA451223	30818	0.944
NULL	Cancer_Imaging_2011_Mar_1_11(1)_1-8.nxml.txt.nlp	21362586	SENT71	20	20	2	2	verapamil	P-gp	PA451868	5243	0.944
NULL	Braz_J_Med_Biol_Res_2014_Mar_3_47(3)_245-251.nxml.txt.nlp	24554037	SENT149	0	0	19	19	atorvastatin	IFN	PA448500	3439	0.944
NULL	Cancer_Immunol_Immunother_2012_Jul_23_61(7)_1101-1111.nxml.txt.nlp	22193989	SENT37	7	7	22	22	oxaliplatin	IL-4	PA131285527	3565	0.944
NULL	Cancer_Med_2014_Oct_18_3(5)_1294-1301.nxml.txt.nlp	24941936	SENT28	24	24	10	10	cetuximab	KRAS	PA10040	3845	0.944
NULL	Biologics_2012_Dec_17_6_429-464.nxml.txt.nlp	23269860	SENT12	3	3	15	15	adalimumab	ACR	PA10004	49	0.944
NULL	Pain_Res_Treat_2011_Aug_14_2011_864605.nxml.txt.nlp	22110933	SENT103	5	5	14	14	ropivacaine	PLP	PA451271	25824;5744	0.944
NULL	Cancers_(Basel)_2011_Apr_1_3(2)_1844-1860.nxml.txt.nlp	24212785	SENT73	13	13	20	20	panitumumab	KRAS	PA162373091	3845	0.944
NULL	Asian_J_Androl_2014_Jan_20_Mar-Apr_16(2)_213-222.nxml.txt.nlp	24385015	SENT2	28	28	33	33	estradiol	aromatase	PA449503	1588	0.944
NULL	J_Thromb_Haemost_2007_May_1_5(5)_910-917.nxml.txt.nlp	17362227	SENT105	11	11	6	6	thrombin	P2X1	PA451674	5023	0.944
NULL	J_Biol_Chem_2009_Jan_2_284(1)_77-84.nxml.txt.nlp	18854318	SENT166	35	35	7	7	forskolin	AMPK	PA146096022	5563	0.944
NULL	Algorithms_Mol_Biol_2010_Jul_15_5_29.nxml.txt.nlp	20633297	SENT241	15	15	0	0	sildenafil	PDE4B	PA451346	5142	0.944
NULL	Breast_Cancer_Res_2011_Jan_17_13(1)_R5.nxml.txt.nlp	21241485	SENT210	12	12	3	3	estradiol	Brn-3b	PA449503	5458	0.944
NULL	Front_Genet_2013_Aug_29_4_163.nxml.txt.nlp	24009622	SENT12	7	7	16	16	ethanol	ABCG2	PA448073	9429	0.944
NULL	Int_J_Gen_Med_2009_Dec_29_2_209-217.nxml.txt.nlp	20360906	SENT139	22	22	28	28	pergolide	PRL	PA450873	5617	0.944
NULL	AIDS_Res_Treat_2012_Nov_8_2012_595762.nxml.txt.nlp	23193464	SENT89	12	12	1	1	etravirine	DUET	PA166014703	8997	0.944
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_16_2012_395912.nxml.txt.nlp	23118789	SENT151	13	13	0	0	flavopiridol	UGT1A9	PA452627	54600	0.944
NULL	Nat_Commun_2012_Dec_27_3_1329.nxml.txt.nlp	23271661	SENT136	14	14	2	2	carrageenan	GPRC6A	PA448814	222545	0.944
NULL	Br_J_Cancer_1995_Oct_72(4)_917-921.nxml.txt.nlp	7547240	SENT10	14	14	0	0	nadh	DTD	PA164755085	1728	0.944
NULL	Ann_Oncol_2012_Dec_2_23(12)_3007-3016.nxml.txt.nlp	22865781	SENT171	23	23	20	20	trastuzumab	IGF1R	PA451743	3480	0.944
NULL	Arch_Med_Sci_2011_Jun_11_7(3)_388-396.nxml.txt.nlp	22312373	SENT4	2	2	5	5	diltiazem	CYP3A	PA449334	1574	0.944
NULL	F1000_Biol_Rep_2009_Sep_8_1_70.nxml.txt.nlp	20948617	SENT8	10	10	21	21	tocilizumab	p40	PA165292659	3921;339541;10314	0.944
NULL	Hum_Genomics_2009_Dec_1_4(2)_91-106.nxml.txt.nlp	20038497	SENT247	24	24	21	21	donepezil	APOE	PA449394	348	0.944
NULL	Dement_Geriatr_Cogn_Dis_Extra_2014_Nov_15_4(3)_450-456.nxml.txt.nlp	25538729	SENT90	7	7	36	36	donepezil	APOE	PA449394	348	0.944
NULL	Glycoconj_J_2013_Apr_29_30(3)_205-225.nxml.txt.nlp	22544341	SENT5	13	13	0	0	galactose	L1CAM	PA449725	3897	0.944
NULL	Oncotarget_2014_Oct_15_5(21)_10763-10777.nxml.txt.nlp	25333257	SENT69	11	11	4	4	sn-38	P-gp		5243	0.944
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT8	5	5	16	16	doxorubicin	B7-H1	PA449412	29126	0.944
NULL	Int_J_Breast_Cancer_2011_Sep_8_2011_595092.nxml.txt.nlp	22295229	SENT88	11	11	27	27	tamoxifen	aromatase	PA451581	1588	0.944
NULL	Indian_J_Med_Res_2014_Aug_140(2)_209-215.nxml.txt.nlp	25297352	SENT103	14	14	5	5	levetiracetam	CLB	PA450206	171425	0.944
NULL	Environ_Health_Perspect_2011_Aug_7_119(8)_1117-1122.nxml.txt.nlp	21382770	SENT102	18	18	21	21	mk-571	MRP		79971	0.944
NULL	Hum_Genomics_2009_Jan_1_3(2)_157-168.nxml.txt.nlp	19164092	SENT150	37	37	3	3	lipase	HSL	PA450239	3991	0.944
NULL	J_Public_Health_Res_2014_Mar_26_3(1)_204.nxml.txt.nlp	25170509	SENT53	3	3	13	13	buprenorphine	OST	PA448685	1650;23263	0.944
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Oct_8_70(Pt_11)_o1151.nxml.txt.nlp	25484795	SENT82	26	26	4	4	ethanol	mol	PA448073	90527	0.944
NULL	Br_J_Pharmacol_2014_Feb_24_171(1)_1019-1032.nxml.txt.nlp	24251620	SENT177	14	14	3	3	nifedipine	TRPM3	PA450631	80036	0.944
NULL	Sci_Rep_2014_Dec_15_4_7490.nxml.txt.nlp	25502402	SENT277	16	16	2	2	cetuximab	AKT	PA10040	207	0.944
NULL	Cancer_Microenviron_2008_Dec_20_1(1)_103-111.nxml.txt.nlp	19308689	SENT62	18	18	0	0	trypsin	PAR-1	PA451806	2011;2149	0.944
NULL	Chem_Rev_2011_Oct_12_111(10)_5899-5921.nxml.txt.nlp	21923193	SENT624	13	13	9	9	indomethacin	COX	PA449982	1351	0.944
NULL	Cancers_(Basel)_2010_May_26_2(2)_970-988.nxml.txt.nlp	24281102	SENT179	0	0	15	15	bevacizumab	VEGFR1	PA130232992	2321	0.944
NULL	J_Biol_2009_Apr_15_8(3)_30.nxml.txt.nlp	19435483	SENT36	39	39	12	12	imatinib	NQO1	PA10804	1728	0.944
NULL	Environ_Health_Perspect_2008_Jun_6_116(6)_752-760.nxml.txt.nlp	18560531	SENT299	30	30	5	5	methimazole	spatial	PA450422	219793	0.944
NULL	Int_J_Surg_Oncol_2012_Jun_12_2012_862879.nxml.txt.nlp	22778941	SENT111	35	35	23	23	cisplatin	c-Myc	PA449014	4609	0.944
NULL	Psychiatry_Investig_2013_Dec_16_10(4)_425-427.nxml.txt.nlp	24474994	SENT41	11	11	22	22	quetiapine	CYP3A4	PA451201	1576	0.944
NULL	Clin_Ophthalmol_2008_Jun_2(2)_339-346.nxml.txt.nlp	19668725	SENT125	25	25	18	18	bevacizumab	VEGF-A	PA130232992	7422	0.944
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Sep_8_68(Pt_10)_o2873.nxml.txt.nlp	23125672	SENT66	5	5	32	32	benzaldehyde	mol	PA448571	90527	0.944
NULL	Acta_Pharmacol_Sin_2013_Jun_8_34(6)_830-836.nxml.txt.nlp	23564080	SENT22	26	26	16	16	simvastatin	RAGE	PA451363	177	0.944
NULL	Case_Rep_Pediatr_2014_Jun_15_2014_650605.nxml.txt.nlp	25024861	SENT54	0	0	13	13	temazepam	UGT	PA451608	7361;7355	0.944
NULL	Cancer_Cell_Int_2013_Apr_16_13_36.nxml.txt.nlp	23590596	SENT87	7	7	13	13	doxorubicin	PI3K	PA449412	5290	0.944
NULL	Cell_Death_Differ_2009_Aug_20_16(8)_1135-1145.nxml.txt.nlp	19300452	SENT185	26	26	29	29	doxycycline	PUMA	PA449415	27113	0.944
NULL	Oncotarget_2014_Jun_1_5(13)_4855-4867.nxml.txt.nlp	24952592	SENT82	26	26	18	18	platinum	MET	PA150595617	4233	0.944
NULL	eLife_2014_Apr_22_3_e02053.nxml.txt.nlp	24755289	SENT102	7	7	27	27	baclofen	R7BP	PA448533	401190	0.944
NULL	Breast_Cancer_Res_2014_Sep_11_16(5)_430.nxml.txt.nlp	25212826	SENT42	25	25	7	7	fulvestrant	AKT	PA164747170	207	0.944
NULL	Cells_2012_Dec_13_1(4)_1261-1292.nxml.txt.nlp	24710554	SENT124	41	41	8	8	heparin	EGFR	PA449855	1956	0.944
NULL	J_Oncol_2012_Jun_19_2012_521215.nxml.txt.nlp	22778735	SENT198	0	0	8	8	gefitinib	EGFR	PA131301952	1956	0.944
NULL	J_Hematol_Oncol_2013_Jul_9_6_49.nxml.txt.nlp	23837843	SENT215	12	12	8	8	verapamil	P-gp	PA451868	5243	0.944
NULL	Cancers_(Basel)_2010_May_28_2(2)_1027-1039.nxml.txt.nlp	24281105	SENT50	10	10	23	23	vatalanib	LDHA	PA7001	3939	0.944
NULL	J_Cell_Biol_1999_Feb_22_144(4)_789-801.nxml.txt.nlp	10037799	SENT68	22	22	4	4	dextran	LYVE-1	PA449261	10894	0.944
NULL	Nucleic_Acids_Res_2011_Mar_23_39(4)_1526-1537.nxml.txt.nlp	20972225	SENT193	38	38	6	6	tetracycline	BCS	PA451640	617	0.944
NULL	Breast_Cancer_Res_2004_Oct_28_6(1)_E1.nxml.txt.nlp	14680487	SENT28	9	9	5	5	tamoxifen	HER2	PA451581	2064	0.944
NULL	Front_Genet_2014_Feb_26_5_40.nxml.txt.nlp	24616734	SENT317	13	13	32	32	docetaxel	VCAM1	PA449383	7412	0.944
NULL	Arthritis_Res_Ther_2010_Dec_21_12(6)_223.nxml.txt.nlp	21205285	SENT73	31	31	35	35	probenecid	URAT1	PA451106	116085	0.944
NULL	J_Thromb_Thrombolysis_2012_Feb_20_33(2)_143-153.nxml.txt.nlp	22183178	SENT7	24	24	22	22	prasugrel	P2Y12	PA154410481	64805	0.944
NULL	Mol_Cancer_2010_Oct_12_9_269.nxml.txt.nlp	20939893	SENT7	10	10	3	3	isoproterenol	STAT3	PA450121	6774	0.943
NULL	Int_J_Endocrinol_2012_Apr_10_2012_268957.nxml.txt.nlp	22550484	SENT596	8	8	12	12	pegvisomant	UGT1A1	PA164749630	54658	0.943
NULL	Int_J_Endocrinol_2010_Aug_29_2010_481326.nxml.txt.nlp	20871656	SENT32	30	30	0	0	glucose	MPG	PA449773	4350	0.943
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jul_11_65(Pt_8)_o1820.nxml.txt.nlp	21583522	SENT49	21	21	7	7	ethanol	mol	PA448073	90527	0.943
NULL	Nat_Med_2012_Jul_18(7)_1118-1122.nxml.txt.nlp	22683780	SENT52	8	8	19	19	crizotinib	FGFR1	PA165946122	2260	0.943
NULL	J_Oncol_2010_Feb_27_2010_214186.nxml.txt.nlp	21461373	SENT266	1	1	21	21	heparin	CD34	PA449855	947	0.943
NULL	Evid_Based_Complement_Alternat_Med_2014_May_8_2014_494528.nxml.txt.nlp	24949077	SENT5	10	10	30	30	cyclophosphamide	CTX	PA449165	1593	0.943
NULL	Cell_Cycle_2013_Mar_15_12(6)_868.nxml.txt.nlp	23442795	SENT27	5	5	15	15	bortezomib	p53	PA10252	7157	0.943
NULL	Cancers_(Basel)_2012_Oct_12_4(4)_989-1035.nxml.txt.nlp	24213498	SENT438	32	32	8	8	gemcitabine	CD133	PA449748	8842	0.943
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT122	5	5	17	17	pp2	LYN		4067	0.943
NULL	Acta_Pharmacol_Sin_2010_Jul_21_31(7)_855-860.nxml.txt.nlp	20562904	SENT12	20	20	38	38	fluconazole	CDR2	PA449653	1039	0.943
NULL	Br_J_Cancer_2014_May_27_110(11)_2716-2727.nxml.txt.nlp	24800946	SENT163	25	25	10	10	cetuximab	AREG	PA10040	374	0.943
NULL	Ann_Hematol_2014_Nov_28_93(3)_361-374.nxml.txt.nlp	24288111	SENT210	6	6	20	20	lenalidomide	CD38	PA162363968	952	0.943
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT220	4	4	10	10	metformin	AKT	PA450395	207	0.943
NULL	J_Thromb_Thrombolysis_2011_Nov_26_32(4)_459-466.nxml.txt.nlp	21706290	SENT216	15	15	3	3	clopidogrel	CYP2C19	PA449053	1557	0.943
NULL	Breast_Cancer_(Auckl)_2008_May_23_2_11-16.nxml.txt.nlp	19430575	SENT25	17	17	21	21	trastuzumab	aromatase	PA451743	1588	0.943
NULL	Sensors_(Basel)_2011_May_4_11(5)_4990-5004.nxml.txt.nlp	22163886	SENT165	7	7	18	18	oxygen	CFD	PA450744	1675	0.943
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1554-1562.nxml.txt.nlp	21970876	SENT169	39	39	24	24	afatinib	HER-2	PA165981154	2064	0.943
NULL	Arthritis_Res_Ther_2006_Apr_12_8(Suppl_1)_S4.nxml.txt.nlp	16820043	SENT143	5	5	13	13	allopurinol	HLA-B	PA448320	3106	0.943
NULL	Cancer_Cell_Int_2010_Sep_9_10_32.nxml.txt.nlp	20828393	SENT137	11	11	2	2	cisplatin	ATF3	PA449014	467	0.943
NULL	Biomed_Res_Int_2013_Aug_4_2013_152909.nxml.txt.nlp	23984319	SENT97	34	34	4	4	cytarabine	MSH2	PA449177	4436	0.943
NULL	Oncotarget_2012_Jan_28_3(1)_22-30.nxml.txt.nlp	22289880	SENT112	10	10	43	43	rituximab	gamma	PA451261	9913	0.943
NULL	Acta_Pharmacol_Sin_2012_May_26_33(5)_675-681.nxml.txt.nlp	22447226	SENT32	22	22	11	11	gefitinib	EGFR	PA131301952	1956	0.943
NULL	J_Cell_Mol_Med_2013_Oct_23_17(10)_1207-1217.nxml.txt.nlp	24106980	SENT126	8	8	28	28	paclitaxel	PTEN	PA450761	5728	0.943
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT171	40	40	11	11	cisplatin	p53	PA449014	7157	0.943
NULL	Gut_Liver_2012_Jan_12_6(1)_10-20.nxml.txt.nlp	22375166	SENT170	12	12	3	3	sitagliptin	GLP-1	PA164748978	100125288	0.943
NULL	Chem_Commun_(Camb)_2013_Jun_21_49(76)_8441-8443.nxml.txt.nlp	23770604	SENT18	3	3	1	1	geldanamycin	Hsp90	PA152031327	3320	0.943
NULL	Biochem_Biophys_Res_Commun_2009_May_22_383(1)_63-67.nxml.txt.nlp	19332024	SENT289	4	4	21	21	lipase	IL-6	PA450239	3569	0.943
NULL	Cell_Death_Dis_2010_May_13_1(5)_e41.nxml.txt.nlp	21364648	SENT96	8	8	24	24	etoposide	p53	PA449552	7157	0.943
NULL	Mediators_Inflamm_2010_Mar_7_2010_364957.nxml.txt.nlp	20224654	SENT108	21	21	4	4	orlistat	IL-6	PA164776864	3569	0.943
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT185	11	11	6	6	cisplatin	p53	PA449014	7157	0.943
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT186	14	14	19	19	curcumin	Bcl-2	PA151958596	596	0.943
NULL	Iran_J_Public_Health_2012_Jun_30_41(6)_65-71.nxml.txt.nlp	23113195	SENT88	18	18	9	9	methotrexate	DHFR	PA450428	1719	0.943
NULL	Breast_Cancer_Res_2005_Nov_11_7(6)_255-257.nxml.txt.nlp	16457700	SENT34	16	16	20	20	tamoxifen	aromatase	PA451581	1588	0.943
NULL	Environ_Health_Perspect_2009_Feb_8_117(2)_175-180.nxml.txt.nlp	19270784	SENT236	15	15	6	6	doxorubicin	BPA	PA449412	667	0.943
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Dec_8_67(Pt_1)_o50.nxml.txt.nlp	21522760	SENT48	18	18	6	6	ethanol	mol	PA448073	90527	0.943
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_13_2013_468537.nxml.txt.nlp	23956772	SENT141	2	2	29	29	paclitaxel	PIG3	PA450761	64975;9540	0.943
NULL	Biomed_Res_Int_2014_Aug_6_2014_967826.nxml.txt.nlp	25165721	SENT354	21	21	7	7	cisplatin	HO-1	PA449014	3162	0.943
NULL	Oncotarget_2013_Aug_21_4(9)_1484-1495.nxml.txt.nlp	23986086	SENT166	18	18	41	41	cetuximab	PIK3CA	PA10040	5290	0.943
NULL	Cell_Death_Dis_2014_Feb_27_5(2)_e1088.nxml.txt.nlp	24577086	SENT43	25	25	16	16	metformin	Bcl-2	PA450395	596	0.943
NULL	Iran_J_Ped_Hematol_Oncol_2014_Jul_20_4(3)_118-126.nxml.txt.nlp	25254091	SENT108	23	23	35	35	imatinib	ABCA2	PA10804	20	0.943
NULL	Mol_Brain_2014_Apr_3_7_25.nxml.txt.nlp	24708812	SENT8	30	30	0	0	chloroquine	ERK	PA448948	5594	0.943
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1013.nxml.txt.nlp	24457957	SENT317	7	7	35	35	bortezomib	NOXA	PA10252	5366	0.943
NULL	Mol_Cancer_2014_Jul_5_13_165.nxml.txt.nlp	24996221	SENT216	15	15	29	29	docetaxel	HMGB1	PA449383	3146	0.943
NULL	Int_J_Mol_Sci_2013_Apr_11_14(4)_7959-7978.nxml.txt.nlp	23579957	SENT189	20	20	11	11	trypsin	CO2	PA451806	4513	0.943
NULL	Cancer_Metab_2013_Jan_23_1_3.nxml.txt.nlp	24280005	SENT396	17	17	8	8	doxycycline	CHOP	PA449415	1649	0.943
NULL	J_Cell_Biol_2002_Jun_10_157(6)_953-962.nxml.txt.nlp	12045185	SENT296	32	32	2	2	metronidazole	B23	PA450484	4869	0.943
NULL	Ann_Hematol_2014_Sep_10_93(1)_1-11.nxml.txt.nlp	24018623	SENT133	16	16	3	3	lenalidomide	CDC25C	PA162363968	995	0.943
NULL	Curr_Pharm_Des_2008_Oct_14(28)_2983-2998.nxml.txt.nlp	18991714	SENT74	0	0	16	16	sunitinib	VEGFR	PA162372840	3791	0.943
NULL	Onco_Targets_Ther_2014_May_12_7_719-728.nxml.txt.nlp	24872713	SENT53	8	8	43	43	sunitinib	p53	PA162372840	7157	0.943
NULL	Oncotarget_2013_Aug_8_4(8)_1130-1142.nxml.txt.nlp	24029073	SENT193	17	17	31	31	cisplatin	NRF2	PA449014	2551;4780	0.943
NULL	Oncol_Rep_2013_Mar_8_29(3)_917-924.nxml.txt.nlp	23314174	SENT116	12	12	26	26	sorafenib	CD44	PA7000	960	0.943
NULL	Br_J_Pharmacol_2011_Nov_164(5)_1522-1533.nxml.txt.nlp	21557728	SENT141	12	12	10	10	cangrelor	P2Y12	PA165945763	64805	0.943
NULL	J_Exp_Med_1977_Dec_1_146(6)_1484-1499.nxml.txt.nlp	925610	SENT6	26	26	1	1	trypsin	C42	PA451806	51654	0.943
NULL	Br_J_Cancer_2011_Mar_1_104(5)_750-755.nxml.txt.nlp	21326243	SENT141	43	43	18	18	olaparib	PARP-1		25976	0.943
NULL	Exp_Ther_Med_2013_Nov_13_6(5)_1317-1321.nxml.txt.nlp	24223665	SENT142	20	20	5	5	curcumin	CD133	PA151958596	8842	0.943
NULL	Neural_Regen_Res_2014_Apr_15_9(8)_878-887.nxml.txt.nlp	25206906	SENT25	14	14	0	0	capsaicin	TRPV1	PA448776	7442	0.943
NULL	Adv_Ther_2014_Sep_23_31(9)_986-999.nxml.txt.nlp	25245811	SENT211	14	14	25	25	metformin	Met	PA450395	79811	0.943
NULL	Oncogene_2009_Feb_5_28(5)_674-685.nxml.txt.nlp	19015634	SENT105	6	6	0	0	mitomycin	FANCA	PA450524	2175	0.943
NULL	Cancer_Manag_Res_2011_Mar_3_3_57-64.nxml.txt.nlp	21556317	SENT49	0	0	9	9	trastuzumab	HER-2	PA451743	2064	0.943
NULL	Case_Rep_Med_2010_Jun_17_2010_472389.nxml.txt.nlp	20589221	SENT10	23	23	28	28	mivacurium	BCHE	PA450528	590	0.943
NULL	Oncotarget_2011_Dec_31_2(12)_1314-1321.nxml.txt.nlp	22248929	SENT140	36	36	21	21	lapatinib	HER3	PA152241907	2065	0.943
NULL	Biologics_2010_Jun_24_4_147-155.nxml.txt.nlp	20631818	SENT235	5	5	3	3	letrozole	aromatase	PA450196	1588	0.943
NULL	Sci_Rep_2014_Dec_1_4_7268.nxml.txt.nlp	25434695	SENT247	17	17	8	8	gefitinib	EGFR	PA131301952	1956	0.943
NULL	Exp_Diabetes_Res_2012_Feb_19_2012_749812.nxml.txt.nlp	22454628	SENT133	33	33	18	18	phenylephrine	AMPK	PA450935	5563	0.943
NULL	J_Carcinog_2011_Dec_22_10_35.nxml.txt.nlp	22279420	SENT122	18	18	5	5	tamoxifen	p53	PA451581	7157	0.943
NULL	Indian_J_Pharmacol_2013_Mar-Apr_45(2)_155-158.nxml.txt.nlp	23716892	SENT116	31	31	14	14	pioglitazone	CYP3A4	PA450970	1576	0.943
NULL	Breast_Cancer_Res_2010_Jan_15_12(1)_R8.nxml.txt.nlp	20078855	SENT227	9	9	20	20	paclitaxel	Hsp90	PA450761	3320	0.943
NULL	Acta_Histochem_Cytochem_2013_Dec_28_46(6)_187-197.nxml.txt.nlp	24610966	SENT127	16	16	6	6	pilocarpine	AQP5	PA450962	362	0.943
NULL	Environ_Health_Perspect_2007_Dec_30_115(12)_1727-1731.nxml.txt.nlp	18087590	SENT167	1	1	32	32	indomethacin	LOX	PA449982	4015	0.943
NULL	Eur_J_Clin_Pharmacol_2010_Nov_29_66(11)_1131-1136.nxml.txt.nlp	20669013	SENT130	14	14	7	7	voriconazole	CYP3A4	PA10233	1576	0.943
NULL	Br_J_Cancer_2011_Jul_26_105(3)_372-381.nxml.txt.nlp	21730979	SENT205	8	8	12	12	cisplatin	ATR	PA449014	390502;84168;545	0.943
NULL	Mol_Pain_2014_Aug_15_10_53.nxml.txt.nlp	25127716	SENT13	0	0	20	20	paclitaxel	CCL3	PA450761	6348	0.943
NULL	CNS_Spectr_2014_Apr_1_19(2)_121-133.nxml.txt.nlp	23903233	SENT161	14	14	18	18	phencyclidine	5-HT7	PA128406980	3363	0.943
NULL	Endocrinol_Metab_(Seoul)_2014_Sep_25_29(3)_379-387.nxml.txt.nlp	25309798	SENT119	29	29	6	6	resveratrol	SIRT1		23411	0.943
NULL	Cell_Cycle_2012_Dec_15_11(24)_4661-4672.nxml.txt.nlp	23187802	SENT101	12	12	22	22	doxorubicin	DREAM	PA449412	30818	0.943
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT178	8	8	0	0	methotrexate	OPG	PA450428	690	0.943
NULL	Cancer_Cell_Int_2013_May_24_13_48.nxml.txt.nlp	23706027	SENT39	12	12	2	2	cisplatin	ADM	PA449014	133	0.943
NULL	Diabetes_2009_Feb_58(2)_352-359.nxml.txt.nlp	19011168	SENT101	12	12	1	1	exenatide	ANOVA	PA164749238	4858	0.943
NULL	ScientificWorldJournal_2012_Apr_26_2012_358102.nxml.txt.nlp	22645419	SENT143	4	4	6	6	captopril	AT2	PA448780	186	0.943
NULL	Ann_Gastroenterol_2014_27(2)_105-112.nxml.txt.nlp	24733569	SENT180	22	22	11	11	entecavir	IFN	PA164784025	3439	0.943
NULL	Oncotarget_2012_Dec_17_4(1)_48-63.nxml.txt.nlp	23295955	SENT184	34	34	3	3	paclitaxel	MTHFD2	PA450761	10797	0.943
NULL	Mycorrhiza_2012_Feb_28_22(2)_149-156.nxml.txt.nlp	21626142	SENT125	4	4	23	23	hyperforin	AMF	PA165985514	2821	0.943
NULL	Br_J_Pharmacol_2012_Dec_29_167(8)_1712-1722.nxml.txt.nlp	22862290	SENT67	13	13	3	3	carbachol	TRPC3	PA448784	7222	0.943
NULL	EJC_Suppl_2013_Sep_5_11(2)_3-22.nxml.txt.nlp	NULL	SENT1021	6	6	24	24	tamoxifen	ATAC	PA451581	6375	0.943
NULL	Clin_Med_Insights_Oncol_2012_Mar_12_6_153-164.nxml.txt.nlp	22550404	SENT81	14	14	28	28	vincristine	Raf-1	PA451879	5894	0.943
NULL	J_Gen_Physiol_2013_Aug_142(2)_137-155.nxml.txt.nlp	23858003	SENT10	2	2	21	21	mibefradil	ACTH	PA450492	5443	0.943
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1554-1562.nxml.txt.nlp	21970876	SENT38	11	11	27	27	erlotinib	EGFR	PA134687924	1956	0.943
NULL	J_Cell_Mol_Med_2013_Dec_6_17(12)_1588-1597.nxml.txt.nlp	24199964	SENT37	9	9	29	29	doxycycline	APT	PA449415	653639	0.943
NULL	Orphanet_J_Rare_Dis_2012_Sep_25_7_71.nxml.txt.nlp	23009155	SENT266	14	14	25	25	plerixafor	CXCR4	PA165958410	7852	0.943
NULL	Biologics_2012_Jan_5_6_13-20.nxml.txt.nlp	22291463	SENT41	12	12	25	25	trastuzumab	HER2	PA451743	2064	0.943
NULL	ARYA_Atheroscler_2011_Summer_7(2)_78-86.nxml.txt.nlp	22577451	SENT89	27	27	15	15	betaine	CRP	PA448603	1401;140913	0.943
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT162	19	19	6	6	neratinib	HER2	PA165291472	2064	0.943
NULL	Oncotarget_2014_Oct_9_5(20)_9564-9576.nxml.txt.nlp	25333255	SENT153	16	16	8	8	nilotinib	CD34	PA165958345	947	0.943
NULL	Acta_Pharmacol_Sin_2014_Jun_4_35(6)_846-852.nxml.txt.nlp	24902791	SENT22	0	0	12	12	lapatinib	EGFR	PA152241907	1956	0.943
NULL	J_Exp_Med_2000_Mar_20_191(6)_1005-1016.nxml.txt.nlp	10727462	SENT159	20	20	5	5	flavopiridol	E2F1	PA452627	1869	0.943
NULL	J_Hematol_Oncol_2009_Apr_22_2_18.nxml.txt.nlp	19386128	SENT67	5	5	0	0	cetuximab	KRAS	PA10040	3845	0.943
NULL	Curr_Med_Chem_2011_Jun_18(18)_2686-2714.nxml.txt.nlp	21649578	SENT214	33	33	44	44	erlotinib	EGFR	PA134687924	1956	0.943
NULL	Biomed_Res_Int_2013_Sep_9_2013_239354.nxml.txt.nlp	24089667	SENT29	2	2	18	18	erlotinib	EGFR	PA134687924	1956	0.943
NULL	Front_Endocrinol_(Lausanne)_2014_Aug_4_5_131.nxml.txt.nlp	25136332	SENT193	0	0	27	27	naltrexone	MC4R	PA450588	4160	0.943
NULL	Clin_Ophthalmol_2008_Jun_2(2)_355-368.nxml.txt.nlp	19668727	SENT182	0	0	30	30	nepafenac	CYP3A4	PA165958407	1576	0.943
NULL	Neuro_Oncol_2010_Apr_27_12(4)_389-400.nxml.txt.nlp	20308316	SENT146	7	7	2	2	chloroquine	p53	PA448948	7157	0.943
NULL	Clin_Epigenetics_2010_Aug_20_1(3-4)_71-83.nxml.txt.nlp	22704201	SENT45	8	8	16	16	resveratrol	SIRT1		23411	0.943
NULL	Br_J_Cancer_2013_Sep_3_109(5)_1243-1251.nxml.txt.nlp	23922111	SENT165	25	25	4	4	bevacizumab	EGFL7	PA130232992	51162	0.943
NULL	Clin_Med_Insights_Arthritis_Musculoskelet_Disord_2012_Jan_5_5_1-14.nxml.txt.nlp	22267947	SENT122	7	7	30	30	risedronate	HIP	PA451255	6767;6159;64399;5068	0.943
NULL	Indian_J_Pharm_Sci_2011_Nov-Dec_73(6)_615-620.nxml.txt.nlp	23112394	SENT143	29	29	5	5	azithromycin	CP2	PA448519	7024	0.943
NULL	Adv_Biomed_Res_2014_Jan_9_3_1.nxml.txt.nlp	24592358	SENT116	5	5	22	22	estradiol	TLR3	PA449503	7098	0.943
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1066.nxml.txt.nlp	24556681	SENT12	13	13	28	28	ethanol	TLR4	PA448073	7099	0.943
NULL	Indian_J_Occup_Environ_Med_2010_Aug_14(2)_31-38.nxml.txt.nlp	21120077	SENT152	15	15	2	2	staurosporine	survivin	PA165109623	332	0.943
NULL	Biologics_2013_Mar_3_7_61-68.nxml.txt.nlp	23493885	SENT49	16	16	20	20	gefitinib	EGFR	PA131301952	1956	0.943
NULL	Br_J_Cancer_2010_Sep_28_103(7)_1008-1018.nxml.txt.nlp	20736947	SENT47	32	32	4	4	docetaxel	CD147	PA449383	682	0.943
NULL	Aging_(Albany_NY)_2011_Jan_18_3(1)_33-43.nxml.txt.nlp	21248371	SENT133	5	5	25	25	oxygen	p53	PA450744	7157	0.943
NULL	Physiol_Rep_2014_Aug_5_2(8)_e12090.nxml.txt.nlp	25096552	SENT210	11	11	22	22	paraformaldehyde	CD137	PA450790	3604	0.943
NULL	Arthritis_Res_Ther_2003_Sep_12_5(Suppl_3)_55.nxml.txt.nlp	NULL	SENT11	10	10	29	29	rosiglitazone	AP-1	PA451283	2353;3727;2354;3725	0.943
NULL	EMBO_Mol_Med_2013_Apr_25_5(4)_531-547.nxml.txt.nlp	23526793	SENT256	31	31	8	8	rosiglitazone	MAP2	PA451283	4133;10988	0.943
NULL	Acta_Pharmacol_Sin_2010_Nov_18_31(11)_1447-1453.nxml.txt.nlp	20953204	SENT146	23	23	10	10	rimonabant	PI3K	PA152407999	5290	0.943
NULL	Acta_Neuropathol_Commun_2014_Dec_10_2(1)_172.nxml.txt.nlp	NULL	SENT129	18	18	5	5	glutaraldehyde	VCP	PA449777	7415	0.943
NULL	Anesth_Pain_Med_2012_Jul_10_Summer_2(1)_12-16.nxml.txt.nlp	24223327	SENT5	0	0	5	5	pregabalin	gamma	PA164754814	9913	0.943
NULL	Brain_2013_May_4_136(5)_1462-1475.nxml.txt.nlp	23460667	SENT265	28	28	17	17	bevacizumab	CD31	PA130232992	5175	0.943
NULL	Core_Evid_2010_Oct_21_5_61-76.nxml.txt.nlp	21042543	SENT137	12	12	7	7	panitumumab	EGFR	PA162373091	1956	0.943
NULL	Indian_J_Endocrinol_Metab_2013_Sep-Oct_17(5)_819-834.nxml.txt.nlp	24083163	SENT316	41	41	14	14	metformin	GLP-1	PA450395	100125288	0.943
NULL	Cancer_Microenviron_2009_Sep_26_2(Suppl_1)_19-204.nxml.txt.nlp	NULL	SENT3586	12	12	26	26	doxorubicin	p53	PA449412	7157	0.943
NULL	Expert_Rev_Mol_Med_2010_Apr_12_e12.nxml.txt.nlp	20398440	SENT348	0	0	27	27	geldanamycin	HSF1	PA152031327	3297	0.943
NULL	Lab_Anim_Res_2012_Jun_26_28(2)_109-114.nxml.txt.nlp	22787484	SENT55	32	32	21	21	reserpine	MKP-1	PA451236	1843	0.943
NULL	Oncotarget_2014_Aug_27_5(17)_7328-7341.nxml.txt.nlp	25193862	SENT184	2	2	17	17	dasatinib	ANOVA	PA162372878	4858	0.943
NULL	Oncotarget_2014_Jun_27_5(13)_4694-4708.nxml.txt.nlp	25051361	SENT136	15	15	11	11	fludarabine	p27	PA449655	5715;10534	0.943
NULL	Oncotarget_2010_Nov_19_1(7)_596-605.nxml.txt.nlp	21317455	SENT59	30	30	13	13	sorafenib	EGF	PA7000	1950	0.943
NULL	Br_J_Cancer_2009_Sep_15_101(6)_940-950.nxml.txt.nlp	19690545	SENT211	20	20	0	0	rimonabant	PC-3	PA152407999	692094	0.943
NULL	Oncoscience_2013_Dec_11_1(1)_30-38.nxml.txt.nlp	25593982	SENT166	34	34	23	23	oxygen	Met	PA450744	79811	0.943
NULL	Hum_Reprod_2013_Sep_11_28(9)_2490-2501.nxml.txt.nlp	23756706	SENT75	23	23	9	9	phenol	CO2	PA450913	4513	0.943
NULL	Physiol_Rep_2014_Oct_24_2(10)_e12175.nxml.txt.nlp	25344477	SENT195	20	20	35	35	paraformaldehyde	cadherin	PA450790	1015	0.943
NULL	Mol_Cancer_2010_Apr_23_9_87.nxml.txt.nlp	20416058	SENT158	23	23	17	17	etoposide	TRAIL	PA449552	8743	0.943
NULL	Child_Adolesc_Psychiatry_Ment_Health_2012_May_29_6_21.nxml.txt.nlp	22643087	SENT205	19	19	11	11	risperidone	CYP2D6	PA451257	1565	0.943
NULL	Pharmaceuticals_(Basel)_2012_Aug_10_5(8)_802-836.nxml.txt.nlp	24280676	SENT40	0	0	23	23	gemcitabine	CNT2	PA449748	9153	0.943
NULL	Cell_Biol_Int_Rep_(2010)_2012_Jun_21_19(1)_e00017.nxml.txt.nlp	23124518	SENT73	14	14	23	23	etoposide	TRAIL	PA449552	8743	0.943
NULL	Biomed_Res_Int_2014_Feb_6_2014_323594.nxml.txt.nlp	24689036	SENT125	27	27	0	0	raloxifene	PC3	PA451221	57332;7832;5122	0.943
NULL	J_Cereb_Blood_Flow_Metab_2011_Oct_20_31(10)_2030-2040.nxml.txt.nlp	21505475	SENT197	22	22	4	4	cilostazol	Bcl-2	PA164746334	596	0.943
NULL	Clinics_(Sao_Paulo)_2013_Feb_68(Suppl_1)_75-79.nxml.txt.nlp	23503956	SENT86	16	16	4	4	letrozole	aromatase	PA450196	1588	0.943
NULL	Curr_Chem_Genomics_2010_Mar_1_4_1-8.nxml.txt.nlp	20448812	SENT120	9	9	42	42	bosentan	OATP1B1	PA10034	10599	0.943
NULL	Acta_Pharmacol_Sin_2011_Nov_10_32(11)_1402-1410.nxml.txt.nlp	21986579	SENT125	14	14	7	7	curcumin	p27	PA151958596	5715;10534	0.943
NULL	Mol_Cancer_2010_Nov_13_9_293.nxml.txt.nlp	21073737	SENT131	7	7	27	27	choline	HIF-1	PA448976	29072	0.943
NULL	Arthritis_Res_Ther_2007_Jun_29_9(Suppl_1)_S2.nxml.txt.nlp	17634141	SENT114	28	28	14	14	denosumab	RANKL	PA166048634	8600	0.943
NULL	J_Hematol_Oncol_2012_Oct_10_5_62.nxml.txt.nlp	23050865	SENT97	34	34	10	10	carboplatin	EGFR	PA448803	1956	0.943
NULL	Br_J_Pharmacol_2014_Jan_23_171(2)_523-535.nxml.txt.nlp	24372553	SENT159	13	13	8	8	metformin	SIRT1	PA450395	23411	0.943
NULL	Biologics_2010_Sep_28_4_273-287.nxml.txt.nlp	21116326	SENT82	29	29	3	3	bortezomib	NOXA	PA10252	5366	0.943
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT268	4	4	14	14	sitagliptin	GLP-1	PA164748978	100125288	0.943
NULL	ScientificWorldJournal_2013_Dec_9_2013_434151.nxml.txt.nlp	24385881	SENT254	20	20	11	11	indomethacin	IL-6	PA449982	3569	0.943
NULL	Acta_Pharmacol_Sin_2009_Sep_24_30(9)_1262-1275.nxml.txt.nlp	19701231	SENT150	17	17	9	9	lovastatin	APOA1	PA450272	335	0.943
NULL	J_Gynecol_Oncol_2013_Jul_4_24(3)_265-272.nxml.txt.nlp	23875077	SENT9	1	1	32	32	thrombin	DKK1	PA451674	22943	0.943
NULL	Acta_Pharmacol_Sin_2011_Aug_11_32(8)_999-1008.nxml.txt.nlp	21743486	SENT16	4	4	23	23	fasudil	JNK	PA165946121	5599	0.943
NULL	EJC_Suppl_2013_Sep_5_11(2)_3-22.nxml.txt.nlp	NULL	SENT366	14	14	6	6	tamoxifen	HER2	PA451581	2064	0.943
NULL	J_Cell_Biol_1998_Jul_13_142(1)_85-100.nxml.txt.nlp	9660865	SENT39	1	1	17	17	tetracycline	RhoA	PA451640	387	0.943
NULL	BMB_Rep_2013_Aug_46(8)_410-415.nxml.txt.nlp	23977989	SENT60	30	30	43	43	curcumin	HO-1	PA151958596	3162	0.943
NULL	Curr_Oncol_2009_Jan_16(1)_16-26.nxml.txt.nlp	19229368	SENT37	0	0	21	21	panitumumab	KRAS	PA162373091	3845	0.943
NULL	Amino_Acids_2011_May_22_40(5)_1369-1383.nxml.txt.nlp	21424716	SENT179	13	13	6	6	creatine	CEE	PA164778930	51608	0.943
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT110	15	15	31	31	trastuzumab	PTEN	PA451743	5728	0.943
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT48	14	14	8	8	resveratrol	IL-6		3569	0.943
NULL	Case_Rep_Oncol_Med_2013_Jul_30_2013_496351.nxml.txt.nlp	23984138	SENT51	39	39	37	37	denosumab	RANKL	PA166048634	8600	0.943
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_15_2012_638197.nxml.txt.nlp	23118795	SENT153	4	4	29	29	ethanol	CYP2E1	PA448073	1571	0.943
NULL	JAKSTAT_2013_Jul_1_2(3)_e24574.nxml.txt.nlp	24069558	SENT150	20	20	27	27	doxycycline	JAK2	PA449415	3717	0.943
NULL	Case_Rep_Neurol_2011_Feb_21_3(1)_54-61.nxml.txt.nlp	21490714	SENT82	21	21	34	34	medroxyprogesterone	aromatase	PA450344	1588	0.943
NULL	Breast_Cancer_Res_2007_Jun_4_9(3)_207.nxml.txt.nlp	17561991	SENT272	17	17	6	6	trastuzumab	HER-2	PA451743	2064	0.943
NULL	Indian_J_Endocrinol_Metab_2015_Jan-Feb_19(1)_148-154.nxml.txt.nlp	25593843	SENT22	0	0	18	18	denosumab	RANKL	PA166048634	8600	0.943
NULL	J_Biomed_Sci_2014_Feb_3_21(1)_10.nxml.txt.nlp	24490900	SENT257	27	27	14	14	alendronate	M-CSF	PA448082	1435	0.943
NULL	Mol_Biol_Cell_2012_Sep_15_23(18)_3499-3510.nxml.txt.nlp	22833567	SENT192	35	35	4	4	arsenite	PKR	PA452638	5610	0.943
NULL	Mol_Cancer_2014_Jun_24_13_157.nxml.txt.nlp	24958351	SENT163	26	26	11	11	lapatinib	XIAP	PA152241907	331	0.943
NULL	Adv_Pharmacol_Sci_2013_Dec_5_2013_387071.nxml.txt.nlp	24381587	SENT28	0	0	6	6	curcumin	DBK	PA151958596	5585	0.943
NULL	Eur_J_Nutr_2009_Jun_24_48(4)_229-234.nxml.txt.nlp	19238310	SENT32	4	4	20	20	capsaicin	TRPV1	PA448776	7442	0.943
NULL	Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.nxml.txt.nlp	24736980	SENT216	0	0	6	6	rosuvastatin	OATP1B1	PA134308647	10599	0.943
NULL	Oncologist_2011_Feb_1_16(2)_136-145.nxml.txt.nlp	21285392	SENT184	22	22	30	30	denosumab	aromatase	PA166048634	1588	0.943
NULL	Front_Endocrinol_(Lausanne)_2014_Jan_16_5_1.nxml.txt.nlp	24474947	SENT89	40	40	29	29	estradiol	GPER	PA449503	2852	0.943
NULL	Front_Immunol_2012_Mar_12_3_20.nxml.txt.nlp	22566904	SENT400	12	12	5	5	imatinib	PTPN22	PA10804	26191	0.943
NULL	J_Am_Heart_Assoc_2013_Dec_19_2(6)_e000355.nxml.txt.nlp	24190878	SENT12	19	19	10	10	phenylephrine	HK2	PA450935	3796;3099;29911;3741	0.943
NULL	Cancer_Res_Treat_2012_Mar_31_44(1)_1-10.nxml.txt.nlp	22500155	SENT45	21	21	12	12	erlotinib	EGFR	PA134687924	1956	0.943
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT269	5	5	13	13	tacrolimus	STAT3	PA451578	6774	0.943
NULL	Oncol_Rep_2013_Mar_8_29(3)_917-924.nxml.txt.nlp	23314174	SENT116	12	12	28	28	sorafenib	CD24	PA7000	100133941	0.943
NULL	Cancer_Immunol_Immunother_2011_Jun_25_60(6)_793-808.nxml.txt.nlp	21350947	SENT42	20	20	5	5	sorafenib	IFNAR2	PA7000	3455	0.943
NULL	Korean_Circ_J_2014_Jan_14_44(1)_42-44.nxml.txt.nlp	24497889	SENT61	5	5	25	25	lovastatin	CYP3A4	PA450272	1576	0.943
NULL	Daru_2011_19(1)_47-56.nxml.txt.nlp	22615639	SENT12	21	21	28	28	ketoprofen	gamma	PA450149	9913	0.943
NULL	Cancer_Immunol_Immunother_2013_Aug_27_62(10)_1637-1648.nxml.txt.nlp	23982484	SENT136	23	23	16	16	lenalidomide	IL-6	PA162363968	3569	0.943
NULL	J_Hum_Genet_2009_Sep_24_54(9)_516-524.nxml.txt.nlp	19629138	SENT106	14	14	7	7	doxycycline	POLG	PA449415	5428	0.943
NULL	JAKSTAT_2013_Jul_1_2(3)_e24574.nxml.txt.nlp	24069558	SENT49	25	25	35	35	doxycycline	JAK2	PA449415	3717	0.943
NULL	Breast_Cancer_Res_2010_May_18_12(Suppl_1)_P54.nxml.txt.nlp	NULL	SENT10	12	12	6	6	tamoxifen	aromatase	PA451581	1588	0.943
NULL	Cardiovasc_Diabetol_2013_Mar_23_12_48.nxml.txt.nlp	23522121	SENT40	16	16	10	10	exenatide	GLP-1	PA164749238	100125288	0.943
NULL	Exp_Neurobiol_2013_Mar_31_22(1)_23-30.nxml.txt.nlp	23585719	SENT162	28	28	12	12	curcumin	spatial	PA151958596	219793	0.943
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_15_2012_591654.nxml.txt.nlp	23118793	SENT182	28	28	41	41	berberine	PPG	PA165860812	5552	0.943
NULL	Br_J_Pharmacol_2008_Sep_9_155(1)_127-137.nxml.txt.nlp	18536750	SENT197	9	9	4	4	piroxicam	IL-10	PA450985	3586	0.943
NULL	Arthritis_Res_Ther_2011_Sep_21_13(5)_239.nxml.txt.nlp	21955617	SENT51	19	19	4	4	indomethacin	COX	PA449982	1351	0.943
NULL	Exp_Ther_Med_2013_Dec_15_6(6)_1565-1569.nxml.txt.nlp	24255692	SENT22	11	11	5	5	atorvastatin	adiponectin	PA448500	9370	0.943
NULL	Reprod_Biol_Endocrinol_2013_Feb_26_11_15.nxml.txt.nlp	23442442	SENT143	5	5	16	16	l-arginine	BAX	PA448478	581	0.943
NULL	J_Obes_2011_Feb_8_2011_636181.nxml.txt.nlp	21331293	SENT213	0	0	17	17	liraglutide	GLP-1	PA165958364	100125288	0.943
NULL	Diabetes_2008_Sep_57(9)_2341-2347.nxml.txt.nlp	18559659	SENT149	12	12	23	23	daclizumab	FOXP3	PA164764446	50943	0.943
NULL	Cancer_Immunol_Immunother_2015_Oct_7_64_61-73.nxml.txt.nlp	25287778	SENT231	14	14	0	0	lenalidomide	IL-2	PA162363968	3558	0.943
NULL	Br_J_Cancer_2012_Feb_14_106(4)_685-692.nxml.txt.nlp	22294184	SENT130	20	20	13	13	lovastatin	p38	PA450272	10598;1432;7965	0.943
NULL	Breast_Cancer_Res_2011_Jun_29_13(3)_R70.nxml.txt.nlp	21707964	SENT193	42	42	5	5	tamoxifen	14-3-3	PA451581	10971	0.943
NULL	Toxins_(Basel)_2010_Oct_26_2(11)_2490-2518.nxml.txt.nlp	22069563	SENT207	22	22	11	11	cisplatin	GM-CSF	PA449014	1437	0.943
NULL	Nat_Commun_2013_Sep_20_4_2444.nxml.txt.nlp	24051492	SENT45	21	21	14	14	nutlin-3	p53		7157	0.943
NULL	Ann_Clin_Transl_Neurol_2014_Dec_21_1(12)_996-1005.nxml.txt.nlp	25574474	SENT193	3	3	36	36	riluzole	P-gp	PA451251	5243	0.943
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT173	11	11	31	31	nutlin-3	DcR2		8793	0.943
NULL	Breast_Cancer_Res_2011_Aug_16_13(4)_312.nxml.txt.nlp	21861853	SENT30	31	31	12	12	tamoxifen	CUEDC2	PA451581	79004	0.943
NULL	Int_J_Nanomedicine_2012_Oct_25_7_5565-5575.nxml.txt.nlp	23118538	SENT138	5	5	31	31	fenofibrate	CO2	PA449594	4513	0.943
NULL	Breast_Cancer_Res_2007_Jun_29_9(3)_107.nxml.txt.nlp	17617929	SENT9	19	19	29	29	tamoxifen	aromatase	PA451581	1588	0.943
NULL	Mol_Cancer_2014_Jan_13_13_7.nxml.txt.nlp	24418169	SENT211	13	13	24	24	sorafenib	Raf-1	PA7000	5894	0.943
NULL	Int_J_Endocrinol_Metab_2013_Jul_1_Summer_11(3)_184-190.nxml.txt.nlp	24348591	SENT155	17	17	2	2	liraglutide	INS-1	PA165958364	2305	0.943
NULL	Exp_Ther_Med_2014_May_20_7(5)_1354-1358.nxml.txt.nlp	24940438	SENT6	18	18	7	7	fluorescein	CD32	PA164746009	2213;2212	0.943
NULL	Eukaryot_Cell_2013_Jul_12(7)_1009-1019.nxml.txt.nlp	23687115	SENT56	36	36	12	12	chloramphenicol	GRASP55	PA448927	26003	0.943
NULL	Blood_Res_2014_Sep_25_49(3)_148-153.nxml.txt.nlp	25325033	SENT47	40	40	15	15	rituximab	B2M	PA451261	567	0.943
NULL	Indian_J_Med_Res_2013_Jan_137(1)_125-129.nxml.txt.nlp	23481061	SENT60	15	15	9	9	cisplatin	GSTM1	PA449014	2944	0.943
NULL	Oncogene_2009_Dec_3_28(48)_4237-4248.nxml.txt.nlp	19734937	SENT28	8	8	0	0	thrombin	PAR-1	PA451674	2011;2149	0.943
NULL	J_Adv_Pharm_Technol_Res_2012_Oct-Dec_3(4)_202-209.nxml.txt.nlp	23378940	SENT101	9	9	18	18	nabilone	CB1	PA164746998	1268	0.943
NULL	J_Cell_Mol_Med_2013_Sep_24_17(9)_1065-1087.nxml.txt.nlp	24151975	SENT268	16	16	7	7	palifermin	p53	PA164744014	7157	0.943
NULL	Cancer_Manag_Res_2014_Jan_28_6_39-51.nxml.txt.nlp	24501545	SENT134	22	22	41	41	dextromethorphan	CYP1A2	PA449273	1544	0.943
NULL	Arthritis_Res_Ther_2012_Jul_12_14(4)_R163.nxml.txt.nlp	22784880	SENT131	12	12	20	20	leflunomide	CYP2C19	PA450192	1557	0.943
NULL	Br_J_Cancer_2013_Apr_16_108(7)_1408-1414.nxml.txt.nlp	23511562	SENT36	7	7	16	16	tamoxifen	aromatase	PA451581	1588	0.943
NULL	Cell_Cycle_2012_Dec_15_11(24)_4661-4672.nxml.txt.nlp	23187802	SENT118	26	26	16	16	doxorubicin	p53	PA449412	7157	0.943
NULL	Mol_Med_Rep_2014_Oct_23_10(4)_1717-1724.nxml.txt.nlp	25069516	SENT192	9	9	0	0	resveratrol	PC-3		692094	0.943
NULL	BMB_Rep_2014_Nov_47(11)_649-654.nxml.txt.nlp	25301019	SENT6	4	4	31	31	l-alanine	STAT3	PA448055	6774	0.943
NULL	Br_J_Ophthalmol_2014_Jun_98(Suppl_1)_i11-i16.nxml.txt.nlp	24836865	SENT21	0	0	30	30	ranibizumab	VEGF-A	PA164746012	7422	0.943
NULL	BMJ_Open_2013_Oct_14_3(10)_e003912.nxml.txt.nlp	24127058	SENT36	23	23	35	35	vancomycin	HAP	PA451850	5915;10313	0.943
NULL	Cancers_(Basel)_2010_Dec_9_2(4)_2058-2083.nxml.txt.nlp	24281218	SENT317	25	25	32	32	erlotinib	EGFR	PA134687924	1956	0.943
NULL	J_Oncol_2010_Dec_15_2010_821717.nxml.txt.nlp	20049172	SENT11	24	24	3	3	paclitaxel	TUBB3	PA450761	10381	0.943
NULL	Front_Neurosci_2010_Nov_19_4_192.nxml.txt.nlp	21151361	SENT117	4	4	12	12	risperidone	5-HT6	PA451257	3362	0.943
NULL	Arthritis_Res_Ther_2010_Feb_9_12(1)_R21.nxml.txt.nlp	20144213	SENT189	8	8	12	12	naproxen	COX	PA450595	1351	0.943
NULL	FEBS_Open_Bio_2014_Jun_2_4_510-521.nxml.txt.nlp	24967154	SENT29	27	27	3	3	spermine	ODC	PA164781199	4953;89874	0.943
NULL	J_Lipids_2011_Jan_13_2011_565316.nxml.txt.nlp	21490804	SENT207	16	16	9	9	paclitaxel	CERT	PA450761	10087	0.943
NULL	J_Radiat_Res_2012_Jul_12_53(4)_551-557.nxml.txt.nlp	22843620	SENT141	34	34	11	11	pp2	EGFR		1956	0.943
NULL	Arch_Med_Sci_2012_Sep_8_8(4)_659-671.nxml.txt.nlp	23056078	SENT174	19	19	0	0	camptothecin	MRP2	PA153590860	100130958;57626;1244	0.943
NULL	Br_J_Cancer_2013_Feb_5_108(2)_469-476.nxml.txt.nlp	23169292	SENT27	25	25	11	11	gemcitabine	EGFR	PA449748	1956	0.943
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT29	34	34	11	11	trastuzumab	HER2	PA451743	2064	0.943
NULL	Int_J_Nanomedicine_2012_Oct_18_7_5475-5489.nxml.txt.nlp	23093903	SENT8	12	12	7	7	mannitol	DPI	PA450320	1832	0.943
NULL	Braz_J_Med_Biol_Res_2014_Sep_5_47(11)_929-939.nxml.txt.nlp	25296354	SENT114	19	19	35	35	erlotinib	EGFR	PA134687924	1956	0.943
NULL	Oncotarget_2013_Nov_22_5(4)_933-943.nxml.txt.nlp	24659749	SENT31	5	5	0	0	nutlin-3	AML2		864	0.943
NULL	Mol_Biol_Int_2012_May_24_2012_705948.nxml.txt.nlp	22693671	SENT167	7	7	13	13	cisplatin	RASSF2	PA449014	9770	0.943
NULL	Br_J_Cancer_2006_Dec_4_95(11)_1504-1513.nxml.txt.nlp	17088902	SENT11	16	16	5	5	trastuzumab	HER2	PA451743	2064	0.943
NULL	Diabetes_Obes_Metab_2011_Apr_13(4)_348-356.nxml.txt.nlp	21205128	SENT197	14	14	25	25	metformin	Met	PA450395	79811	0.943
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_May_20_67(Pt_6)_o1453.nxml.txt.nlp	21754827	SENT63	21	21	6	6	ethanol	mol	PA448073	90527	0.943
NULL	Nat_Med_2012_Mar_4_18(4)_547-554.nxml.txt.nlp	22388091	SENT62	18	18	6	6	methacholine	IL-17A	PA165958382	3605	0.943
NULL	Oncogenesis_2012_Apr_16_1(4)_e7.nxml.txt.nlp	23552604	SENT49	7	7	0	0	nutlin-3	CEACAM1		634	0.943
NULL	Biol_Open_2012_Oct_4_1(12)_1215-1225.nxml.txt.nlp	23259056	SENT171	16	16	29	29	l-isoleucine	LAMP2	PA164750430	3920	0.943
NULL	Environ_Health_Perspect_2001_May_109(5)_539-545.nxml.txt.nlp	11401768	SENT10	14	14	9	9	cholestyramine	TPC	PA448974	8030;60386	0.943
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1196-1204.nxml.txt.nlp	22315058	SENT18	13	13	1	1	gefitinib	EGFR	PA131301952	1956	0.943
NULL	Endocrinology_2011_Jul_10_152(7)_2845-2856.nxml.txt.nlp	21558311	SENT317	5	5	3	3	indomethacin	COX	PA449982	1351	0.943
NULL	Acta_Histochem_Cytochem_2011_Apr_28_44(2)_51-60.nxml.txt.nlp	21614166	SENT108	5	5	25	25	thalidomide	CD31	PA451644	5175	0.943
NULL	J_Inherit_Metab_Dis_2010_Oct_3_33(5)_625-632.nxml.txt.nlp	20814828	SENT132	13	13	3	3	simvastatin	GGTI	PA451363	5229	0.943
NULL	Arthritis_Res_Ther_2008_Apr_16_10(2)_R43.nxml.txt.nlp	18416822	SENT113	32	32	22	22	sr144528	CB1		1268	0.943
NULL	Int_J_Breast_Cancer_2012_Jan_24_2012_385978.nxml.txt.nlp	22461984	SENT13	12	12	19	19	trastuzumab	aromatase	PA451743	1588	0.943
NULL	Cancer_Res_Treat_2013_Mar_31_45(1)_55-62.nxml.txt.nlp	23613671	SENT10	13	13	3	3	oxaliplatin	KRAS	PA131285527	3845	0.943
NULL	Ther_Clin_Risk_Manag_2007_Jun_3(3)_401-410.nxml.txt.nlp	18488071	SENT217	7	7	23	23	tramadol	ACR	PA451735	49	0.943
NULL	J_Thromb_Haemost_2011_Oct_9(10)_2050-2056.nxml.txt.nlp	21794076	SENT99	15	15	5	5	prasugrel	ADP	PA154410481	23038	0.943
NULL	Cell_Death_Dis_2014_Apr_24_5(4)_e1197.nxml.txt.nlp	24763054	SENT103	23	23	1	1	doxorubicin	RUNX3	PA449412	864	0.943
NULL	F1000Res_2014_Mar_18_3_74.nxml.txt.nlp	25580222	SENT115	11	11	5	5	ciprofloxacin	TOX	PA449009	9760	0.943
NULL	Chem_Cent_J_2012_Dec_12_6_155.nxml.txt.nlp	23234331	SENT74	28	28	4	4	ethanol	CTH	PA448073	1491;23584	0.943
NULL	Breast_Cancer_Res_2011_Jan_21_13(1)_R9.nxml.txt.nlp	21255398	SENT214	35	35	31	31	etoposide	RAD21	PA449552	5885	0.943
NULL	J_Gen_Physiol_2000_Jun_1_115(6)_685-696.nxml.txt.nlp	10828243	SENT159	23	23	1	1	genistein	OLF	PA165109660	83857	0.943
NULL	Breast_Cancer_Res_2012_May_4_14(3)_R72.nxml.txt.nlp	22559056	SENT209	8	8	17	17	tamoxifen	FOXM1	PA451581	2305	0.943
NULL	J_Radiat_Res_2014_Nov_16_55(6)_1171-1177.nxml.txt.nlp	25129557	SENT198	30	30	19	19	bevacizumab	LARC	PA130232992	6364	0.943
NULL	J_Hum_Genet_2013_Jun_16_58(6)_353-361.nxml.txt.nlp	23677058	SENT135	19	19	2	2	busulfan	GSTM1	PA448691	2944	0.943
NULL	J_Carcinog_2011_Nov_30_10_28.nxml.txt.nlp	22190870	SENT200	31	31	11	11	carboplatin	VEGF-A	PA448803	7422	0.943
NULL	Front_Oncol_2013_Nov_15_3_281.nxml.txt.nlp	24298448	SENT181	31	31	12	12	oxaliplatin	KRAS	PA131285527	3845	0.943
NULL	Mol_Biol_Cell_2014_Apr_1_25(7)_1050-1060.nxml.txt.nlp	24478453	SENT126	28	28	5	5	iodixanol	OS-9	PA164783998	10956	0.943
NULL	F1000_Biol_Rep_2009_Mar_24_1_23.nxml.txt.nlp	20948663	SENT13	21	21	2	2	doxepin	ABCB1	PA449409	5243	0.943
NULL	Antimicrob_Agents_Chemother_2013_Oct_57(10)_4882-4893.nxml.txt.nlp	23877697	SENT261	5	5	20	20	suramin	CARP	PA10292	27063;80013;767	0.943
NULL	Ther_Clin_Risk_Manag_2007_Jun_3(2)_341-348.nxml.txt.nlp	18360643	SENT144	3	3	8	8	sunitinib	EGFR	PA162372840	1956	0.943
NULL	Clinicoecon_Outcomes_Res_2014_Oct_17_6_451-461.nxml.txt.nlp	25378939	SENT28	0	0	34	34	vancomycin	HAP	PA451850	5915;10313	0.943
NULL	Arch_Med_Sci_2012_Nov_9_8(5)_899-906.nxml.txt.nlp	23185202	SENT97	3	3	14	14	voglibose	PPG	PA164752433	5552	0.943
NULL	Br_J_Cancer_2012_Feb_28_106(5)_876-882.nxml.txt.nlp	22333597	SENT147	14	14	22	22	cisplatin	p53	PA449014	7157	0.943
NULL	Leukemia_2014_Apr_14_28(4)_961-964.nxml.txt.nlp	24418991	SENT21	9	9	24	24	nilotinib	P-gp	PA165958345	5243	0.943
NULL	Diabetes_Care_2011_Apr_21_34(4)_e36-e42.nxml.txt.nlp	21447655	SENT203	13	13	7	7	ramipril	DREAM	PA451223	30818	0.943
NULL	J_Biol_Chem_2008_Oct_31_283(44)_29841-29846.nxml.txt.nlp	18765669	SENT198	11	11	19	19	suramin	P2X1	PA10292	5023	0.943
NULL	Mol_Cancer_2012_Sep_14_11_69.nxml.txt.nlp	22978347	SENT43	33	33	15	15	letrozole	UBE2C	PA450196	11065	0.943
NULL	Mol_Cancer_2012_Jun_18_11_41.nxml.txt.nlp	22709873	SENT16	26	26	5	5	lapatinib	CCND1	PA152241907	595	0.943
NULL	Arthritis_Res_Ther_2014_Apr_11_16(2)_R93.nxml.txt.nlp	24725461	SENT9	19	19	17	17	letrozole	aromatase	PA450196	1588	0.943
NULL	Front_Immunol_2013_Sep_11_4_272.nxml.txt.nlp	24062740	SENT179	15	15	3	3	dextran	IFN	PA449261	3439	0.943
NULL	Breast_Cancer_Res_2004_Aug_5_6(5)_R601-R607.nxml.txt.nlp	15318941	SENT143	3	3	16	16	docetaxel	p27	PA449383	5715;10534	0.943
NULL	Front_Oncol_2013_Apr_29_3_92.nxml.txt.nlp	23641361	SENT67	33	33	23	23	irinotecan	NF1	PA450085	4763	0.943
NULL	Cell_Death_Dis_2010_Oct_21_1(10)_e86.nxml.txt.nlp	21368859	SENT242	16	16	35	35	doxorubicin	TRAIL	PA449412	8743	0.943
NULL	AIDS_Res_Ther_2013_Jan_28_10_5.nxml.txt.nlp	23351618	SENT41	0	0	14	14	capsaicin	TRPV1	PA448776	7442	0.943
NULL	Oncotarget_2014_Aug_8_5(17)_7936-7944.nxml.txt.nlp	25277205	SENT53	17	17	21	21	vemurafenib	AKT	PA165946873	207	0.943
NULL	Cardiol_Res_Pract_2011_May_10_2011_816897.nxml.txt.nlp	21629798	SENT117	14	14	4	4	clarithromycin	CYP3A4	PA449028	1576	0.943
NULL	Mol_Cancer_2009_Dec_10_8_118.nxml.txt.nlp	20003259	SENT215	17	17	11	11	sorafenib	ERM	PA7000	2119	0.943
NULL	Clinics_(Sao_Paulo)_2013_May_68(5)_694-701.nxml.txt.nlp	23778405	SENT178	4	4	6	6	curcumin	P-gp	PA151958596	5243	0.943
NULL	Pediatr_Gastroenterol_Hepatol_Nutr_2014_Jun_30_17(2)_80-84.nxml.txt.nlp	25061582	SENT77	7	7	0	0	metronidazole	NAP1	PA450484	4673;64343;9476;3576;51531	0.943
NULL	Cell_Logist_2014_Jan_9_4_e27732.nxml.txt.nlp	24843827	SENT7	23	23	14	14	perifosine	PI3K	PA165291471	5290	0.943
NULL	Antiviral_Res_2009_May_82(2)_A99-A109.nxml.txt.nlp	19176219	SENT866	8	8	20	20	nelfinavir	CD4	PA450606	920	0.943
NULL	Breast_Cancer_Res_2007_Dec_20_9(Suppl_2)_S13.nxml.txt.nlp	NULL	SENT49	23	23	2	2	anastrozole	IMPACT	PA448432	55364	0.943
NULL	Breast_Cancer_Res_Treat_2013_Jun_5_139(3)_649-655.nxml.txt.nlp	23736997	SENT165	34	34	7	7	tamoxifen	CYP2C19	PA451581	1557	0.943
NULL	Nat_Med_2011_Dec_4_18(1)_111-119.nxml.txt.nlp	22138751	SENT230	17	17	11	11	doxycycline	TERT	PA449415	7015	0.943
NULL	ISRN_Oxidative_Med_2013_2013_831596.nxml.txt.nlp	25506596	SENT148	9	9	16	16	hemin	HO-1	PA449849	3162	0.943
NULL	EMBO_J_2010_Sep_15_29(18)_3170-3183.nxml.txt.nlp	20676059	SENT248	1	1	31	31	fluoxetine	P15	PA449673	1030;29107	0.943
NULL	Nat_Commun_2013_Nov_26_4_2825.nxml.txt.nlp	24281397	SENT51	10	10	0	0	gemfibrozil	LSR	PA449750	51599	0.943
NULL	J_Biol_Chem_2010_Aug_20_285(34)_25928-25940.nxml.txt.nlp	20547488	SENT149	5	5	12	12	cisplatin	p38	PA449014	10598;1432;7965	0.943
NULL	J_Bras_Pneumol_2013_Jan-Feb_39(1)_5-15.nxml.txt.nlp	23503480	SENT129	34	34	3	3	doxycycline	VEGF-D	PA449415	2277	0.943
NULL	Breast_Cancer_(Auckl)_2012_Feb_20_6_47-66.nxml.txt.nlp	22399860	SENT172	4	4	36	36	tamoxifen	SMC3	PA451581	9126	0.943
NULL	Breast_Cancer_Res_2011_Apr_21_13(2)_R46.nxml.txt.nlp	21510863	SENT20	20	20	12	12	lapatinib	HER2	PA152241907	2064	0.943
NULL	J_Cell_Mol_Med_2014_Mar_22_18(3)_422-433.nxml.txt.nlp	24450475	SENT409	21	21	4	4	hyaluronan	LYVE-1	PA165958431	10894	0.943
NULL	Mol_Cancer_2010_Aug_20_9_220.nxml.txt.nlp	20727180	SENT20	5	5	20	20	nicotine	survivin	PA450626	332	0.943
NULL	J_Skin_Cancer_2012_Dec_13_2012_147863.nxml.txt.nlp	23316365	SENT188	1	1	23	23	curcumin	IL-6	PA151958596	3569	0.943
NULL	Oncogene_2009_Dec_3_28(48)_4306-4316.nxml.txt.nlp	19749790	SENT162	17	17	1	1	heparin	FGF1	PA449855	2246	0.943
NULL	J_Thorac_Oncol_2014_Jun_30_9(6)_775-783.nxml.txt.nlp	24828661	SENT157	6	6	15	15	crizotinib	Met	PA165946122	79811	0.943
NULL	Breast_Cancer_(Auckl)_2014_Mar_23_8_51-56.nxml.txt.nlp	24678242	SENT19	10	10	21	21	carboplatin	BRCA1	PA448803	672	0.943
NULL	Int_J_Vasc_Med_2012_Oct_5_2012_784536.nxml.txt.nlp	22007304	SENT225	4	4	2	2	ezetimibe	NPC1L1	PA10816	29881	0.943
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT6	45	45	5	5	tacrolimus	JAK2	PA451578	3717	0.943
NULL	EMBO_Mol_Med_2012_Dec_15_4(12)_1276-1293.nxml.txt.nlp	23065753	SENT175	8	8	0	0	cisplatin	HK1	PA449014	3098;51361;3739	0.943
NULL	Case_Rep_Med_2013_Nov_12_2013_640216.nxml.txt.nlp	24319464	SENT57	40	40	18	18	efavirenz	CD4	PA449441	920	0.943
NULL	J_Cell_Biol_2004_Feb_16_164(4)_527-534.nxml.txt.nlp	14769862	SENT49	20	20	13	13	forskolin	CO2	PA146096022	4513	0.943
NULL	Curr_Neuropharmacol_2013_Mar_11(2)_160-170.nxml.txt.nlp	23997751	SENT245	30	30	3	3	orphenadrine	5-HT2C	PA450715	3358	0.943
NULL	Mol_Biol_Rep_2012_May_20_39(5)_5253-5267.nxml.txt.nlp	22183301	SENT29	3	3	24	24	gliclazide	SUR1	PA10892	6833	0.943
NULL	Oncologist_2010_Mar_9_15(3)_236-245.nxml.txt.nlp	20215359	SENT78	0	0	19	19	bevacizumab	VEGF-A	PA130232992	7422	0.943
NULL	Mol_Biol_Rep_2013_Sep_28_40(10)_5573-5585.nxml.txt.nlp	24078156	SENT211	0	0	17	17	iron	HFE	PA450087	3077	0.943
NULL	Iran_J_Psychiatry_2012_Winter_7(1)_1-10.nxml.txt.nlp	23056111	SENT117	23	23	3	3	risperidone	ANOVA	PA451257	4858	0.943
NULL	Oncotarget_2014_Jun_1_5(13)_4881-4894.nxml.txt.nlp	24952679	SENT90	12	12	9	9	bortezomib	IRE1	PA10252	2081	0.943
NULL	Breast_Cancer_Res_2007_Jun_7_9(3)_R37.nxml.txt.nlp	17555561	SENT167	0	0	11	11	anastrozole	aromatase	PA448432	1588	0.943
NULL	Arthritis_Res_Ther_2008_Mar_14_10(2)_204.nxml.txt.nlp	18373887	SENT96	4	4	23	23	infliximab	CD4	PA452639	920	0.943
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT35	2	2	8	8	trastuzumab	HER2	PA451743	2064	0.943
NULL	Curr_Neuropharmacol_2014_Jul_12(4)_365-379.nxml.txt.nlp	25342944	SENT97	8	8	3	3	fluoxetine	ADAR2	PA449673	104	0.943
NULL	Braz_J_Med_Biol_Res_2014_Nov_4_48(1)_13-24.nxml.txt.nlp	25493378	SENT88	9	9	0	0	cisplatin	ERCC1	PA449014	2067	0.943
NULL	Blood_Cancer_J_2013_Dec_6_3(12)_e167.nxml.txt.nlp	24317089	SENT146	31	31	10	10	lovastatin	GADD153	PA450272	1649	0.943
NULL	J_Immunol_Res_2014_Jan_19_2014_103780.nxml.txt.nlp	24741572	SENT128	6	6	31	31	salmeterol	p38	PA451300	10598;1432;7965	0.943
NULL	Hum_Reprod_2008_Oct_16_23(10)_2273-2281.nxml.txt.nlp	18635530	SENT165	1	1	8	8	etoposide	p53	PA449552	7157	0.943
NULL	Ann_Med_Health_Sci_Res_2013_Apr-Jun_3(2)_282-284.nxml.txt.nlp	23919207	SENT70	38	38	4	4	cefmetazole	RGM	PA164746819	56963	0.943
NULL	Behav_Brain_Funct_2010_Aug_30_6_50.nxml.txt.nlp	20799992	SENT129	33	33	9	9	amphetamine	ADORA2A	PA448408	135	0.943
NULL	Cancer_Cell_Int_2012_Jun_21_12_32.nxml.txt.nlp	22720671	SENT47	38	38	5	5	paraformaldehyde	CD34	PA450790	947	0.943
NULL	Oxid_Med_Cell_Longev_2013_Jun_2_2013_793525.nxml.txt.nlp	23819014	SENT204	8	8	36	36	resveratrol	ROS		6098	0.943
NULL	Breast_Cancer_Res_Treat_2013_Jan_6_137(1)_167-174.nxml.txt.nlp	23129173	SENT208	16	16	5	5	letrozole	aromatase	PA450196	1588	0.943
NULL	Cardiol_Res_Pract_2011_May_10_2011_816897.nxml.txt.nlp	21629798	SENT117	12	12	4	4	itraconazole	CYP3A4	PA450132	1576	0.943
NULL	Cancer_Metastasis_Rev_2014_Dec_28_33(1)_161-171.nxml.txt.nlp	24375389	SENT168	32	32	6	6	doxorubicin	CHFR	PA449412	55743	0.943
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2007_Dec_6_64(Pt_1)_o197.nxml.txt.nlp	21200762	SENT56	11	11	3	3	ethanol	mol	PA448073	90527	0.943
NULL	J_Clin_Biochem_Nutr_2011_Jan_28_48(1)_96-100.nxml.txt.nlp	21297920	SENT52	11	11	15	15	hemin	HO-1	PA449849	3162	0.943
NULL	J_Invest_Dermatol_2012_May_16_132(5)_1435-1442.nxml.txt.nlp	22336948	SENT234	8	8	0	0	doxycycline	TLSP	PA449415	11012	0.943
NULL	J_Cancer_2011_Mar_8_2_142-152.nxml.txt.nlp	21475719	SENT142	8	8	0	0	carboplatin	ERCC1	PA448803	2067	0.943
NULL	Mol_Vis_2012_Nov_29_18_2839-2846.nxml.txt.nlp	23233786	SENT118	3	3	14	14	geldanamycin	CB2	PA152031327	1269	0.943
NULL	Oncologist_2010_Feb_15_15(2)_122-129.nxml.txt.nlp	20156908	SENT31	36	36	34	34	anastrozole	aromatase	PA448432	1588	0.943
NULL	eLife_2013_Oct_15_2_e00822.nxml.txt.nlp	24137534	SENT427	21	21	10	10	doxycycline	c-Myc	PA449415	4609	0.943
NULL	J_Vet_Med_Sci_2014_May_13_76(5)_629-636.nxml.txt.nlp	24419976	SENT154	26	26	11	11	meloxicam	EP4	PA450353	5734	0.943
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_11_2013_910451.nxml.txt.nlp	23840269	SENT238	16	16	12	12	erlotinib	EGFR	PA134687924	1956	0.943
NULL	Int_J_Biomed_Sci_2014_Sep_10(3)_217-220.nxml.txt.nlp	25324704	SENT83	13	13	2	2	amiodarone	APT	PA448383	653639	0.943
NULL	Pharmaceuticals_(Basel)_2012_Dec_27_6(1)_1-24.nxml.txt.nlp	24275784	SENT163	9	9	31	31	vorinostat	CTCL	PA164748224	64061	0.943
NULL	Cell_Death_Dis_2014_Mar_13_5(3)_e1112.nxml.txt.nlp	24625971	SENT125	43	43	9	9	curcumin	CHOP	PA151958596	1649	0.943
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT164	31	31	20	20	lapatinib	HER2	PA152241907	2064	0.943
NULL	J_Cell_Biol_2003_Sep_29_162(7)_1197-1209.nxml.txt.nlp	14517203	SENT228	17	17	10	10	bleomycin	BLM	PA448645	641	0.943
NULL	J_Biomed_Biotechnol_2010_Jun_7_2010_150960.nxml.txt.nlp	20617134	SENT215	1	1	23	23	panitumumab	KRAS	PA162373091	3845	0.943
NULL	Ecancermedicalscience_2009_Jun_9_3_148.nxml.txt.nlp	22276013	SENT13	34	34	8	8	tamoxifen	aromatase	PA451581	1588	0.943
NULL	Bioinformation_2012_Jan_6_8(1)_13-19.nxml.txt.nlp	22359429	SENT142	33	33	16	16	curcumin	MRP2	PA151958596	100130958;57626;1244	0.943
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT8	23	23	16	16	sulindac	AKT	PA451565	207	0.943
NULL	Front_Genet_2014_Oct_31_5_379.nxml.txt.nlp	25400658	SENT553	13	13	8	8	estradiol	HOTAIR	PA449503	100124700	0.943
NULL	Avicenna_J_Phytomed_2014_May-Jun_4(3)_215-224.nxml.txt.nlp	25050319	SENT141	17	17	43	43	diclofenac	MEPI	PA449293	5276	0.943
NULL	Reprod_Biol_Endocrinol_2004_Jul_7_2_55.nxml.txt.nlp	15239837	SENT41	22	22	25	25	letrozole	aromatase	PA450196	1588	0.943
NULL	Oncotarget_2011_Mar_10_2(3)_186-196.nxml.txt.nlp	21406729	SENT112	37	37	8	8	orlistat	SREBP1	PA164776864	6720	0.943
NULL	Oncotarget_2012_Oct_20_3(10)_1236-1245.nxml.txt.nlp	23100449	SENT76	13	13	27	27	doxorubicin	NGAL	PA449412	3934	0.943
NULL	Br_J_Cancer_2011_Aug_23_105(5)_618-627.nxml.txt.nlp	21829197	SENT160	12	12	36	36	lapatinib	CRT	PA152241907	811	0.943
NULL	Breast_Cancer_Res_2010_Apr_30_12(2)_203.nxml.txt.nlp	20459590	SENT64	27	27	37	37	mitomycin	BRCA2	PA450524	675	0.943
NULL	J_Korean_Med_Sci_2011_Aug_27_26(8)_1001-1006.nxml.txt.nlp	21860549	SENT88	7	7	20	20	trastuzumab	HER-2	PA451743	2064	0.943
NULL	Nucleic_Acids_Res_2011_Mar_17_39(6)_2144-2152.nxml.txt.nlp	21087997	SENT37	14	14	10	10	etoposide	CtIP	PA449552	5932	0.943
NULL	Orphanet_J_Rare_Dis_2011_Jul_29_6_52.nxml.txt.nlp	21801394	SENT162	19	19	2	2	allopurinol	HLA-B	PA448320	3106	0.943
NULL	Cancer_Cell_Int_2005_Jul_7_5_20.nxml.txt.nlp	16001980	SENT13	9	9	26	26	doxorubicin	P-gp	PA449412	5243	0.943
NULL	Br_J_Cancer_2011_Jul_26_105(3)_420-427.nxml.txt.nlp	21730982	SENT192	15	15	31	31	cisplatin	EGFR	PA449014	1956	0.943
NULL	Arthritis_Res_Ther_2012_Oct_4_14(5)_R206.nxml.txt.nlp	23036475	SENT32	14	14	30	30	anakinra	MMP3	PA10799	4314	0.943
NULL	Arch_Med_Sci_2012_Feb_29_8(1)_138-153.nxml.txt.nlp	22457688	SENT421	2	2	19	19	atorvastatin	PON1	PA448500	5444	0.943
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT222	13	13	7	7	perifosine	JNK	PA165291471	5599	0.943
NULL	Adv_Hematol_2013_Dec_24_2013_695754.nxml.txt.nlp	24454381	SENT305	16	16	7	7	imatinib	GATA1	PA10804	2623	0.943
NULL	Acta_Pharmacol_Sin_2011_Apr_28_32(4)_503-511.nxml.txt.nlp	21441948	SENT48	12	12	20	20	cisplatin	PTEN	PA449014	5728	0.943
NULL	J_Hematol_Oncol_2013_Nov_22_6_88.nxml.txt.nlp	24261963	SENT322	12	12	4	4	trastuzumab	HER2	PA451743	2064	0.943
NULL	Diabetes_Care_2013_Aug_17_36(Suppl_2)_S180-S189.nxml.txt.nlp	23882044	SENT32	0	0	4	4	exenatide	GLP-1	PA164749238	100125288	0.943
NULL	Cell_Commun_Signal_2004_Jun_30_2_6.nxml.txt.nlp	15228623	SENT96	24	24	3	3	nifedipine	TTN	PA450631	7273	0.943
NULL	Front_Endocrinol_(Lausanne)_2013_Nov_25_4_176.nxml.txt.nlp	24324456	SENT236	19	19	8	8	bumetanide	NKCC1	PA448682	6558	0.943
NULL	Int_J_Biol_Sci_2013_Apr_22_9(4)_350-360.nxml.txt.nlp	23630447	SENT164	22	22	14	14	doxorubicin	adiponectin	PA449412	9370	0.943
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT113	3	3	22	22	cisplatin	XIAP	PA449014	331	0.943
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT3272	22	22	13	13	flucloxacillin	CYP3A4	PA164781042	1576	0.943
NULL	Environ_Health_Perspect_2009_Feb_8_117(2)_175-180.nxml.txt.nlp	19270784	SENT187	19	19	15	15	doxorubicin	BPA	PA449412	667	0.943
NULL	Neuroscience_2014_Mar_7_261(100)_52-59.nxml.txt.nlp	24361736	SENT91	25	25	18	18	heparin	EGF	PA449855	1950	0.943
NULL	Br_J_Cancer_2013_May_14_108(9)_1862-1869.nxml.txt.nlp	23579219	SENT88	35	35	1	1	cetuximab	KRAS	PA10040	3845	0.943
NULL	Chin_J_Cancer_2012_Feb_31(2)_51-57.nxml.txt.nlp	22257384	SENT116	0	0	18	18	sunitinib	P-gp	PA162372840	5243	0.943
NULL	Diabetes_Metab_J_2014_Aug_20_38(4)_274-277.nxml.txt.nlp	25215273	SENT19	13	13	1	1	glucose	NOS	PA449773	4843	0.943
NULL	Alcohol_Res_Health_2008_31(4)_310-339.nxml.txt.nlp	20729980	SENT128	7	7	31	31	ethanol	CB1	PA448073	1268	0.943
NULL	Vet_Res_2013_Oct_2_44(1)_89.nxml.txt.nlp	24088531	SENT5	33	33	39	39	hemin	HO-1	PA449849	3162	0.943
NULL	Breast_Cancer_Res_2008_Jul_24_10(4)_211.nxml.txt.nlp	18671839	SENT151	17	17	5	5	flavopiridol	EGFR	PA452627	1956	0.943
NULL	Ther_Clin_Risk_Manag_2006_Mar_2(1)_87-98.nxml.txt.nlp	18360584	SENT79	10	10	31	31	sorafenib	VEGFR2	PA7000	3791	0.943
NULL	Arthritis_Res_Ther_2012_May_1_14(3)_R99.nxml.txt.nlp	22546542	SENT61	18	18	29	29	infliximab	IL-4	PA452639	3565	0.943
NULL	Leukemia_2014_Mar_20_28(3)_554-565.nxml.txt.nlp	24280866	SENT210	39	39	31	31	doxycycline	IL-3	PA449415	3562	0.943
NULL	J_Gynecol_Oncol_2014_Jul_3_25(3)_249-259.nxml.txt.nlp	25045438	SENT37	0	0	16	16	cetuximab	EGFR	PA10040	1956	0.943
NULL	Korean_J_Anesthesiol_2013_Mar_19_64(3)_212-217.nxml.txt.nlp	23560185	SENT83	4	4	1	1	aprepitant	NK1	PA164747039	11126	0.943
NULL	Breast_Cancer_(Auckl)_2012_Feb_20_6_47-66.nxml.txt.nlp	22399860	SENT172	4	4	26	26	tamoxifen	NF1	PA451581	4763	0.943
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT12	36	36	23	23	tenofovir	CD4	PA10204	920	0.943
NULL	Front_Oncol_2014_Sep_23_4_263.nxml.txt.nlp	25295230	SENT217	20	20	0	0	cytarabine	FLT3	PA449177	2322	0.943
NULL	Cancer_Cell_Int_2010_Sep_9_10_32.nxml.txt.nlp	20828393	SENT135	10	10	2	2	cisplatin	ATF3	PA449014	467	0.943
NULL	Oxid_Med_Cell_Longev_2013_Apr_21_2013_412576.nxml.txt.nlp	23710286	SENT109	17	17	9	9	curcumin	GCLC	PA151958596	2729	0.943
NULL	Eur_J_Clin_Pharmacol_2012_Jan_7_68(1)_55-64.nxml.txt.nlp	21735164	SENT210	15	15	3	3	oxycodone	CYP2D6	PA450741	1565	0.943
NULL	Front_Chem_2014_Mar_14_2_12.nxml.txt.nlp	24790981	SENT118	14	14	4	4	curcumin	MEF2C	PA151958596	4208	0.943
NULL	Allergy_Asthma_Immunol_Res_2014_Nov_19_6(6)_548-557.nxml.txt.nlp	25374755	SENT95	5	5	25	25	lovastatin	IL-4	PA450272	3565	0.943
NULL	Surg_Neurol_Int_2010_Dec_22_1_91.nxml.txt.nlp	21206899	SENT34	28	28	11	11	gentamicin	hole	PA449753	80757	0.943
NULL	Breast_Cancer_Res_2000_Mar_25_2(3)_184-190.nxml.txt.nlp	11250708	SENT42	6	6	1	1	carbachol	EGFR	PA448784	1956	0.943
NULL	Mol_Cell_Biochem_2015_Oct_8_398(1-2)_165-173.nxml.txt.nlp	25292312	SENT112	14	14	19	19	bortezomib	HIF-1	PA10252	29072	0.943
NULL	Exp_Ther_Med_2013_Oct_20_6(4)_899-903.nxml.txt.nlp	24137286	SENT93	9	9	26	26	rosuvastatin	MMP2	PA134308647	4313	0.943
NULL	Br_J_Cancer_2010_Nov_2_103(11)_1671-1679.nxml.txt.nlp	21045835	SENT113	14	14	24	24	gemcitabine	CXCL12	PA449748	6387	0.943
NULL	Oncoimmunology_2012_Oct_1_1(7)_1004-1016.nxml.txt.nlp	23170249	SENT45	11	11	3	3	paclitaxel	HER-2	PA450761	2064	0.943
NULL	Oncotarget_2012_Mar_31_3(3)_236-260.nxml.txt.nlp	22470194	SENT55	16	16	6	6	cetuximab	EGFR	PA10040	1956	0.943
NULL	Oncol_Rep_2013_Jun_22_29(6)_2479-2485.nxml.txt.nlp	23525656	SENT154	8	8	35	35	paclitaxel	MRP7	PA450761	89845;1080	0.943
NULL	Chemother_Res_Pract_2011_Dec_1_2011_715469.nxml.txt.nlp	22312557	SENT153	19	19	15	15	cisplatin	p53	PA449014	7157	0.943
NULL	Oncotarget_2012_May_18_3(5)_525-534.nxml.txt.nlp	22619113	SENT101	24	24	2	2	fludarabine	MCL1	PA449655	4170	0.943
NULL	J_Biol_Chem_2012_Apr_13_287(16)_12952-12965.nxml.txt.nlp	22371491	SENT63	21	21	5	5	labetalol	CXCL8	PA164743150	3576	0.943
NULL	J_Oncol_2009_Jun_14_2009_814140.nxml.txt.nlp	19547715	SENT115	33	33	18	18	etoposide	MDR1	PA449552	5243	0.943
NULL	Br_J_Cancer_2012_Sep_4_107(6)_947-955.nxml.txt.nlp	22892392	SENT11	28	28	1	1	tamoxifen	BCAR4	PA451581	400500	0.943
NULL	Exp_Ther_Med_2014_Mar_10_7(3)_640-648.nxml.txt.nlp	24520260	SENT110	21	21	13	13	resveratrol	p38		10598;1432;7965	0.943
NULL	Biomed_Res_Int_2013_Jul_16_2013_953520.nxml.txt.nlp	23957013	SENT151	6	6	40	40	cyclosporine	P-gp	PA449167	5243	0.943
NULL	Nat_Commun_2013_Oct_29_4_10_1038_ncomms3628.nxml.txt.nlp	24165455	SENT215	30	30	10	10	picrotoxin	EMD	PA164777007	2010	0.942
NULL	Mol_Cancer_2012_Aug_8_11_53.nxml.txt.nlp	22871047	SENT221	26	26	33	33	paclitaxel	ANOVA	PA450761	4858	0.942
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_May_22_66(Pt_6)_o1406.nxml.txt.nlp	21579485	SENT64	0	0	17	17	benzaldehyde	mol	PA448571	90527	0.942
NULL	Adv_Urol_2010_Jul_20_2010_687043.nxml.txt.nlp	20721275	SENT102	24	24	33	33	bevacizumab	IFN	PA130232992	3439	0.942
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Apr_7_9_12.nxml.txt.nlp	20374640	SENT10	15	15	5	5	trimethoprim	TEM	PA451788	64102	0.942
NULL	Oncotarget_2014_Oct_16_5(22)_11442-11451.nxml.txt.nlp	25347345	SENT50	16	16	9	9	oxaliplatin	CT26	PA131285527	168400	0.942
NULL	Biologics_2014_Apr_7_8_141-153.nxml.txt.nlp	24741293	SENT199	8	8	22	22	infliximab	IL-6	PA452639	3569	0.942
NULL	Braz_J_Med_Biol_Res_2014_Feb_17_47(2)_101-109.nxml.txt.nlp	24519125	SENT141	28	28	13	13	forskolin	IL-6	PA146096022	3569	0.942
NULL	Int_J_Breast_Cancer_2011_Jul_12_2011_232435.nxml.txt.nlp	22295213	SENT264	24	24	22	22	letrozole	aromatase	PA450196	1588	0.942
NULL	Int_J_Breast_Cancer_2013_Jan_16_2013_872743.nxml.txt.nlp	23401782	SENT299	29	29	15	15	olaparib	BRCA1		672	0.942
NULL	Front_Oncol_2014_Sep_16_4_249.nxml.txt.nlp	25279352	SENT163	8	8	3	3	salsalate	HIF-1	PA164745462	29072	0.942
NULL	JAKSTAT_2013_Jul_1_2(3)_e24574.nxml.txt.nlp	24069558	SENT219	44	44	7	7	streptomycin	JAK2	PA451512	3717	0.942
NULL	Adv_Biomed_Res_2014_Sep_8_3_189.nxml.txt.nlp	25298958	SENT75	12	12	30	30	omeprazole	NAC	PA450704	22861	0.942
NULL	Osteoporos_Int_2012_Jan_17_23(1)_317-326.nxml.txt.nlp	21927922	SENT29	0	0	11	11	denosumab	RANK	PA166048634	8792	0.942
NULL	Br_J_Pharmacol_2008_Sep_9_155(1)_127-137.nxml.txt.nlp	18536750	SENT185	29	29	22	22	piroxicam	IL-10	PA450985	3586	0.942
NULL	Arthritis_Res_2001_Jan_26_3(Suppl_A)_P094.nxml.txt.nlp	NULL	SENT11	34	34	20	20	infliximab	OPG	PA452639	690	0.942
NULL	Hum_Resour_Health_2013_Jul_18_11_35.nxml.txt.nlp	23866794	SENT98	27	27	3	3	isoniazid	CD4	PA450112	920	0.942
NULL	Hum_Mol_Genet_2013_Nov_15_22(22)_4616-4626.nxml.txt.nlp	23814041	SENT185	17	17	6	6	simvastatin	neuroserpin	PA451363	5274	0.942
NULL	J_Hematol_Oncol_2011_Jan_21_4_5.nxml.txt.nlp	21255411	SENT28	14	14	28	28	carboplatin	EGFR	PA448803	1956	0.942
NULL	Front_Immunol_2012_Jan_11_2_95.nxml.txt.nlp	22566884	SENT198	16	16	23	23	pp2	PAG		55824	0.942
NULL	Cell_Commun_Signal_2013_Oct_21_11_79.nxml.txt.nlp	24144181	SENT406	21	21	4	4	chloramphenicol	IL-8	PA448927	3576	0.942
NULL	F1000_Med_Rep_2009_Dec_9_1_93.nxml.txt.nlp	20948684	SENT88	6	6	20	20	doxycycline	LAM	PA449415	7249;7248	0.942
NULL	ISRN_AIDS_2012_Jul_12_2012_485307.nxml.txt.nlp	24052874	SENT99	29	29	1	1	tenofovir	PTH	PA10204	5741	0.942
NULL	Clin_Pediatr_Endocrinol_2013_Jan_7_22(1)_1-8.nxml.txt.nlp	23966754	SENT66	12	12	1	1	metformin	DPP4	PA450395	1803	0.942
NULL	Nucleic_Acids_Res_2012_Jul_30_40(13)_6319-6337.nxml.txt.nlp	22467215	SENT314	19	19	7	7	cisplatin	Bcl-2	PA449014	596	0.942
NULL	Clin_Ophthalmol_2008_Sep_2(3)_613-621.nxml.txt.nlp	19668762	SENT73	26	26	2	2	travoprost	ANOVA	PA164781371	4858	0.942
NULL	Iran_Red_Crescent_Med_J_2014_Sep_5_16(9)_e20153.nxml.txt.nlp	25593732	SENT62	8	8	30	30	halothane	CYP2E1	PA449845	1571	0.942
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1137-1144.nxml.txt.nlp	20234366	SENT188	21	21	1	1	cetuximab	KRAS	PA10040	3845	0.942
NULL	Pharmaceuticals_(Basel)_2012_Aug_30_5(9)_890-898.nxml.txt.nlp	24280696	SENT63	8	8	6	6	geldanamycin	Hsp90	PA152031327	3320	0.942
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_16_2012_395912.nxml.txt.nlp	23118789	SENT148	31	31	0	0	ezetimibe	UGT1A3	PA10816	54659	0.942
NULL	J_Clin_Biochem_Nutr_2007_Jan_27_40(1)_13-23.nxml.txt.nlp	18437209	SENT144	27	27	21	21	trypsin	IL-8	PA451806	3576	0.942
NULL	Breast_Cancer_Res_2012_Jun_7_14(3)_R89.nxml.txt.nlp	22676470	SENT17	8	8	23	23	trastuzumab	HER2	PA451743	2064	0.942
NULL	Cardiovasc_Diabetol_2013_Mar_4_12_42.nxml.txt.nlp	23452502	SENT220	0	0	11	11	exenatide	GLP1	PA164749238	100125288;2641	0.942
NULL	Breast_Cancer_Res_2012_Jul_6_14(4)_R102.nxml.txt.nlp	22770227	SENT36	25	25	6	6	tamoxifen	aromatase	PA451581	1588	0.942
NULL	Crit_Care_2004_Oct_27_8(6)_R474-R482.nxml.txt.nlp	15566594	SENT39	3	3	10	10	lornoxicam	COX	PA165958395	1351	0.942
NULL	Oncogene_2010_Jul_22_29(29)_4170-4182.nxml.txt.nlp	20498638	SENT121	2	2	12	12	cetuximab	EGFR	PA10040	1956	0.942
NULL	J_Hum_Genet_2013_Jun_23_58(6)_339-345.nxml.txt.nlp	23697979	SENT22	7	7	23	23	clopidogrel	CES1	PA449053	1066	0.942
NULL	Nat_Med_2011_Dec_18_18(1)_120-127.nxml.txt.nlp	22179318	SENT84	24	24	0	0	hemin	HO-1	PA449849	3162	0.942
NULL	Tuberc_Respir_Dis_(Seoul)_2013_Nov_29_75(5)_188-198.nxml.txt.nlp	24348666	SENT49	11	11	2	2	gefitinib	PTEN	PA131301952	5728	0.942
NULL	Int_J_Biol_Sci_2013_Dec_17_10(1)_64-72.nxml.txt.nlp	24391452	SENT60	26	26	33	33	ketanserin	5-HT2B	PA131053734	3357	0.942
NULL	Iran_J_Pharm_Res_2014_Autumn_13(4)_1393-1401.nxml.txt.nlp	25587329	SENT9	3	3	21	21	celecoxib	ABCG2	PA448871	9429	0.942
NULL	J_Mol_Signal_2012_Aug_16_7_12.nxml.txt.nlp	22898329	SENT247	10	10	0	0	fludarabine	NOXA	PA449655	5366	0.942
NULL	Br_J_Cancer_2010_Jul_13_103(2)_186-195.nxml.txt.nlp	20588277	SENT123	27	27	19	19	nutlin-3	p53		7157	0.942
NULL	Breast_Cancer_Res_Treat_2013_Aug_20_141(1)_43-53.nxml.txt.nlp	23959396	SENT10	14	14	4	4	trastuzumab	HER3	PA451743	2065	0.942
NULL	J_Neuroinflammation_2010_Sep_7_7_51.nxml.txt.nlp	20822529	SENT109	6	6	33	33	hemin	HO-1	PA449849	3162	0.942
NULL	Cell_Death_Dis_2014_Jan_16_5(1)_e1000.nxml.txt.nlp	24434508	SENT326	15	15	5	5	etoposide	p53	PA449552	7157	0.942
NULL	Case_Rep_Oncol_Med_2012_Sep_11_2012_726424.nxml.txt.nlp	22997596	SENT11	27	27	15	15	rituximab	PRL	PA451261	5617	0.942
NULL	Int_J_Hypertens_2012_Feb_8_2012_189512.nxml.txt.nlp	22518281	SENT166	11	11	26	26	hemin	HO-2	PA449849	3163	0.942
NULL	J_Biol_2009_Apr_15_8(3)_30.nxml.txt.nlp	19435483	SENT49	3	3	7	7	imatinib	SYK	PA10804	6850	0.942
NULL	Breast_Cancer_Res_2014_Sep_11_16(5)_430.nxml.txt.nlp	25212826	SENT256	3	3	5	5	fulvestrant	PI3K	PA164747170	5290	0.942
NULL	Reprod_Biol_Endocrinol_2003_Oct_9_1_74.nxml.txt.nlp	14613550	SENT96	8	8	16	16	indomethacin	COX	PA449982	1351	0.942
NULL	J_Hematol_Oncol_2010_Mar_23_3_11.nxml.txt.nlp	20331897	SENT18	22	22	12	12	capecitabine	HER2	PA448771	2064	0.942
NULL	Mol_Cancer_2010_Aug_23_9_222.nxml.txt.nlp	20731837	SENT3	3	3	8	8	gefitinib	EGFR	PA131301952	1956	0.942
NULL	Oncotarget_2013_Nov_16_4(11)_1868-1881.nxml.txt.nlp	24240121	SENT15	3	3	12	12	trastuzumab	ERBB2	PA451743	2064	0.942
NULL	Oncol_Lett_2013_Aug_17_6(2)_295-305.nxml.txt.nlp	24137320	SENT176	13	13	8	8	tamoxifen	14-3-3	PA451581	10971	0.942
NULL	Front_Oncol_2014_Sep_23_4_264.nxml.txt.nlp	25295231	SENT98	18	18	38	38	lenalidomide	p53	PA162363968	7157	0.942
NULL	Br_J_Cancer_2012_Nov_6_107(10)_1714-1721.nxml.txt.nlp	23073173	SENT101	20	20	40	40	bicalutamide	RUNX2	PA164746255	860	0.942
NULL	Behav_Brain_Funct_2013_May_3_9_17.nxml.txt.nlp	23642235	SENT187	23	23	4	4	baclofen	ANG	PA448533	283	0.942
NULL	Diagn_Pathol_2014_Jul_10_9_143.nxml.txt.nlp	25012722	SENT13	10	10	4	4	cisplatin	PDCD4	PA449014	27250	0.942
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT282	30	30	11	11	pemetrexed	UNG	PA10810	7374	0.942
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT119	21	21	3	3	nutlin-3	MDM2		4193	0.942
NULL	Pharmaceuticals_(Basel)_2011_Nov_11_4(11)_1503-1517.nxml.txt.nlp	NULL	SENT109	7	7	17	17	capsaicin	TRPV1	PA448776	7442	0.942
NULL	Oncogene_2014_Feb_6_33(6)_713-723.nxml.txt.nlp	23435429	SENT77	28	28	2	2	etoposide	p65	PA449552	5970	0.942
NULL	J_Korean_Med_Sci_2008_Aug_25_23(4)_685-690.nxml.txt.nlp	18756058	SENT132	30	30	10	10	olanzapine	ghrelin	PA450688	51738	0.942
NULL	Br_J_Cancer_2003_Mar_24_88(6)_848-854.nxml.txt.nlp	12644821	SENT161	16	16	21	21	paclitaxel	TP53	PA450761	7157	0.942
NULL	Front_Oncol_2013_Nov_18_3_282.nxml.txt.nlp	24303367	SENT216	13	13	20	20	gemcitabine	HMGA1	PA449748	3159	0.942
NULL	Am_J_Cardiovasc_Drugs_2013_Jun_20_13(5)_331-342.nxml.txt.nlp	23784266	SENT183	12	12	21	21	quinidine	P-gp	PA451209	5243	0.942
NULL	Nat_Med_2014_Jun_11_20(6)_599-606.nxml.txt.nlp	24813251	SENT257	8	8	3	3	imatinib	YAP1	PA10804	10413	0.942
NULL	J_Hematol_Oncol_2010_Mar_23_3_11.nxml.txt.nlp	20331897	SENT24	24	24	4	4	capecitabine	HER2	PA448771	2064	0.942
NULL	Int_J_Mol_Sci_2012_Feb_24_13(3)_2578-2589.nxml.txt.nlp	22489112	SENT64	10	10	35	35	desipramine	GAT1	PA449233	6529	0.942
NULL	Cell_Host_Microbe_2014_Sep_10_16(3)_291-303.nxml.txt.nlp	25211072	SENT86	3	3	30	30	genistein	tetherin	PA165109660	684	0.942
NULL	Chem_Cent_J_2014_Jan_17_8_4.nxml.txt.nlp	24438453	SENT103	28	28	4	4	galactose	MP1	PA449725	10531;8649	0.942
NULL	Oncotarget_2014_Sep_16_5(20)_10034-10047.nxml.txt.nlp	25296981	SENT184	25	25	14	14	doxorubicin	CHK2	PA449412	11200	0.942
NULL	Breast_Cancer_Res_2007_Dec_20_9(Suppl_2)_S11.nxml.txt.nlp	NULL	SENT19	21	21	12	12	tamoxifen	IMPACT	PA451581	55364	0.942
NULL	Case_Rep_Oncol_2014_Feb_20_7(1)_126-131.nxml.txt.nlp	24707260	SENT40	12	12	0	0	gefitinib	EGFR	PA131301952	1956	0.942
NULL	Curr_Health_Sci_J_2014_Dec_29_Jan-Mar_40(1)_12-17.nxml.txt.nlp	24791199	SENT71	21	21	1	1	clozapine	5-HT2C	PA449061	3358	0.942
NULL	Chemother_Res_Pract_2011_Dec_18_2011_965826.nxml.txt.nlp	22295208	SENT179	7	7	21	21	azacitidine	ACT	PA451996	12;11332;9457;641455	0.942
NULL	Lab_Invest_2009_Dec_19_89(12)_1397-1409.nxml.txt.nlp	19841616	SENT156	16	16	4	4	curcumin	LPO	PA151958596	4025	0.942
NULL	Mol_Cancer_2012_Jul_12_11_45.nxml.txt.nlp	22788833	SENT154	24	24	12	12	cisplatin	HER2	PA449014	2064	0.942
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_17_2013_549174.nxml.txt.nlp	23843879	SENT99	13	13	37	37	curcumin	HO-1	PA151958596	3162	0.942
NULL	Oncotarget_2014_Dec_1_5(22)_10965-10966.nxml.txt.nlp	25473898	SENT13	25	25	10	10	doxorubicin	BCL6	PA449412	604	0.942
NULL	Dermatol_Pract_Concept_2011_Jan_31_1(1)_33-47.nxml.txt.nlp	24396718	SENT407	6	6	20	20	phenytoin	por	PA450947	64840	0.942
NULL	Acta_Pharmacol_Sin_2013_Jan_19_34(1)_146-156.nxml.txt.nlp	23160340	SENT174	5	5	15	15	doxorubicin	CYP3A4	PA449412	1576	0.942
NULL	Indian_J_Anaesth_2014_Mar-Apr_58(2)_238-239.nxml.txt.nlp	24963210	SENT48	20	20	8	8	dexmedetomidine	LGS	PA449256	51557	0.942
NULL	Arthritis_Res_Ther_2013_Jan_25_15(1)_R20.nxml.txt.nlp	23351360	SENT27	17	17	10	10	rituximab	ACPA	PA451261	5657	0.942
NULL	Br_J_Cancer_2010_Sep_28_103(7)_1008-1018.nxml.txt.nlp	20736947	SENT47	32	32	8	8	docetaxel	MDR1	PA449383	5243	0.942
NULL	Genome_Med_2010_Jun_14_2(6)_37.nxml.txt.nlp	20546595	SENT315	17	17	10	10	tamoxifen	ERBB2	PA451581	2064	0.942
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT211	11	11	16	16	atorvastatin	RANKL	PA448500	8600	0.942
NULL	Mol_Cancer_2014_Jan_7_13_4.nxml.txt.nlp	24393163	SENT202	23	23	2	2	imatinib	JNK1	PA10804	5599	0.942
NULL	Leukemia_2013_Apr_14_27(4)_803-812.nxml.txt.nlp	23238589	SENT153	9	9	38	38	imatinib	IFN	PA10804	3439	0.942
NULL	J_Exp_Clin_Cancer_Res_2009_Sep_1_28(1)_123.nxml.txt.nlp	19723324	SENT72	17	17	13	13	gefitinib	PTEN	PA131301952	5728	0.942
NULL	Cell_Death_Differ_2010_Apr_16_17(4)_666-676.nxml.txt.nlp	19834494	SENT251	18	18	0	0	oxaliplatin	RAGE	PA131285527	177	0.942
NULL	Gut_Liver_2013_Sep_14_7(5)_552-559.nxml.txt.nlp	24073313	SENT86	2	2	24	24	celecoxib	EGFR	PA448871	1956	0.942
NULL	Biosci_Rep_2012_Dec_20_33(1)_e00011.nxml.txt.nlp	23137297	SENT252	0	0	6	6	heparin	RPSA	PA449855	3921	0.942
NULL	Oncotarget_2011_Dec_24_2(12)_896-917.nxml.txt.nlp	22203527	SENT176	4	4	17	17	metformin	HER2	PA450395	2064	0.942
NULL	Oncotarget_2012_May_4_3(4)_395-398.nxml.txt.nlp	22565037	SENT9	24	24	43	43	trastuzumab	HER2	PA451743	2064	0.942
NULL	Ann_Rheum_Dis_2014_May_6_73(5)_902-905.nxml.txt.nlp	23921994	SENT86	22	22	1	1	methotrexate	SOC	PA450428	91544	0.942
NULL	Br_J_Cancer_2014_Aug_12_111(4)_696-707.nxml.txt.nlp	24937672	SENT133	23	23	16	16	tamoxifen	ABCC10	PA451581	89845	0.942
NULL	Front_Chem_2013_Jun_26_1_8.nxml.txt.nlp	24790937	SENT23	22	22	8	8	lithium	DMC	PA450243	284340;54808	0.942
NULL	Mol_Cancer_2009_May_15_8_28.nxml.txt.nlp	19445670	SENT73	38	38	13	13	doxorubicin	Bcl-2	PA449412	596	0.942
NULL	Oncotarget_2013_Aug_9_4(9)_1332-1333.nxml.txt.nlp	23934763	SENT9	20	20	11	11	dasatinib	ABL1	PA162372878	25	0.942
NULL	Oncol_Lett_2013_Feb_5_5(2)_427-434.nxml.txt.nlp	23420099	SENT166	17	17	4	4	carboplatin	RRM1	PA448803	6240	0.942
NULL	Diabetes_Care_2013_Feb_17_36(2)_422-428.nxml.txt.nlp	23033246	SENT29	15	15	29	29	fenofibrate	PPL	PA449594	5493	0.942
NULL	An_Bras_Dermatol_2014_Mar-Apr_89(2)_266-273.nxml.txt.nlp	24770503	SENT19	7	7	20	20	thalidomide	ENL	PA451644	4298	0.942
NULL	Oncotarget_2014_May_27_5(19)_9049-9064.nxml.txt.nlp	24979294	SENT233	9	9	11	11	dasatinib	EGFR	PA162372878	1956	0.942
NULL	Br_J_Cancer_2009_Sep_15_101(6)_957-966.nxml.txt.nlp	19738618	SENT169	8	8	19	19	dexrazoxane	THBS-1	PA449259	7057	0.942
NULL	Int_J_Biol_Sci_2012_Feb_9_8(3)_310-327.nxml.txt.nlp	22355267	SENT168	34	34	5	5	simvastatin	PCSK9	PA451363	255738	0.942
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_55-78.nxml.txt.nlp	19305788	SENT884	6	6	19	19	ketamine	c-fos	PA450144	2353	0.942
NULL	Aust_N_Z_J_Psychiatry_2011_Sep_3_45(9)_712-725.nxml.txt.nlp	21888608	SENT289	13	13	6	6	reboxetine	CYP2D6	PA144614921	1565	0.942
NULL	Cardiovasc_Diabetol_2013_Nov_4_12_160.nxml.txt.nlp	24188631	SENT33	15	15	7	7	vildagliptin	GLP-1	PA165958346	100125288	0.942
NULL	Aging_Cell_2012_Aug_11(4)_579-587.nxml.txt.nlp	22435726	SENT121	14	14	2	2	etoposide	CD28	PA449552	1493;940	0.942
NULL	Amino_Acids_2014_Feb_20_46(5)_1275-1283.nxml.txt.nlp	24553827	SENT7	29	29	15	15	taurine	CDO	PA451590	50937	0.942
NULL	Curr_Genomics_2014_Jun_15(3)_190-202.nxml.txt.nlp	24955027	SENT175	0	0	16	16	sunitinib	FDG	PA162372840	23583	0.942
NULL	Anal_Chem_Insights_2008_Mar_25_3_45-60.nxml.txt.nlp	19609389	SENT204	15	15	10	10	simvastatin	HMGCR	PA451363	3156	0.942
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT68	7	7	18	18	resveratrol	TRAIL		8743	0.942
NULL	Mol_Cell_Biol_2014_Oct_34(19)_3754-3764.nxml.txt.nlp	25071155	SENT270	33	33	21	21	cisplatin	WWP2	PA449014	11060	0.942
NULL	Acta_Pharmacol_Sin_2010_Sep_16_31(9)_1075-1084.nxml.txt.nlp	20711221	SENT151	27	27	0	0	glucose	AMPK	PA449773	5563	0.942
NULL	Tumour_Biol_2014_Aug_12_35(8)_7807-7819.nxml.txt.nlp	24817012	SENT377	17	17	8	8	carboplatin	ERCC2	PA448803	2068	0.942
NULL	Nat_Commun_2014_Nov_25_5_5548.nxml.txt.nlp	25420520	SENT424	15	15	9	9	colchicine	MDR1	PA449092	5243	0.942
NULL	Antimicrob_Agents_Chemother_2014_Oct_58(10)_5900-5908.nxml.txt.nlp	25070091	SENT295	2	2	16	16	metoprolol	CYP1A2	PA450480	1544	0.942
NULL	Mol_Cancer_2009_Aug_25_8_66.nxml.txt.nlp	19706164	SENT57	13	13	2	2	celecoxib	p53	PA448871	7157	0.942
NULL	Diabetes_Obes_Metab_2011_Nov_13(11)_982-989.nxml.txt.nlp	21615670	SENT19	4	4	15	15	sitagliptin	PPG	PA164748978	5552	0.942
NULL	Case_Rep_Gastroenterol_2012_Aug_9_6(2)_538-544.nxml.txt.nlp	22949894	SENT22	0	0	19	19	sitagliptin	GLP-1	PA164748978	100125288	0.942
NULL	Br_J_Cancer_2004_Mar_22_90(6)_1285-1292.nxml.txt.nlp	15026814	SENT42	37	37	18	18	doxorubicin	p53	PA449412	7157	0.942
NULL	Br_J_Cancer_2009_Jan_27_100(2)_315-321.nxml.txt.nlp	19127256	SENT17	0	0	20	20	everolimus	4E-BP1	PA164746311	1978	0.942
NULL	Clin_Med_Insights_Oncol_2012_Feb_28_6_125-135.nxml.txt.nlp	22408376	SENT90	28	28	8	8	panitumumab	KRAS	PA162373091	3845	0.942
NULL	Oncogenesis_2014_Dec_15_3(12)_e133.nxml.txt.nlp	25500906	SENT304	12	12	6	6	trastuzumab	MYO3B	PA451743	140469	0.942
NULL	Clin_Dev_Immunol_2013_May_22_2013_701305.nxml.txt.nlp	23762095	SENT149	13	13	27	27	vinblastine	MCL1	PA451877	4170	0.942
NULL	Cell_Microbiol_2013_Aug_14_15(8)_1385-1400.nxml.txt.nlp	23421931	SENT295	13	13	29	29	gentamicin	CO2	PA449753	4513	0.942
NULL	Diabetes_Care_2008_Nov_31(11)_2169-2176.nxml.txt.nlp	18678611	SENT114	3	3	24	24	rimonabant	adiponectin	PA152407999	9370	0.942
NULL	Iran_J_Basic_Med_Sci_2012_Nov-Dec_15(6)_1202-1209.nxml.txt.nlp	23653852	SENT160	3	3	36	36	metformin	AMPK	PA450395	5563	0.942
NULL	Indian_J_Endocrinol_Metab_2013_Jul-Aug_17(4)_636-646.nxml.txt.nlp	23961479	SENT151	7	7	22	22	amprenavir	CYP3A4	PA448422	1576	0.942
NULL	Nat_Commun_2014_Mar_17_5_3480.nxml.txt.nlp	24633012	SENT130	4	4	8	8	cisplatin	PRMT1	PA449014	3276	0.942
NULL	J_Cell_Mol_Med_2014_May_14_18(5)_811-823.nxml.txt.nlp	24628949	SENT124	18	18	11	11	docetaxel	FOXM1	PA449383	2305	0.942
NULL	Clin_Pharmacol_2010_Sep_6_2_155-162.nxml.txt.nlp	22291500	SENT63	41	41	26	26	clopidogrel	CYP2C19	PA449053	1557	0.942
NULL	Cancers_(Basel)_2010_May_26_2(2)_970-988.nxml.txt.nlp	24281102	SENT142	32	32	41	41	bevacizumab	VEGFR1	PA130232992	2321	0.942
NULL	Colorectal_Dis_2012_Feb_14(2)_e31-e47.nxml.txt.nlp	21848897	SENT37	2	2	21	21	panitumumab	KRAS	PA162373091	3845	0.942
NULL	Br_J_Cancer_2012_Nov_6_107(10)_1714-1721.nxml.txt.nlp	23073173	SENT192	0	0	16	16	bicalutamide	RUNX2	PA164746255	860	0.942
NULL	Cancer_Cell_Int_2009_Sep_10_9_25.nxml.txt.nlp	19744341	SENT130	35	35	10	10	glucosamine	STAT3	PA164747613	6774	0.942
NULL	Cancer_Res_Treat_2014_Jan_15_46(1)_19-26.nxml.txt.nlp	24520219	SENT92	6	6	2	2	aprepitant	NK1	PA164747039	11126	0.942
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Jul_21_9_20.nxml.txt.nlp	20663145	SENT69	27	27	1	1	erythromycin	LBH	PA449493	81606;221491	0.942
NULL	Cancer_Med_2013_Dec_31_2(6)_826-835.nxml.txt.nlp	24403256	SENT198	12	12	10	10	nutlin-3	HDM2		4193	0.942
NULL	Adv_Hematol_2013_Jan_10_2013_953982.nxml.txt.nlp	23365579	SENT148	25	25	7	7	nilotinib	CXCR4	PA165958345	7852	0.942
NULL	J_Biomed_Sci_2014_Feb_3_21(1)_10.nxml.txt.nlp	24490900	SENT155	18	18	3	3	alendronate	CTR	PA448082	799	0.942
NULL	J_Gen_Physiol_2000_Jun_1_115(6)_685-696.nxml.txt.nlp	10828243	SENT123	30	30	23	23	genistein	OLF	PA165109660	83857	0.942
NULL	Diabetes_2009_Feb_58(2)_352-359.nxml.txt.nlp	19011168	SENT166	4	4	12	12	erythromycin	GLP-1	PA449493	100125288	0.942
NULL	Oncogenesis_2012_Apr_2_1(4)_e5.nxml.txt.nlp	23552603	SENT84	5	5	19	19	celecoxib	IL-6	PA448871	3569	0.942
NULL	Mol_Cancer_2009_Jul_31_8_57.nxml.txt.nlp	19646263	SENT218	6	6	18	18	docetaxel	PC-3	PA449383	692094	0.942
NULL	Cancer_Imaging_2007_May_28_7(1)_84-92.nxml.txt.nlp	17535776	SENT121	8	8	16	16	choline	FDG	PA448976	23583	0.942
NULL	Biol_Open_2014_Dec_12_4(1)_48-61.nxml.txt.nlp	25505152	SENT498	21	21	24	24	metformin	AMPK	PA450395	5563	0.942
NULL	Br_J_Cancer_2011_Jul_12_105(2)_212-220.nxml.txt.nlp	21694723	SENT9	2	2	4	4	curcumin	STAT3	PA151958596	6774	0.942
NULL	Clin_Sci_(Lond)_2012_May_1_122(Pt_9)_421-428.nxml.txt.nlp	22092038	SENT10	20	20	3	3	doxycycline	AP-1	PA449415	2353;3727;2354;3725	0.942
NULL	Arch_Med_Sci_2013_Apr_20_9(2)_332-339.nxml.txt.nlp	23671446	SENT139	12	12	23	23	midazolam	p38	PA450496	10598;1432;7965	0.942
NULL	Prostate_Int_2014_Sep_21_2(3)_105-113.nxml.txt.nlp	25325021	SENT124	15	15	2	2	indomethacin	AKR1C3	PA449982	8644	0.942
NULL	Br_J_Pharmacol_2010_Sep_161(2)_288-307.nxml.txt.nlp	20735416	SENT245	25	25	7	7	isoflurane	TASK	PA450106	3777	0.942
NULL	Oxid_Med_Cell_Longev_2013_Sep_24_2013_985210.nxml.txt.nlp	24205432	SENT137	12	12	27	27	resveratrol	FOXO3		2309	0.942
NULL	Int_J_Surg_Oncol_2012_Aug_27_2012_180574.nxml.txt.nlp	22970358	SENT27	19	19	14	14	letrozole	aromatase	PA450196	1588	0.942
NULL	Ann_Med_Health_Sci_Res_2012_Jul-Dec_2(2)_191-198.nxml.txt.nlp	23439914	SENT165	11	11	1	1	lovastatin	P-gp	PA450272	5243	0.942
NULL	Pharmaceuticals_(Basel)_2013_May_23_6(6)_689-699.nxml.txt.nlp	24276256	SENT106	6	6	27	27	nifedipine	PTB	PA450631	58155	0.942
NULL	Int_J_Mol_Sci_2014_Sep_2_15(9)_15512-15529.nxml.txt.nlp	25184950	SENT75	17	17	9	9	resveratrol	IL-10		3586	0.942
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT88	29	29	11	11	metformin	p53	PA450395	7157	0.942
NULL	Mol_Cancer_2009_Nov_19_8_108.nxml.txt.nlp	19925669	SENT352	1	1	24	24	doxorubicin	CRT	PA449412	811	0.942
NULL	Mol_Cancer_2007_Oct_22_6_66.nxml.txt.nlp	17953743	SENT201	24	24	13	13	cisplatin	TRAIL	PA449014	8743	0.942
NULL	Breast_Cancer_Res_2012_Jan_6_14(1)_R2.nxml.txt.nlp	22225778	SENT219	20	20	34	34	docetaxel	BIRC3	PA449383	330	0.942
NULL	Arthritis_Res_2000_Aug_30_2(6)_472-476.nxml.txt.nlp	11219394	SENT71	9	9	0	0	methylprednisolone	IL-17	PA450466	3605	0.942
NULL	Drug_Des_Devel_Ther_2014_Sep_23_8_1527-1538.nxml.txt.nlp	25284985	SENT11	31	31	8	8	celecoxib	IFN	PA448871	3439	0.942
NULL	Oncol_Rep_2013_Sep_1_30(3)_1045-1052.nxml.txt.nlp	23817662	SENT154	21	21	17	17	afatinib	EGFR	PA165981154	1956	0.942
NULL	Arthritis_Res_Ther_2008_Aug_22_10(4)_R97.nxml.txt.nlp	18718031	SENT37	31	31	6	6	heparin	BAFF	PA449855	10673	0.942
NULL	J_Cell_Sci_2011_Mar_15_124(6)_921-932.nxml.txt.nlp	21378310	SENT196	5	5	25	25	chloroquine	RNF41	PA448948	10193	0.942
NULL	Int_J_Biol_Sci_2014_Jun_5_10(6)_620-626.nxml.txt.nlp	24948875	SENT88	0	0	9	9	cabozantinib	Met	PA165906891	79811	0.942
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT249	17	17	4	4	dasatinib	PP2	PA162372878	4888	0.942
NULL	Diabetes_2011_Jul_20_60(7)_1990-1999.nxml.txt.nlp	21617181	SENT216	7	7	11	11	geldanamycin	Hsp90	PA152031327	3320	0.942
NULL	Front_Oncol_2014_Mar_25_4_54.nxml.txt.nlp	24724051	SENT421	5	5	14	14	nilotinib	LYN	PA165958345	4067	0.942
NULL	Arthritis_Res_Ther_2006_Mar_6_8(2)_R53.nxml.txt.nlp	16519795	SENT26	0	0	6	6	methotrexate	San	PA450428	80218	0.942
NULL	Oncol_Rep_2013_Apr_23_29(4)_1268-1274.nxml.txt.nlp	23354756	SENT184	2	2	12	12	trastuzumab	SLC25A43	PA451743	203427	0.942
NULL	Cancer_Res_Treat_2013_Mar_31_45(1)_55-62.nxml.txt.nlp	23613671	SENT146	8	8	20	20	oxaliplatin	KRAS	PA131285527	3845	0.942
NULL	J_Mol_Med_(Berl)_2014_Jan_10_92(5)_497-507.nxml.txt.nlp	24408111	SENT32	3	3	11	11	pioglitazone	HIF-1	PA450970	29072	0.942
NULL	Br_J_Haematol_2008_Jun_141(5)_659-671.nxml.txt.nlp	18410446	SENT213	5	5	12	12	cerulenin	IRE1	PA164764551	2081	0.942
NULL	Cell_Death_Dis_2013_Sep_5_4(9)_e792.nxml.txt.nlp	24008736	SENT6	25	25	17	17	methotrexate	WOX1	PA450428	51741	0.942
NULL	AMB_Express_2012_Apr_26_2_25.nxml.txt.nlp	22537922	SENT2	15	15	3	3	isoniazid	INA	PA450112	9118	0.942
NULL	Ann_Dermatol_2012_Aug_25_24(3)_295-305.nxml.txt.nlp	22879713	SENT200	14	14	7	7	estradiol	aromatase	PA449503	1588	0.942
NULL	J_Biol_Chem_2013_Jun_14_288(24)_17745-17758.nxml.txt.nlp	23589285	SENT205	14	14	7	7	isoproterenol	KLF11	PA450121	8462	0.942
NULL	Hum_Genomics_2009_Jan_1_3(2)_128-142.nxml.txt.nlp	19164090	SENT261	16	16	5	5	carboplatin	CD44	PA448803	960	0.942
NULL	Br_J_Pharmacol_2014_Feb_24_171(1)_1019-1032.nxml.txt.nlp	24251620	SENT22	4	4	15	15	nifedipine	TRPM3	PA450631	80036	0.942
NULL	Cancer_Res_Treat_2014_Jan_15_46(1)_48-54.nxml.txt.nlp	24520223	SENT131	23	23	4	4	bevacizumab	KRAS	PA130232992	3845	0.942
NULL	Lipids_Health_Dis_2011_Jan_18_10_8.nxml.txt.nlp	21241519	SENT104	11	11	4	4	simvastatin	ABCG5	PA451363	64240	0.942
NULL	Arthritis_Res_Ther_2011_May_25_13(Suppl_1)_S2.nxml.txt.nlp	21624181	SENT232	3	3	10	10	infliximab	IMPACT	PA452639	55364	0.942
NULL	Hum_Genomics_Proteomics_2010_Aug_3_2010_159761.nxml.txt.nlp	20981231	SENT148	19	19	29	29	lithium	BDNF	PA450243	627	0.942
NULL	Mol_Cancer_2011_Sep_30_10_125.nxml.txt.nlp	21962244	SENT25	3	3	14	14	lapatinib	ERBB2	PA152241907	2064	0.942
NULL	Lab_Anim_Res_2013_Jun_24_29(2)_113-126.nxml.txt.nlp	23825484	SENT163	0	0	36	36	genistein	NKCC1	PA165109660	6558	0.942
NULL	J_Gastroenterol_2013_Jan_28_48(1)_1-12.nxml.txt.nlp	23188091	SENT315	11	11	0	0	ribavirin	IL28B	PA451241	282617	0.942
NULL	Oncoimmunology_2012_Dec_1_1(9)_1661-1663.nxml.txt.nlp	23264929	SENT16	9	9	5	5	imiquimod	CCL2	PA449972	6347	0.942
NULL	Target_Oncol_2009_Sep_16_4(3)_235-252.nxml.txt.nlp	19756916	SENT208	9	9	0	0	gefitinib	HER3	PA131301952	2065	0.942
NULL	Br_J_Cancer_2012_Nov_20_107(11)_1864-1868.nxml.txt.nlp	23093229	SENT35	32	32	14	14	cetuximab	EGFR	PA10040	1956	0.942
NULL	Arthritis_Res_Ther_2005_Mar_16_7(Suppl_2)_S15-S20.nxml.txt.nlp	15833144	SENT81	8	8	22	22	abatacept	CD28	PA164747080	1493;940	0.942
NULL	Br_J_Cancer_2009_Jun_16_100(12)_1896-1902.nxml.txt.nlp	19455143	SENT120	12	12	1	1	cisplatin	Bcl-2	PA449014	596	0.942
NULL	Acta_Pharmacol_Sin_2011_Jun_23_32(6)_765-780.nxml.txt.nlp	21602835	SENT318	8	8	28	28	diazoxide	SUR1	PA449285	6833	0.942
NULL	Clinicoecon_Outcomes_Res_2014_Oct_17_6_451-461.nxml.txt.nlp	25378939	SENT142	2	2	23	23	vancomycin	HAP	PA451850	5915;10313	0.942
NULL	Br_J_Cancer_2014_Jan_21_110(2)_330-340.nxml.txt.nlp	24281000	SENT193	13	13	0	0	paclitaxel	CHKA	PA450761	1119	0.942
NULL	Mol_Cancer_2014_Jul_5_13_165.nxml.txt.nlp	24996221	SENT43	3	3	13	13	docetaxel	LC3	PA449383	84557	0.942
NULL	J_Antimicrob_Chemother_2014_Mar_11_69(3)_594-597.nxml.txt.nlp	24216768	SENT43	6	6	19	19	oxacillin	BSAC	PA450725	57591	0.942
NULL	Comp_Hepatol_2004_Jan_14_3(Suppl_1)_S37.nxml.txt.nlp	14960189	SENT93	2	2	12	12	thalidomide	CD14	PA451644	929	0.942
NULL	Breast_Cancer_Res_2007_Jul_5_9(4)_R41.nxml.txt.nlp	17612393	SENT137	9	9	1	1	celecoxib	PARP	PA448871	142	0.942
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1063.nxml.txt.nlp	24556678	SENT72	5	5	10	10	thioridazine	TRAIL	PA451666	8743	0.942
NULL	Breast_Cancer_Res_2002_Jul_29_4(5)_202-204.nxml.txt.nlp	12223125	SENT62	5	5	15	15	tamoxifen	HER-2	PA451581	2064	0.942
NULL	Patient_Prefer_Adherence_2011_Dec_23_6_1-9.nxml.txt.nlp	22272064	SENT5	14	14	2	2	telmisartan	ACE	PA451605	1636	0.942
NULL	Korean_J_Radiol_2010_Oct_29_Nov-Dec_11(6)_640-647.nxml.txt.nlp	21076590	SENT138	3	3	20	20	propofol	IL-10	PA451141	3586	0.942
NULL	Emerg_Infect_Dis_2014_Jul_20(7)_1236-1238.nxml.txt.nlp	24960586	SENT44	31	31	20	20	ciprofloxacin	ST11	PA449009	8466	0.942
NULL	Hum_Reprod_2014_Oct_10_29(10)_2302-2316.nxml.txt.nlp	25139174	SENT376	5	5	2	2	metformin	AMPK	PA450395	5563	0.942
NULL	Int_J_Biol_Sci_2013_Mar_8_9(3)_295-302.nxml.txt.nlp	23493786	SENT124	29	29	12	12	choline	IGF2	PA448976	3481	0.942
NULL	Carcinogenesis_2013_Mar_7_34(3)_703-712.nxml.txt.nlp	23222814	SENT271	16	16	39	39	curcumin	aromatase	PA151958596	1588	0.942
NULL	Biomed_Res_Int_2013_Nov_6_2013_798164.nxml.txt.nlp	24308005	SENT5	15	15	36	36	tacrolimus	IL-21	PA451578	59067;50616;27189	0.942
NULL	Nat_Commun_2013_Aug_15_4_2130.nxml.txt.nlp	23945651	SENT647	43	43	13	13	etoposide	ATG5	PA449552	9474	0.942
NULL	Behav_Brain_Funct_2010_Aug_30_6_50.nxml.txt.nlp	20799992	SENT120	9	9	20	20	cocaine	ADORA2A	PA449072	135	0.942
NULL	Hum_Genomics_2009_Jan_1_3(2)_128-142.nxml.txt.nlp	19164090	SENT266	16	16	11	11	carboplatin	CD44	PA448803	960	0.942
NULL	Mol_Cancer_2009_Aug_3_8_59.nxml.txt.nlp	19650915	SENT58	34	34	16	16	tetracycline	SERCA3	PA451640	489	0.942
NULL	Oncotarget_2014_Feb_25_5(5)_1304-1314.nxml.txt.nlp	24675421	SENT76	5	5	14	14	cisplatin	JNK1	PA449014	5599	0.942
NULL	Int_J_Womens_Health_2012_Oct_10_4_543-549.nxml.txt.nlp	23091400	SENT63	43	43	20	20	resveratrol	aromatase		1588	0.942
NULL	Braz_J_Med_Biol_Res_2014_Mar_3_47(3)_245-251.nxml.txt.nlp	24554037	SENT101	0	0	7	7	atorvastatin	IL-6	PA448500	3569	0.942
NULL	Oxid_Med_Cell_Longev_2013_Apr_21_2013_412576.nxml.txt.nlp	23710286	SENT157	7	7	17	17	curcumin	NRF2	PA151958596	2551;4780	0.942
NULL	Int_J_Mol_Sci_2014_Oct_8_15(10)_17974-17999.nxml.txt.nlp	25299695	SENT158	19	19	6	6	curcumin	HO-1	PA151958596	3162	0.942
NULL	Indian_J_Pharmacol_2009_Dec_41(6)_252-254.nxml.txt.nlp	20407554	SENT13	2	2	12	12	irbesartan	STZ	PA450084	6484	0.942
NULL	Mol_Cancer_2014_Jun_16_13_152.nxml.txt.nlp	24935000	SENT64	15	15	6	6	everolimus	PTEN	PA164746311	5728	0.942
NULL	J_Histochem_Cytochem_2013_Feb_61(2)_101-115.nxml.txt.nlp	23092791	SENT189	8	8	2	2	heparin	VEGF-A	PA449855	7422	0.942
NULL	Br_J_Cancer_2010_Oct_12_103(8)_1139-1143.nxml.txt.nlp	20877357	SENT94	11	11	5	5	gefitinib	EGFR	PA131301952	1956	0.942
NULL	Med_Sci_Monit_2013_Oct_21_19_875-882.nxml.txt.nlp	24145180	SENT183	21	21	10	10	bevacizumab	CXCL8	PA130232992	3576	0.942
NULL	Evid_Based_Complement_Alternat_Med_2011_Feb_20_2011_541209.nxml.txt.nlp	21799681	SENT99	5	5	18	18	curcumin	P21	PA151958596	1026;9338	0.942
NULL	Ann_Surg_Oncol_2014_Feb_22_21(Suppl_4)_546-554.nxml.txt.nlp	24562936	SENT274	12	12	10	10	letrozole	aromatase	PA450196	1588	0.942
NULL	Front_Oncol_2014_Sep_23_4_264.nxml.txt.nlp	25295231	SENT71	6	6	20	20	nutlin-3	p53		7157	0.942
NULL	Anc_Sci_Life_2012_Oct-Dec_32(2)_93-98.nxml.txt.nlp	24167334	SENT113	34	34	4	4	cyclophosphamide	AR7	PA449165	7067	0.942
NULL	Breast_Cancer_Res_2002_Jun_21_4(5)_R9.nxml.txt.nlp	12223126	SENT115	29	29	10	10	tamoxifen	FasL	PA451581	356	0.942
NULL	Crit_Care_2003_Jun_26_7(6)_427-434.nxml.txt.nlp	14624682	SENT181	27	27	5	5	vasopressin	SON	PA451858	6651	0.942
NULL	Breast_Cancer_Res_2007_Oct_26_9(5)_112.nxml.txt.nlp	17980056	SENT36	0	0	15	15	gefitinib	EGFR	PA131301952	1956	0.942
NULL	Neural_Dev_2012_Jun_8_7_20.nxml.txt.nlp	22681904	SENT45	21	21	0	0	heparin	FGF2	PA449855	2247;2258	0.942
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT85	7	7	34	34	trastuzumab	IL-6	PA451743	3569	0.942
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT868	12	12	5	5	indinavir	MRP2	PA449977	100130958;57626;1244	0.942
NULL	Br_J_Cancer_2010_Jan_19_102(2)_342-350.nxml.txt.nlp	20010939	SENT132	3	3	7	7	flavopiridol	CDK9	PA452627	1025	0.942
NULL	Ther_Clin_Risk_Manag_2006_Mar_2(1)_77-86.nxml.txt.nlp	18360583	SENT113	41	41	33	33	alendronate	PTH	PA448082	5741	0.942
NULL	Lab_Invest_2013_Mar_7_93(3)_354-364.nxml.txt.nlp	23295648	SENT73	16	16	2	2	fluorescein	DAXX	PA164746009	1616	0.942
NULL	Arthritis_Res_Ther_2014_Aug_30_16(4)_419.nxml.txt.nlp	25175678	SENT171	20	20	4	4	glibenclamide	AIM2	PA449782	9447	0.942
NULL	Epilepsia_2012_Jun_21_53(Suppl_1)_18-25.nxml.txt.nlp	22612805	SENT121	3	3	13	13	furosemide	CA1	PA449719	759	0.942
NULL	Clin_Pharmacol_2010_Jun_22_2_105-110.nxml.txt.nlp	22291493	SENT49	11	11	6	6	sibutramine	ADIPOQ	PA451344	9370	0.942
NULL	Acta_Neuropathol_2015_Oct_17_129_81-96.nxml.txt.nlp	25322817	SENT158	11	11	6	6	capsaicin	TRPV1	PA448776	7442	0.942
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT51	13	13	24	24	nutlin-3	p53		7157	0.942
NULL	Mol_Brain_2014_May_31_7_42.nxml.txt.nlp	24886461	SENT93	23	23	6	6	suramin	P2Y1	PA10292	5028	0.942
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT6	45	45	10	10	tacrolimus	SOCS3	PA451578	9021	0.942
NULL	Clin_Med_Insights_Oncol_2012_Feb_28_6_125-135.nxml.txt.nlp	22408376	SENT266	22	22	2	2	panitumumab	KRAS	PA162373091	3845	0.942
NULL	Nat_Med_2013_Mar_10_19(3)_313-321.nxml.txt.nlp	23396211	SENT144	4	4	19	19	amlexanox	TBK1	PA164745310	29110	0.942
NULL	Cancer_Manag_Res_2014_Sep_5_6_329-337.nxml.txt.nlp	25228819	SENT42	0	0	38	38	palonosetron	HEC	PA10352	10403	0.942
NULL	Br_J_Cancer_2006_Dec_4_95(11)_1483-1489.nxml.txt.nlp	17106442	SENT145	38	38	19	19	platinum	MST	PA150595617	55154;4357;4294	0.942
NULL	Cancer_Immunol_Immunother_2013_Aug_27_62(10)_1637-1648.nxml.txt.nlp	23982484	SENT147	17	17	2	2	lenalidomide	IL-6	PA162363968	3569	0.942
NULL	J_Neuroinflammation_2010_Sep_7_7_51.nxml.txt.nlp	20822529	SENT111	5	5	19	19	hemin	HO-1	PA449849	3162	0.942
NULL	Oxid_Med_Cell_Longev_2013_Jun_2_2013_793525.nxml.txt.nlp	23819014	SENT122	3	3	13	13	resveratrol	AMPK		5563	0.942
NULL	Mol_Cancer_2012_Apr_26_11_24.nxml.txt.nlp	22537161	SENT139	15	15	46	46	pp2	MUC4		4585	0.942
NULL	Cardiol_Ther_2013_Jun_1_2(1)_111-124.nxml.txt.nlp	25135294	SENT123	19	19	14	14	verapamil	P-gp	PA451868	5243	0.942
NULL	Acta_Pharmacol_Sin_2013_Jan_5_34(1)_24-32.nxml.txt.nlp	23123646	SENT82	32	32	16	16	tolbutamide	SUR1	PA451718	6833	0.942
NULL	Diabetes_Metab_J_2013_Oct_17_37(5)_315-325.nxml.txt.nlp	24199159	SENT193	22	22	12	12	resveratrol	AMPK		5563	0.942
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT151	12	12	19	19	nutlin-3	p53		7157	0.942
NULL	Cancers_(Basel)_2011_Aug_9_3(3)_3189-3205.nxml.txt.nlp	24212952	SENT79	0	0	19	19	hyaluronan	HAS3	PA165958431	3038	0.942
NULL	Acta_Pharmacol_Sin_2010_Nov_18_31(11)_1447-1453.nxml.txt.nlp	20953204	SENT107	8	8	4	4	rimonabant	CB1	PA152407999	1268	0.942
NULL	J_Korean_Med_Sci_2010_Nov_26_25(11)_1626-1632.nxml.txt.nlp	21060752	SENT183	20	20	14	14	forskolin	NAC	PA146096022	22861	0.942
NULL	Cancer_Res_Treat_2014_Jul_15_46(3)_234-242.nxml.txt.nlp	25038758	SENT134	8	8	1	1	paclitaxel	P-gp	PA450761	5243	0.942
NULL	Basic_Clin_Neurosci_2014_Summer_5(3)_218-224.nxml.txt.nlp	25337383	SENT254	3	3	6	6	diazepam	5-HT2B	PA449283	3357	0.942
NULL	J_Gastroenterol_2013_Jan_27_48(1)_22-30.nxml.txt.nlp	23104468	SENT111	38	38	8	8	ribavirin	RVR	PA451241	9975	0.942
NULL	Indian_J_Pharm_Sci_2013_Mar-Apr_75(2)_217-221.nxml.txt.nlp	24019572	SENT85	31	31	8	8	metformin	BGL	PA450395	987	0.942
NULL	EPMA_J_2012_Sep_27_3(1)_10.nxml.txt.nlp	23016735	SENT237	25	25	6	6	warfarin	CYP2C9	PA451906	1559	0.942
NULL	Arthritis_Res_Ther_2005_May_18_7(Suppl_3)_S19-S25.nxml.txt.nlp	15960818	SENT12	28	28	24	24	doxorubicin	CHOP	PA449412	1649	0.942
NULL	Br_J_Cancer_2010_Nov_9_103(10)_1627-1636.nxml.txt.nlp	20959826	SENT185	39	39	31	31	cetuximab	KRAS	PA10040	3845	0.942
NULL	Biosci_Rep_2012_Dec_20_33(1)_e00011.nxml.txt.nlp	23137297	SENT256	3	3	31	31	heparin	RPSA	PA449855	3921	0.942
NULL	Iran_J_Basic_Med_Sci_2012_Nov-Dec_15(6)_1202-1209.nxml.txt.nlp	23653852	SENT2	0	0	11	11	metformin	AMPK	PA450395	5563	0.942
NULL	Br_J_Haematol_2011_Apr_153(1)_83-91.nxml.txt.nlp	21332705	SENT111	26	26	24	24	cangrelor	P2Y12	PA165945763	64805	0.942
NULL	Neural_Plast_2013_Oct_30_2013_587418.nxml.txt.nlp	24288626	SENT79	21	21	11	11	dextromethorphan	NOX2	PA449273	1536	0.942
NULL	eLife_2014_May_6_3_e02482.nxml.txt.nlp	24843002	SENT182	32	32	11	11	etoposide	SETD2	PA449552	29072	0.942
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT96	7	7	27	27	celecoxib	survivin	PA448871	332	0.942
NULL	Mol_Cancer_2013_Sep_11_12_104.nxml.txt.nlp	24025152	SENT115	9	9	2	2	gemcitabine	STAT3	PA449748	6774	0.942
NULL	F1000_Med_Rep_2012_Feb_1_4_4.nxml.txt.nlp	22312414	SENT88	0	0	25	25	vancomycin	VISA	PA451850	57506	0.942
NULL	Acta_Pharmacol_Sin_2010_May_12_31(5)_578-584.nxml.txt.nlp	20383171	SENT158	21	21	10	10	berberine	c-Jun	PA165860812	3725	0.942
NULL	Oncotarget_2013_Jun_4_4(5)_772-784.nxml.txt.nlp	23800712	SENT25	25	25	10	10	bortezomib	EGFR	PA10252	1956	0.942
NULL	Open_Med_Chem_J_2011_Sep_9_5_82-92.nxml.txt.nlp	21966329	SENT321	9	9	4	4	exenatide	GLP-1	PA164749238	100125288	0.942
NULL	Oncol_Rep_2014_Jul_15_32(1)_45-49.nxml.txt.nlp	24841138	SENT94	21	21	11	11	pp2	MMP9		4318	0.942
NULL	Korean_Circ_J_2013_Aug_31_43(8)_541-549.nxml.txt.nlp	24044013	SENT9	33	33	1	1	ticagrelor	CYP2C19	PA165374673	1557	0.942
NULL	Anc_Sci_Life_2006_Jan-Jun_25(3-4)_28-32.nxml.txt.nlp	22557204	SENT3	31	31	6	6	albendazole	PEMP	PA164746058	4354	0.942
NULL	Mol_Cell_Proteomics_2013_Aug_14_12(8)_2313-2323.nxml.txt.nlp	23674616	SENT232	0	0	21	21	levamisole	ALPL	PA450205	249	0.942
NULL	Breast_Cancer_Res_2014_Sep_9_16(5)_433.nxml.txt.nlp	25212966	SENT244	4	4	15	15	aprotinin	ILEI	PA448472	10447	0.942
NULL	Fibrogenesis_Tissue_Repair_2011_May_17_4_12.nxml.txt.nlp	21586112	SENT173	21	21	30	30	bleomycin	CD34	PA448645	947	0.942
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT88	29	29	22	22	metformin	p53	PA450395	7157	0.942
NULL	Nucleic_Acids_Res_2013_May_5_41(10)_5210-5222.nxml.txt.nlp	23563151	SENT211	9	9	3	3	arsenite	GADD45	PA452638	1647	0.942
NULL	J_Hematol_Oncol_2013_Jul_18_6_53.nxml.txt.nlp	23866964	SENT227	8	8	26	26	temsirolimus	CDKN1B	PA164746890	1027	0.942
NULL	Arthritis_Res_Ther_2009_Nov_9_11(6)_R167.nxml.txt.nlp	19900268	SENT36	29	29	2	2	tocilizumab	IL-17	PA165292659	3605	0.942
NULL	Breast_Cancer_Res_2009_Nov_17_11(6)_R84.nxml.txt.nlp	19919679	SENT120	32	32	44	44	gemcitabine	HER2	PA449748	2064	0.942
NULL	Virol_J_2010_Oct_20_7_279.nxml.txt.nlp	20961433	SENT260	8	8	2	2	trypsin	GP2	PA451806	2813	0.942
NULL	Case_Rep_Med_2014_Mar_31_2014_801805.nxml.txt.nlp	24799913	SENT38	6	6	13	13	meropenem	TMP	PA164764445	2012	0.942
NULL	Oncotarget_2014_Nov_2_5(21)_10222-10236.nxml.txt.nlp	25400118	SENT100	13	13	4	4	neratinib	AKT	PA165291472	207	0.942
NULL	Evol_Appl_2011_Mar_4(2)_225-248.nxml.txt.nlp	25567970	SENT157	26	26	29	29	lindane	gamma	PA164754914	9913	0.942
NULL	Crit_Care_2012_Jul_26_16(4)_228.nxml.txt.nlp	22839302	SENT53	2	2	16	16	clopidogrel	P2Y12	PA449053	64805	0.942
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT377	18	18	6	6	pp2	CDH1		51343;999	0.942
NULL	Cell_Death_Dis_2014_Jul_10_5(7)_e1318.nxml.txt.nlp	25010984	SENT28	3	3	18	18	nutlin-3	p53		7157	0.942
NULL	J_Appl_Oral_Sci_2011_Sep-Oct_19(5)_476-482.nxml.txt.nlp	21986652	SENT103	4	4	37	37	mannitol	CO2	PA450320	4513	0.942
NULL	Pharmaceuticals_(Basel)_2013_Aug_2_6(8)_915-928.nxml.txt.nlp	24276376	SENT70	8	8	28	28	thrombin	P2Y12	PA451674	64805	0.942
NULL	Curr_Neuropharmacol_2013_Dec_11(6)_652-663.nxml.txt.nlp	24396340	SENT133	26	26	8	8	capsaicin	TRPV1	PA448776	7442	0.942
NULL	Cancer_Immunol_Immunother_2008_Jul_7_57(7)_931-950.nxml.txt.nlp	18256831	SENT434	13	13	1	1	cyclophosphamide	IL-2	PA449165	3558	0.942
NULL	Cancers_(Basel)_2011_Apr_19_3(2)_2050-2079.nxml.txt.nlp	24212796	SENT215	4	4	11	11	perifosine	AKT	PA165291471	207	0.942
NULL	Arthritis_Res_Ther_2005_Feb_18_7(3)_R476-R484.nxml.txt.nlp	15899034	SENT100	10	10	41	41	thrombin	Rho	PA451674	29984	0.942
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT85	9	9	0	0	methotrexate	MSH2	PA450428	4436	0.942
NULL	Diabetes_2011_Jun_21_60(6)_1770-1778.nxml.txt.nlp	21562078	SENT145	9	9	22	22	metformin	AMPK	PA450395	5563	0.942
NULL	Hum_Genomics_2009_Jan_1_3(2)_128-142.nxml.txt.nlp	19164090	SENT186	17	17	32	32	carboplatin	CD44	PA448803	960	0.942
NULL	FEBS_Open_Bio_2014_Jan_6_4_77-89.nxml.txt.nlp	24490132	SENT10	5	5	23	23	ebselen	GDH	PA161660841	51084;2746	0.942
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1063.nxml.txt.nlp	24556678	SENT66	29	29	12	12	thioridazine	c-FLIP	PA451666	8837	0.942
NULL	Korean_J_Radiol_2010_Oct_29_Nov-Dec_11(6)_640-647.nxml.txt.nlp	21076590	SENT138	3	3	18	18	propofol	IL-6	PA451141	3569	0.942
NULL	Br_J_Cancer_2009_Jul_21_101(2)_238-243.nxml.txt.nlp	19568242	SENT115	12	12	33	33	sunitinib	IFN	PA162372840	3439	0.942
NULL	Cell_Death_Dis_2014_Apr_24_5(4)_e1197.nxml.txt.nlp	24763054	SENT103	21	21	15	15	cisplatin	ARC	PA449014	8996;23237	0.942
NULL	J_Biol_2009_Apr_15_8(3)_30.nxml.txt.nlp	19435483	SENT49	3	3	30	30	imatinib	NQO2	PA10804	4835	0.942
NULL	Acta_Pharmacol_Sin_2013_Jun_8_34(6)_830-836.nxml.txt.nlp	23564080	SENT22	26	26	14	14	simvastatin	HMGB1	PA451363	3146	0.942
NULL	J_Cell_Biol_1998_Jan_26_140(2)_335-345.nxml.txt.nlp	9442109	SENT218	37	37	8	8	chloroquine	NHE	PA448948	285335	0.942
NULL	Fibrogenesis_Tissue_Repair_2011_Jan_10_4_2.nxml.txt.nlp	21219601	SENT75	22	22	4	4	bleomycin	CXCR4	PA448645	7852	0.942
NULL	Bioinformation_2012_Jan_6_8(1)_13-19.nxml.txt.nlp	22359429	SENT7	25	25	9	9	curcumin	MRP1	PA151958596	4437	0.942
NULL	Oncologist_2010_Mar_3_15(3)_216-235.nxml.txt.nlp	20200040	SENT73	0	0	8	8	pertuzumab	HER-2		2064	0.942
NULL	Pharmaceuticals_(Basel)_2013_Apr_17_6(4)_557-578.nxml.txt.nlp	24276125	SENT886	10	10	17	17	vemurafenib	BRAF	PA165946873	673	0.942
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT795	0	0	16	16	imatinib	MRP7	PA10804	89845;1080	0.942
NULL	Diabetes_2013_Mar_14_62(3)_703-705.nxml.txt.nlp	23431016	SENT20	7	7	0	0	nadh	PDH	PA164755085	54704	0.942
NULL	Cancer_Med_2012_Oct_17_1(2)_230-236.nxml.txt.nlp	23342272	SENT27	8	8	11	11	vismodegib	SMO		6608;54498	0.942
NULL	Drugs_R_D_2010_Nov_25_10(4)_219-224.nxml.txt.nlp	21171668	SENT102	6	6	15	15	clopidogrel	DES	PA449053	1674	0.942
NULL	Cancer_Res_Treat_2013_Sep_30_45(3)_178-185.nxml.txt.nlp	24155676	SENT131	18	18	9	9	gefitinib	EGFR	PA131301952	1956	0.942
NULL	Cell_Death_Dis_2012_Mar_15_3(3)_e286.nxml.txt.nlp	22419115	SENT68	13	13	22	22	cisplatin	p53	PA449014	7157	0.942
NULL	Biomed_Res_Int_2014_Feb_19_2014_627510.nxml.txt.nlp	24701578	SENT259	28	28	10	10	docetaxel	CYP1B1	PA449383	1545	0.942
NULL	Exp_Ther_Med_2014_Sep_14_8(3)_836-840.nxml.txt.nlp	25120610	SENT107	0	0	12	12	fasudil	ROCK2	PA165946121	9475	0.942
NULL	Br_J_Cancer_2010_Jun_8_102(12)_1707-1716.nxml.txt.nlp	20461078	SENT43	0	0	17	17	bortezomib	TRAIL	PA10252	8743	0.942
NULL	Adv_Hematol_2012_Aug_2_2012_842945.nxml.txt.nlp	22919394	SENT155	14	14	7	7	lenalidomide	CRBN	PA162363968	51185	0.942
NULL	Front_Mol_Neurosci_2009_May_14_2_1.nxml.txt.nlp	19506703	SENT155	2	2	22	22	candesartan	ACTH	PA448765	5443	0.942
NULL	Antimicrob_Agents_Chemother_2014_Nov_10_59(1)_505-513.nxml.txt.nlp	25385096	SENT249	41	41	3	3	primaquine	CYP2D6	PA451103	1565	0.942
NULL	Front_Genet_2014_Nov_4_5_383.nxml.txt.nlp	25408701	SENT48	36	36	13	13	gefitinib	MDM2	PA131301952	4193	0.942
NULL	Mol_Cell_Biochem_2014_Jul_26_396(1-2)_221-228.nxml.txt.nlp	25063218	SENT96	3	3	9	9	resveratrol	EGFR		1956	0.942
NULL	Acta_Neuropathol_Commun_2014_Oct_21_2(1)_149.nxml.txt.nlp	NULL	SENT189	24	24	7	7	riluzole	gamma	PA451251	9913	0.942
NULL	Amino_Acids_2014_Feb_20_46(5)_1275-1283.nxml.txt.nlp	24553827	SENT193	10	10	0	0	taurine	CDO	PA451590	50937	0.942
NULL	Curr_Opin_Nephrol_Hypertens_2015_Jan_4_24(1)_37-46.nxml.txt.nlp	25427230	SENT179	19	19	30	30	troglitazone	CYP2C8	PA451799	1558	0.942
NULL	Indian_J_Pharmacol_2014_Jan-Feb_46(1)_46-50.nxml.txt.nlp	24550584	SENT29	0	0	18	18	vildagliptin	GLP-1	PA165958346	100125288	0.942
NULL	Arthritis_Res_Ther_2005_Mar_16_7(Suppl_2)_S4-S14.nxml.txt.nlp	15833146	SENT236	42	42	7	7	alefacept	CD58	PA164748040	965	0.942
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT187	3	3	11	11	curcumin	Bcl-2	PA151958596	596	0.942
NULL	Exp_Diabetes_Res_2011_Aug_18_2011_192564.nxml.txt.nlp	21869881	SENT140	7	7	0	0	thrombin	NIK	PA451674	9020;9448	0.942
NULL	Arthritis_Res_Ther_2007_Oct_19_9(Suppl_3)_P23.nxml.txt.nlp	NULL	SENT22	17	17	23	23	chloroquine	TLR9	PA448948	54106	0.942
NULL	Diabetes_Care_2009_Apr_32(4)_531-540.nxml.txt.nlp	19336638	SENT151	0	0	10	10	clopidogrel	P2Y12	PA449053	64805	0.942
NULL	Oncogene_2013_Sep_26_32(39)_10_1038_onc_2012_491.nxml.txt.nlp	23108394	SENT50	12	12	7	7	epirubicin	FOXM1	PA449476	2305	0.942
NULL	Indian_J_Med_Res_2013_Mar_137(3)_527-532.nxml.txt.nlp	23640560	SENT34	35	35	23	23	cisplatin	PARP-1	PA449014	25976	0.942
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_O4.nxml.txt.nlp	NULL	SENT17	14	14	6	6	allopurinol	HLA-B	PA448320	3106	0.942
NULL	Drug_Target_Insights_2011_Jun_7_5_11-32.nxml.txt.nlp	22087060	SENT155	13	13	2	2	vincristine	Hsp90	PA451879	3320	0.942
NULL	Cancer_Cell_Int_2013_Jun_26_13_63.nxml.txt.nlp	23800022	SENT120	19	19	2	2	genistein	MDM2	PA165109660	4193	0.942
NULL	Cancer_Manag_Res_2013_Nov_21_5_387-400.nxml.txt.nlp	24294007	SENT115	37	37	32	32	vemurafenib	EGFR	PA165946873	1956	0.942
NULL	J_Int_Soc_Sports_Nutr_2010_Sep_15_7(Suppl_1)_P22.nxml.txt.nlp	NULL	SENT10	1	1	15	15	l-arginine	ANOVA	PA448478	4858	0.942
NULL	Oncogene_2014_Aug_28_33(35)_4396-4406.nxml.txt.nlp	24531714	SENT73	32	32	5	5	hydroxyurea	p53	PA449942	7157	0.942
NULL	Oxid_Med_Cell_Longev_2013_Mar_18_2013_746432.nxml.txt.nlp	23577226	SENT53	39	39	33	33	cisplatin	NRF2	PA449014	2551;4780	0.942
NULL	Biomed_Res_Int_2013_Nov_6_2013_798164.nxml.txt.nlp	24308005	SENT5	15	15	33	33	tacrolimus	BCL6	PA451578	604	0.942
NULL	Exp_Ther_Med_2015_Jan_11_9(1)_17-24.nxml.txt.nlp	25452770	SENT201	14	14	3	3	trastuzumab	HER-2	PA451743	2064	0.942
NULL	Oncogenesis_2014_Dec_15_3(12)_e133.nxml.txt.nlp	25500906	SENT66	24	24	15	15	trastuzumab	HER2	PA451743	2064	0.942
NULL	Cell_Biol_Int_Rep_(2010)_2012_Jun_21_19(1)_e00017.nxml.txt.nlp	23124518	SENT97	3	3	21	21	etoposide	Mcl-1	PA449552	4170	0.942
NULL	Amino_Acids_2014_Feb_20_46(5)_1275-1283.nxml.txt.nlp	24553827	SENT184	20	20	6	6	taurine	Met	PA451590	79811	0.942
NULL	Breast_Cancer_Res_2012_Feb_14_14(1)_R30.nxml.txt.nlp	22333315	SENT40	3	3	21	21	celecoxib	COX	PA448871	1351	0.942
NULL	Cell_Biochem_Biophys_2013_May_24_66(1)_53-63.nxml.txt.nlp	22918821	SENT269	36	36	27	27	lubiprostone	ClC-2	PA164777012	1181	0.942
NULL	Ann_Oncol_2011_Aug_27_22(8)_1736-1747.nxml.txt.nlp	21709140	SENT205	20	20	13	13	tamoxifen	aromatase	PA451581	1588	0.942
NULL	Reprod_Biol_Endocrinol_2013_Feb_26_11_15.nxml.txt.nlp	23442442	SENT143	5	5	14	14	l-arginine	BCL2	PA448478	596	0.942
NULL	Biologics_2010_May_25_4_119-129.nxml.txt.nlp	20531968	SENT5	0	0	7	7	ustekinumab	p40	PA166048654	3921;339541;10314	0.942
NULL	Int_J_Gen_Med_2012_Nov_9_5_935-942.nxml.txt.nlp	23204857	SENT8	36	36	4	4	isoflurane	AIDA	PA450106	64853	0.942
NULL	Breast_Cancer_Res_2013_Nov_6_15(6)_R105.nxml.txt.nlp	24192331	SENT36	6	6	22	22	tamoxifen	aromatase	PA451581	1588	0.942
NULL	Oncotarget_2012_Mar_3_3(2)_118-131.nxml.txt.nlp	22392765	SENT17	9	9	19	19	sorafenib	VEGFR	PA7000	3791	0.942
NULL	Br_J_Cancer_2011_May_10_104(10)_1558-1563.nxml.txt.nlp	21522148	SENT3	17	17	23	23	tamoxifen	aromatase	PA451581	1588	0.942
NULL	Clin_Interv_Aging_2009_May_14_4_197-205.nxml.txt.nlp	19503782	SENT195	17	17	27	27	idarubicin	CD33	PA449961	945	0.942
NULL	J_Vet_Pharmacol_Ther_2014_Oct_10_37(5)_421-434.nxml.txt.nlp	24611573	SENT302	31	31	2	2	coumarin	CYP3A4	PA134521193	1576	0.942
NULL	Arthritis_Res_Ther_2013_Oct_17_15(5)_R154.nxml.txt.nlp	24286344	SENT245	10	10	5	5	ivermectin	P2X4	PA450133	5025	0.942
NULL	Br_J_Pharmacol_2014_Feb_24_171(1)_1019-1032.nxml.txt.nlp	24251620	SENT176	8	8	6	6	nifedipine	TRPM3	PA450631	80036	0.942
NULL	J_Hematol_Oncol_2013_Jan_17_6_8.nxml.txt.nlp	23327547	SENT45	38	38	20	20	sulindac	p53	PA451565	7157	0.942
NULL	Contemp_Oncol_(Pozn)_2012_Nov_20_16(5)_363-370.nxml.txt.nlp	23788912	SENT64	25	25	2	2	vemurafenib	BRAF	PA165946873	673	0.942
NULL	Breast_Cancer_Res_2005_Jul_27_7(5)_R765-R774.nxml.txt.nlp	16168122	SENT26	20	20	12	12	topotecan	p53	PA451729	7157	0.942
NULL	Ann_Oncol_2011_Mar_8_22(3)_503-514.nxml.txt.nlp	20616198	SENT301	6	6	11	11	exemestane	aromatase	PA449563	1588	0.942
NULL	Int_J_Biol_Sci_2013_Mar_7_9(3)_279-288.nxml.txt.nlp	23493630	SENT18	15	15	1	1	tocilizumab	IL-21	PA165292659	59067;50616;27189	0.942
NULL	Oncol_Lett_2015_Feb_3_9(2)_757-761.nxml.txt.nlp	25621047	SENT103	30	30	7	7	olaparib	RAD51		5888	0.942
NULL	Breast_Cancer_Res_2004_Nov_7_6(1)_R24-R30.nxml.txt.nlp	14680497	SENT106	13	13	0	0	tamoxifen	HER2	PA451581	2064	0.942
NULL	Basic_Clin_Neurosci_2014_Winter_5(1)_66-73.nxml.txt.nlp	25436086	SENT80	8	8	14	14	lidocaine	LHA	PA450226	1081	0.942
NULL	Ann_Med_Health_Sci_Res_2013_Apr-Jun_3(2)_238-244.nxml.txt.nlp	23919197	SENT126	2	2	12	12	caspofungin	NAC	PA164743013	22861	0.942
NULL	Ann_Oncol_2009_Nov_23_20(11)_1803-1812.nxml.txt.nlp	19549706	SENT111	11	11	23	23	sunitinib	IFN	PA162372840	3439	0.942
NULL	Br_J_Pharmacol_2008_Oct_18_155(4)_596-605.nxml.txt.nlp	18852694	SENT171	7	7	19	19	fenofibrate	SREBP2	PA449594	6721	0.942
NULL	Case_Rep_Rheumatol_2013_Dec_17_2013_923497.nxml.txt.nlp	24455384	SENT48	12	12	5	5	etanercept	IL18	PA449515	3606	0.942
NULL	J_Med_Life_2011_Feb_15_4(1)_11-20.nxml.txt.nlp	21505570	SENT190	11	11	2	2	naproxen	COX	PA450595	1351	0.942
NULL	Mol_Cancer_2012_Jun_18_11_41.nxml.txt.nlp	22709873	SENT70	42	42	16	16	lapatinib	NR3C1	PA152241907	2908	0.942
NULL	Br_J_Cancer_2013_May_28_108(10)_1957-1963.nxml.txt.nlp	23640393	SENT25	10	10	17	17	cisplatin	NACT	PA449014	284111	0.942
NULL	Mol_Cancer_2010_Nov_8_9_291.nxml.txt.nlp	21059223	SENT89	17	17	11	11	paclitaxel	ZNF217	PA450761	7764	0.942
NULL	Cancer_Cell_Int_2012_Jul_4_12_19.nxml.txt.nlp	22631225	SENT182	13	13	26	26	heparin	PPIA	PA449855	5478	0.942
NULL	J_Oncol_2010_Dec_24_2010_497429.nxml.txt.nlp	20066162	SENT74	35	35	12	12	carboplatin	AGO	PA448803	55294	0.942
NULL	Acta_Pharmacol_Sin_2009_Apr_9_30(4)_467-477.nxml.txt.nlp	19270721	SENT111	6	6	11	11	cisplatin	IL-24	PA449014	11009	0.942
NULL	Diagn_Pathol_2013_May_9_8_76.nxml.txt.nlp	23656792	SENT26	0	0	7	7	trastuzumab	HER2	PA451743	2064	0.942
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT401	14	14	5	5	dasatinib	Bcl-2	PA162372878	596	0.942
NULL	J_Cell_Mol_Med_2014_Oct_11_18(10)_2031-2043.nxml.txt.nlp	25109475	SENT352	26	26	9	9	valsartan	IL-6	PA451848	3569	0.942
NULL	Endocr_Connect_2012_Jun_8_1(1)_1-12.nxml.txt.nlp	23781298	SENT35	27	27	12	12	fenofibrate	adiponectin	PA449594	9370	0.942
NULL	Arch_Orthop_Trauma_Surg_2009_Oct_2_129(10)_1427-1432.nxml.txt.nlp	18677494	SENT111	26	26	16	16	diclofenac	COX	PA449293	1351	0.942
NULL	J_Mol_Signal_2008_Dec_1_3_18.nxml.txt.nlp	19046439	SENT51	9	9	22	22	metformin	p53	PA450395	7157	0.942
NULL	Cardiol_Res_Pract_2013_Feb_21_2013_127270.nxml.txt.nlp	23509665	SENT175	9	9	21	21	prasugrel	ADP	PA154410481	23038	0.942
NULL	J_Cardiothorac_Surg_2009_May_7_4_20.nxml.txt.nlp	19422707	SENT78	8	8	29	29	heparin	ACT	PA449855	12;11332;9457;641455	0.942
NULL	Acta_Pharmacol_Sin_2014_Aug_4_35(8)_1055-1064.nxml.txt.nlp	25066322	SENT120	9	9	19	19	chloroquine	LC3	PA448948	84557	0.942
NULL	Clin_Interv_Aging_2010_Dec_3_5_403-416.nxml.txt.nlp	21152242	SENT181	2	2	11	11	telmisartan	ACE	PA451605	1636	0.942
NULL	Breast_Cancer_Res_2012_May_3_14(3)_R71.nxml.txt.nlp	22554015	SENT274	20	20	0	0	trastuzumab	HER2	PA451743	2064	0.942
NULL	Exp_Ther_Med_2014_Sep_20_8(3)_968-972.nxml.txt.nlp	25120631	SENT112	27	27	8	8	naringin	ADP	PA151958360	23038	0.942
NULL	Allergy_Asthma_Clin_Immunol_2010_Mar_17_6(1)_5.nxml.txt.nlp	20236545	SENT79	12	12	36	36	azathioprine	IL-5	PA448515	3567	0.942
NULL	Pharmaceuticals_(Basel)_2013_Aug_21_6(8)_988-1038.nxml.txt.nlp	24276379	SENT2132	25	25	9	9	fluorouracil	UGT1A9	PA128406956	54600	0.942
NULL	Cancer_Cell_Int_2005_Jul_24_5_22.nxml.txt.nlp	16042792	SENT129	14	14	17	17	vincristine	MRP1	PA451879	4437	0.942
NULL	Mol_Cancer_2009_Aug_25_8_66.nxml.txt.nlp	19706164	SENT230	15	15	29	29	sulindac	p53	PA451565	7157	0.942
NULL	Front_Genet_2014_Oct_31_5_379.nxml.txt.nlp	25400658	SENT150	10	10	5	5	estradiol	HOTAIR	PA449503	100124700	0.942
NULL	Arthritis_Res_Ther_2009_Aug_28_11(4)_R131.nxml.txt.nlp	19715572	SENT120	7	7	10	10	rituximab	CD4	PA451261	920	0.942
NULL	Mol_Clin_Oncol_2013_Jul_15_1(4)_661-667.nxml.txt.nlp	24649225	SENT28	20	20	5	5	paclitaxel	SLC22A7	PA450761	10864	0.942
NULL	J_Cell_Mol_Med_2013_Sep_24_17(9)_1065-1087.nxml.txt.nlp	24151975	SENT253	0	0	7	7	palifermin	CD4	PA164744014	920	0.942
NULL	Arthritis_Res_Ther_2007_Jun_29_9(Suppl_1)_S3.nxml.txt.nlp	17634142	SENT125	33	33	8	8	denosumab	CTX	PA166048634	1593	0.942
NULL	Cancer_Immunol_Immunother_2013_Feb_26_62(2)_309-320.nxml.txt.nlp	22923191	SENT209	6	6	4	4	cetuximab	EGFR	PA10040	1956	0.942
NULL	Oncologist_2010_Apr_15(4)_372-381.nxml.txt.nlp	20413642	SENT185	17	17	23	23	bortezomib	EGFR	PA10252	1956	0.942
NULL	Front_Genet_2014_Feb_26_5_40.nxml.txt.nlp	24616734	SENT317	13	13	18	18	docetaxel	ADARB1	PA449383	104	0.942
NULL	Orphanet_J_Rare_Dis_2014_Dec_10_9(1)_180.nxml.txt.nlp	NULL	SENT49	9	9	13	13	glucosamine	HGSNAT	PA164747613	138050	0.942
NULL	Mol_Cells_2014_Mar_31_37(3)_226-233.nxml.txt.nlp	24625574	SENT163	29	29	9	9	etoposide	PC3	PA449552	57332;7832;5122	0.942
NULL	Contemp_Oncol_(Pozn)_2012_Feb_29_16(1)_86-89.nxml.txt.nlp	23788860	SENT98	8	8	18	18	irinotecan	DDP	PA450085	1678	0.942
NULL	Infect_Drug_Resist_2014_Dec_12_7_343-363.nxml.txt.nlp	25548523	SENT115	0	0	9	9	tigecycline	NAC	PA164746412	22861	0.942
NULL	Open_Access_J_Urol_2011_May_10_3_69-82.nxml.txt.nlp	24198638	SENT63	19	19	7	7	sorafenib	CYP3A4	PA7000	1576	0.942
NULL	Acta_Pharmacol_Sin_2010_Mar_22_31(3)_329-340.nxml.txt.nlp	20173759	SENT150	10	10	35	35	ethanol	AMPK	PA448073	5563	0.942
NULL	Avicenna_J_Phytomed_2014_May-Jun_4(3)_215-224.nxml.txt.nlp	25050319	SENT148	17	17	43	43	diclofenac	MEPI	PA449293	5276	0.942
NULL	Pharmaceuticals_(Basel)_2013_Apr_17_6(4)_557-578.nxml.txt.nlp	24276125	SENT124	4	4	8	8	ustekinumab	p40	PA166048654	3921;339541;10314	0.942
NULL	Oncoscience_2014_Mar_24_1(3)_196-204.nxml.txt.nlp	25594012	SENT22	3	3	18	18	trastuzumab	HER2	PA451743	2064	0.942
NULL	Exp_Diabetes_Res_2011_Apr_6_2011_928523.nxml.txt.nlp	21603181	SENT42	19	19	15	15	haloperidol	DRD2	PA449841	1813	0.942
NULL	Oncotarget_2014_Jun_5_5(21)_10382-10392.nxml.txt.nlp	25071015	SENT164	14	14	7	7	trastuzumab	HER2	PA451743	2064	0.942
NULL	Cancer_Manag_Res_2013_Nov_21_5_387-400.nxml.txt.nlp	24294007	SENT89	8	8	31	31	panitumumab	NRAS	PA162373091	4893	0.942
NULL	Emerg_Infect_Dis_2012_Nov_18(11)_e2.nxml.txt.nlp	23092736	SENT64	10	10	18	18	ethionamide	DST	PA164768738	667	0.942
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT119	11	11	30	30	atorvastatin	IL-6	PA448500	3569	0.942
NULL	Clin_Drug_Investig_2014_Nov_9_34(2)_107-115.nxml.txt.nlp	24214232	SENT37	3	3	12	12	paricalcitol	IMPACT	PA450798	55364	0.942
NULL	Oncol_Rep_2012_Sep_6_28(3)_785-790.nxml.txt.nlp	22825751	SENT28	25	25	7	7	erlotinib	EGFR	PA134687924	1956	0.942
NULL	Br_J_Cancer_2011_Mar_15_104(6)_941-947.nxml.txt.nlp	21407223	SENT164	15	15	22	22	sorafenib	TKR	PA7000	8277	0.941
NULL	J_Breast_Cancer_2013_Mar_31_16(1)_66-71.nxml.txt.nlp	23593084	SENT25	0	0	10	10	exemestane	aromatase	PA449563	1588	0.941
NULL	Acta_Pharmacol_Sin_2014_Aug_21_35(8)_1082-1092.nxml.txt.nlp	25047514	SENT260	3	3	21	21	letrozole	aromatase	PA450196	1588	0.941
NULL	Chem_Cent_J_2013_Mar_27_7_57.nxml.txt.nlp	23537428	SENT56	4	4	18	18	exemestane	PC3	PA449563	57332;7832;5122	0.941
NULL	Mol_Cancer_2010_Apr_29_9_95.nxml.txt.nlp	20429933	SENT65	13	13	5	5	cisplatin	p53	PA449014	7157	0.941
NULL	Cancer_Microenviron_2009_Sep_26_2(Suppl_1)_19-204.nxml.txt.nlp	NULL	SENT5029	24	24	4	4	hyaluronan	EGFR	PA165958431	1956	0.941
NULL	Indian_J_Nephrol_2011_Jan-Mar_21(1)_56-58.nxml.txt.nlp	21655173	SENT58	10	10	27	27	vincristine	CHOP	PA451879	1649	0.941
NULL	J_Cell_Mol_Med_2013_Sep_11_17(9)_1160-1172.nxml.txt.nlp	23844832	SENT300	8	8	1	1	gefitinib	EGFR	PA131301952	1956	0.941
NULL	BMB_Rep_2013_Aug_46(8)_410-415.nxml.txt.nlp	23977989	SENT54	33	33	23	23	curcumin	HO-1	PA151958596	3162	0.941
NULL	Emerg_Infect_Dis_2007_Jul_13(7)_1024-1030.nxml.txt.nlp	18214174	SENT152	10	10	34	34	linezolid	LSE	PA450233	54414	0.941
NULL	Cancer_Cell_Int_2011_Jun_1_11_15.nxml.txt.nlp	21631944	SENT193	18	18	13	13	etoposide	MICB	PA449552	4277	0.941
NULL	Mol_Cancer_2009_Nov_10_8_99.nxml.txt.nlp	19903356	SENT103	19	19	12	12	imatinib	IGFBP3	PA10804	3486	0.941
NULL	Endocr_Relat_Cancer_2014_Apr_21(2)_175-187.nxml.txt.nlp	24280133	SENT64	9	9	19	19	doxycycline	SOCS2	PA449415	8835	0.941
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_16_2012_395912.nxml.txt.nlp	23118789	SENT150	11	11	0	0	acetaminophen	UGT1A7	PA448015	54577	0.941
NULL	CNS_Spectr_2014_Apr_1_19(2)_121-133.nxml.txt.nlp	23903233	SENT199	3	3	30	30	vilazodone	5-HT1A	PA165958365	3350	0.941
NULL	Front_Oncol_2013_Oct_4_3_241.nxml.txt.nlp	24109588	SENT353	22	22	11	11	temozolomide	Rho	PA451609	29984	0.941
NULL	Mol_Cancer_2012_Jun_18_11_41.nxml.txt.nlp	22709873	SENT38	7	7	20	20	lapatinib	HER2	PA152241907	2064	0.941
NULL	Breast_Cancer_Res_2011_Mar_11_13(2)_R30.nxml.txt.nlp	21396117	SENT270	25	25	31	31	erlotinib	EGFR	PA134687924	1956	0.941
NULL	Int_J_Biol_Sci_2005_Apr_1_1(2)_51-66.nxml.txt.nlp	15951850	SENT52	22	22	5	5	carbachol	RGS2	PA448784	5997	0.941
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2010_Aug_3_3_43-51.nxml.txt.nlp	22879786	SENT84	16	16	4	4	pioglitazone	CYP2C8	PA450970	1558	0.941
NULL	J_Oncol_2012_Sep_5_2012_128608.nxml.txt.nlp	21904549	SENT157	0	0	13	13	sorafenib	FLT3	PA7000	2322	0.941
NULL	Int_J_Mol_Sci_2014_Jun_5_15(6)_10083-10100.nxml.txt.nlp	24905407	SENT5	12	12	34	34	tetracycline	ARG	PA451640	473;27	0.941
NULL	Oncotarget_2012_Sep_11_3(9)_1026-1035.nxml.txt.nlp	22976441	SENT89	42	42	31	31	etoposide	ATM	PA449552	472	0.941
NULL	Br_J_Cancer_2010_Jan_5_102(1)_151-161.nxml.txt.nlp	19935791	SENT9	19	19	24	24	cetuximab	KRAS	PA10040	3845	0.941
NULL	EMBO_Mol_Med_2012_Sep_7_4(9)_896-909.nxml.txt.nlp	22887866	SENT165	16	16	9	9	lovastatin	c-Myc	PA450272	4609	0.941
NULL	Nucleic_Acids_Res_2005_Jun_8_33(10)_3283-3291.nxml.txt.nlp	15944449	SENT156	16	16	13	13	sjg-136	XRCC3		7517	0.941
NULL	Exp_Brain_Res_2014_Jun_27_232(8)_2637-2644.nxml.txt.nlp	24969614	SENT133	10	10	36	36	ondansetron	NK1	PA450705	11126	0.941
NULL	J_Biol_Chem_2010_Aug_20_285(34)_25913-25927.nxml.txt.nlp	20452970	SENT208	2	2	28	28	iloprost	EP2	PA164746843	5732;10407	0.941
NULL	Arthritis_Res_Ther_2006_Jul_3_8(4)_216.nxml.txt.nlp	16879719	SENT105	36	36	9	9	sulfasalazine	ACR	PA451547	49	0.941
NULL	J_Antimicrob_Chemother_2014_Jul_14_69(7)_1945-1953.nxml.txt.nlp	24633206	SENT142	14	14	6	6	tigecycline	RGM	PA164746412	56963	0.941
NULL	Mol_Pain_2013_Jun_10_9_27.nxml.txt.nlp	23758830	SENT177	5	5	17	17	tetracaine	ASIC2a	PA451638	40	0.941
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Feb_5_67(Pt_3)_o573.nxml.txt.nlp	21522335	SENT67	35	35	11	11	ethanol	mol	PA448073	90527	0.941
NULL	Neural_Dev_2013_Mar_7_8_4.nxml.txt.nlp	23497494	SENT157	8	8	21	21	chlorpheniramine	FOXP2	PA448960	93986	0.941
NULL	Environ_Health_Perspect_2007_Oct_19_115(10)_1454-1459.nxml.txt.nlp	17938735	SENT20	0	0	4	4	procainamide	DNMT1	PA451108	1786	0.941
NULL	Nat_Commun_2011_Jul_19_2_402.nxml.txt.nlp	21772273	SENT117	10	10	5	5	etoposide	CHK2	PA449552	11200	0.941
NULL	J_Korean_Med_Sci_2013_Dec_26_28(12)_1716-1722.nxml.txt.nlp	24339699	SENT115	20	20	8	8	infliximab	FARR	PA452639	2395	0.941
NULL	Eur_J_Clin_Pharmacol_2013_Mar_11_69(3)_327-339.nxml.txt.nlp	22782539	SENT271	8	8	4	4	quinidine	P-gp	PA451209	5243	0.941
NULL	Exp_Lung_Res_2013_Oct_1_39(8)_336-348.nxml.txt.nlp	23919450	SENT167	17	17	2	2	thrombin	cadherin	PA451674	1015	0.941
NULL	Biomed_Res_Int_2014_Jun_24_2014_132702.nxml.txt.nlp	25050322	SENT154	0	0	28	28	metformin	AMPK	PA450395	5563	0.941
NULL	Psychiatr_Genet_2013_Aug_28_23(4)_153-162.nxml.txt.nlp	23811784	SENT197	15	15	3	3	clozapine	DRD1	PA449061	1812	0.941
NULL	Br_J_Cancer_2010_Oct_26_103(9)_1380-1390.nxml.txt.nlp	20877355	SENT176	9	9	2	2	etoposide	ASK1	PA449552	4217	0.941
NULL	Front_Genet_2014_Nov_14_5_391.nxml.txt.nlp	25452763	SENT44	27	27	23	23	cisplatin	REV1	PA449014	51455	0.941
NULL	Indian_J_Ophthalmol_2009_Mar-Apr_57(2)_91-97.nxml.txt.nlp	19237780	SENT172	16	16	13	13	rituximab	CHOP	PA451261	1649	0.941
NULL	Br_J_Cancer_2011_Mar_1_104(5)_856-862.nxml.txt.nlp	21285991	SENT28	28	28	8	8	cetuximab	BRAF	PA10040	673	0.941
NULL	Br_J_Cancer_1995_Sep_72(3)_615-619.nxml.txt.nlp	7669570	SENT11	21	21	0	0	cisplatin	EGF	PA449014	1950	0.941
NULL	Cancer_Cell_Int_2011_Mar_25_11_7.nxml.txt.nlp	21439058	SENT217	42	42	30	30	imatinib	NAC	PA10804	22861	0.941
NULL	Exp_Diabetes_Res_2012_Oct_26_2012_820989.nxml.txt.nlp	22110480	SENT135	3	3	5	5	rosiglitazone	LYRM1	PA451283	57149	0.941
NULL	J_Cell_Biol_2000_Jan_10_148(1)_173-188.nxml.txt.nlp	10629227	SENT36	31	31	10	10	estradiol	c-fos	PA449503	2353	0.941
NULL	Exp_Ther_Med_2014_Nov_29_8(5)_1473-1478.nxml.txt.nlp	25289044	SENT118	16	16	3	3	heparin	AZU	PA449855	566	0.941
NULL	Mol_Imaging_Biol_2009_Jul_31_11(4)_241-245.nxml.txt.nlp	19333655	SENT53	27	27	25	25	aprepitant	NK1	PA164747039	11126	0.941
NULL	Breast_Cancer_Res_2011_Mar_30_13(2)_R34.nxml.txt.nlp	21450081	SENT92	8	8	1	1	estradiol	adiponectin	PA449503	9370	0.941
NULL	Comp_Hepatol_2009_May_11_8_1.nxml.txt.nlp	19432992	SENT128	32	32	11	11	methylprednisolone	CYP3A4	PA450466	1576	0.941
NULL	Oncotarget_2011_Nov_9_2(11)_850-861.nxml.txt.nlp	22081665	SENT178	10	10	4	4	idarubicin	DNMT3A	PA449961	1788	0.941
NULL	J_Antimicrob_Chemother_2013_Jan_30_68(1)_17-22.nxml.txt.nlp	22941900	SENT59	3	3	16	16	tetracycline	BSAC	PA451640	57591	0.941
NULL	ISRN_Neurosci_2013_Dec_19_2013_626290.nxml.txt.nlp	25006573	SENT152	0	0	9	9	irinotecan	survivin	PA450085	332	0.941
NULL	Eur_J_Clin_Pharmacol_2012_Apr_8_68(4)_363-370.nxml.txt.nlp	21984116	SENT122	6	6	1	1	tramadol	CYP2D6	PA451735	1565	0.941
NULL	Acta_Pharmacol_Sin_2010_Jul_21_31(7)_855-860.nxml.txt.nlp	20562904	SENT12	15	15	5	5	fluconazole	CDR1	PA449653	1038	0.941
NULL	J_Physiol_2009_Feb_15_587(Pt_4)_731-744.nxml.txt.nlp	19074966	SENT157	7	7	18	18	taurine	PAT1	PA451590	10513;206358	0.941
NULL	Oncogene_2010_Jul_15_29(28)_4090-4100.nxml.txt.nlp	20473326	SENT79	6	6	16	16	doxorubicin	p53	PA449412	7157	0.941
NULL	Acta_Pharmacol_Sin_2011_Nov_10_32(11)_1402-1410.nxml.txt.nlp	21986579	SENT22	9	9	25	25	curcumin	p38	PA151958596	10598;1432;7965	0.941
NULL	ASN_Neuro_2013_Dec_18_5(5)_e00129.nxml.txt.nlp	24215544	SENT224	13	13	19	19	rosiglitazone	mitoNEET	PA451283	55847	0.941
NULL	J_Headache_Pain_2013_Feb_21_14(Suppl_1)_P210.nxml.txt.nlp	NULL	SENT5	0	0	17	17	sumatriptan	5-HT1B	PA451566	3351	0.941
NULL	Brain_Pathol_2009_Jan_19(1)_132-143.nxml.txt.nlp	19076778	SENT231	13	13	20	20	perifosine	AKT	PA165291471	207	0.941
NULL	ScientificWorldJournal_2012_Apr_26_2012_358102.nxml.txt.nlp	22645419	SENT182	22	22	3	3	captopril	AT1	PA448780	9197;185	0.941
NULL	Epidemiol_Rev_2011_Jul_27_33(1)_46-62.nxml.txt.nlp	21622851	SENT298	6	6	0	0	ramipril	DREAM	PA451223	30818	0.941
NULL	Oncotarget_2012_Nov_17_3(12)_1600-1614.nxml.txt.nlp	23307622	SENT148	6	6	1	1	erlotinib	EGFR	PA134687924	1956	0.941
NULL	Acta_Pharmacol_Sin_2014_Sep_25_35(9)_1199-1206.nxml.txt.nlp	25152024	SENT88	15	15	39	39	cisplatin	mig-2	PA449014	10979	0.941
NULL	Int_J_Cell_Biol_2013_Sep_12_2013_153634.nxml.txt.nlp	24159334	SENT140	7	7	22	22	camptothecin	EWS	PA153590860	2130	0.941
NULL	Acta_Pharmacol_Sin_2010_Aug_5_31(8)_938-943.nxml.txt.nlp	20686519	SENT133	22	22	1	1	reserpine	GML	PA451236	2765	0.941
NULL	Iran_Red_Crescent_Med_J_2014_Feb_7_16(2)_e15277.nxml.txt.nlp	24719748	SENT6	0	0	19	19	clopidogrel	ADP	PA449053	23038	0.941
NULL	Pharmaceuticals_(Basel)_2011_Nov_10_4(11)_1488-1502.nxml.txt.nlp	NULL	SENT198	27	27	13	13	trastuzumab	PTEN	PA451743	5728	0.941
NULL	Breast_Cancer_Res_2012_Aug_31_14(4)_212.nxml.txt.nlp	22963717	SENT267	43	43	25	25	tamoxifen	NCOR1	PA451581	9611	0.941
NULL	Front_Endocrinol_(Lausanne)_2014_Oct_27_5_163.nxml.txt.nlp	25386163	SENT283	10	10	25	25	risperidone	ghrelin	PA451257	51738	0.941
NULL	Basic_Clin_Neurosci_2014_Summer_5(3)_218-224.nxml.txt.nlp	25337383	SENT121	15	15	2	2	diazepam	EPM	PA449283	2054	0.941
NULL	Scientifica_(Cairo)_2012_Nov_25_2012_473829.nxml.txt.nlp	24278698	SENT387	28	28	18	18	metformin	MATE1	PA450395	55244	0.941
NULL	Arthritis_Res_Ther_2003_Oct_2_5(Suppl_4)_S17-S21.nxml.txt.nlp	15180893	SENT50	34	34	4	4	cyclophosphamide	ACR	PA449165	49	0.941
NULL	Arch_Orthop_Trauma_Surg_2009_Nov_7_129(11)_1495-1504.nxml.txt.nlp	18989686	SENT102	2	2	15	15	daptomycin	VISA	PA164768820	57506	0.941
NULL	J_Adv_Pharm_Technol_Res_2012_Oct-Dec_3(4)_202-209.nxml.txt.nlp	23378940	SENT164	20	20	5	5	pimozide	CYP3A4	PA450965	1576	0.941
NULL	J_Gen_Physiol_1964_Sep_1_48(1)_43-60.nxml.txt.nlp	14212149	SENT12	3	3	19	19	glucose	spatial	PA449773	219793	0.941
NULL	Br_J_Pharmacol_2012_Jan_165(2)_390-400.nxml.txt.nlp	21671897	SENT235	7	7	4	4	suramin	P2X7	PA10292	5027	0.941
NULL	Mol_Cancer_2009_Nov_24_8_109.nxml.txt.nlp	19930708	SENT185	8	8	15	15	exemestane	EGFR	PA449563	1956	0.941
NULL	Evid_Based_Complement_Alternat_Med_2012_Aug_5_2012_605303.nxml.txt.nlp	22919414	SENT289	4	4	26	26	resveratrol	IL-6		3569	0.941
NULL	Oncogene_2010_Jan_28_29(4)_589-596.nxml.txt.nlp	19881544	SENT128	15	15	23	23	erlotinib	San	PA134687924	80218	0.941
NULL	EMBO_J_2010_Jan_6_29(1)_68-79.nxml.txt.nlp	19927124	SENT46	7	7	1	1	tetracycline	NO66	PA451640	79697	0.941
NULL	F1000Prime_Rep_2014_Dec_1_6_117.nxml.txt.nlp	25580271	SENT66	17	17	38	38	cisplatin	EGFR	PA449014	1956	0.941
NULL	Cells_2014_Apr_29_3(2)_331-362.nxml.txt.nlp	24785347	SENT338	38	38	7	7	capsaicin	TRPA1	PA448776	8989	0.941
NULL	Oncoimmunology_2013_Sep_1_2(9)_e26011.nxml.txt.nlp	24327939	SENT142	27	27	5	5	lenalidomide	NCR2	PA162363968	9436	0.941
NULL	Oncogenesis_2014_May_26_3(5)_e103.nxml.txt.nlp	24861463	SENT92	17	17	3	3	tamoxifen	G6PD	PA451581	2539	0.941
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Apr_24_66(Pt_5)_o1139.nxml.txt.nlp	21579187	SENT73	19	19	11	11	benzaldehyde	mol	PA448571	90527	0.941
NULL	Nanoscale_Res_Lett_2010_Jul_28_5(11)_1749-1754.nxml.txt.nlp	21124643	SENT34	19	19	8	8	ethanol	FTO	PA448073	79068	0.941
NULL	Biomed_Res_Int_2014_Jan_27_2014_696107.nxml.txt.nlp	24587987	SENT220	10	10	20	20	ebselen	NAC	PA161660841	22861	0.941
NULL	Oncotarget_2014_Jun_30_5(12)_4011-4025.nxml.txt.nlp	24994117	SENT112	12	12	5	5	estradiol	WNT4	PA449503	54361	0.941
NULL	Mucosal_Immunol_2014_Mar_24_7(2)_335-347.nxml.txt.nlp	23881354	SENT7	8	8	33	33	galantamine	CD11c	PA449726	3687	0.941
NULL	Ann_Surg_Treat_Res_2014_Feb_22_86(2)_68-75.nxml.txt.nlp	24761411	SENT231	14	14	4	4	oxaliplatin	survivin	PA131285527	332	0.941
NULL	J_Vet_Med_Sci_2014_Mar_5_76(3)_431-433.nxml.txt.nlp	24189617	SENT19	4	4	13	13	clarithromycin	P-gp	PA449028	5243	0.941
NULL	Exp_Hematol_2012_Feb_40(2)_97-106.nxml.txt.nlp	22085453	SENT160	34	34	27	27	sitagliptin	DPPIV	PA164748978	2191;1803	0.941
NULL	J_Oncol_2010_Jun_3_2010_732680.nxml.txt.nlp	20613952	SENT70	0	0	14	14	lenalidomide	IL-8	PA162363968	3576	0.941
NULL	Eur_J_Clin_Pharmacol_2008_Feb_26_64(2)_133-157.nxml.txt.nlp	18224312	SENT81	12	12	6	6	warfarin	CYP2C9	PA451906	1559	0.941
NULL	Mar_Drugs_2014_Jun_27_12(7)_3818-3837.nxml.txt.nlp	24979269	SENT149	39	39	35	35	calcein	MRP1	PA132595336	4437	0.941
NULL	Breast_Cancer_(Auckl)_2009_Sep_2_3_61-75.nxml.txt.nlp	19809577	SENT138	5	5	30	30	curcumin	BRCA1	PA151958596	672	0.941
NULL	Mol_Cancer_2007_Oct_11_6_63.nxml.txt.nlp	17931419	SENT108	46	46	9	9	gefitinib	STAT3	PA131301952	6774	0.941
NULL	Br_J_Cancer_2013_Feb_19_108(3)_557-563.nxml.txt.nlp	23361053	SENT174	19	19	9	9	tamoxifen	PAK1	PA451581	5585;5058	0.941
NULL	J_Nat_Med_2013_Apr_17_67(4)_677-689.nxml.txt.nlp	23591999	SENT233	25	25	41	41	ribavirin	IFN	PA451241	3439	0.941
NULL	Curr_Med_Chem_2009_Aug_16(23)_3041-3053.nxml.txt.nlp	19689281	SENT171	27	27	8	8	napqi	IFN		3439	0.941
NULL	JAKSTAT_2012_Apr_1_1(2)_83-89.nxml.txt.nlp	24058756	SENT64	19	19	32	32	losartan	AT2	PA450268	186	0.941
NULL	ScientificWorldJournal_2014_Feb_6_2014_328513.nxml.txt.nlp	24683330	SENT98	21	21	5	5	remifentanil	IL-6	PA451232	3569	0.941
NULL	Ann_Surg_Treat_Res_2014_Feb_22_86(2)_68-75.nxml.txt.nlp	24761411	SENT123	6	6	16	16	resveratrol	survivin		332	0.941
NULL	J_Skin_Cancer_2011_Oct_11_2011_521947.nxml.txt.nlp	22007305	SENT207	27	27	12	12	dasatinib	KIT	PA162372878	3815	0.941
NULL	Curr_HIV_Res_2014_May_12(3)_174-188.nxml.txt.nlp	24862327	SENT147	14	14	42	42	hemin	MCP-1	PA449849	6347	0.941
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S272-S275.nxml.txt.nlp	21525467	SENT145	19	19	30	30	metformin	Met	PA450395	79811	0.941
NULL	Oncogene_2010_Sep_16_29(37)_5135-5145.nxml.txt.nlp	20622897	SENT153	4	4	1	1	cetuximab	EGFR	PA10040	1956	0.941
NULL	Ann_Neurosci_2010_Jul_17(3)_113-119.nxml.txt.nlp	25205886	SENT98	2	2	17	17	resveratrol	hang		374879	0.941
NULL	Mol_Cancer_2009_Nov_19_8_108.nxml.txt.nlp	19925669	SENT175	3	3	14	14	doxorubicin	CTRL	PA449412	1506	0.941
NULL	J_Med_Case_Reports_2008_May_19_2_167.nxml.txt.nlp	18489739	SENT19	23	23	4	4	cyclophosphamide	PPL	PA449165	5493	0.941
NULL	Br_J_Cancer_2013_Jun_25_108(12)_2505-2515.nxml.txt.nlp	23736036	SENT15	4	4	7	7	capecitabine	MTHFR	PA448771	4524	0.941
NULL	Oncotarget_2014_Jun_19_5(15)_6540-6551.nxml.txt.nlp	25153728	SENT116	19	19	2	2	paclitaxel	p53	PA450761	7157	0.941
NULL	Braz_J_Med_Biol_Res_2014_Mar_3_47(3)_245-251.nxml.txt.nlp	24554037	SENT140	7	7	21	21	simvastatin	gamma	PA451363	9913	0.941
NULL	Diabetes_2013_Jul_14_62(7)_2500-2508.nxml.txt.nlp	23454692	SENT257	12	12	9	9	daclizumab	IL-2	PA164764446	3558	0.941
NULL	Mol_Cancer_2013_Nov_13_12_137.nxml.txt.nlp	24225025	SENT305	35	35	13	13	irinotecan	MRP1	PA450085	4437	0.941
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT118	14	14	6	6	capsaicin	p53	PA448776	7157	0.941
NULL	Curr_Oncol_2006_Jun_13(3)_99-107.nxml.txt.nlp	17576449	SENT115	0	0	6	6	curcumin	BCL2	PA151958596	596	0.941
NULL	J_Headache_Pain_2010_Feb_10_11(1)_5-12.nxml.txt.nlp	20012125	SENT170	6	6	9	9	sumatriptan	NK1	PA451566	11126	0.941
NULL	J_Vis_Exp_2014_Jun_28_(88)_51278.nxml.txt.nlp	24998179	SENT183	11	11	8	8	verapamil	P-gp	PA451868	5243	0.941
NULL	Front_Chem_2013_Jul_12_1_10.nxml.txt.nlp	24790939	SENT59	6	6	21	21	hydroquinone	mol	PA449924	90527	0.941
NULL	Diabetes_Metab_Syndr_Obes_2009_Jun_12_2_83-90.nxml.txt.nlp	21437121	SENT22	9	9	12	12	exenatide	GLP-1	PA164749238	100125288	0.941
NULL	Case_Rep_Neurol_2014_Mar_29_6(1)_101-108.nxml.txt.nlp	24761147	SENT110	16	16	23	23	methotrexate	IVL	PA450428	3713	0.941
NULL	Diabetes_Care_2010_Nov_33(11)_2484-2485.nxml.txt.nlp	20980428	SENT36	23	23	8	8	ranibizumab	VEGF-A	PA164746012	7422	0.941
NULL	BMB_Rep_2013_Aug_46(8)_410-415.nxml.txt.nlp	23977989	SENT54	3	3	14	14	curcumin	HO-1	PA151958596	3162	0.941
NULL	Curr_Opin_Pharmacol_2013_Aug_13(4)_497-503.nxml.txt.nlp	23664091	SENT294	13	13	22	22	panitumumab	KRAS	PA162373091	3845	0.941
NULL	Arthritis_Res_Ther_2006_Feb_3_8(2)_R43.nxml.txt.nlp	16507142	SENT158	28	28	14	14	fluorescein	CXCL12	PA164746009	6387	0.941
NULL	Orphanet_J_Rare_Dis_2011_May_28_6_32.nxml.txt.nlp	21619687	SENT250	12	12	4	4	estradiol	HOXA11	PA449503	3207	0.941
NULL	Anemia_2012_Nov_8_2012_607436.nxml.txt.nlp	23198140	SENT161	21	21	0	0	capsaicin	TRPV1	PA448776	7442	0.941
NULL	Breast_Cancer_(Auckl)_2012_Feb_20_6_47-66.nxml.txt.nlp	22399860	SENT172	4	4	38	38	tamoxifen	PAK1	PA451581	5585;5058	0.941
NULL	Oxid_Med_Cell_Longev_2012_May_28_2012_386527.nxml.txt.nlp	22690271	SENT163	8	8	23	23	resveratrol	p65		5970	0.941
NULL	Breast_Cancer_Res_2007_Oct_26_9(5)_306.nxml.txt.nlp	17980055	SENT24	14	14	11	11	tamoxifen	aromatase	PA451581	1588	0.941
NULL	Arthritis_Res_Ther_2008_Mar_17_10(2)_R33.nxml.txt.nlp	18346273	SENT13	23	23	7	7	infliximab	HMGB1	PA452639	3146	0.941
NULL	Nucl_Recept_Signal_2010_Apr_16_8_e004.nxml.txt.nlp	20419060	SENT168	28	28	7	7	troglitazone	IL-6	PA451799	3569	0.941
NULL	J_Gen_Physiol_2000_Jun_1_115(6)_799-814.nxml.txt.nlp	10828252	SENT87	12	12	41	41	spermine	IRK1	PA164781199	3759	0.941
NULL	Drugs_R_D_2013_Mar_21_13(1)_29-36.nxml.txt.nlp	23322527	SENT179	14	14	4	4	risperidone	CYP2D6	PA451257	1565	0.941
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT389	26	26	8	8	heparin	FGF1	PA449855	2246	0.941
NULL	J_Exp_Med_1998_Jun_1_187(11)_1885-1892.nxml.txt.nlp	9607928	SENT168	24	24	32	32	thalidomide	CD4	PA451644	920	0.941
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_May_14_65(Pt_6)_o1257.nxml.txt.nlp	21583122	SENT58	18	18	6	6	isoniazid	mol	PA450112	90527	0.941
NULL	Eur_Respir_J_2014_Jul_23_44(1)_23-63.nxml.txt.nlp	24659544	SENT918	2	2	16	16	pyrazinamide	DST	PA451182	667	0.941
NULL	Breast_Cancer_Res_2007_Aug_8_9(4)_R50.nxml.txt.nlp	17686159	SENT193	4	4	12	12	trastuzumab	HRG	PA451743	3084;3273	0.941
NULL	Leukemia_2014_Apr_14_28(4)_961-964.nxml.txt.nlp	24418991	SENT39	36	36	15	15	nilotinib	P-gp	PA165958345	5243	0.941
NULL	Clinics_(Sao_Paulo)_2012_Jul_67(7)_827-830.nxml.txt.nlp	22892930	SENT22	6	6	26	26	midazolam	IL-6	PA450496	3569	0.941
NULL	Thorax_2014_Jul_24_69(7)_638-647.nxml.txt.nlp	24567297	SENT243	23	23	8	8	cisplatin	TRAIL	PA449014	8743	0.941
NULL	Bioinformation_2012_Jun_16_8(11)_523-528.nxml.txt.nlp	22829723	SENT128	14	14	21	21	rimonabant	CB1	PA152407999	1268	0.941
NULL	Breast_Cancer_Res_2011_Mar_11_13(2)_R30.nxml.txt.nlp	21396117	SENT251	21	21	7	7	erlotinib	BRCA1	PA134687924	672	0.941
NULL	Arthritis_Res_Ther_2010_Dec_21_12(6)_223.nxml.txt.nlp	21205285	SENT73	29	29	35	35	benzbromarone	URAT1	PA134852920	116085	0.941
NULL	Gene_Regul_Syst_Bio_2014_Mar_4_8_63-73.nxml.txt.nlp	24634581	SENT94	11	11	1	1	minocycline	MT1-MMP	PA450519	4323	0.941
NULL	Arthritis_Res_Ther_2013_Sep_27_15(5)_R138.nxml.txt.nlp	24289726	SENT397	21	21	2	2	etanercept	IL-10	PA449515	3586	0.941
NULL	Mol_Vis_2007_Mar_27_13_443-456.nxml.txt.nlp	17417605	SENT287	2	2	18	18	nifedipine	VEGF-A	PA450631	7422	0.941
NULL	Front_Neurosci_2012_Feb_21_6_26.nxml.txt.nlp	22363256	SENT137	14	14	12	12	indomethacin	COX	PA449982	1351	0.941
NULL	J_Exp_Clin_Cancer_Res_2009_Jan_7_28(1)_3.nxml.txt.nlp	19128503	SENT101	17	17	26	26	doxorubicin	PTEN	PA449412	5728	0.941
NULL	Diabetes_Care_2013_Dec_13_36(12)_4132-4139.nxml.txt.nlp	24130358	SENT110	4	4	25	25	salsalate	adiponectin	PA164745462	9370	0.941
NULL	Biomed_Res_Int_2014_Mar_6_2014_712893.nxml.txt.nlp	24734240	SENT126	11	11	14	14	ethanol	HIF-1alpha	PA448073	3091	0.941
NULL	Arthritis_Res_Ther_2006_May_5_8(3)_R83.nxml.txt.nlp	16677395	SENT143	29	29	12	12	rituximab	CD64	PA451261	2209	0.941
NULL	Acta_Pharmacol_Sin_2010_Mar_8_31(3)_382-386.nxml.txt.nlp	20140004	SENT72	39	39	27	27	pravastatin	APOE	PA451089	348	0.941
NULL	Arthritis_Res_Ther_2008_Jun_2_10(3)_111.nxml.txt.nlp	18557992	SENT35	6	6	24	24	infliximab	HMGB1	PA452639	3146	0.941
NULL	FEBS_Open_Bio_2013_Jun_27_3_291-301.nxml.txt.nlp	23905012	SENT913	3	3	21	21	collagenase	BRAF	PA449107	673	0.941
NULL	Arch_Med_Sci_2010_Dec_29_6(6)_964-970.nxml.txt.nlp	22427774	SENT106	17	17	4	4	methotrexate	IL-18	PA450428	3606	0.941
NULL	Endocrinology_2011_Jul_10_152(7)_2845-2856.nxml.txt.nlp	21558311	SENT211	20	20	23	23	indomethacin	COX	PA449982	1351	0.941
NULL	Diabetes_2013_Sep_15_62(9)_3033-3043.nxml.txt.nlp	23649519	SENT49	33	33	12	12	collagenase	CO2	PA449107	4513	0.941
NULL	J_Cancer_Prev_2013_Jun_18(2)_186-191.nxml.txt.nlp	25337545	SENT6	14	14	7	7	curcumin	CDK4	PA151958596	1019	0.941
NULL	J_Biol_Chem_2009_Sep_4_284(36)_24443-24452.nxml.txt.nlp	19561358	SENT16	17	17	1	1	mitomycin	FANCI	PA450524	55215	0.941
NULL	J_Thorac_Oncol_2014_Jun_30_9(6)_805-811.nxml.txt.nlp	24787964	SENT150	6	6	18	18	afatinib	EGFR	PA165981154	1956	0.941
NULL	Acta_Pharmacol_Sin_2010_Apr_8_31(4)_461-469.nxml.txt.nlp	20208553	SENT48	12	12	24	24	ethanol	adiponectin	PA448073	9370	0.941
NULL	EMBO_Mol_Med_2010_Nov_2(11)_472-486.nxml.txt.nlp	20976827	SENT300	27	27	7	7	tamoxifen	LGR5	PA451581	8549	0.941
NULL	Nat_Chem_Biol_2010_Apr_28_6(4)_291-299.nxml.txt.nlp	20190765	SENT111	23	23	15	15	dasatinib	LCK	PA162372878	3932	0.941
NULL	Support_Care_Cancer_2009_Sep_10_17(9)_1187-1193.nxml.txt.nlp	19205754	SENT114	6	6	22	22	dolasetron	CYP3A4	PA449390	1576	0.941
NULL	Cancer_Cell_Int_2014_Jan_29_14_10.nxml.txt.nlp	24472145	SENT197	25	25	41	41	doxorubicin	HER-2	PA449412	2064	0.941
NULL	Front_Physiol_2013_Dec_24_4_386.nxml.txt.nlp	24399968	SENT207	13	13	4	4	glibenclamide	SUR1	PA449782	6833	0.941
NULL	Pharmaceuticals_(Basel)_2012_Aug_30_5(9)_890-898.nxml.txt.nlp	24280696	SENT228	14	14	0	0	cisplatin	Hsp90	PA449014	3320	0.941
NULL	Front_Neurosci_2014_May_22_8_113.nxml.txt.nlp	24904259	SENT326	9	9	7	7	meloxicam	COX	PA450353	1351	0.941
NULL	J_Infect_Dis_2013_Dec_15_208(12)_2017-2024.nxml.txt.nlp	23945376	SENT34	23	23	6	6	artemisinin	ACT	PA165111696	12;11332;9457;641455	0.941
NULL	Clin_Med_Insights_Oncol_2012_Nov_5_6_363-373.nxml.txt.nlp	23170068	SENT101	22	22	3	3	capecitabine	DPD	PA448771	1806	0.941
NULL	Arthritis_Res_Ther_2012_Jun_12_14(3)_R141.nxml.txt.nlp	22691241	SENT166	43	43	45	45	abatacept	CTLA4	PA164747080	1493	0.941
NULL	Cell_Death_Dis_2013_Jun_13_4(6)_e664.nxml.txt.nlp	23764845	SENT50	11	11	2	2	nadh	NAC	PA164755085	22861	0.941
NULL	J_Viral_Hepat_2009_May_16(5)_315-324.nxml.txt.nlp	19243499	SENT101	14	14	0	0	imiquimod	IFN	PA449972	3439	0.941
NULL	Arthritis_Res_Ther_2010_Jul_19_12(4)_R148.nxml.txt.nlp	20642840	SENT126	13	13	1	1	etanercept	IL-17	PA449515	3605	0.941
NULL	J_Oncol_2009_Jul_14_2009_804108.nxml.txt.nlp	19636422	SENT156	17	17	10	10	cetuximab	EGFR	PA10040	1956	0.941
NULL	Exp_Diabetes_Res_2012_Sep_27_2012_210821.nxml.txt.nlp	23056035	SENT27	7	7	20	20	metformin	AMPK	PA450395	5563	0.941
NULL	ScientificWorldJournal_2013_Sep_25_2013_807284.nxml.txt.nlp	24187524	SENT7	17	17	8	8	genistein	EGFR	PA165109660	1956	0.941
NULL	Mol_Biol_Int_2014_Sep_7_2014_852748.nxml.txt.nlp	25276427	SENT123	36	36	9	9	trastuzumab	HER2	PA451743	2064	0.941
NULL	Psychiatr_Genet_2013_Aug_28_23(4)_153-162.nxml.txt.nlp	23811784	SENT187	4	4	10	10	clozapine	HTR2A	PA449061	3356	0.941
NULL	Arthritis_Res_Ther_2008_Oct_10_10(5)_224.nxml.txt.nlp	18947376	SENT182	6	6	26	26	paclitaxel	HIF-1	PA450761	29072	0.941
NULL	Br_J_Cancer_2013_Oct_15_109(8)_2167-2174.nxml.txt.nlp	24064977	SENT98	0	0	7	7	cyclophosphamide	CT26	PA449165	168400	0.941
NULL	Exp_Mol_Med_2012_Sep_30_44(9)_536-544.nxml.txt.nlp	22771771	SENT56	6	6	11	11	ns-398	p53		7157	0.941
NULL	Endocrinol_Metab_(Seoul)_2014_Sep_25_29(3)_379-387.nxml.txt.nlp	25309798	SENT106	3	3	6	6	resveratrol	SIRT1		23411	0.941
NULL	Breast_Cancer_(Auckl)_2012_Feb_20_6_47-66.nxml.txt.nlp	22399860	SENT172	4	4	20	20	tamoxifen	CEACAM6	PA451581	4680	0.941
NULL	Front_Genet_2014_Feb_26_5_40.nxml.txt.nlp	24616734	SENT317	13	13	22	22	docetaxel	BUD31	PA449383	8896	0.941
NULL	Int_J_Med_Sci_2014_May_1_11(7)_663-673.nxml.txt.nlp	24843314	SENT47	31	31	24	24	tamoxifen	aromatase	PA451581	1588	0.941
NULL	Exp_Ther_Med_2014_Apr_13_7(4)_799-803.nxml.txt.nlp	24669235	SENT76	23	23	11	11	vildagliptin	PPG	PA165958346	5552	0.941
NULL	J_Gynecol_Oncol_2013_Jul_4_24(3)_273-279.nxml.txt.nlp	23875078	SENT136	20	20	8	8	paclitaxel	COX	PA450761	1351	0.941
NULL	J_Interv_Card_Electrophysiol_2013_Apr_14_37(3)_223-231.nxml.txt.nlp	23585240	SENT76	4	4	12	12	heparin	ACT	PA449855	12;11332;9457;641455	0.941
NULL	Cancer_Metastasis_Rev_2014_Dec_28_33(1)_161-171.nxml.txt.nlp	24375389	SENT286	12	12	0	0	docetaxel	CHFR	PA449383	55743	0.941
NULL	EPMA_J_2010_Sep_20_1(3)_421-437.nxml.txt.nlp	23199086	SENT228	27	27	14	14	doxorubicin	CLPTM1	PA449412	1209	0.941
NULL	Evid_Based_Complement_Alternat_Med_2013_May_16_2013_857929.nxml.txt.nlp	23762164	SENT205	9	9	21	21	doxorubicin	p53	PA449412	7157	0.941
NULL	Acta_Pharmacol_Sin_2012_May_16_33(5)_682-690.nxml.txt.nlp	22504904	SENT121	19	19	4	4	celecoxib	Bcl-2	PA448871	596	0.941
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT3	38	38	6	6	lapatinib	HER2	PA152241907	2064	0.941
NULL	Nucleic_Acids_Res_2005_Jun_8_33(10)_3283-3291.nxml.txt.nlp	15944449	SENT434	30	30	14	14	melphalan	ERCC1	PA450354	2067	0.941
NULL	Br_J_Cancer_2010_Sep_28_103(7)_1008-1018.nxml.txt.nlp	20736947	SENT147	26	26	7	7	docetaxel	PC-3	PA449383	692094	0.941
NULL	Vet_Res_2013_Oct_2_44(1)_89.nxml.txt.nlp	24088531	SENT161	9	9	0	0	hemin	HO-1	PA449849	3162	0.941
NULL	Proteome_Sci_2009_Jan_7_7_1.nxml.txt.nlp	19126242	SENT162	7	7	0	0	choline	BHMT	PA448976	635	0.941
NULL	Nanoscale_Res_Lett_2012_Jan_5_7(1)_5.nxml.txt.nlp	22221320	SENT42	10	10	2	2	ethanol	ITO	PA448073	3160	0.941
NULL	Environ_Health_Perspect_2006_Sep_23_114(9)_1401-1406.nxml.txt.nlp	16966095	SENT24	9	9	39	39	arsenite	p53	PA452638	7157	0.941
NULL	J_Oncol_2012_Nov_10_2012_358472.nxml.txt.nlp	22131994	SENT84	30	30	18	18	thalidomide	CD31	PA451644	5175	0.941
NULL	Acta_Pharmacol_Sin_2014_Sep_4_35(9)_1188-1198.nxml.txt.nlp	25087997	SENT93	17	17	5	5	pentobarbital	TA3	PA450859	134860	0.941
NULL	Curr_Neuropharmacol_2011_Dec_9(4)_530-552.nxml.txt.nlp	22654714	SENT401	7	7	15	15	imipramine	VGF	PA449969	7425	0.941
NULL	Open_Access_J_Urol_2011_May_10_3_69-82.nxml.txt.nlp	24198638	SENT67	5	5	31	31	warfarin	UGT1A1	PA451906	54658	0.941
NULL	Ann_Hematol_2010_Sep_13_89(9)_861-871.nxml.txt.nlp	20387067	SENT230	9	9	20	20	dasatinib	CD34	PA162372878	947	0.941
NULL	Drug_Healthc_Patient_Saf_2012_Nov_29_4_173-180.nxml.txt.nlp	23236256	SENT66	38	38	48	48	amisulpride	FGA	PA162565877	2243	0.941
NULL	Oxid_Med_Cell_Longev_2013_Jun_2_2013_793525.nxml.txt.nlp	23819014	SENT125	26	26	21	21	resveratrol	PI3K		5290	0.941
NULL	Ann_Hematol_2014_Sep_12_93(1)_13-32.nxml.txt.nlp	24026426	SENT359	1	1	18	18	flucytosine	BII	PA449654	777	0.941
NULL	Br_J_Pharmacol_2014_May_11_171(9)_2385-2398.nxml.txt.nlp	24467222	SENT215	31	31	11	11	rolipram	CXCL10	PA153906323	3627	0.941
NULL	BMB_Rep_2013_Feb_46(2)_86-91.nxml.txt.nlp	23433110	SENT150	9	9	0	0	nadh	DHPR	PA164755085	5860	0.941
NULL	Behav_Neurol_2014_Nov_16_2014_360978.nxml.txt.nlp	25477708	SENT54	1	1	20	20	nicotine	P56	PA450626	8999	0.941
NULL	Adv_Pharmacol_Sci_2013_Dec_5_2013_387071.nxml.txt.nlp	24381587	SENT118	0	0	24	24	curcumin	TNF	PA151958596	7124	0.941
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT10	40	40	4	4	cisplatin	p53	PA449014	7157	0.941
NULL	Cell_Death_Differ_2010_Oct_30_17(10)_1624-1635.nxml.txt.nlp	20431602	SENT120	31	31	25	25	paclitaxel	Bcl-2	PA450761	596	0.941
NULL	Chemother_Res_Pract_2011_Sep_25_2011_730360.nxml.txt.nlp	22295205	SENT212	5	5	22	22	trastuzumab	HER2	PA451743	2064	0.941
NULL	Cell_Commun_Signal_2011_May_20_9_14.nxml.txt.nlp	21599982	SENT73	22	22	0	0	pp2	CD40		958	0.941
NULL	Cancer_Sci_2012_Nov_17_103(11)_1907-1912.nxml.txt.nlp	22809142	SENT136	20	20	11	11	decitabine	RASD1	PA164749631	51655	0.941
NULL	J_Biol_Chem_2008_Jun_20_283(25)_17194-17204.nxml.txt.nlp	18442977	SENT273	24	24	13	13	fluoxetine	NR1	PA449673	27158	0.941
NULL	Mol_Cancer_2007_Oct_22_6_66.nxml.txt.nlp	17953743	SENT197	38	38	5	5	cisplatin	Mcl-1	PA449014	4170	0.941
NULL	Evid_Based_Complement_Alternat_Med_2004_Sep_1(2)_207-209.nxml.txt.nlp	15480447	SENT43	35	35	1	1	cisplatin	HER-2	PA449014	2064	0.941
NULL	JAKSTAT_2013_Apr_1_2(2)_e23092.nxml.txt.nlp	24058802	SENT85	15	15	1	1	lipase	IFN	PA450239	3439	0.941
NULL	Mol_Biol_Rep_2013_May_11_40(8)_5013-5026.nxml.txt.nlp	23666059	SENT170	16	16	2	2	resveratrol	PPM1D		8493	0.941
NULL	Breast_Cancer_Res_2013_Oct_18_15(5)_R97.nxml.txt.nlp	24135425	SENT20	6	6	8	8	tamoxifen	aromatase	PA451581	1588	0.941
NULL	J_Hematol_Oncol_2013_Jan_15_6_5.nxml.txt.nlp	23320987	SENT138	17	17	10	10	heparin	PI-PLC	PA449855	2923	0.941
NULL	Ann_Med_2014_Nov_21_46(7)_475-489.nxml.txt.nlp	25045928	SENT150	27	27	22	22	clopidogrel	P2Y12	PA449053	64805	0.941
NULL	Breast_Cancer_(Auckl)_2011_Jan_13_5_1-14.nxml.txt.nlp	21494397	SENT42	0	0	16	16	ixabepilone	CYP3A4		1576	0.941
NULL	Mol_Pain_2013_Nov_28_9_60.nxml.txt.nlp	24283218	SENT266	23	23	29	29	capsaicin	TRPV1	PA448776	7442	0.941
NULL	J_Thorac_Oncol_2014_Sep_22_9(9)_1345-1353.nxml.txt.nlp	25122430	SENT149	19	19	27	27	gefitinib	EGFR	PA131301952	1956	0.941
NULL	J_Exerc_Rehabil_2014_Apr_30_10(2)_60-68.nxml.txt.nlp	24877039	SENT26	14	14	26	26	nebivolol	adiponectin	PA151958426	9370	0.941
NULL	J_Korean_Med_Sci_2010_Aug_21_25(8)_1222-1227.nxml.txt.nlp	20676337	SENT64	23	23	17	17	aminophylline	LPA	PA164781029	4018	0.941
NULL	Ann_Rheum_Dis_2013_Sep_14_72(9)_1488-1495.nxml.txt.nlp	22984173	SENT222	11	11	15	15	trastuzumab	HER2	PA451743	2064	0.941
NULL	Avicenna_J_Phytomed_2013_Spring_3(2)_159-170.nxml.txt.nlp	25050270	SENT61	13	13	4	4	ketamine	CO2	PA450144	4513	0.941
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT605	4	4	16	16	amisulpride	PRL	PA162565877	5617	0.941
NULL	Mol_Cytogenet_2014_Feb_27_7_15.nxml.txt.nlp	24576355	SENT30	30	30	28	28	hydroquinone	CYP2E1	PA449924	1571	0.941
NULL	Br_J_Cancer_2009_Mar_10_100(5)_811-816.nxml.txt.nlp	19259096	SENT59	8	8	10	10	tamoxifen	aromatase	PA451581	1588	0.941
NULL	Clin_Exp_Otorhinolaryngol_2011_Mar_17_4(1)_18-23.nxml.txt.nlp	21461058	SENT96	7	7	18	18	furosemide	KCC2	PA449719	57468	0.941
NULL	Front_Aging_Neurosci_2014_Sep_18_6_245.nxml.txt.nlp	25278877	SENT211	13	13	5	5	doxycycline	ADAM12	PA449415	8038	0.941
NULL	Cancer_Cell_Int_2011_Nov_17_11_40.nxml.txt.nlp	22088142	SENT180	20	20	8	8	gemcitabine	MAPK14	PA449748	1432	0.941
NULL	Med_Sci_Monit_2013_Oct_31_19_916-926.nxml.txt.nlp	24172537	SENT113	34	34	7	7	melphalan	FANCG	PA450354	2189	0.941
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT120	22	22	19	19	pertuzumab	HER2		2064	0.941
NULL	Oncologist_2010_Sep_24_15(9)_924-934.nxml.txt.nlp	20736298	SENT21	8	8	12	12	lapatinib	HER-2	PA152241907	2064	0.941
NULL	Lipids_Health_Dis_2011_Feb_28_10_38.nxml.txt.nlp	21352602	SENT84	35	35	25	25	atorvastatin	PCSK9	PA448500	255738	0.941
NULL	EMBO_Mol_Med_2012_Jul_11_4(7)_577-593.nxml.txt.nlp	22496117	SENT67	12	12	25	25	staurosporine	PAP-1	PA165109623	6100	0.941
NULL	Breast_Cancer_Res_2011_Apr_21_13(2)_R46.nxml.txt.nlp	21510863	SENT24	9	9	21	21	trastuzumab	HER2	PA451743	2064	0.941
NULL	Adv_Hematol_2012_May_8_2012_393864.nxml.txt.nlp	22851972	SENT191	12	12	2	2	lenalidomide	CD40	PA162363968	958	0.941
NULL	Cancer_Immunol_Immunother_2013_Jul_20_62(9)_1533-1545.nxml.txt.nlp	23873089	SENT115	25	25	11	11	ixabepilone	CD4		920	0.941
NULL	Case_Rep_Crit_Care_2014_Aug_19_2014_242703.nxml.txt.nlp	25215245	SENT105	5	5	0	0	nicardipine	APE	PA450620	55704;328	0.941
NULL	EJC_Suppl_2013_Sep_5_11(2)_307-309.nxml.txt.nlp	NULL	SENT115	2	2	13	13	erlotinib	EGFR	PA134687924	1956	0.941
NULL	Acta_Pharmacol_Sin_2014_Jun_4_35(6)_752-757.nxml.txt.nlp	24902786	SENT91	21	21	5	5	flutamide	STL2	PA449685	1301	0.941
NULL	Nat_Commun_2013_Oct_1_4_2516.nxml.txt.nlp	24084631	SENT644	14	14	11	11	losartan	CCN2	PA450268	1490	0.941
NULL	Biomed_Res_Int_2013_Nov_28_2013_789184.nxml.txt.nlp	24369535	SENT114	0	0	7	7	imatinib	CYP3A4	PA10804	1576	0.941
NULL	Korean_J_Urol_2010_Dec_21_51(12)_863-869.nxml.txt.nlp	21221208	SENT58	18	18	10	10	rituximab	ABO	PA451261	28	0.941
NULL	Open_Cardiovasc_Med_J_2007_Nov_14_1_22-26.nxml.txt.nlp	18949087	SENT58	12	12	6	6	eprosartan	PON1	PA449481	5444	0.941
NULL	Oncoimmunology_2012_Oct_1_1(7)_1218-1219.nxml.txt.nlp	23170286	SENT13	2	2	27	27	bortezomib	CD83	PA10252	9308	0.941
NULL	J_Clin_Biochem_Nutr_2009_Jul_30_45(1)_37-43.nxml.txt.nlp	19590705	SENT170	24	24	16	16	taurine	TNF-alpha	PA451590	7124	0.941
NULL	Arthritis_Res_Ther_2010_Jan_28_12(1)_R17.nxml.txt.nlp	20109177	SENT48	17	17	10	10	l-glutamine	CO2	PA10090	4513	0.941
NULL	Mol_Cancer_2014_Jun_4_13_141.nxml.txt.nlp	24894453	SENT74	5	5	45	45	cetuximab	EGFR	PA10040	1956	0.941
NULL	Cell_Commun_Signal_2014_Oct_5_12(1)_54.nxml.txt.nlp	NULL	SENT90	17	17	4	4	fasudil	MRCK	PA165946121	8476	0.941
NULL	Biomed_Res_Int_2013_Jul_18_2013_603782.nxml.txt.nlp	23971041	SENT138	6	6	23	23	latanoprost	BAK	PA164774763	578	0.941
NULL	Evid_Based_Complement_Alternat_Med_2015_Jan_6_2015_736431.nxml.txt.nlp	25632290	SENT118	19	19	6	6	curcumin	P-gp	PA151958596	5243	0.941
NULL	Ann_Rheum_Dis_2008_May_21_68(2)_175-182.nxml.txt.nlp	18495735	SENT80	22	22	14	14	infliximab	IL-6	PA452639	3569	0.941
NULL	Cancer_Cell_Int_2013_Apr_16_13_36.nxml.txt.nlp	23590596	SENT9	33	33	17	17	doxorubicin	PI3K	PA449412	5290	0.941
NULL	Braz_J_Med_Biol_Res_2013_Apr_12_46(4)_327-338.nxml.txt.nlp	23579631	SENT210	23	23	16	16	estradiol	SON	PA449503	6651	0.941
NULL	J_Thorac_Oncol_2014_Jun_30_9(6)_805-811.nxml.txt.nlp	24787964	SENT176	9	9	21	21	afatinib	EGFR	PA165981154	1956	0.941
NULL	Pharm_Pract_(Granada)_2011_Mar_15_Jan-Mar_9(1)_1-10.nxml.txt.nlp	25132883	SENT156	2	2	15	15	rivaroxaban	SPAF	PA165958360	166378	0.941
NULL	Br_J_Cancer_2012_Sep_4_107(6)_947-955.nxml.txt.nlp	22892392	SENT213	23	23	6	6	tamoxifen	BCAR4	PA451581	400500	0.941
NULL	Cancer_Cell_2007_Dec_11_12(6)_514-527.nxml.txt.nlp	18068629	SENT79	20	20	2	2	paclitaxel	TGFBI	PA450761	7045	0.941
NULL	Breast_Cancer_Res_2011_Jan_21_13(1)_R9.nxml.txt.nlp	21255398	SENT202	21	21	2	2	cyclophosphamide	RAD21	PA449165	5885	0.941
NULL	Exp_Mol_Med_2012_Sep_30_44(9)_562-570.nxml.txt.nlp	22809900	SENT26	14	14	31	31	rosiglitazone	adiponectin	PA451283	9370	0.941
NULL	Hum_Genomics_2009_Dec_1_4(2)_91-106.nxml.txt.nlp	20038497	SENT247	1	1	21	21	donepezil	APOE	PA449394	348	0.941
NULL	Exp_Ther_Med_2014_Nov_29_8(5)_1473-1478.nxml.txt.nlp	25289044	SENT112	18	18	10	10	heparin	AZU	PA449855	566	0.941
NULL	Evid_Based_Complement_Alternat_Med_2011_Jan_9_2011_619650.nxml.txt.nlp	21799685	SENT141	16	16	34	34	ketanserin	5-HT2A	PA131053734	3356	0.941
NULL	Br_J_Pharmacol_2010_Sep_161(2)_288-307.nxml.txt.nlp	20735416	SENT247	27	27	15	15	halothane	TREK-1	PA449845	3776	0.941
NULL	J_Clin_Biochem_Nutr_2008_Mar_1_42(2)_71-75.nxml.txt.nlp	18385822	SENT27	22	22	12	12	omeprazole	CD11b	PA450704	3684	0.941
NULL	Indian_J_Endocrinol_Metab_2012_Dec_16(Suppl_2)_S242-S244.nxml.txt.nlp	23565389	SENT46	28	28	31	31	metformin	DPPIV	PA450395	2191;1803	0.941
NULL	Br_J_Cancer_2010_May_11_102(10)_1456-1460.nxml.txt.nlp	20461090	SENT74	5	5	12	12	temsirolimus	IFN	PA164746890	3439	0.941
NULL	Exp_Hematol_Oncol_2014_Jun_13_3_16.nxml.txt.nlp	24949228	SENT170	38	38	28	28	imatinib	IKZF1	PA10804	10320	0.941
NULL	J_Immunol_Res_2014_Apr_28_2014_286170.nxml.txt.nlp	24868562	SENT110	5	5	16	16	docetaxel	CD4	PA449383	920	0.941
NULL	Eur_J_Clin_Pharmacol_2014_Oct_8_70(1)_37-45.nxml.txt.nlp	24100471	SENT15	8	8	30	30	omeprazole	CYP2C8	PA450704	1558	0.941
NULL	Br_J_Cancer_2012_Oct_9_107(8)_1277-1285.nxml.txt.nlp	22990652	SENT163	5	5	8	8	axitinib	CYP1A2	PA164924493	1544	0.941
NULL	Front_Physiol_2013_Jul_5_4_159.nxml.txt.nlp	23847541	SENT746	3	3	14	14	bevacizumab	CXCL6	PA130232992	6372	0.941
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT115	7	7	16	16	doxorubicin	B7-H1	PA449412	29126	0.941
NULL	Oncotarget_2013_Jun_29_4(9)_1338-1348.nxml.txt.nlp	23907514	SENT66	3	3	31	31	doxorubicin	PSMA4	PA449412	5685	0.941
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1126-1134.nxml.txt.nlp	21364592	SENT132	44	44	11	11	platinum	ERCC1	PA150595617	2067	0.941
NULL	Oncogene_2014_Sep_18_33(38)_4685-4696.nxml.txt.nlp	24121268	SENT257	7	7	23	23	nutlin-3	p53		7157	0.941
NULL	Nat_Med_2013_Mar_10_19(3)_313-321.nxml.txt.nlp	23396211	SENT72	19	19	13	13	amlexanox	TBK1	PA164745310	29110	0.941
NULL	Acta_Odontol_Scand_2013_Mar_8_71(2)_312-316.nxml.txt.nlp	22564045	SENT21	8	8	10	10	benzbromarone	URAT1	PA134852920	116085	0.941
NULL	Mol_Cancer_2012_Sep_14_11_69.nxml.txt.nlp	22978347	SENT43	33	33	13	13	letrozole	TOP2A	PA450196	7153	0.941
NULL	Mol_Vis_2012_Nov_29_18_2839-2846.nxml.txt.nlp	23233786	SENT121	6	6	15	15	geldanamycin	CB2	PA152031327	1269	0.941
NULL	Breast_Cancer_Res_2002_Aug_27_4(6)_213-217.nxml.txt.nlp	12473165	SENT27	18	18	5	5	tamoxifen	aromatase	PA451581	1588	0.941
NULL	Acta_Pharmacol_Sin_2010_Aug_19_31(8)_999-1004.nxml.txt.nlp	20644548	SENT92	14	14	17	17	metoprolol	CYP2D6	PA450480	1565	0.941
NULL	Croat_Med_J_2013_Apr_54(2)_171-179.nxml.txt.nlp	23630144	SENT113	30	30	25	25	taurine	STZ	PA451590	6484	0.941
NULL	Mol_Cancer_2012_Sep_14_11_69.nxml.txt.nlp	22978347	SENT43	33	33	7	7	letrozole	TRAP1	PA450196	9392;10131	0.941
NULL	Curr_Neuropharmacol_2009_Sep_7(3)_160-179.nxml.txt.nlp	20190959	SENT317	26	26	3	3	tamoxifen	P2X7	PA451581	5027	0.941
NULL	Front_Mol_Neurosci_2013_Jul_5_6_16.nxml.txt.nlp	23847466	SENT10	38	38	8	8	propylthiouracil	TAS2R38	PA451156	5726	0.941
NULL	Front_Neurosci_2014_Jun_3_8_128.nxml.txt.nlp	24917782	SENT808	19	19	27	27	ethanol	MC3	PA448073	4159	0.941
NULL	J_Neuroinflammation_2010_Sep_7_7_51.nxml.txt.nlp	20822529	SENT101	14	14	27	27	hemin	HO-1	PA449849	3162	0.941
NULL	Mol_Cancer_2009_May_15_8_28.nxml.txt.nlp	19445670	SENT80	35	35	7	7	doxorubicin	Bcl-2	PA449412	596	0.941
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S258-S263.nxml.txt.nlp	21525465	SENT205	18	18	30	30	metformin	Met	PA450395	79811	0.941
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_55-78.nxml.txt.nlp	19305788	SENT349	4	4	39	39	memantine	ERG	PA10364	2078	0.941
NULL	Diabetes_Metab_Syndr_Obes_2014_May_23_7_169-183.nxml.txt.nlp	24920930	SENT115	9	9	3	3	clopidogrel	P2Y12	PA449053	64805	0.941
NULL	Biochem_Res_Int_2010_Aug_4_2010_549572.nxml.txt.nlp	21188077	SENT150	29	29	14	14	l-isoleucine	TAT	PA164750430	6898	0.941
NULL	Br_J_Cancer_2009_Mar_10_100(5)_758-763.nxml.txt.nlp	19259094	SENT114	6	6	20	20	decitabine	HDAC	PA164749631	9734	0.941
NULL	Hematol_Rep_2013_Apr_4_5(1)_21-25.nxml.txt.nlp	23888242	SENT109	10	10	35	35	amifostine	HCST	PA448365	10870	0.941
NULL	ISRN_Cardiol_2013_Nov_6_2013_478597.nxml.txt.nlp	24307952	SENT105	22	22	15	15	enalapril	NNT	PA449456	23530	0.941
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1542-1553.nxml.txt.nlp	21970874	SENT251	30	30	16	16	pemetrexed	ERCC1	PA10810	2067	0.941
NULL	Cancer_Cell_Int_2010_Sep_9_10_32.nxml.txt.nlp	20828393	SENT203	18	18	41	41	cisplatin	ATF3	PA449014	467	0.941
NULL	Front_Oncol_2013_Nov_18_3_282.nxml.txt.nlp	24303367	SENT239	11	11	3	3	irinotecan	PARP	PA450085	142	0.941
NULL	Front_Genet_2013_Aug_29_4_163.nxml.txt.nlp	24009622	SENT50	6	6	20	20	ethanol	ABCG2	PA448073	9429	0.941
NULL	Breast_Cancer_Res_2010_Jun_24_12(3)_R41.nxml.txt.nlp	20576088	SENT157	9	9	16	16	paclitaxel	IGF1	PA450761	3479	0.941
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1137-1144.nxml.txt.nlp	20234366	SENT113	16	16	30	30	cetuximab	KRAS	PA10040	3845	0.941
NULL	Korean_J_Urol_2010_Feb_18_51(2)_139-144.nxml.txt.nlp	20414428	SENT50	26	26	20	20	fluorescein	CD86	PA164746009	942	0.941
NULL	Iran_J_Pharm_Res_2013_Winter_12(Suppl)_37-46.nxml.txt.nlp	24250670	SENT5	0	0	26	26	etoposide	P-gp	PA449552	5243	0.941
NULL	J_Korean_Med_Sci_2011_Aug_27_26(8)_1007-1013.nxml.txt.nlp	21860550	SENT19	3	3	22	22	tamoxifen	CYP2D6	PA451581	1565	0.941
NULL	J_Mol_Med_2008_Sep_4_86(9)_1045-1056.nxml.txt.nlp	18600309	SENT117	12	12	22	22	salmeterol	IL-8	PA451300	3576	0.941
NULL	Ann_Dermatol_2014_Oct_26_26(5)_645-646.nxml.txt.nlp	25324664	SENT7	21	21	13	13	methazolamide	HLA-B	PA450413	3106	0.941
NULL	Gastroenterol_Hepatol_Bed_Bench_2011_Spring_4(2)_43-52.nxml.txt.nlp	24834156	SENT104	11	11	1	1	trypsin	TATI	PA451806	6690	0.941
NULL	Front_Endocrinol_(Lausanne)_2014_Oct_9_5_166.nxml.txt.nlp	25346724	SENT120	9	9	15	15	resveratrol	SIRT1		23411	0.941
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Oct_30_66(Pt_11)_o2952.nxml.txt.nlp	21589120	SENT56	19	19	7	7	ethanol	mol	PA448073	90527	0.941
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT320	22	22	12	12	panitumumab	KRAS	PA162373091	3845	0.941
NULL	Nucleic_Acids_Res_2012_Jul_19_40(13)_5910-5925.nxml.txt.nlp	22434882	SENT327	10	10	22	22	etoposide	p53	PA449552	7157	0.941
NULL	Orphanet_J_Rare_Dis_2015_Jan_21_10(1)_1.nxml.txt.nlp	NULL	SENT221	14	14	8	8	estradiol	TRPC6	PA449503	7225	0.941
NULL	Cancer_Cell_Int_2013_Nov_20_13_117.nxml.txt.nlp	24257075	SENT206	19	19	8	8	lenalidomide	CD44	PA162363968	960	0.941
NULL	J_Hematol_Oncol_2009_Apr_22_2_18.nxml.txt.nlp	19386128	SENT148	19	19	28	28	cetuximab	KRAS	PA10040	3845	0.941
NULL	Clin_Epidemiol_2014_Oct_24_6_379-393.nxml.txt.nlp	25368531	SENT145	19	19	0	0	etanercept	TNF	PA449515	7124	0.941
NULL	Clin_Epidemiol_2014_Oct_24_6_379-393.nxml.txt.nlp	25368531	SENT145	24	24	0	0	adalimumab	TNF	PA10004	7124	0.941
NULL	Breast_Cancer_Res_2005_Nov_11_7(6)_255-257.nxml.txt.nlp	16457700	SENT15	43	43	11	11	anastrozole	ATAC	PA448432	6375	0.941
NULL	Diabetes_Care_2008_Oct_31(10)_1939-1944.nxml.txt.nlp	18599530	SENT152	17	17	10	10	gliclazide	KCNJ11	PA10892	3767	0.941
NULL	Int_J_Gen_Med_2009_Jul_30_2_129-140.nxml.txt.nlp	20360896	SENT9	31	31	4	4	tamoxifen	aromatase	PA451581	1588	0.941
NULL	Acta_Pharmacol_Sin_2011_Nov_10_32(11)_1402-1410.nxml.txt.nlp	21986579	SENT157	42	42	21	21	curcumin	CDK2	PA151958596	1017	0.941
NULL	Br_J_Cancer_2013_Feb_19_108(3)_587-596.nxml.txt.nlp	23322202	SENT62	31	31	1	1	glucose	U87	PA449773	677775;641648	0.941
NULL	Case_Rep_Hematol_2012_Mar_26_2012_746098.nxml.txt.nlp	22928128	SENT67	7	7	1	1	vincristine	CHOP	PA451879	1649	0.941
NULL	Neural_Regen_Res_2013_Jul_15_8(20)_1853-1862.nxml.txt.nlp	25206494	SENT186	13	13	10	10	ethanol	p53	PA448073	7157	0.941
NULL	Cell_Death_Dis_2014_Apr_24_5(4)_e1197.nxml.txt.nlp	24763054	SENT89	20	20	23	23	doxorubicin	RUNX3	PA449412	864	0.941
NULL	J_Hematol_Oncol_2013_Jul_18_6_53.nxml.txt.nlp	23866964	SENT124	22	22	20	20	temsirolimus	MTOR	PA164746890	2475	0.941
NULL	Mol_Cancer_2012_Mar_21_11_13.nxml.txt.nlp	22436134	SENT54	28	28	12	12	cisplatin	HuR	PA449014	1994	0.941
NULL	Chem_Cent_J_2014_Jan_3_8_1.nxml.txt.nlp	24386928	SENT140	24	24	1	1	trypsin	PC3	PA451806	57332;7832;5122	0.941
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT121	4	4	18	18	cisplatin	p53	PA449014	7157	0.941
NULL	Front_Oncol_2014_Mar_6_4_40.nxml.txt.nlp	24639951	SENT408	14	14	18	18	paclitaxel	P-gp	PA450761	5243	0.941
NULL	Br_J_Cancer_2011_Mar_1_104(5)_741-745.nxml.txt.nlp	21266975	SENT91	2	2	8	8	temsirolimus	TORC1	PA164746890	23373	0.941
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT1	0	0	26	26	resveratrol	SIRT1		23411	0.941
NULL	Drugs_Aging_2012_Nov_5_29(11)_863-869.nxml.txt.nlp	23038608	SENT101	31	31	9	9	pregabalin	NNT	PA164754814	23530	0.941
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT118	28	28	8	8	trastuzumab	STAT3	PA451743	6774	0.941
NULL	Cell_Cycle_2012_Nov_1_11(21)_3983-3996.nxml.txt.nlp	22987153	SENT86	30	30	37	37	cisplatin	FANCD2	PA449014	2177	0.941
NULL	Indian_J_Pharmacol_2009_Aug_41(4)_167-172.nxml.txt.nlp	20523867	SENT139	38	38	19	19	acetaminophen	CYP2C9	PA448015	1559	0.941
NULL	Anal_Bioanal_Chem_2011_Mar_13_399(8)_2623-2634.nxml.txt.nlp	21225246	SENT263	17	17	10	10	vinblastine	spatial	PA451877	219793	0.941
NULL	J_Korean_Med_Sci_2012_Sep_22_27(9)_1037-1043.nxml.txt.nlp	22969249	SENT112	16	16	6	6	paricalcitol	p65	PA450798	5970	0.941
NULL	J_Nutr_Metab_2011_Jun_1_2011_708183.nxml.txt.nlp	21773024	SENT132	0	0	9	9	metformin	DM2	PA450395	28508	0.941
NULL	J_Hematol_Oncol_2013_Feb_17_6_17.nxml.txt.nlp	23414938	SENT173	32	32	17	17	prasugrel	P2Y12	PA154410481	64805	0.941
NULL	Biomed_Res_Int_2014_Jun_2_2014_946492.nxml.txt.nlp	24991574	SENT157	2	2	30	30	olmesartan	IL-6	PA164742950	3569	0.941
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT5	9	9	5	5	dasatinib	CML	PA162372878	613	0.941
NULL	Oncogene_2010_Sep_16_29(37)_5193-5203.nxml.txt.nlp	20581867	SENT169	37	37	30	30	lapatinib	HRG	PA152241907	3084;3273	0.941
NULL	J_Ginseng_Res_2011_Nov_35(4)_471-478.nxml.txt.nlp	23717094	SENT47	2	2	25	25	ethanol	CaCC	PA448073	1179	0.941
NULL	Clin_Ophthalmol_2010_May_14_4_467-469.nxml.txt.nlp	20505840	SENT5	10	10	6	6	triamcinolone	ERM	PA451749	2119	0.941
NULL	Evid_Based_Complement_Alternat_Med_2011_Jan_20_2011_751671.nxml.txt.nlp	21318106	SENT139	6	6	17	17	tacrolimus	P-gp	PA451578	5243	0.941
NULL	Basic_Res_Cardiol_2014_May_22_109(4)_416.nxml.txt.nlp	24847907	SENT170	3	3	34	34	diazoxide	GAPDH	PA449285	2597	0.941
NULL	Case_Rep_Rheumatol_2011_Dec_15_2011_185657.nxml.txt.nlp	22937439	SENT14	24	24	11	11	etanercept	IL-6	PA449515	3569	0.941
NULL	Oncogene_2014_Mar_20_33(12)_1590-1600.nxml.txt.nlp	23542178	SENT13	6	6	28	28	imatinib	BRAF	PA10804	673	0.941
NULL	Cell_Death_Dis_2013_Jun_13_4(6)_e664.nxml.txt.nlp	23764845	SENT247	3	3	15	15	nadh	ACPA	PA164755085	5657	0.941
NULL	Mol_Cancer_2014_Jun_9_13_146.nxml.txt.nlp	24913494	SENT254	3	3	15	15	metformin	MID1	PA450395	4281	0.941
NULL	Breast_Cancer_Res_2008_Feb_29_10(1)_R21.nxml.txt.nlp	18312651	SENT30	26	26	31	31	tamoxifen	aromatase	PA451581	1588	0.941
NULL	J_Infect_Dis_2014_Oct_1_210(7)_1029-1041.nxml.txt.nlp	24706936	SENT192	14	14	4	4	dextran	p75	PA449261	7133;11168	0.941
NULL	eLife_2014_May_6_3_e02482.nxml.txt.nlp	24843002	SENT246	24	24	12	12	etoposide	53BP1	PA449552	7158	0.941
NULL	Int_J_Cardiovasc_Imaging_2007_Feb_17_23(1)_61-131.nxml.txt.nlp	NULL	SENT2041	21	21	2	2	iohexol	FFR	PA450061	738	0.941
NULL	J_Orthop_Surg_2007_May_21_2_9.nxml.txt.nlp	17511887	SENT92	12	12	6	6	alendronate	DPD	PA448082	1806	0.941
NULL	Mol_Cancer_2012_Sep_25_11_73.nxml.txt.nlp	23009336	SENT256	14	14	23	23	dasatinib	PP2	PA162372878	4888	0.941
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT332	14	14	12	12	rolipram	PDE	PA153906323	501	0.941
NULL	EPMA_J_2010_Sep_4_1(3)_485-494.nxml.txt.nlp	23199090	SENT179	18	18	33	33	oxaliplatin	GSTP1	PA131285527	2950	0.941
NULL	Biomed_Res_Int_2013_Nov_6_2013_798164.nxml.txt.nlp	24308005	SENT26	31	31	8	8	praziquantel	SWAP	PA164764583	6433;50618	0.941
NULL	EPMA_J_2014_Feb_11_5(Suppl_1)_A42.nxml.txt.nlp	NULL	SENT8	20	20	4	4	cetuximab	KRAS	PA10040	3845	0.941
NULL	Int_J_Mol_Imaging_2011_Oct_26_2011_874585.nxml.txt.nlp	21490735	SENT17	15	15	5	5	tamoxifen	FDG	PA451581	23583	0.941
NULL	Arch_Orthop_Trauma_Surg_2009_Oct_2_129(10)_1427-1432.nxml.txt.nlp	18677494	SENT111	24	24	16	16	naproxen	COX	PA450595	1351	0.941
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_May_22_66(Pt_6)_o1398.nxml.txt.nlp	21579477	SENT47	18	18	6	6	ethanol	mol	PA448073	90527	0.941
NULL	Mol_Vis_2007_Jul_12_13_1130-1137.nxml.txt.nlp	17653058	SENT168	9	9	24	24	propofol	IFN	PA451141	3439	0.941
NULL	Drugs_Context_2012_Nov_19_2012_212242.nxml.txt.nlp	24432031	SENT197	15	15	27	27	dacarbazine	BRAF	PA449197	673	0.941
NULL	Int_J_Med_Sci_2013_Jun_15_10(8)_1015-1021.nxml.txt.nlp	23801888	SENT167	21	21	0	0	ribavirin	IL28B	PA451241	282617	0.941
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S31-S40.nxml.txt.nlp	20680106	SENT54	14	14	0	0	cetuximab	KRAS	PA10040	3845	0.941
NULL	Oncotarget_2014_Oct_21_5(22)_11709-11722.nxml.txt.nlp	25365944	SENT212	11	11	32	32	metformin	RhoA	PA450395	387	0.941
NULL	Nat_Chem_Biol_2010_Apr_28_6(4)_291-299.nxml.txt.nlp	20190765	SENT111	23	23	7	7	dasatinib	FYN	PA162372878	2534	0.941
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Mar_23_69(Pt_4)_o558-o559.nxml.txt.nlp	23634097	SENT83	16	16	8	8	vanillin	mol	PA451852	90527	0.941
NULL	Korean_J_Anesthesiol_2013_Dec_26_65(6_Suppl)_S1-S3.nxml.txt.nlp	24478828	SENT46	2	2	7	7	atracurium	BCHE	PA164776840	590	0.941
NULL	Front_Cell_Neurosci_2014_Jan_8_7_287.nxml.txt.nlp	24409119	SENT94	33	33	46	46	probenecid	P2X7	PA451106	5027	0.941
NULL	Cancer_Manag_Res_2011_May_10_3_157-175.nxml.txt.nlp	21625399	SENT136	7	7	27	27	tolbutamide	CYP3A4	PA451718	1576	0.941
NULL	J_Hematol_Oncol_2011_Jun_14_4_29.nxml.txt.nlp	21672194	SENT7	34	34	25	25	everolimus	VEGFR	PA164746311	3791	0.941
NULL	Oncol_Lett_2014_Sep_19_8(3)_1320-1322.nxml.txt.nlp	25120716	SENT17	16	16	5	5	gefitinib	EGFR	PA131301952	1956	0.941
NULL	Oncotarget_2013_Nov_22_5(4)_933-943.nxml.txt.nlp	24659749	SENT81	9	9	0	0	nutlin-3	AML2		864	0.941
NULL	Target_Oncol_2013_Jun_27_8(2)_127-136.nxml.txt.nlp	23625191	SENT48	23	23	4	4	panitumumab	KRAS	PA162373091	3845	0.941
NULL	Endocrinol_Diabetes_Metab_Case_Rep_2014_Dec_1_2014_140083.nxml.txt.nlp	25535576	SENT56	7	7	31	31	ketoconazole	ACTH	PA450146	5443	0.941
NULL	Mol_Vis_2014_Dec_19_20_1680-1694.nxml.txt.nlp	25558172	SENT233	23	23	18	18	ranibizumab	VEGFA	PA164746012	7422	0.941
NULL	Biomed_Res_Int_2014_Jun_25_2014_764981.nxml.txt.nlp	25057499	SENT127	12	12	3	3	sorafenib	PI3	PA7000	5266	0.941
NULL	Ann_Surg_Oncol_2010_Apr_20_17(4)_1168-1176.nxml.txt.nlp	19936839	SENT73	28	28	24	24	cetuximab	KRAS	PA10040	3845	0.941
NULL	Adv_Hematol_2012_Aug_2_2012_842945.nxml.txt.nlp	22919394	SENT159	38	38	22	22	lenalidomide	IL-2	PA162363968	3558	0.941
NULL	Mol_Cancer_2007_Oct_11_6_63.nxml.txt.nlp	17931419	SENT128	39	39	32	32	cetuximab	HIF-1	PA10040	29072	0.941
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT78	32	32	19	19	cisplatin	p53	PA449014	7157	0.941
NULL	J_Cell_Biol_1984_Mar_1_98(3)_1048-1053.nxml.txt.nlp	6321514	SENT6	13	13	1	1	chloroquine	EGF	PA448948	1950	0.941
NULL	J_Invest_Dermatol_2013_Jun_14_133(6)_1541-1549.nxml.txt.nlp	23407395	SENT130	35	35	21	21	imiquimod	CXCL1	PA449972	2919	0.941
NULL	J_Korean_Med_Sci_1994_Dec_9(6)_482-489.nxml.txt.nlp	7786445	SENT10	23	23	0	0	metoprolol	CYP1A2	PA450480	1544	0.941
NULL	Indian_J_Anaesth_2009_Oct_53(5)_582-591.nxml.txt.nlp	20640109	SENT78	2	2	21	21	clopidogrel	ADP	PA449053	23038	0.941
NULL	Exp_Neurobiol_2014_Jun_13_23(2)_124-129.nxml.txt.nlp	24963276	SENT51	8	8	36	36	naringin	GDNF	PA151958360	2668	0.941
NULL	ScientificWorldJournal_2012_Apr_26_2012_358102.nxml.txt.nlp	22645419	SENT192	6	6	3	3	losartan	AT1	PA450268	9197;185	0.941
NULL	Breast_Cancer_Res_2009_Jun_23_11(Suppl_1)_P28.nxml.txt.nlp	NULL	SENT12	27	27	8	8	paclitaxel	EGFR	PA450761	1956	0.941
NULL	J_Lipid_Res_2012_Oct_53(10)_2046-2056.nxml.txt.nlp	22847177	SENT101	32	32	10	10	paraformaldehyde	c-Myc	PA450790	4609	0.941
NULL	Indian_J_Ophthalmol_2014_Apr_62(4)_468-471.nxml.txt.nlp	23619494	SENT18	0	0	19	19	bevacizumab	VEGF-A	PA130232992	7422	0.941
NULL	Orphanet_J_Rare_Dis_2014_Nov_30_9(1)_191.nxml.txt.nlp	NULL	SENT195	19	19	0	0	cladribine	BRAF	PA449027	673	0.941
NULL	Cancer_Cell_Int_2012_Jun_18_12_28.nxml.txt.nlp	22709531	SENT75	27	27	11	11	imatinib	INCA	PA10804	440068	0.941
NULL	Oncotarget_2014_Aug_27_5(17)_7328-7341.nxml.txt.nlp	25193862	SENT54	4	4	21	21	erlotinib	EGFR	PA134687924	1956	0.941
NULL	Arthritis_Res_Ther_2005_Mar_16_7(Suppl_2)_S4-S14.nxml.txt.nlp	15833146	SENT223	6	6	35	35	sulfasalazine	CD4	PA451547	920	0.941
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT195	14	14	8	8	chloroquine	BMPR-II	PA448948	659	0.941
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT18	0	0	20	20	pertuzumab	HER2		2064	0.941
NULL	Cell_Death_Differ_2009_Aug_20_16(8)_1135-1145.nxml.txt.nlp	19300452	SENT165	17	17	28	28	doxycycline	PUMA	PA449415	27113	0.941
NULL	Br_J_Cancer_2009_Jan_27_100(2)_352-359.nxml.txt.nlp	19142187	SENT88	36	36	9	9	ethanol	CO2	PA448073	4513	0.941
NULL	Korean_J_Anesthesiol_2013_Dec_26_65(6_Suppl)_S25-S27.nxml.txt.nlp	24478859	SENT21	19	19	9	9	sevoflurane	CO2	PA451341	4513	0.941
NULL	Cardiovasc_Diabetol_2013_Nov_12_12_169.nxml.txt.nlp	24215514	SENT307	41	41	35	35	valsartan	AT2	PA451848	186	0.941
NULL	Biomed_Res_Int_2014_Feb_19_2014_627510.nxml.txt.nlp	24701578	SENT185	16	16	4	4	docetaxel	CYP1B1	PA449383	1545	0.941
NULL	Acta_Neuropathol_Commun_2013_May_20_1_17.nxml.txt.nlp	24252689	SENT179	31	31	15	15	celecoxib	IQGAP1	PA448871	8826	0.941
NULL	J_Korean_Neurosurg_Soc_2014_Sep_30_56(3)_175-187.nxml.txt.nlp	25368758	SENT193	9	9	30	30	mannitol	GOR	PA450320	254958	0.941
NULL	Clin_Dev_Immunol_2011_Nov_17_2011_565187.nxml.txt.nlp	22162712	SENT181	40	40	3	3	sorafenib	CLIP	PA7000	5443;6249;7461	0.94
NULL	Oncotarget_2010_Oct_30_1(7)_639-650.nxml.txt.nlp	21317459	SENT49	16	16	2	2	nutlin-3	p53		7157	0.94
NULL	Cell_Death_Dis_2010_Nov_18_1(11)_e102.nxml.txt.nlp	21368867	SENT118	15	15	7	7	gentamicin	14-3-3	PA449753	10971	0.94
NULL	Oncogene_2013_Sep_26_32(39)_10_1038_onc_2012_491.nxml.txt.nlp	23108394	SENT49	36	36	31	31	epirubicin	FOXM1	PA449476	2305	0.94
NULL	J_Immunother_Cancer_2013_Nov_7_1(Suppl_1)_P263.nxml.txt.nlp	NULL	SENT14	8	8	23	23	rituximab	IFN	PA451261	3439	0.94
NULL	Oxid_Med_Cell_Longev_2014_Apr_30_2014_149627.nxml.txt.nlp	24876909	SENT113	20	20	33	33	ethanol	CLOCK	PA448073	9575	0.94
NULL	Chemother_Res_Pract_2011_Jun_21_2011_696208.nxml.txt.nlp	22312556	SENT176	24	24	14	14	carboplatin	EGFR	PA448803	1956	0.94
NULL	J_Neuroinflammation_2011_Aug_5_8_91.nxml.txt.nlp	21819568	SENT183	6	6	27	27	pioglitazone	ANOVA	PA450970	4858	0.94
NULL	Case_Rep_Transplant_2011_Jan_5_2011_210178.nxml.txt.nlp	23213600	SENT68	28	28	0	0	everolimus	CYP3A4	PA164746311	1576	0.94
NULL	Cancer_Immunol_Immunother_2013_Aug_27_62(10)_1637-1648.nxml.txt.nlp	23982484	SENT134	21	21	10	10	lenalidomide	IL-6	PA162363968	3569	0.94
NULL	Oncogene_2014_Aug_21_33(34)_4316-4329.nxml.txt.nlp	24362530	SENT54	18	18	8	8	epirubicin	SUMO1	PA449476	7341	0.94
NULL	eLife_2013_Nov_5_2_e00969.nxml.txt.nlp	24192036	SENT554	10	10	19	19	doxorubicin	SAPK	PA449412	5601	0.94
NULL	J_Oncol_2009_Mar_24_2009_491985.nxml.txt.nlp	19325924	SENT150	23	23	3	3	genistein	CXCL12	PA165109660	6387	0.94
NULL	Br_J_Cancer_2010_Nov_2_103(11)_1671-1679.nxml.txt.nlp	21045835	SENT81	27	27	37	37	gemcitabine	CXCL12	PA449748	6387	0.94
NULL	Front_Neurosci_2012_May_30_6_77.nxml.txt.nlp	22661925	SENT186	0	0	33	33	ethanol	MCP-1	PA448073	6347	0.94
NULL	Mol_Cancer_2008_Jun_30_7_60.nxml.txt.nlp	18590557	SENT148	11	11	17	17	doxorubicin	TRAIL	PA449412	8743	0.94
NULL	Eur_J_Med_Res_2009_Nov_24_14(Suppl_3)_30-35.nxml.txt.nlp	19959414	SENT39	0	0	7	7	raltegravir	UGT1A1		54658	0.94
NULL	Orphanet_J_Rare_Dis_2007_Apr_24_2_21.nxml.txt.nlp	17456235	SENT362	16	16	2	2	halothane	RYR1	PA449845	6261	0.94
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT319	20	20	5	5	cisplatin	DcR2	PA449014	8793	0.94
NULL	J_Mol_Med_(Berl)_2014_Jan_10_92(5)_497-507.nxml.txt.nlp	24408111	SENT9	17	17	0	0	pioglitazone	HIF-1	PA450970	29072	0.94
NULL	ScientificWorldJournal_2013_Jun_19_2013_174392.nxml.txt.nlp	23853530	SENT101	29	29	24	24	doxazosin	PC-3	PA449407	692094	0.94
NULL	Nucleic_Acids_Res_2013_Nov_27_41(21)_9786-9799.nxml.txt.nlp	23982513	SENT165	17	17	26	26	arsenite	TIAR	PA452638	7073	0.94
NULL	J_Cardiothorac_Surg_2013_Jun_10_8_149.nxml.txt.nlp	23759026	SENT17	25	25	7	7	cisplatin	ERCC1	PA449014	2067	0.94
NULL	Clin_Dev_Immunol_2013_Sep_17_2013_791262.nxml.txt.nlp	24151519	SENT12	33	33	7	7	heparin	CD69	PA449855	969	0.94
NULL	J_Gen_Physiol_2009_May_133(5)_511-524.nxml.txt.nlp	19398777	SENT136	33	33	31	31	tetracaine	RYR1	PA451638	6261	0.94
NULL	Aging_(Albany_NY)_2009_Jun_3_1(6)_515-528.nxml.txt.nlp	20157535	SENT7	22	22	1	1	resveratrol	S6K1		6198	0.94
NULL	Ind_Psychiatry_J_2014_Jan-Jun_23(1)_18-22.nxml.txt.nlp	25535440	SENT19	0	0	24	24	clozapine	5-HT1A	PA449061	3350	0.94
NULL	J_Neuroinflammation_2010_Sep_7_7_51.nxml.txt.nlp	20822529	SENT23	4	4	9	9	hemin	HO-1	PA449849	3162	0.94
NULL	J_Cardiovasc_Dis_Res_2010_Oct-Dec_1(4)_171-176.nxml.txt.nlp	21264180	SENT101	11	11	20	20	resveratrol	CA1		759	0.94
NULL	Acta_Pharmacol_Sin_2011_Oct_12_32(10)_1259-1265.nxml.txt.nlp	21909126	SENT97	14	14	38	38	fluvastatin	MCP-1	PA449688	6347	0.94
NULL	Breast_Cancer_Res_2007_Aug_8_9(4)_R50.nxml.txt.nlp	17686159	SENT193	4	4	21	21	trastuzumab	AKT	PA451743	207	0.94
NULL	Cell_Death_Dis_2013_Jun_6_4(6)_e654.nxml.txt.nlp	23744354	SENT183	14	14	4	4	fluorescein	P-gp	PA164746009	5243	0.94
NULL	Front_Microbiol_2014_Mar_14_5_99.nxml.txt.nlp	24672516	SENT82	30	30	23	23	caspofungin	TLR9	PA164743013	54106	0.94
NULL	Clin_Pharmacokinet_2014_Jan_16_53(3)_213-225.nxml.txt.nlp	24430725	SENT190	43	43	13	13	verapamil	P-gp	PA451868	5243	0.94
NULL	Exp_Anim_2014_Apr_26_63(2)_257-267.nxml.txt.nlp	24770651	SENT5	29	29	14	14	perindopril	apelin	PA450877	8862	0.94
NULL	Anticancer_Agents_Med_Chem_2012_Feb_12(2)_163-171.nxml.txt.nlp	22043994	SENT178	29	29	18	18	cetuximab	KRAS	PA10040	3845	0.94
NULL	Breast_Cancer_Res_2011_Mar_11_13(2)_R30.nxml.txt.nlp	21396117	SENT338	28	28	9	9	erlotinib	BRCA1	PA134687924	672	0.94
NULL	Int_J_Nanomedicine_2012_May_7_7_2307-2314.nxml.txt.nlp	22661887	SENT165	12	12	2	2	gemcitabine	F10	PA449748	2159	0.94
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Nov_11_65(Pt_12)_o3062.nxml.txt.nlp	21578792	SENT85	29	29	12	12	ethanol	mol	PA448073	90527	0.94
NULL	Case_Rep_Transplant_2012_Nov_4_2012_305920.nxml.txt.nlp	23213610	SENT102	14	14	25	25	foscarnet	EVL	PA449706	51466	0.94
NULL	Front_Oncol_2013_Sep_23_3_250.nxml.txt.nlp	24069582	SENT11	35	35	27	27	letrozole	aromatase	PA450196	1588	0.94
NULL	Cancer_Cell_Int_2010_Feb_19_10_3.nxml.txt.nlp	20170512	SENT124	11	11	1	1	tamoxifen	4E-BP1	PA451581	1978	0.94
NULL	Biologics_2009_Oct_12_3_443-457.nxml.txt.nlp	19851470	SENT118	16	16	6	6	adalimumab	ACR	PA10004	49	0.94
NULL	Acta_Pharmacol_Sin_2009_Sep_24_30(9)_1262-1275.nxml.txt.nlp	19701231	SENT135	20	20	0	0	lovastatin	NR1H4	PA450272	9971	0.94
NULL	Front_Oncol_2013_Nov_15_3_281.nxml.txt.nlp	24298448	SENT118	8	8	11	11	vemurafenib	HDM2	PA165946873	4193	0.94
NULL	Breast_Cancer_Res_2011_Mar_11_13(2)_R29.nxml.txt.nlp	21396094	SENT215	31	31	17	17	cetuximab	HRG	PA10040	3084;3273	0.94
NULL	Front_Aging_Neurosci_2010_Apr_8_2_15.nxml.txt.nlp	20552051	SENT86	11	11	17	17	ketamine	GDX	PA450144	8266	0.94
NULL	J_Geriatr_Cardiol_2013_Jun_10(2)_151-158.nxml.txt.nlp	23888175	SENT157	24	24	19	19	rosuvastatin	AT1	PA134308647	9197;185	0.94
NULL	Br_J_Cancer_2013_Feb_19_108(3)_668-675.nxml.txt.nlp	23348520	SENT9	22	22	16	16	cetuximab	KRAS	PA10040	3845	0.94
NULL	Cell_Death_Differ_2010_Oct_30_17(10)_1624-1635.nxml.txt.nlp	20431602	SENT107	32	32	28	28	paclitaxel	Mcl-1	PA450761	4170	0.94
NULL	Breast_Cancer_Res_2003_Jul_28_5(5)_228-231.nxml.txt.nlp	12927029	SENT2	19	19	2	2	tamoxifen	aromatase	PA451581	1588	0.94
NULL	Cancer_Cell_Int_2013_Jul_8_13_68.nxml.txt.nlp	23834902	SENT170	32	32	35	35	gemcitabine	ING4	PA449748	51147	0.94
NULL	Drug_Des_Devel_Ther_2014_Sep_23_8_1527-1538.nxml.txt.nlp	25284985	SENT131	39	39	2	2	celecoxib	IFN	PA448871	3439	0.94
NULL	Ann_Surg_Oncol_2010_Apr_20_17(4)_1168-1176.nxml.txt.nlp	19936839	SENT104	27	27	9	9	bevacizumab	KRAS	PA130232992	3845	0.94
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT42	3	3	12	12	trastuzumab	HER2	PA451743	2064	0.94
NULL	Biomed_Res_Int_2014_May_29_2014_768758.nxml.txt.nlp	24971349	SENT139	4	4	2	2	plerixafor	CXCR4	PA165958410	7852	0.94
NULL	Mol_Cancer_2014_Jun_30_13_160.nxml.txt.nlp	24976026	SENT148	28	28	7	7	bortezomib	AGR2	PA10252	10551	0.94
NULL	Cell_Death_Dis_2014_Mar_13_5(3)_e1113.nxml.txt.nlp	24625972	SENT85	14	14	5	5	bleomycin	BI-1	PA448645	7009	0.94
NULL	Croat_Med_J_2012_Jun_53(3)_214-223.nxml.txt.nlp	22661134	SENT101	4	4	34	34	diazepam	ACTH	PA449283	5443	0.94
NULL	Front_Neurosci_2012_May_30_6_77.nxml.txt.nlp	22661925	SENT183	8	8	31	31	ethanol	MCP-1	PA448073	6347	0.94
NULL	Clin_Sci_(Lond)_2012_Jul_1_123(Pt_2)_93-98.nxml.txt.nlp	22455352	SENT337	4	4	13	13	capsaicin	p38	PA448776	10598;1432;7965	0.94
NULL	Int_J_Crit_Illn_Inj_Sci_2012_May-Aug_2(2)_82-97.nxml.txt.nlp	22837896	SENT150	12	12	30	30	itraconazole	CD4	PA450132	920	0.94
NULL	Oncotarget_2014_Aug_19_5(18)_8737-8749.nxml.txt.nlp	25228590	SENT64	2	2	29	29	doxycycline	MYCN	PA449415	4613	0.94
NULL	Ther_Clin_Risk_Manag_2006_Sep_2(3)_235-249.nxml.txt.nlp	18360599	SENT223	17	17	10	10	alendronate	BSAP	PA448082	5079	0.94
NULL	Cancers_(Basel)_2010_Sep_27_2(3)_1731-1770.nxml.txt.nlp	24281185	SENT540	5	5	26	26	bleomycin	IL-2	PA448645	3558	0.94
NULL	Eur_J_Med_Res_2010_Feb_26_15(2)_81-83.nxml.txt.nlp	20452889	SENT48	6	6	13	13	raltegravir	CD4		920	0.94
NULL	Cell_Death_Dis_2013_Oct_3_4(10)_e834.nxml.txt.nlp	24091677	SENT73	10	10	5	5	vinblastine	Mcl-1	PA451877	4170	0.94
NULL	eLife_2014_Aug_1_3_e02725.nxml.txt.nlp	25085081	SENT750	28	28	11	11	oxaliplatin	BRAF	PA131285527	673	0.94
NULL	Breast_Cancer_(Dove_Med_Press)_2014_May_2_6_59-71.nxml.txt.nlp	24833917	SENT140	9	9	1	1	exemestane	NNT	PA449563	23530	0.94
NULL	J_Oncol_2012_Feb_6_2012_737981.nxml.txt.nlp	22481932	SENT142	33	33	6	6	paclitaxel	ABCB1	PA450761	5243	0.94
NULL	J_Biol_Chem_2008_Nov_14_283(46)_31679-31689.nxml.txt.nlp	18755684	SENT29	39	39	1	1	iron	FTH1	PA450087	2495	0.94
NULL	Arch_Plast_Surg_2012_Sep_12_39(5)_540-545.nxml.txt.nlp	23094252	SENT9	14	14	11	11	propofol	TCI	PA451141	6947	0.94
NULL	J_Invest_Dermatol_2013_Jun_14_133(6)_1541-1549.nxml.txt.nlp	23407395	SENT269	9	9	16	16	imiquimod	CXCL2	PA449972	2920	0.94
NULL	Evid_Based_Complement_Alternat_Med_2013_May_13_2013_506324.nxml.txt.nlp	23818927	SENT190	18	18	10	10	doxorubicin	S6K1	PA449412	6198	0.94
NULL	Clin_Exp_Metastasis_2013_May_15_30(7)_867-876.nxml.txt.nlp	23673558	SENT5	18	18	14	14	dacarbazine	BRAF	PA449197	673	0.94
NULL	Acta_Pharmacol_Sin_2011_Apr_28_32(4)_441-448.nxml.txt.nlp	21441944	SENT158	17	17	7	7	isoproterenol	CASQ2	PA450121	845	0.94
NULL	J_Cell_Mol_Med_2014_May_15_18(5)_801-810.nxml.txt.nlp	24826900	SENT123	22	22	30	30	bleomycin	FHL2	PA448645	2274	0.94
NULL	Breast_Cancer_Res_2014_Sep_9_16(5)_433.nxml.txt.nlp	25212966	SENT244	4	4	23	23	aprotinin	ILEI	PA448472	10447	0.94
NULL	Cancer_Immunol_Immunother_2015_Oct_7_64_61-73.nxml.txt.nlp	25287778	SENT200	10	10	1	1	lenalidomide	IL-2	PA162363968	3558	0.94
NULL	Br_J_Cancer_2012_Oct_9_107(8)_1233-1238.nxml.txt.nlp	22955852	SENT34	19	19	7	7	docetaxel	RPN2	PA449383	6185	0.94
NULL	Exp_Diabetes_Res_2012_Feb_23_2012_709893.nxml.txt.nlp	22611375	SENT13	11	11	1	1	liraglutide	GLP-1	PA165958364	100125288	0.94
NULL	Clin_Interv_Aging_2012_Oct_5_7_397-407.nxml.txt.nlp	23055706	SENT45	13	13	0	0	zidovudine	EPO	PA451954	7076;8288;2056	0.94
NULL	J_Korean_Med_Sci_2013_Nov_31_28(11)_1595-1602.nxml.txt.nlp	24265521	SENT93	43	43	6	6	gefitinib	EGFR	PA131301952	1956	0.94
NULL	Cancer_Cell_Int_2010_May_11_10_16.nxml.txt.nlp	20459793	SENT140	31	31	1	1	cisplatin	ABCC6	PA449014	368	0.94
NULL	Structure_2012_Apr_4_20(4-2)_654-666.nxml.txt.nlp	22483112	SENT286	32	32	9	9	glutaraldehyde	S100A4	PA449777	6275	0.94
NULL	Clin_Pharmacokinet_2014_Aug_21_53(10)_931-941.nxml.txt.nlp	25141974	SENT35	23	23	16	16	midazolam	CYP3A	PA450496	1574	0.94
NULL	Biosci_Rep_2013_Nov_25_33(6)_e00081.nxml.txt.nlp	24070327	SENT185	19	19	2	2	vincristine	XIAP	PA451879	331	0.94
NULL	Int_J_Endocrinol_Metab_2013_Dec_21_Winter_11(1)_57-61.nxml.txt.nlp	23853622	SENT78	4	4	11	11	bromocriptine	PRL	PA448671	5617	0.94
NULL	Exp_Ther_Med_2014_Nov_29_8(5)_1473-1478.nxml.txt.nlp	25289044	SENT124	19	19	8	8	heparin	AZU	PA449855	566	0.94
NULL	Biology_(Basel)_2012_Dec_31_2(1)_40-63.nxml.txt.nlp	24832651	SENT153	34	34	29	29	mitomycin	BRCA1	PA450524	672	0.94
NULL	Int_J_Mol_Sci_2013_Apr_29_14(5)_9338-9364.nxml.txt.nlp	23629668	SENT66	12	12	25	25	bevacizumab	p53	PA130232992	7157	0.94
NULL	Acta_Pharmacol_Sin_2010_Sep_2_31(9)_1036-1043.nxml.txt.nlp	20676119	SENT140	18	18	7	7	ethanol	HCN	PA448073	378938	0.94
NULL	Biomed_Res_Int_2013_Jul_31_2013_692071.nxml.txt.nlp	23984399	SENT126	8	8	1	1	atropine	OCT1	PA448505	5451;6580	0.94
NULL	Mol_Cancer_2010_Nov_8_9_291.nxml.txt.nlp	21059223	SENT8	30	30	19	19	paclitaxel	ZNF217	PA450761	7764	0.94
NULL	Oncoimmunology_2013_Dec_1_2(12)_e26904.nxml.txt.nlp	24498560	SENT8	19	19	9	9	cetuximab	EGFR	PA10040	1956	0.94
NULL	J_Oncol_2011_Sep_29_2011_232037.nxml.txt.nlp	21977030	SENT130	18	18	40	40	bortezomib	Hsp90	PA10252	3320	0.94
NULL	Arthritis_Res_Ther_2006_Jul_3_8(4)_216.nxml.txt.nlp	16879719	SENT106	28	28	10	10	cyclosporine	ACR	PA449167	49	0.94
NULL	J_Cell_Biol_1998_Jan_26_140(2)_335-345.nxml.txt.nlp	9442109	SENT237	17	17	24	24	chloroquine	NHE	PA448948	285335	0.94
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jun_27_68(Pt_7)_o2237.nxml.txt.nlp	22798893	SENT75	38	38	10	10	ethanol	mol	PA448073	90527	0.94
NULL	Br_J_Cancer_2010_Nov_9_103(10)_1627-1636.nxml.txt.nlp	20959826	SENT185	39	39	33	33	cetuximab	BRAF	PA10040	673	0.94
NULL	Neural_Plast_2007_Jan_1_2007_30585.nxml.txt.nlp	25148070	SENT1386	12	12	21	21	fluoxetine	IGF1	PA449673	3479	0.94
NULL	BMJ_Open_2014_Oct_31_4(10)_e005762.nxml.txt.nlp	25361836	SENT209	15	15	6	6	letrozole	HER-2	PA450196	2064	0.94
NULL	J_Mol_Med_(Berl)_2013_Jul_9_91(7)_883-899.nxml.txt.nlp	23471434	SENT320	33	33	0	0	cisplatin	CD133	PA449014	8842	0.94
NULL	Breast_Cancer_Res_2009_Oct_28_11(5)_211.nxml.txt.nlp	19889200	SENT176	24	24	4	4	anastrozole	ARNO	PA448432	9266	0.94
NULL	Springerplus_2015_Jan_23_4_29.nxml.txt.nlp	25628986	SENT18	18	18	11	11	dapsone	G6PD	PA449211	2539	0.94
NULL	Curr_Med_Chem_2009_Aug_16(23)_3041-3053.nxml.txt.nlp	19689281	SENT171	27	27	4	4	napqi	JNK		5599	0.94
NULL	Cancers_(Basel)_2011_May_18_3(2)_2444-2461.nxml.txt.nlp	24212818	SENT150	25	25	7	7	thrombin	EGFR	PA451674	1956	0.94
NULL	Cardiovasc_Diabetol_2008_Aug_11_7_24.nxml.txt.nlp	18694484	SENT211	23	23	15	15	exenatide	Ray	PA164749238	26751	0.94
NULL	Diabetes_Care_2011_Jul_17_34(7)_1678-1680.nxml.txt.nlp	21709302	SENT72	13	13	7	7	ramipril	DREAM	PA451223	30818	0.94
NULL	Eur_J_Clin_Microbiol_Infect_Dis_2014_Nov_10_33(2)_201-209.nxml.txt.nlp	24213847	SENT154	22	22	36	36	metronidazole	NAP1	PA450484	4673;64343;9476;3576;51531	0.94
NULL	Front_Mol_Neurosci_2012_Nov_12_5_99.nxml.txt.nlp	23162427	SENT278	8	8	0	0	nicotine	HDAC	PA450626	9734	0.94
NULL	Br_J_Cancer_2012_Sep_25_107(7)_1009-1016.nxml.txt.nlp	22948724	SENT53	25	25	16	16	sunitinib	HIF1	PA162372840	3091	0.94
NULL	Breast_Cancer_(Auckl)_2012_Feb_20_6_47-66.nxml.txt.nlp	22399860	SENT172	4	4	22	22	tamoxifen	PTEN	PA451581	5728	0.94
NULL	Arthritis_Res_Ther_2013_Sep_27_15(5)_R138.nxml.txt.nlp	24289726	SENT26	15	15	27	27	anakinra	IL-6	PA10799	3569	0.94
NULL	Onco_Targets_Ther_2014_Jul_12_7_1273-1284.nxml.txt.nlp	25050069	SENT36	0	0	21	21	trabectedin	CYP2D6	PA165958349	1565	0.94
NULL	Balkan_J_Med_Genet_2011_Jun_25_14(1)_25-30.nxml.txt.nlp	24052699	SENT81	10	10	23	23	phenytoin	ABCC1	PA450947	4363	0.94
NULL	Oncoimmunology_2012_May_1_1(3)_326-333.nxml.txt.nlp	22737608	SENT72	7	7	24	24	daclizumab	IL-2	PA164764446	3558	0.94
NULL	Eur_Heart_J_2014_Jul_21_35(28)_1864-1872.nxml.txt.nlp	24561548	SENT150	14	14	24	24	warfarin	TTR	PA451906	7276	0.94
NULL	Br_J_Cancer_2009_Oct_6_101(7)_1155-1161.nxml.txt.nlp	19738614	SENT32	25	25	15	15	gemcitabine	MUC4	PA449748	4585	0.94
NULL	Br_J_Cancer_2012_Nov_20_107(11)_1833-1839.nxml.txt.nlp	23169336	SENT41	14	14	0	0	bleomycin	Men	PA448645	8178	0.94
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_P124.nxml.txt.nlp	NULL	SENT7	11	11	7	7	carbamazepine	HLA-B	PA448785	3106	0.94
NULL	Br_J_Cancer_2012_Jan_3_106(1)_32-38.nxml.txt.nlp	22108523	SENT5	0	0	18	18	trastuzumab	HER2	PA451743	2064	0.94
NULL	Clin_Ophthalmol_2008_Jun_2(2)_355-368.nxml.txt.nlp	19668727	SENT182	0	0	19	19	nepafenac	CYP1A2	PA165958407	1544	0.94
NULL	Cell_Death_Dis_2010_Oct_21_1(10)_e86.nxml.txt.nlp	21368859	SENT216	25	25	33	33	doxorubicin	TRAIL	PA449412	8743	0.94
NULL	Ann_Thorac_Med_2012_Jan-Mar_7(1)_44-47.nxml.txt.nlp	22347351	SENT90	22	22	15	15	propranolol	CO2	PA451145	4513	0.94
NULL	J_Neural_Transm_2014_Feb_19_121(7)_707-715.nxml.txt.nlp	24549572	SENT225	24	24	21	21	rimonabant	CB1	PA152407999	1268	0.94
NULL	J_Biomed_Biotechnol_2011_Jan_2_2011_348765.nxml.txt.nlp	21274268	SENT119	4	4	26	26	minocycline	SOD1	PA450519	6647	0.94
NULL	Cell_Tissue_Res_2013_Feb_23_351(2)_325-337.nxml.txt.nlp	22358849	SENT236	9	9	0	0	thrombin	PAR-1	PA451674	2011;2149	0.94
NULL	Comb_Chem_High_Throughput_Screen_2010_Feb_13(2)_188-206.nxml.txt.nlp	20053163	SENT245	15	15	11	11	lovastatin	CYP3A4	PA450272	1576	0.94
NULL	Bioinformation_2012_Jan_6_8(1)_13-19.nxml.txt.nlp	22359429	SENT175	30	30	2	2	calcein	MRP1	PA132595336	4437	0.94
NULL	Mol_Cancer_2010_Mar_25_9_68.nxml.txt.nlp	20338046	SENT16	23	23	11	11	doxorubicin	GSTP1	PA449412	2950	0.94
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_29_2013_590393.nxml.txt.nlp	23737838	SENT225	4	4	16	16	resveratrol	p53		7157	0.94
NULL	Blood_Cancer_J_2013_Jun_7_3(6)_e120.nxml.txt.nlp	23749045	SENT156	8	8	15	15	bortezomib	MMSET	PA10252	7468	0.94
NULL	Int_J_Biol_Sci_2013_Mar_7_9(3)_279-288.nxml.txt.nlp	23493630	SENT126	13	13	31	31	tocilizumab	IL-2	PA165292659	3558	0.94
NULL	Clin_Genet_2014_Jan_1_86(1)_21-28.nxml.txt.nlp	24684508	SENT55	36	36	6	6	warfarin	VKORC1	PA451906	79001	0.94
NULL	Alcohol_Res_2013_35(1)_47-55.nxml.txt.nlp	24313164	SENT111	36	36	12	12	ethanol	HDAC3	PA448073	8841	0.94
NULL	Arthritis_Res_Ther_2013_Dec_4_15(6)_R207.nxml.txt.nlp	24299175	SENT233	15	15	7	7	rituximab	CD19	PA451261	930	0.94
NULL	Arthritis_Res_Ther_2005_Sep_20_7(6)_R1304-R1315.nxml.txt.nlp	16277684	SENT87	30	30	4	4	l-tryptophan	IFN	PA10323	3439	0.94
NULL	Oncotarget_2011_Sep_9_2(9)_658-668.nxml.txt.nlp	21911919	SENT96	10	10	0	0	cytarabine	NAC	PA449177	22861	0.94
NULL	Mol_Vis_2007_Jul_12_13_1130-1137.nxml.txt.nlp	17653058	SENT178	15	15	5	5	lidocaine	IL-6	PA450226	3569	0.94
NULL	Mol_Vis_2012_Nov_29_18_2839-2846.nxml.txt.nlp	23233786	SENT183	10	10	15	15	geldanamycin	Hsp90	PA152031327	3320	0.94
NULL	Int_J_Mol_Sci_2014_Mar_18_15(3)_4747-4779.nxml.txt.nlp	24646914	SENT352	7	7	3	3	sorafenib	CXCR4	PA7000	7852	0.94
NULL	Indian_J_Ophthalmol_2007_Nov-Dec_55(6)_417-420.nxml.txt.nlp	17951896	SENT2	0	0	21	21	bevacizumab	VEGF-A	PA130232992	7422	0.94
NULL	Cancer_Med_2014_Apr_27_3(2)_245-251.nxml.txt.nlp	24464861	SENT120	13	13	24	24	metformin	HIF1	PA450395	3091	0.94
NULL	Aging_Cell_2012_Aug_11(4)_579-587.nxml.txt.nlp	22435726	SENT90	32	32	25	25	etoposide	CD28	PA449552	1493;940	0.94
NULL	Int_J_Mol_Sci_2014_Sep_5_15(9)_15754-15765.nxml.txt.nlp	25198898	SENT62	4	4	25	25	curcumin	JNK	PA151958596	5599	0.94
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_55-66.nxml.txt.nlp	17912636	SENT75	27	27	32	32	tamoxifen	HER2	PA451581	2064	0.94
NULL	EMBO_Mol_Med_2012_Oct_30_4(10)_1087-1096.nxml.txt.nlp	22933245	SENT19	15	15	33	33	olaparib	BRCA1		672	0.94
NULL	Bone_Marrow_Transplant_2011_Jul_11_46(7)_943-949.nxml.txt.nlp	20935680	SENT106	0	0	31	31	plerixafor	CD34	PA165958410	947	0.94
NULL	Brain_Behav_2013_Mar_6_3(2)_114-133.nxml.txt.nlp	23533150	SENT178	37	37	15	15	ethanol	HSF1	PA448073	3297	0.94
NULL	Cell_Death_Differ_2010_Mar_16_17(3)_439-451.nxml.txt.nlp	19834489	SENT177	2	2	21	21	neomycin	GCG	PA450608	2641	0.94
NULL	Evid_Based_Complement_Alternat_Med_2012_Dec_20_2012_908601.nxml.txt.nlp	23326293	SENT187	23	23	20	20	oxaliplatin	EMT	PA131285527	3702;6581	0.94
NULL	Br_J_Cancer_2011_Mar_1_104(5)_856-862.nxml.txt.nlp	21285991	SENT29	23	23	2	2	cetuximab	BRAF	PA10040	673	0.94
NULL	Cell_Cycle_2013_Sep_1_12(17)_2899-2913.nxml.txt.nlp	23966157	SENT129	14	14	4	4	cisplatin	EMMPRIN	PA449014	682	0.94
NULL	Indian_J_Pharmacol_2014_Mar-Apr_46(2)_191-196.nxml.txt.nlp	24741192	SENT223	21	21	6	6	tropisetron	5-HT3A	PA161925594	3359	0.94
NULL	Breast_Cancer_Res_2012_Feb_14_14(1)_R31.nxml.txt.nlp	22333393	SENT271	11	11	18	18	tamoxifen	NAT1	PA451581	9;1982	0.94
NULL	Breast_Cancer_(Auckl)_2012_Feb_20_6_47-66.nxml.txt.nlp	22399860	SENT172	4	4	44	44	tamoxifen	GPRC5D	PA451581	55507	0.94
NULL	J_Korean_Med_Sci_2010_Sep_14_25(9)_1277-1283.nxml.txt.nlp	20808669	SENT119	9	9	32	32	alendronate	IL-6	PA448082	3569	0.94
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Sep_11_66(Pt_10)_o2550.nxml.txt.nlp	21587538	SENT55	18	18	6	6	ethanol	mol	PA448073	90527	0.94
NULL	Drug_Saf_2014_Feb_19_37(4)_201-211.nxml.txt.nlp	24550106	SENT117	14	14	4	4	phenytoin	CYP2C19	PA450947	1557	0.94
NULL	J_Biol_Chem_2008_Jun_20_283(25)_17194-17204.nxml.txt.nlp	18442977	SENT149	23	23	30	30	fluoxetine	5-HT2A	PA449673	3356	0.94
NULL	Ann_Oncol_2011_Mar_8_22(3)_503-514.nxml.txt.nlp	20616198	SENT25	9	9	27	27	anastrozole	aromatase	PA448432	1588	0.94
NULL	Hum_Mol_Genet_2013_Jun_1_22(11)_2247-2262.nxml.txt.nlp	23424202	SENT207	43	43	0	0	apomorphine	AMPH	PA164781163	273	0.94
NULL	AMB_Express_2011_Sep_1_1_24.nxml.txt.nlp	21906270	SENT158	27	27	20	20	glucose	CO2	PA449773	4513	0.94
NULL	Clin_Psychopharmacol_Neurosci_2011_Apr_30_9(1)_36-43.nxml.txt.nlp	23431025	SENT14	17	17	3	3	haloperidol	FLI	PA449841	2314	0.94
NULL	Exp_Ther_Med_2012_Sep_13_4(3)_409-414.nxml.txt.nlp	23181109	SENT39	27	27	1	1	ethanol	flower	PA448073	11094	0.94
NULL	JAKSTAT_2012_Apr_1_1(2)_83-89.nxml.txt.nlp	24058756	SENT64	19	19	9	9	losartan	STAT3	PA450268	6774	0.94
NULL	Cancer_Cell_Int_2012_Nov_13_12_45.nxml.txt.nlp	23148684	SENT27	21	21	8	8	carboplatin	WEE1	PA448803	7465	0.94
NULL	Case_Rep_Pediatr_2013_Oct_3_2013_703925.nxml.txt.nlp	24222881	SENT14	0	0	9	9	liraglutide	GLP-1	PA165958364	100125288	0.94
NULL	Bioinformation_2008_Dec_31_3(5)_198-204.nxml.txt.nlp	19255634	SENT83	8	8	33	33	omeprazole	CYP2C19	PA450704	1557	0.94
NULL	Lab_Invest_2010_Sep_10_90(9)_1325-1338.nxml.txt.nlp	20458282	SENT133	17	17	32	32	paclitaxel	MDR1	PA450761	5243	0.94
NULL	Mol_Cell_Biochem_2012_Apr_3_363(1-2)_135-145.nxml.txt.nlp	22139302	SENT9	23	23	21	21	curcumin	survivin	PA151958596	332	0.94
NULL	J_Invest_Dermatol_2013_Sep_31_133(9)_2247-2254.nxml.txt.nlp	23370537	SENT73	17	17	1	1	chloroquine	PUMA	PA448948	27113	0.94
NULL	Oncotarget_2013_Aug_29_4(10)_1673-1685.nxml.txt.nlp	24127549	SENT353	33	33	0	0	resveratrol	PC-3		692094	0.94
NULL	Infect_Dis_Ther_2014_Dec_6_3(2)_123-132.nxml.txt.nlp	25193094	SENT70	18	18	30	30	ceftriaxone	CABP	PA448866	6277	0.94
NULL	Br_J_Cancer_1995_Sep_72(3)_615-619.nxml.txt.nlp	7669570	SENT11	11	11	0	0	cisplatin	EGF	PA449014	1950	0.94
NULL	Oncotarget_2014_Dec_4_5(22)_11365-11380.nxml.txt.nlp	25426548	SENT31	9	9	18	18	nutlin-3	p53		7157	0.94
NULL	Arch_Med_Sci_2013_Oct_31_9(5)_936-943.nxml.txt.nlp	24273582	SENT51	0	0	9	9	repaglinide	CYP3A4	PA451234	1576	0.94
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT307	8	8	2	2	cisplatin	p38	PA449014	10598;1432;7965	0.94
NULL	Oxid_Med_Cell_Longev_2013_Apr_21_2013_412576.nxml.txt.nlp	23710286	SENT110	14	14	40	40	curcumin	NRF2	PA151958596	2551;4780	0.94
NULL	Mol_Neurodegener_2011_Aug_8_6_57.nxml.txt.nlp	21819629	SENT248	27	27	8	8	arsenite	TDP-43	PA452638	23435	0.94
NULL	Breast_Cancer_Res_2011_Mar_11_13(2)_R30.nxml.txt.nlp	21396117	SENT338	28	28	26	26	erlotinib	EGFR	PA134687924	1956	0.94
NULL	Surg_Neurol_Int_2013_Jan_29_4_15.nxml.txt.nlp	23493580	SENT240	7	7	16	16	curcumin	STAT3	PA151958596	6774	0.94
NULL	Oxid_Med_Cell_Longev_2013_Jun_2_2013_793525.nxml.txt.nlp	23819014	SENT244	3	3	19	19	resveratrol	PI3K		5290	0.94
NULL	Br_J_Cancer_2012_Feb_28_106(5)_939-946.nxml.txt.nlp	22281663	SENT173	18	18	11	11	imatinib	KIT	PA10804	3815	0.94
NULL	J_Cell_Mol_Med_2013_Oct_16_17(10)_1261-1270.nxml.txt.nlp	23855452	SENT231	11	11	2	2	doxorubicin	CHK2	PA449412	11200	0.94
NULL	Pharmaceuticals_(Basel)_2012_Nov_20_5(11)_1236-1264.nxml.txt.nlp	24281308	SENT771	20	20	2	2	gefitinib	PTEN	PA131301952	5728	0.94
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT486	21	21	1	1	nevirapine	CAR	PA450616	1525;6687;9970	0.94
NULL	Br_J_Cancer_2010_Oct_12_103(8)_1139-1143.nxml.txt.nlp	20877357	SENT93	9	9	1	1	gefitinib	EGF	PA131301952	1950	0.94
NULL	Curr_Neuropharmacol_2013_Dec_11(6)_652-663.nxml.txt.nlp	24396340	SENT171	20	20	15	15	capsaicin	TRPV1	PA448776	7442	0.94
NULL	Oncol_Lett_2013_Mar_28_5(3)_935-942.nxml.txt.nlp	23426424	SENT164	15	15	3	3	cisplatin	ERCC1	PA449014	2067	0.94
NULL	Clin_Cosmet_Investig_Dermatol_2011_Apr_8_4_35-40.nxml.txt.nlp	21691565	SENT11	0	0	29	29	imiquimod	IL-8	PA449972	3576	0.94
NULL	Cardiovasc_Ther_2009_Summer_27(2)_77-82.nxml.txt.nlp	19426243	SENT101	10	10	20	20	heparin	ACT	PA449855	12;11332;9457;641455	0.94
NULL	Case_Rep_Oncol_2013_Feb_19_6(1)_98-103.nxml.txt.nlp	23626552	SENT76	13	13	6	6	sorafenib	HCC	PA7000	84668	0.94
NULL	Pharmaceuticals_(Basel)_2012_Jun_28_5(7)_674-689.nxml.txt.nlp	24281706	SENT6	10	10	28	28	pertuzumab	Hsp90		3320	0.94
NULL	Diabetes_2009_Jan_58(1)_243-249.nxml.txt.nlp	18840785	SENT38	13	13	23	23	glucose	GLP-1	PA449773	100125288	0.94
NULL	Arthritis_Res_Ther_2013_Nov_1_15(6)_R176.nxml.txt.nlp	24456929	SENT262	15	15	26	26	colchicine	MSU	PA449092	593	0.94
NULL	Int_Semin_Surg_Oncol_2008_Apr_28_5_9.nxml.txt.nlp	18442393	SENT90	22	22	15	15	tamoxifen	HER-2	PA451581	2064	0.94
NULL	Cell_Regen_(Lond)_2013_Apr_30_2(1)_3.nxml.txt.nlp	25408875	SENT77	5	5	18	18	colchicine	SNX16	PA449092	64089	0.94
NULL	Int_J_Biol_Sci_2013_Jan_3_9(1)_94-107.nxml.txt.nlp	23355795	SENT62	31	31	7	7	fluorescein	TLR2	PA164746009	7097	0.94
NULL	Oncol_Lett_2013_Apr_28_5(4)_1305-1310.nxml.txt.nlp	23599784	SENT21	12	12	3	3	anastrozole	aromatase	PA448432	1588	0.94
NULL	Curr_Opin_Lipidol_2014_Oct_4_25(5)_387-393.nxml.txt.nlp	25110901	SENT71	13	13	33	33	berberine	PCSK9	PA165860812	255738	0.94
NULL	Br_J_Cancer_1999_Mar_79(9-10)_1356-1365.nxml.txt.nlp	10188876	SENT8	26	26	38	38	vincristine	KAR	PA451879	51144	0.94
NULL	Ther_Clin_Risk_Manag_2006_Dec_2(4)_435-445.nxml.txt.nlp	18360654	SENT143	31	31	5	5	gemcitabine	EGFR	PA449748	1956	0.94
NULL	Mol_Syst_Biol_2011_Apr_26_7_486.nxml.txt.nlp	21525872	SENT133	35	35	12	12	imatinib	CPNE8	PA10804	144402	0.94
NULL	Vet_Res_Forum_2013_Winter_4(1)_19-24.nxml.txt.nlp	25593681	SENT74	24	24	17	17	diclofenac	B12	PA449293	7126;4709	0.94
NULL	Virol_J_2010_Oct_15_7_271.nxml.txt.nlp	20950422	SENT74	12	12	6	6	collagenase	C17	PA449107	54360	0.94
NULL	Environ_Health_Perspect_2006_Sep_23_114(9)_1401-1406.nxml.txt.nlp	16966095	SENT52	16	16	10	10	arsenite	p53	PA452638	7157	0.94
NULL	Oncotarget_2014_Sep_8_5(20)_9619-9625.nxml.txt.nlp	25294813	SENT4	18	18	5	5	trastuzumab	TAZ	PA451743	25937;6901	0.94
NULL	Arthritis_Res_Ther_2003_Dec_2_5(Suppl_4)_S12-S16.nxml.txt.nlp	15180892	SENT75	22	22	18	18	doxorubicin	CHOP	PA449412	1649	0.94
NULL	Breast_Cancer_Res_2012_Jul_20_14(4)_R110.nxml.txt.nlp	22817698	SENT7	23	23	19	19	cisplatin	BRCA1	PA449014	672	0.94
NULL	Pharm_Pract_(Granada)_2011_Mar_15_Jan-Mar_9(1)_1-10.nxml.txt.nlp	25132883	SENT35	6	6	28	28	dabigatran	SPAF		166378	0.94
NULL	Biomed_Res_Int_2013_Jul_17_2013_549359.nxml.txt.nlp	23956990	SENT162	17	17	13	13	erlotinib	EGFR	PA134687924	1956	0.94
NULL	Exp_Neurobiol_2013_Mar_31_22(1)_45-50.nxml.txt.nlp	23585722	SENT108	17	17	22	22	fluoxetine	EPO	PA449673	7076;8288;2056	0.94
NULL	Ther_Clin_Risk_Manag_2006_Dec_2(4)_365-375.nxml.txt.nlp	18360649	SENT30	0	0	27	27	abatacept	CTLA4	PA164747080	1493	0.94
NULL	Pharmaceutics_2011_Nov_18_3(4)_865-913.nxml.txt.nlp	24309312	SENT1229	14	14	8	8	maraviroc	CYP3A4	PA164768835	1576	0.94
NULL	Front_Neurosci_2010_Jun_17_4_35.nxml.txt.nlp	20661455	SENT94	3	3	9	9	pindolol	5-HT1A	PA450966	3350	0.94
NULL	Cancers_(Basel)_2012_Oct_26_4(4)_1106-1146.nxml.txt.nlp	24213501	SENT403	33	33	20	20	docetaxel	PC-3	PA449383	692094	0.94
NULL	Br_J_Cancer_2011_Aug_23_105(5)_618-627.nxml.txt.nlp	21829197	SENT45	11	11	3	3	lapatinib	CRT	PA152241907	811	0.94
NULL	Oncotarget_2013_Nov_22_5(4)_933-943.nxml.txt.nlp	24659749	SENT81	9	9	2	2	nutlin-3	AML3		860	0.94
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT13	5	5	3	3	erlotinib	CYP3A	PA134687924	1574	0.94
NULL	Br_J_Haematol_2014_Mar_28_164(6)_858-866.nxml.txt.nlp	24372446	SENT122	40	40	4	4	rituximab	C5a	PA451261	727	0.94
NULL	Cancer_Metastasis_Rev_2010_Dec_10_29(4)_581-594.nxml.txt.nlp	20830503	SENT367	17	17	24	24	tamoxifen	ARNO	PA451581	9266	0.94
NULL	Oncogene_2010_Sep_16_29(37)_5193-5203.nxml.txt.nlp	20581867	SENT11	15	15	24	24	lapatinib	PI3K	PA152241907	5290	0.94
NULL	J_Neuroinflammation_2011_Aug_5_8_91.nxml.txt.nlp	21819568	SENT205	10	10	37	37	pioglitazone	ANOVA	PA450970	4858	0.94
NULL	Mol_Pain_2014_Feb_6_10_10.nxml.txt.nlp	24499354	SENT328	4	4	27	27	naloxone	TLR4	PA450586	7099	0.94
NULL	Cell_Death_Dis_2013_Jul_11_4(7)_e719.nxml.txt.nlp	23846221	SENT54	17	17	30	30	cisplatin	TRAIL	PA449014	8743	0.94
NULL	Adv_Ther_2013_Oct_25_30(10)_870-884.nxml.txt.nlp	24158787	SENT23	15	15	4	4	exemestane	aromatase	PA449563	1588	0.94
NULL	Exp_Cell_Res_2011_Apr_15_317(7)_1028-1039.nxml.txt.nlp	21237154	SENT98	23	23	17	17	staurosporine	TRAIL	PA165109623	8743	0.94
NULL	Croat_Med_J_2014_Jun_55(3)_218-227.nxml.txt.nlp	24891280	SENT26	0	0	10	10	estradiol	LPO	PA449503	4025	0.94
NULL	Biomed_Res_Int_2014_Apr_10_2014_580852.nxml.txt.nlp	24812624	SENT46	3	3	9	9	resveratrol	PTEN		5728	0.94
NULL	J_Oncol_2012_Aug_14_2012_408131.nxml.txt.nlp	22934112	SENT216	23	23	17	17	gemcitabine	EGFR	PA449748	1956	0.94
NULL	EMBO_Mol_Med_2012_Sep_7_4(9)_896-909.nxml.txt.nlp	22887866	SENT279	16	16	19	19	metformin	c-Myc	PA450395	4609	0.94
NULL	Oncogene_2010_Jan_28_29(4)_589-596.nxml.txt.nlp	19881544	SENT86	16	16	12	12	erlotinib	EGFR	PA134687924	1956	0.94
NULL	Eur_J_Clin_Pharmacol_2010_Sep_16_66(9)_955.nxml.txt.nlp	20552178	SENT10	8	8	18	18	zolpidem	CYP3A4	PA451976	1576	0.94
NULL	Acta_Pharmacol_Sin_2009_Sep_24_30(9)_1262-1275.nxml.txt.nlp	19701231	SENT168	27	27	10	10	lovastatin	SCAP	PA450272	22937	0.94
NULL	Cell_Death_Dis_2011_Aug_11_2(8)_e191.nxml.txt.nlp	21833029	SENT63	11	11	16	16	oxaliplatin	CT26	PA131285527	168400	0.94
NULL	Int_J_Chron_Obstruct_Pulmon_Dis_2007_Sep_2(3)_205-228.nxml.txt.nlp	18229560	SENT309	6	6	18	18	cilomilast	CXCL8	PA165948031	3576	0.94
NULL	Mol_Cancer_2004_Jul_12_3_19.nxml.txt.nlp	15248896	SENT240	4	4	11	11	oxygen	HIF-1	PA450744	29072	0.94
NULL	Cancers_(Basel)_2010_Oct_25_2(4)_1794-1812.nxml.txt.nlp	24281201	SENT237	22	22	28	28	gemcitabine	CD133	PA449748	8842	0.94
NULL	Med_Sci_Monit_2013_Oct_21_19_875-882.nxml.txt.nlp	24145180	SENT33	21	21	10	10	bevacizumab	CXCL8	PA130232992	3576	0.94
NULL	Biomed_Res_Int_2014_Jan_29_2014_831845.nxml.txt.nlp	24605337	SENT122	12	12	28	28	bupivacaine	S6K1	PA135057240	6198	0.94
NULL	Acta_Pharmacol_Sin_2011_Jul_20_32(7)_956-966.nxml.txt.nlp	21685928	SENT24	11	11	23	23	nimodipine	A10	PA450633	28870	0.94
NULL	Nature_2008_Nov_13_456(7219)_269-273.nxml.txt.nlp	18849969	SENT42	25	25	7	7	forskolin	FOXO1	PA146096022	2308	0.94
NULL	Onco_Targets_Ther_2014_Jun_20_7_1123-1127.nxml.txt.nlp	25018638	SENT5	15	15	11	11	doxorubicin	CHOP	PA449412	1649	0.94
NULL	Eur_J_Clin_Pharmacol_2011_May_8_67(5)_493-506.nxml.txt.nlp	21140139	SENT231	16	16	25	25	oxymorphone	CYP3A4	PA450748	1576	0.94
NULL	Eur_J_Immunol_2013_Dec_9_43(12)_3183-3196.nxml.txt.nlp	24030559	SENT107	35	35	10	10	mitomycin	PI3K	PA450524	5290	0.94
NULL	J_Hematol_Oncol_2014_Aug_12_7_57.nxml.txt.nlp	25112836	SENT172	20	20	8	8	vincristine	TLR7	PA451879	51284	0.94
NULL	Breast_Cancer_Res_2011_Mar_24_13(2)_R32.nxml.txt.nlp	21435239	SENT258	25	25	21	21	curcumin	ARNT	PA151958596	405	0.94
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1137-1144.nxml.txt.nlp	20234366	SENT187	9	9	0	0	cetuximab	KRAS	PA10040	3845	0.94
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT112	0	0	20	20	curcumin	PC-3	PA151958596	692094	0.94
NULL	Oncoimmunology_2012_Nov_1_1(8)_1422-1424.nxml.txt.nlp	23243615	SENT22	9	9	12	12	tamoxifen	aromatase	PA451581	1588	0.94
NULL	Oncol_Lett_2014_Nov_14_8(5)_2086-2092.nxml.txt.nlp	25295095	SENT103	19	19	3	3	gemcitabine	LKB1	PA449748	6794	0.94
NULL	J_Biol_Chem_2013_Nov_22_288(47)_34217-34229.nxml.txt.nlp	24106270	SENT374	15	15	30	30	thrombin	GPVI	PA451674	51206	0.94
NULL	Cardiovasc_Ther_2009_27(3)_151-158.nxml.txt.nlp	19604249	SENT24	34	34	5	5	amlodipine	AT1	PA448388	9197;185	0.94
NULL	Anticancer_Agents_Med_Chem_2013_Jun_13(5)_681-688.nxml.txt.nlp	23092289	SENT114	24	24	32	32	trastuzumab	HER-2	PA451743	2064	0.94
NULL	Anat_Cell_Biol_2010_Sep_30_43(3)_194-200.nxml.txt.nlp	21212859	SENT86	21	21	2	2	ethanol	PLP	PA448073	25824;5744	0.94
NULL	Diabetes_Metab_Syndr_Obes_2010_Jul_20_3_263-273.nxml.txt.nlp	21437094	SENT162	14	14	5	5	exenatide	GLP-1	PA164749238	100125288	0.94
NULL	Int_J_Mol_Sci_2012_Aug_23_13(8)_10608-10629.nxml.txt.nlp	22949883	SENT963	4	4	15	15	curcumin	Q10	PA151958596	27161	0.94
NULL	Scientifica_(Cairo)_2013_Feb_7_2013_249101.nxml.txt.nlp	24278770	SENT194	18	18	8	8	alemtuzumab	IFN	PA164783958	3439	0.94
NULL	Oncotarget_2012_Sep_28_3(10)_1169-1181.nxml.txt.nlp	23045411	SENT198	32	32	18	18	doxorubicin	JIP1	PA449412	9479	0.94
NULL	Nucleic_Acids_Res_2011_Mar_23_39(4)_1526-1537.nxml.txt.nlp	20972225	SENT195	1	1	15	15	tetracycline	BCS	PA451640	617	0.94
NULL	Mol_Cancer_2009_Nov_10_8_99.nxml.txt.nlp	19903356	SENT5	36	36	30	30	imatinib	IGFBP3	PA10804	3486	0.94
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT287	26	26	17	17	bevacizumab	VEGF-A	PA130232992	7422	0.94
NULL	Adv_Hematol_2012_Mar_26_2012_932658.nxml.txt.nlp	22548067	SENT77	18	18	38	38	etoposide	CHOP	PA449552	1649	0.94
NULL	Int_J_Endocrinol_2011_Aug_21_2011_742719.nxml.txt.nlp	21869886	SENT167	7	7	1	1	cangrelor	P2Y12	PA165945763	64805	0.94
NULL	J_Cell_Biol_1999_Dec_27_147(7)_1493-1502.nxml.txt.nlp	10613907	SENT623	12	12	40	40	galactose	ANT-1	PA449725	24148	0.94
NULL	Mol_Cell_Proteomics_2012_Mar_13_11(3)_M111_014654.nxml.txt.nlp	22167270	SENT536	12	12	9	9	geldanamycin	Hsp90	PA152031327	3320	0.94
NULL	Cancer_Inform_2008_Jun_10_6_315-355.nxml.txt.nlp	19259415	SENT340	14	14	8	8	cisplatin	IL-6	PA449014	3569	0.94
NULL	Nucleic_Acids_Res_2005_Jun_8_33(10)_3283-3291.nxml.txt.nlp	15944449	SENT156	16	16	9	9	sjg-136	ERCC1		2067	0.94
NULL	Breast_Cancer_Res_2008_Feb_1_10(1)_R10.nxml.txt.nlp	18241344	SENT187	43	43	29	29	cisplatin	CD44	PA449014	960	0.94
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Oct_31_70(Pt_11)_451-453.nxml.txt.nlp	25484772	SENT10	3	3	37	37	coumarin	mol	PA134521193	90527	0.94
NULL	Breast_Cancer_(Auckl)_2011_Jan_13_5_1-14.nxml.txt.nlp	21494397	SENT207	0	0	16	16	ixabepilone	CYP3A4		1576	0.94
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Oct_20_66(Pt_11)_o2853.nxml.txt.nlp	21589038	SENT49	19	19	7	7	ethanol	mol	PA448073	90527	0.94
NULL	EMBO_J_2010_Mar_17_29(6)_1116-1125.nxml.txt.nlp	20186120	SENT98	26	26	9	9	galactose	ICT1	PA449725	3396	0.94
NULL	Indian_J_Pharmacol_2009_Aug_41(4)_167-172.nxml.txt.nlp	20523867	SENT139	38	38	17	17	acetaminophen	CYP2D6	PA448015	1565	0.94
NULL	J_Med_Chem_2014_Jul_24_57(14)_5995-6007.nxml.txt.nlp	24960438	SENT327	21	21	5	5	estradiol	HSD2	PA449503	6060	0.94
NULL	Int_J_Mol_Sci_2012_Feb_24_13(3)_2578-2589.nxml.txt.nlp	22489112	SENT64	10	10	15	15	desipramine	GAT1	PA449233	6529	0.94
NULL	Cancer_2011_Apr_15_117(8)_1670-1678.nxml.txt.nlp	21472714	SENT15	19	19	4	4	cisplatin	SIRT3	PA449014	23410	0.94
NULL	J_Int_Soc_Sports_Nutr_2015_Jan_21_12(1)_5.nxml.txt.nlp	NULL	SENT213	17	17	28	28	curcumin	IL-6	PA151958596	3569	0.94
NULL	Mol_Cancer_2012_Jun_18_11_41.nxml.txt.nlp	22709873	SENT70	42	42	20	20	lapatinib	CCND1	PA152241907	595	0.94
NULL	Br_J_Cancer_2013_Oct_15_109(8)_2051-2057.nxml.txt.nlp	24064969	SENT85	10	10	27	27	capecitabine	SOC	PA448771	91544	0.94
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1449-1456.nxml.txt.nlp	24077631	SENT116	28	28	5	5	tolbutamide	CYP2C9	PA451718	1559	0.94
NULL	Nat_Med_2013_Mar_10_19(3)_313-321.nxml.txt.nlp	23396211	SENT386	11	11	4	4	amlexanox	adiponectin	PA164745310	9370	0.94
NULL	Indian_J_Radiol_Imaging_2008_Aug_18(3)_256-263.nxml.txt.nlp	19774171	SENT30	27	27	13	13	heparin	ACT	PA449855	12;11332;9457;641455	0.94
NULL	Mol_Cancer_2010_Apr_23_9_87.nxml.txt.nlp	20416058	SENT80	26	26	20	20	doxorubicin	TRAIL	PA449412	8743	0.94
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT785	18	18	8	8	rocuronium	OATP1A2	PA164754992	6579	0.94
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT795	2	2	16	16	nilotinib	MRP7	PA165958345	89845;1080	0.94
NULL	Br_J_Cancer_2009_Sep_15_101(6)_957-966.nxml.txt.nlp	19738618	SENT170	10	10	4	4	dexrazoxane	THBS-1	PA449259	7057	0.94
NULL	Oxid_Med_Cell_Longev_2010_Jan-Feb_3(1)_23-34.nxml.txt.nlp	20716925	SENT102	18	18	6	6	genistein	UGT1A7	PA165109660	54577	0.94
NULL	Nucleic_Acids_Res_2005_Jun_8_33(10)_3283-3291.nxml.txt.nlp	15944449	SENT116	21	21	13	13	sjg-136	XRCC3		7517	0.94
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Oct_17_65(Pt_11)_o2775.nxml.txt.nlp	21578368	SENT83	29	29	12	12	ethanol	mol	PA448073	90527	0.94
NULL	Iran_J_Pharm_Res_2014_Autumn_13(4)_1327-1334.nxml.txt.nlp	25587322	SENT21	7	7	2	2	econazole	PC3	PA164746010	57332;7832;5122	0.94
NULL	J_Hematol_Oncol_2012_Jul_16_5_39.nxml.txt.nlp	22800464	SENT94	7	7	19	19	sunitinib	FLT3	PA162372840	2322	0.94
NULL	Allergy_Asthma_Immunol_Res_2009_Oct_25_1(1)_30-35.nxml.txt.nlp	20224667	SENT79	47	47	39	39	aspirin	PPARG	PA448497	5468	0.94
NULL	Front_Behav_Neurosci_2009_Jan_27_3_1.nxml.txt.nlp	19194528	SENT10	33	33	24	24	imipramine	EPM	PA449969	2054	0.94
NULL	J_Immunother_2014_Feb_21_37(2)_105-114.nxml.txt.nlp	24509173	SENT87	7	7	2	2	gemcitabine	WT1	PA449748	7490	0.94
NULL	Clin_Pharmacol_2013_Dec_9_5_185-192.nxml.txt.nlp	24353446	SENT4	20	20	28	28	clopidogrel	CYP3A	PA449053	1574	0.94
NULL	BMB_Rep_2014_Jun_47(6)_299-310.nxml.txt.nlp	24856830	SENT169	20	20	35	35	olaparib	BRCA1		672	0.94
NULL	Mediators_Inflamm_2010_Mar_30_2010_280464.nxml.txt.nlp	20369000	SENT78	4	4	19	19	pp2	ghrelin		51738	0.94
NULL	Cardiovasc_Diabetol_2013_Nov_12_12_169.nxml.txt.nlp	24215514	SENT263	21	21	15	15	valsartan	AT2	PA451848	186	0.94
NULL	Cardiovasc_Ultrasound_2011_Dec_29_9_43.nxml.txt.nlp	22206473	SENT95	13	13	0	0	ethanol	GLP-1	PA448073	100125288	0.94
NULL	Exp_Mol_Med_2012_Oct_31_44(10)_622-632.nxml.txt.nlp	23095254	SENT116	18	18	11	11	glucose	IL-6	PA449773	3569	0.94
NULL	Cell_Commun_Signal_2013_Sep_18_11_69.nxml.txt.nlp	24047462	SENT44	9	9	4	4	doxorubicin	BTG2	PA449412	7832	0.94
NULL	Pharmaceuticals_(Basel)_2012_Aug_30_5(9)_890-898.nxml.txt.nlp	24280696	SENT51	30	30	15	15	geldanamycin	Hsp90	PA152031327	3320	0.94
NULL	Cancers_(Basel)_2013_Jan_31_5(1)_149-169.nxml.txt.nlp	24216702	SENT222	28	28	23	23	erlotinib	EGFR	PA134687924	1956	0.94
NULL	Front_Oncol_2013_Oct_4_3_241.nxml.txt.nlp	24109588	SENT353	22	22	5	5	temozolomide	EGFR	PA451609	1956	0.94
NULL	Oncotarget_2013_Feb_27_4(2)_329-345.nxml.txt.nlp	23593654	SENT9	3	3	16	16	paclitaxel	CD44	PA450761	960	0.94
NULL	Emerg_Infect_Dis_2014_Mar_20(3)_506-507.nxml.txt.nlp	24565423	SENT21	27	27	5	5	linezolid	DST	PA450233	667	0.94
NULL	Int_J_Mol_Sci_2014_Mar_20_15(3)_4965-4976.nxml.txt.nlp	24658440	SENT5	20	20	26	26	tacrolimus	P-gp	PA451578	5243	0.94
NULL	Korean_Circ_J_2013_May_31_43(5)_343-346.nxml.txt.nlp	23755082	SENT52	27	27	8	8	clopidogrel	DES	PA449053	1674	0.94
NULL	Biomed_Res_Int_2013_Mar_19_2013_726375.nxml.txt.nlp	23586056	SENT30	4	4	16	16	erlotinib	EGFR	PA134687924	1956	0.94
NULL	J_Carcinog_2011_Nov_30_10_28.nxml.txt.nlp	22190870	SENT200	34	34	11	11	paclitaxel	VEGF-A	PA450761	7422	0.94
NULL	Br_J_Cancer_2010_Sep_28_103(7)_1008-1018.nxml.txt.nlp	20736947	SENT47	32	32	10	10	docetaxel	MCT1	PA449383	6566	0.94
NULL	Evid_Based_Complement_Alternat_Med_2013_Aug_12_2013_982689.nxml.txt.nlp	23997806	SENT225	15	15	20	20	tolbutamide	APE	PA451718	55704;328	0.94
NULL	Nat_Genet_2011_Jun_5_43(7)_621-629.nxml.txt.nlp	21642992	SENT343	14	14	33	33	doxorubicin	LAP3	PA449412	51056	0.94
NULL	Brain_2014_Apr_27_137(4)_1145-1155.nxml.txt.nlp	24578545	SENT236	44	44	25	25	citalopram	MRI	PA449015	78996	0.94
NULL	Front_Oncol_2014_Mar_3_4_35.nxml.txt.nlp	24624362	SENT141	31	31	15	15	cetuximab	PIK3CA	PA10040	5290	0.94
NULL	J_Radiat_Res_2012_Jul_12_53(4)_551-557.nxml.txt.nlp	22843620	SENT104	16	16	10	10	lindane	CBX	PA164754914	10951	0.94
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT10	9	9	15	15	nutlin-3	p53		7157	0.94
NULL	Mol_Cancer_2007_Mar_7_6_18.nxml.txt.nlp	17343740	SENT389	15	15	27	27	paraformaldehyde	CD44	PA450790	960	0.94
NULL	Br_J_Clin_Pharmacol_2013_Aug_23_76(2)_299-315.nxml.txt.nlp	23701319	SENT230	18	18	7	7	bevacizumab	IL-17	PA130232992	3605	0.94
NULL	BMB_Rep_2013_Feb_46(2)_92-96.nxml.txt.nlp	23433111	SENT18	14	14	4	4	etoposide	BRCA1	PA449552	672	0.94
NULL	Mol_Cancer_2013_Nov_5_12_133.nxml.txt.nlp	24192080	SENT190	21	21	28	28	leflunomide	STAT6	PA450192	6778	0.94
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1137-1144.nxml.txt.nlp	20234366	SENT140	36	36	1	1	cetuximab	KRAS	PA10040	3845	0.94
NULL	Curr_Neuropharmacol_2012_Sep_10(3)_263-271.nxml.txt.nlp	23449968	SENT121	27	27	9	9	methylphenidate	LPHN3	PA450464	23284	0.94
NULL	Breast_Cancer_Res_2012_Mar_9_14(2)_R41.nxml.txt.nlp	22405131	SENT122	33	33	8	8	estradiol	TCL1A	PA449503	8115	0.94
NULL	Chem_Rev_2014_Jun_11_114(11)_5753-5774.nxml.txt.nlp	24758331	SENT404	40	40	28	28	flavopiridol	MRP1	PA452627	4437	0.94
NULL	Front_Genet_2014_Jan_2_4_301.nxml.txt.nlp	24427170	SENT637	8	8	11	11	doxorubicin	PTEN	PA449412	5728	0.94
NULL	Mol_Cancer_2014_Jan_15_13_9.nxml.txt.nlp	24428911	SENT199	11	11	0	0	doxycycline	SRSF2	PA449415	6427	0.94
NULL	Angiogenesis_2011_Sep_31_14(3)_245-253.nxml.txt.nlp	21452059	SENT162	16	16	28	28	topotecan	HIF-1	PA451729	29072	0.94
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT173	3	3	18	18	cisplatin	DR5	PA449014	8795	0.94
NULL	Cancer_Med_2014_Oct_2_3(5)_1385-1395.nxml.txt.nlp	24890702	SENT18	23	23	10	10	panitumumab	EGFR	PA162373091	1956	0.94
NULL	Breast_Cancer_Res_2008_Dec_5_10(6)_R104.nxml.txt.nlp	19061505	SENT281	25	25	2	2	estradiol	Bcl-2	PA449503	596	0.94
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT220	32	32	25	25	paclitaxel	ABCG2	PA450761	9429	0.94
NULL	Avicenna_J_Med_Biotechnol_2013_Apr-Jun_5(2)_87-95.nxml.txt.nlp	23799177	SENT35	15	15	22	22	cisplatin	HER2	PA449014	2064	0.94
NULL	Int_J_Cell_Biol_2012_Mar_27_2012_189794.nxml.txt.nlp	22536246	SENT101	9	9	32	32	resveratrol	Vps34		5289	0.94
NULL	Cancer_Cell_Int_2005_Jul_24_5_22.nxml.txt.nlp	16042792	SENT42	9	9	32	32	vincristine	NAC	PA451879	22861	0.94
NULL	J_Thromb_Thrombolysis_2011_Nov_26_32(4)_459-466.nxml.txt.nlp	21706290	SENT120	5	5	22	22	ticagrelor	CYP2C19	PA165374673	1557	0.94
NULL	Cancer_Res_Treat_2012_Sep_30_44(3)_202-209.nxml.txt.nlp	23091447	SENT121	22	22	20	20	gefitinib	EGFR	PA131301952	1956	0.94
NULL	J_Med_Genet_2013_Sep_24_50(9)_567-578.nxml.txt.nlp	23709754	SENT157	15	15	7	7	staurosporine	IFN	PA165109623	3439	0.94
NULL	Front_Physiol_2013_Jun_26_4_153.nxml.txt.nlp	23805106	SENT573	9	9	3	3	mexiletine	SCN5A	PA450488	6331	0.94
NULL	Arthritis_Res_Ther_2009_Nov_4_11(6)_R165.nxml.txt.nlp	19889203	SENT355	6	6	25	25	curcumin	Bcl-2	PA151958596	596	0.94
NULL	Cancers_(Basel)_2014_Mar_13_6(1)_595-624.nxml.txt.nlp	24633084	SENT274	14	14	28	28	lapatinib	HER2	PA152241907	2064	0.94
NULL	Case_Rep_Oncol_2012_Mar_17_5(1)_125-133.nxml.txt.nlp	22666200	SENT52	4	4	14	14	trastuzumab	HER2	PA451743	2064	0.94
NULL	Adolesc_Health_Med_Ther_2013_Aug_27_4_79-87.nxml.txt.nlp	24600298	SENT35	25	25	4	4	raltegravir	UGT1A1		54658	0.94
NULL	Chin_J_Cancer_2011_May_30(5)_327-335.nxml.txt.nlp	21527065	SENT34	16	16	5	5	lapatinib	PIK3CA	PA152241907	5290	0.94
NULL	Cell_Death_Differ_2010_Mar_16_17(3)_439-451.nxml.txt.nlp	19834489	SENT177	2	2	23	23	neomycin	GCT	PA450608	25797	0.94
NULL	Bone_2010_Mar_46(3)_628-642.nxml.txt.nlp	19857613	SENT680	14	14	2	2	estradiol	AF-1	PA449503	3460;5710	0.94
NULL	Breast_Cancer_Res_Treat_2013_May_12_139(1)_107-113.nxml.txt.nlp	23580070	SENT205	3	3	7	7	trastuzumab	HER2	PA451743	2064	0.94
NULL	Mol_Cancer_2014_Jan_13_13_7.nxml.txt.nlp	24418169	SENT234	29	29	21	21	sorafenib	Raf-1	PA7000	5894	0.94
NULL	Front_Genet_2012_May_30_3_94.nxml.txt.nlp	22666228	SENT115	30	30	7	7	paclitaxel	DAC	PA450761	13	0.94
NULL	J_Inflamm_(Lond)_2008_Jul_29_5_11.nxml.txt.nlp	18664275	SENT115	7	7	23	23	levofloxacin	IL-8	PA450214	3576	0.94
NULL	Acta_Pharmacol_Sin_2011_Jul_9_32(7)_879-887.nxml.txt.nlp	21552292	SENT173	6	6	11	11	metformin	TSC2	PA450395	7249	0.94
NULL	Oncotarget_2014_Mar_14_5(10)_3029-3038.nxml.txt.nlp	24912489	SENT20	22	22	20	20	exemestane	aromatase	PA449563	1588	0.94
NULL	Breast_Cancer_Res_2007_Dec_17_9(6)_R87.nxml.txt.nlp	18086299	SENT11	32	32	15	15	trastuzumab	CD40	PA451743	958	0.94
NULL	Mol_Cells_2014_Nov_30_37(11)_812-818.nxml.txt.nlp	25377255	SENT9	11	11	37	37	doxorubicin	PARP-1	PA449412	25976	0.94
NULL	Comp_Hepatol_2005_Feb_8_4_2.nxml.txt.nlp	15701172	SENT171	14	14	21	21	ketoconazole	CYP3A	PA450146	1574	0.94
NULL	Clin_Ophthalmol_2007_Mar_1(1)_61-64.nxml.txt.nlp	19668467	SENT87	1	1	29	29	tacrolimus	castor	PA451578	54897	0.94
NULL	Biologics_2010_Aug_9_4_173-185.nxml.txt.nlp	20714355	SENT221	27	27	36	36	cetuximab	p16	PA10040	1029	0.94
NULL	Acta_Neuropathol_Commun_2013_Jul_17_1_39.nxml.txt.nlp	24252174	SENT7	20	20	9	9	erlotinib	STZ	PA134687924	6484	0.94
NULL	Br_J_Cancer_2013_Aug_6_109(3)_686-693.nxml.txt.nlp	23839492	SENT136	24	24	13	13	pazopanib	IL-8	PA165291492	3576	0.94
NULL	Surg_Res_Pract_2014_Feb_6_2014_801643.nxml.txt.nlp	25379560	SENT12	16	16	8	8	sirolimus	CD25	PA451365	3669;3559	0.94
NULL	Br_J_Cancer_2013_Mar_19_108(5)_1052-1060.nxml.txt.nlp	23422754	SENT156	48	48	20	20	bevacizumab	VEGF-A	PA130232992	7422	0.94
NULL	Oxid_Med_Cell_Longev_2013_Jun_2_2013_793525.nxml.txt.nlp	23819014	SENT204	42	42	13	13	resveratrol	AMPK		5563	0.94
NULL	Int_J_Chron_Obstruct_Pulmon_Dis_2008_Dec_3(4)_543-561.nxml.txt.nlp	19281073	SENT240	30	30	6	6	rolipram	PDE7A	PA153906323	5150	0.94
NULL	Oncol_Lett_2013_Aug_25_6(2)_480-486.nxml.txt.nlp	24137351	SENT26	0	0	26	26	sorafenib	PTC	PA7000	5979;8030	0.94
NULL	Nat_Med_2014_Jun_18_20(6)_624-632.nxml.txt.nlp	24836577	SENT379	11	11	28	28	isoproterenol	ANOVA	PA450121	4858	0.94
NULL	Cancers_(Basel)_2013_Jan_31_5(1)_149-169.nxml.txt.nlp	24216702	SENT202	26	26	38	38	gefitinib	BRAF	PA131301952	673	0.94
NULL	Cell_J_2014_May_25_Summer_16(2)_163-170.nxml.txt.nlp	24567946	SENT149	30	30	2	2	naloxone	CA1	PA450586	759	0.94
NULL	Front_Immunol_2013_Nov_21_4_393.nxml.txt.nlp	24312100	SENT133	32	32	3	3	hyaluronan	NLRP3	PA165958431	114548	0.94
NULL	Contemp_Oncol_(Pozn)_2013_Apr_29_17(2)_137-143.nxml.txt.nlp	23788980	SENT202	2	2	15	15	octreotide	ACTH	PA450678	5443	0.94
NULL	Breast_Cancer_Res_2002_Apr_4_4(3)_85-89.nxml.txt.nlp	12052249	SENT41	11	11	1	1	tamoxifen	SULT1A1	PA451581	6817	0.94
NULL	Breast_Cancer_Res_2008_Jul_8_10(4)_R56.nxml.txt.nlp	18611244	SENT242	22	22	36	36	tamoxifen	aromatase	PA451581	1588	0.94
NULL	Oncotarget_2014_Jun_1_5(13)_4868-4880.nxml.txt.nlp	24947902	SENT235	5	5	8	8	afatinib	HER2	PA165981154	2064	0.94
NULL	J_Oncol_2012_Feb_6_2012_737981.nxml.txt.nlp	22481932	SENT101	16	16	31	31	cisplatin	STAT3	PA449014	6774	0.94
NULL	Cells_2012_Sep_28_1(4)_699-710.nxml.txt.nlp	24710526	SENT41	20	20	4	4	heparin	HMGB1	PA449855	3146	0.94
NULL	Ecancermedicalscience_2010_Feb_3_4_164.nxml.txt.nlp	22276026	SENT719	29	29	20	20	trastuzumab	IL-6	PA451743	3569	0.94
NULL	Nat_Genet_2014_Feb_15_46(2)_152-160.nxml.txt.nlp	24336168	SENT36	39	39	9	9	galactose	TDP-43	PA449725	23435	0.94
NULL	Cell_Cycle_2012_Jun_15_11(12)_2229.nxml.txt.nlp	22672903	SENT45	20	20	12	12	mitomycin	CDK9	PA450524	1025	0.94
NULL	Breast_Cancer_Res_2010_Aug_23_12(4)_R64.nxml.txt.nlp	20731819	SENT62	26	26	14	14	tamoxifen	CYP2D6	PA451581	1565	0.94
NULL	Diabetes_2011_Mar_21_60(3)_757-765.nxml.txt.nlp	21282370	SENT42	16	16	9	9	isoproterenol	PTRF	PA450121	284119	0.94
NULL	Exp_Neurobiol_2013_Mar_31_22(1)_45-50.nxml.txt.nlp	23585722	SENT123	5	5	8	8	fluoxetine	EPO	PA449673	7076;8288;2056	0.94
NULL	Turk_J_Haematol_2012_Mar_5_29(1)_1-9.nxml.txt.nlp	24744617	SENT52	14	14	2	2	fosaprepitant	NK-1	PA165958390	27087	0.94
NULL	Ann_Dermatol_2011_Oct_31_23(Suppl_2)_S169-S174.nxml.txt.nlp	22148042	SENT104	15	15	11	11	vincristine	CHOP	PA451879	1649	0.94
NULL	Biologics_2012_Sep_25_6_337-345.nxml.txt.nlp	23055691	SENT178	2	2	13	13	erlotinib	EGFR	PA134687924	1956	0.94
NULL	Front_Neuroengineering_2008_Dec_12_1_2.nxml.txt.nlp	19129909	SENT105	39	39	24	24	nadh	GDH	PA164755085	51084;2746	0.939
NULL	Iran_J_Basic_Med_Sci_2012_Jan-Feb_15(1)_669-677.nxml.txt.nlp	23493035	SENT197	8	8	16	16	tamoxifen	EGFR	PA451581	1956	0.939
NULL	Int_J_Mol_Sci_2014_Sep_15_15(9)_16226-16245.nxml.txt.nlp	25226533	SENT187	2	2	5	5	vincristine	HIF-1	PA451879	29072	0.939
NULL	J_Ginseng_Res_2011_Nov_35(4)_471-478.nxml.txt.nlp	23717094	SENT180	10	10	17	17	ethanol	CaCC	PA448073	1179	0.939
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT37	11	11	3	3	neratinib	HER2	PA165291472	2064	0.939
NULL	Br_J_Cancer_2000_Oct_4_83(7)_899-905.nxml.txt.nlp	10970692	SENT4	8	8	3	3	hydralazine	RIF1	PA449894	55183;55791;11172	0.939
NULL	Adv_Nutr_2013_Mar_6_4(2)_226-235.nxml.txt.nlp	23493539	SENT162	2	2	10	10	ethanol	ADH1B	PA448073	125	0.939
NULL	Mol_Vis_2014_Dec_19_20_1680-1694.nxml.txt.nlp	25558172	SENT28	30	30	11	11	bevacizumab	ARMS2	PA130232992	387715	0.939
NULL	Nucl_Recept_Signal_2009_Jan_16_7_e001.nxml.txt.nlp	19240808	SENT425	18	18	31	31	phenytoin	CYP2B	PA450947	1554;1556	0.939
NULL	Mol_Cancer_2010_May_26_9_121.nxml.txt.nlp	20500904	SENT109	12	12	3	3	gefitinib	AKT	PA131301952	207	0.939
NULL	Int_J_Mol_Sci_2014_Sep_29_15(10)_17411-17441.nxml.txt.nlp	25268615	SENT2015	18	18	2	2	paclitaxel	CD147	PA450761	682	0.939
NULL	Br_J_Cancer_2013_Feb_19_108(3)_668-675.nxml.txt.nlp	23348520	SENT28	20	20	10	10	cetuximab	HER2	PA10040	2064	0.939
NULL	Surg_Today_2012_Jan_6_42(1)_8-28.nxml.txt.nlp	22139128	SENT140	17	17	10	10	galactose	PSK	PA449725	9344	0.939
NULL	ScientificWorldJournal_2012_Apr_1_2012_381434.nxml.txt.nlp	22545017	SENT250	9	9	7	7	aprepitant	NK-1	PA164747039	27087	0.939
NULL	Front_Pharmacol_2014_Mar_27_5_52.nxml.txt.nlp	24723889	SENT212	0	0	7	7	resveratrol	SIRT1		23411	0.939
NULL	Front_Synaptic_Neurosci_2010_Feb_22_2_1.nxml.txt.nlp	21423487	SENT101	28	28	14	14	picrotoxin	CA3	PA164777007	761	0.939
NULL	Acta_Pharmacol_Sin_2014_Jun_4_35(6)_752-757.nxml.txt.nlp	24902786	SENT88	5	5	25	25	flutamide	castor	PA449685	54897	0.939
NULL	Eur_J_Clin_Pharmacol_2014_Oct_8_70(1)_37-45.nxml.txt.nlp	24100471	SENT199	2	2	8	8	rifampin	CYP2C8	PA451250	1558	0.939
NULL	Med_Sci_Monit_2013_Oct_31_19_916-926.nxml.txt.nlp	24172537	SENT175	5	5	1	1	gefitinib	EGFR	PA131301952	1956	0.939
NULL	Cancers_(Basel)_2013_May_10_5(2)_529-549.nxml.txt.nlp	24216990	SENT226	0	0	3	3	sunitinib	TKR	PA162372840	8277	0.939
NULL	Nat_Med_2014_Jan_15_20(1)_54-61.nxml.txt.nlp	24336249	SENT116	6	6	24	24	anakinra	IL-17	PA10799	3605	0.939
NULL	Cell_Mol_Life_Sci_2011_Nov_2_68(21)_3573-3587.nxml.txt.nlp	21365278	SENT203	17	17	43	43	iloprost	PGD2	PA164746843	27306	0.939
NULL	Biochemistry_2009_Feb_3_48(4)_800-809.nxml.txt.nlp	19132922	SENT306	11	11	25	25	zaleplon	XOR	PA451952	7498	0.939
NULL	J_Exp_Med_1998_Jun_1_187(11)_1885-1892.nxml.txt.nlp	9607928	SENT133	6	6	17	17	thalidomide	CD4	PA451644	920	0.939
NULL	ScientificWorldJournal_2014_Dec_9_2014_808320.nxml.txt.nlp	25548793	SENT100	6	6	30	30	heparin	RAC	PA449855	207	0.939
NULL	Core_Evid_2010_Oct_21_5_61-76.nxml.txt.nlp	21042543	SENT32	0	0	15	15	panitumumab	EGFR	PA162373091	1956	0.939
NULL	J_Cell_Mol_Med_2014_Oct_11_18(10)_2031-2043.nxml.txt.nlp	25109475	SENT152	9	9	5	5	valsartan	AMPK	PA451848	5563	0.939
NULL	Case_Rep_Oncol_2013_Mar_29_6(1)_189-196.nxml.txt.nlp	23626560	SENT16	1	1	21	21	erlotinib	EGFR	PA134687924	1956	0.939
NULL	Oncotarget_2011_Dec_31_2(12)_1314-1321.nxml.txt.nlp	22248929	SENT62	36	36	21	21	lapatinib	HER3	PA152241907	2065	0.939
NULL	Br_J_Cancer_2012_Jun_26_107(1)_116-122.nxml.txt.nlp	22596240	SENT145	35	35	17	17	imatinib	TRAIL	PA10804	8743	0.939
NULL	Int_J_Biomed_Imaging_2013_Feb_26_2013_230487.nxml.txt.nlp	23533377	SENT152	1	1	9	9	trastuzumab	HER2	PA451743	2064	0.939
NULL	Oncol_Rep_2012_Apr_16_27(4)_1245-1250.nxml.txt.nlp	22266802	SENT100	33	33	20	20	sulindac	p50	PA451565	958;4790	0.939
NULL	Diabetes_Care_2010_Jul_31_33(7)_1544-1548.nxml.txt.nlp	20357370	SENT100	21	21	6	6	metformin	STK11	PA450395	6794	0.939
NULL	Cancer_Cell_Int_2013_Nov_8_13_111.nxml.txt.nlp	24209962	SENT4	3	3	29	29	fluvastatin	A20	PA449688	7128;28935	0.939
NULL	J_Skin_Cancer_2012_Sep_13_2012_907543.nxml.txt.nlp	23024864	SENT76	5	5	3	3	vismodegib	SMO		6608;54498	0.939
NULL	Anal_Chem_Insights_2014_Mar_2_9_1-7.nxml.txt.nlp	24634579	SENT43	40	40	29	29	ethanol	TRB	PA448073	6957	0.939
NULL	Nat_Med_2010_Nov_24_16(11)_1299-1304.nxml.txt.nlp	20972434	SENT189	11	11	34	34	chloroquine	VASP	PA448948	7408	0.939
NULL	Chin_J_Cancer_2012_Oct_31(10)_476-483.nxml.txt.nlp	22692073	SENT134	18	18	12	12	gemcitabine	RRM1	PA449748	6240	0.939
NULL	Cell_Commun_Signal_2013_Oct_1_11_73.nxml.txt.nlp	24083678	SENT105	4	4	32	32	sulindac	HMGB1	PA451565	3146	0.939
NULL	Archaea_2010_Dec_23_2010_690737.nxml.txt.nlp	21234345	SENT14	34	34	9	9	choline	C-1	PA448976	5203	0.939
NULL	Nat_Med_2012_Jan_22_18(2)_224-226.nxml.txt.nlp	22270723	SENT13	12	12	10	10	celecoxib	PTGS2	PA448871	5743	0.939
NULL	N_Am_J_Med_Sci_2011_Jan_3(1)_1-12.nxml.txt.nlp	22540056	SENT134	21	21	18	18	gemcitabine	MRP5	PA449748	10057	0.939
NULL	Oncol_Lett_2013_Apr_8_5(4)_1295-1300.nxml.txt.nlp	23599782	SENT19	0	0	18	18	cetuximab	EGFR	PA10040	1956	0.939
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_7-17.nxml.txt.nlp	17912633	SENT160	7	7	10	10	letrozole	aromatase	PA450196	1588	0.939
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT799	38	38	6	6	rosuvastatin	NTCP	PA134308647	6554	0.939
NULL	J_Korean_Med_Sci_2012_Sep_22_27(9)_1037-1043.nxml.txt.nlp	22969249	SENT141	5	5	9	9	paricalcitol	STAT3	PA450798	6774	0.939
NULL	Thorax_2009_Aug_12_64(8)_671-676.nxml.txt.nlp	19213775	SENT155	10	10	17	17	cilomilast	IL-8	PA165948031	3576	0.939
NULL	Acta_Pharmacol_Sin_2011_Oct_5_32(10)_1266-1275.nxml.txt.nlp	21892202	SENT69	35	35	14	14	trypsin	NAC	PA451806	22861	0.939
NULL	J_Headache_Pain_2008_Oct_31_9(5)_267-276.nxml.txt.nlp	18668197	SENT136	0	0	29	29	fenfluramine	5-HT1A	PA449592	3350	0.939
NULL	Clin_Sci_(Lond)_2011_Feb_1_120(Pt_4)_161-167.nxml.txt.nlp	20828371	SENT94	7	7	17	17	propranolol	CTRL	PA451145	1506	0.939
NULL	Oncotarget_2012_Dec_17_4(1)_48-63.nxml.txt.nlp	23295955	SENT184	30	30	3	3	methotrexate	MTHFD2	PA450428	10797	0.939
NULL	Clin_Dev_Immunol_2007_Jan_20_2007_76396.nxml.txt.nlp	18317531	SENT81	17	17	9	9	sertraline	MCP-1	PA451333	6347	0.939
NULL	Anesth_Essays_Res_2011_Jul-Dec_5(2)_196-200.nxml.txt.nlp	NULL	SENT47	0	0	14	14	fentanyl	NIBP	PA449599	83696	0.939
NULL	Mediators_Inflamm_2011_Jul_3_2011_296069.nxml.txt.nlp	21765615	SENT164	10	10	2	2	glucose	TSP-1	PA449773	7057	0.939
NULL	J_Gynecol_Oncol_2014_Apr_9_25(2)_130-135.nxml.txt.nlp	24761217	SENT122	8	8	21	21	paclitaxel	P-gp	PA450761	5243	0.939
NULL	Eur_J_Clin_Pharmacol_2014_Oct_8_70(1)_37-45.nxml.txt.nlp	24100471	SENT15	4	4	38	38	midazolam	OATP1B1	PA450496	10599	0.939
NULL	Cancer_Immunol_Immunother_2013_Jul_20_62(9)_1533-1545.nxml.txt.nlp	23873089	SENT102	29	29	12	12	ixabepilone	CD4		920	0.939
NULL	Acta_Pharmacol_Sin_2013_Sep_5_34(9)_1192-1200.nxml.txt.nlp	23685957	SENT207	4	4	21	21	curcumin	AP-2	PA151958596	7020	0.939
NULL	Front_Endocrinol_(Lausanne)_2013_Jan_7_3_180.nxml.txt.nlp	23316185	SENT271	18	18	8	8	glucose	CRF2	PA449773	1395	0.939
NULL	Atherosclerosis_2011_Nov_219(1)_109-115.nxml.txt.nlp	21820657	SENT293	31	31	12	12	probucol	CETP	PA451107	1071	0.939
NULL	Br_J_Cancer_2010_Oct_12_103(8)_1297-1304.nxml.txt.nlp	20842126	SENT111	44	44	19	19	choline	SMO	PA448976	6608;54498	0.939
NULL	J_Breast_Cancer_2013_Jun_28_16(2)_138-145.nxml.txt.nlp	23843844	SENT14	7	7	18	18	tamoxifen	STAT3	PA451581	6774	0.939
NULL	Mol_Cancer_2007_Oct_11_6_63.nxml.txt.nlp	17931419	SENT82	8	8	45	45	gefitinib	EGFR	PA131301952	1956	0.939
NULL	AIDS_Res_Ther_2013_May_1_10_10.nxml.txt.nlp	23634877	SENT149	25	25	10	10	atorvastatin	CD4	PA448500	920	0.939
NULL	Pharmaceutics_2011_Oct_12_3(4)_680-705.nxml.txt.nlp	24309303	SENT68	17	17	4	4	glibenclamide	OATP2B1	PA449782	11309	0.939
NULL	Breast_Cancer_Res_2005_Jun_17_7(Suppl_2)_S_13.nxml.txt.nlp	NULL	SENT8	21	21	18	18	anastrozole	aromatase	PA448432	1588	0.939
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT269	5	5	11	11	tacrolimus	JAK2	PA451578	3717	0.939
NULL	Cancers_(Basel)_2014_Mar_26_6(2)_708-722.nxml.txt.nlp	24675568	SENT107	27	27	40	40	afatinib	IL-6	PA165981154	3569	0.939
NULL	Colomb_Med_(Cali)_43(4)_305-311.nxml.txt.nlp	24893304	SENT152	43	43	14	14	ganciclovir	CD4	PA449733	920	0.939
NULL	Cancer_Manag_Res_2014_May_23_6_225-252.nxml.txt.nlp	24904222	SENT117	18	18	9	9	exemestane	aromatase	PA449563	1588	0.939
NULL	Virol_J_2011_May_17_8_235.nxml.txt.nlp	21586146	SENT75	21	21	10	10	ganciclovir	DEF	PA449733	27042	0.939
NULL	Chem_Rev_2014_Jun_11_114(11)_5753-5774.nxml.txt.nlp	24758331	SENT121	24	24	36	36	paclitaxel	P-gp	PA450761	5243	0.939
NULL	J_Invest_Dermatol_2013_May_10_133(5)_1340-1350.nxml.txt.nlp	23303455	SENT177	0	0	22	22	camptothecin	RTCA	PA153590860	8634	0.939
NULL	Nat_Commun_2013_Sep_4_4_2338.nxml.txt.nlp	24005565	SENT125	15	15	7	7	cisplatin	RAD51B	PA449014	5890	0.939
NULL	Acta_Pharmacol_Sin_2010_Jul_28_31(7)_798-804.nxml.txt.nlp	20581852	SENT41	17	17	10	10	phenylephrine	AMPK	PA450935	5563	0.939
NULL	Cancer_Res_Treat_2015_Jan_21_47(1)_72-77.nxml.txt.nlp	25143051	SENT119	33	33	15	15	capecitabine	B12	PA448771	7126;4709	0.939
NULL	Ann_Oncol_2014_Apr_10_25(4)_808-815.nxml.txt.nlp	24615500	SENT8	8	8	28	28	exemestane	aromatase	PA449563	1588	0.939
NULL	J_Oncol_2009_Mar_24_2009_491985.nxml.txt.nlp	19325924	SENT101	8	8	34	34	genistein	CXCL12	PA165109660	6387	0.939
NULL	Nucleic_Acids_Res_2010_Oct_4_38(19)_6375-6388.nxml.txt.nlp	20525792	SENT156	32	32	14	14	doxycycline	YY1	PA449415	7528	0.939
NULL	Oncotarget_2014_Oct_15_5(21)_10763-10777.nxml.txt.nlp	25333257	SENT154	41	41	33	33	sn-38	P-gp		5243	0.939
NULL	Cancer_Res_Treat_2014_Jan_15_46(1)_81-92.nxml.txt.nlp	24520227	SENT183	10	10	4	4	cisplatin	COX	PA449014	1351	0.939
NULL	Exp_Mol_Med_2012_May_31_44(5)_311-318.nxml.txt.nlp	22282402	SENT45	26	26	4	4	cilostazol	MCP-1	PA164746334	6347	0.939
NULL	Diabetes_Care_2013_Jun_15_36(6)_e80.nxml.txt.nlp	23704688	SENT10	26	26	29	29	exenatide	GLP-1	PA164749238	100125288	0.939
NULL	Environ_Health_Perspect_2009_Feb_8_117(2)_175-180.nxml.txt.nlp	19270784	SENT207	14	14	4	4	doxorubicin	BPA	PA449412	667	0.939
NULL	Daru_2012_Nov_30_20(1)_82.nxml.txt.nlp	23351311	SENT159	11	11	21	21	genistein	p53	PA165109660	7157	0.939
NULL	Int_J_Biol_Sci_2014_Sep_6_10(9)_990-996.nxml.txt.nlp	25210497	SENT94	4	4	8	8	capsaicin	TRPV1	PA448776	7442	0.939
NULL	Biomed_Res_Int_2013_Dec_19_2013_817279.nxml.txt.nlp	24455727	SENT195	4	4	0	0	cetuximab	EGFR	PA10040	1956	0.939
NULL	Cancer_Cell_Int_2014_Jun_16_14_53.nxml.txt.nlp	24966801	SENT192	16	16	9	9	metformin	p62	PA450395	8878;10657;23636	0.939
NULL	Open_Biochem_J_2011_Sep_23_5_45-51.nxml.txt.nlp	21966325	SENT71	15	15	9	9	diclofenac	ATF6	PA449293	22926	0.939
NULL	Indian_J_Endocrinol_Metab_2014_Jul-Aug_18(4)_546-551.nxml.txt.nlp	25143915	SENT64	15	15	8	8	alendronate	RANKL	PA448082	8600	0.939
NULL	Curr_Chem_Genomics_2010_Mar_19_4_9-18.nxml.txt.nlp	20502647	SENT167	29	29	43	43	triciribine	DM1	PA165958661	338023;1760;28509	0.939
NULL	Int_J_Mol_Sci_2014_Mar_20_15(3)_4965-4976.nxml.txt.nlp	24658440	SENT35	17	17	22	22	tacrolimus	P-gp	PA451578	5243	0.939
NULL	Int_J_Mol_Sci_2014_Jun_26_15(7)_11416-11434.nxml.txt.nlp	24972137	SENT158	9	9	23	23	sitagliptin	AMPK	PA164748978	5563	0.939
NULL	Arthritis_Res_Ther_2012_Jul_27_14(4)_R175.nxml.txt.nlp	22838733	SENT120	38	38	21	21	adalimumab	CD14	PA10004	929	0.939
NULL	Cancer_Med_2012_Oct_16_1(2)_207-217.nxml.txt.nlp	23342270	SENT204	40	40	8	8	saracatinib	IGFBP2		3485	0.939
NULL	Nat_Genet_2014_Jan_17_46(1)_8-10.nxml.txt.nlp	24241536	SENT12	22	22	6	6	cladribine	IGHV4-34	PA449027	28395	0.939
NULL	Case_Rep_Ophthalmol_2011_Dec_10_2(3)_382-386.nxml.txt.nlp	22220163	SENT60	6	6	3	3	anastrozole	aromatase	PA448432	1588	0.939
NULL	Mol_Cancer_2010_Jun_25_9_165.nxml.txt.nlp	20576164	SENT219	11	11	32	32	curcumin	IFN	PA151958596	3439	0.939
NULL	Blood_Res_2014_Dec_23_49(4)_253-258.nxml.txt.nlp	25548759	SENT75	5	5	17	17	cyclophosphamide	CHOP	PA449165	1649	0.939
NULL	J_Hum_Genet_2013_Jun_16_58(6)_353-361.nxml.txt.nlp	23677058	SENT162	33	33	8	8	gemcitabine	DCK	PA449748	1633	0.939
NULL	Cell_Biol_Int_Rep_(2010)_2012_Jun_21_19(1)_e00017.nxml.txt.nlp	23124518	SENT133	5	5	11	11	etoposide	p65	PA449552	5970	0.939
NULL	Int_J_Biol_Sci_2013_Nov_21_9(10)_1089-1098.nxml.txt.nlp	24339730	SENT158	17	17	5	5	genistein	OSC	PA165109660	4047	0.939
NULL	Mediators_Inflamm_1998_7(3)_221-223.nxml.txt.nlp	9705611	SENT5	19	19	13	13	carrageenan	IL-6	PA448814	3569	0.939
NULL	Cancer_Res_Treat_2012_Sep_30_44(3)_195-201.nxml.txt.nlp	23091446	SENT162	38	38	14	14	etoposide	MKP-1	PA449552	1843	0.939
NULL	Cancers_(Basel)_2010_May_26_2(2)_970-988.nxml.txt.nlp	24281102	SENT142	32	32	43	43	bevacizumab	VEGFR2	PA130232992	3791	0.939
NULL	Clinics_(Sao_Paulo)_2013_May_68(5)_694-701.nxml.txt.nlp	23778405	SENT175	8	8	21	21	curcumin	MDR1	PA151958596	5243	0.939
NULL	Cancer_2011_Apr_15_117(8)_1670-1678.nxml.txt.nlp	21472714	SENT127	32	32	4	4	cisplatin	SIRT3	PA449014	23410	0.939
NULL	Front_Neurosci_2014_Dec_8_8_388.nxml.txt.nlp	25538545	SENT149	12	12	6	6	estradiol	5-HT2A	PA449503	3356	0.939
NULL	Oncotarget_2013_Jul_5_4(7)_984-994.nxml.txt.nlp	23846322	SENT176	21	21	14	14	resveratrol	SIRT1		23411	0.939
NULL	Int_J_Mol_Sci_2014_Mar_20_15(3)_4965-4976.nxml.txt.nlp	24658440	SENT72	0	0	11	11	etanercept	P-gp	PA449515	5243	0.939
NULL	Breast_Cancer_(Auckl)_2014_May_12_8_81-88.nxml.txt.nlp	24855372	SENT16	9	9	27	27	pertuzumab	HER2		2064	0.939
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1821-1889.nxml.txt.nlp	25268160	SENT447	44	44	2	2	sorafenib	SHARP	PA7000	23013	0.939
NULL	Korean_Circ_J_2014_Mar_12_44(2)_82-88.nxml.txt.nlp	24653737	SENT38	26	26	7	7	prasugrel	P2Y12	PA154410481	64805	0.939
NULL	Cancers_(Basel)_2014_Aug_12_6(3)_1631-1669.nxml.txt.nlp	25119536	SENT442	3	3	13	13	imatinib	GM-CSF	PA10804	1437	0.939
NULL	Breast_Cancer_Res_2011_Apr_15_13(2)_R44.nxml.txt.nlp	21496232	SENT240	11	11	6	6	lapatinib	HER2	PA152241907	2064	0.939
NULL	EMBO_J_2013_Oct_16_32(20)_2751-2763.nxml.txt.nlp	24065129	SENT110	10	10	2	2	doxorubicin	STAT1	PA449412	6772	0.939
NULL	Cancer_Med_2014_Jun_19_3(3)_555-564.nxml.txt.nlp	24648042	SENT132	30	30	5	5	cyclophosphamide	NOTCH1	PA449165	4851	0.939
NULL	Eur_J_Clin_Pharmacol_2011_May_9_67(5)_477-482.nxml.txt.nlp	21305273	SENT117	25	25	13	13	dobutamine	ADRB1	PA449381	153	0.939
NULL	Br_J_Cancer_2014_Jan_7_110(1)_55-62.nxml.txt.nlp	24263064	SENT130	21	21	29	29	gefitinib	EGFR	PA131301952	1956	0.939
NULL	Indian_J_Med_Res_2014_Jan_139(1)_117-124.nxml.txt.nlp	24604047	SENT107	18	18	6	6	fluvastatin	RhoA	PA449688	387	0.939
NULL	Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.nxml.txt.nlp	24736980	SENT236	3	3	13	13	rosuvastatin	OATP1B1	PA134308647	10599	0.939
NULL	Oncotarget_2012_Dec_30_3(12)_1505-1521.nxml.txt.nlp	23455493	SENT216	3	3	9	9	celecoxib	NF-kappaB	PA448871	4790	0.939
NULL	Indian_J_Endocrinol_Metab_2014_Mar-Apr_18(2)_241-244.nxml.txt.nlp	24741527	SENT8	11	11	7	7	octreotide	IGF1	PA450678	3479	0.939
NULL	Breast_Cancer_Res_2012_Jan_20_14(1)_R16.nxml.txt.nlp	22264274	SENT22	24	24	32	32	estradiol	aromatase	PA449503	1588	0.939
NULL	Oncogene_2013_Sep_5_32(36)_4252-4263.nxml.txt.nlp	23045288	SENT78	13	13	7	7	cisplatin	CD49f	PA449014	3655	0.939
NULL	Patient_Prefer_Adherence_2011_Dec_23_6_1-9.nxml.txt.nlp	22272064	SENT21	13	13	28	28	telmisartan	ACE	PA451605	1636	0.939
NULL	Psychiatry_Investig_2012_Dec_12_9(4)_422-424.nxml.txt.nlp	23251210	SENT14	33	33	15	15	perphenazine	CYP2D6	PA450882	1565	0.939
NULL	Arthritis_Res_Ther_2006_Jan_9_8(1)_R30.nxml.txt.nlp	16507129	SENT74	19	19	7	7	hydroxychloroquine	BAFF	PA164777036	10673	0.939
NULL	Mol_Syst_Biol_2010_Dec_21_6_456.nxml.txt.nlp	21179027	SENT293	35	35	28	28	tamoxifen	ERBB2	PA451581	2064	0.939
NULL	ARYA_Atheroscler_2011_Summer_7(2)_78-86.nxml.txt.nlp	22577451	SENT11	10	10	40	40	betaine	TNF	PA448603	7124	0.939
NULL	J_Acquir_Immune_Defic_Syndr_2014_Jan_1_65(1)_78-81.nxml.txt.nlp	24419064	SENT32	42	42	16	16	maraviroc	CYP3A4	PA164768835	1576	0.939
NULL	Cancer_Metab_2013_Aug_14_1_18.nxml.txt.nlp	24280377	SENT281	17	17	10	10	metformin	LKB1	PA450395	6794	0.939
NULL	N_Am_J_Med_Sci_2010_Sep_2(9)_433-437.nxml.txt.nlp	22558593	SENT46	26	26	1	1	fluorescein	DIF	PA164746009	7124	0.939
NULL	Oncotarget_2014_Oct_21_5(22)_11252-11268.nxml.txt.nlp	25361004	SENT228	17	17	13	13	metformin	CLIC1	PA450395	1192	0.939
NULL	eLife_2013_Nov_5_2_e00969.nxml.txt.nlp	24192036	SENT115	13	13	5	5	vemurafenib	p53	PA165946873	7157	0.939
NULL	Case_Rep_Hematol_2012_Dec_19_2012_658745.nxml.txt.nlp	23316401	SENT83	8	8	21	21	erythromycin	IFN	PA449493	3439	0.939
NULL	Adv_Urol_2014_Apr_3_2014_957013.nxml.txt.nlp	24803927	SENT126	10	10	0	0	lidocaine	Men	PA450226	8178	0.939
NULL	Arthritis_Res_Ther_2007_Oct_10_9(5)_R105.nxml.txt.nlp	17927818	SENT204	4	4	22	22	pp2	RhoA		387	0.939
NULL	Br_J_Cancer_2013_Feb_5_108(2)_461-468.nxml.txt.nlp	23149842	SENT155	20	20	7	7	cisplatin	NBS1	PA449014	55655	0.939
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jul_31_66(Pt_8)_o2189.nxml.txt.nlp	21588466	SENT79	21	21	8	8	ethanol	mol	PA448073	90527	0.939
NULL	Lipids_Health_Dis_2011_Dec_30_10_246.nxml.txt.nlp	22208561	SENT60	33	33	3	3	ethanol	FGF21	PA448073	26291	0.939
NULL	Sci_Rep_2014_Dec_3_4_7294.nxml.txt.nlp	25465236	SENT61	14	14	12	12	staurosporine	TYK2	PA165109623	7297	0.939
NULL	Clin_Med_Insights_Oncol_2011_Oct_31_5_333-342.nxml.txt.nlp	22084622	SENT53	0	0	36	36	pazopanib	KIT	PA165291492	3815	0.939
NULL	Breast_Cancer_Res_2011_Nov_1_13(6)_224.nxml.txt.nlp	22114931	SENT99	16	16	14	14	everolimus	TORC1	PA164746311	23373	0.939
NULL	Oncotarget_2010_Nov_22_1(7)_606-619.nxml.txt.nlp	21317456	SENT130	4	4	9	9	doxorubicin	RAD51D	PA449412	5892	0.939
NULL	J_Geriatr_Cardiol_2013_Jun_10(2)_151-158.nxml.txt.nlp	23888175	SENT165	23	23	18	18	rosuvastatin	AT1	PA134308647	9197;185	0.939
NULL	J_Immunother_2014_Apr_12_37(3)_180-186.nxml.txt.nlp	24598448	SENT59	13	13	7	7	sorafenib	IL-2	PA7000	3558	0.939
NULL	Indian_J_Med_Paediatr_Oncol_2014_Apr-Jun_35(2)_140-142.nxml.txt.nlp	25197175	SENT32	20	20	6	6	cetuximab	KRAS	PA10040	3845	0.939
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_79-85.nxml.txt.nlp	23864840	SENT106	14	14	10	10	cetuximab	EGFR	PA10040	1956	0.939
NULL	Oncogene_2010_Nov_18_29(46)_6160-6171.nxml.txt.nlp	20729916	SENT95	15	15	1	1	cisplatin	YAP	PA449014	55249	0.939
NULL	Arch_Med_Sci_2013_Apr_20_9(2)_332-339.nxml.txt.nlp	23671446	SENT129	42	42	10	10	midazolam	p38	PA450496	10598;1432;7965	0.939
NULL	Cell_Commun_Signal_2009_Aug_13_7_19.nxml.txt.nlp	19678929	SENT90	14	14	3	3	gemcitabine	EGFR	PA449748	1956	0.939
NULL	Emerg_Microbes_Infect_2013_Sep_18_2(9)_e60.nxml.txt.nlp	NULL	SENT78	12	12	2	2	dextran	IL-17A	PA449261	3605	0.939
NULL	Mol_Cancer_2010_Aug_23_9_222.nxml.txt.nlp	20731837	SENT79	10	10	29	29	gefitinib	ATM	PA131301952	472	0.939
NULL	Eur_J_Clin_Microbiol_Infect_Dis_2012_Apr_29_31(4)_571-574.nxml.txt.nlp	21796345	SENT23	15	15	38	38	lamivudine	LAM	PA450163	7249;7248	0.939
NULL	Case_Rep_Med_2010_Jul_6_2010_426804.nxml.txt.nlp	20671989	SENT73	6	6	14	14	capecitabine	CYP2C9	PA448771	1559	0.939
NULL	Clin_Interv_Aging_2009_Dec_29_4_457-461.nxml.txt.nlp	20054410	SENT136	6	6	14	14	ranibizumab	VEGF-A	PA164746012	7422	0.939
NULL	Front_Immunol_2012_Jan_24_3_3.nxml.txt.nlp	22566889	SENT880	13	13	1	1	rituximab	gamma	PA451261	9913	0.939
NULL	Arthritis_Res_Ther_2011_Feb_4_13(1)_R14.nxml.txt.nlp	21294864	SENT50	22	22	14	14	indomethacin	IL-17	PA449982	3605	0.939
NULL	Emerg_Microbes_Infect_2013_Nov_6_2(11)_e75.nxml.txt.nlp	NULL	SENT44	14	14	31	31	l-glutamine	CO2	PA10090	4513	0.939
NULL	Mediators_Inflamm_2011_Jul_3_2011_296069.nxml.txt.nlp	21765615	SENT77	6	6	18	18	l-arginine	NOS	PA448478	4843	0.939
NULL	J_Biol_Chem_2008_Nov_14_283(46)_31679-31689.nxml.txt.nlp	18755684	SENT29	36	36	1	1	iron	FTH1	PA450087	2495	0.939
NULL	Patient_Prefer_Adherence_2010_Mar_24_4_61-68.nxml.txt.nlp	20361006	SENT155	13	13	24	24	metformin	Met	PA450395	79811	0.939
NULL	Cancer_Manag_Res_2013_Nov_19_5_377-385.nxml.txt.nlp	24399885	SENT24	33	33	16	16	cetuximab	KRAS	PA10040	3845	0.939
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT68	16	16	7	7	docetaxel	ABCC10	PA449383	89845	0.939
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Apr_2_65(Pt_5)_o953.nxml.txt.nlp	21583996	SENT70	18	18	32	32	ethanol	TLC	PA448073	3933	0.939
NULL	Int_J_Biol_Sci_2014_Jun_10_10(7)_654-663.nxml.txt.nlp	25013375	SENT111	15	15	28	28	nelfinavir	AKT	PA450606	207	0.939
NULL	Cancer_Cell_Int_2003_Jul_15_3_11.nxml.txt.nlp	12904267	SENT104	25	25	11	11	vinblastine	p53	PA451877	7157	0.939
NULL	Exp_Diabetes_Res_2011_Mar_13_2011_754132.nxml.txt.nlp	21437212	SENT113	3	3	15	15	heparin	EC-SOD	PA449855	6649	0.939
NULL	J_Invest_Dermatol_2014_Feb_10_134(2)_319-325.nxml.txt.nlp	24108405	SENT119	14	14	19	19	vemurafenib	PTEN	PA165946873	5728	0.939
NULL	Ophthalmol_Eye_Dis_2010_Dec_19_2_75-83.nxml.txt.nlp	23861616	SENT62	0	0	26	26	ranibizumab	VEGF-A	PA164746012	7422	0.939
NULL	Diabetes_Care_2008_Aug_31(8)_1502-1509.nxml.txt.nlp	18487480	SENT5	7	7	10	10	fenofibrate	Q10	PA449594	27161	0.939
NULL	Front_Oncol_2014_Mar_6_4_40.nxml.txt.nlp	24639951	SENT134	29	29	5	5	trastuzumab	HER2	PA451743	2064	0.939
NULL	Cell_Mol_Life_Sci_2012_Oct_24_69(20)_3419-3428.nxml.txt.nlp	22527724	SENT130	40	40	42	42	thrombin	ADP	PA451674	23038	0.939
NULL	Cancer_Cell_Int_2011_Mar_25_11_7.nxml.txt.nlp	21439058	SENT227	8	8	16	16	cyclosporine	P-gp	PA449167	5243	0.939
NULL	Cardiovasc_Diabetol_2013_Nov_12_12_169.nxml.txt.nlp	24215514	SENT308	22	22	3	3	valsartan	AT2	PA451848	186	0.939
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT2404	7	7	21	21	amiodarone	CYP3A4	PA448383	1576	0.939
NULL	Diabetes_Obes_Metab_2011_Apr_13(4)_348-356.nxml.txt.nlp	21205128	SENT169	13	13	19	19	liraglutide	GLP-1	PA165958364	100125288	0.939
NULL	Front_Endocrinol_(Lausanne)_2013_Oct_25_4_158.nxml.txt.nlp	24298267	SENT102	20	20	32	32	losartan	AT2	PA450268	186	0.939
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1224-1233.nxml.txt.nlp	22353810	SENT153	0	0	23	23	doxorubicin	MRP-1	PA449412	928	0.939
NULL	Arthritis_Res_Ther_2013_May_29_15(3)_R64.nxml.txt.nlp	23718630	SENT181	14	14	0	0	anakinra	S100A12	PA10799	6283	0.939
NULL	Mol_Biol_Cell_2013_Aug_1_24(15)_2340-2349.nxml.txt.nlp	23783036	SENT259	32	32	41	41	spectinomycin	CR2	PA164781342	1380	0.939
NULL	J_Hematol_Oncol_2013_Oct_12_6_78.nxml.txt.nlp	24283803	SENT173	20	20	8	8	daunorubicin	STAT3	PA449212	6774	0.939
NULL	Diabetes_2008_Oct_57(10)_2801-2808.nxml.txt.nlp	18633115	SENT94	5	5	17	17	sulfasalazine	PARP-1	PA451547	25976	0.939
NULL	Cell_Death_Dis_2014_Mar_13_5(3)_e1126.nxml.txt.nlp	24625985	SENT102	27	27	5	5	bortezomib	URI	PA10252	8725	0.939
NULL	Acta_Neuropathol_2011_Mar_7_121(3)_327-335.nxml.txt.nlp	21136067	SENT186	37	37	14	14	glucose	MCI	PA449773	345643	0.939
NULL	Mol_Cancer_2012_Apr_26_11_26.nxml.txt.nlp	22537224	SENT14	3	3	10	10	geldanamycin	CHK1	PA152031327	1111	0.939
NULL	Oncotarget_2014_Jun_19_5(15)_6540-6551.nxml.txt.nlp	25153728	SENT114	28	28	18	18	paclitaxel	Bcl-2	PA450761	596	0.939
NULL	Appl_Clin_Genet_2014_May_16_7_93-104.nxml.txt.nlp	24876791	SENT115	24	24	1	1	estradiol	E6-AP	PA449503	7337	0.939
NULL	Aust_N_Z_J_Psychiatry_2011_Sep_3_45(9)_712-725.nxml.txt.nlp	21888608	SENT286	4	4	11	11	paroxetine	CYP2D6	PA450801	1565	0.939
NULL	Mol_Clin_Oncol_2013_Sep_26_1(5)_799-804.nxml.txt.nlp	24649249	SENT103	26	26	20	20	gefitinib	EGFR	PA131301952	1956	0.939
NULL	Front_Cell_Neurosci_2014_Jul_18_8_185.nxml.txt.nlp	25100946	SENT380	26	26	11	11	pp2	Isl-1		3670	0.939
NULL	Iran_J_Psychiatry_2010_Spring_5(2)_60-65.nxml.txt.nlp	22952493	SENT42	18	18	6	6	naltrexone	DBT	PA450588	1629	0.939
NULL	Acta_Neuropathol_Commun_2014_Dec_20_2(1)_160.nxml.txt.nlp	NULL	SENT95	16	16	5	5	paraformaldehyde	CD133	PA450790	8842	0.939
NULL	Mol_Cancer_2009_Nov_12_8_100.nxml.txt.nlp	19909554	SENT28	1	1	13	13	genistein	PI3K	PA165109660	5290	0.939
NULL	Indian_J_Med_Res_2012_Dec_136(6)_926-941.nxml.txt.nlp	23391788	SENT206	29	29	25	25	prasugrel	P2Y12	PA154410481	64805	0.939
NULL	Drugs_R_D_2010_Nov_25_10(4)_219-224.nxml.txt.nlp	21171668	SENT18	7	7	27	27	clopidogrel	P2Y12	PA449053	64805	0.939
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_105-115.nxml.txt.nlp	17912640	SENT280	35	35	33	33	letrozole	aromatase	PA450196	1588	0.939
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_4_2013_929074.nxml.txt.nlp	23861717	SENT47	18	18	2	2	glibenclamide	STZ	PA449782	6484	0.939
NULL	Cell_Death_Dis_2014_Feb_13_5(2)_e1055.nxml.txt.nlp	24525731	SENT309	8	8	40	40	cisplatin	XRCC1	PA449014	7515	0.939
NULL	Oxid_Med_Cell_Longev_2013_Jun_2_2013_793525.nxml.txt.nlp	23819014	SENT204	8	8	31	31	resveratrol	AMPK		5563	0.939
NULL	Drugs_Aging_2014_May_6_31(6)_413-424.nxml.txt.nlp	24797286	SENT122	1	1	13	13	denosumab	CTX	PA166048634	1593	0.939
NULL	Basic_Res_Cardiol_2015_Jan_20_110_4.nxml.txt.nlp	25600226	SENT118	7	7	24	24	berberine	PCSK9	PA165860812	255738	0.939
NULL	Exp_Ther_Med_2014_Feb_25_7(2)_417-422.nxml.txt.nlp	24396417	SENT3	11	11	16	16	estradiol	CD4	PA449503	920	0.939
NULL	Eur_J_Med_Res_2009_Dec_7_14(Suppl_4)_38-41.nxml.txt.nlp	20156722	SENT58	7	7	19	19	heparin	SP-A	PA449855	653509	0.939
NULL	J_Cancer_2013_Jan_11_4(2)_117-132.nxml.txt.nlp	23386910	SENT88	22	22	30	30	docetaxel	HER2	PA449383	2064	0.939
NULL	J_Gastroenterol_2013_Mar_9_48(3)_382-390.nxml.txt.nlp	22875473	SENT30	26	26	39	39	ribavirin	IFN	PA451241	3439	0.939
NULL	Cardiol_Res_Pract_2011_Feb_27_2011_532620.nxml.txt.nlp	21403878	SENT114	4	4	7	7	etanercept	TNF-alpha	PA449515	7124	0.939
NULL	F1000Res_2014_Sep_12_3_219.nxml.txt.nlp	25324965	SENT176	0	0	10	10	resveratrol	AMPK		5563	0.939
NULL	Comb_Chem_High_Throughput_Screen_2010_Feb_13(2)_188-206.nxml.txt.nlp	20053163	SENT245	22	22	11	11	ketoconazole	CYP3A4	PA450146	1576	0.939
NULL	ScientificWorldJournal_2012_Apr_1_2012_381434.nxml.txt.nlp	22545017	SENT326	20	20	26	26	aprepitant	NK-1	PA164747039	27087	0.939
NULL	J_Oncol_2009_Jul_27_2009_305420.nxml.txt.nlp	19644558	SENT97	7	7	22	22	estradiol	PDCD4	PA449503	27250	0.939
NULL	J_Immunother_Cancer_2014_Aug_19_2_27.nxml.txt.nlp	25324973	SENT39	19	19	11	11	dacarbazine	BRAF	PA449197	673	0.939
NULL	Breast_Cancer_Res_2012_Jun_7_14(3)_R89.nxml.txt.nlp	22676470	SENT17	28	28	23	23	lapatinib	HER2	PA152241907	2064	0.939
NULL	Front_Immunol_2012_Jan_24_3_3.nxml.txt.nlp	22566889	SENT149	6	6	13	13	ofatumumab	CHOP	PA165291493	1649	0.939
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Apr_29_67(Pt_5)_o1256.nxml.txt.nlp	21754546	SENT68	14	14	33	33	acetone	mol	PA448025	90527	0.939
NULL	Arthritis_Rheumatol_2014_Jun_27_66(6)_1574-1582.nxml.txt.nlp	24577881	SENT97	0	0	12	12	hydralazine	ERK	PA449894	5594	0.939
NULL	Arthritis_Res_Ther_2012_Jul_12_14(4)_R163.nxml.txt.nlp	22784880	SENT145	32	32	6	6	leflunomide	CYP2C19	PA450192	1557	0.939
NULL	Mol_Cancer_2013_Mar_5_12_17.nxml.txt.nlp	23497256	SENT93	25	25	0	0	sunitinib	HDM2	PA162372840	4193	0.939
NULL	J_Geriatr_Cardiol_2014_Mar_11(1)_63-73.nxml.txt.nlp	24748884	SENT74	26	26	7	7	fenoldopam	DR5	PA164784034	8795	0.939
NULL	Cancer_Cell_Int_2005_Jul_24_5_22.nxml.txt.nlp	16042792	SENT114	23	23	9	9	doxorubicin	NAC	PA449412	22861	0.939
NULL	Mol_Pain_2013_Jan_2_9_1.nxml.txt.nlp	23279936	SENT7	27	27	19	19	capsaicin	TRPV1	PA448776	7442	0.939
NULL	Front_Neurosci_2010_Jun_17_4_35.nxml.txt.nlp	20661455	SENT580	10	10	4	4	fluoxetine	5-HT1A	PA449673	3350	0.939
NULL	Pharmaceuticals_(Basel)_2013_May_23_6(6)_689-699.nxml.txt.nlp	24276256	SENT133	15	15	8	8	salbutamol	PTB	PA448068	58155	0.939
NULL	Int_J_Breast_Cancer_2011_Sep_8_2011_595092.nxml.txt.nlp	22295229	SENT88	36	36	27	27	exemestane	aromatase	PA449563	1588	0.939
NULL	Breast_Cancer_Res_Treat_2012_Jun_3_133(3)_865-880.nxml.txt.nlp	22048815	SENT168	31	31	18	18	carboplatin	RAD17	PA448803	5884	0.939
NULL	Oncotarget_2011_Nov_9_2(11)_850-861.nxml.txt.nlp	22081665	SENT182	19	19	2	2	daunorubicin	DNMT3A	PA449212	1788	0.939
NULL	Mol_Cancer_2010_Aug_27_9_226.nxml.txt.nlp	20799951	SENT149	29	29	0	0	bortezomib	PRAME	PA10252	23532	0.939
NULL	Br_J_Cancer_2012_Nov_20_107(11)_1864-1868.nxml.txt.nlp	23093229	SENT155	24	24	19	19	cetuximab	EGFR	PA10040	1956	0.939
NULL	Oncotarget_2013_Nov_15_5(6)_1458-1474.nxml.txt.nlp	24681547	SENT107	3	3	13	13	celecoxib	CDH11	PA448871	1009	0.939
NULL	Front_Neurosci_2011_Jan_14_4_207.nxml.txt.nlp	21258618	SENT164	22	22	19	19	ethanol	AC7	PA448073	113	0.939
NULL	Allergy_Asthma_Immunol_Res_2014_Mar_15_6(2)_126-130.nxml.txt.nlp	24587948	SENT90	21	21	0	0	salbutamol	TTN	PA448068	7273	0.939
NULL	Cancer_Manag_Res_2015_Jan_19_7_47-50.nxml.txt.nlp	25632239	SENT26	16	16	7	7	vemurafenib	BRAF	PA165946873	673	0.939
NULL	J_Biol_Chem_2009_Aug_21_284(34)_22926-22937.nxml.txt.nlp	19520847	SENT14	16	16	4	4	amrinone	ADP	PA164746803	23038	0.939
NULL	J_Adv_Pharm_Technol_Res_2010_Jul-Sep_1(3)_302-310.nxml.txt.nlp	22247862	SENT160	18	18	3	3	ethanol	CO2	PA448073	4513	0.939
NULL	Cell_Cycle_2012_Nov_1_11(21)_3983-3996.nxml.txt.nlp	22987153	SENT225	10	10	2	2	cisplatin	EXO1	PA449014	9156	0.939
NULL	Osteoporos_Int_2013_May_4_24(10)_2659-2670.nxml.txt.nlp	23644877	SENT268	37	37	18	18	metformin	RANKL	PA450395	8600	0.939
NULL	Endocrinol_Metab_(Seoul)_2014_Jun_26_29(2)_105-111.nxml.txt.nlp	25031882	SENT14	3	3	42	42	heparin	FGF21	PA449855	26291	0.939
NULL	Nucleic_Acids_Res_2013_Feb_19_41(3)_1684-1697.nxml.txt.nlp	23258707	SENT36	31	31	0	0	mitomycin	TNR	PA450524	7143	0.939
NULL	Clin_Interv_Aging_2009_Jun_9_4_241-250.nxml.txt.nlp	19554095	SENT167	11	11	9	9	denosumab	RANKL	PA166048634	8600	0.939
NULL	F1000_Med_Rep_2010_May_24_2_39.nxml.txt.nlp	20948846	SENT28	7	7	19	19	capsaicin	GRPR	PA448776	2925	0.939
NULL	Oncotarget_2014_Jun_5_5(21)_10382-10392.nxml.txt.nlp	25071015	SENT104	32	32	25	25	trastuzumab	HER2	PA451743	2064	0.939
NULL	Indian_J_Med_Paediatr_Oncol_2014_Apr-Jun_35(2)_176-180.nxml.txt.nlp	25197183	SENT35	13	13	4	4	trastuzumab	HER-2	PA451743	2064	0.939
NULL	Diabetes_Care_2013_Aug_17_36(Suppl_2)_S245-S252.nxml.txt.nlp	23882053	SENT9	32	32	10	10	vildagliptin	GLP-1	PA165958346	100125288	0.939
NULL	Arthritis_Res_Ther_2012_May_1_14(3)_R99.nxml.txt.nlp	22546542	SENT61	18	18	39	39	infliximab	IFN	PA452639	3439	0.939
NULL	Cancer_Cell_Int_2014_Jul_2_14_59.nxml.txt.nlp	25120382	SENT219	3	3	26	26	metformin	N-myc	PA450395	4613	0.939
NULL	Breast_Cancer_Res_2012_May_18_14(3)_R78.nxml.txt.nlp	22608253	SENT146	27	27	5	5	letrozole	PDGFRL	PA450196	5157	0.939
NULL	F1000Res_2014_Mar_18_3_74.nxml.txt.nlp	25580222	SENT55	20	20	2	2	chloramphenicol	TOX	PA448927	9760	0.939
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT16	5	5	22	22	sitagliptin	HIP	PA164748978	6767;6159;64399;5068	0.939
NULL	Br_J_Cancer_2012_Sep_4_107(6)_947-955.nxml.txt.nlp	22892392	SENT6	10	10	3	3	lapatinib	BCAR4	PA152241907	400500	0.939
NULL	Arthritis_Res_2002_Mar_19_4(4)_266-273.nxml.txt.nlp	12106498	SENT119	15	15	28	28	methotrexate	CD4	PA450428	920	0.939
NULL	Case_Rep_Dermatol_2011_Oct_11_3(3)_223-227.nxml.txt.nlp	22135629	SENT18	0	0	30	30	trastuzumab	HER2	PA451743	2064	0.939
NULL	Oncogene_2009_Apr_2_28(13)_1616-1625.nxml.txt.nlp	19219073	SENT6	6	6	21	21	nutlin-3	p53		7157	0.939
NULL	Cancer_Cell_2007_Dec_11_12(6)_514-527.nxml.txt.nlp	18068629	SENT180	13	13	25	25	paclitaxel	TGFBI	PA450761	7045	0.939
NULL	Br_J_Pharmacol_2008_Nov_11_155(6)_896-905.nxml.txt.nlp	18695641	SENT134	17	17	46	46	alendronate	CTX	PA448082	1593	0.939
NULL	Biomed_Res_Int_2014_Jun_2_2014_946492.nxml.txt.nlp	24991574	SENT162	2	2	30	30	olmesartan	p47phox	PA164742950	653361	0.939
NULL	J_Immunol_Res_2014_Apr_10_2014_845763.nxml.txt.nlp	24818169	SENT18	24	24	39	39	everolimus	FKBP12	PA164746311	2280	0.939
NULL	J_Mol_Signal_2006_Dec_6_1_8.nxml.txt.nlp	17224083	SENT28	20	20	11	11	thrombin	Rho	PA451674	29984	0.939
NULL	J_Gen_Physiol_1995_Nov_1_106(5)_923-955.nxml.txt.nlp	8648298	SENT20	36	36	17	17	spermine	HRK1	PA164781199	3761	0.939
NULL	J_Cancer_Prev_2014_Mar_19(1)_39-46.nxml.txt.nlp	25337571	SENT21	28	28	12	12	ethanol	p38	PA448073	10598;1432;7965	0.939
NULL	Diabetes_Care_2008_Nov_31(11)_2169-2176.nxml.txt.nlp	18678611	SENT25	0	0	4	4	rimonabant	CB1	PA152407999	1268	0.939
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1676-1682.nxml.txt.nlp	19844234	SENT118	10	10	0	0	lapatinib	IGF1R	PA152241907	3480	0.939
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT30	2	2	7	7	trastuzumab	AKT	PA451743	207	0.939
NULL	Front_Oncol_2014_Apr_8_4_71.nxml.txt.nlp	24782983	SENT248	34	34	25	25	paclitaxel	TUBB3	PA450761	10381	0.939
NULL	J_Hematol_Oncol_2014_Apr_28_7_37.nxml.txt.nlp	24775308	SENT192	21	21	8	8	imatinib	JAK2	PA10804	3717	0.939
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT253	25	25	14	14	perifosine	DR4	PA165291471	8797	0.939
NULL	Case_Rep_Oncol_2014_Feb_20_7(1)_126-131.nxml.txt.nlp	24707260	SENT4	23	23	13	13	gefitinib	EGFR	PA131301952	1956	0.939
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Mar_27_66(Pt_4)_o923.nxml.txt.nlp	21580733	SENT54	19	19	6	6	ethanol	mol	PA448073	90527	0.939
NULL	Oncol_Lett_2014_Jun_3_7(6)_2083-2088.nxml.txt.nlp	24932293	SENT25	8	8	22	22	cyclophosphamide	CXCR4	PA449165	7852	0.939
NULL	Cardiovasc_Diabetol_2013_Nov_12_12_169.nxml.txt.nlp	24215514	SENT308	12	12	3	3	valsartan	AT2	PA451848	186	0.939
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT228	0	0	5	5	nutlin-3	p53		7157	0.939
NULL	Mol_Vis_2011_Aug_25_17_2297-2310.nxml.txt.nlp	21921981	SENT216	23	23	16	16	estradiol	HSD17B2	PA449503	3294	0.939
NULL	Br_J_Cancer_2012_Jun_5_106(12)_1997-2003.nxml.txt.nlp	22596232	SENT104	17	17	5	5	sorafenib	JNK	PA7000	5599	0.939
NULL	Eur_J_Med_Res_2014_Jun_24_19(1)_34.nxml.txt.nlp	24961604	SENT7	26	26	6	6	vincristine	BCL11A	PA451879	53335	0.939
NULL	Front_Neurosci_2014_Jan_10_7_270.nxml.txt.nlp	24454277	SENT154	4	4	7	7	resveratrol	SIRT1		23411	0.939
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT119	11	11	38	38	gefitinib	KRAS	PA131301952	3845	0.939
NULL	Mol_Cancer_2014_Jun_24_13_157.nxml.txt.nlp	24958351	SENT4	4	4	15	15	trastuzumab	HER2	PA451743	2064	0.939
NULL	Carcinogenesis_2014_Sep_3_35(9)_1968-1976.nxml.txt.nlp	24590896	SENT26	12	12	24	24	cisplatin	MKK3	PA449014	5606	0.939
NULL	Tuberc_Respir_Dis_(Seoul)_2014_Feb_27_76(2)_66-74.nxml.txt.nlp	24624215	SENT142	17	17	8	8	vancomycin	HCAP	PA451850	117159;9126	0.939
NULL	Scientifica_(Cairo)_2012_Dec_17_2012_502378.nxml.txt.nlp	24278706	SENT103	29	29	24	24	amiodarone	P-gp	PA448383	5243	0.939
NULL	Ann_Pediatr_Endocrinol_Metab_2014_Jun_30_19(2)_57-68.nxml.txt.nlp	25077087	SENT187	19	19	7	7	diazoxide	GCK	PA449285	5871;2645	0.939
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Dec_10_65(Pt_1)_o91.nxml.txt.nlp	21581729	SENT61	36	36	15	15	ethanol	mol	PA448073	90527	0.939
NULL	Oncotarget_2013_Feb_25_4(2)_310-315.nxml.txt.nlp	23470635	SENT15	8	8	19	19	imatinib	PDGFRA	PA10804	5156	0.939
NULL	Int_J_Mol_Sci_2014_Nov_7_15(11)_20500-20517.nxml.txt.nlp	25387078	SENT164	2	2	11	11	sorafenib	Bcl-2	PA7000	596	0.939
NULL	Front_Genet_2012_May_30_3_94.nxml.txt.nlp	22666228	SENT115	28	28	7	7	vinblastine	DAC	PA451877	13	0.939
NULL	Int_J_Mol_Sci_2014_Nov_7_15(11)_20500-20517.nxml.txt.nlp	25387078	SENT150	12	12	3	3	sorafenib	Bcl-2	PA7000	596	0.939
NULL	Cardiol_Res_Pract_2013_Jan_31_2013_128795.nxml.txt.nlp	23431496	SENT153	16	16	8	8	clopidogrel	CYP2C19	PA449053	1557	0.939
NULL	Br_J_Cancer_2013_Sep_3_109(5)_1137-1146.nxml.txt.nlp	23942078	SENT32	16	16	25	25	sunitinib	RSK4	PA162372840	27330	0.939
NULL	Diabetes_2011_Jan_7_60(1)_127-137.nxml.txt.nlp	20929976	SENT315	24	24	7	7	pp2	Raf-1		5894	0.939
NULL	Biomed_Res_Int_2014_Feb_6_2014_323594.nxml.txt.nlp	24689036	SENT148	25	25	7	7	raloxifene	PC3	PA451221	57332;7832;5122	0.939
NULL	Oncotarget_2014_Aug_29_5(19)_8947-8958.nxml.txt.nlp	25333254	SENT112	4	4	16	16	cytarabine	CD49d	PA449177	3676	0.939
NULL	Mol_Cancer_2009_Aug_25_8_66.nxml.txt.nlp	19706164	SENT215	8	8	36	36	celecoxib	p53	PA448871	7157	0.939
NULL	Br_J_Cancer_2004_Mar_22_90(6)_1274-1278.nxml.txt.nlp	15026812	SENT85	7	7	23	23	bleomycin	ZAG	PA448645	563	0.939
NULL	Nat_Commun_2011_Oct_25_2_513.nxml.txt.nlp	22027593	SENT166	16	16	7	7	nutlin-3	RBM38		55544	0.939
NULL	Breast_Cancer_(Auckl)_2012_Feb_20_6_47-66.nxml.txt.nlp	22399860	SENT172	4	4	30	30	tamoxifen	NIPBL	PA451581	25836	0.939
NULL	Exp_Diabetes_Res_2011_Apr_6_2011_928523.nxml.txt.nlp	21603181	SENT42	19	19	22	22	haloperidol	DRD2	PA449841	1813	0.939
NULL	Exp_Mol_Med_2012_Apr_30_44(4)_281-292.nxml.txt.nlp	22228119	SENT86	9	9	42	42	genistein	activin	PA165109660	83729	0.939
NULL	Mol_Pain_2013_Jun_10_9_27.nxml.txt.nlp	23758830	SENT153	26	26	10	10	tetracaine	ASIC3	PA451638	9311	0.939
NULL	Drugs_2012_Sep_6_72(9)_e1-e25.nxml.txt.nlp	22686620	SENT484	2	2	15	15	lamivudine	CD4	PA450163	920	0.939
NULL	Exp_Hematol_Oncol_2014_Sep_26_3_24.nxml.txt.nlp	25401046	SENT173	0	0	7	7	rituximab	San	PA451261	80218	0.939
NULL	Biochemistry_2011_Dec_13_50(49)_10576-10589.nxml.txt.nlp	22026921	SENT155	16	16	4	4	mesna	IPL	PA450385	7262	0.939
NULL	Mediators_Inflamm_2010_Jun_21_2010_194896.nxml.txt.nlp	20652055	SENT141	5	5	20	20	berberine	CCL2	PA165860812	6347	0.939
NULL	Clin_Psychopharmacol_Neurosci_2014_Apr_24_12(1)_54-64.nxml.txt.nlp	24851122	SENT127	31	31	25	25	methamphetamine	MAPK4	PA450403	5596	0.939
NULL	Oncogene_2014_Jul_24_33(30)_3927-3938.nxml.txt.nlp	23995784	SENT40	14	14	5	5	doxycycline	FOXO1	PA449415	2308	0.939
NULL	Mol_Syst_Biol_2009_Nov_17_5_326.nxml.txt.nlp	19920811	SENT99	21	21	15	15	galactose	GAL	PA449725	51083	0.939
NULL	Oncogenesis_2012_Apr_2_1(4)_e5.nxml.txt.nlp	23552603	SENT257	2	2	18	18	ns-398	DR5		8795	0.939
NULL	Biomed_Res_Int_2013_Jul_7_2013_692751.nxml.txt.nlp	23936834	SENT137	4	4	32	32	naloxone	mol	PA450586	90527	0.939
NULL	J_Cancer_2013_Apr_29_4(4)_330-335.nxml.txt.nlp	23678369	SENT73	35	35	11	11	bevacizumab	p53	PA130232992	7157	0.939
NULL	Neural_Dev_2013_Mar_7_8_4.nxml.txt.nlp	23497494	SENT152	34	34	12	12	chlorpheniramine	MAP2	PA448960	4133;10988	0.939
NULL	Front_Endocrinol_(Lausanne)_2014_Aug_18_5_129.nxml.txt.nlp	25183960	SENT104	27	27	45	45	cabergoline	DRD2	PA448708	1813	0.939
NULL	Mol_Pain_2013_Feb_15_9_3.nxml.txt.nlp	23413875	SENT210	12	12	21	21	resveratrol	TRPV1		7442	0.939
NULL	Clinics_(Sao_Paulo)_2011_Jun_66(6)_1101-1104.nxml.txt.nlp	21808883	SENT40	0	0	14	14	metoclopramide	PRL	PA450475	5617	0.939
NULL	Cell_Cycle_2013_Sep_15_12(18)_3013-3024.nxml.txt.nlp	23974104	SENT73	21	21	14	14	disulfiram	MYH9	PA449376	4627	0.939
NULL	Open_Access_J_Urol_2011_May_10_3_69-82.nxml.txt.nlp	24198638	SENT66	9	9	18	18	cyclophosphamide	CYP2C8	PA449165	1558	0.939
NULL	Patient_Prefer_Adherence_2010_Mar_24_4_61-68.nxml.txt.nlp	20361006	SENT71	13	13	3	3	liraglutide	GLP-1	PA165958364	100125288	0.939
NULL	Drugs_R_D_2010_Nov_25_10(4)_219-224.nxml.txt.nlp	21171668	SENT85	28	28	8	8	clopidogrel	ADP	PA449053	23038	0.939
NULL	Mol_Cancer_2009_Apr_16_8_24.nxml.txt.nlp	19371427	SENT224	10	10	5	5	cisplatin	CHK1	PA449014	1111	0.939
NULL	Cardiovasc_Diabetol_2011_Dec_1_10_109.nxml.txt.nlp	22132774	SENT159	2	2	5	5	exenatide	GLP-1	PA164749238	100125288	0.939
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2675-2684.nxml.txt.nlp	24129246	SENT205	7	7	27	27	etoposide	KSR1	PA449552	8844	0.939
NULL	J_Biol_Chem_2013_Oct_11_288(41)_29642-29653.nxml.txt.nlp	24005673	SENT953	16	16	12	12	hyaluronan	TSG-6	PA165958431	7130	0.939
NULL	Thorax_2010_Jul_13_65(7)_654-658.nxml.txt.nlp	20627927	SENT48	21	21	4	4	colistin	NAG	PA164760862	51594;4669	0.939
NULL	Clin_Epigenetics_2011_Dec_5_3(1)_8.nxml.txt.nlp	22414275	SENT171	14	14	45	45	ribavirin	ESR1	PA451241	2099	0.939
NULL	Front_Genet_2014_Oct_21_5_372.nxml.txt.nlp	25374583	SENT855	11	11	1	1	oxaliplatin	FANCJ	PA131285527	83990	0.939
NULL	Case_Rep_Ophthalmol_2011_Dec_10_2(3)_382-386.nxml.txt.nlp	22220163	SENT60	8	8	3	3	letrozole	aromatase	PA450196	1588	0.939
NULL	Behav_Brain_Funct_2010_Aug_30_6_50.nxml.txt.nlp	20799992	SENT120	9	9	15	15	cocaine	ADORA2A	PA449072	135	0.939
NULL	Evid_Based_Complement_Alternat_Med_2014_Jan_8_2014_976364.nxml.txt.nlp	24527057	SENT180	29	29	12	12	oseltamivir	IL-4	PA450721	3565	0.939
NULL	Br_J_Cancer_2006_Feb_13_94(3)_407-426.nxml.txt.nlp	16434996	SENT346	18	18	0	0	genistein	BRCA1	PA165109660	672	0.939
NULL	Neuropsychopharmacology_2009_Apr_2_34(5)_1135-1148.nxml.txt.nlp	18596687	SENT179	14	14	24	24	betaxolol	CRF	PA448611	1392;10882	0.939
NULL	Breast_Cancer_Res_2005_Mar_4_7(3)_R345-R352.nxml.txt.nlp	15987429	SENT134	16	16	20	20	ns-398	COX		1351	0.939
NULL	Indian_J_Urol_2009_Apr-Jun_25(2)_186-189.nxml.txt.nlp	19672343	SENT50	13	13	2	2	bleomycin	GTS	PA448645	2973	0.939
NULL	Oncol_Lett_2014_Nov_14_8(5)_2086-2092.nxml.txt.nlp	25295095	SENT10	26	26	5	5	gemcitabine	LKB1	PA449748	6794	0.939
NULL	Cancer_Immunol_Immunother_2013_Aug_27_62(10)_1637-1648.nxml.txt.nlp	23982484	SENT240	2	2	11	11	lenalidomide	STAT3	PA162363968	6774	0.939
NULL	Onco_Targets_Ther_2014_Sep_5_7_1551-1562.nxml.txt.nlp	25228814	SENT127	34	34	43	43	bevacizumab	MMP9	PA130232992	4318	0.939
NULL	Br_J_Pharmacol_2012_Apr_165(7)_2191-2202.nxml.txt.nlp	21958009	SENT58	19	19	15	15	ketanserin	5-HT2A	PA131053734	3356	0.939
NULL	Biol_Open_2014_Dec_12_4(1)_48-61.nxml.txt.nlp	25505152	SENT498	21	21	7	7	metformin	SNRK	PA450395	54861	0.939
NULL	Indian_J_Pharmacol_2008_Oct_40(Suppl_2)_S97-S112.nxml.txt.nlp	21593984	SENT303	12	12	16	16	rosiglitazone	gamma	PA451283	9913	0.939
NULL	J_Med_Genet_2013_Sep_24_50(9)_567-578.nxml.txt.nlp	23709754	SENT147	5	5	26	26	staurosporine	STAT1	PA165109623	6772	0.939
NULL	Mol_Pain_2012_Sep_21_8_70.nxml.txt.nlp	22998799	SENT53	19	19	1	1	capsaicin	TRPV1	PA448776	7442	0.939
NULL	Exp_Brain_Res_2014_Jun_27_232(8)_2637-2644.nxml.txt.nlp	24969614	SENT157	18	18	31	31	palonosetron	NK1	PA10352	11126	0.939
NULL	Br_J_Haematol_2014_Jul_25_166(1)_77-83.nxml.txt.nlp	24661044	SENT21	10	10	6	6	doxorubicin	CHOP	PA449412	1649	0.939
NULL	Cell_Death_Dis_2013_Oct_3_4(10)_e827.nxml.txt.nlp	24091670	SENT86	0	0	8	8	nilotinib	CD34	PA165958345	947	0.939
NULL	Arthritis_Res_Ther_2006_Feb_28_8(2)_R50.nxml.txt.nlp	16507178	SENT74	13	13	4	4	paraformaldehyde	CCL5	PA450790	6352	0.939
NULL	Ann_Oncol_2012_Dec_2_23(12)_3007-3016.nxml.txt.nlp	22865781	SENT104	22	22	27	27	trastuzumab	PTEN	PA451743	5728	0.939
NULL	Mol_Cancer_2009_May_15_8_28.nxml.txt.nlp	19445670	SENT86	34	34	4	4	doxorubicin	Bcl-2	PA449412	596	0.939
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT102	18	18	24	24	sitagliptin	HIP	PA164748978	6767;6159;64399;5068	0.939
NULL	J_Biol_Chem_2009_Aug_7_284(32)_21347-21359.nxml.txt.nlp	19520849	SENT68	17	17	6	6	s-adenosylmethionine	PRMT5	PA164754994	10419	0.939
NULL	J_Biol_Chem_2009_Mar_6_284(10)_6260-6269.nxml.txt.nlp	19131328	SENT163	42	42	23	23	staurosporine	TBCA	PA165109623	6902	0.939
NULL	Cell_Cycle_2013_Mar_15_12(6)_889-898.nxml.txt.nlp	23422002	SENT235	11	11	1	1	paraformaldehyde	TRIM16	PA450790	10626	0.939
NULL	Tuberc_Respir_Dis_(Seoul)_2013_Jun_25_74(6)_280-285.nxml.txt.nlp	23814601	SENT112	26	26	13	13	gefitinib	EGFR	PA131301952	1956	0.939
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT166	12	12	7	7	cisplatin	p53	PA449014	7157	0.939
NULL	Biomed_Res_Int_2014_Feb_23_2014_168949.nxml.txt.nlp	24707474	SENT119	10	10	38	38	chloroquine	EGFR	PA448948	1956	0.939
NULL	Breast_Cancer_Res_2009_Jul_15_11(4)_207.nxml.txt.nlp	19664181	SENT153	4	4	21	21	trastuzumab	HER2	PA451743	2064	0.939
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_408-414.nxml.txt.nlp	21372831	SENT31	2	2	25	25	doxorubicin	spatial	PA449412	219793	0.939
NULL	Crit_Care_2003_Jun_26_7(6)_427-434.nxml.txt.nlp	14624682	SENT181	16	16	5	5	vasopressin	SON	PA451858	6651	0.939
NULL	Braz_J_Med_Biol_Res_2013_Aug_13_46(8)_650-658.nxml.txt.nlp	23969971	SENT10	34	34	44	44	cisplatin	STAT3	PA449014	6774	0.939
NULL	Mol_Cancer_2013_May_24_12_47.nxml.txt.nlp	23705854	SENT250	7	7	15	15	celecoxib	MRP1	PA448871	4437	0.939
NULL	J_Korean_Med_Sci_2013_Feb_29_28(2)_173-180.nxml.txt.nlp	23399991	SENT87	6	6	20	20	clopidogrel	DES	PA449053	1674	0.939
NULL	Breast_Cancer_Res_2007_Aug_8_9(4)_R50.nxml.txt.nlp	17686159	SENT174	3	3	16	16	gefitinib	HRG	PA131301952	3084;3273	0.939
NULL	Clin_Ophthalmol_2012_Mar_8_6_377-383.nxml.txt.nlp	22457587	SENT36	6	6	14	14	chloroquine	ERG	PA448948	2078	0.939
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT157	15	15	21	21	dasatinib	PP1	PA162372878	5540;5464	0.939
NULL	Evid_Based_Complement_Alternat_Med_2013_May_13_2013_506324.nxml.txt.nlp	23818927	SENT134	24	24	5	5	doxorubicin	STAT3	PA449412	6774	0.939
NULL	Cancers_(Basel)_2010_Apr_20_2(2)_611-623.nxml.txt.nlp	24281084	SENT329	4	4	1	1	aprepitant	NK-1	PA164747039	27087	0.939
NULL	Am_J_Cardiovasc_Drugs_2013_Jun_20_13(5)_331-342.nxml.txt.nlp	23784266	SENT183	30	30	6	6	atorvastatin	P-gp	PA448500	5243	0.939
NULL	Br_J_Cancer_2012_Apr_24_106(9)_1486-1494.nxml.txt.nlp	22472882	SENT120	11	11	15	15	rosiglitazone	MMP9	PA451283	4318	0.939
NULL	Front_Chem_2013_Jul_12_1_10.nxml.txt.nlp	24790939	SENT57	6	6	36	36	hydroquinone	mol	PA449924	90527	0.939
NULL	Clin_Dev_Immunol_2013_May_29_2013_296031.nxml.txt.nlp	23818913	SENT102	16	16	32	32	hydrocortisone	IL-6	PA449905	3569	0.939
NULL	Environ_Health_Perspect_2005_Oct_14_113(10)_1330-1335.nxml.txt.nlp	16203242	SENT18	3	3	15	15	arsenite	MLC	PA452638	23209	0.939
NULL	Cancer_Cell_Int_2013_Feb_8_13_11.nxml.txt.nlp	23394616	SENT207	22	22	31	31	geldanamycin	Hsp90	PA152031327	3320	0.939
NULL	Curr_Neuropharmacol_2013_May_11(3)_263-275.nxml.txt.nlp	24179463	SENT126	6	6	15	15	desipramine	CB1	PA449233	1268	0.939
NULL	J_Invest_Dermatol_2012_Nov_21_132(11)_2642-2651.nxml.txt.nlp	22718118	SENT229	10	10	0	0	collagenase	CD11b	PA449107	3684	0.939
NULL	Arch_Med_Sci_2013_Apr_20_9(2)_332-339.nxml.txt.nlp	23671446	SENT129	42	42	25	25	midazolam	p38	PA450496	10598;1432;7965	0.939
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_67-74.nxml.txt.nlp	17912637	SENT22	8	8	1	1	tamoxifen	ATAC	PA451581	6375	0.939
NULL	Cancer_Manag_Res_2013_Oct_3_5_327-336.nxml.txt.nlp	24124391	SENT95	30	30	10	10	cisplatin	ERCC1	PA449014	2067	0.939
NULL	Int_J_Mol_Sci_2014_May_9_15(5)_8186-8215.nxml.txt.nlp	24821541	SENT79	22	22	10	10	diazoxide	ADP	PA449285	23038	0.939
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_O5.nxml.txt.nlp	NULL	SENT13	5	5	22	22	vancomycin	IFN	PA451850	3439	0.939
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1522-1532.nxml.txt.nlp	21997136	SENT213	7	7	4	4	irinotecan	EGFR	PA450085	1956	0.939
NULL	Int_J_Mol_Sci_2014_Mar_5_15(3)_3970-3988.nxml.txt.nlp	24603537	SENT183	7	7	30	30	curcumin	MCH	PA151958596	5367	0.939
NULL	J_Ophthalmol_2011_Dec_23_2011_292040.nxml.txt.nlp	21253505	SENT85	20	20	1	1	nilvadipine	FGF2	PA165958385	2247;2258	0.939
NULL	Breast_Cancer_Res_2011_Mar_1_13(2)_R21.nxml.txt.nlp	21362200	SENT70	3	3	19	19	fulvestrant	PI3K	PA164747170	5290	0.939
NULL	Clin_Infect_Dis_2011_Jan_1_52(1)_31-40.nxml.txt.nlp	21148517	SENT255	4	4	14	14	vancomycin	HAP	PA451850	5915;10313	0.939
NULL	Clin_Ophthalmol_2009_Jun_2_3_199-210.nxml.txt.nlp	19668566	SENT185	14	14	0	0	ketorolac	Rho	PA450150	29984	0.939
NULL	Brain_Struct_Funct_2013_Mar_17_218(2)_421-435.nxml.txt.nlp	22527118	SENT84	4	4	15	15	fluorescein	5-HT2C	PA164746009	3358	0.939
NULL	Mol_Vis_2011_Feb_1_17_332-340.nxml.txt.nlp	21297899	SENT116	11	11	23	23	benazepril	DPI	PA448561	1832	0.939
NULL	Comp_Hepatol_2005_May_4_4_4.nxml.txt.nlp	15871734	SENT39	9	9	0	0	nadh	DTD	PA164755085	1728	0.939
NULL	EMBO_Mol_Med_2013_May_15_5(5)_751-761.nxml.txt.nlp	23505126	SENT74	42	42	33	33	trypsin	Vel	PA451806	388588	0.939
NULL	J_Inflamm_(Lond)_2005_Oct_31_2_14.nxml.txt.nlp	16259633	SENT295	33	33	8	8	staurosporine	CCR2	PA165109623	729230	0.939
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Dec_23_68(Pt_1)_o223.nxml.txt.nlp	22259505	SENT64	36	36	29	29	ethanol	mol	PA448073	90527	0.939
NULL	Cancer_Cell_Int_2011_Nov_17_11_40.nxml.txt.nlp	22088142	SENT155	28	28	11	11	doxorubicin	MRP2	PA449412	100130958;57626;1244	0.939
NULL	J_Invest_Dermatol_2013_Jan_16_133(1)_164-171.nxml.txt.nlp	22895364	SENT26	0	0	8	8	ustekinumab	p40	PA166048654	3921;339541;10314	0.939
NULL	Hum_Genomics_2009_Jan_1_3(2)_128-142.nxml.txt.nlp	19164090	SENT262	12	12	3	3	carboplatin	CD44	PA448803	960	0.939
NULL	Cancer_Cell_Int_2010_Apr_29_10_12.nxml.txt.nlp	20429927	SENT181	20	20	3	3	arsenite	HRI	PA452638	27102	0.939
NULL	Gut_Microbes_2013_Mar_1_4(2)_158-164.nxml.txt.nlp	23333861	SENT79	24	24	27	27	vancomycin	CD25	PA451850	3669;3559	0.939
NULL	Mol_Cells_2014_Aug_31_37(8)_598-604.nxml.txt.nlp	25134536	SENT76	41	41	25	25	paraformaldehyde	M-CSF	PA450790	1435	0.939
NULL	JAKSTAT_2014_Jun_12_3_e29554.nxml.txt.nlp	25105067	SENT56	34	34	21	21	propofol	STAT3	PA451141	6774	0.939
NULL	Oncotarget_2014_Jun_8_5(13)_5040-5053.nxml.txt.nlp	24970815	SENT249	27	27	13	13	vemurafenib	EGFR	PA165946873	1956	0.939
NULL	Br_J_Cancer_2014_Oct_14_111(8)_1552-1561.nxml.txt.nlp	25117814	SENT139	7	7	30	30	doxorubicin	AKT	PA449412	207	0.939
NULL	Diabetes_Care_2013_Feb_17_36(2)_245-250.nxml.txt.nlp	23086138	SENT109	27	27	1	1	glimepiride	GLP-1	PA449761	100125288	0.939
NULL	Clin_Med_Insights_Oncol_2011_Sep_21_5_315-323.nxml.txt.nlp	22084620	SENT126	4	4	25	25	gemcitabine	Bcl-2	PA449748	596	0.939
NULL	Front_Neuroeng_2013_Feb_25_6_1.nxml.txt.nlp	23443302	SENT68	9	9	14	14	remifentanil	gamma	PA451232	9913	0.939
NULL	Mol_Cancer_2009_Dec_23_8_129.nxml.txt.nlp	20030852	SENT128	31	31	12	12	curcumin	p65	PA151958596	5970	0.939
NULL	Breast_Cancer_Res_2011_Jun_9_13(3)_R57.nxml.txt.nlp	21658222	SENT103	26	26	30	30	tamoxifen	aromatase	PA451581	1588	0.939
NULL	Clin_Endosc_2013_Nov_19_46(6)_643-646.nxml.txt.nlp	24340258	SENT15	8	8	37	37	triamcinolone	ESD	PA451749	2098	0.939
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R91.nxml.txt.nlp	22541814	SENT17	6	6	1	1	thrombin	HO-1	PA451674	3162	0.938
NULL	Mol_Cancer_2009_Nov_24_8_109.nxml.txt.nlp	19930708	SENT169	3	3	13	13	aminoglutethimide	aromatase	PA448375	1588	0.938
NULL	Acta_Pharmacol_Sin_2011_Jun_30_32(6)_853-860.nxml.txt.nlp	21623392	SENT4	8	8	0	0	capsaicin	TRPV1	PA448776	7442	0.938
NULL	Leukemia_2013_Feb_31_27(2)_278-285.nxml.txt.nlp	22907049	SENT35	7	7	3	3	imatinib	KIT	PA10804	3815	0.938
NULL	Breast_Cancer_Res_2011_Nov_1_13(6)_224.nxml.txt.nlp	22114931	SENT104	18	18	11	11	trastuzumab	HER2	PA451743	2064	0.938
NULL	Int_J_Mol_Sci_2012_Aug_23_13(8)_10608-10629.nxml.txt.nlp	22949883	SENT963	25	25	15	15	resveratrol	Q10		27161	0.938
NULL	Comb_Chem_High_Throughput_Screen_2014_Jan_14(1)_80-88.nxml.txt.nlp	NULL	SENT45	16	16	10	10	paraformaldehyde	CO2	PA450790	4513	0.938
NULL	Cell_Commun_Signal_2009_Feb_26_7(Suppl_1)_A99.nxml.txt.nlp	NULL	SENT8	16	16	11	11	trypsin	PAR2	PA451806	2150;55065;8856	0.938
NULL	Breast_Cancer_Res_2008_Feb_29_10(1)_R21.nxml.txt.nlp	18312651	SENT30	35	35	31	31	exemestane	aromatase	PA449563	1588	0.938
NULL	Oncoimmunology_2013_Sep_1_2(9)_e25595.nxml.txt.nlp	24319634	SENT90	31	31	22	22	cyclophosphamide	TLR7	PA449165	51284	0.938
NULL	Cancer_Med_2012_Aug_12_1(1)_68-75.nxml.txt.nlp	23342255	SENT121	9	9	27	27	sorafenib	EGFR	PA7000	1956	0.938
NULL	BMJ_2013_Sep_17_347_f5307.nxml.txt.nlp	24046285	SENT125	18	18	28	28	ticagrelor	CYP3A4	PA165374673	1576	0.938
NULL	Arthritis_Res_Ther_2013_Oct_17_15(5)_R154.nxml.txt.nlp	24286344	SENT300	0	0	6	6	probenecid	ANK	PA451106	56172	0.938
NULL	Eur_J_Immunol_2014_Jun_10_44(6)_1759-1769.nxml.txt.nlp	24595810	SENT105	38	38	25	25	fludrocortisone	CD62L	PA164743961	6402	0.938
NULL	Breast_Cancer_Res_2012_Aug_14_14(4)_R117.nxml.txt.nlp	22889108	SENT266	22	22	12	12	epirubicin	MDM2	PA449476	4193	0.938
NULL	Breast_Cancer_Res_2010_Jun_24_12(3)_R41.nxml.txt.nlp	20576088	SENT167	9	9	4	4	paclitaxel	PPM1D	PA450761	8493	0.938
NULL	Exp_Diabetes_Res_2012_Mar_15_2012_146194.nxml.txt.nlp	22474415	SENT117	11	11	2	2	valsartan	GLP-1	PA451848	100125288	0.938
NULL	Hum_Genomics_2009_Dec_1_4(2)_91-106.nxml.txt.nlp	20038497	SENT120	48	48	20	20	galantamine	CHRNA7	PA449726	1139	0.938
NULL	Nucleic_Acids_Res_2013_Dec_30_41(22)_10268-10282.nxml.txt.nlp	23997120	SENT6	31	31	8	8	camptothecin	TRF1	PA153590860	7013	0.938
NULL	Front_Immunol_2012_Jan_12_2_98.nxml.txt.nlp	22566887	SENT261	33	33	13	13	celecoxib	TRAIL	PA448871	8743	0.938
NULL	Breast_Cancer_Res_2004_Oct_21_6(1)_13-21.nxml.txt.nlp	14680481	SENT18	22	22	0	0	lovastatin	p27	PA450272	5715;10534	0.938
NULL	Cancer_Metab_2013_Jan_23_1_3.nxml.txt.nlp	24280005	SENT396	17	17	2	2	doxycycline	SREBP1	PA449415	6720	0.938
NULL	Indian_J_Urol_2011_Apr-Jun_27(2)_252-261.nxml.txt.nlp	21814318	SENT192	0	0	13	13	valrubicin	ADM	PA164748616	133	0.938
NULL	Brain_Res_2013_Jul_12_1521(100)_1-15.nxml.txt.nlp	22789905	SENT275	14	14	4	4	colchicine	P-gp	PA449092	5243	0.938
NULL	Ann_Rheum_Dis_2010_Jan_17_69(1)_88-96.nxml.txt.nlp	19297346	SENT175	2	2	19	19	methotrexate	IL6R	PA450428	3570	0.938
NULL	Arch_Drug_Inf_2008_Sep_1(2)_50-55.nxml.txt.nlp	19915714	SENT42	2	2	21	21	naltrexone	CYP3A4	PA450588	1576	0.938
NULL	Oncotarget_2011_May_16_2(5)_378-392.nxml.txt.nlp	21623005	SENT206	15	15	3	3	oxaliplatin	p53	PA131285527	7157	0.938
NULL	Mol_Cancer_2010_May_27_9_124.nxml.txt.nlp	20504375	SENT82	23	23	29	29	doxycycline	HOXB13	PA449415	10481	0.938
NULL	Pak_J_Med_Sci_2013_Jan-Mar_29(1)_97-102.nxml.txt.nlp	24353516	SENT7	24	24	41	41	clopidogrel	ADP	PA449053	23038	0.938
NULL	J_Cancer_2013_Nov_21_4(9)_727-735.nxml.txt.nlp	24312143	SENT59	32	32	2	2	trypsin	U87	PA451806	677775;641648	0.938
NULL	Oncogene_2014_Feb_6_33(6)_713-723.nxml.txt.nlp	23435429	SENT82	28	28	20	20	etoposide	p50	PA449552	958;4790	0.938
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Nov_29_64(Pt_12)_o2496.nxml.txt.nlp	21581457	SENT73	37	37	10	10	ethanol	mol	PA448073	90527	0.938
NULL	Br_J_Nutr_2013_May_14_109(9)_1678-1687.nxml.txt.nlp	22935250	SENT211	26	26	1	1	creatine	SGK1	PA164778930	6446	0.938
NULL	J_Geriatr_Cardiol_2014_Mar_11(1)_63-73.nxml.txt.nlp	24748884	SENT149	16	16	20	20	fenoldopam	DR5	PA164784034	8795	0.938
NULL	J_Hematol_Oncol_2013_Jun_3_6_38.nxml.txt.nlp	23731980	SENT186	4	4	10	10	neratinib	HER2	PA165291472	2064	0.938
NULL	Braz_J_Med_Biol_Res_2014_Sep_5_47(11)_929-939.nxml.txt.nlp	25296354	SENT144	16	16	9	9	gefitinib	EGFR	PA131301952	1956	0.938
NULL	Case_Rep_Oncol_2010_Apr_22_3(2)_98-105.nxml.txt.nlp	20740181	SENT53	0	0	6	6	erlotinib	EGFR	PA134687924	1956	0.938
NULL	Oncotarget_2012_Dec_17_4(1)_48-63.nxml.txt.nlp	23295955	SENT187	30	30	2	2	methotrexate	MTHFD2	PA450428	10797	0.938
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Dec_18_67(Pt_1)_o184-o185.nxml.txt.nlp	21522689	SENT67	43	43	23	23	ethanol	mol	PA448073	90527	0.938
NULL	Cell_Death_Dis_2013_Oct_3_4(10)_e834.nxml.txt.nlp	24091677	SENT71	40	40	7	7	vinblastine	Mcl-1	PA451877	4170	0.938
NULL	Breast_Cancer_Res_2010_Aug_23_12(4)_R64.nxml.txt.nlp	20731819	SENT16	34	34	9	9	tamoxifen	MAF	PA451581	4094	0.938
NULL	Front_Neurosci_2014_Aug_12_8_246.nxml.txt.nlp	25161606	SENT41	28	28	22	22	l-glutamine	B27	PA10090	56246	0.938
NULL	Pharm_Pract_(Granada)_2007_Jun_18_Apr-Jun_5(2)_51-58.nxml.txt.nlp	25247008	SENT15	7	7	20	20	varenicline	OTC	PA164781343	5009	0.938
NULL	Clinics_(Sao_Paulo)_2009_May_64(5)_409-414.nxml.txt.nlp	19488606	SENT106	5	5	18	18	vasopressin	AVP	PA451858	114548;551	0.938
NULL	Oncotarget_2014_Jun_30_5(14)_5591-5601.nxml.txt.nlp	25015320	SENT208	36	36	18	18	heparin	EGF	PA449855	1950	0.938
NULL	Infect_Dis_Ther_2014_Dec_24_3(2)_159-174.nxml.txt.nlp	25134687	SENT181	25	25	31	31	mimosine	HIF-1	PA164752445	29072	0.938
NULL	Cancer_Cell_Int_2011_Aug_19_11_29.nxml.txt.nlp	21854619	SENT274	13	13	7	7	cisplatin	HDAC	PA449014	9734	0.938
NULL	Front_Endocrinol_(Lausanne)_2013_Mar_20_4_32.nxml.txt.nlp	23519268	SENT551	20	20	0	0	cisplatin	p53	PA449014	7157	0.938
NULL	Diabetes_Care_2012_Apr_13_35(4)_868-872.nxml.txt.nlp	22357182	SENT117	13	13	7	7	ramipril	DREAM	PA451223	30818	0.938
NULL	Oncotarget_2013_Feb_27_4(2)_329-345.nxml.txt.nlp	23593654	SENT185	20	20	25	25	paclitaxel	CD44	PA450761	960	0.938
NULL	Int_J_Med_Chem_2012_Dec_13_2012_530392.nxml.txt.nlp	25379286	SENT275	31	31	4	4	ethanol	mol	PA448073	90527	0.938
NULL	Lab_Invest_2009_Dec_19_89(12)_1397-1409.nxml.txt.nlp	19841616	SENT389	26	26	32	32	curcumin	NAC	PA151958596	22861	0.938
NULL	Oxid_Med_Cell_Longev_2013_May_22_2013_791795.nxml.txt.nlp	23766861	SENT124	21	21	44	44	taurine	F12	PA451590	2161	0.938
NULL	Clin_Med_Insights_Oncol_2012_Feb_28_6_125-135.nxml.txt.nlp	22408376	SENT268	11	11	3	3	cetuximab	BRAF	PA10040	673	0.938
NULL	Environ_Health_Perspect_2007_Apr_16_115(4)_556-563.nxml.txt.nlp	17450224	SENT160	24	24	17	17	ethanol	CA1	PA448073	759	0.938
NULL	Oncotarget_2012_Oct_8_3(10)_1112-1123.nxml.txt.nlp	23047041	SENT206	34	34	20	20	heparin	EGF	PA449855	1950	0.938
NULL	Acta_Neuropathol_Commun_2014_Jan_2_2_3.nxml.txt.nlp	24383546	SENT85	8	8	0	0	suramin	SIRT1	PA10292	23411	0.938
NULL	J_Adv_Pract_Oncol_2012_Jul_1_Jul-Aug_3(4)_267-272.nxml.txt.nlp	25031955	SENT31	0	0	21	21	crizotinib	HGFR	PA165946122	4233	0.938
NULL	Arthritis_Res_Ther_2010_Jul_13_12(4)_R140.nxml.txt.nlp	20626857	SENT192	35	35	13	13	etanercept	IL-6	PA449515	3569	0.938
NULL	Curr_Oncol_2009_Aug_16(4)_25-35.nxml.txt.nlp	19672422	SENT174	6	6	0	0	trastuzumab	PI3	PA451743	5266	0.938
NULL	Mol_Pain_2012_Sep_24_8_73.nxml.txt.nlp	23006841	SENT9	2	2	7	7	ketoconazole	TRPV1	PA450146	7442	0.938
NULL	Curr_Neuropharmacol_2012_Mar_10(1)_12-48.nxml.txt.nlp	22942876	SENT357	18	18	22	22	flumazenil	5-HT1A	PA449659	3350	0.938
NULL	J_Mol_Model_2006_Jul_29_12(5)_597-609.nxml.txt.nlp	16261297	SENT191	7	7	18	18	phosphorus	mol	PA450954	90527	0.938
NULL	Mol_Cancer_2010_Jun_24_9_164.nxml.txt.nlp	20576107	SENT195	31	31	7	7	vinblastine	Mcl-1	PA451877	4170	0.938
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT55	2	2	12	12	resveratrol	TRAIL		8743	0.938
NULL	Oncotarget_2011_Dec_24_2(12)_896-917.nxml.txt.nlp	22203527	SENT116	21	21	14	14	metformin	LKB1	PA450395	6794	0.938
NULL	Oncotarget_2014_Jun_1_5(13)_4855-4867.nxml.txt.nlp	24952592	SENT82	26	26	9	9	platinum	NACT	PA150595617	284111	0.938
NULL	Arthritis_Res_Ther_2005_Apr_4_7(4)_R756-R768.nxml.txt.nlp	15987477	SENT26	40	40	4	4	hyaluronidase	PH-20	PA164745713	6677	0.938
NULL	Int_J_Med_Sci_2014_Mar_29_11(5)_528-537.nxml.txt.nlp	24693223	SENT231	5	5	8	8	rimonabant	CB1	PA152407999	1268	0.938
NULL	Front_Neurosci_2014_Jan_10_7_270.nxml.txt.nlp	24454277	SENT184	44	44	36	36	resveratrol	PI3K		5290	0.938
NULL	Int_J_Nanomedicine_2012_May_7_7_2307-2314.nxml.txt.nlp	22661887	SENT12	27	27	11	11	gemcitabine	zeta	PA449748	9907	0.938
NULL	Neural_Plast_2012_Jul_30_2012_976164.nxml.txt.nlp	22919518	SENT47	25	25	0	0	paraformaldehyde	P15	PA450790	1030;29107	0.938
NULL	Mar_Drugs_2014_May_27_12(6)_3091-3115.nxml.txt.nlp	24871460	SENT98	17	17	30	30	rifaximin	CYP3A4	PA164752443	1576	0.938
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT56	20	20	1	1	ritonavir	SLK	PA451260	9748;2534	0.938
NULL	Cancer_Med_2014_Jun_25_3(3)_674-680.nxml.txt.nlp	24668895	SENT30	12	12	5	5	cetuximab	KRAS	PA10040	3845	0.938
NULL	J_Geriatr_Cardiol_2012_Jun_9(2)_180-184.nxml.txt.nlp	22916066	SENT22	41	41	24	24	rosuvastatin	Rho	PA134308647	29984	0.938
NULL	Front_Pharmacol_2014_Dec_10_5_271.nxml.txt.nlp	25540621	SENT132	2	2	27	27	hesperetin	ghrelin	PA164742902	51738	0.938
NULL	Protein_Cell_2014_Jun_19_5(6)_469-479.nxml.txt.nlp	24748116	SENT59	15	15	4	4	paclitaxel	EB1	PA450761	9167;22919;10982	0.938
NULL	Acta_Vet_Scand_2011_Jun_8_53(1)_37.nxml.txt.nlp	21651813	SENT74	12	12	19	19	acepromazine	San	PA164783999	80218	0.938
NULL	J_Oncol_2012_Aug_9_2012_685213.nxml.txt.nlp	22934113	SENT218	10	10	31	31	everolimus	ACTH	PA164746311	5443	0.938
NULL	Cell_J_2012_Dec_22_Winter_13(4)_281-289.nxml.txt.nlp	23507624	SENT20	8	8	28	28	isoproterenol	IL-4	PA450121	3565	0.938
NULL	Toxins_(Basel)_2010_Oct_26_2(11)_2490-2518.nxml.txt.nlp	22069563	SENT136	12	12	5	5	cisplatin	Bcl-2	PA449014	596	0.938
NULL	J_Inflamm_(Lond)_2006_Jul_12_3_10.nxml.txt.nlp	16834783	SENT145	12	12	1	1	mometasone	GM-CSF	PA450541	1437	0.938
NULL	J_Gen_Physiol_2009_Apr_133(4)_421-438.nxml.txt.nlp	19289574	SENT493	7	7	48	48	forskolin	SLC26A9	PA146096022	115019	0.938
NULL	Clin_Ophthalmol_2013_Dec_21_7_7-14.nxml.txt.nlp	23293509	SENT97	37	37	21	21	tafluprost	BAK	PA165958432	578	0.938
NULL	Br_J_Cancer_2011_Jul_12_105(2)_212-220.nxml.txt.nlp	21694723	SENT118	4	4	8	8	curcumin	STAT3	PA151958596	6774	0.938
NULL	Adv_Hematol_2012_Jun_19_2012_851674.nxml.txt.nlp	22778745	SENT224	15	15	11	11	ns-398	COX		1351	0.938
NULL	Int_J_Endocrinol_2013_Oct_21_2013_510540.nxml.txt.nlp	24228028	SENT53	28	28	1	1	lipase	FAAH	PA450239	79152;2166	0.938
NULL	Arthritis_Res_Ther_2014_Apr_11_16(2)_R93.nxml.txt.nlp	24725461	SENT168	9	9	5	5	letrozole	aromatase	PA450196	1588	0.938
NULL	Avicenna_J_Med_2011_Jul-Sep_1(1)_12-17.nxml.txt.nlp	23210004	SENT150	13	13	0	0	thalidomide	GM-CSF	PA451644	1437	0.938
NULL	Nat_Med_2011_Aug_28_17(9)_1094-1100.nxml.txt.nlp	21873989	SENT89	5	5	23	23	imatinib	IFN	PA10804	3439	0.938
NULL	Braz_J_Med_Biol_Res_2014_Sep_5_47(11)_1008-1015.nxml.txt.nlp	25296365	SENT27	38	38	0	0	tamoxifen	TMX	PA451581	81542	0.938
NULL	Breast_Cancer_Res_2014_Jul_24_16(4)_411.nxml.txt.nlp	25056669	SENT189	6	6	24	24	tamoxifen	CD49f	PA451581	3655	0.938
NULL	Eur_J_Clin_Pharmacol_2010_Nov_29_66(11)_1131-1136.nxml.txt.nlp	20669013	SENT25	8	8	15	15	voriconazole	CYP2C19	PA10233	1557	0.938
NULL	J_Cell_Biol_2004_Apr_26_165(2)_175-180.nxml.txt.nlp	15096524	SENT80	6	6	17	17	forskolin	VASP	PA146096022	7408	0.938
NULL	Int_J_Mol_Sci_2012_Dec_5_13(12)_16624-16635.nxml.txt.nlp	23443122	SENT7	14	14	27	27	paclitaxel	MRP3	PA450761	8714	0.938
NULL	Int_J_Mol_Sci_2014_Nov_21_15(11)_21433-21454.nxml.txt.nlp	25421240	SENT98	5	5	22	22	pp2	BIM		10018	0.938
NULL	Oncoscience_2014_Mar_25_1(3)_205-215.nxml.txt.nlp	25594013	SENT43	27	27	12	12	doxycycline	EFEMP1	PA449415	2202	0.938
NULL	J_Oncol_2012_Mar_26_2012_198412.nxml.txt.nlp	22536237	SENT33	26	26	0	0	trastuzumab	GEM	PA451743	2669	0.938
NULL	Br_J_Cancer_2012_Nov_20_107(11)_1815-1819.nxml.txt.nlp	23099804	SENT21	15	15	21	21	tamoxifen	aromatase	PA451581	1588	0.938
NULL	Breast_Cancer_Res_2010_Jun_28_12(3)_R43.nxml.txt.nlp	20579400	SENT116	43	43	25	25	vinorelbine	MAPT	PA451881	4137	0.938
NULL	Braz_J_Med_Biol_Res_2013_Aug_13_46(8)_659-669.nxml.txt.nlp	24036938	SENT227	4	4	7	7	resveratrol	SIRT1		23411	0.938
NULL	Biomed_Res_Int_2013_Jul_31_2013_692071.nxml.txt.nlp	23984399	SENT206	23	23	4	4	sorafenib	OCT1	PA7000	5451;6580	0.938
NULL	Semin_Immunopathol_2012_Nov_11_34(6)_829-846.nxml.txt.nlp	23053394	SENT266	18	18	11	11	piroxicam	IL-10	PA450985	3586	0.938
NULL	BMJ_2010_Feb_8_340_c693.nxml.txt.nlp	20142325	SENT85	29	29	23	23	tamoxifen	CYP2D6	PA451581	1565	0.938
NULL	Oncotarget_2014_Oct_21_5(22)_11252-11268.nxml.txt.nlp	25361004	SENT136	14	14	6	6	metformin	CLIC1	PA450395	1192	0.938
NULL	Clin_Mol_Hepatol_2014_Jun_30_20(2)_89-136.nxml.txt.nlp	25032178	SENT334	8	8	20	20	boceprevir	CYP3A4	PA165948902	1576	0.938
NULL	J_Hematol_Oncol_2012_Sep_18_5_57.nxml.txt.nlp	22989009	SENT227	36	36	19	19	nutlin-3	p53AIP1		63970	0.938
NULL	Target_Oncol_2013_Jun_27_8(2)_127-136.nxml.txt.nlp	23625191	SENT121	27	27	12	12	panitumumab	KRAS	PA162373091	3845	0.938
NULL	Exp_Ther_Med_2013_Apr_5_5(4)_1259-1263.nxml.txt.nlp	23596498	SENT99	4	4	10	10	propofol	TRPV1	PA451141	7442	0.938
NULL	Breast_Cancer_Res_2011_Dec_16_13(6)_R131.nxml.txt.nlp	22177475	SENT287	31	31	22	22	lapatinib	HER2	PA152241907	2064	0.938
NULL	J_Gen_Physiol_1995_Nov_1_106(5)_923-955.nxml.txt.nlp	8648298	SENT20	36	36	8	8	spermine	HRK1	PA164781199	3761	0.938
NULL	Mol_Cell_2014_May_8_54(3)_445-459.nxml.txt.nlp	24746700	SENT501	31	31	21	21	etoposide	BRCA1	PA449552	672	0.938
NULL	Eur_J_Haematol_2008_Feb_80(2)_93-106.nxml.txt.nlp	18081719	SENT315	15	15	7	7	iron	MRI	PA450087	78996	0.938
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT305	17	17	4	4	paliperidone	PRL	PA163518919	5617	0.938
NULL	Biomed_Res_Int_2013_Aug_4_2013_152909.nxml.txt.nlp	23984319	SENT97	29	29	24	24	methotrexate	MSH2	PA450428	4436	0.938
NULL	Leukemia_2013_Jan_11_27(1)_32-40.nxml.txt.nlp	22781593	SENT174	11	11	3	3	ponatinib	FGFR1	PA165980594	2260	0.938
NULL	Int_J_Biol_Sci_2013_Apr_22_9(4)_350-360.nxml.txt.nlp	23630447	SENT187	38	38	29	29	doxorubicin	AKT	PA449412	207	0.938
NULL	Int_J_Mol_Sci_2014_Sep_29_15(10)_17411-17441.nxml.txt.nlp	25268615	SENT216	24	24	15	15	cisplatin	CD147	PA449014	682	0.938
NULL	Breast_Cancer_Res_2008_Dec_5_10(6)_R104.nxml.txt.nlp	19061505	SENT227	28	28	12	12	estradiol	JNK	PA449503	5599	0.938
NULL	Oncotarget_2014_Mar_16_5(12)_4087-4102.nxml.txt.nlp	24961479	SENT195	6	6	2	2	hemin	PC3	PA449849	57332;7832;5122	0.938
NULL	Oncoimmunology_2013_Feb_1_2(2)_e23080.nxml.txt.nlp	23525357	SENT84	16	16	1	1	cyclophosphamide	CD4	PA449165	920	0.938
NULL	Case_Rep_Transplant_2012_Aug_30_2012_672923.nxml.txt.nlp	23259137	SENT80	4	4	21	21	voriconazole	IPA	PA10233	3160	0.938
NULL	Aging_(Albany_NY)_2010_Sep_18_2(9)_535-537.nxml.txt.nlp	20876940	SENT10	36	36	27	27	doxorubicin	TP53	PA449412	7157	0.938
NULL	Biochimie_2012_Sep_94(9)_1997-2005.nxml.txt.nlp	22659570	SENT178	10	10	1	1	pp2	LPA		4018	0.938
NULL	Breast_Cancer_Res_2007_Aug_8_9(4)_R50.nxml.txt.nlp	17686159	SENT146	27	27	9	9	gefitinib	EGFR	PA131301952	1956	0.938
NULL	Breast_Cancer_Res_2007_Mar_2_9(2)_205.nxml.txt.nlp	NULL	SENT26	11	11	4	4	canertinib	HER-2	PA134687925	2064	0.938
NULL	Cells_2014_Sep_12_3(3)_914-938.nxml.txt.nlp	25222270	SENT846	4	4	9	9	capsaicin	TRPV1	PA448776	7442	0.938
NULL	Angew_Chem_Int_Ed_Engl_2013_Jan_2_52(1)_325-330.nxml.txt.nlp	23080482	SENT30	31	31	26	26	thrombin	ACPP	PA451674	55	0.938
NULL	Allergy_Asthma_Immunol_Res_2009_Oct_25_1(1)_30-35.nxml.txt.nlp	20224667	SENT18	20	20	11	11	aspirin	PPARG	PA448497	5468	0.938
NULL	Curr_Neuropharmacol_2009_Sep_7(3)_160-179.nxml.txt.nlp	20190959	SENT258	38	38	15	15	dpcpx	CO2		4513	0.938
NULL	Clin_Epidemiol_2010_Aug_9_2_145-151.nxml.txt.nlp	20865112	SENT66	8	8	5	5	raltegravir	CD4		920	0.938
NULL	Blood_Res_2014_Dec_23_49(4)_279-280.nxml.txt.nlp	25548764	SENT23	4	4	27	27	lenalidomide	CD40	PA162363968	958	0.938
NULL	Mucosal_Immunol_2012_May_8_5(3)_267-276.nxml.txt.nlp	22318492	SENT267	4	4	23	23	omalizumab	CD63	PA164752253	967	0.938
NULL	Br_J_Cancer_2013_Feb_5_108(2)_319-326.nxml.txt.nlp	23322198	SENT20	0	0	21	21	sunitinib	VEGFR2	PA162372840	3791	0.938
NULL	Oncol_Lett_2013_Sep_15_6(3)_648-654.nxml.txt.nlp	24137384	SENT121	31	31	3	3	oxaliplatin	GSTP1	PA131285527	2950	0.938
NULL	J_Vis_Exp_2014_Jun_28_(88)_51278.nxml.txt.nlp	24998179	SENT35	10	10	22	22	cyclosporine	P-gp	PA449167	5243	0.938
NULL	Biomed_Res_Int_2014_Mar_6_2014_712893.nxml.txt.nlp	24734240	SENT163	15	15	2	2	ethanol	JNK	PA448073	5599	0.938
NULL	Clin_Ophthalmol_2012_Apr_27_6_637-644.nxml.txt.nlp	22570544	SENT96	6	6	23	23	bromfenac	COX	PA448670	1351	0.938
NULL	J_Cell_Biol_1998_Jan_26_140(2)_335-345.nxml.txt.nlp	9442109	SENT85	7	7	30	30	chloroquine	NHE	PA448948	285335	0.938
NULL	Comput_Math_Methods_Med_2014_Apr_8_2014_653487.nxml.txt.nlp	24817905	SENT468	7	7	4	4	sorafenib	BRAF	PA7000	673	0.938
NULL	Exp_Diabetes_Res_2007_Dec_17_2007_31867.nxml.txt.nlp	18288248	SENT222	0	0	40	40	triamcinolone	AP-1	PA451749	2353;3727;2354;3725	0.938
NULL	Br_J_Pharmacol_2010_Aug_160(8)_1997-2007.nxml.txt.nlp	20649597	SENT208	5	5	11	11	pp2	RIP2		8767;64283	0.938
NULL	Arthritis_Res_Ther_2007_Oct_19_9(Suppl_3)_P20.nxml.txt.nlp	NULL	SENT18	14	14	3	3	infliximab	p38	PA452639	10598;1432;7965	0.938
NULL	Arthritis_Res_Ther_2011_Apr_28_13(2)_210.nxml.txt.nlp	21542894	SENT94	12	12	2	2	ethanol	TRPV1	PA448073	7442	0.938
NULL	J_Cancer_2013_Aug_28_4(7)_585-596.nxml.txt.nlp	24069069	SENT92	24	24	4	4	verteporfin	CO2	PA451871	4513	0.938
NULL	Environ_Health_Perspect_2011_Apr_16_119(4)_534-541.nxml.txt.nlp	21081300	SENT199	10	10	17	17	genistein	COX	PA165109660	1351	0.938
NULL	Acta_Pharmacol_Sin_2010_Sep_2_31(9)_1172-1180.nxml.txt.nlp	20676117	SENT178	10	10	8	8	bsi-201	PARP1		142	0.938
NULL	Mol_Cancer_2012_Oct_22_11_80.nxml.txt.nlp	23088607	SENT72	11	11	22	22	estradiol	YC1	PA449503	5937	0.938
NULL	J_Thorac_Oncol_2014_Jun_30_9(6)_775-783.nxml.txt.nlp	24828661	SENT127	16	16	21	21	erlotinib	Met	PA134687924	79811	0.938
NULL	Clin_Med_Insights_Ear_Nose_Throat_2012_Apr_3_5_1-16.nxml.txt.nlp	24179404	SENT191	18	18	3	3	gefitinib	TLR9	PA131301952	54106	0.938
NULL	J_Cell_Biol_1997_Jul_28_138(2)_435-448.nxml.txt.nlp	9230084	SENT325	10	10	3	3	paraformaldehyde	IFN	PA450790	3439	0.938
NULL	Cancer_Imaging_2005_Dec_15_5(1)_150-156.nxml.txt.nlp	16361144	SENT23	15	15	9	9	imatinib	KIT	PA10804	3815	0.938
NULL	Int_J_Mol_Sci_2014_Nov_21_15(11)_21433-21454.nxml.txt.nlp	25421240	SENT148	0	0	20	20	heparin	EGFR	PA449855	1956	0.938
NULL	Acta_Pharmacol_Sin_2009_Jun_11_30(6)_723-739.nxml.txt.nlp	19434058	SENT170	7	7	4	4	selegiline	CYP2A6	PA451316	1548	0.938
NULL	Tuberc_Respir_Dis_(Seoul)_2013_Aug_30_75(2)_59-66.nxml.txt.nlp	24023558	SENT142	4	4	14	14	docetaxel	TRAIL	PA449383	8743	0.938
NULL	ScientificWorldJournal_2013_Jun_19_2013_174392.nxml.txt.nlp	23853530	SENT105	28	28	11	11	doxazosin	c-FLIP	PA449407	8837	0.938
NULL	EMBO_Mol_Med_2013_Jan_29_5(1)_137-148.nxml.txt.nlp	23197407	SENT299	3	3	13	13	losartan	TR3	PA450268	8718;3164;10587	0.938
NULL	Indian_J_Med_Res_2013_May_137(5)_977-980.nxml.txt.nlp	23760386	SENT14	9	9	20	20	galantamine	ADP	PA449726	23038	0.938
NULL	Trials_2013_Sep_24_14_311.nxml.txt.nlp	24063608	SENT177	19	19	5	5	praziquantel	STH	PA164764583	246744	0.938
NULL	Eur_J_Neurosci_2010_Mar_31(6)_1019-1026.nxml.txt.nlp	20377616	SENT33	44	44	39	39	halothane	P35	PA449845	2220	0.938
NULL	Cancer_Res_Treat_2014_Jan_15_46(1)_48-54.nxml.txt.nlp	24520223	SENT123	17	17	1	1	bevacizumab	MAX	PA130232992	4149	0.938
NULL	Colorectal_Dis_2012_Feb_14(2)_e31-e47.nxml.txt.nlp	21848897	SENT21	4	4	15	15	cetuximab	KRAS	PA10040	3845	0.938
NULL	Br_J_Cancer_2009_Jun_2_100(11)_1697-1703.nxml.txt.nlp	19384299	SENT88	4	4	10	10	fludarabine	CD4	PA449655	920	0.938
NULL	Acta_Naturae_2013_Jul-Sep_5(3)_99-106.nxml.txt.nlp	24303206	SENT164	40	40	6	6	ethanol	ADH1B	PA448073	125	0.938
NULL	Oncotarget_2011_Aug_30_2(8)_610-626.nxml.txt.nlp	21881167	SENT202	37	37	22	22	doxorubicin	Raf-1	PA449412	5894	0.938
NULL	EPMA_J_2013_Jan_28_4(1)_3.nxml.txt.nlp	23356214	SENT310	22	22	17	17	cetuximab	PIK3CA	PA10040	5290	0.938
NULL	Mol_Biol_Cell_2012_Jun_1_23(11)_2017-2027.nxml.txt.nlp	22496424	SENT114	29	29	17	17	warfarin	PRDX4	PA451906	10549	0.938
NULL	Br_J_Cancer_1996_Jan_73(1)_18-23.nxml.txt.nlp	8554977	SENT8	23	23	3	3	cisplatin	GADD153	PA449014	1649	0.938
NULL	Exp_Ther_Med_2013_Oct_20_6(4)_899-903.nxml.txt.nlp	24137286	SENT10	46	46	36	36	rosuvastatin	c-Jun	PA134308647	3725	0.938
NULL	J_Biol_Chem_2008_Oct_31_283(44)_29841-29846.nxml.txt.nlp	18765669	SENT52	41	41	5	5	l-glutamine	HEK	PA10090	2042	0.938
NULL	Clin_Exp_Reprod_Med_2013_Jun_30_40(2)_67-75.nxml.txt.nlp	23875162	SENT128	17	17	12	12	rosiglitazone	ERK2	PA451283	5594	0.938
NULL	Ecancermedicalscience_2009_Oct_29_3_157.nxml.txt.nlp	22276018	SENT71	22	22	25	25	gefitinib	EGFR	PA131301952	1956	0.938
NULL	Am_J_Cardiovasc_Drugs_2013_Jun_20_13(5)_331-342.nxml.txt.nlp	23784266	SENT195	6	6	14	14	quinidine	P-gp	PA451209	5243	0.938
NULL	Br_J_Cancer_2013_Jul_23_109(2)_502-511.nxml.txt.nlp	23799850	SENT172	15	15	3	3	gemcitabine	SMARCC1	PA449748	6599	0.938
NULL	J_Physiol_2009_Feb_15_587(Pt_4)_731-744.nxml.txt.nlp	19074966	SENT98	21	21	14	14	taurine	PAT1	PA451590	10513;206358	0.938
NULL	Diabetes_Metab_J_2012_Aug_20_36(4)_293-299.nxml.txt.nlp	22950061	SENT141	34	34	6	6	metformin	PI3K	PA450395	5290	0.938
NULL	Mol_Biol_Int_2011_Feb_24_2011_137459.nxml.txt.nlp	22091395	SENT206	16	16	4	4	arsenite	PRMT7	PA452638	54496	0.938
NULL	BMJ_2011_Aug_4_343_d4588.nxml.txt.nlp	21816733	SENT229	29	29	7	7	clopidogrel	CYP2C19	PA449053	1557	0.938
NULL	Arthritis_Res_Ther_2007_Mar_3_9(2)_R23.nxml.txt.nlp	17335581	SENT127	6	6	14	14	sulfasalazine	NAT2	PA451547	10;81539	0.938
NULL	Breast_Cancer_Res_Treat_2014_Sep_25_148(1)_81-90.nxml.txt.nlp	25253174	SENT167	3	3	27	27	metformin	HER2	PA450395	2064	0.938
NULL	J_Carcinog_2013_Dec_31_12_22.nxml.txt.nlp	24574860	SENT5	10	10	5	5	crizotinib	EGFR	PA165946122	1956	0.938
NULL	Blood_Cancer_J_2013_Dec_6_3(12)_e167.nxml.txt.nlp	24317089	SENT301	13	13	8	8	lovastatin	IBP	PA450272	706;50619	0.938
NULL	Asian_J_Androl_2015_Oct_24_Jan-Feb_17(1)_61-67.nxml.txt.nlp	25370206	SENT116	31	31	1	1	tadalafil	SEP2	PA10333	23176;23157	0.938
NULL	Drug_Target_Insights_2013_Aug_19_7_27-34.nxml.txt.nlp	24023511	SENT143	18	18	44	44	biricodar	P-gp		5243	0.938
NULL	Dement_Geriatr_Cogn_Dis_Extra_2014_Nov_15_4(3)_450-456.nxml.txt.nlp	25538729	SENT99	31	31	10	10	donepezil	APOE	PA449394	348	0.938
NULL	Avicenna_J_Phytomed_2014_May-Jun_4(3)_215-224.nxml.txt.nlp	25050319	SENT127	17	17	42	42	diazepam	MEPI	PA449283	5276	0.938
NULL	Virol_J_2012_Dec_27_9_318.nxml.txt.nlp	23270577	SENT39	24	24	33	33	betaine	LAMP	PA448603	4045;27074	0.938
NULL	Clin_Dev_Immunol_2011_Jul_9_2011_730828.nxml.txt.nlp	21776288	SENT112	20	20	5	5	methylprednisolone	IL-10	PA450466	3586	0.938
NULL	Diagn_Pathol_2013_Nov_21_8_191.nxml.txt.nlp	24261710	SENT124	18	18	23	23	trastuzumab	HER2	PA451743	2064	0.938
NULL	Mol_Biol_Cell_2014_Jan_1_25(1)_76-86.nxml.txt.nlp	24173717	SENT309	31	31	9	9	paclitaxel	TUBB6	PA450761	84617	0.938
NULL	Diabetes_Care_2010_Apr_12_33(4)_826-832.nxml.txt.nlp	20067954	SENT33	0	0	20	20	daclizumab	IL-2	PA164764446	3558	0.938
NULL	Evid_Based_Complement_Alternat_Med_2012_Aug_27_2012_809653.nxml.txt.nlp	22969831	SENT171	27	27	22	22	oxazepam	flower	PA450731	11094	0.938
NULL	Aging_Cell_2012_Aug_11(4)_579-587.nxml.txt.nlp	22435726	SENT109	2	2	29	29	etoposide	CD28	PA449552	1493;940	0.938
NULL	Mol_Cancer_2013_Nov_20_12_144.nxml.txt.nlp	24257371	SENT211	33	33	22	22	cisplatin	PRL	PA449014	5617	0.938
NULL	Oncotarget_2014_Sep_25_5(21)_10621-10635.nxml.txt.nlp	25301737	SENT16	10	10	0	0	cisplatin	CD133	PA449014	8842	0.938
NULL	J_Cardiovasc_Dis_Res_2012_Oct-Dec_3(4)_319-322.nxml.txt.nlp	23233778	SENT55	2	2	15	15	azithromycin	MRP2	PA448519	100130958;57626;1244	0.938
NULL	Indian_J_Med_Res_2013_Jan_137(1)_125-129.nxml.txt.nlp	23481061	SENT79	10	10	0	0	oxaliplatin	GSTP1	PA131285527	2950	0.938
NULL	Oncotarget_2013_Jul_21_4(8)_1266-1279.nxml.txt.nlp	23907540	SENT161	9	9	25	25	doxycycline	PTEN	PA449415	5728	0.938
NULL	Osteoporos_Int_2012_Jan_3_23(1)_327-337.nxml.txt.nlp	21892677	SENT187	45	45	25	25	denosumab	RANKL	PA166048634	8600	0.938
NULL	J_Mol_Signal_2008_Mar_31_3_8.nxml.txt.nlp	18377662	SENT72	29	29	9	9	pp2	SHP-1		5777	0.938
NULL	Mol_Biol_Cell_2012_Jun_1_23(11)_2017-2027.nxml.txt.nlp	22496424	SENT100	5	5	45	45	warfarin	PRDX4	PA451906	10549	0.938
NULL	Drug_Healthc_Patient_Saf_2012_Nov_29_4_173-180.nxml.txt.nlp	23236256	SENT68	8	8	17	17	clozapine	FGA	PA449061	2243	0.938
NULL	Indian_J_Psychiatry_2010_Jan_52(Suppl1)_S317-S340.nxml.txt.nlp	21836703	SENT109	17	17	24	24	thiothixene	TFP	PA451669	7034	0.938
NULL	Breast_Cancer_Res_Treat_2007_Oct_27_105(Suppl_1)_19-29.nxml.txt.nlp	17333340	SENT25	6	6	2	2	anastrozole	aromatase	PA448432	1588	0.938
NULL	J_Asthma_Allergy_2010_Jun_28_3_9-17.nxml.txt.nlp	21437035	SENT125	38	38	26	26	bleomycin	CXCL12	PA448645	6387	0.938
NULL	Mol_Cancer_2010_Aug_20_9_220.nxml.txt.nlp	20727180	SENT20	5	5	22	22	nicotine	XIAP	PA450626	331	0.938
NULL	Eur_Respir_J_2014_Jul_23_44(1)_23-63.nxml.txt.nlp	24659544	SENT320	26	26	11	11	isoniazid	DST	PA450112	667	0.938
NULL	Nucleic_Acids_Res_2013_Mar_29_41(5)_2981-2992.nxml.txt.nlp	23361461	SENT110	16	16	13	13	tetracycline	TDP1	PA451640	55775	0.938
NULL	Cancers_(Basel)_2011_Aug_5_3(3)_3114-3142.nxml.txt.nlp	24212948	SENT314	7	7	37	37	daclizumab	CD25	PA164764446	3669;3559	0.938
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S349-S354.nxml.txt.nlp	21525481	SENT112	5	5	0	0	liraglutide	GLP-1	PA165958364	100125288	0.938
NULL	J_Cell_Mol_Med_2014_Sep_4_18(9)_1816-1829.nxml.txt.nlp	24894878	SENT36	0	0	4	4	maraviroc	CCR5	PA164768835	1234	0.938
NULL	Exp_Diabetes_Res_2012_Oct_15_2012_465282.nxml.txt.nlp	23118742	SENT163	5	5	0	0	metformin	AMPK	PA450395	5563	0.938
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT308	37	37	8	8	cisplatin	p38	PA449014	10598;1432;7965	0.938
NULL	Arch_Med_Sci_2013_Apr_20_9(2)_332-339.nxml.txt.nlp	23671446	SENT129	42	42	28	28	midazolam	JNK	PA450496	5599	0.938
NULL	Oncol_Lett_2013_Jul_29_6(1)_118-124.nxml.txt.nlp	23946788	SENT83	34	34	9	9	tamoxifen	AF1	PA451581	1946	0.938
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT43	8	8	34	34	ritonavir	CYP3A4	PA451260	1576	0.938
NULL	Br_J_Pharmacol_2008_Oct_18_155(4)_596-605.nxml.txt.nlp	18852694	SENT147	10	10	6	6	fenofibrate	SREBP2	PA449594	6721	0.938
NULL	Environ_Health_Perspect_2007_Dec_8_115(Suppl_1)_129-136.nxml.txt.nlp	18174961	SENT130	22	22	6	6	lindane	BAX	PA164754914	581	0.938
NULL	Ann_Indian_Acad_Neurol_2008_Jan-Mar_11(1)_3-12.nxml.txt.nlp	19966972	SENT210	28	28	13	13	fluorescein	CO2	PA164746009	4513	0.938
NULL	Ther_Clin_Risk_Manag_2006_Dec_2(4)_435-445.nxml.txt.nlp	18360654	SENT200	18	18	14	14	cetuximab	EGFR	PA10040	1956	0.938
NULL	AAPS_J_2011_Jun_1_13(3)_405-416.nxml.txt.nlp	21630127	SENT251	22	22	2	2	tocilizumab	IL-6	PA165292659	3569	0.938
NULL	Br_J_Cancer_2006_Dec_4_95(11)_1483-1489.nxml.txt.nlp	17106442	SENT81	4	4	20	20	gefitinib	EGFR	PA131301952	1956	0.938
NULL	Diabetes_Care_2009_Nov_32(Suppl_2)_S223-S231.nxml.txt.nlp	19875556	SENT257	20	20	25	25	liraglutide	GLP-1	PA165958364	100125288	0.938
NULL	Acta_Pharmacol_Sin_2014_Oct_25_35(10)_1293-1301.nxml.txt.nlp	25152022	SENT170	21	21	7	7	enalapril	IL-18	PA449456	3606	0.938
NULL	Mol_Cancer_2014_Jun_4_13_141.nxml.txt.nlp	24894453	SENT27	4	4	16	16	cetuximab	EGFR	PA10040	1956	0.938
NULL	Cells_2014_Jun_26_3(3)_662-673.nxml.txt.nlp	24971848	SENT97	37	37	4	4	capsaicin	TRPV1	PA448776	7442	0.938
NULL	Nat_Genet_2011_Jun_5_43(7)_621-629.nxml.txt.nlp	21642992	SENT102	44	44	23	23	doxorubicin	CDKN1A	PA449412	1026	0.938
NULL	Cell_Commun_Signal_2003_Nov_24_1_5.nxml.txt.nlp	14636425	SENT84	19	19	6	6	heparin	CCN5	PA449855	8839	0.938
NULL	Mol_Neurobiol_2010_Jun_2_41(2-3)_392-409.nxml.txt.nlp	20437209	SENT169	14	14	38	38	resveratrol	p67		945;10988	0.938
NULL	N_Am_J_Med_Sci_2011_Jan_3(1)_1-12.nxml.txt.nlp	22540056	SENT409	8	8	22	22	genistein	NF-kappaB	PA165109660	4790	0.938
NULL	Oncotarget_2011_Aug_30_2(8)_610-626.nxml.txt.nlp	21881167	SENT142	17	17	29	29	doxorubicin	Raf-1	PA449412	5894	0.938
NULL	Clin_Med_Insights_Oncol_2013_May_20_7_87-102.nxml.txt.nlp	23761989	SENT141	0	0	20	20	brivanib	EGFR	PA164924492	1956	0.938
NULL	Oncotarget_2013_Aug_9_4(9)_1332-1333.nxml.txt.nlp	23934763	SENT9	18	18	11	11	nilotinib	ABL1	PA165958345	25	0.938
NULL	Breast_Cancer_Res_2010_May_18_12(Suppl_1)_P45.nxml.txt.nlp	NULL	SENT7	23	23	4	4	tamoxifen	FKBPL	PA451581	63943	0.938
NULL	Oncotarget_2011_Dec_15_2(12)_984-996.nxml.txt.nlp	22184287	SENT199	17	17	10	10	olaparib	PARP1		142	0.938
NULL	Nat_Med_2012_Mar_25_18(4)_538-546.nxml.txt.nlp	22447074	SENT49	27	27	19	19	papain	IL-4	PA450778	3565	0.938
NULL	Cell_Mol_Life_Sci_2011_Oct_11_68(19)_3201-3207.nxml.txt.nlp	21833583	SENT155	9	9	25	25	bleomycin	periostin	PA448645	10631	0.938
NULL	Oncoimmunology_2013_Sep_1_2(9)_e26198.nxml.txt.nlp	24228232	SENT27	28	28	22	22	cisplatin	p53	PA449014	7157	0.938
NULL	Acta_Pharmacol_Sin_2010_Jul_28_31(7)_867-873.nxml.txt.nlp	20581857	SENT19	30	30	10	10	docetaxel	PC3	PA449383	57332;7832;5122	0.938
NULL	J_Carcinog_2012_Dec_31_11_20.nxml.txt.nlp	23346013	SENT53	0	0	20	20	erlotinib	EGFR	PA134687924	1956	0.938
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT420	20	20	2	2	resveratrol	SRC3		8202	0.938
NULL	Int_J_Mol_Sci_2014_Oct_30_15(11)_19777-19790.nxml.txt.nlp	25361208	SENT138	21	21	17	17	temozolomide	PI3K	PA451609	5290	0.938
NULL	Indian_J_Pharm_Sci_2009_Nov-Dec_71(6)_608-614.nxml.txt.nlp	20376212	SENT69	0	0	7	7	exenatide	GLP-1	PA164749238	100125288	0.938
NULL	Eur_J_Clin_Pharmacol_2014_Mar_22_70(6)_685-693.nxml.txt.nlp	24658827	SENT45	16	16	6	6	midazolam	POR	PA450496	5447	0.938
NULL	Acta_Pharmacol_Sin_2010_Dec_29_31(12)_1583-1592.nxml.txt.nlp	21113175	SENT172	7	7	29	29	dextran	TLR9	PA449261	54106	0.938
NULL	Cancer_Cell_Int_2012_Jul_4_12_19.nxml.txt.nlp	22631225	SENT182	13	13	46	46	heparin	BSG	PA449855	682	0.938
NULL	Front_Immunol_2013_Nov_18_4_387.nxml.txt.nlp	24302927	SENT255	10	10	2	2	cblb502	TLR5		7100	0.938
NULL	Clin_Ophthalmol_2011_Feb_27_5_275-279.nxml.txt.nlp	21468333	SENT121	23	23	3	3	fluconazole	ARTEMIS	PA449653	64421	0.938
NULL	J_Hematol_Oncol_2011_Feb_7_4_6.nxml.txt.nlp	21299849	SENT10	23	23	9	9	imatinib	RPS6	PA10804	6194	0.938
NULL	Oncotarget_2013_Nov_19_5(2)_309-325.nxml.txt.nlp	24525395	SENT301	9	9	17	17	flavopiridol	Mcl-1	PA452627	4170	0.938
NULL	J_Cell_Biol_2005_Jul_4_170(1)_49-59.nxml.txt.nlp	15983061	SENT55	27	27	7	7	forskolin	HIF1	PA146096022	3091	0.938
NULL	Infect_Dis_Obstet_Gynecol_2013_Dec_11_2013_698736.nxml.txt.nlp	24396265	SENT106	8	8	22	22	miconazole	OTC	PA450494	5009	0.938
NULL	Ann_Hematol_2011_Feb_17_90(2)_173-183.nxml.txt.nlp	20714724	SENT95	11	11	29	29	resveratrol	CD19		930	0.938
NULL	An_Bras_Dermatol_2013_Mar-Apr_88(2)_264-267.nxml.txt.nlp	23739711	SENT59	11	11	7	7	doxorubicin	CHOP	PA449412	1649	0.938
NULL	Acta_Neuropathol_Commun_2014_Oct_21_2(1)_149.nxml.txt.nlp	NULL	SENT186	26	26	20	20	riluzole	gamma	PA451251	9913	0.938
NULL	Brain_Sci_2013_Jun_14_3(2)_941-963.nxml.txt.nlp	24961432	SENT68	9	9	12	12	ethanol	JNK	PA448073	5599	0.938
NULL	Exp_Ther_Med_2013_Feb_13_5(2)_581-585.nxml.txt.nlp	23403473	SENT7	6	6	10	10	etanercept	HMGB1	PA449515	3146	0.938
NULL	Breast_Cancer_Res_2014_May_5_16(3)_R45.nxml.txt.nlp	24887236	SENT292	19	19	10	10	lapatinib	EGFR	PA152241907	1956	0.938
NULL	Indian_J_Pharmacol_2008_Oct_40(Suppl_2)_S112-S142.nxml.txt.nlp	21593965	SENT810	21	21	12	12	pioglitazone	STZ	PA450970	6484	0.938
NULL	Cancer_Immunol_Immunother_2013_Aug_27_62(10)_1637-1648.nxml.txt.nlp	23982484	SENT136	23	23	2	2	lenalidomide	IL-2	PA162363968	3558	0.938
NULL	Diabetes_Metab_J_2013_Oct_17_37(5)_315-325.nxml.txt.nlp	24199159	SENT193	22	22	6	6	resveratrol	SIRT1		23411	0.938
NULL	J_Cell_Sci_2011_Oct_1_124(19)_3344-3355.nxml.txt.nlp	21940797	SENT80	26	26	17	17	arsenite	PABP4	PA452638	728773	0.938
NULL	Cell_Cycle_2013_Sep_15_12(18)_3013-3024.nxml.txt.nlp	23974104	SENT73	21	21	12	12	disulfiram	IQGAP1	PA449376	8826	0.938
NULL	Oncotarget_2014_Mar_16_5(12)_4087-4102.nxml.txt.nlp	24961479	SENT188	6	6	20	20	hemin	PC3	PA449849	57332;7832;5122	0.938
NULL	Diabetes_Care_2010_Jul_31_33(7)_1544-1548.nxml.txt.nlp	20357370	SENT15	3	3	6	6	metformin	STK11	PA450395	6794	0.938
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_24_2012_673132.nxml.txt.nlp	23133498	SENT115	2	2	7	7	berberine	P-gp	PA165860812	5243	0.938
NULL	Mol_Biol_Cell_2014_Jul_1_25(13)_1969-1982.nxml.txt.nlp	24790093	SENT74	11	11	1	1	thiabendazole	TOG	PA164746466	9793	0.938
NULL	Open_Access_J_Urol_2011_May_10_3_69-82.nxml.txt.nlp	24198638	SENT66	11	11	5	5	efavirenz	CYP2B6	PA449441	1555	0.938
NULL	Pain_Res_Treat_2011_Dec_12_2011_507029.nxml.txt.nlp	22220274	SENT12	11	11	5	5	ceftriaxone	GLT-1	PA448866	6506	0.938
NULL	Cancer_Cell_Int_2004_Aug_17_4_5.nxml.txt.nlp	15315711	SENT100	9	9	36	36	genistein	CPP32	PA165109660	836	0.938
NULL	Ther_Clin_Risk_Manag_2006_Mar_2(1)_3-18.nxml.txt.nlp	18360577	SENT129	45	45	3	3	ibandronate	hole	PA10270	80757	0.938
NULL	Core_Evid_2011_Feb_8_6_23-29.nxml.txt.nlp	21468240	SENT46	0	0	21	21	plerixafor	CD34	PA165958410	947	0.938
NULL	Cell_Commun_Signal_2013_Oct_1_11_73.nxml.txt.nlp	24083678	SENT195	6	6	18	18	sulindac	A20	PA451565	7128;28935	0.938
NULL	Front_Neurosci_2014_Feb_14_8_23.nxml.txt.nlp	24592205	SENT182	16	16	34	34	capsaicin	TRPV1	PA448776	7442	0.938
NULL	J_Korean_Neurosurg_Soc_2014_Nov_30_56(5)_431-435.nxml.txt.nlp	25535523	SENT69	0	0	28	28	gefitinib	EGFR	PA131301952	1956	0.938
NULL	Oncotarget_2014_Jun_8_5(13)_5040-5053.nxml.txt.nlp	24970815	SENT58	14	14	7	7	cisplatin	LOX	PA449014	4015	0.938
NULL	J_Cell_Biol_2001_Jun_25_153(7)_1499-1510.nxml.txt.nlp	11425878	SENT189	30	30	19	19	tetracycline	RP3	PA451640	22924	0.938
NULL	Cancer_Metastasis_Rev_2010_Dec_10_29(4)_581-594.nxml.txt.nlp	20830503	SENT66	23	23	9	9	tamoxifen	CYP2D6	PA451581	1565	0.938
NULL	Mol_Syst_Biol_2011_Apr_26_7_486.nxml.txt.nlp	21525872	SENT133	35	35	18	18	imatinib	KCNH8	PA10804	131096	0.938
NULL	AIDS_Res_Treat_2012_Nov_8_2012_595762.nxml.txt.nlp	23193464	SENT91	23	23	10	10	darunavir	DUET	PA163522472	8997	0.938
NULL	Open_Biol_2014_Nov_4(11)_140180.nxml.txt.nlp	25392452	SENT224	10	10	6	6	imatinib	LEF1	PA10804	51176	0.938
NULL	Int_J_Biol_Sci_2013_Dec_17_10(1)_64-72.nxml.txt.nlp	24391452	SENT16	25	25	32	32	verapamil	5-HT2A	PA451868	3356	0.938
NULL	Open_Dent_J_2014_May_30_8_109-124.nxml.txt.nlp	24976875	SENT176	21	21	4	4	minocycline	ADP	PA450519	23038	0.938
NULL	Front_Zool_2013_Aug_29_10_51.nxml.txt.nlp	23988184	SENT297	16	16	13	13	amiloride	NHE	PA448368	285335	0.938
NULL	Front_Physiol_2013_Dec_24_4_386.nxml.txt.nlp	24399968	SENT195	9	9	21	21	glibenclamide	SUR1	PA449782	6833	0.938
NULL	J_Invest_Dermatol_2013_Aug_133(8)_1928-1929.nxml.txt.nlp	23856932	SENT35	9	9	25	25	vemurafenib	STAT3	PA165946873	6774	0.938
NULL	Oncotarget_2012_Sep_28_3(10)_1169-1181.nxml.txt.nlp	23045411	SENT127	2	2	6	6	doxorubicin	JIP1	PA449412	9479	0.938
NULL	Biologics_2014_Apr_23_8_183-192.nxml.txt.nlp	24790411	SENT33	36	36	24	24	afatinib	HER2	PA165981154	2064	0.938
NULL	Exp_Ther_Med_2014_Jun_28_7(6)_1653-1658.nxml.txt.nlp	24926361	SENT130	22	22	16	16	curcumin	p65	PA151958596	5970	0.938
NULL	Cell_Death_Dis_2012_Jun_7_3(6)_e319.nxml.txt.nlp	22673193	SENT56	19	19	11	11	cisplatin	Mcl-1	PA449014	4170	0.938
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT15	16	16	7	7	capsaicin	MDM2	PA448776	4193	0.938
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Mar_15_67(Pt_4)_o880.nxml.txt.nlp	21754157	SENT3	22	22	1	1	benzaldehyde	mol	PA448571	90527	0.938
NULL	Clin_Exp_Reprod_Med_2012_Jun_30_39(2)_46-51.nxml.txt.nlp	22816069	SENT89	15	15	20	20	letrozole	aromatase	PA450196	1588	0.938
NULL	Nucleic_Acids_Res_2012_Jun_10_40(11)_4804-4815.nxml.txt.nlp	22328728	SENT288	4	4	25	25	resveratrol	SIRT1		23411	0.938
NULL	Environ_Health_Perspect_2012_Jul_11_120(7)_1029-1035.nxml.txt.nlp	22494775	SENT65	12	12	18	18	pp2	San		80218	0.938
NULL	eLife_2014_May_20_3_e02523.nxml.txt.nlp	24844246	SENT240	22	22	15	15	sorafenib	CHAC1	PA7000	79094	0.938
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1150.nxml.txt.nlp	24675468	SENT91	31	31	23	23	ethanol	adiponectin	PA448073	9370	0.938
NULL	Osteoarthritis_Cartilage_2010_Apr_18(4)_555-562.nxml.txt.nlp	20060953	SENT425	8	8	3	3	clenbuterol	MNX	PA164745640	3892	0.938
NULL	Aging_(Albany_NY)_2011_Apr_6_3(4)_444-449.nxml.txt.nlp	21483037	SENT74	5	5	0	0	resveratrol	SIRT1		23411	0.938
NULL	Acta_Pharmacol_Sin_2010_Dec_29_31(12)_1583-1592.nxml.txt.nlp	21113175	SENT172	7	7	33	33	dextran	IFN	PA449261	3439	0.938
NULL	Nucleic_Acids_Res_2013_Dec_30_41(22)_10268-10282.nxml.txt.nlp	23997120	SENT6	29	29	8	8	etoposide	TRF1	PA449552	7013	0.938
NULL	Islets_2013_Sep_1_5(5)_201-206.nxml.txt.nlp	24275157	SENT110	38	38	10	10	glucosamine	PDCR	PA164747613	26063	0.938
NULL	J_Biomed_Sci_2014_Apr_29_21(1)_35.nxml.txt.nlp	24780003	SENT34	0	0	11	11	bevacizumab	VEGF-A	PA130232992	7422	0.938
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_11_2014_274786.nxml.txt.nlp	25505920	SENT241	23	23	11	11	oxaliplatin	ERCC1	PA131285527	2067	0.938
NULL	Mol_Cancer_2003_Jan_7_2_10.nxml.txt.nlp	12575899	SENT126	9	9	6	6	indomethacin	COX	PA449982	1351	0.938
NULL	J_Invest_Dermatol_2012_Oct_24_132(10)_2440-2450.nxml.txt.nlp	22622430	SENT60	18	18	8	8	temozolomide	ABCB1	PA451609	5243	0.938
NULL	Oncogene_2013_Sep_26_32(39)_10_1038_onc_2012_491.nxml.txt.nlp	23108394	SENT103	41	41	33	33	epirubicin	FOXM1	PA449476	2305	0.938
NULL	Cancer_Cell_Int_2010_Jul_28_10_24.nxml.txt.nlp	20667086	SENT71	11	11	29	29	l-glutamine	CO2	PA10090	4513	0.938
NULL	J_Oncol_2010_Dec_15_2010_490631.nxml.txt.nlp	21209708	SENT129	10	10	4	4	trastuzumab	aromatase	PA451743	1588	0.938
NULL	Clin_Ophthalmol_2010_May_14_4_437-445.nxml.txt.nlp	20505836	SENT25	16	16	22	22	travoprost	BAK	PA164781371	578	0.938
NULL	Niger_Med_J_2013_Sep-Oct_54(5)_289-294.nxml.txt.nlp	24403703	SENT158	22	22	9	9	thrombin	VIII	PA451674	1351	0.938
NULL	Int_J_Endocrinol_Metab_2013_Jul_1_Summer_11(3)_184-190.nxml.txt.nlp	24348591	SENT157	18	18	2	2	liraglutide	LC3	PA165958364	84557	0.938
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT846	14	14	38	38	resveratrol	IL-6		3569	0.938
NULL	J_Biol_Chem_2012_Apr_20_287(17)_14122-14135.nxml.txt.nlp	22351750	SENT1033	16	16	12	12	hyaluronan	TSG-6	PA165958431	7130	0.938
NULL	Case_Rep_Crit_Care_2014_Aug_19_2014_242703.nxml.txt.nlp	25215245	SENT196	8	8	3	3	nicardipine	APE	PA450620	55704;328	0.938
NULL	J_Viral_Hepat_2010_Feb_17(2)_139-147.nxml.txt.nlp	19674282	SENT21	41	41	4	4	ribavirin	RVR	PA451241	9975	0.938
NULL	Nat_Med_2014_Apr_16_20(4)_385-397.nxml.txt.nlp	24633305	SENT56	8	8	32	32	triciribine	MST1	PA165958661	6789;4485	0.938
NULL	Nat_Neurosci_2012_Sep_5_15(9)_1245-1254.nxml.txt.nlp	22864611	SENT107	20	20	2	2	clozapine	HDAC4	PA449061	9759	0.938
NULL	Cancer_Cell_2007_Dec_11_12(6)_514-527.nxml.txt.nlp	18068629	SENT551	10	10	4	4	paclitaxel	MAP4	PA450761	4134	0.938
NULL	AMB_Express_2014_Aug_30_4_63.nxml.txt.nlp	25401066	SENT289	12	12	25	25	ethanol	TIC	PA448073	23550	0.938
NULL	J_Cell_Mol_Med_2014_May_14_18(5)_811-823.nxml.txt.nlp	24628949	SENT31	14	14	7	7	paclitaxel	FOXM1	PA450761	2305	0.938
NULL	Cell_Death_Differ_2010_Oct_30_17(10)_1624-1635.nxml.txt.nlp	20431602	SENT54	15	15	30	30	paclitaxel	BimS	PA450761	10018	0.938
NULL	Atherosclerosis_2011_Nov_219(1)_109-115.nxml.txt.nlp	21820657	SENT147	14	14	3	3	probucol	CETP	PA451107	1071	0.938
NULL	Curr_Hypertens_Rep_2011_Oct_13_13(5)_356-361.nxml.txt.nlp	21562941	SENT156	13	13	2	2	captopril	ACE2	PA448780	59272	0.938
NULL	Mol_Cancer_2014_Jun_24_13_157.nxml.txt.nlp	24958351	SENT23	9	9	37	37	trastuzumab	HER2	PA451743	2064	0.938
NULL	J_Res_Med_Sci_2012_Sep_17(9)_828-833.nxml.txt.nlp	23826008	SENT57	14	14	2	2	mitoxantrone	IFN	PA450526	3439	0.938
NULL	Int_J_Biol_Sci_2013_Dec_17_10(1)_64-72.nxml.txt.nlp	24391452	SENT91	17	17	15	15	ketanserin	5-HT2A	PA131053734	3356	0.938
NULL	J_Signal_Transduct_2011_Feb_24_2011_804236.nxml.txt.nlp	21637380	SENT24	21	21	15	15	trastuzumab	HER2	PA451743	2064	0.938
NULL	Carcinogenesis_2010_Dec_27_31(12)_2049-2057.nxml.txt.nlp	20876285	SENT32	30	30	13	13	tamoxifen	HER2	PA451581	2064	0.938
NULL	Hum_Genomics_2009_Dec_1_4(2)_91-106.nxml.txt.nlp	20038497	SENT186	19	19	14	14	galantamine	CYP2D6	PA449726	1565	0.938
NULL	Oncotarget_2012_Dec_17_4(1)_48-63.nxml.txt.nlp	23295955	SENT223	19	19	29	29	methotrexate	MTHFD2	PA450428	10797	0.938
NULL	Oncogene_2010_Mar_11_29(10)_1509-1518.nxml.txt.nlp	19946334	SENT53	11	11	0	0	bortezomib	p53	PA10252	7157	0.938
NULL	Biomed_Res_Int_2013_Jul_21_2013_723129.nxml.txt.nlp	23971044	SENT91	2	2	9	9	itraconazole	VDR	PA450132	7421	0.938
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Feb_17_68(Pt_3)_o736.nxml.txt.nlp	22412616	SENT66	31	31	14	14	ethanol	mol	PA448073	90527	0.938
NULL	Int_J_Mol_Sci_2014_Sep_15_15(9)_16226-16245.nxml.txt.nlp	25226533	SENT187	0	0	5	5	colchicine	HIF-1	PA449092	29072	0.938
NULL	Asian-Australas_J_Anim_Sci_2014_Dec_27(12)_1783-1793.nxml.txt.nlp	25358373	SENT240	13	13	9	9	capsaicin	CASP3	PA448776	836	0.938
NULL	Indian_J_Pharmacol_2012_Sep-Oct_44(5)_624-628.nxml.txt.nlp	23112426	SENT7	40	40	2	2	nimodipine	CYP3A4	PA450633	1576	0.938
NULL	J_Physiol_2008_Jul_1_586(Pt_13)_3087-3095.nxml.txt.nlp	18467363	SENT156	18	18	41	41	lipase	TRPC6	PA450239	7225	0.938
NULL	J_Carcinog_2013_Dec_31_12_22.nxml.txt.nlp	24574860	SENT254	9	9	20	20	vemurafenib	BRAF	PA165946873	673	0.938
NULL	Breast_Cancer_(Auckl)_2009_Sep_2_3_61-75.nxml.txt.nlp	19809577	SENT268	16	16	38	38	curcumin	PARP	PA151958596	142	0.938
NULL	Acta_Pharmacol_Sin_2010_Jan_5_31(1)_93-101.nxml.txt.nlp	20048748	SENT154	14	14	2	2	cisplatin	DAPK	PA449014	1612	0.938
NULL	Diabetes_2008_Oct_57(10)_2824-2833.nxml.txt.nlp	18647955	SENT5	4	4	38	38	doxycycline	VEGFR	PA449415	3791	0.938
NULL	FEBS_Open_Bio_2014_Aug_30_4_763-776.nxml.txt.nlp	25349781	SENT171	41	41	30	30	curcumin	NAC	PA151958596	22861	0.938
NULL	Int_J_Biol_Sci_2013_Dec_17_10(1)_64-72.nxml.txt.nlp	24391452	SENT16	34	34	44	44	ketanserin	5-HT2B	PA131053734	3357	0.938
NULL	Eur_J_Clin_Pharmacol_2014_Oct_8_70(1)_37-45.nxml.txt.nlp	24100471	SENT197	11	11	0	0	pioglitazone	CYP2C8	PA450970	1558	0.938
NULL	Biomed_Res_Int_2014_Jun_25_2014_203693.nxml.txt.nlp	25089265	SENT205	9	9	21	21	sorafenib	ASK1	PA7000	4217	0.938
NULL	Clin_Exp_Gastroenterol_2013_Aug_5_6_139-148.nxml.txt.nlp	23950655	SENT71	24	24	9	9	thrombin	ADP	PA451674	23038	0.938
NULL	J_Antimicrob_Chemother_2012_May_8_67(5)_1217-1223.nxml.txt.nlp	22316571	SENT32	0	0	6	6	lopinavir	CYP3A4	PA450264	1576	0.938
NULL	Iran_J_Basic_Med_Sci_2012_Mar-Apr_15(2)_709-718.nxml.txt.nlp	23493500	SENT132	2	2	29	29	ns-398	COX		1351	0.938
NULL	Hum_Genomics_2008_Sep_1_3(1)_7-16.nxml.txt.nlp	19129086	SENT11	24	24	6	6	rosiglitazone	CYP2C8	PA451283	1558	0.938
NULL	J_Gynecol_Oncol_2013_Jul_4_24(3)_273-279.nxml.txt.nlp	23875078	SENT124	14	14	4	4	doxorubicin	COX	PA449412	1351	0.938
NULL	Arthritis_Res_Ther_2009_Aug_28_11(4)_R131.nxml.txt.nlp	19715572	SENT119	5	5	13	13	rituximab	CD4	PA451261	920	0.938
NULL	Breast_Cancer_Res_2011_Feb_23_13(1)_203.nxml.txt.nlp	21392408	SENT145	15	15	13	13	exemestane	aromatase	PA449563	1588	0.938
NULL	Nat_Commun_2014_Dec_8_5_5736.nxml.txt.nlp	25484020	SENT30	24	24	0	0	carrageenan	TRPA1	PA448814	8989	0.938
NULL	Exp_Ther_Med_2012_Oct_3_4(4)_594-604.nxml.txt.nlp	23170111	SENT101	27	27	22	22	propranolol	p42	PA451145	5706;23552	0.938
NULL	Acta_Neuropathol_Commun_2014_Feb_7_2_16.nxml.txt.nlp	24507707	SENT253	28	28	6	6	ethanol	BAX	PA448073	581	0.938
NULL	J_Carcinog_2014_Nov_27_13_13.nxml.txt.nlp	25525412	SENT73	20	20	7	7	cetuximab	KRAS	PA10040	3845	0.938
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT241	0	0	9	9	atazanavir	UGT1A1	PA10251	54658	0.938
NULL	Oncotarget_2013_May_11_4(6)_830-843.nxml.txt.nlp	23919981	SENT91	5	5	15	15	temsirolimus	PI3K	PA164746890	5290	0.938
NULL	J_Ophthalmic_Inflamm_Infect_2011_May_11_1(3)_105-110.nxml.txt.nlp	21559864	SENT81	7	7	36	36	chloramphenicol	CD4	PA448927	920	0.938
NULL	Cancer_Inform_2008_Jun_10_6_315-355.nxml.txt.nlp	19259415	SENT352	9	9	26	26	cisplatin	CDX1	PA449014	1044	0.938
NULL	Exp_Transl_Stroke_Med_2011_Oct_3_3_11.nxml.txt.nlp	21967730	SENT85	19	19	0	0	collagenase	IL-6	PA449107	3569	0.938
NULL	Clin_Drug_Investig_2013_Aug_23_33(10)_727-736.nxml.txt.nlp	23975654	SENT178	29	29	39	39	bupropion	CYP2D6	PA448687	1565	0.938
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT151	9	9	27	27	perifosine	DR5	PA165291471	8795	0.938
NULL	Cancer_Med_2014_Dec_13_3(6)_1579-1594.nxml.txt.nlp	25124282	SENT24	24	24	10	10	cisplatin	PARP-1	PA449014	25976	0.938
NULL	Ann_Oncol_2014_Oct_23_25(10)_1941-1948.nxml.txt.nlp	25057173	SENT112	13	13	7	7	docetaxel	KRAS	PA449383	3845	0.938
NULL	Diabetes_Metab_J_2013_Oct_17_37(5)_315-325.nxml.txt.nlp	24199159	SENT193	1	1	20	20	resveratrol	SIRT1		23411	0.938
NULL	Br_J_Cancer_2013_Jul_23_109(2)_351-359.nxml.txt.nlp	23799854	SENT146	10	10	5	5	paclitaxel	MDR1	PA450761	5243	0.938
NULL	Pharmaceutics_2011_Oct_12_3(4)_680-705.nxml.txt.nlp	24309303	SENT575	3	3	16	16	gemfibrozil	CYP2C9	PA449750	1559	0.938
NULL	Mol_Med_Rep_2015_Feb_5_11(2)_805-814.nxml.txt.nlp	25373883	SENT130	10	10	2	2	colchicine	APE	PA449092	55704;328	0.938
NULL	Indian_J_Pharmacol_2009_Aug_41(4)_167-172.nxml.txt.nlp	20523867	SENT137	24	24	11	11	acetaminophen	CYP3A	PA448015	1574	0.938
NULL	Nat_Commun_2014_Dec_12_5_5775.nxml.txt.nlp	25503391	SENT120	19	19	9	9	paclitaxel	PC3	PA450761	57332;7832;5122	0.938
NULL	J_Hematol_Oncol_2010_Mar_13_3_10.nxml.txt.nlp	20226083	SENT28	12	12	24	24	gemcitabine	RRM1	PA449748	6240	0.938
NULL	EPMA_J_2013_Feb_19_4(1)_6.nxml.txt.nlp	23418957	SENT244	28	28	40	40	lapatinib	HER2	PA152241907	2064	0.938
NULL	J_Gynecol_Oncol_2013_Jan_8_24(1)_66-82.nxml.txt.nlp	23346316	SENT270	5	5	8	8	exemestane	aromatase	PA449563	1588	0.938
NULL	J_Cell_Mol_Med_2014_May_14_18(5)_811-823.nxml.txt.nlp	24628949	SENT159	22	22	7	7	docetaxel	MCAK	PA449383	11004	0.938
NULL	Mar_Drugs_2014_Oct_17_12(10)_5209-5221.nxml.txt.nlp	25329704	SENT3	11	11	26	26	piperazine	P-gp	PA450977	5243	0.938
NULL	Front_Genet_2014_Aug_27_5_281.nxml.txt.nlp	25221567	SENT125	28	28	5	5	4-methylumbelliferone	UGT1A9	PA154081778	54600	0.938
NULL	Iran_J_Pharm_Res_2014_Spring_13(2)_683-693.nxml.txt.nlp	25237365	SENT9	6	6	20	20	tamoxifen	CXCL12	PA451581	6387	0.938
NULL	Oxid_Med_Cell_Longev_2013_Nov_28_2013_568093.nxml.txt.nlp	24379901	SENT48	32	32	2	2	resveratrol	SIRT1		23411	0.938
NULL	J_Hematol_Oncol_2012_Sep_18_5_57.nxml.txt.nlp	22989009	SENT144	14	14	47	47	nutlin-3	HDM2		4193	0.938
NULL	J_Cell_Mol_Med_2014_Mar_10_18(3)_514-529.nxml.txt.nlp	24410795	SENT198	17	17	31	31	resveratrol	SIRT1		23411	0.938
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT58	21	21	9	9	cetuximab	HER-2	PA10040	2064	0.938
NULL	Front_Oncol_2013_Oct_29_3_269.nxml.txt.nlp	24195060	SENT40	24	24	5	5	paclitaxel	THBS1	PA450761	7057	0.938
NULL	Mol_Biol_Cell_2013_Jun_1_24(11)_1801-1811.nxml.txt.nlp	23552691	SENT205	27	27	21	21	phenformin	AMPK	PA1000	5563	0.938
NULL	Br_J_Cancer_2004_May_4_90(9)_1733-1739.nxml.txt.nlp	15150604	SENT88	7	7	4	4	tamoxifen	aromatase	PA451581	1588	0.938
NULL	Open_Virol_J_2012_Dec_28_6_204-215.nxml.txt.nlp	23341856	SENT131	7	7	32	32	lopinavir	p53	PA450264	7157	0.938
NULL	Front_Physiol_2013_May_15_4_103.nxml.txt.nlp	23720630	SENT98	6	6	13	13	simvastatin	ADP	PA451363	23038	0.938
NULL	Mol_Brain_2014_Nov_18_7(1)_84.nxml.txt.nlp	NULL	SENT257	12	12	4	4	pentobarbital	P15	PA450859	1030;29107	0.938
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT193	24	24	4	4	heparin	FGFR1	PA449855	2260	0.938
NULL	ScientificWorldJournal_2012_Apr_26_2012_358102.nxml.txt.nlp	22645419	SENT145	4	4	7	7	losartan	AT1	PA450268	9197;185	0.938
NULL	J_Exp_Med_2000_May_15_191(10)_1789-1798.nxml.txt.nlp	10811871	SENT91	31	31	1	1	tetracycline	TSP-1	PA451640	7057	0.938
NULL	Oncotarget_2014_Mar_16_5(12)_4087-4102.nxml.txt.nlp	24961479	SENT118	17	17	13	13	hemin	PC3	PA449849	57332;7832;5122	0.938
NULL	Br_J_Nutr_2013_May_14_109(9)_1678-1687.nxml.txt.nlp	22935250	SENT210	1	1	20	20	creatine	SGK1	PA164778930	6446	0.938
NULL	Cardiovasc_Ther_2012_Aug_17_30(4)_e174-e182.nxml.txt.nlp	21883999	SENT120	42	42	31	31	prasugrel	P2Y12	PA154410481	64805	0.938
NULL	Scientifica_(Cairo)_2012_Nov_25_2012_578257.nxml.txt.nlp	24278717	SENT55	4	4	27	27	alprostadil	GMP	PA448334	22978	0.938
NULL	Diabetes_2011_Nov_17_60(11)_2691-2700.nxml.txt.nlp	21896928	SENT259	13	13	7	7	resveratrol	SIRT1		23411	0.938
NULL	Int_J_Mol_Sci_2012_Sep_5_13(9)_11012-11026.nxml.txt.nlp	23109835	SENT121	12	12	0	0	cisplatin	DDB2	PA449014	1643	0.938
NULL	Exp_Diabetes_Res_2012_Nov_24_2012_827971.nxml.txt.nlp	22144992	SENT155	10	10	14	14	valsartan	AT1	PA451848	9197;185	0.938
NULL	J_Cancer_2014_Aug_22_5(8)_655-662.nxml.txt.nlp	25157276	SENT135	36	36	6	6	resveratrol	PI3K		5290	0.937
NULL	Cancer_Metastasis_Rev_2013_May_1_32(3-4)_341-352.nxml.txt.nlp	23633034	SENT194	12	12	4	4	cetuximab	BRAF	PA10040	673	0.937
NULL	J_Ophthalmic_Inflamm_Infect_2012_May_14_2(4)_231-233.nxml.txt.nlp	22581347	SENT61	31	31	9	9	infliximab	TNF	PA452639	7124	0.937
NULL	Int_J_Mol_Sci_2014_Mar_19_15(3)_4903-4914.nxml.txt.nlp	24651461	SENT41	21	21	0	0	guanidine	HIP-55	PA164781028	28988	0.937
NULL	Ann_Dermatol_2013_Nov_30_25(4)_500-502.nxml.txt.nlp	24371403	SENT19	14	14	11	11	imatinib	LDE	PA10804	7957	0.937
NULL	Arch_Microbiol_2012_Oct_8_194(10)_887-892.nxml.txt.nlp	22773111	SENT18	6	6	19	19	vancomycin	spatial	PA451850	219793	0.937
NULL	Mol_Cancer_2012_Sep_14_11_69.nxml.txt.nlp	22978347	SENT43	33	33	11	11	letrozole	TFF3	PA450196	7033	0.937
NULL	Mol_Cell_Biochem_2014_Oct_9_385(1-2)_265-275.nxml.txt.nlp	24104452	SENT224	19	19	12	12	bortezomib	U87	PA10252	677775;641648	0.937
NULL	Neural_Plast_2013_Dec_26_2013_424651.nxml.txt.nlp	24455309	SENT16	6	6	1	1	cyanocobalamin	B12	PA451892	7126;4709	0.937
NULL	Arch_Med_Sci_2011_Jun_11_7(3)_388-396.nxml.txt.nlp	22312373	SENT158	6	6	18	18	diltiazem	CYP3A	PA449334	1574	0.937
NULL	Int_J_Endocrinol_Metab_2013_Jul_1_Summer_11(3)_184-190.nxml.txt.nlp	24348591	SENT171	0	0	16	16	liraglutide	GLP-1	PA165958364	100125288	0.937
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1522-1532.nxml.txt.nlp	21997136	SENT214	27	27	9	9	irinotecan	UGT1A1	PA450085	54658	0.937
NULL	eLife_2013_May_28_2_e00658.nxml.txt.nlp	23741618	SENT429	22	22	17	17	paraformaldehyde	MUC5AC	PA450790	4586	0.937
NULL	Cancer_Cell_Int_2011_Aug_19_11_29.nxml.txt.nlp	21854619	SENT238	23	23	12	12	cisplatin	BRCA1	PA449014	672	0.937
NULL	Cancers_(Basel)_2013_Nov_8_5(4)_1504-1521.nxml.txt.nlp	24217116	SENT23	19	19	32	32	erlotinib	VIM	PA134687924	7431	0.937
NULL	Ther_Clin_Risk_Manag_2007_Dec_3(6)_1027-1033.nxml.txt.nlp	18516257	SENT64	16	16	8	8	temozolomide	MRC	PA451609	4345	0.937
NULL	Anesth_Essays_Res_2010_Jul-Dec_4(2)_96-101.nxml.txt.nlp	NULL	SENT58	7	7	18	18	heparin	ACT	PA449855	12;11332;9457;641455	0.937
NULL	Mol_Cancer_2009_Nov_10_8_99.nxml.txt.nlp	19903356	SENT97	21	21	11	11	imatinib	IGFBP3	PA10804	3486	0.937
NULL	J_Biol_Chem_2010_Aug_20_285(34)_25928-25940.nxml.txt.nlp	20547488	SENT150	15	15	7	7	cisplatin	p38	PA449014	10598;1432;7965	0.937
NULL	Breast_Cancer_Res_2011_Feb_23_13(1)_203.nxml.txt.nlp	21392408	SENT145	7	7	5	5	anastrozole	aromatase	PA448432	1588	0.937
NULL	Br_J_Pharmacol_2014_Feb_24_171(1)_1019-1032.nxml.txt.nlp	24251620	SENT277	10	10	17	17	nicardipine	TRPM3	PA450620	80036	0.937
NULL	Biomed_Res_Int_2014_Apr_29_2014_186864.nxml.txt.nlp	24877064	SENT186	15	15	7	7	curcumin	AP-1	PA151958596	2353;3727;2354;3725	0.937
NULL	Front_Physiol_2013_Nov_14_4_323.nxml.txt.nlp	24294204	SENT256	38	38	4	4	carvedilol	CYP2D6	PA448817	1565	0.937
NULL	Exp_Ther_Med_2013_Feb_13_5(2)_581-585.nxml.txt.nlp	23403473	SENT93	5	5	29	29	etanercept	HMGB1	PA449515	3146	0.937
NULL	J_Korean_Med_Sci_2006_Oct_31_21(5)_904-910.nxml.txt.nlp	17043427	SENT55	19	19	3	3	4-methylumbelliferone	NAG	PA154081778	51594;4669	0.937
NULL	Int_J_Mol_Sci_2010_Sep_13_11(9)_3195-3208.nxml.txt.nlp	20957088	SENT219	21	21	5	5	lipase	AT2	PA450239	186	0.937
NULL	Indian_J_Pharm_Sci_2009_Nov-Dec_71(6)_622-629.nxml.txt.nlp	20376214	SENT36	0	0	21	21	captopril	BCS	PA448780	617	0.937
NULL	Clin_Epigenetics_2011_Jun_14_2(2)_151-169.nxml.txt.nlp	22704335	SENT298	0	0	7	7	procainamide	GSTP1	PA451108	2950	0.937
NULL	Clinics_(Sao_Paulo)_2012_Sep_67(9)_1093-1099.nxml.txt.nlp	23018309	SENT112	9	9	17	17	sorafenib	Mcl-1	PA7000	4170	0.937
NULL	Exp_Ther_Med_2014_Aug_10_8(2)_454-458.nxml.txt.nlp	25009600	SENT69	8	8	12	12	genistein	Bcl-2	PA165109660	596	0.937
NULL	Breast_Cancer_(Auckl)_2009_Sep_2_3_61-75.nxml.txt.nlp	19809577	SENT86	5	5	30	30	resveratrol	BRCA1		672	0.937
NULL	Case_Rep_Oncol_Med_2013_Dec_19_2013_208213.nxml.txt.nlp	24455357	SENT91	33	33	23	23	erlotinib	EGFR	PA134687924	1956	0.937
NULL	Biochim_Biophys_Acta_2013_Jul_1832(7)_905-910.nxml.txt.nlp	23032152	SENT141	25	25	23	23	ketanserin	5-HT2A	PA131053734	3356	0.937
NULL	J_Hematol_Oncol_2013_Feb_17_6_17.nxml.txt.nlp	23414938	SENT32	0	0	6	6	prasugrel	ADP	PA154410481	23038	0.937
NULL	Int_J_Endocrinol_2010_Aug_29_2010_481326.nxml.txt.nlp	20871656	SENT32	22	22	0	0	glucose	MPG	PA449773	4350	0.937
NULL	Br_J_Haematol_2009_Nov_2_147(3)_396-410.nxml.txt.nlp	19758122	SENT29	2	2	13	13	chlorambucil	TP53	PA448926	7157	0.937
NULL	Oncotarget_2013_Nov_22_5(4)_933-943.nxml.txt.nlp	24659749	SENT108	42	42	16	16	nutlin-3	p53		7157	0.937
NULL	Bioinformation_2013_Nov_11_9(18)_929-936.nxml.txt.nlp	24307772	SENT27	10	10	3	3	s-adenosylmethionine	MTHFR	PA164754994	4524	0.937
NULL	J_Hematol_Oncol_2013_Nov_5_6_83.nxml.txt.nlp	24283248	SENT58	30	30	24	24	nutlin-3	TP53		7157	0.937
NULL	Mol_Cancer_2010_May_21_9_116.nxml.txt.nlp	20492666	SENT230	32	32	9	9	bortezomib	p27	PA10252	5715;10534	0.937
NULL	J_Cardiovasc_Dis_Res_2012_Oct-Dec_3(4)_319-322.nxml.txt.nlp	23233778	SENT45	21	21	14	14	azithromycin	CYP3A4	PA448519	1576	0.937
NULL	Br_J_Cancer_2012_May_22_106(11)_1722-1727.nxml.txt.nlp	22568966	SENT143	22	22	3	3	cetuximab	KRAS	PA10040	3845	0.937
NULL	Br_J_Cancer_2009_Jul_21_101(2)_238-243.nxml.txt.nlp	19568242	SENT82	23	23	9	9	bevacizumab	IFN	PA130232992	3439	0.937
NULL	Breast_Cancer_Res_2014_May_23_16(3)_R50.nxml.txt.nlp	24887458	SENT166	28	28	33	33	capecitabine	HER2	PA448771	2064	0.937
NULL	Diabetes_Care_2013_Aug_17_36(Suppl_2)_S245-S252.nxml.txt.nlp	23882053	SENT32	5	5	9	9	sitagliptin	HIP	PA164748978	6767;6159;64399;5068	0.937
NULL	Int_J_Cell_Biol_2013_Apr_18_2013_273086.nxml.txt.nlp	23690780	SENT328	8	8	4	4	thrombin	VIII	PA451674	1351	0.937
NULL	Cell_Cycle_2013_Oct_1_12(19)_3194-3202.nxml.txt.nlp	24013423	SENT93	33	33	18	18	arsenite	RRM1	PA452638	6240	0.937
NULL	Cardiovasc_Diabetol_2005_Oct_5_4_16.nxml.txt.nlp	16207378	SENT217	2	2	6	6	glucosamine	perlecan	PA164747613	3339	0.937
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT480	15	15	0	0	iloperidone	PRL	PA161199368	5617	0.937
NULL	Ecancermedicalscience_2009_Oct_29_3_157.nxml.txt.nlp	22276018	SENT67	5	5	18	18	tamoxifen	HER2	PA451581	2064	0.937
NULL	Cancers_(Basel)_2013_May_24_5(2)_591-616.nxml.txt.nlp	24216993	SENT312	0	0	15	15	denosumab	RANKL	PA166048634	8600	0.937
NULL	J_Hematol_Oncol_2012_Apr_30_5_17.nxml.txt.nlp	22546217	SENT135	22	22	38	38	fluorescein	San	PA164746009	80218	0.937
NULL	J_Hematol_Oncol_2013_Jun_3_6_38.nxml.txt.nlp	23731980	SENT182	28	28	20	20	trastuzumab	HER-2	PA451743	2064	0.937
NULL	Oncol_Lett_2014_Jul_7_8(1)_464-466.nxml.txt.nlp	24959297	SENT7	13	13	28	28	temsirolimus	FKBP-12	PA164746890	2280	0.937
NULL	Biomed_Res_Int_2013_Dec_4_2013_685308.nxml.txt.nlp	23509762	SENT133	13	13	29	29	bevacizumab	HIF-1	PA130232992	29072	0.937
NULL	Diabetes_2013_Sep_15_62(9)_3232-3240.nxml.txt.nlp	23835329	SENT152	27	27	8	8	aripiprazole	GLP-1	PA10026	100125288	0.937
NULL	J_Clin_Biochem_Nutr_2008_May_29_42(3)_197-203.nxml.txt.nlp	18545641	SENT87	0	0	17	17	curcumin	HO-1	PA151958596	3162	0.937
NULL	ARYA_Atheroscler_2013_Jan_9(1)_98-101.nxml.txt.nlp	23696766	SENT61	0	0	22	22	hesperidin	DBP	PA449867	3295;1628;2638	0.937
NULL	Gastric_Cancer_2014_Apr_7_17(1)_1-12.nxml.txt.nlp	23563986	SENT76	8	8	27	27	trastuzumab	HER2	PA451743	2064	0.937
NULL	Mol_Cancer_2013_Sep_11_12_104.nxml.txt.nlp	24025152	SENT132	25	25	13	13	gemcitabine	STAT3	PA449748	6774	0.937
NULL	Mol_Cancer_2010_Jun_25_9_166.nxml.txt.nlp	20579378	SENT241	5	5	3	3	gefitinib	SMAD5	PA131301952	4090	0.937
NULL	Br_J_Cancer_2010_May_11_102(10)_1456-1460.nxml.txt.nlp	20461090	SENT100	8	8	11	11	temsirolimus	IFN	PA164746890	3439	0.937
NULL	Front_Physiol_2011_Feb_24_2_4.nxml.txt.nlp	21483730	SENT690	5	5	8	8	midazolam	CYP3A4	PA450496	1576	0.937
NULL	Oncol_Rep_2013_Jan_1_29(1)_13-20.nxml.txt.nlp	23128605	SENT30	39	39	6	6	carboplatin	FUT2	PA448803	2524	0.937
NULL	Int_J_Mol_Sci_2014_May_7_15(5)_8004-8023.nxml.txt.nlp	24810691	SENT24	29	29	18	18	s-adenosylmethionine	MTR	PA164754994	4548	0.937
NULL	Nat_Biotechnol_2009_Jun_17_27(6)_567-571.nxml.txt.nlp	19448630	SENT232	4	4	16	16	imiquimod	IFN	PA449972	3439	0.937
NULL	Chem_Res_Toxicol_2008_Jul_21_21(7)_1359-1367.nxml.txt.nlp	18549251	SENT111	19	19	8	8	hydroquinone	TYR	PA449924	7299	0.937
NULL	Nucleic_Acids_Res_2013_Nov_27_41(21)_9786-9799.nxml.txt.nlp	23982513	SENT216	17	17	26	26	arsenite	TIAR	PA452638	7073	0.937
NULL	Acta_Orthop_2010_Apr_6_81(2)_263-267.nxml.txt.nlp	20148646	SENT153	40	40	29	29	taurine	LIR	PA451590	10871	0.937
NULL	Onco_Targets_Ther_2014_Mar_24_7_491-500.nxml.txt.nlp	24711706	SENT9	45	45	13	13	trastuzumab	EGFR	PA451743	1956	0.937
NULL	J_Headache_Pain_2001_Jun_2(1)_3-11.nxml.txt.nlp	NULL	SENT1	8	8	27	27	naratriptan	5-HT1D	PA450597	3352	0.937
NULL	Drugs_R_D_2011_Mar_27_11(1)_37-51.nxml.txt.nlp	21410294	SENT248	2	2	32	32	itraconazole	CYP3A4	PA450132	1576	0.937
NULL	Br_J_Cancer_2013_Mar_19_108(5)_1079-1091.nxml.txt.nlp	23449353	SENT8	29	29	10	10	docetaxel	MIC-1	PA449383	29919;9518	0.937
NULL	J_Hematol_Oncol_2008_Oct_1_1_16.nxml.txt.nlp	18828924	SENT239	11	11	22	22	vinorelbine	HER2	PA451881	2064	0.937
NULL	Oncoimmunology_2013_Dec_1_2(12)_e26837.nxml.txt.nlp	24501687	SENT14	15	15	22	22	gemcitabine	CD40	PA449748	958	0.937
NULL	Oncogene_2010_Sep_23_29(38)_5299-5310.nxml.txt.nlp	20622903	SENT49	2	2	9	9	melphalan	HMGB1	PA450354	3146	0.937
NULL	Int_J_Gen_Med_2011_May_3_4_345-357.nxml.txt.nlp	21674027	SENT176	19	19	7	7	pioglitazone	PI3	PA450970	5266	0.937
NULL	Biosensors_(Basel)_2013_Jun_28_3(3)_238-258.nxml.txt.nlp	25506422	SENT254	22	22	4	4	etoposide	p53	PA449552	7157	0.937
NULL	J_Hematol_Oncol_2009_Feb_23_2_10.nxml.txt.nlp	19236716	SENT107	22	22	32	32	simvastatin	CYP3A4	PA451363	1576	0.937
NULL	Cell_Res_2013_Jul_21_23(7)_915-930.nxml.txt.nlp	23689279	SENT97	23	23	10	10	ethanol	ALDH2	PA448073	217	0.937
NULL	Front_Aging_Neurosci_2014_Sep_11_6_218.nxml.txt.nlp	25309423	SENT219	16	16	35	35	resveratrol	gamma		9913	0.937
NULL	Acta_Pharmacol_Sin_2010_Jan_28_31(1)_10-18.nxml.txt.nlp	20037604	SENT128	25	25	13	13	valsartan	KLF5	PA451848	688	0.937
NULL	J_Gastroenterol_2013_Jan_27_48(1)_22-30.nxml.txt.nlp	23104468	SENT111	38	38	10	10	ribavirin	IL28B	PA451241	282617	0.937
NULL	BMB_Rep_2013_Aug_46(8)_410-415.nxml.txt.nlp	23977989	SENT66	9	9	0	0	curcumin	HO-1	PA151958596	3162	0.937
NULL	Front_Oncol_2014_Apr_14_4_64.nxml.txt.nlp	24782981	SENT112	17	17	30	30	everolimus	VEGFR	PA164746311	3791	0.937
NULL	Oncotarget_2013_Oct_19_4(11)_2045-2056.nxml.txt.nlp	24185104	SENT6	35	35	10	10	cisplatin	p38	PA449014	10598;1432;7965	0.937
NULL	Cancer_Med_2014_Apr_27_3(2)_245-251.nxml.txt.nlp	24464861	SENT114	24	24	8	8	bicalutamide	HIF1	PA164746255	3091	0.937
NULL	Drug_Target_Insights_2013_Aug_19_7_27-34.nxml.txt.nlp	24023511	SENT143	13	13	44	44	mitotane	P-gp	PA164746157	5243	0.937
NULL	Endocrinol_Metab_(Seoul)_2013_Dec_12_28(4)_262-274.nxml.txt.nlp	24396690	SENT58	20	20	1	1	exenatide	GLP-1	PA164749238	100125288	0.937
NULL	Diabetes_Metab_J_2013_Feb_15_37(1)_22-29.nxml.txt.nlp	23441053	SENT110	8	8	23	23	capsaicin	TRPV1	PA448776	7442	0.937
NULL	J_Thyroid_Res_2011_Aug_2_2011_102636.nxml.txt.nlp	21826256	SENT208	2	2	12	12	axitinib	VEGFR	PA164924493	3791	0.937
NULL	J_Hum_Genet_2013_Jun_2_58(6)_306-312.nxml.txt.nlp	23635953	SENT7	29	29	23	23	anastrozole	aromatase	PA448432	1588	0.937
NULL	Cardiovasc_Diabetol_2005_May_15_4_6.nxml.txt.nlp	15892894	SENT60	11	11	29	29	glucose	ANOVA	PA449773	4858	0.937
NULL	Front_Neurosci_2010_Mar_19_4_22.nxml.txt.nlp	20582262	SENT87	7	7	26	26	bethanechol	P2X2	PA448613	22953	0.937
NULL	Cancer_Cell_Int_2004_Aug_17_4_5.nxml.txt.nlp	15315711	SENT228	22	22	32	32	nadh	NQO1	PA164755085	1728	0.937
NULL	J_Carcinog_2013_Jul_12_12_12.nxml.txt.nlp	23961259	SENT114	18	18	7	7	erlotinib	EGFR	PA134687924	1956	0.937
NULL	Exp_Brain_Res_2014_Jun_27_232(8)_2637-2644.nxml.txt.nlp	24969614	SENT19	1	1	7	7	palonosetron	NK1	PA10352	11126	0.937
NULL	Evid_Based_Complement_Alternat_Med_2013_May_28_2013_629750.nxml.txt.nlp	23781265	SENT243	13	13	9	9	capsaicin	GADD153	PA448776	1649	0.937
NULL	Arthritis_Res_Ther_2007_Jun_29_9(Suppl_1)_S1.nxml.txt.nlp	17634140	SENT105	7	7	17	17	cyclosporine	osterix	PA449167	121340	0.937
NULL	Hum_Genomics_2009_Jan_1_3(2)_128-142.nxml.txt.nlp	19164090	SENT174	39	39	35	35	carboplatin	CD44	PA448803	960	0.937
NULL	Int_J_Surg_Oncol_2012_May_16_2012_863034.nxml.txt.nlp	22666572	SENT41	12	12	16	16	leucovorin	MOF	PA450198	84148	0.937
NULL	Physiol_Rep_2014_Sep_28_2(9)_e12158.nxml.txt.nlp	25263207	SENT333	26	26	13	13	forskolin	TGR5	PA146096022	151306	0.937
NULL	Front_Immunol_2014_Aug_20_5_348.nxml.txt.nlp	25191322	SENT212	24	24	10	10	forskolin	LGALS13	PA146096022	29124	0.937
NULL	Clin_Exp_Otorhinolaryngol_2011_Mar_17_4(1)_18-23.nxml.txt.nlp	21461058	SENT89	20	20	37	37	furosemide	NKCC1	PA449719	6558	0.937
NULL	Nucleic_Acids_Res_2013_Nov_27_41(21)_9786-9799.nxml.txt.nlp	23982513	SENT207	17	17	36	36	arsenite	ADAR1	PA452638	103	0.937
NULL	BMJ_Open_2014_Oct_31_4(10)_e005762.nxml.txt.nlp	25361836	SENT219	15	15	25	25	afatinib	EGFR	PA165981154	1956	0.937
NULL	Mol_Cancer_2010_May_21_9_116.nxml.txt.nlp	20492666	SENT228	14	14	33	33	bortezomib	p27	PA10252	5715;10534	0.937
NULL	Front_Behav_Neurosci_2011_Oct_5_5_63.nxml.txt.nlp	22007164	SENT2510	16	16	21	21	rimonabant	CB1	PA152407999	1268	0.937
NULL	Front_Oncol_2014_Sep_23_4_252.nxml.txt.nlp	25295225	SENT282	13	13	3	3	tamoxifen	AKT	PA451581	207	0.937
NULL	Ann_Dermatol_2011_Oct_31_23(Suppl_2)_S169-S174.nxml.txt.nlp	22148042	SENT104	26	26	11	11	ifosfamide	CHOP	PA449964	1649	0.937
NULL	Ecancermedicalscience_2008_Feb_18_2_75.nxml.txt.nlp	22275966	SENT112	18	18	6	6	gefitinib	EGFR	PA131301952	1956	0.937
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT274	43	43	4	4	glucose	EGFR	PA449773	1956	0.937
NULL	Hematol_Rep_2011_Oct_10_3(2)_e16.nxml.txt.nlp	22184537	SENT71	10	10	17	17	acenocoumarol	CYP2C9	PA452632	1559	0.937
NULL	Braz_J_Med_Biol_Res_2013_Jun_25_46(6)_528-532.nxml.txt.nlp	23802228	SENT35	11	11	15	15	rosiglitazone	PON1	PA451283	5444	0.937
NULL	Br_J_Cancer_2003_Jun_16_88(12)_1963-1970.nxml.txt.nlp	12799644	SENT215	18	18	13	13	gemcitabine	MRP1	PA449748	4437	0.937
NULL	Eur_J_Clin_Microbiol_Infect_Dis_2012_Jul_26_31(7)_1647-1652.nxml.txt.nlp	22278291	SENT121	30	30	10	10	fluconazole	ARTEMIS	PA449653	64421	0.937
NULL	Arthritis_Res_Ther_2009_Aug_17_11(4)_R123.nxml.txt.nlp	19686595	SENT45	7	7	24	24	rituximab	CD19	PA451261	930	0.937
NULL	Eur_J_Clin_Pharmacol_2014_Sep_27_70(1)_65-77.nxml.txt.nlp	24071959	SENT307	18	18	3	3	tacrolimus	CYP3A5	PA451578	1577	0.937
NULL	Front_Genet_2014_Feb_26_5_40.nxml.txt.nlp	24616734	SENT316	1	1	11	11	docetaxel	CCL20	PA449383	6364	0.937
NULL	Front_Oncol_2014_Jun_13_4_141.nxml.txt.nlp	24982846	SENT36	23	23	30	30	crizotinib	BRAF	PA165946122	673	0.937
NULL	Evid_Based_Complement_Alternat_Med_2013_Mar_26_2013_625892.nxml.txt.nlp	23589719	SENT32	11	11	24	24	ofloxacin	GLP-1	PA450684	100125288	0.937
NULL	Mol_Cancer_2010_Dec_20_9_316.nxml.txt.nlp	21172016	SENT159	13	13	4	4	heparin	CCL21	PA449855	6366	0.937
NULL	Oncogene_2009_Aug_27_28(34)_3022-3032.nxml.txt.nlp	19543317	SENT98	10	10	23	23	etoposide	XIAP	PA449552	331	0.937
NULL	Front_Oncol_2014_Sep_29_4_256.nxml.txt.nlp	25325013	SENT165	8	8	20	20	afatinib	EGFR	PA165981154	1956	0.937
NULL	Oncol_Rep_2014_Mar_14_31(3)_1035-1042.nxml.txt.nlp	24424445	SENT58	29	29	2	2	cisplatin	CD133	PA449014	8842	0.937
NULL	eLife_2014_Apr_30_3_e02445.nxml.txt.nlp	24843000	SENT236	7	7	23	23	mimosine	GAPDH	PA164752445	2597	0.937
NULL	Clin_Ophthalmol_2012_Jul_31_6_1211-1223.nxml.txt.nlp	22927730	SENT205	44	44	34	34	rituximab	CD19	PA451261	930	0.937
NULL	Mol_Cancer_2013_May_24_12_47.nxml.txt.nlp	23705854	SENT133	3	3	33	33	celecoxib	MRP1	PA448871	4437	0.937
NULL	Mol_Cancer_2014_Aug_16_13(1)_193.nxml.txt.nlp	NULL	SENT103	15	15	3	3	cisplatin	RKIP	PA449014	5037	0.937
NULL	Cancers_(Basel)_2013_Nov_8_5(4)_1504-1521.nxml.txt.nlp	24217116	SENT23	19	19	30	30	erlotinib	CDH1	PA134687924	51343;999	0.937
NULL	Chemother_Res_Pract_2011_Jun_21_2011_696208.nxml.txt.nlp	22312556	SENT176	22	22	14	14	docetaxel	EGFR	PA449383	1956	0.937
NULL	Cancer_Cell_Int_2011_Nov_17_11_40.nxml.txt.nlp	22088142	SENT150	6	6	4	4	gefitinib	EGFR	PA131301952	1956	0.937
NULL	J_Gerontol_A_Biol_Sci_Med_Sci_2010_Nov_30_65A(11)_1165-1180.nxml.txt.nlp	20675618	SENT200	16	16	3	3	paraformaldehyde	TL1A	PA450790	9966	0.937
NULL	J_Cell_Sci_2014_May_15_127(10)_2313-2325.nxml.txt.nlp	24634514	SENT190	24	24	3	3	forskolin	DRP1	PA146096022	8562;10059;7402	0.937
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jun_18_67(Pt_7)_o1665.nxml.txt.nlp	21837064	SENT58	40	40	7	7	ethanol	mol	PA448073	90527	0.937
NULL	Cancer_Immunol_Immunother_2012_Jul_23_61(7)_1101-1111.nxml.txt.nlp	22193989	SENT111	21	21	31	31	oxaliplatin	IP-10	PA131285527	3627	0.937
NULL	EJC_Suppl_2013_Sep_5_11(2)_92-96.nxml.txt.nlp	NULL	SENT71	34	34	12	12	temozolomide	BRAF	PA451609	673	0.937
NULL	Cancers_(Basel)_2014_Mar_13_6(1)_595-624.nxml.txt.nlp	24633084	SENT220	24	24	13	13	lapatinib	HER2	PA152241907	2064	0.937
NULL	Cancer_Res_Treat_2013_Sep_30_45(3)_178-185.nxml.txt.nlp	24155676	SENT32	30	30	8	8	gefitinib	EGFR	PA131301952	1956	0.937
NULL	Clin_Exp_Otorhinolaryngol_2011_Jun_31_4(2)_77-82.nxml.txt.nlp	21716954	SENT121	23	23	3	3	minocycline	Bcl-2	PA450519	596	0.937
NULL	Front_Genet_2014_Feb_26_5_40.nxml.txt.nlp	24616734	SENT317	13	13	9	9	docetaxel	CCL20	PA449383	6364	0.937
NULL	Emerg_Infect_Dis_2007_Jul_13(7)_1024-1030.nxml.txt.nlp	18214174	SENT149	28	28	7	7	linezolid	LSE	PA450233	54414	0.937
NULL	Mol_Vis_2011_Apr_27_17_1044-1055.nxml.txt.nlp	21552499	SENT32	47	47	6	6	bevacizumab	apelin	PA130232992	8862	0.937
NULL	J_Biomed_Biotechnol_2010_Jun_7_2010_150960.nxml.txt.nlp	20617134	SENT227	15	15	37	37	cetuximab	KRAS	PA10040	3845	0.937
NULL	J_Cell_Mol_Med_2014_Mar_22_18(3)_542-553.nxml.txt.nlp	24447518	SENT319	14	14	20	20	chloroquine	apelin	PA448948	8862	0.937
NULL	Breast_Cancer_Res_2013_Oct_31_15(5)_R102.nxml.txt.nlp	24176089	SENT7	18	18	16	16	letrozole	aromatase	PA450196	1588	0.937
NULL	Cancer_Manag_Res_2012_Mar_29_4_105-111.nxml.txt.nlp	22570564	SENT13	10	10	13	13	letrozole	aromatase	PA450196	1588	0.937
NULL	Oncotarget_2011_Nov_30_2(11)_874-885.nxml.txt.nlp	22141136	SENT185	21	21	10	10	nilotinib	AXL	PA165958345	558	0.937
NULL	Eur_J_Clin_Pharmacol_2012_Jan_7_68(1)_55-64.nxml.txt.nlp	21735164	SENT210	13	13	3	3	oxymorphone	CYP2D6	PA450748	1565	0.937
NULL	Front_Immunol_2013_Nov_18_4_382.nxml.txt.nlp	24302925	SENT177	26	26	14	14	imatinib	KIT	PA10804	3815	0.937
NULL	Ann_Gen_Psychiatry_2014_Apr_1_13_10.nxml.txt.nlp	24690136	SENT174	0	0	11	11	aripiprazole	5-HT1A	PA10026	3350	0.937
NULL	EPMA_J_2010_Sep_20_1(3)_421-437.nxml.txt.nlp	23199086	SENT228	29	29	14	14	cyclophosphamide	CLPTM1	PA449165	1209	0.937
NULL	Exp_Diabetes_Res_2012_Sep_20_2012_936518.nxml.txt.nlp	23049542	SENT12	7	7	13	13	mannitol	TRPV4	PA450320	59341	0.937
NULL	Oncotarget_2014_Aug_29_5(19)_8947-8958.nxml.txt.nlp	25333254	SENT128	8	8	21	21	plerixafor	CXCR7	PA165958410	57007	0.937
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT149	8	8	21	21	ritonavir	UGT1A1	PA451260	54658	0.937
NULL	Biofactors_2014_May_6_40(3)_277-283.nxml.txt.nlp	24353111	SENT78	24	24	17	17	choline	PEMT	PA448976	10400	0.937
NULL	Ann_Hematol_2011_Feb_17_90(2)_173-183.nxml.txt.nlp	20714724	SENT142	6	6	25	25	resveratrol	ZAP-70		7535	0.937
NULL	Ann_Gen_Psychiatry_2008_Dec_23_7_26.nxml.txt.nlp	19105842	SENT61	28	28	34	34	haloperidol	5-HT1A	PA449841	3350	0.937
NULL	Cell_Biol_Int_Rep_(2010)_2012_Jun_21_19(1)_e00017.nxml.txt.nlp	23124518	SENT166	4	4	15	15	etoposide	TRAIL-R2	PA449552	8795	0.937
NULL	Sensors_(Basel)_2008_Oct_16_8(10)_6433-6447.nxml.txt.nlp	NULL	SENT412	18	18	13	13	quinidine	TPO1	PA451209	256987	0.937
NULL	Core_Evid_2009_Jun_15_4_67-82.nxml.txt.nlp	20694066	SENT357	30	30	6	6	citalopram	STAR	PA449015	6770;2984	0.937
NULL	Breast_Cancer_Res_2010_Jun_28_12(3)_R43.nxml.txt.nlp	20579400	SENT177	11	11	4	4	estradiol	MAPT	PA449503	4137	0.937
NULL	Int_J_Med_Sci_2015_Jan_1_12(2)_92-99.nxml.txt.nlp	25589885	SENT162	5	5	25	25	panitumumab	MT1-MMP	PA162373091	4323	0.937
NULL	Oncotarget_2013_Nov_24_4(12)_2430-2438.nxml.txt.nlp	24280348	SENT98	16	16	29	29	gefitinib	STAT3	PA131301952	6774	0.937
NULL	Front_Behav_Neurosci_2014_Sep_29_8_337.nxml.txt.nlp	25324747	SENT211	8	8	1	1	estradiol	aromatase	PA449503	1588	0.937
NULL	Clinics_(Sao_Paulo)_2013_May_68(5)_694-701.nxml.txt.nlp	23778405	SENT175	8	8	24	24	curcumin	P-gp	PA151958596	5243	0.937
NULL	Allergy_Asthma_Immunol_Res_2010_Apr_24_2(2)_65-76.nxml.txt.nlp	20358020	SENT131	33	33	15	15	erythromycin	CYP3A4	PA449493	1576	0.937
NULL	Breast_Cancer_Res_2012_Apr_4_14(2)_R57.nxml.txt.nlp	22475046	SENT77	17	17	2	2	anastrozole	ATAC	PA448432	6375	0.937
NULL	Hum_Genomics_2010_Oct_1_5(1)_61-72.nxml.txt.nlp	21106490	SENT152	37	37	25	25	simvastatin	CYP3A	PA451363	1574	0.937
NULL	Br_J_Haematol_2009_Nov_2_147(3)_396-410.nxml.txt.nlp	19758122	SENT13	10	10	2	2	chlorambucil	p53	PA448926	7157	0.937
NULL	J_Nutr_Metab_2011_May_24_2011_172853.nxml.txt.nlp	21773014	SENT133	18	18	4	4	lipase	NEFA	PA450239	4925	0.937
NULL	Pharmaceuticals_(Basel)_2012_Aug_10_5(8)_802-836.nxml.txt.nlp	24280676	SENT294	10	10	22	22	piroxicam	MRP2	PA450985	100130958;57626;1244	0.937
NULL	Oncotarget_2010_Oct_30_1(7)_639-650.nxml.txt.nlp	21317459	SENT176	25	25	8	8	neomycin	p53	PA450608	7157	0.937
NULL	Virchows_Arch_2012_Feb_16_460(2)_141-149.nxml.txt.nlp	22173329	SENT226	13	13	8	8	cetuximab	BRAF	PA10040	673	0.937
NULL	Diabetes_Care_2012_Jan_9_35(1)_131-136.nxml.txt.nlp	22040838	SENT159	23	23	19	19	metformin	FFM	PA450395	24	0.937
NULL	BMB_Rep_2013_Feb_46(2)_92-96.nxml.txt.nlp	23433111	SENT26	11	11	1	1	etoposide	p53	PA449552	7157	0.937
NULL	Br_J_Cancer_2010_Dec_7_103(12)_1858-1869.nxml.txt.nlp	21063399	SENT40	31	31	28	28	erlotinib	EGFR	PA134687924	1956	0.937
NULL	Mol_Cell_Biochem_2014_Feb_13_391(1-2)_27-35.nxml.txt.nlp	24522554	SENT238	5	5	10	10	resveratrol	NFkappaB		4790	0.937
NULL	Int_J_Mol_Sci_2013_Apr_2_14(4)_7405-7432.nxml.txt.nlp	23549272	SENT62	6	6	26	26	s-adenosylmethionine	Met	PA164754994	79811	0.937
NULL	Breast_Cancer_(Auckl)_2011_Oct_9_5_209-226.nxml.txt.nlp	22084574	SENT30	0	0	5	5	exemestane	CYP3A4	PA449563	1576	0.937
NULL	J_Hematol_Oncol_2013_Jul_18_6_53.nxml.txt.nlp	23866964	SENT77	5	5	10	10	temsirolimus	HDAC1	PA164746890	3065	0.937
NULL	Nucleic_Acids_Res_2010_Oct_21_38(18)_6159-6175.nxml.txt.nlp	20494973	SENT461	13	13	5	5	cetuximab	BRAF	PA10040	673	0.937
NULL	Oncotarget_2010_Jul_14_1(3)_163-166.nxml.txt.nlp	21301046	SENT8	25	25	4	4	choline	PTPS	PA448976	5805	0.937
NULL	Curr_Cardiol_Rev_2011_Nov_7(4)_221-233.nxml.txt.nlp	22758623	SENT159	4	4	10	10	everolimus	FKBP-12	PA164746311	2280	0.937
NULL	Cell_Biol_Toxicol_2012_Apr_19_28(2)_69-87.nxml.txt.nlp	22258563	SENT265	20	20	0	0	midazolam	CYP1A2	PA450496	1544	0.937
NULL	Arthritis_Res_Ther_2011_Apr_28_13(2)_210.nxml.txt.nlp	21542894	SENT207	10	10	14	14	capsaicin	TRPV1	PA448776	7442	0.937
NULL	Diabetes_Care_2010_Feb_33(2)_e20-e25.nxml.txt.nlp	20103551	SENT121	32	32	18	18	sitagliptin	GPR119	PA164748978	139760	0.937
NULL	Br_J_Cancer_2010_Sep_7_103(6)_889-898.nxml.txt.nlp	20664599	SENT243	5	5	10	10	paclitaxel	HER-2	PA450761	2064	0.937
NULL	Cancer_Growth_Metastasis_2013_Aug_8_6_35-52.nxml.txt.nlp	24665206	SENT76	5	5	15	15	curcumin	FANCD2	PA151958596	2177	0.937
NULL	eLife_2013_Nov_5_2_e00969.nxml.txt.nlp	24192036	SENT114	12	12	5	5	vemurafenib	BIM	PA165946873	10018	0.937
NULL	Breast_Cancer_Res_2008_Jul_8_10(4)_R56.nxml.txt.nlp	18611244	SENT156	6	6	10	10	letrozole	PI3K	PA450196	5290	0.937
NULL	Oxid_Med_Cell_Longev_2012_Aug_22_2012_534705.nxml.txt.nlp	22966415	SENT291	2	2	15	15	riluzole	GLT-1	PA451251	6506	0.937
NULL	Oxid_Med_Cell_Longev_2013_May_27_2013_396527.nxml.txt.nlp	23781294	SENT149	10	10	23	23	hemin	NF-kappaB	PA449849	4790	0.937
NULL	J_Hematol_Oncol_2010_Mar_23_3_11.nxml.txt.nlp	20331897	SENT24	27	27	4	4	cisplatin	HER2	PA449014	2064	0.937
NULL	Breast_Cancer_Res_2011_Aug_16_13(4)_312.nxml.txt.nlp	21861853	SENT30	31	31	24	24	tamoxifen	CUEDC2	PA451581	79004	0.937
NULL	Curr_Opin_Lipidol_2014_Oct_4_25(5)_387-393.nxml.txt.nlp	25110901	SENT71	13	13	37	37	berberine	HNF1	PA165860812	6927	0.937
NULL	Cell_Death_Dis_2014_Apr_17_5(4)_e1182.nxml.txt.nlp	24743737	SENT35	5	5	15	15	capsaicin	TRPV1	PA448776	7442	0.937
NULL	Biol_Open_2014_Jul_25_3(8)_777-784.nxml.txt.nlp	25063200	SENT228	26	26	45	45	l-glutamine	B27	PA10090	56246	0.937
NULL	J_Korean_Med_Sci_2011_Aug_27_26(8)_1001-1006.nxml.txt.nlp	21860549	SENT81	24	24	2	2	trastuzumab	HER-2	PA451743	2064	0.937
NULL	Exp_Ther_Med_2014_Nov_26_8(5)_1611-1615.nxml.txt.nlp	25289068	SENT112	24	24	3	3	paclitaxel	P-gp	PA450761	5243	0.937
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT120	16	16	9	9	capsaicin	p53	PA448776	7157	0.937
NULL	ISRN_Nutr_2013_Aug_28_2013_403792.nxml.txt.nlp	24967258	SENT286	15	15	2	2	choline	RIZ1	PA448976	7799	0.937
NULL	Br_J_Cancer_2009_Jul_21_101(2)_269-277.nxml.txt.nlp	19603033	SENT80	18	18	8	8	cisplatin	p53	PA449014	7157	0.937
NULL	Clin_Med_Insights_Oncol_2012_Feb_28_6_125-135.nxml.txt.nlp	22408376	SENT57	8	8	17	17	panitumumab	KRAS	PA162373091	3845	0.937
NULL	F1000Res_2014_Apr_3_3_83.nxml.txt.nlp	24860645	SENT42	26	26	16	16	baclofen	PMP22	PA448533	5376;5827	0.937
NULL	Br_J_Cancer_2009_Jan_13_100(1)_19-23.nxml.txt.nlp	19018262	SENT45	32	32	11	11	sorafenib	SHARP	PA7000	23013	0.937
NULL	Acta_Pharmacol_Sin_2014_Sep_25_35(9)_1199-1206.nxml.txt.nlp	25152024	SENT85	3	3	17	17	cisplatin	mig-2	PA449014	10979	0.937
NULL	Alcohol_Res_Health_2010_33(1-2)_76-86.nxml.txt.nlp	23579938	SENT75	5	5	15	15	resveratrol	SIRT1		23411	0.937
NULL	Carcinogenesis_2014_May_13_35(5)_1055-1066.nxml.txt.nlp	24419232	SENT172	18	18	0	0	metformin	ADAMTS1	PA450395	9510	0.937
NULL	Mol_Brain_2014_Sep_18_7(1)_68.nxml.txt.nlp	NULL	SENT225	4	4	23	23	pentobarbital	CA1	PA450859	759	0.937
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2008_Jun_1_64(Pt_6)_611-619.nxml.txt.nlp	18560148	SENT191	10	10	19	19	heparin	CXCR3	PA449855	2833	0.937
NULL	Int_J_Mol_Sci_2014_Jun_25_15(7)_11220-11233.nxml.txt.nlp	24968265	SENT93	17	17	9	9	temsirolimus	REST	PA164746890	5978	0.937
NULL	Oncotarget_2014_Aug_4_5(17)_7776-7787.nxml.txt.nlp	25277200	SENT46	7	7	2	2	cisplatin	ANXA4	PA449014	307	0.937
NULL	Br_J_Cancer_2013_Apr_16_108(7)_1408-1414.nxml.txt.nlp	23511562	SENT122	19	19	22	22	tamoxifen	aromatase	PA451581	1588	0.937
NULL	Anemia_2012_Nov_8_2012_607436.nxml.txt.nlp	23198140	SENT163	38	38	19	19	capsaicin	TRPV1	PA448776	7442	0.937
NULL	Oncoimmunology_2012_Oct_1_1(7)_1048-1060.nxml.txt.nlp	23170253	SENT62	9	9	22	22	trastuzumab	HER-2	PA451743	2064	0.937
NULL	Breast_Cancer_Res_2010_Jul_22_12(4)_R53.nxml.txt.nlp	20649975	SENT165	23	23	9	9	letrozole	HOXB13	PA450196	10481	0.937
NULL	Biochemistry_2010_Dec_7_49(48)_10267-10276.nxml.txt.nlp	21058655	SENT159	8	8	27	27	rabeprazole	5-HT1D	PA451216	3352	0.937
NULL	Int_J_Gen_Med_2013_Dec_4_6_877-895.nxml.txt.nlp	24403842	SENT57	24	24	12	12	metformin	PPG	PA450395	5552	0.937
NULL	Arthritis_Res_Ther_2014_Apr_30_16(2)_R90.nxml.txt.nlp	25167216	SENT202	16	16	2	2	tocilizumab	CXCL13	PA165292659	10563	0.937
NULL	Breast_Cancer_Res_2009_Oct_28_11(5)_211.nxml.txt.nlp	19889200	SENT176	27	27	4	4	tamoxifen	ARNO	PA451581	9266	0.937
NULL	Oncotarget_2014_Oct_9_5(20)_9564-9576.nxml.txt.nlp	25333255	SENT147	12	12	4	4	dasatinib	CD34	PA162372878	947	0.937
NULL	Acta_Pharmacol_Sin_2013_Sep_5_34(9)_1237-1242.nxml.txt.nlp	23770984	SENT98	29	29	0	0	warfarin	CYP2C9	PA451906	1559	0.937
NULL	Diabetes_2011_Mar_21_60(3)_757-765.nxml.txt.nlp	21282370	SENT115	11	11	22	22	isoproterenol	PTRF	PA450121	284119	0.937
NULL	Cancer_Med_2014_Oct_2_3(5)_1256-1265.nxml.txt.nlp	24890382	SENT33	7	7	18	18	trastuzumab	DM1	PA451743	338023;1760;28509	0.937
NULL	Curr_Pathobiol_Rep_2014_Oct_17_2(4)_257-267.nxml.txt.nlp	25401052	SENT191	22	22	3	3	berberine	NAC	PA165860812	22861	0.937
NULL	Br_J_Cancer_2009_Jul_7_101(1)_55-63.nxml.txt.nlp	19491903	SENT8	6	6	14	14	cisplatin	DTD	PA449014	1728	0.937
NULL	Front_Behav_Neurosci_2011_Sep_8_5_56.nxml.txt.nlp	21927600	SENT196	3	3	10	10	cocaine	DARPP-32	PA449072	84152	0.937
NULL	Carcinogenesis_2010_Dec_27_31(12)_2049-2057.nxml.txt.nlp	20876285	SENT261	13	13	4	4	tamoxifen	HER2	PA451581	2064	0.937
NULL	Int_J_Mol_Sci_2014_Jun_25_15(7)_11220-11233.nxml.txt.nlp	24968265	SENT29	30	30	1	1	temsirolimus	REST	PA164746890	5978	0.937
NULL	Drugs_2014_Jul_18_74(11)_1209-1231.nxml.txt.nlp	25034361	SENT250	13	13	3	3	enoxaparin	STARS	PA449463	137735	0.937
NULL	Acta_Pharmacol_Sin_2013_Oct_7_34(10)_1317-1324.nxml.txt.nlp	23933652	SENT175	3	3	19	19	rosiglitazone	p65	PA451283	5970	0.937
NULL	Drugs_R_D_2010_Nov_25_10(4)_219-224.nxml.txt.nlp	21171668	SENT107	17	17	23	23	clopidogrel	DES	PA449053	1674	0.937
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Feb_17_68(Pt_3)_o737.nxml.txt.nlp	22412617	SENT68	38	38	14	14	ethanol	mol	PA448073	90527	0.937
NULL	J_Adv_Pharm_Technol_Res_2012_Jan-Mar_3(1)_30-40.nxml.txt.nlp	22470891	SENT9	34	34	13	13	furosemide	ANOVA	PA449719	4858	0.937
NULL	Biomed_Res_Int_2014_Feb_6_2014_323594.nxml.txt.nlp	24689036	SENT358	8	8	21	21	raloxifene	PC3	PA451221	57332;7832;5122	0.937
NULL	Breast_Cancer_Res_2007_Jan_23_9(1)_R7.nxml.txt.nlp	17244352	SENT46	10	10	34	34	tamoxifen	SULT1A1	PA451581	6817	0.937
NULL	EMBO_Mol_Med_2012_Aug_16_4(8)_743-760.nxml.txt.nlp	22593025	SENT200	21	21	6	6	paclitaxel	EGFR	PA450761	1956	0.937
NULL	BMB_Rep_2013_Feb_46(2)_92-96.nxml.txt.nlp	23433111	SENT25	26	26	8	8	etoposide	BRCA1	PA449552	672	0.937
NULL	Acta_Pharmacol_Sin_2011_Jul_13_32(7)_967-972.nxml.txt.nlp	21666702	SENT131	1	1	13	13	losartan	P-gp	PA450268	5243	0.937
NULL	Front_Physiol_2013_Nov_14_4_323.nxml.txt.nlp	24294204	SENT256	38	38	7	7	carvedilol	UGT1A1	PA448817	54658	0.937
NULL	Int_J_Chron_Obstruct_Pulmon_Dis_2006_Dec_1(4)_373-379.nxml.txt.nlp	18044094	SENT49	13	13	15	15	roflumilast	PDE4D	PA165948052	5144	0.937
NULL	Osteoporos_Int_2010_Feb_13_21(2)_251-261.nxml.txt.nlp	19436940	SENT192	7	7	19	19	estradiol	PTH	PA449503	5741	0.937
NULL	Cardiol_Res_Pract_2012_Mar_20_2012_656247.nxml.txt.nlp	22536531	SENT91	5	5	29	29	pioglitazone	DDAH	PA450970	23576	0.937
NULL	J_Clin_Biochem_Nutr_2007_Nov_30_41(3)_202-210.nxml.txt.nlp	18299717	SENT20	34	34	23	23	indomethacin	GADD45	PA449982	1647	0.937
NULL	Oncoimmunology_2012_Dec_1_1(9)_1557-1576.nxml.txt.nlp	23264902	SENT81	37	37	9	9	temozolomide	EGFR	PA451609	1956	0.937
NULL	Diabetes_2013_Oct_17_62(10)_3437-3447.nxml.txt.nlp	23801578	SENT263	26	26	13	13	pioglitazone	AS160	PA450970	9882	0.937
NULL	Front_Genet_2012_Nov_26_3_241.nxml.txt.nlp	23233859	SENT36	26	26	18	18	fentanyl	NeuroD	PA449599	4760	0.937
NULL	Breast_Cancer_Res_2004_Nov_25_6(1)_E8.nxml.txt.nlp	14680493	SENT45	27	27	23	23	tamoxifen	STAR	PA451581	6770;2984	0.937
NULL	Cell_Death_Dis_2012_Nov_15_3(11)_e422.nxml.txt.nlp	23152058	SENT89	10	10	3	3	cisplatin	ZNF143	PA449014	7702	0.937
NULL	Diabetes_Care_2009_Sep_32(9)_e104-e111.nxml.txt.nlp	19717816	SENT127	32	32	2	2	exenatide	GLP-1	PA164749238	100125288	0.937
NULL	Curr_Neuropharmacol_2008_Dec_6(4)_311-321.nxml.txt.nlp	19587852	SENT54	7	7	16	16	fluvoxamine	CA3	PA449690	761	0.937
NULL	Leukemia_2015_Jan_26_29(1)_237-241.nxml.txt.nlp	25257991	SENT7	8	8	4	4	doxorubicin	CHOP	PA449412	1649	0.937
NULL	J_Thromb_Thrombolysis_2013_Jul_17_36(1)_31-41.nxml.txt.nlp	23073747	SENT158	18	18	10	10	eptifibatide	ADP	PA449483	23038	0.937
NULL	Biomed_Res_Int_2013_Feb_18_2013_804632.nxml.txt.nlp	23509781	SENT67	12	12	29	29	ethanol	San	PA448073	80218	0.937
NULL	Genome_Med_2010_Nov_30_2(11)_85.nxml.txt.nlp	21122163	SENT211	18	18	8	8	imatinib	gamma	PA10804	9913	0.937
NULL	Oncotarget_2012_May_29_3(5)_581-585.nxml.txt.nlp	22653910	SENT49	12	12	22	22	genistein	P-gp	PA165109660	5243	0.937
NULL	Nat_Genet_2013_Jul_2_45(7)_739-746.nxml.txt.nlp	23727861	SENT171	2	2	9	9	formaldehyde	PC3	PA449703	57332;7832;5122	0.937
NULL	Acta_Pharmacol_Sin_2010_Jul_28_31(7)_775-783.nxml.txt.nlp	20581849	SENT137	27	27	9	9	imipramine	NHC	PA449969	10473	0.937
NULL	Proteome_Sci_2009_May_28_7_20.nxml.txt.nlp	19476632	SENT54	26	26	12	12	galactose	VDAC1	PA449725	7416	0.937
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1033-1038.nxml.txt.nlp	22374460	SENT66	33	33	17	17	capecitabine	HER2	PA448771	2064	0.937
NULL	Cancer_Imaging_2008_Nov_25_8(1)_199-205.nxml.txt.nlp	19028612	SENT137	29	29	20	20	bevacizumab	EGFR	PA130232992	1956	0.937
NULL	Oncotarget_2014_Oct_21_5(22)_11180-11192.nxml.txt.nlp	25361003	SENT128	9	9	0	0	doxycycline	NTRK1	PA449415	4914	0.937
NULL	Diabetes_2011_Jul_20_60(7)_1861-1871.nxml.txt.nlp	21593203	SENT237	15	15	3	3	colesevelam	GLP-1	PA449095	100125288	0.937
NULL	Alcohol_Res_2012_34(3)_282-292.nxml.txt.nlp	23134044	SENT232	14	14	16	16	naltrexone	Ray	PA450588	26751	0.937
NULL	Breast_Cancer_Res_2009_Nov_18_11(6)_R85.nxml.txt.nlp	19922614	SENT181	14	14	32	32	tamoxifen	BCS	PA451581	617	0.937
NULL	Front_Microbiol_2012_Mar_1_3_75.nxml.txt.nlp	22403577	SENT187	32	32	13	13	heparin	nectin-4	PA449855	81607	0.937
NULL	Braz_J_Med_Biol_Res_2014_Sep_5_47(11)_929-939.nxml.txt.nlp	25296354	SENT15	15	15	2	2	gefitinib	EGFR	PA131301952	1956	0.937
NULL	Oncotarget_2014_Aug_19_5(18)_8737-8749.nxml.txt.nlp	25228590	SENT165	19	19	12	12	crizotinib	MYCN	PA165946122	4613	0.937
NULL	Basic_Res_Cardiol_2011_Jan_20_106(1)_51-63.nxml.txt.nlp	20725733	SENT102	19	19	41	41	rolipram	ET1	PA153906323	1906	0.937
NULL	Mol_Cancer_2014_Feb_20_13_32.nxml.txt.nlp	24555657	SENT176	34	34	21	21	cisplatin	SET	PA449014	6418	0.937
NULL	Br_J_Cancer_2009_May_19_100(10)_1517-1522.nxml.txt.nlp	19367275	SENT68	25	25	9	9	trastuzumab	PI3K	PA451743	5290	0.937
NULL	Front_Cell_Neurosci_2013_Dec_3_7_239.nxml.txt.nlp	24348333	SENT240	9	9	34	34	staurosporine	SOD1	PA165109623	6647	0.937
NULL	BMB_Rep_2014_Mar_47(3)_167-172.nxml.txt.nlp	24499665	SENT105	9	9	21	21	nutlin-3	MDM2		4193	0.937
NULL	Drugs_Aging_2014_Oct_10_31(11)_837-848.nxml.txt.nlp	25300507	SENT34	0	0	32	32	ranibizumab	VEGF-A	PA164746012	7422	0.937
NULL	CNS_Spectr_2014_Apr_1_19(2)_121-133.nxml.txt.nlp	23903233	SENT199	3	3	32	32	vilazodone	5-HT7	PA165958365	3363	0.937
NULL	Toxins_(Basel)_2010_Oct_26_2(11)_2490-2518.nxml.txt.nlp	22069563	SENT202	7	7	0	0	cisplatin	IL-10	PA449014	3586	0.937
NULL	Curr_Med_Chem_2009_Aug_16(23)_3041-3053.nxml.txt.nlp	19689281	SENT171	27	27	14	14	napqi	IL6		3569	0.937
NULL	Cell_Death_Dis_2012_Mar_1_3(3)_e275.nxml.txt.nlp	22378068	SENT212	6	6	15	15	doxorubicin	AMPK	PA449412	5563	0.937
NULL	Sci_Rep_2014_Dec_3_4_7298.nxml.txt.nlp	25466238	SENT64	19	19	14	14	chloroquine	UCHL1	PA448948	7345	0.937
NULL	Arthritis_2012_Oct_24_2012_805875.nxml.txt.nlp	23133752	SENT345	13	13	37	37	methotrexate	CD4	PA450428	920	0.937
NULL	Int_J_Biol_Sci_2013_Apr_22_9(4)_350-360.nxml.txt.nlp	23630447	SENT156	17	17	8	8	doxorubicin	MDR1	PA449412	5243	0.937
NULL	Breast_Cancer_Res_2008_Jul_8_10(4)_R56.nxml.txt.nlp	18611244	SENT143	9	9	4	4	letrozole	PI3K	PA450196	5290	0.937
NULL	Br_J_Cancer_2012_Feb_14_106(4)_685-692.nxml.txt.nlp	22294184	SENT155	14	14	2	2	lovastatin	survivin	PA450272	332	0.937
NULL	Br_J_Cancer_2010_Jan_19_102(2)_361-368.nxml.txt.nlp	20010949	SENT215	17	17	8	8	doxorubicin	PSMB7	PA449412	5695	0.937
NULL	Breast_Cancer_Res_2007_Nov_1_9(6)_R75.nxml.txt.nlp	17976236	SENT174	14	14	31	31	tamoxifen	EGFR	PA451581	1956	0.937
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT91	12	12	8	8	cisplatin	MDM2	PA449014	4193	0.937
NULL	Breast_Cancer_Res_2004_Nov_7_6(1)_39-52.nxml.txt.nlp	14680484	SENT156	4	4	17	17	tamoxifen	AF-1	PA451581	3460;5710	0.937
NULL	Cancer_Med_2013_Aug_2_2(4)_571-582.nxml.txt.nlp	24156030	SENT259	4	4	26	26	curcumin	IL-6	PA151958596	3569	0.937
NULL	Int_J_Cell_Biol_2012_Mar_27_2012_189794.nxml.txt.nlp	22536246	SENT103	8	8	23	23	resveratrol	PI3K		5290	0.937
NULL	Acta_Histochem_Cytochem_2012_Apr_26_45(2)_139-146.nxml.txt.nlp	22685356	SENT4	21	21	4	4	vasopressin	AQP2	PA451858	359	0.937
NULL	Biosci_Rep_2012_Dec_13_33(1)_e00007.nxml.txt.nlp	23095119	SENT205	21	21	10	10	forskolin	NEFA	PA146096022	4925	0.937
NULL	Oncol_Lett_2013_Dec_7_6(6)_1624-1630.nxml.txt.nlp	24260056	SENT30	18	18	2	2	tamoxifen	DUSP6	PA451581	1848	0.937
NULL	Cancer_Cell_Int_2013_Jun_26_13_63.nxml.txt.nlp	23800022	SENT125	11	11	3	3	ethanol	ANOVA	PA448073	4858	0.937
NULL	Mol_Cancer_2009_Aug_25_8_66.nxml.txt.nlp	19706164	SENT196	24	24	14	14	celecoxib	p53	PA448871	7157	0.937
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT237	28	28	36	36	perifosine	DR4	PA165291471	8797	0.937
NULL	Eur_J_Med_Res_2009_Dec_7_14(Suppl_4)_32-37.nxml.txt.nlp	20156721	SENT153	31	31	14	14	ketanserin	5-HT2A	PA131053734	3356	0.937
NULL	J_Am_Heart_Assoc_2013_Dec_19_2(6)_e000355.nxml.txt.nlp	24190878	SENT11	12	12	4	4	isoproterenol	HK2	PA450121	3796;3099;29911;3741	0.937
NULL	Br_J_Cancer_2013_Jul_9_109(1)_100-108.nxml.txt.nlp	23756858	SENT105	31	31	18	18	letrozole	HER2	PA450196	2064	0.937
NULL	Diabetes_Care_2010_Apr_12_33(4)_742-744.nxml.txt.nlp	20067964	SENT78	34	34	24	24	pioglitazone	ghrelin	PA450970	51738	0.937
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT193	29	29	12	12	pertuzumab	HER3		2065	0.937
NULL	Br_J_Cancer_2009_Jul_21_101(2)_269-277.nxml.txt.nlp	19603033	SENT124	47	47	41	41	cisplatin	XIAP	PA449014	331	0.937
NULL	Ther_Clin_Risk_Manag_2007_Jun_3(2)_259-268.nxml.txt.nlp	18360634	SENT144	0	0	33	33	natalizumab	IFN	PA164747191	3439	0.937
NULL	Clin_Ophthalmol_2012_Sep_21_6_1547-1552.nxml.txt.nlp	23055677	SENT97	3	3	17	17	latanoprost	SPK	PA164774763	55872;8189	0.937
NULL	Br_J_Cancer_2010_Nov_9_103(10)_1588-1596.nxml.txt.nlp	20978505	SENT85	3	3	30	30	temozolomide	San	PA451609	80218	0.937
NULL	Cancers_(Basel)_2011_Apr_13_3(2)_1957-1974.nxml.txt.nlp	24212791	SENT149	0	0	7	7	cetuximab	EGFR	PA10040	1956	0.937
NULL	Int_J_Nanomedicine_2012_May_7_7_2307-2314.nxml.txt.nlp	22661887	SENT158	13	13	2	2	gemcitabine	F10	PA449748	2159	0.937
NULL	Clin_Ophthalmol_2008_Mar_2(1)_1-14.nxml.txt.nlp	19668384	SENT31	0	0	26	26	ranibizumab	VEGF-A	PA164746012	7422	0.937
NULL	Acta_Pharmacol_Sin_2011_Oct_22_32(10)_1215-1224.nxml.txt.nlp	21863064	SENT146	25	25	3	3	buprenorphine	ORL1	PA448685	4987	0.937
NULL	Br_J_Cancer_2003_Jun_2_88(11)_1785-1792.nxml.txt.nlp	12771996	SENT95	13	13	3	3	staurosporine	p53	PA165109623	7157	0.937
NULL	Diagn_Pathol_2013_Feb_18_8_27.nxml.txt.nlp	23419122	SENT171	22	22	10	10	erlotinib	EGFR	PA134687924	1956	0.937
NULL	Ann_Dermatol_2011_Oct_31_23(Suppl_2)_S169-S174.nxml.txt.nlp	22148042	SENT104	33	33	11	11	vincristine	CHOP	PA451879	1649	0.937
NULL	Oncogenesis_2014_Dec_15_3(12)_e133.nxml.txt.nlp	25500906	SENT110	29	29	23	23	trastuzumab	HER3	PA451743	2065	0.937
NULL	Mol_Cell_Endocrinol_2013_Oct_15_379(1-2)_2-11.nxml.txt.nlp	23769710	SENT169	29	29	10	10	metformin	GLP-1	PA450395	100125288	0.937
NULL	Front_Cell_Neurosci_2014_Feb_4_8_26.nxml.txt.nlp	24550782	SENT307	8	8	17	17	taurine	Ray	PA451590	26751	0.937
NULL	J_Oncol_2009_Mar_24_2009_491985.nxml.txt.nlp	19325924	SENT114	13	13	2	2	genistein	CXCL12	PA165109660	6387	0.937
NULL	J_Carcinog_2011_Nov_30_10_28.nxml.txt.nlp	22190870	SENT115	21	21	7	7	trastuzumab	p27	PA451743	5715;10534	0.937
NULL	J_Invest_Dermatol_2012_May_16_132(5)_1435-1442.nxml.txt.nlp	22336948	SENT239	3	3	6	6	doxycycline	TLSP	PA449415	11012	0.937
NULL	Mol_Cancer_2007_Sep_26_6_61.nxml.txt.nlp	17894897	SENT189	12	12	3	3	etoposide	BAX	PA449552	581	0.937
NULL	Arch_Drug_Inf_2009_Mar_2(1)_8-16.nxml.txt.nlp	19381336	SENT138	35	35	11	11	saquinavir	CYP3A4	PA451305	1576	0.937
NULL	Br_J_Cancer_2010_Jun_29_103(1)_61-72.nxml.txt.nlp	20588279	SENT223	12	12	18	18	trastuzumab	HER-2	PA451743	2064	0.937
NULL	Neural_Regen_Res_2014_Nov_1_9(21)_1897-1901.nxml.txt.nlp	25558239	SENT112	2	2	18	18	diazepam	CA1	PA449283	759	0.937
NULL	Int_J_Biol_Sci_2013_Apr_22_9(4)_350-360.nxml.txt.nlp	23630447	SENT153	7	7	2	2	doxorubicin	MDR1	PA449412	5243	0.937
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT151	4	4	20	20	capecitabine	HER2	PA448771	2064	0.937
NULL	Diabetes_Care_2009_Sep_29_32(9)_1620-1625.nxml.txt.nlp	19564453	SENT155	0	0	17	17	metformin	AMPK	PA450395	5563	0.937
NULL	Tuberc_Respir_Dis_(Seoul)_2014_Sep_30_77(3)_105-110.nxml.txt.nlp	25309604	SENT52	21	21	12	12	warfarin	TTR	PA451906	7276	0.937
NULL	Open_Biochem_J_2011_Sep_23_5_45-51.nxml.txt.nlp	21966325	SENT197	8	8	3	3	diclofenac	PERK	PA449293	9451	0.937
NULL	Ecancermedicalscience_2008_Dec_15_2_126.nxml.txt.nlp	22275992	SENT102	4	4	16	16	lisinopril	ACE	PA450242	1636	0.937
NULL	Int_Neurourol_J_2014_Sep_24_18(3)_115-125.nxml.txt.nlp	25279238	SENT118	30	30	7	7	berberine	CD11b	PA165860812	3684	0.937
NULL	Int_Cardiovasc_Res_J_2014_Sep_1_8(3)_116-123.nxml.txt.nlp	25177675	SENT66	27	27	16	16	fluorescein	CD31	PA164746009	5175	0.937
NULL	Curr_Med_Chem_2014_May_21(14)_1595-1606.nxml.txt.nlp	23992330	SENT145	40	40	17	17	gefitinib	EGFR	PA131301952	1956	0.937
NULL	Clin_Infect_Dis_2013_May_1_56(9)_1330-1339.nxml.txt.nlp	23362284	SENT152	24	24	19	19	nevirapine	HLA-C	PA450616	3107	0.937
NULL	Gene_Regul_Syst_Bio_2014_Mar_4_8_63-73.nxml.txt.nlp	24634581	SENT136	1	1	4	4	minocycline	MT1-MMP	PA450519	4323	0.937
NULL	Br_J_Cancer_2014_Jan_21_110(2)_384-391.nxml.txt.nlp	24346286	SENT133	17	17	9	9	trastuzumab	PTEN	PA451743	5728	0.937
NULL	Oncotarget_2012_Jan_28_3(1)_78-83.nxml.txt.nlp	22289679	SENT85	6	6	25	25	gefitinib	EGFR	PA131301952	1956	0.937
NULL	Br_J_Cancer_2009_Jan_27_100(2)_298-304.nxml.txt.nlp	19127259	SENT124	12	12	15	15	cetuximab	EGFR	PA10040	1956	0.937
NULL	Arthritis_Res_Ther_2011_Mar_24_13(2)_R51.nxml.txt.nlp	21435232	SENT34	29	29	3	3	etanercept	TWEAK	PA449515	8742	0.937
NULL	ScientificWorldJournal_2012_Sep_10_2012_168953.nxml.txt.nlp	22997489	SENT114	0	0	29	29	latanoprost	PI3K	PA164774763	5290	0.937
NULL	Arch_Drug_Inf_2011_Mar_4(1)_1-9.nxml.txt.nlp	21572514	SENT136	3	3	10	10	ciprofloxacin	P-gp	PA449009	5243	0.937
NULL	Acta_Pharmacol_Sin_2014_Jan_9_35(1)_1-10.nxml.txt.nlp	24317012	SENT134	6	6	0	0	cyclophosphamide	CYP2C19	PA449165	1557	0.937
NULL	Orphanet_J_Rare_Dis_2014_Aug_5_9_122.nxml.txt.nlp	25091295	SENT156	0	0	12	12	aminoglutethimide	aromatase	PA448375	1588	0.937
NULL	Br_J_Cancer_2011_Apr_26_104(9)_1393-1400.nxml.txt.nlp	21448163	SENT53	23	23	16	16	anastrozole	aromatase	PA448432	1588	0.937
NULL	Arthritis_Res_Ther_2013_Oct_17_15(5)_R154.nxml.txt.nlp	24286344	SENT309	27	27	34	34	ivermectin	P2X4	PA450133	5025	0.937
NULL	Cell_Death_Dis_2010_Nov_18_1(11)_e102.nxml.txt.nlp	21368867	SENT115	20	20	3	3	gentamicin	14-3-3	PA449753	10971	0.937
NULL	Int_J_Mol_Sci_2014_May_7_15(5)_8004-8023.nxml.txt.nlp	24810691	SENT24	29	29	21	21	s-adenosylmethionine	BHMT	PA164754994	635	0.937
NULL	Indian_J_Endocrinol_Metab_2013_May-Jun_17(3)_413-421.nxml.txt.nlp	23869296	SENT207	16	16	0	0	liraglutide	GLP-1	PA165958364	100125288	0.937
NULL	Cell_Death_Dis_2010_Feb_4_1(2)_e23.nxml.txt.nlp	21364631	SENT8	33	33	30	30	curcumin	AP-1	PA151958596	2353;3727;2354;3725	0.937
NULL	Anal_Bioanal_Chem_2009_Oct_30_395(4)_893-905.nxml.txt.nlp	19484227	SENT143	27	27	17	17	gentamicin	OTC	PA449753	5009	0.937
NULL	Asian-Australas_J_Anim_Sci_2014_Dec_27(12)_1783-1793.nxml.txt.nlp	25358373	SENT191	0	0	32	32	capsaicin	CASP3	PA448776	836	0.937
NULL	J_Cell_Mol_Med_2014_Oct_11_18(10)_2031-2043.nxml.txt.nlp	25109475	SENT278	27	27	16	16	valsartan	STZ	PA451848	6484	0.937
NULL	Cancer_Cell_Int_2014_Jun_11_14_49.nxml.txt.nlp	24991192	SENT8	21	21	25	25	berberine	AMPK	PA165860812	5563	0.937
NULL	Diabetes_Care_2010_Mar_10_33(3)_463-466.nxml.txt.nlp	20007938	SENT83	14	14	24	24	pravastatin	SLCO1B1	PA451089	10599	0.937
NULL	J_Gynecol_Oncol_2012_Jan_9_23(1)_35-42.nxml.txt.nlp	22355465	SENT7	31	31	12	12	cisplatin	BCL2	PA449014	596	0.937
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jun_23_68(Pt_7)_o2172-o2173.nxml.txt.nlp	22798843	SENT5	16	16	1	1	piperazine	mol	PA450977	90527	0.937
NULL	Br_J_Cancer_2013_Mar_5_108(4)_748-754.nxml.txt.nlp	23361058	SENT50	10	10	17	17	vorinostat	RAD50	PA164748224	10111	0.937
NULL	Front_Oncol_2014_Mar_25_4_54.nxml.txt.nlp	24724051	SENT421	5	5	26	26	nilotinib	LYN	PA165958345	4067	0.937
NULL	Cell_Death_Dis_2010_Oct_21_1(10)_e86.nxml.txt.nlp	21368859	SENT76	20	20	1	1	doxorubicin	BimEL	PA449412	10018	0.937
NULL	Diabetes_2008_Sep_57(9)_2272-2279.nxml.txt.nlp	18519799	SENT190	26	26	16	16	rosiglitazone	PDK4	PA451283	5166	0.937
NULL	Diabetes_Care_2013_Mar_13_36(3)_683-689.nxml.txt.nlp	23069838	SENT7	11	11	26	26	nitroprusside	GLP-1	PA451406	100125288	0.937
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT255	12	12	18	18	risperidone	PRL	PA451257	5617	0.937
NULL	F1000_Biol_Rep_2011_Nov_1_3_23.nxml.txt.nlp	22065982	SENT122	10	10	13	13	mitoxantrone	ABCG2	PA450526	9429	0.937
NULL	Cell_Host_Microbe_2014_Sep_10_16(3)_291-303.nxml.txt.nlp	25211072	SENT209	17	17	23	23	genistein	PP2	PA165109660	4888	0.937
NULL	Clin_Med_Insights_Oncol_2013_Jun_20_7_137-149.nxml.txt.nlp	23843723	SENT147	13	13	8	8	imatinib	KIT	PA10804	3815	0.937
NULL	Breast_Cancer_Res_2014_May_30_16(3)_R55.nxml.txt.nlp	24886669	SENT171	0	0	7	7	doxorubicin	p53	PA449412	7157	0.937
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT257	6	6	12	12	gefitinib	AKT	PA131301952	207	0.937
NULL	Front_Cell_Neurosci_2014_Dec_11_8_427.nxml.txt.nlp	25565961	SENT86	4	4	26	26	imatinib	GSAP	PA10804	54103	0.937
NULL	Environ_Health_Perspect_2006_Aug_30_114(8)_1237-1242.nxml.txt.nlp	16882532	SENT198	42	42	25	25	ethanol	ALDH2	PA448073	217	0.937
NULL	J_Hematol_Oncol_2011_Apr_20_4_16.nxml.txt.nlp	21504625	SENT51	14	14	6	6	nutlin-3	MDM2		4193	0.937
NULL	Psychiatry_Investig_2010_Sep_13_7(3)_215-219.nxml.txt.nlp	20927311	SENT9	24	24	16	16	paroxetine	FDG	PA450801	23583	0.937
NULL	Cardiovasc_Ther_2012_Aug_17_30(4)_e174-e182.nxml.txt.nlp	21883999	SENT98	20	20	13	13	clopidogrel	CYP3A	PA449053	1574	0.937
NULL	Breast_Cancer_Res_2012_Jan_19_14(1)_201.nxml.txt.nlp	22277572	SENT243	19	19	8	8	letrozole	aromatase	PA450196	1588	0.937
NULL	Int_J_Environ_Res_Public_Health_2013_Apr_12_10(4)_1527-1546.nxml.txt.nlp	23583964	SENT481	4	4	12	12	arsenite	PARP-1	PA452638	25976	0.937
NULL	Breast_Cancer_Res_2001_Mar_26_3(3)_180-182.nxml.txt.nlp	11305952	SENT25	3	3	1	1	letrozole	aromatase	PA450196	1588	0.937
NULL	Blood_Cancer_J_2014_Jan_10_4(1)_e171.nxml.txt.nlp	24413065	SENT54	0	0	23	23	valinomycin	CO2	PA151917011	4513	0.937
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT215	28	28	14	14	metformin	EGFR	PA450395	1956	0.937
NULL	Cardiovasc_J_Afr_2013_Apr_24(3)_78-81.nxml.txt.nlp	23736131	SENT48	9	9	24	24	hemin	OCT	PA449849	5362	0.937
NULL	J_Neuroinflammation_2010_Sep_7_7_51.nxml.txt.nlp	20822529	SENT13	21	21	14	14	hemin	HO-1	PA449849	3162	0.937
NULL	Oncol_Lett_2014_Jun_28_7(6)_2093-2098.nxml.txt.nlp	24932295	SENT7	24	24	6	6	resveratrol	PI3K		5290	0.937
NULL	J_Hematol_Oncol_2008_Oct_1_1_16.nxml.txt.nlp	18828924	SENT105	30	30	39	39	pertuzumab	HER2		2064	0.937
NULL	Front_Oncol_2014_Sep_29_4_251.nxml.txt.nlp	25325012	SENT508	18	18	30	30	afatinib	EGFR	PA165981154	1956	0.937
NULL	Breast_Cancer_Res_2008_Jul_24_10(4)_211.nxml.txt.nlp	18671839	SENT137	33	33	22	22	flavopiridol	HER2	PA452627	2064	0.937
NULL	Oncol_Rep_2013_Oct_22_30(4)_1535-1541.nxml.txt.nlp	23877481	SENT149	33	33	17	17	etoricoxib	CXCR4	PA164776853	7852	0.937
NULL	Fibrogenesis_Tissue_Repair_2012_Jun_6_5(Suppl_1)_S13.nxml.txt.nlp	23259677	SENT45	5	5	17	17	pravastatin	Rho	PA451089	29984	0.937
NULL	Oncotarget_2014_Jun_13_5(20)_9689-9702.nxml.txt.nlp	25356753	SENT115	26	26	9	9	cisplatin	Bcl-2	PA449014	596	0.937
NULL	Biomed_Res_Int_2013_Jun_9_2013_654354.nxml.txt.nlp	23841084	SENT34	18	18	14	14	erlotinib	EGFR	PA134687924	1956	0.937
NULL	Cell_Death_Dis_2014_Mar_13_5(3)_e1112.nxml.txt.nlp	24625971	SENT100	18	18	15	15	curcumin	CHOP	PA151958596	1649	0.937
NULL	Cancers_(Basel)_2011_Nov_23_3(4)_4170-4190.nxml.txt.nlp	24213132	SENT173	3	3	25	25	flavopiridol	survivin	PA452627	332	0.937
NULL	Sci_Rep_2014_Nov_28_4_7237.nxml.txt.nlp	25429875	SENT108	41	41	21	21	hesperidin	JNK	PA449867	5599	0.937
NULL	Arthritis_Res_Ther_2010_Apr_14_12(2)_R67.nxml.txt.nlp	20398273	SENT23	0	0	24	24	abatacept	CD28	PA164747080	1493;940	0.937
NULL	EMBO_J_2013_Feb_20_32(4)_511-523.nxml.txt.nlp	23241948	SENT129	3	3	22	22	kanamycin	FRP	PA450137	11167;6422	0.937
NULL	Mol_Cancer_2008_Jan_9_7_3.nxml.txt.nlp	18184435	SENT123	27	27	8	8	estradiol	p15	PA449503	10923;10573	0.937
NULL	Oncotarget_2014_Oct_21_5(22)_11252-11268.nxml.txt.nlp	25361004	SENT263	32	32	2	2	metformin	CLIC1	PA450395	1192	0.937
NULL	Oncotarget_2013_Oct_19_4(11)_2045-2056.nxml.txt.nlp	24185104	SENT76	23	23	9	9	cisplatin	14-3-3	PA449014	10971	0.937
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_13_2013_468537.nxml.txt.nlp	23956772	SENT141	2	2	32	32	paclitaxel	BAX	PA450761	581	0.937
NULL	Clin_Pharmacokinet_2014_Sep_3_53(1)_1-16.nxml.txt.nlp	23999929	SENT287	19	19	30	30	erythromycin	P-gp	PA449493	5243	0.937
NULL	Eur_J_Endocrinol_2011_Jan_164(1)_69-74.nxml.txt.nlp	20961967	SENT125	2	2	10	10	pioglitazone	OPG	PA450970	690	0.937
NULL	Cell_Death_Differ_2010_Apr_16_17(4)_666-676.nxml.txt.nlp	19834494	SENT310	11	11	3	3	oxaliplatin	RAGE	PA131285527	177	0.937
NULL	Gut_Liver_2012_Jan_12_6(1)_10-20.nxml.txt.nlp	22375166	SENT170	14	14	3	3	vildagliptin	GLP-1	PA165958346	100125288	0.937
NULL	Neural_Regen_Res_2014_Mar_15_9(6)_622-629.nxml.txt.nlp	25206865	SENT71	15	15	8	8	vasopressin	p38	PA451858	10598;1432;7965	0.937
NULL	J_Gen_Physiol_2003_May_121(5)_353-373.nxml.txt.nlp	12719483	SENT44	23	23	5	5	nifedipine	Q10	PA450631	27161	0.937
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_O5.nxml.txt.nlp	NULL	SENT13	5	5	35	35	vancomycin	IL-4	PA451850	3565	0.937
NULL	Br_J_Cancer_2004_Mar_22_90(6)_1285-1292.nxml.txt.nlp	15026814	SENT142	29	29	11	11	doxorubicin	p53	PA449412	7157	0.937
NULL	Cardiovasc_Res_2011_Apr_1_90(1)_105-112.nxml.txt.nlp	21123217	SENT193	42	42	35	35	mibefradil	Bcl-2	PA450492	596	0.937
NULL	Hum_Genomics_2010_Apr_1_4(4)_238-249.nxml.txt.nlp	20511137	SENT83	18	18	9	9	raloxifene	UGT1A1	PA451221	54658	0.937
NULL	Pharmaceuticals_(Basel)_2012_Nov_20_5(11)_1236-1264.nxml.txt.nlp	24281308	SENT1605	4	4	8	8	paclitaxel	MTOR	PA450761	2475	0.937
NULL	Lancet_2009_May_16_373(9676)_1681-1692.nxml.txt.nlp	19447249	SENT67	14	14	8	8	tamoxifen	aromatase	PA451581	1588	0.937
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Feb_28_65(Pt_3)_o641.nxml.txt.nlp	21582290	SENT57	11	11	3	3	ethanol	mol	PA448073	90527	0.936
NULL	Nat_Genet_2011_Jan_12_43(1)_27-33.nxml.txt.nlp	21151129	SENT164	9	9	32	32	tamoxifen	FOXA1	PA451581	3169	0.936
NULL	Indian_J_Med_Res_2012_Mar_135(3)_359-364.nxml.txt.nlp	22561623	SENT115	8	8	3	3	ceftazidime	ACC-1	PA448861	597	0.936
NULL	J_Cardiothorac_Surg_2010_Apr_19_5_26.nxml.txt.nlp	20403156	SENT137	11	11	18	18	etomidate	RAI	PA164743987	10848;6050	0.936
NULL	Med_Sci_Monit_2013_Nov_17_19_1006-1012.nxml.txt.nlp	24241246	SENT155	18	18	10	10	fluvastatin	CD16	PA449688	2215;2214	0.936
NULL	Mol_Cancer_2013_Sep_11_12_104.nxml.txt.nlp	24025152	SENT48	28	28	13	13	gemcitabine	EGFR	PA449748	1956	0.936
NULL	Environ_Health_Perspect_1996_Dec_104(Suppl_6)_1247-1250.nxml.txt.nlp	9118900	SENT6	10	10	28	28	hydroquinone	GM-CSF	PA449924	1437	0.936
NULL	Br_J_Cancer_2013_Mar_19_108(5)_1126-1132.nxml.txt.nlp	23511629	SENT36	22	22	8	8	sunitinib	CYP3A5	PA162372840	1577	0.936
NULL	Breast_Cancer_Res_2013_Nov_6_15(6)_R105.nxml.txt.nlp	24192331	SENT36	19	19	8	8	tamoxifen	aromatase	PA451581	1588	0.936
NULL	Acta_Orthop_2010_Dec_26_81(6)_748-755.nxml.txt.nlp	21067431	SENT153	28	28	13	13	sc-560	COX		1351	0.936
NULL	Int_Arch_Med_2011_Feb_4_4_6.nxml.txt.nlp	21294887	SENT100	21	21	8	8	methylphenidate	ANOVA	PA450464	4858	0.936
NULL	Cancer_Imaging_2005_Jun_21_5(1)_51-57.nxml.txt.nlp	16154820	SENT44	17	17	5	5	imatinib	FDG	PA10804	23583	0.936
NULL	Lab_Anim_Res_2011_Jun_22_27(2)_85-90.nxml.txt.nlp	21826167	SENT80	0	0	3	3	irbesartan	AT1	PA450084	9197;185	0.936
NULL	Br_J_Pharmacol_2012_Jan_165(2)_390-400.nxml.txt.nlp	21671897	SENT237	31	31	19	19	suramin	P2X1	PA10292	5023	0.936
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT1911	17	17	11	11	acetaminophen	CYP1A2	PA448015	1544	0.936
NULL	Breast_Cancer_Res_2001_Mar_26_3(3)_180-182.nxml.txt.nlp	11305952	SENT24	17	17	12	12	letrozole	aromatase	PA450196	1588	0.936
NULL	Genet_Sel_Evol_2014_Mar_4_46(1)_19.nxml.txt.nlp	24592996	SENT165	29	29	10	10	taurine	PCDHB7	PA451590	56129	0.936
NULL	Breast_Cancer_(Auckl)_2012_Feb_20_6_47-66.nxml.txt.nlp	22399860	SENT172	4	4	32	32	tamoxifen	CCND1	PA451581	595	0.936
NULL	Biomed_Res_Int_2014_Feb_11_2014_578974.nxml.txt.nlp	24678510	SENT149	0	0	4	4	irbesartan	AT1	PA450084	9197;185	0.936
NULL	Biomed_Res_Int_2013_Oct_27_2013_798261.nxml.txt.nlp	24282821	SENT216	0	0	21	21	ethanol	DAI	PA448073	81030	0.936
NULL	ASN_Neuro_2010_Jul_23_2(3)_e00038.nxml.txt.nlp	20664705	SENT99	10	10	6	6	trypsin	VIII	PA451806	1351	0.936
NULL	Cancer_Microenviron_2013_Jan_22_6(3)_231-240.nxml.txt.nlp	23335094	SENT67	29	29	1	1	simvastatin	PC-3	PA451363	692094	0.936
NULL	Oncol_Lett_2014_Jun_14_7(6)_2130-2134.nxml.txt.nlp	24932302	SENT3	0	0	6	6	eltrombopag	TPO	PA165981594	7066;7173	0.936
NULL	Arthritis_Res_Ther_2011_May_25_13(Suppl_1)_S5.nxml.txt.nlp	21624184	SENT269	0	0	14	14	ustekinumab	IL-23	PA166048654	51561	0.936
NULL	J_Exp_Clin_Cancer_Res_2009_Jul_10_28(1)_99.nxml.txt.nlp	19591692	SENT29	17	17	13	13	zosuquidar	ABCB1		5243	0.936
NULL	Oncol_Rep_2014_Jul_15_32(1)_45-49.nxml.txt.nlp	24841138	SENT11	16	16	12	12	pp2	MMP9		4318	0.936
NULL	Breast_Cancer_Res_2005_May_27_7(Suppl_1)_S29.nxml.txt.nlp	NULL	SENT3	18	18	16	16	letrozole	aromatase	PA450196	1588	0.936
NULL	Prostate_Int_2014_Sep_21_2(3)_105-113.nxml.txt.nlp	25325021	SENT147	20	20	17	17	finasteride	SRD5A2	PA449627	6716	0.936
NULL	Ann_Oncol_2014_Oct_18_25(10)_1871-1888.nxml.txt.nlp	25234545	SENT319	25	25	9	9	fulvestrant	aromatase	PA164747170	1588	0.936
NULL	Nat_Commun_2014_Aug_4_5_4535.nxml.txt.nlp	25088745	SENT285	22	22	1	1	tamoxifen	LKB1	PA451581	6794	0.936
NULL	Case_Rep_Oncol_2014_Sep_27_7(3)_681-684.nxml.txt.nlp	25408663	SENT14	36	36	14	14	crizotinib	ALK	PA165946122	238	0.936
NULL	Indian_J_Pharm_Sci_2014_Mar-Apr_76(2)_125-131.nxml.txt.nlp	24843185	SENT155	12	12	18	18	resveratrol	S100B		6285	0.936
NULL	J_Hematol_Oncol_2008_Oct_1_1_16.nxml.txt.nlp	18828924	SENT261	12	12	17	17	docetaxel	HER2	PA449383	2064	0.936
NULL	Mol_Cancer_2009_Aug_25_8_66.nxml.txt.nlp	19706164	SENT78	4	4	2	2	celecoxib	p53	PA448871	7157	0.936
NULL	Psychiatry_Investig_2008_Jun_30_5(2)_102-105.nxml.txt.nlp	20046352	SENT60	24	24	1	1	carbamazepine	DTNBP1	PA448785	84062	0.936
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_13_2013_468537.nxml.txt.nlp	23956772	SENT141	4	4	29	29	etoposide	PIG3	PA449552	64975;9540	0.936
NULL	Mol_Vis_2012_May_1_18_1115-1122.nxml.txt.nlp	22605923	SENT126	20	20	10	10	estradiol	p38	PA449503	10598;1432;7965	0.936
NULL	J_Hematol_Oncol_2011_Apr_1_4_13.nxml.txt.nlp	21453545	SENT183	14	14	27	27	geldanamycin	FLT3	PA152031327	2322	0.936
NULL	Indian_J_Palliat_Care_2011_Jan-Apr_17(1)_78b-79.nxml.txt.nlp	21633628	SENT12	21	21	8	8	aprepitant	NK1	PA164747039	11126	0.936
NULL	Oncol_Lett_2013_Mar_8_5(3)_805-812.nxml.txt.nlp	23426281	SENT197	21	21	9	9	gemcitabine	B7-H3	PA449748	80381	0.936
NULL	Br_J_Cancer_2010_Jan_19_102(2)_268-275.nxml.txt.nlp	20010948	SENT23	6	6	14	14	sorafenib	VEGFR1	PA7000	2321	0.936
NULL	Breast_Cancer_(Auckl)_2012_Mar_7_6_67-77.nxml.txt.nlp	22438669	SENT168	1	1	14	14	trastuzumab	HER2	PA451743	2064	0.936
NULL	Crit_Care_2004_Oct_27_8(6)_R474-R482.nxml.txt.nlp	15566594	SENT119	0	0	18	18	lornoxicam	COX	PA165958395	1351	0.936
NULL	Nat_Med_2011_Sep_11_17(10)_1235-1241.nxml.txt.nlp	21909103	SENT126	7	7	23	23	denosumab	RANKL	PA166048634	8600	0.936
NULL	Clin_Pharmacol_2011_Jun_22_3_13-25.nxml.txt.nlp	22287853	SENT17	26	26	22	22	ketoconazole	CYP3A4	PA450146	1576	0.936
NULL	Ann_Hematol_2011_May_12_90(5)_557-568.nxml.txt.nlp	20938660	SENT130	10	10	1	1	plerixafor	CD34	PA165958410	947	0.936
NULL	eLife_2014_Aug_1_3_e02725.nxml.txt.nlp	25085081	SENT764	16	16	8	8	cisplatin	MSH3	PA449014	4437	0.936
NULL	J_Oncol_2010_Jun_3_2010_732680.nxml.txt.nlp	20613952	SENT70	0	0	12	12	lenalidomide	IL-6	PA162363968	3569	0.936
NULL	Clin_Cosmet_Investig_Dermatol_2013_Sep_26_6_233-244.nxml.txt.nlp	24101875	SENT165	21	21	31	31	bevacizumab	VEGF-A	PA130232992	7422	0.936
NULL	J_Breast_Cancer_2011_Mar_31_14(1)_46-51.nxml.txt.nlp	21847394	SENT113	19	19	2	2	trastuzumab	HER2	PA451743	2064	0.936
NULL	Mol_Cancer_2014_Jan_13_13_7.nxml.txt.nlp	24418169	SENT240	6	6	19	19	sorafenib	SHP-1	PA7000	5777	0.936
NULL	Ann_Med_Health_Sci_Res_2012_Jul-Dec_2(2)_191-198.nxml.txt.nlp	23439914	SENT165	9	9	1	1	nifedipine	P-gp	PA450631	5243	0.936
NULL	Daru_2013_Jan_29_21(1)_11.nxml.txt.nlp	23356399	SENT150	4	4	14	14	curcumin	TIC	PA151958596	23550	0.936
NULL	Diabetol_Metab_Syndr_2014_Dec_2_6(1)_132.nxml.txt.nlp	NULL	SENT7	23	23	6	6	heparin	adiponectin	PA449855	9370	0.936
NULL	Acta_Pharmacol_Sin_2010_Jul_28_31(7)_798-804.nxml.txt.nlp	20581852	SENT7	28	28	9	9	phenylephrine	AMPK	PA450935	5563	0.936
NULL	Leukemia_2013_Feb_3_27(2)_315-324.nxml.txt.nlp	22751450	SENT41	3	3	10	10	sorafenib	Mcl-1	PA7000	4170	0.936
NULL	Acta_Pharmacol_Sin_2012_May_16_33(5)_682-690.nxml.txt.nlp	22504904	SENT121	19	19	2	2	celecoxib	Mcl-1	PA448871	4170	0.936
NULL	Mol_Cancer_2010_Jun_25_9_165.nxml.txt.nlp	20576164	SENT169	19	19	28	28	curcumin	IFN	PA151958596	3439	0.936
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT78	34	34	19	19	nutlin-3	p53		7157	0.936
NULL	Curr_Neuropharmacol_2013_Jul_11(4)_338-378.nxml.txt.nlp	24381528	SENT396	35	35	12	12	curcumin	IL-8	PA151958596	3576	0.936
NULL	Evid_Based_Complement_Alternat_Med_2011_Mar_1_2011_207034.nxml.txt.nlp	21423686	SENT140	10	10	15	15	omeprazole	CYP2C19	PA450704	1557	0.936
NULL	J_Physiol_2011_Oct_15_589(Pt_20)_4921-4934.nxml.txt.nlp	21859823	SENT44	42	42	33	33	isoflurane	P14	PA450106	11102;;6280;56259	0.936
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT26	0	0	16	16	trastuzumab	HER2	PA451743	2064	0.936
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1137-1144.nxml.txt.nlp	20234366	SENT140	36	36	33	33	cetuximab	MKP-1	PA10040	1843	0.936
NULL	Front_Oncol_2013_Sep_23_3_250.nxml.txt.nlp	24069582	SENT141	17	17	13	13	trastuzumab	HER2	PA451743	2064	0.936
NULL	Oncol_Lett_2013_Feb_30_5(2)_588-592.nxml.txt.nlp	23420263	SENT81	18	18	2	2	lenalidomide	NKX2-1	PA162363968	7080	0.936
NULL	Open_Cardiovasc_Med_J_2008_Jul_30_2_60-69.nxml.txt.nlp	18949101	SENT16	13	13	9	9	sirolimus	DES	PA451365	1674	0.936
NULL	Acta_Neuropathol_2014_Nov_9_127(2)_303-305.nxml.txt.nlp	24212601	SENT30	15	15	22	22	trypsin	RD3	PA451806	343035	0.936
NULL	Genetics_2013_Jan_193(1)_1-50.nxml.txt.nlp	23275493	SENT206	48	48	6	6	cerulenin	DAG	PA164764551	1605	0.936
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Jul_23_6_103-113.nxml.txt.nlp	25114588	SENT180	17	17	12	12	capecitabine	PIK3CA	PA448771	5290	0.936
NULL	Biol_Open_2014_May_2_3(6)_418-430.nxml.txt.nlp	24795145	SENT39	20	20	3	3	etoposide	RanBPM	PA449552	10048	0.936
NULL	Ann_Oncol_2010_Jul_23_21(7)_1436-1441.nxml.txt.nlp	20032126	SENT42	21	21	8	8	trastuzumab	HER2	PA451743	2064	0.936
NULL	Nucleic_Acids_Res_2005_Jun_8_33(10)_3283-3291.nxml.txt.nlp	15944449	SENT157	26	26	5	5	sjg-136	XRCC2		7516	0.936
NULL	Mol_Cancer_2008_Jun_5_7_50.nxml.txt.nlp	18534018	SENT143	23	23	7	7	bortezomib	p38	PA10252	10598;1432;7965	0.936
NULL	Cancers_(Basel)_2010_Jan_14_2(1)_1-19.nxml.txt.nlp	24281029	SENT1030	4	4	21	21	neratinib	San	PA165291472	80218	0.936
NULL	Indian_J_Med_Res_2011_Sep_134(3)_295-301.nxml.txt.nlp	21985811	SENT28	19	19	7	7	phenytoin	CYP2C9	PA450947	1559	0.936
NULL	Indian_J_Nephrol_2011_Jan-Mar_21(1)_56-58.nxml.txt.nlp	21655173	SENT58	33	33	27	27	vincristine	CHOP	PA451879	1649	0.936
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Sep_12_69(Pt_10)_o1529.nxml.txt.nlp	24098217	SENT70	15	15	24	24	ethanol	mol	PA448073	90527	0.936
NULL	Cell_Death_Dis_2013_Jan_31_4(1)_e480.nxml.txt.nlp	23370280	SENT143	23	23	9	9	cisplatin	WWOX	PA449014	51741	0.936
NULL	Oncotarget_2014_Aug_25_5(17)_7945-7959.nxml.txt.nlp	25277206	SENT27	22	22	6	6	sunitinib	Raf-1	PA162372840	5894	0.936
NULL	J_Gynecol_Oncol_2013_Jan_8_24(1)_66-82.nxml.txt.nlp	23346316	SENT270	3	3	8	8	everolimus	aromatase	PA164746311	1588	0.936
NULL	Clin_Ophthalmol_2014_Jun_24_8_1187-1198.nxml.txt.nlp	25028531	SENT121	3	3	13	13	ranibizumab	PED	PA164746012	8682	0.936
NULL	Support_Care_Cancer_2009_Sep_10_17(9)_1187-1193.nxml.txt.nlp	19205754	SENT28	3	3	10	10	granisetron	CYP3A4	PA449809	1576	0.936
NULL	J_Exp_Med_2003_Jan_20_197(2)_221-232.nxml.txt.nlp	12538661	SENT123	8	8	20	20	ns-398	COX		1351	0.936
NULL	Indian_J_Pharm_Sci_2014_Sep-Oct_76(5)_415-422.nxml.txt.nlp	25425755	SENT55	1	1	24	24	curcumin	AXL	PA151958596	558	0.936
NULL	EMBO_Mol_Med_2013_Aug_1_5(8)_1196-1212.nxml.txt.nlp	23818228	SENT111	15	15	5	5	doxycycline	ROBO1	PA449415	6091	0.936
NULL	Front_Oncol_2014_Sep_15_4_244.nxml.txt.nlp	25309870	SENT161	33	33	43	43	afatinib	EGFR	PA165981154	1956	0.936
NULL	Mol_Cancer_2009_Apr_22_8_26.nxml.txt.nlp	19386116	SENT130	12	12	9	9	ritonavir	Hsp90	PA451260	3320	0.936
NULL	J_Exp_Bot_2011_Oct_4_62(14)_4787-4803.nxml.txt.nlp	21821598	SENT246	9	9	20	20	mannitol	M6PR	PA450320	4074	0.936
NULL	Breast_Cancer_Res_2005_Jul_29_7(5)_E6.nxml.txt.nlp	16168100	SENT9	43	43	12	12	tamoxifen	CYP2D6	PA451581	1565	0.936
NULL	Diabetes_2009_Jun_31_58(6)_1434-1439.nxml.txt.nlp	19336679	SENT145	24	24	6	6	metformin	SLC22A1	PA450395	6580	0.936
NULL	Breast_Cancer_Res_2012_Jul_19_14(4)_R109.nxml.txt.nlp	22812567	SENT292	34	34	13	13	gemcitabine	CHK1	PA449748	1111	0.936
NULL	Clin_Med_Insights_Oncol_2013_Aug_21_7_221-234.nxml.txt.nlp	24179413	SENT59	15	15	12	12	gefitinib	EGFR	PA131301952	1956	0.936
NULL	Breast_Cancer_Res_2012_Jul_20_14(4)_R110.nxml.txt.nlp	22817698	SENT149	34	34	17	17	methotrexate	BRCA1	PA450428	672	0.936
NULL	eLife_2013_Nov_5_2_e00969.nxml.txt.nlp	24192036	SENT114	28	28	16	16	vemurafenib	NOXA	PA165946873	5366	0.936
NULL	Cell_Death_Dis_2014_Jan_16_5(1)_e1000.nxml.txt.nlp	24434508	SENT87	19	19	14	14	etoposide	p53	PA449552	7157	0.936
NULL	Tuberc_Respir_Dis_(Seoul)_2013_Nov_29_75(5)_188-198.nxml.txt.nlp	24348666	SENT38	29	29	23	23	gefitinib	HER2	PA131301952	2064	0.936
NULL	Br_J_Haematol_2008_Aug_28_142(4)_505-514.nxml.txt.nlp	18510682	SENT149	32	32	5	5	alemtuzumab	CD4	PA164783958	920	0.936
NULL	Eur_J_Endocrinol_2013_Aug_169(2)_187-201.nxml.txt.nlp	23704713	SENT83	16	16	5	5	ethanol	GLP1	PA448073	100125288;2641	0.936
NULL	Mol_Cancer_2014_Jan_13_13_7.nxml.txt.nlp	24418169	SENT177	28	28	24	24	sorafenib	SHP-1	PA7000	5777	0.936
NULL	Biochem_Res_Int_2012_Jun_15_2012_387626.nxml.txt.nlp	22745910	SENT129	11	11	25	25	choline	p53	PA448976	7157	0.936
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_1-20.nxml.txt.nlp	19305785	SENT205	0	0	7	7	furosemide	KCC2	PA449719	57468	0.936
NULL	J_Cell_Mol_Med_2013_Jan_10_17(1)_30-54.nxml.txt.nlp	23301832	SENT222	16	16	24	24	doxorubicin	HIF-1	PA449412	29072	0.936
NULL	Br_J_Cancer_2013_Jun_11_108(11)_2281-2290.nxml.txt.nlp	23640395	SENT217	14	14	20	20	curcumin	IL-6	PA151958596	3569	0.936
NULL	Curr_Hematol_Malig_Rep_2014_Jun_18_9(3)_212-216.nxml.txt.nlp	24939521	SENT155	7	7	33	33	vinblastine	HD7	PA451877	9734	0.936
NULL	Gut_2008_Jul_4_57(7)_923-929.nxml.txt.nlp	18252749	SENT201	18	18	24	24	capsaicin	TRPV1	PA448776	7442	0.936
NULL	Iran_J_Basic_Med_Sci_2011_Sep-Oct_14(5)_436-442.nxml.txt.nlp	23493930	SENT78	4	4	13	13	glibenclamide	STZ	PA449782	6484	0.936
NULL	Front_Chem_2014_Mar_25_2_13.nxml.txt.nlp	24790982	SENT59	28	28	25	25	ethanol	CO2	PA448073	4513	0.936
NULL	Mol_Biol_Rep_2013_Sep_28_40(10)_5573-5585.nxml.txt.nlp	24078156	SENT43	4	4	21	21	iron	IRP2	PA450087	3658	0.936
NULL	J_Korean_Med_Sci_2006_Jun_21_21(3)_418-424.nxml.txt.nlp	16778382	SENT39	17	17	1	1	hemin	INS-1	PA449849	2305	0.936
NULL	Acta_Pharmacol_Sin_2012_May_16_33(5)_682-690.nxml.txt.nlp	22504904	SENT167	12	12	16	16	celecoxib	STAT3	PA448871	6774	0.936
NULL	Clin_Epigenetics_2011_Dec_5_3(1)_8.nxml.txt.nlp	22414275	SENT101	14	14	1	1	ribavirin	ESR1	PA451241	2099	0.936
NULL	Br_J_Cancer_2009_Jul_21_101(2)_350-356.nxml.txt.nlp	19513075	SENT126	4	4	10	10	doxorubicin	MDM2	PA449412	4193	0.936
NULL	J_Exp_Med_1977_Dec_1_146(6)_1484-1499.nxml.txt.nlp	925610	SENT6	7	7	1	1	trypsin	C42	PA451806	51654	0.936
NULL	Exp_Hematol_Oncol_2014_Feb_17_3_6.nxml.txt.nlp	24528501	SENT58	29	29	11	11	dasatinib	CD34	PA162372878	947	0.936
NULL	Oncol_Lett_2013_Apr_7_5(4)_1382-1384.nxml.txt.nlp	23599798	SENT58	19	19	37	37	temsirolimus	IFN	PA164746890	3439	0.936
NULL	Mol_Cancer_2008_Oct_23_7_82.nxml.txt.nlp	18947424	SENT279	25	25	28	28	doxazosin	EGFR	PA449407	1956	0.936
NULL	Mol_Cancer_2014_Aug_16_13(1)_193.nxml.txt.nlp	NULL	SENT16	22	22	9	9	cisplatin	RKIP	PA449014	5037	0.936
NULL	Br_J_Cancer_2010_Nov_9_103(10)_1580-1587.nxml.txt.nlp	20959823	SENT139	3	3	8	8	bortezomib	PMP22	PA10252	5376;5827	0.936
NULL	Toxins_(Basel)_2010_Mar_31_2(4)_517-551.nxml.txt.nlp	22069598	SENT763	1	1	9	9	curcumin	STAT3	PA151958596	6774	0.936
NULL	Cancers_(Basel)_2012_Apr_5_4(2)_354-378.nxml.txt.nlp	24213315	SENT153	12	12	30	30	cisplatin	TRAIL	PA449014	8743	0.936
NULL	Oncol_Lett_2013_Mar_11_5(3)_1010-1016.nxml.txt.nlp	23426784	SENT109	11	11	22	22	midazolam	TRPM7	PA450496	54822	0.936
NULL	Braz_J_Med_Biol_Res_2013_Mar_19_46(3)_257-262.nxml.txt.nlp	23558860	SENT65	18	18	6	6	proparacaine	ERG	PA164776849	2078	0.936
NULL	Ann_Dermatol_2011_Dec_27_23(Suppl_3)_S360-S363.nxml.txt.nlp	22346278	SENT11	0	0	30	30	imatinib	CML	PA10804	613	0.936
NULL	Biomed_Res_Int_2014_Jun_2_2014_946492.nxml.txt.nlp	24991574	SENT75	5	5	17	17	olmesartan	ATRAP	PA164742950	57085	0.936
NULL	Oxid_Med_Cell_Longev_2013_Jul_24_2013_825928.nxml.txt.nlp	23983900	SENT77	16	16	29	29	resveratrol	SIRT1		23411	0.936
NULL	Exp_Ther_Med_2014_Feb_13_7(2)_513-517.nxml.txt.nlp	24396436	SENT84	26	26	0	0	chymotrypsin	TFPI-2	PA448994	7980	0.936
NULL	Eur_J_Clin_Pharmacol_2012_Sep_15_68(9)_1267-1274.nxml.txt.nlp	22418828	SENT96	44	44	24	24	pantoprazole	CYP2C19	PA450774	1557	0.936
NULL	Comput_Struct_Biotechnol_J_2013_Mar_12_4_e201301008.nxml.txt.nlp	24688689	SENT168	27	27	2	2	ethanol	NAT	PA448073	6046	0.936
NULL	J_Cell_Biol_1998_Jan_26_140(2)_335-345.nxml.txt.nlp	9442109	SENT87	10	10	6	6	chloroquine	NHE	PA448948	285335	0.936
NULL	Indian_J_Med_Res_2014_Feb_139(2)_216-225.nxml.txt.nlp	24718395	SENT127	18	18	4	4	gabapentin	PMPS	PA449720	5377	0.936
NULL	Acta_Pharmacol_Sin_2013_Jan_5_34(1)_24-32.nxml.txt.nlp	23123646	SENT82	34	34	16	16	glibenclamide	SUR1	PA449782	6833	0.936
NULL	Front_Oncol_2014_Oct_6_4_270.nxml.txt.nlp	25340039	SENT186	14	14	4	4	methylcholanthrene	p53	PA165816878	7157	0.936
NULL	Blood_Cancer_J_2013_Apr_12_3(4)_e108.nxml.txt.nlp	23584398	SENT180	37	37	22	22	sn-38	P2X7		5027	0.936
NULL	Mol_Cancer_2013_May_24_12_47.nxml.txt.nlp	23705854	SENT133	3	3	31	31	celecoxib	P-gp	PA448871	5243	0.936
NULL	Br_J_Cancer_2012_Jun_5_106(12)_1997-2003.nxml.txt.nlp	22596232	SENT167	9	9	2	2	sorafenib	JNK	PA7000	5599	0.936
NULL	Acta_Neuropathol_Commun_2014_May_30_2_57.nxml.txt.nlp	24887326	SENT186	21	21	23	23	etoposide	MED1	PA449552	5469;8930	0.936
NULL	Case_Rep_Oncol_2013_Apr_6_6(1)_197-203.nxml.txt.nlp	23626561	SENT87	19	19	24	24	rituximab	CHOP	PA451261	1649	0.936
NULL	Curr_Neuropharmacol_2012_Mar_10(1)_72-79.nxml.txt.nlp	22942880	SENT85	14	14	30	30	vincristine	GSTP1	PA451879	2950	0.936
NULL	Front_Oncol_2014_Apr_10_4_74.nxml.txt.nlp	24782985	SENT77	36	36	13	13	hyaluronan	HMGB1	PA165958431	3146	0.936
NULL	Korean_Circ_J_2013_Jun_30_43(6)_400-407.nxml.txt.nlp	23882289	SENT134	17	17	13	13	doxorubicin	p38	PA449412	10598;1432;7965	0.936
NULL	Oncotarget_2014_Feb_25_5(5)_1304-1314.nxml.txt.nlp	24675421	SENT10	9	9	26	26	cisplatin	MKK4	PA449014	6416	0.936
NULL	Case_Rep_Med_2012_Dec_3_2012_163173.nxml.txt.nlp	23326270	SENT15	12	12	8	8	bezafibrate	CPT2	PA162364313	1376	0.936
NULL	Oncogene_2009_Dec_3_28(48)_4237-4248.nxml.txt.nlp	19734937	SENT102	22	22	1	1	collagenase	PAR-1	PA449107	2011;2149	0.936
NULL	Exp_Ther_Med_2014_Apr_13_7(4)_799-803.nxml.txt.nlp	24669235	SENT69	7	7	13	13	vildagliptin	GLP-1	PA165958346	100125288	0.936
NULL	J_Gerontol_A_Biol_Sci_Med_Sci_2014_Jun_8_69(Suppl_1)_S21-S27.nxml.txt.nlp	24833582	SENT275	1	1	8	8	resveratrol	SIRT1		23411	0.936
NULL	Clin_Exp_Reprod_Med_2013_Jun_30_40(2)_67-75.nxml.txt.nlp	23875162	SENT11	42	42	26	26	rosiglitazone	aromatase	PA451283	1588	0.936
NULL	Biol_Open_2014_Dec_12_4(1)_48-61.nxml.txt.nlp	25505152	SENT498	21	21	38	38	metformin	SNRK	PA450395	54861	0.936
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT40	9	9	31	31	raltitrexed	UNG	PA131625240	7374	0.936
NULL	Cancer_Cell_Int_2013_Jan_15_13_3.nxml.txt.nlp	23320839	SENT135	13	13	33	33	sorafenib	ABCC2	PA7000	1244	0.936
NULL	Oncotarget_2012_Sep_28_3(10)_1169-1181.nxml.txt.nlp	23045411	SENT173	18	18	15	15	doxorubicin	JIP1	PA449412	9479	0.936
NULL	Int_J_Mol_Sci_2014_Oct_17_15(10)_18762-18775.nxml.txt.nlp	25329617	SENT132	21	21	34	34	heparin	EGFR	PA449855	1956	0.936
NULL	Front_Microbiol_2012_Mar_1_3_75.nxml.txt.nlp	22403577	SENT187	24	24	13	13	heparin	nectin-4	PA449855	81607	0.936
NULL	Stroke_Res_Treat_2010_Dec_28_2011_534362.nxml.txt.nlp	21234312	SENT88	5	5	28	28	warfarin	AIS	PA451906	367	0.936
NULL	Int_J_Mol_Sci_2012_Feb_24_13(3)_2578-2589.nxml.txt.nlp	22489112	SENT64	10	10	33	33	desipramine	GAT3	PA449233	6538	0.936
NULL	Breast_Cancer_Res_Treat_2013_Oct_4_141(3)_385-395.nxml.txt.nlp	24091769	SENT142	22	22	0	0	lapatinib	MVD	PA152241907	4597	0.936
NULL	Braz_J_Med_Biol_Res_2012_Mar_2_45(3)_250-255.nxml.txt.nlp	22370705	SENT99	14	14	26	26	mecamylamine	ADM	PA450334	133	0.936
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT222	6	6	28	28	metformin	AKT	PA450395	207	0.936
NULL	Cardiol_Res_Pract_2012_Jan_29_2012_852829.nxml.txt.nlp	22400124	SENT128	25	25	22	22	losartan	AT1	PA450268	9197;185	0.936
NULL	Cardiovasc_Diabetol_2013_Jun_7_12_84.nxml.txt.nlp	23759020	SENT184	5	5	30	30	dipyridamole	LSR	PA449367	51599	0.936
NULL	Br_J_Cancer_1998_May_77(10)_1645-1652.nxml.txt.nlp	9635842	SENT10	16	16	11	11	sn-38	TPT		23590;6469	0.936
NULL	Biomed_Res_Int_2013_Aug_6_2013_602987.nxml.txt.nlp	24027759	SENT274	38	38	18	18	paclitaxel	SMF	PA450761	22993	0.936
NULL	Onco_Targets_Ther_2014_Sep_9_7_1571-1582.nxml.txt.nlp	25228815	SENT177	22	22	11	11	sunitinib	VEGFR2	PA162372840	3791	0.936
NULL	Aging_(Albany_NY)_2011_Apr_6_3(4)_444-449.nxml.txt.nlp	21483037	SENT70	8	8	11	11	resveratrol	AMPK		5563	0.936
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_39-54.nxml.txt.nlp	19305787	SENT125	4	4	28	28	ethanol	NR1	PA448073	27158	0.936
NULL	Nat_Genet_2013_Jul_2_45(7)_747-755.nxml.txt.nlp	23727860	SENT146	35	35	37	37	dutasteride	SRD5A1	PA164749300	6715	0.936
NULL	Cell_Death_Dis_2012_Mar_15_3(3)_e286.nxml.txt.nlp	22419115	SENT217	0	0	8	8	cisplatin	p53	PA449014	7157	0.936
NULL	Breast_Cancer_Res_2005_Jun_17_7(Suppl_2)_S_13.nxml.txt.nlp	NULL	SENT14	15	15	18	18	tamoxifen	aromatase	PA451581	1588	0.936
NULL	Crit_Care_2011_Jun_24_15(3)_R153.nxml.txt.nlp	21702944	SENT103	4	4	1	1	dexmedetomidine	HK2	PA449256	3796;3099;29911;3741	0.936
NULL	J_Cell_Biol_2000_Dec_25_151(7)_1381-1390.nxml.txt.nlp	11134068	SENT41	35	35	6	6	neomycin	53BP1	PA450608	7158	0.936
NULL	Curr_Chem_Genomics_2010_Mar_1_4_1-8.nxml.txt.nlp	20448812	SENT94	32	32	38	38	moricizine	OATP1B3	PA164747738	28234	0.936
NULL	J_Cardiovasc_Dis_Res_2010_Jul-Sep_1(3)_116-121.nxml.txt.nlp	21187864	SENT8	2	2	20	20	glucose	CAD	PA449773	1677;790	0.936
NULL	Br_J_Cancer_2003_Mar_24_88(6)_848-854.nxml.txt.nlp	12644821	SENT161	16	16	9	9	paclitaxel	TP53	PA450761	7157	0.936
NULL	Oncotarget_2014_Jun_26_5(14)_5510-5522.nxml.txt.nlp	24980816	SENT93	30	30	18	18	doxycycline	BSP	PA449415	3381	0.936
NULL	Breast_Cancer_Res_Treat_2009_Jul_22_116(2)_371-378.nxml.txt.nlp	18941892	SENT81	30	30	20	20	letrozole	aromatase	PA450196	1588	0.936
NULL	Diabetes_Obes_Metab_2011_Nov_13(11)_982-989.nxml.txt.nlp	21615670	SENT156	9	9	32	32	exenatide	PPG	PA164749238	5552	0.936
NULL	Br_J_Cancer_2012_Jul_10_107(2)_360-369.nxml.txt.nlp	22713663	SENT128	20	20	22	22	bevacizumab	DDP	PA130232992	1678	0.936
NULL	Cell_Res_2013_Oct_27_23(10)_1163-1171.nxml.txt.nlp	23979020	SENT121	37	37	8	8	doxycycline	MSI1	PA449415	4440	0.936
NULL	Eur_J_Immunol_2013_Sep_25_43(9)_2361-2372.nxml.txt.nlp	23686382	SENT25	28	28	5	5	heparin	CD4	PA449855	920	0.936
NULL	Angiogenesis_2009_Dec_21_12(4)_303-311.nxml.txt.nlp	19544080	SENT38	23	23	4	4	oxygen	CO2	PA450744	4513	0.936
NULL	Arch_Drug_Inf_2011_Mar_4(1)_1-9.nxml.txt.nlp	21572514	SENT8	12	12	8	8	ciprofloxacin	MDR1	PA449009	5243	0.936
NULL	Ann_Hematol_2014_Apr_1_93(8)_1371-1380.nxml.txt.nlp	24687382	SENT27	3	3	10	10	thalidomide	CRBN	PA451644	51185	0.936
NULL	Acta_Pharmacol_Sin_2011_Sep_1_32(9)_1109-1115.nxml.txt.nlp	21804575	SENT158	2	2	5	5	irbesartan	AT1	PA450084	9197;185	0.936
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Dec_4_67(Pt_1)_o32.nxml.txt.nlp	21522744	SENT58	23	23	11	11	ethanol	mol	PA448073	90527	0.936
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT299	16	16	12	12	olanzapine	PRL	PA450688	5617	0.936
NULL	Neural_Develop_2008_Oct_22_3_27.nxml.txt.nlp	18945340	SENT304	13	13	23	23	mimosine	Rho	PA164752445	29984	0.936
NULL	Oncotarget_2014_Jun_19_5(15)_6540-6551.nxml.txt.nlp	25153728	SENT116	14	14	2	2	paclitaxel	p53	PA450761	7157	0.936
NULL	Cancers_(Basel)_2013_Apr_15_5(2)_430-461.nxml.txt.nlp	24216985	SENT361	32	32	15	15	bortezomib	p53	PA10252	7157	0.936
NULL	Acta_Pharmacol_Sin_2010_Mar_8_31(3)_382-386.nxml.txt.nlp	20140004	SENT27	30	30	13	13	irinotecan	SLCO1B1	PA450085	10599	0.936
NULL	Eur_J_Clin_Pharmacol_2012_Jan_8_68(1)_29-37.nxml.txt.nlp	21739267	SENT31	26	26	28	28	itraconazole	CYP3A4	PA450132	1576	0.936
NULL	Curr_Neuropharmacol_2013_Mar_11(2)_160-170.nxml.txt.nlp	23997751	SENT125	2	2	12	12	haloperidol	5-HT1A	PA449841	3350	0.936
NULL	Aging_(Albany_NY)_2012_Apr_16_4(4)_247-255.nxml.txt.nlp	22511639	SENT82	12	12	38	38	metformin	p300	PA450395	2033	0.936
NULL	Mol_Cancer_2009_Mar_6_8_17.nxml.txt.nlp	19267923	SENT212	5	5	12	12	tamoxifen	p27	PA451581	5715;10534	0.936
NULL	J_Hematol_Oncol_2013_Jun_3_6_38.nxml.txt.nlp	23731980	SENT55	25	25	31	31	paclitaxel	HER2	PA450761	2064	0.936
NULL	Acta_Pharmacol_Sin_2010_Jul_28_31(7)_867-873.nxml.txt.nlp	20581857	SENT154	15	15	6	6	docetaxel	PDCD4	PA449383	27250	0.936
NULL	Diabetes_Obes_Metab_2012_Apr_14(4)_304-314.nxml.txt.nlp	22051096	SENT70	5	5	13	13	liraglutide	GLP-1	PA165958364	100125288	0.936
NULL	J_Med_Case_Reports_2011_Aug_23_5_405.nxml.txt.nlp	21861919	SENT49	22	22	14	14	ketoconazole	ACTH	PA450146	5443	0.936
NULL	Biologics_2012_Sep_25_6_337-345.nxml.txt.nlp	23055691	SENT99	12	12	18	18	cetuximab	EGFR	PA10040	1956	0.936
NULL	Breast_Cancer_(Auckl)_2014_Oct_15_8_145-155.nxml.txt.nlp	25368521	SENT92	28	28	21	21	cisplatin	BRCA1	PA449014	672	0.936
NULL	Infect_Dis_Obstet_Gynecol_2009_Jul_20_2009_473971.nxml.txt.nlp	19639046	SENT29	16	16	6	6	chloroquine	IPT	PA448948	54802	0.936
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT173	8	8	10	10	metformin	HIP	PA450395	6767;6159;64399;5068	0.936
NULL	J_Hematol_Oncol_2012_Sep_18_5_57.nxml.txt.nlp	22989009	SENT160	15	15	6	6	nutlin-3	HDM2		4193	0.936
NULL	Curr_Hepat_Rep_2010_May_21_9(2)_75-90.nxml.txt.nlp	20461127	SENT290	12	12	6	6	telbivudine	ASAT	PA164760861	22	0.936
NULL	Oncol_Lett_2014_May_11_7(5)_1401-1408.nxml.txt.nlp	24765145	SENT108	3	3	19	19	paclitaxel	HIF-1	PA450761	29072	0.936
NULL	Nucleic_Acids_Res_2013_May_5_41(10)_5210-5222.nxml.txt.nlp	23563151	SENT261	27	27	4	4	arsenite	MDM2	PA452638	4193	0.936
NULL	Pak_J_Med_Sci_2013_Sep-Oct_29(5)_1158-1161.nxml.txt.nlp	24353711	SENT83	23	23	0	0	gemcitabine	ERCC1	PA449748	2067	0.936
NULL	ISRN_Cardiol_2013_Jun_23_2013_748736.nxml.txt.nlp	23862074	SENT106	28	28	17	17	clopidogrel	DES	PA449053	1674	0.936
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT153	20	20	1	1	perifosine	JNK	PA165291471	5599	0.936
NULL	J_Hum_Genet_2013_Jun_2_58(6)_306-312.nxml.txt.nlp	23635953	SENT15	29	29	19	19	letrozole	aromatase	PA450196	1588	0.936
NULL	Angiogenesis_2010_Dec_7_13(4)_305-315.nxml.txt.nlp	20927579	SENT39	8	8	21	21	resveratrol	p53		7157	0.936
NULL	Exp_Ther_Med_2015_Jan_18_9(1)_105-111.nxml.txt.nlp	25452783	SENT175	27	27	36	36	celecoxib	COX	PA448871	1351	0.936
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1563-1573.nxml.txt.nlp	22015557	SENT123	2	2	8	8	sunitinib	c-Myc	PA162372840	4609	0.936
NULL	Evid_Based_Complement_Alternat_Med_2014_Jul_24_2014_604152.nxml.txt.nlp	25147575	SENT89	3	3	19	19	gefitinib	EGFR	PA131301952	1956	0.936
NULL	J_Cell_Biol_1997_Mar_24_136(6)_1213-1226.nxml.txt.nlp	9087438	SENT148	16	16	8	8	chymotrypsin	p180	PA448994	5422	0.936
NULL	Mol_Vis_2012_Oct_5_18_2454-2467.nxml.txt.nlp	23077404	SENT236	22	22	6	6	bevacizumab	HIF-1	PA130232992	29072	0.936
NULL	EMBO_Mol_Med_2012_Sep_20_4(9)_980-991.nxml.txt.nlp	22903875	SENT169	25	25	3	3	paraformaldehyde	BACE2	PA450790	25825	0.936
NULL	Breast_Cancer_Res_2010_Dec_16_12(6)_215.nxml.txt.nlp	21176175	SENT306	0	0	18	18	denosumab	RANKL	PA166048634	8600	0.936
NULL	Nat_Commun_2014_Dec_17_5_5777.nxml.txt.nlp	25517116	SENT11	17	17	31	31	isoproterenol	Bcl-2	PA450121	596	0.936
NULL	Dement_Geriatr_Cogn_Dis_Extra_2014_Nov_15_4(3)_450-456.nxml.txt.nlp	25538729	SENT33	13	13	20	20	donepezil	CYP2D6	PA449394	1565	0.936
NULL	Cancer_Cell_Int_2010_May_11_10_16.nxml.txt.nlp	20459793	SENT193	13	13	21	21	cisplatin	ANOVA	PA449014	4858	0.936
NULL	Open_Med_Chem_J_2009_Nov_18_3_8-13.nxml.txt.nlp	19966921	SENT72	31	31	44	44	urea	iNOS	PA451831	4843	0.936
NULL	Arthritis_Res_Ther_2010_Apr_29_12(2)_R73.nxml.txt.nlp	20429888	SENT282	6	6	25	25	bortezomib	COL1A2	PA10252	1278	0.936
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_127043.nxml.txt.nlp	23227093	SENT191	16	16	24	24	gemfibrozil	CYP2C8	PA449750	1558	0.936
NULL	Br_J_Pharmacol_2012_Jan_165(2)_380-389.nxml.txt.nlp	21585347	SENT126	38	38	29	29	rosiglitazone	ATGL	PA451283	57104	0.936
NULL	Oncogene_2009_Jan_29_28(4)_479-491.nxml.txt.nlp	18978811	SENT252	18	18	32	32	doxycycline	DPPIV	PA449415	2191;1803	0.936
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT121	24	24	10	10	nutlin-3	MDM2		4193	0.936
NULL	Cell_Death_Dis_2012_Mar_15_3(3)_e286.nxml.txt.nlp	22419115	SENT67	0	0	11	11	cisplatin	p53	PA449014	7157	0.936
NULL	Cancer_Immunol_Immunother_2013_Aug_27_62(10)_1637-1648.nxml.txt.nlp	23982484	SENT289	15	15	3	3	lenalidomide	CD40	PA162363968	958	0.936
NULL	Oncotarget_2011_Dec_31_2(12)_1314-1321.nxml.txt.nlp	22248929	SENT148	18	18	5	5	lapatinib	FDG	PA152241907	23583	0.936
NULL	Mol_Cancer_2008_Mar_26_7_27.nxml.txt.nlp	18366759	SENT80	7	7	37	37	etoposide	CLK1	PA449552	1195	0.936
NULL	Case_Rep_Psychiatry_2013_Jan_30_2013_381261.nxml.txt.nlp	23424703	SENT57	23	23	0	0	pseudoephedrine	OTC	PA451170	5009	0.936
NULL	Br_J_Cancer_2013_Jul_23_109(2)_351-359.nxml.txt.nlp	23799854	SENT278	12	12	5	5	paclitaxel	MDR1	PA450761	5243	0.936
NULL	Korean_J_Anesthesiol_2013_Mar_19_64(3)_251-256.nxml.txt.nlp	23560192	SENT7	37	37	20	20	propofol	BDP	PA451141	10620;152926	0.936
NULL	Front_Neurosci_2011_Dec_5_5_131.nxml.txt.nlp	22164129	SENT95	33	33	6	6	midazolam	TSPO	PA450496	706	0.936
NULL	N_Am_J_Med_Sci_2011_Jan_3(1)_1-12.nxml.txt.nlp	22540056	SENT187	33	33	16	16	erlotinib	KRAS	PA134687924	3845	0.936
NULL	Cardiovasc_J_Afr_2010_Oct_21(5)_280-285.nxml.txt.nlp	20972517	SENT84	14	14	20	20	naringenin	AMPK	PA151958361	5563	0.936
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT74	7	7	22	22	nutlin-3	p53		7157	0.936
NULL	Cell_Death_Dis_2013_Oct_3_4(10)_e827.nxml.txt.nlp	24091670	SENT103	23	23	15	15	nilotinib	PI3K	PA165958345	5290	0.936
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT115	26	26	42	42	adalimumab	CD36	PA10004	948	0.936
NULL	Front_Physiol_2011_Jun_30_2_33.nxml.txt.nlp	21747769	SENT287	4	4	14	14	berberine	KCNQ1	PA165860812	3784	0.936
NULL	Int_J_Chron_Obstruct_Pulmon_Dis_2007_Jun_2(2)_121-129.nxml.txt.nlp	18044684	SENT56	21	21	8	8	rolipram	IL-8	PA153906323	3576	0.936
NULL	Exp_Diabetes_Res_2012_Oct_17_2012_420854.nxml.txt.nlp	23118741	SENT125	22	22	15	15	ezetimibe	GLP-1	PA10816	100125288	0.936
NULL	Front_Immunol_2013_Nov_12_4_370.nxml.txt.nlp	24273542	SENT160	3	3	14	14	gemcitabine	NLRP3	PA449748	114548	0.936
NULL	J_Antimicrob_Chemother_2009_Nov_18_64(5)_910-928.nxml.txt.nlp	19767318	SENT233	19	19	26	26	simvastatin	CYP3A4	PA451363	1576	0.936
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT203	11	11	2	2	cetuximab	KRAS	PA10040	3845	0.936
NULL	Iran_J_Pharm_Res_2015_Winter_14(1)_321-328.nxml.txt.nlp	25561938	SENT106	0	0	8	8	forskolin	VASP	PA146096022	7408	0.936
NULL	Neural_Regen_Res_2013_Mar_25_8(9)_825-832.nxml.txt.nlp	25206730	SENT106	0	0	9	9	isoflurane	P2X7	PA450106	5027	0.936
NULL	Ann_Clin_Transl_Neurol_2014_Dec_21_1(12)_996-1005.nxml.txt.nlp	25574474	SENT128	5	5	12	12	elacridar	P-gp		5243	0.936
NULL	J_Oncol_2012_Apr_10_2012_931071.nxml.txt.nlp	22570654	SENT91	12	12	2	2	plerixafor	CD34	PA165958410	947	0.936
NULL	J_Cell_Mol_Med_2013_Jan_11_17(1)_134-146.nxml.txt.nlp	23305490	SENT12	10	10	30	30	curcumin	TASK	PA151958596	3777	0.936
NULL	J_Korean_Med_Sci_2013_May_2_28(5)_700-708.nxml.txt.nlp	23678261	SENT218	41	41	14	14	losartan	NCX	PA450268	3196	0.936
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jun_23_66(Pt_7)_o1753.nxml.txt.nlp	21587969	SENT74	30	30	6	6	ethanol	mol	PA448073	90527	0.936
NULL	Cancer_Med_2013_Feb_3_2(1)_76-85.nxml.txt.nlp	24133630	SENT174	24	24	22	22	vemurafenib	BRAF	PA165946873	673	0.936
NULL	Breast_Cancer_Res_2011_Mar_11_13(2)_R30.nxml.txt.nlp	21396117	SENT35	12	12	9	9	erlotinib	EGFR	PA134687924	1956	0.936
NULL	J_Psychopharmacol_2010_Nov_24(4_supplement)_91-118.nxml.txt.nlp	18801830	SENT135	11	11	46	46	fenfluramine	FGA	PA449592	2243	0.936
NULL	Cases_J_2009_Jun_17_2_7246.nxml.txt.nlp	19829938	SENT67	0	0	7	7	iron	UROD	PA450087	7389	0.936
NULL	Scientifica_(Cairo)_2012_Sep_10_2012_482423.nxml.txt.nlp	24278703	SENT59	12	12	2	2	ezetimibe	SHARP	PA10816	23013	0.936
NULL	J_Biol_Chem_2013_Nov_22_288(47)_34217-34229.nxml.txt.nlp	24106270	SENT17	17	17	7	7	thrombin	RhoG	PA451674	391	0.936
NULL	Tuberc_Respir_Dis_(Seoul)_2013_Nov_29_75(5)_188-198.nxml.txt.nlp	24348666	SENT174	29	29	8	8	crizotinib	EGFR	PA165946122	1956	0.936
NULL	Arthritis_Res_Ther_2014_Mar_11_16(2)_R65.nxml.txt.nlp	24612997	SENT220	25	25	16	16	valsartan	IL-8	PA451848	3576	0.936
NULL	Hum_Immunol_2013_Nov_74(11)_1459-1462.nxml.txt.nlp	23777935	SENT81	33	33	41	41	cyclosporine	CD86	PA449167	942	0.936
NULL	Acta_Pharmacol_Sin_2014_Jun_5_35(6)_727-737.nxml.txt.nlp	24793312	SENT13	20	20	14	14	telmisartan	B27	PA451605	56246	0.936
NULL	Oncogene_2013_Sep_5_32(36)_4252-4263.nxml.txt.nlp	23045288	SENT78	13	13	9	9	cisplatin	CD49f	PA449014	3655	0.936
NULL	Cancer_Cell_Int_2014_Jan_23_14_6.nxml.txt.nlp	24456610	SENT223	34	34	30	30	gefitinib	EGFR	PA131301952	1956	0.936
NULL	Cell_Cycle_2013_Dec_15_12(24)_3791-3803.nxml.txt.nlp	24107631	SENT26	27	27	7	7	doxycycline	YB-1	PA449415	4904	0.936
NULL	Nat_Commun_2014_Dec_8_5_5736.nxml.txt.nlp	25484020	SENT652	10	10	18	18	anastrozole	TRPA1	PA448432	8989	0.936
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT616	11	11	39	39	amisulpride	PRL	PA162565877	5617	0.936
NULL	Breast_Cancer_Res_2002_Sep_10_4(6)_218-221.nxml.txt.nlp	12473166	SENT61	5	5	1	1	tamoxifen	STAR	PA451581	6770;2984	0.936
NULL	Chem_Rev_2011_Oct_12_111(10)_5899-5921.nxml.txt.nlp	21923193	SENT563	20	20	3	3	meloxicam	FAAH	PA450353	79152;2166	0.936
NULL	Oncotarget_2013_Nov_22_5(4)_933-943.nxml.txt.nlp	24659749	SENT55	23	23	32	32	nutlin-3	p53		7157	0.936
NULL	FEBS_Open_Bio_2011_Dec_27_2_1-5.nxml.txt.nlp	23650573	SENT126	23	23	13	13	sunitinib	VEGFR	PA162372840	3791	0.936
NULL	Ann_Clin_Transl_Neurol_2014_Jan_20_1(1)_15-26.nxml.txt.nlp	25356379	SENT110	15	15	1	1	isoflurane	gamma	PA450106	9913	0.936
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT430	8	8	0	0	aripiprazole	PRL	PA10026	5617	0.936
NULL	J_Ophthalmol_2010_Jun_22_2010_170393.nxml.txt.nlp	20652047	SENT145	9	9	20	20	olmesartan	RAGE	PA164742950	177	0.936
NULL	Nat_Genet_2011_Feb_26_43(2)_117-120.nxml.txt.nlp	21186350	SENT77	13	13	30	30	metformin	AMPK	PA450395	5563	0.936
NULL	Cancer_Metastasis_Rev_2010_Dec_10_29(4)_581-594.nxml.txt.nlp	20830503	SENT280	29	29	5	5	letrozole	STA	PA450196	2010;2656	0.936
NULL	Mol_Cancer_2007_Oct_11_6_63.nxml.txt.nlp	17931419	SENT13	16	16	7	7	cetuximab	EGFR	PA10040	1956	0.936
NULL	Breast_Cancer_Res_2014_May_22_16(3)_R49.nxml.txt.nlp	24887419	SENT325	4	4	28	28	estradiol	tuberin	PA449503	7249	0.936
NULL	Evid_Based_Complement_Alternat_Med_2013_May_13_2013_506324.nxml.txt.nlp	23818927	SENT187	38	38	19	19	doxorubicin	STAT3	PA449412	6774	0.936
NULL	Amyloid_2014_Sep_11_21(3)_175-184.nxml.txt.nlp	24918964	SENT157	14	14	7	7	anakinra	BiP	PA10799	3309	0.936
NULL	Oncogene_2014_Feb_6_33(6)_713-723.nxml.txt.nlp	23435429	SENT64	31	31	6	6	camptothecin	p50	PA153590860	958;4790	0.936
NULL	Clin_Med_Insights_Ear_Nose_Throat_2012_Apr_3_5_1-16.nxml.txt.nlp	24179404	SENT191	16	16	3	3	cetuximab	TLR9	PA10040	54106	0.936
NULL	Cancers_(Basel)_2014_Mar_26_6(2)_708-722.nxml.txt.nlp	24675568	SENT103	3	3	8	8	gefitinib	EGFR	PA131301952	1956	0.936
NULL	Open_Access_J_Urol_2011_May_10_3_69-82.nxml.txt.nlp	24198638	SENT67	14	14	31	31	warfarin	UGT1A1	PA451906	54658	0.936
NULL	Biologics_2010_May_25_4_83-90.nxml.txt.nlp	20531966	SENT86	17	17	12	12	gefitinib	EGFR	PA131301952	1956	0.936
NULL	Indian_J_Endocrinol_Metab_2014_Jan-Feb_18(1)_77-82.nxml.txt.nlp	24701434	SENT74	24	24	3	3	metformin	PPG	PA450395	5552	0.936
NULL	Diabetes_Care_2009_Jan_32(1)_14-18.nxml.txt.nlp	18931099	SENT27	16	16	11	11	exenatide	GLP-1	PA164749238	100125288	0.936
NULL	Oncogene_2013_Nov_28_32(48)_5439-5448.nxml.txt.nlp	23563182	SENT180	0	0	9	9	etoposide	Mcl-1	PA449552	4170	0.936
NULL	Biomed_Res_Int_2014_Aug_6_2014_967826.nxml.txt.nlp	25165721	SENT70	0	0	22	22	cisplatin	p53	PA449014	7157	0.936
NULL	Indian_J_Anaesth_2009_Aug_53(4)_489-491.nxml.txt.nlp	20640215	SENT33	27	27	13	13	sevoflurane	CO2	PA451341	4513	0.936
NULL	Br_J_Cancer_2006_Dec_4_95(11)_1483-1489.nxml.txt.nlp	17106442	SENT172	2	2	6	6	gefitinib	EGFR	PA131301952	1956	0.936
NULL	Diabetes_2011_Jul_20_60(7)_1990-1999.nxml.txt.nlp	21617181	SENT216	7	7	37	37	geldanamycin	STAT3	PA152031327	6774	0.936
NULL	Nat_Commun_2014_Dec_8_5_5736.nxml.txt.nlp	25484020	SENT36	5	5	20	20	exemestane	TRPA1	PA449563	8989	0.936
NULL	EMBO_Mol_Med_2013_Mar_22_5(3)_353-365.nxml.txt.nlp	23341130	SENT255	7	7	11	11	imatinib	CD34	PA10804	947	0.936
NULL	Curr_Neuropharmacol_2014_Jul_12(4)_365-379.nxml.txt.nlp	25342944	SENT27	34	34	7	7	fluoxetine	5-HT2B	PA449673	3357	0.936
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jul_22_65(Pt_8)_o1944.nxml.txt.nlp	21583625	SENT59	11	11	3	3	ethanol	mol	PA448073	90527	0.936
NULL	ScientificWorldJournal_2014_Feb_6_2014_328513.nxml.txt.nlp	24683330	SENT98	21	21	8	8	remifentanil	IL-10	PA451232	3586	0.936
NULL	Environ_Health_Perspect_2006_Sep_23_114(9)_1401-1406.nxml.txt.nlp	16966095	SENT110	3	3	22	22	arsenite	p53	PA452638	7157	0.936
NULL	Nat_Commun_2013_4_1332.nxml.txt.nlp	23299882	SENT165	4	4	34	34	ebselen	CO2	PA161660841	4513	0.936
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT172	6	6	34	34	vinorelbine	MVP	PA451881	9961	0.936
NULL	Cancer_Med_2014_Dec_13_3(6)_1579-1594.nxml.txt.nlp	25124282	SENT12	14	14	25	25	cisplatin	DNA-PKcs	PA449014	5591	0.936
NULL	Diabetes_Care_2010_Apr_12_33(4)_742-744.nxml.txt.nlp	20067964	SENT78	34	34	2	2	pioglitazone	ghrelin	PA450970	51738	0.936
NULL	J_Cancer_2013_Sep_27_4(8)_662-670.nxml.txt.nlp	24155778	SENT180	34	34	13	13	carboplatin	UCHL1	PA448803	7345	0.936
NULL	J_Korean_Med_Sci_2014_Jul_11_29(7)_965-972.nxml.txt.nlp	25045229	SENT127	27	27	9	9	metformin	B12	PA450395	7126;4709	0.936
NULL	Oncol_Rep_2014_Feb_16_31(2)_573-580.nxml.txt.nlp	24337632	SENT42	18	18	12	12	cisplatin	AKT	PA449014	207	0.936
NULL	Acta_Pharmacol_Sin_2011_Jul_9_32(7)_879-887.nxml.txt.nlp	21552292	SENT143	25	25	8	8	metformin	AMPK	PA450395	5563	0.936
NULL	Nucleic_Acids_Res_2007_Jan_7_35(1)_186-192.nxml.txt.nlp	17158155	SENT21	27	27	11	11	cytarabine	TRO	PA449177	7216	0.936
NULL	Int_J_Biol_Sci_2014_Jun_3_10(6)_596-601.nxml.txt.nlp	24948872	SENT71	19	19	10	10	bicalutamide	CYP17A1	PA164746255	1586	0.936
NULL	Curr_Control_Trials_Cardiovasc_Med_2001_Jul_26_2(4)_171-179.nxml.txt.nlp	11806792	SENT50	44	44	9	9	eptifibatide	IMPACT	PA449483	55364	0.936
NULL	Int_J_Med_Sci_2014_Sep_6_11(11)_1185-1200.nxml.txt.nlp	25249787	SENT121	7	7	17	17	metformin	AMPK	PA450395	5563	0.936
NULL	Ann_Rheum_Dis_2008_Nov_14_67(11)_1516-1523.nxml.txt.nlp	18625622	SENT133	36	36	15	15	methotrexate	AST	PA450428	26503	0.936
NULL	Eur_J_Clin_Pharmacol_2012_Sep_15_68(9)_1267-1274.nxml.txt.nlp	22418828	SENT10	38	38	23	23	pantoprazole	CYP2C19	PA450774	1557	0.936
NULL	Diabetes_2011_Nov_17_60(11)_2691-2700.nxml.txt.nlp	21896928	SENT131	1	1	9	9	resveratrol	SIRT1		23411	0.936
NULL	Indian_J_Med_Res_2013_Oct_138(4)_461-491.nxml.txt.nlp	24434254	SENT449	24	24	30	30	rosuvastatin	2A9	PA134308647	6277	0.936
NULL	Front_Neurosci_2010_Jun_17_4_35.nxml.txt.nlp	20661455	SENT89	9	9	4	4	buspirone	5-HT1A	PA448689	3350	0.936
NULL	ACS_Med_Chem_Lett_2013_Mar_25_4(5)_486-490.nxml.txt.nlp	23687559	SENT74	12	12	10	10	indomethacin	COX	PA449982	1351	0.936
NULL	Br_J_Cancer_2009_Oct_6_101(7)_1155-1161.nxml.txt.nlp	19738614	SENT185	16	16	6	6	gemcitabine	14-3-3	PA449748	10971	0.936
NULL	Exp_Ther_Med_2013_Nov_13_6(5)_1317-1321.nxml.txt.nlp	24223665	SENT170	11	11	1	1	curcumin	CD133	PA151958596	8842	0.936
NULL	Blood_Res_2013_Jun_25_48(2)_72-73.nxml.txt.nlp	23826573	SENT12	9	9	32	32	plerixafor	CD34	PA165958410	947	0.936
NULL	Oncoimmunology_2013_Dec_1_2(12)_e27215.nxml.txt.nlp	24501692	SENT32	29	29	34	34	cetuximab	EGFR	PA10040	1956	0.936
NULL	Oncotarget_2012_May_19_3(5)_535-545.nxml.txt.nlp	22619121	SENT100	7	7	12	12	camptothecin	MYCN	PA153590860	4613	0.936
NULL	Oncogene_2010_Sep_9_29(36)_5048-5060.nxml.txt.nlp	20639907	SENT252	18	18	13	13	cisplatin	TRAIL	PA449014	8743	0.936
NULL	Crit_Care_2011_Feb_3_15(1)_R49.nxml.txt.nlp	21291554	SENT170	31	31	3	3	piperacillin	CLCR	PA450975	11330	0.936
NULL	Case_Rep_Nephrol_2013_Sep_12_2013_640976.nxml.txt.nlp	24527248	SENT73	17	17	30	30	carbamazepine	ADH	PA448785	551	0.936
NULL	Oncol_Lett_2014_Sep_19_8(3)_1269-1274.nxml.txt.nlp	25120704	SENT164	8	8	0	0	cisplatin	Met	PA449014	79811	0.936
NULL	Cancer_Res_Treat_2013_Sep_30_45(3)_178-185.nxml.txt.nlp	24155676	SENT18	22	22	9	9	gefitinib	EGFR	PA131301952	1956	0.936
NULL	Mol_Brain_2013_Feb_12_6_8.nxml.txt.nlp	23402298	SENT114	5	5	13	13	remifentanil	CACNA2D2	PA451232	9254	0.936
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Sep_20_64(Pt_10)_o1972.nxml.txt.nlp	21201172	SENT62	0	0	20	20	benzaldehyde	mol	PA448571	90527	0.936
NULL	Aging_(Albany_NY)_2010_May_15_2(5)_265-273.nxml.txt.nlp	20519781	SENT227	2	2	9	9	metformin	AMPK	PA450395	5563	0.936
NULL	Int_J_Alzheimers_Dis_2010_Jul_20_2010_825918.nxml.txt.nlp	20798900	SENT60	12	12	21	21	carbachol	CA1	PA448784	759	0.936
NULL	Arthritis_Res_Ther_2011_Apr_15_13(2)_R64.nxml.txt.nlp	21496249	SENT87	31	31	3	3	collagenase	CD166	PA449107	214	0.936
NULL	Indian_J_Anaesth_2014_Mar-Apr_58(2)_154-159.nxml.txt.nlp	24963179	SENT72	21	21	30	30	midazolam	ANOVA	PA450496	4858	0.936
NULL	Breast_Cancer_(Auckl)_2012_Feb_20_6_47-66.nxml.txt.nlp	22399860	SENT172	4	4	28	28	tamoxifen	PAX2	PA451581	5076	0.936
NULL	Breast_Cancer_Res_2007_May_14_9(3)_R29.nxml.txt.nlp	17501995	SENT136	0	0	19	19	estradiol	CD34	PA449503	947	0.936
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT294	6	6	28	28	metformin	HIF-1	PA450395	29072	0.936
NULL	Acta_Pharmacol_Sin_2010_Mar_8_31(3)_382-386.nxml.txt.nlp	20140004	SENT72	17	17	25	25	pravastatin	CYP7A1	PA451089	1581	0.936
NULL	Mol_Cell_2012_Feb_10_45(3)_371-383.nxml.txt.nlp	22325354	SENT727	20	20	10	10	olaparib	S14		5714;6208;7069	0.936
NULL	Ann_Hematol_2011_Feb_17_90(2)_173-183.nxml.txt.nlp	20714724	SENT7	8	8	18	18	resveratrol	CD38		952	0.936
NULL	Cells_2012_Oct_15_1(4)_754-773.nxml.txt.nlp	24710529	SENT841	4	4	13	13	capsaicin	p38	PA448776	10598;1432;7965	0.936
NULL	Breast_Cancer_Res_2010_Dec_20_12(Suppl_4)_S19.nxml.txt.nlp	21172081	SENT36	32	32	16	16	bevacizumab	HIF-1	PA130232992	29072	0.936
NULL	Hum_Mol_Genet_2008_Jul_15_17(14)_2101-2107.nxml.txt.nlp	18413323	SENT25	5	5	26	26	ezetimibe	NPC1L1	PA10816	29881	0.936
NULL	Acta_Pharmacol_Sin_2013_May_8_34(5)_612-624.nxml.txt.nlp	23564085	SENT113	6	6	9	9	metformin	AMPK	PA450395	5563	0.936
NULL	Case_Rep_Oncol_Med_2012_Sep_18_2012_343491.nxml.txt.nlp	23029628	SENT76	8	8	24	24	rituximab	Bcl-2	PA451261	596	0.936
NULL	Protein_Cell_2014_Jun_7_5(6)_457-468.nxml.txt.nlp	24801752	SENT151	11	11	0	0	geldanamycin	PI4KII	PA152031327	55361	0.936
NULL	Mol_Brain_2013_Dec_16_6_56.nxml.txt.nlp	24330819	SENT5	4	4	25	25	phencyclidine	GluN2D	PA128406980	2906	0.936
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT244	12	12	27	27	chloroquine	BMPR-II	PA448948	659	0.936
NULL	Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.nxml.txt.nlp	24736980	SENT33	0	0	5	5	rosuvastatin	OATP1B1	PA134308647	10599	0.936
NULL	Acta_Orthop_2010_Apr_6_81(2)_263-267.nxml.txt.nlp	20148646	SENT107	36	36	16	16	taurine	LIR	PA451590	10871	0.936
NULL	Int_J_Mol_Sci_2010_Oct_19_11(10)_3999-4013.nxml.txt.nlp	21152316	SENT202	3	3	17	17	meloxicam	gamma	PA450353	9913	0.936
NULL	Braz_J_Microbiol_2008_Jun_1_Apr-Jun_39(2)_219-225.nxml.txt.nlp	24031205	SENT10	24	24	20	20	fluconazole	CDR2	PA449653	1039	0.936
NULL	ScientificWorldJournal_2014_Mar_24_2014_694326.nxml.txt.nlp	24782665	SENT61	29	29	2	2	metformin	FDG	PA450395	23583	0.936
NULL	Biomed_Res_Int_2014_Jan_2_2014_126586.nxml.txt.nlp	24527434	SENT124	9	9	21	21	trastuzumab	HER2	PA451743	2064	0.936
NULL	Genome_Biol_2008_Oct_13_9(10)_R150.nxml.txt.nlp	18851746	SENT230	19	19	15	15	nutlin-3	MDM2		4193	0.936
NULL	Indian_J_Endocrinol_Metab_2012_Jul-Aug_16(4)_525-527.nxml.txt.nlp	22837910	SENT24	15	15	10	10	liraglutide	GLP-1	PA165958364	100125288	0.936
NULL	Ther_Clin_Risk_Manag_2006_Sep_2(3)_235-249.nxml.txt.nlp	18360599	SENT299	7	7	37	37	alendronate	PTH	PA448082	5741	0.936
NULL	Breast_Cancer_Res_2011_Jun_29_13(3)_R70.nxml.txt.nlp	21707964	SENT3	48	48	2	2	tamoxifen	YWHAZ	PA451581	7534	0.936
NULL	Pharmaceuticals_(Basel)_2012_Aug_30_5(9)_890-898.nxml.txt.nlp	24280696	SENT80	25	25	16	16	vemurafenib	Hsp90	PA165946873	3320	0.936
NULL	Oncol_Lett_2013_Feb_30_5(2)_588-592.nxml.txt.nlp	23420263	SENT75	28	28	24	24	lenalidomide	NKX2-1	PA162363968	7080	0.936
NULL	Open_Med_Chem_J_2011_Sep_9_5_82-92.nxml.txt.nlp	21966329	SENT7	7	7	3	3	exenatide	GLP-1	PA164749238	100125288	0.936
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_7-17.nxml.txt.nlp	17912633	SENT75	3	3	16	16	letrozole	aromatase	PA450196	1588	0.936
NULL	Front_Immunol_2014_Apr_22_5_184.nxml.txt.nlp	24795726	SENT333	28	28	10	10	imatinib	KIR2DS1	PA10804	3806	0.936
NULL	Acta_Pharmacol_Sin_2011_Jun_3_32(6)_845-852.nxml.txt.nlp	21642952	SENT91	19	19	23	23	capsaicin	TRPV1	PA448776	7442	0.936
NULL	Clin_Dev_Immunol_2013_Sep_17_2013_791262.nxml.txt.nlp	24151519	SENT12	33	33	3	3	heparin	CD80	PA449855	941	0.936
NULL	Nat_Med_2012_Jul_18(7)_1118-1122.nxml.txt.nlp	22683780	SENT49	5	5	21	21	crizotinib	HGF	PA165946122	3569;6654;3082	0.936
NULL	Mol_Cancer_2012_Jun_26_11_43.nxml.txt.nlp	22731636	SENT242	1	1	17	17	pp2	PP2		4888	0.936
NULL	Breast_Cancer_Res_2012_Mar_20_14(2)_R53.nxml.txt.nlp	22433433	SENT110	20	20	30	30	cisplatin	CDK9	PA449014	1025	0.936
NULL	Biologics_2014_Apr_17_8_169-182.nxml.txt.nlp	24790410	SENT93	16	16	0	0	etanercept	ACR	PA449515	49	0.936
NULL	Front_Neurosci_2010_May_15_4_13.nxml.txt.nlp	20859447	SENT1066	6	6	39	39	phencyclidine	PCP	PA128406980	5547	0.936
NULL	Ther_Clin_Risk_Manag_2006_Jun_2(2)_129-158.nxml.txt.nlp	18360588	SENT213	3	3	11	11	vincristine	CYP3A4	PA451879	1576	0.936
NULL	Evid_Based_Complement_Alternat_Med_2013_Dec_12_2013_324618.nxml.txt.nlp	24416065	SENT112	14	14	20	20	nevirapine	CYP3A4	PA450616	1576	0.936
NULL	Biosci_Rep_2013_Sep_4_33(5)_e00064.nxml.txt.nlp	23889169	SENT61	15	15	8	8	thrombin	PAR3	PA451674	56288;2151	0.936
NULL	Breast_Cancer_Res_2012_Jun_7_14(3)_R89.nxml.txt.nlp	22676470	SENT18	33	33	0	0	trastuzumab	HER2	PA451743	2064	0.936
NULL	Anesth_Essays_Res_2012_Jan-Jun_6(1)_62-69.nxml.txt.nlp	NULL	SENT104	14	14	36	36	isoflurane	TOF	PA450106	55079	0.936
NULL	Cancer_Immunol_Immunother_2011_Jun_25_60(6)_793-808.nxml.txt.nlp	21350947	SENT207	18	18	10	10	sorafenib	IFN	PA7000	3439	0.936
NULL	Tuberc_Respir_Dis_(Seoul)_2013_Nov_29_75(5)_188-198.nxml.txt.nlp	24348666	SENT226	22	22	9	9	crizotinib	EGFR	PA165946122	1956	0.936
NULL	J_Gynecol_Oncol_2013_Jul_4_24(3)_273-279.nxml.txt.nlp	23875078	SENT87	9	9	1	1	paclitaxel	COX	PA450761	1351	0.936
NULL	Mol_Cancer_2009_Nov_24_8_109.nxml.txt.nlp	19930708	SENT189	5	5	21	21	exemestane	EGFR	PA449563	1956	0.936
NULL	Onco_Targets_Ther_2014_Sep_9_7_1571-1582.nxml.txt.nlp	25228815	SENT267	13	13	9	9	sunitinib	VEGFR2	PA162372840	3791	0.936
NULL	Nat_Chem_Biol_2010_Apr_28_6(4)_291-299.nxml.txt.nlp	20190765	SENT128	44	44	28	28	dasatinib	EGFR	PA162372878	1956	0.936
NULL	Biologics_2012_Dec_17_6_429-464.nxml.txt.nlp	23269860	SENT198	1	1	15	15	etanercept	ACR	PA449515	49	0.936
NULL	Clin_Drug_Investig_2015_Dec_16_35_141-147.nxml.txt.nlp	25511640	SENT71	10	10	23	23	miglitol	GLP-1	PA164776726	100125288	0.936
NULL	Evid_Based_Complement_Alternat_Med_2012_Dec_29_2012_138954.nxml.txt.nlp	23346188	SENT235	17	17	8	8	indomethacin	IL-6	PA449982	3569	0.936
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jul_8_65(Pt_8)_o1796.nxml.txt.nlp	21583502	SENT61	0	0	26	26	benzaldehyde	mol	PA448571	90527	0.936
NULL	Mol_Cancer_2003_Jan_22_2_12.nxml.txt.nlp	12605718	SENT171	24	24	3	3	gemcitabine	VEGF-A	PA449748	7422	0.936
NULL	J_Gynecol_Oncol_2013_Jul_4_24(3)_273-279.nxml.txt.nlp	23875078	SENT102	36	36	38	38	paclitaxel	COX	PA450761	1351	0.936
NULL	Oxid_Med_Cell_Longev_2012_Jun_3_2012_914273.nxml.txt.nlp	22701758	SENT235	7	7	13	13	resveratrol	IL-17		3605	0.936
NULL	Br_J_Cancer_2012_Nov_20_107(11)_1820-1825.nxml.txt.nlp	23079575	SENT15	15	15	3	3	erlotinib	EGFR	PA134687924	1956	0.936
NULL	Case_Rep_Rheumatol_2013_Jul_24_2013_249471.nxml.txt.nlp	23984159	SENT36	6	6	9	9	colchicine	MEFV	PA449092	4210	0.936
NULL	Viruses_2009_Nov_10_1(3)_873-894.nxml.txt.nlp	21994574	SENT199	34	34	10	10	camptothecin	TOP1	PA153590860	7150	0.936
NULL	J_Vet_Med_Sci_2014_Jun_15_76(6)_813-817.nxml.txt.nlp	24531829	SENT90	13	13	4	4	artesunate	DPT	PA165111697	1805	0.936
NULL	Cells_2012_Aug_3_1(3)_492-519.nxml.txt.nlp	24710487	SENT99	14	14	29	29	dextran	IL-18	PA449261	3606	0.936
NULL	Biochem_Res_Int_2010_Aug_4_2010_549572.nxml.txt.nlp	21188077	SENT150	25	25	14	14	l-leucine	TAT	PA450197	6898	0.936
NULL	Acta_Neuropathol_Commun_2014_Oct_21_2(1)_149.nxml.txt.nlp	NULL	SENT186	26	26	6	6	riluzole	gamma	PA451251	9913	0.936
NULL	Nat_Commun_2014_Nov_19_5_5479.nxml.txt.nlp	25407222	SENT38	5	5	37	37	dextran	YTS	PA449261	8565	0.936
NULL	Cell_Death_Dis_2014_Mar_6_5(3)_e1108.nxml.txt.nlp	24603336	SENT180	16	16	5	5	cetuximab	p53	PA10040	7157	0.936
NULL	J_Biomed_Biotechnol_2011_Dec_6_2011_856985.nxml.txt.nlp	21188173	SENT292	24	24	16	16	trastuzumab	San	PA451743	80218	0.936
NULL	Case_Rep_Oncol_2010_May_7_3(2)_154-159.nxml.txt.nlp	20740189	SENT91	7	7	1	1	panitumumab	CEA	PA162373091	5670;1087	0.936
NULL	Breast_Cancer_Res_Treat_2012_Jul_28_134(1)_267-276.nxml.txt.nlp	22453754	SENT219	3	3	6	6	tamoxifen	aromatase	PA451581	1588	0.936
NULL	Cells_2014_Nov_27_3(4)_1089-1101.nxml.txt.nlp	25437439	SENT104	17	17	24	24	naltrexone	TRPM7	PA450588	54822	0.936
NULL	Clin_Med_Oncol_2008_Jul_8_2_471-475.nxml.txt.nlp	21892320	SENT47	24	24	37	37	thalidomide	GM-CSF	PA451644	1437	0.936
NULL	Anal_Bioanal_Chem_2011_Jan_24_399(3)_1081-1091.nxml.txt.nlp	21107826	SENT202	20	20	6	6	adalimumab	CDR1	PA10004	1038	0.936
NULL	Brain_2014_Sep_2_137(9)_2480-2492.nxml.txt.nlp	24993959	SENT9	41	41	3	3	levodopa	GCH1	PA450213	2643	0.936
NULL	Cell_Commun_Signal_2011_May_20_9_14.nxml.txt.nlp	21599982	SENT19	14	14	28	28	pp2	STAT1		6772	0.936
NULL	Clin_Med_Insights_Womens_Health_2013_Jan_22_6_1-11.nxml.txt.nlp	24665209	SENT102	12	12	9	9	tamoxifen	aromatase	PA451581	1588	0.936
NULL	Mol_Cancer_2012_Sep_28_11_74.nxml.txt.nlp	23021083	SENT213	23	23	5	5	gemcitabine	CEACAM6	PA449748	4680	0.936
NULL	Int_J_Mol_Sci_2012_Dec_5_13(12)_16624-16635.nxml.txt.nlp	23443122	SENT80	20	20	9	9	cisplatin	P-gp	PA449014	5243	0.936
NULL	Ann_Saudi_Med_2011_Jul-Aug_31(4)_417-420.nxml.txt.nlp	21293067	SENT17	9	9	14	14	lamivudine	CD4	PA450163	920	0.936
NULL	AIDS_Res_Ther_2012_Mar_12_9_7.nxml.txt.nlp	22409770	SENT159	24	24	10	10	vorinostat	CD4	PA164748224	920	0.936
NULL	Alcohol_Res_2013_35(1)_47-55.nxml.txt.nlp	24313164	SENT50	11	11	16	16	ethanol	miR-217	PA448073	406999	0.936
NULL	Oxid_Med_Cell_Longev_2011_Sep_8_2011_293769.nxml.txt.nlp	21912722	SENT248	18	18	4	4	sildenafil	PKG	PA451346	5592	0.936
NULL	Breast_Cancer_Res_2007_Jul_5_9(4)_R41.nxml.txt.nlp	17612393	SENT17	14	14	1	1	celecoxib	Bcl-2	PA448871	596	0.936
NULL	J_Exp_Clin_Cancer_Res_2009_Nov_24_28(1)_144.nxml.txt.nlp	19930704	SENT121	36	36	18	18	etoposide	P-gp	PA449552	5243	0.936
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S31-S40.nxml.txt.nlp	20680106	SENT191	12	12	2	2	cetuximab	BRAF	PA10040	673	0.936
NULL	Chem_Rev_2011_Oct_12_111(10)_5899-5921.nxml.txt.nlp	21923193	SENT585	17	17	8	8	nimesulide	CB1	PA137179528	1268	0.936
NULL	Oncogene_2013_Sep_26_32(39)_10_1038_onc_2012_491.nxml.txt.nlp	23108394	SENT250	14	14	4	4	epirubicin	FOXM1	PA449476	2305	0.936
NULL	F1000_Biol_Rep_2009_Mar_24_1_23.nxml.txt.nlp	20948663	SENT17	39	39	17	17	venlafaxine	ABCB1	PA451866	5243	0.936
NULL	Avicenna_J_Phytomed_2014_Jul-Aug_4(4)_231-238.nxml.txt.nlp	25068137	SENT107	3	3	15	15	phenol	flower	PA450913	11094	0.936
NULL	Br_J_Cancer_2012_Nov_6_107(10)_1692-1701.nxml.txt.nlp	23037716	SENT200	18	18	2	2	paclitaxel	P-gp	PA450761	5243	0.936
NULL	Onco_Targets_Ther_2014_Sep_9_7_1571-1582.nxml.txt.nlp	25228815	SENT165	30	30	19	19	sunitinib	VEGFR3	PA162372840	2324	0.936
NULL	Cell_Death_Dis_2012_Mar_15_3(3)_e285.nxml.txt.nlp	22419114	SENT52	31	31	11	11	doxorubicin	p300	PA449412	2033	0.936
NULL	Apoptosis_2008_May_9_13(5)_681-692.nxml.txt.nlp	18392938	SENT124	38	38	0	0	forskolin	C10	PA146096022	113246	0.936
NULL	Case_Rep_Pulmonol_2014_Jul_15_2014_837612.nxml.txt.nlp	25126437	SENT6	13	13	22	22	warfarin	PTPA	PA451906	5524	0.936
NULL	Surg_Res_Pract_2014_Feb_6_2014_801643.nxml.txt.nlp	25379560	SENT12	16	16	10	10	sirolimus	CD95	PA451365	355	0.936
NULL	Open_Access_J_Urol_2010_Mar_12_2_35-40.nxml.txt.nlp	24198612	SENT72	15	15	22	22	sunitinib	FLT3	PA162372840	2322	0.936
NULL	Oncotarget_2011_Mar_23_2(3)_165-177.nxml.txt.nlp	21444946	SENT174	20	20	5	5	docetaxel	KRAS	PA449383	3845	0.936
NULL	Biomed_Res_Int_2014_Jun_3_2014_598654.nxml.txt.nlp	24995313	SENT171	7	7	21	21	cimetidine	IFN	PA449001	3439	0.936
NULL	Breast_Cancer_Res_2012_Jun_19_14(3)_311.nxml.txt.nlp	22713135	SENT3	13	13	31	31	everolimus	aromatase	PA164746311	1588	0.936
NULL	Case_Rep_Hematol_2013_Nov_7_2013_615189.nxml.txt.nlp	24312736	SENT124	6	6	21	21	exemestane	aromatase	PA449563	1588	0.936
NULL	Br_J_Cancer_2014_Jan_21_110(2)_330-340.nxml.txt.nlp	24281000	SENT15	22	22	3	3	doxorubicin	CHKA	PA449412	1119	0.936
NULL	Breast_Cancer_Res_2012_Feb_14_14(1)_R30.nxml.txt.nlp	22333315	SENT38	31	31	23	23	indomethacin	COX	PA449982	1351	0.936
NULL	Ann_Clin_Transl_Neurol_2014_Jan_20_1(1)_15-26.nxml.txt.nlp	25356379	SENT15	21	21	13	13	isoflurane	gamma	PA450106	9913	0.936
NULL	Cancer_Cell_Int_2011_Aug_19_11_29.nxml.txt.nlp	21854619	SENT205	1	1	9	9	cisplatin	BRCA1	PA449014	672	0.936
NULL	Front_Genet_2012_Nov_5_3_236.nxml.txt.nlp	23133441	SENT26	7	7	24	24	indinavir	P-gp	PA449977	5243	0.936
NULL	Cancer_Cell_Int_2010_Jan_21_10_2.nxml.txt.nlp	20142997	SENT199	41	41	33	33	doxorubicin	TGM2	PA449412	7052	0.936
NULL	Nat_Commun_2012_Dec_4_3_1248.nxml.txt.nlp	23212377	SENT569	31	31	12	12	nadh	NADK	PA164755085	65220	0.935
NULL	Clin_Interv_Aging_2010_Dec_3_5_403-416.nxml.txt.nlp	21152242	SENT177	24	24	10	10	telmisartan	ACE	PA451605	1636	0.935
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jan_8_67(Pt_2)_o240.nxml.txt.nlp	21522934	SENT56	18	18	6	6	ethanol	mol	PA448073	90527	0.935
NULL	Int_J_Appl_Basic_Med_Res_2013_Jul-Dec_3(2)_75-76.nxml.txt.nlp	24083139	SENT18	24	24	3	3	ticagrelor	ADP	PA165374673	23038	0.935
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT111	6	6	36	36	atorvastatin	PIK3CA	PA448500	5290	0.935
NULL	Int_J_Gen_Med_2009_Jul_30_2_91-108.nxml.txt.nlp	20360893	SENT197	4	4	19	19	carmustine	PDF	PA448810	64146;9518	0.935
NULL	Case_Rep_Med_2012_Dec_3_2012_163173.nxml.txt.nlp	23326270	SENT14	8	8	24	24	bezafibrate	CPT2	PA162364313	1376	0.935
NULL	Oncogenesis_2012_Apr_16_1(4)_e7.nxml.txt.nlp	23552604	SENT48	14	14	23	23	nutlin-3	CEACAM1		634	0.935
NULL	Case_Rep_Oncol_2009_Feb_16_2(1)_12-19.nxml.txt.nlp	20740139	SENT26	7	7	3	3	erlotinib	CEA	PA134687924	5670;1087	0.935
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT235	13	13	6	6	capsaicin	p53	PA448776	7157	0.935
NULL	Chin_J_Cancer_2011_Mar_30(3)_163-172.nxml.txt.nlp	21352693	SENT202	13	13	1	1	perifosine	BSG	PA165291471	682	0.935
NULL	Acta_Neuropathol_Commun_2013_Aug_9_1_49.nxml.txt.nlp	24252504	SENT111	13	13	3	3	arsenite	TDP-43	PA452638	23435	0.935
NULL	Environ_Health_Perspect_2009_Feb_8_117(2)_175-180.nxml.txt.nlp	19270784	SENT44	23	23	4	4	estradiol	BPA	PA449503	667	0.935
NULL	Oncotarget_2011_May_16_2(5)_418-421.nxml.txt.nlp	21789791	SENT20	21	21	34	34	bortezomib	TRAIL	PA10252	8743	0.935
NULL	Front_Neurosci_2014_Feb_6_8_12.nxml.txt.nlp	24567701	SENT360	28	28	19	19	citalopram	IDO1	PA449015	3620	0.935
NULL	Fibrogenesis_Tissue_Repair_2012_Jul_23_5_11.nxml.txt.nlp	22824096	SENT101	43	43	5	5	bleomycin	CD28	PA448645	1493;940	0.935
NULL	Oncogene_2010_Jun_10_29(23)_3335-3348.nxml.txt.nlp	20383197	SENT54	8	8	2	2	curcumin	JNK	PA151958596	5599	0.935
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT52	0	0	7	7	erlotinib	San	PA134687924	80218	0.935
NULL	Evid_Based_Complement_Alternat_Med_2011_May_24_2011_841564.nxml.txt.nlp	21716682	SENT116	21	21	4	4	epirubicin	JNK	PA449476	5599	0.935
NULL	Oncotarget_2014_Nov_3_5(20)_10127-10139.nxml.txt.nlp	25333256	SENT173	14	14	11	11	vemurafenib	BRAF	PA165946873	673	0.935
NULL	Arthritis_Res_Ther_2013_Oct_2_15(5)_R141.nxml.txt.nlp	24286116	SENT15	36	36	22	22	infliximab	IL-6	PA452639	3569	0.935
NULL	Br_J_Cancer_2013_Jul_23_109(2)_351-359.nxml.txt.nlp	23799854	SENT42	14	14	23	23	paclitaxel	San	PA450761	80218	0.935
NULL	Mol_Cancer_2008_Mar_26_7_27.nxml.txt.nlp	18366759	SENT79	7	7	14	14	etoposide	BCL2A1	PA449552	597	0.935
NULL	Cell_Commun_Signal_2010_Sep_22_8_27.nxml.txt.nlp	20860841	SENT159	13	13	0	0	hydroxyurea	PP5	PA449942	7980;5536	0.935
NULL	Oncol_Lett_2014_Mar_19_7(3)_674-678.nxml.txt.nlp	24527071	SENT13	10	10	2	2	cisplatin	AKR1C2	PA449014	1646	0.935
NULL	J_Cancer_2013_Jan_11_4(2)_117-132.nxml.txt.nlp	23386910	SENT86	9	9	32	32	trastuzumab	HER-2	PA451743	2064	0.935
NULL	Clinics_(Sao_Paulo)_2014_Apr_69(4)_225-233.nxml.txt.nlp	24714829	SENT128	12	12	31	31	mannitol	adiponectin	PA450320	9370	0.935
NULL	ScientificWorldJournal_2014_Mar_11_2014_946265.nxml.txt.nlp	24741367	SENT97	11	11	7	7	exenatide	GLP-1	PA164749238	100125288	0.935
NULL	Front_Neurosci_2014_Nov_10_8_364.nxml.txt.nlp	25426018	SENT236	23	23	20	20	fluorescein	Casper	PA164746009	8837	0.935
NULL	ASN_Neuro_2009_Nov_9_1(4)_e00019.nxml.txt.nlp	19839939	SENT219	0	0	11	11	resveratrol	SIRT1		23411	0.935
NULL	Int_J_Mol_Imaging_2012_Oct_17_2012_189254.nxml.txt.nlp	23119157	SENT8	32	32	9	9	ezetimibe	NIRF	PA10816	27190;115426	0.935
NULL	Cancers_(Basel)_2014_Nov_25_6(4)_2313-2329.nxml.txt.nlp	25534569	SENT94	15	15	38	38	crizotinib	HGF	PA165946122	3569;6654;3082	0.935
NULL	Cancer_Cell_Int_2013_Mar_4_13_21.nxml.txt.nlp	23497288	SENT13	17	17	9	9	doxorubicin	EWS	PA449412	2130	0.935
NULL	Cancers_(Basel)_2010_Dec_22_2(4)_2153-2170.nxml.txt.nlp	21390244	SENT247	9	9	4	4	gefitinib	AREG	PA131301952	374	0.935
NULL	Acta_Pharmacol_Sin_2009_Sep_24_30(9)_1323-1329.nxml.txt.nlp	19701237	SENT107	17	17	6	6	clarithromycin	CYP3A	PA449028	1574	0.935
NULL	Indian_J_Med_Res_2011_Dec_134(6)_787-800.nxml.txt.nlp	22310814	SENT33	7	7	33	33	nevirapine	CD4	PA450616	920	0.935
NULL	ScientificWorldJournal_2014_Jul_23_2014_854093.nxml.txt.nlp	25147870	SENT165	44	44	8	8	chlorophyll	gamma	PA448942	9913	0.935
NULL	J_Invest_Dermatol_2013_Jul_13_133(7)_1742-1751.nxml.txt.nlp	23407402	SENT254	14	14	3	3	etanercept	TREM-1	PA449515	54210	0.935
NULL	Front_Mol_Neurosci_2012_May_7_5_60.nxml.txt.nlp	22586367	SENT99	0	0	7	7	ivermectin	5-HT3R	PA450133	3359	0.935
NULL	J_Hematol_Oncol_2011_Dec_21_4_53.nxml.txt.nlp	22189016	SENT69	13	13	5	5	dabigatran	P-gp		5243	0.935
NULL	Eur_J_Haematol_2008_Feb_80(2)_93-106.nxml.txt.nlp	18081719	SENT157	19	19	4	4	iron	MRI	PA450087	78996	0.935
NULL	Br_J_Cancer_1994_Sep_70(3)_409-414.nxml.txt.nlp	8080723	SENT8	23	23	11	11	doxorubicin	CH1	PA449412	51430	0.935
NULL	J_Biol_Chem_2009_Sep_18_284(38)_26096-26105.nxml.txt.nlp	19628870	SENT117	1	1	10	10	pp2	PP2		4888	0.935
NULL	Oncotarget_2014_Nov_11_5(22)_10963-10964.nxml.txt.nlp	25460503	SENT13	34	34	19	19	trastuzumab	ADAM10	PA451743	102	0.935
NULL	Evid_Based_Complement_Alternat_Med_2013_Aug_14_2013_147670.nxml.txt.nlp	24023569	SENT141	28	28	30	30	indomethacin	COX	PA449982	1351	0.935
NULL	Oncologist_2010_Feb_15_15(2)_122-129.nxml.txt.nlp	20156908	SENT35	14	14	12	12	letrozole	aromatase	PA450196	1588	0.935
NULL	J_Hematol_Oncol_2009_Jan_21_2_2.nxml.txt.nlp	19159467	SENT138	15	15	5	5	erlotinib	EGFR	PA134687924	1956	0.935
NULL	Breast_Cancer_Res_2011_Nov_16_13(Suppl_2)_P7.nxml.txt.nlp	NULL	SENT14	19	19	30	30	tamoxifen	aromatase	PA451581	1588	0.935
NULL	Ecancermedicalscience_2009_Oct_29_3_157.nxml.txt.nlp	22276018	SENT71	17	17	25	25	tamoxifen	EGFR	PA451581	1956	0.935
NULL	Oxid_Med_Cell_Longev_2013_Jun_2_2013_793525.nxml.txt.nlp	23819014	SENT204	8	8	33	33	resveratrol	PI3K		5290	0.935
NULL	Breast_Cancer_Res_2012_Feb_14_14(1)_R30.nxml.txt.nlp	22333315	SENT21	15	15	7	7	celecoxib	COX	PA448871	1351	0.935
NULL	Oncotarget_2014_Aug_29_5(19)_8947-8958.nxml.txt.nlp	25333254	SENT20	13	13	17	17	plerixafor	CXCR4	PA165958410	7852	0.935
NULL	J_Cell_Mol_Med_2014_Nov_12_18(11)_2252-2265.nxml.txt.nlp	25216078	SENT256	15	15	36	36	geldanamycin	AKT	PA152031327	207	0.935
NULL	Cancers_(Basel)_2010_Jun_14_2(2)_1288-1311.nxml.txt.nlp	24281116	SENT229	1	1	34	34	oxygen	p53	PA450744	7157	0.935
NULL	J_Cancer_2011_May_19_2_292-301.nxml.txt.nlp	21611110	SENT178	3	3	25	25	vincristine	spatial	PA451879	219793	0.935
NULL	Cancer_Res_Treat_2012_Jun_30_44(2)_85-96.nxml.txt.nlp	22802746	SENT239	6	6	14	14	imatinib	KIT	PA10804	3815	0.935
NULL	Oncotarget_2013_Jul_7_4(7)_1065-1074.nxml.txt.nlp	23867252	SENT129	21	21	28	28	geldanamycin	Hsp90	PA152031327	3320	0.935
NULL	EPMA_J_2013_Jan_28_4(1)_3.nxml.txt.nlp	23356214	SENT156	4	4	10	10	sorafenib	BRAF	PA7000	673	0.935
NULL	Clin_Exp_Metastasis_2013_Apr_27_30(4)_447-455.nxml.txt.nlp	23187934	SENT9	19	19	5	5	oxaliplatin	HAI	PA131285527	6692;6768	0.935
NULL	Mol_Vis_2010_Sep_2_16_1781-1790.nxml.txt.nlp	20824160	SENT240	26	26	15	15	rolipram	p38	PA153906323	10598;1432;7965	0.935
NULL	Ther_Clin_Risk_Manag_2007_Aug_3(4)_591-604.nxml.txt.nlp	18472981	SENT59	4	4	33	33	cyclosporine	castor	PA449167	54897	0.935
NULL	Endocrinol_Metab_(Seoul)_2013_Dec_12_28(4)_262-274.nxml.txt.nlp	24396690	SENT98	13	13	3	3	liraglutide	GLP-1	PA165958364	100125288	0.935
NULL	Front_Physiol_2011_Jun_30_2_33.nxml.txt.nlp	21747769	SENT252	2	2	15	15	berberine	KCNQ1	PA165860812	3784	0.935
NULL	Front_Behav_Neurosci_2013_Dec_19_7_196.nxml.txt.nlp	24391561	SENT251	22	22	32	32	estradiol	NCM	PA449503	57703	0.935
NULL	Adv_Pharmacol_Sci_2013_Jun_24_2013_987692.nxml.txt.nlp	23864853	SENT142	20	20	13	13	acetaminophen	AST	PA448015	26503	0.935
NULL	Eur_J_Appl_Physiol_2011_Feb_24_111(2)_275-283.nxml.txt.nlp	20865425	SENT106	20	20	3	3	glucose	APE	PA449773	55704;328	0.935
NULL	Acta_Pharmacol_Sin_2010_Nov_18_31(11)_1447-1453.nxml.txt.nlp	20953204	SENT136	20	20	4	4	rimonabant	adiponectin	PA152407999	9370	0.935
NULL	Oncogene_2009_Dec_3_28(48)_4237-4248.nxml.txt.nlp	19734937	SENT86	6	6	9	9	thrombin	PAR-1	PA451674	2011;2149	0.935
NULL	Clin_Ophthalmol_2013_Dec_21_7_7-14.nxml.txt.nlp	23293509	SENT97	44	44	21	21	latanoprost	BAK	PA164774763	578	0.935
NULL	Chin_J_Cancer_2011_May_30(5)_327-335.nxml.txt.nlp	21527065	SENT180	33	33	8	8	trastuzumab	PI3K	PA451743	5290	0.935
NULL	J_Lipid_Res_2014_Jan_55(1)_94-103.nxml.txt.nlp	24179149	SENT318	15	15	7	7	lovastatin	ABCA1	PA450272	19	0.935
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_315-322.nxml.txt.nlp	20049735	SENT57	6	6	1	1	cisplatin	PTEN	PA449014	5728	0.935
NULL	Oncoscience_2014_Mar_31_1(3)_216-228.nxml.txt.nlp	25594014	SENT104	15	15	7	7	cisplatin	STAT3	PA449014	6774	0.935
NULL	Br_J_Cancer_2011_Aug_23_105(5)_649-657.nxml.txt.nlp	21811251	SENT164	11	11	21	21	gefitinib	IGF1R	PA131301952	3480	0.935
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_75-89.nxml.txt.nlp	17912638	SENT121	14	14	2	2	anastrozole	ATAC	PA448432	6375	0.935
NULL	Front_Endocrinol_(Lausanne)_2014_Jan_16_5_1.nxml.txt.nlp	24474947	SENT44	27	27	6	6	estradiol	aromatase	PA449503	1588	0.935
NULL	Pharmaceuticals_(Basel)_2013_Aug_21_6(8)_988-1038.nxml.txt.nlp	24276379	SENT257	26	26	3	3	sn-38	UGT1A1		54658	0.935
NULL	Clin_Ophthalmol_2010_Sep_7_4_993-1001.nxml.txt.nlp	20856595	SENT82	11	11	22	22	azelastine	CYP3A4	PA448517	1576	0.935
NULL	Br_J_Cancer_2013_Jul_23_109(2)_502-511.nxml.txt.nlp	23799850	SENT152	16	16	4	4	gemcitabine	SMARCC1	PA449748	6599	0.935
NULL	Case_Rep_Hematol_2014_Apr_14_2014_359158.nxml.txt.nlp	24822133	SENT49	11	11	5	5	vincristine	POMP	PA451879	51371;51251	0.935
NULL	Bone_Marrow_Res_2012_May_28_2012_917361.nxml.txt.nlp	22693672	SENT54	0	0	4	4	plerixafor	CXCR4	PA165958410	7852	0.935
NULL	Oncotarget_2014_Aug_27_5(17)_7328-7341.nxml.txt.nlp	25193862	SENT276	5	5	11	11	dasatinib	ANOVA	PA162372878	4858	0.935
NULL	Comput_Struct_Biotechnol_J_2012_Oct_27_2_e201209012.nxml.txt.nlp	24688653	SENT117	4	4	19	19	lipase	CAST	PA450239	10849;26059;831	0.935
NULL	Adipocyte_2013_Jan_1_2(1)_17-27.nxml.txt.nlp	23599907	SENT108	27	27	10	10	glucose	IRAP	PA449773	3557	0.935
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S31-S40.nxml.txt.nlp	20680106	SENT28	7	7	3	3	cetuximab	EGFR	PA10040	1956	0.935
NULL	Mol_Cells_2014_Mar_31_37(3)_234-240.nxml.txt.nlp	24642709	SENT104	39	39	10	10	capsaicin	HMGB1	PA448776	3146	0.935
NULL	Neural_Plast_2007_Dec_11_2007_73079.nxml.txt.nlp	NULL	SENT3377	14	14	5	5	reboxetine	U87	PA144614921	677775;641648	0.935
NULL	Biotechnol_Res_Int_2013_Dec_1_2013_253286.nxml.txt.nlp	24363937	SENT136	3	3	36	36	sugar	DAP	PA451529	23549;3375;1611	0.935
NULL	Arthritis_Res_Ther_2008_Mar_17_10(2)_R33.nxml.txt.nlp	18346273	SENT125	13	13	2	2	infliximab	HMGB1	PA452639	3146	0.935
NULL	Mol_Cancer_2009_Jun_8_8_34.nxml.txt.nlp	19500427	SENT201	32	32	16	16	gemcitabine	p53	PA449748	7157	0.935
NULL	Asian_J_Transfus_Sci_2011_Jan_5(1)_32-34.nxml.txt.nlp	21572712	SENT28	3	3	20	20	lamivudine	DAN	PA450163	5073;4681	0.935
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT171	18	18	28	28	nutlin-3	p53		7157	0.935
NULL	Arthritis_Res_2002_Feb_4_4(Suppl_1)_40.nxml.txt.nlp	NULL	SENT4	11	11	2	2	thrombin	PAR3	PA451674	56288;2151	0.935
NULL	J_Biol_Chem_2013_Aug_23_288(34)_24848-24856.nxml.txt.nlp	23843457	SENT220	35	35	4	4	baclofen	KCTD12	PA448533	115207	0.935
NULL	Environ_Health_Perspect_2010_Sep_28_118(9)_1267-1272.nxml.txt.nlp	20427257	SENT93	25	25	0	0	estradiol	BPA	PA449503	667	0.935
NULL	J_Cell_Biol_2002_Mar_4_156(5)_791-795.nxml.txt.nlp	11877457	SENT98	13	13	4	4	staurosporine	AP2	PA165109623	2971	0.935
NULL	Alcohol_Res_2012_34(4)_468-483.nxml.txt.nlp	23584113	SENT283	23	23	10	10	naltrexone	ACTH	PA450588	5443	0.935
NULL	Cancer_Inform_2008_Apr_23_6_381-387.nxml.txt.nlp	19259418	SENT56	39	39	24	24	ribavirin	IFN	PA451241	3439	0.935
NULL	Exp_Brain_Res_2014_Jun_27_232(8)_2637-2644.nxml.txt.nlp	24969614	SENT135	20	20	11	11	palonosetron	NK1	PA10352	11126	0.935
NULL	Biologics_2010_May_25_4_139-145.nxml.txt.nlp	20531970	SENT123	10	10	4	4	eltrombopag	TPO	PA165981594	7066;7173	0.935
NULL	Drug_Target_Insights_2013_Aug_19_7_27-34.nxml.txt.nlp	24023511	SENT83	29	29	9	9	roxithromycin	P-gp	PA164750505	5243	0.935
NULL	Aging_(Albany_NY)_2012_Feb_21_4(2)_133-143.nxml.txt.nlp	22361433	SENT163	12	12	6	6	glucose	MEF2C	PA449773	4208	0.935
NULL	Cardiovasc_Res_2012_Dec_1_96(3)_552-560.nxml.txt.nlp	22918977	SENT72	13	13	10	10	losartan	AT1	PA450268	9197;185	0.935
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT108	28	28	15	15	phenformin	p53	PA1000	7157	0.935
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT420	20	20	0	0	resveratrol	SRC1		8648	0.935
NULL	Support_Care_Cancer_2014_Oct_19_22(2)_469-477.nxml.txt.nlp	24141698	SENT160	30	30	11	11	palonosetron	HEC	PA10352	10403	0.935
NULL	Arthritis_Res_Ther_2013_Sep_16_15(5)_R120.nxml.txt.nlp	24286160	SENT152	22	22	10	10	propylthiouracil	RHO	PA451156	6010	0.935
NULL	Cell_Commun_Signal_2011_May_15_9_13.nxml.txt.nlp	21569639	SENT232	24	24	7	7	quinacrine	P-gp	PA164745551	5243	0.935
NULL	Nat_Commun_2014_Dec_8_5_5736.nxml.txt.nlp	25484020	SENT724	8	8	0	0	letrozole	TRPA1	PA450196	8989	0.935
NULL	F1000_Biol_Rep_2010_Feb_11_2_10.nxml.txt.nlp	20948822	SENT54	28	28	8	8	gemcitabine	San	PA449748	80218	0.935
NULL	Int_J_Gen_Med_2012_Jun_18_5_535-540.nxml.txt.nlp	22807641	SENT62	16	16	6	6	pitavastatin	adiponectin	PA142650384	9370	0.935
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT60	19	19	6	6	ranibizumab	VEGF-A	PA164746012	7422	0.935
NULL	Cell_Death_Dis_2014_Jul_31_5(7)_e1359.nxml.txt.nlp	25077545	SENT24	28	28	11	11	erlotinib	EGFR	PA134687924	1956	0.935
NULL	Front_Endocrinol_(Lausanne)_2014_Jan_16_5_1.nxml.txt.nlp	24474947	SENT54	5	5	14	14	estradiol	ESR1	PA449503	2099	0.935
NULL	J_Carcinog_2014_Nov_27_13_13.nxml.txt.nlp	25525412	SENT106	40	40	12	12	cetuximab	KRAS	PA10040	3845	0.935
NULL	Front_Physiol_2010_Jul_15_1_14.nxml.txt.nlp	21423357	SENT68	21	21	3	3	ritonavir	CYP2D6	PA451260	1565	0.935
NULL	Front_Endocrinol_(Lausanne)_2014_Aug_18_5_129.nxml.txt.nlp	25183960	SENT258	19	19	12	12	octreotide	ghrelin	PA450678	51738	0.935
NULL	Curr_Chem_Genomics_2010_Mar_19_4_9-18.nxml.txt.nlp	20502647	SENT49	34	34	1	1	tetracycline	MYOD	PA451640	4654	0.935
NULL	Arthritis_Res_Ther_2012_Oct_4_14(5)_R206.nxml.txt.nlp	23036475	SENT32	14	14	32	32	anakinra	MMP13	PA10799	4322	0.935
NULL	J_Thorac_Oncol_2014_Jun_30_9(6)_805-811.nxml.txt.nlp	24787964	SENT146	24	24	35	35	gemcitabine	EGFR	PA449748	1956	0.935
NULL	Oxid_Med_Cell_Longev_2013_Jul_9_2013_574029.nxml.txt.nlp	23936610	SENT164	4	4	43	43	resveratrol	IL-10		3586	0.935
NULL	Sensors_(Basel)_2010_Sep_28_10(10)_8850-8864.nxml.txt.nlp	22163384	SENT101	25	25	8	8	diclofenac	DOS	PA449293	255057	0.935
NULL	Mol_Neurodegener_2010_Nov_10_5_50.nxml.txt.nlp	21067605	SENT69	33	33	25	25	calcein	LIP	PA132595336	23049	0.935
NULL	Br_J_Cancer_2012_Jun_5_106(12)_1997-2003.nxml.txt.nlp	22596232	SENT142	19	19	2	2	sorafenib	JNK	PA7000	5599	0.935
NULL	Acta_Pharmacol_Sin_2010_Oct_30_31(10)_1359-1366.nxml.txt.nlp	20802507	SENT189	17	17	25	25	forskolin	ADM	PA146096022	133	0.935
NULL	J_Biol_Chem_2013_Feb_8_288(6)_3918-3928.nxml.txt.nlp	23239877	SENT107	22	22	32	32	thrombin	PAR4	PA451674	9002;5074	0.935
NULL	Acta_Pharmacol_Sin_2014_Aug_21_35(8)_1082-1092.nxml.txt.nlp	25047514	SENT122	18	18	24	24	letrozole	aromatase	PA450196	1588	0.935
NULL	Breast_Cancer_Res_2002_Jul_29_4(5)_202-204.nxml.txt.nlp	12223125	SENT82	14	14	22	22	resveratrol	CYP1B1		1545	0.935
NULL	Eur_J_Clin_Pharmacol_2014_Oct_8_70(1)_37-45.nxml.txt.nlp	24100471	SENT203	0	0	23	23	rosuvastatin	OATP1B1	PA134308647	10599	0.935
NULL	J_Thorac_Oncol_2014_Jun_30_9(6)_805-811.nxml.txt.nlp	24787964	SENT146	17	17	35	35	erlotinib	EGFR	PA134687924	1956	0.935
NULL	J_Obes_2011_Sep_19_2011_984245.nxml.txt.nlp	20885921	SENT170	2	2	15	15	saxagliptin	GLP-1	PA165958362	100125288	0.935
NULL	Trials_2013_May_4_14_125.nxml.txt.nlp	23782591	SENT183	4	4	32	32	donepezil	CYP2D6	PA449394	1565	0.935
NULL	Diabetes_Care_2010_Jul_22_33(7)_1516-1522.nxml.txt.nlp	20413513	SENT7	16	16	7	7	metformin	HSD1	PA450395	26871	0.935
NULL	Br_J_Cancer_2011_Aug_23_105(5)_649-657.nxml.txt.nlp	21811251	SENT147	8	8	26	26	gefitinib	EGFR	PA131301952	1956	0.935
NULL	Front_Oncol_2014_Sep_23_4_263.nxml.txt.nlp	25295230	SENT418	13	13	6	6	sorafenib	FLT3	PA7000	2322	0.935
NULL	Clin_Ophthalmol_2008_Dec_2(4)_727-733.nxml.txt.nlp	19668423	SENT21	0	0	13	13	ranibizumab	VEGF-A	PA164746012	7422	0.935
NULL	Brain_Sci_2013_Jun_19_3(2)_964-991.nxml.txt.nlp	24961433	SENT89	12	12	3	3	ethanol	ngn1	PA448073	4762	0.935
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_3_2012_856029.nxml.txt.nlp	23091559	SENT237	2	2	11	11	cetrorelix	EGF	PA164764506	1950	0.935
NULL	Curr_Neuropharmacol_2013_Dec_11(6)_652-663.nxml.txt.nlp	24396340	SENT81	0	0	14	14	paclitaxel	PAR2	PA450761	2150;55065;8856	0.935
NULL	Asian-Australas_J_Anim_Sci_2014_Dec_27(12)_1783-1793.nxml.txt.nlp	25358373	SENT191	0	0	30	30	capsaicin	BAX	PA448776	581	0.935
NULL	Cancer_Immunol_Immunother_2012_Jan_17_61(1)_79-88.nxml.txt.nlp	21847632	SENT232	10	10	24	24	berberine	AP-1	PA165860812	2353;3727;2354;3725	0.935
NULL	Cough_2007_Dec_23_3_10.nxml.txt.nlp	18154688	SENT87	8	8	0	0	capsaicin	TRPV1	PA448776	7442	0.935
NULL	Arthritis_Res_Ther_2007_Sep_23_9(5)_R96.nxml.txt.nlp	17888176	SENT129	25	25	11	11	etanercept	OPG	PA449515	690	0.935
NULL	Glia_2013_Aug_6_61(8)_1331-1346.nxml.txt.nlp	23832647	SENT76	25	25	43	43	plerixafor	CXCR4	PA165958410	7852	0.935
NULL	Oncotarget_2010_May_1_1(1)_6-8.nxml.txt.nlp	21293050	SENT26	46	46	40	40	imatinib	KIT	PA10804	3815	0.935
NULL	Tuberc_Respir_Dis_(Seoul)_2013_Nov_29_75(5)_181-187.nxml.txt.nlp	24348665	SENT21	12	12	28	28	erlotinib	EGFR	PA134687924	1956	0.935
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT755	20	20	9	9	resveratrol	SIRT1		23411	0.935
NULL	Blood_Cancer_J_2012_Mar_9_2(3)_e60.nxml.txt.nlp	22829255	SENT117	8	8	12	12	flavopiridol	FLT3	PA452627	2322	0.935
NULL	Front_Oncol_2014_Jun_18_4_153.nxml.txt.nlp	24995158	SENT728	20	20	13	13	paclitaxel	Bcl-2	PA450761	596	0.935
NULL	Carcinogenesis_2010_Dec_27_31(12)_2049-2057.nxml.txt.nlp	20876285	SENT31	24	24	12	12	trastuzumab	HER2	PA451743	2064	0.935
NULL	BMB_Rep_2013_Aug_46(8)_410-415.nxml.txt.nlp	23977989	SENT64	11	11	4	4	curcumin	HO-1	PA151958596	3162	0.935
NULL	J_Adv_Pharm_Technol_Res_2013_Jan-Mar_4(1)_31-41.nxml.txt.nlp	23662280	SENT38	5	5	24	24	naproxen	COX	PA450595	1351	0.935
NULL	Neural_Develop_2007_Jun_8_2_11.nxml.txt.nlp	17559664	SENT329	12	12	19	19	tamoxifen	E16	PA451581	8140	0.935
NULL	Evid_Based_Complement_Alternat_Med_2013_Aug_22_2013_423164.nxml.txt.nlp	24027594	SENT204	5	5	31	31	berberine	AP-1	PA165860812	2353;3727;2354;3725	0.935
NULL	Gastric_Cancer_2013_Jul_12_16(3)_345-354.nxml.txt.nlp	22968820	SENT164	14	14	5	5	oxaliplatin	FANCJ	PA131285527	83990	0.935
NULL	Hum_Genomics_Proteomics_2010_Apr_13_2010_164906.nxml.txt.nlp	20981232	SENT250	11	11	6	6	thrombin	RAC1	PA451674	5879	0.935
NULL	Mol_Med_Rep_2015_Jan_22_11(1)_83-90.nxml.txt.nlp	25338529	SENT160	10	10	21	21	octreotide	HO-1	PA450678	3162	0.935
NULL	Oncol_Lett_2013_Sep_12_6(3)_860-864.nxml.txt.nlp	24137426	SENT29	13	13	32	32	omeprazole	CYP3A4	PA450704	1576	0.935
NULL	J_Inherit_Metab_Dis_2012_Jul_6_35(4)_571-587.nxml.txt.nlp	22391998	SENT343	14	14	0	0	choline	MADD	PA448976	8567;2108	0.935
NULL	Br_J_Cancer_2012_May_8_106(10)_1587-1590.nxml.txt.nlp	22568998	SENT77	37	37	30	30	sunitinib	IFN	PA162372840	3439	0.935
NULL	J_Hematol_Oncol_2013_Jun_3_6_38.nxml.txt.nlp	23731980	SENT187	16	16	23	23	neratinib	HER2	PA165291472	2064	0.935
NULL	Br_J_Cancer_2011_Oct_25_105(9)_1322-1330.nxml.txt.nlp	21952624	SENT89	6	6	21	21	paraformaldehyde	mol	PA450790	90527	0.935
NULL	Oxid_Med_Cell_Longev_2011_May_23_2011_213286.nxml.txt.nlp	NULL	SENT120	9	9	15	15	ethanol	ALDH2	PA448073	217	0.935
NULL	Cancer_Immunol_Immunother_2015_Oct_7_64_61-73.nxml.txt.nlp	25287778	SENT178	15	15	3	3	lenalidomide	IFN	PA162363968	3439	0.935
NULL	Arthritis_Res_Ther_2012_Oct_4_14(5)_R206.nxml.txt.nlp	23036475	SENT32	14	14	28	28	anakinra	MMP1	PA10799	4312	0.935
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_55-78.nxml.txt.nlp	19305788	SENT158	6	6	24	24	memantine	CA1	PA10364	759	0.935
NULL	Cell_Death_Differ_2009_Aug_20_16(8)_1135-1145.nxml.txt.nlp	19300452	SENT274	9	9	12	12	doxycycline	PUMA	PA449415	27113	0.935
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Sep_30_66(Pt_10)_o2667.nxml.txt.nlp	21587638	SENT66	11	11	3	3	ethanol	mol	PA448073	90527	0.935
NULL	Braz_J_Med_Biol_Res_2014_Sep_5_47(11)_1008-1015.nxml.txt.nlp	25296365	SENT122	32	32	44	44	fluoxetine	CYP2D6	PA449673	1565	0.935
NULL	Nat_Med_2012_Apr_15_18(5)_774-782.nxml.txt.nlp	22504483	SENT298	15	15	9	9	forskolin	ADORA2B	PA146096022	136	0.935
NULL	Am_J_Trop_Med_Hyg_2011_Jan_5_84(1)_5-14.nxml.txt.nlp	21212194	SENT46	13	13	24	24	mebendazole	STH	PA164776669	246744	0.935
NULL	Br_J_Pharmacol_2008_Dec_25_155(7)_1056-1065.nxml.txt.nlp	18724386	SENT258	0	0	8	8	nitrendipine	GLP-1	PA146096020	100125288	0.935
NULL	J_Biol_Chem_2013_Oct_11_288(41)_29836-29845.nxml.txt.nlp	23965989	SENT75	5	5	16	16	doxycycline	GCH1	PA449415	2643	0.935
NULL	Diabetes_Care_2013_Jun_15_36(6)_1779-1788.nxml.txt.nlp	23704680	SENT76	20	20	28	28	metformin	GLP-1	PA450395	100125288	0.935
NULL	Cell_Death_Dis_2010_Feb_4_1(2)_e23.nxml.txt.nlp	21364631	SENT272	35	35	13	13	desipramine	c-Jun	PA449233	3725	0.935
NULL	Biomed_Res_Int_2013_Mar_28_2013_154073.nxml.txt.nlp	23607088	SENT18	18	18	7	7	clopidogrel	CYP2C19	PA449053	1557	0.935
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Sep_14_67(Pt_10)_o2642.nxml.txt.nlp	22058772	SENT70	5	5	32	32	phenol	mol	PA450913	90527	0.935
NULL	Chemother_Res_Pract_2011_Sep_25_2011_730360.nxml.txt.nlp	22295205	SENT184	12	12	17	17	trastuzumab	HER2	PA451743	2064	0.935
NULL	J_Korean_Med_Sci_2006_Feb_20_21(1)_52-57.nxml.txt.nlp	16479065	SENT8	21	21	6	6	leucovorin	LARC	PA450198	6364	0.935
NULL	J_Mol_Med_2008_Jul_2_86(7)_747-759.nxml.txt.nlp	18246321	SENT467	6	6	4	4	curcumin	NF-kappaB	PA151958596	4790	0.935
NULL	Mol_Cancer_2009_Dec_23_8_129.nxml.txt.nlp	20030852	SENT7	15	15	3	3	curcumin	CXCL1	PA151958596	2919	0.935
NULL	ScientificWorldJournal_2012_Apr_1_2012_987508.nxml.txt.nlp	22566785	SENT22	19	19	15	15	montelukast	CysLT1	PA450546	10800	0.935
NULL	Chin_J_Cancer_2012_Feb_31(2)_73-99.nxml.txt.nlp	22098950	SENT25	24	24	8	8	verapamil	P-gp	PA451868	5243	0.935
NULL	Breast_Cancer_Res_2011_Mar_14_13(2)_205.nxml.txt.nlp	21457526	SENT27	41	41	15	15	tamoxifen	ATAC	PA451581	6375	0.935
NULL	Cancer_Cell_Int_2013_Feb_12_13_14.nxml.txt.nlp	23402310	SENT34	13	13	7	7	celecoxib	p65	PA448871	5970	0.935
NULL	J_Cell_Biol_2004_Feb_16_164(4)_527-534.nxml.txt.nlp	14769862	SENT196	3	3	15	15	forskolin	CO2	PA146096022	4513	0.935
NULL	Ther_Clin_Risk_Manag_2006_Mar_2(1)_77-86.nxml.txt.nlp	18360583	SENT111	20	20	7	7	alendronate	PTH	PA448082	5741	0.935
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT240	24	24	4	4	cisplatin	UNG	PA449014	7374	0.935
NULL	Basic_Res_Cardiol_2012_Jul_24_107(4)_273.nxml.txt.nlp	22622703	SENT147	17	17	22	22	resveratrol	SIRT1		23411	0.935
NULL	J_Int_Soc_Sports_Nutr_2013_Feb_12_10_7.nxml.txt.nlp	23402436	SENT11	2	2	22	22	creatine	DOM	PA164778930	6663	0.935
NULL	Mol_Cancer_2013_Mar_5_12_17.nxml.txt.nlp	23497256	SENT279	41	41	18	18	tetracycline	p53	PA451640	7157	0.935
NULL	Evid_Based_Complement_Alternat_Med_2015_Jan_6_2015_802903.nxml.txt.nlp	25632291	SENT111	4	4	9	9	berberine	CYP2D6	PA165860812	1565	0.935
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1059-1066.nxml.txt.nlp	21364577	SENT0	18	18	16	16	anastrozole	aromatase	PA448432	1588	0.935
NULL	Clin_Ophthalmol_2014_Jun_24_8_1187-1198.nxml.txt.nlp	25028531	SENT19	15	15	3	3	ranibizumab	VEGF-A	PA164746012	7422	0.935
NULL	Tuberc_Respir_Dis_(Seoul)_2014_Feb_27_76(2)_66-74.nxml.txt.nlp	24624215	SENT144	28	28	15	15	vancomycin	HCAP	PA451850	117159;9126	0.935
NULL	J_Cell_Mol_Med_2015_Jan_30_19(1)_210-226.nxml.txt.nlp	25266063	SENT9	14	14	32	32	forskolin	MYCN	PA146096022	4613	0.935
NULL	Mol_Cancer_2012_Sep_11_11_66.nxml.txt.nlp	22966907	SENT574	9	9	44	44	hyaluronan	CD44	PA165958431	960	0.935
NULL	Pain_Res_Treat_2012_Apr_23_2012_295926.nxml.txt.nlp	22577544	SENT60	15	15	45	45	dexketoprofen	ARC	PA166049175	8996;23237	0.935
NULL	J_Thromb_Thrombolysis_2012_Feb_20_33(2)_143-153.nxml.txt.nlp	22183178	SENT20	8	8	2	2	ticagrelor	P2Y12	PA165374673	64805	0.935
NULL	Mol_Cancer_2013_Mar_5_12_17.nxml.txt.nlp	23497256	SENT160	11	11	2	2	sunitinib	p53	PA162372840	7157	0.935
NULL	J_Physiol_2011_Sep_1_589(Pt_17)_4243-4257.nxml.txt.nlp	21708905	SENT93	17	17	4	4	picrotoxin	5-HT3A	PA164777007	3359	0.935
NULL	Mol_Vis_2007_Jun_8_13_823-832.nxml.txt.nlp	17615543	SENT260	20	20	3	3	etoposide	CD133	PA449552	8842	0.935
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT1911	14	14	0	0	phenacetin	CYP3A	PA450897	1574	0.935
NULL	ACS_Chem_Biol_2010_Sep_17_5(9)_863-873.nxml.txt.nlp	20849068	SENT309	3	3	10	10	resveratrol	SIRT1		23411	0.935
NULL	J_Cell_Biol_2002_May_13_157(4)_579-589.nxml.txt.nlp	11994314	SENT116	32	32	9	9	paraformaldehyde	CENP-A	PA450790	1058	0.935
NULL	Indian_J_Endocrinol_Metab_2012_May-Jun_16(3)_349-357.nxml.txt.nlp	22629498	SENT155	30	30	15	15	raloxifene	CTX	PA451221	1593	0.935
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Apr_23_64(Pt_5)_o881.nxml.txt.nlp	21202365	SENT59	37	37	10	10	ethanol	mol	PA448073	90527	0.935
NULL	Mol_Cancer_2014_Jul_28_13_179.nxml.txt.nlp	25070035	SENT310	28	28	8	8	paraformaldehyde	NY-ESO-1	PA450790	1485	0.935
NULL	J_Autoimmune_Dis_2005_May_3_2_4.nxml.txt.nlp	15869713	SENT185	15	15	2	2	lovastatin	NAC	PA450272	22861	0.935
NULL	Nucleic_Acids_Res_2008_Feb_20_36(3)_998-1008.nxml.txt.nlp	18096616	SENT31	0	0	17	17	heparin	PKR	PA449855	5610	0.935
NULL	J_Cerebrovasc_Endovasc_Neurosurg_2012_Mar_31_14(1)_44-49.nxml.txt.nlp	23210029	SENT8	9	9	26	26	acetazolamide	ACZ	PA448018	27445	0.935
NULL	Drug_Des_Devel_Ther_2014_Sep_26_8_1595-1611.nxml.txt.nlp	25302015	SENT113	8	8	12	12	docetaxel	EGFR	PA449383	1956	0.935
NULL	Basic_Clin_Pharmacol_Toxicol_2013_Feb_5_112(2)_132-137.nxml.txt.nlp	22900583	SENT169	9	9	0	0	prasugrel	CYP2B6	PA154410481	1555	0.935
NULL	Mol_Cancer_2009_Mar_5_8_14.nxml.txt.nlp	19265551	SENT80	4	4	7	7	camptothecin	p53	PA153590860	7157	0.935
NULL	Cell_Death_Differ_2010_Mar_16_17(3)_499-512.nxml.txt.nlp	19834490	SENT11	6	6	15	15	bevacizumab	VEGFR1	PA130232992	2321	0.935
NULL	Curr_Oncol_2009_May_16(Suppl_1)_S52-S59.nxml.txt.nlp	19478903	SENT178	21	21	11	11	temsirolimus	CYP3A4	PA164746890	1576	0.935
NULL	Breast_Cancer_Res_2013_Oct_3_15(5)_R93.nxml.txt.nlp	24088226	SENT19	1	1	15	15	tamoxifen	CYP2D6	PA451581	1565	0.935
NULL	J_Gastroenterol_2013_Jan_27_48(1)_22-30.nxml.txt.nlp	23104468	SENT2	6	6	13	13	ribavirin	SOC	PA451241	91544	0.935
NULL	Br_J_Cancer_2010_Jan_19_102(2)_268-275.nxml.txt.nlp	20010948	SENT23	6	6	16	16	sorafenib	VEGFR2	PA7000	3791	0.935
NULL	Curr_Oncol_2009_Mar_16(2)_36-43.nxml.txt.nlp	19370178	SENT68	16	16	38	38	flavopiridol	Mcl-1	PA452627	4170	0.935
NULL	Ann_Rheum_Dis_2008_Oct_25_68(10)_1644-1650.nxml.txt.nlp	18957484	SENT14	4	4	16	16	leflunomide	CD54	PA450192	3383	0.935
NULL	Case_Rep_Transplant_2011_Jan_5_2011_210178.nxml.txt.nlp	23213600	SENT39	40	40	11	11	tacrolimus	CYP3A	PA451578	1574	0.935
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT171	38	38	28	28	nutlin-3	p53		7157	0.935
NULL	Environ_Health_Perspect_2008_Jun_116(6)_A240a.nxml.txt.nlp	NULL	SENT32	24	24	3	3	aspartame	ERF	PA448493	2077	0.935
NULL	Curr_Opin_Oncol_2014_Jul_6_26(4)_428-433.nxml.txt.nlp	24840521	SENT111	27	27	39	39	olaparib	MRI		78996	0.935
NULL	Cell_Biol_Int_Rep_(2010)_2012_Jun_21_19(1)_e00017.nxml.txt.nlp	23124518	SENT5	6	6	18	18	etoposide	Mcl-1	PA449552	4170	0.935
NULL	Mol_Cancer_2014_Feb_5_13_24.nxml.txt.nlp	24495306	SENT253	14	14	8	8	collagenase	ADAM17	PA449107	6868	0.935
NULL	Mediators_Inflamm_2010_Mar_22_2010_823486.nxml.txt.nlp	20339530	SENT137	24	24	32	32	hyaluronan	TLR2	PA165958431	7097	0.935
NULL	Evid_Based_Complement_Alternat_Med_2014_Jan_8_2014_976364.nxml.txt.nlp	24527057	SENT180	29	29	14	14	oseltamivir	TLR7	PA450721	51284	0.935
NULL	Exp_Diabetes_Res_2007_Apr_12_2007_15803.nxml.txt.nlp	17641739	SENT137	3	3	23	23	curcumin	STZ	PA151958596	6484	0.935
NULL	Breast_Cancer_Res_2004_Aug_5_6(5)_R601-R607.nxml.txt.nlp	15318941	SENT39	14	14	3	3	docetaxel	p27	PA449383	5715;10534	0.935
NULL	J_Cardiothorac_Surg_2007_Jun_5_2_28.nxml.txt.nlp	17550621	SENT77	2	2	12	12	heparin	ACT	PA449855	12;11332;9457;641455	0.935
NULL	Endocr_Relat_Cancer_2013_Aug_20(5)_677-689.nxml.txt.nlp	23913484	SENT195	11	11	5	5	paclitaxel	IL6	PA450761	3569	0.935
NULL	Environ_Health_Perspect_2012_Apr_24_120(4)_560-565.nxml.txt.nlp	22275727	SENT64	3	3	28	28	estradiol	gamma	PA449503	9913	0.935
NULL	Biomed_Res_Int_2013_Dec_17_2013_696317.nxml.txt.nlp	24455716	SENT170	15	15	2	2	l-arginine	NAC	PA448478	22861	0.935
NULL	Mol_Cancer_2013_Sep_11_12_104.nxml.txt.nlp	24025152	SENT50	23	23	12	12	gemcitabine	STAT3	PA449748	6774	0.935
NULL	Cell_Death_Dis_2014_Jul_10_5(7)_e1318.nxml.txt.nlp	25010984	SENT9	22	22	9	9	nutlin-3	p53		7157	0.935
NULL	Drug_Des_Devel_Ther_2014_Dec_1_8_2391-2400.nxml.txt.nlp	25489237	SENT118	9	9	29	29	bupropion	GLP-1	PA448687	100125288	0.935
NULL	Oncotarget_2013_Aug_24_4(10)_1618-1631.nxml.txt.nlp	24113128	SENT194	4	4	26	26	sorafenib	p53	PA7000	7157	0.935
NULL	J_Invest_Dermatol_2014_Jul_134(7)_1786-1788.nxml.txt.nlp	24924756	SENT82	0	0	13	13	aprepitant	IL-17	PA164747039	3605	0.935
NULL	Breast_Cancer_Res_2007_Dec_17_9(6)_R87.nxml.txt.nlp	18086299	SENT169	40	40	27	27	trastuzumab	San	PA451743	80218	0.935
NULL	AIDS_Res_Ther_2013_May_1_10_10.nxml.txt.nlp	23634877	SENT134	7	7	24	24	lovastatin	CCR5	PA450272	1234	0.935
NULL	eLife_2013_May_28_2_e00658.nxml.txt.nlp	23741618	SENT71	24	24	6	6	paraformaldehyde	MUC5AC	PA450790	4586	0.935
NULL	Biomed_Res_Int_2013_Aug_6_2013_602987.nxml.txt.nlp	24027759	SENT308	11	11	21	21	cyclophosphamide	SMF	PA449165	22993	0.935
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT119	17	17	34	34	nutlin-3	MDM2		4193	0.935
NULL	Indian_J_Pharmacol_2014_Sep-Oct_46(5)_547-548.nxml.txt.nlp	25298587	SENT51	4	4	23	23	verapamil	CYP3A	PA451868	1574	0.935
NULL	JAKSTAT_2012_Apr_1_1(2)_83-89.nxml.txt.nlp	24058756	SENT9	0	0	11	11	losartan	JAK2	PA450268	3717	0.935
NULL	Acta_Neuropathol_Commun_2014_May_30_2_57.nxml.txt.nlp	24887326	SENT11	15	15	2	2	etoposide	ABCB1	PA449552	5243	0.935
NULL	Front_Immunol_2012_Jan_12_2_98.nxml.txt.nlp	22566887	SENT255	0	0	26	26	celecoxib	Mcl-1	PA448871	4170	0.935
NULL	Stroke_Res_Treat_2009_Dec_20_2010_386389.nxml.txt.nlp	20700422	SENT202	6	6	11	11	pioglitazone	MCP-1	PA450970	6347	0.935
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Dec_17_3(12)_e152.nxml.txt.nlp	25518025	SENT80	25	25	17	17	ketoconazole	UGT	PA450146	7361;7355	0.935
NULL	Pharmaceutics_2011_Oct_12_3(4)_680-705.nxml.txt.nlp	24309303	SENT575	5	5	18	18	itraconazole	CYP3A4	PA450132	1576	0.935
NULL	J_Headache_Pain_2014_Dec_8_15(1)_85.nxml.txt.nlp	25488888	SENT102	18	18	10	10	eletriptan	5-HT1B	PA134687947	3351	0.935
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT153	12	12	2	2	doxorubicin	B7-H1	PA449412	29126	0.935
NULL	Exp_Ther_Med_2014_Apr_13_7(4)_799-803.nxml.txt.nlp	24669235	SENT70	6	6	11	11	vildagliptin	GLP-1	PA165958346	100125288	0.935
NULL	eLife_2014_May_6_3_e02482.nxml.txt.nlp	24843002	SENT193	11	11	25	25	etoposide	SETD2	PA449552	29072	0.935
NULL	Cancer_Cell_Int_2011_Nov_2_11_39.nxml.txt.nlp	22047021	SENT418	15	15	6	6	cyclophosphamide	REV1	PA449165	51455	0.935
NULL	Cancer_Cell_Int_2010_Sep_9_10_32.nxml.txt.nlp	20828393	SENT126	25	25	22	22	cisplatin	ATF3	PA449014	467	0.935
NULL	Nucleic_Acids_Res_2011_Jun_9_39(11)_4640-4652.nxml.txt.nlp	21310710	SENT309	13	13	7	7	camptothecin	SATB1	PA153590860	6304	0.935
NULL	Mol_Biol_Cell_2014_Jun_1_25(11)_1782-1792.nxml.txt.nlp	24719457	SENT111	8	8	12	12	nicotine	p53	PA450626	7157	0.935
NULL	Nat_Commun_2014_Nov_19_5_5479.nxml.txt.nlp	25407222	SENT86	34	34	17	17	dextran	YTS	PA449261	8565	0.935
NULL	Biomed_Res_Int_2013_May_26_2013_161456.nxml.txt.nlp	23781496	SENT19	13	13	7	7	carbidopa	DDC	PA448794	1644	0.935
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1059-1066.nxml.txt.nlp	21364577	SENT6	3	3	26	26	anastrozole	aromatase	PA448432	1588	0.935
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT157	17	17	6	6	tacrolimus	OPG	PA451578	690	0.935
NULL	Protein_Cell_2014_Jun_19_5(6)_469-479.nxml.txt.nlp	24748116	SENT35	11	11	0	0	paclitaxel	EB1	PA450761	9167;22919;10982	0.935
NULL	Br_J_Cancer_1997_76(10)_1328-1332.nxml.txt.nlp	9374379	SENT10	10	10	43	43	cisplatin	IFN	PA449014	3439	0.935
NULL	J_Cell_Biol_2001_Apr_2_153(1)_207-220.nxml.txt.nlp	11285286	SENT132	39	39	6	6	carbachol	DGK	PA448784	8526;1607	0.935
NULL	Breast_Cancer_Res_2012_Feb_13_14(1)_R28.nxml.txt.nlp	22330809	SENT155	14	14	17	17	trastuzumab	ERBB2	PA451743	2064	0.935
NULL	An_Bras_Dermatol_2014_Nov-Dec_89(6)_865-877.nxml.txt.nlp	25387490	SENT74	31	31	16	16	dapsone	IL-8	PA449211	3576	0.935
NULL	J_Med_Life_2011_Feb_15_4(1)_11-20.nxml.txt.nlp	21505570	SENT185	38	38	45	45	flurbiprofen	FAAH	PA449683	79152;2166	0.935
NULL	Front_Oncol_2014_Apr_17_4_78.nxml.txt.nlp	24860780	SENT754	43	43	41	41	vemurafenib	BRAF	PA165946873	673	0.935
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT238	0	0	41	41	pp2	JNK		5599	0.935
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_O4.nxml.txt.nlp	NULL	SENT10	19	19	4	4	allopurinol	HLA-B	PA448320	3106	0.935
NULL	J_Int_Soc_Sports_Nutr_2013_Apr_30_10_25.nxml.txt.nlp	23627832	SENT33	10	10	17	17	capsaicin	DBX	PA448776	1654	0.935
NULL	J_Headache_Pain_2008_Oct_8_9(5)_317-323.nxml.txt.nlp	18688693	SENT187	6	6	9	9	sumatriptan	NK1	PA451566	11126	0.935
NULL	Cardiovasc_Diabetol_2005_Sep_16_4_14.nxml.txt.nlp	16168052	SENT10	9	9	22	22	bezafibrate	gamma	PA162364313	9913	0.935
NULL	Neuro_Oncol_2010_Apr_27_12(4)_389-400.nxml.txt.nlp	20308316	SENT19	4	4	13	13	chloroquine	p53	PA448948	7157	0.935
NULL	Mol_Cancer_2012_Sep_14_11_69.nxml.txt.nlp	22978347	SENT43	33	33	9	9	letrozole	TFF1	PA450196	7031	0.935
NULL	Aging_(Albany_NY)_2010_Dec_29_2(12)_914-923.nxml.txt.nlp	21212461	SENT4	25	25	5	5	cyclosporine	SIRT3	PA449167	23410	0.935
NULL	Allergy_2014_Jul_29_69(7)_817-827.nxml.txt.nlp	24773466	SENT175	7	7	16	16	pitrakinra	IL-13	PA165983754	3596	0.935
NULL	J_Hematol_Oncol_2009_Feb_23_2_9.nxml.txt.nlp	19236713	SENT42	12	12	4	4	cetuximab	KRAS	PA10040	3845	0.935
NULL	Cancer_Immunol_Immunother_2012_Jul_23_61(7)_1101-1111.nxml.txt.nlp	22193989	SENT111	21	21	37	37	oxaliplatin	IFN	PA131285527	3439	0.935
NULL	Mol_Cancer_2010_Aug_20_9_220.nxml.txt.nlp	20727180	SENT231	20	20	8	8	nicotine	p53	PA450626	7157	0.935
NULL	Pharmaceutics_2012_Jan_31_4(1)_93-103.nxml.txt.nlp	24300182	SENT23	26	26	0	0	indomethacin	PDF	PA449982	64146;9518	0.935
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1224-1233.nxml.txt.nlp	22353810	SENT191	13	13	29	29	etoposide	MRP-1	PA449552	928	0.935
NULL	Cancer_Metab_2014_May_28_2(Suppl_1)_P90.nxml.txt.nlp	NULL	SENT17	5	5	17	17	metformin	4E-BP1	PA450395	1978	0.935
NULL	Cancer_Microenviron_2009_Sep_26_2(Suppl_1)_19-204.nxml.txt.nlp	NULL	SENT3586	12	12	5	5	doxorubicin	p53	PA449412	7157	0.935
NULL	Eur_J_Clin_Pharmacol_2010_Nov_29_66(11)_1131-1136.nxml.txt.nlp	20669013	SENT130	22	22	7	7	voriconazole	CYP3A4	PA10233	1576	0.935
NULL	Breast_Cancer_Res_2004_Jan_29_6(2)_84-87.nxml.txt.nlp	14979912	SENT26	10	10	14	14	tamoxifen	aromatase	PA451581	1588	0.935
NULL	Endocrinol_Metab_(Seoul)_2014_Sep_25_29(3)_379-387.nxml.txt.nlp	25309798	SENT119	29	29	21	21	resveratrol	CLOCK		9575	0.935
NULL	Br_J_Cancer_2014_Jan_21_110(2)_384-391.nxml.txt.nlp	24346286	SENT15	20	20	10	10	trastuzumab	PTEN	PA451743	5728	0.935
NULL	Int_J_Hypertens_2011_May_22_2011_346985.nxml.txt.nlp	21747976	SENT164	3	3	22	22	captopril	AMPK	PA448780	5563	0.935
NULL	Clin_Sci_(Lond)_2011_Mar_1_120(Pt_5)_195-206.nxml.txt.nlp	20840078	SENT178	4	4	10	10	indomethacin	LOX	PA449982	4015	0.935
NULL	Cardiovasc_Drugs_Ther_2011_Jun_12_25(3)_223-232.nxml.txt.nlp	21562974	SENT103	10	10	25	25	esmolol	AKT	PA449500	207	0.935
NULL	JAKSTAT_2013_Jul_1_2(3)_e24574.nxml.txt.nlp	24069558	SENT226	14	14	24	24	doxycycline	JAK2	PA449415	3717	0.935
NULL	Mol_Clin_Oncol_2013_Sep_24_1(5)_918-924.nxml.txt.nlp	24649271	SENT96	6	6	15	15	gemcitabine	EGFR	PA449748	1956	0.935
NULL	Int_J_Mol_Sci_2012_Dec_5_13(12)_16624-16635.nxml.txt.nlp	23443122	SENT281	15	15	9	9	colchicine	MDR1	PA449092	5243	0.935
NULL	Int_J_Mol_Sci_2014_Nov_7_15(11)_20500-20517.nxml.txt.nlp	25387078	SENT125	33	33	40	40	sorafenib	c-FLIP	PA7000	8837	0.935
NULL	Int_J_Endocrinol_Metab_2013_Jul_1_Summer_11(3)_184-190.nxml.txt.nlp	24348591	SENT106	15	15	0	0	liraglutide	INS-1	PA165958364	2305	0.935
NULL	Int_J_Med_Sci_2015_Jan_1_12(1)_78-82.nxml.txt.nlp	25552922	SENT100	21	21	5	5	warfarin	CYP2C9	PA451906	1559	0.935
NULL	Environ_Health_Perspect_2006_Apr_27_114(4)_500-506.nxml.txt.nlp	16581536	SENT194	18	18	3	3	estradiol	aromatase	PA449503	1588	0.935
NULL	Biomed_Res_Int_2014_Jun_3_2014_656370.nxml.txt.nlp	24995318	SENT87	13	13	43	43	risperidone	FGA	PA451257	2243	0.935
NULL	J_Immunol_Res_2014_Jul_13_2014_964069.nxml.txt.nlp	25126586	SENT90	26	26	4	4	tocilizumab	IL-6	PA165292659	3569	0.935
NULL	Mol_Cancer_2014_Jan_13_13_7.nxml.txt.nlp	24418169	SENT258	10	10	21	21	sorafenib	STAT3	PA7000	6774	0.935
NULL	Front_Neurosci_2010_Mar_19_4_22.nxml.txt.nlp	20582262	SENT87	7	7	33	33	bethanechol	P2X3	PA448613	5024	0.935
NULL	Arch_Med_Sci_2013_Aug_30_9(4)_739-744.nxml.txt.nlp	24049538	SENT107	25	25	33	33	candesartan	PC-3	PA448765	692094	0.935
NULL	Indian_J_Med_Paediatr_Oncol_2014_Apr-Jun_35(2)_140-142.nxml.txt.nlp	25197175	SENT61	24	24	13	13	cetuximab	KRAS	PA10040	3845	0.935
NULL	AIDS_Res_Ther_2009_Apr_9_6_3.nxml.txt.nlp	19358725	SENT7	31	31	19	19	abacavir	CD4	PA448004	920	0.935
NULL	Mol_Cancer_2009_Apr_16_8_24.nxml.txt.nlp	19371427	SENT219	14	14	17	17	cisplatin	CHK1	PA449014	1111	0.935
NULL	Leukemia_2014_May_29_28(5)_1081-1091.nxml.txt.nlp	24166297	SENT259	24	24	20	20	doxycycline	THP1	PA449415	2736	0.935
NULL	Onco_Targets_Ther_2014_Sep_9_7_1571-1582.nxml.txt.nlp	25228815	SENT109	10	10	20	20	sunitinib	VEGFR1	PA162372840	2321	0.935
NULL	Cancer_Immunol_Immunother_2013_Jul_20_62(9)_1533-1545.nxml.txt.nlp	23873089	SENT150	2	2	33	33	gemcitabine	CD11b	PA449748	3684	0.935
NULL	Arch_Med_Sci_2013_Aug_30_9(4)_739-744.nxml.txt.nlp	24049538	SENT122	25	25	33	33	candesartan	PC-3	PA448765	692094	0.935
NULL	J_Cell_Biol_1977_May_1_73(2)_366-381.nxml.txt.nlp	858741	SENT8	12	12	32	32	vasopressin	SON	PA451858	6651	0.935
NULL	Gut_Liver_2014_Jan_5_8(1)_49-57.nxml.txt.nlp	24516701	SENT151	17	17	4	4	diclofenac	cPLA2	PA449293	10524	0.935
NULL	Front_Aging_Neurosci_2015_Jan_6_6_342.nxml.txt.nlp	25610395	SENT167	28	28	4	4	imatinib	GSAP	PA10804	54103	0.935
NULL	Mol_Cancer_2014_Feb_24_13_35.nxml.txt.nlp	24565101	SENT99	3	3	26	26	doxorubicin	p65	PA449412	5970	0.935
NULL	Eur_J_Med_Res_2011_Jul_25_16(7)_303-314.nxml.txt.nlp	21813371	SENT38	0	0	26	26	telaprevir	IFN	PA165958354	3439	0.935
NULL	Viruses_2014_Aug_12_6(8)_3080-3096.nxml.txt.nlp	25118638	SENT40	24	24	12	12	heparin	EGF	PA449855	1950	0.935
NULL	Cells_2012_Oct_15_1(4)_754-773.nxml.txt.nlp	24710529	SENT42	6	6	10	10	2-methoxyestradiol	14-3-3	PA134967247	10971	0.935
NULL	J_Immunother_Cancer_2013_Nov_7_1(Suppl_1)_P123.nxml.txt.nlp	NULL	SENT14	5	5	27	27	chloroquine	HMGB1	PA448948	3146	0.935
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_9_2013_801374.nxml.txt.nlp	23662153	SENT131	4	4	26	26	gentamicin	HAP	PA449753	5915;10313	0.935
NULL	Cancer_Metab_2013_Feb_4_1_7.nxml.txt.nlp	24280108	SENT140	0	0	8	8	doxycycline	MYC	PA449415	4609	0.935
NULL	Neural_Dev_2010_Feb_25_5_6.nxml.txt.nlp	20184720	SENT264	14	14	0	0	paraformaldehyde	E12	PA450790	64100	0.935
NULL	Diabetes_2009_Dec_31_58(12)_2851-2862.nxml.txt.nlp	19720788	SENT143	41	41	20	20	forskolin	CHOP	PA146096022	1649	0.935
NULL	Breast_Cancer_Res_2007_Dec_20_9(Suppl_2)_S11.nxml.txt.nlp	NULL	SENT31	26	26	23	23	tamoxifen	aromatase	PA451581	1588	0.935
NULL	Mol_Cancer_2007_Oct_11_6_63.nxml.txt.nlp	17931419	SENT130	11	11	20	20	cetuximab	EGFR	PA10040	1956	0.935
NULL	Gastroenterol_Hepatol_Bed_Bench_2014_Summer_7(3)_177-182.nxml.txt.nlp	25120900	SENT93	0	0	27	27	sorafenib	RET1	PA7000	338917	0.935
NULL	Mol_Vis_2012_Aug_8_18_2195-2204.nxml.txt.nlp	22919267	SENT195	5	5	12	12	latanoprost	KCS	PA164774763	3771	0.935
NULL	Clin_Psychopharmacol_Neurosci_2011_Apr_30_9(1)_36-43.nxml.txt.nlp	23431025	SENT109	15	15	2	2	haloperidol	HIP	PA449841	6767;6159;64399;5068	0.935
NULL	Arthritis_Res_Ther_2011_Sep_1_13(5)_R141.nxml.txt.nlp	21884601	SENT18	0	0	13	13	tocilizumab	IL-6	PA165292659	3569	0.935
NULL	Mol_Cell_Proteomics_2012_Feb_7_11(2)_M111_014480.nxml.txt.nlp	22074704	SENT110	12	12	2	2	etoposide	PC1	PA449552	5122	0.935
NULL	Orphanet_J_Rare_Dis_2010_Dec_16_5_39.nxml.txt.nlp	21162721	SENT78	31	31	4	4	phenytoin	HLA-B	PA450947	3106	0.935
NULL	Zookeys_2014_Nov_12_(454)_29-39.nxml.txt.nlp	25493065	SENT25	7	7	13	13	ethanol	EOS	PA448073	260429	0.935
NULL	Diabetes_Metab_Syndr_Obes_2014_Mar_18_7_107-120.nxml.txt.nlp	24672252	SENT35	5	5	21	21	sitagliptin	GLP-1	PA164748978	100125288	0.935
NULL	Eur_J_Clin_Microbiol_Infect_Dis_2013_Jun_13_32(6)_745-754.nxml.txt.nlp	23314745	SENT17	27	27	5	5	ribavirin	IL-28B	PA451241	282617	0.935
NULL	J_Infect_Dis_2013_Dec_15_208(12)_2046-2057.nxml.txt.nlp	23911710	SENT88	16	16	6	6	thrombin	LTA	PA451674	4049	0.935
NULL	Ann_Hematol_2010_Sep_13_89(9)_861-871.nxml.txt.nlp	20387067	SENT213	12	12	6	6	dasatinib	CD34	PA162372878	947	0.935
NULL	J_Am_Heart_Assoc_2013_Dec_19_2(6)_e000355.nxml.txt.nlp	24190878	SENT29	17	17	2	2	phenylephrine	HK2	PA450935	3796;3099;29911;3741	0.935
NULL	Cells_2014_May_23_3(2)_517-545.nxml.txt.nlp	24861977	SENT105	7	7	16	16	capsaicin	TRPV1	PA448776	7442	0.935
NULL	Reprod_Biol_Endocrinol_2013_Feb_26_11_15.nxml.txt.nlp	23442442	SENT195	20	20	6	6	l-arginine	BAX	PA448478	581	0.935
NULL	Mol_Med_Rep_2015_Feb_5_11(2)_805-814.nxml.txt.nlp	25373883	SENT119	14	14	6	6	colchicine	APE	PA449092	55704;328	0.935
NULL	J_Hematol_Oncol_2013_Sep_3_6_64.nxml.txt.nlp	24004697	SENT11	23	23	6	6	imatinib	PPP2R5C	PA10804	5527	0.935
NULL	Crit_Care_2007_Mar_22_11(Suppl_2)_P12.nxml.txt.nlp	NULL	SENT5	10	10	19	19	octreotide	IL-6	PA450678	3569	0.935
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Jul_23_3(7)_e126.nxml.txt.nlp	25054314	SENT71	15	15	6	6	docetaxel	MRP2	PA449383	100130958;57626;1244	0.935
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2013_Sep_1_6_25-37.nxml.txt.nlp	24031162	SENT56	2	2	11	11	sitagliptin	GLP-1	PA164748978	100125288	0.935
NULL	J_Cell_Mol_Med_2014_Apr_20_18(4)_709-720.nxml.txt.nlp	24444314	SENT245	3	3	14	14	losartan	p53	PA450268	7157	0.935
NULL	Breast_Cancer_Res_2011_Jan_17_13(1)_R5.nxml.txt.nlp	21241485	SENT198	18	18	4	4	estradiol	Brn-3b	PA449503	5458	0.935
NULL	Int_J_Mol_Sci_2014_Sep_16_15(9)_16381-16417.nxml.txt.nlp	25229821	SENT89	6	6	13	13	tocilizumab	IL-6	PA165292659	3569	0.935
NULL	Case_Rep_Oncol_2013_Jul_20_6(2)_382-386.nxml.txt.nlp	23904849	SENT17	21	21	9	9	cetuximab	EGFR	PA10040	1956	0.935
NULL	Cancer_Immunol_Immunother_2012_Jul_23_61(7)_1101-1111.nxml.txt.nlp	22193989	SENT223	8	8	5	5	oxaliplatin	PD-L1	PA131285527	29126	0.935
NULL	Ther_Clin_Risk_Manag_2006_Mar_2(1)_77-86.nxml.txt.nlp	18360583	SENT116	18	18	30	30	alendronate	PTH	PA448082	5741	0.935
NULL	J_Geriatr_Cardiol_2012_Jun_9(2)_180-184.nxml.txt.nlp	22916066	SENT109	23	23	7	7	rosuvastatin	Rho	PA134308647	29984	0.935
NULL	Acta_Pharmacol_Sin_2009_Dec_4_30(12)_1601-1606.nxml.txt.nlp	19960006	SENT111	7	7	13	13	suramin	DPI	PA10292	1832	0.935
NULL	Int_J_Biol_Sci_2014_Sep_6_10(9)_1007-1017.nxml.txt.nlp	25210499	SENT17	6	6	10	10	tamoxifen	p63	PA451581	8626	0.935
NULL	J_Clin_Biochem_Nutr_2007_Jan_27_40(1)_13-23.nxml.txt.nlp	18437209	SENT145	28	28	21	21	trypsin	IL-8	PA451806	3576	0.935
NULL	Indian_J_Med_Res_2011_Dec_134(6)_749-768.nxml.txt.nlp	22310811	SENT155	15	15	7	7	nevirapine	DRB1	PA450616	129831	0.935
NULL	Oncotarget_2013_Apr_10_4(4)_622-635.nxml.txt.nlp	23599172	SENT229	27	27	20	20	vemurafenib	BRAF	PA165946873	673	0.935
NULL	Front_Immunol_2012_Jul_12_3_175.nxml.txt.nlp	22807925	SENT352	0	0	15	15	maraviroc	CCR5	PA164768835	1234	0.935
NULL	Protein_Eng_Des_Sel_2013_Jul_24_26(7)_463-470.nxml.txt.nlp	23708321	SENT48	30	30	25	25	trimethoprim	DHFR	PA451788	1719	0.935
NULL	Arthritis_Res_Ther_2009_Jan_26_11(1)_R12.nxml.txt.nlp	19171052	SENT245	19	19	4	4	dipyridamole	ACTH	PA449367	5443	0.935
NULL	Mol_Biol_Rep_2013_May_11_40(8)_5013-5026.nxml.txt.nlp	23666059	SENT132	22	22	2	2	resveratrol	p53		7157	0.935
NULL	Clin_Epigenetics_2011_Jul_16_2(2)_411-416.nxml.txt.nlp	22704352	SENT64	28	28	10	10	vorinostat	JAK2	PA164748224	3717	0.935
NULL	Breast_Cancer_Res_2007_Dec_17_9(6)_R87.nxml.txt.nlp	18086299	SENT128	32	32	0	0	trastuzumab	HER-2	PA451743	2064	0.935
NULL	Biomed_Res_Int_2013_Jan_8_2013_252158.nxml.txt.nlp	23509696	SENT72	10	10	17	17	perindopril	CD34	PA450877	947	0.935
NULL	Clin_Med_Insights_Cardiol_2011_Jun_28_5_55-66.nxml.txt.nlp	21792345	SENT111	16	16	4	4	bucindolol	BEST	PA165945764	7439	0.935
NULL	Cell_Death_Dis_2012_Nov_15_3(11)_e422.nxml.txt.nlp	23152058	SENT348	37	37	17	17	cisplatin	GCLC	PA449014	2729	0.935
NULL	Clin_Interv_Aging_2009_Jun_29_4_289-303.nxml.txt.nlp	19750231	SENT71	11	11	0	0	pamidronate	Men	PA450767	8178	0.935
NULL	Psychol_Res_Behav_Manag_2010_Dec_6_3_109-118.nxml.txt.nlp	22110334	SENT114	34	34	17	17	paroxetine	CYP2D6	PA450801	1565	0.935
NULL	Oncotarget_2011_Apr_2_2(4)_305-312.nxml.txt.nlp	21471610	SENT84	25	25	17	17	doxorubicin	CAV1	PA449412	857	0.935
NULL	Diabetes_2011_Jan_4_60(1)_119-126.nxml.txt.nlp	20921208	SENT80	35	35	5	5	diazoxide	TRPM2	PA449285	7226	0.935
NULL	Cancers_(Basel)_2014_Sep_30_6(4)_2035-2048.nxml.txt.nlp	25271833	SENT137	23	23	10	10	gefitinib	EGFR	PA131301952	1956	0.935
NULL	Clin_Endosc_2014_Jul_28_47(4)_353-357.nxml.txt.nlp	25133125	SENT32	8	8	0	0	midazolam	ESD	PA450496	2098	0.935
NULL	Front_Neurosci_2011_Feb_2_5_12.nxml.txt.nlp	21344007	SENT229	12	12	0	0	capsaicin	NR1	PA448776	27158	0.935
NULL	Biomed_Res_Int_2013_Dec_19_2013_817279.nxml.txt.nlp	24455727	SENT125	6	6	19	19	panitumumab	EGFR	PA162373091	1956	0.935
NULL	Arthritis_Res_Ther_2006_May_5_8(3)_R83.nxml.txt.nlp	16677395	SENT109	20	20	0	0	rituximab	CD4	PA451261	920	0.935
NULL	Mol_Cancer_2010_Aug_20_9_220.nxml.txt.nlp	20727180	SENT152	38	38	31	31	nicotine	p53	PA450626	7157	0.935
NULL	Autophagy_2013_Jul_1_9(7)_996-1008.nxml.txt.nlp	23580233	SENT126	5	5	44	44	cisplatin	LC3	PA449014	84557	0.935
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT176	9	9	14	14	metformin	HIF-1	PA450395	29072	0.935
NULL	Oncotarget_2013_Nov_15_4(11)_1866-1867.nxml.txt.nlp	24272818	SENT36	20	20	7	7	pertuzumab	PIK3CA		5290	0.935
NULL	Oncol_Rep_2012_Aug_1_28(2)_429-438.nxml.txt.nlp	22664934	SENT98	15	15	6	6	trypsin	CTRL	PA451806	1506	0.935
NULL	Cough_2009_Dec_16_5_11.nxml.txt.nlp	20015366	SENT112	7	7	4	4	dextromethorphan	OTC	PA449273	5009	0.935
NULL	J_Hematol_Oncol_2013_Jan_4_6_1.nxml.txt.nlp	23286345	SENT113	14	14	7	7	rituximab	FCGR3A	PA451261	2214	0.935
NULL	Breast_Cancer_Res_2008_Mar_29_10(2)_R28.nxml.txt.nlp	18373870	SENT165	20	20	13	13	estradiol	HSPC111	PA449503	51491	0.935
NULL	Pharmaceutics_2013_Dec_19_6(1)_1-25.nxml.txt.nlp	24662363	SENT274	20	20	14	14	doxorubicin	mol	PA449412	90527	0.935
NULL	Biomed_Res_Int_2014_Jan_29_2014_831845.nxml.txt.nlp	24605337	SENT114	3	3	0	0	bupivacaine	S6K1	PA135057240	6198	0.935
NULL	J_Biol_Chem_2013_Nov_22_288(47)_34217-34229.nxml.txt.nlp	24106270	SENT272	14	14	2	2	thrombin	RhoG	PA451674	391	0.935
NULL	J_Hum_Genet_2013_Jun_16_58(6)_353-361.nxml.txt.nlp	23677058	SENT169	43	43	8	8	cytarabine	RRM1	PA449177	6240	0.935
NULL	Int_J_Nanomedicine_2010_Feb_2_5_63-75.nxml.txt.nlp	20161988	SENT29	30	30	19	19	cisplatin	zeta	PA449014	9907	0.935
NULL	Br_J_Cancer_2012_Aug_21_107(5)_793-799.nxml.txt.nlp	22850551	SENT114	20	20	7	7	erlotinib	HER2	PA134687924	2064	0.935
NULL	Clin_Dev_Immunol_2013_May_22_2013_701305.nxml.txt.nlp	23762095	SENT78	8	8	21	21	vincristine	FBW7	PA451879	55294	0.935
NULL	Mol_Cancer_2010_Apr_15_9_77.nxml.txt.nlp	20398291	SENT50	10	10	6	6	geldanamycin	Hsp90	PA152031327	3320	0.935
NULL	Breast_Cancer_Res_2004_Nov_7_6(1)_R24-R30.nxml.txt.nlp	14680497	SENT110	26	26	8	8	fluorouracil	HER2	PA128406956	2064	0.935
NULL	Ther_Clin_Risk_Manag_2005_Mar_1(1)_3-13.nxml.txt.nlp	18360537	SENT36	4	4	24	24	ritonavir	CYP3A4	PA451260	1576	0.935
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT102	30	30	11	11	metformin	HIP	PA450395	6767;6159;64399;5068	0.935
NULL	J_Int_AIDS_Soc_2012_Nov_11_15(6Suppl_4)_18154.nxml.txt.nlp	NULL	SENT19	8	8	6	6	maraviroc	CCR5	PA164768835	1234	0.935
NULL	Br_J_Cancer_2012_Jan_3_106(1)_107-115.nxml.txt.nlp	22116303	SENT110	8	8	13	13	vorinostat	AKT	PA164748224	207	0.935
NULL	Acta_Pharmacol_Sin_2013_Jun_8_34(6)_830-836.nxml.txt.nlp	23564080	SENT143	47	47	30	30	simvastatin	RAGE	PA451363	177	0.935
NULL	EMBO_Mol_Med_2012_Sep_20_4(9)_980-991.nxml.txt.nlp	22903875	SENT169	25	25	0	0	paraformaldehyde	BACE1	PA450790	23621	0.935
NULL	Breast_Cancer_Res_2005_May_27_7(Suppl_1)_S29.nxml.txt.nlp	NULL	SENT3	18	18	6	6	letrozole	aromatase	PA450196	1588	0.935
NULL	Int_J_Mol_Sci_2014_Oct_23_15(10)_19265-19280.nxml.txt.nlp	25342321	SENT128	9	9	25	25	cisplatin	MVD	PA449014	4597	0.935
NULL	Acta_Pharmacol_Sin_2014_Jan_16_35(1)_24-32.nxml.txt.nlp	24335837	SENT194	16	16	0	0	paroxetine	Bcl-2	PA450801	596	0.935
NULL	Cell_Cycle_2013_May_15_12(10)_1492-1500.nxml.txt.nlp	23598717	SENT139	15	15	2	2	doxorubicin	ROCK1	PA449412	6093	0.935
NULL	Biologics_2013_Apr_26_7_91-101.nxml.txt.nlp	23671386	SENT110	7	7	13	13	crizotinib	KIT	PA165946122	3815	0.935
NULL	Int_J_Nanomedicine_2012_May_7_7_2307-2314.nxml.txt.nlp	22661887	SENT109	20	20	11	11	gemcitabine	F10	PA449748	2159	0.935
NULL	Oncol_Lett_2014_Jul_25_8(1)_313-316.nxml.txt.nlp	24959268	SENT64	6	6	21	21	sulindac	PC-3	PA451565	692094	0.935
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_67-74.nxml.txt.nlp	17912637	SENT43	24	24	17	17	letrozole	aromatase	PA450196	1588	0.935
NULL	Br_J_Pharmacol_2012_Jan_165(2)_390-400.nxml.txt.nlp	21671897	SENT201	11	11	6	6	suramin	P2X2	PA10292	22953	0.935
NULL	Cancer_Immunol_Immunother_2012_Jul_23_61(7)_1101-1111.nxml.txt.nlp	22193989	SENT143	6	6	1	1	oxaliplatin	PD-L1	PA131285527	29126	0.935
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2675-2684.nxml.txt.nlp	24129246	SENT205	7	7	43	43	etoposide	p53	PA449552	7157	0.935
NULL	EJC_Suppl_2013_Sep_5_11(2)_299-300.nxml.txt.nlp	NULL	SENT28	5	5	12	12	tamoxifen	aromatase	PA451581	1588	0.935
NULL	J_Adv_Pract_Oncol_2013_Jul_1_Jul-Aug_4(4)_238-250.nxml.txt.nlp	25032004	SENT128	16	16	3	3	imatinib	CML	PA10804	613	0.935
NULL	eLife_2014_May_27_3_e02200.nxml.txt.nlp	24867637	SENT573	18	18	7	7	doxorubicin	p53	PA449412	7157	0.935
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT102	30	30	14	14	metformin	HIP	PA450395	6767;6159;64399;5068	0.935
NULL	Oncogene_2010_Sep_23_29(38)_5286-5298.nxml.txt.nlp	20603611	SENT93	13	13	29	29	heparin	Met	PA449855	79811	0.935
NULL	J_Hematol_Oncol_2012_Jun_18_5_31.nxml.txt.nlp	22709792	SENT162	3	3	15	15	trastuzumab	HER2	PA451743	2064	0.935
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT20	30	30	12	12	pp2	PP2		4888	0.935
NULL	Int_J_Endocrinol_Metab_2013_Dec_21_Winter_11(1)_57-61.nxml.txt.nlp	23853622	SENT39	9	9	22	22	clozapine	FGA	PA449061	2243	0.935
NULL	Environ_Health_Perspect_2012_Jul_11_120(7)_1029-1035.nxml.txt.nlp	22494775	SENT284	23	23	15	15	estradiol	AF-1	PA449503	3460;5710	0.935
NULL	Springerplus_2013_Jun_15_2_264.nxml.txt.nlp	23875128	SENT28	7	7	0	0	ribavirin	IFN	PA451241	3439	0.935
NULL	Mol_Cancer_2007_Sep_18_6_56.nxml.txt.nlp	17877814	SENT19	18	18	9	9	gefitinib	EGFR	PA131301952	1956	0.935
NULL	J_Immunother_2014_Feb_21_37(2)_105-114.nxml.txt.nlp	24509173	SENT15	29	29	3	3	gemcitabine	WT1	PA449748	7490	0.935
NULL	Crit_Care_2009_Jun_23_13(3)_R98.nxml.txt.nlp	19549333	SENT26	27	27	3	3	vasopressin	AVP	PA451858	114548;551	0.935
NULL	Nucl_Recept_Signal_2009_Jan_16_7_e001.nxml.txt.nlp	19240808	SENT112	40	40	0	0	nifedipine	SXR	PA450631	8856	0.935
NULL	Springerplus_2014_Sep_17_3_535.nxml.txt.nlp	25279326	SENT154	21	21	30	30	fulvestrant	aromatase	PA164747170	1588	0.935
NULL	Curr_Oncol_2009_Jan_16(1)_27-48.nxml.txt.nlp	19229369	SENT268	17	17	35	35	gefitinib	KRAS	PA131301952	3845	0.935
NULL	Breast_Cancer_Res_2012_Feb_13_14(1)_R28.nxml.txt.nlp	22330809	SENT152	7	7	15	15	lapatinib	ERBB2	PA152241907	2064	0.935
NULL	J_Oncol_2009_Jun_22_2009_849051.nxml.txt.nlp	19584908	SENT64	33	33	15	15	cetuximab	EGFR	PA10040	1956	0.935
NULL	Cancer_Med_2014_Jun_27_3(3)_462-471.nxml.txt.nlp	24573979	SENT236	29	29	23	23	sunitinib	MVD	PA162372840	4597	0.935
NULL	J_Obes_2011_Feb_8_2011_636181.nxml.txt.nlp	21331293	SENT192	0	0	15	15	exenatide	GLP-1	PA164749238	100125288	0.935
NULL	J_Oncol_2013_Aug_20_2013_732047.nxml.txt.nlp	24027583	SENT190	18	18	6	6	trastuzumab	HER2	PA451743	2064	0.935
NULL	Arthritis_Res_Ther_2010_Apr_9_12(2)_R65.nxml.txt.nlp	20380722	SENT88	2	2	27	27	imatinib	MIP1	PA10804	79109;3842	0.935
NULL	Iran_Red_Crescent_Med_J_2011_Jun_1_13(6)_420-423.nxml.txt.nlp	22737505	SENT64	18	18	6	6	iloprost	Ray	PA164746843	26751	0.935
NULL	Nat_Commun_2013_Aug_15_4_2130.nxml.txt.nlp	23945651	SENT130	25	25	12	12	etoposide	ATG5	PA449552	9474	0.935
NULL	Vet_Res_Forum_2013_Winter_4(1)_19-24.nxml.txt.nlp	25593681	SENT10	17	17	10	10	diclofenac	B12	PA449293	7126;4709	0.935
NULL	Breast_Cancer_Res_2005_Jan_28_7(3)_R284-R290.nxml.txt.nlp	15987423	SENT95	16	16	24	24	tamoxifen	SULT1A1	PA451581	6817	0.935
NULL	Int_J_Mol_Sci_2014_Oct_15_15(10)_18574-18592.nxml.txt.nlp	25322151	SENT79	22	22	19	19	sirolimus	IL-2	PA451365	3558	0.935
NULL	Case_Rep_Dermatol_2011_Jun_30_3(2)_130-136.nxml.txt.nlp	21743808	SENT5	26	26	18	18	cetuximab	EGFR	PA10040	1956	0.935
NULL	Front_Oncol_2014_Sep_29_4_256.nxml.txt.nlp	25325013	SENT161	33	33	43	43	afatinib	EGFR	PA165981154	1956	0.935
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT168	5	5	14	14	rosiglitazone	CD36	PA451283	948	0.935
NULL	J_Carcinog_2013_Mar_18_12_7.nxml.txt.nlp	23599689	SENT35	13	13	3	3	gefitinib	EGFR	PA131301952	1956	0.935
NULL	Cell_J_2014_May_25_Summer_16(2)_163-170.nxml.txt.nlp	24567946	SENT14	34	34	40	40	naloxone	CA1	PA450586	759	0.935
NULL	Cancer_Cell_Int_2013_Apr_10_13_33.nxml.txt.nlp	23574945	SENT161	19	19	7	7	cisplatin	p53	PA449014	7157	0.935
NULL	Cell_Death_Dis_2013_Oct_3_4(10)_e827.nxml.txt.nlp	24091670	SENT93	11	11	24	24	nilotinib	CD38	PA165958345	952	0.935
NULL	Multidiscip_Respir_Med_2013_Feb_27_8(1)_16.nxml.txt.nlp	23442499	SENT120	0	0	10	10	heparin	ACT	PA449855	12;11332;9457;641455	0.935
NULL	Br_J_Clin_Pharmacol_2011_Oct_72(4)_647-657.nxml.txt.nlp	21518389	SENT144	25	25	13	13	prasugrel	P2Y12	PA154410481	64805	0.935
NULL	Oncol_Lett_2014_Nov_12_8(5)_2203-2208.nxml.txt.nlp	25295109	SENT128	11	11	23	23	celecoxib	GLI1	PA448871	2735	0.935
NULL	Oncol_Rep_2013_Mar_3_29(3)_855-860.nxml.txt.nlp	23291663	SENT73	0	0	34	34	metformin	aromatase	PA450395	1588	0.935
NULL	J_Invest_Dermatol_2012_May_16_132(5)_1435-1442.nxml.txt.nlp	22336948	SENT232	29	29	10	10	doxycycline	TLSP	PA449415	11012	0.935
NULL	Biomed_Res_Int_2013_Feb_18_2013_529589.nxml.txt.nlp	23509736	SENT304	9	9	20	20	busulfan	VASA	PA448691	54514	0.935
NULL	Osteoporos_Int_2011_Jun_12_22(6)_1935-1946.nxml.txt.nlp	20938767	SENT31	11	11	23	23	alendronate	PTH	PA448082	5741	0.935
NULL	Eur_J_Clin_Pharmacol_2012_Jan_8_68(1)_29-37.nxml.txt.nlp	21739267	SENT12	10	10	31	31	paroxetine	CYP2D6	PA450801	1565	0.935
NULL	J_Cardiothorac_Surg_2014_Jun_19_9_105.nxml.txt.nlp	24942178	SENT45	0	0	10	10	heparin	ACT	PA449855	12;11332;9457;641455	0.935
NULL	Int_J_Womens_Health_2012_Oct_10_4_543-549.nxml.txt.nlp	23091400	SENT7	20	20	3	3	resveratrol	aromatase		1588	0.935
NULL	Cells_2014_Apr_29_3(2)_331-362.nxml.txt.nlp	24785347	SENT138	8	8	27	27	capsaicin	TRPV1	PA448776	7442	0.935
NULL	Biologics_2014_Apr_7_8_141-153.nxml.txt.nlp	24741293	SENT199	12	12	22	22	adalimumab	IL-6	PA10004	3569	0.935
NULL	Cardiol_Ther_2013_Jun_26_2(1)_69-84.nxml.txt.nlp	25135290	SENT104	17	17	1	1	everolimus	DES	PA164746311	1674	0.934
NULL	Br_J_Cancer_2000_Jun_18_82(12)_2000-2006.nxml.txt.nlp	10864209	SENT4	16	16	0	0	flurbiprofen	c-fos	PA449683	2353	0.934
NULL	Clin_Med_Insights_Cardiol_2015_Jan_5_8(Suppl_1)_39-44.nxml.txt.nlp	25628512	SENT76	26	26	40	40	diflunisal	TTR	PA449313	7276	0.934
NULL	Clin_Exp_Gastroenterol_2011_May_3_4_75-119.nxml.txt.nlp	21753893	SENT937	23	23	35	35	capecitabine	MITF	PA448771	4286	0.934
NULL	Br_J_Ophthalmol_2008_Sep_22_92(9)_1275-1282.nxml.txt.nlp	18723745	SENT22	38	38	24	24	latanoprost	BAK	PA164774763	578	0.934
NULL	Int_J_Surg_Oncol_2012_May_17_2012_406830.nxml.txt.nlp	22675625	SENT49	39	39	24	24	gefitinib	EGFR	PA131301952	1956	0.934
NULL	Braz_J_Med_Biol_Res_2014_Jan_10_47(1)_60-69.nxml.txt.nlp	24519092	SENT9	21	21	32	32	doxorubicin	zeta	PA449412	9907	0.934
NULL	J_Gastrointest_Cancer_2013_Aug_7_44(4)_385-392.nxml.txt.nlp	23921604	SENT64	28	28	38	38	imatinib	PDGFRA	PA10804	5156	0.934
NULL	J_Exp_Clin_Cancer_Res_2009_Feb_15_28(1)_19.nxml.txt.nlp	19216799	SENT177	10	10	2	2	cisplatin	AEG-1	PA449014	92140	0.934
NULL	Open_Biomed_Eng_J_2013_Dec_27_7_147-158.nxml.txt.nlp	24478807	SENT74	12	12	27	27	collagenase	GMP	PA449107	22978	0.934
NULL	Biomed_Res_Int_2014_Aug_6_2014_967826.nxml.txt.nlp	25165721	SENT207	7	7	1	1	cisplatin	TNF-alpha	PA449014	7124	0.934
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_May_5_68(Pt_6)_o1625.nxml.txt.nlp	22719428	SENT4	26	26	6	6	nitrile	mol	PA450636	90527	0.934
NULL	Toxins_(Basel)_2010_Oct_25_2(10)_2467-2477.nxml.txt.nlp	22069561	SENT20	9	9	5	5	cisplatin	JNK	PA449014	5599	0.934
NULL	Blood_Cancer_J_2013_Oct_4_3(10)_e150.nxml.txt.nlp	24096714	SENT132	16	16	8	8	bortezomib	IL2	PA10252	3558	0.934
NULL	Int_J_Biol_Sci_2013_Apr_22_9(4)_350-360.nxml.txt.nlp	23630447	SENT166	27	27	6	6	doxorubicin	TCL1A	PA449412	8115	0.934
NULL	Curr_Neuropharmacol_2010_Jun_8(2)_122-127.nxml.txt.nlp	21119883	SENT41	32	32	21	21	capsaicin	AQP1	PA448776	358	0.934
NULL	Acta_Pharmacol_Sin_2011_Oct_15_32(10)_1303-1308.nxml.txt.nlp	21841812	SENT134	36	36	11	11	losartan	CYP2C9	PA450268	1559	0.934
NULL	Gastroenterol_Hepatol_Bed_Bench_2013_6(Suppl_1)_S39-S44.nxml.txt.nlp	24834286	SENT50	17	17	9	9	streptomycin	FBS	PA451512	64319;26269	0.934
NULL	Clin_Med_Insights_Oncol_2012_Dec_6_6_407-421.nxml.txt.nlp	23239933	SENT43	19	19	8	8	gefitinib	ABCG2	PA131301952	9429	0.934
NULL	Clin_Ophthalmol_2013_Dec_21_7_7-14.nxml.txt.nlp	23293509	SENT97	42	42	12	12	travoprost	BAK	PA164781371	578	0.934
NULL	Acta_Pharmacol_Sin_2012_Jan_28_33(1)_66-74.nxml.txt.nlp	22120966	SENT37	4	4	15	15	genistein	OPG	PA165109660	690	0.934
NULL	Autophagy_2012_Dec_1_8(12)_1875-1876.nxml.txt.nlp	22874642	SENT24	2	2	13	13	chloroquine	MTOR	PA448948	2475	0.934
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Aug_11_68(Pt_9)_o2695-o2696.nxml.txt.nlp	22969587	SENT72	11	11	34	34	piperazine	mol	PA450977	90527	0.934
NULL	Basic_Res_Cardiol_2014_May_22_109(4)_416.nxml.txt.nlp	24847907	SENT170	3	3	20	20	diazoxide	GAPDH	PA449285	2597	0.934
NULL	Oxid_Med_Cell_Longev_2013_Apr_21_2013_412576.nxml.txt.nlp	23710286	SENT167	0	0	19	19	curcumin	NRF2	PA151958596	2551;4780	0.934
NULL	Cancer_Cell_Int_2006_Aug_9_6_20.nxml.txt.nlp	16899133	SENT187	3	3	16	16	l-methionine	p27	PA450423	5715;10534	0.934
NULL	Oncotarget_2014_Feb_13_5(3)_577-586.nxml.txt.nlp	24583697	SENT190	3	3	15	15	methotrexate	HMGB1	PA450428	3146	0.934
NULL	Br_J_Cancer_2011_Aug_23_105(5)_649-657.nxml.txt.nlp	21811251	SENT159	31	31	7	7	gefitinib	IGF1R	PA131301952	3480	0.934
NULL	Mol_Cancer_2010_Aug_16_9_217.nxml.txt.nlp	20712901	SENT157	9	9	12	12	curcumin	STAT3	PA151958596	6774	0.934
NULL	J_Mol_Signal_2006_Dec_6_1_8.nxml.txt.nlp	17224083	SENT148	10	10	35	35	thrombin	Rho	PA451674	29984	0.934
NULL	Br_J_Cancer_2011_Jul_26_105(3)_353-359.nxml.txt.nlp	21750549	SENT159	8	8	20	20	vemurafenib	BRAF	PA165946873	673	0.934
NULL	Reprod_Biol_Endocrinol_2003_Feb_6_1_12.nxml.txt.nlp	12646063	SENT212	8	8	30	30	estradiol	PRL	PA449503	5617	0.934
NULL	Clin_Dev_Immunol_2013_Sep_17_2013_791262.nxml.txt.nlp	24151519	SENT12	33	33	5	5	heparin	CD86	PA449855	942	0.934
NULL	Oncoscience_2014_Jul_3_1(6)_407-422.nxml.txt.nlp	25594039	SENT199	19	19	9	9	olaparib	BRCA2		675	0.934
NULL	Ann_Rheum_Dis_2008_Aug_29_67(8)_1096-1103.nxml.txt.nlp	18055472	SENT122	10	10	4	4	abatacept	ACR	PA164747080	49	0.934
NULL	Br_J_Pharmacol_2014_Apr_28_171(8)_1798-1817.nxml.txt.nlp	24116962	SENT208	3	3	19	19	l-arginine	MELAS	PA448478	4219	0.934
NULL	EJC_Suppl_2013_Sep_5_11(2)_80.nxml.txt.nlp	NULL	SENT14	23	23	3	3	dacarbazine	BRAF	PA449197	673	0.934
NULL	Oncotarget_2013_Aug_26_4(10)_1662-1672.nxml.txt.nlp	24091566	SENT12	4	4	8	8	trastuzumab	HER2	PA451743	2064	0.934
NULL	Mol_Biol_Rep_2012_May_20_39(5)_5253-5267.nxml.txt.nlp	22183301	SENT68	8	8	0	0	gliclazide	NAC	PA10892	22861	0.934
NULL	Food_Dig_2011_Dec_15_2(1-3)_52-61.nxml.txt.nlp	22558059	SENT81	1	1	12	12	lipase	LIP	PA450239	23049	0.934
NULL	Diabetes_2009_Jan_58(1)_104-115.nxml.txt.nlp	18835938	SENT166	32	32	15	15	pioglitazone	MCP-3	PA450970	6354	0.934
NULL	Ann_Surg_Treat_Res_2014_Feb_22_86(2)_68-75.nxml.txt.nlp	24761411	SENT191	9	9	14	14	oxaliplatin	survivin	PA131285527	332	0.934
NULL	Drugs_R_D_2010_Nov_25_10(4)_219-224.nxml.txt.nlp	21171668	SENT10	16	16	32	32	clopidogrel	DES	PA449053	1674	0.934
NULL	Arthritis_Res_Ther_2013_Jul_9_15(4)_R73.nxml.txt.nlp	23837669	SENT308	15	15	0	0	colchicine	MICL	PA449092	160364	0.934
NULL	Indian_J_Dermatol_2014_May-Jun_59(3)_271-274.nxml.txt.nlp	24891659	SENT3	8	8	5	5	erlotinib	EGFR	PA134687924	1956	0.934
NULL	Mol_Vis_2014_Mar_30_20_441-457.nxml.txt.nlp	24715760	SENT49	10	10	32	32	geldanamycin	HIF-1	PA152031327	29072	0.934
NULL	Leukemia_2014_Apr_14_28(4)_961-964.nxml.txt.nlp	24418991	SENT39	34	34	15	15	imatinib	P-gp	PA10804	5243	0.934
NULL	Allergy_Asthma_Immunol_Res_2013_Sep_27_5(5)_258-276.nxml.txt.nlp	24003382	SENT54	16	16	3	3	pranlukast	CYSLTR1	PA134698661	10800	0.934
NULL	Br_J_Cancer_2012_Nov_6_107(10)_1702-1713.nxml.txt.nlp	23047550	SENT323	16	16	21	21	sunitinib	KDR	PA162372840	3791	0.934
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT258	40	40	19	19	gefitinib	PTEN	PA131301952	5728	0.934
NULL	Nucleic_Acids_Res_2011_Jun_9_39(11)_4640-4652.nxml.txt.nlp	21310710	SENT310	12	12	20	20	camptothecin	SATB1	PA153590860	6304	0.934
NULL	Am_J_Cardiovasc_Drugs_2013_Jun_20_13(5)_331-342.nxml.txt.nlp	23784266	SENT220	6	6	15	15	dabigatran	P-gp		5243	0.934
NULL	Eur_Heart_J_2014_Jun_14_35(23)_1510-1514.nxml.txt.nlp	24748565	SENT24	26	26	6	6	clopidogrel	P2Y12	PA449053	64805	0.934
NULL	Clin_Pharmacol_2011_May_24_3_5-12.nxml.txt.nlp	22287852	SENT112	18	18	7	7	eculizumab	C3b	PA164776637	718	0.934
NULL	Avicenna_J_Phytomed_2014_Sep-Oct_4(5)_354-363.nxml.txt.nlp	25386398	SENT105	6	6	10	10	rosuvastatin	ANOVA	PA134308647	4858	0.934
NULL	Clin_Ophthalmol_2011_Feb_11_5_167-170.nxml.txt.nlp	21383944	SENT18	15	15	1	1	bevacizumab	hole	PA130232992	80757	0.934
NULL	Onco_Targets_Ther_2014_May_8_7_697-702.nxml.txt.nlp	24855380	SENT51	4	4	9	9	sunitinib	VEGFR	PA162372840	3791	0.934
NULL	Patient_Prefer_Adherence_2013_May_20_7_435-446.nxml.txt.nlp	23717037	SENT126	33	33	3	3	teriparatide	ACR	PA451620	49	0.934
NULL	ScientificWorldJournal_2014_Nov_3_2014_342143.nxml.txt.nlp	25530997	SENT53	42	42	33	33	oxacillin	San	PA450725	80218	0.934
NULL	Behav_Brain_Funct_2005_Jul_15_1_9.nxml.txt.nlp	16022733	SENT218	12	12	3	3	methylphenidate	DRD1	PA450464	1812	0.934
NULL	J_Hematol_Oncol_2013_Jan_4_6_1.nxml.txt.nlp	23286345	SENT144	21	21	7	7	cetuximab	KRAS	PA10040	3845	0.934
NULL	Front_Oncol_2014_Sep_16_4_238.nxml.txt.nlp	25279350	SENT195	35	35	45	45	afatinib	EGFR	PA165981154	1956	0.934
NULL	Endocrinol_Metab_(Seoul)_2014_Sep_25_29(3)_379-387.nxml.txt.nlp	25309798	SENT134	21	21	16	16	resveratrol	SIRT1		23411	0.934
NULL	Scientifica_(Cairo)_2012_Jul_11_2012_306830.nxml.txt.nlp	24278684	SENT124	0	0	6	6	thrombin	PAR-1	PA451674	2011;2149	0.934
NULL	Cancer_Manag_Res_2011_Jul_13_3_257-266.nxml.txt.nlp	21792334	SENT114	11	11	18	18	trastuzumab	HER2	PA451743	2064	0.934
NULL	Oncotarget_2013_Nov_15_4(11)_1866-1867.nxml.txt.nlp	24272818	SENT3	13	13	22	22	pertuzumab	HER2		2064	0.934
NULL	Chem_Rev_2013_Jul_10_113(7)_4633-4679.nxml.txt.nlp	23514336	SENT300	5	5	22	22	collagenase	GAPDH	PA449107	2597	0.934
NULL	Adv_Pharmacol_Sci_2014_Apr_17_2014_354264.nxml.txt.nlp	24822061	SENT299	28	28	16	16	heparin	ADP	PA449855	23038	0.934
NULL	J_Cancer_2013_Jun_21_4(5)_391-401.nxml.txt.nlp	23833684	SENT172	0	0	4	4	geldanamycin	Hsp90	PA152031327	3320	0.934
NULL	ScientificWorldJournal_2013_Oct_22_2013_346910.nxml.txt.nlp	24235885	SENT65	31	31	5	5	phenol	KSA	PA450913	4072	0.934
NULL	Br_J_Cancer_1996_Oct_74(7)_1120-1125.nxml.txt.nlp	8855985	SENT17	27	27	13	13	tamoxifen	pS2	PA451581	7031	0.934
NULL	Br_J_Cancer_2011_May_24_104(11)_1686-1690.nxml.txt.nlp	21540861	SENT3	0	0	11	11	vatalanib	KIT	PA7001	3815	0.934
NULL	Case_Rep_Ophthalmol_Med_2012_Dec_18_2012_379132.nxml.txt.nlp	23320223	SENT41	32	32	0	0	gefitinib	EGFR	PA131301952	1956	0.934
NULL	Br_J_Pharmacol_2008_Oct_18_155(4)_596-605.nxml.txt.nlp	18852694	SENT116	10	10	3	3	fenofibrate	aP2	PA449594	2167	0.934
NULL	Nat_Commun_2014_Dec_8_5_5736.nxml.txt.nlp	25484020	SENT662	10	10	18	18	anastrozole	TRPA1	PA448432	8989	0.934
NULL	Comp_Hepatol_2005_Feb_8_4_2.nxml.txt.nlp	15701172	SENT205	16	16	22	22	coumarin	CYP3A4	PA134521193	1576	0.934
NULL	Indian_J_Dermatol_2013_Jan-Feb_58(1)_61-64.nxml.txt.nlp	23372216	SENT99	4	4	12	12	paroxetine	CYP3A4	PA450801	1576	0.934
NULL	Fibrogenesis_Tissue_Repair_2010_Aug_5_3_13.nxml.txt.nlp	20687922	SENT329	5	5	12	12	bevacizumab	VEGF-A	PA130232992	7422	0.934
NULL	Ann_Gastroenterol_2014_27(4)_304-312.nxml.txt.nlp	25331715	SENT180	34	34	30	30	allopurinol	TPMT	PA448320	7172	0.934
NULL	Mol_Cancer_2009_Dec_3_8_115.nxml.txt.nlp	19958544	SENT147	17	17	8	8	nutlin-3	PUMA		27113	0.934
NULL	Diabetes_Care_2008_Oct_31(10)_2062-2069.nxml.txt.nlp	18820229	SENT129	8	8	15	15	acarbose	DREAM	PA448010	30818	0.934
NULL	Arch_Drug_Inf_2011_Mar_4(1)_1-9.nxml.txt.nlp	21572514	SENT28	10	10	20	20	ciprofloxacin	P-gp	PA449009	5243	0.934
NULL	Nat_Med_2013_Feb_6_19(2)_217-226.nxml.txt.nlp	23291629	SENT92	22	22	12	12	isoproterenol	TRIP-Br2	PA450121	9792	0.934
NULL	Front_Neurosci_2013_Jul_31_7_132.nxml.txt.nlp	23914152	SENT210	33	33	17	17	paroxetine	NAT	PA450801	6046	0.934
NULL	Mol_Cancer_2009_Jul_3_8_43.nxml.txt.nlp	19575780	SENT230	9	9	5	5	paclitaxel	survivin	PA450761	332	0.934
NULL	Oncotarget_2011_Aug_30_2(8)_610-626.nxml.txt.nlp	21881167	SENT119	20	20	5	5	doxorubicin	Raf-1	PA449412	5894	0.934
NULL	Angew_Chem_Int_Ed_Engl_2013_Jan_2_52(1)_325-330.nxml.txt.nlp	23080482	SENT67	19	19	1	1	thrombin	spatial	PA451674	219793	0.934
NULL	Cent_European_J_Urol_2013_Dec_19_66(4)_394-404.nxml.txt.nlp	24757527	SENT261	6	6	12	12	bevacizumab	IFN	PA130232992	3439	0.934
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Mar_27_66(Pt_4)_o924.nxml.txt.nlp	21580734	SENT52	18	18	6	6	ethanol	mol	PA448073	90527	0.934
NULL	Acta_Neuropathol_Commun_2014_Jul_22_2(1)_84.nxml.txt.nlp	NULL	SENT198	0	0	16	16	thalidomide	IL-6	PA451644	3569	0.934
NULL	Ecancermedicalscience_2010_Apr_30_4_ed6.nxml.txt.nlp	24966881	SENT9	30	30	23	23	trastuzumab	PTEN	PA451743	5728	0.934
NULL	Diabetol_Metab_Syndr_2014_Sep_23_6(1)_102.nxml.txt.nlp	NULL	SENT35	10	10	20	20	atorvastatin	RAGE	PA448500	177	0.934
NULL	Front_Endocrinol_(Lausanne)_2014_Oct_9_5_166.nxml.txt.nlp	25346724	SENT120	9	9	21	21	resveratrol	VEGF-A		7422	0.934
NULL	J_Gen_Physiol_2012_Nov_140(5)_541-555.nxml.txt.nlp	23109716	SENT323	14	14	12	12	capsaicin	TRPV1	PA448776	7442	0.934
NULL	Eur_Respir_J_2014_Jul_23_44(1)_23-63.nxml.txt.nlp	24659544	SENT373	7	7	21	21	pyrazinamide	DST	PA451182	667	0.934
NULL	Br_J_Cancer_2012_Sep_4_107(6)_947-955.nxml.txt.nlp	22892392	SENT213	23	23	11	11	tamoxifen	ERBB2	PA451581	2064	0.934
NULL	Br_J_Cancer_2000_Jun_82(11)_1851-1859.nxml.txt.nlp	10839301	SENT8	26	26	13	13	bleomycin	CD95	PA448645	355	0.934
NULL	Evid_Based_Complement_Alternat_Med_2013_Mar_26_2013_625892.nxml.txt.nlp	23589719	SENT249	7	7	13	13	probenecid	TAS2R16	PA451106	50833	0.934
NULL	J_Cell_Mol_Med_2014_Oct_11_18(10)_2031-2043.nxml.txt.nlp	25109475	SENT357	7	7	24	24	valsartan	AMPK	PA451848	5563	0.934
NULL	Neuroimage_Clin_2013_Sep_6_3_290-300.nxml.txt.nlp	24273714	SENT865	19	19	43	43	pioglitazone	ANOVA	PA450970	4858	0.934
NULL	Cell_Death_Dis_2010_Nov_18_1(11)_e102.nxml.txt.nlp	21368867	SENT119	9	9	13	13	gentamicin	14-3-3	PA449753	10971	0.934
NULL	Cancers_(Basel)_2014_Nov_25_6(4)_2313-2329.nxml.txt.nlp	25534569	SENT3	16	16	26	26	cabozantinib	Met	PA165906891	79811	0.934
NULL	Curr_Mol_Med_2014_Jun_14(5)_603-615.nxml.txt.nlp	24894176	SENT86	10	10	18	18	daunorubicin	BI-1	PA449212	7009	0.934
NULL	Pharmaceuticals_(Basel)_2013_Jan_16_6(1)_85-107.nxml.txt.nlp	23667320	SENT199	19	19	28	28	doxorubicin	MSN	PA449412	4478	0.934
NULL	Cancer_Immunol_Immunother_2011_Jun_25_60(6)_793-808.nxml.txt.nlp	21350947	SENT220	9	9	40	40	sorafenib	IFN	PA7000	3439	0.934
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT249	20	20	5	5	pertuzumab	HER2		2064	0.934
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT189	17	17	2	2	tacrolimus	JAK2	PA451578	3717	0.934
NULL	Mol_Vis_2012_Nov_29_18_2839-2846.nxml.txt.nlp	23233786	SENT125	3	3	11	11	geldanamycin	CB2	PA152031327	1269	0.934
NULL	Diabetes_Care_2013_Jul_12_36(7)_2126-2132.nxml.txt.nlp	23645884	SENT48	36	36	28	28	sitagliptin	GLP-1	PA164748978	100125288	0.934
NULL	Evid_Based_Complement_Alternat_Med_2007_Jun_2_4(2)_195-202.nxml.txt.nlp	17549236	SENT64	38	38	4	4	pentobarbital	mol	PA450859	90527	0.934
NULL	Cancer_Cell_Int_2010_Sep_9_10_32.nxml.txt.nlp	20828393	SENT132	24	24	18	18	cisplatin	ATF3	PA449014	467	0.934
NULL	Br_J_Cancer_2010_Sep_7_103(6)_765-771.nxml.txt.nlp	20700120	SENT101	9	9	2	2	sertraline	CYP2D6	PA451333	1565	0.934
NULL	Br_J_Cancer_2013_Feb_19_108(3)_557-563.nxml.txt.nlp	23361053	SENT119	18	18	6	6	tamoxifen	PAK1	PA451581	5585;5058	0.934
NULL	Br_J_Cancer_2011_Apr_12_104(8)_1278-1287.nxml.txt.nlp	21487429	SENT245	15	15	3	3	cisplatin	c-FLIP	PA449014	8837	0.934
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT233	10	10	13	13	sn-38	ABCG2		9429	0.934
NULL	Exp_Ther_Med_2013_Apr_5_5(4)_1259-1263.nxml.txt.nlp	23596498	SENT105	14	14	26	26	capsaicin	TRPV1	PA448776	7442	0.934
NULL	Environ_Health_Perspect_2007_Oct_19_115(10)_1454-1459.nxml.txt.nlp	17938735	SENT122	1	1	24	24	procainamide	DNMT1	PA451108	1786	0.934
NULL	Gastroenterol_Hepatol_Bed_Bench_2011_Spring_4(2)_43-52.nxml.txt.nlp	24834156	SENT112	12	12	2	2	trypsin	TATI	PA451806	6690	0.934
NULL	AIDS_Res_Ther_2008_Mar_28_5_5.nxml.txt.nlp	18373851	SENT16	1	1	15	15	ritonavir	ATV	PA451260	4683	0.934
NULL	Diabetes_Care_2012_Aug_14_35(8)_1701-1707.nxml.txt.nlp	22584136	SENT26	24	24	5	5	lipase	FABP4	PA450239	2167	0.934
NULL	Br_J_Cancer_2013_Mar_19_108(5)_1079-1091.nxml.txt.nlp	23449353	SENT214	19	19	32	32	docetaxel	MIC-1	PA449383	29919;9518	0.934
NULL	Breast_Cancer_Res_2010_May_18_12(Suppl_1)_P20.nxml.txt.nlp	NULL	SENT8	12	12	2	2	doxycycline	AP-2	PA449415	7020	0.934
NULL	Pharmaceuticals_(Basel)_2014_Sep_17_7(9)_943-953.nxml.txt.nlp	25232798	SENT8	28	28	14	14	trastuzumab	HER2	PA451743	2064	0.934
NULL	Acta_Pharmacol_Sin_2011_Oct_15_32(10)_1233-1238.nxml.txt.nlp	21841815	SENT12	6	6	40	40	mecamylamine	CTX	PA450334	1593	0.934
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT260	36	36	21	21	gefitinib	PTEN	PA131301952	5728	0.934
NULL	Cancer_Immunol_Immunother_2014_Jul_24_63(9)_985-989.nxml.txt.nlp	25056819	SENT48	42	42	25	25	cyclophosphamide	CCL17	PA449165	6361	0.934
NULL	Breast_Cancer_Res_Treat_2014_Apr_9_145(1)_73-82.nxml.txt.nlp	24715380	SENT82	7	7	2	2	tamoxifen	CXCR3	PA451581	2833	0.934
NULL	Cell_Death_Dis_2011_Aug_11_2(8)_e191.nxml.txt.nlp	21833029	SENT63	11	11	4	4	oxaliplatin	CT26	PA131285527	168400	0.934
NULL	Acta_Pharmacol_Sin_2009_Sep_17_30(9)_1316-1322.nxml.txt.nlp	19684609	SENT112	16	16	46	46	rosiglitazone	PTEN	PA451283	5728	0.934
NULL	Oncogene_2013_Oct_10_32(41)_4892-4902.nxml.txt.nlp	23178494	SENT240	24	24	28	28	tamoxifen	TMX	PA451581	81542	0.934
NULL	Cancers_(Basel)_2012_Oct_29_4(4)_1146-1160.nxml.txt.nlp	24213502	SENT465	6	6	24	24	tamoxifen	ATAC	PA451581	6375	0.934
NULL	Eur_J_Clin_Pharmacol_2011_May_8_67(5)_493-506.nxml.txt.nlp	21140139	SENT298	41	41	16	16	oxycodone	CYP3A4	PA450741	1576	0.934
NULL	Cancer_Cell_Int_2005_Jun_1_5_18.nxml.txt.nlp	15929791	SENT81	5	5	25	25	bortezomib	CD31	PA10252	5175	0.934
NULL	Mol_Cancer_2009_Jun_9_8_37.nxml.txt.nlp	19508729	SENT10	17	17	6	6	gemcitabine	HO-1	PA449748	3162	0.934
NULL	Clin_Med_Insights_Case_Rep_2011_Dec_4_4_73-77.nxml.txt.nlp	22174593	SENT79	23	23	12	12	warfarin	CYP2C9	PA451906	1559	0.934
NULL	Indian_J_Med_Res_2013_Nov_138(5)_717-731.nxml.txt.nlp	24434324	SENT278	30	30	27	27	tocilizumab	IL-6	PA165292659	3569	0.934
NULL	J_Antimicrob_Chemother_2014_Feb_29_69(2)_368-374.nxml.txt.nlp	24080503	SENT134	6	6	36	36	sulfamethoxazole	DHPS	PA451544	1725	0.934
NULL	Arthritis_Res_Ther_2006_May_11_8(3)_209.nxml.txt.nlp	16712713	SENT446	40	40	28	28	rituximab	TNF	PA451261	7124	0.934
NULL	Protein_Cell_2014_Dec_29_5(12)_945-949.nxml.txt.nlp	25261996	SENT27	21	21	8	8	chloroquine	C42	PA448948	51654	0.934
NULL	Br_J_Cancer_2011_Apr_12_104(8)_1278-1287.nxml.txt.nlp	21487429	SENT135	34	34	38	38	cisplatin	p53	PA449014	7157	0.934
NULL	Oncol_Lett_2014_Mar_19_7(3)_674-678.nxml.txt.nlp	24527071	SENT149	18	18	5	5	cisplatin	AKR1C2	PA449014	1646	0.934
NULL	Trials_2013_Apr_23_14_105.nxml.txt.nlp	23782520	SENT184	28	28	4	4	fluoxetine	ANOVA	PA449673	4858	0.934
NULL	Br_J_Haematol_2014_Mar_13_164(1)_811-821.nxml.txt.nlp	24328678	SENT213	5	5	19	19	lenalidomide	Aiolos	PA162363968	22806	0.934
NULL	Br_J_Cancer_2012_May_22_106(11)_1779-1789.nxml.txt.nlp	22549178	SENT31	15	15	24	24	pertuzumab	HER2		2064	0.934
NULL	JAKSTAT_2013_Jul_1_2(3)_e24574.nxml.txt.nlp	24069558	SENT79	20	20	27	27	doxycycline	JAK2	PA449415	3717	0.934
NULL	Oncotarget_2013_Nov_22_5(4)_933-943.nxml.txt.nlp	24659749	SENT124	11	11	2	2	nutlin-3	AML3		860	0.934
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT253	25	25	10	10	perifosine	DR5	PA165291471	8795	0.934
NULL	Diabetes_2011_Mar_21_60(3)_757-765.nxml.txt.nlp	21282370	SENT161	24	24	42	42	isoproterenol	PTRF	PA450121	284119	0.934
NULL	Tumour_Biol_2014_Aug_12_35(8)_7807-7819.nxml.txt.nlp	24817012	SENT377	19	19	6	6	gemcitabine	ERCC1	PA449748	2067	0.934
NULL	Breast_Cancer_Res_2010_Jun_24_12(3)_R41.nxml.txt.nlp	20576088	SENT172	26	26	38	38	paclitaxel	EGFR	PA450761	1956	0.934
NULL	Mol_Cancer_2014_Jan_13_13_7.nxml.txt.nlp	24418169	SENT213	13	13	30	30	sorafenib	STAT3	PA7000	6774	0.934
NULL	Case_Rep_Oncol_2012_Aug_9_5(2)_428-433.nxml.txt.nlp	22949905	SENT68	16	16	41	41	irinotecan	KRAS	PA450085	3845	0.934
NULL	Int_J_Mol_Sci_2010_Sep_13_11(9)_3195-3208.nxml.txt.nlp	20957088	SENT54	6	6	0	0	lipase	AT2	PA450239	186	0.934
NULL	Oncol_Lett_2014_Jun_2_7(6)_1889-1894.nxml.txt.nlp	24932254	SENT28	24	24	8	8	cisplatin	OCT1	PA449014	5451;6580	0.934
NULL	Oncotarget_2014_Jun_22_5(13)_4581-4602.nxml.txt.nlp	25015035	SENT307	34	34	17	17	bortezomib	AKT	PA10252	207	0.934
NULL	Cell_Death_Differ_2010_Apr_16_17(4)_666-676.nxml.txt.nlp	19834494	SENT272	18	18	6	6	melphalan	HMGB1	PA450354	3146	0.934
NULL	Int_J_Mol_Sci_2014_Oct_8_15(10)_17974-17999.nxml.txt.nlp	25299695	SENT117	6	6	0	0	curcumin	HO-1	PA151958596	3162	0.934
NULL	Indian_J_Pharmacol_2014_Jan-Feb_46(1)_3-12.nxml.txt.nlp	24550577	SENT298	24	24	10	10	vismodegib	CYP2C8		1558	0.934
NULL	Eur_J_Med_Res_2009_Nov_24_14(Suppl_3)_17-21.nxml.txt.nlp	19959412	SENT79	12	12	31	31	raltegravir	UGT		7361;7355	0.934
NULL	Breast_Cancer_Res_2006_Nov_27_8(6)_R66.nxml.txt.nlp	17129383	SENT144	5	5	14	14	paclitaxel	HER2	PA450761	2064	0.934
NULL	Front_Psychol_2014_Sep_1_5_925.nxml.txt.nlp	25225489	SENT1161	3	3	6	6	rosiglitazone	PPARgamma	PA451283	5468	0.934
NULL	Acta_Pharmacol_Sin_2011_Oct_15_32(10)_1253-1258.nxml.txt.nlp	21970837	SENT96	18	18	8	8	darapladib	MCP-1	PA165884699	6347	0.934
NULL	Comput_Struct_Biotechnol_J_2012_Oct_31_3_e201210005.nxml.txt.nlp	24688665	SENT143	9	9	1	1	nadh	PDH	PA164755085	54704	0.934
NULL	Chemother_Res_Pract_2012_Aug_29_2012_817297.nxml.txt.nlp	22970367	SENT107	26	26	14	14	gefitinib	PIK3CA	PA131301952	5290	0.934
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT268	11	11	4	4	aripiprazole	PRL	PA10026	5617	0.934
NULL	Int_J_Mol_Sci_2007_Mar_13_8(3)_229-240.nxml.txt.nlp	NULL	SENT146	29	29	38	38	acetazolamide	AQP1	PA448018	358	0.934
NULL	Carcinogenesis_2010_Dec_27_31(12)_2049-2057.nxml.txt.nlp	20876285	SENT6	32	32	14	14	tamoxifen	HER2	PA451581	2064	0.934
NULL	Oncotarget_2014_Jun_3_5(13)_4920-4928.nxml.txt.nlp	24952482	SENT187	4	4	8	8	crizotinib	ALK	PA165946122	238	0.934
NULL	Breast_Cancer_Res_Treat_2012_Jun_15_133(3)_1057-1065.nxml.txt.nlp	22418700	SENT34	2	2	27	27	afatinib	HER2	PA165981154	2064	0.934
NULL	Int_J_Biol_Sci_2012_Sep_6_8(8)_1109-1120.nxml.txt.nlp	22991499	SENT152	1	1	9	9	l-arginine	ARG	PA448478	473;27	0.934
NULL	Breast_Cancer_Res_Treat_2014_Nov_24_143(1)_125-133.nxml.txt.nlp	24272078	SENT133	12	12	24	24	fulvestrant	aromatase	PA164747170	1588	0.934
NULL	J_Gen_Physiol_2003_Mar_121(3)_181-197.nxml.txt.nlp	12601083	SENT342	5	5	16	16	tolbutamide	SUR1	PA451718	6833	0.934
NULL	Breast_Cancer_Res_2010_Jun_28_12(3)_R43.nxml.txt.nlp	20579400	SENT102	36	36	5	5	doxorubicin	MAPT	PA449412	4137	0.934
NULL	Ital_J_Pediatr_2014_Aug_11_40(Suppl_1)_A26.nxml.txt.nlp	NULL	SENT10	5	5	17	17	tocilizumab	IL-6	PA165292659	3569	0.934
NULL	Oncotarget_2013_Nov_23_5(1)_196-210.nxml.txt.nlp	24344116	SENT69	18	18	31	31	doxorubicin	ICAM1	PA449412	3383	0.934
NULL	Oncol_Lett_2014_May_11_7(5)_1401-1408.nxml.txt.nlp	24765145	SENT155	25	25	14	14	paclitaxel	PI3K	PA450761	5290	0.934
NULL	Br_J_Cancer_2010_Jan_5_102(1)_151-161.nxml.txt.nlp	19935791	SENT9	21	21	10	10	panitumumab	TOPK	PA162373091	55872	0.934
NULL	Oncotarget_2011_Mar_23_2(3)_165-177.nxml.txt.nlp	21444946	SENT141	35	35	9	9	erlotinib	EGFR	PA134687924	1956	0.934
NULL	Curr_Opin_Endocrinol_Diabetes_Obes_2014_Oct_28_21(5)_394-404.nxml.txt.nlp	25122493	SENT100	28	28	1	1	thyroglobulin	RAI	PA164754910	10848;6050	0.934
NULL	Nucleic_Acids_Res_2005_Jun_8_33(10)_3283-3291.nxml.txt.nlp	15944449	SENT166	1	1	11	11	melphalan	ERCC1	PA450354	2067	0.934
NULL	J_Cell_Mol_Med_2014_Oct_11_18(10)_2031-2043.nxml.txt.nlp	25109475	SENT344	3	3	9	9	valsartan	LKB1	PA451848	6794	0.934
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT271	27	27	22	22	tacrolimus	SOCS3	PA451578	9021	0.934
NULL	Front_Physiol_2010_Jun_18_1_13.nxml.txt.nlp	21423356	SENT98	41	41	2	2	furosemide	Ray	PA449719	26751	0.934
NULL	Gastric_Cancer_2014_Jan_12_17(4)_638-647.nxml.txt.nlp	24414131	SENT2	28	28	13	13	trastuzumab	HER2	PA451743	2064	0.934
NULL	Clin_Genet_2014_Jan_1_86(1)_21-28.nxml.txt.nlp	24684508	SENT64	8	8	27	27	warfarin	CYP2C9	PA451906	1559	0.934
NULL	Mol_Cancer_2010_Apr_15_9_77.nxml.txt.nlp	20398291	SENT38	4	4	0	0	geldanamycin	Hsp90	PA152031327	3320	0.934
NULL	Int_J_Biol_Sci_2011_Oct_26_7(8)_1180-1187.nxml.txt.nlp	22043175	SENT49	13	13	27	27	tamoxifen	PINK1	PA451581	65018	0.934
NULL	Front_Synaptic_Neurosci_2013_Oct_17_5_8.nxml.txt.nlp	24146648	SENT401	23	23	4	4	forskolin	RIM1	PA146096022	22999	0.934
NULL	Int_J_Endocrinol_Metab_2013_Dec_21_Winter_11(1)_57-61.nxml.txt.nlp	23853622	SENT106	12	12	3	3	bromocriptine	PRL	PA448671	5617	0.934
NULL	Crit_Care_2011_Nov_30_15(6)_R289.nxml.txt.nlp	22129171	SENT145	3	3	18	18	dipyridamole	IL-10	PA449367	3586	0.934
NULL	Leukemia_2014_Aug_4_28(8)_1573-1585.nxml.txt.nlp	24496300	SENT218	4	4	1	1	cyclosporine	P-gp	PA449167	5243	0.934
NULL	Endocr_Connect_2012_Jun_8_1(1)_1-12.nxml.txt.nlp	23781298	SENT13	26	26	33	33	fenofibrate	adiponectin	PA449594	9370	0.934
NULL	Ital_J_Pediatr_2011_Aug_22_37_39.nxml.txt.nlp	21859484	SENT12	9	9	14	14	salbutamol	BDP	PA448068	10620;152926	0.934
NULL	Eur_J_Med_Res_2009_Nov_24_14(Suppl_3)_17-21.nxml.txt.nlp	19959412	SENT80	16	16	6	6	efavirenz	UGT1A1	PA449441	54658	0.934
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1149.nxml.txt.nlp	24675467	SENT19	2	2	11	11	trastuzumab	HER2	PA451743	2064	0.934
NULL	Arthritis_Res_Ther_2005_Apr_1_7(3)_R694-R703.nxml.txt.nlp	15899055	SENT201	38	38	20	20	leflunomide	IL-4	PA450192	3565	0.934
NULL	Cancer_Immunol_Immunother_2012_Jul_23_61(7)_1101-1111.nxml.txt.nlp	22193989	SENT108	5	5	20	20	oxaliplatin	IFN	PA131285527	3439	0.934
NULL	Br_J_Cancer_2004_May_4_90(9)_1733-1739.nxml.txt.nlp	15150604	SENT133	9	9	31	31	anastrozole	aromatase	PA448432	1588	0.934
NULL	Clin_Dev_Immunol_2013_Sep_17_2013_791262.nxml.txt.nlp	24151519	SENT12	33	33	9	9	heparin	CD25	PA449855	3669;3559	0.934
NULL	Adv_Hematol_2009_Dec_22_2009_924301.nxml.txt.nlp	20049174	SENT30	11	11	4	4	fluorescein	RUNX1	PA164746009	861	0.934
NULL	Cell_Death_Differ_2010_Mar_25_17(3)_398-407.nxml.txt.nlp	19779497	SENT98	7	7	20	20	doxorubicin	OCN	PA449412	632	0.934
NULL	Diabetes_2011_Nov_17_60(11)_2792-2801.nxml.txt.nlp	21911751	SENT70	4	4	21	21	sildenafil	ANOVA	PA451346	4858	0.934
NULL	Exp_Diabetes_Res_2012_Aug_15_2012_712617.nxml.txt.nlp	22927833	SENT131	13	13	30	30	estradiol	SUR1	PA449503	6833	0.934
NULL	J_Oncol_2012_Feb_2_2012_542851.nxml.txt.nlp	22481930	SENT239	2	2	7	7	ampicillin	TC1	PA448419	6947	0.934
NULL	Drug_Target_Insights_2013_Aug_19_7_27-34.nxml.txt.nlp	24023511	SENT83	27	27	9	9	clarithromycin	P-gp	PA449028	5243	0.934
NULL	Indian_J_Pharmacol_2013_Sep-Oct_45(5)_458-463.nxml.txt.nlp	24130379	SENT120	29	29	5	5	carvedilol	TLR4	PA448817	7099	0.934
NULL	Breast_Cancer_Res_2007_Aug_8_9(4)_R50.nxml.txt.nlp	17686159	SENT146	27	27	13	13	gefitinib	AKT	PA131301952	207	0.934
NULL	Biologics_2009_Oct_12_3_469-474.nxml.txt.nlp	19851472	SENT83	48	48	36	36	desloratadine	IL-5	PA164776964	3567	0.934
NULL	Hum_Genomics_Proteomics_2010_Aug_3_2010_159761.nxml.txt.nlp	20981231	SENT243	3	3	20	20	lithium	IMPA2	PA450243	3613	0.934
NULL	Neural_Regen_Res_2013_Jul_15_8(20)_1853-1862.nxml.txt.nlp	25206494	SENT169	34	34	7	7	ethanol	JNK	PA448073	5599	0.934
NULL	Cell_Biol_Int_Rep_(2010)_2012_Jun_21_19(1)_e00017.nxml.txt.nlp	23124518	SENT101	3	3	13	13	etoposide	Mcl-1	PA449552	4170	0.934
NULL	Nat_Med_2013_Dec_10_19(12)_10_1038_nm_3385.nxml.txt.nlp	24216752	SENT38	28	28	9	9	thrombin	PAR1	PA451674	79581;2149	0.934
NULL	J_Hematol_Oncol_2011_Apr_20_4_16.nxml.txt.nlp	21504625	SENT212	9	9	13	13	bsi-201	PARP-1		25976	0.934
NULL	ScientificWorldJournal_2012_Mar_12_2012_285274.nxml.txt.nlp	22536131	SENT158	13	13	5	5	diphenhydramine	IFN	PA449349	3439	0.934
NULL	J_Cell_Biol_1984_Mar_1_98(3)_1048-1053.nxml.txt.nlp	6321514	SENT6	13	13	45	45	chloroquine	EGF	PA448948	1950	0.934
NULL	Br_J_Cancer_2013_Feb_19_108(3)_557-563.nxml.txt.nlp	23361053	SENT204	21	21	5	5	tamoxifen	PAK1	PA451581	5585;5058	0.934
NULL	J_Cell_Biol_1998_May_18_141(4)_849-862.nxml.txt.nlp	9585405	SENT347	5	5	19	19	paraformaldehyde	CLIP-170	PA450790	6249	0.934
NULL	BMB_Rep_2014_Nov_47(11)_649-654.nxml.txt.nlp	25301019	SENT161	19	19	39	39	l-serine	IL-10	PA451330	3586	0.934
NULL	Arthritis_Res_Ther_2010_Apr_29_12(2)_R73.nxml.txt.nlp	20429888	SENT216	17	17	3	3	bortezomib	AP-1	PA10252	2353;3727;2354;3725	0.934
NULL	HSR_Proc_Intensive_Care_Cardiovasc_Anesth_2009_1(3)_13-21.nxml.txt.nlp	23439962	SENT126	14	14	2	2	nesiritide	NAPA	PA164781045	9476;8775	0.934
NULL	Orphanet_J_Rare_Dis_2007_Jan_4_2_1.nxml.txt.nlp	17204147	SENT91	11	11	7	7	trypsin	SPINK1	PA451806	6690	0.934
NULL	Arch_Med_Sci_2013_Aug_30_9(4)_739-744.nxml.txt.nlp	24049538	SENT107	25	25	21	21	candesartan	PC-3	PA448765	692094	0.934
NULL	Curr_Gerontol_Geriatr_Res_2010_Jun_8_2010_915296.nxml.txt.nlp	20631897	SENT178	12	12	20	20	rosuvastatin	CYP3A4	PA134308647	1576	0.934
NULL	J_Mol_Med_(Berl)_2013_Jul_9_91(7)_883-899.nxml.txt.nlp	23471434	SENT320	31	31	0	0	paclitaxel	CD133	PA450761	8842	0.934
NULL	Neural_Regen_Res_2013_May_25_8(15)_1349-1359.nxml.txt.nlp	25206429	SENT19	23	23	9	9	nimodipine	NR1	PA450633	27158	0.934
NULL	Acta_Pharmacol_Sin_2010_Apr_8_31(4)_461-469.nxml.txt.nlp	20208553	SENT173	16	16	4	4	ethanol	adiponectin	PA448073	9370	0.934
NULL	J_Korean_Neurosurg_Soc_2014_Nov_30_56(5)_431-435.nxml.txt.nlp	25535523	SENT39	4	4	12	12	gefitinib	gamma	PA131301952	9913	0.934
NULL	Cell_Commun_Signal_2011_May_20_9_14.nxml.txt.nlp	21599982	SENT73	22	22	5	5	pp2	MCP-1		6347	0.934
NULL	Mol_Cancer_2010_Aug_16_9_217.nxml.txt.nlp	20712901	SENT50	31	31	9	9	curcumin	STAT3	PA151958596	6774	0.934
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT417	12	12	2	2	cetuximab	BRAF	PA10040	673	0.934
NULL	J_Mol_Signal_2008_Dec_1_3_18.nxml.txt.nlp	19046439	SENT45	15	15	18	18	metformin	AMPK	PA450395	5563	0.934
NULL	Cancers_(Basel)_2011_Aug_19_3(3)_3370-3393.nxml.txt.nlp	24212958	SENT1027	23	23	9	9	cetuximab	KRAS	PA10040	3845	0.934
NULL	Oncol_Lett_2014_Jun_8_7(6)_2035-2040.nxml.txt.nlp	24932285	SENT150	22	22	3	3	irinotecan	ABCG2	PA450085	9429	0.934
NULL	Nat_Chem_Biol_2010_Apr_28_6(4)_291-299.nxml.txt.nlp	20190765	SENT80	19	19	32	32	dasatinib	CDCP1	PA162372878	64866	0.934
NULL	Mol_Cancer_2014_Feb_5_13_24.nxml.txt.nlp	24495306	SENT8	12	12	33	33	collagenase	ADAM17	PA449107	6868	0.934
NULL	Cancer_Med_2013_Aug_2_2(4)_571-582.nxml.txt.nlp	24156030	SENT234	27	27	6	6	curcumin	IL-6	PA151958596	3569	0.934
NULL	Mol_Cell_Biochem_2015_Oct_8_398(1-2)_165-173.nxml.txt.nlp	25292312	SENT149	27	27	7	7	bortezomib	ORP150	PA10252	10525	0.934
NULL	Exp_Diabetes_Res_2011_Jun_22_2011_279530.nxml.txt.nlp	21747825	SENT99	14	14	17	17	exenatide	GLP-1	PA164749238	100125288	0.934
NULL	Br_J_Cancer_2011_May_10_104(10)_1628-1640.nxml.txt.nlp	21505453	SENT45	16	16	26	26	pp2	San		80218	0.934
NULL	Iran_Red_Crescent_Med_J_2014_Sep_5_16(9)_e20153.nxml.txt.nlp	25593732	SENT104	41	41	26	26	desflurane	CYP2E1	PA164749136	1571	0.934
NULL	Brain_Sci_2013_Jun_19_3(2)_964-991.nxml.txt.nlp	24961433	SENT306	21	21	5	5	choline	spatial	PA448976	219793	0.934
NULL	Int_J_Mol_Sci_2014_Oct_20_15(10)_18840-18855.nxml.txt.nlp	25334060	SENT156	8	8	36	36	heparin	OPG	PA449855	690	0.934
NULL	Tuberc_Res_Treat_2013_Mar_27_2013_285094.nxml.txt.nlp	23634300	SENT31	19	19	4	4	ethambutol	PTB	PA164784021	58155	0.934
NULL	Br_J_Cancer_1999_Feb_79(5-6)_831-837.nxml.txt.nlp	10070877	SENT6	2	2	9	9	epirubicin	MX2	PA449476	4600	0.934
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT89	17	17	5	5	methotrexate	MSH2	PA450428	4436	0.934
NULL	Oxid_Med_Cell_Longev_2011_Aug_4_2011_471590.nxml.txt.nlp	21904644	SENT4	12	12	34	34	probucol	CA1	PA451107	759	0.934
NULL	Braz_J_Med_Biol_Res_2013_Aug_13_46(8)_650-658.nxml.txt.nlp	23969971	SENT127	38	38	0	0	cisplatin	STAT3	PA449014	6774	0.934
NULL	Diabetes_2009_Dec_31_58(12)_2851-2862.nxml.txt.nlp	19720788	SENT128	12	12	17	17	forskolin	PP1	PA146096022	5540;5464	0.934
NULL	Curr_Rheumatol_Rep_2010_Feb_8_12(1)_45-52.nxml.txt.nlp	20425533	SENT23	26	26	7	7	thrombin	VIII	PA451674	1351	0.934
NULL	Oncol_Rep_2014_Apr_28_31(4)_1605-1612.nxml.txt.nlp	24481648	SENT144	11	11	17	17	ponatinib	MRP7	PA165980594	89845;1080	0.934
NULL	Int_J_Breast_Cancer_2013_Jun_24_2013_137414.nxml.txt.nlp	23864953	SENT224	15	15	7	7	lapatinib	HER2	PA152241907	2064	0.934
NULL	Acta_Pharmacol_Sin_2013_Sep_5_34(9)_1208-1216.nxml.txt.nlp	23852087	SENT129	13	13	7	7	disulfiram	EPO	PA449376	7076;8288;2056	0.934
NULL	J_Innate_Immun_2011_Dec_12_4(1)_69-79.nxml.txt.nlp	21997473	SENT174	12	12	36	36	trypsin	gp39	PA451806	959	0.934
NULL	Int_J_Cell_Biol_2010_Apr_29_2010_928169.nxml.txt.nlp	20454702	SENT217	39	39	13	13	amiloride	AP-2	PA448368	7020	0.934
NULL	Mol_Cancer_2012_May_14_11_33.nxml.txt.nlp	22583829	SENT174	20	20	32	32	cisplatin	TLR4	PA449014	7099	0.934
NULL	Environ_Health_Perspect_2006_Sep_23_114(9)_1401-1406.nxml.txt.nlp	16966095	SENT137	15	15	2	2	tetracycline	p53	PA451640	7157	0.934
NULL	Chem_Cent_J_2012_Nov_23_6_139.nxml.txt.nlp	23173901	SENT200	26	26	32	32	thrombin	PAR1	PA451674	79581;2149	0.934
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_24_2012_673132.nxml.txt.nlp	23133498	SENT121	10	10	19	19	berberine	P-gp	PA165860812	5243	0.934
NULL	Oncoimmunology_2014_May_29_3_e28925.nxml.txt.nlp	25083322	SENT103	20	20	28	28	dasatinib	CD4	PA162372878	920	0.934
NULL	Scientifica_(Cairo)_2013_Dec_10_2013_691251.nxml.txt.nlp	24386592	SENT194	31	31	19	19	epirubicin	SIRT6	PA449476	51548	0.934
NULL	Ann_Oncol_2014_Jul_5_25(7)_1328-1333.nxml.txt.nlp	24603643	SENT12	24	24	15	15	palonosetron	NK1	PA10352	11126	0.934
NULL	Ther_Clin_Risk_Manag_2007_Dec_3(6)_1097-1104.nxml.txt.nlp	18516268	SENT171	2	2	28	28	abacavir	ATV	PA448004	4683	0.934
NULL	Front_Pharmacol_2014_May_27_5_123.nxml.txt.nlp	24904424	SENT101	19	19	0	0	thrombin	PAR1	PA451674	79581;2149	0.934
NULL	Clin_Interv_Aging_2009_Nov_18_4_445-449.nxml.txt.nlp	19966913	SENT34	15	15	1	1	risedronate	HIP	PA451255	6767;6159;64399;5068	0.934
NULL	J_Cell_Biol_1998_Jan_26_140(2)_335-345.nxml.txt.nlp	9442109	SENT246	8	8	4	4	chloroquine	NHE	PA448948	285335	0.934
NULL	Ann_Oncol_2013_Aug_12_24(8)_1994-1999.nxml.txt.nlp	23670096	SENT105	8	8	15	15	tamoxifen	AIB1	PA451581	8202	0.934
NULL	Oncotarget_2013_Aug_29_4(10)_1673-1685.nxml.txt.nlp	24127549	SENT259	2	2	23	23	resveratrol	SIRT1		23411	0.934
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT300	6	6	11	11	resveratrol	XIAP		331	0.934
NULL	Psychiatry_Investig_2012_Dec_12_9(4)_422-424.nxml.txt.nlp	23251210	SENT14	10	10	7	7	perphenazine	CYP2D6	PA450882	1565	0.934
NULL	Cell_Death_Dis_2014_Jul_3_5(7)_e1316.nxml.txt.nlp	24991768	SENT204	6	6	2	2	pemetrexed	ATF4	PA10810	468	0.934
NULL	Chemother_Res_Pract_2011_Feb_6_2011_249867.nxml.txt.nlp	22312550	SENT92	34	34	7	7	moxifloxacin	CAP	PA450555	23476;9200;4012;5269;10580;10487	0.934
NULL	Saudi_J_Anaesth_2013_Oct-Dec_7(4)_442-446.nxml.txt.nlp	24348298	SENT106	19	19	32	32	cyclosporine	CYP3A4	PA449167	1576	0.934
NULL	Oncol_Lett_2014_Sep_13_8(3)_1249-1254.nxml.txt.nlp	25120700	SENT96	15	15	0	0	cetuximab	BRAF	PA10040	673	0.934
NULL	Br_J_Cancer_2012_Jun_5_106(12)_1997-2003.nxml.txt.nlp	22596232	SENT183	7	7	2	2	sorafenib	CD133	PA7000	8842	0.934
NULL	J_Geriatr_Cardiol_2013_Mar_10(1)_21-27.nxml.txt.nlp	23610570	SENT58	24	24	35	35	theophylline	CD62P	PA451647	6403	0.934
NULL	J_Oncol_2010_Jan_14_2010_740472.nxml.txt.nlp	20130818	SENT137	0	0	11	11	trastuzumab	ERBB2	PA451743	2064	0.934
NULL	Cancers_(Basel)_2014_Mar_26_6(2)_708-722.nxml.txt.nlp	24675568	SENT62	2	2	6	6	niclosamide	STAT3	PA165958408	6774	0.934
NULL	Chem_Rev_2012_May_9_112(5)_2593-2603.nxml.txt.nlp	22335786	SENT52	10	10	0	0	choline	ATX	PA448976	5168;23049	0.934
NULL	Clin_Pharmacol_2012_Feb_20_4_13-20.nxml.txt.nlp	22427735	SENT70	16	16	0	0	clopidogrel	PON1	PA449053	5444	0.934
NULL	Oncotarget_2011_Oct_17_2(10)_797-809.nxml.txt.nlp	22006582	SENT85	8	8	34	34	propranolol	U87	PA451145	677775;641648	0.934
NULL	Ann_Rheum_Dis_2013_Aug_21_72(8)_1287-1294.nxml.txt.nlp	22915624	SENT124	21	21	7	7	abatacept	MRI	PA164747080	78996	0.934
NULL	Breast_Cancer_Res_2007_Mar_2_9(2)_205.nxml.txt.nlp	NULL	SENT45	12	12	29	29	lapatinib	HER-2	PA152241907	2064	0.934
NULL	Indian_J_Endocrinol_Metab_2013_Jul-Aug_17(4)_636-646.nxml.txt.nlp	23961479	SENT155	3	3	17	17	cyclosporine	CYP2C9	PA449167	1559	0.934
NULL	Curr_Neuropharmacol_2012_Jun_10(2)_97-123.nxml.txt.nlp	23204981	SENT227	2	2	18	18	desipramine	IL-10	PA449233	3586	0.934
NULL	Clin_Dev_Immunol_2011_Mar_22_2011_790460.nxml.txt.nlp	21603161	SENT410	3	3	17	17	atorvastatin	IFN	PA448500	3439	0.934
NULL	Clinics_(Sao_Paulo)_2013_May_68(5)_694-701.nxml.txt.nlp	23778405	SENT225	22	22	13	13	curcumin	survivin	PA151958596	332	0.934
NULL	Curr_Neuropharmacol_2013_Dec_11(6)_652-663.nxml.txt.nlp	24396340	SENT193	8	8	28	28	enflurane	TRPA1	PA449461	8989	0.934
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT149	2	2	21	21	raltegravir	UGT1A1		54658	0.934
NULL	Psychiatry_Investig_2012_Dec_12_9(4)_422-424.nxml.txt.nlp	23251210	SENT8	10	10	7	7	perphenazine	CYP2D6	PA450882	1565	0.934
NULL	Oncogenesis_2014_Mar_3_3(3)_e90.nxml.txt.nlp	24590311	SENT61	29	29	0	0	nilotinib	CD34	PA165958345	947	0.934
NULL	Br_J_Cancer_2012_Jun_26_107(1)_129-136.nxml.txt.nlp	22644295	SENT197	23	23	45	45	ethanol	TAK1	PA448073	7182	0.934
NULL	Antiviral_Res_2009_May_82(2)_A99-A109.nxml.txt.nlp	19176219	SENT178	8	8	19	19	nelfinavir	OCT1	PA450606	5451;6580	0.934
NULL	Nat_Med_2013_Mar_10_19(3)_313-321.nxml.txt.nlp	23396211	SENT153	0	0	33	33	amlexanox	TBK1	PA164745310	29110	0.934
NULL	Cancer_Inform_2008_Jun_10_6_315-355.nxml.txt.nlp	19259415	SENT356	18	18	5	5	cisplatin	CDX1	PA449014	1044	0.934
NULL	Breast_Cancer_Res_2008_Jan_11_10(1)_R4.nxml.txt.nlp	18190680	SENT165	27	27	3	3	ibandronate	NPS	PA10270	594857	0.934
NULL	Neural_Regen_Res_2013_Mar_25_8(9)_825-832.nxml.txt.nlp	25206730	SENT104	6	6	14	14	isoflurane	P2X7	PA450106	5027	0.934
NULL	J_Infect_Chemother_2012_Oct_28_18(5)_753-755.nxml.txt.nlp	22203121	SENT26	7	7	25	25	cyclophosphamide	ADM	PA449165	133	0.934
NULL	Orphanet_J_Rare_Dis_2010_Dec_16_5_39.nxml.txt.nlp	21162721	SENT72	12	12	8	8	carbamazepine	HLA-B	PA448785	3106	0.934
NULL	Front_Physiol_2013_Jul_15_4_182.nxml.txt.nlp	23874305	SENT73	17	17	7	7	paraformaldehyde	PKD1L3	PA450790	342372	0.934
NULL	Drugs_Aging_2012_Nov_5_29(11)_863-869.nxml.txt.nlp	23038608	SENT101	24	24	9	9	gabapentin	NNT	PA449720	23530	0.934
NULL	Cancer_Cell_Int_2014_Jul_2_14_59.nxml.txt.nlp	25120382	SENT93	15	15	10	10	metformin	CTR	PA450395	799	0.934
NULL	Mol_Cancer_2012_Mar_21_11_13.nxml.txt.nlp	22436134	SENT258	40	40	6	6	gemcitabine	HuR	PA449748	1994	0.934
NULL	N_Am_J_Med_Sci_2014_Dec_6(12)_625-632.nxml.txt.nlp	25599050	SENT37	3	3	19	19	telmisartan	API	PA451605	5345	0.934
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_13_2014_849783.nxml.txt.nlp	25477998	SENT102	19	19	7	7	isoproterenol	TLR4	PA450121	7099	0.934
NULL	Cell_Death_Dis_2010_Jun_3_1(6)_e47.nxml.txt.nlp	21364653	SENT174	18	18	7	7	paraformaldehyde	CADM1	PA450790	23705	0.934
NULL	Cancers_(Basel)_2012_Apr_25_4(2)_442-473.nxml.txt.nlp	24213319	SENT1253	1	1	7	7	curcumin	NF-kappaB	PA151958596	4790	0.934
NULL	Carcinogenesis_2014_Sep_1_35(9)_2142-2153.nxml.txt.nlp	24986896	SENT227	12	12	0	0	everolimus	STAT3	PA164746311	6774	0.934
NULL	Int_J_Mol_Sci_2014_Mar_12_15(3)_4356-4392.nxml.txt.nlp	24625663	SENT278	43	43	9	9	staurosporine	NEU3	PA165109623	10825	0.934
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jan_15_67(Pt_2)_o426.nxml.txt.nlp	21523094	SENT3	30	30	2	2	ethanol	mol	PA448073	90527	0.934
NULL	J_Viral_Hepat_2009_May_16(5)_315-324.nxml.txt.nlp	19243499	SENT101	27	27	7	7	imiquimod	TLR9	PA449972	54106	0.934
NULL	Mol_Biol_Cell_2013_Sep_1_24(17)_2739-2752.nxml.txt.nlp	23825024	SENT84	30	30	17	17	doxorubicin	p53	PA449412	7157	0.934
NULL	Biomed_Res_Int_2013_May_2_2013_210604.nxml.txt.nlp	23738323	SENT198	23	23	7	7	curcumin	HO-1	PA151958596	3162	0.934
NULL	Acta_Pharmacol_Sin_2010_Oct_13_31(10)_1350-1358.nxml.txt.nlp	20835264	SENT153	4	4	25	25	simvastatin	gamma	PA451363	9913	0.934
NULL	J_Mol_Signal_2011_Aug_10_6_8.nxml.txt.nlp	21831305	SENT112	11	11	39	39	isoproterenol	AKAP5	PA450121	9495	0.934
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT217	7	7	20	20	metformin	EGFR	PA450395	1956	0.934
NULL	Int_J_Biol_Sci_2014_Jan_20_10(2)_171-180.nxml.txt.nlp	24520215	SENT277	21	21	9	9	cerulenin	L-FABP	PA164764551	2168	0.934
NULL	Acta_Pharmacol_Sin_2010_May_12_31(5)_578-584.nxml.txt.nlp	20383171	SENT15	15	15	6	6	berberine	PERK	PA165860812	9451	0.934
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT107	15	15	20	20	everolimus	HER2	PA164746311	2064	0.934
NULL	FEBS_Open_Bio_2012_Aug_22_2_279-283.nxml.txt.nlp	23650611	SENT345	5	5	18	18	tamoxifen	IFN	PA451581	3439	0.934
NULL	Acta_Pharmacol_Sin_2011_Aug_18_32(8)_1078-1084.nxml.txt.nlp	21765448	SENT17	16	16	4	4	iptakalim	KCNJ11	PA165949694	3767	0.934
NULL	Ann_Rehabil_Med_2012_Dec_28_36(6)_857-860.nxml.txt.nlp	23342320	SENT67	3	3	36	36	warfarin	VKORC1	PA451906	79001	0.934
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT151	9	9	29	29	perifosine	DR4	PA165291471	8797	0.934
NULL	J_Oral_Pathol_Med_2013_Jul_18_42(6)_499-506.nxml.txt.nlp	23331485	SENT14	6	6	2	2	celecoxib	COX	PA448871	1351	0.934
NULL	Mol_Syst_Biol_2009_Jul_28_5_289.nxml.txt.nlp	19638970	SENT37	20	20	15	15	resveratrol	HuR		1994	0.934
NULL	Gut_2013_Aug_9_62(8)_1142-1152.nxml.txt.nlp	23144054	SENT57	20	20	7	7	busulfan	IL-7	PA448691	3574	0.934
NULL	Nucleic_Acids_Res_2011_Jun_9_39(11)_4640-4652.nxml.txt.nlp	21310710	SENT329	7	7	10	10	camptothecin	BCL2	PA153590860	596	0.934
NULL	Cancer_Cell_2007_Dec_11_12(6)_514-527.nxml.txt.nlp	18068629	SENT13	27	27	17	17	paclitaxel	TGFBI	PA450761	7045	0.934
NULL	Br_J_Pharmacol_2014_Apr_28_171(8)_1798-1817.nxml.txt.nlp	24116962	SENT243	0	0	20	20	resveratrol	CPT2		1376	0.934
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT40	2	2	7	7	curcumin	TRAIL	PA151958596	8743	0.934
NULL	Gut_Liver_2014_Jan_14_8(1)_24-28.nxml.txt.nlp	24516697	SENT57	25	25	38	38	fluorescein	CD27	PA164746009	939	0.934
NULL	Exp_Ther_Med_2014_Nov_11_8(5)_1660-1664.nxml.txt.nlp	25289077	SENT126	0	0	7	7	resveratrol	OTC		5009	0.934
NULL	J_Antimicrob_Chemother_2014_Mar_13_69(3)_651-663.nxml.txt.nlp	24235095	SENT118	22	22	6	6	pentamidine	AQP2	PA450850	359	0.934
NULL	Leukemia_2014_Aug_4_28(8)_1573-1585.nxml.txt.nlp	24496300	SENT218	12	12	1	1	quinidine	P-gp	PA451209	5243	0.934
NULL	Acta_Pharmacol_Sin_2012_Jan_3_33(1)_82-90.nxml.txt.nlp	22212431	SENT133	12	12	1	1	rosiglitazone	adiponectin	PA451283	9370	0.934
NULL	Indian_J_Anaesth_2009_Oct_53(5)_582-591.nxml.txt.nlp	20640109	SENT38	3	3	39	39	sirolimus	p27	PA451365	5715;10534	0.934
NULL	J_Inflamm_(Lond)_2006_Jul_12_3_10.nxml.txt.nlp	16834783	SENT100	6	6	18	18	mometasone	CXCR4	PA450541	7852	0.934
NULL	J_Hematol_Oncol_2013_Mar_27_6_23.nxml.txt.nlp	23531342	SENT100	12	12	5	5	mi-63	MDM2		4193	0.934
NULL	Oncol_Lett_2013_Jun_29_5(6)_1943-1947.nxml.txt.nlp	23833672	SENT111	11	11	35	35	celecoxib	mol	PA448871	90527	0.934
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT237	28	28	20	20	perifosine	NAC	PA165291471	22861	0.934
NULL	Case_Rep_Pulmonol_2013_Sep_5_2013_813786.nxml.txt.nlp	24093069	SENT51	29	29	32	32	montelukast	CysLT1	PA450546	10800	0.934
NULL	Indian_J_Pharmacol_2013_Nov-Dec_45(6)_597-602.nxml.txt.nlp	24347768	SENT23	37	37	3	3	etoposide	P-gp	PA449552	5243	0.934
NULL	Diabetes_Care_2009_Nov_32(Suppl_2)_S223-S231.nxml.txt.nlp	19875556	SENT127	21	21	8	8	exenatide	AMIGO	PA164749238	57463	0.934
NULL	Diabetes_2009_Dec_31_58(12)_2851-2862.nxml.txt.nlp	19720788	SENT206	14	14	8	8	forskolin	Bcl-2	PA146096022	596	0.934
NULL	Br_J_Cancer_2010_Jun_8_102(12)_1687-1691.nxml.txt.nlp	20485287	SENT121	13	13	8	8	cetuximab	EGFR	PA10040	1956	0.934
NULL	Oncotarget_2014_Jun_22_5(13)_4581-4602.nxml.txt.nlp	25015035	SENT355	25	25	10	10	cisplatin	ESG	PA449014	7089;7088;7090;7091	0.934
NULL	Arthritis_Res_Ther_2014_Apr_11_16(2)_R93.nxml.txt.nlp	24725461	SENT193	18	18	1	1	estradiol	aromatase	PA449503	1588	0.934
NULL	Aging_(Albany_NY)_2012_Mar_12_4(3)_146-158.nxml.txt.nlp	22436213	SENT61	33	33	16	16	resveratrol	SIRT1		23411	0.934
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_14_2012_617085.nxml.txt.nlp	23097677	SENT174	4	4	2	2	verapamil	ABCG2	PA451868	9429	0.934
NULL	Iran_Red_Crescent_Med_J_2014_Feb_7_16(2)_e15277.nxml.txt.nlp	24719748	SENT152	45	45	30	30	clopidogrel	ADP	PA449053	23038	0.934
NULL	Indian_J_Pharm_Sci_2009_Nov-Dec_71(6)_622-629.nxml.txt.nlp	20376214	SENT184	3	3	10	10	captopril	B10	PA448780	5169	0.934
NULL	Basic_Res_Cardiol_2012_Jul_24_107(4)_273.nxml.txt.nlp	22622703	SENT147	17	17	24	24	resveratrol	SIRT3		23410	0.934
NULL	Br_J_Cancer_2009_Mar_10_100(5)_758-763.nxml.txt.nlp	19259094	SENT16	28	28	17	17	temozolomide	MGMT	PA451609	4255	0.934
NULL	Oncogene_2010_Sep_16_29(37)_5135-5145.nxml.txt.nlp	20622897	SENT79	20	20	6	6	cetuximab	STAT3	PA10040	6774	0.934
NULL	Biosci_Rep_2014_Aug_6_34(4)_e00131.nxml.txt.nlp	24975826	SENT6	7	7	2	2	probenecid	TRPA1	PA451106	8989	0.934
NULL	Nat_Chem_Biol_2010_Apr_28_6(4)_291-299.nxml.txt.nlp	20190765	SENT134	30	30	2	2	dasatinib	AKT	PA162372878	207	0.934
NULL	Front_Neurosci_2014_Nov_10_8_364.nxml.txt.nlp	25426018	SENT234	23	23	20	20	fluorescein	Casper	PA164746009	8837	0.934
NULL	Arthritis_Res_Ther_2005_Apr_4_7(3)_R666-R676.nxml.txt.nlp	15899052	SENT30	10	10	29	29	infliximab	p55	PA452639	6624;2078;8503;5718	0.934
NULL	Cell_Death_Dis_2012_Mar_1_3(3)_e275.nxml.txt.nlp	22378068	SENT220	6	6	15	15	temsirolimus	AMPK	PA164746890	5563	0.934
NULL	Cell_Commun_Signal_2010_Dec_22_8_31.nxml.txt.nlp	21176168	SENT57	27	27	6	6	etoposide	PARP-1	PA449552	25976	0.934
NULL	Diabetes_Care_2012_Feb_16_35(2)_327-333.nxml.txt.nlp	22179958	SENT122	24	24	38	38	metformin	B12	PA450395	7126;4709	0.934
NULL	Clin_Endosc_2014_Jul_28_47(4)_353-357.nxml.txt.nlp	25133125	SENT32	10	10	0	0	propofol	ESD	PA451141	2098	0.934
NULL	Clinics_(Sao_Paulo)_2013_May_68(5)_694-701.nxml.txt.nlp	23778405	SENT178	4	4	14	14	curcumin	P-gp	PA151958596	5243	0.934
NULL	Drug_Des_Devel_Ther_2014_Sep_23_8_1527-1538.nxml.txt.nlp	25284985	SENT11	10	10	29	29	celecoxib	IFN	PA448871	3439	0.934
NULL	Arch_Drug_Inf_2011_Mar_4(1)_1-9.nxml.txt.nlp	21572514	SENT148	0	0	6	6	dicloxacillin	P-gp	PA164749649	5243	0.934
NULL	Ophthalmol_Eye_Dis_2010_Jul_29_2_43-56.nxml.txt.nlp	23861613	SENT32	19	19	36	36	l-serine	ASCT1	PA451330	6509	0.934
NULL	Cancer_Med_2012_Oct_1_1(2)_114-127.nxml.txt.nlp	23342262	SENT34	34	34	28	28	sirolimus	EGFR	PA451365	1956	0.934
NULL	Drugs_2014_Jul_18_74(11)_1209-1231.nxml.txt.nlp	25034361	SENT246	35	35	0	0	enoxaparin	STARS	PA449463	137735	0.934
NULL	EPMA_J_2013_Jan_28_4(1)_3.nxml.txt.nlp	23356214	SENT352	17	17	34	34	cetuximab	KRAS	PA10040	3845	0.934
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1986-2011.nxml.txt.nlp	25268165	SENT68	31	31	21	21	resveratrol	CD133		8842	0.934
NULL	Oncotarget_2014_Aug_27_5(17)_7328-7341.nxml.txt.nlp	25193862	SENT200	11	11	19	19	dasatinib	EGFR	PA162372878	1956	0.934
NULL	Biomed_Res_Int_2013_Aug_6_2013_602987.nxml.txt.nlp	24027759	SENT274	20	20	36	36	paclitaxel	SMF	PA450761	22993	0.934
NULL	J_Thromb_Haemost_2007_May_1_5(5)_910-917.nxml.txt.nlp	17362227	SENT107	22	22	2	2	thrombin	P2X1	PA451674	5023	0.934
NULL	Nucleic_Acids_Res_2010_Oct_21_38(18)_6148-6158.nxml.txt.nlp	20494979	SENT308	26	26	45	45	staurosporine	HLJ1	PA165109623	11080	0.934
NULL	J_Biol_Chem_2009_May_1_284(18)_11953-11962.nxml.txt.nlp	19254952	SENT231	13	13	25	25	pp2	ANG		283	0.934
NULL	Diabetes_Care_2010_Mar_15_33(3)_608-613.nxml.txt.nlp	20009095	SENT172	10	10	4	4	ramipril	DREAM	PA451223	30818	0.934
NULL	Pharmaceuticals_(Basel)_2012_Feb_2_5(2)_114-132.nxml.txt.nlp	24288084	SENT109	14	14	0	0	capsaicin	TRPV1	PA448776	7442	0.934
NULL	Exp_Ther_Med_2014_Nov_29_8(5)_1473-1478.nxml.txt.nlp	25289044	SENT142	0	0	12	12	heparin	AZU	PA449855	566	0.934
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT74	7	7	18	18	resveratrol	TRAIL		8743	0.934
NULL	Case_Rep_Oncol_2009_Dec_11_2(3)_234-241.nxml.txt.nlp	20737043	SENT79	9	9	31	31	carboplatin	CD34	PA448803	947	0.934
NULL	Nucleic_Acids_Res_2005_Aug_12_33(14)_4584-4592.nxml.txt.nlp	16100380	SENT117	26	26	4	4	paromomycin	GCN2	PA164784023	440275	0.934
NULL	Br_J_Cancer_2012_Jun_26_107(1)_116-122.nxml.txt.nlp	22596240	SENT145	35	35	21	21	imatinib	PRAME	PA10804	23532	0.934
NULL	J_Cell_Biol_2002_Mar_4_156(5)_791-795.nxml.txt.nlp	11877457	SENT98	13	13	25	25	staurosporine	AP2	PA165109623	2971	0.934
NULL	Breast_Cancer_Res_2007_Aug_8_9(4)_R50.nxml.txt.nlp	17686159	SENT195	5	5	21	21	trastuzumab	AKT	PA451743	207	0.934
NULL	Drug_Healthc_Patient_Saf_2012_Nov_29_4_173-180.nxml.txt.nlp	23236256	SENT66	10	10	22	22	sertindole	FGA	PA164784002	2243	0.934
NULL	Cardiovasc_Diabetol_2011_Dec_1_10_109.nxml.txt.nlp	22132774	SENT157	20	20	1	1	liraglutide	GLP-1	PA165958364	100125288	0.934
NULL	Brief_Bioinform_2014_Jul_31_15(4)_648-659.nxml.txt.nlp	23376192	SENT15	19	19	35	35	cisplatin	KIT	PA449014	3815	0.934
NULL	Int_J_Surg_Oncol_2012_Sep_4_2012_761364.nxml.txt.nlp	22988495	SENT257	8	8	3	3	letrozole	aromatase	PA450196	1588	0.934
NULL	J_Oncol_2010_Dec_28_2010_414676.nxml.txt.nlp	20066160	SENT102	11	11	37	37	cetuximab	EGF	PA10040	1950	0.934
NULL	Mol_Med_Rep_2015_Feb_5_11(2)_805-814.nxml.txt.nlp	25373883	SENT123	13	13	5	5	colchicine	APE	PA449092	55704;328	0.934
NULL	Cancer_Med_2013_Feb_3_2(1)_76-85.nxml.txt.nlp	24133630	SENT174	24	24	27	27	vemurafenib	PI3K	PA165946873	5290	0.934
NULL	Mol_Biol_Cell_2013_Dec_15_24(24)_3819-3831.nxml.txt.nlp	24152729	SENT197	21	21	27	27	paraformaldehyde	AURKA	PA450790	6790	0.934
NULL	Ther_Clin_Risk_Manag_2006_Sep_2(3)_235-249.nxml.txt.nlp	18360599	SENT340	13	13	30	30	alendronate	PTH	PA448082	5741	0.934
NULL	J_Cancer_2013_Sep_27_4(8)_662-670.nxml.txt.nlp	24155778	SENT235	9	9	2	2	cisplatin	UCHL1	PA449014	7345	0.934
NULL	Mol_Cancer_2013_Mar_5_12_17.nxml.txt.nlp	23497256	SENT198	32	32	10	10	sunitinib	HDMX	PA162372840	4194;4193	0.934
NULL	J_Cell_Biol_2002_Jun_24_157(7)_1151-1160.nxml.txt.nlp	12082077	SENT180	8	8	2	2	trypsin	COX	PA451806	1351	0.934
NULL	Clin_Ophthalmol_2014_Jun_25_8_1209-1212.nxml.txt.nlp	25028534	SENT55	19	19	29	29	amfenac	COX2	PA166049186	4513;5743	0.933
NULL	Oxid_Med_Cell_Longev_2013_Jun_2_2013_793525.nxml.txt.nlp	23819014	SENT244	3	3	15	15	resveratrol	SIRT1		23411	0.933
NULL	Mol_Cancer_2012_Aug_8_11_53.nxml.txt.nlp	22871047	SENT228	24	24	6	6	paclitaxel	HIN-1	PA450761	92304	0.933
NULL	Oncotarget_2014_Mar_16_5(12)_4087-4102.nxml.txt.nlp	24961479	SENT195	6	6	13	13	hemin	HO-1	PA449849	3162	0.933
NULL	Oncogene_2013_Sep_12_32(37)_4355-4365.nxml.txt.nlp	23108409	SENT35	43	43	31	31	hyaluronan	HAS2	PA165958431	3037	0.933
NULL	Br_J_Cancer_2011_Dec_6_105(12)_1920-1926.nxml.txt.nlp	22095222	SENT25	35	35	15	15	gefitinib	PIK3CA	PA131301952	5290	0.933
NULL	Oncotarget_2012_Nov_17_3(12)_1600-1614.nxml.txt.nlp	23307622	SENT79	6	6	19	19	gefitinib	ATG12	PA131301952	9140	0.933
NULL	Front_Pharmacol_2014_Dec_10_5_271.nxml.txt.nlp	25540621	SENT93	15	15	21	21	cisplatin	ghrelin	PA449014	51738	0.933
NULL	Cell_Cycle_2013_Mar_15_12(6)_868.nxml.txt.nlp	23442795	SENT20	9	9	5	5	bortezomib	p53	PA10252	7157	0.933
NULL	Ann_Oncol_2013_Apr_31_24(4)_1067-1073.nxml.txt.nlp	23117073	SENT48	0	0	9	9	aprepitant	CYP3A4	PA164747039	1576	0.933
NULL	Indian_J_Endocrinol_Metab_2015_Jan-Feb_19(1)_30-38.nxml.txt.nlp	25593823	SENT97	13	13	7	7	pioglitazone	adiponectin	PA450970	9370	0.933
NULL	J_Korean_Med_Sci_2014_Jul_11_29(7)_965-972.nxml.txt.nlp	25045229	SENT134	12	12	7	7	metformin	B12	PA450395	7126;4709	0.933
NULL	Cancer_Cell_Int_2010_Apr_29_10_12.nxml.txt.nlp	20429927	SENT179	29	29	19	19	bortezomib	HRI	PA10252	27102	0.933
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT13	30	30	1	1	pp2	STZ		6484	0.933
NULL	Br_J_Cancer_2012_Nov_6_107(10)_1745-1753.nxml.txt.nlp	23099808	SENT22	10	10	19	19	docetaxel	EGFR	PA449383	1956	0.933
NULL	Mol_Brain_2014_Apr_21_7_28.nxml.txt.nlp	24751148	SENT135	2	2	18	18	minocycline	TLR4	PA450519	7099	0.933
NULL	Arthritis_Res_Ther_2012_May_1_14(3)_R99.nxml.txt.nlp	22546542	SENT149	24	24	19	19	infliximab	IL-17	PA452639	3605	0.933
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jun_23_66(Pt_7)_o1753.nxml.txt.nlp	21587969	SENT74	30	30	13	13	ethanol	mol	PA448073	90527	0.933
NULL	Indian_J_Pharm_Sci_2011_Sep-Oct_73(5)_510-516.nxml.txt.nlp	22923863	SENT136	10	10	18	18	venlafaxine	ANOVA	PA451866	4858	0.933
NULL	Breast_Cancer_Res_2005_Jul_18_7(5)_187-189.nxml.txt.nlp	16168136	SENT45	36	36	7	7	fulvestrant	HER2	PA164747170	2064	0.933
NULL	Int_J_Hypertens_2012_Feb_8_2012_189512.nxml.txt.nlp	22518281	SENT116	4	4	1	1	hemin	HO-1	PA449849	3162	0.933
NULL	Int_Clin_Psychopharmacol_2014_Mar_31_29(2)_86-92.nxml.txt.nlp	24247740	SENT176	16	16	23	23	citalopram	STAR	PA449015	6770;2984	0.933
NULL	Biomed_Res_Int_2013_Jan_14_2013_930962.nxml.txt.nlp	23509810	SENT97	18	18	11	11	paraformaldehyde	VASA	PA450790	54514	0.933
NULL	Indian_J_Pharm_Sci_2008_May-Jun_70(3)_381-383.nxml.txt.nlp	20046753	SENT28	23	23	7	7	ethanol	mol	PA448073	90527	0.933
NULL	Indian_J_Med_Res_2013_Nov_138(5)_717-731.nxml.txt.nlp	24434324	SENT278	30	30	37	37	tocilizumab	IL-6	PA165292659	3569	0.933
NULL	Mol_Cancer_2012_Mar_8_11_9.nxml.txt.nlp	22401581	SENT140	14	14	0	0	calcein	IGFBP3	PA132595336	3486	0.933
NULL	Basic_Res_Cardiol_2015_Jan_20_110_4.nxml.txt.nlp	25600226	SENT132	28	28	21	21	atorvastatin	PCSK9	PA448500	255738	0.933
NULL	eLife_2013_Nov_5_2_e00969.nxml.txt.nlp	24192036	SENT114	12	12	3	3	vemurafenib	MCL1	PA165946873	4170	0.933
NULL	Br_J_Cancer_2006_Feb_13_94(3)_407-426.nxml.txt.nlp	16434996	SENT226	16	16	4	4	genistein	BRCA1	PA165109660	672	0.933
NULL	J_Cell_Biol_2001_Jul_9_154(1)_187-196.nxml.txt.nlp	11449000	SENT325	24	24	3	3	paraformaldehyde	E12	PA450790	64100	0.933
NULL	J_Hematol_Oncol_2010_May_2_3_18.nxml.txt.nlp	20433767	SENT178	17	17	23	23	carboplatin	EGFR	PA448803	1956	0.933
NULL	Cancer_Med_2014_Jun_19_3(3)_555-564.nxml.txt.nlp	24648042	SENT132	25	25	3	3	fludarabine	SF3B1	PA449655	23451	0.933
NULL	Cancer_Cell_Int_2010_Sep_9_10_32.nxml.txt.nlp	20828393	SENT128	31	31	2	2	cisplatin	ATF3	PA449014	467	0.933
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jul_15_65(Pt_8)_o1860-o1861.nxml.txt.nlp	21583558	SENT52	23	23	7	7	ethanol	mol	PA448073	90527	0.933
NULL	ScientificWorldJournal_2014_Jul_24_2014_272794.nxml.txt.nlp	25152905	SENT77	31	31	5	5	phenol	KSA	PA450913	4072	0.933
NULL	Evid_Based_Complement_Alternat_Med_2013_Aug_28_2013_516017.nxml.txt.nlp	24066014	SENT139	2	2	30	30	doxorubicin	AT1	PA449412	9197;185	0.933
NULL	J_Cardiothorac_Surg_2014_Sep_17_9(1)_129.nxml.txt.nlp	NULL	SENT79	18	18	2	2	protamine	ACT	PA10366	12;11332;9457;641455	0.933
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_3_2014_473213.nxml.txt.nlp	25538791	SENT126	19	19	3	3	rifampin	MDR1	PA451250	5243	0.933
NULL	Arthritis_Res_Ther_2008_Dec_10_10(6)_R141.nxml.txt.nlp	19068145	SENT34	20	20	7	7	tocilizumab	IL-6	PA165292659	3569	0.933
NULL	Br_J_Cancer_2012_Jan_3_106(1)_148-156.nxml.txt.nlp	22045191	SENT248	30	30	27	27	cetuximab	EGFR	PA10040	1956	0.933
NULL	Oncotarget_2013_Jun_29_4(9)_1338-1348.nxml.txt.nlp	23907514	SENT66	3	3	39	39	doxorubicin	PSMB4	PA449412	5692	0.933
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT176	23	23	35	35	dasatinib	JNK	PA162372878	5599	0.933
NULL	Cell_Biol_Int_Rep_(2010)_2012_Jun_21_19(1)_e00017.nxml.txt.nlp	23124518	SENT99	17	17	9	9	etoposide	Mcl-1	PA449552	4170	0.933
NULL	Arthritis_Res_Ther_2014_Apr_28_16(2)_R104.nxml.txt.nlp	24774748	SENT107	13	13	3	3	cyclophosphamide	CD4	PA449165	920	0.933
NULL	Arthritis_Res_Ther_2013_Dec_2_15(6)_R204.nxml.txt.nlp	24295403	SENT100	7	7	12	12	tocilizumab	IL-6	PA165292659	3569	0.933
NULL	Biol_Proced_Online_2004_Jun_7_6_105-112.nxml.txt.nlp	15192755	SENT145	23	23	7	7	valinomycin	VGLUT1	PA151917011	57030	0.933
NULL	Cell_Commun_Signal_2013_Apr_17_11_27.nxml.txt.nlp	23594441	SENT93	4	4	11	11	doxorubicin	p53	PA449412	7157	0.933
NULL	J_Clin_Exp_Pathol_2012_May_17_Suppl_4_7327.nxml.txt.nlp	25379357	SENT192	7	7	15	15	resveratrol	AMPK		5563	0.933
NULL	Breast_Cancer_Res_2002_Jun_21_4(5)_R9.nxml.txt.nlp	12223126	SENT10	7	7	16	16	tamoxifen	FasL	PA451581	356	0.933
NULL	J_Biol_Chem_2009_Mar_27_284(13)_8855-8865.nxml.txt.nlp	19171933	SENT41	13	13	4	4	thrombin	AKT	PA451674	207	0.933
NULL	Acta_Pharmacol_Sin_2014_Oct_25_35(10)_1293-1301.nxml.txt.nlp	25152022	SENT170	21	21	23	23	enalapril	NLRP3	PA449456	114548	0.933
NULL	Br_J_Cancer_2012_Feb_28_106(5)_883-888.nxml.txt.nlp	22315050	SENT98	11	11	34	34	cetuximab	EGFR	PA10040	1956	0.933
NULL	Ann_Hematol_2011_Dec_8_90(12)_1399-1407.nxml.txt.nlp	21476016	SENT89	28	28	13	13	epirubicin	CHOP	PA449476	1649	0.933
NULL	J_Korean_Med_Sci_2006_Aug_22_21(4)_596-601.nxml.txt.nlp	16891799	SENT29	10	10	15	15	etanercept	p75	PA449515	7133;11168	0.933
NULL	Int_J_Surg_Oncol_2012_Sep_4_2012_761364.nxml.txt.nlp	22988495	SENT255	15	15	1	1	raloxifene	STAR	PA451221	6770;2984	0.933
NULL	Acta_Pharmacol_Sin_2013_Apr_11_34(4)_473-479.nxml.txt.nlp	23474709	SENT9	0	0	3	3	probenecid	MRP1	PA451106	4437	0.933
NULL	Br_J_Cancer_2012_Feb_14_106(4)_685-692.nxml.txt.nlp	22294184	SENT203	10	10	4	4	lovastatin	p27	PA450272	5715;10534	0.933
NULL	Clin_Mol_Allergy_2011_Jul_26_9_11.nxml.txt.nlp	21791043	SENT56	5	5	27	27	omalizumab	CD4	PA164752253	920	0.933
NULL	Clin_Med_Insights_Ear_Nose_Throat_2012_Apr_3_5_1-16.nxml.txt.nlp	24179404	SENT203	21	21	16	16	cetuximab	HIF1	PA10040	3091	0.933
NULL	Exp_Ther_Med_2013_Sep_4_6(3)_663-670.nxml.txt.nlp	24137243	SENT229	2	2	24	24	berberine	IL-6	PA165860812	3569	0.933
NULL	J_Acquir_Immune_Defic_Syndr_2014_Jan_1_65(1)_78-81.nxml.txt.nlp	24419064	SENT32	13	13	16	16	ritonavir	CYP3A4	PA451260	1576	0.933
NULL	Oncotarget_2014_Feb_25_5(5)_1304-1314.nxml.txt.nlp	24675421	SENT10	9	9	6	6	cisplatin	RIP1	PA449014	10928;7386	0.933
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_2_2014_659343.nxml.txt.nlp	25530786	SENT488	5	5	10	10	lidocaine	spatial	PA450226	219793	0.933
NULL	Cancer_Res_Treat_2013_Mar_31_45(1)_55-62.nxml.txt.nlp	23613671	SENT147	15	15	3	3	irinotecan	KRAS	PA450085	3845	0.933
NULL	Hum_Genomics_Proteomics_2010_Sep_13_2010_754919.nxml.txt.nlp	20981234	SENT92	24	24	2	2	phenprocoumon	CYP2C9	PA450921	1559	0.933
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT36	0	0	22	22	carboplatin	HER2	PA448803	2064	0.933
NULL	Curr_Neuropharmacol_2007_Dec_5(4)_268-277.nxml.txt.nlp	19305743	SENT205	12	12	38	38	methamphetamine	CB2	PA450403	1269	0.933
NULL	Blood_Res_2014_Dec_23_49(4)_279-280.nxml.txt.nlp	25548764	SENT23	4	4	29	29	lenalidomide	CD80	PA162363968	941	0.933
NULL	AAPS_J_2011_Dec_22_14(1)_68-78.nxml.txt.nlp	22189899	SENT179	8	8	21	21	ketoconazole	CYP3A4	PA450146	1576	0.933
NULL	Ann_Rheum_Dis_2014_Mar_25_73(3)_492-509.nxml.txt.nlp	24161836	SENT467	37	37	16	16	methotrexate	P2X7	PA450428	5027	0.933
NULL	Oncotarget_2014_Oct_16_5(20)_9546-9563.nxml.txt.nlp	25337673	SENT146	16	16	8	8	gefitinib	AXL	PA131301952	558	0.933
NULL	Oncol_Lett_2013_Aug_25_6(2)_480-486.nxml.txt.nlp	24137351	SENT38	1	1	37	37	thyroglobulin	RAI	PA164754910	10848;6050	0.933
NULL	Acta_Pharmacol_Sin_2011_Oct_15_32(10)_1233-1238.nxml.txt.nlp	21841815	SENT76	9	9	24	24	naloxone	CTX	PA450586	1593	0.933
NULL	Crit_Care_2011_Mar_22_15(2)_208.nxml.txt.nlp	21457506	SENT103	5	5	25	25	bleomycin	RAGE	PA448645	177	0.933
NULL	Aging_(Albany_NY)_2011_Apr_4_3(4)_348-362.nxml.txt.nlp	21483040	SENT192	28	28	20	20	metformin	HGPS	PA450395	4000;10269;64221	0.933
NULL	Int_J_Mol_Sci_2014_Nov_25_15(12)_21703-21722.nxml.txt.nlp	25429431	SENT67	3	3	20	20	curcumin	Se2	PA151958596	2524	0.933
NULL	Diabetes_2008_Sep_57(9)_2341-2347.nxml.txt.nlp	18559659	SENT149	12	12	19	19	daclizumab	CD4	PA164764446	920	0.933
NULL	Fibrogenesis_Tissue_Repair_2012_Jul_23_5_11.nxml.txt.nlp	22824096	SENT392	23	23	10	10	thrombin	PAR-1	PA451674	2011;2149	0.933
NULL	Mol_Cancer_2007_Oct_22_6_66.nxml.txt.nlp	17953743	SENT197	17	17	5	5	cisplatin	Mcl-1	PA449014	4170	0.933
NULL	Mol_Vis_2012_Jul_18_18_1966-1972.nxml.txt.nlp	22876123	SENT149	3	3	15	15	curcumin	IL-4	PA151958596	3565	0.933
NULL	Arthritis_Res_2002_Oct_16_4(1)_36-44.nxml.txt.nlp	11879536	SENT110	32	32	1	1	misoprostol	ACR	PA450523	49	0.933
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_13_2013_468537.nxml.txt.nlp	23956772	SENT141	4	4	27	27	etoposide	PUMA	PA449552	27113	0.933
NULL	Pharmaceutics_2011_Jul_13_3(3)_425-439.nxml.txt.nlp	24310588	SENT15	17	17	8	8	hydrocodone	OTC	PA449900	5009	0.933
NULL	Arthritis_Res_Ther_2012_Jul_27_14(4)_R175.nxml.txt.nlp	22838733	SENT120	38	38	16	16	adalimumab	CD14	PA10004	929	0.933
NULL	Clin_Dev_Immunol_2013_May_2_2013_373579.nxml.txt.nlp	23737811	SENT126	0	0	21	21	efalizumab	LFA-1	PA164748817	3683;3689	0.933
NULL	Clin_Dev_Immunol_2013_Oct_3_2013_349067.nxml.txt.nlp	24198842	SENT115	12	12	3	3	paraformaldehyde	CD34	PA450790	947	0.933
NULL	Oncotarget_2013_Jun_30_4(7)_1037-1049.nxml.txt.nlp	23900414	SENT183	2	2	32	32	pp2	PP2		4888	0.933
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT43	4	4	16	16	neratinib	HER2	PA165291472	2064	0.933
NULL	Exp_Diabetes_Res_2012_Jun_14_2012_859395.nxml.txt.nlp	22778716	SENT132	42	42	8	8	glucose	CD11c	PA449773	3687	0.933
NULL	Exp_Ther_Med_2013_Nov_13_6(5)_1317-1321.nxml.txt.nlp	24223665	SENT132	14	14	4	4	cisplatin	CD133	PA449014	8842	0.933
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT304	18	18	8	8	paliperidone	PRL	PA163518919	5617	0.933
NULL	Acta_Pharmacol_Sin_2011_Oct_15_32(10)_1303-1308.nxml.txt.nlp	21841812	SENT10	10	10	5	5	losartan	CYP2C9	PA450268	1559	0.933
NULL	Nucleic_Acids_Res_2012_Jul_16_40(Web_Server_issue)_W214-W221.nxml.txt.nlp	22600737	SENT133	14	14	3	3	staurosporine	ADP	PA165109623	23038	0.933
NULL	Ethiop_J_Health_Sci_2011_Nov_21(3)_195-201.nxml.txt.nlp	22435000	SENT98	24	24	28	28	l-arginine	IL-8	PA448478	3576	0.933
NULL	Cell_Logist_2014_Jan_9_4_e27732.nxml.txt.nlp	24843827	SENT62	9	9	2	2	perifosine	AS160	PA165291471	9882	0.933
NULL	Breast_Cancer_(Auckl)_2012_Feb_20_6_47-66.nxml.txt.nlp	22399860	SENT172	4	4	42	42	tamoxifen	NSD1	PA451581	64324	0.933
NULL	Behav_Neurol_2014_Nov_16_2014_360978.nxml.txt.nlp	25477708	SENT54	1	1	18	18	nicotine	P28	PA450626	9446;7802;9527	0.933
NULL	Arthritis_Res_Ther_2009_Aug_28_11(4)_R131.nxml.txt.nlp	19715572	SENT107	3	3	10	10	rituximab	CD27	PA451261	939	0.933
NULL	Acta_Pharmacol_Sin_2014_Sep_4_35(9)_1157-1166.nxml.txt.nlp	25088002	SENT123	27	27	32	32	curcumin	JAK2	PA151958596	3717	0.933
NULL	Mol_Cancer_2014_Jan_13_13_7.nxml.txt.nlp	24418169	SENT40	27	27	36	36	sorafenib	STAT3	PA7000	6774	0.933
NULL	Diabetes_Metab_Syndr_Obes_2014_Mar_6_7_85-94.nxml.txt.nlp	24623984	SENT57	16	16	40	40	metformin	GLP-1	PA450395	100125288	0.933
NULL	F1000_Med_Rep_2009_Dec_9_1_93.nxml.txt.nlp	20948684	SENT82	22	22	42	42	doxycycline	LAM	PA449415	7249;7248	0.933
NULL	Acta_Pharmacol_Sin_2009_Apr_23_30(4)_442-450.nxml.txt.nlp	19305423	SENT48	42	42	17	17	ethanol	PLAB	PA448073	9518	0.933
NULL	Cancer_Inform_2008_Jun_10_6_315-355.nxml.txt.nlp	19259415	SENT356	18	18	7	7	cisplatin	AIM1	PA449014	202	0.933
NULL	Breast_Cancer_Res_2008_May_13_10(Suppl_2)_P95.nxml.txt.nlp	NULL	SENT12	26	26	5	5	carboplatin	PARP-1	PA448803	25976	0.933
NULL	Oncol_Lett_2014_Aug_19_8(2)_809-812.nxml.txt.nlp	25009658	SENT21	8	8	23	23	metformin	HO-1	PA450395	3162	0.933
NULL	Cancer_Microenviron_2009_Sep_26_2(Suppl_1)_19-204.nxml.txt.nlp	NULL	SENT2492	14	14	23	23	plerixafor	CXCR4	PA165958410	7852	0.933
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT486	17	17	1	1	carbamazepine	CAR	PA448785	1525;6687;9970	0.933
NULL	Cancer_Metastasis_Rev_2013_Aug_2_32(3-4)_673-705.nxml.txt.nlp	23907184	SENT621	0	0	27	27	metformin	AMPK	PA450395	5563	0.933
NULL	Cell_Commun_Signal_2014_May_8_12_31.nxml.txt.nlp	24884945	SENT46	7	7	4	4	erlotinib	EGFR	PA134687924	1956	0.933
NULL	Protein_Cell_2014_Jun_19_5(6)_469-479.nxml.txt.nlp	24748116	SENT93	16	16	9	9	paclitaxel	EB1	PA450761	9167;22919;10982	0.933
NULL	Front_Oncol_2014_Apr_9_4_75.nxml.txt.nlp	24782986	SENT261	16	16	9	9	paclitaxel	CD34	PA450761	947	0.933
NULL	Diabetes_Metab_Syndr_Obes_2014_Jan_18_7_15-24.nxml.txt.nlp	24465132	SENT21	20	20	7	7	metformin	GLP-1	PA450395	100125288	0.933
NULL	J_Thromb_Haemost_2011_Oct_9(10)_2103-2105.nxml.txt.nlp	21812912	SENT37	15	15	19	19	ticagrelor	P2Y12	PA165374673	64805	0.933
NULL	Blood_Cancer_J_2013_May_17_3(5)_e115.nxml.txt.nlp	23686003	SENT40	40	40	14	14	thalidomide	SET	PA451644	6418	0.933
NULL	Front_Neurol_2010_Oct_12_1_120.nxml.txt.nlp	21206764	SENT44	13	13	19	19	heparin	ACT	PA449855	12;11332;9457;641455	0.933
NULL	Breast_Cancer_Res_2011_Apr_15_13(2)_R44.nxml.txt.nlp	21496232	SENT401	8	8	29	29	lapatinib	EGF	PA152241907	1950	0.933
NULL	Br_J_Cancer_2011_Jun_7_104(12)_1848-1853.nxml.txt.nlp	21610704	SENT144	33	33	7	7	panitumumab	KRAS	PA162373091	3845	0.933
NULL	Exp_Diabetes_Res_2012_Oct_15_2012_465282.nxml.txt.nlp	23118742	SENT94	21	21	19	19	metformin	FGF21	PA450395	26291	0.933
NULL	Cell_Death_Dis_2013_Jun_27_4(6)_e696.nxml.txt.nlp	23807225	SENT97	21	21	18	18	doxycycline	ACL	PA449415	47	0.933
NULL	AAPS_J_2011_Jun_1_13(3)_405-416.nxml.txt.nlp	21630127	SENT243	24	24	9	9	lovastatin	CYP3A4	PA450272	1576	0.933
NULL	Br_J_Cancer_2012_Jul_24_107(3)_516-526.nxml.txt.nlp	22782351	SENT101	17	17	4	4	tamoxifen	TIGAR	PA451581	57103	0.933
NULL	Clin_Med_Insights_Womens_Health_2013_Jan_22_6_1-11.nxml.txt.nlp	24665209	SENT43	7	7	15	15	anastrozole	aromatase	PA448432	1588	0.933
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_May_21_64(Pt_6)_m834.nxml.txt.nlp	21202515	SENT61	26	26	7	7	ethanol	mol	PA448073	90527	0.933
NULL	Exp_Cell_Res_2011_Apr_15_317(7)_1028-1039.nxml.txt.nlp	21237154	SENT123	0	0	32	32	staurosporine	TRAIL	PA165109623	8743	0.933
NULL	Nat_Commun_2013_4_1966.nxml.txt.nlp	23739662	SENT190	22	22	4	4	platinum	ORF	PA150595617	537	0.933
NULL	Acta_Pharmacol_Sin_2011_Jan_6_32(1)_133-138.nxml.txt.nlp	21131997	SENT44	16	16	2	2	heparin	ACT	PA449855	12;11332;9457;641455	0.933
NULL	Oncotarget_2014_Feb_16_5(4)_1062-1070.nxml.txt.nlp	24658085	SENT119	9	9	48	48	pemetrexed	4E-BP1	PA10810	1978	0.933
NULL	J_Biol_Chem_2010_Apr_16_285(16)_11892-11902.nxml.txt.nlp	20177059	SENT102	6	6	23	23	olmesartan	API	PA164742950	5345	0.933
NULL	Br_J_Cancer_1999_Jul_80(9)_1332-1341.nxml.txt.nlp	10424733	SENT14	1	1	33	33	cisplatin	MX1	PA449014	4599	0.933
NULL	Br_J_Cancer_2010_Mar_16_102(6)_995-1002.nxml.txt.nlp	20179708	SENT41	13	13	20	20	capecitabine	HER2	PA448771	2064	0.933
NULL	Acta_Orthop_2010_Dec_26_81(6)_748-755.nxml.txt.nlp	21067431	SENT75	7	7	17	17	rofecoxib	ANOVA	PA451268	4858	0.933
NULL	Adv_Hematol_2012_Feb_26_2012_529572.nxml.txt.nlp	22474449	SENT96	9	9	13	13	crizotinib	ALK	PA165946122	238	0.933
NULL	Indian_J_Endocrinol_Metab_2013_Oct_17(Suppl1)_S64-S67.nxml.txt.nlp	24251223	SENT48	39	39	7	7	liraglutide	GLP-1	PA165958364	100125288	0.933
NULL	Clin_Exp_Otorhinolaryngol_2011_Dec_15_4(4)_177-183.nxml.txt.nlp	22232712	SENT18	7	7	10	10	doxycycline	MUC5B	PA449415	727897	0.933
NULL	Oncotarget_2011_Dec_31_2(12)_1314-1321.nxml.txt.nlp	22248929	SENT70	18	18	5	5	lapatinib	FDG	PA152241907	23583	0.933
NULL	EMBO_Mol_Med_2012_Apr_4(4)_298-312.nxml.txt.nlp	22331558	SENT141	9	9	19	19	etoposide	p53	PA449552	7157	0.933
NULL	Mol_Cancer_2007_Oct_11_6_63.nxml.txt.nlp	17931419	SENT57	15	15	7	7	cetuximab	EGFR	PA10040	1956	0.933
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Sep_24_64(Pt_10)_o2005.nxml.txt.nlp	21201203	SENT66	0	0	24	24	benzaldehyde	mol	PA448571	90527	0.933
NULL	Adv_Urol_2012_Oct_26_2012_812398.nxml.txt.nlp	22110495	SENT119	16	16	12	12	cisplatin	ERCC1	PA449014	2067	0.933
NULL	Case_Reports_Hepatol_2013_Jul_15_2013_964828.nxml.txt.nlp	25374723	SENT19	0	0	12	12	tocilizumab	IL-6	PA165292659	3569	0.933
NULL	Acta_Pharmacol_Sin_2010_Aug_5_31(8)_1005-1012.nxml.txt.nlp	20686525	SENT186	10	10	1	1	metformin	BKS	PA450395	55620	0.933
NULL	Cancer_Imaging_2008_Nov_25_8(1)_199-205.nxml.txt.nlp	19028612	SENT42	0	0	14	14	erlotinib	EGFR	PA134687924	1956	0.933
NULL	Mol_Vis_2007_Jul_9_13_1083-1093.nxml.txt.nlp	17653053	SENT153	2	2	35	35	minocycline	MCP-1	PA450519	6347	0.933
NULL	Oncotarget_2013_Apr_13_4(4)_502-530.nxml.txt.nlp	23594434	SENT272	27	27	21	21	nelfinavir	AKT	PA450606	207	0.933
NULL	Infect_Dis_Rep_2011_Nov_22_3(2)_e14.nxml.txt.nlp	24470911	SENT39	41	41	6	6	sildenafil	CD4	PA451346	920	0.933
NULL	Breast_Cancer_Res_Treat_2012_Jun_15_133(3)_1057-1065.nxml.txt.nlp	22418700	SENT34	2	2	36	36	afatinib	HER3	PA165981154	2065	0.933
NULL	Toxins_(Basel)_2010_May_25_2(5)_1148-1165.nxml.txt.nlp	22069631	SENT85	23	23	7	7	chymotrypsin	ETB	PA448994	1910	0.933
NULL	Int_J_Biochem_Cell_Biol_2013_Feb_45(2)_283-291.nxml.txt.nlp	23085378	SENT40	16	16	27	27	trypsin	CO2	PA451806	4513	0.933
NULL	J_Hum_Reprod_Sci_2008_Jul-Dec_1(2)_86-89.nxml.txt.nlp	19562053	SENT2	37	37	4	4	estradiol	EFS	PA449503	10278	0.933
NULL	Clin_Ophthalmol_2008_Jun_2(2)_355-368.nxml.txt.nlp	19668727	SENT81	9	9	34	34	nepafenac	COX2	PA165958407	4513;5743	0.933
NULL	Cancers_(Basel)_2013_May_27_5(2)_617-638.nxml.txt.nlp	24216994	SENT340	12	12	19	19	curcumin	MMP9	PA151958596	4318	0.933
NULL	Cancers_(Basel)_2010_Jan_14_2(1)_1-19.nxml.txt.nlp	24281029	SENT1014	4	4	25	25	neratinib	San	PA165291472	80218	0.933
NULL	Semin_Immunopathol_2010_Dec_30_32(4)_383-396.nxml.txt.nlp	20589500	SENT209	18	18	29	29	hydroxychloroquine	p53	PA164777036	7157	0.933
NULL	Oncol_Lett_2014_Jul_16_8(1)_211-217.nxml.txt.nlp	24959248	SENT20	32	32	3	3	lipase	ANGPTL4	PA450239	51129	0.933
NULL	Case_Rep_Transplant_2011_Jan_5_2011_210178.nxml.txt.nlp	23213600	SENT69	35	35	11	11	efavirenz	CYP3A4	PA449441	1576	0.933
NULL	Breast_Cancer_Res_2010_Jul_26_12(4)_R55.nxml.txt.nlp	20659323	SENT309	3	3	22	22	fulvestrant	MYB	PA164747170	4602	0.933
NULL	Mol_Cancer_2012_Oct_22_11_80.nxml.txt.nlp	23088607	SENT72	13	13	20	20	estradiol	HIF-1	PA449503	29072	0.933
NULL	Curr_Cardiol_Rev_2014_May_10(2)_161-171.nxml.txt.nlp	24527681	SENT177	13	13	4	4	losartan	FBN1	PA450268	2200	0.933
NULL	Diabetes_Care_2013_Jul_12_36(7)_2015-2019.nxml.txt.nlp	23340883	SENT123	10	10	18	18	glucose	SII	PA449773	6917	0.933
NULL	Diabetes_2009_Aug_28_58(8)_1757-1765.nxml.txt.nlp	19478146	SENT68	8	8	30	30	ethanol	mol	PA448073	90527	0.933
NULL	Asian_J_Androl_2014_Apr_11_Jul-Aug_16(4)_505-510.nxml.txt.nlp	24759577	SENT89	7	7	27	27	dutasteride	aromatase	PA164749300	1588	0.933
NULL	J_Hematol_Oncol_2013_Mar_27_6_23.nxml.txt.nlp	23531342	SENT102	14	14	40	40	mi-63	RITA		55422;84934	0.933
NULL	J_Immunol_Res_2014_Apr_30_2014_857143.nxml.txt.nlp	24877157	SENT323	3	3	21	21	cyclosporine	FKBP12	PA449167	2280	0.933
NULL	Ann_Hematol_2014_Sep_10_93(1)_1-11.nxml.txt.nlp	24018623	SENT195	32	32	25	25	lenalidomide	CD34	PA162363968	947	0.933
NULL	Cancers_(Basel)_2011_Apr_1_3(2)_1844-1860.nxml.txt.nlp	24212785	SENT73	13	13	4	4	panitumumab	ACRC	PA162373091	93953	0.933
NULL	Front_Behav_Neurosci_2009_Jan_27_3_1.nxml.txt.nlp	19194528	SENT10	35	35	24	24	fluoxetine	EPM	PA449673	2054	0.933
NULL	Front_Oncol_2014_Apr_2_4_70.nxml.txt.nlp	24765614	SENT146	9	9	18	18	sunitinib	CD4	PA162372840	920	0.933
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT173	8	8	28	28	pertuzumab	HER2		2064	0.933
NULL	Cancer_Inform_2008_Jun_10_6_315-355.nxml.txt.nlp	19259415	SENT352	9	9	36	36	cisplatin	AIM1	PA449014	202	0.933
NULL	Nat_Commun_2014_5_3361.nxml.txt.nlp	24553445	SENT73	19	19	3	3	olaparib	BRCA1		672	0.933
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_P103.nxml.txt.nlp	NULL	SENT16	36	36	17	17	amoxicillin	MDM	PA448406	57152	0.933
NULL	Int_J_Mol_Sci_2012_Feb_1_13(2)_1512-1523.nxml.txt.nlp	22408405	SENT8	27	27	6	6	olmesartan	LOX-1	PA164742950	4973	0.933
NULL	Br_J_Cancer_2014_Jan_21_110(2)_421-429.nxml.txt.nlp	24300973	SENT247	22	22	10	10	oxaliplatin	DAP3	PA131285527	58512;7818	0.933
NULL	COPD_2008_Jun_13_5(3)_187-200.nxml.txt.nlp	18568843	SENT160	41	41	27	27	salmeterol	NNT	PA451300	23530	0.933
NULL	Arch_Gynecol_Obstet_2012_May_30_285(5)_1447-1453.nxml.txt.nlp	22127553	SENT9	9	9	0	0	epirubicin	TEC	PA449476	7006	0.933
NULL	eLife_2014_May_20_3_e01763.nxml.txt.nlp	24844244	SENT498	16	16	4	4	doxycycline	MELK	PA449415	9833	0.933
NULL	Cell_Cycle_2013_May_15_12(10)_1492-1500.nxml.txt.nlp	23598717	SENT5	3	3	20	20	doxorubicin	ROCK2	PA449412	9475	0.933
NULL	Br_J_Cancer_2010_Mar_16_102(6)_1003-1009.nxml.txt.nlp	20179710	SENT114	1	1	27	27	doxorubicin	SLC22A16	PA449412	85413	0.933
NULL	Clin_Psychopharmacol_Neurosci_2011_Apr_30_9(1)_36-43.nxml.txt.nlp	23431025	SENT84	19	19	7	7	aripiprazole	FLI	PA10026	2314	0.933
NULL	Br_J_Cancer_2013_Feb_19_108(3)_557-563.nxml.txt.nlp	23361053	SENT15	12	12	6	6	tamoxifen	PAK1	PA451581	5585;5058	0.933
NULL	J_Exp_Clin_Cancer_Res_2009_Jul_10_28(1)_99.nxml.txt.nlp	19591692	SENT29	28	28	20	20	elacridar	ABCG2		9429	0.933
NULL	Cancers_(Basel)_2014_Nov_25_6(4)_2313-2329.nxml.txt.nlp	25534569	SENT3	16	16	7	7	cabozantinib	HGF	PA165906891	3569;6654;3082	0.933
NULL	Oncol_Rep_2012_Apr_16_27(4)_1245-1250.nxml.txt.nlp	22266802	SENT100	33	33	26	26	sulindac	p65	PA451565	5970	0.933
NULL	Int_J_Mol_Sci_2014_Nov_14_15(11)_21155-21178.nxml.txt.nlp	25405743	SENT211	12	12	17	17	hemin	HO-1	PA449849	3162	0.933
NULL	Mol_Cancer_2007_Sep_26_6_61.nxml.txt.nlp	17894897	SENT13	38	38	40	40	etoposide	p53	PA449552	7157	0.933
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_25_2013_127075.nxml.txt.nlp	23878590	SENT113	27	27	6	6	genistein	GDNF	PA165109660	2668	0.933
NULL	Front_Neurol_2011_Dec_16_2_72.nxml.txt.nlp	22203815	SENT199	23	23	13	13	protamine	IL-17	PA10366	3605	0.933
NULL	J_Cancer_2014_Apr_24_5(5)_390-397.nxml.txt.nlp	24799957	SENT47	8	8	28	28	fosaprepitant	CHOP	PA165958390	1649	0.933
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Sep_30_66(Pt_10)_o2686.nxml.txt.nlp	21587654	SENT54	18	18	6	6	ethanol	mol	PA448073	90527	0.933
NULL	F1000_Med_Rep_2010_Apr_27_2_30.nxml.txt.nlp	20948855	SENT52	0	0	13	13	thalidomide	ENL	PA451644	4298	0.933
NULL	Physiol_Rep_2014_Aug_28_2(8)_e12143.nxml.txt.nlp	25168879	SENT10	3	3	25	25	staurosporine	COX	PA165109623	1351	0.933
NULL	Cancer_Cell_Int_2005_Aug_23_5_27.nxml.txt.nlp	16117829	SENT9	21	21	4	4	doxycycline	p53	PA449415	7157	0.933
NULL	J_Exp_Clin_Cancer_Res_2009_Oct_7_28(1)_134.nxml.txt.nlp	19811659	SENT127	8	8	17	17	sunitinib	VEGFR	PA162372840	3791	0.933
NULL	Environ_Health_Perspect_2008_Jun_6_116(6)_752-760.nxml.txt.nlp	18560531	SENT299	30	30	19	19	methimazole	spatial	PA450422	219793	0.933
NULL	Nat_Commun_2014_Dec_8_5_5736.nxml.txt.nlp	25484020	SENT9	8	8	2	2	exemestane	aromatase	PA449563	1588	0.933
NULL	Interdiscip_Toxicol_2011_Dec_4(4)_173-183.nxml.txt.nlp	22319251	SENT124	21	21	15	15	genistein	DES	PA165109660	1674	0.933
NULL	J_Cell_Biol_2004_Jun_7_165(5)_653-662.nxml.txt.nlp	15173192	SENT175	12	12	10	10	amiloride	NHE	PA448368	285335	0.933
NULL	Cell_Death_Dis_2014_Jan_16_5(1)_e997.nxml.txt.nlp	24434520	SENT31	6	6	14	14	cyclosporine	AMPK	PA449167	5563	0.933
NULL	J_Cell_Mol_Med_2014_May_14_18(5)_811-823.nxml.txt.nlp	24628949	SENT33	17	17	11	11	docetaxel	FOXM1	PA449383	2305	0.933
NULL	Anal_Bioanal_Chem_2011_Jan_3_399(2)_527-539.nxml.txt.nlp	20814668	SENT142	15	15	2	2	heparin	NIR	PA449855	26155	0.933
NULL	Arthritis_Res_Ther_2009_Jan_26_11(1)_R12.nxml.txt.nlp	19171052	SENT243	16	16	3	3	dipyridamole	ACTH	PA449367	5443	0.933
NULL	F1000_Biol_Rep_2009_Sep_8_1_70.nxml.txt.nlp	20948617	SENT8	10	10	30	30	tocilizumab	IL-23	PA165292659	51561	0.933
NULL	Cancer_Biol_Med_2013_Dec_10(4)_192-205.nxml.txt.nlp	24349829	SENT271	29	29	27	27	gefitinib	EGFR	PA131301952	1956	0.933
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT264	17	17	35	35	resveratrol	ROS		6098	0.933
NULL	Oncotarget_2013_Dec_17_5(1)_67-77.nxml.txt.nlp	24393766	SENT167	8	8	16	16	curcumin	AKT	PA151958596	207	0.933
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT361	30	30	4	4	metformin	p53	PA450395	7157	0.933
NULL	Cancer_Inform_2010_Apr_27_9_93-103.nxml.txt.nlp	20467479	SENT18	8	8	24	24	tamoxifen	CYP2D6	PA451581	1565	0.933
NULL	F1000Res_2013_Oct_8_2_173.nxml.txt.nlp	24555085	SENT258	43	43	25	25	hydrocortisone	BDP	PA449905	10620;152926	0.933
NULL	Oncogenesis_2012_Apr_16_1(4)_e7.nxml.txt.nlp	23552604	SENT48	14	14	2	2	nutlin-3	BTG2		7832	0.933
NULL	Br_J_Pharmacol_2011_Apr_162(8)_1832-1842.nxml.txt.nlp	21232033	SENT19	27	27	11	11	resveratrol	SAP97		1739	0.933
NULL	Cardiovasc_Drugs_Ther_2010_Dec_13_24(5-6)_391-399.nxml.txt.nlp	20640495	SENT46	27	27	15	15	simvastatin	DIP	PA451363	23151;1831	0.933
NULL	Oncoscience_2014_Mar_24_1(3)_196-204.nxml.txt.nlp	25594012	SENT117	9	9	2	2	trastuzumab	PTEN	PA451743	5728	0.933
NULL	Clin_Kidney_J_2013_Jun_11_6(3)_287-294.nxml.txt.nlp	23717787	SENT154	21	21	3	3	cinacalcet	PTH	PA164776671	5741	0.933
NULL	ScientificWorldJournal_2012_Jun_4_2012_721313.nxml.txt.nlp	22701369	SENT121	35	35	12	12	imatinib	ZNF43	PA10804	7594	0.933
NULL	Int_J_Med_Sci_2013_Mar_20_10(5)_607-616.nxml.txt.nlp	23569423	SENT81	16	16	26	26	losartan	AT2	PA450268	186	0.933
NULL	Indian_J_Endocrinol_Metab_2012_Mar_16(Suppl1)_S110-S113.nxml.txt.nlp	22701828	SENT30	0	0	23	23	vildagliptin	GLP-1	PA165958346	100125288	0.933
NULL	J_Thromb_Haemost_2011_Oct_9(10)_2103-2105.nxml.txt.nlp	21812912	SENT28	35	35	6	6	ticagrelor	P2Y12	PA165374673	64805	0.933
NULL	Int_J_Med_Chem_2012_Dec_13_2012_530392.nxml.txt.nlp	25379286	SENT301	46	46	20	20	ethanol	mol	PA448073	90527	0.933
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT190	24	24	2	2	pertuzumab	COL17A1		1308	0.933
NULL	Nucleic_Acids_Res_2011_Sep_19_39(16)_6932-6943.nxml.txt.nlp	21596782	SENT291	5	5	8	8	resveratrol	SIRT1		23411	0.933
NULL	Diabetes_Care_2009_Aug_9_32(8)_1485-1490.nxml.txt.nlp	19509012	SENT119	29	29	21	21	valsartan	REN	PA451848	5972;147040	0.933
NULL	Ann_Indian_Acad_Neurol_2009_Apr-Jun_12(2)_89-98.nxml.txt.nlp	20142853	SENT202	17	17	26	26	oxcarbazepine	MRP2	PA450732	100130958;57626;1244	0.933
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT16	3	3	22	22	metformin	HIP	PA450395	6767;6159;64399;5068	0.933
NULL	J_Hematol_Oncol_2013_Jul_18_6_53.nxml.txt.nlp	23866964	SENT227	8	8	17	17	temsirolimus	HDAC4	PA164746890	9759	0.933
NULL	Viruses_2014_Jan_7_6(1)_137-150.nxml.txt.nlp	24402304	SENT110	12	12	1	1	paraformaldehyde	AAMP	PA450790	14	0.933
NULL	Br_J_Cancer_2013_Jul_23_109(2)_342-350.nxml.txt.nlp	23807172	SENT123	23	23	34	34	sorafenib	NAC	PA7000	22861	0.933
NULL	Br_J_Cancer_2009_Jun_2_100(11)_1739-1745.nxml.txt.nlp	19436299	SENT166	5	5	24	24	everolimus	FDG	PA164746311	23583	0.933
NULL	Clin_Psychopharmacol_Neurosci_2014_Apr_24_12(1)_54-64.nxml.txt.nlp	24851122	SENT121	16	16	7	7	methamphetamine	MRO	PA450403	83876	0.933
NULL	Cancer_Metastasis_Rev_2012_Jun_20_31(1-2)_143-162.nxml.txt.nlp	22101807	SENT153	27	27	5	5	urokinase	LPA	PA451836	4018	0.933
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT157	23	23	8	8	atorvastatin	OPG	PA448500	690	0.933
NULL	Oncotarget_2013_Oct_27_4(11)_2080-2095.nxml.txt.nlp	24231268	SENT216	40	40	19	19	nutlin-3	TP53		7157	0.933
NULL	Clin_Drug_Investig_2013_Aug_23_33(10)_727-736.nxml.txt.nlp	23975654	SENT184	29	29	18	18	quinidine	CYP2D6	PA451209	1565	0.933
NULL	Endocrinol_Metab_(Seoul)_2014_Sep_25_29(3)_379-387.nxml.txt.nlp	25309798	SENT186	41	41	26	26	resveratrol	SIRT1		23411	0.933
NULL	Genet_Vaccines_Ther_2011_Jun_23_9_11.nxml.txt.nlp	21699699	SENT27	16	16	10	10	ribavirin	IFN	PA451241	3439	0.933
NULL	Exp_Hematol_Oncol_2013_Nov_8_2_30.nxml.txt.nlp	24499550	SENT130	29	29	14	14	vemurafenib	BRAF	PA165946873	673	0.933
NULL	Mediators_Inflamm_2010_Mar_22_2010_823486.nxml.txt.nlp	20339530	SENT137	24	24	30	30	hyaluronan	TLR4	PA165958431	7099	0.933
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Jan_16_64(Pt_2)_o441.nxml.txt.nlp	21201468	SENT3	10	10	21	21	pefloxacin	mol	PA164742856	90527	0.933
NULL	Environ_Health_Perspect_2011_Aug_7_119(8)_1117-1122.nxml.txt.nlp	21382770	SENT182	22	22	25	25	mk-571	MRP		79971	0.933
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT260	6	6	21	21	lapatinib	HRG	PA152241907	3084;3273	0.933
NULL	Mol_Biol_Evol_2013_Feb_27_30(2)_448-456.nxml.txt.nlp	23104081	SENT187	13	13	0	0	doxycycline	LCB2	PA449415	9517	0.933
NULL	Orphanet_J_Rare_Dis_2014_Sep_2_9(1)_130.nxml.txt.nlp	NULL	SENT254	31	31	1	1	cyanocobalamin	B12	PA451892	7126;4709	0.933
NULL	Int_J_Mol_Sci_2014_Dec_2_15(12)_22128-22141.nxml.txt.nlp	25474084	SENT6	30	30	15	15	cisplatin	p53	PA449014	7157	0.933
NULL	Clin_Interv_Aging_2010_Sep_7_5_253-258.nxml.txt.nlp	20852672	SENT68	35	35	0	0	aripiprazole	Men	PA10026	8178	0.933
NULL	Antimicrob_Agents_Chemother_2014_Aug_58(8)_4971-4973.nxml.txt.nlp	24913169	SENT10	30	30	4	4	primaquine	G6PD	PA451103	2539	0.933
NULL	Exp_Ther_Med_2014_Aug_4_8(2)_657-661.nxml.txt.nlp	25009636	SENT91	5	5	17	17	propofol	CCR2	PA451141	729230	0.933
NULL	Clin_Infect_Dis_2013_Mar_1_56(5)_694-696.nxml.txt.nlp	23175557	SENT45	8	8	12	12	primaquine	G6PD	PA451103	2539	0.933
NULL	Br_J_Pharmacol_2012_Jan_165(2)_380-389.nxml.txt.nlp	21585347	SENT156	28	28	19	19	rosiglitazone	ATGL	PA451283	57104	0.933
NULL	AAPS_J_2014_Jun_11_16(5)_1029-1037.nxml.txt.nlp	24917180	SENT5	10	10	8	8	quinidine	P-gp	PA451209	5243	0.933
NULL	Mol_Vis_2011_Feb_1_17_332-340.nxml.txt.nlp	21297899	SENT179	6	6	19	19	telmisartan	NAC	PA451605	22861	0.933
NULL	J_Invest_Dermatol_2013_Aug_133(8)_1928-1929.nxml.txt.nlp	23856932	SENT21	5	5	12	12	vemurafenib	PAX3	PA165946873	5077	0.933
NULL	Int_J_Biol_Sci_2013_Dec_17_10(1)_64-72.nxml.txt.nlp	24391452	SENT91	17	17	35	35	ketanserin	5-HT2B	PA131053734	3357	0.933
NULL	Cell_Cycle_2012_Nov_1_11(21)_3983-3996.nxml.txt.nlp	22987153	SENT142	33	33	8	8	cisplatin	DNA2	PA449014	1763	0.933
NULL	Biomed_Res_Int_2013_Jun_17_2013_312656.nxml.txt.nlp	23844360	SENT152	0	0	9	9	plerixafor	HSPC	PA165958410	5688	0.933
NULL	J_Cell_Mol_Med_2013_Oct_23_17(10)_1207-1217.nxml.txt.nlp	24106980	SENT136	17	17	25	25	paclitaxel	PTEN	PA450761	5728	0.933
NULL	Breast_Cancer_Res_2010_Jun_28_12(3)_R43.nxml.txt.nlp	20579400	SENT102	33	33	11	11	vinorelbine	MTS	PA451881	1678	0.933
NULL	Avicenna_J_Med_Biotechnol_2014_Jan-Mar_6(1)_10-20.nxml.txt.nlp	24523953	SENT81	7	7	30	30	trypsin	CD105	PA451806	2022	0.933
NULL	eLife_2013_Sep_3_2_e00036.nxml.txt.nlp	24015354	SENT475	0	0	26	26	colchicine	CO2	PA449092	4513	0.933
NULL	Oncotarget_2013_Nov_19_5(2)_309-325.nxml.txt.nlp	24525395	SENT162	11	11	24	24	bortezomib	Mcl-1	PA10252	4170	0.933
NULL	Ann_Gen_Psychiatry_2009_May_18_8_13.nxml.txt.nlp	19450269	SENT134	5	5	2	2	naratriptan	5-HT1B	PA450597	3351	0.933
NULL	Br_J_Cancer_1995_Oct_72(4)_952-957.nxml.txt.nlp	7547247	SENT11	14	14	6	6	etoposide	p53	PA449552	7157	0.933
NULL	Acta_Pharmacol_Sin_2012_Jan_12_33(1)_91-100.nxml.txt.nlp	22158107	SENT168	2	2	22	22	2-methoxyestradiol	U87	PA134967247	677775;641648	0.933
NULL	Breast_Cancer_Res_2008_Dec_18_10(Suppl_4)_S20.nxml.txt.nlp	19128434	SENT20	29	29	41	41	fulvestrant	aromatase	PA164747170	1588	0.933
NULL	Cancers_(Basel)_2011_Apr_1_3(2)_1844-1860.nxml.txt.nlp	24212785	SENT657	16	16	0	0	cetuximab	PIK3CA	PA10040	5290	0.933
NULL	Cell_Death_Dis_2012_Nov_15_3(11)_e422.nxml.txt.nlp	23152058	SENT348	37	37	19	19	cisplatin	GCLM	PA449014	2730	0.933
NULL	Cancer_Manag_Res_2014_Feb_3_6_63-75.nxml.txt.nlp	24520205	SENT14	14	14	21	21	bevacizumab	San	PA130232992	80218	0.933
NULL	Int_J_Mol_Sci_2014_Sep_29_15(10)_17411-17441.nxml.txt.nlp	25268615	SENT313	16	16	24	24	methotrexate	CD147	PA450428	682	0.933
NULL	Oncotarget_2011_Nov_30_2(11)_874-885.nxml.txt.nlp	22141136	SENT186	18	18	7	7	nilotinib	AXL	PA165958345	558	0.933
NULL	Acta_Pharmacol_Sin_2009_Oct_21_30(10)_1392-1398.nxml.txt.nlp	19767766	SENT119	4	4	20	20	atorvastatin	ROS	PA448500	6098	0.933
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT95	19	19	9	9	curcumin	BimL	PA151958596	10018	0.933
NULL	J_Inherit_Metab_Dis_2012_Nov_24_35(6)_1137-1145.nxml.txt.nlp	22447153	SENT211	19	19	11	11	fenofibrate	PMP70	PA449594	5825	0.933
NULL	Hum_Genomics_2010_Aug_1_4(6)_411-420.nxml.txt.nlp	20846931	SENT89	19	19	0	0	taurine	BAAT	PA451590	570	0.933
NULL	Mucosal_Immunol_2012_May_8_5(3)_267-276.nxml.txt.nlp	22318492	SENT267	4	4	21	21	omalizumab	CD203c	PA164752253	5169	0.933
NULL	BMB_Rep_2014_Jul_47(7)_376-381.nxml.txt.nlp	24286332	SENT93	11	11	6	6	thrombin	PPG	PA451674	5552	0.933
NULL	Diabetes_Care_2013_Jul_12_36(7)_1933-1940.nxml.txt.nlp	23462665	SENT20	0	0	7	7	exenatide	GLP-1	PA164749238	100125288	0.933
NULL	Case_Rep_Hematol_2013_Oct_9_2013_458303.nxml.txt.nlp	24224106	SENT37	17	17	13	13	doxorubicin	CHOP	PA449412	1649	0.933
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S272-S275.nxml.txt.nlp	21525467	SENT108	7	7	10	10	sitagliptin	GLP-1	PA164748978	100125288	0.933
NULL	Basic_Res_Cardiol_2010_Jul_25_105(4)_523-533.nxml.txt.nlp	20336304	SENT305	22	22	29	29	levosimendan	PI3K	PA164749138	5290	0.933
NULL	J_Oncol_2010_Jan_5_2010_257058.nxml.txt.nlp	20069126	SENT225	5	5	3	3	metformin	AMPK	PA450395	5563	0.933
NULL	Br_J_Cancer_2010_Jun_29_103(1)_61-72.nxml.txt.nlp	20588279	SENT258	23	23	11	11	trastuzumab	PTEN	PA451743	5728	0.933
NULL	J_Exp_Med_1998_Jun_1_187(11)_1863-1870.nxml.txt.nlp	9607926	SENT34	44	44	16	16	neomycin	CD45-AP	PA450608	5790	0.933
NULL	Clin_Endosc_2013_Nov_19_46(6)_643-646.nxml.txt.nlp	24340258	SENT67	10	10	22	22	triamcinolone	ESD	PA451749	2098	0.933
NULL	Cancers_(Basel)_2014_Jun_27_6(3)_1363-1381.nxml.txt.nlp	24978438	SENT220	9	9	0	0	bortezomib	CD138	PA10252	6382	0.933
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2011_Mar_14_4_13-24.nxml.txt.nlp	22879790	SENT134	24	24	9	9	metformin	GLP-1	PA450395	100125288	0.933
NULL	Br_J_Cancer_2006_Dec_4_95(11)_1504-1513.nxml.txt.nlp	17088902	SENT10	8	8	22	22	gefitinib	PI3K	PA131301952	5290	0.933
NULL	Mol_Biol_Cell_2012_Sep_1_23(17)_3473-3484.nxml.txt.nlp	22787275	SENT263	15	15	33	33	doxorubicin	San	PA449412	80218	0.933
NULL	Int_J_Cardiovasc_Imaging_2007_Feb_17_23(1)_61-131.nxml.txt.nlp	NULL	SENT2041	14	14	2	2	iohexol	FFR	PA450061	738	0.933
NULL	Ann_Indian_Acad_Neurol_2008_Jan-Mar_11(1)_20-27.nxml.txt.nlp	19966974	SENT80	12	12	23	23	acetazolamide	SCN4A	PA448018	6329	0.933
NULL	Oncotarget_2014_Jun_6_5(12)_4060-4070.nxml.txt.nlp	24938183	SENT114	25	25	23	23	vemurafenib	BRAF	PA165946873	673	0.933
NULL	Cancer_Imaging_2011_Mar_1_11(1)_1-8.nxml.txt.nlp	21362586	SENT97	12	12	18	18	verapamil	P-gp	PA451868	5243	0.933
NULL	Cardiol_Res_Pract_2011_May_10_2011_816897.nxml.txt.nlp	21629798	SENT92	0	0	13	13	sorafenib	CYP3A4	PA7000	1576	0.933
NULL	BMJ_2010_Feb_8_340_c693.nxml.txt.nlp	20142325	SENT206	13	13	2	2	tamoxifen	CYP2D6	PA451581	1565	0.933
NULL	Front_Cell_Neurosci_2013_Dec_26_7_277.nxml.txt.nlp	24421756	SENT752	14	14	1	1	apomorphine	ANKK1	PA164781163	255239	0.933
NULL	Onco_Targets_Ther_2014_Sep_9_7_1571-1582.nxml.txt.nlp	25228815	SENT193	9	9	13	13	sunitinib	VEGFR2	PA162372840	3791	0.933
NULL	Mol_Pain_2013_Jun_10_9_27.nxml.txt.nlp	23758830	SENT194	10	10	2	2	lidocaine	TRPV1	PA450226	7442	0.933
NULL	Cancer_Med_2014_Apr_27_3(2)_310-321.nxml.txt.nlp	24464839	SENT220	14	14	3	3	everolimus	MVD	PA164746311	4597	0.933
NULL	Springerplus_2014_Sep_17_3_535.nxml.txt.nlp	25279326	SENT154	21	21	13	13	fulvestrant	aromatase	PA164747170	1588	0.933
NULL	Curr_Neuropharmacol_2013_May_11(3)_263-275.nxml.txt.nlp	24179463	SENT138	14	14	7	7	imipramine	CB1	PA449969	1268	0.933
NULL	Int_J_Biol_Sci_2013_Dec_17_10(1)_64-72.nxml.txt.nlp	24391452	SENT91	8	8	15	15	verapamil	5-HT2A	PA451868	3356	0.933
NULL	Trials_2013_Sep_24_14_311.nxml.txt.nlp	24063608	SENT60	0	0	5	5	amodiaquine	IPT	PA448404	54802	0.933
NULL	Hum_Genomics_Proteomics_2010_Apr_13_2010_164906.nxml.txt.nlp	20981232	SENT253	12	12	4	4	thrombin	ERK1	PA451674	5595	0.933
NULL	Mol_Cell_Biochem_2014_Oct_9_385(1-2)_265-275.nxml.txt.nlp	24104452	SENT229	9	9	33	33	bortezomib	U87	PA10252	677775;641648	0.933
NULL	Oncogene_2010_Sep_16_29(37)_5193-5203.nxml.txt.nlp	20581867	SENT21	8	8	16	16	lapatinib	PI3K	PA152241907	5290	0.933
NULL	Oncol_Lett_2014_Aug_19_8(2)_809-812.nxml.txt.nlp	25009658	SENT79	13	13	1	1	metformin	AMPK	PA450395	5563	0.933
NULL	J_Mol_Signal_2010_Jun_11_5_6.nxml.txt.nlp	20540776	SENT4	20	20	0	0	etoposide	SSBP2	PA449552	23635	0.933
NULL	Cardiovasc_Res_2014_Mar_1_101(3)_513-521.nxml.txt.nlp	24323316	SENT27	35	35	10	10	maraviroc	CCR5	PA164768835	1234	0.933
NULL	ScientificWorldJournal_2012_Aug_13_2012_496453.nxml.txt.nlp	22927782	SENT153	9	9	18	18	liraglutide	GLP-1	PA165958364	100125288	0.933
NULL	Biomed_Res_Int_2013_Sep_5_2013_929531.nxml.txt.nlp	24083250	SENT136	7	7	28	28	hyaluronan	RHAMM	PA165958431	3161	0.933
NULL	Environ_Health_Perspect_2005_Oct_14_113(10)_1330-1335.nxml.txt.nlp	16203242	SENT221	10	10	15	15	phenylephrine	MLC	PA450935	23209	0.933
NULL	Ther_Clin_Risk_Manag_2007_Aug_3(4)_533-542.nxml.txt.nlp	18472974	SENT143	38	38	16	16	fluconazole	CDR2	PA449653	1039	0.933
NULL	Gastroenterol_Hepatol_Bed_Bench_2013_Summer_6(3)_115-119.nxml.txt.nlp	24834257	SENT76	3	3	30	30	lactulose	CLDN4	PA164748762	1364	0.933
NULL	Biogerontology_2014_Nov_16_15(1)_47-64.nxml.txt.nlp	24243065	SENT182	32	32	13	13	doxorubicin	p53	PA449412	7157	0.933
NULL	Leukemia_2013_Jan_11_27(1)_32-40.nxml.txt.nlp	22781593	SENT191	8	8	15	15	ponatinib	FGFR1	PA165980594	2260	0.933
NULL	Oncotarget_2014_Oct_21_5(22)_11180-11192.nxml.txt.nlp	25361003	SENT111	20	20	33	33	tetracycline	NTRK1	PA451640	4914	0.933
NULL	Int_J_Cell_Biol_2012_Sep_9_2012_683897.nxml.txt.nlp	22991514	SENT58	7	7	20	20	oxygen	CO2	PA450744	4513	0.933
NULL	Breast_Cancer_Res_2004_Oct_6_6(6)_262-268.nxml.txt.nlp	15535857	SENT108	19	19	25	25	tamoxifen	aromatase	PA451581	1588	0.933
NULL	Breast_Cancer_Res_2011_Nov_1_13(6)_224.nxml.txt.nlp	22114931	SENT112	20	20	10	10	trastuzumab	PI3K	PA451743	5290	0.933
NULL	Mol_Cancer_2010_Apr_15_9_77.nxml.txt.nlp	20398291	SENT8	8	8	5	5	geldanamycin	Hsp90	PA152031327	3320	0.933
NULL	F1000Prime_Rep_2014_Dec_1_6_117.nxml.txt.nlp	25580271	SENT83	12	12	16	16	bevacizumab	EGFR	PA130232992	1956	0.933
NULL	Acta_Naturae_2013_Apr-Jun_5(2)_19-39.nxml.txt.nlp	23819034	SENT209	5	5	13	13	thrombin	FVIII	PA451674	2157	0.933
NULL	Ther_Clin_Risk_Manag_2007_Jun_3(2)_259-268.nxml.txt.nlp	18360634	SENT28	0	0	16	16	natalizumab	DMT	PA164747191	2039	0.933
NULL	Diabetes_2008_Sep_57(9)_2272-2279.nxml.txt.nlp	18519799	SENT277	45	45	6	6	rosiglitazone	PDK4	PA451283	5166	0.933
NULL	Acta_Naturae_2014_Jul-Sep_6(3)_89-97.nxml.txt.nlp	25349717	SENT165	13	13	44	44	collagenase	ADAMTS-4	PA449107	9508	0.933
NULL	Front_Physiol_2013_Nov_14_4_323.nxml.txt.nlp	24294204	SENT200	35	35	10	10	carvedilol	UGT1A1	PA448817	54658	0.933
NULL	Diagn_Pathol_2013_Jul_17_8_120.nxml.txt.nlp	23866960	SENT100	28	28	6	6	nitrofurazone	ANOVA	PA164754877	4858	0.933
NULL	Indian_J_Psychiatry_2010_Jan_52(Suppl1)_S317-S340.nxml.txt.nlp	21836703	SENT107	6	6	10	10	thiothixene	TFP	PA451669	7034	0.933
NULL	Int_J_Chron_Obstruct_Pulmon_Dis_2007_Dec_2(4)_517-533.nxml.txt.nlp	18268925	SENT333	4	4	14	14	cilomilast	CD68	PA165948031	968	0.933
NULL	Nucleic_Acids_Res_2013_Nov_27_41(21)_9786-9799.nxml.txt.nlp	23982513	SENT194	23	23	7	7	arsenite	ADAR1	PA452638	103	0.933
NULL	Cancers_(Basel)_2010_Jul_27_2(3)_1528-1554.nxml.txt.nlp	24281171	SENT332	10	10	3	3	daunorubicin	CD38	PA449212	952	0.933
NULL	Toxins_(Basel)_2010_Oct_26_2(11)_2490-2518.nxml.txt.nlp	22069563	SENT200	33	33	12	12	cisplatin	IL-10	PA449014	3586	0.933
NULL	Cancer_Manag_Res_2012_Dec_18_4_431-445.nxml.txt.nlp	23293538	SENT17	11	11	2	2	propranolol	RANKL	PA451145	8600	0.933
NULL	Breast_Cancer_(Auckl)_2009_Sep_2_3_61-75.nxml.txt.nlp	19809577	SENT115	4	4	19	19	curcumin	BRCA1	PA151958596	672	0.933
NULL	Eur_J_Clin_Pharmacol_2008_Jul_16_64(7)_683-690.nxml.txt.nlp	18415093	SENT127	7	7	15	15	artesunate	ACT	PA165111697	12;11332;9457;641455	0.933
NULL	J_Biomed_Biotechnol_2011_Dec_6_2011_856985.nxml.txt.nlp	21188173	SENT179	12	12	22	22	vorinostat	EGFR	PA164748224	1956	0.933
NULL	Int_J_Biol_Sci_2013_Nov_21_9(10)_1089-1098.nxml.txt.nlp	24339730	SENT164	24	24	15	15	genistein	OSC	PA165109660	4047	0.933
NULL	Case_Rep_Hematol_2014_Dec_24_2014_460574.nxml.txt.nlp	25610674	SENT9	22	22	3	3	rituximab	PHL	PA451261	613	0.933
NULL	Oncotarget_2014_Jul_25_5(21)_10460-10472.nxml.txt.nlp	25361005	SENT136	9	9	2	2	everolimus	AKT	PA164746311	207	0.933
NULL	Acta_Neuropathol_Commun_2013_May_9_1_10.nxml.txt.nlp	24252471	SENT160	18	18	2	2	ifosfamide	ALDH1A1	PA449964	216	0.933
NULL	J_Cell_Mol_Med_2013_Mar_23_17(3)_325-336.nxml.txt.nlp	23521716	SENT255	2	2	24	24	cetuximab	EGFR	PA10040	1956	0.933
NULL	Acta_Pharmacol_Sin_2010_Oct_27_31(10)_1389-1394.nxml.txt.nlp	20871620	SENT143	8	8	12	12	carbachol	JNK	PA448784	5599	0.933
NULL	J_Cell_Mol_Med_2013_Sep_11_17(9)_1160-1172.nxml.txt.nlp	23844832	SENT156	12	12	3	3	gefitinib	EGFR	PA131301952	1956	0.933
NULL	J_Immunother_Cancer_2014_Jan_27_2_2.nxml.txt.nlp	24829759	SENT124	20	20	14	14	sorafenib	IL-21	PA7000	59067;50616;27189	0.933
NULL	Drugs_R_D_2011_Mar_27_11(1)_37-51.nxml.txt.nlp	21410294	SENT2	30	30	27	27	itraconazole	CYP3A4	PA450132	1576	0.933
NULL	Exp_Ther_Med_2013_Sep_4_6(3)_663-670.nxml.txt.nlp	24137243	SENT239	2	2	18	18	berberine	IL-6	PA165860812	3569	0.933
NULL	Acta_Pharmacol_Sin_2010_May_12_31(5)_578-584.nxml.txt.nlp	20383171	SENT120	2	2	28	28	berberine	JNK	PA165860812	5599	0.933
NULL	Breast_Cancer_(Auckl)_2009_Apr_7_3_23-34.nxml.txt.nlp	21556247	SENT106	23	23	3	3	celecoxib	AKT	PA448871	207	0.933
NULL	Diabetes_2009_Feb_58(2)_329-336.nxml.txt.nlp	19171749	SENT13	36	36	24	24	imatinib	TRB3	PA10804	50838;57761	0.933
NULL	Oncol_Rep_2015_Feb_11_33(2)_526-532.nxml.txt.nlp	25501339	SENT9	17	17	15	15	gefitinib	EGFR	PA131301952	1956	0.933
NULL	Clin_Med_Insights_Oncol_2012_May_16_6_205-217.nxml.txt.nlp	22654526	SENT197	23	23	37	37	plerixafor	CXCR4	PA165958410	7852	0.933
NULL	Breast_Cancer_Res_2010_Jun_24_12(3)_R41.nxml.txt.nlp	20576088	SENT192	34	34	8	8	paclitaxel	PPM1D	PA450761	8493	0.933
NULL	Cell_Res_2013_Feb_15_23(2)_201-212.nxml.txt.nlp	23318584	SENT35	37	37	4	4	l-cysteine	NLRP3	PA449173	114548	0.933
NULL	Oncogene_2014_Feb_6_33(6)_713-723.nxml.txt.nlp	23435429	SENT48	20	20	7	7	etoposide	BRCA1	PA449552	672	0.933
NULL	Mol_Cancer_2014_Jun_3_13_139.nxml.txt.nlp	24894297	SENT221	24	24	16	16	cisplatin	HES1	PA449014	3280;8209	0.933
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_3_2014_473213.nxml.txt.nlp	25538791	SENT112	2	2	19	19	fexofenadine	MDR1	PA449621	5243	0.933
NULL	J_Invest_Dermatol_2012_Nov_21_132(11)_2642-2651.nxml.txt.nlp	22718118	SENT151	6	6	0	0	collagenase	CD11b	PA449107	3684	0.933
NULL	Sarcoma_1999_Sep_3(2)_79-84.nxml.txt.nlp	18521267	SENT11	18	18	25	25	ifosfamide	mol	PA449964	90527	0.933
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jul_10_68(Pt_8)_o2422.nxml.txt.nlp	22904873	SENT63	13	13	6	6	ethanol	mol	PA448073	90527	0.933
NULL	Front_Pharmacol_2014_Oct_20_5_230.nxml.txt.nlp	25368579	SENT22	10	10	26	26	berberine	IL-6	PA165860812	3569	0.933
NULL	Oncotarget_2014_Mar_14_5(10)_3029-3038.nxml.txt.nlp	24912489	SENT20	28	28	20	20	exemestane	aromatase	PA449563	1588	0.933
NULL	Leukemia_2013_Feb_3_27(2)_315-324.nxml.txt.nlp	22751450	SENT140	23	23	7	7	sorafenib	AKT	PA7000	207	0.933
NULL	Breast_Cancer_Res_2008_Dec_18_10(Suppl_4)_S24.nxml.txt.nlp	19128438	SENT47	34	34	2	2	anastrozole	IMPACT	PA448432	55364	0.933
NULL	Clin_Pharmacol_2011_Jun_22_3_13-25.nxml.txt.nlp	22287853	SENT179	12	12	24	24	saxagliptin	CYP3A4	PA165958362	1576	0.933
NULL	J_Clin_Biochem_Nutr_2009_May_25_44(3)_205-211.nxml.txt.nlp	19430607	SENT112	25	25	4	4	lansoprazole	ESD	PA450180	2098	0.933
NULL	Mol_Pain_2012_Sep_22_8_71.nxml.txt.nlp	22998838	SENT14	19	19	4	4	cisplatin	CB2	PA449014	1269	0.933
NULL	Oncotarget_2011_Aug_30_2(8)_610-626.nxml.txt.nlp	21881167	SENT154	13	13	1	1	doxorubicin	p53	PA449412	7157	0.933
NULL	ScientificWorldJournal_2014_Jan_12_2014_171439.nxml.txt.nlp	24672293	SENT93	14	14	9	9	fluorescein	CD99	PA164746009	4267	0.933
NULL	Cancer_Med_2013_Apr_24_2(2)_185-195.nxml.txt.nlp	23634286	SENT179	4	4	28	28	sunitinib	HIF1	PA162372840	3091	0.933
NULL	Int_J_Mol_Sci_2014_Oct_20_15(10)_18856-18891.nxml.txt.nlp	25334061	SENT275	5	5	7	7	metformin	AMPK	PA450395	5563	0.933
NULL	Br_J_Cancer_2013_Mar_19_108(5)_1126-1132.nxml.txt.nlp	23511629	SENT7	11	11	17	17	sunitinib	VEGFR	PA162372840	3791	0.933
NULL	F1000Res_2014_Sep_2_3_207.nxml.txt.nlp	25383187	SENT110	7	7	24	24	methylphenidate	p53	PA450464	7157	0.933
NULL	Ann_Clin_Microbiol_Antimicrob_2005_Sep_13_4_13.nxml.txt.nlp	16159399	SENT249	28	28	0	0	ribavirin	IFN	PA451241	3439	0.933
NULL	Spermatogenesis_2012_Oct_1_2(4)_253-263.nxml.txt.nlp	23248766	SENT86	10	10	39	39	tamoxifen	H19	PA451581	283120	0.933
NULL	J_Hematol_Oncol_2011_Jan_21_4_5.nxml.txt.nlp	21255411	SENT240	28	28	38	38	carboplatin	GC-E	PA448803	390226	0.933
NULL	F1000Res_2013_Feb_28_2_65.nxml.txt.nlp	24358861	SENT358	20	20	5	5	naloxone	TLR4	PA450586	7099	0.933
NULL	Oncol_Rep_2014_Feb_13_31(2)_581-588.nxml.txt.nlp	24337105	SENT180	18	18	6	6	capsaicin	ATF4	PA448776	468	0.933
NULL	Mol_Vis_2010_Sep_2_16_1781-1790.nxml.txt.nlp	20824160	SENT165	4	4	14	14	forskolin	p38	PA146096022	10598;1432;7965	0.933
NULL	Cardiovasc_Diabetol_2010_Sep_23_9_57.nxml.txt.nlp	20863381	SENT144	0	0	16	16	pioglitazone	DM2	PA450970	28508	0.933
NULL	Cancer_Cell_Int_2009_Jan_8_9_3.nxml.txt.nlp	19128511	SENT96	33	33	6	6	oxaliplatin	PI3K	PA131285527	5290	0.933
NULL	Ann_Oncol_2013_Aug_12_24(8)_1994-1999.nxml.txt.nlp	23670096	SENT137	4	4	23	23	tamoxifen	AIB1	PA451581	8202	0.933
NULL	Exp_Ther_Med_2014_Oct_24_8(4)_1092-1096.nxml.txt.nlp	25187802	SENT92	11	11	24	24	carvedilol	Bcl-2	PA448817	596	0.933
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT184	2	2	16	16	tacrolimus	IL-6	PA451578	3569	0.933
NULL	Breast_Cancer_Res_2011_Nov_28_13(6)_R121.nxml.txt.nlp	22123186	SENT323	17	17	30	30	pertuzumab	EGFR		1956	0.933
NULL	Oncologist_2010_Aug_29_15(8)_799-809.nxml.txt.nlp	20671105	SENT185	42	42	12	12	capecitabine	HER-2	PA448771	2064	0.933
NULL	Cell_Death_Dis_2014_Feb_13_5(2)_e1055.nxml.txt.nlp	24525731	SENT93	16	16	3	3	cisplatin	XRCC1	PA449014	7515	0.933
NULL	Pharmaceutics_2011_Sep_14_3(3)_615-635.nxml.txt.nlp	24310600	SENT641	4	4	18	18	dasatinib	ABCG2	PA162372878	9429	0.933
NULL	Int_J_Biol_Sci_2007_Apr_19_3(5)_263-273.nxml.txt.nlp	17505539	SENT79	11	11	2	2	trypsin	ICAT	PA451806	56998	0.933
NULL	Oncotarget_2012_Nov_17_4(1)_9-17.nxml.txt.nlp	23327903	SENT15	3	3	9	9	trastuzumab	HER2	PA451743	2064	0.933
NULL	Cancer_2014_Aug_1_120(15)_2343-2351.nxml.txt.nlp	24752945	SENT8	17	17	5	5	cisplatin	RRM1	PA449014	6240	0.933
NULL	Drug_Des_Devel_Ther_2014_Sep_23_8_1527-1538.nxml.txt.nlp	25284985	SENT156	34	34	11	11	celecoxib	IFN	PA448871	3439	0.933
NULL	Nat_Commun_2014_5_3361.nxml.txt.nlp	24553445	SENT186	2	2	10	10	olaparib	Hsp90		3320	0.933
NULL	Mol_Biol_Rep_2013_Sep_28_40(10)_5573-5585.nxml.txt.nlp	24078156	SENT211	0	0	19	19	iron	HJV	PA450087	148738	0.933
NULL	J_Clin_Biochem_Nutr_2010_Sep_6_47(2)_121-129.nxml.txt.nlp	20838567	SENT65	22	22	7	7	ethanol	ATX	PA448073	5168;23049	0.933
NULL	Ann_Clin_Transl_Neurol_2014_Dec_21_1(12)_996-1005.nxml.txt.nlp	25574474	SENT147	26	26	5	5	elacridar	P-gp		5243	0.933
NULL	Braz_J_Med_Biol_Res_2014_Oct_24_48(1)_65-76.nxml.txt.nlp	25493385	SENT219	1	1	22	22	losartan	AT1	PA450268	9197;185	0.933
NULL	EPMA_J_2010_Sep_20_1(3)_421-437.nxml.txt.nlp	23199086	SENT273	34	34	18	18	docetaxel	HER2	PA449383	2064	0.933
NULL	Cardiovasc_Diabetol_2013_May_4_12_73.nxml.txt.nlp	23642288	SENT15	3	3	39	39	acarbose	GLP-1	PA448010	100125288	0.933
NULL	Breast_Cancer_Res_2005_Jul_20_7(5)_205-211.nxml.txt.nlp	16168139	SENT119	31	31	27	27	tamoxifen	aromatase	PA451581	1588	0.933
NULL	Diabetes_Care_2012_Jan_9_35(1)_131-136.nxml.txt.nlp	22040838	SENT168	19	19	6	6	metformin	NEFA	PA450395	4925	0.933
NULL	Drug_Saf_2014_Feb_19_37(4)_201-211.nxml.txt.nlp	24550106	SENT131	10	10	24	24	esomeprazole	CYP2D6	PA10075	1565	0.933
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT122	33	33	5	5	dasatinib	PP2	PA162372878	4888	0.933
NULL	Clinicoecon_Outcomes_Res_2014_Oct_17_6_451-461.nxml.txt.nlp	25378939	SENT28	0	0	21	21	vancomycin	HAP	PA451850	5915;10313	0.933
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT112	0	0	15	15	curcumin	cIAP1	PA151958596	329	0.933
NULL	Crit_Care_2010_Aug_12_14(4)_229.nxml.txt.nlp	20836899	SENT85	4	4	9	9	halothane	TREK-1	PA449845	3776	0.933
NULL	Appl_Biochem_Biotechnol_2010_May_12_161(1-8)_116-123.nxml.txt.nlp	20012508	SENT73	26	26	5	5	deferoxamine	PM5	PA164746490	23420;283820	0.933
NULL	Br_J_Cancer_2011_Jan_4_104(1)_91-100.nxml.txt.nlp	21139584	SENT133	5	5	27	27	geldanamycin	Hsp90	PA152031327	3320	0.933
NULL	Oncol_Lett_2014_Nov_14_8(5)_2086-2092.nxml.txt.nlp	25295095	SENT147	22	22	16	16	gemcitabine	LKB1	PA449748	6794	0.933
NULL	Diabetes_2013_May_16_62(5)_1689-1696.nxml.txt.nlp	23274908	SENT217	11	11	24	24	diazoxide	ABCC8	PA449285	6833	0.933
NULL	Indian_J_Crit_Care_Med_2010_Oct-Dec_14(4)_188-195.nxml.txt.nlp	21572750	SENT90	40	40	25	25	clopidogrel	CYP3A4	PA449053	1576	0.933
NULL	Osteoporos_Int_2013_Oct_19_24(1)_23-57.nxml.txt.nlp	23079689	SENT508	12	12	40	40	teriparatide	PTH	PA451620	5741	0.933
NULL	Front_Genet_2014_Feb_26_5_40.nxml.txt.nlp	24616734	SENT317	13	13	30	30	docetaxel	RAI14	PA449383	26064	0.932
NULL	Tuberc_Respir_Dis_(Seoul)_2013_Aug_30_75(2)_59-66.nxml.txt.nlp	24023558	SENT25	6	6	1	1	docetaxel	FOXO1	PA449383	2308	0.932
NULL	Br_J_Cancer_2006_Feb_13_94(3)_363-371.nxml.txt.nlp	16465172	SENT8	16	16	33	33	bevacizumab	NACT	PA130232992	284111	0.932
NULL	F1000Prime_Rep_2013_Jul_1_5_23.nxml.txt.nlp	23864930	SENT31	29	29	9	9	methysergide	LTF	PA164743265	4057	0.932
NULL	Oncogene_2009_Apr_2_28(13)_1616-1625.nxml.txt.nlp	19219073	SENT100	8	8	18	18	nutlin-3	p53		7157	0.932
NULL	Emerg_Infect_Dis_2012_Nov_18(11)_e2.nxml.txt.nlp	23092736	SENT64	23	23	3	3	cycloserine	DST	PA164764600	667	0.932
NULL	Cancer_Cell_Int_2009_Feb_17_9_4.nxml.txt.nlp	19222856	SENT224	18	18	9	9	cisplatin	p53	PA449014	7157	0.932
NULL	Evid_Based_Complement_Alternat_Med_2011_Aug_22_2011_796723.nxml.txt.nlp	21876712	SENT129	3	3	19	19	ramipril	STZ	PA451223	6484	0.932
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT88	0	0	8	8	efavirenz	CYP2D6	PA449441	1565	0.932
NULL	Oncologist_2010_Feb_15_15(2)_122-129.nxml.txt.nlp	20156908	SENT35	9	9	12	12	lapatinib	aromatase	PA152241907	1588	0.932
NULL	Oncogene_2013_Sep_12_32(37)_4355-4365.nxml.txt.nlp	23108409	SENT51	35	35	23	23	hyaluronan	HAS2	PA165958431	3037	0.932
NULL	Mol_Pain_2013_Jun_17_9_29.nxml.txt.nlp	23773289	SENT85	3	3	22	22	minocycline	cPLA2	PA450519	10524	0.932
NULL	Oxid_Med_Cell_Longev_2010_Mar-Apr_3(2)_101-108.nxml.txt.nlp	20716934	SENT42	29	29	2	2	pioglitazone	RAGE	PA450970	177	0.932
NULL	J_Invest_Dermatol_2013_Apr_6_133(4)_988-998.nxml.txt.nlp	23223142	SENT47	26	26	11	11	fluorescein	TLR2	PA164746009	7097	0.932
NULL	Mol_Cancer_2007_Aug_21_6_53.nxml.txt.nlp	17711579	SENT218	13	13	8	8	cisplatin	p53	PA449014	7157	0.932
NULL	Oncotarget_2014_May_27_5(19)_9049-9064.nxml.txt.nlp	24979294	SENT19	4	4	8	8	dasatinib	ABL	PA162372878	4547	0.932
NULL	Acta_Neuropathol_Commun_2013_May_20_1_17.nxml.txt.nlp	24252689	SENT179	31	31	13	13	celecoxib	CD36	PA448871	948	0.932
NULL	Oncologist_2010_Apr_15(4)_372-381.nxml.txt.nlp	20413642	SENT156	6	6	11	11	cetuximab	EGFR	PA10040	1956	0.932
NULL	Front_Genet_2014_Oct_14_5_314.nxml.txt.nlp	25352860	SENT117	20	20	12	12	napqi	CYP2E1		1571	0.932
NULL	Core_Evid_2013_Sep_30_8_69-78.nxml.txt.nlp	24115917	SENT27	12	12	30	30	lapatinib	HER-2	PA152241907	2064	0.932
NULL	Br_J_Cancer_2010_Jun_29_103(1)_18-28.nxml.txt.nlp	20551952	SENT182	24	24	0	0	vatalanib	VEGFR	PA7001	3791	0.932
NULL	Hum_Genomics_2008_Sep_1_3(1)_7-16.nxml.txt.nlp	19129086	SENT169	14	14	20	20	rosiglitazone	OATP1B1	PA451283	10599	0.932
NULL	Cancer_Manag_Res_2013_Nov_21_5_387-400.nxml.txt.nlp	24294007	SENT115	37	37	22	22	vemurafenib	EGFR	PA165946873	1956	0.932
NULL	Arthritis_Res_Ther_2009_Aug_17_11(4)_R123.nxml.txt.nlp	19686595	SENT204	32	32	17	17	rituximab	CD27	PA451261	939	0.932
NULL	Br_J_Cancer_2009_Oct_6_101(7)_1155-1161.nxml.txt.nlp	19738614	SENT111	17	17	5	5	gemcitabine	14-3-3	PA449748	10971	0.932
NULL	Clinics_(Sao_Paulo)_2012_Apr_67(4)_335-340.nxml.txt.nlp	22522758	SENT129	22	22	15	15	clomipramine	HTR2C	PA449048	3358	0.932
NULL	Nat_Commun_2010_Nov_2_1_109.nxml.txt.nlp	21045827	SENT32	21	21	6	6	neomycin	TRPM7	PA450608	54822	0.932
NULL	Mol_Cancer_2013_May_4_12_37.nxml.txt.nlp	23642048	SENT230	30	30	8	8	curcumin	PI3K	PA151958596	5290	0.932
NULL	Cell_Death_Dis_2013_Jun_20_4(6)_e686.nxml.txt.nlp	23788043	SENT123	30	30	15	15	l-glutamine	B27	PA10090	56246	0.932
NULL	J_Exp_Med_1998_Jun_1_187(11)_1885-1892.nxml.txt.nlp	9607928	SENT168	24	24	11	11	thalidomide	CD4	PA451644	920	0.932
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_3_2012_908562.nxml.txt.nlp	23082087	SENT207	6	6	16	16	amrinone	IL-6	PA164746803	3569	0.932
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2012_Nov_21_1(11)_e15.nxml.txt.nlp	23835797	SENT98	25	25	3	3	doxorubicin	MVD	PA449412	4597	0.932
NULL	Oncol_Lett_2014_Jul_25_8(1)_313-316.nxml.txt.nlp	24959268	SENT98	23	23	3	3	sulindac	PC-3	PA451565	692094	0.932
NULL	Blood_Cancer_J_2012_Sep_7_2(9)_e89.nxml.txt.nlp	22961061	SENT68	14	14	44	44	doxorubicin	FGFR3	PA449412	2261	0.932
NULL	J_Hematol_Oncol_2013_Nov_5_6_83.nxml.txt.nlp	24283248	SENT33	17	17	7	7	nutlin-3	TP53		7157	0.932
NULL	Front_Neurosci_2014_Jan_10_7_270.nxml.txt.nlp	24454277	SENT19	6	6	20	20	resveratrol	PI3K		5290	0.932
NULL	Indian_J_Med_Res_2014_Aug_140(2)_209-215.nxml.txt.nlp	25297352	SENT103	16	16	5	5	lamotrigine	CLB	PA450164	171425	0.932
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_45-53.nxml.txt.nlp	17912635	SENT2	6	6	1	1	letrozole	aromatase	PA450196	1588	0.932
NULL	Exp_Ther_Med_2013_Mar_21_5(3)_987-991.nxml.txt.nlp	23407636	SENT83	3	3	10	10	losartan	IL-8	PA450268	3576	0.932
NULL	J_Obes_2011_Dec_15_2011_928165.nxml.txt.nlp	21197151	SENT195	2	2	24	24	exenatide	GLP-1	PA164749238	100125288	0.932
NULL	Br_J_Cancer_2010_Jul_13_103(2)_178-185.nxml.txt.nlp	20551959	SENT19	22	22	33	33	tariquidar	P-gp		5243	0.932
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1013.nxml.txt.nlp	24457957	SENT27	46	46	35	35	cisplatin	NOXA	PA449014	5366	0.932
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT10	40	40	26	26	cisplatin	IBP	PA449014	706;50619	0.932
NULL	Inflamm_Res_2010_Sep_26_59(9)_699-709.nxml.txt.nlp	20339899	SENT29	33	33	26	26	trypsin	PAR4	PA451806	9002;5074	0.932
NULL	Br_J_Haematol_2014_Mar_13_164(1)_811-821.nxml.txt.nlp	24328678	SENT198	25	25	4	4	lenalidomide	Aiolos	PA162363968	22806	0.932
NULL	Oncotarget_2013_Dec_18_5(2)_375-385.nxml.txt.nlp	24495868	SENT4	8	8	22	22	flavopiridol	CD34	PA452627	947	0.932
NULL	Br_J_Cancer_2012_Jan_3_106(1)_18-24.nxml.txt.nlp	22108516	SENT78	4	4	1	1	topotecan	TDP1	PA451729	55775	0.932
NULL	Oxid_Med_Cell_Longev_2010_Mar-Apr_3(2)_101-108.nxml.txt.nlp	20716934	SENT42	27	27	38	38	rosiglitazone	RAGE	PA451283	177	0.932
NULL	Pharmaceuticals_(Basel)_2012_Aug_17_5(8)_837-852.nxml.txt.nlp	24280677	SENT60	27	27	0	0	capsaicin	TRPV1	PA448776	7442	0.932
NULL	Lipids_Health_Dis_2011_Feb_28_10_38.nxml.txt.nlp	21352602	SENT84	35	35	8	8	atorvastatin	PCSK9	PA448500	255738	0.932
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2011_Sep_13_4_47-62.nxml.txt.nlp	22879794	SENT108	4	4	22	22	liraglutide	GLP-1	PA165958364	100125288	0.932
NULL	Mol_Cells_2014_Mar_31_37(3)_234-240.nxml.txt.nlp	24642709	SENT122	37	37	29	29	capsaicin	HO-1	PA448776	3162	0.932
NULL	Clin_Med_Insights_Cardiol_2010_Dec_1_4_117-128.nxml.txt.nlp	21151850	SENT181	11	11	18	18	clopidogrel	CYP2C19	PA449053	1557	0.932
NULL	Open_Access_J_Urol_2010_Mar_12_2_35-40.nxml.txt.nlp	24198612	SENT79	8	8	12	12	pazopanib	VEGFR	PA165291492	3791	0.932
NULL	ScientificWorldJournal_2012_Jul_31_2012_392734.nxml.txt.nlp	22919315	SENT86	0	0	6	6	gemfibrozil	CYP3A4	PA449750	1576	0.932
NULL	ScientificWorldJournal_2013_Oct_27_2013_260298.nxml.txt.nlp	24288471	SENT41	12	12	23	23	aliskiren	AT1	PA143487910	9197;185	0.932
NULL	Mol_Cancer_2010_Apr_23_9_87.nxml.txt.nlp	20416058	SENT146	28	28	14	14	etoposide	TRAIL	PA449552	8743	0.932
NULL	Onco_Targets_Ther_2014_Oct_16_7_1891-1899.nxml.txt.nlp	25342912	SENT112	11	11	3	3	paclitaxel	CLU	PA450761	1191	0.932
NULL	Breast_Cancer_Res_2001_Oct_1_3(6)_361-364.nxml.txt.nlp	11737886	SENT30	26	26	7	7	doxorubicin	HER-2	PA449412	2064	0.932
NULL	Endocrinol_Diabetes_Metab_Case_Rep_2014_Mar_1_2014_140001.nxml.txt.nlp	24683487	SENT113	30	30	3	3	vasopressin	ACTH	PA451858	5443	0.932
NULL	Exp_Diabetes_Res_2011_Jun_23_2011_898913.nxml.txt.nlp	21747834	SENT172	20	20	15	15	exenatide	GLP-1	PA164749238	100125288	0.932
NULL	Br_J_Cancer_2013_Jun_11_108(11)_2205-2240.nxml.txt.nlp	23744281	SENT980	22	22	29	29	tamoxifen	aromatase	PA451581	1588	0.932
NULL	Scientifica_(Cairo)_2012_Nov_25_2012_473829.nxml.txt.nlp	24278698	SENT339	8	8	18	18	cisplatin	OCTN2	PA449014	6584	0.932
NULL	Indian_J_Anaesth_2010_Mar-Apr_54(2)_147-153.nxml.txt.nlp	20661354	SENT46	0	0	16	16	heparin	ACT	PA449855	12;11332;9457;641455	0.932
NULL	Br_J_Cancer_2013_Feb_5_108(2)_469-476.nxml.txt.nlp	23169292	SENT27	27	27	6	6	erlotinib	KRAS	PA134687924	3845	0.932
NULL	Acta_Naturae_2013_Apr-Jun_5(2)_19-39.nxml.txt.nlp	23819034	SENT226	14	14	5	5	heparin	FVIII	PA449855	2157	0.932
NULL	Arthritis_Res_Ther_2010_Apr_29_12(2)_R73.nxml.txt.nlp	20429888	SENT276	31	31	9	9	bortezomib	AP-1	PA10252	2353;3727;2354;3725	0.932
NULL	Mol_Neurodegener_2011_Nov_17_6_78.nxml.txt.nlp	22093090	SENT45	27	27	7	7	sr144528	fractalkine		6376	0.932
NULL	Breast_Cancer_Res_2004_Jun_18_6(4)_179-180.nxml.txt.nlp	NULL	SENT25	32	32	10	10	raloxifene	STAR	PA451221	6770;2984	0.932
NULL	Acta_Pharmacol_Sin_2012_Jan_3_33(1)_49-56.nxml.txt.nlp	22212430	SENT38	8	8	15	15	thrombin	JNK	PA451674	5599	0.932
NULL	J_Gen_Physiol_2003_Jan_121(1)_49-60.nxml.txt.nlp	12508053	SENT39	12	12	0	0	tetracycline	TRPM7	PA451640	54822	0.932
NULL	J_Cell_Biol_2005_Jul_4_170(1)_49-59.nxml.txt.nlp	15983061	SENT145	48	48	33	33	forskolin	MITF	PA146096022	4286	0.932
NULL	Nucleic_Acids_Res_2013_May_5_41(10)_5210-5222.nxml.txt.nlp	23563151	SENT207	5	5	11	11	arsenite	GADD45	PA452638	1647	0.932
NULL	Breast_Cancer_Res_2004_Mar_18_6(3)_119-127.nxml.txt.nlp	15084232	SENT110	10	10	17	17	tamoxifen	pS2	PA451581	7031	0.932
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT262	3	3	17	17	tacrolimus	STAT3	PA451578	6774	0.932
NULL	Br_J_Cancer_2009_Jul_7_101(1)_38-47.nxml.txt.nlp	19513066	SENT170	0	0	4	4	dasatinib	N-WASP	PA162372878	8976	0.932
NULL	Nucleic_Acids_Res_2012_Apr_16_40(8)_3511-3523.nxml.txt.nlp	22180533	SENT214	6	6	0	0	doxycycline	E2F7	PA449415	144455	0.932
NULL	Arch_Gynecol_Obstet_2012_May_25_285(5)_1331-1338.nxml.txt.nlp	22116314	SENT81	2	2	18	18	alendronate	OCN	PA448082	632	0.932
NULL	Acta_Physiol_(Oxf)_2008_Apr_192(4)_505-517.nxml.txt.nlp	17973950	SENT121	10	10	2	2	propranolol	PES	PA451145	23481	0.932
NULL	Physiol_Rep_2014_Sep_28_2(9)_e12158.nxml.txt.nlp	25263207	SENT419	38	38	3	3	forskolin	TGR5	PA146096022	151306	0.932
NULL	Biologics_2009_Jul_13_3_225-232.nxml.txt.nlp	19707411	SENT115	27	27	39	39	rituximab	CTX	PA451261	1593	0.932
NULL	Mol_Neurobiol_2010_Jun_2_41(2-3)_392-409.nxml.txt.nlp	20437209	SENT318	3	3	15	15	curcumin	LOX	PA151958596	4015	0.932
NULL	Breast_Cancer_Res_2011_Nov_1_13(6)_224.nxml.txt.nlp	22114931	SENT129	32	32	11	11	trastuzumab	HER2	PA451743	2064	0.932
NULL	Mol_Cell_Biochem_2014_Jul_26_396(1-2)_221-228.nxml.txt.nlp	25063218	SENT157	20	20	9	9	resveratrol	EGFR		1956	0.932
NULL	Breast_Cancer_Res_2013_Nov_29_15(6)_R114.nxml.txt.nlp	24289103	SENT216	24	24	18	18	tamoxifen	EGFR	PA451581	1956	0.932
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT204	3	3	21	21	dasatinib	LYN	PA162372878	4067	0.932
NULL	AIDS_Res_Treat_2011_Jul_25_2011_743597.nxml.txt.nlp	21804938	SENT23	31	31	7	7	efavirenz	CD4	PA449441	920	0.932
NULL	Case_Rep_Hematol_2013_Jul_10_2013_709164.nxml.txt.nlp	23936692	SENT116	14	14	4	4	imatinib	PDGFRB	PA10804	5159	0.932
NULL	Br_J_Cancer_2010_Aug_24_103(5)_715-726.nxml.txt.nlp	20664600	SENT172	7	7	4	4	fluoxetine	ANO1	PA449673	55107	0.932
NULL	Indian_J_Pharmacol_2013_Mar-Apr_45(2)_155-158.nxml.txt.nlp	23716892	SENT116	20	20	12	12	glibenclamide	CYP2C19	PA449782	1557	0.932
NULL	J_Exp_Med_1998_Jun_1_187(11)_1863-1870.nxml.txt.nlp	9607926	SENT34	44	44	34	34	neomycin	CD45-AP	PA450608	5790	0.932
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT25	20	20	2	2	heparin	VEGF-A	PA449855	7422	0.932
NULL	Eur_J_Neurosci_2009_Apr_29(8)_1604-1614.nxml.txt.nlp	19419423	SENT207	4	4	28	28	ketanserin	5-HT2C	PA131053734	3358	0.932
NULL	J_Carcinog_2011_Nov_30_10_29.nxml.txt.nlp	22190871	SENT163	2	2	24	24	lapatinib	AKT	PA152241907	207	0.932
NULL	Bone_Marrow_Res_2011_Mar_2_2011_924058.nxml.txt.nlp	22046572	SENT168	0	0	33	33	denosumab	OPG	PA166048634	690	0.932
NULL	F1000_Med_Rep_2009_Dec_9_1_93.nxml.txt.nlp	20948684	SENT94	22	22	29	29	sirolimus	LAM	PA451365	7249;7248	0.932
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT170	18	18	2	2	metformin	AMPK	PA450395	5563	0.932
NULL	Clinics_(Sao_Paulo)_2014_Jan_69(Suppl_1)_8-16.nxml.txt.nlp	24860853	SENT19	3	3	29	29	alemtuzumab	CD4	PA164783958	920	0.932
NULL	Br_J_Pharmacol_2010_Feb_159(4)_772-786.nxml.txt.nlp	20105183	SENT81	0	0	30	30	forskolin	CO2	PA146096022	4513	0.932
NULL	Diabetes_2011_Jan_60(1)_28-29.nxml.txt.nlp	21193737	SENT32	15	15	19	19	tolbutamide	TRPM2	PA451718	7226	0.932
NULL	Prz_Gastroenterol_2014_Sep_16_9(4)_214-219.nxml.txt.nlp	25276252	SENT41	0	0	21	21	vincristine	DDP	PA451879	1678	0.932
NULL	Cardiovasc_Diabetol_2013_May_29_12_80.nxml.txt.nlp	23718574	SENT134	4	4	12	12	mannitol	CD36	PA450320	948	0.932
NULL	Biochemistry_2012_Sep_25_51(38)_7456-7464.nxml.txt.nlp	22947085	SENT107	13	13	0	0	glutaraldehyde	7B2	PA449777	6447	0.932
NULL	Mol_Vis_2007_Jul_9_13_1083-1093.nxml.txt.nlp	17653053	SENT144	4	4	41	41	minocycline	MCP-3	PA450519	6354	0.932
NULL	Breast_Cancer_Res_2007_Jan_23_9(1)_R7.nxml.txt.nlp	17244352	SENT148	38	38	32	32	tamoxifen	SULT1A1	PA451581	6817	0.932
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT153	16	16	34	34	capsaicin	p53	PA448776	7157	0.932
NULL	J_Cell_Biol_2004_Dec_6_167(5)_863-874.nxml.txt.nlp	15569715	SENT21	7	7	11	11	galactose	DAG	PA449725	1605	0.932
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT129	19	19	4	4	doxorubicin	SLK	PA449412	9748;2534	0.932
NULL	Nat_Commun_2012_3_1147.nxml.txt.nlp	23093184	SENT217	19	19	6	6	tetracycline	ND5	PA451640	4540	0.932
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT357	8	8	28	28	ziprasidone	PRL	PA451974	5617	0.932
NULL	J_Cancer_2012_Jul_6_3_310-321.nxml.txt.nlp	22866165	SENT217	6	6	31	31	estradiol	CYP1B1	PA449503	1545	0.932
NULL	Basic_Res_Cardiol_2011_Jan_20_106(1)_51-63.nxml.txt.nlp	20725733	SENT8	32	32	17	17	rolipram	PLB	PA153906323	151056	0.932
NULL	Protein_Cell_2014_Jun_19_5(6)_469-479.nxml.txt.nlp	24748116	SENT96	16	16	9	9	paclitaxel	EB1	PA450761	9167;22919;10982	0.932
NULL	Breast_Cancer_(Auckl)_2009_Apr_7_3_23-34.nxml.txt.nlp	21556247	SENT106	23	23	17	17	celecoxib	AKT	PA448871	207	0.932
NULL	Mol_Cancer_2008_Mar_26_7_27.nxml.txt.nlp	18366759	SENT145	26	26	11	11	etoposide	AP-1	PA449552	2353;3727;2354;3725	0.932
NULL	Biologics_2014_Apr_23_8_183-192.nxml.txt.nlp	24790411	SENT33	36	36	22	22	afatinib	EGFR	PA165981154	1956	0.932
NULL	Ann_Gastroenterol_2012_25(3)_207-217.nxml.txt.nlp	24713803	SENT154	2	2	16	16	metformin	DM2	PA450395	28508	0.932
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_105-115.nxml.txt.nlp	17912640	SENT16	15	15	10	10	letrozole	aromatase	PA450196	1588	0.932
NULL	J_Biol_Chem_2013_Dec_6_288(49)_35387-35395.nxml.txt.nlp	24142790	SENT186	10	10	23	23	meclizine	PCYT2	PA450338	5833	0.932
NULL	Indian_J_Ophthalmol_2014_May_62(5)_642-644.nxml.txt.nlp	23571268	SENT8	12	12	7	7	hydroxychloroquine	APS	PA164777036	10603	0.932
NULL	Diabetes_Care_2010_Oct_13_33(10)_2250-2253.nxml.txt.nlp	20628086	SENT8	13	13	7	7	ramipril	DREAM	PA451223	30818	0.932
NULL	Pain_Ther_2014_Dec_29_3(2)_73-84.nxml.txt.nlp	25069571	SENT38	29	29	1	1	capsaicin	TRPV1	PA448776	7442	0.932
NULL	Acta_Pharmacol_Sin_2010_Nov_18_31(11)_1447-1453.nxml.txt.nlp	20953204	SENT111	22	22	7	7	rimonabant	IL-6	PA152407999	3569	0.932
NULL	Curr_Neuropharmacol_2012_Jun_10(2)_167-178.nxml.txt.nlp	23204986	SENT218	33	33	11	11	capsaicin	c-fos	PA448776	2353	0.932
NULL	J_Adv_Pract_Oncol_2012_May_1_May-Jun_3(3)_161-169.nxml.txt.nlp	25031942	SENT70	24	24	9	9	fluorouracil	ACT	PA128406956	12;11332;9457;641455	0.932
NULL	Biomed_Res_Int_2014_Aug_6_2014_967826.nxml.txt.nlp	25165721	SENT210	11	11	14	14	pentoxifylline	TNF-alpha	PA450864	7124	0.932
NULL	Front_Physiol_2012_Oct_5_3_398.nxml.txt.nlp	23060821	SENT227	3	3	17	17	capsaicin	SNA	PA448776	6615	0.932
NULL	Eur_J_Med_Res_2011_Apr_28_16(4)_159-166.nxml.txt.nlp	21486730	SENT185	27	27	8	8	micafungin	FAH	PA164781026	2175;2184	0.932
NULL	Cancers_(Basel)_2010_Sep_9_2(3)_1661-1682.nxml.txt.nlp	24281180	SENT1189	12	12	2	2	etoposide	NF-kappaB	PA449552	4790	0.932
NULL	J_Oncol_2010_Jan_24_2010_105269.nxml.txt.nlp	21318146	SENT128	35	35	30	30	doxorubicin	BCRP1	PA449412	317687	0.932
NULL	Evid_Based_Complement_Alternat_Med_2012_Aug_23_2012_643973.nxml.txt.nlp	22956975	SENT188	3	3	24	24	amitriptyline	GLAST	PA448385	6507	0.932
NULL	Cancer_Cell_Int_2010_Sep_9_10_32.nxml.txt.nlp	20828393	SENT132	24	24	13	13	cisplatin	ATF3	PA449014	467	0.932
NULL	Oncotarget_2014_Dec_4_5(22)_11365-11380.nxml.txt.nlp	25426548	SENT3	9	9	7	7	nutlin-3	MDM2		4193	0.932
NULL	Breast_Cancer_Res_2012_Jun_19_14(3)_311.nxml.txt.nlp	22713135	SENT22	44	44	25	25	exemestane	PI3K	PA449563	5290	0.932
NULL	Am_J_Trop_Med_Hyg_2012_Nov_7_87(5_Suppl)_6-10.nxml.txt.nlp	23136272	SENT140	16	16	5	5	lumefantrine	RDT	PA165111722	6598	0.932
NULL	Cell_Commun_Signal_2011_May_15_9_13.nxml.txt.nlp	21569639	SENT316	17	17	2	2	quinacrine	p65	PA164745551	5970	0.932
NULL	Core_Evid_2007_Nov_30_2(2)_121-129.nxml.txt.nlp	21221180	SENT230	8	8	32	32	rituximab	CHOP	PA451261	1649	0.932
NULL	Int_J_Mol_Sci_2013_Apr_29_14(5)_9338-9364.nxml.txt.nlp	23629668	SENT34	8	8	5	5	bevacizumab	VEGF-A	PA130232992	7422	0.932
NULL	Oncotarget_2014_Feb_7_5(3)_775-787.nxml.txt.nlp	24519956	SENT153	4	4	21	21	dasatinib	PC3	PA162372878	57332;7832;5122	0.932
NULL	FEBS_Open_Bio_2014_May_9_4_458-467.nxml.txt.nlp	24918061	SENT449	30	30	11	11	doxorubicin	p53	PA449412	7157	0.932
NULL	Diabetes_2011_Jun_21_60(6)_1797-1804.nxml.txt.nlp	21536946	SENT73	3	3	20	20	diazoxide	ADP	PA449285	23038	0.932
NULL	Diabetes_2013_Mar_14_62(3)_953-964.nxml.txt.nlp	23223176	SENT149	4	4	24	24	paroxetine	ROS	PA450801	6098	0.932
NULL	J_Cancer_2013_Jan_11_4(2)_117-132.nxml.txt.nlp	23386910	SENT65	2	2	15	15	trastuzumab	DM1	PA451743	338023;1760;28509	0.932
NULL	Biomed_Res_Int_2014_Aug_6_2014_967826.nxml.txt.nlp	25165721	SENT74	5	5	0	0	cisplatin	PUMA	PA449014	27113	0.932
NULL	Oncotarget_2014_Aug_4_5(17)_7776-7787.nxml.txt.nlp	25277200	SENT59	15	15	4	4	cisplatin	ANXA4	PA449014	307	0.932
NULL	Oncotarget_2012_Sep_11_3(9)_1026-1035.nxml.txt.nlp	22976441	SENT31	11	11	28	28	oxygen	p53	PA450744	7157	0.932
NULL	Mol_Syst_Biol_2011_Apr_26_7_486.nxml.txt.nlp	21525872	SENT133	35	35	27	27	imatinib	PDGFRA	PA10804	5156	0.932
NULL	Mol_Vis_2007_Jan_24_13_57-65.nxml.txt.nlp	17277739	SENT155	29	29	27	27	heparin	FGF2	PA449855	2247;2258	0.932
NULL	J_Hematol_Oncol_2008_Aug_11_1_11.nxml.txt.nlp	18694493	SENT96	4	4	13	13	temsirolimus	IFN	PA164746890	3439	0.932
NULL	Acta_Pharmacol_Sin_2011_Jan_6_32(1)_133-138.nxml.txt.nlp	21131997	SENT8	6	6	28	28	heparin	HSI	PA449855	57016	0.932
NULL	J_Oncol_2012_Mar_11_2012_382159.nxml.txt.nlp	22481926	SENT90	32	32	16	16	gemcitabine	HER2	PA449748	2064	0.932
NULL	Chemother_Res_Pract_2012_Aug_29_2012_817297.nxml.txt.nlp	22970367	SENT125	17	17	5	5	erlotinib	AXL	PA134687924	558	0.932
NULL	Asian_J_Androl_2014_Apr_11_Jul-Aug_16(4)_505-510.nxml.txt.nlp	24759577	SENT89	21	21	27	27	letrozole	aromatase	PA450196	1588	0.932
NULL	Drug_Target_Insights_2013_Aug_19_7_27-34.nxml.txt.nlp	24023511	SENT143	23	23	44	44	elacridar	P-gp		5243	0.932
NULL	Biomed_Res_Int_2014_Jan_20_2014_948427.nxml.txt.nlp	24563867	SENT41	33	33	20	20	buspirone	COB	PA448689	4519	0.932
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT256	3	3	16	16	risperidone	PRL	PA451257	5617	0.932
NULL	Acta_Pharmacol_Sin_2009_Sep_17_30(9)_1316-1322.nxml.txt.nlp	19684609	SENT126	17	17	7	7	rosiglitazone	PTEN	PA451283	5728	0.932
NULL	Carcinogenesis_2013_Mar_7_34(3)_703-712.nxml.txt.nlp	23222814	SENT78	38	38	27	27	curcumin	p53	PA151958596	7157	0.932
NULL	Bone_Joint_Res_2014_Mar_1_3(3)_51-59.nxml.txt.nlp	24615710	SENT146	39	39	24	24	resveratrol	RUNX2		860	0.932
NULL	J_Cancer_2013_Jan_11_4(2)_117-132.nxml.txt.nlp	23386910	SENT60	21	21	5	5	trastuzumab	HER-2	PA451743	2064	0.932
NULL	Cancer_Cell_Int_2013_Mar_4_13_21.nxml.txt.nlp	23497288	SENT34	17	17	9	9	doxorubicin	EWS	PA449412	2130	0.932
NULL	Nat_Methods_2011_Jun_24_8(6)_487-493.nxml.txt.nlp	21516115	SENT67	30	30	24	24	erlotinib	EGF	PA134687924	1950	0.932
NULL	Nanoscale_Res_Lett_2009_Apr_25_4(8)_789-793.nxml.txt.nlp	20596333	SENT39	17	17	1	1	ethanol	TEM	PA448073	64102	0.932
NULL	Mol_Cancer_2014_Jun_5_13_143.nxml.txt.nlp	24898067	SENT94	3	3	25	25	trastuzumab	IL-2	PA451743	3558	0.932
NULL	Br_J_Cancer_2012_Jan_31_106(3)_475-481.nxml.txt.nlp	22187040	SENT147	0	0	11	11	imatinib	EGFR	PA10804	1956	0.932
NULL	Clin_Ophthalmol_2010_Apr_26_4_369-374.nxml.txt.nlp	20463807	SENT32	11	11	25	25	verteporfin	PED	PA451871	8682	0.932
NULL	Biomed_Res_Int_2013_Aug_4_2013_152909.nxml.txt.nlp	23984319	SENT29	17	17	32	32	methotrexate	MSH2	PA450428	4436	0.932
NULL	Clinicoecon_Outcomes_Res_2014_Oct_17_6_451-461.nxml.txt.nlp	25378939	SENT121	45	45	14	14	vancomycin	HAP	PA451850	5915;10313	0.932
NULL	Indian_J_Nucl_Med_2013_Dec_28(Suppl_1)_S36-S54.nxml.txt.nlp	NULL	SENT691	0	0	13	13	trastuzumab	HER-2	PA451743	2064	0.932
NULL	Clin_Med_Insights_Cardiol_2011_Jun_28_5_55-66.nxml.txt.nlp	21792345	SENT120	11	11	1	1	bucindolol	BEST	PA165945764	7439	0.932
NULL	Breast_Cancer_Res_2008_Mar_27_10(2)_R26.nxml.txt.nlp	18371194	SENT448	35	35	29	29	trastuzumab	HER2	PA451743	2064	0.932
NULL	Arch_Gynecol_Obstet_2013_Mar_8_287(3)_563-570.nxml.txt.nlp	23135210	SENT38	41	41	8	8	vinblastine	MRP2	PA451877	100130958;57626;1244	0.932
NULL	J_Oncol_2011_Jun_12_2011_542358.nxml.txt.nlp	21772843	SENT368	27	27	0	0	doxorubicin	EGFR	PA449412	1956	0.932
NULL	Breast_Cancer_Res_2007_Jun_4_9(3)_207.nxml.txt.nlp	17561991	SENT268	26	26	19	19	trastuzumab	HER-2	PA451743	2064	0.932
NULL	Autoimmune_Dis_2013_Aug_28_2013_613086.nxml.txt.nlp	24069534	SENT6	21	21	38	38	etanercept	p40	PA449515	3921;339541;10314	0.932
NULL	Cost_Eff_Resour_Alloc_2004_Apr_15_2_2.nxml.txt.nlp	15086954	SENT9	35	35	24	24	metformin	PPG	PA450395	5552	0.932
NULL	Arthritis_Res_Ther_2009_Oct_14_11(5)_251.nxml.txt.nlp	19849819	SENT297	6	6	16	16	alendronate	PTH	PA448082	5741	0.932
NULL	J_Oncol_2010_Nov_19_2010_568938.nxml.txt.nlp	20037743	SENT134	7	7	30	30	tamoxifen	EGFR	PA451581	1956	0.932
NULL	Oncoimmunology_2013_Oct_1_2(10)_e27025.nxml.txt.nlp	24353914	SENT179	10	10	26	26	cisplatin	CD4	PA449014	920	0.932
NULL	Leukemia_2013_Jan_11_27(1)_32-40.nxml.txt.nlp	22781593	SENT166	3	3	14	14	ponatinib	CD34	PA165980594	947	0.932
NULL	Diabetes_2009_Feb_58(2)_329-336.nxml.txt.nlp	19171749	SENT240	41	41	18	18	imatinib	CHOP	PA10804	1649	0.932
NULL	Toxins_(Basel)_2010_May_28_2(6)_1207-1224.nxml.txt.nlp	22069634	SENT252	22	22	32	32	vinblastine	MRP1	PA451877	4437	0.932
NULL	Appl_Clin_Genet_2011_Jan_26_4_21-27.nxml.txt.nlp	23776364	SENT107	13	13	34	34	canakinumab	NLRP3	PA165958358	114548	0.932
NULL	Breast_Cancer_Res_2014_Oct_28_16(5)_456.nxml.txt.nlp	25349073	SENT72	23	23	6	6	bevacizumab	HER2	PA130232992	2064	0.932
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Oct_30_66(Pt_11)_o2952.nxml.txt.nlp	21589120	SENT56	19	19	13	13	ethanol	mol	PA448073	90527	0.932
NULL	Eur_Radiol_2011_Jun_28_21(6)_1277-1285.nxml.txt.nlp	21274717	SENT40	25	25	6	6	choline	FDG	PA448976	23583	0.932
NULL	Ecancermedicalscience_2008_Aug_15_2_91.nxml.txt.nlp	22275974	SENT227	20	20	5	5	thalidomide	CD4	PA451644	920	0.932
NULL	Diabetes_Care_2012_Apr_13_35(4)_706-710.nxml.txt.nlp	22357189	SENT154	43	43	9	9	glucose	PCA	PA449773	28982	0.932
NULL	eLife_2014_May_6_3_e02482.nxml.txt.nlp	24843002	SENT588	4	4	22	22	etoposide	SETD2	PA449552	29072	0.932
NULL	J_Clin_Exp_Pathol_2012_May_17_Suppl_4_7327.nxml.txt.nlp	25379357	SENT143	6	6	28	28	metformin	GCN5	PA450395	2648;8850	0.932
NULL	Oncotarget_2014_Aug_29_5(19)_8947-8958.nxml.txt.nlp	25333254	SENT186	19	19	4	4	plerixafor	CXCR4	PA165958410	7852	0.932
NULL	Expert_Rev_Mol_Med_2008_Nov_10_e32.nxml.txt.nlp	18980707	SENT267	13	13	30	30	thrombin	HMGB1	PA451674	3146	0.932
NULL	Braz_J_Med_Biol_Res_2013_Aug_13_46(8)_650-658.nxml.txt.nlp	23969971	SENT172	45	45	12	12	cisplatin	STAT3	PA449014	6774	0.932
NULL	Diabetes_2008_Oct_57(10)_2801-2808.nxml.txt.nlp	18633115	SENT198	16	16	38	38	sulfasalazine	p105	PA451547	4790;4791	0.932
NULL	Cell_Death_Dis_2014_Jan_9_5(1)_e991.nxml.txt.nlp	24407244	SENT61	16	16	33	33	cisplatin	Bcl-2	PA449014	596	0.932
NULL	J_Biol_Chem_2012_Aug_10_287(33)_28169-28179.nxml.txt.nlp	22584573	SENT284	19	19	0	0	rosiglitazone	HDX	PA451283	139324	0.932
NULL	FEBS_J_2009_Jan_276(1)_199-209.nxml.txt.nlp	19032597	SENT141	22	22	25	25	geldanamycin	Hsp90	PA152031327	3320	0.932
NULL	J_Cell_Biol_2002_May_13_157(4)_603-613.nxml.txt.nlp	12011110	SENT60	24	24	14	14	galactose	LEU2	PA449725	8847	0.932
NULL	Biomed_Res_Int_2013_Apr_23_2013_282913.nxml.txt.nlp	23710439	SENT304	7	7	19	19	imiquimod	TLR7	PA449972	51284	0.932
NULL	Br_J_Cancer_2012_Jun_5_106(12)_1945-1952.nxml.txt.nlp	22588555	SENT149	30	30	24	24	sorafenib	Mcl-1	PA7000	4170	0.932
NULL	Front_Oncol_2013_Nov_18_3_282.nxml.txt.nlp	24303367	SENT203	8	8	2	2	erlotinib	EGFR	PA134687924	1956	0.932
NULL	Clin_Ophthalmol_2014_Jun_26_8_1213-1219.nxml.txt.nlp	25061267	SENT27	16	16	44	44	tetracaine	PRK	PA451638	1263	0.932
NULL	Acta_Pharmacol_Sin_2012_Feb_3_33(2)_173-181.nxml.txt.nlp	22301857	SENT137	17	17	14	14	liraglutide	GLP1	PA165958364	100125288;2641	0.932
NULL	Breast_Cancer_Res_2014_May_5_16(3)_R45.nxml.txt.nlp	24887236	SENT200	3	3	12	12	lapatinib	EGFR	PA152241907	1956	0.932
NULL	Oncotarget_2014_Jun_3_5(13)_4920-4928.nxml.txt.nlp	24952482	SENT116	0	0	8	8	crizotinib	EGFR	PA165946122	1956	0.932
NULL	Orphanet_J_Rare_Dis_2011_Apr_12_6_14.nxml.txt.nlp	21486454	SENT70	37	37	7	7	chloroquine	AAT	PA448948	5265	0.932
NULL	Oncoimmunology_2013_Dec_1_2(12)_e26663.nxml.txt.nlp	24498552	SENT15	11	11	30	30	doxorubicin	NKG2D	PA449412	22914	0.932
NULL	Oncoimmunology_2014_Apr_25_3_e28518.nxml.txt.nlp	25071979	SENT56	6	6	42	42	oxaliplatin	CRT	PA131285527	811	0.932
NULL	Chin_J_Cancer_2012_Jun_31(6)_266-280.nxml.txt.nlp	22313597	SENT244	16	16	7	7	tamoxifen	IGFBP5	PA451581	3488	0.932
NULL	Cancer_Manag_Res_2013_Jun_11_5_103-115.nxml.txt.nlp	23807861	SENT60	14	14	33	33	bevacizumab	VEGF-A	PA130232992	7422	0.932
NULL	J_Gen_Physiol_2003_Jan_121(1)_3-16.nxml.txt.nlp	12508050	SENT14	9	9	12	12	nifedipine	DHPR	PA450631	5860	0.932
NULL	Fibrogenesis_Tissue_Repair_2012_Jul_23_5_11.nxml.txt.nlp	22824096	SENT101	27	27	5	5	bleomycin	CD28	PA448645	1493;940	0.932
NULL	Arch_Med_Sci_2013_Dec_30_9(6)_1138-1151.nxml.txt.nlp	24482663	SENT14	24	24	0	0	levodopa	CD34	PA450213	947	0.932
NULL	Cancer_Med_2012_Oct_1_1(2)_114-127.nxml.txt.nlp	23342262	SENT157	8	8	34	34	sirolimus	EGFR	PA451365	1956	0.932
NULL	Acta_Pharmacol_Sin_2011_Mar_31_32(3)_393-398.nxml.txt.nlp	21278781	SENT3	21	21	10	10	cisplatin	alkB	PA449014	8846	0.932
NULL	Basic_Res_Cardiol_2012_Jul_24_107(4)_273.nxml.txt.nlp	22622703	SENT214	27	27	2	2	isoflurane	p53	PA450106	7157	0.932
NULL	Acta_Pharmacol_Sin_2010_Sep_16_31(9)_1095-1102.nxml.txt.nlp	20711228	SENT102	19	19	17	17	indomethacin	COX	PA449982	1351	0.932
NULL	Reprod_Biol_Endocrinol_2013_Mar_5_11_19.nxml.txt.nlp	23510640	SENT113	15	15	13	13	letrozole	aromatase	PA450196	1588	0.932
NULL	Oncotarget_2013_Nov_22_5(4)_933-943.nxml.txt.nlp	24659749	SENT47	14	14	5	5	nutlin-3	AML3		860	0.932
NULL	Ann_Gastroenterol_2014_27(1)_53-59.nxml.txt.nlp	24714782	SENT137	13	13	23	23	ciprofloxacin	CYP1A2	PA449009	1544	0.932
NULL	Br_J_Cancer_1995_Mar_71(3)_619-624.nxml.txt.nlp	7880748	SENT11	34	34	1	1	cisplatin	HOP	PA449014	84525;10963	0.932
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_13_2013_468537.nxml.txt.nlp	23956772	SENT141	2	2	14	14	paclitaxel	p53	PA450761	7157	0.932
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT52	0	0	14	14	pemetrexed	UNG	PA10810	7374	0.932
NULL	Emerg_Med_J_2011_Apr_26_28(4)_313-315.nxml.txt.nlp	20581384	SENT101	23	23	6	6	atropine	PON1	PA448505	5444	0.932
NULL	Cell_Death_Dis_2014_Jul_3_5(7)_e1311.nxml.txt.nlp	24991763	SENT296	31	31	11	11	ketamine	DLX1	PA450144	1745	0.932
NULL	J_Mol_Med_(Berl)_2014_May_10_92(7)_709-722.nxml.txt.nlp	24811491	SENT105	13	13	31	31	cetuximab	KRAS	PA10040	3845	0.932
NULL	Breast_Cancer_Res_Treat_2013_Jan_13_137(2)_471-482.nxml.txt.nlp	23239151	SENT206	17	17	2	2	pazopanib	HER2	PA165291492	2064	0.932
NULL	J_Gastroenterol_2013_Feb_22_48(2)_222-237.nxml.txt.nlp	22722906	SENT302	13	13	7	7	ethanol	JNK	PA448073	5599	0.932
NULL	J_Korean_Med_Sci_2013_Feb_29_28(2)_220-226.nxml.txt.nlp	23400387	SENT116	14	14	5	5	plerixafor	CD34	PA165958410	947	0.932
NULL	Cardiol_Res_Pract_2011_Apr_26_2011_874802.nxml.txt.nlp	21577272	SENT80	6	6	1	1	ketoconazole	CYP3A4	PA450146	1576	0.932
NULL	J_Cell_Biol_2001_Apr_2_153(1)_207-220.nxml.txt.nlp	11285286	SENT118	12	12	6	6	carbachol	DGK	PA448784	8526;1607	0.932
NULL	Cancer_Manag_Res_2013_Jun_7_5_91-101.nxml.txt.nlp	23785245	SENT145	32	32	11	11	erlotinib	EGFR	PA134687924	1956	0.932
NULL	Clin_Pharmacokinet_2014_Sep_3_53(1)_1-16.nxml.txt.nlp	23999929	SENT342	21	21	7	7	dabigatran	P-gp		5243	0.932
NULL	Front_Oncol_2014_Jun_10_4_134.nxml.txt.nlp	24959420	SENT107	9	9	0	0	alemtuzumab	CD52	PA164783958	1043	0.932
NULL	J_Clin_Biochem_Nutr_2011_Jul_17_49(1)_50-56.nxml.txt.nlp	21765607	SENT170	27	27	8	8	arsenite	HO-1	PA452638	3162	0.932
NULL	Br_J_Cancer_2014_Nov_25_111(11)_2033-2038.nxml.txt.nlp	25268375	SENT113	12	12	19	19	lapatinib	HER2	PA152241907	2064	0.932
NULL	Chemother_Res_Pract_2012_Dec_20_2012_743193.nxml.txt.nlp	23320171	SENT125	0	0	27	27	trastuzumab	DM1	PA451743	338023;1760;28509	0.932
NULL	Cell_Regen_(Lond)_2012_Jun_28_1(1)_4.nxml.txt.nlp	25408867	SENT44	22	22	36	36	trypsin	SNX17	PA451806	9784	0.932
NULL	Oxid_Med_Cell_Longev_2010_Jan-Feb_3(1)_53-60.nxml.txt.nlp	20716928	SENT133	9	9	42	42	l-glutamine	CO2	PA10090	4513	0.932
NULL	Nat_Methods_2013_Dec_27_10(12)_10_1038_nmeth_2702.nxml.txt.nlp	24162924	SENT178	30	30	13	13	trypsin	CDK4	PA451806	1019	0.932
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_May_22_66(Pt_6)_o1400.nxml.txt.nlp	21579479	SENT47	19	19	6	6	ethanol	mol	PA448073	90527	0.932
NULL	Front_Neurosci_2014_Feb_25_8_36.nxml.txt.nlp	24616658	SENT143	33	33	19	19	yohimbine	NAC	PA451946	22861	0.932
NULL	J_Korean_Med_Sci_2011_Aug_27_26(8)_1007-1013.nxml.txt.nlp	21860550	SENT126	28	28	19	19	tamoxifen	CYP2D6	PA451581	1565	0.932
NULL	Ann_Hematol_2011_May_12_90(5)_557-568.nxml.txt.nlp	20938660	SENT6	15	15	4	4	plerixafor	CD34	PA165958410	947	0.932
NULL	Evid_Based_Complement_Alternat_Med_2012_Dec_17_2012_857123.nxml.txt.nlp	23365602	SENT195	6	6	0	0	capsaicin	TRPV1	PA448776	7442	0.932
NULL	J_Cheminform_2012_Mar_8_4_6.nxml.txt.nlp	22401035	SENT317	37	37	17	17	troglitazone	CYP2D6	PA451799	1565	0.932
NULL	Clin_Pharmacol_2011_Jun_22_3_13-25.nxml.txt.nlp	22287853	SENT119	14	14	0	0	saxagliptin	ANOVA	PA165958362	4858	0.932
NULL	Evid_Based_Complement_Alternat_Med_2011_Jan_20_2011_751671.nxml.txt.nlp	21318106	SENT140	6	6	14	14	tacrolimus	P-gp	PA451578	5243	0.932
NULL	Oncotarget_2011_Jun_15_2(6)_518-524.nxml.txt.nlp	21680956	SENT37	24	24	19	19	methotrexate	DHFR	PA450428	1719	0.932
NULL	Br_J_Cancer_2012_Jun_5_106(12)_1997-2003.nxml.txt.nlp	22596232	SENT141	18	18	11	11	sorafenib	JNK	PA7000	5599	0.932
NULL	Open_Med_2007_Dec_18_1(3)_e184-e190.nxml.txt.nlp	21673951	SENT67	5	5	36	36	tamoxifen	aromatase	PA451581	1588	0.932
NULL	Front_Aging_Neurosci_2011_May_20_3_7.nxml.txt.nlp	21647396	SENT3458	0	0	19	19	milnacipran	5-HT1A	PA164752812	3350	0.932
NULL	Indian_J_Pharmacol_2013_Sep-Oct_45(5)_458-463.nxml.txt.nlp	24130379	SENT2	19	19	4	4	carvedilol	TLR4	PA448817	7099	0.932
NULL	Clin_Ophthalmol_2014_Jan_8_8_187-190.nxml.txt.nlp	24531503	SENT4	0	0	7	7	tocilizumab	IL-6	PA165292659	3569	0.932
NULL	Patient_Prefer_Adherence_2010_Jul_21_4_231-245.nxml.txt.nlp	20694183	SENT403	5	5	18	18	risedronate	IMPACT	PA451255	55364	0.932
NULL	Cancer_Manag_Res_2011_Sep_9_3_301-309.nxml.txt.nlp	21931504	SENT138	9	9	39	39	spermine	CXCR4	PA164781199	7852	0.932
NULL	Cell_Res_2013_Jul_21_23(7)_915-930.nxml.txt.nlp	23689279	SENT355	4	4	11	11	ethanol	ALDH2	PA448073	217	0.932
NULL	Int_J_Appl_Basic_Med_Res_2013_Jan-Jun_3(1)_37-47.nxml.txt.nlp	23776838	SENT12	30	30	19	19	donepezil	spatial	PA449394	219793	0.932
NULL	Ann_Hematol_2011_May_12_90(5)_557-568.nxml.txt.nlp	20938660	SENT217	17	17	35	35	plerixafor	CD34	PA165958410	947	0.932
NULL	Mol_Cancer_2009_Dec_23_8_129.nxml.txt.nlp	20030852	SENT193	7	7	25	25	curcumin	ABCA1	PA151958596	19	0.932
NULL	Breast_Cancer_Res_2011_Apr_6_13(2)_207.nxml.txt.nlp	21586099	SENT56	0	0	9	9	denosumab	RANKL	PA166048634	8600	0.932
NULL	Braz_J_Med_Biol_Res_2014_Mar_21_47(4)_273-278.nxml.txt.nlp	24676475	SENT98	10	10	4	4	doxorubicin	CIAPIN1	PA449412	57019	0.932
NULL	Int_J_Vasc_Med_2011_Jun_30_2011_250518.nxml.txt.nlp	21761004	SENT56	11	11	30	30	ticlopidine	ADP	PA451686	23038	0.932
NULL	Cancer_Manag_Res_2013_Nov_21_5_387-400.nxml.txt.nlp	24294007	SENT92	39	39	8	8	cetuximab	BRAF	PA10040	673	0.932
NULL	J_Hematol_Oncol_2013_Feb_18_6_18.nxml.txt.nlp	23415012	SENT234	7	7	27	27	perifosine	CD34	PA165291471	947	0.932
NULL	Oncotarget_2013_Jun_3_4(6)_875-883.nxml.txt.nlp	23900261	SENT159	10	10	16	16	geldanamycin	ESR1	PA152031327	2099	0.932
NULL	Clinics_(Sao_Paulo)_2012_Sep_67(9)_1093-1099.nxml.txt.nlp	23018309	SENT142	8	8	22	22	sorafenib	Mcl-1	PA7000	4170	0.932
NULL	Cell_Commun_Signal_2005_Oct_5_3_11.nxml.txt.nlp	16207372	SENT217	15	15	0	0	paraformaldehyde	MPL	PA450790	4352	0.932
NULL	Cancer_Microenviron_2009_Sep_26_2(Suppl_1)_19-204.nxml.txt.nlp	NULL	SENT2561	5	5	9	9	tamoxifen	ENL	PA451581	4298	0.932
NULL	Oncotarget_2012_May_23_3(5)_518-524.nxml.txt.nlp	22643838	SENT85	22	22	3	3	imatinib	MYL	PA10804	5371	0.932
NULL	Mol_Biol_Cell_2013_Aug_1_24(15)_2340-2349.nxml.txt.nlp	23783036	SENT256	8	8	15	15	spectinomycin	CR1	PA164781342	1378	0.932
NULL	Nucleic_Acids_Res_2011_Sep_7_39(17)_7465-7476.nxml.txt.nlp	21653549	SENT348	15	15	5	5	nutlin-3	DEK		7913	0.932
NULL	Calcif_Tissue_Int_2010_Aug_23_87(2)_130-136.nxml.txt.nlp	20571786	SENT3	28	28	15	15	teriparatide	CSA	PA451620	1442;1161	0.932
NULL	Indian_Dermatol_Online_J_2014_Jul-Sep_5(3)_276-281.nxml.txt.nlp	25165643	SENT38	22	22	6	6	glucose	AGA	PA449773	175	0.932
NULL	Cancer_Immunol_Immunother_2013_Aug_27_62(10)_1637-1648.nxml.txt.nlp	23982484	SENT152	15	15	11	11	lenalidomide	IL-6	PA162363968	3569	0.932
NULL	Int_J_Endocrinol_2010_Aug_29_2010_481326.nxml.txt.nlp	20871656	SENT29	7	7	23	23	glucose	MPG	PA449773	4350	0.932
NULL	Acta_Pharmacol_Sin_2010_May_12_31(5)_531-539.nxml.txt.nlp	20383168	SENT196	28	28	8	8	fasudil	RhoA	PA165946121	387	0.932
NULL	Drugs_R_D_2014_Jun_2_14(2)_63-71.nxml.txt.nlp	24691742	SENT38	31	31	47	47	moxifloxacin	E14	PA450555	4863	0.932
NULL	Cancer_Cell_Int_2011_Nov_18_11_41.nxml.txt.nlp	22098917	SENT3	24	24	10	10	arsenite	ENO2	PA452638	2026	0.932
NULL	Evid_Based_Complement_Alternat_Med_2014_Oct_29_2014_402126.nxml.txt.nlp	25530781	SENT110	22	22	1	1	baclofen	K12	PA448533	6398;3859	0.932
NULL	Can_J_Infect_Dis_Med_Microbiol_2014_Nov-Dec_25(6)_327-343.nxml.txt.nlp	25587296	SENT181	22	22	14	14	itraconazole	P-gp	PA450132	5243	0.932
NULL	Oncotarget_2011_Aug_30_2(8)_610-626.nxml.txt.nlp	21881167	SENT119	20	20	25	25	doxorubicin	Raf-1	PA449412	5894	0.932
NULL	J_Immunother_Cancer_2014_Jan_27_2_2.nxml.txt.nlp	24829759	SENT106	30	30	10	10	sorafenib	IL-21	PA7000	59067;50616;27189	0.932
NULL	Mol_Immunol_2009_Mar_46(6)_1149-1162.nxml.txt.nlp	19100624	SENT595	19	19	7	7	nystatin	C5L2	PA450666	27202	0.932
NULL	Hum_Reprod_2008_Oct_16_23(10)_2273-2281.nxml.txt.nlp	18635530	SENT148	13	13	4	4	etoposide	CTB	PA449552	9468	0.932
NULL	Indian_J_Endocrinol_Metab_2012_May-Jun_16(3)_371-376.nxml.txt.nlp	22629501	SENT42	22	22	3	3	thyroglobulin	FDG	PA164754910	23583	0.932
NULL	Front_Chem_2014_Dec_23_2_113.nxml.txt.nlp	25566531	SENT159	11	11	0	0	curcumin	IL-8	PA151958596	3576	0.932
NULL	Oncol_Lett_2013_Jun_4_5(6)_1872-1876.nxml.txt.nlp	23833659	SENT124	5	5	10	10	flavopiridol	Bcl-2	PA452627	596	0.932
NULL	Evid_Based_Complement_Alternat_Med_2011_May_24_2011_841564.nxml.txt.nlp	21716682	SENT116	21	21	7	7	epirubicin	p38	PA449476	10598;1432;7965	0.932
NULL	Breast_Cancer_Res_2012_Jun_19_14(3)_209.nxml.txt.nlp	22713170	SENT52	0	0	11	11	pertuzumab	HER2		2064	0.932
NULL	Arthritis_Rheumatol_2014_Jun_27_66(6)_1574-1582.nxml.txt.nlp	24577881	SENT145	24	24	18	18	hydralazine	ERK	PA449894	5594	0.932
NULL	Korean_Circ_J_2014_Mar_12_44(2)_82-88.nxml.txt.nlp	24653737	SENT38	24	24	31	31	clopidogrel	ADP	PA449053	23038	0.932
NULL	Br_J_Cancer_2013_Jul_9_109(1)_100-108.nxml.txt.nlp	23756858	SENT105	31	31	20	20	letrozole	aromatase	PA450196	1588	0.932
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S279-S284.nxml.txt.nlp	21525469	SENT63	5	5	11	11	exenatide	GLP-1	PA164749238	100125288	0.932
NULL	Front_Cell_Neurosci_2013_Dec_5_7_243.nxml.txt.nlp	24367290	SENT122	10	10	25	25	resveratrol	SIRT1		23411	0.932
NULL	Biosci_Rep_2013_Sep_25_33(5)_e00071.nxml.txt.nlp	23980545	SENT212	29	29	8	8	imiglucerase	CD11c	PA164742934	3687	0.932
NULL	Braz_J_Med_Biol_Res_2012_Jul_27_45(10)_948-954.nxml.txt.nlp	22832600	SENT171	23	23	31	31	fluoxetine	5-HT4	PA449673	3360	0.932
NULL	Indian_J_Med_Res_2011_Jan_133(1)_50-56.nxml.txt.nlp	21321419	SENT104	14	14	5	5	lamivudine	HAI	PA450163	6692;6768	0.932
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT190	35	35	11	11	heparin	FGF1	PA449855	2246	0.932
NULL	Nat_Med_2013_Mar_3_19(3)_295-304.nxml.txt.nlp	23377280	SENT225	24	24	6	6	erlotinib	EGFR	PA134687924	1956	0.932
NULL	Oncotarget_2014_Oct_18_5(22)_11604-11619.nxml.txt.nlp	25344099	SENT236	8	8	12	12	etoposide	RYBP	PA449552	23429	0.932
NULL	Indian_J_Endocrinol_Metab_2012_Dec_16(Suppl_2)_S195-S198.nxml.txt.nlp	23565377	SENT55	3	3	18	18	bromocriptine	PRL	PA448671	5617	0.932
NULL	FEBS_J_2009_Jan_276(1)_199-209.nxml.txt.nlp	19032597	SENT154	16	16	34	34	geldanamycin	ADP	PA152031327	23038	0.932
NULL	Int_J_Nanomedicine_2012_May_7_7_2307-2314.nxml.txt.nlp	22661887	SENT171	13	13	2	2	gemcitabine	F10	PA449748	2159	0.932
NULL	Mol_Cancer_2003_Jan_7_2_5.nxml.txt.nlp	12537586	SENT113	5	5	34	34	fluvastatin	EGF	PA449688	1950	0.932
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT80	8	8	22	22	nutlin-3	IBP		706;50619	0.932
NULL	Front_Oncol_2014_Jun_18_4_159.nxml.txt.nlp	24995161	SENT150	2	2	11	11	estradiol	HSD1	PA449503	26871	0.932
NULL	Oncoimmunology_2012_May_1_1(3)_279-286.nxml.txt.nlp	22737603	SENT147	6	6	24	24	doxorubicin	CD47	PA449412	961	0.932
NULL	Indian_J_Endocrinol_Metab_2011_Jan-Mar_15(1)_9-17.nxml.txt.nlp	21584160	SENT58	4	4	16	16	liraglutide	GLP-1	PA165958364	100125288	0.932
NULL	Br_J_Pharmacol_2011_Aug_163(8)_1679-1690.nxml.txt.nlp	21371008	SENT149	33	33	19	19	ns-398	COX		1351	0.932
NULL	Springerplus_2015_Jan_23_4_29.nxml.txt.nlp	25628986	SENT6	5	5	13	13	dapsone	G6PD	PA449211	2539	0.932
NULL	J_Mol_Signal_2012_Aug_16_7_12.nxml.txt.nlp	22898329	SENT247	25	25	0	0	dacarbazine	NOXA	PA449197	5366	0.932
NULL	J_Nat_Sci_Biol_Med_2012_Jul-Dec_3(2)_189-191.nxml.txt.nlp	23225984	SENT63	0	0	33	33	plerixafor	CD34	PA165958410	947	0.932
NULL	Int_J_Biol_Sci_2014_Sep_6_10(9)_990-996.nxml.txt.nlp	25210497	SENT155	23	23	10	10	capsaicin	TRPV1	PA448776	7442	0.932
NULL	Cancer_Cell_Int_2009_Sep_10_9_25.nxml.txt.nlp	19744341	SENT141	20	20	12	12	glucosamine	survivin	PA164747613	332	0.932
NULL	Eur_J_Med_Res_2011_Feb_24_16(2)_79-84.nxml.txt.nlp	21463987	SENT113	9	9	26	26	lipase	HLP	PA450239	6499;9001;3002	0.932
NULL	Acta_Pharmacol_Sin_2011_Jul_13_32(7)_967-972.nxml.txt.nlp	21666702	SENT132	16	16	20	20	ticlopidine	P-gp	PA451686	5243	0.932
NULL	Nat_Chem_Biol_2010_Apr_28_6(4)_291-299.nxml.txt.nlp	20190765	SENT282	16	16	9	9	dasatinib	EGFR	PA162372878	1956	0.932
NULL	Diabetes_2009_Apr_23_58(4)_917-925.nxml.txt.nlp	19168598	SENT81	35	35	14	14	mannitol	FOXO1	PA450320	2308	0.932
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT79	22	22	9	9	metformin	AMPK	PA450395	5563	0.932
NULL	Int_J_Breast_Cancer_2012_Oct_15_2012_809291.nxml.txt.nlp	22295251	SENT179	12	12	7	7	erlotinib	EGFR	PA134687924	1956	0.932
NULL	Arthritis_Res_Ther_2005_Nov_2_7(1)_1-11.nxml.txt.nlp	15642148	SENT169	6	6	15	15	collagenase	IL-6	PA449107	3569	0.932
NULL	Clin_Interv_Aging_2013_Jul_16_8_889-897.nxml.txt.nlp	23898224	SENT22	22	22	6	6	gemcitabine	SIRT1	PA449748	23411	0.932
NULL	Autoimmune_Dis_2013_Aug_28_2013_613086.nxml.txt.nlp	24069534	SENT6	26	26	38	38	infliximab	p40	PA452639	3921;339541;10314	0.932
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Jul_23_6_103-113.nxml.txt.nlp	25114588	SENT36	2	2	31	31	trastuzumab	HER2	PA451743	2064	0.932
NULL	Addict_Sci_Clin_Pract_2014_Sep_13_9(1)_20.nxml.txt.nlp	25217046	SENT207	20	20	13	13	naltrexone	OPRM1	PA450588	4988	0.932
NULL	Cancer_Res_Treat_2014_Jan_15_46(1)_48-54.nxml.txt.nlp	24520223	SENT29	16	16	7	7	bevacizumab	EGFR	PA130232992	1956	0.932
NULL	Crit_Care_2011_Jul_8_15(4)_R163.nxml.txt.nlp	21740551	SENT60	13	13	1	1	fluorescein	CD62P	PA164746009	6403	0.932
NULL	J_Oncol_2010_Nov_19_2010_568938.nxml.txt.nlp	20037743	SENT163	13	13	6	6	gefitinib	EGFR	PA131301952	1956	0.932
NULL	Ann_Oncol_2011_Mar_8_22(3)_503-514.nxml.txt.nlp	20616198	SENT332	12	12	1	1	tamoxifen	aromatase	PA451581	1588	0.932
NULL	Eur_J_Med_Res_2009_Nov_24_14(Suppl_3)_17-21.nxml.txt.nlp	19959412	SENT56	5	5	12	12	midazolam	UGT	PA450496	7361;7355	0.932
NULL	Front_Physiol_2012_Oct_4_3_396.nxml.txt.nlp	23060820	SENT325	24	24	14	14	remifentanil	c-fos	PA451232	2353	0.932
NULL	J_Oncol_2009_Jul_27_2009_305420.nxml.txt.nlp	19644558	SENT97	7	7	24	24	estradiol	PTEN	PA449503	5728	0.932
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT240	24	24	9	9	cisplatin	UNG	PA449014	7374	0.932
NULL	Br_J_Cancer_2013_Jul_9_109(1)_100-108.nxml.txt.nlp	23756858	SENT109	32	32	18	18	letrozole	survivin	PA450196	332	0.932
NULL	Oncol_Rep_2014_Apr_28_31(4)_1605-1612.nxml.txt.nlp	24481648	SENT98	3	3	20	20	ponatinib	MRP7	PA165980594	89845;1080	0.932
NULL	Curr_Pharm_Biotechnol_2012_May_13(6)_969-986.nxml.txt.nlp	22039792	SENT178	24	24	15	15	ivermectin	P-gp	PA450133	5243	0.932
NULL	Oncologist_2010_Sep_26_15(9)_944-953.nxml.txt.nlp	20798196	SENT23	3	3	38	38	lapatinib	HER-2	PA152241907	2064	0.932
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT115	17	17	31	31	neratinib	HER2	PA165291472	2064	0.932
NULL	Crit_Care_2004_Oct_27_8(6)_R474-R482.nxml.txt.nlp	15566594	SENT36	27	27	12	12	indomethacin	PGD2	PA449982	27306	0.932
NULL	Curr_Clin_Pharmacol_2008_Sep_3(3)_198-203.nxml.txt.nlp	18781906	SENT107	6	6	10	10	oxcarbazepine	CYP3A4	PA450732	1576	0.932
NULL	Alzheimers_Res_Ther_2010_Dec_15_2(6)_33.nxml.txt.nlp	21159211	SENT59	31	31	4	4	memantine	STEP	PA10364	84867	0.932
NULL	Epigenetics_2012_Nov_1_7(11)_1225-1229.nxml.txt.nlp	23069641	SENT56	4	4	16	16	cisplatin	BRCA1	PA449014	672	0.932
NULL	Mol_Pain_2014_Aug_15_10_53.nxml.txt.nlp	25127716	SENT108	11	11	21	21	paclitaxel	SDH	PA450761	1757;10993	0.932
NULL	Nat_Biotechnol_2013_Jul_30_31(7)_630-637.nxml.txt.nlp	23811600	SENT180	15	15	5	5	crizotinib	TESK1	PA165946122	7016	0.932
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2675-2684.nxml.txt.nlp	24129246	SENT205	7	7	34	34	etoposide	SIRT1	PA449552	23411	0.932
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT178	14	14	25	25	doxorubicin	B7-H1	PA449412	29126	0.932
NULL	Pain_2009_Jul_144(1-2)_110-118.nxml.txt.nlp	19410369	SENT195	20	20	32	32	capsaicin	TRPV1	PA448776	7442	0.932
NULL	Endocr_Relat_Cancer_2014_Jun_21(3)_R209-R225.nxml.txt.nlp	24500760	SENT137	10	10	34	34	resveratrol	COX2		4513;5743	0.932
NULL	Biosci_Rep_2014_Aug_6_34(4)_e00131.nxml.txt.nlp	24975826	SENT6	7	7	0	0	probenecid	TRPM8	PA451106	79054	0.932
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT278	31	31	13	13	neratinib	HER2	PA165291472	2064	0.932
NULL	Mol_Cancer_2010_Nov_2_9_289.nxml.txt.nlp	21044322	SENT165	21	21	8	8	cisplatin	RGS17	PA449014	26575	0.932
NULL	Int_J_Environ_Res_Public_Health_2010_Feb_11_7(2)_473-493.nxml.txt.nlp	20616986	SENT121	18	18	11	11	ethanol	CRF1	PA448073	1394	0.932
NULL	Front_Neurosci_2014_Aug_19_8_211.nxml.txt.nlp	25191214	SENT1653	15	15	21	21	pioglitazone	gamma	PA450970	9913	0.932
NULL	Oncotarget_2013_Aug_24_4(10)_1618-1631.nxml.txt.nlp	24113128	SENT105	22	22	15	15	sorafenib	p53	PA7000	7157	0.932
NULL	Breast_Cancer_Res_2010_Aug_23_12(4)_R64.nxml.txt.nlp	20731819	SENT5	7	7	0	0	tamoxifen	CYP2D6	PA451581	1565	0.932
NULL	Osteoporos_Int_2013_Jan_10_24(1)_227-235.nxml.txt.nlp	22776860	SENT116	9	9	16	16	denosumab	BSAP	PA166048634	5079	0.932
NULL	Oncotarget_2014_Jun_5_5(21)_10382-10392.nxml.txt.nlp	25071015	SENT157	46	46	37	37	trastuzumab	HER2	PA451743	2064	0.932
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT258	6	6	4	4	trastuzumab	HRG	PA451743	3084;3273	0.932
NULL	Biomed_Res_Int_2014_Jan_20_2014_948427.nxml.txt.nlp	24563867	SENT143	2	2	24	24	buspirone	CRP	PA448689	1401;140913	0.932
NULL	J_Korean_Med_Sci_1994_Dec_9(6)_482-489.nxml.txt.nlp	7786445	SENT10	25	25	2	2	isoniazid	CYP2D6	PA450112	1565	0.932
NULL	Cancer_Med_2013_Apr_20_2(2)_130-143.nxml.txt.nlp	23634281	SENT214	7	7	22	22	rituximab	CD59	PA451261	966	0.932
NULL	Neural_Plast_2014_Jan_8_2014_628531.nxml.txt.nlp	24511395	SENT165	23	23	14	14	glibenclamide	CTX	PA449782	1593	0.932
NULL	J_Inherit_Metab_Dis_2012_May_19_35(3)_531-540.nxml.txt.nlp	22008945	SENT14	5	5	14	14	heparin	GPIHBP1	PA449855	338328	0.932
NULL	South_Asian_J_Cancer_2014_Jul-Sep_3(3)_182-184.nxml.txt.nlp	25136528	SENT82	24	24	0	0	clarithromycin	CYP3A4	PA449028	1576	0.932
NULL	Biosci_Rep_2012_Dec_6_33(1)_e00006.nxml.txt.nlp	23050906	SENT143	19	19	6	6	lovastatin	DHCR24	PA450272	1718	0.932
NULL	Apoptosis_2012_Mar_30_17(3)_219-228.nxml.txt.nlp	22127644	SENT74	15	15	13	13	verapamil	MDR1	PA451868	5243	0.932
NULL	Thorax_2014_Jul_24_69(7)_638-647.nxml.txt.nlp	24567297	SENT93	14	14	17	17	doxycycline	TRAIL	PA449415	8743	0.932
NULL	Indian_J_Pharmacol_2009_Dec_41(6)_252-254.nxml.txt.nlp	20407554	SENT37	3	3	32	32	irbesartan	STZ	PA450084	6484	0.932
NULL	Cell_Commun_Signal_2013_Jul_4_11_47.nxml.txt.nlp	23826796	SENT148	18	18	9	9	rolipram	CC2D1A	PA153906323	54862	0.932
NULL	South_Asian_J_Cancer_2014_Jan-Mar_3(1)_71-73.nxml.txt.nlp	24665452	SENT52	29	29	8	8	tamoxifen	BRCA1	PA451581	672	0.932
NULL	Oncologist_2010_May_28_15(5)_436-446.nxml.txt.nlp	20427383	SENT130	7	7	31	31	sunitinib	EGFR	PA162372840	1956	0.932
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT299	21	21	5	5	nutlin-3	MDM2		4193	0.932
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_75-89.nxml.txt.nlp	17912638	SENT231	18	18	5	5	anastrozole	ATAC	PA448432	6375	0.932
NULL	ACS_Med_Chem_Lett_2014_May_14_5(7)_736-741.nxml.txt.nlp	25057340	SENT313	2	2	11	11	sulindac	AKT	PA451565	207	0.932
NULL	Acta_Pharmacol_Sin_2013_Sep_5_34(9)_1237-1242.nxml.txt.nlp	23770984	SENT98	31	31	0	0	phenytoin	CYP2C9	PA450947	1559	0.932
NULL	Braz_J_Med_Biol_Res_2014_Mar_3_47(3)_245-251.nxml.txt.nlp	24554037	SENT137	13	13	5	5	creatine	IL-6	PA164778930	3569	0.932
NULL	Cancers_(Basel)_2010_Mar_25_2(2)_209-232.nxml.txt.nlp	24281068	SENT219	32	32	27	27	docetaxel	Bcl-2	PA449383	596	0.932
NULL	Clin_Mol_Hepatol_2013_Sep_30_19(3)_216-254.nxml.txt.nlp	24133661	SENT497	26	26	30	30	thalidomide	adiponectin	PA451644	9370	0.932
NULL	Cardiovasc_Diabetol_2010_Oct_18_9_64.nxml.txt.nlp	20955583	SENT6	33	33	27	27	rosiglitazone	PPARgamma	PA451283	5468	0.932
NULL	Nat_Med_2012_Jun_18(6)_956-960.nxml.txt.nlp	22610278	SENT250	4	4	33	33	auranofin	DTNB	PA448510	1838	0.932
NULL	Ann_Clin_Microbiol_Antimicrob_2011_Jun_24_10_27.nxml.txt.nlp	21702921	SENT110	28	28	5	5	fosfomycin	MDR2	PA164748039	5244	0.932
NULL	Ann_Med_Health_Sci_Res_2014_Jul-Aug_4(4)_466-471.nxml.txt.nlp	25221689	SENT101	13	13	3	3	piperaquine	CYP3A4	PA166104279	1576	0.932
NULL	Indian_J_Anaesth_2009_Aug_53(4)_399-400.nxml.txt.nlp	20640200	SENT12	6	6	11	11	rocuronium	NMB	PA164754992	10457;4828	0.932
NULL	Breast_Cancer_Res_Treat_2012_Jun_18_133(3)_937-947.nxml.txt.nlp	22094936	SENT148	47	47	21	21	tamoxifen	CCNE2	PA451581	9134	0.932
NULL	Clin_Ophthalmol_2014_Sep_26_8_1967-1985.nxml.txt.nlp	25328381	SENT121	3	3	9	9	latanoprost	BAK	PA164774763	578	0.932
NULL	Appl_Microbiol_Biotechnol_2014_Feb_18_98(8)_3829-3840.nxml.txt.nlp	24535257	SENT219	32	32	15	15	ethanol	PE-2	PA448073	2077	0.932
NULL	Mol_Cancer_2010_May_19_9_114.nxml.txt.nlp	20482878	SENT197	28	28	4	4	pentoxifylline	p53	PA450864	7157	0.932
NULL	Oncogene_2010_Oct_21_29(42)_5700-5711.nxml.txt.nlp	20676140	SENT105	9	9	23	23	doxorubicin	p53	PA449412	7157	0.932
NULL	Chem_Rev_2011_Oct_12_111(10)_5899-5921.nxml.txt.nlp	21923193	SENT563	18	18	14	14	nimesulide	COX	PA137179528	1351	0.932
NULL	J_Biomed_Sci_2014_Jan_9_21(1)_2.nxml.txt.nlp	24405633	SENT127	4	4	9	9	metformin	aromatase	PA450395	1588	0.932
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Dec_17_3(12)_e152.nxml.txt.nlp	25518025	SENT59	6	6	11	11	oxycodone	CYP3A4	PA450741	1576	0.932
NULL	Breast_Cancer_Res_2012_Jul_20_14(4)_R110.nxml.txt.nlp	22817698	SENT166	16	16	11	11	cisplatin	BRCA1	PA449014	672	0.932
NULL	Adv_Hematol_2009_Jul_7_2009_495863.nxml.txt.nlp	19960059	SENT152	0	0	22	22	ticlopidine	ADAMTS13	PA451686	11093	0.932
NULL	Emerg_Infect_Dis_2011_Mar_17(3)_510-513.nxml.txt.nlp	21392446	SENT24	9	9	0	0	ofloxacin	DST	PA450684	667	0.932
NULL	Arthritis_Rheum_2011_Oct_63(10)_2854-2864.nxml.txt.nlp	21618201	SENT61	10	10	24	24	abatacept	ACR	PA164747080	49	0.932
NULL	Orphanet_J_Rare_Dis_2008_May_19_3_12.nxml.txt.nlp	18489744	SENT372	0	0	6	6	letrozole	aromatase	PA450196	1588	0.932
NULL	Br_J_Cancer_2013_Feb_19_108(3)_557-563.nxml.txt.nlp	23361053	SENT13	26	26	10	10	tamoxifen	PAK1	PA451581	5585;5058	0.932
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT276	9	9	1	1	etoposide	ABCC2	PA449552	1244	0.932
NULL	Br_J_Cancer_2010_Oct_12_103(8)_1284-1291.nxml.txt.nlp	20859285	SENT134	10	10	4	4	tamoxifen	ERBB3	PA451581	2065	0.932
NULL	Int_Clin_Psychopharmacol_2014_Nov_3_29(6)_351-356.nxml.txt.nlp	24978955	SENT128	20	20	3	3	citalopram	STAR	PA449015	6770;2984	0.932
NULL	Oncotarget_2014_Jun_7_5(13)_5017-5028.nxml.txt.nlp	24970809	SENT125	13	13	0	0	doxycycline	GCIP	PA449415	23582	0.932
NULL	Cancer_Cell_Int_2014_Jan_29_14_10.nxml.txt.nlp	24472145	SENT197	25	25	15	15	doxorubicin	HER-2	PA449412	2064	0.932
NULL	Mol_Vis_2014_Nov_4_20_1518-1526.nxml.txt.nlp	25489225	SENT159	7	7	12	12	fenofibrate	IL-6	PA449594	3569	0.932
NULL	Chem_Rev_2011_Oct_12_111(10)_5899-5921.nxml.txt.nlp	21923193	SENT563	18	18	3	3	nimesulide	FAAH	PA137179528	79152;2166	0.932
NULL	Mol_Syst_Biol_2010_Oct_19_6_420.nxml.txt.nlp	20959818	SENT85	9	9	28	28	galactose	GAL	PA449725	51083	0.932
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT61	5	5	25	25	curcumin	PC-3	PA151958596	692094	0.932
NULL	Cell_Death_Dis_2013_Sep_5_4(9)_e791.nxml.txt.nlp	24008735	SENT28	4	4	11	11	gemcitabine	p53	PA449748	7157	0.932
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT89	2	2	15	15	chloroquine	BMPR-II	PA448948	659	0.932
NULL	Exp_Transl_Stroke_Med_2010_Jul_20_2_14.nxml.txt.nlp	20646278	SENT122	5	5	28	28	isoflurane	TASK	PA450106	3777	0.932
NULL	Mol_Clin_Oncol_2013_Jul_20_1(4)_599-609.nxml.txt.nlp	24649216	SENT174	14	14	9	9	medroxyprogesterone	aromatase	PA450344	1588	0.932
NULL	Breast_Cancer_Res_2008_Jul_16_10(4)_R60.nxml.txt.nlp	18631394	SENT105	0	0	7	7	trastuzumab	HER2	PA451743	2064	0.932
NULL	Drug_Target_Insights_2012_Aug_6_6_19-39.nxml.txt.nlp	22915839	SENT260	16	16	27	27	doxorubicin	MDR1	PA449412	5243	0.931
NULL	Cancer_Res_Treat_2013_Mar_31_45(1)_55-62.nxml.txt.nlp	23613671	SENT85	30	30	25	25	oxaliplatin	KRAS	PA131285527	3845	0.931
NULL	Oncotarget_2013_Nov_24_4(12)_2430-2438.nxml.txt.nlp	24280348	SENT130	36	36	47	47	gefitinib	STAT3	PA131301952	6774	0.931
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1013.nxml.txt.nlp	24457957	SENT116	6	6	14	14	bortezomib	NOXA	PA10252	5366	0.931
NULL	Exp_Mol_Med_2012_Sep_30_44(9)_545-553.nxml.txt.nlp	22809901	SENT63	34	34	6	6	clozapine	PRDM16	PA449061	63976	0.931
NULL	Mol_Cell_Proteomics_2012_Feb_7_11(2)_M111_014480.nxml.txt.nlp	22074704	SENT110	14	14	2	2	tamoxifen	PC1	PA451581	5122	0.931
NULL	Front_Genet_2014_Oct_28_5_364.nxml.txt.nlp	25389432	SENT101	0	0	25	25	curcumin	APOE	PA151958596	348	0.931
NULL	J_Hematol_Oncol_2011_Nov_4_4_44.nxml.txt.nlp	22053759	SENT114	28	28	20	20	thrombin	PAR1	PA451674	79581;2149	0.931
NULL	Mol_Cancer_2010_Jun_25_9_166.nxml.txt.nlp	20579378	SENT214	29	29	18	18	gefitinib	MDM2	PA131301952	4193	0.931
NULL	Oncoscience_2014_Mar_16_1(2)_132-157.nxml.txt.nlp	25594007	SENT248	9	9	4	4	oxaliplatin	ID3	PA131285527	3399	0.931
NULL	Indian_J_Nephrol_2012_Mar-Apr_22(2)_139-142.nxml.txt.nlp	22787319	SENT111	17	17	22	22	cyclosporine	P-gp	PA449167	5243	0.931
NULL	Environ_Health_Perspect_1990_Apr_85_89-94.nxml.txt.nlp	2384071	SENT7	10	10	4	4	methylprednisolone	NAC	PA450466	22861	0.931
NULL	Curr_Neuropharmacol_2012_Jun_10(2)_97-123.nxml.txt.nlp	23204981	SENT199	9	9	18	18	reboxetine	IFN	PA144614921	3439	0.931
NULL	J_Cell_Biol_1998_Jan_26_140(2)_259-270.nxml.txt.nlp	9442102	SENT123	16	16	33	33	trypsin	SUMO-1	PA451806	7341	0.931
NULL	Br_J_Cancer_2013_Feb_19_108(3)_549-556.nxml.txt.nlp	23329233	SENT35	27	27	7	7	trastuzumab	HER-2	PA451743	2064	0.931
NULL	Ann_Hematol_2011_Feb_17_90(2)_173-183.nxml.txt.nlp	20714724	SENT102	16	16	6	6	resveratrol	CD19		930	0.931
NULL	EMBO_Mol_Med_2013_Jun_7_5(6)_858-869.nxml.txt.nlp	23653322	SENT267	24	24	11	11	doxycycline	TIE2	PA449415	7010	0.931
NULL	Comp_Hepatol_2005_Feb_8_4_2.nxml.txt.nlp	15701172	SENT157	20	20	8	8	ketoconazole	CYP3A	PA450146	1574	0.931
NULL	J_Carcinog_2011_Nov_30_10_28.nxml.txt.nlp	22190870	SENT152	0	0	10	10	pertuzumab	San		80218	0.931
NULL	Croat_Med_J_2013_Apr_54(2)_171-179.nxml.txt.nlp	23630144	SENT16	0	0	26	26	taurine	HO-1	PA451590	3162	0.931
NULL	Acta_Pharmacol_Sin_2012_May_26_33(5)_675-681.nxml.txt.nlp	22447226	SENT129	11	11	37	37	gefitinib	PLK1	PA131301952	5347	0.931
NULL	Oncoscience_2014_Mar_12_1(2)_167-179.nxml.txt.nlp	25126591	SENT248	18	18	42	42	sorafenib	MYC	PA7000	4609	0.931
NULL	Br_J_Cancer_2013_Dec_10_109(12)_3034-3041.nxml.txt.nlp	24178758	SENT142	29	29	16	16	tamoxifen	BiP	PA451581	3309	0.931
NULL	J_Cell_Mol_Med_2014_Dec_7_18(12)_2536-2552.nxml.txt.nlp	25287328	SENT174	13	13	27	27	estradiol	PKD1	PA449503	5310	0.931
NULL	Cell_Commun_Signal_2013_Dec_20_11_97.nxml.txt.nlp	24359404	SENT256	27	27	0	0	sunitinib	PDGF-A	PA162372840	5154	0.931
NULL	Oncotarget_2014_Jun_1_5(13)_4868-4880.nxml.txt.nlp	24947902	SENT265	6	6	18	18	afatinib	CO2	PA165981154	4513	0.931
NULL	Breast_Cancer_Res_2004_Nov_7_6(1)_R24-R30.nxml.txt.nlp	14680497	SENT110	26	26	10	10	fluorouracil	p53	PA128406956	7157	0.931
NULL	Arthritis_Res_Ther_2008_Mar_17_10(2)_R33.nxml.txt.nlp	18346273	SENT140	13	13	3	3	infliximab	HMGB1	PA452639	3146	0.931
NULL	Front_Oncol_2011_Aug_22_1_22.nxml.txt.nlp	22666659	SENT167	3	3	10	10	sorafenib	p38	PA7000	10598;1432;7965	0.931
NULL	Orphanet_J_Rare_Dis_2014_Apr_27_9_61.nxml.txt.nlp	24767411	SENT42	4	4	22	22	diflunisal	TTR	PA449313	7276	0.931
NULL	J_Neuroinflammation_2011_Aug_5_8_91.nxml.txt.nlp	21819568	SENT167	6	6	27	27	pioglitazone	ANOVA	PA450970	4858	0.931
NULL	J_Hematol_Oncol_2012_Sep_16_5_55.nxml.txt.nlp	22980425	SENT132	6	6	21	21	flavopiridol	p53	PA452627	7157	0.931
NULL	Arch_Med_Sci_2012_Nov_9_8(5)_907-917.nxml.txt.nlp	23185203	SENT117	5	5	20	20	metformin	ghrelin	PA450395	51738	0.931
NULL	Cancers_(Basel)_2013_Nov_11_5(4)_1522-1544.nxml.txt.nlp	24351670	SENT193	18	18	8	8	etoposide	CD9	PA449552	928	0.931
NULL	Clin_Drug_Investig_2014_Nov_9_34(2)_107-115.nxml.txt.nlp	24214232	SENT58	25	25	7	7	cinacalcet	IMPACT	PA164776671	55364	0.931
NULL	Biomed_Res_Int_2013_Dec_10_2013_565218.nxml.txt.nlp	24386638	SENT245	19	19	1	1	imipramine	DIO2	PA449969	1734	0.931
NULL	J_Cell_Mol_Med_2013_Nov_9_17(11)_1484-1493.nxml.txt.nlp	24015932	SENT8	6	6	9	9	berberine	c-Myc	PA165860812	4609	0.931
NULL	Clin_Ophthalmol_2011_May_24_5_715-719.nxml.txt.nlp	21629579	SENT22	0	0	30	30	bevacizumab	San	PA130232992	80218	0.931
NULL	Respir_Med_Case_Rep_2013_Jul_17_10_10-12.nxml.txt.nlp	NULL	SENT110	11	11	0	0	gefitinib	EGFR	PA131301952	1956	0.931
NULL	Cell_Death_Dis_2013_Oct_3_4(10)_e827.nxml.txt.nlp	24091670	SENT86	0	0	11	11	nilotinib	CD38	PA165958345	952	0.931
NULL	Neuro_Oncol_2010_Apr_27_12(4)_389-400.nxml.txt.nlp	20308316	SENT81	25	25	16	16	chloroquine	p53	PA448948	7157	0.931
NULL	Brain_Behav_2014_Jul_10_4(4)_453-467.nxml.txt.nlp	25161813	SENT62	26	26	11	11	vasopressin	NPFF	PA451858	8620	0.931
NULL	Viruses_2014_Apr_23_6(4)_1861-1875.nxml.txt.nlp	24762393	SENT181	20	20	11	11	paraformaldehyde	CO2	PA450790	4513	0.931
NULL	Oncogene_2014_Sep_11_33(37)_4579-4588.nxml.txt.nlp	24662835	SENT78	48	48	3	3	tamoxifen	MAGEA2	PA451581	4101;266740	0.931
NULL	Acta_Pharmacol_Sin_2009_Jun_5_30(6)_859-867.nxml.txt.nlp	19498425	SENT19	0	0	14	14	carbachol	CA1	PA448784	759	0.931
NULL	Cancer_Cell_Int_2005_Aug_24_5_28.nxml.txt.nlp	16120219	SENT63	2	2	9	9	etoposide	p53	PA449552	7157	0.931
NULL	Cell_Death_Dis_2014_Jul_3_5(7)_e1316.nxml.txt.nlp	24991768	SENT47	25	25	31	31	pemetrexed	ATF4	PA10810	468	0.931
NULL	Mol_Cancer_2012_Jul_25_11_47.nxml.txt.nlp	22830443	SENT144	39	39	3	3	panitumumab	EGFR	PA162373091	1956	0.931
NULL	Oncotarget_2014_Aug_19_5(18)_8737-8749.nxml.txt.nlp	25228590	SENT148	7	7	18	18	crizotinib	MYCN	PA165946122	4613	0.931
NULL	Diabetologia_2010_Dec_19_53(12)_2621-2628.nxml.txt.nlp	20853098	SENT268	6	6	15	15	lactulose	HLA-DQB1	PA164748762	3119	0.931
NULL	Int_J_Mol_Sci_2014_Nov_10_15(11)_20607-20637.nxml.txt.nlp	25391045	SENT70	4	4	27	27	rosuvastatin	OATP1C1	PA134308647	53919	0.931
NULL	J_Cardiothorac_Surg_2013_Mar_15_8_47.nxml.txt.nlp	23497403	SENT53	17	17	28	28	protamine	ACT	PA10366	12;11332;9457;641455	0.931
NULL	Cell_Commun_Signal_2009_Sep_8_7_22.nxml.txt.nlp	19737390	SENT451	42	42	40	40	gefitinib	EGFR	PA131301952	1956	0.931
NULL	Oncotarget_2013_Oct_27_4(11)_2080-2095.nxml.txt.nlp	24231268	SENT216	40	40	13	13	nutlin-3	MDM2		4193	0.931
NULL	Cells_2014_May_23_3(2)_517-545.nxml.txt.nlp	24861977	SENT245	16	16	21	21	capsaicin	TRPV1	PA448776	7442	0.931
NULL	Breast_Cancer_Res_2011_Mar_10_13(2)_R28.nxml.txt.nlp	21392397	SENT201	5	5	11	11	erlotinib	YB-1	PA134687924	4904	0.931
NULL	Cancer_Cell_Int_2010_Apr_29_10_12.nxml.txt.nlp	20429927	SENT193	20	20	39	39	bortezomib	HRI	PA10252	27102	0.931
NULL	Arthritis_Res_Ther_2009_Feb_3_11(1)_R15.nxml.txt.nlp	19192274	SENT223	18	18	30	30	diclofenac	IL-6	PA449293	3569	0.931
NULL	Lab_Invest_2011_Jun_28_91(6)_955-967.nxml.txt.nlp	21445059	SENT43	28	28	17	17	paclitaxel	DES	PA450761	1674	0.931
NULL	Asian_J_Androl_2014_Mar_18_May-Jun_16(3)_426-431.nxml.txt.nlp	24675654	SENT245	6	6	11	11	docetaxel	CYP17A1	PA449383	1586	0.931
NULL	Clin_Transl_Allergy_2013_May_3_3(Suppl_1)_P1.nxml.txt.nlp	NULL	SENT20	2	2	21	21	omalizumab	SAA	PA164752253	6287	0.931
NULL	Cell_Death_Dis_2014_Jul_3_5(7)_e1316.nxml.txt.nlp	24991768	SENT47	25	25	33	33	pemetrexed	ATF3	PA10810	467	0.931
NULL	Oncotarget_2013_Dec_28_5(6)_1475-1490.nxml.txt.nlp	24721996	SENT208	4	4	7	7	celecoxib	CD31	PA448871	5175	0.931
NULL	Curr_Gerontol_Geriatr_Res_2010_Mar_3_2010_927503.nxml.txt.nlp	20204184	SENT60	28	28	10	10	cyclophosphamide	FVIII	PA449165	2157	0.931
NULL	Oncotarget_2012_Aug_10_3(8)_744-758.nxml.txt.nlp	22889873	SENT46	35	35	28	28	trastuzumab	HER2	PA451743	2064	0.931
NULL	Biologics_2014_Apr_23_8_183-192.nxml.txt.nlp	24790411	SENT155	3	3	14	14	afatinib	EGFR	PA165981154	1956	0.931
NULL	EMBO_Mol_Med_2010_Mar_2(3)_98-110.nxml.txt.nlp	20201032	SENT322	8	8	22	22	imatinib	Bcl-2	PA10804	596	0.931
NULL	Exp_Ther_Med_2013_Nov_6_6(5)_1089-1095.nxml.txt.nlp	24223627	SENT32	11	11	2	2	epirubicin	NAC	PA449476	22861	0.931
NULL	J_Biol_Chem_2009_Sep_25_284(39)_26447-26455.nxml.txt.nlp	19633293	SENT17	18	18	6	6	hyaluronan	HAS1	PA165958431	3036	0.931
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Aug_3_69(Pt_9)_o1376.nxml.txt.nlp	24427020	SENT77	15	15	34	34	ethanol	mol	PA448073	90527	0.931
NULL	Cancer_Biol_Med_2012_Mar_9(1)_18-22.nxml.txt.nlp	23691449	SENT79	11	11	19	19	gefitinib	KRAS	PA131301952	3845	0.931
NULL	Breast_Cancer_Res_2010_Jun_24_12(3)_R41.nxml.txt.nlp	20576088	SENT135	28	28	0	0	paclitaxel	CASP3	PA450761	836	0.931
NULL	Arch_Med_Sci_2013_Aug_30_9(4)_739-744.nxml.txt.nlp	24049538	SENT122	25	25	21	21	candesartan	PC-3	PA448765	692094	0.931
NULL	Curr_Gerontol_Geriatr_Res_2010_Jun_20_2010_348174.nxml.txt.nlp	20672050	SENT32	0	0	8	8	gefitinib	EGFR	PA131301952	1956	0.931
NULL	Mol_Vis_2012_Apr_11_18_901-908.nxml.txt.nlp	22539869	SENT209	19	19	12	12	curcumin	HO-1	PA151958596	3162	0.931
NULL	ScientificWorldJournal_2013_Sep_21_2013_208309.nxml.txt.nlp	24170980	SENT145	24	24	17	17	lenalidomide	MRP8	PA162363968	6833;6279;85320	0.931
NULL	Nature_2008_Oct_23_455(7216)_1076-1081.nxml.txt.nlp	18948948	SENT10	18	18	8	8	staurosporine	BAX	PA165109623	581	0.931
NULL	Biomed_Res_Int_2014_Feb_13_2014_309151.nxml.txt.nlp	24683546	SENT6	19	19	21	21	rosiglitazone	STZ	PA451283	6484	0.931
NULL	Aust_N_Z_J_Psychiatry_2011_Sep_3_45(9)_712-725.nxml.txt.nlp	21888608	SENT285	28	28	6	6	warfarin	CYP1A2	PA451906	1544	0.931
NULL	Arthritis_Res_Ther_2008_Sep_24_10(5)_R115.nxml.txt.nlp	18816401	SENT178	39	39	13	13	etanercept	BMP7	PA449515	655	0.931
NULL	J_Exp_Clin_Cancer_Res_2009_Jan_7_28(1)_3.nxml.txt.nlp	19128503	SENT101	17	17	8	8	doxorubicin	PTEN	PA449412	5728	0.931
NULL	Br_J_Cancer_2011_Jul_26_105(3)_372-381.nxml.txt.nlp	21730979	SENT32	5	5	2	2	caffeine	ATR	PA448710	390502;84168;545	0.931
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_7-17.nxml.txt.nlp	17912633	SENT376	37	37	31	31	exemestane	AMH	PA449563	268	0.931
NULL	Clin_Med_Insights_Oncol_2013_Jun_3_7_103-122.nxml.txt.nlp	23843721	SENT139	32	32	10	10	trastuzumab	PTEN	PA451743	5728	0.931
NULL	Acta_Histochem_Cytochem_2012_Apr_26_45(2)_139-146.nxml.txt.nlp	22685356	SENT111	28	28	2	2	forskolin	AQP2	PA146096022	359	0.931
NULL	Breast_Cancer_Res_2010_Jun_24_12(3)_R41.nxml.txt.nlp	20576088	SENT264	19	19	3	3	paclitaxel	SP1	PA450761	6667	0.931
NULL	Ann_Dermatol_2014_Aug_31_26(4)_517-520.nxml.txt.nlp	25143685	SENT27	23	23	3	3	tazarotene	Bcl-2	PA164746821	596	0.931
NULL	Adv_Pharmacol_Sci_2014_Apr_7_2014_483051.nxml.txt.nlp	24803925	SENT159	0	0	22	22	ethanol	IL-6	PA448073	3569	0.931
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1224-1233.nxml.txt.nlp	22353810	SENT13	6	6	19	19	doxorubicin	MRP-1	PA449412	928	0.931
NULL	Breast_Cancer_Res_Treat_2013_Aug_20_141(1)_43-53.nxml.txt.nlp	23959396	SENT201	35	35	23	23	trastuzumab	HER3	PA451743	2065	0.931
NULL	Acta_Pharmacol_Sin_2014_Jun_5_35(6)_727-737.nxml.txt.nlp	24793312	SENT217	6	6	1	1	telmisartan	AT1	PA451605	9197;185	0.931
NULL	Br_J_Cancer_2010_Mar_2_102(5)_815-826.nxml.txt.nlp	20145614	SENT160	2	2	23	23	trastuzumab	HER3	PA451743	2065	0.931
NULL	Nat_Commun_2014_Jun_20_5_4122.nxml.txt.nlp	24947823	SENT197	13	13	1	1	capsaicin	TRPV1	PA448776	7442	0.931
NULL	Curr_Chem_Genomics_2010_Mar_1_4_1-8.nxml.txt.nlp	20448812	SENT28	24	24	14	14	methotrexate	OATP1B3	PA450428	28234	0.931
NULL	Int_J_Mol_Sci_2014_May_8_15(5)_8106-8121.nxml.txt.nlp	24815071	SENT55	28	28	21	21	atorvastatin	SQSTM1	PA448500	8878	0.931
NULL	Basic_Clin_Pharmacol_Toxicol_2013_Feb_5_112(2)_132-137.nxml.txt.nlp	22900583	SENT23	29	29	39	39	atorvastatin	CYP3A	PA448500	1574	0.931
NULL	Exp_Diabetes_Res_2012_Oct_15_2012_465282.nxml.txt.nlp	23118742	SENT110	16	16	12	12	metformin	FGF21	PA450395	26291	0.931
NULL	Cancer_Med_2014_Feb_10_3(1)_134-142.nxml.txt.nlp	24407937	SENT182	13	13	17	17	tamoxifen	HER2	PA451581	2064	0.931
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT15	23	23	8	8	sulindac	survivin	PA451565	332	0.931
NULL	BMJ_Open_2014_Feb_27_4(2)_e004071.nxml.txt.nlp	24578536	SENT19	14	14	2	2	warfarin	TTR	PA451906	7276	0.931
NULL	J_Immunother_2014_Feb_21_37(2)_105-114.nxml.txt.nlp	24509173	SENT169	19	19	14	14	gemcitabine	WT1	PA449748	7490	0.931
NULL	Cell_Res_2013_Jul_21_23(7)_915-930.nxml.txt.nlp	23689279	SENT99	3	3	12	12	ethanol	ALDH2	PA448073	217	0.931
NULL	Biomed_Res_Int_2014_Feb_27_2014_214587.nxml.txt.nlp	24716192	SENT141	11	11	27	27	atorvastatin	LPA	PA448500	4018	0.931
NULL	Int_J_Mol_Sci_2012_Feb_24_13(3)_2578-2589.nxml.txt.nlp	22489112	SENT64	8	8	35	35	amitriptyline	GAT1	PA448385	6529	0.931
NULL	Arthritis_Res_Ther_2011_Feb_15_13(1)_R24.nxml.txt.nlp	21324111	SENT216	0	0	28	28	etanercept	M-CSF	PA449515	1435	0.931
NULL	Br_J_Cancer_2010_Jun_29_103(1)_61-72.nxml.txt.nlp	20588279	SENT273	18	18	8	8	trastuzumab	PTEN	PA451743	5728	0.931
NULL	Biomed_Res_Int_2014_Jun_3_2014_463895.nxml.txt.nlp	24995297	SENT19	0	0	6	6	atorvastatin	BCS	PA448500	617	0.931
NULL	Viruses_2014_Oct_23_6(10)_4024-4046.nxml.txt.nlp	25341665	SENT201	2	2	23	23	heparin	p85	PA449855	5296;5295;54776;23368	0.931
NULL	Eur_J_Clin_Pharmacol_2014_Oct_8_70(12)_1433-1441.nxml.txt.nlp	25291992	SENT111	22	22	3	3	risperidone	FES	PA451257	2242	0.931
NULL	J_Oncol_2009_Mar_24_2009_491985.nxml.txt.nlp	19325924	SENT80	5	5	12	12	genistein	CXCL12	PA165109660	6387	0.931
NULL	Nucleic_Acids_Res_2013_Nov_16_41(20)_9349-9360.nxml.txt.nlp	23956219	SENT184	10	10	34	34	cisplatin	OB1	PA449014	84525	0.931
NULL	Clin_Med_Insights_Circ_Respir_Pulm_Med_2013_Nov_13_7_61-77.nxml.txt.nlp	24324354	SENT164	13	13	28	28	tobramycin	TIP	PA451704	81533;79828	0.931
NULL	Oncol_Rep_2013_May_21_29(5)_1721-1729.nxml.txt.nlp	23440494	SENT21	22	22	7	7	melphalan	FANCF	PA450354	2188	0.931
NULL	Nat_Med_2013_Mar_3_19(3)_295-304.nxml.txt.nlp	23377280	SENT82	39	39	5	5	erlotinib	EGFR	PA134687924	1956	0.931
NULL	Aliment_Pharmacol_Ther_2012_Apr_22_35(7)_745-767.nxml.txt.nlp	22356640	SENT10	8	8	2	2	tegaserod	5-HT4	PA130413154	3360	0.931
NULL	J_Adv_Pract_Oncol_2014_Jan_1_Jan-Feb_5(1)_47-50.nxml.txt.nlp	25032033	SENT44	8	8	4	4	ketoconazole	CYP3A4	PA450146	1576	0.931
NULL	J_Exp_Med_2003_Aug_4_198(3)_411-421.nxml.txt.nlp	12900517	SENT208	9	9	16	16	rosiglitazone	IL-5	PA451283	3567	0.931
NULL	Arthritis_Res_Ther_2011_Jun_21_13(3)_R98.nxml.txt.nlp	21693018	SENT245	0	0	14	14	tiludronate	ACL	PA451688	47	0.931
NULL	Oncogene_2009_Apr_2_28(13)_1616-1625.nxml.txt.nlp	19219073	SENT51	27	27	47	47	etoposide	p53	PA449552	7157	0.931
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT703	18	18	8	8	tamoxifen	CD24	PA451581	100133941	0.931
NULL	Cancer_Cell_Int_2005_Jul_24_5_22.nxml.txt.nlp	16042792	SENT168	8	8	39	39	vincristine	CO2	PA451879	4513	0.931
NULL	Br_J_Anaesth_2014_Jul_22_113(1)_157-167.nxml.txt.nlp	24154701	SENT260	4	4	12	12	sevoflurane	TREK-1	PA451341	3776	0.931
NULL	Breast_Cancer_Res_2014_Dec_19_16(6)_499.nxml.txt.nlp	25522654	SENT194	30	30	20	20	estradiol	CYP19A1	PA449503	1588	0.931
NULL	Neuropsychopharmacology_2009_Nov_5_34(12)_2560-2573.nxml.txt.nlp	19657330	SENT143	37	37	4	4	ethanol	CB1	PA448073	1268	0.931
NULL	Br_J_Cancer_2012_Feb_14_106(4)_685-692.nxml.txt.nlp	22294184	SENT196	10	10	28	28	lovastatin	p38	PA450272	10598;1432;7965	0.931
NULL	Front_Neurol_2012_Feb_28_3_4.nxml.txt.nlp	22403566	SENT61	10	10	25	25	isoflurane	CO2	PA450106	4513	0.931
NULL	Acta_Pharmacol_Sin_2009_Jul_22_30(7)_956-964.nxml.txt.nlp	19543298	SENT182	12	12	3	3	simvastatin	SLC22A1	PA451363	6580	0.931
NULL	EJC_Suppl_2013_Sep_5_11(2)_307-309.nxml.txt.nlp	NULL	SENT50	8	8	20	20	afatinib	EGFR	PA165981154	1956	0.931
NULL	Nat_Genet_2013_May_31_45(5)_531-536.nxml.txt.nlp	23542698	SENT79	15	15	5	5	eculizumab	DGKE	PA164776637	8526	0.931
NULL	Cell_Death_Dis_2012_Mar_1_3(3)_e275.nxml.txt.nlp	22378068	SENT194	18	18	6	6	metformin	CD34	PA450395	947	0.931
NULL	Front_Genet_2014_Feb_26_5_40.nxml.txt.nlp	24616734	SENT317	13	13	20	20	docetaxel	PRKCA	PA449383	5578	0.931
NULL	Arthritis_Res_Ther_2004_Feb_24_6(Suppl_1)_24.nxml.txt.nlp	NULL	SENT15	23	23	4	4	etanercept	OPGL	PA449515	8600	0.931
NULL	Br_J_Cancer_2014_Nov_25_111(11)_2091-2102.nxml.txt.nlp	25349971	SENT152	16	16	9	9	imatinib	KIT	PA10804	3815	0.931
NULL	Allergy_Asthma_Immunol_Res_2009_Oct_25_1(1)_30-35.nxml.txt.nlp	20224667	SENT27	17	17	6	6	aspirin	PPARG	PA448497	5468	0.931
NULL	Oncogenesis_2014_Dec_15_3(12)_e133.nxml.txt.nlp	25500906	SENT78	8	8	24	24	trastuzumab	PDPK1	PA451743	5170	0.931
NULL	Nucleic_Acids_Res_2005_Jun_9_33(10)_3323-3330.nxml.txt.nlp	15947132	SENT15	19	19	4	4	cisplatin	MSH2	PA449014	4436	0.931
NULL	Oncoimmunology_2012_Aug_1_1(5)_618-629.nxml.txt.nlp	22934254	SENT192	20	20	27	27	nilotinib	CD19	PA165958345	930	0.931
NULL	Br_J_Cancer_2013_May_28_108(10)_2039-2044.nxml.txt.nlp	23652306	SENT82	26	26	3	3	tamoxifen	SRC3	PA451581	8202	0.931
NULL	J_Immunol_Res_2014_May_12_2014_897249.nxml.txt.nlp	24901013	SENT106	22	22	1	1	natalizumab	ANOVA	PA164747191	4858	0.931
NULL	Ann_Oncol_2014_Oct_23_25(10)_1941-1948.nxml.txt.nlp	25057173	SENT15	27	27	3	3	docetaxel	KRAS	PA449383	3845	0.931
NULL	J_Hematol_Oncol_2013_Jul_18_6_53.nxml.txt.nlp	23866964	SENT56	41	41	8	8	temsirolimus	LC3	PA164746890	84557	0.931
NULL	Cardiovasc_Intervent_Radiol_2014_Jan_9_37(3)_763-769.nxml.txt.nlp	24402644	SENT50	23	23	45	45	heparin	ACT	PA449855	12;11332;9457;641455	0.931
NULL	Oncotarget_2013_Aug_21_4(9)_1484-1495.nxml.txt.nlp	23986086	SENT166	31	31	6	6	cetuximab	PIK3CA	PA10040	5290	0.931
NULL	Br_J_Cancer_2010_Nov_9_103(11)_1692-1697.nxml.txt.nlp	21063402	SENT64	32	32	25	25	doxycycline	TRAIL	PA449415	8743	0.931
NULL	Breast_Cancer_Res_2010_Oct_22_12(Suppl_2)_S1.nxml.txt.nlp	21050422	SENT208	3	3	32	32	pertuzumab	HER2		2064	0.931
NULL	Br_J_Cancer_2012_Jun_5_106(12)_1960-1966.nxml.txt.nlp	22596237	SENT125	10	10	23	23	saracatinib	PC3		57332;7832;5122	0.931
NULL	Am_J_Cardiovasc_Drugs_2013_Jun_20_13(5)_331-342.nxml.txt.nlp	23784266	SENT183	14	14	21	21	dronedarone	P-gp	PA153619853	5243	0.931
NULL	Drug_Des_Devel_Ther_2014_Oct_16_8_1929-1939.nxml.txt.nlp	25342886	SENT142	31	31	23	23	doxycycline	HPRT1	PA449415	3251	0.931
NULL	BMB_Rep_2014_Nov_47(11)_649-654.nxml.txt.nlp	25301019	SENT161	19	19	36	36	l-serine	CCL2	PA451330	6347	0.931
NULL	eLife_2014_May_6_3_e02482.nxml.txt.nlp	24843002	SENT540	4	4	22	22	etoposide	SETD2	PA449552	29072	0.931
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S279-S284.nxml.txt.nlp	21525469	SENT136	34	34	5	5	exenatide	GLP-1	PA164749238	100125288	0.931
NULL	J_Hematol_Oncol_2010_Apr_9_3_14.nxml.txt.nlp	20377918	SENT13	27	27	15	15	imatinib	IFN	PA10804	3439	0.931
NULL	Biomed_Res_Int_2014_Feb_26_2014_236930.nxml.txt.nlp	24719848	SENT221	16	16	18	18	fenoldopam	NAC	PA164784034	22861	0.931
NULL	Mol_Biol_Cell_2012_Nov_1_23(21)_4212-4225.nxml.txt.nlp	22956765	SENT161	18	18	0	0	thrombin	SHP2	PA451674	5781	0.931
NULL	J_Oral_Pathol_Med_2013_Jul_18_42(6)_499-506.nxml.txt.nlp	23331485	SENT66	22	22	7	7	celecoxib	COX	PA448871	1351	0.931
NULL	Cancer_Cell_Int_2010_Sep_1_10_30.nxml.txt.nlp	20809984	SENT37	14	14	19	19	hydrocortisone	EGF	PA449905	1950	0.931
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Nov_29_64(Pt_12)_o2496.nxml.txt.nlp	21581457	SENT73	37	37	19	19	ethanol	mol	PA448073	90527	0.931
NULL	Drugs_R_D_2010_Nov_25_10(4)_219-224.nxml.txt.nlp	21171668	SENT18	29	29	5	5	ticlopidine	P2Y12	PA451686	64805	0.931
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Oct_7_65(Pt_11)_o2667.nxml.txt.nlp	21578277	SENT83	29	29	6	6	ethanol	mol	PA448073	90527	0.931
NULL	J_Breast_Cancer_2013_Jun_28_16(2)_133-137.nxml.txt.nlp	23843843	SENT58	4	4	14	14	curcumin	PRL-3	PA151958596	11156	0.931
NULL	Biologics_2014_Dec_4_8_281-291.nxml.txt.nlp	25506209	SENT112	26	26	23	23	vemurafenib	BRAF	PA165946873	673	0.931
NULL	Front_Oncol_2014_Nov_10_4_318.nxml.txt.nlp	25426449	SENT111	0	0	31	31	perifosine	AKT	PA165291471	207	0.931
NULL	Environ_Health_Perspect_1990_Apr_85_89-94.nxml.txt.nlp	2384071	SENT8	12	12	6	6	methylprednisolone	NAC	PA450466	22861	0.931
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT83	8	8	15	15	curcumin	DR4	PA151958596	8797	0.931
NULL	Curr_Pain_Headache_Rep_2011_Aug_12_15(4)_271-279.nxml.txt.nlp	21479998	SENT162	21	21	3	3	quinidine	CYP2D6	PA451209	1565	0.931
NULL	Diabetes_2011_May_23_60(5)_1493-1503.nxml.txt.nlp	21478464	SENT23	29	29	4	4	metformin	AMPK	PA450395	5563	0.931
NULL	Oncotarget_2013_Nov_4_5(1)_161-172.nxml.txt.nlp	24389287	SENT119	10	10	17	17	propranolol	p53	PA451145	7157	0.931
NULL	Oncotarget_2014_Jun_30_5(12)_4011-4025.nxml.txt.nlp	24994117	SENT112	12	12	3	3	estradiol	AREG	PA449503	374	0.931
NULL	Br_J_Cancer_2013_Dec_10_109(12)_3067-3072.nxml.txt.nlp	24263065	SENT39	24	24	14	14	irinotecan	BRAF	PA450085	673	0.931
NULL	Chin_J_Cancer_2011_May_30(5)_327-335.nxml.txt.nlp	21527065	SENT183	12	12	17	17	capecitabine	PIK3CA	PA448771	5290	0.931
NULL	Oncogene_2013_Sep_12_32(37)_4355-4365.nxml.txt.nlp	23108409	SENT74	30	30	4	4	hyaluronan	HAS2	PA165958431	3037	0.931
NULL	Cancer_Metastasis_Rev_2010_Sep_24_29(3)_465-482.nxml.txt.nlp	20730632	SENT267	5	5	9	9	genistein	MEK4	PA165109660	6416	0.931
NULL	Emerg_Infect_Dis_2011_Oct_17(10)_1971-1973.nxml.txt.nlp	22000391	SENT22	25	25	7	7	vancomycin	API	PA451850	5345	0.931
NULL	Nucleic_Acids_Res_2013_Nov_27_41(21)_9786-9799.nxml.txt.nlp	23982513	SENT118	17	17	26	26	arsenite	TIAR	PA452638	7073	0.931
NULL	Lipids_Health_Dis_2011_Jan_28_10_25.nxml.txt.nlp	21272376	SENT32	14	14	32	32	scopolamine	spatial	PA451308	219793	0.931
NULL	J_Immunother_Cancer_2013_Dec_16_1_21.nxml.txt.nlp	24829757	SENT11	37	37	28	28	temozolomide	miR-17-92	PA451609	407975	0.931
NULL	Ann_Dermatol_2014_Aug_31_26(4)_517-520.nxml.txt.nlp	25143685	SENT38	41	41	24	24	tazarotene	Bcl-2	PA164746821	596	0.931
NULL	Mol_Cancer_2014_Jan_13_13_7.nxml.txt.nlp	24418169	SENT11	31	31	25	25	sorafenib	survivin	PA7000	332	0.931
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Aug_30_70(Pt_9)_153-156.nxml.txt.nlp	25309166	SENT47	30	30	7	7	nitrile	mol	PA450636	90527	0.931
NULL	Arch_Drug_Inf_2011_Mar_4(1)_1-9.nxml.txt.nlp	21572514	SENT156	5	5	16	16	cyclosporine	PEPT1	PA449167	6564	0.931
NULL	J_Immunother_Cancer_2013_Nov_7_1(Suppl_1)_P252.nxml.txt.nlp	NULL	SENT18	9	9	17	17	doxorubicin	CD86	PA449412	942	0.931
NULL	Drugs_2014_Jul_18_74(11)_1209-1231.nxml.txt.nlp	25034361	SENT59	16	16	1	1	dronedarone	P-gp	PA153619853	5243	0.931
NULL	Cell_Death_Dis_2011_Aug_11_2(8)_e191.nxml.txt.nlp	21833029	SENT12	21	21	4	4	oxaliplatin	CT26	PA131285527	168400	0.931
NULL	Breast_Cancer_Res_2011_Nov_1_13(6)_224.nxml.txt.nlp	22114931	SENT131	6	6	14	14	trastuzumab	TORC1	PA451743	23373	0.931
NULL	Nucleic_Acids_Res_2013_Nov_27_41(21)_9786-9799.nxml.txt.nlp	23982513	SENT150	17	17	26	26	arsenite	TIAR	PA452638	7073	0.931
NULL	Biomed_Res_Int_2014_Jan_2_2014_126586.nxml.txt.nlp	24527434	SENT150	16	16	20	20	metformin	CD133	PA450395	8842	0.931
NULL	Epigenetics_Chromatin_2014_Jan_20_7_2.nxml.txt.nlp	24443974	SENT87	23	23	4	4	protamine	PRM1	PA10366	5619	0.931
NULL	Tuberc_Respir_Dis_(Seoul)_2014_Nov_28_77(5)_227-229.nxml.txt.nlp	25473412	SENT59	29	29	4	4	clarithromycin	RGM	PA449028	56963	0.931
NULL	Mol_Cancer_2009_Mar_20_8_21.nxml.txt.nlp	19298677	SENT91	4	4	36	36	curcumin	IL-2	PA151958596	3558	0.931
NULL	Biol_Open_2014_Nov_13_3(12)_1164-1172.nxml.txt.nlp	25395667	SENT226	10	10	34	34	capsaicin	TRPV1	PA448776	7442	0.931
NULL	Oncogene_2014_Feb_6_33(6)_713-723.nxml.txt.nlp	23435429	SENT64	31	31	8	8	camptothecin	p65	PA153590860	5970	0.931
NULL	Evid_Based_Complement_Alternat_Med_2014_Jan_8_2014_976364.nxml.txt.nlp	24527057	SENT180	29	29	18	18	oseltamivir	JNK	PA450721	5599	0.931
NULL	Cancer_Med_2014_Oct_2_3(5)_1256-1265.nxml.txt.nlp	24890382	SENT147	37	37	9	9	rituximab	HER2	PA451261	2064	0.931
NULL	Cancers_(Basel)_2010_Aug_19_2(3)_1629-1641.nxml.txt.nlp	24281178	SENT116	5	5	18	18	gemcitabine	CD133	PA449748	8842	0.931
NULL	Iran_J_Reprod_Med_2012_Jan_10(1)_29-32.nxml.txt.nlp	25242971	SENT38	0	0	4	4	letrozole	aromatase	PA450196	1588	0.931
NULL	Hum_Genomics_Proteomics_2010_Sep_13_2010_754919.nxml.txt.nlp	20981234	SENT92	24	24	0	0	phenprocoumon	CYP3A4	PA450921	1576	0.931
NULL	Leukemia_2013_Jan_11_27(1)_32-40.nxml.txt.nlp	22781593	SENT112	26	26	40	40	dasatinib	FGFR1	PA162372878	2260	0.931
NULL	J_Cell_Mol_Med_2014_May_14_18(5)_811-823.nxml.txt.nlp	24628949	SENT261	14	14	10	10	docetaxel	FOXM1	PA449383	2305	0.931
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1522-1532.nxml.txt.nlp	21997136	SENT199	31	31	28	28	irinotecan	EGFR	PA450085	1956	0.931
NULL	Diabetes_Metab_J_2013_Feb_15_37(1)_22-29.nxml.txt.nlp	23441053	SENT109	10	10	25	25	capsaicin	TRPV1	PA448776	7442	0.931
NULL	Case_Rep_Dermatol_2011_Oct_11_3(3)_223-227.nxml.txt.nlp	22135629	SENT65	8	8	16	16	trastuzumab	HER2	PA451743	2064	0.931
NULL	Acta_Pharmacol_Sin_2011_Jul_9_32(7)_879-887.nxml.txt.nlp	21552292	SENT11	19	19	23	23	metformin	AMPK	PA450395	5563	0.931
NULL	Br_J_Cancer_2012_May_8_106(10)_1618-1625.nxml.txt.nlp	22531635	SENT36	9	9	11	11	tamoxifen	aromatase	PA451581	1588	0.931
NULL	Mol_Cancer_2010_May_3_9_99.nxml.txt.nlp	20438634	SENT61	5	5	7	7	genistein	IL6	PA165109660	3569	0.931
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1059-1066.nxml.txt.nlp	21364577	SENT10	14	14	31	31	letrozole	aromatase	PA450196	1588	0.931
NULL	Cell_Res_2013_Jul_21_23(7)_915-930.nxml.txt.nlp	23689279	SENT150	1	1	12	12	ethanol	ALDH2	PA448073	217	0.931
NULL	J_RNAi_Gene_Silencing_2010_May_29_6(1)_386-400.nxml.txt.nlp	20628499	SENT237	8	8	4	4	flavopiridol	ACH2	PA452627	641371	0.931
NULL	Front_Endocrinol_(Lausanne)_2014_Oct_27_5_163.nxml.txt.nlp	25386163	SENT283	8	8	25	25	olanzapine	ghrelin	PA450688	51738	0.931
NULL	Evid_Based_Complement_Alternat_Med_2011_Feb_14_2011_248231.nxml.txt.nlp	19233878	SENT290	29	29	19	19	rosiglitazone	DBT	PA451283	1629	0.931
NULL	Arch_Med_Sci_2011_Feb_8_7(1)_27-33.nxml.txt.nlp	22291729	SENT147	4	4	0	0	rituximab	CHOP	PA451261	1649	0.931
NULL	Br_J_Pharmacol_2014_Feb_24_171(1)_1019-1032.nxml.txt.nlp	24251620	SENT279	35	35	9	9	nifedipine	TRPM3	PA450631	80036	0.931
NULL	Hum_Genomics_2009_Jan_1_3(2)_103-105.nxml.txt.nlp	19164087	SENT49	31	31	5	5	ethanol	ADH4	PA448073	127	0.931
NULL	Biomed_Res_Int_2013_Jul_15_2013_386074.nxml.txt.nlp	23956980	SENT27	3	3	10	10	clopidogrel	P2Y12	PA449053	64805	0.931
NULL	Gene_Regul_Syst_Bio_2014_Mar_4_8_63-73.nxml.txt.nlp	24634581	SENT121	2	2	6	6	minocycline	NANOS1	PA450519	340719	0.931
NULL	Case_Rep_Otolaryngol_2013_Dec_15_2013_918132.nxml.txt.nlp	24396622	SENT77	28	28	24	24	doxorubicin	CHOP	PA449412	1649	0.931
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Sep_30_66(Pt_10)_o2685.nxml.txt.nlp	21587653	SENT57	19	19	7	7	ethanol	mol	PA448073	90527	0.931
NULL	Int_J_Mol_Sci_2014_Mar_20_15(3)_4965-4976.nxml.txt.nlp	24658440	SENT70	24	24	4	4	infliximab	P-gp	PA452639	5243	0.931
NULL	Acta_Pharmacol_Sin_2010_Oct_13_31(10)_1381-1388.nxml.txt.nlp	20835263	SENT211	27	27	15	15	losartan	AT1	PA450268	9197;185	0.931
NULL	AAPS_J_2011_Jun_1_13(3)_405-416.nxml.txt.nlp	21630127	SENT252	25	25	20	20	simvastatin	CYP2C19	PA451363	1557	0.931
NULL	Cancer_Cell_Int_2006_Jan_25_6_1.nxml.txt.nlp	16436212	SENT118	17	17	1	1	trypsin	U87	PA451806	677775;641648	0.931
NULL	Ann_Hematol_2014_Apr_1_93(8)_1371-1380.nxml.txt.nlp	24687382	SENT27	5	5	16	16	lenalidomide	CRBN	PA162363968	51185	0.931
NULL	Arthritis_Res_Ther_2008_Jan_7_10(1)_R1.nxml.txt.nlp	18179697	SENT214	6	6	11	11	oxaliplatin	HMGB1	PA131285527	3146	0.931
NULL	Cancer_Metastasis_Rev_2010_Dec_10_29(4)_581-594.nxml.txt.nlp	20830503	SENT93	35	35	4	4	tamoxifen	TTR	PA451581	7276	0.931
NULL	J_Mol_Signal_2012_Aug_16_7_12.nxml.txt.nlp	22898329	SENT247	20	20	0	0	imiquimod	NOXA	PA449972	5366	0.931
NULL	Crit_Care_2012_Jul_26_16(4)_228.nxml.txt.nlp	22839302	SENT53	6	6	16	16	prasugrel	P2Y12	PA154410481	64805	0.931
NULL	Diabetes_Care_2013_May_13_36(5)_1368-1376.nxml.txt.nlp	23275363	SENT24	0	0	15	15	exenatide	GLP-1	PA164749238	100125288	0.931
NULL	Osteoporos_Int_2015_Sep_19_26_361-372.nxml.txt.nlp	25236877	SENT137	2	2	25	25	risedronate	PTH	PA451255	5741	0.931
NULL	Evid_Based_Complement_Alternat_Med_2014_Oct_29_2014_594354.nxml.txt.nlp	25530784	SENT6	3	3	31	31	4-methylumbelliferone	UGT	PA154081778	7361;7355	0.931
NULL	J_Hematol_Oncol_2013_Jul_18_6_53.nxml.txt.nlp	23866964	SENT61	20	20	27	27	temsirolimus	LC3	PA164746890	84557	0.931
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1059-1066.nxml.txt.nlp	21364577	SENT170	13	13	7	7	trastuzumab	aromatase	PA451743	1588	0.931
NULL	Indian_J_Med_Paediatr_Oncol_2014_Apr-Jun_35(2)_140-142.nxml.txt.nlp	25197175	SENT18	30	30	18	18	leucovorin	KRAS	PA450198	3845	0.931
NULL	Open_Biol_2014_Jan_4(1)_130138.nxml.txt.nlp	24403013	SENT321	6	6	11	11	etoposide	PP1	PA449552	5540;5464	0.931
NULL	J_Exp_Clin_Cancer_Res_2009_Nov_24_28(1)_144.nxml.txt.nlp	19930704	SENT121	22	22	18	18	doxorubicin	P-gp	PA449412	5243	0.931
NULL	Cell_Death_Differ_2010_Apr_23_17(4)_699-709.nxml.txt.nlp	19851330	SENT312	15	15	30	30	tetracycline	PUMA	PA451640	27113	0.931
NULL	Ann_Gen_Psychiatry_2008_Oct_15_7_19.nxml.txt.nlp	18922171	SENT153	13	13	7	7	bupropion	CD50	PA448687	3385	0.931
NULL	Brain_2013_May_4_136(5)_1462-1475.nxml.txt.nlp	23460667	SENT273	41	41	14	14	bevacizumab	CD133	PA130232992	8842	0.931
NULL	Adv_Biosci_Biotechnol_2013_Oct_1_4(10C)_15-30.nxml.txt.nlp	24558636	SENT296	26	26	31	31	2-methoxyestradiol	HIF-1	PA134967247	29072	0.931
NULL	Orphanet_J_Rare_Dis_2011_Apr_12_6_14.nxml.txt.nlp	21486454	SENT70	21	21	7	7	doxycycline	AAT	PA449415	5265	0.931
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jan_12_67(Pt_2)_o322.nxml.txt.nlp	21523008	SENT61	0	0	26	26	benzaldehyde	mol	PA448571	90527	0.931
NULL	Cancer_Manag_Res_2011_Aug_10_3_273-285.nxml.txt.nlp	21931501	SENT142	1	1	20	20	pazopanib	IFN	PA165291492	3439	0.931
NULL	Korean_J_Anesthesiol_2013_Mar_19_64(3)_251-256.nxml.txt.nlp	23560192	SENT7	37	37	7	7	propofol	BDP	PA451141	10620;152926	0.931
NULL	Br_J_Cancer_2013_Mar_5_108(4)_887-900.nxml.txt.nlp	23462807	SENT126	18	18	5	5	sunitinib	CYP3A4	PA162372840	1576	0.931
NULL	Oncol_Rep_2013_Oct_22_30(4)_1535-1541.nxml.txt.nlp	23877481	SENT149	13	13	31	31	bevacizumab	COX2	PA130232992	4513;5743	0.931
NULL	Clin_Epigenetics_2011_Jun_27_2(2)_171-185.nxml.txt.nlp	21949547	SENT54	31	31	24	24	doxorubicin	P-gp	PA449412	5243	0.931
NULL	Diabetes_Care_2010_Mar_15_33(3)_605-607.nxml.txt.nlp	20009090	SENT103	8	8	13	13	rimonabant	CB1	PA152407999	1268	0.931
NULL	Cardiovasc_Diabetol_2011_Feb_1_10_14.nxml.txt.nlp	21284833	SENT174	29	29	8	8	glucose	adiponectin	PA449773	9370	0.931
NULL	Diabetes_Care_2009_Aug_32(8)_1398-1403.nxml.txt.nlp	19549737	SENT106	18	18	2	2	telmisartan	ANOVA	PA451605	4858	0.931
NULL	Eur_J_Med_Res_2009_Dec_7_14(Suppl_4)_71-77.nxml.txt.nlp	20156730	SENT84	5	5	25	25	tobramycin	PARI	PA451704	55010	0.931
NULL	Clin_Med_Insights_Cardiol_2010_Dec_1_4_117-128.nxml.txt.nlp	21151850	SENT120	7	7	11	11	itraconazole	CYP3A4	PA450132	1576	0.931
NULL	Curr_Oncol_2009_Jul_16(Suppl_2)_S14-S23.nxml.txt.nlp	19672417	SENT134	23	23	2	2	anastrozole	ATAC	PA448432	6375	0.931
NULL	J_Clin_Biochem_Nutr_2010_Sep_3_47(2)_138-147.nxml.txt.nlp	20838569	SENT23	0	0	14	14	loxoprofen	COX	PA166049180	1351	0.931
NULL	Curr_Neuropharmacol_2012_Sep_10(3)_231-238.nxml.txt.nlp	23449756	SENT224	33	33	22	22	paroxetine	5-HT1A	PA450801	3350	0.931
NULL	Br_J_Cancer_2011_Jan_4_104(1)_91-100.nxml.txt.nlp	21139584	SENT156	7	7	5	5	geldanamycin	Hsp90	PA152031327	3320	0.931
NULL	Br_J_Cancer_2010_Feb_2_102(3)_457-461.nxml.txt.nlp	20010942	SENT117	27	27	2	2	gefitinib	EGF	PA131301952	1950	0.931
NULL	Clinics_(Sao_Paulo)_2010_Jun_65(6)_645-646.nxml.txt.nlp	20613942	SENT7	3	3	17	17	orlistat	CEA	PA164776864	5670;1087	0.931
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT42	9	9	18	18	capsaicin	p53	PA448776	7157	0.931
NULL	Mol_Imaging_Radionucl_Ther_2014_Jun_5_23(2)_54-59.nxml.txt.nlp	24963446	SENT54	17	17	0	0	liothyronine	WBS	PA164778866	2006	0.931
NULL	Diabetes_2014_Jan_13_63(1)_39-41.nxml.txt.nlp	24357692	SENT28	11	11	14	14	febuxostat	XOR	PA165958521	7498	0.931
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_May_31_70(Pt_6)_o720.nxml.txt.nlp	24940289	SENT64	14	14	27	27	ethanol	mol	PA448073	90527	0.931
NULL	Curr_Hepat_Rep_2010_May_21_9(2)_75-90.nxml.txt.nlp	20461127	SENT255	9	9	21	21	telbivudine	LAM	PA164760861	7249;7248	0.931
NULL	Breast_Cancer_Res_2011_Mar_1_13(2)_R21.nxml.txt.nlp	21362200	SENT296	40	40	30	30	fulvestrant	PI3K	PA164747170	5290	0.931
NULL	Oncotarget_2011_Mar_7_2(3)_122-134.nxml.txt.nlp	21399234	SENT134	0	0	22	22	erlotinib	EGFR	PA134687924	1956	0.931
NULL	Clin_Interv_Aging_2012_Dec_30_7_1-13.nxml.txt.nlp	22291468	SENT56	6	6	1	1	ketoconazole	CYP3A4	PA450146	1576	0.931
NULL	Hum_Mol_Genet_2008_Jul_15_17(14)_2101-2107.nxml.txt.nlp	18413323	SENT228	4	4	10	10	ezetimibe	NPC1L1	PA10816	29881	0.931
NULL	Int_J_Mol_Sci_2012_Feb_10_13(2)_1886-1918.nxml.txt.nlp	22408430	SENT250	21	21	6	6	sorafenib	AKT	PA7000	207	0.931
NULL	Arthritis_Res_Ther_2011_Mar_14_13(2)_R42.nxml.txt.nlp	21401925	SENT198	39	39	19	19	infliximab	IL6	PA452639	3569	0.931
NULL	Ann_Pediatr_Cardiol_2011_Jan-Jun_4(1)_28-33.nxml.txt.nlp	21677801	SENT56	1	1	15	15	heparin	ACT	PA449855	12;11332;9457;641455	0.931
NULL	Mediators_Inflamm_2011_Jun_7_2011_432080.nxml.txt.nlp	21772662	SENT11	7	7	27	27	rivaroxaban	MCP-1	PA165958360	6347	0.931
NULL	Breast_Cancer_Res_2002_Sep_10_4(6)_218-221.nxml.txt.nlp	12473166	SENT41	14	14	4	4	tamoxifen	ATAC	PA451581	6375	0.931
NULL	Cancer_Cell_Int_2008_Mar_18_8_3.nxml.txt.nlp	18348720	SENT123	14	14	4	4	gefitinib	EGF	PA131301952	1950	0.931
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Nov_19_67(Pt_12)_o3365.nxml.txt.nlp	22199859	SENT64	11	11	3	3	ethanol	mol	PA448073	90527	0.931
NULL	Biol_Proced_Online_2002_Apr_8_3_70-78.nxml.txt.nlp	12734577	SENT136	13	13	16	16	indomethacin	mol	PA449982	90527	0.931
NULL	Ann_Saudi_Med_2009_Sep-Oct_29(5)_402-406.nxml.txt.nlp	19700901	SENT19	13	13	26	26	metronidazole	ISK	PA450484	3753	0.931
NULL	Adv_Ther_2014_Oct_1_31(10)_1045-1058.nxml.txt.nlp	25269854	SENT221	4	4	20	20	olopatadine	IL-8	PA450698	3576	0.931
NULL	J_Vis_Exp_2014_Mar_28_(85)_51300.nxml.txt.nlp	24747269	SENT333	33	33	7	7	thrombin	Rho	PA451674	29984	0.931
NULL	Cancers_(Basel)_2010_Apr_13_2(2)_436-482.nxml.txt.nlp	21297902	SENT475	16	16	7	7	indomethacin	EP3	PA449982	5733	0.931
NULL	Br_J_Cancer_2003_Mar_10_88(5)_788-795.nxml.txt.nlp	12618891	SENT145	10	10	16	16	bosentan	FasL	PA10034	356	0.931
NULL	BMB_Rep_2014_Feb_47(2)_60-68.nxml.txt.nlp	24411465	SENT84	0	0	10	10	efalizumab	LFA-1	PA164748817	3683;3689	0.931
NULL	Biotechnol_Res_Int_2013_Dec_1_2013_253286.nxml.txt.nlp	24363937	SENT38	13	13	21	21	urea	DAP	PA451831	23549;3375;1611	0.931
NULL	Brain_2013_Jul_24_136(7)_2279-2297.nxml.txt.nlp	23801741	SENT168	5	5	0	0	tamoxifen	NRG1	PA451581	3084	0.931
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT139	17	17	5	5	doxorubicin	B7-H1	PA449412	29126	0.931
NULL	Int_J_Biol_Sci_2013_Dec_17_10(1)_64-72.nxml.txt.nlp	24391452	SENT60	17	17	33	33	verapamil	5-HT2B	PA451868	3357	0.931
NULL	Cancer_Inform_2007_Jan_12_3_275-284.nxml.txt.nlp	19455247	SENT248	10	10	37	37	cisplatin	EGFR	PA449014	1956	0.931
NULL	Front_Aging_Neurosci_2009_Nov_27_1_2.nxml.txt.nlp	20552053	SENT1898	31	31	21	21	nimodipine	CA1	PA450633	759	0.931
NULL	Chonnam_Med_J_2011_Aug_31_47(2)_116-121.nxml.txt.nlp	22111071	SENT7	33	33	20	20	mannitol	LPO	PA450320	4025	0.931
NULL	Nat_Biotechnol_2010_May_28(5)_478-485.nxml.txt.nlp	20458318	SENT76	1	1	8	8	cisplatin	NAG	PA449014	51594;4669	0.931
NULL	Diabetes_Metab_J_2013_Feb_15_37(1)_36-39.nxml.txt.nlp	23441298	SENT10	0	0	32	32	vildagliptin	GLP-1	PA165958346	100125288	0.931
NULL	Evid_Based_Complement_Alternat_Med_2014_Mar_26_2014_924560.nxml.txt.nlp	24795772	SENT162	44	44	25	25	calcein	JNK	PA132595336	5599	0.931
NULL	Sci_Rep_2014_Dec_3_4_7201.nxml.txt.nlp	25467193	SENT256	12	12	2	2	gemcitabine	NRF2	PA449748	2551;4780	0.931
NULL	Mol_Cancer_2012_Mar_21_11_13.nxml.txt.nlp	22436134	SENT136	11	11	0	0	doxorubicin	HuR	PA449412	1994	0.931
NULL	Infect_Dis_Obstet_Gynecol_2012_Nov_29_2012_543916.nxml.txt.nlp	23251074	SENT37	7	7	38	38	lamivudine	CD4	PA450163	920	0.931
NULL	Nat_Commun_2014_Apr_11_5_3687.nxml.txt.nlp	24722317	SENT295	8	8	19	19	doxycycline	P19	PA449415	51561	0.931
NULL	Diabetes_Care_2010_Jul_31_33(7)_1544-1548.nxml.txt.nlp	20357370	SENT23	3	3	18	18	metformin	AMPK	PA450395	5563	0.931
NULL	Gut_Liver_2011_Jun_24_5(2)_160-164.nxml.txt.nlp	21814595	SENT6	13	13	23	23	meperidine	ESD	PA450369	2098	0.931
NULL	Cases_J_2009_Apr_28_2_6602.nxml.txt.nlp	19829828	SENT68	16	16	24	24	amiodarone	CYP3A4	PA448383	1576	0.931
NULL	Breast_Cancer_Res_2004_Nov_7_6(1)_39-52.nxml.txt.nlp	14680484	SENT80	19	19	7	7	tamoxifen	N-CoR	PA451581	9611	0.931
NULL	Exp_Diabetes_Res_2011_Jun_23_2011_898913.nxml.txt.nlp	21747834	SENT171	14	14	3	3	exenatide	GLP-1	PA164749238	100125288	0.931
NULL	Breast_Cancer_Res_2014_May_30_16(3)_R55.nxml.txt.nlp	24886669	SENT39	41	41	26	26	doxorubicin	p53	PA449412	7157	0.931
NULL	Acta_Neuropathol_Commun_2013_Aug_9_1_49.nxml.txt.nlp	24252504	SENT38	8	8	15	15	arsenite	TDP-43	PA452638	23435	0.931
NULL	Cancer_Cell_2007_Dec_11_12(6)_514-527.nxml.txt.nlp	18068629	SENT131	11	11	5	5	paclitaxel	Rho	PA450761	29984	0.931
NULL	J_Oncol_2010_Dec_16_2010_151750.nxml.txt.nlp	20049345	SENT62	29	29	10	10	temozolomide	PARP-1	PA451609	25976	0.931
NULL	Clin_Interv_Aging_2013_Oct_2_8_1329-1337.nxml.txt.nlp	24124355	SENT68	8	8	2	2	pranlukast	CysLT1	PA134698661	10800	0.931
NULL	Oncogene_2014_Feb_6_33(6)_713-723.nxml.txt.nlp	23435429	SENT84	39	39	29	29	etoposide	p50	PA449552	958;4790	0.931
NULL	Aging_(Albany_NY)_2013_Jan_29_5(1)_3-17.nxml.txt.nlp	23363843	SENT51	32	32	46	46	etoposide	p53	PA449552	7157	0.931
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Apr_17_6_43-57.nxml.txt.nlp	24833916	SENT284	25	25	34	34	everolimus	PTEN	PA164746311	5728	0.931
NULL	Clinics_(Sao_Paulo)_2013_May_68(5)_694-701.nxml.txt.nlp	23778405	SENT23	26	26	9	9	vincristine	survivin	PA451879	332	0.931
NULL	Environ_Health_Perspect_2011_Apr_16_119(4)_534-541.nxml.txt.nlp	21081300	SENT122	3	3	15	15	ketoconazole	PGD2	PA450146	27306	0.931
NULL	EJNMMI_Res_2011_Jul_29_1_12.nxml.txt.nlp	22214199	SENT97	12	12	20	20	cyclosporine	ANOVA	PA449167	4858	0.931
NULL	Int_J_Biol_Sci_2011_May_24_7(5)_673-684.nxml.txt.nlp	21647250	SENT202	22	22	1	1	berberine	AMPK	PA165860812	5563	0.931
NULL	J_Hematol_Oncol_2009_Feb_23_2_10.nxml.txt.nlp	19236716	SENT107	29	29	25	25	rifampin	CYP3A4	PA451250	1576	0.931
NULL	Arthritis_Res_Ther_2013_Sep_12_15(5)_R116.nxml.txt.nlp	24028507	SENT146	10	10	4	4	papain	IL-6	PA450778	3569	0.931
NULL	Mol_Cancer_2007_Oct_11_6_63.nxml.txt.nlp	17931419	SENT125	14	14	7	7	cetuximab	HIF-1	PA10040	29072	0.931
NULL	FEBS_Open_Bio_2014_Jul_5_4_659-671.nxml.txt.nlp	25161875	SENT322	26	26	14	14	etoposide	XIAP	PA449552	331	0.931
NULL	Breast_Cancer_Res_Treat_2012_Jun_18_133(3)_937-947.nxml.txt.nlp	22094936	SENT147	24	24	14	14	tamoxifen	CCNE1	PA451581	898	0.931
NULL	Thorax_2014_Jul_24_69(7)_638-647.nxml.txt.nlp	24567297	SENT86	15	15	12	12	doxycycline	TRAIL	PA449415	8743	0.931
NULL	Clinicoecon_Outcomes_Res_2014_Oct_17_6_451-461.nxml.txt.nlp	25378939	SENT18	19	19	17	17	vancomycin	HAP	PA451850	5915;10313	0.931
NULL	Nat_Med_2012_Jul_18(7)_1118-1122.nxml.txt.nlp	22683780	SENT54	27	27	20	20	crizotinib	FGFR1	PA165946122	2260	0.931
NULL	Breast_Cancer_Res_2014_May_28_16(3)_R53.nxml.txt.nlp	24886537	SENT130	19	19	16	16	letrozole	aromatase	PA450196	1588	0.931
NULL	Cancers_(Basel)_2011_May_3_3(2)_2255-2273.nxml.txt.nlp	24212808	SENT141	2	2	25	25	erlotinib	AAP	PA134687924	5345	0.931
NULL	Curr_Oncol_2009_Aug_16(4)_9-21.nxml.txt.nlp	19672420	SENT255	36	36	22	22	bevacizumab	EGFR	PA130232992	1956	0.931
NULL	Exp_Ther_Med_2014_Nov_29_8(5)_1473-1478.nxml.txt.nlp	25289044	SENT167	27	27	7	7	heparin	AZU	PA449855	566	0.931
NULL	Breast_Cancer_Res_2010_Oct_14_12(5)_R84.nxml.txt.nlp	20946630	SENT303	7	7	31	31	choline	Hsp90	PA448976	3320	0.931
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT87	14	14	9	9	trastuzumab	HER2	PA451743	2064	0.931
NULL	Evid_Based_Complement_Alternat_Med_2012_Aug_26_2012_487380.nxml.txt.nlp	22966242	SENT6	42	42	31	31	indomethacin	VIII	PA449982	1351	0.931
NULL	J_Oncol_2010_Jan_3_2010_149362.nxml.txt.nlp	20069122	SENT173	9	9	20	20	olaparib	PARP-1		25976	0.931
NULL	Lab_Invest_2009_Dec_19_89(12)_1397-1409.nxml.txt.nlp	19841616	SENT388	15	15	24	24	curcumin	NAC	PA151958596	22861	0.931
NULL	Braz_J_Med_Biol_Res_2013_Feb_1_46(2)_171-177.nxml.txt.nlp	23369979	SENT146	23	23	31	31	enalapril	IL-6	PA449456	3569	0.931
NULL	Biochem_Res_Int_2012_Aug_15_2012_940405.nxml.txt.nlp	22928112	SENT272	5	5	21	21	crizotinib	ROS1	PA165946122	6098	0.931
NULL	J_Hematol_Oncol_2013_Nov_22_6_88.nxml.txt.nlp	24261963	SENT184	7	7	29	29	fulvestrant	aromatase	PA164747170	1588	0.931
NULL	J_Hum_Genet_2013_Jun_2_58(6)_306-312.nxml.txt.nlp	23635953	SENT15	12	12	19	19	raloxifene	aromatase	PA451221	1588	0.931
NULL	Asian_J_Androl_2014_Jun_24_Nov-Dec_16(6)_817-823.nxml.txt.nlp	24994782	SENT160	8	8	33	33	flutamide	KRT33B	PA449685	3884	0.931
NULL	Front_Chem_2014_Dec_23_2_113.nxml.txt.nlp	25566531	SENT160	34	34	21	21	curcumin	IL-8	PA151958596	3576	0.931
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Jul_21_9_20.nxml.txt.nlp	20663145	SENT94	10	10	3	3	clindamycin	AAP	PA449035	5345	0.931
NULL	J_Oncol_2010_Dec_16_2010_151750.nxml.txt.nlp	20049345	SENT62	29	29	26	26	temozolomide	PARP-1	PA451609	25976	0.931
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT133	7	7	26	26	adalimumab	CD36	PA10004	948	0.931
NULL	Int_J_Mol_Sci_2014_Mar_20_15(3)_4965-4976.nxml.txt.nlp	24658440	SENT35	19	19	22	22	cyclosporine	P-gp	PA449167	5243	0.931
NULL	Cancers_(Basel)_2011_Sep_13_3(3)_3506-3524.nxml.txt.nlp	24212966	SENT143	15	15	1	1	gemcitabine	RRM1	PA449748	6240	0.931
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1107-1116.nxml.txt.nlp	22343619	SENT315	12	12	5	5	tamoxifen	IRS1	PA451581	3667	0.931
NULL	Am_J_Trop_Med_Hyg_2012_Sep_5_87(3)_437-446.nxml.txt.nlp	22848096	SENT13	17	17	8	8	sulfadoxine	ACT	PA451540	12;11332;9457;641455	0.931
NULL	J_Cell_Mol_Med_2014_May_20_18(5)_844-851.nxml.txt.nlp	24444371	SENT120	13	13	26	26	mannitol	MAD2B	PA450320	10459	0.931
NULL	Hum_Genomics_2008_Sep_1_3(1)_24-35.nxml.txt.nlp	19129088	SENT13	38	38	4	4	ethanol	ALDH1A1	PA448073	216	0.931
NULL	Front_Immunol_2013_Nov_18_4_382.nxml.txt.nlp	24302925	SENT81	15	15	6	6	cisplatin	KIT	PA449014	3815	0.931
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT173	18	18	4	4	sitagliptin	HIP	PA164748978	6767;6159;64399;5068	0.931
NULL	Cytokine_2011_Jan_53(1)_52-59.nxml.txt.nlp	20943413	SENT81	32	32	4	4	trypsin	IFN	PA451806	3439	0.931
NULL	J_Cell_Mol_Med_2014_Oct_11_18(10)_2031-2043.nxml.txt.nlp	25109475	SENT305	5	5	28	28	valsartan	AMPK	PA451848	5563	0.931
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Oct_29_67(Pt_11)_o3069-o3070.nxml.txt.nlp	22220078	SENT65	32	32	18	18	ethanol	mol	PA448073	90527	0.931
NULL	Indian_J_Urol_2010_Jan-Mar_26(1)_26-35.nxml.txt.nlp	20535281	SENT138	17	17	11	11	indomethacin	EP1	PA449982	5731	0.931
NULL	Eur_J_Med_Res_2014_Sep_16_19(1)_50.nxml.txt.nlp	25223338	SENT49	16	16	21	21	docetaxel	DDP	PA449383	1678	0.931
NULL	Oncol_Rep_2013_Apr_5_29(4)_1671-1677.nxml.txt.nlp	23404329	SENT165	14	14	26	26	aspirin	SFN	PA448497	25996;2810	0.931
NULL	Crit_Care_2005_Sep_8_9(1)_37-44.nxml.txt.nlp	15693982	SENT117	7	7	14	14	vasopressin	ACTH	PA451858	5443	0.931
NULL	Nat_Med_2010_Nov_24_16(11)_1299-1304.nxml.txt.nlp	20972434	SENT189	21	21	4	4	forskolin	ASM	PA146096022	6609;283120	0.931
NULL	Oncotarget_2012_Dec_17_4(1)_48-63.nxml.txt.nlp	23295955	SENT187	34	34	2	2	paclitaxel	MTHFD2	PA450761	10797	0.931
NULL	J_Med_Chem_2014_Jun_26_57(12)_5395-5404.nxml.txt.nlp	24867590	SENT245	16	16	34	34	l-glutamine	CO2	PA10090	4513	0.931
NULL	J_Korean_Med_Sci_2014_Aug_30_29(8)_1126-1131.nxml.txt.nlp	25120324	SENT33	35	35	3	3	oxygen	RDS	PA450744	7263	0.931
NULL	Biomed_Res_Int_2014_Feb_6_2014_323594.nxml.txt.nlp	24689036	SENT193	6	6	0	0	raloxifene	PC3	PA451221	57332;7832;5122	0.931
NULL	Acta_Pharmacol_Sin_2012_May_4_33(5)_644-651.nxml.txt.nlp	22555371	SENT168	6	6	11	11	sulodexide	eNOS	PA164746343	4846	0.931
NULL	Proteome_Sci_2009_May_28_7_20.nxml.txt.nlp	19476632	SENT174	23	23	13	13	galactose	NDUFS1	PA449725	4719	0.931
NULL	Int_J_Cell_Biol_2012_Sep_9_2012_683897.nxml.txt.nlp	22991514	SENT58	7	7	30	30	oxygen	ROS	PA450744	6098	0.931
NULL	Indian_J_Hum_Genet_2014_Apr-Jun_20(2)_175-184.nxml.txt.nlp	25400347	SENT9	46	46	27	27	clopidogrel	SLCO1B1	PA449053	10599	0.931
NULL	Reprod_Biol_Endocrinol_2003_Aug_6_1_54.nxml.txt.nlp	12932297	SENT282	20	20	4	4	hyaluronidase	SPAM1	PA164745713	6677	0.931
NULL	Mol_Cancer_2010_Oct_12_9_269.nxml.txt.nlp	20939893	SENT103	12	12	7	7	isoproterenol	STAT3	PA450121	6774	0.931
NULL	Cardiovasc_Diabetol_2007_Apr_3_6_12.nxml.txt.nlp	17407587	SENT34	7	7	16	16	irbesartan	gamma	PA450084	9913	0.931
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Jun_25_3(6)_e120.nxml.txt.nlp	24964282	SENT13	38	38	34	34	midazolam	CYP3A4	PA450496	1576	0.931
NULL	Exp_Ther_Med_2013_Jan_1_5(1)_338-342.nxml.txt.nlp	23251295	SENT92	12	12	5	5	everolimus	HK2	PA164746311	3796;3099;29911;3741	0.931
NULL	J_Mol_Med_2008_Sep_4_86(9)_1045-1056.nxml.txt.nlp	18600309	SENT140	5	5	33	33	salmeterol	CXCR2	PA451300	3579	0.931
NULL	Oncotarget_2014_Oct_21_5(22)_11252-11268.nxml.txt.nlp	25361004	SENT181	5	5	2	2	metformin	CLIC1	PA450395	1192	0.931
NULL	Int_J_Chron_Obstruct_Pulmon_Dis_2007_Sep_2(3)_205-228.nxml.txt.nlp	18229560	SENT309	27	27	18	18	cilomilast	CXCL8	PA165948031	3576	0.931
NULL	Front_Immunol_2013_Mar_27_4_76.nxml.txt.nlp	23543707	SENT218	29	29	15	15	cetuximab	KRAS	PA10040	3845	0.931
NULL	J_Thromb_Haemost_2013_Jan_11(1)_132-141.nxml.txt.nlp	23205847	SENT45	6	6	0	0	thrombin	FVIII	PA451674	2157	0.931
NULL	Nucleic_Acids_Res_2011_Sep_7_39(17)_7465-7476.nxml.txt.nlp	21653549	SENT348	17	17	5	5	chlorambucil	DEK	PA448926	7913	0.931
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_16_2014_926087.nxml.txt.nlp	25478000	SENT96	9	9	20	20	ezetimibe	PCSK9	PA10816	255738	0.931
NULL	Br_J_Cancer_2012_Sep_4_107(6)_947-955.nxml.txt.nlp	22892392	SENT198	27	27	6	6	lapatinib	ERBB2	PA152241907	2064	0.931
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT224	9	9	18	18	perifosine	DR5	PA165291471	8795	0.931
NULL	J_Med_Case_Reports_2008_May_19_2_167.nxml.txt.nlp	18489739	SENT19	25	25	4	4	doxorubicin	PPL	PA449412	5493	0.931
NULL	Cell_Death_Dis_2013_Jan_31_4(1)_e478.nxml.txt.nlp	23370278	SENT78	22	22	13	13	cisplatin	KAP1	PA449014	10155	0.931
NULL	Indian_J_Pharmacol_2013_May-Jun_45(3)_248-251.nxml.txt.nlp	23833367	SENT7	14	14	42	42	diazepam	EPM	PA449283	2054	0.931
NULL	Diabetes_2008_Oct_57(10)_2784-2793.nxml.txt.nlp	18599521	SENT145	10	10	2	2	simvastatin	GAPDH	PA451363	2597	0.931
NULL	Arthritis_Res_Ther_2010_Apr_29_12(2)_R73.nxml.txt.nlp	20429888	SENT271	6	6	31	31	bortezomib	COL1A1	PA10252	1277	0.931
NULL	Calcif_Tissue_Int_2011_Aug_3_89(2)_91-104.nxml.txt.nlp	21637997	SENT251	10	10	12	12	teriparatide	PTH	PA451620	5741	0.931
NULL	Hum_Genomics_2009_Jan_1_3(2)_103-105.nxml.txt.nlp	19164087	SENT48	22	22	4	4	ethanol	ADH4	PA448073	127	0.931
NULL	Cardiovasc_Drugs_Ther_2010_Apr_20_24(2)_139-149.nxml.txt.nlp	20490905	SENT325	19	19	16	16	valsartan	AT1	PA451848	9197;185	0.931
NULL	Cent_European_J_Urol_2011_Dec_9_64(4)_256-257.nxml.txt.nlp	24578906	SENT54	23	23	12	12	doxazosin	CD133	PA449407	8842	0.931
NULL	Cases_J_2009_May_18_2_7593.nxml.txt.nlp	19830001	SENT86	17	17	12	12	carbamazepine	CYP3A4	PA448785	1576	0.931
NULL	Clin_Ophthalmol_2010_Apr_26_4_349-358.nxml.txt.nlp	20463804	SENT168	10	10	26	26	travoprost	C-1	PA164781371	5203	0.931
NULL	Curr_Oncol_2009_Jul_16(Suppl_2)_S14-S23.nxml.txt.nlp	19672417	SENT134	19	19	2	2	tamoxifen	ATAC	PA451581	6375	0.931
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_P23.nxml.txt.nlp	NULL	SENT16	14	14	3	3	amitriptyline	DAO	PA448385	26;1610	0.931
NULL	Arthritis_Res_Ther_2014_Sep_26_16(5)_429.nxml.txt.nlp	25606593	SENT126	4	4	18	18	celecoxib	ADAMTS5	PA448871	11096	0.931
NULL	Eur_J_Clin_Pharmacol_2014_Oct_8_70(12)_1433-1441.nxml.txt.nlp	25291992	SENT165	27	27	12	12	olanzapine	B12	PA450688	7126;4709	0.931
NULL	Oncotarget_2012_Nov_17_3(12)_1600-1614.nxml.txt.nlp	23307622	SENT83	34	34	7	7	cisplatin	ATG12	PA449014	9140	0.931
NULL	Cardiovasc_Res_2010_Feb_1_85(3)_424-433.nxml.txt.nlp	19748906	SENT170	25	25	14	14	staurosporine	GRK2	PA165109623	156	0.931
NULL	J_Biol_Chem_2009_Jan_2_284(1)_77-84.nxml.txt.nlp	18854318	SENT162	42	42	22	22	forskolin	BRSK2	PA146096022	9024	0.931
NULL	Iran_J_Pharm_Res_2014_Winter_13(1)_253-262.nxml.txt.nlp	24734078	SENT92	2	2	12	12	propofol	LPO	PA451141	4025	0.931
NULL	Cell_Oncol_(Dordr)_2011_Apr_11_34(2)_89-95.nxml.txt.nlp	21394646	SENT193	17	17	7	7	trastuzumab	HER2	PA451743	2064	0.931
NULL	Reprod_Biol_Endocrinol_2003_Oct_9_1_74.nxml.txt.nlp	14613550	SENT96	6	6	16	16	diclofenac	COX	PA449293	1351	0.931
NULL	Int_J_Hypertens_2013_Jul_22_2013_808353.nxml.txt.nlp	23970958	SENT145	22	22	2	2	collagenase	IGFR	PA449107	3480	0.931
NULL	Oxid_Med_Cell_Longev_2013_Apr_21_2013_412576.nxml.txt.nlp	23710286	SENT275	4	4	16	16	curcumin	NRF2	PA151958596	2551;4780	0.931
NULL	Br_J_Cancer_2010_Nov_9_103(10)_1627-1636.nxml.txt.nlp	20959826	SENT185	22	22	31	31	cetuximab	KRAS	PA10040	3845	0.931
NULL	J_Korean_Med_Sci_2001_Apr_16(2)_135-139.nxml.txt.nlp	11306736	SENT15	23	23	5	5	etoposide	MDM2	PA449552	4193	0.931
NULL	Diabetes_Obes_Metab_2011_Nov_13(11)_982-989.nxml.txt.nlp	21615670	SENT23	0	0	5	5	exenatide	GLP-1	PA164749238	100125288	0.931
NULL	Adv_Hematol_2012_Sep_14_2012_524308.nxml.txt.nlp	21941553	SENT251	20	20	26	26	chlorambucil	BCL2	PA448926	596	0.931
NULL	Breast_Cancer_Res_2004_Aug_12_6(5)_219-224.nxml.txt.nlp	15318929	SENT69	17	17	8	8	doxorubicin	PTEN	PA449412	5728	0.931
NULL	Arthritis_Res_Ther_2010_Jul_13_12(4)_R140.nxml.txt.nlp	20626857	SENT192	37	37	13	13	infliximab	IL-6	PA452639	3569	0.931
NULL	Acta_Pharmacol_Sin_2009_Jul_22_30(7)_956-964.nxml.txt.nlp	19543298	SENT132	7	7	0	0	atorvastatin	SLCO1B1	PA448500	10599	0.931
NULL	Dis_Markers_2011_Sep_6_31(2)_55-65.nxml.txt.nlp	21896999	SENT6	15	15	32	32	dipyridamole	TSP-1	PA449367	7057	0.931
NULL	Pharmaceutics_2011_Oct_12_3(4)_680-705.nxml.txt.nlp	24309303	SENT80	21	21	30	30	atorvastatin	OATP1B1	PA448500	10599	0.931
NULL	Int_J_Mol_Imaging_2011_Oct_26_2011_874585.nxml.txt.nlp	21490735	SENT160	15	15	8	8	tamoxifen	FDG	PA451581	23583	0.931
NULL	Mol_Cancer_2009_Dec_23_8_129.nxml.txt.nlp	20030852	SENT137	15	15	9	9	curcumin	CXCL1	PA151958596	2919	0.931
NULL	J_Hematol_Oncol_2011_Aug_15_4_34.nxml.txt.nlp	21843362	SENT19	11	11	5	5	vincristine	CHOP	PA451879	1649	0.931
NULL	Breast_Cancer_Res_2007_Dec_20_9(Suppl_2)_S25.nxml.txt.nlp	NULL	SENT13	29	29	27	27	anastrozole	aromatase	PA448432	1588	0.931
NULL	Oncol_Rep_2013_Apr_5_29(4)_1671-1677.nxml.txt.nlp	23404329	SENT156	16	16	0	0	curcumin	MIA	PA151958596	8190	0.931
NULL	Ther_Clin_Risk_Manag_2006_Sep_2(3)_235-249.nxml.txt.nlp	18360599	SENT212	15	15	30	30	alendronate	BSAP	PA448082	5079	0.931
NULL	Acta_Pharmacol_Sin_2012_Jan_3_33(1)_49-56.nxml.txt.nlp	22212430	SENT175	11	11	18	18	thrombin	JNK	PA451674	5599	0.931
NULL	J_Carcinog_2011_Nov_30_10_28.nxml.txt.nlp	22190870	SENT104	28	28	8	8	trastuzumab	PIK3CA	PA451743	5290	0.931
NULL	Balkan_J_Med_Genet_2011_Jun_25_14(1)_25-30.nxml.txt.nlp	24052699	SENT81	10	10	25	25	phenytoin	ABCC2	PA450947	1244	0.931
NULL	Cancer_Cell_Int_2013_Feb_8_13_11.nxml.txt.nlp	23394616	SENT111	25	25	20	20	geldanamycin	Hsp90	PA152031327	3320	0.931
NULL	Open_Microbiol_J_2008_May_14_2_49-59.nxml.txt.nlp	19088911	SENT141	4	4	1	1	imiquimod	TLR7	PA449972	51284	0.931
NULL	Clin_Pharmacol_2012_Feb_20_4_13-20.nxml.txt.nlp	22427735	SENT87	27	27	18	18	clopidogrel	PON1	PA449053	5444	0.931
NULL	Br_J_Cancer_2004_May_4_90(9)_1733-1739.nxml.txt.nlp	15150604	SENT133	11	11	31	31	letrozole	aromatase	PA450196	1588	0.931
NULL	Mol_Biol_Rep_2013_May_11_40(8)_5013-5026.nxml.txt.nlp	23666059	SENT284	31	31	8	8	resveratrol	p53		7157	0.931
NULL	Arch_Drug_Inf_2011_Mar_4(1)_1-9.nxml.txt.nlp	21572514	SENT156	5	5	0	0	cyclosporine	P-gp	PA449167	5243	0.931
NULL	Ann_Hematol_2011_May_12_90(5)_557-568.nxml.txt.nlp	20938660	SENT217	30	30	9	9	plerixafor	CD34	PA165958410	947	0.931
NULL	J_Immunother_2014_Apr_12_37(3)_180-186.nxml.txt.nlp	24598448	SENT53	0	0	13	13	sorafenib	IL-2	PA7000	3558	0.931
NULL	J_Gen_Physiol_2013_Aug_142(2)_137-155.nxml.txt.nlp	23858003	SENT8	9	9	3	3	forskolin	TREK-1	PA146096022	3776	0.931
NULL	CNS_Drugs_2014_Apr_11_28(6)_535-558.nxml.txt.nlp	24723124	SENT361	15	15	0	0	natalizumab	IFN	PA164747191	3439	0.931
NULL	Exp_Ther_Med_2013_Mar_8_5(3)_707-710.nxml.txt.nlp	23404433	SENT148	14	14	34	34	cisplatin	Bcl-2	PA449014	596	0.931
NULL	Biol_Proced_Online_2004_Oct_25_6_250-256.nxml.txt.nlp	15514699	SENT176	13	13	16	16	flavopiridol	survivin	PA452627	332	0.931
NULL	Crit_Care_2008_Nov_12_12(6)_235.nxml.txt.nlp	19040780	SENT177	17	17	13	13	amiodarone	CYP3A4	PA448383	1576	0.931
NULL	Environ_Health_2009_Aug_18_8_37.nxml.txt.nlp	19689815	SENT91	7	7	0	0	estradiol	DES	PA449503	1674	0.931
NULL	Environ_Health_Perspect_2005_Jan_30_113(1)_17-24.nxml.txt.nlp	15626642	SENT161	0	0	7	7	verapamil	P-gp	PA451868	5243	0.931
NULL	Cancers_(Basel)_2014_Sep_5_6(3)_1769-1792.nxml.txt.nlp	25198391	SENT84	9	9	22	22	trastuzumab	IGF1R	PA451743	3480	0.931
NULL	J_Cell_Biol_1997_Jun_30_137(7)_1639-1649.nxml.txt.nlp	9199177	SENT159	19	19	7	7	paraformaldehyde	ZAP-70	PA450790	7535	0.931
NULL	Breast_Cancer_Res_Treat_2007_Dec_27_106(2)_161-170.nxml.txt.nlp	17260092	SENT249	34	34	6	6	tamoxifen	aromatase	PA451581	1588	0.931
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT276	16	16	6	6	resveratrol	NAC		22861	0.931
NULL	J_Gen_Physiol_2010_Jul_136(1)_101-116.nxml.txt.nlp	20548054	SENT194	22	22	19	19	tetracaine	RYR	PA451638	6261	0.931
NULL	Asia_Pac_Allergy_2013_Oct_31_3(4)_231-240.nxml.txt.nlp	24260728	SENT26	25	25	0	0	theophylline	CYP1A2	PA451647	1544	0.931
NULL	Curr_Neuropharmacol_2010_Sep_8(3)_287-304.nxml.txt.nlp	21358978	SENT228	9	9	16	16	agomelatine	5-HT2C	PA165958363	3358	0.931
NULL	Eur_J_Med_Res_2010_Feb_26_15(2)_47-53.nxml.txt.nlp	20452883	SENT124	3	3	16	16	fentanyl	ESG	PA449599	7089;7088;7090;7091	0.931
NULL	Oncotarget_2012_Aug_10_3(8)_744-758.nxml.txt.nlp	22889873	SENT232	42	42	23	23	pertuzumab	EGFR		1956	0.931
NULL	Front_Genet_2014_Oct_31_5_379.nxml.txt.nlp	25400658	SENT148	26	26	3	3	tamoxifen	HOTAIR	PA451581	100124700	0.931
NULL	Acta_Pharmacol_Sin_2013_Feb_12_34(2)_255-261.nxml.txt.nlp	23147557	SENT113	17	17	5	5	pioglitazone	PPG	PA450970	5552	0.931
NULL	Br_J_Cancer_2012_Sep_25_107(7)_1009-1016.nxml.txt.nlp	22948724	SENT97	9	9	22	22	temsirolimus	HIF1	PA164746890	3091	0.931
NULL	Mol_Cancer_2010_Apr_23_9_87.nxml.txt.nlp	20416058	SENT174	32	32	26	26	doxorubicin	TRAIL	PA449412	8743	0.931
NULL	J_Hematol_Oncol_2009_Feb_23_2_10.nxml.txt.nlp	19236716	SENT107	29	29	32	32	rifampin	CYP3A4	PA451250	1576	0.931
NULL	Br_J_Pharmacol_2011_Apr_162(8)_1832-1842.nxml.txt.nlp	21232033	SENT269	32	32	5	5	resveratrol	SIRT1		23411	0.931
NULL	Acta_Pharmacol_Sin_2010_Sep_16_31(9)_1075-1084.nxml.txt.nlp	20711221	SENT134	18	18	7	7	metformin	AMPK	PA450395	5563	0.931
NULL	Front_Psychol_2011_Sep_15_2_233.nxml.txt.nlp	21954390	SENT298	19	19	12	12	lorazepam	PES	PA450267	23481	0.931
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT258	15	15	7	7	resveratrol	NAC		22861	0.931
NULL	Cardiovasc_Ther_2012_Aug_17_30(4)_e174-e182.nxml.txt.nlp	21883999	SENT98	37	37	13	13	prasugrel	CYP3A	PA154410481	1574	0.931
NULL	Cancers_(Basel)_2014_Jan_15_6(1)_143-152.nxml.txt.nlp	24434543	SENT80	9	9	22	22	lapatinib	HER2	PA152241907	2064	0.931
NULL	J_Hematol_Oncol_2012_Jul_11_5_16.nxml.txt.nlp	22534171	SENT153	4	4	2	2	erlotinib	EGFR	PA134687924	1956	0.931
NULL	Iran_J_Basic_Med_Sci_2012_May-Jun_15(3)_795-802.nxml.txt.nlp	23493622	SENT157	11	11	2	2	capsaicin	TRPV1	PA448776	7442	0.931
NULL	Osteoporos_Int_2013_Jan_24_24(1)_219-226.nxml.txt.nlp	23093347	SENT131	23	23	11	11	teriparatide	CTX	PA451620	1593	0.931
NULL	Crit_Care_2001_Mar_2_5(Suppl_1)_P103.nxml.txt.nlp	NULL	SENT7	15	15	2	2	staurosporine	ATIII	PA165109623	462	0.93
NULL	Cardiol_Res_Pract_2013_Feb_19_2013_195456.nxml.txt.nlp	23533940	SENT139	20	20	15	15	clopidogrel	P2Y12	PA449053	64805	0.93
NULL	Scientifica_(Cairo)_2013_Dec_10_2013_691251.nxml.txt.nlp	24386592	SENT94	5	5	11	11	nadh	P2X7	PA164755085	5027	0.93
NULL	Acta_Pharmacol_Sin_2014_Jul_9_35(7)_889-898.nxml.txt.nlp	24909515	SENT223	15	15	25	25	bromocriptine	SULT2A1	PA448671	6822	0.93
NULL	Arthritis_Res_Ther_2010_Jan_22_12(1)_R11.nxml.txt.nlp	20096109	SENT179	21	21	36	36	infliximab	IFN	PA452639	3439	0.93
NULL	EMBO_J_2010_Jan_6_29(1)_68-79.nxml.txt.nlp	19927124	SENT45	13	13	34	34	tetracycline	NO66	PA451640	79697	0.93
NULL	J_Biomed_Biotechnol_2011_Jul_6_2011_783528.nxml.txt.nlp	21785566	SENT148	16	16	9	9	ritonavir	CYP3A4	PA451260	1576	0.93
NULL	EMBO_Mol_Med_2013_Aug_1_5(8)_1196-1212.nxml.txt.nlp	23818228	SENT398	17	17	22	22	temozolomide	ZEB1	PA451609	6935	0.93
NULL	Chin_J_Cancer_2011_Sep_30(9)_638-644.nxml.txt.nlp	21880185	SENT22	14	14	4	4	verapamil	P-gp	PA451868	5243	0.93
NULL	Mol_Cancer_2010_Nov_8_9_291.nxml.txt.nlp	21059223	SENT180	28	28	5	5	doxorubicin	ZNF217	PA449412	7764	0.93
NULL	Eur_J_Immunol_2014_Feb_17_44(2)_533-544.nxml.txt.nlp	24136450	SENT48	8	8	22	22	paraformaldehyde	UXT	PA450790	8409	0.93
NULL	Cancers_(Basel)_2010_Oct_25_2(4)_1794-1812.nxml.txt.nlp	24281201	SENT236	10	10	0	0	gemcitabine	MUC4	PA449748	4585	0.93
NULL	Oncol_Lett_2014_Jul_25_8(1)_313-316.nxml.txt.nlp	24959268	SENT67	8	8	25	25	sulindac	JNK1	PA451565	5599	0.93
NULL	Mol_Pain_2014_Apr_18_10_27.nxml.txt.nlp	24742127	SENT8	37	37	28	28	paclitaxel	CB2	PA450761	1269	0.93
NULL	Nat_Chem_2013_Mar_17_5(3)_221-227.nxml.txt.nlp	23422564	SENT220	20	20	36	36	calcein	CO2	PA132595336	4513	0.93
NULL	BMB_Rep_2014_Jul_47(7)_376-381.nxml.txt.nlp	24286332	SENT141	19	19	9	9	thrombin	PPG	PA451674	5552	0.93
NULL	Mol_Cancer_2010_Nov_8_9_291.nxml.txt.nlp	21059223	SENT91	13	13	20	20	paclitaxel	ZNF217	PA450761	7764	0.93
NULL	Acta_Pharmacol_Sin_2012_Dec_22_33(12)_1511-1517.nxml.txt.nlp	23085741	SENT114	15	15	7	7	zileuton	CysLT1	PA451955	10800	0.93
NULL	Patient_Prefer_Adherence_2013_Mar_27_7_245-258.nxml.txt.nlp	23569364	SENT1	0	0	4	4	exemestane	aromatase	PA449563	1588	0.93
NULL	Front_Chem_2014_Aug_26_2_72.nxml.txt.nlp	25207271	SENT109	0	0	18	18	ethanol	mol	PA448073	90527	0.93
NULL	Front_Pharmacol_2014_Nov_25_5_256.nxml.txt.nlp	25505414	SENT192	11	11	4	4	diazepam	CA1	PA449283	759	0.93
NULL	J_Oncol_2011_Dec_9_2011_352616.nxml.txt.nlp	21197469	SENT324	19	19	24	24	gefitinib	EGFR	PA131301952	1956	0.93
NULL	Evid_Based_Complement_Alternat_Med_2014_Jan_8_2014_976364.nxml.txt.nlp	24527057	SENT180	29	29	20	20	oseltamivir	p38	PA450721	10598;1432;7965	0.93
NULL	Mol_Biol_Cell_2012_Jun_15_23(12)_2302-2318.nxml.txt.nlp	22553350	SENT345	17	17	32	32	doxycycline	MARK2	PA449415	2011	0.93
NULL	Oncol_Lett_2014_Nov_14_8(5)_2086-2092.nxml.txt.nlp	25295095	SENT166	7	7	1	1	gemcitabine	LKB1	PA449748	6794	0.93
NULL	Eur_J_Haematol_2014_Feb_25_92(2)_127-136.nxml.txt.nlp	24118452	SENT26	17	17	1	1	anagrelide	ELN	PA164742986	2006	0.93
NULL	Eur_J_Clin_Pharmacol_2011_May_8_67(5)_493-506.nxml.txt.nlp	21140139	SENT287	28	28	7	7	oxycodone	CYP3A4	PA450741	1576	0.93
NULL	Cancer_Inform_2012_Jul_24_11_147-156.nxml.txt.nlp	22872785	SENT20	13	13	7	7	cisplatin	BL2	PA449014	23705	0.93
NULL	Braz_J_Med_Biol_Res_2013_Jul_30_46(8)_643-649.nxml.txt.nlp	23903687	SENT169	13	13	7	7	hydroxyurea	p16INK4a	PA449942	1029	0.93
NULL	Exp_Diabetes_Res_2012_Oct_15_2012_465282.nxml.txt.nlp	23118742	SENT102	2	2	7	7	metformin	AMPK	PA450395	5563	0.93
NULL	EMBO_Mol_Med_2013_Aug_4_5(8)_1247-1262.nxml.txt.nlp	23737459	SENT153	35	35	6	6	nilotinib	parkin	PA165958345	5071	0.93
NULL	BMB_Rep_2013_Nov_46(11)_544-549.nxml.txt.nlp	24152910	SENT3	13	13	11	11	thrombin	PAR-1	PA451674	2011;2149	0.93
NULL	Acta_Neuropathol_Commun_2014_May_30_2_57.nxml.txt.nlp	24887326	SENT15	13	13	0	0	vardenafil	ABCB1	PA10229	5243	0.93
NULL	Cancer_Cell_Int_2004_Aug_17_4_5.nxml.txt.nlp	15315711	SENT66	7	7	4	4	genistein	PC3	PA165109660	57332;7832;5122	0.93
NULL	Biomed_Res_Int_2014_Jan_20_2014_948427.nxml.txt.nlp	24563867	SENT122	24	24	8	8	glucose	5-HT1A	PA449773	3350	0.93
NULL	Front_Neurosci_2012_Feb_21_6_26.nxml.txt.nlp	22363256	SENT137	4	4	12	12	estradiol	COX	PA449503	1351	0.93
NULL	Oncotarget_2011_Dec_15_2(12)_984-996.nxml.txt.nlp	22184287	SENT206	24	24	14	14	olaparib	p53		7157	0.93
NULL	Breast_Cancer_Res_2010_Oct_14_12(5)_R84.nxml.txt.nlp	20946630	SENT269	6	6	19	19	choline	SLC44A1	PA448976	23446	0.93
NULL	Interdiscip_Toxicol_2011_Sep_4(3)_114-124.nxml.txt.nlp	22058652	SENT194	0	0	20	20	doxorubicin	SERCA2	PA449412	488	0.93
NULL	Indian_J_Endocrinol_Metab_2012_May-Jun_16(3)_343-348.nxml.txt.nlp	22629497	SENT33	4	4	12	12	teriparatide	PTH	PA451620	5741	0.93
NULL	Diabetes_Care_2009_Sep_19_32(9)_1663-1668.nxml.txt.nlp	19542207	SENT117	16	16	5	5	anakinra	IL-6	PA10799	3569	0.93
NULL	J_Exp_Med_2003_Dec_1_198(11)_1677-1688.nxml.txt.nlp	14657220	SENT48	19	19	3	3	pentobarbital	CD40	PA450859	958	0.93
NULL	Hum_Genomics_2004_Jan_1_1(2)_111-125.nxml.txt.nlp	15601539	SENT129	1	1	33	33	lipase	HDL2	PA450239	57338	0.93
NULL	Emerg_Infect_Dis_2012_Jan_18(1)_113-116.nxml.txt.nlp	22260877	SENT11	25	25	40	40	isoniazid	CA1	PA450112	759	0.93
NULL	Int_J_Mol_Sci_2014_Sep_2_15(9)_15512-15529.nxml.txt.nlp	25184950	SENT98	23	23	32	32	resveratrol	IL-10		3586	0.93
NULL	Case_Rep_Rheumatol_2013_Dec_17_2013_923497.nxml.txt.nlp	24455384	SENT64	36	36	5	5	cyclosporine	IL18	PA449167	3606	0.93
NULL	J_Biol_Chem_2013_Feb_22_288(8)_5562-5571.nxml.txt.nlp	23319583	SENT35	16	16	0	0	denosumab	OPG	PA166048634	690	0.93
NULL	Oncoimmunology_2012_Sep_1_1(6)_884-893.nxml.txt.nlp	23162756	SENT29	15	15	12	12	imiquimod	GLAST	PA449972	6507	0.93
NULL	Aging_Cell_2009_Apr_8(2)_113-127.nxml.txt.nlp	19239417	SENT243	4	4	22	22	resveratrol	AMPK		5563	0.93
NULL	Ann_Hematol_2011_Feb_17_90(2)_173-183.nxml.txt.nlp	20714724	SENT168	7	7	26	26	resveratrol	BAX		581	0.93
NULL	Mar_Drugs_2014_Sep_25_12(9)_4934-4972.nxml.txt.nlp	25257784	SENT283	11	11	35	35	carrageenan	IL-10	PA448814	3586	0.93
NULL	J_Hematol_Oncol_2012_Sep_18_5_57.nxml.txt.nlp	22989009	SENT227	36	36	26	26	nutlin-3	HDM2		4193	0.93
NULL	Blood_Cancer_J_2013_Mar_1_3(3)_e103.nxml.txt.nlp	23454896	SENT100	20	20	14	14	nelfinavir	JNK	PA450606	5599	0.93
NULL	J_Invest_Dermatol_2012_Oct_24_132(10)_2440-2450.nxml.txt.nlp	22622430	SENT60	18	18	10	10	temozolomide	ABCB5	PA451609	340273	0.93
NULL	Neuroimage_Clin_2013_Sep_6_3_290-300.nxml.txt.nlp	24273714	SENT33	6	6	15	15	pioglitazone	gamma	PA450970	9913	0.93
NULL	Vet_Res_Forum_2013_Winter_4(1)_19-24.nxml.txt.nlp	25593681	SENT81	15	15	8	8	diclofenac	B12	PA449293	7126;4709	0.93
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT91	24	24	12	12	resveratrol	TRAIL		8743	0.93
NULL	Mol_Cancer_2012_Dec_12_11_91.nxml.txt.nlp	23234355	SENT184	9	9	37	37	gefitinib	ULBP1	PA131301952	80329	0.93
NULL	Arthritis_Rheumatol_2014_Jun_27_66(6)_1574-1582.nxml.txt.nlp	24577881	SENT163	15	15	0	0	hydralazine	CD4	PA449894	920	0.93
NULL	Ann_Hematol_2014_Nov_28_93(3)_361-374.nxml.txt.nlp	24288111	SENT146	21	21	14	14	fludarabine	CD49d	PA449655	3676	0.93
NULL	Diabetologia_2010_Jan_21_53(1)_21-26.nxml.txt.nlp	19844672	SENT115	14	14	10	10	sitagliptin	HIP	PA164748978	6767;6159;64399;5068	0.93
NULL	Cancers_(Basel)_2014_Dec_16_6(4)_2387-2403.nxml.txt.nlp	25521854	SENT105	0	0	15	15	cabozantinib	VEGFR2	PA165906891	3791	0.93
NULL	Hematol_Rep_2012_Jun_26_4(2)_e10.nxml.txt.nlp	22826792	SENT20	36	36	10	10	eltrombopag	TPO	PA165981594	7066;7173	0.93
NULL	Oxid_Med_Cell_Longev_2013_Nov_28_2013_568093.nxml.txt.nlp	24379901	SENT154	3	3	20	20	resveratrol	AMPK		5563	0.93
NULL	Emerg_Infect_Dis_2011_Mar_17(3)_432-440.nxml.txt.nlp	21392434	SENT45	12	12	4	4	isoniazid	DST	PA450112	667	0.93
NULL	Ann_Gastroenterol_2014_27(3)_200-206.nxml.txt.nlp	24976114	SENT83	8	8	0	0	thrombin	PAR1	PA451674	79581;2149	0.93
NULL	Acta_Vet_Scand_2011_Feb_22_53(1)_12.nxml.txt.nlp	21342526	SENT219	36	36	19	19	flutamide	PD2	PA449685	54623	0.93
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1149.nxml.txt.nlp	24675467	SENT16	4	4	18	18	trastuzumab	HER2	PA451743	2064	0.93
NULL	Arthritis_Res_Ther_2009_Aug_17_11(4)_R123.nxml.txt.nlp	19686595	SENT239	27	27	22	22	rituximab	CD19	PA451261	930	0.93
NULL	Cancers_(Basel)_2014_Nov_25_6(4)_2313-2329.nxml.txt.nlp	25534569	SENT94	26	26	38	38	cabozantinib	HGF	PA165906891	3569;6654;3082	0.93
NULL	Oncotarget_2013_Jul_14_4(8)_1185-1198.nxml.txt.nlp	23852390	SENT197	27	27	15	15	cisplatin	TRAIL	PA449014	8743	0.93
NULL	Aging_(Albany_NY)_2009_Jun_3_1(6)_515-528.nxml.txt.nlp	20157535	SENT103	13	13	41	41	resveratrol	S6K1		6198	0.93
NULL	J_Gen_Physiol_2013_Aug_142(2)_137-155.nxml.txt.nlp	23858003	SENT439	14	14	25	25	forskolin	TREK-2	PA146096022	54207	0.93
NULL	Oxid_Med_Cell_Longev_2013_Apr_21_2013_412576.nxml.txt.nlp	23710286	SENT109	17	17	12	12	curcumin	GCLM	PA151958596	2730	0.93
NULL	Indian_J_Med_Paediatr_Oncol_2014_Apr-Jun_35(2)_176-180.nxml.txt.nlp	25197183	SENT85	39	39	24	24	cetuximab	KRAS	PA10040	3845	0.93
NULL	Exp_Diabetes_Res_2012_Dec_13_2012_721256.nxml.txt.nlp	23304118	SENT92	42	42	7	7	sulfanilamide	NO3	PA451545	4681	0.93
NULL	Eur_J_Clin_Pharmacol_2012_Sep_15_68(9)_1267-1274.nxml.txt.nlp	22418828	SENT33	33	33	17	17	pantoprazole	CYP2C19	PA450774	1557	0.93
NULL	Front_Immunol_2014_Aug_12_5_368.nxml.txt.nlp	25161652	SENT40	10	10	5	5	ustekinumab	IL-23	PA166048654	51561	0.93
NULL	Appl_Microbiol_Biotechnol_2014_Feb_18_98(8)_3829-3840.nxml.txt.nlp	24535257	SENT139	29	29	40	40	ethanol	PE-2	PA448073	2077	0.93
NULL	J_Carcinog_2014_Nov_27_13_13.nxml.txt.nlp	25525412	SENT92	28	28	10	10	cetuximab	KRAS	PA10040	3845	0.93
NULL	Case_Rep_Dermatol_2012_Sep_16_4(3)_256-260.nxml.txt.nlp	23275770	SENT73	25	25	16	16	isotretinoin	OMG	PA450128	4974	0.93
NULL	Ann_Surg_Oncol_2009_Aug_10_16(8)_2086-2088.nxml.txt.nlp	19513600	SENT72	29	29	15	15	cetuximab	KRAS	PA10040	3845	0.93
NULL	Nature_2008_Dec_11_456(7223)_819-823.nxml.txt.nlp	18849970	SENT209	30	30	9	9	etoposide	CD69	PA449552	969	0.93
NULL	Arq_Bras_Cardiol_2013_Oct_101(4)_304-310.nxml.txt.nlp	24008655	SENT82	7	7	34	34	carvedilol	mol	PA448817	90527	0.93
NULL	Curr_Med_Chem_2014_May_21(14)_1595-1606.nxml.txt.nlp	23992330	SENT346	19	19	8	8	everolimus	KRAS	PA164746311	3845	0.93
NULL	Oncogenesis_2014_Dec_15_3(12)_e133.nxml.txt.nlp	25500906	SENT12	13	13	7	7	trastuzumab	MYO3B	PA451743	140469	0.93
NULL	Cell_Commun_Signal_2013_Nov_11_11_86.nxml.txt.nlp	24215724	SENT18	7	7	32	32	trypsin	PAR1	PA451806	79581;2149	0.93
NULL	Osteoporos_Int_2008_Apr_12_19(4)_399-428.nxml.txt.nlp	18266020	SENT246	12	12	39	39	teriparatide	PTH	PA451620	5741	0.93
NULL	Case_Rep_Oncol_2010_Jan_13_3(1)_14-18.nxml.txt.nlp	20740152	SENT64	7	7	3	3	anastrozole	aromatase	PA448432	1588	0.93
NULL	Acta_Pharmacol_Sin_2014_Jun_4_35(6)_752-757.nxml.txt.nlp	24902786	SENT91	23	23	5	5	letrozole	STL2	PA450196	1301	0.93
NULL	Front_Neurosci_2014_Jan_10_7_270.nxml.txt.nlp	24454277	SENT57	3	3	14	14	resveratrol	SIRT1		23411	0.93
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT217	3	3	9	9	metformin	San	PA450395	80218	0.93
NULL	Evol_Appl_2011_Mar_4(2)_225-248.nxml.txt.nlp	25567970	SENT157	26	26	14	14	lindane	DDT	PA164754914	1652	0.93
NULL	Arch_Med_Sci_2013_Aug_30_9(4)_739-744.nxml.txt.nlp	24049538	SENT107	25	25	3	3	candesartan	PC-3	PA448765	692094	0.93
NULL	Br_J_Cancer_2010_Feb_2_102(3)_520-529.nxml.txt.nlp	20029417	SENT19	15	15	7	7	trastuzumab	HER2	PA451743	2064	0.93
NULL	Braz_J_Med_Biol_Res_2013_Mar_15_46(3)_299-305.nxml.txt.nlp	23532269	SENT127	4	4	18	18	propofol	CD14	PA451141	929	0.93
NULL	Diabetes_2009_Feb_58(2)_352-359.nxml.txt.nlp	19011168	SENT141	33	33	19	19	exenatide	GLP-1	PA164749238	100125288	0.93
NULL	Front_Neurosci_2009_Dec_4_3_48.nxml.txt.nlp	20582275	SENT48	9	9	22	22	capsaicin	TRPV1	PA448776	7442	0.93
NULL	Arthritis_Res_Ther_2012_Mar_8_14(Suppl_2)_A13.nxml.txt.nlp	NULL	SENT13	4	4	12	12	denosumab	RANK	PA166048634	8792	0.93
NULL	Am_J_Cardiovasc_Drugs_2013_Jun_20_13(5)_331-342.nxml.txt.nlp	23784266	SENT195	8	8	14	14	amiodarone	P-gp	PA448383	5243	0.93
NULL	Hum_Genomics_2008_Sep_1_3(1)_7-16.nxml.txt.nlp	19129086	SENT154	32	32	10	10	rosiglitazone	CYP2C8	PA451283	1558	0.93
NULL	Front_Oncol_2014_Sep_23_4_264.nxml.txt.nlp	25295231	SENT265	30	30	25	25	fludarabine	p53	PA449655	7157	0.93
NULL	Mol_Cancer_2013_Mar_5_12_17.nxml.txt.nlp	23497256	SENT127	17	17	37	37	sunitinib	CD11b	PA162372840	3684	0.93
NULL	Eur_J_Clin_Nutr_2014_Oct_25_68(10)_1148-1153.nxml.txt.nlp	24961547	SENT110	16	16	6	6	mannitol	GCLC	PA450320	2729	0.93
NULL	J_Breast_Cancer_2011_Jun_18_14(2)_140-146.nxml.txt.nlp	21847410	SENT172	6	6	19	19	vinorelbine	HER2	PA451881	2064	0.93
NULL	Br_J_Cancer_2012_Nov_6_107(10)_1714-1721.nxml.txt.nlp	23073173	SENT121	22	22	16	16	docetaxel	RUNX2	PA449383	860	0.93
NULL	J_Oncol_2012_Mar_26_2012_986725.nxml.txt.nlp	22545054	SENT196	14	14	9	9	gefitinib	p110	PA131301952	9733	0.93
NULL	Hum_Reprod_2008_Nov_24_23(11)_2535-2548.nxml.txt.nlp	18658158	SENT183	32	32	7	7	collagenase	CD14	PA449107	929	0.93
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1075.nxml.txt.nlp	24556690	SENT67	7	7	0	0	spermine	SMO	PA164781199	6608;54498	0.93
NULL	Am_J_Trop_Med_Hyg_2012_Mar_1_86(3)_489-495.nxml.txt.nlp	22403324	SENT177	33	33	23	23	ritonavir	P-gp	PA451260	5243	0.93
NULL	Diabetes_Obes_Metab_2011_Apr_13(4)_348-356.nxml.txt.nlp	21205128	SENT21	0	0	8	8	liraglutide	GLP-1	PA165958364	100125288	0.93
NULL	Ann_Surg_Oncol_2010_Apr_20_17(4)_1168-1176.nxml.txt.nlp	19936839	SENT204	11	11	6	6	cetuximab	BRAF	PA10040	673	0.93
NULL	Br_J_Cancer_2013_Feb_19_108(3)_557-563.nxml.txt.nlp	23361053	SENT148	12	12	18	18	tamoxifen	PAK1	PA451581	5585;5058	0.93
NULL	Scientifica_(Cairo)_2012_Dec_16_2012_402783.nxml.txt.nlp	24278688	SENT154	14	14	35	35	thrombin	C3a	PA451674	718	0.93
NULL	Acta_Pharmacol_Sin_2010_May_12_31(5)_578-584.nxml.txt.nlp	20383171	SENT17	11	11	0	0	berberine	AKT	PA165860812	207	0.93
NULL	J_Cell_Biol_2000_Jul_10_150(1)_213-224.nxml.txt.nlp	10893269	SENT323	6	6	12	12	neomycin	NHE	PA450608	285335	0.93
NULL	Indian_J_Nucl_Med_2011_Jul-Sep_26(Suppl1)_S37-S49.nxml.txt.nlp	NULL	SENT21	8	8	30	30	choline	FDG	PA448976	23583	0.93
NULL	Acta_Pharmacol_Sin_2012_Apr_12_33(4)_542-550.nxml.txt.nlp	22407228	SENT42	7	7	16	16	perifosine	ATG5	PA165291471	9474	0.93
NULL	Gynecol_Oncol_Case_Rep_2013_Sep_21_6_42-44.nxml.txt.nlp	24371718	SENT74	0	0	7	7	anastrozole	aromatase	PA448432	1588	0.93
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT151	16	16	20	20	chloroquine	BMPR-II	PA448948	659	0.93
NULL	F1000Res_2013_Oct_3_2_202.nxml.txt.nlp	24795806	SENT121	24	24	12	12	celecoxib	EGFR	PA448871	1956	0.93
NULL	J_Clin_Gastroenterol_2014_Sep_24_48(8)_679-686.nxml.txt.nlp	24921215	SENT238	16	16	5	5	ribavirin	IL28B	PA451241	282617	0.93
NULL	J_Carcinog_2014_Mar_5_13_5.nxml.txt.nlp	24799832	SENT30	23	23	40	40	leuprolide	DES	PA450203	1674	0.93
NULL	J_Hematol_Oncol_2013_Jun_3_6_38.nxml.txt.nlp	23731980	SENT62	15	15	33	33	bevacizumab	HER2	PA130232992	2064	0.93
NULL	NMR_Biomed_2013_Oct_7_26(10)_1258-1270.nxml.txt.nlp	23564602	SENT185	28	28	3	3	estradiol	OATP1B1	PA449503	10599	0.93
NULL	Cancer_Manag_Res_2013_Nov_21_5_387-400.nxml.txt.nlp	24294007	SENT61	8	8	17	17	cetuximab	EGFR	PA10040	1956	0.93
NULL	Breast_Cancer_(Auckl)_2011_Jul_27_5_175-199.nxml.txt.nlp	21863131	SENT398	19	19	7	7	panitumumab	EGFR	PA162373091	1956	0.93
NULL	J_Res_Med_Sci_2011_Sep_16(9)_1210-1216.nxml.txt.nlp	22973391	SENT67	13	13	35	35	bupivacaine	ANOVA	PA135057240	4858	0.93
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT234	13	13	11	11	gefitinib	EGFR	PA131301952	1956	0.93
NULL	AIDS_Res_Ther_2013_May_1_10_10.nxml.txt.nlp	23634877	SENT149	23	23	6	6	lovastatin	CCL5	PA450272	6352	0.93
NULL	Arthritis_Res_Ther_2005_Feb_18_7(3)_R476-R484.nxml.txt.nlp	15899034	SENT100	16	16	41	41	thrombin	Rho	PA451674	29984	0.93
NULL	Structure_2013_Sep_3_21(9)_1648-1658.nxml.txt.nlp	23932590	SENT112	20	20	7	7	mitomycin	FAAP24	PA450524	91442	0.93
NULL	J_Mol_Signal_2011_Jul_20_6_7.nxml.txt.nlp	21774804	SENT50	41	41	8	8	dasatinib	p53	PA162372878	7157	0.93
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT306	37	37	30	30	pp2	ERK		5594	0.93
NULL	Evid_Based_Complement_Alternat_Med_2013_Aug_28_2013_516017.nxml.txt.nlp	24066014	SENT141	4	4	1	1	telmisartan	AT1	PA451605	9197;185	0.93
NULL	Chin_J_Cancer_2011_May_30(5)_327-335.nxml.txt.nlp	21527065	SENT183	10	10	17	17	lapatinib	PIK3CA	PA152241907	5290	0.93
NULL	J_Am_Heart_Assoc_2013_Aug_23_2(4)_e000271.nxml.txt.nlp	23842280	SENT297	11	11	36	36	flutamide	p38	PA449685	10598;1432;7965	0.93
NULL	Kidney_Int_Suppl_(2011)_2013_Dec_27_3(4)_392-409.nxml.txt.nlp	NULL	SENT165	12	12	18	18	cinacalcet	PTH	PA164776671	5741	0.93
NULL	Cell_Cycle_2012_Nov_1_11(21)_3983-3996.nxml.txt.nlp	22987153	SENT225	15	15	0	0	cisplatin	DNA2	PA449014	1763	0.93
NULL	Front_Neurol_2011_Dec_16_2_72.nxml.txt.nlp	22203815	SENT199	23	23	8	8	protamine	IL-17	PA10366	3605	0.93
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1063.nxml.txt.nlp	24556678	SENT233	10	10	3	3	thioridazine	c-FLIP	PA451666	8837	0.93
NULL	Ann_Saudi_Med_2011_Mar-Apr_31(2)_111-128.nxml.txt.nlp	21403406	SENT421	0	0	22	22	denosumab	OPG	PA166048634	690	0.93
NULL	Oncotarget_2013_Aug_26_4(10)_1662-1672.nxml.txt.nlp	24091566	SENT79	4	4	8	8	trastuzumab	HER2	PA451743	2064	0.93
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Dec_18_67(Pt_1)_o165.nxml.txt.nlp	21522672	SENT68	37	37	10	10	ethanol	mol	PA448073	90527	0.93
NULL	Clin_Sarcoma_Res_2013_Mar_7_3_3.nxml.txt.nlp	23497641	SENT33	18	18	9	9	imatinib	EGFR	PA10804	1956	0.93
NULL	Diabetes_Care_2013_Aug_17_36(Suppl_2)_S127-S138.nxml.txt.nlp	23882037	SENT232	0	0	7	7	metformin	GLP-1	PA450395	100125288	0.93
NULL	Mol_Vis_2012_Oct_11_18_2509-2517.nxml.txt.nlp	23112566	SENT172	8	8	18	18	bevacizumab	VEGF-A	PA130232992	7422	0.93
NULL	Front_Oncol_2014_Jun_23_4_162.nxml.txt.nlp	25003082	SENT19	22	22	1	1	estradiol	AKR1C3	PA449503	8644	0.93
NULL	Cancer_Cell_Int_2013_Jun_26_13_63.nxml.txt.nlp	23800022	SENT223	27	27	22	22	genistein	XIAP	PA165109660	331	0.93
NULL	Biomed_Res_Int_2013_Sep_4_2013_185362.nxml.txt.nlp	24093091	SENT115	18	18	35	35	cyclophosphamide	CHOP	PA449165	1649	0.93
NULL	Oncol_Lett_2013_Mar_8_5(3)_805-812.nxml.txt.nlp	23426281	SENT186	27	27	17	17	gemcitabine	survivin	PA449748	332	0.93
NULL	Acta_Pharmacol_Sin_2009_Apr_9_30(4)_467-477.nxml.txt.nlp	19270721	SENT125	4	4	11	11	cisplatin	IL-24	PA449014	11009	0.93
NULL	Chemother_Res_Pract_2011_Feb_6_2011_249867.nxml.txt.nlp	22312550	SENT92	10	10	7	7	moxifloxacin	CAP	PA450555	23476;9200;4012;5269;10580;10487	0.93
NULL	Eur_J_Clin_Microbiol_Infect_Dis_2014_Feb_23_33(6)_879-910.nxml.txt.nlp	24563274	SENT164	20	20	27	27	cefotaxime	19A	PA448852	57823	0.93
NULL	Psychol_Res_Behav_Manag_2010_Dec_6_3_109-118.nxml.txt.nlp	22110334	SENT114	34	34	13	13	paroxetine	CYP2C19	PA450801	1557	0.93
NULL	Curr_Med_Chem_2009_Aug_16(23)_3041-3053.nxml.txt.nlp	19689281	SENT171	27	27	10	10	napqi	FasL		356	0.93
NULL	J_Gen_Physiol_2009_May_133(5)_511-524.nxml.txt.nlp	19398777	SENT154	30	30	33	33	nifedipine	DHPR	PA450631	5860	0.93
NULL	Eur_J_Nucl_Med_Mol_Imaging_2008_May_22_35(5)_1008-1018.nxml.txt.nlp	18157531	SENT58	0	0	9	9	trastuzumab	San	PA451743	80218	0.93
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1051.nxml.txt.nlp	24503543	SENT46	30	30	39	39	thioridazine	EGFR	PA451666	1956	0.93
NULL	Pharmaceutics_2011_Nov_18_3(4)_865-913.nxml.txt.nlp	24309312	SENT50	5	5	14	14	clarithromycin	P-gp	PA449028	5243	0.93
NULL	Breast_Cancer_Res_2010_Jun_28_12(3)_R43.nxml.txt.nlp	20579400	SENT158	11	11	4	4	estradiol	MAPT	PA449503	4137	0.93
NULL	Mol_Med_Rep_2014_Oct_23_10(4)_1717-1724.nxml.txt.nlp	25069516	SENT192	17	17	0	0	resveratrol	PC-3		692094	0.93
NULL	Arch_Med_Sci_2011_Apr_17_7(2)_230-234.nxml.txt.nlp	22291761	SENT75	23	23	9	9	curcumin	SMN2	PA151958596	6607	0.93
NULL	Breast_Cancer_Res_2003_Jul_28_5(5)_276-279.nxml.txt.nlp	12927039	SENT94	7	7	18	18	trastuzumab	HER-2	PA451743	2064	0.93
NULL	Mol_Vis_2012_May_1_18_1115-1122.nxml.txt.nlp	22605923	SENT155	37	37	25	25	estradiol	p38	PA449503	10598;1432;7965	0.93
NULL	Aging_(Albany_NY)_2011_Jan_18_3(1)_33-43.nxml.txt.nlp	21248371	SENT120	4	4	6	6	zinc	MDM2	PA451956	4193	0.93
NULL	J_Oncol_2010_Apr_8_2010_785934.nxml.txt.nlp	20396391	SENT153	4	4	21	21	pemetrexed	MTHFR	PA10810	4524	0.93
NULL	Breast_Cancer_Res_Treat_2013_Jun_5_139(3)_649-655.nxml.txt.nlp	23736997	SENT17	14	14	5	5	tamoxifen	CYP2C19	PA451581	1557	0.93
NULL	ScientificWorldJournal_2012_Apr_30_2012_327071.nxml.txt.nlp	22654592	SENT148	3	3	17	17	ethanol	LPO	PA448073	4025	0.93
NULL	J_Vet_Med_Sci_2014_May_13_76(5)_629-636.nxml.txt.nlp	24419976	SENT154	28	28	9	9	indomethacin	EP2	PA449982	5732;10407	0.93
NULL	Arthritis_Res_Ther_2011_Mar_16_13(2)_R44.nxml.txt.nlp	21410959	SENT17	4	4	12	12	glucosamine	RANKL	PA164747613	8600	0.93
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Jun_7_64(Pt_7)_o1211.nxml.txt.nlp	21202850	SENT72	30	30	21	21	ethanol	mol	PA448073	90527	0.93
NULL	Breast_Cancer_Res_2011_Apr_21_13(2)_R46.nxml.txt.nlp	21510863	SENT98	10	10	4	4	trastuzumab	HER2	PA451743	2064	0.93
NULL	Br_J_Cancer_1980_Sep_42(3)_455-461.nxml.txt.nlp	7426347	SENT13	14	14	4	4	indomethacin	PTH	PA449982	5741	0.93
NULL	Ann_Oncol_2012_Dec_2_23(12)_3007-3016.nxml.txt.nlp	22865781	SENT107	25	25	16	16	trastuzumab	HER2	PA451743	2064	0.93
NULL	Balkan_J_Med_Genet_2012_Jun_20_15(1)_19-24.nxml.txt.nlp	24052718	SENT21	36	36	21	21	phenytoin	SCN1A	PA450947	6323	0.93
NULL	Br_J_Cancer_2013_Jul_9_109(1)_68-75.nxml.txt.nlp	23807173	SENT210	11	11	2	2	cisplatin	ERCC1	PA449014	2067	0.93
NULL	Breast_Cancer_Res_2005_Nov_21_7(6)_R1153-R1158.nxml.txt.nlp	16457695	SENT70	16	16	4	4	tamoxifen	BRCA1	PA451581	672	0.93
NULL	Oncotarget_2014_Aug_29_5(19)_8947-8958.nxml.txt.nlp	25333254	SENT221	11	11	17	17	plerixafor	FLT3	PA165958410	2322	0.93
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Jun_22_69(Pt_7)_o1137.nxml.txt.nlp	24046688	SENT69	40	40	12	12	ethanol	mol	PA448073	90527	0.93
NULL	Islets_2012_Jan_1_4(1)_64-70.nxml.txt.nlp	22504862	SENT202	30	30	14	14	dipyridamole	ADP	PA449367	23038	0.93
NULL	Case_Rep_Pulmonol_2013_Sep_5_2013_813786.nxml.txt.nlp	24093069	SENT50	8	8	22	22	montelukast	CysLT1	PA450546	10800	0.93
NULL	Breast_Cancer_Res_2008_Dec_4_10(6)_R103.nxml.txt.nlp	19055788	SENT106	4	4	24	24	tamoxifen	CDH1	PA451581	51343;999	0.93
NULL	Cardiovasc_Diabetol_2013_Mar_23_12_48.nxml.txt.nlp	23522121	SENT40	36	36	10	10	sitagliptin	GLP-1	PA164748978	100125288	0.93
NULL	J_Antimicrob_Chemother_2009_Nov_18_64(5)_910-928.nxml.txt.nlp	19767318	SENT111	18	18	8	8	efavirenz	CD4	PA449441	920	0.93
NULL	Iran_J_Pharm_Res_2014_Autumn_13(4)_1393-1401.nxml.txt.nlp	25587329	SENT169	2	2	26	26	celecoxib	MDR1	PA448871	5243	0.93
NULL	Proteome_Sci_2008_Dec_24_6_36.nxml.txt.nlp	19108728	SENT204	2	2	8	8	trypsin	San	PA451806	80218	0.93
NULL	Nucleic_Acids_Res_2011_Sep_11_39(17)_7750-7763.nxml.txt.nlp	21666256	SENT174	31	31	7	7	doxycycline	PDE12	PA449415	201626	0.93
NULL	Cardiovasc_Diabetol_2013_Oct_17_12_150.nxml.txt.nlp	24134550	SENT17	23	23	13	13	pioglitazone	activin	PA450970	83729	0.93
NULL	Breast_Cancer_Res_2010_Jul_1_12(4)_R45.nxml.txt.nlp	20594311	SENT135	2	2	37	37	nelfinavir	AKT	PA450606	207	0.93
NULL	J_Clin_Biochem_Nutr_2007_Jan_27_40(1)_13-23.nxml.txt.nlp	18437209	SENT575	37	37	12	12	trypsin	IL-8	PA451806	3576	0.93
NULL	Int_J_Mol_Sci_2012_Feb_1_13(2)_1512-1523.nxml.txt.nlp	22408405	SENT55	4	4	16	16	olmesartan	Bcl-2	PA164742950	596	0.93
NULL	J_Mol_Signal_2010_May_10_5_4.nxml.txt.nlp	20459745	SENT109	14	14	39	39	cisplatin	p53	PA449014	7157	0.93
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT12	2	2	16	16	dasatinib	LYN	PA162372878	4067	0.93
NULL	J_Cell_Mol_Med_2014_Dec_9_18(12)_2499-2511.nxml.txt.nlp	24912879	SENT104	13	13	0	0	docetaxel	DACH1	PA449383	1602	0.93
NULL	J_Biol_Chem_2009_Mar_27_284(13)_8855-8865.nxml.txt.nlp	19171933	SENT271	14	14	9	9	thrombin	AKT	PA451674	207	0.93
NULL	Int_J_Mol_Sci_2012_Feb_1_13(2)_1512-1523.nxml.txt.nlp	22408405	SENT9	4	4	17	17	olmesartan	LOX-1	PA164742950	4973	0.93
NULL	Diabetes_2013_Mar_14_62(3)_953-964.nxml.txt.nlp	23223176	SENT145	10	10	12	12	paroxetine	PRX	PA450801	9588;57716	0.93
NULL	J_Hematol_Oncol_2013_Jul_8_6_48.nxml.txt.nlp	23829943	SENT133	17	17	14	14	ridaforolimus	CYP3A4	PA165291475	1576	0.93
NULL	Nat_Commun_2013_Aug_15_4_2130.nxml.txt.nlp	23945651	SENT130	25	25	3	3	etoposide	survivin	PA449552	332	0.93
NULL	Int_J_Biochem_Cell_Biol_2010_Jan_42(1)_113-119.nxml.txt.nlp	19800021	SENT14	42	42	18	18	curcumin	p65	PA151958596	5970	0.93
NULL	Case_Rep_Neurol_Med_2014_Dec_8_2014_701761.nxml.txt.nlp	25548692	SENT53	17	17	10	10	l-carnitine	Q10	PA450154	27161	0.93
NULL	Exp_Ther_Med_2013_Oct_20_6(4)_899-903.nxml.txt.nlp	24137286	SENT9	6	6	33	33	rosuvastatin	MMP9	PA134308647	4318	0.93
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT208	27	27	16	16	perifosine	DR4	PA165291471	8797	0.93
NULL	ScientificWorldJournal_2014_Jan_9_2014_921581.nxml.txt.nlp	24526924	SENT202	24	24	8	8	arsenite	ArsB	PA452638	57152	0.93
NULL	Reprod_Biol_Endocrinol_2003_Apr_28_1_39.nxml.txt.nlp	12737634	SENT180	6	6	0	0	heparin	BSP	PA449855	3381	0.93
NULL	Int_J_Endocrinol_Metab_2013_Dec_21_Winter_11(1)_57-61.nxml.txt.nlp	23853622	SENT125	17	17	11	11	bromocriptine	PRL	PA448671	5617	0.93
NULL	Int_J_Surg_Oncol_2011_Aug_8_2011_374012.nxml.txt.nlp	22312502	SENT168	18	18	12	12	tamoxifen	BRCA1	PA451581	672	0.93
NULL	Cancer_Cell_Int_2013_Feb_12_13_14.nxml.txt.nlp	23402310	SENT2	0	0	6	6	celecoxib	COX	PA448871	1351	0.93
NULL	Int_J_Surg_Oncol_2012_Jun_12_2012_862879.nxml.txt.nlp	22778941	SENT111	35	35	15	15	cisplatin	c-Myc	PA449014	4609	0.93
NULL	ChemistryOpen_2014_Jun_18_3(3)_115-123.nxml.txt.nlp	25050230	SENT237	8	8	31	31	heparin	CD44	PA449855	960	0.93
NULL	Int_Clin_Psychopharmacol_2014_Jul_26_29(4)_206-211.nxml.txt.nlp	24374906	SENT82	12	12	27	27	doxepin	CYP2C9	PA449409	1559	0.93
NULL	J_Neuroinflammation_2011_Feb_4_8_10.nxml.txt.nlp	21294877	SENT6	15	15	3	3	capsaicin	TRPV1	PA448776	7442	0.93
NULL	Ann_Rheum_Dis_2009_Jan_21_68(1)_57-62.nxml.txt.nlp	18292102	SENT204	21	21	8	8	methotrexate	HLA-DRB1	PA450428	3123	0.93
NULL	Exp_Ther_Med_2014_Apr_7_7(4)_827-834.nxml.txt.nlp	24660031	SENT243	23	23	2	2	mitomycin	CD25	PA450524	3669;3559	0.93
NULL	Appl_Clin_Genet_2010_Oct_29_3_85-101.nxml.txt.nlp	23776354	SENT35	25	25	13	13	imatinib	PDGFRA	PA10804	5156	0.93
NULL	J_Signal_Transduct_2011_Jun_7_2011_982879.nxml.txt.nlp	21776391	SENT150	22	22	17	17	cetuximab	EGFR	PA10040	1956	0.93
NULL	J_Headache_Pain_2013_Mar_12_14(1)_25.nxml.txt.nlp	23566208	SENT134	23	23	30	30	topiramate	P24	PA451728	928	0.93
NULL	Oncotarget_2014_Oct_16_5(20)_9546-9563.nxml.txt.nlp	25337673	SENT146	16	16	10	10	gefitinib	CDCP1	PA131301952	64866	0.93
NULL	Exp_Ther_Med_2014_Feb_28_7(2)_316-322.nxml.txt.nlp	24396397	SENT104	11	11	33	33	cerivastatin	IL-6	PA448897	3569	0.93
NULL	Eur_J_Med_Res_2009_Nov_24_14(Suppl_3)_36-42.nxml.txt.nlp	19959415	SENT37	12	12	36	36	raltegravir	gamma		9913	0.93
NULL	Hum_Genomics_2010_Apr_1_4(4)_238-249.nxml.txt.nlp	20511137	SENT69	36	36	15	15	irinotecan	ABCB1	PA450085	5243	0.93
NULL	Oncol_Rep_2013_Apr_23_29(4)_1268-1274.nxml.txt.nlp	23354756	SENT118	2	2	23	23	trastuzumab	SLC25A43	PA451743	203427	0.93
NULL	Crit_Care_2008_Aug_4_12(4)_R99.nxml.txt.nlp	18680591	SENT166	12	12	8	8	metoprolol	AVP	PA450480	114548;551	0.93
NULL	Biomed_Res_Int_2013_Jul_31_2013_692071.nxml.txt.nlp	23984399	SENT177	16	16	0	0	mitoxantrone	OCT1	PA450526	5451;6580	0.93
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT171	18	18	32	32	nutlin-3	MDM2		4193	0.93
NULL	Diabetes_Care_2013_Aug_11_36(8)_2311-2316.nxml.txt.nlp	23462667	SENT140	16	16	9	9	ketamine	KCNJ11	PA450144	3767	0.93
NULL	Mol_Cancer_2010_Apr_23_9_87.nxml.txt.nlp	20416058	SENT177	29	29	23	23	doxorubicin	TRAIL	PA449412	8743	0.93
NULL	Cancers_(Basel)_2014_Feb_28_6(1)_472-490.nxml.txt.nlp	24589997	SENT541	0	0	11	11	sorafenib	LCK	PA7000	3932	0.93
NULL	Front_Behav_Neurosci_2014_Dec_16_8_437.nxml.txt.nlp	25566005	SENT74	26	26	12	12	menthol	TRPM8	PA164776605	79054	0.93
NULL	Nat_Commun_2014_Nov_25_5_5437.nxml.txt.nlp	25421715	SENT75	36	36	5	5	cisplatin	NPM1	PA449014	4869	0.93
NULL	J_Mol_Signal_2008_Dec_2_3_19.nxml.txt.nlp	19055733	SENT58	16	16	38	38	isoproterenol	AKAP5	PA450121	9495	0.93
NULL	Nucleic_Acids_Res_2013_Nov_16_41(20)_9349-9360.nxml.txt.nlp	23956219	SENT184	10	10	33	33	cisplatin	RMI1	PA449014	80010	0.93
NULL	J_Invest_Dermatol_2012_May_16_132(5)_1435-1442.nxml.txt.nlp	22336948	SENT99	6	6	9	9	doxycycline	TLSP	PA449415	11012	0.93
NULL	Int_J_Mol_Sci_2010_Nov_15_11(11)_4539-4555.nxml.txt.nlp	21151455	SENT58	25	25	35	35	naringenin	mol	PA151958361	90527	0.93
NULL	Mol_Pain_2014_Apr_9_10_24.nxml.txt.nlp	24716552	SENT243	14	14	11	11	capsaicin	TRPV1	PA448776	7442	0.93
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT6	20	20	8	8	ranibizumab	VEGF-A	PA164746012	7422	0.93
NULL	Biologics_2013_May_6_7_115-122.nxml.txt.nlp	23674887	SENT96	16	16	20	20	ketoconazole	CYP3A4	PA450146	1576	0.93
NULL	Int_J_Biol_Sci_2006_Oct_15_3(1)_20-26.nxml.txt.nlp	17200688	SENT144	0	0	19	19	geldanamycin	HSF1	PA152031327	3297	0.93
NULL	Cancer_Cell_Int_2003_Apr_8_3_5.nxml.txt.nlp	12718757	SENT119	22	22	26	26	cisplatin	DDP	PA449014	1678	0.93
NULL	Oncol_Lett_2014_Nov_10_8(5)_2333-2339.nxml.txt.nlp	25295120	SENT48	22	22	6	6	sorafenib	ADM	PA7000	133	0.93
NULL	Acta_Pharmacol_Sin_2012_Nov_22_33(11)_1395-1400.nxml.txt.nlp	23085738	SENT26	0	0	7	7	prasugrel	ADP	PA154410481	23038	0.93
NULL	J_Cell_Mol_Med_2013_Oct_2_17(10)_1218-1235.nxml.txt.nlp	23998913	SENT316	25	25	3	3	hydroxyurea	PDGFRA	PA449942	5156	0.93
NULL	Environ_Health_Perspect_2006_Sep_23_114(9)_1401-1406.nxml.txt.nlp	16966095	SENT149	11	11	4	4	arsenite	p53	PA452638	7157	0.93
NULL	Exp_Diabetes_Res_2012_Oct_26_2012_820989.nxml.txt.nlp	22110480	SENT128	7	7	9	9	rosiglitazone	LYRM1	PA451283	57149	0.93
NULL	Diabetes_Metab_J_2012_Aug_20_36(4)_293-299.nxml.txt.nlp	22950061	SENT112	33	33	24	24	metformin	NPY	PA450395	4852	0.93
NULL	J_Neuroeng_Rehabil_2014_Sep_11_11(1)_135.nxml.txt.nlp	NULL	SENT35	35	35	0	0	levodopa	DBS	PA450213	23263;4036	0.93
NULL	Oncotarget_2014_Dec_4_5(22)_11365-11380.nxml.txt.nlp	25426548	SENT212	21	21	16	16	nutlin-3	p53		7157	0.93
NULL	Eur_J_Immunol_2013_Dec_9_43(12)_3183-3196.nxml.txt.nlp	24030559	SENT274	24	24	0	0	mitomycin	CD4	PA450524	920	0.93
NULL	Stroke_Res_Treat_2009_Dec_20_2010_386389.nxml.txt.nlp	20700422	SENT201	9	9	28	28	ebselen	JNK	PA161660841	5599	0.93
NULL	FEBS_Open_Bio_2014_Jul_5_4_659-671.nxml.txt.nlp	25161875	SENT251	23	23	15	15	etoposide	XIAP	PA449552	331	0.93
NULL	Indian_J_Endocrinol_Metab_2012_Sep-Oct_16(5)_698-705.nxml.txt.nlp	23087852	SENT153	6	6	1	1	letrozole	aromatase	PA450196	1588	0.93
NULL	Int_J_Breast_Cancer_2011_Sep_6_2011_352182.nxml.txt.nlp	22295219	SENT142	28	28	42	42	trastuzumab	PIK3CA	PA451743	5290	0.93
NULL	Breast_Cancer_Res_2011_Apr_15_13(2)_R44.nxml.txt.nlp	21496232	SENT44	2	2	36	36	trastuzumab	HER2	PA451743	2064	0.93
NULL	Br_J_Cancer_2013_Jul_9_109(1)_1-7.nxml.txt.nlp	23736035	SENT100	24	24	4	4	raloxifene	STAR	PA451221	6770;2984	0.93
NULL	Oncotarget_2013_Jun_4_4(5)_772-784.nxml.txt.nlp	23800712	SENT25	17	17	10	10	dasatinib	EGFR	PA162372878	1956	0.93
NULL	Diabetes_2011_Mar_21_60(3)_1008-1018.nxml.txt.nlp	21282362	SENT240	16	16	1	1	glucose	FADS1	PA449773	3992	0.93
NULL	Clin_Mol_Allergy_2011_Jul_26_9_11.nxml.txt.nlp	21791043	SENT10	6	6	14	14	omalizumab	CD4	PA164752253	920	0.93
NULL	Curr_Neuropharmacol_2008_Sep_6(3)_215-234.nxml.txt.nlp	19506722	SENT628	13	13	9	9	paroxetine	5-HT1B	PA450801	3351	0.93
NULL	Breast_Cancer_Res_2011_Mar_1_13(2)_R21.nxml.txt.nlp	21362200	SENT171	31	31	16	16	estradiol	PI3K	PA449503	5290	0.93
NULL	Front_Physiol_2015_Jan_5_5_507.nxml.txt.nlp	25601839	SENT43	30	30	21	21	tamoxifen	NFAT5	PA451581	10725	0.93
NULL	Hum_Mol_Genet_2013_Nov_15_22(22)_4616-4626.nxml.txt.nlp	23814041	SENT147	22	22	12	12	simvastatin	neuroserpin	PA451363	5274	0.93
NULL	Mol_Pain_2012_Sep_12_8_66.nxml.txt.nlp	22971321	SENT143	16	16	0	0	capsaicin	TRPV1	PA448776	7442	0.93
NULL	Br_J_Haematol_2014_Mar_13_164(1)_811-821.nxml.txt.nlp	24328678	SENT257	16	16	0	0	lenalidomide	Aiolos	PA162363968	22806	0.93
NULL	J_Young_Pharm_2010_Oct-Dec_2(4)_428-429.nxml.txt.nlp	21264109	SENT5	8	8	42	42	metformin	B12	PA450395	7126;4709	0.93
NULL	Curr_Oncol_2009_Jan_16(1)_27-48.nxml.txt.nlp	19229369	SENT268	17	17	26	26	gefitinib	EGFR	PA131301952	1956	0.93
NULL	FEBS_Open_Bio_2013_Aug_11_3_334-340.nxml.txt.nlp	24251092	SENT141	3	3	19	19	hydroxyurea	AurA	PA449942	6790	0.93
NULL	J_Burns_Wounds_2007_Jul_10_7_e2.nxml.txt.nlp	17846661	SENT192	7	7	12	12	trypsin	TFPI-2	PA451806	7980	0.93
NULL	BMJ_2009_Feb_25_338_b438.nxml.txt.nlp	19244302	SENT48	14	14	1	1	tamoxifen	aromatase	PA451581	1588	0.93
NULL	Cancer_2014_Aug_1_120(15)_2343-2351.nxml.txt.nlp	24752945	SENT8	19	19	3	3	gemcitabine	ERCC1	PA449748	2067	0.93
NULL	EMBO_Mol_Med_2013_Dec_8_5(12)_1821-1834.nxml.txt.nlp	24293316	SENT170	13	13	18	18	doxorubicin	p53	PA449412	7157	0.93
NULL	Cell_Death_Differ_2010_Apr_16_17(4)_666-676.nxml.txt.nlp	19834494	SENT56	18	18	3	3	oxaliplatin	RAGE	PA131285527	177	0.93
NULL	J_Indian_Assoc_Pediatr_Surg_2012_Apr-Jun_17(2)_84-86.nxml.txt.nlp	22529558	SENT83	8	8	40	40	cyclophosphamide	FDG	PA449165	23583	0.93
NULL	J_Neuroinflammation_2011_Feb_4_8_10.nxml.txt.nlp	21294877	SENT6	29	29	3	3	capsaicin	TRPV1	PA448776	7442	0.93
NULL	Cell_Cycle_2012_Aug_1_11(15)_2780-2781.nxml.txt.nlp	22833047	SENT5	8	8	3	3	trastuzumab	HER2	PA451743	2064	0.93
NULL	Exp_Ther_Med_2013_Mar_21_5(3)_987-991.nxml.txt.nlp	23407636	SENT86	28	28	15	15	losartan	IL-8	PA450268	3576	0.93
NULL	Cardiovasc_Diabetol_2013_Mar_4_12_42.nxml.txt.nlp	23452502	SENT228	5	5	13	13	isoflurane	DPP4	PA450106	1803	0.93
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_7-17.nxml.txt.nlp	17912633	SENT368	6	6	4	4	letrozole	aromatase	PA450196	1588	0.93
NULL	South_Asian_J_Cancer_2014_Jan-Mar_3(1)_71-73.nxml.txt.nlp	24665452	SENT52	29	29	13	13	tamoxifen	BRCA2	PA451581	675	0.93
NULL	Front_Aging_Neurosci_2014_Sep_11_6_218.nxml.txt.nlp	25309423	SENT219	16	16	28	28	resveratrol	SIRT1		23411	0.93
NULL	Sci_Rep_2014_Dec_12_4_7456.nxml.txt.nlp	25503852	SENT94	2	2	8	8	resveratrol	SIRT1		23411	0.93
NULL	Ann_Rheum_Dis_2009_Dec_1_68(12)_1819-1826.nxml.txt.nlp	19054822	SENT45	39	39	8	8	abatacept	CDP	PA164747080	1523	0.93
NULL	Arthritis_Res_Ther_2014_Apr_3_16(2)_R86.nxml.txt.nlp	24708674	SENT229	4	4	18	18	bosentan	BLM	PA10034	641	0.93
NULL	Sci_Rep_2014_Nov_28_4_7237.nxml.txt.nlp	25429875	SENT123	34	34	32	32	hesperidin	p38	PA449867	10598;1432;7965	0.93
NULL	Mol_Syst_Biol_2010_Oct_19_6_420.nxml.txt.nlp	20959818	SENT85	33	33	28	28	galactose	GAL	PA449725	51083	0.93
NULL	Front_Chem_2013_Jun_26_1_8.nxml.txt.nlp	24790937	SENT23	22	22	13	13	lithium	DMC	PA450243	284340;54808	0.93
NULL	Mol_Biol_Rep_2013_Sep_25_40(10)_5953-5958.nxml.txt.nlp	24065531	SENT54	18	18	6	6	aprotinin	MMP8	PA448472	4317	0.93
NULL	J_Mol_Signal_2008_Dec_1_3_18.nxml.txt.nlp	19046439	SENT27	4	4	16	16	metformin	AMPK	PA450395	5563	0.93
NULL	J_Vet_Med_Sci_2014_Mar_1_76(3)_323-330.nxml.txt.nlp	24189582	SENT12	4	4	1	1	atovaquone	DHODH	PA448502	1723	0.93
NULL	Clin_Pharmacol_2013_Jul_4_5_117-129.nxml.txt.nlp	23861604	SENT27	26	26	41	41	denosumab	RANK	PA166048634	8792	0.93
NULL	Int_J_Breast_Cancer_2012_Feb_26_2012_761917.nxml.txt.nlp	22482061	SENT154	6	6	9	9	tamoxifen	HER2	PA451581	2064	0.93
NULL	Oncoscience_2013_Dec_11_1(1)_21-29.nxml.txt.nlp	25593981	SENT99	19	19	12	12	auranofin	HSP27	PA448510	3315	0.93
NULL	Mol_Med_Rep_2015_Feb_5_11(2)_805-814.nxml.txt.nlp	25373883	SENT157	11	11	3	3	colchicine	APE	PA449092	55704;328	0.93
NULL	Cancer_Cell_Int_2002_Jul_5_2_7.nxml.txt.nlp	12234376	SENT10	11	11	34	34	staurosporine	BRCA1	PA165109623	672	0.93
NULL	Oncogene_2009_Jan_15_28(2)_157-169.nxml.txt.nlp	18931700	SENT14	5	5	27	27	geldanamycin	ERBB2	PA152031327	2064	0.93
NULL	Br_J_Pharmacol_2014_Oct_26_171(20)_4785-4796.nxml.txt.nlp	25074741	SENT42	14	14	25	25	guanfacine	NK1R	PA449825	6869	0.93
NULL	Br_J_Cancer_2014_Nov_25_111(11)_2091-2102.nxml.txt.nlp	25349971	SENT132	7	7	28	28	imatinib	KIT	PA10804	3815	0.93
NULL	Mol_Cancer_2014_Jun_27_13_159.nxml.txt.nlp	24972933	SENT184	16	16	0	0	cytarabine	DCK	PA449177	1633	0.93
NULL	Diabetes_2009_Dec_31_58(12)_2851-2862.nxml.txt.nlp	19720788	SENT145	29	29	6	6	forskolin	CHOP	PA146096022	1649	0.93
NULL	Oncogene_2013_Sep_12_32(37)_4355-4365.nxml.txt.nlp	23108409	SENT101	25	25	7	7	4-methylumbelliferone	HAS2	PA154081778	3037	0.93
NULL	Int_J_Mol_Sci_2013_Apr_15_14(4)_8213-8227.nxml.txt.nlp	23591839	SENT145	1	1	4	4	metformin	AMPK	PA450395	5563	0.93
NULL	Diabetes_Care_2011_Jul_17_34(7)_e115-e120.nxml.txt.nlp	21709286	SENT93	16	16	11	11	metformin	AMPK	PA450395	5563	0.93
NULL	Cell_Mol_Life_Sci_2012_Jul_15_69(14)_2279-2282.nxml.txt.nlp	22585058	SENT96	22	22	4	4	cisplatin	NOX3	PA449014	50508	0.93
NULL	Protein_J_2012_Aug_5_31(6)_511-518.nxml.txt.nlp	22763563	SENT136	3	3	9	9	atorvastatin	MSR1	PA448500	4481	0.93
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT196	0	0	23	23	erlotinib	EGFR	PA134687924	1956	0.93
NULL	Oncotarget_2012_Nov_17_3(12)_1600-1614.nxml.txt.nlp	23307622	SENT102	20	20	12	12	trastuzumab	ATG12	PA451743	9140	0.93
NULL	J_Inflamm_(Lond)_2008_Jul_29_5_11.nxml.txt.nlp	18664275	SENT116	9	9	15	15	grepafloxacin	IL-8	PA449812	3576	0.93
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT14	23	23	15	15	tacrolimus	SOCS3	PA451578	9021	0.93
NULL	Curr_Oncol_2009_Jan_16(1)_16-26.nxml.txt.nlp	19229368	SENT51	16	16	2	2	panitumumab	KRAS	PA162373091	3845	0.93
NULL	Environ_Health_Perspect_2005_Oct_14_113(10)_1330-1335.nxml.txt.nlp	16203242	SENT157	15	15	8	8	arsenite	MLC	PA452638	23209	0.93
NULL	Curr_Neuropharmacol_2008_Sep_6(3)_215-234.nxml.txt.nlp	19506722	SENT77	19	19	0	0	paroxetine	5-HT1B	PA450801	3351	0.93
NULL	J_Obes_2010_Jan_14_2010_970865.nxml.txt.nlp	20798864	SENT107	13	13	31	31	metformin	AMPK	PA450395	5563	0.93
NULL	Eur_J_Med_Res_2014_Jun_24_19(1)_34.nxml.txt.nlp	24961604	SENT7	26	26	22	22	vincristine	BCL11A	PA451879	53335	0.93
NULL	Acta_Pharmacol_Sin_2011_Oct_15_32(10)_1303-1308.nxml.txt.nlp	21841812	SENT138	30	30	14	14	losartan	CYP2C9	PA450268	1559	0.93
NULL	Indian_J_Psychiatry_2007_Oct-Dec_49(4)_271-276.nxml.txt.nlp	20680140	SENT67	18	18	7	7	clozapine	spatial	PA449061	219793	0.93
NULL	Carcinogenesis_2010_Dec_15_31(12)_2031-2038.nxml.txt.nlp	20952512	SENT175	18	18	1	1	hydroxyurea	RAD51	PA449942	5888	0.93
NULL	Acta_Pharmacol_Sin_2010_Oct_13_31(10)_1350-1358.nxml.txt.nlp	20835264	SENT12	4	4	32	32	simvastatin	gamma	PA451363	9913	0.93
NULL	Br_J_Cancer_2010_Mar_16_102(6)_1003-1009.nxml.txt.nlp	20179710	SENT64	15	15	8	8	exemestane	aromatase	PA449563	1588	0.93
NULL	Ann_Gastroenterol_2015_Jan-Mar_28(1)_55-65.nxml.txt.nlp	25608803	SENT138	34	34	4	4	telaprevir	IL28B	PA165958354	282617	0.93
NULL	Eur_J_Clin_Pharmacol_2012_Sep_15_68(9)_1267-1274.nxml.txt.nlp	22418828	SENT10	38	38	3	3	pantoprazole	CYP2C19	PA450774	1557	0.93
NULL	Acta_Pharmacol_Sin_2014_Jul_9_35(7)_889-898.nxml.txt.nlp	24909515	SENT223	15	15	8	8	bromocriptine	DRD2	PA448671	1813	0.93
NULL	Reprod_Biol_Endocrinol_2004_Jul_7_2_55.nxml.txt.nlp	15239837	SENT9	10	10	13	13	letrozole	aromatase	PA450196	1588	0.93
NULL	Core_Evid_2008_Jun_3(1)_31-43.nxml.txt.nlp	20694082	SENT287	2	2	16	16	conivaptan	CYP3A4	PA164742939	1576	0.93
NULL	CNS_Neurosci_Ther_2010_Oct_16(5)_e138-e156.nxml.txt.nlp	20626426	SENT95	38	38	16	16	vasopressin	ACTH	PA451858	5443	0.93
NULL	Indian_J_Endocrinol_Metab_2011_Jan-Mar_15(1)_9-17.nxml.txt.nlp	21584160	SENT110	23	23	16	16	exenatide	PPG	PA164749238	5552	0.93
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1044.nxml.txt.nlp	24503536	SENT359	20	20	12	12	cisplatin	XIAP	PA449014	331	0.93
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT6	18	18	8	8	bevacizumab	VEGF-A	PA130232992	7422	0.93
NULL	Eur_J_Clin_Pharmacol_2010_Sep_16_66(9)_955.nxml.txt.nlp	20552178	SENT6	15	15	37	37	zolpidem	CYP3A	PA451976	1574	0.93
NULL	Arthritis_Res_Ther_2014_Jul_18_16(4)_R153.nxml.txt.nlp	25037855	SENT169	3	3	9	9	adalimumab	CD14	PA10004	929	0.93
NULL	Br_J_Cancer_1995_Oct_72(4)_952-957.nxml.txt.nlp	7547247	SENT11	16	16	6	6	bleomycin	p53	PA448645	7157	0.93
NULL	Oncogene_2009_Dec_3_28(48)_4237-4248.nxml.txt.nlp	19734937	SENT58	17	17	24	24	thrombin	PAR-1	PA451674	2011;2149	0.93
NULL	Clin_Exp_Otorhinolaryngol_2011_Jun_31_4(2)_77-82.nxml.txt.nlp	21716954	SENT201	4	4	6	6	minocycline	Bcl-2	PA450519	596	0.93
NULL	Chin_J_Cancer_2012_Aug_31(8)_364-372.nxml.txt.nlp	22739265	SENT85	26	26	12	12	etoposide	p53	PA449552	7157	0.93
NULL	Mol_Cell_Biochem_2014_Jul_26_396(1-2)_221-228.nxml.txt.nlp	25063218	SENT6	9	9	17	17	resveratrol	EGFR		1956	0.93
NULL	J_Exp_Med_1962_Feb_28_115(3)_623-639.nxml.txt.nlp	13891303	SENT6	14	14	9	9	papain	gamma	PA450778	9913	0.93
NULL	Cardiovasc_Res_2015_Jan_1_105(1)_31-43.nxml.txt.nlp	25341891	SENT15	6	6	34	34	phenylephrine	p38	PA450935	10598;1432;7965	0.93
NULL	Int_J_Nanomedicine_2012_Nov_20_7_5781-5792.nxml.txt.nlp	23185118	SENT79	22	22	8	8	etoposide	CO2	PA449552	4513	0.93
NULL	Cell_Death_Dis_2014_Jul_17_5(7)_e1333.nxml.txt.nlp	25032856	SENT34	3	3	12	12	candesartan	EAAC1	PA448765	6505	0.93
NULL	Clin_Pharmacokinet_2014_Oct_15_53(2)_155-164.nxml.txt.nlp	24127209	SENT29	43	43	22	22	clopidogrel	CYP2C9	PA449053	1559	0.93
NULL	Clin_Infect_Dis_2013_May_1_56(9)_1330-1339.nxml.txt.nlp	23362284	SENT111	9	9	4	4	nevirapine	HLA-C	PA450616	3107	0.93
NULL	EJC_Suppl_2013_Sep_5_11(2)_92-96.nxml.txt.nlp	NULL	SENT71	5	5	12	12	dacarbazine	BRAF	PA449197	673	0.93
NULL	Adv_Hematol_2012_Jan_18_2012_195484.nxml.txt.nlp	22312366	SENT24	13	13	6	6	rituximab	CHOP	PA451261	1649	0.93
NULL	Clin_Med_Insights_Oncol_2012_Feb_28_6_125-135.nxml.txt.nlp	22408376	SENT193	11	11	44	44	panitumumab	KRAS	PA162373091	3845	0.93
NULL	Aging_(Albany_NY)_2010_Jun_28_2(6)_353-360.nxml.txt.nlp	20606253	SENT104	20	20	31	31	resveratrol	SIRT1		23411	0.93
NULL	Diabetes_Care_2010_Apr_19_33(4)_914-919.nxml.txt.nlp	20086255	SENT181	12	12	6	6	ramipril	DREAM	PA451223	30818	0.93
NULL	Ann_Dermatol_2011_Dec_27_23(Suppl_3)_S290-S295.nxml.txt.nlp	22346260	SENT57	5	5	3	3	dapsone	EED	PA449211	8726	0.93
NULL	J_Physiol_2014_Nov_15_592(22)_5093-5107.nxml.txt.nlp	25239460	SENT156	14	14	12	12	ketoprofen	COX	PA450149	1351	0.93
NULL	J_Acquir_Immune_Defic_Syndr_2014_Jan_1_65(1)_78-81.nxml.txt.nlp	24419064	SENT22	0	0	4	4	maraviroc	CCR5	PA164768835	1234	0.93
NULL	Exp_Mol_Med_2012_Apr_30_44(4)_281-292.nxml.txt.nlp	22228119	SENT94	37	37	5	5	genistein	activin	PA165109660	83729	0.93
NULL	Arthritis_Res_Ther_2006_Jul_17_8(4)_R107.nxml.txt.nlp	16846531	SENT168	0	0	7	7	thrombin	CXCL8	PA451674	3576	0.93
NULL	Case_Rep_Oncol_2010_Jun_8_3(2)_182-188.nxml.txt.nlp	20740194	SENT9	0	0	17	17	erlotinib	EGFR	PA134687924	1956	0.93
NULL	Diabetes_Care_2008_Jul_31(7)_1427-1432.nxml.txt.nlp	18390799	SENT128	22	22	5	5	metformin	RBP4	PA450395	5433;5950	0.93
NULL	Cases_J_2009_Apr_28_2_6602.nxml.txt.nlp	19829828	SENT68	0	0	24	24	diclofenac	CYP3A4	PA449293	1576	0.93
NULL	J_Mol_Signal_2012_May_14_7_4.nxml.txt.nlp	22583680	SENT191	1	1	14	14	rolipram	AKAP5	PA153906323	9495	0.93
NULL	Indian_J_Crit_Care_Med_2011_Jul-Sep_15(3)_179-181.nxml.txt.nlp	22013312	SENT24	10	10	3	3	levofloxacin	NRP	PA450214	8829;4673;10133	0.93
NULL	Acta_Pharmacol_Sin_2011_Oct_12_32(10)_1259-1265.nxml.txt.nlp	21909126	SENT122	8	8	30	30	candesartan	LOX-1	PA448765	4973	0.93
NULL	Case_Rep_Dermatol_2011_Oct_11_3(3)_223-227.nxml.txt.nlp	22135629	SENT20	15	15	3	3	trastuzumab	HER2	PA451743	2064	0.93
NULL	Br_J_Cancer_2009_Mar_24_100(6)_941-949.nxml.txt.nlp	19240716	SENT264	5	5	19	19	gefitinib	Met	PA131301952	79811	0.93
NULL	Nat_Commun_2010_Jun_1_1(3)_1-9.nxml.txt.nlp	20975695	SENT129	0	0	21	21	tamoxifen	E12	PA451581	64100	0.93
NULL	Cell_Death_Dis_2012_Mar_1_3(3)_e275.nxml.txt.nlp	22378068	SENT52	19	19	13	13	metformin	AKT	PA450395	207	0.93
NULL	Chin_J_Cancer_2011_Jul_30(7)_490-496.nxml.txt.nlp	21718595	SENT88	18	18	7	7	oxaliplatin	LC3	PA131285527	84557	0.93
NULL	Addict_Sci_Clin_Pract_2010_Dec_5(2)_17-29.nxml.txt.nlp	22002450	SENT50	11	11	20	20	hydrocodone	CYP2D6	PA449900	1565	0.93
NULL	Int_J_Nanomedicine_2012_Sep_24_7_5109-5117.nxml.txt.nlp	23055723	SENT127	22	22	0	0	cyclosporine	Q10	PA449167	27161	0.93
NULL	Oxid_Med_Cell_Longev_2013_Mar_5_2013_264935.nxml.txt.nlp	23533686	SENT169	26	26	14	14	hemin	HO-1	PA449849	3162	0.93
NULL	Acta_Neuropathol_Commun_2013_Aug_9_1_49.nxml.txt.nlp	24252504	SENT111	15	15	3	3	arsenite	TDP-43	PA452638	23435	0.93
NULL	J_Psychopharmacol_2010_Jan_24(1)_27-38.nxml.txt.nlp	19204064	SENT387	9	9	18	18	morphine	NK1	PA450550	11126	0.93
NULL	Reprod_Biol_Endocrinol_2013_Oct_3_11_97.nxml.txt.nlp	24090109	SENT4	0	0	4	4	letrozole	aromatase	PA450196	1588	0.93
NULL	BMJ_Open_2013_Sep_3_3(9)_e003201.nxml.txt.nlp	24002982	SENT209	10	10	20	20	voglibose	PI3	PA164752433	5266	0.93
NULL	J_Headache_Pain_2013_Mar_12_14(1)_25.nxml.txt.nlp	23566208	SENT29	25	25	7	7	flunarizine	LEP	PA164776636	3952	0.93
NULL	Mol_Brain_2014_Aug_21_7_59.nxml.txt.nlp	25139109	SENT27	12	12	9	9	imiquimod	TLR7	PA449972	51284	0.93
NULL	BMB_Rep_2014_May_47(5)_274-279.nxml.txt.nlp	24286313	SENT74	14	14	33	33	bortezomib	GAPDH	PA10252	2597	0.93
NULL	Cancers_(Basel)_2011_Apr_1_3(2)_1844-1860.nxml.txt.nlp	24212785	SENT98	29	29	7	7	irinotecan	PTEN	PA450085	5728	0.93
NULL	Arthritis_Res_Ther_2010_Jun_2_12(3)_R107.nxml.txt.nlp	20525198	SENT119	17	17	7	7	rolipram	IL-10	PA153906323	3586	0.93
NULL	Biomed_Res_Int_2014_Feb_6_2014_323594.nxml.txt.nlp	24689036	SENT390	11	11	4	4	raloxifene	PC3	PA451221	57332;7832;5122	0.93
NULL	Cell_Commun_Signal_2013_Oct_1_11_73.nxml.txt.nlp	24083678	SENT126	22	22	11	11	sulindac	IL-8	PA451565	3576	0.93
NULL	Oncotarget_2012_May_18_3(5)_525-534.nxml.txt.nlp	22619113	SENT39	11	11	29	29	fludarabine	IL-4	PA449655	3565	0.93
NULL	Mol_Pain_2013_Mar_4_9_9.nxml.txt.nlp	23497345	SENT182	7	7	16	16	capsaicin	TRPV1	PA448776	7442	0.93
NULL	Cancer_Cell_Int_2010_Apr_29_10_12.nxml.txt.nlp	20429927	SENT182	23	23	18	18	bortezomib	HRI	PA10252	27102	0.93
NULL	J_Biol_Chem_2012_Apr_27_287(18)_14644-14658.nxml.txt.nlp	22375002	SENT208	32	32	24	24	forskolin	CC2D1A	PA146096022	54862	0.93
NULL	J_Biol_Chem_2009_Feb_27_284(9)_5645-5653.nxml.txt.nlp	19095655	SENT85	10	10	38	38	phenformin	AMPK	PA1000	5563	0.93
NULL	Acta_Pharmacol_Sin_2013_Jun_8_34(6)_830-836.nxml.txt.nlp	23564080	SENT121	22	22	5	5	simvastatin	HMGB1	PA451363	3146	0.93
NULL	Oxid_Med_Cell_Longev_2013_Nov_12_2013_820679.nxml.txt.nlp	24327827	SENT17	5	5	14	14	resveratrol	PI3		5266	0.93
NULL	Breast_Cancer_Res_2008_Dec_18_10(Suppl_4)_S26.nxml.txt.nlp	19128440	SENT44	15	15	12	12	tamoxifen	aromatase	PA451581	1588	0.93
NULL	Clin_Drug_Investig_2013_Jul_24_33(9)_621-631.nxml.txt.nlp	23881565	SENT104	4	4	23	23	pioglitazone	IPT	PA450970	54802	0.93
NULL	Curr_Opin_Lipidol_2014_Oct_4_25(5)_387-393.nxml.txt.nlp	25110901	SENT71	13	13	5	5	berberine	PCSK9	PA165860812	255738	0.93
NULL	Acta_Pharmacol_Sin_2012_Oct_17_33(10)_1301-1310.nxml.txt.nlp	22983390	SENT205	30	30	14	14	cisplatin	p53	PA449014	7157	0.93
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT70	11	11	5	5	paclitaxel	ABCC10	PA450761	89845	0.93
NULL	Front_Genet_2014_Feb_26_5_40.nxml.txt.nlp	24616734	SENT317	13	13	28	28	docetaxel	UPB1	PA449383	51733	0.93
NULL	J_Headache_Pain_2014_Dec_8_15(1)_85.nxml.txt.nlp	25488888	SENT181	8	8	19	19	naratriptan	5-HT1D	PA450597	3352	0.93
NULL	Oncol_Lett_2014_Jun_8_7(6)_2035-2040.nxml.txt.nlp	24932285	SENT144	17	17	3	3	irinotecan	UGT1A1	PA450085	54658	0.93
NULL	Nat_Chem_Biol_2009_Apr_26_5(4)_236-243.nxml.txt.nlp	19172146	SENT321	13	13	18	18	ns-398	COX		1351	0.93
NULL	Ann_Hematol_2014_Sep_10_93(1)_1-11.nxml.txt.nlp	24018623	SENT130	10	10	13	13	lenalidomide	CDC25C	PA162363968	995	0.93
NULL	Nat_Med_2010_Feb_24_16(2)_214-218.nxml.txt.nlp	20098429	SENT61	23	23	2	2	epirubicin	LAPTM4B	PA449476	55353	0.93
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT128	15	15	35	35	midazolam	CYP3A	PA450496	1574	0.93
NULL	BMB_Rep_2014_Mar_47(3)_167-172.nxml.txt.nlp	24499665	SENT115	13	13	11	11	nutlin-3	MDM2		4193	0.93
NULL	Oncotarget_2013_Feb_25_4(2)_310-315.nxml.txt.nlp	23470635	SENT15	8	8	21	21	imatinib	KIT	PA10804	3815	0.93
NULL	Cancers_(Basel)_2013_Jan_15_5(1)_27-47.nxml.txt.nlp	24216697	SENT1082	9	9	14	14	temozolomide	p53	PA451609	7157	0.93
NULL	J_Cell_Biol_1998_Nov_16_143(4)_901-910.nxml.txt.nlp	9817749	SENT10	28	28	34	34	geldanamycin	Hsp90	PA152031327	3320	0.93
NULL	Clinics_(Sao_Paulo)_2010_Jun_65(6)_645-646.nxml.txt.nlp	20613942	SENT42	14	14	29	29	orlistat	CEA	PA164776864	5670;1087	0.93
NULL	Br_J_Cancer_1996_Feb_73(3)_316-322.nxml.txt.nlp	8562336	SENT9	10	10	44	44	chloramphenicol	CYP1A1	PA448927	1543	0.93
NULL	Breast_Cancer_Res_2011_Mar_11_13(2)_R30.nxml.txt.nlp	21396117	SENT228	3	3	23	23	erlotinib	BRCA1	PA134687924	672	0.93
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Oct_31_65(Pt_11)_o2934.nxml.txt.nlp	21578510	SENT48	20	20	6	6	ethanol	mol	PA448073	90527	0.93
NULL	Pain_Res_Treat_2012_Aug_23_2012_960780.nxml.txt.nlp	21984961	SENT80	14	14	0	0	capsaicin	TRPV1	PA448776	7442	0.93
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT173	8	8	0	0	metformin	HIP	PA450395	6767;6159;64399;5068	0.93
NULL	J_Clin_Biochem_Nutr_2007_Jan_27_40(1)_13-23.nxml.txt.nlp	18437209	SENT142	16	16	8	8	thrombin	PAR3	PA451674	56288;2151	0.93
NULL	Endocrinol_Diabetes_Metab_Case_Rep_2014_Aug_1_2014_140058.nxml.txt.nlp	25276353	SENT72	19	19	0	0	hydrocortisone	BAH	PA449905	444	0.93
NULL	Front_Neurosci_2014_Feb_6_8_12.nxml.txt.nlp	24567701	SENT360	28	28	9	9	citalopram	STAR	PA449015	6770;2984	0.93
NULL	Br_J_Cancer_2013_May_14_108(9)_1807-1809.nxml.txt.nlp	23612454	SENT53	14	14	8	8	trastuzumab	PI3K	PA451743	5290	0.93
NULL	J_Cell_Physiol_2011_Nov_15_226(11)_2979-2986.nxml.txt.nlp	21328349	SENT9	17	17	2	2	econazole	TRPV5	PA164746010	56302	0.93
NULL	Ann_Dermatol_2011_Dec_27_23(Suppl_3)_S360-S363.nxml.txt.nlp	22346278	SENT21	11	11	7	7	imatinib	CML	PA10804	613	0.93
NULL	Exp_Anim_2014_Feb_7_63(1)_11-19.nxml.txt.nlp	24521859	SENT40	8	8	0	0	ethanol	E14	PA448073	4863	0.93
NULL	Oncol_Lett_2014_Jul_8_8(1)_47-54.nxml.txt.nlp	24959217	SENT32	5	5	30	30	vemurafenib	NRAS	PA165946873	4893	0.93
NULL	Nucleic_Acids_Res_2011_Jun_9_39(11)_4640-4652.nxml.txt.nlp	21310710	SENT321	35	35	11	11	camptothecin	SATB1	PA153590860	6304	0.93
NULL	J_Inherit_Metab_Dis_2012_Jan_10_35(1)_141-149.nxml.txt.nlp	21556832	SENT156	27	27	10	10	creatine	CRTR	PA164778930	6535	0.93
NULL	Support_Care_Cancer_2012_Nov_2_20(11)_2669-2677.nxml.txt.nlp	22298194	SENT193	19	19	16	16	aprepitant	NK1	PA164747039	11126	0.93
NULL	Cell_Commun_Signal_2013_Oct_3_11_75.nxml.txt.nlp	24090133	SENT27	32	32	8	8	heparin	CCN2	PA449855	1490	0.93
NULL	Br_J_Cancer_2009_Jul_21_101(2)_238-243.nxml.txt.nlp	19568242	SENT145	20	20	33	33	sunitinib	IFN	PA162372840	3439	0.93
NULL	J_Neuroinflammation_2010_Sep_7_7_51.nxml.txt.nlp	20822529	SENT176	20	20	38	38	hemin	CXCL10	PA449849	3627	0.93
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1137-1144.nxml.txt.nlp	20234366	SENT58	20	20	27	27	cetuximab	KRAS	PA10040	3845	0.93
NULL	J_Biol_Chem_2009_Apr_24_284(17)_11613-11621.nxml.txt.nlp	19234302	SENT148	0	0	24	24	gentamicin	SEPT11	PA449753	55752	0.93
NULL	Mol_Cell_Proteomics_2012_Feb_6_11(2)_M111_015222.nxml.txt.nlp	22147731	SENT215	23	23	11	11	gefitinib	EGF	PA131301952	1950	0.93
NULL	Br_J_Cancer_2009_Oct_6_101(7)_1155-1161.nxml.txt.nlp	19738614	SENT148	14	14	10	10	gemcitabine	MUC4	PA449748	4585	0.929
NULL	Indian_J_Pharmacol_2012_Sep-Oct_44(5)_624-628.nxml.txt.nlp	23112426	SENT137	17	17	10	10	nimodipine	CYP3A4	PA450633	1576	0.929
NULL	Oncol_Lett_2014_Nov_12_8(5)_2203-2208.nxml.txt.nlp	25295109	SENT128	11	11	18	18	celecoxib	SMO	PA448871	6608;54498	0.929
NULL	Clin_Ophthalmol_2010_Apr_26_4_275-283.nxml.txt.nlp	20463795	SENT133	2	2	13	13	bevacizumab	San	PA130232992	80218	0.929
NULL	Exp_Diabetes_Res_2012_Oct_15_2012_465282.nxml.txt.nlp	23118742	SENT84	29	29	11	11	metformin	FGF21	PA450395	26291	0.929
NULL	Oncogene_2010_Jul_22_29(29)_4170-4182.nxml.txt.nlp	20498638	SENT130	20	20	2	2	gefitinib	EGFR	PA131301952	1956	0.929
NULL	Oncotarget_2012_Dec_17_4(1)_48-63.nxml.txt.nlp	23295955	SENT188	5	5	34	34	methotrexate	MTHFD2	PA450428	10797	0.929
NULL	Comp_Hepatol_2005_Feb_8_4_2.nxml.txt.nlp	15701172	SENT92	24	24	36	36	ketoconazole	CYP3A	PA450146	1574	0.929
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT171	38	38	32	32	nutlin-3	MDM2		4193	0.929
NULL	F1000Prime_Rep_2014_Dec_1_6_117.nxml.txt.nlp	25580271	SENT66	19	19	38	38	pemetrexed	EGFR	PA10810	1956	0.929
NULL	Cancer_Cell_Int_2013_Sep_23_13_94.nxml.txt.nlp	24059699	SENT212	42	42	9	9	bevacizumab	VEGFR1	PA130232992	2321	0.929
NULL	Open_Biochem_J_2011_Sep_23_5_45-51.nxml.txt.nlp	21966325	SENT109	39	39	30	30	diclofenac	ATF6	PA449293	22926	0.929
NULL	Br_J_Pharmacol_2012_Apr_165(7)_2191-2202.nxml.txt.nlp	21958009	SENT16	5	5	1	1	ketanserin	5-HT2A	PA131053734	3356	0.929
NULL	Arthritis_Res_Ther_2003_Oct_2_5(Suppl_4)_S17-S21.nxml.txt.nlp	15180893	SENT54	3	3	17	17	rituximab	ACR	PA451261	49	0.929
NULL	Mol_Cancer_2009_Aug_25_8_66.nxml.txt.nlp	19706164	SENT221	15	15	8	8	celecoxib	p53	PA448871	7157	0.929
NULL	Diabetes_Metab_Syndr_Obes_2009_Jun_24_2_101-109.nxml.txt.nlp	21437123	SENT3	0	0	10	10	repaglinide	PPG	PA451234	5552	0.929
NULL	J_Exp_Med_2000_Nov_20_192(10)_1501-1508.nxml.txt.nlp	11085751	SENT133	4	4	32	32	trypsin	HCC-1	PA451806	6358	0.929
NULL	Environ_Health_Perspect_2005_Aug_15_113(8)_1009-1014.nxml.txt.nlp	16079071	SENT225	2	2	19	19	captopril	p38	PA448780	10598;1432;7965	0.929
NULL	Br_J_Cancer_1998_77(2)_201-209.nxml.txt.nlp	9460989	SENT11	29	29	8	8	chlorambucil	MRP1	PA448926	4437	0.929
NULL	Eur_J_Clin_Microbiol_Infect_Dis_2012_Apr_29_31(4)_571-574.nxml.txt.nlp	21796345	SENT23	15	15	31	31	lamivudine	LAM	PA450163	7249;7248	0.929
NULL	Breast_Cancer_Res_2008_Jul_24_10(4)_211.nxml.txt.nlp	18671839	SENT78	36	36	7	7	tamoxifen	HER2	PA451581	2064	0.929
NULL	Nucleic_Acids_Res_2012_Jul_19_40(13)_5910-5925.nxml.txt.nlp	22434882	SENT344	4	4	9	9	etoposide	p65	PA449552	5970	0.929
NULL	Indian_J_Pharmacol_2008_Oct_40(Suppl_2)_S112-S142.nxml.txt.nlp	21593965	SENT765	6	6	26	26	fenofibrate	STZ	PA449594	6484	0.929
NULL	Mol_Cancer_2010_Mar_4_9_49.nxml.txt.nlp	20202195	SENT129	13	13	5	5	vorinostat	HDAC3	PA164748224	8841	0.929
NULL	Mol_Vis_2011_Feb_1_17_332-340.nxml.txt.nlp	21297899	SENT116	11	11	30	30	benazepril	NAC	PA448561	22861	0.929
NULL	Ayu_2013_Oct-Dec_34(4)_433-439.nxml.txt.nlp	24696583	SENT66	12	12	3	3	metformin	STZ	PA450395	6484	0.929
NULL	Crit_Care_2011_Nov_30_15(6)_R289.nxml.txt.nlp	22129171	SENT145	3	3	24	24	dipyridamole	IL-10	PA449367	3586	0.929
NULL	J_Biomed_Sci_2014_Feb_3_21(1)_10.nxml.txt.nlp	24490900	SENT171	19	19	3	3	alendronate	CTR	PA448082	799	0.929
NULL	Br_J_Pharmacol_2008_Sep_9_155(1)_127-137.nxml.txt.nlp	18536750	SENT60	35	35	30	30	piroxicam	IL-10	PA450985	3586	0.929
NULL	Mol_Brain_2014_Aug_21_7_59.nxml.txt.nlp	25139109	SENT43	14	14	33	33	imiquimod	TLR4	PA449972	7099	0.929
NULL	Int_J_Breast_Cancer_2012_Dec_18_2012_502092.nxml.txt.nlp	23320178	SENT180	0	0	5	5	flavopiridol	CDK2	PA452627	1017	0.929
NULL	Case_Rep_Transplant_2011_Jan_5_2011_210178.nxml.txt.nlp	23213600	SENT39	0	0	11	11	tacrolimus	CYP3A	PA451578	1574	0.929
NULL	Oncogene_2014_Sep_11_33(37)_4579-4588.nxml.txt.nlp	24662835	SENT115	1	1	27	27	fulvestrant	MAGEA2	PA164747170	4101;266740	0.929
NULL	Breast_Cancer_Res_2002_Aug_27_4(6)_213-217.nxml.txt.nlp	12473165	SENT28	23	23	19	19	tamoxifen	aromatase	PA451581	1588	0.929
NULL	Case_Rep_Oncol_2014_May_24_7(2)_343-348.nxml.txt.nlp	24987354	SENT82	22	22	9	9	vemurafenib	BRAF	PA165946873	673	0.929
NULL	Acta_Pharmacol_Sin_2012_Jan_3_33(1)_82-90.nxml.txt.nlp	22212431	SENT157	24	24	19	19	rosiglitazone	adiponectin	PA451283	9370	0.929
NULL	Am_J_Trop_Med_Hyg_2010_Apr_82(4)_542-547.nxml.txt.nlp	20348496	SENT16	0	0	27	27	primaquine	G6PD	PA451103	2539	0.929
NULL	Mol_Cancer_2009_Dec_23_8_129.nxml.txt.nlp	20030852	SENT126	30	30	35	35	curcumin	p65	PA151958596	5970	0.929
NULL	Int_J_Chron_Obstruct_Pulmon_Dis_2007_Jun_2(2)_121-129.nxml.txt.nlp	18044684	SENT69	0	0	6	6	cilomilast	PDE4D	PA165948031	5144	0.929
NULL	Adv_Ther_2014_Jan_30_31(2)_202-216.nxml.txt.nlp	24477354	SENT30	6	6	2	2	exenatide	GLP-1	PA164749238	100125288	0.929
NULL	Leukemia_2014_Mar_20_28(3)_554-565.nxml.txt.nlp	24280866	SENT242	21	21	11	11	imatinib	BCL2	PA10804	596	0.929
NULL	Int_J_Breast_Cancer_2012_Dec_19_2012_654698.nxml.txt.nlp	22295247	SENT13	3	3	15	15	tamoxifen	aromatase	PA451581	1588	0.929
NULL	Springerplus_2015_Jan_23_4_29.nxml.txt.nlp	25628986	SENT21	6	6	14	14	dapsone	G6PD	PA449211	2539	0.929
NULL	Biomed_Res_Int_2013_Jul_17_2013_549359.nxml.txt.nlp	23956990	SENT177	9	9	14	14	gefitinib	AKT	PA131301952	207	0.929
NULL	J_Nat_Sci_Biol_Med_2011_Jan-Jun_2(1)_119-124.nxml.txt.nlp	22470245	SENT142	0	0	33	33	ondansetron	NNT	PA450705	23530	0.929
NULL	J_Cell_Mol_Med_2013_Oct_15_17(10)_1325-1334.nxml.txt.nlp	23947778	SENT11	10	10	30	30	estradiol	ADAMTS-4	PA449503	9508	0.929
NULL	Open_Access_J_Urol_2011_May_10_3_69-82.nxml.txt.nlp	24198638	SENT66	22	22	5	5	amodiaquine	CYP2B6	PA448404	1555	0.929
NULL	Oncogenesis_2014_Dec_15_3(12)_e133.nxml.txt.nlp	25500906	SENT17	46	46	27	27	trastuzumab	HER2	PA451743	2064	0.929
NULL	Br_J_Cancer_2011_May_24_104(11)_1786-1790.nxml.txt.nlp	21559018	SENT110	15	15	19	19	irinotecan	EGFR	PA450085	1956	0.929
NULL	Acta_Pharmacol_Sin_2014_Jun_4_35(6)_792-805.nxml.txt.nlp	24902787	SENT13	5	5	2	2	paroxetine	INS-1	PA450801	2305	0.929
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT94	29	29	48	48	trastuzumab	HER2	PA451743	2064	0.929
NULL	Environ_Health_Perspect_2006_Sep_23_114(9)_1401-1406.nxml.txt.nlp	16966095	SENT22	5	5	17	17	arsenite	p53	PA452638	7157	0.929
NULL	Oncotarget_2014_Aug_19_5(18)_8737-8749.nxml.txt.nlp	25228590	SENT80	24	24	11	11	crizotinib	PI3K	PA165946122	5290	0.929
NULL	Int_J_Mol_Sci_2014_Mar_14_15(3)_4492-4522.nxml.txt.nlp	24637934	SENT300	21	21	8	8	glucosamine	ADP	PA164747613	23038	0.929
NULL	Acta_Neuropathol_Commun_2013_Jul_17_1_39.nxml.txt.nlp	24252174	SENT152	6	6	33	33	erlotinib	Erb	PA134687924	2100	0.929
NULL	Nat_Med_2013_Jun_26_19(6)_713-721.nxml.txt.nlp	23708291	SENT119	20	20	32	32	indomethacin	COX2	PA449982	4513;5743	0.929
NULL	Front_Neurosci_2014_Nov_10_8_364.nxml.txt.nlp	25426018	SENT93	6	6	20	20	fluorescein	Casper	PA164746009	8837	0.929
NULL	Cell_Death_Dis_2012_Jun_21_3(6)_e327.nxml.txt.nlp	22717582	SENT75	7	7	0	0	etoposide	p53	PA449552	7157	0.929
NULL	Diabetes_2009_Jun_31_58(6)_1434-1439.nxml.txt.nlp	19336679	SENT5	16	16	8	8	metformin	SLC22A1	PA450395	6580	0.929
NULL	Biosci_Rep_2014_Aug_6_34(4)_e00131.nxml.txt.nlp	24975826	SENT11	9	9	2	2	pp2	TRPM8		79054	0.929
NULL	Case_Rep_Oncol_2014_Mar_26_7(1)_204-209.nxml.txt.nlp	24803896	SENT6	6	6	4	4	trabectedin	MRCL	PA165958349	348174	0.929
NULL	Cell_Death_Dis_2013_Jul_11_4(7)_e719.nxml.txt.nlp	23846221	SENT70	16	16	14	14	cisplatin	TRAIL	PA449014	8743	0.929
NULL	Int_J_Endocrinol_2014_Jun_25_2014_534904.nxml.txt.nlp	25053942	SENT128	17	17	11	11	amiodarone	AIT	PA448383	160728	0.929
NULL	Biomed_Res_Int_2013_Aug_6_2013_909613.nxml.txt.nlp	24027765	SENT8	19	19	3	3	hydrocortisone	IL-10	PA449905	3586	0.929
NULL	Arthritis_Res_Ther_2004_Feb_24_6(Suppl_1)_24.nxml.txt.nlp	NULL	SENT13	2	2	6	6	infliximab	OPG	PA452639	690	0.929
NULL	Case_Rep_Endocrinol_2015_Jan_5_2015_268714.nxml.txt.nlp	25628901	SENT42	19	19	27	27	thyroglobulin	CD10	PA164754910	4311	0.929
NULL	Breast_Cancer_Res_Treat_2014_Dec_21_143(3)_459-467.nxml.txt.nlp	24362951	SENT215	14	14	34	34	tamoxifen	aromatase	PA451581	1588	0.929
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT125	7	7	13	13	tenofovir	ABCC2	PA10204	1244	0.929
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT136	0	0	11	11	capsaicin	MDM2	PA448776	4193	0.929
NULL	Trials_2013_Aug_19_14_261.nxml.txt.nlp	23958221	SENT165	16	16	3	3	gemcitabine	HER2	PA449748	2064	0.929
NULL	Thorax_2012_Mar_28_67(3)_229-237.nxml.txt.nlp	21957094	SENT222	4	4	45	45	carbachol	Rho	PA448784	29984	0.929
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT80	20	20	16	16	metformin	p53	PA450395	7157	0.929
NULL	J_Cell_Physiol_2012_Apr_26_227(4)_1485-1492.nxml.txt.nlp	21618539	SENT19	2	2	20	20	clozapine	IRS1	PA449061	3667	0.929
NULL	Chemother_Res_Pract_2012_Aug_29_2012_817297.nxml.txt.nlp	22970367	SENT21	15	15	4	4	erlotinib	EGFR	PA134687924	1956	0.929
NULL	J_Cachexia_Sarcopenia_Muscle_2010_Sep_26_1(1)_43-128.nxml.txt.nlp	22477519	SENT1189	16	16	25	25	l-carnitine	TBC	PA450154	23216	0.929
NULL	J_Hematol_Oncol_2011_Apr_1_4_13.nxml.txt.nlp	21453545	SENT183	14	14	33	33	geldanamycin	FLT3	PA152031327	2322	0.929
NULL	Br_J_Pharmacol_2008_Sep_9_155(1)_127-137.nxml.txt.nlp	18536750	SENT185	8	8	22	22	piroxicam	IL-10	PA450985	3586	0.929
NULL	Nat_Med_2010_Feb_24_16(2)_214-218.nxml.txt.nlp	20098429	SENT57	11	11	6	6	doxorubicin	YWHAZ	PA449412	7534	0.929
NULL	Arthritis_Res_Ther_2014_Apr_11_16(2)_R93.nxml.txt.nlp	24725461	SENT194	13	13	11	11	letrozole	aromatase	PA450196	1588	0.929
NULL	Curr_Genomics_2013_Nov_14(7)_441-452.nxml.txt.nlp	24396276	SENT427	22	22	25	25	cisplatin	Bcl-2	PA449014	596	0.929
NULL	Br_J_Cancer_1996_Jul_74(1)_63-68.nxml.txt.nlp	8679460	SENT13	34	34	5	5	doxorubicin	P-gp	PA449412	5243	0.929
NULL	Front_Oncol_2014_Sep_15_4_244.nxml.txt.nlp	25309870	SENT86	0	0	5	5	afatinib	EGFR	PA165981154	1956	0.929
NULL	Cell_Death_Differ_2010_May_13_17(5)_774-786.nxml.txt.nlp	19911006	SENT313	4	4	13	13	doxycycline	AATF	PA449415	26574	0.929
NULL	Arthritis_Res_Ther_2005_May_18_7(Suppl_3)_S19-S25.nxml.txt.nlp	15960818	SENT12	30	30	24	24	vincristine	CHOP	PA451879	1649	0.929
NULL	Eur_J_Med_Res_2010_Feb_26_15(2)_47-53.nxml.txt.nlp	20452883	SENT15	15	15	1	1	etomidate	ESG	PA164743987	7089;7088;7090;7091	0.929
NULL	Breast_Cancer_Res_2011_Apr_1_13(2)_R35.nxml.txt.nlp	21457545	SENT155	21	21	16	16	gefitinib	EGFR	PA131301952	1956	0.929
NULL	EMBO_Mol_Med_2011_Dec_3(12)_713-725.nxml.txt.nlp	22038924	SENT278	37	37	22	22	plerixafor	CCR5	PA165958410	1234	0.929
NULL	J_Histochem_Cytochem_2014_Nov_62(11)_802-812.nxml.txt.nlp	25124006	SENT38	0	0	8	8	l-leucine	GDH	PA450197	51084;2746	0.929
NULL	Endocrinol_Diabetes_Metab_Case_Rep_2013_Nov_8_2013_130041.nxml.txt.nlp	24616771	SENT125	0	0	14	14	diazoxide	ABCC8	PA449285	6833	0.929
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT111	20	20	8	8	metformin	p53	PA450395	7157	0.929
NULL	Oncotarget_2011_Dec_31_2(12)_935-947.nxml.txt.nlp	22249213	SENT225	10	10	6	6	paclitaxel	MCAK	PA450761	11004	0.929
NULL	Oncogene_2013_Oct_24_32(43)_5176-5185.nxml.txt.nlp	23208500	SENT136	26	26	12	12	camptothecin	p53	PA153590860	7157	0.929
NULL	J_Ophthalmol_2012_Nov_29_2012_861384.nxml.txt.nlp	22174999	SENT20	0	0	19	19	bevacizumab	VEGF-A	PA130232992	7422	0.929
NULL	Oncotarget_2014_Jun_1_5(13)_4868-4880.nxml.txt.nlp	24947902	SENT29	4	4	10	10	trastuzumab	HER2	PA451743	2064	0.929
NULL	Korean_Circ_J_2013_Oct_30_43(10)_699-701.nxml.txt.nlp	24255655	SENT11	14	14	4	4	amiodarone	APT	PA448383	653639	0.929
NULL	Anticancer_Agents_Med_Chem_2012_Feb_12(2)_163-171.nxml.txt.nlp	22043994	SENT209	28	28	11	11	cetuximab	KRAS	PA10040	3845	0.929
NULL	Mol_Cancer_2014_Jun_30_13_160.nxml.txt.nlp	24976026	SENT148	28	28	5	5	bortezomib	AGR2	PA10252	10551	0.929
NULL	Front_Endocrinol_(Lausanne)_2013_Sep_30_4_127.nxml.txt.nlp	24137156	SENT20	0	0	18	18	estradiol	activin	PA449503	83729	0.929
NULL	J_Hematol_Oncol_2011_Apr_20_4_17.nxml.txt.nlp	21507255	SENT55	42	42	16	16	cisplatin	HDAC	PA449014	9734	0.929
NULL	J_Gen_Physiol_2010_Jan_135(1)_3-13.nxml.txt.nlp	20038523	SENT272	9	9	38	38	bumetanide	ANOVA	PA448682	4858	0.929
NULL	Eur_J_Med_Res_2014_Jun_19_19(Suppl_1)_S21.nxml.txt.nlp	NULL	SENT26	4	4	18	18	oxygen	EGF	PA450744	1950	0.929
NULL	Front_Mol_Neurosci_2009_Nov_6_2_24.nxml.txt.nlp	19936315	SENT160	0	0	19	19	tamoxifen	P90	PA451581	821	0.929
NULL	Acta_Neuropathol_Commun_2014_Oct_21_2(1)_149.nxml.txt.nlp	NULL	SENT248	20	20	42	42	riluzole	p38	PA451251	10598;1432;7965	0.929
NULL	Diabetes_Care_2010_Feb_16_33(2)_322-326.nxml.txt.nlp	19918015	SENT32	17	17	5	5	metformin	LKB1	PA450395	6794	0.929
NULL	Environ_Health_Perspect_2012_Mar_23_120(3)_458-463.nxml.txt.nlp	22113848	SENT155	29	29	17	17	estradiol	aromatase	PA449503	1588	0.929
NULL	Braz_J_Med_Biol_Res_2014_Jun_13_47(7)_605-616.nxml.txt.nlp	24919175	SENT29	24	24	36	36	aripiprazole	AAP	PA10026	5345	0.929
NULL	J_Cell_Biol_2005_Nov_21_171(4)_729-738.nxml.txt.nlp	16286510	SENT182	14	14	2	2	heparin	MMP7	PA449855	4316	0.929
NULL	Oncotarget_2013_Nov_24_4(12)_2430-2438.nxml.txt.nlp	24280348	SENT64	42	42	14	14	gefitinib	EGFR	PA131301952	1956	0.929
NULL	Br_J_Cancer_2011_Mar_1_104(5)_856-862.nxml.txt.nlp	21285991	SENT28	24	24	8	8	bevacizumab	BRAF	PA130232992	673	0.929
NULL	Cancer_Cell_Int_2008_Jan_4_8_1.nxml.txt.nlp	18177496	SENT5	0	0	13	13	gefitinib	EGFR	PA131301952	1956	0.929
NULL	J_Breast_Cancer_2013_Sep_30_16(3)_266-273.nxml.txt.nlp	24155755	SENT144	15	15	9	9	trastuzumab	HER2	PA451743	2064	0.929
NULL	Indian_J_Med_Res_2013_Nov_138(5)_717-731.nxml.txt.nlp	24434324	SENT278	8	8	37	37	anakinra	IL-6	PA10799	3569	0.929
NULL	Front_Genet_2012_Nov_28_3_258.nxml.txt.nlp	23226154	SENT575	15	15	2	2	tamoxifen	CYP2D6	PA451581	1565	0.929
NULL	Arthritis_Res_Ther_2011_May_25_13(Suppl_1)_S2.nxml.txt.nlp	21624181	SENT232	3	3	13	13	infliximab	IMPACT	PA452639	55364	0.929
NULL	Front_Physiol_2013_Jul_15_4_182.nxml.txt.nlp	23874305	SENT73	17	17	3	3	paraformaldehyde	TRPM5	PA450790	29850	0.929
NULL	Mediators_Inflamm_2010_May_18_2010_359732.nxml.txt.nlp	20508722	SENT178	5	5	3	3	hemin	JNK	PA449849	5599	0.929
NULL	Biologics_2012_Sep_25_6_337-345.nxml.txt.nlp	23055691	SENT151	24	24	35	35	gemcitabine	EGFR	PA449748	1956	0.929
NULL	J_Clin_Biochem_Nutr_2009_Jul_30_45(1)_9-13.nxml.txt.nlp	19590701	SENT43	2	2	9	9	lansoprazole	HO-1	PA450180	3162	0.929
NULL	J_Cell_Biol_2008_Jan_28_180(2)_389-402.nxml.txt.nlp	18209100	SENT273	27	27	3	3	l-glutamine	VPS4B	PA10090	9525	0.929
NULL	Exp_Ther_Med_2013_Oct_20_6(4)_899-903.nxml.txt.nlp	24137286	SENT93	9	9	28	28	rosuvastatin	MMP9	PA134308647	4318	0.929
NULL	Clin_Cosmet_Investig_Dermatol_2014_Sep_2_7_243-249.nxml.txt.nlp	25214798	SENT34	12	12	4	4	ustekinumab	ACR	PA166048654	49	0.929
NULL	Cost_Eff_Resour_Alloc_2004_Apr_15_2_2.nxml.txt.nlp	15086954	SENT81	20	20	38	38	metformin	PPG	PA450395	5552	0.929
NULL	Breast_Cancer_Res_Treat_2013_Oct_4_141(3)_385-395.nxml.txt.nlp	24091769	SENT10	36	36	8	8	lapatinib	MVD	PA152241907	4597	0.929
NULL	Int_J_Biol_Sci_2012_Feb_9_8(3)_310-327.nxml.txt.nlp	22355267	SENT156	18	18	29	29	simvastatin	PCSK9	PA451363	255738	0.929
NULL	Protein_Cell_2014_Jun_19_5(6)_469-479.nxml.txt.nlp	24748116	SENT58	23	23	9	9	vinblastine	EB1	PA451877	9167;22919;10982	0.929
NULL	Nat_Commun_2013_Sep_20_4_2444.nxml.txt.nlp	24051492	SENT48	6	6	11	11	nutlin-3	p53		7157	0.929
NULL	Cardiovasc_Diabetol_2008_Dec_23_7_36.nxml.txt.nlp	19108709	SENT10	16	16	3	3	eptifibatide	c-Jun	PA449483	3725	0.929
NULL	Acta_Neuropathol_2012_Dec_11_124(6)_763-775.nxml.txt.nlp	23143192	SENT373	3	3	12	12	bevacizumab	CXCR4	PA130232992	7852	0.929
NULL	Nat_Commun_2013_Sep_4_4_2338.nxml.txt.nlp	24005565	SENT125	15	15	24	24	cisplatin	RAD51D	PA449014	5892	0.929
NULL	Indian_J_Med_Res_2012_Sep_136(3)_391-403.nxml.txt.nlp	23041732	SENT165	4	4	40	40	doxorubicin	HCC	PA449412	84668	0.929
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT211	2	2	25	25	curcumin	DR5	PA151958596	8795	0.929
NULL	Front_Genet_2014_Feb_26_5_40.nxml.txt.nlp	24616734	SENT317	13	13	16	16	docetaxel	EGFL6	PA449383	25975	0.929
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT90	3	3	10	10	resveratrol	TNF		7124	0.929
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_1-2.nxml.txt.nlp	17221160	SENT2	0	0	17	17	letrozole	aromatase	PA450196	1588	0.929
NULL	Front_Genet_2012_Nov_22_3_249.nxml.txt.nlp	23189085	SENT1112	17	17	0	0	imatinib	ABCB1	PA10804	5243	0.929
NULL	Breast_Cancer_Res_2008_Apr_29_10(2)_206.nxml.txt.nlp	18492214	SENT122	6	6	1	1	anastrozole	aromatase	PA448432	1588	0.929
NULL	Osteoporos_Int_2012_Jan_3_23(1)_327-337.nxml.txt.nlp	21892677	SENT30	4	4	7	7	denosumab	RANKL	PA166048634	8600	0.929
NULL	J_Thromb_Haemost_2010_Mar_8(3)_577-587.nxml.txt.nlp	20040043	SENT87	14	14	29	29	rosiglitazone	mol	PA451283	90527	0.929
NULL	Indian_J_Nephrol_2011_Jan-Mar_21(1)_56-58.nxml.txt.nlp	21655173	SENT58	31	31	27	27	doxorubicin	CHOP	PA449412	1649	0.929
NULL	Int_J_Mol_Sci_2014_Dec_2_15(12)_22128-22141.nxml.txt.nlp	25474084	SENT28	28	28	13	13	cisplatin	PUMA	PA449014	27113	0.929
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT138	18	18	6	6	methotrexate	OGG1	PA450428	4968	0.929
NULL	Cell_Death_Dis_2014_Feb_13_5(2)_e1055.nxml.txt.nlp	24525731	SENT128	9	9	2	2	cisplatin	XRCC1	PA449014	7515	0.929
NULL	Ther_Clin_Risk_Manag_2006_Sep_2(3)_303-308.nxml.txt.nlp	18360605	SENT44	28	28	15	15	naratriptan	5-HT7	PA450597	3363	0.929
NULL	Oncotarget_2012_Oct_20_3(10)_1068-1111.nxml.txt.nlp	23085539	SENT849	23	23	19	19	docetaxel	EGFR	PA449383	1956	0.929
NULL	Core_Evid_2007_Nov_30_2(2)_121-129.nxml.txt.nlp	21221180	SENT234	5	5	36	36	rituximab	CHOP	PA451261	1649	0.929
NULL	J_Korean_Med_Sci_2010_Sep_14_25(9)_1277-1283.nxml.txt.nlp	20808669	SENT119	9	9	37	37	alendronate	IFN	PA448082	3439	0.929
NULL	Drugs_R_D_2011_Jun_27_11(2)_101-111.nxml.txt.nlp	21679003	SENT62	14	14	1	1	cetuximab	BRAF	PA10040	673	0.929
NULL	Hum_Genomics_Proteomics_2010_Aug_3_2010_159761.nxml.txt.nlp	20981231	SENT147	17	17	2	2	lithium	BDNF	PA450243	627	0.929
NULL	Br_J_Cancer_1990_Jan_61(1)_32-38.nxml.txt.nlp	2153395	SENT15	17	17	3	3	tamoxifen	pNR-2	PA451581	7031	0.929
NULL	Exp_Ther_Med_2014_Aug_4_8(2)_657-661.nxml.txt.nlp	25009636	SENT9	17	17	4	4	propofol	CCR2	PA451141	729230	0.929
NULL	Exp_Diabetes_Res_2012_May_28_2012_924168.nxml.txt.nlp	22693487	SENT37	11	11	23	23	liraglutide	GLP-1	PA165958364	100125288	0.929
NULL	Cancers_(Basel)_2010_Dec_22_2(4)_2153-2170.nxml.txt.nlp	21390244	SENT265	14	14	22	22	gefitinib	EGFR	PA131301952	1956	0.929
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_315-322.nxml.txt.nlp	20049735	SENT57	6	6	22	22	cisplatin	ANOVA	PA449014	4858	0.929
NULL	Evid_Based_Complement_Alternat_Med_2011_Mar_9_2011_750230.nxml.txt.nlp	21423639	SENT17	12	12	20	20	bevacizumab	EGFR	PA130232992	1956	0.929
NULL	Environ_Health_Perspect_2006_Sep_23_114(9)_1401-1406.nxml.txt.nlp	16966095	SENT20	30	30	0	0	arsenite	p53	PA452638	7157	0.929
NULL	Oncol_Lett_2013_Mar_11_5(3)_1010-1016.nxml.txt.nlp	23426784	SENT106	37	37	29	29	midazolam	TRPM7	PA450496	54822	0.929
NULL	Glycoconj_J_2012_Apr_14_29(2-3)_93-105.nxml.txt.nlp	22246380	SENT235	19	19	35	35	glucose	ABH	PA449773	8846	0.929
NULL	J_Carcinog_2014_Feb_20_13_4.nxml.txt.nlp	24737952	SENT285	7	7	19	19	vorinostat	KRAS	PA164748224	3845	0.929
NULL	BMJ_2010_Feb_8_340_c693.nxml.txt.nlp	20142325	SENT137	39	39	26	26	fluoxetine	CYP2D6	PA449673	1565	0.929
NULL	Oncotarget_2011_Aug_30_2(8)_610-626.nxml.txt.nlp	21881167	SENT134	17	17	42	42	tamoxifen	Raf-1	PA451581	5894	0.929
NULL	Carcinogenesis_2010_Dec_27_31(12)_2049-2057.nxml.txt.nlp	20876285	SENT111	6	6	40	40	tamoxifen	HER2	PA451581	2064	0.929
NULL	Clin_Dev_Immunol_2007_Jan_20_2007_76396.nxml.txt.nlp	18317531	SENT81	17	17	3	3	sertraline	IL-2	PA451333	3558	0.929
NULL	Oncogene_2013_Oct_17_32(42)_5058-5065.nxml.txt.nlp	23160381	SENT81	41	41	23	23	docetaxel	p53	PA449383	7157	0.929
NULL	Int_J_Mol_Sci_2014_Mar_5_15(3)_3970-3988.nxml.txt.nlp	24603537	SENT183	32	32	5	5	curcumin	MCH	PA151958596	5367	0.929
NULL	Breast_Cancer_Res_2011_Jan_28_13(1)_R11.nxml.txt.nlp	21276249	SENT326	26	26	7	7	tamoxifen	aromatase	PA451581	1588	0.929
NULL	ACS_Catal_2014_Feb_7_4(2)_546-552.nxml.txt.nlp	24634794	SENT78	44	44	29	29	hemin	TTN	PA449849	7273	0.929
NULL	Eur_J_Clin_Pharmacol_2011_May_8_67(5)_493-506.nxml.txt.nlp	21140139	SENT95	24	24	35	35	oxymorphone	CYP2D6	PA450748	1565	0.929
NULL	Int_J_Breast_Cancer_2011_Feb_24_2011_967419.nxml.txt.nlp	22332018	SENT164	28	28	12	12	olaparib	BRCA1		672	0.929
NULL	Mol_Vis_2011_Dec_24_17_3384-3391.nxml.txt.nlp	22219634	SENT133	25	25	20	20	mannitol	IL-6	PA450320	3569	0.929
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_29_2013_590393.nxml.txt.nlp	23737838	SENT223	4	4	19	19	resveratrol	p53		7157	0.929
NULL	Ann_Hematol_2010_Mar_2_89(3)_283-289.nxml.txt.nlp	19727725	SENT141	2	2	13	13	rituximab	CHOP	PA451261	1649	0.929
NULL	BMJ_Open_2014_Feb_27_4(2)_e004071.nxml.txt.nlp	24578536	SENT147	14	14	1	1	warfarin	TTR	PA451906	7276	0.929
NULL	Acta_Pharmacol_Sin_2009_Jun_11_30(6)_723-739.nxml.txt.nlp	19434058	SENT168	14	14	12	12	methoxsalen	CYP2A6	PA450433	1548	0.929
NULL	J_Gynecol_Oncol_2013_Jul_4_24(3)_273-279.nxml.txt.nlp	23875078	SENT15	25	25	17	17	paclitaxel	COX	PA450761	1351	0.929
NULL	Cell_Death_Dis_2014_Jul_17_5(7)_e1333.nxml.txt.nlp	25032856	SENT45	8	8	41	41	candesartan	EAAC1	PA448765	6505	0.929
NULL	Nucleic_Acids_Res_2011_Mar_12_39(6)_2188-2209.nxml.txt.nlp	21075799	SENT210	32	32	3	3	galactose	CBP80	PA449725	4686	0.929
NULL	Adolesc_Health_Med_Ther_2012_Jun_20_3_85-93.nxml.txt.nlp	24600289	SENT62	29	29	14	14	adalimumab	ACR	PA10004	49	0.929
NULL	ScientificWorldJournal_2012_Apr_1_2012_381434.nxml.txt.nlp	22545017	SENT250	35	35	7	7	paroxetine	NK-1	PA450801	27087	0.929
NULL	Front_Oncol_2014_Sep_22_4_258.nxml.txt.nlp	25295228	SENT210	17	17	29	29	afatinib	EGFR	PA165981154	1956	0.929
NULL	Cell_Cycle_2012_Dec_15_11(24)_4661-4672.nxml.txt.nlp	23187802	SENT33	15	15	23	23	doxorubicin	p53	PA449412	7157	0.929
NULL	Front_Neurosci_2014_Jun_3_8_128.nxml.txt.nlp	24917782	SENT16	5	5	26	26	ethanol	MC4R	PA448073	4160	0.929
NULL	J_Cell_Biol_1995_Mar_2_128(6)_1185-1196.nxml.txt.nlp	7896881	SENT4	21	21	15	15	mitomycin	p53	PA450524	7157	0.929
NULL	Oncogene_2009_Jan_15_28(2)_279-288.nxml.txt.nlp	18836480	SENT117	28	28	2	2	pp2	PP2		4888	0.929
NULL	Diabetes_Obes_Metab_2012_Dec_19_14(12)_1097-1103.nxml.txt.nlp	22734440	SENT29	4	4	37	37	exenatide	GLP-1	PA164749238	100125288	0.929
NULL	Cardiovasc_J_Afr_2009_Feb_20(1)_43-51.nxml.txt.nlp	19287816	SENT74	25	25	31	31	alprenolol	p38	PA164750541	10598;1432;7965	0.929
NULL	J_Immunol_Res_2014_Nov_11_2014_385352.nxml.txt.nlp	25436214	SENT144	11	11	5	5	infliximab	CD4	PA452639	920	0.929
NULL	Ann_Clin_Microbiol_Antimicrob_2007_Nov_12_6_15.nxml.txt.nlp	17997852	SENT114	3	3	19	19	metronidazole	ANOVA	PA450484	4858	0.929
NULL	J_Antimicrob_Chemother_2009_Oct_13_64(4)_829-836.nxml.txt.nlp	19679597	SENT17	15	15	1	1	tobramycin	SMF	PA451704	22993	0.929
NULL	Can_J_Infect_Dis_Med_Microbiol_2014_Nov-Dec_25(6)_327-343.nxml.txt.nlp	25587296	SENT75	0	0	12	12	itraconazole	CYP3A4	PA450132	1576	0.929
NULL	Reprod_Biol_Endocrinol_2004_Jan_7_2_2.nxml.txt.nlp	14711377	SENT164	7	7	23	23	thrombin	PAR1	PA451674	79581;2149	0.929
NULL	F1000_Med_Rep_2012_Jun_1_4_12.nxml.txt.nlp	22719795	SENT59	12	12	25	25	midazolam	CYP3A	PA450496	1574	0.929
NULL	Br_J_Cancer_2010_Jul_13_103(2)_186-195.nxml.txt.nlp	20588277	SENT7	13	13	19	19	nutlin-3	MDM2		4193	0.929
NULL	Oncotarget_2011_May_16_2(5)_418-421.nxml.txt.nlp	21789791	SENT26	16	16	31	31	bortezomib	TRAIL	PA10252	8743	0.929
NULL	Lab_Invest_2009_Dec_19_89(12)_1397-1409.nxml.txt.nlp	19841616	SENT196	12	12	0	0	curcumin	NAC	PA151958596	22861	0.929
NULL	J_Invest_Dermatol_2012_Sep_10_132(9)_2255-2262.nxml.txt.nlp	22572817	SENT49	28	28	6	6	forskolin	MC1R	PA146096022	4157	0.929
NULL	Arthritis_Rheum_2013_Jan_65(1)_28-38.nxml.txt.nlp	23169319	SENT63	10	10	30	30	abatacept	ACR	PA164747080	49	0.929
NULL	Ann_Oncol_2011_Mar_8_22(3)_503-514.nxml.txt.nlp	20616198	SENT172	10	10	30	30	anastrozole	aromatase	PA448432	1588	0.929
NULL	Case_Rep_Oncol_2013_Aug_8_6(2)_410-415.nxml.txt.nlp	24019780	SENT4	15	15	3	3	temozolomide	CD4	PA451609	920	0.929
NULL	Mol_Cancer_2013_Mar_5_12_17.nxml.txt.nlp	23497256	SENT232	11	11	8	8	sunitinib	HDM2	PA162372840	4193	0.929
NULL	J_Cell_Mol_Med_2014_May_14_18(5)_811-823.nxml.txt.nlp	24628949	SENT167	28	28	11	11	docetaxel	FOXM1	PA449383	2305	0.929
NULL	Toxins_(Basel)_2010_Oct_26_2(11)_2490-2518.nxml.txt.nlp	22069563	SENT326	17	17	7	7	cisplatin	TLR4	PA449014	7099	0.929
NULL	Mol_Biol_Cell_2013_Sep_1_24(17)_2678-2688.nxml.txt.nlp	23864716	SENT115	13	13	18	18	thrombin	Rho	PA451674	29984	0.929
NULL	Braz_J_Med_Biol_Res_2012_Jul_27_45(10)_948-954.nxml.txt.nlp	22832600	SENT108	7	7	11	11	tegaserod	5-HT4	PA130413154	3360	0.929
NULL	Cell_Death_Dis_2010_May_13_1(5)_e41.nxml.txt.nlp	21364648	SENT146	26	26	11	11	etoposide	p53	PA449552	7157	0.929
NULL	Front_Behav_Neurosci_2012_Sep_18_6_61.nxml.txt.nlp	23049505	SENT114	25	25	35	35	donepezil	ANOVA	PA449394	4858	0.929
NULL	Hum_Genomics_2008_Sep_1_3(1)_53-70.nxml.txt.nlp	19129090	SENT120	4	4	0	0	perifosine	DZIP3	PA165291471	9666	0.929
NULL	Drugs_R_D_2013_Sep_28_13(3)_191-197.nxml.txt.nlp	23982688	SENT130	7	7	1	1	warfarin	TTR	PA451906	7276	0.929
NULL	Breast_Cancer_(Auckl)_2011_Sep_25_5_201-208.nxml.txt.nlp	22084573	SENT17	34	34	19	19	cisplatin	BRCA1	PA449014	672	0.929
NULL	Bioinformation_2012_Dec_19_8(25)_1249-1254.nxml.txt.nlp	23275729	SENT8	3	3	19	19	curcumin	VEGFR	PA151958596	3791	0.929
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Feb_21_65(Pt_3)_o556.nxml.txt.nlp	21582214	SENT68	21	21	15	15	ethanol	mol	PA448073	90527	0.929
NULL	J_Hum_Genet_2013_Jun_23_58(6)_339-345.nxml.txt.nlp	23697979	SENT14	20	20	4	4	ticagrelor	ADP	PA165374673	23038	0.929
NULL	Emerg_Infect_Dis_2013_Mar_19(3)_449-455.nxml.txt.nlp	23622714	SENT45	16	16	1	1	amikacin	DST	PA164744372	667	0.929
NULL	Br_J_Cancer_2004_Mar_22_90(6)_1285-1292.nxml.txt.nlp	15026814	SENT51	12	12	5	5	doxorubicin	p53	PA449412	7157	0.929
NULL	Ann_Saudi_Med_2011_Jul-Aug_31(4)_402-406.nxml.txt.nlp	21727749	SENT4	14	14	10	10	sitagliptin	DPP4	PA164748978	1803	0.929
NULL	FEBS_Open_Bio_2014_Jan_6_4_77-89.nxml.txt.nlp	24490132	SENT762	6	6	20	20	ebselen	GDH	PA161660841	51084;2746	0.929
NULL	Int_J_Hypertens_2012_Sep_22_2012_915057.nxml.txt.nlp	21961055	SENT111	24	24	17	17	isoproterenol	CXCR4	PA450121	7852	0.929
NULL	Mar_Drugs_2011_Feb_10_9(2)_224-241.nxml.txt.nlp	21566796	SENT228	42	42	0	0	l-glutamine	RAC	PA10090	207	0.929
NULL	Mol_Cancer_2014_Jan_13_13_7.nxml.txt.nlp	24418169	SENT203	0	0	6	6	sorafenib	STAT3	PA7000	6774	0.929
NULL	Thorax_2011_Dec_23_66(12)_1029-1035.nxml.txt.nlp	21606476	SENT46	0	0	8	8	indomethacin	COX	PA449982	1351	0.929
NULL	J_Gen_Physiol_2000_Jun_1_115(6)_685-696.nxml.txt.nlp	10828243	SENT157	3	3	9	9	genistein	OLF	PA165109660	83857	0.929
NULL	Int_J_Mol_Sci_2014_Jun_5_15(6)_10083-10100.nxml.txt.nlp	24905407	SENT2	5	5	32	32	tetracycline	TRB	PA451640	6957	0.929
NULL	Environ_Health_Perspect_2009_Feb_8_117(2)_175-180.nxml.txt.nlp	19270784	SENT207	29	29	4	4	vinblastine	BPA	PA451877	667	0.929
NULL	J_Infect_Dis_2014_Aug_15_210(4)_656-666.nxml.txt.nlp	24634497	SENT163	12	12	5	5	zileuton	TLR4	PA451955	7099	0.929
NULL	Case_Rep_Gastrointest_Med_2014_Jul_1_2014_579352.nxml.txt.nlp	25093126	SENT43	16	16	10	10	doxorubicin	CHOP	PA449412	1649	0.929
NULL	Breast_Cancer_Res_2000_Apr_13_2(3)_E007.nxml.txt.nlp	NULL	SENT100	12	12	16	16	tamoxifen	p53	PA451581	7157	0.929
NULL	J_Cell_Biol_1988_Feb_1_106(2)_395-401.nxml.txt.nlp	3276717	SENT8	6	6	25	25	choline	EGF	PA448976	1950	0.929
NULL	Apoptosis_2013_May_14_18(10)_1145-1153.nxml.txt.nlp	23670020	SENT84	20	20	6	6	dibucaine	Bcl-2	PA449286	596	0.929
NULL	Cell_Commun_Signal_2005_Nov_2_3_13.nxml.txt.nlp	16266433	SENT14	3	3	11	11	suramin	P2Y4	PA10292	5030	0.929
NULL	Environ_Health_Perspect_2007_Dec_8_115(Suppl_1)_77-83.nxml.txt.nlp	18174954	SENT182	28	28	26	26	genistein	TPO	PA165109660	7066;7173	0.929
NULL	Mol_Cancer_2009_Aug_25_8_66.nxml.txt.nlp	19706164	SENT288	3	3	23	23	celecoxib	ANOVA	PA448871	4858	0.929
NULL	F1000_Biol_Rep_2010_Feb_11_2_10.nxml.txt.nlp	20948822	SENT54	30	30	8	8	carboplatin	San	PA448803	80218	0.929
NULL	Clin_Drug_Investig_2013_Aug_23_33(10)_727-736.nxml.txt.nlp	23975654	SENT178	29	29	21	21	bupropion	CYP2D6	PA448687	1565	0.929
NULL	Aging_(Albany_NY)_2014_Oct_28_6(10)_820-834.nxml.txt.nlp	25361036	SENT161	7	7	27	27	resveratrol	PARP-1		25976	0.929
NULL	Exp_Brain_Res_2014_Jun_27_232(8)_2637-2644.nxml.txt.nlp	24969614	SENT6	18	18	4	4	palonosetron	NK1	PA10352	11126	0.929
NULL	Ann_Rheum_Dis_2008_Sep_11_68(7)_1146-1152.nxml.txt.nlp	18794178	SENT86	25	25	5	5	sulfasalazine	ACR	PA451547	49	0.929
NULL	Cancers_(Basel)_2012_May_8_4(2)_523-530.nxml.txt.nlp	24213322	SENT19	24	24	33	33	gefitinib	EGFR	PA131301952	1956	0.929
NULL	Nat_Commun_2014_Jun_20_5_4122.nxml.txt.nlp	24947823	SENT217	10	10	22	22	capsaicin	TRPV1	PA448776	7442	0.929
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_May_12_66(Pt_6)_o1324-o1325.nxml.txt.nlp	21579416	SENT66	43	43	15	15	ethanol	mol	PA448073	90527	0.929
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT130	17	17	8	8	resveratrol	TNF		7124	0.929
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Oct_23_66(Pt_11)_o2941.nxml.txt.nlp	21589111	SENT48	18	18	6	6	ethanol	mol	PA448073	90527	0.929
NULL	J_Invest_Dermatol_2012_Nov_21_132(11)_2642-2651.nxml.txt.nlp	22718118	SENT220	10	10	15	15	collagenase	CD11b	PA449107	3684	0.929
NULL	Oncologist_2011_Feb_25_16(2)_155-164.nxml.txt.nlp	21266401	SENT118	19	19	7	7	trastuzumab	HER-2	PA451743	2064	0.929
NULL	Mol_Cancer_2009_Oct_8_8_83.nxml.txt.nlp	19814803	SENT217	1	1	7	7	triciribine	AKT	PA165958661	207	0.929
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT37	34	34	24	24	tamoxifen	TFF3	PA451581	7033	0.929
NULL	J_Mol_Signal_2012_Aug_16_7_12.nxml.txt.nlp	22898329	SENT139	10	10	0	0	bortezomib	NOXA	PA10252	5366	0.929
NULL	Pharmaceuticals_(Basel)_2013_Aug_2_6(8)_915-928.nxml.txt.nlp	24276376	SENT127	41	41	38	38	aspirin	CAD	PA448497	1677;790	0.929
NULL	Breast_Cancer_Res_2011_Jan_17_13(1)_R5.nxml.txt.nlp	21241485	SENT207	16	16	5	5	tamoxifen	Brn-3b	PA451581	5458	0.929
NULL	Biosci_Microbiota_Food_Health_2014_Jan_30_33(1)_41-46.nxml.txt.nlp	24936381	SENT32	22	22	4	4	mitomycin	CD4	PA450524	920	0.929
NULL	N_Am_J_Med_Sci_2010_Oct_2(10)_491-495.nxml.txt.nlp	22558553	SENT106	20	20	10	10	napqi	CYP3A4		1576	0.929
NULL	Int_J_Biomed_Sci_2013_Sep_9(3)_112-122.nxml.txt.nlp	24170986	SENT137	3	3	30	30	imatinib	ZAP70	PA10804	7535	0.929
NULL	Oncogene_2010_May_20_29(20)_2962-2972.nxml.txt.nlp	20228846	SENT61	26	26	2	2	imatinib	HIF-1	PA10804	29072	0.929
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT59	12	12	19	19	nutlin-3	p53		7157	0.929
NULL	Curr_Neuropharmacol_2014_Jul_12(4)_365-379.nxml.txt.nlp	25342944	SENT61	20	20	12	12	fluoxetine	5-HT1A	PA449673	3350	0.929
NULL	Viruses_2014_Jul_31_6(8)_2960-2973.nxml.txt.nlp	25089538	SENT232	11	11	19	19	nevirapine	CD4	PA450616	920	0.929
NULL	J_Biomed_Sci_2014_Feb_3_21(1)_10.nxml.txt.nlp	24490900	SENT137	6	6	9	9	alendronate	RANKL	PA448082	8600	0.929
NULL	Arthritis_Res_Ther_2013_Dec_2_15(6)_R204.nxml.txt.nlp	24295403	SENT118	14	14	9	9	tocilizumab	IL-6	PA165292659	3569	0.929
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_39-54.nxml.txt.nlp	19305787	SENT239	23	23	0	0	ethanol	DARPP-32	PA448073	84152	0.929
NULL	J_Biomed_Sci_2012_Oct_25_19(1)_91.nxml.txt.nlp	23098564	SENT252	8	8	21	21	urokinase	CXCR4	PA451836	7852	0.929
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT259	9	9	14	14	chloroquine	BMPR-II	PA448948	659	0.929
NULL	Infect_Drug_Resist_2010_Mar_11_3_45-51.nxml.txt.nlp	21694893	SENT113	21	21	3	3	itraconazole	CYP3A4	PA450132	1576	0.929
NULL	Mol_Cell_2013_Nov_7_52(3)_393-405.nxml.txt.nlp	24120663	SENT654	26	26	16	16	flavopiridol	MPS1	PA452627	7272;3425;6232	0.929
NULL	Springerplus_2014_Sep_17_3_535.nxml.txt.nlp	25279326	SENT30	18	18	8	8	everolimus	aromatase	PA164746311	1588	0.929
NULL	Cancer_Cell_Int_2005_Jul_24_5_22.nxml.txt.nlp	16042792	SENT91	34	34	2	2	vincristine	NAC	PA451879	22861	0.929
NULL	Exp_Ther_Med_2013_Nov_13_6(5)_1317-1321.nxml.txt.nlp	24223665	SENT111	23	23	17	17	cisplatin	CD133	PA449014	8842	0.929
NULL	Biomed_Res_Int_2013_Sep_4_2013_185362.nxml.txt.nlp	24093091	SENT115	20	20	35	35	epirubicin	CHOP	PA449476	1649	0.929
NULL	Cancers_(Basel)_2011_Apr_1_3(2)_1844-1860.nxml.txt.nlp	24212785	SENT602	16	16	9	9	cetuximab	PIK3CA	PA10040	5290	0.929
NULL	Front_Oncol_2013_Sep_23_3_250.nxml.txt.nlp	24069582	SENT101	9	9	5	5	raloxifene	STAR	PA451221	6770;2984	0.929
NULL	Cancer_Cell_Int_2005_Jul_24_5_22.nxml.txt.nlp	16042792	SENT17	13	13	4	4	vincristine	NAC	PA451879	22861	0.929
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_13_2012_636848.nxml.txt.nlp	23258994	SENT145	19	19	17	17	capsaicin	TRPV1	PA448776	7442	0.929
NULL	Acta_Pharmacol_Sin_2009_Sep_24_30(9)_1262-1275.nxml.txt.nlp	19701231	SENT145	15	15	3	3	lovastatin	SOAT1	PA450272	6646	0.929
NULL	Br_J_Clin_Pharmacol_2013_Apr_10_75(4)_979-989.nxml.txt.nlp	22882281	SENT190	21	21	16	16	liraglutide	GLP-1	PA165958364	100125288	0.929
NULL	Cancer_Manag_Res_2013_Nov_21_5_387-400.nxml.txt.nlp	24294007	SENT115	37	37	12	12	vemurafenib	BRAF	PA165946873	673	0.929
NULL	Arthritis_Res_Ther_2012_Sep_24_14(5)_R200.nxml.txt.nlp	23006144	SENT42	16	16	3	3	cyclosporine	IL-20	PA449167	27190;50604	0.929
NULL	Br_J_Cancer_2011_Apr_12_104(8)_1278-1287.nxml.txt.nlp	21487429	SENT170	22	22	18	18	cisplatin	DR5	PA449014	8795	0.929
NULL	Front_Genet_2014_Nov_4_5_383.nxml.txt.nlp	25408701	SENT53	18	18	11	11	cisplatin	ABCC1	PA449014	4363	0.929
NULL	Br_J_Cancer_2012_May_22_106(11)_1779-1789.nxml.txt.nlp	22549178	SENT24	0	0	14	14	pertuzumab	CA125		4077;94025	0.929
NULL	Mucosal_Immunol_2012_May_22_5(3)_320-331.nxml.txt.nlp	22354319	SENT34	34	34	20	20	mitomycin	CD4	PA450524	920	0.929
NULL	Diabetes_2013_Nov_18_62(11)_3817-3827.nxml.txt.nlp	23835338	SENT43	42	42	12	12	losartan	SREBP1	PA450268	6720	0.929
NULL	BMJ_2014_Nov_11_349_g6419.nxml.txt.nlp	25389143	SENT205	29	29	11	11	bivalirudin	P2Y12	PA10032	64805	0.929
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT210	22	22	10	10	cetuximab	KRAS	PA10040	3845	0.929
NULL	Breast_Cancer_(Auckl)_2012_Mar_7_6_67-77.nxml.txt.nlp	22438669	SENT145	28	28	22	22	bevacizumab	VEGFR	PA130232992	3791	0.929
NULL	Neuropsychopharmacology_2009_Jul_25_34(8)_1968-1978.nxml.txt.nlp	19322168	SENT252	31	31	19	19	clozapine	PI3K	PA449061	5290	0.929
NULL	Front_Oncol_2014_Apr_14_4_64.nxml.txt.nlp	24782981	SENT142	5	5	8	8	everolimus	aromatase	PA164746311	1588	0.929
NULL	J_Mol_Med_2008_Jul_2_86(7)_747-759.nxml.txt.nlp	18246321	SENT467	6	6	27	27	curcumin	NF-kappaB	PA151958596	4790	0.929
NULL	Am_J_Trop_Med_Hyg_2012_Nov_7_87(5)_783-784.nxml.txt.nlp	23136171	SENT24	29	29	15	15	mefloquine	ACT	PA450348	12;11332;9457;641455	0.929
NULL	Cancer_Immunol_Immunother_2011_Jun_25_60(6)_793-808.nxml.txt.nlp	21350947	SENT204	20	20	8	8	sorafenib	IFNAR2	PA7000	3455	0.929
NULL	Acta_Pharmacol_Sin_2013_Sep_5_34(9)_1192-1200.nxml.txt.nlp	23685957	SENT200	9	9	16	16	curcumin	AP-2	PA151958596	7020	0.929
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT367	7	7	18	18	pp2	CDH1		51343;999	0.929
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1063.nxml.txt.nlp	24556678	SENT44	1	1	23	23	thioridazine	c-FLIP	PA451666	8837	0.929
NULL	Eur_J_Dent_2014_Oct-Dec_8(4)_475-480.nxml.txt.nlp	25512727	SENT38	18	18	36	36	warfarin	OAT	PA451906	4942	0.929
NULL	Cancer_Cell_Int_2010_May_11_10_16.nxml.txt.nlp	20459793	SENT138	14	14	3	3	cisplatin	ABCC1	PA449014	4363	0.929
NULL	Mol_Cancer_2009_Aug_25_8_66.nxml.txt.nlp	19706164	SENT20	10	10	4	4	celecoxib	p53	PA448871	7157	0.929
NULL	Case_Rep_Otolaryngol_2013_Feb_11_2013_740241.nxml.txt.nlp	23476858	SENT16	3	3	0	0	rituximab	CHOP	PA451261	1649	0.929
NULL	J_Biomed_Biotechnol_2010_Jun_7_2010_150960.nxml.txt.nlp	20617134	SENT199	5	5	11	11	erlotinib	KRAS	PA134687924	3845	0.929
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1107-1116.nxml.txt.nlp	22343619	SENT323	28	28	22	22	carboplatin	EGFR	PA448803	1956	0.929
NULL	Clin_Drug_Investig_2013_Aug_23_33(10)_727-736.nxml.txt.nlp	23975654	SENT142	31	31	33	33	omeprazole	CYP2C19	PA450704	1557	0.929
NULL	Blood_Res_2013_Mar_25_48(1)_35-39.nxml.txt.nlp	23589793	SENT81	3	3	19	19	bortezomib	CD4	PA10252	920	0.929
NULL	Br_J_Cancer_2011_Jul_12_105(2)_212-220.nxml.txt.nlp	21694723	SENT37	0	0	19	19	curcumin	STAT3	PA151958596	6774	0.929
NULL	Clin_Ophthalmol_2009_Jun_2_3_199-210.nxml.txt.nlp	19668566	SENT84	17	17	9	9	ketorolac	COX	PA450150	1351	0.929
NULL	eLife_2014_May_20_3_e01763.nxml.txt.nlp	24844244	SENT497	9	9	35	35	doxycycline	MELK	PA449415	9833	0.929
NULL	J_Cell_Biol_2005_May_23_169(4)_681-691.nxml.txt.nlp	15911882	SENT74	16	16	6	6	heparin	MMP3	PA449855	4314	0.929
NULL	J_Hematol_Oncol_2008_Oct_23_1_19.nxml.txt.nlp	18947412	SENT125	15	15	33	33	alemtuzumab	CD34	PA164783958	947	0.929
NULL	Oncotarget_2014_Nov_8_5(21)_10280-10292.nxml.txt.nlp	25373733	SENT197	10	10	4	4	bortezomib	HIF-1	PA10252	29072	0.929
NULL	Arch_Med_Sci_2013_Oct_31_9(5)_936-943.nxml.txt.nlp	24273582	SENT37	7	7	39	39	nateglinide	SUR2	PA450600	10060	0.929
NULL	Oncotarget_2013_Jul_26_4(8)_1317-1328.nxml.txt.nlp	23945331	SENT15	8	8	10	10	tamoxifen	aromatase	PA451581	1588	0.929
NULL	J_Med_Chem_2014_Feb_13_57(3)_1063-1078.nxml.txt.nlp	24450337	SENT242	0	0	13	13	dextromethorphan	CYP3A4	PA449273	1576	0.929
NULL	Cell_Death_Dis_2012_Nov_15_3(11)_e422.nxml.txt.nlp	23152058	SENT95	9	9	3	3	cisplatin	ZNF143	PA449014	7702	0.929
NULL	Arthritis_Res_Ther_2012_May_1_14(3)_R99.nxml.txt.nlp	22546542	SENT215	10	10	4	4	infliximab	CD4	PA452639	920	0.929
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT133	20	20	9	9	adalimumab	CD36	PA10004	948	0.929
NULL	Acta_Pharmacol_Sin_2010_Feb_5_31(2)_184-190.nxml.txt.nlp	20139901	SENT133	34	34	24	24	estradiol	OCT1	PA449503	5451;6580	0.929
NULL	Drug_Target_Insights_2013_Aug_19_7_27-34.nxml.txt.nlp	24023511	SENT143	3	3	44	44	zosuquidar	P-gp		5243	0.929
NULL	Breast_Cancer_Res_Treat_2014_Apr_6_145(1)_33-44.nxml.txt.nlp	24706169	SENT46	3	3	15	15	trastuzumab	HER2	PA451743	2064	0.929
NULL	Oncol_Lett_2013_Apr_22_5(4)_1093-1100.nxml.txt.nlp	23599746	SENT221	35	35	26	26	paclitaxel	MDR1	PA450761	5243	0.929
NULL	Eur_J_Nutr_2012_Aug_15_51(5)_513-528.nxml.txt.nlp	22584415	SENT272	37	37	12	12	etanercept	adiponectin	PA449515	9370	0.929
NULL	Cancer_Cell_Int_2010_Jan_11_10_1.nxml.txt.nlp	20142996	SENT152	29	29	40	40	erlotinib	U87	PA134687924	677775;641648	0.929
NULL	Biologics_2009_Oct_12_3_469-474.nxml.txt.nlp	19851472	SENT103	26	26	0	0	montelukast	IFN	PA450546	3439	0.929
NULL	ISRN_Obstet_Gynecol_2011_Nov_17_2011_242864.nxml.txt.nlp	22191042	SENT3	0	0	3	3	letrozole	aromatase	PA450196	1588	0.929
NULL	Mol_Clin_Oncol_2013_Jul_15_1(4)_661-667.nxml.txt.nlp	24649225	SENT29	21	21	12	12	methotrexate	SLC19A1	PA450428	6573	0.929
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT38	9	9	13	13	lapatinib	HER2	PA152241907	2064	0.929
NULL	Front_Comput_Neurosci_2013_Apr_5_7_22.nxml.txt.nlp	23576979	SENT51	25	25	3	3	ketamine	HCN1	PA450144	348980	0.929
NULL	Ann_Intensive_Care_2011_Apr_13_1_7.nxml.txt.nlp	21906332	SENT58	29	29	5	5	hydrocortisone	ACTH	PA449905	5443	0.929
NULL	Croat_Med_J_2013_Apr_54(2)_171-179.nxml.txt.nlp	23630144	SENT113	30	30	19	19	taurine	STZ	PA451590	6484	0.929
NULL	J_Adv_Pharm_Technol_Res_2012_Oct-Dec_3(4)_202-209.nxml.txt.nlp	23378940	SENT127	1	1	8	8	aprepitant	CYP3A4	PA164747039	1576	0.929
NULL	BMB_Rep_2014_May_47(5)_274-279.nxml.txt.nlp	24286313	SENT122	3	3	10	10	alemtuzumab	CD52	PA164783958	1043	0.929
NULL	Front_Oncol_2014_Mar_3_4_34.nxml.txt.nlp	24624361	SENT106	13	13	7	7	cisplatin	BRCA1	PA449014	672	0.929
NULL	Eur_J_Clin_Pharmacol_2014_Oct_8_70(12)_1433-1441.nxml.txt.nlp	25291992	SENT102	6	6	17	17	olanzapine	B12	PA450688	7126;4709	0.929
NULL	Mol_Cancer_2008_Mar_26_7_27.nxml.txt.nlp	18366759	SENT76	6	6	16	16	etoposide	BAX	PA449552	581	0.929
NULL	Cancer_Med_2014_Oct_3_3(5)_1322-1335.nxml.txt.nlp	24989836	SENT197	26	26	5	5	vorinostat	PC3	PA164748224	57332;7832;5122	0.929
NULL	J_Cardiothorac_Surg_2014_Sep_17_9(1)_129.nxml.txt.nlp	NULL	SENT37	23	23	13	13	heparin	ACT	PA449855	12;11332;9457;641455	0.929
NULL	Cell_Death_Dis_2014_Feb_13_5(2)_e1055.nxml.txt.nlp	24525731	SENT53	12	12	45	45	cisplatin	XRCC1	PA449014	7515	0.929
NULL	Antimicrob_Agents_Chemother_2014_Aug_58(8)_4971-4973.nxml.txt.nlp	24913169	SENT9	4	4	17	17	primaquine	G6PD	PA451103	2539	0.929
NULL	Cell_Death_Dis_2014_Jul_17_5(7)_e1333.nxml.txt.nlp	25032856	SENT69	10	10	6	6	candesartan	TLR4	PA448765	7099	0.929
NULL	Korean_J_Anesthesiol_2013_Dec_26_65(6_Suppl)_S16-S18.nxml.txt.nlp	24478855	SENT21	13	13	22	22	thiopental	ANOVA	PA451664	4858	0.929
NULL	Chin_J_Cancer_2012_Jun_31(6)_306-314.nxml.txt.nlp	22640627	SENT14	6	6	31	31	rituximab	MUM-1	PA451261	84939	0.929
NULL	J_Oncol_2012_Dec_22_2012_682480.nxml.txt.nlp	22235203	SENT139	10	10	17	17	pertuzumab	HER2		2064	0.929
NULL	Oncotarget_2011_May_16_2(5)_418-421.nxml.txt.nlp	21789791	SENT26	16	16	7	7	bortezomib	TRAIL	PA10252	8743	0.929
NULL	Cost_Eff_Resour_Alloc_2004_Apr_15_2_2.nxml.txt.nlp	15086954	SENT9	39	39	24	24	metformin	PPG	PA450395	5552	0.929
NULL	Oncotarget_2014_Oct_4_5(20)_10140-10150.nxml.txt.nlp	25294812	SENT43	6	6	16	16	chloroquine	CPX	PA448948	1371;10682;1377	0.929
NULL	Cancer_Cell_Int_2004_Aug_17_4_5.nxml.txt.nlp	15315711	SENT228	22	22	17	17	nadh	NQO1	PA164755085	1728	0.929
NULL	Orthop_Rev_(Pavia)_2014_Sep_18_6(3)_5405.nxml.txt.nlp	25317308	SENT60	19	19	25	25	acetaminophen	PRN	PA448015	64428	0.929
NULL	Br_J_Cancer_2012_Sep_25_107(7)_1044-1050.nxml.txt.nlp	22910317	SENT112	10	10	38	38	vatalanib	CD31	PA7001	5175	0.929
NULL	Biomed_Res_Int_2013_Jul_31_2013_692071.nxml.txt.nlp	23984399	SENT174	15	15	11	11	pancuronium	OCT1	PA450771	5451;6580	0.929
NULL	Oncogene_2014_Jul_24_33(30)_3959-3969.nxml.txt.nlp	24096481	SENT159	24	24	4	4	nutlin-3	p53		7157	0.929
NULL	J_Korean_Med_Sci_2010_Aug_21_25(8)_1222-1227.nxml.txt.nlp	20676337	SENT64	0	0	17	17	propofol	LPA	PA451141	4018	0.929
NULL	Child_Adolesc_Psychiatry_Ment_Health_2012_Jun_22_6_25.nxml.txt.nlp	22726236	SENT81	5	5	11	11	risperidone	B12	PA451257	7126;4709	0.929
NULL	Int_J_Circumpolar_Health_2013_Aug_5_72_10_3402_ijch_v72i0_20854.nxml.txt.nlp	23984273	SENT122	12	12	4	4	erythromycin	19A	PA449493	57823	0.929
NULL	Front_Endocrinol_(Lausanne)_2013_Mar_28_4_22.nxml.txt.nlp	23543285	SENT315	11	11	33	33	estradiol	ARC	PA449503	8996;23237	0.929
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2011_Sep_13_4_47-62.nxml.txt.nlp	22879794	SENT78	18	18	2	2	liraglutide	PPG	PA165958364	5552	0.929
NULL	Mol_Med_Rep_2014_Oct_23_10(4)_1717-1724.nxml.txt.nlp	25069516	SENT129	14	14	8	8	resveratrol	PC-3		692094	0.929
NULL	Clin_Interv_Aging_2013_Jul_16_8_889-897.nxml.txt.nlp	23898224	SENT20	25	25	32	32	gemcitabine	SIRT1	PA449748	23411	0.929
NULL	Exp_Lung_Res_2013_Oct_1_39(8)_336-348.nxml.txt.nlp	23919450	SENT100	23	23	8	8	argatroban	PAR-1	PA164745516	2011;2149	0.929
NULL	Case_Rep_Rheumatol_2013_Dec_17_2013_923497.nxml.txt.nlp	24455384	SENT64	36	36	25	25	cyclosporine	IL6	PA449167	3569	0.929
NULL	Hematol_Rep_2011_Oct_28_3(3_Suppl)_e3.nxml.txt.nlp	22586511	SENT26	6	6	32	32	vindesine	CHOP	PA10232	1649	0.929
NULL	Diabetes_2008_Sep_57(9)_2288-2295.nxml.txt.nlp	18535187	SENT193	40	40	14	14	pioglitazone	adiponectin	PA450970	9370	0.929
NULL	Cardiol_Res_Pract_2013_Feb_21_2013_127270.nxml.txt.nlp	23509665	SENT33	2	2	10	10	prasugrel	P2Y12	PA154410481	64805	0.929
NULL	An_Bras_Dermatol_2014_Mar-Apr_89(2)_301-310.nxml.txt.nlp	24770508	SENT198	7	7	25	25	imatinib	KIT	PA10804	3815	0.929
NULL	Biomed_Res_Int_2014_Apr_10_2014_580852.nxml.txt.nlp	24812624	SENT10	17	17	24	24	resveratrol	PTEN		5728	0.929
NULL	J_Geriatr_Cardiol_2014_Sep_11(3)_200-205.nxml.txt.nlp	25278967	SENT142	3	3	9	9	clopidogrel	ADP	PA449053	23038	0.929
NULL	Br_J_Ophthalmol_2013_Sep_13_97(9)_1161-1167.nxml.txt.nlp	23850682	SENT223	11	11	19	19	ranibizumab	VEGF-A	PA164746012	7422	0.929
NULL	Acta_Pharmacol_Sin_2014_Jul_9_35(7)_889-898.nxml.txt.nlp	24909515	SENT223	15	15	30	30	bromocriptine	SULT1E1	PA448671	6783	0.929
NULL	Adv_Hematol_2013_Oct_28_2013_176418.nxml.txt.nlp	24288536	SENT55	19	19	11	11	alemtuzumab	CD34	PA164783958	947	0.929
NULL	Br_J_Cancer_2011_Jul_26_105(3)_407-412.nxml.txt.nlp	21730976	SENT76	2	2	40	40	pha-665752	STAT3		6774	0.929
NULL	Indian_J_Pharmacol_2013_Nov-Dec_45(6)_597-602.nxml.txt.nlp	24347768	SENT23	32	32	3	3	vinblastine	P-gp	PA451877	5243	0.929
NULL	eLife_2013_Nov_5_2_e00969.nxml.txt.nlp	24192036	SENT14	8	8	19	19	vemurafenib	BRAF	PA165946873	673	0.929
NULL	Adv_Hematol_2012_Aug_2_2012_842945.nxml.txt.nlp	22919394	SENT15	0	0	14	14	lenalidomide	2-21	PA162363968	54097	0.929
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT86	14	14	26	26	trastuzumab	HER2	PA451743	2064	0.929
NULL	Clin_Psychopharmacol_Neurosci_2011_Apr_30_9(1)_1-8.nxml.txt.nlp	23430384	SENT102	0	0	17	17	aripiprazole	5-HT2A	PA10026	3356	0.929
NULL	Indian_J_Anaesth_2009_Aug_53(4)_467-474.nxml.txt.nlp	20640210	SENT72	9	9	19	19	sufentanil	ANOVA	PA451527	4858	0.929
NULL	Curr_Neuropharmacol_2007_Dec_5(4)_232-243.nxml.txt.nlp	19305740	SENT144	0	0	14	14	curcumin	AP-1	PA151958596	2353;3727;2354;3725	0.929
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT271	24	24	18	18	hydrocortisone	EGF	PA449905	1950	0.929
NULL	Br_J_Cancer_2012_Sep_25_107(7)_1009-1016.nxml.txt.nlp	22948724	SENT103	14	14	17	17	temsirolimus	IFN	PA164746890	3439	0.929
NULL	Int_J_Cosmet_Sci_2014_Jun_27_36(3)_253-261.nxml.txt.nlp	24697191	SENT229	20	20	3	3	isotretinoin	PRLR	PA450128	5618	0.929
NULL	Hum_Genomics_2010_Apr_1_4(4)_238-249.nxml.txt.nlp	20511137	SENT67	8	8	20	20	sn-38	UGT1A1		54658	0.929
NULL	J_Autoimmune_Dis_2005_Mar_11_2_1.nxml.txt.nlp	15762980	SENT412	15	15	3	3	thyroglobulin	ZFAT	PA164754910	57623	0.929
NULL	JRSM_Cardiovasc_Dis_2012_Apr_5_1(1)_cvd_2012_012001.nxml.txt.nlp	24175062	SENT250	20	20	13	13	abacavir	HLA-B	PA448004	3106	0.929
NULL	Mol_Brain_2014_Aug_29_7_62.nxml.txt.nlp	25167838	SENT142	4	4	9	9	resveratrol	SIRT1		23411	0.929
NULL	Curr_Chem_Genomics_2010_Mar_1_4_1-8.nxml.txt.nlp	20448812	SENT27	30	30	42	42	fluorescein	OATP1B1	PA164746009	10599	0.929
NULL	Neural_Regen_Res_2013_Jul_15_8(20)_1853-1862.nxml.txt.nlp	25206494	SENT18	4	4	22	22	ethanol	c-Jun	PA448073	3725	0.929
NULL	Croat_Med_J_2012_Aug_53(4)_314-320.nxml.txt.nlp	22911523	SENT123	5	5	15	15	cetuximab	KRAS	PA10040	3845	0.929
NULL	Arthritis_Res_Ther_2010_Apr_29_12(2)_R73.nxml.txt.nlp	20429888	SENT289	18	18	9	9	bortezomib	SP1	PA10252	6667	0.929
NULL	Oncotarget_2013_Feb_24_4(2)_231-241.nxml.txt.nlp	23548208	SENT20	30	30	25	25	cetuximab	EGFR	PA10040	1956	0.929
NULL	Nat_Commun_2011_Feb_8_2_190.nxml.txt.nlp	21304519	SENT110	26	26	24	24	indomethacin	COX	PA449982	1351	0.929
NULL	Oxid_Med_Cell_Longev_2010_Jan-Feb_3(1)_23-34.nxml.txt.nlp	20716925	SENT102	18	18	8	8	genistein	UGT1A10	PA165109660	54575	0.928
NULL	Br_J_Pharmacol_2008_Sep_9_155(1)_127-137.nxml.txt.nlp	18536750	SENT183	13	13	8	8	piroxicam	IL-10	PA450985	3586	0.928
NULL	Curr_HIV_Res_2011_Jan_9(1)_40-53.nxml.txt.nlp	21198432	SENT351	20	20	32	32	raltegravir	ART		181	0.928
NULL	Cancers_(Basel)_2014_Jul_7_6(3)_1441-1463.nxml.txt.nlp	25003395	SENT1251	16	16	10	10	trastuzumab	AKT	PA451743	207	0.928
NULL	Arthritis_Res_Ther_2014_Apr_15_16(2)_R95.nxml.txt.nlp	24735586	SENT201	24	24	14	14	etanercept	CD27	PA449515	939	0.928
NULL	Exp_Ther_Med_2013_Nov_6_6(5)_1089-1095.nxml.txt.nlp	24223627	SENT44	19	19	28	28	tamoxifen	aromatase	PA451581	1588	0.928
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT94	29	29	10	10	trastuzumab	HER3	PA451743	2065	0.928
NULL	Cell_Mol_Life_Sci_2011_Nov_2_68(21)_3573-3587.nxml.txt.nlp	21365278	SENT172	15	15	45	45	iloprost	PGD2	PA164746843	27306	0.928
NULL	J_Korean_Med_Sci_2013_Feb_29_28(2)_220-226.nxml.txt.nlp	23400387	SENT115	5	5	12	12	plerixafor	CD34	PA165958410	947	0.928
NULL	Curr_Neuropharmacol_2013_Jul_11(4)_338-378.nxml.txt.nlp	24381528	SENT573	4	4	14	14	curcumin	p53	PA151958596	7157	0.928
NULL	Br_J_Cancer_2011_May_24_104(11)_1786-1790.nxml.txt.nlp	21559018	SENT108	15	15	19	19	irinotecan	EGFR	PA450085	1956	0.928
NULL	Front_Physiol_2010_Oct_4_1_134.nxml.txt.nlp	21423375	SENT406	5	5	10	10	amiloride	NHE	PA448368	285335	0.928
NULL	Emerg_Infect_Dis_2014_Mar_20(3)_506-507.nxml.txt.nlp	24565423	SENT21	19	19	5	5	moxifloxacin	DST	PA450555	667	0.928
NULL	Exp_Diabetes_Res_2011_Jun_23_2011_898913.nxml.txt.nlp	21747834	SENT96	5	5	19	19	exenatide	AMIGO	PA164749238	57463	0.928
NULL	Nat_Commun_2014_Nov_24_5_5514.nxml.txt.nlp	25417698	SENT767	15	15	9	9	curcumin	p62	PA151958596	8878;10657;23636	0.928
NULL	Mol_Biol_Cell_2014_Jun_1_25(11)_1782-1792.nxml.txt.nlp	24719457	SENT120	17	17	21	21	nicotine	S3A	PA450626	6189	0.928
NULL	Cancer_Metab_2014_May_28_2(Suppl_1)_P65.nxml.txt.nlp	NULL	SENT20	0	0	13	13	resveratrol	NAMPT		10135	0.928
NULL	Oncotarget_2010_Oct_30_1(7)_639-650.nxml.txt.nlp	21317459	SENT41	8	8	3	3	nutlin-3	p53		7157	0.928
NULL	Indian_Dermatol_Online_J_2013_Jul-Sep_4(3)_246-249.nxml.txt.nlp	23984250	SENT38	43	43	35	35	capecitabine	EGFR	PA448771	1956	0.928
NULL	Int_J_Mol_Sci_2014_Jun_25_15(7)_11324-11349.nxml.txt.nlp	24968272	SENT1301	11	11	16	16	methotrexate	TNF-alpha	PA450428	7124	0.928
NULL	Cancer_Med_2014_Jun_25_3(3)_674-680.nxml.txt.nlp	24668895	SENT29	16	16	0	0	cetuximab	KRAS	PA10040	3845	0.928
NULL	J_Cancer_2013_Nov_23_4(9)_736-754.nxml.txt.nlp	24312144	SENT100	12	12	8	8	neratinib	EGFR	PA165291472	1956	0.928
NULL	Arthritis_Res_Ther_2004_Feb_24_6(Suppl_1)_24.nxml.txt.nlp	NULL	SENT13	2	2	13	13	infliximab	OPG	PA452639	690	0.928
NULL	Mol_Cancer_2012_Sep_21_11_72.nxml.txt.nlp	22995644	SENT44	23	23	8	8	imatinib	PRL-3	PA10804	11156	0.928
NULL	Br_J_Cancer_2011_Jul_26_105(3)_403-406.nxml.txt.nlp	21730978	SENT69	5	5	16	16	cetuximab	MUT	PA10040	4594	0.928
NULL	Br_J_Cancer_2010_Oct_12_103(8)_1284-1291.nxml.txt.nlp	20859285	SENT142	11	11	4	4	tamoxifen	EGF	PA451581	1950	0.928
NULL	Mol_Cancer_2009_Nov_10_8_99.nxml.txt.nlp	19903356	SENT118	10	10	3	3	imatinib	IGFBP3	PA10804	3486	0.928
NULL	J_Ayurveda_Integr_Med_2013_Apr-Jun_4(2)_99-106.nxml.txt.nlp	23930042	SENT131	1	1	27	27	glipizide	PPG	PA449762	5552	0.928
NULL	Int_J_Biol_Sci_2014_Jun_10_10(7)_654-663.nxml.txt.nlp	25013375	SENT111	9	9	28	28	bortezomib	AKT	PA10252	207	0.928
NULL	Int_J_Breast_Cancer_2011_Feb_14_2011_618757.nxml.txt.nlp	22332014	SENT150	41	41	6	6	tamoxifen	ATAC	PA451581	6375	0.928
NULL	EMBO_J_2014_Nov_3_33(21)_2521-2533.nxml.txt.nlp	25193968	SENT265	27	27	23	23	hydroxyurea	FANCJ	PA449942	83990	0.928
NULL	Blood_Cancer_J_2014_May_9_4(5)_e213.nxml.txt.nlp	24813081	SENT14	18	18	1	1	fludarabine	NMA	PA449655	25805	0.928
NULL	Cancer_2014_Apr_8_120(8)_1145-1154.nxml.txt.nlp	24501009	SENT195	16	16	20	20	erlotinib	KRAS	PA134687924	3845	0.928
NULL	Diabetes_2011_Jun_21_60(6)_1734-1742.nxml.txt.nlp	21498783	SENT4	12	12	24	24	lipase	HSL	PA450239	3991	0.928
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Jan_4_69(Pt_2)_o167-o168.nxml.txt.nlp	23424455	SENT77	15	15	7	7	ethanol	mol	PA448073	90527	0.928
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT176	23	23	18	18	dasatinib	LYN	PA162372878	4067	0.928
NULL	Int_J_Mol_Sci_2014_Nov_21_15(11)_21433-21454.nxml.txt.nlp	25421240	SENT98	5	5	11	11	pp2	PI3K		5290	0.928
NULL	Br_J_Cancer_2010_Jul_13_103(2)_186-195.nxml.txt.nlp	20588277	SENT96	27	27	6	6	nutlin-3	p53		7157	0.928
NULL	J_Cancer_2013_Nov_23_4(9)_736-754.nxml.txt.nlp	24312144	SENT118	13	13	33	33	erlotinib	Met	PA134687924	79811	0.928
NULL	Breast_Cancer_Res_Treat_2013_Jan_15_137(2)_397-406.nxml.txt.nlp	23242584	SENT229	11	11	31	31	tamoxifen	aromatase	PA451581	1588	0.928
NULL	Patient_Prefer_Adherence_2013_Mar_27_7_245-258.nxml.txt.nlp	23569364	SENT104	17	17	13	13	celecoxib	aromatase	PA448871	1588	0.928
NULL	Nucleic_Acids_Res_2011_Dec_31_39(22)_9536-9548.nxml.txt.nlp	21880590	SENT178	31	31	21	21	etoposide	BRCA1	PA449552	672	0.928
NULL	Biomed_Res_Int_2013_Jun_6_2013_626910.nxml.txt.nlp	23841079	SENT158	36	36	11	11	ibritumomab	gamma	PA164781375	9913	0.928
NULL	J_Carcinog_2013_Dec_31_12_22.nxml.txt.nlp	24574860	SENT252	12	12	33	33	vemurafenib	BRAF	PA165946873	673	0.928
NULL	Cell_Biol_Int_Rep_(2010)_2012_Jun_21_19(1)_e00017.nxml.txt.nlp	23124518	SENT163	20	20	8	8	etoposide	Mcl-1	PA449552	4170	0.928
NULL	Acta_Pharmacol_Sin_2012_Nov_23_33(11)_1409-1416.nxml.txt.nlp	22820910	SENT145	16	16	4	4	clozapine	CYP1A2	PA449061	1544	0.928
NULL	Br_J_Cancer_2012_Nov_6_107(10)_1714-1721.nxml.txt.nlp	23073173	SENT101	36	36	40	40	bicalutamide	RUNX2	PA164746255	860	0.928
NULL	Int_Semin_Surg_Oncol_2006_Sep_18_3_31.nxml.txt.nlp	16981992	SENT13	6	6	1	1	letrozole	aromatase	PA450196	1588	0.928
NULL	ScientificWorldJournal_2012_Apr_26_2012_358102.nxml.txt.nlp	22645419	SENT118	17	17	19	19	losartan	AT2	PA450268	186	0.928
NULL	Cancer_Cell_Int_2013_Jun_26_13_63.nxml.txt.nlp	23800022	SENT146	9	9	1	1	ethanol	ANOVA	PA448073	4858	0.928
NULL	Int_J_Biomed_Sci_2013_Sep_9(3)_112-122.nxml.txt.nlp	24170986	SENT90	24	24	14	14	heparin	RAGE	PA449855	177	0.928
NULL	Cancer_Med_2013_Feb_3_2(1)_40-49.nxml.txt.nlp	24133626	SENT5	18	18	38	38	cisplatin	PDE3B	PA449014	5140	0.928
NULL	Clin_Drug_Investig_2013_Aug_23_33(10)_727-736.nxml.txt.nlp	23975654	SENT61	27	27	30	30	bupropion	CYP2B6	PA448687	1555	0.928
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT16	2	2	10	10	pp2	JNK		5599	0.928
NULL	Acta_Pharmacol_Sin_2013_Jan_3_34(1)_119-128.nxml.txt.nlp	23202804	SENT181	6	6	26	26	rimonabant	CB1	PA152407999	1268	0.928
NULL	J_Cell_Biol_2002_Jun_24_157(7)_1151-1160.nxml.txt.nlp	12082077	SENT161	26	26	2	2	trypsin	COX	PA451806	1351	0.928
NULL	Cytojournal_2014_May_22_11_11.nxml.txt.nlp	24987442	SENT60	21	21	14	14	thyroglobulin	CK7	PA164754910	3855	0.928
NULL	Indian_J_Endocrinol_Metab_2012_Mar-Apr_16(2)_158-163.nxml.txt.nlp	22470850	SENT63	0	0	25	25	calcidiol	CYP27B1	PA164745614	1594	0.928
NULL	J_Biomed_Sci_2014_May_8_21(1)_40.nxml.txt.nlp	24884657	SENT181	27	27	6	6	etoposide	p53	PA449552	7157	0.928
NULL	Hum_Genomics_2008_Sep_1_3(1)_7-16.nxml.txt.nlp	19129086	SENT171	24	24	2	2	repaglinide	SLCO1B1	PA451234	10599	0.928
NULL	Cancer_Res_Treat_2012_Sep_30_44(3)_195-201.nxml.txt.nlp	23091446	SENT107	12	12	17	17	irinotecan	MKP-1	PA450085	1843	0.928
NULL	Breast_Cancer_Res_2000_Jul_13_2(5)_360-366.nxml.txt.nlp	11250729	SENT25	20	20	6	6	tamoxifen	AF1	PA451581	1946	0.928
NULL	J_Hematol_Oncol_2013_Jun_3_6_38.nxml.txt.nlp	23731980	SENT55	27	27	31	31	lapatinib	HER2	PA152241907	2064	0.928
NULL	Breast_Cancer_Res_2005_May_24_7(5)_R589-R597.nxml.txt.nlp	16168102	SENT92	19	19	36	36	doxorubicin	HER2	PA449412	2064	0.928
NULL	J_Adv_Pract_Oncol_2012_Nov_1_Nov-Dec_3(6)_391-394.nxml.txt.nlp	25031970	SENT64	2	2	10	10	pertuzumab	HER2		2064	0.928
NULL	Oncol_Lett_2013_Jun_3_5(6)_1760-1764.nxml.txt.nlp	23833637	SENT92	15	15	9	9	gemcitabine	TRAIL	PA449748	8743	0.928
NULL	Mol_Cancer_2003_Sep_23_2_33.nxml.txt.nlp	14572313	SENT154	23	23	35	35	pp2	MEK1		5604	0.928
NULL	J_Med_Case_Reports_2011_Dec_21_5_593.nxml.txt.nlp	22188652	SENT55	0	0	15	15	erlotinib	EGFR	PA134687924	1956	0.928
NULL	Evid_Based_Complement_Alternat_Med_2012_Feb_13_2012_982396.nxml.txt.nlp	22454693	SENT256	21	21	2	2	resveratrol	CCR5		1234	0.928
NULL	Free_Radic_Biol_Med_2014_Oct_75_48-59.nxml.txt.nlp	25048970	SENT146	42	42	36	36	desipramine	NAC	PA449233	22861	0.928
NULL	Oncoimmunology_2012_Aug_1_1(5)_618-629.nxml.txt.nlp	22934254	SENT162	12	12	6	6	nilotinib	JNK	PA165958345	5599	0.928
NULL	Case_Rep_Genet_2011_Jul_6_2011_913020.nxml.txt.nlp	23074682	SENT61	7	7	29	29	hydroxyprogesterone	ACTH	PA449932	5443	0.928
NULL	Diabetes_2011_Nov_17_60(11)_2691-2700.nxml.txt.nlp	21896928	SENT177	18	18	6	6	resveratrol	SIRT1		23411	0.928
NULL	Eur_J_Clin_Pharmacol_2007_Apr_21_63(4)_335-343.nxml.txt.nlp	17318526	SENT234	37	37	7	7	sulfamethoxazole	CYP2C8	PA451544	1558	0.928
NULL	Clin_Transl_Allergy_2014_Mar_14_4(Suppl_1)_O4.nxml.txt.nlp	NULL	SENT12	6	6	26	26	montelukast	IL-8	PA450546	3576	0.928
NULL	J_Cardiothorac_Surg_2014_May_9_9_81.nxml.txt.nlp	24885948	SENT152	0	0	12	12	sorafenib	c-Raf	PA7000	5894	0.928
NULL	Oncol_Lett_2013_Mar_8_5(3)_805-812.nxml.txt.nlp	23426281	SENT165	20	20	12	12	gemcitabine	B7-H3	PA449748	80381	0.928
NULL	FEBS_Open_Bio_2014_Jan_6_4_77-89.nxml.txt.nlp	24490132	SENT8	3	3	37	37	ebselen	NAC	PA161660841	22861	0.928
NULL	Mar_Drugs_2014_Sep_25_12(9)_4984-5020.nxml.txt.nlp	25257786	SENT123	21	21	0	0	heparin	SP2	PA449855	6668	0.928
NULL	Mol_Biol_Cell_2013_Jun_1_24(11)_1801-1811.nxml.txt.nlp	23552691	SENT205	27	27	16	16	phenformin	AMPK	PA1000	5563	0.928
NULL	Breast_Cancer_Res_2011_Mar_1_13(2)_R21.nxml.txt.nlp	21362200	SENT217	16	16	9	9	fulvestrant	aromatase	PA164747170	1588	0.928
NULL	J_Hematol_Oncol_2012_Oct_10_5_62.nxml.txt.nlp	23050865	SENT101	14	14	7	7	gemcitabine	EGFR	PA449748	1956	0.928
NULL	Eur_J_Clin_Pharmacol_2010_Nov_29_66(11)_1131-1136.nxml.txt.nlp	20669013	SENT24	14	14	20	20	voriconazole	CYP2C19	PA10233	1557	0.928
NULL	Acta_Pharmacol_Sin_2009_Oct_5_30(10)_1428-1435.nxml.txt.nlp	19801997	SENT145	9	9	26	26	artemether	p38	PA165111698	10598;1432;7965	0.928
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT366	18	18	5	5	pp2	CDH1		51343;999	0.928
NULL	Ophthalmol_Eye_Dis_2010_Feb_23_2_5-8.nxml.txt.nlp	23861611	SENT9	0	0	28	28	tacrolimus	IL-2	PA451578	3558	0.928
NULL	Int_J_Biol_Sci_2012_Oct_17_8(8)_1197-1205.nxml.txt.nlp	23091417	SENT69	15	15	40	40	captopril	ACE2	PA448780	59272	0.928
NULL	Oncogene_2013_Oct_10_32(41)_4892-4902.nxml.txt.nlp	23178494	SENT240	24	24	5	5	tamoxifen	IL-6	PA451581	3569	0.928
NULL	Cells_2014_Apr_29_3(2)_331-362.nxml.txt.nlp	24785347	SENT61	23	23	39	39	capsaicin	TRPV1	PA448776	7442	0.928
NULL	Cancer_Med_2014_Aug_6_3(4)_988-997.nxml.txt.nlp	24905030	SENT209	17	17	44	44	cetuximab	KRAS	PA10040	3845	0.928
NULL	Am_J_Physiol_Endocrinol_Metab_2013_Nov_1_305(9)_E1134-E1144.nxml.txt.nlp	24022868	SENT202	13	13	23	23	rosiglitazone	PPARG	PA451283	5468	0.928
NULL	Exp_Mol_Med_2012_Sep_30_44(9)_521-528.nxml.txt.nlp	22684244	SENT129	10	10	33	33	staurosporine	CO2	PA165109623	4513	0.928
NULL	Cardiovasc_Res_2014_Mar_1_101(3)_513-521.nxml.txt.nlp	24323316	SENT13	15	15	6	6	maraviroc	CCL4	PA164768835	6351	0.928
NULL	Leukemia_2013_Jan_11_27(1)_32-40.nxml.txt.nlp	22781593	SENT167	13	13	6	6	ponatinib	FGFR1	PA165980594	2260	0.928
NULL	Int_J_Environ_Res_Public_Health_2010_Apr_30_7(4)_1448-1466.nxml.txt.nlp	20617039	SENT157	30	30	4	4	ethanol	L1CAM	PA448073	3897	0.928
NULL	Front_Neurosci_2011_Jan_14_4_207.nxml.txt.nlp	21258618	SENT164	22	22	11	11	ethanol	AC7	PA448073	113	0.928
NULL	Acta_Pharmacol_Sin_2013_Feb_12_34(2)_255-261.nxml.txt.nlp	23147557	SENT126	38	38	14	14	pioglitazone	CYP2C8	PA450970	1558	0.928
NULL	Clin_Cosmet_Investig_Dermatol_2011_Jul_1_4_93-99.nxml.txt.nlp	21760744	SENT99	9	9	3	3	etanercept	IL-17	PA449515	3605	0.928
NULL	Hum_Reprod_2011_Jun_5_26(6)_1377-1383.nxml.txt.nlp	21467200	SENT90	5	5	24	24	alfentanil	PCB	PA448084	5091	0.928
NULL	Curr_Chem_Genomics_2010_Mar_1_4_1-8.nxml.txt.nlp	20448812	SENT28	32	32	14	14	methotrexate	OATP1B3	PA450428	28234	0.928
NULL	Cancers_(Basel)_2013_Nov_26_5(4)_1601-1618.nxml.txt.nlp	24287743	SENT788	4	4	0	0	gefitinib	Met	PA131301952	79811	0.928
NULL	Am_J_Trop_Med_Hyg_2012_Aug_1_87(2)_231-241.nxml.txt.nlp	22855752	SENT38	15	15	6	6	artemisinin	ACT	PA165111696	12;11332;9457;641455	0.928
NULL	Tuberc_Respir_Dis_(Seoul)_2013_Nov_29_75(5)_188-198.nxml.txt.nlp	24348666	SENT97	33	33	16	16	gefitinib	HER3	PA131301952	2065	0.928
NULL	Front_Endocrinol_(Lausanne)_2014_Nov_28_5_201.nxml.txt.nlp	25506340	SENT254	27	27	19	19	losartan	ANG	PA450268	283	0.928
NULL	J_Int_Soc_Sports_Nutr_2014_Aug_15_11_40.nxml.txt.nlp	25302053	SENT182	39	39	14	14	creatine	SUP	PA164778930	9709	0.928
NULL	Br_J_Cancer_2010_Jun_8_102(12)_1762-1768.nxml.txt.nlp	20485284	SENT107	5	5	0	0	cetuximab	KRAS	PA10040	3845	0.928
NULL	Diabetes_2011_Mar_21_60(3)_757-765.nxml.txt.nlp	21282370	SENT160	21	21	7	7	isoproterenol	PTRF	PA450121	284119	0.928
NULL	Anesth_Essays_Res_2013_Jan-Apr_7(1)_44-48.nxml.txt.nlp	NULL	SENT100	15	15	11	11	clonidine	CO2	PA449051	4513	0.928
NULL	Int_J_Mol_Sci_2012_Sep_19_13(9)_11881-11894.nxml.txt.nlp	23109889	SENT60	30	30	0	0	fluconazole	YAP1	PA449653	10413	0.928
NULL	Front_Behav_Neurosci_2011_Sep_13_5_57.nxml.txt.nlp	21949506	SENT27	13	13	6	6	rimonabant	CB1	PA152407999	1268	0.928
NULL	Chem_Cent_J_2014_Sep_17_8(1)_59.nxml.txt.nlp	NULL	SENT100	22	22	10	10	moxifloxacin	MOX	PA450555	26002	0.928
NULL	Diabetes_2009_Jan_58(1)_174-184.nxml.txt.nlp	18984736	SENT230	18	18	9	9	diazoxide	TRPV2	PA449285	51393	0.928
NULL	Cell_Death_Differ_2010_Apr_16_17(4)_666-676.nxml.txt.nlp	19834494	SENT106	32	32	25	25	oxaliplatin	RAGE	PA131285527	177	0.928
NULL	Diabetes_Metab_Syndr_Obes_2009_Jun_24_2_101-109.nxml.txt.nlp	21437123	SENT105	0	0	8	8	repaglinide	PPG	PA451234	5552	0.928
NULL	Pharmaceuticals_(Basel)_2013_Aug_2_6(8)_915-928.nxml.txt.nlp	24276376	SENT127	28	28	24	24	aspirin	CAD	PA448497	1677;790	0.928
NULL	Br_J_Cancer_2011_Nov_22_105(11)_1759-1767.nxml.txt.nlp	22045189	SENT32	13	13	30	30	cetuximab	ERCC1	PA10040	2067	0.928
NULL	Clin_Ophthalmol_2010_Oct_28_4_1249-1252.nxml.txt.nlp	21151329	SENT23	20	20	29	29	ranibizumab	San	PA164746012	80218	0.928
NULL	Cell_Death_Dis_2014_Mar_13_5(3)_e1112.nxml.txt.nlp	24625971	SENT86	23	23	12	12	curcumin	CHOP	PA151958596	1649	0.928
NULL	Mol_Cancer_2012_Jun_18_11_41.nxml.txt.nlp	22709873	SENT70	42	42	12	12	lapatinib	RB1CC1	PA152241907	9821	0.928
NULL	Oncol_Lett_2014_Nov_14_8(5)_2086-2092.nxml.txt.nlp	25295095	SENT99	30	30	21	21	gemcitabine	CHK2	PA449748	11200	0.928
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT134	23	23	12	12	pp2	PP2		4888	0.928
NULL	Sensors_(Basel)_2013_Dec_27_14(1)_458-467.nxml.txt.nlp	24379050	SENT44	0	0	9	9	glucose	MTB	PA449773	54892;4498	0.928
NULL	EPMA_J_2011_Dec_22_3(1)_1.nxml.txt.nlp	22738081	SENT189	14	14	0	0	temsirolimus	CAIX	PA164746890	768	0.928
NULL	Br_J_Cancer_2009_Mar_24_100(6)_870-873.nxml.txt.nlp	19293806	SENT53	1	1	11	11	gemcitabine	CDA	PA449748	978	0.928
NULL	Mol_Cancer_2012_Jul_25_11_46.nxml.txt.nlp	22830422	SENT94	35	35	5	5	rolipram	PDE4B	PA153906323	5142	0.928
NULL	Mol_Cancer_2012_Aug_8_11_53.nxml.txt.nlp	22871047	SENT225	7	7	16	16	paclitaxel	HIN-1	PA450761	92304	0.928
NULL	Int_J_Mol_Imaging_2011_Oct_26_2011_874585.nxml.txt.nlp	21490735	SENT162	11	11	4	4	docetaxel	FDG	PA449383	23583	0.928
NULL	Arthritis_Res_Ther_2009_Oct_14_11(5)_245.nxml.txt.nlp	19849817	SENT203	7	7	34	34	rituximab	ACR	PA451261	49	0.928
NULL	ACS_Med_Chem_Lett_2011_Jul_17_2(9)_678-681.nxml.txt.nlp	21927646	SENT4	17	17	10	10	estradiol	HSD1	PA449503	26871	0.928
NULL	Br_J_Cancer_2012_Jul_24_107(3)_516-526.nxml.txt.nlp	22782351	SENT108	37	37	8	8	tamoxifen	p53	PA451581	7157	0.928
NULL	Environ_Health_Perspect_2007_Dec_8_115(Suppl_1)_77-83.nxml.txt.nlp	18174954	SENT99	20	20	9	9	genistein	TTR	PA165109660	7276	0.928
NULL	Br_J_Cancer_2012_Sep_4_107(6)_947-955.nxml.txt.nlp	22892392	SENT212	9	9	12	12	lapatinib	aromatase	PA152241907	1588	0.928
NULL	J_Biol_Chem_2011_Sep_16_286(37)_32834-32842.nxml.txt.nlp	21795713	SENT61	33	33	16	16	kanamycin	RILP	PA450137	83547	0.928
NULL	Oxid_Med_Cell_Longev_2013_Apr_21_2013_412576.nxml.txt.nlp	23710286	SENT161	19	19	25	25	curcumin	NRF2	PA151958596	2551;4780	0.928
NULL	Biologics_2012_Feb_1_6_31-35.nxml.txt.nlp	22355257	SENT3	11	11	29	29	rituximab	IL-7	PA451261	3574	0.928
NULL	Br_J_Cancer_2013_Mar_5_108(4)_887-900.nxml.txt.nlp	23462807	SENT126	18	18	34	34	sunitinib	NR1I3	PA162372840	9970	0.928
NULL	Int_J_Chron_Obstruct_Pulmon_Dis_2006_Dec_1(4)_409-423.nxml.txt.nlp	18044097	SENT245	16	16	23	23	cilomilast	PDE4D	PA165948031	5144	0.928
NULL	Int_J_Surg_Oncol_2012_Jun_12_2012_862879.nxml.txt.nlp	22778941	SENT125	11	11	4	4	cisplatin	PARP1	PA449014	142	0.928
NULL	Front_Immunol_2012_Jan_2_2_82.nxml.txt.nlp	22566871	SENT717	9	9	2	2	infliximab	CX3CL1	PA452639	6376	0.928
NULL	Biomed_Res_Int_2013_Jul_9_2013_580796.nxml.txt.nlp	23936821	SENT4	30	30	9	9	ribavirin	IL28B	PA451241	282617	0.928
NULL	Biomed_Res_Int_2014_Feb_19_2014_814208.nxml.txt.nlp	24672796	SENT276	37	37	25	25	ganciclovir	FDG	PA449733	23583	0.928
NULL	J_Res_Med_Sci_2012_Mar_17(3)_313.nxml.txt.nlp	23267388	SENT11	25	25	15	15	aprotinin	BART	PA448472	7809;23568	0.928
NULL	Diabetes_Metab_Syndr_Obes_2010_May_17_3_155-163.nxml.txt.nlp	21437085	SENT9	23	23	17	17	liraglutide	GLP-1	PA165958364	100125288	0.928
NULL	J_Korean_Assoc_Oral_Maxillofac_Surg_2014_Dec_26_40(6)_291-296.nxml.txt.nlp	25551094	SENT87	13	13	8	8	alendronate	OPG	PA448082	690	0.928
NULL	ScientificWorldJournal_2013_Sep_21_2013_208309.nxml.txt.nlp	24170980	SENT163	23	23	16	16	lenalidomide	MRP8	PA162363968	6833;6279;85320	0.928
NULL	Oncoimmunology_2013_Dec_1_2(12)_e26961.nxml.txt.nlp	24575379	SENT12	13	13	28	28	temsirolimus	MTOR	PA164746890	2475	0.928
NULL	Environ_Health_Perspect_2009_Feb_8_117(2)_175-180.nxml.txt.nlp	19270784	SENT200	29	29	4	4	vinblastine	BPA	PA451877	667	0.928
NULL	Anesthesiol_Res_Pract_2012_Mar_14_2012_598593.nxml.txt.nlp	22496684	SENT74	18	18	32	32	propofol	ERG	PA451141	2078	0.928
NULL	Breast_Cancer_(Auckl)_2014_Jul_29_8_109-118.nxml.txt.nlp	25125981	SENT39	3	3	6	6	pertuzumab	HER2		2064	0.928
NULL	Front_Chem_2013_Jul_12_1_10.nxml.txt.nlp	24790939	SENT106	22	22	27	27	hydroquinone	mol	PA449924	90527	0.928
NULL	Evid_Based_Complement_Alternat_Med_2014_Oct_19_2014_628712.nxml.txt.nlp	25389442	SENT175	8	8	25	25	erlotinib	PTEN	PA134687924	5728	0.928
NULL	Diabetes_Care_2010_Oct_13_33(10)_2250-2253.nxml.txt.nlp	20628086	SENT112	12	12	6	6	ramipril	DREAM	PA451223	30818	0.928
NULL	Nat_Commun_2013_Oct_25_4_2667.nxml.txt.nlp	24157709	SENT673	23	23	12	12	nutlin-3	p53		7157	0.928
NULL	Breast_Cancer_Res_2012_Mar_20_14(2)_R53.nxml.txt.nlp	22433433	SENT222	20	20	0	0	paclitaxel	CCNE1	PA450761	898	0.928
NULL	Mol_Cancer_2002_Nov_14_1_7.nxml.txt.nlp	12473178	SENT106	20	20	6	6	cyproterone	ARA70	PA10049	8031	0.928
NULL	Atherosclerosis_2011_Nov_219(1)_109-115.nxml.txt.nlp	21820657	SENT296	0	0	7	7	probucol	CETP	PA451107	1071	0.928
NULL	Clin_Epigenetics_2011_Jun_14_2(2)_151-169.nxml.txt.nlp	22704335	SENT300	3	3	26	26	procainamide	GSTP1	PA451108	2950	0.928
NULL	J_Exp_Med_1977_Dec_1_146(6)_1484-1499.nxml.txt.nlp	925610	SENT6	31	31	1	1	trypsin	C42	PA451806	51654	0.928
NULL	Oncotarget_2014_Aug_29_5(18)_8052-8082.nxml.txt.nlp	25211298	SENT216	22	22	7	7	captopril	ATR1	PA448780	6519	0.928
NULL	Adipocyte_2013_Jan_1_2(1)_17-27.nxml.txt.nlp	23599907	SENT109	20	20	9	9	glucose	IRAP	PA449773	3557	0.928
NULL	Br_J_Ophthalmol_2008_Sep_22_92(9)_1275-1282.nxml.txt.nlp	18723745	SENT95	9	9	15	15	latanoprost	BAK	PA164774763	578	0.928
NULL	Exp_Hematol_Oncol_2014_Mar_11_3_7.nxml.txt.nlp	24618035	SENT230	25	25	3	3	imatinib	CXCL12	PA10804	6387	0.928
NULL	Arthritis_Res_Ther_2008_Mar_14_10(2)_204.nxml.txt.nlp	18373887	SENT96	4	4	19	19	infliximab	CD62L	PA452639	6402	0.928
NULL	Ecancermedicalscience_2008_Feb_18_2_75.nxml.txt.nlp	22275966	SENT157	26	26	32	32	cisplatin	ERCC1	PA449014	2067	0.928
NULL	Arthritis_Res_Ther_2009_Aug_28_11(4)_R131.nxml.txt.nlp	19715572	SENT14	0	0	9	9	rituximab	CD4	PA451261	920	0.928
NULL	Pharmaceuticals_(Basel)_2012_Jul_25_5(8)_779-801.nxml.txt.nlp	24280675	SENT1086	5	5	1	1	bortezomib	Hsp90	PA10252	3320	0.928
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1066.nxml.txt.nlp	24556681	SENT52	6	6	18	18	ethanol	LC3	PA448073	84557	0.928
NULL	Cell_Death_Dis_2014_Mar_13_5(3)_e1118.nxml.txt.nlp	24625977	SENT45	10	10	32	32	etoposide	mot-2	PA449552	3313	0.928
NULL	Oncotarget_2014_Jun_26_5(14)_5559-5569.nxml.txt.nlp	24980819	SENT184	10	10	21	21	vemurafenib	p53	PA165946873	7157	0.928
NULL	J_Clin_Biochem_Nutr_2007_Sep_29_41(2)_84-91.nxml.txt.nlp	18193101	SENT119	15	15	6	6	lansoprazole	IL-8	PA450180	3576	0.928
NULL	Cancer_Med_2014_Apr_27_3(2)_293-299.nxml.txt.nlp	24464780	SENT35	18	18	33	33	capecitabine	DPYD	PA448771	1806	0.928
NULL	Oncol_Lett_2013_Sep_1_6(3)_821-828.nxml.txt.nlp	24137418	SENT155	14	14	5	5	octreotide	SSTR5	PA450678	6755	0.928
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1449-1456.nxml.txt.nlp	24077631	SENT27	42	42	8	8	tolbutamide	CYP2C9	PA451718	1559	0.928
NULL	Cell_Death_Differ_2010_Mar_16_17(3)_439-451.nxml.txt.nlp	19834489	SENT177	2	2	35	35	neomycin	CCT	PA450608	907	0.928
NULL	Mol_Biol_Cell_2012_Nov_1_23(21)_4212-4225.nxml.txt.nlp	22956765	SENT200	11	11	27	27	thrombin	SHP2	PA451674	5781	0.928
NULL	J_Cell_Biol_2005_Jul_4_170(1)_49-59.nxml.txt.nlp	15983061	SENT55	27	27	11	11	forskolin	HIF1	PA146096022	3091	0.928
NULL	Cancer_Cell_Int_2013_Mar_4_13_21.nxml.txt.nlp	23497288	SENT209	16	16	8	8	doxorubicin	EWS	PA449412	2130	0.928
NULL	Nucleic_Acids_Res_2012_Apr_16_40(8)_3511-3523.nxml.txt.nlp	22180533	SENT143	16	16	4	4	doxycycline	E2F7	PA449415	144455	0.928
NULL	J_Headache_Pain_2001_Jun_2(1)_3-11.nxml.txt.nlp	NULL	SENT1	10	10	27	27	rizatriptan	5-HT1D	PA451264	3352	0.928
NULL	Int_J_Med_Sci_2013_Mar_19_10(5)_599-606.nxml.txt.nlp	23569422	SENT12	22	22	16	16	propofol	JNK	PA451141	5599	0.928
NULL	J_Hematol_Oncol_2008_Oct_23_1_19.nxml.txt.nlp	18947412	SENT185	38	38	14	14	alemtuzumab	CD34	PA164783958	947	0.928
NULL	Curr_Neuropharmacol_2008_Sep_6(3)_215-234.nxml.txt.nlp	19506722	SENT77	12	12	0	0	fluoxetine	5-HT1B	PA449673	3351	0.928
NULL	Nucl_Recept_Signal_2010_Nov_19_8_e005.nxml.txt.nlp	21383957	SENT31	26	26	11	11	taurine	CYP8B1	PA451590	1582	0.928
NULL	Int_J_Biol_Sci_2014_Jan_20_10(2)_171-180.nxml.txt.nlp	24520215	SENT275	7	7	15	15	cerulenin	L-FABP	PA164764551	2168	0.928
NULL	Diabetes_Care_2009_Sep_29_32(9)_1620-1625.nxml.txt.nlp	19564453	SENT155	0	0	19	19	metformin	LKB1	PA450395	6794	0.928
NULL	Oncoscience_2014_Aug_7_1(8)_540-549.nxml.txt.nlp	25594061	SENT70	31	31	21	21	cetuximab	KRAS	PA10040	3845	0.928
NULL	J_RNAi_Gene_Silencing_2009_Mar_9_5(1)_321-330.nxml.txt.nlp	19771229	SENT163	3	3	15	15	hydroxyurea	RRM1	PA449942	6240	0.928
NULL	Cases_J_2009_Jun_26_2_6384.nxml.txt.nlp	19829800	SENT16	14	14	10	10	doxorubicin	CHOP	PA449412	1649	0.928
NULL	Exp_Hematol_Oncol_2012_Sep_4_1_25.nxml.txt.nlp	23211188	SENT23	12	12	0	0	oxaliplatin	BIRC6	PA131285527	57448	0.928
NULL	Clin_Pharmacol_2013_Dec_9_5_185-192.nxml.txt.nlp	24353446	SENT4	14	14	28	28	clopidogrel	CYP3A	PA449053	1574	0.928
NULL	Curr_Gerontol_Geriatr_Res_2011_Sep_8_2011_526379.nxml.txt.nlp	21912543	SENT94	10	10	24	24	collagenase	EGF	PA449107	1950	0.928
NULL	Oncotarget_2014_Aug_27_5(17)_7328-7341.nxml.txt.nlp	25193862	SENT188	2	2	15	15	dasatinib	ANOVA	PA162372878	4858	0.928
NULL	Adolesc_Health_Med_Ther_2012_Jun_20_3_85-93.nxml.txt.nlp	24600289	SENT27	3	3	9	9	etanercept	TNF	PA449515	7124	0.928
NULL	Biochim_Biophys_Acta_2013_Jul_1832(7)_905-910.nxml.txt.nlp	23032152	SENT105	16	16	7	7	ketanserin	5-HT2A	PA131053734	3356	0.928
NULL	J_Nucleic_Acids_2010_Aug_9_2010_931394.nxml.txt.nlp	20814583	SENT52	25	25	15	15	etoposide	CC3	PA449552	10553	0.928
NULL	Alcohol_Res_2012_34(3)_282-292.nxml.txt.nlp	23134044	SENT59	26	26	14	14	ethanol	CB1	PA448073	1268	0.928
NULL	Acta_Naturae_2012_Jul-Sep_4(3)_72-81.nxml.txt.nlp	23150805	SENT137	3	3	15	15	heparin	EC-SOD	PA449855	6649	0.928
NULL	Br_J_Cancer_2009_Sep_15_101(6)_875-878.nxml.txt.nlp	19672259	SENT34	24	24	8	8	tamoxifen	ATAC	PA451581	6375	0.928
NULL	Drugs_R_D_2013_Jun_5_13(2)_153-157.nxml.txt.nlp	23737454	SENT134	9	9	7	7	ticagrelor	P2Y12	PA165374673	64805	0.928
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_105-115.nxml.txt.nlp	17912640	SENT146	12	12	26	26	anastrozole	aromatase	PA448432	1588	0.928
NULL	Front_Genet_2012_Nov_12_3_235.nxml.txt.nlp	23162568	SENT148	9	9	4	4	methamphetamine	CYP2D6	PA450403	1565	0.928
NULL	Nat_Genet_2011_Jan_12_43(1)_27-33.nxml.txt.nlp	21151129	SENT30	28	28	3	3	tamoxifen	FOXA1	PA451581	3169	0.928
NULL	Cancer_Res_Treat_2014_Jan_15_46(1)_48-54.nxml.txt.nlp	24520223	SENT150	12	12	18	18	bevacizumab	KRAS	PA130232992	3845	0.928
NULL	Br_J_Cancer_2010_Jul_13_103(2)_265-274.nxml.txt.nlp	20551953	SENT209	17	17	9	9	doxorubicin	DUSP16	PA449412	80824	0.928
NULL	Gut_2015_Jan_19_64(1)_111-120.nxml.txt.nlp	24647007	SENT17	18	18	12	12	capecitabine	ENOSF1	PA448771	55556	0.928
NULL	Emerg_Infect_Dis_2014_Aug_20(8)_1280-1286.nxml.txt.nlp	25061906	SENT22	16	16	11	11	pyrimethamine	DHPS	PA451193	1725	0.928
NULL	J_Adv_Pract_Oncol_2014_May_1_May-Jun_5(3)_205-210.nxml.txt.nlp	25089219	SENT95	17	17	6	6	oxaliplatin	DPD	PA131285527	1806	0.928
NULL	BMB_Rep_2013_Aug_46(8)_410-415.nxml.txt.nlp	23977989	SENT34	31	31	8	8	curcumin	HO-1	PA151958596	3162	0.928
NULL	Cancer_Med_2013_Aug_29_2(4)_478-487.nxml.txt.nlp	24156020	SENT168	24	24	5	5	gemcitabine	CD4	PA449748	920	0.928
NULL	J_Gen_Intern_Med_2009_Nov_18_24(Suppl_2)_389-394.nxml.txt.nlp	19838837	SENT332	3	3	8	8	denosumab	aromatase	PA166048634	1588	0.928
NULL	Onco_Targets_Ther_2014_Sep_9_7_1571-1582.nxml.txt.nlp	25228815	SENT247	7	7	13	13	pazopanib	VEGFR1	PA165291492	2321	0.928
NULL	Nat_Commun_2014_Nov_19_5_5479.nxml.txt.nlp	25407222	SENT50	16	16	35	35	dextran	YTS	PA449261	8565	0.928
NULL	Acta_Pharmacol_Sin_2011_May_18_32(5)_591-600.nxml.txt.nlp	21499286	SENT195	8	8	10	10	bezafibrate	AMPK	PA162364313	5563	0.928
NULL	J_Biol_2009_Apr_15_8(3)_30.nxml.txt.nlp	19435483	SENT54	10	10	26	26	imatinib	KIT	PA10804	3815	0.928
NULL	Clin_Drug_Investig_2013_Aug_23_33(10)_727-736.nxml.txt.nlp	23975654	SENT175	15	15	29	29	fluconazole	CYP2C19	PA449653	1557	0.928
NULL	Patient_Prefer_Adherence_2010_Sep_7_4_313-324.nxml.txt.nlp	20859458	SENT50	15	15	2	2	exenatide	AMIGO	PA164749238	57463	0.928
NULL	Br_J_Cancer_2013_Mar_19_108(5)_1079-1091.nxml.txt.nlp	23449353	SENT214	19	19	3	3	docetaxel	MIC-1	PA449383	29919;9518	0.928
NULL	Nat_Med_2010_Jun_23_16(6)_671-677.nxml.txt.nlp	20495567	SENT62	5	5	36	36	sorafenib	ATF5	PA7000	22809	0.928
NULL	Springerplus_2014_Oct_24_3_628.nxml.txt.nlp	25392798	SENT37	21	21	0	0	ezetimibe	NPC1L1	PA10816	29881	0.928
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Aug_4_6_123-133.nxml.txt.nlp	25177151	SENT56	25	25	17	17	fulvestrant	aromatase	PA164747170	1588	0.928
NULL	Alzheimers_Res_Ther_2013_Nov_7_5(6)_54.nxml.txt.nlp	24229456	SENT22	27	27	2	2	bexarotene	ABCA1	PA164752250	19	0.928
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Jan_10_6_1-13.nxml.txt.nlp	24648765	SENT53	2	2	13	13	trastuzumab	HER2	PA451743	2064	0.928
NULL	Nat_Med_2011_Nov_13_17(12)_1577-1584.nxml.txt.nlp	22081023	SENT144	5	5	20	20	pioglitazone	Met	PA450970	79811	0.928
NULL	Oncoscience_2014_Oct_24_1(10)_665-673.nxml.txt.nlp	25593995	SENT79	21	21	5	5	doxorubicin	MDR1	PA449412	5243	0.928
NULL	J_Hematol_Oncol_2013_Mar_27_6_23.nxml.txt.nlp	23531342	SENT102	28	28	40	40	bortezomib	RITA	PA10252	55422;84934	0.928
NULL	Cancer_Cell_Int_2014_Jul_2_14_59.nxml.txt.nlp	25120382	SENT204	26	26	21	21	metformin	CTR	PA450395	799	0.928
NULL	Cancer_Metastasis_Rev_2010_Sep_24_29(3)_465-482.nxml.txt.nlp	20730632	SENT281	0	0	21	21	genistein	MEK4	PA165109660	6416	0.928
NULL	Arthritis_Res_Ther_2006_Jul_21_8(4)_R130.nxml.txt.nlp	16859540	SENT114	6	6	29	29	atorvastatin	CD59	PA448500	966	0.928
NULL	JAKSTAT_2012_Oct_1_1(4)_257-260.nxml.txt.nlp	24058781	SENT81	14	14	2	2	resveratrol	STAT3		6774	0.928
NULL	Diabetes_2009_Feb_58(2)_329-336.nxml.txt.nlp	19171749	SENT112	2	2	37	37	imatinib	JNK	PA10804	5599	0.928
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Oct_31_66(Pt_11)_o2999.nxml.txt.nlp	21589160	SENT65	36	36	12	12	ethanol	mol	PA448073	90527	0.928
NULL	F1000Res_2013_Oct_3_2_202.nxml.txt.nlp	24795806	SENT119	6	6	1	1	gefitinib	EGFR	PA131301952	1956	0.928
NULL	Cancer_Cell_2007_Dec_11_12(6)_514-527.nxml.txt.nlp	18068629	SENT148	3	3	18	18	paclitaxel	TGFBI	PA450761	7045	0.928
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT173	3	3	31	31	cisplatin	DcR2	PA449014	8793	0.928
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT152	11	11	26	26	sulindac	survivin	PA451565	332	0.928
NULL	Cancer_Immunol_Immunother_2012_Jul_23_61(7)_1101-1111.nxml.txt.nlp	22193989	SENT174	3	3	7	7	oxaliplatin	SHP-1	PA131285527	5777	0.928
NULL	Arch_Med_Sci_2012_May_9_8(2)_310-315.nxml.txt.nlp	22662005	SENT53	36	36	31	31	cisplatin	BRCA1	PA449014	672	0.928
NULL	Patient_Prefer_Adherence_2011_Dec_23_6_1-9.nxml.txt.nlp	22272064	SENT4	13	13	8	8	telmisartan	ACE	PA451605	1636	0.928
NULL	Korean_J_Anesthesiol_2013_Dec_26_65(6)_501-507.nxml.txt.nlp	24427455	SENT51	34	34	42	42	glycopyrrolate	NMB	PA164754882	10457;4828	0.928
NULL	Clin_Pharmacokinet_2014_Sep_3_53(1)_1-16.nxml.txt.nlp	23999929	SENT123	14	14	8	8	rivaroxaban	CLCR	PA165958360	11330	0.928
NULL	Cancer_Res_Treat_2014_Jan_15_46(1)_55-64.nxml.txt.nlp	24520224	SENT29	19	19	8	8	irinotecan	TRAP1	PA450085	9392;10131	0.928
NULL	Clin_Ophthalmol_2007_Dec_1(4)_519-525.nxml.txt.nlp	19668531	SENT102	11	11	20	20	azithromycin	BAK	PA448519	578	0.928
NULL	Breast_Cancer_Res_2010_May_18_12(Suppl_1)_P35.nxml.txt.nlp	NULL	SENT10	28	28	14	14	paclitaxel	MAD2	PA450761	4085;4601	0.928
NULL	EMBO_Mol_Med_2012_Oct_30_4(10)_1087-1096.nxml.txt.nlp	22933245	SENT105	16	16	3	3	olaparib	NAMPT		10135	0.928
NULL	Clin_Pharmacol_2013_Dec_9_5_185-192.nxml.txt.nlp	24353446	SENT81	25	25	10	10	clopidogrel	CYP3A4	PA449053	1576	0.928
NULL	Angiogenesis_2012_Sep_27_15(3)_361-376.nxml.txt.nlp	22451299	SENT155	3	3	30	30	resveratrol	MCP-1		6347	0.928
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT33	9	9	4	4	gefitinib	KRAS	PA131301952	3845	0.928
NULL	Protein_Cell_2014_Jun_19_5(6)_469-479.nxml.txt.nlp	24748116	SENT109	30	30	24	24	paclitaxel	EB1	PA450761	9167;22919;10982	0.928
NULL	Oncol_Lett_2013_Sep_12_6(3)_860-864.nxml.txt.nlp	24137426	SENT29	13	13	25	25	omeprazole	CYP1A2	PA450704	1544	0.928
NULL	Br_J_Pharmacol_2013_Jun_27_169(4)_736-747.nxml.txt.nlp	23489111	SENT160	14	14	2	2	morphine	5-HT3A	PA450550	3359	0.928
NULL	Mol_Cell_Proteomics_2012_Mar_13_11(3)_M111_014654.nxml.txt.nlp	22167270	SENT27	9	9	2	2	geldanamycin	Hsp90	PA152031327	3320	0.928
NULL	Exp_Mol_Med_2012_Apr_30_44(4)_281-292.nxml.txt.nlp	22228119	SENT86	9	9	22	22	genistein	activin	PA165109660	83729	0.928
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT167	4	4	10	10	atorvastatin	p38	PA448500	10598;1432;7965	0.928
NULL	Nat_Commun_2014_Nov_25_5_5582.nxml.txt.nlp	25420773	SENT111	13	13	32	32	erlotinib	EGFR	PA134687924	1956	0.928
NULL	Oncogene_2013_Sep_26_32(39)_10_1038_onc_2012_491.nxml.txt.nlp	23108394	SENT78	28	28	18	18	epirubicin	BRIP1	PA449476	64979;83990	0.928
NULL	Breast_Cancer_Res_2011_Apr_15_13(2)_R44.nxml.txt.nlp	21496232	SENT402	11	11	28	28	erlotinib	HER2	PA134687924	2064	0.928
NULL	Breast_Cancer_Res_2010_May_18_12(Suppl_1)_P41.nxml.txt.nlp	NULL	SENT16	18	18	7	7	cisplatin	MCPH1	PA449014	79648	0.928
NULL	Protein_Cell_2014_Jun_19_5(6)_469-479.nxml.txt.nlp	24748116	SENT155	14	14	17	17	paclitaxel	EB1	PA450761	9167;22919;10982	0.928
NULL	Cancer_Metab_2014_Nov_3_2(1)_20.nxml.txt.nlp	NULL	SENT208	13	13	3	3	erlotinib	PDK4	PA134687924	5166	0.928
NULL	Br_J_Cancer_2012_May_22_106(11)_1779-1789.nxml.txt.nlp	22549178	SENT31	1	1	24	24	trastuzumab	HER2	PA451743	2064	0.928
NULL	Biomed_Res_Int_2013_Dec_22_2013_835850.nxml.txt.nlp	24455731	SENT83	14	14	18	18	heparin	ACT	PA449855	12;11332;9457;641455	0.928
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1420-1426.nxml.txt.nlp	24056704	SENT136	10	10	13	13	atorvastatin	CYP3A	PA448500	1574	0.928
NULL	Diabetes_Care_2011_Jul_17_34(7)_e115-e120.nxml.txt.nlp	21709286	SENT93	16	16	9	9	metformin	LKB1	PA450395	6794	0.928
NULL	Philos_Trans_R_Soc_Lond_B_Biol_Sci_2010_Mar_12_365(1541)_749-763.nxml.txt.nlp	20124342	SENT269	3	3	38	38	nadh	PDH	PA164755085	54704	0.928
NULL	J_Cell_Biol_1998_Jul_27_142(2)_557-571.nxml.txt.nlp	9679152	SENT161	24	24	3	3	hyaluronidase	p27	PA164745713	5715;10534	0.928
NULL	Colorectal_Dis_2012_Feb_14(2)_e31-e47.nxml.txt.nlp	21848897	SENT117	33	33	28	28	cetuximab	KRAS	PA10040	3845	0.928
NULL	Blood_Cancer_J_2014_Aug_22_4(8)_e240.nxml.txt.nlp	25148222	SENT356	19	19	11	11	pimozide	IL-3	PA450965	3562	0.928
NULL	Case_Rep_Neurol_2012_Jan_17_4(1)_13-19.nxml.txt.nlp	22379480	SENT37	6	6	11	11	heparin	ICAD	PA449855	1676	0.928
NULL	Int_J_Environ_Res_Public_Health_2012_Aug_3_9(8)_2788-2800.nxml.txt.nlp	23066397	SENT35	31	31	8	8	phenol	CYP2E1	PA450913	1571	0.928
NULL	J_Korean_Med_Sci_2005_Oct_31_20(5)_853-859.nxml.txt.nlp	16224162	SENT128	13	13	0	0	thyroglobulin	TTF-1	PA164754910	7080	0.928
NULL	Addict_Sci_Clin_Pract_2014_May_22_9(1)_8.nxml.txt.nlp	24886786	SENT22	22	22	0	0	methamphetamine	San	PA450403	80218	0.928
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT122	33	33	17	17	dasatinib	LYN	PA162372878	4067	0.928
NULL	Biomed_Res_Int_2013_Aug_4_2013_152909.nxml.txt.nlp	23984319	SENT106	19	19	2	2	temozolomide	MSH2	PA451609	4436	0.928
NULL	Endocr_Connect_2012_Jun_8_1(1)_1-12.nxml.txt.nlp	23781298	SENT195	41	41	7	7	fenofibrate	adiponectin	PA449594	9370	0.928
NULL	Acta_Neuropathol_2014_Nov_9_127(2)_303-305.nxml.txt.nlp	24212601	SENT21	21	21	26	26	trypsin	RD3	PA451806	343035	0.928
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1066.nxml.txt.nlp	24556681	SENT206	17	17	4	4	ethanol	IFN	PA448073	3439	0.928
NULL	Adv_Hematol_2012_Jul_24_2012_513702.nxml.txt.nlp	22888354	SENT152	0	0	18	18	lenalidomide	CD40	PA162363968	958	0.928
NULL	Ann_Rheum_Dis_2009_Jul_4_68(7)_1220-1227.nxml.txt.nlp	18772191	SENT115	20	20	5	5	abatacept	CD68	PA164747080	968	0.928
NULL	Brain_Res_2013_Jul_12_1521(100)_1-15.nxml.txt.nlp	22789905	SENT70	6	6	4	4	verapamil	P-gp	PA451868	5243	0.928
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT96	9	9	21	21	atorvastatin	IL-6	PA448500	3569	0.928
NULL	Cells_2014_May_23_3(2)_517-545.nxml.txt.nlp	24861977	SENT246	16	16	3	3	capsaicin	TRPV1	PA448776	7442	0.928
NULL	J_Biomed_Biotechnol_2010_May_20_2010_263810.nxml.txt.nlp	20508848	SENT108	0	0	8	8	ribavirin	IFN	PA451241	3439	0.928
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Dec_10_65(Pt_1)_o74.nxml.txt.nlp	21581713	SENT60	25	25	7	7	ethanol	mol	PA448073	90527	0.928
NULL	BMB_Rep_2014_Nov_47(11)_649-654.nxml.txt.nlp	25301019	SENT5	7	7	23	23	l-serine	p38	PA451330	10598;1432;7965	0.928
NULL	Eur_J_Clin_Pharmacol_2014_Oct_8_70(12)_1433-1441.nxml.txt.nlp	25291992	SENT111	10	10	17	17	olanzapine	B12	PA450688	7126;4709	0.928
NULL	Br_J_Ophthalmol_2014_Aug_10_98(8)_1036-1041.nxml.txt.nlp	24723616	SENT11	7	7	26	26	bevacizumab	CRT	PA130232992	811	0.928
NULL	Acta_Pharmacol_Sin_2011_Sep_1_32(9)_1109-1115.nxml.txt.nlp	21804575	SENT165	5	5	8	8	candesartan	AT1	PA448765	9197;185	0.928
NULL	J_Hematol_Oncol_2011_Apr_1_4_13.nxml.txt.nlp	21453545	SENT183	14	14	3	3	geldanamycin	Hsp90	PA152031327	3320	0.928
NULL	Int_J_Mol_Sci_2014_Oct_6_15(10)_17886-17900.nxml.txt.nlp	25290095	SENT146	10	10	26	26	resveratrol	SIRT1		23411	0.928
NULL	Mol_Cancer_2012_Jul_25_11_46.nxml.txt.nlp	22830422	SENT134	17	17	5	5	rolipram	AKT	PA153906323	207	0.928
NULL	Toxins_(Basel)_2010_Oct_26_2(11)_2490-2518.nxml.txt.nlp	22069563	SENT207	22	22	7	7	cisplatin	IL-2	PA449014	3558	0.928
NULL	J_Oncol_2010_Dec_15_2010_821717.nxml.txt.nlp	20049172	SENT165	30	30	13	13	paclitaxel	TUBB3	PA450761	10381	0.928
NULL	Mol_Cancer_2009_Jun_23_8_39.nxml.txt.nlp	19549337	SENT13	12	12	3	3	etoposide	PC-3	PA449552	692094	0.928
NULL	F1000Res_2014_Aug_19_3_198.nxml.txt.nlp	25400908	SENT109	19	19	1	1	tamoxifen	ATAC	PA451581	6375	0.928
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1554-1562.nxml.txt.nlp	21970876	SENT157	14	14	12	12	afatinib	EGFR	PA165981154	1956	0.928
NULL	EMBO_Mol_Med_2010_May_2(5)_146-158.nxml.txt.nlp	20432502	SENT25	23	23	9	9	trastuzumab	PIK3CA	PA451743	5290	0.928
NULL	Br_J_Cancer_2013_May_14_108(9)_1807-1809.nxml.txt.nlp	23612454	SENT61	22	22	7	7	lapatinib	PI3K	PA152241907	5290	0.928
NULL	Br_J_Cancer_2012_Sep_4_107(6)_947-955.nxml.txt.nlp	22892392	SENT43	26	26	10	10	tamoxifen	BCAR4	PA451581	400500	0.928
NULL	Clin_Med_Insights_Oncol_2013_May_20_7_87-102.nxml.txt.nlp	23761989	SENT242	12	12	3	3	everolimus	TSC1	PA164746311	7248	0.928
NULL	Acta_Pharmacol_Sin_2014_Jan_9_35(1)_1-10.nxml.txt.nlp	24317012	SENT70	24	24	0	0	cisplatin	MRP2	PA449014	100130958;57626;1244	0.928
NULL	J_Breast_Cancer_2013_Jun_28_16(2)_138-145.nxml.txt.nlp	23843844	SENT110	27	27	19	19	tamoxifen	STAT3	PA451581	6774	0.928
NULL	Acta_Pharmacol_Sin_2013_Dec_18_34(12)_1568-1574.nxml.txt.nlp	24241343	SENT95	17	17	2	2	doxazosin	ANOVA	PA449407	4858	0.928
NULL	Cancers_(Basel)_2010_Apr_9_2(2)_397-419.nxml.txt.nlp	24281076	SENT266	11	11	18	18	docetaxel	EGFR	PA449383	1956	0.928
NULL	Mol_Cancer_2009_Nov_19_8_108.nxml.txt.nlp	19925669	SENT242	8	8	29	29	doxorubicin	MRP3	PA449412	8714	0.928
NULL	J_Biomed_Biotechnol_2011_Dec_6_2011_856985.nxml.txt.nlp	21188173	SENT261	21	21	7	7	tamoxifen	PAK1	PA451581	5585;5058	0.928
NULL	Oncol_Lett_2014_Apr_22_7(4)_1191-1196.nxml.txt.nlp	24944691	SENT115	20	20	10	10	paclitaxel	MDR1	PA450761	5243	0.928
NULL	Arch_Drug_Inf_2008_Sep_1(2)_56-62.nxml.txt.nlp	19915709	SENT51	2	2	21	21	naltrexone	CYP3A4	PA450588	1576	0.928
NULL	Int_J_Hypertens_2012_Feb_8_2012_189512.nxml.txt.nlp	22518281	SENT106	4	4	1	1	hemin	HO-1	PA449849	3162	0.928
NULL	Oncotarget_2011_Dec_31_2(12)_1314-1321.nxml.txt.nlp	22248929	SENT69	11	11	18	18	lapatinib	PI3K	PA152241907	5290	0.928
NULL	Clin_Pharmacol_2013_Jul_4_5_117-129.nxml.txt.nlp	23861604	SENT27	26	26	45	45	denosumab	RANKL	PA166048634	8600	0.928
NULL	Int_J_Mol_Sci_2014_Mar_24_15(3)_5140-5162.nxml.txt.nlp	24663085	SENT103	16	16	26	26	cyclophosphamide	IFN	PA449165	3439	0.928
NULL	Breast_Cancer_Res_2005_May_24_7(5)_R589-R597.nxml.txt.nlp	16168102	SENT95	19	19	7	7	doxorubicin	HER3	PA449412	2065	0.928
NULL	J_Immunother_Cancer_2013_Nov_7_1(Suppl_1)_P234.nxml.txt.nlp	NULL	SENT6	6	6	0	0	mitoxantrone	CT26	PA450526	168400	0.928
NULL	Nucleic_Acids_Res_2005_Jun_8_33(10)_3283-3291.nxml.txt.nlp	15944449	SENT128	6	6	33	33	melphalan	XPB	PA450354	2071	0.928
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_67-74.nxml.txt.nlp	17912637	SENT209	7	7	3	3	anastrozole	aromatase	PA448432	1588	0.928
NULL	ScientificWorldJournal_2014_Mar_23_2014_183147.nxml.txt.nlp	24790551	SENT19	0	0	12	12	aprepitant	NK1	PA164747039	11126	0.928
NULL	Cancer_Cell_2007_Dec_11_12(6)_514-527.nxml.txt.nlp	18068629	SENT28	32	32	6	6	paclitaxel	TGFBI	PA450761	7045	0.928
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1098-1105.nxml.txt.nlp	21386838	SENT160	6	6	25	25	cisplatin	DTD	PA449014	1728	0.928
NULL	Br_J_Ophthalmol_2014_Jul_98(Suppl_2)_ii24-ii29.nxml.txt.nlp	24934220	SENT171	14	14	6	6	bevacizumab	OCT	PA130232992	5362	0.928
NULL	Breast_Cancer_Res_2011_Mar_1_13(2)_R21.nxml.txt.nlp	21362200	SENT231	7	7	16	16	fulvestrant	PI3K	PA164747170	5290	0.928
NULL	Mol_Cancer_2012_Jul_25_11_47.nxml.txt.nlp	22830443	SENT117	26	26	6	6	panitumumab	EGFR	PA162373091	1956	0.928
NULL	Mol_Cancer_2008_Jun_5_7_50.nxml.txt.nlp	18534018	SENT102	28	28	15	15	bortezomib	HSP27	PA10252	3315	0.928
NULL	J_Adv_Pharm_Technol_Res_2011_Apr-Jun_2(2)_81-87.nxml.txt.nlp	22171298	SENT4	11	11	28	28	simvastatin	BCS	PA451363	617	0.928
NULL	Evid_Based_Complement_Alternat_Med_2012_May_7_2012_242810.nxml.txt.nlp	22645625	SENT325	10	10	29	29	rifampin	CYP3A4	PA451250	1576	0.928
NULL	EMBO_Mol_Med_2012_Dec_15_4(12)_1276-1293.nxml.txt.nlp	23065753	SENT154	18	18	2	2	cisplatin	HK1	PA449014	3098;51361;3739	0.928
NULL	Clinicoecon_Outcomes_Res_2014_Oct_17_6_451-461.nxml.txt.nlp	25378939	SENT31	28	28	34	34	vancomycin	HAP	PA451850	5915;10313	0.928
NULL	Int_J_Biol_Sci_2011_Nov_5_8(1)_1-14.nxml.txt.nlp	22211100	SENT141	7	7	33	33	gemcitabine	PI3K	PA449748	5290	0.928
NULL	Ann_Rheum_Dis_2009_Jan_28_68(1)_69-74.nxml.txt.nlp	18375541	SENT162	28	28	14	14	methotrexate	HLA-DRB1	PA450428	3123	0.928
NULL	Oncotarget_2011_Oct_17_2(10)_797-809.nxml.txt.nlp	22006582	SENT85	6	6	34	34	paclitaxel	U87	PA450761	677775;641648	0.928
NULL	Breast_Cancer_Res_2011_Feb_23_13(1)_203.nxml.txt.nlp	21392408	SENT145	15	15	5	5	exemestane	aromatase	PA449563	1588	0.928
NULL	Ann_Oncol_2013_Sep_4_24(9)_2206-2223.nxml.txt.nlp	23917950	SENT245	20	20	15	15	tamoxifen	aromatase	PA451581	1588	0.928
NULL	JAKSTAT_2012_Apr_1_1(2)_83-89.nxml.txt.nlp	24058756	SENT9	0	0	4	4	losartan	AT1	PA450268	9197;185	0.928
NULL	Evid_Based_Complement_Alternat_Med_2013_Mar_26_2013_974313.nxml.txt.nlp	23589723	SENT155	7	7	2	2	metformin	AMPK	PA450395	5563	0.928
NULL	Cell_Death_Dis_2014_Apr_24_5(4)_e1197.nxml.txt.nlp	24763054	SENT332	23	23	5	5	cisplatin	ARC	PA449014	8996;23237	0.928
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jul_7_68(Pt_8)_o2392-o2393.nxml.txt.nlp	22904850	SENT72	36	36	19	19	benzaldehyde	mol	PA448571	90527	0.928
NULL	Cancer_Cell_Int_2005_Aug_24_5_28.nxml.txt.nlp	16120219	SENT167	3	3	10	10	etoposide	p53	PA449552	7157	0.928
NULL	Cancer_Immunol_Immunother_2013_Aug_27_62(10)_1637-1648.nxml.txt.nlp	23982484	SENT182	9	9	22	22	lenalidomide	IL-6	PA162363968	3569	0.928
NULL	Front_Psychol_2014_Jul_29_5_832.nxml.txt.nlp	25120524	SENT93	7	7	15	15	losartan	AT1	PA450268	9197;185	0.928
NULL	Mol_Cancer_2014_Jul_5_13_165.nxml.txt.nlp	24996221	SENT143	18	18	40	40	docetaxel	p62	PA449383	8878;10657;23636	0.928
NULL	Oncotarget_2011_Mar_11_2(3)_135-164.nxml.txt.nlp	21411864	SENT341	1	1	4	4	paclitaxel	PI3K	PA450761	5290	0.928
NULL	J_Geriatr_Cardiol_2012_Jun_9(2)_180-184.nxml.txt.nlp	22916066	SENT126	4	4	18	18	rosuvastatin	Rho	PA134308647	29984	0.928
NULL	Int_J_Mol_Sci_2014_Oct_8_15(10)_17974-17999.nxml.txt.nlp	25299695	SENT112	2	2	7	7	curcumin	HO-1	PA151958596	3162	0.928
NULL	Orphanet_J_Rare_Dis_2013_Sep_8_8_137.nxml.txt.nlp	24011030	SENT326	30	30	26	26	vemurafenib	BRAF	PA165946873	673	0.928
NULL	Pharmaceuticals_(Basel)_2012_Aug_30_5(9)_890-898.nxml.txt.nlp	24280696	SENT51	30	30	26	26	geldanamycin	Hsp90	PA152031327	3320	0.928
NULL	Exp_Ther_Med_2013_Feb_13_5(2)_581-585.nxml.txt.nlp	23403473	SENT93	27	27	36	36	etanercept	p38	PA449515	10598;1432;7965	0.928
NULL	Endocrinol_Metab_(Seoul)_2014_Dec_29_29(4)_450-456.nxml.txt.nlp	25325263	SENT43	25	25	1	1	octreotide	OST	PA450678	1650;23263	0.928
NULL	Nat_Chem_Biol_2010_Apr_28_6(4)_291-299.nxml.txt.nlp	20190765	SENT57	29	29	8	8	dasatinib	EGFR	PA162372878	1956	0.928
NULL	Br_J_Cancer_2012_May_8_106(10)_1587-1590.nxml.txt.nlp	22568998	SENT100	18	18	26	26	sunitinib	IFN	PA162372840	3439	0.928
NULL	Blood_Res_2013_Jun_25_48(2)_115-120.nxml.txt.nlp	23826580	SENT19	6	6	15	15	rituximab	CHOP	PA451261	1649	0.928
NULL	Comp_Hepatol_2005_Feb_8_4_2.nxml.txt.nlp	15701172	SENT205	6	6	22	22	coumarin	CYP3A4	PA134521193	1576	0.928
NULL	Cancer_Immunol_Immunother_2012_Oct_8_61(10)_1713-1720.nxml.txt.nlp	22399057	SENT6	41	41	24	24	plerixafor	CXCR4	PA165958410	7852	0.928
NULL	Exp_Dermatol_2014_Apr_28_23(4)_247-252.nxml.txt.nlp	24533866	SENT110	6	6	16	16	estradiol	ABCC11	PA449503	85320	0.928
NULL	Diabetes_2009_Mar_58(3)_641-651.nxml.txt.nlp	19073764	SENT323	15	15	0	0	forskolin	CD4	PA146096022	920	0.928
NULL	Biomed_Res_Int_2014_Apr_13_2014_904634.nxml.txt.nlp	24895626	SENT15	0	0	23	23	methotrexate	DHFR	PA450428	1719	0.928
NULL	Oncotarget_2014_Aug_29_5(19)_8947-8958.nxml.txt.nlp	25333254	SENT25	16	16	13	13	plerixafor	CXCR4	PA165958410	7852	0.928
NULL	Oncol_Rep_2013_Mar_8_29(3)_917-924.nxml.txt.nlp	23314174	SENT124	2	2	14	14	sorafenib	CD24	PA7000	100133941	0.928
NULL	Int_J_Cell_Biol_2013_Aug_28_2013_151839.nxml.txt.nlp	24069033	SENT324	10	10	4	4	amiloride	AKT	PA448368	207	0.928
NULL	Br_J_Cancer_1996_Sep_74(5)_704-710.nxml.txt.nlp	8795571	SENT22	9	9	18	18	paclitaxel	PA1	PA450761	79447	0.928
NULL	Clin_Interv_Aging_2009_Jun_9_4_241-250.nxml.txt.nlp	19554095	SENT163	3	3	8	8	denosumab	aromatase	PA166048634	1588	0.928
NULL	Acta_Pharmacol_Sin_2010_Apr_8_31(4)_461-469.nxml.txt.nlp	20208553	SENT51	29	29	18	18	ethanol	adiponectin	PA448073	9370	0.928
NULL	J_Exp_Med_1998_Jun_1_187(11)_1885-1892.nxml.txt.nlp	9607928	SENT172	1	1	8	8	thalidomide	ENL	PA451644	4298	0.928
NULL	Oncol_Lett_2014_Mar_2_7(3)_791-796.nxml.txt.nlp	24527087	SENT126	13	13	8	8	imatinib	CDK1	PA10804	983	0.928
NULL	Cancer_Cell_Int_2010_May_11_10_16.nxml.txt.nlp	20459793	SENT138	14	14	5	5	cisplatin	ABCC5	PA449014	10057	0.928
NULL	Mol_Cell_Proteomics_2012_Feb_6_11(2)_M111_015222.nxml.txt.nlp	22147731	SENT9	21	21	17	17	gefitinib	EGFR	PA131301952	1956	0.928
NULL	Oxid_Med_Cell_Longev_2013_Apr_3_2013_781050.nxml.txt.nlp	23691267	SENT132	24	24	30	30	ethanol	CYP2E1	PA448073	1571	0.928
NULL	Virchows_Arch_2010_Dec_3_457(6)_677-692.nxml.txt.nlp	20890764	SENT387	5	5	17	17	hyaluronan	CD11b	PA165958431	3684	0.928
NULL	J_Geriatr_Cardiol_2013_Jun_10(2)_151-158.nxml.txt.nlp	23888175	SENT185	1	1	10	10	rosuvastatin	AT1	PA134308647	9197;185	0.928
NULL	Cardiovasc_Res_2014_Mar_1_101(3)_513-521.nxml.txt.nlp	24323316	SENT83	22	22	15	15	maraviroc	CCL4	PA164768835	6351	0.928
NULL	Curr_Cardiol_Rev_2008_Nov_4(4)_287-292.nxml.txt.nlp	20066136	SENT105	19	19	32	32	potassium	SNS	PA451047	6336	0.928
NULL	Mol_Cancer_2013_Nov_20_12_144.nxml.txt.nlp	24257371	SENT205	3	3	23	23	cilengitide	PRLR	PA164924491	5618	0.928
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT118	9	9	27	27	nilotinib	ABCB1	PA165958345	5243	0.928
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_9_2013_486047.nxml.txt.nlp	23662138	SENT122	21	21	3	3	glibenclamide	SDH	PA449782	1757;10993	0.928
NULL	J_Cell_Biol_1988_Feb_1_106(2)_415-422.nxml.txt.nlp	2448314	SENT9	12	12	5	5	heparin	SMC	PA449855	54808	0.928
NULL	Front_Chem_2013_Jul_12_1_10.nxml.txt.nlp	24790939	SENT59	6	6	11	11	hydroquinone	mol	PA449924	90527	0.928
NULL	Facts_Views_Vis_Obgyn_2011_3(3)_189-202.nxml.txt.nlp	24753865	SENT160	18	18	7	7	paclitaxel	HER-2	PA450761	2064	0.928
NULL	Hum_Genomics_2010_Apr_1_4(4)_238-249.nxml.txt.nlp	20511137	SENT105	9	9	17	17	sn-38	CYP3A4		1576	0.928
NULL	Ann_Surg_Treat_Res_2014_Feb_22_86(2)_68-75.nxml.txt.nlp	24761411	SENT51	19	19	8	8	resveratrol	survivin		332	0.928
NULL	J_Oncol_2010_Jun_21_2010_430142.nxml.txt.nlp	20652056	SENT196	35	35	13	13	temozolomide	EGFR	PA451609	1956	0.928
NULL	Exp_Ther_Med_2013_Apr_5_5(4)_1259-1263.nxml.txt.nlp	23596498	SENT101	13	13	1	1	capsaicin	TRPV1	PA448776	7442	0.928
NULL	Oncotarget_2012_Oct_20_3(10)_1068-1111.nxml.txt.nlp	23085539	SENT849	26	26	19	19	carboplatin	EGFR	PA448803	1956	0.928
NULL	Diabetes_2013_Jun_17_62(6)_1913-1922.nxml.txt.nlp	23349495	SENT196	11	11	7	7	sildenafil	VASP	PA451346	7408	0.928
NULL	Nucleic_Acids_Res_2012_Jul_30_40(13)_6319-6337.nxml.txt.nlp	22467215	SENT273	21	21	14	14	cisplatin	HER2	PA449014	2064	0.928
NULL	Case_Rep_Med_2012_May_28_2012_757696.nxml.txt.nlp	22685471	SENT7	14	14	9	9	promethazine	CHS	PA451128	1130	0.928
NULL	Mol_Vis_2012_May_1_18_1115-1122.nxml.txt.nlp	22605923	SENT11	22	22	11	11	estradiol	p38	PA449503	10598;1432;7965	0.928
NULL	Indian_J_Pharmacol_2014_Nov-Dec_46(6)_627-632.nxml.txt.nlp	25538335	SENT118	5	5	8	8	metformin	Q10	PA450395	27161	0.928
NULL	Oncotarget_2013_Oct_19_4(11)_2045-2056.nxml.txt.nlp	24185104	SENT99	19	19	11	11	cisplatin	p38	PA449014	10598;1432;7965	0.928
NULL	Allergy_Asthma_Clin_Immunol_2011_Aug_25_7(1)_13.nxml.txt.nlp	21867553	SENT166	12	12	27	27	budesonide	ACTH	PA448681	5443	0.928
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT81	19	19	7	7	metformin	p53	PA450395	7157	0.928
NULL	Mol_Biol_Cell_2014_Jul_1_25(13)_2116-2127.nxml.txt.nlp	24807908	SENT231	17	17	39	39	hemin	GAPDH	PA449849	2597	0.928
NULL	Clin_Med_Insights_Womens_Health_2013_Jan_22_6_1-11.nxml.txt.nlp	24665209	SENT38	25	25	16	16	tamoxifen	aromatase	PA451581	1588	0.928
NULL	Mol_Cell_Biochem_2014_Oct_26_386(1-2)_117-124.nxml.txt.nlp	24158524	SENT30	0	0	6	6	bevacizumab	VEGF-A	PA130232992	7422	0.928
NULL	Mol_Cancer_2009_Nov_19_8_108.nxml.txt.nlp	19925669	SENT252	33	33	0	0	doxorubicin	MRP3	PA449412	8714	0.928
NULL	Clin_Ophthalmol_2008_Mar_2(1)_1-14.nxml.txt.nlp	19668384	SENT32	0	0	24	24	ranibizumab	San	PA164746012	80218	0.928
NULL	J_Oncol_2010_Dec_16_2010_151750.nxml.txt.nlp	20049345	SENT79	27	27	43	43	bsi-201	PARP-1		25976	0.928
NULL	Scientifica_(Cairo)_2012_Nov_25_2012_473829.nxml.txt.nlp	24278698	SENT219	14	14	4	4	cisplatin	ATP7B	PA449014	540	0.928
NULL	J_Cell_Mol_Med_2013_Oct_23_17(10)_1207-1217.nxml.txt.nlp	24106980	SENT130	28	28	6	6	paclitaxel	PDCD4	PA450761	27250	0.928
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT36	17	17	13	13	sitagliptin	HIP	PA164748978	6767;6159;64399;5068	0.928
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_29_2013_590393.nxml.txt.nlp	23737838	SENT223	25	25	8	8	resveratrol	p53		7157	0.928
NULL	Mol_Vis_2011_Dec_24_17_3384-3391.nxml.txt.nlp	22219634	SENT133	25	25	22	22	mannitol	IL-8	PA450320	3576	0.928
NULL	Int_J_Lab_Hematol_2009_Aug_31(4)_468-470.nxml.txt.nlp	18294236	SENT13	42	42	17	17	rituximab	CHOP	PA451261	1649	0.928
NULL	Mucosal_Immunol_2011_Sep_13_4(5)_484-495.nxml.txt.nlp	21750585	SENT247	21	21	12	12	dextran	NOD2	PA449261	64127	0.928
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT133	20	20	8	8	docetaxel	VEGF-A	PA449383	7422	0.928
NULL	Ther_Clin_Risk_Manag_2006_Mar_2(1)_115-125.nxml.txt.nlp	18360586	SENT215	22	22	6	6	buprenorphine	CYP3A4	PA448685	1576	0.928
NULL	Clin_Interv_Aging_2009_May_14_4_197-205.nxml.txt.nlp	19503782	SENT291	13	13	6	6	daunorubicin	MDR1	PA449212	5243	0.928
NULL	Eur_J_Clin_Pharmacol_2014_Mar_22_70(6)_685-693.nxml.txt.nlp	24658827	SENT238	12	12	3	3	simvastatin	CYP3A4	PA451363	1576	0.928
NULL	Mol_Cancer_2007_Oct_11_6_63.nxml.txt.nlp	17931419	SENT114	21	21	25	25	gefitinib	HIF-1	PA131301952	29072	0.928
NULL	Cancer_Cell_Int_2014_Jul_2_14_59.nxml.txt.nlp	25120382	SENT95	20	20	15	15	metformin	CTR	PA450395	799	0.928
NULL	Nat_Med_2011_Dec_11_18(1)_74-82.nxml.txt.nlp	22157681	SENT236	16	16	3	3	gefitinib	BIM	PA131301952	10018	0.928
NULL	J_Mol_Signal_2010_Jun_11_5_6.nxml.txt.nlp	20540776	SENT51	12	12	21	21	etoposide	SSBP2	PA449552	23635	0.928
NULL	Biochem_Res_Int_2012_Feb_12_2012_346972.nxml.txt.nlp	22400115	SENT54	8	8	0	0	hyaluronan	LYVE-1	PA165958431	10894	0.928
NULL	J_Korean_Med_Sci_2013_Aug_31_28(8)_1238-1243.nxml.txt.nlp	23960454	SENT13	27	27	7	7	amiloride	ASIC3	PA448368	9311	0.928
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT43	2	2	10	10	curcumin	TRAIL	PA151958596	8743	0.928
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_May_31_70(Pt_6)_o717-o718.nxml.txt.nlp	24940287	SENT80	15	15	7	7	piperazine	mol	PA450977	90527	0.928
NULL	Br_J_Cancer_2009_Jul_21_101(2)_263-268.nxml.txt.nlp	19603032	SENT92	5	5	11	11	dasatinib	PC-3	PA162372878	692094	0.928
NULL	Cancer_Immunol_Immunother_2013_Aug_27_62(10)_1637-1648.nxml.txt.nlp	23982484	SENT104	21	21	13	13	lenalidomide	IFN	PA162363968	3439	0.928
NULL	Patient_Prefer_Adherence_2011_Dec_23_6_1-9.nxml.txt.nlp	22272064	SENT66	43	43	13	13	telmisartan	ACE	PA451605	1636	0.928
NULL	Ann_N_Y_Acad_Sci_2013_Mar_28_1280(1)_19-23.nxml.txt.nlp	23551097	SENT32	15	15	43	43	fulvestrant	PI3K	PA164747170	5290	0.928
NULL	Acta_Pharmacol_Sin_2011_Nov_10_32(11)_1402-1410.nxml.txt.nlp	21986579	SENT228	6	6	44	44	curcumin	p27	PA151958596	5715;10534	0.928
NULL	J_Cell_Mol_Med_2014_Oct_11_18(10)_2031-2043.nxml.txt.nlp	25109475	SENT352	26	26	14	14	valsartan	TLR-4	PA451848	7099	0.928
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Mar_27_66(Pt_4)_o927.nxml.txt.nlp	21580737	SENT54	18	18	6	6	ethanol	mol	PA448073	90527	0.928
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1522-1532.nxml.txt.nlp	21997136	SENT199	31	31	7	7	irinotecan	ABCG2	PA450085	9429	0.928
NULL	Bioinformation_2011_Oct_31_7(5)_246-250.nxml.txt.nlp	22125393	SENT23	9	9	1	1	rofecoxib	COX	PA451268	1351	0.928
NULL	Sci_Rep_2014_Dec_4_4_7310.nxml.txt.nlp	25472472	SENT36	21	21	6	6	decitabine	CD34	PA164749631	947	0.928
NULL	Arthritis_Res_Ther_2006_Aug_18_8(5)_R142.nxml.txt.nlp	16919164	SENT111	6	6	21	21	collagenase	OSM	PA449107	5008	0.928
NULL	Cancer_Cell_Int_2013_Oct_22_13_103.nxml.txt.nlp	24148306	SENT175	18	18	8	8	etoposide	PRL	PA449552	5617	0.928
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT106	9	9	13	13	trastuzumab	HER2	PA451743	2064	0.928
NULL	Breast_Cancer_(Auckl)_2011_Jan_13_5_1-14.nxml.txt.nlp	21494397	SENT208	23	23	27	27	capecitabine	CYP3A4	PA448771	1576	0.928
NULL	Clin_Pharmacokinet_2014_Oct_15_53(2)_155-164.nxml.txt.nlp	24127209	SENT103	43	43	28	28	clopidogrel	ADP	PA449053	23038	0.928
NULL	Br_J_Cancer_2009_Sep_15_101(6)_957-966.nxml.txt.nlp	19738618	SENT89	3	3	5	5	dexrazoxane	THBS-1	PA449259	7057	0.928
NULL	Blood_Cancer_J_2012_Sep_7_2(9)_e89.nxml.txt.nlp	22961061	SENT68	12	12	44	44	melphalan	FGFR3	PA450354	2261	0.928
NULL	Mol_Biol_Cell_2014_May_1_25(9)_1411-1420.nxml.txt.nlp	24623724	SENT116	5	5	42	42	tetracycline	XIAP	PA451640	331	0.928
NULL	Biomed_Res_Int_2014_Aug_4_2014_986768.nxml.txt.nlp	25162040	SENT34	18	18	24	24	bevacizumab	VEGF-A	PA130232992	7422	0.928
NULL	J_Hematol_Oncol_2011_Jan_21_4_5.nxml.txt.nlp	21255411	SENT166	19	19	2	2	gefitinib	EGFR	PA131301952	1956	0.928
NULL	Front_Neurosci_2011_Jan_20_5_3.nxml.txt.nlp	21270945	SENT131	19	19	23	23	ethanol	ANOVA	PA448073	4858	0.928
NULL	EMBO_Mol_Med_2010_Jul_2(7)_247-257.nxml.txt.nlp	20597104	SENT156	30	30	38	38	losartan	AT1B	PA450268	185	0.928
NULL	Diabetes_Metab_Syndr_Obes_2010_Apr_26_3_95-112.nxml.txt.nlp	21437080	SENT239	0	0	8	8	rimonabant	CBR1	PA152407999	873	0.928
NULL	Cancers_(Basel)_2011_Mar_3_3(1)_1014-1041.nxml.txt.nlp	24212652	SENT1144	8	8	6	6	gefitinib	EGFR	PA131301952	1956	0.928
NULL	Cell_Death_Dis_2014_Apr_24_5(4)_e1197.nxml.txt.nlp	24763054	SENT332	33	33	5	5	doxorubicin	ARC	PA449412	8996;23237	0.928
NULL	J_Health_Popul_Nutr_2007_Jun_25(2)_179-188.nxml.txt.nlp	17985819	SENT69	23	23	5	5	ampicillin	Spn	PA448419	84687	0.928
NULL	Front_Oncol_2013_Aug_13_3_208.nxml.txt.nlp	23986880	SENT108	8	8	13	13	docetaxel	mol	PA449383	90527	0.928
NULL	Br_J_Cancer_2013_Aug_6_109(3)_686-693.nxml.txt.nlp	23839492	SENT12	2	2	6	6	sunitinib	HIF-1	PA162372840	29072	0.928
NULL	Diabetes_2009_Mar_58(3)_641-651.nxml.txt.nlp	19073764	SENT154	0	0	18	18	forskolin	CD4	PA146096022	920	0.928
NULL	Angiogenesis_2011_Sep_31_14(3)_245-253.nxml.txt.nlp	21452059	SENT24	5	5	7	7	topotecan	HIF-1	PA451729	29072	0.927
NULL	Br_J_Haematol_2014_Mar_6_164(6)_759-766.nxml.txt.nlp	24387053	SENT121	17	17	24	24	rituximab	ADAMTS13	PA451261	11093	0.927
NULL	Curr_Neuropharmacol_2012_Sep_10(3)_231-238.nxml.txt.nlp	23449756	SENT224	10	10	22	22	imipramine	5-HT1A	PA449969	3350	0.927
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_4_2013_378657.nxml.txt.nlp	23662132	SENT495	25	25	3	3	vildagliptin	GLP-1	PA165958346	100125288	0.927
NULL	J_Cell_Biol_2002_Nov_11_159(3)_453-463.nxml.txt.nlp	12427868	SENT167	6	6	15	15	marimastat	TIMP2	PA164748329	7077	0.927
NULL	Acta_Pharmacol_Sin_2010_Feb_5_31(2)_137-144.nxml.txt.nlp	20139896	SENT192	16	16	2	2	zileuton	p38	PA451955	10598;1432;7965	0.927
NULL	Eur_J_Haematol_2009_Apr_82(4)_277-287.nxml.txt.nlp	19187270	SENT163	3	3	29	29	pha-665752	MM1		23654	0.927
NULL	J_Obes_2011_Sep_30_2011_431985.nxml.txt.nlp	20953366	SENT247	4	4	7	7	exenatide	GLP-1	PA164749238	100125288	0.927
NULL	Basic_Res_Cardiol_2007_Mar_24_102(2)_183-193.nxml.txt.nlp	17122889	SENT196	1	1	13	13	collagenase	MT1-MMP	PA449107	4323	0.927
NULL	Case_Rep_Oncol_Med_2014_Sep_14_2014_532924.nxml.txt.nlp	25298899	SENT63	22	22	3	3	epirubicin	NAC	PA449476	22861	0.927
NULL	J_Biomed_Biotechnol_2011_Feb_23_2011_187103.nxml.txt.nlp	21403873	SENT275	17	17	8	8	midazolam	CYP3A4	PA450496	1576	0.927
NULL	Br_J_Cancer_2011_May_24_104(11)_1786-1790.nxml.txt.nlp	21559018	SENT110	15	15	24	24	irinotecan	EGFR	PA450085	1956	0.927
NULL	Oncotarget_2013_Aug_24_4(10)_1618-1631.nxml.txt.nlp	24113128	SENT168	21	21	5	5	sorafenib	p53	PA7000	7157	0.927
NULL	Acta_Pharmacol_Sin_2009_Oct_21_30(10)_1392-1398.nxml.txt.nlp	19767766	SENT121	11	11	13	13	atorvastatin	ROS	PA448500	6098	0.927
NULL	J_Invest_Dermatol_2013_Aug_133(8)_1928-1929.nxml.txt.nlp	23856932	SENT5	26	26	22	22	vemurafenib	BRAF	PA165946873	673	0.927
NULL	Nat_Chem_Biol_2010_Apr_28_6(4)_291-299.nxml.txt.nlp	20190765	SENT159	3	3	36	36	dasatinib	FRK	PA162372878	2444	0.927
NULL	J_Cell_Biol_2000_Dec_11_151(6)_1221-1234.nxml.txt.nlp	11121437	SENT156	20	20	3	3	collagenase	CD34	PA449107	947	0.927
NULL	Ann_Rheum_Dis_2010_Oct_27_70(2)_299-304.nxml.txt.nlp	20980704	SENT107	33	33	9	9	infliximab	FCGR3B	PA452639	2215	0.927
NULL	AAPS_J_2012_Jan_4_14(1)_87-96.nxml.txt.nlp	22215264	SENT253	8	8	31	31	quinidine	P-gp	PA451209	5243	0.927
NULL	Biosensors_(Basel)_2012_Sep_10_2(3)_318-340.nxml.txt.nlp	25585933	SENT302	37	37	33	33	bleomycin	p53	PA448645	7157	0.927
NULL	Pharmaceuticals_(Basel)_2012_Jul_25_5(8)_779-801.nxml.txt.nlp	24280675	SENT79	2	2	12	12	geldanamycin	Hsp90	PA152031327	3320	0.927
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_127043.nxml.txt.nlp	23227093	SENT17	9	9	36	36	lovastatin	RYR	PA450272	6261	0.927
NULL	Mol_Cancer_2008_Sep_30_7_73.nxml.txt.nlp	18826597	SENT84	29	29	18	18	doxycycline	c-Myc	PA449415	4609	0.927
NULL	Br_J_Cancer_2013_May_28_108(10)_2021-2032.nxml.txt.nlp	23632475	SENT242	13	13	6	6	etoposide	AMPK	PA449552	5563	0.927
NULL	Mol_Brain_2014_Apr_3_7_25.nxml.txt.nlp	24708812	SENT340	19	19	3	3	acetone	ANOVA	PA448025	4858	0.927
NULL	Support_Care_Cancer_2012_Jul_27_20(7)_1353-1360.nxml.txt.nlp	22539050	SENT196	10	10	1	1	denosumab	NNT	PA166048634	23530	0.927
NULL	Hum_Genomics_2012_Nov_17_6(1)_23.nxml.txt.nlp	23158014	SENT97	13	13	22	22	cisplatin	PTEN	PA449014	5728	0.927
NULL	Cell_Death_Dis_2010_Nov_18_1(11)_e101.nxml.txt.nlp	21368866	SENT23	7	7	20	20	cisplatin	PC3	PA449014	57332;7832;5122	0.927
NULL	J_Int_Soc_Sports_Nutr_2009_Feb_19_6_6.nxml.txt.nlp	19228401	SENT165	8	8	20	20	creatine	CRT	PA164778930	811	0.927
NULL	Oncotarget_2012_May_18_3(5)_525-534.nxml.txt.nlp	22619113	SENT99	16	16	21	21	fludarabine	CFLAR	PA449655	8837	0.927
NULL	Cancers_(Basel)_2014_Nov_14_6(4)_2275-2295.nxml.txt.nlp	25405526	SENT231	20	20	14	14	etoposide	CHOP	PA449552	1649	0.927
NULL	Nucleic_Acids_Res_2012_Sep_28_40(17)_8440-8448.nxml.txt.nlp	22753029	SENT175	26	26	5	5	hydroxyurea	CHK1	PA449942	1111	0.927
NULL	Cells_2014_Nov_27_3(4)_1089-1101.nxml.txt.nlp	25437439	SENT68	14	14	3	3	spermine	TRPM7	PA164781199	54822	0.927
NULL	Oncotarget_2010_Nov_19_1(7)_596-605.nxml.txt.nlp	21317455	SENT59	30	30	17	17	sorafenib	IGF1	PA7000	3479	0.927
NULL	Endocrinol_Metab_(Seoul)_2014_Sep_25_29(3)_379-387.nxml.txt.nlp	25309798	SENT186	10	10	32	32	resveratrol	CLOCK		9575	0.927
NULL	EMBO_Mol_Med_2012_Jun_13_4(6)_515-527.nxml.txt.nlp	22416035	SENT185	11	11	26	26	olaparib	PARP-1		25976	0.927
NULL	Oncotarget_2014_Oct_22_5(20)_9530-9531.nxml.txt.nlp	25393980	SENT22	10	10	23	23	ustekinumab	IL-23	PA166048654	51561	0.927
NULL	J_Cell_Biol_2008_Jan_28_180(2)_341-355.nxml.txt.nlp	18209102	SENT638	19	19	1	1	melphalan	Bcl-2	PA450354	596	0.927
NULL	Curr_Neuropharmacol_2008_Jun_6(2)_164-178.nxml.txt.nlp	19305795	SENT243	17	17	2	2	nadh	p53	PA164755085	7157	0.927
NULL	Clin_Med_Cardiol_2009_Sep_3_3_77-91.nxml.txt.nlp	20508768	SENT119	15	15	3	3	clopidogrel	P2Y12	PA449053	64805	0.927
NULL	Breast_Cancer_Res_Treat_2013_Jun_5_139(3)_649-655.nxml.txt.nlp	23736997	SENT144	23	23	8	8	tamoxifen	CYP2C19	PA451581	1557	0.927
NULL	Acta_Pharmacol_Sin_2009_Apr_9_30(4)_451-457.nxml.txt.nlp	19270722	SENT152	5	5	18	18	imatinib	P-gp	PA10804	5243	0.927
NULL	Mol_Pain_2013_Jan_2_9_1.nxml.txt.nlp	23279936	SENT28	19	19	14	14	capsaicin	TRPV1	PA448776	7442	0.927
NULL	Basic_Clin_Neurosci_2013_Spring_4(2)_130-135.nxml.txt.nlp	25337339	SENT176	5	5	0	0	naloxone	ACTH	PA450586	5443	0.927
NULL	Int_J_Med_Sci_2015_Jan_5_12(2)_135-140.nxml.txt.nlp	25589889	SENT77	14	14	3	3	ziprasidone	NMS	PA451974	129521	0.927
NULL	Clinics_(Sao_Paulo)_2010_Aug_65(8)_803b-807.nxml.txt.nlp	20835559	SENT73	18	18	30	30	l-arginine	spatial	PA448478	219793	0.927
NULL	Cell_Commun_Signal_2014_Sep_25_12(1)_61.nxml.txt.nlp	NULL	SENT405	15	15	0	0	doxycycline	PC-3	PA449415	692094	0.927
NULL	Infect_Drug_Resist_2011_Feb_3_4_43-53.nxml.txt.nlp	21694908	SENT188	23	23	3	3	fluconazole	ARTEMIS	PA449653	64421	0.927
NULL	Cell_Biol_Int_Rep_(2010)_2012_Jun_21_19(1)_e00017.nxml.txt.nlp	23124518	SENT196	16	16	12	12	etoposide	NF-kappaB	PA449552	4790	0.927
NULL	Cancer_Cell_Int_2009_Jan_8_9_3.nxml.txt.nlp	19128511	SENT13	3	3	6	6	oxaliplatin	PI3K	PA131285527	5290	0.927
NULL	J_Hematol_Oncol_2012_Aug_13_5_49.nxml.txt.nlp	22889180	SENT25	14	14	10	10	doxorubicin	CHOP	PA449412	1649	0.927
NULL	Br_J_Cancer_2012_Sep_25_107(7)_1009-1016.nxml.txt.nlp	22948724	SENT102	22	22	25	25	temsirolimus	IFN	PA164746890	3439	0.927
NULL	Br_J_Cancer_2009_Mar_24_100(6)_941-949.nxml.txt.nlp	19240716	SENT160	24	24	4	4	lapatinib	EGFR	PA152241907	1956	0.927
NULL	ScientificWorldJournal_2012_May_1_2012_490968.nxml.txt.nlp	22645425	SENT122	14	14	11	11	montelukast	CysLT1	PA450546	10800	0.927
NULL	Breast_Cancer_Res_2012_Nov_5_14(6)_R143.nxml.txt.nlp	23127292	SENT166	39	39	29	29	tamoxifen	p53	PA451581	7157	0.927
NULL	Br_J_Cancer_2011_Apr_12_104(8)_1278-1287.nxml.txt.nlp	21487429	SENT140	15	15	7	7	cisplatin	DR5	PA449014	8795	0.927
NULL	J_Carcinog_2012_Sep_13_11_15.nxml.txt.nlp	23230392	SENT127	22	22	19	19	gefitinib	EGFR	PA131301952	1956	0.927
NULL	Curr_Neuropharmacol_2008_Sep_6(3)_215-234.nxml.txt.nlp	19506722	SENT139	19	19	29	29	fluoxetine	5-HT6	PA449673	3362	0.927
NULL	Curr_Med_Chem_2014_May_21(14)_1569-1582.nxml.txt.nlp	23992304	SENT307	32	32	3	3	cisplatin	AKT2	PA449014	208	0.927
NULL	Mol_Vis_2012_Nov_29_18_2839-2846.nxml.txt.nlp	23233786	SENT136	8	8	12	12	sr144528	CB2		1269	0.927
NULL	Oncotarget_2014_Aug_19_5(18)_8737-8749.nxml.txt.nlp	25228590	SENT39	29	29	15	15	crizotinib	MYCN	PA165946122	4613	0.927
NULL	Front_Pharmacol_2014_Oct_27_5_233.nxml.txt.nlp	25386143	SENT189	22	22	12	12	erythromycin	IL-17	PA449493	3605	0.927
NULL	J_Mol_Med_2008_Sep_4_86(9)_1045-1056.nxml.txt.nlp	18600309	SENT244	1	1	10	10	salmeterol	IL-8	PA451300	3576	0.927
NULL	Front_Genet_2013_Apr_4_4_14.nxml.txt.nlp	23577018	SENT191	16	16	4	4	fluorescein	NIR	PA164746009	26155	0.927
NULL	Mol_Biol_Cell_2014_Jun_1_25(11)_1782-1792.nxml.txt.nlp	24719457	SENT99	38	38	9	9	nicotine	ASCL1	PA450626	429	0.927
NULL	Evid_Based_Complement_Alternat_Med_2015_Jan_6_2015_802903.nxml.txt.nlp	25632291	SENT105	10	10	25	25	berberine	CYP1A2	PA165860812	1544	0.927
NULL	Br_J_Cancer_2012_Jan_17_106(2)_248-253.nxml.txt.nlp	22166804	SENT76	27	27	30	30	tamoxifen	aromatase	PA451581	1588	0.927
NULL	Arthritis_Res_Ther_2010_Apr_29_12(2)_R73.nxml.txt.nlp	20429888	SENT300	1	1	29	29	bortezomib	SP1	PA10252	6667	0.927
NULL	Mol_Cell_Proteomics_2012_Mar_13_11(3)_M111_014654.nxml.txt.nlp	22167270	SENT34	15	15	5	5	geldanamycin	Hsp90	PA152031327	3320	0.927
NULL	Autophagy_2012_Dec_1_8(12)_1875-1876.nxml.txt.nlp	22874642	SENT24	2	2	25	25	chloroquine	MTOR	PA448948	2475	0.927
NULL	Lab_Anim_Res_2012_Sep_26_28(3)_171-179.nxml.txt.nlp	23091517	SENT149	21	21	3	3	creatine	AMPK	PA164778930	5563	0.927
NULL	Oncotarget_2013_Jul_26_4(8)_1317-1328.nxml.txt.nlp	23945331	SENT15	8	8	33	33	tamoxifen	HER2	PA451581	2064	0.927
NULL	Biologics_2010_Sep_28_4_273-287.nxml.txt.nlp	21116326	SENT70	8	8	22	22	bortezomib	JNK	PA10252	5599	0.927
NULL	Behav_Brain_Res_2014_Feb_1_259(100)_330-335.nxml.txt.nlp	24239689	SENT138	14	14	18	18	citalopram	Gen	PA449015	348654	0.927
NULL	Ann_Oncol_2010_Feb_21(2)_217-222.nxml.txt.nlp	20110292	SENT148	30	30	0	0	erlotinib	RAPGEF5	PA134687924	9771	0.927
NULL	Adv_Hematol_2010_Dec_5_2010_595934.nxml.txt.nlp	21151515	SENT117	9	9	17	17	prasugrel	ADP	PA154410481	23038	0.927
NULL	Curr_Cardiol_Rev_2011_Nov_7(4)_221-233.nxml.txt.nlp	22758623	SENT181	14	14	21	21	toremifene	aromatase	PA451731	1588	0.927
NULL	Diabetes_2008_Sep_57(9)_2272-2279.nxml.txt.nlp	18519799	SENT196	17	17	9	9	rosiglitazone	PDK4	PA451283	5166	0.927
NULL	Anc_Sci_Life_2011_Oct-Dec_31(2)_52-57.nxml.txt.nlp	23284206	SENT72	12	12	23	23	iron	API5	PA450087	8539	0.927
NULL	Antimicrob_Resist_Infect_Control_2012_May_30_1_21.nxml.txt.nlp	22958440	SENT192	9	9	0	0	erythromycin	TC1	PA449493	6947	0.927
NULL	Int_Clin_Psychopharmacol_2014_Jul_26_29(4)_185-196.nxml.txt.nlp	24424469	SENT10	23	23	11	11	escitalopram	CYP2D6	PA10074	1565	0.927
NULL	Front_Neurosci_2014_Jan_10_7_270.nxml.txt.nlp	24454277	SENT19	30	30	20	20	resveratrol	PI3K		5290	0.927
NULL	Oncol_Rep_2013_Apr_23_29(4)_1268-1274.nxml.txt.nlp	23354756	SENT98	16	16	9	9	paclitaxel	SLC25A43	PA450761	203427	0.927
NULL	Int_J_Mol_Sci_2013_Apr_11_14(4)_7959-7978.nxml.txt.nlp	23579957	SENT182	20	20	11	11	trypsin	CO2	PA451806	4513	0.927
NULL	Onco_Targets_Ther_2014_May_23_7_799-805.nxml.txt.nlp	24920920	SENT86	16	16	4	4	erlotinib	EGFR	PA134687924	1956	0.927
NULL	Oncotarget_2010_Oct_25_1(7)_497-514.nxml.txt.nlp	21165163	SENT198	21	21	15	15	erlotinib	EGFR	PA134687924	1956	0.927
NULL	Onco_Targets_Ther_2014_Dec_4_7_2249-2255.nxml.txt.nlp	25587220	SENT119	20	20	32	32	verapamil	MRP1	PA451868	4437	0.927
NULL	J_Adv_Pharm_Technol_Res_2012_Oct-Dec_3(4)_202-209.nxml.txt.nlp	23378940	SENT128	7	7	19	19	aprepitant	CYP3A4	PA164747039	1576	0.927
NULL	Oncoscience_2013_Dec_11_1(1)_21-29.nxml.txt.nlp	25593981	SENT202	11	11	4	4	gemcitabine	NFkappaB	PA449748	4790	0.927
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT33	7	7	18	18	erlotinib	UGT	PA134687924	7361;7355	0.927
NULL	J_Biol_Chem_2009_Sep_25_284(39)_26447-26455.nxml.txt.nlp	19633293	SENT17	18	18	8	8	hyaluronan	HAS2	PA165958431	3037	0.927
NULL	J_Adv_Pract_Oncol_2012_Nov_1_Nov-Dec_3(6)_391-394.nxml.txt.nlp	25031970	SENT18	5	5	13	13	pertuzumab	HER2		2064	0.927
NULL	Braz_J_Microbiol_2013_Apr_9_44(1)_245-252.nxml.txt.nlp	24159311	SENT85	16	16	41	41	lipase	castor	PA450239	54897	0.927
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT132	8	8	1	1	tenofovir	ABCC10	PA10204	89845	0.927
NULL	J_Exp_Med_2000_Mar_6_191(5)_771-780.nxml.txt.nlp	10704459	SENT39	15	15	7	7	ganciclovir	IL-15	PA449733	3600	0.927
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT168	18	18	35	35	simvastatin	AKT	PA451363	207	0.927
NULL	Braz_J_Med_Biol_Res_2014_May_9_47(6)_505-514.nxml.txt.nlp	24878606	SENT83	24	24	1	1	estradiol	ANOVA	PA449503	4858	0.927
NULL	Korean_Circ_J_2013_Aug_31_43(8)_541-549.nxml.txt.nlp	24044013	SENT29	10	10	41	41	prasugrel	CYP2C19	PA154410481	1557	0.927
NULL	Cancer_Cell_Int_2013_May_15_13_42.nxml.txt.nlp	23672670	SENT205	22	22	4	4	paclitaxel	PIDD	PA450761	55367	0.927
NULL	Br_J_Cancer_2009_Mar_24_100(6)_870-873.nxml.txt.nlp	19293806	SENT39	3	3	27	27	gemcitabine	CDA	PA449748	978	0.927
NULL	Hematol_Rep_2012_Jun_26_4(2)_e10.nxml.txt.nlp	22826792	SENT20	36	36	25	25	eltrombopag	TPO	PA165981594	7066;7173	0.927
NULL	J_Biol_Chem_2013_Nov_22_288(47)_34217-34229.nxml.txt.nlp	24106270	SENT168	16	16	9	9	thrombin	RhoG	PA451674	391	0.927
NULL	Nucleic_Acids_Res_2010_Oct_21_38(18)_6148-6158.nxml.txt.nlp	20494979	SENT308	24	24	45	45	paclitaxel	HLJ1	PA450761	11080	0.927
NULL	Ann_Rheum_Dis_2013_Sep_14_72(9)_1488-1495.nxml.txt.nlp	22984173	SENT227	40	40	19	19	tocilizumab	IL-6	PA165292659	3569	0.927
NULL	J_Korean_Assoc_Oral_Maxillofac_Surg_2014_Dec_26_40(6)_291-296.nxml.txt.nlp	25551094	SENT112	15	15	20	20	zoledronate	RANKL	PA10235	8600	0.927
NULL	Patient_Prefer_Adherence_2013_Apr_26_7_369-377.nxml.txt.nlp	23641151	SENT40	0	0	37	37	ustekinumab	IL-23	PA166048654	51561	0.927
NULL	J_Hematol_Oncol_2013_Jul_18_6_53.nxml.txt.nlp	23866964	SENT140	15	15	6	6	temsirolimus	HDAC3	PA164746890	8841	0.927
NULL	Stroke_Res_Treat_2011_Nov_10_2011_212485.nxml.txt.nlp	22135769	SENT150	18	18	22	22	ticagrelor	ADP	PA165374673	23038	0.927
NULL	Cell_Death_Dis_2014_Mar_13_5(3)_e1111.nxml.txt.nlp	24625970	SENT22	29	29	10	10	etoposide	p53	PA449552	7157	0.927
NULL	Aging_(Albany_NY)_2011_Feb_21_3(2)_148-157.nxml.txt.nlp	21386129	SENT117	11	11	2	2	metformin	HER-2	PA450395	2064	0.927
NULL	Int_J_Gen_Med_2009_Jul_30_2_129-140.nxml.txt.nlp	20360896	SENT163	29	29	6	6	tamoxifen	IMPACT	PA451581	55364	0.927
NULL	Front_Oncol_2013_Nov_18_3_282.nxml.txt.nlp	24303367	SENT239	11	11	16	16	irinotecan	PARP	PA450085	142	0.927
NULL	Breast_Cancer_Res_2005_Jan_28_7(3)_R284-R290.nxml.txt.nlp	15987423	SENT150	20	20	16	16	tamoxifen	SULT1A1	PA451581	6817	0.927
NULL	Nat_Chem_Biol_2010_Apr_28_6(4)_291-299.nxml.txt.nlp	20190765	SENT104	8	8	25	25	dasatinib	EGFR	PA162372878	1956	0.927
NULL	Arthritis_Res_Ther_2011_Mar_16_13(2)_R44.nxml.txt.nlp	21410959	SENT348	29	29	11	11	glucosamine	RANKL	PA164747613	8600	0.927
NULL	Clin_Drug_Investig_2014_Nov_9_34(2)_107-115.nxml.txt.nlp	24214232	SENT58	23	23	7	7	paricalcitol	IMPACT	PA450798	55364	0.927
NULL	J_Cancer_2014_Jan_5_5(2)_86-97.nxml.txt.nlp	24494026	SENT115	22	22	6	6	trastuzumab	HER2	PA451743	2064	0.927
NULL	J_Signal_Transduct_2010_Sep_1_2010_643642.nxml.txt.nlp	21637354	SENT56	25	25	16	16	pp2	ghrelin		51738	0.927
NULL	Ther_Clin_Risk_Manag_2006_Jun_2(2)_129-158.nxml.txt.nlp	18360588	SENT126	3	3	12	12	astemizole	CYP3A4	PA448498	1576	0.927
NULL	Open_Biochem_J_2012_May_16_6_51-55.nxml.txt.nlp	22654997	SENT172	5	5	8	8	naproxen	COX	PA450595	1351	0.927
NULL	Acta_Neuropathol_2012_Jun_27_123(6)_807-823.nxml.txt.nlp	22539017	SENT29	32	32	3	3	tetracycline	TDP-43	PA451640	23435	0.927
NULL	Int_J_Biol_Sci_2014_Aug_23_10(8)_921-939.nxml.txt.nlp	25170305	SENT277	25	25	13	13	cyclosporine	EPO	PA449167	7076;8288;2056	0.927
NULL	Clin_Ophthalmol_2009_Jun_2_3_199-210.nxml.txt.nlp	19668566	SENT84	33	33	9	9	bromfenac	COX	PA448670	1351	0.927
NULL	Natl_J_Maxillofac_Surg_2011_Jul-Dec_2(2)_210-213.nxml.txt.nlp	22639517	SENT63	16	16	8	8	doxorubicin	CHOP	PA449412	1649	0.927
NULL	Nat_Chem_Biol_2010_Apr_28_6(4)_291-299.nxml.txt.nlp	20190765	SENT159	3	3	26	26	dasatinib	EGFR	PA162372878	1956	0.927
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT115	10	10	20	20	atorvastatin	IL-6	PA448500	3569	0.927
NULL	Core_Evid_2012_Dec_11_7_131-143.nxml.txt.nlp	23271985	SENT225	6	6	14	14	linezolid	HAP	PA450233	5915;10313	0.927
NULL	Cancer_Manag_Res_2011_Aug_10_3_273-285.nxml.txt.nlp	21931501	SENT64	12	12	16	16	pazopanib	VEGFR2	PA165291492	3791	0.927
NULL	Mol_Cell_Proteomics_2012_Feb_13_11(2)_M111_013904.nxml.txt.nlp	21997733	SENT196	12	12	2	2	hyaluronan	ITIH2	PA165958431	3698	0.927
NULL	Clin_Interv_Aging_2012_Sep_17_7_363-372.nxml.txt.nlp	23049248	SENT86	29	29	1	1	denosumab	RANKL	PA166048634	8600	0.927
NULL	Oncogene_2013_Sep_26_32(39)_10_1038_onc_2012_491.nxml.txt.nlp	23108394	SENT103	27	27	35	35	epirubicin	BRIP1	PA449476	64979;83990	0.927
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT157	24	24	18	18	trastuzumab	HER2	PA451743	2064	0.927
NULL	Curr_Oncol_2009_Jul_16(Suppl_2)_S14-S23.nxml.txt.nlp	19672417	SENT120	30	30	28	28	paroxetine	CYP2D6	PA450801	1565	0.927
NULL	EJC_Suppl_2013_Sep_5_11(2)_254-256.nxml.txt.nlp	NULL	SENT41	7	7	31	31	everolimus	aromatase	PA164746311	1588	0.927
NULL	Nat_Chem_Biol_2010_Apr_28_6(4)_291-299.nxml.txt.nlp	20190765	SENT142	25	25	14	14	dasatinib	AKT	PA162372878	207	0.927
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT121	40	40	18	18	oxaliplatin	EGFR	PA131285527	1956	0.927
NULL	Mol_Biol_Rep_2014_Nov_10_41(1)_331-336.nxml.txt.nlp	24213830	SENT159	11	11	3	3	carbamazepine	MDR1	PA448785	5243	0.927
NULL	Diabetes_Care_2010_Feb_33(2)_e20-e25.nxml.txt.nlp	20103551	SENT65	31	31	39	39	exenatide	GLP-1	PA164749238	100125288	0.927
NULL	Biomed_Res_Int_2014_Apr_29_2014_186864.nxml.txt.nlp	24877064	SENT189	22	22	2	2	curcumin	AP-1	PA151958596	2353;3727;2354;3725	0.927
NULL	Cancer_Cell_Int_2008_Jan_4_8_1.nxml.txt.nlp	18177496	SENT71	10	10	1	1	gefitinib	EWS	PA131301952	2130	0.927
NULL	Cell_Death_Dis_2010_Nov_18_1(11)_e102.nxml.txt.nlp	21368867	SENT338	1	1	13	13	gentamicin	14-3-3	PA449753	10971	0.927
NULL	Mol_Cancer_2008_Mar_26_7_27.nxml.txt.nlp	18366759	SENT145	24	24	5	5	etoposide	AP-1	PA449552	2353;3727;2354;3725	0.927
NULL	Cell_Res_2013_Jul_21_23(7)_915-930.nxml.txt.nlp	23689279	SENT269	16	16	3	3	nadh	ALDH2	PA164755085	217	0.927
NULL	Oncotarget_2014_Feb_25_5(5)_1304-1314.nxml.txt.nlp	24675421	SENT146	29	29	20	20	cisplatin	MKK4	PA449014	6416	0.927
NULL	Crit_Care_2004_May_25_8(4)_243-252.nxml.txt.nlp	15312206	SENT65	5	5	13	13	naloxone	ACTH	PA450586	5443	0.927
NULL	Case_Rep_Med_2011_Oct_5_2011_432917.nxml.txt.nlp	22007232	SENT147	0	0	8	8	sunitinib	TFE3	PA162372840	7030	0.927
NULL	Int_J_Gen_Med_2009_Jul_30_2_129-140.nxml.txt.nlp	20360896	SENT208	22	22	19	19	tamoxifen	aromatase	PA451581	1588	0.927
NULL	Oncogene_2014_Jul_24_33(30)_3959-3969.nxml.txt.nlp	24096481	SENT24	11	11	27	27	doxorubicin	p53	PA449412	7157	0.927
NULL	J_Cell_Mol_Med_2014_Dec_7_18(12)_2536-2552.nxml.txt.nlp	25287328	SENT147	18	18	38	38	estradiol	PKD1	PA449503	5310	0.927
NULL	Indian_J_Psychol_Med_2009_Jan-Jun_31(1)_3-10.nxml.txt.nlp	21938084	SENT177	17	17	22	22	citalopram	5-HT2A	PA449015	3356	0.927
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jan_11_68(Pt_2)_o340-o341.nxml.txt.nlp	22346970	SENT72	36	36	12	12	ethanol	mol	PA448073	90527	0.927
NULL	J_Oncol_2012_Nov_20_2012_236530.nxml.txt.nlp	23213333	SENT126	19	19	40	40	curcumin	PTEN	PA151958596	5728	0.927
NULL	J_Korean_Med_Sci_2010_Jun_24_25(6)_841-845.nxml.txt.nlp	20514303	SENT89	8	8	40	40	imatinib	FLT3	PA10804	2322	0.927
NULL	Oncotarget_2012_Oct_20_3(10)_1068-1111.nxml.txt.nlp	23085539	SENT415	20	20	12	12	celecoxib	PDK1	PA448871	5170;5163	0.927
NULL	Reprod_Biol_Endocrinol_2004_Jan_7_2_3.nxml.txt.nlp	14711376	SENT67	22	22	4	4	heparin	N-syndecan	PA449855	9672	0.927
NULL	Aging_(Albany_NY)_2009_Jan_16_1(1)_28-37.nxml.txt.nlp	19851476	SENT81	26	26	42	42	etoposide	HGPS	PA449552	4000;10269;64221	0.927
NULL	Comput_Struct_Biotechnol_J_2012_Nov_8_3_e201210007.nxml.txt.nlp	24688667	SENT144	26	26	3	3	ethanol	H10	PA448073	3005	0.927
NULL	Angiogenesis_2012_Sep_27_15(3)_361-376.nxml.txt.nlp	22451299	SENT155	3	3	15	15	resveratrol	IL-8		3576	0.927
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1066.nxml.txt.nlp	24556681	SENT52	6	6	20	20	ethanol	ATG5	PA448073	9474	0.927
NULL	Cancer_Res_Treat_2014_Jul_15_46(3)_261-269.nxml.txt.nlp	25038761	SENT56	10	10	25	25	procarbazine	CRT	PA451112	811	0.927
NULL	Oncotarget_2012_Oct_27_3(10)_1052-1053.nxml.txt.nlp	23165648	SENT23	14	14	24	24	nutlin-3	CD34		947	0.927
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT99	12	12	6	6	methotrexate	MSH2	PA450428	4436	0.927
NULL	Behav_Brain_Funct_2005_Jul_15_1_9.nxml.txt.nlp	16022733	SENT218	12	12	27	27	methylphenidate	DRD1	PA450464	1812	0.927
NULL	Ann_Oncol_2014_May_6_25(5)_959-967.nxml.txt.nlp	24504448	SENT33	7	7	3	3	vemurafenib	BRAF	PA165946873	673	0.927
NULL	ScientificWorldJournal_2013_Dec_19_2013_313492.nxml.txt.nlp	24453831	SENT13	15	15	25	25	clopidogrel	VWF	PA449053	7450	0.927
NULL	Biology_(Basel)_2012_Dec_31_2(1)_40-63.nxml.txt.nlp	24832651	SENT127	8	8	25	25	hydroxyurea	BRCA1	PA449942	672	0.927
NULL	Int_J_Mol_Sci_2014_Mar_6_15(3)_4088-4103.nxml.txt.nlp	24663083	SENT17	18	18	31	31	l-arginine	PRMT1	PA448478	3276	0.927
NULL	Cancer_Res_Treat_2014_Jan_15_46(1)_55-64.nxml.txt.nlp	24520224	SENT33	26	26	9	9	oxaliplatin	ERCC1	PA131285527	2067	0.927
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT31	9	9	3	3	heparin	FGF1	PA449855	2246	0.927
NULL	Front_Endocrinol_(Lausanne)_2014_Sep_3_5_138.nxml.txt.nlp	25232350	SENT118	6	6	19	19	metformin	AMPK	PA450395	5563	0.927
NULL	Case_Rep_Pulmonol_2013_Sep_5_2013_813786.nxml.txt.nlp	24093069	SENT51	29	29	15	15	montelukast	CysLT1	PA450546	10800	0.927
NULL	Comp_Hepatol_2005_Feb_8_4_2.nxml.txt.nlp	15701172	SENT115	15	15	13	13	ketoconazole	CYP3A	PA450146	1574	0.927
NULL	Oncogene_2009_Apr_2_28(13)_1616-1625.nxml.txt.nlp	19219073	SENT124	26	26	8	8	etoposide	p53	PA449552	7157	0.927
NULL	AIDS_Res_Ther_2009_Apr_9_6_3.nxml.txt.nlp	19358725	SENT57	27	27	8	8	fosamprenavir	ATV	PA10084	4683	0.927
NULL	Basic_Res_Cardiol_2012_Jul_24_107(4)_273.nxml.txt.nlp	22622703	SENT86	5	5	8	8	resveratrol	SIRT1		23411	0.927
NULL	AAPS_J_2011_Jun_1_13(3)_405-416.nxml.txt.nlp	21630127	SENT334	21	21	8	8	bevacizumab	HER2	PA130232992	2064	0.927
NULL	Curr_Hypertens_Rep_2011_Oct_13_13(5)_356-361.nxml.txt.nlp	21562941	SENT98	11	11	20	20	captopril	ACE2	PA448780	59272	0.927
NULL	Breast_Cancer_Res_Treat_2014_Dec_19_143(2)_351-358.nxml.txt.nlp	24352574	SENT17	5	5	12	12	vinorelbine	HER-2	PA451881	2064	0.927
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT52	28	28	15	15	metformin	p53	PA450395	7157	0.927
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT107	34	34	5	5	celecoxib	IL-6	PA448871	3569	0.927
NULL	J_Immunother_2014_Feb_21_37(2)_105-114.nxml.txt.nlp	24509173	SENT14	5	5	0	0	gemcitabine	WT1	PA449748	7490	0.927
NULL	Iran_J_Public_Health_2010_Mar_31_39(1)_57-63.nxml.txt.nlp	23112990	SENT31	4	4	21	21	oxygen	ROS	PA450744	6098	0.927
NULL	Cardiovasc_Diabetol_2013_Oct_17_12_150.nxml.txt.nlp	24134550	SENT109	29	29	7	7	metformin	activin	PA450395	83729	0.927
NULL	Oncotarget_2010_Nov_22_1(7)_606-619.nxml.txt.nlp	21317456	SENT160	23	23	3	3	doxorubicin	BRCA2	PA449412	675	0.927
NULL	Drugs_R_D_2011_Jun_27_11(2)_101-111.nxml.txt.nlp	21679003	SENT12	26	26	12	12	bevacizumab	KRAS	PA130232992	3845	0.927
NULL	Nucleic_Acids_Res_2013_Dec_17_41(22)_10371-10378.nxml.txt.nlp	24049076	SENT158	11	11	2	2	cisplatin	MEC1	PA449014	545	0.927
NULL	Exp_Ther_Med_2013_Jul_25_6(1)_109-114.nxml.txt.nlp	23935730	SENT137	13	13	24	24	doxorubicin	CHOP	PA449412	1649	0.927
NULL	Int_J_Mol_Sci_2014_Oct_13_15(10)_18362-18380.nxml.txt.nlp	25314299	SENT17	30	30	7	7	capsaicin	TRPV1	PA448776	7442	0.927
NULL	J_Exp_Clin_Cancer_Res_2009_Jul_10_28(1)_99.nxml.txt.nlp	19591692	SENT29	28	28	13	13	elacridar	ABCB1		5243	0.927
NULL	Front_Microbiol_2012_Mar_29_3_116.nxml.txt.nlp	22479260	SENT208	32	32	6	6	geldanamycin	Hsp90	PA152031327	3320	0.927
NULL	Acta_Pharmacol_Sin_2010_Mar_22_31(3)_329-340.nxml.txt.nlp	20173759	SENT145	4	4	7	7	ethanol	MEF2D	PA448073	4209	0.927
NULL	Acta_Pharmacol_Sin_2013_Sep_5_34(9)_1192-1200.nxml.txt.nlp	23685957	SENT132	8	8	14	14	curcumin	AP-2	PA151958596	7020	0.927
NULL	Biomed_Imaging_Interv_J_2007_Jan_1_3(1)_e6.nxml.txt.nlp	21614267	SENT43	26	26	13	13	sorafenib	IL2	PA7000	3558	0.927
NULL	Oncotarget_2013_Nov_24_4(12)_2430-2438.nxml.txt.nlp	24280348	SENT63	5	5	15	15	gefitinib	EGFR	PA131301952	1956	0.927
NULL	J_Breast_Cancer_2013_Jun_28_16(2)_220-228.nxml.txt.nlp	23843857	SENT168	3	3	21	21	anastrozole	ATAC	PA448432	6375	0.927
NULL	Onco_Targets_Ther_2014_Sep_9_7_1571-1582.nxml.txt.nlp	25228815	SENT266	10	10	7	7	sunitinib	VEGFR1	PA162372840	2321	0.927
NULL	Int_J_Breast_Cancer_2013_Dec_12_2013_659723.nxml.txt.nlp	24416595	SENT20	4	4	30	30	metformin	AMPK	PA450395	5563	0.927
NULL	Nat_Neurosci_2012_Sep_5_15(9)_1245-1254.nxml.txt.nlp	22864611	SENT457	27	27	10	10	haloperidol	mGlu2	PA449841	2912	0.927
NULL	Cell_Death_Differ_2010_Oct_30_17(10)_1624-1635.nxml.txt.nlp	20431602	SENT58	1	1	20	20	paclitaxel	Bcl-2	PA450761	596	0.927
NULL	Curr_Neuropharmacol_2013_Dec_11(6)_652-663.nxml.txt.nlp	24396340	SENT77	18	18	5	5	cisplatin	TRPA1	PA449014	8989	0.927
NULL	Cardiovasc_Diabetol_2006_Aug_30_5_17.nxml.txt.nlp	16939660	SENT25	23	23	37	37	metformin	IL-6	PA450395	3569	0.927
NULL	Front_Oncol_2013_Sep_11_3_228.nxml.txt.nlp	24062981	SENT189	21	21	12	12	camptothecin	PARP1	PA153590860	142	0.927
NULL	Front_Genet_2014_Feb_26_5_40.nxml.txt.nlp	24616734	SENT317	13	13	24	24	docetaxel	CD93	PA449383	22918	0.927
NULL	Indian_J_Anaesth_2013_Jan-Feb_57(1)_88-89.nxml.txt.nlp	23716781	SENT19	15	15	27	27	isoflurane	CO2	PA450106	4513	0.927
NULL	Breast_Cancer_Res_Treat_2014_Sep_25_148(1)_81-90.nxml.txt.nlp	25253174	SENT92	25	25	15	15	metformin	adiponectin	PA450395	9370	0.927
NULL	Arch_Med_Sci_2013_Aug_30_9(4)_622-628.nxml.txt.nlp	24049520	SENT168	7	7	20	20	atorvastatin	ADP	PA448500	23038	0.927
NULL	Ann_Oncol_2013_Aug_12_24(8)_1994-1999.nxml.txt.nlp	23670096	SENT131	12	12	5	5	tamoxifen	AIB1	PA451581	8202	0.927
NULL	Allergy_Asthma_Immunol_Res_2013_Jan_29_5(1)_55-58.nxml.txt.nlp	23277879	SENT38	7	7	21	21	aspirin	IPA	PA448497	3160	0.927
NULL	Breast_Cancer_Res_2012_Aug_8_14(4)_R116.nxml.txt.nlp	22873525	SENT158	5	5	10	10	trastuzumab	HER2	PA451743	2064	0.927
NULL	Curr_Control_Trials_Cardiovasc_Med_2001_Jul_26_2(4)_171-179.nxml.txt.nlp	11806792	SENT50	31	31	9	9	eptifibatide	IMPACT	PA449483	55364	0.927
NULL	Front_Chem_2014_Mar_14_2_12.nxml.txt.nlp	24790981	SENT78	9	9	3	3	curcumin	GATA4	PA151958596	2626	0.927
NULL	Ann_Lab_Med_2012_Mar_23_32(2)_139-144.nxml.txt.nlp	22389881	SENT86	9	9	4	4	methylprednisolone	ACR	PA450466	49	0.927
NULL	Tuberc_Respir_Dis_(Seoul)_2013_Nov_29_75(5)_188-198.nxml.txt.nlp	24348666	SENT226	22	22	6	6	crizotinib	EGFR	PA165946122	1956	0.927
NULL	Cell_Commun_Signal_2013_May_17_11_34.nxml.txt.nlp	23683503	SENT415	1	1	21	21	carbidopa	COMT	PA448794	1312	0.927
NULL	Korean_J_Anesthesiol_2013_Jan_21_64(1)_54-60.nxml.txt.nlp	23372887	SENT119	20	20	2	2	esmolol	CRT	PA449500	811	0.927
NULL	Cell_Cycle_2013_Dec_15_12(24)_3791-3803.nxml.txt.nlp	24107631	SENT188	5	5	11	11	doxorubicin	YB-1	PA449412	4904	0.927
NULL	Drug_Des_Devel_Ther_2014_Oct_31_8_2121-2128.nxml.txt.nlp	25382970	SENT8	2	2	10	10	curcumin	TTR	PA151958596	7276	0.927
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_16_2013_146142.nxml.txt.nlp	23843863	SENT99	6	6	26	26	ns-398	IL6		3569	0.927
NULL	Cells_2014_Apr_8_3(2)_258-287.nxml.txt.nlp	24717323	SENT270	23	23	0	0	carbachol	TRPC6	PA448784	7225	0.927
NULL	Br_J_Cancer_2010_Oct_26_103(9)_1380-1390.nxml.txt.nlp	20877355	SENT211	4	4	15	15	etoposide	ASK1	PA449552	4217	0.927
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Oct_20_66(Pt_11)_o2851.nxml.txt.nlp	21589036	SENT59	27	27	7	7	ethanol	mol	PA448073	90527	0.927
NULL	Nature_2012_Aug_16_488(7411)_394-398.nxml.txt.nlp	22810587	SENT90	18	18	26	26	forskolin	APJ	PA146096022	187	0.927
NULL	Case_Rep_Otolaryngol_2013_Dec_15_2013_918132.nxml.txt.nlp	24396622	SENT77	30	30	24	24	vincristine	CHOP	PA451879	1649	0.927
NULL	Breast_Cancer_Res_2012_Jul_19_14(4)_R109.nxml.txt.nlp	22812567	SENT301	21	21	8	8	gemcitabine	CHK1	PA449748	1111	0.927
NULL	Exp_Neurobiol_2013_Mar_31_22(1)_45-50.nxml.txt.nlp	23585722	SENT127	22	22	17	17	fluoxetine	EPO	PA449673	7076;8288;2056	0.927
NULL	Gene_Ther_2010_Jul_27_17(7)_922-929.nxml.txt.nlp	20508601	SENT41	17	17	33	33	bevacizumab	VEGFR2	PA130232992	3791	0.927
NULL	Eur_J_Immunol_2013_Dec_9_43(12)_3183-3196.nxml.txt.nlp	24030559	SENT276	33	33	6	6	mitomycin	CD4	PA450524	920	0.927
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_33-43.nxml.txt.nlp	17912634	SENT166	8	8	1	1	letrozole	aromatase	PA450196	1588	0.927
NULL	J_Korean_Med_Sci_2013_Aug_31_28(8)_1238-1243.nxml.txt.nlp	23960454	SENT118	33	33	13	13	amiloride	ASIC3	PA448368	9311	0.927
NULL	J_Bras_Pneumol_2013_Jan-Feb_39(1)_5-15.nxml.txt.nlp	23503480	SENT9	30	30	26	26	doxycycline	LAM	PA449415	7249;7248	0.927
NULL	Oncol_Rep_2013_Oct_22_30(4)_1535-1541.nxml.txt.nlp	23877481	SENT41	40	40	23	23	gefitinib	EGF	PA131301952	1950	0.927
NULL	Mediators_Inflamm_2001_Jun_10(3)_125-133.nxml.txt.nlp	11545249	SENT9	18	18	28	28	metyrapone	CTX	PA450486	1593	0.927
NULL	Oncol_Lett_2014_Jan_12_7(1)_17-22.nxml.txt.nlp	24348813	SENT111	0	0	16	16	curcumin	COX	PA151958596	1351	0.927
NULL	Mol_Cancer_2010_May_26_9_123.nxml.txt.nlp	20504344	SENT98	3	3	15	15	fludarabine	p53	PA449655	7157	0.927
NULL	J_Cell_Biol_2000_Dec_11_151(6)_1235-1246.nxml.txt.nlp	11121438	SENT185	14	14	0	0	heparin	p29	PA449855	25949;9588	0.927
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT253	25	25	6	6	perifosine	DR4	PA165291471	8797	0.927
NULL	Exp_Hematol_Oncol_2014_Sep_8_3_23.nxml.txt.nlp	25243101	SENT38	18	18	16	16	letrozole	aromatase	PA450196	1588	0.927
NULL	J_Thromb_Haemost_2011_Oct_9(10)_2050-2056.nxml.txt.nlp	21794076	SENT23	17	17	10	10	prasugrel	P2Y12	PA154410481	64805	0.927
NULL	J_Hematol_Oncol_2013_Jan_4_6_1.nxml.txt.nlp	23286345	SENT145	16	16	9	9	cetuximab	KRAS	PA10040	3845	0.927
NULL	Int_J_Biomed_Sci_2005_Jun_1(1)_67-71.nxml.txt.nlp	23674956	SENT28	26	26	1	1	collagenase	hole	PA449107	80757	0.927
NULL	Lipids_Health_Dis_2011_Feb_27_10_37.nxml.txt.nlp	21352586	SENT24	16	16	0	0	lipase	IL-6	PA450239	3569	0.927
NULL	J_Mol_Signal_2012_Aug_16_7_12.nxml.txt.nlp	22898329	SENT251	20	20	2	2	bortezomib	NOXA	PA10252	5366	0.927
NULL	Blood_Cancer_J_2013_Mar_1_3(3)_e103.nxml.txt.nlp	23454896	SENT100	20	20	16	16	nelfinavir	p38	PA450606	10598;1432;7965	0.927
NULL	Ann_Dermatol_2014_Oct_26_26(5)_645-646.nxml.txt.nlp	25324664	SENT7	27	27	13	13	brinzolamide	HLA-B	PA164744929	3106	0.927
NULL	Oncotarget_2014_Aug_4_5(17)_7776-7787.nxml.txt.nlp	25277200	SENT8	1	1	16	16	cisplatin	ANXA4	PA449014	307	0.927
NULL	Breast_Cancer_Res_2009_Jul_15_11(4)_207.nxml.txt.nlp	19664181	SENT175	9	9	21	21	trastuzumab	DM1	PA451743	338023;1760;28509	0.927
NULL	Biologics_2012_Dec_17_6_429-464.nxml.txt.nlp	23269860	SENT198	3	3	15	15	adalimumab	ACR	PA10004	49	0.927
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT203	0	0	4	4	methotrexate	MSH2	PA450428	4436	0.927
NULL	Gut_Liver_2011_Jun_24_5(2)_160-164.nxml.txt.nlp	21814595	SENT5	0	0	27	27	propofol	ESD	PA451141	2098	0.927
NULL	Adv_Bioinformatics_2012_Jun_6_2012_582765.nxml.txt.nlp	22719757	SENT128	34	34	30	30	thrombin	EGF	PA451674	1950	0.927
NULL	Front_Endocrinol_(Lausanne)_2013_Nov_11_4_166.nxml.txt.nlp	24273531	SENT236	25	25	3	3	losartan	ANG	PA450268	283	0.927
NULL	Clin_Infect_Dis_2011_Jan_1_52(1)_31-40.nxml.txt.nlp	21148517	SENT32	3	3	11	11	vancomycin	HAP	PA451850	5915;10313	0.927
NULL	Breast_Cancer_Res_2010_Jun_28_12(3)_R43.nxml.txt.nlp	20579400	SENT279	32	32	1	1	fulvestrant	MTS	PA164747170	1678	0.927
NULL	J_Oncol_2012_Mar_11_2012_382159.nxml.txt.nlp	22481926	SENT94	18	18	2	2	paclitaxel	PI3K	PA450761	5290	0.927
NULL	Breast_Cancer_Res_2005_Mar_4_7(3)_R345-R352.nxml.txt.nlp	15987429	SENT221	15	15	17	17	carbachol	CARB	PA448784	9482	0.927
NULL	Br_J_Pharmacol_2008_Oct_18_155(4)_596-605.nxml.txt.nlp	18852694	SENT146	10	10	13	13	fenofibrate	SREBP2	PA449594	6721	0.927
NULL	Infect_Dis_Ther_2014_Jun_29_3(1)_45-53.nxml.txt.nlp	25134811	SENT100	23	23	2	2	cephalexin	SOC	PA448883	91544	0.927
NULL	Iran_J_Reprod_Med_2012_Jul_10(4)_329-336.nxml.txt.nlp	25246894	SENT23	29	29	3	3	protamine	PRM1	PA10366	5619	0.927
NULL	Cardiovasc_Diabetol_2008_Dec_23_7_36.nxml.txt.nlp	19108709	SENT34	0	0	8	8	eptifibatide	San	PA449483	80218	0.927
NULL	HPB_Surg_2014_May_20_2014_954604.nxml.txt.nlp	24963215	SENT142	4	4	0	0	hyaluronan	LYVE-1	PA165958431	10894	0.927
NULL	Acta_Pharmacol_Sin_2009_Oct_21_30(10)_1392-1398.nxml.txt.nlp	19767766	SENT102	14	14	3	3	atorvastatin	p38	PA448500	10598;1432;7965	0.927
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT44	2	2	18	18	pertuzumab	HER2		2064	0.927
NULL	Mol_Cell_Proteomics_2012_Feb_6_11(2)_M111_015222.nxml.txt.nlp	22147731	SENT618	7	7	16	16	cetuximab	AKT	PA10040	207	0.927
NULL	J_Hematol_Oncol_2013_Jun_3_6_38.nxml.txt.nlp	23731980	SENT122	31	31	5	5	pertuzumab	HER2		2064	0.927
NULL	Oncogene_2014_May_8_33(19)_2478-2486.nxml.txt.nlp	23752180	SENT13	41	41	16	16	trastuzumab	HER2	PA451743	2064	0.927
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Sep_30_66(Pt_10)_o2696.nxml.txt.nlp	21587664	SENT56	8	8	39	39	benzaldehyde	mol	PA448571	90527	0.927
NULL	Eur_J_Clin_Pharmacol_2012_Sep_15_68(9)_1267-1274.nxml.txt.nlp	22418828	SENT181	35	35	3	3	lansoprazole	CYP2C19	PA450180	1557	0.927
NULL	Cases_J_2009_Jul_30_2_7134.nxml.txt.nlp	19829918	SENT62	3	3	22	22	ropinirole	LCE	PA164749035	79071	0.927
NULL	Br_J_Haematol_2008_Mar_3_144(5)_677-685.nxml.txt.nlp	19055662	SENT87	6	6	13	13	vindesine	CHOP	PA10232	1649	0.927
NULL	Exp_Ther_Med_2013_Apr_5_5(4)_1259-1263.nxml.txt.nlp	23596498	SENT98	2	2	23	23	capsaicin	TRPV1	PA448776	7442	0.927
NULL	Br_J_Cancer_2012_Oct_9_107(8)_1277-1285.nxml.txt.nlp	22990652	SENT162	0	0	6	6	axitinib	CYP3A4	PA164924493	1576	0.927
NULL	Arthritis_Res_Ther_2012_Dec_7_14(6)_R265.nxml.txt.nlp	23217273	SENT172	0	0	12	12	thalidomide	CLE	PA451644	51637	0.927
NULL	Nat_Commun_2012_3_1147.nxml.txt.nlp	23093184	SENT217	19	19	12	12	tetracycline	ND5	PA451640	4540	0.927
NULL	Acta_Pharmacol_Sin_2013_Feb_3_34(2)_221-230.nxml.txt.nlp	23202797	SENT122	8	8	23	23	flecainide	mol	PA449646	90527	0.927
NULL	Front_Oncol_2013_Apr_29_3_92.nxml.txt.nlp	23641361	SENT226	6	6	3	3	bevacizumab	NF2	PA130232992	4771	0.927
NULL	J_Nat_Sci_Biol_Med_2012_Jul-Dec_3(2)_189-191.nxml.txt.nlp	23225984	SENT63	0	0	30	30	plerixafor	CD34	PA165958410	947	0.927
NULL	Front_Chem_2014_Dec_23_2_113.nxml.txt.nlp	25566531	SENT160	34	34	12	12	curcumin	ACOX1	PA151958596	51	0.927
NULL	Lipids_Health_Dis_2011_Feb_28_10_38.nxml.txt.nlp	21352602	SENT82	7	7	20	20	atorvastatin	PCSK9	PA448500	255738	0.927
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_75-89.nxml.txt.nlp	17912638	SENT200	21	21	5	5	tamoxifen	ATAC	PA451581	6375	0.927
NULL	Mol_Cancer_2010_Aug_23_9_222.nxml.txt.nlp	20731837	SENT206	18	18	3	3	gefitinib	ATR	PA131301952	390502;84168;545	0.927
NULL	BMB_Rep_2014_May_47(5)_274-279.nxml.txt.nlp	24286313	SENT54	13	13	32	32	bortezomib	GAPDH	PA10252	2597	0.927
NULL	Biosci_Rep_2012_Dec_13_33(1)_e00007.nxml.txt.nlp	23095119	SENT205	21	21	6	6	forskolin	AMPK	PA146096022	5563	0.927
NULL	Br_J_Cancer_2006_Dec_4_95(11)_1504-1513.nxml.txt.nlp	17088902	SENT6	29	29	38	38	trastuzumab	HER2	PA451743	2064	0.927
NULL	Scientifica_(Cairo)_2012_Nov_25_2012_473829.nxml.txt.nlp	24278698	SENT298	33	33	12	12	lamivudine	OCT2	PA450163	6582;5452	0.927
NULL	Diabetes_2013_Nov_18_62(11)_3909-3919.nxml.txt.nlp	23835339	SENT103	32	32	11	11	gliclazide	NBS1	PA10892	55655	0.927
NULL	Mol_Pain_2012_Sep_22_8_71.nxml.txt.nlp	22998838	SENT183	19	19	2	2	cisplatin	CB2	PA449014	1269	0.927
NULL	Int_J_Med_Sci_2013_Mar_19_10(5)_599-606.nxml.txt.nlp	23569422	SENT56	32	32	17	17	propofol	HO-1	PA451141	3162	0.927
NULL	J_Oncol_2011_Dec_23_2011_591427.nxml.txt.nlp	21253528	SENT101	10	10	19	19	paclitaxel	CD44	PA450761	960	0.927
NULL	Int_J_Breast_Cancer_2012_Jan_24_2012_385978.nxml.txt.nlp	22461984	SENT89	12	12	7	7	cisplatin	BRCA1	PA449014	672	0.927
NULL	Proteome_Sci_2009_May_28_7_20.nxml.txt.nlp	19476632	SENT54	26	26	7	7	galactose	NDUFA9	PA449725	4704	0.927
NULL	Mol_Cancer_2010_Aug_20_9_220.nxml.txt.nlp	20727180	SENT29	22	22	9	9	nicotine	p53	PA450626	7157	0.927
NULL	Eur_J_Haematol_2014_Feb_25_92(2)_127-136.nxml.txt.nlp	24118452	SENT35	19	19	7	7	anagrelide	ELN	PA164742986	2006	0.927
NULL	Oncogene_2014_Jul_24_33(30)_3959-3969.nxml.txt.nlp	24096481	SENT25	27	27	38	38	doxorubicin	p53	PA449412	7157	0.927
NULL	Mol_Cancer_2010_Apr_23_9_87.nxml.txt.nlp	20416058	SENT177	35	35	23	23	etoposide	TRAIL	PA449552	8743	0.927
NULL	Cardiovasc_Diabetol_2008_Jun_19_7_18.nxml.txt.nlp	18565233	SENT92	4	4	14	14	bezafibrate	gamma	PA162364313	9913	0.927
NULL	Diabetes_Metab_Syndr_Obes_2014_Jun_24_7_229-239.nxml.txt.nlp	25018644	SENT161	16	16	3	3	exenatide	GLP-1	PA164749238	100125288	0.927
NULL	Breast_Cancer_(Auckl)_2009_Sep_2_3_61-75.nxml.txt.nlp	19809577	SENT127	38	38	19	19	curcumin	PARP	PA151958596	142	0.927
NULL	Eur_J_Med_Res_2011_Feb_24_16(2)_71-75.nxml.txt.nlp	21463985	SENT122	17	17	10	10	cisplatin	HAI	PA449014	6692;6768	0.927
NULL	Breast_Cancer_Res_2007_Oct_19_9(5)_111.nxml.txt.nlp	17983482	SENT41	23	23	3	3	trastuzumab	HER3	PA451743	2065	0.927
NULL	Oncotarget_2012_May_18_3(5)_525-534.nxml.txt.nlp	22619113	SENT99	16	16	23	23	fludarabine	BIRC5	PA449655	332	0.927
NULL	Anal_Bioanal_Chem_2010_Feb_29_396(3)_1281-1290.nxml.txt.nlp	20091155	SENT52	36	36	6	6	trypsin	DAO	PA451806	26;1610	0.927
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1150.nxml.txt.nlp	24675468	SENT53	20	20	17	17	ethanol	Bcl-2	PA448073	596	0.927
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S18-S30.nxml.txt.nlp	20680104	SENT197	15	15	25	25	irinotecan	IFL	PA450085	3439	0.927
NULL	Cent_European_J_Urol_2011_Dec_9_64(4)_256-257.nxml.txt.nlp	24578906	SENT52	11	11	16	16	doxazosin	CD133	PA449407	8842	0.927
NULL	Interdiscip_Toxicol_2011_Sep_4(3)_114-124.nxml.txt.nlp	22058652	SENT260	22	22	7	7	rosiglitazone	SERCA2	PA451283	488	0.927
NULL	Eur_J_Med_Res_2014_Mar_11_19(1)_13.nxml.txt.nlp	24612760	SENT59	0	0	10	10	heparin	ACT	PA449855	12;11332;9457;641455	0.927
NULL	J_Exerc_Rehabil_2014_Apr_30_10(2)_60-68.nxml.txt.nlp	24877039	SENT26	9	9	26	26	glimepiride	adiponectin	PA449761	9370	0.927
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2010_Aug_3_3_43-51.nxml.txt.nlp	22879786	SENT84	26	26	4	4	rifampin	CYP2C8	PA451250	1558	0.927
NULL	Clin_Endosc_2011_Sep_30_44(1)_22-26.nxml.txt.nlp	22741108	SENT112	34	34	30	30	midazolam	ESD	PA450496	2098	0.927
NULL	Clin_Pharmacokinet_2014_Jan_16_53(3)_213-225.nxml.txt.nlp	24430725	SENT190	0	0	7	7	verapamil	P-gp	PA451868	5243	0.927
NULL	Oncotarget_2014_Dec_4_5(22)_11365-11380.nxml.txt.nlp	25426548	SENT201	10	10	25	25	nutlin-3	p53		7157	0.927
NULL	Indian_J_Endocrinol_Metab_2013_Jan-Feb_17(1)_19-30.nxml.txt.nlp	23776849	SENT73	19	19	5	5	diazoxide	ABCC8	PA449285	6833	0.927
NULL	Crit_Care_2011_Mar_22_15(2)_211.nxml.txt.nlp	21457505	SENT43	23	23	0	0	heparin	PF4	PA449855	5196	0.927
NULL	Breast_Cancer_(Auckl)_2011_Oct_9_5_209-226.nxml.txt.nlp	22084574	SENT198	16	16	23	23	tamoxifen	ARNO	PA451581	9266	0.927
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jul_31_66(Pt_8)_o2157.nxml.txt.nlp	21588441	SENT47	24	24	11	11	ethanol	mol	PA448073	90527	0.927
NULL	J_Hematol_Oncol_2008_Oct_1_1_16.nxml.txt.nlp	18828924	SENT234	11	11	32	32	trastuzumab	HER2	PA451743	2064	0.927
NULL	Cell_Death_Dis_2014_Jul_3_5(7)_e1316.nxml.txt.nlp	24991768	SENT47	4	4	31	31	pemetrexed	ATF4	PA10810	468	0.927
NULL	Environ_Health_Perspect_2009_Feb_8_117(2)_175-180.nxml.txt.nlp	19270784	SENT200	14	14	4	4	doxorubicin	BPA	PA449412	667	0.927
NULL	Cardiovasc_Diabetol_2007_Oct_30_6_35.nxml.txt.nlp	17971205	SENT191	34	34	0	0	rosiglitazone	ATV	PA451283	4683	0.927
NULL	J_Gen_Physiol_1993_Nov_1_102(5)_817-831.nxml.txt.nlp	7507974	SENT0	20	20	1	1	amiloride	Gen	PA448368	348654	0.927
NULL	Hum_Genomics_2009_Jan_1_3(2)_128-142.nxml.txt.nlp	19164090	SENT264	9	9	1	1	carboplatin	PAK1	PA448803	5585;5058	0.927
NULL	Breast_Cancer_(Auckl)_2012_Mar_7_6_67-77.nxml.txt.nlp	22438669	SENT49	15	15	6	6	lapatinib	HER2	PA152241907	2064	0.927
NULL	Target_Oncol_2012_Mar_19_7(Suppl_1)_29-34.nxml.txt.nlp	22258705	SENT100	19	19	1	1	filgrastim	CD34	PA449626	947	0.927
NULL	Adv_Urol_2010_Jul_20_2010_687043.nxml.txt.nlp	20721275	SENT102	24	24	45	45	bevacizumab	IFN	PA130232992	3439	0.927
NULL	Core_Evid_2011_Mar_17_6_31-42.nxml.txt.nlp	21468241	SENT77	2	2	8	8	ticagrelor	P2Y12	PA165374673	64805	0.927
NULL	Oncotarget_2012_Nov_14_3(12)_1557-1565.nxml.txt.nlp	23238683	SENT88	0	0	8	8	ponatinib	CD34	PA165980594	947	0.927
NULL	Indian_J_Anaesth_2009_Oct_53(5)_582-591.nxml.txt.nlp	20640109	SENT78	2	2	15	15	clopidogrel	CYP3A4	PA449053	1576	0.927
NULL	Br_J_Cancer_2010_Jan_19_102(2)_294-300.nxml.txt.nlp	19953095	SENT28	37	37	21	21	tamoxifen	CYP2D6	PA451581	1565	0.927
NULL	Cell_Cycle_2012_Nov_1_11(21)_3983-3996.nxml.txt.nlp	22987153	SENT86	30	30	35	35	cisplatin	DNA2	PA449014	1763	0.927
NULL	J_Brachial_Plex_Peripher_Nerve_Inj_2008_Oct_25_3_22.nxml.txt.nlp	18950516	SENT46	22	22	8	8	midazolam	SGB	PA450496	2719	0.927
NULL	Front_Genet_2014_Jun_2_5_162.nxml.txt.nlp	24917882	SENT1025	7	7	0	0	abacavir	HLA-B	PA448004	3106	0.927
NULL	Nat_Med_2012_Mar_25_18(4)_538-546.nxml.txt.nlp	22447074	SENT51	5	5	20	20	papain	IL-4	PA450778	3565	0.927
NULL	Evid_Based_Complement_Alternat_Med_2013_May_26_2013_161628.nxml.txt.nlp	23781255	SENT253	2	2	10	10	sorafenib	RAF1	PA7000	5894	0.927
NULL	Open_Access_J_Urol_2011_May_10_3_69-82.nxml.txt.nlp	24198638	SENT66	13	13	5	5	ifosfamide	CYP2B6	PA449964	1555	0.927
NULL	Lipids_Health_Dis_2011_Jan_18_10_8.nxml.txt.nlp	21241519	SENT104	11	11	6	6	simvastatin	ABCB4	PA451363	5244	0.927
NULL	Gut_Liver_2011_Jun_24_5(2)_160-164.nxml.txt.nlp	21814595	SENT107	12	12	43	43	meperidine	ESD	PA450369	2098	0.927
NULL	J_Cancer_2012_Jul_6_3_310-321.nxml.txt.nlp	22866165	SENT217	15	15	31	31	estradiol	CYP1B1	PA449503	1545	0.927
NULL	Ther_Clin_Risk_Manag_2007_Aug_3(4)_591-604.nxml.txt.nlp	18472981	SENT83	7	7	11	11	cyclosporine	P-gp	PA449167	5243	0.927
NULL	Int_J_Circumpolar_Health_2013_Aug_5_72_10_3402_ijch_v72i0_20854.nxml.txt.nlp	23984273	SENT167	17	17	11	11	erythromycin	19A	PA449493	57823	0.927
NULL	Int_J_Nanomedicine_2012_Nov_12_7_5733-5744.nxml.txt.nlp	23166438	SENT37	17	17	9	9	ethanol	Q10	PA448073	27161	0.927
NULL	Mol_Vis_2012_Apr_11_18_901-908.nxml.txt.nlp	22539869	SENT161	6	6	28	28	curcumin	HO-1	PA151958596	3162	0.927
NULL	Nat_Med_2012_Jul_18(7)_1118-1122.nxml.txt.nlp	22683780	SENT125	31	31	3	3	crizotinib	FGFR1	PA165946122	2260	0.927
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1107-1116.nxml.txt.nlp	22343619	SENT315	12	12	3	3	tamoxifen	IGF1R	PA451581	3480	0.927
NULL	J_Oncol_2013_Feb_17_2013_872957.nxml.txt.nlp	23476648	SENT104	2	2	15	15	cisplatin	SFN	PA449014	25996;2810	0.927
NULL	Curr_Pharm_Des_2008_Oct_14(28)_2983-2998.nxml.txt.nlp	18991714	SENT85	17	17	12	12	ekb-569	EGFR		1956	0.927
NULL	Br_J_Haematol_2008_Mar_3_144(5)_677-685.nxml.txt.nlp	19055662	SENT87	4	4	13	13	cyclophosphamide	CHOP	PA449165	1649	0.927
NULL	Adipocyte_2012_Jul_1_1(3)_182-187.nxml.txt.nlp	23700531	SENT46	26	26	17	17	lipase	ATGL	PA450239	57104	0.927
NULL	Breast_Cancer_Res_2011_Nov_1_13(6)_224.nxml.txt.nlp	22114931	SENT99	26	26	14	14	everolimus	TORC1	PA164746311	23373	0.927
NULL	Nat_Med_2011_Dec_18_18(1)_120-127.nxml.txt.nlp	22179318	SENT92	7	7	11	11	hemin	HO-1	PA449849	3162	0.927
NULL	J_Hematol_Oncol_2013_Jun_3_6_38.nxml.txt.nlp	23731980	SENT121	10	10	22	22	pertuzumab	HER2		2064	0.927
NULL	J_Hematol_Oncol_2013_Dec_17_6_93.nxml.txt.nlp	24341609	SENT23	28	28	9	9	erlotinib	EGFR	PA134687924	1956	0.927
NULL	Mol_Cancer_2010_May_28_9_127.nxml.txt.nlp	20509860	SENT47	12	12	4	4	mitomycin	FANCD2	PA450524	2177	0.927
NULL	Int_J_Environ_Res_Public_Health_2010_May_27_7(5)_1872-1888.nxml.txt.nlp	20622998	SENT91	5	5	35	35	ethanol	AMPK	PA448073	5563	0.927
NULL	Orphanet_J_Rare_Dis_2014_Oct_29_9(1)_162.nxml.txt.nlp	NULL	SENT253	10	10	19	19	rosuvastatin	CYP3A4	PA134308647	1576	0.927
NULL	Curr_Gerontol_Geriatr_Res_2012_Mar_4_2012_361218.nxml.txt.nlp	22474448	SENT130	14	14	1	1	estradiol	HSD17B1	PA449503	3292	0.927
NULL	Br_J_Cancer_2012_Jan_17_106(2)_274-278.nxml.txt.nlp	22215062	SENT22	17	17	10	10	cetuximab	EGFR	PA10040	1956	0.927
NULL	Indian_J_Pharm_Sci_2014_Mar-Apr_76(2)_125-131.nxml.txt.nlp	24843185	SENT180	3	3	24	24	resveratrol	S100B		6285	0.927
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Nov_11_65(Pt_12)_o3062.nxml.txt.nlp	21578792	SENT85	29	29	6	6	ethanol	mol	PA448073	90527	0.927
NULL	Infect_Drug_Resist_2011_Feb_3_4_43-53.nxml.txt.nlp	21694908	SENT117	6	6	1	1	rifampin	CYP3A4	PA451250	1576	0.927
NULL	Arthritis_Res_Ther_2009_Jun_29_11(3)_R100.nxml.txt.nlp	19563672	SENT145	14	14	0	0	infliximab	IFN	PA452639	3439	0.927
NULL	Front_Mol_Neurosci_2012_Nov_12_5_99.nxml.txt.nlp	23162427	SENT286	39	39	23	23	cocaine	CPP	PA449072	340451	0.927
NULL	Cell_Death_Dis_2012_May_3_3(5)_e303.nxml.txt.nlp	22552280	SENT54	2	2	16	16	phenformin	AMPK	PA1000	5563	0.927
NULL	Indian_J_Med_Res_2011_Dec_134(6)_878-897.nxml.txt.nlp	22310820	SENT344	4	4	9	9	suramin	CD4	PA10292	920	0.927
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_75-89.nxml.txt.nlp	17912638	SENT21	7	7	2	2	letrozole	aromatase	PA450196	1588	0.927
NULL	Cancers_(Basel)_2014_Apr_16_6(2)_926-957.nxml.txt.nlp	24743778	SENT1379	14	14	2	2	resveratrol	STAT3		6774	0.927
NULL	J_Lipid_Res_2013_Nov_54(11)_3085-3097.nxml.txt.nlp	23883581	SENT177	7	7	4	4	indomethacin	COX	PA449982	1351	0.927
NULL	Arthritis_2013_Nov_10_2013_154812.nxml.txt.nlp	24324885	SENT344	15	15	7	7	hyaluronan	CD44	PA165958431	960	0.927
NULL	Indian_J_Med_Res_2013_Jan_137(1)_125-129.nxml.txt.nlp	23481061	SENT11	20	20	6	6	cisplatin	GSTM1	PA449014	2944	0.927
NULL	Acta_Pharmacol_Sin_2010_Nov_18_31(11)_1447-1453.nxml.txt.nlp	20953204	SENT108	1	1	7	7	rimonabant	CB1	PA152407999	1268	0.927
NULL	Mol_Cancer_2012_Mar_21_11_13.nxml.txt.nlp	22436134	SENT226	12	12	28	28	doxorubicin	HuR	PA449412	1994	0.927
NULL	Cell_Death_Dis_2010_Nov_18_1(11)_e102.nxml.txt.nlp	21368867	SENT338	1	1	19	19	gentamicin	14-3-3	PA449753	10971	0.927
NULL	Carcinogenesis_2010_Dec_27_31(12)_2049-2057.nxml.txt.nlp	20876285	SENT32	30	30	7	7	tamoxifen	HER2	PA451581	2064	0.927
NULL	Oncotarget_2013_Nov_22_5(4)_933-943.nxml.txt.nlp	24659749	SENT43	17	17	5	5	nutlin-3	AML3		860	0.927
NULL	J_Int_Soc_Sports_Nutr_2013_Aug_22_10_39.nxml.txt.nlp	23967897	SENT136	20	20	5	5	betaine	ANOVA	PA448603	4858	0.927
NULL	Arthritis_Res_Ther_2009_Oct_14_11(5)_251.nxml.txt.nlp	19849819	SENT296	14	14	9	9	alendronate	PTH	PA448082	5741	0.927
NULL	Inflamm_Res_2013_Aug_11_62(10)_903-910.nxml.txt.nlp	23934070	SENT147	0	0	4	4	capsaicin	TRPV1	PA448776	7442	0.927
NULL	Oncotarget_2014_Jun_22_5(13)_4581-4602.nxml.txt.nlp	25015035	SENT390	14	14	22	22	temsirolimus	EGFR	PA164746890	1956	0.927
NULL	Onco_Targets_Ther_2014_May_28_7_841-852.nxml.txt.nlp	24920926	SENT20	3	3	27	27	gefitinib	EGFR	PA131301952	1956	0.927
NULL	Genet_Sel_Evol_2014_Mar_4_46(1)_19.nxml.txt.nlp	24592996	SENT165	29	29	12	12	taurine	PCDHB13	PA451590	56123	0.927
NULL	Br_J_Cancer_2013_May_14_108(9)_1771-1777.nxml.txt.nlp	23612453	SENT132	11	11	9	9	letrozole	aromatase	PA450196	1588	0.927
NULL	Front_Oncol_2014_Mar_3_4_34.nxml.txt.nlp	24624361	SENT84	38	38	14	14	cisplatin	p53	PA449014	7157	0.927
NULL	Leukemia_2014_Aug_7_28(8)_1636-1646.nxml.txt.nlp	24418989	SENT88	25	25	2	2	chloroquine	SQSTM1	PA448948	8878	0.927
NULL	Oncotarget_2013_Nov_22_5(4)_933-943.nxml.txt.nlp	24659749	SENT113	9	9	2	2	nutlin-3	AML3		860	0.927
NULL	Environ_Health_Perspect_1976_Dec_18_167-179.nxml.txt.nlp	1037611	SENT6	0	0	14	14	diethylstilbestrol	DES	PA449307	1674	0.927
NULL	Commun_Integr_Biol_2013_Sep_1_6(5)_e25145.nxml.txt.nlp	24255740	SENT60	10	10	25	25	neomycin	DAG	PA450608	1605	0.927
NULL	Korean_J_Radiol_2010_Oct_29_Nov-Dec_11(6)_640-647.nxml.txt.nlp	21076590	SENT138	5	5	20	20	remifentanil	IL-10	PA451232	3586	0.927
NULL	Nat_Commun_2014_Nov_25_5_5548.nxml.txt.nlp	25420520	SENT105	47	47	4	4	docetaxel	ERG	PA449383	2078	0.927
NULL	Breast_Cancer_Res_2002_Aug_27_4(6)_213-217.nxml.txt.nlp	12473165	SENT131	0	0	21	21	tamoxifen	aromatase	PA451581	1588	0.927
NULL	Exp_Ther_Med_2015_Jan_18_9(1)_105-111.nxml.txt.nlp	25452783	SENT124	17	17	3	3	celecoxib	ABCG2	PA448871	9429	0.927
NULL	Acta_Pharmacol_Sin_2012_Jan_28_33(1)_75-81.nxml.txt.nlp	22120969	SENT184	19	19	14	14	exenatide	GLP-1	PA164749238	100125288	0.927
NULL	Adv_Synth_Catal_2013_Nov_11_355(16)_3095-3118.nxml.txt.nlp	24971045	SENT206	18	18	8	8	benzaldehyde	mol	PA448571	90527	0.927
NULL	Arthritis_Res_Ther_2014_Sep_26_16(5)_429.nxml.txt.nlp	25606593	SENT104	21	21	16	16	anakinra	IL-6	PA10799	3569	0.926
NULL	Arthritis_Res_Ther_2013_Jan_8_15(1)_R5.nxml.txt.nlp	23298463	SENT144	0	0	7	7	tamoxifen	MMP13	PA451581	4322	0.926
NULL	J_Cell_Mol_Med_2013_Jan_11_17(1)_134-146.nxml.txt.nlp	23305490	SENT12	10	10	32	32	curcumin	TREK-1	PA151958596	3776	0.926
NULL	Nucleic_Acids_Res_2010_Oct_4_38(19)_6375-6388.nxml.txt.nlp	20525792	SENT271	36	36	14	14	doxycycline	YY1	PA449415	7528	0.926
NULL	J_Oncol_2013_Aug_20_2013_732047.nxml.txt.nlp	24027583	SENT192	0	0	13	13	ertumaxomab	HER2	PA165291442	2064	0.926
NULL	Mol_Biol_Cell_2012_Jul_15_23(14)_2692-2701.nxml.txt.nlp	22621896	SENT148	31	31	3	3	doxycycline	CO2	PA449415	4513	0.926
NULL	Ther_Clin_Risk_Manag_2006_Sep_2(3)_235-249.nxml.txt.nlp	18360599	SENT335	13	13	5	5	teriparatide	PTH	PA451620	5741	0.926
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1717-1723.nxml.txt.nlp	19844230	SENT123	15	15	40	40	pazopanib	GM-CSF	PA165291492	1437	0.926
NULL	Int_J_Mol_Sci_2012_Apr_19_13(4)_4949-4967.nxml.txt.nlp	22606022	SENT102	15	15	0	0	resveratrol	GPE		2996	0.926
NULL	Osteoporos_Int_2012_May_19_23(5)_1613-1622.nxml.txt.nlp	21769661	SENT163	14	14	21	21	teriparatide	VCF	PA451620	7413	0.926
NULL	Front_Neurosci_2011_Jan_14_4_207.nxml.txt.nlp	21258618	SENT164	22	22	13	13	ethanol	CRF1	PA448073	1394	0.926
NULL	Oncotarget_2014_Oct_21_5(22)_11252-11268.nxml.txt.nlp	25361004	SENT135	29	29	6	6	metformin	CLIC1	PA450395	1192	0.926
NULL	Nat_Commun_2013_Aug_15_4_2130.nxml.txt.nlp	23945651	SENT224	23	23	10	10	etoposide	survivin	PA449552	332	0.926
NULL	Oncogene_2014_Aug_28_33(35)_4407-4417.nxml.txt.nlp	24469038	SENT244	34	34	17	17	cisplatin	p53	PA449014	7157	0.926
NULL	Acta_Pharmacol_Sin_2012_Aug_23_33(8)_1095-1100.nxml.txt.nlp	22820908	SENT112	23	23	14	14	clarithromycin	CYP2C19	PA449028	1557	0.926
NULL	J_Adv_Pract_Oncol_2013_Nov_1_Nov-Dec_4(6)_451-455.nxml.txt.nlp	25032026	SENT26	3	3	10	10	dasatinib	KIT	PA162372878	3815	0.926
NULL	Oncoimmunology_2013_Jan_1_2(1)_e23033.nxml.txt.nlp	23483678	SENT0	19	19	12	12	carboplatin	CD40	PA448803	958	0.926
NULL	Lipids_Health_Dis_2011_Jan_18_10_8.nxml.txt.nlp	21241519	SENT117	24	24	19	19	simvastatin	ABCG1	PA451363	9619	0.926
NULL	Int_J_Breast_Cancer_2011_Sep_6_2011_352182.nxml.txt.nlp	22295219	SENT119	16	16	1	1	hyaluronan	HER2	PA165958431	2064	0.926
NULL	Diabetes_Care_2010_Aug_33(8)_1908-1910.nxml.txt.nlp	20668159	SENT63	10	10	4	4	ramipril	DREAM	PA451223	30818	0.926
NULL	Breast_Cancer_Res_2007_Jun_4_9(3)_207.nxml.txt.nlp	17561991	SENT46	40	40	21	21	trastuzumab	CISH	PA451743	1154	0.926
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT93	6	6	11	11	dasatinib	ABCG2	PA162372878	9429	0.926
NULL	Mol_Cancer_2012_Oct_22_11_80.nxml.txt.nlp	23088607	SENT67	14	14	27	27	fulvestrant	HIF-1	PA164747170	29072	0.926
NULL	Br_J_Cancer_1987_Mar_55(3)_255-257.nxml.txt.nlp	3567059	SENT12	27	27	8	8	tamoxifen	IFN	PA451581	3439	0.926
NULL	Cancer_Cell_Int_2006_Aug_9_6_20.nxml.txt.nlp	16899133	SENT180	13	13	21	21	metformin	p27	PA450395	5715;10534	0.926
NULL	Allergy_Asthma_Clin_Immunol_2013_Apr_8_9(1)_13.nxml.txt.nlp	23566643	SENT52	33	33	17	17	albendazole	STH	PA164746058	246744	0.926
NULL	Acta_Pharmacol_Sin_2010_Mar_22_31(3)_329-340.nxml.txt.nlp	20173759	SENT150	10	10	28	28	ethanol	AMPK	PA448073	5563	0.926
NULL	Breast_Cancer_Res_2007_Mar_2_9(2)_205.nxml.txt.nlp	NULL	SENT40	18	18	5	5	erlotinib	EGFR	PA134687924	1956	0.926
NULL	Biomed_Res_Int_2013_Sep_8_2013_639725.nxml.txt.nlp	24083233	SENT23	4	4	30	30	iron	ROS	PA450087	6098	0.926
NULL	J_Cell_Biol_2008_Jul_28_182(2)_367-379.nxml.txt.nlp	18644892	SENT226	12	12	0	0	pp2	PP2		4888	0.926
NULL	Support_Care_Cancer_2012_Sep_17_20(9)_1991-1997.nxml.txt.nlp	22089428	SENT135	25	25	19	19	trastuzumab	HER-2	PA451743	2064	0.926
NULL	Br_J_Cancer_2011_Oct_25_105(9)_1331-1337.nxml.txt.nlp	21970881	SENT74	38	38	3	3	dextran	CD34	PA449261	947	0.926
NULL	Genome_Biol_2011_May_25_12(5)_R46.nxml.txt.nlp	21609475	SENT136	8	8	3	3	etoposide	CCND1	PA449552	595	0.926
NULL	Open_Cardiovasc_Med_J_2007_Nov_14_1_22-26.nxml.txt.nlp	18949087	SENT78	9	9	1	1	eprosartan	PON1	PA449481	5444	0.926
NULL	J_Korean_Med_Sci_2014_Jul_11_29(7)_965-972.nxml.txt.nlp	25045229	SENT109	4	4	20	20	metformin	B12	PA450395	7126;4709	0.926
NULL	Cancer_Immunol_Immunother_2013_Aug_27_62(10)_1637-1648.nxml.txt.nlp	23982484	SENT128	18	18	9	9	lenalidomide	IL-2	PA162363968	3558	0.926
NULL	Am_J_Cardiovasc_Drugs_2013_Jun_20_13(5)_331-342.nxml.txt.nlp	23784266	SENT183	10	10	6	6	verapamil	P-gp	PA451868	5243	0.926
NULL	Clin_Exp_Otorhinolaryngol_2011_Dec_15_4(4)_177-183.nxml.txt.nlp	22232712	SENT161	3	3	13	13	doxycycline	MUC5B	PA449415	727897	0.926
NULL	Cardiol_Res_Pract_2013_Jan_31_2013_128795.nxml.txt.nlp	23431496	SENT123	20	20	30	30	clopidogrel	CYP2C19	PA449053	1557	0.926
NULL	Breast_Cancer_Res_2011_Mar_11_13(2)_R30.nxml.txt.nlp	21396117	SENT228	3	3	19	19	erlotinib	BRCA1	PA134687924	672	0.926
NULL	Database_(Oxford)_2014_Dec_23_2014_bau124.nxml.txt.nlp	25539768	SENT129	10	10	7	7	erlotinib	EGFR	PA134687924	1956	0.926
NULL	Diabetes_2011_May_23_60(5)_1519-1527.nxml.txt.nlp	21430087	SENT26	18	18	4	4	lipase	adiponectin	PA450239	9370	0.926
NULL	Oncotarget_2013_Apr_23_4(6)_816-829.nxml.txt.nlp	23615731	SENT115	18	18	5	5	doxycycline	HSF1	PA449415	3297	0.926
NULL	Cancers_(Basel)_2014_Apr_16_6(2)_926-957.nxml.txt.nlp	24743778	SENT990	18	18	8	8	tamoxifen	CD24	PA451581	100133941	0.926
NULL	Drugs_R_D_2011_Dec_27_11(4)_295-302.nxml.txt.nlp	22007990	SENT16	10	10	22	22	tipranavir	CCR5	PA163522473	1234	0.926
NULL	Pharmaceutics_2011_Oct_12_3(4)_680-705.nxml.txt.nlp	24309303	SENT575	5	5	16	16	itraconazole	CYP2C9	PA450132	1559	0.926
NULL	Int_J_Endocrinol_2014_Mar_11_2014_927317.nxml.txt.nlp	24738001	SENT145	20	20	8	8	sitagliptin	GLP-1	PA164748978	100125288	0.926
NULL	Clin_Drug_Investig_2015_Dec_4_35_45-51.nxml.txt.nlp	25471740	SENT146	34	34	26	26	rosiglitazone	CYP2C19	PA451283	1557	0.926
NULL	Dermatoendocrinol_2012_Jan_1_4(1)_8-9.nxml.txt.nlp	22870345	SENT35	10	10	15	15	atorvastatin	SR-BI	PA448500	949	0.926
NULL	Acta_Pharmacol_Sin_2014_Jun_5_35(6)_727-737.nxml.txt.nlp	24793312	SENT171	24	24	5	5	telmisartan	Bcl-2	PA451605	596	0.926
NULL	Front_Syst_Neurosci_2014_Dec_22_8_238.nxml.txt.nlp	25565991	SENT1086	8	8	4	4	rimonabant	CB1	PA152407999	1268	0.926
NULL	Int_J_Endocrinol_2014_Feb_18_2014_232454.nxml.txt.nlp	24695544	SENT118	19	19	28	28	metformin	SIRT1	PA450395	23411	0.926
NULL	Mol_Cancer_2013_Nov_11_12_134.nxml.txt.nlp	24215614	SENT186	35	35	10	10	lapatinib	PTEN	PA152241907	5728	0.926
NULL	Ther_Clin_Risk_Manag_2007_Mar_3(1)_133-148.nxml.txt.nlp	18360621	SENT97	17	17	1	1	adalimumab	STAR	PA10004	6770;2984	0.926
NULL	Cell_Mol_Life_Sci_2012_Apr_1_69(8)_1377-1389.nxml.txt.nlp	22130515	SENT101	15	15	9	9	tamoxifen	TBX3	PA451581	6926	0.926
NULL	Mol_Cell_Proteomics_2012_Feb_6_11(2)_M111_015222.nxml.txt.nlp	22147731	SENT167	4	4	11	11	cetuximab	EGFR	PA10040	1956	0.926
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Aug_17_69(Pt_9)_o1442.nxml.txt.nlp	24427070	SENT70	19	19	6	6	ethanol	mol	PA448073	90527	0.926
NULL	Indian_J_Pharmacol_2013_Nov-Dec_45(6)_597-602.nxml.txt.nlp	24347768	SENT23	24	24	3	3	epirubicin	P-gp	PA449476	5243	0.926
NULL	Amino_Acids_2012_Oct_10_43(4)_1751-1759.nxml.txt.nlp	22407485	SENT187	29	29	5	5	carrageenan	ghrelin	PA448814	51738	0.926
NULL	Oncotarget_2011_Dec_31_2(12)_894-895.nxml.txt.nlp	22248868	SENT3	20	20	2	2	erlotinib	EGFR	PA134687924	1956	0.926
NULL	Breast_Cancer_Res_Treat_2013_May_12_139(1)_107-113.nxml.txt.nlp	23580070	SENT195	2	2	16	16	trastuzumab	HER-2	PA451743	2064	0.926
NULL	Oncotarget_2013_Jan_14_4(1)_118-127.nxml.txt.nlp	23435217	SENT20	0	0	3	3	erlotinib	EGFR	PA134687924	1956	0.926
NULL	Sci_Rep_2014_Nov_28_4_7237.nxml.txt.nlp	25429875	SENT121	12	12	29	29	hesperidin	vRNA	PA449867	56664	0.926
NULL	Cost_Eff_Resour_Alloc_2006_May_31_4_9.nxml.txt.nlp	16737538	SENT127	39	39	29	29	celecoxib	OTC	PA448871	5009	0.926
NULL	J_Cancer_2013_Sep_27_4(8)_662-670.nxml.txt.nlp	24155778	SENT203	9	9	17	17	cisplatin	UCHL1	PA449014	7345	0.926
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_May_29_65(Pt_6)_o1402.nxml.txt.nlp	21583247	SENT60	26	26	13	13	ethanol	mol	PA448073	90527	0.926
NULL	Clinicoecon_Outcomes_Res_2014_Oct_17_6_451-461.nxml.txt.nlp	25378939	SENT140	12	12	25	25	linezolid	HAP	PA450233	5915;10313	0.926
NULL	Basic_Clin_Pharmacol_Toxicol_2013_Feb_5_112(2)_132-137.nxml.txt.nlp	22900583	SENT169	21	21	0	0	tramadol	CYP2B6	PA451735	1555	0.926
NULL	Nat_Biotechnol_2013_Jul_30_31(7)_630-637.nxml.txt.nlp	23811600	SENT191	3	3	9	9	crizotinib	NTRK3	PA165946122	4916	0.926
NULL	Drug_Saf_2014_Feb_19_37(4)_201-211.nxml.txt.nlp	24550106	SENT131	10	10	26	26	esomeprazole	CYP2E1	PA10075	1571	0.926
NULL	J_Hematol_Oncol_2013_Jun_3_6_38.nxml.txt.nlp	23731980	SENT144	17	17	32	32	lapatinib	HER2	PA152241907	2064	0.926
NULL	Breast_Cancer_Res_2011_Nov_1_13(6)_224.nxml.txt.nlp	22114931	SENT104	20	20	11	11	lapatinib	HER2	PA152241907	2064	0.926
NULL	Cancer_Med_2014_Aug_9_3(4)_825-834.nxml.txt.nlp	24810801	SENT26	29	29	22	22	brivanib	VEGFR2	PA164924492	3791	0.926
NULL	Clin_Med_Insights_Oncol_2013_Aug_21_7_235-245.nxml.txt.nlp	24179414	SENT52	22	22	32	32	gemfibrozil	CYP3A4	PA449750	1576	0.926
NULL	Pharmaceuticals_(Basel)_2013_Apr_8_6(4)_500-509.nxml.txt.nlp	24276120	SENT294	1	1	9	9	fenoldopam	DA1	PA164784034	28495;7169	0.926
NULL	Oncogene_2010_Sep_16_29(37)_5193-5203.nxml.txt.nlp	20581867	SENT21	8	8	2	2	lapatinib	HER2	PA152241907	2064	0.926
NULL	Breast_Cancer_Res_2010_Jun_28_12(3)_R43.nxml.txt.nlp	20579400	SENT28	12	12	17	17	paclitaxel	MAPT	PA450761	4137	0.926
NULL	Oncotarget_2014_Nov_8_5(21)_10280-10292.nxml.txt.nlp	25373733	SENT3	3	3	9	9	bortezomib	HIF-1	PA10252	29072	0.926
NULL	Hum_Reprod_Update_2008_Sep_26_Nov-Dec_14(6)_605-621.nxml.txt.nlp	18820005	SENT247	14	14	31	31	letrozole	Casper	PA450196	8837	0.926
NULL	BMB_Rep_2013_Aug_46(8)_410-415.nxml.txt.nlp	23977989	SENT58	12	12	4	4	curcumin	HO-1	PA151958596	3162	0.926
NULL	Ann_Hematol_2011_Feb_17_90(2)_173-183.nxml.txt.nlp	20714724	SENT130	10	10	30	30	resveratrol	ZAP-70		7535	0.926
NULL	Oncoimmunology_2013_Dec_1_2(12)_e26663.nxml.txt.nlp	24498552	SENT15	11	11	32	32	doxorubicin	DNAM-1	PA449412	10666	0.926
NULL	Cancers_(Basel)_2014_Apr_9_6(2)_829-859.nxml.txt.nlp	24722453	SENT2099	22	22	13	13	etoposide	PC-3	PA449552	692094	0.926
NULL	Breast_Cancer_2014_Feb_13_21(6)_703-714.nxml.txt.nlp	23404211	SENT166	24	24	11	11	toremifene	aromatase	PA451731	1588	0.926
NULL	Neuroscience_2009_Jun_30_161(2-3)_572-577.nxml.txt.nlp	19327387	SENT59	8	8	14	14	capsaicin	NAPE-PLD	PA448776	222236	0.926
NULL	Indian_J_Endocrinol_Metab_2013_Dec_17(Suppl_3)_S674-S679.nxml.txt.nlp	24910836	SENT144	45	45	26	26	metformin	PPG	PA450395	5552	0.926
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Jul_9_3(7)_e124.nxml.txt.nlp	25006781	SENT13	18	18	3	3	rosuvastatin	OATP1B1	PA134308647	10599	0.926
NULL	Cardiovasc_J_Afr_2013_Apr_24(3)_78-81.nxml.txt.nlp	23736131	SENT18	25	25	35	35	hemin	HO-1	PA449849	3162	0.926
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_79-85.nxml.txt.nlp	23864840	SENT22	0	0	13	13	pemetrexed	EGFR	PA10810	1956	0.926
NULL	Ann_Coloproctol_2013_Oct_31_29(5)_192-197.nxml.txt.nlp	24278857	SENT35	20	20	29	29	capecitabine	LARC	PA448771	6364	0.926
NULL	Indian_J_Dermatol_2013_Sep-Oct_58(5)_388-392.nxml.txt.nlp	24082187	SENT96	27	27	13	13	imatinib	LDE	PA10804	7957	0.926
NULL	Biol_Open_2012_Jun_28_1(8)_789-801.nxml.txt.nlp	23213472	SENT156	1	1	23	23	tetracycline	PER1	PA451640	93210;5187	0.926
NULL	Oncol_Lett_2014_Mar_2_7(3)_791-796.nxml.txt.nlp	24527087	SENT112	8	8	28	28	imatinib	CD34	PA10804	947	0.926
NULL	Front_Pharmacol_2014_Oct_20_5_230.nxml.txt.nlp	25368579	SENT93	9	9	16	16	berberine	IL-6	PA165860812	3569	0.926
NULL	J_Cell_Mol_Med_2014_Sep_3_18(9)_1840-1850.nxml.txt.nlp	24894955	SENT254	18	18	4	4	ethanol	TFR1	PA448073	7037	0.926
NULL	Mol_Cancer_2007_Oct_11_6_63.nxml.txt.nlp	17931419	SENT117	16	16	2	2	cetuximab	HIF-1	PA10040	29072	0.926
NULL	Mol_Cancer_2014_Aug_16_13(1)_193.nxml.txt.nlp	NULL	SENT143	12	12	6	6	cisplatin	RKIP	PA449014	5037	0.926
NULL	J_Biol_Chem_2009_Mar_20_284(12)_7623-7630.nxml.txt.nlp	19131342	SENT81	1	1	21	21	pentobarbital	H-PGDS	PA450859	27306	0.926
NULL	J_Clin_Biochem_Nutr_2008_Mar_1_42(2)_71-75.nxml.txt.nlp	18385822	SENT27	24	24	12	12	lansoprazole	CD11b	PA450180	3684	0.926
NULL	Mol_Cancer_2012_May_14_11_33.nxml.txt.nlp	22583829	SENT33	22	22	18	18	cisplatin	TLR4	PA449014	7099	0.926
NULL	Acta_Pharmacol_Sin_2011_Jul_9_32(7)_879-887.nxml.txt.nlp	21552292	SENT176	3	3	8	8	metformin	AMPK	PA450395	5563	0.926
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_15_2012_769508.nxml.txt.nlp	22203879	SENT103	19	19	1	1	l-glutamine	IL-4	PA10090	3565	0.926
NULL	Int_J_Mol_Sci_2014_Mar_26_15(4)_5292-5303.nxml.txt.nlp	24675697	SENT79	39	39	24	24	paclitaxel	BECN1	PA450761	8678	0.926
NULL	Curr_Control_Trials_Cardiovasc_Med_2001_Feb_2_2(1)_20-23.nxml.txt.nlp	11806769	SENT35	42	42	25	25	bucindolol	BEST	PA165945764	7439	0.926
NULL	J_Mol_Signal_2010_Jul_12_5_8.nxml.txt.nlp	20624308	SENT126	13	13	18	18	gefitinib	Met	PA131301952	79811	0.926
NULL	Breast_Cancer_Res_2007_Mar_2_9(2)_205.nxml.txt.nlp	NULL	SENT115	24	24	8	8	lapatinib	HER-2	PA152241907	2064	0.926
NULL	Cell_Death_Dis_2014_Mar_13_5(3)_e1125.nxml.txt.nlp	24625984	SENT57	11	11	43	43	glucose	CD40LG	PA449773	959	0.926
NULL	J_Hum_Genet_2013_Jun_16_58(6)_353-361.nxml.txt.nlp	23677058	SENT135	19	19	4	4	busulfan	GSTT1	PA448691	2952	0.926
NULL	Br_J_Cancer_2009_Jul_21_101(2)_269-277.nxml.txt.nlp	19603033	SENT196	8	8	3	3	cisplatin	MLH1	PA449014	4292	0.926
NULL	Breast_Cancer_Res_2014_Oct_3_16(5)_452.nxml.txt.nlp	25277819	SENT30	7	7	5	5	anastrozole	aromatase	PA448432	1588	0.926
NULL	Br_J_Cancer_2011_Jun_28_105(1)_1-8.nxml.txt.nlp	21654681	SENT148	33	33	15	15	erlotinib	EGFR	PA134687924	1956	0.926
NULL	Oncotarget_2014_Feb_25_5(5)_1304-1314.nxml.txt.nlp	24675421	SENT10	9	9	13	13	cisplatin	JNK	PA449014	5599	0.926
NULL	J_Hematol_Oncol_2013_Jul_10_6_50.nxml.txt.nlp	23841999	SENT15	6	6	0	0	gefitinib	EGF	PA131301952	1950	0.926
NULL	Acta_Pharmacol_Sin_2014_Aug_7_35(8)_1023-1030.nxml.txt.nlp	24998255	SENT187	28	28	12	12	octreotide	STAT3	PA450678	6774	0.926
NULL	Breast_Cancer_Res_2014_Sep_12_16(5)_436.nxml.txt.nlp	25213081	SENT264	10	10	5	5	tamoxifen	CD44	PA451581	960	0.926
NULL	Cancer_Imaging_2005_Nov_23_5(Spec_No_A)_S27-S32.nxml.txt.nlp	16361133	SENT124	17	17	6	6	choline	FDG	PA448976	23583	0.926
NULL	Nat_Genet_2011_Feb_26_43(2)_117-120.nxml.txt.nlp	21186350	SENT24	22	22	9	9	metformin	ATM	PA450395	472	0.926
NULL	Cancers_(Basel)_2011_Apr_1_3(2)_1844-1860.nxml.txt.nlp	24212785	SENT12	24	24	35	35	cetuximab	EGFR	PA10040	1956	0.926
NULL	Int_J_Environ_Res_Public_Health_2005_May_30_2(1)_51-57.nxml.txt.nlp	16705801	SENT61	20	20	34	34	gentamicin	CO2	PA449753	4513	0.926
NULL	Biomed_Res_Int_2013_Mar_18_2013_720975.nxml.txt.nlp	23586055	SENT6	2	2	14	14	ceftazidime	CXCL8	PA448861	3576	0.926
NULL	Oxid_Med_Cell_Longev_2013_Nov_28_2013_568093.nxml.txt.nlp	24379901	SENT83	2	2	13	13	resveratrol	SIRT1		23411	0.926
NULL	J_Cell_Mol_Med_2014_May_14_18(5)_811-823.nxml.txt.nlp	24628949	SENT156	16	16	7	7	docetaxel	MCAK	PA449383	11004	0.926
NULL	Cancers_(Basel)_2011_Oct_21_3(4)_3921-3956.nxml.txt.nlp	24213118	SENT123	4	4	13	13	imatinib	Mcl-1	PA10804	4170	0.926
NULL	Oncol_Lett_2013_Feb_5_5(2)_424-426.nxml.txt.nlp	23420786	SENT49	20	20	0	0	dacarbazine	IL-2	PA449197	3558	0.926
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT185	17	17	13	13	sitagliptin	HIP	PA164748978	6767;6159;64399;5068	0.926
NULL	Biomed_Res_Int_2014_Feb_6_2014_323594.nxml.txt.nlp	24689036	SENT200	28	28	14	14	raloxifene	PC3	PA451221	57332;7832;5122	0.926
NULL	Adv_Hematol_2011_Apr_10_2011_960137.nxml.txt.nlp	21547266	SENT27	13	13	5	5	chlorambucil	NHL	PA448926	51750	0.926
NULL	Biomed_Res_Int_2013_Nov_28_2013_789184.nxml.txt.nlp	24369535	SENT115	17	17	4	4	imatinib	CYP3A4	PA10804	1576	0.926
NULL	Arthritis_Res_Ther_2011_Feb_16_13(1)_R25.nxml.txt.nlp	21324169	SENT140	46	46	11	11	abatacept	TNF	PA164747080	7124	0.926
NULL	Acta_Pharmacol_Sin_2009_May_5_30(5)_646-652.nxml.txt.nlp	19417737	SENT9	28	28	2	2	midazolam	CYP3A4	PA450496	1576	0.926
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT82	13	13	24	24	celecoxib	IL-6	PA448871	3569	0.926
NULL	Eur_J_Neurosci_2008_Sep_28(6)_1146-1156.nxml.txt.nlp	18783372	SENT271	38	38	13	13	clotrimazole	ADP	PA449057	23038	0.926
NULL	J_Hematol_Oncol_2010_Apr_9_3_14.nxml.txt.nlp	20377918	SENT58	10	10	4	4	imatinib	IFN	PA10804	3439	0.926
NULL	J_Oncol_2010_Aug_24_2010_654348.nxml.txt.nlp	20871846	SENT69	16	16	2	2	anastrozole	ATAC	PA448432	6375	0.926
NULL	Cancers_(Basel)_2012_Feb_22_4(1)_218-243.nxml.txt.nlp	24213237	SENT214	5	5	17	17	ganciclovir	CD11b	PA449733	3684	0.926
NULL	Toxins_(Basel)_2010_Oct_28_2(11)_2584-2592.nxml.txt.nlp	22069565	SENT69	1	1	21	21	warfarin	CYP2C9	PA451906	1559	0.926
NULL	Eur_J_Clin_Pharmacol_2012_Sep_15_68(9)_1267-1274.nxml.txt.nlp	22418828	SENT204	27	27	8	8	pantoprazole	MDR1	PA450774	5243	0.926
NULL	J_Med_Life_2011_Feb_15_4(1)_11-20.nxml.txt.nlp	21505570	SENT190	9	9	2	2	ketoprofen	COX	PA450149	1351	0.926
NULL	Br_J_Cancer_2012_Feb_14_106(4)_685-692.nxml.txt.nlp	22294184	SENT172	36	36	20	20	docetaxel	p53	PA449383	7157	0.926
NULL	Br_J_Haematol_2008_Jun_141(5)_659-671.nxml.txt.nlp	18410446	SENT110	37	37	9	9	thalidomide	CD138	PA451644	6382	0.926
NULL	Int_J_Breast_Cancer_2012_May_9_2012_415170.nxml.txt.nlp	22649737	SENT56	6	6	21	21	trastuzumab	HER2	PA451743	2064	0.926
NULL	J_Invest_Dermatol_2014_Feb_10_134(2)_319-325.nxml.txt.nlp	24108405	SENT90	10	10	25	25	vemurafenib	MEK1	PA165946873	5604	0.926
NULL	J_Biol_Chem_2013_Feb_22_288(8)_5562-5571.nxml.txt.nlp	23319583	SENT35	16	16	3	3	denosumab	RANK	PA166048634	8792	0.926
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_7-17.nxml.txt.nlp	17912633	SENT72	4	4	11	11	letrozole	aromatase	PA450196	1588	0.926
NULL	Neural_Regen_Res_2013_Jul_15_8(20)_1853-1862.nxml.txt.nlp	25206494	SENT113	28	28	5	5	ethanol	JNK	PA448073	5599	0.926
NULL	Ann_Oncol_2013_Aug_12_24(8)_1994-1999.nxml.txt.nlp	23670096	SENT71	7	7	21	21	tamoxifen	STEPP	PA451581	222659	0.926
NULL	F1000Res_2013_Oct_29_2_229.nxml.txt.nlp	25339983	SENT626	24	24	13	13	collagenase	AP-1	PA449107	2353;3727;2354;3725	0.926
NULL	Arthritis_Res_Ther_2012_May_1_14(3)_R99.nxml.txt.nlp	22546542	SENT59	40	40	10	10	infliximab	IL-2	PA452639	3558	0.926
NULL	J_Korean_Med_Sci_2010_Jun_24_25(6)_846-852.nxml.txt.nlp	20514304	SENT150	21	21	9	9	cisplatin	GSTP1	PA449014	2950	0.926
NULL	Cancer_Cell_Int_2011_Aug_19_11_29.nxml.txt.nlp	21854619	SENT249	29	29	15	15	doxorubicin	HDAC	PA449412	9734	0.926
NULL	Indian_J_Pharmacol_2014_Nov-Dec_46(6)_627-632.nxml.txt.nlp	25538335	SENT137	37	37	40	40	metformin	Q10	PA450395	27161	0.926
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Sep_30_67(Pt_10)_o2750.nxml.txt.nlp	22058808	SENT52	23	23	6	6	ethanol	mol	PA448073	90527	0.926
NULL	J_Invest_Dermatol_2012_Nov_21_132(11)_2642-2651.nxml.txt.nlp	22718118	SENT245	13	13	0	0	collagenase	CD11b	PA449107	3684	0.926
NULL	Front_Oncol_2014_Mar_3_4_35.nxml.txt.nlp	24624362	SENT102	17	17	13	13	panitumumab	KRAS	PA162373091	3845	0.926
NULL	Front_Oncol_2014_Oct_24_4_295.nxml.txt.nlp	25386409	SENT83	18	18	23	23	docetaxel	CYP17A1	PA449383	1586	0.926
NULL	J_Geriatr_Cardiol_2012_Dec_9(4)_321-327.nxml.txt.nlp	23341835	SENT121	11	11	3	3	furosemide	APE	PA449719	55704;328	0.926
NULL	Biomed_Res_Int_2014_May_18_2014_291280.nxml.txt.nlp	24949432	SENT162	38	38	8	8	tamoxifen	HER2	PA451581	2064	0.926
NULL	J_Cell_Mol_Med_2014_Oct_11_18(10)_2031-2043.nxml.txt.nlp	25109475	SENT184	3	3	27	27	valsartan	AMPK	PA451848	5563	0.926
NULL	Nat_Commun_2013_Nov_19_4_2773.nxml.txt.nlp	24253479	SENT129	15	15	41	41	cyclosporine	ITGA2B	PA449167	3674	0.926
NULL	Oncotarget_2011_Apr_10_2(4)_321-328.nxml.txt.nlp	21487159	SENT65	18	18	11	11	estradiol	INPP4B	PA449503	8821	0.926
NULL	Arthritis_Res_Ther_2012_Jun_12_14(3)_R141.nxml.txt.nlp	22691241	SENT11	4	4	6	6	abatacept	CTLA4	PA164747080	1493	0.926
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1495-1502.nxml.txt.nlp	21989186	SENT81	8	8	30	30	panitumumab	KRAS	PA162373091	3845	0.926
NULL	Mol_Cancer_2007_Sep_26_6_61.nxml.txt.nlp	17894897	SENT193	26	26	8	8	etoposide	survivin	PA449552	332	0.926
NULL	Eur_J_Med_Res_2009_Nov_24_14(Suppl_3)_36-42.nxml.txt.nlp	19959415	SENT110	19	19	17	17	gs-9350	CYP3A		1574	0.926
NULL	Br_J_Cancer_2013_Dec_10_109(12)_2959-2964.nxml.txt.nlp	24157828	SENT31	33	33	26	26	tamoxifen	aromatase	PA451581	1588	0.926
NULL	Br_J_Cancer_2012_Jan_3_106(1)_6-13.nxml.txt.nlp	22215104	SENT70	0	0	25	25	neratinib	HER2	PA165291472	2064	0.926
NULL	J_Inherit_Metab_Dis_2012_Jan_10_35(1)_141-149.nxml.txt.nlp	21556832	SENT28	2	2	20	20	creatine	CRTR	PA164778930	6535	0.926
NULL	Cases_J_2008_Sep_30_1_195.nxml.txt.nlp	18826630	SENT25	23	23	15	15	levomepromazine	hang	PA134687942	374879	0.926
NULL	Ann_Oncol_2013_Aug_12_24(8)_1994-1999.nxml.txt.nlp	23670096	SENT92	10	10	1	1	tamoxifen	AIB1	PA451581	8202	0.926
NULL	Mol_Cancer_2013_Nov_5_12_133.nxml.txt.nlp	24192080	SENT190	21	21	8	8	leflunomide	STAT6	PA450192	6778	0.926
NULL	Oncotarget_2013_Nov_19_5(2)_309-325.nxml.txt.nlp	24525395	SENT207	6	6	30	30	curcumin	Mcl-1	PA151958596	4170	0.926
NULL	Indian_J_Pharmacol_2013_Mar-Apr_45(2)_155-158.nxml.txt.nlp	23716892	SENT119	13	13	25	25	voriconazole	CYP3A4	PA10233	1576	0.926
NULL	Oncogene_2013_Sep_12_32(37)_4366-4376.nxml.txt.nlp	23085756	SENT307	20	20	27	27	doxycycline	GRM1	PA449415	2911	0.926
NULL	Mol_Cancer_2009_Nov_10_8_99.nxml.txt.nlp	19903356	SENT8	26	26	10	10	imatinib	IGFBP3	PA10804	3486	0.926
NULL	Clin_Med_Insights_Cardiol_2011_Jun_28_5_55-66.nxml.txt.nlp	21792345	SENT58	33	33	17	17	bucindolol	ADRB1	PA165945764	153	0.926
NULL	Clin_Sci_(Lond)_2009_Apr_1_116(Pt_8)_607-620.nxml.txt.nlp	19275766	SENT228	5	5	19	19	atorvastatin	AMPK	PA448500	5563	0.926
NULL	Mol_Cancer_2014_Jan_28_13_17.nxml.txt.nlp	24472312	SENT35	7	7	31	31	ponatinib	VEGFR	PA165980594	3791	0.926
NULL	Onco_Targets_Ther_2014_Dec_4_7_2249-2255.nxml.txt.nlp	25587220	SENT119	20	20	15	15	verapamil	P-gp	PA451868	5243	0.926
NULL	Breast_Cancer_Res_2011_Jun_21_13(3)_R66.nxml.txt.nlp	21693010	SENT253	7	7	16	16	sunitinib	VEGF-D	PA162372840	2277	0.926
NULL	Ann_Med_2013_Mar_28_45(2)_194-202.nxml.txt.nlp	22928964	SENT148	27	27	17	17	bortezomib	IRE1	PA10252	2081	0.926
NULL	Oncotarget_2013_Apr_13_4(4)_502-530.nxml.txt.nlp	23594434	SENT270	11	11	15	15	nelfinavir	AKT	PA450606	207	0.926
NULL	Diabetes_Care_2010_Apr_12_33(4)_861-868.nxml.txt.nlp	20067962	SENT14	17	17	31	31	hyaluronan	TLR2	PA165958431	7097	0.926
NULL	Curr_Control_Trials_Cardiovasc_Med_2001_Jul_26_2(4)_171-179.nxml.txt.nlp	11806792	SENT49	0	0	21	21	eptifibatide	IMPACT	PA449483	55364	0.926
NULL	Cancers_(Basel)_2010_Oct_25_2(4)_1794-1812.nxml.txt.nlp	24281201	SENT736	12	12	3	3	forskolin	MUC5AC	PA146096022	4586	0.926
NULL	Exp_Lung_Res_2013_Oct_1_39(8)_336-348.nxml.txt.nlp	23919450	SENT106	6	6	17	17	thrombin	PAR-1	PA451674	2011;2149	0.926
NULL	Indian_J_Pharmacol_2008_Oct_40(Suppl_2)_S112-S142.nxml.txt.nlp	21593965	SENT775	3	3	13	13	fenofibrate	STZ	PA449594	6484	0.926
NULL	Support_Care_Cancer_2011_Oct_8_19(10)_1505-1510.nxml.txt.nlp	20694798	SENT59	33	33	26	26	doxorubicin	CHOP	PA449412	1649	0.926
NULL	Indian_J_Med_Res_2010_Dec_132(6)_676-682.nxml.txt.nlp	21245614	SENT77	29	29	12	12	zinc	ROS	PA451956	6098	0.926
NULL	Biomed_Res_Int_2013_Sep_4_2013_419176.nxml.txt.nlp	24093097	SENT118	22	22	6	6	everolimus	AKT	PA164746311	207	0.926
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT151	38	38	5	5	glucose	p38	PA449773	10598;1432;7965	0.926
NULL	J_Oncol_2011_Dec_5_2011_465343.nxml.txt.nlp	21188169	SENT186	12	12	15	15	gemcitabine	CD133	PA449748	8842	0.926
NULL	Nat_Methods_2012_Oct_9_9(10)_1005-1012.nxml.txt.nlp	22961245	SENT268	19	19	29	29	papain	B27	PA450778	56246	0.926
NULL	Niger_Med_J_2013_Mar-Apr_54(2)_100-106.nxml.txt.nlp	23798795	SENT5	20	20	47	47	indomethacin	PTEN	PA449982	5728	0.926
NULL	Ulster_Med_J_2008_May_77(2)_106-109.nxml.txt.nlp	18711628	SENT45	32	32	20	20	protamine	ACT	PA10366	12;11332;9457;641455	0.926
NULL	Cancer_Immunol_Immunother_2015_Oct_7_64_61-73.nxml.txt.nlp	25287778	SENT136	0	0	16	16	lenalidomide	CD54	PA162363968	3383	0.926
NULL	Clin_Interv_Aging_2009_Jun_9_4_251-258.nxml.txt.nlp	19554096	SENT141	14	14	9	9	fluoxetine	CYP3A4	PA449673	1576	0.926
NULL	Acta_Pharmacol_Sin_2011_Feb_4_32(2)_259-269.nxml.txt.nlp	21293479	SENT177	31	31	6	6	sn-38	UGT1A6		54578	0.926
NULL	Cell_Death_Dis_2014_Jan_16_5(1)_e1000.nxml.txt.nlp	24434508	SENT332	29	29	11	11	etoposide	p53	PA449552	7157	0.926
NULL	Ethiop_J_Health_Sci_2011_Nov_21(3)_195-201.nxml.txt.nlp	22435000	SENT97	24	24	39	39	l-arginine	IL-8	PA448478	3576	0.926
NULL	J_Clin_Biochem_Nutr_2007_Jul_27_41(1)_32-42.nxml.txt.nlp	18392098	SENT147	11	11	4	4	curcumin	ROS	PA151958596	6098	0.926
NULL	Theranostics_2013_Nov_30_3(12)_943-952.nxml.txt.nlp	24396505	SENT133	30	30	33	33	gefitinib	EGFR	PA131301952	1956	0.926
NULL	EPMA_J_2010_Sep_20_1(3)_421-437.nxml.txt.nlp	23199086	SENT192	5	5	16	16	tamoxifen	HOXB13	PA451581	10481	0.926
NULL	Drug_Des_Devel_Ther_2014_Sep_23_8_1527-1538.nxml.txt.nlp	25284985	SENT98	5	5	38	38	celecoxib	IFN	PA448871	3439	0.926
NULL	Braz_J_Med_Biol_Res_2014_Oct_24_48(1)_65-76.nxml.txt.nlp	25493385	SENT151	25	25	31	31	l-arginine	AT1	PA448478	9197;185	0.926
NULL	J_Gen_Physiol_2009_Apr_133(4)_421-438.nxml.txt.nlp	19289574	SENT469	29	29	2	2	forskolin	SLC26A9	PA146096022	115019	0.926
NULL	Cancer_Metab_2014_Nov_3_2(1)_20.nxml.txt.nlp	NULL	SENT194	7	7	1	1	erlotinib	PDK4	PA134687924	5166	0.926
NULL	Onco_Targets_Ther_2014_Jun_11_7_969-983.nxml.txt.nlp	24959084	SENT115	7	7	4	4	ketoconazole	CYP3A4	PA450146	1576	0.926
NULL	Cancer_Immunol_Immunother_2015_Oct_7_64_61-73.nxml.txt.nlp	25287778	SENT218	18	18	3	3	lenalidomide	CD56	PA162363968	4684	0.926
NULL	Cancers_(Basel)_2010_Dec_30_3(1)_106-125.nxml.txt.nlp	24212609	SENT936	38	38	6	6	gemcitabine	MRP5	PA449748	10057	0.926
NULL	J_Hematol_Oncol_2011_Dec_21_4_53.nxml.txt.nlp	22189016	SENT70	10	10	7	7	verapamil	P-gp	PA451868	5243	0.926
NULL	Thorax_2010_Jul_13_65(7)_654-658.nxml.txt.nlp	20627927	SENT48	27	27	4	4	tobramycin	NAG	PA451704	51594;4669	0.926
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_May_29_65(Pt_6)_m691-m692.nxml.txt.nlp	21583048	SENT79	31	31	9	9	copper	mol	PA449114	90527	0.926
NULL	F1000_Med_Rep_2010_May_24_2_40.nxml.txt.nlp	20948844	SENT43	15	15	4	4	heparin	APC	PA449855	324	0.926
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1066.nxml.txt.nlp	24556681	SENT91	13	13	23	23	ethanol	TLR4	PA448073	7099	0.926
NULL	Oxid_Med_Cell_Longev_2013_Jun_2_2013_793525.nxml.txt.nlp	23819014	SENT68	14	14	0	0	resveratrol	SGBS		2719	0.926
NULL	Clin_Ophthalmol_2014_Mar_2_8_343-346.nxml.txt.nlp	24591809	SENT78	23	23	10	10	ranibizumab	PED	PA164746012	8682	0.926
NULL	Int_J_Med_Sci_2012_Dec_28_10(2)_110-118.nxml.txt.nlp	23329881	SENT55	11	11	3	3	epirubicin	NACT	PA449476	284111	0.926
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_33-43.nxml.txt.nlp	17912634	SENT90	14	14	2	2	tamoxifen	aromatase	PA451581	1588	0.926
NULL	Cost_Eff_Resour_Alloc_2006_May_31_4_9.nxml.txt.nlp	16737538	SENT128	21	21	1	1	celecoxib	OTC	PA448871	5009	0.926
NULL	Arch_Med_Sci_2011_Dec_31_7(6)_977-983.nxml.txt.nlp	22328880	SENT137	25	25	4	4	heparin	PAPP-A	PA449855	5069	0.926
NULL	Front_Oncol_2013_Nov_15_3_281.nxml.txt.nlp	24298448	SENT187	13	13	5	5	cetuximab	BRAF	PA10040	673	0.926
NULL	J_Cell_Biol_2005_Jul_4_170(1)_49-59.nxml.txt.nlp	15983061	SENT97	20	20	37	37	forskolin	ERK2	PA146096022	5594	0.926
NULL	Open_Cardiovasc_Med_J_2014_Feb_7_8_12-17.nxml.txt.nlp	24653785	SENT111	23	23	8	8	simvastatin	CYP3A4	PA451363	1576	0.926
NULL	Ann_Rheum_Dis_2010_Jun_1_69(6)_1029-1035.nxml.txt.nlp	20444755	SENT100	38	38	31	31	etanercept	TNF	PA449515	7124	0.926
NULL	Ann_Rheum_Dis_2008_Nov_14_67(11)_1516-1523.nxml.txt.nlp	18625622	SENT214	39	39	17	17	tocilizumab	IL-6	PA165292659	3569	0.926
NULL	J_Skin_Cancer_2012_Dec_13_2012_147863.nxml.txt.nlp	23316365	SENT183	6	6	24	24	curcumin	IL-6	PA151958596	3569	0.926
NULL	Neuroscience_2009_Jun_30_161(2-3)_572-577.nxml.txt.nlp	19327387	SENT80	3	3	6	6	capsaicin	NAPE-PLD	PA448776	222236	0.926
NULL	Oncotarget_2014_Oct_16_5(20)_9546-9563.nxml.txt.nlp	25337673	SENT110	12	12	31	31	crizotinib	AXL	PA165946122	558	0.926
NULL	Arthritis_Res_Ther_2008_Dec_1_10(6)_R139.nxml.txt.nlp	19046432	SENT325	22	22	38	38	rosiglitazone	AP-1	PA451283	2353;3727;2354;3725	0.926
NULL	Evid_Based_Complement_Alternat_Med_2012_Dec_24_2012_976926.nxml.txt.nlp	23326296	SENT25	4	4	24	24	tocilizumab	IL-6	PA165292659	3569	0.926
NULL	Endocr_Relat_Cancer_2013_Aug_20(5)_677-689.nxml.txt.nlp	23913484	SENT196	19	19	5	5	docetaxel	IRF9	PA449383	10379	0.926
NULL	J_Thorac_Oncol_2014_Jun_30_9(6)_805-811.nxml.txt.nlp	24787964	SENT152	12	12	31	31	afatinib	EGFR	PA165981154	1956	0.926
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1137-1144.nxml.txt.nlp	20234366	SENT161	36	36	14	14	cetuximab	BRAF	PA10040	673	0.926
NULL	Dermatoendocrinol_2013_Apr_1_5(2)_252-263.nxml.txt.nlp	24194965	SENT20	27	27	16	16	metformin	mitoNEET	PA450395	55847	0.926
NULL	Acta_Histochem_Cytochem_2013_Dec_28_46(6)_187-197.nxml.txt.nlp	24610966	SENT171	37	37	9	9	pilocarpine	AQP5	PA450962	362	0.926
NULL	Acta_Pharmacol_Sin_2009_Feb_26_30(2)_219-227.nxml.txt.nlp	19169271	SENT43	8	8	4	4	atropine	CTX	PA448505	1593	0.926
NULL	Indian_J_Med_Res_2013_Jan_137(1)_36-47.nxml.txt.nlp	23481050	SENT135	28	28	34	34	primaquine	G6PD	PA451103	2539	0.926
NULL	Front_Endocrinol_(Lausanne)_2011_Mar_3_2_6.nxml.txt.nlp	21633718	SENT140	10	10	3	3	tetracycline	GPCR	PA451640	151306;165140	0.926
NULL	Indian_J_Pharmacol_2009_Aug_41(4)_167-172.nxml.txt.nlp	20523867	SENT2	0	0	10	10	imatinib	CML	PA10804	613	0.926
NULL	Br_J_Cancer_2010_Sep_7_103(6)_845-851.nxml.txt.nlp	20700125	SENT150	16	16	36	36	cisplatin	ERCC1	PA449014	2067	0.926
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1137-1144.nxml.txt.nlp	20234366	SENT205	33	33	26	26	cetuximab	KRAS	PA10040	3845	0.926
NULL	Evid_Based_Complement_Alternat_Med_2011_Jan_20_2011_751671.nxml.txt.nlp	21318106	SENT23	0	0	9	9	tacrolimus	P-gp	PA451578	5243	0.926
NULL	Br_J_Cancer_2010_Sep_7_103(6)_765-771.nxml.txt.nlp	20700120	SENT81	37	37	40	40	tamoxifen	CYP2D6	PA451581	1565	0.926
NULL	BMB_Rep_2013_Nov_46(11)_544-549.nxml.txt.nlp	24152910	SENT81	4	4	17	17	thrombin	HMGB1	PA451674	3146	0.926
NULL	J_Hematol_Oncol_2012_Feb_2_5_2.nxml.txt.nlp	22300941	SENT147	26	26	12	12	teniposide	MPN	PA451611	83886	0.926
NULL	Adv_Ther_2014_Sep_23_31(9)_986-999.nxml.txt.nlp	25245811	SENT27	0	0	7	7	liraglutide	GLP-1	PA165958364	100125288	0.926
NULL	FASEB_J_2011_Apr_25(4)_1133-1144.nxml.txt.nlp	21163859	SENT342	2	2	17	17	imipramine	ASM	PA449969	6609;283120	0.926
NULL	J_Young_Pharm_2010_Oct-Dec_2(4)_428-429.nxml.txt.nlp	21264109	SENT3	14	14	3	3	metformin	B12	PA450395	7126;4709	0.926
NULL	Exp_Diabetes_Res_2012_Nov_1_2012_892706.nxml.txt.nlp	23197976	SENT209	5	5	13	13	vildagliptin	HIF-1	PA165958346	29072	0.926
NULL	Ital_J_Pediatr_2012_Jun_26_38_29.nxml.txt.nlp	22734451	SENT107	32	32	25	25	montelukast	URI	PA450546	8725	0.926
NULL	Open_Biol_2014_Jul_4(7)_140071.nxml.txt.nlp	25030607	SENT54	39	39	12	12	clopidogrel	CYP2C9	PA449053	1559	0.926
NULL	J_Korean_Med_Sci_1999_Jun_14(3)_231-238.nxml.txt.nlp	10402163	SENT13	0	0	6	6	sulfasalazine	NF-kappaB	PA451547	4790	0.926
NULL	Oncotarget_2014_Aug_29_5(19)_8947-8958.nxml.txt.nlp	25333254	SENT215	5	5	13	13	plerixafor	CXCR4	PA165958410	7852	0.926
NULL	Cell_Death_Dis_2014_Jan_16_5(1)_e1000.nxml.txt.nlp	24434508	SENT53	4	4	7	7	etoposide	p53	PA449552	7157	0.926
NULL	Oncotarget_2014_Aug_19_5(18)_8737-8749.nxml.txt.nlp	25228590	SENT57	7	7	0	0	crizotinib	MYCN	PA165946122	4613	0.926
NULL	J_Res_Med_Sci_2011_Mar_16(Suppl1)_S395-S400.nxml.txt.nlp	22247724	SENT43	30	30	47	47	halothane	CO2	PA449845	4513	0.926
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_39-54.nxml.txt.nlp	19305787	SENT150	21	21	10	10	ethanol	NR1	PA448073	27158	0.926
NULL	Oncotarget_2013_Jun_29_4(9)_1338-1348.nxml.txt.nlp	23907514	SENT124	18	18	11	11	doxorubicin	PSMA5	PA449412	5686	0.926
NULL	Mol_Clin_Oncol_2013_Jul_15_1(4)_661-667.nxml.txt.nlp	24649225	SENT28	20	20	0	0	paclitaxel	OAT2	PA450761	10864	0.926
NULL	Allergy_Asthma_Immunol_Res_2014_Sep_28_6(5)_401-408.nxml.txt.nlp	25228996	SENT110	4	4	22	22	capsaicin	TRPA1	PA448776	8989	0.926
NULL	Ann_Hematol_2014_Sep_12_93(1)_13-32.nxml.txt.nlp	24026426	SENT74	2	2	14	14	posaconazole	BII	PA151958574	777	0.926
NULL	Mol_Cancer_2012_Sep_21_11_72.nxml.txt.nlp	22995644	SENT64	15	15	7	7	imatinib	PRL-3	PA10804	11156	0.926
NULL	J_Hum_Genet_2013_Jun_2_58(6)_306-312.nxml.txt.nlp	23635953	SENT188	19	19	2	2	raloxifene	CYP2D6	PA451221	1565	0.926
NULL	Int_J_Mol_Sci_2012_Dec_5_13(12)_16624-16635.nxml.txt.nlp	23443122	SENT8	8	8	18	18	carboplatin	MRP3	PA448803	8714	0.926
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT275	35	35	8	8	acetaminophen	TNF	PA448015	7124	0.926
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1420-1426.nxml.txt.nlp	24056704	SENT107	10	10	28	28	ketoconazole	CYP3A	PA450146	1574	0.926
NULL	Breast_Cancer_(Auckl)_2011_Jul_27_5_175-199.nxml.txt.nlp	21863131	SENT372	19	19	13	13	epirubicin	HER2	PA449476	2064	0.926
NULL	Clin_Sarcoma_Res_2014_Aug_12_4_11.nxml.txt.nlp	25126409	SENT96	34	34	7	7	cisplatin	Bcl-2	PA449014	596	0.926
NULL	Curr_Med_Chem_2012_Aug_19(22)_3763-3778.nxml.txt.nlp	22680930	SENT79	7	7	3	3	zileuton	5-LOX	PA451955	240	0.926
NULL	J_Korean_Med_Sci_2013_May_2_28(5)_700-708.nxml.txt.nlp	23678261	SENT215	40	40	14	14	losartan	NCX	PA450268	3196	0.926
NULL	Basic_Clin_Neurosci_2013_Autumn_4(4)_323-328.nxml.txt.nlp	25337364	SENT112	2	2	11	11	colchicine	CA1	PA449092	759	0.926
NULL	Nat_Chem_Biol_2010_Apr_28_6(4)_291-299.nxml.txt.nlp	20190765	SENT51	13	13	7	7	dasatinib	EPHB4	PA162372878	2050	0.926
NULL	BMB_Rep_2014_Nov_47(11)_649-654.nxml.txt.nlp	25301019	SENT85	5	5	21	21	l-alanine	CCL2	PA448055	6347	0.926
NULL	Eur_J_Clin_Pharmacol_2012_Jan_7_68(1)_55-64.nxml.txt.nlp	21735164	SENT214	16	16	10	10	oxycodone	CYP2D6	PA450741	1565	0.926
NULL	Diagn_Pathol_2014_Jul_10_9_143.nxml.txt.nlp	25012722	SENT103	9	9	31	31	cisplatin	PDCD4	PA449014	27250	0.926
NULL	Biosci_Rep_2013_Nov_25_33(6)_e00081.nxml.txt.nlp	24070327	SENT195	32	32	28	28	imatinib	survivin	PA10804	332	0.926
NULL	Curr_Pharm_Biotechnol_2012_May_13(6)_969-986.nxml.txt.nlp	22039792	SENT178	24	24	8	8	ivermectin	P-gp	PA450133	5243	0.926
NULL	Case_Rep_Oncol_2011_Aug_18_4(2)_385-391.nxml.txt.nlp	21941487	SENT94	19	19	34	34	sunitinib	CYP3A4	PA162372840	1576	0.926
NULL	Ther_Clin_Risk_Manag_2006_Mar_2(1)_77-86.nxml.txt.nlp	18360583	SENT116	18	18	11	11	alendronate	PTH	PA448082	5741	0.926
NULL	Indian_J_Urol_2007_Apr-Jun_23(2)_91-96.nxml.txt.nlp	19675781	SENT175	29	29	25	25	doxazosin	NNT	PA449407	23530	0.926
NULL	Mol_Cancer_2013_Oct_8_12_119.nxml.txt.nlp	24103454	SENT169	30	30	5	5	irinotecan	TOP1	PA450085	7150	0.926
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT418	18	18	8	8	cetuximab	NRAS	PA10040	4893	0.926
NULL	Exp_Ther_Med_2013_Feb_30_5(2)_616-620.nxml.txt.nlp	23407814	SENT25	11	11	17	17	oxygen	ROS	PA450744	6098	0.926
NULL	Br_J_Cancer_2013_Jul_9_109(1)_100-108.nxml.txt.nlp	23756858	SENT24	26	26	17	17	exemestane	aromatase	PA449563	1588	0.926
NULL	Int_Neurourol_J_2014_Mar_31_18(1)_16-22.nxml.txt.nlp	24729923	SENT131	28	28	15	15	scopolamine	CA1	PA451308	759	0.926
NULL	J_Neural_Transm_2014_Feb_19_121(7)_707-715.nxml.txt.nlp	24549572	SENT206	16	16	29	29	clonazepam	CB2	PA449050	1269	0.926
NULL	Ann_Med_Health_Sci_Res_2013_Apr-Jun_3(2)_282-284.nxml.txt.nlp	23919207	SENT70	13	13	4	4	rifampin	RGM	PA451250	56963	0.926
NULL	Emerg_Infect_Dis_2011_Mar_17(3)_495-497.nxml.txt.nlp	21392442	SENT17	28	28	1	1	levofloxacin	DST	PA450214	667	0.926
NULL	Diabetes_Care_2010_Jan_33(Suppl_1)_S11-S61.nxml.txt.nlp	20042772	SENT1972	14	14	8	8	ramipril	DREAM	PA451223	30818	0.926
NULL	Anticancer_Drugs_2015_Feb_22_26(2)_139-147.nxml.txt.nlp	25203626	SENT212	10	10	25	25	sorafenib	EZH2	PA7000	2146	0.926
NULL	Breast_Cancer_Res_2012_Apr_17_14(2)_R61.nxml.txt.nlp	22510481	SENT35	0	0	22	22	trastuzumab	San	PA451743	80218	0.926
NULL	J_Cell_Mol_Med_2013_May_12_17(5)_636-647.nxml.txt.nlp	23577651	SENT121	26	26	8	8	quinacrine	CD41	PA164745551	3674	0.926
NULL	Theranostics_2013_Nov_30_3(12)_943-952.nxml.txt.nlp	24396505	SENT133	39	39	33	33	gefitinib	EGFR	PA131301952	1956	0.926
NULL	Front_Immunol_2014_Apr_23_5_182.nxml.txt.nlp	24795724	SENT113	1	1	32	32	heparin	VLP	PA449855	391104	0.926
NULL	J_Int_AIDS_Soc_2012_Oct_22_15(Suppl_3)_10_7448_IAS_15_5_18440.nxml.txt.nlp	NULL	SENT908	15	15	0	0	doxycycline	Men	PA449415	8178	0.926
NULL	Front_Immunol_2012_Jun_4_3_129.nxml.txt.nlp	22675324	SENT97	3	3	29	29	ustekinumab	IL-17	PA166048654	3605	0.926
NULL	Front_Endocrinol_(Lausanne)_2013_Nov_11_4_166.nxml.txt.nlp	24273531	SENT236	25	25	17	17	losartan	AT1	PA450268	9197;185	0.926
NULL	Oncotarget_2012_Sep_28_3(10)_1169-1181.nxml.txt.nlp	23045411	SENT173	18	18	3	3	doxorubicin	JIP1	PA449412	9479	0.926
NULL	J_Hematol_Oncol_2009_Feb_23_2_10.nxml.txt.nlp	19236716	SENT108	21	21	4	4	dasatinib	CYP3A4	PA162372878	1576	0.926
NULL	Oncotarget_2013_Nov_15_5(6)_1458-1474.nxml.txt.nlp	24681547	SENT6	4	4	27	27	celecoxib	CDH11	PA448871	1009	0.926
NULL	Braz_J_Med_Biol_Res_2012_Jul_20_45(10)_935-941.nxml.txt.nlp	22801415	SENT149	10	10	23	23	pioglitazone	ghrelin	PA450970	51738	0.926
NULL	J_Oncol_2012_Oct_9_2012_261750.nxml.txt.nlp	22007214	SENT132	9	9	21	21	cabozantinib	VEGFR	PA165906891	3791	0.926
NULL	Mol_Cancer_2014_Jun_4_13_141.nxml.txt.nlp	24894453	SENT22	15	15	1	1	erlotinib	EGFR	PA134687924	1956	0.926
NULL	Acta_Pharmacol_Sin_2013_Dec_18_34(12)_1508-1514.nxml.txt.nlp	24241347	SENT31	0	0	6	6	ketanserin	5-HT2A	PA131053734	3356	0.926
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT12	8	8	2	2	atorvastatin	OPG	PA448500	690	0.926
NULL	Mol_Imaging_Biol_2013_Apr_11_15(2)_136-147.nxml.txt.nlp	22886728	SENT218	24	24	16	16	orlistat	FDG	PA164776864	23583	0.926
NULL	Bioinformation_2008_Dec_31_3(5)_198-204.nxml.txt.nlp	19255634	SENT83	8	8	18	18	omeprazole	CYP3A4	PA450704	1576	0.926
NULL	Arch_Drug_Inf_2008_Dec_1(3)_97-106.nxml.txt.nlp	19639031	SENT147	25	25	14	14	irinotecan	UGT1A1	PA450085	54658	0.926
NULL	Nat_Commun_2013_Sep_20_4_2444.nxml.txt.nlp	24051492	SENT391	14	14	3	3	nutlin-3	p53		7157	0.926
NULL	Cancer_Cell_Int_2013_Sep_23_13_94.nxml.txt.nlp	24059699	SENT202	39	39	11	11	bevacizumab	VEGFA	PA130232992	7422	0.926
NULL	J_Oncol_2010_Jan_13_2010_314326.nxml.txt.nlp	20111741	SENT102	8	8	1	1	lapatinib	EGFR	PA152241907	1956	0.926
NULL	Br_J_Pharmacol_2014_Feb_24_171(1)_1019-1032.nxml.txt.nlp	24251620	SENT48	20	20	29	29	nimodipine	TRPM3	PA450633	80036	0.926
NULL	Mol_Pain_2014_Aug_15_10_53.nxml.txt.nlp	25127716	SENT108	11	11	7	7	paclitaxel	SDH	PA450761	1757;10993	0.926
NULL	Blood_Res_2014_Sep_25_49(3)_162-169.nxml.txt.nlp	25325035	SENT124	3	3	20	20	rituximab	CHOP	PA451261	1649	0.926
NULL	Br_J_Cancer_2012_Feb_28_106(5)_876-882.nxml.txt.nlp	22333597	SENT147	9	9	22	22	everolimus	p53	PA164746311	7157	0.926
NULL	Oncol_Lett_2014_Sep_19_8(3)_1269-1274.nxml.txt.nlp	25120704	SENT105	11	11	4	4	cisplatin	Met	PA449014	79811	0.926
NULL	Nat_Med_2012_Mar_4_18(4)_547-554.nxml.txt.nlp	22388091	SENT241	25	25	21	21	methacholine	IL-17A	PA165958382	3605	0.926
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT190	35	35	18	18	perifosine	NAC	PA165291471	22861	0.926
NULL	Br_J_Cancer_2013_Nov_26_109(11)_2778-2782.nxml.txt.nlp	24169350	SENT45	30	30	45	45	fluorouracil	NACT	PA128406956	284111	0.926
NULL	Int_J_Mol_Imaging_2012_Oct_17_2012_189254.nxml.txt.nlp	23119157	SENT194	9	9	13	13	ezetimibe	FAST	PA10816	10922	0.926
NULL	Breast_Cancer_Res_2010_Jun_22_12(3)_R39.nxml.txt.nlp	20569502	SENT163	17	17	4	4	tamoxifen	IGFBP5	PA451581	3488	0.926
NULL	Surg_Today_2012_Jan_6_42(1)_8-28.nxml.txt.nlp	22139128	SENT170	34	34	10	10	docetaxel	PSK	PA449383	9344	0.926
NULL	Nat_Commun_2014_Dec_10_5_5715.nxml.txt.nlp	25493654	SENT252	12	12	3	3	trastuzumab	EGFR	PA451743	1956	0.926
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Nov_21_65(Pt_12)_o3125.nxml.txt.nlp	21578848	SENT59	19	19	7	7	ethanol	mol	PA448073	90527	0.926
NULL	Breast_Cancer_Res_2014_May_28_16(3)_R53.nxml.txt.nlp	24886537	SENT290	9	9	4	4	tamoxifen	VAV3	PA451581	10451	0.926
NULL	Contemp_Oncol_(Pozn)_2012_Sep_29_16(4)_316-321.nxml.txt.nlp	23788901	SENT110	13	13	7	7	etoposide	STAT3	PA449552	6774	0.926
NULL	Clin_Psychopharmacol_Neurosci_2011_Apr_30_9(1)_36-43.nxml.txt.nlp	23431025	SENT109	9	9	2	2	aripiprazole	HIP	PA10026	6767;6159;64399;5068	0.926
NULL	Indian_J_Hum_Genet_2014_Apr-Jun_20(2)_175-184.nxml.txt.nlp	25400347	SENT137	30	30	15	15	warfarin	CYP2C9	PA451906	1559	0.926
NULL	Case_Rep_Rheumatol_2013_Jul_24_2013_249471.nxml.txt.nlp	23984159	SENT57	20	20	4	4	colchicine	PAPA	PA449092	2737;5069	0.926
NULL	Crit_Care_2005_Sep_9_9(2)_212-222.nxml.txt.nlp	15774080	SENT166	3	3	18	18	vasopressin	AVP	PA451858	114548;551	0.926
NULL	Arthritis_Res_Ther_2006_Jul_21_8(4)_R130.nxml.txt.nlp	16859540	SENT184	18	18	4	4	atorvastatin	CD59	PA448500	966	0.926
NULL	Breast_Cancer_Res_2011_Nov_1_13(6)_224.nxml.txt.nlp	22114931	SENT129	34	34	11	11	lapatinib	HER2	PA152241907	2064	0.926
NULL	Mycobiology_2013_Mar_28_41(1)_1-12.nxml.txt.nlp	23610533	SENT132	13	13	33	33	ethanol	YAK1	PA448073	10114	0.926
NULL	Cell_Death_Dis_2014_Feb_27_5(2)_e1088.nxml.txt.nlp	24577086	SENT346	5	5	32	32	metformin	AMPK	PA450395	5563	0.926
NULL	Evid_Based_Complement_Alternat_Med_2013_Aug_12_2013_982689.nxml.txt.nlp	23997806	SENT221	0	0	17	17	tolbutamide	CYP2C	PA451718	1562	0.926
NULL	Drug_Des_Devel_Ther_2014_Sep_16_8_1391-1403.nxml.txt.nlp	25258509	SENT114	6	6	15	15	ethanol	ANOVA	PA448073	4858	0.926
NULL	Int_J_Fertil_Steril_2014_Jul_8_Jul-Sep_8(2)_183-192.nxml.txt.nlp	25083184	SENT172	12	12	0	0	estradiol	COX2	PA449503	4513;5743	0.926
NULL	Ann_Surg_Oncol_2010_Apr_20_17(4)_1168-1176.nxml.txt.nlp	19936839	SENT85	9	9	18	18	cetuximab	KRAS	PA10040	3845	0.926
NULL	Neuro_Oncol_2010_Apr_27_12(4)_389-400.nxml.txt.nlp	20308316	SENT172	3	3	14	14	chloroquine	p53	PA448948	7157	0.926
NULL	Diagn_Pathol_2007_Dec_19_2_49.nxml.txt.nlp	18093326	SENT76	16	16	10	10	vincristine	CHOP	PA451879	1649	0.926
NULL	Biochemistry_2012_Sep_25_51(38)_7456-7464.nxml.txt.nlp	22947085	SENT58	10	10	1	1	glutaraldehyde	7B2	PA449777	6447	0.926
NULL	Arthritis_Rheumatol_2014_Jun_27_66(6)_1574-1582.nxml.txt.nlp	24577881	SENT113	4	4	13	13	hydralazine	CD28	PA449894	1493;940	0.926
NULL	J_Immunother_Cancer_2014_Jan_27_2_2.nxml.txt.nlp	24829759	SENT14	15	15	6	6	sorafenib	IL-21	PA7000	59067;50616;27189	0.926
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT248	13	13	24	24	perifosine	JNK	PA165291471	5599	0.926
NULL	Arthritis_Res_Ther_2013_Jul_11_15(4)_216.nxml.txt.nlp	23856014	SENT103	5	5	31	31	daclizumab	CD4	PA164764446	920	0.926
NULL	Mol_Cancer_2013_Mar_7_12_19.nxml.txt.nlp	23497317	SENT139	24	24	17	17	dasatinib	KIT	PA162372878	3815	0.926
NULL	Cancers_(Basel)_2013_Jan_21_5(1)_64-91.nxml.txt.nlp	24216699	SENT131	19	19	26	26	gefitinib	EGFR	PA131301952	1956	0.926
NULL	ScientificWorldJournal_2012_Apr_26_2012_358102.nxml.txt.nlp	22645419	SENT192	6	6	11	11	losartan	AT2	PA450268	186	0.926
NULL	Int_J_Endocrinol_2013_Nov_27_2013_259676.nxml.txt.nlp	24369462	SENT193	22	22	19	19	sr144528	CB2		1269	0.926
NULL	Oncogene_2014_Jun_19_33(25)_3298-3306.nxml.txt.nlp	23912460	SENT114	8	8	5	5	erlotinib	EGFR	PA134687924	1956	0.926
NULL	Indian_J_Psychiatry_2009_Jul-Sep_51(3)_222-224.nxml.txt.nlp	19881055	SENT63	7	7	12	12	bupropion	CYP2D6	PA448687	1565	0.926
NULL	Br_J_Clin_Pharmacol_2013_Aug_23_76(2)_299-315.nxml.txt.nlp	23701319	SENT230	20	20	7	7	infliximab	IL-17	PA452639	3605	0.926
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT217	18	18	21	21	perifosine	JNK	PA165291471	5599	0.926
NULL	Biomed_Imaging_Interv_J_2008_Jul_1_4(3)_e40.nxml.txt.nlp	21611006	SENT139	37	37	18	18	trastuzumab	HER2	PA451743	2064	0.926
NULL	Clin_Pharmacol_2013_Dec_9_5_185-192.nxml.txt.nlp	24353446	SENT94	34	34	24	24	clopidogrel	CYP3A4	PA449053	1576	0.926
NULL	Breast_Cancer_Res_2007_Mar_2_9(2)_205.nxml.txt.nlp	NULL	SENT103	11	11	6	6	gefitinib	EGFR	PA131301952	1956	0.926
NULL	Mol_Cancer_2009_Jun_8_8_34.nxml.txt.nlp	19500427	SENT90	12	12	3	3	gemcitabine	ANOVA	PA449748	4858	0.926
NULL	Eur_J_Clin_Pharmacol_2011_Dec_23_67(12)_1231-1241.nxml.txt.nlp	21698374	SENT246	20	20	13	13	tacrolimus	CYP3A5	PA451578	1577	0.926
NULL	Infect_Dis_Ther_2013_Dec_8_2(2)_95-110.nxml.txt.nlp	25134474	SENT159	31	31	11	11	daptomycin	VISA	PA164768820	57506	0.926
NULL	Indian_J_Med_Res_2012_Apr_135(4)_494-499.nxml.txt.nlp	22664496	SENT140	3	3	17	17	chloroquine	ACT	PA448948	12;11332;9457;641455	0.926
NULL	Nat_Commun_2013_Nov_29_4_10_1038_ncomms3812.nxml.txt.nlp	24287487	SENT235	19	19	3	3	doxycycline	Dicer	PA449415	23405	0.926
NULL	Mol_Cancer_2009_Sep_7_8_72.nxml.txt.nlp	19735553	SENT193	17	17	27	27	cisplatin	p53	PA449014	7157	0.926
NULL	J_Vet_Med_Sci_2014_Oct_16_76(10)_1383-1387.nxml.txt.nlp	24931645	SENT67	2	2	30	30	sitagliptin	GLP-1	PA164748978	100125288	0.926
NULL	Drug_Target_Insights_2012_Aug_6_6_19-39.nxml.txt.nlp	22915839	SENT111	22	22	9	9	doxorubicin	p53	PA449412	7157	0.926
NULL	Cell_Mol_Life_Sci_2011_Nov_2_68(21)_3573-3587.nxml.txt.nlp	21365278	SENT172	15	15	43	43	iloprost	eotaxin	PA164746843	6356	0.926
NULL	Nucleic_Acids_Res_2005_Apr_22_33(7)_2310-2317.nxml.txt.nlp	15849317	SENT116	3	3	5	5	geldanamycin	Hsp90	PA152031327	3320	0.926
NULL	Mol_Cell_2014_May_8_54(3)_445-459.nxml.txt.nlp	24746700	SENT85	12	12	8	8	etoposide	BCLAF1	PA449552	9774	0.926
NULL	BMB_Rep_2014_Nov_47(11)_649-654.nxml.txt.nlp	25301019	SENT128	3	3	12	12	l-serine	STAT3	PA451330	6774	0.926
NULL	Oncotarget_2013_Jun_29_4(9)_1338-1348.nxml.txt.nlp	23907514	SENT172	19	19	10	10	doxorubicin	PSMA1	PA449412	5682	0.926
NULL	Ann_Oncol_2011_Aug_27_22(8)_1736-1747.nxml.txt.nlp	21709140	SENT318	6	6	29	29	trastuzumab	San	PA451743	80218	0.926
NULL	Adv_Hematol_2012_May_28_2012_945138.nxml.txt.nlp	22693514	SENT129	13	13	16	16	rituximab	CHOP	PA451261	1649	0.926
NULL	Mol_Cancer_2007_Jan_14_6_5.nxml.txt.nlp	17222355	SENT9	16	16	11	11	doxorubicin	HMGA2	PA449412	8091	0.926
NULL	J_Cell_Mol_Med_2014_Mar_10_18(3)_514-529.nxml.txt.nlp	24410795	SENT197	20	20	3	3	resveratrol	SIRT1		23411	0.926
NULL	Clin_Ophthalmol_2008_Sep_2(3)_613-621.nxml.txt.nlp	19668762	SENT34	23	23	29	29	latanoprost	BAK	PA164774763	578	0.926
NULL	J_Young_Pharm_2010_Oct-Dec_2(4)_417-419.nxml.txt.nlp	21264106	SENT4	16	16	3	3	lamivudine	API	PA450163	5345	0.926
NULL	J_Viral_Hepat_2009_May_16(5)_315-324.nxml.txt.nlp	19243499	SENT101	19	19	7	7	imiquimod	TLR9	PA449972	54106	0.926
NULL	Int_J_Mol_Sci_2013_Apr_11_14(4)_7923-7931.nxml.txt.nlp	23579955	SENT80	23	23	16	16	galactose	CGB	PA449725	1082	0.926
NULL	Oncologist_2010_Mar_3_15(3)_216-235.nxml.txt.nlp	20200040	SENT179	9	9	19	19	everolimus	HER-2	PA164746311	2064	0.926
NULL	J_Hematol_Oncol_2013_Jun_3_6_38.nxml.txt.nlp	23731980	SENT55	25	25	7	7	paclitaxel	San	PA450761	80218	0.926
NULL	Nat_Chem_Biol_2010_Apr_28_6(4)_291-299.nxml.txt.nlp	20190765	SENT142	25	25	12	12	dasatinib	EGFR	PA162372878	1956	0.926
NULL	Arthritis_Res_Ther_2012_Jul_27_14(4)_R175.nxml.txt.nlp	22838733	SENT120	38	38	26	26	adalimumab	CD14	PA10004	929	0.926
NULL	AMIA_Jt_Summits_Transl_Sci_Proc_2012_Mar_19_2012_25-34.nxml.txt.nlp	22779044	SENT161	7	7	1	1	ethanol	PPARA	PA448073	5465	0.926
NULL	BMB_Rep_2013_Aug_46(8)_410-415.nxml.txt.nlp	23977989	SENT103	21	21	3	3	curcumin	HO-1	PA151958596	3162	0.926
NULL	Clin_Exp_Gastroenterol_2013_Aug_5_6_139-148.nxml.txt.nlp	23950655	SENT69	37	37	11	11	thrombin	ADP	PA451674	23038	0.926
NULL	Br_J_Cancer_2012_Sep_4_107(6)_977-987.nxml.txt.nlp	22892389	SENT134	18	18	7	7	orlistat	VEGFA	PA164776864	7422	0.926
NULL	Cardiovasc_Diabetol_2005_Sep_16_4_14.nxml.txt.nlp	16168052	SENT68	9	9	22	22	bezafibrate	gamma	PA162364313	9913	0.926
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT210	21	21	11	11	metformin	p53	PA450395	7157	0.926
NULL	Arthritis_Res_Ther_2008_Apr_16_10(2)_R43.nxml.txt.nlp	18416822	SENT240	8	8	25	25	sr144528	p42		5706;23552	0.926
NULL	J_Hematol_Oncol_2008_Aug_11_1_11.nxml.txt.nlp	18694493	SENT59	11	11	19	19	sunitinib	IFN	PA162372840	3439	0.926
NULL	Comp_Hepatol_2005_Feb_8_4_2.nxml.txt.nlp	15701172	SENT151	5	5	1	1	ketoconazole	CYP3A	PA450146	1574	0.926
NULL	Mol_Cancer_2007_Oct_11_6_63.nxml.txt.nlp	17931419	SENT87	33	33	16	16	cetuximab	EGFR	PA10040	1956	0.926
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT133	25	25	35	35	dasatinib	LYN	PA162372878	4067	0.926
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT222	6	6	14	14	metformin	AKT	PA450395	207	0.926
NULL	Front_Behav_Neurosci_2011_Sep_8_5_56.nxml.txt.nlp	21927600	SENT159	22	22	35	35	cocaine	DARPP-32	PA449072	84152	0.926
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_127043.nxml.txt.nlp	23227093	SENT181	11	11	6	6	lovastatin	RYR	PA450272	6261	0.926
NULL	Patient_Prefer_Adherence_2011_Dec_23_6_1-9.nxml.txt.nlp	22272064	SENT3	29	29	26	26	enalapril	ACE	PA449456	1636	0.926
NULL	Diabetes_2013_Mar_14_62(3)_953-964.nxml.txt.nlp	23223176	SENT180	26	26	28	28	paroxetine	PRX	PA450801	9588;57716	0.926
NULL	Clin_Interv_Aging_2013_Jan_31_8_103-110.nxml.txt.nlp	23386786	SENT110	36	36	7	7	atorvastatin	IL-6	PA448500	3569	0.926
NULL	Oncologist_2010_Jan_19_15(1)_3-5.nxml.txt.nlp	20086166	SENT28	26	26	9	9	carboplatin	EGFR	PA448803	1956	0.926
NULL	Colorectal_Dis_2012_Feb_14(2)_e31-e47.nxml.txt.nlp	21848897	SENT41	0	0	7	7	cetuximab	KRAS	PA10040	3845	0.925
NULL	Clin_Exp_Otorhinolaryngol_2011_Jun_31_4(2)_77-82.nxml.txt.nlp	21716954	SENT40	23	23	25	25	minocycline	p38	PA450519	10598;1432;7965	0.925
NULL	Breast_Cancer_Res_2014_May_5_16(3)_R45.nxml.txt.nlp	24887236	SENT290	8	8	22	22	cetuximab	HER2	PA10040	2064	0.925
NULL	Clin_Med_Insights_Oncol_2013_Jun_3_7_103-122.nxml.txt.nlp	23843721	SENT132	9	9	5	5	trastuzumab	PTEN	PA451743	5728	0.925
NULL	Cells_2014_Apr_8_3(2)_258-287.nxml.txt.nlp	24717323	SENT104	26	26	9	9	capsaicin	TRPV2	PA448776	51393	0.925
NULL	Cancers_(Basel)_2010_Apr_21_2(2)_653-669.nxml.txt.nlp	24281087	SENT77	23	23	17	17	doxorubicin	HMGA2	PA449412	8091	0.925
NULL	An_Bras_Dermatol_2013_Mar-Apr_88(2)_264-267.nxml.txt.nlp	23739711	SENT59	13	13	7	7	vincristine	CHOP	PA451879	1649	0.925
NULL	Cancer_Med_2013_Jun_25_2(3)_277-285.nxml.txt.nlp	23930204	SENT107	4	4	38	38	bevacizumab	PTEN	PA130232992	5728	0.925
NULL	Mol_Cancer_2010_Nov_25_9_305.nxml.txt.nlp	21108789	SENT94	11	11	15	15	cisplatin	MLH1	PA449014	4292	0.925
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_1-20.nxml.txt.nlp	19305785	SENT205	0	0	9	9	furosemide	NKCC1	PA449719	6558	0.925
NULL	Ann_Rheum_Dis_2009_Dec_1_68(12)_1819-1826.nxml.txt.nlp	19054822	SENT41	25	25	4	4	abatacept	CDP	PA164747080	1523	0.925
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT344	18	18	28	28	paliperidone	PRL	PA163518919	5617	0.925
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT81	19	19	15	15	metformin	p53	PA450395	7157	0.925
NULL	Acta_Pharmacol_Sin_2010_Jul_21_31(7)_855-860.nxml.txt.nlp	20562904	SENT145	7	7	28	28	fluconazole	CDR2	PA449653	1039	0.925
NULL	Nat_Commun_2014_Nov_19_5_5479.nxml.txt.nlp	25407222	SENT125	29	29	16	16	dextran	YTS	PA449261	8565	0.925
NULL	Acta_Pharmacol_Sin_2012_Dec_22_33(12)_1511-1517.nxml.txt.nlp	23085741	SENT40	8	8	5	5	pranlukast	CysLT1	PA134698661	10800	0.925
NULL	Int_J_Breast_Cancer_2012_May_9_2012_415170.nxml.txt.nlp	22649737	SENT161	1	1	28	28	afatinib	HER2	PA165981154	2064	0.925
NULL	Diabetes_2011_Mar_21_60(3)_757-765.nxml.txt.nlp	21282370	SENT123	32	32	0	0	isoproterenol	PTRF	PA450121	284119	0.925
NULL	Cardiol_Res_Pract_2013_Feb_21_2013_127270.nxml.txt.nlp	23509665	SENT175	32	32	21	21	prasugrel	ADP	PA154410481	23038	0.925
NULL	J_Mol_Signal_2013_Mar_25_8_3.nxml.txt.nlp	23531275	SENT29	22	22	15	15	thrombin	LARG	PA451674	23365	0.925
NULL	Curr_Neuropharmacol_2013_Jul_11(4)_338-378.nxml.txt.nlp	24381528	SENT659	32	32	15	15	curcumin	AP-1	PA151958596	2353;3727;2354;3725	0.925
NULL	Open_Access_J_Urol_2011_May_10_3_69-82.nxml.txt.nlp	24198638	SENT67	5	5	33	33	warfarin	UGT1A9	PA451906	54600	0.925
NULL	Clin_Med_Insights_Oncol_2012_Mar_12_6_137-147.nxml.txt.nlp	22550402	SENT81	10	10	30	30	erlotinib	EGFR	PA134687924	1956	0.925
NULL	Open_Access_J_Urol_2011_May_10_3_69-82.nxml.txt.nlp	24198638	SENT59	4	4	14	14	ketoconazole	CYP3A4	PA450146	1576	0.925
NULL	Oncoscience_2014_Mar_16_1(2)_132-157.nxml.txt.nlp	25594007	SENT248	9	9	2	2	oxaliplatin	ID1	PA131285527	3397	0.925
NULL	Indian_J_Psychiatry_1980_Apr-Jun_22(2)_182-184.nxml.txt.nlp	22058460	SENT0	14	14	11	11	imipramine	FOR	PA449969	51741	0.925
NULL	Cancer_Cell_Int_2014_Jul_2_14_59.nxml.txt.nlp	25120382	SENT200	29	29	24	24	metformin	CTR	PA450395	799	0.925
NULL	Oncogene_2010_Jul_8_29(27)_3896-3907.nxml.txt.nlp	20453888	SENT94	26	26	21	21	trastuzumab	HER2	PA451743	2064	0.925
NULL	Ther_Clin_Risk_Manag_2007_Jun_3(2)_245-258.nxml.txt.nlp	18360633	SENT57	12	12	18	18	etanercept	p55	PA449515	6624;2078;8503;5718	0.925
NULL	Front_Plant_Sci_2012_May_15_3_93.nxml.txt.nlp	22639676	SENT67	7	7	23	23	galactose	SGT1	PA449725	10910	0.925
NULL	Korean_J_Radiol_2010_Oct_29_Nov-Dec_11(6)_640-647.nxml.txt.nlp	21076590	SENT138	5	5	18	18	remifentanil	IL-6	PA451232	3569	0.925
NULL	Mol_Cancer_2014_Jul_17_13_174.nxml.txt.nlp	25033833	SENT75	24	24	4	4	doxorubicin	SFRP1	PA449412	6422	0.925
NULL	Cardiol_Res_Pract_2011_Jul_2_2011_615087.nxml.txt.nlp	21747989	SENT51	0	0	8	8	heparin	ACT	PA449855	12;11332;9457;641455	0.925
NULL	Arch_Med_Sci_2013_Aug_30_9(4)_724-730.nxml.txt.nlp	24049536	SENT81	24	24	7	7	genistein	PTH	PA165109660	5741	0.925
NULL	Front_Neurosci_2012_Aug_21_6_122.nxml.txt.nlp	22936897	SENT121	5	5	36	36	pilocarpine	c-src	PA450962	6714	0.925
NULL	Cells_2013_Jan_10_2(1)_43-56.nxml.txt.nlp	24709643	SENT17	14	14	8	8	doxycycline	MYC	PA449415	4609	0.925
NULL	Cell_Death_Differ_2010_Sep_5_17(9)_1511-1523.nxml.txt.nlp	20203690	SENT334	12	12	3	3	ethanol	PC-3	PA448073	692094	0.925
NULL	Breast_Cancer_Res_2011_Jan_17_13(1)_R5.nxml.txt.nlp	21241485	SENT15	15	15	3	3	estradiol	Brn-3b	PA449503	5458	0.925
NULL	J_Hematol_Oncol_2013_Mar_27_6_23.nxml.txt.nlp	23531342	SENT165	6	6	31	31	bortezomib	p53	PA10252	7157	0.925
NULL	J_Korean_Med_Sci_2008_Aug_25_23(4)_685-690.nxml.txt.nlp	18756058	SENT89	28	28	9	9	olanzapine	ghrelin	PA450688	51738	0.925
NULL	Drug_Target_Insights_2006_Oct_23_1_5-10.nxml.txt.nlp	21901053	SENT140	39	39	45	45	aprotinin	INCA	PA448472	440068	0.925
NULL	Cancer_Manag_Res_2013_Jun_7_5_91-101.nxml.txt.nlp	23785245	SENT64	31	31	6	6	gefitinib	EGFR	PA131301952	1956	0.925
NULL	Anal_Bioanal_Chem_2010_Apr_26_396(8)_3027-3040.nxml.txt.nlp	20186537	SENT191	38	38	34	34	phenol	CO2	PA450913	4513	0.925
NULL	Cell_Logist_2012_Jul_1_2(3)_151-160.nxml.txt.nlp	23181198	SENT41	30	30	43	43	choline	DAG	PA448976	1605	0.925
NULL	EMBO_J_2013_Oct_16_32(20)_2751-2763.nxml.txt.nlp	24065129	SENT99	10	10	29	29	etoposide	IRF9	PA449552	10379	0.925
NULL	Oncologist_2010_Feb_15_15(2)_122-129.nxml.txt.nlp	20156908	SENT21	3	3	34	34	lapatinib	HER-2	PA152241907	2064	0.925
NULL	Cardiovasc_Drugs_Ther_2009_Oct_26_23(5)_415-417.nxml.txt.nlp	19784766	SENT16	3	3	35	35	pentobarbital	CO2	PA450859	4513	0.925
NULL	Patient_Prefer_Adherence_2011_Dec_23_6_1-9.nxml.txt.nlp	22272064	SENT3	29	29	8	8	enalapril	ACE	PA449456	1636	0.925
NULL	BMB_Rep_2013_Aug_46(8)_410-415.nxml.txt.nlp	23977989	SENT102	5	5	7	7	curcumin	HO-1	PA151958596	3162	0.925
NULL	Nucleic_Acids_Res_2007_Jan_7_35(2)_e9.nxml.txt.nlp	17158148	SENT134	22	22	11	11	cisplatin	RAD18	PA449014	56852	0.925
NULL	Ann_Rheum_Dis_2015_Jan_28_74(1)_35-43.nxml.txt.nlp	25169728	SENT204	42	42	19	19	tocilizumab	IL-6	PA165292659	3569	0.925
NULL	Case_Rep_Endocrinol_2014_Feb_10_2014_479641.nxml.txt.nlp	24660072	SENT70	12	12	27	27	cinacalcet	PTH	PA164776671	5741	0.925
NULL	Oncogene_2009_Jan_15_28(2)_157-169.nxml.txt.nlp	18931700	SENT14	5	5	29	29	geldanamycin	CDK4	PA152031327	1019	0.925
NULL	Am_J_Physiol_Cell_Physiol_2014_Jan_15_306(2)_C89-C97.nxml.txt.nlp	24133067	SENT178	20	20	5	5	trastuzumab	CD44	PA451743	960	0.925
NULL	Channels_(Austin)_2010_Jan_1_4(1)_22-41.nxml.txt.nlp	19934650	SENT418	37	37	40	40	quinidine	Slo3	PA451209	157855	0.925
NULL	Can_J_Infect_Dis_Med_Microbiol_2014_Nov-Dec_25(6)_327-343.nxml.txt.nlp	25587296	SENT301	12	12	3	3	tacrolimus	CYP3A4	PA451578	1576	0.925
NULL	Int_J_Biol_Sci_2013_Apr_22_9(4)_350-360.nxml.txt.nlp	23630447	SENT187	38	38	25	25	doxorubicin	TCL1A	PA449412	8115	0.925
NULL	Biomed_Res_Int_2013_Dec_16_2013_741403.nxml.txt.nlp	24455721	SENT60	21	21	9	9	ketoconazole	CYP3A4	PA450146	1576	0.925
NULL	Clinics_(Sao_Paulo)_2010_Sep_65(9)_885-894.nxml.txt.nlp	21049217	SENT161	34	34	12	12	haloperidol	Rho	PA449841	29984	0.925
NULL	Breast_Cancer_(Auckl)_2009_Sep_2_3_61-75.nxml.txt.nlp	19809577	SENT114	10	10	2	2	curcumin	BRCA1	PA151958596	672	0.925
NULL	Gynecol_Oncol_Case_Rep_2013_Apr_11_5_37-39.nxml.txt.nlp	24371692	SENT11	7	7	22	22	bevacizumab	CA125	PA130232992	4077;94025	0.925
NULL	Breast_Cancer_Res_2011_Jun_21_13(3)_R66.nxml.txt.nlp	21693010	SENT123	18	18	5	5	sunitinib	c-Raf	PA162372840	5894	0.925
NULL	Breast_Cancer_Res_2004_Aug_5_6(5)_R601-R607.nxml.txt.nlp	15318941	SENT131	18	18	28	28	camptothecin	p27	PA153590860	5715;10534	0.925
NULL	Breast_Cancer_Res_2010_Jun_28_12(3)_R43.nxml.txt.nlp	20579400	SENT15	11	11	0	0	estradiol	MAPT	PA449503	4137	0.925
NULL	J_Gastroenterol_2013_Feb_23_48(12)_1373-1383.nxml.txt.nlp	23435670	SENT73	36	36	25	25	entecavir	LAM	PA164784025	7249;7248	0.925
NULL	Front_Mol_Neurosci_2012_Jun_6_5_69.nxml.txt.nlp	22685426	SENT41	26	26	6	6	etoposide	JNK	PA449552	5599	0.925
NULL	Clin_Interv_Aging_2010_Nov_19_5_345-354.nxml.txt.nlp	21228900	SENT137	4	4	7	7	denosumab	RANKL	PA166048634	8600	0.925
NULL	Mol_Vis_2012_Apr_11_18_901-908.nxml.txt.nlp	22539869	SENT126	4	4	16	16	curcumin	HO-1	PA151958596	3162	0.925
NULL	Indian_J_Med_Res_2013_May_137(5)_977-980.nxml.txt.nlp	23760386	SENT77	5	5	18	18	galantamine	ADP	PA449726	23038	0.925
NULL	Acta_Pharmacol_Sin_2010_Jun_4_31(6)_709-717.nxml.txt.nlp	20523342	SENT147	25	25	3	3	repaglinide	OATP1B1	PA451234	10599	0.925
NULL	F1000_Med_Rep_2010_May_24_2_40.nxml.txt.nlp	20948844	SENT45	9	9	15	15	heparin	APC	PA449855	324	0.925
NULL	Diabetes_Care_2008_Oct_31(10)_2013-2017.nxml.txt.nlp	18650372	SENT129	23	23	6	6	estradiol	aromatase	PA449503	1588	0.925
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Sep_19_65(Pt_10)_o2495.nxml.txt.nlp	21577945	SENT58	15	15	28	28	ethanol	mol	PA448073	90527	0.925
NULL	Daru_2012_Sep_3_20(1)_24.nxml.txt.nlp	23351176	SENT177	18	18	1	1	itopride	EPO	PA152432599	7076;8288;2056	0.925
NULL	Br_J_Cancer_2011_Jul_12_105(2)_221-230.nxml.txt.nlp	21750559	SENT10	24	24	10	10	fludarabine	Mcl-1	PA449655	4170	0.925
NULL	Br_J_Cancer_2012_Feb_14_106(4)_685-692.nxml.txt.nlp	22294184	SENT196	10	10	6	6	lovastatin	JNK	PA450272	5599	0.925
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT95	13	13	9	9	methotrexate	MSH2	PA450428	4436	0.925
NULL	Arthritis_Res_Ther_2008_Sep_24_10(5)_R115.nxml.txt.nlp	18816401	SENT178	39	39	19	19	etanercept	GDF5	PA449515	8200	0.925
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1449-1456.nxml.txt.nlp	24077631	SENT111	23	23	6	6	diclofenac	CYP2C9	PA449293	1559	0.925
NULL	Biologics_2009_Jul_13_3_225-232.nxml.txt.nlp	19707411	SENT108	19	19	0	0	rituximab	CD19	PA451261	930	0.925
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT60	19	19	24	24	ranibizumab	VEGF-A	PA164746012	7422	0.925
NULL	Breast_Cancer_Res_2009_Jun_29_11(3)_R41.nxml.txt.nlp	19563669	SENT154	12	12	7	7	gefitinib	EGFR	PA131301952	1956	0.925
NULL	Cell_Death_Differ_2010_Apr_16_17(4)_666-676.nxml.txt.nlp	19834494	SENT124	36	36	7	7	oxaliplatin	RAGE	PA131285527	177	0.925
NULL	J_Hum_Reprod_Sci_2008_Jul-Dec_1(2)_65-72.nxml.txt.nlp	19562048	SENT249	0	0	3	3	letrozole	aromatase	PA450196	1588	0.925
NULL	Int_J_Biol_Sci_2013_Mar_7_9(3)_279-288.nxml.txt.nlp	23493630	SENT16	4	4	15	15	tocilizumab	CD4	PA165292659	920	0.925
NULL	J_Biomed_Sci_2014_Feb_3_21(1)_10.nxml.txt.nlp	24490900	SENT179	2	2	4	4	alendronate	RANKL	PA448082	8600	0.925
NULL	Tanaffos_2012_11(1)_12-17.nxml.txt.nlp	25191395	SENT98	10	10	0	0	cisplatin	BRCA1	PA449014	672	0.925
NULL	Arthritis_Res_Ther_2006_Dec_28_8(1)_R18.nxml.txt.nlp	16507118	SENT98	13	13	0	0	infliximab	IL-15	PA452639	3600	0.925
NULL	Biochem_Res_Int_2012_Feb_12_2012_346972.nxml.txt.nlp	22400115	SENT35	26	26	0	0	hyaluronan	HARE	PA165958431	55576	0.925
NULL	EMBO_Mol_Med_2012_Oct_30_4(10)_1087-1096.nxml.txt.nlp	22933245	SENT178	19	19	12	12	olaparib	NAMPT		10135	0.925
NULL	Cancer_Metab_2013_Feb_4_1_7.nxml.txt.nlp	24280108	SENT72	2	2	19	19	glucose	FBS	PA449773	64319;26269	0.925
NULL	Cancers_(Basel)_2012_Oct_12_4(4)_989-1035.nxml.txt.nlp	24213498	SENT438	2	2	8	8	gemcitabine	CD133	PA449748	8842	0.925
NULL	J_Neuroinflammation_2011_Feb_4_8_10.nxml.txt.nlp	21294877	SENT111	14	14	23	23	capsaicin	NK1	PA448776	11126	0.925
NULL	Breast_Cancer_Res_2005_Jan_26_7(2)_R256-R266.nxml.txt.nlp	15743506	SENT29	38	38	22	22	methotrexate	HER-2	PA450428	2064	0.925
NULL	Cancers_(Basel)_2013_Aug_22_5(3)_1086-1102.nxml.txt.nlp	24202335	SENT116	30	30	9	9	imatinib	TERT	PA10804	7015	0.925
NULL	Br_J_Cancer_2000_Feb_18_82(3)_560-567.nxml.txt.nlp	10682666	SENT1	40	40	11	11	methotrexate	p53	PA450428	7157	0.925
NULL	Nat_Med_2014_Apr_16_20(4)_385-397.nxml.txt.nlp	24633305	SENT56	8	8	10	10	triciribine	AKT	PA165958661	207	0.925
NULL	Oncotarget_2011_Apr_10_2(4)_321-328.nxml.txt.nlp	21487159	SENT64	11	11	5	5	estradiol	INPP4B	PA449503	8821	0.925
NULL	Exp_Ther_Med_2014_Feb_4_7(2)_478-482.nxml.txt.nlp	24396429	SENT116	18	18	5	5	glucose	HO-1	PA449773	3162	0.925
NULL	Diabetes_Metab_Syndr_Obes_2014_Mar_18_7_107-120.nxml.txt.nlp	24672252	SENT40	0	0	4	4	liraglutide	GLP-1	PA165958364	100125288	0.925
NULL	Int_J_Mol_Sci_2014_Sep_23_15(9)_16911-16935.nxml.txt.nlp	25250910	SENT142	0	0	27	27	paraformaldehyde	mol	PA450790	90527	0.925
NULL	Curr_Neuropharmacol_2010_Jun_8(2)_97-104.nxml.txt.nlp	21119880	SENT44	16	16	2	2	arsenite	AQP9	PA452638	366;364	0.925
NULL	Eur_J_Nutr_2009_Jun_24_48(4)_229-234.nxml.txt.nlp	19238310	SENT20	4	4	23	23	capsaicin	ghrelin	PA448776	51738	0.925
NULL	Br_J_Cancer_2010_Jan_19_102(2)_342-350.nxml.txt.nlp	20010939	SENT132	3	3	18	18	flavopiridol	p53	PA452627	7157	0.925
NULL	Oncogene_2013_Sep_26_32(39)_10_1038_onc_2012_491.nxml.txt.nlp	23108394	SENT51	10	10	6	6	epirubicin	FOXM1	PA449476	2305	0.925
NULL	Environ_Health_Perspect_2009_Feb_8_117(2)_175-180.nxml.txt.nlp	19270784	SENT99	6	6	32	32	doxorubicin	BPA	PA449412	667	0.925
NULL	AMB_Express_2014_May_1_4_41.nxml.txt.nlp	24949274	SENT97	5	5	12	12	ethanol	HPX	PA448073	3263	0.925
NULL	Breast_Cancer_Res_2011_Nov_1_13(6)_224.nxml.txt.nlp	22114931	SENT104	6	6	11	11	fulvestrant	HER2	PA164747170	2064	0.925
NULL	Oncoimmunology_2013_Sep_1_2(9)_e25789.nxml.txt.nlp	24244905	SENT31	3	3	24	24	cyclophosphamide	p53	PA449165	7157	0.925
NULL	Ann_Oncol_2011_Mar_8_22(3)_503-514.nxml.txt.nlp	20616198	SENT126	3	3	17	17	exemestane	aromatase	PA449563	1588	0.925
NULL	Mol_Cancer_2012_May_14_11_33.nxml.txt.nlp	22583829	SENT175	12	12	2	2	cisplatin	TLR4	PA449014	7099	0.925
NULL	Indian_J_Med_Res_2014_Feb_139(2)_195-204.nxml.txt.nlp	24718393	SENT165	0	0	32	32	fluconazole	CYP3A4	PA449653	1576	0.925
NULL	Cancer_Cell_Int_2013_Jan_15_13_3.nxml.txt.nlp	23320839	SENT135	7	7	33	33	gefitinib	ABCC2	PA131301952	1244	0.925
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1449-1456.nxml.txt.nlp	24077631	SENT117	27	27	7	7	tolbutamide	CYP2C9	PA451718	1559	0.925
NULL	Reprod_Biol_Endocrinol_2004_Aug_4_2_59.nxml.txt.nlp	15294019	SENT126	13	13	25	25	forskolin	EGF	PA146096022	1950	0.925
NULL	Mol_Brain_2014_Apr_21_7_28.nxml.txt.nlp	24751148	SENT174	2	2	14	14	minocycline	TLR4	PA450519	7099	0.925
NULL	Iran_J_Reprod_Med_2013_Sep_11(9)_693-704.nxml.txt.nlp	24639808	SENT66	2	2	21	21	estradiol	KIT	PA449503	3815	0.925
NULL	Cancer_Cell_Int_2009_Jan_2_9_1.nxml.txt.nlp	19118501	SENT25	2	2	27	27	curcumin	JNK	PA151958596	5599	0.925
NULL	Breast_Cancer_Res_2009_Nov_17_11(6)_R84.nxml.txt.nlp	19919679	SENT120	40	40	44	44	lapatinib	HER2	PA152241907	2064	0.925
NULL	Age_(Dordr)_2010_Mar_12_32(1)_109-121.nxml.txt.nlp	19908165	SENT39	13	13	25	25	estradiol	San	PA449503	80218	0.925
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1137-1144.nxml.txt.nlp	20234366	SENT58	20	20	15	15	cetuximab	MKP-1	PA10040	1843	0.925
NULL	AAPS_J_2014_Jun_11_16(5)_1029-1037.nxml.txt.nlp	24917180	SENT140	2	2	11	11	quinidine	P-gp	PA451209	5243	0.925
NULL	Oncotarget_2010_May_10_1(1)_69-76.nxml.txt.nlp	20657741	SENT96	19	19	28	28	bevacizumab	VEGF-A	PA130232992	7422	0.925
NULL	Oncotarget_2014_Sep_2_5(19)_9308-9321.nxml.txt.nlp	25301721	SENT71	25	25	15	15	rolipram	MRP4	PA153906323	10257	0.925
NULL	J_Carcinog_2014_Nov_27_13_13.nxml.txt.nlp	25525412	SENT98	20	20	12	12	panitumumab	KRAS	PA162373091	3845	0.925
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT134	12	12	23	23	pp2	PP2		4888	0.925
NULL	Patient_Prefer_Adherence_2011_Dec_23_6_1-9.nxml.txt.nlp	22272064	SENT3	34	34	8	8	ramipril	ACE	PA451223	1636	0.925
NULL	Br_J_Cancer_2011_Jun_28_105(1)_1-8.nxml.txt.nlp	21654681	SENT62	14	14	3	3	gefitinib	EGFR	PA131301952	1956	0.925
NULL	Breast_Cancer_Res_2007_Dec_17_9(6)_R87.nxml.txt.nlp	18086299	SENT13	10	10	0	0	trastuzumab	CD40	PA451743	958	0.925
NULL	Commun_Integr_Biol_2012_Nov_1_5(6)_553-556.nxml.txt.nlp	23336024	SENT54	20	20	5	5	chloroquine	GluA1	PA448948	2890	0.925
NULL	Environ_Health_Perspect_2005_Apr_14_113(4)_431-439.nxml.txt.nlp	15811834	SENT22	6	6	0	0	nifedipine	PRL	PA450631	5617	0.925
NULL	Braz_J_Microbiol_2008_Jun_1_Apr-Jun_39(2)_219-225.nxml.txt.nlp	24031205	SENT10	24	24	18	18	fluconazole	CDR1	PA449653	1038	0.925
NULL	J_Immunother_Cancer_2014_Nov_6_2(Suppl_3)_P210.nxml.txt.nlp	NULL	SENT8	0	0	23	23	curcumin	STAT3	PA151958596	6774	0.925
NULL	Oncotarget_2013_Dec_28_5(6)_1475-1490.nxml.txt.nlp	24721996	SENT177	23	23	2	2	celecoxib	CD133	PA448871	8842	0.925
NULL	Oncotarget_2011_Jun_15_2(6)_518-524.nxml.txt.nlp	21680956	SENT138	3	3	22	22	pimozide	STAT3	PA450965	6774	0.925
NULL	Breast_Cancer_Res_2004_May_18_6(4)_148-152.nxml.txt.nlp	15217485	SENT37	15	15	18	18	tamoxifen	aromatase	PA451581	1588	0.925
NULL	Cell_Cycle_2012_Dec_15_11(24)_4661-4672.nxml.txt.nlp	23187802	SENT56	18	18	5	5	doxorubicin	p53	PA449412	7157	0.925
NULL	Cell_Death_Dis_2013_Jun_13_4(6)_e664.nxml.txt.nlp	23764845	SENT247	3	3	30	30	nadh	NAC	PA164755085	22861	0.925
NULL	Breast_Cancer_Res_Treat_2012_Jun_18_133(3)_937-947.nxml.txt.nlp	22094936	SENT210	14	14	23	23	tamoxifen	EZH2	PA451581	2146	0.925
NULL	Hum_Mol_Genet_2011_May_15_20(10)_2037-2047.nxml.txt.nlp	21372148	SENT12	19	19	3	3	oxygen	CLN3	PA450744	1201	0.925
NULL	Cancers_(Basel)_2014_Jun_27_6(3)_1298-1327.nxml.txt.nlp	24978435	SENT114	29	29	18	18	bicalutamide	PI3	PA164746255	5266	0.925
NULL	Clin_Dev_Immunol_2011_Oct_20_2011_947858.nxml.txt.nlp	22046194	SENT34	22	22	6	6	cisplatin	p110	PA449014	9733	0.925
NULL	Exp_Cell_Res_2009_Nov_15_315(19)_3433-3441.nxml.txt.nlp	19716819	SENT187	38	38	22	22	hyaluronidase	CD44	PA164745713	960	0.925
NULL	Cardiovasc_Res_2014_Mar_1_101(3)_513-521.nxml.txt.nlp	24323316	SENT27	35	35	23	23	maraviroc	CCL4	PA164768835	6351	0.925
NULL	Acta_Pharmacol_Sin_2009_Feb_5_30(2)_228-234.nxml.txt.nlp	19122672	SENT125	21	21	2	2	isoflurane	HO-1	PA450106	3162	0.925
NULL	Pharmaceuticals_(Basel)_2012_Jul_25_5(8)_779-801.nxml.txt.nlp	24280675	SENT148	2	2	17	17	imatinib	FLT3	PA10804	2322	0.925
NULL	Int_J_Mol_Sci_2012_Dec_7_13(12)_16751-16768.nxml.txt.nlp	23222680	SENT166	3	3	18	18	tranylcypromine	LSD1	PA451741	23028	0.925
NULL	Curr_HIV_Res_2014_May_12(3)_174-188.nxml.txt.nlp	24862327	SENT127	1	1	14	14	ethanol	HO-1	PA448073	3162	0.925
NULL	Cancer_Cell_Int_2009_Sep_10_9_25.nxml.txt.nlp	19744341	SENT180	28	28	25	25	glucosamine	STAT3	PA164747613	6774	0.925
NULL	Oncotarget_2014_Oct_18_5(22)_11604-11619.nxml.txt.nlp	25344099	SENT133	24	24	3	3	cisplatin	RYBP	PA449014	23429	0.925
NULL	Tuberc_Respir_Dis_(Seoul)_2012_Oct_31_73(4)_197-203.nxml.txt.nlp	23166554	SENT65	8	8	3	3	gefitinib	EGFR	PA131301952	1956	0.925
NULL	Breast_Cancer_Res_2005_Jul_27_7(5)_R765-R774.nxml.txt.nlp	16168122	SENT26	20	20	32	32	topotecan	p53	PA451729	7157	0.925
NULL	Mol_Vis_2011_Feb_1_17_332-340.nxml.txt.nlp	21297899	SENT190	8	8	15	15	telmisartan	DPI	PA451605	1832	0.925
NULL	J_Adv_Pharm_Technol_Res_2014_Jan-Mar_5(1)_21-27.nxml.txt.nlp	24696814	SENT56	40	40	23	23	ethanol	mol	PA448073	90527	0.925
NULL	Cell_Res_2011_Mar_11_21(3)_530-545.nxml.txt.nlp	21221130	SENT101	39	39	23	23	thrombin	CD42b	PA451674	2811	0.925
NULL	Genome_Announc_2014_Oct_16_2(5)_e01017-14.nxml.txt.nlp	25323711	SENT21	16	16	6	6	ethambutol	DST	PA164784021	667	0.925
NULL	Nucleic_Acids_Res_2005_Jun_8_33(10)_3283-3291.nxml.txt.nlp	15944449	SENT157	26	26	3	3	sjg-136	ERCC1		2067	0.925
NULL	Drug_Des_Devel_Ther_2014_Sep_23_8_1527-1538.nxml.txt.nlp	25284985	SENT156	13	13	32	32	celecoxib	IFN	PA448871	3439	0.925
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT277	20	20	8	8	resveratrol	NAC		22861	0.925
NULL	J_Mol_Signal_2011_Aug_12_6_9.nxml.txt.nlp	21838893	SENT233	13	13	21	21	formoterol	SSTR5	PA134687907	6755	0.925
NULL	Cancer_Cell_Int_2005_Jul_24_5_22.nxml.txt.nlp	16042792	SENT91	28	28	2	2	vincristine	NAC	PA451879	22861	0.925
NULL	Br_J_Cancer_2009_Jul_21_101(2)_269-277.nxml.txt.nlp	19603033	SENT124	47	47	4	4	cisplatin	XIAP	PA449014	331	0.925
NULL	Drugs_R_D_2013_Dec_30_13(4)_281-288.nxml.txt.nlp	24170256	SENT15	0	0	33	33	olanzapine	FAST	PA450688	10922	0.925
NULL	Front_Syst_Neurosci_2014_Mar_10_8_27.nxml.txt.nlp	24653682	SENT14	27	27	3	3	baclofen	spatial	PA448533	219793	0.925
NULL	Mol_Cancer_2007_Jan_14_6_5.nxml.txt.nlp	17222355	SENT38	16	16	11	11	doxorubicin	HMGA2	PA449412	8091	0.925
NULL	Mol_Biol_Cell_2014_May_15_25(10)_1641-1652.nxml.txt.nlp	24648491	SENT134	3	3	19	19	cisplatin	NPM1	PA449014	4869	0.925
NULL	Mol_Cancer_2012_May_28_11_36.nxml.txt.nlp	22640878	SENT301	25	25	7	7	paclitaxel	TGFBI	PA450761	7045	0.925
NULL	J_Carcinog_2013_Dec_31_12_22.nxml.txt.nlp	24574860	SENT84	47	47	17	17	afatinib	EGFR	PA165981154	1956	0.925
NULL	Chem_Rev_2012_May_9_112(5)_2593-2603.nxml.txt.nlp	22335786	SENT56	27	27	14	14	choline	ATX	PA448976	5168;23049	0.925
NULL	Breast_Cancer_Res_2010_Mar_5_12(2)_R16.nxml.txt.nlp	20205716	SENT9	16	16	5	5	lovastatin	CDC42	PA450272	998	0.925
NULL	Acta_Pharmacol_Sin_2014_Jun_4_35(6)_752-757.nxml.txt.nlp	24902786	SENT94	12	12	5	5	flutamide	STL2	PA449685	1301	0.925
NULL	J_Biol_Chem_2008_Nov_7_283(45)_30735-30744.nxml.txt.nlp	18786921	SENT156	26	26	17	17	nadh	ALDH2	PA164755085	217	0.925
NULL	Int_J_Endocrinol_2013_Nov_13_2013_686315.nxml.txt.nlp	24324494	SENT99	29	29	7	7	metformin	KCNJ11	PA450395	3767	0.925
NULL	J_Cell_Biol_2003_Dec_8_163(5)_1099-1109.nxml.txt.nlp	14662748	SENT83	20	20	18	18	forskolin	AVP	PA146096022	114548;551	0.925
NULL	Mol_Cancer_2013_Mar_5_12_17.nxml.txt.nlp	23497256	SENT181	11	11	8	8	sunitinib	p53	PA162372840	7157	0.925
NULL	J_Cell_Biol_1998_Jul_13_142(1)_153-165.nxml.txt.nlp	9660870	SENT244	1	1	28	28	colchicine	B10	PA449092	5169	0.925
NULL	J_Cell_Biol_1995_Mar_2_128(6)_1185-1196.nxml.txt.nlp	7896881	SENT4	21	21	4	4	mitomycin	p53	PA450524	7157	0.925
NULL	Eur_J_Clin_Pharmacol_2010_Nov_29_66(11)_1131-1136.nxml.txt.nlp	20669013	SENT115	23	23	27	27	erythromycin	CYP2C19	PA449493	1557	0.925
NULL	ScientificWorldJournal_2012_Apr_26_2012_358102.nxml.txt.nlp	22645419	SENT182	6	6	3	3	losartan	AT1	PA450268	9197;185	0.925
NULL	Nucleic_Acids_Res_2010_Oct_21_38(18)_6148-6158.nxml.txt.nlp	20494979	SENT308	26	26	38	38	staurosporine	HLJ1	PA165109623	11080	0.925
NULL	Biomed_Res_Int_2014_Aug_6_2014_621827.nxml.txt.nlp	25165710	SENT302	6	6	13	13	dexmedetomidine	CD68	PA449256	968	0.925
NULL	Nat_Commun_2013_Apr_23_4_1758.nxml.txt.nlp	23612299	SENT185	15	15	0	0	isoproterenol	SOD1	PA450121	6647	0.925
NULL	Mol_Cancer_2012_Jul_12_11_45.nxml.txt.nlp	22788833	SENT123	17	17	26	26	cisplatin	EGFR	PA449014	1956	0.925
NULL	Int_J_Mol_Sci_2014_Nov_7_15(11)_20449-20468.nxml.txt.nlp	25387075	SENT290	3	3	12	12	nadh	FN1	PA164755085	2335	0.925
NULL	Curr_Hematol_Malig_Rep_2014_Feb_6_9(1)_9-16.nxml.txt.nlp	24500518	SENT100	5	5	20	20	imatinib	CD34	PA10804	947	0.925
NULL	FEBS_Open_Bio_2012_Aug_22_2_279-283.nxml.txt.nlp	23650611	SENT368	5	5	18	18	raloxifene	IFN	PA451221	3439	0.925
NULL	Case_Rep_Oncol_2012_May_23_5(2)_253-259.nxml.txt.nlp	22712013	SENT75	0	0	2	2	erlotinib	EGFR	PA134687924	1956	0.925
NULL	Cardiol_Res_Pract_2011_Apr_26_2011_874802.nxml.txt.nlp	21577272	SENT114	9	9	17	17	dronedarone	CYP3A4	PA153619853	1576	0.925
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1563-1573.nxml.txt.nlp	22015557	SENT126	6	6	24	24	sunitinib	c-Myc	PA162372840	4609	0.925
NULL	Emerg_Infect_Dis_2003_Jun_9(6)_657-664.nxml.txt.nlp	12781004	SENT21	9	9	0	0	vancomycin	VISA	PA451850	57506	0.925
NULL	Breast_Cancer_Res_2002_Apr_18_4(3)_95-99.nxml.txt.nlp	12052251	SENT85	10	10	28	28	trastuzumab	HER2	PA451743	2064	0.925
NULL	Cell_Commun_Signal_2013_Sep_18_11_67.nxml.txt.nlp	24047406	SENT90	22	22	13	13	paraformaldehyde	MEK1	PA450790	5604	0.925
NULL	Endocrinology_2012_Jan_15_153(1)_200-211.nxml.txt.nlp	22087024	SENT177	20	20	4	4	methylprednisolone	c-fos	PA450466	2353	0.925
NULL	Scientifica_(Cairo)_2013_Dec_10_2013_691251.nxml.txt.nlp	24386592	SENT194	7	7	19	19	paclitaxel	SIRT6	PA450761	51548	0.925
NULL	J_Geriatr_Cardiol_2013_Jun_10(2)_151-158.nxml.txt.nlp	23888175	SENT23	4	4	26	26	rosuvastatin	AT1	PA134308647	9197;185	0.925
NULL	J_Headache_Pain_2014_Dec_8_15(1)_85.nxml.txt.nlp	25488888	SENT102	18	18	12	12	eletriptan	5-HT1D	PA134687947	3352	0.925
NULL	Adv_Urol_2012_Oct_26_2012_812398.nxml.txt.nlp	22110495	SENT6	28	28	4	4	cisplatin	ERCC1	PA449014	2067	0.925
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT246	15	15	1	1	cisplatin	IBP	PA449014	706;50619	0.925
NULL	Int_J_Mol_Sci_2014_Jun_5_15(6)_10083-10100.nxml.txt.nlp	24905407	SENT192	13	13	27	27	tetracycline	San	PA451640	80218	0.925
NULL	Nucleic_Acids_Res_2005_Aug_12_33(14)_4584-4592.nxml.txt.nlp	16100380	SENT121	2	2	6	6	paromomycin	GCN2	PA164784023	440275	0.925
NULL	Clin_Pediatr_Endocrinol_2013_Jan_7_22(1)_1-8.nxml.txt.nlp	23966754	SENT82	4	4	34	34	metformin	GLP-1	PA450395	100125288	0.925
NULL	Aust_N_Z_J_Psychiatry_2011_Sep_3_45(9)_712-725.nxml.txt.nlp	21888608	SENT286	2	2	11	11	fluoxetine	CYP2D6	PA449673	1565	0.925
NULL	Oncol_Lett_2014_Nov_12_8(5)_2203-2208.nxml.txt.nlp	25295109	SENT111	37	37	26	26	celecoxib	PTCH1	PA448871	5727	0.925
NULL	Breast_Cancer_Res_Treat_2014_Sep_13_147(3)_631-638.nxml.txt.nlp	25216762	SENT2	2	2	9	9	capecitabine	HER-2	PA448771	2064	0.925
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_91-103.nxml.txt.nlp	17912639	SENT70	8	8	41	41	trastuzumab	HER2	PA451743	2064	0.925
NULL	Evid_Based_Complement_Alternat_Med_2012_Dec_24_2012_976926.nxml.txt.nlp	23326296	SENT25	4	4	11	11	tocilizumab	IL-6	PA165292659	3569	0.925
NULL	Arthritis_Res_Ther_2012_Sep_24_14(5)_R200.nxml.txt.nlp	23006144	SENT169	6	6	24	24	alefacept	IL-20	PA164748040	27190;50604	0.925
NULL	Drug_Des_Devel_Ther_2014_Sep_24_8_1563-1575.nxml.txt.nlp	25284986	SENT152	16	16	2	2	metoprolol	BCS	PA450480	617	0.925
NULL	Cancer_Cell_Int_2013_Nov_8_13_111.nxml.txt.nlp	24209962	SENT129	5	5	0	0	fluvastatin	A20	PA449688	7128;28935	0.925
NULL	J_Mol_Signal_2011_Aug_10_6_8.nxml.txt.nlp	21831305	SENT112	11	11	24	24	isoproterenol	AKAP12	PA450121	9590	0.925
NULL	J_Cell_Physiol_2011_Nov_15_226(11)_2979-2986.nxml.txt.nlp	21328349	SENT225	3	3	10	10	econazole	TRPV5	PA164746010	56302	0.925
NULL	Front_Neurosci_2014_Dec_8_8_388.nxml.txt.nlp	25538545	SENT154	13	13	4	4	estradiol	5-HT2A	PA449503	3356	0.925
NULL	Front_Endocrinol_(Lausanne)_2013_Oct_11_4_140.nxml.txt.nlp	24130552	SENT311	34	34	11	11	estradiol	ARC	PA449503	8996;23237	0.925
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_15_2012_638197.nxml.txt.nlp	23118795	SENT169	13	13	22	22	ethanol	CYP2E1	PA448073	1571	0.925
NULL	BMB_Rep_2013_Nov_46(11)_544-549.nxml.txt.nlp	24152910	SENT21	3	3	8	8	thrombin	PAR-1	PA451674	2011;2149	0.925
NULL	Breast_Cancer_Res_2001_Dec_20_3(2)_91-94.nxml.txt.nlp	11250752	SENT18	23	23	1	1	lovastatin	p27	PA450272	5715;10534	0.925
NULL	Breast_Cancer_(Auckl)_2011_Jul_27_5_175-199.nxml.txt.nlp	21863131	SENT166	0	0	7	7	olaparib	PARP2		10038	0.925
NULL	Nucl_Recept_Signal_2008_Nov_26_6_e010.nxml.txt.nlp	19079612	SENT502	13	13	20	20	bicalutamide	IL-8	PA164746255	3576	0.925
NULL	Emerg_Infect_Dis_2011_Mar_17(3)_495-497.nxml.txt.nlp	21392442	SENT17	30	30	1	1	amikacin	DST	PA164744372	667	0.925
NULL	Arch_Dis_Child_2008_Jul_1_93(7)_620-625.nxml.txt.nlp	18381346	SENT226	10	10	6	6	sildenafil	PAP	PA451346	11333;10884;10914;11334;8853;50807	0.925
NULL	Expert_Rev_Mol_Med_2011_Nov_13_e35.nxml.txt.nlp	22088887	SENT466	12	12	10	10	nutlin-3	MDM2		4193	0.925
NULL	J_Thorac_Oncol_2015_Jan_29_10(1)_156-163.nxml.txt.nlp	25247337	SENT295	4	4	16	16	afatinib	EGFR	PA165981154	1956	0.925
NULL	Curr_Colorectal_Cancer_Rep_2014_Jan_12_10(1)_45-54.nxml.txt.nlp	24659930	SENT104	37	37	17	17	oxaliplatin	HER2	PA131285527	2064	0.925
NULL	Eur_J_Clin_Pharmacol_2014_Oct_8_70(12)_1433-1441.nxml.txt.nlp	25291992	SENT173	32	32	22	22	olanzapine	CPZ	PA450688	8532	0.925
NULL	Front_Neurosci_2012_May_30_6_78.nxml.txt.nlp	22661926	SENT11	22	22	34	34	vasopressin	VR2	PA451858	56663	0.925
NULL	Viruses_2014_Apr_22_6(4)_1837-1860.nxml.txt.nlp	24759213	SENT316	12	12	5	5	imatinib	M-CSF	PA10804	1435	0.925
NULL	Clin_Endocrinol_(Oxf)_2014_Jan_1_81(2)_289-293.nxml.txt.nlp	24735400	SENT77	21	21	7	7	hydrocortisone	ACTH	PA449905	5443	0.925
NULL	Cell_Microbiol_2013_Jun_9_15(6)_977-991.nxml.txt.nlp	23241026	SENT268	26	26	31	31	ethanol	CO2	PA448073	4513	0.925
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_May_26_66(Pt_6)_o1471.nxml.txt.nlp	21579539	SENT54	20	20	7	7	ethanol	mol	PA448073	90527	0.925
NULL	J_Biomed_Sci_2012_Nov_21_19(1)_99.nxml.txt.nlp	23170833	SENT126	30	30	20	20	atorvastatin	CXCR4	PA448500	7852	0.925
NULL	J_Cardiothorac_Surg_2014_May_9_9_81.nxml.txt.nlp	24885948	SENT14	3	3	43	43	sorafenib	GATA4	PA7000	2626	0.925
NULL	Biomed_Res_Int_2013_Jan_1_2013_384734.nxml.txt.nlp	23484114	SENT70	18	18	3	3	thioguanine	GDNF	PA451663	2668	0.925
NULL	Int_J_Mol_Sci_2014_Mar_3_15(3)_3768-3783.nxml.txt.nlp	24595239	SENT112	7	7	16	16	hyaluronan	TSG-6	PA165958431	7130	0.925
NULL	Breast_Cancer_Res_2010_Jun_22_12(3)_R39.nxml.txt.nlp	20569502	SENT163	17	17	0	0	tamoxifen	MCM2	PA451581	4171	0.925
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT262	3	3	15	15	tacrolimus	JAK2	PA451578	3717	0.925
NULL	Anesth_Essays_Res_2014_Sep-Dec_8(3)_307-312.nxml.txt.nlp	NULL	SENT49	12	12	24	24	clonidine	Era	PA449051	2099	0.925
NULL	Nucleic_Acids_Res_2013_Nov_27_41(21)_9786-9799.nxml.txt.nlp	23982513	SENT321	17	17	26	26	arsenite	TIAR	PA452638	7073	0.925
NULL	Clin_Ophthalmol_2007_Sep_1(3)_225-232.nxml.txt.nlp	19668476	SENT41	8	8	25	25	travoprost	C-1	PA164781371	5203	0.925
NULL	J_Hematol_Oncol_2013_Jan_4_6_1.nxml.txt.nlp	23286345	SENT149	25	25	7	7	cetuximab	FCGR2A	PA10040	2212	0.925
NULL	J_Thorac_Oncol_2014_Feb_23_9(2)_231-238.nxml.txt.nlp	24419421	SENT190	19	19	37	37	paclitaxel	EGFR	PA450761	1956	0.925
NULL	Indian_J_Med_Res_2012_Dec_136(6)_907-925.nxml.txt.nlp	23391787	SENT515	10	10	4	4	artesunate	ACT	PA165111697	12;11332;9457;641455	0.925
NULL	Mol_Cancer_2010_May_28_9_130.nxml.txt.nlp	20509890	SENT11	11	11	4	4	paclitaxel	TGFBI	PA450761	7045	0.925
NULL	Mol_Cancer_2009_Jul_3_8_43.nxml.txt.nlp	19575780	SENT229	22	22	13	13	paclitaxel	survivin	PA450761	332	0.925
NULL	Mol_Cancer_2014_Jun_24_13_157.nxml.txt.nlp	24958351	SENT125	8	8	30	30	trastuzumab	S3A	PA451743	6189	0.925
NULL	J_Cancer_2013_Aug_28_4(7)_585-596.nxml.txt.nlp	24069069	SENT217	12	12	6	6	gemcitabine	LC3	PA449748	84557	0.925
NULL	Biol_Open_2013_Aug_6_2(10)_1022-1031.nxml.txt.nlp	24167712	SENT272	34	34	41	41	doxycycline	PLK1	PA449415	5347	0.925
NULL	AIDS_Res_Treat_2012_Mar_21_2012_186987.nxml.txt.nlp	22536495	SENT37	24	24	5	5	etravirine	TYPE	PA166014703	6445	0.925
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Nov_22_64(Pt_12)_o2409.nxml.txt.nlp	21581378	SENT57	25	25	7	7	ethanol	mol	PA448073	90527	0.925
NULL	Br_J_Pharmacol_2011_Feb_162(4)_989-999.nxml.txt.nlp	21054342	SENT220	10	10	39	39	ketoconazole	CYP3A4	PA450146	1576	0.925
NULL	Indian_J_Med_Paediatr_Oncol_2014_Apr-Jun_35(2)_176-180.nxml.txt.nlp	25197183	SENT35	18	18	4	4	lapatinib	HER-2	PA152241907	2064	0.925
NULL	Br_J_Cancer_2011_Aug_23_105(5)_649-657.nxml.txt.nlp	21811251	SENT155	31	31	9	9	gefitinib	IGF1R	PA131301952	3480	0.925
NULL	South_Asian_J_Cancer_2014_Jul-Sep_3(3)_182-184.nxml.txt.nlp	25136528	SENT82	12	12	9	9	ketoconazole	CYP3A4	PA450146	1576	0.925
NULL	Front_Oncol_2014_Jun_20_4_163.nxml.txt.nlp	24999452	SENT193	24	24	6	6	cisplatin	ENG	PA449014	2022	0.925
NULL	J_Cereb_Blood_Flow_Metab_2014_Oct_23_34(10)_1585-1598.nxml.txt.nlp	25052556	SENT192	7	7	35	35	indomethacin	CTH	PA449982	1491;23584	0.925
NULL	Arthritis_Res_Ther_2013_Dec_19_15(6)_R218.nxml.txt.nlp	24351550	SENT22	37	37	41	41	methotrexate	AMPK	PA450428	5563	0.925
NULL	Breast_Cancer_Res_2000_Mar_12_2(Suppl_1)_P5_01.nxml.txt.nlp	NULL	SENT5	39	39	24	24	doxorubicin	p16	PA449412	1029	0.925
NULL	Oncol_Rep_2014_Jan_13_31(1)_376-383.nxml.txt.nlp	24220856	SENT86	16	16	4	4	paclitaxel	PA1	PA450761	79447	0.925
NULL	Brain_2014_Oct_30_137(10)_2743-2758.nxml.txt.nlp	25080285	SENT35	31	31	5	5	levodopa	COMT	PA450213	1312	0.925
NULL	Br_J_Cancer_2009_Jul_21_101(2)_238-243.nxml.txt.nlp	19568242	SENT143	15	15	28	28	bevacizumab	IFN	PA130232992	3439	0.925
NULL	Int_J_Gen_Med_2012_Apr_13_5_317-322.nxml.txt.nlp	22536087	SENT4	0	0	9	9	liraglutide	GLP-1	PA165958364	100125288	0.925
NULL	Front_Genet_2014_Nov_14_5_391.nxml.txt.nlp	25452763	SENT724	12	12	7	7	cisplatin	ATP7B	PA449014	540	0.925
NULL	Br_J_Clin_Pharmacol_2013_Aug_23_76(2)_299-315.nxml.txt.nlp	23701319	SENT176	26	26	1	1	alemtuzumab	CD4	PA164783958	920	0.925
NULL	Psychol_Res_Behav_Manag_2010_Dec_6_3_109-118.nxml.txt.nlp	22110334	SENT114	34	34	15	15	paroxetine	CYP2C9	PA450801	1559	0.925
NULL	Clin_Interv_Aging_2015_Jan_14_10_269-275.nxml.txt.nlp	25609939	SENT32	16	16	24	24	galantamine	CYP2D6	PA449726	1565	0.925
NULL	Oncotarget_2014_Aug_29_5(18)_8052-8082.nxml.txt.nlp	25211298	SENT251	0	0	7	7	celecoxib	COX	PA448871	1351	0.925
NULL	Biomed_Res_Int_2014_Jan_29_2014_831845.nxml.txt.nlp	24605337	SENT110	39	39	6	6	bupivacaine	S6K1	PA135057240	6198	0.925
NULL	Clin_Ophthalmol_2012_Oct_30_6_1749-1753.nxml.txt.nlp	23152652	SENT11	3	3	32	32	latanoprost	ANOVA	PA164774763	4858	0.925
NULL	Breast_Cancer_Res_2000_Mar_12_2(Suppl_1)_P7_04.nxml.txt.nlp	NULL	SENT14	5	5	12	12	cisplatin	BRCA1	PA449014	672	0.925
NULL	J_Korean_Med_Sci_2005_Dec_31_20(6)_1076-1078.nxml.txt.nlp	16361827	SENT45	11	11	31	31	vasopressin	AVPR2	PA451858	554	0.925
NULL	Breast_Cancer_Res_2011_Jun_27_13(3)_212.nxml.txt.nlp	21787441	SENT163	26	26	7	7	trastuzumab	HER2	PA451743	2064	0.925
NULL	Leukemia_2013_Feb_31_27(2)_278-285.nxml.txt.nlp	22907049	SENT35	11	11	3	3	sorafenib	KIT	PA7000	3815	0.925
NULL	Breast_Cancer_Res_Treat_2012_Jun_18_133(3)_937-947.nxml.txt.nlp	22094936	SENT38	25	25	17	17	tamoxifen	EZH2	PA451581	2146	0.925
NULL	Oncotarget_2011_Mar_23_2(3)_165-177.nxml.txt.nlp	21444946	SENT133	22	22	11	11	carboplatin	EGFR	PA448803	1956	0.925
NULL	Case_Rep_Hematol_2013_Sep_5_2013_708489.nxml.txt.nlp	24083040	SENT68	19	19	10	10	iron	B12	PA450087	7126;4709	0.925
NULL	J_Clin_Biochem_Nutr_2011_Mar_26_48(2)_126-133.nxml.txt.nlp	21373265	SENT140	6	6	10	10	hemin	CD4	PA449849	920	0.925
NULL	Cell_Death_Dis_2010_Feb_4_1(2)_e23.nxml.txt.nlp	21364631	SENT8	33	33	20	20	curcumin	JNK	PA151958596	5599	0.925
NULL	Open_Biochem_J_2011_Sep_23_5_45-51.nxml.txt.nlp	21966325	SENT109	39	39	20	20	diclofenac	ATF6	PA449293	22926	0.925
NULL	Ann_Rheum_Dis_2013_Apr_11_72(4)_583-589.nxml.txt.nlp	23144446	SENT143	16	16	12	12	tocilizumab	IL-6	PA165292659	3569	0.925
NULL	BMB_Rep_2013_Aug_46(8)_410-415.nxml.txt.nlp	23977989	SENT107	8	8	19	19	curcumin	HO-1	PA151958596	3162	0.925
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT31	5	5	13	13	atorvastatin	IL-6	PA448500	3569	0.925
NULL	Indian_J_Anaesth_2014_Jul-Aug_58(4)_423-429.nxml.txt.nlp	25197110	SENT43	9	9	3	3	ondansetron	ODF4	PA450705	146852	0.925
NULL	Cancers_(Basel)_2010_May_26_2(2)_970-988.nxml.txt.nlp	24281102	SENT179	0	0	17	17	bevacizumab	VEGFR2	PA130232992	3791	0.925
NULL	J_Korean_Med_Sci_2011_Feb_24_26(2)_304-307.nxml.txt.nlp	21286027	SENT45	28	28	10	10	methotrexate	CHOP	PA450428	1649	0.925
NULL	Br_J_Cancer_2004_Mar_5_90(Suppl_1)_S2-S6.nxml.txt.nlp	15094757	SENT65	33	33	4	4	fulvestrant	AF1	PA164747170	1946	0.925
NULL	Oncotarget_2014_Nov_4_5(19)_8906-8923.nxml.txt.nlp	25275298	SENT193	10	10	36	36	doxycycline	SMAD7	PA449415	4092	0.925
NULL	Oncotarget_2013_Aug_21_4(9)_1484-1495.nxml.txt.nlp	23986086	SENT165	7	7	11	11	metformin	HER2	PA450395	2064	0.925
NULL	J_Immunother_2014_Feb_21_37(2)_105-114.nxml.txt.nlp	24509173	SENT8	28	28	2	2	gemcitabine	HLA-A	PA449748	3105	0.925
NULL	Iran_J_Pharm_Res_2013_Winter_12(Suppl)_3-10.nxml.txt.nlp	24250666	SENT138	13	13	36	36	ethanol	ANOVA	PA448073	4858	0.925
NULL	Crit_Care_2007_Sep_19_11(5)_229.nxml.txt.nlp	17903310	SENT30	44	44	32	32	etoposide	HMGB1	PA449552	3146	0.925
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT44	19	19	8	8	trastuzumab	STAT3	PA451743	6774	0.925
NULL	Cancers_(Basel)_2010_Dec_24_3(1)_43-60.nxml.txt.nlp	24212605	SENT200	4	4	23	23	capsaicin	VR1	PA448776	56664	0.925
NULL	Daru_2012_Nov_30_20(1)_82.nxml.txt.nlp	23351311	SENT19	7	7	27	27	genistein	p53	PA165109660	7157	0.925
NULL	J_Clin_Biochem_Nutr_2007_Jul_27_41(1)_12-17.nxml.txt.nlp	18392103	SENT87	10	10	6	6	infliximab	p75	PA452639	7133;11168	0.925
NULL	J_Exp_Med_2000_Mar_6_191(5)_771-780.nxml.txt.nlp	10704459	SENT478	15	15	7	7	ganciclovir	IL-15	PA449733	3600	0.925
NULL	Curr_Pathobiol_Rep_2014_Oct_17_2(4)_257-267.nxml.txt.nlp	25401052	SENT191	28	28	3	3	resveratrol	NAC		22861	0.925
NULL	J_Cancer_2013_Sep_27_4(8)_662-670.nxml.txt.nlp	24155778	SENT20	10	10	2	2	cisplatin	UCHL1	PA449014	7345	0.925
NULL	Chin_J_Cancer_2011_Jul_30(7)_490-496.nxml.txt.nlp	21718595	SENT91	13	13	0	0	oxaliplatin	LC3	PA131285527	84557	0.925
NULL	Oncol_Lett_2013_Jul_29_6(1)_118-124.nxml.txt.nlp	23946788	SENT90	32	32	8	8	tamoxifen	HER-2	PA451581	2064	0.925
NULL	J_Cell_Mol_Med_2014_Jan_4_18(1)_38-48.nxml.txt.nlp	24188742	SENT227	4	4	35	35	hyaluronan	PAX3	PA165958431	5077	0.925
NULL	Indian_Dermatol_Online_J_2014_Apr-Jun_5(2)_167-169.nxml.txt.nlp	24860753	SENT69	11	11	19	19	tadalafil	OTC	PA10333	5009	0.925
NULL	Oncotarget_2014_May_27_5(19)_9049-9064.nxml.txt.nlp	24979294	SENT217	8	8	39	39	fulvestrant	EGF	PA164747170	1950	0.925
NULL	J_Korean_Med_Sci_2010_Apr_19_25(4)_557-563.nxml.txt.nlp	20357998	SENT159	23	23	3	3	cisplatin	MCP-1	PA449014	6347	0.925
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_7-17.nxml.txt.nlp	17912633	SENT300	38	38	10	10	aminoglutethimide	aromatase	PA448375	1588	0.925
NULL	Br_J_Cancer_2012_Feb_14_106(4)_719-726.nxml.txt.nlp	22240798	SENT165	8	8	13	13	lapatinib	EGFR	PA152241907	1956	0.925
NULL	Breast_Cancer_(Auckl)_2012_Nov_19_6_191-207.nxml.txt.nlp	23226023	SENT84	39	39	12	12	lapatinib	HER2	PA152241907	2064	0.925
NULL	Am_J_Trop_Med_Hyg_2012_Aug_1_87(2)_231-241.nxml.txt.nlp	22855752	SENT16	13	13	0	0	artesunate	ACT	PA165111697	12;11332;9457;641455	0.925
NULL	Int_J_Mol_Sci_2012_Dec_7_13(12)_16751-16768.nxml.txt.nlp	23222680	SENT170	28	28	12	12	rasagiline	LSD2	PA164764584	221656	0.925
NULL	Mol_Cancer_2006_Oct_17_5_45.nxml.txt.nlp	17044934	SENT13	29	29	17	17	resveratrol	COX		1351	0.925
NULL	Onco_Targets_Ther_2014_May_28_7_841-852.nxml.txt.nlp	24920926	SENT67	3	3	17	17	gefitinib	EGFR	PA131301952	1956	0.925
NULL	Ann_Rheum_Dis_2013_Apr_21_72(4)_482-492.nxml.txt.nlp	23172750	SENT335	11	11	7	7	tocilizumab	IL-6	PA165292659	3569	0.925
NULL	Eur_J_Clin_Pharmacol_2012_Jan_8_68(1)_29-37.nxml.txt.nlp	21739267	SENT31	24	24	18	18	ketoconazole	CYP2D6	PA450146	1565	0.925
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT39	11	11	17	17	pemetrexed	UNG	PA10810	7374	0.925
NULL	Oncotarget_2014_Jun_19_5(15)_6540-6551.nxml.txt.nlp	25153728	SENT110	17	17	4	4	paclitaxel	Bcl-2	PA450761	596	0.925
NULL	Mol_Cancer_2010_Aug_20_9_220.nxml.txt.nlp	20727180	SENT110	35	35	4	4	nicotine	p53	PA450626	7157	0.925
NULL	Vet_Res_2013_Oct_2_44(1)_89.nxml.txt.nlp	24088531	SENT169	27	27	17	17	hemin	HO-1	PA449849	3162	0.925
NULL	Allergy_Asthma_Immunol_Res_2009_Oct_25_1(1)_30-35.nxml.txt.nlp	20224667	SENT95	18	18	4	4	aspirin	PPARG	PA448497	5468	0.925
NULL	Br_J_Pharmacol_2008_Oct_18_155(4)_596-605.nxml.txt.nlp	18852694	SENT153	3	3	14	14	fenofibrate	SCAP	PA449594	22937	0.925
NULL	J_Biol_Chem_2010_Aug_20_285(34)_25928-25940.nxml.txt.nlp	20547488	SENT302	27	27	3	3	arsenite	MSK1	PA452638	9252	0.925
NULL	Cell_Death_Dis_2014_Jul_17_5(7)_e1339.nxml.txt.nlp	25032862	SENT10	41	41	6	6	etoposide	ATG5	PA449552	9474	0.925
NULL	Int_J_Vasc_Med_2014_Jul_22_2014_659617.nxml.txt.nlp	25140254	SENT153	26	26	39	39	isoflurane	AVP	PA450106	114548;551	0.925
NULL	Breast_Cancer_Res_2005_Jul_20_7(5)_205-211.nxml.txt.nlp	16168139	SENT171	32	32	21	21	tamoxifen	EGFR	PA451581	1956	0.925
NULL	Front_Immunol_2012_Jul_12_3_175.nxml.txt.nlp	22807925	SENT121	24	24	5	5	heparin	CXCL4	PA449855	5196	0.925
NULL	Oncotarget_2012_Aug_31_3(9)_998-1010.nxml.txt.nlp	22948175	SENT100	10	10	30	30	camptothecin	ABCG2	PA153590860	9429	0.925
NULL	Diabetes_2009_Jan_58(1)_174-184.nxml.txt.nlp	18984736	SENT11	14	14	19	19	tranilast	TRPV2	PA131890628	51393	0.925
NULL	Clin_Exp_Otorhinolaryngol_2011_Jun_31_4(2)_77-82.nxml.txt.nlp	21716954	SENT202	9	9	11	11	minocycline	Bcl-2	PA450519	596	0.925
NULL	Cancer_Cell_Int_2009_Feb_17_9_4.nxml.txt.nlp	19222856	SENT195	10	10	3	3	cisplatin	p53	PA449014	7157	0.925
NULL	Breast_Cancer_Res_2010_Nov_16_12(6)_R96.nxml.txt.nlp	21080941	SENT261	13	13	0	0	lapatinib	HRG	PA152241907	3084;3273	0.925
NULL	F1000_Med_Rep_2009_Dec_9_1_94.nxml.txt.nlp	20948683	SENT33	0	0	18	18	bevacizumab	VEGFR2	PA130232992	3791	0.925
NULL	Mol_Cancer_2009_Apr_22_8_26.nxml.txt.nlp	19386116	SENT128	1	1	12	12	ritonavir	AKT	PA451260	207	0.925
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT214	7	7	28	28	capsaicin	p53	PA448776	7157	0.925
NULL	Toxins_(Basel)_2010_Oct_26_2(11)_2490-2518.nxml.txt.nlp	22069563	SENT207	22	22	9	9	cisplatin	MCP-1	PA449014	6347	0.925
NULL	Oncogene_2014_May_1_33(18)_2307-2316.nxml.txt.nlp	23686305	SENT150	27	27	21	21	trypsin	EGF	PA451806	1950	0.925
NULL	Evid_Based_Complement_Alternat_Med_2006_Sep_20_3(3)_365-372.nxml.txt.nlp	16951721	SENT187	23	23	11	11	ginseng	Bcl-2	PA164781150	596	0.925
NULL	J_Med_Chem_2014_Jul_24_57(14)_5995-6007.nxml.txt.nlp	24960438	SENT349	14	14	2	2	estradiol	HSD2	PA449503	6060	0.925
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT141	24	24	8	8	trastuzumab	HER2	PA451743	2064	0.925
NULL	Oncotarget_2014_Oct_21_5(22)_11709-11722.nxml.txt.nlp	25365944	SENT9	15	15	4	4	metformin	JNK	PA450395	5599	0.925
NULL	J_Lipid_Res_2015_Jan_56(1)_109-121.nxml.txt.nlp	25421061	SENT35	35	35	25	25	lipase	ATGL	PA450239	57104	0.925
NULL	Clin_Pharmacol_2013_Apr_19_5_67-83.nxml.txt.nlp	23650452	SENT178	25	25	21	21	ticagrelor	P2Y12	PA165374673	64805	0.925
NULL	Hum_Mol_Genet_2013_Jul_1_22(13)_2676-2688.nxml.txt.nlp	23474818	SENT158	5	5	36	36	arsenite	ANOVA	PA452638	4858	0.925
NULL	Biosci_Rep_2013_Nov_25_33(6)_e00081.nxml.txt.nlp	24070327	SENT119	1	1	6	6	verapamil	ABCB1	PA451868	5243	0.925
NULL	Br_J_Cancer_2013_May_14_108(9)_1862-1869.nxml.txt.nlp	23579219	SENT57	20	20	12	12	bevacizumab	ANXA11	PA130232992	311	0.925
NULL	Indian_J_Ophthalmol_2007_Nov-Dec_55(6)_421-425.nxml.txt.nlp	17951897	SENT4	0	0	25	25	ranibizumab	VEGF-A	PA164746012	7422	0.925
NULL	Mol_Vis_2012_Oct_11_18_2509-2517.nxml.txt.nlp	23112566	SENT9	22	22	28	28	bevacizumab	VEGF-A	PA130232992	7422	0.925
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT16	2	2	8	8	pp2	LYN		4067	0.925
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT605	6	6	16	16	risperidone	PRL	PA451257	5617	0.925
NULL	Osteoporos_Int_2012_Feb_4_23(Suppl_1)_S1-S23.nxml.txt.nlp	22311111	SENT388	19	19	10	10	raloxifene	STAR	PA451221	6770;2984	0.925
NULL	Oncotarget_2013_Nov_24_5(1)_185-195.nxml.txt.nlp	24368337	SENT45	10	10	38	38	doxorubicin	KRAS	PA449412	3845	0.925
NULL	Indian_J_Palliat_Care_2011_Jan-Apr_17(1)_78b-79.nxml.txt.nlp	21633628	SENT12	31	31	8	8	aprepitant	NK1	PA164747039	11126	0.925
NULL	J_Cell_Biol_2008_Jul_14_182(1)_197-213.nxml.txt.nlp	18625847	SENT187	26	26	18	18	nutlin-3	53BP1		7158	0.925
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT188	24	24	5	5	heparin	FGFR1	PA449855	2260	0.925
NULL	Int_J_Environ_Res_Public_Health_2014_Apr_28_11(4)_3586-3598.nxml.txt.nlp	24686488	SENT20	21	21	3	3	lipase	IL-6	PA450239	3569	0.925
NULL	Breast_Cancer_Res_2011_Jan_17_13(1)_R5.nxml.txt.nlp	21241485	SENT217	19	19	24	24	estradiol	Brn-3b	PA449503	5458	0.925
NULL	Cardiovasc_Diabetol_2008_Jun_19_7_18.nxml.txt.nlp	18565233	SENT92	4	4	35	35	bezafibrate	gamma	PA162364313	9913	0.925
NULL	Eur_J_Med_Res_2010_Feb_26_15(2)_47-53.nxml.txt.nlp	20452883	SENT140	40	40	10	10	fentanyl	ESG	PA449599	7089;7088;7090;7091	0.925
NULL	Exp_Ther_Med_2013_Mar_24_5(3)_902-906.nxml.txt.nlp	23408108	SENT102	14	14	7	7	anastrozole	aromatase	PA448432	1588	0.925
NULL	Oncotarget_2014_Aug_29_5(19)_8947-8958.nxml.txt.nlp	25333254	SENT128	8	8	16	16	plerixafor	CXCR4	PA165958410	7852	0.925
NULL	Cancer_Cell_Int_2013_Jun_26_13_63.nxml.txt.nlp	23800022	SENT78	9	9	1	1	ethanol	ANOVA	PA448073	4858	0.925
NULL	Case_Rep_Oncol_2010_Apr_29_3(2)_137-141.nxml.txt.nlp	20740186	SENT6	17	17	22	22	tamoxifen	GCDFP-15	PA451581	5304	0.925
NULL	Scientifica_(Cairo)_2012_Sep_11_2012_927352.nxml.txt.nlp	24278757	SENT342	8	8	17	17	atorvastatin	PCSK9	PA448500	255738	0.925
NULL	Neural_Plast_2014_Mar_17_2014_123026.nxml.txt.nlp	24757568	SENT196	7	7	25	25	fluoxetine	CA3	PA449673	761	0.925
NULL	Mol_Cancer_2010_Nov_2_9_289.nxml.txt.nlp	21044322	SENT165	32	32	8	8	docetaxel	RGS17	PA449383	26575	0.925
NULL	Dermatoendocrinol_2013_Apr_1_5(2)_252-263.nxml.txt.nlp	24194965	SENT84	4	4	17	17	metformin	MATE2	PA450395	146802	0.925
NULL	Indian_J_Pharmacol_2014_Jan-Feb_46(1)_3-12.nxml.txt.nlp	24550577	SENT226	13	13	16	16	rosiglitazone	CYP2C8	PA451283	1558	0.925
NULL	Brain_Sci_2013_Jun_14_3(2)_941-963.nxml.txt.nlp	24961432	SENT235	6	6	15	15	ethanol	CDK2	PA448073	1017	0.925
NULL	Asia_Pac_Allergy_2013_Jul_30_3(3)_194-199.nxml.txt.nlp	23956966	SENT70	2	2	25	25	methacholine	IL-13	PA165958382	3596	0.925
NULL	Nucleic_Acids_Res_2005_Apr_22_33(7)_2310-2317.nxml.txt.nlp	15849317	SENT13	14	14	9	9	geldanamycin	Hsp90	PA152031327	3320	0.925
NULL	Breast_Cancer_Res_2011_Jun_27_13(3)_212.nxml.txt.nlp	21787441	SENT214	18	18	1	1	tamoxifen	SET	PA451581	6418	0.925
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT126	19	19	14	14	dasatinib	LYN	PA162372878	4067	0.925
NULL	Oncogene_2010_Oct_21_29(42)_5700-5711.nxml.txt.nlp	20676140	SENT105	9	9	19	19	doxorubicin	cIAP2	PA449412	330	0.925
NULL	Front_Neural_Circuits_2014_Jul_10_8_76.nxml.txt.nlp	25071457	SENT92	0	0	16	16	trimethoprim	TMP	PA451788	2012	0.925
NULL	Mol_Biol_Cell_2012_Nov_1_23(21)_4212-4225.nxml.txt.nlp	22956765	SENT261	8	8	15	15	thrombin	SHP2	PA451674	5781	0.925
NULL	Crit_Care_2011_Oct_26_15(5)_R257.nxml.txt.nlp	22030215	SENT257	4	4	26	26	dexmedetomidine	SAPS	PA449256	8935	0.925
NULL	Hum_Genomics_Proteomics_2010_Aug_3_2010_159761.nxml.txt.nlp	20981231	SENT254	13	13	5	5	lithium	BDNF	PA450243	627	0.925
NULL	Onco_Targets_Ther_2014_May_12_7_719-728.nxml.txt.nlp	24872713	SENT17	0	0	8	8	sunitinib	VEGFR	PA162372840	3791	0.925
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT100	12	12	2	2	lapatinib	HER2	PA152241907	2064	0.925
NULL	J_Gastroenterol_2013_Jan_27_48(1)_22-30.nxml.txt.nlp	23104468	SENT318	16	16	3	3	telaprevir	ITPA	PA165958354	3704	0.925
NULL	J_Thorac_Oncol_2015_Jan_29_10(1)_156-163.nxml.txt.nlp	25247337	SENT105	2	2	17	17	afatinib	TTF	PA165981154	399	0.925
NULL	Acta_Pharmacol_Sin_2011_Nov_3_32(11)_1351-1356.nxml.txt.nlp	21963894	SENT24	1	1	35	35	levothyroxine	VIII	PA450221	1351	0.925
NULL	Cell_Death_Differ_2009_Aug_20_16(8)_1135-1145.nxml.txt.nlp	19300452	SENT177	2	2	25	25	chloroquine	PUMA	PA448948	27113	0.925
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_May_22_66(Pt_6)_o1397.nxml.txt.nlp	21579476	SENT47	24	24	11	11	ethanol	mol	PA448073	90527	0.925
NULL	Oncogene_2014_Feb_6_33(6)_713-723.nxml.txt.nlp	23435429	SENT64	31	31	4	4	camptothecin	BRCA1	PA153590860	672	0.925
NULL	EMBO_Mol_Med_2012_Oct_30_4(10)_1087-1096.nxml.txt.nlp	22933245	SENT85	15	15	5	5	olaparib	NAMPT		10135	0.925
NULL	Onco_Targets_Ther_2014_Sep_9_7_1571-1582.nxml.txt.nlp	25228815	SENT164	4	4	20	20	sorafenib	VEGFR2	PA7000	3791	0.925
NULL	Exp_Mol_Med_2012_Aug_31_44(8)_473-482.nxml.txt.nlp	22627808	SENT112	10	10	5	5	lapatinib	HER3	PA152241907	2065	0.925
NULL	Cancer_Med_2013_Dec_31_2(6)_950-963.nxml.txt.nlp	24403269	SENT262	4	4	36	36	cisplatin	RAB25	PA449014	57111	0.925
NULL	Adv_Appl_Bioinforma_Chem_2008_Oct_30_1_85-98.nxml.txt.nlp	21918608	SENT168	14	14	2	2	bortezomib	SPARC	PA10252	6678	0.925
NULL	Arch_Plast_Surg_2012_Sep_12_39(5)_540-545.nxml.txt.nlp	23094252	SENT56	4	4	27	27	propofol	TCI	PA451141	6947	0.925
NULL	J_Oncol_2010_Jan_5_2010_257058.nxml.txt.nlp	20069126	SENT232	26	26	14	14	curcumin	AMPK	PA151958596	5563	0.925
NULL	Environ_Health_Perspect_2008_Mar_11_116(3)_297-302.nxml.txt.nlp	18335094	SENT129	8	8	23	23	lindane	solo	PA164754914	55701	0.925
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jun_25_67(Pt_7)_o1792.nxml.txt.nlp	21837165	SENT59	23	23	6	6	ethanol	mol	PA448073	90527	0.925
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT154	2	2	7	7	dasatinib	JNK	PA162372878	5599	0.925
NULL	Environ_Health_Perspect_2006_Apr_21_114(Suppl_1)_9-12.nxml.txt.nlp	16818240	SENT90	8	8	18	18	estradiol	CYP3A	PA449503	1574	0.925
NULL	Emerg_Infect_Dis_2013_Mar_19(3)_449-455.nxml.txt.nlp	23622714	SENT45	11	11	1	1	ofloxacin	DST	PA450684	667	0.925
NULL	Cancer_Res_Treat_2014_Jul_15_46(3)_234-242.nxml.txt.nlp	25038758	SENT25	6	6	20	20	paclitaxel	P-gp	PA450761	5243	0.925
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT171	40	40	28	28	cisplatin	p53	PA449014	7157	0.925
NULL	Mol_Clin_Oncol_2013_Sep_18_1(5)_839-844.nxml.txt.nlp	24649257	SENT94	14	14	7	7	fluorouracil	NAC	PA128406956	22861	0.925
NULL	Oncotarget_2013_Jun_4_4(5)_772-784.nxml.txt.nlp	23800712	SENT131	47	47	2	2	dasatinib	EGFR	PA162372878	1956	0.925
NULL	Clin_Med_Insights_Arthritis_Musculoskelet_Disord_2012_Mar_5_5_27-42.nxml.txt.nlp	22438671	SENT65	19	19	27	27	methotrexate	ACR	PA450428	49	0.925
NULL	Orphanet_J_Rare_Dis_2014_Dec_10_9(1)_201.nxml.txt.nlp	NULL	SENT384	15	15	39	39	naltrexone	CMT1A	PA450588	1248	0.925
NULL	Adipocyte_2013_Jan_1_2(1)_17-27.nxml.txt.nlp	23599907	SENT100	14	14	3	3	glucose	TPC	PA449773	8030;60386	0.925
NULL	Acta_Pharmacol_Sin_2011_Jan_6_32(1)_133-138.nxml.txt.nlp	21131997	SENT47	13	13	6	6	heparin	ACT	PA449855	12;11332;9457;641455	0.925
NULL	Int_J_Biol_Sci_2011_May_19_7(5)_645-650.nxml.txt.nlp	21647332	SENT95	38	38	21	21	metformin	AMPK	PA450395	5563	0.925
NULL	Int_J_Environ_Res_Public_Health_2011_Mar_1_8(3)_683-697.nxml.txt.nlp	21556173	SENT67	12	12	28	28	imatinib	KIT	PA10804	3815	0.925
NULL	Braz_J_Microbiol_2010_Jun_1_Apr-Jun_41(2)_452-460.nxml.txt.nlp	24031516	SENT115	12	12	42	42	tetracycline	OTC	PA451640	5009	0.925
NULL	Indian_J_Crit_Care_Med_2012_Oct-Dec_16(4)_225-227.nxml.txt.nlp	23559734	SENT7	0	0	9	9	methotrexate	DHFR	PA450428	1719	0.925
NULL	J_Skin_Cancer_2013_Mar_21_2013_684050.nxml.txt.nlp	23577258	SENT220	20	20	14	14	erlotinib	EGFR	PA134687924	1956	0.925
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_25_2013_127075.nxml.txt.nlp	23878590	SENT100	6	6	19	19	genistein	GDNF	PA165109660	2668	0.925
NULL	Oxid_Med_Cell_Longev_2012_Jan_19_2012_390678.nxml.txt.nlp	22315655	SENT5	24	24	29	29	gliclazide	NAC	PA10892	22861	0.925
NULL	Clin_Psychopharmacol_Neurosci_2011_Aug_31_9(2)_45-53.nxml.txt.nlp	23429653	SENT79	11	11	4	4	quetiapine	TMAP	PA451201	26586	0.925
NULL	Br_J_Cancer_2012_Jul_10_107(2)_230-233.nxml.txt.nlp	22735900	SENT68	20	20	6	6	tamoxifen	CYP2D6	PA451581	1565	0.925
NULL	Clin_Interv_Aging_2012_Sep_3_7_331-338.nxml.txt.nlp	22977302	SENT39	8	8	27	27	denosumab	aromatase	PA166048634	1588	0.925
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT68	30	30	16	16	methotrexate	MSH2	PA450428	4436	0.925
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Nov_7_65(Pt_12)_o3013.nxml.txt.nlp	21578750	SENT58	24	24	12	12	ethanol	mol	PA448073	90527	0.925
NULL	Cancer_Manag_Res_2013_Aug_27_5_225-233.nxml.txt.nlp	24023523	SENT108	20	20	14	14	rituximab	CHOP	PA451261	1649	0.925
NULL	Breast_Cancer_(Auckl)_2010_Feb_16_4_1-3.nxml.txt.nlp	20697527	SENT7	6	6	41	41	curcumin	BRCA1	PA151958596	672	0.925
NULL	Br_J_Cancer_2012_Oct_9_107(8)_1233-1238.nxml.txt.nlp	22955852	SENT115	9	9	4	4	docetaxel	RPN2	PA449383	6185	0.925
NULL	Br_J_Cancer_1995_Jul_72(1)_82-89.nxml.txt.nlp	7599070	SENT10	6	6	17	17	daunorubicin	P-gp	PA449212	5243	0.925
NULL	ScientificWorldJournal_2012_Jun_4_2012_721313.nxml.txt.nlp	22701369	SENT121	35	35	14	14	imatinib	ZNF85	PA10804	7639	0.925
NULL	J_Biol_Chem_2013_Nov_22_288(47)_34217-34229.nxml.txt.nlp	24106270	SENT312	31	31	22	22	thrombin	RhoG	PA451674	391	0.925
NULL	Biomed_Eng_Online_2007_Apr_20_6_14.nxml.txt.nlp	17448235	SENT455	10	10	23	23	nadh	ADP	PA164755085	23038	0.925
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Oct_9_66(Pt_11)_o2728.nxml.txt.nlp	21588938	SENT55	18	18	6	6	ethanol	mol	PA448073	90527	0.925
NULL	Colorectal_Dis_2012_Feb_14(2)_e31-e47.nxml.txt.nlp	21848897	SENT117	35	35	28	28	panitumumab	KRAS	PA162373091	3845	0.925
NULL	Mediators_Inflamm_2001_Jun_10(3)_109-115.nxml.txt.nlp	11545247	SENT0	24	24	9	9	risperidone	IL-6	PA451257	3569	0.925
NULL	Cancer_Metab_2014_May_28_2(Suppl_1)_P23.nxml.txt.nlp	NULL	SENT25	27	27	16	16	metformin	AMPK	PA450395	5563	0.925
NULL	J_Gynecol_Oncol_2013_Jan_8_24(1)_66-82.nxml.txt.nlp	23346316	SENT53	14	14	33	33	bevacizumab	BBP	PA130232992	83941	0.924
NULL	Breast_Cancer_Res_Treat_2013_Jan_13_137(2)_471-482.nxml.txt.nlp	23239151	SENT242	24	24	7	7	bevacizumab	HER2	PA130232992	2064	0.924
NULL	Cancer_Cell_Int_2010_Sep_6_10_31.nxml.txt.nlp	20819205	SENT148	24	24	43	43	streptomycin	CO2	PA451512	4513	0.924
NULL	Exp_Diabetes_Res_2012_Feb_28_2012_481840.nxml.txt.nlp	22474423	SENT196	12	12	24	24	taurine	PERK	PA451590	9451	0.924
NULL	Int_J_Endocrinol_Metab_2013_Dec_21_Winter_11(1)_57-61.nxml.txt.nlp	23853622	SENT134	10	10	36	36	bromocriptine	PRL	PA448671	5617	0.924
NULL	Br_J_Cancer_2010_Mar_2_102(5)_815-826.nxml.txt.nlp	20145614	SENT160	2	2	21	21	trastuzumab	HER2	PA451743	2064	0.924
NULL	Br_J_Cancer_2006_Dec_4_95(11)_1483-1489.nxml.txt.nlp	17106442	SENT5	23	23	19	19	gefitinib	EGFR	PA131301952	1956	0.924
NULL	Ann_Oncol_2009_Aug_17_20(8)_1319-1329.nxml.txt.nlp	19535820	SENT108	25	25	20	20	tamoxifen	aromatase	PA451581	1588	0.924
NULL	Blood_Res_2014_Sep_25_49(3)_148-153.nxml.txt.nlp	25325033	SENT47	27	27	15	15	cyclophosphamide	B2M	PA449165	567	0.924
NULL	J_Immunother_Cancer_2013_Jul_15_1_10.nxml.txt.nlp	24829747	SENT42	9	9	26	26	tadalafil	NOS2	PA10333	339345;4843	0.924
NULL	Aging_(Albany_NY)_2009_Jun_22_1(6)_529-541.nxml.txt.nlp	20157536	SENT147	6	6	14	14	resveratrol	AMPK		5563	0.924
NULL	Curr_Med_Chem_2012_Aug_19(22)_3763-3778.nxml.txt.nlp	22680930	SENT79	7	7	25	25	zileuton	5-LOX	PA451955	240	0.924
NULL	Balkan_J_Med_Genet_2011_Jun_25_14(1)_25-30.nxml.txt.nlp	24052699	SENT81	5	5	21	21	carbamazepine	ABCB1	PA448785	5243	0.924
NULL	Pharmaceuticals_(Basel)_2012_Feb_24_5(3)_279-296.nxml.txt.nlp	24281379	SENT129	26	26	44	44	rivaroxaban	ANOVA	PA165958360	4858	0.924
NULL	Br_J_Cancer_2012_Apr_10_106(8)_1367-1373.nxml.txt.nlp	22454081	SENT160	9	9	3	3	trastuzumab	MUC1	PA451743	4582	0.924
NULL	Br_J_Cancer_2012_Jan_3_106(1)_18-24.nxml.txt.nlp	22108516	SENT48	29	29	2	2	camptothecin	TDP1	PA153590860	55775	0.924
NULL	J_Biol_2010_Apr_8_9(3)_16.nxml.txt.nlp	20377920	SENT76	7	7	24	24	simvastatin	CCM2	PA451363	83605	0.924
NULL	Cell_Commun_Signal_2013_Jan_11_11_2.nxml.txt.nlp	23305203	SENT136	36	36	4	4	forskolin	TIMAP	PA146096022	26051	0.924
NULL	J_Oncol_2009_Mar_24_2009_491985.nxml.txt.nlp	19325924	SENT77	9	9	0	0	genistein	CXCR4	PA165109660	7852	0.924
NULL	J_Exp_Med_2003_Aug_4_198(3)_505-512.nxml.txt.nlp	12900524	SENT120	8	8	13	13	dextran	CCL21	PA449261	6366	0.924
NULL	J_Korean_Assoc_Oral_Maxillofac_Surg_2014_Dec_26_40(6)_291-296.nxml.txt.nlp	25551094	SENT93	15	15	7	7	alendronate	RANKL	PA448082	8600	0.924
NULL	Front_Synaptic_Neurosci_2014_May_30_6_12.nxml.txt.nlp	24910611	SENT151	23	23	4	4	l-alanine	asc-1	PA448055	56301	0.924
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1137-1144.nxml.txt.nlp	20234366	SENT159	13	13	19	19	cetuximab	BRAF	PA10040	673	0.924
NULL	Clin_Exp_Otorhinolaryngol_2011_Mar_17_4(1)_18-23.nxml.txt.nlp	21461058	SENT89	20	20	35	35	furosemide	KCC2	PA449719	57468	0.924
NULL	Front_Neural_Circuits_2013_Aug_1_7_129.nxml.txt.nlp	23914157	SENT220	21	21	0	0	ethanol	NPY	PA448073	4852	0.924
NULL	Breast_Cancer_Res_2007_Jan_23_9(1)_R7.nxml.txt.nlp	17244352	SENT133	26	26	5	5	tamoxifen	CYP2D6	PA451581	1565	0.924
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT195	27	27	19	19	amiodarone	CYP3A4	PA448383	1576	0.924
NULL	Front_Neurol_2011_Dec_26_2_83.nxml.txt.nlp	22363312	SENT105	23	23	7	7	clopidogrel	San	PA449053	80218	0.924
NULL	Nat_Commun_2014_Nov_21_5_5383.nxml.txt.nlp	25415230	SENT773	19	19	8	8	bicalutamide	GJB1	PA164746255	2705	0.924
NULL	Arthritis_Res_Ther_2012_Sep_24_14(5)_R200.nxml.txt.nlp	23006144	SENT18	9	9	0	0	alefacept	IL-20	PA164748040	27190;50604	0.924
NULL	J_Hum_Genet_2013_Jun_2_58(6)_306-312.nxml.txt.nlp	23635953	SENT7	16	16	23	23	raloxifene	aromatase	PA451221	1588	0.924
NULL	Diabetologia_2010_Jun_27_53(6)_1142-1150.nxml.txt.nlp	20349036	SENT158	26	26	7	7	spermine	AMPK	PA164781199	5563	0.924
NULL	Cancer_Cell_Int_2010_Sep_9_10_32.nxml.txt.nlp	20828393	SENT12	14	14	24	24	cisplatin	ATF3	PA449014	467	0.924
NULL	Cancer_Cell_Int_2005_Jul_24_5_22.nxml.txt.nlp	16042792	SENT91	28	28	36	36	vincristine	NAC	PA451879	22861	0.924
NULL	Colomb_Med_(Cali)_44(1)_42-45.nxml.txt.nlp	24892321	SENT4	4	4	1	1	cyanocobalamin	B12	PA451892	7126;4709	0.924
NULL	J_Mol_Signal_2010_May_10_5_4.nxml.txt.nlp	20459745	SENT147	19	19	4	4	cisplatin	p53	PA449014	7157	0.924
NULL	Bioinorg_Chem_Appl_2013_Sep_19_2013_541030.nxml.txt.nlp	24170995	SENT58	4	4	18	18	amoxicillin	SBF	PA448406	7702	0.924
NULL	Chin_J_Cancer_2012_Jun_31(6)_306-314.nxml.txt.nlp	22640627	SENT14	6	6	27	27	rituximab	CD10	PA451261	4311	0.924
NULL	Genome_Med_2010_Jun_29_2(6)_41.nxml.txt.nlp	20587003	SENT176	3	3	22	22	imatinib	SHIP2	PA10804	3636	0.924
NULL	Saudi_J_Anaesth_2013_Oct-Dec_7(4)_420-426.nxml.txt.nlp	24348294	SENT233	0	0	7	7	phenol	gamma	PA450913	9913	0.924
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT144	4	4	20	20	trastuzumab	HRG	PA451743	3084;3273	0.924
NULL	Front_Oncol_2014_Apr_9_4_75.nxml.txt.nlp	24782986	SENT265	29	29	18	18	cisplatin	STAT3	PA449014	6774	0.924
NULL	Clin_Med_Insights_Cardiol_2011_Jun_28_5_55-66.nxml.txt.nlp	21792345	SENT55	19	19	5	5	bucindolol	BEST	PA165945764	7439	0.924
NULL	Mol_Biol_Cell_2012_Jun_1_23(11)_2017-2027.nxml.txt.nlp	22496424	SENT100	5	5	32	32	warfarin	PRDX4	PA451906	10549	0.924
NULL	Tob_Control_2009_Feb_13_18(1)_34-42.nxml.txt.nlp	18845621	SENT275	15	15	6	6	promethazine	CYP2B6	PA451128	1555	0.924
NULL	Cardiovasc_Drugs_Ther_2011_Jun_12_25(3)_223-232.nxml.txt.nlp	21562974	SENT7	5	5	27	27	milrinone	AKT	PA164749171	207	0.924
NULL	J_Cell_Mol_Med_2014_Dec_22_18(12)_2519-2529.nxml.txt.nlp	25338520	SENT206	0	0	18	18	tamoxifen	c-Jun	PA451581	3725	0.924
NULL	Front_Public_Health_2013_Nov_14_1_50.nxml.txt.nlp	24350219	SENT119	9	9	14	14	hydrocortisone	TREM-1	PA449905	54210	0.924
NULL	Nat_Chem_Biol_2010_Feb_6(2)_117-124.nxml.txt.nlp	20081827	SENT203	12	12	1	1	heparin	p110	PA449855	9733	0.924
NULL	Front_Immunol_2012_Mar_5_3_33.nxml.txt.nlp	22566917	SENT54	32	32	21	21	vancomycin	TLR5	PA451850	7100	0.924
NULL	J_Oncol_2012_Aug_7_2012_803294.nxml.txt.nlp	22919383	SENT81	13	13	26	26	indomethacin	COX	PA449982	1351	0.924
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Jul_3_5_16.nxml.txt.nlp	16817961	SENT122	15	15	22	22	vancomycin	VISA	PA451850	57506	0.924
NULL	Breast_Cancer_Res_2006_Jul_17_8(4)_R37.nxml.txt.nlp	16846534	SENT162	8	8	18	18	trypsin	MUC1	PA451806	4582	0.924
NULL	Breast_Cancer_Res_2014_May_5_16(3)_R45.nxml.txt.nlp	24887236	SENT290	8	8	20	20	cetuximab	EGFR	PA10040	1956	0.924
NULL	BMB_Rep_2014_Apr_47(4)_221-226.nxml.txt.nlp	24286312	SENT74	16	16	4	4	nutlin-3	p53		7157	0.924
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Dec_10_3(12)_e151.nxml.txt.nlp	25494035	SENT114	44	44	31	31	rosuvastatin	OATP1B1	PA134308647	10599	0.924
NULL	J_Korean_Med_Sci_2011_Aug_27_26(8)_1007-1013.nxml.txt.nlp	21860550	SENT149	22	22	14	14	tamoxifen	CYP2D6	PA451581	1565	0.924
NULL	Int_J_Biol_Sci_2012_Sep_6_8(8)_1109-1120.nxml.txt.nlp	22991499	SENT35	0	0	15	15	l-arginine	ODC	PA448478	4953;89874	0.924
NULL	Arq_Bras_Cardiol_2013_Oct_101(4)_304-310.nxml.txt.nlp	24008655	SENT82	7	7	11	11	carvedilol	mol	PA448817	90527	0.924
NULL	Acta_Pharmacol_Sin_2014_Oct_25_35(10)_1293-1301.nxml.txt.nlp	25152022	SENT170	21	21	30	30	enalapril	IL-18	PA449456	3606	0.924
NULL	J_Pain_Res_2014_Oct_17_7_589-608.nxml.txt.nlp	25378948	SENT59	32	32	26	26	fentanyl	CYP2D6	PA449599	1565	0.924
NULL	Breast_Cancer_Res_2005_Jul_20_7(5)_205-211.nxml.txt.nlp	16168139	SENT47	16	16	12	12	tamoxifen	AIB1	PA451581	8202	0.924
NULL	AMIA_Jt_Summits_Transl_Sci_Proc_2012_Mar_19_2012_25-34.nxml.txt.nlp	22779044	SENT172	35	35	3	3	glucose	TGFB1	PA449773	7040	0.924
NULL	Cells_2014_May_23_3(2)_517-545.nxml.txt.nlp	24861977	SENT16	20	20	9	9	capsaicin	TRPV1	PA448776	7442	0.924
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT127	21	21	3	3	tenofovir	ABCC2	PA10204	1244	0.924
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT174	7	7	15	15	cisplatin	p53	PA449014	7157	0.924
NULL	Ann_Med_2011_Nov_5_43(7)_531-544.nxml.txt.nlp	21815879	SENT114	0	0	27	27	prasugrel	ADP	PA154410481	23038	0.924
NULL	eLife_2014_May_27_3_e02667.nxml.txt.nlp	24867643	SENT455	4	4	9	9	nutlin-3	p53		7157	0.924
NULL	J_Korean_Med_Sci_2009_Jun_12_24(3)_448-452.nxml.txt.nlp	19543508	SENT98	22	22	16	16	gefitinib	EGFR	PA131301952	1956	0.924
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jul_7_68(Pt_8)_o2392-o2393.nxml.txt.nlp	22904850	SENT72	36	36	7	7	benzaldehyde	mol	PA448571	90527	0.924
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_19_2012_967573.nxml.txt.nlp	23304232	SENT126	0	0	31	31	indomethacin	MSU	PA449982	593	0.924
NULL	Acta_Pharmacol_Sin_2009_Apr_3_30(4)_478-484.nxml.txt.nlp	19343062	SENT130	9	9	12	12	cyclosporine	CYP3A4	PA449167	1576	0.924
NULL	J_Mol_Signal_2010_May_10_5_4.nxml.txt.nlp	20459745	SENT132	3	3	27	27	cisplatin	p53	PA449014	7157	0.924
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT215	9	9	13	13	imatinib	p38	PA10804	10598;1432;7965	0.924
NULL	J_Invest_Dermatol_2012_May_16_132(5)_1435-1442.nxml.txt.nlp	22336948	SENT69	7	7	36	36	doxycycline	TLSP	PA449415	11012	0.924
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2014_Jun_29_70(Pt_7)_1922-1933.nxml.txt.nlp	25004969	SENT13	21	21	32	32	cycloserine	PLP	PA164764600	25824;5744	0.924
NULL	Ann_Oncol_2011_Mar_8_22(3)_503-514.nxml.txt.nlp	20616198	SENT77	33	33	18	18	anastrozole	aromatase	PA448432	1588	0.924
NULL	Br_J_Cancer_2013_Sep_3_109(5)_1214-1222.nxml.txt.nlp	23922104	SENT176	26	26	31	31	doxorubicin	TP53	PA449412	7157	0.924
NULL	AMB_Express_2011_May_18_1_6.nxml.txt.nlp	21906338	SENT91	18	18	12	12	l-leucine	mol	PA450197	90527	0.924
NULL	Leukemia_2013_Dec_27_27(12)_2322-2331.nxml.txt.nlp	24072044	SENT137	16	16	5	5	plerixafor	CXCR4	PA165958410	7852	0.924
NULL	Allergy_Asthma_Clin_Immunol_2010_Nov_26_6(Suppl_3)_P8.nxml.txt.nlp	NULL	SENT20	2	2	35	35	ribavirin	IFN	PA451241	3439	0.924
NULL	Neural_Plast_2007_Oct_10_2007_23250.nxml.txt.nlp	NULL	SENT4475	4	4	8	8	anastrozole	aromatase	PA448432	1588	0.924
NULL	J_Hematol_Oncol_2013_Jan_15_6_5.nxml.txt.nlp	23320987	SENT143	25	25	14	14	heparin	PI-PLC	PA449855	2923	0.924
NULL	Drug_Target_Insights_2007_Mar_6_2_71-81.nxml.txt.nlp	21901064	SENT163	22	22	16	16	saquinavir	P-gp	PA451305	5243	0.924
NULL	F1000_Biol_Rep_2009_Mar_24_1_23.nxml.txt.nlp	20948663	SENT51	34	34	38	38	citalopram	STAR	PA449015	6770;2984	0.924
NULL	Carcinogenesis_2013_Feb_3_34(2)_351-360.nxml.txt.nlp	23125222	SENT344	4	4	11	11	curcumin	NF-kappaB	PA151958596	4790	0.924
NULL	Cancer_Growth_Metastasis_2013_Nov_27_6_61-80.nxml.txt.nlp	24665208	SENT285	9	9	18	18	cabozantinib	VEGFR2	PA165906891	3791	0.924
NULL	Nucleic_Acids_Res_2005_Aug_12_33(14)_4584-4592.nxml.txt.nlp	16100380	SENT110	34	34	41	41	paromomycin	GCN2	PA164784023	440275	0.924
NULL	Br_J_Cancer_2010_Nov_9_103(10)_1627-1636.nxml.txt.nlp	20959826	SENT185	22	22	33	33	cetuximab	BRAF	PA10040	673	0.924
NULL	Breast_Cancer_Res_2011_Jan_17_13(1)_R5.nxml.txt.nlp	21241485	SENT227	31	31	11	11	estradiol	Brn-3b	PA449503	5458	0.924
NULL	Oncotarget_2014_Jun_7_5(13)_5017-5028.nxml.txt.nlp	24970809	SENT127	23	23	3	3	doxycycline	GCIP	PA449415	23582	0.924
NULL	Front_Oncol_2014_Nov_25_4_329.nxml.txt.nlp	25505733	SENT225	28	28	20	20	erlotinib	KRAS	PA134687924	3845	0.924
NULL	Oncotarget_2011_Dec_22_2(12)_1176-1190.nxml.txt.nlp	22202492	SENT128	7	7	17	17	fluvastatin	PLA2G7	PA449688	7941	0.924
NULL	Mol_Cancer_2008_Mar_26_7_27.nxml.txt.nlp	18366759	SENT76	6	6	18	18	etoposide	MDM2	PA449552	4193	0.924
NULL	Mol_Cancer_2010_Nov_25_9_305.nxml.txt.nlp	21108789	SENT282	31	31	23	23	decitabine	AQP5	PA164749631	362	0.924
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT418	18	18	11	11	cetuximab	PIK3CA	PA10040	5290	0.924
NULL	Eur_J_Clin_Pharmacol_2014_Oct_8_70(1)_37-45.nxml.txt.nlp	24100471	SENT15	8	8	32	32	omeprazole	CYP2C19	PA450704	1557	0.924
NULL	Exp_Ther_Med_2014_Nov_29_8(5)_1473-1478.nxml.txt.nlp	25289044	SENT94	2	2	23	23	heparin	AZU	PA449855	566	0.924
NULL	Exp_Diabetes_Res_2012_Mar_15_2012_146194.nxml.txt.nlp	22474415	SENT153	3	3	10	10	valsartan	MCP-1	PA451848	6347	0.924
NULL	Clin_Drug_Investig_2013_Aug_23_33(10)_727-736.nxml.txt.nlp	23975654	SENT184	23	23	18	18	bupropion	CYP2D6	PA448687	1565	0.924
NULL	Indian_J_Pharmacol_2014_Sep-Oct_46(5)_547-548.nxml.txt.nlp	25298587	SENT51	2	2	23	23	ketoconazole	CYP3A	PA450146	1574	0.924
NULL	Breast_Cancer_Res_2002_Apr_4_4(3)_85-89.nxml.txt.nlp	12052249	SENT41	28	28	1	1	tamoxifen	SULT1A1	PA451581	6817	0.924
NULL	Iran_Red_Crescent_Med_J_2012_Feb_1_14(2)_75-78.nxml.txt.nlp	22737559	SENT121	24	24	5	5	phenytoin	San	PA450947	80218	0.924
NULL	J_Cardiothorac_Surg_2010_Dec_6_5_123.nxml.txt.nlp	21134285	SENT36	0	0	11	11	heparin	ACT	PA449855	12;11332;9457;641455	0.924
NULL	J_Ginseng_Res_2011_Nov_35(4)_471-478.nxml.txt.nlp	23717094	SENT201	21	21	36	36	ethanol	CaCC	PA448073	1179	0.924
NULL	Clin_Interv_Aging_2014_Oct_21_9_1783-1791.nxml.txt.nlp	25364236	SENT144	15	15	44	44	rivastigmine	APOE	PA451262	348	0.924
NULL	J_Cell_Biol_2005_Jul_4_170(1)_37-47.nxml.txt.nlp	15998798	SENT240	5	5	10	10	doxycycline	CRT	PA449415	811	0.924
NULL	Front_Immunol_2013_May_24_4_126.nxml.txt.nlp	23745124	SENT258	9	9	4	4	indomethacin	COX	PA449982	1351	0.924
NULL	Diabetes_Metab_Syndr_Obes_2009_Jun_24_2_101-109.nxml.txt.nlp	21437123	SENT3	13	13	10	10	metformin	PPG	PA450395	5552	0.924
NULL	Indian_Dermatol_Online_J_2010_Jul-Dec_1(1)_14-17.nxml.txt.nlp	23130185	SENT8	15	15	12	12	lapatinib	EGFR	PA152241907	1956	0.924
NULL	Ann_Hematol_2014_Apr_1_93(8)_1371-1380.nxml.txt.nlp	24687382	SENT32	7	7	22	22	lenalidomide	IL-2	PA162363968	3558	0.924
NULL	Acta_Pharmacol_Sin_2012_May_16_33(5)_682-690.nxml.txt.nlp	22504904	SENT166	3	3	16	16	celecoxib	IL-6	PA448871	3569	0.924
NULL	Br_J_Cancer_2012_Nov_20_107(11)_1833-1839.nxml.txt.nlp	23169336	SENT41	18	18	0	0	etoposide	Men	PA449552	8178	0.924
NULL	Arch_Med_Sci_2012_May_9_8(2)_375-388.nxml.txt.nlp	22662015	SENT256	6	6	28	28	cilostazol	CYP2C19	PA164746334	1557	0.924
NULL	Aging_(Albany_NY)_2009_Jan_10_1(1)_6-8.nxml.txt.nlp	20157591	SENT50	33	33	6	6	resveratrol	p53		7157	0.924
NULL	Oncotarget_2014_Aug_27_5(17)_7328-7341.nxml.txt.nlp	25193862	SENT134	19	19	4	4	erlotinib	EGFR	PA134687924	1956	0.924
NULL	J_Obes_2011_Jul_6_2011_432607.nxml.txt.nlp	21773005	SENT4	4	4	1	1	rimonabant	CB1	PA152407999	1268	0.924
NULL	J_Mol_Signal_2011_May_16_6_4.nxml.txt.nlp	21575178	SENT134	26	26	12	12	forskolin	HSP27	PA146096022	3315	0.924
NULL	Oncotarget_2013_Aug_30_4(10)_1698-1711.nxml.txt.nlp	24091605	SENT124	7	7	13	13	cisplatin	PDCL	PA449014	5082	0.924
NULL	J_Korean_Med_Sci_2014_Jul_11_29(7)_965-972.nxml.txt.nlp	25045229	SENT78	25	25	5	5	metformin	B12	PA450395	7126;4709	0.924
NULL	Cancers_(Basel)_2014_Apr_16_6(2)_926-957.nxml.txt.nlp	24743778	SENT351	24	24	12	12	niclosamide	STAT3	PA165958408	6774	0.924
NULL	J_Cancer_Prev_2014_Mar_19(1)_39-46.nxml.txt.nlp	25337571	SENT100	12	12	0	0	ethanol	CDK2	PA448073	1017	0.924
NULL	Int_J_Breast_Cancer_2011_Feb_24_2011_967419.nxml.txt.nlp	22332018	SENT142	32	32	19	19	doxorubicin	p53	PA449412	7157	0.924
NULL	Br_J_Cancer_2012_Oct_9_107(8)_1233-1238.nxml.txt.nlp	22955852	SENT111	8	8	17	17	docetaxel	RPN2	PA449383	6185	0.924
NULL	EPMA_J_2013_Jan_28_4(1)_3.nxml.txt.nlp	23356214	SENT151	25	25	9	9	erlotinib	EGFR	PA134687924	1956	0.924
NULL	Clin_Mol_Allergy_2011_Apr_28_9_7.nxml.txt.nlp	21527026	SENT76	33	33	5	5	omalizumab	CD4	PA164752253	920	0.924
NULL	Int_J_Mol_Sci_2014_May_12_15(5)_8335-8351.nxml.txt.nlp	24823879	SENT107	3	3	22	22	resveratrol	DAPK2		23604	0.924
NULL	Exp_Ther_Med_2014_Oct_24_8(4)_1092-1096.nxml.txt.nlp	25187802	SENT23	37	37	40	40	carvedilol	TLR4	PA448817	7099	0.924
NULL	Int_J_Biol_Sci_2011_Nov_5_8(1)_1-14.nxml.txt.nlp	22211100	SENT175	17	17	29	29	gemcitabine	Bcl-2	PA449748	596	0.924
NULL	Cardiovasc_Diabetol_2007_Aug_15_6_20.nxml.txt.nlp	17697384	SENT70	9	9	3	3	ramipril	DREAM	PA451223	30818	0.924
NULL	Indian_J_Pharmacol_2013_May-Jun_45(3)_274-277.nxml.txt.nlp	23833372	SENT88	1	1	15	15	colchicine	CA1	PA449092	759	0.924
NULL	Cells_2012_Oct_15_1(4)_754-773.nxml.txt.nlp	24710529	SENT200	29	29	3	3	etoposide	14-3-3	PA449552	10971	0.924
NULL	J_Carcinog_2011_Nov_30_10_28.nxml.txt.nlp	22190870	SENT103	34	34	5	5	trastuzumab	PIK3CA	PA451743	5290	0.924
NULL	Mol_Biol_Rep_2013_Sep_28_40(10)_5573-5585.nxml.txt.nlp	24078156	SENT26	2	2	30	30	iron	DMT1	PA450087	4891;1761	0.924
NULL	J_Cell_Biol_2008_Jul_14_182(1)_197-213.nxml.txt.nlp	18625847	SENT226	35	35	18	18	nutlin-3	BRCA1		672	0.924
NULL	Cell_Mol_Life_Sci_2012_Dec_8_69(23)_3953-3961.nxml.txt.nlp	22678663	SENT35	12	12	20	20	pioglitazone	gamma	PA450970	9913	0.924
NULL	Pediatr_Gastroenterol_Hepatol_Nutr_2013_Jun_30_16(2)_65-70.nxml.txt.nlp	24010109	SENT35	9	9	3	3	furosemide	TPMT	PA449719	7172	0.924
NULL	Breast_Cancer_Res_2007_Dec_20_9(Suppl_2)_S25.nxml.txt.nlp	NULL	SENT15	13	13	18	18	trastuzumab	aromatase	PA451743	1588	0.924
NULL	Oncol_Lett_2014_Jun_28_7(6)_1747-1754.nxml.txt.nlp	24932227	SENT102	6	6	0	0	trypsin	SPINK1	PA451806	6690	0.924
NULL	Oncotarget_2013_May_11_4(6)_830-843.nxml.txt.nlp	23919981	SENT50	5	5	37	37	temsirolimus	CXCL8	PA164746890	3576	0.924
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jul_17_66(Pt_8)_o2061.nxml.txt.nlp	21588365	SENT47	19	19	6	6	ethanol	mol	PA448073	90527	0.924
NULL	Int_J_Mol_Sci_2014_Sep_17_15(9)_16430-16457.nxml.txt.nlp	25233127	SENT216	19	19	5	5	cyclophosphamide	LPO	PA449165	4025	0.924
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2675-2684.nxml.txt.nlp	24129246	SENT235	22	22	33	33	etoposide	KSR1	PA449552	8844	0.924
NULL	J_Biol_Chem_2013_Mar_29_288(13)_8935-8951.nxml.txt.nlp	23386614	SENT329	10	10	14	14	heparin	BACE1	PA449855	23621	0.924
NULL	Diabetes_Obes_Metab_2012_Apr_14(4)_304-314.nxml.txt.nlp	22051096	SENT73	11	11	31	31	exenatide	PPG	PA164749238	5552	0.924
NULL	Curr_Neuropharmacol_2012_Jun_10(2)_97-123.nxml.txt.nlp	23204981	SENT268	4	4	15	15	ramelteon	IL-2	PA164744896	3558	0.924
NULL	Curr_Hepat_Rep_2010_May_21_9(2)_75-90.nxml.txt.nlp	20461127	SENT272	21	21	27	27	telbivudine	LAM	PA164760861	7249;7248	0.924
NULL	Virol_J_2010_Nov_12_7_312.nxml.txt.nlp	21073718	SENT210	45	45	2	2	l-glutamine	U87	PA10090	677775;641648	0.924
NULL	ASN_Neuro_2009_Oct_21_1(4)_e00018.nxml.txt.nlp	19807694	SENT76	11	11	33	33	ganciclovir	E12	PA449733	64100	0.924
NULL	Nucleic_Acids_Res_2005_Jun_8_33(10)_3283-3291.nxml.txt.nlp	15944449	SENT157	26	26	7	7	sjg-136	XRCC3		7517	0.924
NULL	J_Biomed_Sci_2013_Dec_20_20(1)_99.nxml.txt.nlp	24358977	SENT195	38	38	22	22	methotrexate	DHFR	PA450428	1719	0.924
NULL	Genome_Med_2010_Apr_28_2(4)_27.nxml.txt.nlp	20423530	SENT203	20	20	13	13	ethanol	p38	PA448073	10598;1432;7965	0.924
NULL	J_Hematol_Oncol_2013_Mar_27_6_23.nxml.txt.nlp	23531342	SENT98	19	19	7	7	doxorubicin	RITA	PA449412	55422;84934	0.924
NULL	J_Cell_Mol_Med_2014_Feb_5_18(2)_263-273.nxml.txt.nlp	24304472	SENT124	7	7	20	20	prazosin	p38	PA451093	10598;1432;7965	0.924
NULL	Biomed_Res_Int_2014_Jan_20_2014_948427.nxml.txt.nlp	24563867	SENT170	2	2	6	6	buspirone	5-HT1A	PA448689	3350	0.924
NULL	Neural_Regen_Res_2014_May_15_9(10)_1055-1062.nxml.txt.nlp	25206759	SENT218	25	25	23	23	furosemide	KCC2	PA449719	57468	0.924
NULL	J_Mol_Signal_2008_Mar_31_3_8.nxml.txt.nlp	18377662	SENT80	6	6	30	30	pp2	SHP-1		5777	0.924
NULL	J_Exerc_Nutrition_Biochem_2014_Mar_25_18(1)_79-87.nxml.txt.nlp	25566442	SENT107	33	33	39	39	resveratrol	IL-10		3586	0.924
NULL	J_Cell_Biol_1983_Mar_1_96(3)_633-638.nxml.txt.nlp	6833374	SENT5	12	12	21	21	chymotrypsin	MP26	PA448994	4284	0.924
NULL	Cancer_Cell_2015_Jan_12_27(1)_85-96.nxml.txt.nlp	25500121	SENT251	6	6	10	10	vemurafenib	BRAF	PA165946873	673	0.924
NULL	Ther_Clin_Risk_Manag_2006_Sep_2(3)_297-301.nxml.txt.nlp	18360604	SENT18	5	5	15	15	paricalcitol	PTH	PA450798	5741	0.924
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT274	17	17	7	7	atorvastatin	PIK3CA	PA448500	5290	0.924
NULL	Pharmaceutics_2011_Oct_12_3(4)_680-705.nxml.txt.nlp	24309303	SENT55	16	16	6	6	nateglinide	OATP1B1	PA450600	10599	0.924
NULL	Biologics_2009_Jul_13_3_289-301.nxml.txt.nlp	19707416	SENT144	20	20	7	7	paclitaxel	HER2	PA450761	2064	0.924
NULL	Acta_Histochem_Cytochem_2014_Aug_29_47(4)_155-164.nxml.txt.nlp	25392569	SENT120	6	6	24	24	diethylstilbestrol	PRL	PA449307	5617	0.924
NULL	Oncologist_2010_May_28_15(5)_436-446.nxml.txt.nlp	20427383	SENT168	0	0	10	10	pazopanib	VEGFR	PA165291492	3791	0.924
NULL	Crit_Care_2011_Jul_8_15(4)_R163.nxml.txt.nlp	21740551	SENT60	13	13	17	17	fluorescein	CD61	PA164746009	3690	0.924
NULL	Biochem_Res_Int_2010_Feb_10_2010_965716.nxml.txt.nlp	21188079	SENT21	30	30	6	6	amikacin	gamma	PA164744372	9913	0.924
NULL	Breast_Cancer_Res_Treat_2014_Nov_24_143(1)_125-133.nxml.txt.nlp	24272078	SENT133	7	7	24	24	exemestane	aromatase	PA449563	1588	0.924
NULL	J_Invest_Dermatol_2012_May_16_132(5)_1435-1442.nxml.txt.nlp	22336948	SENT98	28	28	18	18	doxycycline	TLSP	PA449415	11012	0.924
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT286	23	23	11	11	bevacizumab	VEGF-A	PA130232992	7422	0.924
NULL	Mol_Cancer_2007_Oct_22_6_66.nxml.txt.nlp	17953743	SENT91	6	6	9	9	cisplatin	TRAIL	PA449014	8743	0.924
NULL	Braz_J_Med_Biol_Res_2014_Sep_5_47(11)_929-939.nxml.txt.nlp	25296354	SENT85	38	38	16	16	afatinib	EGFR	PA165981154	1956	0.924
NULL	Cancers_(Basel)_2011_Aug_10_3(3)_3206-3224.nxml.txt.nlp	24212953	SENT140	0	0	32	32	sulindac	COX	PA451565	1351	0.924
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT321	30	30	34	34	cisplatin	XIAP	PA449014	331	0.924
NULL	FEBS_Open_Bio_2013_Aug_17_3_352-356.nxml.txt.nlp	24251095	SENT3	13	13	7	7	hyaluronan	KIAA1199	PA165958431	57214	0.924
NULL	Nucleic_Acids_Res_2013_Mar_29_41(5)_2981-2992.nxml.txt.nlp	23361461	SENT107	15	15	21	21	tetracycline	TDP1	PA451640	55775	0.924
NULL	Apoptosis_2012_Sep_30_17(9)_989-997.nxml.txt.nlp	22460505	SENT120	23	23	6	6	thioridazine	CDK2	PA451666	1017	0.924
NULL	Biol_Open_2012_May_21_1(7)_629-639.nxml.txt.nlp	23125914	SENT53	41	41	29	29	doxycycline	PITX1	PA449415	5307	0.924
NULL	Front_Oncol_2013_Aug_5_3_195.nxml.txt.nlp	23936763	SENT57	34	34	26	26	dasatinib	EGFR	PA162372878	1956	0.924
NULL	Exp_Ther_Med_2014_Jun_28_7(6)_1653-1658.nxml.txt.nlp	24926361	SENT165	7	7	29	29	curcumin	p65	PA151958596	5970	0.924
NULL	J_Korean_Med_Sci_2009_Oct_24_24(5)_910-917.nxml.txt.nlp	19794992	SENT18	9	9	3	3	paclitaxel	HER2	PA450761	2064	0.924
NULL	J_Breast_Cancer_2012_Jun_28_15(2)_141-147.nxml.txt.nlp	22807930	SENT124	10	10	5	5	trastuzumab	HSF1	PA451743	3297	0.924
NULL	Angiogenesis_2010_Dec_7_13(4)_305-315.nxml.txt.nlp	20927579	SENT39	8	8	15	15	resveratrol	TSP1		7057	0.924
NULL	J_Int_Soc_Sports_Nutr_2010_Feb_4_7_9.nxml.txt.nlp	20205771	SENT163	8	8	33	33	creatine	ADP	PA164778930	23038	0.924
NULL	Int_J_Biol_Sci_2012_Sep_6_8(8)_1109-1120.nxml.txt.nlp	22991499	SENT152	1	1	18	18	l-arginine	IFN	PA448478	3439	0.924
NULL	Core_Evid_2009_Jun_15_4_149-158.nxml.txt.nlp	20694071	SENT236	14	14	8	8	maraviroc	CYP3A4	PA164768835	1576	0.924
NULL	Case_Rep_Hematol_2013_Jul_11_2013_871476.nxml.txt.nlp	23956893	SENT6	27	27	9	9	nilotinib	p230	PA165958345	2803	0.924
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_55-66.nxml.txt.nlp	17912636	SENT75	27	27	6	6	tamoxifen	HER2	PA451581	2064	0.924
NULL	J_Exp_Med_1998_Mar_16_187(6)_855-864.nxml.txt.nlp	9500788	SENT127	5	5	13	13	paraformaldehyde	CD4	PA450790	920	0.924
NULL	Physiol_Rep_2014_Aug_5_2(8)_e12090.nxml.txt.nlp	25096552	SENT217	22	22	9	9	dextran	CD137	PA449261	3604	0.924
NULL	Cardiol_Res_Pract_2013_Feb_19_2013_195456.nxml.txt.nlp	23533940	SENT127	5	5	25	25	clopidogrel	CYP2C19	PA449053	1557	0.924
NULL	Oncotarget_2013_Jun_4_4(5)_772-784.nxml.txt.nlp	23800712	SENT158	15	15	1	1	erlotinib	PIK3CA	PA134687924	5290	0.924
NULL	Breast_Cancer_(Auckl)_2012_Mar_7_6_67-77.nxml.txt.nlp	22438669	SENT69	13	13	23	23	paclitaxel	HER2	PA450761	2064	0.924
NULL	Biochimie_2012_Aug_94(8)_1749-1753.nxml.txt.nlp	22522093	SENT120	15	15	44	44	fluorescein	XRCC1	PA164746009	7515	0.924
NULL	Oncoscience_2014_Mar_16_1(2)_132-157.nxml.txt.nlp	25594007	SENT257	10	10	3	3	oxaliplatin	ID1	PA131285527	3397	0.924
NULL	Korean_J_Thorac_Cardiovasc_Surg_2014_Aug_5_47(4)_350-357.nxml.txt.nlp	25207243	SENT55	0	0	17	17	heparin	ACT	PA449855	12;11332;9457;641455	0.924
NULL	Cancer_Immunol_Immunother_2013_Aug_27_62(10)_1637-1648.nxml.txt.nlp	23982484	SENT104	21	21	2	2	lenalidomide	IL-2	PA162363968	3558	0.924
NULL	J_Gen_Physiol_2004_Aug_124(2)_125-137.nxml.txt.nlp	15277574	SENT45	31	31	14	14	forskolin	CFTR	PA146096022	1080	0.924
NULL	Br_J_Cancer_2012_Jun_5_106(12)_1997-2003.nxml.txt.nlp	22596232	SENT204	4	4	9	9	sorafenib	JNK	PA7000	5599	0.924
NULL	Exp_Ther_Med_2012_Oct_3_4(4)_594-604.nxml.txt.nlp	23170111	SENT100	31	31	17	17	propranolol	JNK	PA451145	5599	0.924
NULL	Oncotarget_2012_Sep_28_3(10)_1169-1181.nxml.txt.nlp	23045411	SENT184	2	2	4	4	doxorubicin	JNK	PA449412	5599	0.924
NULL	Am_J_Cardiovasc_Drugs_2013_Jun_20_13(5)_331-342.nxml.txt.nlp	23784266	SENT17	10	10	3	3	dronedarone	P-gp	PA153619853	5243	0.924
NULL	Int_J_Gen_Med_2009_Dec_29_2_209-217.nxml.txt.nlp	20360906	SENT139	18	18	9	9	bromocriptine	PRL	PA448671	5617	0.924
NULL	Eur_J_Clin_Pharmacol_2010_Nov_29_66(11)_1131-1136.nxml.txt.nlp	20669013	SENT133	41	41	35	35	erythromycin	CYP2C19	PA449493	1557	0.924
NULL	Cancer_Med_2012_Oct_13_1(2)_218-229.nxml.txt.nlp	23342271	SENT210	19	19	9	9	paclitaxel	p53	PA450761	7157	0.924
NULL	Front_Oncol_2014_Sep_29_4_251.nxml.txt.nlp	25325012	SENT508	20	20	30	30	cisplatin	EGFR	PA449014	1956	0.924
NULL	Nat_Commun_2014_Dec_9_5_5691.nxml.txt.nlp	25487737	SENT588	34	34	17	17	doxorubicin	SUV39H2	PA449412	79723	0.924
NULL	Br_J_Cancer_2013_Mar_19_108(5)_1079-1091.nxml.txt.nlp	23449353	SENT115	19	19	6	6	docetaxel	PC3	PA449383	57332;7832;5122	0.924
NULL	F1000Res_2014_Jul_1_3_149.nxml.txt.nlp	25352980	SENT114	19	19	10	10	galactose	ARG1	PA449725	383;64129	0.924
NULL	Biochem_Res_Int_2011_Dec_20_2011_896474.nxml.txt.nlp	21197476	SENT156	4	4	37	37	taurine	HFE	PA451590	3077	0.924
NULL	J_Cell_Biol_1998_Jun_15_141(6)_1415-1422.nxml.txt.nlp	9628897	SENT59	12	12	33	33	aprotinin	BRUCE	PA448472	57448	0.924
NULL	Front_Neurosci_2014_Dec_8_8_388.nxml.txt.nlp	25538545	SENT156	18	18	2	2	estradiol	5-HT1A	PA449503	3350	0.924
NULL	Indian_J_Med_Res_2014_Jan_139(1)_76-82.nxml.txt.nlp	24604041	SENT30	26	26	9	9	albendazole	STH	PA164746058	246744	0.924
NULL	J_Oncol_2010_Jun_29_2010_586905.nxml.txt.nlp	20671917	SENT248	15	15	4	4	urokinase	TSP-1	PA451836	7057	0.924
NULL	Nucleic_Acids_Res_2013_Apr_17_41(7)_4129-4143.nxml.txt.nlp	23420868	SENT283	25	25	12	12	hemin	CD235a	PA449849	2993	0.924
NULL	Diabetes_Metab_Syndr_Obes_2014_Jul_1_7_265-275.nxml.txt.nlp	25061325	SENT155	5	5	22	22	sibutramine	adiponectin	PA451344	9370	0.924
NULL	Acta_Pharmacol_Sin_2013_Apr_25_34(4)_455-463.nxml.txt.nlp	23524568	SENT181	35	35	13	13	pioglitazone	BACE1	PA450970	23621	0.924
NULL	Clin_Drug_Investig_2012_Dec_13_32(8)_e1-e15.nxml.txt.nlp	22712629	SENT145	19	19	10	10	memantine	ANOVA	PA10364	4858	0.924
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT48	3	3	16	16	metformin	p53	PA450395	7157	0.924
NULL	Breast_Cancer_Res_2009_May_18_11(3)_303.nxml.txt.nlp	19519950	SENT10	25	25	11	11	bevacizumab	ACT	PA130232992	12;11332;9457;641455	0.924
NULL	J_Cancer_2013_Jan_11_4(2)_117-132.nxml.txt.nlp	23386910	SENT189	3	3	7	7	everolimus	aromatase	PA164746311	1588	0.924
NULL	Br_J_Pharmacol_2011_Feb_162(4)_989-999.nxml.txt.nlp	21054342	SENT157	17	17	12	12	ketoconazole	CYP2C8	PA450146	1558	0.924
NULL	Arthritis_Res_Ther_2005_Feb_17_7(Suppl_1)_S11.nxml.txt.nlp	NULL	SENT17	2	2	4	4	collagenase	MT1-MMP	PA449107	4323	0.924
NULL	Mol_Cancer_2010_Apr_23_9_87.nxml.txt.nlp	20416058	SENT177	29	29	44	44	doxorubicin	TRAIL	PA449412	8743	0.924
NULL	Ann_Dermatol_2011_Aug_6_23(3)_329-337.nxml.txt.nlp	21909203	SENT81	9	9	27	27	cyclophosphamide	CHOP	PA449165	1649	0.924
NULL	Biochem_Res_Int_2012_Nov_1_2012_738471.nxml.txt.nlp	22110962	SENT136	11	11	1	1	choline	DAG	PA448976	1605	0.924
NULL	Cancer_Med_2013_Feb_3_2(1)_40-49.nxml.txt.nlp	24133626	SENT170	5	5	13	13	cilostazol	PDE3B	PA164746334	5140	0.924
NULL	Comp_Hepatol_2005_Feb_8_4_2.nxml.txt.nlp	15701172	SENT98	26	26	16	16	ketoconazole	CYP3A4	PA450146	1576	0.924
NULL	Mol_Cancer_2009_Aug_25_8_66.nxml.txt.nlp	19706164	SENT57	24	24	2	2	celecoxib	p53	PA448871	7157	0.924
NULL	Breast_Cancer_Res_2009_Mar_23_11(2)_R17.nxml.txt.nlp	19309506	SENT169	10	10	4	4	methotrexate	TLE3	PA450428	7090	0.924
NULL	Evid_Based_Complement_Alternat_Med_2013_Oct_29_2013_795365.nxml.txt.nlp	24319485	SENT215	20	20	15	15	thrombin	ADP	PA451674	23038	0.924
NULL	Arthritis_Res_2001_Jan_26_3(Suppl_A)_P090.nxml.txt.nlp	NULL	SENT5	40	40	13	13	methotrexate	TNF-alpha	PA450428	7124	0.924
NULL	J_Hematol_Oncol_2013_Jul_18_6_53.nxml.txt.nlp	23866964	SENT227	8	8	15	15	temsirolimus	HDAC3	PA164746890	8841	0.924
NULL	Chem_Cent_J_2013_Mar_27_7_57.nxml.txt.nlp	23537428	SENT28	5	5	37	37	exemestane	aromatase	PA449563	1588	0.924
NULL	Cell_Commun_Signal_2013_Sep_18_11_69.nxml.txt.nlp	24047462	SENT110	12	12	14	14	estradiol	BTG2	PA449503	7832	0.924
NULL	Acta_Pharmacol_Sin_2011_Aug_11_32(8)_999-1008.nxml.txt.nlp	21743486	SENT190	0	0	16	16	fasudil	JNK	PA165946121	5599	0.924
NULL	Crit_Care_2011_Nov_20_15(6)_R275.nxml.txt.nlp	22099212	SENT60	7	7	17	17	heparin	ACT	PA449855	12;11332;9457;641455	0.924
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S18-S30.nxml.txt.nlp	20680104	SENT81	33	33	26	26	panitumumab	STEPP	PA162373091	222659	0.924
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT121	37	37	18	18	irinotecan	EGFR	PA450085	1956	0.924
NULL	Nat_Genet_2013_Sep_28_45(9)_1004-1012.nxml.txt.nlp	23892607	SENT174	5	5	21	21	tamoxifen	P28	PA451581	9446;7802;9527	0.924
NULL	Clin_Med_Insights_Oncol_2012_May_16_6_205-217.nxml.txt.nlp	22654526	SENT158	17	17	22	22	azacitidine	FLT3	PA451996	2322	0.924
NULL	Arthritis_Res_Ther_2011_May_25_13(Suppl_1)_S2.nxml.txt.nlp	21624181	SENT260	19	19	6	6	infliximab	IMPACT	PA452639	55364	0.924
NULL	J_Oncol_2012_Jun_19_2012_521215.nxml.txt.nlp	22778735	SENT139	26	26	30	30	cetuximab	EGFR	PA10040	1956	0.924
NULL	Nucleic_Acids_Res_2007_Jan_7_35(1)_214-222.nxml.txt.nlp	17158161	SENT110	44	44	5	5	kanamycin	ORF	PA450137	537	0.924
NULL	Surg_Neurol_Int_2014_Aug_28_5(Suppl_7)_S373-S375.nxml.txt.nlp	25289164	SENT66	5	5	12	12	denosumab	RANK	PA166048634	8792	0.924
NULL	Indian_J_Anaesth_2013_Jan-Feb_57(1)_91-92.nxml.txt.nlp	23716783	SENT18	3	3	37	37	rocuronium	PORC	PA164754992	64840;5448	0.924
NULL	Oncotarget_2012_May_19_3(5)_535-545.nxml.txt.nlp	22619121	SENT108	6	6	0	0	camptothecin	B-MYB	PA153590860	4605	0.924
NULL	Mol_Cancer_2009_Aug_25_8_66.nxml.txt.nlp	19706164	SENT61	12	12	2	2	celecoxib	p53	PA448871	7157	0.924
NULL	Case_Rep_Crit_Care_2014_Jun_24_2014_650916.nxml.txt.nlp	25057417	SENT46	29	29	1	1	iron	MRI	PA450087	78996	0.924
NULL	Indian_J_Hum_Genet_2014_Apr-Jun_20(2)_175-184.nxml.txt.nlp	25400347	SENT9	39	39	22	22	warfarin	MYBPC3	PA451906	4607	0.924
NULL	J_Biomed_Biotechnol_2003_Mar_19_2003(1)_48-70.nxml.txt.nlp	12686722	SENT209	42	42	7	7	nadh	CYP2B6	PA164755085	1555	0.924
NULL	Int_J_Biol_Sci_2013_Dec_17_10(1)_64-72.nxml.txt.nlp	24391452	SENT16	25	25	44	44	verapamil	5-HT2B	PA451868	3357	0.924
NULL	Biomed_Res_Int_2013_Apr_18_2013_351031.nxml.txt.nlp	23691498	SENT253	3	3	14	14	methotrexate	U87	PA450428	677775;641648	0.924
NULL	Ann_Oncol_2014_Apr_26_25(4)_801-807.nxml.txt.nlp	24577117	SENT73	14	14	21	21	cetuximab	p16	PA10040	1029	0.924
NULL	J_Oncol_2012_Mar_11_2012_382159.nxml.txt.nlp	22481926	SENT132	33	33	18	18	irinotecan	p38	PA450085	10598;1432;7965	0.924
NULL	Curr_Genomics_2013_Nov_14(7)_477-484.nxml.txt.nlp	24396279	SENT170	13	13	8	8	cyclosporine	MYO1E	PA449167	4643	0.924
NULL	Evid_Based_Complement_Alternat_Med_2013_Aug_28_2013_516017.nxml.txt.nlp	24066014	SENT52	11	11	39	39	indomethacin	EDH	PA449982	10804	0.924
NULL	Breast_Cancer_Res_2010_Nov_16_12(6)_R95.nxml.txt.nlp	21080930	SENT260	24	24	41	41	cisplatin	BRCA1	PA449014	672	0.924
NULL	Acta_Neuropathol_2012_Mar_16_123(3)_369-380.nxml.txt.nlp	22083253	SENT57	24	24	43	43	lovastatin	NF1	PA450272	4763	0.924
NULL	Exp_Ther_Med_2014_Mar_10_7(3)_640-648.nxml.txt.nlp	24520260	SENT40	15	15	24	24	triciribine	San	PA165958661	80218	0.924
NULL	Gut_Pathog_2009_Nov_26_1_20.nxml.txt.nlp	19941660	SENT22	28	28	6	6	levodopa	B12	PA450213	7126;4709	0.924
NULL	Blood_Cancer_J_2013_Dec_6_3(12)_e167.nxml.txt.nlp	24317089	SENT129	2	2	15	15	lovastatin	IRE1	PA450272	2081	0.924
NULL	Arthritis_Res_2002_Mar_27_4(Suppl_2)_S29-S33.nxml.txt.nlp	12110155	SENT145	5	5	1	1	infliximab	NNT	PA452639	23530	0.924
NULL	Crit_Care_1999_Jun_25_3(3)_R35-R46.nxml.txt.nlp	11094481	SENT448	4	4	13	13	buspirone	5-HT1A	PA448689	3350	0.924
NULL	Mol_Biol_Cell_2013_Aug_1_24(15)_2340-2349.nxml.txt.nlp	23783036	SENT259	19	19	41	41	erythromycin	CR2	PA449493	1380	0.924
NULL	Diabetes_2009_Jul_31_58(7)_1488-1498.nxml.txt.nlp	19336678	SENT64	1	1	11	11	lipase	San	PA450239	80218	0.924
NULL	Biomed_Res_Int_2013_Jul_18_2013_635143.nxml.txt.nlp	23971042	SENT73	22	22	9	9	indomethacin	ANOVA	PA449982	4858	0.924
NULL	Ann_Surg_Oncol_2008_Apr_23_15(4)_956-960.nxml.txt.nlp	18214617	SENT161	4	4	0	0	paclitaxel	HER2	PA450761	2064	0.924
NULL	Br_J_Clin_Pharmacol_2013_Aug_23_76(2)_299-315.nxml.txt.nlp	23701319	SENT240	6	6	16	16	basiliximab	CD25	PA164747126	3669;3559	0.924
NULL	Cancers_(Basel)_2012_Jun_27_4(3)_618-657.nxml.txt.nlp	22946011	SENT705	2	2	14	14	hyaluronan	CD11b	PA165958431	3684	0.924
NULL	Indian_J_Pharm_Sci_2013_Jan-Feb_75(1)_3-10.nxml.txt.nlp	23901154	SENT41	12	12	29	29	bevacizumab	EGFR	PA130232992	1956	0.924
NULL	Front_Neurosci_2015_Jan_12_8_445.nxml.txt.nlp	25628526	SENT1665	19	19	6	6	methamphetamine	JNK	PA450403	5599	0.924
NULL	Mol_Clin_Oncol_2013_Sep_26_1(5)_799-804.nxml.txt.nlp	24649249	SENT112	2	2	5	5	lapatinib	EGFR	PA152241907	1956	0.924
NULL	J_Physiol_2014_Nov_15_592(22)_5093-5107.nxml.txt.nlp	25239460	SENT60	21	21	23	23	ketoprofen	COX	PA450149	1351	0.924
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_650809.nxml.txt.nlp	23258995	SENT170	28	28	8	8	vasopressin	AQP3	PA451858	360	0.924
NULL	Drug_Des_Devel_Ther_2014_Sep_18_8_1419-1427.nxml.txt.nlp	25258511	SENT66	14	14	22	22	bupropion	POMC	PA448687	5443	0.924
NULL	Front_Neurosci_2014_May_27_8_129.nxml.txt.nlp	24904269	SENT154	16	16	5	5	ethanol	AC5	PA448073	111	0.924
NULL	Int_J_Mol_Imaging_2011_Oct_26_2011_874585.nxml.txt.nlp	21490735	SENT15	18	18	11	11	tamoxifen	FDG	PA451581	23583	0.924
NULL	Mol_Cancer_2013_Oct_5_12_115.nxml.txt.nlp	24094005	SENT107	32	32	7	7	doxycycline	CD164	PA449415	8763	0.924
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_25_2013_421051.nxml.txt.nlp	23878598	SENT44	25	25	43	43	l-glutamine	CO2	PA10090	4513	0.924
NULL	Cardiol_Res_Pract_2011_Apr_26_2011_874802.nxml.txt.nlp	21577272	SENT115	26	26	9	9	dronedarone	CYP3A4	PA153619853	1576	0.924
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Dec_17_3(12)_e152.nxml.txt.nlp	25518025	SENT41	16	16	3	3	paroxetine	CYP3A	PA450801	1574	0.924
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT247	20	20	7	7	cetuximab	KRAS	PA10040	3845	0.924
NULL	J_Asthma_Allergy_2010_Jul_16_3_57-63.nxml.txt.nlp	21437040	SENT155	8	8	0	0	simvastatin	CD4	PA451363	920	0.924
NULL	J_Oncol_2010_May_24_2010_729725.nxml.txt.nlp	20508816	SENT79	0	0	26	26	thalidomide	IL-6	PA451644	3569	0.924
NULL	Cancer_Cell_2007_Dec_11_12(6)_514-527.nxml.txt.nlp	18068629	SENT39	7	7	2	2	paclitaxel	TGFBI	PA450761	7045	0.924
NULL	Biosci_Rep_2014_Dec_12_34(6)_e00160.nxml.txt.nlp	25495645	SENT94	36	36	47	47	rosiglitazone	ANGPTL3	PA451283	27329	0.924
NULL	Adv_Hematol_2012_May_8_2012_393864.nxml.txt.nlp	22851972	SENT30	5	5	14	14	lenalidomide	CD28	PA162363968	1493;940	0.924
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S31-S40.nxml.txt.nlp	20680106	SENT70	27	27	34	34	cetuximab	KRAS	PA10040	3845	0.924
NULL	EMBO_Mol_Med_2010_May_2(5)_172-187.nxml.txt.nlp	20432503	SENT297	18	18	27	27	indomethacin	CysLT1	PA449982	10800	0.924
NULL	Crit_Care_2000_Mar_21_4(Suppl_1)_P163.nxml.txt.nlp	NULL	SENT19	13	13	1	1	propofol	BIC	PA451141	114614	0.924
NULL	J_Korean_Med_Sci_2007_Feb_28_22(1)_26-29.nxml.txt.nlp	17297247	SENT69	21	21	27	27	pyrazinamide	DST	PA451182	667	0.924
NULL	Br_J_Pharmacol_2012_Dec_29_167(8)_1712-1722.nxml.txt.nlp	22862290	SENT159	38	38	36	36	carbachol	TRPC3	PA448784	7222	0.924
NULL	Colorectal_Dis_2012_Feb_14(2)_e31-e47.nxml.txt.nlp	21848897	SENT117	43	43	28	28	cetuximab	KRAS	PA10040	3845	0.924
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT160	6	6	1	1	pertuzumab	HER2		2064	0.924
NULL	J_Histochem_Cytochem_2013_Feb_61(2)_101-115.nxml.txt.nlp	23092791	SENT481	8	8	18	18	bevacizumab	CXCR4	PA130232992	7852	0.924
NULL	J_Biol_Chem_2008_Jun_20_283(25)_17194-17204.nxml.txt.nlp	18442977	SENT125	38	38	34	34	ketanserin	5-HT2A	PA131053734	3356	0.924
NULL	J_Adv_Pharm_Technol_Res_2012_Oct-Dec_3(4)_202-209.nxml.txt.nlp	23378940	SENT157	6	6	33	33	fosaprepitant	NK-1	PA165958390	27087	0.924
NULL	J_Gastroenterol_2013_Jan_27_48(1)_22-30.nxml.txt.nlp	23104468	SENT318	13	13	3	3	ribavirin	ITPA	PA451241	3704	0.924
NULL	Case_Rep_Oncol_2014_Jan_31_7(1)_97-101.nxml.txt.nlp	24575024	SENT60	30	30	43	43	topotecan	EGFR	PA451729	1956	0.924
NULL	J_Viral_Hepat_2009_May_16(5)_315-324.nxml.txt.nlp	19243499	SENT135	35	35	3	3	imiquimod	CD86	PA449972	942	0.924
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT236	40	40	2	2	metformin	LKB1	PA450395	6794	0.924
NULL	Orphanet_J_Rare_Dis_2014_Sep_18_9(1)_143.nxml.txt.nlp	NULL	SENT149	2	2	36	36	miglustat	ABCA1	PA10140	19	0.924
NULL	Acta_Pharmacol_Sin_2013_Sep_5_34(9)_1192-1200.nxml.txt.nlp	23685957	SENT140	19	19	22	22	curcumin	AP-2	PA151958596	7020	0.924
NULL	Clin_Pediatr_Endocrinol_2007_Nov_17_16(4)_81-84.nxml.txt.nlp	24790350	SENT58	0	0	18	18	levodopa	PRL	PA450213	5617	0.924
NULL	Nucleic_Acids_Res_2012_Jun_10_40(11)_4804-4815.nxml.txt.nlp	22328728	SENT217	21	21	13	13	hemin	SIRT1	PA449849	23411	0.924
NULL	Oncotarget_2013_Nov_24_4(12)_2186-2207.nxml.txt.nlp	24327604	SENT130	30	30	22	22	vincristine	MDM2	PA451879	4193	0.924
NULL	BioData_Min_2008_Jul_17_1_2.nxml.txt.nlp	18822146	SENT8	37	37	20	20	ethanol	MTHFR	PA448073	4524	0.924
NULL	J_Inflamm_(Lond)_2006_May_4_3_8.nxml.txt.nlp	16674821	SENT140	13	13	30	30	pp2	SKI-1		8720	0.924
NULL	Evid_Based_Complement_Alternat_Med_2011_Jan_4_2011_392627.nxml.txt.nlp	19542183	SENT112	24	24	9	9	phenylephrine	mol	PA450935	90527	0.924
NULL	Anticancer_Agents_Med_Chem_2012_Feb_12(2)_163-171.nxml.txt.nlp	22043994	SENT171	26	26	6	6	cetuximab	BRAF	PA10040	673	0.924
NULL	Mol_Cancer_2013_Mar_5_12_17.nxml.txt.nlp	23497256	SENT214	24	24	11	11	sunitinib	GM-CSF	PA162372840	1437	0.924
NULL	Pharmaceuticals_(Basel)_2012_Aug_10_5(8)_802-836.nxml.txt.nlp	24280676	SENT90	27	27	16	16	gemcitabine	CNT1	PA449748	9154	0.924
NULL	Drug_Healthc_Patient_Saf_2014_Jun_24_6_77-88.nxml.txt.nlp	25018652	SENT112	28	28	24	24	vemurafenib	BRAF	PA165946873	673	0.924
NULL	Ann_Dermatol_2014_Dec_26_26(6)_706-712.nxml.txt.nlp	25473222	SENT28	11	11	14	14	isotretinoin	EPO	PA450128	7076;8288;2056	0.924
NULL	Nat_Chem_Biol_2010_Apr_28_6(4)_291-299.nxml.txt.nlp	20190765	SENT51	13	13	5	5	dasatinib	EPHB2	PA162372878	2048	0.924
NULL	Lab_Anim_Res_2013_Jun_24_29(2)_84-95.nxml.txt.nlp	23825481	SENT196	10	10	0	0	nifedipine	INS-1	PA450631	2305	0.924
NULL	Cardiovasc_Diabetol_2013_May_4_12_73.nxml.txt.nlp	23642288	SENT136	11	11	21	21	acarbose	GLP-1	PA448010	100125288	0.924
NULL	Oxid_Med_Cell_Longev_2012_Jun_3_2012_914273.nxml.txt.nlp	22701758	SENT235	7	7	15	15	resveratrol	IL-10		3586	0.924
NULL	J_Hematol_Oncol_2009_Dec_23_2_50.nxml.txt.nlp	20030851	SENT268	23	23	16	16	rituximab	MDM2	PA451261	4193	0.924
NULL	Oncoimmunology_2012_Aug_1_1(5)_618-629.nxml.txt.nlp	22934254	SENT195	38	38	25	25	nilotinib	p38	PA165958345	10598;1432;7965	0.924
NULL	J_Gastroenterol_2013_Jan_28_48(1)_1-12.nxml.txt.nlp	23188091	SENT285	13	13	3	3	ribavirin	ITPA	PA451241	3704	0.924
NULL	Front_Endocrinol_(Lausanne)_2013_Oct_25_4_158.nxml.txt.nlp	24298267	SENT157	13	13	10	10	candesartan	AT1	PA448765	9197;185	0.924
NULL	Oncogenesis_2012_Apr_2_1(4)_e5.nxml.txt.nlp	23552603	SENT257	2	2	11	11	ns-398	DR4		8797	0.924
NULL	Psychiatry_Investig_2009_Mar_31_6(1)_39-43.nxml.txt.nlp	20046372	SENT17	24	24	13	13	olanzapine	GNB3	PA450688	2784	0.924
NULL	Environ_Health_Perspect_2005_Apr_14_113(4)_431-439.nxml.txt.nlp	15811834	SENT140	5	5	0	0	nifedipine	PRL	PA450631	5617	0.924
NULL	Curr_Pharm_Biotechnol_2011_Jan_12(1)_35-41.nxml.txt.nlp	20932261	SENT73	25	25	10	10	hyperforin	TRPC6	PA165985514	7225	0.924
NULL	J_Cancer_Epidemiol_2012_Oct_24_2012_294730.nxml.txt.nlp	23150730	SENT243	25	25	3	3	panitumumab	KRAS	PA162373091	3845	0.924
NULL	Colomb_Med_(Cali)_43(4)_305-311.nxml.txt.nlp	24893304	SENT152	43	43	8	8	ganciclovir	CD4	PA449733	920	0.924
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT323	18	18	14	14	risperidone	PRL	PA451257	5617	0.924
NULL	Br_J_Cancer_2010_Jun_29_103(1)_61-72.nxml.txt.nlp	20588279	SENT281	8	8	33	33	trastuzumab	PTEN	PA451743	5728	0.924
NULL	Croat_Med_J_2012_Jun_53(3)_214-223.nxml.txt.nlp	22661134	SENT100	6	6	43	43	reserpine	ACTH	PA451236	5443	0.924
NULL	Cell_Death_Dis_2014_Mar_6_5(3)_e1108.nxml.txt.nlp	24603336	SENT236	12	12	5	5	etoposide	p53	PA449552	7157	0.924
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT173	18	18	20	20	sitagliptin	HIP	PA164748978	6767;6159;64399;5068	0.924
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1986-2011.nxml.txt.nlp	25268165	SENT166	28	28	6	6	doxorubicin	STAT3	PA449412	6774	0.924
NULL	Br_J_Cancer_2006_Dec_4_95(11)_1504-1513.nxml.txt.nlp	17088902	SENT10	34	34	22	22	gefitinib	PI3K	PA131301952	5290	0.924
NULL	J_Young_Pharm_2010_Oct-Dec_2(4)_428-429.nxml.txt.nlp	21264109	SENT26	24	24	12	12	metformin	B12	PA450395	7126;4709	0.924
NULL	Int_J_Breast_Cancer_2013_Jun_24_2013_137414.nxml.txt.nlp	23864953	SENT41	9	9	20	20	trastuzumab	HER2	PA451743	2064	0.924
NULL	Cancer_Med_2013_Jun_25_2(3)_277-285.nxml.txt.nlp	23930204	SENT157	8	8	21	21	bevacizumab	PTEN	PA130232992	5728	0.924
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT140	11	11	3	3	atorvastatin	IL-6	PA448500	3569	0.924
NULL	F1000Res_2013_Jul_9_2_150.nxml.txt.nlp	24627787	SENT19	21	21	36	36	olanzapine	DIP	PA450688	23151;1831	0.924
NULL	Leukemia_2013_Jan_11_27(1)_32-40.nxml.txt.nlp	22781593	SENT8	5	5	15	15	ponatinib	CD34	PA165980594	947	0.924
NULL	Arthritis_Res_Ther_2009_Aug_28_11(4)_R131.nxml.txt.nlp	19715572	SENT89	29	29	14	14	rituximab	CD19	PA451261	930	0.924
NULL	Cancer_Med_2014_Oct_2_3(5)_1256-1265.nxml.txt.nlp	24890382	SENT20	0	0	17	17	trastuzumab	HER2	PA451743	2064	0.924
NULL	Orphanet_J_Rare_Dis_2014_Dec_10_9(1)_201.nxml.txt.nlp	NULL	SENT199	9	9	27	27	baclofen	CMT1A	PA448533	1248	0.924
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT174	40	40	16	16	metformin	HIF-1	PA450395	29072	0.924
NULL	Oncol_Lett_2013_Sep_28_6(3)_795-800.nxml.txt.nlp	24137413	SENT99	30	30	5	5	paclitaxel	HIF-1	PA450761	29072	0.924
NULL	Acta_Pharmacol_Sin_2010_Jul_21_31(7)_855-860.nxml.txt.nlp	20562904	SENT12	20	20	5	5	fluconazole	CDR1	PA449653	1038	0.924
NULL	Oncotarget_2012_May_19_3(5)_535-545.nxml.txt.nlp	22619121	SENT116	5	5	23	23	camptothecin	MYCN	PA153590860	4613	0.924
NULL	Asian_J_Transfus_Sci_2011_Jan_5(1)_32-34.nxml.txt.nlp	21572712	SENT45	25	25	0	0	ethanol	DAN	PA448073	5073;4681	0.924
NULL	Acta_Pharmacol_Sin_2009_Sep_24_30(9)_1262-1275.nxml.txt.nlp	19701231	SENT10	16	16	2	2	lovastatin	INSIG2	PA450272	51141	0.924
NULL	Mol_Cancer_2009_Jun_23_8_39.nxml.txt.nlp	19549337	SENT142	22	22	12	12	etoposide	TRAIL	PA449552	8743	0.924
NULL	Cell_Death_Differ_2010_Oct_30_17(10)_1624-1635.nxml.txt.nlp	20431602	SENT112	16	16	8	8	paclitaxel	Mcl-1	PA450761	4170	0.924
NULL	Oncotarget_2013_Jun_29_4(9)_1338-1348.nxml.txt.nlp	23907514	SENT66	3	3	23	23	doxorubicin	PSMA1	PA449412	5682	0.924
NULL	Pharmaceutics_2011_Aug_10_3(3)_474-484.nxml.txt.nlp	24310591	SENT16	0	0	20	20	cyanocobalamin	B12	PA451892	7126;4709	0.924
NULL	J_Vis_Exp_2014_Jun_28_(88)_51278.nxml.txt.nlp	24998179	SENT35	8	8	22	22	verapamil	P-gp	PA451868	5243	0.924
NULL	Open_Access_J_Urol_2011_May_10_3_69-82.nxml.txt.nlp	24198638	SENT63	22	22	7	7	sorafenib	CYP3A4	PA7000	1576	0.924
NULL	Cancers_(Basel)_2014_Aug_12_6(3)_1631-1669.nxml.txt.nlp	25119536	SENT250	42	42	21	21	imatinib	MMP2	PA10804	4313	0.924
NULL	Oncol_Lett_2014_Nov_14_8(5)_2086-2092.nxml.txt.nlp	25295095	SENT99	30	30	15	15	gemcitabine	CHK1	PA449748	1111	0.924
NULL	Oncotarget_2013_Oct_19_4(11)_2045-2056.nxml.txt.nlp	24185104	SENT3	17	17	9	9	cisplatin	RhoGDI2	PA449014	397	0.924
NULL	Oncoscience_2014_Aug_7_1(8)_540-549.nxml.txt.nlp	25594061	SENT92	5	5	13	13	panitumumab	EGFR	PA162373091	1956	0.924
NULL	Cancer_Res_Treat_2012_Sep_30_44(3)_195-201.nxml.txt.nlp	23091446	SENT96	24	24	3	3	cisplatin	MKP-1	PA449014	1843	0.924
NULL	Ther_Clin_Risk_Manag_2005_Dec_1(4)_299-306.nxml.txt.nlp	18360572	SENT79	23	23	32	32	saquinavir	CYP3A4	PA451305	1576	0.924
NULL	Ital_J_Pediatr_2011_Aug_22_37_39.nxml.txt.nlp	21859484	SENT79	10	10	15	15	salbutamol	BDP	PA448068	10620;152926	0.924
NULL	Front_Synaptic_Neurosci_2014_May_30_6_12.nxml.txt.nlp	24910611	SENT146	10	10	0	0	l-serine	ASCT1	PA451330	6509	0.924
NULL	Diabetes_Obes_Metab_2011_Nov_13(11)_982-989.nxml.txt.nlp	21615670	SENT140	7	7	19	19	sitagliptin	PPG	PA164748978	5552	0.924
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_P112.nxml.txt.nlp	NULL	SENT19	9	9	23	23	ximelagatran	DRB1	PA161748474	129831	0.924
NULL	Drug_Des_Devel_Ther_2014_Oct_14_8_1839-1849.nxml.txt.nlp	25342883	SENT196	15	15	44	44	paclitaxel	CO2	PA450761	4513	0.924
NULL	Biosci_Rep_2014_Dec_12_34(6)_e00160.nxml.txt.nlp	25495645	SENT105	12	12	2	2	rosiglitazone	ANGPTL3	PA451283	27329	0.924
NULL	Hum_Genomics_2009_Dec_1_4(2)_91-106.nxml.txt.nlp	20038497	SENT68	5	5	21	21	donepezil	CYP3A4	PA449394	1576	0.924
NULL	J_Oncol_2011_Jun_12_2011_542358.nxml.txt.nlp	21772843	SENT364	40	40	34	34	doxorubicin	p53	PA449412	7157	0.924
NULL	J_Antimicrob_Chemother_2009_Oct_13_64(4)_829-836.nxml.txt.nlp	19679597	SENT18	14	14	6	6	fosfomycin	SMF	PA164748039	22993	0.924
NULL	Mol_Cancer_2014_Jul_5_13_165.nxml.txt.nlp	24996221	SENT81	26	26	6	6	docetaxel	HMGB1	PA449383	3146	0.924
NULL	Br_J_Cancer_2012_Apr_24_106(9)_1543-1550.nxml.txt.nlp	22531721	SENT65	6	6	39	39	trastuzumab	CD46	PA451743	4179	0.924
NULL	Breast_Cancer_Res_2011_Jun_27_13(3)_212.nxml.txt.nlp	21787441	SENT213	29	29	2	2	tamoxifen	SET	PA451581	6418	0.924
NULL	Breast_Cancer_Res_2012_Jun_14_14(3)_R95.nxml.txt.nlp	22697792	SENT460	16	16	19	19	tamoxifen	aromatase	PA451581	1588	0.924
NULL	Mol_Cell_Biochem_2012_Apr_3_363(1-2)_135-145.nxml.txt.nlp	22139302	SENT9	23	23	27	27	curcumin	survivin	PA151958596	332	0.924
NULL	J_Exp_Med_2000_Mar_6_191(5)_859-870.nxml.txt.nlp	10704466	SENT160	29	29	13	13	arsenite	p38	PA452638	10598;1432;7965	0.924
NULL	Int_J_Mol_Imaging_2011_Oct_26_2011_874585.nxml.txt.nlp	21490735	SENT66	7	7	35	35	trypsin	FDG	PA451806	23583	0.924
NULL	Acta_Pharmacol_Sin_2011_Nov_10_32(11)_1402-1410.nxml.txt.nlp	21986579	SENT157	42	42	23	23	curcumin	CDK4	PA151958596	1019	0.924
NULL	Oncoscience_2014_Mar_12_1(2)_158-166.nxml.txt.nlp	25594008	SENT124	25	25	17	17	dasatinib	PTRF	PA162372878	284119	0.924
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT66	5	5	23	23	cetuximab	EGFR	PA10040	1956	0.924
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Oct_31_65(Pt_11)_o2919.nxml.txt.nlp	21578497	SENT54	21	21	7	7	ethanol	mol	PA448073	90527	0.924
NULL	Int_J_Med_Sci_2013_Mar_19_10(5)_599-606.nxml.txt.nlp	23569422	SENT79	14	14	23	23	propofol	HO-1	PA451141	3162	0.924
NULL	Oncotarget_2014_Oct_21_5(22)_11709-11722.nxml.txt.nlp	25365944	SENT145	4	4	7	7	metformin	RhoA	PA450395	387	0.924
NULL	Mediators_Inflamm_2011_Jun_7_2011_432080.nxml.txt.nlp	21772662	SENT11	7	7	22	22	rivaroxaban	IL-6	PA165958360	3569	0.924
NULL	Ann_Hematol_2011_May_12_90(5)_557-568.nxml.txt.nlp	20938660	SENT131	15	15	4	4	plerixafor	CD34	PA165958410	947	0.924
NULL	J_Adv_Pract_Oncol_2013_Jul_1_Jul-Aug_4(4)_238-250.nxml.txt.nlp	25032004	SENT28	22	22	5	5	imatinib	KIT	PA10804	3815	0.924
NULL	J_Oncol_2012_Mar_11_2012_382159.nxml.txt.nlp	22481926	SENT86	2	2	8	8	erlotinib	EGFR	PA134687924	1956	0.924
NULL	Oncotarget_2011_Sep_9_2(9)_658-668.nxml.txt.nlp	21911919	SENT84	7	7	1	1	cytarabine	HO-1	PA449177	3162	0.924
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT321	30	30	19	19	cisplatin	XIAP	PA449014	331	0.924
NULL	Interdiscip_Toxicol_2011_Mar_4(1)_20-26.nxml.txt.nlp	21577280	SENT135	2	2	15	15	phenylephrine	FMLP	PA450935	2357	0.924
NULL	Cancers_(Basel)_2012_May_8_4(2)_523-530.nxml.txt.nlp	24213322	SENT171	10	10	15	15	gefitinib	EGFR	PA131301952	1956	0.924
NULL	Int_J_Mol_Sci_2012_Aug_16_13(8)_10193-10211.nxml.txt.nlp	22949855	SENT62	37	37	11	11	oxygen	CAT	PA450744	847	0.924
NULL	Int_J_Biomed_Imaging_2013_Feb_26_2013_230487.nxml.txt.nlp	23533377	SENT176	6	6	16	16	trastuzumab	Hsp90	PA451743	3320	0.924
NULL	Mol_Cancer_2008_Oct_23_7_82.nxml.txt.nlp	18947424	SENT679	8	8	14	14	tamoxifen	P-gp	PA451581	5243	0.924
NULL	Protein_Cell_2014_Jun_7_5(6)_457-468.nxml.txt.nlp	24801752	SENT140	5	5	23	23	geldanamycin	EGFR	PA152031327	1956	0.924
NULL	Diabetes_Care_2010_Feb_33(2)_428-433.nxml.txt.nlp	20103558	SENT81	32	32	7	7	sitagliptin	HIP	PA164748978	6767;6159;64399;5068	0.924
NULL	Oncol_Rep_2013_Jan_1_29(1)_13-20.nxml.txt.nlp	23128605	SENT30	39	39	4	4	carboplatin	FUT1	PA448803	2523	0.924
NULL	Int_J_Mol_Sci_2014_Oct_20_15(10)_18985-18999.nxml.txt.nlp	25334066	SENT123	8	8	20	20	genistein	HOTAIR	PA165109660	100124700	0.924
NULL	Int_J_Mol_Sci_2014_Sep_9_15(9)_15924-15950.nxml.txt.nlp	25207602	SENT117	16	16	25	25	mirtazapine	5-HT2C	PA450522	3358	0.924
NULL	Nature_2007_Jan_25_445(7126)_437-441.nxml.txt.nlp	17206155	SENT42	28	28	24	24	erlotinib	HER2	PA134687924	2064	0.924
NULL	Int_J_Mol_Sci_2012_Feb_1_13(2)_1512-1523.nxml.txt.nlp	22408405	SENT62	33	33	25	25	olmesartan	LOX-1	PA164742950	4973	0.924
NULL	J_Carcinog_2011_Jul_19_10_17.nxml.txt.nlp	21799661	SENT62	12	12	8	8	l-glutamine	F12	PA10090	2161	0.924
NULL	Oncol_Lett_2013_Feb_9_5(2)_552-558.nxml.txt.nlp	23420128	SENT31	11	11	21	21	imatinib	KIT	PA10804	3815	0.924
NULL	Breast_Cancer_Res_2011_Mar_14_13(2)_205.nxml.txt.nlp	21457526	SENT139	24	24	3	3	estradiol	aromatase	PA449503	1588	0.924
NULL	FEBS_Open_Bio_2014_Jul_5_4_659-671.nxml.txt.nlp	25161875	SENT23	11	11	22	22	etoposide	XIAP	PA449552	331	0.924
NULL	Indian_J_Pharmacol_2008_Oct_40(Suppl_2)_S37-S56.nxml.txt.nlp	21593978	SENT838	3	3	11	11	captopril	AT1	PA448780	9197;185	0.924
NULL	Arch_Med_Sci_2012_Nov_9_8(5)_907-917.nxml.txt.nlp	23185203	SENT117	5	5	18	18	metformin	adiponectin	PA450395	9370	0.924
NULL	Open_Neurol_J_2013_May_31_7_23-31.nxml.txt.nlp	23894259	SENT69	1	1	23	23	clozapine	5-HT2C	PA449061	3358	0.924
NULL	Biomed_Res_Int_2013_Jun_6_2013_928271.nxml.txt.nlp	23841099	SENT53	4	4	26	26	phenylephrine	ADP	PA450935	23038	0.924
NULL	Cell_Cycle_2013_Dec_15_12(24)_3791-3803.nxml.txt.nlp	24107631	SENT55	31	31	8	8	doxorubicin	YB-1	PA449412	4904	0.924
NULL	Exp_Ther_Med_2014_Mar_10_7(3)_640-648.nxml.txt.nlp	24520260	SENT157	11	11	22	22	resveratrol	p38		10598;1432;7965	0.924
NULL	Exp_Ther_Med_2014_Nov_29_8(5)_1473-1478.nxml.txt.nlp	25289044	SENT121	10	10	30	30	heparin	AZU	PA449855	566	0.924
NULL	Oncogene_2011_Apr_28_30(17)_1984-1994.nxml.txt.nlp	21217774	SENT155	13	13	17	17	estradiol	RAC3	PA449503	5881;8202	0.923
NULL	Adv_Hematol_2012_Jan_18_2012_195484.nxml.txt.nlp	22312366	SENT22	9	9	30	30	vincristine	CHOP	PA451879	1649	0.923
NULL	Adv_Biomed_Res_2014_Jan_27_3_53.nxml.txt.nlp	24627861	SENT33	6	6	32	32	heparin	VIII	PA449855	1351	0.923
NULL	Br_J_Cancer_2012_May_22_106(11)_1779-1789.nxml.txt.nlp	22549178	SENT134	6	6	25	25	trastuzumab	HER2	PA451743	2064	0.923
NULL	Blood_Cancer_J_2014_Jun_27_4(6)_e221.nxml.txt.nlp	24972150	SENT16	9	9	22	22	ifosfamide	NPM1	PA449964	4869	0.923
NULL	Int_J_Gen_Med_2012_Nov_9_5_935-942.nxml.txt.nlp	23204857	SENT52	21	21	10	10	naloxone	AIDA	PA450586	64853	0.923
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_315-322.nxml.txt.nlp	20049735	SENT63	0	0	6	6	paclitaxel	PTEN	PA450761	5728	0.923
NULL	Exp_Lung_Res_2013_Oct_1_39(8)_336-348.nxml.txt.nlp	23919450	SENT8	3	3	14	14	thrombin	PAR-1	PA451674	2011;2149	0.923
NULL	Front_Physiol_2013_Nov_14_4_323.nxml.txt.nlp	24294204	SENT200	17	17	10	10	carvedilol	UGT1A1	PA448817	54658	0.923
NULL	J_Cell_Mol_Med_2014_Dec_22_18(12)_2519-2529.nxml.txt.nlp	25338520	SENT206	0	0	16	16	tamoxifen	JNK	PA451581	5599	0.923
NULL	Arthritis_Res_Ther_2005_Apr_4_7(3)_R666-R676.nxml.txt.nlp	15899052	SENT30	15	15	29	29	adalimumab	p55	PA10004	6624;2078;8503;5718	0.923
NULL	Nat_Med_2013_Mar_3_19(3)_295-304.nxml.txt.nlp	23377280	SENT8	4	4	7	7	erlotinib	EGFR	PA134687924	1956	0.923
NULL	Evid_Based_Complement_Alternat_Med_2012_Dec_11_2012_310872.nxml.txt.nlp	23304196	SENT150	3	3	7	7	tamoxifen	aromatase	PA451581	1588	0.923
NULL	J_Cell_Mol_Med_2013_May_12_17(5)_636-647.nxml.txt.nlp	23577651	SENT189	6	6	20	20	sirolimus	ADP	PA451365	23038	0.923
NULL	Mol_Cancer_2014_Jun_5_13_143.nxml.txt.nlp	24898067	SENT190	25	25	14	14	gefitinib	EGFR	PA131301952	1956	0.923
NULL	Indian_J_Dermatol_2013_Jan-Feb_58(1)_61-64.nxml.txt.nlp	23372216	SENT99	4	4	6	6	paroxetine	CYP2D6	PA450801	1565	0.923
NULL	Oncotarget_2014_Jun_8_5(17)_7446-7457.nxml.txt.nlp	25277184	SENT111	6	6	14	14	cisplatin	TRIM8	PA449014	81603	0.923
NULL	Neural_Dev_2014_Oct_29_9_23.nxml.txt.nlp	25352248	SENT230	23	23	14	14	heparin	FGF2	PA449855	2247;2258	0.923
NULL	Clin_Exp_Reprod_Med_2014_Sep_30_41(3)_120-124.nxml.txt.nlp	25309856	SENT100	42	42	4	4	estradiol	ADAMTS16	PA449503	170690	0.923
NULL	Br_J_Ophthalmol_2012_Jul_26_96(7)_1023-1028.nxml.txt.nlp	22539748	SENT16	0	0	24	24	bevacizumab	TER	PA130232992	9524	0.923
NULL	Br_J_Cancer_2013_May_28_108(10)_2013-2020.nxml.txt.nlp	23632482	SENT108	23	23	42	42	paclitaxel	HER2	PA450761	2064	0.923
NULL	ScientificWorldJournal_2014_Mar_12_2014_731462.nxml.txt.nlp	24715817	SENT173	15	15	30	30	diclofenac	IL-6	PA449293	3569	0.923
NULL	Arthritis_Res_Ther_2006_Apr_12_8(Suppl_1)_S3.nxml.txt.nlp	16820042	SENT127	35	35	25	25	indomethacin	ACTH	PA449982	5443	0.923
NULL	Breast_Cancer_Res_Treat_2014_Apr_9_145(1)_73-82.nxml.txt.nlp	24715380	SENT85	3	3	10	10	tamoxifen	CXCL10	PA451581	3627	0.923
NULL	Oncol_Lett_2013_Feb_9_5(2)_552-558.nxml.txt.nlp	23420128	SENT6	5	5	18	18	imatinib	KIT	PA10804	3815	0.923
NULL	Arthritis_Res_Ther_2012_Jul_12_14(4)_R163.nxml.txt.nlp	22784880	SENT168	3	3	14	14	leflunomide	CYP2C19	PA450192	1557	0.923
NULL	Iran_J_Pharm_Res_2014_Spring_13(2)_683-693.nxml.txt.nlp	25237365	SENT95	8	8	23	23	tamoxifen	CXCR4	PA451581	7852	0.923
NULL	Mol_Vis_2012_Nov_29_18_2839-2846.nxml.txt.nlp	23233786	SENT9	0	0	16	16	geldanamycin	CB2	PA152031327	1269	0.923
NULL	Breast_Cancer_Res_2002_Apr_4_4(3)_85-89.nxml.txt.nlp	12052249	SENT41	11	11	3	3	tamoxifen	CYP3A4	PA451581	1576	0.923
NULL	J_Biomed_Sci_2014_Aug_2_21(1)_68.nxml.txt.nlp	25084970	SENT28	10	10	0	0	bumetanide	NKCC2	PA448682	6557	0.923
NULL	Cell_Div_2012_Mar_29_7_11.nxml.txt.nlp	22458775	SENT24	0	0	15	15	flavopiridol	CDK9	PA452627	1025	0.923
NULL	Br_J_Cancer_2014_Jan_21_110(2)_421-429.nxml.txt.nlp	24300973	SENT174	20	20	12	12	oxaliplatin	DAP3	PA131285527	58512;7818	0.923
NULL	Front_Pharmacol_2014_Dec_2_5_252.nxml.txt.nlp	25520658	SENT128	9	9	15	15	vemurafenib	c-Raf	PA165946873	5894	0.923
NULL	Breast_Cancer_Res_2010_Oct_14_12(5)_R84.nxml.txt.nlp	20946630	SENT269	6	6	12	12	choline	SLC5A7	PA448976	60482	0.923
NULL	Infect_Dis_Ther_2013_Dec_2_2(2)_123-144.nxml.txt.nlp	25134476	SENT262	36	36	9	9	efavirenz	CYP3A4	PA449441	1576	0.923
NULL	Gut_2012_Jan_3_61(1)_6-32.nxml.txt.nlp	22052063	SENT364	1	1	28	28	octreotide	SSTR5	PA450678	6755	0.923
NULL	Int_J_Biol_Sci_2015_Jan_1_11(2)_144-155.nxml.txt.nlp	25561897	SENT242	24	24	10	10	epirubicin	POLB	PA449476	5423	0.923
NULL	Pharmaceuticals_(Basel)_2014_Apr_10_7(4)_433-452.nxml.txt.nlp	24727459	SENT439	8	8	2	2	lopinavir	P-gp	PA450264	5243	0.923
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Oct_31_65(Pt_11)_o2938.nxml.txt.nlp	21578514	SENT51	25	25	11	11	ethanol	mol	PA448073	90527	0.923
NULL	Cancer_Med_2013_Apr_6_2(2)_234-242.nxml.txt.nlp	23634291	SENT218	6	6	15	15	bevacizumab	CXCR4	PA130232992	7852	0.923
NULL	Neural_Plast_2014_Mar_17_2014_123026.nxml.txt.nlp	24757568	SENT151	10	10	28	28	fluoxetine	CA3	PA449673	761	0.923
NULL	Arthritis_Res_Ther_2013_Jul_9_15(4)_R73.nxml.txt.nlp	23837669	SENT263	6	6	8	8	colchicine	IL-8	PA449092	3576	0.923
NULL	Carcinogenesis_2014_Apr_30_35(4)_784-794.nxml.txt.nlp	24293407	SENT394	11	11	15	15	vemurafenib	BRAF	PA165946873	673	0.923
NULL	Br_J_Cancer_2010_Mar_16_102(6)_1003-1009.nxml.txt.nlp	20179710	SENT64	13	13	8	8	letrozole	aromatase	PA450196	1588	0.923
NULL	Acta_Pharmacol_Sin_2011_Jun_3_32(6)_845-852.nxml.txt.nlp	21642952	SENT91	19	19	3	3	capsaicin	TRPV1	PA448776	7442	0.923
NULL	Breast_Cancer_Res_2012_May_2_14(3)_R70.nxml.txt.nlp	22551440	SENT252	17	17	28	28	trastuzumab	TP53	PA451743	7157	0.923
NULL	Oncol_Lett_2013_Mar_28_5(3)_935-942.nxml.txt.nlp	23426424	SENT165	15	15	3	3	oxaliplatin	ERCC1	PA131285527	2067	0.923
NULL	Gut_Liver_2014_Jan_14_8(1)_24-28.nxml.txt.nlp	24516697	SENT57	25	25	35	35	fluorescein	CD19	PA164746009	930	0.923
NULL	Cancer_Cell_Int_2006_Nov_3_6_24.nxml.txt.nlp	17081316	SENT208	19	19	7	7	vincristine	MDR1	PA451879	5243	0.923
NULL	Crit_Care_2011_Jan_24_15(1)_202.nxml.txt.nlp	21345279	SENT74	0	0	18	18	heparin	CD14	PA449855	929	0.923
NULL	Chin_J_Cancer_2012_Nov_31(11)_541-548.nxml.txt.nlp	23114088	SENT120	17	17	32	32	paclitaxel	SPARC	PA450761	6678	0.923
NULL	Int_J_Mol_Sci_2010_Nov_24_11(12)_4796-4813.nxml.txt.nlp	21614174	SENT339	17	17	10	10	trastuzumab	PI3K	PA451743	5290	0.923
NULL	Cell_Death_Dis_2010_Oct_21_1(10)_e86.nxml.txt.nlp	21368859	SENT76	20	20	3	3	doxorubicin	Mcl-1	PA449412	4170	0.923
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1495-1502.nxml.txt.nlp	21989186	SENT11	18	18	9	9	panitumumab	KRAS	PA162373091	3845	0.923
NULL	Breast_Cancer_Res_2011_Nov_30_13(6)_221.nxml.txt.nlp	22217398	SENT172	12	12	21	21	everolimus	PIK3CA	PA164746311	5290	0.923
NULL	J_Biol_Chem_2008_Oct_31_283(44)_29841-29846.nxml.txt.nlp	18765669	SENT85	5	5	22	22	suramin	P2X1	PA10292	5023	0.923
NULL	Pharmaceuticals_(Basel)_2013_May_23_6(6)_689-699.nxml.txt.nlp	24276256	SENT141	6	6	15	15	nifedipine	PTB	PA450631	58155	0.923
NULL	Cancers_(Basel)_2011_Oct_14_3(4)_3894-3908.nxml.txt.nlp	24213116	SENT138	11	11	29	29	cetuximab	EGFR	PA10040	1956	0.923
NULL	Curr_Oncol_2006_Feb_13(1)_2-7.nxml.txt.nlp	17576435	SENT76	19	19	16	16	tamoxifen	aromatase	PA451581	1588	0.923
NULL	Eur_J_Dent_2009_Jan_3(1)_3-9.nxml.txt.nlp	19262725	SENT101	31	31	46	46	glutaraldehyde	HEMA	PA449777	2157	0.923
NULL	Mol_Cancer_2009_Aug_25_8_66.nxml.txt.nlp	19706164	SENT177	0	0	24	24	celecoxib	p53	PA448871	7157	0.923
NULL	Breast_Cancer_Res_Treat_2014_Apr_9_145(1)_73-82.nxml.txt.nlp	24715380	SENT128	11	11	4	4	tamoxifen	CXCR3	PA451581	2833	0.923
NULL	Chin_J_Cancer_2012_Apr_31(4)_178-184.nxml.txt.nlp	22237038	SENT77	10	10	23	23	niclosamide	S100A4	PA165958408	6275	0.923
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Oct_30_66(Pt_11)_o2981.nxml.txt.nlp	21589147	SENT60	36	36	12	12	ethanol	mol	PA448073	90527	0.923
NULL	Exp_Ther_Med_2014_Aug_4_8(2)_657-661.nxml.txt.nlp	25009636	SENT108	22	22	5	5	propofol	CCR2	PA451141	729230	0.923
NULL	Oncoscience_2014_Oct_22_1(10)_614-623.nxml.txt.nlp	25593991	SENT95	36	36	7	7	cetuximab	KRAS	PA10040	3845	0.923
NULL	J_Mol_Med_(Berl)_2014_May_10_92(7)_709-722.nxml.txt.nlp	24811491	SENT213	4	4	8	8	vemurafenib	BRAF	PA165946873	673	0.923
NULL	Br_J_Cancer_2012_Jul_24_107(3)_435-441.nxml.txt.nlp	22767144	SENT147	9	9	2	2	docetaxel	TEF	PA449383	7008	0.923
NULL	J_Gynecol_Oncol_2013_Jan_8_24(1)_66-82.nxml.txt.nlp	23346316	SENT264	20	20	32	32	everolimus	aromatase	PA164746311	1588	0.923
NULL	J_Hematol_Oncol_2014_Aug_20_7_62.nxml.txt.nlp	25139395	SENT175	20	20	14	14	gemcitabine	p53	PA449748	7157	0.923
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT159	18	18	8	8	trastuzumab	HER2	PA451743	2064	0.923
NULL	Brain_2014_Oct_30_137(10)_2743-2758.nxml.txt.nlp	25080285	SENT302	10	10	1	1	levodopa	COMT	PA450213	1312	0.923
NULL	Nucleic_Acids_Res_2005_Oct_27_33(18)_6024-6033.nxml.txt.nlp	16254079	SENT166	8	8	0	0	bicalutamide	HDAC2	PA164746255	3066	0.923
NULL	Cancers_(Basel)_2014_Apr_4_6(2)_796-812.nxml.txt.nlp	24713998	SENT155	20	20	32	32	erlotinib	EGF	PA134687924	1950	0.923
NULL	Int_J_Gen_Med_2009_Jul_30_2_129-140.nxml.txt.nlp	20360896	SENT19	16	16	11	11	anastrozole	aromatase	PA448432	1588	0.923
NULL	Chemother_Res_Pract_2011_Sep_25_2011_730360.nxml.txt.nlp	22295205	SENT226	0	0	21	21	pertuzumab	HER2		2064	0.923
NULL	Curr_Neuropharmacol_2010_Sep_8(3)_254-267.nxml.txt.nlp	21358975	SENT191	14	14	32	32	topiramate	CYP3A4	PA451728	1576	0.923
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT106	11	11	41	41	atorvastatin	IL-6	PA448500	3569	0.923
NULL	Oncogene_2011_Apr_28_30(17)_1984-1994.nxml.txt.nlp	21217774	SENT155	13	13	4	4	estradiol	TFF1	PA449503	7031	0.923
NULL	Eur_J_Immunol_2012_Nov_18_42(11)_3049-3061.nxml.txt.nlp	22806397	SENT183	28	28	21	21	imiquimod	CD127	PA449972	3575	0.923
NULL	J_Carcinog_2011_Jul_19_10_17.nxml.txt.nlp	21799661	SENT124	14	14	25	25	metformin	ANOVA	PA450395	4858	0.923
NULL	Mediators_Inflamm_2011_Feb_21_2011_670613.nxml.txt.nlp	21403895	SENT147	5	5	16	16	carbamazepine	P-gp	PA448785	5243	0.923
NULL	Cardiovasc_J_Afr_2013_Jun_24(4)_107-109.nxml.txt.nlp	24217039	SENT36	9	9	13	13	heparin	ACT	PA449855	12;11332;9457;641455	0.923
NULL	Biomed_Res_Int_2013_May_16_2013_389672.nxml.txt.nlp	23762842	SENT167	4	4	8	8	imatinib	FDG	PA10804	23583	0.923
NULL	Crit_Care_2011_Sep_14_15(5)_R213.nxml.txt.nlp	21917139	SENT13	5	5	8	8	acetazolamide	SAPS	PA448018	8935	0.923
NULL	Cardiovasc_Diabetol_2005_May_15_4_6.nxml.txt.nlp	15892894	SENT127	27	27	22	22	telmisartan	DBP	PA451605	3295;1628;2638	0.923
NULL	Iran_J_Pharm_Res_2013_Summer_12(3)_457-469.nxml.txt.nlp	24250652	SENT44	8	8	4	4	indomethacin	COX	PA449982	1351	0.923
NULL	Arch_Med_Sci_2013_Aug_30_9(4)_739-744.nxml.txt.nlp	24049538	SENT122	25	25	8	8	candesartan	PC-3	PA448765	692094	0.923
NULL	Diabetes_Care_2008_Aug_31(8)_1697-1703.nxml.txt.nlp	18663234	SENT149	9	9	1	1	rosiglitazone	DREAM	PA451283	30818	0.923
NULL	Oncogene_2010_Oct_21_29(42)_5700-5711.nxml.txt.nlp	20676140	SENT105	9	9	4	4	doxorubicin	p53	PA449412	7157	0.923
NULL	Oncotarget_2011_Mar_23_2(3)_165-177.nxml.txt.nlp	21444946	SENT111	19	19	12	12	erlotinib	EGFR	PA134687924	1956	0.923
NULL	J_Hematol_Oncol_2011_Aug_15_4_34.nxml.txt.nlp	21843362	SENT19	9	9	5	5	doxorubicin	CHOP	PA449412	1649	0.923
NULL	Clin_Drug_Investig_2013_Jun_20_33(6)_419-427.nxml.txt.nlp	23605507	SENT20	11	11	5	5	ciprofloxacin	DPI	PA449009	1832	0.923
NULL	Patient_Prefer_Adherence_2011_Dec_23_6_1-9.nxml.txt.nlp	22272064	SENT108	46	46	21	21	ramipril	ACE	PA451223	1636	0.923
NULL	Cardiovasc_Ther_2012_Aug_17_30(4)_e174-e182.nxml.txt.nlp	21883999	SENT159	9	9	5	5	prasugrel	P2Y12	PA154410481	64805	0.923
NULL	Cell_Cycle_2013_Dec_15_12(24)_3791-3803.nxml.txt.nlp	24107631	SENT34	21	21	11	11	doxycycline	YB-1	PA449415	4904	0.923
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_P112.nxml.txt.nlp	NULL	SENT19	18	18	12	12	lumiracoxib	HLA-DRB1	PA164769031	3123	0.923
NULL	Hum_Mol_Genet_2013_Nov_15_22(22)_4602-4615.nxml.txt.nlp	23814040	SENT144	4	4	18	18	l-cysteine	COX	PA449173	1351	0.923
NULL	Br_J_Cancer_2010_Oct_12_103(8)_1284-1291.nxml.txt.nlp	20859285	SENT6	35	35	0	0	tamoxifen	BCAR4	PA451581	400500	0.923
NULL	Exp_Ther_Med_2014_Apr_13_7(4)_799-803.nxml.txt.nlp	24669235	SENT16	5	5	33	33	metformin	PPG	PA450395	5552	0.923
NULL	Cerebrospinal_Fluid_Res_2009_Sep_7_6_10.nxml.txt.nlp	19735572	SENT150	7	7	9	9	sc-560	PGHS-1		5742	0.923
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_19_2013_642920.nxml.txt.nlp	23861709	SENT152	21	21	10	10	choline	TRAIL	PA448976	8743	0.923
NULL	Acta_Pharmacol_Sin_2012_May_2_33(5)_615-624.nxml.txt.nlp	22465948	SENT13	15	15	25	25	estradiol	PRG	PA449503	5544	0.923
NULL	Exp_Lung_Res_2013_Oct_1_39(8)_336-348.nxml.txt.nlp	23919450	SENT99	0	0	7	7	thrombin	PAR-1	PA451674	2011;2149	0.923
NULL	Cancer_Med_2013_Feb_3_2(1)_11-20.nxml.txt.nlp	24133623	SENT385	7	7	1	1	cetuximab	PTEN	PA10040	5728	0.923
NULL	J_Immunol_Res_2014_May_12_2014_897249.nxml.txt.nlp	24901013	SENT181	17	17	8	8	natalizumab	CD25	PA164747191	3669;3559	0.923
NULL	Diabetologia_2010_Jan_21_53(1)_21-26.nxml.txt.nlp	19844672	SENT114	41	41	14	14	sitagliptin	HIP	PA164748978	6767;6159;64399;5068	0.923
NULL	Clin_Med_Oncol_2008_Feb_9_2_47-61.nxml.txt.nlp	21892266	SENT255	6	6	24	24	chloroquine	EGFR	PA448948	1956	0.923
NULL	Br_J_Cancer_2009_Oct_20_101(8)_1290-1297.nxml.txt.nlp	19755992	SENT182	4	4	25	25	oxaliplatin	CC3	PA131285527	10553	0.923
NULL	Ann_Rheum_Dis_2008_Jun_2_68(5)_654-657.nxml.txt.nlp	18519424	SENT89	34	34	1	1	tocilizumab	IL6	PA165292659	3569	0.923
NULL	Ann_Hematol_2014_Sep_10_93(1)_1-11.nxml.txt.nlp	24018623	SENT140	23	23	12	12	lenalidomide	CD34	PA162363968	947	0.923
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT176	23	23	31	31	dasatinib	LYN	PA162372878	4067	0.923
NULL	Ann_Gen_Psychiatry_2013_Aug_13_12_26.nxml.txt.nlp	23941527	SENT146	8	8	23	23	paroxetine	NMA	PA450801	25805	0.923
NULL	Protein_J_2014_Feb_25_33(2)_174-183.nxml.txt.nlp	24567122	SENT140	26	26	7	7	trypsin	FIX	PA451806	2158	0.923
NULL	Eur_J_Med_Res_2009_Nov_24_14(Suppl_3)_17-21.nxml.txt.nlp	19959412	SENT80	25	25	6	6	etravirine	UGT1A1	PA166014703	54658	0.923
NULL	Oncotarget_2014_Oct_18_5(21)_10206-10221.nxml.txt.nlp	25344914	SENT128	20	20	8	8	vemurafenib	NRAS	PA165946873	4893	0.923
NULL	Diabetes_Obes_Metab_2011_Nov_13(11)_982-989.nxml.txt.nlp	21615670	SENT23	0	0	20	20	exenatide	GLP-1	PA164749238	100125288	0.923
NULL	Mol_Cancer_2010_Aug_23_9_222.nxml.txt.nlp	20731837	SENT197	11	11	21	21	gefitinib	EGFR	PA131301952	1956	0.923
NULL	F1000Prime_Rep_2014_Aug_1_6_65.nxml.txt.nlp	25165564	SENT44	19	19	31	31	alemtuzumab	p53	PA164783958	7157	0.923
NULL	Iran_J_Pharm_Res_2014_Spring_13(2)_683-693.nxml.txt.nlp	25237365	SENT9	6	6	23	23	tamoxifen	CXCL12	PA451581	6387	0.923
NULL	J_Radiat_Res_2014_Nov_16_55(6)_1171-1177.nxml.txt.nlp	25129557	SENT169	17	17	5	5	capecitabine	CRT	PA448771	811	0.923
NULL	Br_J_Clin_Pharmacol_2013_Apr_10_75(4)_979-989.nxml.txt.nlp	22882281	SENT190	19	19	16	16	exenatide	GLP-1	PA164749238	100125288	0.923
NULL	Cancer_Cell_Int_2006_Mar_6_6_5.nxml.txt.nlp	16519802	SENT33	7	7	13	13	estradiol	SSTR2	PA449503	6752	0.923
NULL	Pharmaceuticals_(Basel)_2012_Aug_10_5(8)_802-836.nxml.txt.nlp	24280676	SENT25	18	18	6	6	gemcitabine	CNT1	PA449748	9154	0.923
NULL	Exp_Ther_Med_2014_Nov_29_8(5)_1473-1478.nxml.txt.nlp	25289044	SENT178	24	24	15	15	heparin	AZU	PA449855	566	0.923
NULL	Cell_Death_Dis_2014_Mar_13_5(3)_e1118.nxml.txt.nlp	24625977	SENT303	13	13	34	34	etoposide	UBXN2A	PA449552	165324	0.923
NULL	BMJ_Open_2014_Feb_18_4(2)_e004258.nxml.txt.nlp	24549163	SENT117	4	4	10	10	heparin	ACT	PA449855	12;11332;9457;641455	0.923
NULL	Med_Sci_Monit_2013_Oct_21_19_875-882.nxml.txt.nlp	24145180	SENT154	31	31	7	7	bevacizumab	CXCL8	PA130232992	3576	0.923
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_67-74.nxml.txt.nlp	17912637	SENT64	21	21	46	46	tamoxifen	ATAC	PA451581	6375	0.923
NULL	Aging_(Albany_NY)_2012_Mar_12_4(3)_146-158.nxml.txt.nlp	22436213	SENT61	7	7	16	16	resveratrol	SIRT1		23411	0.923
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT295	8	8	24	24	metformin	PI3K	PA450395	5290	0.923
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT119	11	11	18	18	gefitinib	AKT	PA131301952	207	0.923
NULL	Mol_Cancer_2010_May_20_9_115.nxml.txt.nlp	20487546	SENT265	9	9	19	19	fludarabine	SULF2	PA449655	55959	0.923
NULL	Adv_Ther_2014_Sep_12_31(9)_932-944.nxml.txt.nlp	25213118	SENT21	4	4	23	23	tafluprost	EP3	PA165958432	5733	0.923
NULL	Mol_Cancer_2010_Aug_23_9_222.nxml.txt.nlp	20731837	SENT101	19	19	4	4	cetuximab	EGFR	PA10040	1956	0.923
NULL	Br_J_Cancer_2010_Oct_26_103(9)_1380-1390.nxml.txt.nlp	20877355	SENT176	17	17	2	2	doxorubicin	ASK1	PA449412	4217	0.923
NULL	Oncotarget_2013_Apr_13_4(4)_502-530.nxml.txt.nlp	23594434	SENT272	27	27	10	10	nelfinavir	PTEN	PA450606	5728	0.923
NULL	Cell_Commun_Signal_2014_Oct_5_12(1)_54.nxml.txt.nlp	NULL	SENT90	17	17	10	10	fasudil	ADP	PA165946121	23038	0.923
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1063.nxml.txt.nlp	24556678	SENT31	13	13	2	2	thioridazine	TRAIL	PA451666	8743	0.923
NULL	Colorectal_Dis_2012_Feb_14(2)_e31-e47.nxml.txt.nlp	21848897	SENT117	45	45	28	28	panitumumab	KRAS	PA162373091	3845	0.923
NULL	Evid_Based_Complement_Alternat_Med_2013_Mar_26_2013_625892.nxml.txt.nlp	23589719	SENT339	2	2	7	7	probenecid	GLP-1	PA451106	100125288	0.923
NULL	Br_J_Cancer_2012_Jan_3_106(1)_148-156.nxml.txt.nlp	22045191	SENT27	14	14	11	11	erlotinib	EGFR	PA134687924	1956	0.923
NULL	Oncotarget_2010_Oct_15_1(7)_515-529.nxml.txt.nlp	21317448	SENT104	25	25	33	33	irinotecan	IFL	PA450085	3439	0.923
NULL	Support_Care_Cancer_2012_Jul_6_20(7)_1533-1540.nxml.txt.nlp	21822636	SENT59	35	35	28	28	exemestane	aromatase	PA449563	1588	0.923
NULL	Diagn_Pathol_2013_Feb_15_8_25.nxml.txt.nlp	23414240	SENT124	14	14	6	6	tamoxifen	EMP	PA451581	10296	0.923
NULL	Diabetes_Metab_Syndr_Obes_2014_Aug_1_7_381-389.nxml.txt.nlp	25120374	SENT182	6	6	3	3	salsalate	adiponectin	PA164745462	9370	0.923
NULL	Diabetes_Care_2013_Feb_17_36(2)_422-428.nxml.txt.nlp	23033246	SENT29	21	21	29	29	simvastatin	PPL	PA451363	5493	0.923
NULL	Cell_Death_Differ_2010_Apr_16_17(4)_666-676.nxml.txt.nlp	19834494	SENT271	10	10	3	3	melphalan	HMGB1	PA450354	3146	0.923
NULL	Indian_J_Urol_2007_Apr-Jun_23(2)_91-96.nxml.txt.nlp	19675781	SENT177	18	18	1	1	finasteride	NNT	PA449627	23530	0.923
NULL	Arthritis_Res_Ther_2003_Oct_24_5(1)_R25-R31.nxml.txt.nlp	12716450	SENT180	17	17	8	8	cyclophosphamide	TNF-alpha	PA449165	7124	0.923
NULL	Breast_Cancer_Res_Treat_2007_Dec_27_106(2)_161-170.nxml.txt.nlp	17260092	SENT249	34	34	37	37	tamoxifen	aromatase	PA451581	1588	0.923
NULL	Br_J_Cancer_2013_Jan_15_108(1)_82-90.nxml.txt.nlp	23321512	SENT166	15	15	7	7	paclitaxel	TUBB	PA450761	203068	0.923
NULL	Oncotarget_2014_Jun_7_5(14)_5257-5271.nxml.txt.nlp	24913448	SENT92	21	21	3	3	nilotinib	LASP1	PA165958345	3927	0.923
NULL	Cell_Death_Dis_2013_Jun_27_4(6)_e694.nxml.txt.nlp	23807223	SENT107	6	6	23	23	chloroquine	HMGB1	PA448948	3146	0.923
NULL	Mol_Biol_Rep_2014_Jan_19_41(2)_957-965.nxml.txt.nlp	24442315	SENT155	13	13	6	6	estradiol	PDGFRA	PA449503	5156	0.923
NULL	Br_J_Cancer_2013_Dec_10_109(12)_2951-2953.nxml.txt.nlp	24253504	SENT8	20	20	22	22	tamoxifen	aromatase	PA451581	1588	0.923
NULL	Diabetes_Metab_Syndr_Obes_2010_Mar_26_3_43-48.nxml.txt.nlp	21437075	SENT77	8	8	3	3	phenytoin	CYP3A4	PA450947	1576	0.923
NULL	Oncotarget_2014_Aug_29_5(19)_8947-8958.nxml.txt.nlp	25333254	SENT133	2	2	19	19	plerixafor	CXCR4	PA165958410	7852	0.923
NULL	Cancers_(Basel)_2012_Sep_25_4(4)_969-988.nxml.txt.nlp	24213497	SENT154	23	23	28	28	fulvestrant	EGFR	PA164747170	1956	0.923
NULL	Oncol_Rep_2013_Jun_2_29(6)_2095-2100.nxml.txt.nlp	23563900	SENT32	27	27	40	40	sorafenib	Mcl-1	PA7000	4170	0.923
NULL	Clin_Infect_Dis_2013_Mar_1_56(5)_694-696.nxml.txt.nlp	23175557	SENT41	16	16	36	36	primaquine	ACT	PA451103	12;11332;9457;641455	0.923
NULL	J_Exp_Med_1998_May_18_187(10)_1633-1640.nxml.txt.nlp	9584141	SENT130	8	8	45	45	chloroquine	IFN	PA448948	3439	0.923
NULL	Breast_Cancer_Res_2005_Jan_28_7(3)_R284-R290.nxml.txt.nlp	15987423	SENT96	25	25	19	19	tamoxifen	SULT1A1	PA451581	6817	0.923
NULL	Blood_Cancer_J_2012_May_25_2(5)_e73.nxml.txt.nlp	22829975	SENT171	29	29	6	6	cyclophosphamide	CD73	PA449165	4907	0.923
NULL	Oncotarget_2013_Nov_24_4(12)_2430-2438.nxml.txt.nlp	24280348	SENT79	17	17	6	6	gefitinib	STAT3	PA131301952	6774	0.923
NULL	Nucleic_Acids_Res_2011_Sep_7_39(17)_7465-7476.nxml.txt.nlp	21653549	SENT219	8	8	38	38	hydroxyurea	DEK	PA449942	7913	0.923
NULL	J_Breast_Cancer_2011_Dec_27_14(4)_276-282.nxml.txt.nlp	22323913	SENT20	9	9	20	20	trastuzumab	ERBB2	PA451743	2064	0.923
NULL	Drug_Saf_2014_Feb_19_37(4)_201-211.nxml.txt.nlp	24550106	SENT131	10	10	18	18	esomeprazole	CYP1A2	PA10075	1544	0.923
NULL	Oncotarget_2011_May_16_2(5)_418-421.nxml.txt.nlp	21789791	SENT37	12	12	28	28	bortezomib	TRAIL	PA10252	8743	0.923
NULL	Oncogene_2014_Feb_6_33(6)_713-723.nxml.txt.nlp	23435429	SENT108	13	13	17	17	camptothecin	BRCA1	PA153590860	672	0.923
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT253	25	25	8	8	perifosine	DR5	PA165291471	8795	0.923
NULL	J_Oncol_2012_Mar_11_2012_382159.nxml.txt.nlp	22481926	SENT90	7	7	16	16	trastuzumab	HER2	PA451743	2064	0.923
NULL	Acta_Neuropathol_Commun_2014_Jan_2_2_3.nxml.txt.nlp	24383546	SENT269	18	18	8	8	resveratrol	SIRT1		23411	0.923
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT268	18	18	8	8	metformin	HIF-1	PA450395	29072	0.923
NULL	Exp_Diabetes_Res_2012_Apr_11_2012_728325.nxml.txt.nlp	22566995	SENT62	0	0	36	36	ranibizumab	VEGF-A	PA164746012	7422	0.923
NULL	Cancer_Cell_Int_2013_Feb_12_13_14.nxml.txt.nlp	23402310	SENT157	5	5	10	10	celecoxib	p65	PA448871	5970	0.923
NULL	Biosci_Rep_2012_Aug_1_32(Pt_4)_361-374.nxml.txt.nlp	22762204	SENT164	35	35	10	10	irinotecan	BRCA1	PA450085	672	0.923
NULL	Breast_Cancer_Res_Treat_2014_Nov_11_148(3)_563-570.nxml.txt.nlp	25385180	SENT173	19	19	13	13	erlotinib	EGFR	PA134687924	1956	0.923
NULL	Br_J_Cancer_2011_Oct_25_105(9)_1273-1278.nxml.txt.nlp	21959871	SENT26	2	2	35	35	trastuzumab	HER2	PA451743	2064	0.923
NULL	Br_J_Cancer_2010_Jan_5_102(1)_151-161.nxml.txt.nlp	19935791	SENT9	19	19	26	26	cetuximab	BRAF	PA10040	673	0.923
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1224-1233.nxml.txt.nlp	22353810	SENT198	9	9	17	17	etoposide	MRP-1	PA449552	928	0.923
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT6	23	23	7	7	imatinib	ABCG2	PA10804	9429	0.923
NULL	Cancer_Res_Treat_2014_Jul_15_46(3)_280-287.nxml.txt.nlp	25038763	SENT89	31	31	33	33	tamoxifen	aromatase	PA451581	1588	0.923
NULL	Cancers_(Basel)_2011_Aug_9_3(3)_3189-3205.nxml.txt.nlp	24212952	SENT63	6	6	15	15	hyaluronan	TLR2	PA165958431	7097	0.923
NULL	Iran_J_Pharm_Res_2013_Winter_12(1)_141-146.nxml.txt.nlp	24250582	SENT8	15	15	7	7	rifampin	NAC	PA451250	22861	0.923
NULL	Crit_Care_2007_Sep_19_11(5)_229.nxml.txt.nlp	17903310	SENT30	47	47	32	32	camptothecin	HMGB1	PA153590860	3146	0.923
NULL	Oncol_Lett_2014_May_11_7(5)_1401-1408.nxml.txt.nlp	24765145	SENT162	27	27	14	14	paclitaxel	PI3K	PA450761	5290	0.923
NULL	Open_Dent_J_2014_May_30_8_109-124.nxml.txt.nlp	24976875	SENT176	21	21	11	11	minocycline	PARP-1	PA450519	25976	0.923
NULL	Mol_Cancer_2014_Jul_5_13_165.nxml.txt.nlp	24996221	SENT335	11	11	2	2	docetaxel	HMGB1	PA449383	3146	0.923
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1150.nxml.txt.nlp	24675468	SENT100	15	15	34	34	metformin	adiponectin	PA450395	9370	0.923
NULL	BMB_Rep_2014_Sep_47(9)_483-487.nxml.txt.nlp	25027595	SENT35	27	27	17	17	gefitinib	TM4SF5	PA131301952	9032	0.923
NULL	J_Headache_Pain_2014_Dec_8_15(1)_85.nxml.txt.nlp	25488888	SENT181	8	8	17	17	naratriptan	5-HT1B	PA450597	3351	0.923
NULL	Br_J_Cancer_2011_May_10_104(10)_1628-1640.nxml.txt.nlp	21505453	SENT45	8	8	4	4	suramin	TRK	PA10292	4914;7170	0.923
NULL	Oncol_Rep_2013_Oct_22_30(4)_1535-1541.nxml.txt.nlp	23877481	SENT149	11	11	24	24	sunitinib	EGFR	PA162372840	1956	0.923
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1059-1066.nxml.txt.nlp	21364577	SENT46	16	16	25	25	exemestane	aromatase	PA449563	1588	0.923
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Jun_23_70(Pt_7)_31-35.nxml.txt.nlp	25161500	SENT64	36	36	14	14	ethanol	mol	PA448073	90527	0.923
NULL	Acta_Pharmacol_Sin_2012_Jan_28_33(1)_66-74.nxml.txt.nlp	22120966	SENT198	8	8	18	18	genistein	OPG	PA165109660	690	0.923
NULL	J_Carcinog_2011_Dec_22_10_35.nxml.txt.nlp	22279420	SENT125	29	29	8	8	tamoxifen	p53	PA451581	7157	0.923
NULL	Cancer_Cell_2007_Dec_11_12(6)_514-527.nxml.txt.nlp	18068629	SENT147	9	9	3	3	paclitaxel	TGFBI	PA450761	7045	0.923
NULL	ASN_Neuro_2009_Oct_21_1(4)_e00018.nxml.txt.nlp	19807694	SENT55	20	20	31	31	ganciclovir	E12	PA449733	64100	0.923
NULL	Curr_Cardiol_Rev_2012_Aug_8(3)_239-249.nxml.txt.nlp	22935021	SENT50	14	14	31	31	clopidogrel	CYP2C19	PA449053	1557	0.923
NULL	Evid_Based_Complement_Alternat_Med_2012_Aug_27_2012_205451.nxml.txt.nlp	22969824	SENT88	2	2	12	12	clopidogrel	ADP	PA449053	23038	0.923
NULL	Front_Neurosci_2014_Jun_24_8_176.nxml.txt.nlp	25009459	SENT1333	4	4	7	7	ethanol	P2X4	PA448073	5025	0.923
NULL	Diabetes_Care_2013_Aug_17_36(Suppl_2)_S245-S252.nxml.txt.nlp	23882053	SENT72	18	18	20	20	liraglutide	GLP-1	PA165958364	100125288	0.923
NULL	Cancer_Med_2013_Apr_11_2(2)_155-163.nxml.txt.nlp	23634283	SENT46	11	11	19	19	isoflurane	CO2	PA450106	4513	0.923
NULL	Cancer_Manag_Res_2013_Jul_31_5_187-195.nxml.txt.nlp	23986650	SENT61	24	24	20	20	lapatinib	HER2	PA152241907	2064	0.923
NULL	Ital_J_Pediatr_2010_Feb_8_36_15.nxml.txt.nlp	20181122	SENT270	8	8	21	21	vigabatrin	ACTH	PA10231	5443	0.923
NULL	Ther_Clin_Risk_Manag_2005_Mar_1(1)_3-13.nxml.txt.nlp	18360537	SENT91	28	28	26	26	clarithromycin	CYP3A	PA449028	1574	0.923
NULL	Mol_Cancer_2009_Nov_10_8_99.nxml.txt.nlp	19903356	SENT33	19	19	3	3	imatinib	IGFBP3	PA10804	3486	0.923
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT222	8	8	34	34	erlotinib	EGFR	PA134687924	1956	0.923
NULL	Eur_Respir_J_2012_Jun_17_39(6)_1511-1519.nxml.txt.nlp	22005918	SENT213	41	41	4	4	isoniazid	DST	PA450112	667	0.923
NULL	Reprod_Biol_Endocrinol_2003_Oct_7_1_71.nxml.txt.nlp	14577832	SENT117	5	5	37	37	cisplatin	JNK	PA449014	5599	0.923
NULL	Exp_Diabetes_Res_2012_Jan_29_2012_159874.nxml.txt.nlp	22319521	SENT138	17	17	24	24	candesartan	Hes1	PA448765	3280	0.923
NULL	Algorithms_Mol_Biol_2010_Jul_15_5_29.nxml.txt.nlp	20633297	SENT241	15	15	2	2	sildenafil	PDE5A	PA451346	8654	0.923
NULL	Br_J_Cancer_2003_Mar_10_88(5)_754-759.nxml.txt.nlp	12618886	SENT164	5	5	8	8	amifostine	p53	PA448365	7157	0.923
NULL	Front_Physiol_2013_Dec_24_4_386.nxml.txt.nlp	24399968	SENT207	15	15	4	4	carbamazepine	SUR1	PA448785	6833	0.923
NULL	J_Neurol_2011_Oct_3_258(10)_1820-1826.nxml.txt.nlp	21461958	SENT110	39	39	1	1	amitriptyline	DM2	PA448385	28508	0.923
NULL	Aging_Cell_2012_Aug_11(4)_579-587.nxml.txt.nlp	22435726	SENT163	14	14	23	23	etoposide	CD28	PA449552	1493;940	0.923
NULL	J_Immunother_Cancer_2013_Dec_16_1_21.nxml.txt.nlp	24829757	SENT11	37	37	13	13	temozolomide	U87	PA451609	677775;641648	0.923
NULL	Acta_Pharmacol_Sin_2012_Oct_3_33(10)_1311-1318.nxml.txt.nlp	22941289	SENT160	11	11	5	5	sorafenib	VEGFR2	PA7000	3791	0.923
NULL	Oncol_Lett_2014_May_24_7(5)_1594-1598.nxml.txt.nlp	24765183	SENT25	14	14	38	38	erlotinib	Gem	PA134687924	51053	0.923
NULL	J_Hematol_Oncol_2014_Apr_28_7_37.nxml.txt.nlp	24775308	SENT137	15	15	7	7	imatinib	JAK2	PA10804	3717	0.923
NULL	Chem_Rev_2012_May_9_112(5)_2593-2603.nxml.txt.nlp	22335786	SENT139	19	19	27	27	l-histidine	ATX	PA449882	5168;23049	0.923
NULL	Bioinformation_2012_Apr_30_8(8)_369-380.nxml.txt.nlp	22570518	SENT68	17	17	13	13	artemisinin	C10	PA165111696	113246	0.923
NULL	Diabetes_Metab_Syndr_Obes_2014_Aug_1_7_381-389.nxml.txt.nlp	25120374	SENT182	6	6	1	1	salsalate	adiponectin	PA164745462	9370	0.923
NULL	Int_J_Mol_Sci_2014_Mar_24_15(3)_5140-5162.nxml.txt.nlp	24663085	SENT745	10	10	3	3	cyclophosphamide	LP1	PA449165	6176	0.923
NULL	Breast_Cancer_Res_2011_May_26_13(3)_209.nxml.txt.nlp	21635709	SENT157	21	21	6	6	letrozole	HER2	PA450196	2064	0.923
NULL	Exp_Neurobiol_2013_Mar_31_22(1)_23-30.nxml.txt.nlp	23585719	SENT162	30	30	12	12	curcumin	spatial	PA151958596	219793	0.923
NULL	J_Lipids_2011_Dec_6_2011_167958.nxml.txt.nlp	22191036	SENT55	23	23	6	6	glibenclamide	STZ	PA449782	6484	0.923
NULL	Case_Rep_Rheumatol_2011_Dec_15_2011_185657.nxml.txt.nlp	22937439	SENT57	8	8	0	0	etanercept	TNF-alpha	PA449515	7124	0.923
NULL	Cancer_Cell_Int_2014_Jul_2_14_59.nxml.txt.nlp	25120382	SENT97	15	15	10	10	metformin	CTR	PA450395	799	0.923
NULL	Br_J_Cancer_2009_Jul_21_101(2)_238-243.nxml.txt.nlp	19568242	SENT19	12	12	25	25	bevacizumab	IFN	PA130232992	3439	0.923
NULL	Adv_Ther_2014_Feb_18_31(3)_247-263.nxml.txt.nlp	24535624	SENT52	2	2	23	23	exenatide	GLP-1	PA164749238	100125288	0.923
NULL	Eur_J_Med_Res_2010_Feb_26_15(2)_47-53.nxml.txt.nlp	20452883	SENT145	21	21	14	14	fentanyl	ESG	PA449599	7089;7088;7090;7091	0.923
NULL	Breast_Cancer_Res_Treat_2009_Jul_22_116(2)_371-378.nxml.txt.nlp	18941892	SENT81	32	32	20	20	tamoxifen	aromatase	PA451581	1588	0.923
NULL	Cell_Death_Differ_2010_Apr_16_17(4)_666-676.nxml.txt.nlp	19834494	SENT56	25	25	3	3	melphalan	RAGE	PA450354	177	0.923
NULL	Mol_Vis_2012_Feb_24_18_495-503.nxml.txt.nlp	22393276	SENT86	17	17	0	0	nadh	SDH	PA164755085	1757;10993	0.923
NULL	Exp_Ther_Med_2014_Jun_27_7(6)_1703-1707.nxml.txt.nlp	24926370	SENT97	25	25	12	12	heparin	TLR4	PA449855	7099	0.923
NULL	Int_J_Nanomedicine_2010_Feb_2_5_63-75.nxml.txt.nlp	20161988	SENT203	15	15	2	2	cisplatin	zeta	PA449014	9907	0.923
NULL	Cell_Res_2011_Mar_11_21(3)_530-545.nxml.txt.nlp	21221130	SENT100	3	3	18	18	thrombin	PAC-1	PA451674	1844	0.923
NULL	Br_J_Cancer_2010_Sep_7_103(6)_759-764.nxml.txt.nlp	20700118	SENT82	8	8	20	20	tamoxifen	aromatase	PA451581	1588	0.923
NULL	Arthritis_Res_Ther_2009_Jan_26_11(1)_R12.nxml.txt.nlp	19171052	SENT337	0	0	35	35	dipyridamole	ACTH	PA449367	5443	0.923
NULL	Br_J_Clin_Pharmacol_2011_Oct_72(4)_647-657.nxml.txt.nlp	21518389	SENT218	14	14	22	22	clopidogrel	ADP	PA449053	23038	0.923
NULL	Cancer_Res_Treat_2013_Mar_31_45(1)_55-62.nxml.txt.nlp	23613671	SENT96	7	7	16	16	oxaliplatin	KRAS	PA131285527	3845	0.923
NULL	Diabetes_2011_Jan_4_60(1)_119-126.nxml.txt.nlp	20921208	SENT252	17	17	3	3	glucose	TRPM2	PA449773	7226	0.923
NULL	Leukemia_2014_Mar_20_28(3)_554-565.nxml.txt.nlp	24280866	SENT231	24	24	19	19	doxycycline	IL-3	PA449415	3562	0.923
NULL	Cancer_Inform_2008_Jun_10_6_315-355.nxml.txt.nlp	19259415	SENT352	9	9	18	18	cisplatin	GAS1	PA449014	2619	0.923
NULL	Anal_Lett_2008_Oct_2_41(15)_2844-2859.nxml.txt.nlp	19112518	SENT108	7	7	12	12	ethanol	mol	PA448073	90527	0.923
NULL	Int_J_Endocrinol_2013_Nov_27_2013_592576.nxml.txt.nlp	24369464	SENT214	0	0	24	24	atorvastatin	SCAP	PA448500	22937	0.923
NULL	Oncogene_2010_Sep_16_29(37)_5135-5145.nxml.txt.nlp	20622897	SENT102	13	13	9	9	cetuximab	HIF-1	PA10040	29072	0.923
NULL	Onco_Targets_Ther_2014_Sep_23_7_1653-1661.nxml.txt.nlp	25285015	SENT20	24	24	13	13	irinotecan	UGT1A1	PA450085	54658	0.923
NULL	Mol_Biol_Cell_2014_May_15_25(10)_1620-1628.nxml.txt.nlp	24648493	SENT197	17	17	19	19	nystatin	JNK	PA450666	5599	0.923
NULL	Acta_Pharmacol_Sin_2014_Jul_26_35(7)_916-928.nxml.txt.nlp	24858311	SENT35	9	9	6	6	lapatinib	EGFR	PA152241907	1956	0.923
NULL	Br_J_Pharmacol_2014_Feb_24_171(1)_1019-1032.nxml.txt.nlp	24251620	SENT271	28	28	22	22	nifedipine	TRPM3	PA450631	80036	0.923
NULL	Cancer_Cell_Int_2013_Sep_23_13_94.nxml.txt.nlp	24059699	SENT201	30	30	7	7	bevacizumab	VEGFA	PA130232992	7422	0.923
NULL	Emerg_Infect_Dis_2007_Jul_13(7)_1001-1007.nxml.txt.nlp	18214171	SENT41	15	15	8	8	stavudine	CD4	PA451494	920	0.923
NULL	Breast_Cancer_Res_2012_Jun_19_14(3)_209.nxml.txt.nlp	22713170	SENT132	0	0	10	10	afatinib	EGFR	PA165981154	1956	0.923
NULL	Med_Sci_Monit_2012_Jun_1_18(6)_BR208-BR214.nxml.txt.nlp	22648241	SENT62	11	11	20	20	allopurinol	GIT	PA448320	5034	0.923
NULL	Daru_2011_19(6)_455-461.nxml.txt.nlp	23008692	SENT149	6	6	27	27	daunorubicin	survivin	PA449212	332	0.923
NULL	Mol_Syst_Biol_2011_Apr_26_7_486.nxml.txt.nlp	21525872	SENT133	35	35	41	41	imatinib	PDGFRA	PA10804	5156	0.923
NULL	Emerg_Infect_Dis_2007_Jul_13(7)_1001-1007.nxml.txt.nlp	18214171	SENT41	34	34	8	8	efavirenz	CD4	PA449441	920	0.923
NULL	Indian_J_Pharmacol_2008_Mar-Apr_40(2)_84-86.nxml.txt.nlp	21279172	SENT89	15	15	4	4	fluvoxamine	CYP1A2	PA449690	1544	0.923
NULL	Lung_2011_Jun_21_189(3)_257-258.nxml.txt.nlp	21509562	SENT24	5	5	48	48	capsaicin	TRPV1	PA448776	7442	0.923
NULL	J_Thorac_Oncol_2014_Oct_23_9(10)_1532-1539.nxml.txt.nlp	25170639	SENT190	26	26	5	5	crizotinib	EGFR	PA165946122	1956	0.923
NULL	Mol_Cancer_2014_Jan_13_13_7.nxml.txt.nlp	24418169	SENT11	31	31	27	27	sorafenib	SHP-1	PA7000	5777	0.923
NULL	Vet_Res_2013_Oct_2_44(1)_89.nxml.txt.nlp	24088531	SENT178	20	20	24	24	hemin	IFN	PA449849	3439	0.923
NULL	Libyan_J_Med_2008_Mar_1_3(1)_42-48.nxml.txt.nlp	21499481	SENT72	0	0	7	7	artemether	ACT	PA165111698	12;11332;9457;641455	0.923
NULL	J_Oncol_2012_Jul_8_2012_537861.nxml.txt.nlp	22973309	SENT393	3	3	12	12	bevacizumab	HIF-1	PA130232992	29072	0.923
NULL	Oncogene_2014_Oct_9_33(41)_4941-4951.nxml.txt.nlp	24681952	SENT89	3	3	29	29	metformin	HIF1	PA450395	3091	0.923
NULL	Mol_Pain_2013_Apr_8_9_19.nxml.txt.nlp	23566343	SENT107	14	14	2	2	carrageenan	COMT	PA448814	1312	0.923
NULL	Nucleic_Acids_Res_2013_Dec_4_41(22)_10124-10134.nxml.txt.nlp	24005039	SENT84	19	19	12	12	ethanol	CYC1	PA448073	1537	0.923
NULL	J_Immunother_Cancer_2014_Jan_27_2_2.nxml.txt.nlp	24829759	SENT171	19	19	3	3	sorafenib	IL-21	PA7000	59067;50616;27189	0.923
NULL	Int_J_Biol_Sci_2012_Mar_7_8(4)_470-485.nxml.txt.nlp	22419892	SENT262	14	14	20	20	tamoxifen	HER2	PA451581	2064	0.923
NULL	J_Carcinog_2012_Oct_27_11_16.nxml.txt.nlp	23230393	SENT128	14	14	5	5	tamoxifen	HER-2	PA451581	2064	0.923
NULL	Am_J_Surg_Pathol_2013_Dec_26_37(12)_1797-1814.nxml.txt.nlp	24061524	SENT465	11	11	15	15	vemurafenib	BRAF	PA165946873	673	0.923
NULL	Oncol_Lett_2013_Sep_28_6(3)_795-800.nxml.txt.nlp	24137413	SENT98	28	28	5	5	paclitaxel	HIF-1	PA450761	29072	0.923
NULL	Hum_Genomics_2010_Oct_1_5(1)_61-72.nxml.txt.nlp	21106490	SENT152	33	33	25	25	atorvastatin	CYP3A	PA448500	1574	0.923
NULL	Autoimmune_Dis_2012_Dec_17_2012_357101.nxml.txt.nlp	23346387	SENT108	35	35	26	26	natalizumab	San	PA164747191	80218	0.923
NULL	Exp_Ther_Med_2013_Feb_13_5(2)_581-585.nxml.txt.nlp	23403473	SENT93	27	27	19	19	etanercept	HMGB1	PA449515	3146	0.923
NULL	Diabetes_Metab_Syndr_Obes_2009_Jun_12_2_83-90.nxml.txt.nlp	21437121	SENT23	4	4	7	7	liraglutide	GLP-1	PA165958364	100125288	0.923
NULL	Diabetes_2011_Mar_21_60(3)_757-765.nxml.txt.nlp	21282370	SENT13	15	15	3	3	isoproterenol	PTRF	PA450121	284119	0.923
NULL	Oncotarget_2012_Jul_13_3(6)_601-607.nxml.txt.nlp	22802145	SENT6	10	10	34	34	doxorubicin	p53	PA449412	7157	0.923
NULL	Br_J_Cancer_2010_May_11_102(10)_1503-1510.nxml.txt.nlp	20461093	SENT182	20	20	6	6	tamoxifen	HER2	PA451581	2064	0.923
NULL	Mol_Cancer_2009_Jun_23_8_39.nxml.txt.nlp	19549337	SENT121	6	6	2	2	resveratrol	TRAIL		8743	0.923
NULL	Br_J_Pharmacol_2014_Aug_17_171(15)_3651-3665.nxml.txt.nlp	24712679	SENT270	1	1	17	17	liraglutide	GLP-1	PA165958364	100125288	0.923
NULL	Oncogene_2014_Aug_28_33(35)_4407-4417.nxml.txt.nlp	24469038	SENT57	19	19	8	8	cisplatin	p53	PA449014	7157	0.923
NULL	Arthritis_Res_2002_Feb_4_4(Suppl_1)_44.nxml.txt.nlp	NULL	SENT4	6	6	16	16	pp2	PI3		5266	0.923
NULL	Oncogenesis_2012_Apr_16_1(4)_e7.nxml.txt.nlp	23552604	SENT48	14	14	6	6	nutlin-3	p53		7157	0.923
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1059-1066.nxml.txt.nlp	21364577	SENT184	17	17	15	15	letrozole	aromatase	PA450196	1588	0.923
NULL	J_Exp_Med_2000_Jun_5_191(11)_1905-1920.nxml.txt.nlp	10839806	SENT63	26	26	2	2	heparin	N-WASP	PA449855	8976	0.923
NULL	Breast_Cancer_Res_2008_Apr_29_10(2)_206.nxml.txt.nlp	18492214	SENT122	4	4	1	1	letrozole	aromatase	PA450196	1588	0.923
NULL	Ann_Clin_Transl_Neurol_2014_Jan_20_1(1)_15-26.nxml.txt.nlp	25356379	SENT108	2	2	17	17	isoflurane	EGO	PA450106	100126791	0.923
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Mar_26_3(3)_e107.nxml.txt.nlp	24670388	SENT90	11	11	2	2	midazolam	CYP3A	PA450496	1574	0.923
NULL	J_Clin_Biochem_Nutr_2011_May_13_48(3)_237-244.nxml.txt.nlp	21562645	SENT162	7	7	9	9	resveratrol	AMPK		5563	0.923
NULL	Exp_Ther_Med_2013_May_15_5(5)_1371-1374.nxml.txt.nlp	23737882	SENT28	18	18	13	13	fluorescein	ED5	PA164746009	10913	0.923
NULL	Crit_Care_2011_Jun_24_15(3)_R153.nxml.txt.nlp	21702944	SENT250	0	0	19	19	dexmedetomidine	TLR4	PA449256	7099	0.923
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Aug_13_64(Pt_9)_o1744.nxml.txt.nlp	21201726	SENT60	23	23	10	10	ethanol	mol	PA448073	90527	0.923
NULL	Cell_Biochem_Biophys_2013_May_24_66(1)_53-63.nxml.txt.nlp	22918821	SENT2	16	16	19	19	lubiprostone	ClC-2	PA164777012	1181	0.923
NULL	Breast_Cancer_Res_2007_Aug_8_9(4)_R50.nxml.txt.nlp	17686159	SENT195	3	3	8	8	gefitinib	HRG	PA131301952	3084;3273	0.923
NULL	Hum_Reprod_2008_Oct_16_23(10)_2273-2281.nxml.txt.nlp	18635530	SENT73	11	11	18	18	etoposide	p53	PA449552	7157	0.923
NULL	Br_J_Cancer_2010_Sep_7_103(6)_765-771.nxml.txt.nlp	20700120	SENT101	5	5	2	2	paroxetine	CYP2D6	PA450801	1565	0.923
NULL	Clin_Med_Insights_Cardiol_2011_Oct_6_5_103-119.nxml.txt.nlp	22084608	SENT251	19	19	9	9	amiodarone	ARTEMIS	PA448383	64421	0.923
NULL	Cancers_(Basel)_2013_Aug_22_5(3)_1103-1119.nxml.txt.nlp	24202336	SENT91	24	24	36	36	temozolomide	p53	PA451609	7157	0.923
NULL	Front_Neuroanat_2011_Jul_12_5_38.nxml.txt.nlp	21808606	SENT870	11	11	2	2	haloperidol	c-fos	PA449841	2353	0.923
NULL	Front_Chem_2013_Jul_12_1_10.nxml.txt.nlp	24790939	SENT57	6	6	26	26	hydroquinone	mol	PA449924	90527	0.923
NULL	Nat_Commun_2014_Dec_9_5_5691.nxml.txt.nlp	25487737	SENT582	31	31	14	14	doxorubicin	SUV39H2	PA449412	79723	0.923
NULL	Oncotarget_2014_Feb_25_5(5)_1304-1314.nxml.txt.nlp	24675421	SENT66	35	35	10	10	cisplatin	JNK	PA449014	5599	0.923
NULL	Evid_Based_Complement_Alternat_Med_2014_Jan_8_2014_976364.nxml.txt.nlp	24527057	SENT180	29	29	25	25	oseltamivir	RANTES	PA450721	6352	0.923
NULL	Crit_Care_2010_Mar_15_14(2)_R30.nxml.txt.nlp	20226064	SENT184	5	5	27	27	midazolam	IL-6	PA450496	3569	0.923
NULL	Clin_Psychopharmacol_Neurosci_2012_Aug_31_10(2)_78-87.nxml.txt.nlp	23430971	SENT75	26	26	22	22	haloperidol	FES	PA449841	2242	0.923
NULL	Mol_Cancer_2009_Apr_16_8_24.nxml.txt.nlp	19371427	SENT214	8	8	5	5	cisplatin	CHK1	PA449014	1111	0.923
NULL	Breast_Cancer_Res_2014_Sep_11_16(5)_430.nxml.txt.nlp	25212826	SENT341	14	14	7	7	fulvestrant	AKT	PA164747170	207	0.923
NULL	Mol_Biol_Cell_2014_Jan_1_25(1)_145-159.nxml.txt.nlp	24196833	SENT450	34	34	7	7	glutaraldehyde	Fis1	PA449777	51024	0.923
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Oct_29_67(Pt_11)_m1633.nxml.txt.nlp	22219855	SENT62	20	20	35	35	ethanol	mol	PA448073	90527	0.923
NULL	Br_J_Cancer_2011_May_10_104(10)_1628-1640.nxml.txt.nlp	21505453	SENT45	8	8	16	16	suramin	PP2	PA10292	4888	0.923
NULL	Front_Plant_Sci_2012_May_14_3_90.nxml.txt.nlp	22645600	SENT64	24	24	13	13	heparin	RBP	PA449855	5973;57794	0.923
NULL	Core_Evid_2009_Jun_15_4_83-92.nxml.txt.nlp	20694067	SENT73	24	24	14	14	ritonavir	CYP3A4	PA451260	1576	0.923
NULL	Acta_Pharmacol_Sin_2012_May_4_33(5)_644-651.nxml.txt.nlp	22555371	SENT128	21	21	11	11	sulodexide	eNOS	PA164746343	4846	0.923
NULL	Anticancer_Drugs_2014_Sep_28_25(8)_950-957.nxml.txt.nlp	24949917	SENT72	25	25	7	7	l-glutamine	CO2	PA10090	4513	0.923
NULL	Eur_Arch_Psychiatry_Clin_Neurosci_2010_Mar_12_260(2)_101-111.nxml.txt.nlp	19856012	SENT23	11	11	1	1	creatine	MRI	PA164778930	78996	0.923
NULL	Eur_J_Endocrinol_2011_Jan_164(1)_69-74.nxml.txt.nlp	20961967	SENT79	16	16	22	22	pioglitazone	OPG	PA450970	690	0.923
NULL	Indian_J_Urol_2010_Oct-Dec_26(4)_502-506.nxml.txt.nlp	21369380	SENT92	21	21	4	4	estradiol	aromatase	PA449503	1588	0.923
NULL	Oncol_Lett_2013_Apr_28_5(4)_1149-1154.nxml.txt.nlp	23599754	SENT163	3	3	9	9	cisplatin	Dicer	PA449014	23405	0.923
NULL	Dement_Geriatr_Cogn_Dis_Extra_2012_Aug_16_2(1)_304-311.nxml.txt.nlp	22962554	SENT12	10	10	23	23	naproxen	APOE	PA450595	348	0.923
NULL	Oncotarget_2014_Jun_7_5(14)_5257-5271.nxml.txt.nlp	24913448	SENT100	20	20	27	27	nilotinib	LASP1	PA165958345	3927	0.923
NULL	Oncotarget_2012_May_18_3(5)_525-534.nxml.txt.nlp	22619113	SENT70	44	44	15	15	fludarabine	IL-4	PA449655	3565	0.923
NULL	Environ_Health_Perspect_2010_Jul_3_118(7)_936-942.nxml.txt.nlp	20199942	SENT213	19	19	6	6	arsenite	mot-2	PA452638	3313	0.923
NULL	Mol_Cancer_2012_Jun_18_11_41.nxml.txt.nlp	22709873	SENT297	25	25	4	4	lapatinib	CCND1	PA152241907	595	0.923
NULL	Br_J_Cancer_2009_Nov_3_101(9)_1555-1564.nxml.txt.nlp	19826422	SENT163	20	20	7	7	tamoxifen	A20	PA451581	7128;28935	0.923
NULL	Drug_Saf_2014_Feb_19_37(4)_201-211.nxml.txt.nlp	24550106	SENT123	0	0	7	7	omeprazole	CYP2C19	PA450704	1557	0.923
NULL	Adv_Hematol_2012_Mar_8_2012_856341.nxml.txt.nlp	22496694	SENT79	28	28	44	44	thrombin	VIII	PA451674	1351	0.923
NULL	Case_Rep_Oncol_2013_Jan_29_6(1)_72-77.nxml.txt.nlp	23466899	SENT52	32	32	3	3	capecitabine	GTX	PA448771	84504	0.923
NULL	Int_J_Environ_Res_Public_Health_2010_Apr_30_7(4)_1448-1466.nxml.txt.nlp	20617039	SENT69	9	9	3	3	ethanol	NR1	PA448073	27158	0.923
NULL	J_Hematol_Oncol_2009_Feb_23_2_10.nxml.txt.nlp	19236716	SENT97	13	13	4	4	dasatinib	UGT	PA162372878	7361;7355	0.923
NULL	Acta_Pharmacol_Sin_2011_May_18_32(5)_591-600.nxml.txt.nlp	21499286	SENT145	35	35	7	7	bezafibrate	AMPK	PA162364313	5563	0.923
NULL	J_Biol_Chem_2012_Dec_14_287(51)_43094-43107.nxml.txt.nlp	23118219	SENT270	15	15	4	4	hyaluronidase	CD44	PA164745713	960	0.923
NULL	Br_J_Pharmacol_2014_Nov_5_171(21)_4820-4830.nxml.txt.nlp	24467283	SENT126	39	39	34	34	meloxicam	COX	PA450353	1351	0.923
NULL	Int_J_Mol_Sci_2014_Sep_17_15(9)_16430-16457.nxml.txt.nlp	25233127	SENT106	7	7	35	35	capsaicin	TRPV1	PA448776	7442	0.923
NULL	Anal_Chem_2009_Sep_1_81(17)_7342-7348.nxml.txt.nlp	19637924	SENT41	36	36	17	17	methamphetamine	CHAMP	PA450403	283489;54456	0.923
NULL	Open_Neurol_J_2009_Apr_2_3_27-44.nxml.txt.nlp	19461897	SENT369	4	4	16	16	rosiglitazone	APO	PA451283	84909	0.923
NULL	J_Breast_Cancer_2012_Mar_28_15(1)_71-78.nxml.txt.nlp	22493631	SENT125	32	32	25	25	trastuzumab	HER2	PA451743	2064	0.923
NULL	Br_J_Cancer_2010_Nov_2_103(11)_1671-1679.nxml.txt.nlp	21045835	SENT174	7	7	39	39	gemcitabine	survivin	PA449748	332	0.923
NULL	Oncogenesis_2014_Dec_15_3(12)_e133.nxml.txt.nlp	25500906	SENT12	13	13	5	5	trastuzumab	MYO3A	PA451743	53904	0.923
NULL	Cancer_Cell_Int_2011_Nov_17_11_40.nxml.txt.nlp	22088142	SENT180	20	20	4	4	gemcitabine	RAF1	PA449748	5894	0.923
NULL	Br_J_Cancer_2006_Dec_4_95(11)_1483-1489.nxml.txt.nlp	17106442	SENT95	8	8	5	5	gefitinib	EGFR	PA131301952	1956	0.923
NULL	Br_J_Cancer_1999_Dec_81(8)_1294-1303.nxml.txt.nlp	10604725	SENT13	13	13	9	9	cisplatin	CH1	PA449014	51430	0.923
NULL	Br_J_Cancer_2003_Jun_2_88(11)_1755-1762.nxml.txt.nlp	12771992	SENT191	33	33	5	5	sulindac	ILK	PA451565	3611	0.923
NULL	Ann_Clin_Transl_Neurol_2014_Sep_30_1(9)_721-732.nxml.txt.nlp	25493285	SENT106	19	19	25	25	liraglutide	GLP-1	PA165958364	100125288	0.923
NULL	Indian_J_Pharmacol_2013_Mar-Apr_45(2)_155-158.nxml.txt.nlp	23716892	SENT116	20	20	14	14	glibenclamide	CYP3A4	PA449782	1576	0.923
NULL	Oncotarget_2014_Feb_7_5(3)_775-787.nxml.txt.nlp	24519956	SENT119	41	41	28	28	docetaxel	PC3	PA449383	57332;7832;5122	0.923
NULL	Gut_2012_Jan_3_61(1)_6-32.nxml.txt.nlp	22052063	SENT364	1	1	24	24	octreotide	SSTR2	PA450678	6752	0.923
NULL	Aging_(Albany_NY)_2010_Dec_20_2(12)_959-968.nxml.txt.nlp	21191146	SENT117	16	16	28	28	cisplatin	LKB1	PA449014	6794	0.923
NULL	Nat_Commun_2013_Sep_20_4_2444.nxml.txt.nlp	24051492	SENT335	13	13	21	21	nutlin-3	p53		7157	0.923
NULL	Pharmaceuticals_(Basel)_2013_Aug_2_6(8)_915-928.nxml.txt.nlp	24276376	SENT186	18	18	4	4	aspirin	PAR-1	PA448497	2011;2149	0.923
NULL	J_Cell_Mol_Med_2014_Sep_5_18(9)_1773-1784.nxml.txt.nlp	25091058	SENT279	12	12	20	20	bleomycin	IL-17A	PA448645	3605	0.923
NULL	Case_Rep_Dermatol_2014_Feb_12_6(1)_37-42.nxml.txt.nlp	24707248	SENT56	19	19	7	7	cytarabine	CHOP	PA449177	1649	0.923
NULL	J_Cell_Biol_1998_May_4_141(3)_727-739.nxml.txt.nlp	9566972	SENT125	19	19	40	40	neomycin	NF-M	PA450608	4741	0.923
NULL	Br_J_Cancer_2012_Sep_25_107(7)_1009-1016.nxml.txt.nlp	22948724	SENT48	22	22	6	6	sunitinib	CAIX	PA162372840	768	0.923
NULL	Oncogene_2013_Oct_24_32(43)_5176-5185.nxml.txt.nlp	23208500	SENT153	8	8	22	22	camptothecin	p53	PA153590860	7157	0.923
NULL	Arch_Drug_Inf_2008_Dec_1(3)_97-106.nxml.txt.nlp	19639031	SENT28	40	40	19	19	sn-38	UGT1A1		54658	0.923
NULL	Br_J_Pharmacol_2008_Oct_18_155(4)_596-605.nxml.txt.nlp	18852694	SENT117	13	13	8	8	fenofibrate	aP2	PA449594	2167	0.923
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jul_16_67(Pt_8)_o2069.nxml.txt.nlp	22091093	SENT52	24	24	6	6	ethanol	mol	PA448073	90527	0.923
NULL	Oncol_Lett_2013_Feb_5_5(2)_427-434.nxml.txt.nlp	23420099	SENT166	19	19	6	6	gemcitabine	ERCC1	PA449748	2067	0.923
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT102	28	28	24	24	sitagliptin	HIP	PA164748978	6767;6159;64399;5068	0.923
NULL	Evid_Based_Complement_Alternat_Med_2014_May_5_2014_730678.nxml.txt.nlp	24883070	SENT209	13	13	31	31	epirubicin	CXCR4	PA449476	7852	0.923
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT276	11	11	1	1	doxorubicin	ABCC2	PA449412	1244	0.923
NULL	Indian_J_Med_Res_2014_Jul_140(1)_109-115.nxml.txt.nlp	25222785	SENT43	9	9	2	2	celecoxib	DMC	PA448871	284340;54808	0.923
NULL	J_Gynecol_Oncol_2013_Jul_4_24(3)_273-279.nxml.txt.nlp	23875078	SENT112	7	7	23	23	paclitaxel	MDR1	PA450761	5243	0.923
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_May_5_68(Pt_6)_o1640-o1641.nxml.txt.nlp	22719441	SENT71	34	34	4	4	ethanol	mol	PA448073	90527	0.923
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT16	4	4	17	17	phenprocoumon	VKORC1	PA450921	79001	0.923
NULL	J_Hematol_Oncol_2011_Apr_20_4_17.nxml.txt.nlp	21507255	SENT55	42	42	13	13	cisplatin	HDAC	PA449014	9734	0.923
NULL	J_Breast_Cancer_2011_Mar_31_14(1)_20-27.nxml.txt.nlp	21847390	SENT193	9	9	21	21	estradiol	CLDN6	PA449503	9074	0.923
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1059-1066.nxml.txt.nlp	21364577	SENT6	5	5	26	26	letrozole	aromatase	PA450196	1588	0.923
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_105-115.nxml.txt.nlp	17912640	SENT44	29	29	4	4	tamoxifen	HER2	PA451581	2064	0.923
NULL	Cancer_Med_2013_Jun_23_2(3)_296-304.nxml.txt.nlp	23930206	SENT30	38	38	29	29	erlotinib	EGFR	PA134687924	1956	0.923
NULL	Brain_2014_Apr_27_137(4)_1145-1155.nxml.txt.nlp	24578545	SENT44	12	12	4	4	citalopram	MRI	PA449015	78996	0.923
NULL	Int_J_Biomed_Sci_2014_Sep_10(3)_146-157.nxml.txt.nlp	25324695	SENT9	5	5	9	9	lovastatin	LFA-1	PA450272	3683;3689	0.923
NULL	EMBO_Mol_Med_2012_Oct_30_4(10)_1087-1096.nxml.txt.nlp	22933245	SENT95	23	23	14	14	olaparib	NAMPT		10135	0.923
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_7-17.nxml.txt.nlp	17912633	SENT72	6	6	11	11	anastrozole	aromatase	PA448432	1588	0.923
NULL	Oncoimmunology_2014_Jan_1_3_e27414.nxml.txt.nlp	24701376	SENT31	24	24	12	12	vorinostat	CD4	PA164748224	920	0.923
NULL	Nat_Commun_2013_Apr_9_4_1684.nxml.txt.nlp	23575688	SENT75	5	5	26	26	roflumilast	CYLD	PA165948052	1540	0.923
NULL	Oncotarget_2011_Mar_23_2(3)_165-177.nxml.txt.nlp	21444946	SENT184	9	9	2	2	cetuximab	KRAS	PA10040	3845	0.923
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_13_2013_468537.nxml.txt.nlp	23956772	SENT141	0	0	29	29	doxorubicin	PIG3	PA449412	64975;9540	0.923
NULL	J_Cell_Biol_2001_Apr_30_153(3)_613-620.nxml.txt.nlp	11331310	SENT65	2	2	44	44	cisplatin	53BP1	PA449014	7158	0.923
NULL	Breast_Cancer_Res_2008_Feb_29_10(1)_R21.nxml.txt.nlp	18312651	SENT30	45	45	31	31	fulvestrant	aromatase	PA164747170	1588	0.923
NULL	Hum_Mol_Genet_2013_Nov_15_22(22)_4602-4615.nxml.txt.nlp	23814040	SENT141	5	5	25	25	l-cysteine	TRMU	PA449173	55687	0.923
NULL	Alcohol_Res_Health_2007_30(1)_48-54.nxml.txt.nlp	17718401	SENT120	10	10	19	19	ethanol	MMP2	PA448073	4313	0.923
NULL	Diagn_Pathol_2014_Jul_10_9_143.nxml.txt.nlp	25012722	SENT94	17	17	3	3	cisplatin	PDCD4	PA449014	27250	0.923
NULL	Ann_Dermatol_2014_Jun_12_26(3)_363-373.nxml.txt.nlp	24966637	SENT131	15	15	5	5	imiquimod	MT1-MMP	PA449972	4323	0.923
NULL	Cell_Commun_Signal_2013_Jan_11_11_2.nxml.txt.nlp	23305203	SENT261	10	10	0	0	thrombin	RACK1	PA451674	10399	0.923
NULL	Int_J_Appl_Basic_Med_Res_2012_Jul-Dec_2(2)_77-83.nxml.txt.nlp	23776817	SENT117	0	0	10	10	conivaptan	CYP3A4	PA164742939	1576	0.923
NULL	Aging_Cell_2012_Aug_11(4)_579-587.nxml.txt.nlp	22435726	SENT157	38	38	6	6	etoposide	p53	PA449552	7157	0.923
NULL	Cell_Commun_Signal_2013_Oct_1_11_73.nxml.txt.nlp	24083678	SENT44	9	9	34	34	sulindac	ICAM1	PA451565	3383	0.923
NULL	Clin_Med_Insights_Oncol_2013_Jul_4_7_159-163.nxml.txt.nlp	23885182	SENT86	22	22	46	46	vincristine	CHOP	PA451879	1649	0.923
NULL	J_Gen_Physiol_2004_Aug_124(2)_125-137.nxml.txt.nlp	15277574	SENT181	11	11	28	28	benzaldehyde	CFTR	PA448571	1080	0.923
NULL	Emerg_Med_J_2011_Apr_26_28(4)_313-315.nxml.txt.nlp	20581384	SENT101	23	23	18	18	atropine	PON1	PA448505	5444	0.923
NULL	Cell_Death_Dis_2012_Jun_21_3(6)_e327.nxml.txt.nlp	22717582	SENT94	21	21	4	4	vincristine	NOXA	PA451879	5366	0.923
NULL	Br_J_Cancer_2013_Jul_23_109(2)_351-359.nxml.txt.nlp	23799854	SENT122	21	21	3	3	paclitaxel	BLT2	PA450761	56413	0.923
NULL	Breast_Cancer_Res_Treat_2012_Jun_18_133(3)_937-947.nxml.txt.nlp	22094936	SENT147	24	24	16	16	tamoxifen	CDC2	PA451581	5424	0.923
NULL	BMJ_2010_Feb_8_340_c693.nxml.txt.nlp	20142325	SENT261	22	22	17	17	paroxetine	CYP2D6	PA450801	1565	0.923
NULL	Case_Rep_Nephrol_Urol_2012_Apr_11_2(1)_20-24.nxml.txt.nlp	23197951	SENT66	17	17	3	3	colchicine	NAC	PA449092	22861	0.923
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_7-17.nxml.txt.nlp	17912633	SENT90	0	0	5	5	letrozole	aromatase	PA450196	1588	0.923
NULL	Oncogene_2010_Sep_16_29(37)_5193-5203.nxml.txt.nlp	20581867	SENT127	23	23	14	14	lapatinib	PI3K	PA152241907	5290	0.923
NULL	Breast_Cancer_Res_2011_Mar_10_13(2)_R28.nxml.txt.nlp	21392397	SENT72	4	4	16	16	erlotinib	API	PA134687924	5345	0.923
NULL	Diabetes_Metab_Syndr_Obes_2009_Jun_24_2_101-109.nxml.txt.nlp	21437123	SENT105	11	11	8	8	metformin	PPG	PA450395	5552	0.923
NULL	Bone_Marrow_Transplant_2011_Mar_24_46(3)_430-435.nxml.txt.nlp	20498647	SENT25	2	2	18	18	infliximab	CD25	PA452639	3669;3559	0.923
NULL	BMB_Rep_2013_Aug_46(8)_410-415.nxml.txt.nlp	23977989	SENT103	21	21	14	14	curcumin	HO-1	PA151958596	3162	0.923
NULL	Biomed_Res_Int_2014_Apr_10_2014_580852.nxml.txt.nlp	24812624	SENT31	2	2	33	33	resveratrol	PI3K		5290	0.923
NULL	ARYA_Atheroscler_2013_Sep_9(5)_306-310.nxml.txt.nlp	24302941	SENT40	27	27	24	24	heparin	MCP-1	PA449855	6347	0.923
NULL	Allergy_Asthma_Clin_Immunol_2011_Aug_25_7(1)_13.nxml.txt.nlp	21867553	SENT221	19	19	28	28	itraconazole	CYP3A4	PA450132	1576	0.923
NULL	Pharmaceuticals_(Basel)_2014_Jan_9_7(1)_46-57.nxml.txt.nlp	24451403	SENT84	21	21	14	14	ritonavir	p107	PA451260	5933	0.923
NULL	Asian_J_Androl_2015_Oct_24_Jan-Feb_17(1)_61-67.nxml.txt.nlp	25370206	SENT151	15	15	1	1	sildenafil	SEP2	PA451346	23176;23157	0.923
NULL	Hum_Genomics_2008_Sep_1_3(1)_7-16.nxml.txt.nlp	19129086	SENT161	10	10	17	17	rosiglitazone	CYP2C8	PA451283	1558	0.923
NULL	Case_Rep_Oncol_2012_Oct_10_5(3)_546-553.nxml.txt.nlp	23139670	SENT25	15	15	23	23	gefitinib	EGFR	PA131301952	1956	0.923
NULL	Ann_Rheum_Dis_2008_Jun_2_68(5)_654-657.nxml.txt.nlp	18519424	SENT102	14	14	20	20	tocilizumab	IL6	PA165292659	3569	0.922
NULL	Drugs_R_D_2013_Mar_21_13(1)_29-36.nxml.txt.nlp	23322527	SENT156	25	25	1	1	risperidone	ANOVA	PA451257	4858	0.922
NULL	Arthritis_Res_Ther_2010_Feb_9_12(1)_R21.nxml.txt.nlp	20144213	SENT195	3	3	12	12	naproxen	5-LOX	PA450595	240	0.922
NULL	Int_J_Biol_Sci_2013_Mar_16_9(3)_303-312.nxml.txt.nlp	23569435	SENT147	10	10	0	0	vemurafenib	BRAF	PA165946873	673	0.922
NULL	Anal_Biochem_2014_Jun_1_454(100)_17-22.nxml.txt.nlp	24637157	SENT20	28	28	3	3	camptothecin	TOP1	PA153590860	7150	0.922
NULL	Ann_Gen_Psychiatry_2009_Aug_13_8_18.nxml.txt.nlp	19674486	SENT138	15	15	8	8	fluoxetine	B12	PA449673	7126;4709	0.922
NULL	Front_Neurosci_2010_Nov_19_4_191.nxml.txt.nlp	21151372	SENT236	3	3	9	9	mefloquine	P-gp	PA450348	5243	0.922
NULL	Br_J_Cancer_2013_May_14_108(9)_1862-1869.nxml.txt.nlp	23579219	SENT101	8	8	36	36	bevacizumab	ANXA11	PA130232992	311	0.922
NULL	J_Inherit_Metab_Dis_2011_Apr_29_34(2)_315-325.nxml.txt.nlp	20668944	SENT204	0	0	17	17	bezafibrate	CPT2	PA162364313	1376	0.922
NULL	Exp_Ther_Med_2014_Nov_29_8(5)_1473-1478.nxml.txt.nlp	25289044	SENT124	19	19	31	31	heparin	AZU	PA449855	566	0.922
NULL	Am_J_Cardiovasc_Drugs_2013_Jun_20_13(5)_331-342.nxml.txt.nlp	23784266	SENT220	8	8	15	15	rivaroxaban	P-gp	PA165958360	5243	0.922
NULL	Cardiovasc_Diabetol_2010_Oct_18_9_64.nxml.txt.nlp	20955583	SENT110	14	14	6	6	rosiglitazone	MCP-1	PA451283	6347	0.922
NULL	J_Nutr_Biochem_2012_Apr_23(4-2)_332-340.nxml.txt.nlp	21543215	SENT78	2	2	13	13	taurine	API	PA451590	5345	0.922
NULL	Mol_Cancer_2010_Aug_23_9_222.nxml.txt.nlp	20731837	SENT197	11	11	23	23	gefitinib	KRAS	PA131301952	3845	0.922
NULL	Int_J_Cell_Biol_2013_Sep_3_2013_642853.nxml.txt.nlp	24082883	SENT143	0	0	16	16	camptothecin	YB-1	PA153590860	4904	0.922
NULL	Curr_Neuropharmacol_2013_Dec_11(6)_652-663.nxml.txt.nlp	24396340	SENT193	6	6	18	18	sevoflurane	TRPV1	PA451341	7442	0.922
NULL	Ann_Oncol_2009_Aug_20(Suppl_6)_vi35-vi40.nxml.txt.nlp	19617296	SENT88	19	19	10	10	imatinib	CDK4	PA10804	1019	0.922
NULL	Int_J_Mol_Sci_2010_Sep_13_11(9)_3195-3208.nxml.txt.nlp	20957088	SENT219	19	19	5	5	lipase	AT2	PA450239	186	0.922
NULL	Mol_Cells_2014_Aug_31_37(8)_585-591.nxml.txt.nlp	25134539	SENT99	6	6	32	32	indacaterol	ADRB2	PA165958348	154	0.922
NULL	Case_Rep_Dermatol_2011_Oct_11_3(3)_223-227.nxml.txt.nlp	22135629	SENT67	11	11	26	26	paclitaxel	HER2	PA450761	2064	0.922
NULL	Cell_Death_Differ_2010_Apr_23_17(4)_699-709.nxml.txt.nlp	19851330	SENT312	3	3	30	30	tetracycline	PUMA	PA451640	27113	0.922
NULL	J_Viral_Hepat_2010_Feb_17(2)_139-147.nxml.txt.nlp	19674282	SENT177	1	1	21	21	ribavirin	RVR	PA451241	9975	0.922
NULL	Ann_Rheum_Dis_2010_Sep_1_69(9)_1629-1635.nxml.txt.nlp	20488885	SENT119	19	19	10	10	rituximab	CD19	PA451261	930	0.922
NULL	Cell_Death_Dis_2014_Apr_24_5(4)_e1197.nxml.txt.nlp	24763054	SENT89	18	18	23	23	cisplatin	RUNX3	PA449014	864	0.922
NULL	Oncotarget_2011_Aug_30_2(8)_610-626.nxml.txt.nlp	21881167	SENT95	2	2	18	18	doxorubicin	Raf-1	PA449412	5894	0.922
NULL	Braz_J_Med_Biol_Res_2013_Aug_13_46(8)_650-658.nxml.txt.nlp	23969971	SENT10	27	27	22	22	cisplatin	STAT3	PA449014	6774	0.922
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT133	25	25	17	17	dasatinib	PP2	PA162372878	4888	0.922
NULL	Biochim_Biophys_Acta_2014_Jul_1842(7)_959-970.nxml.txt.nlp	24594481	SENT312	31	31	39	39	lipase	FGF21	PA450239	26291	0.922
NULL	Mol_Cancer_2012_Sep_21_11_72.nxml.txt.nlp	22995644	SENT113	17	17	2	2	imatinib	PRL-3	PA10804	11156	0.922
NULL	Adv_Biomed_Res_2014_Oct_21_3_219.nxml.txt.nlp	25371876	SENT210	6	6	18	18	raloxifene	CA1	PA451221	759	0.922
NULL	J_Am_Heart_Assoc_2013_Dec_19_2(6)_e000439.nxml.txt.nlp	24334905	SENT298	13	13	9	9	doxorubicin	AMPK	PA449412	5563	0.922
NULL	Endocrinol_Metab_(Seoul)_2014_Jun_26_29(2)_105-111.nxml.txt.nlp	25031882	SENT14	3	3	30	30	heparin	FGF23	PA449855	8074	0.922
NULL	Breast_Cancer_Res_2007_Jan_23_9(1)_R7.nxml.txt.nlp	17244352	SENT46	10	10	38	38	tamoxifen	UGT2B15	PA451581	7366	0.922
NULL	Ann_Dermatol_2014_Feb_17_26(1)_141-143.nxml.txt.nlp	24648711	SENT16	10	10	0	0	tacrolimus	LDE	PA451578	7957	0.922
NULL	Br_J_Cancer_2013_May_14_108(9)_1862-1869.nxml.txt.nlp	23579219	SENT28	20	20	25	25	cetuximab	ISX	PA10040	91464	0.922
NULL	Nat_Med_2013_Jun_26_19(6)_713-721.nxml.txt.nlp	23708291	SENT119	28	28	32	32	celecoxib	COX2	PA448871	4513;5743	0.922
NULL	J_Cell_Mol_Med_2013_Oct_23_17(10)_1207-1217.nxml.txt.nlp	24106980	SENT131	10	10	13	13	docetaxel	PDCD4	PA449383	27250	0.922
NULL	Indian_J_Endocrinol_Metab_2012_Mar_16(Suppl1)_S110-S113.nxml.txt.nlp	22701828	SENT35	23	23	10	10	vildagliptin	GLP-1	PA165958346	100125288	0.922
NULL	J_Oncol_2012_Apr_10_2012_931071.nxml.txt.nlp	22570654	SENT73	28	28	2	2	plerixafor	CD34	PA165958410	947	0.922
NULL	BMB_Rep_2013_Aug_46(8)_410-415.nxml.txt.nlp	23977989	SENT99	7	7	22	22	curcumin	HO-1	PA151958596	3162	0.922
NULL	Nucleic_Acids_Res_2005_Jun_8_33(10)_3283-3291.nxml.txt.nlp	15944449	SENT186	8	8	22	22	sjg-136	XRCC2		7516	0.922
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_3_2013_361832.nxml.txt.nlp	23861704	SENT179	19	19	0	0	collagenase	PDGF-A	PA449107	5154	0.922
NULL	Indian_J_Endocrinol_Metab_2013_Oct_17(Suppl1)_S373-S394.nxml.txt.nlp	NULL	SENT823	19	19	1	1	metformin	adiponectin	PA450395	9370	0.922
NULL	Hum_Genomics_Proteomics_2010_Sep_13_2010_754919.nxml.txt.nlp	20981234	SENT101	1	1	16	16	phenprocoumon	CYP2C9	PA450921	1559	0.922
NULL	Mol_Cancer_2010_May_21_9_116.nxml.txt.nlp	20492666	SENT16	28	28	7	7	bortezomib	RNF	PA10252	11074	0.922
NULL	Eur_J_Neurosci_2008_Apr_1_27(7)_1722-1730.nxml.txt.nlp	18380669	SENT165	20	20	17	17	sr144528	CB2		1269	0.922
NULL	Ann_Hematol_2011_Dec_8_90(12)_1399-1407.nxml.txt.nlp	21476016	SENT89	44	44	13	13	cyclophosphamide	CHOP	PA449165	1649	0.922
NULL	Curr_Oncol_2010_Feb_17(1)_81-86.nxml.txt.nlp	20179808	SENT116	18	18	12	12	fluoxetine	CYP2D6	PA449673	1565	0.922
NULL	Clin_Sarcoma_Res_2014_Aug_12_4_11.nxml.txt.nlp	25126409	SENT99	14	14	10	10	doxorubicin	Bcl-2	PA449412	596	0.922
NULL	Int_J_Biol_Sci_2006_Oct_15_3(1)_20-26.nxml.txt.nlp	17200688	SENT144	0	0	16	16	geldanamycin	HSF1	PA152031327	3297	0.922
NULL	J_Cardiovasc_Pharmacol_2014_Sep_18_64(3)_199-208.nxml.txt.nlp	24785346	SENT300	7	7	14	14	levosimendan	PI3K	PA164749138	5290	0.922
NULL	Acta_Pharmacol_Sin_2009_Nov_12_30(11)_1566-1572.nxml.txt.nlp	19820718	SENT7	28	28	23	23	verapamil	P-gp	PA451868	5243	0.922
NULL	Exp_Ther_Med_2014_Mar_10_7(3)_640-648.nxml.txt.nlp	24520260	SENT110	21	21	15	15	resveratrol	JNK		5599	0.922
NULL	Arthritis_Res_Ther_2006_Jul_21_8(4)_R130.nxml.txt.nlp	16859540	SENT96	13	13	17	17	atorvastatin	CD59	PA448500	966	0.922
NULL	Mol_Cancer_2013_Mar_2_12_16.nxml.txt.nlp	23452820	SENT110	14	14	28	28	chloroquine	Bcl-2	PA448948	596	0.922
NULL	Oncoscience_2014_Mar_16_1(2)_132-157.nxml.txt.nlp	25594007	SENT257	10	10	5	5	oxaliplatin	ID3	PA131285527	3399	0.922
NULL	Biochim_Biophys_Acta_2014_Jul_1842(7)_959-970.nxml.txt.nlp	24594481	SENT289	15	15	1	1	lipase	FGF21	PA450239	26291	0.922
NULL	Br_J_Cancer_2013_May_14_108(9)_1862-1869.nxml.txt.nlp	23579219	SENT28	20	20	32	32	cetuximab	ANXA11	PA10040	311	0.922
NULL	J_Biomed_Sci_2012_Nov_21_19(1)_99.nxml.txt.nlp	23170833	SENT114	20	20	13	13	atorvastatin	CXCR4	PA448500	7852	0.922
NULL	Fibrogenesis_Tissue_Repair_2010_Aug_25_3_15.nxml.txt.nlp	20738867	SENT180	10	10	1	1	bleomycin	IL-13	PA448645	3596	0.922
NULL	J_Invest_Dermatol_2013_Apr_6_133(4)_988-998.nxml.txt.nlp	23223142	SENT46	17	17	3	3	fluorescein	TLR2	PA164746009	7097	0.922
NULL	Clin_Interv_Aging_2014_Oct_21_9_1783-1791.nxml.txt.nlp	25364236	SENT145	22	22	9	9	donepezil	APOE	PA449394	348	0.922
NULL	Int_J_Breast_Cancer_2012_May_9_2012_415170.nxml.txt.nlp	22649737	SENT76	38	38	5	5	trastuzumab	HER2	PA451743	2064	0.922
NULL	Mol_Clin_Oncol_2013_Jul_27_1(4)_711-715.nxml.txt.nlp	24649233	SENT33	0	0	14	14	gefitinib	EGFR	PA131301952	1956	0.922
NULL	Exp_Diabetes_Res_2011_Dec_27_2011_604989.nxml.txt.nlp	21253359	SENT50	42	42	21	21	clonidine	GLP-1	PA449051	100125288	0.922
NULL	J_Hematol_Oncol_2013_Jan_4_6_1.nxml.txt.nlp	23286345	SENT124	24	24	2	2	rituximab	PRIMA	PA451261	145270	0.922
NULL	J_Invest_Dermatol_2012_Jan_1_132(1)_105-113.nxml.txt.nlp	21881590	SENT85	20	20	7	7	etanercept	CCL20	PA449515	6364	0.922
NULL	J_Gen_Physiol_1960_Mar_1_43(4)_753-758.nxml.txt.nlp	14433991	SENT1	35	35	8	8	dextran	gamma	PA449261	9913	0.922
NULL	JRSM_Cardiovasc_Dis_2012_Sep_24_1(6)_cvd_2012_012015.nxml.txt.nlp	24175073	SENT12	45	45	35	35	clopidogrel	P2Y12	PA449053	64805	0.922
NULL	Front_Pharmacol_2014_Nov_26_5_258.nxml.txt.nlp	25505415	SENT29	36	36	18	18	rosuvastatin	OATP1B1	PA134308647	10599	0.922
NULL	Case_Rep_Hematol_2013_Feb_27_2013_931519.nxml.txt.nlp	23533850	SENT48	29	29	17	17	fludarabine	CD4	PA449655	920	0.922
NULL	Cancers_(Basel)_2010_Aug_19_2(3)_1629-1641.nxml.txt.nlp	24281178	SENT116	5	5	35	35	gemcitabine	CD133	PA449748	8842	0.922
NULL	Cell_Commun_Signal_2013_Nov_5_11_83.nxml.txt.nlp	24192293	SENT249	16	16	27	27	doxycycline	IL-6	PA449415	3569	0.922
NULL	Mol_Cancer_2010_Aug_23_9_222.nxml.txt.nlp	20731837	SENT101	19	19	28	28	cetuximab	EGFR	PA10040	1956	0.922
NULL	Diabetes_2008_Oct_57(10)_2784-2793.nxml.txt.nlp	18599521	SENT301	8	8	43	43	simvastatin	Rho	PA451363	29984	0.922
NULL	Int_J_Mol_Sci_2014_Oct_20_15(10)_18840-18855.nxml.txt.nlp	25334060	SENT156	31	31	36	36	heparin	OPG	PA449855	690	0.922
NULL	Breast_Cancer_Res_Treat_2013_May_12_139(1)_107-113.nxml.txt.nlp	23580070	SENT24	38	38	27	27	trastuzumab	HER3	PA451743	2065	0.922
NULL	Cell_Death_Dis_2014_Jul_17_5(7)_e1339.nxml.txt.nlp	25032862	SENT9	15	15	6	6	etoposide	ATG5	PA449552	9474	0.922
NULL	Gastric_Cancer_2014_Apr_7_17(1)_1-12.nxml.txt.nlp	23563986	SENT162	7	7	17	17	trastuzumab	DM1	PA451743	338023;1760;28509	0.922
NULL	Br_J_Pharmacol_2014_May_171(10)_2659-2670.nxml.txt.nlp	24116661	SENT206	3	3	6	6	naringenin	TRPP2	PA151958361	5311	0.922
NULL	Diabetes_Care_2011_Sep_19_34(9)_2072-2077.nxml.txt.nlp	21788633	SENT179	13	13	18	18	vildagliptin	GLP-1	PA165958346	100125288	0.922
NULL	J_Immunol_Res_2014_Mar_13_2014_734068.nxml.txt.nlp	24741620	SENT135	10	10	5	5	methotrexate	HLA-G	PA450428	3135	0.922
NULL	EMBO_Rep_2011_Apr_1_12(4)_321-326.nxml.txt.nlp	21350502	SENT115	16	16	28	28	ampicillin	CO2	PA448419	4513	0.922
NULL	Oncotarget_2014_Aug_19_5(18)_8737-8749.nxml.txt.nlp	25228590	SENT241	10	10	0	0	doxycycline	MYCN	PA449415	4613	0.922
NULL	Br_J_Cancer_2012_Jun_5_106(12)_1997-2003.nxml.txt.nlp	22596232	SENT6	21	21	3	3	sorafenib	c-Jun	PA7000	3725	0.922
NULL	Mol_Biol_Int_2014_Nov_20_2014_686984.nxml.txt.nlp	25505994	SENT158	18	18	0	0	staurosporine	4E-BP1	PA165109623	1978	0.922
NULL	Int_J_Mol_Sci_2014_May_13_15(5)_8393-8406.nxml.txt.nlp	24828201	SENT545	35	35	5	5	cisplatin	SOX2	PA449014	6657	0.922
NULL	Int_J_Biol_Sci_2013_May_8_9(5)_435-443.nxml.txt.nlp	23678293	SENT152	6	6	33	33	imatinib	STAT3	PA10804	6774	0.922
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_67-74.nxml.txt.nlp	17912637	SENT2	10	10	2	2	anastrozole	aromatase	PA448432	1588	0.922
NULL	Antiviral_Res_2009_May_82(2)_A99-A109.nxml.txt.nlp	19176219	SENT178	8	8	21	21	nelfinavir	OCT2	PA450606	6582;5452	0.922
NULL	Anat_Cell_Biol_2011_Mar_31_44(1)_14-24.nxml.txt.nlp	21519545	SENT105	45	45	17	17	cyclophosphamide	CK8	PA449165	3856	0.922
NULL	Acta_Pharmacol_Sin_2011_Feb_4_32(2)_223-229.nxml.txt.nlp	21293474	SENT3	6	6	42	42	isoproterenol	FKBP12	PA450121	2280	0.922
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2735-2743.nxml.txt.nlp	24129244	SENT177	12	12	10	10	crizotinib	ALK	PA165946122	238	0.922
NULL	Br_J_Haematol_2008_Aug_28_142(4)_505-514.nxml.txt.nlp	18510682	SENT148	15	15	10	10	rituximab	B19	PA451261	59271	0.922
NULL	Mol_Cancer_2012_Apr_26_11_24.nxml.txt.nlp	22537161	SENT139	15	15	34	34	pp2	MUC4		4585	0.922
NULL	Ann_Oncol_2011_Jul_6_22(7)_1561-1570.nxml.txt.nlp	21135055	SENT302	7	7	11	11	olaparib	BRCA1		672	0.922
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Nov_19_67(Pt_12)_o3364.nxml.txt.nlp	22199858	SENT64	24	24	16	16	ethanol	mol	PA448073	90527	0.922
NULL	Cancer_Metastasis_Rev_2010_Sep_24_29(3)_465-482.nxml.txt.nlp	20730632	SENT302	12	12	5	5	genistein	MEK4	PA165109660	6416	0.922
NULL	Gynecol_Oncol_Case_Rep_2013_Sep_12_7_7-9.nxml.txt.nlp	24624320	SENT38	11	11	14	14	letrozole	aromatase	PA450196	1588	0.922
NULL	Target_Oncol_2012_Mar_2_7(1)_55-68.nxml.txt.nlp	22383042	SENT108	16	16	4	4	heparin	IL-7	PA449855	3574	0.922
NULL	Curr_Pharm_Des_2008_Oct_14(28)_2983-2998.nxml.txt.nlp	18991714	SENT117	2	2	32	32	cetuximab	gamma	PA10040	9913	0.922
NULL	Ann_Surg_Treat_Res_2014_Feb_22_86(2)_68-75.nxml.txt.nlp	24761411	SENT153	14	14	4	4	oxaliplatin	survivin	PA131285527	332	0.922
NULL	Front_Oncol_2014_Aug_11_4_204.nxml.txt.nlp	25157335	SENT216	33	33	13	13	erlotinib	KRAS	PA134687924	3845	0.922
NULL	Int_J_Cell_Biol_2012_May_29_2012_259142.nxml.txt.nlp	22690219	SENT55	15	15	26	26	l-glutamine	CO2	PA10090	4513	0.922
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT309	31	31	8	8	tenofovir	ABCC10	PA10204	89845	0.922
NULL	Front_Immunol_2012_Jul_12_3_175.nxml.txt.nlp	22807925	SENT121	24	24	3	3	heparin	CXCL4L1	PA449855	5197	0.922
NULL	Open_Cardiovasc_Med_J_2011_Feb_15_5_15-21.nxml.txt.nlp	21660251	SENT136	22	22	11	11	sr144528	CB2		1269	0.922
NULL	Physiol_Rep_2014_Sep_28_2(9)_e12158.nxml.txt.nlp	25263207	SENT420	25	25	8	8	forskolin	TGR5	PA146096022	151306	0.922
NULL	Aging_(Albany_NY)_2011_Feb_20_3(2)_85-93.nxml.txt.nlp	21386133	SENT139	13	13	4	4	metformin	AMPK	PA450395	5563	0.922
NULL	Breast_Cancer_Res_2013_Nov_29_15(6)_R114.nxml.txt.nlp	24289103	SENT35	5	5	13	13	tamoxifen	EGFR	PA451581	1956	0.922
NULL	Mol_Cancer_2013_Apr_22_12_29.nxml.txt.nlp	23601052	SENT240	34	34	8	8	mitomycin	CO2	PA450524	4513	0.922
NULL	Cancer_Cell_Int_2014_Jul_2_14_59.nxml.txt.nlp	25120382	SENT132	16	16	11	11	metformin	CTR	PA450395	799	0.922
NULL	J_Mol_Recognit_2014_Dec_16_27(12)_739-745.nxml.txt.nlp	25319622	SENT64	36	36	13	13	chloramphenicol	San	PA448927	80218	0.922
NULL	Cell_Death_Dis_2014_Apr_17_5(4)_e1182.nxml.txt.nlp	24743737	SENT81	8	8	13	13	capsaicin	AMPK	PA448776	5563	0.922
NULL	Behav_Genet_2012_Jul_17_42(4)_509-527.nxml.txt.nlp	22426781	SENT384	26	26	36	36	l-glutamine	CO2	PA10090	4513	0.922
NULL	Acta_Pharmacol_Sin_2011_Oct_5_32(10)_1276-1284.nxml.txt.nlp	21970838	SENT172	15	15	10	10	ritonavir	CYP3A	PA451260	1574	0.922
NULL	Oncotarget_2014_Oct_15_5(21)_10763-10777.nxml.txt.nlp	25333257	SENT68	22	22	5	5	irinotecan	P-gp	PA450085	5243	0.922
NULL	J_Mol_Med_2008_Sep_4_86(9)_1045-1056.nxml.txt.nlp	18600309	SENT256	2	2	19	19	salmeterol	CXCR2	PA451300	3579	0.922
NULL	Oncol_Rep_2012_Apr_13_27(4)_979-986.nxml.txt.nlp	22179630	SENT52	17	17	8	8	paclitaxel	DDP	PA450761	1678	0.922
NULL	Breast_Cancer_Res_2007_Feb_6_9(1)_R17.nxml.txt.nlp	17280616	SENT28	0	0	26	26	tamoxifen	HER-2	PA451581	2064	0.922
NULL	Facts_Views_Vis_Obgyn_2013_5(4)_265-273.nxml.txt.nlp	24753954	SENT33	16	16	7	7	estradiol	aromatase	PA449503	1588	0.922
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_May_22_66(Pt_6)_o1414.nxml.txt.nlp	21579493	SENT58	25	25	12	12	ethanol	mol	PA448073	90527	0.922
NULL	JRSM_Cardiovasc_Dis_2012_Sep_24_1(6)_cvd_2012_012015.nxml.txt.nlp	24175073	SENT101	26	26	41	41	prasugrel	HPR	PA154410481	3250	0.922
NULL	Oncotarget_2013_Aug_24_4(10)_1618-1631.nxml.txt.nlp	24113128	SENT202	14	14	3	3	sorafenib	p53	PA7000	7157	0.922
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT171	18	18	11	11	nutlin-3	p53		7157	0.922
NULL	J_Immunol_Res_2014_Oct_12_2014_570685.nxml.txt.nlp	25371908	SENT156	20	20	12	12	levofloxacin	CXCL10	PA450214	3627	0.922
NULL	Iran_J_Ped_Hematol_Oncol_2014_Jul_20_4(3)_118-126.nxml.txt.nlp	25254091	SENT9	10	10	5	5	mitoxantrone	ABCA2	PA450526	20	0.922
NULL	Cell_Death_Dis_2014_Apr_24_5(4)_e1197.nxml.txt.nlp	24763054	SENT89	20	20	36	36	doxorubicin	RUNX3	PA449412	864	0.922
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_91-103.nxml.txt.nlp	17912639	SENT18	7	7	2	2	letrozole	aromatase	PA450196	1588	0.922
NULL	Mol_Immunol_2009_Mar_46(6)_1149-1162.nxml.txt.nlp	19100624	SENT212	20	20	31	31	amantadine	C5L2	PA448360	27202	0.922
NULL	Ann_Oncol_2012_Dec_2_23(12)_3007-3016.nxml.txt.nlp	22865781	SENT100	14	14	22	22	trastuzumab	PTEN	PA451743	5728	0.922
NULL	Anticancer_Drugs_2015_Feb_22_26(2)_139-147.nxml.txt.nlp	25203626	SENT181	10	10	26	26	sorafenib	EZH2	PA7000	2146	0.922
NULL	J_Carcinog_2013_Dec_31_12_22.nxml.txt.nlp	24574860	SENT252	12	12	31	31	vemurafenib	BRAF	PA165946873	673	0.922
NULL	Hum_Reprod_Update_2009_Mar_11_Sep-Oct_15(5)_517-535.nxml.txt.nlp	19279047	SENT273	8	8	31	31	estradiol	CD4	PA449503	920	0.922
NULL	Breast_Cancer_Res_2004_Mar_26_6(3)_R252-R263.nxml.txt.nlp	15084249	SENT179	27	27	5	5	tamoxifen	NAT1	PA451581	9;1982	0.922
NULL	Int_J_Cell_Biol_2013_May_16_2013_639401.nxml.txt.nlp	23762063	SENT292	3	3	15	15	curcumin	ARNT	PA151958596	405	0.922
NULL	Acta_Pharmacol_Sin_2014_Jun_5_35(6)_727-737.nxml.txt.nlp	24793312	SENT140	7	7	19	19	telmisartan	B27	PA451605	56246	0.922
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT156	10	10	21	21	trastuzumab	HER3	PA451743	2065	0.922
NULL	Front_Neuroanat_2014_Oct_9_8_112.nxml.txt.nlp	25346662	SENT213	21	21	39	39	yohimbine	NTR2	PA451946	23620	0.922
NULL	EMBO_Mol_Med_2013_Jul_30_5(7)_932-948.nxml.txt.nlp	23723167	SENT291	15	15	5	5	pilocarpine	MMP13	PA450962	4322	0.922
NULL	Int_J_Breast_Cancer_2011_Sep_6_2011_352182.nxml.txt.nlp	22295219	SENT138	6	6	0	0	trastuzumab	PI3K	PA451743	5290	0.922
NULL	Mol_Biol_Evol_2013_Dec_11_30(12)_2541-2552.nxml.txt.nlp	24030553	SENT263	33	33	14	14	fluorescein	SP6	PA164746009	80320	0.922
NULL	Breast_Cancer_Res_2010_May_18_12(Suppl_1)_P48.nxml.txt.nlp	NULL	SENT16	21	21	9	9	tamoxifen	CYP2D6	PA451581	1565	0.922
NULL	Drug_Saf_2014_Feb_19_37(4)_201-211.nxml.txt.nlp	24550106	SENT131	10	10	20	20	esomeprazole	CYP2A6	PA10075	1548	0.922
NULL	Breast_Cancer_(Auckl)_2012_Nov_19_6_191-207.nxml.txt.nlp	23226023	SENT84	25	25	12	12	trastuzumab	HER2	PA451743	2064	0.922
NULL	Indian_J_Pharmacol_2013_Mar-Apr_45(2)_155-158.nxml.txt.nlp	23716892	SENT116	20	20	39	39	glibenclamide	CYP3A4	PA449782	1576	0.922
NULL	Oncogene_2010_Jun_3_29(22)_3208-3216.nxml.txt.nlp	20383201	SENT250	8	8	24	24	dasatinib	EGF	PA162372878	1950	0.922
NULL	Eur_J_Clin_Pharmacol_2012_Jan_7_68(1)_55-64.nxml.txt.nlp	21735164	SENT205	15	15	21	21	oxycodone	CYP2D6	PA450741	1565	0.922
NULL	Exp_Diabetes_Res_2011_Jun_23_2011_898913.nxml.txt.nlp	21747834	SENT33	5	5	15	15	metformin	GLP-1	PA450395	100125288	0.922
NULL	J_Hematol_Oncol_2011_Apr_20_4_16.nxml.txt.nlp	21504625	SENT8	9	9	7	7	bsi-201	PARP-1		25976	0.922
NULL	Neural_Plast_2012_Nov_2_2012_309494.nxml.txt.nlp	22164341	SENT7	3	3	15	15	raloxifene	CA1	PA451221	759	0.922
NULL	Clin_Mol_Hepatol_2013_Sep_30_19(3)_288-299.nxml.txt.nlp	24133667	SENT133	23	23	39	39	sorafenib	SHARP	PA7000	23013	0.922
NULL	Oncoimmunology_2013_Jan_1_2(1)_e22890.nxml.txt.nlp	23483066	SENT18	4	4	33	33	vemurafenib	BRAF	PA165946873	673	0.922
NULL	Oncol_Lett_2013_Mar_14_5(3)_756-760.nxml.txt.nlp	23426872	SENT10	4	4	7	7	cisplatin	JAK2	PA449014	3717	0.922
NULL	J_Oncol_2010_Jun_22_2010_939407.nxml.txt.nlp	20652010	SENT33	6	6	17	17	heparin	CXCR2	PA449855	3579	0.922
NULL	Open_Dent_J_2011_Mar_29_5_48-51.nxml.txt.nlp	21566720	SENT100	11	11	26	26	phenylephrine	EGFR	PA450935	1956	0.922
NULL	Hum_Genomics_2010_Oct_1_5(1)_61-72.nxml.txt.nlp	21106490	SENT149	14	14	20	20	lovastatin	CYP3A4	PA450272	1576	0.922
NULL	Mol_Cancer_2012_Sep_21_11_72.nxml.txt.nlp	22995644	SENT45	5	5	28	28	imatinib	PRL-3	PA10804	11156	0.922
NULL	Br_J_Cancer_2010_Jun_8_102(12)_1762-1768.nxml.txt.nlp	20485284	SENT111	26	26	0	0	cetuximab	BRAF	PA10040	673	0.922
NULL	Diabetes_Obes_Metab_2011_Nov_13(11)_982-989.nxml.txt.nlp	21615670	SENT146	15	15	3	3	exenatide	PPG	PA164749238	5552	0.922
NULL	Health_Policy_Plan_2012_Dec_29_27(8)_677-686.nxml.txt.nlp	22460007	SENT306	4	4	22	22	artemether	ACT	PA165111698	12;11332;9457;641455	0.922
NULL	Indian_J_Pharmacol_2013_Sep-Oct_45(5)_447-452.nxml.txt.nlp	24130377	SENT103	0	0	8	8	efavirenz	AKT	PA449441	207	0.922
NULL	Clin_Endosc_2014_Mar_31_47(2)_141-150.nxml.txt.nlp	24765596	SENT84	13	13	24	24	propofol	ACLS	PA451141	46;2737	0.922
NULL	Cardiovasc_Diabetol_2008_Jul_24_7_22.nxml.txt.nlp	18652658	SENT53	5	5	0	0	ramipril	DREAM	PA451223	30818	0.922
NULL	Case_Rep_Oncol_2009_Dec_11_2(3)_234-241.nxml.txt.nlp	20737043	SENT79	5	5	31	31	etoposide	CD34	PA449552	947	0.922
NULL	Oncogene_2009_Jan_15_28(2)_279-288.nxml.txt.nlp	18836480	SENT262	16	16	12	12	pp2	PP2		4888	0.922
NULL	EMBO_Mol_Med_2013_Aug_4_5(8)_1180-1195.nxml.txt.nlp	23828858	SENT200	36	36	14	14	rituximab	MYC	PA451261	4609	0.922
NULL	Oncotarget_2012_Sep_28_3(10)_1169-1181.nxml.txt.nlp	23045411	SENT199	29	29	9	9	doxorubicin	JIP1	PA449412	9479	0.922
NULL	Eur_J_Clin_Pharmacol_2012_Sep_15_68(9)_1267-1274.nxml.txt.nlp	22418828	SENT93	6	6	14	14	pantoprazole	CYP2C19	PA450774	1557	0.922
NULL	Cancer_Cell_Int_2011_Aug_19_11_29.nxml.txt.nlp	21854619	SENT275	3	3	26	26	platinum	BRCA1	PA150595617	672	0.922
NULL	Br_J_Cancer_2001_Sep_85(7)_953-958.nxml.txt.nlp	11592764	SENT1	0	0	36	36	thalidomide	IL-6	PA451644	3569	0.922
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Oct_31_65(Pt_11)_o2935.nxml.txt.nlp	21578511	SENT58	26	26	12	12	ethanol	mol	PA448073	90527	0.922
NULL	Front_Neurosci_2014_Dec_16_8_414.nxml.txt.nlp	25565944	SENT173	37	37	17	17	fluorescein	SPG	PA164746009	55764	0.922
NULL	Protein_Cell_2014_Jun_7_5(6)_457-468.nxml.txt.nlp	24801752	SENT140	5	5	16	16	geldanamycin	PI4KII	PA152031327	55361	0.922
NULL	J_Biol_Chem_2012_Apr_20_287(17)_13868-13876.nxml.txt.nlp	22389490	SENT70	12	12	20	20	capsaicin	TRPV1	PA448776	7442	0.922
NULL	J_Med_Case_Reports_2011_Oct_5_5_504.nxml.txt.nlp	21975443	SENT26	9	9	18	18	imatinib	KIT	PA10804	3815	0.922
NULL	Nanoscale_Res_Lett_2011_Feb_24_6(1)_169.nxml.txt.nlp	21711685	SENT8	12	12	17	17	l-methionine	zeta	PA450423	9907	0.922
NULL	Iran_J_Neurol_2013_12(4)_129-135.nxml.txt.nlp	24250922	SENT34	9	9	0	0	thrombin	PAR-1	PA451674	2011;2149	0.922
NULL	Int_J_Anal_Chem_2013_Jul_16_2013_419716.nxml.txt.nlp	23956748	SENT6	4	4	31	31	heparin	PF6	PA449855	200162	0.922
NULL	Can_J_Infect_Dis_Med_Microbiol_2014_Nov-Dec_25(6)_327-343.nxml.txt.nlp	25587296	SENT301	10	10	3	3	cyclosporine	CYP3A4	PA449167	1576	0.922
NULL	AMB_Express_2012_Dec_7_2_65.nxml.txt.nlp	23217124	SENT296	17	17	7	7	ethanol	SHF	PA448073	90525	0.922
NULL	Cancer_Metastasis_Rev_2010_Jun_28_29(2)_317-329.nxml.txt.nlp	20422276	SENT427	28	28	13	13	anakinra	JCH	PA10799	3512	0.922
NULL	Clin_Med_Insights_Cardiol_2011_Oct_6_5_103-119.nxml.txt.nlp	22084608	SENT46	0	0	5	5	dronedarone	CYP2C9	PA153619853	1559	0.922
NULL	Pharmaceuticals_(Basel)_2012_Nov_20_5(11)_1236-1264.nxml.txt.nlp	24281308	SENT518	13	13	6	6	trastuzumab	PI3K	PA451743	5290	0.922
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Nov_20_64(Pt_12)_o2370.nxml.txt.nlp	21581342	SENT55	20	20	7	7	ethanol	mol	PA448073	90527	0.922
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Sep_14_67(Pt_10)_o2574.nxml.txt.nlp	22058740	SENT52	23	23	17	17	ethanol	mol	PA448073	90527	0.922
NULL	Core_Evid_2009_Jun_15_4_131-147.nxml.txt.nlp	20694070	SENT153	19	19	9	9	raltegravir	UGT1A1		54658	0.922
NULL	Int_J_Mol_Sci_2014_Oct_21_15(10)_19037-19055.nxml.txt.nlp	25338045	SENT87	0	0	8	8	sulfasalazine	NGC	PA451547	10675	0.922
NULL	Mol_Cancer_2013_Sep_11_12_104.nxml.txt.nlp	24025152	SENT21	26	26	10	10	gemcitabine	STAT3	PA449748	6774	0.922
NULL	Oncotarget_2010_Oct_25_1(7)_497-514.nxml.txt.nlp	21165163	SENT134	19	19	36	36	gefitinib	SRC-3	PA131301952	8202	0.922
NULL	Mol_Pain_2013_Jun_10_9_27.nxml.txt.nlp	23758830	SENT71	9	9	6	6	tetracaine	ASIC3	PA451638	9311	0.922
NULL	Oncol_Rep_2013_Oct_22_30(4)_1535-1541.nxml.txt.nlp	23877481	SENT147	15	15	6	6	etoricoxib	COX2	PA164776853	4513;5743	0.922
NULL	Curr_Neuropharmacol_2012_Jun_10(2)_97-123.nxml.txt.nlp	23204981	SENT198	6	6	10	10	reboxetine	IL-10	PA144614921	3586	0.922
NULL	Cancer_Cell_Int_2013_Jan_15_13_3.nxml.txt.nlp	23320839	SENT101	20	20	15	15	doxorubicin	MRP3	PA449412	8714	0.922
NULL	Curr_Pain_Headache_Rep_2011_Aug_12_15(4)_271-279.nxml.txt.nlp	21479998	SENT43	2	2	14	14	mianserin	CYP2D6	PA134687937	1565	0.922
NULL	Cancer_Res_Treat_2014_Jan_15_46(1)_55-64.nxml.txt.nlp	24520224	SENT167	21	21	16	16	irinotecan	ERCC1	PA450085	2067	0.922
NULL	Ann_Oncol_2013_Apr_31_24(4)_1067-1073.nxml.txt.nlp	23117073	SENT48	6	6	9	9	fosaprepitant	CYP3A4	PA165958390	1576	0.922
NULL	Nat_Genet_2011_Jan_12_43(1)_27-33.nxml.txt.nlp	21151129	SENT176	24	24	4	4	tamoxifen	FOXA1	PA451581	3169	0.922
NULL	Mol_Cancer_2009_Jun_23_8_39.nxml.txt.nlp	19549337	SENT13	12	12	5	5	etoposide	TRAIL	PA449552	8743	0.922
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT201	8	8	18	18	chloroquine	BMP9	PA448948	2658	0.922
NULL	Acta_Orthop_2010_Apr_6_81(2)_263-267.nxml.txt.nlp	20148646	SENT25	5	5	20	20	taurine	Men	PA451590	8178	0.922
NULL	N_Am_J_Med_Sci_2012_Dec_4(12)_648-650.nxml.txt.nlp	23272308	SENT20	10	10	2	2	gentamicin	CRA	PA449753	51747;10903	0.922
NULL	Breast_Cancer_Res_2012_Jul_6_14(4)_R102.nxml.txt.nlp	22770227	SENT73	19	19	26	26	tamoxifen	aromatase	PA451581	1588	0.922
NULL	Apoptosis_2012_Sep_30_17(9)_989-997.nxml.txt.nlp	22460505	SENT56	18	18	46	46	thioridazine	San	PA451666	80218	0.922
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Nov_13_64(Pt_12)_o2320.nxml.txt.nlp	21581296	SENT59	20	20	14	14	ethanol	mol	PA448073	90527	0.922
NULL	Ann_Neurosci_2013_Jan_20(1)_10-12.nxml.txt.nlp	25206002	SENT89	8	8	12	12	glibenclamide	SUR1	PA449782	6833	0.922
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_May_11_67(Pt_6)_o1383.nxml.txt.nlp	21754773	SENT8	16	16	14	14	nimesulide	aromatase	PA137179528	1588	0.922
NULL	Clin_Ophthalmol_2014_Jun_28_8_1241-1252.nxml.txt.nlp	25061271	SENT151	18	18	28	28	latanoprost	BAK	PA164774763	578	0.922
NULL	J_Oncol_2012_Aug_8_2012_635614.nxml.txt.nlp	22927847	SENT329	14	14	21	21	metformin	PI3K	PA450395	5290	0.922
NULL	J_Gen_Physiol_2000_Dec_1_116(6)_769-780.nxml.txt.nlp	11099346	SENT136	32	32	3	3	tetracaine	DAG	PA451638	1605	0.922
NULL	AIDS_Res_Ther_2006_Sep_14_3_21.nxml.txt.nlp	16970827	SENT32	9	9	26	26	efavirenz	CD4	PA449441	920	0.922
NULL	Front_Behav_Neurosci_2014_May_27_8_191.nxml.txt.nlp	24904342	SENT63	18	18	36	36	vasopressin	AVP	PA451858	114548;551	0.922
NULL	BMJ_2013_Feb_5_346_e5793.nxml.txt.nlp	23386361	SENT82	30	30	18	18	warfarin	CYP2C9	PA451906	1559	0.922
NULL	Mol_Cancer_2014_Jan_13_13_7.nxml.txt.nlp	24418169	SENT234	29	29	18	18	sorafenib	STAT3	PA7000	6774	0.922
NULL	Oncotarget_2013_Nov_15_4(11)_1866-1867.nxml.txt.nlp	24272818	SENT29	13	13	7	7	trastuzumab	PIK3CA	PA451743	5290	0.922
NULL	Oncotarget_2011_Dec_20_2(12)_1094-1108.nxml.txt.nlp	22190353	SENT88	18	18	9	9	gemcitabine	MDM2	PA449748	4193	0.922
NULL	Case_Rep_Gastroenterol_2012_Sep_26_6(3)_618-623.nxml.txt.nlp	23139652	SENT96	27	27	2	2	azathioprine	VIII	PA448515	1351	0.922
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT172	14	14	22	22	nutlin-3	MDM2		4193	0.922
NULL	Cancer_Cell_Int_2014_Jul_2_14_59.nxml.txt.nlp	25120382	SENT196	20	20	15	15	metformin	CTR	PA450395	799	0.922
NULL	Chin_J_Cancer_2012_Jun_31(6)_306-314.nxml.txt.nlp	22640627	SENT23	6	6	34	34	rituximab	MUM-1	PA451261	84939	0.922
NULL	J_Headache_Pain_2012_Mar_27_13(2)_103-111.nxml.txt.nlp	22200764	SENT69	4	4	18	18	ethanol	TRPV1	PA448073	7442	0.922
NULL	Pain_Res_Treat_2012_Apr_23_2012_295926.nxml.txt.nlp	22577544	SENT60	28	28	45	45	dicyclomine	ARC	PA164744928	8996;23237	0.922
NULL	Exp_Diabetes_Res_2012_Apr_17_2012_635472.nxml.txt.nlp	22577369	SENT112	7	7	3	3	liraglutide	GLP-1	PA165958364	100125288	0.922
NULL	Case_Rep_Oncol_2014_May_24_7(2)_343-348.nxml.txt.nlp	24987354	SENT79	40	40	15	15	vemurafenib	BRAF	PA165946873	673	0.922
NULL	Diabetes_Care_2011_Mar_17_34(3)_730-733.nxml.txt.nlp	21289232	SENT34	0	0	30	30	pioglitazone	IL-10	PA450970	3586	0.922
NULL	Cancer_Cell_Int_2013_Jun_26_13_64.nxml.txt.nlp	23802572	SENT35	0	0	32	32	curcumin	Bcl-2	PA151958596	596	0.922
NULL	J_Oncol_2010_Aug_24_2010_398564.nxml.txt.nlp	20862373	SENT88	22	22	28	28	sorafenib	BRAF	PA7000	673	0.922
NULL	Br_J_Cancer_2013_Mar_19_108(5)_1079-1091.nxml.txt.nlp	23449353	SENT116	16	16	33	33	docetaxel	PC3	PA449383	57332;7832;5122	0.922
NULL	Cancer_Cell_Int_2013_Mar_4_13_21.nxml.txt.nlp	23497288	SENT27	14	14	10	10	doxorubicin	MRP1	PA449412	4437	0.922
NULL	Cardiol_Res_Pract_2013_Feb_19_2013_195456.nxml.txt.nlp	23533940	SENT67	21	21	9	9	clopidogrel	IPA	PA449053	3160	0.922
NULL	Emerg_Infect_Dis_2011_Oct_17(10)_1917-1920.nxml.txt.nlp	22000371	SENT72	1	1	9	9	bacitracin	OTC	PA448531	5009	0.922
NULL	J_Med_Case_Reports_2011_Feb_14_5_62.nxml.txt.nlp	21320328	SENT136	22	22	9	9	icatibant	C1-INH	PA164749185	710	0.922
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT214	12	12	27	27	curcumin	TRAIL	PA151958596	8743	0.922
NULL	Diabetol_Metab_Syndr_2014_May_18_6_56.nxml.txt.nlp	24860622	SENT165	6	6	26	26	atorvastatin	adiponectin	PA448500	9370	0.922
NULL	Allergy_Asthma_Clin_Immunol_2007_Jun_15_3(2)_70-72.nxml.txt.nlp	20525146	SENT8	11	11	4	4	amoxicillin	DLST	PA448406	1743	0.922
NULL	Cancers_(Basel)_2014_Nov_7_6(4)_2259-2274.nxml.txt.nlp	25386788	SENT102	5	5	28	28	neomycin	CD21	PA450608	1380	0.922
NULL	Cardiovasc_J_Afr_2014_Jun_25(3)_114-117.nxml.txt.nlp	24691795	SENT48	1	1	11	11	heparin	ACT	PA449855	12;11332;9457;641455	0.922
NULL	Clin_Pharmacol_2011_Jun_22_3_13-25.nxml.txt.nlp	22287853	SENT127	22	22	27	27	ketoconazole	ANOVA	PA450146	4858	0.922
NULL	Oncoimmunology_2013_Sep_1_2(9)_e26198.nxml.txt.nlp	24228232	SENT49	18	18	36	36	cisplatin	CD83	PA449014	9308	0.922
NULL	Virulence_2014_Jan_1_5(1)_36-44.nxml.txt.nlp	23774844	SENT140	5	5	0	0	trypsin	PAR2	PA451806	2150;55065;8856	0.922
NULL	Br_J_Cancer_2012_Jan_3_106(1)_6-13.nxml.txt.nlp	22215104	SENT20	1	1	36	36	trastuzumab	HER3	PA451743	2065	0.922
NULL	Nat_Commun_2011_Feb_8_2_190.nxml.txt.nlp	21304519	SENT215	35	35	1	1	indomethacin	PTGER4	PA449982	5734	0.922
NULL	Oncotarget_2012_Sep_20_3(9)_954-987.nxml.txt.nlp	23006971	SENT373	7	7	0	0	metformin	AMPK	PA450395	5563	0.922
NULL	Oncoscience_2014_Mar_25_1(3)_205-215.nxml.txt.nlp	25594013	SENT33	15	15	11	11	doxycycline	EFEMP1	PA449415	2202	0.922
NULL	FEBS_Open_Bio_2014_Jan_6_4_77-89.nxml.txt.nlp	24490132	SENT764	21	21	12	12	ebselen	GDH	PA161660841	51084;2746	0.922
NULL	Crit_Care_2011_Aug_11_15(4)_226.nxml.txt.nlp	21892977	SENT58	28	28	20	20	vasopressin	P2X5	PA451858	5026	0.922
NULL	J_Biomed_Biotechnol_2010_May_13_2010_270985.nxml.txt.nlp	20490265	SENT39	31	31	13	13	neomycin	CEA	PA450608	5670;1087	0.922
NULL	Open_Biochem_J_2011_Sep_23_5_45-51.nxml.txt.nlp	21966325	SENT124	25	25	14	14	diclofenac	JNK	PA449293	5599	0.922
NULL	Arthritis_Res_Ther_2006_Feb_3_8(2)_R43.nxml.txt.nlp	16507142	SENT52	14	14	4	4	fluorescein	CXCL12	PA164746009	6387	0.922
NULL	Biomed_Res_Int_2014_Feb_6_2014_323594.nxml.txt.nlp	24689036	SENT397	11	11	0	0	raloxifene	PC3	PA451221	57332;7832;5122	0.922
NULL	Oncoimmunology_2014_Jan_17_3_e27574.nxml.txt.nlp	24800167	SENT4	24	24	10	10	cyclophosphamide	TH1	PA449165	51497	0.922
NULL	Eur_J_Med_Res_2010_Apr_8_15(4)_145-151.nxml.txt.nlp	20554495	SENT63	27	27	13	13	abacavir	HLA-B	PA448004	3106	0.922
NULL	Front_Oncol_2014_Nov_5_4_281.nxml.txt.nlp	25414829	SENT21	31	31	1	1	afatinib	EGFR	PA165981154	1956	0.922
NULL	Diabetes_Obes_Metab_2010_Jul_12(7)_604-612.nxml.txt.nlp	20590735	SENT29	0	0	10	10	liraglutide	GLP-1	PA165958364	100125288	0.922
NULL	Case_Rep_Oncol_2014_Mar_26_7(1)_204-209.nxml.txt.nlp	24803896	SENT15	4	4	15	15	trabectedin	MRCL	PA165958349	348174	0.922
NULL	Acta_Pharmacol_Sin_2012_May_16_33(5)_682-690.nxml.txt.nlp	22504904	SENT167	24	24	38	38	celecoxib	IL-6	PA448871	3569	0.922
NULL	Arthritis_Res_Ther_2013_Jul_9_15(4)_R73.nxml.txt.nlp	23837669	SENT251	18	18	11	11	colchicine	MSU	PA449092	593	0.922
NULL	Cardiovasc_Diabetol_2010_Nov_25_9_78.nxml.txt.nlp	21106105	SENT148	11	11	17	17	phenylephrine	STZ	PA450935	6484	0.922
NULL	Breast_Cancer_Res_2010_Oct_22_12(Suppl_2)_S1.nxml.txt.nlp	21050422	SENT133	14	14	10	10	erlotinib	EGFR	PA134687924	1956	0.922
NULL	Mol_Vis_2007_Jul_9_13_1083-1093.nxml.txt.nlp	17653053	SENT153	2	2	37	37	minocycline	MCP-3	PA450519	6354	0.922
NULL	Biochimie_2015_Jan_108_40-47.nxml.txt.nlp	25447146	SENT201	9	9	1	1	trypsin	TFP	PA451806	7034	0.922
NULL	Drug_Target_Insights_2013_Aug_19_7_27-34.nxml.txt.nlp	24023511	SENT83	31	31	9	9	azithromycin	P-gp	PA448519	5243	0.922
NULL	Clin_Drug_Investig_2013_Aug_23_33(10)_727-736.nxml.txt.nlp	23975654	SENT172	8	8	22	22	bupropion	CYP2D6	PA448687	1565	0.922
NULL	Int_J_Mol_Sci_2014_Nov_10_15(11)_20607-20637.nxml.txt.nlp	25391045	SENT40	16	16	24	24	atorvastatin	CYP3A4	PA448500	1576	0.922
NULL	Nucl_Recept_Signal_2009_Jan_16_7_e001.nxml.txt.nlp	19240808	SENT417	22	22	2	2	estradiol	SXR	PA449503	8856	0.922
NULL	Oncotarget_2014_Oct_18_5(22)_11604-11619.nxml.txt.nlp	25344099	SENT231	4	4	6	6	cisplatin	RYBP	PA449014	23429	0.922
NULL	Br_J_Haematol_2014_Mar_13_164(1)_811-821.nxml.txt.nlp	24328678	SENT164	14	14	0	0	lenalidomide	Aiolos	PA162363968	22806	0.922
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_29_2013_327629.nxml.txt.nlp	23737827	SENT145	10	10	0	0	azathioprine	TPMT	PA448515	7172	0.922
NULL	Evid_Based_Complement_Alternat_Med_2012_May_22_2012_340787.nxml.txt.nlp	22675379	SENT37	3	3	5	5	fluconazole	S26	PA449653	6231	0.922
NULL	Curr_Med_Chem_2013_Jan_20(3)_438-447.nxml.txt.nlp	23157636	SENT309	6	6	17	17	amisulpride	5-HT7	PA162565877	3363	0.922
NULL	Front_Genet_2014_Jun_2_5_162.nxml.txt.nlp	24917882	SENT997	11	11	6	6	cetuximab	BRAF	PA10040	673	0.922
NULL	Int_J_Hypertens_2011_May_22_2011_346985.nxml.txt.nlp	21747976	SENT84	22	22	9	9	eplerenone	MCP-1	PA164749044	6347	0.922
NULL	Cancers_(Basel)_2011_Apr_1_3(2)_1844-1860.nxml.txt.nlp	24212785	SENT71	36	36	7	7	cetuximab	KRAS	PA10040	3845	0.922
NULL	Iran_J_Pharm_Res_2014_Summer_13(3)_919-926.nxml.txt.nlp	25276192	SENT108	20	20	8	8	doxorubicin	p53	PA449412	7157	0.922
NULL	Breast_Cancer_Res_Treat_2014_Sep_13_147(3)_631-638.nxml.txt.nlp	25216762	SENT42	9	9	16	16	capecitabine	HER-2	PA448771	2064	0.922
NULL	J_Cell_Mol_Med_2013_Jan_10_17(1)_30-54.nxml.txt.nlp	23301832	SENT274	18	18	11	11	2-methoxyestradiol	HIF-1	PA134967247	29072	0.922
NULL	Adv_Appl_Bioinform_Chem_2014_Mar_24_7_1-9.nxml.txt.nlp	24711707	SENT86	6	6	12	12	quinidine	P-gp	PA451209	5243	0.922
NULL	Br_J_Cancer_2004_Mar_8_90(5)_944-949.nxml.txt.nlp	14997187	SENT50	21	21	18	18	fulvestrant	aromatase	PA164747170	1588	0.922
NULL	Mol_Brain_2014_Apr_21_7_28.nxml.txt.nlp	24751148	SENT181	29	29	40	40	minocycline	TLR4	PA450519	7099	0.922
NULL	Curr_Genomics_2013_Nov_14(7)_453-467.nxml.txt.nlp	24396277	SENT322	30	30	15	15	glucose	PCSK1	PA449773	5122	0.922
NULL	Endocrinology_2014_Oct_22_155(10)_3732-3738.nxml.txt.nlp	25051442	SENT123	40	40	25	25	sibutramine	ARC	PA451344	8996;23237	0.922
NULL	Crit_Care_2007_Jun_8_11(3)_215.nxml.txt.nlp	17567927	SENT122	20	20	34	34	isoniazid	MARS	PA450112	4141	0.922
NULL	Breast_Cancer_Res_Treat_2007_Dec_27_106(2)_161-170.nxml.txt.nlp	17260092	SENT249	3	3	6	6	tamoxifen	aromatase	PA451581	1588	0.922
NULL	Mol_Cancer_2010_Nov_2_9_289.nxml.txt.nlp	21044322	SENT173	25	25	7	7	docetaxel	RGS10	PA449383	6001	0.922
NULL	Nat_Med_2012_Jul_18(7)_1118-1122.nxml.txt.nlp	22683780	SENT40	19	19	27	27	crizotinib	HGF	PA165946122	3569;6654;3082	0.922
NULL	Diagn_Pathol_2013_Feb_18_8_27.nxml.txt.nlp	23419122	SENT18	26	26	19	19	gefitinib	EGFR	PA131301952	1956	0.922
NULL	J_Gen_Physiol_2004_Jul_124(1)_1b.nxml.txt.nlp	NULL	SENT1202	31	31	21	21	betaine	SAPK	PA448603	5601	0.922
NULL	Br_J_Cancer_2012_Sep_25_107(7)_1009-1016.nxml.txt.nlp	22948724	SENT83	8	8	29	29	sunitinib	VEGFR2	PA162372840	3791	0.922
NULL	Indian_J_Med_Res_2012_Sep_136(3)_391-403.nxml.txt.nlp	23041732	SENT191	14	14	19	19	gemcitabine	HCC	PA449748	84668	0.922
NULL	Endocr_Relat_Cancer_2014_Apr_21(2)_355-369.nxml.txt.nlp	24481325	SENT10	9	9	19	19	estradiol	GPER	PA449503	2852	0.922
NULL	Behav_Brain_Funct_2009_Jan_15_5_3.nxml.txt.nlp	19146665	SENT264	25	25	10	10	ethanol	P15	PA448073	1030;29107	0.922
NULL	Front_Physiol_2011_Jun_30_2_33.nxml.txt.nlp	21747769	SENT231	20	20	15	15	berberine	KCNQ1	PA165860812	3784	0.922
NULL	Clin_Ophthalmol_2010_Apr_26_4_349-358.nxml.txt.nlp	20463804	SENT45	17	17	33	33	travoprost	C-1	PA164781371	5203	0.922
NULL	Breast_Cancer_Res_2007_Jun_4_9(3)_207.nxml.txt.nlp	17561991	SENT268	26	26	6	6	trastuzumab	HER-2	PA451743	2064	0.922
NULL	Cardiovasc_J_Afr_2013_Apr_24(3)_58-65.nxml.txt.nlp	23736127	SENT82	20	20	16	16	losartan	AT1	PA450268	9197;185	0.922
NULL	Oncotarget_2012_Oct_3_3(10)_1182-1193.nxml.txt.nlp	23045412	SENT158	19	19	32	32	imatinib	SIRT1	PA10804	23411	0.922
NULL	Endocr_Connect_2012_Jun_8_1(1)_1-12.nxml.txt.nlp	23781298	SENT253	4	4	15	15	fenofibrate	ATROGIN1	PA449594	114907	0.922
NULL	Oncogene_2014_Aug_21_33(34)_4316-4329.nxml.txt.nlp	24362530	SENT44	10	10	6	6	epirubicin	FOXM1	PA449476	2305	0.922
NULL	Neuropsychopharmacology_2009_Dec_12_34(13)_2675-2690.nxml.txt.nlp	19675535	SENT292	15	15	6	6	haloperidol	c-fos	PA449841	2353	0.922
NULL	Core_Evid_2011_Mar_17_6_31-42.nxml.txt.nlp	21468241	SENT57	19	19	6	6	thrombin	P2Y12	PA451674	64805	0.922
NULL	Oncogene_2009_Dec_3_28(48)_4237-4248.nxml.txt.nlp	19734937	SENT53	21	21	26	26	thrombin	PAR1	PA451674	79581;2149	0.922
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R91.nxml.txt.nlp	22541814	SENT239	6	6	16	16	pp2	HO-1		3162	0.922
NULL	Oncol_Lett_2013_Feb_5_5(2)_521-526.nxml.txt.nlp	23420529	SENT131	23	23	5	5	cetuximab	EGFR	PA10040	1956	0.922
NULL	Oxid_Med_Cell_Longev_2012_Jan_19_2012_390678.nxml.txt.nlp	22315655	SENT114	4	4	18	18	gliclazide	NAC	PA10892	22861	0.922
NULL	Br_J_Cancer_2009_Nov_3_101(9)_1555-1564.nxml.txt.nlp	19826422	SENT164	3	3	17	17	tamoxifen	TRAIL	PA451581	8743	0.922
NULL	Oncotarget_2013_Nov_22_5(4)_933-943.nxml.txt.nlp	24659749	SENT90	18	18	3	3	nutlin-3	p53		7157	0.922
NULL	J_Cancer_2013_Jan_11_4(2)_117-132.nxml.txt.nlp	23386910	SENT286	22	22	14	14	trastuzumab	HER-2	PA451743	2064	0.922
NULL	Arthritis_Rheumatol_2014_Jun_27_66(6)_1574-1582.nxml.txt.nlp	24577881	SENT167	16	16	2	2	hydralazine	CD4	PA449894	920	0.922
NULL	Arthritis_Res_Ther_2013_Nov_28_15(6)_R202.nxml.txt.nlp	24283517	SENT188	9	9	33	33	curcumin	p65	PA151958596	5970	0.922
NULL	J_Cell_Biol_2000_Dec_25_151(7)_1381-1390.nxml.txt.nlp	11134068	SENT683	13	13	6	6	etoposide	53BP1	PA449552	7158	0.922
NULL	Int_J_Biol_Sci_2013_Dec_17_10(1)_64-72.nxml.txt.nlp	24391452	SENT60	17	17	24	24	verapamil	5-HT2A	PA451868	3356	0.922
NULL	Ann_Surg_Treat_Res_2014_Apr_25_86(4)_220-225.nxml.txt.nlp	24783183	SENT7	0	0	14	14	sunitinib	KIT	PA162372840	3815	0.922
NULL	Part_Fibre_Toxicol_2013_Aug_13_10_39.nxml.txt.nlp	23937860	SENT32	24	24	2	2	anakinra	IL-8	PA10799	3576	0.922
NULL	Cell_Death_Dis_2013_Sep_5_4(9)_e791.nxml.txt.nlp	24008735	SENT121	23	23	6	6	gemcitabine	14-3-3	PA449748	10971	0.922
NULL	Paediatr_Drugs_2013_Apr_20_15(2)_119-131.nxml.txt.nlp	23512128	SENT315	14	14	4	4	pantoprazole	CYP2C19	PA450774	1557	0.922
NULL	Ann_Clin_Microbiol_Antimicrob_2007_Nov_12_6_15.nxml.txt.nlp	17997852	SENT114	3	3	5	5	metronidazole	ANOVA	PA450484	4858	0.922
NULL	Breast_Cancer_Res_2007_Mar_2_9(2)_205.nxml.txt.nlp	NULL	SENT45	12	12	24	24	lapatinib	HER-2	PA152241907	2064	0.922
NULL	Br_J_Pharmacol_2012_Apr_165(7)_2191-2202.nxml.txt.nlp	21958009	SENT164	6	6	9	9	ketanserin	5-HT2A	PA131053734	3356	0.922
NULL	Breast_Cancer_Res_Treat_2013_May_12_139(1)_107-113.nxml.txt.nlp	23580070	SENT4	5	5	2	2	trastuzumab	Hsp90	PA451743	3320	0.922
NULL	Br_J_Cancer_2006_Feb_13_94(3)_407-426.nxml.txt.nlp	16434996	SENT264	20	20	7	7	genistein	BRCA1	PA165109660	672	0.922
NULL	Ann_Hematol_2012_Sep_1_91(9)_1333-1343.nxml.txt.nlp	22547053	SENT187	17	17	8	8	vorinostat	DAC	PA164748224	13	0.922
NULL	J_Headache_Pain_2013_Aug_13_14(1)_71.nxml.txt.nlp	23941062	SENT117	8	8	16	16	napqi	TRPA1		8989	0.922
NULL	Clin_Med_Insights_Womens_Health_2013_Jan_22_6_1-11.nxml.txt.nlp	24665209	SENT43	9	9	15	15	letrozole	aromatase	PA450196	1588	0.922
NULL	Br_J_Cancer_2009_Sep_15_101(6)_875-878.nxml.txt.nlp	19672259	SENT103	24	24	30	30	tamoxifen	aromatase	PA451581	1588	0.922
NULL	BMB_Rep_2013_Jan_46(1)_59-64.nxml.txt.nlp	23351386	SENT29	3	3	9	9	auranofin	STAT3	PA448510	6774	0.922
NULL	Arthritis_Res_Ther_2013_Jan_8_15(1)_R5.nxml.txt.nlp	23298463	SENT118	0	0	7	7	tamoxifen	MMP13	PA451581	4322	0.922
NULL	Case_Rep_Genet_2014_Jan_22_2014_413743.nxml.txt.nlp	24627811	SENT64	11	11	48	48	warfarin	VKORC1	PA451906	79001	0.922
NULL	Front_Physiol_2013_May_15_4_103.nxml.txt.nlp	23720630	SENT63	0	0	13	13	simvastatin	ADP	PA451363	23038	0.922
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2010_Aug_3_3_43-51.nxml.txt.nlp	22879786	SENT84	8	8	22	22	gemfibrozil	CYP2C8	PA449750	1558	0.922
NULL	Front_Neurosci_2012_May_30_6_77.nxml.txt.nlp	22661925	SENT262	11	11	24	24	rolipram	DCX	PA153906323	1641	0.922
NULL	Mol_Cancer_2007_Oct_11_6_63.nxml.txt.nlp	17931419	SENT81	20	20	9	9	cetuximab	EGFR	PA10040	1956	0.922
NULL	J_Gynecol_Oncol_2013_Jan_8_24(1)_66-82.nxml.txt.nlp	23346316	SENT270	3	3	24	24	everolimus	aromatase	PA164746311	1588	0.922
NULL	Curr_Neuropharmacol_2013_Jul_11(4)_338-378.nxml.txt.nlp	24381528	SENT698	6	6	21	21	curcumin	Bcl-2	PA151958596	596	0.922
NULL	Biochem_Res_Int_2012_May_9_2012_290971.nxml.txt.nlp	22649731	SENT38	6	6	21	21	staurosporine	FFR	PA165109623	738	0.922
NULL	Crit_Care_2011_Aug_11_15(4)_226.nxml.txt.nlp	21892977	SENT58	8	8	20	20	vasopressin	P2X5	PA451858	5026	0.922
NULL	Front_Neurosci_2012_Feb_8_6_10.nxml.txt.nlp	22347156	SENT211	13	13	6	6	allopregnanolone	TSPO	PA142320763	706	0.922
NULL	J_Cell_Biol_1977_May_1_73(2)_366-381.nxml.txt.nlp	858741	SENT7	16	16	25	25	vasopressin	SON	PA451858	6651	0.922
NULL	Eur_J_Clin_Pharmacol_2012_Jan_7_68(1)_55-64.nxml.txt.nlp	21735164	SENT230	16	16	8	8	oxycodone	CYP2D6	PA450741	1565	0.922
NULL	Med_Sci_Monit_2012_Jan_1_18(1)_RA1-RA11.nxml.txt.nlp	22207127	SENT215	5	5	19	19	raloxifene	OPG	PA451221	690	0.922
NULL	Br_J_Cancer_2004_Mar_22_90(6)_1285-1292.nxml.txt.nlp	15026814	SENT146	22	22	13	13	doxorubicin	p53	PA449412	7157	0.922
NULL	F1000Res_2013_Oct_10_2_134.nxml.txt.nlp	24358901	SENT299	11	11	15	15	vemurafenib	BRAF	PA165946873	673	0.922
NULL	Ann_Hematol_2011_May_12_90(5)_557-568.nxml.txt.nlp	20938660	SENT132	13	13	5	5	plerixafor	CD34	PA165958410	947	0.922
NULL	Ecancermedicalscience_2009_Sep_24_3_153.nxml.txt.nlp	22276017	SENT58	17	17	11	11	oxaliplatin	ERCC1	PA131285527	2067	0.922
NULL	J_Korean_Med_Sci_2013_Apr_27_28(4)_527-533.nxml.txt.nlp	23580227	SENT150	15	15	21	21	genistein	TRAIL	PA165109660	8743	0.922
NULL	Clinics_(Sao_Paulo)_2013_May_68(5)_694-701.nxml.txt.nlp	23778405	SENT23	24	24	9	9	curcumin	survivin	PA151958596	332	0.922
NULL	Cancers_(Basel)_2011_Apr_1_3(2)_1861-1876.nxml.txt.nlp	24212786	SENT973	11	11	3	3	erlotinib	KRAS	PA134687924	3845	0.922
NULL	Breast_Cancer_Res_2006_Oct_24_8(5)_R59.nxml.txt.nlp	17062128	SENT15	13	13	28	28	urokinase	CD44	PA451836	960	0.922
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT90	5	5	12	12	resveratrol	TRAIL		8743	0.922
NULL	Dermatoendocrinol_2013_Apr_1_5(2)_252-263.nxml.txt.nlp	24194965	SENT84	4	4	15	15	metformin	MATE1	PA450395	55244	0.922
NULL	Cardiol_Res_Pract_2011_Apr_26_2011_874802.nxml.txt.nlp	21577272	SENT78	0	0	8	8	dronedarone	CYP3A4	PA153619853	1576	0.922
NULL	Aging_Cell_2007_Aug_6(4)_577-591.nxml.txt.nlp	17578512	SENT324	10	10	1	1	phenol	HP1	PA450913	23468	0.922
NULL	Indian_J_Dermatol_2010_Oct-Dec_55(4)_316-324.nxml.txt.nlp	21430881	SENT165	16	16	9	9	pentoxifylline	ENL	PA450864	4298	0.922
NULL	J_Cell_Mol_Med_2014_Oct_11_18(10)_2031-2043.nxml.txt.nlp	25109475	SENT344	3	3	6	6	valsartan	AMPK	PA451848	5563	0.922
NULL	Eur_J_Cancer_2014_Sep_50(14)_2367-2374.nxml.txt.nlp	25027307	SENT135	19	19	28	28	tamoxifen	aromatase	PA451581	1588	0.922
NULL	Cell_Death_Dis_2014_Mar_13_5(3)_e1113.nxml.txt.nlp	24625972	SENT351	18	18	8	8	bleomycin	BI-1	PA448645	7009	0.922
NULL	Mol_Biol_Rep_2013_May_11_40(8)_5013-5026.nxml.txt.nlp	23666059	SENT229	11	11	5	5	resveratrol	MDM2		4193	0.922
NULL	Br_J_Clin_Pharmacol_2013_Apr_10_75(4)_979-989.nxml.txt.nlp	22882281	SENT30	0	0	6	6	exenatide	GLP-1	PA164749238	100125288	0.922
NULL	Avicenna_J_Phytomed_2013_Autumn_3(4)_302-312.nxml.txt.nlp	25050287	SENT60	3	3	12	12	ethanol	hole	PA448073	80757	0.922
NULL	Hum_Reprod_Update_2008_Sep_26_Nov-Dec_14(6)_605-621.nxml.txt.nlp	18820005	SENT247	14	14	5	5	letrozole	aromatase	PA450196	1588	0.922
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT89	14	14	4	4	pp2	PP2		4888	0.922
NULL	Breast_Cancer_Res_2012_Nov_26_14(6)_R150.nxml.txt.nlp	23181561	SENT46	10	10	4	4	trastuzumab	ERBB2	PA451743	2064	0.922
NULL	Front_Immunol_2013_Nov_7_4_360.nxml.txt.nlp	24223576	SENT23	5	5	0	0	imiquimod	IRF5	PA449972	3663	0.922
NULL	Mol_Cancer_2014_Jan_15_13_9.nxml.txt.nlp	24428911	SENT114	24	24	18	18	gefitinib	EGFR	PA131301952	1956	0.922
NULL	Oncol_Lett_2014_Jan_29_7(1)_183-188.nxml.txt.nlp	24348845	SENT169	10	10	0	0	cisplatin	PDCD4	PA449014	27250	0.922
NULL	Mol_Cancer_2008_Mar_26_7_27.nxml.txt.nlp	18366759	SENT76	6	6	10	10	etoposide	p53	PA449552	7157	0.922
NULL	Anal_Bioanal_Chem_2011_Sep_14_401(4)_1109-1125.nxml.txt.nlp	21755271	SENT146	9	9	3	3	morphine	PEBP	PA450550	5037	0.922
NULL	J_Cell_Biol_1998_Jan_26_140(2)_335-345.nxml.txt.nlp	9442109	SENT216	15	15	1	1	chloroquine	NHE	PA448948	285335	0.922
NULL	Front_Oncol_2013_Aug_5_3_195.nxml.txt.nlp	23936763	SENT54	6	6	4	4	dasatinib	DDR2	PA162372878	4921	0.922
NULL	Oncotarget_2014_Aug_29_5(19)_8947-8958.nxml.txt.nlp	25333254	SENT138	6	6	1	1	plerixafor	CXCR7	PA165958410	57007	0.922
NULL	Int_J_Breast_Cancer_2012_May_8_2012_764570.nxml.txt.nlp	22645687	SENT30	20	20	11	11	trastuzumab	aromatase	PA451743	1588	0.922
NULL	J_Am_Heart_Assoc_2013_Dec_19_2(6)_e000355.nxml.txt.nlp	24190878	SENT250	14	14	3	3	isoproterenol	HK2	PA450121	3796;3099;29911;3741	0.922
NULL	Br_J_Cancer_2003_Mar_10_88(5)_788-795.nxml.txt.nlp	12618891	SENT128	10	10	39	39	bosentan	FasL	PA10034	356	0.922
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Apr_17_6_43-57.nxml.txt.nlp	24833916	SENT122	3	3	14	14	everolimus	aromatase	PA164746311	1588	0.922
NULL	Breast_Cancer_Res_Treat_2013_Oct_16_142(1)_89-99.nxml.txt.nlp	24129974	SENT185	8	8	23	23	pertuzumab	aromatase		1588	0.922
NULL	Nat_Genet_2011_Feb_26_43(2)_117-120.nxml.txt.nlp	21186350	SENT25	40	40	29	29	metformin	AMPK	PA450395	5563	0.922
NULL	Breast_Cancer_Res_2007_Oct_26_9(5)_R74.nxml.txt.nlp	17963511	SENT41	17	17	3	3	trastuzumab	HER2	PA451743	2064	0.922
NULL	J_Mol_Med_2008_Sep_4_86(9)_1045-1056.nxml.txt.nlp	18600309	SENT196	9	9	0	0	salmeterol	MKP-1	PA451300	1843	0.922
NULL	Chin_J_Cancer_2012_Feb_31(2)_110-118.nxml.txt.nlp	22098951	SENT201	12	12	7	7	imatinib	P-gp	PA10804	5243	0.922
NULL	Case_Rep_Endocrinol_2014_Feb_10_2014_479641.nxml.txt.nlp	24660072	SENT61	18	18	7	7	cinacalcet	PTH	PA164776671	5741	0.921
NULL	Pharmaceuticals_(Basel)_2013_Mar_14_6(3)_295-319.nxml.txt.nlp	23894227	SENT196	37	37	14	14	trypsin	PC3	PA451806	57332;7832;5122	0.921
NULL	Arthritis_Res_Ther_2009_Aug_28_11(4)_R131.nxml.txt.nlp	19715572	SENT132	9	9	14	14	rituximab	CD19	PA451261	930	0.921
NULL	J_Cell_Mol_Med_2014_Dec_9_18(12)_2425-2436.nxml.txt.nlp	25297942	SENT196	31	31	1	1	cisplatin	HOTAIR	PA449014	100124700	0.921
NULL	Gut_Liver_2011_Jun_24_5(2)_160-164.nxml.txt.nlp	21814595	SENT26	4	4	15	15	meperidine	ESD	PA450369	2098	0.921
NULL	Endocr_Relat_Cancer_2014_Apr_21(2)_355-369.nxml.txt.nlp	24481325	SENT10	9	9	15	15	estradiol	GPER	PA449503	2852	0.921
NULL	Mol_Cancer_2014_Jan_13_13_7.nxml.txt.nlp	24418169	SENT40	27	27	12	12	sorafenib	STAT3	PA7000	6774	0.921
NULL	Neuropsychopharmacology_2009_Jul_25_34(8)_1968-1978.nxml.txt.nlp	19322168	SENT258	10	10	35	35	clozapine	PI3K	PA449061	5290	0.921
NULL	Crit_Care_2009_Mar_13_13(Suppl_1)_P406.nxml.txt.nlp	NULL	SENT4	8	8	19	19	clonidine	UROD	PA449051	7389	0.921
NULL	Diabetes_2013_Oct_17_62(10)_3404-3417.nxml.txt.nlp	23835326	SENT300	15	15	0	0	nadh	PDH	PA164755085	54704	0.921
NULL	J_Hematol_Oncol_2010_Mar_13_3_10.nxml.txt.nlp	20226083	SENT106	31	31	22	22	gemcitabine	RRM1	PA449748	6240	0.921
NULL	Mol_Cancer_2010_May_26_9_123.nxml.txt.nlp	20504344	SENT165	14	14	19	19	fludarabine	p53	PA449655	7157	0.921
NULL	J_Gastroenterol_2014_Sep_25_49(8)_1253-1263.nxml.txt.nlp	24065124	SENT286	13	13	3	3	ribavirin	ITPA	PA451241	3704	0.921
NULL	J_Biol_Eng_2013_May_29_7_14.nxml.txt.nlp	23718629	SENT269	34	34	10	10	nadh	FBA	PA164755085	26273	0.921
NULL	Drugs_Context_2012_Nov_19_2012_212242.nxml.txt.nlp	24432031	SENT438	3	3	7	7	vemurafenib	BRAF	PA165946873	673	0.921
NULL	Mol_Vis_2012_Jun_22_18_1696-1700.nxml.txt.nlp	22773907	SENT90	20	20	14	14	colchicine	MDR1	PA449092	5243	0.921
NULL	Acta_Pharmacol_Sin_2011_Nov_10_32(11)_1402-1410.nxml.txt.nlp	21986579	SENT203	40	40	30	30	curcumin	p27	PA151958596	5715;10534	0.921
NULL	Open_Biomed_Eng_J_2011_Jan_19_5_1-7.nxml.txt.nlp	21625374	SENT66	29	29	3	3	metformin	EGI	PA450395	1957	0.921
NULL	Oncotarget_2014_Jun_6_5(12)_4060-4070.nxml.txt.nlp	24938183	SENT11	19	19	11	11	vemurafenib	BRAF	PA165946873	673	0.921
NULL	Chin_J_Cancer_2012_Jun_31(6)_281-286.nxml.txt.nlp	22507220	SENT104	22	22	15	15	cisplatin	XRCC1	PA449014	7515	0.921
NULL	Breast_Cancer_Res_2010_Oct_22_12(Suppl_2)_S1.nxml.txt.nlp	21050422	SENT124	29	29	12	12	cetuximab	TRN	PA10040	3842	0.921
NULL	Trials_2013_Aug_19_14_262.nxml.txt.nlp	23958271	SENT64	18	18	1	1	pentoxifylline	COPE	PA450864	11316	0.921
NULL	Acta_Pharmacol_Sin_2013_Feb_12_34(2)_255-261.nxml.txt.nlp	23147557	SENT138	38	38	27	27	pioglitazone	PTPRD	PA450970	5789	0.921
NULL	Exp_Ther_Med_2014_Jun_31_7(6)_1647-1652.nxml.txt.nlp	24926360	SENT29	0	0	29	29	fluvastatin	UII	PA449688	10911	0.921
NULL	J_Cell_Biol_2002_Jun_24_157(7)_1151-1160.nxml.txt.nlp	12082077	SENT161	8	8	2	2	trypsin	COX	PA451806	1351	0.921
NULL	Front_Endocrinol_(Lausanne)_2013_Nov_11_4_166.nxml.txt.nlp	24273531	SENT245	20	20	2	2	losartan	ANG	PA450268	283	0.921
NULL	Biologics_2014_Apr_7_8_141-153.nxml.txt.nlp	24741293	SENT199	31	31	22	22	abatacept	IL-6	PA164747080	3569	0.921
NULL	J_Biomed_Sci_2012_Nov_21_19(1)_99.nxml.txt.nlp	23170833	SENT125	10	10	4	4	atorvastatin	CXCR4	PA448500	7852	0.921
NULL	Balkan_J_Med_Genet_2012_Dec_22_15(Suppl)_67-69.nxml.txt.nlp	24052747	SENT55	35	35	17	17	ribavirin	OASL	PA451241	8638	0.921
NULL	Cancer_Manag_Res_2013_Nov_21_5_387-400.nxml.txt.nlp	24294007	SENT82	29	29	8	8	panitumumab	KRAS	PA162373091	3845	0.921
NULL	Braz_J_Med_Biol_Res_2011_Dec_9_45(1)_13-19.nxml.txt.nlp	22147192	SENT56	25	25	5	5	isoflurane	P28	PA450106	9446;7802;9527	0.921
NULL	J_Asthma_Allergy_2012_Sep_17_5_51-59.nxml.txt.nlp	23055753	SENT32	29	29	13	13	tetracycline	CC10	PA451640	7356	0.921
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT58	25	25	7	7	pertuzumab	EGFR		1956	0.921
NULL	Oncogene_2013_Sep_26_32(39)_10_1038_onc_2012_491.nxml.txt.nlp	23108394	SENT79	15	15	9	9	epirubicin	BRIP1	PA449476	64979;83990	0.921
NULL	J_Inflamm_(Lond)_2004_Sep_30_1_3.nxml.txt.nlp	15813980	SENT89	5	5	8	8	tranilast	AT1	PA131890628	9197;185	0.921
NULL	ScientificWorldJournal_2014_Dec_9_2014_808320.nxml.txt.nlp	25548793	SENT73	25	25	20	20	argatroban	RAC	PA164745516	207	0.921
NULL	Cancers_(Basel)_2014_Nov_14_6(4)_2275-2295.nxml.txt.nlp	25405526	SENT201	17	17	28	28	cyclophosphamide	CHOP	PA449165	1649	0.921
NULL	Evid_Based_Complement_Alternat_Med_2012_Dec_17_2012_857123.nxml.txt.nlp	23365602	SENT200	6	6	0	0	capsaicin	TRPV1	PA448776	7442	0.921
NULL	An_Bras_Dermatol_2013_Jan-Feb_88(1)_117-120.nxml.txt.nlp	23539016	SENT41	39	39	43	43	cyclosporine	TNF-alpha	PA449167	7124	0.921
NULL	Breast_Cancer_Res_Treat_2007_Oct_27_105(Suppl_1)_19-29.nxml.txt.nlp	17333340	SENT39	13	13	1	1	aminoglutethimide	aromatase	PA448375	1588	0.921
NULL	Cancer_Manag_Res_2011_Aug_10_3_273-285.nxml.txt.nlp	21931501	SENT145	9	9	31	31	pazopanib	IFN	PA165291492	3439	0.921
NULL	Exp_Diabetes_Res_2012_Oct_19_2012_628978.nxml.txt.nlp	22028701	SENT219	4	4	12	12	oxygen	ROS	PA450744	6098	0.921
NULL	Clin_Pharmacol_2011_Jun_22_3_13-25.nxml.txt.nlp	22287853	SENT119	22	22	0	0	diltiazem	ANOVA	PA449334	4858	0.921
NULL	Br_J_Cancer_2012_May_8_106(10)_1638-1647.nxml.txt.nlp	22498643	SENT59	5	5	36	36	deferoxamine	c-Myc	PA164746490	4609	0.921
NULL	J_Invest_Dermatol_2015_Feb_9_135(2)_389-399.nxml.txt.nlp	25184961	SENT269	2	2	21	21	rosiglitazone	STAT3	PA451283	6774	0.921
NULL	Oncologist_2010_Aug_29_15(8)_799-809.nxml.txt.nlp	20671105	SENT185	40	40	12	12	capecitabine	HER-2	PA448771	2064	0.921
NULL	Nat_Biotechnol_2010_Mar_14_28(3)_249-255.nxml.txt.nlp	20160716	SENT72	4	4	21	21	deferoxamine	HIF1	PA164746490	3091	0.921
NULL	Mol_Syst_Biol_2009_Jul_28_5_288.nxml.txt.nlp	19638969	SENT179	31	31	23	23	resveratrol	HuR		1994	0.921
NULL	Orphanet_J_Rare_Dis_2014_Dec_10_9(1)_180.nxml.txt.nlp	NULL	SENT266	26	26	38	38	glucosamine	HGSNAT	PA164747613	138050	0.921
NULL	Front_Neurosci_2014_Jun_3_8_128.nxml.txt.nlp	24917782	SENT145	32	32	8	8	ethanol	MC3R	PA448073	4159	0.921
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2675-2684.nxml.txt.nlp	24129246	SENT315	22	22	12	12	etoposide	KSR1	PA449552	8844	0.921
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Oct_31_65(Pt_11)_o2963.nxml.txt.nlp	21578534	SENT47	20	20	6	6	ethanol	mol	PA448073	90527	0.921
NULL	Hum_Genomics_2012_Nov_17_6(1)_23.nxml.txt.nlp	23158014	SENT97	13	13	31	31	cisplatin	PTEN	PA449014	5728	0.921
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1013.nxml.txt.nlp	24457957	SENT96	8	8	13	13	orlistat	NOXA	PA164776864	5366	0.921
NULL	Case_Rep_Neurol_Med_2013_Jul_1_2013_451206.nxml.txt.nlp	23936696	SENT48	12	12	6	6	diltiazem	CYP3A4	PA449334	1576	0.921
NULL	Cell_Cycle_2013_Dec_15_12(24)_3791-3803.nxml.txt.nlp	24107631	SENT59	8	8	20	20	doxorubicin	YB-1	PA449412	4904	0.921
NULL	Mol_Cancer_2009_Mar_6_8_17.nxml.txt.nlp	19267923	SENT37	23	23	1	1	l-glutamine	PC-3	PA10090	692094	0.921
NULL	Hum_Genomics_2010_Apr_1_4(4)_238-249.nxml.txt.nlp	20511137	SENT37	19	19	6	6	carvedilol	UGT1A1	PA448817	54658	0.921
NULL	Oncotarget_2011_Aug_30_2(8)_610-626.nxml.txt.nlp	21881167	SENT202	37	37	15	15	doxorubicin	Raf-1	PA449412	5894	0.921
NULL	ScientificWorldJournal_2012_Mar_12_2012_527347.nxml.txt.nlp	22536142	SENT65	14	14	4	4	heparin	CR1	PA449855	1378	0.921
NULL	Evid_Based_Complement_Alternat_Med_2013_May_26_2013_161628.nxml.txt.nlp	23781255	SENT253	2	2	12	12	sorafenib	MEK1	PA7000	5604	0.921
NULL	Springerplus_2014_Nov_6_3_661.nxml.txt.nlp	25485197	SENT73	12	12	9	9	montelukast	CysLT1	PA450546	10800	0.921
NULL	Breast_Cancer_Res_2007_Dec_17_9(6)_R87.nxml.txt.nlp	18086299	SENT154	3	3	8	8	trastuzumab	PTEN	PA451743	5728	0.921
NULL	Trials_2012_Aug_31_13_156.nxml.txt.nlp	22937736	SENT56	15	15	4	4	azithromycin	BEST	PA448519	7439	0.921
NULL	Arthritis_Res_Ther_2008_Jan_7_10(1)_R1.nxml.txt.nlp	18179697	SENT176	9	9	20	20	oxaliplatin	IFN	PA131285527	3439	0.921
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_127043.nxml.txt.nlp	23227093	SENT217	24	24	16	16	lovastatin	RYR	PA450272	6261	0.921
NULL	Cancer_Cell_Int_2014_Jul_2_14_59.nxml.txt.nlp	25120382	SENT197	20	20	15	15	metformin	CTR	PA450395	799	0.921
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT222	6	6	16	16	metformin	EGFR	PA450395	1956	0.921
NULL	Cardiovasc_Diabetol_2013_Mar_4_12_42.nxml.txt.nlp	23452502	SENT228	5	5	26	26	isoflurane	GLP1	PA450106	100125288;2641	0.921
NULL	Diabetes_Care_2008_Jul_31(7)_1427-1432.nxml.txt.nlp	18390799	SENT190	16	16	3	3	metformin	RBP4	PA450395	5433;5950	0.921
NULL	N_Am_J_Med_Sci_2013_Jul_5(7)_432-437.nxml.txt.nlp	24020054	SENT63	8	8	20	20	bleomycin	CHOP	PA448645	1649	0.921
NULL	Aging_(Albany_NY)_2011_Jan_18_3(1)_33-43.nxml.txt.nlp	21248371	SENT120	4	4	17	17	zinc	HIPK2	PA451956	28996	0.921
NULL	Clin_Pediatr_Endocrinol_2006_Aug_2_15(3)_101-107.nxml.txt.nlp	24790329	SENT63	14	14	28	28	alendronate	PTH	PA448082	5741	0.921
NULL	J_Breast_Cancer_2014_Sep_30_17(3)_287-290.nxml.txt.nlp	25320628	SENT66	11	11	2	2	doxorubicin	HIF-1	PA449412	29072	0.921
NULL	Oncotarget_2013_Aug_21_4(9)_1484-1495.nxml.txt.nlp	23986086	SENT160	33	33	20	20	metformin	PIK3CA	PA450395	5290	0.921
NULL	J_Thorac_Oncol_2014_Jun_30_9(6)_775-783.nxml.txt.nlp	24828661	SENT12	0	0	4	4	crizotinib	Met	PA165946122	79811	0.921
NULL	Diabetes_2011_Jun_21_60(6)_1705-1715.nxml.txt.nlp	21521872	SENT194	20	20	0	0	doxycycline	Bcl-2	PA449415	596	0.921
NULL	Breast_Cancer_Res_2004_Jun_29_6(5)_R488-R498.nxml.txt.nlp	15318931	SENT175	28	28	21	21	estradiol	UGT2B15	PA449503	7366	0.921
NULL	Brain_Res_2011_Mar_25_1382(C)_29-36.nxml.txt.nlp	21276431	SENT122	45	45	4	4	ketanserin	5-HT2A	PA131053734	3356	0.921
NULL	J_Invest_Dermatol_2012_Mar_15_132(3)_896-905.nxml.txt.nlp	22170491	SENT90	1	1	16	16	fluorescein	CD19	PA164746009	930	0.921
NULL	Br_J_Cancer_2003_Jun_16_88(12)_1963-1970.nxml.txt.nlp	12799644	SENT200	31	31	1	1	gemcitabine	TK2	PA449748	7084	0.921
NULL	Pain_Res_Treat_2011_Aug_14_2011_864605.nxml.txt.nlp	22110933	SENT128	9	9	22	22	duloxetine	PLP	PA10066	25824;5744	0.921
NULL	Exp_Ther_Med_2013_Aug_20_6(2)_355-360.nxml.txt.nlp	24137188	SENT10	20	20	0	0	docetaxel	CEA	PA449383	5670;1087	0.921
NULL	Front_Mol_Neurosci_2013_Apr_10_6_7.nxml.txt.nlp	23596389	SENT415	15	15	4	4	furosemide	KCC2	PA449719	57468	0.921
NULL	Front_Hum_Neurosci_2010_Nov_2_4_187.nxml.txt.nlp	21103019	SENT31	40	40	15	15	carbachol	gamma	PA448784	9913	0.921
NULL	Open_Biol_2014_May_4(5)_140065.nxml.txt.nlp	24850914	SENT147	22	22	3	3	bortezomib	USP15	PA10252	9958	0.921
NULL	J_Cell_Biol_1988_Dec_1_107(6)_2293-2305.nxml.txt.nlp	2461949	SENT18	13	13	25	25	heparin	p30	PA449855	201161	0.921
NULL	Pharmaceuticals_(Basel)_2011_Jun_14_4(6)_804-821.nxml.txt.nlp	23997653	SENT134	7	7	16	16	ethanol	OX1R	PA448073	3061	0.921
NULL	Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.nxml.txt.nlp	24736980	SENT7	8	8	3	3	rosuvastatin	OATP1B1	PA134308647	10599	0.921
NULL	Eur_J_Clin_Pharmacol_2012_Sep_15_68(9)_1267-1274.nxml.txt.nlp	22418828	SENT180	15	15	38	38	pantoprazole	CYP2C19	PA450774	1557	0.921
NULL	J_Cell_Mol_Med_2015_Jan_30_19(1)_210-226.nxml.txt.nlp	25266063	SENT282	4	4	17	17	forskolin	EP4	PA146096022	5734	0.921
NULL	Oncogene_2014_Feb_6_33(6)_713-723.nxml.txt.nlp	23435429	SENT7	13	13	9	9	etoposide	BRCA1	PA449552	672	0.921
NULL	Cell_Cycle_2012_Nov_1_11(21)_3983-3996.nxml.txt.nlp	22987153	SENT142	33	33	10	10	cisplatin	EXO1	PA449014	9156	0.921
NULL	Nat_Commun_2014_Aug_6_5_4602.nxml.txt.nlp	25098764	SENT62	12	12	1	1	chloroquine	HGK	PA448948	9448	0.921
NULL	J_Mol_Med_2008_Jul_2_86(7)_747-759.nxml.txt.nlp	18246321	SENT467	29	29	4	4	curcumin	NF-kappaB	PA151958596	4790	0.921
NULL	Pain_Res_Treat_2013_Jan_30_2013_217864.nxml.txt.nlp	23431433	SENT77	17	17	6	6	amiloride	NHE	PA448368	285335	0.921
NULL	Oncogene_2010_Sep_9_29(36)_5048-5060.nxml.txt.nlp	20639907	SENT73	4	4	12	12	cisplatin	TRAIL	PA449014	8743	0.921
NULL	Neural_Plast_2007_Jun_19_2007_52908.nxml.txt.nlp	17641734	SENT188	11	11	8	8	rimonabant	CB1	PA152407999	1268	0.921
NULL	Br_J_Cancer_2012_Apr_10_106(8)_1367-1373.nxml.txt.nlp	22454081	SENT122	12	12	22	22	trastuzumab	IGF1R	PA451743	3480	0.921
NULL	EMBO_Mol_Med_2011_May_3(5)_266-278.nxml.txt.nlp	21438154	SENT26	9	9	6	6	oxaliplatin	TRPM8	PA131285527	79054	0.921
NULL	Bone_Marrow_Res_2011_Mar_2_2011_924058.nxml.txt.nlp	22046572	SENT41	2	2	17	17	rituximab	SCT	PA451261	6343	0.921
NULL	BMJ_2014_Oct_24_349_g6269.nxml.txt.nlp	NULL	SENT103	21	21	12	12	cangrelor	P2Y12	PA165945763	64805	0.921
NULL	Breast_Cancer_Res_2012_May_4_14(3)_R72.nxml.txt.nlp	22559056	SENT15	26	26	0	0	tamoxifen	CENP-A	PA451581	1058	0.921
NULL	Int_Cardiovasc_Res_J_2013_Dec_1_7(4)_130-134.nxml.txt.nlp	24757637	SENT48	7	7	33	33	isoflurane	CO2	PA450106	4513	0.921
NULL	Clin_Med_Insights_Oncol_2012_Nov_20_6_381-393.nxml.txt.nlp	23226079	SENT136	23	23	7	7	sunitinib	CYP3A4	PA162372840	1576	0.921
NULL	Cardiovasc_Ther_2009_27(4)_259-274.nxml.txt.nlp	19604248	SENT8	33	33	23	23	clopidogrel	IPA	PA449053	3160	0.921
NULL	J_Cell_Biol_2000_Feb_21_148(4)_791-800.nxml.txt.nlp	10684259	SENT173	40	40	5	5	estradiol	Raf-1	PA449503	5894	0.921
NULL	Front_Oncol_2014_Sep_23_4_263.nxml.txt.nlp	25295230	SENT406	19	19	12	12	sorafenib	CXCR4	PA7000	7852	0.921
NULL	Nature_2011_Sep_7_477(7366)_601-605.nxml.txt.nlp	21900893	SENT77	19	19	3	3	tamoxifen	SUMO1	PA451581	7341	0.921
NULL	Front_Aging_Neurosci_2009_Dec_9_1_4.nxml.txt.nlp	20552055	SENT153	19	19	8	8	resveratrol	CA1		759	0.921
NULL	Mol_Cancer_2006_Oct_18_5_46.nxml.txt.nlp	17044945	SENT192	2	2	0	0	imatinib	KIT	PA10804	3815	0.921
NULL	J_Oncol_2010_Apr_11_2010_251231.nxml.txt.nlp	20414333	SENT307	18	18	9	9	imatinib	CD133	PA10804	8842	0.921
NULL	Nat_Chem_Biol_2010_Apr_28_6(4)_291-299.nxml.txt.nlp	20190765	SENT141	25	25	16	16	dasatinib	EGFR	PA162372878	1956	0.921
NULL	Acta_Pharmacol_Sin_2010_Jan_5_31(1)_81-92.nxml.txt.nlp	20048747	SENT283	18	18	37	37	resveratrol	LC3		84557	0.921
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1953-1985.nxml.txt.nlp	25268164	SENT319	0	0	9	9	gefitinib	PI3K	PA131301952	5290	0.921
NULL	Core_Evid_2012_Sep_27_7_105-114.nxml.txt.nlp	23055948	SENT185	36	36	4	4	icatibant	C1-INH	PA164749185	710	0.921
NULL	An_Bras_Dermatol_2014_Mar-Apr_89(2)_266-273.nxml.txt.nlp	24770503	SENT84	18	18	5	5	thalidomide	ENL	PA451644	4298	0.921
NULL	Cell_Death_Dis_2012_Nov_15_3(11)_e422.nxml.txt.nlp	23152058	SENT11	27	27	18	18	cisplatin	GPX1	PA449014	2876	0.921
NULL	J_Histochem_Cytochem_2012_Oct_60(10)_749-760.nxml.txt.nlp	22821669	SENT266	18	18	5	5	hyaluronan	TSG-6	PA165958431	7130	0.921
NULL	Front_Pharmacol_2014_May_9_5_103.nxml.txt.nlp	24847272	SENT167	11	11	15	15	dextromethorphan	CYP2D6	PA449273	1565	0.921
NULL	Br_J_Cancer_2012_Jun_26_107(1)_116-122.nxml.txt.nlp	22596240	SENT142	25	25	13	13	etoposide	p53	PA449552	7157	0.921
NULL	Fibrogenesis_Tissue_Repair_2011_Feb_15_4_6.nxml.txt.nlp	21324139	SENT25	24	24	12	12	bleomycin	CCL18	PA448645	6362	0.921
NULL	Br_J_Clin_Pharmacol_2013_Aug_23_76(2)_299-315.nxml.txt.nlp	23701319	SENT125	31	31	5	5	bevacizumab	IL-8	PA130232992	3576	0.921
NULL	Cardiovasc_J_Afr_2009_Feb_20(1)_43-51.nxml.txt.nlp	19287816	SENT74	25	25	4	4	alprenolol	p38	PA164750541	10598;1432;7965	0.921
NULL	Cancer_Med_2013_Oct_19_2(5)_646-653.nxml.txt.nlp	24403230	SENT166	12	12	30	30	trastuzumab	p38	PA451743	10598;1432;7965	0.921
NULL	Eur_J_Nucl_Med_Mol_Imaging_2008_May_22_35(5)_1008-1018.nxml.txt.nlp	18157531	SENT43	14	14	35	35	trastuzumab	HER2	PA451743	2064	0.921
NULL	Front_Genet_2012_Nov_2_3_234.nxml.txt.nlp	23130020	SENT113	23	23	6	6	tamoxifen	HER3	PA451581	2065	0.921
NULL	Cell_Commun_Signal_2013_Aug_14_11_58.nxml.txt.nlp	23945128	SENT146	25	25	1	1	trypsin	mol	PA451806	90527	0.921
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT170	13	13	4	4	neratinib	HER2	PA165291472	2064	0.921
NULL	Nat_Neurosci_2011_May_17_14(5)_612-619.nxml.txt.nlp	21499254	SENT105	14	14	29	29	ethanol	GAL4	PA448073	3960	0.921
NULL	Cardiovasc_Diabetol_2013_Jun_7_12_84.nxml.txt.nlp	23759020	SENT56	23	23	4	4	dipyridamole	LSR	PA449367	51599	0.921
NULL	Korean_J_Anesthesiol_2013_Jun_24_64(6)_517-523.nxml.txt.nlp	23814652	SENT98	10	10	31	31	ondansetron	CYP2D6	PA450705	1565	0.921
NULL	Cancer_Cell_Int_2013_May_15_13_42.nxml.txt.nlp	23672670	SENT221	11	11	23	23	paclitaxel	RAIDD	PA450761	8738	0.921
NULL	Oncotarget_2011_Sep_9_2(9)_658-668.nxml.txt.nlp	21911919	SENT137	16	16	6	6	cytarabine	HO-1	PA449177	3162	0.921
NULL	Clinics_(Sao_Paulo)_2010_Jan_65(1)_29-34.nxml.txt.nlp	20126343	SENT141	32	32	44	44	ropivacaine	LPSB	PA451271	8991	0.921
NULL	Cell_Res_2013_Jul_21_23(7)_915-930.nxml.txt.nlp	23689279	SENT446	4	4	11	11	ethanol	ALDH2	PA448073	217	0.921
NULL	Eur_J_Endocrinol_2010_May_162(5)_987-992.nxml.txt.nlp	20164212	SENT15	14	14	5	5	diazoxide	HNF4A	PA449285	3172	0.921
NULL	Clin_Pharmacokinet_2014_Sep_3_53(1)_1-16.nxml.txt.nlp	23999929	SENT275	23	23	14	14	rivaroxaban	CYP3A4	PA165958360	1576	0.921
NULL	J_Cell_Biol_2001_May_28_153(5)_1071-1084.nxml.txt.nlp	11381091	SENT211	18	18	6	6	staurosporine	LPA	PA165109623	4018	0.921
NULL	Diabetes_2013_Sep_15_62(9)_3232-3240.nxml.txt.nlp	23835329	SENT236	5	5	8	8	aripiprazole	AAP	PA10026	5345	0.921
NULL	Pain_Res_Treat_2012_Apr_23_2012_295926.nxml.txt.nlp	22577544	SENT54	19	19	30	30	dicyclomine	ARC	PA164744928	8996;23237	0.921
NULL	Cardiovasc_J_Afr_2013_Apr_24(3)_78-81.nxml.txt.nlp	23736131	SENT79	9	9	23	23	hemin	HO-1	PA449849	3162	0.921
NULL	Neural_Plast_2014_Mar_17_2014_123026.nxml.txt.nlp	24757568	SENT163	12	12	19	19	fluoxetine	CA3	PA449673	761	0.921
NULL	Oncotarget_2011_Sep_9_2(9)_658-668.nxml.txt.nlp	21911919	SENT84	9	9	1	1	daunorubicin	HO-1	PA449212	3162	0.921
NULL	Clin_Pharmacol_2012_Feb_20_4_13-20.nxml.txt.nlp	22427735	SENT22	28	28	8	8	clopidogrel	PON1	PA449053	5444	0.921
NULL	Nucleic_Acids_Res_2013_Dec_30_41(22)_10268-10282.nxml.txt.nlp	23997120	SENT118	24	24	12	12	etoposide	TRF1	PA449552	7013	0.921
NULL	Oncotarget_2012_Sep_27_3(10)_1137-1145.nxml.txt.nlp	23087155	SENT52	24	24	9	9	decitabine	THP1	PA164749631	2736	0.921
NULL	Int_J_Mol_Sci_2014_Sep_11_15(9)_16069-16082.nxml.txt.nlp	25216339	SENT396	9	9	3	3	cisplatin	Oct4	PA449014	5460	0.921
NULL	Neuro_Oncol_2011_Nov_22_13(11)_1178-1191.nxml.txt.nlp	21940738	SENT258	3	3	12	12	imatinib	SOX2	PA10804	6657	0.921
NULL	J_Invest_Dermatol_2012_May_16_132(5)_1435-1442.nxml.txt.nlp	22336948	SENT61	0	0	9	9	doxycycline	TLSP	PA449415	11012	0.921
NULL	J_Mol_Signal_2012_May_31_7_5.nxml.txt.nlp	22651821	SENT66	21	21	3	3	neomycin	SSTR3	PA450608	6753	0.921
NULL	J_Oncol_2010_Mar_9_2010_835680.nxml.txt.nlp	20224655	SENT64	22	22	10	10	bevacizumab	VEGF-A	PA130232992	7422	0.921
NULL	Cancers_(Basel)_2011_May_3_3(2)_2255-2273.nxml.txt.nlp	24212808	SENT141	4	4	0	0	gefitinib	EGFR	PA131301952	1956	0.921
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Dec_17_3(12)_e152.nxml.txt.nlp	25518025	SENT72	22	22	14	14	itraconazole	CYP2D6	PA450132	1565	0.921
NULL	Anat_Cell_Biol_2010_Sep_30_43(3)_194-200.nxml.txt.nlp	21212859	SENT98	23	23	8	8	ethanol	PLP	PA448073	25824;5744	0.921
NULL	BMJ_Open_2013_Nov_4_3(11)_e003556.nxml.txt.nlp	24189081	SENT265	13	13	36	36	epirubicin	AGO	PA449476	55294	0.921
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT94	4	4	26	26	chloroquine	BMPR-II	PA448948	659	0.921
NULL	Front_Oncol_2013_Sep_17_3_230.nxml.txt.nlp	24062983	SENT304	40	40	19	19	doxorubicin	p53	PA449412	7157	0.921
NULL	BMJ_Open_2014_Oct_31_4(10)_e005762.nxml.txt.nlp	25361836	SENT221	4	4	16	16	afatinib	EGFR	PA165981154	1956	0.921
NULL	Cell_Commun_Signal_2013_May_17_11_34.nxml.txt.nlp	23683503	SENT415	3	3	21	21	levodopa	COMT	PA450213	1312	0.921
NULL	Acta_Pharmacol_Sin_2014_Sep_4_35(9)_1157-1166.nxml.txt.nlp	25088002	SENT13	2	2	9	9	curcumin	p300	PA151958596	2033	0.921
NULL	Breast_Cancer_Res_Treat_2014_Dec_21_143(3)_459-467.nxml.txt.nlp	24362951	SENT213	13	13	17	17	exemestane	aromatase	PA449563	1588	0.921
NULL	Braz_J_Med_Biol_Res_2013_Aug_13_46(8)_650-658.nxml.txt.nlp	23969971	SENT183	18	18	12	12	cisplatin	STAT3	PA449014	6774	0.921
NULL	Trials_2012_Sep_8_13_160.nxml.txt.nlp	22958580	SENT47	26	26	14	14	succinylcholine	MVD	PA451522	4597	0.921
NULL	Biomed_Res_Int_2014_Jun_3_2014_656370.nxml.txt.nlp	24995318	SENT87	16	16	43	43	quetiapine	FGA	PA451201	2243	0.921
NULL	Arch_Med_Sci_2013_Apr_20_9(2)_332-339.nxml.txt.nlp	23671446	SENT158	6	6	11	11	midazolam	p38	PA450496	10598;1432;7965	0.921
NULL	J_Young_Pharm_2010_Jul-Sep_2(3)_273-279.nxml.txt.nlp	21042485	SENT33	21	21	34	34	benzaldehyde	mol	PA448571	90527	0.921
NULL	Acta_Pharmacol_Sin_2011_Oct_12_32(10)_1259-1265.nxml.txt.nlp	21909126	SENT95	5	5	12	12	fluvastatin	MCP-1	PA449688	6347	0.921
NULL	Lipids_Health_Dis_2011_Feb_28_10_38.nxml.txt.nlp	21352602	SENT10	3	3	10	10	fenofibrate	PCSK9	PA449594	255738	0.921
NULL	Clin_Dev_Immunol_2013_Oct_1_2013_764395.nxml.txt.nlp	24194774	SENT249	16	16	0	0	terbutaline	IFN	PA451616	3439	0.921
NULL	J_Cancer_2013_Nov_14_4(9)_697-702.nxml.txt.nlp	24312139	SENT39	23	23	12	12	paclitaxel	CDK2	PA450761	1017	0.921
NULL	Exp_Diabetes_Res_2011_Jun_23_2011_898913.nxml.txt.nlp	21747834	SENT179	27	27	3	3	liraglutide	GLP-1	PA165958364	100125288	0.921
NULL	Br_J_Cancer_2009_Jun_2_100(11)_1739-1745.nxml.txt.nlp	19436299	SENT66	21	21	0	0	isoflurane	FDG	PA450106	23583	0.921
NULL	Cancer_Immunol_Immunother_2013_Aug_27_62(10)_1637-1648.nxml.txt.nlp	23982484	SENT161	3	3	7	7	lenalidomide	STAT3	PA162363968	6774	0.921
NULL	Breast_Cancer_Res_2008_Dec_5_10(6)_R104.nxml.txt.nlp	19061505	SENT224	16	16	0	0	estradiol	JNK	PA449503	5599	0.921
NULL	J_Korean_Med_Sci_2014_Jul_11_29(7)_965-972.nxml.txt.nlp	25045229	SENT78	25	25	36	36	metformin	B12	PA450395	7126;4709	0.921
NULL	J_Adv_Pract_Oncol_2012_Jan_1_Jan-Feb_3(1)_49-54.nxml.txt.nlp	25031928	SENT40	16	16	25	25	plerixafor	CD34	PA165958410	947	0.921
NULL	Mol_Cancer_2009_Dec_23_8_129.nxml.txt.nlp	20030852	SENT11	14	14	38	38	curcumin	p65	PA151958596	5970	0.921
NULL	Int_J_Mol_Sci_2014_Nov_17_15(11)_21229-21252.nxml.txt.nlp	25407528	SENT101	15	15	0	0	trypsin	PLG	PA451806	5340	0.921
NULL	Adolesc_Health_Med_Ther_2014_Mar_26_5_35-48.nxml.txt.nlp	24729739	SENT31	39	39	32	32	abatacept	IL-6	PA164747080	3569	0.921
NULL	Case_Rep_Dermatol_2011_Oct_11_3(3)_223-227.nxml.txt.nlp	22135629	SENT20	17	17	3	3	paclitaxel	HER2	PA450761	2064	0.921
NULL	Biochem_Res_Int_2012_Mar_4_2012_875742.nxml.txt.nlp	22500233	SENT201	6	6	0	0	collagenase	MMP1	PA449107	4312	0.921
NULL	Nat_Commun_2013_Apr_9_4_1684.nxml.txt.nlp	23575688	SENT566	13	13	23	23	rolipram	IL-8	PA153906323	3576	0.921
NULL	Front_Physiol_2013_Dec_24_4_386.nxml.txt.nlp	24399968	SENT221	7	7	27	27	carbamazepine	SUR1	PA448785	6833	0.921
NULL	AAPS_J_2013_Aug_20_15(4)_1119-1127.nxml.txt.nlp	23959685	SENT223	4	4	13	13	caffeine	CPE	PA448710	1363	0.921
NULL	Oncoscience_2014_Mar_12_1(2)_158-166.nxml.txt.nlp	25594008	SENT124	25	25	15	15	dasatinib	IGFBP2	PA162372878	3485	0.921
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Oct_20_66(Pt_11)_o2822.nxml.txt.nlp	21589010	SENT65	26	26	12	12	ethanol	mol	PA448073	90527	0.921
NULL	Front_Neurosci_2011_Jan_20_5_3.nxml.txt.nlp	21270945	SENT173	5	5	39	39	ethanol	ANOVA	PA448073	4858	0.921
NULL	Front_Genet_2012_Nov_22_3_249.nxml.txt.nlp	23189085	SENT100	24	24	14	14	mitoxantrone	ABCB1	PA450526	5243	0.921
NULL	Breast_Cancer_Res_2013_Nov_8_15(6)_R107.nxml.txt.nlp	24207099	SENT16	20	20	45	45	ethanol	CYP2E1	PA448073	1571	0.921
NULL	Osteoporos_Int_2008_Apr_12_19(4)_399-428.nxml.txt.nlp	18266020	SENT251	12	12	10	10	teriparatide	PTH	PA451620	5741	0.921
NULL	J_Aging_Res_2011_Sep_28_2011_251517.nxml.txt.nlp	21969914	SENT38	15	15	12	12	letrozole	aromatase	PA450196	1588	0.921
NULL	Cell_Death_Dis_2014_Mar_13_5(3)_e1118.nxml.txt.nlp	24625977	SENT80	40	40	29	29	etoposide	UBXN2A	PA449552	165324	0.921
NULL	Br_J_Cancer_2014_Nov_25_111(11)_2091-2102.nxml.txt.nlp	25349971	SENT152	16	16	11	11	imatinib	PDGFRA	PA10804	5156	0.921
NULL	Arthritis_Res_Ther_2008_Jun_30_10(3)_209.nxml.txt.nlp	18598385	SENT244	1	1	21	21	oxaliplatin	HMGB1	PA131285527	3146	0.921
NULL	Clin_Interv_Aging_2013_Jul_16_8_889-897.nxml.txt.nlp	23898224	SENT25	0	0	22	22	gemcitabine	SIRT1	PA449748	23411	0.921
NULL	Inflamm_Res_2012_Oct_14_61(10)_1041-1052.nxml.txt.nlp	22890476	SENT207	8	8	0	0	capsaicin	TRPV1	PA448776	7442	0.921
NULL	Angiogenesis_2012_Sep_27_15(3)_361-376.nxml.txt.nlp	22451299	SENT213	3	3	17	17	resveratrol	HHS		2591	0.921
NULL	Diabetes_Care_2013_Aug_17_36(Suppl_2)_S325-S330.nxml.txt.nlp	23882066	SENT125	35	35	12	12	amiodarone	CYP3A4	PA448383	1576	0.921
NULL	Clin_Transl_Allergy_2013_Sep_2_3_29.nxml.txt.nlp	24004581	SENT150	24	24	13	13	omalizumab	IL-4	PA164752253	3565	0.921
NULL	Cancers_(Basel)_2014_Aug_12_6(3)_1631-1669.nxml.txt.nlp	25119536	SENT250	42	42	19	19	imatinib	IL-8	PA10804	3576	0.921
NULL	J_Am_Heart_Assoc_2013_Apr_24_2(2)_e000131.nxml.txt.nlp	23537811	SENT70	14	14	25	25	clopidogrel	ADP	PA449053	23038	0.921
NULL	Oncotarget_2014_Jun_8_5(17)_7446-7457.nxml.txt.nlp	25277184	SENT40	6	6	10	10	cisplatin	p53	PA449014	7157	0.921
NULL	JAKSTAT_2012_Apr_1_1(2)_83-89.nxml.txt.nlp	24058756	SENT9	0	0	13	13	losartan	STAT3	PA450268	6774	0.921
NULL	Daru_2012_Sep_10_20(1)_30.nxml.txt.nlp	23351387	SENT134	2	2	10	10	indomethacin	IL-6	PA449982	3569	0.921
NULL	Mol_Cancer_2009_Apr_22_8_26.nxml.txt.nlp	19386116	SENT128	1	1	7	7	ritonavir	AKT	PA451260	207	0.921
NULL	Diabetes_2013_Jun_17_62(6)_2141-2150.nxml.txt.nlp	23378610	SENT162	10	10	2	2	betaine	RISC	PA448603	59342	0.921
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT280	3	3	11	11	chloroquine	BMPR-II	PA448948	659	0.921
NULL	Breast_Cancer_Res_2004_Aug_5_6(5)_R601-R607.nxml.txt.nlp	15318941	SENT131	18	18	10	10	camptothecin	p27	PA153590860	5715;10534	0.921
NULL	Breast_Cancer_Res_2008_Dec_18_10(Suppl_4)_S18.nxml.txt.nlp	19128431	SENT26	14	14	4	4	tamoxifen	B14	PA451581	4700	0.921
NULL	J_Gerontol_A_Biol_Sci_Med_Sci_2014_Jun_8_69(Suppl_1)_S21-S27.nxml.txt.nlp	24833582	SENT31	26	26	30	30	metformin	AMPK	PA450395	5563	0.921
NULL	Oncotarget_2013_Nov_24_4(12)_2430-2438.nxml.txt.nlp	24280348	SENT119	7	7	0	0	gefitinib	STAT3	PA131301952	6774	0.921
NULL	Eur_J_Clin_Pharmacol_2011_Dec_23_67(12)_1231-1241.nxml.txt.nlp	21698374	SENT247	21	21	17	17	tacrolimus	CYP3A5	PA451578	1577	0.921
NULL	Mol_Vis_2012_Oct_5_18_2454-2467.nxml.txt.nlp	23077404	SENT180	2	2	4	4	bevacizumab	VEGF-A	PA130232992	7422	0.921
NULL	Clin_Sarcoma_Res_2014_Aug_12_4_11.nxml.txt.nlp	25126409	SENT96	32	32	7	7	doxorubicin	Bcl-2	PA449412	596	0.921
NULL	J_Biomed_Biotechnol_2011_Dec_6_2011_856985.nxml.txt.nlp	21188173	SENT281	10	10	13	13	tamoxifen	aromatase	PA451581	1588	0.921
NULL	Indian_J_Med_Res_2010_Dec_132(6)_676-682.nxml.txt.nlp	21245614	SENT97	11	11	18	18	zinc	p53	PA451956	7157	0.921
NULL	Croat_Med_J_2013_Apr_54(2)_171-179.nxml.txt.nlp	23630144	SENT91	25	25	14	14	taurine	STZ	PA451590	6484	0.921
NULL	Front_Behav_Neurosci_2012_Oct_11_6_68.nxml.txt.nlp	23087630	SENT431	19	19	11	11	fluoxetine	5-HT1A	PA449673	3350	0.921
NULL	Open_Access_J_Urol_2011_May_10_3_69-82.nxml.txt.nlp	24198638	SENT66	9	9	5	5	cyclophosphamide	CYP2B6	PA449165	1555	0.921
NULL	J_Cancer_2012_Apr_1_3_145-151.nxml.txt.nlp	22481980	SENT149	8	8	1	1	trastuzumab	HER2	PA451743	2064	0.921
NULL	Clin_Toxicol_(Phila)_2007_Jun_20_Jun-Aug_45(5)_565-570.nxml.txt.nlp	17558630	SENT155	5	5	12	12	methacholine	Rho	PA165958382	29984	0.921
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT307	8	8	17	17	cisplatin	JNK	PA449014	5599	0.921
NULL	Diabetes_2008_Sep_57(9)_2288-2295.nxml.txt.nlp	18535187	SENT12	12	12	19	19	pioglitazone	mol	PA450970	90527	0.921
NULL	Nucleic_Acids_Res_2011_Mar_23_39(4)_1526-1537.nxml.txt.nlp	20972225	SENT104	12	12	34	34	paraformaldehyde	SP5	PA450790	389058	0.921
NULL	Lab_Invest_2011_Oct_18_91(10)_1414-1426.nxml.txt.nlp	21769085	SENT189	42	42	25	25	gefitinib	EGFR	PA131301952	1956	0.921
NULL	Nat_Neurosci_2012_Jun_15(6)_845-852.nxml.txt.nlp	22522402	SENT239	17	17	4	4	paraformaldehyde	GluK2	PA450790	2898	0.921
NULL	J_Biomed_Biotechnol_2011_Jan_24_2011_250860.nxml.txt.nlp	21318107	SENT164	0	0	12	12	lenalidomide	IL-6	PA162363968	3569	0.921
NULL	Arthritis_Res_Ther_2010_Apr_29_12(2)_R73.nxml.txt.nlp	20429888	SENT158	24	24	9	9	bortezomib	COL1A1	PA10252	1277	0.921
NULL	Mol_Cancer_2012_Jul_12_11_45.nxml.txt.nlp	22788833	SENT132	17	17	5	5	cisplatin	EGFR	PA449014	1956	0.921
NULL	Pharmaceuticals_(Basel)_2012_Feb_24_5(3)_279-296.nxml.txt.nlp	24281379	SENT129	22	22	44	44	clopidogrel	ANOVA	PA449053	4858	0.921
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1063.nxml.txt.nlp	24556678	SENT52	4	4	21	21	thioridazine	TRAIL	PA451666	8743	0.921
NULL	J_Cell_Biol_2008_Jul_14_182(1)_197-213.nxml.txt.nlp	18625847	SENT31	28	28	11	11	gemcitabine	p53	PA449748	7157	0.921
NULL	Clin_Pharmacol_2013_Apr_19_5_67-83.nxml.txt.nlp	23650452	SENT4	28	28	15	15	clopidogrel	P2Y12	PA449053	64805	0.921
NULL	Exp_Lung_Res_2013_Oct_1_39(8)_336-348.nxml.txt.nlp	23919450	SENT184	0	0	25	25	thrombin	PAR-1	PA451674	2011;2149	0.921
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT203	7	7	30	30	metformin	PI3K	PA450395	5290	0.921
NULL	J_Inherit_Metab_Dis_2013_Mar_13_36(2)_363-371.nxml.txt.nlp	22971959	SENT93	35	35	25	25	gentamicin	ARSB	PA449753	411	0.921
NULL	Avicenna_J_Med_Biotechnol_2014_Jan-Mar_6(1)_10-20.nxml.txt.nlp	24523953	SENT179	29	29	9	9	trypsin	CD105	PA451806	2022	0.921
NULL	Cancer_Immunol_Immunother_2012_Jul_23_61(7)_1101-1111.nxml.txt.nlp	22193989	SENT137	14	14	3	3	oxaliplatin	PD-L1	PA131285527	29126	0.921
NULL	J_Clin_Biochem_Nutr_2009_Jan_27_44(1)_79-84.nxml.txt.nlp	19177192	SENT61	19	19	8	8	curcumin	CO2	PA151958596	4513	0.921
NULL	Eur_J_Clin_Pharmacol_2010_Nov_29_66(11)_1131-1136.nxml.txt.nlp	20669013	SENT14	13	13	4	4	voriconazole	CYP3A4	PA10233	1576	0.921
NULL	Cardiol_Res_Pract_2010_Jul_1_2010_134564.nxml.txt.nlp	20672024	SENT226	9	9	1	1	isradipine	MIDAS	PA450131	64083	0.921
NULL	Br_J_Cancer_2009_May_19_100(10)_1523-1529.nxml.txt.nlp	19401686	SENT81	4	4	27	27	tanespimycin	HER-2	PA165291490	2064	0.921
NULL	Breast_Cancer_Res_Treat_2014_Dec_19_143(2)_351-358.nxml.txt.nlp	24352574	SENT6	0	0	28	28	docetaxel	2-21	PA449383	54097	0.921
NULL	Oncol_Lett_2013_Apr_28_5(4)_1149-1154.nxml.txt.nlp	23599754	SENT102	25	25	5	5	cisplatin	Dicer	PA449014	23405	0.921
NULL	Oncotarget_2014_Mar_13_5(4)_1101-1110.nxml.txt.nlp	24658355	SENT11	26	26	4	4	tamoxifen	MKP-2	PA451581	1846	0.921
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT79	42	42	24	24	curcumin	DR4	PA151958596	8797	0.921
NULL	Front_Cell_Neurosci_2015_Jan_15_8_459.nxml.txt.nlp	25642166	SENT16	36	36	7	7	hemin	HO-1	PA449849	3162	0.921
NULL	Front_Genet_2012_Nov_2_3_234.nxml.txt.nlp	23130020	SENT113	25	25	6	6	trastuzumab	HER3	PA451743	2065	0.921
NULL	J_Gen_Physiol_2008_Oct_132(4)_397-405.nxml.txt.nlp	18794377	SENT159	7	7	20	20	nifedipine	NCX	PA450631	3196	0.921
NULL	Oncol_Lett_2014_Nov_14_8(5)_2086-2092.nxml.txt.nlp	25295095	SENT10	36	36	5	5	gemcitabine	LKB1	PA449748	6794	0.921
NULL	Nat_Commun_2013_Apr_9_4_1684.nxml.txt.nlp	23575688	SENT584	12	12	22	22	rolipram	IL-8	PA153906323	3576	0.921
NULL	Chem_Cent_J_2012_Jan_22_6_7.nxml.txt.nlp	22264235	SENT193	16	16	20	20	chloramphenicol	PC1	PA448927	5122	0.921
NULL	Am_J_Cardiovasc_Drugs_2013_Jun_20_13(5)_331-342.nxml.txt.nlp	23784266	SENT226	28	28	24	24	dronedarone	P-gp	PA153619853	5243	0.921
NULL	Korean_Circ_J_2014_Mar_12_44(2)_97-104.nxml.txt.nlp	24653739	SENT81	11	11	4	4	bosentan	Bcl-2	PA10034	596	0.921
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT120	17	17	24	24	cisplatin	p53	PA449014	7157	0.921
NULL	Front_Oncol_2014_Apr_2_4_70.nxml.txt.nlp	24765614	SENT127	33	33	36	36	bevacizumab	VEGF-A	PA130232992	7422	0.921
NULL	Emerg_Infect_Dis_2007_Jul_13(7)_1024-1030.nxml.txt.nlp	18214174	SENT150	4	4	14	14	linezolid	LSE	PA450233	54414	0.921
NULL	Clin_Med_Insights_Oncol_2012_Dec_20_7_1-12.nxml.txt.nlp	23362372	SENT21	11	11	32	32	cabazitaxel	P-gp	PA165958401	5243	0.921
NULL	Aging_(Albany_NY)_2012_Mar_12_4(3)_146-158.nxml.txt.nlp	22436213	SENT50	7	7	9	9	resveratrol	SIRT1		23411	0.921
NULL	Cardiovasc_Diabetol_2013_Oct_17_12_150.nxml.txt.nlp	24134550	SENT107	28	28	4	4	pioglitazone	activin	PA450970	83729	0.921
NULL	J_Med_Case_Reports_2012_Feb_15_6_64.nxml.txt.nlp	22335966	SENT65	4	4	14	14	lidocaine	SPG	PA450226	55764	0.921
NULL	Oncotarget_2013_Jun_30_4(7)_1037-1049.nxml.txt.nlp	23900414	SENT177	25	25	42	42	pp2	EGF		1950	0.921
NULL	Breast_Cancer_2014_Feb_13_21(6)_703-714.nxml.txt.nlp	23404211	SENT166	27	27	11	11	fulvestrant	aromatase	PA164747170	1588	0.921
NULL	Acta_Pharmacol_Sin_2013_Feb_31_34(2)_231-238.nxml.txt.nlp	23274414	SENT193	8	8	26	26	amiloride	Bcl-2	PA448368	596	0.921
NULL	Oxid_Med_Cell_Longev_2013_Nov_28_2013_568093.nxml.txt.nlp	24379901	SENT126	5	5	31	31	resveratrol	SIRT1		23411	0.921
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Oct_31_65(Pt_11)_o2959.nxml.txt.nlp	21578530	SENT47	20	20	6	6	ethanol	mol	PA448073	90527	0.921
NULL	Braz_J_Microbiol_2010_Jun_1_Apr-Jun_41(2)_452-460.nxml.txt.nlp	24031516	SENT115	33	33	42	42	tetracycline	OTC	PA451640	5009	0.921
NULL	J_Korean_Med_Sci_2009_Jan_29_24(Suppl_1)_S161-S169.nxml.txt.nlp	19194547	SENT8	5	5	13	13	hydrochlorothiazide	TRPV5	PA449899	56302	0.921
NULL	Oncol_Rep_2013_Apr_23_29(4)_1268-1274.nxml.txt.nlp	23354756	SENT116	19	19	4	4	trastuzumab	SLC25A43	PA451743	203427	0.921
NULL	Br_J_Cancer_2013_Jan_15_108(1)_82-90.nxml.txt.nlp	23321512	SENT156	39	39	30	30	paclitaxel	TUBB3	PA450761	10381	0.921
NULL	Blood_Cancer_J_2014_Oct_10_4(10)_e249.nxml.txt.nlp	25303368	SENT146	17	17	7	7	rituximab	BCL2	PA451261	596	0.921
NULL	Arch_Med_Sci_2012_Nov_9_8(5)_899-906.nxml.txt.nlp	23185202	SENT116	37	37	14	14	glibenclamide	adiponectin	PA449782	9370	0.921
NULL	Autophagy_2013_Jul_1_9(7)_996-1008.nxml.txt.nlp	23580233	SENT126	5	5	39	39	cisplatin	LC3	PA449014	84557	0.921
NULL	Breast_Cancer_Res_2000_Jul_7_2(5)_353-359.nxml.txt.nlp	11250728	SENT88	12	12	19	19	tamoxifen	DES	PA451581	1674	0.921
NULL	Breast_Cancer_Res_2011_Jun_29_13(3)_R70.nxml.txt.nlp	21707964	SENT193	42	42	29	29	tamoxifen	EGFR	PA451581	1956	0.921
NULL	Diabetologia_2010_Oct_26_53(10)_2209-2219.nxml.txt.nlp	20582536	SENT198	9	9	20	20	indinavir	VAMP5	PA449977	10791	0.921
NULL	Cell_Death_Dis_2013_Oct_3_4(10)_e827.nxml.txt.nlp	24091670	SENT37	10	10	34	34	nilotinib	CD38	PA165958345	952	0.921
NULL	Scientifica_(Cairo)_2012_Oct_9_2012_821549.nxml.txt.nlp	24278743	SENT338	11	11	22	22	olanzapine	5-HT2A	PA450688	3356	0.921
NULL	Anal_Bioanal_Chem_2011_Jan_3_399(2)_527-539.nxml.txt.nlp	20814668	SENT140	11	11	37	37	heparin	NIR	PA449855	26155	0.921
NULL	Brain_Sci_2013_Jun_14_3(2)_941-963.nxml.txt.nlp	24961432	SENT186	13	13	15	15	ethanol	RhoA	PA448073	387	0.921
NULL	Oncotarget_2014_Oct_21_5(22)_11252-11268.nxml.txt.nlp	25361004	SENT210	22	22	11	11	metformin	CLIC1	PA450395	1192	0.921
NULL	J_Cell_Mol_Med_2013_Dec_6_17(12)_1588-1597.nxml.txt.nlp	24199964	SENT166	23	23	4	4	doxycycline	APT	PA449415	653639	0.921
NULL	Br_J_Cancer_2013_Jul_23_109(2)_351-359.nxml.txt.nlp	23799854	SENT195	25	25	14	14	paclitaxel	P-gp	PA450761	5243	0.921
NULL	Arthritis_Res_Ther_2013_Jul_9_15(4)_R73.nxml.txt.nlp	23837669	SENT252	11	11	27	27	colchicine	MICL	PA449092	160364	0.921
NULL	Behav_Brain_Funct_2014_Feb_13_10_5.nxml.txt.nlp	24524628	SENT213	9	9	11	11	capsaicin	TRPV1	PA448776	7442	0.921
NULL	Am_J_Case_Rep_2014_May_14_15_212-215.nxml.txt.nlp	24847412	SENT85	14	14	3	3	hydrocortisone	ACTH	PA449905	5443	0.921
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_39-54.nxml.txt.nlp	19305787	SENT195	4	4	30	30	ethanol	NR1	PA448073	27158	0.921
NULL	Scientifica_(Cairo)_2012_Nov_25_2012_473829.nxml.txt.nlp	24278698	SENT379	22	22	5	5	cisplatin	MATE1	PA449014	55244	0.921
NULL	Arthritis_Res_Ther_2012_Nov_30_14(Suppl_4)_S3.nxml.txt.nlp	23281796	SENT95	18	18	23	23	rituximab	BAFF	PA451261	10673	0.921
NULL	Clin_Pharmacokinet_2014_Oct_15_53(2)_155-164.nxml.txt.nlp	24127209	SENT29	43	43	26	26	clopidogrel	CYP3A4	PA449053	1576	0.921
NULL	Ann_Rheum_Dis_2008_Sep_30_67(9)_1222-1228.nxml.txt.nlp	18055477	SENT22	0	0	8	8	bosentan	ETB	PA10034	1910	0.921
NULL	AMB_Express_2014_Jun_14_4_48.nxml.txt.nlp	25401061	SENT36	21	21	26	26	cyanocobalamin	B12	PA451892	7126;4709	0.921
NULL	J_Cell_Mol_Med_2014_Aug_6_18(8)_1519-1539.nxml.txt.nlp	25100284	SENT128	22	22	33	33	gefitinib	EGFR	PA131301952	1956	0.921
NULL	Oncotarget_2013_Feb_26_4(2)_298-309.nxml.txt.nlp	23593653	SENT62	6	6	15	15	quinacrine	SFRP1	PA164745551	6422	0.921
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Mar_27_66(Pt_4)_o927.nxml.txt.nlp	21580737	SENT54	18	18	12	12	ethanol	mol	PA448073	90527	0.921
NULL	Iran_J_Psychiatry_2010_Fall_5(4)_119-127.nxml.txt.nlp	22952505	SENT176	2	2	5	5	minocycline	p75	PA450519	7133;11168	0.921
NULL	Biologics_2009_Sep_15_3_419-428.nxml.txt.nlp	19774209	SENT30	8	8	4	4	erlotinib	EGFR	PA134687924	1956	0.921
NULL	Arthritis_Res_Ther_2012_Mar_12_14(2)_R57.nxml.txt.nlp	22409963	SENT105	16	16	8	8	rituximab	BAFF	PA451261	10673	0.921
NULL	J_Biol_2010_Apr_8_9(3)_16.nxml.txt.nlp	20377920	SENT76	7	7	3	3	simvastatin	Rho	PA451363	29984	0.921
NULL	Breast_Cancer_Res_2011_Feb_23_13(1)_203.nxml.txt.nlp	21392408	SENT55	13	13	21	21	tamoxifen	aromatase	PA451581	1588	0.921
NULL	Biomed_Res_Int_2013_Aug_14_2013_275805.nxml.txt.nlp	24288671	SENT50	14	14	10	10	doxorubicin	CHOP	PA449412	1649	0.921
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1033-1038.nxml.txt.nlp	22374460	SENT8	17	17	12	12	capecitabine	HER2	PA448771	2064	0.921
NULL	J_Immunother_Cancer_2014_Aug_19_2_27.nxml.txt.nlp	25324973	SENT38	45	45	32	32	vemurafenib	BRAF	PA165946873	673	0.921
NULL	J_Physiol_2009_Feb_15_587(Pt_4)_731-744.nxml.txt.nlp	19074966	SENT84	23	23	12	12	taurine	PAT1	PA451590	10513;206358	0.921
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jan_11_68(Pt_2)_o324-o325.nxml.txt.nlp	22346958	SENT70	36	36	12	12	ethanol	mol	PA448073	90527	0.921
NULL	Brain_Behav_2013_Mar_6_3(2)_114-133.nxml.txt.nlp	23533150	SENT244	38	38	6	6	ethanol	HSF1	PA448073	3297	0.921
NULL	J_Cancer_2014_Jul_4_5(7)_559-571.nxml.txt.nlp	25057307	SENT189	21	21	8	8	tamoxifen	CYP2D6	PA451581	1565	0.921
NULL	J_Oncol_2013_Aug_20_2013_732047.nxml.txt.nlp	24027583	SENT190	11	11	6	6	trastuzumab	HER2	PA451743	2064	0.921
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT289	7	7	10	10	metformin	HIF-1	PA450395	29072	0.921
NULL	Int_J_Mol_Sci_2014_Sep_29_15(10)_17411-17441.nxml.txt.nlp	25268615	SENT216	12	12	15	15	cisplatin	CD147	PA449014	682	0.921
NULL	Curr_Neuropharmacol_2013_Dec_11(6)_652-663.nxml.txt.nlp	24396340	SENT171	20	20	28	28	capsaicin	TRPV1	PA448776	7442	0.921
NULL	J_Cell_Mol_Med_2013_Oct_16_17(10)_1261-1270.nxml.txt.nlp	23855452	SENT231	16	16	2	2	etoposide	CHK2	PA449552	11200	0.921
NULL	Front_Genet_2015_Jan_14_5_469.nxml.txt.nlp	25642242	SENT244	27	27	9	9	paromomycin	MRPS12	PA164784023	6183	0.921
NULL	FEBS_Open_Bio_2014_Oct_22_4_905-914.nxml.txt.nlp	25383314	SENT100	6	6	19	19	physostigmine	L-FABP	PA450957	2168	0.921
NULL	Lab_Invest_2009_Dec_19_89(12)_1397-1409.nxml.txt.nlp	19841616	SENT193	27	27	33	33	curcumin	NAC	PA151958596	22861	0.921
NULL	Arthritis_Res_Ther_2004_Jun_21_6(Suppl_2)_S12-S18.nxml.txt.nlp	15228616	SENT136	15	15	2	2	adalimumab	STAR	PA10004	6770;2984	0.921
NULL	Acta_Pharmacol_Sin_2013_Jan_17_34(1)_157-166.nxml.txt.nlp	23247593	SENT16	0	0	10	10	berberine	Set9	PA165860812	80854	0.921
NULL	Cardiol_Res_Pract_2010_Sep_19_2010_649164.nxml.txt.nlp	20886058	SENT167	26	26	14	14	acetylcysteine	NAC	PA448033	22861	0.921
NULL	Appl_Microbiol_Biotechnol_2014_Feb_18_98(8)_3829-3840.nxml.txt.nlp	24535257	SENT139	4	4	40	40	ethanol	PE-2	PA448073	2077	0.921
NULL	Leukemia_2014_Apr_31_28(4)_948-951.nxml.txt.nlp	24172825	SENT27	13	13	25	25	imatinib	EGF	PA10804	1950	0.921
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_39-54.nxml.txt.nlp	19305787	SENT239	42	42	0	0	ethanol	DARPP-32	PA448073	84152	0.921
NULL	Breast_Cancer_Res_2010_Jun_28_12(3)_R43.nxml.txt.nlp	20579400	SENT159	10	10	12	12	tamoxifen	MAPT	PA451581	4137	0.921
NULL	Cell_Commun_Signal_2013_May_29_11_38.nxml.txt.nlp	23718910	SENT107	10	10	28	28	pp2	p65		5970	0.921
NULL	Breast_Cancer_Res_2005_Nov_16_7(1)_R82-R92.nxml.txt.nlp	15642172	SENT26	26	26	14	14	tamoxifen	aromatase	PA451581	1588	0.921
NULL	Arthritis_Res_Ther_2010_Feb_24_12(1)_R32.nxml.txt.nlp	20181277	SENT231	8	8	11	11	imatinib	M-CSF	PA10804	1435	0.921
NULL	Br_J_Cancer_2010_Jul_13_103(2)_186-195.nxml.txt.nlp	20588277	SENT126	8	8	26	26	nutlin-3	p53		7157	0.921
NULL	Oncogene_2014_Mar_20_33(12)_1495-1505.nxml.txt.nlp	23604115	SENT195	0	0	11	11	nilotinib	TRF2	PA165958345	7014;9519	0.921
NULL	Acta_Pharmacol_Sin_2010_Sep_9_31(9)_1181-1188.nxml.txt.nlp	20694025	SENT147	20	20	33	33	irinotecan	KRAS	PA450085	3845	0.921
NULL	Adv_Urol_2010_Jul_20_2010_687043.nxml.txt.nlp	20721275	SENT91	0	0	28	28	sunitinib	BRAF	PA162372840	673	0.921
NULL	J_Nat_Sci_Biol_Med_2011_Jul-Dec_2(2)_180-184.nxml.txt.nlp	22346232	SENT8	33	33	2	2	ethanol	SGB	PA448073	2719	0.921
NULL	AIDS_Res_Ther_2014_Aug_4_11_25.nxml.txt.nlp	25120580	SENT7	15	15	18	18	esomeprazole	CYP2C19	PA10075	1557	0.921
NULL	Diabetol_Metab_Syndr_2014_Mar_31_6_47.nxml.txt.nlp	24684779	SENT105	5	5	27	27	pioglitazone	IL-6	PA450970	3569	0.921
NULL	Endocr_Relat_Cancer_2013_Aug_20(5)_677-689.nxml.txt.nlp	23913484	SENT196	12	12	5	5	paclitaxel	IRF9	PA450761	10379	0.921
NULL	Surg_Neurol_Int_2014_May_8_5_64.nxml.txt.nlp	24991467	SENT181	10	10	4	4	imatinib	EGFR	PA10804	1956	0.921
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_105-115.nxml.txt.nlp	17912640	SENT45	15	15	32	32	trastuzumab	HER2	PA451743	2064	0.921
NULL	Int_J_Biomed_Sci_2014_Sep_10(3)_146-157.nxml.txt.nlp	25324695	SENT7	3	3	13	13	lovastatin	LFA-1	PA450272	3683;3689	0.921
NULL	Int_J_Cell_Biol_2013_Sep_12_2013_153634.nxml.txt.nlp	24159334	SENT140	7	7	35	35	camptothecin	YB-1	PA153590860	4904	0.921
NULL	Ann_Neurol_2013_Oct_24_74(4)_527-536.nxml.txt.nlp	23794460	SENT170	8	8	3	3	hydrocortisone	ACTH	PA449905	5443	0.921
NULL	Mol_Syst_Biol_2010_Jul_27_6_392.nxml.txt.nlp	20664638	SENT105	7	7	4	4	sr144528	CB2		1269	0.921
NULL	Exp_Ther_Med_2013_Apr_5_5(4)_1259-1263.nxml.txt.nlp	23596498	SENT95	11	11	9	9	capsaicin	TRPV1	PA448776	7442	0.921
NULL	J_Mol_Signal_2011_Aug_10_6_8.nxml.txt.nlp	21831305	SENT189	13	13	4	4	isoproterenol	AKAP12	PA450121	9590	0.921
NULL	Anal_Chem_Insights_2009_Apr_7_4_1-9.nxml.txt.nlp	19652757	SENT99	20	20	14	14	citalopram	mol	PA449015	90527	0.921
NULL	Mutagenesis_2009_Jul_16_24(4)_309-316.nxml.txt.nlp	19372135	SENT35	13	13	3	3	carboplatin	XPC	PA448803	7508	0.921
NULL	Cancers_(Basel)_2011_May_18_3(2)_2444-2461.nxml.txt.nlp	24212818	SENT173	16	16	13	13	sorafenib	EGFR	PA7000	1956	0.921
NULL	Oncotarget_2012_Jan_28_3(1)_78-83.nxml.txt.nlp	22289679	SENT86	7	7	10	10	gefitinib	EGFR	PA131301952	1956	0.921
NULL	Cancer_Manag_Res_2013_Aug_30_5_301-313.nxml.txt.nlp	24039449	SENT26	18	18	27	27	sr144528	CB2		1269	0.921
NULL	J_Indian_Assoc_Pediatr_Surg_2012_Apr-Jun_17(2)_84-86.nxml.txt.nlp	22529558	SENT83	17	17	40	40	vincristine	FDG	PA451879	23583	0.921
NULL	Theranostics_2013_Oct_4_3(10)_757-773.nxml.txt.nlp	24312149	SENT57	14	14	7	7	toremifene	FDG	PA451731	23583	0.921
NULL	Nucleic_Acids_Res_2013_Mar_29_41(5)_2981-2992.nxml.txt.nlp	23361461	SENT110	16	16	7	7	tetracycline	TDP1	PA451640	55775	0.921
NULL	Br_J_Cancer_2012_May_22_106(11)_1779-1789.nxml.txt.nlp	22549178	SENT134	6	6	34	34	trastuzumab	HER3	PA451743	2065	0.921
NULL	Drug_Des_Devel_Ther_2014_Oct_14_8_1839-1849.nxml.txt.nlp	25342883	SENT196	22	22	44	44	paclitaxel	CO2	PA450761	4513	0.921
NULL	EMBO_Mol_Med_2011_Aug_3(8)_451-464.nxml.txt.nlp	21656687	SENT131	33	33	5	5	tamoxifen	SPINK1	PA451581	6690	0.921
NULL	Physiol_Rep_2014_Aug_28_2(8)_e12143.nxml.txt.nlp	25168879	SENT19	22	22	14	14	staurosporine	COX	PA165109623	1351	0.921
NULL	J_Cell_Biol_2001_Aug_6_154(3)_599-610.nxml.txt.nlp	11481345	SENT204	19	19	7	7	doxycycline	ARNO	PA449415	9266	0.921
NULL	Surg_Neurol_Int_2014_Aug_28_5(Suppl_7)_S373-S375.nxml.txt.nlp	25289164	SENT8	23	23	30	30	denosumab	RANK	PA166048634	8792	0.921
NULL	Oncoscience_2014_Mar_12_1(2)_158-166.nxml.txt.nlp	25594008	SENT124	25	25	5	5	dasatinib	ANXA1	PA162372878	301	0.921
NULL	J_Biol_Chem_2009_May_8_284(19)_13213-13222.nxml.txt.nlp	19270337	SENT12	23	23	4	4	lipase	ANGPTL4	PA450239	51129	0.921
NULL	Breast_Cancer_Res_2010_May_12_12(3)_R27.nxml.txt.nlp	20462431	SENT249	45	45	9	9	trastuzumab	HER2	PA451743	2064	0.921
NULL	FEBS_Open_Bio_2014_Oct_22_4_905-914.nxml.txt.nlp	25383314	SENT162	16	16	6	6	atropine	L-FABP	PA448505	2168	0.921
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT376	17	17	9	9	resveratrol	CBP		55824;1387	0.921
NULL	Br_J_Cancer_2010_Oct_12_103(8)_1284-1291.nxml.txt.nlp	20859285	SENT4	7	7	3	3	tamoxifen	BCAR4	PA451581	400500	0.921
NULL	Oncotarget_2014_Mar_16_5(12)_4087-4102.nxml.txt.nlp	24961479	SENT51	12	12	8	8	hemin	PC3	PA449849	57332;7832;5122	0.921
NULL	Oncoscience_2014_Mar_16_1(2)_132-157.nxml.txt.nlp	25594007	SENT29	0	0	22	22	cetuximab	EGFR	PA10040	1956	0.921
NULL	Br_J_Cancer_2009_Jul_21_101(2)_357-362.nxml.txt.nlp	19536092	SENT13	13	13	7	7	oxaliplatin	ERCC5	PA131285527	2073	0.921
NULL	Allergy_Asthma_Clin_Immunol_2007_Mar_15_3(1)_24-30.nxml.txt.nlp	20525150	SENT79	12	12	27	27	nimesulide	COX	PA137179528	1351	0.921
NULL	AIDS_Res_Ther_2013_May_31_10_14.nxml.txt.nlp	23721408	SENT34	0	0	20	20	efavirenz	BCS	PA449441	617	0.921
NULL	Oxid_Med_Cell_Longev_2013_Jul_9_2013_574029.nxml.txt.nlp	23936610	SENT27	4	4	22	22	resveratrol	RAGE		177	0.921
NULL	Int_J_Med_Sci_2013_Jan_3_10(2)_141-147.nxml.txt.nlp	23329885	SENT60	12	12	1	1	creatine	AGAT	PA164778930	2628	0.921
NULL	Breast_Cancer_Res_2008_Dec_18_10(Suppl_4)_S22.nxml.txt.nlp	19128436	SENT133	30	30	21	21	epirubicin	TP53	PA449476	7157	0.921
NULL	Breast_Cancer_Res_2013_Nov_27_15(6)_R113.nxml.txt.nlp	24283570	SENT337	21	21	14	14	estradiol	KLF4	PA449503	9314	0.921
NULL	AIDS_Res_Ther_2013_May_1_10_10.nxml.txt.nlp	23634877	SENT148	3	3	20	20	lovastatin	CCR5	PA450272	1234	0.921
NULL	Br_J_Cancer_2013_Feb_19_108(3)_493-502.nxml.txt.nlp	23299530	SENT24	8	8	14	14	bevacizumab	VEGF-A	PA130232992	7422	0.921
NULL	Mol_Cancer_2010_Nov_25_9_305.nxml.txt.nlp	21108789	SENT113	8	8	6	6	decitabine	TRAIL	PA164749631	8743	0.921
NULL	J_Cell_Biol_2001_Oct_1_155(1)_27-40.nxml.txt.nlp	11581284	SENT348	25	25	6	6	paraformaldehyde	NFATc	PA450790	4772	0.921
NULL	Clin_Psychopharmacol_Neurosci_2011_Apr_30_9(1)_1-8.nxml.txt.nlp	23430384	SENT102	0	0	23	23	aripiprazole	5-HT1A	PA10026	3350	0.921
NULL	Hum_Genomics_2010_Apr_1_4(4)_238-249.nxml.txt.nlp	20511137	SENT37	23	23	6	6	lamotrigine	UGT1A1	PA450164	54658	0.921
NULL	Biomed_Res_Int_2014_Feb_24_2014_540238.nxml.txt.nlp	24707490	SENT136	18	18	20	20	topiramate	GluK1	PA451728	2897	0.921
NULL	J_Cell_Mol_Med_2014_Aug_1_18(8)_1599-1611.nxml.txt.nlp	24889822	SENT245	23	23	10	10	resveratrol	SIRT1		23411	0.921
NULL	Ann_Gen_Psychiatry_2010_Apr_22_9(Suppl_1)_S224.nxml.txt.nlp	NULL	SENT7	5	5	1	1	aripiprazole	NNT	PA10026	23530	0.921
NULL	Oncotarget_2014_Jun_7_5(13)_5017-5028.nxml.txt.nlp	24970809	SENT196	17	17	7	7	carboplatin	GCIP	PA448803	23582	0.921
NULL	Behav_Brain_Funct_2005_Jul_15_1_9.nxml.txt.nlp	16022733	SENT175	26	26	16	16	clonidine	NET1	PA449051	55119;10276	0.921
NULL	Br_J_Cancer_2013_Feb_5_108(2)_319-326.nxml.txt.nlp	23322198	SENT157	29	29	17	17	celecoxib	VEGFR	PA448871	3791	0.921
NULL	J_Korean_Med_Sci_2010_Nov_26_25(11)_1626-1632.nxml.txt.nlp	21060752	SENT144	8	8	23	23	forskolin	JNK	PA146096022	5599	0.921
NULL	Atherosclerosis_2014_Nov_237(1)_287-300.nxml.txt.nlp	25299963	SENT921	21	21	25	25	rosiglitazone	gamma	PA451283	9913	0.921
NULL	Adv_Urol_2012_Oct_26_2012_812398.nxml.txt.nlp	22110495	SENT116	44	44	32	32	cisplatin	ERCC1	PA449014	2067	0.921
NULL	Acta_Pharmacol_Sin_2014_Aug_21_35(8)_1082-1092.nxml.txt.nlp	25047514	SENT200	8	8	26	26	letrozole	aromatase	PA450196	1588	0.921
NULL	Br_J_Anaesth_2014_Jul_22_113(1)_157-167.nxml.txt.nlp	24154701	SENT265	10	10	8	8	sevoflurane	TREK-1	PA451341	3776	0.921
NULL	Front_Immunol_2012_Jan_12_2_98.nxml.txt.nlp	22566887	SENT261	24	24	13	13	ns-398	TRAIL		8743	0.921
NULL	Arthritis_Res_Ther_2014_Sep_26_16(5)_429.nxml.txt.nlp	25606593	SENT104	2	2	16	16	rituximab	IL-6	PA451261	3569	0.921
NULL	J_Cancer_2014_Jul_4_5(7)_559-571.nxml.txt.nlp	25057307	SENT239	12	12	2	2	tamoxifen	STAT3	PA451581	6774	0.921
NULL	Cancers_(Basel)_2014_Jul_8_6(3)_1487-1499.nxml.txt.nlp	25006835	SENT48	5	5	14	14	cisplatin	AMPK	PA449014	5563	0.921
NULL	Ann_Pediatr_Cardiol_2008_Jul-Dec_1(2)_131-134.nxml.txt.nlp	20300255	SENT36	0	0	21	21	heparin	ACT	PA449855	12;11332;9457;641455	0.921
NULL	Breast_Cancer_Res_2010_Jun_24_12(3)_R41.nxml.txt.nlp	20576088	SENT157	33	33	16	16	paclitaxel	IGF1	PA450761	3479	0.921
NULL	Acta_Pharmacol_Sin_2014_Aug_7_35(8)_1023-1030.nxml.txt.nlp	24998255	SENT14	8	8	24	24	octreotide	STAT3	PA450678	6774	0.921
NULL	Mol_Cancer_2009_Apr_16_8_24.nxml.txt.nlp	19371427	SENT14	25	25	22	22	cisplatin	CHK1	PA449014	1111	0.921
NULL	Cell_Death_Dis_2013_Jun_27_4(6)_e694.nxml.txt.nlp	23807223	SENT56	2	2	12	12	chloroquine	p38	PA448948	10598;1432;7965	0.921
NULL	Cell_Death_Dis_2014_Jan_16_5(1)_e1000.nxml.txt.nlp	24434508	SENT326	15	15	2	2	etoposide	p53	PA449552	7157	0.921
NULL	Bioinformation_2011_Sep_6_7(2)_59-63.nxml.txt.nlp	21938206	SENT98	27	27	11	11	cefazolin	PON1	PA448839	5444	0.921
NULL	J_Hematol_Oncol_2010_May_2_3_18.nxml.txt.nlp	20433767	SENT97	13	13	3	3	erlotinib	EGFR	PA134687924	1956	0.921
NULL	J_Korean_Med_Sci_2013_Apr_27_28(4)_527-533.nxml.txt.nlp	23580227	SENT107	8	8	1	1	genistein	TRAIL	PA165109660	8743	0.921
NULL	Oncol_Rep_2013_Oct_24_30(4)_1587-1592.nxml.txt.nlp	23900512	SENT117	16	16	12	12	pargyline	NOXA	PA450797	5366	0.921
NULL	J_Cell_Biol_2005_Jul_4_170(1)_49-59.nxml.txt.nlp	15983061	SENT152	44	44	27	27	forskolin	MITF	PA146096022	4286	0.921
NULL	Evid_Based_Complement_Alternat_Med_2012_Dec_17_2012_485262.nxml.txt.nlp	23304202	SENT103	19	19	12	12	thrombin	ADP	PA451674	23038	0.921
NULL	Curr_Oncol_2009_Jan_16(1)_16-26.nxml.txt.nlp	19229368	SENT50	13	13	23	23	panitumumab	KRAS	PA162373091	3845	0.921
NULL	Adv_Hematol_2012_Jul_24_2012_513702.nxml.txt.nlp	22888354	SENT60	0	0	15	15	lenalidomide	MDM2	PA162363968	4193	0.921
NULL	Br_J_Cancer_2013_Sep_17_109(6)_1625-1635.nxml.txt.nlp	23969726	SENT161	13	13	17	17	imatinib	KIT	PA10804	3815	0.92
NULL	Oxid_Med_Cell_Longev_2011_May_23_2011_213286.nxml.txt.nlp	NULL	SENT125	21	21	16	16	ethanol	CYP2E1	PA448073	1571	0.92
NULL	Front_Immunol_2013_Oct_28_4_346.nxml.txt.nlp	24194739	SENT180	5	5	3	3	vemurafenib	BRAF	PA165946873	673	0.92
NULL	J_Korean_Med_Sci_2011_Dec_29_26(12)_1563-1568.nxml.txt.nlp	22147992	SENT93	14	14	12	12	ekb-569	EGFR		1956	0.92
NULL	Curr_Neuropharmacol_2013_Jul_11(4)_414-429.nxml.txt.nlp	24381531	SENT468	7	7	4	4	fenofibrate	NF-kappaB	PA449594	4790	0.92
NULL	Oncotarget_2014_Oct_18_5(22)_11641-11652.nxml.txt.nlp	25361002	SENT85	3	3	8	8	cisplatin	NAC	PA449014	22861	0.92
NULL	Acta_Pharmacol_Sin_2012_Oct_3_33(10)_1311-1318.nxml.txt.nlp	22941289	SENT138	5	5	19	19	sorafenib	VEGFR2	PA7000	3791	0.92
NULL	Mol_Cancer_2013_Nov_13_12_137.nxml.txt.nlp	24225025	SENT206	47	47	11	11	doxorubicin	HMGB1	PA449412	3146	0.92
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Nov_10_68(Pt_12)_o3314.nxml.txt.nlp	23476159	SENT69	27	27	8	8	ethanol	mol	PA448073	90527	0.92
NULL	Arthritis_Res_2001_Sep_13_3(6)_342-347.nxml.txt.nlp	11714388	SENT193	13	13	10	10	heparin	PRELP	PA449855	5549	0.92
NULL	Cardiovasc_Diabetol_2011_Aug_10_10_74.nxml.txt.nlp	21827713	SENT31	0	0	13	13	candesartan	AT1	PA448765	9197;185	0.92
NULL	Acta_Pharmacol_Sin_2013_Jul_5_34(7)_870-879.nxml.txt.nlp	23624759	SENT140	26	26	11	11	tamoxifen	Bcl-2	PA451581	596	0.92
NULL	J_Cell_Mol_Med_2014_Feb_5_18(2)_263-273.nxml.txt.nlp	24304472	SENT212	13	13	4	4	prazosin	p38	PA451093	10598;1432;7965	0.92
NULL	J_Cancer_2013_Mar_15_4(3)_241-250.nxml.txt.nlp	23459666	SENT96	11	11	4	4	vemurafenib	EGFR	PA165946873	1956	0.92
NULL	Mol_Cancer_2012_May_14_11_33.nxml.txt.nlp	22583829	SENT9	22	22	10	10	cisplatin	TLR4	PA449014	7099	0.92
NULL	J_Neuroinflammation_2010_Sep_7_7_51.nxml.txt.nlp	20822529	SENT102	5	5	2	2	hemin	HO-1	PA449849	3162	0.92
NULL	J_Adv_Pract_Oncol_2013_Jul_1_Jul-Aug_4(4)_263-268.nxml.txt.nlp	25032007	SENT102	2	2	13	13	tramadol	CYP2D6	PA451735	1565	0.92
NULL	Oncotarget_2013_Dec_24_5(9)_2418-2427.nxml.txt.nlp	24810714	SENT82	38	38	25	25	cisplatin	NAC	PA449014	22861	0.92
NULL	Indian_J_Endocrinol_Metab_2013_Sep-Oct_17(5)_835-843.nxml.txt.nlp	24083164	SENT214	31	31	34	34	liraglutide	GLP-1	PA165958364	100125288	0.92
NULL	J_Immunother_Cancer_2013_Nov_7_1(Suppl_1)_P91.nxml.txt.nlp	NULL	SENT12	17	17	10	10	docetaxel	CD133	PA449383	8842	0.92
NULL	Pharmaceuticals_(Basel)_2012_Aug_10_5(8)_802-836.nxml.txt.nlp	24280676	SENT25	18	18	8	8	gemcitabine	CNT2	PA449748	9153	0.92
NULL	Indian_J_Pharm_Sci_2013_Jan-Feb_75(1)_94-98.nxml.txt.nlp	23901167	SENT82	3	3	17	17	tolbutamide	CYP2C9	PA451718	1559	0.92
NULL	Blood_Cancer_J_2012_Oct_19_2(10)_e95.nxml.txt.nlp	23085780	SENT153	14	14	45	45	nilotinib	CML	PA165958345	613	0.92
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_16_2012_395912.nxml.txt.nlp	23118789	SENT149	11	11	0	0	doxepin	UGT1A4	PA449409	54657	0.92
NULL	Evid_Based_Complement_Alternat_Med_2014_May_21_2014_375986.nxml.txt.nlp	24963322	SENT239	8	8	23	23	ethanol	VEGFR2	PA448073	3791	0.92
NULL	J_Mol_Med_2008_Sep_4_86(9)_1045-1056.nxml.txt.nlp	18600309	SENT203	4	4	23	23	salmeterol	MKP-1	PA451300	1843	0.92
NULL	Endocrinology_2012_Jan_15_153(1)_200-211.nxml.txt.nlp	22087024	SENT229	33	33	31	31	methylprednisolone	ACTH	PA450466	5443	0.92
NULL	Cancer_Metab_2013_Jan_23_1_4.nxml.txt.nlp	24280026	SENT15	11	11	15	15	docetaxel	TK1	PA449383	7083	0.92
NULL	EJC_Suppl_2013_Sep_5_11(2)_307-309.nxml.txt.nlp	NULL	SENT50	6	6	1	1	neratinib	EGFR	PA165291472	1956	0.92
NULL	Nucleic_Acids_Res_2013_Mar_29_41(5)_2981-2992.nxml.txt.nlp	23361461	SENT226	14	14	11	11	tetracycline	TDP1	PA451640	55775	0.92
NULL	Nat_Med_2010_Feb_24_16(2)_214-218.nxml.txt.nlp	20098429	SENT57	11	11	4	4	doxorubicin	LAPTM4B	PA449412	55353	0.92
NULL	Ann_Gen_Psychiatry_2013_Aug_13_12_26.nxml.txt.nlp	23941527	SENT177	5	5	1	1	venlafaxine	NMA	PA451866	25805	0.92
NULL	Cancer_Med_2013_Aug_2_2(4)_571-582.nxml.txt.nlp	24156030	SENT234	27	27	15	15	curcumin	IL-6	PA151958596	3569	0.92
NULL	Biologics_2014_Apr_23_8_183-192.nxml.txt.nlp	24790411	SENT25	0	0	31	31	afatinib	EGFR	PA165981154	1956	0.92
NULL	BioDrugs_2013_May_9_27(5)_469-478.nxml.txt.nlp	23658121	SENT90	12	12	2	2	gemcitabine	TPC	PA449748	8030;60386	0.92
NULL	Mol_Cancer_2014_Jul_5_13_165.nxml.txt.nlp	24996221	SENT220	38	38	28	28	docetaxel	HMGB1	PA449383	3146	0.92
NULL	J_Hematol_Oncol_2013_Nov_5_6_83.nxml.txt.nlp	24283248	SENT38	6	6	21	21	nutlin-3	TP53		7157	0.92
NULL	Ann_Hematol_2010_Nov_25_89(11)_1115-1124.nxml.txt.nlp	20499237	SENT155	5	5	30	30	simvastatin	CD19	PA451363	930	0.92
NULL	J_Biomed_Biotechnol_2011_Dec_6_2011_856985.nxml.txt.nlp	21188173	SENT300	14	14	18	18	vorinostat	aromatase	PA164748224	1588	0.92
NULL	Oncol_Lett_2014_May_11_7(5)_1401-1408.nxml.txt.nlp	24765145	SENT135	23	23	16	16	paclitaxel	HIF-1	PA450761	29072	0.92
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_May_22_66(Pt_6)_o1397.nxml.txt.nlp	21579476	SENT47	24	24	18	18	ethanol	mol	PA448073	90527	0.92
NULL	Nucleic_Acids_Res_2005_Dec_9_33(22)_6972-6981.nxml.txt.nlp	16340007	SENT135	10	10	20	20	bleomycin	DNA-PKcs	PA448645	5591	0.92
NULL	Neural_Plast_2007_Jan_10_2007_78171.nxml.txt.nlp	17502911	SENT48	30	30	19	19	tiagabine	spatial	PA451682	219793	0.92
NULL	Blood_Cancer_J_2013_Jul_19_3(7)_e128.nxml.txt.nlp	23872707	SENT100	31	31	28	28	everolimus	TSC1	PA164746311	7248	0.92
NULL	Cancer_Manag_Res_2012_Feb_24_4_67-73.nxml.txt.nlp	22427733	SENT27	16	16	26	26	granisetron	CYP2D6	PA449809	1565	0.92
NULL	Br_J_Clin_Pharmacol_2013_Aug_23_76(2)_299-315.nxml.txt.nlp	23701319	SENT230	14	14	7	7	alemtuzumab	IL-17	PA164783958	3605	0.92
NULL	Oncotarget_2014_Nov_8_5(21)_10280-10292.nxml.txt.nlp	25373733	SENT200	21	21	11	11	bevacizumab	HIF-1	PA130232992	29072	0.92
NULL	Mol_Cancer_2012_May_14_11_33.nxml.txt.nlp	22583829	SENT14	17	17	27	27	cisplatin	TLR4	PA449014	7099	0.92
NULL	Patient_Prefer_Adherence_2011_Dec_23_6_1-9.nxml.txt.nlp	22272064	SENT79	0	0	23	23	telmisartan	ACE	PA451605	1636	0.92
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT782	14	14	8	8	maraviroc	CYP3A4	PA164768835	1576	0.92
NULL	J_Korean_Med_Sci_2011_Jul_20_26(7)_919-926.nxml.txt.nlp	21738346	SENT176	5	5	12	12	hyaluronidase	CD44	PA164745713	960	0.92
NULL	Oncol_Lett_2014_May_26_7(5)_1345-1351.nxml.txt.nlp	24765136	SENT96	0	0	15	15	sorafenib	VEGFR	PA7000	3791	0.92
NULL	J_Int_AIDS_Soc_2011_Nov_15_14_55.nxml.txt.nlp	22085598	SENT194	24	24	21	21	maraviroc	CCR5	PA164768835	1234	0.92
NULL	Chemother_Res_Pract_2011_Dec_1_2011_715469.nxml.txt.nlp	22312557	SENT40	21	21	17	17	cisplatin	p53	PA449014	7157	0.92
NULL	Epilepsia_2012_Jun_21_53(Suppl_1)_18-25.nxml.txt.nlp	22612805	SENT120	6	6	22	22	furosemide	CA1	PA449719	759	0.92
NULL	Mol_Cancer_2007_Aug_21_6_53.nxml.txt.nlp	17711579	SENT212	30	30	17	17	cisplatin	p53	PA449014	7157	0.92
NULL	Indian_J_Urol_2007_Jul-Sep_23(3)_334-335.nxml.txt.nlp	19718350	SENT27	2	2	7	7	dutasteride	MVD	PA164749300	4597	0.92
NULL	Acta_Crystallogr_Sect_F_Struct_Biol_Cryst_Commun_2011_Aug_16_67(Pt_9)_1070-1077.nxml.txt.nlp	21904052	SENT373	3	3	23	23	pemetrexed	DHFR	PA10810	1719	0.92
NULL	Chemother_Res_Pract_2012_Aug_29_2012_817297.nxml.txt.nlp	22970367	SENT54	5	5	8	8	erlotinib	IGF1R	PA134687924	3480	0.92
NULL	Indian_J_Med_Paediatr_Oncol_2014_Apr-Jun_35(2)_176-180.nxml.txt.nlp	25197183	SENT25	38	38	20	20	gemcitabine	TANGO	PA449748	375056	0.92
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_33-43.nxml.txt.nlp	17912634	SENT196	22	22	27	27	tamoxifen	HER2	PA451581	2064	0.92
NULL	Acta_Orthop_2009_Feb_26_80(1)_46-50.nxml.txt.nlp	19234885	SENT6	9	9	21	21	celecoxib	TKR	PA448871	8277	0.92
NULL	Target_Oncol_2013_Mar_30_8(1)_27-33.nxml.txt.nlp	23361373	SENT67	22	22	2	2	gefitinib	EGFR	PA131301952	1956	0.92
NULL	J_Oncol_2010_Dec_28_2010_414676.nxml.txt.nlp	20066160	SENT102	13	13	37	37	carboplatin	EGF	PA448803	1950	0.92
NULL	Indian_J_Med_Res_2014_Feb_139(2)_195-204.nxml.txt.nlp	24718393	SENT165	0	0	30	30	fluconazole	CYP2C9	PA449653	1559	0.92
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT277	16	16	8	8	resveratrol	NAC		22861	0.92
NULL	Int_J_Mol_Sci_2014_Mar_20_15(3)_4965-4976.nxml.txt.nlp	24658440	SENT5	12	12	7	7	cyclosporine	P-gp	PA449167	5243	0.92
NULL	Comp_Hepatol_2005_Feb_8_4_2.nxml.txt.nlp	15701172	SENT92	24	24	7	7	ketoconazole	CYP3A	PA450146	1574	0.92
NULL	Cancers_(Basel)_2010_Dec_30_3(1)_106-125.nxml.txt.nlp	24212609	SENT114	22	22	0	0	doxycycline	MRP5	PA449415	10057	0.92
NULL	F1000Res_2014_Aug_19_3_198.nxml.txt.nlp	25400908	SENT173	0	0	13	13	trastuzumab	p27	PA451743	5715;10534	0.92
NULL	J_Cell_Biol_2008_Jun_16_181(6)_1013-1026.nxml.txt.nlp	18541700	SENT57	13	13	36	36	heparin	RhoA	PA449855	387	0.92
NULL	Arch_Pharm_Res_2013_Apr_27_36(9)_1126-1132.nxml.txt.nlp	23625750	SENT62	6	6	23	23	lipase	LIPA	PA450239	3988;10648	0.92
NULL	Diabetes_Care_2008_Oct_31(10)_1939-1944.nxml.txt.nlp	18599530	SENT119	19	19	4	4	gliclazide	SUR1	PA10892	6833	0.92
NULL	Cell_Commun_Signal_2014_Sep_30_12(1)_63.nxml.txt.nlp	NULL	SENT260	2	2	15	15	ns-398	COX		1351	0.92
NULL	Breast_Cancer_Res_2011_Oct_12_13(5)_220.nxml.txt.nlp	22018398	SENT212	37	37	27	27	tamoxifen	STAT5B	PA451581	6777	0.92
NULL	Front_Oncol_2013_Apr_23_3_86.nxml.txt.nlp	23630663	SENT105	8	8	20	20	ertumaxomab	ERBB2	PA165291442	2064	0.92
NULL	J_Korean_Neurosurg_Soc_2013_Oct_31_54(4)_329-335.nxml.txt.nlp	24294457	SENT183	31	31	34	34	trastuzumab	HER-2	PA451743	2064	0.92
NULL	Pharmaceutics_2011_Oct_12_3(4)_680-705.nxml.txt.nlp	24309303	SENT73	4	4	17	17	clarithromycin	CYP3A4	PA449028	1576	0.92
NULL	Front_Neurosci_2014_Feb_6_8_12.nxml.txt.nlp	24567701	SENT200	20	20	7	7	probenecid	KMO	PA451106	8564	0.92
NULL	Front_Genet_2011_Jul_18_2_49.nxml.txt.nlp	22303345	SENT140	7	7	2	2	estradiol	EGFR	PA449503	1956	0.92
NULL	Br_J_Cancer_2010_Dec_7_103(12)_1765-1772.nxml.txt.nlp	21139621	SENT105	19	19	10	10	cetuximab	EGFR	PA10040	1956	0.92
NULL	Curr_Cardiol_Rev_2010_Nov_6(4)_298-308.nxml.txt.nlp	22043206	SENT156	2	2	19	19	forskolin	p47phox	PA146096022	653361	0.92
NULL	Front_Neurosci_2010_Nov_19_4_192.nxml.txt.nlp	21151361	SENT227	22	22	32	32	methamphetamine	spatial	PA450403	219793	0.92
NULL	J_Geriatr_Cardiol_2013_Sep_10(3)_211-212.nxml.txt.nlp	24133505	SENT6	29	29	1	1	paclitaxel	DES	PA450761	1674	0.92
NULL	Cancer_Med_2013_Feb_3_2(1)_76-85.nxml.txt.nlp	24133630	SENT176	14	14	17	17	vemurafenib	PI3K	PA165946873	5290	0.92
NULL	J_Cardiothorac_Surg_2014_Sep_17_9(1)_129.nxml.txt.nlp	NULL	SENT80	3	3	15	15	protamine	ACT	PA10366	12;11332;9457;641455	0.92
NULL	JAKSTAT_2014_Jun_12_3_e29554.nxml.txt.nlp	25105067	SENT41	33	33	3	3	propofol	STAT3	PA451141	6774	0.92
NULL	Onco_Targets_Ther_2014_Jul_1_7_1185-1193.nxml.txt.nlp	25061320	SENT153	12	12	20	20	vinorelbine	EGFR	PA451881	1956	0.92
NULL	Mol_Cancer_2010_Apr_21_9_83.nxml.txt.nlp	20409325	SENT192	12	12	0	0	cisplatin	AKT2	PA449014	208	0.92
NULL	Oncotarget_2011_Jul_1_2(7)_538-550.nxml.txt.nlp	21730367	SENT196	21	21	14	14	doxorubicin	PTEN	PA449412	5728	0.92
NULL	Indian_J_Pharm_Sci_2013_Jan-Feb_75(1)_94-98.nxml.txt.nlp	23901167	SENT30	10	10	32	32	phenacetin	CYP2C19	PA450897	1557	0.92
NULL	Oncotarget_2014_Oct_16_5(20)_9546-9563.nxml.txt.nlp	25337673	SENT117	10	10	17	17	erlotinib	EGFR	PA134687924	1956	0.92
NULL	J_Immunother_Cancer_2014_Nov_6_2(Suppl_3)_P168.nxml.txt.nlp	NULL	SENT21	38	38	12	12	rituximab	CD19	PA451261	930	0.92
NULL	Br_J_Cancer_2009_Jul_7_101(1)_166-173.nxml.txt.nlp	19513072	SENT150	15	15	43	43	bortezomib	UBE2C	PA10252	11065	0.92
NULL	Case_Rep_Pulmonol_2014_Jul_15_2014_837612.nxml.txt.nlp	25126437	SENT6	6	6	22	22	furosemide	PTPA	PA449719	5524	0.92
NULL	Genome_Biol_2008_Nov_25_9(11)_R166.nxml.txt.nlp	19032775	SENT176	28	28	11	11	suramin	EGFR	PA10292	1956	0.92
NULL	Support_Care_Cancer_2012_Mar_20_20(3)_647-652.nxml.txt.nlp	22101611	SENT21	14	14	10	10	doxorubicin	CHOP	PA449412	1649	0.92
NULL	Oncotarget_2014_Feb_25_5(5)_1304-1314.nxml.txt.nlp	24675421	SENT146	29	29	3	3	cisplatin	JNK	PA449014	5599	0.92
NULL	Acta_Pharmacol_Sin_2011_Aug_18_32(8)_1031-1037.nxml.txt.nlp	21765446	SENT114	1	1	22	22	raloxifene	MCP-1	PA451221	6347	0.92
NULL	Curr_Neuropharmacol_2013_Mar_11(2)_160-170.nxml.txt.nlp	23997751	SENT124	18	18	4	4	haloperidol	5-HT1A	PA449841	3350	0.92
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT392	46	46	27	27	heparin	FGF2	PA449855	2247;2258	0.92
NULL	Int_J_Mol_Sci_2014_Oct_8_15(10)_17974-17999.nxml.txt.nlp	25299695	SENT137	19	19	13	13	curcumin	HO-2	PA151958596	3163	0.92
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_91-103.nxml.txt.nlp	17912639	SENT357	20	20	6	6	aminoglutethimide	aromatase	PA448375	1588	0.92
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT285	2	2	21	21	atorvastatin	PIK3CA	PA448500	5290	0.92
NULL	Respir_Med_Case_Rep_2013_Aug_8_10_27-30.nxml.txt.nlp	NULL	SENT47	32	32	1	1	everolimus	DLST	PA164746311	1743	0.92
NULL	Front_Oncol_2014_Mar_6_4_40.nxml.txt.nlp	24639951	SENT134	0	0	5	5	lapatinib	HER2	PA152241907	2064	0.92
NULL	Cough_2007_Dec_23_3_10.nxml.txt.nlp	18154688	SENT93	0	0	16	16	capsaicin	TRPV1	PA448776	7442	0.92
NULL	Clin_Sci_(Lond)_2012_Oct_1_123(Pt_8)_473-486.nxml.txt.nlp	22757958	SENT74	0	0	28	28	glucosamine	HBP	PA164747613	3069;50865;7884;566	0.92
NULL	Cancer_Med_2013_Jun_25_2(3)_277-285.nxml.txt.nlp	23930204	SENT8	22	22	8	8	bevacizumab	PTEN	PA130232992	5728	0.92
NULL	Br_J_Cancer_2011_Dec_6_105(12)_1850-1855.nxml.txt.nlp	22095231	SENT20	11	11	9	9	gefitinib	EGFR	PA131301952	1956	0.92
NULL	Breast_Cancer_Res_2002_Jan_14_4(2)_65-69.nxml.txt.nlp	11879566	SENT72	20	20	9	9	estradiol	IL-4	PA449503	3565	0.92
NULL	Cell_Death_Dis_2010_Nov_18_1(11)_e102.nxml.txt.nlp	21368867	SENT134	12	12	26	26	gentamicin	CLIMP-63	PA449753	10970	0.92
NULL	Adv_Hematol_2012_Mar_25_2012_302570.nxml.txt.nlp	22536253	SENT301	4	4	19	19	coumarin	p53	PA134521193	7157	0.92
NULL	Mol_Cancer_2013_Mar_5_12_18.nxml.txt.nlp	23497290	SENT138	16	16	7	7	doxycycline	GRK6	PA449415	2870	0.92
NULL	Support_Care_Cancer_2012_Jul_6_20(7)_1533-1540.nxml.txt.nlp	21822636	SENT59	23	23	28	28	tamoxifen	aromatase	PA451581	1588	0.92
NULL	J_Invest_Dermatol_2014_Jul_31_134(7)_1903-1911.nxml.txt.nlp	24487305	SENT221	21	21	26	26	chloroquine	IL-9	PA448948	3578	0.92
NULL	Breast_Cancer_Res_2010_Aug_9_12(4)_R62.nxml.txt.nlp	20696059	SENT241	0	0	23	23	trastuzumab	AKT	PA451743	207	0.92
NULL	Cancer_Manag_Res_2013_Jul_31_5_187-195.nxml.txt.nlp	23986650	SENT61	41	41	20	20	carboplatin	HER2	PA448803	2064	0.92
NULL	J_Hematol_Oncol_2010_Mar_13_3_10.nxml.txt.nlp	20226083	SENT31	7	7	23	23	docetaxel	RRM1	PA449383	6240	0.92
NULL	Lung_2010_Jan_16_188(Suppl_1)_99-103.nxml.txt.nlp	19756864	SENT30	0	0	10	10	mannitol	DPI	PA450320	1832	0.92
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Nov_21_65(Pt_12)_o3125.nxml.txt.nlp	21578848	SENT59	19	19	13	13	ethanol	mol	PA448073	90527	0.92
NULL	Diabetes_2011_Jul_20_60(7)_1907-1916.nxml.txt.nlp	21593200	SENT247	27	27	0	0	glucose	TNF	PA449773	7124	0.92
NULL	Arthritis_Res_Ther_2007_Oct_9_9(5)_R104.nxml.txt.nlp	17925024	SENT149	23	23	12	12	glucosamine	JNK	PA164747613	5599	0.92
NULL	Cancer_Imaging_2013_Jul_22_13(3)_306-313.nxml.txt.nlp	23876444	SENT172	7	7	26	26	vemurafenib	FDG	PA165946873	23583	0.92
NULL	Arch_Osteoporos_2013_Mar_29_8(1-2)_131.nxml.txt.nlp	23539323	SENT64	8	8	11	11	teriparatide	PTH	PA451620	5741	0.92
NULL	Acta_Pharmacol_Sin_2009_Feb_5_30(2)_228-234.nxml.txt.nlp	19122672	SENT122	5	5	8	8	isoflurane	HO-1	PA450106	3162	0.92
NULL	Int_J_Biol_Sci_2014_Sep_10_10(9)_1024-1038.nxml.txt.nlp	25285035	SENT338	24	24	43	43	haloperidol	Yes	PA449841	7525	0.92
NULL	Mol_Vis_2011_Feb_1_17_332-340.nxml.txt.nlp	21297899	SENT116	17	17	30	30	telmisartan	NAC	PA451605	22861	0.92
NULL	Front_Oncol_2014_Jun_16_4_148.nxml.txt.nlp	24982848	SENT101	6	6	34	34	cisplatin	p38	PA449014	10598;1432;7965	0.92
NULL	Exp_Ther_Med_2014_Oct_31_8(4)_1185-1190.nxml.txt.nlp	25187821	SENT69	17	17	6	6	mannitol	RAGE	PA450320	177	0.92
NULL	J_Cancer_2014_Jan_28_5(3)_173-181.nxml.txt.nlp	24563672	SENT46	6	6	11	11	metformin	aromatase	PA450395	1588	0.92
NULL	Indian_J_Nephrol_2010_Jan-Mar_20(1)_9-14.nxml.txt.nlp	20535264	SENT45	19	19	6	6	lovastatin	PON2	PA450272	5445	0.92
NULL	Addiction_2013_Nov_5_108(11)_1905-1914.nxml.txt.nlp	23692519	SENT134	22	22	44	44	ethanol	2-19	PA448073	60343	0.92
NULL	Case_Rep_Oncol_2013_Feb_16_6(1)_90-97.nxml.txt.nlp	23626551	SENT86	5	5	13	13	sunitinib	EWSR1	PA162372840	2130	0.92
NULL	J_Cell_Mol_Med_2014_Dec_9_18(12)_2499-2511.nxml.txt.nlp	24912879	SENT18	10	10	2	2	docetaxel	DACH1	PA449383	1602	0.92
NULL	J_Gen_Physiol_2000_Jun_1_115(6)_685-696.nxml.txt.nlp	10828243	SENT7	3	3	14	14	genistein	OLF	PA165109660	83857	0.92
NULL	Nat_Commun_2014_Nov_25_5_5548.nxml.txt.nlp	25420520	SENT12	13	13	0	0	docetaxel	ERG	PA449383	2078	0.92
NULL	FEBS_Open_Bio_2014_Jan_6_4_77-89.nxml.txt.nlp	24490132	SENT50	7	7	11	11	ebselen	GDH	PA161660841	51084;2746	0.92
NULL	J_Res_Med_Sci_2012_Feb_17(2)_159-163.nxml.txt.nlp	23264790	SENT30	8	8	18	18	imatinib	CD117	PA10804	3815	0.92
NULL	Mol_Cancer_2007_Mar_7_6_18.nxml.txt.nlp	17343740	SENT472	7	7	21	21	docetaxel	RANK	PA449383	8792	0.92
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1013.nxml.txt.nlp	24457957	SENT89	5	5	20	20	bortezomib	NOXA	PA10252	5366	0.92
NULL	Cancer_Cell_Int_2013_Sep_23_13_94.nxml.txt.nlp	24059699	SENT148	18	18	6	6	bevacizumab	VEGFR2	PA130232992	3791	0.92
NULL	Front_Oncol_2014_Mar_6_4_40.nxml.txt.nlp	24639951	SENT410	10	10	17	17	cisplatin	P-gp	PA449014	5243	0.92
NULL	Antimicrob_Agents_Chemother_2014_Nov_10_59(1)_505-513.nxml.txt.nlp	25385096	SENT244	15	15	0	0	primaquine	CYP2D6	PA451103	1565	0.92
NULL	J_Oncol_2013_Aug_20_2013_732047.nxml.txt.nlp	24027583	SENT109	15	15	4	4	cyclophosphamide	HER2	PA449165	2064	0.92
NULL	J_Hum_Genet_2013_Jun_16_58(6)_353-361.nxml.txt.nlp	23677058	SENT125	11	11	16	16	etoposide	ABCC3	PA449552	8714	0.92
NULL	Int_J_Mol_Sci_2013_Aug_14_14(8)_16719-16731.nxml.txt.nlp	23949634	SENT20	30	30	8	8	thrombin	ACPP	PA451674	55	0.92
NULL	Biosci_Rep_2014_Jan_17_34(1)_e00090.nxml.txt.nlp	24262079	SENT84	24	24	29	29	trastuzumab	HER2	PA451743	2064	0.92
NULL	J_Headache_Pain_2014_Sep_18_15(Suppl_1)_D11.nxml.txt.nlp	NULL	SENT13	2	2	20	20	natalizumab	MIDAS	PA164747191	64083	0.92
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT307	8	8	13	13	cisplatin	p38	PA449014	10598;1432;7965	0.92
NULL	Front_Oncol_2013_Apr_23_3_86.nxml.txt.nlp	23630663	SENT155	25	25	20	20	lapatinib	ERBB2	PA152241907	2064	0.92
NULL	Oncotarget_2011_Aug_28_2(8)_588-589.nxml.txt.nlp	21876228	SENT16	17	17	3	3	lapatinib	PTPN12	PA152241907	5782	0.92
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e147.nxml.txt.nlp	21509037	SENT139	24	24	17	17	gentamicin	B27	PA449753	56246	0.92
NULL	Pharmacogn_Rev_2011_Jul-Dec_5(10)_189-194.nxml.txt.nlp	22279377	SENT27	9	9	14	14	artemisinin	ACT	PA165111696	12;11332;9457;641455	0.92
NULL	Mol_Vis_2010_Sep_2_16_1781-1790.nxml.txt.nlp	20824160	SENT102	2	2	15	15	forskolin	ZO-1	PA146096022	7082	0.92
NULL	J_Oncol_2012_Nov_10_2012_358472.nxml.txt.nlp	22131994	SENT89	0	0	11	11	sorafenib	VEGFR2	PA7000	3791	0.92
NULL	J_Mol_Med_(Berl)_2013_Apr_10_91(4)_473-483.nxml.txt.nlp	23052483	SENT165	22	22	10	10	bevacizumab	LC3	PA130232992	84557	0.92
NULL	Acta_Naturae_2012_Apr-Jun_4(2)_98-101.nxml.txt.nlp	22880163	SENT80	3	3	24	24	thrombin	spatial	PA451674	219793	0.92
NULL	Diabetes_Care_2009_Nov_32(Suppl_2)_S223-S231.nxml.txt.nlp	19875556	SENT257	37	37	25	25	metformin	GLP-1	PA450395	100125288	0.92
NULL	Arthritis_Res_Ther_2009_Aug_28_11(4)_R131.nxml.txt.nlp	19715572	SENT107	3	3	8	8	rituximab	CD19	PA451261	930	0.92
NULL	Eur_Respir_J_2013_May_27_41(5)_1107-1115.nxml.txt.nlp	23018904	SENT25	0	0	11	11	ciprofloxacin	DPI	PA449009	1832	0.92
NULL	J_Cell_Biol_2002_Nov_25_159(4)_637-648.nxml.txt.nlp	12438416	SENT72	21	21	10	10	etoposide	p115	PA449552	8615;393	0.92
NULL	Mol_Cancer_2010_May_20_9_115.nxml.txt.nlp	20487546	SENT168	7	7	28	28	fludarabine	TP53	PA449655	7157	0.92
NULL	Cell_Commun_Signal_2013_Nov_5_11_83.nxml.txt.nlp	24192293	SENT110	5	5	9	9	doxycycline	IL-6	PA449415	3569	0.92
NULL	Adv_Hematol_2012_Jul_11_2012_906247.nxml.txt.nlp	22829835	SENT117	5	5	22	22	lenalidomide	CD34	PA162363968	947	0.92
NULL	Evid_Based_Complement_Alternat_Med_2006_Jun_5_3(2)_255-260.nxml.txt.nlp	16786056	SENT93	0	0	3	3	indomethacin	COX	PA449982	1351	0.92
NULL	Chin_J_Cancer_2012_Aug_31(8)_373-380.nxml.txt.nlp	22739266	SENT139	20	20	16	16	cytarabine	MSH6	PA449177	2956	0.92
NULL	Biol_Open_2014_Jul_25_3(8)_767-776.nxml.txt.nlp	25063197	SENT26	0	0	6	6	denosumab	RANKL	PA166048634	8600	0.92
NULL	Apoptosis_2012_Sep_30_17(9)_989-997.nxml.txt.nlp	22460505	SENT112	3	3	16	16	thioridazine	PI3K	PA451666	5290	0.92
NULL	Onco_Targets_Ther_2014_Dec_4_7_2249-2255.nxml.txt.nlp	25587220	SENT119	20	20	23	23	verapamil	ABCG2	PA451868	9429	0.92
NULL	Acta_Pharmacol_Sin_2013_Jun_8_34(6)_830-836.nxml.txt.nlp	23564080	SENT180	36	36	16	16	simvastatin	HMGB1	PA451363	3146	0.92
NULL	Brain_Sci_2013_Apr_26_3(2)_670-703.nxml.txt.nlp	24961420	SENT70	9	9	25	25	ethanol	p38	PA448073	10598;1432;7965	0.92
NULL	J_Oncol_2012_Sep_5_2012_128608.nxml.txt.nlp	21904549	SENT168	8	8	6	6	sorafenib	FLT3	PA7000	2322	0.92
NULL	Oncol_Rep_2013_Oct_22_30(4)_1535-1541.nxml.txt.nlp	23877481	SENT106	24	24	16	16	bevacizumab	EGFR	PA130232992	1956	0.92
NULL	Nucleic_Acids_Res_2011_Sep_7_39(17)_7465-7476.nxml.txt.nlp	21653549	SENT180	11	11	2	2	etoposide	DEK	PA449552	7913	0.92
NULL	Pediatr_Blood_Cancer_2013_Sep_3_60(9)_1520-1527.nxml.txt.nlp	23733511	SENT101	9	9	23	23	cyclosporine	CD34	PA449167	947	0.92
NULL	Clin_Med_Insights_Cardiol_2015_Jan_5_8(Suppl_1)_39-44.nxml.txt.nlp	25628512	SENT88	12	12	8	8	doxycycline	TTR	PA449415	7276	0.92
NULL	ScientificWorldJournal_2014_Mar_12_2014_731462.nxml.txt.nlp	24715817	SENT131	9	9	23	23	carrageenan	IL-6	PA448814	3569	0.92
NULL	Arthritis_Res_Ther_2012_May_1_14(3)_R99.nxml.txt.nlp	22546542	SENT106	21	21	6	6	infliximab	IL-6	PA452639	3569	0.92
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT253	7	7	0	0	pp2	Bcl-2		596	0.92
NULL	Lancet_2011_Jun_9_377(9784)_2181-2192.nxml.txt.nlp	21663949	SENT210	15	15	1	1	ezetimibe	SHARP	PA10816	23013	0.92
NULL	Cardiovasc_Res_2013_May_1_98(2)_286-296.nxml.txt.nlp	23334259	SENT180	25	25	3	3	flecainide	NCX	PA449646	3196	0.92
NULL	Diabetes_2011_Nov_17_60(11)_2730-2739.nxml.txt.nlp	21926273	SENT76	15	15	4	4	resveratrol	SIRT1		23411	0.92
NULL	Breast_Cancer_Res_2009_Jun_16_11(3)_R35.nxml.txt.nlp	19531217	SENT25	20	20	5	5	letrozole	aromatase	PA450196	1588	0.92
NULL	Cell_Death_Dis_2012_Nov_15_3(11)_e423.nxml.txt.nlp	23152059	SENT12	14	14	2	2	oxaliplatin	Bcl-2	PA131285527	596	0.92
NULL	J_Cell_Mol_Med_2013_Dec_6_17(12)_1588-1597.nxml.txt.nlp	24199964	SENT61	15	15	1	1	doxycycline	APT	PA449415	653639	0.92
NULL	Cancer_Cell_Int_2013_Sep_23_13_94.nxml.txt.nlp	24059699	SENT14	33	33	14	14	bevacizumab	VEGFA	PA130232992	7422	0.92
NULL	Acta_Pharmacol_Sin_2012_Jul_18_33(7)_918-923.nxml.txt.nlp	22705728	SENT132	20	20	7	7	genistein	aromatase	PA165109660	1588	0.92
NULL	Diabetes_Obes_Metab_2012_Apr_14(4)_304-314.nxml.txt.nlp	22051096	SENT73	41	41	31	31	liraglutide	PPG	PA165958364	5552	0.92
NULL	Cancers_(Basel)_2011_Aug_15_3(3)_3331-3352.nxml.txt.nlp	24212957	SENT242	11	11	5	5	bevacizumab	CD133	PA130232992	8842	0.92
NULL	Mol_Cancer_2012_Oct_22_11_80.nxml.txt.nlp	23088607	SENT70	4	4	14	14	estradiol	HIF-1	PA449503	29072	0.92
NULL	Autophagy_2012_May_1_8(5)_853-855.nxml.txt.nlp	22617440	SENT68	16	16	2	2	imatinib	BECN1	PA10804	8678	0.92
NULL	EMBO_J_2010_May_19_29(10)_1652-1658.nxml.txt.nlp	20389283	SENT78	2	2	26	26	choline	AQP0	PA448976	4284	0.92
NULL	J_Hematol_Oncol_2013_Mar_27_6_23.nxml.txt.nlp	23531342	SENT97	19	19	3	3	mi-63	RITA		55422;84934	0.92
NULL	Breast_Cancer_2013_Mar_1_20(4)_302-309.nxml.txt.nlp	23456736	SENT174	25	25	28	28	tamoxifen	aromatase	PA451581	1588	0.92
NULL	Patient_Prefer_Adherence_2014_Apr_8_8_463-471.nxml.txt.nlp	24748775	SENT154	2	2	26	26	denosumab	RANK	PA166048634	8792	0.92
NULL	Cancer_Med_2014_Aug_14_3(4)_1010-1024.nxml.txt.nlp	24931821	SENT280	34	34	42	42	rituximab	IVL	PA451261	3713	0.92
NULL	Br_J_Cancer_2013_May_14_108(9)_1862-1869.nxml.txt.nlp	23579219	SENT139	2	2	18	18	cetuximab	KRAS	PA10040	3845	0.92
NULL	J_Cardiothorac_Surg_2013_Apr_8_8_71.nxml.txt.nlp	23566712	SENT47	3	3	13	13	heparin	ACT	PA449855	12;11332;9457;641455	0.92
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT14	13	13	3	3	dasatinib	ABCG2	PA162372878	9429	0.92
NULL	Cancers_(Basel)_2013_May_27_5(2)_617-638.nxml.txt.nlp	24216994	SENT7	7	7	3	3	curcumin	PC3	PA151958596	57332;7832;5122	0.92
NULL	Cancer_Cell_Int_2006_Aug_9_6_20.nxml.txt.nlp	16899133	SENT186	10	10	27	27	l-methionine	p27	PA450423	5715;10534	0.92
NULL	Mol_Cancer_2007_Oct_11_6_63.nxml.txt.nlp	17931419	SENT24	36	36	15	15	cetuximab	EGFR	PA10040	1956	0.92
NULL	Int_J_Mol_Sci_2014_Mar_12_15(3)_4356-4392.nxml.txt.nlp	24625663	SENT252	21	21	12	12	gefitinib	EGFR	PA131301952	1956	0.92
NULL	Cancers_(Basel)_2013_Aug_22_5(3)_1103-1119.nxml.txt.nlp	24202336	SENT91	24	24	27	27	temozolomide	EGFR	PA451609	1956	0.92
NULL	Mol_Brain_2013_May_4_6_22.nxml.txt.nlp	23641686	SENT31	6	6	37	37	memantine	NR2D	PA10364	2906	0.92
NULL	J_Korean_Med_Sci_2013_Jul_3_28(7)_1111-1113.nxml.txt.nlp	23853500	SENT70	25	25	15	15	naloxone	ACTH	PA450586	5443	0.92
NULL	Acta_Pharmacol_Sin_2014_Jun_5_35(6)_758-769.nxml.txt.nlp	24793309	SENT305	19	19	8	8	chloroquine	p62	PA448948	8878;10657;23636	0.92
NULL	Cancer_Growth_Metastasis_2013_Aug_8_6_35-52.nxml.txt.nlp	24665206	SENT81	7	7	0	0	curcumin	TRPV1	PA151958596	7442	0.92
NULL	Oncotarget_2013_Feb_27_4(2)_329-345.nxml.txt.nlp	23593654	SENT187	18	18	14	14	paclitaxel	CD44	PA450761	960	0.92
NULL	Ecancermedicalscience_2009_Jun_9_3_148.nxml.txt.nlp	22276013	SENT13	17	17	8	8	letrozole	aromatase	PA450196	1588	0.92
NULL	Cancer_Manag_Res_2014_Jan_28_6_39-51.nxml.txt.nlp	24501545	SENT134	22	22	13	13	dextromethorphan	CYP1A2	PA449273	1544	0.92
NULL	Drug_Saf_2014_Feb_19_37(4)_201-211.nxml.txt.nlp	24550106	SENT118	6	6	3	3	omeprazole	CYP2C19	PA450704	1557	0.92
NULL	Oncoimmunology_2013_Dec_1_2(12)_e26837.nxml.txt.nlp	24501687	SENT20	13	13	17	17	gemcitabine	CD40	PA449748	958	0.92
NULL	Acta_Pharmacol_Sin_2011_Jun_3_32(6)_845-852.nxml.txt.nlp	21642952	SENT91	19	19	7	7	capsaicin	TRPV1	PA448776	7442	0.92
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT294	3	3	11	11	neratinib	EGFR	PA165291472	1956	0.92
NULL	Oncotarget_2012_May_18_3(5)_525-534.nxml.txt.nlp	22619113	SENT85	15	15	3	3	fludarabine	Hsp90	PA449655	3320	0.92
NULL	Mol_Cancer_2007_Sep_26_6_61.nxml.txt.nlp	17894897	SENT189	12	12	5	5	etoposide	BAK	PA449552	578	0.92
NULL	Mol_Vis_2007_Jul_9_13_1083-1093.nxml.txt.nlp	17653053	SENT144	4	4	39	39	minocycline	MCP-1	PA450519	6347	0.92
NULL	Brief_Bioinform_2013_Jul_9_14(4)_491-505.nxml.txt.nlp	22877768	SENT116	11	11	27	27	gefitinib	EGFR	PA131301952	1956	0.92
NULL	Case_Rep_Oncol_2011_Jan_18_4(1)_19-24.nxml.txt.nlp	21526002	SENT27	16	16	6	6	trastuzumab	HER-2	PA451743	2064	0.92
NULL	Emerg_Infect_Dis_2012_Mar_18(3)_537-539.nxml.txt.nlp	22377132	SENT22	11	11	7	7	moxifloxacin	EMB	PA450555	133418	0.92
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_33-43.nxml.txt.nlp	17912634	SENT131	12	12	18	18	tamoxifen	HER2	PA451581	2064	0.92
NULL	Int_J_Surg_Oncol_2012_May_17_2012_406830.nxml.txt.nlp	22675625	SENT125	27	27	11	11	oxaliplatin	STAR	PA131285527	6770;2984	0.92
NULL	Cell_Death_Dis_2014_Apr_24_5(4)_e1197.nxml.txt.nlp	24763054	SENT178	9	9	18	18	doxorubicin	RUNX3	PA449412	864	0.92
NULL	EMBO_Mol_Med_2013_Jul_13_5(7)_983-998.nxml.txt.nlp	23666744	SENT301	20	20	5	5	vinorelbine	TUBGCP4	PA451881	27229	0.92
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1047.nxml.txt.nlp	24503539	SENT85	10	10	7	7	resveratrol	SIRT3		23410	0.92
NULL	Breast_Cancer_Res_2010_Jul_20_12(4)_R52.nxml.txt.nlp	20646288	SENT158	29	29	26	26	letrozole	aromatase	PA450196	1588	0.92
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2007_Dec_6_64(Pt_1)_o213.nxml.txt.nlp	21200779	SENT60	14	14	24	24	ethanol	mol	PA448073	90527	0.92
NULL	Int_J_Biol_Sci_2013_Nov_21_9(10)_1089-1098.nxml.txt.nlp	24339730	SENT164	24	24	10	10	genistein	RUNX2	PA165109660	860	0.92
NULL	Indian_J_Ophthalmol_2010_May-Jun_58(3)_232-234.nxml.txt.nlp	20413928	SENT4	3	3	30	30	triamcinolone	hole	PA451749	80757	0.92
NULL	Orphanet_J_Rare_Dis_2014_Sep_26_9(1)_145.nxml.txt.nlp	NULL	SENT49	20	20	18	18	denosumab	RANKL	PA166048634	8600	0.92
NULL	Front_Neurosci_2014_Jan_17_7_271.nxml.txt.nlp	24478617	SENT110	27	27	8	8	isoflurane	CD4	PA450106	920	0.92
NULL	Cardiovasc_Drugs_Ther_2010_Dec_13_24(5-6)_391-399.nxml.txt.nlp	20640495	SENT163	18	18	11	11	atorvastatin	DIP	PA448500	23151;1831	0.92
NULL	Mol_Biol_Cell_2014_Jun_1_25(11)_1782-1792.nxml.txt.nlp	24719457	SENT99	38	38	25	25	nicotine	ASCL1	PA450626	429	0.92
NULL	Bone_Marrow_Transplant_2015_Jan_6_50(1)_153-154.nxml.txt.nlp	25285805	SENT17	5	5	16	16	fludarabine	CD34	PA449655	947	0.92
NULL	Ther_Clin_Risk_Manag_2007_Jun_3(3)_401-410.nxml.txt.nlp	18488071	SENT227	0	0	29	29	tramadol	ACR	PA451735	49	0.92
NULL	Mol_Cell_Biochem_2014_Jul_26_396(1-2)_221-228.nxml.txt.nlp	25063218	SENT147	9	9	21	21	resveratrol	EGFR		1956	0.92
NULL	J_Gen_Physiol_2000_Jun_1_115(6)_685-696.nxml.txt.nlp	10828243	SENT6	8	8	33	33	genistein	OLF	PA165109660	83857	0.92
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Oct_17_65(Pt_11)_o2775.nxml.txt.nlp	21578368	SENT83	29	29	6	6	ethanol	mol	PA448073	90527	0.92
NULL	Cent_European_J_Urol_2013_Dec_19_66(4)_394-404.nxml.txt.nlp	24757527	SENT177	29	29	38	38	temsirolimus	AKT	PA164746890	207	0.92
NULL	Oncotarget_2014_Aug_19_5(18)_8703-8715.nxml.txt.nlp	25237928	SENT52	38	38	21	21	glucose	CD44	PA449773	960	0.92
NULL	Curr_Neuropharmacol_2013_Dec_11(6)_652-663.nxml.txt.nlp	24396340	SENT196	12	12	27	27	lidocaine	TRPV1	PA450226	7442	0.92
NULL	Oncogene_2013_Sep_12_32(37)_4355-4365.nxml.txt.nlp	23108409	SENT88	27	27	8	8	hyaluronan	HAS2	PA165958431	3037	0.92
NULL	Cancers_(Basel)_2011_Apr_19_3(2)_2080-2105.nxml.txt.nlp	24212797	SENT1169	6	6	2	2	panitumumab	KRAS	PA162373091	3845	0.92
NULL	Cancers_(Basel)_2010_Apr_9_2(2)_397-419.nxml.txt.nlp	24281076	SENT188	0	0	15	15	resveratrol	p53		7157	0.92
NULL	Carcinogenesis_2013_Jan_8_34(1)_102-108.nxml.txt.nlp	23054610	SENT15	32	32	16	16	cisplatin	ADP	PA449014	23038	0.92
NULL	Mol_Vis_2012_Oct_5_18_2454-2467.nxml.txt.nlp	23077404	SENT152	13	13	33	33	bevacizumab	VEGF-A	PA130232992	7422	0.92
NULL	Oncol_Rep_2014_Feb_16_31(2)_573-580.nxml.txt.nlp	24337632	SENT111	18	18	8	8	doxorubicin	AKT	PA449412	207	0.92
NULL	Adv_Hematol_2012_Jan_18_2012_195484.nxml.txt.nlp	22312366	SENT96	17	17	21	21	rituximab	CHOP	PA451261	1649	0.92
NULL	Antimicrob_Agents_Chemother_2014_Aug_58(8)_4971-4973.nxml.txt.nlp	24913169	SENT33	46	46	8	8	primaquine	G6PD	PA451103	2539	0.92
NULL	J_Vis_Exp_2011_Mar_21_(49)_2693.nxml.txt.nlp	21445052	SENT31	16	16	27	27	l-glutamine	CO2	PA10090	4513	0.92
NULL	Anat_Cell_Biol_2010_Sep_30_43(3)_194-200.nxml.txt.nlp	21212859	SENT85	10	10	28	28	ethanol	GAPDH	PA448073	2597	0.92
NULL	Clin_Sci_(Lond)_2013_Feb_1_124(Pt_3)_153-164.nxml.txt.nlp	23075334	SENT115	7	7	27	27	resveratrol	AMPK		5563	0.92
NULL	Tuberc_Respir_Dis_(Seoul)_2014_Nov_28_77(5)_227-229.nxml.txt.nlp	25473412	SENT59	34	34	4	4	cefoxitin	RGM	PA448856	56963	0.92
NULL	Cell_Death_Differ_2010_May_13_17(5)_774-786.nxml.txt.nlp	19911006	SENT313	18	18	11	11	doxycycline	AATF	PA449415	26574	0.92
NULL	Breast_Cancer_Res_2008_Dec_18_10(Suppl_4)_S20.nxml.txt.nlp	19128434	SENT20	15	15	41	41	exemestane	aromatase	PA449563	1588	0.92
NULL	Evid_Based_Complement_Alternat_Med_2013_Oct_29_2013_795365.nxml.txt.nlp	24319485	SENT207	20	20	15	15	thrombin	ADP	PA451674	23038	0.92
NULL	Front_Neuroanat_2011_Jul_12_5_38.nxml.txt.nlp	21808606	SENT86	5	5	20	20	haloperidol	DARPP-32	PA449841	84152	0.92
NULL	Exp_Ther_Med_2014_Feb_25_7(2)_417-422.nxml.txt.nlp	24396417	SENT3	11	11	18	18	estradiol	CD25	PA449503	3669;3559	0.92
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT199	7	7	17	17	amiodarone	NAPA	PA448383	9476;8775	0.92
NULL	Int_J_Breast_Cancer_2011_Sep_6_2011_352182.nxml.txt.nlp	22295219	SENT261	32	32	39	39	lapatinib	HER2	PA152241907	2064	0.92
NULL	J_Cell_Biol_1988_Feb_1_106(2)_415-422.nxml.txt.nlp	2448314	SENT13	14	14	18	18	heparin	SMC	PA449855	54808	0.92
NULL	Oncol_Rep_2013_Jun_2_29(6)_2095-2100.nxml.txt.nlp	23563900	SENT122	21	21	5	5	sorafenib	HER-2	PA7000	2064	0.92
NULL	Front_Oncol_2014_Jun_10_4_142.nxml.txt.nlp	24959421	SENT95	14	14	18	18	vemurafenib	BRAF	PA165946873	673	0.92
NULL	JRSM_Short_Rep_2012_Apr_27_3(4)_26.nxml.txt.nlp	22715427	SENT62	6	6	9	9	trastuzumab	aromatase	PA451743	1588	0.92
NULL	Diabetes_Care_2009_Sep_28_32(9)_1649-1655.nxml.txt.nlp	19478198	SENT165	43	43	15	15	glucose	PPG	PA449773	5552	0.92
NULL	J_Cell_Mol_Med_2014_May_14_18(5)_811-823.nxml.txt.nlp	24628949	SENT234	5	5	9	9	docetaxel	FOXM1	PA449383	2305	0.92
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT119	8	8	3	3	cisplatin	MDM2	PA449014	4193	0.92
NULL	Biomed_Res_Int_2013_Oct_10_2013_767496.nxml.txt.nlp	24222915	SENT116	13	13	11	11	estradiol	aromatase	PA449503	1588	0.92
NULL	Oncotarget_2012_May_19_3(5)_535-545.nxml.txt.nlp	22619121	SENT62	15	15	8	8	camptothecin	MYCN	PA153590860	4613	0.92
NULL	J_Invest_Dermatol_2012_Jan_1_132(1)_105-113.nxml.txt.nlp	21881590	SENT249	22	22	7	7	etanercept	CCL20	PA449515	6364	0.92
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1449-1456.nxml.txt.nlp	24077631	SENT117	27	27	4	4	tolbutamide	CYP2C9	PA451718	1559	0.92
NULL	Eur_J_Clin_Pharmacol_2011_May_8_67(5)_493-506.nxml.txt.nlp	21140139	SENT154	28	28	10	10	hydroxyzine	CYP2D6	PA449943	1565	0.92
NULL	Br_J_Cancer_2010_Sep_7_103(6)_765-771.nxml.txt.nlp	20700120	SENT82	35	35	25	25	tamoxifen	CYP2D6	PA451581	1565	0.92
NULL	Int_J_Biol_Sci_2013_Nov_21_9(10)_1089-1098.nxml.txt.nlp	24339730	SENT164	24	24	6	6	genistein	BMP2	PA165109660	650	0.92
NULL	Breast_Cancer_Res_2004_Nov_7_6(1)_R24-R30.nxml.txt.nlp	14680497	SENT110	30	30	10	10	cyclophosphamide	p53	PA449165	7157	0.92
NULL	Exp_Hematol_Oncol_2014_Dec_17_3(1)_30.nxml.txt.nlp	NULL	SENT244	38	38	0	0	rivaroxaban	IL-8	PA165958360	3576	0.92
NULL	J_Exp_Clin_Cancer_Res_2009_Jul_22_28(1)_105.nxml.txt.nlp	19624845	SENT49	11	11	30	30	risedronate	CO2	PA451255	4513	0.92
NULL	Oncotarget_2011_Mar_27_2(3)_209-221.nxml.txt.nlp	21444945	SENT226	24	24	30	30	bortezomib	p53	PA10252	7157	0.92
NULL	Br_J_Cancer_2013_Jun_25_108(12)_2485-2494.nxml.txt.nlp	23695022	SENT160	11	11	18	18	vincristine	P-gp	PA451879	5243	0.92
NULL	Breast_Cancer_Res_2012_Mar_20_14(2)_R53.nxml.txt.nlp	22433433	SENT110	18	18	30	30	doxorubicin	CDK9	PA449412	1025	0.92
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT807	9	9	3	3	maraviroc	CYP3A4	PA164768835	1576	0.92
NULL	Case_Rep_Endocrinol_2012_Oct_14_2012_503290.nxml.txt.nlp	23097726	SENT75	34	34	2	2	vasopressin	ACTH	PA451858	5443	0.92
NULL	Case_Rep_Hematol_2014_Dec_24_2014_460574.nxml.txt.nlp	25610674	SENT9	24	24	3	3	cyclophosphamide	PHL	PA449165	613	0.92
NULL	Oncogenesis_2012_Apr_2_1(4)_e5.nxml.txt.nlp	23552603	SENT84	3	3	13	13	ns-398	IL-8		3576	0.92
NULL	Oncol_Lett_2013_Feb_27_5(2)_483-488.nxml.txt.nlp	23420047	SENT115	28	28	16	16	cetuximab	KRAS	PA10040	3845	0.92
NULL	Cell_Death_Dis_2014_Jan_16_5(1)_e1000.nxml.txt.nlp	24434508	SENT55	17	17	3	3	bleomycin	p53	PA448645	7157	0.92
NULL	J_Cell_Mol_Med_2014_Aug_6_18(8)_1519-1539.nxml.txt.nlp	25100284	SENT201	2	2	14	14	gefitinib	EGFR	PA131301952	1956	0.92
NULL	Cell_Death_Dis_2014_Jul_17_5(7)_e1338.nxml.txt.nlp	25032861	SENT112	15	15	8	8	pp2	EGF		1950	0.92
NULL	Cancer_Cell_Int_2014_Jun_11_14_49.nxml.txt.nlp	24991192	SENT128	11	11	21	21	berberine	AMPK	PA165860812	5563	0.92
NULL	Oncoimmunology_2013_Mar_1_2(3)_e24567.nxml.txt.nlp	23802090	SENT11	5	5	30	30	trastuzumab	ERBB2	PA451743	2064	0.92
NULL	Diabetes_Care_2009_Oct_8_32(10)_1873-1879.nxml.txt.nlp	19587362	SENT218	27	27	24	24	valsartan	AT1	PA451848	9197;185	0.92
NULL	J_Immunol_Res_2014_May_12_2014_897249.nxml.txt.nlp	24901013	SENT259	27	27	13	13	natalizumab	E2F1	PA164747191	1869	0.92
NULL	Cancer_Med_2013_Oct_19_2(5)_646-653.nxml.txt.nlp	24403230	SENT132	19	19	3	3	trastuzumab	GADD45	PA451743	1647	0.92
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT13	24	24	18	18	clozapine	PRL	PA449061	5617	0.92
NULL	Oncotarget_2011_Mar_11_2(3)_135-164.nxml.txt.nlp	21411864	SENT306	3	3	6	6	doxorubicin	p53	PA449412	7157	0.92
NULL	Indian_J_Endocrinol_Metab_2011_Jul-Sep_15(3)_175-181.nxml.txt.nlp	21897893	SENT150	4	4	24	24	denosumab	RANKL	PA166048634	8600	0.92
NULL	Breast_Cancer_Res_2007_Jul_5_9(4)_R41.nxml.txt.nlp	17612393	SENT159	37	37	31	31	celecoxib	Bcl-2	PA448871	596	0.92
NULL	Breast_Cancer_Res_Treat_2014_Dec_19_143(2)_351-358.nxml.txt.nlp	24352574	SENT192	17	17	6	6	trastuzumab	HER-2	PA451743	2064	0.92
NULL	J_Adv_Pharm_Technol_Res_2014_Oct-Dec_5(4)_185-190.nxml.txt.nlp	25364697	SENT103	8	8	23	23	metoprolol	ANOVA	PA450480	4858	0.92
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT8	25	25	16	16	simvastatin	AKT	PA451363	207	0.92
NULL	Drugs_R_D_2010_Sep_27_10(3)_165-178.nxml.txt.nlp	20945947	SENT194	15	15	24	24	ridaforolimus	BP1	PA165291475	1748	0.92
NULL	ScientificWorldJournal_2013_Oct_1_2013_654829.nxml.txt.nlp	24198725	SENT33	0	0	14	14	naproxen	COX	PA450595	1351	0.92
NULL	Exp_Ther_Med_2013_Nov_13_6(5)_1317-1321.nxml.txt.nlp	24223665	SENT6	23	23	29	29	curcumin	CD133	PA151958596	8842	0.92
NULL	Oncotarget_2011_Aug_30_2(8)_610-626.nxml.txt.nlp	21881167	SENT142	40	40	29	29	doxorubicin	Raf-1	PA449412	5894	0.92
NULL	Arthritis_Res_Ther_2009_Aug_28_11(4)_R131.nxml.txt.nlp	19715572	SENT106	5	5	9	9	rituximab	CD19	PA451261	930	0.92
NULL	Front_Oncol_2013_Sep_11_3_228.nxml.txt.nlp	24062981	SENT442	15	15	19	19	vemurafenib	BRAF	PA165946873	673	0.92
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2012_Jan_1_68(Pt_1)_82-92.nxml.txt.nlp	22194336	SENT26	9	9	11	11	vancomycin	VISA	PA451850	57506	0.92
NULL	Comb_Chem_High_Throughput_Screen_2010_Feb_13(2)_188-206.nxml.txt.nlp	20053163	SENT245	17	17	11	11	terfenadine	CYP3A4	PA451619	1576	0.92
NULL	J_Hematol_Oncol_2012_Jun_18_5_31.nxml.txt.nlp	22709792	SENT127	8	8	28	28	trastuzumab	HER2	PA451743	2064	0.92
NULL	Clin_Epigenetics_2011_May_7_2(2)_249-256.nxml.txt.nlp	22704340	SENT155	15	15	22	22	doxorubicin	DNMT1	PA449412	1786	0.92
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_13_2014_849783.nxml.txt.nlp	25477998	SENT102	19	19	5	5	isoproterenol	HMGB1	PA450121	3146	0.92
NULL	Oncotarget_2012_Dec_30_3(12)_1522-1532.nxml.txt.nlp	23455653	SENT42	8	8	12	12	temsirolimus	PI3K	PA164746890	5290	0.92
NULL	Front_Oncol_2014_Sep_24_4_259.nxml.txt.nlp	25309875	SENT21	0	0	10	10	trastuzumab	HER2	PA451743	2064	0.92
NULL	Int_J_Gen_Med_2012_Jan_31_5_105-115.nxml.txt.nlp	22319248	SENT75	5	5	16	16	filgrastim	GM-CSF	PA449626	1437	0.92
NULL	Core_Evid_2010_Oct_21_5_77-90.nxml.txt.nlp	21042544	SENT177	25	25	6	6	cisapride	CYP3A4	PA449011	1576	0.92
NULL	Oncol_Rep_2014_Mar_14_31(3)_1035-1042.nxml.txt.nlp	24424445	SENT167	11	11	2	2	doxorubicin	ABCG2	PA449412	9429	0.92
NULL	Crit_Care_2011_Feb_23_15(1)_R69.nxml.txt.nlp	21345192	SENT48	0	0	10	10	heparin	ACT	PA449855	12;11332;9457;641455	0.92
NULL	Biomed_Res_Int_2013_Dec_31_2013_273498.nxml.txt.nlp	23484100	SENT122	27	27	3	3	genistein	OTC	PA165109660	5009	0.92
NULL	J_Korean_Med_Sci_2010_Jun_24_25(6)_846-852.nxml.txt.nlp	20514304	SENT151	24	24	13	13	oxaliplatin	GSTP1	PA131285527	2950	0.92
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Feb_28_65(Pt_3)_m337-m338.nxml.txt.nlp	21582105	SENT57	15	15	26	26	ethanol	NO3	PA448073	4681	0.92
NULL	J_Equine_Sci_2011_Apr_26_22(1)_9-15.nxml.txt.nlp	24833982	SENT90	24	24	1	1	estradiol	aromatase	PA449503	1588	0.92
NULL	Bacteriophage_2012_Apr_1_2(2)_98-104.nxml.txt.nlp	23050220	SENT43	31	31	4	4	mitomycin	SMG	PA450524	23034	0.92
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2011_Mar_14_4_13-24.nxml.txt.nlp	22879790	SENT33	2	2	8	8	exenatide	PPG	PA164749238	5552	0.92
NULL	Diabetes_Care_2010_Jul_31_33(7)_1544-1548.nxml.txt.nlp	20357370	SENT133	15	15	7	7	metformin	LKB1	PA450395	6794	0.92
NULL	Biomed_Res_Int_2013_Jul_18_2013_487610.nxml.txt.nlp	23971039	SENT277	14	14	20	20	indomethacin	COX	PA449982	1351	0.92
NULL	J_Physiol_2009_Feb_15_587(Pt_4)_731-744.nxml.txt.nlp	19074966	SENT115	4	4	14	14	taurine	PAT1	PA451590	10513;206358	0.92
NULL	Cancer_Med_2014_Feb_26_3(1)_81-90.nxml.txt.nlp	24402778	SENT213	3	3	15	15	bleomycin	WISP1	PA448645	8840	0.92
NULL	Aging_(Albany_NY)_2009_Oct_13_1(10)_842-844.nxml.txt.nlp	20157556	SENT25	21	21	17	17	nutlin-3	p53		7157	0.92
NULL	Oncotarget_2012_Sep_28_3(10)_1169-1181.nxml.txt.nlp	23045411	SENT184	2	2	29	29	doxorubicin	JNK	PA449412	5599	0.92
NULL	Fibrogenesis_Tissue_Repair_2010_Sep_3_3_18.nxml.txt.nlp	20815874	SENT48	12	12	0	0	bleomycin	CCR7	PA448645	1236	0.92
NULL	Nat_Commun_2013_Nov_29_4_10_1038_ncomms3812.nxml.txt.nlp	24287487	SENT237	18	18	3	3	doxycycline	Dicer	PA449415	23405	0.92
NULL	Indian_Dermatol_Online_J_2014_Apr-Jun_5(2)_167-169.nxml.txt.nlp	24860753	SENT69	13	13	19	19	sildenafil	OTC	PA451346	5009	0.92
NULL	Breast_Cancer_Res_2010_Jul_26_12(4)_R55.nxml.txt.nlp	20659323	SENT249	5	5	2	2	fulvestrant	MYB	PA164747170	4602	0.92
NULL	Mol_Cell_2014_May_8_54(3)_445-459.nxml.txt.nlp	24746700	SENT501	31	31	8	8	etoposide	ATRIP	PA449552	84126	0.92
NULL	Cancers_(Basel)_2010_Jan_14_2(1)_1-19.nxml.txt.nlp	24281029	SENT1014	11	11	25	25	capecitabine	San	PA448771	80218	0.92
NULL	Biomed_Res_Int_2014_Jun_30_2014_936891.nxml.txt.nlp	25101301	SENT46	15	15	5	5	quinacrine	LAMP1	PA164745551	3916	0.92
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Dec_10_3(12)_e151.nxml.txt.nlp	25494035	SENT114	44	44	26	26	rosuvastatin	OATP1B1	PA134308647	10599	0.92
NULL	Diabetes_Care_2013_May_13_36(5)_1290-1296.nxml.txt.nlp	23250800	SENT76	5	5	14	14	l-arginine	ANOVA	PA448478	4858	0.92
NULL	J_Immunother_Cancer_2013_Nov_7_1(Suppl_1)_P1.nxml.txt.nlp	NULL	SENT5	10	10	20	20	cyclophosphamide	IL-2	PA449165	3558	0.92
NULL	Oncotarget_2014_Feb_25_5(7)_1812-1828.nxml.txt.nlp	24729020	SENT23	0	0	9	9	trastuzumab	HER2	PA451743	2064	0.92
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Sep_14_67(Pt_10)_o2587-o2588.nxml.txt.nlp	22064439	SENT80	4	4	27	27	piperazine	mol	PA450977	90527	0.92
NULL	Pharmaceuticals_(Basel)_2014_Jul_24_7(8)_850-865.nxml.txt.nlp	25061796	SENT77	42	42	17	17	etoricoxib	NNT	PA164776853	23530	0.92
NULL	J_Korean_Med_Sci_2007_Jun_30_22(3)_393-399.nxml.txt.nlp	17596643	SENT19	12	12	5	5	erlotinib	EGFR	PA134687924	1956	0.92
NULL	Diabetes_Metab_Syndr_Obes_2014_Jul_3_7_277-288.nxml.txt.nlp	25050071	SENT72	24	24	15	15	metformin	PPG	PA450395	5552	0.92
NULL	Diabetes_Care_2013_Jul_12_36(7)_2118-2125.nxml.txt.nlp	23645885	SENT50	8	8	26	26	liraglutide	GLP-1	PA165958364	100125288	0.92
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Feb_13_66(Pt_3)_o627.nxml.txt.nlp	21580384	SENT58	19	19	6	6	ethanol	mol	PA448073	90527	0.92
NULL	Infect_Dis_Ther_2013_Dec_8_2(2)_95-110.nxml.txt.nlp	25134474	SENT158	26	26	22	22	vancomycin	VISA	PA451850	57506	0.92
NULL	Cell_Death_Dis_2014_Jul_3_5(7)_e1316.nxml.txt.nlp	24991768	SENT47	4	4	33	33	pemetrexed	ATF3	PA10810	467	0.92
NULL	BMB_Rep_2014_Jul_47(7)_388-392.nxml.txt.nlp	24286329	SENT84	11	11	28	28	berberine	AP-1	PA165860812	2353;3727;2354;3725	0.92
NULL	J_Int_Soc_Sports_Nutr_2014_Jun_14_11_29.nxml.txt.nlp	25006332	SENT164	13	13	0	0	creatine	GAMT	PA164778930	2593	0.92
NULL	Support_Care_Cancer_2011_Mar_16_19(3)_353-361.nxml.txt.nlp	20157746	SENT39	13	13	1	1	doxorubicin	CTX	PA449412	1593	0.92
NULL	Arthritis_Res_Ther_2009_Aug_28_11(4)_R131.nxml.txt.nlp	19715572	SENT98	6	6	13	13	rituximab	CD27	PA451261	939	0.92
NULL	Oncotarget_2011_Dec_31_2(12)_1314-1321.nxml.txt.nlp	22248929	SENT147	11	11	18	18	lapatinib	PI3K	PA152241907	5290	0.92
NULL	Mol_Neurodegener_2011_Aug_8_6_57.nxml.txt.nlp	21819629	SENT13	13	13	0	0	arsenite	JNK	PA452638	5599	0.92
NULL	Mol_Cancer_2010_Aug_20_9_220.nxml.txt.nlp	20727180	SENT152	38	38	7	7	nicotine	p53	PA450626	7157	0.92
NULL	Front_Neurosci_2010_Jun_17_4_35.nxml.txt.nlp	20661455	SENT89	7	7	4	4	pindolol	5-HT1A	PA450966	3350	0.92
NULL	J_Gen_Physiol_2000_Jun_1_115(6)_685-696.nxml.txt.nlp	10828243	SENT8	12	12	38	38	genistein	OLF	PA165109660	83857	0.92
NULL	Indian_J_Dermatol_2010_Apr-Jun_55(2)_161-170.nxml.txt.nlp	20606887	SENT6	4	4	10	10	ustekinumab	p40	PA166048654	3921;339541;10314	0.92
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Sep_14_67(Pt_10)_o2575.nxml.txt.nlp	22058741	SENT57	28	28	11	11	ethanol	mol	PA448073	90527	0.92
NULL	Case_Rep_Emerg_Med_2014_Nov_25_2014_160396.nxml.txt.nlp	25525527	SENT25	28	28	24	24	heparin	P2Y12	PA449855	64805	0.92
NULL	Oncotarget_2012_Aug_10_3(8)_744-758.nxml.txt.nlp	22889873	SENT148	42	42	7	7	cetuximab	AKT	PA10040	207	0.92
NULL	Oncogene_2014_Feb_6_33(6)_713-723.nxml.txt.nlp	23435429	SENT64	29	29	20	20	etoposide	XIAP	PA449552	331	0.92
NULL	Front_Oncol_2014_Sep_23_4_264.nxml.txt.nlp	25295231	SENT90	9	9	2	2	lenalidomide	CDC25C	PA162363968	995	0.92
NULL	Curr_Oncol_2009_Aug_16(4)_9-21.nxml.txt.nlp	19672420	SENT247	21	21	3	3	erlotinib	EGFR	PA134687924	1956	0.92
NULL	Mol_Cancer_2008_Mar_26_7_27.nxml.txt.nlp	18366759	SENT212	17	17	25	25	etoposide	HIF-1	PA449552	29072	0.92
NULL	Colorectal_Dis_2012_Feb_14(2)_e31-e47.nxml.txt.nlp	21848897	SENT37	0	0	21	21	cetuximab	KRAS	PA10040	3845	0.92
NULL	Arthritis_Res_Ther_2013_Jul_9_15(4)_R73.nxml.txt.nlp	23837669	SENT263	6	6	18	18	colchicine	MICL	PA449092	160364	0.92
NULL	Infect_Drug_Resist_2009_Apr_24_2_13-26.nxml.txt.nlp	21694884	SENT303	22	22	6	6	entecavir	TDF	PA164784025	6736	0.92
NULL	Sci_Rep_2014_Nov_28_4_7237.nxml.txt.nlp	25429875	SENT114	26	26	7	7	hesperidin	p38	PA449867	10598;1432;7965	0.92
NULL	Curr_Neuropharmacol_2014_Jul_12(4)_365-379.nxml.txt.nlp	25342944	SENT41	24	24	2	2	fluoxetine	5-HT1A	PA449673	3350	0.92
NULL	Curr_Med_Chem_2012_Aug_19(22)_3763-3778.nxml.txt.nlp	22680930	SENT70	25	25	31	31	zileuton	5-LOX	PA451955	240	0.92
NULL	Nat_Commun_2013_Aug_15_4_2130.nxml.txt.nlp	23945651	SENT115	10	10	5	5	cisplatin	ATG5	PA449014	9474	0.92
NULL	Cells_2014_May_23_3(2)_517-545.nxml.txt.nlp	24861977	SENT28	30	30	22	22	capsaicin	TRPV1	PA448776	7442	0.92
NULL	Mol_Cancer_2009_Nov_19_8_108.nxml.txt.nlp	19925669	SENT128	21	21	5	5	doxorubicin	CRT	PA449412	811	0.92
NULL	Acta_Pharmacol_Sin_2013_Sep_5_34(9)_1208-1216.nxml.txt.nlp	23852087	SENT101	20	20	17	17	disulfiram	HIF-1	PA449376	29072	0.92
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT204	16	16	21	21	lapatinib	HER3	PA152241907	2065	0.92
NULL	J_Cancer_Epidemiol_2012_Oct_24_2012_294730.nxml.txt.nlp	23150730	SENT243	25	25	6	6	panitumumab	KRAS	PA162373091	3845	0.92
NULL	J_Hematol_Oncol_2013_Jul_18_6_53.nxml.txt.nlp	23866964	SENT145	3	3	6	6	temsirolimus	MYC	PA164746890	4609	0.92
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT126	19	19	21	21	dasatinib	PP2	PA162372878	4888	0.92
NULL	Arthritis_Res_Ther_2013_Jul_9_15(4)_R73.nxml.txt.nlp	23837669	SENT62	6	6	14	14	colchicine	MICL	PA449092	160364	0.92
NULL	Core_Evid_2010_Oct_22_5_91-105.nxml.txt.nlp	21468365	SENT113	25	25	13	13	atorvastatin	CYP3A4	PA448500	1576	0.92
NULL	Adipocyte_2013_Jan_1_2(1)_17-27.nxml.txt.nlp	23599907	SENT100	21	21	3	3	glucose	TPC	PA449773	8030;60386	0.92
NULL	Mol_Pain_2013_Jun_10_9_27.nxml.txt.nlp	23758830	SENT50	19	19	5	5	tetracaine	ASIC3	PA451638	9311	0.92
NULL	Int_J_Biol_Sci_2013_Mar_16_9(3)_303-312.nxml.txt.nlp	23569435	SENT35	12	12	4	4	trastuzumab	HER2	PA451743	2064	0.92
NULL	Arthritis_Res_Ther_2009_Aug_28_11(4)_R131.nxml.txt.nlp	19715572	SENT97	3	3	10	10	rituximab	CD19	PA451261	930	0.92
NULL	Brain_Behav_2013_Mar_6_3(2)_114-133.nxml.txt.nlp	23533150	SENT176	26	26	32	32	ethanol	HSF1	PA448073	3297	0.92
NULL	Acta_Histochem_Cytochem_2006_Dec_28_39(6)_163-172.nxml.txt.nlp	17327903	SENT172	21	21	14	14	sevoflurane	ERK	PA451341	5594	0.92
NULL	J_Lipid_Res_2014_Dec_55(12)_2606-2619.nxml.txt.nlp	25339683	SENT296	27	27	0	0	desipramine	ASM	PA449233	6609;283120	0.92
NULL	BioDrugs_2013_May_9_27(5)_469-478.nxml.txt.nlp	23658121	SENT259	10	10	16	16	trastuzumab	HER2	PA451743	2064	0.92
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Mar_27_66(Pt_4)_o922.nxml.txt.nlp	21580732	SENT56	19	19	6	6	ethanol	mol	PA448073	90527	0.919
NULL	Cardiol_Res_Pract_2011_Apr_3_2011_320983.nxml.txt.nlp	21559260	SENT6	16	16	34	34	sirolimus	DES	PA451365	1674	0.919
NULL	Anesth_Essays_Res_2014_Sep-Dec_8(3)_339-344.nxml.txt.nlp	NULL	SENT48	0	0	18	18	fentanyl	NIBP	PA449599	83696	0.919
NULL	Oncotarget_2014_Jun_26_5(14)_5559-5569.nxml.txt.nlp	24980819	SENT99	4	4	40	40	vemurafenib	p53	PA165946873	7157	0.919
NULL	Indian_J_Endocrinol_Metab_2013_Jul-Aug_17(4)_636-646.nxml.txt.nlp	23961479	SENT138	2	2	9	9	simvastatin	CYP3A4	PA451363	1576	0.919
NULL	Nucleic_Acids_Res_2005_Dec_9_33(22)_6972-6981.nxml.txt.nlp	16340007	SENT135	10	10	17	17	bleomycin	DNA-PKcs	PA448645	5591	0.919
NULL	Aliment_Pharmacol_Ther_2012_Apr_22_35(7)_745-767.nxml.txt.nlp	22356640	SENT163	33	33	3	3	tegaserod	5-HT4	PA130413154	3360	0.919
NULL	BMB_Rep_2014_Nov_47(11)_649-654.nxml.txt.nlp	25301019	SENT120	6	6	17	17	l-alanine	CCL2	PA448055	6347	0.919
NULL	Br_J_Cancer_2009_Jul_7_101(1)_38-47.nxml.txt.nlp	19513066	SENT176	19	19	7	7	dasatinib	PI3K	PA162372878	5290	0.919
NULL	Mol_Syst_Biol_2009_Jul_28_5_288.nxml.txt.nlp	19638969	SENT218	3	3	20	20	resveratrol	HuR		1994	0.919
NULL	Mol_Cancer_2010_Nov_8_9_291.nxml.txt.nlp	21059223	SENT145	15	15	23	23	paclitaxel	Bcl-2	PA450761	596	0.919
NULL	Multidiscip_Respir_Med_2013_Oct_5_8(1)_65.nxml.txt.nlp	24094028	SENT171	20	20	8	8	tipifarnib	CD38	PA165110778	952	0.919
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT160	7	7	0	0	atorvastatin	RANK	PA448500	8792	0.919
NULL	Braz_J_Med_Biol_Res_2013_Mar_15_46(3)_299-305.nxml.txt.nlp	23532269	SENT127	4	4	20	20	propofol	TLR4	PA451141	7099	0.919
NULL	Clin_Exp_Otorhinolaryngol_2011_Jun_31_4(2)_77-82.nxml.txt.nlp	21716954	SENT164	4	4	18	18	minocycline	JNK	PA450519	5599	0.919
NULL	Clin_Med_Insights_Oncol_2013_May_20_7_87-102.nxml.txt.nlp	23761989	SENT141	0	0	18	18	brivanib	VEGFR	PA164924492	3791	0.919
NULL	Acta_Pharmacol_Sin_2012_Dec_17_33(12)_1441-1458.nxml.txt.nlp	22983389	SENT266	9	9	11	11	pertuzumab	HER-2		2064	0.919
NULL	Int_J_Mol_Sci_2012_Aug_16_13(8)_10193-10211.nxml.txt.nlp	22949855	SENT62	39	39	11	11	nitrogen	CAT	PA450643	847	0.919
NULL	Gut_2008_Nov_2_57(11)_1509-1517.nxml.txt.nlp	18596194	SENT187	21	21	14	14	curcumin	JNK	PA151958596	5599	0.919
NULL	Oncogene_2014_Feb_27_33(9)_1135-1147.nxml.txt.nlp	23455325	SENT30	18	18	29	29	bortezomib	RELA	PA10252	5970	0.919
NULL	Mol_Cancer_2013_Sep_23_12_107.nxml.txt.nlp	24053443	SENT261	3	3	12	12	gefitinib	EGFR	PA131301952	1956	0.919
NULL	Diabetes_2009_Dec_31_58(12)_2731-2740.nxml.txt.nlp	19720798	SENT125	9	9	5	5	troglitazone	adiponectin	PA451799	9370	0.919
NULL	Am_J_Case_Rep_2014_Feb_24_15_85-89.nxml.txt.nlp	24587856	SENT94	7	7	14	14	fulvestrant	aromatase	PA164747170	1588	0.919
NULL	Cell_Death_Differ_2010_Apr_16_17(4)_666-676.nxml.txt.nlp	19834494	SENT94	18	18	0	0	oxaliplatin	RAGE	PA131285527	177	0.919
NULL	Arthritis_Res_Ther_2005_Apr_4_7(4)_R756-R768.nxml.txt.nlp	15987477	SENT140	20	20	9	9	hyaluronidase	PH-20	PA164745713	6677	0.919
NULL	Mol_Cancer_2009_Nov_24_8_109.nxml.txt.nlp	19930708	SENT103	16	16	13	13	exemestane	aromatase	PA449563	1588	0.919
NULL	Int_J_Biol_Sci_2014_Sep_6_10(9)_1007-1017.nxml.txt.nlp	25210499	SENT92	22	22	3	3	tamoxifen	p63	PA451581	8626	0.919
NULL	Bone_Marrow_Transplant_2014_Feb_4_49(2)_201-205.nxml.txt.nlp	24185588	SENT93	19	19	5	5	plerixafor	CD34	PA165958410	947	0.919
NULL	Oncol_Lett_2014_Jun_8_7(6)_1903-1910.nxml.txt.nlp	24932256	SENT16	4	4	25	25	cisplatin	DRAM1	PA449014	55332	0.919
NULL	Asia_Pac_Allergy_2013_Oct_31_3(4)_215-223.nxml.txt.nlp	24260726	SENT100	15	15	29	29	oxcarbazepine	HLA-B	PA450732	3106	0.919
NULL	Nat_Biotechnol_2009_Oct_13_27(10)_925-932.nxml.txt.nlp	19749770	SENT209	30	30	7	7	paraformaldehyde	TLR9	PA450790	54106	0.919
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1013.nxml.txt.nlp	24457957	SENT143	23	23	17	17	bortezomib	NOXA	PA10252	5366	0.919
NULL	Contemp_Clin_Dent_2011_Oct-Dec_2(4)_278-282.nxml.txt.nlp	22346152	SENT9	16	16	7	7	potassium	GCF	PA451047	6936	0.919
NULL	Cell_Death_Dis_2014_Mar_13_5(3)_e1113.nxml.txt.nlp	24625972	SENT87	35	35	28	28	bleomycin	BI-1	PA448645	7009	0.919
NULL	Arthritis_Res_Ther_2014_Apr_30_16(2)_R90.nxml.txt.nlp	25167216	SENT202	11	11	2	2	adalimumab	CXCL13	PA10004	10563	0.919
NULL	Mol_Biol_Cell_2012_Sep_1_23(17)_3290-3298.nxml.txt.nlp	22809627	SENT37	16	16	9	9	geldanamycin	Hsp90	PA152031327	3320	0.919
NULL	J_Cell_Mol_Med_2014_Feb_8_18(2)_197-207.nxml.txt.nlp	24400890	SENT94	19	19	9	9	ethanol	TLR4	PA448073	7099	0.919
NULL	Acta_Pharmacol_Sin_2011_Jun_30_32(6)_853-860.nxml.txt.nlp	21623392	SENT31	4	4	7	7	capsaicin	TRPV1	PA448776	7442	0.919
NULL	Biomed_Res_Int_2014_Apr_13_2014_275178.nxml.txt.nlp	24822191	SENT135	0	0	7	7	pioglitazone	gamma	PA450970	9913	0.919
NULL	Clin_Sci_(Lond)_2009_Nov_16_118(Pt_4)_269-279.nxml.txt.nlp	19698082	SENT129	0	0	20	20	ramipril	ACE2	PA451223	59272	0.919
NULL	Clinics_(Sao_Paulo)_2014_May_69(5)_308-313.nxml.txt.nlp	24838894	SENT71	7	7	15	15	losartan	ANOVA	PA450268	4858	0.919
NULL	Mol_Cancer_2012_Dec_12_11_91.nxml.txt.nlp	23234355	SENT13	12	12	20	20	cetuximab	EGFR	PA10040	1956	0.919
NULL	Nat_Chem_Biol_2010_Apr_28_6(4)_291-299.nxml.txt.nlp	20190765	SENT129	3	3	28	28	dasatinib	EGFR	PA162372878	1956	0.919
NULL	J_Gen_Physiol_2009_Apr_133(4)_421-438.nxml.txt.nlp	19289574	SENT214	25	25	8	8	glibenclamide	SLC26A9	PA449782	115019	0.919
NULL	Breast_Cancer_Res_2010_Dec_20_12(Suppl_4)_S19.nxml.txt.nlp	21172081	SENT36	32	32	13	13	bevacizumab	CA9	PA130232992	768	0.919
NULL	J_Med_Chem_2014_Jan_23_57(2)_449-461.nxml.txt.nlp	24387105	SENT154	28	28	13	13	benzaldehyde	ALDH3A1	PA448571	218	0.919
NULL	J_Hum_Genet_2013_Jun_23_58(6)_339-345.nxml.txt.nlp	23697979	SENT14	16	16	4	4	clopidogrel	ADP	PA449053	23038	0.919
NULL	Cancer_Cell_Int_2014_Jun_16_14_53.nxml.txt.nlp	24966801	SENT140	9	9	2	2	metformin	p53	PA450395	7157	0.919
NULL	Acta_Histochem_Cytochem_2011_Apr_28_44(2)_81-90.nxml.txt.nlp	21614169	SENT329	6	6	18	18	hyaluronan	CD11b	PA165958431	3684	0.919
NULL	Oncoimmunology_2013_May_1_2(5)_e24271.nxml.txt.nlp	23762805	SENT236	22	22	16	16	cisplatin	Oct4	PA449014	5460	0.919
NULL	Case_Rep_Transplant_2014_Jan_2_2014_548243.nxml.txt.nlp	24575309	SENT72	16	16	10	10	simvastatin	CYP3A	PA451363	1574	0.919
NULL	Int_J_Mol_Sci_2013_Apr_24_14(5)_8818-8831.nxml.txt.nlp	23615472	SENT26	22	22	39	39	trypsin	VIII	PA451806	1351	0.919
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT120	5	5	20	20	gefitinib	KRAS	PA131301952	3845	0.919
NULL	Lab_Invest_2009_Nov_7_89(11)_1275-1290.nxml.txt.nlp	19736547	SENT313	7	7	9	9	pioglitazone	LOX-1	PA450970	4973	0.919
NULL	Chin_J_Cancer_2012_Jun_31(6)_266-280.nxml.txt.nlp	22313597	SENT282	12	12	17	17	exemestane	IGFBP5	PA449563	3488	0.919
NULL	Diabetes_2011_Jun_21_60(6)_1770-1778.nxml.txt.nlp	21562078	SENT288	10	10	6	6	metformin	AMPK	PA450395	5563	0.919
NULL	Reprod_Biol_Endocrinol_2003_Oct_9_1_74.nxml.txt.nlp	14613550	SENT96	10	10	16	16	resveratrol	COX		1351	0.919
NULL	Oncotarget_2011_Sep_10_2(9)_695-704.nxml.txt.nlp	21911917	SENT59	25	25	21	21	imatinib	KIT	PA10804	3815	0.919
NULL	Chem_Rev_2014_Jun_11_114(11)_5753-5774.nxml.txt.nlp	24758331	SENT121	26	26	5	5	doxorubicin	P-gp	PA449412	5243	0.919
NULL	Gut_Liver_2013_May_9_7(3)_329-334.nxml.txt.nlp	23710315	SENT139	9	9	11	11	lamivudine	LAM	PA450163	7249;7248	0.919
NULL	Exp_Ther_Med_2013_Jan_1_5(1)_338-342.nxml.txt.nlp	23251295	SENT35	2	2	28	28	everolimus	HK2	PA164746311	3796;3099;29911;3741	0.919
NULL	Biomed_Eng_Online_2013_Oct_12_12_103.nxml.txt.nlp	24120254	SENT99	22	22	0	0	copper	MEC	PA449114	56477	0.919
NULL	J_Anaesthesiol_Clin_Pharmacol_2011_Jul-Sep_27(3)_307-314.nxml.txt.nlp	21897498	SENT71	20	20	30	30	oxycodone	P600	PA450741	3596	0.919
NULL	AAPS_J_2011_Jun_1_13(3)_405-416.nxml.txt.nlp	21630127	SENT334	21	21	30	30	bevacizumab	HER2	PA130232992	2064	0.919
NULL	Epilepsia_2012_Jun_21_53(Suppl_1)_18-25.nxml.txt.nlp	22612805	SENT107	6	6	10	10	furosemide	KCC1	PA449719	6560	0.919
NULL	Breast_Cancer_Res_2007_Aug_8_9(4)_R50.nxml.txt.nlp	17686159	SENT155	0	0	8	8	gefitinib	AKT	PA131301952	207	0.919
NULL	Diabetes_Care_2009_Apr_32(4)_531-540.nxml.txt.nlp	19336638	SENT23	2	2	10	10	ticlopidine	P2Y12	PA451686	64805	0.919
NULL	J_Infect_Dis_2014_Dec_15_210(12)_2001-2008.nxml.txt.nlp	24994911	SENT34	13	13	22	22	chloroquine	ACT	PA448948	12;11332;9457;641455	0.919
NULL	Oncol_Rep_2014_Mar_14_31(3)_1035-1042.nxml.txt.nlp	24424445	SENT58	27	27	2	2	doxorubicin	CD133	PA449412	8842	0.919
NULL	J_Korean_Med_Sci_2014_Jul_11_29(7)_965-972.nxml.txt.nlp	25045229	SENT113	39	39	26	26	metformin	B12	PA450395	7126;4709	0.919
NULL	Oncotarget_2011_Mar_27_2(3)_209-221.nxml.txt.nlp	21444945	SENT226	26	26	15	15	bortezomib	p53	PA10252	7157	0.919
NULL	N_Am_J_Med_Sci_2013_Mar_5(3)_207-212.nxml.txt.nlp	23626957	SENT34	20	20	33	33	oxygen	ROS	PA450744	6098	0.919
NULL	Br_J_Cancer_2013_Feb_19_108(3)_557-563.nxml.txt.nlp	23361053	SENT41	1	1	6	6	tamoxifen	HER-2	PA451581	2064	0.919
NULL	Clin_Med_Insights_Arthritis_Musculoskelet_Disord_2012_Mar_5_5_27-42.nxml.txt.nlp	22438671	SENT249	8	8	26	26	tocilizumab	ACR	PA165292659	49	0.919
NULL	J_Oral_Pathol_Med_2013_Jul_18_42(6)_499-506.nxml.txt.nlp	23331485	SENT9	6	6	1	1	celecoxib	COX	PA448871	1351	0.919
NULL	J_Neurosci_Methods_2009_Oct_15_183(2)_107-113.nxml.txt.nlp	19524611	SENT95	14	14	46	46	carbachol	DSI	PA448784	5034	0.919
NULL	Br_J_Cancer_2013_Jul_23_109(2)_351-359.nxml.txt.nlp	23799854	SENT34	27	27	19	19	paclitaxel	BLT2	PA450761	56413	0.919
NULL	Int_J_Environ_Res_Public_Health_2012_Aug_27_9(8)_2636-2657.nxml.txt.nlp	23066388	SENT158	13	13	18	18	cisplatin	ERCC1	PA449014	2067	0.919
NULL	Oncol_Rep_2013_Jun_2_29(6)_2095-2100.nxml.txt.nlp	23563900	SENT26	10	10	7	7	cetuximab	EGFR	PA10040	1956	0.919
NULL	Cancer_Cell_Int_2013_Jan_15_13_3.nxml.txt.nlp	23320839	SENT135	7	7	29	29	gefitinib	ABCB1	PA131301952	5243	0.919
NULL	Arch_Med_Sci_2013_Oct_31_9(5)_936-943.nxml.txt.nlp	24273582	SENT37	7	7	37	37	nateglinide	SUR1	PA450600	6833	0.919
NULL	Case_Rep_Hematol_2012_Sep_10_2012_517546.nxml.txt.nlp	22997594	SENT121	6	6	15	15	imatinib	KIT	PA10804	3815	0.919
NULL	Ann_Gen_Psychiatry_2010_Apr_22_9(Suppl_1)_S59.nxml.txt.nlp	NULL	SENT7	5	5	1	1	aripiprazole	NNT	PA10026	23530	0.919
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT171	9	9	14	14	metformin	HIF-1	PA450395	29072	0.919
NULL	Blood_Cancer_J_2013_Oct_4_3(10)_e150.nxml.txt.nlp	24096714	SENT157	35	35	24	24	bortezomib	IL6	PA10252	3569	0.919
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jun_5_66(Pt_7)_o1565.nxml.txt.nlp	21587808	SENT58	20	20	6	6	ethanol	mol	PA448073	90527	0.919
NULL	Mol_Cancer_2009_May_15_8_28.nxml.txt.nlp	19445670	SENT80	35	35	24	24	doxorubicin	XIAP	PA449412	331	0.919
NULL	Breast_Cancer_Res_2014_May_28_16(3)_R53.nxml.txt.nlp	24886537	SENT311	8	8	25	25	erlotinib	VAV3	PA134687924	10451	0.919
NULL	Med_Sci_Monit_2013_Nov_17_19_1006-1012.nxml.txt.nlp	24241246	SENT162	3	3	11	11	rosuvastatin	CD14	PA134308647	929	0.919
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2010_Aug_3_3_43-51.nxml.txt.nlp	22879786	SENT84	8	8	4	4	gemfibrozil	CYP2C8	PA449750	1558	0.919
NULL	Breast_Cancer_Res_Treat_2009_Jul_22_116(2)_371-378.nxml.txt.nlp	18941892	SENT23	44	44	6	6	letrozole	aromatase	PA450196	1588	0.919
NULL	J_Cell_Biol_1998_Jan_26_140(2)_335-345.nxml.txt.nlp	9442109	SENT85	21	21	30	30	chloroquine	NHE	PA448948	285335	0.919
NULL	Osteoporos_Int_2013_May_4_24(10)_2659-2670.nxml.txt.nlp	23644877	SENT276	10	10	14	14	metformin	AMPK	PA450395	5563	0.919
NULL	Br_J_Cancer_2013_Feb_19_108(3)_668-675.nxml.txt.nlp	23348520	SENT27	21	21	7	7	erlotinib	HER2	PA134687924	2064	0.919
NULL	Acta_Pharmacol_Sin_2010_Jul_28_31(7)_867-873.nxml.txt.nlp	20581857	SENT123	11	11	24	24	docetaxel	PDCD4	PA449383	27250	0.919
NULL	Acta_Pharmacol_Sin_2014_Jun_4_35(6)_846-852.nxml.txt.nlp	24902791	SENT22	0	0	14	14	lapatinib	HER2	PA152241907	2064	0.919
NULL	Mol_Pain_2014_Aug_15_10_53.nxml.txt.nlp	25127716	SENT26	5	5	13	13	paclitaxel	SDH	PA450761	1757;10993	0.919
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT151	23	23	7	7	perifosine	DR4	PA165291471	8797	0.919
NULL	J_Oncol_2009_Jul_14_2009_896407.nxml.txt.nlp	19636423	SENT115	28	28	1	1	irinotecan	EGFR	PA450085	1956	0.919
NULL	Br_J_Anaesth_2014_Jul_22_113(1)_157-167.nxml.txt.nlp	24154701	SENT245	13	13	20	20	sevoflurane	TREK-1	PA451341	3776	0.919
NULL	Oncotarget_2012_Dec_30_3(12)_1505-1521.nxml.txt.nlp	23455493	SENT195	6	6	9	9	vincristine	Bcl-2	PA451879	596	0.919
NULL	Biomed_Res_Int_2014_Aug_5_2014_952159.nxml.txt.nlp	25162038	SENT48	37	37	25	25	methotrexate	ATIC	PA450428	471	0.919
NULL	Support_Care_Cancer_2012_Jan_22_20(1)_107-117.nxml.txt.nlp	21258948	SENT69	22	22	4	4	cisplatin	HEC	PA449014	10403	0.919
NULL	Br_J_Cancer_2013_May_14_108(9)_1807-1809.nxml.txt.nlp	23612454	SENT51	9	9	21	21	trastuzumab	PIK3CA	PA451743	5290	0.919
NULL	Neural_Plast_2014_Jan_16_2014_254574.nxml.txt.nlp	24551459	SENT120	21	21	18	18	indomethacin	COX	PA449982	1351	0.919
NULL	Emerg_Infect_Dis_2014_Apr_20(4)_701-704.nxml.txt.nlp	24655438	SENT58	17	17	3	3	chloramphenicol	CT28	PA448927	51213	0.919
NULL	Chem_Rev_2011_Oct_12_111(10)_5899-5921.nxml.txt.nlp	21923193	SENT43	7	7	0	0	lipase	DAG	PA450239	1605	0.919
NULL	J_Korean_Med_Sci_2010_Feb_19_25(2)_333-335.nxml.txt.nlp	20119596	SENT66	14	14	5	5	aripiprazole	5-HT1A	PA10026	3350	0.919
NULL	Breast_Cancer_Res_2011_Jan_24_13(1)_401.nxml.txt.nlp	21349137	SENT15	9	9	3	3	lapatinib	AMPK	PA152241907	5563	0.919
NULL	Eur_J_Clin_Pharmacol_2008_Feb_26_64(2)_133-157.nxml.txt.nlp	18224312	SENT314	34	34	24	24	trastuzumab	HER2	PA451743	2064	0.919
NULL	J_Korean_Med_Sci_2009_Jun_16_24(3)_525-528.nxml.txt.nlp	19543522	SENT14	10	10	6	6	doxorubicin	CHOP	PA449412	1649	0.919
NULL	Eur_J_Endocrinol_2014_Mar_170(3)_451-459.nxml.txt.nlp	24362411	SENT152	15	15	6	6	metformin	GLP1	PA450395	100125288;2641	0.919
NULL	Int_J_Mol_Sci_2012_Feb_24_13(3)_2578-2589.nxml.txt.nlp	22489112	SENT64	12	12	33	33	maprotiline	GAT3	PA450322	6538	0.919
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT111	6	6	39	39	atorvastatin	PTEN	PA448500	5728	0.919
NULL	Mol_Cancer_2014_Jun_27_13_159.nxml.txt.nlp	24972933	SENT180	20	20	36	36	gemcitabine	DCK	PA449748	1633	0.919
NULL	Clin_Exp_Reprod_Med_2014_Sep_30_41(3)_120-124.nxml.txt.nlp	25309856	SENT88	15	15	9	9	forskolin	ADAMTS16	PA146096022	170690	0.919
NULL	Clin_Ophthalmol_2009_Jun_2_3_199-210.nxml.txt.nlp	19668566	SENT84	25	25	9	9	ketorolac	COX	PA450150	1351	0.919
NULL	Ann_Hematol_2011_Feb_17_90(2)_173-183.nxml.txt.nlp	20714724	SENT195	2	2	20	20	resveratrol	CD38		952	0.919
NULL	Acta_Pharmacol_Sin_2012_Dec_22_33(12)_1511-1517.nxml.txt.nlp	23085741	SENT115	8	8	15	15	zileuton	CysLT1	PA451955	10800	0.919
NULL	Acta_Neuropathol_2012_Feb_19_123(2)_247-258.nxml.txt.nlp	22009304	SENT118	21	21	32	32	tamoxifen	flower	PA451581	11094	0.919
NULL	Iran_J_Pharm_Res_2014_Winter_13(1)_29-37.nxml.txt.nlp	24734054	SENT206	3	3	31	31	gliclazide	STZ	PA10892	6484	0.919
NULL	Int_J_Mol_Sci_2014_Jun_26_15(7)_11416-11434.nxml.txt.nlp	24972137	SENT10	8	8	22	22	sitagliptin	AMPK	PA164748978	5563	0.919
NULL	Mol_Cancer_2009_Dec_23_8_129.nxml.txt.nlp	20030852	SENT244	7	7	22	22	curcumin	ABCA1	PA151958596	19	0.919
NULL	J_Immune_Based_Ther_Vaccines_2006_Nov_28_4_7.nxml.txt.nlp	17132168	SENT51	17	17	37	37	hydroxyurea	GM-CSF	PA449942	1437	0.919
NULL	Int_J_Mol_Sci_2014_Oct_27_15(11)_19458-19471.nxml.txt.nlp	25350111	SENT163	33	33	0	0	formaldehyde	CAT	PA449703	847	0.919
NULL	EMBO_Mol_Med_2012_Jun_13_4(6)_515-527.nxml.txt.nlp	22416035	SENT222	15	15	8	8	olaparib	p53		7157	0.919
NULL	J_Hematol_Oncol_2014_Apr_16_7_34.nxml.txt.nlp	24739401	SENT42	32	32	7	7	rituximab	CD44	PA451261	960	0.919
NULL	J_Brachial_Plex_Peripher_Nerve_Inj_2009_Apr_23_4_2.nxml.txt.nlp	19389231	SENT76	19	19	6	6	lidocaine	CROM	PA450226	1604	0.919
NULL	Open_Med_Chem_J_2010_May_27_4_20-36.nxml.txt.nlp	21160908	SENT111	43	43	11	11	clozapine	c-fos	PA449061	2353	0.919
NULL	Front_Neural_Circuits_2014_Jul_10_8_76.nxml.txt.nlp	25071457	SENT92	0	0	30	30	trimethoprim	TMP	PA451788	2012	0.919
NULL	Psychol_Res_Behav_Manag_2010_Dec_6_3_109-118.nxml.txt.nlp	22110334	SENT114	0	0	11	11	fluvoxamine	CYP1A2	PA449690	1544	0.919
NULL	Hum_Genomics_2009_Jan_1_3(2)_128-142.nxml.txt.nlp	19164090	SENT212	9	9	5	5	carboplatin	CD44	PA448803	960	0.919
NULL	Diabetes_Care_2013_Jun_15_36(6)_1765-1771.nxml.txt.nlp	23704676	SENT238	20	20	36	36	gliclazide	PPARgamma	PA10892	5468	0.919
NULL	EMBO_Mol_Med_2012_Oct_30_4(10)_1097-1111.nxml.txt.nlp	22933306	SENT324	10	10	16	16	l-glutamine	B27	PA10090	56246	0.919
NULL	Clin_Exp_Metastasis_2013_May_15_30(7)_867-876.nxml.txt.nlp	23673558	SENT5	18	18	16	16	dacarbazine	NRAS	PA449197	4893	0.919
NULL	Cardiovasc_Diabetol_2006_Dec_4_5_26.nxml.txt.nlp	17144912	SENT9	34	34	17	17	dobutamine	ANOVA	PA449381	4858	0.919
NULL	Indian_J_Endocrinol_Metab_2013_Jul-Aug_17(4)_636-646.nxml.txt.nlp	23961479	SENT138	2	2	16	16	simvastatin	CYP2C9	PA451363	1559	0.919
NULL	Front_Oncol_2013_Aug_5_3_195.nxml.txt.nlp	23936763	SENT248	17	17	13	13	erlotinib	PTEN	PA134687924	5728	0.919
NULL	J_Immunotoxicol_2013_Jan_11_10(1)_75-82.nxml.txt.nlp	22967038	SENT96	21	21	1	1	rituximab	IL-2	PA451261	3558	0.919
NULL	Cardiovasc_Psychiatry_Neurol_2010_Jul_8_2010_801295.nxml.txt.nlp	20671945	SENT156	15	15	22	22	mannitol	S100B	PA450320	6285	0.919
NULL	Nat_Med_2011_Jul_3_17(7)_860-866.nxml.txt.nlp	21725296	SENT110	18	18	12	12	choline	iPLA2	PA448976	8398	0.919
NULL	Best_Pract_Res_Clin_Gastroenterol_2011_Apr_25(2-4)_245-258.nxml.txt.nlp	21497742	SENT242	10	10	4	4	gentamicin	TLR4	PA449753	7099	0.919
NULL	J_Gynecol_Oncol_2013_Jul_4_24(3)_273-279.nxml.txt.nlp	23875078	SENT21	9	9	0	0	paclitaxel	COX	PA450761	1351	0.919
NULL	Evid_Based_Complement_Alternat_Med_2014_Oct_29_2014_594354.nxml.txt.nlp	25530784	SENT6	10	10	31	31	trifluoperazine	UGT	PA451771	7361;7355	0.919
NULL	Environ_Health_Perspect_2006_Sep_23_114(9)_1401-1406.nxml.txt.nlp	16966095	SENT152	13	13	7	7	arsenite	p53	PA452638	7157	0.919
NULL	Indian_J_Med_Res_2013_Nov_138(5)_717-731.nxml.txt.nlp	24434324	SENT278	8	8	27	27	anakinra	IL-6	PA10799	3569	0.919
NULL	Adv_Biomed_Res_2014_Sep_8_3_189.nxml.txt.nlp	25298958	SENT92	21	21	4	4	lansoprazole	NAC	PA450180	22861	0.919
NULL	Clin_Exp_Otorhinolaryngol_2011_Dec_15_4(4)_177-183.nxml.txt.nlp	22232712	SENT129	3	3	20	20	doxycycline	MUC5B	PA449415	727897	0.919
NULL	Mol_Cancer_2008_Jun_5_7_50.nxml.txt.nlp	18534018	SENT65	7	7	13	13	bortezomib	p53	PA10252	7157	0.919
NULL	Acta_Pharmacol_Sin_2010_May_5_31(5)_540-545.nxml.txt.nlp	20364157	SENT98	2	2	8	8	hemin	HO-1	PA449849	3162	0.919
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1224-1233.nxml.txt.nlp	22353810	SENT198	7	7	31	31	doxorubicin	MRP-1	PA449412	928	0.919
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT280	23	23	36	36	cetuximab	EGFR	PA10040	1956	0.919
NULL	Cardiovasc_Res_2013_May_1_98(2)_286-296.nxml.txt.nlp	23334259	SENT187	19	19	10	10	flecainide	NCX	PA449646	3196	0.919
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT255	14	14	16	16	chloroquine	BMPR-II	PA448948	659	0.919
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT157	13	13	10	10	neratinib	HER3	PA165291472	2065	0.919
NULL	J_Hematol_Oncol_2008_Oct_23_1_19.nxml.txt.nlp	18947412	SENT35	15	15	30	30	alemtuzumab	CD34	PA164783958	947	0.919
NULL	Biomed_Res_Int_2013_Jun_9_2013_654354.nxml.txt.nlp	23841084	SENT31	32	32	25	25	erlotinib	EGFR	PA134687924	1956	0.919
NULL	Mol_Pain_2012_Sep_24_8_73.nxml.txt.nlp	23006841	SENT36	0	0	8	8	ketoconazole	MPL	PA450146	4352	0.919
NULL	J_Invest_Dermatol_2014_Mar_13_134(3)_791-800.nxml.txt.nlp	24037342	SENT113	28	28	36	36	glutaraldehyde	p53	PA449777	7157	0.919
NULL	Case_Rep_Endocrinol_2014_Dec_21_2014_481823.nxml.txt.nlp	25587468	SENT212	13	13	19	19	aldesleukin	IFN	PA448081	3439	0.919
NULL	Front_Neurosci_2014_Jan_10_7_270.nxml.txt.nlp	24454277	SENT34	3	3	6	6	resveratrol	SIRT1		23411	0.919
NULL	Diabetes_2013_Nov_18_62(11)_3751-3759.nxml.txt.nlp	23897951	SENT170	26	26	9	9	rosiglitazone	FGF21	PA451283	26291	0.919
NULL	Pharmaceuticals_(Basel)_2014_Jan_9_7(1)_46-57.nxml.txt.nlp	24451403	SENT84	21	21	16	16	ritonavir	p130	PA451260	5934	0.919
NULL	Braz_J_Med_Biol_Res_2014_Jan_10_47(1)_11-18.nxml.txt.nlp	24519089	SENT28	14	14	23	23	methysergide	ANG	PA164743265	283	0.919
NULL	Breast_Cancer_Res_2011_Nov_1_13(6)_224.nxml.txt.nlp	22114931	SENT127	35	35	21	21	trastuzumab	PTEN	PA451743	5728	0.919
NULL	Br_J_Pharmacol_2014_Jan_23_171(2)_523-535.nxml.txt.nlp	24372553	SENT14	2	2	13	13	metformin	SIRT1	PA450395	23411	0.919
NULL	Clin_Cosmet_Investig_Dermatol_2013_Mar_14_6_75-80.nxml.txt.nlp	23515267	SENT84	0	0	7	7	infliximab	TNF-alpha	PA452639	7124	0.919
NULL	Aging_(Albany_NY)_2011_Jan_18_3(1)_33-43.nxml.txt.nlp	21248371	SENT125	4	4	24	24	zinc	p53	PA451956	7157	0.919
NULL	Exp_Ther_Med_2013_Apr_5_5(4)_1259-1263.nxml.txt.nlp	23596498	SENT26	26	26	15	15	propofol	TRPV1	PA451141	7442	0.919
NULL	Cancers_(Basel)_2014_Apr_4_6(2)_796-812.nxml.txt.nlp	24713998	SENT155	6	6	1	1	doxorubicin	NGAL	PA449412	3934	0.919
NULL	Cancer_Metab_2014_Nov_3_2(1)_20.nxml.txt.nlp	NULL	SENT210	33	33	2	2	erlotinib	PDK4	PA134687924	5166	0.919
NULL	Br_J_Cancer_2012_Jun_26_107(1)_108-115.nxml.txt.nlp	22627319	SENT135	31	31	20	20	idarubicin	TOP2B	PA449961	7155	0.919
NULL	Int_J_Biol_Sci_2012_Feb_9_8(3)_310-327.nxml.txt.nlp	22355267	SENT168	34	34	21	21	simvastatin	PCSK9	PA451363	255738	0.919
NULL	Br_J_Pharmacol_2011_Feb_162(4)_989-999.nxml.txt.nlp	21054342	SENT157	8	8	12	12	omeprazole	CYP2C8	PA450704	1558	0.919
NULL	Biomed_Res_Int_2014_Jan_20_2014_948427.nxml.txt.nlp	24563867	SENT101	3	3	31	31	buspirone	STZ	PA448689	6484	0.919
NULL	Breast_Cancer_Res_Treat_2013_Sep_1_141(2)_243-248.nxml.txt.nlp	23996142	SENT111	7	7	17	17	tamoxifen	aromatase	PA451581	1588	0.919
NULL	Front_Genet_2014_Feb_26_5_40.nxml.txt.nlp	24616734	SENT317	13	13	26	26	docetaxel	CCNA1	PA449383	8900	0.919
NULL	Indian_J_Dermatol_2009_Apr-Jun_54(2)_100-109.nxml.txt.nlp	20101303	SENT208	32	32	38	38	alefacept	CD4	PA164748040	920	0.919
NULL	Oxid_Med_Cell_Longev_2013_Nov_28_2013_568093.nxml.txt.nlp	24379901	SENT71	41	41	21	21	resveratrol	JNK		5599	0.919
NULL	Arthritis_Res_Ther_2010_Apr_22_12(2)_112.nxml.txt.nlp	20441607	SENT2	11	11	37	37	rituximab	BAFF	PA451261	10673	0.919
NULL	J_Cell_Biol_2001_Oct_15_155(2)_207-216.nxml.txt.nlp	11591730	SENT92	17	17	24	24	camptothecin	p53	PA153590860	7157	0.919
NULL	Chemother_Res_Pract_2011_Jun_21_2011_696208.nxml.txt.nlp	22312556	SENT177	16	16	13	13	cetuximab	EGFR	PA10040	1956	0.919
NULL	Cerebrospinal_Fluid_Res_2010_Aug_12_7_11.nxml.txt.nlp	20704740	SENT34	7	7	0	0	valspodar	P-gp		5243	0.919
NULL	Br_J_Clin_Pharmacol_2013_Aug_23_76(2)_299-315.nxml.txt.nlp	23701319	SENT72	18	18	6	6	infliximab	IL-2	PA452639	3558	0.919
NULL	FEBS_J_2012_May_279(10)_1857-1870.nxml.txt.nlp	22420714	SENT38	16	16	3	3	capsaicin	TRPV1	PA448776	7442	0.919
NULL	Breast_Cancer_Res_2010_Apr_16_12(2)_R24.nxml.txt.nlp	20398352	SENT151	35	35	7	7	tamoxifen	ATAC	PA451581	6375	0.919
NULL	Br_J_Cancer_2003_Jun_16_88(12)_1956-1962.nxml.txt.nlp	12799643	SENT188	36	36	10	10	doxorubicin	p53	PA449412	7157	0.919
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Sep_30_66(Pt_10)_o2696.nxml.txt.nlp	21587664	SENT56	24	24	11	11	ethanol	mol	PA448073	90527	0.919
NULL	Cancers_(Basel)_2014_Aug_12_6(3)_1631-1669.nxml.txt.nlp	25119536	SENT250	42	42	23	23	imatinib	MMP9	PA10804	4318	0.919
NULL	Eur_J_Med_Res_2009_Dec_7_14(Suppl_4)_108-111.nxml.txt.nlp	20156738	SENT75	19	19	4	4	formoterol	FKBP51	PA134687907	2289	0.919
NULL	ScientificWorldJournal_2014_Feb_5_2014_912640.nxml.txt.nlp	24688447	SENT129	9	9	3	3	indomethacin	COX	PA449982	1351	0.919
NULL	J_Cell_Biol_2003_Dec_8_163(5)_1133-1143.nxml.txt.nlp	14662751	SENT266	0	0	33	33	trypsin	CD64	PA451806	2209	0.919
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_16_2012_395912.nxml.txt.nlp	23118789	SENT149	9	9	0	0	amitriptyline	UGT1A4	PA448385	54657	0.919
NULL	Indian_J_Med_Res_2013_Jan_137(1)_125-129.nxml.txt.nlp	23481061	SENT79	8	8	0	0	cisplatin	GSTP1	PA449014	2950	0.919
NULL	Breast_Cancer_Res_2008_Dec_4_10(6)_R103.nxml.txt.nlp	19055788	SENT38	19	19	33	33	tamoxifen	aromatase	PA451581	1588	0.919
NULL	J_Hematol_Oncol_2013_Jul_18_6_53.nxml.txt.nlp	23866964	SENT227	8	8	24	24	temsirolimus	CDKN1A	PA164746890	1026	0.919
NULL	CNS_Drugs_2014_May_27_28(8)_679-697.nxml.txt.nlp	24861337	SENT241	22	22	14	14	etanercept	TNF-alpha	PA449515	7124	0.919
NULL	Curr_Neuropharmacol_2014_Mar_12(2)_186-192.nxml.txt.nlp	24669211	SENT241	25	25	14	14	metformin	Met	PA450395	79811	0.919
NULL	Mol_Cancer_2010_May_26_9_123.nxml.txt.nlp	20504344	SENT23	16	16	5	5	fludarabine	p53	PA449655	7157	0.919
NULL	EMBO_Mol_Med_2013_Jul_13_5(7)_983-998.nxml.txt.nlp	23666744	SENT301	20	20	7	7	vinorelbine	NAT10	PA451881	55226	0.919
NULL	Breast_Cancer_Res_2012_May_4_14(3)_R72.nxml.txt.nlp	22559056	SENT36	30	30	3	3	tamoxifen	CENP-A	PA451581	1058	0.919
NULL	J_Biomed_Biotechnol_2011_Jun_14_2011_571784.nxml.txt.nlp	21716904	SENT119	10	10	5	5	estradiol	CYP1B1	PA449503	1545	0.919
NULL	Tuberc_Respir_Dis_(Seoul)_2014_Dec_31_77(6)_258-261.nxml.txt.nlp	25580142	SENT55	27	27	33	33	crizotinib	EGFR	PA165946122	1956	0.919
NULL	Braz_J_Med_Biol_Res_2013_Feb_1_46(2)_171-177.nxml.txt.nlp	23369979	SENT146	13	13	31	31	enalapril	IL-6	PA449456	3569	0.919
NULL	Front_Oncol_2014_Sep_23_4_263.nxml.txt.nlp	25295230	SENT418	11	11	6	6	sunitinib	FLT3	PA162372840	2322	0.919
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT93	9	9	5	5	metformin	HIP	PA450395	6767;6159;64399;5068	0.919
NULL	Br_J_Pharmacol_2011_Apr_162(8)_1832-1842.nxml.txt.nlp	21232033	SENT192	9	9	0	0	ethanol	HL-1	PA448073	55600	0.919
NULL	Gene_Ther_2010_Jan_27_17(1)_117-131.nxml.txt.nlp	19710705	SENT285	11	11	1	1	pentobarbital	ERG	PA450859	2078	0.919
NULL	Acta_Pharmacol_Sin_2010_Jan_5_31(1)_93-101.nxml.txt.nlp	20048748	SENT221	9	9	12	12	cisplatin	DAPK	PA449014	1612	0.919
NULL	Mol_Cancer_2014_Jun_4_13_141.nxml.txt.nlp	24894453	SENT95	18	18	11	11	cetuximab	EGFR	PA10040	1956	0.919
NULL	Eur_J_Clin_Pharmacol_2012_Sep_15_68(9)_1267-1274.nxml.txt.nlp	22418828	SENT165	20	20	25	25	pantoprazole	CYP2C19	PA450774	1557	0.919
NULL	Crit_Care_2010_Sep_14_14(5)_R166.nxml.txt.nlp	20840773	SENT221	12	12	0	0	galactose	GDH	PA449725	51084;2746	0.919
NULL	Oncol_Lett_2013_Mar_28_5(3)_983-991.nxml.txt.nlp	23426861	SENT27	29	29	6	6	paclitaxel	BRCA1	PA450761	672	0.919
NULL	J_Neuroinflammation_2010_Sep_7_7_51.nxml.txt.nlp	20822529	SENT178	16	16	22	22	hemin	p38	PA449849	10598;1432;7965	0.919
NULL	Chin_J_Cancer_2011_Nov_30(11)_749-756.nxml.txt.nlp	22035855	SENT92	0	0	6	6	tamoxifen	HER2	PA451581	2064	0.919
NULL	Clin_Med_Insights_Case_Rep_2010_Aug_12_3_31-39.nxml.txt.nlp	21769252	SENT86	0	0	7	7	anastrozole	aromatase	PA448432	1588	0.919
NULL	Arthritis_Res_Ther_2012_Oct_18_14(5)_R224.nxml.txt.nlp	23079134	SENT170	1	1	12	12	alendronate	PTH	PA448082	5741	0.919
NULL	Br_J_Cancer_2009_Oct_20_101(8)_1253-1260.nxml.txt.nlp	19755984	SENT135	22	22	12	12	tamoxifen	HER-2	PA451581	2064	0.919
NULL	Nature_2009_Apr_2_458(7238)_591-596.nxml.txt.nlp	19234442	SENT76	23	23	5	5	etoposide	Fe65	PA449552	322	0.919
NULL	Apoptosis_2014_Apr_23_19(7)_1055-1068.nxml.txt.nlp	24756955	SENT313	0	0	8	8	metformin	p53	PA450395	7157	0.919
NULL	Cancer_Cell_Int_2011_Dec_29_11_44.nxml.txt.nlp	22206574	SENT99	9	9	5	5	sorafenib	Mcl-1	PA7000	4170	0.919
NULL	N_Am_J_Med_Sci_2012_Dec_4(12)_648-650.nxml.txt.nlp	23272308	SENT20	12	12	2	2	ceftazidime	CRA	PA448861	51747;10903	0.919
NULL	Case_Rep_Oncol_2013_Jan_29_6(1)_72-77.nxml.txt.nlp	23466899	SENT101	24	24	0	0	gemcitabine	GTX	PA449748	84504	0.919
NULL	Pharmaceuticals_(Basel)_2013_Apr_17_6(4)_557-578.nxml.txt.nlp	24276125	SENT139	3	3	13	13	ustekinumab	IL-23	PA166048654	51561	0.919
NULL	J_Cell_Biol_2004_Jun_21_165(6)_801-812.nxml.txt.nlp	15197177	SENT40	2	2	8	8	hydroxyurea	BLM	PA449942	641	0.919
NULL	Front_Chem_2014_May_1_2_20.nxml.txt.nlp	24822174	SENT259	39	39	13	13	maytansine	HER2	PA165291473	2064	0.919
NULL	Cell_Cycle_2012_Nov_15_11(22)_4135-4146.nxml.txt.nlp	22983125	SENT77	7	7	15	15	nadh	HIF1	PA164755085	3091	0.919
NULL	Int_J_Gen_Med_2009_Jul_30_2_129-140.nxml.txt.nlp	20360896	SENT84	22	22	19	19	tamoxifen	aromatase	PA451581	1588	0.919
NULL	Ann_Med_Health_Sci_Res_2014_Sep-Oct_4(Suppl_3)_S185-S192.nxml.txt.nlp	25364587	SENT157	11	11	14	14	letrozole	aromatase	PA450196	1588	0.919
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT71	24	24	34	34	pp2	PP2		4888	0.919
NULL	Breast_Cancer_Res_2005_Jul_20_7(5)_205-211.nxml.txt.nlp	16168139	SENT171	0	0	21	21	tamoxifen	EGFR	PA451581	1956	0.919
NULL	J_Korean_Med_Sci_2010_Sep_14_25(9)_1277-1283.nxml.txt.nlp	20808669	SENT94	4	4	17	17	alendronate	IL-6	PA448082	3569	0.919
NULL	J_Cell_Sci_2011_Oct_1_124(19)_3344-3355.nxml.txt.nlp	21940797	SENT79	26	26	19	19	arsenite	PABP4	PA452638	728773	0.919
NULL	Diabetologia_2009_Oct_4_52(10)_2182-2189.nxml.txt.nlp	19652946	SENT103	20	20	12	12	rosiglitazone	AMPK	PA451283	5563	0.919
NULL	Nat_Med_2014_Apr_16_20(4)_385-397.nxml.txt.nlp	24633305	SENT56	8	8	28	28	triciribine	AKT	PA165958661	207	0.919
NULL	Eur_J_Clin_Pharmacol_2011_May_9_67(5)_477-482.nxml.txt.nlp	21305273	SENT121	5	5	40	40	atropine	ADRB1	PA448505	153	0.919
NULL	Brain_Sci_2012_Nov_13_2(4)_619-633.nxml.txt.nlp	24961263	SENT560	1	1	22	22	disulfiram	5-HT1A	PA449376	3350	0.919
NULL	Mol_Cancer_2014_Jun_14_13_150.nxml.txt.nlp	24927996	SENT163	3	3	10	10	geldanamycin	Hsp90	PA152031327	3320	0.919
NULL	J_Hematol_Oncol_2008_Oct_1_1_16.nxml.txt.nlp	18828924	SENT96	19	19	12	12	trastuzumab	HER2	PA451743	2064	0.919
NULL	Diabetes_Metab_J_2014_Jun_17_38(3)_181-186.nxml.txt.nlp	25003070	SENT39	0	0	21	21	metformin	PDK4	PA450395	5166	0.919
NULL	J_Clin_Exp_Pathol_2012_May_17_Suppl_4_7327.nxml.txt.nlp	25379357	SENT32	34	34	39	39	resveratrol	SIRT1		23411	0.919
NULL	Neural_Plast_2007_Sep_19_2007_26496.nxml.txt.nlp	18301726	SENT122	20	20	5	5	fluoxetine	TIEG1	PA449673	7071	0.919
NULL	J_Antimicrob_Chemother_2014_Nov_5_69(11)_2901-2912.nxml.txt.nlp	25096079	SENT248	22	22	25	25	vancomycin	NNT	PA451850	23530	0.919
NULL	Oncotarget_2014_Oct_18_5(21)_10206-10221.nxml.txt.nlp	25344914	SENT120	12	12	29	29	imatinib	BRAF	PA10804	673	0.919
NULL	Eur_J_Pediatr_2014_Nov_20_173(12)_1639-1642.nxml.txt.nlp	24253372	SENT93	4	4	17	17	olanzapine	CYP1A2	PA450688	1544	0.919
NULL	Oncogene_2013_Sep_12_32(37)_4355-4365.nxml.txt.nlp	23108409	SENT88	30	30	8	8	hyaluronidase	HAS2	PA164745713	3037	0.919
NULL	Mar_Drugs_2014_Sep_25_12(9)_4984-5020.nxml.txt.nlp	25257786	SENT123	7	7	0	0	thrombin	SP2	PA451674	6668	0.919
NULL	Oncotarget_2012_Nov_14_3(12)_1557-1565.nxml.txt.nlp	23238683	SENT85	0	0	5	5	ponatinib	CD34	PA165980594	947	0.919
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_105-115.nxml.txt.nlp	17912640	SENT146	10	10	26	26	letrozole	aromatase	PA450196	1588	0.919
NULL	J_Cell_Biol_2002_Jun_24_157(7)_1267-1278.nxml.txt.nlp	12082084	SENT156	20	20	28	28	thrombin	AC6	PA451674	112	0.919
NULL	Br_J_Pharmacol_2008_Dec_25_155(7)_1056-1065.nxml.txt.nlp	18724386	SENT254	39	39	26	26	diazoxide	GLP-1	PA449285	100125288	0.919
NULL	Front_Oncol_2013_Aug_5_3_195.nxml.txt.nlp	23936763	SENT248	17	17	28	28	erlotinib	EGFR	PA134687924	1956	0.919
NULL	Arthritis_Res_Ther_2003_Dec_2_5(Suppl_4)_S12-S16.nxml.txt.nlp	15180892	SENT75	24	24	18	18	vincristine	CHOP	PA451879	1649	0.919
NULL	AAPS_J_2011_Dec_22_14(1)_68-78.nxml.txt.nlp	22189899	SENT195	14	14	28	28	rifampin	CYP3A4	PA451250	1576	0.919
NULL	Biomed_Res_Int_2014_Feb_6_2014_323594.nxml.txt.nlp	24689036	SENT389	11	11	0	0	raloxifene	PC3	PA451221	57332;7832;5122	0.919
NULL	Oncotarget_2014_Oct_21_5(22)_11252-11268.nxml.txt.nlp	25361004	SENT268	18	18	3	3	metformin	CLIC1	PA450395	1192	0.919
NULL	Ann_Clin_Transl_Neurol_2014_Dec_21_1(12)_996-1005.nxml.txt.nlp	25574474	SENT123	28	28	14	14	riluzole	P-gp	PA451251	5243	0.919
NULL	Arthritis_2012_Oct_24_2012_805875.nxml.txt.nlp	23133752	SENT345	13	13	39	39	methotrexate	CD25	PA450428	3669;3559	0.919
NULL	Case_Rep_Dermatol_2013_Mar_20_5(1)_79-83.nxml.txt.nlp	23626544	SENT5	31	31	7	7	tacrolimus	CD163	PA451578	9332	0.919
NULL	Indian_J_Med_Res_2014_Jan_139(1)_7-9.nxml.txt.nlp	24604036	SENT11	9	9	17	17	albendazole	STH	PA164746058	246744	0.919
NULL	J_Thromb_Thrombolysis_2012_Feb_20_33(2)_143-153.nxml.txt.nlp	22183178	SENT116	33	33	39	39	ticagrelor	P2Y12	PA165374673	64805	0.919
NULL	Case_Rep_Oncol_2014_May_24_7(2)_343-348.nxml.txt.nlp	24987354	SENT76	19	19	16	16	vemurafenib	BRAF	PA165946873	673	0.919
NULL	Clin_Med_Insights_Oncol_2013_Oct_29_7_269-277.nxml.txt.nlp	24250243	SENT113	32	32	5	5	pazopanib	VEGFR	PA165291492	3791	0.919
NULL	Oncogene_2009_Feb_5_28(5)_674-685.nxml.txt.nlp	19015634	SENT102	38	38	5	5	melphalan	FANCD2	PA450354	2177	0.919
NULL	Oncoscience_2014_Oct_22_1(10)_614-623.nxml.txt.nlp	25593991	SENT97	19	19	10	10	afatinib	EGFR	PA165981154	1956	0.919
NULL	Oncotarget_2014_Jun_8_5(17)_7446-7457.nxml.txt.nlp	25277184	SENT111	8	8	14	14	nutlin-3	TRIM8		81603	0.919
NULL	Diabetes_2009_Feb_58(2)_329-336.nxml.txt.nlp	19171749	SENT240	41	41	15	15	imatinib	TRB	PA10804	6957	0.919
NULL	Cardiovasc_Diabetol_2013_Mar_23_12_48.nxml.txt.nlp	23522121	SENT40	38	38	10	10	pioglitazone	GLP-1	PA450970	100125288	0.919
NULL	Nature_2012_Aug_16_488(7411)_337-342.nxml.txt.nlp	22895339	SENT131	36	36	2	2	doxycycline	ENO2	PA449415	2026	0.919
NULL	Acta_Pharmacol_Sin_2011_Oct_12_32(10)_1259-1265.nxml.txt.nlp	21909126	SENT97	16	16	38	38	losartan	MCP-1	PA450268	6347	0.919
NULL	Environ_Health_Perspect_2008_Jan_11_116(1)_57-63.nxml.txt.nlp	18197300	SENT99	7	7	13	13	chlorzoxazone	CYP2E1	PA448971	1571	0.919
NULL	Int_J_Endocrinol_2014_Feb_13_2014_329456.nxml.txt.nlp	24688539	SENT225	1	1	8	8	vardenafil	IL-8	PA10229	3576	0.919
NULL	Ann_Rheum_Dis_2013_Apr_11_72(4)_583-589.nxml.txt.nlp	23144446	SENT135	40	40	17	17	tocilizumab	IL-6	PA165292659	3569	0.919
NULL	Oncoimmunology_2013_Dec_1_2(12)_e27215.nxml.txt.nlp	24501692	SENT32	29	29	11	11	cetuximab	STAT3	PA10040	6774	0.919
NULL	J_Biol_Chem_2008_May_30_283(22)_15440-15450.nxml.txt.nlp	18385140	SENT275	7	7	14	14	staurosporine	BAX	PA165109623	581	0.919
NULL	Reprod_Biol_Endocrinol_2013_Jun_19_11_53.nxml.txt.nlp	23782518	SENT138	10	10	31	31	cisplatin	CD44	PA449014	960	0.919
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2013_Jul_31_6_15-24.nxml.txt.nlp	23966808	SENT52	10	10	19	19	metformin	B12	PA450395	7126;4709	0.919
NULL	Oncoimmunology_2013_Oct_1_2(10)_e27025.nxml.txt.nlp	24353914	SENT110	41	41	12	12	cisplatin	CD4	PA449014	920	0.919
NULL	Oncotarget_2013_Dec_18_5(3)_634-648.nxml.txt.nlp	24504138	SENT167	24	24	9	9	bortezomib	Bcl-2	PA10252	596	0.919
NULL	J_Cell_Biol_2001_Feb_19_152(4)_683-692.nxml.txt.nlp	11266460	SENT153	14	14	6	6	trypsin	DHFR	PA451806	1719	0.919
NULL	Mol_Cancer_2010_Apr_23_9_87.nxml.txt.nlp	20416058	SENT245	18	18	11	11	doxorubicin	TRAIL	PA449412	8743	0.919
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT385	5	5	38	38	resveratrol	p65		5970	0.919
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT306	37	37	28	28	pp2	EGFR		1956	0.919
NULL	Acta_Vet_Scand_2008_Nov_27_50(1)_47.nxml.txt.nlp	19038035	SENT20	8	8	31	31	mephenytoin	CYP2C19	PA450373	1557	0.919
NULL	Target_Oncol_2013_Jun_27_8(2)_127-136.nxml.txt.nlp	23625191	SENT87	9	9	21	21	panitumumab	KRAS	PA162373091	3845	0.919
NULL	Br_J_Haematol_2014_Mar_13_164(1)_811-821.nxml.txt.nlp	24328678	SENT109	21	21	6	6	thalidomide	CRBN	PA451644	51185	0.919
NULL	Case_Rep_Oncol_2010_Apr_29_3(2)_131-136.nxml.txt.nlp	20740185	SENT72	26	26	4	4	tamoxifen	HER2	PA451581	2064	0.919
NULL	eLife_2013_Nov_5_2_e00969.nxml.txt.nlp	24192036	SENT501	6	6	10	10	vemurafenib	BRAF	PA165946873	673	0.919
NULL	Korean_J_Radiol_2010_Jun_21_Jul-Aug_11(4)_449-456.nxml.txt.nlp	20592929	SENT88	7	7	15	15	paraformaldehyde	VEGFR2	PA450790	3791	0.919
NULL	N_Am_J_Med_Sci_2009_Jul_1(2)_58-62.nxml.txt.nlp	22666671	SENT50	5	5	11	11	ethanol	ANOVA	PA448073	4858	0.919
NULL	Breast_Cancer_Res_2007_Aug_8_9(4)_R50.nxml.txt.nlp	17686159	SENT13	5	5	25	25	trastuzumab	AKT	PA451743	207	0.919
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT125	12	12	1	1	imatinib	ABCB1	PA10804	5243	0.919
NULL	Hum_Genomics_2008_Sep_1_3(1)_7-16.nxml.txt.nlp	19129086	SENT30	39	39	34	34	rosiglitazone	CYP2C8	PA451283	1558	0.919
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT42	3	3	14	14	trastuzumab	HER3	PA451743	2065	0.919
NULL	Arthritis_Res_Ther_2009_Mar_6_11(2)_R32.nxml.txt.nlp	19265537	SENT215	24	24	6	6	infliximab	S100A8	PA452639	6279	0.919
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT20	3	3	13	13	perifosine	PDK1	PA165291471	5170;5163	0.919
NULL	FEBS_Open_Bio_2013_Dec_30_4_96-104.nxml.txt.nlp	24490130	SENT83	17	17	1	1	cisplatin	BRCA1	PA449014	672	0.919
NULL	Biomed_Res_Int_2014_Jun_29_2014_974309.nxml.txt.nlp	25093192	SENT113	10	10	32	32	bortezomib	NEDD8	PA10252	4738	0.919
NULL	Br_J_Cancer_2013_Oct_15_109(8)_2096-2105.nxml.txt.nlp	24064970	SENT145	26	26	36	36	cisplatin	ERCC1	PA449014	2067	0.919
NULL	Diabetes_Care_2010_Nov_33(11)_2484-2485.nxml.txt.nlp	20980428	SENT37	14	14	8	8	pegaptanib	VEGF-A	PA164771236	7422	0.919
NULL	Breast_Cancer_Res_2003_Oct_31_5(Suppl_1)_62.nxml.txt.nlp	NULL	SENT10	26	26	21	21	anastrozole	ATAC	PA448432	6375	0.919
NULL	Cent_European_J_Urol_2013_Nov_18_66(3)_344-349.nxml.txt.nlp	24707382	SENT8	37	37	4	4	basiliximab	ABO	PA164747126	28	0.919
NULL	Mol_Cancer_2010_Apr_23_9_87.nxml.txt.nlp	20416058	SENT207	19	19	7	7	doxorubicin	DR5	PA449412	8795	0.919
NULL	J_Hematol_Oncol_2012_Aug_13_5_49.nxml.txt.nlp	22889180	SENT25	16	16	10	10	vincristine	CHOP	PA451879	1649	0.919
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT256	3	3	8	8	risperidone	PRL	PA451257	5617	0.919
NULL	Indian_J_Endocrinol_Metab_2012_Mar-Apr_16(2)_183-191.nxml.txt.nlp	22470853	SENT206	12	12	7	7	vasopressin	AVP	PA451858	114548;551	0.919
NULL	Oncotarget_2013_Jul_7_4(7)_1065-1074.nxml.txt.nlp	23867252	SENT5	21	21	27	27	geldanamycin	Hsp90	PA152031327	3320	0.919
NULL	Breast_Cancer_Res_2007_Mar_2_9(2)_205.nxml.txt.nlp	NULL	SENT116	21	21	2	2	lapatinib	PTEN	PA152241907	5728	0.919
NULL	J_Biomed_Sci_2013_Dec_20_20(1)_99.nxml.txt.nlp	24358977	SENT179	26	26	9	9	cisplatin	PTEN	PA449014	5728	0.919
NULL	Arthritis_Res_Ther_2010_Jul_7_12(4)_R131.nxml.txt.nlp	20609215	SENT203	28	28	10	10	iloprost	HSF1	PA164746843	3297	0.919
NULL	J_Invest_Dermatol_2013_Sep_25_133(9)_2212-2220.nxml.txt.nlp	23439393	SENT127	20	20	8	8	imiquimod	TRAIL	PA449972	8743	0.919
NULL	Onco_Targets_Ther_2014_Mar_21_7_469-476.nxml.txt.nlp	24711703	SENT25	0	0	28	28	bevacizumab	VEGF-A	PA130232992	7422	0.919
NULL	Int_J_Breast_Cancer_2012_May_9_2012_415170.nxml.txt.nlp	22649737	SENT69	7	7	22	22	trastuzumab	IGF1R	PA451743	3480	0.919
NULL	J_Carcinog_2011_Nov_30_10_29.nxml.txt.nlp	22190871	SENT163	35	35	24	24	lapatinib	AKT	PA152241907	207	0.919
NULL	Br_J_Cancer_2013_Feb_19_108(3)_557-563.nxml.txt.nlp	23361053	SENT201	27	27	7	7	tamoxifen	PAK1	PA451581	5585;5058	0.919
NULL	Cardiol_Res_Pract_2011_Apr_26_2011_874802.nxml.txt.nlp	21577272	SENT80	8	8	1	1	erythromycin	CYP3A4	PA449493	1576	0.919
NULL	Cell_Res_2014_Jul_9_24(7)_820-841.nxml.txt.nlp	24810299	SENT474	6	6	22	22	doxycycline	CD34	PA449415	947	0.919
NULL	Vet_Res_2013_Oct_2_44(1)_89.nxml.txt.nlp	24088531	SENT240	18	18	15	15	hemin	HO-1	PA449849	3162	0.919
NULL	J_Korean_Med_Sci_2013_Feb_29_28(2)_308-314.nxml.txt.nlp	23399960	SENT151	3	3	43	43	gabapentin	IL-6	PA449720	3569	0.919
NULL	J_Biol_Eng_2012_Apr_2_6_3.nxml.txt.nlp	22472487	SENT124	17	17	7	7	glucose	PSM	PA449773	2346	0.919
NULL	Cell_Cycle_2014_Jan_1_13(1)_90-95.nxml.txt.nlp	24196441	SENT99	19	19	32	32	camptothecin	P21	PA153590860	1026;9338	0.919
NULL	Neuro_Oncol_2011_Nov_22_13(11)_1178-1191.nxml.txt.nlp	21940738	SENT160	10	10	19	19	imatinib	SOX2	PA10804	6657	0.919
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT18	4	4	8	8	tacrolimus	RANKL	PA451578	8600	0.919
NULL	Clin_Transl_Allergy_2013_Sep_2_3_29.nxml.txt.nlp	24004581	SENT100	24	24	13	13	omalizumab	IL-4	PA164752253	3565	0.919
NULL	Ecancermedicalscience_2009_Oct_29_3_157.nxml.txt.nlp	22276018	SENT67	5	5	8	8	tamoxifen	HER2	PA451581	2064	0.919
NULL	Aging_(Albany_NY)_2011_Jan_18_3(1)_33-43.nxml.txt.nlp	21248371	SENT126	5	5	14	14	zinc	HIPK2	PA451956	28996	0.919
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_16_2012_395912.nxml.txt.nlp	23118789	SENT149	13	13	0	0	promethazine	UGT1A4	PA451128	54657	0.919
NULL	Blood_Cancer_J_2012_Oct_19_2(10)_e95.nxml.txt.nlp	23085780	SENT117	23	23	6	6	dasatinib	PAH	PA162372878	5053	0.919
NULL	Acta_Pharmacol_Sin_2013_Sep_5_34(9)_1208-1216.nxml.txt.nlp	23852087	SENT101	8	8	2	2	disulfiram	HIF-1	PA449376	29072	0.919
NULL	Cancer_Manag_Res_2011_Aug_10_3_273-285.nxml.txt.nlp	21931501	SENT211	7	7	14	14	pazopanib	IFN	PA165291492	3439	0.919
NULL	J_Korean_Med_Sci_1996_Aug_11(4)_314-318.nxml.txt.nlp	8878799	SENT11	40	40	14	14	methacholine	TDI	PA165958382	100038246	0.919
NULL	Cancer_Cell_Int_2013_Feb_12_13_14.nxml.txt.nlp	23402310	SENT20	0	0	6	6	celecoxib	COX	PA448871	1351	0.919
NULL	Nucleic_Acids_Res_2012_Jul_19_40(13)_5910-5925.nxml.txt.nlp	22434882	SENT305	15	15	4	4	curcumin	HBZ	PA151958596	3050	0.919
NULL	Case_Rep_Oncol_2012_Dec_6_5(3)_651-656.nxml.txt.nlp	23275781	SENT29	0	0	15	15	imatinib	KIT	PA10804	3815	0.919
NULL	Breast_Cancer_Res_2012_Jan_19_14(1)_201.nxml.txt.nlp	22277572	SENT117	19	19	11	11	letrozole	HER2	PA450196	2064	0.919
NULL	Lab_Invest_2012_Mar_12_92(3)_420-436.nxml.txt.nlp	22157717	SENT306	30	30	6	6	carbachol	CXCR4	PA448784	7852	0.919
NULL	Cancer_Res_Treat_2012_Mar_31_44(1)_1-10.nxml.txt.nlp	22500155	SENT160	13	13	6	6	dacarbazine	BRAF	PA449197	673	0.919
NULL	Ann_Med_Health_Sci_Res_2014_Jul-Aug_4(4)_466-471.nxml.txt.nlp	25221689	SENT110	12	12	1	1	piperaquine	CYP3A4	PA166104279	1576	0.919
NULL	J_Gen_Physiol_1994_Nov_1_104(5)_961-983.nxml.txt.nlp	7533207	SENT0	22	22	1	1	valinomycin	Gen	PA151917011	348654	0.919
NULL	J_Korean_Neurosurg_Soc_2014_Nov_30_56(5)_431-435.nxml.txt.nlp	25535523	SENT12	4	4	11	11	gefitinib	gamma	PA131301952	9913	0.919
NULL	Adv_Urol_2012_Oct_26_2012_812398.nxml.txt.nlp	22110495	SENT116	44	44	4	4	cisplatin	ERCC1	PA449014	2067	0.919
NULL	Oncogene_2010_Sep_16_29(37)_5135-5145.nxml.txt.nlp	20622897	SENT10	19	19	13	13	cetuximab	HIF1	PA10040	3091	0.919
NULL	ScientificWorldJournal_2012_Apr_19_2012_804730.nxml.txt.nlp	22606063	SENT138	19	19	11	11	latanoprost	ANOVA	PA164774763	4858	0.919
NULL	Oncoimmunology_2013_Oct_1_2(10)_e27025.nxml.txt.nlp	24353914	SENT179	19	19	26	26	docetaxel	CD4	PA449383	920	0.919
NULL	Nat_Chem_Biol_2010_Apr_28_6(4)_291-299.nxml.txt.nlp	20190765	SENT129	3	3	18	18	dasatinib	EGFR	PA162372878	1956	0.919
NULL	Oxid_Med_Cell_Longev_2013_Nov_10_2013_680414.nxml.txt.nlp	24319532	SENT138	30	30	6	6	minocycline	PARP-1	PA450519	25976	0.919
NULL	Eur_J_Clin_Pharmacol_2012_Sep_15_68(9)_1267-1274.nxml.txt.nlp	22418828	SENT177	16	16	3	3	omeprazole	CYP2C19	PA450704	1557	0.919
NULL	Diabetol_Metab_Syndr_2014_Mar_31_6_48.nxml.txt.nlp	24684803	SENT85	8	8	18	18	miglitol	STEP	PA164776726	84867	0.919
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_650809.nxml.txt.nlp	23258995	SENT183	14	14	4	4	vasopressin	AQP2	PA451858	359	0.919
NULL	J_Oncol_2010_May_11_2010_659231.nxml.txt.nlp	20467564	SENT54	4	4	24	24	tetracycline	Ang2	PA451640	285	0.919
NULL	Curr_Chem_Genomics_2010_Mar_1_4_1-8.nxml.txt.nlp	20448812	SENT28	23	23	12	12	fluorescein	OATP1B1	PA164746009	10599	0.919
NULL	J_Int_Soc_Sports_Nutr_2013_Aug_6_10_36.nxml.txt.nlp	23919405	SENT19	8	8	24	24	creatine	FFM	PA164778930	24	0.919
NULL	Cancer_Cell_2007_Dec_11_12(6)_514-527.nxml.txt.nlp	18068629	SENT169	11	11	4	4	paclitaxel	TGFBI	PA450761	7045	0.918
NULL	Indian_J_Pharmacol_2014_Jan-Feb_46(1)_3-12.nxml.txt.nlp	24550577	SENT177	0	0	11	11	vismodegib	BCS		617	0.918
NULL	Indian_J_Med_Res_2011_Dec_134(6)_823-834.nxml.txt.nlp	22310816	SENT25	35	35	2	2	trimethoprim	CD4	PA451788	920	0.918
NULL	Cell_Cycle_2013_Aug_1_12(15)_2348-2354.nxml.txt.nlp	23839046	SENT88	31	31	4	4	etoposide	FMN2	PA449552	56776	0.918
NULL	J_Headache_Pain_2014_Sep_18_15(Suppl_1)_G26.nxml.txt.nlp	NULL	SENT11	9	9	1	1	sumatriptan	NNT	PA451566	23530	0.918
NULL	Breast_Cancer_Res_2012_Jul_19_14(4)_R108.nxml.txt.nlp	22812534	SENT218	9	9	30	30	pargyline	HER2	PA450797	2064	0.918
NULL	Br_J_Cancer_2011_Jun_28_105(1)_118-123.nxml.txt.nlp	21654685	SENT114	5	5	11	11	dasatinib	S100beta	PA162372878	6285	0.918
NULL	Iran_J_Ped_Hematol_Oncol_2014_Mar_15_4(1)_32-38.nxml.txt.nlp	24734162	SENT5	22	22	3	3	mercaptopurine	TPMT	PA450379	7172	0.918
NULL	Cancer_Cell_Int_2008_Jan_4_8_1.nxml.txt.nlp	18177496	SENT89	16	16	8	8	gefitinib	EGFR	PA131301952	1956	0.918
NULL	Breast_Cancer_Res_2010_Apr_30_12(2)_203.nxml.txt.nlp	20459590	SENT270	25	25	18	18	cisplatin	BRCA2	PA449014	675	0.918
NULL	Curr_Genomics_2014_Feb_15(1)_38-51.nxml.txt.nlp	24653662	SENT622	7	7	18	18	bortezomib	Bcl-2	PA10252	596	0.918
NULL	Nat_Med_2014_Jun_4_20(6)_607-615.nxml.txt.nlp	24793239	SENT100	4	4	24	24	sulindac	FasL	PA451565	356	0.918
NULL	Nat_Commun_2013_Oct_25_4_2667.nxml.txt.nlp	24157709	SENT673	23	23	4	4	nutlin-3	p53		7157	0.918
NULL	Curr_Pain_Headache_Rep_2011_Aug_12_15(4)_271-279.nxml.txt.nlp	21479998	SENT52	8	8	14	14	tramadol	5-HT1A	PA451735	3350	0.918
NULL	Clin_Exp_Otorhinolaryngol_2012_Sep_27_5(3)_117-121.nxml.txt.nlp	22977707	SENT6	26	26	13	13	kanamycin	NKCC1	PA450137	6558	0.918
NULL	Br_J_Cancer_2012_Oct_9_107(8)_1277-1285.nxml.txt.nlp	22990652	SENT162	0	0	13	13	axitinib	CYP1A2	PA164924493	1544	0.918
NULL	J_Cancer_2013_Jan_11_4(2)_117-132.nxml.txt.nlp	23386910	SENT277	22	22	14	14	trastuzumab	HER-2	PA451743	2064	0.918
NULL	Arthritis_Res_Ther_2012_May_1_14(3)_R99.nxml.txt.nlp	22546542	SENT61	18	18	33	33	infliximab	IL-10	PA452639	3586	0.918
NULL	Ann_Hematol_2010_Sep_13_89(9)_861-871.nxml.txt.nlp	20387067	SENT3	17	17	11	11	dasatinib	CD34	PA162372878	947	0.918
NULL	Oncogene_2014_Jul_17_33(29)_3784-3793.nxml.txt.nlp	24013225	SENT268	7	7	17	17	heparin	EGF	PA449855	1950	0.918
NULL	Acta_Pharmacol_Sin_2009_Nov_12_30(11)_1566-1572.nxml.txt.nlp	19820718	SENT13	20	20	31	31	ketoconazole	CYP3A4	PA450146	1576	0.918
NULL	Clin_Med_Insights_Oncol_2013_Feb_28_7_53-73.nxml.txt.nlp	23492937	SENT353	3	3	14	14	bortezomib	Bcl-2	PA10252	596	0.918
NULL	Indian_J_Ophthalmol_2013_May_61(5)_213-217.nxml.txt.nlp	23314254	SENT77	9	9	16	16	bevacizumab	San	PA130232992	80218	0.918
NULL	Eur_J_Clin_Pharmacol_2007_Apr_21_63(4)_335-343.nxml.txt.nlp	17318526	SENT224	40	40	34	34	acenocoumarol	CYP2C9	PA452632	1559	0.918
NULL	Case_Rep_Oncol_2014_Mar_19_7(1)_210-216.nxml.txt.nlp	24803897	SENT7	16	16	4	4	cisplatin	HER2	PA449014	2064	0.918
NULL	Breast_Cancer_(Auckl)_2010_Feb_16_4_1-3.nxml.txt.nlp	20697527	SENT7	6	6	43	43	curcumin	14-3-3	PA151958596	10971	0.918
NULL	Arthritis_Res_Ther_2006_Jul_28_8(Suppl_2)_S4.nxml.txt.nlp	16899108	SENT4	27	27	20	20	tocilizumab	IL-6	PA165292659	3569	0.918
NULL	Front_Physiol_2012_Sep_18_3_355.nxml.txt.nlp	23060802	SENT1198	10	10	3	3	cisplatin	JNK	PA449014	5599	0.918
NULL	J_Cardiothorac_Surg_2013_May_13_8_127.nxml.txt.nlp	23668669	SENT41	8	8	1	1	ropivacaine	EDA	PA451271	1896	0.918
NULL	Core_Evid_2007_Nov_30_2(2)_121-129.nxml.txt.nlp	21221180	SENT234	5	5	31	31	rituximab	CHOP	PA451261	1649	0.918
NULL	Cell_Death_Dis_2010_Feb_4_1(2)_e23.nxml.txt.nlp	21364631	SENT272	35	35	9	9	desipramine	c-Jun	PA449233	3725	0.918
NULL	J_Hematol_Oncol_2009_Jan_21_2_2.nxml.txt.nlp	19159467	SENT57	41	41	31	31	erlotinib	EGFR	PA134687924	1956	0.918
NULL	Mol_Cancer_2013_Nov_11_12_134.nxml.txt.nlp	24215614	SENT186	35	35	23	23	lapatinib	PTEN	PA152241907	5728	0.918
NULL	Cardiovasc_Diabetol_2006_Aug_30_5_17.nxml.txt.nlp	16939660	SENT25	23	23	21	21	metformin	AMPK	PA450395	5563	0.918
NULL	Mol_Cell_2014_May_8_54(3)_445-459.nxml.txt.nlp	24746700	SENT501	31	31	13	13	etoposide	EXO1	PA449552	9156	0.918
NULL	Evid_Based_Complement_Alternat_Med_2014_May_4_2014_684508.nxml.txt.nlp	24876877	SENT293	1	1	28	28	sorafenib	EGFR	PA7000	1956	0.918
NULL	Acta_Neuropathol_Commun_2013_May_20_1_17.nxml.txt.nlp	24252689	SENT179	31	31	17	17	celecoxib	ICAM1	PA448871	3383	0.918
NULL	Cancer_Med_2014_Oct_2_3(5)_1256-1265.nxml.txt.nlp	24890382	SENT43	4	4	10	10	trastuzumab	San	PA451743	80218	0.918
NULL	Int_J_Gen_Med_2009_Jul_30_2_129-140.nxml.txt.nlp	20360896	SENT9	7	7	4	4	letrozole	aromatase	PA450196	1588	0.918
NULL	Cardiovasc_Diabetol_2008_Aug_11_7_24.nxml.txt.nlp	18694484	SENT217	37	37	0	0	exenatide	Ray	PA164749238	26751	0.918
NULL	Oncotarget_2013_Oct_19_4(11)_2045-2056.nxml.txt.nlp	24185104	SENT144	31	31	25	25	cisplatin	p38	PA449014	10598;1432;7965	0.918
NULL	Oncol_Rep_2014_Apr_28_31(4)_1605-1612.nxml.txt.nlp	24481648	SENT10	27	27	23	23	paclitaxel	MRP7	PA450761	89845;1080	0.918
NULL	Exp_Ther_Med_2013_Mar_21_5(3)_987-991.nxml.txt.nlp	23407636	SENT86	28	28	17	17	losartan	MCP-1	PA450268	6347	0.918
NULL	Environ_Health_Perspect_2009_Nov_26_117(11)_1737-1744.nxml.txt.nlp	20049126	SENT175	32	32	6	6	arsenite	XRCC3	PA452638	7517	0.918
NULL	Front_Oncol_2013_Nov_27_3_290.nxml.txt.nlp	24350055	SENT122	7	7	26	26	docetaxel	CHFR	PA449383	55743	0.918
NULL	ScientificWorldJournal_2012_May_1_2012_490968.nxml.txt.nlp	22645425	SENT113	3	3	22	22	montelukast	IL-6	PA450546	3569	0.918
NULL	J_Cell_Biol_2001_Apr_2_153(1)_221-228.nxml.txt.nlp	11285287	SENT91	27	27	25	25	etoposide	TRAIL	PA449552	8743	0.918
NULL	Ann_Oncol_2011_Aug_27_22(8)_1736-1747.nxml.txt.nlp	21709140	SENT168	21	21	25	25	tamoxifen	aromatase	PA451581	1588	0.918
NULL	Front_Oncol_2014_Apr_17_4_78.nxml.txt.nlp	24860780	SENT659	19	19	23	23	irinotecan	KRAS	PA450085	3845	0.918
NULL	Autophagy_2013_Jul_1_9(7)_985-995.nxml.txt.nlp	23584039	SENT83	8	8	0	0	resveratrol	LC3		84557	0.918
NULL	Acta_Pharmacol_Sin_2014_Aug_21_35(8)_994-1004.nxml.txt.nlp	25042549	SENT284	37	37	18	18	pravastatin	PCSK9	PA451089	255738	0.918
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT224	5	5	26	26	atorvastatin	p38	PA448500	10598;1432;7965	0.918
NULL	Mol_Cancer_2010_Jun_25_9_166.nxml.txt.nlp	20579378	SENT9	7	7	13	13	gefitinib	EGFR	PA131301952	1956	0.918
NULL	Oncol_Lett_2014_Jun_14_7(6)_2130-2134.nxml.txt.nlp	24932302	SENT20	0	0	6	6	eltrombopag	TPO	PA165981594	7066;7173	0.918
NULL	Breast_Cancer_(Auckl)_2009_Apr_7_3_23-34.nxml.txt.nlp	21556247	SENT106	23	23	20	20	celecoxib	AKT	PA448871	207	0.918
NULL	Int_J_Biochem_Cell_Biol_2013_Feb_45(2)_283-291.nxml.txt.nlp	23085378	SENT172	20	20	28	28	estradiol	aromatase	PA449503	1588	0.918
NULL	Ther_Clin_Risk_Manag_2005_Dec_1(4)_299-306.nxml.txt.nlp	18360572	SENT72	10	10	8	8	warfarin	CYP3A4	PA451906	1576	0.918
NULL	J_Cardiothorac_Surg_2007_Jul_5_2_31.nxml.txt.nlp	17615074	SENT25	0	0	10	10	heparin	ACT	PA449855	12;11332;9457;641455	0.918
NULL	Oncotarget_2014_May_27_5(19)_9049-9064.nxml.txt.nlp	24979294	SENT201	2	2	16	16	fulvestrant	AKT	PA164747170	207	0.918
NULL	Open_Access_J_Urol_2011_May_10_3_69-82.nxml.txt.nlp	24198638	SENT66	9	9	27	27	cyclophosphamide	CYP2C9	PA449165	1559	0.918
NULL	Mol_Cancer_2010_Mar_9_9_54.nxml.txt.nlp	20214788	SENT68	20	20	3	3	tetracycline	JDP2	PA451640	122953	0.918
NULL	J_Hematol_Oncol_2011_Apr_20_4_17.nxml.txt.nlp	21507255	SENT221	28	28	16	16	cisplatin	HDAC	PA449014	9734	0.918
NULL	Cell_Logist_2013_Jan_1_3(1)_e26331.nxml.txt.nlp	24475373	SENT55	24	24	28	28	paraformaldehyde	AKAP350	PA450790	10142	0.918
NULL	Behav_Brain_Funct_2005_Apr_22_1_2.nxml.txt.nlp	15916700	SENT112	24	24	27	27	methylphenidate	spatial	PA450464	219793	0.918
NULL	Indian_J_Pharmacol_2012_Nov-Dec_44(6)_694-698.nxml.txt.nlp	23248396	SENT41	12	12	4	4	ethanol	flower	PA448073	11094	0.918
NULL	Diabetes_2009_Feb_58(2)_329-336.nxml.txt.nlp	19171749	SENT159	16	16	10	10	imatinib	JNK	PA10804	5599	0.918
NULL	BMB_Rep_2014_May_47(5)_274-279.nxml.txt.nlp	24286313	SENT30	12	12	4	4	bortezomib	CD52	PA10252	1043	0.918
NULL	Case_Rep_Rheumatol_2011_Dec_15_2011_185657.nxml.txt.nlp	22937439	SENT14	24	24	4	4	etanercept	TNF-alpha	PA449515	7124	0.918
NULL	Front_Neural_Circuits_2014_Apr_23_8_37.nxml.txt.nlp	24795570	SENT151	37	37	18	18	tetracycline	c-fos	PA451640	2353	0.918
NULL	Mol_Pain_2012_Sep_22_8_71.nxml.txt.nlp	22998838	SENT217	38	38	29	29	paclitaxel	CXCR4	PA450761	7852	0.918
NULL	Arch_Drug_Inf_2008_Sep_1(2)_56-62.nxml.txt.nlp	19915709	SENT51	14	14	21	21	fentanyl	CYP3A4	PA449599	1576	0.918
NULL	Cell_Cycle_2013_Dec_15_12(24)_3759-3769.nxml.txt.nlp	24107633	SENT187	4	4	32	32	metformin	IL-6	PA450395	3569	0.918
NULL	Acta_Neuropathol_Commun_2013_Dec_5_1(1)_79.nxml.txt.nlp	24314025	SENT182	9	9	6	6	geldanamycin	Hsp90	PA152031327	3320	0.918
NULL	Mol_Cancer_2010_May_21_9_116.nxml.txt.nlp	20492666	SENT230	32	32	17	17	bortezomib	p27	PA10252	5715;10534	0.918
NULL	J_Cell_Biol_1998_Nov_30_143(5)_1183-1199.nxml.txt.nlp	9832548	SENT93	40	40	6	6	mannitol	Met	PA450320	79811	0.918
NULL	Cancer_Med_2013_Aug_30_2(4)_457-467.nxml.txt.nlp	24156018	SENT4	12	12	28	28	temozolomide	MMP14	PA451609	4323	0.918
NULL	Arthritis_Res_Ther_2014_May_16_16(3)_R113.nxml.txt.nlp	24886859	SENT333	4	4	13	13	tranylcypromine	LSD1	PA451741	23028	0.918
NULL	J_Int_AIDS_Soc_2011_Nov_15_14_55.nxml.txt.nlp	22085598	SENT194	17	17	21	21	etravirine	CCR5	PA166014703	1234	0.918
NULL	J_Korean_Med_Sci_2008_Aug_25_23(4)_685-690.nxml.txt.nlp	18756058	SENT124	21	21	15	15	olanzapine	ghrelin	PA450688	51738	0.918
NULL	Sci_Rep_2015_Jan_6_5_7641.nxml.txt.nlp	25560734	SENT105	17	17	4	4	tamoxifen	CLTC	PA451581	1213	0.918
NULL	Front_Synaptic_Neurosci_2014_May_30_6_12.nxml.txt.nlp	24910611	SENT162	15	15	7	7	l-serine	asc-1	PA451330	56301	0.918
NULL	Cancers_(Basel)_2014_Aug_12_6(3)_1631-1669.nxml.txt.nlp	25119536	SENT236	21	21	6	6	imatinib	Met	PA10804	79811	0.918
NULL	J_Biol_Chem_2013_Feb_22_288(8)_5530-5538.nxml.txt.nlp	23235146	SENT135	25	25	6	6	hyaluronan	TSG-6	PA165958431	7130	0.918
NULL	Mol_Syst_Biol_2009_Jul_28_5_288.nxml.txt.nlp	19638969	SENT452	6	6	21	21	resveratrol	HuR		1994	0.918
NULL	Front_Behav_Neurosci_2009_Jun_29_3_10.nxml.txt.nlp	19587848	SENT874	15	15	17	17	diethylstilbestrol	DES	PA449307	1674	0.918
NULL	Diabetes_Care_2009_Nov_32(Suppl_2)_S223-S231.nxml.txt.nlp	19875556	SENT102	9	9	1	1	exenatide	AMIGO	PA164749238	57463	0.918
NULL	J_Ophthalmol_2012_Feb_28_2012_786870.nxml.txt.nlp	22523653	SENT27	0	0	20	20	bevacizumab	VEGF-A	PA130232992	7422	0.918
NULL	Cancer_Cell_Int_2013_Feb_8_13_11.nxml.txt.nlp	23394616	SENT186	36	36	24	24	geldanamycin	FOXO1	PA152031327	2308	0.918
NULL	Evid_Based_Complement_Alternat_Med_2012_Sep_4_2012_485042.nxml.txt.nlp	22988474	SENT126	13	13	26	26	paclitaxel	P-gp	PA450761	5243	0.918
NULL	Acta_Orthop_2010_Dec_26_81(6)_748-755.nxml.txt.nlp	21067431	SENT146	8	8	3	3	rofecoxib	COX	PA451268	1351	0.918
NULL	Evid_Based_Complement_Alternat_Med_2012_May_7_2012_242810.nxml.txt.nlp	22645625	SENT46	21	21	29	29	rifampin	CYP3A4	PA451250	1576	0.918
NULL	Breast_Cancer_Res_2010_May_18_12(Suppl_1)_O5.nxml.txt.nlp	NULL	SENT5	38	38	17	17	doxorubicin	CD24	PA449412	100133941	0.918
NULL	J_Hematol_Oncol_2014_Aug_1_7_52.nxml.txt.nlp	25085632	SENT155	10	10	28	28	sunitinib	KRAS	PA162372840	3845	0.918
NULL	Arthritis_Res_Ther_2006_Jun_14_8(4)_R94.nxml.txt.nlp	16774691	SENT139	29	29	22	22	simvastatin	RhoA	PA451363	387	0.918
NULL	Indian_J_Pharm_Sci_2008_Sep-Oct_70(5)_591-595.nxml.txt.nlp	21394254	SENT21	10	10	5	5	atenolol	NEB	PA448499	4703	0.918
NULL	Nucleic_Acids_Res_2011_Dec_31_39(22)_9536-9548.nxml.txt.nlp	21880590	SENT164	20	20	34	34	paclitaxel	BRCA1	PA450761	672	0.918
NULL	Arthritis_Res_Ther_2014_Jul_18_16(4)_R153.nxml.txt.nlp	25037855	SENT212	20	20	32	32	fluorescein	CD14	PA164746009	929	0.918
NULL	J_Exp_Med_1998_Jun_1_187(11)_1885-1892.nxml.txt.nlp	9607928	SENT213	5	5	14	14	thalidomide	IFN	PA451644	3439	0.918
NULL	Br_J_Cancer_2011_Dec_6_105(12)_1920-1926.nxml.txt.nlp	22095222	SENT25	35	35	24	24	gefitinib	PTEN	PA131301952	5728	0.918
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT26	3	3	23	23	imatinib	ABCB1	PA10804	5243	0.918
NULL	Cell_Commun_Signal_2013_Jan_11_11_2.nxml.txt.nlp	23305203	SENT160	17	17	8	8	forskolin	TIMAP	PA146096022	26051	0.918
NULL	Endocr_Connect_2012_Jun_8_1(1)_1-12.nxml.txt.nlp	23781298	SENT145	7	7	12	12	fenofibrate	ATROGIN1	PA449594	114907	0.918
NULL	Br_J_Cancer_1997_75(11)_1559-1566.nxml.txt.nlp	9184169	SENT8	16	16	10	10	genistein	p53	PA165109660	7157	0.918
NULL	Clin_Ophthalmol_2008_Jun_2(2)_339-346.nxml.txt.nlp	19668725	SENT125	11	11	18	18	pegaptanib	VEGF-A	PA164771236	7422	0.918
NULL	J_Mol_Med_2008_Sep_4_86(9)_1045-1056.nxml.txt.nlp	18600309	SENT140	5	5	31	31	salmeterol	CXCR1	PA451300	3577	0.918
NULL	Protein_Cell_2014_Jun_19_5(6)_469-479.nxml.txt.nlp	24748116	SENT75	19	19	0	0	vinblastine	EB1	PA451877	9167;22919;10982	0.918
NULL	Evid_Based_Complement_Alternat_Med_2011_Jan_9_2011_619650.nxml.txt.nlp	21799685	SENT7	2	2	5	5	ketanserin	5-HT2A	PA131053734	3356	0.918
NULL	Pharmaceutics_2012_Jan_31_4(1)_93-103.nxml.txt.nlp	24300182	SENT23	21	21	0	0	saquinavir	PDF	PA451305	64146;9518	0.918
NULL	Cell_Death_Dis_2014_Jul_3_5(7)_e1311.nxml.txt.nlp	24991763	SENT287	18	18	2	2	ketamine	BAX	PA450144	581	0.918
NULL	Core_Evid_2009_Jun_15_4_207-213.nxml.txt.nlp	20694077	SENT159	3	3	11	11	nilotinib	ABCG2	PA165958345	9429	0.918
NULL	Mol_Cancer_2014_Jan_13_13_7.nxml.txt.nlp	24418169	SENT258	10	10	16	16	sorafenib	STAT3	PA7000	6774	0.918
NULL	J_Korean_Med_Sci_2014_Jul_11_29(7)_965-972.nxml.txt.nlp	25045229	SENT25	10	10	6	6	metformin	B12	PA450395	7126;4709	0.918
NULL	Cardiovasc_Drugs_Ther_2013_Jul_26_27(6)_521-530.nxml.txt.nlp	23887740	SENT34	7	7	12	12	clopidogrel	ADP	PA449053	23038	0.918
NULL	Environ_Health_Perspect_2005_Oct_14_113(10)_1330-1335.nxml.txt.nlp	16203242	SENT21	5	5	11	11	arsenite	MLC	PA452638	23209	0.918
NULL	J_Radiat_Res_2014_Jan_14_55(1)_113-120.nxml.txt.nlp	23772086	SENT34	12	12	6	6	sorafenib	HCC	PA7000	84668	0.918
NULL	Clin_Mol_Allergy_2007_Jan_25_5_1.nxml.txt.nlp	17254346	SENT228	6	6	15	15	curcumin	STAT1	PA151958596	6772	0.918
NULL	Oncotarget_2014_Oct_21_5(22)_11252-11268.nxml.txt.nlp	25361004	SENT177	0	0	11	11	metformin	CLIC1	PA450395	1192	0.918
NULL	Br_J_Cancer_2013_Dec_10_109(12)_2954-2958.nxml.txt.nlp	24231949	SENT96	24	24	7	7	gemcitabine	p53	PA449748	7157	0.918
NULL	Oncol_Lett_2014_Nov_14_8(5)_2086-2092.nxml.txt.nlp	25295095	SENT97	17	17	4	4	gemcitabine	LKB1	PA449748	6794	0.918
NULL	Eur_J_Clin_Pharmacol_2014_Oct_8_70(1)_37-45.nxml.txt.nlp	24100471	SENT15	4	4	30	30	midazolam	CYP2C8	PA450496	1558	0.918
NULL	Oncotarget_2013_Jul_7_4(7)_1065-1074.nxml.txt.nlp	23867252	SENT20	33	33	27	27	geldanamycin	Hsp90	PA152031327	3320	0.918
NULL	Core_Evid_2010_Oct_21_5_61-76.nxml.txt.nlp	21042543	SENT346	15	15	4	4	cetuximab	KRAS	PA10040	3845	0.918
NULL	Mediators_Inflamm_2010_Jun_24_2010_393946.nxml.txt.nlp	20652007	SENT200	0	0	27	27	hyaluronan	TLR2	PA165958431	7097	0.918
NULL	Adv_Urol_2010_Jul_20_2010_687043.nxml.txt.nlp	20721275	SENT111	35	35	25	25	bevacizumab	IFN	PA130232992	3439	0.918
NULL	Oncogenesis_2014_Dec_15_3(12)_e133.nxml.txt.nlp	25500906	SENT110	15	15	8	8	trastuzumab	HER3	PA451743	2065	0.918
NULL	Cancer_Cell_Int_2014_Jul_2_14_59.nxml.txt.nlp	25120382	SENT91	18	18	13	13	metformin	CTR	PA450395	799	0.918
NULL	Diabetes_Care_2009_Oct_8_32(10)_1796-1801.nxml.txt.nlp	19587369	SENT184	20	20	5	5	rosiglitazone	DREAM	PA451283	30818	0.918
NULL	Eur_J_Immunol_2013_Dec_9_43(12)_3183-3196.nxml.txt.nlp	24030559	SENT275	30	30	3	3	mitomycin	CD4	PA450524	920	0.918
NULL	Mol_Clin_Oncol_2013_Sep_26_1(5)_799-804.nxml.txt.nlp	24649249	SENT112	2	2	9	9	lapatinib	HER2	PA152241907	2064	0.918
NULL	Asian_J_Transfus_Sci_2007_Jan-Jun_1(1)_16-23.nxml.txt.nlp	21938228	SENT140	6	6	21	21	pegfilgrastim	CD34	PA164781387	947	0.918
NULL	Pharmaceuticals_(Basel)_2012_Feb_24_5(3)_279-296.nxml.txt.nlp	24281379	SENT129	20	20	44	44	rivaroxaban	ANOVA	PA165958360	4858	0.918
NULL	Cancers_(Basel)_2011_Apr_19_3(2)_2080-2105.nxml.txt.nlp	24212797	SENT139	40	40	25	25	cetuximab	KRAS	PA10040	3845	0.918
NULL	Cardiovasc_Diabetol_2013_Oct_17_12_150.nxml.txt.nlp	24134550	SENT111	26	26	2	2	metformin	activin	PA450395	83729	0.918
NULL	J_Thromb_Thrombolysis_2011_Nov_26_32(4)_459-466.nxml.txt.nlp	21706290	SENT229	12	12	5	5	clopidogrel	CYP2C19	PA449053	1557	0.918
NULL	Int_J_Mol_Sci_2014_Mar_6_15(3)_4088-4103.nxml.txt.nlp	24663083	SENT17	18	18	39	39	l-arginine	DDAH1	PA448478	23576	0.918
NULL	Br_J_Cancer_2012_Oct_23_107(9)_1474-1480.nxml.txt.nlp	23033004	SENT23	23	23	11	11	docetaxel	EGFR	PA449383	1956	0.918
NULL	Br_J_Cancer_2010_Oct_26_103(9)_1380-1390.nxml.txt.nlp	20877355	SENT183	12	12	5	5	etoposide	FasL	PA449552	356	0.918
NULL	J_Oncol_2013_Feb_28_2013_897025.nxml.txt.nlp	23533410	SENT84	17	17	20	20	temsirolimus	AKT	PA164746890	207	0.918
NULL	Arch_Drug_Inf_2009_Mar_2(1)_8-16.nxml.txt.nlp	19381336	SENT6	17	17	22	22	saquinavir	CYP3A4	PA451305	1576	0.918
NULL	Clin_Dev_Immunol_2011_Nov_28_2011_780839.nxml.txt.nlp	22162713	SENT116	14	14	0	0	paraformaldehyde	DR4	PA450790	8797	0.918
NULL	J_Oral_Pathol_Med_2013_Jul_18_42(6)_499-506.nxml.txt.nlp	23331485	SENT9	4	4	1	1	indomethacin	COX	PA449982	1351	0.918
NULL	Endocrinol_Metab_(Seoul)_2014_Sep_25_29(3)_379-387.nxml.txt.nlp	25309798	SENT143	1	1	18	18	resveratrol	SIRT1		23411	0.918
NULL	Front_Neurosci_2014_Jan_31_8_6.nxml.txt.nlp	24550768	SENT214	12	12	25	25	capsaicin	TRPV1	PA448776	7442	0.918
NULL	Nat_Genet_2013_Sep_28_45(9)_1004-1012.nxml.txt.nlp	23892607	SENT72	29	29	19	19	doxycycline	PC2	PA449415	5126;5311;8535	0.918
NULL	Cell_Cycle_2013_Feb_15_12(4)_625-634.nxml.txt.nlp	23324396	SENT67	13	13	1	1	doxycycline	p53	PA449415	7157	0.918
NULL	J_Exp_Bot_2012_Mar_15_63(5)_1969-1983.nxml.txt.nlp	22174442	SENT220	24	24	31	31	l-alanine	NO3	PA448055	4681	0.918
NULL	Breast_Cancer_Res_2005_Dec_7_7(1)_R156-R163.nxml.txt.nlp	15642164	SENT6	0	0	3	3	letrozole	aromatase	PA450196	1588	0.918
NULL	Mol_Syst_Biol_2009_Jul_28_5_288.nxml.txt.nlp	19638969	SENT225	3	3	26	26	resveratrol	HuR		1994	0.918
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT80	4	4	19	19	efavirenz	CYP3A4	PA449441	1576	0.918
NULL	Cancer_Cell_Int_2010_Apr_29_10_12.nxml.txt.nlp	20429927	SENT92	15	15	8	8	bortezomib	HRI	PA10252	27102	0.918
NULL	J_Gynecol_Oncol_2013_Jul_4_24(3)_265-272.nxml.txt.nlp	23875077	SENT176	19	19	8	8	thrombin	DKK1	PA451674	22943	0.918
NULL	Indian_Dermatol_Online_J_2011_Jul-Dec_2(2)_111-119.nxml.txt.nlp	23130241	SENT326	27	27	22	22	calcipotriol	FAE	PA448714	2178	0.918
NULL	Indian_J_Med_Paediatr_Oncol_2014_Apr-Jun_35(2)_176-180.nxml.txt.nlp	25197183	SENT85	43	43	24	24	bevacizumab	KRAS	PA130232992	3845	0.918
NULL	J_Immunol_Res_2014_Apr_30_2014_857143.nxml.txt.nlp	24877157	SENT323	7	7	9	9	sirolimus	IL-2	PA451365	3558	0.918
NULL	Cancers_(Basel)_2014_Jul_8_6(3)_1487-1499.nxml.txt.nlp	25006835	SENT48	5	5	11	11	cisplatin	p38	PA449014	10598;1432;7965	0.918
NULL	Int_J_Gen_Med_2014_Jan_7_7_49-58.nxml.txt.nlp	24470767	SENT112	3	3	48	48	fentanyl	PTEN	PA449599	5728	0.918
NULL	Braz_J_Med_Biol_Res_2013_May_24_46(5)_426-432.nxml.txt.nlp	23739746	SENT106	5	5	28	28	diethylpropion	ANOVA	PA164778098	4858	0.918
NULL	Arthritis_Res_Ther_2012_May_1_14(3)_R99.nxml.txt.nlp	22546542	SENT213	25	25	1	1	infliximab	CD4	PA452639	920	0.918
NULL	Theranostics_2014_Jan_29_4(4)_336-365.nxml.txt.nlp	24578720	SENT123	4	4	29	29	octreotide	SSTR5	PA450678	6755	0.918
NULL	Nucleic_Acids_Res_2005_Jun_9_33(10)_3323-3330.nxml.txt.nlp	15947132	SENT90	22	22	4	4	cisplatin	MSH2	PA449014	4436	0.918
NULL	Nucleic_Acids_Res_2011_Dec_31_39(22)_9536-9548.nxml.txt.nlp	21880590	SENT211	18	18	2	2	cisplatin	FOXM1	PA449014	2305	0.918
NULL	Indian_J_Pharmacol_2013_Mar-Apr_45(2)_155-158.nxml.txt.nlp	23716892	SENT116	20	20	37	37	glibenclamide	CYP2C8	PA449782	1558	0.918
NULL	Front_Neurosci_2012_Feb_22_6_27.nxml.txt.nlp	22371696	SENT99	14	14	6	6	halothane	E12	PA449845	64100	0.918
NULL	Biol_Open_2014_Nov_13_3(12)_1164-1172.nxml.txt.nlp	25395667	SENT163	3	3	1	1	capsaicin	TRPV1	PA448776	7442	0.918
NULL	Ecancermedicalscience_2010_Nov_3_4_178.nxml.txt.nlp	22276032	SENT107	23	23	8	8	gefitinib	CEA	PA131301952	5670;1087	0.918
NULL	Oncol_Lett_2014_Aug_16_8(2)_673-678.nxml.txt.nlp	25009649	SENT36	4	4	27	27	aprotinin	San	PA448472	80218	0.918
NULL	Diabetes_Metab_J_2013_Aug_14_37(4)_240-248.nxml.txt.nlp	23991401	SENT92	10	10	3	3	ezetimibe	NPC1L1	PA10816	29881	0.918
NULL	Int_Clin_Psychopharmacol_2014_Jul_26_29(4)_206-211.nxml.txt.nlp	24374906	SENT78	21	21	1	1	doxepin	CYP2C19	PA449409	1557	0.918
NULL	Oncoscience_2014_Mar_31_1(3)_216-228.nxml.txt.nlp	25594014	SENT104	15	15	9	9	cisplatin	STAT3	PA449014	6774	0.918
NULL	Mol_Cells_2014_Sep_30_37(9)_664-671.nxml.txt.nlp	25234467	SENT44	16	16	3	3	cisplatin	miR-217	PA449014	406999	0.918
NULL	eLife_2013_Nov_5_2_e00969.nxml.txt.nlp	24192036	SENT109	6	6	17	17	vemurafenib	NOXA	PA165946873	5366	0.918
NULL	Oncotarget_2011_Jun_7_2(6)_491-496.nxml.txt.nlp	21653999	SENT18	12	12	36	36	tamoxifen	PAK1	PA451581	5585;5058	0.918
NULL	Br_J_Cancer_2012_Jun_5_106(12)_1997-2003.nxml.txt.nlp	22596232	SENT115	4	4	8	8	sorafenib	CD133	PA7000	8842	0.918
NULL	Mediators_Inflamm_2010_Jun_24_2010_393946.nxml.txt.nlp	20652007	SENT200	0	0	29	29	hyaluronan	TLR4	PA165958431	7099	0.918
NULL	Breast_Cancer_Res_2010_Oct_22_12(Suppl_2)_S1.nxml.txt.nlp	21050422	SENT124	31	31	12	12	cetuximab	TRN	PA10040	3842	0.918
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1542-1553.nxml.txt.nlp	21970874	SENT132	30	30	4	4	pemetrexed	ERCC1	PA10810	2067	0.918
NULL	Oncotarget_2012_Sep_11_3(9)_1026-1035.nxml.txt.nlp	22976441	SENT89	42	42	22	22	etoposide	CKI	PA449552	1119	0.918
NULL	Ann_Hematol_2011_Dec_8_90(12)_1399-1407.nxml.txt.nlp	21476016	SENT89	17	17	13	13	doxorubicin	CHOP	PA449412	1649	0.918
NULL	J_Young_Pharm_2010_Apr-Jun_2(2)_196-200.nxml.txt.nlp	21264125	SENT127	5	5	9	9	glimepiride	CYP2C9	PA449761	1559	0.918
NULL	Acta_Vet_Scand_2003_Sep_30_44(3)_121-129.nxml.txt.nlp	15074625	SENT118	14	14	20	20	neomycin	TMP	PA450608	2012	0.918
NULL	F1000Prime_Rep_2014_Aug_1_6_65.nxml.txt.nlp	25165564	SENT31	16	16	5	5	ofatumumab	NOTCH1	PA165291493	4851	0.918
NULL	J_Asthma_Allergy_2009_May_8_2_49-62.nxml.txt.nlp	21437144	SENT107	14	14	28	28	omalizumab	IL-4	PA164752253	3565	0.918
NULL	J_Physiol_2011_Mar_1_589(Pt_5)_1081-1093.nxml.txt.nlp	21224236	SENT190	39	39	4	4	diazoxide	GLP-1	PA449285	100125288	0.918
NULL	Exp_Ther_Med_2013_Nov_2_6(5)_1312-1316.nxml.txt.nlp	24223664	SENT33	20	20	8	8	dextran	IL-6	PA449261	3569	0.918
NULL	Ann_Hematol_2010_Nov_25_89(11)_1115-1124.nxml.txt.nlp	20499237	SENT118	35	35	2	2	fludarabine	CD19	PA449655	930	0.918
NULL	Cancer_Med_2012_Dec_26_1(3)_318-327.nxml.txt.nlp	23342281	SENT19	10	10	15	15	tamoxifen	aromatase	PA451581	1588	0.918
NULL	J_Cell_Mol_Med_2013_Dec_6_17(12)_1588-1597.nxml.txt.nlp	24199964	SENT131	35	35	6	6	dobutamine	APT	PA449381	653639	0.918
NULL	Cardiovasc_Res_2012_Dec_1_96(3)_552-560.nxml.txt.nlp	22918977	SENT220	2	2	15	15	losartan	ANG	PA450268	283	0.918
NULL	Mol_Neurobiol_2010_Jun_2_41(2-3)_392-409.nxml.txt.nlp	20437209	SENT297	1	1	25	25	curcumin	cPLA2	PA151958596	10524	0.918
NULL	Blood_Cancer_J_2014_Mar_7_4(3)_e190.nxml.txt.nlp	24608734	SENT98	6	6	14	14	cyclophosphamide	CHOP	PA449165	1649	0.918
NULL	Ann_Gastroenterol_2014_27(3)_200-206.nxml.txt.nlp	24976114	SENT83	8	8	2	2	thrombin	PAR3	PA451674	56288;2151	0.918
NULL	Oncoscience_2014_Jun_6_1(6)_423-426.nxml.txt.nlp	25594040	SENT30	25	25	6	6	nilotinib	PI3K	PA165958345	5290	0.918
NULL	Curr_Neuropharmacol_2012_Mar_10(1)_72-79.nxml.txt.nlp	22942880	SENT85	8	8	36	36	cisplatin	p53	PA449014	7157	0.918
NULL	Multidiscip_Respir_Med_2012_Aug_29_7(1)_26.nxml.txt.nlp	22958272	SENT78	16	16	18	18	budesonide	CYP3A4	PA448681	1576	0.918
NULL	Front_Surg_2014_May_27_1_16.nxml.txt.nlp	25593940	SENT67	15	15	26	26	collagenase	CO2	PA449107	4513	0.918
NULL	Cancer_Immunol_Immunother_2014_Sep_4_63(12)_1297-1306.nxml.txt.nlp	25186613	SENT174	4	4	1	1	indomethacin	COX	PA449982	1351	0.918
NULL	Oncol_Lett_2014_Sep_19_8(3)_1269-1274.nxml.txt.nlp	25120704	SENT104	20	20	2	2	cisplatin	Met	PA449014	79811	0.918
NULL	Adv_Pharmacol_Sci_2013_Jun_24_2013_987692.nxml.txt.nlp	23864853	SENT142	20	20	16	16	acetaminophen	ALP	PA448015	6590;10850;27295;80150;470;26033	0.918
NULL	Neural_Regen_Res_2013_Jun_25_8(18)_1673-1684.nxml.txt.nlp	25206464	SENT162	3	3	19	19	choline	CA1	PA448976	759	0.918
NULL	JRSM_Cardiovasc_Dis_2012_Sep_24_1(6)_cvd_2012_012015.nxml.txt.nlp	24175073	SENT14	13	13	20	20	clopidogrel	CYP2C19	PA449053	1557	0.918
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT308	37	37	19	19	cisplatin	p38	PA449014	10598;1432;7965	0.918
NULL	Cell_Death_Dis_2010_Nov_18_1(11)_e102.nxml.txt.nlp	21368867	SENT10	0	0	28	28	gentamicin	CLIMP-63	PA449753	10970	0.918
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Jul_9_3(7)_e124.nxml.txt.nlp	25006781	SENT344	10	10	14	14	rosuvastatin	OATP1B1	PA134308647	10599	0.918
NULL	Ecancermedicalscience_2008_Jul_8_2_63.nxml.txt.nlp	22275960	SENT94	18	18	7	7	trastuzumab	aromatase	PA451743	1588	0.918
NULL	Ann_Clin_Microbiol_Antimicrob_2009_Jan_15_8_2.nxml.txt.nlp	19146672	SENT132	39	39	31	31	isoniazid	EMB	PA450112	133418	0.918
NULL	Adv_Biomed_Res_2014_Jan_27_3_53.nxml.txt.nlp	24627861	SENT31	3	3	8	8	heparin	ACT	PA449855	12;11332;9457;641455	0.918
NULL	Cancer_Res_Treat_2015_Jan_25_47(1)_46-54.nxml.txt.nlp	25327492	SENT123	15	15	22	22	cisplatin	CRT	PA449014	811	0.918
NULL	Cardiol_Res_Pract_2011_May_10_2011_816897.nxml.txt.nlp	21629798	SENT117	16	16	4	4	ritonavir	CYP3A4	PA451260	1576	0.918
NULL	Front_Genet_2014_Jun_2_5_154.nxml.txt.nlp	24917878	SENT152	17	17	24	24	ethanol	POMC	PA448073	5443	0.918
NULL	Genome_Med_2010_Jun_29_2(6)_41.nxml.txt.nlp	20587003	SENT176	3	3	24	24	imatinib	Dok-2	PA10804	9046	0.918
NULL	Front_Oncol_2014_Sep_29_4_256.nxml.txt.nlp	25325013	SENT165	10	10	20	20	cisplatin	EGFR	PA449014	1956	0.918
NULL	Breast_Cancer_Res_2012_Feb_14_14(1)_R30.nxml.txt.nlp	22333315	SENT242	7	7	3	3	indomethacin	COX	PA449982	1351	0.918
NULL	Cardiovasc_Diabetol_2013_Jan_9_12_8.nxml.txt.nlp	23298374	SENT145	5	5	11	11	sitagliptin	adiponectin	PA164748978	9370	0.918
NULL	Br_J_Cancer_2011_Jun_28_105(1)_1-8.nxml.txt.nlp	21654681	SENT12	5	5	16	16	cetuximab	EGFR	PA10040	1956	0.918
NULL	Acta_Pharmacol_Sin_2010_Sep_16_31(9)_1075-1084.nxml.txt.nlp	20711221	SENT178	0	0	8	8	resveratrol	AMPK		5563	0.918
NULL	Aging_(Albany_NY)_2012_Apr_16_4(4)_247-255.nxml.txt.nlp	22511639	SENT82	12	12	27	27	metformin	CH1	PA450395	51430	0.918
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT172	19	19	6	6	chloroquine	BMP9	PA448948	2658	0.918
NULL	Aging_(Albany_NY)_2010_Oct_27_2(10)_709-726.nxml.txt.nlp	21076178	SENT250	13	13	28	28	hydroxyurea	CLS	PA449942	1210	0.918
NULL	Nucleic_Acids_Res_2012_Apr_16_40(8)_3511-3523.nxml.txt.nlp	22180533	SENT147	24	24	18	18	doxycycline	E2F7	PA449415	144455	0.918
NULL	Oncotarget_2013_Nov_19_5(2)_309-325.nxml.txt.nlp	24525395	SENT282	13	13	37	37	curcumin	p53	PA151958596	7157	0.918
NULL	Mol_Cell_Endocrinol_2012_Jan_30_348-135(2-3)_440-449.nxml.txt.nlp	21925568	SENT990	26	26	17	17	rosiglitazone	SRC1	PA451283	8648	0.918
NULL	Nat_Med_2011_Dec_11_18(1)_74-82.nxml.txt.nlp	22157681	SENT100	9	9	39	39	gefitinib	Dicer	PA131301952	23405	0.918
NULL	Mol_Brain_2013_Dec_16_6_56.nxml.txt.nlp	24330819	SENT201	4	4	17	17	dantrolene	c-fos	PA449208	2353	0.918
NULL	Nat_Med_2013_Nov_27_19(11)_10_1038_nm_3352.nxml.txt.nlp	24162815	SENT180	33	33	8	8	gefitinib	NTRK1	PA131301952	4914	0.918
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT208	27	27	12	12	perifosine	DR5	PA165291471	8795	0.918
NULL	Ann_Gastroenterol_2012_25(2)_96-99.nxml.txt.nlp	24714074	SENT37	0	0	4	4	tegaserod	5-HT4	PA130413154	3360	0.918
NULL	Int_J_Cell_Biol_2012_May_17_2012_908724.nxml.txt.nlp	22675362	SENT70	18	18	25	25	vorinostat	SMN2	PA164748224	6607	0.918
NULL	J_Cardiothorac_Surg_2011_Oct_14_6_138.nxml.txt.nlp	21999189	SENT126	21	21	1	1	creatine	ANOVA	PA164778930	4858	0.918
NULL	Arthritis_Res_Ther_2006_Jul_21_8(4)_R130.nxml.txt.nlp	16859540	SENT185	23	23	14	14	atorvastatin	CD59	PA448500	966	0.918
NULL	Arthritis_Res_Ther_2008_Mar_17_10(2)_R33.nxml.txt.nlp	18346273	SENT41	1	1	19	19	oxaliplatin	HMGB1	PA131285527	3146	0.918
NULL	Biologics_2009_Oct_12_3_469-474.nxml.txt.nlp	19851472	SENT98	32	32	0	0	montelukast	IFN	PA450546	3439	0.918
NULL	Aging_(Albany_NY)_2012_Apr_18_4(4)_279-289.nxml.txt.nlp	22529334	SENT127	3	3	0	0	copper	SOD1	PA449114	6647	0.918
NULL	Cancers_(Basel)_2014_Sep_5_6(3)_1769-1792.nxml.txt.nlp	25198391	SENT655	15	15	7	7	trastuzumab	PIK3CA	PA451743	5290	0.918
NULL	Allergy_2014_Jul_29_69(7)_817-827.nxml.txt.nlp	24773466	SENT175	7	7	14	14	pitrakinra	IL-4	PA165983754	3565	0.918
NULL	FEBS_Open_Bio_2012_May_30_2_119-128.nxml.txt.nlp	23650590	SENT56	32	32	0	0	l-glutamine	PC3	PA10090	57332;7832;5122	0.918
NULL	Front_Pharmacol_2014_May_9_5_103.nxml.txt.nlp	24847272	SENT226	10	10	5	5	midazolam	POR	PA450496	5447	0.918
NULL	Cell_Death_Dis_2014_Feb_27_5(2)_e1088.nxml.txt.nlp	24577086	SENT99	22	22	3	3	metformin	p62	PA450395	8878;10657;23636	0.918
NULL	Cancer_Res_Treat_2013_Mar_31_45(1)_55-62.nxml.txt.nlp	23613671	SENT132	16	16	23	23	irinotecan	KRAS	PA450085	3845	0.918
NULL	Oncol_Lett_2014_May_18_7(5)_1632-1638.nxml.txt.nlp	24765191	SENT120	0	0	14	14	trastuzumab	HER-2	PA451743	2064	0.918
NULL	Cell_Res_2013_Jun_21_23(6)_746-758.nxml.txt.nlp	23689277	SENT41	6	6	8	8	resveratrol	SIRT1		23411	0.918
NULL	Breast_Cancer_Res_2007_Mar_2_9(2)_205.nxml.txt.nlp	NULL	SENT144	16	16	26	26	capecitabine	HER-2	PA448771	2064	0.918
NULL	Oncotarget_2014_Feb_7_5(3)_775-787.nxml.txt.nlp	24519956	SENT188	20	20	0	0	docetaxel	PC3	PA449383	57332;7832;5122	0.918
NULL	BMJ_Open_2015_Jan_6_5(1)_e006251.nxml.txt.nlp	25564143	SENT108	28	28	7	7	simvastatin	IL-6	PA451363	3569	0.918
NULL	Cancer_Cell_Int_2014_Jun_11_14_49.nxml.txt.nlp	24991192	SENT128	11	11	16	16	berberine	AMPK	PA165860812	5563	0.918
NULL	Iran_Red_Crescent_Med_J_2014_Aug_5_16(8)_e12106.nxml.txt.nlp	25389471	SENT17	17	17	2	2	glucose	CAD	PA449773	1677;790	0.918
NULL	Indian_J_Med_Res_2011_Dec_134(6)_904-911.nxml.txt.nlp	22310822	SENT104	17	17	26	26	nevirapine	CD4	PA450616	920	0.918
NULL	Core_Evid_2010_Oct_21_5_61-76.nxml.txt.nlp	21042543	SENT76	25	25	11	11	panitumumab	IFL	PA162373091	3439	0.918
NULL	Oncogenesis_2014_Dec_15_3(12)_e133.nxml.txt.nlp	25500906	SENT60	30	30	19	19	trastuzumab	HER2	PA451743	2064	0.918
NULL	J_Thorac_Oncol_2014_Oct_23_9(10)_1532-1539.nxml.txt.nlp	25170639	SENT190	26	26	17	17	crizotinib	EGFR	PA165946122	1956	0.918
NULL	Mol_Cell_Proteomics_2014_May_17_13(5)_1273-1285.nxml.txt.nlp	24637012	SENT198	18	18	4	4	lisuride	5-HT2A	PA164749019	3356	0.918
NULL	Mol_Brain_2014_Sep_25_7(1)_70.nxml.txt.nlp	NULL	SENT26	7	7	4	4	papaverine	PDE10A	PA164745550	10846	0.918
NULL	Ther_Clin_Risk_Manag_2006_Mar_2(1)_87-98.nxml.txt.nlp	18360584	SENT105	39	39	6	6	sorafenib	LOX	PA7000	4015	0.918
NULL	Mol_Vis_2007_Jul_12_13_1130-1137.nxml.txt.nlp	17653058	SENT168	9	9	41	41	propofol	IL-6	PA451141	3569	0.918
NULL	Oncotarget_2013_Aug_24_4(10)_1618-1631.nxml.txt.nlp	24113128	SENT205	25	25	1	1	sorafenib	p53	PA7000	7157	0.918
NULL	Iran_J_Pediatr_2012_Jun_22(2)_145-157.nxml.txt.nlp	23056879	SENT253	18	18	14	14	escitalopram	5-HT2B	PA10074	3357	0.918
NULL	J_Cancer_Prev_2014_Mar_19(1)_39-46.nxml.txt.nlp	25337571	SENT19	5	5	17	17	ethanol	c-Jun	PA448073	3725	0.918
NULL	Cell_Biol_Int_Rep_(2010)_2012_Jun_21_19(1)_e00017.nxml.txt.nlp	23124518	SENT5	6	6	32	32	etoposide	TRAIL	PA449552	8743	0.918
NULL	Crit_Care_2008_Dec_17_12(6)_R159.nxml.txt.nlp	19091080	SENT120	20	20	30	30	forskolin	CD14	PA146096022	929	0.918
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_24_2012_673132.nxml.txt.nlp	23133498	SENT24	4	4	15	15	berberine	P-gp	PA165860812	5243	0.918
NULL	Br_J_Cancer_2011_Jun_28_105(1)_118-123.nxml.txt.nlp	21654685	SENT114	5	5	7	7	dasatinib	HOXC11	PA162372878	3227	0.918
NULL	Curr_Oncol_2009_Jul_16(Suppl_2)_S14-S23.nxml.txt.nlp	19672417	SENT210	13	13	7	7	tamoxifen	aromatase	PA451581	1588	0.918
NULL	Breast_Cancer_Res_2009_Jun_23_11(Suppl_1)_P28.nxml.txt.nlp	NULL	SENT12	27	27	20	20	paclitaxel	EGFR	PA450761	1956	0.918
NULL	J_Oncol_2009_Jul_14_2009_896407.nxml.txt.nlp	19636423	SENT115	26	26	1	1	cetuximab	EGFR	PA10040	1956	0.918
NULL	Clin_Epigenetics_2011_Dec_5_3(1)_8.nxml.txt.nlp	22414275	SENT164	7	7	20	20	ribavirin	ESR1	PA451241	2099	0.918
NULL	Nanoscale_Res_Lett_2012_Oct_22_7(1)_576.nxml.txt.nlp	23088756	SENT43	5	5	22	22	dextran	mol	PA449261	90527	0.918
NULL	Anesthesiol_Res_Pract_2014_Feb_11_2014_848051.nxml.txt.nlp	24672542	SENT108	17	17	6	6	mivacurium	NMB	PA450528	10457;4828	0.918
NULL	Diabetes_2008_Sep_57(9)_2470-2479.nxml.txt.nlp	18511847	SENT112	8	8	22	22	pioglitazone	CD68	PA450970	968	0.918
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_22_2012_195367.nxml.txt.nlp	23243433	SENT76	20	20	45	45	pentobarbital	LPO	PA450859	4025	0.918
NULL	Front_Immunol_2013_Sep_30_4_305.nxml.txt.nlp	24137161	SENT271	24	24	27	27	doxycycline	FOXP3	PA449415	50943	0.918
NULL	Cell_Commun_Signal_2009_Feb_26_7(Suppl_1)_A99.nxml.txt.nlp	NULL	SENT8	8	8	0	0	thrombin	PAR1	PA451674	79581;2149	0.918
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT373	13	13	7	7	quetiapine	PRL	PA451201	5617	0.918
NULL	Cell_Death_Dis_2014_Feb_13_5(2)_e1055.nxml.txt.nlp	24525731	SENT331	17	17	33	33	cisplatin	TXNL1	PA449014	9352	0.918
NULL	Aging_(Albany_NY)_2009_Sep_25_1(10)_845-854.nxml.txt.nlp	20157557	SENT164	24	24	34	34	doxorubicin	p53	PA449412	7157	0.918
NULL	Bioconjug_Chem_2013_Apr_17_24(4)_712-723.nxml.txt.nlp	23488616	SENT98	6	6	38	38	indomethacin	COX	PA449982	1351	0.918
NULL	Curr_Neuropharmacol_2014_Jul_12(4)_365-379.nxml.txt.nlp	25342944	SENT237	5	5	9	9	fluoxetine	5-HT2C	PA449673	3358	0.918
NULL	Clin_Endosc_2011_Sep_30_44(1)_22-26.nxml.txt.nlp	22741108	SENT31	16	16	9	9	midazolam	ESD	PA450496	2098	0.918
NULL	Front_Behav_Neurosci_2013_Dec_23_7_211.nxml.txt.nlp	24391566	SENT105	14	14	27	27	propranolol	ANOVA	PA451145	4858	0.918
NULL	Aging_(Albany_NY)_2010_Oct_31_2(10)_669-677.nxml.txt.nlp	21076179	SENT108	6	6	18	18	vorinostat	GCN2	PA164748224	440275	0.918
NULL	Br_J_Cancer_2009_May_5_100(9)_1379-1384.nxml.txt.nlp	19401697	SENT32	5	5	3	3	bortezomib	EGFR	PA10252	1956	0.918
NULL	Exp_Diabetes_Res_2007_Jun_28_2007_52487.nxml.txt.nlp	17713597	SENT72	0	0	27	27	ranibizumab	VEGF-A	PA164746012	7422	0.918
NULL	J_Biol_Phys_2010_Jan_2_36(1)_71-93.nxml.txt.nlp	19669425	SENT296	38	38	14	14	ketamine	gamma	PA450144	9913	0.918
NULL	FEBS_J_2012_May_279(10)_1857-1870.nxml.txt.nlp	22420714	SENT137	42	42	8	8	capsaicin	PKD2L1	PA448776	9033	0.918
NULL	Oncotarget_2012_May_4_3(4)_371-394.nxml.txt.nlp	22564882	SENT270	21	21	4	4	etoposide	p110	PA449552	9733	0.918
NULL	Case_Rep_Gastroenterol_2011_Oct_4_5(3)_583-589.nxml.txt.nlp	22110419	SENT56	5	5	10	10	imatinib	KIT	PA10804	3815	0.918
NULL	Oncol_Lett_2013_Feb_7_5(2)_440-446.nxml.txt.nlp	23420122	SENT151	4	4	24	24	sorafenib	Bcl-2	PA7000	596	0.918
NULL	Case_Rep_Ophthalmol_Med_2012_Dec_18_2012_379132.nxml.txt.nlp	23320223	SENT40	14	14	34	34	gefitinib	EGFR	PA131301952	1956	0.918
NULL	Aging_(Albany_NY)_2011_Jan_18_3(1)_33-43.nxml.txt.nlp	21248371	SENT123	20	20	30	30	zinc	HIF-1	PA451956	29072	0.918
NULL	F1000Res_2013_Oct_3_2_202.nxml.txt.nlp	24795806	SENT139	18	18	6	6	vorinostat	EGFR	PA164748224	1956	0.918
NULL	Arthritis_Res_Ther_2010_Jan_29_12(1)_R18.nxml.txt.nlp	20113495	SENT197	2	2	7	7	glucosamine	NAPA	PA164747613	9476;8775	0.918
NULL	Oncotarget_2014_Oct_21_5(22)_11252-11268.nxml.txt.nlp	25361004	SENT298	10	10	5	5	metformin	CLIC1	PA450395	1192	0.918
NULL	Oncol_Lett_2013_Aug_20_6(2)_329-335.nxml.txt.nlp	24137325	SENT48	19	19	36	36	phenol	PP2	PA450913	4888	0.918
NULL	J_Bras_Pneumol_2013_Jan-Feb_39(1)_5-15.nxml.txt.nlp	23503480	SENT125	35	35	23	23	doxycycline	VEGF-D	PA449415	2277	0.918
NULL	Cardiol_Ther_2013_Jun_1_2(1)_111-124.nxml.txt.nlp	25135294	SENT121	21	21	14	14	dronedarone	P-gp	PA153619853	5243	0.918
NULL	Biologics_2010_Aug_9_4_173-185.nxml.txt.nlp	20714355	SENT209	36	36	8	8	cetuximab	EGFR	PA10040	1956	0.918
NULL	J_Infect_Dis_2013_Feb_15_207(4)_656-660.nxml.txt.nlp	23186785	SENT67	10	10	0	0	proguanil	C10	PA451124	113246	0.918
NULL	Breast_Cancer_Res_2012_Jun_19_14(3)_209.nxml.txt.nlp	22713170	SENT132	0	0	12	12	afatinib	HER2	PA165981154	2064	0.918
NULL	J_Med_Life_2011_Nov_14_4(4)_432-439.nxml.txt.nlp	22514580	SENT107	18	18	1	1	ritonavir	ATV	PA451260	4683	0.918
NULL	J_Nat_Sci_Biol_Med_2011_Jan-Jun_2(1)_119-124.nxml.txt.nlp	22470245	SENT143	10	10	25	25	ondansetron	NNT	PA450705	23530	0.918
NULL	Oncogene_2014_May_1_33(18)_2307-2316.nxml.txt.nlp	23686305	SENT282	36	36	42	42	trypsin	EGF	PA451806	1950	0.918
NULL	Diabetes_Care_2011_Mar_17_34(3)_730-733.nxml.txt.nlp	21289232	SENT52	2	2	20	20	pioglitazone	IL-10	PA450970	3586	0.918
NULL	J_Antimicrob_Chemother_2011_Oct_3_66(10)_2235-2239.nxml.txt.nlp	21816764	SENT63	12	12	6	6	tetracycline	BSAC	PA451640	57591	0.918
NULL	Cardiovasc_Diabetol_2010_Sep_23_9_57.nxml.txt.nlp	20863381	SENT42	15	15	23	23	pioglitazone	DM2	PA450970	28508	0.918
NULL	J_Cell_Biol_2002_Nov_11_159(3)_453-463.nxml.txt.nlp	12427868	SENT176	19	19	34	34	marimastat	TIMP2	PA164748329	7077	0.918
NULL	Clin_Sci_(Lond)_2009_Nov_16_118(Pt_4)_269-279.nxml.txt.nlp	19698082	SENT8	7	7	26	26	ramipril	ACE2	PA451223	59272	0.918
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jan_8_67(Pt_2)_o313-o314.nxml.txt.nlp	21523001	SENT73	16	16	6	6	benzaldehyde	mol	PA448571	90527	0.918
NULL	Front_Neurosci_2011_Jan_20_5_3.nxml.txt.nlp	21270945	SENT146	29	29	37	37	ethanol	ANOVA	PA448073	4858	0.918
NULL	J_Biol_Chem_2013_Nov_15_288(46)_33049-33059.nxml.txt.nlp	24089524	SENT183	0	0	27	27	nicotine	CAM	PA450626	889	0.918
NULL	Exp_Mol_Med_2012_Jun_30_44(6)_403-411.nxml.txt.nlp	22510730	SENT46	10	10	6	6	anastrozole	aromatase	PA448432	1588	0.918
NULL	Front_Oncol_2014_May_19_4_113.nxml.txt.nlp	24904827	SENT87	24	24	17	17	potassium	AGO2	PA451047	27161	0.918
NULL	Br_J_Cancer_2011_Aug_23_105(5)_618-627.nxml.txt.nlp	21829197	SENT15	12	12	1	1	lapatinib	CRT	PA152241907	811	0.918
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_May_22_66(Pt_6)_o1429.nxml.txt.nlp	21579505	SENT57	20	20	7	7	ethanol	mol	PA448073	90527	0.918
NULL	Int_J_Biol_Sci_2011_Nov_5_8(1)_1-14.nxml.txt.nlp	22211100	SENT239	7	7	23	23	evodiamine	PTEN	PA165860788	5728	0.918
NULL	BMB_Rep_2013_Aug_46(8)_410-415.nxml.txt.nlp	23977989	SENT102	5	5	26	26	curcumin	HO-1	PA151958596	3162	0.918
NULL	Evid_Based_Complement_Alternat_Med_2012_Sep_4_2012_485042.nxml.txt.nlp	22988474	SENT39	0	0	15	15	berberine	NAT	PA165860812	6046	0.918
NULL	Arthritis_Res_Ther_2014_Apr_15_16(2)_R95.nxml.txt.nlp	24735586	SENT224	24	24	10	10	rituximab	CD27	PA451261	939	0.918
NULL	J_Cell_Mol_Med_2014_Nov_11_18(11)_2275-2286.nxml.txt.nlp	25208472	SENT231	32	32	7	7	cisplatin	p53	PA449014	7157	0.918
NULL	Arthritis_Res_Ther_2008_Mar_14_10(2)_204.nxml.txt.nlp	18373887	SENT96	4	4	25	25	infliximab	CD25	PA452639	3669;3559	0.918
NULL	Mol_Cell_Endocrinol_2013_Jan_30_365(2)_303-308.nxml.txt.nlp	23178796	SENT152	8	8	5	5	rimonabant	CB1	PA152407999	1268	0.918
NULL	Endocrinol_Diabetes_Metab_Case_Rep_2014_Mar_1_2014_140001.nxml.txt.nlp	24683487	SENT10	19	19	6	6	mitotane	ACTH	PA164746157	5443	0.918
NULL	Clin_Epigenetics_2010_Sep_18_1(3-4)_101-116.nxml.txt.nlp	21258631	SENT247	4	4	11	11	curcumin	p300	PA151958596	2033	0.918
NULL	Br_J_Cancer_2012_Jul_24_107(3)_516-526.nxml.txt.nlp	22782351	SENT132	20	20	5	5	tamoxifen	p53	PA451581	7157	0.918
NULL	J_Infect_Dis_2014_Jan_1_209(1)_120-129.nxml.txt.nlp	23943850	SENT208	36	36	43	43	levamisole	CD36	PA450205	948	0.918
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT319	23	23	29	29	nutlin-3	DR5		8795	0.918
NULL	Indian_J_Pharmacol_2013_Jul-Aug_45(4)_365-370.nxml.txt.nlp	24014912	SENT171	7	7	9	9	capsaicin	TRPV1	PA448776	7442	0.918
NULL	Cancer_Med_2013_Aug_29_2(4)_478-487.nxml.txt.nlp	24156020	SENT168	24	24	7	7	gemcitabine	CD25	PA449748	3669;3559	0.918
NULL	Breast_Cancer_Res_2011_Mar_10_13(2)_R27.nxml.txt.nlp	21392396	SENT254	20	20	0	0	tamoxifen	MPG	PA451581	4350	0.918
NULL	Arthritis_Res_Ther_2009_Aug_28_11(4)_R131.nxml.txt.nlp	19715572	SENT87	27	27	9	9	rituximab	CD19	PA451261	930	0.918
NULL	Reprod_Biol_Endocrinol_2013_Oct_3_11_97.nxml.txt.nlp	24090109	SENT31	0	0	4	4	letrozole	aromatase	PA450196	1588	0.918
NULL	J_Inflamm_(Lond)_2008_Jul_29_5_11.nxml.txt.nlp	18664275	SENT120	4	4	11	11	clarithromycin	IL-8	PA449028	3576	0.918
NULL	J_Cancer_2014_Jan_5_5(2)_86-97.nxml.txt.nlp	24494026	SENT60	0	0	8	8	bevacizumab	VEGF-A	PA130232992	7422	0.918
NULL	J_Cancer_2013_Nov_23_4(9)_736-754.nxml.txt.nlp	24312144	SENT107	38	38	15	15	cetuximab	EGFR	PA10040	1956	0.918
NULL	Breast_Cancer_Res_2011_Mar_10_13(2)_R28.nxml.txt.nlp	21392397	SENT234	0	0	14	14	erlotinib	PI3K	PA134687924	5290	0.918
NULL	Am_J_Pathol_2011_Mar_178(3)_1245-1256.nxml.txt.nlp	21356375	SENT158	27	27	30	30	indomethacin	COX	PA449982	1351	0.918
NULL	J_Headache_Pain_2011_Feb_23_12(1)_81-88.nxml.txt.nlp	20862509	SENT220	13	13	5	5	naratriptan	5-HT1D	PA450597	3352	0.918
NULL	Front_Oncol_2013_Oct_9_3_261.nxml.txt.nlp	24130964	SENT205	17	17	5	5	gefitinib	EGFR	PA131301952	1956	0.918
NULL	Basic_Clin_Pharmacol_Toxicol_2013_Feb_5_112(2)_132-137.nxml.txt.nlp	22900583	SENT23	29	29	32	32	atorvastatin	CYP3A	PA448500	1574	0.918
NULL	Protein_Pept_Lett_2014_Aug_21(8)_828-839.nxml.txt.nlp	23855671	SENT213	25	25	11	11	ribavirin	AIM2	PA451241	9447	0.918
NULL	Cancer_Res_Treat_2012_Mar_31_44(1)_1-10.nxml.txt.nlp	22500155	SENT96	31	31	16	16	erlotinib	EGFR	PA134687924	1956	0.918
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Oct_13_68(Pt_11)_o3104-o3105.nxml.txt.nlp	23284431	SENT75	34	34	6	6	ethanol	mol	PA448073	90527	0.918
NULL	Cancer_Res_Treat_2014_Jan_15_46(1)_48-54.nxml.txt.nlp	24520223	SENT120	18	18	28	28	bevacizumab	IFL	PA130232992	3439	0.918
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT19	3	3	15	15	sulindac	AKT	PA451565	207	0.918
NULL	Mol_Cancer_2008_Jun_30_7_60.nxml.txt.nlp	18590557	SENT72	22	22	39	39	tamoxifen	TRAIL	PA451581	8743	0.918
NULL	Oncol_Lett_2014_Sep_19_8(3)_1320-1322.nxml.txt.nlp	25120716	SENT35	22	22	7	7	cisplatin	GEM	PA449014	2669	0.918
NULL	Contemp_Oncol_(Pozn)_2012_Nov_20_16(5)_401-406.nxml.txt.nlp	23788917	SENT36	11	11	30	30	gefitinib	EGFR	PA131301952	1956	0.918
NULL	Biomed_Res_Int_2013_Oct_28_2013_161396.nxml.txt.nlp	24288663	SENT89	15	15	22	22	losartan	CYP11B2	PA450268	1585	0.918
NULL	Oncotarget_2014_Oct_21_5(22)_11252-11268.nxml.txt.nlp	25361004	SENT141	4	4	12	12	metformin	CLIC1	PA450395	1192	0.918
NULL	Clin_Interv_Aging_2009_Dec_29_4_463-472.nxml.txt.nlp	20054411	SENT53	0	0	11	11	vardenafil	SEP2	PA10229	23176;23157	0.918
NULL	Int_J_Biol_Sci_2011_Nov_5_8(1)_1-14.nxml.txt.nlp	22211100	SENT239	7	7	28	28	evodiamine	PI3K	PA165860788	5290	0.918
NULL	Indian_J_Palliat_Care_2012_Sep-Dec_18(3)_155-161.nxml.txt.nlp	23439674	SENT179	15	15	5	5	pregabalin	NNT	PA164754814	23530	0.918
NULL	Ann_Surg_Oncol_2010_Apr_20_17(4)_1168-1176.nxml.txt.nlp	19936839	SENT71	7	7	25	25	cetuximab	KRAS	PA10040	3845	0.918
NULL	Breast_Cancer_Res_2008_Dec_18_10(Suppl_4)_S19.nxml.txt.nlp	19128432	SENT13	39	39	22	22	tamoxifen	IMPACT	PA451581	55364	0.918
NULL	Acta_Pharmacol_Sin_2010_Jul_28_31(7)_867-873.nxml.txt.nlp	20581857	SENT40	21	21	5	5	docetaxel	PDCD4	PA449383	27250	0.918
NULL	Br_J_Cancer_2013_Jul_23_109(2)_351-359.nxml.txt.nlp	23799854	SENT14	31	31	3	3	paclitaxel	BLT2	PA450761	56413	0.918
NULL	Aging_(Albany_NY)_2011_Apr_6_3(4)_444-449.nxml.txt.nlp	21483037	SENT99	4	4	18	18	resveratrol	SIRT1		23411	0.918
NULL	Mol_Cancer_2009_Nov_24_8_109.nxml.txt.nlp	19930708	SENT45	28	28	8	8	exemestane	aromatase	PA449563	1588	0.918
NULL	Mediators_Inflamm_2010_Jun_21_2010_194896.nxml.txt.nlp	20652055	SENT140	11	11	15	15	berberine	MCP-1	PA165860812	6347	0.917
NULL	Front_Aging_Neurosci_2014_Sep_11_6_218.nxml.txt.nlp	25309423	SENT224	0	0	25	25	resveratrol	AMPK		5563	0.917
NULL	Exp_Ther_Med_2013_May_15_5(5)_1327-1331.nxml.txt.nlp	23737873	SENT191	15	15	3	3	imidapril	AVP	PA452640	114548;551	0.917
NULL	Front_Physiol_2013_Dec_25_4_387.nxml.txt.nlp	24399969	SENT1551	9	9	0	0	doxorubicin	RLIP76	PA449412	10928	0.917
NULL	Breast_Cancer_Res_2011_Apr_14_13(2)_R43.nxml.txt.nlp	21492444	SENT133	43	43	15	15	doxycycline	HER2	PA449415	2064	0.917
NULL	J_Cancer_Prev_2013_Jun_18(2)_186-191.nxml.txt.nlp	25337545	SENT100	11	11	18	18	curcumin	STAT3	PA151958596	6774	0.917
NULL	Drugs_R_D_2011_Sep_25_11(3)_227-249.nxml.txt.nlp	21902286	SENT359	4	4	12	12	curcumin	ATP7B	PA151958596	540	0.917
NULL	J_Int_AIDS_Soc_2011_Nov_11_14_53.nxml.txt.nlp	22078415	SENT111	12	12	1	1	fluorescein	CD4	PA164746009	920	0.917
NULL	Cancer_Med_2013_Dec_31_2(6)_950-963.nxml.txt.nlp	24403269	SENT314	35	35	8	8	cisplatin	RAB25	PA449014	57111	0.917
NULL	Int_J_Mol_Sci_2014_Oct_17_15(10)_18762-18775.nxml.txt.nlp	25329617	SENT132	21	21	1	1	heparin	EGFR	PA449855	1956	0.917
NULL	Eur_J_Med_Res_2010_Nov_30_15(12)_533-543.nxml.txt.nlp	21163728	SENT34	17	17	1	1	vancomycin	VISA	PA451850	57506	0.917
NULL	Oncotarget_2013_Nov_24_4(12)_2186-2207.nxml.txt.nlp	24327604	SENT233	31	31	19	19	bortezomib	IL-8	PA10252	3576	0.917
NULL	Cancers_(Basel)_2012_Sep_25_4(4)_969-988.nxml.txt.nlp	24213497	SENT153	12	12	8	8	fulvestrant	EGFR	PA164747170	1956	0.917
NULL	Oncotarget_2012_May_4_3(4)_395-398.nxml.txt.nlp	22565037	SENT28	20	20	11	11	metformin	CD24	PA450395	100133941	0.917
NULL	Breast_Cancer_Res_2008_Dec_4_10(6)_R103.nxml.txt.nlp	19055788	SENT184	22	22	15	15	exemestane	aromatase	PA449563	1588	0.917
NULL	J_Cell_Mol_Med_2014_Oct_11_18(10)_2031-2043.nxml.txt.nlp	25109475	SENT146	21	21	5	5	valsartan	AMPK	PA451848	5563	0.917
NULL	Chin_J_Cancer_2012_Feb_31(2)_110-118.nxml.txt.nlp	22098951	SENT34	20	20	30	30	imatinib	P-gp	PA10804	5243	0.917
NULL	Nat_Genet_2013_Sep_28_45(9)_1004-1012.nxml.txt.nlp	23892607	SENT315	23	23	14	14	doxycycline	PC2	PA449415	5126;5311;8535	0.917
NULL	Ther_Clin_Risk_Manag_2006_Jun_2(2)_187-192.nxml.txt.nlp	18360592	SENT49	19	19	30	30	olanzapine	5-HT2A	PA450688	3356	0.917
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT27	15	15	2	2	imatinib	ABCB1	PA10804	5243	0.917
NULL	Nat_Genet_2011_Feb_26_43(2)_117-120.nxml.txt.nlp	21186350	SENT77	32	32	21	21	metformin	ATM	PA450395	472	0.917
NULL	Mol_Biol_Cell_2014_Jun_1_25(11)_1782-1792.nxml.txt.nlp	24719457	SENT29	5	5	7	7	nicotine	ASCL1	PA450626	429	0.917
NULL	Arthritis_Res_Ther_2006_May_11_8(3)_209.nxml.txt.nlp	16712713	SENT446	22	22	28	28	adalimumab	TNF	PA10004	7124	0.917
NULL	Arthritis_Res_Ther_2010_Apr_9_12(2)_R65.nxml.txt.nlp	20380722	SENT88	2	2	22	22	imatinib	IL8	PA10804	3576	0.917
NULL	Nat_Biotechnol_2013_Jul_30_31(7)_630-637.nxml.txt.nlp	23811600	SENT180	15	15	9	9	crizotinib	EPHA2	PA165946122	1969	0.917
NULL	Curr_Neuropharmacol_2007_Dec_5(4)_232-243.nxml.txt.nlp	19305740	SENT100	9	9	17	17	sulindac	COX	PA451565	1351	0.917
NULL	Neural_Develop_2007_Jun_8_2_11.nxml.txt.nlp	17559664	SENT360	9	9	2	2	trypsin	E14	PA451806	4863	0.917
NULL	Summit_on_Translat_Bioinforma_2010_Mar_1_2010_71-75.nxml.txt.nlp	21347153	SENT59	5	5	42	42	tacrolimus	WIZ	PA451578	58525	0.917
NULL	J_Cell_Mol_Med_2013_Sep_24_17(9)_1065-1087.nxml.txt.nlp	24151975	SENT263	3	3	34	34	palifermin	CD4	PA164744014	920	0.917
NULL	Ther_Clin_Risk_Manag_2005_Dec_1(4)_299-306.nxml.txt.nlp	18360572	SENT79	26	26	32	32	amprenavir	CYP3A4	PA448422	1576	0.917
NULL	Arthritis_Res_Ther_2012_Jun_12_14(3)_R142.nxml.txt.nlp	22691272	SENT229	17	17	5	5	mianserin	TLR7	PA134687937	51284	0.917
NULL	Mol_Cancer_2009_Aug_25_8_66.nxml.txt.nlp	19706164	SENT59	13	13	3	3	celecoxib	p53	PA448871	7157	0.917
NULL	Cancers_(Basel)_2010_Jul_12_2(3)_1453-1491.nxml.txt.nlp	24281168	SENT1856	23	23	2	2	infliximab	IL-6	PA452639	3569	0.917
NULL	Ann_Rheum_Dis_2011_Sep_12_70(11)_2003-2007.nxml.txt.nlp	21914628	SENT41	30	30	7	7	abatacept	ACR	PA164747080	49	0.917
NULL	Nat_Biotechnol_2013_Jul_30_31(7)_630-637.nxml.txt.nlp	23811600	SENT235	13	13	0	0	crizotinib	NTRK3	PA165946122	4916	0.917
NULL	Oncogene_2010_Sep_16_29(37)_5135-5145.nxml.txt.nlp	20622897	SENT77	1	1	15	15	cetuximab	STAT3	PA10040	6774	0.917
NULL	Crit_Care_2011_Apr_20_15(2)_221.nxml.txt.nlp	21586104	SENT126	13	13	8	8	rosiglitazone	CLP	PA451283	23406;810;8048	0.917
NULL	Mol_Cancer_2012_Apr_26_11_26.nxml.txt.nlp	22537224	SENT41	31	31	10	10	cisplatin	RAD51	PA449014	5888	0.917
NULL	Adv_Pharmacol_Sci_2014_Sep_3_2014_847574.nxml.txt.nlp	25276123	SENT146	12	12	7	7	coumarin	p53	PA134521193	7157	0.917
NULL	Med_Sci_Monit_2012_Mar_1_18(3)_PI11-PI15.nxml.txt.nlp	22367138	SENT110	23	23	8	8	omalizumab	TRAIL	PA164752253	8743	0.917
NULL	Indian_Dermatol_Online_J_2013_Oct-Dec_4(4)_283-287.nxml.txt.nlp	24350006	SENT74	11	11	0	0	oxygen	CAD	PA450744	1677;790	0.917
NULL	Aging_(Albany_NY)_2009_Sep_25_1(10)_845-854.nxml.txt.nlp	20157557	SENT164	18	18	34	34	doxorubicin	p53	PA449412	7157	0.917
NULL	Evid_Based_Complement_Alternat_Med_2012_May_9_2012_928234.nxml.txt.nlp	22649479	SENT133	0	0	19	19	atorvastatin	ACAT2	PA448500	39;8435	0.917
NULL	Gut_Liver_2013_May_9_7(3)_329-334.nxml.txt.nlp	23710315	SENT9	4	4	18	18	lamivudine	LAM	PA450163	7249;7248	0.917
NULL	Can_J_Infect_Dis_Med_Microbiol_2014_Nov-Dec_25(6)_327-343.nxml.txt.nlp	25587296	SENT301	14	14	3	3	sirolimus	CYP3A4	PA451365	1576	0.917
NULL	Br_J_Cancer_2013_Jul_23_109(2)_351-359.nxml.txt.nlp	23799854	SENT165	13	13	31	31	paclitaxel	BLT2	PA450761	56413	0.917
NULL	Iran_J_Reprod_Med_2014_Apr_12(4)_257-262.nxml.txt.nlp	24976820	SENT31	29	29	3	3	protamine	PRM1	PA10366	5619	0.917
NULL	Oncoimmunology_2013_Jun_1_2(6)_e24841.nxml.txt.nlp	23894724	SENT94	34	34	41	41	papain	SNA	PA450778	6615	0.917
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Sep_12_65(Pt_10)_o2430.nxml.txt.nlp	21577886	SENT83	12	12	7	7	ethanol	mol	PA448073	90527	0.917
NULL	Front_Oncol_2014_May_1_4_80.nxml.txt.nlp	24822169	SENT315	20	20	27	27	curcumin	DNMT1	PA151958596	1786	0.917
NULL	Br_J_Cancer_1999_Dec_81(8)_1285-1293.nxml.txt.nlp	10604724	SENT2	6	6	14	14	sn-38	p53		7157	0.917
NULL	J_Int_Soc_Sports_Nutr_2013_Aug_6_10_36.nxml.txt.nlp	23919405	SENT138	8	8	24	24	creatine	FFM	PA164778930	24	0.917
NULL	Clin_Ophthalmol_2008_Jun_2(2)_355-368.nxml.txt.nlp	19668727	SENT82	14	14	9	9	ketorolac	COX	PA450150	1351	0.917
NULL	Breast_Cancer_(Auckl)_2009_Sep_2_3_61-75.nxml.txt.nlp	19809577	SENT109	6	6	21	21	curcumin	BRCA1	PA151958596	672	0.917
NULL	Iran_J_Pharm_Res_2014_Winter_13(Suppl)_79-86.nxml.txt.nlp	24711832	SENT74	13	13	39	39	flumazenil	San	PA449659	80218	0.917
NULL	Anal_Bioanal_Chem_2014_Jan_23_406(15)_3667-3680.nxml.txt.nlp	24452745	SENT187	26	26	0	0	ketoprofen	KET	PA450149	8626	0.917
NULL	Eur_J_Endocrinol_2011_Oct_165(4)_517-525.nxml.txt.nlp	21810856	SENT24	9	9	19	19	octreotide	SSTR2	PA450678	6752	0.917
NULL	Ann_Oncol_2014_Jul_7_25(7)_1340-1346.nxml.txt.nlp	24608196	SENT7	32	32	18	18	palonosetron	NK1	PA10352	11126	0.917
NULL	Br_J_Cancer_1996_May_73(9)_1063-1068.nxml.txt.nlp	8624264	SENT8	4	4	35	35	staurosporine	P-gp	PA165109623	5243	0.917
NULL	Open_Neurol_J_2013_May_31_7_23-31.nxml.txt.nlp	23894259	SENT71	0	0	11	11	ziprasidone	5-HT2C	PA451974	3358	0.917
NULL	Indian_J_Med_Res_2011_Sep_134(3)_295-301.nxml.txt.nlp	21985811	SENT123	45	45	24	24	phenytoin	CYP2C9	PA450947	1559	0.917
NULL	Br_J_Cancer_2002_Feb_1_86(3)_477-484.nxml.txt.nlp	11875718	SENT52	36	36	2	2	l-glutamine	U87	PA10090	677775;641648	0.917
NULL	Case_Rep_Genet_2014_Jan_22_2014_413743.nxml.txt.nlp	24627811	SENT50	5	5	15	15	warfarin	CYP2C9	PA451906	1559	0.917
NULL	Acta_Pharmacol_Sin_2014_Aug_21_35(8)_1082-1092.nxml.txt.nlp	25047514	SENT145	11	11	8	8	letrozole	aromatase	PA450196	1588	0.917
NULL	J_Oncol_2010_Dec_14_2010_426956.nxml.txt.nlp	20049170	SENT298	29	29	7	7	genistein	CXCL12	PA165109660	6387	0.917
NULL	J_Geriatr_Cardiol_2014_Sep_11(3)_259-273.nxml.txt.nlp	25278976	SENT128	40	40	18	18	atorvastatin	FDG	PA448500	23583	0.917
NULL	Mediators_Inflamm_2010_Jun_21_2010_194896.nxml.txt.nlp	20652055	SENT110	12	12	15	15	berberine	MCP-1	PA165860812	6347	0.917
NULL	Cell_Cycle_2013_Nov_15_12(22)_3490-3499.nxml.txt.nlp	24240433	SENT126	10	10	21	21	metformin	FDG	PA450395	23583	0.917
NULL	Onco_Targets_Ther_2014_Dec_4_7_2249-2255.nxml.txt.nlp	25587220	SENT55	16	16	30	30	cyclosporine	P-gp	PA449167	5243	0.917
NULL	Breast_Cancer_Res_2007_Jan_23_9(1)_R7.nxml.txt.nlp	17244352	SENT46	10	10	17	17	tamoxifen	CYP2D6	PA451581	1565	0.917
NULL	Nat_Med_2013_Feb_6_19(2)_217-226.nxml.txt.nlp	23291629	SENT92	24	24	41	41	forskolin	HSL	PA146096022	3991	0.917
NULL	Behav_Brain_Res_2008_Dec_22_195(2)_223-230.nxml.txt.nlp	18840473	SENT459	34	34	27	27	clozapine	5-HT1A	PA449061	3350	0.917
NULL	Orthop_Rev_(Pavia)_2014_Sep_18_6(3)_5405.nxml.txt.nlp	25317308	SENT121	4	4	16	16	acetaminophen	PRP	PA448015	7001;5621	0.917
NULL	EMBO_J_2008_Mar_19_27(6)_852-864.nxml.txt.nlp	18309296	SENT72	13	13	36	36	nutlin-3	p53		7157	0.917
NULL	Front_Endocrinol_(Lausanne)_2013_Jun_26_4_75.nxml.txt.nlp	23805127	SENT109	37	37	26	26	gemfibrozil	UGT2B15	PA449750	7366	0.917
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_91-103.nxml.txt.nlp	17912639	SENT70	33	33	11	11	anastrozole	HER2	PA448432	2064	0.917
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Jul_21_9_20.nxml.txt.nlp	20663145	SENT94	8	8	3	3	clarithromycin	AAP	PA449028	5345	0.917
NULL	Cancers_(Basel)_2013_Apr_11_5(2)_418-429.nxml.txt.nlp	24216984	SENT38	6	6	13	13	irinotecan	HIF-1	PA450085	29072	0.917
NULL	Biomed_Res_Int_2013_Jul_16_2013_953520.nxml.txt.nlp	23957013	SENT26	18	18	5	5	cyclosporine	CYP3A	PA449167	1574	0.917
NULL	J_Cell_Mol_Med_2014_Oct_11_18(10)_2031-2043.nxml.txt.nlp	25109475	SENT261	3	3	0	0	valsartan	AMPK	PA451848	5563	0.917
NULL	Anticancer_Drugs_2015_Feb_22_26(2)_139-147.nxml.txt.nlp	25203626	SENT170	0	0	8	8	sorafenib	EZH2	PA7000	2146	0.917
NULL	Oncotarget_2010_Oct_25_1(7)_497-514.nxml.txt.nlp	21165163	SENT122	31	31	36	36	gefitinib	EGFR	PA131301952	1956	0.917
NULL	Cell_Commun_Signal_2014_Sep_25_12(1)_61.nxml.txt.nlp	NULL	SENT71	12	12	23	23	doxycycline	INPP4B	PA449415	8821	0.917
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_33-43.nxml.txt.nlp	17912634	SENT197	11	11	16	16	tamoxifen	HER2	PA451581	2064	0.917
NULL	J_Neurovirol_2013_Jun_4_19(4)_351-358.nxml.txt.nlp	23733308	SENT163	16	16	21	21	mefloquine	SOC	PA450348	91544	0.917
NULL	Cerebrum_2010_Sep_22_2010_18.nxml.txt.nlp	23447764	SENT69	0	0	10	10	allopregnanolone	gamma	PA142320763	9913	0.917
NULL	Mol_Biol_Cell_2013_Sep_1_24(17)_2739-2752.nxml.txt.nlp	23825024	SENT90	32	32	23	23	tetracycline	p53	PA451640	7157	0.917
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT119	13	13	30	30	celecoxib	IL-6	PA448871	3569	0.917
NULL	Diabetes_Care_2010_Mar_33(3)_683-689.nxml.txt.nlp	20190297	SENT78	0	0	20	20	miglitol	GLP-1	PA164776726	100125288	0.917
NULL	J_Adv_Pract_Oncol_2012_Jan_1_Jan-Feb_3(1)_49-54.nxml.txt.nlp	25031928	SENT39	8	8	21	21	plerixafor	CD34	PA165958410	947	0.917
NULL	Br_J_Cancer_2014_Jan_21_110(2)_469-478.nxml.txt.nlp	24346288	SENT60	19	19	36	36	gentamicin	CO2	PA449753	4513	0.917
NULL	Br_J_Pharmacol_2012_Jan_165(2)_390-400.nxml.txt.nlp	21671897	SENT185	22	22	29	29	suramin	P2X1	PA10292	5023	0.917
NULL	Front_Oncol_2013_Sep_11_3_228.nxml.txt.nlp	24062981	SENT276	24	24	28	28	olaparib	BRCA1		672	0.917
NULL	Oncotarget_2013_Apr_23_4(6)_816-829.nxml.txt.nlp	23615731	SENT197	7	7	1	1	doxycycline	HSF1	PA449415	3297	0.917
NULL	Hum_Mol_Genet_2013_Oct_15_22(20)_4117-4126.nxml.txt.nlp	23740942	SENT210	13	13	21	21	heparin	FGFR3	PA449855	2261	0.917
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT8	7	7	3	3	nutlin-3	p53		7157	0.917
NULL	Br_J_Clin_Pharmacol_2012_Feb_73(2)_203-209.nxml.txt.nlp	21848574	SENT183	0	0	34	34	ketoconazole	P-gp	PA450146	5243	0.917
NULL	J_Hematol_Oncol_2014_Aug_20_7_62.nxml.txt.nlp	25139395	SENT175	20	20	8	8	gemcitabine	p53	PA449748	7157	0.917
NULL	Br_J_Pharmacol_2011_Apr_162(7)_1509-1520.nxml.txt.nlp	21108630	SENT252	13	13	10	10	allopregnanolone	TRPC5	PA142320763	7224	0.917
NULL	Pharmaceuticals_(Basel)_2013_Aug_21_6(8)_988-1038.nxml.txt.nlp	24276379	SENT485	19	19	11	11	vemurafenib	PIK3CA	PA165946873	5290	0.917
NULL	Oncoscience_2014_Oct_22_1(10)_614-623.nxml.txt.nlp	25593991	SENT92	25	25	18	18	imatinib	HER2	PA10804	2064	0.917
NULL	Oncotarget_2013_Jul_26_4(8)_1317-1328.nxml.txt.nlp	23945331	SENT44	35	35	9	9	trastuzumab	HER2	PA451743	2064	0.917
NULL	Arthritis_Res_Ther_2005_Feb_17_7(Suppl_1)_P61.nxml.txt.nlp	NULL	SENT12	25	25	0	0	urokinase	OSM	PA451836	5008	0.917
NULL	Front_Oncol_2014_Mar_18_4_55.nxml.txt.nlp	24672775	SENT88	17	17	6	6	sunitinib	FLT3	PA162372840	2322	0.917
NULL	Arthritis_Res_Ther_2009_Apr_6_11(Suppl_1)_S1.nxml.txt.nlp	19368701	SENT114	24	24	14	14	abatacept	ACR	PA164747080	49	0.917
NULL	Oncogene_2013_Sep_26_32(39)_10_1038_onc_2012_491.nxml.txt.nlp	23108394	SENT130	29	29	43	43	fluorouracil	FOXM1	PA128406956	2305	0.917
NULL	Diabetes_Care_2011_Sep_19_34(9)_2072-2077.nxml.txt.nlp	21788633	SENT109	16	16	23	23	acarbose	ANOVA	PA448010	4858	0.917
NULL	ScientificWorldJournal_2013_Dec_24_2013_196541.nxml.txt.nlp	24453810	SENT108	7	7	27	27	trastuzumab	HER2	PA451743	2064	0.917
NULL	Int_J_Mol_Sci_2014_Mar_7_15(3)_4104-4125.nxml.txt.nlp	24608924	SENT128	17	17	5	5	cisplatin	IFN	PA449014	3439	0.917
NULL	Cancer_Med_2014_Apr_27_3(2)_310-321.nxml.txt.nlp	24464839	SENT232	20	20	12	12	everolimus	CD31	PA164746311	5175	0.917
NULL	Indian_J_Pharmacol_2013_Jul-Aug_45(4)_365-370.nxml.txt.nlp	24014912	SENT49	8	8	18	18	propranolol	AT1	PA451145	9197;185	0.917
NULL	J_Cell_Mol_Med_2013_Oct_23_17(10)_1207-1217.nxml.txt.nlp	24106980	SENT146	19	19	2	2	etoposide	P-gp	PA449552	5243	0.917
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT376	17	17	11	11	resveratrol	NMNAT1		64802	0.917
NULL	Indian_J_Anaesth_2009_Oct_53(5)_582-591.nxml.txt.nlp	20640109	SENT84	2	2	27	27	clopidogrel	ADP	PA449053	23038	0.917
NULL	Int_J_Cell_Biol_2014_Sep_17_2014_272689.nxml.txt.nlp	25313309	SENT232	15	15	21	21	cisplatin	p38	PA449014	10598;1432;7965	0.917
NULL	Evid_Based_Complement_Alternat_Med_2013_Oct_28_2013_989670.nxml.txt.nlp	24288572	SENT50	17	17	1	1	ethanol	TLN	PA448073	7087	0.917
NULL	Br_J_Pharmacol_2012_Jan_165(2)_380-389.nxml.txt.nlp	21585347	SENT100	0	0	10	10	rosiglitazone	ATGL	PA451283	57104	0.917
NULL	F1000_Biol_Rep_2009_Mar_24_1_23.nxml.txt.nlp	20948663	SENT17	37	37	17	17	citalopram	ABCB1	PA449015	5243	0.917
NULL	Brain_Res_2015_Jan_21_1595_74-83.nxml.txt.nlp	25446456	SENT5	11	11	28	28	estradiol	spatial	PA449503	219793	0.917
NULL	ASN_Neuro_2009_Dec_8_1(5)_e00022.nxml.txt.nlp	19906012	SENT223	16	16	36	36	colchicine	ANOVA	PA449092	4858	0.917
NULL	Pharmaceutics_2011_Nov_18_3(4)_865-913.nxml.txt.nlp	24309312	SENT163	10	10	33	33	raltegravir	UGT		7361;7355	0.917
NULL	Clin_Cosmet_Investig_Dermatol_2013_Sep_26_6_233-244.nxml.txt.nlp	24101875	SENT87	8	8	15	15	bevacizumab	VEGF-A	PA130232992	7422	0.917
NULL	Arthritis_Res_Ther_2003_Sep_3_5(6)_R317-R328.nxml.txt.nlp	14680506	SENT172	13	13	3	3	rolipram	IL-10	PA153906323	3586	0.917
NULL	Br_J_Cancer_2012_Oct_9_107(8)_1233-1238.nxml.txt.nlp	22955852	SENT118	9	9	2	2	docetaxel	RPN2	PA449383	6185	0.917
NULL	Endocr_Relat_Cancer_2014_Jun_21(3)_R209-R225.nxml.txt.nlp	24500760	SENT62	10	10	17	17	resveratrol	IGF1		3479	0.917
NULL	F1000_Med_Rep_2010_Jun_23_2_45.nxml.txt.nlp	20948839	SENT31	34	34	24	24	zoledronate	IL-2	PA10235	3558	0.917
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT10	13	13	37	37	atorvastatin	survivin	PA448500	332	0.917
NULL	Int_J_Chron_Obstruct_Pulmon_Dis_2007_Dec_2(4)_517-533.nxml.txt.nlp	18268925	SENT92	0	0	11	11	theophylline	IL-8	PA451647	3576	0.917
NULL	Br_J_Cancer_2011_Jun_7_104(12)_1848-1853.nxml.txt.nlp	21610704	SENT48	15	15	37	37	panitumumab	REL	PA162373091	5966	0.917
NULL	Clinics_(Sao_Paulo)_2013_May_68(5)_694-701.nxml.txt.nlp	23778405	SENT225	22	22	16	16	curcumin	MDR1	PA151958596	5243	0.917
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Nov_20_66(Pt_12)_o3256.nxml.txt.nlp	21589540	SENT47	18	18	6	6	ethanol	mol	PA448073	90527	0.917
NULL	Cancer_Cell_Int_2010_Feb_19_10_3.nxml.txt.nlp	20170512	SENT47	8	8	23	23	tamoxifen	p27	PA451581	5715;10534	0.917
NULL	Aging_(Albany_NY)_2011_Jan_18_3(1)_33-43.nxml.txt.nlp	21248371	SENT119	4	4	6	6	zinc	HIF-1	PA451956	29072	0.917
NULL	J_Neuroinflammation_2011_Feb_4_8_10.nxml.txt.nlp	21294877	SENT19	36	36	6	6	capsaicin	TAC1	PA448776	6863	0.917
NULL	Clin_Med_Insights_Cardiol_2012_Feb_1_6_17-33.nxml.txt.nlp	22442638	SENT25	0	0	27	27	rosuvastatin	CYP3A4	PA134308647	1576	0.917
NULL	Breast_Cancer_Res_2010_Jun_24_12(3)_R41.nxml.txt.nlp	20576088	SENT137	6	6	12	12	paclitaxel	EGFR	PA450761	1956	0.917
NULL	Cell_Death_Dis_2014_Feb_13_5(2)_e1055.nxml.txt.nlp	24525731	SENT331	17	17	31	31	cisplatin	XRCC1	PA449014	7515	0.917
NULL	Environ_Health_Perspect_2006_Sep_23_114(9)_1401-1406.nxml.txt.nlp	16966095	SENT139	41	41	14	14	tetracycline	p53	PA451640	7157	0.917
NULL	Oncogenesis_2012_Apr_2_1(4)_e5.nxml.txt.nlp	23552603	SENT149	2	2	11	11	ns-398	RhoA		387	0.917
NULL	Iran_J_Pharm_Res_2014_Spring_13(2)_383-389.nxml.txt.nlp	25237334	SENT73	42	42	7	7	verapamil	ANOVA	PA451868	4858	0.917
NULL	Oncotarget_2013_Mar_26_4(3)_397-412.nxml.txt.nlp	23651630	SENT308	22	22	18	18	doxorubicin	CHOP	PA449412	1649	0.917
NULL	EJNMMI_Res_2011_Nov_10_1_25.nxml.txt.nlp	22214344	SENT213	21	21	24	24	carbidopa	COMT	PA448794	1312	0.917
NULL	Int_J_Chron_Obstruct_Pulmon_Dis_2007_Dec_2(4)_409-428.nxml.txt.nlp	18268916	SENT140	19	19	11	11	chymotrypsin	SLPI	PA448994	6590	0.917
NULL	Oncotarget_2014_Jun_7_5(14)_5257-5271.nxml.txt.nlp	24913448	SENT101	16	16	8	8	nilotinib	LASP1	PA165958345	3927	0.917
NULL	Mol_Cancer_2010_Nov_2_9_289.nxml.txt.nlp	21044322	SENT149	30	30	6	6	vincristine	RGS2	PA451879	5997	0.917
NULL	Oncologist_2010_Mar_9_15(3)_236-245.nxml.txt.nlp	20215359	SENT61	13	13	23	23	sunitinib	IFN	PA162372840	3439	0.917
NULL	ASN_Neuro_2010_Oct_4_2(5)_e00046.nxml.txt.nlp	20957077	SENT49	16	16	27	27	ganciclovir	E12	PA449733	64100	0.917
NULL	J_Inherit_Metab_Dis_2012_Nov_24_35(6)_1137-1145.nxml.txt.nlp	22447153	SENT210	5	5	15	15	fenofibrate	PMP70	PA449594	5825	0.917
NULL	Int_J_Mol_Sci_2014_Oct_6_15(10)_17886-17900.nxml.txt.nlp	25290095	SENT11	27	27	10	10	resveratrol	OPG		690	0.917
NULL	Endocrinol_Metab_(Seoul)_2014_Sep_25_29(3)_379-387.nxml.txt.nlp	25309798	SENT119	29	29	19	19	resveratrol	SIRT1		23411	0.917
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_75-89.nxml.txt.nlp	17912638	SENT169	17	17	1	1	tamoxifen	ATAC	PA451581	6375	0.917
NULL	Eur_J_Haematol_2014_Feb_25_92(2)_127-136.nxml.txt.nlp	24118452	SENT74	27	27	7	7	anagrelide	CRT	PA164742986	811	0.917
NULL	F1000Res_2014_Aug_19_3_198.nxml.txt.nlp	25400908	SENT188	7	7	13	13	trastuzumab	HER2	PA451743	2064	0.917
NULL	Cancer_Cell_Int_2013_Jun_17_13_61.nxml.txt.nlp	23773282	SENT465	16	16	4	4	etoposide	DR4	PA449552	8797	0.917
NULL	J_Cell_Biol_2001_Oct_15_155(2)_239-250.nxml.txt.nlp	11591731	SENT269	11	11	15	15	galactose	GAL	PA449725	51083	0.917
NULL	Am_J_Cardiovasc_Drugs_2013_Jun_20_13(5)_331-342.nxml.txt.nlp	23784266	SENT223	30	30	13	13	erythromycin	CYP3A4	PA449493	1576	0.917
NULL	J_Korean_Med_Sci_1994_Dec_9(6)_482-489.nxml.txt.nlp	7786445	SENT10	25	25	0	0	isoniazid	CYP1A2	PA450112	1544	0.917
NULL	Ann_Hematol_2014_Sep_10_93(1)_1-11.nxml.txt.nlp	24018623	SENT108	10	10	22	22	lenalidomide	CD34	PA162363968	947	0.917
NULL	Front_Neurosci_2011_Jan_14_4_207.nxml.txt.nlp	21258618	SENT164	22	22	4	4	ethanol	AC7	PA448073	113	0.917
NULL	Breast_Cancer_Res_2012_Feb_13_14(1)_R28.nxml.txt.nlp	22330809	SENT152	7	7	2	2	lapatinib	ERBB2	PA152241907	2064	0.917
NULL	Epilepsy_Res_Treat_2010_Feb_8_2010_725696.nxml.txt.nlp	22937227	SENT108	21	21	30	30	lidocaine	HNP	PA450226	11202	0.917
NULL	Int_J_Nephrol_2011_Jun_16_2011_436856.nxml.txt.nlp	21716699	SENT29	15	15	7	7	ciprofloxacin	VAN	PA449009	10318	0.917
NULL	Chemother_Res_Pract_2011_Feb_6_2011_249867.nxml.txt.nlp	22312550	SENT91	11	11	9	9	moxifloxacin	CAP	PA450555	23476;9200;4012;5269;10580;10487	0.917
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT249	10	10	7	7	doxorubicin	B7-H1	PA449412	29126	0.917
NULL	Oncotarget_2014_Oct_23_5(22)_11154-11167.nxml.txt.nlp	25525888	SENT194	6	6	28	28	sunitinib	PLGF	PA162372840	5228	0.917
NULL	Breast_Cancer_Res_2008_Jun_9_10(3)_R52.nxml.txt.nlp	18541018	SENT140	23	23	38	38	fluorescein	CD24	PA164746009	100133941	0.917
NULL	Mol_Cancer_2007_Jan_14_6_5.nxml.txt.nlp	17222355	SENT205	8	8	16	16	doxorubicin	HMGA2	PA449412	8091	0.917
NULL	Ann_Rheum_Dis_2008_Sep_16_68(7)_1171-1176.nxml.txt.nlp	18801760	SENT179	33	33	26	26	infliximab	NFkappaB	PA452639	4790	0.917
NULL	J_Mol_Med_(Berl)_2012_Oct_20_90(10)_1223-1231.nxml.txt.nlp	22527886	SENT7	30	30	27	27	mk-571	CysLT1		10800	0.917
NULL	Exp_Diabetes_Res_2011_Jun_4_2011_489708.nxml.txt.nlp	21747829	SENT136	28	28	22	22	aliskiren	GLP-1	PA143487910	100125288	0.917
NULL	Cell_Death_Differ_2010_Oct_30_17(10)_1655-1664.nxml.txt.nlp	20431598	SENT228	37	37	14	14	etoposide	CD4	PA449552	920	0.917
NULL	Br_J_Cancer_2011_Jun_7_104(12)_1828-1835.nxml.txt.nlp	21559012	SENT167	12	12	10	10	gefitinib	EGFR	PA131301952	1956	0.917
NULL	Oncotarget_2014_Nov_11_5(22)_11490-11500.nxml.txt.nlp	25359780	SENT59	14	14	32	32	docetaxel	CXCL12	PA449383	6387	0.917
NULL	Iran_Red_Crescent_Med_J_2014_Jul_5_16(7)_e16388.nxml.txt.nlp	25237564	SENT161	8	8	0	0	fentanyl	Erb	PA449599	2100	0.917
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1137-1144.nxml.txt.nlp	20234366	SENT153	16	16	3	3	cetuximab	KRAS	PA10040	3845	0.917
NULL	Drug_Target_Insights_2012_Aug_6_6_19-39.nxml.txt.nlp	22915839	SENT92	7	7	25	25	doxorubicin	Hsp90	PA449412	3320	0.917
NULL	Mol_Cancer_2009_Nov_24_8_109.nxml.txt.nlp	19930708	SENT45	19	19	8	8	letrozole	aromatase	PA450196	1588	0.917
NULL	Acta_Pharmacol_Sin_2009_Feb_5_30(2)_228-234.nxml.txt.nlp	19122672	SENT26	6	6	23	23	isoflurane	HIF-1	PA450106	29072	0.917
NULL	Open_Cardiovasc_Med_J_2014_Feb_7_8_12-17.nxml.txt.nlp	24653785	SENT103	3	3	13	13	lovastatin	CYP3A5	PA450272	1577	0.917
NULL	Arthritis_Res_Ther_2011_Aug_23_13(4)_303.nxml.txt.nlp	21892971	SENT317	8	8	0	0	capsaicin	TRPV1	PA448776	7442	0.917
NULL	Braz_J_Med_Biol_Res_2013_Mar_15_46(3)_299-305.nxml.txt.nlp	23532269	SENT175	8	8	35	35	propofol	TLR4	PA451141	7099	0.917
NULL	Exp_Ther_Med_2013_Nov_13_6(5)_1317-1321.nxml.txt.nlp	24223665	SENT69	7	7	10	10	curcumin	CD133	PA151958596	8842	0.917
NULL	Br_J_Cancer_2010_Jun_29_103(1)_61-72.nxml.txt.nlp	20588279	SENT132	14	14	40	40	trastuzumab	EGF	PA451743	1950	0.917
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_7-17.nxml.txt.nlp	17912633	SENT386	4	4	9	9	letrozole	aromatase	PA450196	1588	0.917
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT80	20	20	8	8	metformin	p53	PA450395	7157	0.917
NULL	Front_Surg_2015_Jan_5_1_50.nxml.txt.nlp	25593974	SENT192	6	6	0	0	cetuximab	KRAS	PA10040	3845	0.917
NULL	J_Immunother_2014_Apr_12_37(3)_180-186.nxml.txt.nlp	24598448	SENT27	7	7	5	5	sorafenib	IL-2	PA7000	3558	0.917
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1013.nxml.txt.nlp	24457957	SENT139	13	13	2	2	bortezomib	NOXA	PA10252	5366	0.917
NULL	J_Hematol_Oncol_2012_Sep_18_5_57.nxml.txt.nlp	22989009	SENT246	6	6	14	14	nutlin-3	p53		7157	0.917
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Sep_6_64(Pt_10)_m1225.nxml.txt.nlp	21200986	SENT61	16	16	3	3	zinc	mol	PA451956	90527	0.917
NULL	Br_J_Cancer_2006_Dec_4_95(11)_1483-1489.nxml.txt.nlp	17106442	SENT81	4	4	14	14	gefitinib	EGFR	PA131301952	1956	0.917
NULL	Tuberc_Respir_Dis_(Seoul)_2013_Nov_29_75(5)_188-198.nxml.txt.nlp	24348666	SENT43	23	23	13	13	gefitinib	HER2	PA131301952	2064	0.917
NULL	Cell_Death_Dis_2014_Jul_3_5(7)_e1311.nxml.txt.nlp	24991763	SENT296	31	31	16	16	ketamine	LHX6	PA450144	26468	0.917
NULL	Arthritis_Res_Ther_2014_Feb_5_16(1)_R44.nxml.txt.nlp	24495480	SENT252	8	8	0	0	collagenase	JNK	PA449107	5599	0.917
NULL	BMB_Rep_2013_Aug_46(8)_410-415.nxml.txt.nlp	23977989	SENT36	5	5	8	8	curcumin	HO-1	PA151958596	3162	0.917
NULL	Eur_J_Clin_Pharmacol_2012_Sep_15_68(9)_1267-1274.nxml.txt.nlp	22418828	SENT215	7	7	12	12	escitalopram	CYP2C19	PA10074	1557	0.917
NULL	J_Hematol_Oncol_2013_Jul_9_6_49.nxml.txt.nlp	23837843	SENT281	32	32	28	28	cyclosporine	P-gp	PA449167	5243	0.917
NULL	Acta_Vet_Scand_2014_Sep_7_56(1)_57.nxml.txt.nlp	25195062	SENT35	10	10	29	29	pentobarbital	IFN	PA450859	3439	0.917
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT52	11	11	26	26	atazanavir	CYP3A4	PA10251	1576	0.917
NULL	Am_J_Trop_Med_Hyg_2012_Nov_7_87(5_Suppl)_6-10.nxml.txt.nlp	23136272	SENT140	14	14	5	5	artemether	RDT	PA165111698	6598	0.917
NULL	BMJ_Open_2014_Oct_31_4(10)_e005762.nxml.txt.nlp	25361836	SENT221	6	6	16	16	cisplatin	EGFR	PA449014	1956	0.917
NULL	J_Headache_Pain_2014_Dec_8_15(1)_85.nxml.txt.nlp	25488888	SENT102	21	21	31	31	rizatriptan	5-HT1B	PA451264	3351	0.917
NULL	Exp_Lung_Res_2013_Oct_1_39(8)_336-348.nxml.txt.nlp	23919450	SENT218	13	13	16	16	thrombin	PAR-1	PA451674	2011;2149	0.917
NULL	Mol_Cancer_2007_Aug_21_6_53.nxml.txt.nlp	17711579	SENT395	8	8	26	26	cisplatin	p53	PA449014	7157	0.917
NULL	J_Inflamm_(Lond)_2008_Dec_5_5_23.nxml.txt.nlp	19061493	SENT197	18	18	9	9	hemin	HO-1	PA449849	3162	0.917
NULL	J_Cell_Mol_Med_2014_Oct_11_18(10)_2031-2043.nxml.txt.nlp	25109475	SENT149	3	3	5	5	valsartan	AMPK	PA451848	5563	0.917
NULL	J_Immunother_Cancer_2013_Nov_7_1(Suppl_1)_P175.nxml.txt.nlp	NULL	SENT14	19	19	10	10	cetuximab	EGFR	PA10040	1956	0.917
NULL	eLife_2013_Nov_5_2_e00969.nxml.txt.nlp	24192036	SENT20	19	19	14	14	vemurafenib	JNK	PA165946873	5599	0.917
NULL	Breast_Cancer_(Auckl)_2012_Oct_25_6_159-171.nxml.txt.nlp	23133315	SENT86	15	15	5	5	paclitaxel	BRCA1	PA450761	672	0.917
NULL	J_Biomed_Sci_2014_Feb_3_21(1)_10.nxml.txt.nlp	24490900	SENT133	5	5	18	18	alendronate	CTR	PA448082	799	0.917
NULL	Cancer_Cell_Int_2013_May_15_13_42.nxml.txt.nlp	23672670	SENT199	24	24	3	3	paclitaxel	PIDD	PA450761	55367	0.917
NULL	Onco_Targets_Ther_2014_Nov_21_7_2143-2146.nxml.txt.nlp	25473295	SENT31	10	10	22	22	irinotecan	KRAS	PA450085	3845	0.917
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Aug_27_67(Pt_9)_o2453.nxml.txt.nlp	22059021	SENT47	23	23	6	6	ethanol	mol	PA448073	90527	0.917
NULL	Diabetes_Care_2009_Apr_32(4)_531-540.nxml.txt.nlp	19336638	SENT221	4	4	23	23	cilostazol	P2Y12	PA164746334	64805	0.917
NULL	Br_J_Cancer_2013_Jul_23_109(2)_351-359.nxml.txt.nlp	23799854	SENT166	18	18	14	14	paclitaxel	P-gp	PA450761	5243	0.917
NULL	Drug_Des_Devel_Ther_2014_Oct_14_8_1911-1922.nxml.txt.nlp	25342884	SENT107	23	23	28	28	fulvestrant	aromatase	PA164747170	1588	0.917
NULL	Cancer_Res_Treat_2013_Mar_31_45(1)_55-62.nxml.txt.nlp	23613671	SENT37	15	15	8	8	oxaliplatin	KRAS	PA131285527	3845	0.917
NULL	Int_J_Surg_Oncol_2012_Sep_4_2012_761364.nxml.txt.nlp	22988495	SENT257	6	6	3	3	anastrozole	aromatase	PA448432	1588	0.917
NULL	Br_J_Cancer_2010_Jan_5_102(1)_151-161.nxml.txt.nlp	19935791	SENT149	7	7	12	12	cetuximab	TOPK	PA10040	55872	0.917
NULL	Br_J_Haematol_2009_Nov_2_147(3)_396-410.nxml.txt.nlp	19758122	SENT29	0	0	13	13	dasatinib	TP53	PA162372878	7157	0.917
NULL	Braz_J_Med_Biol_Res_2012_Mar_30_45(4)_314-320.nxml.txt.nlp	22450372	SENT53	4	4	12	12	pentagastrin	PAG	PA450849	55824	0.917
NULL	Cancer_Med_2014_Dec_13_3(6)_1579-1594.nxml.txt.nlp	25124282	SENT24	26	26	10	10	carboplatin	PARP-1	PA448803	25976	0.917
NULL	Indian_J_Pharm_Sci_2008_Mar-Apr_70(2)_251-255.nxml.txt.nlp	20046726	SENT10	0	0	10	10	olanzapine	TLC	PA450688	3933	0.917
NULL	Arthritis_Res_Ther_2013_Nov_6_15(6)_124.nxml.txt.nlp	24229459	SENT27	16	16	21	21	tocilizumab	IL-6	PA165292659	3569	0.917
NULL	Mol_Cancer_2014_Jan_13_13_7.nxml.txt.nlp	24418169	SENT40	19	19	12	12	sorafenib	STAT3	PA7000	6774	0.917
NULL	Cancer_Med_2014_Apr_7_3(2)_349-361.nxml.txt.nlp	24515895	SENT95	18	18	8	8	tetracycline	GAL7	PA451640	3963;653499	0.917
NULL	Acta_Pharmacol_Sin_2012_Jan_3_33(1)_49-56.nxml.txt.nlp	22212430	SENT38	8	8	23	23	thrombin	AP-1	PA451674	2353;3727;2354;3725	0.917
NULL	Oncotarget_2011_Jun_15_2(6)_518-524.nxml.txt.nlp	21680956	SENT101	10	10	27	27	pimozide	STAT3	PA450965	6774	0.917
NULL	Oncotarget_2014_Feb_25_5(5)_1304-1314.nxml.txt.nlp	24675421	SENT136	20	20	25	25	cisplatin	JNK	PA449014	5599	0.917
NULL	Mol_Cancer_2009_Nov_24_8_109.nxml.txt.nlp	19930708	SENT179	46	46	33	33	exemestane	aromatase	PA449563	1588	0.917
NULL	Mol_Cancer_2012_Jul_25_11_47.nxml.txt.nlp	22830443	SENT93	8	8	4	4	panitumumab	EGFR	PA162373091	1956	0.917
NULL	Cancer_Cell_Int_2014_Jan_29_14_10.nxml.txt.nlp	24472145	SENT10	25	25	5	5	cisplatin	HER-2	PA449014	2064	0.917
NULL	Ther_Clin_Risk_Manag_2006_Sep_2(3)_235-249.nxml.txt.nlp	18360599	SENT340	13	13	38	38	alendronate	PTH	PA448082	5741	0.917
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT29	26	26	37	37	atorvastatin	survivin	PA448500	332	0.917
NULL	Breast_Cancer_Res_2011_Jun_29_13(3)_R70.nxml.txt.nlp	21707964	SENT70	15	15	4	4	tamoxifen	14-3-3	PA451581	10971	0.917
NULL	Int_J_Crit_Illn_Inj_Sci_2012_May-Aug_2(2)_82-97.nxml.txt.nlp	22837896	SENT150	19	19	30	30	fluconazole	CD4	PA449653	920	0.917
NULL	Trials_2014_Jan_9_15_14.nxml.txt.nlp	24405833	SENT300	8	8	16	16	adalimumab	ACR	PA10004	49	0.917
NULL	Arthritis_Res_Ther_2010_Jan_29_12(1)_R18.nxml.txt.nlp	20113495	SENT122	2	2	7	7	glucosamine	NAPA	PA164747613	9476;8775	0.917
NULL	Cell_Death_Dis_2014_Feb_13_5(2)_e1055.nxml.txt.nlp	24525731	SENT331	11	11	31	31	irinotecan	XRCC1	PA450085	7515	0.917
NULL	Cardiol_Ther_2013_Jun_1_2(1)_111-124.nxml.txt.nlp	25135294	SENT123	26	26	14	14	clarithromycin	P-gp	PA449028	5243	0.917
NULL	Neuropsychopharmacology_2009_Aug_25_34(9)_2072-2080.nxml.txt.nlp	19322169	SENT108	15	15	2	2	rimonabant	ANOVA	PA152407999	4858	0.917
NULL	Breast_Cancer_Res_2010_Mar_5_12(2)_R16.nxml.txt.nlp	20205716	SENT238	12	12	2	2	lovastatin	NDRG1	PA450272	10397	0.917
NULL	Biomed_Res_Int_2014_Jan_29_2014_831845.nxml.txt.nlp	24605337	SENT7	30	30	16	16	bupivacaine	S6K1	PA135057240	6198	0.917
NULL	Case_Rep_Hematol_2014_Dec_24_2014_460574.nxml.txt.nlp	25610674	SENT9	28	28	3	3	vincristine	PHL	PA451879	613	0.917
NULL	Avicenna_J_Phytomed_2013_Summer_3(3)_201-204.nxml.txt.nlp	25050275	SENT48	15	15	9	9	cyclosporine	CYP3A4	PA449167	1576	0.917
NULL	Case_Rep_Rheumatol_2011_Dec_15_2011_185657.nxml.txt.nlp	22937439	SENT77	13	13	5	5	etanercept	TNF-alpha	PA449515	7124	0.917
NULL	Int_J_Biol_Sci_2013_Nov_21_9(10)_1089-1098.nxml.txt.nlp	24339730	SENT164	24	24	8	8	genistein	SMAD5	PA165109660	4090	0.917
NULL	Front_Physiol_2013_Nov_14_4_323.nxml.txt.nlp	24294204	SENT256	36	36	4	4	metoprolol	CYP2D6	PA450480	1565	0.917
NULL	Drug_Saf_2014_Feb_19_37(4)_201-211.nxml.txt.nlp	24550106	SENT152	13	13	27	27	phenytoin	CYP2C19	PA450947	1557	0.917
NULL	Aging_(Albany_NY)_2014_Jan_14_6(1)_70-81.nxml.txt.nlp	24429382	SENT217	11	11	0	0	hydroxyurea	WRN	PA449942	7486	0.917
NULL	Br_J_Pharmacol_2014_May_11_171(9)_2385-2398.nxml.txt.nlp	24467222	SENT177	15	15	7	7	rolipram	Rho	PA153906323	29984	0.917
NULL	Breast_Cancer_Res_2006_Jul_25_8(4)_R48.nxml.txt.nlp	16869955	SENT103	17	17	30	30	tamoxifen	p53	PA451581	7157	0.917
NULL	Diabetes_2013_Nov_18_62(11)_3817-3827.nxml.txt.nlp	23835338	SENT43	42	42	15	15	losartan	SREBP2	PA450268	6721	0.917
NULL	Front_Genet_2014_Feb_26_5_40.nxml.txt.nlp	24616734	SENT317	13	13	35	35	docetaxel	PSTPIP2	PA449383	9050	0.917
NULL	Cancer_Med_2013_Feb_3_2(1)_11-20.nxml.txt.nlp	24133623	SENT277	11	11	6	6	cetuximab	BRAF	PA10040	673	0.917
NULL	Cancer_Cell_Int_2014_Jul_2_14_59.nxml.txt.nlp	25120382	SENT134	15	15	10	10	metformin	CTR	PA450395	799	0.917
NULL	Diabetes_Care_2012_Dec_14_35(12)_e84.nxml.txt.nlp	23173145	SENT20	4	4	15	15	metformin	B12	PA450395	7126;4709	0.917
NULL	Aging_(Albany_NY)_2012_Jul_31_4(7)_499-508.nxml.txt.nlp	22868943	SENT133	6	6	12	12	resveratrol	SIRT1		23411	0.917
NULL	Crit_Care_2011_Nov_11_15(6)_1006.nxml.txt.nlp	22082120	SENT38	23	23	5	5	aprotinin	BART	PA448472	7809;23568	0.917
NULL	Open_Biol_2014_Dec_4(12)_140178.nxml.txt.nlp	25520185	SENT50	32	32	14	14	geldanamycin	SGT1	PA152031327	10910	0.917
NULL	Clin_Exp_Reprod_Med_2013_Jun_30_40(2)_67-75.nxml.txt.nlp	23875162	SENT70	12	12	7	7	rosiglitazone	aromatase	PA451283	1588	0.917
NULL	Biomed_Res_Int_2014_Jun_25_2014_764981.nxml.txt.nlp	25057499	SENT159	3	3	23	23	sorafenib	Met	PA7000	79811	0.917
NULL	Cell_Cycle_2012_Jul_1_11(13)_2418.nxml.txt.nlp	22722497	SENT24	20	20	15	15	flavopiridol	CDK9	PA452627	1025	0.917
NULL	J_Int_Soc_Sports_Nutr_2009_Feb_19_6_6.nxml.txt.nlp	19228401	SENT238	2	2	18	18	creatine	CEE	PA164778930	51608	0.917
NULL	Mol_Cancer_2009_Aug_25_8_66.nxml.txt.nlp	19706164	SENT287	4	4	19	19	celecoxib	ANOVA	PA448871	4858	0.917
NULL	Int_J_Mol_Sci_2014_Sep_11_15(9)_15994-16011.nxml.txt.nlp	25216334	SENT38	14	14	23	23	bevacizumab	VEGFR	PA130232992	3791	0.917
NULL	J_Hematol_Oncol_2012_Sep_16_5_55.nxml.txt.nlp	22980425	SENT125	30	30	14	14	fludarabine	TP53	PA449655	7157	0.917
NULL	Oncol_Lett_2014_Mar_16_7(3)_827-833.nxml.txt.nlp	24527090	SENT86	3	3	10	10	cisplatin	IFN	PA449014	3439	0.917
NULL	Cancers_(Basel)_2014_Mar_26_6(2)_708-722.nxml.txt.nlp	24675568	SENT122	0	0	3	3	niclosamide	STAT3	PA165958408	6774	0.917
NULL	Brain_2013_May_4_136(5)_1462-1475.nxml.txt.nlp	23460667	SENT273	41	41	16	16	bevacizumab	CD44	PA130232992	960	0.917
NULL	Int_J_Mol_Sci_2014_Mar_14_15(3)_4531-4549.nxml.txt.nlp	24637936	SENT128	9	9	18	18	suramin	P2X1	PA10292	5023	0.917
NULL	Anticancer_Drugs_2015_Feb_22_26(2)_139-147.nxml.txt.nlp	25203626	SENT171	13	13	5	5	sorafenib	EZH2	PA7000	2146	0.917
NULL	Breast_Cancer_Res_2010_Oct_22_12(Suppl_2)_S2.nxml.txt.nlp	21050423	SENT70	19	19	0	0	paclitaxel	MRP1	PA450761	4437	0.917
NULL	Mol_Cancer_2009_Apr_22_8_26.nxml.txt.nlp	19386116	SENT254	18	18	3	3	ritonavir	AKT	PA451260	207	0.917
NULL	Protein_Cell_2014_Feb_29_5(2)_113-123.nxml.txt.nlp	24474196	SENT127	5	5	29	29	metformin	AMPK	PA450395	5563	0.917
NULL	J_Hematol_Oncol_2013_Dec_17_6_93.nxml.txt.nlp	24341609	SENT113	5	5	26	26	gefitinib	EGF	PA131301952	1950	0.917
NULL	Oxid_Med_Cell_Longev_2013_May_27_2013_396527.nxml.txt.nlp	23781294	SENT149	10	10	13	13	hemin	HO-1	PA449849	3162	0.917
NULL	Pain_Res_Treat_2012_Dec_5_2012_256024.nxml.txt.nlp	23304492	SENT99	8	8	15	15	methotrexate	SFN	PA450428	25996;2810	0.917
NULL	Front_Neurosci_2014_Dec_5_8_398.nxml.txt.nlp	25538552	SENT17	14	14	7	7	glucose	gamma	PA449773	9913	0.917
NULL	Front_Immunol_2013_Oct_28_4_346.nxml.txt.nlp	24194739	SENT144	21	21	25	25	vemurafenib	BRAF	PA165946873	673	0.917
NULL	Acta_Pharmacol_Sin_2012_May_16_33(5)_682-690.nxml.txt.nlp	22504904	SENT167	24	24	16	16	celecoxib	STAT3	PA448871	6774	0.917
NULL	Cell_Death_Dis_2013_Jun_13_4(6)_e665.nxml.txt.nlp	23764846	SENT28	9	9	25	25	sorafenib	BLM	PA7000	641	0.917
NULL	Arthritis_Res_Ther_2003_Oct_2_5(Suppl_4)_S17-S21.nxml.txt.nlp	15180893	SENT54	5	5	37	37	cyclophosphamide	ACR	PA449165	49	0.917
NULL	Core_Evid_2009_Jun_15_4_25-36.nxml.txt.nlp	20694062	SENT172	32	32	11	11	allopurinol	FACT	PA448320	11198	0.917
NULL	Oncotarget_2012_Sep_11_3(9)_1026-1035.nxml.txt.nlp	22976441	SENT89	4	4	19	19	etoposide	CKI	PA449552	1119	0.917
NULL	BMB_Rep_2014_Jan_47(1)_33-38.nxml.txt.nlp	24209634	SENT83	11	11	7	7	cisplatin	CXCR4	PA449014	7852	0.917
NULL	Cancer_Manag_Res_2013_Nov_21_5_387-400.nxml.txt.nlp	24294007	SENT89	27	27	31	31	panitumumab	NRAS	PA162373091	4893	0.917
NULL	Br_J_Cancer_1997_76(10)_1322-1327.nxml.txt.nlp	9374378	SENT0	21	21	16	16	cisplatin	CPP32	PA449014	836	0.917
NULL	J_Biol_Chem_2009_Jul_31_284(31)_20556-20561.nxml.txt.nlp	19473966	SENT75	16	16	37	37	ampicillin	HO-2	PA448419	3163	0.917
NULL	Mol_Cells_2014_Sep_30_37(9)_664-671.nxml.txt.nlp	25234467	SENT14	18	18	3	3	cisplatin	miR-217	PA449014	406999	0.917
NULL	Oncogene_2010_Sep_16_29(37)_5135-5145.nxml.txt.nlp	20622897	SENT11	24	24	18	18	cetuximab	HIF1	PA10040	3091	0.917
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT190	10	10	6	6	doxorubicin	B7-H1	PA449412	29126	0.917
NULL	Clin_Sci_(Lond)_2012_May_1_122(Pt_9)_421-428.nxml.txt.nlp	22092038	SENT195	8	8	28	28	doxycycline	AP-1	PA449415	2353;3727;2354;3725	0.917
NULL	J_Thromb_Haemost_2014_Feb_7_12(2)_261-272.nxml.txt.nlp	24735118	SENT297	2	2	12	12	vasopressin	GRK2	PA451858	156	0.917
NULL	Infect_Dis_Obstet_Gynecol_2012_Feb_28_2012_137192.nxml.txt.nlp	22536010	SENT128	22	22	16	16	lamotrigine	CYP3A	PA450164	1574	0.917
NULL	Indian_J_Pharmacol_2013_Jul-Aug_45(4)_365-370.nxml.txt.nlp	24014912	SENT172	9	9	6	6	capsaicin	TRPV1	PA448776	7442	0.917
NULL	Br_J_Cancer_2009_Mar_24_100(6)_941-949.nxml.txt.nlp	19240716	SENT8	10	10	1	1	gefitinib	EGFR	PA131301952	1956	0.917
NULL	Int_J_Mol_Sci_2014_Oct_8_15(10)_17974-17999.nxml.txt.nlp	25299695	SENT121	31	31	15	15	curcumin	HO-1	PA151958596	3162	0.917
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT150	13	13	8	8	methotrexate	MSH2	PA450428	4436	0.917
NULL	Eur_J_Clin_Pharmacol_2012_Sep_15_68(9)_1267-1274.nxml.txt.nlp	22418828	SENT181	15	15	3	3	omeprazole	CYP2C19	PA450704	1557	0.917
NULL	Lab_Invest_2011_Jan_9_91(1)_138-146.nxml.txt.nlp	20697379	SENT69	31	31	5	5	thyroglobulin	p63	PA164754910	8626	0.917
NULL	Indian_J_Endocrinol_Metab_2013_Jul-Aug_17(4)_636-646.nxml.txt.nlp	23961479	SENT151	15	15	22	22	saquinavir	CYP3A4	PA451305	1576	0.917
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT240	5	5	16	16	levothyroxine	UGT1A1	PA450221	54658	0.917
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT150	8	8	4	4	sitagliptin	HIP	PA164748978	6767;6159;64399;5068	0.917
NULL	Neuropsychopharmacology_2009_Jul_11_34(8)_1946-1957.nxml.txt.nlp	19279569	SENT142	25	25	10	10	cocaine	DOR	PA449072	58476	0.917
NULL	Apoptosis_2012_Sep_30_17(9)_989-997.nxml.txt.nlp	22460505	SENT154	30	30	16	16	thioridazine	EGF	PA451666	1950	0.917
NULL	Br_J_Cancer_2012_May_22_106(11)_1779-1789.nxml.txt.nlp	22549178	SENT215	12	12	20	20	pertuzumab	HER2		2064	0.917
NULL	J_Thyroid_Res_2011_Apr_10_2011_895923.nxml.txt.nlp	21603172	SENT184	7	7	1	1	thyroglobulin	IL-4	PA164754910	3565	0.917
NULL	Front_Pharmacol_2014_May_30_5_132.nxml.txt.nlp	24910615	SENT133	35	35	8	8	estradiol	PDE7B	PA449503	27115	0.917
NULL	J_Nat_Med_2014_Feb_19_68(2)_253-266.nxml.txt.nlp	24550097	SENT193	11	11	28	28	berberine	AMPK	PA165860812	5563	0.917
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT1222	0	0	5	5	raltegravir	SLC22A6		9356	0.917
NULL	Mol_Cancer_2014_Jun_5_13_143.nxml.txt.nlp	24898067	SENT110	25	25	10	10	gefitinib	AKT	PA131301952	207	0.917
NULL	Nucleic_Acids_Res_2013_Mar_29_41(5)_2981-2992.nxml.txt.nlp	23361461	SENT171	9	9	0	0	neomycin	TDP1	PA450608	55775	0.917
NULL	Arch_Plast_Surg_2012_Sep_12_39(5)_540-545.nxml.txt.nlp	23094252	SENT36	14	14	11	11	propofol	TCI	PA451141	6947	0.917
NULL	J_Hematol_Oncol_2013_Sep_5_6_66.nxml.txt.nlp	24010946	SENT129	14	14	21	21	oxaliplatin	CRT	PA131285527	811	0.917
NULL	Curr_Neuropharmacol_2013_Jul_11(4)_338-378.nxml.txt.nlp	24381528	SENT1248	10	10	12	12	curcumin	alpha-synuclein	PA151958596	6622	0.917
NULL	Anticancer_Drugs_2015_Feb_22_26(2)_139-147.nxml.txt.nlp	25203626	SENT181	10	10	31	31	sorafenib	GAPDH	PA7000	2597	0.917
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT139	18	18	13	13	capsaicin	p53	PA448776	7157	0.917
NULL	Oncol_Rep_2013_Apr_23_29(4)_1268-1274.nxml.txt.nlp	23354756	SENT118	6	6	23	23	paclitaxel	SLC25A43	PA450761	203427	0.917
NULL	Osteoporos_Int_2007_Jan_15_18(1)_25-34.nxml.txt.nlp	17106785	SENT105	24	24	5	5	risedronate	PROC	PA451255	5624	0.917
NULL	Indian_J_Pharm_Sci_2014_Mar-Apr_76(2)_125-131.nxml.txt.nlp	24843185	SENT28	20	20	7	7	resveratrol	S100B		6285	0.917
NULL	Indian_Dermatol_Online_J_2014_Nov_5(Suppl_1)_S9-S16.nxml.txt.nlp	25506579	SENT36	0	0	12	12	estradiol	aromatase	PA449503	1588	0.917
NULL	Tuberc_Respir_Dis_(Seoul)_2014_Jan_29_76(1)_8-14.nxml.txt.nlp	24523812	SENT65	16	16	22	22	gemcitabine	EGFR	PA449748	1956	0.917
NULL	Brain_Struct_Funct_2013_Mar_17_218(2)_421-435.nxml.txt.nlp	22527118	SENT84	4	4	13	13	fluorescein	NPY	PA164746009	4852	0.917
NULL	Tuberc_Respir_Dis_(Seoul)_2014_Feb_27_76(2)_66-74.nxml.txt.nlp	24624215	SENT144	28	28	24	24	vancomycin	HCAP	PA451850	117159;9126	0.917
NULL	Nat_Biotechnol_2011_Jul_17_29(8)_757-761.nxml.txt.nlp	21765402	SENT148	30	30	10	10	ampicillin	SOC	PA448419	91544	0.917
NULL	Breast_Cancer_(Auckl)_2012_Nov_19_6_191-207.nxml.txt.nlp	23226023	SENT42	30	30	39	39	trastuzumab	HER2	PA451743	2064	0.917
NULL	Mol_Cancer_2011_Sep_30_10_125.nxml.txt.nlp	21962244	SENT23	9	9	12	12	erlotinib	AKT	PA134687924	207	0.917
NULL	Oncogene_2014_Aug_21_33(34)_4316-4329.nxml.txt.nlp	24362530	SENT25	10	10	20	20	epirubicin	FOXM1	PA449476	2305	0.917
NULL	Br_J_Cancer_2011_Jun_28_105(1)_1-8.nxml.txt.nlp	21654681	SENT55	17	17	9	9	docetaxel	EGFR	PA449383	1956	0.917
NULL	Breast_Cancer_Res_2012_Jul_19_14(4)_R109.nxml.txt.nlp	22812567	SENT244	6	6	3	3	gemcitabine	CHK1	PA449748	1111	0.917
NULL	Cells_2014_May_23_3(2)_517-545.nxml.txt.nlp	24861977	SENT108	5	5	18	18	capsaicin	CD4	PA448776	920	0.917
NULL	Indian_J_Pharm_Sci_2014_Mar-Apr_76(2)_125-131.nxml.txt.nlp	24843185	SENT144	21	21	8	8	resveratrol	CA1		759	0.917
NULL	Br_J_Cancer_2012_Jan_31_106(3)_482-489.nxml.txt.nlp	22233925	SENT162	11	11	3	3	carboplatin	PEO1	PA448803	56652	0.917
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_29_2013_590393.nxml.txt.nlp	23737838	SENT220	20	20	14	14	resveratrol	p53		7157	0.917
NULL	Cell_Res_2014_Feb_12_24(2)_143-160.nxml.txt.nlp	24217768	SENT67	29	29	21	21	heparin	FGF2	PA449855	2247;2258	0.917
NULL	Acta_Pharmacol_Sin_2012_Aug_23_33(8)_1095-1100.nxml.txt.nlp	22820908	SENT112	23	23	16	16	clarithromycin	CYP3A4	PA449028	1576	0.917
NULL	Curr_Oncol_2010_Feb_17(1)_81-86.nxml.txt.nlp	20179808	SENT57	22	22	43	43	letrozole	aromatase	PA450196	1588	0.917
NULL	Scientifica_(Cairo)_2013_Dec_12_2013_635203.nxml.txt.nlp	24416617	SENT397	12	12	16	16	vemurafenib	BRAF	PA165946873	673	0.917
NULL	Acta_Pharmacol_Sin_2010_Sep_9_31(9)_1181-1188.nxml.txt.nlp	20694025	SENT147	20	20	34	34	irinotecan	gene59	PA450085	1762	0.917
NULL	Mol_Cancer_2008_Mar_26_7_27.nxml.txt.nlp	18366759	SENT76	6	6	14	14	etoposide	GADD45	PA449552	1647	0.917
NULL	Infect_Dis_Obstet_Gynecol_2012_Nov_29_2012_543916.nxml.txt.nlp	23251074	SENT37	5	5	38	38	zidovudine	CD4	PA451954	920	0.917
NULL	Int_J_Nanomedicine_2012_Nov_29_7_5915-5927.nxml.txt.nlp	23226697	SENT102	20	20	13	13	heparin	FGF1	PA449855	2246	0.917
NULL	Breast_Cancer_Res_2014_May_28_16(3)_R53.nxml.txt.nlp	24886537	SENT29	15	15	8	8	tamoxifen	VAV3	PA451581	10451	0.917
NULL	Biomed_Res_Int_2014_Jun_26_2014_249780.nxml.txt.nlp	25054134	SENT178	19	19	4	4	ethanol	mol	PA448073	90527	0.917
NULL	Physiol_Rep_2014_Aug_28_2(8)_e12124.nxml.txt.nlp	25168873	SENT57	5	5	23	23	creatine	ADP	PA164778930	23038	0.917
NULL	J_Neuroinflammation_2010_Sep_7_7_51.nxml.txt.nlp	20822529	SENT176	8	8	38	38	hemin	CXCL10	PA449849	3627	0.917
NULL	Mol_Cancer_2009_Jun_8_8_34.nxml.txt.nlp	19500427	SENT228	21	21	9	9	gemcitabine	ANOVA	PA449748	4858	0.917
NULL	Mol_Cancer_2012_Jun_18_11_41.nxml.txt.nlp	22709873	SENT318	9	9	3	3	lapatinib	RB1CC1	PA152241907	9821	0.917
NULL	Br_J_Cancer_2010_Sep_28_103(7)_1008-1018.nxml.txt.nlp	20736947	SENT212	19	19	29	29	docetaxel	CD147	PA449383	682	0.917
NULL	Oncotarget_2014_Aug_29_5(19)_8947-8958.nxml.txt.nlp	25333254	SENT128	33	33	21	21	plerixafor	CXCR7	PA165958410	57007	0.917
NULL	Front_Genet_2012_Nov_22_3_249.nxml.txt.nlp	23189085	SENT191	29	29	11	11	vincristine	CYP3A5	PA451879	1577	0.917
NULL	Insights_Imaging_2013_Jan_29_4(2)_163-175.nxml.txt.nlp	23359240	SENT162	6	6	1	1	trastuzumab	HER2	PA451743	2064	0.917
NULL	Clin_Genet_2014_Jan_1_86(1)_21-28.nxml.txt.nlp	24684508	SENT81	15	15	8	8	carbamazepine	HLA-B	PA448785	3106	0.917
NULL	Int_J_Biol_Sci_2014_Feb_20_10(3)_268-277.nxml.txt.nlp	24644425	SENT108	15	15	23	23	metformin	AMPK	PA450395	5563	0.917
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT274	21	21	15	15	hydrocortisone	EGF	PA449905	1950	0.917
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT187	13	13	20	20	resveratrol	TRAIL		8743	0.917
NULL	J_Carcinog_2013_Dec_31_12_22.nxml.txt.nlp	24574860	SENT220	15	15	30	30	dasatinib	BRAF	PA162372878	673	0.917
NULL	Case_Rep_Rheumatol_2011_Dec_15_2011_185657.nxml.txt.nlp	22937439	SENT78	17	17	6	6	etanercept	TNF-alpha	PA449515	7124	0.917
NULL	Open_Biol_2014_Jun_4(6)_140030.nxml.txt.nlp	24920276	SENT240	7	7	11	11	vemurafenib	BRAF	PA165946873	673	0.917
NULL	Biomed_Res_Int_2014_Apr_24_2014_915797.nxml.txt.nlp	24868553	SENT58	17	17	11	11	ethanol	mol	PA448073	90527	0.917
NULL	Nat_Med_2013_Sep_11_19(9)_1153-1156.nxml.txt.nlp	23933983	SENT162	18	18	38	38	estradiol	AVP	PA449503	114548;551	0.917
NULL	Oncotarget_2014_Aug_19_5(18)_8703-8715.nxml.txt.nlp	25237928	SENT62	15	15	3	3	glucose	CD44	PA449773	960	0.917
NULL	J_Cell_Biol_2001_Apr_2_153(1)_207-220.nxml.txt.nlp	11285286	SENT120	16	16	3	3	carbachol	DGK	PA448784	8526;1607	0.917
NULL	Cancers_(Basel)_2014_Nov_25_6(4)_2313-2329.nxml.txt.nlp	25534569	SENT29	11	11	8	8	crizotinib	Met	PA165946122	79811	0.917
NULL	Int_J_Biomed_Sci_2014_Sep_10(3)_146-157.nxml.txt.nlp	25324695	SENT9	7	7	16	16	pravastatin	LFA-1	PA451089	3683;3689	0.917
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_7-17.nxml.txt.nlp	17912633	SENT368	39	39	4	4	letrozole	aromatase	PA450196	1588	0.917
NULL	J_Cell_Biol_1998_Jan_26_140(2)_335-345.nxml.txt.nlp	9442109	SENT215	14	14	24	24	chloroquine	NHE	PA448948	285335	0.917
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_16_2013_146142.nxml.txt.nlp	23843863	SENT99	6	6	28	28	ns-398	IL8		3576	0.917
NULL	Acta_Pharmacol_Sin_2014_Aug_7_35(8)_1023-1030.nxml.txt.nlp	24998255	SENT196	27	27	7	7	octreotide	STAT3	PA450678	6774	0.917
NULL	Cancer_Cell_Int_2010_Sep_9_10_32.nxml.txt.nlp	20828393	SENT205	6	6	1	1	cisplatin	ATF3	PA449014	467	0.917
NULL	Curr_Pharm_Des_2008_Oct_14(28)_2983-2998.nxml.txt.nlp	18991714	SENT85	15	15	12	12	canertinib	EGFR	PA134687925	1956	0.917
NULL	Int_J_Biol_Sci_2012_Oct_24_8(9)_1227-1236.nxml.txt.nlp	23136551	SENT56	2	2	16	16	tocilizumab	IL-6	PA165292659	3569	0.917
NULL	Adv_Ther_2013_Oct_25_30(10)_870-884.nxml.txt.nlp	24158787	SENT23	11	11	4	4	letrozole	aromatase	PA450196	1588	0.917
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT222	8	8	28	28	erlotinib	AKT	PA134687924	207	0.917
NULL	Oncotarget_2014_May_27_5(19)_9049-9064.nxml.txt.nlp	24979294	SENT233	9	9	13	13	dasatinib	HER-2	PA162372878	2064	0.917
NULL	Mol_Cancer_2013_Sep_11_12_104.nxml.txt.nlp	24025152	SENT194	17	17	20	20	gemcitabine	EGFR	PA449748	1956	0.917
NULL	Mol_Cell_Proteomics_2013_Aug_14_12(8)_2313-2323.nxml.txt.nlp	23674616	SENT216	13	13	8	8	levamisole	ALPL	PA450205	249	0.917
NULL	J_Immunother_Cancer_2014_Nov_6_2(Suppl_3)_P67.nxml.txt.nlp	NULL	SENT5	3	3	10	10	vemurafenib	BRAF	PA165946873	673	0.917
NULL	BMB_Rep_2014_Nov_47(11)_649-654.nxml.txt.nlp	25301019	SENT6	6	6	31	31	l-serine	STAT3	PA451330	6774	0.917
NULL	Springerplus_2014_Sep_9_3_510.nxml.txt.nlp	25279302	SENT37	3	3	20	20	creatine	CKM	PA164778930	1158	0.917
NULL	Mol_Cancer_2010_Dec_20_9_317.nxml.txt.nlp	21172025	SENT283	26	26	33	33	tamoxifen	p27	PA451581	5715;10534	0.917
NULL	Front_Physiol_2013_Jul_5_4_159.nxml.txt.nlp	23847541	SENT746	3	3	12	12	bevacizumab	CXCR4	PA130232992	7852	0.917
NULL	Nat_Commun_2014_Apr_28_5_3695.nxml.txt.nlp	24770583	SENT176	10	10	3	3	doxycycline	p97	PA449415	50628;10428;1982;7415	0.917
NULL	Int_J_Nanomedicine_2009_Dec_29_4_299-319.nxml.txt.nlp	20054434	SENT273	4	4	41	41	cyclosporine	HLA-A	PA449167	3105	0.917
NULL	Indian_J_Pharm_Sci_2014_Jul-Aug_76(4)_281-286.nxml.txt.nlp	25284925	SENT4	26	26	18	18	clopidogrel	CYP2C19	PA449053	1557	0.917
NULL	Case_Rep_Dermatol_2011_Jun_30_3(2)_130-136.nxml.txt.nlp	21743808	SENT15	24	24	16	16	cetuximab	EGFR	PA10040	1956	0.917
NULL	Acta_Pharmacol_Sin_2014_Jan_9_35(1)_1-10.nxml.txt.nlp	24317012	SENT134	4	4	0	0	thalidomide	CYP2C19	PA451644	1557	0.917
NULL	Clin_Interv_Aging_2012_Dec_30_7_1-13.nxml.txt.nlp	22291468	SENT56	16	16	1	1	dronedarone	CYP3A4	PA153619853	1576	0.917
NULL	Diabetes_Care_2012_Jun_11_35(6)_e40.nxml.txt.nlp	22619292	SENT19	33	33	8	8	glibenclamide	KCNJ11	PA449782	3767	0.916
NULL	Acta_Oncol_2014_Oct_9_53(10)_1347-1355.nxml.txt.nlp	24909504	SENT191	20	20	10	10	epirubicin	MDM2	PA449476	4193	0.916
NULL	Case_Rep_Neurol_2011_Feb_21_3(1)_54-61.nxml.txt.nlp	21490714	SENT83	14	14	11	11	letrozole	aromatase	PA450196	1588	0.916
NULL	Curr_Neuropharmacol_2010_Sep_8(3)_254-267.nxml.txt.nlp	21358975	SENT177	21	21	7	7	phenytoin	CYP3A4	PA450947	1576	0.916
NULL	Adv_Hematol_2012_Aug_2_2012_842945.nxml.txt.nlp	22919394	SENT159	19	19	22	22	lenalidomide	IL-2	PA162363968	3558	0.916
NULL	Arthritis_Res_Ther_2009_Jun_23_11(3)_R95.nxml.txt.nlp	19549290	SENT216	24	24	11	11	abatacept	ACR	PA164747080	49	0.916
NULL	Mol_Cancer_2010_Nov_2_9_289.nxml.txt.nlp	21044322	SENT212	18	18	11	11	cisplatin	RGS10	PA449014	6001	0.916
NULL	Cancer_Immunol_Immunother_2011_Jan_21_60(1)_75-85.nxml.txt.nlp	20857100	SENT225	5	5	9	9	fludarabine	STAT1	PA449655	6772	0.916
NULL	Br_J_Cancer_2012_Jan_3_106(1)_148-156.nxml.txt.nlp	22045191	SENT187	10	10	7	7	erlotinib	EGFR	PA134687924	1956	0.916
NULL	J_Gynecol_Oncol_2013_Jan_8_24(1)_66-82.nxml.txt.nlp	23346316	SENT264	22	22	32	32	exemestane	aromatase	PA449563	1588	0.916
NULL	Environ_Health_Perspect_2008_Jan_5_116(1)_1-6.nxml.txt.nlp	18197291	SENT169	7	7	3	3	arsenite	ROS	PA452638	6098	0.916
NULL	Cancer_Cell_Int_2010_Oct_1_10_36.nxml.txt.nlp	20920299	SENT21	19	19	9	9	cisplatin	survivin	PA449014	332	0.916
NULL	Oncologist_2010_Mar_3_15(3)_216-235.nxml.txt.nlp	20200040	SENT76	5	5	11	11	neratinib	HER-2	PA165291472	2064	0.916
NULL	Iran_J_Reprod_Med_2014_Apr_12(4)_257-262.nxml.txt.nlp	24976820	SENT31	29	29	5	5	protamine	PRM2	PA10366	5620	0.916
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1013.nxml.txt.nlp	24457957	SENT143	23	23	9	9	bortezomib	NOXA	PA10252	5366	0.916
NULL	Mol_Cancer_2014_Jan_28_13_17.nxml.txt.nlp	24472312	SENT232	5	5	36	36	ponatinib	Mcl-1	PA165980594	4170	0.916
NULL	Dermatoendocrinol_2013_Apr_1_5(2)_252-263.nxml.txt.nlp	24194965	SENT159	0	0	39	39	methotrexate	B12	PA450428	7126;4709	0.916
NULL	Brain_2008_Dec_6_131(12)_3361-3379.nxml.txt.nlp	18988638	SENT142	5	5	30	30	apomorphine	ANOVA	PA164781163	4858	0.916
NULL	Case_Rep_Ophthalmol_2010_Dec_4_1(2)_105-109.nxml.txt.nlp	21373382	SENT6	32	32	9	9	triamcinolone	B27	PA451749	56246	0.916
NULL	Int_J_Nanomedicine_2012_Sep_13_7_4917-4926.nxml.txt.nlp	23028220	SENT237	2	2	17	17	calcein	mol	PA132595336	90527	0.916
NULL	J_Cell_Biol_1998_Jan_26_140(2)_259-270.nxml.txt.nlp	9442102	SENT74	8	8	1	1	thrombin	SUMO-1	PA451674	7341	0.916
NULL	Evid_Based_Complement_Alternat_Med_2012_May_22_2012_340787.nxml.txt.nlp	22675379	SENT37	3	3	7	7	fluconazole	S27	PA449653	6232	0.916
NULL	Nucleic_Acids_Res_2012_Sep_28_40(17)_8440-8448.nxml.txt.nlp	22753029	SENT158	36	36	30	30	hydroxyurea	CHK1	PA449942	1111	0.916
NULL	J_Hematol_Oncol_2013_Dec_17_6_93.nxml.txt.nlp	24341609	SENT111	21	21	17	17	gefitinib	EGFR	PA131301952	1956	0.916
NULL	Drug_Des_Devel_Ther_2014_Oct_31_8_2121-2128.nxml.txt.nlp	25382970	SENT101	22	22	9	9	curcumin	TTR	PA151958596	7276	0.916
NULL	Acta_Pharmacol_Sin_2014_Jun_4_35(6)_752-757.nxml.txt.nlp	24902786	SENT98	35	35	5	5	letrozole	STL2	PA450196	1301	0.916
NULL	Oncol_Lett_2013_Sep_28_6(3)_795-800.nxml.txt.nlp	24137413	SENT99	30	30	10	10	paclitaxel	HIF-1	PA450761	29072	0.916
NULL	Pharmaceutics_2010_Sep_9_2(3)_291-299.nxml.txt.nlp	NULL	SENT74	32	32	18	18	tacrolimus	CYP3A	PA451578	1574	0.916
NULL	Hematol_Rep_2011_Oct_28_3(3_Suppl)_e3.nxml.txt.nlp	22586511	SENT26	8	8	32	32	bleomycin	CHOP	PA448645	1649	0.916
NULL	Genet_Vaccines_Ther_2011_Apr_6_9_7.nxml.txt.nlp	21466709	SENT35	18	18	31	31	ribavirin	IFN	PA451241	3439	0.916
NULL	Cancers_(Basel)_2014_Mar_26_6(2)_708-722.nxml.txt.nlp	24675568	SENT103	3	3	25	25	gefitinib	EGFR	PA131301952	1956	0.916
NULL	Anticancer_Agents_Med_Chem_2012_Feb_12(2)_163-171.nxml.txt.nlp	22043994	SENT240	7	7	3	3	panitumumab	KRAS	PA162373091	3845	0.916
NULL	Contemp_Oncol_(Pozn)_2012_Jan_4_16(6)_480-484.nxml.txt.nlp	23788933	SENT127	14	14	2	2	crizotinib	EGFR	PA165946122	1956	0.916
NULL	Oncologist_2010_Nov_2_15(11)_1133-1134.nxml.txt.nlp	21045190	SENT41	25	25	0	0	doxorubicin	Yes	PA449412	7525	0.916
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_15_2012_726025.nxml.txt.nlp	23118796	SENT49	39	39	24	24	streptomycin	FBS	PA451512	64319;26269	0.916
NULL	Indian_J_Hum_Genet_2014_Apr-Jun_20(2)_175-184.nxml.txt.nlp	25400347	SENT9	46	46	22	22	clopidogrel	MYBPC3	PA449053	4607	0.916
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT255	14	14	6	6	chloroquine	BMPR-II	PA448948	659	0.916
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT52	13	13	26	26	indinavir	CYP3A4	PA449977	1576	0.916
NULL	Mol_Biol_Cell_2014_May_15_25(10)_1620-1628.nxml.txt.nlp	24648493	SENT149	23	23	11	11	nystatin	JNK	PA450666	5599	0.916
NULL	Breast_Cancer_Res_2010_Jun_28_12(3)_R44.nxml.txt.nlp	20584310	SENT209	17	17	4	4	doxycycline	ERBB2	PA449415	2064	0.916
NULL	Int_J_Endocrinol_2014_May_12_2014_917813.nxml.txt.nlp	24899894	SENT154	0	0	8	8	phentermine	TAAR1	PA164748099	134864	0.916
NULL	Acta_Pharmacol_Sin_2010_Aug_19_31(8)_963-969.nxml.txt.nlp	20644547	SENT135	9	9	16	16	troglitazone	PDX-1	PA451799	3651	0.916
NULL	Breast_Cancer_Res_2010_Aug_9_12(4)_R62.nxml.txt.nlp	20696059	SENT57	0	0	11	11	trastuzumab	San	PA451743	80218	0.916
NULL	Lancet_2011_Jun_18_377(9783)_2103-2114.nxml.txt.nlp	21641636	SENT191	24	24	10	10	cetuximab	EGFR	PA10040	1956	0.916
NULL	Iran_J_Neurol_2012_11(2)_70-73.nxml.txt.nlp	24250865	SENT6	12	12	28	28	doxycycline	IFN	PA449415	3439	0.916
NULL	Acta_Pharmacol_Sin_2011_Oct_12_32(10)_1259-1265.nxml.txt.nlp	21909126	SENT111	12	12	28	28	fluvastatin	MCP-1	PA449688	6347	0.916
NULL	Evid_Based_Complement_Alternat_Med_2012_Feb_16_2012_430262.nxml.txt.nlp	22454664	SENT109	35	35	0	0	citalopram	CYP2C19	PA449015	1557	0.916
NULL	Addict_Sci_Clin_Pract_2014_Sep_13_9(1)_20.nxml.txt.nlp	25217046	SENT178	15	15	8	8	naltrexone	OPRM1	PA450588	4988	0.916
NULL	Chin_J_Cancer_2012_Feb_31(2)_110-118.nxml.txt.nlp	22098951	SENT17	17	17	7	7	imatinib	P-gp	PA10804	5243	0.916
NULL	Cancers_(Basel)_2013_Apr_3_5(2)_334-356.nxml.txt.nlp	24216980	SENT245	21	21	11	11	vorinostat	ZEB1	PA164748224	6935	0.916
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jul_31_66(Pt_8)_o2157.nxml.txt.nlp	21588441	SENT47	8	8	39	39	benzaldehyde	mol	PA448571	90527	0.916
NULL	Oncotarget_2014_Aug_29_5(19)_8947-8958.nxml.txt.nlp	25333254	SENT128	8	8	18	18	plerixafor	CD49d	PA165958410	3676	0.916
NULL	Exp_Ther_Med_2013_May_8_5(5)_1491-1495.nxml.txt.nlp	23737905	SENT8	4	4	7	7	hemin	HO-1	PA449849	3162	0.916
NULL	Cancers_(Basel)_2011_Oct_26_3(4)_4024-4045.nxml.txt.nlp	24213123	SENT201	8	8	25	25	paclitaxel	PC-3	PA450761	692094	0.916
NULL	Mol_Cancer_2010_Nov_2_9_289.nxml.txt.nlp	21044322	SENT173	25	25	9	9	docetaxel	RGS17	PA449383	26575	0.916
NULL	Target_Oncol_2013_Mar_30_8(1)_27-33.nxml.txt.nlp	23361373	SENT104	16	16	23	23	gefitinib	EGFR	PA131301952	1956	0.916
NULL	Cancers_(Basel)_2014_Jul_3_6(3)_1408-1440.nxml.txt.nlp	24995504	SENT1480	14	14	2	2	resveratrol	STAT3		6774	0.916
NULL	Curr_Neuropharmacol_2014_Jul_12(4)_365-379.nxml.txt.nlp	25342944	SENT56	3	3	7	7	fluoxetine	5-HT2B	PA449673	3357	0.916
NULL	Mol_Cancer_2009_Sep_7_8_72.nxml.txt.nlp	19735553	SENT349	8	8	21	21	doxorubicin	WT1	PA449412	7490	0.916
NULL	J_Med_Case_Reports_2011_May_21_5_197.nxml.txt.nlp	21600007	SENT10	24	24	11	11	imatinib	KIT	PA10804	3815	0.916
NULL	Nature_2012_Aug_16_488(7411)_384-388.nxml.txt.nlp	22820255	SENT190	11	11	2	2	doxycycline	CD4	PA449415	920	0.916
NULL	Diabetes_Care_2008_Oct_31(10)_1939-1944.nxml.txt.nlp	18599530	SENT119	19	19	10	10	gliclazide	ABCC8	PA10892	6833	0.916
NULL	Case_Rep_Hematol_2012_Dec_19_2012_658745.nxml.txt.nlp	23316401	SENT83	8	8	24	24	erythromycin	IL-4	PA449493	3565	0.916
NULL	Ann_Hematol_2011_Feb_17_90(2)_173-183.nxml.txt.nlp	20714724	SENT131	10	10	27	27	resveratrol	CD38		952	0.916
NULL	Arch_Drug_Inf_2009_Mar_2(1)_8-16.nxml.txt.nlp	19381336	SENT5	0	0	12	12	rifampin	CYP3A4	PA451250	1576	0.916
NULL	Clin_Dev_Immunol_2011_Dec_26_2011_890758.nxml.txt.nlp	22235224	SENT120	9	9	6	6	cetuximab	HER2	PA10040	2064	0.916
NULL	Breast_Cancer_Res_2011_Nov_30_13(6)_221.nxml.txt.nlp	22217398	SENT123	11	11	35	35	exemestane	San	PA449563	80218	0.916
NULL	Pharmaceuticals_(Basel)_2011_Nov_11_4(11)_1503-1517.nxml.txt.nlp	NULL	SENT8	0	0	11	11	capsaicin	TRPV1	PA448776	7442	0.916
NULL	Neural_Plast_2007_Dec_11_2007_73079.nxml.txt.nlp	NULL	SENT4434	8	8	31	31	propranolol	CA1	PA451145	759	0.916
NULL	Front_Genet_2012_Oct_19_3_180.nxml.txt.nlp	23091478	SENT658	17	17	1	1	cetuximab	KRAS	PA10040	3845	0.916
NULL	J_Cardiothorac_Surg_2012_Jun_28_7_61.nxml.txt.nlp	22741616	SENT68	12	12	4	4	amiodarone	NAC	PA448383	22861	0.916
NULL	Int_J_Breast_Cancer_2011_Sep_6_2011_352182.nxml.txt.nlp	22295219	SENT119	5	5	10	10	trastuzumab	CD44	PA451743	960	0.916
NULL	Breast_Cancer_Res_2004_Jul_29_6(5)_204-210.nxml.txt.nlp	15318926	SENT95	22	22	10	10	erlotinib	EGFR	PA134687924	1956	0.916
NULL	Oncotarget_2014_Jun_7_5(14)_5257-5271.nxml.txt.nlp	24913448	SENT92	21	21	1	1	nilotinib	CRKL	PA165958345	1399	0.916
NULL	Cells_2014_Apr_4_3(2)_199-235.nxml.txt.nlp	24709958	SENT421	15	15	11	11	gefitinib	EGFR	PA131301952	1956	0.916
NULL	Cell_Cycle_2012_Sep_1_11(17)_3143-3144.nxml.txt.nlp	22894901	SENT31	20	20	7	7	etoposide	TOP2B	PA449552	7155	0.916
NULL	J_Gen_Physiol_2013_Jan_141(1)_119-132.nxml.txt.nlp	23277478	SENT286	21	21	17	17	furosemide	NKCC1	PA449719	6558	0.916
NULL	Int_J_Mol_Sci_2014_Mar_5_15(3)_3970-3988.nxml.txt.nlp	24603537	SENT2	8	8	0	0	curcumin	MCH	PA151958596	5367	0.916
NULL	Indian_J_Endocrinol_Metab_2013_Jul-Aug_17(4)_636-646.nxml.txt.nlp	23961479	SENT159	20	20	24	24	rosuvastatin	CYP2C9	PA134308647	1559	0.916
NULL	Mol_Cancer_2009_Dec_23_8_129.nxml.txt.nlp	20030852	SENT172	33	33	5	5	curcumin	ABCA1	PA151958596	19	0.916
NULL	Am_J_Case_Rep_2012_Jun_5_13_96-98.nxml.txt.nlp	23569499	SENT96	11	11	23	23	rituximab	CHOP	PA451261	1649	0.916
NULL	J_Invest_Dermatol_2014_Jul_134(7)_1786-1788.nxml.txt.nlp	24924756	SENT82	0	0	9	9	aprepitant	CD5	PA164747039	921	0.916
NULL	FEBS_Open_Bio_2014_May_2_4_450-457.nxml.txt.nlp	24918060	SENT120	24	24	8	8	sulfasalazine	RAC3	PA451547	5881;8202	0.916
NULL	Front_Endocrinol_(Lausanne)_2013_Jan_2_3_174.nxml.txt.nlp	23293631	SENT175	17	17	6	6	creatine	UII	PA164778930	10911	0.916
NULL	Oncotarget_2013_Nov_22_5(4)_933-943.nxml.txt.nlp	24659749	SENT124	11	11	0	0	nutlin-3	AML2		864	0.916
NULL	Clin_Ophthalmol_2010_Oct_5_4_1137-1143.nxml.txt.nlp	20957061	SENT85	26	26	7	7	bimatoprost	BAK	PA164748867	578	0.916
NULL	Diabetes_2009_Dec_31_58(12)_2851-2862.nxml.txt.nlp	19720788	SENT223	27	27	8	8	forskolin	XIAP	PA146096022	331	0.916
NULL	Int_J_Mol_Sci_2014_Oct_23_15(10)_19265-19280.nxml.txt.nlp	25342321	SENT128	6	6	25	25	sc-560	MVD		4597	0.916
NULL	JRSM_Short_Rep_2013_Mar_27_4(4)_30.nxml.txt.nlp	23560230	SENT159	0	0	8	8	clopidogrel	ADP	PA449053	23038	0.916
NULL	Indian_J_Med_Res_2013_Dec_138(6)_969-976.nxml.txt.nlp	24521644	SENT155	45	45	30	30	ethanol	CK1	PA448073	1452	0.916
NULL	Br_J_Pharmacol_2008_Oct_18_155(4)_596-605.nxml.txt.nlp	18852694	SENT148	7	7	11	11	fenofibrate	SREBP2	PA449594	6721	0.916
NULL	Cell_J_2012_Dec_22_Winter_13(4)_281-289.nxml.txt.nlp	23507624	SENT20	15	15	28	28	propranolol	IL-4	PA451145	3565	0.916
NULL	Oncotarget_2014_Oct_16_5(20)_9546-9563.nxml.txt.nlp	25337673	SENT111	12	12	5	5	crizotinib	AXL	PA165946122	558	0.916
NULL	J_Cell_Mol_Med_2014_Apr_8_18(4)_698-708.nxml.txt.nlp	24400868	SENT304	22	22	17	17	resveratrol	ZEB1		6935	0.916
NULL	Breast_Cancer_Res_2012_Feb_14_14(1)_R30.nxml.txt.nlp	22333315	SENT165	23	23	3	3	celecoxib	CXCL9	PA448871	4283	0.916
NULL	Br_J_Cancer_2013_May_28_108(10)_2013-2020.nxml.txt.nlp	23632482	SENT154	27	27	4	4	trastuzumab	E2F4	PA451743	1874	0.916
NULL	Front_Oncol_2014_Jun_13_4_141.nxml.txt.nlp	24982846	SENT251	16	16	20	20	vemurafenib	BRAF	PA165946873	673	0.916
NULL	Curr_Hepat_Rep_2010_May_21_9(2)_75-90.nxml.txt.nlp	20461127	SENT369	25	25	6	6	entecavir	LAM	PA164784025	7249;7248	0.916
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Nov_27_66(Pt_12)_o3337.nxml.txt.nlp	21589611	SENT46	19	19	6	6	ethanol	mol	PA448073	90527	0.916
NULL	Mol_Biol_Cell_2012_Nov_1_23(21)_4212-4225.nxml.txt.nlp	22956765	SENT244	20	20	11	11	thrombin	SHP2	PA451674	5781	0.916
NULL	Pak_J_Med_Sci_2013_Nov-Dec_29(6)_1459-1461.nxml.txt.nlp	24550976	SENT7	3	3	22	22	heparin	ACT	PA449855	12;11332;9457;641455	0.916
NULL	Aging_(Albany_NY)_2011_Jan_18_3(1)_33-43.nxml.txt.nlp	21248371	SENT126	5	5	9	9	zinc	HIF-1	PA451956	29072	0.916
NULL	Arthritis_Res_Ther_2010_Apr_29_12(2)_R73.nxml.txt.nlp	20429888	SENT300	1	1	17	17	bortezomib	SP1	PA10252	6667	0.916
NULL	Acta_Diabetol_2011_Mar_21_48(1)_71-77.nxml.txt.nlp	20963449	SENT163	17	17	10	10	miglitol	PPG	PA164776726	5552	0.916
NULL	J_Int_Soc_Sports_Nutr_2009_Feb_19_6_6.nxml.txt.nlp	19228401	SENT165	13	13	20	20	creatine	CRT	PA164778930	811	0.916
NULL	Oncogene_2010_Jun_10_29(23)_3335-3348.nxml.txt.nlp	20383197	SENT14	16	16	9	9	cetuximab	HER2	PA10040	2064	0.916
NULL	Indian_Dermatol_Online_J_2013_Oct-Dec_4(4)_365-368.nxml.txt.nlp	24350028	SENT76	27	27	21	21	erythromycin	P-gp	PA449493	5243	0.916
NULL	Mol_Pain_2012_Sep_22_8_71.nxml.txt.nlp	22998838	SENT106	19	19	5	5	paclitaxel	CXCR4	PA450761	7852	0.916
NULL	F1000Prime_Rep_2014_Dec_1_6_117.nxml.txt.nlp	25580271	SENT66	33	33	22	22	cisplatin	EGFR	PA449014	1956	0.916
NULL	Br_J_Pharmacol_2013_Jun_27_169(4)_933-948.nxml.txt.nlp	23517055	SENT203	21	21	8	8	bepridil	NCX	PA164754755	3196	0.916
NULL	Cell_Biosci_2015_Jan_5_5(1)_1.nxml.txt.nlp	NULL	SENT36	21	21	12	12	ribavirin	IMPDH2	PA451241	3615	0.916
NULL	Acta_Pharmacol_Sin_2009_Oct_14_30(10)_1436-1442.nxml.txt.nlp	19749785	SENT153	7	7	3	3	cisplatin	YB-1	PA449014	4904	0.916
NULL	Oncoimmunology_2013_Sep_1_2(9)_e26198.nxml.txt.nlp	24228232	SENT49	18	18	38	38	cisplatin	CD86	PA449014	942	0.916
NULL	Int_J_Biol_Sci_2013_Mar_7_9(3)_279-288.nxml.txt.nlp	23493630	SENT114	40	40	26	26	tocilizumab	CD19	PA165292659	930	0.916
NULL	Eur_J_Neurosci_2010_Mar_31(6)_1019-1026.nxml.txt.nlp	20377616	SENT33	44	44	6	6	halothane	San	PA449845	80218	0.916
NULL	Indian_J_Dermatol_2010_Apr-Jun_55(2)_161-170.nxml.txt.nlp	20606887	SENT34	0	0	12	12	ustekinumab	IL-23	PA166048654	51561	0.916
NULL	Antiviral_Res_2009_May_82(2)_A99-A109.nxml.txt.nlp	19176219	SENT79	18	18	15	15	nevirapine	P-gp	PA450616	5243	0.916
NULL	Biomed_Res_Int_2014_Feb_6_2014_323594.nxml.txt.nlp	24689036	SENT148	25	25	46	46	raloxifene	CO2	PA451221	4513	0.916
NULL	EPMA_J_2010_Jun_29_1(2)_273-292.nxml.txt.nlp	23199065	SENT316	7	7	2	2	levodopa	SNCA	PA450213	6622	0.916
NULL	Oncol_Lett_2013_Mar_28_5(3)_935-942.nxml.txt.nlp	23426424	SENT13	31	31	6	6	oxaliplatin	ERCC1	PA131285527	2067	0.916
NULL	Hematol_Rep_2012_Sep_28_4(3)_e19.nxml.txt.nlp	23087808	SENT155	15	15	5	5	doxorubicin	STAT1	PA449412	6772	0.916
NULL	Exp_Diabetes_Res_2012_Mar_15_2012_146194.nxml.txt.nlp	22474415	SENT221	7	7	12	12	valsartan	GLP-1	PA451848	100125288	0.916
NULL	Breast_Cancer_Res_2001_Mar_26_3(3)_180-182.nxml.txt.nlp	11305952	SENT24	15	15	12	12	anastrozole	aromatase	PA448432	1588	0.916
NULL	Cancers_(Basel)_2010_Dec_22_2(4)_2153-2170.nxml.txt.nlp	21390244	SENT245	17	17	30	30	gefitinib	AREG	PA131301952	374	0.916
NULL	Br_J_Pharmacol_2011_May_163(2)_261-271.nxml.txt.nlp	21054345	SENT122	13	13	1	1	forskolin	GLP-1	PA146096022	100125288	0.916
NULL	Mol_Cancer_2012_Sep_28_11_74.nxml.txt.nlp	23021083	SENT210	16	16	33	33	gemcitabine	CEACAM6	PA449748	4680	0.916
NULL	Oncotarget_2013_Dec_28_5(6)_1475-1490.nxml.txt.nlp	24721996	SENT174	2	2	11	11	celecoxib	CD44	PA448871	960	0.916
NULL	Br_J_Cancer_2010_Jan_5_102(1)_151-161.nxml.txt.nlp	19935791	SENT149	7	7	19	19	cetuximab	BRAF	PA10040	673	0.916
NULL	Genet_Vaccines_Ther_2008_Feb_15_6_7.nxml.txt.nlp	18279512	SENT14	10	10	29	29	imiquimod	IL-4	PA449972	3565	0.916
NULL	Cancer_Manag_Res_2013_Nov_21_5_387-400.nxml.txt.nlp	24294007	SENT116	12	12	16	16	vemurafenib	BRAF	PA165946873	673	0.916
NULL	Oncotarget_2014_Sep_16_5(20)_9980-9991.nxml.txt.nlp	25296971	SENT143	31	31	8	8	oxaliplatin	c-Myc	PA131285527	4609	0.916
NULL	Clin_Med_Insights_Oncol_2012_Feb_28_6_125-135.nxml.txt.nlp	22408376	SENT101	18	18	3	3	panitumumab	KRAS	PA162373091	3845	0.916
NULL	Breast_Cancer_Res_Treat_2009_Jul_22_116(2)_371-378.nxml.txt.nlp	18941892	SENT3	22	22	6	6	letrozole	aromatase	PA450196	1588	0.916
NULL	Nucl_Recept_Signal_2009_Jan_16_7_e001.nxml.txt.nlp	19240808	SENT410	33	33	29	29	paclitaxel	SXR	PA450761	8856	0.916
NULL	Mol_Cancer_2010_Nov_2_9_289.nxml.txt.nlp	21044322	SENT290	25	25	9	9	cisplatin	RGS10	PA449014	6001	0.916
NULL	Cancer_Med_2013_Dec_31_2(6)_826-835.nxml.txt.nlp	24403256	SENT181	9	9	15	15	daunorubicin	HDM2	PA449212	4193	0.916
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT111	26	26	33	33	celecoxib	IL-6	PA448871	3569	0.916
NULL	J_Hematol_Oncol_2013_Nov_22_6_88.nxml.txt.nlp	24261963	SENT184	7	7	25	25	fulvestrant	aromatase	PA164747170	1588	0.916
NULL	Oncoimmunology_2012_May_1_1(3)_298-305.nxml.txt.nlp	22737605	SENT79	28	28	37	37	cyclophosphamide	TLR3	PA449165	7098	0.916
NULL	Cancers_(Basel)_2014_Oct_21_6(4)_2137-2154.nxml.txt.nlp	25337831	SENT58	9	9	4	4	gemcitabine	MRP5	PA449748	10057	0.916
NULL	Breast_Cancer_Res_2007_May_30_9(3)_R34.nxml.txt.nlp	17537232	SENT173	41	41	8	8	tamoxifen	TP53	PA451581	7157	0.916
NULL	J_Inflamm_(Lond)_2009_Apr_15_6_10.nxml.txt.nlp	19368720	SENT252	0	0	19	19	tocilizumab	IL-6	PA165292659	3569	0.916
NULL	J_Nutr_Metab_2011_Jul_28_2011_237932.nxml.txt.nlp	21822485	SENT19	0	0	3	3	exenatide	GLP-1	PA164749238	100125288	0.916
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Sep_30_67(Pt_10)_o2783-o2784.nxml.txt.nlp	22064768	SENT84	4	4	32	32	piperazine	mol	PA450977	90527	0.916
NULL	Cancer_Metastasis_Rev_2010_Dec_10_29(4)_581-594.nxml.txt.nlp	20830503	SENT278	30	30	11	11	tamoxifen	ARNO	PA451581	9266	0.916
NULL	Cancers_(Basel)_2010_Apr_20_2(2)_611-623.nxml.txt.nlp	24281084	SENT211	20	20	17	17	aprepitant	NK-1	PA164747039	27087	0.916
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT245	46	46	39	39	pertuzumab	HER3		2065	0.916
NULL	Front_Oncol_2014_Sep_23_4_252.nxml.txt.nlp	25295225	SENT290	18	18	11	11	trastuzumab	PI3K	PA451743	5290	0.916
NULL	Oncogene_2013_Sep_26_32(39)_10_1038_onc_2012_491.nxml.txt.nlp	23108394	SENT82	30	30	20	20	epirubicin	FOXM1	PA449476	2305	0.916
NULL	Indian_J_Palliat_Care_2013_Jan-Apr_19(1)_48-53.nxml.txt.nlp	23766595	SENT106	5	5	14	14	gefitinib	KRAS	PA131301952	3845	0.916
NULL	Orphanet_J_Rare_Dis_2014_Aug_18_9(1)_132.nxml.txt.nlp	NULL	SENT157	11	11	3	3	rituximab	CHS	PA451261	1130	0.916
NULL	Core_Evid_2010_Oct_21_5_77-90.nxml.txt.nlp	21042544	SENT177	22	22	6	6	astemizole	CYP3A4	PA448498	1576	0.916
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT84	26	26	10	10	tacrolimus	IL-6	PA451578	3569	0.916
NULL	Br_J_Pharmacol_2011_Aug_163(8)_1626-1638.nxml.txt.nlp	21410464	SENT46	13	13	37	37	rolipram	CA1	PA153906323	759	0.916
NULL	Ecancermedicalscience_2008_Feb_18_2_75.nxml.txt.nlp	22275966	SENT176	28	28	3	3	cetuximab	AREG	PA10040	374	0.916
NULL	Oncol_Lett_2013_Feb_7_5(2)_440-446.nxml.txt.nlp	23420122	SENT121	33	33	25	25	gemcitabine	Bcl-2	PA449748	596	0.916
NULL	Exp_Ther_Med_2014_Aug_10_8(2)_454-458.nxml.txt.nlp	25009600	SENT93	6	6	17	17	genistein	Bcl-2	PA165109660	596	0.916
NULL	J_Vis_Exp_2011_Mar_14_(49)_2668.nxml.txt.nlp	21445040	SENT52	26	26	18	18	heparin	CD4	PA449855	920	0.916
NULL	Nat_Neurosci_2012_Sep_5_15(9)_1245-1254.nxml.txt.nlp	22864611	SENT508	18	18	0	0	clozapine	HDAC2	PA449061	3066	0.916
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT88	36	36	6	6	efavirenz	CYP1A2	PA449441	1544	0.916
NULL	Breast_Cancer_Res_2010_Oct_22_12(Suppl_2)_S1.nxml.txt.nlp	21050422	SENT133	4	4	24	24	lapatinib	EGFR	PA152241907	1956	0.916
NULL	Mol_Cancer_2010_Mar_9_9_54.nxml.txt.nlp	20214788	SENT178	4	4	26	26	doxycycline	JDP2	PA449415	122953	0.916
NULL	Biomed_Res_Int_2014_Jan_23_2014_312647.nxml.txt.nlp	24587984	SENT174	0	0	20	20	infliximab	ABCA1	PA452639	19	0.916
NULL	J_Hematol_Oncol_2013_Jun_3_6_38.nxml.txt.nlp	23731980	SENT79	24	24	6	6	lapatinib	HER2	PA152241907	2064	0.916
NULL	Breast_Cancer_Res_2010_Jul_20_12(4)_R52.nxml.txt.nlp	20646288	SENT4	23	23	20	20	letrozole	aromatase	PA450196	1588	0.916
NULL	Clin_Epigenetics_2011_Jul_9_2(2)_197-212.nxml.txt.nlp	22704337	SENT17	10	10	28	28	imatinib	MPN	PA10804	83886	0.916
NULL	Am_J_Trop_Med_Hyg_2009_Jan_80(1)_126-132.nxml.txt.nlp	19141850	SENT52	0	0	7	7	artesunate	API	PA165111697	5345	0.916
NULL	Breast_Cancer_Res_2009_Jun_23_11(Suppl_1)_P28.nxml.txt.nlp	NULL	SENT12	27	27	10	10	paclitaxel	VEGFR	PA450761	3791	0.916
NULL	Mol_Biol_Cell_2012_Nov_1_23(21)_4212-4225.nxml.txt.nlp	22956765	SENT133	21	21	13	13	thrombin	cadherin	PA451674	1015	0.916
NULL	Br_J_Cancer_2009_Jul_21_101(2)_238-243.nxml.txt.nlp	19568242	SENT123	24	24	32	32	sunitinib	IFN	PA162372840	3439	0.916
NULL	Cancers_(Basel)_2010_Jul_14_2(3)_1492-1512.nxml.txt.nlp	24281169	SENT14	21	21	27	27	gemcitabine	EGFR	PA449748	1956	0.916
NULL	Neural_Regen_Res_2013_May_5_8(13)_1180-1189.nxml.txt.nlp	25206412	SENT19	3	3	22	22	fasudil	RhoA	PA165946121	387	0.916
NULL	Diabetes_Care_2011_Aug_16_34(8)_1854-1859.nxml.txt.nlp	21715518	SENT73	14	14	21	21	estradiol	San	PA449503	80218	0.916
NULL	J_Vet_Med_Sci_2014_Feb_8_76(2)_173-182.nxml.txt.nlp	24107430	SENT59	33	33	21	21	heparin	AVP	PA449855	114548;551	0.916
NULL	Mol_Biol_Cell_2013_Dec_15_24(24)_3939-3944.nxml.txt.nlp	24152728	SENT49	31	31	0	0	tamoxifen	CCN2	PA451581	1490	0.916
NULL	Acta_Pharmacol_Sin_2010_Feb_5_31(2)_184-190.nxml.txt.nlp	20139901	SENT112	26	26	5	5	metformin	SLC22A2	PA450395	6582	0.916
NULL	J_Biol_Chem_2009_Jan_9_284(2)_784-791.nxml.txt.nlp	19008230	SENT193	11	11	23	23	forskolin	CO2	PA146096022	4513	0.916
NULL	Adv_Hematol_2010_Dec_30_2010_627401.nxml.txt.nlp	21234094	SENT107	10	10	6	6	doxorubicin	CHOP	PA449412	1649	0.916
NULL	Vet_Res_2012_Dec_4_43(1)_81.nxml.txt.nlp	23210796	SENT175	17	17	33	33	cisplatin	p53	PA449014	7157	0.916
NULL	Iran_J_Basic_Med_Sci_2011_Nov-Dec_14(6)_485-498.nxml.txt.nlp	23493821	SENT121	18	18	8	8	nifedipine	CYP3A	PA450631	1574	0.916
NULL	Arthritis_Res_Ther_2008_Jan_7_10(1)_R1.nxml.txt.nlp	18179697	SENT189	31	31	7	7	oxaliplatin	IFN	PA131285527	3439	0.916
NULL	Cell_Death_Dis_2010_Feb_4_1(2)_e23.nxml.txt.nlp	21364631	SENT29	35	35	7	7	curcumin	AP-1	PA151958596	2353;3727;2354;3725	0.916
NULL	Br_J_Cancer_2010_Mar_16_102(6)_987-994.nxml.txt.nlp	20216541	SENT186	22	22	3	3	capecitabine	GSTP1	PA448771	2950	0.916
NULL	Br_J_Cancer_2013_Jul_9_109(1)_68-75.nxml.txt.nlp	23807173	SENT111	23	23	11	11	cisplatin	XPA	PA449014	7507	0.916
NULL	Br_J_Cancer_2010_Oct_12_103(8)_1284-1291.nxml.txt.nlp	20859285	SENT134	10	10	2	2	tamoxifen	ERBB2	PA451581	2064	0.916
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jul_2_67(Pt_8)_o1888-o1889.nxml.txt.nlp	22090940	SENT60	30	30	21	21	l-serine	C10	PA451330	113246	0.916
NULL	Oncotarget_2013_Nov_23_5(1)_196-210.nxml.txt.nlp	24344116	SENT69	18	18	33	33	doxorubicin	TNFAIP3	PA449412	7128	0.916
NULL	Oncotarget_2013_Jul_15_4(8)_1241-1252.nxml.txt.nlp	23872733	SENT137	12	12	29	29	etoposide	TRAIL	PA449552	8743	0.916
NULL	Exp_Neurol_2012_Jun_235(2)_528-538.nxml.txt.nlp	22417924	SENT380	18	18	24	24	pioglitazone	gamma	PA450970	9913	0.916
NULL	Breast_Cancer_Res_2001_Dec_22_3(2)_118-121.nxml.txt.nlp	11250758	SENT33	6	6	13	13	tamoxifen	SMRT	PA451581	9612	0.916
NULL	Acta_Pharmacol_Sin_2012_May_16_33(5)_682-690.nxml.txt.nlp	22504904	SENT164	14	14	5	5	celecoxib	STAT3	PA448871	6774	0.916
NULL	Mol_Cancer_2010_Apr_29_9_95.nxml.txt.nlp	20429933	SENT64	16	16	9	9	cisplatin	p53	PA449014	7157	0.916
NULL	Clin_Dev_Immunol_2013_Nov_26_2013_325481.nxml.txt.nlp	24371447	SENT89	8	8	20	20	propofol	IL-6	PA451141	3569	0.916
NULL	J_Korean_Med_Sci_2007_Apr_30_22(2)_209-212.nxml.txt.nlp	17449925	SENT46	38	38	22	22	pamidronate	PTH	PA450767	5741	0.916
NULL	Oncoscience_2014_Jan_30_1(1)_57-68.nxml.txt.nlp	25593988	SENT292	7	7	14	14	imatinib	CD34	PA10804	947	0.916
NULL	Br_J_Cancer_2013_Jul_23_109(2)_502-511.nxml.txt.nlp	23799850	SENT45	22	22	15	15	gemcitabine	PSN1	PA449748	51251	0.916
NULL	Diabetes_2013_Oct_17_62(10)_3500-3513.nxml.txt.nlp	23884882	SENT271	4	4	14	14	resveratrol	NKX6-1		4825	0.916
NULL	Br_J_Pharmacol_2012_Jan_165(2)_380-389.nxml.txt.nlp	21585347	SENT117	35	35	24	24	rosiglitazone	ATGL	PA451283	57104	0.916
NULL	Cardiovasc_Diabetol_2011_Dec_1_10_109.nxml.txt.nlp	22132774	SENT29	0	0	6	6	liraglutide	GLP-1	PA165958364	100125288	0.916
NULL	J_Mol_Signal_2008_Dec_1_3_18.nxml.txt.nlp	19046439	SENT167	17	17	9	9	metformin	AMPK	PA450395	5563	0.916
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT13	3	3	38	38	pemetrexed	UNG	PA10810	7374	0.916
NULL	J_Gen_Physiol_2013_Aug_142(2)_137-155.nxml.txt.nlp	23858003	SENT443	3	3	8	8	forskolin	TREK-1	PA146096022	3776	0.916
NULL	Cancer_Cell_Int_2013_Jun_26_13_63.nxml.txt.nlp	23800022	SENT120	19	19	0	0	genistein	XIAP	PA165109660	331	0.916
NULL	Exp_Mol_Med_2012_Oct_31_44(10)_622-632.nxml.txt.nlp	23095254	SENT113	28	28	2	2	glucose	STAMP2	PA449773	79689	0.916
NULL	Clin_Ophthalmol_2014_Jun_26_8_1213-1219.nxml.txt.nlp	25061267	SENT96	14	14	1	1	tetracaine	PRK	PA451638	1263	0.916
NULL	Exp_Cell_Res_2009_Nov_15_315(19)_3433-3441.nxml.txt.nlp	19716819	SENT188	23	23	33	33	hyaluronidase	CD44	PA164745713	960	0.916
NULL	Mol_Cancer_2009_Mar_5_8_14.nxml.txt.nlp	19265551	SENT61	9	9	30	30	camptothecin	p53	PA153590860	7157	0.916
NULL	Cardiovasc_Drugs_Ther_2011_Jun_12_25(3)_223-232.nxml.txt.nlp	21562974	SENT103	12	12	25	25	milrinone	AKT	PA164749171	207	0.916
NULL	Europace_2014_Oct_12_16(10)_1443-1449.nxml.txt.nlp	25115168	SENT68	13	13	6	6	heparin	ACT	PA449855	12;11332;9457;641455	0.916
NULL	Ther_Clin_Risk_Manag_2007_Jun_3(3)_363-379.nxml.txt.nlp	18488081	SENT361	23	23	16	16	rabeprazole	MDR1	PA451216	5243	0.916
NULL	Nat_Commun_2014_Aug_4_5_4535.nxml.txt.nlp	25088745	SENT29	21	21	2	2	metformin	AMPK	PA450395	5563	0.916
NULL	Mol_Vis_2011_Dec_2_17_3137-3146.nxml.txt.nlp	22171160	SENT38	0	0	10	10	capsaicin	TAK1	PA448776	7182	0.916
NULL	Breast_Cancer_Res_2014_May_23_16(3)_R50.nxml.txt.nlp	24887458	SENT26	1	1	18	18	trastuzumab	HER2	PA451743	2064	0.916
NULL	Cardiovasc_Diabetol_2006_Dec_4_5_26.nxml.txt.nlp	17144912	SENT68	34	34	17	17	dobutamine	ANOVA	PA449381	4858	0.916
NULL	Breast_Cancer_(Auckl)_2011_Oct_9_5_209-226.nxml.txt.nlp	22084574	SENT30	0	0	7	7	exemestane	CYP4A11	PA449563	1579	0.916
NULL	Br_J_Cancer_2010_Jun_29_103(1)_1-5.nxml.txt.nlp	20461086	SENT129	4	4	12	12	oxygen	HIF-1	PA450744	29072	0.916
NULL	Mol_Cells_2014_Mar_31_37(3)_234-240.nxml.txt.nlp	24642709	SENT104	4	4	10	10	cisplatin	HMGB1	PA449014	3146	0.916
NULL	Nat_Med_2010_Jun_23_16(6)_671-677.nxml.txt.nlp	20495567	SENT223	15	15	25	25	sorafenib	JNK	PA7000	5599	0.916
NULL	BMJ_Open_2014_Oct_31_4(10)_e005781.nxml.txt.nlp	25361837	SENT207	26	26	12	12	clopidogrel	ADP	PA449053	23038	0.916
NULL	J_Thromb_Haemost_2010_Mar_8(3)_577-587.nxml.txt.nlp	20040043	SENT189	15	15	3	3	rosiglitazone	mol	PA451283	90527	0.916
NULL	Breast_Cancer_Res_2012_Jun_7_14(3)_R89.nxml.txt.nlp	22676470	SENT18	35	35	0	0	lapatinib	HER2	PA152241907	2064	0.916
NULL	J_Anaesthesiol_Clin_Pharmacol_2011_Oct-Dec_27(4)_447-458.nxml.txt.nlp	22096275	SENT188	8	8	21	21	pentobarbital	CO2	PA450859	4513	0.916
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jul_8_65(Pt_8)_o1791.nxml.txt.nlp	21583497	SENT56	17	17	5	5	ethanol	mol	PA448073	90527	0.916
NULL	Cell_Commun_Signal_2009_Aug_13_7_19.nxml.txt.nlp	19678929	SENT47	5	5	20	20	cetuximab	KRAS	PA10040	3845	0.916
NULL	Indian_J_Pharmacol_2014_Sep-Oct_46(5)_547-548.nxml.txt.nlp	25298587	SENT62	9	9	17	17	ranolazine	CYP3A	PA164746007	1574	0.916
NULL	Mediators_Inflamm_1995_Jul_4(4)_263-269.nxml.txt.nlp	18475649	SENT13	10	10	3	3	heparin	IL-8	PA449855	3576	0.916
NULL	J_Hepatol_2013_Jan_58(1)_155-168.nxml.txt.nlp	22885388	SENT113	6	6	24	24	budesonide	AE2	PA448681	84224	0.916
NULL	Eur_J_Med_Res_2009_Nov_24_14(Suppl_3)_17-21.nxml.txt.nlp	19959412	SENT99	24	24	20	20	phenytoin	UGT	PA450947	7361;7355	0.916
NULL	Breast_Cancer_Res_2004_Oct_21_6(1)_13-21.nxml.txt.nlp	14680481	SENT106	20	20	17	17	lovastatin	p27	PA450272	5715;10534	0.916
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT88	36	36	16	16	efavirenz	CYP2C9	PA449441	1559	0.916
NULL	Diabetes_Metab_Syndr_Obes_2010_May_17_3_155-163.nxml.txt.nlp	21437085	SENT52	1	1	18	18	exenatide	GLP-1	PA164749238	100125288	0.916
NULL	Cancers_(Basel)_2014_Jul_8_6(3)_1487-1499.nxml.txt.nlp	25006835	SENT81	22	22	19	19	cisplatin	JNK	PA449014	5599	0.916
NULL	Scientifica_(Cairo)_2012_Sep_3_2012_757890.nxml.txt.nlp	24278738	SENT145	12	12	22	22	curcumin	IL-10	PA151958596	3586	0.916
NULL	Indian_J_Endocrinol_Metab_2013_Jul-Aug_17(4)_636-646.nxml.txt.nlp	23961479	SENT146	8	8	4	4	phenobarbital	CYP2C9	PA450911	1559	0.916
NULL	Br_J_Cancer_2012_Sep_4_107(6)_947-955.nxml.txt.nlp	22892392	SENT89	15	15	3	3	lapatinib	BCAR4	PA152241907	400500	0.916
NULL	Nat_Commun_2013_4_2910.nxml.txt.nlp	24335996	SENT70	24	24	35	35	fasudil	GRAF3	PA165946121	143872	0.916
NULL	Oncogene_2010_Sep_9_29(36)_5048-5060.nxml.txt.nlp	20639907	SENT253	18	18	13	13	cisplatin	TRAIL	PA449014	8743	0.916
NULL	Cancers_(Basel)_2010_Oct_25_2(4)_1794-1812.nxml.txt.nlp	24281201	SENT237	22	22	0	0	gemcitabine	MUC4	PA449748	4585	0.916
NULL	J_Gen_Physiol_2013_Aug_142(2)_137-155.nxml.txt.nlp	23858003	SENT259	7	7	21	21	forskolin	TREK-1	PA146096022	3776	0.916
NULL	N_Am_J_Med_Sci_2013_Jul_5(7)_432-437.nxml.txt.nlp	24020054	SENT63	24	24	20	20	doxorubicin	CHOP	PA449412	1649	0.916
NULL	Brain_2013_May_4_136(5)_1462-1475.nxml.txt.nlp	23460667	SENT273	41	41	12	12	bevacizumab	CD31	PA130232992	5175	0.916
NULL	Oncotarget_2013_Nov_15_5(6)_1458-1474.nxml.txt.nlp	24681547	SENT126	6	6	17	17	celecoxib	CDH11	PA448871	1009	0.916
NULL	Mol_Cancer_2007_Oct_22_6_66.nxml.txt.nlp	17953743	SENT158	12	12	0	0	cisplatin	NAC	PA449014	22861	0.916
NULL	Exp_Ther_Med_2013_Nov_13_6(5)_1317-1321.nxml.txt.nlp	24223665	SENT71	4	4	10	10	cisplatin	CD133	PA449014	8842	0.916
NULL	Epilepsia_2014_Jun_6_55(6)_806-818.nxml.txt.nlp	24802699	SENT152	6	6	13	13	bumetanide	NKCC1	PA448682	6558	0.916
NULL	Breast_Cancer_Res_2012_Jul_19_14(4)_210.nxml.txt.nlp	22809143	SENT92	8	8	24	24	estradiol	ADAM17	PA449503	6868	0.916
NULL	J_Hum_Genet_2013_Jun_2_58(6)_306-312.nxml.txt.nlp	23635953	SENT188	17	17	2	2	tamoxifen	CYP2D6	PA451581	1565	0.916
NULL	Cells_2014_May_23_3(2)_517-545.nxml.txt.nlp	24861977	SENT245	16	16	9	9	capsaicin	TRPV1	PA448776	7442	0.916
NULL	J_Exp_Clin_Cancer_Res_2009_Jul_3_28(1)_97.nxml.txt.nlp	19575783	SENT137	14	14	0	0	cisplatin	HER2	PA449014	2064	0.916
NULL	Nat_Commun_2013_Apr_9_4_1684.nxml.txt.nlp	23575688	SENT96	2	2	27	27	rolipram	PDE4B	PA153906323	5142	0.916
NULL	J_Hematol_Oncol_2013_Jul_18_6_53.nxml.txt.nlp	23866964	SENT137	29	29	16	16	temsirolimus	HDAC1	PA164746890	3065	0.916
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Aug_27_67(Pt_9)_o2492.nxml.txt.nlp	22059042	SENT56	23	23	6	6	ethanol	mol	PA448073	90527	0.916
NULL	Oncotarget_2012_Sep_28_3(10)_1169-1181.nxml.txt.nlp	23045411	SENT99	7	7	10	10	doxorubicin	JIP1	PA449412	9479	0.916
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Dec_3_65(Pt_1)_o7.nxml.txt.nlp	21581708	SENT50	0	0	24	24	phenol	mol	PA450913	90527	0.916
NULL	Anal_Chem_2014_Feb_4_86(3)_1845-1852.nxml.txt.nlp	24383576	SENT141	24	24	0	0	taurine	HCN	PA451590	378938	0.916
NULL	Cancer_Manag_Res_2014_Jan_28_6_39-51.nxml.txt.nlp	24501545	SENT134	37	37	26	26	theophylline	CYP2D6	PA451647	1565	0.916
NULL	Int_J_Breast_Cancer_2013_Jun_24_2013_137414.nxml.txt.nlp	23864953	SENT89	14	14	26	26	tamoxifen	HER2	PA451581	2064	0.916
NULL	Chemother_Res_Pract_2011_Sep_25_2011_730360.nxml.txt.nlp	22295205	SENT5	3	3	14	14	trastuzumab	HER2	PA451743	2064	0.916
NULL	Orphanet_J_Rare_Dis_2010_Jun_16_5_18.nxml.txt.nlp	20550723	SENT64	8	8	20	20	rituximab	CD55	PA451261	1604	0.916
NULL	Int_J_Nanomedicine_2012_Sep_13_7_4917-4926.nxml.txt.nlp	23028220	SENT231	2	2	17	17	calcein	mol	PA132595336	90527	0.916
NULL	Cancer_Cell_Int_2013_Jan_15_13_3.nxml.txt.nlp	23320839	SENT101	20	20	13	13	doxorubicin	MRP1	PA449412	4437	0.916
NULL	Br_J_Cancer_2002_Jan_21_86(2)_218-221.nxml.txt.nlp	11870509	SENT30	30	30	13	13	tamoxifen	BRCA2	PA451581	675	0.916
NULL	Comput_Math_Methods_Med_2012_Dec_19_2012_473572.nxml.txt.nlp	23365616	SENT108	15	15	6	6	letrozole	aromatase	PA450196	1588	0.916
NULL	Curr_Neuropharmacol_2014_Jul_12(4)_365-379.nxml.txt.nlp	25342944	SENT61	22	22	12	12	paroxetine	5-HT1A	PA450801	3350	0.916
NULL	Eur_J_Clin_Pharmacol_2013_Mar_11_69(3)_327-339.nxml.txt.nlp	22782539	SENT271	17	17	4	4	clarithromycin	P-gp	PA449028	5243	0.916
NULL	J_Gen_Physiol_2009_Oct_134(4)_323-337.nxml.txt.nlp	19786585	SENT13	2	2	13	13	dantrolene	ClC-1	PA449208	1180	0.916
NULL	Curr_Hepat_Rep_2010_May_21_9(2)_75-90.nxml.txt.nlp	20461127	SENT302	19	19	5	5	tenofovir	LAM	PA10204	7249;7248	0.916
NULL	Cell_Cycle_2013_Dec_15_12(24)_3759-3769.nxml.txt.nlp	24107633	SENT187	4	4	44	44	metformin	EGFR	PA450395	1956	0.916
NULL	Surg_Today_2012_Jan_6_42(1)_8-28.nxml.txt.nlp	22139128	SENT239	6	6	23	23	cyclophosphamide	PSK	PA449165	9344	0.916
NULL	Oncotarget_2013_Jan_14_4(1)_118-127.nxml.txt.nlp	23435217	SENT160	15	15	41	41	bevacizumab	EGFR	PA130232992	1956	0.916
NULL	Oncotarget_2011_Sep_9_2(9)_658-668.nxml.txt.nlp	21911919	SENT88	23	23	10	10	daunorubicin	HO-1	PA449212	3162	0.916
NULL	Cases_J_2009_Jun_9_2_7455.nxml.txt.nlp	19829966	SENT91	0	0	9	9	palivizumab	AAP	PA164748781	5345	0.916
NULL	J_Med_Case_Rep_2013_Jun_20_7_161.nxml.txt.nlp	23786681	SENT88	13	13	3	3	mitomycin	pT1	PA450524	58492	0.916
NULL	Oncoimmunology_2012_Oct_1_1(7)_1004-1016.nxml.txt.nlp	23170249	SENT52	11	11	3	3	paclitaxel	HER-2	PA450761	2064	0.916
NULL	J_Ayurveda_Integr_Med_2010_Oct-Dec_1(4)_273-279.nxml.txt.nlp	21731374	SENT28	11	11	21	21	estradiol	aromatase	PA449503	1588	0.916
NULL	J_Adv_Pract_Oncol_2013_Jan_1_Jan-Feb_4(1)_25-35.nxml.txt.nlp	25031978	SENT28	0	0	12	12	denosumab	RANKL	PA166048634	8600	0.916
NULL	Infect_Drug_Resist_2010_Mar_11_3_45-51.nxml.txt.nlp	21694893	SENT112	9	9	23	23	posaconazole	CYP1A2	PA151958574	1544	0.916
NULL	F1000Res_2013_Jul_31_2_120.nxml.txt.nlp	24627782	SENT292	5	5	9	9	vemurafenib	BRAF	PA165946873	673	0.916
NULL	Pain_2009_Jul_144(1-2)_110-118.nxml.txt.nlp	19410369	SENT487	9	9	5	5	capsaicin	TRPV1	PA448776	7442	0.916
NULL	Br_J_Cancer_2011_Jul_26_105(3)_372-381.nxml.txt.nlp	21730979	SENT114	4	4	28	28	temozolomide	p53	PA451609	7157	0.916
NULL	Oncotarget_2013_Nov_4_5(1)_161-172.nxml.txt.nlp	24389287	SENT30	0	0	13	13	propranolol	p53	PA451145	7157	0.916
NULL	Acta_Pharmacol_Sin_2012_Aug_23_33(8)_1095-1100.nxml.txt.nlp	22820908	SENT108	34	34	14	14	omeprazole	CYP3A	PA450704	1574	0.916
NULL	J_Mol_Med_(Berl)_2014_Jan_10_92(5)_497-507.nxml.txt.nlp	24408111	SENT14	0	0	2	2	pioglitazone	HIF-1	PA450970	29072	0.916
NULL	Pharmaceutics_2010_Jun_2_2(2)_258-274.nxml.txt.nlp	NULL	SENT25	4	4	11	11	risperidone	P-gp	PA451257	5243	0.916
NULL	Case_Rep_Med_2009_Aug_9_2009_378287.nxml.txt.nlp	19721707	SENT16	3	3	27	27	simvastatin	CYP2C8	PA451363	1558	0.916
NULL	Mol_Cancer_2012_Sep_19_11_70.nxml.txt.nlp	22992329	SENT22	0	0	6	6	bevacizumab	VEGF-A	PA130232992	7422	0.916
NULL	Int_J_Mol_Sci_2012_Aug_21_13(8)_10461-10477.nxml.txt.nlp	22949874	SENT122	32	32	22	22	paclitaxel	aromatase	PA450761	1588	0.916
NULL	FEBS_Open_Bio_2011_Dec_27_2_1-5.nxml.txt.nlp	23650573	SENT10	11	11	4	4	sunitinib	MDM2	PA162372840	4193	0.916
NULL	Evid_Based_Complement_Alternat_Med_2011_Feb_14_2011_429843.nxml.txt.nlp	21869897	SENT54	9	9	25	25	ethanol	PC6	PA448073	5125	0.916
NULL	Evid_Based_Complement_Alternat_Med_2012_Dec_17_2012_485262.nxml.txt.nlp	23304202	SENT188	32	32	26	26	thrombin	ADP	PA451674	23038	0.916
NULL	Front_Physiol_2013_Dec_24_4_386.nxml.txt.nlp	24399968	SENT195	9	9	23	23	glibenclamide	SUR2	PA449782	10060	0.916
NULL	Breast_Cancer_Res_2010_Jun_28_12(3)_R43.nxml.txt.nlp	20579400	SENT269	18	18	15	15	fulvestrant	aromatase	PA164747170	1588	0.916
NULL	Indian_J_Ophthalmol_2011_Sep-Oct_59(5)_403a.nxml.txt.nlp	21836356	SENT18	5	5	14	14	nifedipine	CYP3A	PA450631	1574	0.916
NULL	Indian_J_Med_Paediatr_Oncol_2014_Apr-Jun_35(2)_176-180.nxml.txt.nlp	25197183	SENT13	6	6	2	2	tamoxifen	aromatase	PA451581	1588	0.916
NULL	Cancers_(Basel)_2010_Jun_4_2(2)_1125-1154.nxml.txt.nlp	24281110	SENT185	19	19	0	0	trypsin	SPINK1	PA451806	6690	0.916
NULL	J_Clin_Biochem_Nutr_2010_Jan_29_46(1)_87-92.nxml.txt.nlp	20104270	SENT101	22	22	11	11	hesperidin	STZ	PA449867	6484	0.916
NULL	Proteome_Sci_2010_Apr_13_8_22.nxml.txt.nlp	20388209	SENT8	25	25	5	5	trypsin	PARG	PA451806	8505	0.916
NULL	Mediators_Inflamm_1996_Oct_5(5)_346-357.nxml.txt.nlp	18475729	SENT8	24	24	15	15	dextran	IL-8	PA449261	3576	0.916
NULL	Cancers_(Basel)_2010_Jan_14_2(1)_1-19.nxml.txt.nlp	24281029	SENT858	0	0	19	19	lapatinib	HER2	PA152241907	2064	0.916
NULL	Oncotarget_2014_Nov_2_5(21)_10222-10236.nxml.txt.nlp	25400118	SENT65	13	13	10	10	gefitinib	EGFR	PA131301952	1956	0.916
NULL	J_Lipid_Res_2014_Oct_55(10)_2103-2112.nxml.txt.nlp	25139399	SENT36	13	13	33	33	atorvastatin	PCSK9	PA448500	255738	0.916
NULL	Eur_J_Clin_Pharmacol_2013_Feb_12_69(2)_209-215.nxml.txt.nlp	22688722	SENT162	2	2	22	22	duloxetine	LIM	PA10066	10611	0.916
NULL	Int_J_Med_Sci_2012_Nov_7_9(10)_881-893.nxml.txt.nlp	23155362	SENT28	16	16	13	13	letrozole	aromatase	PA450196	1588	0.916
NULL	Ann_Rheum_Dis_2008_Dec_3_68(7)_1105-1112.nxml.txt.nlp	19054823	SENT86	14	14	23	23	doxycycline	ACR	PA449415	49	0.916
NULL	Cardiovasc_Diabetol_2005_Oct_5_4_16.nxml.txt.nlp	16207378	SENT220	6	6	16	16	glucosamine	perlecan	PA164747613	3339	0.916
NULL	Adv_Appl_Bioinforma_Chem_2008_Oct_30_1_85-98.nxml.txt.nlp	21918608	SENT78	24	24	6	6	bortezomib	SPARC	PA10252	6678	0.916
NULL	Breast_Cancer_Res_2012_Nov_16_14(6)_R148.nxml.txt.nlp	23158001	SENT286	19	19	27	27	tamoxifen	EGFR	PA451581	1956	0.916
NULL	Contemp_Oncol_(Pozn)_2012_Nov_20_16(5)_401-406.nxml.txt.nlp	23788917	SENT96	33	33	29	29	afatinib	EGFR	PA165981154	1956	0.916
NULL	Hum_Genomics_2009_Jan_1_3(2)_128-142.nxml.txt.nlp	19164090	SENT186	17	17	29	29	carboplatin	CD44	PA448803	960	0.916
NULL	Evid_Based_Complement_Alternat_Med_2014_Sep_3_2014_809083.nxml.txt.nlp	25276218	SENT136	2	2	13	13	berberine	IL-6	PA165860812	3569	0.916
NULL	Basic_Res_Cardiol_2015_Jan_20_110_4.nxml.txt.nlp	25600226	SENT411	9	9	5	5	ezetimibe	PCSK9	PA10816	255738	0.916
NULL	Nat_Genet_2011_Feb_26_43(2)_117-120.nxml.txt.nlp	21186350	SENT91	25	25	41	41	metformin	AMPK	PA450395	5563	0.916
NULL	Onco_Targets_Ther_2014_Sep_9_7_1571-1582.nxml.txt.nlp	25228815	SENT164	2	2	20	20	pazopanib	VEGFR2	PA165291492	3791	0.916
NULL	Cell_Commun_Signal_2011_May_15_9_13.nxml.txt.nlp	21569639	SENT293	5	5	10	10	quinacrine	p53	PA164745551	7157	0.916
NULL	Acta_Pharmacol_Sin_2011_Jul_9_32(7)_879-887.nxml.txt.nlp	21552292	SENT14	3	3	23	23	metformin	AMPK	PA450395	5563	0.916
NULL	Br_J_Cancer_2013_Feb_5_108(2)_461-468.nxml.txt.nlp	23149842	SENT155	20	20	22	22	cisplatin	PARP1	PA449014	142	0.916
NULL	Blood_Cancer_J_2012_Oct_12_2(10)_e93.nxml.txt.nlp	23064741	SENT37	15	15	11	11	doxorubicin	CHOP	PA449412	1649	0.916
NULL	Int_J_Breast_Cancer_2013_Jun_24_2013_137414.nxml.txt.nlp	23864953	SENT89	14	14	37	37	tamoxifen	HER2	PA451581	2064	0.916
NULL	J_Immigr_Minor_Health_2012_Apr_26_14(2)_281-286.nxml.txt.nlp	21442300	SENT106	24	24	3	3	methamphetamine	San	PA450403	80218	0.916
NULL	Biomed_Res_Int_2013_Aug_7_2013_546318.nxml.txt.nlp	23986907	SENT98	0	0	18	18	gefitinib	AKT	PA131301952	207	0.916
NULL	J_Signal_Transduct_2011_Jun_7_2011_982879.nxml.txt.nlp	21776391	SENT152	11	11	7	7	cetuximab	HIF1	PA10040	3091	0.916
NULL	Int_J_Surg_Oncol_2010_Oct_28_2010_251621.nxml.txt.nlp	22312487	SENT117	13	13	9	9	trastuzumab	aromatase	PA451743	1588	0.916
NULL	Genet_Sel_Evol_2014_Mar_4_46(1)_19.nxml.txt.nlp	24592996	SENT165	29	29	6	6	taurine	PCDHB4	PA451590	56131	0.916
NULL	Psychiatry_Investig_2012_Jun_30_9(2)_187-190.nxml.txt.nlp	22707971	SENT68	18	18	5	5	capsaicin	POMC	PA448776	5443	0.916
NULL	Diabetes_Obes_Metab_2012_Apr_14(4)_304-314.nxml.txt.nlp	22051096	SENT160	23	23	3	3	exenatide	GLP-1	PA164749238	100125288	0.916
NULL	Mol_Cancer_2014_Jul_5_13_165.nxml.txt.nlp	24996221	SENT18	14	14	2	2	docetaxel	HMGB1	PA449383	3146	0.916
NULL	Oncol_Rep_2014_Sep_20_32(3)_875-886.nxml.txt.nlp	24969320	SENT85	16	16	30	30	bevacizumab	VEGF-A	PA130232992	7422	0.916
NULL	Aging_(Albany_NY)_2010_Dec_30_2(12)_897-899.nxml.txt.nlp	21212463	SENT55	0	0	23	23	metformin	AMPK	PA450395	5563	0.916
NULL	Cancers_(Basel)_2011_Oct_11_3(4)_3824-3837.nxml.txt.nlp	24213113	SENT111	32	32	0	0	l-glutamine	PC3	PA10090	57332;7832;5122	0.916
NULL	Blood_Cancer_J_2014_Aug_8_4(8)_e237.nxml.txt.nlp	25105536	SENT11	25	25	7	7	sorafenib	CYP3A4	PA7000	1576	0.916
NULL	Int_J_Biol_Sci_2013_Nov_21_9(10)_1089-1098.nxml.txt.nlp	24339730	SENT177	32	32	7	7	genistein	BMP2	PA165109660	650	0.916
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT271	27	27	15	15	tacrolimus	SOCS3	PA451578	9021	0.916
NULL	Onco_Targets_Ther_2014_Jul_31_7_1367-1373.nxml.txt.nlp	25114575	SENT39	7	7	24	24	lapatinib	survivin	PA152241907	332	0.916
NULL	Br_J_Cancer_2010_Jan_5_102(1)_97-103.nxml.txt.nlp	19904270	SENT15	10	10	5	5	vinorelbine	XIAP	PA451881	331	0.916
NULL	Curr_Genomics_2013_Nov_14(7)_453-467.nxml.txt.nlp	24396277	SENT155	11	11	19	19	iron	haemojuvelin	PA450087	148738	0.916
NULL	Br_J_Cancer_2012_Feb_28_106(5)_846-853.nxml.txt.nlp	22333601	SENT21	17	17	1	1	hyaluronan	CD44	PA165958431	960	0.916
NULL	Nat_Chem_Biol_2009_Jan_23_5(1)_37-44.nxml.txt.nlp	19029917	SENT68	18	18	7	7	lipase	CB2	PA450239	1269	0.916
NULL	Mol_Cancer_2007_Oct_11_6_63.nxml.txt.nlp	17931419	SENT82	32	32	42	42	cetuximab	EGFR	PA10040	1956	0.916
NULL	Oncotarget_2013_Jul_21_4(8)_1253-1265.nxml.txt.nlp	23896512	SENT23	28	28	3	3	gefitinib	EGFR	PA131301952	1956	0.916
NULL	Neural_Regen_Res_2013_Mar_25_8(9)_825-832.nxml.txt.nlp	25206730	SENT9	11	11	20	20	isoflurane	P2X7	PA450106	5027	0.916
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Mar_28_68(Pt_4)_o1219.nxml.txt.nlp	22606156	SENT59	23	23	6	6	ethanol	mol	PA448073	90527	0.916
NULL	Ann_Rheum_Dis_2014_Mar_25_73(3)_492-509.nxml.txt.nlp	24161836	SENT513	42	42	19	19	tocilizumab	IL-6	PA165292659	3569	0.916
NULL	Evid_Based_Complement_Alternat_Med_2012_Dec_20_2012_908601.nxml.txt.nlp	23326293	SENT8	16	16	25	25	oxaliplatin	CD24	PA131285527	100133941	0.916
NULL	J_Cell_Biol_2001_May_14_153(4)_785-794.nxml.txt.nlp	11352939	SENT640	13	13	5	5	tetracycline	LIP	PA451640	23049	0.916
NULL	Eur_J_Clin_Pharmacol_2012_Sep_15_68(9)_1267-1274.nxml.txt.nlp	22418828	SENT150	17	17	30	30	mephenytoin	CYP2C19	PA450373	1557	0.916
NULL	Pharmaceuticals_(Basel)_2014_Feb_11_7(2)_192-206.nxml.txt.nlp	24521925	SENT177	4	4	6	6	cisplatin	PC-3	PA449014	692094	0.916
NULL	Diabetes_2009_Jan_58(1)_174-184.nxml.txt.nlp	18984736	SENT245	15	15	12	12	tranilast	TRPV2	PA131890628	51393	0.916
NULL	Gene_Regul_Syst_Bio_2014_Mar_4_8_63-73.nxml.txt.nlp	24634581	SENT136	1	1	17	17	minocycline	MT1-MMP	PA450519	4323	0.916
NULL	Eukaryot_Cell_2014_Aug_13(8)_1077-1084.nxml.txt.nlp	24951438	SENT193	24	24	3	3	doxycycline	RSP5	PA449415	23327	0.916
NULL	Nat_Commun_2014_5_3128.nxml.txt.nlp	24451681	SENT37	40	40	18	18	gemcitabine	DHFR	PA449748	1719	0.916
NULL	J_Cell_Mol_Med_2013_Jun_4_17(6)_713-722.nxml.txt.nlp	23551576	SENT132	15	15	13	13	cblb502	TLR5		7100	0.916
NULL	Breast_Cancer_Res_2012_Jun_19_14(3)_209.nxml.txt.nlp	22713170	SENT52	0	0	18	18	pertuzumab	HER2		2064	0.916
NULL	Avicenna_J_Phytomed_2013_Autumn_3(4)_302-312.nxml.txt.nlp	25050287	SENT60	3	3	15	15	ethanol	hole	PA448073	80757	0.916
NULL	Cancer_Metab_2013_Jan_23_1_4.nxml.txt.nlp	24280026	SENT15	11	11	30	30	docetaxel	TK1	PA449383	7083	0.916
NULL	Sci_Rep_2014_Nov_28_4_7237.nxml.txt.nlp	25429875	SENT123	22	22	32	32	hesperidin	p38	PA449867	10598;1432;7965	0.916
NULL	Oncotarget_2014_Oct_18_5(22)_11604-11619.nxml.txt.nlp	25344099	SENT133	24	24	15	15	cisplatin	RYBP	PA449014	23429	0.916
NULL	Diabetes_Obes_Metab_2010_Aug_12(8)_700-708.nxml.txt.nlp	20590747	SENT190	29	29	11	11	voglibose	PPG	PA164752433	5552	0.916
NULL	Aging_Cell_2013_Jun_27_12(3)_435-445.nxml.txt.nlp	23448364	SENT414	8	8	12	12	doxorubicin	p66	PA449412	6464	0.916
NULL	Mol_Vis_2011_Feb_1_17_332-340.nxml.txt.nlp	21297899	SENT179	0	0	19	19	benazepril	NAC	PA448561	22861	0.916
NULL	Oncol_Rep_2013_Jul_23_30(1)_50-56.nxml.txt.nlp	23612786	SENT77	27	27	9	9	paraformaldehyde	CO2	PA450790	4513	0.916
NULL	Biomed_Res_Int_2013_Jul_31_2013_692071.nxml.txt.nlp	23984399	SENT122	12	12	6	6	l-carnitine	OCT1	PA450154	5451;6580	0.916
NULL	Oncogene_2013_Sep_26_32(39)_10_1038_onc_2012_491.nxml.txt.nlp	23108394	SENT79	15	15	36	36	epirubicin	FOXM1	PA449476	2305	0.916
NULL	Int_J_Mol_Sci_2013_Aug_14_14(8)_16719-16731.nxml.txt.nlp	23949634	SENT2	11	11	16	16	thrombin	TPC	PA451674	8030;60386	0.916
NULL	EPMA_J_2013_Jan_28_4(1)_3.nxml.txt.nlp	23356214	SENT311	33	33	9	9	panitumumab	PIK3CA	PA162373091	5290	0.916
NULL	Biochemistry_2011_May_31_50(21)_4393-4395.nxml.txt.nlp	21520952	SENT44	7	7	14	14	benzbromarone	P-gp	PA134852920	5243	0.916
NULL	Biomed_Res_Int_2014_May_12_2014_651831.nxml.txt.nlp	24900976	SENT42	14	14	21	21	nystatin	mol	PA450666	90527	0.916
NULL	Cancers_(Basel)_2014_Jun_27_6(3)_1382-1393.nxml.txt.nlp	24978439	SENT428	28	28	0	0	trastuzumab	Hsp90	PA451743	3320	0.916
NULL	Mol_Biol_Cell_2014_Jun_1_25(11)_1782-1792.nxml.txt.nlp	24719457	SENT107	17	17	28	28	nicotine	GAPDH	PA450626	2597	0.916
NULL	Front_Behav_Neurosci_2012_Dec_27_6_87.nxml.txt.nlp	23293591	SENT828	19	19	12	12	scopolamine	spatial	PA451308	219793	0.916
NULL	Braz_J_Med_Biol_Res_2012_Jul_27_45(10)_948-954.nxml.txt.nlp	22832600	SENT145	8	8	0	0	fluoxetine	5-HT4	PA449673	3360	0.916
NULL	Onco_Targets_Ther_2014_Mar_24_7_491-500.nxml.txt.nlp	24711706	SENT187	10	10	20	20	trastuzumab	HER-2	PA451743	2064	0.916
NULL	Acta_Histochem_Cytochem_2013_Dec_28_46(6)_187-197.nxml.txt.nlp	24610966	SENT147	25	25	7	7	cevimeline	AQP5	PA164754754	362	0.916
NULL	Eur_J_Neurosci_2007_Sep_26(6)_1657-1669.nxml.txt.nlp	17880399	SENT363	8	8	10	10	chlorpromazine	DAO	PA448964	26;1610	0.916
NULL	Br_J_Cancer_2011_Jul_12_105(2)_212-220.nxml.txt.nlp	21694723	SENT3	17	17	4	4	curcumin	STAT3	PA151958596	6774	0.916
NULL	Breast_Cancer_Res_2008_Jan_20_10(1)_R7.nxml.txt.nlp	18205950	SENT202	10	10	2	2	staurosporine	derlin-1	PA165109623	79139	0.916
NULL	Clin_Interv_Aging_2009_May_14_4_197-205.nxml.txt.nlp	19503782	SENT319	10	10	14	14	mitoxantrone	CD33	PA450526	945	0.916
NULL	Acta_Neuropathol_Commun_2014_Oct_21_2(1)_149.nxml.txt.nlp	NULL	SENT248	20	20	44	44	riluzole	GAPDH	PA451251	2597	0.916
NULL	Anesthesiol_Res_Pract_2012_Nov_24_2012_921405.nxml.txt.nlp	22162685	SENT114	32	32	8	8	lidocaine	NPY	PA450226	4852	0.916
NULL	Biosci_Rep_2012_Aug_1_32(Pt_4)_361-374.nxml.txt.nlp	22762204	SENT183	27	27	18	18	paclitaxel	LATS1	PA450761	9113	0.916
NULL	Case_Rep_Med_2014_Nov_12_2014_231651.nxml.txt.nlp	25477968	SENT113	1	1	9	9	amiodarone	RAI	PA448383	10848;6050	0.916
NULL	Chemother_Res_Pract_2011_Sep_25_2011_730360.nxml.txt.nlp	22295205	SENT41	7	7	25	25	trastuzumab	HER2	PA451743	2064	0.916
NULL	Indian_Dermatol_Online_J_2014_Jul-Sep_5(3)_250-259.nxml.txt.nlp	25165639	SENT253	3	3	21	21	rituximab	CLE	PA451261	51637	0.916
NULL	J_Clin_Immunol_2007_May_14_27(3)_275-283.nxml.txt.nlp	17510806	SENT108	2	2	14	14	rosiglitazone	ZO-1	PA451283	7082	0.916
NULL	Gynecol_Oncol_Case_Rep_2013_Apr_11_5_37-39.nxml.txt.nlp	24371692	SENT12	11	11	27	27	bevacizumab	CA125	PA130232992	4077;94025	0.916
NULL	Mol_Pain_2013_Jul_31_9_38.nxml.txt.nlp	23898828	SENT149	23	23	11	11	losartan	p38	PA450268	10598;1432;7965	0.916
NULL	Evid_Based_Complement_Alternat_Med_2013_May_13_2013_506324.nxml.txt.nlp	23818927	SENT196	11	11	29	29	doxorubicin	STAT3	PA449412	6774	0.916
NULL	Cell_Cycle_2013_Sep_15_12(18)_3025-3036.nxml.txt.nlp	23974102	SENT127	16	16	21	21	infliximab	CD4	PA452639	920	0.916
NULL	Oncol_Lett_2013_Feb_5_5(2)_427-434.nxml.txt.nlp	23420099	SENT166	19	19	8	8	gemcitabine	ERCC2	PA449748	2068	0.916
NULL	Indian_J_Pharmacol_2013_Mar-Apr_45(2)_155-158.nxml.txt.nlp	23716892	SENT116	20	20	45	45	glibenclamide	CYP2C9	PA449782	1559	0.916
NULL	Exp_Mol_Med_2012_Jun_30_44(6)_403-411.nxml.txt.nlp	22510730	SENT7	18	18	16	16	anastrozole	aromatase	PA448432	1588	0.916
NULL	Indian_J_Endocrinol_Metab_2013_Dec_17(Suppl_3)_S674-S679.nxml.txt.nlp	24910836	SENT137	25	25	35	35	acarbose	GLP-1	PA448010	100125288	0.916
NULL	Nat_Genet_2011_Jan_12_43(1)_27-33.nxml.txt.nlp	21151129	SENT300	22	22	18	18	tamoxifen	FOXA1	PA451581	3169	0.916
NULL	J_Int_Soc_Sports_Nutr_2008_Oct_24_5_19.nxml.txt.nlp	18950510	SENT21	14	14	1	1	ephedrine	OTC	PA449466	5009	0.916
NULL	Breast_Cancer_Res_2012_Feb_6_14(1)_R22.nxml.txt.nlp	22309939	SENT34	11	11	13	13	tamoxifen	aromatase	PA451581	1588	0.916
NULL	Br_J_Cancer_2010_Oct_12_103(8)_1297-1304.nxml.txt.nlp	20842126	SENT128	16	16	7	7	taurine	SMO	PA451590	6608;54498	0.916
NULL	Front_Neurosci_2014_Jan_10_7_270.nxml.txt.nlp	24454277	SENT57	27	27	1	1	ethanol	SIRT1	PA448073	23411	0.916
NULL	J_Am_Heart_Assoc_2013_Aug_23_2(4)_e000318.nxml.txt.nlp	23926118	SENT107	36	36	3	3	isoproterenol	AC3	PA450121	109	0.916
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Aug_1_70(Pt_9)_o959.nxml.txt.nlp	25309279	SENT9	19	19	5	5	nitrile	mol	PA450636	90527	0.916
NULL	J_Gastroenterol_2014_Dec_24_49(12)_1536-1547.nxml.txt.nlp	24366288	SENT153	38	38	8	8	rabeprazole	CYP2C19	PA451216	1557	0.915
NULL	Acta_Histochem_Cytochem_2006_Dec_28_39(6)_163-172.nxml.txt.nlp	17327903	SENT127	2	2	7	7	staurosporine	ERK	PA165109623	5594	0.915
NULL	Tumour_Biol_2012_Jun_21_33(3)_607-615.nxml.txt.nlp	22270450	SENT40	4	4	25	25	erlotinib	EGFR	PA134687924	1956	0.915
NULL	J_Cell_Mol_Med_2014_Sep_5_18(9)_1773-1784.nxml.txt.nlp	25091058	SENT279	12	12	30	30	bleomycin	IL-17A	PA448645	3605	0.915
NULL	Ther_Clin_Risk_Manag_2007_Jun_3(3)_363-379.nxml.txt.nlp	18488081	SENT96	8	8	3	3	rabeprazole	CYP2C19	PA451216	1557	0.915
NULL	J_Obes_2011_Sep_19_2011_984245.nxml.txt.nlp	20885921	SENT145	5	5	14	14	liraglutide	GLP-1	PA165958364	100125288	0.915
NULL	BMB_Rep_2013_Nov_46(11)_544-549.nxml.txt.nlp	24152910	SENT68	9	9	30	30	thrombin	HMGB1	PA451674	3146	0.915
NULL	Appl_Clin_Genet_2010_Oct_29_3_85-101.nxml.txt.nlp	23776354	SENT136	12	12	31	31	imatinib	PDGFRA	PA10804	5156	0.915
NULL	Onco_Targets_Ther_2014_Mar_20_7_457-467.nxml.txt.nlp	24672248	SENT99	15	15	10	10	everolimus	BRAF	PA164746311	673	0.915
NULL	Cardiovasc_Diabetol_2011_Dec_22_10_115.nxml.txt.nlp	22189184	SENT130	1	1	14	14	sitagliptin	GLP-1	PA164748978	100125288	0.915
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_79-96.nxml.txt.nlp	19305789	SENT273	0	0	2	2	ethanol	TRPM8	PA448073	79054	0.915
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT81	25	25	21	21	cetuximab	KRAS	PA10040	3845	0.915
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_29_2013_590393.nxml.txt.nlp	23737838	SENT304	20	20	12	12	resveratrol	p53		7157	0.915
NULL	Mol_Cancer_2012_Jun_18_11_41.nxml.txt.nlp	22709873	SENT257	34	34	10	10	lapatinib	NR3C1	PA152241907	2908	0.915
NULL	J_Obes_2011_Jan_17_2011_893629.nxml.txt.nlp	21318056	SENT90	5	5	20	20	olanzapine	5-HT2C	PA450688	3358	0.915
NULL	AAPS_J_2011_Jun_1_13(3)_405-416.nxml.txt.nlp	21630127	SENT252	25	25	33	33	simvastatin	OATP1B1	PA451363	10599	0.915
NULL	Clin_Endosc_2011_Sep_30_44(1)_22-26.nxml.txt.nlp	22741108	SENT6	26	26	32	32	propofol	ESD	PA451141	2098	0.915
NULL	Crit_Care_2007_Mar_22_11(Suppl_2)_P31.nxml.txt.nlp	NULL	SENT18	9	9	7	7	dobutamine	JNK	PA449381	5599	0.915
NULL	Semin_Immunol_2011_Aug_23(4)_293-303.nxml.txt.nlp	21616680	SENT175	6	6	20	20	efalizumab	LFA-1	PA164748817	3683;3689	0.915
NULL	Eplasty_2008_Jun_24_8_e33.nxml.txt.nlp	18650963	SENT32	17	17	5	5	thrombin	ADM	PA451674	133	0.915
NULL	Cell_J_2012_Dec_22_Winter_13(4)_281-289.nxml.txt.nlp	23507624	SENT20	8	8	25	25	isoproterenol	IFN	PA450121	3439	0.915
NULL	Breast_Cancer_Res_2010_Oct_20_12(5)_315.nxml.txt.nlp	21062517	SENT32	12	12	7	7	tamoxifen	PI3K	PA451581	5290	0.915
NULL	Diabetes_Care_2010_Apr_19_33(4)_914-919.nxml.txt.nlp	20086255	SENT114	3	3	19	19	valsartan	adiponectin	PA451848	9370	0.915
NULL	Core_Evid_2009_Jun_15_4_25-36.nxml.txt.nlp	20694062	SENT185	27	27	10	10	allopurinol	FACT	PA448320	11198	0.915
NULL	Acta_Pharmacol_Sin_2012_Apr_5_33(4)_551-557.nxml.txt.nlp	22388075	SENT115	3	3	7	7	imatinib	Wip1	PA10804	8493	0.915
NULL	Front_Neurol_2014_Feb_18_5_17.nxml.txt.nlp	24600432	SENT107	10	10	18	18	levetiracetam	CD95	PA450206	355	0.915
NULL	Br_J_Clin_Pharmacol_2013_Aug_23_76(2)_299-315.nxml.txt.nlp	23701319	SENT7	6	6	30	30	bevacizumab	IL-2	PA130232992	3558	0.915
NULL	Biomed_Res_Int_2014_Jun_3_2014_459823.nxml.txt.nlp	25025052	SENT199	9	9	28	28	fluspirilene	ATG5	PA162565878	9474	0.915
NULL	Sci_Rep_2014_Dec_11_4_7438.nxml.txt.nlp	25500904	SENT573	26	26	11	11	azithromycin	CD4	PA448519	920	0.915
NULL	Cancer_Immunol_Immunother_2011_Jul_24_60(7)_943-951.nxml.txt.nlp	21431918	SENT148	11	11	4	4	doxorubicin	CD34	PA449412	947	0.915
NULL	Breast_Cancer_Res_2010_Aug_23_12(4)_R64.nxml.txt.nlp	20731819	SENT61	26	26	14	14	tamoxifen	CYP2D6	PA451581	1565	0.915
NULL	Genome_Med_2010_Aug_11_2(8)_53.nxml.txt.nlp	20701793	SENT45	14	14	8	8	pazopanib	VEGFR	PA165291492	3791	0.915
NULL	Br_J_Cancer_2011_Jul_26_105(3)_366-371.nxml.txt.nlp	21750556	SENT117	22	22	4	4	trastuzumab	T-bet	PA451743	30009	0.915
NULL	J_Cardiothorac_Surg_2014_Apr_23_9_72.nxml.txt.nlp	24758270	SENT61	0	0	11	11	heparin	ACT	PA449855	12;11332;9457;641455	0.915
NULL	Front_Oncol_2013_Aug_12_3_206.nxml.txt.nlp	23964347	SENT187	18	18	4	4	paclitaxel	ERCC1	PA450761	2067	0.915
NULL	J_Psychopharmacol_2010_Jan_24(1)_27-38.nxml.txt.nlp	19204064	SENT18	17	17	3	3	morphine	NK1R	PA450550	6869	0.915
NULL	Diabetes_Care_2013_Aug_17_36(Suppl_2)_S245-S252.nxml.txt.nlp	23882053	SENT9	17	17	10	10	liraglutide	GLP-1	PA165958364	100125288	0.915
NULL	Bioinformation_2012_Jan_6_8(1)_13-19.nxml.txt.nlp	22359429	SENT102	3	3	26	26	curcumin	MRP1	PA151958596	4437	0.915
NULL	Cancer_Cell_Int_2013_Feb_14_13_16.nxml.txt.nlp	23409704	SENT179	0	0	12	12	pp2	San		80218	0.915
NULL	J_Mol_Signal_2011_Jul_20_6_7.nxml.txt.nlp	21774804	SENT50	43	43	4	4	curcumin	p53	PA151958596	7157	0.915
NULL	Curr_Heart_Fail_Rep_2011_Dec_13_8(4)_242-251.nxml.txt.nlp	21842146	SENT139	37	37	24	24	vildagliptin	GLP-1	PA165958346	100125288	0.915
NULL	Cancer_Cell_Int_2014_Jan_23_14_6.nxml.txt.nlp	24456610	SENT31	9	9	1	1	erlotinib	EGFR	PA134687924	1956	0.915
NULL	Indian_J_Pharm_Sci_2014_Jan-Feb_76(1)_72-77.nxml.txt.nlp	24799741	SENT117	25	25	19	19	ketoconazole	CYP2C9	PA450146	1559	0.915
NULL	Diabetes_2011_Nov_17_60(11)_2928-2938.nxml.txt.nlp	21885868	SENT137	19	19	43	43	curcumin	IL-6	PA151958596	3569	0.915
NULL	Arthritis_Res_Ther_2009_Aug_28_11(4)_R131.nxml.txt.nlp	19715572	SENT152	37	37	15	15	rituximab	CD27	PA451261	939	0.915
NULL	Cancers_(Basel)_2012_Sep_25_4(4)_969-988.nxml.txt.nlp	24213497	SENT160	20	20	12	12	fulvestrant	VEGFR	PA164747170	3791	0.915
NULL	Acta_Pharmacol_Sin_2010_Feb_5_31(2)_184-190.nxml.txt.nlp	20139901	SENT29	4	4	20	20	metformin	OCT2	PA450395	6582;5452	0.915
NULL	Open_Biomed_Eng_J_2011_Jan_19_5_1-7.nxml.txt.nlp	21625374	SENT57	33	33	16	16	metformin	EGI	PA450395	1957	0.915
NULL	Int_J_Mol_Sci_2014_Sep_11_15(9)_16043-16056.nxml.txt.nlp	25216337	SENT39	38	38	12	12	doxycycline	IFN	PA449415	3439	0.915
NULL	Indian_J_Crit_Care_Med_2008_Oct-Dec_12(4)_181-189.nxml.txt.nlp	19742267	SENT207	22	22	2	2	abatacept	ACR	PA164747080	49	0.915
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT151	22	22	18	18	sitagliptin	HIP	PA164748978	6767;6159;64399;5068	0.915
NULL	Biology_(Basel)_2012_Dec_31_2(1)_40-63.nxml.txt.nlp	24832651	SENT54	22	22	33	33	hydroxyurea	BRCA1	PA449942	672	0.915
NULL	J_Hematol_Oncol_2012_Jul_27_5_42.nxml.txt.nlp	22839530	SENT166	27	27	5	5	cytarabine	SRSF1	PA449177	6426	0.915
NULL	Psychol_Res_Behav_Manag_2010_Dec_6_3_109-118.nxml.txt.nlp	22110334	SENT114	34	34	28	28	paroxetine	CYP2D6	PA450801	1565	0.915
NULL	Arch_Med_Sci_2013_Aug_30_9(4)_739-744.nxml.txt.nlp	24049538	SENT107	25	25	8	8	candesartan	PC-3	PA448765	692094	0.915
NULL	Nat_Med_2011_Aug_28_17(9)_1094-1100.nxml.txt.nlp	21873989	SENT198	22	22	11	11	imatinib	CD4	PA10804	920	0.915
NULL	Front_Oncol_2014_May_26_4_123.nxml.txt.nlp	24904834	SENT399	15	15	19	19	vemurafenib	BRAF	PA165946873	673	0.915
NULL	Oncotarget_2011_Dec_17_2(12)_1011-1027.nxml.txt.nlp	22184288	SENT342	15	15	10	10	azd1152	AurB		9212	0.915
NULL	Front_Cell_Neurosci_2013_Dec_3_7_244.nxml.txt.nlp	24348337	SENT202	14	14	27	27	forskolin	RIM1	PA146096022	22999	0.915
NULL	Ann_Gastroenterol_2014_27(3)_200-206.nxml.txt.nlp	24976114	SENT105	4	4	1	1	tegaserod	5-HT4	PA130413154	3360	0.915
NULL	Oncotarget_2012_Oct_20_3(10)_1068-1111.nxml.txt.nlp	23085539	SENT826	1	1	4	4	paclitaxel	PI3K	PA450761	5290	0.915
NULL	Int_J_Endocrinol_2014_Jun_25_2014_534904.nxml.txt.nlp	25053942	SENT108	32	32	18	18	amiodarone	AIT	PA448383	160728	0.915
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT31	11	11	16	16	paclitaxel	HER2	PA450761	2064	0.915
NULL	Pharmaceutics_2011_Nov_18_3(4)_865-913.nxml.txt.nlp	24309312	SENT344	4	4	13	13	midazolam	CYP3A	PA450496	1574	0.915
NULL	Arthritis_Res_Ther_2003_Oct_2_5(Suppl_4)_S17-S21.nxml.txt.nlp	15180893	SENT54	9	9	17	17	rituximab	ACR	PA451261	49	0.915
NULL	Breast_Cancer_Res_2007_Jan_22_9(1)_202.nxml.txt.nlp	17274834	SENT12	15	15	9	9	trastuzumab	HER2	PA451743	2064	0.915
NULL	Cell_Mol_Life_Sci_2011_Feb_24_68(3)_369-395.nxml.txt.nlp	21107637	SENT441	22	22	14	14	methotrexate	HLA-G	PA450428	3135	0.915
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_7-17.nxml.txt.nlp	17912633	SENT368	6	6	37	37	letrozole	aromatase	PA450196	1588	0.915
NULL	Mol_Cell_Proteomics_2013_Oct_22_12(10)_2791-2803.nxml.txt.nlp	23793018	SENT134	12	12	21	21	galactose	GAL	PA449725	51083	0.915
NULL	Br_J_Pharmacol_2008_Sep_9_155(1)_127-137.nxml.txt.nlp	18536750	SENT188	23	23	18	18	piroxicam	IL-10	PA450985	3586	0.915
NULL	Br_J_Cancer_2000_Jun_82(11)_1851-1859.nxml.txt.nlp	10839301	SENT8	24	24	4	4	topotecan	CD95	PA451729	355	0.915
NULL	J_Hematol_Oncol_2010_May_2_3_18.nxml.txt.nlp	20433767	SENT178	19	19	13	13	paclitaxel	EGFR	PA450761	1956	0.915
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_105-115.nxml.txt.nlp	17912640	SENT55	17	17	4	4	tamoxifen	HER2	PA451581	2064	0.915
NULL	Br_J_Cancer_2010_Sep_7_103(6)_889-898.nxml.txt.nlp	20664599	SENT14	19	19	0	0	paclitaxel	HER-2	PA450761	2064	0.915
NULL	J_Cancer_Prev_2014_Mar_19(1)_39-46.nxml.txt.nlp	25337571	SENT108	14	14	19	19	ethanol	JNK	PA448073	5599	0.915
NULL	Acta_Pharmacol_Sin_2013_Apr_11_34(4)_473-479.nxml.txt.nlp	23474709	SENT26	19	19	6	6	carbamazepine	MRP1	PA448785	4437	0.915
NULL	Nat_Biotechnol_2013_Jul_30_31(7)_630-637.nxml.txt.nlp	23811600	SENT180	15	15	7	7	crizotinib	INSRR	PA165946122	3645	0.915
NULL	Ann_Dermatol_2014_Aug_31_26(4)_517-520.nxml.txt.nlp	25143685	SENT50	32	32	5	5	tazarotene	TIG3	PA164746821	5920	0.915
NULL	ScientificWorldJournal_2012_Apr_1_2012_381434.nxml.txt.nlp	22545017	SENT326	20	20	10	10	aprepitant	NK-1	PA164747039	27087	0.915
NULL	Arthritis_Res_Ther_2008_Jun_5_10(3)_R66.nxml.txt.nlp	18534002	SENT111	35	35	2	2	mitomycin	CD4	PA450524	920	0.915
NULL	Breast_Cancer_Res_2005_May_24_7(5)_R589-R597.nxml.txt.nlp	16168102	SENT137	24	24	12	12	doxorubicin	HER2	PA449412	2064	0.915
NULL	J_Hematol_Oncol_2009_Aug_12_2_36.nxml.txt.nlp	19674465	SENT133	14	14	27	27	lenalidomide	CD34	PA162363968	947	0.915
NULL	Int_J_Mol_Sci_2014_Nov_10_15(11)_20607-20637.nxml.txt.nlp	25391045	SENT70	6	6	27	27	pravastatin	OATP1C1	PA451089	53919	0.915
NULL	J_Gynecol_Oncol_2013_Jan_8_24(1)_66-82.nxml.txt.nlp	23346316	SENT250	2	2	18	18	pertuzumab	HER2		2064	0.915
NULL	Evid_Based_Complement_Alternat_Med_2012_Dec_11_2012_310872.nxml.txt.nlp	23304196	SENT149	15	15	24	24	tamoxifen	aromatase	PA451581	1588	0.915
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Jun_15_69(Pt_7)_o1107.nxml.txt.nlp	24046666	SENT5	13	13	6	6	naltrexone	mol	PA450588	90527	0.915
NULL	Diabetol_Metab_Syndr_2014_Mar_31_6_47.nxml.txt.nlp	24684779	SENT152	2	2	12	12	pioglitazone	IL-6	PA450970	3569	0.915
NULL	Chin_J_Cancer_2011_Dec_30(12)_815-820.nxml.txt.nlp	22059910	SENT91	12	12	2	2	cetuximab	EGFR	PA10040	1956	0.915
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT154	15	15	22	22	erlotinib	PTEN	PA134687924	5728	0.915
NULL	G3_(Bethesda)_2014_Nov_6_5(1)_21-33.nxml.txt.nlp	25380729	SENT71	25	25	2	2	galactose	GAL7	PA449725	3963;653499	0.915
NULL	J_Exp_Med_2000_May_15_191(10)_1789-1798.nxml.txt.nlp	10811871	SENT90	15	15	10	10	tetracycline	p53	PA451640	7157	0.915
NULL	Oncogene_2013_Sep_26_32(39)_10_1038_onc_2012_491.nxml.txt.nlp	23108394	SENT123	42	42	32	32	epirubicin	FOXM1	PA449476	2305	0.915
NULL	Br_J_Pharmacol_2014_May_171(10)_2659-2670.nxml.txt.nlp	24116661	SENT153	35	35	5	5	naringenin	TRPP2	PA151958361	5311	0.915
NULL	Cancer_Cell_Int_2013_Jun_26_13_63.nxml.txt.nlp	23800022	SENT39	2	2	9	9	genistein	XIAP	PA165109660	331	0.915
NULL	Clin_Interv_Aging_2013_Mar_26_8_347-352.nxml.txt.nlp	23569367	SENT112	14	14	1	1	levodopa	GRK6	PA450213	2870	0.915
NULL	Open_Access_J_Urol_2010_Mar_12_2_35-40.nxml.txt.nlp	24198612	SENT111	12	12	3	3	pazopanib	VEGFR	PA165291492	3791	0.915
NULL	Oncologist_2010_Apr_15(4)_372-381.nxml.txt.nlp	20413642	SENT147	0	0	16	16	gefitinib	EGFR	PA131301952	1956	0.915
NULL	Neural_Regen_Res_2014_Mar_15_9(6)_622-629.nxml.txt.nlp	25206865	SENT70	10	10	4	4	vasopressin	p38	PA451858	10598;1432;7965	0.915
NULL	FEBS_J_2012_May_279(10)_1857-1870.nxml.txt.nlp	22420714	SENT285	26	26	30	30	capsaicin	TRPV1	PA448776	7442	0.915
NULL	Oncologist_2010_Mar_9_15(3)_236-245.nxml.txt.nlp	20215359	SENT10	16	16	30	30	sorafenib	VEGFR	PA7000	3791	0.915
NULL	Clin_Med_Insights_Womens_Health_2013_Jan_22_6_1-11.nxml.txt.nlp	24665209	SENT43	17	17	15	15	exemestane	aromatase	PA449563	1588	0.915
NULL	Biologics_2014_Apr_17_8_169-182.nxml.txt.nlp	24790410	SENT227	13	13	28	28	infliximab	ACR	PA452639	49	0.915
NULL	Breast_Cancer_Res_2007_Jul_5_9(4)_R41.nxml.txt.nlp	17612393	SENT155	9	9	7	7	celecoxib	Bcl-2	PA448871	596	0.915
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1013.nxml.txt.nlp	24457957	SENT139	15	15	2	2	orlistat	NOXA	PA164776864	5366	0.915
NULL	Clin_Infect_Dis_2014_Apr_1_58(7)_928-936.nxml.txt.nlp	24399087	SENT119	29	29	3	3	stavudine	API	PA451494	5345	0.915
NULL	Hum_Mol_Genet_2013_Nov_15_22(22)_4616-4626.nxml.txt.nlp	23814041	SENT164	24	24	3	3	simvastatin	neuroserpin	PA451363	5274	0.915
NULL	Breast_Cancer_Res_2012_Jan_6_14(1)_R2.nxml.txt.nlp	22225778	SENT219	20	20	23	23	docetaxel	TNFSF13	PA449383	8741	0.915
NULL	Acta_Pharmacol_Sin_2012_Jun_14_33(6)_832-838.nxml.txt.nlp	22580740	SENT13	30	30	8	8	cisplatin	ADM	PA449014	133	0.915
NULL	Oncotarget_2013_Oct_19_4(11)_2045-2056.nxml.txt.nlp	24185104	SENT79	0	0	19	19	cisplatin	14-3-3	PA449014	10971	0.915
NULL	Breast_Cancer_Res_2010_Dec_20_12(Suppl_4)_S15.nxml.txt.nlp	21172077	SENT37	25	25	16	16	tamoxifen	CYP2D6	PA451581	1565	0.915
NULL	J_Exerc_Rehabil_2014_Apr_30_10(2)_60-68.nxml.txt.nlp	24877039	SENT24	14	14	22	22	losartan	adiponectin	PA450268	9370	0.915
NULL	Arthritis_Res_Ther_2013_Dec_30_15(6)_R223.nxml.txt.nlp	24373218	SENT171	18	18	5	5	carprofen	FN1	PA164781361	2335	0.915
NULL	Br_J_Cancer_2010_Jun_8_102(12)_1707-1716.nxml.txt.nlp	20461078	SENT99	7	7	29	29	bortezomib	PARP	PA10252	142	0.915
NULL	Cancers_(Basel)_2014_Apr_16_6(2)_926-957.nxml.txt.nlp	24743778	SENT267	2	2	15	15	celecoxib	STAT3	PA448871	6774	0.915
NULL	Open_Med_2007_Dec_18_1(3)_e184-e190.nxml.txt.nlp	21673951	SENT67	44	44	36	36	anastrozole	aromatase	PA448432	1588	0.915
NULL	Breast_Cancer_Res_2009_Jun_29_11(3)_R41.nxml.txt.nlp	19563669	SENT157	5	5	12	12	gefitinib	EGFR	PA131301952	1956	0.915
NULL	Int_J_Endocrinol_2011_Aug_21_2011_742719.nxml.txt.nlp	21869886	SENT167	5	5	1	1	ticagrelor	P2Y12	PA165374673	64805	0.915
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1986-2011.nxml.txt.nlp	25268165	SENT68	31	31	15	15	resveratrol	CD133		8842	0.915
NULL	Arch_Med_Sci_2012_Jul_4_8(3)_509-514.nxml.txt.nlp	22852008	SENT80	12	12	19	19	ipratropium	PED	PA450082	8682	0.915
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT60	5	5	0	0	trastuzumab	STAT3	PA451743	6774	0.915
NULL	Oncoimmunology_2013_Dec_1_2(12)_e27215.nxml.txt.nlp	24501692	SENT32	29	29	5	5	cetuximab	STAT1	PA10040	6772	0.915
NULL	Eur_J_Med_Res_2009_Nov_24_14(Suppl_3)_5-16.nxml.txt.nlp	19959411	SENT135	0	0	15	15	raltegravir	UGT1A1		54658	0.915
NULL	Br_J_Cancer_2011_Jun_7_104(12)_1848-1853.nxml.txt.nlp	21610704	SENT83	11	11	38	38	panitumumab	REL	PA162373091	5966	0.915
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT64	17	17	15	15	nutlin-3	p53		7157	0.915
NULL	Front_Behav_Neurosci_2011_Sep_13_5_57.nxml.txt.nlp	21949506	SENT1372	8	8	5	5	rimonabant	CB1	PA152407999	1268	0.915
NULL	J_Gastrointest_Cancer_2013_Aug_7_44(4)_385-392.nxml.txt.nlp	23921604	SENT234	17	17	22	22	imatinib	KIT	PA10804	3815	0.915
NULL	BMB_Rep_2013_Aug_46(8)_410-415.nxml.txt.nlp	23977989	SENT34	6	6	8	8	curcumin	HO-1	PA151958596	3162	0.915
NULL	Reprod_Biol_Endocrinol_2013_Nov_26_11_109.nxml.txt.nlp	24279306	SENT188	36	36	29	29	hyaluronan	TNFAIP6	PA165958431	7130	0.915
NULL	Curr_Cardiol_Rev_2012_Aug_8(3)_177-180.nxml.txt.nlp	22920485	SENT58	20	20	28	28	bivalirudin	P2Y12	PA10032	64805	0.915
NULL	Front_Oncol_2014_Mar_18_4_55.nxml.txt.nlp	24672775	SENT218	19	19	32	32	cyclophosphamide	CD33	PA449165	945	0.915
NULL	Biomed_Res_Int_2013_Jan_17_2013_146716.nxml.txt.nlp	23484081	SENT139	24	24	27	27	indomethacin	COX	PA449982	1351	0.915
NULL	Eur_J_Med_Res_2011_Oct_10_16(10)_427-436.nxml.txt.nlp	22024421	SENT165	35	35	7	7	tenofovir	CD4	PA10204	920	0.915
NULL	Aging_(Albany_NY)_2014_Jan_14_6(1)_70-81.nxml.txt.nlp	24429382	SENT202	23	23	14	14	etoposide	WRN	PA449552	7486	0.915
NULL	Protein_J_2012_Aug_5_31(6)_511-518.nxml.txt.nlp	22763563	SENT169	16	16	24	24	atorvastatin	MSR1	PA448500	4481	0.915
NULL	J_Neuroinflammation_2011_Feb_4_8_10.nxml.txt.nlp	21294877	SENT156	31	31	7	7	capsaicin	TRPV1	PA448776	7442	0.915
NULL	Oncogene_2014_Feb_6_33(6)_713-723.nxml.txt.nlp	23435429	SENT47	6	6	4	4	etoposide	BRCA1	PA449552	672	0.915
NULL	Oncogenesis_2014_Oct_6_3(10)_e120.nxml.txt.nlp	25285406	SENT226	12	12	10	10	ethanol	LPA	PA448073	4018	0.915
NULL	J_Med_Case_Reports_2011_Oct_21_5_518.nxml.txt.nlp	22017919	SENT18	27	27	15	15	thrombin	HAP	PA451674	5915;10313	0.915
NULL	Exp_Lung_Res_2013_Oct_1_39(8)_336-348.nxml.txt.nlp	23919450	SENT166	29	29	8	8	thrombin	PAR-1	PA451674	2011;2149	0.915
NULL	Int_J_Mol_Sci_2014_Sep_2_15(9)_15512-15529.nxml.txt.nlp	25184950	SENT98	0	0	32	32	resveratrol	IL-10		3586	0.915
NULL	J_Cell_Biol_2003_Sep_29_162(7)_1197-1209.nxml.txt.nlp	14517203	SENT36	22	22	0	0	hydroxyurea	BLM	PA449942	641	0.915
NULL	Am_J_Trop_Med_Hyg_2012_Aug_1_87(2)_231-241.nxml.txt.nlp	22855752	SENT16	26	26	0	0	amodiaquine	ACT	PA448404	12;11332;9457;641455	0.915
NULL	Front_Oncol_2014_Mar_18_4_55.nxml.txt.nlp	24672775	SENT218	17	17	32	32	busulfan	CD33	PA448691	945	0.915
NULL	Breast_Cancer_Res_Treat_2009_Jul_22_116(2)_371-378.nxml.txt.nlp	18941892	SENT3	20	20	6	6	tamoxifen	aromatase	PA451581	1588	0.915
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT12	3	3	28	28	curcumin	TRAIL	PA151958596	8743	0.915
NULL	Biologics_2014_Apr_7_8_141-153.nxml.txt.nlp	24741293	SENT7	32	32	11	11	tocilizumab	IL-6	PA165292659	3569	0.915
NULL	Cancer_Metastasis_Rev_2010_Dec_10_29(4)_581-594.nxml.txt.nlp	20830503	SENT167	28	28	15	15	anastrozole	ARNO	PA448432	9266	0.915
NULL	Front_Genet_2013_Aug_30_4_166.nxml.txt.nlp	24009623	SENT655	7	7	0	0	tacrolimus	CYP3A5	PA451578	1577	0.915
NULL	J_Int_AIDS_Soc_2012_Nov_11_15(6Suppl_4)_18154.nxml.txt.nlp	NULL	SENT4	17	17	15	15	maraviroc	CCR5	PA164768835	1234	0.915
NULL	Core_Evid_2012_Jul_9_7_49-59.nxml.txt.nlp	22826692	SENT136	0	0	9	9	rivaroxaban	CYP3A4	PA165958360	1576	0.915
NULL	Cardiol_Ther_2013_Jun_1_2(1)_111-124.nxml.txt.nlp	25135294	SENT121	19	19	14	14	ketoconazole	P-gp	PA450146	5243	0.915
NULL	Oncogene_2014_Jul_24_33(30)_3959-3969.nxml.txt.nlp	24096481	SENT25	27	27	12	12	doxorubicin	PIG3	PA449412	64975;9540	0.915
NULL	Angiogenesis_2009_Dec_21_12(4)_303-311.nxml.txt.nlp	19544080	SENT188	25	25	17	17	oxygen	HIF-1	PA450744	29072	0.915
NULL	J_Carcinog_2011_Nov_30_10_28.nxml.txt.nlp	22190870	SENT119	25	25	13	13	trastuzumab	CDK2	PA451743	1017	0.915
NULL	Aging_(Albany_NY)_2009_Jun_3_1(6)_515-528.nxml.txt.nlp	20157535	SENT77	35	35	5	5	resveratrol	S6K1		6198	0.915
NULL	Breast_Cancer_Res_2012_Jul_19_14(4)_R109.nxml.txt.nlp	22812567	SENT196	6	6	3	3	gemcitabine	CHK1	PA449748	1111	0.915
NULL	Front_Pharmacol_2014_Nov_26_5_258.nxml.txt.nlp	25505415	SENT63	15	15	4	4	metoprolol	CYP2D6	PA450480	1565	0.915
NULL	Br_J_Haematol_2009_Nov_2_147(3)_396-410.nxml.txt.nlp	19758122	SENT9	1	1	18	18	dasatinib	TP53	PA162372878	7157	0.915
NULL	Patient_Prefer_Adherence_2011_Dec_23_6_1-9.nxml.txt.nlp	22272064	SENT66	43	43	36	36	telmisartan	ACE	PA451605	1636	0.915
NULL	Mol_Biol_Cell_2014_Jan_1_25(1)_76-86.nxml.txt.nlp	24173717	SENT230	12	12	9	9	paclitaxel	TUBB6	PA450761	84617	0.915
NULL	J_Antimicrob_Chemother_2009_Nov_18_64(5)_910-928.nxml.txt.nlp	19767318	SENT132	19	19	7	7	efavirenz	CCR5	PA449441	1234	0.915
NULL	J_Breast_Cancer_2013_Mar_31_16(1)_23-31.nxml.txt.nlp	23593078	SENT142	17	17	8	8	genistein	MBD2	PA165109660	8932	0.915
NULL	Blood_Cancer_J_2014_Jun_27_4(6)_e221.nxml.txt.nlp	24972150	SENT16	13	13	22	22	etoposide	NPM1	PA449552	4869	0.915
NULL	Mol_Cancer_2009_Apr_22_8_26.nxml.txt.nlp	19386116	SENT90	10	10	29	29	ritonavir	Bcl-2	PA451260	596	0.915
NULL	Clin_Med_Insights_Oncol_2011_Mar_16_5_35-43.nxml.txt.nlp	21499557	SENT46	9	9	3	3	trabectedin	p53	PA165958349	7157	0.915
NULL	Diabetes_Care_2008_Nov_31(11)_2169-2176.nxml.txt.nlp	18678611	SENT107	8	8	4	4	rimonabant	CB1	PA152407999	1268	0.915
NULL	J_Korean_Med_Sci_2009_Jun_12_24(3)_448-452.nxml.txt.nlp	19543508	SENT71	8	8	20	20	gefitinib	EGFR	PA131301952	1956	0.915
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_P43.nxml.txt.nlp	NULL	SENT11	12	12	38	38	abacavir	HLA-B	PA448004	3106	0.915
NULL	Oncol_Rep_2012_Apr_30_27(4)_1177-1187.nxml.txt.nlp	22209971	SENT80	26	26	0	0	ethanol	ABCG2	PA448073	9429	0.915
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT351	41	41	26	26	haloperidol	PRL	PA449841	5617	0.915
NULL	Br_J_Pharmacol_2012_Jan_165(2)_390-400.nxml.txt.nlp	21671897	SENT229	24	24	32	32	suramin	P2X2	PA10292	22953	0.915
NULL	Arthritis_Res_Ther_2008_Jan_7_10(1)_R1.nxml.txt.nlp	18179697	SENT157	3	3	20	20	oxaliplatin	HMGB1	PA131285527	3146	0.915
NULL	Arthritis_Res_Ther_2006_Jun_14_8(4)_R94.nxml.txt.nlp	16774691	SENT139	29	29	14	14	simvastatin	RhoA	PA451363	387	0.915
NULL	Mol_Pain_2014_Aug_15_10_53.nxml.txt.nlp	25127716	SENT90	16	16	0	0	paclitaxel	CCR5	PA450761	1234	0.915
NULL	Biomed_Res_Int_2013_Jul_31_2013_692071.nxml.txt.nlp	23984399	SENT4	35	35	4	4	metformin	SLC22A1	PA450395	6580	0.915
NULL	Pak_J_Med_Sci_2013_Nov-Dec_29(6)_1459-1461.nxml.txt.nlp	24550976	SENT57	8	8	23	23	protamine	ACT	PA10366	12;11332;9457;641455	0.915
NULL	J_Exp_Clin_Cancer_Res_2009_Feb_15_28(1)_19.nxml.txt.nlp	19216799	SENT12	14	14	20	20	cisplatin	AEG-1	PA449014	92140	0.915
NULL	Gut_Liver_2014_Sep_24_8(5)_480-486.nxml.txt.nlp	25228971	SENT52	24	24	3	3	lansoprazole	ESD	PA450180	2098	0.915
NULL	Arthritis_Res_Ther_2013_Oct_17_15(5)_R154.nxml.txt.nlp	24286344	SENT15	22	22	25	25	ivermectin	P2X4	PA450133	5025	0.915
NULL	J_Cell_Biol_1992_Feb_1_116(3)_817-825.nxml.txt.nlp	1730778	SENT16	21	21	29	29	heparin	CD44	PA449855	960	0.915
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT180	9	9	4	4	chloroquine	BMP9	PA448948	2658	0.915
NULL	Exp_Diabetes_Res_2012_Apr_17_2012_635472.nxml.txt.nlp	22577369	SENT100	23	23	7	7	sitagliptin	GLP-1	PA164748978	100125288	0.915
NULL	Braz_J_Med_Biol_Res_2012_Jul_20_45(10)_935-941.nxml.txt.nlp	22801415	SENT155	28	28	5	5	pioglitazone	ghrelin	PA450970	51738	0.915
NULL	Arch_Med_Sci_2013_Jun_20_9(3)_472-478.nxml.txt.nlp	23847669	SENT29	9	9	6	6	anastrozole	aromatase	PA448432	1588	0.915
NULL	Fibrogenesis_Tissue_Repair_2010_Nov_24_3_23.nxml.txt.nlp	21106092	SENT109	31	31	15	15	imiquimod	TLR3	PA449972	7098	0.915
NULL	Environ_Health_Perspect_2006_Sep_23_114(9)_1401-1406.nxml.txt.nlp	16966095	SENT123	21	21	10	10	tetracycline	p53	PA451640	7157	0.915
NULL	Genome_Biol_2011_Nov_11_12(11)_233.nxml.txt.nlp	22078297	SENT54	9	9	3	3	sugar	TIMP3	PA451529	7078	0.915
NULL	J_Cancer_Prev_2014_Jun_19(2)_97-102.nxml.txt.nlp	25337577	SENT113	11	11	27	27	resveratrol	p38		10598;1432;7965	0.915
NULL	Int_J_Biol_Sci_2013_May_8_9(5)_435-443.nxml.txt.nlp	23678293	SENT152	6	6	27	27	imatinib	AKT	PA10804	207	0.915
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1059-1066.nxml.txt.nlp	21364577	SENT170	15	15	7	7	lapatinib	aromatase	PA152241907	1588	0.915
NULL	Breast_Cancer_Res_2011_Mar_1_13(2)_R21.nxml.txt.nlp	21362200	SENT233	21	21	43	43	estradiol	aromatase	PA449503	1588	0.915
NULL	Br_J_Cancer_2009_Jul_21_101(2)_238-243.nxml.txt.nlp	19568242	SENT139	17	17	22	22	bevacizumab	IFN	PA130232992	3439	0.915
NULL	N_Am_J_Med_Sci_2011_Oct_3(10)_441-450.nxml.txt.nlp	22363081	SENT315	14	14	2	2	gemcitabine	HuR	PA449748	1994	0.915
NULL	Int_J_Biol_Sci_2014_Jun_10_10(7)_654-663.nxml.txt.nlp	25013375	SENT116	12	12	23	23	nelfinavir	CDK4	PA450606	1019	0.915
NULL	Arthritis_Res_Ther_2005_Apr_4_7(4)_R756-R768.nxml.txt.nlp	15987477	SENT185	11	11	3	3	hyaluronidase	PH-20	PA164745713	6677	0.915
NULL	Cells_2012_Jul_6_1(3)_284-312.nxml.txt.nlp	24710477	SENT300	4	4	19	19	lapatinib	Mcl-1	PA152241907	4170	0.915
NULL	Cancer_Immunol_Immunother_2013_Aug_27_62(10)_1637-1648.nxml.txt.nlp	23982484	SENT136	23	23	13	13	lenalidomide	IFN	PA162363968	3439	0.915
NULL	Case_Rep_Psychiatry_2012_Jun_5_2012_496364.nxml.txt.nlp	22934218	SENT51	8	8	17	17	risperidone	FGA	PA451257	2243	0.915
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT88	4	4	23	23	resveratrol	TRAIL		8743	0.915
NULL	Hum_Genomics_2013_Sep_23_7(1)_20.nxml.txt.nlp	24060470	SENT100	10	10	5	5	nutlin-3	p53		7157	0.915
NULL	Front_Genet_2014_Nov_14_5_391.nxml.txt.nlp	25452763	SENT1231	14	14	0	0	paclitaxel	ERCC1	PA450761	2067	0.915
NULL	Mol_Cancer_2014_Jun_9_13_146.nxml.txt.nlp	24913494	SENT245	10	10	19	19	metformin	MID1	PA450395	4281	0.915
NULL	Mol_Cancer_2009_Nov_10_8_99.nxml.txt.nlp	19903356	SENT146	19	19	6	6	imatinib	IGFBP3	PA10804	3486	0.915
NULL	Tumour_Biol_2014_Aug_12_35(8)_7807-7819.nxml.txt.nlp	24817012	SENT377	19	19	4	4	gemcitabine	RRM1	PA449748	6240	0.915
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2675-2684.nxml.txt.nlp	24129246	SENT317	12	12	9	9	etoposide	KSR1	PA449552	8844	0.915
NULL	Iran_J_Basic_Med_Sci_2012_Jul-Aug_15(4)_907-915.nxml.txt.nlp	23493917	SENT98	0	0	19	19	glibenclamide	ANOVA	PA449782	4858	0.915
NULL	Nat_Biotechnol_2009_Oct_13_27(10)_925-932.nxml.txt.nlp	19749770	SENT209	30	30	12	12	paraformaldehyde	Dicer	PA450790	23405	0.915
NULL	Oncotarget_2014_Oct_21_5(22)_11252-11268.nxml.txt.nlp	25361004	SENT66	5	5	17	17	metformin	U87	PA450395	677775;641648	0.915
NULL	Int_J_Breast_Cancer_2012_May_8_2012_764570.nxml.txt.nlp	22645687	SENT30	9	9	17	17	tamoxifen	HER-2	PA451581	2064	0.915
NULL	Oncotarget_2014_Oct_18_5(21)_10206-10221.nxml.txt.nlp	25344914	SENT123	7	7	29	29	vemurafenib	ERBB3	PA165946873	2065	0.915
NULL	Clin_Interv_Aging_2013_Oct_2_8_1329-1337.nxml.txt.nlp	24124355	SENT68	6	6	2	2	montelukast	CysLT1	PA450546	10800	0.915
NULL	Oncol_Rep_2013_Mar_8_29(3)_917-924.nxml.txt.nlp	23314174	SENT154	11	11	18	18	sorafenib	CD44	PA7000	960	0.915
NULL	Int_J_Biol_Sci_2013_Mar_7_9(3)_279-288.nxml.txt.nlp	23493630	SENT126	13	13	6	6	tocilizumab	CD4	PA165292659	920	0.915
NULL	Environ_Health_Perspect_2005_Jan_30_113(1)_17-24.nxml.txt.nlp	15626642	SENT120	7	7	3	3	quinidine	P-gp	PA451209	5243	0.915
NULL	Br_J_Cancer_2012_Jun_5_106(12)_1997-2003.nxml.txt.nlp	22596232	SENT203	0	0	9	9	sorafenib	JNK	PA7000	5599	0.915
NULL	Clin_Transl_Allergy_2013_Sep_2_3_29.nxml.txt.nlp	24004581	SENT147	22	22	15	15	omalizumab	IL-4	PA164752253	3565	0.915
NULL	Biologics_2014_Mar_17_8_91-105.nxml.txt.nlp	24669185	SENT166	11	11	8	8	denosumab	RANKL	PA166048634	8600	0.915
NULL	Breast_Cancer_Res_2010_May_18_12(Suppl_1)_P58.nxml.txt.nlp	NULL	SENT13	11	11	19	19	doxorubicin	TRAIL-R2	PA449412	8795	0.915
NULL	Allergy_Asthma_Immunol_Res_2010_Apr_24_2(2)_134-140.nxml.txt.nlp	20358028	SENT80	14	14	25	25	methacholine	IL-13	PA165958382	3596	0.915
NULL	Indian_J_Pharmacol_2014_Jan-Feb_46(1)_3-12.nxml.txt.nlp	24550577	SENT298	7	7	10	10	rosiglitazone	CYP2C8	PA451283	1558	0.915
NULL	Brain_Res_2011_Mar_25_1382(C)_29-36.nxml.txt.nlp	21276431	SENT139	28	28	26	26	ondansetron	5-HT3R	PA450705	3359	0.915
NULL	Onco_Targets_Ther_2014_Nov_28_7_2183-2195.nxml.txt.nlp	25506223	SENT13	21	21	36	36	doxorubicin	MICA	PA449412	100507436	0.915
NULL	Indian_J_Med_Res_2014_Jul_140(1)_32-39.nxml.txt.nlp	25222775	SENT110	17	17	0	0	isoniazid	AAP	PA450112	5345	0.915
NULL	Diabetes_2009_Dec_31_58(12)_2851-2862.nxml.txt.nlp	19720788	SENT143	41	41	3	3	forskolin	CHOP	PA146096022	1649	0.915
NULL	J_Biomed_Sci_2013_May_4_20(1)_27.nxml.txt.nlp	23642268	SENT90	22	22	3	3	kanamycin	CNBP	PA450137	7555	0.915
NULL	J_Histochem_Cytochem_2012_Oct_60(10)_749-760.nxml.txt.nlp	22821669	SENT237	2	2	15	15	hyaluronan	TSG-6	PA165958431	7130	0.915
NULL	Brain_2014_Oct_17_137(10)_2731-2742.nxml.txt.nlp	25034897	SENT143	17	17	35	35	levodopa	COMT	PA450213	1312	0.915
NULL	Indian_J_Pharmacol_2013_Sep-Oct_45(5)_458-463.nxml.txt.nlp	24130379	SENT127	0	0	5	5	carvedilol	p50	PA448817	958;4790	0.915
NULL	Blood_Cancer_J_2013_Dec_6_3(12)_e167.nxml.txt.nlp	24317089	SENT160	10	10	6	6	lovastatin	GRP94	PA450272	7184	0.915
NULL	Exp_Mol_Med_2012_Sep_30_44(9)_536-544.nxml.txt.nlp	22771771	SENT25	14	14	4	4	indomethacin	COX	PA449982	1351	0.915
NULL	Breast_Cancer_Res_2002_May_15_4(4)_133-136.nxml.txt.nlp	12100736	SENT96	8	8	17	17	exemestane	aromatase	PA449563	1588	0.915
NULL	Mol_Cancer_2010_Apr_23_9_87.nxml.txt.nlp	20416058	SENT280	34	34	26	26	doxorubicin	TRAIL	PA449412	8743	0.915
NULL	Mol_Cancer_2013_Sep_11_12_104.nxml.txt.nlp	24025152	SENT187	2	2	19	19	gemcitabine	STAT3	PA449748	6774	0.915
NULL	Curr_Hepat_Rep_2010_Aug_19_9(3)_147-154.nxml.txt.nlp	20676191	SENT101	28	28	17	17	ribavirin	RVR	PA451241	9975	0.915
NULL	Saudi_J_Anaesth_2013_Apr-Jun_7(2)_151-154.nxml.txt.nlp	23956714	SENT64	4	4	11	11	theophylline	NAC	PA451647	22861	0.915
NULL	Cell_Death_Dis_2013_Sep_19_4(9)_e810.nxml.txt.nlp	24052078	SENT235	7	7	13	13	erlotinib	EGFR	PA134687924	1956	0.915
NULL	Orphanet_J_Rare_Dis_2014_Oct_11_9(1)_150.nxml.txt.nlp	NULL	SENT3	16	16	14	14	glucosamine	GNE	PA164747613	10020	0.915
NULL	Diabetes_2011_Nov_17_60(11)_2691-2700.nxml.txt.nlp	21896928	SENT27	8	8	1	1	resveratrol	SIRT1		23411	0.915
NULL	Hum_Mol_Genet_2014_Apr_1_23(7)_1709-1722.nxml.txt.nlp	24203695	SENT94	12	12	5	5	creatine	COL4A2	PA164778930	1284	0.915
NULL	Int_J_Mol_Sci_2014_Oct_8_15(10)_17974-17999.nxml.txt.nlp	25299695	SENT302	13	13	20	20	curcumin	HO-1	PA151958596	3162	0.915
NULL	J_Physiol_2011_Oct_15_589(Pt_20)_4921-4934.nxml.txt.nlp	21859823	SENT174	37	37	7	7	carbachol	CA3	PA448784	761	0.915
NULL	EMBO_Mol_Med_2013_Dec_8_5(12)_1821-1834.nxml.txt.nlp	24293316	SENT110	6	6	14	14	doxorubicin	UNC5B	PA449412	219699	0.915
NULL	Open_Ophthalmol_J_2013_Feb_1_7_4-10.nxml.txt.nlp	23459241	SENT122	0	0	23	23	bevacizumab	VEGF-A	PA130232992	7422	0.915
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT57	11	11	24	24	neratinib	HER2	PA165291472	2064	0.915
NULL	Mol_Cells_2014_Aug_31_37(8)_598-604.nxml.txt.nlp	25134536	SENT76	41	41	19	19	paraformaldehyde	RANKL	PA450790	8600	0.915
NULL	Environ_Sci_Pollut_Res_Int_2012_Jun_2_19(5)_1605-1611.nxml.txt.nlp	22134861	SENT156	0	0	20	20	nitrogen	NO3	PA450643	4681	0.915
NULL	Mol_Cancer_2009_Dec_23_8_129.nxml.txt.nlp	20030852	SENT134	6	6	9	9	curcumin	p65	PA151958596	5970	0.915
NULL	Diabetes_2013_Mar_14_62(3)_789-800.nxml.txt.nlp	22966074	SENT220	8	8	11	11	forskolin	AMPK	PA146096022	5563	0.915
NULL	eLife_2014_May_20_3_e02523.nxml.txt.nlp	24844246	SENT757	10	10	31	31	sorafenib	ATF4	PA7000	468	0.915
NULL	Aging_(Albany_NY)_2011_Dec_17_3(12)_1127-1129.nxml.txt.nlp	22184281	SENT19	19	19	25	25	ethanol	CLS	PA448073	1210	0.915
NULL	Br_J_Cancer_2012_Sep_25_107(7)_1009-1016.nxml.txt.nlp	22948724	SENT48	30	30	6	6	sorafenib	CAIX	PA7000	768	0.915
NULL	Environ_Health_Perspect_2010_Jan_10_118(1)_108-115.nxml.txt.nlp	20056578	SENT253	14	14	0	0	arsenite	PTEN	PA452638	5728	0.915
NULL	J_Thorac_Oncol_2014_Jun_30_9(6)_775-783.nxml.txt.nlp	24828661	SENT127	12	12	21	21	crizotinib	Met	PA165946122	79811	0.915
NULL	Eur_J_Endocrinol_2011_Jan_164(1)_69-74.nxml.txt.nlp	20961967	SENT4	13	13	26	26	pioglitazone	OPG	PA450970	690	0.915
NULL	Arch_Med_Sci_2013_Aug_30_9(4)_589-593.nxml.txt.nlp	24049515	SENT95	29	29	11	11	epirubicin	PHD3	PA449476	112399	0.915
NULL	Cancer_Cell_Int_2012_Dec_15_12_52.nxml.txt.nlp	23241263	SENT76	33	33	13	13	imatinib	WT1	PA10804	7490	0.915
NULL	Br_J_Cancer_2012_Aug_7_107(4)_626-631.nxml.txt.nlp	22805329	SENT36	7	7	13	13	cetuximab	KRAS	PA10040	3845	0.915
NULL	Biochemistry_2012_Jun_26_51(25)_5125-5141.nxml.txt.nlp	22647192	SENT306	17	17	9	9	daunorubicin	ADP	PA449212	23038	0.915
NULL	Indian_J_Med_Res_2013_Nov_138(5)_766-778.nxml.txt.nlp	24434330	SENT53	31	31	12	12	ribavirin	RVR	PA451241	9975	0.915
NULL	Arthritis_Res_Ther_2010_Apr_1_12(2)_R60.nxml.txt.nlp	20359365	SENT152	29	29	23	23	bleomycin	SPARC	PA448645	6678	0.915
NULL	Cardiol_Res_Pract_2013_Feb_19_2013_195456.nxml.txt.nlp	23533940	SENT66	3	3	18	18	prasugrel	CYP3A4	PA154410481	1576	0.915
NULL	Br_J_Pharmacol_2014_Jan_23_171(2)_523-535.nxml.txt.nlp	24372553	SENT202	11	11	13	13	metformin	SIRT1	PA450395	23411	0.915
NULL	Evid_Based_Complement_Alternat_Med_2013_Mar_4_2013_957078.nxml.txt.nlp	23533531	SENT22	20	20	2	2	cisplatin	ABCC2	PA449014	1244	0.915
NULL	J_Korean_Med_Sci_2014_Jul_11_29(7)_965-972.nxml.txt.nlp	25045229	SENT91	27	27	2	2	metformin	B12	PA450395	7126;4709	0.915
NULL	Oncotarget_2010_Oct_30_1(7)_639-650.nxml.txt.nlp	21317459	SENT47	15	15	20	20	nutlin-3	p53		7157	0.915
NULL	Thorax_2012_Oct_12_67(10)_891-900.nxml.txt.nlp	22693178	SENT162	38	38	16	16	capsaicin	TRPA1	PA448776	8989	0.915
NULL	Diabetes_Care_2013_Dec_13_36(12)_4083-4090.nxml.txt.nlp	24130353	SENT205	20	20	2	2	metformin	DPP4	PA450395	1803	0.915
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Dec_18_67(Pt_1)_o165.nxml.txt.nlp	21522672	SENT68	37	37	20	20	ethanol	mol	PA448073	90527	0.915
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_29_2013_590393.nxml.txt.nlp	23737838	SENT302	3	3	17	17	resveratrol	p53		7157	0.915
NULL	Pharmaceutics_2011_Oct_12_3(4)_680-705.nxml.txt.nlp	24309303	SENT115	16	16	8	8	rosiglitazone	P-gp	PA451283	5243	0.915
NULL	Exp_Diabetes_Res_2012_Apr_11_2012_728325.nxml.txt.nlp	22566995	SENT67	0	0	25	25	bevacizumab	VEGF-A	PA130232992	7422	0.915
NULL	Biomed_Res_Int_2014_Apr_15_2014_232817.nxml.txt.nlp	24822185	SENT70	31	31	14	14	carboplatin	ALK7	PA448803	130399	0.915
NULL	Chin_J_Cancer_2012_Mar_31(3)_150-158.nxml.txt.nlp	22360854	SENT175	10	10	2	2	mitoxantrone	ABCG2	PA450526	9429	0.915
NULL	Nat_Genet_2011_Jun_5_43(7)_621-629.nxml.txt.nlp	21642992	SENT102	44	44	29	29	doxorubicin	CDKN1A	PA449412	1026	0.915
NULL	Cancers_(Basel)_2010_Sep_27_2(3)_1731-1770.nxml.txt.nlp	24281185	SENT540	5	5	30	30	bleomycin	GM-CSF	PA448645	1437	0.915
NULL	Front_Neurol_2011_Dec_26_2_83.nxml.txt.nlp	22363312	SENT925	7	7	2	2	clopidogrel	CYP2C19	PA449053	1557	0.915
NULL	Allergy_Asthma_Clin_Immunol_2013_Oct_3_9(1)_39.nxml.txt.nlp	24219860	SENT22	0	0	19	19	rituximab	BAFF	PA451261	10673	0.915
NULL	Front_Oncol_2014_Sep_15_4_248.nxml.txt.nlp	25309873	SENT214	22	22	34	34	afatinib	EGFR	PA165981154	1956	0.915
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_16_2012_395912.nxml.txt.nlp	23118789	SENT149	15	15	0	0	chlorpromazine	UGT1A4	PA448964	54657	0.915
NULL	Orphanet_J_Rare_Dis_2011_Aug_10_6_55.nxml.txt.nlp	21831279	SENT27	8	8	11	11	laronidase	IDUA	PA164776670	3425	0.915
NULL	Front_Immunol_2013_Nov_7_4_360.nxml.txt.nlp	24223576	SENT216	5	5	0	0	imiquimod	IRF5	PA449972	3663	0.915
NULL	Ann_Rheum_Dis_2011_Nov_25_71(5)_687-693.nxml.txt.nlp	22121130	SENT207	41	41	18	18	tocilizumab	IL-6	PA165292659	3569	0.915
NULL	Br_J_Cancer_2009_May_19_100(10)_1523-1529.nxml.txt.nlp	19401686	SENT104	17	17	19	19	tamoxifen	aromatase	PA451581	1588	0.915
NULL	Acta_Pharmacol_Sin_2012_Jun_14_33(6)_832-838.nxml.txt.nlp	22580740	SENT13	11	11	32	32	gemcitabine	DDP	PA449748	1678	0.915
NULL	J_Lipid_Res_2014_Feb_55(2)_307-312.nxml.txt.nlp	24262094	SENT168	16	16	19	19	orlistat	PNLIP	PA164776864	5406	0.915
NULL	Mol_Cancer_2007_Oct_11_6_63.nxml.txt.nlp	17931419	SENT87	28	28	16	16	gefitinib	EGFR	PA131301952	1956	0.915
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT104	8	8	12	12	doxorubicin	B7-H1	PA449412	29126	0.915
NULL	Arch_Drug_Inf_2011_Mar_4(1)_1-9.nxml.txt.nlp	21572514	SENT21	28	28	14	14	ciprofloxacin	P-gp	PA449009	5243	0.915
NULL	Evid_Based_Complement_Alternat_Med_2012_Aug_27_2012_361516.nxml.txt.nlp	22969825	SENT148	23	23	33	33	verapamil	P-gp	PA451868	5243	0.915
NULL	Acta_Pharmacol_Sin_2011_Feb_4_32(2)_160-166.nxml.txt.nlp	21293467	SENT120	15	15	25	25	carrageenan	NR1	PA448814	27158	0.915
NULL	Nat_Commun_2013_4_1963.nxml.txt.nlp	23739639	SENT375	19	19	11	11	cyclophosphamide	MARCO	PA449165	8685	0.915
NULL	J_Thorac_Oncol_2014_Jun_30_9(6)_805-811.nxml.txt.nlp	24787964	SENT150	8	8	18	18	cisplatin	EGFR	PA449014	1956	0.915
NULL	Biomed_Res_Int_2014_Apr_28_2014_549742.nxml.txt.nlp	24877113	SENT133	0	0	14	14	bevacizumab	VEGF-A	PA130232992	7422	0.915
NULL	Cardiovasc_Diabetol_2013_Nov_12_12_169.nxml.txt.nlp	24215514	SENT264	10	10	3	3	valsartan	AT2	PA451848	186	0.915
NULL	J_Cardiothorac_Surg_2012_Jul_18_7_70.nxml.txt.nlp	22808929	SENT33	0	0	8	8	doxorubicin	CHOP	PA449412	1649	0.915
NULL	Cancers_(Basel)_2011_Apr_18_3(2)_2014-2031.nxml.txt.nlp	24212794	SENT212	6	6	2	2	panitumumab	KRAS	PA162373091	3845	0.915
NULL	Nat_Chem_Biol_2010_Apr_28_6(4)_291-299.nxml.txt.nlp	20190765	SENT129	16	16	33	33	dasatinib	EGFR	PA162372878	1956	0.915
NULL	Breast_Cancer_Res_2010_Oct_22_12(Suppl_2)_S1.nxml.txt.nlp	21050422	SENT178	0	0	8	8	neratinib	HER2	PA165291472	2064	0.915
NULL	J_Carcinog_2014_Feb_20_13_4.nxml.txt.nlp	24737952	SENT55	9	9	21	21	cisplatin	HER2	PA449014	2064	0.915
NULL	Case_Rep_Med_2013_Aug_4_2013_373981.nxml.txt.nlp	23983708	SENT75	30	30	17	17	imatinib	KIT	PA10804	3815	0.915
NULL	Cell_Death_Dis_2014_Mar_13_5(3)_e1118.nxml.txt.nlp	24625977	SENT303	13	13	32	32	etoposide	p53	PA449552	7157	0.915
NULL	Cell_Res_2013_Mar_4_23(3)_340-350.nxml.txt.nlp	23208419	SENT42	16	16	22	22	doxorubicin	p53	PA449412	7157	0.915
NULL	Clin_Ophthalmol_2014_Mar_2_8_343-346.nxml.txt.nlp	24591809	SENT80	10	10	15	15	ranibizumab	PED	PA164746012	8682	0.915
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Jan_16_64(Pt_2)_o444.nxml.txt.nlp	21201471	SENT63	10	10	4	4	ethanol	mol	PA448073	90527	0.915
NULL	Int_J_Med_Sci_2013_Jan_22_10(3)_250-254.nxml.txt.nlp	23372431	SENT98	8	8	26	26	tacrolimus	IL-2	PA451578	3558	0.915
NULL	Br_J_Cancer_2013_Feb_19_108(3)_557-563.nxml.txt.nlp	23361053	SENT21	20	20	25	25	tamoxifen	aromatase	PA451581	1588	0.915
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_19_2013_746486.nxml.txt.nlp	23861712	SENT144	0	0	12	12	sn-38	UGT		7361;7355	0.915
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT195	19	19	14	14	methotrexate	MSH2	PA450428	4436	0.915
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT58	25	25	40	40	docetaxel	ABCC10	PA449383	89845	0.915
NULL	Arthritis_Res_Ther_2011_Feb_4_13(1)_R14.nxml.txt.nlp	21294864	SENT15	28	28	17	17	indomethacin	M-CSF	PA449982	1435	0.915
NULL	Autoimmune_Dis_2013_Aug_28_2013_613086.nxml.txt.nlp	24069534	SENT6	33	33	38	38	ustekinumab	p40	PA166048654	3921;339541;10314	0.915
NULL	Nucleic_Acids_Res_2013_Apr_17_41(7)_4129-4143.nxml.txt.nlp	23420868	SENT161	13	13	1	1	hemin	GATA-1	PA449849	2623	0.915
NULL	Front_Chem_2014_Jul_29_2_56.nxml.txt.nlp	25121087	SENT121	16	16	34	34	l-glutamine	CO2	PA10090	4513	0.915
NULL	Oncotarget_2013_Nov_23_5(1)_196-210.nxml.txt.nlp	24344116	SENT69	18	18	27	27	doxorubicin	CXCL1	PA449412	2919	0.915
NULL	Cell_Res_2013_Jul_21_23(7)_915-930.nxml.txt.nlp	23689279	SENT110	29	29	8	8	ethanol	ALDH2	PA448073	217	0.915
NULL	Alcohol_Res_Health_2007_30(1)_38-47.nxml.txt.nlp	17718399	SENT60	8	8	21	21	ethanol	CYP2E1	PA448073	1571	0.915
NULL	Case_Rep_Ophthalmol_Med_2012_Feb_14_2012_894062.nxml.txt.nlp	22606505	SENT35	22	22	18	18	doxorubicin	CHOP	PA449412	1649	0.915
NULL	J_Cell_Mol_Med_2013_Oct_16_17(10)_1261-1270.nxml.txt.nlp	23855452	SENT231	28	28	2	2	cisplatin	CHK2	PA449014	11200	0.915
NULL	Cancers_(Basel)_2013_May_27_5(2)_617-638.nxml.txt.nlp	24216994	SENT340	12	12	2	2	curcumin	PC3	PA151958596	57332;7832;5122	0.915
NULL	Cancer_Cell_2007_Dec_11_12(6)_514-527.nxml.txt.nlp	18068629	SENT53	4	4	17	17	paclitaxel	TGFBI	PA450761	7045	0.915
NULL	Breast_Cancer_Res_2012_Feb_14_14(1)_R30.nxml.txt.nlp	22333315	SENT165	15	15	3	3	celecoxib	CXCL9	PA448871	4283	0.915
NULL	Br_J_Cancer_2009_May_19_100(10)_1517-1522.nxml.txt.nlp	19367275	SENT68	25	25	14	14	trastuzumab	PTEN	PA451743	5728	0.915
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1059-1066.nxml.txt.nlp	21364577	SENT3	13	13	10	10	anastrozole	aromatase	PA448432	1588	0.915
NULL	Front_Integr_Neurosci_2012_Jun_14_6_29.nxml.txt.nlp	22712007	SENT176	5	5	20	20	temozolomide	spatial	PA451609	219793	0.915
NULL	Diabetes_Care_2009_Sep_15_32(9)_1656-1662.nxml.txt.nlp	19528367	SENT50	12	12	40	40	pioglitazone	U100	PA450970	692149	0.915
NULL	Mediators_Inflamm_2010_Mar_7_2010_364957.nxml.txt.nlp	20224654	SENT133	10	10	21	21	metformin	IL-6	PA450395	3569	0.915
NULL	Indian_J_Med_Res_2014_Aug_140(2)_262-270.nxml.txt.nlp	25297360	SENT96	27	27	10	10	meropenem	P24	PA164764445	928	0.915
NULL	Arthritis_Rheum_2013_Dec_27_65(12)_3058-3062.nxml.txt.nlp	24022229	SENT113	0	0	18	18	rituximab	BACH2	PA451261	60468	0.915
NULL	Mol_Cancer_2012_Mar_25_11_16.nxml.txt.nlp	22443473	SENT423	7	7	19	19	fasudil	CD34	PA165946121	947	0.915
NULL	Infect_Ecol_Epidemiol_2012_Mar_27_2_10_3402_iee_v2i0_7438.nxml.txt.nlp	22957135	SENT9	17	17	39	39	ciprofloxacin	VAN	PA449009	10318	0.915
NULL	Drugs_R_D_2010_Sep_27_10(3)_179-202.nxml.txt.nlp	20945948	SENT348	10	10	40	40	telaprevir	TPR2	PA165958354	7266	0.915
NULL	Br_J_Cancer_2009_Jul_21_101(2)_238-243.nxml.txt.nlp	19568242	SENT12	3	3	10	10	sunitinib	IFN	PA162372840	3439	0.915
NULL	Cardiol_Res_Pract_2013_Feb_19_2013_195456.nxml.txt.nlp	23533940	SENT223	12	12	9	9	cangrelor	P2Y12	PA165945763	64805	0.915
NULL	Int_J_Mol_Sci_2014_Sep_11_15(9)_15994-16011.nxml.txt.nlp	25216334	SENT38	30	30	23	23	pazopanib	VEGFR	PA165291492	3791	0.915
NULL	Oncotarget_2013_Jul_15_4(8)_1241-1252.nxml.txt.nlp	23872733	SENT137	14	14	29	29	doxorubicin	TRAIL	PA449412	8743	0.915
NULL	AAPS_J_2013_Aug_20_15(4)_1119-1127.nxml.txt.nlp	23959685	SENT163	18	18	28	28	caffeine	CPE	PA448710	1363	0.915
NULL	Ann_Oncol_2011_Mar_8_22(3)_503-514.nxml.txt.nlp	20616198	SENT173	14	14	11	11	tamoxifen	aromatase	PA451581	1588	0.915
NULL	Ann_Rheum_Dis_2008_Apr_20_67(4)_511-517.nxml.txt.nlp	17644552	SENT13	13	13	4	4	infliximab	IL-6	PA452639	3569	0.915
NULL	Breast_Cancer_Res_2005_Nov_11_7(6)_255-257.nxml.txt.nlp	16457700	SENT10	6	6	30	30	anastrozole	aromatase	PA448432	1588	0.915
NULL	Adv_Urol_2012_Oct_26_2012_812398.nxml.txt.nlp	22110495	SENT98	28	28	9	9	cisplatin	ERCC1	PA449014	2067	0.915
NULL	Biomed_Res_Int_2014_Jan_29_2014_232870.nxml.txt.nlp	24592384	SENT128	7	7	9	9	tamoxifen	HEXIM1	PA451581	10614	0.915
NULL	Nucleic_Acids_Res_2013_May_5_41(10)_5210-5222.nxml.txt.nlp	23563151	SENT207	5	5	36	36	arsenite	GADD45	PA452638	1647	0.915
NULL	J_Korean_Med_Sci_2014_Jul_11_29(7)_965-972.nxml.txt.nlp	25045229	SENT96	16	16	9	9	metformin	B12	PA450395	7126;4709	0.915
NULL	Mol_Cancer_2006_Oct_17_5_45.nxml.txt.nlp	17044934	SENT90	12	12	39	39	resveratrol	COX		1351	0.915
NULL	J_Neuroinflammation_2010_Sep_7_7_51.nxml.txt.nlp	20822529	SENT154	1	1	20	20	hemin	p38	PA449849	10598;1432;7965	0.915
NULL	Oncotarget_2013_Nov_22_5(4)_933-943.nxml.txt.nlp	24659749	SENT43	17	17	3	3	nutlin-3	AML2		864	0.915
NULL	Cancer_Biol_Med_2012_Mar_9(1)_1-8.nxml.txt.nlp	23691447	SENT171	5	5	17	17	lipase	LPA	PA450239	4018	0.915
NULL	Mol_Vis_2007_Jul_12_13_1130-1137.nxml.txt.nlp	17653058	SENT178	15	15	8	8	lidocaine	IL-8	PA450226	3576	0.915
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Dec_18_67(Pt_1)_o202.nxml.txt.nlp	21522704	SENT59	12	12	4	4	ethanol	mol	PA448073	90527	0.915
NULL	Eukaryot_Cell_2014_Aug_13(8)_1077-1084.nxml.txt.nlp	24951438	SENT155	21	21	2	2	doxycycline	HSF1	PA449415	3297	0.915
NULL	Cancer_Med_2014_Aug_18_3(4)_1025-1034.nxml.txt.nlp	24944108	SENT30	5	5	18	18	metformin	aromatase	PA450395	1588	0.915
NULL	Oncotarget_2012_Dec_31_3(12)_1653-1668.nxml.txt.nlp	23391506	SENT170	17	17	8	8	carmustine	U87	PA448810	677775;641648	0.915
NULL	Oncogene_2009_Feb_5_28(5)_742-751.nxml.txt.nlp	19043454	SENT74	26	26	9	9	doxorubicin	TOP2A	PA449412	7153	0.915
NULL	Hum_Genomics_Proteomics_2010_Aug_3_2010_159761.nxml.txt.nlp	20981231	SENT151	20	20	5	5	lithium	BDNF	PA450243	627	0.915
NULL	Ann_Rheum_Dis_2012_Dec_6_71(12)_1950-1954.nxml.txt.nlp	22615456	SENT152	11	11	7	7	tocilizumab	IL-6	PA165292659	3569	0.915
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT198	25	25	28	28	sitagliptin	10C	PA164748978	64333	0.915
NULL	Basic_Res_Cardiol_2015_Jan_20_110_4.nxml.txt.nlp	25600226	SENT363	17	17	2	2	fenofibrate	PCSK9	PA449594	255738	0.915
NULL	Curr_Hepat_Rep_2010_May_21_9(2)_75-90.nxml.txt.nlp	20461127	SENT278	19	19	13	13	telbivudine	LAM	PA164760861	7249;7248	0.915
NULL	Oncotarget_2014_Jun_22_5(13)_4581-4602.nxml.txt.nlp	25015035	SENT390	31	31	22	22	temsirolimus	EGFR	PA164746890	1956	0.915
NULL	Eur_J_Clin_Pharmacol_2007_Apr_21_63(4)_335-343.nxml.txt.nlp	17318526	SENT234	35	35	42	42	trimethoprim	CYP2C8	PA451788	1558	0.915
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT126	14	14	11	11	atorvastatin	RANKL	PA448500	8600	0.915
NULL	Mol_Cancer_2007_Aug_21_6_53.nxml.txt.nlp	17711579	SENT395	8	8	36	36	cisplatin	p53	PA449014	7157	0.915
NULL	Ann_Oncol_2011_Mar_8_22(3)_503-514.nxml.txt.nlp	20616198	SENT25	14	14	27	27	exemestane	aromatase	PA449563	1588	0.915
NULL	Adv_Hematol_2012_Jul_24_2012_513702.nxml.txt.nlp	22888354	SENT40	4	4	27	27	lenalidomide	FOXP3	PA162363968	50943	0.915
NULL	Cell_Cycle_2012_Nov_1_11(21)_3983-3996.nxml.txt.nlp	22987153	SENT209	16	16	24	24	cisplatin	FANCD2	PA449014	2177	0.915
NULL	Int_J_Breast_Cancer_2011_Jul_12_2011_232435.nxml.txt.nlp	22295213	SENT263	0	0	7	7	tamoxifen	EGFR	PA451581	1956	0.915
NULL	Cell_Death_Dis_2014_Feb_27_5(2)_e1088.nxml.txt.nlp	24577086	SENT99	22	22	7	7	metformin	LC3	PA450395	84557	0.915
NULL	Exp_Lung_Res_2013_Oct_1_39(8)_336-348.nxml.txt.nlp	23919450	SENT28	7	7	9	9	thrombin	PAR-1	PA451674	2011;2149	0.914
NULL	Breast_Cancer_Res_2002_Sep_10_4(6)_218-221.nxml.txt.nlp	12473166	SENT44	16	16	6	6	anastrozole	ATAC	PA448432	6375	0.914
NULL	Clin_Pharmacokinet_2014_Jun_27_53(8)_741-751.nxml.txt.nlp	24968986	SENT311	12	12	1	1	temozolomide	MDR1	PA451609	5243	0.914
NULL	J_Cell_Mol_Med_2014_May_14_18(5)_811-823.nxml.txt.nlp	24628949	SENT216	11	11	3	3	docetaxel	FOXM1	PA449383	2305	0.914
NULL	Oncol_Lett_2014_Mar_19_7(3)_674-678.nxml.txt.nlp	24527071	SENT7	19	19	13	13	cisplatin	AKR1C2	PA449014	1646	0.914
NULL	J_Cancer_Res_Clin_Oncol_2012_Jul_10_138(7)_1113-1120.nxml.txt.nlp	22402597	SENT153	15	15	2	2	fludarabine	CD4	PA449655	920	0.914
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT6	45	45	28	28	tacrolimus	IL-6	PA451578	3569	0.914
NULL	Eur_J_Neurosci_2008_Apr_1_27(7)_1722-1730.nxml.txt.nlp	18380669	SENT235	8	8	5	5	sr144528	CB2		1269	0.914
NULL	Breast_Cancer_Res_2007_Aug_10_9(4)_R52.nxml.txt.nlp	17692126	SENT5	9	9	13	13	exemestane	aromatase	PA449563	1588	0.914
NULL	Int_J_Mol_Sci_2014_Sep_29_15(10)_17411-17441.nxml.txt.nlp	25268615	SENT338	21	21	5	5	paclitaxel	CD147	PA450761	682	0.914
NULL	Autoimmune_Dis_2014_Jan_16_2014_731806.nxml.txt.nlp	24527208	SENT15	31	31	21	21	cyclophosphamide	gamma	PA449165	9913	0.914
NULL	Br_J_Cancer_2012_Sep_25_107(7)_1044-1050.nxml.txt.nlp	22910317	SENT188	14	14	17	17	vatalanib	CD31	PA7001	5175	0.914
NULL	Biomed_Res_Int_2014_May_20_2014_418975.nxml.txt.nlp	24967364	SENT251	12	12	24	24	taurine	IL-10	PA451590	3586	0.914
NULL	Int_J_Endocrinol_2014_Mar_11_2014_927317.nxml.txt.nlp	24738001	SENT9	12	12	1	1	sitagliptin	GLP-1	PA164748978	100125288	0.914
NULL	Oncotarget_2013_Jun_26_4(7)_1008-1018.nxml.txt.nlp	23900284	SENT155	29	29	21	21	bortezomib	SLAMF7	PA10252	57823	0.914
NULL	Part_Fibre_Toxicol_2012_May_31_9_18.nxml.txt.nlp	22650444	SENT311	7	7	43	43	glutaraldehyde	TEM	PA449777	64102	0.914
NULL	Arthritis_Res_Ther_2014_Jul_18_16(4)_R153.nxml.txt.nlp	25037855	SENT143	19	19	31	31	adalimumab	CD14	PA10004	929	0.914
NULL	Ther_Clin_Risk_Manag_2006_Dec_2(4)_435-445.nxml.txt.nlp	18360654	SENT143	33	33	5	5	gemcitabine	EGFR	PA449748	1956	0.914
NULL	Case_Rep_Oncol_2013_Aug_14_6(2)_430-433.nxml.txt.nlp	24019783	SENT9	28	28	16	16	crizotinib	Met	PA165946122	79811	0.914
NULL	Cancer_Immunol_Immunother_2011_Jun_25_60(6)_793-808.nxml.txt.nlp	21350947	SENT264	28	28	20	20	temsirolimus	IFN	PA164746890	3439	0.914
NULL	Pharmaceuticals_(Basel)_2013_Aug_21_6(8)_988-1038.nxml.txt.nlp	24276379	SENT2898	15	15	19	19	cetuximab	KRAS	PA10040	3845	0.914
NULL	Cancers_(Basel)_2013_Nov_1_5(4)_1379-1412.nxml.txt.nlp	24202450	SENT160	9	9	14	14	sunitinib	IFN	PA162372840	3439	0.914
NULL	Br_J_Cancer_2012_Feb_28_106(5)_883-888.nxml.txt.nlp	22315050	SENT98	11	11	19	19	cetuximab	KRAS	PA10040	3845	0.914
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT259	10	10	21	21	erlotinib	PI3K	PA134687924	5290	0.914
NULL	Oncol_Lett_2014_Sep_19_8(3)_1269-1274.nxml.txt.nlp	25120704	SENT11	15	15	5	5	cisplatin	Met	PA449014	79811	0.914
NULL	Acta_Pharmacol_Sin_2010_Apr_8_31(4)_461-469.nxml.txt.nlp	20208553	SENT48	21	21	1	1	ethanol	adiponectin	PA448073	9370	0.914
NULL	Ann_Rheum_Dis_2011_Sep_12_70(11)_2003-2007.nxml.txt.nlp	21914628	SENT130	11	11	7	7	tocilizumab	IL-6	PA165292659	3569	0.914
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_75-89.nxml.txt.nlp	17912638	SENT1	7	7	2	2	letrozole	aromatase	PA450196	1588	0.914
NULL	Ann_Rheum_Dis_2008_Oct_25_68(10)_1644-1650.nxml.txt.nlp	18957484	SENT14	4	4	18	18	leflunomide	CD69	PA450192	969	0.914
NULL	Breast_Cancer_Res_2012_Nov_5_14(6)_R143.nxml.txt.nlp	23127292	SENT169	37	37	42	42	tamoxifen	p53	PA451581	7157	0.914
NULL	Clin_Drug_Investig_2013_Aug_23_33(10)_727-736.nxml.txt.nlp	23975654	SENT172	25	25	22	22	fluvoxamine	CYP2D6	PA449690	1565	0.914
NULL	J_Cancer_2014_Jul_4_5(7)_559-571.nxml.txt.nlp	25057307	SENT189	35	35	8	8	tamoxifen	CYP2D6	PA451581	1565	0.914
NULL	Br_J_Cancer_2012_Jun_26_107(1)_53-62.nxml.txt.nlp	22677907	SENT13	36	36	11	11	bortezomib	PC-3	PA10252	692094	0.914
NULL	Breast_Cancer_Res_2011_Dec_16_13(6)_R131.nxml.txt.nlp	22177475	SENT12	9	9	46	46	trastuzumab	AKT	PA451743	207	0.914
NULL	J_Korean_Med_Sci_2013_Aug_31_28(8)_1248-1252.nxml.txt.nlp	23960456	SENT35	28	28	12	12	imatinib	FDG	PA10804	23583	0.914
NULL	Arch_Med_Sci_2012_May_9_8(2)_375-388.nxml.txt.nlp	22662015	SENT256	32	32	26	26	cimetidine	CYP3A4	PA449001	1576	0.914
NULL	Breast_Cancer_Res_2004_Oct_24_6(1)_R8-R17.nxml.txt.nlp	14680495	SENT181	24	24	37	37	tamoxifen	BRCA2	PA451581	675	0.914
NULL	Cancer_Metastasis_Rev_2010_Sep_24_29(3)_465-482.nxml.txt.nlp	20730632	SENT295	31	31	18	18	genistein	CXCL12	PA165109660	6387	0.914
NULL	Oncol_Rep_2013_Jun_22_29(6)_2479-2485.nxml.txt.nlp	23525656	SENT31	4	4	19	19	nilotinib	KIT	PA165958345	3815	0.914
NULL	Br_J_Cancer_2012_May_8_106(10)_1587-1590.nxml.txt.nlp	22568998	SENT98	7	7	22	22	sunitinib	IFN	PA162372840	3439	0.914
NULL	Acta_Orthop_2010_Dec_26_81(6)_748-755.nxml.txt.nlp	21067431	SENT75	40	40	17	17	sc-560	ANOVA		4858	0.914
NULL	Acta_Pharmacol_Sin_2014_Jun_5_35(6)_727-737.nxml.txt.nlp	24793312	SENT135	4	4	10	10	telmisartan	B27	PA451605	56246	0.914
NULL	Cancer_Metab_2014_Aug_28_2_12.nxml.txt.nlp	25184038	SENT311	12	12	24	24	metformin	CO2	PA450395	4513	0.914
NULL	Diabetes_Care_2013_Jul_12_36(7)_1913-1918.nxml.txt.nlp	23359361	SENT143	33	33	24	24	sitagliptin	GLP-1	PA164748978	100125288	0.914
NULL	Glycobiology_2008_Jun_4_18(6)_426-440.nxml.txt.nlp	18390826	SENT78	0	0	19	19	heparin	IL8	PA449855	3576	0.914
NULL	Breast_Cancer_Res_2007_Aug_10_9(4)_R52.nxml.txt.nlp	17692126	SENT245	23	23	15	15	exemestane	aromatase	PA449563	1588	0.914
NULL	Oxid_Med_Cell_Longev_2013_Jun_2_2013_793525.nxml.txt.nlp	23819014	SENT125	26	26	5	5	resveratrol	SGBS		2719	0.914
NULL	Br_J_Cancer_2009_Jul_21_101(2)_269-277.nxml.txt.nlp	19603033	SENT7	13	13	26	26	cisplatin	p53	PA449014	7157	0.914
NULL	Exp_Ther_Med_2013_Apr_11_5(4)_1147-1152.nxml.txt.nlp	23599738	SENT121	15	15	8	8	fentanyl	OPRM1	PA449599	4988	0.914
NULL	Oncologist_2010_Sep_24_15(9)_924-934.nxml.txt.nlp	20736298	SENT172	14	14	18	18	lapatinib	HER-2	PA152241907	2064	0.914
NULL	Front_Endocrinol_(Lausanne)_2015_Jan_9_5_235.nxml.txt.nlp	25620956	SENT300	12	12	5	5	glucosamine	c-Rel	PA164747613	5966	0.914
NULL	Environ_Health_Perspect_2005_Jun_24_113(6)_675-679.nxml.txt.nlp	15929888	SENT134	34	34	17	17	estradiol	p38	PA449503	10598;1432;7965	0.914
NULL	Mol_Cancer_2014_Jul_2_13_163.nxml.txt.nlp	24990559	SENT212	14	14	5	5	hyaluronan	CD44	PA165958431	960	0.914
NULL	Arthritis_Res_Ther_2006_Mar_21_8(2)_206.nxml.txt.nlp	16569256	SENT374	27	27	21	21	alendronate	ACL	PA448082	47	0.914
NULL	Acta_Pharmacol_Sin_2009_May_6_30(5)_576-581.nxml.txt.nlp	19349965	SENT120	8	8	27	27	genistein	VR1	PA165109660	56664	0.914
NULL	Brain_Sci_2013_Jun_19_3(2)_964-991.nxml.txt.nlp	24961433	SENT87	16	16	28	28	ethanol	ngn1	PA448073	4762	0.914
NULL	Oncol_Rep_2014_Apr_28_31(4)_1605-1612.nxml.txt.nlp	24481648	SENT98	12	12	20	20	cisplatin	MRP7	PA449014	89845;1080	0.914
NULL	Open_AIDS_J_2011_Jul_11_5_62-66.nxml.txt.nlp	21772932	SENT14	11	11	36	36	stavudine	CD4	PA451494	920	0.914
NULL	Patient_Prefer_Adherence_2011_Dec_23_6_1-9.nxml.txt.nlp	22272064	SENT70	13	13	16	16	telmisartan	ACE	PA451605	1636	0.914
NULL	Int_J_Breast_Cancer_2011_Sep_6_2011_352182.nxml.txt.nlp	22295219	SENT133	22	22	13	13	trastuzumab	PTEN	PA451743	5728	0.914
NULL	Curr_Neuropharmacol_2013_Dec_11(6)_592-597.nxml.txt.nlp	24396335	SENT92	33	33	14	14	naloxone	PAR1	PA450586	79581;2149	0.914
NULL	Diabetes_Obes_Metab_2010_Aug_12(8)_700-708.nxml.txt.nlp	20590747	SENT27	12	12	35	35	vildagliptin	GLP-1	PA165958346	100125288	0.914
NULL	J_Cell_Mol_Med_2014_Mar_10_18(3)_514-529.nxml.txt.nlp	24410795	SENT198	17	17	3	3	resveratrol	SIRT1		23411	0.914
NULL	Int_J_Biol_Sci_2013_May_8_9(5)_435-443.nxml.txt.nlp	23678293	SENT152	6	6	31	31	imatinib	STAT1	PA10804	6772	0.914
NULL	Pharmaceuticals_(Basel)_2013_Aug_21_6(8)_988-1038.nxml.txt.nlp	24276379	SENT353	18	18	9	9	cetuximab	PTEN	PA10040	5728	0.914
NULL	Thorax_2009_Sep_22_64(9)_763-769.nxml.txt.nlp	19237390	SENT55	25	25	35	35	salmeterol	ANOVA	PA451300	4858	0.914
NULL	J_Cell_Biol_2006_Sep_25_174(7)_1097-1106.nxml.txt.nlp	16982797	SENT148	33	33	8	8	trypsin	SDC1	PA451806	6382	0.914
NULL	BioDrugs_2013_May_9_27(5)_469-478.nxml.txt.nlp	23658121	SENT90	10	10	2	2	vinorelbine	TPC	PA451881	8030;60386	0.914
NULL	Ann_Dermatol_2014_Feb_17_26(1)_79-87.nxml.txt.nlp	24648690	SENT77	28	28	8	8	paraformaldehyde	SFRP2	PA450790	6423	0.914
NULL	Oxid_Med_Cell_Longev_2013_Apr_21_2013_412576.nxml.txt.nlp	23710286	SENT7	3	3	16	16	curcumin	NRF1	PA151958596	4899;4779	0.914
NULL	Trials_2013_May_4_14_125.nxml.txt.nlp	23782591	SENT183	4	4	37	37	donepezil	CYP3A5	PA449394	1577	0.914
NULL	Eukaryot_Cell_2014_Aug_13(8)_1077-1084.nxml.txt.nlp	24951438	SENT182	24	24	5	5	doxycycline	RSP5	PA449415	23327	0.914
NULL	Aging_(Albany_NY)_2013_Feb_21_5(2)_94-95.nxml.txt.nlp	23518473	SENT13	12	12	19	19	resveratrol	SIRT1		23411	0.914
NULL	Indian_J_Dermatol_2012_Nov-Dec_57(6)_466-474.nxml.txt.nlp	23248365	SENT62	4	4	16	16	tacrolimus	IL-2	PA451578	3558	0.914
NULL	Open_Access_J_Urol_2011_May_10_3_69-82.nxml.txt.nlp	24198638	SENT66	13	13	27	27	ifosfamide	CYP2C9	PA449964	1559	0.914
NULL	J_Exp_Med_1998_Jun_1_187(11)_1885-1892.nxml.txt.nlp	9607928	SENT118	15	15	9	9	thalidomide	IFN	PA451644	3439	0.914
NULL	Blood_Cancer_J_2012_Sep_7_2(9)_e89.nxml.txt.nlp	22961061	SENT68	20	20	44	44	bortezomib	FGFR3	PA10252	2261	0.914
NULL	Case_Rep_Oncol_Med_2012_Sep_11_2012_726424.nxml.txt.nlp	22997596	SENT11	19	19	15	15	cyclophosphamide	PRL	PA449165	5617	0.914
NULL	Bone_Joint_Res_2014_Mar_1_3(3)_51-59.nxml.txt.nlp	24615710	SENT185	8	8	27	27	resveratrol	SOX9		6662	0.914
NULL	Br_J_Clin_Pharmacol_2012_Feb_73(2)_203-209.nxml.txt.nlp	21848574	SENT44	11	11	4	4	moxifloxacin	E14	PA450555	4863	0.914
NULL	Iran_J_Ped_Hematol_Oncol_2014_Mar_15_4(1)_32-38.nxml.txt.nlp	24734162	SENT42	16	16	13	13	allopurinol	XDH	PA448320	7498	0.914
NULL	Pharmaceutics_2011_Oct_12_3(4)_680-705.nxml.txt.nlp	24309303	SENT1025	30	30	2	2	repaglinide	OATP1B1	PA451234	10599	0.914
NULL	FEBS_J_2009_Jan_276(1)_199-209.nxml.txt.nlp	19032597	SENT141	22	22	35	35	geldanamycin	Hsp90	PA152031327	3320	0.914
NULL	Cancer_Imaging_2008_Mar_25_8(1)_57-69.nxml.txt.nlp	18390389	SENT209	26	26	10	10	thyroglobulin	FDG	PA164754910	23583	0.914
NULL	J_Biomed_Biotechnol_2010_Mar_22_2010_702836.nxml.txt.nlp	20339474	SENT98	27	27	25	25	fluoxetine	5-HTT	PA449673	6532	0.914
NULL	J_Invest_Dermatol_2013_Jun_14_133(6)_1541-1549.nxml.txt.nlp	23407395	SENT130	35	35	23	23	imiquimod	CXCL2	PA449972	2920	0.914
NULL	Mol_Cancer_2013_May_24_12_47.nxml.txt.nlp	23705854	SENT249	11	11	16	16	nimesulide	MRP1	PA137179528	4437	0.914
NULL	Adv_Prev_Med_2012_Sep_20_2012_507571.nxml.txt.nlp	21991452	SENT184	13	13	18	18	cyanocobalamin	B12	PA451892	7126;4709	0.914
NULL	Oncotarget_2014_Oct_21_5(22)_11180-11192.nxml.txt.nlp	25361003	SENT221	11	11	24	24	forskolin	NRG1	PA146096022	3084	0.914
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT376	17	17	7	7	resveratrol	SMRT		9612	0.914
NULL	Diabetes_Care_2013_Jul_12_36(7)_2062-2069.nxml.txt.nlp	23359363	SENT49	24	24	10	10	aprotinin	GLP-1	PA448472	100125288	0.914
NULL	Oncotarget_2013_Jul_15_4(8)_1126-1127.nxml.txt.nlp	23907591	SENT21	9	9	5	5	denosumab	RANKL	PA166048634	8600	0.914
NULL	J_Oncol_2010_May_24_2010_729725.nxml.txt.nlp	20508816	SENT37	21	21	6	6	sunitinib	VEGFR	PA162372840	3791	0.914
NULL	Front_Oncol_2014_Apr_9_4_75.nxml.txt.nlp	24782986	SENT190	3	3	11	11	paclitaxel	CD34	PA450761	947	0.914
NULL	Diabetes_Obes_Metab_2011_Nov_13(11)_982-989.nxml.txt.nlp	21615670	SENT140	5	5	19	19	exenatide	PPG	PA164749238	5552	0.914
NULL	Anticancer_Drugs_2015_Feb_22_26(2)_139-147.nxml.txt.nlp	25203626	SENT172	4	4	10	10	sorafenib	EZH2	PA7000	2146	0.914
NULL	Mol_Cancer_2010_Nov_8_9_291.nxml.txt.nlp	21059223	SENT93	2	2	21	21	paclitaxel	ZNF217	PA450761	7764	0.914
NULL	Clin_Med_Insights_Arthritis_Musculoskelet_Disord_2013_Aug_8_6_35-43.nxml.txt.nlp	23997576	SENT204	5	5	2	2	tocilizumab	IL-6	PA165292659	3569	0.914
NULL	Oncol_Lett_2013_Jun_4_5(6)_1872-1876.nxml.txt.nlp	23833659	SENT123	11	11	15	15	flavopiridol	Bcl-2	PA452627	596	0.914
NULL	Oncol_Lett_2014_Jul_16_8(1)_211-217.nxml.txt.nlp	24959248	SENT94	29	29	6	6	cisplatin	ANGPTL4	PA449014	51129	0.914
NULL	J_Breast_Cancer_2014_Jun_27_17(2)_113-120.nxml.txt.nlp	25013431	SENT152	4	4	6	6	trastuzumab	HER2	PA451743	2064	0.914
NULL	Adv_Ther_2013_Oct_25_30(10)_870-884.nxml.txt.nlp	24158787	SENT210	10	10	14	14	exemestane	aromatase	PA449563	1588	0.914
NULL	J_Oncol_2013_Aug_20_2013_732047.nxml.txt.nlp	24027583	SENT109	28	28	4	4	paclitaxel	HER2	PA450761	2064	0.914
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT281	17	17	13	13	resveratrol	IL-6		3569	0.914
NULL	Acta_Pharmacol_Sin_2014_Jan_9_35(1)_1-10.nxml.txt.nlp	24317012	SENT23	28	28	9	9	irinotecan	SLCO1B3	PA450085	28234	0.914
NULL	Evid_Based_Complement_Alternat_Med_2014_May_8_2014_404505.nxml.txt.nlp	24899908	SENT145	11	11	24	24	warfarin	CYP2C9	PA451906	1559	0.914
NULL	Breast_Cancer_Res_2011_Dec_16_13(6)_R131.nxml.txt.nlp	22177475	SENT12	15	15	36	36	gefitinib	HER2	PA131301952	2064	0.914
NULL	Int_J_Mol_Sci_2014_Mar_24_15(3)_5140-5162.nxml.txt.nlp	24663085	SENT116	22	22	10	10	galactose	LP1	PA449725	6176	0.914
NULL	Oncotarget_2012_Sep_28_3(10)_1169-1181.nxml.txt.nlp	23045411	SENT83	19	19	6	6	doxorubicin	JIP1	PA449412	9479	0.914
NULL	Cancer_Cell_Int_2010_Apr_29_10_12.nxml.txt.nlp	20429927	SENT140	22	22	15	15	bortezomib	HRI	PA10252	27102	0.914
NULL	Basic_Clin_Neurosci_2014_Winter_5(1)_31-41.nxml.txt.nlp	25436082	SENT234	24	24	14	14	remifentanil	c-fos	PA451232	2353	0.914
NULL	Diabetes_2009_Jan_58(1)_250-259.nxml.txt.nlp	18840786	SENT265	36	36	9	9	rosiglitazone	FGF21	PA451283	26291	0.914
NULL	Chin_J_Cancer_2012_Mar_31(3)_150-158.nxml.txt.nlp	22360854	SENT175	10	10	13	13	mitoxantrone	ABCG2	PA450526	9429	0.914
NULL	Ann_Oncol_2011_Mar_8_22(3)_503-514.nxml.txt.nlp	20616198	SENT172	33	33	30	30	tamoxifen	aromatase	PA451581	1588	0.914
NULL	Indian_Dermatol_Online_J_2013_Jul-Sep_4(3)_167-171.nxml.txt.nlp	23984225	SENT109	7	7	27	27	azathioprine	TPMT	PA448515	7172	0.914
NULL	Arthritis_Res_Ther_2007_Mar_5_9(2)_205.nxml.txt.nlp	17349064	SENT134	13	13	6	6	rituximab	CD19	PA451261	930	0.914
NULL	Clin_Transl_Allergy_2013_Sep_26_3_32.nxml.txt.nlp	24070009	SENT60	8	8	40	40	anakinra	IL1RN	PA10799	3557	0.914
NULL	Acta_Crystallogr_Sect_F_Struct_Biol_Cryst_Commun_2008_Mar_29_64(Pt_4)_313-317.nxml.txt.nlp	18391435	SENT33	4	4	0	0	thrombin	HNF4	PA451674	3172	0.914
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT166	41	41	1	1	nifedipine	TDI	PA450631	100038246	0.914
NULL	J_Cell_Biol_2001_Apr_2_153(1)_207-220.nxml.txt.nlp	11285286	SENT528	10	10	0	0	carbachol	CD69	PA448784	969	0.914
NULL	F1000Res_2013_Oct_8_2_173.nxml.txt.nlp	24555085	SENT181	8	8	22	22	hydrocortisone	CYP3A5	PA449905	1577	0.914
NULL	Infect_Drug_Resist_2009_Apr_24_2_13-26.nxml.txt.nlp	21694884	SENT303	4	4	6	6	tenofovir	TDF	PA10204	6736	0.914
NULL	Evid_Based_Complement_Alternat_Med_2012_May_7_2012_242810.nxml.txt.nlp	22645625	SENT32	5	5	20	20	rifampin	CYP3A4	PA451250	1576	0.914
NULL	Mycopathologia_2014_Dec_6_177(1-2)_11-18.nxml.txt.nlp	24306184	SENT137	25	25	15	15	anidulafungin	IPA	PA164742938	3160	0.914
NULL	Mol_Cancer_2012_Apr_26_11_24.nxml.txt.nlp	22537161	SENT139	15	15	36	36	pp2	PP2		4888	0.914
NULL	Front_Immunol_2013_Oct_18_4_341.nxml.txt.nlp	24151496	SENT176	11	11	26	26	rituximab	AAV	PA451261	17	0.914
NULL	eLife_2013_May_28_2_e00498.nxml.txt.nlp	23741617	SENT239	17	17	10	10	doxycycline	IRE1	PA449415	2081	0.914
NULL	Mol_Cancer_2004_Nov_17_3_31.nxml.txt.nlp	15548330	SENT124	20	20	7	7	etoposide	PC-3	PA449552	692094	0.914
NULL	Int_J_Biol_Sci_2014_Jun_10_10(7)_654-663.nxml.txt.nlp	25013375	SENT113	14	14	25	25	nelfinavir	AKT	PA450606	207	0.914
NULL	Nat_Med_2012_Jul_18(7)_1118-1122.nxml.txt.nlp	22683780	SENT42	25	25	19	19	crizotinib	MET	PA165946122	4233	0.914
NULL	Endocrinology_2012_Jul_5_153(7)_3190-3198.nxml.txt.nlp	22669896	SENT167	0	0	8	8	genistein	PI3K	PA165109660	5290	0.914
NULL	Cell_Death_Dis_2014_Jan_16_5(1)_e994.nxml.txt.nlp	24434517	SENT82	5	5	33	33	ivermectin	DD2	PA450133	1646	0.914
NULL	Mol_Biol_Cell_2013_Jun_1_24(11)_1619-1637.nxml.txt.nlp	23576546	SENT113	11	11	2	2	trypsin	SIMPLE	PA451806	9516	0.914
NULL	BMB_Rep_2014_Jul_47(7)_393-398.nxml.txt.nlp	24314142	SENT22	10	10	18	18	neomycin	BI-1	PA450608	7009	0.914
NULL	Lancet_2008_Jul_12_372(9633)_127-138.nxml.txt.nlp	18620950	SENT152	20	20	2	2	amodiaquine	IPT	PA448404	54802	0.914
NULL	Eur_J_Lipid_Sci_Technol_2011_Jul_113(7)_812-831.nxml.txt.nlp	22102794	SENT142	8	8	0	0	choline	DAG	PA448976	1605	0.914
NULL	Cell_Commun_Signal_2009_Oct_27_7_25.nxml.txt.nlp	19860902	SENT54	22	22	11	11	tacrolimus	NFATc	PA451578	4772	0.914
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Mar_24_68(Pt_4)_o1180.nxml.txt.nlp	22606121	SENT63	4	4	27	27	piperazine	mol	PA450977	90527	0.914
NULL	J_Mol_Signal_2014_Mar_6_9_1.nxml.txt.nlp	24597858	SENT107	5	5	12	12	alprenolol	EGFR	PA164750541	1956	0.914
NULL	HSR_Proc_Intensive_Care_Cardiovasc_Anesth_2010_2(3)_161-175.nxml.txt.nlp	23441054	SENT287	10	10	33	33	pentoxifylline	IL-6	PA450864	3569	0.914
NULL	Oncoimmunology_2013_Jan_1_2(1)_e22890.nxml.txt.nlp	23483066	SENT109	7	7	3	3	vemurafenib	IFN	PA165946873	3439	0.914
NULL	Case_Rep_Crit_Care_2014_Aug_19_2014_242703.nxml.txt.nlp	25215245	SENT135	9	9	6	6	nicardipine	APE	PA450620	55704;328	0.914
NULL	Aging_(Albany_NY)_2012_Mar_12_4(3)_146-158.nxml.txt.nlp	22436213	SENT57	5	5	9	9	resveratrol	AMPK		5563	0.914
NULL	Oxid_Med_Cell_Longev_2013_Apr_21_2013_412576.nxml.txt.nlp	23710286	SENT125	4	4	16	16	curcumin	NRF2	PA151958596	2551;4780	0.914
NULL	Arthritis_Res_Ther_2003_Sep_9_5(Suppl_2)_6.nxml.txt.nlp	NULL	SENT18	13	13	2	2	infliximab	ACR	PA452639	49	0.914
NULL	Acta_Pharmacol_Sin_2011_May_25_32(5)_565-572.nxml.txt.nlp	21516132	SENT30	23	23	13	13	imiquimod	TLR8	PA449972	51311	0.914
NULL	Oncotarget_2014_Nov_4_5(22)_11308-11318.nxml.txt.nlp	25350956	SENT266	27	27	34	34	imatinib	CDK2	PA10804	1017	0.914
NULL	Arthritis_Res_Ther_2014_Apr_28_16(2)_R104.nxml.txt.nlp	24774748	SENT152	29	29	17	17	cyclophosphamide	CD4	PA449165	920	0.914
NULL	Breast_Cancer_Res_2007_Oct_26_9(5)_R74.nxml.txt.nlp	17963511	SENT30	24	24	15	15	lapatinib	HER2	PA152241907	2064	0.914
NULL	Eur_J_Clin_Pharmacol_2012_Jan_8_68(1)_29-37.nxml.txt.nlp	21739267	SENT187	12	12	8	8	fluoxetine	CYP2D6	PA449673	1565	0.914
NULL	BMJ_Open_2014_Feb_13_4(2)_e003960.nxml.txt.nlp	24525389	SENT123	33	33	20	20	warfarin	OAT	PA451906	4942	0.914
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT16	28	28	42	42	capsaicin	p53	PA448776	7157	0.914
NULL	Oncogene_2010_Jan_7_29(1)_81-92.nxml.txt.nlp	19784067	SENT174	27	27	18	18	cisplatin	BRG1	PA449014	6597	0.914
NULL	Ther_Clin_Risk_Manag_2007_Mar_3(1)_99-105.nxml.txt.nlp	18360618	SENT15	0	0	26	26	etanercept	p75	PA449515	7133;11168	0.914
NULL	Mol_Cancer_2009_Aug_25_8_66.nxml.txt.nlp	19706164	SENT119	19	19	38	38	celecoxib	p53	PA448871	7157	0.914
NULL	J_Hematol_Oncol_2008_Aug_11_1_11.nxml.txt.nlp	18694493	SENT135	10	10	17	17	bevacizumab	IFN	PA130232992	3439	0.914
NULL	J_Cell_Mol_Med_2013_Oct_23_17(10)_1207-1217.nxml.txt.nlp	24106980	SENT134	22	22	13	13	paclitaxel	PDCD4	PA450761	27250	0.914
NULL	J_Korean_Med_Sci_2010_Jun_24_25(6)_846-852.nxml.txt.nlp	20514304	SENT134	17	17	12	12	cisplatin	GSTP1	PA449014	2950	0.914
NULL	J_Mol_Med_(Berl)_2012_Apr_30_90(4)_401-411.nxml.txt.nlp	22038171	SENT197	9	9	27	27	tetracycline	HIF-1	PA451640	29072	0.914
NULL	Arch_Drug_Inf_2011_Mar_4(1)_1-9.nxml.txt.nlp	21572514	SENT183	9	9	3	3	sulfinpyrazone	P-gp	PA451550	5243	0.914
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Dec_17_3(12)_e152.nxml.txt.nlp	25518025	SENT80	27	27	17	17	itraconazole	UGT	PA450132	7361;7355	0.914
NULL	Nat_Med_2013_Nov_27_19(11)_10_1038_nm_3364.nxml.txt.nlp	24162813	SENT193	33	33	19	19	imatinib	PTH	PA10804	5741	0.914
NULL	Mol_Cell_Proteomics_2014_May_17_13(5)_1273-1285.nxml.txt.nlp	24637012	SENT198	18	18	21	21	lisuride	5-HT2A	PA164749019	3356	0.914
NULL	J_Headache_Pain_2014_Sep_18_15(Suppl_1)_G16.nxml.txt.nlp	NULL	SENT7	0	0	22	22	capsaicin	TRPV1	PA448776	7442	0.914
NULL	Lipids_Health_Dis_2011_Feb_12_10_31.nxml.txt.nlp	21314960	SENT125	2	2	12	12	hemin	HO-1	PA449849	3162	0.914
NULL	Cancer_Cell_Int_2013_Jan_15_13_3.nxml.txt.nlp	23320839	SENT132	7	7	17	17	dasatinib	ABCG1	PA162372878	9619	0.914
NULL	Blood_Cancer_J_2012_Oct_12_2(10)_e93.nxml.txt.nlp	23064741	SENT37	17	17	11	11	vincristine	CHOP	PA451879	1649	0.914
NULL	J_Nucl_Cardiol_2012_Dec_17_19(6)_1211-1225.nxml.txt.nlp	23073913	SENT110	12	12	20	20	simvastatin	FDG	PA451363	23583	0.914
NULL	J_Physiol_2008_Jul_1_586(Pt_13)_3087-3095.nxml.txt.nlp	18467363	SENT98	10	10	20	20	lipase	DAG	PA450239	1605	0.914
NULL	Ann_Hematol_2010_Sep_13_89(9)_861-871.nxml.txt.nlp	20387067	SENT135	31	31	19	19	dasatinib	CD34	PA162372878	947	0.914
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT521	21	21	15	15	resveratrol	SRC		6714	0.914
NULL	Int_J_Med_Sci_2013_Jan_3_10(2)_141-147.nxml.txt.nlp	23329885	SENT60	6	6	1	1	creatine	AGAT	PA164778930	2628	0.914
NULL	Oncotarget_2013_Aug_24_4(10)_1618-1631.nxml.txt.nlp	24113128	SENT211	31	31	38	38	sorafenib	p53	PA7000	7157	0.914
NULL	Arthritis_Res_Ther_2006_Nov_30_8(1)_R10.nxml.txt.nlp	16356198	SENT27	21	21	5	5	bleomycin	CCR2	PA448645	729230	0.914
NULL	Support_Care_Cancer_2009_Sep_10_17(9)_1187-1193.nxml.txt.nlp	19205754	SENT41	15	15	5	5	dolasetron	CYP2D6	PA449390	1565	0.914
NULL	Int_J_Mol_Imaging_2011_Oct_26_2011_874585.nxml.txt.nlp	21490735	SENT204	32	32	0	0	tamoxifen	FDG	PA451581	23583	0.914
NULL	Indian_J_Dermatol_2011_May-Jun_56(3)_306-308.nxml.txt.nlp	21772594	SENT69	25	25	11	11	doxorubicin	CHP	PA449412	11261	0.914
NULL	Bioinformation_2012_Jan_6_8(1)_13-19.nxml.txt.nlp	22359429	SENT51	40	40	3	3	curcumin	MRP1	PA151958596	4437	0.914
NULL	Biosci_Rep_2013_Sep_4_33(5)_e00064.nxml.txt.nlp	23889169	SENT61	30	30	18	18	thrombin	PAR2	PA451674	2150;55065;8856	0.914
NULL	Ecancermedicalscience_2008_Feb_18_2_75.nxml.txt.nlp	22275966	SENT139	23	23	35	35	gefitinib	PTEN	PA131301952	5728	0.914
NULL	Lipids_Health_Dis_2011_Feb_28_10_38.nxml.txt.nlp	21352602	SENT73	11	11	18	18	atorvastatin	PCSK9	PA448500	255738	0.914
NULL	Antimicrob_Agents_Chemother_2014_Dec_58(12)_7340-7346.nxml.txt.nlp	25267661	SENT202	0	0	2	2	piperaquine	CYP3A4	PA166104279	1576	0.914
NULL	Biosci_Rep_2013_Nov_25_33(6)_e00081.nxml.txt.nlp	24070327	SENT189	23	23	8	8	vincristine	survivin	PA451879	332	0.914
NULL	Front_Oncol_2014_Mar_25_4_54.nxml.txt.nlp	24724051	SENT421	5	5	28	28	nilotinib	SYK	PA165958345	6850	0.914
NULL	Mol_Cancer_2010_Oct_12_9_269.nxml.txt.nlp	20939893	SENT130	10	10	0	0	isoproterenol	c-Jun	PA450121	3725	0.914
NULL	EMBO_Mol_Med_2012_Apr_4(4)_298-312.nxml.txt.nlp	22331558	SENT167	7	7	41	41	etoposide	SIRT1	PA449552	23411	0.914
NULL	J_Thromb_Thrombolysis_2011_Nov_26_32(4)_459-466.nxml.txt.nlp	21706290	SENT88	13	13	7	7	clopidogrel	CYP2C19	PA449053	1557	0.914
NULL	Oncoimmunology_2014_Apr_25_3_e28497.nxml.txt.nlp	25050215	SENT88	14	14	28	28	hydralazine	MMP9	PA449894	4318	0.914
NULL	J_Cardiovasc_Dis_Res_2012_Jan-Mar_3(1)_12-18.nxml.txt.nlp	22346139	SENT122	10	10	0	0	heparin	EC-SOD	PA449855	6649	0.914
NULL	Int_J_Mol_Sci_2010_Oct_25_11(10)_4165-4174.nxml.txt.nlp	21152328	SENT111	27	27	7	7	ethanol	mol	PA448073	90527	0.914
NULL	Br_J_Cancer_2009_Sep_15_101(6)_957-966.nxml.txt.nlp	19738618	SENT170	25	25	13	13	dexrazoxane	THBS-1	PA449259	7057	0.914
NULL	Oncol_Rep_2013_Sep_1_30(3)_1045-1052.nxml.txt.nlp	23817662	SENT142	13	13	17	17	erlotinib	EGFR	PA134687924	1956	0.914
NULL	Mol_Cancer_2008_Mar_6_7_24.nxml.txt.nlp	18325101	SENT76	9	9	28	28	cisplatin	FANCD2	PA449014	2177	0.914
NULL	Acta_Pharmacol_Sin_2012_Jun_14_33(6)_832-838.nxml.txt.nlp	22580740	SENT13	30	30	13	13	cisplatin	GEM	PA449014	2669	0.914
NULL	Blood_Cancer_J_2012_Oct_19_2(10)_e95.nxml.txt.nlp	23085780	SENT51	17	17	10	10	dasatinib	PAH	PA162372878	5053	0.914
NULL	J_Cell_Biol_2002_Jun_24_157(7)_1151-1160.nxml.txt.nlp	12082077	SENT98	25	25	6	6	trypsin	COX	PA451806	1351	0.914
NULL	Mol_Cancer_2010_Aug_23_9_222.nxml.txt.nlp	20731837	SENT210	6	6	13	13	gefitinib	ATM	PA131301952	472	0.914
NULL	J_Thorac_Oncol_2014_Oct_23_9(10)_1443-1448.nxml.txt.nlp	25521397	SENT105	33	33	27	27	crizotinib	EGFR	PA165946122	1956	0.914
NULL	Behav_Brain_Funct_2008_Aug_15_4_37.nxml.txt.nlp	18702828	SENT101	39	39	24	24	methamphetamine	FZD3	PA450403	7976;8326	0.914
NULL	Arthritis_Res_Ther_2014_Apr_3_16(2)_R86.nxml.txt.nlp	24708674	SENT190	0	0	13	13	bosentan	COL1A2	PA10034	1278	0.914
NULL	Ann_Thorac_Med_2014_Apr-Jun_9(2)_124-126.nxml.txt.nlp	24791177	SENT5	27	27	5	5	sirolimus	LAM	PA451365	7249;7248	0.914
NULL	EMBO_Mol_Med_2012_Feb_4(2)_93-108.nxml.txt.nlp	22246988	SENT91	10	10	32	32	tetracycline	ATF3	PA451640	467	0.914
NULL	Indian_J_Pharmacol_2013_May-Jun_45(3)_298-300.nxml.txt.nlp	23833379	SENT13	8	8	23	23	zidovudine	CD4	PA451954	920	0.914
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT159	5	5	31	31	nutlin-3	p53		7157	0.914
NULL	J_Cell_Biol_2001_Apr_2_153(1)_207-220.nxml.txt.nlp	11285286	SENT497	10	10	0	0	carbachol	CD69	PA448784	969	0.914
NULL	Evid_Based_Complement_Alternat_Med_2011_Jan_20_2011_713523.nxml.txt.nlp	21318104	SENT119	32	32	0	0	naproxen	SRM	PA450595	6723;6725	0.914
NULL	Br_J_Cancer_2013_Jun_25_108(12)_2464-2469.nxml.txt.nlp	23695016	SENT16	11	11	17	17	carboplatin	CRT	PA448803	811	0.914
NULL	Acta_Pharmacol_Sin_2010_Mar_22_31(3)_329-340.nxml.txt.nlp	20173759	SENT80	19	19	39	39	ethanol	AMPK	PA448073	5563	0.914
NULL	Chem_Rev_2011_Oct_12_111(10)_5899-5921.nxml.txt.nlp	21923193	SENT563	20	20	14	14	meloxicam	COX	PA450353	1351	0.914
NULL	Ann_Oncol_2012_Dec_2_23(12)_3007-3016.nxml.txt.nlp	22865781	SENT81	12	12	25	25	pertuzumab	HER2		2064	0.914
NULL	Mol_Biol_Cell_2012_Oct_15_23(20)_3936-3947.nxml.txt.nlp	22933571	SENT113	15	15	29	29	galactose	TIM10	PA449725	26519	0.914
NULL	Cancers_(Basel)_2012_May_8_4(2)_523-530.nxml.txt.nlp	24213322	SENT19	35	35	9	9	cetuximab	EGFR	PA10040	1956	0.914
NULL	Acta_Histochem_Cytochem_2011_Apr_28_44(2)_51-60.nxml.txt.nlp	21614166	SENT460	35	35	9	9	thalidomide	CD31	PA451644	5175	0.914
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_P104.nxml.txt.nlp	NULL	SENT19	2	2	0	0	nevirapine	DPT	PA450616	1805	0.914
NULL	Oncotarget_2014_Jun_3_5(13)_4920-4928.nxml.txt.nlp	24952482	SENT116	0	0	6	6	crizotinib	EGFR	PA165946122	1956	0.914
NULL	Exp_Diabetes_Res_2012_May_14_2012_470851.nxml.txt.nlp	22666230	SENT5	17	17	12	12	exenatide	GLP-1	PA164749238	100125288	0.914
NULL	Cell_Res_2013_Jul_21_23(7)_915-930.nxml.txt.nlp	23689279	SENT107	11	11	16	16	ethanol	ALDH2	PA448073	217	0.914
NULL	Cell_Cycle_2013_Sep_15_12(18)_3013-3024.nxml.txt.nlp	23974104	SENT74	15	15	9	9	disulfiram	MYH9	PA449376	4627	0.914
NULL	Mol_Cancer_2014_Jun_24_13_157.nxml.txt.nlp	24958351	SENT170	28	28	15	15	lapatinib	AKT	PA152241907	207	0.914
NULL	Breast_Cancer_Res_2010_Jun_24_12(3)_R41.nxml.txt.nlp	20576088	SENT253	7	7	28	28	paclitaxel	PPM1D	PA450761	8493	0.914
NULL	Mar_Drugs_2014_Nov_24_12(11)_5698-5718.nxml.txt.nlp	25421324	SENT22	7	7	2	2	s-adenosylmethionine	STX	PA164754994	8128	0.914
NULL	Br_J_Pharmacol_2008_Sep_9_155(1)_127-137.nxml.txt.nlp	18536750	SENT190	13	13	8	8	piroxicam	IL-10	PA450985	3586	0.914
NULL	Leukemia_2014_Aug_4_28(8)_1573-1585.nxml.txt.nlp	24496300	SENT218	14	14	1	1	verapamil	P-gp	PA451868	5243	0.914
NULL	Calcif_Tissue_Int_2011_Aug_3_89(2)_91-104.nxml.txt.nlp	21637997	SENT157	3	3	0	0	denosumab	RANKL	PA166048634	8600	0.914
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2013_Dec_8_6_75-79.nxml.txt.nlp	24348081	SENT66	14	14	23	23	colesevelam	GLP-1	PA449095	100125288	0.914
NULL	Nat_Commun_2013_Apr_9_4_1684.nxml.txt.nlp	23575688	SENT135	11	11	7	7	forskolin	CYLD	PA146096022	1540	0.914
NULL	Eur_J_Haematol_2007_Nov_79(5)_455-461.nxml.txt.nlp	17908180	SENT129	4	4	25	25	rituximab	IL-6	PA451261	3569	0.914
NULL	Iran_J_Pharm_Res_2014_Winter_13(Suppl)_35-42.nxml.txt.nlp	24711827	SENT229	16	16	6	6	cangrelor	P2Y12	PA165945763	64805	0.914
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT131	13	13	24	24	sulindac	survivin	PA451565	332	0.914
NULL	Clin_Interv_Aging_2012_Dec_30_7_1-13.nxml.txt.nlp	22291468	SENT136	0	0	35	35	dronedarone	CYP3A4	PA153619853	1576	0.914
NULL	Br_J_Cancer_2011_Oct_25_105(9)_1331-1337.nxml.txt.nlp	21970881	SENT135	30	30	21	21	olmesartan	MVD	PA164742950	4597	0.914
NULL	Breast_Cancer_Res_2007_Dec_17_9(6)_R87.nxml.txt.nlp	18086299	SENT185	38	38	13	13	trastuzumab	PTEN	PA451743	5728	0.914
NULL	Br_J_Cancer_2010_Nov_2_103(11)_1671-1679.nxml.txt.nlp	21045835	SENT10	6	6	14	14	gemcitabine	CXCL12	PA449748	6387	0.914
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT122	7	7	31	31	dasatinib	PP2	PA162372878	4888	0.914
NULL	Blood_Cancer_J_2013_Mar_1_3(3)_e103.nxml.txt.nlp	23454896	SENT149	39	39	10	10	saquinavir	AKT	PA451305	207	0.914
NULL	Front_Oncol_2014_Sep_15_4_244.nxml.txt.nlp	25309870	SENT28	5	5	1	1	erlotinib	EGFR	PA134687924	1956	0.914
NULL	Mol_Pain_2014_Feb_6_10_10.nxml.txt.nlp	24499354	SENT330	6	6	8	8	cyclophosphamide	CTX	PA449165	1593	0.914
NULL	Diabetes_2013_Jun_17_62(6)_2095-2105.nxml.txt.nlp	23349482	SENT32	4	4	40	40	fenofibrate	XBP1	PA449594	7494	0.914
NULL	Allergy_Asthma_Clin_Immunol_2013_Oct_3_9(1)_39.nxml.txt.nlp	24219860	SENT39	3	3	8	8	rituximab	BAFF	PA451261	10673	0.914
NULL	Breast_Cancer_Res_2001_Oct_11_3(6)_380-384.nxml.txt.nlp	11737889	SENT92	5	5	22	22	paclitaxel	HER-2	PA450761	2064	0.914
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2007_Dec_21_64(Pt_1)_o313.nxml.txt.nlp	21200875	SENT59	35	35	7	7	acetone	mol	PA448025	90527	0.914
NULL	Int_J_Mol_Sci_2014_Jun_5_15(6)_10083-10100.nxml.txt.nlp	24905407	SENT59	15	15	20	20	tetracycline	TRB	PA451640	6957	0.914
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_7-17.nxml.txt.nlp	17912633	SENT386	4	4	33	33	letrozole	aromatase	PA450196	1588	0.914
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jul_11_65(Pt_8)_o1820.nxml.txt.nlp	21583522	SENT49	21	21	16	16	ethanol	mol	PA448073	90527	0.914
NULL	Cardiol_Res_Pract_2012_Jan_5_2012_909154.nxml.txt.nlp	22347666	SENT208	4	4	14	14	clopidogrel	P2Y12	PA449053	64805	0.914
NULL	Clin_Transl_Allergy_2013_Sep_2_3_29.nxml.txt.nlp	24004581	SENT169	16	16	5	5	omalizumab	IL-4	PA164752253	3565	0.914
NULL	Br_J_Cancer_2012_May_8_106(10)_1689-1696.nxml.txt.nlp	22531631	SENT210	13	13	0	0	rosuvastatin	PC-3	PA134308647	692094	0.914
NULL	J_Cancer_Prev_2014_Mar_19(1)_39-46.nxml.txt.nlp	25337571	SENT108	14	14	26	26	ethanol	p38	PA448073	10598;1432;7965	0.914
NULL	Breast_Cancer_Res_2006_Nov_6_8(6)_215.nxml.txt.nlp	17096862	SENT104	13	13	30	30	lapatinib	EGFR	PA152241907	1956	0.914
NULL	Clin_Med_Insights_Cardiol_2010_Dec_1_4_117-128.nxml.txt.nlp	21151850	SENT56	21	21	0	0	clopidogrel	CYP2C19	PA449053	1557	0.914
NULL	Onco_Targets_Ther_2014_Sep_18_7_1619-1624.nxml.txt.nlp	25258542	SENT58	18	18	6	6	cetuximab	EGFR	PA10040	1956	0.914
NULL	Front_Neurosci_2010_Jun_17_4_35.nxml.txt.nlp	20661455	SENT664	3	3	14	14	milnacipran	5-HT1A	PA164752812	3350	0.914
NULL	Ann_Hematol_2010_Nov_25_89(11)_1115-1124.nxml.txt.nlp	20499237	SENT118	19	19	5	5	simvastatin	CD5	PA451363	921	0.914
NULL	Mol_Cancer_2009_May_15_8_28.nxml.txt.nlp	19445670	SENT46	13	13	0	0	doxorubicin	Bcl-2	PA449412	596	0.914
NULL	Acta_Pharmacol_Sin_2012_Apr_12_33(4)_542-550.nxml.txt.nlp	22407228	SENT18	13	13	27	27	perifosine	ATG5	PA165291471	9474	0.914
NULL	Br_J_Cancer_2012_Sep_4_107(6)_947-955.nxml.txt.nlp	22892392	SENT5	12	12	3	3	tamoxifen	ERBB2	PA451581	2064	0.914
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_13_2012_636848.nxml.txt.nlp	23258994	SENT154	19	19	0	0	carrageenan	TRPV4	PA448814	59341	0.914
NULL	Oncotarget_2012_Oct_20_3(10)_1068-1111.nxml.txt.nlp	23085539	SENT60	12	12	23	23	vemurafenib	BRAF	PA165946873	673	0.914
NULL	Cancer_Res_Treat_2014_Jul_15_46(3)_261-269.nxml.txt.nlp	25038761	SENT56	6	6	25	25	rituximab	CRT	PA451261	811	0.914
NULL	Chin_J_Cancer_2012_Oct_31(10)_476-483.nxml.txt.nlp	22692073	SENT140	17	17	25	25	cisplatin	RRM1	PA449014	6240	0.914
NULL	J_Headache_Pain_2007_Jun_11_8(3)_175-179.nxml.txt.nlp	17563841	SENT32	14	14	5	5	diclofenac	COX	PA449293	1351	0.914
NULL	Anesth_Pain_Med_2014_Sep_2_4(4)_e18488.nxml.txt.nlp	25337472	SENT82	23	23	3	3	vecuronium	Sak	PA164748865	10733	0.914
NULL	Cancer_Immunol_Immunother_2011_Jun_25_60(6)_793-808.nxml.txt.nlp	21350947	SENT17	25	25	9	9	sorafenib	IFNAR2	PA7000	3455	0.914
NULL	Cell_Oncol_(Dordr)_2011_Apr_11_34(2)_89-95.nxml.txt.nlp	21394646	SENT193	17	17	38	38	trastuzumab	HER2	PA451743	2064	0.914
NULL	Eur_J_Clin_Pharmacol_2010_Nov_29_66(11)_1131-1136.nxml.txt.nlp	20669013	SENT132	15	15	9	9	voriconazole	CYP3A4	PA10233	1576	0.914
NULL	Front_Cell_Neurosci_2015_Jan_15_8_459.nxml.txt.nlp	25642166	SENT338	13	13	0	0	hemin	PI3K	PA449849	5290	0.914
NULL	Cases_J_2009_Apr_28_2_6602.nxml.txt.nlp	19829828	SENT67	27	27	20	20	colchicine	CYP3A4	PA449092	1576	0.914
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT789	18	18	8	8	imatinib	SLCO1A2	PA10804	6579	0.914
NULL	Mol_Cancer_2012_May_28_11_36.nxml.txt.nlp	22640878	SENT285	25	25	43	43	paclitaxel	TGFBI	PA450761	7045	0.914
NULL	Biochim_Biophys_Acta_2014_Apr_1841(4)_588-594.nxml.txt.nlp	24440819	SENT33	20	20	0	0	lipase	ATGL	PA450239	57104	0.914
NULL	J_Cell_Mol_Med_2014_Aug_1_18(8)_1599-1611.nxml.txt.nlp	24889822	SENT299	13	13	5	5	resveratrol	SIRT1		23411	0.914
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1149.nxml.txt.nlp	24675467	SENT293	17	17	44	44	artesunate	p62	PA165111697	8878;10657;23636	0.914
NULL	Virol_J_2011_Nov_28_8_523.nxml.txt.nlp	22122911	SENT7	11	11	8	8	heparin	RANTES	PA449855	6352	0.914
NULL	Oncotarget_2014_Dec_4_5(22)_11365-11380.nxml.txt.nlp	25426548	SENT39	7	7	14	14	nutlin-3	p53		7157	0.914
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT216	12	12	16	16	perifosine	DR5	PA165291471	8795	0.914
NULL	Breast_Cancer_Res_2004_Nov_7_6(1)_39-52.nxml.txt.nlp	14680484	SENT80	19	19	9	9	tamoxifen	SMRT	PA451581	9612	0.914
NULL	Curr_Opin_Obstet_Gynecol_2014_Aug_3_26(4)_226-236.nxml.txt.nlp	24978853	SENT254	3	3	23	23	cyclophosphamide	AMH	PA449165	268	0.914
NULL	J_Neuroengineering_Rehabil_2006_Jul_19_3_16.nxml.txt.nlp	16854224	SENT40	8	8	0	0	acetazolamide	CO2	PA448018	4513	0.914
NULL	EMBO_Mol_Med_2012_Oct_2_4(10)_1043-1056.nxml.txt.nlp	23027611	SENT291	32	32	5	5	phencyclidine	5-HT6	PA128406980	3362	0.914
NULL	Cell_Biochem_Biophys_2013_May_28_67(1)_25-43.nxml.txt.nlp	23712866	SENT128	14	14	2	2	cisplatin	USP2	PA449014	9099	0.914
NULL	Angiogenesis_2010_Dec_7_13(4)_305-315.nxml.txt.nlp	20927579	SENT172	2	2	28	28	resveratrol	TSP1		7057	0.914
NULL	Int_J_Med_Sci_2015_Jan_1_12(1)_78-82.nxml.txt.nlp	25552922	SENT25	24	24	13	13	warfarin	CYP2C9	PA451906	1559	0.914
NULL	Drugs_R_D_2013_Jun_25_13(2)_119-128.nxml.txt.nlp	23615868	SENT86	3	3	14	14	lisdexamfetamine	API	PA164748975	5345	0.914
NULL	Arthritis_Res_Ther_2012_Dec_7_14(6)_R265.nxml.txt.nlp	23217273	SENT168	13	13	25	25	lenalidomide	CLE	PA162363968	51637	0.914
NULL	Cells_2014_May_23_3(2)_517-545.nxml.txt.nlp	24861977	SENT132	5	5	14	14	capsaicin	TRPV1	PA448776	7442	0.914
NULL	COPD_2014_Jun_2_11(3)_310-318.nxml.txt.nlp	24295402	SENT51	9	9	27	27	trypsin	CD73	PA451806	4907	0.914
NULL	Indian_J_Med_Res_2011_Sep_134(3)_369-374.nxml.txt.nlp	21985821	SENT53	22	22	10	10	ethanol	HAP	PA448073	5915;10313	0.914
NULL	Oxid_Med_Cell_Longev_2013_Nov_28_2013_568093.nxml.txt.nlp	24379901	SENT83	2	2	6	6	resveratrol	FOXO1		2308	0.914
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1063.nxml.txt.nlp	24556678	SENT44	21	21	23	23	thioridazine	c-FLIP	PA451666	8837	0.914
NULL	Breast_Cancer_(Auckl)_2012_Mar_7_6_67-77.nxml.txt.nlp	22438669	SENT170	9	9	27	27	lapatinib	HER2	PA152241907	2064	0.914
NULL	Acta_Pharmacol_Sin_2012_Jan_3_33(1)_49-56.nxml.txt.nlp	22212430	SENT109	17	17	14	14	curcumin	A10	PA151958596	28870	0.914
NULL	J_Korean_Med_Sci_2013_Jul_3_28(7)_1005-1014.nxml.txt.nlp	23853482	SENT36	16	16	7	7	cisplatin	TGM2	PA449014	7052	0.914
NULL	Nat_Genet_2014_Feb_12_46(2)_166-170.nxml.txt.nlp	24413734	SENT183	24	24	35	35	dasatinib	FYN	PA162372878	2534	0.914
NULL	Case_Rep_Oncol_Med_2013_Apr_11_2013_485025.nxml.txt.nlp	23878753	SENT96	9	9	21	21	thyroglobulin	EGFR	PA164754910	1956	0.914
NULL	Cells_2012_Jun_25_1(3)_204-247.nxml.txt.nlp	24710474	SENT343	15	15	27	27	geldanamycin	NIK	PA152031327	9020;9448	0.914
NULL	Neuroscience_2009_Jun_30_161(2-3)_572-577.nxml.txt.nlp	19327387	SENT59	8	8	22	22	capsaicin	GAPDH	PA448776	2597	0.914
NULL	JRSM_Cardiovasc_Dis_2012_Sep_24_1(6)_cvd_2012_012015.nxml.txt.nlp	24175073	SENT171	28	28	17	17	ticagrelor	CYP2C19	PA165374673	1557	0.914
NULL	Int_J_Mol_Sci_2013_Apr_24_14(5)_8818-8831.nxml.txt.nlp	23615472	SENT26	19	19	39	39	collagenase	VIII	PA449107	1351	0.914
NULL	Br_J_Cancer_2010_Oct_26_103(9)_1331-1334.nxml.txt.nlp	20877352	SENT32	3	3	13	13	trastuzumab	HER2	PA451743	2064	0.914
NULL	Int_J_Biol_Sci_2013_Apr_22_9(4)_350-360.nxml.txt.nlp	23630447	SENT172	14	14	3	3	doxorubicin	MDR1	PA449412	5243	0.914
NULL	Biomed_Res_Int_2013_Jul_1_2013_416534.nxml.txt.nlp	23936796	SENT37	5	5	14	14	curcumin	EGFR	PA151958596	1956	0.914
NULL	Mar_Drugs_2014_Jun_27_12(7)_3818-3837.nxml.txt.nlp	24979269	SENT149	39	39	3	3	calcein	P-gp	PA132595336	5243	0.914
NULL	Int_J_Mol_Sci_2014_Sep_4_15(9)_15700-15733.nxml.txt.nlp	25192291	SENT1214	15	15	8	8	cisplatin	EGF	PA449014	1950	0.914
NULL	Ecancermedicalscience_2009_Sep_24_3_153.nxml.txt.nlp	22276017	SENT8	24	24	0	0	oxaliplatin	ERCC1	PA131285527	2067	0.914
NULL	Biomed_Res_Int_2013_Aug_6_2013_909613.nxml.txt.nlp	24027765	SENT8	17	17	3	3	metronidazole	IL-10	PA450484	3586	0.914
NULL	Osteoporos_Int_2009_Sep_16_20(9)_1631.nxml.txt.nlp	19085029	SENT3	33	33	23	23	teriparatide	PTH	PA451620	5741	0.914
NULL	Breast_Cancer_Res_2008_Dec_18_10(Suppl_4)_S25.nxml.txt.nlp	19128439	SENT12	38	38	17	17	tamoxifen	ATAC	PA451581	6375	0.914
NULL	Indian_J_Pharm_Sci_2014_Mar-Apr_76(2)_125-131.nxml.txt.nlp	24843185	SENT176	21	21	7	7	resveratrol	S100B		6285	0.914
NULL	J_Neuroinflammation_2011_Feb_4_8_10.nxml.txt.nlp	21294877	SENT104	0	0	7	7	capsaicin	NK1	PA448776	11126	0.914
NULL	Cancer_Res_Treat_2014_Jul_15_46(3)_261-269.nxml.txt.nlp	25038761	SENT56	27	27	25	25	temozolomide	CRT	PA451609	811	0.914
NULL	Oncoimmunology_2012_Oct_1_1(7)_1004-1016.nxml.txt.nlp	23170249	SENT74	9	9	2	2	paclitaxel	HER-2	PA450761	2064	0.914
NULL	Cell_Death_Dis_2014_Mar_20_5(3)_e1133.nxml.txt.nlp	24651436	SENT113	31	31	3	3	l-glutamine	CLS	PA10090	1210	0.914
NULL	J_Psychopharmacol_2010_Jan_24(1)_27-38.nxml.txt.nlp	19204064	SENT6	22	22	4	4	methylphenidate	NK1R	PA450464	6869	0.914
NULL	Blood_Res_2014_Sep_25_49(3)_148-153.nxml.txt.nlp	25325033	SENT47	24	24	15	15	rituximab	B2M	PA451261	567	0.914
NULL	Nat_Commun_2014_Dec_8_5_5736.nxml.txt.nlp	25484020	SENT36	7	7	20	20	letrozole	TRPA1	PA450196	8989	0.914
NULL	Inflammation_2014_Apr_6_37(5)_1476-1485.nxml.txt.nlp	24706026	SENT132	43	43	29	29	curcumin	GATA3	PA151958596	2625	0.914
NULL	Cardiovasc_Ther_2009_27(4)_259-274.nxml.txt.nlp	19604248	SENT47	0	0	4	4	ticagrelor	P2Y12	PA165374673	64805	0.914
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT90	33	33	7	7	erlotinib	EGFR	PA134687924	1956	0.914
NULL	Arch_Med_Sci_2012_Sep_8_8(4)_589-597.nxml.txt.nlp	23056066	SENT129	0	0	12	12	daclizumab	IL-2	PA164764446	3558	0.914
NULL	Cancers_(Basel)_2011_Aug_9_3(3)_3189-3205.nxml.txt.nlp	24212952	SENT79	0	0	14	14	hyaluronan	HAS1	PA165958431	3036	0.914
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1150.nxml.txt.nlp	24675468	SENT12	0	0	30	30	metformin	adiponectin	PA450395	9370	0.914
NULL	Diabetes_Metab_Syndr_Obes_2014_Aug_1_7_381-389.nxml.txt.nlp	25120374	SENT107	4	4	13	13	salsalate	adiponectin	PA164745462	9370	0.914
NULL	Cells_2014_Apr_8_3(2)_258-287.nxml.txt.nlp	24717323	SENT230	19	19	10	10	capsaicin	PAO	PA448776	196743;54498	0.914
NULL	Psychiatry_Investig_2012_Jun_30_9(2)_187-190.nxml.txt.nlp	22707971	SENT9	32	32	1	1	capsaicin	POMC	PA448776	5443	0.914
NULL	J_Korean_Med_Sci_2007_Dec_20_22(6)_946-951.nxml.txt.nlp	18162704	SENT32	24	24	15	15	acetazolamide	SCN4A	PA448018	6329	0.914
NULL	Oncogene_2010_Jul_15_29(28)_4090-4100.nxml.txt.nlp	20473326	SENT79	8	8	16	16	nutlin-3	p53		7157	0.914
NULL	Arch_Plast_Surg_2012_Sep_12_39(5)_540-545.nxml.txt.nlp	23094252	SENT22	13	13	9	9	remifentanil	TCI	PA451232	6947	0.914
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_67-74.nxml.txt.nlp	17912637	SENT2	8	8	2	2	letrozole	aromatase	PA450196	1588	0.914
NULL	J_Ayurveda_Integr_Med_2013_Jan-Mar_4(1)_13-18.nxml.txt.nlp	23741156	SENT74	18	18	3	3	indomethacin	IL-6	PA449982	3569	0.914
NULL	Cancer_2014_Jul_15_120(14)_2130-2141.nxml.txt.nlp	24737397	SENT122	14	14	4	4	daunorubicin	PRL3	PA449212	10879;11156	0.914
NULL	Core_Evid_2010_Oct_22_5_91-105.nxml.txt.nlp	21468365	SENT113	5	5	13	13	atorvastatin	CYP3A4	PA448500	1576	0.914
NULL	Environ_Health_Perspect_2006_Sep_23_114(9)_1401-1406.nxml.txt.nlp	16966095	SENT138	23	23	16	16	tetracycline	p53	PA451640	7157	0.914
NULL	J_Cell_Biol_1998_May_18_141(4)_863-874.nxml.txt.nlp	9585406	SENT79	23	23	16	16	glutaraldehyde	CRM1	PA449777	7514	0.914
NULL	Ital_J_Pediatr_2012_Sep_19_38_45.nxml.txt.nlp	22992442	SENT41	0	0	27	27	fluorescein	CD27	PA164746009	939	0.914
NULL	Int_J_Med_Sci_2012_Oct_23_9(9)_748-756.nxml.txt.nlp	23136537	SENT28	9	9	2	2	cisplatin	CRT	PA449014	811	0.914
NULL	Diabetes_2013_Mar_14_62(3)_953-964.nxml.txt.nlp	23223176	SENT141	35	35	15	15	glucose	PRX	PA449773	9588;57716	0.914
NULL	Nat_Med_2013_Apr_10_19(4)_418-420.nxml.txt.nlp	23475203	SENT82	8	8	13	13	midazolam	CYP3A	PA450496	1574	0.914
NULL	Front_Oncol_2014_Nov_10_4_318.nxml.txt.nlp	25426449	SENT113	12	12	4	4	doxorubicin	PI3K	PA449412	5290	0.914
NULL	Exp_Neurobiol_2014_Jun_13_23(2)_130-137.nxml.txt.nlp	24963277	SENT41	13	13	30	30	tamoxifen	p75	PA451581	7133;11168	0.914
NULL	Pharmacogn_Mag_2014_Oct-Dec_10(40)_536-540.nxml.txt.nlp	25422558	SENT119	11	11	18	18	ethanol	SLB	PA448073	26160	0.914
NULL	Breast_Cancer_Res_2011_Apr_15_13(2)_R44.nxml.txt.nlp	21496232	SENT322	21	21	15	15	erlotinib	HER2	PA134687924	2064	0.914
NULL	Clin_Ophthalmol_2010_Oct_21_4_1229-1236.nxml.txt.nlp	21060677	SENT88	15	15	40	40	latanoprost	BAK	PA164774763	578	0.914
NULL	Patient_Prefer_Adherence_2013_Sep_11_7_891-895.nxml.txt.nlp	24049440	SENT52	14	14	39	39	efavirenz	ART	PA449441	181	0.914
NULL	AAPS_J_2013_Aug_20_15(4)_1119-1127.nxml.txt.nlp	23959685	SENT154	27	27	41	41	ketoprofen	CPE	PA450149	1363	0.914
NULL	Clin_Drug_Investig_2014_Nov_9_34(2)_107-115.nxml.txt.nlp	24214232	SENT40	18	18	6	6	cinacalcet	IMPACT	PA164776671	55364	0.914
NULL	J_Gynecol_Oncol_2012_Jan_9_23(1)_53-64.nxml.txt.nlp	22355468	SENT69	11	11	26	26	olaparib	BRCA2		675	0.914
NULL	Cancer_Immunol_Immunother_2011_Jun_25_60(6)_793-808.nxml.txt.nlp	21350947	SENT154	20	20	17	17	sorafenib	IFN	PA7000	3439	0.914
NULL	Cancer_Manag_Res_2012_Jul_31_4_207-214.nxml.txt.nlp	22904642	SENT32	16	16	24	24	octreotide	S6K1	PA450678	6198	0.914
NULL	Clin_Med_Insights_Oncol_2013_Aug_21_7_221-234.nxml.txt.nlp	24179413	SENT39	2	2	14	14	erlotinib	EGFR	PA134687924	1956	0.914
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Dec_17_3(12)_e152.nxml.txt.nlp	25518025	SENT125	18	18	8	8	ketoconazole	CYP3A	PA450146	1574	0.914
NULL	Iran_J_Pharm_Res_2013_Summer_12(3)_457-469.nxml.txt.nlp	24250652	SENT197	34	34	23	23	indomethacin	spatial	PA449982	219793	0.914
NULL	Cardiol_Res_Pract_2011_Mar_23_2011_568095.nxml.txt.nlp	21559218	SENT42	25	25	22	22	sildenafil	PDE5A	PA451346	8654	0.914
NULL	Acta_Vet_Scand_2001_Jun_30_42(2)_295-302.nxml.txt.nlp	11503375	SENT90	10	10	28	28	tetracycline	spatial	PA451640	219793	0.914
NULL	J_Oncol_2013_Feb_17_2013_872957.nxml.txt.nlp	23476648	SENT107	11	11	2	2	cisplatin	SFN	PA449014	25996;2810	0.914
NULL	Br_J_Cancer_2009_Jul_21_101(2)_238-243.nxml.txt.nlp	19568242	SENT27	17	17	22	22	bevacizumab	IFN	PA130232992	3439	0.914
NULL	Cell_Death_Dis_2013_Sep_5_4(9)_e791.nxml.txt.nlp	24008735	SENT284	1	1	13	13	gemcitabine	PUMA	PA449748	27113	0.914
NULL	Evid_Based_Complement_Alternat_Med_2014_Jan_8_2014_497456.nxml.txt.nlp	24523821	SENT181	9	9	6	6	cisplatin	DDP	PA449014	1678	0.914
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT67	9	9	3	3	curcumin	PC-3	PA151958596	692094	0.914
NULL	Oncotarget_2014_Jun_8_5(13)_5040-5053.nxml.txt.nlp	24970815	SENT252	38	38	34	34	lapatinib	BRAF	PA152241907	673	0.914
NULL	Oncologist_2010_Feb_15_15(2)_122-129.nxml.txt.nlp	20156908	SENT132	5	5	15	15	letrozole	HER-2	PA450196	2064	0.914
NULL	J_Hematol_Oncol_2009_Feb_23_2_9.nxml.txt.nlp	19236713	SENT224	24	24	3	3	gemcitabine	SPARC	PA449748	6678	0.914
NULL	J_Exp_Med_2000_Nov_20_192(10)_1403-1414.nxml.txt.nlp	11085743	SENT103	17	17	9	9	staurosporine	IL-3	PA165109623	3562	0.914
NULL	Br_J_Cancer_2011_Dec_6_105(12)_1920-1926.nxml.txt.nlp	22095222	SENT117	10	10	2	2	erlotinib	KRAS	PA134687924	3845	0.914
NULL	Breast_Cancer_Res_2014_Sep_9_16(5)_433.nxml.txt.nlp	25212966	SENT177	0	0	14	14	thrombin	ILEI	PA451674	10447	0.914
NULL	Br_J_Cancer_2012_Dec_4_107(12)_1950-1955.nxml.txt.nlp	23169295	SENT18	26	26	1	1	oxaliplatin	ERCC1	PA131285527	2067	0.914
NULL	Br_J_Pharmacol_2014_Jan_23_171(2)_523-535.nxml.txt.nlp	24372553	SENT209	41	41	9	9	metformin	SIRT1	PA450395	23411	0.914
NULL	Lab_Anim_Res_2011_Jun_22_27(2)_85-90.nxml.txt.nlp	21826167	SENT22	0	0	3	3	losartan	AT1	PA450268	9197;185	0.914
NULL	Br_J_Cancer_2010_Jan_19_102(2)_383-391.nxml.txt.nlp	20010943	SENT140	21	21	17	17	cisplatin	JNK	PA449014	5599	0.914
NULL	Mol_Biol_Cell_2013_Jul_15_24(14)_2186-2200.nxml.txt.nlp	23699397	SENT86	39	39	45	45	staurosporine	TRAIL	PA165109623	8743	0.914
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT111	20	20	16	16	metformin	p53	PA450395	7157	0.914
NULL	J_Headache_Pain_2012_Nov_16_13(8)_677-684.nxml.txt.nlp	23070400	SENT133	4	4	12	12	nabilone	DAI	PA164746998	81030	0.914
NULL	Oncotarget_2011_Dec_24_2(12)_896-917.nxml.txt.nlp	22203527	SENT182	18	18	10	10	metformin	HER2	PA450395	2064	0.914
NULL	Breast_Cancer_(Auckl)_2014_Jul_29_8_109-118.nxml.txt.nlp	25125981	SENT89	12	12	16	16	neratinib	HER2	PA165291472	2064	0.914
NULL	Int_J_Mol_Sci_2014_May_12_15(5)_8335-8351.nxml.txt.nlp	24823879	SENT107	3	3	24	24	resveratrol	BNIP3		664	0.914
NULL	Breast_Cancer_Res_2011_Mar_10_13(2)_R28.nxml.txt.nlp	21392397	SENT69	3	3	6	6	erlotinib	PI3K	PA134687924	5290	0.914
NULL	Br_J_Cancer_2012_Jul_10_107(2)_230-233.nxml.txt.nlp	22735900	SENT47	12	12	4	4	quinidine	CYP2D6	PA451209	1565	0.914
NULL	Cancer_Manag_Res_2011_Sep_9_3_301-309.nxml.txt.nlp	21931504	SENT138	9	9	16	16	spermine	CXCR4	PA164781199	7852	0.914
NULL	Br_J_Cancer_2013_Feb_5_108(2)_334-341.nxml.txt.nlp	23257893	SENT237	14	14	5	5	sorafenib	NOXA	PA7000	5366	0.914
NULL	Biomed_Res_Int_2013_Dec_5_2013_642848.nxml.txt.nlp	24381940	SENT138	31	31	11	11	telmisartan	IL-6	PA451605	3569	0.914
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_127043.nxml.txt.nlp	23227093	SENT170	11	11	7	7	lovastatin	CYP3A4	PA450272	1576	0.913
NULL	Biomed_Res_Int_2013_Jul_31_2013_692071.nxml.txt.nlp	23984399	SENT181	17	17	9	9	irinotecan	OCT1	PA450085	5451;6580	0.913
NULL	Cancers_(Basel)_2014_Jul_8_6(3)_1487-1499.nxml.txt.nlp	25006835	SENT106	14	14	17	17	cisplatin	HGF	PA449014	3569;6654;3082	0.913
NULL	Indian_J_Endocrinol_Metab_2013_Jan-Feb_17(1)_19-30.nxml.txt.nlp	23776849	SENT270	2	2	14	14	diazoxide	ABCC8	PA449285	6833	0.913
NULL	Br_J_Cancer_2013_Dec_10_109(12)_3067-3072.nxml.txt.nlp	24263065	SENT39	24	24	12	12	irinotecan	KRAS	PA450085	3845	0.913
NULL	Cancers_(Basel)_2014_Apr_16_6(2)_926-957.nxml.txt.nlp	24743778	SENT990	18	18	4	4	tamoxifen	CD44	PA451581	960	0.913
NULL	Int_J_Gen_Med_2010_Oct_5_3_313-320.nxml.txt.nlp	21042570	SENT5	0	0	17	17	natalizumab	CD5	PA164747191	921	0.913
NULL	Int_J_Mol_Imaging_2011_Oct_26_2011_874585.nxml.txt.nlp	21490735	SENT149	46	46	28	28	docetaxel	FDG	PA449383	23583	0.913
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT247	16	16	14	14	nutlin-3	MDM2		4193	0.913
NULL	Nature_2008_Nov_13_456(7219)_269-273.nxml.txt.nlp	18849969	SENT73	17	17	9	9	staurosporine	CRTC2	PA165109623	200186	0.913
NULL	Mol_Cancer_2012_Jul_25_11_47.nxml.txt.nlp	22830443	SENT144	15	15	3	3	panitumumab	EGFR	PA162373091	1956	0.913
NULL	Breast_Cancer_Res_2007_Jul_5_9(4)_R41.nxml.txt.nlp	17612393	SENT15	26	26	13	13	celecoxib	PARP	PA448871	142	0.913
NULL	F1000_Biol_Rep_2011_Nov_1_3_23.nxml.txt.nlp	22065982	SENT140	6	6	18	18	probenecid	URAT1	PA451106	116085	0.913
NULL	Oncotarget_2014_Jun_19_5(15)_6540-6551.nxml.txt.nlp	25153728	SENT129	6	6	9	9	paclitaxel	PI3K	PA450761	5290	0.913
NULL	Oncol_Lett_2013_Feb_7_5(2)_440-446.nxml.txt.nlp	23420122	SENT12	32	32	19	19	sorafenib	EGFR	PA7000	1956	0.913
NULL	Nat_Commun_2014_Dec_8_5_5736.nxml.txt.nlp	25484020	SENT330	2	2	17	17	anastrozole	ATAC	PA448432	6375	0.913
NULL	Cancer_Metastasis_Rev_2010_Sep_24_29(3)_465-482.nxml.txt.nlp	20730632	SENT271	17	17	21	21	genistein	MEK4	PA165109660	6416	0.913
NULL	Breast_Cancer_(Auckl)_2012_Nov_19_6_191-207.nxml.txt.nlp	23226023	SENT244	11	11	18	18	pertuzumab	HER2		2064	0.913
NULL	Br_J_Clin_Pharmacol_2012_Apr_7_73(4)_518-535.nxml.txt.nlp	22053916	SENT51	41	41	16	16	pitavastatin	OATP1B1	PA142650384	10599	0.913
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Aug_18_66(Pt_9)_o2302.nxml.txt.nlp	21588652	SENT57	26	26	13	13	ethanol	mol	PA448073	90527	0.913
NULL	J_Cell_Mol_Med_2014_May_14_18(5)_811-823.nxml.txt.nlp	24628949	SENT98	20	20	15	15	docetaxel	FOXM1	PA449383	2305	0.913
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_13_2013_468537.nxml.txt.nlp	23956772	SENT141	4	4	14	14	etoposide	p53	PA449552	7157	0.913
NULL	J_Cell_Biol_1986_Jul_1_103(1)_87-94.nxml.txt.nlp	3013901	SENT9	9	9	25	25	glutaraldehyde	EGF	PA449777	1950	0.913
NULL	Mol_Cancer_2006_Sep_5_5_34.nxml.txt.nlp	16953886	SENT113	8	8	13	13	doxorubicin	XIAP	PA449412	331	0.913
NULL	Cancer_Microenviron_2009_Sep_26_2(Suppl_1)_19-204.nxml.txt.nlp	NULL	SENT3487	30	30	4	4	sunitinib	U87	PA162372840	677775;641648	0.913
NULL	Nucleic_Acids_Res_2013_Nov_27_41(21)_9786-9799.nxml.txt.nlp	23982513	SENT262	23	23	10	10	arsenite	ZBP1	PA452638	81030	0.913
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2014_Jun_29_70(Pt_7)_1922-1933.nxml.txt.nlp	25004969	SENT13	21	21	16	16	cycloserine	PLP	PA164764600	25824;5744	0.913
NULL	Osteoporos_Int_2009_Sep_16_20(9)_1631.nxml.txt.nlp	19085029	SENT8	17	17	7	7	teriparatide	PTH	PA451620	5741	0.913
NULL	Adv_Hematol_2012_Sep_14_2012_524308.nxml.txt.nlp	21941553	SENT250	16	16	3	3	fludarabine	BFL1	PA449655	597	0.913
NULL	Mol_Cancer_2010_Aug_20_9_220.nxml.txt.nlp	20727180	SENT37	22	22	4	4	nicotine	p53	PA450626	7157	0.913
NULL	Eur_Heart_J_2014_Jul_21_35(28)_1864-1872.nxml.txt.nlp	24561548	SENT129	8	8	21	21	warfarin	TTR	PA451906	7276	0.913
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1063.nxml.txt.nlp	24556678	SENT90	4	4	11	11	thioridazine	TRAIL	PA451666	8743	0.913
NULL	Oncotarget_2014_Nov_2_5(21)_10222-10236.nxml.txt.nlp	25400118	SENT224	26	26	36	36	trastuzumab	EGFR	PA451743	1956	0.913
NULL	Orphanet_J_Rare_Dis_2011_May_28_6_32.nxml.txt.nlp	21619687	SENT250	12	12	2	2	estradiol	HOXA10	PA449503	3206	0.913
NULL	BMB_Rep_2013_Mar_46(3)_157-162.nxml.txt.nlp	23527859	SENT110	17	17	34	34	galactose	mol	PA449725	90527	0.913
NULL	Ann_Oncol_2013_Aug_12_24(8)_1994-1999.nxml.txt.nlp	23670096	SENT105	8	8	1	1	tamoxifen	STEPP	PA451581	222659	0.913
NULL	Arthritis_Res_Ther_2011_Feb_28_13(1)_205.nxml.txt.nlp	21371351	SENT64	15	15	30	30	etanercept	TNF	PA449515	7124	0.913
NULL	Mol_Pain_2012_Sep_22_8_71.nxml.txt.nlp	22998838	SENT124	18	18	7	7	cisplatin	CB2	PA449014	1269	0.913
NULL	Cell_Cycle_2013_Dec_15_12(24)_3759-3769.nxml.txt.nlp	24107633	SENT187	4	4	35	35	metformin	EGF	PA450395	1950	0.913
NULL	Aging_(Albany_NY)_2009_Mar_31_1(4)_412-424.nxml.txt.nlp	20195491	SENT29	0	0	32	32	resveratrol	AMPK		5563	0.913
NULL	Int_J_Cell_Biol_2014_Jan_22_2014_709828.nxml.txt.nlp	24578708	SENT93	2	2	14	14	choline	CTL1	PA448976	23446	0.913
NULL	Hum_Genomics_2009_Jan_1_3(2)_128-142.nxml.txt.nlp	19164090	SENT234	34	34	12	12	carboplatin	CD44	PA448803	960	0.913
NULL	Exp_Ther_Med_2012_Sep_8_4(3)_519-523.nxml.txt.nlp	23181129	SENT84	24	24	1	1	iodine	PTC	PA450049	5979;8030	0.913
NULL	Gut_Liver_2011_Sep_18_5(3)_253-266.nxml.txt.nlp	21927652	SENT65	33	33	23	23	tegaserod	5-HT4	PA130413154	3360	0.913
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT429	15	15	4	4	cetuximab	KRAS	PA10040	3845	0.913
NULL	Gene_Ther_2010_May_18_17(5)_634-642.nxml.txt.nlp	20164856	SENT93	46	46	15	15	paraformaldehyde	CD4	PA450790	920	0.913
NULL	Acta_Pharmacol_Sin_2011_Oct_19_32(10)_1294-1302.nxml.txt.nlp	21927013	SENT22	13	13	4	4	tacrolimus	BCS	PA451578	617	0.913
NULL	Protein_Cell_2014_Apr_14_5(4)_265-296.nxml.txt.nlp	24622842	SENT63	20	20	39	39	s-adenosylmethionine	DNMT3B	PA164754994	1789	0.913
NULL	Exp_Ther_Med_2013_Oct_20_6(4)_899-903.nxml.txt.nlp	24137286	SENT91	7	7	21	21	rosuvastatin	MMP2	PA134308647	4313	0.913
NULL	Acta_Histochem_Cytochem_2012_Apr_26_45(2)_139-146.nxml.txt.nlp	22685356	SENT114	24	24	5	5	forskolin	AQP2	PA146096022	359	0.913
NULL	Diabetologia_2010_Jul_2_53(7)_1270-1287.nxml.txt.nlp	20361178	SENT273	20	20	28	28	pioglitazone	adiponectin	PA450970	9370	0.913
NULL	Arthritis_Res_2002_Mar_27_4(Suppl_2)_S22-S28.nxml.txt.nlp	12110154	SENT80	28	28	13	13	infliximab	IL-8	PA452639	3576	0.913
NULL	J_Immunol_Res_2014_May_8_2014_628289.nxml.txt.nlp	24901012	SENT136	26	26	3	3	calcipotriol	S100A7	PA448714	6278	0.913
NULL	J_Physiol_2013_May_15_591(10)_2429-2441.nxml.txt.nlp	23381899	SENT151	8	8	18	18	picrotoxin	ANOVA	PA164777007	4858	0.913
NULL	Contemp_Oncol_(Pozn)_2012_Nov_20_16(5)_401-406.nxml.txt.nlp	23788917	SENT162	18	18	10	10	canertinib	EGFR	PA134687925	1956	0.913
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_May_12_68(Pt_6)_o1668.nxml.txt.nlp	22719463	SENT67	1	1	15	15	benzaldehyde	mol	PA448571	90527	0.913
NULL	Int_J_Biol_Sci_2012_Oct_25_8(9)_1281-1290.nxml.txt.nlp	23136556	SENT85	40	40	5	5	methacholine	IL-6	PA165958382	3569	0.913
NULL	Basic_Res_Cardiol_2012_Mar_19_107(2)_242.nxml.txt.nlp	22258067	SENT271	24	24	7	7	indomethacin	COX2	PA449982	4513;5743	0.913
NULL	Mol_Cell_Proteomics_2014_May_17_13(5)_1273-1285.nxml.txt.nlp	24637012	SENT19	14	14	32	32	ergotamine	5-HT2A	PA164747651	3356	0.913
NULL	Br_J_Cancer_2012_Nov_20_107(11)_1864-1868.nxml.txt.nlp	23093229	SENT144	16	16	6	6	cetuximab	EGFR	PA10040	1956	0.913
NULL	J_Carcinog_2011_Nov_30_10_29.nxml.txt.nlp	22190871	SENT163	2	2	16	16	lapatinib	AKT	PA152241907	207	0.913
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT105	2	2	5	5	neratinib	HER2	PA165291472	2064	0.913
NULL	Front_Oncol_2014_Apr_9_4_75.nxml.txt.nlp	24782986	SENT250	9	9	13	13	paclitaxel	CA125	PA450761	4077;94025	0.913
NULL	Breast_Cancer_Res_2011_Feb_8_13(1)_202.nxml.txt.nlp	21392411	SENT162	7	7	33	33	metformin	CD24	PA450395	100133941	0.913
NULL	Breast_Cancer_Res_2010_Jun_28_12(3)_R43.nxml.txt.nlp	20579400	SENT42	16	16	13	13	fulvestrant	aromatase	PA164747170	1588	0.913
NULL	Int_J_Womens_Health_2010_Aug_9_1_11-20.nxml.txt.nlp	21072271	SENT147	43	43	25	25	raloxifene	STAR	PA451221	6770;2984	0.913
NULL	Front_Cell_Neurosci_2015_Jan_15_8_459.nxml.txt.nlp	25642166	SENT81	39	39	24	24	hemin	HO-1	PA449849	3162	0.913
NULL	Front_Oncol_2014_Apr_8_4_71.nxml.txt.nlp	24782983	SENT256	15	15	2	2	cisplatin	PTEN	PA449014	5728	0.913
NULL	EMBO_Mol_Med_2013_Dec_8_5(12)_1821-1834.nxml.txt.nlp	24293316	SENT80	5	5	25	25	doxorubicin	UNC5D	PA449412	137970	0.913
NULL	Breast_Cancer_Res_2007_Feb_6_9(1)_R17.nxml.txt.nlp	17280616	SENT27	16	16	18	18	tamoxifen	aromatase	PA451581	1588	0.913
NULL	Endocrinol_Metab_(Seoul)_2014_Sep_25_29(3)_379-387.nxml.txt.nlp	25309798	SENT119	29	29	24	24	resveratrol	BMAL1		406	0.913
NULL	Contemp_Oncol_(Pozn)_2012_Nov_20_16(5)_401-406.nxml.txt.nlp	23788917	SENT30	29	29	23	23	gefitinib	EGFR	PA131301952	1956	0.913
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_May_22_66(Pt_6)_o1399.nxml.txt.nlp	21579478	SENT47	19	19	6	6	ethanol	mol	PA448073	90527	0.913
NULL	Front_Endocrinol_(Lausanne)_2014_Aug_4_5_131.nxml.txt.nlp	25136332	SENT193	0	0	31	31	naltrexone	MC4R	PA450588	4160	0.913
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT231	13	13	6	6	capsaicin	p53	PA448776	7157	0.913
NULL	J_Exp_Med_1998_Jun_1_187(11)_1885-1892.nxml.txt.nlp	9607928	SENT166	6	6	21	21	thalidomide	CD4	PA451644	920	0.913
NULL	J_Viral_Hepat_2013_Mar_20(3)_167-173.nxml.txt.nlp	23383655	SENT30	4	4	32	32	telaprevir	IFN	PA165958354	3439	0.913
NULL	Int_J_Mol_Sci_2012_Feb_24_13(3)_2578-2589.nxml.txt.nlp	22489112	SENT64	12	12	35	35	maprotiline	GAT1	PA450322	6529	0.913
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2654-2664.nxml.txt.nlp	24136149	SENT272	3	3	15	15	doxorubicin	DNA-PKcs	PA449412	5591	0.913
NULL	Oncotarget_2013_Feb_27_4(2)_178-179.nxml.txt.nlp	23563503	SENT12	9	9	44	44	nutlin-3	p53		7157	0.913
NULL	Exp_Diabetes_Res_2012_Jan_29_2012_159874.nxml.txt.nlp	22319521	SENT242	16	16	3	3	telmisartan	VEGF-A	PA451605	7422	0.913
NULL	Front_Mol_Neurosci_2009_Jul_24_2_7.nxml.txt.nlp	19668709	SENT56	24	24	6	6	paraformaldehyde	P15	PA450790	1030;29107	0.913
NULL	J_Adv_Pharm_Technol_Res_2014_Oct-Dec_5(4)_185-190.nxml.txt.nlp	25364697	SENT103	12	12	23	23	metoprolol	ANOVA	PA450480	4858	0.913
NULL	Chemother_Res_Pract_2012_Dec_20_2012_743193.nxml.txt.nlp	23320171	SENT49	11	11	19	19	paclitaxel	HER2	PA450761	2064	0.913
NULL	Int_J_Biol_Sci_2011_Nov_5_8(1)_1-14.nxml.txt.nlp	22211100	SENT239	9	9	23	23	gemcitabine	PTEN	PA449748	5728	0.913
NULL	Neural_Plast_2013_Oct_30_2013_587418.nxml.txt.nlp	24288626	SENT79	25	25	11	11	minocycline	NOX2	PA450519	1536	0.913
NULL	Br_J_Cancer_2013_Apr_16_108(7)_1408-1414.nxml.txt.nlp	23511562	SENT118	13	13	16	16	tamoxifen	aromatase	PA451581	1588	0.913
NULL	EPMA_J_2010_Mar_23_1(1)_56-72.nxml.txt.nlp	23199041	SENT289	23	23	31	31	valsartan	ERG	PA451848	2078	0.913
NULL	Clin_Med_Insights_Circ_Respir_Pulm_Med_2012_Jun_12_6_27-40.nxml.txt.nlp	22745565	SENT25	8	8	31	31	omalizumab	IL-4	PA164752253	3565	0.913
NULL	Cancers_(Basel)_2011_Apr_1_3(2)_1844-1860.nxml.txt.nlp	24212785	SENT56	16	16	8	8	cetuximab	EGFR	PA10040	1956	0.913
NULL	Br_J_Cancer_2011_Jul_12_105(2)_255-262.nxml.txt.nlp	21694725	SENT167	4	4	12	12	cetuximab	KRAS	PA10040	3845	0.913
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Sep_14_67(Pt_10)_o2574.nxml.txt.nlp	22058740	SENT52	23	23	6	6	ethanol	mol	PA448073	90527	0.913
NULL	Curr_Oncol_2009_Sep_16(5)_91-110.nxml.txt.nlp	NULL	SENT902	6	6	15	15	cisplatin	BRCA1	PA449014	672	0.913
NULL	Pharmaceutics_2011_Oct_12_3(4)_680-705.nxml.txt.nlp	24309303	SENT575	3	3	18	18	gemfibrozil	CYP3A4	PA449750	1576	0.913
NULL	J_Korean_Med_Sci_2010_Mar_18_25(3)_496-500.nxml.txt.nlp	20191056	SENT43	11	11	20	20	cyclophosphamide	CHOP	PA449165	1649	0.913
NULL	Clin_Dev_Immunol_2013_Nov_26_2013_325481.nxml.txt.nlp	24371447	SENT125	5	5	13	13	propofol	IL-6	PA451141	3569	0.913
NULL	FEBS_Open_Bio_2014_Jan_6_4_77-89.nxml.txt.nlp	24490132	SENT195	0	0	2	2	ebselen	GDH	PA161660841	51084;2746	0.913
NULL	Breast_Cancer_Res_2009_Jun_29_11(3)_R41.nxml.txt.nlp	19563669	SENT184	23	23	11	11	gefitinib	XIAP	PA131301952	331	0.913
NULL	Cancers_(Basel)_2014_Jul_31_6(3)_1579-1596.nxml.txt.nlp	25089666	SENT429	14	14	2	2	resveratrol	STAT3		6774	0.913
NULL	Springerplus_2013_Feb_18_2_56.nxml.txt.nlp	23487030	SENT161	13	13	36	36	curcumin	ACR	PA151958596	49	0.913
NULL	Cell_Commun_Signal_2013_Jan_11_11_2.nxml.txt.nlp	23305203	SENT191	6	6	20	20	forskolin	RACK1	PA146096022	10399	0.913
NULL	Clinicoecon_Outcomes_Res_2014_Oct_17_6_451-461.nxml.txt.nlp	25378939	SENT139	11	11	21	21	vancomycin	HAP	PA451850	5915;10313	0.913
NULL	Oncogene_2010_Sep_23_29(38)_5299-5310.nxml.txt.nlp	20622903	SENT64	24	24	5	5	melphalan	p53	PA450354	7157	0.913
NULL	Infect_Drug_Resist_2014_May_20_7_129-135.nxml.txt.nlp	24876786	SENT28	27	27	32	32	vancomycin	HAP	PA451850	5915;10313	0.913
NULL	Ann_Oncol_2014_Oct_18_25(10)_1871-1888.nxml.txt.nlp	25234545	SENT317	13	13	7	7	fulvestrant	aromatase	PA164747170	1588	0.913
NULL	Comput_Struct_Biotechnol_J_2013_Oct_18_6_e201303014.nxml.txt.nlp	24688722	SENT128	4	4	1	1	camptothecin	TOP1	PA153590860	7150	0.913
NULL	Pharmaceuticals_(Basel)_2014_Sep_17_7(9)_943-953.nxml.txt.nlp	25232798	SENT23	0	0	21	21	trastuzumab	HER2	PA451743	2064	0.913
NULL	J_Breast_Cancer_2013_Mar_31_16(1)_23-31.nxml.txt.nlp	23593078	SENT142	21	21	8	8	resveratrol	MBD2		8932	0.913
NULL	Ann_Dermatol_2012_Nov_8_24(4)_393-397.nxml.txt.nlp	23197903	SENT107	7	7	0	0	collagenase	MMP1	PA449107	4312	0.913
NULL	Cancers_(Basel)_2010_Mar_12_2(1)_165-189.nxml.txt.nlp	24281039	SENT373	0	0	11	11	nilotinib	PDGFRA	PA165958345	5156	0.913
NULL	Braz_J_Med_Biol_Res_2014_Oct_24_48(1)_65-76.nxml.txt.nlp	25493385	SENT160	18	18	27	27	l-arginine	AT2	PA448478	186	0.913
NULL	Cell_Res_2013_Jul_21_23(7)_915-930.nxml.txt.nlp	23689279	SENT99	3	3	35	35	ethanol	ALDH2	PA448073	217	0.913
NULL	Diabetologia_2010_Jan_6_53(1)_1-6.nxml.txt.nlp	19894028	SENT99	23	23	38	38	sitagliptin	HSM	PA164748978	94030	0.913
NULL	Onco_Targets_Ther_2014_Jun_11_7_969-983.nxml.txt.nlp	24959084	SENT115	29	29	20	20	rifampin	CYP3A4	PA451250	1576	0.913
NULL	J_Biol_Chem_2011_Oct_7_286(40)_34998-35006.nxml.txt.nlp	21757733	SENT34	14	14	30	30	lipase	ATGL	PA450239	57104	0.913
NULL	Cancer_Metab_2013_Feb_4_1_7.nxml.txt.nlp	24280108	SENT199	21	21	8	8	doxycycline	GPT2	PA449415	84706	0.913
NULL	Diabetes_2009_Dec_31_58(12)_2851-2862.nxml.txt.nlp	19720788	SENT149	22	22	13	13	forskolin	CHOP	PA146096022	1649	0.913
NULL	Br_J_Cancer_2010_Jan_5_102(1)_115-123.nxml.txt.nlp	19997099	SENT221	12	12	24	24	cyclophosphamide	GEM	PA449165	2669	0.913
NULL	Tuberc_Respir_Dis_(Seoul)_2013_Aug_30_75(2)_59-66.nxml.txt.nlp	24023558	SENT136	8	8	4	4	docetaxel	FOXO1	PA449383	2308	0.913
NULL	Br_J_Cancer_1988_Nov_58(5)_640-643.nxml.txt.nlp	3064798	SENT11	0	0	10	10	carboplatin	CLB	PA448803	171425	0.913
NULL	Arch_Drug_Inf_2008_Sep_1(2)_50-55.nxml.txt.nlp	19915714	SENT42	14	14	21	21	fentanyl	CYP3A4	PA449599	1576	0.913
NULL	Mol_Cancer_2010_May_20_9_115.nxml.txt.nlp	20487546	SENT153	7	7	28	28	fludarabine	TP53	PA449655	7157	0.913
NULL	J_Biomed_Biotechnol_2011_Dec_6_2011_856985.nxml.txt.nlp	21188173	SENT206	8	8	19	19	tamoxifen	HDAC1	PA451581	3065	0.913
NULL	Pharmaceutics_2011_Sep_14_3(3)_615-635.nxml.txt.nlp	24310600	SENT82	17	17	2	2	sn-38	ABCG2		9429	0.913
NULL	J_Cereb_Blood_Flow_Metab_2012_Apr_4_32(4)_731-744.nxml.txt.nlp	22214903	SENT119	42	42	2	2	zolpidem	ANOVA	PA451976	4858	0.913
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT134	5	5	20	20	tenofovir	ABCB1	PA10204	5243	0.913
NULL	Exp_Ther_Med_2013_Oct_2_6(4)_1062-1066.nxml.txt.nlp	24137317	SENT91	31	31	11	11	erlotinib	SF2	PA134687924	6426	0.913
NULL	Ann_Oncol_2011_Dec_17_22(12)_2610-2615.nxml.txt.nlp	21415234	SENT7	2	2	18	18	lapatinib	EGFR	PA152241907	1956	0.913
NULL	Arch_Toxicol_2009_Jun_27_83(6)_609-617.nxml.txt.nlp	18754102	SENT188	0	0	19	19	curcumin	PC-3	PA151958596	692094	0.913
NULL	Br_J_Cancer_2014_Dec_9_111(12)_2214-2219.nxml.txt.nlp	25211661	SENT128	9	9	7	7	vemurafenib	BRAF	PA165946873	673	0.913
NULL	J_Gynecol_Oncol_2013_Jan_8_24(1)_66-82.nxml.txt.nlp	23346316	SENT71	24	24	8	8	olaparib	BRCA2		675	0.913
NULL	Pharmaceuticals_(Basel)_2013_Aug_2_6(8)_915-928.nxml.txt.nlp	24276376	SENT76	1	1	9	9	thrombin	PAR-1	PA451674	2011;2149	0.913
NULL	Nat_Commun_2014_Aug_6_5_4602.nxml.txt.nlp	25098764	SENT644	22	22	9	9	chloroquine	HGK	PA448948	9448	0.913
NULL	Mol_Cancer_2014_Feb_21_13_33.nxml.txt.nlp	24555688	SENT175	22	22	27	27	doxorubicin	E2F5	PA449412	1875	0.913
NULL	Oxid_Med_Cell_Longev_2013_Apr_21_2013_412576.nxml.txt.nlp	23710286	SENT109	17	17	7	7	curcumin	HMOX1	PA151958596	3162	0.913
NULL	Open_Cardiovasc_Med_J_2011_Feb_24_5_24-34.nxml.txt.nlp	21660248	SENT97	10	10	35	35	sibutramine	adiponectin	PA451344	9370	0.913
NULL	Gut_Liver_2015_Jan_9(1)_18-27.nxml.txt.nlp	NULL	SENT60	33	33	4	4	infliximab	ACT	PA452639	12;11332;9457;641455	0.913
NULL	Oncotarget_2012_Nov_17_4(1)_18-28.nxml.txt.nlp	23248157	SENT142	35	35	13	13	pargyline	p53	PA450797	7157	0.913
NULL	Cardiovasc_Diabetol_2011_Dec_22_10_115.nxml.txt.nlp	22189184	SENT96	1	1	11	11	sitagliptin	GLP-1	PA164748978	100125288	0.913
NULL	Oncogenesis_2012_Apr_2_1(4)_e5.nxml.txt.nlp	23552603	SENT242	23	23	11	11	celecoxib	MCL1	PA448871	4170	0.913
NULL	J_Inherit_Metab_Dis_2010_Oct_3_33(5)_625-632.nxml.txt.nlp	20814828	SENT77	13	13	6	6	simvastatin	RhoA	PA451363	387	0.913
NULL	Drugs_R_D_2013_Jun_5_13(2)_153-157.nxml.txt.nlp	23737454	SENT34	9	9	1	1	ticagrelor	P2Y12	PA165374673	64805	0.913
NULL	Ther_Clin_Risk_Manag_2007_Aug_3(4)_665-673.nxml.txt.nlp	18472989	SENT137	22	22	14	14	letrozole	EGF	PA450196	1950	0.913
NULL	Clin_Interv_Aging_2013_Jul_16_8_889-897.nxml.txt.nlp	23898224	SENT3	22	22	19	19	gemcitabine	SIRT1	PA449748	23411	0.913
NULL	J_Hematol_Oncol_2013_Jan_15_6_5.nxml.txt.nlp	23320987	SENT114	4	4	0	0	heparin	PI-PLC	PA449855	2923	0.913
NULL	Front_Immunol_2013_Mar_27_4_76.nxml.txt.nlp	23543707	SENT659	10	10	2	2	alemtuzumab	FCGR2A	PA164783958	2212	0.913
NULL	Cell_Commun_Signal_2013_Nov_5_11_83.nxml.txt.nlp	24192293	SENT154	11	11	28	28	doxycycline	SOCS3	PA449415	9021	0.913
NULL	Mol_Pain_2014_Apr_18_10_27.nxml.txt.nlp	24742127	SENT269	19	19	8	8	paclitaxel	CB2	PA450761	1269	0.913
NULL	Oncotarget_2014_Feb_7_5(3)_775-787.nxml.txt.nlp	24519956	SENT219	19	19	0	0	docetaxel	PC3	PA449383	57332;7832;5122	0.913
NULL	Oncol_Rep_2014_Mar_30_31(3)_1043-1050.nxml.txt.nlp	24378760	SENT18	11	11	27	27	olaparib	BRCA2		675	0.913
NULL	Nat_Commun_2012_Apr_17_3_783.nxml.txt.nlp	22510688	SENT522	18	18	35	35	tamoxifen	HIF-1	PA451581	29072	0.913
NULL	Mol_Cell_Proteomics_2012_Feb_6_11(2)_M111_015222.nxml.txt.nlp	22147731	SENT409	22	22	18	18	cetuximab	CLDN4	PA10040	1364	0.913
NULL	Front_Neurol_2014_Feb_18_5_17.nxml.txt.nlp	24600432	SENT111	14	14	1	1	levetiracetam	CD178	PA450206	356	0.913
NULL	Oncotarget_2011_Dec_24_2(12)_896-917.nxml.txt.nlp	22203527	SENT261	28	28	8	8	doxorubicin	p53	PA449412	7157	0.913
NULL	J_Hematol_Oncol_2013_Dec_10_6_92.nxml.txt.nlp	24326130	SENT235	13	13	4	4	imatinib	KIT	PA10804	3815	0.913
NULL	J_Biol_Eng_2009_Oct_16_3_18.nxml.txt.nlp	19835592	SENT56	24	24	12	12	tetracycline	CPZ	PA451640	8532	0.913
NULL	Cancer_Cell_Int_2004_May_17_4_4.nxml.txt.nlp	15147581	SENT128	13	13	21	21	sulindac	EGF	PA451565	1950	0.913
NULL	Mol_Brain_2014_Nov_6_7(1)_78.nxml.txt.nlp	NULL	SENT63	46	46	23	23	nitrogen	CA1	PA450643	759	0.913
NULL	Arthritis_Res_Ther_2012_Apr_30_14(2)_R96.nxml.txt.nlp	22546471	SENT4	0	0	15	15	methotrexate	SLC19A1	PA450428	6573	0.913
NULL	J_Biol_Chem_2013_Dec_6_288(49)_35387-35395.nxml.txt.nlp	24142790	SENT244	16	16	6	6	meclizine	PCYT2	PA450338	5833	0.913
NULL	Indian_J_Endocrinol_Metab_2014_Mar-Apr_18(2)_138-141.nxml.txt.nlp	24741507	SENT47	8	8	12	12	metformin	DPP4	PA450395	1803	0.913
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT143	12	12	27	27	sulindac	survivin	PA451565	332	0.913
NULL	Crit_Care_2011_Mar_11_15(Suppl_1)_P251.nxml.txt.nlp	NULL	SENT15	14	14	4	4	thrombin	PAR-1	PA451674	2011;2149	0.913
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT281	17	17	7	7	atorvastatin	PIK3CA	PA448500	5290	0.913
NULL	Nat_Med_2013_Jun_19_19(6)_704-712.nxml.txt.nlp	23685840	SENT125	9	9	12	12	tamoxifen	TGFBR2	PA451581	7048	0.913
NULL	AIDS_Res_Treat_2013_Mar_7_2013_249171.nxml.txt.nlp	23533730	SENT135	11	11	26	26	lamivudine	MDC	PA450163	6367	0.913
NULL	J_Biomed_Sci_2014_Feb_3_21(1)_10.nxml.txt.nlp	24490900	SENT138	5	5	12	12	alendronate	CTR	PA448082	799	0.913
NULL	Onco_Targets_Ther_2014_Jun_19_7_1025-1032.nxml.txt.nlp	24971016	SENT99	3	3	6	6	bevacizumab	VEGFR	PA130232992	3791	0.913
NULL	Breast_Cancer_Res_2014_May_5_16(3)_R45.nxml.txt.nlp	24887236	SENT236	22	22	13	13	lapatinib	EGFR	PA152241907	1956	0.913
NULL	Br_J_Cancer_2012_Nov_6_107(10)_1714-1721.nxml.txt.nlp	23073173	SENT101	36	36	6	6	bicalutamide	RUNX2	PA164746255	860	0.913
NULL	Diabetes_2011_May_23_60(5)_1493-1503.nxml.txt.nlp	21478464	SENT112	5	5	20	20	metformin	AMPK	PA450395	5563	0.913
NULL	Subst_Abuse_Rehabil_2014_Aug_14_5_95-105.nxml.txt.nlp	25187752	SENT78	14	14	22	22	tamoxifen	aromatase	PA451581	1588	0.913
NULL	Pharmaceuticals_(Basel)_2011_Jan_26_4(2)_285-342.nxml.txt.nlp	NULL	SENT1459	2	2	18	18	venlafaxine	5-HT1A	PA451866	3350	0.913
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT262	1	1	11	11	aripiprazole	PRL	PA10026	5617	0.913
NULL	Indian_J_Endocrinol_Metab_2013_May-Jun_17(3)_413-421.nxml.txt.nlp	23869296	SENT207	18	18	0	0	exenatide	GLP-1	PA164749238	100125288	0.913
NULL	Oncotarget_2013_Nov_7_4(12)_2550-2566.nxml.txt.nlp	24334291	SENT203	18	18	41	41	dasatinib	BCL-W	PA162372878	599	0.913
NULL	Biomed_Res_Int_2013_Jun_18_2013_794984.nxml.txt.nlp	23853771	SENT26	28	28	20	20	rituximab	TRO	PA451261	7216	0.913
NULL	Eur_Respir_J_2013_Dec_30_42(6)_1484-1494.nxml.txt.nlp	23722616	SENT124	12	12	4	4	indacaterol	TDI	PA165958348	100038246	0.913
NULL	Pharmaceuticals_(Basel)_2012_Nov_20_5(11)_1236-1264.nxml.txt.nlp	24281308	SENT216	0	0	3	3	everolimus	EGFR	PA164746311	1956	0.913
NULL	Mol_Cancer_2008_Jun_5_7_50.nxml.txt.nlp	18534018	SENT146	11	11	6	6	bortezomib	HSP27	PA10252	3315	0.913
NULL	Indian_Dermatol_Online_J_2011_Jul-Dec_2(2)_111-119.nxml.txt.nlp	23130241	SENT326	27	27	0	0	calcipotriol	FAE	PA448714	2178	0.913
NULL	EPMA_J_2010_Sep_20_1(3)_421-437.nxml.txt.nlp	23199086	SENT443	10	10	4	4	docetaxel	BRCA2	PA449383	675	0.913
NULL	Acta_Pharmacol_Sin_2009_Aug_6_30(8)_1204-1210.nxml.txt.nlp	19578385	SENT59	14	14	3	3	ibandronate	CTX	PA10270	1593	0.913
NULL	Cancer_Cell_Int_2013_Jun_26_13_63.nxml.txt.nlp	23800022	SENT220	5	5	9	9	genistein	AKT	PA165109660	207	0.913
NULL	J_Adv_Pract_Oncol_2012_May_1_May-Jun_3(3)_184-190.nxml.txt.nlp	25031945	SENT10	19	19	15	15	doxorubicin	CHOP	PA449412	1649	0.913
NULL	Cell_Death_Dis_2014_Feb_27_5(2)_e1091.nxml.txt.nlp	24577089	SENT177	11	11	4	4	cetuximab	AKT	PA10040	207	0.913
NULL	Oncotarget_2012_Dec_18_3(12)_1615-1628.nxml.txt.nlp	23271044	SENT76	15	15	25	25	clofarabine	TOR	PA164754863	6097	0.913
NULL	Behav_Brain_Funct_2013_May_3_9_17.nxml.txt.nlp	23642235	SENT189	22	22	12	12	baclofen	AT1	PA448533	9197;185	0.913
NULL	Oncol_Rep_2014_Apr_28_31(4)_1605-1612.nxml.txt.nlp	24481648	SENT115	8	8	17	17	ponatinib	MRP7	PA165980594	89845;1080	0.913
NULL	Acta_Pharmacol_Sin_2012_Apr_19_33(4)_470-478.nxml.txt.nlp	22426698	SENT45	38	38	40	40	nifedipine	CPU	PA450631	1361	0.913
NULL	Cancer_Med_2013_Aug_30_2(4)_457-467.nxml.txt.nlp	24156018	SENT157	13	13	6	6	temozolomide	MMP14	PA451609	4323	0.913
NULL	Breast_Cancer_Res_2010_Oct_22_12(Suppl_2)_S1.nxml.txt.nlp	21050422	SENT133	16	16	24	24	gefitinib	EGFR	PA131301952	1956	0.913
NULL	Breast_Cancer_Res_Treat_2013_Apr_12_138(2)_427-435.nxml.txt.nlp	23479422	SENT27	8	8	11	11	trastuzumab	HER2	PA451743	2064	0.913
NULL	Arthritis_Res_Ther_2005_Feb_18_7(3)_R476-R484.nxml.txt.nlp	15899034	SENT100	10	10	36	36	thrombin	GEF	PA451674	56731	0.913
NULL	J_Cancer_Prev_2014_Mar_19(1)_39-46.nxml.txt.nlp	25337571	SENT120	14	14	2	2	ethanol	CDK2	PA448073	1017	0.913
NULL	Front_Oncol_2014_Mar_3_4_35.nxml.txt.nlp	24624362	SENT69	17	17	19	19	cetuximab	PIK3CA	PA10040	5290	0.913
NULL	Front_Neurosci_2011_Jan_14_4_207.nxml.txt.nlp	21258618	SENT38	6	6	0	0	ethanol	AC7	PA448073	113	0.913
NULL	Hum_Genet_2015_Dec_9_134_231-245.nxml.txt.nlp	25487306	SENT208	7	7	25	25	cisplatin	CLPTM1L	PA449014	81037	0.913
NULL	Acta_Pharmacol_Sin_2012_Oct_3_33(10)_1311-1318.nxml.txt.nlp	22941289	SENT114	0	0	2	2	sorafenib	VEGFR2	PA7000	3791	0.913
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT190	0	0	4	4	methotrexate	MSH2	PA450428	4436	0.913
NULL	Dermatoendocrinol_2013_Apr_1_5(2)_252-263.nxml.txt.nlp	24194965	SENT87	23	23	10	10	metformin	OCT2	PA450395	6582;5452	0.913
NULL	Nature_2007_Jan_25_445(7126)_437-441.nxml.txt.nlp	17206155	SENT33	30	30	38	38	gefitinib	HER2	PA131301952	2064	0.913
NULL	Arch_Med_Sci_2011_Apr_17_7(2)_230-234.nxml.txt.nlp	22291761	SENT9	18	18	8	8	curcumin	SMN2	PA151958596	6607	0.913
NULL	Breast_Cancer_Res_2012_Feb_9_14(1)_R27.nxml.txt.nlp	22321971	SENT78	18	18	7	7	ethanol	LAS	PA448073	11019	0.913
NULL	Front_Oncol_2014_Sep_15_4_244.nxml.txt.nlp	25309870	SENT101	35	35	29	29	erlotinib	EGFR	PA134687924	1956	0.913
NULL	J_Hematol_Oncol_2009_Apr_22_2_18.nxml.txt.nlp	19386128	SENT159	12	12	24	24	cetuximab	KRAS	PA10040	3845	0.913
NULL	Mol_Vis_2010_Sep_2_16_1781-1790.nxml.txt.nlp	20824160	SENT101	3	3	11	11	forskolin	ZO-1	PA146096022	7082	0.913
NULL	Curr_Neuropharmacol_2013_Dec_11(6)_652-663.nxml.txt.nlp	24396340	SENT78	12	12	23	23	oxaliplatin	TRPA1	PA131285527	8989	0.913
NULL	JAKSTAT_2012_Apr_1_1(2)_55-64.nxml.txt.nlp	24058751	SENT46	4	4	9	9	imatinib	STAT3	PA10804	6774	0.913
NULL	Nat_Neurosci_2013_Apr_3_16(4)_394-406.nxml.txt.nlp	23455607	SENT245	13	13	7	7	tetracycline	LRRK2	PA451640	120892	0.913
NULL	Breast_Cancer_Res_Treat_2014_Apr_9_145(1)_73-82.nxml.txt.nlp	24715380	SENT123	14	14	24	24	tamoxifen	CXCR3	PA451581	2833	0.913
NULL	Mol_Biol_Rep_2013_May_11_40(8)_5013-5026.nxml.txt.nlp	23666059	SENT130	32	32	8	8	resveratrol	MDM2		4193	0.913
NULL	Ann_Hematol_2010_Nov_25_89(11)_1115-1124.nxml.txt.nlp	20499237	SENT119	35	35	2	2	cladribine	CD19	PA449027	930	0.913
NULL	J_Korean_Med_Sci_2009_Oct_24_24(5)_910-917.nxml.txt.nlp	19794992	SENT18	9	9	16	16	paclitaxel	HER2	PA450761	2064	0.913
NULL	Nucleic_Acids_Res_2008_Feb_20_36(3)_998-1008.nxml.txt.nlp	18096616	SENT31	0	0	11	11	heparin	PKR	PA449855	5610	0.913
NULL	Indian_J_Pharmacol_2008_Oct_40(Suppl_2)_S91-S97.nxml.txt.nlp	21593983	SENT7	22	22	14	14	esomeprazole	CYP2C19	PA10075	1557	0.913
NULL	EJC_Suppl_2013_Sep_5_11(2)_3-22.nxml.txt.nlp	NULL	SENT894	19	19	13	13	epirubicin	HER2	PA449476	2064	0.913
NULL	Gynecol_Oncol_Case_Rep_2013_Dec_28_8_4-6.nxml.txt.nlp	24567884	SENT38	19	19	3	3	cisplatin	NAC	PA449014	22861	0.913
NULL	Ind_Psychiatry_J_2013_Jan-Jun_22(1)_47-53.nxml.txt.nlp	24459374	SENT180	31	31	1	1	olanzapine	Gen	PA450688	348654	0.913
NULL	Allergy_Asthma_Immunol_Res_2014_Nov_19_6(6)_548-557.nxml.txt.nlp	25374755	SENT18	5	5	8	8	lovastatin	IL-6	PA450272	3569	0.913
NULL	Br_J_Pharmacol_2013_Apr_25_168(8)_1868-1877.nxml.txt.nlp	23194305	SENT215	7	7	26	26	bortezomib	ALDH2	PA10252	217	0.913
NULL	Br_J_Cancer_2013_Jul_23_109(2)_342-350.nxml.txt.nlp	23807172	SENT27	4	4	21	21	sorafenib	Mcl-1	PA7000	4170	0.913
NULL	J_Cereb_Blood_Flow_Metab_2011_Oct_20_31(10)_2030-2040.nxml.txt.nlp	21505475	SENT204	8	8	32	32	cilostazol	Bcl-2	PA164746334	596	0.913
NULL	Br_J_Pharmacol_2008_Sep_9_155(1)_127-137.nxml.txt.nlp	18536750	SENT179	17	17	1	1	piroxicam	IL-10	PA450985	3586	0.913
NULL	J_Cancer_Prev_2013_Jun_18(2)_186-191.nxml.txt.nlp	25337545	SENT97	17	17	25	25	curcumin	CDK4	PA151958596	1019	0.913
NULL	ScientificWorldJournal_2012_May_2_2012_823493.nxml.txt.nlp	22629209	SENT131	20	20	2	2	ketanserin	5-HT2B	PA131053734	3357	0.913
NULL	Front_Behav_Neurosci_2014_Sep_3_8_303.nxml.txt.nlp	25232310	SENT27	10	10	0	0	methylphenidate	DAT	PA450464	6531	0.913
NULL	J_Hematol_Oncol_2011_Apr_20_4_17.nxml.txt.nlp	21507255	SENT237	38	38	15	15	cisplatin	XPC	PA449014	7508	0.913
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT152	7	7	10	10	chloroquine	BMPR-II	PA448948	659	0.913
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Jul_23_6_103-113.nxml.txt.nlp	25114588	SENT42	24	24	1	1	pertuzumab	HER2		2064	0.913
NULL	Oncol_Rep_2014_Sep_2_32(3)_887-892.nxml.txt.nlp	24994673	SENT107	26	26	2	2	oxaliplatin	DPD	PA131285527	1806	0.913
NULL	Cardiovasc_Ther_2009_27(4)_259-274.nxml.txt.nlp	19604248	SENT57	3	3	18	18	ticagrelor	ADP	PA165374673	23038	0.913
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S202-S209.nxml.txt.nlp	21525456	SENT145	0	0	12	12	liraglutide	GLP-1	PA165958364	100125288	0.913
NULL	Mol_Cells_2014_Mar_31_37(3)_234-240.nxml.txt.nlp	24642709	SENT14	4	4	6	6	capsaicin	HO-1	PA448776	3162	0.913
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jan_29_67(Pt_2)_o513.nxml.txt.nlp	21523164	SENT3	15	15	7	7	gabapentin	NO3	PA449720	4681	0.913
NULL	Int_J_Breast_Cancer_2012_May_9_2012_415170.nxml.txt.nlp	22649737	SENT76	3	3	41	41	trastuzumab	MUC4	PA451743	4585	0.913
NULL	Neural_Regen_Res_2013_Jul_25_8(21)_1925-1937.nxml.txt.nlp	25206501	SENT101	30	30	3	3	atorvastatin	HO-1	PA448500	3162	0.913
NULL	Indian_J_Pharmacol_2013_Mar-Apr_45(2)_155-158.nxml.txt.nlp	23716892	SENT119	13	13	23	23	voriconazole	CYP2C9	PA10233	1559	0.913
NULL	Breast_Cancer_Res_2007_Mar_2_9(2)_205.nxml.txt.nlp	NULL	SENT26	39	39	22	22	erlotinib	HER-2	PA134687924	2064	0.913
NULL	Diabetes_2009_Aug_28_58(8)_1835-1843.nxml.txt.nlp	19401418	SENT65	16	16	9	9	collagenase	CO2	PA449107	4513	0.913
NULL	Oncotarget_2012_May_9_3(4)_363-364.nxml.txt.nlp	22622047	SENT14	27	27	0	0	imatinib	SIRT1	PA10804	23411	0.913
NULL	Nucleic_Acids_Res_2011_Nov_23_39(20)_8677-8688.nxml.txt.nlp	21785136	SENT75	11	11	0	0	glutaraldehyde	GRN	PA449777	2896	0.913
NULL	Front_Neurosci_2013_Jan_10_6_191.nxml.txt.nlp	23335875	SENT18	8	8	20	20	vasopressin	ghrelin	PA451858	51738	0.913
NULL	Breast_Cancer_Res_2008_Jul_24_10(4)_211.nxml.txt.nlp	18671839	SENT10	23	23	2	2	bevacizumab	HER2	PA130232992	2064	0.913
NULL	Exp_Hematol_Oncol_2014_Mar_11_3_7.nxml.txt.nlp	24618035	SENT30	18	18	0	0	imatinib	ABL1	PA10804	25	0.913
NULL	Breast_Cancer_Res_Treat_2013_Sep_1_141(2)_243-248.nxml.txt.nlp	23996142	SENT107	5	5	20	20	tamoxifen	aromatase	PA451581	1588	0.913
NULL	Cell_Death_Dis_2014_Feb_13_5(2)_e1055.nxml.txt.nlp	24525731	SENT123	46	46	28	28	cisplatin	XRCC1	PA449014	7515	0.913
NULL	Nat_Genet_2011_Feb_26_43(2)_117-120.nxml.txt.nlp	21186350	SENT91	38	38	6	6	metformin	ATM	PA450395	472	0.913
NULL	Int_J_Med_Sci_2015_Jan_5_12(2)_135-140.nxml.txt.nlp	25589889	SENT77	20	20	3	3	haloperidol	NMS	PA449841	129521	0.913
NULL	Breast_Cancer_Res_2007_Aug_10_9(4)_R52.nxml.txt.nlp	17692126	SENT274	5	5	9	9	exemestane	aromatase	PA449563	1588	0.913
NULL	Br_J_Haematol_2008_Jun_141(5)_659-671.nxml.txt.nlp	18410446	SENT110	35	35	9	9	melphalan	CD138	PA450354	6382	0.913
NULL	J_Hematol_Oncol_2010_Mar_23_3_11.nxml.txt.nlp	20331897	SENT87	0	0	16	16	sorafenib	SHARP	PA7000	23013	0.913
NULL	J_Cancer_Prev_2014_Mar_19(1)_39-46.nxml.txt.nlp	25337571	SENT21	28	28	32	32	ethanol	p38	PA448073	10598;1432;7965	0.913
NULL	Indian_J_Urol_2008_Apr-Jun_24(2)_150-154.nxml.txt.nlp	19468388	SENT65	32	32	17	17	nadh	CO2	PA164755085	4513	0.913
NULL	Clin_Ophthalmol_2008_Mar_2(1)_15-20.nxml.txt.nlp	19668385	SENT62	0	0	12	12	bimatoprost	PGF	PA164748867	5228	0.913
NULL	Contemp_Oncol_(Pozn)_2012_Jul_6_16(3)_197-200.nxml.txt.nlp	23788878	SENT161	7	7	13	13	vemurafenib	BRAF	PA165946873	673	0.913
NULL	Front_Immunol_2012_May_7_3_101.nxml.txt.nlp	22783250	SENT253	30	30	25	25	papain	IL-2	PA450778	3558	0.913
NULL	Front_Endocrinol_(Lausanne)_2015_Jan_9_5_235.nxml.txt.nlp	25620956	SENT50	20	20	30	30	glucosamine	GFAT	PA164747613	2673	0.913
NULL	Cell_Death_Dis_2013_Sep_5_4(9)_e789.nxml.txt.nlp	24008733	SENT132	30	30	18	18	paraformaldehyde	CO2	PA450790	4513	0.913
NULL	Chonnam_Med_J_2014_Apr_22_50(1)_27-30.nxml.txt.nlp	24855605	SENT62	5	5	10	10	rituximab	CHOP	PA451261	1649	0.913
NULL	J_Allergy_(Cairo)_2011_Apr_26_2011_736319.nxml.txt.nlp	21747870	SENT48	27	27	3	3	l-arginine	CAT-2	PA448478	6542	0.913
NULL	N_Am_J_Med_Sci_2013_Jun_5(6)_386-391.nxml.txt.nlp	23923114	SENT127	30	30	8	8	vemurafenib	BRAF	PA165946873	673	0.913
NULL	Biologics_2009_Sep_15_3_419-428.nxml.txt.nlp	19774209	SENT170	11	11	20	20	everolimus	PTEN	PA164746311	5728	0.913
NULL	Exp_Ther_Med_2014_Jun_27_7(6)_1752-1756.nxml.txt.nlp	24926379	SENT18	0	0	15	15	vildagliptin	GLP-1	PA165958346	100125288	0.913
NULL	Mol_Clin_Oncol_2013_Sep_18_1(5)_839-844.nxml.txt.nlp	24649257	SENT94	10	10	7	7	cyclophosphamide	NAC	PA449165	22861	0.913
NULL	Case_Rep_Endocrinol_2014_Feb_10_2014_479641.nxml.txt.nlp	24660072	SENT28	7	7	14	14	cinacalcet	PTH	PA164776671	5741	0.913
NULL	Orphanet_J_Rare_Dis_2014_Dec_10_9(1)_201.nxml.txt.nlp	NULL	SENT384	13	13	39	39	baclofen	CMT1A	PA448533	1248	0.913
NULL	FEBS_Open_Bio_2014_Aug_30_4_763-776.nxml.txt.nlp	25349781	SENT510	23	23	13	13	curcumin	NAC	PA151958596	22861	0.913
NULL	Oncoimmunology_2013_Oct_1_2(10)_e27025.nxml.txt.nlp	24353914	SENT181	8	8	13	13	docetaxel	CD4	PA449383	920	0.913
NULL	J_Med_Chem_2014_Jul_24_57(14)_5995-6007.nxml.txt.nlp	24960438	SENT327	16	16	5	5	estradiol	HSD2	PA449503	6060	0.913
NULL	Biochim_Biophys_Acta_2014_Jul_1842(7)_959-970.nxml.txt.nlp	24594481	SENT14	4	4	21	21	lipase	FGF21	PA450239	26291	0.913
NULL	J_Cancer_2013_Nov_21_4(9)_727-735.nxml.txt.nlp	24312143	SENT159	34	34	43	43	cisplatin	SRPK1	PA449014	6732	0.913
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT8	0	0	34	34	curcumin	TRAIL	PA151958596	8743	0.913
NULL	Pharmaceuticals_(Basel)_2012_Nov_20_5(11)_1236-1264.nxml.txt.nlp	24281308	SENT1605	10	10	8	8	everolimus	MTOR	PA164746311	2475	0.913
NULL	Cardiol_Res_Pract_2011_May_10_2011_816897.nxml.txt.nlp	21629798	SENT131	17	17	3	3	pazopanib	CYP3A4	PA165291492	1576	0.913
NULL	Oncol_Lett_2014_May_11_7(5)_1401-1408.nxml.txt.nlp	24765145	SENT34	9	9	17	17	paclitaxel	PI3K	PA450761	5290	0.913
NULL	Infect_Dis_Ther_2014_Dec_6_3(2)_123-132.nxml.txt.nlp	25193094	SENT156	16	16	3	3	ceftriaxone	CABP	PA448866	6277	0.913
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2735-2743.nxml.txt.nlp	24129244	SENT177	12	12	18	18	crizotinib	NSCL	PA165946122	4807	0.913
NULL	Onco_Targets_Ther_2014_Mar_24_7_491-500.nxml.txt.nlp	24711706	SENT9	45	45	11	11	trastuzumab	HER2	PA451743	2064	0.913
NULL	Ann_Indian_Acad_Neurol_2010_Jan-Mar_13(1)_6-13.nxml.txt.nlp	20436740	SENT263	36	36	14	14	thrombin	ADP	PA451674	23038	0.913
NULL	Br_J_Cancer_2006_Dec_4_95(11)_1504-1513.nxml.txt.nlp	17088902	SENT11	14	14	5	5	gefitinib	HER2	PA131301952	2064	0.913
NULL	Mol_Cancer_2013_Mar_5_12_17.nxml.txt.nlp	23497256	SENT60	13	13	6	6	sunitinib	p53	PA162372840	7157	0.913
NULL	Acta_Histochem_Cytochem_2012_Apr_26_45(2)_139-146.nxml.txt.nlp	22685356	SENT107	21	21	13	13	forskolin	AQP2	PA146096022	359	0.913
NULL	Cancer_Cell_2007_Dec_11_12(6)_514-527.nxml.txt.nlp	18068629	SENT575	7	7	2	2	paclitaxel	TGFBI	PA450761	7045	0.913
NULL	J_Biol_Chem_2013_Nov_15_288(46)_33049-33059.nxml.txt.nlp	24089524	SENT279	11	11	21	21	nicotine	GATA6	PA450626	2627	0.913
NULL	Br_J_Cancer_2013_Mar_5_108(4)_983-992.nxml.txt.nlp	23361057	SENT260	14	14	9	9	cytarabine	NAC	PA449177	22861	0.913
NULL	Environ_Health_Perspect_2005_Jan_30_113(1)_17-24.nxml.txt.nlp	15626642	SENT120	9	9	3	3	verapamil	P-gp	PA451868	5243	0.913
NULL	Mol_Cancer_2009_Apr_22_8_26.nxml.txt.nlp	19386116	SENT187	4	4	8	8	ritonavir	AKT	PA451260	207	0.913
NULL	J_Cell_Biol_1995_Mar_2_128(6)_1185-1196.nxml.txt.nlp	7896881	SENT5	11	11	3	3	mitomycin	p53	PA450524	7157	0.913
NULL	Indian_J_Pharm_Sci_2013_Jan-Feb_75(1)_94-98.nxml.txt.nlp	23901167	SENT30	8	8	32	32	tolbutamide	CYP2C19	PA451718	1557	0.913
NULL	Int_J_Mol_Sci_2013_Apr_17_14(4)_8422-8436.nxml.txt.nlp	23594994	SENT68	14	14	22	22	flutamide	HIF-1	PA449685	29072	0.913
NULL	Mol_Cancer_2010_Aug_16_9_217.nxml.txt.nlp	20712901	SENT85	39	39	23	23	curcumin	IL-6	PA151958596	3569	0.913
NULL	Patient_Prefer_Adherence_2011_Dec_23_6_1-9.nxml.txt.nlp	22272064	SENT1	0	0	24	24	telmisartan	ACE	PA451605	1636	0.913
NULL	Breast_Cancer_Res_2012_Jul_19_14(4)_R108.nxml.txt.nlp	22812534	SENT296	8	8	16	16	pargyline	PELP1	PA450797	27043	0.913
NULL	Breast_Cancer_Res_2010_Jul_1_12(4)_R45.nxml.txt.nlp	20594311	SENT135	0	0	37	37	tamoxifen	AKT	PA451581	207	0.913
NULL	Biomed_Res_Int_2013_Oct_29_2013_185476.nxml.txt.nlp	24350249	SENT6	16	16	2	2	ethanol	flower	PA448073	11094	0.913
NULL	J_Korean_Med_Sci_2007_Dec_20_22(6)_1055-1059.nxml.txt.nlp	18162722	SENT5	20	20	7	7	famotidine	ESD	PA449586	2098	0.913
NULL	Acta_Pharmacol_Sin_2012_Oct_3_33(10)_1311-1318.nxml.txt.nlp	22941289	SENT178	20	20	6	6	sorafenib	VEGFR2	PA7000	3791	0.913
NULL	Eur_Respir_J_2014_Jul_23_44(1)_23-63.nxml.txt.nlp	24659544	SENT729	36	36	26	26	pyrazinamide	DST	PA451182	667	0.913
NULL	Front_Immunol_2014_Aug_12_5_386.nxml.txt.nlp	25161655	SENT413	22	22	13	13	salmeterol	TLR4	PA451300	7099	0.913
NULL	Nucleic_Acids_Res_2013_May_5_41(10)_5210-5222.nxml.txt.nlp	23563151	SENT11	4	4	23	23	arsenite	GADD45	PA452638	1647	0.913
NULL	Biosci_Rep_2013_Sep_17_33(5)_e00069.nxml.txt.nlp	23984917	SENT135	31	31	0	0	potassium	OPRM1	PA451047	4988	0.913
NULL	Oncotarget_2014_Jun_3_5(13)_4920-4928.nxml.txt.nlp	24952482	SENT22	4	4	20	20	geldanamycin	Hsp90	PA152031327	3320	0.913
NULL	Br_J_Cancer_2012_Sep_4_107(6)_947-955.nxml.txt.nlp	22892392	SENT11	28	28	3	3	tamoxifen	ERBB2	PA451581	2064	0.913
NULL	Oncoimmunology_2012_Oct_1_1(7)_1038-1047.nxml.txt.nlp	23170252	SENT126	7	7	35	35	cyclophosphamide	IL-10	PA449165	3586	0.913
NULL	Biomed_Res_Int_2014_Aug_5_2014_952159.nxml.txt.nlp	25162038	SENT48	37	37	15	15	methotrexate	MTHFR	PA450428	4524	0.913
NULL	AIDS_Res_Treat_2011_Jun_7_2011_354908.nxml.txt.nlp	21716719	SENT219	8	8	19	19	cidofovir	OAT1	PA448997	9356	0.913
NULL	Ann_Rheum_Dis_2008_May_21_68(2)_175-182.nxml.txt.nlp	18495735	SENT191	31	31	24	24	infliximab	NFkappaB	PA452639	4790	0.913
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Apr_17_6_43-57.nxml.txt.nlp	24833916	SENT325	2	2	33	33	exemestane	aromatase	PA449563	1588	0.913
NULL	Gut_2013_Apr_14_62(4)_540-549.nxml.txt.nlp	22798500	SENT248	11	11	7	7	panitumumab	KRAS	PA162373091	3845	0.913
NULL	Int_J_Mol_Sci_2014_Mar_20_15(3)_4946-4964.nxml.txt.nlp	24658439	SENT62	4	4	16	16	capsaicin	GBF	PA448776	1316	0.913
NULL	Cell_Cycle_2012_Nov_1_11(21)_3983-3996.nxml.txt.nlp	22987153	SENT225	15	15	2	2	cisplatin	EXO1	PA449014	9156	0.913
NULL	Mol_Cancer_2010_Aug_23_9_222.nxml.txt.nlp	20731837	SENT106	5	5	12	12	gefitinib	EGFR	PA131301952	1956	0.913
NULL	J_Exp_Clin_Cancer_Res_2010_Aug_11_29(1)_110.nxml.txt.nlp	20701792	SENT39	21	21	1	1	paclitaxel	CSE1L	PA450761	1434	0.913
NULL	Cancer_Microenviron_2008_Dec_20_1(1)_103-111.nxml.txt.nlp	19308689	SENT62	9	9	0	0	thrombin	PAR-1	PA451674	2011;2149	0.913
NULL	J_Exp_Med_2000_Nov_20_192(10)_1491-1500.nxml.txt.nlp	11085750	SENT514	0	0	12	12	trypsin	CD4	PA451806	920	0.913
NULL	Bioinformation_2011_Sep_28_7(3)_130-133.nxml.txt.nlp	22125383	SENT48	5	5	26	26	econazole	PLP1	PA164746010	5354	0.913
NULL	Tumour_Biol_2014_Aug_13_35(10)_9447-9457.nxml.txt.nlp	25117071	SENT94	12	12	1	1	doxorubicin	CD40L	PA449412	959	0.913
NULL	Front_Oncol_2014_Oct_22_4_288.nxml.txt.nlp	25374843	SENT115	11	11	32	32	cyclophosphamide	GM-CSF	PA449165	1437	0.913
NULL	Hum_Genomics_2010_Apr_1_4(4)_238-249.nxml.txt.nlp	20511137	SENT49	27	27	11	11	atazanavir	UGT1A1	PA10251	54658	0.913
NULL	Int_Semin_Surg_Oncol_2008_Apr_28_5_9.nxml.txt.nlp	18442393	SENT74	11	11	6	6	tamoxifen	HER-2	PA451581	2064	0.913
NULL	Case_Rep_Rheumatol_2012_Oct_10_2012_406963.nxml.txt.nlp	23094181	SENT92	27	27	24	24	tocilizumab	IL-6	PA165292659	3569	0.913
NULL	Braz_J_Med_Biol_Res_2014_Jan_10_47(1)_60-69.nxml.txt.nlp	24519092	SENT28	10	10	31	31	doxorubicin	zeta	PA449412	9907	0.913
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT213	5	5	13	13	nutlin-3	DR5		8795	0.913
NULL	J_Adv_Pharm_Technol_Res_2012_Oct-Dec_3(4)_202-209.nxml.txt.nlp	23378940	SENT86	18	18	28	28	palonosetron	GIT	PA10352	5034	0.913
NULL	Evid_Based_Complement_Alternat_Med_2012_Dec_18_2012_352091.nxml.txt.nlp	23320028	SENT17	18	18	2	2	cyclophosphamide	ACR	PA449165	49	0.913
NULL	Hum_Psychopharmacol_2014_Sep_4_29(5)_470-482.nxml.txt.nlp	25087600	SENT31	0	0	21	21	agomelatine	5-HT2C	PA165958363	3358	0.913
NULL	Br_J_Cancer_2012_May_22_106(11)_1728-1734.nxml.txt.nlp	22531637	SENT127	19	19	10	10	carboplatin	CYP3A4	PA448803	1576	0.913
NULL	Mol_Cancer_2010_Dec_15_9_314.nxml.txt.nlp	21159167	SENT231	22	22	3	3	cisplatin	BCL2	PA449014	596	0.913
NULL	Mol_Pain_2013_Jun_10_9_27.nxml.txt.nlp	23758830	SENT189	10	10	21	21	tetracaine	ASIC3	PA451638	9311	0.913
NULL	Int_J_Inflam_2010_Aug_9_2010_151097.nxml.txt.nlp	21152121	SENT373	36	36	10	10	thrombin	CXCR4	PA451674	7852	0.913
NULL	J_Biol_Chem_2009_May_1_284(18)_11953-11962.nxml.txt.nlp	19254952	SENT103	19	19	1	1	valsartan	ANG	PA451848	283	0.913
NULL	AIDS_Res_Ther_2013_May_1_10_10.nxml.txt.nlp	23634877	SENT134	7	7	22	22	lovastatin	CXCR4	PA450272	7852	0.913
NULL	Diabetes_Care_2013_Jun_15_36(6)_1765-1771.nxml.txt.nlp	23704676	SENT234	12	12	9	9	metformin	B12	PA450395	7126;4709	0.913
NULL	Nat_Chem_Biol_2010_Apr_28_6(4)_291-299.nxml.txt.nlp	20190765	SENT44	5	5	13	13	dasatinib	CSK	PA162372878	1445	0.913
NULL	Front_Cell_Neurosci_2015_Jan_15_8_467.nxml.txt.nlp	25642170	SENT59	15	15	6	6	cisplatin	ClC-3	PA449014	1182	0.913
NULL	Oncotarget_2014_Mar_13_5(5)_1326-1337.nxml.txt.nlp	24658369	SENT158	17	17	8	8	hydroxyurea	FANCD2	PA449942	2177	0.913
NULL	Anat_Cell_Biol_2011_Sep_29_44(3)_194-203.nxml.txt.nlp	22025971	SENT197	2	2	12	12	resveratrol	AMPK		5563	0.913
NULL	J_Clin_Biochem_Nutr_2009_Jan_27_44(1)_79-84.nxml.txt.nlp	19177192	SENT14	11	11	14	14	curcumin	HO-1	PA151958596	3162	0.913
NULL	Acta_Pharmacol_Sin_2012_Oct_17_33(10)_1301-1310.nxml.txt.nlp	22983390	SENT119	3	3	8	8	cisplatin	migfilin	PA449014	54751	0.913
NULL	Open_Cardiovasc_Med_J_2014_Feb_7_8_12-17.nxml.txt.nlp	24653785	SENT2	14	14	7	7	simvastatin	CYP3A5	PA451363	1577	0.913
NULL	Cancers_(Basel)_2014_Apr_9_6(2)_829-859.nxml.txt.nlp	24722453	SENT1476	1	1	4	4	capsaicin	IL-6	PA448776	3569	0.913
NULL	Diabetes_Obes_Metab_2012_Apr_14(4)_304-314.nxml.txt.nlp	22051096	SENT22	11	11	24	24	liraglutide	GLP-1	PA165958364	100125288	0.913
NULL	Int_J_Mol_Sci_2014_Oct_8_15(10)_17974-17999.nxml.txt.nlp	25299695	SENT158	4	4	6	6	curcumin	HO-1	PA151958596	3162	0.913
NULL	Biomed_Res_Int_2014_May_19_2014_456037.nxml.txt.nlp	24967371	SENT166	44	44	2	2	bortezomib	San	PA10252	80218	0.913
NULL	Acta_Pharmacol_Sin_2011_Oct_15_32(10)_1233-1238.nxml.txt.nlp	21841815	SENT77	11	11	19	19	naloxone	CTX	PA450586	1593	0.913
NULL	Chin_J_Cancer_2012_Feb_31(2)_73-99.nxml.txt.nlp	22098950	SENT131	29	29	9	9	mitoxantrone	MXR	PA450526	9429	0.913
NULL	J_Cancer_Prev_2014_Mar_19(1)_39-46.nxml.txt.nlp	25337571	SENT110	35	35	26	26	ethanol	JNK	PA448073	5599	0.913
NULL	Cancer_Cell_Int_2012_Sep_20_12_41.nxml.txt.nlp	22995409	SENT257	25	25	14	14	erlotinib	BTZ	PA134687924	22794	0.913
NULL	Braz_J_Med_Biol_Res_2013_Feb_1_46(2)_171-177.nxml.txt.nlp	23369979	SENT137	5	5	13	13	enalapril	IL-6	PA449456	3569	0.913
NULL	Clin_Pharmacol_2011_Jun_22_3_13-25.nxml.txt.nlp	22287853	SENT127	14	14	0	0	saxagliptin	ANOVA	PA165958362	4858	0.913
NULL	Exp_Ther_Med_2012_Oct_9_4(4)_699-704.nxml.txt.nlp	23170129	SENT77	20	20	9	9	lipase	APOC3	PA450239	345	0.913
NULL	Int_J_Environ_Res_Public_Health_2011_Jun_8_8(6)_2090-2108.nxml.txt.nlp	21776218	SENT210	24	24	16	16	arsenite	KCNH2	PA452638	3757	0.913
NULL	Oncotarget_2013_Aug_19_4(12)_2212-2224.nxml.txt.nlp	24344100	SENT50	18	18	33	33	temozolomide	MITF	PA451609	4286	0.913
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT69	25	25	14	14	curcumin	TRAIL	PA151958596	8743	0.913
NULL	Biomed_Res_Int_2013_Dec_5_2013_239020.nxml.txt.nlp	NULL	SENT13	0	0	8	8	montelukast	CysLT1	PA450546	10800	0.913
NULL	J_Cancer_2014_Jan_5_5(2)_103-114.nxml.txt.nlp	24494028	SENT191	12	12	24	24	genistein	TP53INP2	PA165109660	58476	0.913
NULL	Aging_(Albany_NY)_2013_May_12_5(5)_347-356.nxml.txt.nlp	23748164	SENT123	21	21	13	13	l-glutamine	CO2	PA10090	4513	0.913
NULL	Acta_Pharmacol_Sin_2011_Nov_10_32(11)_1402-1410.nxml.txt.nlp	21986579	SENT139	34	34	5	5	curcumin	p38	PA151958596	10598;1432;7965	0.913
NULL	EJC_Suppl_2013_Sep_5_11(2)_3-22.nxml.txt.nlp	NULL	SENT825	4	4	0	0	paclitaxel	HER2	PA450761	2064	0.913
NULL	Arthritis_Res_Ther_2008_Nov_25_10(6)_228.nxml.txt.nlp	19090963	SENT204	25	25	14	14	infliximab	NOD2	PA452639	64127	0.913
NULL	Int_J_Mol_Sci_2014_May_9_15(5)_8153-8168.nxml.txt.nlp	24821539	SENT447	22	22	3	3	heparin	p27	PA449855	5715;10534	0.913
NULL	Br_J_Haematol_2008_Jun_141(5)_659-671.nxml.txt.nlp	18410446	SENT266	17	17	25	25	cerulenin	JNK	PA164764551	5599	0.913
NULL	Oncotarget_2013_Nov_26_4(12)_2502-2511.nxml.txt.nlp	24318446	SENT101	18	18	5	5	doxycycline	PHGDH	PA449415	26227	0.913
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1542-1553.nxml.txt.nlp	21970874	SENT259	28	28	37	37	gefitinib	AP-1	PA131301952	2353;3727;2354;3725	0.913
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Dec_11_67(Pt_1)_o64.nxml.txt.nlp	21522775	SENT48	20	20	7	7	ethanol	mol	PA448073	90527	0.913
NULL	Case_Rep_Ophthalmol_2014_Aug_4_5(2)_249-254.nxml.txt.nlp	25232338	SENT62	7	7	24	24	ranibizumab	VEGF-A	PA164746012	7422	0.913
NULL	Br_J_Cancer_2012_Oct_23_107(9)_1488-1497.nxml.txt.nlp	23033007	SENT175	0	0	21	21	disulfiram	JNK	PA449376	5599	0.913
NULL	FASEB_J_2011_Apr_25(4)_1133-1144.nxml.txt.nlp	21163859	SENT273	2	2	18	18	imipramine	ASM	PA449969	6609;283120	0.913
NULL	Aging_(Albany_NY)_2013_Jun_23_5(7)_515-530.nxml.txt.nlp	24018842	SENT198	6	6	14	14	fenofibrate	AMPK	PA449594	5563	0.913
NULL	Br_J_Cancer_2012_Nov_6_107(10)_1714-1721.nxml.txt.nlp	23073173	SENT114	4	4	9	9	bicalutamide	RUNX2	PA164746255	860	0.913
NULL	Mol_Med_Rep_2014_Sep_7_10(3)_1195-1204.nxml.txt.nlp	25017766	SENT23	11	11	16	16	ethanol	miR-217	PA448073	406999	0.913
NULL	Evid_Based_Complement_Alternat_Med_2013_Oct_29_2013_795365.nxml.txt.nlp	24319485	SENT206	32	32	30	30	thrombin	ADP	PA451674	23038	0.913
NULL	Cancers_(Basel)_2014_Nov_26_6(4)_2330-2342.nxml.txt.nlp	25534570	SENT194	18	18	11	11	bevacizumab	NRP1	PA130232992	8829	0.913
NULL	J_Hum_Genet_2013_Jun_23_58(6)_339-345.nxml.txt.nlp	23697979	SENT114	12	12	41	41	clopidogrel	CYP2C19	PA449053	1557	0.913
NULL	Case_Rep_Oncol_Med_2012_Sep_23_2012_685919.nxml.txt.nlp	23050177	SENT51	20	20	13	13	tamoxifen	CHOP	PA451581	1649	0.913
NULL	Front_Neural_Circuits_2013_Oct_24_7_170.nxml.txt.nlp	24167475	SENT107	25	25	36	36	vigabatrin	GAT1	PA10231	6529	0.913
NULL	Chin_J_Cancer_2012_Feb_31(2)_73-99.nxml.txt.nlp	22098950	SENT239	14	14	25	25	erlotinib	P-gp	PA134687924	5243	0.913
NULL	Ann_Oncol_2013_Aug_12_24(8)_1994-1999.nxml.txt.nlp	23670096	SENT153	14	14	8	8	tamoxifen	AIB1	PA451581	8202	0.913
NULL	Allergy_Asthma_Immunol_Res_2011_Oct_1_3(4)_226-235.nxml.txt.nlp	21966602	SENT186	47	47	9	9	doxycycline	IL-5	PA449415	3567	0.913
NULL	J_Gastrointest_Surg_2012_Apr_13_16(4)_842-848.nxml.txt.nlp	22246855	SENT94	20	20	12	12	cetuximab	EGFR	PA10040	1956	0.913
NULL	Gut_Liver_2015_Jan_15_9(1)_52-58.nxml.txt.nlp	NULL	SENT41	19	19	1	1	propofol	ESD	PA451141	2098	0.913
NULL	Cell_Death_Dis_2013_Jul_18_4(7)_e732.nxml.txt.nlp	23868065	SENT313	13	13	18	18	glucosamine	JNK	PA164747613	5599	0.913
NULL	ScientificWorldJournal_2012_Sep_2_2012_516408.nxml.txt.nlp	22973173	SENT64	9	9	19	19	ethanol	CO2	PA448073	4513	0.913
NULL	Case_Rep_Crit_Care_2014_Aug_19_2014_242703.nxml.txt.nlp	25215245	SENT195	7	7	0	0	nifedipine	APE	PA450631	55704;328	0.913
NULL	Orphanet_J_Rare_Dis_2014_Oct_29_9(1)_162.nxml.txt.nlp	NULL	SENT256	14	14	2	2	erythromycin	CYP3A4	PA449493	1576	0.913
NULL	J_Immunol_Res_2014_Jul_16_2014_696812.nxml.txt.nlp	25133198	SENT118	21	21	10	10	rifaximin	CD4	PA164752443	920	0.913
NULL	Oncogene_2014_Feb_6_33(6)_713-723.nxml.txt.nlp	23435429	SENT101	23	23	6	6	camptothecin	p50	PA153590860	958;4790	0.913
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_May_11_69(Pt_6)_o863-o864.nxml.txt.nlp	23795045	SENT73	17	17	9	9	ethanol	mol	PA448073	90527	0.913
NULL	Ann_Rheum_Dis_2008_Aug_29_67(8)_1096-1103.nxml.txt.nlp	18055472	SENT189	4	4	29	29	abatacept	ACR	PA164747080	49	0.913
NULL	Genome_Med_2010_Aug_11_2(8)_53.nxml.txt.nlp	20701793	SENT132	15	15	26	26	paclitaxel	CERT	PA450761	10087	0.913
NULL	Ann_Rheum_Dis_2010_Jun_1_69(6)_1158-1161.nxml.txt.nlp	20439295	SENT115	40	40	17	17	tocilizumab	IL-6	PA165292659	3569	0.913
NULL	Clin_Genet_2011_Jun_79(6)_582-587.nxml.txt.nlp	20573158	SENT21	2	2	6	6	diazoxide	SUR1	PA449285	6833	0.913
NULL	Endocrinol_Diabetes_Metab_Case_Rep_2014_Mar_1_2014_140001.nxml.txt.nlp	24683487	SENT10	21	21	6	6	ketoconazole	ACTH	PA450146	5443	0.913
NULL	J_Invest_Dermatol_2012_Nov_21_132(11)_2642-2651.nxml.txt.nlp	22718118	SENT158	17	17	7	7	collagenase	CD11b	PA449107	3684	0.913
NULL	Arthritis_Res_Ther_2014_Sep_26_16(5)_429.nxml.txt.nlp	25606593	SENT104	8	8	16	16	abatacept	IL-6	PA164747080	3569	0.913
NULL	Biomed_Res_Int_2013_Jun_5_2013_348167.nxml.txt.nlp	23862143	SENT109	10	10	35	35	choline	NAC	PA448976	22861	0.913
NULL	Front_Neurosci_2011_Feb_2_5_12.nxml.txt.nlp	21344007	SENT228	15	15	3	3	capsaicin	NR1	PA448776	27158	0.913
NULL	Int_J_Breast_Cancer_2011_Jul_12_2011_232435.nxml.txt.nlp	22295213	SENT261	17	17	5	5	tamoxifen	CDK7	PA451581	1022	0.913
NULL	Int_J_Chron_Obstruct_Pulmon_Dis_2008_Dec_3(4)_771-780.nxml.txt.nlp	19281092	SENT21	12	12	6	6	tiotropium	TDI	PA164769056	100038246	0.913
NULL	Cancer_Cell_Int_2009_Feb_17_9_4.nxml.txt.nlp	19222856	SENT195	10	10	31	31	cisplatin	p53	PA449014	7157	0.913
NULL	Breast_Cancer_Res_2011_Sep_29_13(5)_219.nxml.txt.nlp	22017761	SENT7	19	19	16	16	fulvestrant	aromatase	PA164747170	1588	0.913
NULL	Front_Oncol_2012_Oct_31_2_157.nxml.txt.nlp	23120745	SENT609	10	10	15	15	temozolomide	p53	PA451609	7157	0.913
NULL	Colomb_Med_(Cali)_43(4)_305-311.nxml.txt.nlp	24893304	SENT152	45	45	14	14	valganciclovir	CD4	PA10227	920	0.913
NULL	J_Cardiovasc_Dis_Res_2012_Oct-Dec_3(4)_319-322.nxml.txt.nlp	23233778	SENT41	6	6	3	3	clarithromycin	CYP3A4	PA449028	1576	0.913
NULL	Gene_Ther_2010_Sep_13_17(9)_1085-1097.nxml.txt.nlp	20463761	SENT67	31	31	21	21	ampicillin	TSP1	PA448419	7057	0.913
NULL	Mol_Cancer_2013_Oct_8_12_119.nxml.txt.nlp	24103454	SENT37	13	13	39	39	irinotecan	TOP1	PA450085	7150	0.913
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT72	3	3	9	9	metformin	AKT	PA450395	207	0.913
NULL	Breast_Cancer_Res_2010_May_10_12(3)_R26.nxml.txt.nlp	20459744	SENT125	37	37	14	14	cyclophosphamide	CYP3A4	PA449165	1576	0.912
NULL	Ann_Rheum_Dis_2011_Aug_17_70(12)_2148-2151.nxml.txt.nlp	21852254	SENT121	41	41	18	18	tocilizumab	IL-6	PA165292659	3569	0.912
NULL	Cell_Death_Dis_2012_Mar_15_3(3)_e286.nxml.txt.nlp	22419115	SENT87	4	4	17	17	cisplatin	p53	PA449014	7157	0.912
NULL	Breast_Cancer_Res_2011_Feb_23_13(1)_203.nxml.txt.nlp	21392408	SENT145	7	7	13	13	anastrozole	aromatase	PA448432	1588	0.912
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT206	2	2	18	18	telatinib	ABCG2	PA165980595	9429	0.912
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT170	13	13	18	18	neratinib	HER2	PA165291472	2064	0.912
NULL	Leukemia_2014_Aug_4_28(8)_1573-1585.nxml.txt.nlp	24496300	SENT220	8	8	4	4	enoxacin	CYP1A2	PA449462	1544	0.912
NULL	Mol_Cancer_2007_Oct_11_6_63.nxml.txt.nlp	17931419	SENT117	16	16	12	12	cetuximab	EGFR	PA10040	1956	0.912
NULL	Protein_Cell_2014_Jun_19_5(6)_469-479.nxml.txt.nlp	24748116	SENT109	30	30	9	9	paclitaxel	EB1	PA450761	9167;22919;10982	0.912
NULL	Oncol_Lett_2014_May_26_7(5)_1341-1344.nxml.txt.nlp	24765135	SENT42	17	17	24	24	tamoxifen	aromatase	PA451581	1588	0.912
NULL	Nat_Chem_Biol_2009_Jan_23_5(1)_37-44.nxml.txt.nlp	19029917	SENT13	35	35	23	23	lipase	FAAH	PA450239	79152;2166	0.912
NULL	FEBS_Open_Bio_2013_Sep_17_3_394-397.nxml.txt.nlp	24251101	SENT39	0	0	6	6	geldanamycin	San	PA152031327	80218	0.912
NULL	Arch_Med_Sci_2013_Oct_31_9(5)_936-943.nxml.txt.nlp	24273582	SENT103	19	19	5	5	nateglinide	GLP-1	PA450600	100125288	0.912
NULL	Ann_Saudi_Med_2009_Sep-Oct_29(5)_402-406.nxml.txt.nlp	19700901	SENT19	11	11	26	26	cefuroxime	ISK	PA448868	3753	0.912
NULL	Breast_Cancer_Res_Treat_2013_Jul_5_140(1)_63-71.nxml.txt.nlp	23828499	SENT192	41	41	31	31	paclitaxel	HER2	PA450761	2064	0.912
NULL	Cancer_Cell_Int_2002_Jul_5_2_7.nxml.txt.nlp	12234376	SENT48	14	14	2	2	staurosporine	BRCA1	PA165109623	672	0.912
NULL	Clin_Pharmacokinet_2014_Jul_24_53(1)_73-87.nxml.txt.nlp	23881596	SENT369	11	11	5	5	fluvastatin	ABCB1	PA449688	5243	0.912
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT346	22	22	8	8	glucose	BMK1	PA449773	5598	0.912
NULL	Clin_Med_Oncol_2008_Jan_22_2_27-35.nxml.txt.nlp	21892263	SENT171	43	43	21	21	cisplatin	ERCC1	PA449014	2067	0.912
NULL	Nucleic_Acids_Res_2013_Dec_21_41(22)_10283-10297.nxml.txt.nlp	24005041	SENT38	27	27	18	18	camptothecin	FANCD2	PA153590860	2177	0.912
NULL	Br_J_Cancer_2012_Sep_4_107(6)_967-976.nxml.txt.nlp	22892391	SENT138	27	27	12	12	cisplatin	BCL2	PA449014	596	0.912
NULL	Curr_Opin_HIV_AIDS_2014_Jan_6_9(1)_87-94.nxml.txt.nlp	24247666	SENT91	7	7	16	16	nevirapine	CD4	PA450616	920	0.912
NULL	Orphanet_J_Rare_Dis_2013_Apr_9_8_57.nxml.txt.nlp	23570448	SENT154	12	12	0	0	nadh	SDH	PA164755085	1757;10993	0.912
NULL	Oxid_Med_Cell_Longev_2013_Apr_18_2013_239854.nxml.txt.nlp	23710284	SENT86	4	4	19	19	zonisamide	HRD1	PA451978	84447	0.912
NULL	Mol_Cancer_2009_Apr_22_8_26.nxml.txt.nlp	19386116	SENT142	13	13	22	22	ritonavir	AKT	PA451260	207	0.912
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT179	13	13	45	45	heparin	FGF1	PA449855	2246	0.912
NULL	Int_J_Mol_Sci_2014_Nov_10_15(11)_20607-20637.nxml.txt.nlp	25391045	SENT280	4	4	18	18	simvastatin	Rho	PA451363	29984	0.912
NULL	Mol_Cancer_2007_Apr_16_6_30.nxml.txt.nlp	17437646	SENT26	20	20	13	13	erlotinib	PTEN	PA134687924	5728	0.912
NULL	Arthritis_Res_Ther_2005_Oct_26_7(6)_253-269.nxml.txt.nlp	16277701	SENT313	18	18	7	7	adalimumab	DPPIV	PA10004	2191;1803	0.912
NULL	Acta_Pharmacol_Sin_2010_Mar_8_31(3)_382-386.nxml.txt.nlp	20140004	SENT72	17	17	27	27	pravastatin	APOE	PA451089	348	0.912
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT210	36	36	23	23	cisplatin	B7-H1	PA449014	29126	0.912
NULL	Chemother_Res_Pract_2012_Dec_20_2012_743193.nxml.txt.nlp	23320171	SENT75	0	0	3	3	trastuzumab	HER2	PA451743	2064	0.912
NULL	Crit_Care_2011_Jul_12_15(4)_R166.nxml.txt.nlp	21749676	SENT179	27	27	14	14	levosimendan	IL-6	PA164749138	3569	0.912
NULL	Br_J_Cancer_2012_Nov_20_107(11)_1815-1819.nxml.txt.nlp	23099804	SENT96	18	18	13	13	anastrozole	aromatase	PA448432	1588	0.912
NULL	Am_J_Rhinol_Allergy_2013_Nov-Dec_27(6)_482-489.nxml.txt.nlp	24274224	SENT147	8	8	22	22	zileuton	LTA	PA451955	4049	0.912
NULL	Cancers_(Basel)_2013_May_27_5(2)_617-638.nxml.txt.nlp	24216994	SENT145	20	20	34	34	curcumin	PC3	PA151958596	57332;7832;5122	0.912
NULL	Adv_Biomed_Res_2014_Mar_25_3_97.nxml.txt.nlp	24800186	SENT128	5	5	33	33	sertraline	IL-4	PA451333	3565	0.912
NULL	Clin_Ophthalmol_2008_Jun_2(2)_355-368.nxml.txt.nlp	19668727	SENT62	15	15	13	13	indomethacin	COX	PA449982	1351	0.912
NULL	Front_Oncol_2014_Jun_18_4_153.nxml.txt.nlp	24995158	SENT175	2	2	12	12	etoposide	AP-1	PA449552	2353;3727;2354;3725	0.912
NULL	Braz_J_Med_Biol_Res_2012_Feb_17_45(3)_244-249.nxml.txt.nlp	22331137	SENT16	13	13	29	29	gentamicin	PAG	PA449753	55824	0.912
NULL	AAPS_J_2011_Jun_1_13(3)_405-416.nxml.txt.nlp	21630127	SENT252	15	15	30	30	omeprazole	CYP3A4	PA450704	1576	0.912
NULL	Front_Neural_Circuits_2014_Jul_10_8_76.nxml.txt.nlp	25071457	SENT91	21	21	4	4	tamoxifen	P56	PA451581	8999	0.912
NULL	Mol_Cancer_2014_Jul_5_13_165.nxml.txt.nlp	24996221	SENT143	18	18	42	42	docetaxel	HMGB1	PA449383	3146	0.912
NULL	Oncogenesis_2012_Apr_2_1(4)_e5.nxml.txt.nlp	23552603	SENT570	7	7	12	12	ns-398	BAX		581	0.912
NULL	eLife_2014_May_6_3_e02482.nxml.txt.nlp	24843002	SENT200	8	8	20	20	etoposide	SETD2	PA449552	29072	0.912
NULL	J_Mol_Med_(Berl)_2014_May_10_92(7)_709-722.nxml.txt.nlp	24811491	SENT2	30	30	25	25	panitumumab	EGFR	PA162373091	1956	0.912
NULL	Clin_Dev_Immunol_2013_Sep_29_2013_282870.nxml.txt.nlp	24187562	SENT151	4	4	20	20	fluorescein	SP4	PA164746009	6671	0.912
NULL	Crit_Care_2007_May_24_11(3)_R61.nxml.txt.nlp	17524133	SENT170	8	8	28	28	fluconazole	RAI	PA449653	10848;6050	0.912
NULL	Mediators_Inflamm_1998_7(3)_221-223.nxml.txt.nlp	9705611	SENT6	5	5	27	27	carrageenan	IL-6	PA448814	3569	0.912
NULL	ScientificWorldJournal_2013_Jun_19_2013_174392.nxml.txt.nlp	23853530	SENT147	21	21	26	26	doxazosin	c-FLIP	PA449407	8837	0.912
NULL	Curr_Cardiol_Rev_2010_Nov_6(4)_298-308.nxml.txt.nlp	22043206	SENT57	10	10	24	24	isoproterenol	MNS	PA450121	2996	0.912
NULL	Interdiscip_Toxicol_2012_Dec_5(4)_192-200.nxml.txt.nlp	23554563	SENT10	20	20	5	5	ceftriaxone	ALAD	PA448866	210	0.912
NULL	J_Viral_Hepat_2007_Jun_1_14(6)_371-386.nxml.txt.nlp	17501757	SENT176	0	0	33	33	didanosine	gamma	PA449301	9913	0.912
NULL	J_Exp_Med_2003_Jan_20_197(2)_207-220.nxml.txt.nlp	12538660	SENT281	9	9	28	28	tetracycline	RAG1	PA451640	5896	0.912
NULL	Front_Genet_2012_Nov_5_3_236.nxml.txt.nlp	23133441	SENT26	9	9	24	24	nelfinavir	P-gp	PA450606	5243	0.912
NULL	Br_J_Cancer_2010_Dec_7_103(12)_1858-1869.nxml.txt.nlp	21063399	SENT41	23	23	15	15	panitumumab	EGFR	PA162373091	1956	0.912
NULL	Patient_Prefer_Adherence_2013_Sep_11_7_891-895.nxml.txt.nlp	24049440	SENT52	32	32	20	20	ritonavir	ART	PA451260	181	0.912
NULL	Indian_J_Anaesth_2014_Jan-Feb_58(1)_63-65.nxml.txt.nlp	24700903	SENT10	18	18	26	26	propofol	adrenoleukodystrophy	PA451141	215	0.912
NULL	Nat_Commun_2013_Apr_9_4_1685.nxml.txt.nlp	23575689	SENT125	6	6	16	16	staurosporine	CRTC2	PA165109623	200186	0.912
NULL	Indian_J_Med_Paediatr_Oncol_2014_Oct-Dec_35(4)_253-262.nxml.txt.nlp	25538401	SENT17	7	7	14	14	trastuzumab	HER-2	PA451743	2064	0.912
NULL	Cancers_(Basel)_2010_Feb_23_2(1)_88-113.nxml.txt.nlp	24281034	SENT1052	4	4	25	25	pertuzumab	HER2		2064	0.912
NULL	Nat_Chem_Biol_2013_Mar_20_9(3)_163-168.nxml.txt.nlp	23340338	SENT274	32	32	11	11	l-glutamine	p53	PA10090	7157	0.912
NULL	F1000Res_2014_Mar_18_3_74.nxml.txt.nlp	25580222	SENT152	5	5	15	15	ciprofloxacin	TOX	PA449009	9760	0.912
NULL	Can_Geriatr_J_2013_Jun_3_16(2)_38-42.nxml.txt.nlp	23737927	SENT88	11	11	21	21	fluoxetine	AQP2	PA449673	359	0.912
NULL	Mol_Neurodegener_2010_Nov_10_5_50.nxml.txt.nlp	21067605	SENT62	17	17	0	0	calcein	LIP	PA132595336	23049	0.912
NULL	Br_J_Cancer_2011_Mar_15_104(6)_941-947.nxml.txt.nlp	21407223	SENT163	9	9	7	7	sorafenib	survivin	PA7000	332	0.912
NULL	J_Thromb_Thrombolysis_2009_Nov_6_28(4)_410-417.nxml.txt.nlp	19504052	SENT33	4	4	36	36	clopidogrel	DES	PA449053	1674	0.912
NULL	Cancer_Cell_Int_2011_Sep_23_11_33.nxml.txt.nlp	21943203	SENT249	4	4	7	7	trastuzumab	CD4	PA451743	920	0.912
NULL	Nucleic_Acids_Res_2013_May_5_41(10)_5210-5222.nxml.txt.nlp	23563151	SENT224	4	4	26	26	arsenite	GADD45	PA452638	1647	0.912
NULL	Am_J_Trop_Med_Hyg_2012_Dec_5_87(6)_1004-1011.nxml.txt.nlp	23091194	SENT39	22	22	3	3	lumefantrine	RDT	PA165111722	6598	0.912
NULL	Pharmaceuticals_(Basel)_2014_Sep_17_7(9)_943-953.nxml.txt.nlp	25232798	SENT154	22	22	3	3	trastuzumab	HER2	PA451743	2064	0.912
NULL	J_Cancer_2013_Nov_14_4(9)_703-715.nxml.txt.nlp	24312140	SENT223	26	26	9	9	curcumin	BRCA2	PA151958596	675	0.912
NULL	Contemp_Oncol_(Pozn)_2013_Apr_29_17(2)_128-133.nxml.txt.nlp	23788978	SENT44	26	26	11	11	oxymorphone	CYP3A4	PA450748	1576	0.912
NULL	Br_J_Cancer_2012_Nov_6_107(10)_1714-1721.nxml.txt.nlp	23073173	SENT119	31	31	16	16	docetaxel	RUNX2	PA449383	860	0.912
NULL	Breast_Cancer_Res_2005_Jan_12_7(2)_48-51.nxml.txt.nlp	15743510	SENT42	14	14	18	18	anastrozole	aromatase	PA448432	1588	0.912
NULL	J_Cancer_Epidemiol_2012_Aug_27_2012_978391.nxml.txt.nlp	22969803	SENT127	0	0	7	7	rituximab	CHOP	PA451261	1649	0.912
NULL	Cell_Res_2014_Jul_30_24(7)_809-819.nxml.txt.nlp	24874954	SENT45	14	14	18	18	estradiol	WHSC1	PA449503	7468	0.912
NULL	Oncotarget_2014_Jun_5_5(21)_10382-10392.nxml.txt.nlp	25071015	SENT157	46	46	10	10	trastuzumab	p53	PA451743	7157	0.912
NULL	Oncol_Lett_2014_Mar_2_7(3)_791-796.nxml.txt.nlp	24527087	SENT96	3	3	11	11	imatinib	CD34	PA10804	947	0.912
NULL	Case_Rep_Endocrinol_2012_Oct_14_2012_503290.nxml.txt.nlp	23097726	SENT75	34	34	6	6	vasopressin	ACTH	PA451858	5443	0.912
NULL	J_Oncol_2012_Aug_14_2012_408131.nxml.txt.nlp	22934112	SENT198	19	19	15	15	sorafenib	VEGFR	PA7000	3791	0.912
NULL	Acta_Pharmacol_Sin_2014_Jan_9_35(1)_1-10.nxml.txt.nlp	24317012	SENT23	28	28	2	2	irinotecan	OATP1B3	PA450085	28234	0.912
NULL	Indian_J_Nephrol_2014_Nov-Dec_24(6)_349-355.nxml.txt.nlp	25484527	SENT57	3	3	27	27	fluorescein	CD4	PA164746009	920	0.912
NULL	Lab_Invest_2014_May_10_94(5)_503-516.nxml.txt.nlp	24614199	SENT474	17	17	27	27	curcumin	NAC	PA151958596	22861	0.912
NULL	Oncotarget_2011_Dec_21_2(12)_1134-1144.nxml.txt.nlp	22193779	SENT134	20	20	14	14	gefitinib	PC3	PA131301952	57332;7832;5122	0.912
NULL	Arthritis_Res_Ther_2009_Aug_24_11(4)_R127.nxml.txt.nlp	19703304	SENT144	38	38	10	10	adalimumab	OASIS	PA10004	90993	0.912
NULL	Endocrinol_Metab_(Seoul)_2014_Sep_25_29(3)_379-387.nxml.txt.nlp	25309798	SENT106	3	3	15	15	resveratrol	SIRT1		23411	0.912
NULL	Mol_Cancer_2014_Jul_5_13_165.nxml.txt.nlp	24996221	SENT13	13	13	0	0	docetaxel	HMGB1	PA449383	3146	0.912
NULL	Cent_European_J_Urol_2013_Dec_19_66(4)_394-404.nxml.txt.nlp	24757527	SENT172	10	10	18	18	temsirolimus	IFN	PA164746890	3439	0.912
NULL	Core_Evid_2011_Feb_8_6_23-29.nxml.txt.nlp	21468240	SENT32	25	25	19	19	plerixafor	CD34	PA165958410	947	0.912
NULL	Carcinogenesis_2010_Dec_27_31(12)_2049-2057.nxml.txt.nlp	20876285	SENT6	32	32	16	16	tamoxifen	HER2	PA451581	2064	0.912
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Oct_29_6_169-177.nxml.txt.nlp	25378949	SENT84	11	11	6	6	trastuzumab	HER2	PA451743	2064	0.912
NULL	Mol_Cancer_2006_Oct_17_5_45.nxml.txt.nlp	17044934	SENT154	7	7	27	27	resveratrol	PGF		5228	0.912
NULL	Cardiol_Res_Pract_2013_Feb_19_2013_195456.nxml.txt.nlp	23533940	SENT66	25	25	18	18	ticagrelor	CYP3A4	PA165374673	1576	0.912
NULL	Ann_Oncol_2013_Aug_12_24(8)_1994-1999.nxml.txt.nlp	23670096	SENT155	24	24	18	18	tamoxifen	AIB1	PA451581	8202	0.912
NULL	J_Cell_Mol_Med_2014_Sep_7_18(9)_1785-1796.nxml.txt.nlp	24909956	SENT194	27	27	10	10	cangrelor	CD44	PA165945763	960	0.912
NULL	Mar_Drugs_2014_Mar_7_12(3)_1377-1389.nxml.txt.nlp	24608973	SENT110	36	36	9	9	flavopiridol	CDK4	PA452627	1019	0.912
NULL	Ann_Biomed_Eng_2011_Apr_1_39(4)_1174-1185.nxml.txt.nlp	21120695	SENT172	19	19	9	9	calcein	DM2	PA132595336	28508	0.912
NULL	Front_Oncol_2014_Apr_1_4_67.nxml.txt.nlp	24744992	SENT181	24	24	21	21	erlotinib	EGFR	PA134687924	1956	0.912
NULL	Mol_Brain_2014_Oct_9_7(1)_74.nxml.txt.nlp	NULL	SENT290	9	9	20	20	phencyclidine	GLAST	PA128406980	6507	0.912
NULL	Drug_Saf_2014_Feb_19_37(4)_201-211.nxml.txt.nlp	24550106	SENT131	10	10	22	22	esomeprazole	CYP2C9	PA10075	1559	0.912
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT138	21	21	7	7	doxorubicin	B7-H1	PA449412	29126	0.912
NULL	Breast_Cancer_Res_2009_Jun_16_11(3)_R35.nxml.txt.nlp	19531217	SENT25	18	18	5	5	anastrozole	aromatase	PA448432	1588	0.912
NULL	Front_Oncol_2013_Nov_15_3_281.nxml.txt.nlp	24298448	SENT86	10	10	15	15	irinotecan	BRAF	PA450085	673	0.912
NULL	Oncotarget_2014_Mar_16_5(12)_4087-4102.nxml.txt.nlp	24961479	SENT179	18	18	24	24	hemin	HO-1	PA449849	3162	0.912
NULL	Oncologist_2010_Sep_26_15(9)_944-953.nxml.txt.nlp	20798196	SENT41	24	24	32	32	capecitabine	HER-2	PA448771	2064	0.912
NULL	Onco_Targets_Ther_2014_Dec_4_7_2249-2255.nxml.txt.nlp	25587220	SENT119	17	17	15	15	cyclosporine	P-gp	PA449167	5243	0.912
NULL	Clin_Interv_Aging_2013_Sep_16_8_1229-1236.nxml.txt.nlp	24072968	SENT83	24	24	20	20	doxorubicin	CHOP	PA449412	1649	0.912
NULL	Breast_Cancer_Res_2008_Dec_18_10(Suppl_4)_S16.nxml.txt.nlp	19128429	SENT26	23	23	10	10	tamoxifen	aromatase	PA451581	1588	0.912
NULL	Oncotarget_2012_May_19_3(5)_535-545.nxml.txt.nlp	22619121	SENT100	7	7	3	3	camptothecin	B-MYB	PA153590860	4605	0.912
NULL	Diabetes_2008_Sep_57(9)_2272-2279.nxml.txt.nlp	18519799	SENT139	8	8	10	10	rosiglitazone	PDK4	PA451283	5166	0.912
NULL	J_Inflamm_(Lond)_2006_Jul_12_3_10.nxml.txt.nlp	16834783	SENT18	18	18	6	6	mometasone	CXCR4	PA450541	7852	0.912
NULL	Cardiovasc_Diabetol_2013_Nov_21_12_172.nxml.txt.nlp	24261558	SENT290	12	12	7	7	eplerenone	FABP3	PA164749044	2170	0.912
NULL	Core_Evid_2007_Nov_30_2(2)_121-129.nxml.txt.nlp	21221180	SENT106	10	10	20	20	rituximab	EFS	PA451261	10278	0.912
NULL	J_Int_Soc_Sports_Nutr_2014_Aug_13_11_38.nxml.txt.nlp	25132809	SENT137	19	19	3	3	creatine	MSTN	PA164778930	2660	0.912
NULL	Ann_Rheum_Dis_2010_Jun_1_69(6)_964-975.nxml.txt.nlp	20444750	SENT340	41	41	18	18	tocilizumab	IL-6	PA165292659	3569	0.912
NULL	Virol_J_2009_Dec_1_6_213.nxml.txt.nlp	19951438	SENT147	10	10	16	16	etoposide	TRAIL	PA449552	8743	0.912
NULL	Pharmaceuticals_(Basel)_2013_Feb_7_6(2)_269-286.nxml.txt.nlp	24275951	SENT91	16	16	9	9	staurosporine	PKG	PA165109623	5592	0.912
NULL	Eur_J_Clin_Pharmacol_2010_Nov_29_66(11)_1131-1136.nxml.txt.nlp	20669013	SENT130	4	4	7	7	voriconazole	CYP3A4	PA10233	1576	0.912
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1013.nxml.txt.nlp	24457957	SENT79	5	5	28	28	bortezomib	NOXA	PA10252	5366	0.912
NULL	Protein_J_2012_Aug_5_31(6)_511-518.nxml.txt.nlp	22763563	SENT144	3	3	9	9	atorvastatin	CD36	PA448500	948	0.912
NULL	J_Cell_Biol_2002_Jun_24_157(7)_1151-1160.nxml.txt.nlp	12082077	SENT278	28	28	23	23	trypsin	COX	PA451806	1351	0.912
NULL	Onco_Targets_Ther_2014_Oct_24_7_1971-1977.nxml.txt.nlp	25368524	SENT145	13	13	17	17	belinostat	CHOP		1649	0.912
NULL	Cell_Tissue_Res_2014_Dec_6_355(2)_365-374.nxml.txt.nlp	24310606	SENT118	17	17	7	7	trypsin	NT5E	PA451806	4907	0.912
NULL	J_Mol_Signal_2013_Mar_25_8_3.nxml.txt.nlp	23531275	SENT30	12	12	23	23	thrombin	LPA	PA451674	4018	0.912
NULL	Arthritis_Rheumatol_2014_Jun_27_66(6)_1574-1582.nxml.txt.nlp	24577881	SENT157	23	23	15	15	hydralazine	ERK	PA449894	5594	0.912
NULL	Neuropsychopharmacology_2009_Jul_11_34(8)_1946-1957.nxml.txt.nlp	19279569	SENT161	15	15	24	24	cocaine	DOR	PA449072	58476	0.912
NULL	Curr_HIV_Res_2014_May_12(3)_174-188.nxml.txt.nlp	24862327	SENT147	14	14	46	46	hemin	HO-1	PA449849	3162	0.912
NULL	Breast_Cancer_Res_2000_Dec_17_2(1)_10-12.nxml.txt.nlp	11250686	SENT53	27	27	21	21	raloxifene	STAR	PA451221	6770;2984	0.912
NULL	Mol_Cancer_2008_Mar_26_7_27.nxml.txt.nlp	18366759	SENT145	24	24	11	11	etoposide	AP-1	PA449552	2353;3727;2354;3725	0.912
NULL	J_Oncol_2012_Jun_19_2012_521215.nxml.txt.nlp	22778735	SENT236	3	3	16	16	afatinib	HER2	PA165981154	2064	0.912
NULL	Acta_Histochem_Cytochem_2010_May_1_43(2)_61-68.nxml.txt.nlp	20514293	SENT323	6	6	18	18	hyaluronan	CD11b	PA165958431	3684	0.912
NULL	J_Breast_Cancer_2013_Mar_31_16(1)_23-31.nxml.txt.nlp	23593078	SENT136	17	17	28	28	resveratrol	HDAC1		3065	0.912
NULL	Nucleic_Acids_Res_2011_Oct_9_39(18)_e123.nxml.txt.nlp	21745820	SENT104	7	7	23	23	l-glutamine	CO2	PA10090	4513	0.912
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT37	40	40	24	24	tamoxifen	TFF3	PA451581	7033	0.912
NULL	Curr_Oncol_Rep_2011_Apr_12_13(2)_103-111.nxml.txt.nlp	21318618	SENT145	11	11	7	7	telatinib	VEGFR	PA165980595	3791	0.912
NULL	Acta_Pharmacol_Sin_2013_Jan_17_34(1)_157-166.nxml.txt.nlp	23247593	SENT12	5	5	15	15	berberine	IL-6	PA165860812	3569	0.912
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT137	10	10	0	0	imatinib	ABCB1	PA10804	5243	0.912
NULL	J_Biomed_Sci_2014_May_13_21(1)_42.nxml.txt.nlp	24884799	SENT77	19	19	9	9	paraformaldehyde	CO2	PA450790	4513	0.912
NULL	Evid_Based_Complement_Alternat_Med_2014_Oct_15_2014_152063.nxml.txt.nlp	25386216	SENT239	11	11	3	3	methamphetamine	gamma	PA450403	9913	0.912
NULL	Mol_Cancer_2010_Apr_15_9_77.nxml.txt.nlp	20398291	SENT30	28	28	11	11	cisplatin	survivin	PA449014	332	0.912
NULL	Cancers_(Basel)_2011_Apr_1_3(2)_1844-1860.nxml.txt.nlp	24212785	SENT71	36	36	17	17	cetuximab	ACRC	PA10040	93953	0.912
NULL	G3_(Bethesda)_2014_Feb_20_4(4)_761-767.nxml.txt.nlp	24558266	SENT38	29	29	1	1	galactose	PIS1	PA449725	10423	0.912
NULL	J_Ophthalmol_2009_Sep_6_2009_360764.nxml.txt.nlp	20339564	SENT333	27	27	31	31	cyanocobalamin	ARM	PA451892	80210	0.912
NULL	J_Geriatr_Cardiol_2014_Mar_11(1)_63-73.nxml.txt.nlp	24748884	SENT149	16	16	11	11	fenoldopam	DR3	PA164784034	8718	0.912
NULL	Cancer_Metastasis_Rev_2014_Apr_18_33(2-3)_695-720.nxml.txt.nlp	24744103	SENT310	33	33	43	43	gefitinib	EGFR	PA131301952	1956	0.912
NULL	Biomed_Res_Int_2013_Aug_7_2013_546318.nxml.txt.nlp	23986907	SENT98	0	0	29	29	gefitinib	p27	PA131301952	5715;10534	0.912
NULL	Biol_Proced_Online_2003_Feb_17_5_43-52.nxml.txt.nlp	12734557	SENT13	5	5	13	13	bupivacaine	IFN	PA135057240	3439	0.912
NULL	Front_Oncol_2013_Sep_23_3_250.nxml.txt.nlp	24069582	SENT366	14	14	29	29	anastrozole	ATAC	PA448432	6375	0.912
NULL	Nat_Commun_2013_Nov_26_4_10_1038_ncomms3816.nxml.txt.nlp	24281383	SENT170	13	13	45	45	allopregnanolone	S14	PA142320763	5714;6208;7069	0.912
NULL	Cardiovasc_Diabetol_2005_Oct_5_4_16.nxml.txt.nlp	16207378	SENT151	14	14	8	8	glucosamine	perlecan	PA164747613	3339	0.912
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1046.nxml.txt.nlp	24503538	SENT12	23	23	17	17	oxaliplatin	FGFR4	PA131285527	2264	0.912
NULL	Leukemia_2014_Mar_20_28(3)_554-565.nxml.txt.nlp	24280866	SENT137	16	16	6	6	imatinib	BCL2	PA10804	596	0.912
NULL	Mol_Cancer_2010_Oct_12_9_269.nxml.txt.nlp	20939893	SENT212	6	6	21	21	isoproterenol	STAT3	PA450121	6774	0.912
NULL	Br_J_Cancer_2009_Jul_21_101(2)_350-356.nxml.txt.nlp	19513075	SENT109	32	32	16	16	methotrexate	TP53	PA450428	7157	0.912
NULL	Breast_Cancer_Res_Treat_2012_Jun_3_133(3)_865-880.nxml.txt.nlp	22048815	SENT11	23	23	27	27	carboplatin	BRCA1	PA448803	672	0.912
NULL	Ann_Rheum_Dis_2013_Apr_21_72(4)_482-492.nxml.txt.nlp	23172750	SENT343	44	44	23	23	tocilizumab	IL-6	PA165292659	3569	0.912
NULL	Front_Neurosci_2014_Jan_31_8_6.nxml.txt.nlp	24550768	SENT214	12	12	10	10	capsaicin	TRPV1	PA448776	7442	0.912
NULL	J_Cell_Biol_2002_Jun_24_157(7)_1151-1160.nxml.txt.nlp	12082077	SENT180	28	28	2	2	trypsin	COX	PA451806	1351	0.912
NULL	Breast_Cancer_Res_2011_Jan_24_13(1)_401.nxml.txt.nlp	21349137	SENT28	31	31	6	6	lapatinib	AMPK	PA152241907	5563	0.912
NULL	Oncotarget_2014_May_27_5(19)_9049-9064.nxml.txt.nlp	24979294	SENT245	11	11	42	42	fulvestrant	c-Myc	PA164747170	4609	0.912
NULL	Neural_Regen_Res_2013_Mar_25_8(9)_825-832.nxml.txt.nlp	25206730	SENT37	2	2	7	7	isoflurane	P2X7	PA450106	5027	0.912
NULL	Allergy_Asthma_Immunol_Res_2014_Nov_28_6(6)_567-572.nxml.txt.nlp	25374757	SENT104	10	10	19	19	fexofenadine	IL-6	PA449621	3569	0.912
NULL	Oncogene_2014_Jul_24_33(30)_3959-3969.nxml.txt.nlp	24096481	SENT25	27	27	10	10	doxorubicin	MDM2	PA449412	4193	0.912
NULL	J_Lipid_Res_2012_Sep_53(9)_1840-1850.nxml.txt.nlp	22711909	SENT297	10	10	16	16	resveratrol	ABCA1		19	0.912
NULL	Br_J_Cancer_2003_Mar_10_88(5)_754-759.nxml.txt.nlp	12618886	SENT163	15	15	19	19	amifostine	p53	PA448365	7157	0.912
NULL	J_Cardiothorac_Surg_2009_Nov_13_4_65.nxml.txt.nlp	19912629	SENT17	5	5	13	13	cabergoline	5-HT2B	PA448708	3357	0.912
NULL	Cancer_Manag_Res_2011_Aug_10_3_273-285.nxml.txt.nlp	21931501	SENT142	13	13	20	20	sunitinib	IFN	PA162372840	3439	0.912
NULL	Hum_Genomics_2008_Sep_1_3(1)_7-16.nxml.txt.nlp	19129086	SENT148	3	3	10	10	rosiglitazone	CYP2C8	PA451283	1558	0.912
NULL	Eur_J_Clin_Pharmacol_2011_May_8_67(5)_493-506.nxml.txt.nlp	21140139	SENT41	33	33	27	27	quinidine	CYP2D6	PA451209	1565	0.912
NULL	Lipids_Health_Dis_2011_Feb_28_10_38.nxml.txt.nlp	21352602	SENT102	0	0	25	25	atorvastatin	PCSK9	PA448500	255738	0.912
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2012_Nov_14_1(11)_e14.nxml.txt.nlp	23835796	SENT41	4	4	36	36	denosumab	RANKL	PA166048634	8600	0.912
NULL	Mol_Brain_2013_Apr_9_6_16.nxml.txt.nlp	23570271	SENT237	0	0	40	40	sulindac	SOD1	PA451565	6647	0.912
NULL	J_Biomed_Biotechnol_2010_Jun_7_2010_150960.nxml.txt.nlp	20617134	SENT218	24	24	5	5	cetuximab	KRAS	PA10040	3845	0.912
NULL	Breast_Cancer_Res_2011_Jan_28_13(1)_R11.nxml.txt.nlp	21276249	SENT273	17	17	19	19	tamoxifen	aromatase	PA451581	1588	0.912
NULL	Breast_Cancer_Res_2012_Jul_19_14(4)_R109.nxml.txt.nlp	22812567	SENT16	19	19	13	13	gemcitabine	CHK1	PA449748	1111	0.912
NULL	Pharmaceuticals_(Basel)_2013_Aug_2_6(8)_915-928.nxml.txt.nlp	24276376	SENT12	33	33	22	22	aspirin	ADP	PA448497	23038	0.912
NULL	Cancers_(Basel)_2010_Jul_27_2(3)_1528-1554.nxml.txt.nlp	24281171	SENT313	21	21	11	11	docetaxel	CD44	PA449383	960	0.912
NULL	Biologics_2012_Jul_26_6_233-244.nxml.txt.nlp	22904615	SENT95	28	28	3	3	imatinib	EGFR	PA10804	1956	0.912
NULL	Anat_Cell_Biol_2010_Dec_31_43(4)_325-331.nxml.txt.nlp	21267407	SENT85	24	24	38	38	minocycline	TNF-alpha	PA450519	7124	0.912
NULL	AIDS_Res_Ther_2008_Mar_28_5_5.nxml.txt.nlp	18373851	SENT131	1	1	15	15	ritonavir	ATV	PA451260	4683	0.912
NULL	Braz_J_Med_Biol_Res_2014_Oct_24_48(1)_65-76.nxml.txt.nlp	25493385	SENT165	33	33	12	12	l-arginine	AT2	PA448478	186	0.912
NULL	Chin_J_Cancer_2012_Feb_31(2)_58-72.nxml.txt.nlp	22098952	SENT122	3	3	13	13	cisplatin	MRP2	PA449014	100130958;57626;1244	0.912
NULL	FEBS_Open_Bio_2014_Aug_30_4_763-776.nxml.txt.nlp	25349781	SENT534	26	26	16	16	curcumin	NAC	PA151958596	22861	0.912
NULL	Eur_J_Clin_Pharmacol_2011_Dec_23_67(12)_1231-1241.nxml.txt.nlp	21698374	SENT128	11	11	4	4	tacrolimus	CYP3A5	PA451578	1577	0.912
NULL	Diabetes_Metab_J_2013_Oct_17_37(5)_315-325.nxml.txt.nlp	24199159	SENT194	10	10	12	12	resveratrol	SIRT1		23411	0.912
NULL	Adv_Bioinformatics_2012_Dec_19_2012_705435.nxml.txt.nlp	23316227	SENT83	5	5	25	25	resveratrol	SIRT1		23411	0.912
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jul_17_66(Pt_8)_o2053-o2054.nxml.txt.nlp	21588360	SENT80	0	0	26	26	benzaldehyde	mol	PA448571	90527	0.912
NULL	Cancers_(Basel)_2014_Jul_22_6(3)_1540-1552.nxml.txt.nlp	25055117	SENT700	4	4	0	0	gefitinib	Met	PA131301952	79811	0.912
NULL	Indian_J_Med_Res_2011_Aug_134(2)_200-207.nxml.txt.nlp	21911973	SENT47	15	15	0	0	phenol	TLR3	PA450913	7098	0.912
NULL	Mol_Cancer_2010_Apr_15_9_77.nxml.txt.nlp	20398291	SENT242	9	9	20	20	indomethacin	survivin	PA449982	332	0.912
NULL	Croat_Med_J_2014_Jun_55(3)_206-217.nxml.txt.nlp	24891279	SENT73	16	16	24	24	doxorubicin	p53	PA449412	7157	0.912
NULL	Ther_Clin_Risk_Manag_2007_Mar_3(1)_107-118.nxml.txt.nlp	18360619	SENT168	0	0	3	3	tegaserod	5-HT4	PA130413154	3360	0.912
NULL	Mol_Cancer_2013_Mar_5_12_17.nxml.txt.nlp	23497256	SENT143	12	12	25	25	sunitinib	HDM2	PA162372840	4193	0.912
NULL	Br_J_Cancer_2009_Mar_10_100(5)_758-763.nxml.txt.nlp	19259094	SENT6	4	4	17	17	decitabine	MLH1	PA164749631	4292	0.912
NULL	J_Biomed_Biotechnol_2010_Jun_8_2010_757301.nxml.txt.nlp	20625414	SENT218	19	19	28	28	aprotinin	B12	PA448472	7126;4709	0.912
NULL	Cardiovasc_Diabetol_2010_Oct_18_9_64.nxml.txt.nlp	20955583	SENT135	4	4	17	17	rosiglitazone	CD36	PA451283	948	0.912
NULL	Aging_(Albany_NY)_2013_Aug_21_5(8)_623-636.nxml.txt.nlp	23974852	SENT171	9	9	26	26	metformin	AMPK	PA450395	5563	0.912
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT58	25	25	9	9	pertuzumab	HER-2		2064	0.912
NULL	Mol_Cancer_2014_Aug_22_13(1)_195.nxml.txt.nlp	NULL	SENT15	14	14	8	8	cisplatin	TBL1XR1	PA449014	79718	0.912
NULL	Anticancer_Agents_Med_Chem_2012_Feb_12(2)_163-171.nxml.txt.nlp	22043994	SENT178	29	29	20	20	cetuximab	BRAF	PA10040	673	0.912
NULL	J_Biomed_Biotechnol_2011_Dec_6_2011_856985.nxml.txt.nlp	21188173	SENT292	24	24	27	27	trastuzumab	HER2	PA451743	2064	0.912
NULL	Nat_Med_2010_Jun_23_16(6)_671-677.nxml.txt.nlp	20495567	SENT217	20	20	26	26	sorafenib	JNK	PA7000	5599	0.912
NULL	Chemother_Res_Pract_2012_Aug_29_2012_817297.nxml.txt.nlp	22970367	SENT170	7	7	17	17	afatinib	ERBB2	PA165981154	2064	0.912
NULL	Curr_Control_Trials_Cardiovasc_Med_2001_Feb_2_2(1)_20-23.nxml.txt.nlp	11806769	SENT39	21	21	1	1	bucindolol	BEST	PA165945764	7439	0.912
NULL	J_Carcinog_2012_Sep_13_11_15.nxml.txt.nlp	23230392	SENT127	13	13	19	19	cetuximab	EGFR	PA10040	1956	0.912
NULL	Mol_Cancer_2010_May_20_9_115.nxml.txt.nlp	20487546	SENT267	21	21	25	25	fludarabine	p53	PA449655	7157	0.912
NULL	Oncotarget_2012_Oct_20_3(10)_1068-1111.nxml.txt.nlp	23085539	SENT29	0	0	12	12	sorafenib	SHARP	PA7000	23013	0.912
NULL	Curr_Neuropharmacol_2013_Mar_11(2)_218-230.nxml.txt.nlp	23997756	SENT1	0	0	26	26	vasopressin	SON	PA451858	6651	0.912
NULL	J_Gynecol_Oncol_2012_Jul_2_23(3)_139-140.nxml.txt.nlp	NULL	SENT26	24	24	7	7	paclitaxel	EZH2	PA450761	2146	0.912
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT221	6	6	14	14	chloroquine	BMPR-II	PA448948	659	0.912
NULL	Oncotarget_2014_Feb_7_5(3)_775-787.nxml.txt.nlp	24519956	SENT104	28	28	10	10	docetaxel	PC3	PA449383	57332;7832;5122	0.912
NULL	Am_J_Case_Rep_2014_Feb_24_15_85-89.nxml.txt.nlp	24587856	SENT94	10	10	14	14	exemestane	aromatase	PA449563	1588	0.912
NULL	Arthritis_Res_Ther_2005_Mar_16_7(Suppl_2)_S4-S14.nxml.txt.nlp	15833146	SENT223	6	6	21	21	sulfasalazine	IFN	PA451547	3439	0.912
NULL	Blood_Res_2014_Sep_25_49(3)_139-140.nxml.txt.nlp	25325028	SENT27	28	28	1	1	trastuzumab	FCGR3A	PA451743	2214	0.912
NULL	Br_J_Cancer_2012_Nov_6_107(10)_1722-1728.nxml.txt.nlp	23079576	SENT97	8	8	4	4	tamoxifen	TP53	PA451581	7157	0.912
NULL	Oxid_Med_Cell_Longev_2013_Jun_11_2013_870472.nxml.txt.nlp	23840921	SENT73	25	25	16	16	chloroquine	HO-1	PA448948	3162	0.912
NULL	Indian_J_Med_Res_2011_Sep_134(3)_295-301.nxml.txt.nlp	21985811	SENT123	45	45	13	13	phenytoin	CYP2C19	PA450947	1557	0.912
NULL	Acta_Pharmacol_Sin_2012_Oct_3_33(10)_1311-1318.nxml.txt.nlp	22941289	SENT126	4	4	30	30	sorafenib	VEGFR2	PA7000	3791	0.912
NULL	Diabetes_Care_2010_Mar_22_33(3)_589-594.nxml.txt.nlp	20028939	SENT210	15	15	1	1	diazoxide	FOXP3	PA449285	50943	0.912
NULL	Mol_Vis_2012_Nov_29_18_2839-2846.nxml.txt.nlp	23233786	SENT12	5	5	11	11	geldanamycin	Hsp90	PA152031327	3320	0.912
NULL	Cancer_Cell_Int_2011_Jun_1_11_15.nxml.txt.nlp	21631944	SENT146	24	24	40	40	etoposide	GAPDH	PA449552	2597	0.912
NULL	Br_J_Cancer_2012_Jan_3_106(1)_126-132.nxml.txt.nlp	22095227	SENT135	11	11	4	4	cisplatin	ANKRD1	PA449014	27063	0.912
NULL	Arthritis_Res_Ther_2012_May_1_14(3)_R99.nxml.txt.nlp	22546542	SENT125	24	24	10	10	infliximab	IL-17	PA452639	3605	0.912
NULL	Exp_Ther_Med_2013_Mar_8_5(3)_707-710.nxml.txt.nlp	23404433	SENT98	13	13	35	35	cisplatin	Bcl-2	PA449014	596	0.912
NULL	Cancers_(Basel)_2014_Sep_5_6(3)_1769-1792.nxml.txt.nlp	25198391	SENT635	13	13	6	6	trastuzumab	PI3K	PA451743	5290	0.912
NULL	Int_J_Mol_Sci_2012_Dec_5_13(12)_16624-16635.nxml.txt.nlp	23443122	SENT11	4	4	15	15	carboplatin	MRP3	PA448803	8714	0.912
NULL	Mol_Cancer_2008_Jun_3_7_47.nxml.txt.nlp	18519000	SENT110	12	12	18	18	gefitinib	EGFR	PA131301952	1956	0.912
NULL	Br_J_Cancer_2011_Aug_23_105(5)_649-657.nxml.txt.nlp	21811251	SENT159	31	31	10	10	gefitinib	EGFR	PA131301952	1956	0.912
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT248	13	13	15	15	perifosine	JNK	PA165291471	5599	0.912
NULL	Open_Neurol_J_2011_Oct_20_5_63-67.nxml.txt.nlp	22046203	SENT107	24	24	46	46	phenytoin	PHB	PA450947	5245	0.912
NULL	Oncotarget_2014_Aug_27_5(17)_7328-7341.nxml.txt.nlp	25193862	SENT200	26	26	19	19	dasatinib	EGFR	PA162372878	1956	0.912
NULL	Patient_Prefer_Adherence_2011_Dec_23_6_1-9.nxml.txt.nlp	22272064	SENT3	31	31	26	26	lisinopril	ACE	PA450242	1636	0.912
NULL	Oncotarget_2014_Jun_30_5(12)_4011-4025.nxml.txt.nlp	24994117	SENT173	23	23	6	6	estradiol	IRF7	PA449503	3665	0.912
NULL	Mol_Cancer_2010_Dec_2_9_309.nxml.txt.nlp	21122157	SENT334	19	19	33	33	paclitaxel	IL-6	PA450761	3569	0.912
NULL	Cell_Death_Dis_2014_Feb_13_5(2)_e1055.nxml.txt.nlp	24525731	SENT331	11	11	33	33	irinotecan	TXNL1	PA450085	9352	0.912
NULL	Int_J_Mol_Imaging_2011_Oct_26_2011_874585.nxml.txt.nlp	21490735	SENT128	24	24	19	19	tamoxifen	FDG	PA451581	23583	0.912
NULL	J_Cell_Mol_Med_2013_Jan_11_17(1)_134-146.nxml.txt.nlp	23305490	SENT12	6	6	32	32	lidocaine	TREK-1	PA450226	3776	0.912
NULL	Br_J_Cancer_1995_Mar_71(3)_619-624.nxml.txt.nlp	7880748	SENT11	25	25	1	1	vincristine	HOP	PA451879	84525;10963	0.912
NULL	Chem_Cent_J_2012_May_11_6_41.nxml.txt.nlp	22578215	SENT119	4	4	29	29	lipase	castor	PA450239	54897	0.912
NULL	Open_Access_J_Urol_2010_Mar_12_2_35-40.nxml.txt.nlp	24198612	SENT75	12	12	5	5	pazopanib	GM-CSF	PA165291492	1437	0.912
NULL	Br_J_Cancer_2012_Jun_5_106(12)_1960-1966.nxml.txt.nlp	22596237	SENT121	19	19	10	10	saracatinib	PC3		57332;7832;5122	0.912
NULL	J_Cancer_2013_Aug_16_4(7)_557-565.nxml.txt.nlp	23983820	SENT8	37	37	33	33	trastuzumab	EGFR	PA451743	1956	0.912
NULL	Br_J_Cancer_2012_Aug_7_107(4)_626-631.nxml.txt.nlp	22805329	SENT20	12	12	26	26	cetuximab	KRAS	PA10040	3845	0.912
NULL	Front_Oncol_2013_Oct_9_3_261.nxml.txt.nlp	24130964	SENT213	13	13	20	20	erlotinib	EGFR	PA134687924	1956	0.912
NULL	Mol_Cancer_2008_Mar_6_7_24.nxml.txt.nlp	18325101	SENT42	14	14	28	28	cisplatin	p53	PA449014	7157	0.912
NULL	Acta_Pharmacol_Sin_2009_Oct_21_30(10)_1392-1398.nxml.txt.nlp	19767766	SENT140	9	9	24	24	atorvastatin	ROS	PA448500	6098	0.912
NULL	Ann_Oncol_2010_Oct_19_21(10)_1952-1960.nxml.txt.nlp	20305037	SENT166	12	12	6	6	cetuximab	BRAF	PA10040	673	0.912
NULL	Biologics_2014_Apr_23_8_183-192.nxml.txt.nlp	24790411	SENT157	0	0	8	8	afatinib	EGFR	PA165981154	1956	0.912
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT139	26	26	35	35	efavirenz	CYP3A	PA449441	1574	0.912
NULL	Cancers_(Basel)_2010_Jan_14_2(1)_1-19.nxml.txt.nlp	24281029	SENT858	6	6	19	19	paclitaxel	HER2	PA450761	2064	0.912
NULL	Oncotarget_2010_May_1_1(1)_6-8.nxml.txt.nlp	21293050	SENT28	6	6	28	28	bortezomib	KIT	PA10252	3815	0.912
NULL	Ann_Oncol_2014_Apr_26_25(4)_801-807.nxml.txt.nlp	24577117	SENT135	39	39	24	24	panitumumab	EGFR	PA162373091	1956	0.912
NULL	Cardiol_Ther_2013_Jun_28_2(1)_47-56.nxml.txt.nlp	25135288	SENT158	13	13	6	6	clopidogrel	CYP2C19	PA449053	1557	0.912
NULL	Acta_Crystallogr_Sect_F_Struct_Biol_Cryst_Commun_2011_Aug_13_67(Pt_9)_998-1005.nxml.txt.nlp	21904040	SENT30	19	19	12	12	ampicillin	TEM1	PA448419	57124	0.912
NULL	Acta_Pharmacol_Sin_2012_Jan_3_33(1)_49-56.nxml.txt.nlp	22212430	SENT37	5	5	29	29	thrombin	AP-1	PA451674	2353;3727;2354;3725	0.912
NULL	Evid_Based_Complement_Alternat_Med_2012_May_7_2012_242810.nxml.txt.nlp	22645625	SENT365	7	7	33	33	rifampin	NQO1	PA451250	1728	0.912
NULL	Acta_Pharmacol_Sin_2011_Jul_6_32(7)_921-929.nxml.txt.nlp	21643005	SENT148	3	3	20	20	cerulenin	5-LOX	PA164764551	240	0.912
NULL	Br_J_Cancer_2013_Sep_17_109(6)_1685-1692.nxml.txt.nlp	23982604	SENT149	31	31	5	5	cisplatin	TNFAIP8	PA449014	25816	0.912
NULL	Lipids_Health_Dis_2011_Jan_18_10_8.nxml.txt.nlp	21241519	SENT157	4	4	27	27	simvastatin	ABCG5	PA451363	64240	0.912
NULL	Child_Adolesc_Psychiatry_Ment_Health_2012_Jun_22_6_25.nxml.txt.nlp	22726236	SENT18	0	0	6	6	risperidone	B12	PA451257	7126;4709	0.912
NULL	Aging_(Albany_NY)_2014_May_17_6(5)_369-379.nxml.txt.nlp	24860943	SENT81	16	16	12	12	l-arginine	S6K1	PA448478	6198	0.912
NULL	Front_Neurosci_2010_Jun_17_4_35.nxml.txt.nlp	20661455	SENT572	16	16	6	6	fluoxetine	5-HT1B	PA449673	3351	0.912
NULL	Osteoporos_Int_2013_May_4_24(10)_2659-2670.nxml.txt.nlp	23644877	SENT227	26	26	8	8	metformin	AMPK	PA450395	5563	0.912
NULL	Breast_Cancer_Res_2005_Aug_5_7(5)_212-214.nxml.txt.nlp	16168140	SENT15	12	12	2	2	trastuzumab	PTEN	PA451743	5728	0.912
NULL	Arch_Med_Sci_2012_Jul_4_8(3)_549-554.nxml.txt.nlp	22852014	SENT92	20	20	37	37	clopidogrel	CYP3A4	PA449053	1576	0.912
NULL	J_Antimicrob_Chemother_2013_Dec_5_68(12)_2755-2765.nxml.txt.nlp	23833178	SENT65	23	23	3	3	tetracycline	TC2	PA451640	6948	0.912
NULL	Oncoimmunology_2012_Oct_1_1(7)_1218-1219.nxml.txt.nlp	23170286	SENT13	2	2	29	29	bortezomib	CD86	PA10252	942	0.912
NULL	Cancers_(Basel)_2010_Jul_27_2(3)_1528-1554.nxml.txt.nlp	24281171	SENT301	24	24	2	2	etoposide	CD133	PA449552	8842	0.912
NULL	Eur_Respir_J_2013_Dec_30_42(6)_1484-1494.nxml.txt.nlp	23722616	SENT122	25	25	0	0	tiotropium	TDI	PA164769056	100038246	0.912
NULL	Evid_Based_Complement_Alternat_Med_2014_Jan_8_2014_976364.nxml.txt.nlp	24527057	SENT16	34	34	13	13	oseltamivir	IL-4	PA450721	3565	0.912
NULL	Case_Rep_Oncol_2011_Mar_12_4(1)_136-142.nxml.txt.nlp	21691572	SENT72	29	29	10	10	rituximab	CD4	PA451261	920	0.912
NULL	Oncogene_2013_Sep_12_32(37)_4355-4365.nxml.txt.nlp	23108409	SENT92	27	27	18	18	hyaluronan	HAS2	PA165958431	3037	0.912
NULL	Biomed_Res_Int_2014_Jan_20_2014_948427.nxml.txt.nlp	24563867	SENT3	6	6	23	23	buspirone	STZ	PA448689	6484	0.912
NULL	Pharmaceuticals_(Basel)_2014_Apr_14_7(4)_453-463.nxml.txt.nlp	24736104	SENT160	6	6	17	17	diclofenac	GIT	PA449293	5034	0.912
NULL	J_Cell_Mol_Med_2013_Jan_11_17(1)_134-146.nxml.txt.nlp	23305490	SENT12	6	6	30	30	lidocaine	TASK	PA450226	3777	0.912
NULL	Mol_Cancer_2012_May_14_11_33.nxml.txt.nlp	22583829	SENT15	12	12	2	2	cisplatin	TLR4	PA449014	7099	0.912
NULL	Arthritis_Rheumatol_2014_Jun_27_66(6)_1574-1582.nxml.txt.nlp	24577881	SENT156	19	19	10	10	hydralazine	ERK	PA449894	5594	0.912
NULL	Pharmaceuticals_(Basel)_2013_Sep_30_6(10)_1195-1220.nxml.txt.nlp	24275848	SENT236	26	26	6	6	temozolomide	CD133	PA451609	8842	0.912
NULL	Clin_Med_Insights_Arthritis_Musculoskelet_Disord_2012_Jan_5_5_1-14.nxml.txt.nlp	22267947	SENT122	33	33	13	13	risedronate	NNT	PA451255	23530	0.912
NULL	Onco_Targets_Ther_2014_Dec_4_7_2249-2255.nxml.txt.nlp	25587220	SENT119	17	17	23	23	cyclosporine	ABCG2	PA449167	9429	0.912
NULL	Oncol_Rep_2014_Mar_30_31(3)_1043-1050.nxml.txt.nlp	24378760	SENT18	11	11	25	25	olaparib	BRCA1		672	0.912
NULL	Braz_J_Med_Biol_Res_2013_Aug_13_46(8)_650-658.nxml.txt.nlp	23969971	SENT32	3	3	11	11	oxaliplatin	STAT3	PA131285527	6774	0.912
NULL	Sleep_Disord_2014_Feb_5_2014_527109.nxml.txt.nlp	24649369	SENT66	40	40	6	6	zolpidem	CYP3A4	PA451976	1576	0.912
NULL	Clin_Psychopharmacol_Neurosci_2011_Apr_30_9(1)_36-43.nxml.txt.nlp	23431025	SENT75	30	30	10	10	haloperidol	ANOVA	PA449841	4858	0.912
NULL	Cell_Cycle_2013_Oct_1_12(19)_3194-3202.nxml.txt.nlp	24013423	SENT74	16	16	7	7	arsenite	FUS	PA452638	2521	0.912
NULL	Oncotarget_2014_Mar_13_5(4)_1101-1110.nxml.txt.nlp	24658355	SENT60	8	8	4	4	tamoxifen	MKP-1	PA451581	1843	0.912
NULL	Bioinformation_2012_Jan_6_8(1)_13-19.nxml.txt.nlp	22359429	SENT36	8	8	30	30	curcumin	MRP1	PA151958596	4437	0.912
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT221	13	13	3	3	panitumumab	KRAS	PA162373091	3845	0.912
NULL	Br_J_Cancer_2006_Dec_4_95(11)_1504-1513.nxml.txt.nlp	17088902	SENT6	11	11	38	38	gefitinib	HER2	PA131301952	2064	0.912
NULL	Bone_Joint_Res_2014_Mar_1_3(3)_51-59.nxml.txt.nlp	24615710	SENT86	10	10	30	30	resveratrol	CO2		4513	0.912
NULL	Indian_J_Nephrol_2011_Jan-Mar_21(1)_56-58.nxml.txt.nlp	21655173	SENT58	7	7	27	27	cyclophosphamide	CHOP	PA449165	1649	0.912
NULL	Front_Public_Health_2013_Nov_14_1_50.nxml.txt.nlp	24350219	SENT17	12	12	1	1	hydrocortisone	TREM-1	PA449905	54210	0.912
NULL	Mol_Biol_Cell_2012_Nov_1_23(21)_4212-4225.nxml.txt.nlp	22956765	SENT85	14	14	2	2	thrombin	SHP2	PA451674	5781	0.912
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT212	15	15	9	9	perifosine	DR5	PA165291471	8795	0.912
NULL	J_Hematol_Oncol_2009_Feb_23_2_9.nxml.txt.nlp	19236713	SENT48	19	19	4	4	cetuximab	KRAS	PA10040	3845	0.912
NULL	Mol_Cell_2013_Dec_12_52(5)_707-719.nxml.txt.nlp	24239293	SENT557	18	18	4	4	galactose	RRP5	PA449725	22984	0.912
NULL	Oncotarget_2014_Oct_9_5(20)_9564-9576.nxml.txt.nlp	25333255	SENT135	21	21	5	5	imatinib	STAT3	PA10804	6774	0.912
NULL	Br_J_Cancer_2012_Jul_10_107(2)_230-233.nxml.txt.nlp	22735900	SENT47	14	14	4	4	bupropion	CYP2D6	PA448687	1565	0.912
NULL	Br_J_Cancer_2009_Jul_21_101(2)_238-243.nxml.txt.nlp	19568242	SENT124	22	22	28	28	sunitinib	IFN	PA162372840	3439	0.912
NULL	Clin_Pharmacol_2010_Jun_24_2_131-134.nxml.txt.nlp	22291496	SENT4	17	17	21	21	liraglutide	GLP-1	PA165958364	100125288	0.912
NULL	Ann_Rheum_Dis_2008_Nov_14_67(11)_1516-1523.nxml.txt.nlp	18625622	SENT7	33	33	9	9	methotrexate	TNF	PA450428	7124	0.912
NULL	Mol_Cancer_2009_Nov_19_8_108.nxml.txt.nlp	19925669	SENT264	30	30	21	21	doxorubicin	CRT	PA449412	811	0.912
NULL	Cancer_Manag_Res_2014_May_23_6_225-252.nxml.txt.nlp	24904222	SENT117	15	15	9	9	anastrozole	aromatase	PA448432	1588	0.912
NULL	Case_Rep_Dermatol_2014_Sep_25_6(3)_227-231.nxml.txt.nlp	25408651	SENT47	21	21	18	18	docetaxel	EGFR	PA449383	1956	0.912
NULL	Int_J_Surg_Oncol_2012_Jun_12_2012_862879.nxml.txt.nlp	22778941	SENT112	17	17	4	4	cisplatin	BIN1	PA449014	274	0.912
NULL	Indian_J_Hum_Genet_2014_Apr-Jun_20(2)_175-184.nxml.txt.nlp	25400347	SENT144	20	20	10	10	warfarin	VKORC1	PA451906	79001	0.912
NULL	J_Cell_Biol_2001_Jun_11_153(6)_1277-1286.nxml.txt.nlp	11402070	SENT70	15	15	2	2	glutaraldehyde	PSGL-1	PA449777	6404	0.912
NULL	Anal_Bioanal_Chem_2011_Sep_14_401(4)_1109-1125.nxml.txt.nlp	21755271	SENT327	13	13	5	5	dasatinib	ABL	PA162372878	4547	0.912
NULL	Arthritis_Res_Ther_2014_Apr_30_16(2)_R90.nxml.txt.nlp	25167216	SENT219	19	19	10	10	tocilizumab	ACR	PA165292659	49	0.912
NULL	J_Med_Case_Reports_2011_Aug_16_5_386.nxml.txt.nlp	21846347	SENT97	46	46	22	22	octreotide	SSTR5	PA450678	6755	0.912
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT194	16	16	2	2	pertuzumab	HER2		2064	0.912
NULL	Biologics_2012_Feb_1_6_31-35.nxml.txt.nlp	22355257	SENT78	8	8	19	19	rituximab	IL-10	PA451261	3586	0.912
NULL	Mol_Cancer_2010_Aug_20_9_220.nxml.txt.nlp	20727180	SENT133	8	8	15	15	nicotine	p53	PA450626	7157	0.912
NULL	J_Oral_Pathol_Med_2013_Jul_18_42(6)_499-506.nxml.txt.nlp	23331485	SENT198	20	20	32	32	indomethacin	IL-6	PA449982	3569	0.912
NULL	J_Hematol_Oncol_2013_Jul_18_6_53.nxml.txt.nlp	23866964	SENT154	35	35	26	26	temsirolimus	CO2	PA164746890	4513	0.912
NULL	Breast_Cancer_Res_2007_Dec_17_9(6)_R87.nxml.txt.nlp	18086299	SENT154	3	3	26	26	trastuzumab	HER-2	PA451743	2064	0.912
NULL	Front_Synaptic_Neurosci_2014_May_30_6_12.nxml.txt.nlp	24910611	SENT162	13	13	7	7	l-alanine	asc-1	PA448055	56301	0.912
NULL	Ann_Rheum_Dis_2010_Jan_17_69(1)_88-96.nxml.txt.nlp	19297346	SENT95	16	16	9	9	tocilizumab	ACR	PA165292659	49	0.912
NULL	J_Cell_Mol_Med_2014_Mar_25_18(3)_492-502.nxml.txt.nlp	24460759	SENT43	35	35	11	11	l-glutamine	CO2	PA10090	4513	0.912
NULL	Cancer_Biol_Med_2013_Dec_10(4)_192-205.nxml.txt.nlp	24349829	SENT297	10	10	6	6	panitumumab	KRAS	PA162373091	3845	0.912
NULL	Pharmaceuticals_(Basel)_2012_Aug_10_5(8)_802-836.nxml.txt.nlp	24280676	SENT90	27	27	8	8	gemcitabine	CNT1	PA449748	9154	0.912
NULL	Chemother_Res_Pract_2012_Aug_29_2012_817297.nxml.txt.nlp	22970367	SENT170	7	7	15	15	afatinib	EGFR	PA165981154	1956	0.912
NULL	Biologics_2009_Oct_12_3_469-474.nxml.txt.nlp	19851472	SENT80	42	42	27	27	mometasone	IL-5	PA450541	3567	0.912
NULL	Environ_Health_Perspect_2006_Sep_23_114(9)_1401-1406.nxml.txt.nlp	16966095	SENT20	30	30	5	5	arsenite	p53	PA452638	7157	0.912
NULL	Biomed_Res_Int_2014_Jan_20_2014_948427.nxml.txt.nlp	24563867	SENT126	8	8	4	4	buspirone	5-HT1A	PA448689	3350	0.912
NULL	Int_J_Breast_Cancer_2012_Oct_15_2012_809291.nxml.txt.nlp	22295251	SENT197	30	30	16	16	cetuximab	EGFR	PA10040	1956	0.912
NULL	Int_J_Mol_Sci_2012_Apr_16_13(4)_4831-4838.nxml.txt.nlp	22606012	SENT49	15	15	6	6	curcumin	JNK	PA151958596	5599	0.912
NULL	Breast_Cancer_Res_2009_Oct_15_11(5)_110.nxml.txt.nlp	19849815	SENT43	26	26	22	22	trastuzumab	HER2	PA451743	2064	0.912
NULL	Cancer_Imaging_2006_Oct_31_6(Spec_No_A)_S126-S130.nxml.txt.nlp	17114065	SENT75	28	28	17	17	imatinib	HER-2	PA10804	2064	0.912
NULL	Breast_Cancer_Res_2010_Aug_23_12(4)_R64.nxml.txt.nlp	20731819	SENT216	11	11	7	7	fluoxetine	CYP2D6	PA449673	1565	0.912
NULL	Subst_Abuse_Rehabil_2011_Aug_18_2_145-162.nxml.txt.nlp	24474854	SENT217	4	4	1	1	thioridazine	CYP1A2	PA451666	1544	0.912
NULL	Diabetes_2013_May_16_62(5)_1689-1696.nxml.txt.nlp	23274908	SENT34	33	33	20	20	diazoxide	ABCC8	PA449285	6833	0.912
NULL	Support_Care_Cancer_2011_Oct_8_19(10)_1505-1510.nxml.txt.nlp	20694798	SENT59	35	35	26	26	vincristine	CHOP	PA451879	1649	0.912
NULL	J_Gen_Physiol_2009_Apr_133(4)_421-438.nxml.txt.nlp	19289574	SENT227	6	6	12	12	glibenclamide	SLC26A9	PA449782	115019	0.912
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jan_22_67(Pt_2)_o445-o446.nxml.txt.nlp	21523109	SENT80	37	37	26	26	ethanol	mol	PA448073	90527	0.912
NULL	Crit_Care_2002_Oct_14_6(6)_481-490.nxml.txt.nlp	12493069	SENT95	0	0	33	33	tyloxapol	IL-8	PA164743726	3576	0.912
NULL	Cancers_(Basel)_2010_May_26_2(2)_1013-1026.nxml.txt.nlp	24281104	SENT25	27	27	11	11	lipase	FAAH	PA450239	79152;2166	0.912
NULL	Ann_Oncol_2011_Mar_8_22(3)_503-514.nxml.txt.nlp	20616198	SENT126	1	1	17	17	tamoxifen	aromatase	PA451581	1588	0.912
NULL	Acta_Histochem_Cytochem_2011_Apr_28_44(2)_113-118.nxml.txt.nlp	21614172	SENT8	8	8	29	29	everolimus	HIF-1	PA164746311	29072	0.912
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT250	5	5	18	18	rituximab	CD36	PA451261	948	0.912
NULL	J_Cell_Mol_Med_2014_Dec_9_18(12)_2425-2436.nxml.txt.nlp	25297942	SENT194	8	8	1	1	cisplatin	HOTAIR	PA449014	100124700	0.912
NULL	Clin_Psychopharmacol_Neurosci_2014_Apr_24_12(1)_54-64.nxml.txt.nlp	24851122	SENT19	14	14	4	4	methamphetamine	MAPK4	PA450403	5596	0.912
NULL	Diabetes_2011_Nov_17_60(11)_2730-2739.nxml.txt.nlp	21926273	SENT24	42	42	0	0	nadh	AMPK	PA164755085	5563	0.912
NULL	J_Hematol_Oncol_2012_May_15_5_23.nxml.txt.nlp	22587422	SENT25	28	28	19	19	imatinib	ALL	PA10804	613	0.912
NULL	Oncotarget_2012_Sep_28_3(10)_1169-1181.nxml.txt.nlp	23045411	SENT233	16	16	29	29	doxorubicin	CTB	PA449412	9468	0.912
NULL	Oncologist_2010_Feb_15_15(2)_122-129.nxml.txt.nlp	20156908	SENT137	26	26	4	4	letrozole	HER-2	PA450196	2064	0.912
NULL	Int_J_Breast_Cancer_2011_Sep_6_2011_352182.nxml.txt.nlp	22295219	SENT185	11	11	14	14	trastuzumab	IGF1R	PA451743	3480	0.912
NULL	Mol_Cancer_2012_Jul_25_11_47.nxml.txt.nlp	22830443	SENT164	4	4	8	8	panitumumab	EGFR	PA162373091	1956	0.912
NULL	Oncol_Lett_2013_Mar_28_5(3)_935-942.nxml.txt.nlp	23426424	SENT10	32	32	8	8	oxaliplatin	ERCC1	PA131285527	2067	0.912
NULL	ASN_Neuro_2013_Dec_18_5(5)_e00129.nxml.txt.nlp	24215544	SENT224	4	4	19	19	pioglitazone	mitoNEET	PA450970	55847	0.912
NULL	J_Headache_Pain_2008_Oct_31_9(5)_267-276.nxml.txt.nlp	18668197	SENT136	0	0	11	11	fenfluramine	5-HT2B	PA449592	3357	0.912
NULL	Br_J_Dermatol_2014_Feb_18_170(1)_342-351.nxml.txt.nlp	24547721	SENT132	24	24	4	4	pantoprazole	CLE	PA450774	51637	0.912
NULL	Oncol_Lett_2013_Oct_26_6(4)_1063-1067.nxml.txt.nlp	24137465	SENT97	7	7	17	17	afatinib	HER2	PA165981154	2064	0.912
NULL	Indian_J_Dermatol_2011_May-Jun_56(3)_306-308.nxml.txt.nlp	21772594	SENT69	27	27	11	11	vincristine	CHP	PA451879	11261	0.912
NULL	Curr_Health_Sci_J_2014_Dec_29_Jan-Mar_40(1)_62-66.nxml.txt.nlp	24791209	SENT80	16	16	13	13	cyclosporine	ACE	PA449167	1636	0.912
NULL	Breast_Cancer_Res_2010_Jul_26_12(4)_R55.nxml.txt.nlp	20659323	SENT130	5	5	19	19	doxycycline	MYB	PA449415	4602	0.912
NULL	Int_J_Surg_Oncol_2012_Aug_27_2012_180574.nxml.txt.nlp	22970358	SENT27	33	33	7	7	tamoxifen	IMPACT	PA451581	55364	0.912
NULL	Acta_Neuropathol_2015_Oct_17_129_81-96.nxml.txt.nlp	25322817	SENT158	29	29	6	6	capsaicin	TRPV1	PA448776	7442	0.912
NULL	Breast_Cancer_Res_2004_Oct_6_6(6)_262-268.nxml.txt.nlp	15535857	SENT108	21	21	25	25	fulvestrant	aromatase	PA164747170	1588	0.912
NULL	Br_J_Cancer_1996_Nov_74(10)_1545-1552.nxml.txt.nlp	8932333	SENT14	9	9	21	21	doxorubicin	P85	PA449412	8874	0.912
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jun_25_67(Pt_7)_o1796.nxml.txt.nlp	21837169	SENT56	23	23	6	6	ethanol	mol	PA448073	90527	0.912
NULL	Arthritis_Res_Ther_2006_Aug_6_8(5)_R138.nxml.txt.nlp	16889669	SENT144	4	4	10	10	terbutaline	CD4	PA451616	920	0.912
NULL	Mol_Cancer_2010_May_20_9_115.nxml.txt.nlp	20487546	SENT153	7	7	38	38	fludarabine	IPA	PA449655	3160	0.912
NULL	Cancers_(Basel)_2009_Dec_15_1(1)_23-28.nxml.txt.nlp	20535236	SENT98	17	17	11	11	cisplatin	TRX	PA449014	7295	0.912
NULL	Mol_Cancer_2010_Aug_23_9_222.nxml.txt.nlp	20731837	SENT191	9	9	16	16	gefitinib	EGFR	PA131301952	1956	0.912
NULL	EPMA_J_2012_Jun_18_3(1)_6.nxml.txt.nlp	22738201	SENT78	4	4	27	27	erlotinib	BIM	PA134687924	10018	0.912
NULL	Curr_Control_Trials_Cardiovasc_Med_2001_May_31_2(3)_129-140.nxml.txt.nlp	11806786	SENT81	4	4	13	13	heparin	ACT	PA449855	12;11332;9457;641455	0.912
NULL	Eur_J_Clin_Pharmacol_2012_Jan_7_68(1)_55-64.nxml.txt.nlp	21735164	SENT125	14	14	41	41	oxycodone	ANOVA	PA450741	4858	0.912
NULL	Psychol_Res_Behav_Manag_2010_Dec_6_3_109-118.nxml.txt.nlp	22110334	SENT114	34	34	20	20	paroxetine	CYP3A4	PA450801	1576	0.912
NULL	Case_Rep_Gastroenterol_2014_Apr_10_8(1)_134-140.nxml.txt.nlp	24847196	SENT76	16	16	11	11	doxorubicin	CHOP	PA449412	1649	0.912
NULL	Arthritis_Res_Ther_2010_Feb_15_12(1)_203.nxml.txt.nlp	20236483	SENT56	8	8	26	26	methotrexate	ACPA	PA450428	5657	0.912
NULL	Br_J_Pharmacol_2014_Feb_24_171(1)_1019-1032.nxml.txt.nlp	24251620	SENT175	9	9	13	13	nicardipine	TRPM3	PA450620	80036	0.912
NULL	Mol_Neurodegener_2011_Aug_8_6_57.nxml.txt.nlp	21819629	SENT251	11	11	19	19	arsenite	HuR	PA452638	1994	0.912
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Apr_21_68(Pt_5)_o1472.nxml.txt.nlp	22590345	SENT57	20	20	14	14	ethanol	mol	PA448073	90527	0.912
NULL	Lab_Invest_2014_Jul_5_94(7)_752-765.nxml.txt.nlp	24791743	SENT80	14	14	20	20	heparin	SEMA3A	PA449855	10371	0.912
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT24	13	13	4	4	trastuzumab	STAT3	PA451743	6774	0.912
NULL	Chin_J_Cancer_2012_Feb_31(2)_110-118.nxml.txt.nlp	22098951	SENT34	35	35	30	30	imatinib	P-gp	PA10804	5243	0.911
NULL	Arthritis_Res_Ther_2005_Jan_21_7(2)_55-61.nxml.txt.nlp	15743490	SENT106	6	6	39	39	simvastatin	CD86	PA451363	942	0.911
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_408-414.nxml.txt.nlp	21372831	SENT138	6	6	1	1	doxorubicin	CHOP	PA449412	1649	0.911
NULL	FEBS_Open_Bio_2014_Jan_21_4_153-161.nxml.txt.nlp	24490140	SENT334	12	12	0	0	doxorubicin	WT1	PA449412	7490	0.911
NULL	J_Breast_Cancer_2012_Mar_28_15(1)_34-42.nxml.txt.nlp	22493626	SENT47	10	10	16	16	trastuzumab	San	PA451743	80218	0.911
NULL	AAPS_J_2014_Jun_19_16(5)_1056-1063.nxml.txt.nlp	24942210	SENT191	12	12	24	24	bevacizumab	VEGF-A	PA130232992	7422	0.911
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Apr_4_68(Pt_5)_o1275.nxml.txt.nlp	22590190	SENT58	20	20	14	14	ethanol	mol	PA448073	90527	0.911
NULL	Emerg_Med_J_2011_Apr_26_28(4)_313-315.nxml.txt.nlp	20581384	SENT116	12	12	5	5	atropine	PON1	PA448505	5444	0.911
NULL	Breast_Cancer_Res_2010_Jun_24_12(3)_R41.nxml.txt.nlp	20576088	SENT137	6	6	0	0	paclitaxel	EGFR	PA450761	1956	0.911
NULL	Front_Oncol_2014_Mar_25_4_54.nxml.txt.nlp	24724051	SENT346	9	9	30	30	imatinib	p53	PA10804	7157	0.911
NULL	Oncogene_2014_Aug_28_33(35)_4407-4417.nxml.txt.nlp	24469038	SENT107	3	3	22	22	arsenite	TIAR	PA452638	7073	0.911
NULL	Neuropsychopharmacology_2009_Sep_3_34(10)_2296-2304.nxml.txt.nlp	19494804	SENT173	5	5	11	11	sevoflurane	CA1	PA451341	759	0.911
NULL	Cell_Death_Dis_2014_Feb_27_5(2)_e1091.nxml.txt.nlp	24577089	SENT176	22	22	20	20	cetuximab	AKT	PA10040	207	0.911
NULL	Neuropsychopharmacology_2009_Apr_2_34(5)_1135-1148.nxml.txt.nlp	18596687	SENT17	26	26	7	7	cocaine	CRF	PA449072	1392;10882	0.911
NULL	Leukemia_2013_Jan_11_27(1)_32-40.nxml.txt.nlp	22781593	SENT123	8	8	27	27	ponatinib	ZNF112	PA165980594	7771	0.911
NULL	Appl_Clin_Genet_2010_Oct_29_3_85-101.nxml.txt.nlp	23776354	SENT146	10	10	4	4	imatinib	PDGFRA	PA10804	5156	0.911
NULL	Evid_Based_Complement_Alternat_Med_2011_Mar_9_2011_750230.nxml.txt.nlp	21423639	SENT17	14	14	18	18	cetuximab	VEGFR	PA10040	3791	0.911
NULL	Clin_Ophthalmol_2014_Jun_26_8_1213-1219.nxml.txt.nlp	25061267	SENT7	25	25	19	19	tetracaine	PRK	PA451638	1263	0.911
NULL	Reprod_Biol_Endocrinol_2003_Aug_27_1_59.nxml.txt.nlp	12967350	SENT138	23	23	12	12	estradiol	XIAP	PA449503	331	0.911
NULL	Oncotarget_2014_Nov_3_5(20)_10127-10139.nxml.txt.nlp	25333256	SENT176	15	15	12	12	vemurafenib	BRAF	PA165946873	673	0.911
NULL	Oncotarget_2013_Oct_19_4(11)_2045-2056.nxml.txt.nlp	24185104	SENT61	10	10	3	3	cisplatin	14-3-3	PA449014	10971	0.911
NULL	Front_Oncol_2013_Apr_23_3_86.nxml.txt.nlp	23630663	SENT143	24	24	12	12	afatinib	ERBB2	PA165981154	2064	0.911
NULL	Arch_Med_Sci_2013_Oct_31_9(5)_936-943.nxml.txt.nlp	24273582	SENT103	27	27	5	5	nateglinide	GLP-1	PA450600	100125288	0.911
NULL	Mol_Cancer_2012_Sep_14_11_69.nxml.txt.nlp	22978347	SENT176	10	10	30	30	letrozole	TRAP1	PA450196	9392;10131	0.911
NULL	Nat_Chem_Biol_2010_Apr_28_6(4)_291-299.nxml.txt.nlp	20190765	SENT140	2	2	23	23	dasatinib	EGFR	PA162372878	1956	0.911
NULL	Multidiscip_Respir_Med_2012_Sep_25_7(1)_31.nxml.txt.nlp	23009348	SENT58	17	17	1	1	midazolam	ANOVA	PA450496	4858	0.911
NULL	Exp_Cell_Res_2011_Apr_15_317(7)_1028-1039.nxml.txt.nlp	21237154	SENT127	34	34	18	18	staurosporine	TRAIL	PA165109623	8743	0.911
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT195	25	25	19	19	disopyramide	CYP3A4	PA449373	1576	0.911
NULL	EMBO_Mol_Med_2012_Jul_18_4(7)_557-560.nxml.txt.nlp	22610822	SENT38	7	7	12	12	resveratrol	AMPK		5563	0.911
NULL	Am_J_Med_Genet_B_Neuropsychiatr_Genet_2014_Jun_9_165(4)_373-380.nxml.txt.nlp	24817687	SENT38	13	13	5	5	ethanol	NK1R	PA448073	6869	0.911
NULL	Neuro_Oncol_2010_Apr_27_12(4)_389-400.nxml.txt.nlp	20308316	SENT20	5	5	14	14	chloroquine	p53	PA448948	7157	0.911
NULL	Breast_Cancer_Res_2014_Sep_11_16(5)_430.nxml.txt.nlp	25212826	SENT24	29	29	2	2	tamoxifen	PI3K	PA451581	5290	0.911
NULL	Libyan_J_Med_2007_Dec_1_2(4)_176-179.nxml.txt.nlp	21503241	SENT9	17	17	7	7	vancomycin	VISA	PA451850	57506	0.911
NULL	Chin_J_Cancer_2011_May_30(5)_287-292.nxml.txt.nlp	21527061	SENT64	17	17	7	7	gefitinib	EGFR	PA131301952	1956	0.911
NULL	ASN_Neuro_2009_Apr_14_1(1)_e00005.nxml.txt.nlp	19570022	SENT35	37	37	21	21	pp2	CBX		10951	0.911
NULL	Mol_Biol_Cell_2012_Oct_15_23(20)_4097-4108.nxml.txt.nlp	22918955	SENT233	33	33	21	21	tetracycline	MMP3	PA451640	4314	0.911
NULL	Ann_Rheum_Dis_2008_Apr_20_67(4)_511-517.nxml.txt.nlp	17644552	SENT12	11	11	3	3	infliximab	IL-6	PA452639	3569	0.911
NULL	Autophagy_2013_Jul_1_9(7)_985-995.nxml.txt.nlp	23584039	SENT128	27	27	12	12	propranolol	PI-PLC	PA451145	2923	0.911
NULL	ScientificWorldJournal_2013_Dec_24_2013_196541.nxml.txt.nlp	24453810	SENT106	7	7	14	14	trastuzumab	HER2	PA451743	2064	0.911
NULL	Eur_J_Clin_Pharmacol_2013_Mar_11_69(3)_327-339.nxml.txt.nlp	22782539	SENT259	0	0	4	4	clopidogrel	ADP	PA449053	23038	0.911
NULL	Endocr_Relat_Cancer_2014_Apr_21(2)_311-326.nxml.txt.nlp	24478054	SENT26	0	0	17	17	cabozantinib	AXL	PA165906891	558	0.911
NULL	J_Gen_Physiol_2000_Jun_1_115(6)_685-696.nxml.txt.nlp	10828243	SENT202	10	10	14	14	genistein	OLF	PA165109660	83857	0.911
NULL	J_Biol_Chem_2013_Oct_11_288(41)_29642-29653.nxml.txt.nlp	24005673	SENT809	17	17	4	4	hyaluronan	TSG-6	PA165958431	7130	0.911
NULL	Arthritis_Res_Ther_2010_Jan_29_12(1)_R18.nxml.txt.nlp	20113495	SENT184	2	2	7	7	glucosamine	NAPA	PA164747613	9476;8775	0.911
NULL	J_Hematol_Oncol_2009_Apr_22_2_18.nxml.txt.nlp	19386128	SENT159	12	12	27	27	cetuximab	KRAS	PA10040	3845	0.911
NULL	Patient_Prefer_Adherence_2010_Mar_24_4_61-68.nxml.txt.nlp	20361006	SENT67	36	36	2	2	liraglutide	GLP-1	PA165958364	100125288	0.911
NULL	Diabetes_2013_Nov_18_62(11)_3817-3827.nxml.txt.nlp	23835338	SENT43	42	42	6	6	losartan	ABCA1	PA450268	19	0.911
NULL	J_Breast_Cancer_2013_Mar_31_16(1)_23-31.nxml.txt.nlp	23593078	SENT136	13	13	28	28	genistein	HDAC1	PA165109660	3065	0.911
NULL	Brain_Sci_2013_Apr_26_3(2)_670-703.nxml.txt.nlp	24961420	SENT196	7	7	3	3	ethanol	AMPK	PA448073	5563	0.911
NULL	Core_Evid_2009_Jun_15_4_149-158.nxml.txt.nlp	20694071	SENT128	11	11	1	1	darunavir	DUET	PA163522472	8997	0.911
NULL	J_Hematol_Oncol_2011_Apr_20_4_17.nxml.txt.nlp	21507255	SENT53	41	41	30	30	cisplatin	HDAC	PA449014	9734	0.911
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1137-1144.nxml.txt.nlp	20234366	SENT139	15	15	19	19	cetuximab	MKP-1	PA10040	1843	0.911
NULL	Oncotarget_2013_Jul_21_4(8)_1253-1265.nxml.txt.nlp	23896512	SENT10	12	12	10	10	lapatinib	HER2	PA152241907	2064	0.911
NULL	Int_J_Biol_Sci_2013_Mar_7_9(3)_279-288.nxml.txt.nlp	23493630	SENT126	13	13	21	21	tocilizumab	IL-17	PA165292659	3605	0.911
NULL	Mol_Vis_2011_Dec_27_17_3415-3422.nxml.txt.nlp	22219637	SENT145	15	15	5	5	estradiol	JNK	PA449503	5599	0.911
NULL	Acta_Pharmacol_Sin_2014_Sep_4_35(9)_1157-1166.nxml.txt.nlp	25088002	SENT103	5	5	26	26	curcumin	STAT3	PA151958596	6774	0.911
NULL	Br_J_Cancer_2009_Oct_20_101(8)_1290-1297.nxml.txt.nlp	19755992	SENT158	14	14	7	7	oxaliplatin	HIF-1	PA131285527	29072	0.911
NULL	Clin_Exp_Reprod_Med_2011_Mar_31_38(1)_18-23.nxml.txt.nlp	22384413	SENT10	6	6	8	8	diethylstilbestrol	DES	PA449307	1674	0.911
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT216	40	40	14	14	cisplatin	p53	PA449014	7157	0.911
NULL	Clin_Epigenetics_2011_Dec_5_3(1)_8.nxml.txt.nlp	22414275	SENT124	16	16	7	7	ribavirin	ESR1	PA451241	2099	0.911
NULL	Oncol_Lett_2013_Feb_5_5(2)_427-434.nxml.txt.nlp	23420099	SENT166	19	19	4	4	gemcitabine	RRM1	PA449748	6240	0.911
NULL	Case_Rep_Dermatol_2014_Sep_25_6(3)_227-231.nxml.txt.nlp	25408651	SENT47	23	23	18	18	capecitabine	EGFR	PA448771	1956	0.911
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT52	4	4	13	13	tamoxifen	p27	PA451581	5715;10534	0.911
NULL	Blood_Res_2013_Jun_25_48(2)_115-120.nxml.txt.nlp	23826580	SENT19	19	19	15	15	doxorubicin	CHOP	PA449412	1649	0.911
NULL	Neural_Regen_Res_2013_Oct_25_8(30)_2820-2826.nxml.txt.nlp	25206603	SENT130	28	28	10	10	trypsin	CO2	PA451806	4513	0.911
NULL	Cancers_(Basel)_2014_Nov_25_6(4)_2313-2329.nxml.txt.nlp	25534569	SENT30	0	0	15	15	crizotinib	ALK	PA165946122	238	0.911
NULL	Oncol_Rep_2013_Mar_8_29(3)_917-924.nxml.txt.nlp	23314174	SENT177	2	2	9	9	sorafenib	CD24	PA7000	100133941	0.911
NULL	Diabetol_Metab_Syndr_2014_Mar_31_6_48.nxml.txt.nlp	24684803	SENT145	20	20	38	38	metformin	STEP	PA450395	84867	0.911
NULL	Chin_J_Cancer_2012_Jun_31(6)_306-314.nxml.txt.nlp	22640627	SENT139	11	11	4	4	rituximab	Bcl-2	PA451261	596	0.911
NULL	Mol_Pain_2014_Aug_14_10_52.nxml.txt.nlp	25123228	SENT232	20	20	2	2	diclofenac	IL-6	PA449293	3569	0.911
NULL	Int_J_Gen_Med_2012_Apr_13_5_317-322.nxml.txt.nlp	22536087	SENT95	0	0	14	14	liraglutide	GLP-1	PA165958364	100125288	0.911
NULL	Cancer_Cell_Int_2013_Jun_26_13_63.nxml.txt.nlp	23800022	SENT141	4	4	36	36	genistein	XIAP	PA165109660	331	0.911
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Sep_30_67(Pt_10)_o2750.nxml.txt.nlp	22058808	SENT52	23	23	17	17	ethanol	mol	PA448073	90527	0.911
NULL	Emerg_Infect_Dis_2001_Nov-Dec_7(6)_1023-1025.nxml.txt.nlp	11747733	SENT15	13	13	1	1	oxacillin	VISA	PA450725	57506	0.911
NULL	Breast_Cancer_(Auckl)_2009_Apr_7_3_23-34.nxml.txt.nlp	21556247	SENT11	22	22	44	44	celecoxib	AKT	PA448871	207	0.911
NULL	Clinics_(Sao_Paulo)_2014_Feb_69(2)_145-149.nxml.txt.nlp	24519206	SENT44	11	11	19	19	candesartan	AT-1	PA448765	9197	0.911
NULL	Breast_Cancer_Res_2012_Jul_20_14(4)_R110.nxml.txt.nlp	22817698	SENT54	7	7	4	4	platinum	aromatase	PA150595617	1588	0.911
NULL	J_Oncol_2010_Jan_13_2010_314326.nxml.txt.nlp	20111741	SENT102	10	10	1	1	canertinib	EGFR	PA134687925	1956	0.911
NULL	Breast_Cancer_Res_2011_Mar_11_13(2)_R30.nxml.txt.nlp	21396117	SENT231	47	47	38	38	erlotinib	EGFR	PA134687924	1956	0.911
NULL	Cancers_(Basel)_2014_Mar_13_6(1)_595-624.nxml.txt.nlp	24633084	SENT222	14	14	9	9	pertuzumab	HER2		2064	0.911
NULL	Interdiscip_Toxicol_2011_Sep_4(3)_132-143.nxml.txt.nlp	22058654	SENT185	44	44	37	37	clonazepam	IL-2	PA449050	3558	0.911
NULL	Diabetes_2011_Nov_17_60(11)_3034-3043.nxml.txt.nlp	21940783	SENT202	33	33	5	5	mannitol	RAGE	PA450320	177	0.911
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT686	9	9	17	17	resveratrol	PPARgamma		5468	0.911
NULL	Behav_Brain_Funct_2006_Mar_28_2_12.nxml.txt.nlp	16569246	SENT73	12	12	21	21	methamphetamine	NAC	PA450403	22861	0.911
NULL	BMJ_Open_2014_Oct_31_4(10)_e005781.nxml.txt.nlp	25361837	SENT196	5	5	1	1	cangrelor	ADP	PA165945763	23038	0.911
NULL	Acta_Pharmacol_Sin_2013_Apr_5_34(4)_581.nxml.txt.nlp	NULL	SENT9	10	10	0	0	celecoxib	IL-6	PA448871	3569	0.911
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT312	30	30	16	16	hydrocortisone	B27	PA449905	56246	0.911
NULL	Front_Neurosci_2014_Jun_3_8_128.nxml.txt.nlp	24917782	SENT131	25	25	39	39	ethanol	MC3R	PA448073	4159	0.911
NULL	Mol_Cancer_2009_Apr_22_8_26.nxml.txt.nlp	19386116	SENT90	10	10	33	33	ritonavir	p53	PA451260	7157	0.911
NULL	Cell_Death_Dis_2014_Mar_13_5(3)_e1125.nxml.txt.nlp	24625984	SENT57	11	11	45	45	glucose	IL-12A	PA449773	3592	0.911
NULL	Oncogenesis_2014_Dec_15_3(12)_e133.nxml.txt.nlp	25500906	SENT78	8	8	26	26	trastuzumab	AKT1	PA451743	207	0.911
NULL	Ann_Oncol_2010_Apr_4_21(4)_815-819.nxml.txt.nlp	19889613	SENT25	3	3	14	14	trastuzumab	HER2	PA451743	2064	0.911
NULL	Mol_Pain_2012_Sep_22_8_71.nxml.txt.nlp	22998838	SENT160	27	27	25	25	cisplatin	CXCR4	PA449014	7852	0.911
NULL	Oncologist_2010_Nov_4_15(11)_1147-1158.nxml.txt.nlp	21051658	SENT278	21	21	26	26	denosumab	aromatase	PA166048634	1588	0.911
NULL	Hum_Genomics_2009_Dec_1_4(2)_91-106.nxml.txt.nlp	20038497	SENT167	15	15	7	7	rivastigmine	BCHE	PA451262	590	0.911
NULL	Allergy_Asthma_Clin_Immunol_2009_Dec_17_5(1)_14.nxml.txt.nlp	20066054	SENT40	8	8	10	10	cetirizine	IL-8	PA448905	3576	0.911
NULL	Bioinformation_2012_Jan_6_8(1)_13-19.nxml.txt.nlp	22359429	SENT146	3	3	26	26	curcumin	MRP1	PA151958596	4437	0.911
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT263	10	10	25	25	metformin	PTEN	PA450395	5728	0.911
NULL	Curr_Neuropharmacol_2014_Mar_12(2)_186-192.nxml.txt.nlp	24669211	SENT33	42	42	35	35	metformin	Met	PA450395	79811	0.911
NULL	Diabetes_2011_May_23_60(5)_1632-1636.nxml.txt.nlp	21464442	SENT58	18	18	8	8	ethanol	CO2	PA448073	4513	0.911
NULL	Br_J_Cancer_2010_Feb_2_102(3)_457-461.nxml.txt.nlp	20010942	SENT117	27	27	25	25	gefitinib	EGFR	PA131301952	1956	0.911
NULL	Antiviral_Res_2012_Dec_96(3)_376-385.nxml.txt.nlp	23041142	SENT129	15	15	5	5	oseltamivir	ANOVA	PA450721	4858	0.911
NULL	AAPS_J_2014_Jun_11_16(5)_1029-1037.nxml.txt.nlp	24917180	SENT32	10	10	8	8	quinidine	P-gp	PA451209	5243	0.911
NULL	Front_Neural_Circuits_2014_Nov_6_8_132.nxml.txt.nlp	25414645	SENT462	3	3	44	44	atropine	T13	PA448505	29123	0.911
NULL	Front_Oncol_2013_Aug_12_3_189.nxml.txt.nlp	23964346	SENT89	3	3	7	7	vemurafenib	BRAF	PA165946873	673	0.911
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_29_2013_590393.nxml.txt.nlp	23737838	SENT223	4	4	8	8	resveratrol	p53		7157	0.911
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_6_2014_270930.nxml.txt.nlp	25431606	SENT29	4	4	21	21	simvastatin	MCP-1	PA451363	6347	0.911
NULL	Acta_Pharmacol_Sin_2014_Aug_30_35(8)_1045-1054.nxml.txt.nlp	24976155	SENT129	9	9	2	2	resveratrol	STAT3		6774	0.911
NULL	Case_Rep_Oncol_2013_Sep_10_6(3)_450-455.nxml.txt.nlp	24163659	SENT28	9	9	21	21	paclitaxel	HER2	PA450761	2064	0.911
NULL	Breast_Cancer_(Auckl)_2012_Mar_7_6_67-77.nxml.txt.nlp	22438669	SENT85	28	28	38	38	capecitabine	HER2	PA448771	2064	0.911
NULL	Acta_Pharmacol_Sin_2014_Jun_4_35(6)_752-757.nxml.txt.nlp	24902786	SENT98	39	39	5	5	tamoxifen	STL2	PA451581	1301	0.911
NULL	J_Oncol_2010_Aug_24_2010_654348.nxml.txt.nlp	20871846	SENT42	27	27	15	15	tamoxifen	ATAC	PA451581	6375	0.911
NULL	F1000_Biol_Rep_2009_Sep_8_1_70.nxml.txt.nlp	20948617	SENT8	24	24	21	21	ustekinumab	p40	PA166048654	3921;339541;10314	0.911
NULL	Ther_Clin_Risk_Manag_2006_Sep_2(3)_235-249.nxml.txt.nlp	18360599	SENT351	12	12	20	20	alendronate	PTH	PA448082	5741	0.911
NULL	Oncol_Rep_2012_Apr_30_27(4)_954-958.nxml.txt.nlp	22209887	SENT81	5	5	31	31	collagenase	HSC3	PA449107	150353	0.911
NULL	Biomed_Res_Int_2014_Jan_16_2014_821513.nxml.txt.nlp	24527458	SENT84	10	10	22	22	propofol	Bcl-2	PA451141	596	0.911
NULL	Contemp_Oncol_(Pozn)_2012_Nov_20_16(5)_401-406.nxml.txt.nlp	23788917	SENT62	4	4	16	16	afatinib	EGFR	PA165981154	1956	0.911
NULL	Indian_J_Hum_Genet_2014_Apr-Jun_20(2)_175-184.nxml.txt.nlp	25400347	SENT9	46	46	42	42	clopidogrel	CYP2C19	PA449053	1557	0.911
NULL	Acta_Neuropathol_Commun_2013_Jul_11_1_34.nxml.txt.nlp	24252661	SENT189	5	5	25	25	paraformaldehyde	CA1	PA450790	759	0.911
NULL	Curr_Chem_Genomics_2010_Mar_1_4_1-8.nxml.txt.nlp	20448812	SENT94	32	32	20	20	moricizine	OATP1B1	PA164747738	10599	0.911
NULL	Arthritis_Res_Ther_2014_Apr_11_16(2)_R93.nxml.txt.nlp	24725461	SENT45	26	26	18	18	letrozole	CYP1A1	PA450196	1543	0.911
NULL	Br_J_Cancer_2012_Jul_24_107(3)_516-526.nxml.txt.nlp	22782351	SENT195	21	21	16	16	tamoxifen	TIGAR	PA451581	57103	0.911
NULL	Adv_Hematol_2012_Jul_24_2012_513702.nxml.txt.nlp	22888354	SENT49	2	2	11	11	lenalidomide	CD4	PA162363968	920	0.911
NULL	Int_J_Environ_Res_Public_Health_2011_Jul_30_8(7)_2747-2757.nxml.txt.nlp	21845156	SENT50	16	16	1	1	trypsin	SPINK1	PA451806	6690	0.911
NULL	Hum_Genomics_Proteomics_2010_Aug_3_2010_159761.nxml.txt.nlp	20981231	SENT152	4	4	9	9	lithium	BDNF	PA450243	627	0.911
NULL	ISRN_Cardiol_2012_Jun_27_2012_692761.nxml.txt.nlp	22792485	SENT124	33	33	7	7	esomeprazole	CYP2C19	PA10075	1557	0.911
NULL	Am_J_Physiol_Cell_Physiol_2014_Jan_15_306(2)_C89-C97.nxml.txt.nlp	24133067	SENT41	16	16	27	27	hyaluronan	CD44	PA165958431	960	0.911
NULL	Clin_Dev_Immunol_2011_Dec_29_2011_160250.nxml.txt.nlp	22242035	SENT208	2	2	16	16	cyclophosphamide	CD4	PA449165	920	0.911
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Jun_22_69(Pt_7)_o1145-o1146.nxml.txt.nlp	24046694	SENT75	32	32	6	6	piperazine	C10	PA450977	113246	0.911
NULL	Clin_Ophthalmol_2013_Dec_21_7_7-14.nxml.txt.nlp	23293509	SENT97	44	44	12	12	latanoprost	BAK	PA164774763	578	0.911
NULL	Acta_Pharmacol_Sin_2014_Jun_5_35(6)_716-726.nxml.txt.nlp	24793311	SENT273	2	2	33	33	atorvastatin	IL-6	PA448500	3569	0.911
NULL	Cancers_(Basel)_2011_Aug_5_3(3)_3114-3142.nxml.txt.nlp	24212948	SENT144	23	23	33	33	cetuximab	EGFR	PA10040	1956	0.911
NULL	Anesth_Pain_Med_2013_Dec_26_4(1)_e11187.nxml.txt.nlp	24660143	SENT128	6	6	23	23	dextromethorphan	OTC	PA449273	5009	0.911
NULL	Ann_Rheum_Dis_2013_Aug_21_72(8)_1287-1294.nxml.txt.nlp	22915624	SENT17	10	10	1	1	abatacept	MRI	PA164747080	78996	0.911
NULL	J_Korean_Neurosurg_Soc_2013_Mar_31_53(3)_139-144.nxml.txt.nlp	23634262	SENT143	24	24	14	14	isoflurane	CA3	PA450106	761	0.911
NULL	Iran_J_Reprod_Med_2012_Jul_10(4)_329-336.nxml.txt.nlp	25246894	SENT23	29	29	5	5	protamine	PRM2	PA10366	5620	0.911
NULL	Diabetes_Care_2013_Aug_17_36(Suppl_2)_S180-S189.nxml.txt.nlp	23882044	SENT87	16	16	5	5	exenatide	GLP-1	PA164749238	100125288	0.911
NULL	Ann_N_Y_Acad_Sci_2013_Mar_28_1280(1)_19-23.nxml.txt.nlp	23551097	SENT84	10	10	16	16	trastuzumab	PTEN	PA451743	5728	0.911
NULL	F1000Res_2013_Oct_8_2_173.nxml.txt.nlp	24555085	SENT254	34	34	8	8	hydrocortisone	BDP	PA449905	10620;152926	0.911
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT159	18	18	5	5	trastuzumab	MUC1	PA451743	4582	0.911
NULL	Clin_Med_Insights_Case_Rep_2014_Oct_1_7_117-121.nxml.txt.nlp	25336995	SENT33	20	20	37	37	carmustine	CD34	PA448810	947	0.911
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_3_2014_473213.nxml.txt.nlp	25538791	SENT110	3	3	0	0	itraconazole	MDR1	PA450132	5243	0.911
NULL	Mol_Cancer_2009_Jun_9_8_37.nxml.txt.nlp	19508729	SENT74	10	10	2	2	gemcitabine	HO-1	PA449748	3162	0.911
NULL	Oncotarget_2014_Nov_12_5(20)_9626-9640.nxml.txt.nlp	25275299	SENT77	14	14	4	4	thrombin	RhoA	PA451674	387	0.911
NULL	Genome_Announc_2013_Mar_7_1(2)_e00073-13.nxml.txt.nlp	23516204	SENT8	25	25	12	12	l-alanine	CO2	PA448055	4513	0.911
NULL	J_Gastroenterol_2014_Sep_25_49(8)_1253-1263.nxml.txt.nlp	24065124	SENT286	16	16	3	3	telaprevir	ITPA	PA165958354	3704	0.911
NULL	Oncotarget_2013_Nov_7_4(12)_2550-2566.nxml.txt.nlp	24334291	SENT210	9	9	27	27	chloroquine	AMPK	PA448948	5563	0.911
NULL	Mol_Pain_2013_Feb_15_9_3.nxml.txt.nlp	23413875	SENT178	28	28	2	2	resveratrol	TRPA1		8989	0.911
NULL	Arthritis_Res_Ther_2008_Jan_18_10(1)_R8.nxml.txt.nlp	18205921	SENT50	3	3	13	13	hyaluronan	HABP	PA165958431	3026	0.911
NULL	Arthritis_Res_Ther_2010_Apr_22_12(2)_112.nxml.txt.nlp	20441607	SENT12	13	13	0	0	rituximab	IL-6	PA451261	3569	0.911
NULL	Oncotarget_2012_Feb_22_3(2)_203-211.nxml.txt.nlp	22361516	SENT138	26	26	30	30	everolimus	PI3	PA164746311	5266	0.911
NULL	Front_Oncol_2014_May_16_4_108.nxml.txt.nlp	24904824	SENT49	26	26	15	15	methotrexate	DHFR	PA450428	1719	0.911
NULL	Crit_Care_2006_Mar_15_10(2)_R46.nxml.txt.nlp	16542504	SENT94	15	15	6	6	dobutamine	IL-6	PA449381	3569	0.911
NULL	Thorax_2009_Aug_12_64(8)_671-676.nxml.txt.nlp	19213775	SENT155	10	10	20	20	cilomilast	GM-CSF	PA165948031	1437	0.911
NULL	Clin_Epigenetics_2010_Aug_20_1(3-4)_71-83.nxml.txt.nlp	22704201	SENT44	7	7	5	5	resveratrol	SIRT1		23411	0.911
NULL	Oncotarget_2014_Aug_29_5(19)_8947-8958.nxml.txt.nlp	25333254	SENT7	8	8	16	16	plerixafor	CXCR4	PA165958410	7852	0.911
NULL	Clin_Ophthalmol_2014_Jun_3_8_1057-1064.nxml.txt.nlp	24940042	SENT33	1	1	10	10	bevacizumab	CST	PA130232992	9514	0.911
NULL	J_Hematol_Oncol_2012_Oct_10_5_62.nxml.txt.nlp	23050865	SENT97	30	30	10	10	cisplatin	EGFR	PA449014	1956	0.911
NULL	Int_J_Med_Sci_2015_Jan_5_12(2)_135-140.nxml.txt.nlp	25589889	SENT35	3	3	27	27	haloperidol	NMS	PA449841	129521	0.911
NULL	Eur_J_Neurosci_2009_Jul_30(2)_299-306.nxml.txt.nlp	19614978	SENT19	12	12	22	22	piperazine	5-HT2C	PA450977	3358	0.911
NULL	Exp_Ther_Med_2013_Jan_1_5(1)_338-342.nxml.txt.nlp	23251295	SENT151	3	3	25	25	everolimus	HK2	PA164746311	3796;3099;29911;3741	0.911
NULL	Int_J_Biol_Sci_2012_Oct_25_8(9)_1281-1290.nxml.txt.nlp	23136556	SENT85	40	40	17	17	methacholine	IL-6	PA165958382	3569	0.911
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2010_Aug_3_3_43-51.nxml.txt.nlp	22879786	SENT84	34	34	4	4	pioglitazone	CYP2C8	PA450970	1558	0.911
NULL	Behav_Brain_Funct_2011_Sep_7_7_39.nxml.txt.nlp	21899751	SENT79	22	22	6	6	phenytoin	KCNA1	PA450947	3736	0.911
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT126	27	27	13	13	perifosine	DR4	PA165291471	8797	0.911
NULL	Ann_Gen_Psychiatry_2008_Oct_15_7_19.nxml.txt.nlp	18922171	SENT96	23	23	1	1	bupropion	CD50	PA448687	3385	0.911
NULL	Oncotarget_2013_Feb_26_4(2)_298-309.nxml.txt.nlp	23593653	SENT61	9	9	20	20	quinacrine	SFRP1	PA164745551	6422	0.911
NULL	Eur_J_Med_Res_2014_Nov_22_19(1)_64.nxml.txt.nlp	25416032	SENT100	20	20	16	16	doxorubicin	CHOP	PA449412	1649	0.911
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Apr_21_68(Pt_5)_o1472.nxml.txt.nlp	22590345	SENT57	20	20	6	6	ethanol	mol	PA448073	90527	0.911
NULL	Oncol_Lett_2014_Jul_25_8(1)_313-316.nxml.txt.nlp	24959268	SENT15	5	5	26	26	sulindac	JNK1	PA451565	5599	0.911
NULL	Psychiatry_Investig_2012_Jun_30_9(2)_187-190.nxml.txt.nlp	22707971	SENT58	5	5	15	15	capsaicin	POMC	PA448776	5443	0.911
NULL	Cancer_Inform_2007_Jan_12_3_275-284.nxml.txt.nlp	19455247	SENT25	30	30	11	11	gefitinib	EGFR	PA131301952	1956	0.911
NULL	Mol_Biol_Rep_2013_May_11_40(8)_5013-5026.nxml.txt.nlp	23666059	SENT34	8	8	11	11	resveratrol	p53		7157	0.911
NULL	Theranostics_2013_Jan_13_3(1)_18-25.nxml.txt.nlp	23382782	SENT44	15	15	36	36	maraviroc	CXCR4	PA164768835	7852	0.911
NULL	Front_Neurosci_2014_Apr_10_8_74.nxml.txt.nlp	24782704	SENT55	17	17	25	25	heparin	EGF	PA449855	1950	0.911
NULL	Curr_Pain_Headache_Rep_2011_Aug_12_15(4)_271-279.nxml.txt.nlp	21479998	SENT48	11	11	22	22	hydroxytryptamine	CYP2D6	PA140222718	1565	0.911
NULL	Eur_J_Clin_Pharmacol_2010_Nov_29_66(11)_1131-1136.nxml.txt.nlp	20669013	SENT112	34	34	13	13	erythromycin	CYP2C19	PA449493	1557	0.911
NULL	Leukemia_2014_Jun_25_28(6)_1280-1288.nxml.txt.nlp	24270737	SENT202	26	26	11	11	azacitidine	CTLA4	PA451996	1493	0.911
NULL	Br_J_Cancer_2010_Jan_19_102(2)_342-350.nxml.txt.nlp	20010939	SENT4	4	4	23	23	tamoxifen	CDK2	PA451581	1017	0.911
NULL	Diabetologia_2014_Sep_29_57(1)_192-203.nxml.txt.nlp	24078137	SENT176	41	41	28	28	metformin	CNGA1	PA450395	1259	0.911
NULL	Cell_Death_Dis_2011_Aug_11_2(8)_e190.nxml.txt.nlp	21833028	SENT408	30	30	8	8	doxorubicin	p38	PA449412	10598;1432;7965	0.911
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT146	14	14	10	10	dasatinib	ABCG2	PA162372878	9429	0.911
NULL	Anesth_Essays_Res_2011_Jul-Dec_5(2)_182-186.nxml.txt.nlp	NULL	SENT24	18	18	30	30	ondansetron	CYP1A2	PA450705	1544	0.911
NULL	Cardiovasc_Diabetol_2006_Mar_30_5_6.nxml.txt.nlp	16573830	SENT180	32	32	4	4	heparin	RAGE	PA449855	177	0.911
NULL	Daru_2012_Oct_4_20(1)_45.nxml.txt.nlp	23351300	SENT36	20	20	39	39	piroxicam	API	PA450985	5345	0.911
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT788	9	9	14	14	imatinib	OATP1A2	PA10804	6579	0.911
NULL	Br_J_Cancer_2011_May_24_104(11)_1675-1679.nxml.txt.nlp	21522147	SENT4	7	7	26	26	trastuzumab	HER-2	PA451743	2064	0.911
NULL	Oncol_Rep_2012_Apr_30_27(4)_923-928.nxml.txt.nlp	22209766	SENT155	11	11	29	29	erlotinib	EGFR	PA134687924	1956	0.911
NULL	Pharmaceuticals_(Basel)_2012_Feb_23_5(3)_249-278.nxml.txt.nlp	24281378	SENT360	4	4	2	2	capsaicin	TRPA1	PA448776	8989	0.911
NULL	Aging_(Albany_NY)_2009_Feb_18_1(3)_335-349.nxml.txt.nlp	20195489	SENT130	15	15	6	6	etoposide	p65	PA449552	5970	0.911
NULL	Croat_Med_J_2012_Jun_53(3)_214-223.nxml.txt.nlp	22661134	SENT94	30	30	13	13	diazepam	ACTH	PA449283	5443	0.911
NULL	Breast_Cancer_Res_2004_Oct_6_6(6)_269-274.nxml.txt.nlp	15535858	SENT45	6	6	2	2	tamoxifen	aromatase	PA451581	1588	0.911
NULL	Cardiovasc_Diabetol_2006_Sep_26_5_20.nxml.txt.nlp	17002798	SENT52	11	11	13	13	aspirin	ACE	PA448497	1636	0.911
NULL	J_Immunother_Cancer_2013_Nov_7_1(Suppl_1)_P255.nxml.txt.nlp	NULL	SENT27	11	11	22	22	cyclophosphamide	CD4	PA449165	920	0.911
NULL	Cell_Death_Dis_2014_Mar_13_5(3)_e1125.nxml.txt.nlp	24625984	SENT57	11	11	41	41	glucose	IL-2	PA449773	3558	0.911
NULL	Curr_Opin_Nephrol_Hypertens_2015_Jan_4_24(1)_37-46.nxml.txt.nlp	25427230	SENT179	19	19	32	32	troglitazone	CYP2C9	PA451799	1559	0.911
NULL	Front_Synaptic_Neurosci_2014_May_30_6_12.nxml.txt.nlp	24910611	SENT138	19	19	3	3	l-serine	asc-1	PA451330	56301	0.911
NULL	Front_Oncol_2014_Jun_18_4_153.nxml.txt.nlp	24995158	SENT175	2	2	9	9	etoposide	c-Jun	PA449552	3725	0.911
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_May_29_65(Pt_6)_m691-m692.nxml.txt.nlp	21583048	SENT79	31	31	19	19	copper	mol	PA449114	90527	0.911
NULL	Cancer_Res_Treat_2014_Jul_15_46(3)_209-222.nxml.txt.nlp	25038756	SENT169	22	22	4	4	gemcitabine	EZH2	PA449748	2146	0.911
NULL	Front_Behav_Neurosci_2011_Sep_13_5_57.nxml.txt.nlp	21949506	SENT64	38	38	35	35	rimonabant	CB1	PA152407999	1268	0.911
NULL	Open_Neurol_J_2013_May_31_7_23-31.nxml.txt.nlp	23894259	SENT33	23	23	15	15	clozapine	FGA	PA449061	2243	0.911
NULL	Br_J_Cancer_2011_May_24_104(11)_1786-1790.nxml.txt.nlp	21559018	SENT30	28	28	13	13	irinotecan	EGFR	PA450085	1956	0.911
NULL	Iran_J_Neurol_2012_11(2)_70-73.nxml.txt.nlp	24250865	SENT6	12	12	17	17	doxycycline	IFN	PA449415	3439	0.911
NULL	Mol_Vis_2007_Apr_5_13_578-587.nxml.txt.nlp	17438523	SENT190	8	8	28	28	staurosporine	CHOP	PA165109623	1649	0.911
NULL	Exp_Diabetes_Res_2012_Jan_29_2012_159874.nxml.txt.nlp	22319521	SENT138	6	6	24	24	candesartan	Hes1	PA448765	3280	0.911
NULL	Am_J_Cardiovasc_Drugs_2013_Jun_20_13(5)_331-342.nxml.txt.nlp	23784266	SENT183	12	12	6	6	quinidine	P-gp	PA451209	5243	0.911
NULL	Br_J_Cancer_2009_Jul_21_101(2)_350-356.nxml.txt.nlp	19513075	SENT126	2	2	10	10	camptothecin	MDM2	PA153590860	4193	0.911
NULL	Drugs_2012_Sep_6_72(9)_e1-e25.nxml.txt.nlp	22686620	SENT281	3	3	14	14	maraviroc	CCR5	PA164768835	1234	0.911
NULL	Mol_Cancer_2013_Mar_5_12_17.nxml.txt.nlp	23497256	SENT5	12	12	15	15	sunitinib	HDM2	PA162372840	4193	0.911
NULL	Clin_Epigenetics_2011_Jun_14_2(2)_151-169.nxml.txt.nlp	22704335	SENT297	3	3	8	8	procainamide	DNMT1	PA451108	1786	0.911
NULL	Inflammation_2012_Apr_24_35(2)_566-573.nxml.txt.nlp	21607702	SENT20	20	20	7	7	fluorescein	VASP	PA164746009	7408	0.911
NULL	Front_Oncol_2014_Apr_7_4_50.nxml.txt.nlp	24778990	SENT145	11	11	9	9	irinotecan	CRT	PA450085	811	0.911
NULL	Colorectal_Dis_2012_Feb_14(2)_e31-e47.nxml.txt.nlp	21848897	SENT109	0	0	19	19	cetuximab	KRAS	PA10040	3845	0.911
NULL	Biologics_2010_May_25_4_91-101.nxml.txt.nlp	20531964	SENT3	11	11	29	29	everolimus	VEGFR	PA164746311	3791	0.911
NULL	Int_J_Biomed_Sci_2013_Sep_9(3)_153-161.nxml.txt.nlp	24170990	SENT180	4	4	16	16	bezafibrate	SR-BI	PA162364313	949	0.911
NULL	Clin_Ophthalmol_2008_Dec_2(4)_919-930.nxml.txt.nlp	19668445	SENT256	17	17	6	6	ranibizumab	San	PA164746012	80218	0.911
NULL	Acta_Histochem_Cytochem_2006_Dec_28_39(6)_163-172.nxml.txt.nlp	17327903	SENT16	8	8	5	5	sevoflurane	ERK	PA451341	5594	0.911
NULL	Diabetes_Care_2009_Nov_32(Suppl_2)_S322-S325.nxml.txt.nlp	19875573	SENT106	9	9	21	21	exenatide	GLP-1	PA164749238	100125288	0.911
NULL	J_Neuroinflammation_2011_Feb_4_8_10.nxml.txt.nlp	21294877	SENT163	36	36	19	19	capsaicin	NK1	PA448776	11126	0.911
NULL	Breast_Cancer_Res_2012_Jun_7_14(3)_R89.nxml.txt.nlp	22676470	SENT332	5	5	17	17	geldanamycin	HER2	PA152031327	2064	0.911
NULL	Curr_Hematol_Malig_Rep_2014_Feb_6_9(1)_9-16.nxml.txt.nlp	24500518	SENT260	15	15	3	3	imatinib	CD34	PA10804	947	0.911
NULL	ISRN_Neurosci_2014_Jan_16_2014_258040.nxml.txt.nlp	24967314	SENT44	0	0	25	25	cyanocobalamin	B12	PA451892	7126;4709	0.911
NULL	Diabetes_2009_Dec_31_58(12)_2851-2862.nxml.txt.nlp	19720788	SENT268	28	28	18	18	forskolin	PP1	PA146096022	5540;5464	0.911
NULL	Mol_Pain_2012_Sep_22_8_71.nxml.txt.nlp	22998838	SENT160	27	27	13	13	cisplatin	CB2	PA449014	1269	0.911
NULL	Cardiovasc_Drugs_Ther_2010_Dec_13_24(5-6)_391-399.nxml.txt.nlp	20640495	SENT5	19	19	8	8	simvastatin	DIP	PA451363	23151;1831	0.911
NULL	Breast_Cancer_Res_Treat_2014_Apr_9_145(1)_73-82.nxml.txt.nlp	24715380	SENT116	22	22	32	32	tamoxifen	CXCL10	PA451581	3627	0.911
NULL	Cells_2012_Nov_1_1(4)_926-950.nxml.txt.nlp	24710536	SENT209	2	2	30	30	ethanol	HAC1	PA448073	10612	0.911
NULL	Br_J_Cancer_2012_Apr_24_106(9)_1481-1485.nxml.txt.nlp	22472884	SENT178	23	23	25	25	cisplatin	TRAIL	PA449014	8743	0.911
NULL	Br_J_Pharmacol_2014_Jun_15_171(11)_2705-2725.nxml.txt.nlp	24467436	SENT5	7	7	2	2	hydralazine	NAT	PA449894	6046	0.911
NULL	Oncoimmunology_2013_Aug_1_2(8)_e25123.nxml.txt.nlp	24083076	SENT17	28	28	8	8	everolimus	EGFR	PA164746311	1956	0.911
NULL	Front_Neural_Circuits_2014_Jun_17_8_65.nxml.txt.nlp	24987336	SENT116	6	6	1	1	furosemide	KCC2	PA449719	57468	0.911
NULL	Oncotarget_2013_Nov_4_5(1)_161-172.nxml.txt.nlp	24389287	SENT173	6	6	16	16	propranolol	HDM2	PA451145	4193	0.911
NULL	Breast_Cancer_Res_2010_Jun_28_12(3)_R43.nxml.txt.nlp	20579400	SENT265	10	10	4	4	tamoxifen	MAPT	PA451581	4137	0.911
NULL	Support_Care_Cancer_2014_Dec_14_22(3)_837-846.nxml.txt.nlp	24337717	SENT19	10	10	16	16	rifampin	CYP3A4	PA451250	1576	0.911
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT210	21	21	16	16	metformin	p53	PA450395	7157	0.911
NULL	Breast_Cancer_(Auckl)_2011_Oct_9_5_209-226.nxml.txt.nlp	22084574	SENT29	29	29	6	6	exemestane	aromatase	PA449563	1588	0.911
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT121	6	6	2	2	simvastatin	survivin	PA451363	332	0.911
NULL	J_Invest_Dermatol_2012_May_16_132(5)_1435-1442.nxml.txt.nlp	22336948	SENT5	44	44	11	11	doxycycline	KLK5	PA449415	25818	0.911
NULL	Nat_Commun_2014_Dec_18_5_5815.nxml.txt.nlp	25519973	SENT138	16	16	24	24	tranylcypromine	ATN1	PA451741	1822	0.911
NULL	Evid_Based_Complement_Alternat_Med_2013_Oct_27_2013_170290.nxml.txt.nlp	24282432	SENT84	13	13	32	32	loperamide	castor	PA450262	54897	0.911
NULL	Exp_Ther_Med_2013_Dec_15_6(6)_1565-1569.nxml.txt.nlp	24255692	SENT3	11	11	18	18	atorvastatin	adiponectin	PA448500	9370	0.911
NULL	Carcinogenesis_2010_Dec_27_31(12)_2049-2057.nxml.txt.nlp	20876285	SENT234	33	33	10	10	tamoxifen	HER2	PA451581	2064	0.911
NULL	Br_J_Cancer_2013_Sep_3_109(5)_1214-1222.nxml.txt.nlp	23922104	SENT165	14	14	26	26	dasatinib	IDH1	PA162372878	3417	0.911
NULL	Lab_Anim_Res_2011_Jun_22_27(2)_85-90.nxml.txt.nlp	21826167	SENT21	0	0	4	4	olmesartan	AT1	PA164742950	9197;185	0.911
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT13	0	0	2	2	tacrolimus	RANKL	PA451578	8600	0.911
NULL	J_Oncol_2012_Feb_6_2012_737981.nxml.txt.nlp	22481932	SENT83	24	24	37	37	cyclophosphamide	MUC16	PA449165	94025	0.911
NULL	BMJ_Open_2015_Jan_6_5(1)_e006251.nxml.txt.nlp	25564143	SENT108	28	28	9	9	simvastatin	IL-10	PA451363	3586	0.911
NULL	Biol_Open_2012_Oct_4_1(12)_1215-1225.nxml.txt.nlp	23259056	SENT201	11	11	27	27	l-glutamine	S6K1	PA10090	6198	0.911
NULL	Scientifica_(Cairo)_2012_Dec_16_2012_402783.nxml.txt.nlp	24278688	SENT185	29	29	46	46	thrombin	C5a	PA451674	727	0.911
NULL	Am_J_Trop_Med_Hyg_2014_Oct_1_91(4)_833-843.nxml.txt.nlp	25048375	SENT145	31	31	17	17	artemisinin	ACT	PA165111696	12;11332;9457;641455	0.911
NULL	Cancers_(Basel)_2013_May_27_5(2)_617-638.nxml.txt.nlp	24216994	SENT188	15	15	11	11	curcumin	PC3	PA151958596	57332;7832;5122	0.911
NULL	Nat_Med_2014_Jun_25_20(6)_676-681.nxml.txt.nlp	24859530	SENT44	5	5	23	23	fluorescein	CD11b	PA164746009	3684	0.911
NULL	Biomed_Res_Int_2014_Jun_3_2014_459823.nxml.txt.nlp	25025052	SENT106	9	9	28	28	fluspirilene	ATG5	PA162565878	9474	0.911
NULL	Gut_2012_Jan_3_61(1)_6-32.nxml.txt.nlp	22052063	SENT364	1	1	26	26	octreotide	SSTR3	PA450678	6753	0.911
NULL	Int_J_Chron_Obstruct_Pulmon_Dis_2006_Dec_1(4)_477-483.nxml.txt.nlp	18044104	SENT63	19	19	4	4	salbutamol	ANOVA	PA448068	4858	0.911
NULL	Emerg_Infect_Dis_2011_Oct_17(10)_1966-1968.nxml.txt.nlp	22000388	SENT9	35	35	6	6	tenofovir	CD4	PA10204	920	0.911
NULL	Arthritis_Res_Ther_2012_Aug_15_14(4)_R186.nxml.txt.nlp	22894827	SENT160	10	10	34	34	etanercept	ACTH	PA449515	5443	0.911
NULL	Arch_Drug_Inf_2011_Mar_4(1)_1-9.nxml.txt.nlp	21572514	SENT148	2	2	6	6	trimethoprim	P-gp	PA451788	5243	0.911
NULL	Ann_Indian_Acad_Neurol_2008_Jan-Mar_11(1)_13-19.nxml.txt.nlp	19966973	SENT114	3	3	14	14	curcumin	IL-6	PA151958596	3569	0.911
NULL	Exp_Diabetes_Res_2012_Nov_12_2012_618923.nxml.txt.nlp	23197974	SENT151	31	31	15	15	telmisartan	STZ	PA451605	6484	0.911
NULL	J_Asthma_Allergy_2014_Dec_2_7_165-167.nxml.txt.nlp	25506230	SENT10	6	6	12	12	rituximab	San	PA451261	80218	0.911
NULL	Mol_Cells_2014_Mar_31_37(3)_202-212.nxml.txt.nlp	24625573	SENT194	30	30	18	18	mexiletine	ClC-1	PA450488	1180	0.911
NULL	Oncol_Lett_2014_Sep_11_8(3)_1222-1228.nxml.txt.nlp	25120693	SENT30	12	12	21	21	olaparib	XRCC2		7516	0.911
NULL	Acta_Pharmacol_Sin_2012_Dec_29_33(12)_1518-1524.nxml.txt.nlp	23103625	SENT127	23	23	17	17	telmisartan	ACE2	PA451605	59272	0.911
NULL	Br_J_Cancer_2012_Nov_6_107(10)_1714-1721.nxml.txt.nlp	23073173	SENT101	20	20	6	6	bicalutamide	RUNX2	PA164746255	860	0.911
NULL	Oncologist_2010_Sep_26_15(9)_944-953.nxml.txt.nlp	20798196	SENT43	21	21	11	11	lapatinib	HER-2	PA152241907	2064	0.911
NULL	Exp_Anim_2014_Apr_26_63(2)_257-267.nxml.txt.nlp	24770651	SENT182	20	20	6	6	olmesartan	apelin	PA164742950	8862	0.911
NULL	J_Cell_Mol_Med_2014_Dec_6_18(12)_2331-2339.nxml.txt.nlp	25284457	SENT153	22	22	9	9	bleomycin	RAGE	PA448645	177	0.911
NULL	J_Invest_Dermatol_2012_Oct_24_132(10)_2440-2450.nxml.txt.nlp	22622430	SENT78	35	35	45	45	temozolomide	IL-8	PA451609	3576	0.911
NULL	Drugs_R_D_2014_Sep_25_14(3)_165-176.nxml.txt.nlp	24962635	SENT49	5	5	8	8	glimepiride	CYP2C9	PA449761	1559	0.911
NULL	Ann_Neurosci_2012_Jul_19(3)_125-132.nxml.txt.nlp	25205985	SENT105	9	9	4	4	bumetanide	NKCC1	PA448682	6558	0.911
NULL	Nat_Med_2010_Feb_24_16(2)_214-218.nxml.txt.nlp	20098429	SENT44	13	13	3	3	doxorubicin	YWHAZ	PA449412	7534	0.911
NULL	Cancer_Med_2013_Jun_25_2(3)_277-285.nxml.txt.nlp	23930204	SENT114	6	6	40	40	bevacizumab	PTEN	PA130232992	5728	0.911
NULL	BMB_Rep_2013_Aug_46(8)_410-415.nxml.txt.nlp	23977989	SENT101	31	31	17	17	curcumin	HO-1	PA151958596	3162	0.911
NULL	Eur_J_Clin_Pharmacol_2012_Jan_7_68(1)_55-64.nxml.txt.nlp	21735164	SENT38	10	10	4	4	oxycodone	CYP2D6	PA450741	1565	0.911
NULL	Cardiol_Res_Pract_2011_Feb_20_2011_747861.nxml.txt.nlp	21403897	SENT212	0	0	3	3	exenatide	GLP-1	PA164749238	100125288	0.911
NULL	Iran_J_Reprod_Med_2012_Jul_10(4)_329-336.nxml.txt.nlp	25246894	SENT23	29	29	7	7	protamine	TNP2	PA10366	7142	0.911
NULL	Cancer_2014_Jun_15_120(12)_1871-1880.nxml.txt.nlp	24634003	SENT139	9	9	22	22	sunitinib	IFN	PA162372840	3439	0.911
NULL	COPD_2014_Jun_2_11(3)_310-318.nxml.txt.nlp	24295402	SENT51	9	9	29	29	trypsin	CD105	PA451806	2022	0.911
NULL	Breast_Cancer_Res_2011_Mar_11_13(2)_R29.nxml.txt.nlp	21396094	SENT8	17	17	5	5	fulvestrant	HRG	PA164747170	3084;3273	0.911
NULL	Anat_Cell_Biol_2012_Jun_30_45(2)_114-120.nxml.txt.nlp	22822466	SENT16	1	1	24	24	vasopressin	SON	PA451858	6651	0.911
NULL	J_Cell_Biol_2005_Jun_20_169(6)_871-884.nxml.txt.nlp	15967811	SENT97	13	13	34	34	arsenite	G3BP	PA452638	10146	0.911
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1150.nxml.txt.nlp	24675468	SENT12	0	0	21	21	metformin	AMPK	PA450395	5563	0.911
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT337	13	13	1	1	risperidone	PRL	PA451257	5617	0.911
NULL	Nucleic_Acids_Res_2012_Jul_19_40(13)_5910-5925.nxml.txt.nlp	22434882	SENT346	3	3	16	16	etoposide	HBZ	PA449552	3050	0.911
NULL	Oncotarget_2013_Nov_4_5(1)_161-172.nxml.txt.nlp	24389287	SENT120	3	3	28	28	propranolol	p53	PA451145	7157	0.911
NULL	J_Hematol_Oncol_2012_May_17_5_24.nxml.txt.nlp	22594538	SENT183	14	14	10	10	doxorubicin	CHOP	PA449412	1649	0.911
NULL	Behav_Brain_Funct_2011_Oct_5_7_41.nxml.txt.nlp	21974752	SENT30	34	34	9	9	fluvoxamine	EPM	PA449690	2054	0.911
NULL	Eur_J_Clin_Pharmacol_2010_Nov_29_66(11)_1131-1136.nxml.txt.nlp	20669013	SENT130	2	2	7	7	erythromycin	CYP3A4	PA449493	1576	0.911
NULL	Ther_Clin_Risk_Manag_2005_Mar_1(1)_3-13.nxml.txt.nlp	18360537	SENT46	7	7	5	5	diltiazem	CYP3A	PA449334	1574	0.911
NULL	Front_Genet_2012_Nov_5_3_236.nxml.txt.nlp	23133441	SENT26	5	5	24	24	efavirenz	P-gp	PA449441	5243	0.911
NULL	J_Vet_Med_Sci_2014_Jun_15_76(6)_813-817.nxml.txt.nlp	24531829	SENT145	18	18	2	2	artesunate	DPT	PA165111697	1805	0.911
NULL	Exp_Ther_Med_2012_Oct_3_4(4)_594-604.nxml.txt.nlp	23170111	SENT89	5	5	16	16	propranolol	HIF1	PA451145	3091	0.911
NULL	Chin_J_Cancer_2011_Sep_30(9)_645-654.nxml.txt.nlp	21880186	SENT53	15	15	26	26	ifosfamide	DDP	PA449964	1678	0.911
NULL	J_Cancer_Prev_2014_Mar_19(1)_39-46.nxml.txt.nlp	25337571	SENT100	12	12	2	2	ethanol	CDK4	PA448073	1019	0.911
NULL	Nat_Commun_2014_Aug_4_5_4535.nxml.txt.nlp	25088745	SENT26	6	6	24	24	metformin	AMPK	PA450395	5563	0.911
NULL	Acta_Pharmacol_Sin_2009_Dec_4_30(12)_1585-1593.nxml.txt.nlp	19960004	SENT10	18	18	23	23	phenylephrine	mol	PA450935	90527	0.911
NULL	Cardiovasc_Diabetol_2005_Oct_5_4_16.nxml.txt.nlp	16207378	SENT154	4	4	7	7	glucosamine	perlecan	PA164747613	3339	0.911
NULL	J_Oncol_2014_Mar_26_2014_625060.nxml.txt.nlp	24795759	SENT45	26	26	30	30	ibandronate	aromatase	PA10270	1588	0.911
NULL	Br_J_Anaesth_2011_Oct_17_107(4)_490-502.nxml.txt.nlp	21852280	SENT53	27	27	1	1	capsaicin	TRPV1	PA448776	7442	0.911
NULL	Arthritis_Res_Ther_2007_Oct_10_9(5)_R105.nxml.txt.nlp	17927818	SENT173	5	5	13	13	pp2	RhoA		387	0.911
NULL	Breast_Cancer_Res_2012_Feb_21_14(1)_R35.nxml.txt.nlp	22353783	SENT372	20	20	5	5	metformin	LKB1	PA450395	6794	0.911
NULL	Eur_J_Pediatr_2011_Jun_8_170(6)_709-718.nxml.txt.nlp	20931226	SENT201	14	14	45	45	ciclesonide	BDP	PA164781399	10620;152926	0.911
NULL	Mol_Cells_2014_Mar_31_37(3)_234-240.nxml.txt.nlp	24642709	SENT165	30	30	21	21	capsaicin	HO-1	PA448776	3162	0.911
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Jul_9_3(7)_e124.nxml.txt.nlp	25006781	SENT72	1	1	29	29	rosuvastatin	OATP1B1	PA134308647	10599	0.911
NULL	Mol_Cancer_2010_Jun_7_9_139.nxml.txt.nlp	20529262	SENT25	4	4	8	8	gefitinib	EGFR	PA131301952	1956	0.911
NULL	Int_J_Circumpolar_Health_2013_Aug_5_72_10_3402_ijch_v72i0_20854.nxml.txt.nlp	23984273	SENT170	11	11	19	19	tetracycline	TMP	PA451640	2012	0.911
NULL	J_Exp_Clin_Cancer_Res_2009_Jul_22_28(1)_105.nxml.txt.nlp	19624845	SENT154	14	14	12	12	clodronate	MT1-MMP	PA10239	4323	0.911
NULL	AIDS_Res_Ther_2013_May_1_10_10.nxml.txt.nlp	23634877	SENT149	23	23	10	10	lovastatin	CD4	PA450272	920	0.911
NULL	Mol_Cancer_2014_Jun_27_13_159.nxml.txt.nlp	24972933	SENT184	22	22	0	0	cladribine	DCK	PA449027	1633	0.911
NULL	Int_J_Vasc_Med_2012_Feb_12_2012_918267.nxml.txt.nlp	22611498	SENT591	10	10	24	24	rosiglitazone	AMPK	PA451283	5563	0.911
NULL	Can_J_Infect_Dis_Med_Microbiol_2014_Nov-Dec_25(6)_311-320.nxml.txt.nlp	25587293	SENT140	11	11	7	7	rifampin	P-gp	PA451250	5243	0.911
NULL	Biochem_Res_Int_2012_Mar_4_2012_685267.nxml.txt.nlp	22496978	SENT224	6	6	18	18	plerixafor	CXCR4	PA165958410	7852	0.911
NULL	Nat_Med_2011_Sep_11_17(10)_1235-1241.nxml.txt.nlp	21909103	SENT320	30	30	3	3	doxycycline	RANKL	PA449415	8600	0.911
NULL	Indian_J_Pharm_Sci_2013_Jan-Feb_75(1)_94-98.nxml.txt.nlp	23901167	SENT30	12	12	32	32	omeprazole	CYP2C19	PA450704	1557	0.911
NULL	Cancer_Cell_Int_2013_Mar_4_13_21.nxml.txt.nlp	23497288	SENT15	24	24	8	8	etoposide	EWS	PA449552	2130	0.911
NULL	Cancer_Cell_Int_2013_Jun_26_13_63.nxml.txt.nlp	23800022	SENT141	4	4	34	34	genistein	MDM2	PA165109660	4193	0.911
NULL	BMJ_Open_2014_May_5_4(5)_e005268.nxml.txt.nlp	24801283	SENT89	10	10	24	24	prasugrel	SAS	PA154410481	54187	0.911
NULL	Breast_Cancer_Res_2000_Mar_12_2(Suppl_1)_P7_04.nxml.txt.nlp	NULL	SENT14	3	3	12	12	etoposide	BRCA1	PA449552	672	0.911
NULL	Mol_Cancer_2010_Apr_29_9_95.nxml.txt.nlp	20429933	SENT65	13	13	32	32	cisplatin	p53	PA449014	7157	0.911
NULL	Breast_Cancer_Res_2011_Jun_27_13(3)_212.nxml.txt.nlp	21787441	SENT213	17	17	2	2	tamoxifen	SET	PA451581	6418	0.911
NULL	Front_Genet_2015_Jan_14_5_469.nxml.txt.nlp	25642242	SENT244	27	27	22	22	paromomycin	MRPS12	PA164784023	6183	0.911
NULL	Oxid_Med_Cell_Longev_2013_May_7_2013_984546.nxml.txt.nlp	23738048	SENT174	29	29	16	16	arsenite	NQO1	PA452638	1728	0.911
NULL	Acta_Pharmacol_Sin_2009_Sep_24_30(9)_1262-1275.nxml.txt.nlp	19701231	SENT10	16	16	6	6	lovastatin	LRP1	PA450272	10438;4035	0.911
NULL	Mol_Cancer_2008_May_19_7_40.nxml.txt.nlp	18489772	SENT208	7	7	22	22	bortezomib	PIR	PA10252	8544	0.911
NULL	Mol_Biol_Cell_2013_Jul_15_24(14)_2186-2200.nxml.txt.nlp	23699397	SENT95	5	5	35	35	staurosporine	TRAIL	PA165109623	8743	0.911
NULL	Breast_Cancer_Res_2010_Aug_23_12(4)_R64.nxml.txt.nlp	20731819	SENT97	4	4	0	0	fluoxetine	CYP2D6	PA449673	1565	0.911
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT168	16	16	7	7	sulindac	AKT	PA451565	207	0.911
NULL	Case_Rep_Rheumatol_2012_Apr_9_2012_517059.nxml.txt.nlp	22937453	SENT83	9	9	12	12	propylthiouracil	ANA	PA451156	10950	0.911
NULL	Diabetes_Care_2010_Apr_12_33(4)_742-744.nxml.txt.nlp	20067964	SENT22	6	6	21	21	pioglitazone	ghrelin	PA450970	51738	0.911
NULL	Arthritis_Res_Ther_2010_Dec_21_12(6)_223.nxml.txt.nlp	21205285	SENT73	33	33	35	35	losartan	URAT1	PA450268	116085	0.911
NULL	Indian_J_Pharm_Sci_2014_Jan-Feb_76(1)_72-77.nxml.txt.nlp	24799741	SENT117	27	27	19	19	metronidazole	CYP2C9	PA450484	1559	0.911
NULL	eLife_2013_Nov_5_2_e01319.nxml.txt.nlp	24192038	SENT180	5	5	15	15	rolipram	PDE4D	PA153906323	5144	0.911
NULL	Ann_Neurol_2013_Feb_31_73(2)_246-258.nxml.txt.nlp	23281025	SENT12	8	8	11	11	apomorphine	NRF2	PA164781163	2551;4780	0.911
NULL	Int_J_Mol_Sci_2012_Sep_26_13(10)_12268-12286.nxml.txt.nlp	23202898	SENT106	5	5	10	10	gefitinib	EGFR	PA131301952	1956	0.911
NULL	Case_Rep_Med_2012_May_28_2012_757696.nxml.txt.nlp	22685471	SENT7	12	12	9	9	ondansetron	CHS	PA450705	1130	0.911
NULL	Int_J_Inflam_2010_Nov_25_2010_910283.nxml.txt.nlp	21151692	SENT134	19	19	17	17	trypsin	HD-5	PA451806	1670	0.911
NULL	Nucl_Recept_Signal_2009_Jan_16_7_e001.nxml.txt.nlp	19240808	SENT417	22	22	8	8	estradiol	CYP3A4	PA449503	1576	0.911
NULL	Nucleic_Acids_Res_2013_May_5_41(10)_5210-5222.nxml.txt.nlp	23563151	SENT21	0	0	22	22	arsenite	GADD45	PA452638	1647	0.911
NULL	Int_J_Chron_Obstruct_Pulmon_Dis_2006_Dec_1(4)_425-434.nxml.txt.nlp	18044098	SENT190	18	18	31	31	acetylcysteine	NAC	PA448033	22861	0.911
NULL	Cancer_Cell_Int_2011_Aug_12_11_27.nxml.txt.nlp	21838899	SENT188	2	2	28	28	chlorpromazine	AP-2	PA448964	7020	0.911
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_75-89.nxml.txt.nlp	17912638	SENT381	4	4	2	2	exemestane	aromatase	PA449563	1588	0.911
NULL	Chin_J_Cancer_2011_Sep_30(9)_645-654.nxml.txt.nlp	21880186	SENT53	13	13	26	26	bleomycin	DDP	PA448645	1678	0.911
NULL	Cancer_Cell_Int_2005_Jul_24_5_22.nxml.txt.nlp	16042792	SENT91	34	34	36	36	vincristine	NAC	PA451879	22861	0.911
NULL	Front_Psychol_2014_Mar_26_5_183.nxml.txt.nlp	24723897	SENT256	13	13	24	24	methylphenidate	ATX	PA450464	5168;23049	0.911
NULL	J_Obes_2011_Dec_12_2011_179674.nxml.txt.nlp	21197148	SENT191	2	2	7	7	exenatide	GLP1	PA164749238	100125288;2641	0.911
NULL	Mol_Cancer_2009_Jun_9_8_37.nxml.txt.nlp	19508729	SENT51	1	1	18	18	gemcitabine	HO-1	PA449748	3162	0.911
NULL	Protein_J_2012_Aug_5_31(6)_511-518.nxml.txt.nlp	22763563	SENT83	21	21	12	12	atorvastatin	CD36	PA448500	948	0.911
NULL	Gastric_Cancer_2013_Jul_12_16(3)_345-354.nxml.txt.nlp	22968820	SENT137	8	8	2	2	oxaliplatin	PMS2	PA131285527	5395	0.911
NULL	Cancer_Immunol_Immunother_2011_Jun_24_60(6)_771-780.nxml.txt.nlp	21347809	SENT170	9	9	1	1	rituximab	JNK	PA451261	5599	0.911
NULL	Mol_Cancer_2014_Aug_20_13(1)_194.nxml.txt.nlp	NULL	SENT187	21	21	5	5	vemurafenib	BRAF	PA165946873	673	0.911
NULL	Oncol_Rep_2014_Apr_28_31(4)_1605-1612.nxml.txt.nlp	24481648	SENT144	11	11	13	13	ponatinib	MRP7	PA165980594	89845;1080	0.911
NULL	Biomed_Res_Int_2014_Aug_7_2014_621437.nxml.txt.nlp	25170513	SENT167	2	2	10	10	pioglitazone	adiponectin	PA450970	9370	0.911
NULL	Acta_Histochem_Cytochem_2006_Dec_28_39(6)_163-172.nxml.txt.nlp	17327903	SENT173	8	8	5	5	sevoflurane	ERK	PA451341	5594	0.911
NULL	Mol_Cancer_2007_Oct_11_6_63.nxml.txt.nlp	17931419	SENT130	11	11	2	2	cetuximab	HIF-1	PA10040	29072	0.911
NULL	AIDS_Res_Ther_2014_Aug_4_11_25.nxml.txt.nlp	25120580	SENT59	11	11	4	4	voriconazole	CYP3A4	PA10233	1576	0.911
NULL	Oncotarget_2014_Jun_3_5(13)_4920-4928.nxml.txt.nlp	24952482	SENT22	4	4	28	28	geldanamycin	Hsp90	PA152031327	3320	0.911
NULL	Nanoscale_Res_Lett_2011_Feb_24_6(1)_169.nxml.txt.nlp	21711685	SENT129	13	13	1	1	l-methionine	zeta	PA450423	9907	0.911
NULL	Braz_J_Med_Biol_Res_2014_Sep_5_47(11)_929-939.nxml.txt.nlp	25296354	SENT106	10	10	23	23	erlotinib	EGFR	PA134687924	1956	0.911
NULL	Cell_Death_Dis_2014_Feb_27_5(2)_e1088.nxml.txt.nlp	24577086	SENT208	20	20	14	14	metformin	Bcl-2	PA450395	596	0.911
NULL	Int_Clin_Psychopharmacol_2014_Mar_31_29(2)_86-92.nxml.txt.nlp	24247740	SENT23	0	0	6	6	vilazodone	5-HT1A	PA165958365	3350	0.911
NULL	Clinics_(Sao_Paulo)_2013_Jun_68(6)_766-771.nxml.txt.nlp	23778483	SENT24	6	6	10	10	hydroxychloroquine	IL-17	PA164777036	3605	0.911
NULL	J_Hematol_Oncol_2012_Feb_2_5_2.nxml.txt.nlp	22300941	SENT147	28	28	12	12	etoposide	MPN	PA449552	83886	0.911
NULL	Breast_Cancer_Res_2011_Jun_21_13(3)_R66.nxml.txt.nlp	21693010	SENT123	18	18	12	12	sunitinib	c-Raf	PA162372840	5894	0.911
NULL	J_Oncol_2013_Apr_29_2013_854121.nxml.txt.nlp	23737784	SENT118	12	12	3	3	trastuzumab	PTEN	PA451743	5728	0.911
NULL	Breast_Cancer_Res_2012_Jun_14_14(3)_R95.nxml.txt.nlp	22697792	SENT460	27	27	19	19	letrozole	aromatase	PA450196	1588	0.911
NULL	Oncotarget_2013_Aug_30_4(10)_1698-1711.nxml.txt.nlp	24091605	SENT183	19	19	7	7	gefitinib	CD44	PA131301952	960	0.911
NULL	Br_J_Pharmacol_2008_Sep_9_155(1)_127-137.nxml.txt.nlp	18536750	SENT310	9	9	4	4	piroxicam	IL-10	PA450985	3586	0.911
NULL	Am_J_Case_Rep_2014_Feb_24_15_85-89.nxml.txt.nlp	24587856	SENT87	3	3	12	12	exemestane	aromatase	PA449563	1588	0.911
NULL	Arthritis_Res_2002_Mar_27_4(Suppl_2)_S22-S28.nxml.txt.nlp	12110154	SENT78	11	11	23	23	infliximab	CD68	PA452639	968	0.911
NULL	Breast_Cancer_Res_2007_Aug_8_9(4)_R50.nxml.txt.nlp	17686159	SENT202	4	4	13	13	gefitinib	AKT	PA131301952	207	0.911
NULL	Alcohol_Res_Health_2010_33(1-2)_64-75.nxml.txt.nlp	23579937	SENT263	19	19	2	2	ethanol	ALDH2	PA448073	217	0.911
NULL	Cancer_Res_Treat_2011_Jun_30_43(2)_89-95.nxml.txt.nlp	21811424	SENT50	9	9	12	12	goserelin	aromatase	PA164747674	1588	0.911
NULL	Crit_Care_2013_Mar_19_17(Suppl_2)_P448.nxml.txt.nlp	NULL	SENT17	4	4	21	21	estradiol	aromatase	PA449503	1588	0.911
NULL	Adolesc_Health_Med_Ther_2012_Jun_20_3_85-93.nxml.txt.nlp	24600289	SENT65	18	18	1	1	adalimumab	ACR	PA10004	49	0.911
NULL	Hum_Mol_Genet_2010_Aug_15_19(16)_3254-3265.nxml.txt.nlp	20538880	SENT137	16	16	3	3	etoposide	HSPB8	PA449552	26353	0.911
NULL	Iran_J_Pharm_Res_2014_Summer_13(3)_919-926.nxml.txt.nlp	25276192	SENT108	20	20	10	10	doxorubicin	Bcl-2	PA449412	596	0.911
NULL	Curr_Med_Chem_2011_Jun_18(18)_2686-2714.nxml.txt.nlp	21649578	SENT214	31	31	44	44	gefitinib	EGFR	PA131301952	1956	0.911
NULL	Med_Sci_Monit_2013_Sep_9_19_751-756.nxml.txt.nlp	24019010	SENT20	41	41	19	19	entecavir	LAM	PA164784025	7249;7248	0.911
NULL	Indian_J_Psychol_Med_2013_Jul-Sep_35(3)_290-298.nxml.txt.nlp	24249933	SENT5	0	0	7	7	buspirone	5-HT1A	PA448689	3350	0.911
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_May_28_67(Pt_6)_m813-m814.nxml.txt.nlp	21754686	SENT3	38	38	20	20	phenol	NO3	PA450913	4681	0.911
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1196-1204.nxml.txt.nlp	22315058	SENT141	44	44	30	30	gefitinib	EGFR	PA131301952	1956	0.911
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT63	15	15	1	1	paraformaldehyde	AKT	PA450790	207	0.911
NULL	Arthritis_Res_Ther_2012_Sep_24_14(5)_R200.nxml.txt.nlp	23006144	SENT158	6	6	16	16	alefacept	IL-20	PA164748040	27190;50604	0.911
NULL	Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.nxml.txt.nlp	24736980	SENT181	26	26	5	5	rosuvastatin	OATP1B1	PA134308647	10599	0.911
NULL	Neuropsychopharmacology_2009_Apr_2_34(5)_1135-1148.nxml.txt.nlp	18596687	SENT7	3	3	13	13	betaxolol	CRF	PA448611	1392;10882	0.911
NULL	Mol_Cancer_2009_Nov_24_8_109.nxml.txt.nlp	19930708	SENT126	27	27	7	7	exemestane	EGFR	PA449563	1956	0.911
NULL	Breast_Cancer_Res_2011_Mar_1_13(2)_R21.nxml.txt.nlp	21362200	SENT21	10	10	6	6	fulvestrant	PI3K	PA164747170	5290	0.911
NULL	Aquat_Biosyst_2012_Apr_17_8_9.nxml.txt.nlp	22510370	SENT5	11	11	2	2	nadh	PHB	PA164755085	5245	0.91
NULL	Cell_Death_Dis_2014_Mar_13_5(3)_e1118.nxml.txt.nlp	24625977	SENT80	40	40	31	31	etoposide	p53	PA449552	7157	0.91
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT263	3	3	12	12	tacrolimus	JAK2	PA451578	3717	0.91
NULL	Arthritis_Res_Ther_2013_Sep_10_15(5)_R110.nxml.txt.nlp	24020899	SENT152	13	13	3	3	pioglitazone	IL-6	PA450970	3569	0.91
NULL	Acta_Pharmacol_Sin_2014_Jun_4_35(6)_792-805.nxml.txt.nlp	24902787	SENT288	13	13	6	6	paroxetine	STZ	PA450801	6484	0.91
NULL	Mol_Cancer_2009_Aug_25_8_66.nxml.txt.nlp	19706164	SENT61	25	25	2	2	celecoxib	p53	PA448871	7157	0.91
NULL	Br_J_Cancer_2003_Mar_24_88(6)_822-827.nxml.txt.nlp	12644816	SENT34	27	27	3	3	thalidomide	PSA	PA451644	29968;9520;354	0.91
NULL	J_Cell_Biol_2002_May_28_157(5)_761-770.nxml.txt.nlp	12034770	SENT329	37	37	20	20	doxycycline	TFF1	PA449415	7031	0.91
NULL	Int_J_Endocrinol_2011_Aug_21_2011_742719.nxml.txt.nlp	21869886	SENT128	41	41	33	33	clopidogrel	CYP2C9	PA449053	1559	0.91
NULL	Hum_Mol_Genet_2013_Nov_15_22(22)_4602-4615.nxml.txt.nlp	23814040	SENT141	5	5	10	10	l-cysteine	TRMU	PA449173	55687	0.91
NULL	Target_Oncol_2013_Jun_27_8(2)_127-136.nxml.txt.nlp	23625191	SENT50	27	27	2	2	panitumumab	KRAS	PA162373091	3845	0.91
NULL	Cancer_Cell_Int_2011_Aug_19_11_29.nxml.txt.nlp	21854619	SENT12	16	16	27	27	cisplatin	BRCA1	PA449014	672	0.91
NULL	Ann_Surg_Treat_Res_2014_Feb_22_86(2)_68-75.nxml.txt.nlp	24761411	SENT171	15	15	19	19	oxaliplatin	survivin	PA131285527	332	0.91
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Mar_27_66(Pt_4)_o923.nxml.txt.nlp	21580733	SENT54	19	19	13	13	ethanol	mol	PA448073	90527	0.91
NULL	Br_J_Cancer_2010_Jun_8_102(12)_1699-1706.nxml.txt.nlp	20485286	SENT160	3	3	25	25	ifosfamide	CYP3A	PA449964	1574	0.91
NULL	Hum_Genomics_2009_Dec_1_4(2)_91-106.nxml.txt.nlp	20038497	SENT120	18	18	33	33	rivastigmine	CYP2D6	PA451262	1565	0.91
NULL	Arthritis_Res_Ther_2009_Nov_24_11(6)_134.nxml.txt.nlp	20017888	SENT4	30	30	13	13	rituximab	CD27	PA451261	939	0.91
NULL	J_Hematol_Oncol_2009_Jan_21_2_2.nxml.txt.nlp	19159467	SENT57	39	39	31	31	gefitinib	EGFR	PA131301952	1956	0.91
NULL	Cancer_Immunol_Immunother_2014_Jul_24_63(9)_985-989.nxml.txt.nlp	25056819	SENT48	42	42	27	27	cyclophosphamide	APOA1	PA449165	335	0.91
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Dec_17_3(12)_e152.nxml.txt.nlp	25518025	SENT41	16	16	13	13	paroxetine	CYP2D6	PA450801	1565	0.91
NULL	Biochem_Res_Int_2012_Jul_1_2012_832059.nxml.txt.nlp	22811914	SENT229	7	7	13	13	doxorubicin	PC3	PA449412	57332;7832;5122	0.91
NULL	Arch_Med_Sci_2013_Oct_31_9(5)_936-943.nxml.txt.nlp	24273582	SENT103	3	3	42	42	nateglinide	GLP-1	PA450600	100125288	0.91
NULL	J_Org_Chem_2011_Aug_19_76(16)_6703-6714.nxml.txt.nlp	21739961	SENT256	13	13	7	7	ethanol	mol	PA448073	90527	0.91
NULL	ScientificWorldJournal_2014_May_19_2014_567148.nxml.txt.nlp	24971383	SENT133	23	23	7	7	epirubicin	Bcl-2	PA449476	596	0.91
NULL	Oncologist_2010_Feb_15_15(2)_122-129.nxml.txt.nlp	20156908	SENT36	22	22	10	10	letrozole	HER-2	PA450196	2064	0.91
NULL	J_Cardiothorac_Surg_2010_Jan_11_5_1.nxml.txt.nlp	20064238	SENT101	4	4	9	9	methylprednisolone	CD11b	PA450466	3684	0.91
NULL	Cancer_Manag_Res_2012_Nov_9_4_383-395.nxml.txt.nlp	23204869	SENT109	4	4	0	0	carmustine	PC-3	PA448810	692094	0.91
NULL	J_Gynecol_Oncol_2013_Jul_4_24(3)_265-272.nxml.txt.nlp	23875077	SENT176	19	19	5	5	thrombin	SMAD2	PA451674	4087	0.91
NULL	Oncotarget_2013_Dec_15_4(12)_2577-2590.nxml.txt.nlp	24342878	SENT108	4	4	7	7	auranofin	AKT	PA448510	207	0.91
NULL	Arthritis_Res_Ther_2009_Aug_17_11(4)_R123.nxml.txt.nlp	19686595	SENT169	21	21	3	3	rituximab	CD38	PA451261	952	0.91
NULL	Biologics_2010_Nov_9_4_289-298.nxml.txt.nlp	21116327	SENT29	38	38	24	24	panitumumab	EGFR	PA162373091	1956	0.91
NULL	J_Breast_Cancer_2011_Mar_31_14(1)_46-51.nxml.txt.nlp	21847394	SENT113	19	19	36	36	trastuzumab	HER2	PA451743	2064	0.91
NULL	Case_Rep_Transplant_2011_Jan_5_2011_210178.nxml.txt.nlp	23213600	SENT10	17	17	2	2	tacrolimus	CYP2C19	PA451578	1557	0.91
NULL	Mol_Cancer_2010_Aug_20_9_220.nxml.txt.nlp	20727180	SENT33	12	12	15	15	nicotine	p53	PA450626	7157	0.91
NULL	Ann_Intensive_Care_2011_Dec_30_1_53.nxml.txt.nlp	22208725	SENT132	12	12	23	23	potassium	ARF	PA451047	1029	0.91
NULL	Cardiol_Res_Pract_2013_Jan_31_2013_128795.nxml.txt.nlp	23431496	SENT109	24	24	8	8	clopidogrel	CYP2C19	PA449053	1557	0.91
NULL	Mar_Drugs_2014_Jun_27_12(7)_3818-3837.nxml.txt.nlp	24979269	SENT66	38	38	31	31	doxorubicin	P-gp	PA449412	5243	0.91
NULL	Br_J_Cancer_2011_Dec_6_105(12)_1885-1893.nxml.txt.nlp	22068819	SENT51	30	30	15	15	trypsin	CO2	PA451806	4513	0.91
NULL	Emerg_Infect_Dis_2007_Jul_13(7)_1001-1007.nxml.txt.nlp	18214171	SENT41	17	17	8	8	lamivudine	CD4	PA450163	920	0.91
NULL	Nat_Neurosci_2013_Aug_7_16(8)_1101-1110.nxml.txt.nlp	23831965	SENT234	28	28	2	2	neomycin	GluN2B	PA450608	2904	0.91
NULL	Mol_Cancer_2008_Jan_25_7_14.nxml.txt.nlp	18221502	SENT221	6	6	14	14	oxaliplatin	PSAT1	PA131285527	29968	0.91
NULL	Oncotarget_2014_Oct_21_5(22)_11709-11722.nxml.txt.nlp	25365944	SENT95	8	8	12	12	metformin	AKT	PA450395	207	0.91
NULL	ScientificWorldJournal_2012_Jun_18_2012_564939.nxml.txt.nlp	22778699	SENT6	0	0	32	32	tramadol	IL-6	PA451735	3569	0.91
NULL	Clin_Drug_Investig_2014_Nov_9_34(2)_107-115.nxml.txt.nlp	24214232	SENT10	17	17	4	4	cinacalcet	IMPACT	PA164776671	55364	0.91
NULL	EMBO_Mol_Med_2012_Oct_30_4(10)_1087-1096.nxml.txt.nlp	22933245	SENT111	26	26	1	1	olaparib	PARP1		142	0.91
NULL	Int_J_Mol_Sci_2014_Oct_6_15(10)_17886-17900.nxml.txt.nlp	25290095	SENT160	39	39	27	27	resveratrol	SIRT1		23411	0.91
NULL	Br_J_Cancer_2011_Jul_12_105(2)_246-254.nxml.txt.nlp	21712828	SENT31	6	6	1	1	cetuximab	EGFR	PA10040	1956	0.91
NULL	Eur_J_Clin_Pharmacol_2012_Sep_15_68(9)_1267-1274.nxml.txt.nlp	22418828	SENT203	13	13	3	3	pantoprazole	CYP2C19	PA450774	1557	0.91
NULL	J_Gastrointest_Surg_2012_Apr_13_16(4)_842-848.nxml.txt.nlp	22246855	SENT94	22	22	6	6	lapatinib	EGFR	PA152241907	1956	0.91
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT260	6	6	10	10	lapatinib	ADAM17	PA152241907	6868	0.91
NULL	Leukemia_2013_Jan_11_27(1)_32-40.nxml.txt.nlp	22781593	SENT208	11	11	38	38	ponatinib	CD34	PA165980594	947	0.91
NULL	Iran_J_Pharm_Res_2014_Spring_13(2)_635-639.nxml.txt.nlp	25237359	SENT20	11	11	42	42	tolbutamide	BUP	PA451718	23412	0.91
NULL	Iran_J_Pediatr_2011_Dec_21(4)_441-448.nxml.txt.nlp	23056829	SENT139	27	27	38	38	ampicillin	Dakar	PA448419	22900	0.91
NULL	Int_J_Nanomedicine_2012_Sep_13_7_4917-4926.nxml.txt.nlp	23028220	SENT212	2	2	17	17	calcein	mol	PA132595336	90527	0.91
NULL	Diabetes_Care_2009_Sep_15_32(9)_1656-1662.nxml.txt.nlp	19528367	SENT50	8	8	40	40	metformin	U100	PA450395	692149	0.91
NULL	J_Skin_Cancer_2012_Dec_13_2012_147863.nxml.txt.nlp	23316365	SENT35	22	22	41	41	curcumin	MTOR	PA151958596	2475	0.91
NULL	J_Med_Case_Reports_2011_Oct_5_5_504.nxml.txt.nlp	21975443	SENT24	17	17	23	23	imatinib	KIT	PA10804	3815	0.91
NULL	Chonnam_Med_J_2013_Apr_25_49(1)_31-37.nxml.txt.nlp	23678475	SENT90	12	12	23	23	rosuvastatin	adiponectin	PA134308647	9370	0.91
NULL	Br_J_Cancer_2011_Dec_6_105(12)_1920-1926.nxml.txt.nlp	22095222	SENT7	27	27	8	8	gefitinib	PIK3CA	PA131301952	5290	0.91
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Dec_10_65(Pt_1)_o74.nxml.txt.nlp	21581713	SENT60	25	25	19	19	ethanol	mol	PA448073	90527	0.91
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1224-1233.nxml.txt.nlp	22353810	SENT199	10	10	6	6	vincristine	MRP-1	PA451879	928	0.91
NULL	Daru_2011_19(4)_306-311.nxml.txt.nlp	22615674	SENT27	0	0	36	36	pentoxifylline	IL-8	PA450864	3576	0.91
NULL	Int_J_Biol_Sci_2012_Mar_7_8(4)_470-485.nxml.txt.nlp	22419892	SENT349	23	23	8	8	tamoxifen	SRC-3	PA451581	8202	0.91
NULL	Lipids_Health_Dis_2011_Jan_18_10_8.nxml.txt.nlp	21241519	SENT146	7	7	10	10	simvastatin	SR-BI	PA451363	949	0.91
NULL	Oncol_Lett_2014_Oct_9_8(4)_1551-1556.nxml.txt.nlp	25202366	SENT99	14	14	8	8	rituximab	PLB	PA451261	151056	0.91
NULL	Int_J_Biol_Sci_2013_Nov_21_9(10)_1089-1098.nxml.txt.nlp	24339730	SENT22	31	31	25	25	genistein	RUNX2	PA165109660	860	0.91
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT703	18	18	4	4	tamoxifen	CD44	PA451581	960	0.91
NULL	Diabetes_Metab_J_2014_Dec_15_38(6)_416-425.nxml.txt.nlp	25541604	SENT99	24	24	16	16	ranibizumab	CRT	PA164746012	811	0.91
NULL	J_Cell_Biol_2008_Jul_14_182(1)_197-213.nxml.txt.nlp	18625847	SENT340	21	21	7	7	nutlin-3	BRCA1		672	0.91
NULL	Virulence_2013_May_15_4(4)_335-343.nxml.txt.nlp	NULL	SENT126	6	6	1	1	arsenite	AQP9	PA452638	366;364	0.91
NULL	CNS_Spectr_2014_Apr_1_19(2)_121-133.nxml.txt.nlp	23903233	SENT22	14	14	8	8	pindolol	5-HT1A	PA450966	3350	0.91
NULL	Mol_Cancer_2014_Jul_5_13_165.nxml.txt.nlp	24996221	SENT104	22	22	5	5	docetaxel	HMGB1	PA449383	3146	0.91
NULL	Clin_Med_Insights_Womens_Health_2013_Jan_22_6_1-11.nxml.txt.nlp	24665209	SENT43	9	9	5	5	letrozole	aromatase	PA450196	1588	0.91
NULL	Summit_on_Translat_Bioinforma_2010_Mar_1_2010_71-75.nxml.txt.nlp	21347153	SENT102	4	4	23	23	tacrolimus	WIZ	PA451578	58525	0.91
NULL	Cancers_(Basel)_2014_Nov_25_6(4)_2313-2329.nxml.txt.nlp	25534569	SENT29	13	13	8	8	cabozantinib	Met	PA165906891	79811	0.91
NULL	Saudi_J_Anaesth_2013_Jul-Sep_7(3)_301-304.nxml.txt.nlp	24015134	SENT49	10	10	2	2	heparin	ACT	PA449855	12;11332;9457;641455	0.91
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Mar_26_67(Pt_4)_m487.nxml.txt.nlp	21753998	SENT78	17	17	2	2	ethanol	NO3	PA448073	4681	0.91
NULL	Br_J_Cancer_2013_Aug_6_109(3)_686-693.nxml.txt.nlp	23839492	SENT77	34	34	2	2	everolimus	ANOVA	PA164746311	4858	0.91
NULL	Arthritis_Res_Ther_2013_Aug_30_15(4)_R100.nxml.txt.nlp	24000795	SENT140	29	29	4	4	methotrexate	CD22	PA450428	933	0.91
NULL	J_Skin_Cancer_2014_Jul_21_2014_284582.nxml.txt.nlp	25136458	SENT86	11	11	23	23	cisplatin	CRT	PA449014	811	0.91
NULL	Breast_Cancer_Res_2010_Jul_19_12(4)_R51.nxml.txt.nlp	20642837	SENT77	25	25	13	13	hydrocortisone	EGF	PA449905	1950	0.91
NULL	Oncol_Rep_2014_Jul_13_32(1)_419-424.nxml.txt.nlp	24841903	SENT29	27	27	20	20	itraconazole	HIF1	PA450132	3091	0.91
NULL	Nucleic_Acids_Res_2013_Dec_21_41(22)_10283-10297.nxml.txt.nlp	24005041	SENT38	27	27	13	13	camptothecin	RAD51	PA153590860	5888	0.91
NULL	Br_J_Cancer_2004_Mar_5_90(Suppl_1)_S7-S10.nxml.txt.nlp	15094758	SENT93	21	21	2	2	fulvestrant	CYP3A4	PA164747170	1576	0.91
NULL	Toxins_(Basel)_2010_Jun_9_2(6)_1381-1398.nxml.txt.nlp	22069643	SENT106	20	20	4	4	zidovudine	OAT2	PA451954	10864	0.91
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Mar_17_66(Pt_4)_o864-o865.nxml.txt.nlp	21580687	SENT73	36	36	18	18	ethanol	mol	PA448073	90527	0.91
NULL	Breast_Cancer_Res_2006_Nov_6_8(6)_215.nxml.txt.nlp	17096862	SENT175	16	16	34	34	trastuzumab	HER2	PA451743	2064	0.91
NULL	Biomed_Res_Int_2014_May_11_2014_942960.nxml.txt.nlp	24901002	SENT93	6	6	32	32	nadh	Q10	PA164755085	27161	0.91
NULL	Hum_Genomics_2013_Oct_30_7(1)_22.nxml.txt.nlp	24172014	SENT202	17	17	7	7	heparin	SERPIND1	PA449855	3053	0.91
NULL	Br_J_Cancer_1980_Nov_42(5)_712-721.nxml.txt.nlp	6257267	SENT12	26	26	17	17	collagenase	alpha-chain	PA449107	2217	0.91
NULL	Br_J_Pharmacol_2012_Apr_165(8)_2611-2619.nxml.txt.nlp	21718301	SENT58	17	17	37	37	rimonabant	GPR55	PA152407999	9290	0.91
NULL	J_Cell_Mol_Med_2014_May_14_18(5)_811-823.nxml.txt.nlp	24628949	SENT264	9	9	3	3	docetaxel	FOXM1	PA449383	2305	0.91
NULL	Front_Chem_2013_Jul_12_1_10.nxml.txt.nlp	24790939	SENT12	32	32	37	37	hydroquinone	mol	PA449924	90527	0.91
NULL	Arthritis_Res_Ther_2012_Jan_8_14(1)_R6.nxml.txt.nlp	22225620	SENT196	31	31	17	17	rituximab	CXCL13	PA451261	10563	0.91
NULL	Int_J_Mol_Sci_2014_Oct_27_15(11)_19444-19457.nxml.txt.nlp	25350110	SENT162	21	21	2	2	isoflurane	EAAC1	PA450106	6505	0.91
NULL	Mol_Cancer_2012_Sep_21_11_72.nxml.txt.nlp	22995644	SENT58	7	7	2	2	imatinib	PRL-3	PA10804	11156	0.91
NULL	Drugs_R_D_2013_Mar_21_13(1)_29-36.nxml.txt.nlp	23322527	SENT189	8	8	1	1	risperidone	CYP2D6	PA451257	1565	0.91
NULL	Breast_Cancer_Res_2007_Jul_5_9(4)_R41.nxml.txt.nlp	17612393	SENT183	24	24	11	11	celecoxib	Bcl-2	PA448871	596	0.91
NULL	Nat_Commun_2010_Nov_30_1_130.nxml.txt.nlp	21119643	SENT52	11	11	20	20	fenofibrate	PS1	PA449594	5663	0.91
NULL	Int_J_Breast_Cancer_2011_Jul_12_2011_232435.nxml.txt.nlp	22295213	SENT107	17	17	21	21	tamoxifen	CDK7	PA451581	1022	0.91
NULL	Breast_Cancer_Res_2003_Feb_5_5(2)_113-116.nxml.txt.nlp	12631392	SENT52	7	7	4	4	tamoxifen	aromatase	PA451581	1588	0.91
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1196-1204.nxml.txt.nlp	22315058	SENT146	36	36	14	14	gefitinib	HER2	PA131301952	2064	0.91
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT272	8	8	19	19	lapatinib	EGF	PA152241907	1950	0.91
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_29_2013_590393.nxml.txt.nlp	23737838	SENT189	26	26	18	18	resveratrol	p53		7157	0.91
NULL	Braz_J_Med_Biol_Res_2014_Sep_5_47(11)_929-939.nxml.txt.nlp	25296354	SENT85	32	32	16	16	erlotinib	EGFR	PA134687924	1956	0.91
NULL	Insights_Imaging_2013_Sep_10_4(5)_701-709.nxml.txt.nlp	24018755	SENT171	3	3	7	7	vemurafenib	BRAF	PA165946873	673	0.91
NULL	Cell_Cycle_2013_Dec_15_12(24)_3759-3769.nxml.txt.nlp	24107633	SENT66	31	31	9	9	metformin	HER2	PA450395	2064	0.91
NULL	Biologics_2011_Aug_9_5_87-94.nxml.txt.nlp	21847344	SENT75	42	42	11	11	docetaxel	San	PA449383	80218	0.91
NULL	Acta_Pharmacol_Sin_2014_Jun_5_35(6)_727-737.nxml.txt.nlp	24793312	SENT196	10	10	24	24	telmisartan	B27	PA451605	56246	0.91
NULL	Clin_Cosmet_Investig_Dermatol_2011_Jul_1_4_93-99.nxml.txt.nlp	21760744	SENT99	9	9	5	5	etanercept	IL-22	PA449515	50616;53342	0.91
NULL	Cancer_Cell_2015_Jan_12_27(1)_72-84.nxml.txt.nlp	25533335	SENT164	13	13	3	3	tamoxifen	p53	PA451581	7157	0.91
NULL	Oncogenesis_2012_Apr_16_1(4)_e7.nxml.txt.nlp	23552604	SENT37	16	16	4	4	etoposide	BTG2	PA449552	7832	0.91
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_650809.nxml.txt.nlp	23258995	SENT170	0	0	8	8	vasopressin	AQP3	PA451858	360	0.91
NULL	Aging_(Albany_NY)_2011_Jan_18_3(1)_33-43.nxml.txt.nlp	21248371	SENT120	4	4	13	13	zinc	p53	PA451956	7157	0.91
NULL	Gut_Pathog_2011_Sep_25_3_14.nxml.txt.nlp	21943280	SENT152	20	20	3	3	tetracycline	IL-4	PA451640	3565	0.91
NULL	BMJ_2011_Aug_4_343_d4588.nxml.txt.nlp	21816733	SENT464	12	12	4	4	clopidogrel	CYP2C19	PA449053	1557	0.91
NULL	Cardiol_Res_Pract_2013_Feb_19_2013_195456.nxml.txt.nlp	23533940	SENT66	1	1	18	18	clopidogrel	CYP3A4	PA449053	1576	0.91
NULL	Diabetes_2013_Sep_15_62(9)_3033-3043.nxml.txt.nlp	23649519	SENT349	23	23	15	15	metformin	STZ	PA450395	6484	0.91
NULL	Clin_Med_Insights_Oncol_2011_Mar_16_5_35-43.nxml.txt.nlp	21499557	SENT46	25	25	3	3	doxorubicin	p53	PA449412	7157	0.91
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1018.nxml.txt.nlp	24457962	SENT162	0	0	6	6	bevacizumab	VEGFR	PA130232992	3791	0.91
NULL	Ann_Gen_Psychiatry_2013_Jan_24_12_1.nxml.txt.nlp	23347694	SENT384	30	30	20	20	ketoconazole	CYP3A4	PA450146	1576	0.91
NULL	Biologics_2009_Sep_15_3_419-428.nxml.txt.nlp	19774209	SENT155	26	26	6	6	gefitinib	PTEN	PA131301952	5728	0.91
NULL	Oncotarget_2011_Sep_9_2(9)_658-668.nxml.txt.nlp	21911919	SENT74	7	7	1	1	cytarabine	HO-1	PA449177	3162	0.91
NULL	Ayu_2012_Apr-Jun_33(2)_307-310.nxml.txt.nlp	23559810	SENT94	9	9	16	16	diclofenac	COX	PA449293	1351	0.91
NULL	Breast_Cancer_Res_2011_Nov_30_13(6)_221.nxml.txt.nlp	22217398	SENT123	13	13	35	35	fulvestrant	San	PA164747170	80218	0.91
NULL	Br_J_Cancer_2011_May_24_104(11)_1786-1790.nxml.txt.nlp	21559018	SENT108	15	15	24	24	irinotecan	EGFR	PA450085	1956	0.91
NULL	J_Neuroinflammation_2011_Feb_4_8_10.nxml.txt.nlp	21294877	SENT117	0	0	7	7	capsaicin	NK1	PA448776	11126	0.91
NULL	J_Antimicrob_Chemother_2009_Nov_18_64(5)_910-928.nxml.txt.nlp	19767318	SENT233	0	0	26	26	efavirenz	CYP3A4	PA449441	1576	0.91
NULL	Protein_Cell_2014_Jun_19_5(6)_469-479.nxml.txt.nlp	24748116	SENT101	21	21	14	14	paclitaxel	EB1	PA450761	9167;22919;10982	0.91
NULL	Cancer_Cell_Int_2008_Jan_4_8_1.nxml.txt.nlp	18177496	SENT88	8	8	16	16	gefitinib	EGFR	PA131301952	1956	0.91
NULL	Breast_Cancer_Res_2005_Jul_27_7(5)_R753-R764.nxml.txt.nlp	16168121	SENT188	17	17	12	12	tamoxifen	HER2	PA451581	2064	0.91
NULL	Indian_J_Pharmacol_2014_Jan-Feb_46(1)_3-12.nxml.txt.nlp	24550577	SENT221	23	23	7	7	modafinil	CYP3A4	PA450530	1576	0.91
NULL	J_Cancer_2011_May_1_2_232-261.nxml.txt.nlp	21552384	SENT119	35	35	24	24	celecoxib	aromatase	PA448871	1588	0.91
NULL	Mol_Cancer_2014_Jan_13_13_7.nxml.txt.nlp	24418169	SENT11	2	2	27	27	sorafenib	SHP-1	PA7000	5777	0.91
NULL	Exp_Diabetes_Res_2011_Dec_27_2011_604989.nxml.txt.nlp	21253359	SENT187	38	38	14	14	clonidine	GLP-1	PA449051	100125288	0.91
NULL	Breast_Cancer_Res_2010_Jun_24_12(3)_R41.nxml.txt.nlp	20576088	SENT137	16	16	0	0	paclitaxel	EGFR	PA450761	1956	0.91
NULL	Mol_Pain_2013_Feb_15_9_3.nxml.txt.nlp	23413875	SENT11	8	8	13	13	resveratrol	TRPA1		8989	0.91
NULL	Chem_Cent_J_2012_May_30_6_50.nxml.txt.nlp	22647291	SENT178	24	24	19	19	ethanol	mol	PA448073	90527	0.91
NULL	J_Hematol_Oncol_2011_Mar_9_4_9.nxml.txt.nlp	21388537	SENT55	11	11	5	5	rifampin	UGT1A1	PA451250	54658	0.91
NULL	Acta_Neuropathol_Commun_2013_Aug_9_1_49.nxml.txt.nlp	24252504	SENT186	22	22	18	18	arsenite	TDP-43	PA452638	23435	0.91
NULL	Int_J_Mol_Sci_2013_Apr_9_14(4)_7716-7741.nxml.txt.nlp	23571495	SENT147	29	29	11	11	lipase	mol	PA450239	90527	0.91
NULL	Environ_Health_Perspect_2008_Mar_26_116(3)_322-328.nxml.txt.nlp	18335098	SENT187	19	19	26	26	estradiol	FES	PA449503	2242	0.91
NULL	Oncol_Lett_2013_Feb_7_5(2)_440-446.nxml.txt.nlp	23420122	SENT166	19	19	8	8	sorafenib	EGFR	PA7000	1956	0.91
NULL	J_Korean_Med_Sci_2013_Jul_3_28(7)_1005-1014.nxml.txt.nlp	23853482	SENT143	11	11	6	6	erlotinib	EGFR	PA134687924	1956	0.91
NULL	Pharmaceutics_2011_Oct_12_3(4)_680-705.nxml.txt.nlp	24309303	SENT53	3	3	24	24	cyclosporine	CYP3A4	PA449167	1576	0.91
NULL	Clin_Sci_(Lond)_2013_Feb_1_124(Pt_3)_153-164.nxml.txt.nlp	23075334	SENT114	24	24	27	27	resveratrol	SIRT1		23411	0.91
NULL	Cancers_(Basel)_2011_Sep_28_3(4)_3740-3761.nxml.txt.nlp	24213109	SENT198	0	0	27	27	trabectedin	CXCL8	PA165958349	3576	0.91
NULL	J_Epilepsy_Res_2014_Jun_30_4(1)_7-13.nxml.txt.nlp	24977124	SENT64	26	26	18	18	pilocarpine	CA3	PA450962	761	0.91
NULL	Indian_J_Pharmacol_2008_Oct_40(Suppl_2)_S97-S112.nxml.txt.nlp	21593984	SENT465	5	5	21	21	benazepril	STZ	PA448561	6484	0.91
NULL	Mol_Cancer_2010_Aug_20_9_220.nxml.txt.nlp	20727180	SENT123	15	15	13	13	nicotine	AP-1	PA450626	2353;3727;2354;3725	0.91
NULL	Front_Microbiol_2014_Oct_8_5_513.nxml.txt.nlp	25339943	SENT176	6	6	34	34	ceftriaxone	MAFF	PA448866	23764	0.91
NULL	J_Oncol_2011_Apr_14_2011_853931.nxml.txt.nlp	21559248	SENT30	14	14	17	17	bevacizumab	EGFR	PA130232992	1956	0.91
NULL	ARYA_Atheroscler_2011_Summer_7(2)_78-86.nxml.txt.nlp	22577451	SENT11	26	26	40	40	choline	TNF	PA448976	7124	0.91
NULL	J_Invest_Dermatol_2013_Jun_14_133(6)_1541-1549.nxml.txt.nlp	23407395	SENT194	22	22	6	6	imiquimod	CCL2	PA449972	6347	0.91
NULL	Vet_Res_Forum_2013_Winter_4(1)_19-24.nxml.txt.nlp	25593681	SENT42	21	21	14	14	diclofenac	B12	PA449293	7126;4709	0.91
NULL	Br_J_Cancer_2011_May_24_104(11)_1686-1690.nxml.txt.nlp	21540861	SENT41	9	9	5	5	sunitinib	KDR	PA162372840	3791	0.91
NULL	Front_Genet_2014_Nov_4_5_383.nxml.txt.nlp	25408701	SENT53	18	18	2	2	cisplatin	NRF2	PA449014	2551;4780	0.91
NULL	Cells_2012_Aug_21_1(3)_535-557.nxml.txt.nlp	24710489	SENT1206	6	6	2	2	irinotecan	p38	PA450085	10598;1432;7965	0.91
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_13_2013_468537.nxml.txt.nlp	23956772	SENT141	0	0	27	27	doxorubicin	PUMA	PA449412	27113	0.91
NULL	Ecancermedicalscience_2009_Oct_29_3_157.nxml.txt.nlp	22276018	SENT67	5	5	28	28	tamoxifen	HER2	PA451581	2064	0.91
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_P103.nxml.txt.nlp	NULL	SENT16	36	36	12	12	amoxicillin	PPL	PA448406	5493	0.91
NULL	Stroke_Res_Treat_2012_Feb_28_2012_904534.nxml.txt.nlp	22577603	SENT79	8	8	1	1	clopidogrel	CYP2C19	PA449053	1557	0.91
NULL	Br_J_Cancer_2010_Jan_5_102(1)_80-86.nxml.txt.nlp	19920817	SENT4	20	20	6	6	sunitinib	IFN	PA162372840	3439	0.91
NULL	Front_Pharmacol_2014_Nov_28_5_255.nxml.txt.nlp	25506327	SENT197	0	0	15	15	cinacalcet	PTH	PA164776671	5741	0.91
NULL	Theranostics_2014_Aug_15_4(11)_1072-1084.nxml.txt.nlp	25250092	SENT172	17	17	23	23	bevacizumab	EGFR	PA130232992	1956	0.91
NULL	Arthritis_Res_Ther_2006_Apr_13_8(3)_R69.nxml.txt.nlp	16613612	SENT197	27	27	45	45	methylprednisolone	S100A9	PA450466	6280	0.91
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT166	18	18	11	11	cisplatin	p53	PA449014	7157	0.91
NULL	Mol_Cancer_2012_Aug_8_11_53.nxml.txt.nlp	22871047	SENT239	18	18	7	7	paclitaxel	HIN-1	PA450761	92304	0.91
NULL	Curr_Neuropharmacol_2009_Dec_7(4)_276-285.nxml.txt.nlp	20514207	SENT60	3	3	12	12	guanidine	GDI1	PA164781028	2664	0.91
NULL	Br_J_Cancer_2010_Feb_16_102(4)_774-782.nxml.txt.nlp	20087350	SENT121	4	4	18	18	tetracycline	CLCN4	PA451640	1183	0.91
NULL	J_Biomed_Biotechnol_2004_Jun_30_2004(2)_113-120.nxml.txt.nlp	15240922	SENT172	26	26	11	11	thyroglobulin	SAGE	PA164754910	55511	0.91
NULL	Mol_Cancer_2009_Apr_22_8_26.nxml.txt.nlp	19386116	SENT152	3	3	8	8	ritonavir	AKT	PA451260	207	0.91
NULL	Diabetes_2009_Feb_58(2)_344-351.nxml.txt.nlp	19008341	SENT179	2	2	13	13	resveratrol	SIRT1		23411	0.91
NULL	Case_Rep_Oncol_2014_May_24_7(2)_343-348.nxml.txt.nlp	24987354	SENT27	9	9	17	17	vemurafenib	BRAF	PA165946873	673	0.91
NULL	Chem_Cent_J_2012_Jul_2_6_64.nxml.txt.nlp	22748424	SENT131	3	3	9	9	dapsone	mol	PA449211	90527	0.91
NULL	Alcohol_Res_Health_2007_30(1)_38-47.nxml.txt.nlp	17718399	SENT60	8	8	19	19	ethanol	ADH	PA448073	551	0.91
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Apr_4_68(Pt_5)_o1275.nxml.txt.nlp	22590190	SENT58	20	20	6	6	ethanol	mol	PA448073	90527	0.91
NULL	Acta_Pharmacol_Sin_2012_Oct_17_33(10)_1301-1310.nxml.txt.nlp	22983390	SENT187	37	37	17	17	cisplatin	migfilin	PA449014	54751	0.91
NULL	EPMA_J_2010_Sep_22_1(3)_377-387.nxml.txt.nlp	23199082	SENT314	19	19	15	15	panitumumab	KRAS	PA162373091	3845	0.91
NULL	Breast_Cancer_Res_2007_Mar_2_9(2)_205.nxml.txt.nlp	NULL	SENT26	39	39	31	31	erlotinib	HER-2	PA134687924	2064	0.91
NULL	Atten_Defic_Hyperact_Disord_2014_Jul_14_6(3)_175-202.nxml.txt.nlp	25017045	SENT308	26	26	13	13	citalopram	COMT	PA449015	1312	0.91
NULL	Oxid_Med_Cell_Longev_2013_Mar_5_2013_264935.nxml.txt.nlp	23533686	SENT5	9	9	19	19	hemin	HO-1	PA449849	3162	0.91
NULL	Clin_Exp_Metastasis_2013_May_15_30(7)_867-876.nxml.txt.nlp	23673558	SENT267	3	3	7	7	vemurafenib	BRAF	PA165946873	673	0.91
NULL	Mol_Cancer_2014_Jun_19_13_154.nxml.txt.nlp	24941944	SENT13	40	40	23	23	temozolomide	BRAF	PA451609	673	0.91
NULL	Patient_Prefer_Adherence_2013_Sep_11_7_891-895.nxml.txt.nlp	24049440	SENT52	16	16	39	39	nevirapine	ART	PA450616	181	0.91
NULL	Mol_Cancer_2010_Dec_7_9_311.nxml.txt.nlp	21138557	SENT160	4	4	17	17	etoposide	p53	PA449552	7157	0.91
NULL	Breast_Cancer_Res_2011_Oct_14_13(5)_316.nxml.txt.nlp	22017807	SENT12	35	35	2	2	tamoxifen	CDK10	PA451581	8558	0.91
NULL	Breast_Cancer_Res_2012_Apr_4_14(2)_R57.nxml.txt.nlp	22475046	SENT41	16	16	45	45	anastrozole	CCND1	PA448432	595	0.91
NULL	Oncotarget_2013_Dec_28_5(6)_1475-1490.nxml.txt.nlp	24721996	SENT7	4	4	10	10	celecoxib	CD44	PA448871	960	0.91
NULL	Nucleic_Acids_Res_2008_Feb_20_36(3)_998-1008.nxml.txt.nlp	18096616	SENT21	4	4	7	7	heparin	PKR	PA449855	5610	0.91
NULL	Front_Genet_2014_Aug_15_5_263.nxml.txt.nlp	25177341	SENT176	14	14	9	9	erlotinib	EGFR	PA134687924	1956	0.91
NULL	BMJ_2011_Aug_4_343_d4588.nxml.txt.nlp	21816733	SENT364	13	13	2	2	ticagrelor	CYP2C19	PA165374673	1557	0.91
NULL	J_Immunother_Cancer_2013_Nov_7_1(Suppl_1)_P43.nxml.txt.nlp	NULL	SENT4	26	26	3	3	rituximab	CD19	PA451261	930	0.91
NULL	Pain_2014_Nov_155(11)_2243-2252.nxml.txt.nlp	24978826	SENT175	33	33	25	25	propofol	TRPV1	PA451141	7442	0.91
NULL	Oncogene_2014_Sep_11_33(37)_4579-4588.nxml.txt.nlp	24662835	SENT51	10	10	15	15	tamoxifen	MAGEA2	PA451581	4101;266740	0.91
NULL	Acta_Naturae_2011_Jul-Sep_3(3)_12-28.nxml.txt.nlp	22649690	SENT312	27	27	11	11	ritonavir	CD4	PA451260	920	0.91
NULL	FEBS_Open_Bio_2013_Dec_25_4_60-64.nxml.txt.nlp	24392305	SENT55	28	28	14	14	paraformaldehyde	STZ	PA450790	6484	0.91
NULL	Acta_Pharmacol_Sin_2010_Mar_8_31(3)_382-386.nxml.txt.nlp	20140004	SENT24	17	17	8	8	pitavastatin	SLCO1B1	PA142650384	10599	0.91
NULL	Ann_Clin_Transl_Neurol_2014_Dec_21_1(12)_996-1005.nxml.txt.nlp	25574474	SENT132	1	1	9	9	elacridar	P-gp		5243	0.91
NULL	Br_J_Pharmacol_2014_Jan_23_171(2)_523-535.nxml.txt.nlp	24372553	SENT209	41	41	20	20	metformin	p53	PA450395	7157	0.91
NULL	Mediators_Inflamm_2001_Aug_10(4)_199-208.nxml.txt.nlp	11577996	SENT6	1	1	20	20	methotrexate	TNF-alpha	PA450428	7124	0.91
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT106	24	24	41	41	l-leucine	S6K1	PA450197	6198	0.91
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Sep_30_66(Pt_10)_o2685.nxml.txt.nlp	21587653	SENT57	19	19	13	13	ethanol	mol	PA448073	90527	0.91
NULL	Braz_J_Med_Biol_Res_2013_Jun_25_46(6)_528-532.nxml.txt.nlp	23802228	SENT84	25	25	27	27	rosiglitazone	PON1	PA451283	5444	0.91
NULL	Cancer_Med_2014_Oct_3_3(5)_1416-1429.nxml.txt.nlp	24890561	SENT185	18	18	0	0	epirubicin	San	PA449476	80218	0.91
NULL	FEBS_Open_Bio_2012_Mar_5_2_32-36.nxml.txt.nlp	23650578	SENT9	3	3	7	7	isoproterenol	PDK4	PA450121	5166	0.91
NULL	Br_J_Cancer_2013_Dec_10_109(12)_2954-2958.nxml.txt.nlp	24231949	SENT70	13	13	25	25	nutlin-3	p53		7157	0.91
NULL	Breast_Cancer_Res_2001_Oct_1_3(6)_361-364.nxml.txt.nlp	11737886	SENT26	10	10	6	6	doxorubicin	HER-2	PA449412	2064	0.91
NULL	Leukemia_2014_Jun_17_28(6)_1216-1226.nxml.txt.nlp	24301524	SENT106	12	12	3	3	bortezomib	p50	PA10252	958;4790	0.91
NULL	Oncotarget_2013_Apr_15_4(4)_636-646.nxml.txt.nlp	23592437	SENT66	18	18	20	20	decitabine	DAC	PA164749631	13	0.91
NULL	Clin_Ophthalmol_2014_Mar_2_8_343-346.nxml.txt.nlp	24591809	SENT20	19	19	14	14	ranibizumab	PED	PA164746012	8682	0.91
NULL	Br_J_Cancer_2013_May_28_108(10)_2039-2044.nxml.txt.nlp	23652306	SENT84	14	14	9	9	tamoxifen	SRC3	PA451581	8202	0.91
NULL	Oncotarget_2013_Feb_27_4(2)_329-345.nxml.txt.nlp	23593654	SENT48	14	14	5	5	paclitaxel	CD44	PA450761	960	0.91
NULL	EJNMMI_Res_2011_Jul_29_1_12.nxml.txt.nlp	22214199	SENT185	16	16	14	14	tariquidar	P-gp		5243	0.91
NULL	Clin_Mol_Hepatol_2014_Sep_25_20(3)_283-290.nxml.txt.nlp	25320732	SENT95	33	33	2	2	propranolol	EVL	PA451145	51466	0.91
NULL	Eur_J_Endocrinol_2013_Apr_168(4)_557-564.nxml.txt.nlp	23345197	SENT105	13	13	3	3	diazoxide	ABCC8	PA449285	6833	0.91
NULL	Brain_Sci_2013_Jun_14_3(2)_941-963.nxml.txt.nlp	24961432	SENT64	4	4	35	35	ethanol	NQO1	PA448073	1728	0.91
NULL	Diabetes_2008_Sep_57(9)_2272-2279.nxml.txt.nlp	18519799	SENT205	0	0	25	25	rosiglitazone	PDK4	PA451283	5166	0.91
NULL	Pharmaceuticals_(Basel)_2013_Aug_21_6(8)_988-1038.nxml.txt.nlp	24276379	SENT246	16	16	13	13	oxaliplatin	GSTP1	PA131285527	2950	0.91
NULL	Int_Semin_Surg_Oncol_2006_Sep_18_3_31.nxml.txt.nlp	16981992	SENT13	4	4	1	1	anastrozole	aromatase	PA448432	1588	0.91
NULL	Neuroimage_Clin_2013_Sep_6_3_290-300.nxml.txt.nlp	24273714	SENT660	18	18	24	24	pioglitazone	gamma	PA450970	9913	0.91
NULL	Daru_2013_Jan_18_21(1)_10.nxml.txt.nlp	23351340	SENT132	15	15	2	2	tramadol	mol	PA451735	90527	0.91
NULL	Front_Genet_2012_Nov_12_3_235.nxml.txt.nlp	23162568	SENT168	12	12	21	21	methamphetamine	CYP2D6	PA450403	1565	0.91
NULL	J_Mol_Med_(Berl)_2013_Aug_17_91(11)_1257-1271.nxml.txt.nlp	23955016	SENT188	2	2	14	14	thrombin	p38	PA451674	10598;1432;7965	0.91
NULL	Oncogene_2014_Aug_28_33(35)_4407-4417.nxml.txt.nlp	24469038	SENT244	34	34	22	22	cisplatin	p53	PA449014	7157	0.91
NULL	Pharmaceuticals_(Basel)_2012_Aug_10_5(8)_802-836.nxml.txt.nlp	24280676	SENT90	27	27	30	30	gemcitabine	CNT1	PA449748	9154	0.91
NULL	J_Radiat_Res_2013_Nov_31_54(6)_1057-1064.nxml.txt.nlp	23728323	SENT109	2	2	15	15	octreotide	c-myb	PA450678	4602	0.91
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT229	9	9	23	23	metformin	PI3K	PA450395	5290	0.91
NULL	Ital_J_Pediatr_2010_Jan_15_36_4.nxml.txt.nlp	20180963	SENT52	17	17	7	7	oxatomide	RNF	PA163522137	11074	0.91
NULL	Oncotarget_2013_Nov_24_4(12)_2430-2438.nxml.txt.nlp	24280348	SENT81	0	0	6	6	gefitinib	STAT3	PA131301952	6774	0.91
NULL	Breast_Cancer_Res_2012_May_18_14(3)_R78.nxml.txt.nlp	22608253	SENT257	5	5	29	29	nilotinib	AKT	PA165958345	207	0.91
NULL	Br_J_Cancer_2004_Mar_5_90(Suppl_1)_S15-S18.nxml.txt.nlp	15094760	SENT33	22	22	17	17	anastrozole	aromatase	PA448432	1588	0.91
NULL	Chem_Cent_J_2012_Oct_6_6_114.nxml.txt.nlp	23039933	SENT17	27	27	14	14	atorvastatin	VIII	PA448500	1351	0.91
NULL	Indian_J_Med_Res_2014_Apr_139(4)_572-578.nxml.txt.nlp	24927344	SENT81	7	7	13	13	acenocoumarol	CYP4F2	PA452632	8529	0.91
NULL	Orphanet_J_Rare_Dis_2014_Dec_10_9(1)_201.nxml.txt.nlp	NULL	SENT199	13	13	27	27	d-sorbitol	CMT1A	PA451455	1248	0.91
NULL	Arthritis_Res_Ther_2008_Jan_18_10(1)_R8.nxml.txt.nlp	18205921	SENT34	34	34	4	4	tadalafil	MRP5	PA10333	10057	0.91
NULL	Cancers_(Basel)_2014_Jul_22_6(3)_1540-1552.nxml.txt.nlp	25055117	SENT226	4	4	19	19	crizotinib	Met	PA165946122	79811	0.91
NULL	CNS_Drugs_2014_Jun_24_28(10)_875-886.nxml.txt.nlp	24958205	SENT150	7	7	2	2	exenatide	GLP-1	PA164749238	100125288	0.91
NULL	Cardiovasc_Ultrasound_2008_Aug_5_6_39.nxml.txt.nlp	18681971	SENT114	23	23	14	14	dobutamine	CRT	PA449381	811	0.91
NULL	J_Asthma_Allergy_2008_Sep_19_1_19-29.nxml.txt.nlp	21436982	SENT110	30	30	10	10	fexofenadine	IL-8	PA449621	3576	0.91
NULL	Ann_Hematol_2013_Apr_13_92(4)_481-486.nxml.txt.nlp	23238896	SENT3	33	33	31	31	cyclophosphamide	CHOP	PA449165	1649	0.91
NULL	Breast_Cancer_Res_Treat_2013_May_12_139(1)_107-113.nxml.txt.nlp	23580070	SENT156	32	32	14	14	trastuzumab	HER2	PA451743	2064	0.91
NULL	ScientificWorldJournal_2014_Mar_23_2014_183147.nxml.txt.nlp	24790551	SENT83	7	7	1	1	aprepitant	NK1	PA164747039	11126	0.91
NULL	Cell_Res_2013_Jul_21_23(7)_915-930.nxml.txt.nlp	23689279	SENT117	3	3	14	14	staurosporine	ALDH2	PA165109623	217	0.91
NULL	Acta_Pharmacol_Sin_2013_Sep_5_34(9)_1208-1216.nxml.txt.nlp	23852087	SENT222	8	8	17	17	disulfiram	HIF-1	PA449376	29072	0.91
NULL	Alcohol_Res_2013_35(1)_69-76.nxml.txt.nlp	24313166	SENT72	6	6	22	22	ethanol	PDYN	PA448073	5173	0.91
NULL	J_Headache_Pain_2014_Dec_8_15(1)_85.nxml.txt.nlp	25488888	SENT102	16	16	10	10	zolmitriptan	5-HT1B	PA451975	3351	0.91
NULL	Clin_Med_Insights_Cardiol_2013_Aug_11_7_127-140.nxml.txt.nlp	23997577	SENT84	3	3	16	16	amiodarone	CYP3A4	PA448383	1576	0.91
NULL	Crit_Care_2014_Mar_17_18(Suppl_1)_P260.nxml.txt.nlp	NULL	SENT8	21	21	28	28	fosfomycin	PARI	PA164748039	55010	0.91
NULL	J_Hematol_Oncol_2012_Jul_16_5_39.nxml.txt.nlp	22800464	SENT94	9	9	19	19	sorafenib	FLT3	PA7000	2322	0.91
NULL	Cells_2012_Aug_30_1(3)_631-645.nxml.txt.nlp	23745169	SENT121	11	11	0	0	arsenite	HRI	PA452638	27102	0.91
NULL	Arthritis_Res_Ther_2010_Jan_22_12(1)_R11.nxml.txt.nlp	20096109	SENT178	7	7	21	21	etanercept	IFN	PA449515	3439	0.91
NULL	J_Biol_Chem_2011_Sep_30_286(39)_33931-33941.nxml.txt.nlp	21795714	SENT278	26	26	10	10	choline	KAT1	PA448976	8520	0.91
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Mar_28_68(Pt_4)_o1220.nxml.txt.nlp	22606157	SENT57	19	19	6	6	ethanol	mol	PA448073	90527	0.91
NULL	Reprod_Biol_Endocrinol_2003_Feb_14_1_22.nxml.txt.nlp	12646054	SENT174	30	30	6	6	estradiol	aromatase	PA449503	1588	0.91
NULL	Cancer_Res_Treat_2013_Mar_31_45(1)_55-62.nxml.txt.nlp	23613671	SENT132	13	13	23	23	oxaliplatin	KRAS	PA131285527	3845	0.91
NULL	Front_Pharmacol_2014_May_30_5_132.nxml.txt.nlp	24910615	SENT134	6	6	18	18	estradiol	PDE7B	PA449503	27115	0.91
NULL	J_Biol_Chem_2013_Feb_8_288(6)_3918-3928.nxml.txt.nlp	23239877	SENT112	34	34	16	16	thrombin	PAR4	PA451674	9002;5074	0.91
NULL	Cell_Cycle_2013_Sep_15_12(18)_3025-3036.nxml.txt.nlp	23974102	SENT5	13	13	18	18	infliximab	CD4	PA452639	920	0.91
NULL	Mol_Pain_2013_Mar_7_9_11.nxml.txt.nlp	23497285	SENT216	9	9	19	19	remifentanil	ANOVA	PA451232	4858	0.91
NULL	Oncotarget_2014_Oct_21_5(22)_11723-11736.nxml.txt.nlp	25375091	SENT166	0	0	6	6	everolimus	MTOR	PA164746311	2475	0.91
NULL	Clin_Pharmacol_2010_Sep_17_2_185-198.nxml.txt.nlp	22291504	SENT112	22	22	4	4	creatine	spatial	PA164778930	219793	0.91
NULL	Gut_Liver_2011_Dec_21_5(4)_397-405.nxml.txt.nlp	22195236	SENT32	24	24	21	21	hyaluronan	CD44	PA165958431	960	0.91
NULL	J_Korean_Med_Sci_2010_Jun_24_25(6)_829-834.nxml.txt.nlp	20514301	SENT110	14	14	23	23	papain	IL-25	PA450778	64806;56005	0.91
NULL	Cell_J_2012_Dec_22_Winter_13(4)_281-289.nxml.txt.nlp	23507624	SENT20	8	8	31	31	isoproterenol	IL-17	PA450121	3605	0.91
NULL	Biomed_Res_Int_2014_Feb_26_2014_236930.nxml.txt.nlp	24719848	SENT217	21	21	23	23	fenoldopam	NAC	PA164784034	22861	0.91
NULL	Br_J_Pharmacol_2010_Sep_161(2)_308-320.nxml.txt.nlp	20735417	SENT241	18	18	16	16	rimonabant	GPR55	PA152407999	9290	0.91
NULL	Br_J_Cancer_2006_Dec_4_95(11)_1483-1489.nxml.txt.nlp	17106442	SENT147	6	6	3	3	gefitinib	EGFR	PA131301952	1956	0.91
NULL	Int_J_Biomed_Sci_2014_Sep_10(3)_146-157.nxml.txt.nlp	25324695	SENT123	35	35	12	12	lovastatin	RANTES	PA450272	6352	0.91
NULL	Open_Cardiovasc_Med_J_2008_Nov_28_2_110-114.nxml.txt.nlp	19471553	SENT88	6	6	12	12	atorvastatin	CD68	PA448500	968	0.91
NULL	Oncogene_2010_Jun_3_29(22)_3208-3216.nxml.txt.nlp	20383201	SENT180	8	8	16	16	dasatinib	EGF	PA162372878	1950	0.91
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT53	12	12	4	4	pp2	PP1		5540;5464	0.91
NULL	Front_Neurol_2014_Jul_1_5_111.nxml.txt.nlp	25071699	SENT138	16	16	1	1	pilocarpine	MRI	PA450962	78996	0.91
NULL	Cancer_Cell_Int_2013_Dec_23_13_123.nxml.txt.nlp	24365069	SENT27	20	20	2	2	imatinib	CD34	PA10804	947	0.91
NULL	Breast_Cancer_Res_2006_Nov_6_8(6)_215.nxml.txt.nlp	17096862	SENT95	2	2	42	42	pertuzumab	HER2		2064	0.91
NULL	Front_Oncol_2013_Sep_17_3_230.nxml.txt.nlp	24062983	SENT304	42	42	19	19	vincristine	p53	PA451879	7157	0.91
NULL	Biochem_Res_Int_2012_Mar_20_2012_951539.nxml.txt.nlp	22482055	SENT255	12	12	22	22	doxorubicin	AMPK	PA449412	5563	0.91
NULL	Biomed_Res_Int_2013_Sep_5_2013_730714.nxml.txt.nlp	24083238	SENT103	25	25	35	35	hydroxyurea	WRN	PA449942	7486	0.91
NULL	Biosci_Rep_2013_Jul_16_33(4)_e00049.nxml.txt.nlp	23738776	SENT219	30	30	11	11	ebselen	IFN	PA161660841	3439	0.91
NULL	Arthritis_Res_Ther_2013_Dec_5_15(6)_R208.nxml.txt.nlp	24314202	SENT82	15	15	5	5	chymotrypsin	PPIase	PA448994	2281;2289;8468;2286;2287	0.91
NULL	J_Adv_Pract_Oncol_2012_Nov_1_Nov-Dec_3(6)_411-414.nxml.txt.nlp	25031974	SENT83	43	43	40	40	letrozole	aromatase	PA450196	1588	0.91
NULL	Clin_Med_Insights_Cardiol_2010_Oct_11_4_89-93.nxml.txt.nlp	20981132	SENT93	0	0	29	29	benazepril	ACS	PA448561	55902;84680	0.91
NULL	Mol_Brain_2014_Apr_3_7_25.nxml.txt.nlp	24708812	SENT10	24	24	6	6	chloroquine	ERK	PA448948	5594	0.91
NULL	Ther_Clin_Risk_Manag_2007_Aug_3(4)_591-604.nxml.txt.nlp	18472981	SENT201	0	0	19	19	ritonavir	castor	PA451260	54897	0.91
NULL	Breast_Cancer_Res_2012_Mar_9_14(2)_R41.nxml.txt.nlp	22405131	SENT11	0	0	5	5	estradiol	TCL1A	PA449503	8115	0.91
NULL	Mol_Neurodegener_2011_Aug_16_6_58.nxml.txt.nlp	21846363	SENT34	20	20	18	18	candesartan	AT1	PA448765	9197;185	0.91
NULL	Cancer_Cell_Int_2011_Oct_28_11_35.nxml.txt.nlp	22035360	SENT208	19	19	2	2	l-glutamine	U87	PA10090	677775;641648	0.91
NULL	Cancers_(Basel)_2014_Mar_13_6(1)_595-624.nxml.txt.nlp	24633084	SENT274	14	14	32	32	lapatinib	HER2	PA152241907	2064	0.91
NULL	Case_Rep_Neurol_Med_2012_Oct_9_2012_745430.nxml.txt.nlp	23091751	SENT72	33	33	22	22	rivastigmine	OAT	PA451262	4942	0.91
NULL	Clin_Exp_Otorhinolaryngol_2012_Sep_27_5(3)_132-138.nxml.txt.nlp	22977709	SENT9	16	16	7	7	fluorescein	P14	PA164746009	11102;;6280;56259	0.91
NULL	J_Mol_Med_(Berl)_2014_May_10_92(7)_709-722.nxml.txt.nlp	24811491	SENT80	27	27	0	0	cetuximab	KRAS	PA10040	3845	0.91
NULL	Br_J_Cancer_2011_Jun_28_105(1)_53-57.nxml.txt.nlp	21654688	SENT29	0	0	22	22	irinotecan	UGT	PA450085	7361;7355	0.91
NULL	Environ_Health_Perspect_2005_Aug_15_113(8)_1009-1014.nxml.txt.nlp	16079071	SENT144	16	16	6	6	losartan	p38	PA450268	10598;1432;7965	0.91
NULL	Pak_J_Med_Sci_2013_May-Jun_29(3)_768-772.nxml.txt.nlp	24353625	SENT37	27	27	36	36	ceftazidime	CTX	PA448861	1593	0.91
NULL	Oncotarget_2014_Oct_18_5(21)_10206-10221.nxml.txt.nlp	25344914	SENT242	22	22	3	3	vemurafenib	IFNAR1	PA165946873	3454	0.91
NULL	Br_J_Cancer_1998_Sep_78(Suppl_4)_1-4.nxml.txt.nlp	9741780	SENT15	19	19	14	14	anastrozole	aromatase	PA448432	1588	0.91
NULL	J_Cell_Mol_Med_2014_Sep_7_18(9)_1785-1796.nxml.txt.nlp	24909956	SENT179	20	20	10	10	montelukast	GPR17	PA450546	2840	0.91
NULL	J_Oncol_2012_Oct_22_2012_391629.nxml.txt.nlp	23133451	SENT262	13	13	41	41	axitinib	VEGFR	PA164924493	3791	0.91
NULL	J_Skin_Cancer_2012_Dec_13_2012_147863.nxml.txt.nlp	23316365	SENT135	15	15	4	4	curcumin	IL6	PA151958596	3569	0.91
NULL	Cancers_(Basel)_2010_Apr_13_2(2)_483-497.nxml.txt.nlp	24281078	SENT100	23	23	0	0	curcumin	p65	PA151958596	5970	0.91
NULL	Br_J_Pharmacol_2014_May_171(10)_2659-2670.nxml.txt.nlp	24116661	SENT175	0	0	26	26	metformin	TRPP2	PA450395	5311	0.91
NULL	Gastric_Cancer_2013_Jul_12_16(3)_345-354.nxml.txt.nlp	22968820	SENT37	23	23	12	12	oxaliplatin	FANCJ	PA131285527	83990	0.91
NULL	J_Thromb_Thrombolysis_2011_Nov_26_32(4)_459-466.nxml.txt.nlp	21706290	SENT211	13	13	5	5	clopidogrel	CYP2C9	PA449053	1559	0.91
NULL	Ther_Clin_Risk_Manag_2007_Mar_3(1)_107-118.nxml.txt.nlp	18360619	SENT160	0	0	3	3	tegaserod	5-HT4	PA130413154	3360	0.91
NULL	Oncogene_2014_Aug_21_33(34)_4316-4329.nxml.txt.nlp	24362530	SENT113	7	7	12	12	epirubicin	FOXM1	PA449476	2305	0.91
NULL	Cancers_(Basel)_2011_Mar_3_3(1)_1042-1080.nxml.txt.nlp	24212653	SENT427	10	10	18	18	trastuzumab	HER2	PA451743	2064	0.91
NULL	EMBO_Mol_Med_2012_Oct_30_4(10)_1087-1096.nxml.txt.nlp	22933245	SENT163	15	15	4	4	olaparib	NAMPT		10135	0.91
NULL	Eur_J_Clin_Pharmacol_2012_Jan_7_68(1)_55-64.nxml.txt.nlp	21735164	SENT306	6	6	16	16	oxycodone	CYP2D6	PA450741	1565	0.91
NULL	Oncol_Rep_2013_Oct_22_30(4)_1535-1541.nxml.txt.nlp	23877481	SENT149	28	28	6	6	gefitinib	VEGFR	PA131301952	3791	0.91
NULL	Breast_Cancer_Res_2010_Jun_22_12(3)_R39.nxml.txt.nlp	20569502	SENT212	21	21	7	7	tamoxifen	IGFBP5	PA451581	3488	0.91
NULL	Front_Oncol_2014_Oct_31_4_306.nxml.txt.nlp	25401091	SENT200	11	11	45	45	dextran	mol	PA449261	90527	0.91
NULL	Exp_Hematol_Oncol_2012_Oct_16_1_32.nxml.txt.nlp	23210733	SENT46	8	8	27	27	thiotepa	CD34	PA451668	947	0.91
NULL	Clin_Pharmacokinet_2014_Sep_3_53(1)_1-16.nxml.txt.nlp	23999929	SENT85	17	17	31	31	rivaroxaban	ABCG2	PA165958360	9429	0.91
NULL	Exp_Ther_Med_2013_Dec_15_6(6)_1565-1569.nxml.txt.nlp	24255692	SENT23	7	7	15	15	atorvastatin	adiponectin	PA448500	9370	0.91
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT133	17	17	35	35	pp2	LYN		4067	0.91
NULL	J_Cell_Biol_1995_Mar_2_128(6)_1185-1196.nxml.txt.nlp	7896881	SENT4	21	21	6	6	mitomycin	HC11	PA450524	6347	0.91
NULL	Front_Neurosci_2012_Mar_26_6_38.nxml.txt.nlp	22470317	SENT20	3	3	6	6	tegaserod	5-HT4	PA130413154	3360	0.91
NULL	Pharmaceutics_2012_Nov_7_4(4)_563-589.nxml.txt.nlp	24300371	SENT170	0	0	16	16	everolimus	FKBP-12	PA164746311	2280	0.91
NULL	Arthritis_Res_Ther_2010_Apr_9_12(2)_R65.nxml.txt.nlp	20380722	SENT88	2	2	33	33	imatinib	MMP3	PA10804	4314	0.91
NULL	BMJ_Open_2014_Sep_17_4(9)_e005651.nxml.txt.nlp	25231491	SENT342	20	20	10	10	ketamine	c-Jun	PA450144	3725	0.91
NULL	J_Cell_Mol_Med_2014_Dec_7_18(12)_2536-2552.nxml.txt.nlp	25287328	SENT280	26	26	2	2	tamoxifen	PKD1	PA451581	5310	0.91
NULL	Breast_Cancer_Res_2012_Dec_5_14(6)_R153.nxml.txt.nlp	23216744	SENT10	17	17	3	3	auranofin	SNO	PA448510	6498	0.91
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_4_2013_378657.nxml.txt.nlp	23662132	SENT75	21	21	8	8	sitagliptin	GLP-1	PA164748978	100125288	0.91
NULL	J_Inherit_Metab_Dis_2010_Oct_3_33(5)_625-632.nxml.txt.nlp	20814828	SENT132	13	13	9	9	simvastatin	RhoA	PA451363	387	0.91
NULL	Clin_Pharmacol_2013_Dec_9_5_185-192.nxml.txt.nlp	24353446	SENT20	18	18	35	35	clopidogrel	ARNT	PA449053	405	0.91
NULL	Open_Access_J_Urol_2011_May_10_3_69-82.nxml.txt.nlp	24198638	SENT60	25	25	14	14	omeprazole	CYP3A4	PA450704	1576	0.91
NULL	Cell_Commun_Signal_2013_May_29_11_38.nxml.txt.nlp	23718910	SENT254	3	3	8	8	pp2	p65		5970	0.91
NULL	Oncotarget_2013_Nov_24_4(12)_2430-2438.nxml.txt.nlp	24280348	SENT28	3	3	12	12	gefitinib	SOCS1	PA131301952	8651	0.91
NULL	Oncoimmunology_2014_May_29_3_e28925.nxml.txt.nlp	25083322	SENT68	2	2	38	38	dasatinib	IFN	PA162372878	3439	0.91
NULL	Pan_Afr_Med_J_2012_Mar_7_11_39.nxml.txt.nlp	22593775	SENT201	15	15	31	31	stavudine	CD4	PA451494	920	0.91
NULL	Eur_J_Clin_Pharmacol_2014_Oct_8_70(1)_37-45.nxml.txt.nlp	24100471	SENT195	0	0	10	10	midazolam	CYP3A4	PA450496	1576	0.91
NULL	Patient_Prefer_Adherence_2010_Sep_7_4_313-324.nxml.txt.nlp	20859458	SENT42	0	0	20	20	liraglutide	GLP-1	PA165958364	100125288	0.91
NULL	Breast_Cancer_Res_2010_Jun_28_12(3)_R43.nxml.txt.nlp	20579400	SENT27	20	20	6	6	paclitaxel	MAPT	PA450761	4137	0.91
NULL	J_Cell_Biol_1998_Mar_23_140(6)_1307-1320.nxml.txt.nlp	9508765	SENT186	11	11	16	16	coumarin	ADP	PA134521193	23038	0.91
NULL	J_Korean_Med_Sci_2008_Aug_25_23(4)_685-690.nxml.txt.nlp	18756058	SENT128	33	33	8	8	olanzapine	ghrelin	PA450688	51738	0.91
NULL	Mol_Cancer_2007_Mar_7_6_18.nxml.txt.nlp	17343740	SENT472	7	7	24	24	docetaxel	RANK	PA449383	8792	0.91
NULL	Arch_Drug_Inf_2011_Mar_4(1)_1-9.nxml.txt.nlp	21572514	SENT152	0	0	4	4	sulfinpyrazone	MRP1	PA451550	4437	0.91
NULL	Front_Immunol_2013_Nov_8_4_363.nxml.txt.nlp	24265631	SENT542	16	16	20	20	vemurafenib	BRAF	PA165946873	673	0.91
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT207	9	9	34	34	metformin	PTEN	PA450395	5728	0.91
NULL	Curr_Hematol_Malig_Rep_2014_Feb_6_9(1)_9-16.nxml.txt.nlp	24500518	SENT264	7	7	14	14	imatinib	CD34	PA10804	947	0.91
NULL	Hum_Mol_Genet_2008_Jul_1_17(13)_2006-2017.nxml.txt.nlp	18397877	SENT234	34	34	0	0	neomycin	TSC1	PA450608	7248	0.91
NULL	J_Viral_Hepat_2012_Feb_19(2)_e134-e142.nxml.txt.nlp	22239511	SENT28	9	9	16	16	telaprevir	SOC	PA165958354	91544	0.91
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT332	8	8	17	17	forskolin	IL-6	PA146096022	3569	0.91
NULL	Contemp_Oncol_(Pozn)_2012_Nov_20_16(5)_401-406.nxml.txt.nlp	23788917	SENT154	8	8	19	19	everolimus	EGFR	PA164746311	1956	0.91
NULL	BMJ_Open_2014_Feb_13_4(2)_e003960.nxml.txt.nlp	24525389	SENT121	4	4	8	8	warfarin	OAT	PA451906	4942	0.91
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2011_Mar_14_4_13-24.nxml.txt.nlp	22879790	SENT11	0	0	4	4	exenatide	GLP-1	PA164749238	100125288	0.91
NULL	Br_J_Haematol_2014_Feb_16_164(4)_586-596.nxml.txt.nlp	24236640	SENT161	16	16	9	9	carboplatin	EPO	PA448803	7076;8288;2056	0.91
NULL	Front_Zool_2013_Feb_21_10_8.nxml.txt.nlp	23433033	SENT233	0	0	4	4	letrozole	aromatase	PA450196	1588	0.91
NULL	Drugs_Context_2012_Nov_19_2012_212242.nxml.txt.nlp	24432031	SENT441	5	5	34	34	vemurafenib	BRAF	PA165946873	673	0.91
NULL	Diabetes_Metab_Syndr_Obes_2013_Sep_2_6_317-325.nxml.txt.nlp	24039439	SENT58	7	7	19	19	mitiglinide	GLP-1	PA164748124	100125288	0.91
NULL	Scientifica_(Cairo)_2014_Aug_19_2014_901586.nxml.txt.nlp	25215263	SENT101	12	12	5	5	erythromycin	CYP3A4	PA449493	1576	0.91
NULL	Eur_J_Clin_Pharmacol_2012_Apr_8_68(4)_363-370.nxml.txt.nlp	21984116	SENT122	6	6	22	22	tramadol	CYP2D6	PA451735	1565	0.91
NULL	Parasit_Vectors_2011_Dec_13_4_232.nxml.txt.nlp	22166365	SENT91	17	17	24	24	albendazole	STH	PA164746058	246744	0.91
NULL	Osteoporos_Int_2011_Jun_12_22(6)_1935-1946.nxml.txt.nlp	20938767	SENT178	13	13	15	15	teriparatide	PTH	PA451620	5741	0.91
NULL	Mol_Cancer_2006_Oct_17_5_45.nxml.txt.nlp	17044934	SENT91	13	13	37	37	resveratrol	COX		1351	0.91
NULL	J_Invest_Dermatol_2014_Apr_11_134(4)_1083-1090.nxml.txt.nlp	24335898	SENT56	11	11	23	23	nutlin-3	p53		7157	0.91
NULL	Evid_Based_Complement_Alternat_Med_2013_May_16_2013_857929.nxml.txt.nlp	23762164	SENT188	7	7	26	26	doxorubicin	AKT	PA449412	207	0.91
NULL	J_Cell_Mol_Med_2014_Aug_6_18(8)_1519-1539.nxml.txt.nlp	25100284	SENT22	20	20	26	26	erlotinib	EGFR	PA134687924	1956	0.91
NULL	Carcinogenesis_2010_Dec_27_31(12)_2049-2057.nxml.txt.nlp	20876285	SENT127	35	35	23	23	tamoxifen	HER2	PA451581	2064	0.91
NULL	Biomed_Res_Int_2013_Dec_17_2013_696317.nxml.txt.nlp	24455716	SENT171	18	18	4	4	l-arginine	NAC	PA448478	22861	0.91
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT149	4	4	21	21	atazanavir	UGT1A1	PA10251	54658	0.91
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_29_2013_590393.nxml.txt.nlp	23737838	SENT223	25	25	19	19	resveratrol	p53		7157	0.91
NULL	Breast_Cancer_Res_2004_Jul_6_6(5)_R514-R530.nxml.txt.nlp	15318933	SENT79	20	20	1	1	phenol	BRI	PA450913	9445	0.91
NULL	Int_J_Med_Sci_2014_Sep_6_11(11)_1185-1200.nxml.txt.nlp	25249787	SENT147	9	9	0	0	exenatide	GLP-1	PA164749238	100125288	0.91
NULL	Cancer_Med_2013_Aug_10_2(4)_545-552.nxml.txt.nlp	24156027	SENT30	15	15	12	12	sunitinib	VEGFR	PA162372840	3791	0.91
NULL	Oncotarget_2013_Aug_15_4(9)_1438-1448.nxml.txt.nlp	23988457	SENT89	6	6	0	0	doxorubicin	RINF	PA449412	51523	0.91
NULL	Cell_J_2012_Dec_22_Winter_13(4)_265-274.nxml.txt.nlp	23507995	SENT99	12	12	2	2	ethanol	ANOVA	PA448073	4858	0.91
NULL	Breast_Cancer_Res_2004_Nov_7_6(1)_R24-R30.nxml.txt.nlp	14680497	SENT110	30	30	8	8	cyclophosphamide	HER2	PA449165	2064	0.91
NULL	Crit_Care_2008_Aug_4_12(4)_R99.nxml.txt.nlp	18680591	SENT164	21	21	5	5	metoprolol	AVP	PA450480	114548;551	0.91
NULL	Clin_Psychopharmacol_Neurosci_2012_Apr_30_10(1)_25-33.nxml.txt.nlp	23429852	SENT90	38	38	2	2	olanzapine	alpha-synuclein	PA450688	6622	0.91
NULL	Braz_J_Med_Biol_Res_2014_Sep_5_47(11)_929-939.nxml.txt.nlp	25296354	SENT56	12	12	8	8	erlotinib	EGFR	PA134687924	1956	0.91
NULL	Cancers_(Basel)_2011_Oct_14_3(4)_3894-3908.nxml.txt.nlp	24213116	SENT138	11	11	18	18	cetuximab	EGFR	PA10040	1956	0.91
NULL	Diabetes_Care_2008_Jul_31(7)_1427-1432.nxml.txt.nlp	18390799	SENT163	7	7	1	1	metformin	RBP4	PA450395	5433;5950	0.91
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT57	28	28	3	3	cisplatin	ASC	PA449014	29108	0.91
NULL	Contemp_Oncol_(Pozn)_2012_Nov_20_16(5)_363-370.nxml.txt.nlp	23788912	SENT316	7	7	13	13	vemurafenib	BRAF	PA165946873	673	0.91
NULL	Onco_Targets_Ther_2014_May_23_7_799-805.nxml.txt.nlp	24920920	SENT86	21	21	4	4	afatinib	EGFR	PA165981154	1956	0.91
NULL	Biosci_Rep_2013_Sep_6_33(5)_e00065.nxml.txt.nlp	23895241	SENT179	19	19	7	7	indomethacin	UCP1	PA449982	7350	0.91
NULL	Biochemistry_2012_Sep_18_51(37)_7330-7341.nxml.txt.nlp	22928810	SENT32	4	4	0	0	thrombin	NLRP4	PA451674	147945	0.91
NULL	Clin_Transl_Allergy_2013_Sep_2_3_29.nxml.txt.nlp	24004581	SENT79	7	7	28	28	omalizumab	IL-4	PA164752253	3565	0.91
NULL	Int_J_Mol_Sci_2012_Dec_5_13(12)_16624-16635.nxml.txt.nlp	23443122	SENT77	26	26	36	36	vincristine	MDR1	PA451879	5243	0.91
NULL	Oncotarget_2014_Aug_16_5(18)_8637-8650.nxml.txt.nlp	25226617	SENT30	37	37	8	8	dasatinib	JAK2	PA162372878	3717	0.91
NULL	Oncol_Rep_2013_Oct_22_30(4)_1535-1541.nxml.txt.nlp	23877481	SENT43	14	14	11	11	gefitinib	EGFR	PA131301952	1956	0.91
NULL	Eukaryot_Cell_2014_Aug_13(8)_1077-1084.nxml.txt.nlp	24951438	SENT180	23	23	8	8	doxycycline	RSP5	PA449415	23327	0.909
NULL	Exp_Ther_Med_2013_Nov_13_6(5)_1317-1321.nxml.txt.nlp	24223665	SENT112	21	21	17	17	cisplatin	CD133	PA449014	8842	0.909
NULL	Mol_Cancer_2013_Sep_11_12_104.nxml.txt.nlp	24025152	SENT48	28	28	17	17	gemcitabine	EGFR	PA449748	1956	0.909
NULL	Oncotarget_2014_Feb_7_5(3)_775-787.nxml.txt.nlp	24519956	SENT104	5	5	10	10	dasatinib	PC3	PA162372878	57332;7832;5122	0.909
NULL	Biomed_Res_Int_2013_Oct_29_2013_185476.nxml.txt.nlp	24350249	SENT6	34	34	2	2	misoprostol	flower	PA450523	11094	0.909
NULL	Adv_Ther_2013_Oct_25_30(10)_870-884.nxml.txt.nlp	24158787	SENT221	9	9	29	29	tamoxifen	aromatase	PA451581	1588	0.909
NULL	Open_Cardiovasc_Med_J_2013_Nov_29_7_122-126.nxml.txt.nlp	24358062	SENT116	16	16	3	3	amiodarone	AIT	PA448383	160728	0.909
NULL	Breast_Cancer_Res_2011_Jan_20_13(1)_R8.nxml.txt.nlp	21251330	SENT37	36	36	31	31	letrozole	aromatase	PA450196	1588	0.909
NULL	Nat_Med_2013_Dec_10_19(12)_10_1038_nm_3385.nxml.txt.nlp	24216752	SENT41	4	4	26	26	thrombin	PAR1	PA451674	79581;2149	0.909
NULL	J_Hum_Genet_2013_Jun_2_58(6)_306-312.nxml.txt.nlp	23635953	SENT7	33	33	23	23	letrozole	aromatase	PA450196	1588	0.909
NULL	Arch_Med_Sci_2013_Oct_31_9(5)_936-943.nxml.txt.nlp	24273582	SENT103	19	19	21	21	nateglinide	GLP-1	PA450600	100125288	0.909
NULL	J_Neuroinflammation_2011_Feb_4_8_10.nxml.txt.nlp	21294877	SENT156	31	31	36	36	capsaicin	TRPV1	PA448776	7442	0.909
NULL	Int_Neurourol_J_2011_Jun_30_15(2)_64-73.nxml.txt.nlp	21811695	SENT93	26	26	6	6	desmopressin	AVP	PA449237	114548;551	0.909
NULL	Front_Synaptic_Neurosci_2014_Apr_21_6_9.nxml.txt.nlp	24795622	SENT45	17	17	5	5	l-serine	PLP	PA451330	25824;5744	0.909
NULL	Nat_Med_2011_Aug_7_17(9)_1116-1120.nxml.txt.nlp	21822287	SENT65	29	29	5	5	doxycycline	c-Myc	PA449415	4609	0.909
NULL	Exp_Ther_Med_2013_Dec_14_6(6)_1499-1503.nxml.txt.nlp	24255681	SENT136	11	11	7	7	fluorouracil	S100A3	PA128406956	6274	0.909
NULL	Diabetes_2011_May_23_60(5)_1493-1503.nxml.txt.nlp	21478464	SENT112	5	5	11	11	metformin	AMPK	PA450395	5563	0.909
NULL	Acta_Pharmacol_Sin_2010_Sep_2_31(9)_1172-1180.nxml.txt.nlp	20676117	SENT162	26	26	24	24	bsi-201	PARP1		142	0.909
NULL	Acta_Pharmacol_Sin_2014_Jun_4_35(6)_752-757.nxml.txt.nlp	24902786	SENT93	10	10	3	3	flutamide	STL2	PA449685	1301	0.909
NULL	Protein_J_2012_Aug_5_31(6)_511-518.nxml.txt.nlp	22763563	SENT174	11	11	18	18	cerivastatin	CD36	PA448897	948	0.909
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT141	9	9	7	7	dasatinib	PP2	PA162372878	4888	0.909
NULL	Case_Rep_Ophthalmol_Med_2011_Jan_31_2011_679751.nxml.txt.nlp	22606470	SENT6	15	15	8	8	bevacizumab	hole	PA130232992	80757	0.909
NULL	Oxid_Med_Cell_Longev_2013_Apr_18_2013_239854.nxml.txt.nlp	23710284	SENT86	4	4	7	7	zonisamide	SEL1L	PA451978	6400	0.909
NULL	Acta_Pharmacol_Sin_2012_Jan_28_33(1)_66-74.nxml.txt.nlp	22120966	SENT233	2	2	13	13	genistein	OPG	PA165109660	690	0.909
NULL	Korean_J_Anesthesiol_2013_Jan_21_64(1)_47-53.nxml.txt.nlp	23372886	SENT33	25	25	4	4	bupivacaine	IGK	PA135057240	50802	0.909
NULL	BMB_Rep_2013_Jan_46(1)_59-64.nxml.txt.nlp	23351386	SENT7	12	12	18	18	auranofin	STAT3	PA448510	6774	0.909
NULL	Comp_Hepatol_2004_Jan_14_3(Suppl_1)_S31.nxml.txt.nlp	14960183	SENT19	13	13	24	24	ethanol	TNF-alpha	PA448073	7124	0.909
NULL	Clin_Pediatr_Endocrinol_2012_Oct_30_21(4)_75-80.nxml.txt.nlp	23926414	SENT82	7	7	22	22	hydrocortisone	ACTH	PA449905	5443	0.909
NULL	Br_J_Cancer_2012_Nov_6_107(10)_1714-1721.nxml.txt.nlp	23073173	SENT252	16	16	12	12	docetaxel	Bcl-2	PA449383	596	0.909
NULL	Ther_Clin_Risk_Manag_2006_Sep_2(3)_235-249.nxml.txt.nlp	18360599	SENT351	12	12	5	5	alendronate	PTH	PA448082	5741	0.909
NULL	Genet_Mol_Biol_2009_Sep_1_Jul-Sep_32(3)_516-520.nxml.txt.nlp	21637514	SENT65	0	0	17	17	estradiol	EGF	PA449503	1950	0.909
NULL	Indian_J_Pharmacol_2013_Mar-Apr_45(2)_155-158.nxml.txt.nlp	23716892	SENT116	20	20	10	10	glibenclamide	CYP2C9	PA449782	1559	0.909
NULL	Am_J_Cardiovasc_Drugs_2013_Jun_20_13(5)_331-342.nxml.txt.nlp	23784266	SENT223	23	23	16	16	ketoconazole	P-gp	PA450146	5243	0.909
NULL	Ital_J_Pediatr_2014_Feb_13_40_17.nxml.txt.nlp	24524345	SENT85	22	22	6	6	methylprednisolone	CHP	PA450466	11261	0.909
NULL	J_Cancer_Res_Clin_Oncol_2013_Feb_10_139(2)_269-280.nxml.txt.nlp	23052698	SENT44	15	15	10	10	letrozole	aromatase	PA450196	1588	0.909
NULL	Int_J_Anal_Chem_2012_Feb_8_2012_546282.nxml.txt.nlp	22505920	SENT208	6	6	39	39	terazosin	PF6	PA451612	200162	0.909
NULL	Biologics_2012_Sep_25_6_337-345.nxml.txt.nlp	23055691	SENT5	31	31	29	29	afatinib	EGFR	PA165981154	1956	0.909
NULL	Ann_Hematol_2010_Nov_25_89(11)_1115-1124.nxml.txt.nlp	20499237	SENT155	5	5	33	33	simvastatin	CD5	PA451363	921	0.909
NULL	Respir_Med_Case_Rep_2013_Oct_26_10_53-55.nxml.txt.nlp	NULL	SENT71	5	5	19	19	ustekinumab	IL-6	PA166048654	3569	0.909
NULL	Acta_Pharmacol_Sin_2013_Mar_11_34(3)_403-413.nxml.txt.nlp	23396374	SENT205	3	3	0	0	tocilizumab	IL-6	PA165292659	3569	0.909
NULL	J_Cardiothorac_Surg_2013_Aug_29_8_186.nxml.txt.nlp	23985062	SENT54	0	0	12	12	heparin	ACT	PA449855	12;11332;9457;641455	0.909
NULL	Oncotarget_2013_Aug_25_4(10)_1647-1661.nxml.txt.nlp	24072592	SENT70	27	27	6	6	staurosporine	S6K1	PA165109623	6198	0.909
NULL	Cancer_Med_2013_Jun_25_2(3)_277-285.nxml.txt.nlp	23930204	SENT182	40	40	6	6	cetuximab	BRAF	PA10040	673	0.909
NULL	Cell_Death_Differ_2010_Apr_16_17(4)_666-676.nxml.txt.nlp	19834494	SENT94	20	20	0	0	melphalan	RAGE	PA450354	177	0.909
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_May_14_67(Pt_6)_o1431.nxml.txt.nlp	21754810	SENT60	24	24	37	37	ethanol	mol	PA448073	90527	0.909
NULL	Diabetes_2011_Jun_21_60(6)_1734-1742.nxml.txt.nlp	21498783	SENT4	22	22	14	14	lipase	ATGL	PA450239	57104	0.909
NULL	Cell_Death_Dis_2013_Oct_3_4(10)_e828.nxml.txt.nlp	24091671	SENT86	6	6	30	30	cetuximab	CD54	PA10040	3383	0.909
NULL	Acta_Pharmacol_Sin_2014_Aug_21_35(8)_994-1004.nxml.txt.nlp	25042549	SENT222	13	13	9	9	pravastatin	PCSK9	PA451089	255738	0.909
NULL	Cancer_Cell_Int_2013_Jan_15_13_3.nxml.txt.nlp	23320839	SENT135	7	7	31	31	gefitinib	ABCC1	PA131301952	4363	0.909
NULL	Front_Pharmacol_2014_May_30_5_132.nxml.txt.nlp	24910615	SENT133	33	33	8	8	estradiol	PDE7B	PA449503	27115	0.909
NULL	Carcinogenesis_2014_May_13_35(5)_1055-1066.nxml.txt.nlp	24419232	SENT274	16	16	31	31	metformin	CD34	PA450395	947	0.909
NULL	J_Radiat_Res_2013_Jul_21_54(4)_748-754.nxml.txt.nlp	23436229	SENT188	0	0	10	10	hyaluronan	CD44	PA165958431	960	0.909
NULL	J_Immunother_Cancer_2013_Nov_7_1(Suppl_1)_P123.nxml.txt.nlp	NULL	SENT14	5	5	29	29	chloroquine	IL-6	PA448948	3569	0.909
NULL	Br_J_Cancer_2012_Jul_24_107(3)_516-526.nxml.txt.nlp	22782351	SENT132	20	20	12	12	tamoxifen	TIGAR	PA451581	57103	0.909
NULL	Arthritis_Res_Ther_2014_Jul_18_16(4)_R153.nxml.txt.nlp	25037855	SENT180	4	4	12	12	adalimumab	CD14	PA10004	929	0.909
NULL	J_Korean_Med_Sci_2011_Feb_24_26(2)_304-307.nxml.txt.nlp	21286027	SENT45	14	14	10	10	doxorubicin	CHOP	PA449412	1649	0.909
NULL	J_Biomed_Sci_2013_Jun_25_20(1)_41.nxml.txt.nlp	23800047	SENT90	34	34	13	13	trypsin	F12	PA451806	2161	0.909
NULL	Biologics_2011_Aug_9_5_87-94.nxml.txt.nlp	21847344	SENT75	40	40	11	11	trastuzumab	San	PA451743	80218	0.909
NULL	Acta_Pharmacol_Sin_2014_Aug_21_35(8)_994-1004.nxml.txt.nlp	25042549	SENT16	9	9	30	30	pravastatin	PCSK9	PA451089	255738	0.909
NULL	Drug_Healthc_Patient_Saf_2012_Nov_29_4_173-180.nxml.txt.nlp	23236256	SENT66	8	8	22	22	quetiapine	FGA	PA451201	2243	0.909
NULL	Arthritis_Res_Ther_2006_Jan_16_8(2)_R36.nxml.txt.nlp	16469114	SENT15	33	33	0	0	heparin	CCN2	PA449855	1490	0.909
NULL	Br_J_Clin_Pharmacol_2013_Aug_23_76(2)_299-315.nxml.txt.nlp	23701319	SENT150	5	5	22	22	alemtuzumab	IL-13	PA164783958	3596	0.909
NULL	Arthritis_Res_Ther_2013_Nov_28_15(6)_R202.nxml.txt.nlp	24283517	SENT188	9	9	16	16	curcumin	p65	PA151958596	5970	0.909
NULL	J_Cardiovasc_Magn_Reson_2014_Sep_27_16(1)_80.nxml.txt.nlp	25270330	SENT38	8	8	39	39	iron	spatial	PA450087	219793	0.909
NULL	ScientificWorldJournal_2014_Feb_4_2014_978351.nxml.txt.nlp	24688450	SENT71	46	46	16	16	ofatumumab	IL-6	PA165291493	3569	0.909
NULL	Open_Biochem_J_2014_Nov_1_8_74-82.nxml.txt.nlp	25400709	SENT168	18	18	7	7	resveratrol	AKT		207	0.909
NULL	N_Am_J_Med_Sci_2013_Mar_5(3)_202-206.nxml.txt.nlp	23626956	SENT5	28	28	10	10	cetuximab	EGFR	PA10040	1956	0.909
NULL	Environ_Health_Perspect_2010_Jul_3_118(7)_936-942.nxml.txt.nlp	20199942	SENT170	44	44	11	11	arsenite	mot-2	PA452638	3313	0.909
NULL	Acta_Pharmacol_Sin_2013_Jan_5_34(1)_24-32.nxml.txt.nlp	23123646	SENT169	15	15	5	5	tolbutamide	CA1	PA451718	759	0.909
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT255	8	8	18	18	aripiprazole	PRL	PA10026	5617	0.909
NULL	Front_Oncol_2014_Sep_15_4_248.nxml.txt.nlp	25309873	SENT214	24	24	34	34	cisplatin	EGFR	PA449014	1956	0.909
NULL	Evid_Based_Complement_Alternat_Med_2013_Aug_7_2013_168134.nxml.txt.nlp	23990845	SENT57	9	9	27	27	etanercept	ACR	PA449515	49	0.909
NULL	Oncogene_2014_Jul_24_33(30)_3927-3938.nxml.txt.nlp	23995784	SENT40	14	14	29	29	doxycycline	FOXO1	PA449415	2308	0.909
NULL	Environ_Health_Perspect_2010_Dec_12_118(12)_1707-1713.nxml.txt.nlp	20705543	SENT207	12	12	25	25	bleomycin	XRCC1	PA448645	7515	0.909
NULL	Diabetes_Care_2011_Jun_20_34(6)_e61-e99.nxml.txt.nlp	21617108	SENT646	24	24	5	5	nadh	HBA	PA164755085	85340	0.909
NULL	Cancer_Cell_Int_2010_Sep_9_10_32.nxml.txt.nlp	20828393	SENT125	7	7	11	11	cisplatin	ATF3	PA449014	467	0.909
NULL	Leukemia_2013_Dec_27_27(12)_2322-2331.nxml.txt.nlp	24072044	SENT224	10	10	4	4	plerixafor	CXCR4	PA165958410	7852	0.909
NULL	Br_J_Cancer_2010_Nov_9_103(11)_1692-1697.nxml.txt.nlp	21063402	SENT88	33	33	26	26	doxycycline	TRAIL	PA449415	8743	0.909
NULL	Oncotarget_2010_Oct_25_1(7)_497-514.nxml.txt.nlp	21165163	SENT266	38	38	23	23	gefitinib	EGFR	PA131301952	1956	0.909
NULL	Breast_Cancer_Res_2012_May_2_14(3)_R70.nxml.txt.nlp	22551440	SENT219	12	12	6	6	docetaxel	p53	PA449383	7157	0.909
NULL	Int_J_Biol_Sci_2013_Aug_27_9(8)_842-852.nxml.txt.nlp	23983617	SENT136	0	0	3	3	heparin	PPX	PA449855	5531	0.909
NULL	Br_J_Cancer_2012_Sep_4_107(6)_947-955.nxml.txt.nlp	22892392	SENT247	0	0	3	3	lapatinib	ERBB2	PA152241907	2064	0.909
NULL	Oncotarget_2012_Oct_20_3(10)_1068-1111.nxml.txt.nlp	23085539	SENT216	7	7	26	26	vemurafenib	MEK1	PA165946873	5604	0.909
NULL	Front_Oncol_2014_Apr_22_4_86.nxml.txt.nlp	24795863	SENT674	21	21	25	25	olaparib	BRCA1		672	0.909
NULL	Cell_Commun_Signal_2013_Nov_5_11_83.nxml.txt.nlp	24192293	SENT154	11	11	15	15	doxycycline	IL-6	PA449415	3569	0.909
NULL	Ann_Pediatr_Cardiol_2008_Jan-Jun_1(1)_18-26.nxml.txt.nlp	20300233	SENT189	3	3	18	18	flecainide	LQT7	PA449646	3759	0.909
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Sep_30_67(Pt_10)_o2733.nxml.txt.nlp	22065506	SENT5	10	10	1	1	phenol	mol	PA450913	90527	0.909
NULL	Front_Integr_Neurosci_2012_May_11_6_16.nxml.txt.nlp	22593737	SENT348	12	12	2	2	olanzapine	COMT	PA450688	1312	0.909
NULL	J_Thorac_Oncol_2014_Feb_23_9(2)_189-194.nxml.txt.nlp	24419415	SENT148	3	3	20	20	erlotinib	EGFR	PA134687924	1956	0.909
NULL	Cancer_Cell_Int_2005_Jun_1_5_18.nxml.txt.nlp	15929791	SENT48	29	29	7	7	bortezomib	p27	PA10252	5715;10534	0.909
NULL	Br_J_Cancer_2013_Jul_23_109(2)_502-511.nxml.txt.nlp	23799850	SENT34	8	8	14	14	gemcitabine	SMARCC1	PA449748	6599	0.909
NULL	Br_J_Cancer_2010_Jan_19_102(2)_383-391.nxml.txt.nlp	20010943	SENT99	0	0	19	19	cisplatin	P31	PA449014	529	0.909
NULL	Br_J_Cancer_2010_Jul_13_103(2)_186-195.nxml.txt.nlp	20588277	SENT154	30	30	14	14	nutlin-3	p53		7157	0.909
NULL	Oncogene_2011_Apr_28_30(17)_1984-1994.nxml.txt.nlp	21217774	SENT248	27	27	4	4	estradiol	RAC3	PA449503	5881;8202	0.909
NULL	AIDS_Res_Ther_2012_Mar_12_9_7.nxml.txt.nlp	22409770	SENT107	27	27	39	39	auranofin	CD27	PA448510	939	0.909
NULL	Oncotarget_2014_Jun_8_5(17)_7446-7457.nxml.txt.nlp	25277184	SENT33	21	21	29	29	cisplatin	p53	PA449014	7157	0.909
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_79-85.nxml.txt.nlp	23864840	SENT106	25	25	10	10	lapatinib	EGFR	PA152241907	1956	0.909
NULL	Biomed_Res_Int_2013_Jul_16_2013_953520.nxml.txt.nlp	23957013	SENT26	18	18	7	7	cyclosporine	P-gp	PA449167	5243	0.909
NULL	J_Neuroinflammation_2011_Feb_4_8_10.nxml.txt.nlp	21294877	SENT174	9	9	5	5	capsaicin	TRPV1	PA448776	7442	0.909
NULL	Mol_Cells_2014_Mar_31_37(3)_234-240.nxml.txt.nlp	24642709	SENT159	18	18	4	4	cisplatin	HO-1	PA449014	3162	0.909
NULL	Clinics_(Sao_Paulo)_2013_May_68(5)_694-701.nxml.txt.nlp	23778405	SENT124	4	4	9	9	curcumin	P-gp	PA151958596	5243	0.909
NULL	Br_J_Cancer_2012_Sep_25_107(7)_1009-1016.nxml.txt.nlp	22948724	SENT97	9	9	20	20	temsirolimus	PTEN	PA164746890	5728	0.909
NULL	Acta_Pharmacol_Sin_2012_Oct_3_33(10)_1311-1318.nxml.txt.nlp	22941289	SENT131	25	25	6	6	sorafenib	VEGFR2	PA7000	3791	0.909
NULL	Hum_Genomics_2008_Sep_1_3(1)_7-16.nxml.txt.nlp	19129086	SENT175	24	24	37	37	rosiglitazone	CYP2C8	PA451283	1558	0.909
NULL	Curr_Neuropharmacol_2008_Jun_6(2)_151-163.nxml.txt.nlp	19305794	SENT119	19	19	16	16	indomethacin	TRPV1	PA449982	7442	0.909
NULL	Acta_Pharmacol_Sin_2012_Aug_23_33(8)_1095-1100.nxml.txt.nlp	22820908	SENT113	17	17	9	9	ilaprazole	CYP3A5	PA165947499	1577	0.909
NULL	Mol_Cell_Proteomics_2013_Oct_22_12(10)_2791-2803.nxml.txt.nlp	23793018	SENT130	16	16	25	25	galactose	GAL	PA449725	51083	0.909
NULL	Br_J_Cancer_2011_Jul_26_105(3)_372-381.nxml.txt.nlp	21730979	SENT171	4	4	20	20	caffeine	ATR	PA448710	390502;84168;545	0.909
NULL	AAPS_J_2013_Aug_20_15(4)_1119-1127.nxml.txt.nlp	23959685	SENT223	6	6	13	13	ketoprofen	CPE	PA450149	1363	0.909
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT279	9	9	2	2	acetaminophen	IL-10	PA448015	3586	0.909
NULL	Environ_Health_Perspect_2008_Mar_26_116(3)_322-328.nxml.txt.nlp	18335098	SENT109	34	34	1	1	estradiol	PMI	PA449503	8834;5373	0.909
NULL	Breast_Cancer_Res_2009_Nov_17_11(6)_R84.nxml.txt.nlp	19919679	SENT120	30	30	44	44	vinorelbine	HER2	PA451881	2064	0.909
NULL	Carcinogenesis_2010_Dec_27_31(12)_2049-2057.nxml.txt.nlp	20876285	SENT336	21	21	9	9	tamoxifen	Bcl-2	PA451581	596	0.909
NULL	Arch_Med_Sci_2014_Feb_24_10(1)_154-160.nxml.txt.nlp	24701228	SENT133	27	27	13	13	thrombin	MCP-1	PA451674	6347	0.909
NULL	Ann_Hematol_2010_Sep_13_89(9)_861-871.nxml.txt.nlp	20387067	SENT212	10	10	16	16	dasatinib	CD34	PA162372878	947	0.909
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT242	16	16	2	2	doxorubicin	ABCB1	PA449412	5243	0.909
NULL	Pharmaceutics_2011_Oct_12_3(4)_680-705.nxml.txt.nlp	24309303	SENT69	22	22	31	31	glibenclamide	OATP2B1	PA449782	11309	0.909
NULL	Nat_Commun_2014_Jun_25_5_4182.nxml.txt.nlp	24964370	SENT221	28	28	10	10	cisplatin	CT26	PA449014	168400	0.909
NULL	J_Cancer_2013_Sep_27_4(8)_662-670.nxml.txt.nlp	24155778	SENT53	19	19	11	11	cisplatin	UCHL1	PA449014	7345	0.909
NULL	Arthritis_Res_Ther_2010_Feb_24_12(1)_R32.nxml.txt.nlp	20181277	SENT222	17	17	3	3	imatinib	M-CSF	PA10804	1435	0.909
NULL	Ann_Oncol_2009_Sep_18_20(9)_1499-1504.nxml.txt.nlp	19299408	SENT178	19	19	1	1	letrozole	HER-2	PA450196	2064	0.909
NULL	Cardiovasc_Res_2010_Oct_1_88(1)_51-57.nxml.txt.nlp	20558439	SENT98	21	21	2	2	ethanol	ALDH2	PA448073	217	0.909
NULL	J_Invest_Dermatol_2011_Jul_31_131(7)_1579-1583.nxml.txt.nlp	21451543	SENT20	19	19	32	32	collagenase	BRAF	PA449107	673	0.909
NULL	Br_J_Pharmacol_2008_Nov_11_155(6)_896-905.nxml.txt.nlp	18695641	SENT150	0	0	23	23	genistein	RANKL	PA165109660	8600	0.909
NULL	Mol_Cancer_2012_Jul_25_11_47.nxml.txt.nlp	22830443	SENT91	24	24	4	4	panitumumab	EGFR	PA162373091	1956	0.909
NULL	Indian_J_Endocrinol_Metab_2013_Jan-Feb_17(1)_91-94.nxml.txt.nlp	23776858	SENT106	14	14	22	22	exenatide	GLP-1	PA164749238	100125288	0.909
NULL	J_Inflamm_(Lond)_2007_May_4_4_10.nxml.txt.nlp	17480224	SENT303	34	34	26	26	ketamine	IL-4	PA450144	3565	0.909
NULL	Int_J_Hypertens_2012_Jan_19_2012_594361.nxml.txt.nlp	22315665	SENT257	28	28	25	25	fasudil	Rho	PA165946121	29984	0.909
NULL	BMB_Rep_2014_Jan_47(1)_33-38.nxml.txt.nlp	24209634	SENT112	28	28	13	13	cisplatin	CXCR4	PA449014	7852	0.909
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Aug_27_67(Pt_9)_o2492.nxml.txt.nlp	22059042	SENT56	23	23	17	17	ethanol	mol	PA448073	90527	0.909
NULL	Ann_Biomed_Eng_2011_Apr_1_39(4)_1174-1185.nxml.txt.nlp	21120695	SENT172	19	19	7	7	calcein	DM1	PA132595336	338023;1760;28509	0.909
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Aug_13_64(Pt_9)_o1743.nxml.txt.nlp	21201725	SENT57	21	21	15	15	ethanol	mol	PA448073	90527	0.909
NULL	Oncol_Lett_2014_Oct_31_8(4)_1849-1855.nxml.txt.nlp	25202424	SENT17	2	2	10	10	bevacizumab	VEGF-A	PA130232992	7422	0.909
NULL	J_Breast_Cancer_2013_Jun_28_16(2)_133-137.nxml.txt.nlp	23843843	SENT35	13	13	30	30	curcumin	Bcl-2	PA151958596	596	0.909
NULL	Mol_Cancer_2010_Apr_23_9_87.nxml.txt.nlp	20416058	SENT177	35	35	44	44	etoposide	TRAIL	PA449552	8743	0.909
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT220	34	34	25	25	doxorubicin	ABCG2	PA449412	9429	0.909
NULL	Breast_Cancer_Res_Treat_2013_Jan_6_137(1)_167-174.nxml.txt.nlp	23129173	SENT177	11	11	26	26	letrozole	CYP19A1	PA450196	1588	0.909
NULL	J_Carcinog_2011_Jun_17_10_16.nxml.txt.nlp	NULL	SENT74	25	25	15	15	resveratrol	p53		7157	0.909
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT85	7	7	12	12	trastuzumab	IL-10	PA451743	3586	0.909
NULL	Exp_Diabetes_Res_2012_May_28_2012_924168.nxml.txt.nlp	22693487	SENT20	9	9	12	12	liraglutide	GLP-1	PA165958364	100125288	0.909
NULL	Mediators_Inflamm_2011_Jun_28_2011_949072.nxml.txt.nlp	21772670	SENT143	6	6	11	11	estradiol	APOE	PA449503	348	0.909
NULL	Int_J_Endocrinol_2010_Feb_10_2010_625852.nxml.txt.nlp	20169119	SENT123	8	8	35	35	paricalcitol	PTH	PA450798	5741	0.909
NULL	Ind_Psychiatry_J_2012_Jul-Dec_21(2)_163-167.nxml.txt.nlp	24250054	SENT77	3	3	8	8	buspirone	5-HT1A	PA448689	3350	0.909
NULL	Clin_J_Gastroenterol_2012_Apr_28_5(2)_141-145.nxml.txt.nlp	22593772	SENT15	21	21	16	16	ribavirin	IFN	PA451241	3439	0.909
NULL	Cardiovasc_Res_2014_Mar_1_101(3)_513-521.nxml.txt.nlp	24323316	SENT156	10	10	6	6	maraviroc	CCL4	PA164768835	6351	0.909
NULL	Cell_Death_Dis_2014_Feb_27_5(2)_e1093.nxml.txt.nlp	24577091	SENT93	17	17	10	10	curcumin	AP-1	PA151958596	2353;3727;2354;3725	0.909
NULL	Adv_Biomed_Res_2014_Feb_28_3_82.nxml.txt.nlp	24761390	SENT77	5	5	15	15	asparaginase	SDS	PA448492	51119;10993	0.909
NULL	Br_J_Haematol_2008_Jun_141(5)_659-671.nxml.txt.nlp	18410446	SENT168	16	16	24	24	cerulenin	JNK	PA164764551	5599	0.909
NULL	Diabetes_Metab_Syndr_Obes_2010_Jul_9_3_227-242.nxml.txt.nlp	21437091	SENT179	0	0	9	9	exenatide	PPG	PA164749238	5552	0.909
NULL	BMB_Rep_2014_Jan_47(1)_1-7.nxml.txt.nlp	24388105	SENT68	3	3	14	14	pravastatin	LOX-1	PA451089	4973	0.909
NULL	Ann_Rheum_Dis_2010_Dec_27_70(5)_755-759.nxml.txt.nlp	21187298	SENT158	13	13	9	9	tocilizumab	IL-6	PA165292659	3569	0.909
NULL	Ann_N_Y_Acad_Sci_2013_Apr_29_1281(1)_1-15.nxml.txt.nlp	23360422	SENT86	14	14	7	7	choline	DIPP	PA448976	11165	0.909
NULL	Arthritis_Res_Ther_2011_Dec_9_13(6)_R202.nxml.txt.nlp	22152723	SENT114	34	34	9	9	canakinumab	IL-6	PA165958358	3569	0.909
NULL	Mar_Drugs_2010_Oct_14_8(10)_2659-2672.nxml.txt.nlp	21116413	SENT59	18	18	7	7	daunorubicin	Bcl-2	PA449212	596	0.909
NULL	Mediators_Inflamm_1995_Jul_4(4)_263-269.nxml.txt.nlp	18475649	SENT13	10	10	14	14	heparin	IL-8	PA449855	3576	0.909
NULL	J_Oncol_2010_Dec_14_2010_426956.nxml.txt.nlp	20049170	SENT298	29	29	5	5	genistein	CXCR4	PA165109660	7852	0.909
NULL	Mol_Cancer_2010_Aug_20_9_220.nxml.txt.nlp	20727180	SENT150	16	16	12	12	nicotine	p53	PA450626	7157	0.909
NULL	Breast_Cancer_Res_2009_Jun_29_11(3)_R41.nxml.txt.nlp	19563669	SENT278	29	29	12	12	gefitinib	XIAP	PA131301952	331	0.909
NULL	Oncotarget_2013_Jun_4_4(5)_772-784.nxml.txt.nlp	23800712	SENT131	45	45	2	2	erlotinib	EGFR	PA134687924	1956	0.909
NULL	Inflammation_2014_Sep_5_37(1)_1-9.nxml.txt.nlp	24005897	SENT152	17	17	28	28	diclofenac	COX	PA449293	1351	0.909
NULL	Oncogene_2010_Jul_22_29(29)_4170-4182.nxml.txt.nlp	20498638	SENT121	2	2	20	20	cetuximab	PI3K	PA10040	5290	0.909
NULL	Cent_European_J_Urol_2013_Dec_19_66(4)_394-404.nxml.txt.nlp	24757527	SENT177	45	45	38	38	temsirolimus	AKT	PA164746890	207	0.909
NULL	Cell_Commun_Signal_2004_Jun_30_2_6.nxml.txt.nlp	15228623	SENT96	26	26	3	3	verapamil	TTN	PA451868	7273	0.909
NULL	Cancer_Cell_Int_2005_Jul_24_5_22.nxml.txt.nlp	16042792	SENT116	20	20	7	7	probenecid	MRP1	PA451106	4437	0.909
NULL	J_Cell_Mol_Med_2014_Sep_7_18(9)_1785-1796.nxml.txt.nlp	24909956	SENT238	18	18	13	13	montelukast	GPR17	PA450546	2840	0.909
NULL	Oncotarget_2014_Jun_6_5(13)_4935-4944.nxml.txt.nlp	24952732	SENT111	5	5	19	19	doxazosin	PDK1	PA449407	5170;5163	0.909
NULL	Oncoimmunology_2012_Dec_1_1(9)_1661-1663.nxml.txt.nlp	23264929	SENT9	30	30	8	8	imiquimod	TLR7	PA449972	51284	0.909
NULL	Lab_Invest_2011_Jun_14_91(6)_852-858.nxml.txt.nlp	21403643	SENT15	18	18	1	1	tenofovir	OAT1	PA10204	9356	0.909
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Oct_20_66(Pt_11)_o2853.nxml.txt.nlp	21589038	SENT49	19	19	13	13	ethanol	mol	PA448073	90527	0.909
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1033-1038.nxml.txt.nlp	22374460	SENT187	28	28	4	4	capecitabine	HER2	PA448771	2064	0.909
NULL	Clin_Cosmet_Investig_Dermatol_2013_Mar_14_6_75-80.nxml.txt.nlp	23515267	SENT84	5	5	7	7	etanercept	TNF-alpha	PA449515	7124	0.909
NULL	Int_J_Hypertens_2013_Jul_22_2013_808353.nxml.txt.nlp	23970958	SENT145	22	22	0	0	collagenase	EGFR	PA449107	1956	0.909
NULL	J_Cancer_2013_Nov_14_4(9)_703-715.nxml.txt.nlp	24312140	SENT223	22	22	9	9	resveratrol	BRCA2		675	0.909
NULL	Clin_Interv_Aging_2009_May_14_4_197-205.nxml.txt.nlp	19503782	SENT315	7	7	13	13	cyclosporine	CD33	PA449167	945	0.909
NULL	Clin_Sarcoma_Res_2014_Jun_26_4_5.nxml.txt.nlp	25018868	SENT221	10	10	7	7	letrozole	aromatase	PA450196	1588	0.909
NULL	Alzheimers_Res_Ther_2010_Oct_29_2(5)_31.nxml.txt.nlp	21062519	SENT65	5	5	13	13	simvastatin	PSEN1	PA451363	5663	0.909
NULL	Surg_Res_Pract_2014_Feb_6_2014_801643.nxml.txt.nlp	25379560	SENT12	21	21	8	8	cyclosporine	CD25	PA449167	3669;3559	0.909
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_May_22_66(Pt_6)_o1399.nxml.txt.nlp	21579478	SENT47	19	19	13	13	ethanol	mol	PA448073	90527	0.909
NULL	Cardiol_Res_Pract_2011_May_10_2011_816897.nxml.txt.nlp	21629798	SENT131	13	13	3	3	clarithromycin	CYP3A4	PA449028	1576	0.909
NULL	Front_Pharmacol_2014_Nov_21_5_257.nxml.txt.nlp	25484865	SENT247	10	10	6	6	imatinib	ABCB1	PA10804	5243	0.909
NULL	Pharmaceuticals_(Basel)_2011_Jan_26_4(2)_285-342.nxml.txt.nlp	NULL	SENT2260	15	15	4	4	venlafaxine	5-HT1A	PA451866	3350	0.909
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Dec_17_3(12)_e152.nxml.txt.nlp	25518025	SENT17	10	10	35	35	quinidine	CYP3A	PA451209	1574	0.909
NULL	Ann_Rheum_Dis_2014_Sep_18_73(9)_1607-1615.nxml.txt.nlp	24641941	SENT229	12	12	8	8	tocilizumab	IL-6	PA165292659	3569	0.909
NULL	Case_Rep_Oncol_2013_Sep_10_6(3)_450-455.nxml.txt.nlp	24163659	SENT67	25	25	13	13	trastuzumab	HER2	PA451743	2064	0.909
NULL	Biomed_Res_Int_2013_Mar_31_2013_826435.nxml.txt.nlp	23662285	SENT48	28	28	20	20	cetuximab	EGFR	PA10040	1956	0.909
NULL	Mol_Cancer_2012_Dec_12_11_91.nxml.txt.nlp	23234355	SENT199	11	11	19	19	cetuximab	EGFR	PA10040	1956	0.909
NULL	Diabetes_Care_2013_Aug_17_36(Suppl_2)_S325-S330.nxml.txt.nlp	23882066	SENT125	35	35	31	31	amiodarone	CYP2C9	PA448383	1559	0.909
NULL	Lab_Invest_2009_Nov_7_89(11)_1275-1290.nxml.txt.nlp	19736547	SENT378	14	14	8	8	curcumin	LOX-1	PA151958596	4973	0.909
NULL	Diabetes_Care_2013_Aug_17_36(Suppl_2)_S180-S189.nxml.txt.nlp	23882044	SENT80	34	34	4	4	exenatide	GLP-1	PA164749238	100125288	0.909
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT300	6	6	13	13	resveratrol	survivin		332	0.909
NULL	Front_Aging_Neurosci_2010_Mar_19_2_11.nxml.txt.nlp	20552049	SENT311	2	2	33	33	sulindac	GluN1	PA451565	2902	0.909
NULL	Open_Cardiovasc_Med_J_2014_Feb_7_8_12-17.nxml.txt.nlp	24653785	SENT103	7	7	13	13	atorvastatin	CYP3A5	PA448500	1577	0.909
NULL	EMBO_Mol_Med_2013_Aug_5_5(8)_1149-1150.nxml.txt.nlp	23918227	SENT34	23	23	8	8	rituximab	MYC	PA451261	4609	0.909
NULL	Oncogene_2013_Sep_12_32(37)_4355-4365.nxml.txt.nlp	23108409	SENT66	9	9	37	37	hyaluronan	ZO-1	PA165958431	7082	0.909
NULL	Cancers_(Basel)_2014_Feb_13_6(1)_396-415.nxml.txt.nlp	24531055	SENT91	17	17	26	26	cisplatin	periostin	PA449014	10631	0.909
NULL	Ecancermedicalscience_2008_Jul_8_2_63.nxml.txt.nlp	22275960	SENT94	5	5	7	7	tamoxifen	aromatase	PA451581	1588	0.909
NULL	J_Cell_Biol_2008_Jan_28_180(2)_417-426.nxml.txt.nlp	18227283	SENT36	20	20	18	18	letrozole	aromatase	PA450196	1588	0.909
NULL	J_Inherit_Metab_Dis_2013_Jan_23_36(1)_29-34.nxml.txt.nlp	22729817	SENT133	20	20	10	10	estradiol	AMH	PA449503	268	0.909
NULL	Basic_Clin_Neurosci_2014_Winter_5(1)_66-73.nxml.txt.nlp	25436086	SENT126	2	2	4	4	lidocaine	LHA	PA450226	1081	0.909
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R91.nxml.txt.nlp	22541814	SENT40	13	13	3	3	thrombin	PAR-1	PA451674	2011;2149	0.909
NULL	Mol_Cancer_2014_Jun_19_13_154.nxml.txt.nlp	24941944	SENT55	24	24	9	9	cisplatin	BRAF	PA449014	673	0.909
NULL	Pharmaceuticals_(Basel)_2013_Mar_14_6(3)_295-319.nxml.txt.nlp	23894227	SENT196	37	37	8	8	trypsin	PC3	PA451806	57332;7832;5122	0.909
NULL	Clin_Interv_Aging_2012_Dec_30_7_1-13.nxml.txt.nlp	22291468	SENT267	22	22	15	15	voriconazole	CYP3A4	PA10233	1576	0.909
NULL	J_Korean_Med_Sci_2007_Jun_30_22(3)_557-559.nxml.txt.nlp	17596671	SENT16	0	0	5	5	warfarin	CYP2C9	PA451906	1559	0.909
NULL	J_Hematol_Oncol_2008_Oct_23_1_19.nxml.txt.nlp	18947412	SENT54	2	2	12	12	alemtuzumab	CD34	PA164783958	947	0.909
NULL	Curr_Neuropharmacol_2008_Jun_6(2)_151-163.nxml.txt.nlp	19305794	SENT28	25	25	3	3	capsaicin	TRPV1	PA448776	7442	0.909
NULL	Clin_Pharmacokinet_2014_Aug_21_53(10)_931-941.nxml.txt.nlp	25141974	SENT3	24	24	22	22	midazolam	CYP3A	PA450496	1574	0.909
NULL	Case_Rep_Psychiatry_2012_Jun_5_2012_496364.nxml.txt.nlp	22934218	SENT46	11	11	19	19	olanzapine	FGA	PA450688	2243	0.909
NULL	Oncol_Rep_2014_Jul_15_32(1)_45-49.nxml.txt.nlp	24841138	SENT11	16	16	10	10	pp2	MMP2		4313	0.909
NULL	Protein_Eng_Des_Sel_2011_Jul_3_24(7)_565-578.nxml.txt.nlp	21642284	SENT224	32	32	13	13	spectinomycin	p85	PA164781342	5296;5295;54776;23368	0.909
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2675-2684.nxml.txt.nlp	24129246	SENT187	29	29	19	19	doxorubicin	KSR1	PA449412	8844	0.909
NULL	Eur_J_Haematol_2009_Apr_82(4)_277-287.nxml.txt.nlp	19187270	SENT186	10	10	23	23	pha-665752	MM1		23654	0.909
NULL	Curr_Neuropharmacol_2009_Dec_7(4)_269-275.nxml.txt.nlp	20514206	SENT3	7	7	16	16	tetracycline	AT1	PA451640	9197;185	0.909
NULL	J_Biol_Chem_2013_Nov_15_288(46)_33016-33026.nxml.txt.nlp	24089531	SENT245	35	35	1	1	nadh	NDUFS7	PA164755085	374291	0.909
NULL	Aging_(Albany_NY)_2012_Jul_22_4(7)_480-498.nxml.txt.nlp	22837425	SENT89	14	14	1	1	metformin	LKB1	PA450395	6794	0.909
NULL	Int_J_Mol_Sci_2012_Sep_26_13(10)_12268-12286.nxml.txt.nlp	23202898	SENT876	16	16	5	5	trastuzumab	PI3K	PA451743	5290	0.909
NULL	EPMA_J_2010_Mar_13_1(1)_138-163.nxml.txt.nlp	23199048	SENT212	10	10	19	19	metformin	B12	PA450395	7126;4709	0.909
NULL	Exp_Ther_Med_2013_Nov_6_6(5)_1089-1095.nxml.txt.nlp	24223627	SENT32	26	26	2	2	epirubicin	NAC	PA449476	22861	0.909
NULL	Oncol_Lett_2014_Mar_19_7(3)_674-678.nxml.txt.nlp	24527071	SENT135	14	14	3	3	cisplatin	AKR1C2	PA449014	1646	0.909
NULL	Br_J_Cancer_2011_Sep_6_105(6)_807-813.nxml.txt.nlp	21847121	SENT86	29	29	11	11	pha-665752	HER3		2065	0.909
NULL	Cancer_Cell_Int_2009_Feb_17_9_4.nxml.txt.nlp	19222856	SENT231	31	31	46	46	cisplatin	p53	PA449014	7157	0.909
NULL	Diabetes_2013_Jun_17_62(6)_2141-2150.nxml.txt.nlp	23378610	SENT177	10	10	1	1	betaine	SLC6A12	PA448603	6539	0.909
NULL	Br_J_Cancer_2011_Nov_22_105(11)_1654-1662.nxml.txt.nlp	22045187	SENT132	37	37	3	3	irinotecan	UGT1A1	PA450085	54658	0.909
NULL	Chemother_Res_Pract_2011_Feb_6_2011_249867.nxml.txt.nlp	22312550	SENT47	17	17	9	9	moxifloxacin	CAP	PA450555	23476;9200;4012;5269;10580;10487	0.909
NULL	Chin_J_Cancer_2011_Nov_30(11)_739-748.nxml.txt.nlp	22035854	SENT41	19	19	13	13	fludarabine	p53	PA449655	7157	0.909
NULL	J_Gynecol_Oncol_2013_Jul_4_24(3)_273-279.nxml.txt.nlp	23875078	SENT112	7	7	26	26	paclitaxel	P-gp	PA450761	5243	0.909
NULL	Int_J_Endocrinol_2011_Jun_2_2011_251410.nxml.txt.nlp	21747852	SENT143	3	3	14	14	cinacalcet	PTH	PA164776671	5741	0.909
NULL	Diabetes_Care_2010_Apr_12_33(4)_730-732.nxml.txt.nlp	20067974	SENT44	26	26	2	2	vildagliptin	GLP-1	PA165958346	100125288	0.909
NULL	Onco_Targets_Ther_2014_Dec_3_7_2237-2248.nxml.txt.nlp	25506227	SENT126	0	0	14	14	brivanib	VEGFR	PA164924492	3791	0.909
NULL	Exp_Ther_Med_2014_Apr_13_7(4)_843-848.nxml.txt.nlp	24660032	SENT12	4	4	38	38	resveratrol	Bcl-2		596	0.909
NULL	Acta_Pharmacol_Sin_2013_Jun_20_34(6)_732-740.nxml.txt.nlp	23685952	SENT186	11	11	4	4	cyclophosphamide	VEGFR2	PA449165	3791	0.909
NULL	Curr_Oncol_2009_Jul_16(Suppl_2)_S1-S13.nxml.txt.nlp	19672416	SENT72	14	14	11	11	exemestane	aromatase	PA449563	1588	0.909
NULL	Hum_Genomics_2010_Apr_1_4(4)_238-249.nxml.txt.nlp	20511137	SENT89	22	22	7	7	raltegravir	UGT1A1		54658	0.909
NULL	Front_Endocrinol_(Lausanne)_2013_Nov_11_4_166.nxml.txt.nlp	24273531	SENT244	38	38	14	14	losartan	ANG	PA450268	283	0.909
NULL	Cancer_Cell_Int_2007_Sep_10_7_14.nxml.txt.nlp	17845729	SENT262	28	28	20	20	decitabine	GADD45A	PA164749631	1647	0.909
NULL	Mol_Neurodegener_2011_Aug_8_6_57.nxml.txt.nlp	21819629	SENT53	36	36	14	14	arsenite	TDP-43	PA452638	23435	0.909
NULL	Cell_Cycle_2012_Sep_1_11(17)_3143-3144.nxml.txt.nlp	22894901	SENT31	20	20	14	14	etoposide	TOP2B	PA449552	7155	0.909
NULL	Neuropsychopharmacology_2009_Jul_11_34(8)_1946-1957.nxml.txt.nlp	19279569	SENT160	7	7	17	17	cocaine	DOR	PA449072	58476	0.909
NULL	Int_J_Med_Sci_2013_Feb_11_10(3)_320-330.nxml.txt.nlp	23423768	SENT94	6	6	26	26	gefitinib	EGFR	PA131301952	1956	0.909
NULL	Biomed_Res_Int_2014_Jun_2_2014_946492.nxml.txt.nlp	24991574	SENT162	2	2	36	36	olmesartan	p40phox	PA164742950	4689	0.909
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT246	13	13	11	11	zosuquidar	ABCB1		5243	0.909
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1013.nxml.txt.nlp	24457957	SENT92	5	5	19	19	bortezomib	NOXA	PA10252	5366	0.909
NULL	Int_J_Endocrinol_2014_Jun_25_2014_534904.nxml.txt.nlp	25053942	SENT108	32	32	26	26	amiodarone	AIT	PA448383	160728	0.909
NULL	Br_J_Pharmacol_2012_Apr_165(7)_2191-2202.nxml.txt.nlp	21958009	SENT176	12	12	18	18	ketanserin	5-HT2A	PA131053734	3356	0.909
NULL	Breast_Cancer_Res_2007_Jan_23_9(1)_R7.nxml.txt.nlp	17244352	SENT112	9	9	15	15	tamoxifen	SULT1A1	PA451581	6817	0.909
NULL	J_Cancer_Prev_2014_Mar_19(1)_39-46.nxml.txt.nlp	25337571	SENT117	11	11	5	5	ethanol	p53	PA448073	7157	0.909
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2008_Sep_1_64(Pt_9)_977-984.nxml.txt.nlp	18703847	SENT52	24	24	11	11	thrombin	DHFR	PA451674	1719	0.909
NULL	J_Bras_Pneumol_2013_Nov-Dec_39(6)_644-649.nxml.txt.nlp	24473757	SENT79	15	15	22	22	metformin	LKB1	PA450395	6794	0.909
NULL	Neural_Regen_Res_2014_May_15_9(10)_1055-1062.nxml.txt.nlp	25206759	SENT153	5	5	0	0	fluorescein	NKCC1	PA164746009	6558	0.909
NULL	Cell_Commun_Signal_2010_Jun_12_8_11.nxml.txt.nlp	20540792	SENT335	29	29	20	20	thalidomide	CRBN	PA451644	51185	0.909
NULL	Ital_J_Pediatr_2012_Jun_26_38_29.nxml.txt.nlp	22734451	SENT107	32	32	39	39	montelukast	URI	PA450546	8725	0.909
NULL	J_Cell_Biol_2001_Dec_10_155(6)_893-898.nxml.txt.nlp	11733546	SENT151	10	10	14	14	glutaraldehyde	MAP1B	PA449777	4131	0.909
NULL	Diabetes_2009_Jan_58(1)_250-259.nxml.txt.nlp	18840786	SENT279	36	36	9	9	rosiglitazone	FGF21	PA451283	26291	0.909
NULL	Oncotarget_2012_Sep_28_3(10)_1169-1181.nxml.txt.nlp	23045411	SENT198	15	15	18	18	doxorubicin	JIP1	PA449412	9479	0.909
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT19	3	3	19	19	sulindac	survivin	PA451565	332	0.909
NULL	Avicenna_J_Phytomed_2012_Autumn_2(4)_212-221.nxml.txt.nlp	25050251	SENT188	11	11	21	21	metformin	STZ	PA450395	6484	0.909
NULL	Breast_Cancer_(Auckl)_2011_Jan_13_5_1-14.nxml.txt.nlp	21494397	SENT52	24	24	9	9	rifabutin	CYP3A4	PA451249	1576	0.909
NULL	Indian_J_Ophthalmol_2014_Oct_62(10)_999-1002.nxml.txt.nlp	25449934	SENT72	3	3	13	13	rituximab	TRO	PA451261	7216	0.909
NULL	Front_Cell_Neurosci_2015_Jan_15_8_459.nxml.txt.nlp	25642166	SENT39	4	4	1	1	hemin	HO-1	PA449849	3162	0.909
NULL	Anesth_Pain_Med_2014_Apr_7_4(2)_e15460.nxml.txt.nlp	24790902	SENT97	25	25	19	19	nicardipine	NTG	PA450620	4976	0.909
NULL	Clin_Med_Insights_Oncol_2011_Jun_23_5_185-199.nxml.txt.nlp	21792346	SENT60	12	12	30	30	dasatinib	ABL1	PA162372878	25	0.909
NULL	Turk_J_Haematol_2013_Dec_5_30(4)_387-393.nxml.txt.nlp	24385829	SENT119	20	20	15	15	imatinib	KIT	PA10804	3815	0.909
NULL	Anc_Sci_Life_2006_Jan-Jun_25(3-4)_28-32.nxml.txt.nlp	22557204	SENT3	37	37	6	6	piperazine	PEMP	PA450977	4354	0.909
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT99	10	10	5	5	nutlin-3	MDM2		4193	0.909
NULL	Nucleic_Acids_Res_2013_May_5_41(10)_5210-5222.nxml.txt.nlp	23563151	SENT21	0	0	15	15	arsenite	GADD45	PA452638	1647	0.909
NULL	Tuberc_Respir_Dis_(Seoul)_2014_Mar_29_76(3)_99-104.nxml.txt.nlp	24734096	SENT88	0	0	13	13	oxygen	CO2	PA450744	4513	0.909
NULL	Oncogene_2013_Sep_26_32(39)_10_1038_onc_2012_491.nxml.txt.nlp	23108394	SENT89	16	16	4	4	epirubicin	BRIP1	PA449476	64979;83990	0.909
NULL	Br_J_Cancer_2012_Feb_14_106(4)_646-650.nxml.txt.nlp	22240794	SENT92	30	30	32	32	sunitinib	IFN	PA162372840	3439	0.909
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT72	5	5	7	7	erlotinib	EGFR	PA134687924	1956	0.909
NULL	Osteopath_Med_Prim_Care_2009_Jan_6_3_1.nxml.txt.nlp	19126235	SENT55	8	8	12	12	naproxen	OTC	PA450595	5009	0.909
NULL	Crit_Care_2009_Mar_13_13(Suppl_1)_P328.nxml.txt.nlp	NULL	SENT18	2	2	15	15	etomidate	RAI	PA164743987	10848;6050	0.909
NULL	J_Inherit_Metab_Dis_2010_Oct_3_33(5)_625-632.nxml.txt.nlp	20814828	SENT111	10	10	26	26	simvastatin	RhoA	PA451363	387	0.909
NULL	Cancer_Med_2013_Jun_25_2(3)_277-285.nxml.txt.nlp	23930204	SENT182	40	40	11	11	cetuximab	PTEN	PA10040	5728	0.909
NULL	Front_Plant_Sci_2011_Jun_6_2_18.nxml.txt.nlp	22645527	SENT118	17	17	3	3	trypsin	MP17	PA451806	3982	0.909
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT301	2	2	13	13	atorvastatin	AKT	PA448500	207	0.909
NULL	Eur_J_Clin_Pharmacol_2011_May_9_67(5)_477-482.nxml.txt.nlp	21305273	SENT121	31	31	40	40	atropine	ADRB1	PA448505	153	0.909
NULL	Adv_Virol_2011_Mar_24_2011_260561.nxml.txt.nlp	22312337	SENT103	15	15	28	28	cidofovir	OTC	PA448997	5009	0.909
NULL	Front_Physiol_2013_Nov_14_4_323.nxml.txt.nlp	24294204	SENT200	17	17	8	8	carvedilol	CYP2D6	PA448817	1565	0.909
NULL	Drug_Target_Insights_2012_Aug_6_6_19-39.nxml.txt.nlp	22915839	SENT262	3	3	7	7	doxorubicin	Hsp90	PA449412	3320	0.909
NULL	EMBO_Mol_Med_2013_Dec_8_5(12)_1821-1834.nxml.txt.nlp	24293316	SENT113	40	40	27	27	doxorubicin	UNC5B	PA449412	219699	0.909
NULL	Neural_Plast_2000_7(4)_245-259.nxml.txt.nlp	11486485	SENT7	8	8	38	38	pentobarbital	hole	PA450859	80757	0.909
NULL	Indian_J_Dermatol_2010_Jul-Sep_55(3)_255-258.nxml.txt.nlp	21063518	SENT55	5	5	11	11	phenol	TRAIL	PA450913	8743	0.909
NULL	FEBS_Open_Bio_2012_Aug_22_2_279-283.nxml.txt.nlp	23650611	SENT104	14	14	11	11	raloxifene	IFN	PA451221	3439	0.909
NULL	Oncol_Lett_2013_Aug_4_6(2)_537-541.nxml.txt.nlp	24137363	SENT162	17	17	23	23	aldesleukin	IFN	PA448081	3439	0.909
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT104	0	0	13	13	pertuzumab	HER3		2065	0.909
NULL	Front_Mol_Neurosci_2012_May_7_5_60.nxml.txt.nlp	22586367	SENT139	8	8	4	4	ivermectin	P2X4	PA450133	5025	0.909
NULL	Diabetes_Care_2010_Feb_33(2)_453-455.nxml.txt.nlp	20103562	SENT63	24	24	9	9	exenatide	HIP	PA164749238	6767;6159;64399;5068	0.909
NULL	Cancer_Med_2013_Jun_2_2(3)_286-295.nxml.txt.nlp	23930205	SENT193	37	37	20	20	gefitinib	EGFR	PA131301952	1956	0.909
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT110	13	13	31	31	everolimus	PTEN	PA164746311	5728	0.909
NULL	Clin_Transl_Allergy_2013_Sep_2_3_29.nxml.txt.nlp	24004581	SENT129	21	21	14	14	omalizumab	IL-4	PA164752253	3565	0.909
NULL	Cancer_Cell_Int_2013_Jan_15_13_3.nxml.txt.nlp	23320839	SENT15	2	2	13	13	gemcitabine	MRP1	PA449748	4437	0.909
NULL	Cell_Death_Differ_2010_Mar_16_17(3)_499-512.nxml.txt.nlp	19834490	SENT11	6	6	17	17	bevacizumab	VEGFR2	PA130232992	3791	0.909
NULL	Diabetes_Metab_Syndr_Obes_2008_Oct_23_1_25-31.nxml.txt.nlp	21437153	SENT143	2	2	15	15	pioglitazone	MCP-1	PA450970	6347	0.909
NULL	Oncotarget_2011_Jun_15_2(6)_518-524.nxml.txt.nlp	21680956	SENT93	12	12	15	15	pimozide	STAT3	PA450965	6774	0.909
NULL	Mol_Cancer_2009_Apr_22_8_26.nxml.txt.nlp	19386116	SENT142	13	13	10	10	ritonavir	AKT	PA451260	207	0.909
NULL	Cell_Commun_Signal_2011_May_15_9_13.nxml.txt.nlp	21569639	SENT320	12	12	37	37	quinacrine	AKT	PA164745551	207	0.909
NULL	Front_Cell_Neurosci_2015_Jan_15_8_459.nxml.txt.nlp	25642166	SENT16	36	36	23	23	hemin	HO-1	PA449849	3162	0.909
NULL	Cell_Death_Dis_2014_Jul_17_5(7)_e1333.nxml.txt.nlp	25032856	SENT76	18	18	25	25	candesartan	TLR4	PA448765	7099	0.909
NULL	Sci_Rep_2014_Dec_3_4_7294.nxml.txt.nlp	25465236	SENT532	25	25	12	12	erlotinib	EGFR	PA134687924	1956	0.909
NULL	Ann_Clin_Microbiol_Antimicrob_2008_May_30_7_12.nxml.txt.nlp	18513394	SENT55	23	23	26	26	meropenem	PA1	PA164764445	79447	0.909
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT141	9	9	4	4	dasatinib	LYN	PA162372878	4067	0.909
NULL	J_Immunother_Cancer_2014_Jan_27_2_2.nxml.txt.nlp	24829759	SENT77	19	19	13	13	sorafenib	IL-21	PA7000	59067;50616;27189	0.909
NULL	J_Exp_Med_2000_Jun_5_191(11)_1905-1920.nxml.txt.nlp	10839806	SENT67	45	45	2	2	thrombin	Rho	PA451674	29984	0.909
NULL	J_Mol_Signal_2008_Mar_31_3_8.nxml.txt.nlp	18377662	SENT69	9	9	37	37	pp2	SHP-1		5777	0.909
NULL	Mol_Cancer_2010_Nov_2_9_289.nxml.txt.nlp	21044322	SENT165	21	21	6	6	cisplatin	RGS10	PA449014	6001	0.909
NULL	J_Cell_Biol_2003_Dec_8_163(5)_1099-1109.nxml.txt.nlp	14662748	SENT18	14	14	5	5	vasopressin	AVP	PA451858	114548;551	0.909
NULL	Brain_Res_2013_Jul_12_1521(100)_1-15.nxml.txt.nlp	22789905	SENT835	14	14	12	12	verapamil	P-gp	PA451868	5243	0.909
NULL	J_Invest_Dermatol_2012_Sep_10_132(9)_2255-2262.nxml.txt.nlp	22572817	SENT105	25	25	9	9	forskolin	HBD3	PA146096022	414325	0.909
NULL	Cancer_Imaging_2009_Jun_29_9(1)_35-43.nxml.txt.nlp	19602470	SENT38	12	12	24	24	diazepam	FDG	PA449283	23583	0.909
NULL	Genome_Biol_2003_Oct_15_4(11)_233.nxml.txt.nlp	14611650	SENT112	37	37	45	45	galactose	MAL	PA449725	57591;4118	0.909
NULL	J_Hematol_Oncol_2012_Oct_11_5_63.nxml.txt.nlp	23057939	SENT118	0	0	11	11	sunitinib	KIT	PA162372840	3815	0.909
NULL	Ann_Coloproctol_2014_Aug_26_30(4)_165-174.nxml.txt.nlp	25210685	SENT143	8	8	15	15	panitumumab	KRAS	PA162373091	3845	0.909
NULL	Oncol_Lett_2013_Mar_14_5(3)_756-760.nxml.txt.nlp	23426872	SENT10	4	4	9	9	cisplatin	STAT3	PA449014	6774	0.909
NULL	Clin_Med_Insights_Case_Rep_2014_Oct_1_7_117-121.nxml.txt.nlp	25336995	SENT33	22	22	37	37	etoposide	CD34	PA449552	947	0.909
NULL	Mol_Cancer_2008_Jun_5_7_50.nxml.txt.nlp	18534018	SENT59	13	13	3	3	bortezomib	p53	PA10252	7157	0.909
NULL	Breast_Cancer_Res_2011_Mar_10_13(2)_R28.nxml.txt.nlp	21392397	SENT232	29	29	32	32	erlotinib	PI3K	PA134687924	5290	0.909
NULL	Pharmaceutics_2011_Dec_9_3(4)_932-953.nxml.txt.nlp	24309315	SENT164	23	23	8	8	amiloride	ASIC1	PA448368	41	0.909
NULL	Diabetes_Care_2012_Feb_16_35(2)_327-333.nxml.txt.nlp	22179958	SENT3	21	21	36	36	metformin	B12	PA450395	7126;4709	0.909
NULL	Oncol_Lett_2014_May_26_7(5)_1345-1351.nxml.txt.nlp	24765136	SENT110	0	0	20	20	nilotinib	AMPK	PA165958345	5563	0.909
NULL	Ann_Rheum_Dis_2015_Jan_23_74(1)_252-259.nxml.txt.nlp	24152419	SENT117	10	10	8	8	capsaicin	TRPV1	PA448776	7442	0.909
NULL	Mol_Cancer_2009_Aug_25_8_66.nxml.txt.nlp	19706164	SENT159	0	0	11	11	celecoxib	LC3	PA448871	84557	0.909
NULL	Ann_Oncol_2010_Mar_18_21(3)_655-661.nxml.txt.nlp	19767314	SENT226	22	22	17	17	trastuzumab	HER2	PA451743	2064	0.909
NULL	Adv_Hematol_2012_May_8_2012_393864.nxml.txt.nlp	22851972	SENT186	21	21	26	26	fludarabine	TP53	PA449655	7157	0.909
NULL	Breast_Cancer_Res_2005_Jan_28_7(3)_R284-R290.nxml.txt.nlp	15987423	SENT29	11	11	21	21	tamoxifen	CYP2D6	PA451581	1565	0.909
NULL	Cancer_Cell_Int_2013_Sep_23_13_94.nxml.txt.nlp	24059699	SENT125	5	5	16	16	bevacizumab	VEGFR2	PA130232992	3791	0.909
NULL	Amino_Acids_2014_Feb_20_46(5)_1275-1283.nxml.txt.nlp	24553827	SENT22	22	22	34	34	taurine	CDO	PA451590	50937	0.909
NULL	Osteoporos_Int_2012_Jan_3_23(1)_327-337.nxml.txt.nlp	21892677	SENT281	4	4	9	9	denosumab	aromatase	PA166048634	1588	0.909
NULL	Carcinogenesis_2010_Dec_27_31(12)_2049-2057.nxml.txt.nlp	20876285	SENT152	32	32	6	6	tamoxifen	HER2	PA451581	2064	0.909
NULL	J_Exp_Bot_2009_Apr_8_60(6)_1859-1871.nxml.txt.nlp	19357433	SENT84	27	27	36	36	kanamycin	NAGS	PA450137	162417	0.909
NULL	Indian_J_Endocrinol_Metab_2013_Dec_17(Suppl_3)_S674-S679.nxml.txt.nlp	24910836	SENT142	4	4	8	8	acarbose	PPG	PA448010	5552	0.909
NULL	Br_J_Cancer_2001_Sep_85(6)_902-908.nxml.txt.nlp	11556844	SENT7	3	3	17	17	vinblastine	MN1	PA451877	4330	0.909
NULL	Ann_Gastroenterol_2015_Jan-Mar_28(1)_55-65.nxml.txt.nlp	25608803	SENT138	32	32	4	4	boceprevir	IL28B	PA165948902	282617	0.909
NULL	Aging_(Albany_NY)_2010_Aug_5_2(8)_527-534.nxml.txt.nlp	20689156	SENT21	3	3	12	12	resveratrol	SIRT1		23411	0.909
NULL	J_Thromb_Thrombolysis_2012_Feb_20_33(2)_143-153.nxml.txt.nlp	22183178	SENT262	11	11	8	8	clopidogrel	ADP	PA449053	23038	0.909
NULL	J_Exp_Clin_Cancer_Res_2009_Feb_14_28(1)_18.nxml.txt.nlp	19216794	SENT67	9	9	19	19	ertumaxomab	GMP	PA165291442	22978	0.909
NULL	J_Invest_Dermatol_2014_Jul_31_134(7)_1903-1911.nxml.txt.nlp	24487305	SENT221	21	21	2	2	chloroquine	HLA-A	PA448948	3105	0.909
NULL	Oncotarget_2012_Oct_20_3(10)_1068-1111.nxml.txt.nlp	23085539	SENT532	30	30	27	27	neratinib	HER2	PA165291472	2064	0.909
NULL	Pharmaceuticals_(Basel)_2014_Apr_10_7(4)_433-452.nxml.txt.nlp	24727459	SENT382	18	18	28	28	ketoconazole	CYP3A4	PA450146	1576	0.909
NULL	Br_J_Cancer_2009_Mar_24_100(6)_941-949.nxml.txt.nlp	19240716	SENT126	37	37	13	13	gefitinib	Met	PA131301952	79811	0.909
NULL	J_Radiat_Res_2012_Jul_12_53(4)_551-557.nxml.txt.nlp	22843620	SENT59	28	28	39	39	l-glutamine	CO2	PA10090	4513	0.909
NULL	J_Cell_Biol_2005_Nov_21_171(4)_729-738.nxml.txt.nlp	16286510	SENT185	8	8	0	0	heparin	FGF2	PA449855	2247;2258	0.909
NULL	Mol_Cancer_2007_Oct_11_6_63.nxml.txt.nlp	17931419	SENT33	19	19	17	17	cetuximab	EGFR	PA10040	1956	0.909
NULL	Oncogene_2013_Sep_12_32(37)_4355-4365.nxml.txt.nlp	23108409	SENT72	31	31	22	22	hyaluronan	HAS2	PA165958431	3037	0.909
NULL	Cancer_Med_2013_Feb_3_2(1)_11-20.nxml.txt.nlp	24133623	SENT223	5	5	1	1	panitumumab	KRAS	PA162373091	3845	0.909
NULL	J_Cell_Biol_2005_Nov_7_171(3)_505-516.nxml.txt.nlp	16275754	SENT316	8	8	27	27	pp2	MEK1		5604	0.909
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT96	2	2	31	31	pertuzumab	HER2		2064	0.909
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2007_Dec_12_64(Pt_1)_o247.nxml.txt.nlp	21200812	SENT56	24	24	6	6	ethanol	mol	PA448073	90527	0.909
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Apr_17_6_43-57.nxml.txt.nlp	24833916	SENT145	39	39	24	24	everolimus	PI3K	PA164746311	5290	0.909
NULL	Br_J_Cancer_2014_Nov_25_111(11)_2033-2038.nxml.txt.nlp	25268375	SENT56	20	20	6	6	lapatinib	EGFR	PA152241907	1956	0.909
NULL	Cancer_Med_2014_Jun_19_3(3)_555-564.nxml.txt.nlp	24648042	SENT107	38	38	12	12	rituximab	PI3K	PA451261	5290	0.909
NULL	Cancer_Med_2014_Oct_2_3(5)_1385-1395.nxml.txt.nlp	24890702	SENT166	27	27	13	13	cetuximab	KRAS	PA10040	3845	0.909
NULL	J_Gen_Physiol_2010_Apr_135(4)_333-353.nxml.txt.nlp	20231374	SENT427	8	8	14	14	fluoxetine	P2X4	PA449673	5025	0.909
NULL	Braz_J_Med_Biol_Res_2012_Aug_24_45(11)_1002-1010.nxml.txt.nlp	22911344	SENT119	24	24	9	9	heparin	CO2	PA449855	4513	0.909
NULL	Oncotarget_2010_May_1_1(1)_48-58.nxml.txt.nlp	21293053	SENT130	33	33	8	8	cisplatin	p53	PA449014	7157	0.909
NULL	Diabetes_Care_2010_Jan_6_33(1)_49-54.nxml.txt.nlp	19808929	SENT143	17	17	11	11	ramipril	DREAM	PA451223	30818	0.909
NULL	Anc_Sci_Life_2012_Jul-Sep_32(1)_11-15.nxml.txt.nlp	23929987	SENT150	3	3	24	24	scopolamine	spatial	PA451308	219793	0.909
NULL	Mol_Cell_Proteomics_2012_Feb_6_11(2)_M111_015222.nxml.txt.nlp	22147731	SENT215	23	23	16	16	gefitinib	EGF	PA131301952	1950	0.909
NULL	Carcinogenesis_2014_May_13_35(5)_1055-1066.nxml.txt.nlp	24419232	SENT192	7	7	0	0	metformin	AMPK	PA450395	5563	0.909
NULL	eLife_2013_Nov_5_2_e00969.nxml.txt.nlp	24192036	SENT350	13	13	24	24	vemurafenib	ERK	PA165946873	5594	0.909
NULL	Arthritis_Res_Ther_2009_Jun_29_11(3)_R100.nxml.txt.nlp	19563672	SENT8	33	33	0	0	infliximab	IFN	PA452639	3439	0.909
NULL	Protein_Cell_2014_Jun_19_5(6)_469-479.nxml.txt.nlp	24748116	SENT58	16	16	9	9	paclitaxel	EB1	PA450761	9167;22919;10982	0.909
NULL	Int_J_Biol_Sci_2014_Sep_10_10(9)_1024-1038.nxml.txt.nlp	25285035	SENT338	24	24	26	26	haloperidol	Yes	PA449841	7525	0.909
NULL	Protein_Cell_2014_Jun_19_5(6)_469-479.nxml.txt.nlp	24748116	SENT91	16	16	9	9	paclitaxel	EB1	PA450761	9167;22919;10982	0.909
NULL	Ecancermedicalscience_2008_Feb_18_2_75.nxml.txt.nlp	22275966	SENT139	21	21	35	35	erlotinib	PTEN	PA134687924	5728	0.909
NULL	Ann_Hematol_2014_Sep_10_93(1)_1-11.nxml.txt.nlp	24018623	SENT139	44	44	33	33	lenalidomide	CD34	PA162363968	947	0.909
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT6	23	23	10	10	imatinib	ABCB1	PA10804	5243	0.909
NULL	Nucl_Recept_Signal_2012_Feb_27_10_e001.nxml.txt.nlp	22438791	SENT139	17	17	26	26	tamoxifen	aromatase	PA451581	1588	0.909
NULL	Oncoscience_2014_Mar_12_1(2)_158-166.nxml.txt.nlp	25594008	SENT126	12	12	4	4	dasatinib	IGFBP2	PA162372878	3485	0.909
NULL	Curr_Cardiol_Rev_2012_Aug_8(3)_239-249.nxml.txt.nlp	22935021	SENT101	6	6	13	13	prasugrel	P2Y12	PA154410481	64805	0.909
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1522-1532.nxml.txt.nlp	21997136	SENT144	18	18	6	6	lapatinib	p53	PA152241907	7157	0.909
NULL	Breast_Cancer_Res_2014_Sep_9_16(5)_433.nxml.txt.nlp	25212966	SENT376	19	19	10	10	aprotinin	ILEI	PA448472	10447	0.909
NULL	Oncogene_2014_Sep_18_33(38)_4664-4674.nxml.txt.nlp	24096486	SENT10	16	16	12	12	erlotinib	EGFR	PA134687924	1956	0.909
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT486	19	19	1	1	efavirenz	CAR	PA449441	1525;6687;9970	0.909
NULL	J_Breast_Cancer_2013_Mar_31_16(1)_117-121.nxml.txt.nlp	23593092	SENT58	19	19	17	17	letrozole	aromatase	PA450196	1588	0.909
NULL	Int_J_Gen_Med_2012_Nov_9_5_935-942.nxml.txt.nlp	23204857	SENT77	21	21	10	10	naloxone	AIDA	PA450586	64853	0.909
NULL	Cardiol_Res_Pract_2014_Nov_20_2014_784018.nxml.txt.nlp	25506463	SENT142	9	9	30	30	heparin	ACT	PA449855	12;11332;9457;641455	0.909
NULL	Biosci_Rep_2012_Aug_1_32(Pt_4)_361-374.nxml.txt.nlp	22762204	SENT1150	13	13	6	6	trastuzumab	PI3K	PA451743	5290	0.909
NULL	Arthritis_Res_Ther_2014_Apr_3_16(2)_R86.nxml.txt.nlp	24708674	SENT247	10	10	34	34	bosentan	Fli1	PA10034	2314	0.908
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT375	23	23	4	4	pp2	CDH1		51343;999	0.908
NULL	Acta_Pharmacol_Sin_2010_Nov_18_31(11)_1447-1453.nxml.txt.nlp	20953204	SENT102	12	12	6	6	rimonabant	CB1	PA152407999	1268	0.908
NULL	Evid_Based_Complement_Alternat_Med_2012_Dec_27_2012_827278.nxml.txt.nlp	22253647	SENT269	31	31	19	19	fenofibrate	mol	PA449594	90527	0.908
NULL	Cancer_Metastasis_Rev_2010_Dec_10_29(4)_581-594.nxml.txt.nlp	20830503	SENT96	12	12	26	26	tamoxifen	TTR	PA451581	7276	0.908
NULL	J_Gastroenterol_2014_Dec_24_49(12)_1536-1547.nxml.txt.nlp	24366288	SENT153	35	35	8	8	omeprazole	CYP2C19	PA450704	1557	0.908
NULL	J_Cheminform_2012_Mar_8_4_6.nxml.txt.nlp	22401035	SENT317	10	10	5	5	troglitazone	CYP3A4	PA451799	1576	0.908
NULL	J_Cell_Mol_Med_2013_May_12_17(5)_636-647.nxml.txt.nlp	23577651	SENT136	20	20	5	5	quinacrine	CD41	PA164745551	3674	0.908
NULL	Indian_J_Dermatol_2013_Jan-Feb_58(1)_61-64.nxml.txt.nlp	23372216	SENT98	31	31	17	17	pimozide	CYP3A4	PA450965	1576	0.908
NULL	Mol_Brain_2014_Apr_3_7_25.nxml.txt.nlp	24708812	SENT184	28	28	6	6	chloroquine	ERK	PA448948	5594	0.908
NULL	Int_J_Mol_Sci_2014_Jun_26_15(7)_11416-11434.nxml.txt.nlp	24972137	SENT612	4	4	21	21	sitagliptin	GLP-1	PA164748978	100125288	0.908
NULL	Arthritis_Res_Ther_2010_Jun_2_12(3)_R107.nxml.txt.nlp	20525198	SENT210	5	5	21	21	rolipram	TNF	PA153906323	7124	0.908
NULL	Diabetes_Care_2012_Jul_12_35(7)_1473-1478.nxml.txt.nlp	22446170	SENT64	19	19	13	13	pioglitazone	PPG	PA450970	5552	0.908
NULL	Evid_Based_Complement_Alternat_Med_2011_Jan_4_2011_392627.nxml.txt.nlp	19542183	SENT130	30	30	18	18	phenylephrine	mol	PA450935	90527	0.908
NULL	Biochem_Res_Int_2011_Sep_22_2011_285618.nxml.txt.nlp	21949907	SENT129	10	10	19	19	resveratrol	adiponectin		9370	0.908
NULL	J_Cell_Biol_2003_Dec_8_163(5)_1133-1143.nxml.txt.nlp	14662751	SENT266	0	0	27	27	trypsin	CD14	PA451806	929	0.908
NULL	Arthritis_Res_Ther_2010_May_28_12(3)_R105.nxml.txt.nlp	20509880	SENT22	20	20	1	1	celecoxib	p38	PA448871	10598;1432;7965	0.908
NULL	Nat_Med_2011_Sep_11_17(10)_1235-1241.nxml.txt.nlp	21909103	SENT124	4	4	9	9	denosumab	RANKL	PA166048634	8600	0.908
NULL	Lab_Invest_2010_Sep_10_90(9)_1325-1338.nxml.txt.nlp	20458282	SENT133	2	2	32	32	resveratrol	MDR1		5243	0.908
NULL	Comp_Hepatol_2004_Jan_14_3(Suppl_1)_S31.nxml.txt.nlp	14960183	SENT22	18	18	7	7	ethanol	TNF-alpha	PA448073	7124	0.908
NULL	Cancers_(Basel)_2012_Oct_12_4(4)_989-1035.nxml.txt.nlp	24213498	SENT435	3	3	25	25	gemcitabine	CD24	PA449748	100133941	0.908
NULL	Neuropsychopharmacology_2009_Jun_21_34(7)_1733-1742.nxml.txt.nlp	19158669	SENT29	43	43	14	14	phenol	CB1	PA450913	1268	0.908
NULL	Breast_Cancer_Res_2008_Mar_27_10(2)_R26.nxml.txt.nlp	18371194	SENT113	23	23	12	12	cisplatin	BRCA2	PA449014	675	0.908
NULL	Cancer_Immunol_Immunother_2012_Jul_23_61(7)_1101-1111.nxml.txt.nlp	22193989	SENT229	22	22	25	25	oxaliplatin	PD-L1	PA131285527	29126	0.908
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S31-S40.nxml.txt.nlp	20680106	SENT71	38	38	22	22	cetuximab	KRAS	PA10040	3845	0.908
NULL	Biochem_Res_Int_2012_Mar_4_2012_685267.nxml.txt.nlp	22496978	SENT251	10	10	21	21	thrombin	CXCR4	PA451674	7852	0.908
NULL	EMBO_Mol_Med_2013_Dec_8_5(12)_1821-1834.nxml.txt.nlp	24293316	SENT51	25	25	18	18	doxorubicin	UNC5C	PA449412	8633	0.908
NULL	Br_J_Cancer_2011_Jul_26_105(3)_366-371.nxml.txt.nlp	21750556	SENT122	18	18	32	32	paclitaxel	IL-2	PA450761	3558	0.908
NULL	Lancet_2011_Jun_18_377(9783)_2103-2114.nxml.txt.nlp	21641636	SENT72	12	12	24	24	cetuximab	KRAS	PA10040	3845	0.908
NULL	Biomed_Res_Int_2013_Mar_28_2013_154073.nxml.txt.nlp	23607088	SENT124	22	22	6	6	clopidogrel	CYP2C19	PA449053	1557	0.908
NULL	Breast_Cancer_Res_2009_Jun_29_11(3)_R41.nxml.txt.nlp	19563669	SENT224	39	39	31	31	gefitinib	TRAIL	PA131301952	8743	0.908
NULL	Patient_Prefer_Adherence_2011_Dec_23_6_1-9.nxml.txt.nlp	22272064	SENT63	21	21	17	17	telmisartan	ACE	PA451605	1636	0.908
NULL	Case_Rep_Pediatr_2014_Jun_30_2014_368256.nxml.txt.nlp	25093136	SENT28	20	20	5	5	tobramycin	IL-6	PA451704	3569	0.908
NULL	J_Cancer_2013_Aug_16_4(7)_557-565.nxml.txt.nlp	23983820	SENT34	28	28	16	16	lapatinib	EGFR	PA152241907	1956	0.908
NULL	Br_J_Pharmacol_2014_May_11_171(9)_2385-2398.nxml.txt.nlp	24467222	SENT180	0	0	2	2	rolipram	Rho	PA153906323	29984	0.908
NULL	Oncol_Rep_2012_Sep_26_28(3)_777-784.nxml.txt.nlp	22751903	SENT31	20	20	24	24	sulindac	COX	PA451565	1351	0.908
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT55	39	39	26	26	curcumin	TRAIL	PA151958596	8743	0.908
NULL	Clin_Med_Insights_Oncol_2012_Nov_20_6_381-393.nxml.txt.nlp	23226079	SENT137	26	26	15	15	clarithromycin	CYP3A4	PA449028	1576	0.908
NULL	Cancers_(Basel)_2010_Jun_2_2(2)_1066-1091.nxml.txt.nlp	24281107	SENT1022	10	10	2	2	erlotinib	KRAS	PA134687924	3845	0.908
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT56	17	17	1	1	atazanavir	SLK	PA10251	9748;2534	0.908
NULL	J_Biomed_Sci_2014_Jul_31_21(1)_69.nxml.txt.nlp	25077570	SENT156	20	20	2	2	mitomycin	IFN	PA450524	3439	0.908
NULL	Int_J_Tryptophan_Res_2013_Aug_19_6_35-45.nxml.txt.nlp	24023520	SENT103	13	13	36	36	iron	IDO1	PA450087	3620	0.908
NULL	Ann_Oncol_2012_Dec_2_23(12)_3007-3016.nxml.txt.nlp	22865781	SENT111	33	33	16	16	triciribine	PTEN	PA165958661	5728	0.908
NULL	Mol_Biol_Int_2014_Feb_19_2014_375325.nxml.txt.nlp	24693428	SENT103	10	10	26	26	cisplatin	ABCG2	PA449014	9429	0.908
NULL	Oxid_Med_Cell_Longev_2013_Jun_11_2013_870472.nxml.txt.nlp	23840921	SENT69	0	0	2	2	chloroquine	HO-1	PA448948	3162	0.908
NULL	Ther_Clin_Risk_Manag_2006_Sep_2(3)_229-234.nxml.txt.nlp	18360598	SENT56	5	5	25	25	oxymorphone	CYP2D6	PA450748	1565	0.908
NULL	Nucleic_Acids_Res_2013_May_3_41(9)_4976-4987.nxml.txt.nlp	23558749	SENT101	16	16	32	32	doxorubicin	p53	PA449412	7157	0.908
NULL	Cancer_Res_Treat_2013_Dec_31_45(4)_251-262.nxml.txt.nlp	24453997	SENT141	16	16	10	10	cisplatin	ASS1	PA449014	445	0.908
NULL	Oncotarget_2014_Feb_7_5(3)_775-787.nxml.txt.nlp	24519956	SENT197	21	21	0	0	docetaxel	PC3	PA449383	57332;7832;5122	0.908
NULL	J_Invest_Dermatol_2012_Sep_10_132(9)_2255-2262.nxml.txt.nlp	22572817	SENT53	8	8	21	21	forskolin	MC1R	PA146096022	4157	0.908
NULL	Lab_Invest_2009_Dec_19_89(12)_1397-1409.nxml.txt.nlp	19841616	SENT192	16	16	22	22	curcumin	NAC	PA151958596	22861	0.908
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_11_2014_274786.nxml.txt.nlp	25505920	SENT527	25	25	0	0	oxaliplatin	ERCC1	PA131285527	2067	0.908
NULL	J_Cell_Biol_1998_Jul_13_142(1)_229-240.nxml.txt.nlp	9660876	SENT194	0	0	16	16	suramin	LPA	PA10292	4018	0.908
NULL	Breast_Cancer_Res_2005_Jul_20_7(5)_205-211.nxml.txt.nlp	16168139	SENT123	31	31	6	6	tamoxifen	EGF	PA451581	1950	0.908
NULL	Osteoporos_Int_2015_Sep_19_26_361-372.nxml.txt.nlp	25236877	SENT332	6	6	12	12	teriparatide	DANCE	PA451620	10516	0.908
NULL	Environ_Health_Perspect_2013_Aug_12_121(8)_951-956.nxml.txt.nlp	23761051	SENT163	28	28	39	39	ethanol	TDI	PA448073	100038246	0.908
NULL	Br_J_Cancer_2001_Sep_85(5)_772-779.nxml.txt.nlp	11531266	SENT9	3	3	5	5	trypsin	AP2	PA451806	2971	0.908
NULL	Crit_Care_2011_Aug_2_15(4)_177.nxml.txt.nlp	21861863	SENT9	12	12	20	20	fenoldopam	NGAL	PA164784034	3934	0.908
NULL	Front_Oncol_2013_Sep_23_3_250.nxml.txt.nlp	24069582	SENT11	33	33	27	27	anastrozole	aromatase	PA448432	1588	0.908
NULL	Pharm_Methods_2011_Jul-Sep_2(3)_203-208.nxml.txt.nlp	23781457	SENT33	3	3	13	13	teriparatide	PTH	PA451620	5741	0.908
NULL	Cancer_Cell_Int_2010_Apr_29_10_12.nxml.txt.nlp	20429927	SENT189	6	6	3	3	bortezomib	HRI	PA10252	27102	0.908
NULL	Br_J_Cancer_2011_Jun_28_105(1)_53-57.nxml.txt.nlp	21654688	SENT5	0	0	19	19	irinotecan	UGT1A1	PA450085	54658	0.908
NULL	J_Korean_Med_Sci_2008_Apr_20_23(2)_320-323.nxml.txt.nlp	18437019	SENT68	26	26	11	11	deferoxamine	IL-2	PA164746490	3558	0.908
NULL	Diabetes_Care_2011_Jul_17_34(7)_e115-e120.nxml.txt.nlp	21709286	SENT205	8	8	10	10	metformin	aromatase	PA450395	1588	0.908
NULL	Acta_Pharmacol_Sin_2010_Feb_5_31(2)_184-190.nxml.txt.nlp	20139901	SENT29	4	4	28	28	metformin	OCT2	PA450395	6582;5452	0.908
NULL	Cancer_Med_2014_Oct_17_3(5)_1284-1293.nxml.txt.nlp	24935402	SENT225	8	8	23	23	lovastatin	MICA	PA450272	100507436	0.908
NULL	Int_J_Environ_Res_Public_Health_2010_May_28_7(5)_1996-2007.nxml.txt.nlp	20632473	SENT40	23	23	12	12	streptomycin	FBS	PA451512	64319;26269	0.908
NULL	Ther_Clin_Risk_Manag_2007_Jun_3(2)_333-339.nxml.txt.nlp	18360642	SENT53	7	7	15	15	ondansetron	NNT	PA450705	23530	0.908
NULL	J_Oncol_2012_Oct_5_2012_794172.nxml.txt.nlp	22007215	SENT37	29	29	43	43	gentamicin	CO2	PA449753	4513	0.908
NULL	J_Hematol_Oncol_2014_Apr_4_7_30.nxml.txt.nlp	24708874	SENT51	30	30	17	17	sulfasalazine	xCT	PA451547	23657	0.908
NULL	Endocrinol_Metab_(Seoul)_2014_Sep_25_29(3)_379-387.nxml.txt.nlp	25309798	SENT143	29	29	18	18	resveratrol	SIRT1		23411	0.908
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT282	13	13	21	21	clozapine	PRL	PA449061	5617	0.908
NULL	Virol_J_2011_Nov_28_8_523.nxml.txt.nlp	22122911	SENT226	9	9	6	6	heparin	RANTES	PA449855	6352	0.908
NULL	Oncol_Rep_2012_Apr_30_27(4)_923-928.nxml.txt.nlp	22209766	SENT127	35	35	9	9	erlotinib	EGFR	PA134687924	1956	0.908
NULL	Int_J_Mol_Sci_2014_Oct_27_15(11)_19516-19534.nxml.txt.nlp	25350114	SENT714	0	0	9	9	resveratrol	SIRT1		23411	0.908
NULL	Breast_Cancer_Res_2006_Nov_30_8(6)_216.nxml.txt.nlp	17164010	SENT191	12	12	1	1	tamoxifen	IMPACT	PA451581	55364	0.908
NULL	Clin_Med_Insights_Oncol_2012_Mar_12_6_153-164.nxml.txt.nlp	22550404	SENT81	16	16	28	28	doxorubicin	Raf-1	PA449412	5894	0.908
NULL	Clin_Interv_Aging_2013_Apr_19_8_433-442.nxml.txt.nlp	23626463	SENT152	6	6	18	18	bevacizumab	IFN	PA130232992	3439	0.908
NULL	J_Biol_Chem_2012_Aug_10_287(33)_28169-28179.nxml.txt.nlp	22584573	SENT289	27	27	14	14	rosiglitazone	HDX	PA451283	139324	0.908
NULL	Indian_J_Dermatol_2013_Jul-Aug_58(4)_328a.nxml.txt.nlp	23919029	SENT74	4	4	8	8	tocilizumab	IL-6	PA165292659	3569	0.908
NULL	Eur_J_Med_Res_2010_Apr_8_15(4)_145-151.nxml.txt.nlp	20554495	SENT127	20	20	25	25	abacavir	HLA-B	PA448004	3106	0.908
NULL	J_Lipid_Res_2012_May_53(5)_1000-1011.nxml.txt.nlp	22368281	SENT14	8	8	40	40	atorvastatin	LPA	PA448500	4018	0.908
NULL	Adv_Pharmacol_Sci_2013_Jun_24_2013_987692.nxml.txt.nlp	23864853	SENT7	41	41	26	26	acetaminophen	ALP	PA448015	6590;10850;27295;80150;470;26033	0.908
NULL	Breast_Cancer_Res_2011_Dec_16_13(6)_R131.nxml.txt.nlp	22177475	SENT275	31	31	23	23	trastuzumab	AKT	PA451743	207	0.908
NULL	Mol_Pain_2014_Apr_18_10_27.nxml.txt.nlp	24742127	SENT303	0	0	22	22	paclitaxel	CD11b	PA450761	3684	0.908
NULL	Indian_J_Endocrinol_Metab_2012_Nov-Dec_16(6)_1026-1028.nxml.txt.nlp	23226658	SENT62	12	12	18	18	teriparatide	PTH	PA451620	5741	0.908
NULL	Diabetes_Care_2012_Jul_12_35(7)_1473-1478.nxml.txt.nlp	22446170	SENT64	36	36	13	13	pioglitazone	PPG	PA450970	5552	0.908
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Oct_13_68(Pt_11)_o3117.nxml.txt.nlp	23284442	SENT3	27	27	3	3	phenol	mol	PA450913	90527	0.908
NULL	Leukemia_2014_Jan_12_28(1)_15-33.nxml.txt.nlp	23778311	SENT254	21	21	36	36	imatinib	TP53	PA10804	7157	0.908
NULL	Arthritis_Res_Ther_2010_Jan_8_12(1)_R4.nxml.txt.nlp	20064200	SENT263	17	17	15	15	diclofenac	COX	PA449293	1351	0.908
NULL	N_Am_J_Med_Sci_2011_Oct_3(10)_441-450.nxml.txt.nlp	22363081	SENT315	14	14	5	5	gemcitabine	DR5	PA449748	8795	0.908
NULL	Breast_Cancer_Res_2007_Jan_23_9(1)_R7.nxml.txt.nlp	17244352	SENT46	10	10	13	13	tamoxifen	CYP3A5	PA451581	1577	0.908
NULL	Chin_J_Cancer_2012_Feb_31(2)_110-118.nxml.txt.nlp	22098951	SENT162	11	11	6	6	imatinib	P-gp	PA10804	5243	0.908
NULL	Oxid_Med_Cell_Longev_2013_Apr_18_2013_239854.nxml.txt.nlp	23710284	SENT86	4	4	12	12	zonisamide	HRD1	PA451978	84447	0.908
NULL	J_Cell_Biol_1988_Jul_1_107(1)_287-298.nxml.txt.nlp	2455725	SENT7	15	15	6	6	suramin	c-fos	PA10292	2353	0.908
NULL	Calcif_Tissue_Int_2010_Aug_23_87(2)_130-136.nxml.txt.nlp	20571786	SENT128	9	9	18	18	teriparatide	CSA	PA451620	1442;1161	0.908
NULL	Fibrogenesis_Tissue_Repair_2011_Aug_2_4_18.nxml.txt.nlp	21810214	SENT232	13	13	5	5	bleomycin	IL-13	PA448645	3596	0.908
NULL	Cancer_Cell_Int_2013_Nov_8_13_111.nxml.txt.nlp	24209962	SENT137	10	10	20	20	fluvastatin	LC3	PA449688	84557	0.908
NULL	Mol_Biol_Cell_2013_Aug_1_24(15)_2340-2349.nxml.txt.nlp	23783036	SENT259	25	25	41	41	lincomycin	CR2	PA164749212	1380	0.908
NULL	Eur_J_Clin_Pharmacol_2014_Oct_8_70(12)_1433-1441.nxml.txt.nlp	25291992	SENT10	25	25	36	36	risperidone	B12	PA451257	7126;4709	0.908
NULL	Biol_Open_2012_May_21_1(7)_629-639.nxml.txt.nlp	23125914	SENT7	44	44	7	7	doxycycline	PITX1	PA449415	5307	0.908
NULL	Ann_Indian_Acad_Neurol_2009_Apr-Jun_12(2)_89-98.nxml.txt.nlp	20142853	SENT202	17	17	28	28	oxcarbazepine	MRP5	PA450732	10057	0.908
NULL	Breast_Cancer_Res_2012_Jan_19_14(1)_201.nxml.txt.nlp	22277572	SENT117	21	21	11	11	anastrozole	HER2	PA448432	2064	0.908
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT157	3	3	10	10	pertuzumab	HER2		2064	0.908
NULL	Br_J_Pharmacol_2014_Jan_23_171(2)_523-535.nxml.txt.nlp	24372553	SENT147	24	24	8	8	metformin	SIRT1	PA450395	23411	0.908
NULL	Indian_J_Psychiatry_2014_Jan_56(Suppl_1)_S63-S96.nxml.txt.nlp	NULL	SENT818	11	11	36	36	clozapine	OGC	PA449061	8402	0.908
NULL	J_Antimicrob_Chemother_2012_Feb_17_67(2)_404-414.nxml.txt.nlp	22101217	SENT97	19	19	11	11	amikacin	CO2	PA164744372	4513	0.908
NULL	Biologics_2009_Jul_13_3_289-301.nxml.txt.nlp	19707416	SENT144	18	18	7	7	lapatinib	HER2	PA152241907	2064	0.908
NULL	Ann_N_Y_Acad_Sci_2012_Oct_10_1271(1)_44-52.nxml.txt.nlp	23050963	SENT161	22	22	2	2	doxorubicin	p53	PA449412	7157	0.908
NULL	Oncotarget_2013_Aug_30_4(10)_1698-1711.nxml.txt.nlp	24091605	SENT131	10	10	19	19	cisplatin	PDCL	PA449014	5082	0.908
NULL	Mol_Biol_Rep_2013_May_11_40(8)_5013-5026.nxml.txt.nlp	23666059	SENT163	15	15	5	5	resveratrol	CHK2		11200	0.908
NULL	FEMS_Microbiol_Lett_2007_Jun_20_271(2)_214-221.nxml.txt.nlp	17451448	SENT55	35	35	20	20	erythromycin	FRE	PA449493	2487	0.908
NULL	Clin_Med_Insights_Cardiol_2013_Aug_11_7_127-140.nxml.txt.nlp	23997577	SENT84	3	3	9	9	amiodarone	CYP2D6	PA448383	1565	0.908
NULL	Acta_Pharmacol_Sin_2011_Apr_28_32(4)_441-448.nxml.txt.nlp	21441944	SENT117	19	19	0	0	sildenafil	CASQ2	PA451346	845	0.908
NULL	Mol_Cancer_2012_Jun_18_11_41.nxml.txt.nlp	22709873	SENT308	17	17	7	7	lapatinib	CCND1	PA152241907	595	0.908
NULL	Nat_Commun_2013_4_10_1038_ncomms3472.nxml.txt.nlp	24045463	SENT127	21	21	3	3	propranolol	PEP3	PA451145	57617	0.908
NULL	Diabetologia_2010_Jan_6_53(1)_1-6.nxml.txt.nlp	19894028	SENT99	28	28	11	11	metformin	HIP	PA450395	6767;6159;64399;5068	0.908
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2007_Dec_21_64(Pt_1)_o313.nxml.txt.nlp	21200875	SENT59	13	13	29	29	acetone	mol	PA448025	90527	0.908
NULL	Front_Neural_Circuits_2014_Mar_25_8_20.nxml.txt.nlp	24723852	SENT236	38	38	13	13	propofol	gamma	PA451141	9913	0.908
NULL	Arthritis_Res_Ther_2005_Dec_1_7(1)_R149-R155.nxml.txt.nlp	15642135	SENT67	7	7	9	9	infliximab	OPG	PA452639	690	0.908
NULL	EJNMMI_Res_2011_Jul_29_1_12.nxml.txt.nlp	22214199	SENT170	26	26	5	5	cyclosporine	P-gp	PA449167	5243	0.908
NULL	Front_Oncol_2014_Sep_29_4_251.nxml.txt.nlp	25325012	SENT249	1	1	28	28	afatinib	EGFR	PA165981154	1956	0.908
NULL	Front_Immunol_2013_Oct_18_4_341.nxml.txt.nlp	24151496	SENT176	13	13	26	26	cyclosporine	AAV	PA449167	17	0.908
NULL	Int_Cardiovasc_Res_J_2012_Sep_15_6(3)_70-74.nxml.txt.nlp	24757595	SENT41	15	15	22	22	heparin	ACT	PA449855	12;11332;9457;641455	0.908
NULL	Asia_Pac_Allergy_2013_Oct_31_3(4)_215-223.nxml.txt.nlp	24260726	SENT100	20	20	29	29	lamotrigine	HLA-B	PA450164	3106	0.908
NULL	Breast_Cancer_Res_2006_Nov_6_8(6)_215.nxml.txt.nlp	17096862	SENT177	18	18	5	5	trastuzumab	HER2	PA451743	2064	0.908
NULL	J_Hematol_Oncol_2010_Sep_9_3_31.nxml.txt.nlp	20828403	SENT43	19	19	14	14	capecitabine	HER2	PA448771	2064	0.908
NULL	Theranostics_2013_Jan_15_3(1)_47-75.nxml.txt.nlp	23382786	SENT349	14	14	24	24	hydroxychloroquine	CXCR4	PA164777036	7852	0.908
NULL	Biol_Open_2014_May_2_3(6)_418-430.nxml.txt.nlp	24795145	SENT126	15	15	9	9	etoposide	RanBPM	PA449552	10048	0.908
NULL	Breast_Cancer_Res_Treat_2014_Apr_9_145(1)_73-82.nxml.txt.nlp	24715380	SENT116	22	22	14	14	tamoxifen	CXCL10	PA451581	3627	0.908
NULL	Arch_Med_Sci_2010_Aug_30_6(4)_513-518.nxml.txt.nlp	22371793	SENT0	34	34	18	18	indapamide	Q10	PA449975	27161	0.908
NULL	J_Thromb_Haemost_2010_Mar_8(3)_577-587.nxml.txt.nlp	20040043	SENT153	9	9	18	18	rosiglitazone	mol	PA451283	90527	0.908
NULL	Clin_Med_Insights_Womens_Health_2013_Jan_22_6_1-11.nxml.txt.nlp	24665209	SENT38	25	25	31	31	tamoxifen	aromatase	PA451581	1588	0.908
NULL	Bone_Marrow_Transplant_2013_Feb_9_48(2)_269-277.nxml.txt.nlp	22773122	SENT34	10	10	36	36	filgrastim	CD34	PA449626	947	0.908
NULL	Int_J_Biol_Sci_2012_Sep_6_8(8)_1109-1120.nxml.txt.nlp	22991499	SENT24	29	29	6	6	l-arginine	IFN	PA448478	3439	0.908
NULL	ScientificWorldJournal_2012_Mar_12_2012_134876.nxml.txt.nlp	22536120	SENT158	8	8	19	19	ethanol	zeta	PA448073	9907	0.908
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_650809.nxml.txt.nlp	23258995	SENT170	28	28	20	20	vasopressin	AQP2	PA451858	359	0.908
NULL	J_Am_Heart_Assoc_2013_Apr_24_2(2)_e000104.nxml.txt.nlp	23557751	SENT31	24	24	1	1	glucose	GFR	PA449773	9771	0.908
NULL	Front_Plant_Sci_2011_Jun_6_2_18.nxml.txt.nlp	22645527	SENT121	17	17	9	9	trypsin	MP17	PA451806	3982	0.908
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1063.nxml.txt.nlp	24556678	SENT65	21	21	10	10	thioridazine	c-FLIP	PA451666	8837	0.908
NULL	Br_J_Cancer_2012_Sep_4_107(6)_977-987.nxml.txt.nlp	22892389	SENT141	34	34	14	14	orlistat	VEGFA	PA164776864	7422	0.908
NULL	BMB_Rep_2014_May_47(5)_274-279.nxml.txt.nlp	24286313	SENT10	13	13	6	6	bortezomib	CD52	PA10252	1043	0.908
NULL	Croat_Med_J_2012_Aug_53(4)_343-349.nxml.txt.nlp	22911527	SENT105	16	16	29	29	isoproterenol	NIF	PA450121	6280	0.908
NULL	Iran_J_Pharm_Res_2013_Winter_12(Suppl)_153-159.nxml.txt.nlp	24250683	SENT118	22	22	10	10	celecoxib	C-1	PA448871	5203	0.908
NULL	Breast_Cancer_Res_2010_Oct_14_12(5)_R84.nxml.txt.nlp	20946630	SENT14	36	36	12	12	choline	Hsp90	PA448976	3320	0.908
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_May_7_67(Pt_6)_o1308-o1309.nxml.txt.nlp	21754710	SENT67	23	23	6	6	ethanol	mol	PA448073	90527	0.908
NULL	Anesth_Essays_Res_2011_Jan-Jun_5(1)_63-66.nxml.txt.nlp	NULL	SENT69	5	5	20	20	vecuronium	CO2	PA164748865	4513	0.908
NULL	Ann_Hematol_2014_Sep_12_93(1)_13-32.nxml.txt.nlp	24026426	SENT56	8	8	18	18	voriconazole	BII	PA10233	777	0.908
NULL	Front_Oncol_2014_Apr_9_4_75.nxml.txt.nlp	24782986	SENT238	16	16	39	39	paclitaxel	Oct4	PA450761	5460	0.908
NULL	Br_J_Cancer_1996_Dec_74(11)_1719-1729.nxml.txt.nlp	8956784	SENT10	14	14	8	8	epirubicin	ACL	PA449476	47	0.908
NULL	Oncotarget_2013_Nov_15_5(6)_1458-1474.nxml.txt.nlp	24681547	SENT109	18	18	35	35	celecoxib	CDH11	PA448871	1009	0.908
NULL	Cancer_Immunol_Immunother_2011_Jun_25_60(6)_793-808.nxml.txt.nlp	21350947	SENT284	21	21	10	10	sorafenib	IFNAR2	PA7000	3455	0.908
NULL	Front_Pharmacol_2014_Dec_10_5_271.nxml.txt.nlp	25540621	SENT131	13	13	35	35	cisplatin	ghrelin	PA449014	51738	0.908
NULL	Oncotarget_2013_Nov_4_5(1)_161-172.nxml.txt.nlp	24389287	SENT179	19	19	22	22	propranolol	COX	PA451145	1351	0.908
NULL	Cell_Commun_Signal_2013_May_29_11_38.nxml.txt.nlp	23718910	SENT10	0	0	19	19	pp2	p65		5970	0.908
NULL	Cancer_Cell_Int_2014_Jan_29_14_10.nxml.txt.nlp	24472145	SENT179	2	2	14	14	cisplatin	HER-2	PA449014	2064	0.908
NULL	Eur_J_Clin_Pharmacol_2012_Sep_15_68(9)_1267-1274.nxml.txt.nlp	22418828	SENT204	27	27	6	6	pantoprazole	CYP2C19	PA450774	1557	0.908
NULL	J_Exp_Bot_2012_Mar_15_63(5)_1969-1983.nxml.txt.nlp	22174442	SENT80	43	43	0	0	nitroprusside	NO3	PA451406	4681	0.908
NULL	J_Mol_Signal_2010_May_10_5_4.nxml.txt.nlp	20459745	SENT122	16	16	2	2	cisplatin	p53	PA449014	7157	0.908
NULL	Br_J_Cancer_1999_Mar_79(7-8)_1104-1110.nxml.txt.nlp	10098743	SENT8	24	24	10	10	oxaliplatin	JNK	PA131285527	5599	0.908
NULL	Ann_Rheum_Dis_2011_Nov_25_71(5)_687-693.nxml.txt.nlp	22121130	SENT174	12	12	8	8	tocilizumab	IL-6	PA165292659	3569	0.908
NULL	Br_J_Cancer_2010_Mar_16_102(6)_1076-1077.nxml.txt.nlp	NULL	SENT12	39	39	24	24	irinotecan	KRAS	PA450085	3845	0.908
NULL	Cancer_Med_2013_Dec_10_2(6)_899-906.nxml.txt.nlp	24403263	SENT243	4	4	8	8	vemurafenib	BRAF	PA165946873	673	0.908
NULL	NMR_Biomed_2013_Oct_7_26(10)_1258-1270.nxml.txt.nlp	23564602	SENT54	10	10	25	25	estradiol	OATP	PA449503	6579	0.908
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT32	9	9	2	2	gefitinib	PI3K	PA131301952	5290	0.908
NULL	Mol_Cancer_2012_Jun_18_11_41.nxml.txt.nlp	22709873	SENT41	8	8	14	14	trastuzumab	HER2	PA451743	2064	0.908
NULL	Curr_Neuropharmacol_2013_Mar_11(2)_171-185.nxml.txt.nlp	23997752	SENT281	11	11	35	35	reboxetine	ERK2	PA144614921	5594	0.908
NULL	Int_J_Mol_Sci_2014_Mar_24_15(3)_5140-5162.nxml.txt.nlp	24663085	SENT747	11	11	4	4	cyclophosphamide	LP1	PA449165	6176	0.908
NULL	Arch_Drug_Inf_2011_Mar_4(1)_1-9.nxml.txt.nlp	21572514	SENT195	17	17	46	46	ciprofloxacin	P-gp	PA449009	5243	0.908
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT300	4	4	8	8	chloroquine	BMPR-II	PA448948	659	0.908
NULL	Br_J_Cancer_2012_Nov_20_107(11)_1833-1839.nxml.txt.nlp	23169336	SENT41	6	6	0	0	cisplatin	Men	PA449014	8178	0.908
NULL	J_Gen_Physiol_2000_Jun_1_115(6)_685-696.nxml.txt.nlp	10828243	SENT159	23	23	10	10	genistein	OLF	PA165109660	83857	0.908
NULL	J_Cardiovasc_Dis_Res_2010_Jan-Mar_1(1)_19-22.nxml.txt.nlp	21188085	SENT150	25	25	44	44	valsartan	AT2	PA451848	186	0.908
NULL	J_Hematol_Oncol_2011_Dec_1_4_49.nxml.txt.nlp	22128838	SENT132	11	11	4	4	bortezomib	Mcl-1	PA10252	4170	0.908
NULL	Clin_Interv_Aging_2010_Feb_2_5_7-18.nxml.txt.nlp	20169038	SENT203	27	27	10	10	allopurinol	FACT	PA448320	11198	0.908
NULL	Br_J_Cancer_2012_Jan_3_106(1)_18-24.nxml.txt.nlp	22108516	SENT97	15	15	22	22	irinotecan	XRCC1	PA450085	7515	0.908
NULL	Mol_Cell_2014_May_8_54(3)_445-459.nxml.txt.nlp	24746700	SENT476	29	29	14	14	etoposide	BCLAF1	PA449552	9774	0.908
NULL	Cell_Commun_Signal_2013_Feb_20_11_13.nxml.txt.nlp	23425659	SENT37	3	3	14	14	diazepam	IL-8	PA449283	3576	0.908
NULL	Breast_Cancer_Res_2012_Mar_20_14(2)_R53.nxml.txt.nlp	22433433	SENT110	20	20	26	26	cisplatin	CDK1	PA449014	983	0.908
NULL	Curr_Neuropharmacol_2014_Jan_12(1)_44-56.nxml.txt.nlp	24533015	SENT486	4	4	8	8	gabapentin	NF-kappaB	PA449720	4790	0.908
NULL	Breast_Cancer_Res_Treat_2012_Aug_5_134(3)_1149-1159.nxml.txt.nlp	22763464	SENT36	0	0	3	3	afatinib	HER3	PA165981154	2065	0.908
NULL	Curr_Neuropharmacol_2013_Mar_11(2)_218-230.nxml.txt.nlp	23997756	SENT16	2	2	19	19	vasopressin	SON	PA451858	6651	0.908
NULL	J_Thromb_Thrombolysis_2012_Aug_29_34(2)_214-221.nxml.txt.nlp	22457161	SENT126	17	17	12	12	ticagrelor	P2Y12	PA165374673	64805	0.908
NULL	Trials_2013_Sep_23_14_307.nxml.txt.nlp	24059911	SENT250	8	8	21	21	clindamycin	ACT	PA449035	12;11332;9457;641455	0.908
NULL	Trials_2014_Oct_30_15(1)_423.nxml.txt.nlp	NULL	SENT39	7	7	26	26	paclitaxel	DES	PA450761	1674	0.908
NULL	Indian_J_Pharmacol_2014_Jan-Feb_46(1)_3-12.nxml.txt.nlp	24550577	SENT326	6	6	12	12	vismodegib	SMO		6608;54498	0.908
NULL	Breast_Cancer_(Auckl)_2009_Sep_2_3_61-75.nxml.txt.nlp	19809577	SENT271	20	20	35	35	curcumin	survivin	PA151958596	332	0.908
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT119	4	4	18	18	curcumin	IL-8	PA151958596	3576	0.908
NULL	Bone_Marrow_Transplant_2014_Feb_4_49(2)_201-205.nxml.txt.nlp	24185588	SENT93	13	13	5	5	plerixafor	CD34	PA165958410	947	0.908
NULL	Clin_Psychopharmacol_Neurosci_2013_Dec_24_11(3)_144-151.nxml.txt.nlp	24465251	SENT13	2	2	25	25	quetiapine	IL-4	PA451201	3565	0.908
NULL	Clin_Pharmacokinet_2014_Sep_3_53(1)_1-16.nxml.txt.nlp	23999929	SENT85	17	17	21	21	rivaroxaban	P-gp	PA165958360	5243	0.908
NULL	Oncotarget_2014_May_27_5(19)_9049-9064.nxml.txt.nlp	24979294	SENT203	5	5	13	13	fulvestrant	c-Myc	PA164747170	4609	0.908
NULL	BMJ_Open_2013_Feb_14_3(2)_e002577.nxml.txt.nlp	23418302	SENT79	36	36	5	5	morphine	PCA	PA450550	28982	0.908
NULL	Exp_Neurobiol_2013_Mar_31_22(1)_51-57.nxml.txt.nlp	23585723	SENT19	22	22	7	7	capsaicin	TRPV1	PA448776	7442	0.908
NULL	Arthritis_Res_Ther_2010_Jan_29_12(1)_R18.nxml.txt.nlp	20113495	SENT139	2	2	7	7	glucosamine	NAPA	PA164747613	9476;8775	0.908
NULL	Exp_Mol_Med_2012_Apr_30_44(4)_293-302.nxml.txt.nlp	22248567	SENT42	6	6	16	16	cetuximab	EGFR	PA10040	1956	0.908
NULL	Insights_Imaging_2013_Jan_29_4(2)_163-175.nxml.txt.nlp	23359240	SENT153	9	9	0	0	trastuzumab	HER2	PA451743	2064	0.908
NULL	Cancer_Immunol_Immunother_2011_Jun_25_60(6)_793-808.nxml.txt.nlp	21350947	SENT220	9	9	25	25	sorafenib	IFN	PA7000	3439	0.908
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT420	20	20	10	10	resveratrol	SRC3		8202	0.908
NULL	Exp_Diabetes_Res_2012_Oct_15_2012_465282.nxml.txt.nlp	23118742	SENT6	28	28	11	11	metformin	FGF21	PA450395	26291	0.908
NULL	Mol_Biol_Int_2012_May_24_2012_705948.nxml.txt.nlp	22693671	SENT167	7	7	2	2	cisplatin	RASSF2	PA449014	9770	0.908
NULL	Braz_J_Med_Biol_Res_2012_Sep_21_45(12)_1240-1243.nxml.txt.nlp	22983178	SENT101	29	29	8	8	indomethacin	CB2	PA449982	1269	0.908
NULL	ScientificWorldJournal_2013_Dec_18_2013_460202.nxml.txt.nlp	24453853	SENT49	12	12	25	25	kanamycin	CO2	PA450137	4513	0.908
NULL	Diabetes_Metab_Syndr_Obes_2014_Jul_1_7_265-275.nxml.txt.nlp	25061325	SENT174	6	6	23	23	sibutramine	5-HT2C	PA451344	3358	0.908
NULL	Exp_Diabetes_Res_2012_May_14_2012_470851.nxml.txt.nlp	22666230	SENT203	30	30	6	6	exenatide	GLP-1	PA164749238	100125288	0.908
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1224-1233.nxml.txt.nlp	22353810	SENT191	13	13	37	37	etoposide	MRP-1	PA449552	928	0.908
NULL	Oncogene_2014_Jul_24_33(30)_3959-3969.nxml.txt.nlp	24096481	SENT22	23	23	12	12	nutlin-3	p53		7157	0.908
NULL	Cell_Death_Differ_2010_Apr_16_17(4)_666-676.nxml.txt.nlp	19834494	SENT124	36	36	30	30	oxaliplatin	RAGE	PA131285527	177	0.908
NULL	J_Mol_Med_2008_Sep_4_86(9)_1045-1056.nxml.txt.nlp	18600309	SENT251	11	11	24	24	salmeterol	IL-8	PA451300	3576	0.908
NULL	Exp_Ther_Med_2013_Jan_19_5(1)_23-27.nxml.txt.nlp	23251236	SENT137	5	5	23	23	curcumin	EGR1	PA151958596	1958	0.908
NULL	Case_Rep_Rheumatol_2011_Dec_15_2011_185657.nxml.txt.nlp	22937439	SENT56	23	23	8	8	etanercept	p75	PA449515	7133;11168	0.908
NULL	Int_Arch_Med_2010_Apr_14_3_5.nxml.txt.nlp	20398245	SENT24	0	0	15	15	doxorubicin	TLR-4	PA449412	7099	0.908
NULL	Cell_Death_Dis_2014_Apr_24_5(4)_e1197.nxml.txt.nlp	24763054	SENT89	18	18	36	36	cisplatin	RUNX3	PA449014	864	0.908
NULL	Adipocyte_2012_Jul_1_1(3)_132-181.nxml.txt.nlp	23700522	SENT190	4	4	48	48	collagenase	CO2	PA449107	4513	0.908
NULL	F1000Prime_Rep_2014_Dec_1_6_117.nxml.txt.nlp	25580271	SENT66	17	17	22	22	cisplatin	EGFR	PA449014	1956	0.908
NULL	J_Med_Case_Reports_2011_Dec_21_5_593.nxml.txt.nlp	22188652	SENT52	31	31	26	26	erlotinib	CYP1A2	PA134687924	1544	0.908
NULL	Evid_Based_Complement_Alternat_Med_2014_May_18_2014_156276.nxml.txt.nlp	24963318	SENT5	4	4	20	20	hesperidin	SOD1	PA449867	6647	0.908
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT119	14	14	31	31	dasatinib	ABCG2	PA162372878	9429	0.908
NULL	Hum_Mol_Genet_2008_Aug_15_17(16)_2441-2455.nxml.txt.nlp	18469343	SENT326	9	9	1	1	glutaraldehyde	E12	PA449777	64100	0.908
NULL	Breast_Cancer_Res_2007_Aug_8_9(4)_R50.nxml.txt.nlp	17686159	SENT265	7	7	14	14	trastuzumab	AKT	PA451743	207	0.908
NULL	Hum_Genomics_2011_May_1_5(4)_265-282.nxml.txt.nlp	21712189	SENT139	37	37	7	7	lopinavir	CYP3A4	PA450264	1576	0.908
NULL	Gut_Liver_2015_Jan_9(1)_18-27.nxml.txt.nlp	NULL	SENT60	33	33	1	1	infliximab	ACT	PA452639	12;11332;9457;641455	0.908
NULL	Oncotarget_2012_Nov_17_4(1)_18-28.nxml.txt.nlp	23248157	SENT64	17	17	3	3	pargyline	U87	PA450797	677775;641648	0.908
NULL	Cell_Death_Dis_2010_Feb_4_1(2)_e23.nxml.txt.nlp	21364631	SENT56	21	21	32	32	imipramine	MKK4	PA449969	6416	0.908
NULL	Oncol_Lett_2014_Mar_2_7(3)_791-796.nxml.txt.nlp	24527087	SENT121	18	18	21	21	imatinib	CD34	PA10804	947	0.908
NULL	Mol_Cancer_2007_Oct_11_6_63.nxml.txt.nlp	17931419	SENT112	8	8	26	26	cetuximab	HIF-1	PA10040	29072	0.908
NULL	Breast_Cancer_Res_2011_Dec_16_13(6)_R131.nxml.txt.nlp	22177475	SENT275	31	31	21	21	trastuzumab	HER2	PA451743	2064	0.908
NULL	ScientificWorldJournal_2014_Mar_11_2014_946265.nxml.txt.nlp	24741367	SENT109	24	24	27	27	exenatide	GLP-1	PA164749238	100125288	0.908
NULL	Nat_Commun_2014_Dec_8_5_5736.nxml.txt.nlp	25484020	SENT9	12	12	2	2	anastrozole	aromatase	PA448432	1588	0.908
NULL	Mol_Biol_Cell_2012_May_1_23(9)_1728-1741.nxml.txt.nlp	22419820	SENT408	12	12	4	4	glutaraldehyde	ADAMTS9	PA449777	56999	0.908
NULL	Eur_J_Clin_Pharmacol_2011_Dec_23_67(12)_1231-1241.nxml.txt.nlp	21698374	SENT33	19	19	6	6	tacrolimus	CYP3A5	PA451578	1577	0.908
NULL	J_Exp_Med_2003_Dec_1_198(11)_1653-1663.nxml.txt.nlp	14657218	SENT53	22	22	0	0	gentamicin	CD14	PA449753	929	0.908
NULL	Comp_Funct_Genomics_2012_Feb_6_2012_876893.nxml.txt.nlp	22400011	SENT134	11	11	0	0	zinc	CPSF2	PA451956	53981	0.908
NULL	Clin_Ophthalmol_2010_Apr_26_4_369-374.nxml.txt.nlp	20463807	SENT15	3	3	13	13	pegaptanib	PED	PA164771236	8682	0.908
NULL	Oncol_Lett_2014_Mar_2_7(3)_791-796.nxml.txt.nlp	24527087	SENT122	5	5	11	11	imatinib	CD34	PA10804	947	0.908
NULL	Ann_Oncol_2014_Oct_18_25(10)_1871-1888.nxml.txt.nlp	25234545	SENT304	14	14	11	11	tamoxifen	aromatase	PA451581	1588	0.908
NULL	Br_J_Cancer_2009_Mar_24_100(6)_932-940.nxml.txt.nlp	19240717	SENT232	42	42	17	17	oxygen	EGF	PA450744	1950	0.908
NULL	Springerplus_2014_Sep_17_3_535.nxml.txt.nlp	25279326	SENT151	6	6	11	11	fulvestrant	aromatase	PA164747170	1588	0.908
NULL	Int_J_Med_Chem_2012_Dec_13_2012_530392.nxml.txt.nlp	25379286	SENT217	19	19	7	7	ethanol	mol	PA448073	90527	0.908
NULL	Mol_Vis_2012_Apr_11_18_901-908.nxml.txt.nlp	22539869	SENT143	37	37	17	17	curcumin	HO-1	PA151958596	3162	0.908
NULL	Croat_Med_J_2012_Jun_53(3)_214-223.nxml.txt.nlp	22661134	SENT100	14	14	43	43	yohimbine	ACTH	PA451946	5443	0.908
NULL	Clinics_(Sao_Paulo)_2011_Apr_66(4)_673-679.nxml.txt.nlp	21655764	SENT19	37	37	10	10	estradiol	spatial	PA449503	219793	0.908
NULL	Curr_Neuropharmacol_2008_Sep_6(3)_215-234.nxml.txt.nlp	19506722	SENT277	44	44	2	2	vasopressin	AVP	PA451858	114548;551	0.908
NULL	Exp_Ther_Med_2013_Dec_26_6(6)_1359-1364.nxml.txt.nlp	24255662	SENT167	31	31	11	11	dexmedetomidine	IL-6	PA449256	3569	0.908
NULL	Mol_Cancer_2010_Dec_2_9_309.nxml.txt.nlp	21122157	SENT244	11	11	16	16	paclitaxel	IL-6	PA450761	3569	0.908
NULL	Diabetes_Care_2013_Aug_17_36(Suppl_2)_S180-S189.nxml.txt.nlp	23882044	SENT79	21	21	9	9	metformin	GLP-1	PA450395	100125288	0.908
NULL	Aging_(Albany_NY)_2012_Apr_16_4(4)_247-255.nxml.txt.nlp	22511639	SENT82	12	12	33	33	metformin	CH1	PA450395	51430	0.908
NULL	ISRN_Cardiol_2012_Jun_27_2012_692761.nxml.txt.nlp	22792485	SENT108	28	28	14	14	clopidogrel	DES	PA449053	1674	0.908
NULL	Clin_Ophthalmol_2013_Aug_7_7_1591-1595.nxml.txt.nlp	23966764	SENT76	4	4	15	15	ranibizumab	VEGF-A	PA164746012	7422	0.908
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT218	7	7	17	17	heparin	FGF1	PA449855	2246	0.908
NULL	Front_Oncol_2014_Jun_11_4_145.nxml.txt.nlp	24967214	SENT376	37	37	22	22	fludarabine	CD4	PA449655	920	0.908
NULL	Hum_Mol_Genet_2013_Nov_15_22(22)_4602-4615.nxml.txt.nlp	23814040	SENT144	4	4	24	24	l-cysteine	NDUFB8	PA449173	4714	0.908
NULL	EMBO_Mol_Med_2012_Oct_30_4(10)_1087-1096.nxml.txt.nlp	22933245	SENT19	15	15	35	35	olaparib	BRCA2		675	0.908
NULL	Oncol_Lett_2013_Jul_8_6(1)_3-8.nxml.txt.nlp	23946768	SENT125	7	7	3	3	irinotecan	p38	PA450085	10598;1432;7965	0.908
NULL	Clinics_(Sao_Paulo)_2014_Jan_69(1)_68-74.nxml.txt.nlp	24473562	SENT22	5	5	35	35	nutlin-3	p53		7157	0.908
NULL	Cardiovasc_Res_2014_Mar_1_101(3)_513-521.nxml.txt.nlp	24323316	SENT27	35	35	25	25	maraviroc	CCL5	PA164768835	6352	0.908
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2011_Jun_7_4_29-37.nxml.txt.nlp	22879792	SENT37	10	10	2	2	ketoconazole	CYP2C8	PA450146	1558	0.908
NULL	Br_J_Cancer_2010_Sep_28_103(7)_1008-1018.nxml.txt.nlp	20736947	SENT47	32	32	12	12	docetaxel	MCT4	PA449383	9122;9123	0.908
NULL	Arthritis_Res_Ther_2007_Sep_23_9(5)_R96.nxml.txt.nlp	17888176	SENT44	17	17	2	2	etanercept	OPG	PA449515	690	0.908
NULL	J_Biomed_Biotechnol_2010_Jun_7_2010_150960.nxml.txt.nlp	20617134	SENT199	5	5	15	15	erlotinib	KRAS	PA134687924	3845	0.908
NULL	Br_J_Cancer_2011_Aug_9_105(4)_469-474.nxml.txt.nlp	21712825	SENT127	22	22	6	6	cisplatin	UCP1	PA449014	7350	0.908
NULL	Diabetes_Care_2013_Jun_15_36(6)_e80.nxml.txt.nlp	23704688	SENT10	26	26	12	12	exenatide	GLP-1	PA164749238	100125288	0.908
NULL	J_Mol_Med_(Berl)_2014_May_10_92(7)_709-722.nxml.txt.nlp	24811491	SENT70	17	17	11	11	cetuximab	HER2	PA10040	2064	0.908
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_May_12_66(Pt_6)_o1324-o1325.nxml.txt.nlp	21579416	SENT66	20	20	6	6	ethanol	mol	PA448073	90527	0.908
NULL	J_Cell_Biol_2003_Sep_29_162(7)_1197-1209.nxml.txt.nlp	14517203	SENT36	22	22	2	2	hydroxyurea	WRN	PA449942	7486	0.908
NULL	Behav_Brain_Funct_2009_Jun_4_5_23.nxml.txt.nlp	19497110	SENT54	3	3	24	24	ethanol	P31	PA448073	529	0.908
NULL	Carcinogenesis_2010_Dec_27_31(12)_2049-2057.nxml.txt.nlp	20876285	SENT293	11	11	18	18	tamoxifen	p27	PA451581	5715;10534	0.908
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_79-85.nxml.txt.nlp	23864840	SENT106	12	12	17	17	afatinib	EGFR	PA165981154	1956	0.908
NULL	J_Exp_Clin_Cancer_Res_2009_Jul_10_28(1)_99.nxml.txt.nlp	19591692	SENT13	23	23	9	9	imatinib	ABCG2	PA10804	9429	0.908
NULL	J_Hum_Genet_2013_Jun_23_58(6)_339-345.nxml.txt.nlp	23697979	SENT121	32	32	27	27	prasugrel	CYP2C19	PA154410481	1557	0.908
NULL	Biomed_Res_Int_2013_Sep_8_2013_843748.nxml.txt.nlp	24083244	SENT179	32	32	44	44	colchicine	CN2	PA449092	55748	0.908
NULL	Ann_Rheum_Dis_2009_Jan_15_69(1)_301-304.nxml.txt.nlp	19147618	SENT76	24	24	3	3	infliximab	TWEAK	PA452639	8742	0.908
NULL	Hum_Mol_Genet_2012_Jan_15_21(2)_300-310.nxml.txt.nlp	21979946	SENT199	22	22	6	6	nadh	NQO1	PA164755085	1728	0.908
NULL	Br_J_Cancer_2012_Oct_9_107(8)_1277-1285.nxml.txt.nlp	22990652	SENT164	32	32	5	5	paclitaxel	CYP2C8	PA450761	1558	0.908
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT167	9	9	12	12	metformin	HIF-1	PA450395	29072	0.908
NULL	Cancer_Med_2013_Jun_25_2(3)_277-285.nxml.txt.nlp	23930204	SENT179	9	9	5	5	panitumumab	KRAS	PA162373091	3845	0.908
NULL	J_Young_Pharm_2010_Oct-Dec_2(4)_428-429.nxml.txt.nlp	21264109	SENT5	8	8	19	19	metformin	B12	PA450395	7126;4709	0.908
NULL	eLife_2013_Nov_5_2_e00969.nxml.txt.nlp	24192036	SENT212	0	0	18	18	vemurafenib	MKK7	PA165946873	5609	0.908
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2012_Aug_1_68(Pt_8)_975-984.nxml.txt.nlp	22868763	SENT137	28	28	19	19	trypsin	BEST	PA451806	7439	0.908
NULL	Arthritis_Res_2002_Oct_16_4(1)_36-44.nxml.txt.nlp	11879536	SENT110	16	16	1	1	misoprostol	ACR	PA450523	49	0.908
NULL	Cell_Commun_Signal_2011_May_15_9_13.nxml.txt.nlp	21569639	SENT233	17	17	9	9	vinblastine	P-gp	PA451877	5243	0.908
NULL	Eur_J_Epidemiol_2011_Aug_30_26(8)_657-686.nxml.txt.nlp	21877163	SENT941	28	28	10	10	lactulose	CYP2C9	PA164748762	1559	0.908
NULL	Scientifica_(Cairo)_2013_Dec_30_2013_637629.nxml.txt.nlp	24490108	SENT340	24	24	10	10	doxorubicin	POH1	PA449412	10213	0.908
NULL	Exp_Ther_Med_2013_May_15_5(5)_1327-1331.nxml.txt.nlp	23737873	SENT28	41	41	13	13	imidapril	AQP2	PA452640	359	0.908
NULL	Eur_J_Clin_Pharmacol_2014_Oct_8_70(1)_37-45.nxml.txt.nlp	24100471	SENT15	11	11	32	32	rosuvastatin	CYP2C19	PA134308647	1557	0.908
NULL	Arthritis_Res_Ther_2008_Aug_22_10(4)_R97.nxml.txt.nlp	18718031	SENT37	31	31	3	3	heparin	BAFF	PA449855	10673	0.908
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT185	28	28	20	20	bevacizumab	VEGFR1	PA130232992	2321	0.908
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Mar_24_68(Pt_4)_o1180.nxml.txt.nlp	22606121	SENT63	18	18	10	10	ethanol	mol	PA448073	90527	0.908
NULL	Br_J_Cancer_2009_Mar_10_100(5)_732-738.nxml.txt.nlp	19259093	SENT128	33	33	6	6	cisplatin	EGFR	PA449014	1956	0.908
NULL	Nat_Commun_2013_Apr_9_4_1684.nxml.txt.nlp	23575688	SENT75	3	3	22	22	rolipram	CYLD	PA153906323	1540	0.908
NULL	Curr_Oncol_2009_Jul_16(Suppl_2)_S14-S23.nxml.txt.nlp	19672417	SENT214	15	15	9	9	tamoxifen	aromatase	PA451581	1588	0.908
NULL	J_Gen_Physiol_2003_Mar_121(3)_181-197.nxml.txt.nlp	12601083	SENT396	10	10	8	8	forskolin	GLP-1	PA146096022	100125288	0.908
NULL	Oncol_Rep_2012_Apr_30_27(4)_923-928.nxml.txt.nlp	22209766	SENT149	13	13	4	4	erlotinib	EGFR	PA134687924	1956	0.908
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Dec_10_65(Pt_1)_o52.nxml.txt.nlp	21581693	SENT57	20	20	7	7	ethanol	mol	PA448073	90527	0.908
NULL	Breast_Cancer_Res_2008_Dec_4_10(6)_R103.nxml.txt.nlp	19055788	SENT184	20	20	15	15	letrozole	aromatase	PA450196	1588	0.908
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Sep_19_65(Pt_10)_o2502.nxml.txt.nlp	21577951	SENT63	25	25	15	15	ethanol	mol	PA448073	90527	0.908
NULL	J_Hematol_Oncol_2012_Jul_27_5_42.nxml.txt.nlp	22839530	SENT166	22	22	5	5	vincristine	SRSF1	PA451879	6426	0.908
NULL	Breast_Cancer_Res_2011_Jun_29_13(3)_R70.nxml.txt.nlp	21707964	SENT144	11	11	21	21	tamoxifen	14-3-3	PA451581	10971	0.908
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT151	23	23	5	5	perifosine	DR5	PA165291471	8795	0.908
NULL	Ann_Hematol_2011_Dec_8_90(12)_1399-1407.nxml.txt.nlp	21476016	SENT89	42	42	13	13	doxorubicin	CHOP	PA449412	1649	0.908
NULL	Eur_J_Haematol_2014_Nov_28_93(5)_369-376.nxml.txt.nlp	24797664	SENT22	8	8	3	3	thrombin	FVIII	PA451674	2157	0.908
NULL	FEBS_Open_Bio_2014_Oct_22_4_905-914.nxml.txt.nlp	25383314	SENT102	20	20	4	4	physostigmine	L-FABP	PA450957	2168	0.908
NULL	Nat_Biotechnol_2011_Aug_10_29(9)_824-828.nxml.txt.nlp	21832997	SENT192	34	34	12	12	forskolin	F12	PA146096022	2161	0.908
NULL	Br_J_Cancer_2004_Mar_22_90(6)_1285-1292.nxml.txt.nlp	15026814	SENT37	33	33	7	7	cisplatin	San	PA449014	80218	0.908
NULL	Adv_Pharmacol_Sci_2014_Feb_24_2014_809438.nxml.txt.nlp	24707284	SENT304	21	21	40	40	glibenclamide	ANOVA	PA449782	4858	0.908
NULL	Front_Neurosci_2011_Jan_20_5_3.nxml.txt.nlp	21270945	SENT208	32	32	25	25	ethanol	ANOVA	PA448073	4858	0.908
NULL	Biochem_Res_Int_2012_Mar_4_2012_875742.nxml.txt.nlp	22500233	SENT124	11	11	5	5	collagenase	MMP1	PA449107	4312	0.908
NULL	EJC_Suppl_2013_Sep_5_11(2)_92-96.nxml.txt.nlp	NULL	SENT184	3	3	7	7	vemurafenib	BRAF	PA165946873	673	0.908
NULL	Int_J_Anal_Chem_2010_Jul_12_2010_234808.nxml.txt.nlp	20706537	SENT140	9	9	12	12	cosyntropin	ACTH	PA164749052	5443	0.908
NULL	Carcinogenesis_2011_Nov_1_32(11)_1724-1733.nxml.txt.nlp	21890461	SENT48	6	6	16	16	acetone	San	PA448025	80218	0.908
NULL	Onco_Targets_Ther_2014_Sep_9_7_1571-1582.nxml.txt.nlp	25228815	SENT130	14	14	4	4	sorafenib	VEGFR1	PA7000	2321	0.908
NULL	Oncotarget_2014_Aug_4_5(17)_7776-7787.nxml.txt.nlp	25277200	SENT61	7	7	0	0	cisplatin	ANXA4	PA449014	307	0.908
NULL	Clin_Mol_Hepatol_2012_Dec_21_18(4)_360-367.nxml.txt.nlp	23323251	SENT8	8	8	14	14	ribavirin	IL28B	PA451241	282617	0.908
NULL	Mol_Cell_Proteomics_2012_Nov_10_11(11)_1289-1305.nxml.txt.nlp	22888148	SENT312	25	25	15	15	chloroquine	LC3	PA448948	84557	0.908
NULL	Cell_Death_Dis_2014_Feb_13_5(2)_e1055.nxml.txt.nlp	24525731	SENT140	22	22	11	11	cisplatin	XRCC1	PA449014	7515	0.908
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_16_2013_146142.nxml.txt.nlp	23843863	SENT99	6	6	12	12	ns-398	COX2		4513;5743	0.908
NULL	Arthritis_Res_Ther_2012_Jan_17_14(1)_R11.nxml.txt.nlp	22251436	SENT25	0	0	18	18	maraviroc	CCR5	PA164768835	1234	0.908
NULL	Cancer_Metab_2013_Nov_7_1_20.nxml.txt.nlp	24279929	SENT280	8	8	2	2	estradiol	aromatase	PA449503	1588	0.908
NULL	Oncol_Lett_2013_Feb_30_5(2)_588-592.nxml.txt.nlp	23420263	SENT75	8	8	24	24	lenalidomide	NKX2-1	PA162363968	7080	0.908
NULL	Ann_Hematol_2010_Nov_25_89(11)_1115-1124.nxml.txt.nlp	20499237	SENT181	17	17	22	22	simvastatin	CD19	PA451363	930	0.908
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1554-1562.nxml.txt.nlp	21970876	SENT169	39	39	13	13	afatinib	EGFR	PA165981154	1956	0.908
NULL	J_Thromb_Thrombolysis_2012_Feb_20_33(2)_143-153.nxml.txt.nlp	22183178	SENT178	14	14	16	16	clopidogrel	CYP2C19	PA449053	1557	0.908
NULL	J_Inj_Violence_Res_2014_Jul_6(2)_72-78.nxml.txt.nlp	24121451	SENT148	16	16	19	19	ibudilast	TLR4	PA165958351	7099	0.908
NULL	J_Cell_Biol_1998_Nov_2_143(3)_637-644.nxml.txt.nlp	9813086	SENT194	37	37	46	46	paraformaldehyde	CD59	PA450790	966	0.908
NULL	Front_Genet_2012_Nov_5_3_236.nxml.txt.nlp	23133441	SENT130	18	18	1	1	efavirenz	ABCB1	PA449441	5243	0.907
NULL	FASEB_J_2013_Mar_27(3)_1084-1094.nxml.txt.nlp	23195034	SENT205	17	17	22	22	bortezomib	Mcl-1	PA10252	4170	0.907
NULL	ScientificWorldJournal_2014_Mar_2_2014_794078.nxml.txt.nlp	24723825	SENT125	16	16	5	5	clopidogrel	DES	PA449053	1674	0.907
NULL	J_Infect_Dis_2014_Jan_1_209(1)_120-129.nxml.txt.nlp	23943850	SENT208	36	36	18	18	levamisole	CD36	PA450205	948	0.907
NULL	Indian_J_Endocrinol_Metab_2013_Jul-Aug_17(4)_636-646.nxml.txt.nlp	23961479	SENT146	10	10	4	4	phenytoin	CYP2C9	PA450947	1559	0.907
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT9	0	0	17	17	perifosine	DR4	PA165291471	8797	0.907
NULL	Environ_Health_Perspect_2010_Jul_3_118(7)_936-942.nxml.txt.nlp	20199942	SENT133	24	24	13	13	arsenite	mot-2	PA452638	3313	0.907
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT83	13	13	10	10	cisplatin	XPA	PA449014	7507	0.907
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT51	13	13	22	22	nutlin-3	p53		7157	0.907
NULL	J_Cell_Biol_1998_Aug_24_142(4)_923-936.nxml.txt.nlp	9722606	SENT253	24	24	15	15	dextran	TGN	PA449261	7038	0.907
NULL	Indian_J_Endocrinol_Metab_2013_May-Jun_17(3)_509-513.nxml.txt.nlp	23869312	SENT145	16	16	6	6	estradiol	aromatase	PA449503	1588	0.907
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_29_2012_985151.nxml.txt.nlp	23259003	SENT166	15	15	19	19	ribavirin	PED	PA451241	8682	0.907
NULL	Case_Rep_Hematol_2013_Jul_11_2013_871476.nxml.txt.nlp	23956893	SENT17	39	39	9	9	nilotinib	p230	PA165958345	2803	0.907
NULL	Breast_Cancer_Res_2014_May_28_16(3)_R53.nxml.txt.nlp	24886537	SENT32	9	9	2	2	erlotinib	VAV3	PA134687924	10451	0.907
NULL	Braz_J_Microbiol_2014_Jan_15_44(3)_665-671.nxml.txt.nlp	24516432	SENT140	0	0	7	7	ethanol	GPD2	PA448073	2820	0.907
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT9	19	19	3	3	doxorubicin	SLK	PA449412	9748;2534	0.907
NULL	Biomed_Res_Int_2014_May_13_2014_697935.nxml.txt.nlp	24949465	SENT120	29	29	9	9	risperidone	EGF	PA451257	1950	0.907
NULL	Front_Chem_2013_Jul_12_1_10.nxml.txt.nlp	24790939	SENT57	6	6	11	11	hydroquinone	mol	PA449924	90527	0.907
NULL	J_Hum_Genet_2013_Jun_16_58(6)_353-361.nxml.txt.nlp	23677058	SENT125	11	11	6	6	etoposide	ABCC3	PA449552	8714	0.907
NULL	Ann_Indian_Acad_Neurol_2009_Apr-Jun_12(2)_89-98.nxml.txt.nlp	20142853	SENT202	15	15	26	26	carbamazepine	MRP2	PA448785	100130958;57626;1244	0.907
NULL	Croat_Med_J_2013_Apr_54(2)_171-179.nxml.txt.nlp	23630144	SENT144	26	26	19	19	taurine	STZ	PA451590	6484	0.907
NULL	Core_Evid_2009_Jun_15_4_171-179.nxml.txt.nlp	20694073	SENT224	2	2	9	9	agomelatine	5-HT2C	PA165958363	3358	0.907
NULL	Indian_J_Urol_2009_Oct-Dec_25(4)_427-436.nxml.txt.nlp	19955664	SENT110	17	17	24	24	erlotinib	EGFR	PA134687924	1956	0.907
NULL	Arthritis_Res_Ther_2011_Oct_7_13(5)_R161.nxml.txt.nlp	21982514	SENT66	8	8	33	33	etanercept	San	PA449515	80218	0.907
NULL	Oncoscience_2014_Aug_21_1(8)_513-521.nxml.txt.nlp	25594058	SENT27	16	16	21	21	cisplatin	EGFR	PA449014	1956	0.907
NULL	Case_Rep_Hematol_2014_May_14_2014_484563.nxml.txt.nlp	24955264	SENT12	5	5	11	11	cyclophosphamide	FVIII	PA449165	2157	0.907
NULL	Ann_Hematol_2011_Feb_17_90(2)_173-183.nxml.txt.nlp	20714724	SENT7	8	8	16	16	resveratrol	ZAP-70		7535	0.907
NULL	Int_J_Chron_Obstruct_Pulmon_Dis_2006_Mar_1(1)_15-29.nxml.txt.nlp	18046899	SENT207	5	5	12	12	curcumin	IL-8	PA151958596	3576	0.907
NULL	Ann_Rheum_Dis_2010_Jan_17_69(1)_88-96.nxml.txt.nlp	19297346	SENT200	39	39	18	18	tocilizumab	IL-6	PA165292659	3569	0.907
NULL	Oncoimmunology_2013_Feb_1_2(2)_e23288.nxml.txt.nlp	23525955	SENT3	9	9	23	23	temozolomide	CD4	PA451609	920	0.907
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT126	1	1	20	20	erlotinib	CYP3A	PA134687924	1574	0.907
NULL	Ann_Oncol_2011_Mar_8_22(3)_503-514.nxml.txt.nlp	20616198	SENT185	26	26	31	31	tamoxifen	aromatase	PA451581	1588	0.907
NULL	Korean_J_Thorac_Cardiovasc_Surg_2014_Oct_5_47(5)_478-482.nxml.txt.nlp	25346905	SENT27	13	13	3	3	hydroxyurea	PDGFRB	PA449942	5159	0.907
NULL	Cancer_Med_2013_Dec_31_2(6)_826-835.nxml.txt.nlp	24403256	SENT218	11	11	18	18	daunorubicin	HDM2	PA449212	4193	0.907
NULL	Braz_J_Med_Biol_Res_2014_Sep_5_47(11)_929-939.nxml.txt.nlp	25296354	SENT105	0	0	25	25	afatinib	EGFR	PA165981154	1956	0.907
NULL	Environ_Health_2013_Mar_26_12_26.nxml.txt.nlp	23530988	SENT15	22	22	6	6	estradiol	JNK	PA449503	5599	0.907
NULL	F1000_Med_Rep_2009_Mar_17_1_20.nxml.txt.nlp	20948761	SENT42	0	0	9	9	pertuzumab	HER2		2064	0.907
NULL	Neuro_Oncol_2010_Apr_27_12(4)_389-400.nxml.txt.nlp	20308316	SENT115	3	3	16	16	chloroquine	p53	PA448948	7157	0.907
NULL	Mol_Cancer_2010_May_3_9_99.nxml.txt.nlp	20438634	SENT386	6	6	4	4	genistein	NF-kappaB	PA165109660	4790	0.907
NULL	Front_Oncol_2014_Oct_31_4_306.nxml.txt.nlp	25401091	SENT53	1	1	7	7	verapamil	MDR1	PA451868	5243	0.907
NULL	Diabetes_Care_2013_Aug_17_36(Suppl_2)_S180-S189.nxml.txt.nlp	23882044	SENT208	9	9	5	5	metformin	GLP-1	PA450395	100125288	0.907
NULL	J_Cell_Biol_2008_Jul_14_182(1)_197-213.nxml.txt.nlp	18625847	SENT193	11	11	2	2	nutlin-3	p53		7157	0.907
NULL	Int_J_Mol_Sci_2013_Apr_9_14(4)_7716-7741.nxml.txt.nlp	23571495	SENT201	2	2	15	15	raloxifene	HDL2	PA451221	57338	0.907
NULL	Pan_Afr_Med_J_2014_Jul_6_18_205.nxml.txt.nlp	25419332	SENT46	10	10	6	6	doxorubicin	CHOP	PA449412	1649	0.907
NULL	Diabetes_2013_Sep_15_62(9)_3232-3240.nxml.txt.nlp	23835329	SENT7	3	3	6	6	olanzapine	AAP	PA450688	5345	0.907
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT89	0	0	15	15	etravirine	CYP2C9	PA166014703	1559	0.907
NULL	Br_J_Cancer_2013_Jul_23_109(2)_433-443.nxml.txt.nlp	23807168	SENT112	22	22	10	10	bortezomib	ATF4	PA10252	468	0.907
NULL	Oncotarget_2013_Dec_18_5(3)_634-648.nxml.txt.nlp	24504138	SENT189	2	2	27	27	bortezomib	IL-6	PA10252	3569	0.907
NULL	Ann_Gastroenterol_2014_27(4)_380-386.nxml.txt.nlp	25331321	SENT27	29	29	14	14	entecavir	IFN	PA164784025	3439	0.907
NULL	Oncotarget_2014_May_27_5(19)_9049-9064.nxml.txt.nlp	24979294	SENT188	0	0	13	13	fulvestrant	AKT	PA164747170	207	0.907
NULL	Br_J_Cancer_2011_Apr_12_104(8)_1278-1287.nxml.txt.nlp	21487429	SENT163	20	20	7	7	cisplatin	c-FLIP	PA449014	8837	0.907
NULL	Int_J_Breast_Cancer_2011_Jul_12_2011_232435.nxml.txt.nlp	22295213	SENT242	40	40	17	17	tamoxifen	EZH2	PA451581	2146	0.907
NULL	J_Headache_Pain_2013_Feb_21_14(Suppl_1)_P69.nxml.txt.nlp	NULL	SENT18	26	26	10	10	naloxone	5-HT1B	PA450586	3351	0.907
NULL	Ann_Rheum_Dis_2013_Apr_21_72(4)_482-492.nxml.txt.nlp	23172750	SENT197	27	27	7	7	abatacept	IL-6	PA164747080	3569	0.907
NULL	Biologics_2010_Aug_9_4_173-185.nxml.txt.nlp	20714355	SENT40	21	21	6	6	cetuximab	EGFR	PA10040	1956	0.907
NULL	Acta_Pharmacol_Sin_2011_Jul_6_32(7)_921-929.nxml.txt.nlp	21643005	SENT19	8	8	22	22	cerulenin	5-LOX	PA164764551	240	0.907
NULL	Cancers_(Basel)_2010_Feb_23_2(1)_88-113.nxml.txt.nlp	24281034	SENT1015	5	5	1	1	panitumumab	KRAS	PA162373091	3845	0.907
NULL	Blood_Cancer_J_2014_Mar_7_4(3)_e190.nxml.txt.nlp	24608734	SENT98	8	8	14	14	vindesine	CHOP	PA10232	1649	0.907
NULL	Diabetes_2009_Feb_58(2)_422-432.nxml.txt.nlp	19033399	SENT315	16	16	29	29	carbachol	CHOP	PA448784	1649	0.907
NULL	J_Cell_Mol_Med_2013_Sep_24_17(9)_1065-1087.nxml.txt.nlp	24151975	SENT348	0	0	17	17	palifermin	CXCL2	PA164744014	2920	0.907
NULL	J_Hematol_Oncol_2009_Oct_27_2_45.nxml.txt.nlp	19860903	SENT238	3	3	6	6	everolimus	EGFR	PA164746311	1956	0.907
NULL	ARYA_Atheroscler_2011_Summer_7(2)_78-86.nxml.txt.nlp	22577451	SENT11	4	4	38	38	choline	IL-6	PA448976	3569	0.907
NULL	Eur_J_Appl_Physiol_2014_Jun_5_114(3)_545-559.nxml.txt.nlp	23737006	SENT230	2	2	25	25	phentolamine	CO2	PA450926	4513	0.907
NULL	Eur_J_Clin_Pharmacol_2008_Feb_26_64(2)_133-157.nxml.txt.nlp	18224312	SENT38	4	4	23	23	succinylcholine	BCHE	PA451522	590	0.907
NULL	J_Inflamm_(Lond)_2004_Sep_27_1_1.nxml.txt.nlp	15813979	SENT46	33	33	9	9	celecoxib	COX2	PA448871	4513;5743	0.907
NULL	FEBS_Open_Bio_2011_Dec_27_2_1-5.nxml.txt.nlp	23650573	SENT103	1	1	15	15	sunitinib	MDM2	PA162372840	4193	0.907
NULL	Nat_Commun_2014_Dec_12_5_5775.nxml.txt.nlp	25503391	SENT120	19	19	2	2	paclitaxel	CLU	PA450761	1191	0.907
NULL	J_Hematol_Oncol_2013_Jun_3_6_38.nxml.txt.nlp	23731980	SENT72	17	17	6	6	lapatinib	HER2	PA152241907	2064	0.907
NULL	Curr_Neuropharmacol_2012_Jun_10(2)_97-123.nxml.txt.nlp	23204981	SENT187	5	5	23	23	paroxetine	COX	PA450801	1351	0.907
NULL	ScientificWorldJournal_2012_Aug_13_2012_496453.nxml.txt.nlp	22927782	SENT48	27	27	23	23	sitagliptin	GLP-1	PA164748978	100125288	0.907
NULL	Indian_J_Pharmacol_2012_Sep-Oct_44(5)_624-628.nxml.txt.nlp	23112426	SENT145	10	10	20	20	nimodipine	CYP3A	PA450633	1574	0.907
NULL	Arthritis_Res_Ther_2009_Mar_16_11(2)_R41.nxml.txt.nlp	19291317	SENT29	12	12	19	19	collagenase	IL-8	PA449107	3576	0.907
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT7	17	17	7	7	cisplatin	p53	PA449014	7157	0.907
NULL	Diabetes_2009_Jan_58(1)_104-115.nxml.txt.nlp	18835938	SENT166	32	32	13	13	pioglitazone	MCP-1	PA450970	6347	0.907
NULL	Cancer_Med_2012_Oct_6_1(2)_198-206.nxml.txt.nlp	23342269	SENT164	23	23	4	4	oxaliplatin	GSTP1	PA131285527	2950	0.907
NULL	Acta_Pharmacol_Sin_2012_Oct_3_33(10)_1311-1318.nxml.txt.nlp	22941289	SENT138	12	12	0	0	sorafenib	VEGFR2	PA7000	3791	0.907
NULL	Mol_Vis_2011_Feb_1_17_332-340.nxml.txt.nlp	21297899	SENT179	6	6	12	12	telmisartan	DPI	PA451605	1832	0.907
NULL	Environ_Health_Perspect_2013_Mar_3_121(3)_332-338.nxml.txt.nlp	23458687	SENT69	9	9	25	25	ethanol	hole	PA448073	80757	0.907
NULL	Case_Rep_Med_2012_Jun_19_2012_680431.nxml.txt.nlp	22778751	SENT92	24	24	18	18	doxorubicin	CHOP	PA449412	1649	0.907
NULL	Exp_Cell_Res_2011_May_1_317(8)_1093-1107.nxml.txt.nlp	21320486	SENT331	14	14	37	37	bortezomib	APPL1	PA10252	26060	0.907
NULL	Case_Rep_Neurol_Med_2013_May_28_2013_516325.nxml.txt.nlp	23781357	SENT30	3	3	10	10	meclizine	OTC	PA450338	5009	0.907
NULL	Angiogenesis_2010_Dec_7_13(4)_305-315.nxml.txt.nlp	20927579	SENT168	5	5	2	2	resveratrol	HIF-1		29072	0.907
NULL	Arthritis_Res_Ther_2012_Apr_16_14(2)_R76.nxml.txt.nlp	22507741	SENT171	4	4	13	13	estradiol	IL-10	PA449503	3586	0.907
NULL	Case_Rep_Ophthalmol_2011_Dec_10_2(3)_382-386.nxml.txt.nlp	22220163	SENT60	10	10	3	3	exemestane	aromatase	PA449563	1588	0.907
NULL	Asia_Pac_Allergy_2013_Oct_31_3(4)_231-240.nxml.txt.nlp	24260728	SENT77	14	14	25	25	theophylline	ANOVA	PA451647	4858	0.907
NULL	Genome_Biol_2005_Jul_29_6(8)_228.nxml.txt.nlp	16086858	SENT44	14	14	3	3	daunorubicin	CBR1	PA449212	873	0.907
NULL	Bonekey_Rep_2013_Mar_13_2_306.nxml.txt.nlp	23951543	SENT49	5	5	18	18	fluorescein	MDC	PA164746009	6367	0.907
NULL	Mol_Cancer_2009_Apr_22_8_26.nxml.txt.nlp	19386116	SENT185	28	28	23	23	cisplatin	AKT	PA449014	207	0.907
NULL	Arthritis_Res_Ther_2010_Apr_9_12(2)_R65.nxml.txt.nlp	20380722	SENT88	2	2	17	17	imatinib	IL6	PA10804	3569	0.907
NULL	Clin_Pharmacokinet_2014_Oct_15_53(2)_155-164.nxml.txt.nlp	24127209	SENT29	6	6	24	24	clopidogrel	CYP2C19	PA449053	1557	0.907
NULL	J_Oncol_2010_Dec_28_2010_135354.nxml.txt.nlp	21318160	SENT22	17	17	4	4	eltrombopag	TPO	PA165981594	7066;7173	0.907
NULL	Biosci_Rep_2012_Dec_1_32(Pt_6)_511-519.nxml.txt.nlp	NULL	SENT88	5	5	13	13	pitavastatin	Rho	PA142650384	29984	0.907
NULL	Ann_Rheum_Dis_2009_Oct_17_68(10)_1580-1584.nxml.txt.nlp	19019888	SENT179	11	11	7	7	tocilizumab	IL-6	PA165292659	3569	0.907
NULL	Nat_Neurosci_2012_Mar_11_15(5)_703-712.nxml.txt.nlp	22406547	SENT82	15	15	11	11	heparin	NgR3	PA449855	146760	0.907
NULL	Arthritis_Res_Ther_2012_Nov_2_14(Suppl_4)_S2.nxml.txt.nlp	23281926	SENT134	7	7	3	3	rituximab	BAFF	PA451261	10673	0.907
NULL	Toxins_(Basel)_2010_Jun_9_2(6)_1381-1398.nxml.txt.nlp	22069643	SENT169	8	8	0	0	vincristine	P-gp	PA451879	5243	0.907
NULL	Semin_Immunopathol_2012_Jan_4_34(1)_93-106.nxml.txt.nlp	21845431	SENT5	0	0	17	17	thrombin	ADAMTS13	PA451674	11093	0.907
NULL	Carcinogenesis_2010_Dec_15_31(12)_2031-2038.nxml.txt.nlp	20952512	SENT175	18	18	3	3	hydroxyurea	BRCA1	PA449942	672	0.907
NULL	Acta_Pharmacol_Sin_2011_Jun_23_32(6)_765-780.nxml.txt.nlp	21602835	SENT320	0	0	15	15	diazoxide	GDH	PA449285	51084;2746	0.907
NULL	Pharmaceuticals_(Basel)_2012_Sep_17_5(9)_1021-1031.nxml.txt.nlp	24280703	SENT39	29	29	3	3	thioridazine	CPZ	PA451666	8532	0.907
NULL	Front_Neurosci_2014_Jun_24_8_176.nxml.txt.nlp	25009459	SENT1314	5	5	2	2	ethanol	P2X4	PA448073	5025	0.907
NULL	Acta_Pharmacol_Sin_2009_Sep_24_30(9)_1323-1329.nxml.txt.nlp	19701237	SENT105	21	21	3	3	clarithromycin	CYP3A	PA449028	1574	0.907
NULL	Clin_Pharmacol_2010_Apr_27_2_77-82.nxml.txt.nlp	22291489	SENT40	0	0	9	9	cosyntropin	ACTH	PA164749052	5443	0.907
NULL	Anal_Chem_Insights_2009_Apr_7_4_1-9.nxml.txt.nlp	19652757	SENT99	11	11	23	23	escitalopram	mol	PA10074	90527	0.907
NULL	AIDS_2014_Mar_13_28(5)_717-725.nxml.txt.nlp	24983542	SENT3	19	19	8	8	efavirenz	CCR5	PA449441	1234	0.907
NULL	J_Immunol_Res_2014_May_12_2014_897249.nxml.txt.nlp	24901013	SENT165	16	16	6	6	natalizumab	TGFBR2	PA164747191	7048	0.907
NULL	Viruses_2014_Feb_18_6(2)_875-892.nxml.txt.nlp	24553110	SENT185	0	0	5	5	erlotinib	EGFR	PA134687924	1956	0.907
NULL	Environ_Health_Perspect_2006_Feb_18_114(2)_297-301.nxml.txt.nlp	16451871	SENT92	31	31	17	17	heparin	SeP	PA449855	6414	0.907
NULL	Breast_Cancer_Res_2008_Mar_31_10(2)_205.nxml.txt.nlp	18394187	SENT128	16	16	6	6	tamoxifen	HER2	PA451581	2064	0.907
NULL	Diabetes_Care_2013_Jul_12_36(7)_2098-2106.nxml.txt.nlp	23695817	SENT138	4	4	20	20	liraglutide	GLP-1	PA165958364	100125288	0.907
NULL	Diabetes_Care_2010_Sep_33(9)_2074-2076.nxml.txt.nlp	20805279	SENT62	0	0	3	3	exenatide	GLP-1	PA164749238	100125288	0.907
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT108	15	15	10	10	methotrexate	MSH2	PA450428	4436	0.907
NULL	Cancer_Med_2013_Jun_25_2(3)_277-285.nxml.txt.nlp	23930204	SENT107	4	4	17	17	bevacizumab	PTEN	PA130232992	5728	0.907
NULL	Br_J_Cancer_2011_Nov_22_105(11)_1628-1634.nxml.txt.nlp	22009028	SENT70	23	23	0	0	leuprolide	Men	PA450203	8178	0.907
NULL	Br_J_Cancer_1998_Aug_78(3)_375-381.nxml.txt.nlp	9703286	SENT9	31	31	4	4	paclitaxel	TP53	PA450761	7157	0.907
NULL	Br_J_Cancer_2009_Mar_24_100(6)_941-949.nxml.txt.nlp	19240716	SENT285	16	16	9	9	gefitinib	Met	PA131301952	79811	0.907
NULL	Br_J_Cancer_1996_Dec_74(11)_1821-1827.nxml.txt.nlp	8956800	SENT16	9	9	36	36	cyclophosphamide	CD34	PA449165	947	0.907
NULL	Aging_(Albany_NY)_2009_Mar_31_1(4)_412-424.nxml.txt.nlp	20195491	SENT86	13	13	39	39	resveratrol	TXNIP		10628	0.907
NULL	Environ_Health_Perspect_2008_Jan_11_116(1)_57-63.nxml.txt.nlp	18197300	SENT161	17	17	8	8	chlorzoxazone	GSTT1	PA448971	2952	0.907
NULL	Crit_Care_2010_Apr_19_14(2)_R70.nxml.txt.nlp	20403177	SENT259	16	16	34	34	thrombin	cPLA2	PA451674	10524	0.907
NULL	J_Biol_Chem_2009_Jan_9_284(2)_751-758.nxml.txt.nlp	19010784	SENT211	26	26	39	39	thrombin	ADP	PA451674	23038	0.907
NULL	Environ_Health_Perspect_2006_Sep_23_114(9)_1401-1406.nxml.txt.nlp	16966095	SENT199	7	7	3	3	arsenite	ID1	PA452638	3397	0.907
NULL	Hum_Mol_Genet_2014_Apr_1_23(7)_1709-1722.nxml.txt.nlp	24203695	SENT94	12	12	3	3	creatine	COL4A1	PA164778930	1282	0.907
NULL	J_Oncol_2009_Mar_24_2009_491985.nxml.txt.nlp	19325924	SENT22	2	2	10	10	genistein	CYP1A1	PA165109660	1543	0.907
NULL	Eur_J_Clin_Pharmacol_2014_Oct_8_70(1)_37-45.nxml.txt.nlp	24100471	SENT195	0	0	12	12	midazolam	CYP2C19	PA450496	1557	0.907
NULL	Oncotarget_2014_Mar_26_5(21)_10342-10355.nxml.txt.nlp	25431950	SENT22	17	17	5	5	sunitinib	EGFR	PA162372840	1956	0.907
NULL	Nat_Genet_2014_Feb_12_46(2)_166-170.nxml.txt.nlp	24413734	SENT55	6	6	13	13	dasatinib	FYN	PA162372878	2534	0.907
NULL	Oncotarget_2013_Nov_22_5(4)_933-943.nxml.txt.nlp	24659749	SENT108	42	42	34	34	nutlin-3	AML3		860	0.907
NULL	Biochem_Res_Int_2012_Jul_5_2012_371415.nxml.txt.nlp	22844597	SENT237	18	18	20	20	dobutamine	DBT	PA449381	1629	0.907
NULL	Biochem_Res_Int_2012_May_7_2012_395974.nxml.txt.nlp	22611495	SENT247	19	19	8	8	sirolimus	GLP-1	PA451365	100125288	0.907
NULL	Acta_Pharmacol_Sin_2012_May_16_33(5)_682-690.nxml.txt.nlp	22504904	SENT233	0	0	2	2	celecoxib	STAT3	PA448871	6774	0.907
NULL	Oncol_Lett_2013_Apr_28_5(4)_1149-1154.nxml.txt.nlp	23599754	SENT7	13	13	2	2	cisplatin	Dicer	PA449014	23405	0.907
NULL	Nat_Chem_Biol_2010_Apr_28_6(4)_291-299.nxml.txt.nlp	20190765	SENT190	8	8	23	23	dasatinib	EGFR	PA162372878	1956	0.907
NULL	Oncotarget_2011_Dec_31_2(12)_1314-1321.nxml.txt.nlp	22248929	SENT62	13	13	2	2	lapatinib	HER3	PA152241907	2065	0.907
NULL	Chem_Res_Toxicol_2011_Aug_15_24(8)_1275-1282.nxml.txt.nlp	21749116	SENT126	17	17	14	14	geldanamycin	Hsp90	PA152031327	3320	0.907
NULL	Vet_Res_2013_Sep_9_44(1)_82.nxml.txt.nlp	24016341	SENT183	25	25	10	10	imiquimod	IFN	PA449972	3439	0.907
NULL	Exp_Cell_Res_2011_Mar_10_317(5)_556-568.nxml.txt.nlp	21272574	SENT73	25	25	6	6	heparin	DARC	PA449855	2532	0.907
NULL	Acta_Pharmacol_Sin_2010_Feb_21_31(2)_145-149.nxml.txt.nlp	20023694	SENT20	13	13	20	20	vasopressin	SON	PA451858	6651	0.907
NULL	Front_Genet_2013_Aug_29_4_163.nxml.txt.nlp	24009622	SENT343	16	16	2	2	imatinib	p53	PA10804	7157	0.907
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Feb_10_68(Pt_3)_o683-o684.nxml.txt.nlp	22412578	SENT73	10	10	19	19	benzaldehyde	mol	PA448571	90527	0.907
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R91.nxml.txt.nlp	22541814	SENT142	32	32	38	38	thrombin	HO-1	PA451674	3162	0.907
NULL	BMJ_2009_Feb_25_338_b438.nxml.txt.nlp	19244302	SENT46	27	27	21	21	letrozole	aromatase	PA450196	1588	0.907
NULL	Clin_Pharmacokinet_2014_Sep_3_53(1)_1-16.nxml.txt.nlp	23999929	SENT287	19	19	8	8	erythromycin	CYP3A4	PA449493	1576	0.907
NULL	Int_J_Mol_Sci_2014_Mar_24_15(3)_5140-5162.nxml.txt.nlp	24663085	SENT793	10	10	3	3	cyclophosphamide	LP1	PA449165	6176	0.907
NULL	Curr_Pharm_Biotechnol_2012_May_13(6)_969-986.nxml.txt.nlp	22039792	SENT232	5	5	30	30	ivermectin	MDR1	PA450133	5243	0.907
NULL	Pharmaceuticals_(Basel)_2011_Jun_30_4(7)_976-991.nxml.txt.nlp	NULL	SENT43	12	12	9	9	rimonabant	CB1	PA152407999	1268	0.907
NULL	FEBS_Open_Bio_2011_Dec_27_2_1-5.nxml.txt.nlp	23650573	SENT104	20	20	38	38	sunitinib	MDM2	PA162372840	4193	0.907
NULL	Int_J_Mol_Imaging_2011_Oct_26_2011_874585.nxml.txt.nlp	21490735	SENT125	6	6	43	43	tamoxifen	FDG	PA451581	23583	0.907
NULL	Case_Rep_Oncol_Med_2013_Dec_5_2013_838941.nxml.txt.nlp	24381773	SENT63	8	8	3	3	doxorubicin	CHOP	PA449412	1649	0.907
NULL	J_Radiat_Res_2014_May_28_55(3)_432-442.nxml.txt.nlp	24375278	SENT116	16	16	5	5	metformin	PARP-1	PA450395	25976	0.907
NULL	J_Hematol_Oncol_2013_Jul_9_6_49.nxml.txt.nlp	23837843	SENT89	12	12	2	2	verapamil	Rho	PA451868	29984	0.907
NULL	Acta_Pharmacol_Sin_2012_Dec_5_33(12)_1502-1510.nxml.txt.nlp	23123644	SENT126	0	0	14	14	losartan	LARG	PA450268	23365	0.907
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Aug_13_64(Pt_9)_o1744.nxml.txt.nlp	21201726	SENT60	23	23	17	17	ethanol	mol	PA448073	90527	0.907
NULL	Cancers_(Basel)_2010_Jan_14_2(1)_1-19.nxml.txt.nlp	24281029	SENT1001	4	4	21	21	neratinib	San	PA165291472	80218	0.907
NULL	Asian_J_Androl_2015_Aug_29_Jan-Feb_17(1)_32-39.nxml.txt.nlp	25219908	SENT157	12	12	0	0	sildenafil	Men	PA451346	8178	0.907
NULL	Oncoscience_2014_Oct_22_1(10)_614-623.nxml.txt.nlp	25593991	SENT97	16	16	10	10	gefitinib	EGFR	PA131301952	1956	0.907
NULL	Cancers_(Basel)_2014_Nov_25_6(4)_2313-2329.nxml.txt.nlp	25534569	SENT389	0	0	9	9	cabozantinib	VEGFR2	PA165906891	3791	0.907
NULL	J_Hum_Genet_2013_Jun_2_58(6)_306-312.nxml.txt.nlp	23635953	SENT7	14	14	23	23	tamoxifen	aromatase	PA451581	1588	0.907
NULL	Oncotarget_2014_Aug_29_5(19)_8947-8958.nxml.txt.nlp	25333254	SENT232	8	8	5	5	plerixafor	CXCR4	PA165958410	7852	0.907
NULL	Front_Neurosci_2013_Jan_10_6_191.nxml.txt.nlp	23335875	SENT240	7	7	19	19	vasopressin	ghrelin	PA451858	51738	0.907
NULL	Br_J_Cancer_2012_Oct_9_107(8)_1361-1373.nxml.txt.nlp	22929890	SENT48	5	5	14	14	cisplatin	p53	PA449014	7157	0.907
NULL	J_Cell_Biol_2002_Jun_10_157(6)_975-984.nxml.txt.nlp	12045187	SENT169	26	26	4	4	doxycycline	p53	PA449415	7157	0.907
NULL	Breast_Cancer_Res_2010_Mar_5_12(2)_R16.nxml.txt.nlp	20205716	SENT283	11	11	33	33	lovastatin	AKT	PA450272	207	0.907
NULL	Ann_Oncol_2010_Jul_25_21(7)_1455-1461.nxml.txt.nlp	20100773	SENT98	3	3	17	17	cetuximab	gamma	PA10040	9913	0.907
NULL	Clin_Endosc_2011_Sep_30_44(1)_22-26.nxml.txt.nlp	22741108	SENT19	5	5	1	1	propofol	ESD	PA451141	2098	0.907
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT82	3	3	8	8	nutlin-3	p53		7157	0.907
NULL	Arthritis_Res_Ther_2013_Dec_2_15(6)_R204.nxml.txt.nlp	24295403	SENT114	10	10	33	33	tocilizumab	IL-6	PA165292659	3569	0.907
NULL	Br_J_Cancer_2010_Jan_5_102(1)_115-123.nxml.txt.nlp	19997099	SENT215	7	7	19	19	cyclophosphamide	GEM	PA449165	2669	0.907
NULL	EMBO_Mol_Med_2013_Dec_8_5(12)_1821-1834.nxml.txt.nlp	24293316	SENT51	25	25	14	14	doxorubicin	UNC5A	PA449412	90249	0.907
NULL	Oncotarget_2014_Mar_16_5(12)_4087-4102.nxml.txt.nlp	24961479	SENT133	11	11	16	16	hemin	HO-1	PA449849	3162	0.907
NULL	Apoptosis_2012_Sep_30_17(9)_989-997.nxml.txt.nlp	22460505	SENT131	9	9	3	3	thioridazine	p53	PA451666	7157	0.907
NULL	Breast_Cancer_Res_2005_Nov_11_7(6)_255-257.nxml.txt.nlp	16457700	SENT39	17	17	24	24	letrozole	ATAC	PA450196	6375	0.907
NULL	Cancer_Cell_2011_Oct_18_20(4)_524-537.nxml.txt.nlp	22014577	SENT127	25	25	10	10	trypsin	KEAP1	PA451806	9817	0.907
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_May_21_64(Pt_6)_m834.nxml.txt.nlp	21202515	SENT61	26	26	18	18	ethanol	mol	PA448073	90527	0.907
NULL	Clin_Psychopharmacol_Neurosci_2011_Apr_30_9(1)_36-43.nxml.txt.nlp	23431025	SENT125	10	10	31	31	aripiprazole	CA3	PA10026	761	0.907
NULL	Drug_Target_Insights_2013_Aug_19_7_27-34.nxml.txt.nlp	24023511	SENT31	26	26	11	11	verapamil	P-gp	PA451868	5243	0.907
NULL	Pharmaceuticals_(Basel)_2013_Sep_30_6(10)_1195-1220.nxml.txt.nlp	24275848	SENT224	8	8	36	36	sunitinib	San	PA162372840	80218	0.907
NULL	Biomed_Res_Int_2013_Aug_7_2013_546318.nxml.txt.nlp	23986907	SENT98	0	0	4	4	gefitinib	EGFR	PA131301952	1956	0.907
NULL	Breast_Cancer_Res_2012_Dec_5_14(6)_R153.nxml.txt.nlp	23216744	SENT156	7	7	28	28	auranofin	p53	PA448510	7157	0.907
NULL	Breast_Cancer_Res_2010_Jun_22_12(3)_R39.nxml.txt.nlp	20569502	SENT163	17	17	2	2	tamoxifen	CKS2	PA451581	1164	0.907
NULL	Int_J_Mol_Sci_2014_Sep_5_15(9)_15754-15765.nxml.txt.nlp	25198898	SENT6	2	2	9	9	curcumin	NAC	PA151958596	22861	0.907
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1137-1144.nxml.txt.nlp	20234366	SENT151	13	13	22	22	cetuximab	KRAS	PA10040	3845	0.907
NULL	J_Thorac_Oncol_2015_Jan_29_10(1)_156-163.nxml.txt.nlp	25247337	SENT32	17	17	29	29	afatinib	EGFR	PA165981154	1956	0.907
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jul_18_65(Pt_8)_o1892.nxml.txt.nlp	21583582	SENT70	10	10	4	4	ethanol	mol	PA448073	90527	0.907
NULL	Front_Neuroenergetics_2010_Jun_3_2_6.nxml.txt.nlp	20577638	SENT448	4	4	16	16	nadh	ADP	PA164755085	23038	0.907
NULL	J_Mol_Signal_2009_Apr_28_4_2.nxml.txt.nlp	19400946	SENT101	37	37	2	2	genistein	PRL	PA165109660	5617	0.907
NULL	Oncotarget_2012_Dec_31_3(12)_1653-1668.nxml.txt.nlp	23391506	SENT106	11	11	5	5	docetaxel	HIF-1	PA449383	29072	0.907
NULL	Br_J_Cancer_2013_Mar_5_108(4)_859-865.nxml.txt.nlp	23385729	SENT110	35	35	14	14	panitumumab	EGFR	PA162373091	1956	0.907
NULL	Endocrinol_Metab_(Seoul)_2014_Dec_29_29(4)_450-456.nxml.txt.nlp	25325263	SENT43	8	8	1	1	octreotide	OST	PA450678	1650;23263	0.907
NULL	Arthritis_Res_Ther_2006_Jul_21_8(4)_R130.nxml.txt.nlp	16859540	SENT169	9	9	35	35	atorvastatin	CD59	PA448500	966	0.907
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Sep_17_64(Pt_10)_o1951.nxml.txt.nlp	21201155	SENT59	27	27	7	7	ethanol	mol	PA448073	90527	0.907
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2751-2762.nxml.txt.nlp	24169358	SENT13	0	0	15	15	fulvestrant	ERBB2	PA164747170	2064	0.907
NULL	Br_J_Cancer_2012_Apr_10_106(8)_1395-1405.nxml.txt.nlp	22460269	SENT159	2	2	4	4	sulindac	ABCB1	PA451565	5243	0.907
NULL	Nat_Med_2011_Oct_9_17(11)_1448-1455.nxml.txt.nlp	21983856	SENT104	3	3	13	13	fluoxetine	GAD65	PA449673	2572	0.907
NULL	Int_J_Cell_Biol_2013_Feb_12_2013_805975.nxml.txt.nlp	23476653	SENT199	13	13	9	9	temozolomide	CD133	PA451609	8842	0.907
NULL	Patient_Prefer_Adherence_2009_Nov_3_3_51-59.nxml.txt.nlp	19936145	SENT7	10	10	18	18	carbidopa	COMT	PA448794	1312	0.907
NULL	Pharmaceutics_2011_Nov_18_3(4)_865-913.nxml.txt.nlp	24309312	SENT208	4	4	32	32	buspirone	CYP3A4	PA448689	1576	0.907
NULL	Ann_Rheum_Dis_2010_Sep_1_69(9)_1629-1635.nxml.txt.nlp	20488885	SENT82	2	2	19	19	rituximab	ACR	PA451261	49	0.907
NULL	Oncotarget_2013_Dec_18_5(3)_634-648.nxml.txt.nlp	24504138	SENT150	21	21	8	8	bortezomib	p65	PA10252	5970	0.907
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT366	5	5	11	11	clozapine	PRL	PA449061	5617	0.907
NULL	Hum_Genomics_Proteomics_2010_Apr_13_2010_164906.nxml.txt.nlp	20981232	SENT257	27	27	12	12	thrombin	STAT3	PA451674	6774	0.907
NULL	Acta_Pharmacol_Sin_2014_Jun_4_35(6)_752-757.nxml.txt.nlp	24902786	SENT92	13	13	9	9	flutamide	STZ	PA449685	6484	0.907
NULL	Front_Mol_Neurosci_2009_Nov_6_2_24.nxml.txt.nlp	19936315	SENT117	8	8	23	23	tamoxifen	P90	PA451581	821	0.907
NULL	Mol_Biol_Int_2012_May_24_2012_705948.nxml.txt.nlp	22693671	SENT200	6	6	2	2	cisplatin	RASSF2	PA449014	9770	0.907
NULL	J_Mol_Signal_2011_Aug_10_6_8.nxml.txt.nlp	21831305	SENT93	11	11	3	3	isoproterenol	AKAP5	PA450121	9495	0.907
NULL	Pain_Ther_2014_Jun_13_3(1)_59-69.nxml.txt.nlp	25135388	SENT174	4	4	19	19	curcumin	HSD1	PA151958596	26871	0.907
NULL	Indian_J_Pharmacol_2008_Oct_40(Suppl_2)_S211-S221.nxml.txt.nlp	21593975	SENT198	9	9	5	5	rimonabant	CB1	PA152407999	1268	0.907
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Aug_17_69(Pt_9)_o1442.nxml.txt.nlp	24427070	SENT70	19	19	13	13	ethanol	mol	PA448073	90527	0.907
NULL	Hum_Genomics_2005_Jun_1_2(2)_138-143.nxml.txt.nlp	16004729	SENT34	17	17	0	0	daunorubicin	ALDH1A1	PA449212	216	0.907
NULL	Diabetes_Metab_Syndr_Obes_2010_May_17_3_165-172.nxml.txt.nlp	21437086	SENT141	0	0	5	5	exenatide	GLP-1	PA164749238	100125288	0.907
NULL	Curr_Hematol_Malig_Rep_2014_Jun_18_9(3)_212-216.nxml.txt.nlp	24939521	SENT155	10	10	33	33	dacarbazine	HD7	PA449197	9734	0.907
NULL	Nat_Biotechnol_2010_Aug_2_28(8)_839-847.nxml.txt.nlp	20601939	SENT183	23	23	2	2	l-glutamine	CD34	PA10090	947	0.907
NULL	Crit_Care_2002_Oct_14_6(6)_481-490.nxml.txt.nlp	12493069	SENT95	0	0	31	31	tyloxapol	IL-6	PA164743726	3569	0.907
NULL	Mol_Cancer_2014_Jun_30_13_160.nxml.txt.nlp	24976026	SENT146	18	18	8	8	bortezomib	AGR2	PA10252	10551	0.907
NULL	Evid_Based_Complement_Alternat_Med_2014_Jul_24_2014_204840.nxml.txt.nlp	25152758	SENT117	10	10	29	29	atorvastatin	MKP-1	PA448500	1843	0.907
NULL	Mol_Cancer_2010_Jun_25_9_165.nxml.txt.nlp	20576164	SENT30	7	7	22	22	curcumin	STAT1	PA151958596	6772	0.907
NULL	J_Adv_Pharm_Technol_Res_2010_Jul-Sep_1(3)_348-353.nxml.txt.nlp	22247870	SENT21	0	0	23	23	letrozole	aromatase	PA450196	1588	0.907
NULL	Case_Rep_Oncol_2010_Apr_29_3(2)_131-136.nxml.txt.nlp	20740185	SENT72	21	21	4	4	fulvestrant	HER2	PA164747170	2064	0.907
NULL	Br_J_Cancer_2009_Jul_21_101(2)_269-277.nxml.txt.nlp	19603033	SENT80	18	18	45	45	cisplatin	p53	PA449014	7157	0.907
NULL	Ther_Clin_Risk_Manag_2007_Jun_3(2)_259-268.nxml.txt.nlp	18360634	SENT60	0	0	24	24	natalizumab	IFN	PA164747191	3439	0.907
NULL	Ann_Surg_Treat_Res_2014_Feb_22_86(2)_68-75.nxml.txt.nlp	24761411	SENT151	6	6	16	16	oxaliplatin	survivin	PA131285527	332	0.907
NULL	Cardiovasc_Res_2012_Dec_1_96(3)_552-560.nxml.txt.nlp	22918977	SENT198	2	2	14	14	losartan	JAM-A	PA450268	50848	0.907
NULL	J_Gen_Physiol_2003_Mar_121(3)_181-197.nxml.txt.nlp	12601083	SENT46	6	6	15	15	forskolin	GLP-1	PA146096022	100125288	0.907
NULL	Br_J_Cancer_2011_Jan_4_104(1)_91-100.nxml.txt.nlp	21139584	SENT65	11	11	1	1	fluorescein	Hsp90	PA164746009	3320	0.907
NULL	Osteoporos_Int_2014_Oct_10_25(3)_1173-1180.nxml.txt.nlp	24108429	SENT144	19	19	5	5	teriparatide	PTH	PA451620	5741	0.907
NULL	Ann_Hematol_2011_Dec_8_90(12)_1399-1407.nxml.txt.nlp	21476016	SENT89	40	40	13	13	bleomycin	CHOP	PA448645	1649	0.907
NULL	Arthritis_Res_Ther_2011_Feb_16_13(1)_R25.nxml.txt.nlp	21324169	SENT97	3	3	26	26	etanercept	TNF	PA449515	7124	0.907
NULL	Clin_Interv_Aging_2009_May_14_4_197-205.nxml.txt.nlp	19503782	SENT315	3	3	13	13	fludarabine	CD33	PA449655	945	0.907
NULL	Oncotarget_2014_Aug_29_5(19)_8947-8958.nxml.txt.nlp	25333254	SENT6	4	4	11	11	plerixafor	CXCR4	PA165958410	7852	0.907
NULL	Eur_J_Med_Res_2010_Apr_8_15(4)_145-151.nxml.txt.nlp	20554495	SENT147	18	18	13	13	abacavir	HLA-B	PA448004	3106	0.907
NULL	Surg_Today_2012_Jan_6_42(1)_8-28.nxml.txt.nlp	22139128	SENT170	34	34	38	38	docetaxel	survivin	PA449383	332	0.907
NULL	Emerg_Infect_Dis_2011_Jul_17(7)_1277-1279.nxml.txt.nlp	21762586	SENT29	39	39	8	8	glucosamine	API	PA164747613	5345	0.907
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Dec_15_67(Pt_1)_o128-o129.nxml.txt.nlp	21522639	SENT68	36	36	47	47	ethanol	mol	PA448073	90527	0.907
NULL	Exp_Ther_Med_2015_Jan_10_9(1)_267-271.nxml.txt.nlp	25452814	SENT26	29	29	4	4	clopidogrel	P-gp	PA449053	5243	0.907
NULL	Cancer_Metastasis_Rev_2014_Dec_28_33(1)_161-171.nxml.txt.nlp	24375389	SENT286	14	14	0	0	gemcitabine	CHFR	PA449748	55743	0.907
NULL	Cancers_(Basel)_2010_Jul_27_2(3)_1528-1554.nxml.txt.nlp	24281171	SENT313	21	21	27	27	docetaxel	CD44	PA449383	960	0.907
NULL	Front_Immunol_2013_May_13_4_111.nxml.txt.nlp	23717309	SENT97	21	21	10	10	thrombin	Rho	PA451674	29984	0.907
NULL	J_Invest_Dermatol_2014_Feb_10_134(2)_319-325.nxml.txt.nlp	24108405	SENT132	10	10	13	13	vemurafenib	FOXD3	PA165946873	27022	0.907
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1522-1532.nxml.txt.nlp	21997136	SENT16	8	8	5	5	irinotecan	EGFR	PA450085	1956	0.907
NULL	Cell_Commun_Signal_2003_Nov_24_1_5.nxml.txt.nlp	14636425	SENT201	5	5	16	16	heparin	CCN5	PA449855	8839	0.907
NULL	EMBO_Mol_Med_2012_Jun_13_4(6)_515-527.nxml.txt.nlp	22416035	SENT177	3	3	24	24	olaparib	p53		7157	0.907
NULL	J_Hematol_Oncol_2012_Oct_11_5_63.nxml.txt.nlp	23057939	SENT109	15	15	26	26	bevacizumab	VEGF-A	PA130232992	7422	0.907
NULL	Br_J_Cancer_2013_Jan_15_108(1)_170-178.nxml.txt.nlp	23321518	SENT191	14	14	19	19	bortezomib	PDK1	PA10252	5170;5163	0.907
NULL	Oncol_Lett_2014_May_11_7(5)_1401-1408.nxml.txt.nlp	24765145	SENT162	27	27	18	18	paclitaxel	HIF-1	PA450761	29072	0.907
NULL	Cardiol_Res_Pract_2011_Jul_2_2011_615087.nxml.txt.nlp	21747989	SENT83	17	17	7	7	heparin	ACT	PA449855	12;11332;9457;641455	0.907
NULL	J_Thromb_Thrombolysis_2012_Feb_20_33(2)_143-153.nxml.txt.nlp	22183178	SENT259	25	25	11	11	clopidogrel	P2Y12	PA449053	64805	0.907
NULL	Acta_Pharmacol_Sin_2010_Nov_18_31(11)_1447-1453.nxml.txt.nlp	20953204	SENT124	17	17	15	15	rimonabant	CB1	PA152407999	1268	0.907
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT82	21	21	7	7	gemcitabine	HER2	PA449748	2064	0.907
NULL	Chemother_Res_Pract_2012_Jul_15_2012_905796.nxml.txt.nlp	22844591	SENT177	5	5	18	18	oxaliplatin	AST	PA131285527	26503	0.907
NULL	Breast_Cancer_Res_Treat_2013_Jun_5_139(3)_649-655.nxml.txt.nlp	23736997	SENT131	16	16	8	8	tamoxifen	CYP2C19	PA451581	1557	0.907
NULL	Oncol_Lett_2014_Mar_2_7(3)_791-796.nxml.txt.nlp	24527087	SENT120	9	9	16	16	imatinib	CD34	PA10804	947	0.907
NULL	Mol_Cancer_2010_Aug_6_9_212.nxml.txt.nlp	20691072	SENT79	19	19	25	25	verapamil	ABCG2	PA451868	9429	0.907
NULL	J_Mol_Med_2008_Sep_4_86(9)_1045-1056.nxml.txt.nlp	18600309	SENT268	8	8	19	19	salmeterol	c-fos	PA451300	2353	0.907
NULL	J_Korean_Med_Sci_2010_Nov_26_25(11)_1626-1632.nxml.txt.nlp	21060752	SENT145	16	16	19	19	forskolin	JNK	PA146096022	5599	0.907
NULL	Ann_Rheum_Dis_2014_May_13_73(5)_810-816.nxml.txt.nlp	24525910	SENT183	12	12	8	8	tocilizumab	IL-6	PA165292659	3569	0.907
NULL	Int_J_Mol_Sci_2012_Dec_5_13(12)_16658-16667.nxml.txt.nlp	23443124	SENT237	16	16	5	5	cisplatin	ERCC1	PA449014	2067	0.907
NULL	Int_J_Mol_Sci_2014_Jun_3_15(6)_9924-9944.nxml.txt.nlp	24897026	SENT181	28	28	20	20	ethanol	AMPK	PA448073	5563	0.907
NULL	Nucleic_Acids_Res_2012_Jun_10_40(11)_4804-4815.nxml.txt.nlp	22328728	SENT165	7	7	10	10	resveratrol	SIRT1		23411	0.907
NULL	Arthritis_Res_2002_Mar_19_4(4)_266-273.nxml.txt.nlp	12106498	SENT121	7	7	1	1	methotrexate	IL-6	PA450428	3569	0.907
NULL	Acta_Pharmacol_Sin_2010_Oct_13_31(10)_1367-1375.nxml.txt.nlp	20835270	SENT5	34	34	15	15	pentoxifylline	RAGE	PA450864	177	0.907
NULL	Case_Rep_Transplant_2011_Jan_5_2011_210178.nxml.txt.nlp	23213600	SENT79	14	14	10	10	tacrolimus	CYP3A4	PA451578	1576	0.907
NULL	Cell_Commun_Signal_2014_Oct_5_12(1)_54.nxml.txt.nlp	NULL	SENT110	31	31	22	22	doxycycline	MRCK	PA449415	8476	0.907
NULL	Oncogene_2009_Feb_12_28(6)_866-875.nxml.txt.nlp	19060929	SENT181	7	7	0	0	fluorescein	AURKA	PA164746009	6790	0.907
NULL	Exp_Diabetes_Res_2012_Feb_26_2012_548732.nxml.txt.nlp	22474425	SENT85	0	0	28	28	bevacizumab	VEGF-A	PA130232992	7422	0.907
NULL	Toxins_(Basel)_2010_Oct_25_2(10)_2467-2477.nxml.txt.nlp	22069561	SENT28	4	4	18	18	cisplatin	Bcl-2	PA449014	596	0.907
NULL	Eur_J_Neurosci_2011_Mar_33(5)_914-922.nxml.txt.nlp	21255131	SENT114	10	10	21	21	pentobarbital	gamma	PA450859	9913	0.907
NULL	Carcinogenesis_2010_Dec_27_31(12)_2049-2057.nxml.txt.nlp	20876285	SENT204	13	13	6	6	tamoxifen	HER2	PA451581	2064	0.907
NULL	Environ_Health_Perspect_2006_Jun_2_114(6)_898-904.nxml.txt.nlp	16759992	SENT57	18	18	0	0	ethanol	DES	PA448073	1674	0.907
NULL	J_Biomed_Biotechnol_2010_Jun_7_2010_150960.nxml.txt.nlp	20617134	SENT241	46	46	13	13	bevacizumab	KRAS	PA130232992	3845	0.907
NULL	Case_Rep_Med_2013_Jun_19_2013_465906.nxml.txt.nlp	23861687	SENT49	38	38	5	5	primaquine	RDT	PA451103	6598	0.907
NULL	eLife_2014_May_27_3_e02667.nxml.txt.nlp	24867643	SENT455	4	4	19	19	nutlin-3	p53		7157	0.907
NULL	Acta_Pharmacol_Sin_2011_Oct_15_32(10)_1233-1238.nxml.txt.nlp	21841815	SENT107	23	23	9	9	atropine	CTX	PA448505	1593	0.907
NULL	Daru_2011_19(1)_47-56.nxml.txt.nlp	22615639	SENT155	3	3	31	31	ketoprofen	gamma	PA450149	9913	0.907
NULL	Br_J_Pharmacol_2013_Jun_27_169(4)_736-747.nxml.txt.nlp	23489111	SENT164	5	5	17	17	morphine	5-HT3A	PA450550	3359	0.907
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Apr_30_66(Pt_5)_o1233-o1234.nxml.txt.nlp	21579255	SENT78	19	19	32	32	ethanol	mol	PA448073	90527	0.907
NULL	Calcif_Tissue_Int_2010_Nov_20_87(5)_375-384.nxml.txt.nlp	20725827	SENT326	22	22	28	28	teriparatide	DANCE	PA451620	10516	0.907
NULL	J_Obes_2012_Apr_17_2012_104706.nxml.txt.nlp	22577523	SENT57	41	41	35	35	diclofenac	IL-10	PA449293	3586	0.907
NULL	J_Neuroinflammation_2011_Feb_4_8_10.nxml.txt.nlp	21294877	SENT191	6	6	9	9	capsaicin	TAC1	PA448776	6863	0.907
NULL	Nat_Med_2014_Jun_17_20(6)_633-641.nxml.txt.nlp	24743305	SENT137	4	4	20	20	heparin	CD43	PA449855	6693	0.907
NULL	Oncotarget_2014_Mar_11_5(4)_901-907.nxml.txt.nlp	24658650	SENT111	40	40	27	27	hydroxyurea	DHFR	PA449942	1719	0.907
NULL	Int_J_Mol_Sci_2012_Dec_5_13(12)_16636-16657.nxml.txt.nlp	23443123	SENT660	7	7	14	14	imatinib	CD34	PA10804	947	0.907
NULL	Pharmaceutics_2011_Sep_14_3(3)_615-635.nxml.txt.nlp	24310600	SENT82	13	13	2	2	mitoxantrone	ABCG2	PA450526	9429	0.907
NULL	J_Hematol_Oncol_2011_Feb_7_4_6.nxml.txt.nlp	21299849	SENT268	16	16	11	11	dasatinib	ABL1	PA162372878	25	0.907
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT79	42	42	14	14	curcumin	TRAIL	PA151958596	8743	0.907
NULL	Ecancermedicalscience_2008_Feb_18_2_75.nxml.txt.nlp	22275966	SENT148	17	17	37	37	erlotinib	EGFR	PA134687924	1956	0.907
NULL	J_Exp_Clin_Cancer_Res_2009_Jul_10_28(1)_99.nxml.txt.nlp	19591692	SENT29	17	17	20	20	zosuquidar	ABCG2		9429	0.907
NULL	Front_Synaptic_Neurosci_2014_May_30_6_12.nxml.txt.nlp	24910611	SENT151	30	30	4	4	l-cysteine	asc-1	PA449173	56301	0.907
NULL	Exp_Mol_Med_2012_Dec_17_44(12)_707-722.nxml.txt.nlp	23143559	SENT164	4	4	23	23	capsaicin	TRPV4	PA448776	59341	0.907
NULL	Ann_Lab_Med_2012_Jul_20_32(4)_264-269.nxml.txt.nlp	22779067	SENT92	17	17	22	22	ethambutol	DST	PA164784021	667	0.907
NULL	Mol_Cancer_2007_Oct_22_6_66.nxml.txt.nlp	17953743	SENT153	23	23	14	14	cisplatin	survivin	PA449014	332	0.907
NULL	Cent_European_J_Urol_2013_Apr_26_66(1)_23-29.nxml.txt.nlp	24578981	SENT173	34	34	30	30	estradiol	CYP1B1	PA449503	1545	0.907
NULL	Br_J_Cancer_2012_Sep_4_107(6)_947-955.nxml.txt.nlp	22892392	SENT195	5	5	10	10	lapatinib	ERBB2	PA152241907	2064	0.907
NULL	Cases_J_2009_Jun_9_2_8099.nxml.txt.nlp	19918269	SENT27	30	30	19	19	trastuzumab	HER-2	PA451743	2064	0.907
NULL	Exp_Mol_Med_2012_Sep_30_44(9)_536-544.nxml.txt.nlp	22771771	SENT56	6	6	32	32	ns-398	p16		1029	0.907
NULL	J_Carcinog_2014_Feb_7_13_1.nxml.txt.nlp	24737949	SENT232	28	28	1	1	vemurafenib	CTLA4	PA165946873	1493	0.907
NULL	Arch_Drug_Inf_2011_Mar_4(1)_1-9.nxml.txt.nlp	21572514	SENT156	26	26	16	16	ciprofloxacin	PEPT1	PA449009	6564	0.907
NULL	Biochemistry_2014_Jan_28_53(3)_505-517.nxml.txt.nlp	24383758	SENT542	4	4	15	15	aprotinin	Yes	PA448472	7525	0.907
NULL	J_Cancer_Res_Clin_Oncol_2012_Sep_3_138(9)_1569-1577.nxml.txt.nlp	22552718	SENT127	9	9	24	24	estradiol	aromatase	PA449503	1588	0.907
NULL	Front_Behav_Neurosci_2011_Sep_8_5_56.nxml.txt.nlp	21927600	SENT277	8	8	13	13	lithium	DARPP-32	PA450243	84152	0.907
NULL	Behav_Brain_Funct_2006_Mar_28_2_12.nxml.txt.nlp	16569246	SENT76	1	1	19	19	methamphetamine	NAC	PA450403	22861	0.907
NULL	Br_J_Cancer_2009_Jul_7_101(1)_139-144.nxml.txt.nlp	19568272	SENT76	30	30	6	6	l-glutamine	CO2	PA10090	4513	0.907
NULL	Mol_Cancer_2014_Jun_5_13_143.nxml.txt.nlp	24898067	SENT37	19	19	35	35	maytansine	HER-2	PA165291473	2064	0.907
NULL	Br_J_Cancer_2010_Oct_26_103(9)_1331-1334.nxml.txt.nlp	20877352	SENT5	9	9	14	14	trastuzumab	HER2	PA451743	2064	0.907
NULL	Oncotarget_2014_Oct_4_5(21)_10791-10802.nxml.txt.nlp	25301731	SENT27	17	17	23	23	decitabine	DAC	PA164749631	13	0.907
NULL	Front_Oncol_2014_Apr_9_4_73.nxml.txt.nlp	24782984	SENT40	35	35	41	41	octreotide	gamma	PA450678	9913	0.907
NULL	Acta_Neuropathol_Commun_2014_May_30_2_57.nxml.txt.nlp	24887326	SENT274	18	18	16	16	verapamil	ABCB1	PA451868	5243	0.907
NULL	Autism_Res_Treat_2011_Jun_7_2011_307152.nxml.txt.nlp	22937244	SENT136	5	5	29	29	minocycline	NF-kappaB	PA450519	4790	0.907
NULL	Case_Rep_Neurol_2014_Mar_29_6(1)_101-108.nxml.txt.nlp	24761147	SENT109	17	17	4	4	methotrexate	CHOP	PA450428	1649	0.907
NULL	J_Gen_Physiol_2009_Apr_133(4)_421-438.nxml.txt.nlp	19289574	SENT503	30	30	10	10	glibenclamide	SLC26A9	PA449782	115019	0.907
NULL	Indian_J_Endocrinol_Metab_2013_Jul-Aug_17(4)_759-762.nxml.txt.nlp	23961503	SENT31	35	35	14	14	desmopressin	ACTH	PA449237	5443	0.907
NULL	Mol_Cancer_2012_Sep_25_11_73.nxml.txt.nlp	23009336	SENT119	16	16	8	8	gefitinib	EGFR	PA131301952	1956	0.907
NULL	Gut_Liver_2011_Dec_21_5(4)_406-417.nxml.txt.nlp	22195237	SENT123	5	5	3	3	boceprevir	EPO	PA165948902	7076;8288;2056	0.907
NULL	Cardiovasc_Diabetol_2006_Sep_26_5_20.nxml.txt.nlp	17002798	SENT98	3	3	19	19	niacin	CDP	PA450617	1523	0.907
NULL	Acta_Neuropathol_2010_Nov_17_120(5)_567-584.nxml.txt.nlp	20714900	SENT274	17	17	25	25	temozolomide	ADP	PA451609	23038	0.907
NULL	J_Mol_Med_2008_Sep_4_86(9)_1045-1056.nxml.txt.nlp	18600309	SENT119	43	43	30	30	salmeterol	IL-8	PA451300	3576	0.907
NULL	Diabetes_Care_2011_Nov_15_34(11)_2381-2386.nxml.txt.nlp	21926282	SENT67	12	12	0	0	metformin	Men	PA450395	8178	0.907
NULL	Breast_Cancer_Res_2011_Apr_1_13(2)_R36.nxml.txt.nlp	21457548	SENT315	9	9	32	32	flutamide	RSK1	PA449685	6195	0.907
NULL	Case_Rep_Transplant_2012_Aug_30_2012_672923.nxml.txt.nlp	23259137	SENT80	6	6	21	21	caspofungin	IPA	PA164743013	3160	0.907
NULL	Int_J_Mol_Sci_2012_Apr_16_13(4)_4831-4838.nxml.txt.nlp	22606012	SENT45	2	2	16	16	curcumin	p65	PA151958596	5970	0.907
NULL	Br_J_Cancer_2001_Sep_85(6)_902-908.nxml.txt.nlp	11556844	SENT3	13	13	18	18	vinblastine	MN1	PA451877	4330	0.907
NULL	Biomed_Res_Int_2013_May_16_2013_389672.nxml.txt.nlp	23762842	SENT120	4	4	8	8	imatinib	FDG	PA10804	23583	0.907
NULL	Cancer_Immunol_Immunother_2013_Aug_27_62(10)_1637-1648.nxml.txt.nlp	23982484	SENT160	10	10	18	18	lenalidomide	IL-6	PA162363968	3569	0.907
NULL	Indian_J_Dermatol_2014_Nov-Dec_59(6)_630b.nxml.txt.nlp	25484410	SENT5	35	35	9	9	isotretinoin	B12	PA450128	7126;4709	0.907
NULL	EMBO_Mol_Med_2012_Jun_13_4(6)_515-527.nxml.txt.nlp	22416035	SENT216	28	28	20	20	olaparib	p53		7157	0.907
NULL	Leukemia_2014_Apr_14_28(4)_961-964.nxml.txt.nlp	24418991	SENT32	2	2	13	13	nilotinib	P-gp	PA165958345	5243	0.907
NULL	Open_Biol_2014_Dec_4(12)_140178.nxml.txt.nlp	25520185	SENT50	32	32	20	20	geldanamycin	NOD2	PA152031327	64127	0.907
NULL	Indian_J_Pharmacol_2013_Sep-Oct_45(5)_537-538.nxml.txt.nlp	24130399	SENT36	24	24	15	15	olanzapine	5-HT1A	PA450688	3350	0.907
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Aug_17_67(Pt_9)_o2351.nxml.txt.nlp	22058967	SENT78	15	15	7	7	ethanol	mol	PA448073	90527	0.907
NULL	Oxid_Med_Cell_Longev_2013_Apr_21_2013_412576.nxml.txt.nlp	23710286	SENT111	11	11	6	6	curcumin	KEAP1	PA151958596	9817	0.907
NULL	Evid_Based_Complement_Alternat_Med_2012_Dec_9_2012_329171.nxml.txt.nlp	23304197	SENT41	12	12	3	3	fenofibrate	MSD	PA449594	4434	0.907
NULL	J_Hematol_Oncol_2009_Apr_22_2_18.nxml.txt.nlp	19386128	SENT106	29	29	14	14	irinotecan	EGFR	PA450085	1956	0.907
NULL	Bone_Marrow_Transplant_2014_Feb_4_49(2)_201-205.nxml.txt.nlp	24185588	SENT99	8	8	21	21	lenalidomide	CD34	PA162363968	947	0.907
NULL	Oncotarget_2014_Jun_26_5(14)_5559-5569.nxml.txt.nlp	24980819	SENT103	19	19	1	1	vemurafenib	p53	PA165946873	7157	0.907
NULL	J_Korean_Assoc_Oral_Maxillofac_Surg_2014_Dec_26_40(6)_291-296.nxml.txt.nlp	25551094	SENT115	13	13	19	19	risedronate	RANKL	PA451255	8600	0.907
NULL	Oncotarget_2012_Sep_28_3(10)_1169-1181.nxml.txt.nlp	23045411	SENT106	27	27	6	6	doxorubicin	JIP1	PA449412	9479	0.907
NULL	Breast_Cancer_Res_2010_Jul_22_12(4)_R53.nxml.txt.nlp	20649975	SENT12	7	7	2	2	tamoxifen	HOXB13	PA451581	10481	0.907
NULL	Clin_Exp_Otorhinolaryngol_2011_Mar_17_4(1)_18-23.nxml.txt.nlp	21461058	SENT77	14	14	24	24	furosemide	KCC2	PA449719	57468	0.907
NULL	Int_J_Med_Sci_2013_Jul_5_10(9)_1121-1134.nxml.txt.nlp	23869188	SENT31	18	18	26	26	amiloride	NHE	PA448368	285335	0.907
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_P80.nxml.txt.nlp	NULL	SENT17	4	4	2	2	cefuroxime	OPT	PA448868	51430	0.907
NULL	Clin_Pharmacokinet_2014_Oct_15_53(2)_155-164.nxml.txt.nlp	24127209	SENT230	14	14	6	6	clopidogrel	CYP2C9	PA449053	1559	0.907
NULL	Mol_Cell_Proteomics_2012_Feb_6_11(2)_M111_015222.nxml.txt.nlp	22147731	SENT334	29	29	8	8	cetuximab	TOMM20	PA10040	9804	0.907
NULL	J_Biol_Chem_2010_Aug_20_285(34)_26406-26416.nxml.txt.nlp	20530490	SENT10	16	16	35	35	artemisinin	SERCA1	PA165111696	487	0.907
NULL	Case_Rep_Oncol_2009_Jan_17_2(1)_1-6.nxml.txt.nlp	20844570	SENT42	13	13	6	6	amsacrine	LAM	PA10309	7249;7248	0.907
NULL	Nat_Commun_2013_Sep_27_4_2519.nxml.txt.nlp	24071738	SENT254	34	34	39	39	bortezomib	OTUB1	PA10252	55611	0.907
NULL	Oncol_Lett_2014_Jun_4_7(6)_2175-2179.nxml.txt.nlp	24932311	SENT103	17	17	5	5	choline	PEMT	PA448976	10400	0.907
NULL	Cardiovasc_Res_2014_Mar_1_101(3)_513-521.nxml.txt.nlp	24323316	SENT83	22	22	20	20	maraviroc	CCL4	PA164768835	6351	0.907
NULL	J_Vet_Med_Sci_2014_Aug_15_76(8)_1173-1176.nxml.txt.nlp	24829080	SENT42	11	11	25	25	sargramostim	GM-CSF	PA164748631	1437	0.907
NULL	Br_J_Anaesth_2011_Oct_17_107(4)_490-502.nxml.txt.nlp	21852280	SENT12	46	46	16	16	capsaicin	TRPV1	PA448776	7442	0.907
NULL	J_Hematol_Oncol_2013_Jan_4_6_1.nxml.txt.nlp	23286345	SENT146	27	27	17	17	cetuximab	KRAS	PA10040	3845	0.907
NULL	Oncotarget_2011_Dec_15_2(12)_984-996.nxml.txt.nlp	22184287	SENT237	6	6	4	4	olaparib	PARP1		142	0.907
NULL	Acta_Pharmacol_Sin_2010_Feb_5_31(2)_184-190.nxml.txt.nlp	20139901	SENT133	34	34	20	20	estradiol	OCT2	PA449503	6582;5452	0.907
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Oct_23_65(Pt_11)_o2830.nxml.txt.nlp	21578420	SENT63	16	16	34	34	ethanol	mol	PA448073	90527	0.907
NULL	Breast_Cancer_Res_Treat_2013_May_12_139(1)_107-113.nxml.txt.nlp	23580070	SENT5	38	38	8	8	trastuzumab	HER2	PA451743	2064	0.907
NULL	Clin_Med_Insights_Oncol_2012_Mar_12_6_153-164.nxml.txt.nlp	22550404	SENT81	18	18	28	28	bortezomib	Raf-1	PA10252	5894	0.907
NULL	J_Immunother_Cancer_2014_Nov_6_2(Suppl_3)_P199.nxml.txt.nlp	NULL	SENT10	26	26	0	0	cetuximab	JAK2	PA10040	3717	0.907
NULL	Int_J_Mol_Sci_2014_Sep_2_15(9)_15512-15529.nxml.txt.nlp	25184950	SENT74	0	0	10	10	resveratrol	IL-10		3586	0.907
NULL	EMBO_Mol_Med_2012_Dec_15_4(12)_1276-1293.nxml.txt.nlp	23065753	SENT191	23	23	0	0	cisplatin	HK1	PA449014	3098;51361;3739	0.907
NULL	Ecancermedicalscience_2009_Sep_24_3_153.nxml.txt.nlp	22276017	SENT56	6	6	24	24	irinotecan	ERCC1	PA450085	2067	0.907
NULL	Cancers_(Basel)_2011_Apr_1_3(2)_1844-1860.nxml.txt.nlp	24212785	SENT538	2	2	10	10	cetuximab	KRAS	PA10040	3845	0.907
NULL	Cancer_Inform_2007_Apr_3_5_10-18.nxml.txt.nlp	19390665	SENT90	26	26	29	29	gefitinib	EGFR	PA131301952	1956	0.907
NULL	Carcinogenesis_2014_May_13_35(5)_1055-1066.nxml.txt.nlp	24419232	SENT274	16	16	33	33	metformin	CD31	PA450395	5175	0.907
NULL	Adv_Pharmacol_Sci_2013_Jun_24_2013_987692.nxml.txt.nlp	23864853	SENT7	41	41	24	24	acetaminophen	AST	PA448015	26503	0.907
NULL	Clin_Ophthalmol_2008_Jun_2(2)_377-388.nxml.txt.nlp	19668729	SENT172	0	0	32	32	vatalanib	KDR	PA7001	3791	0.907
NULL	Behav_Brain_Funct_2005_Jul_15_1_9.nxml.txt.nlp	16022733	SENT172	13	13	5	5	methylphenidate	NET1	PA450464	55119;10276	0.907
NULL	Case_Rep_Hematol_2014_Feb_6_2014_806541.nxml.txt.nlp	24649385	SENT9	16	16	5	5	cyclosporine	AAT	PA449167	5265	0.907
NULL	Breast_Cancer_Res_2006_Nov_1_8(Suppl_2)_P26.nxml.txt.nlp	NULL	SENT13	27	27	16	16	doxycycline	CYP1B1	PA449415	1545	0.907
NULL	BMB_Rep_2013_Jan_46(1)_59-64.nxml.txt.nlp	23351386	SENT84	2	2	13	13	auranofin	STAT3	PA448510	6774	0.907
NULL	Front_Genet_2012_Nov_5_3_236.nxml.txt.nlp	23133441	SENT15	12	12	1	1	efavirenz	ABCB1	PA449441	5243	0.907
NULL	Oncol_Rep_2013_Oct_22_30(4)_1535-1541.nxml.txt.nlp	23877481	SENT41	42	42	15	15	erlotinib	EGFR	PA134687924	1956	0.907
NULL	Cancers_(Basel)_2010_Oct_25_2(4)_1794-1812.nxml.txt.nlp	24281201	SENT152	11	11	38	38	forskolin	MUC5AC	PA146096022	4586	0.906
NULL	J_Carcinog_2011_Jan_15_10_2.nxml.txt.nlp	21297922	SENT49	23	23	11	11	trypsin	CO2	PA451806	4513	0.906
NULL	Adv_Hematol_2012_Feb_16_2012_535709.nxml.txt.nlp	22400031	SENT84	33	33	17	17	imatinib	MPN	PA10804	83886	0.906
NULL	Br_J_Cancer_2011_Nov_22_105(11)_1654-1662.nxml.txt.nlp	22045187	SENT132	37	37	15	15	irinotecan	SLCO1B1	PA450085	10599	0.906
NULL	J_Biol_Chem_2012_Apr_20_287(17)_13868-13876.nxml.txt.nlp	22389490	SENT23	25	25	8	8	capsaicin	TRPV1	PA448776	7442	0.906
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT236	40	40	48	48	metformin	LKB1	PA450395	6794	0.906
NULL	Arthritis_Res_Ther_2007_Oct_10_9(5)_R105.nxml.txt.nlp	17927818	SENT50	17	17	43	43	pp2	PP2		4888	0.906
NULL	Oncogene_2009_Jan_15_28(2)_157-169.nxml.txt.nlp	18931700	SENT14	5	5	31	31	geldanamycin	CRAF	PA152031327	5894	0.906
NULL	Cell_Cycle_2013_May_15_12(10)_1492-1500.nxml.txt.nlp	23598717	SENT139	15	15	7	7	doxorubicin	ROCK2	PA449412	9475	0.906
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT232	21	21	10	10	methotrexate	MSH2	PA450428	4436	0.906
NULL	F1000Res_2014_Jul_1_3_149.nxml.txt.nlp	25352980	SENT109	25	25	33	33	galactose	GAL4	PA449725	3960	0.906
NULL	Front_Neural_Circuits_2013_Aug_1_7_129.nxml.txt.nlp	23914157	SENT220	21	21	26	26	ethanol	NPY	PA448073	4852	0.906
NULL	Breast_Cancer_Res_2004_Feb_25_6(3)_R157-R169.nxml.txt.nlp	15084239	SENT94	28	28	15	15	trypsin	CO2	PA451806	4513	0.906
NULL	Hum_Genomics_2009_Dec_1_4(2)_91-106.nxml.txt.nlp	20038497	SENT120	18	18	35	35	rivastigmine	CYP3A4	PA451262	1576	0.906
NULL	Oncotarget_2012_May_19_3(5)_535-545.nxml.txt.nlp	22619121	SENT9	17	17	13	13	camptothecin	MYCN	PA153590860	4613	0.906
NULL	Arch_Toxicol_2014_Nov_5_88(12)_2135-2190.nxml.txt.nlp	25370008	SENT1020	1	1	12	12	4-methylumbelliferone	UGT1	PA154081778	7355	0.906
NULL	Support_Care_Cancer_2009_Sep_10_17(9)_1187-1193.nxml.txt.nlp	19205754	SENT123	28	28	17	17	dolasetron	CYP2D6	PA449390	1565	0.906
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S18-S30.nxml.txt.nlp	20680104	SENT81	33	33	22	22	panitumumab	EGFR	PA162373091	1956	0.906
NULL	Exp_Diabetes_Res_2012_Mar_4_2012_653678.nxml.txt.nlp	22474428	SENT100	20	20	10	10	repaglinide	LPO	PA451234	4025	0.906
NULL	Mol_Cancer_2013_Sep_24_12_109.nxml.txt.nlp	24063540	SENT349	28	28	3	3	doxorubicin	NAP1	PA449412	4673;64343;9476;3576;51531	0.906
NULL	Ann_Rheum_Dis_2009_Dec_1_68(12)_1819-1826.nxml.txt.nlp	19054822	SENT45	19	19	8	8	methotrexate	CDP	PA450428	1523	0.906
NULL	Int_J_Gen_Med_2009_Jul_30_2_129-140.nxml.txt.nlp	20360896	SENT163	24	24	45	45	anastrozole	IMPACT	PA448432	55364	0.906
NULL	Case_Rep_Oncol_Med_2014_Sep_14_2014_532924.nxml.txt.nlp	25298899	SENT63	14	14	3	3	cisplatin	NAC	PA449014	22861	0.906
NULL	Diabetes_Care_2013_Feb_17_36(2)_422-428.nxml.txt.nlp	23033246	SENT29	36	36	29	29	simvastatin	PPL	PA451363	5493	0.906
NULL	J_Neuroinflammation_2010_Sep_7_7_51.nxml.txt.nlp	20822529	SENT176	8	8	11	11	hemin	HO-1	PA449849	3162	0.906
NULL	Behav_Neurol_2014_Aug_7_2014_294149.nxml.txt.nlp	25177106	SENT83	28	28	13	13	memantine	ANOVA	PA10364	4858	0.906
NULL	Biomed_Res_Int_2013_Jul_15_2013_458571.nxml.txt.nlp	23956983	SENT128	11	11	45	45	l-serine	PLP	PA451330	25824;5744	0.906
NULL	J_Cell_Biol_1998_Jan_26_140(2)_335-345.nxml.txt.nlp	9442109	SENT83	6	6	1	1	amiloride	NHE	PA448368	285335	0.906
NULL	ScientificWorldJournal_2014_Feb_11_2014_898361.nxml.txt.nlp	24678280	SENT85	3	3	14	14	curcumin	p38	PA151958596	10598;1432;7965	0.906
NULL	Emerg_Infect_Dis_2012_Mar_18(3)_537-539.nxml.txt.nlp	22377132	SENT81	27	27	0	0	rifampin	Bravo	PA451250	4897	0.906
NULL	JAKSTAT_2012_Apr_1_1(2)_83-89.nxml.txt.nlp	24058756	SENT65	6	6	15	15	losartan	STAT3	PA450268	6774	0.906
NULL	Cancer_Nanotechnol_2015_Jan_24_6_1.nxml.txt.nlp	25642297	SENT192	4	4	8	8	vemurafenib	BRAF	PA165946873	673	0.906
NULL	Exp_Brain_Res_2014_Jun_27_232(8)_2637-2644.nxml.txt.nlp	24969614	SENT17	28	28	6	6	palonosetron	NK1	PA10352	11126	0.906
NULL	Clin_Sci_(Lond)_2013_May_1_124(Pt_9)_567-578.nxml.txt.nlp	23113760	SENT288	22	22	9	9	docetaxel	RRM2	PA449383	6241	0.906
NULL	Ann_Pediatr_Cardiol_2008_Jan-Jun_1(1)_18-26.nxml.txt.nlp	20300233	SENT292	12	12	8	8	flecainide	LQT3	PA449646	6331	0.906
NULL	ARYA_Atheroscler_2013_Sep_9(5)_306-310.nxml.txt.nlp	24302941	SENT40	27	27	21	21	heparin	MCP-1	PA449855	6347	0.906
NULL	Apoptosis_2012_Sep_30_17(9)_989-997.nxml.txt.nlp	22460505	SENT118	11	11	3	3	thioridazine	p27	PA451666	5715;10534	0.906
NULL	Oncotarget_2011_Nov_30_2(11)_874-885.nxml.txt.nlp	22141136	SENT19	27	27	5	5	dasatinib	AXL	PA162372878	558	0.906
NULL	Oncogene_2010_Sep_16_29(37)_5193-5203.nxml.txt.nlp	20581867	SENT10	16	16	0	0	trastuzumab	HRG	PA451743	3084;3273	0.906
NULL	Environ_Health_Perspect_2006_Sep_23_114(9)_1401-1406.nxml.txt.nlp	16966095	SENT139	41	41	27	27	tetracycline	p53	PA451640	7157	0.906
NULL	Eur_Arch_Psychiatry_Clin_Neurosci_2010_Sep_9_260(6)_499-506.nxml.txt.nlp	19997739	SENT179	11	11	9	9	escitalopram	DRP-2	PA10074	1808	0.906
NULL	J_Biol_Chem_2013_Jul_19_288(29)_21448-21457.nxml.txt.nlp	23760505	SENT216	35	35	15	15	haloperidol	CRM1	PA449841	7514	0.906
NULL	Mol_Biol_Cell_2013_Aug_1_24(15)_2477-2490.nxml.txt.nlp	23761072	SENT151	19	19	13	13	arsenite	CHOP	PA452638	1649	0.906
NULL	Oncogenesis_2014_Dec_15_3(12)_e133.nxml.txt.nlp	25500906	SENT127	14	14	23	23	trastuzumab	HER2	PA451743	2064	0.906
NULL	J_Gynecol_Oncol_2013_Jul_4_24(3)_273-279.nxml.txt.nlp	23875078	SENT59	18	18	12	12	paclitaxel	COX	PA450761	1351	0.906
NULL	Genome_Med_2010_Jun_14_2(6)_37.nxml.txt.nlp	20546595	SENT95	22	22	19	19	doxorubicin	p53	PA449412	7157	0.906
NULL	Cell_Commun_Signal_2012_Dec_20_10_43.nxml.txt.nlp	23253402	SENT549	15	15	1	1	rituximab	BAFF	PA451261	10673	0.906
NULL	Breast_Cancer_Res_2007_Dec_20_9(Suppl_2)_S14.nxml.txt.nlp	NULL	SENT23	39	39	5	5	mitomycin	TP53	PA450524	7157	0.906
NULL	J_Hematol_Oncol_2009_Feb_23_2_9.nxml.txt.nlp	19236713	SENT71	16	16	31	31	bevacizumab	KRAS	PA130232992	3845	0.906
NULL	Mol_Cell_Proteomics_2014_Dec_1_13(12)_3585-3601.nxml.txt.nlp	25277244	SENT603	18	18	10	10	estradiol	HSP27	PA449503	3315	0.906
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT196	17	17	11	11	methotrexate	MSH2	PA450428	4436	0.906
NULL	Cardiovasc_Ther_2012_Aug_17_30(4)_e174-e182.nxml.txt.nlp	21883999	SENT98	7	7	13	13	clopidogrel	CYP3A	PA449053	1574	0.906
NULL	Acta_Neuropathol_Commun_2014_May_30_2_57.nxml.txt.nlp	24887326	SENT185	42	42	3	3	vardenafil	ABCB1	PA10229	5243	0.906
NULL	Mol_Cells_2014_Sep_30_37(9)_664-671.nxml.txt.nlp	25234467	SENT174	15	15	4	4	cisplatin	miR-217	PA449014	406999	0.906
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_91-103.nxml.txt.nlp	17912639	SENT70	22	22	41	41	trastuzumab	HER2	PA451743	2064	0.906
NULL	Curr_Neuropharmacol_2013_Dec_11(6)_652-663.nxml.txt.nlp	24396340	SENT193	6	6	28	28	sevoflurane	TRPA1	PA451341	8989	0.906
NULL	Mol_Cancer_2010_Dec_15_9_314.nxml.txt.nlp	21159167	SENT282	18	18	14	14	doxorubicin	MDR1	PA449412	5243	0.906
NULL	Behav_Brain_Funct_2008_Aug_15_4_37.nxml.txt.nlp	18702828	SENT7	30	30	6	6	methamphetamine	FZD3	PA450403	7976;8326	0.906
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT188	0	0	46	46	curcumin	survivin	PA151958596	332	0.906
NULL	Indian_J_Pharmacol_2008_Oct_40(Suppl_2)_S112-S142.nxml.txt.nlp	21593965	SENT1372	9	9	19	19	perindopril	STZ	PA450877	6484	0.906
NULL	Mol_Cancer_2009_Dec_23_8_129.nxml.txt.nlp	20030852	SENT13	2	2	8	8	curcumin	ABCA1	PA151958596	19	0.906
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT175	14	14	0	0	cisplatin	p53	PA449014	7157	0.906
NULL	Diabetes_2013_Mar_14_62(3)_953-964.nxml.txt.nlp	23223176	SENT221	15	15	31	31	paroxetine	ROS	PA450801	6098	0.906
NULL	J_Exp_Clin_Cancer_Res_2009_Jul_10_28(1)_99.nxml.txt.nlp	19591692	SENT108	13	13	11	11	tariquidar	ABCG2		9429	0.906
NULL	J_Cell_Biol_2004_Jun_21_165(6)_893-902.nxml.txt.nlp	15197174	SENT128	6	6	28	28	trifluoperazine	CD44	PA451771	960	0.906
NULL	Acta_Pharmacol_Sin_2014_Jun_5_35(6)_716-726.nxml.txt.nlp	24793311	SENT194	40	40	28	28	atorvastatin	IL-6	PA448500	3569	0.906
NULL	Croat_Med_J_2012_Jun_53(3)_214-223.nxml.txt.nlp	22661134	SENT10	2	2	12	12	clonidine	ACTH	PA449051	5443	0.906
NULL	Cell_Death_Differ_2012_Jul_20_19(7)_1162-1174.nxml.txt.nlp	22261617	SENT154	38	38	0	0	l-glutamine	BMP2	PA10090	650	0.906
NULL	Osteoporos_Int_2013_Oct_19_24(1)_23-57.nxml.txt.nlp	23079689	SENT512	12	12	10	10	teriparatide	PTH	PA451620	5741	0.906
NULL	Ann_Med_2011_Nov_5_43(7)_531-544.nxml.txt.nlp	21815879	SENT117	23	23	4	4	clopidogrel	ADP	PA449053	23038	0.906
NULL	Protein_J_2012_Aug_5_31(6)_511-518.nxml.txt.nlp	22763563	SENT110	14	14	1	1	fluorescein	CD36	PA164746009	948	0.906
NULL	Case_Rep_Crit_Care_2014_Aug_19_2014_242703.nxml.txt.nlp	25215245	SENT23	12	12	9	9	nicardipine	APE	PA450620	55704;328	0.906
NULL	Clin_Drug_Investig_2013_Aug_23_33(10)_727-736.nxml.txt.nlp	23975654	SENT80	16	16	19	19	ketoconazole	CYP3A	PA450146	1574	0.906
NULL	J_Inherit_Metab_Dis_2012_Jan_10_35(1)_141-149.nxml.txt.nlp	21556832	SENT27	22	22	29	29	l-arginine	CRTR	PA448478	6535	0.906
NULL	Adv_Hematol_2010_Dec_21_2010_320624.nxml.txt.nlp	21253465	SENT25	4	4	2	2	cyclophosphamide	CHOP	PA449165	1649	0.906
NULL	Clin_Exp_Reprod_Med_2011_Jun_30_38(2)_93-97.nxml.txt.nlp	22384425	SENT81	27	27	7	7	estradiol	AMH	PA449503	268	0.906
NULL	J_Cell_Mol_Med_2014_Aug_1_18(8)_1599-1611.nxml.txt.nlp	24889822	SENT267	8	8	0	0	resveratrol	SIRT1		23411	0.906
NULL	Arthritis_Res_Ther_2014_Apr_11_16(2)_R93.nxml.txt.nlp	24725461	SENT156	40	40	10	10	letrozole	aromatase	PA450196	1588	0.906
NULL	Oncoimmunology_2013_Oct_1_2(10)_e27025.nxml.txt.nlp	24353914	SENT180	18	18	10	10	cisplatin	CD4	PA449014	920	0.906
NULL	Nat_Commun_2013_Aug_15_4_2130.nxml.txt.nlp	23945651	SENT178	9	9	13	13	cisplatin	ATG5	PA449014	9474	0.906
NULL	Exp_Ther_Med_2014_Mar_17_7(3)_703-708.nxml.txt.nlp	24520271	SENT79	16	16	33	33	doxorubicin	IFN	PA449412	3439	0.906
NULL	Oncotarget_2014_Jun_8_5(17)_7446-7457.nxml.txt.nlp	25277184	SENT33	19	19	29	29	nutlin-3	p53		7157	0.906
NULL	Diabetes_Care_2011_Mar_17_34(3)_730-733.nxml.txt.nlp	21289232	SENT34	0	0	18	18	pioglitazone	IL-10	PA450970	3586	0.906
NULL	Front_Oncol_2014_Mar_25_4_54.nxml.txt.nlp	24724051	SENT123	5	5	10	10	temsirolimus	TORC1	PA164746890	23373	0.906
NULL	Arthritis_Rheumatol_2014_Jun_27_66(6)_1574-1582.nxml.txt.nlp	24577881	SENT161	25	25	11	11	hydralazine	ERK	PA449894	5594	0.906
NULL	Mol_Cancer_2012_Dec_12_11_91.nxml.txt.nlp	23234355	SENT169	12	12	28	28	cetuximab	EGFR	PA10040	1956	0.906
NULL	Acta_Pharmacol_Sin_2013_Jan_23_34(1)_33-38.nxml.txt.nlp	22820909	SENT99	12	12	18	18	flurbiprofen	ASIC3	PA449683	9311	0.906
NULL	ISRN_Neurol_2014_Jan_21_2014_515716.nxml.txt.nlp	24579051	SENT166	0	0	14	14	pioglitazone	STAT3	PA450970	6774	0.906
NULL	Nucleic_Acids_Res_2014_Jan_2_42(Database_issue)_D178-D183.nxml.txt.nlp	24302579	SENT144	27	27	23	23	imatinib	GATA1	PA10804	2623	0.906
NULL	Breast_Cancer_Res_2012_Jan_6_14(1)_R2.nxml.txt.nlp	22225778	SENT219	20	20	31	31	docetaxel	TNFSF14	PA449383	8740	0.906
NULL	Ann_Rheum_Dis_2014_Sep_18_73(9)_1607-1615.nxml.txt.nlp	24641941	SENT234	41	41	18	18	tocilizumab	IL-6	PA165292659	3569	0.906
NULL	Oncogene_2014_Jul_24_33(30)_3959-3969.nxml.txt.nlp	24096481	SENT22	2	2	12	12	doxorubicin	p53	PA449412	7157	0.906
NULL	Mol_Biol_Cell_2014_Feb_1_25(3)_324-336.nxml.txt.nlp	24336522	SENT91	0	0	17	17	marimastat	PKD2	PA164748329	5311;25865	0.906
NULL	Oncol_Lett_2014_Jan_29_7(1)_121-124.nxml.txt.nlp	24348832	SENT49	20	20	38	38	cisplatin	CO2	PA449014	4513	0.906
NULL	Indian_J_Dermatol_2013_Jan-Feb_58(1)_61-64.nxml.txt.nlp	23372216	SENT98	29	29	17	17	carbamazepine	CYP3A4	PA448785	1576	0.906
NULL	J_Biol_2003_Sep_24_2(4)_28.nxml.txt.nlp	14511394	SENT150	21	21	25	25	phenformin	AMPK	PA1000	5563	0.906
NULL	ISRN_Otolaryngol_2012_Oct_16_2012_706896.nxml.txt.nlp	23762616	SENT24	16	16	30	30	vasopressin	AQP5	PA451858	362	0.906
NULL	Open_Access_J_Urol_2011_May_10_3_69-82.nxml.txt.nlp	24198638	SENT66	11	11	18	18	efavirenz	CYP2C8	PA449441	1558	0.906
NULL	J_Antimicrob_Chemother_2010_Aug_19_65(8)_1702-1711.nxml.txt.nlp	20562429	SENT55	0	0	15	15	oxacillin	BSAC	PA450725	57591	0.906
NULL	Cancer_Med_2013_Jun_25_2(3)_277-285.nxml.txt.nlp	23930204	SENT114	6	6	19	19	bevacizumab	PTEN	PA130232992	5728	0.906
NULL	Mar_Drugs_2014_Jun_27_12(7)_3818-3837.nxml.txt.nlp	24979269	SENT225	38	38	6	6	doxorubicin	P-gp	PA449412	5243	0.906
NULL	Adv_Hematol_2012_Jun_19_2012_851674.nxml.txt.nlp	22778745	SENT241	14	14	12	12	sulindac	COX	PA451565	1351	0.906
NULL	Oncoimmunology_2013_Dec_1_2(12)_e26837.nxml.txt.nlp	24501687	SENT15	20	20	13	13	gemcitabine	CD40	PA449748	958	0.906
NULL	Front_Physiol_2011_Jun_30_2_33.nxml.txt.nlp	21747769	SENT313	3	3	11	11	berberine	KCNQ1	PA165860812	3784	0.906
NULL	Parasit_Vectors_2011_Aug_24_4_164.nxml.txt.nlp	21864384	SENT77	16	16	3	3	praziquantel	LAMP	PA164764583	4045;27074	0.906
NULL	Antimicrob_Agents_Chemother_2014_Nov_10_59(1)_505-513.nxml.txt.nlp	25385096	SENT249	0	0	3	3	chloroquine	CYP2D6	PA448948	1565	0.906
NULL	Trials_2014_Apr_9_15_115.nxml.txt.nlp	24716668	SENT30	5	5	3	3	levothyroxine	AIT	PA450221	160728	0.906
NULL	Indian_J_Med_Paediatr_Oncol_2013_Oct-Dec_34(4)_292-298.nxml.txt.nlp	24604960	SENT36	36	36	34	34	rituximab	CHOP	PA451261	1649	0.906
NULL	Mol_Cancer_2009_Aug_25_8_66.nxml.txt.nlp	19706164	SENT36	6	6	4	4	aspirin	COX	PA448497	1351	0.906
NULL	ScientificWorldJournal_2012_Dec_27_2012_529151.nxml.txt.nlp	23346016	SENT135	21	21	13	13	sorafenib	KIT	PA7000	3815	0.906
NULL	Breast_Cancer_Res_2011_Mar_1_13(2)_R21.nxml.txt.nlp	21362200	SENT155	3	3	10	10	estradiol	PI3K	PA449503	5290	0.906
NULL	Diabetes_Care_2013_Jul_12_36(7)_2126-2132.nxml.txt.nlp	23645884	SENT56	8	8	5	5	liraglutide	GLP-1	PA165958364	100125288	0.906
NULL	Exp_Cell_Res_2012_Aug_1_318(13-16)_1517-1527.nxml.txt.nlp	22516051	SENT539	16	16	4	4	urokinase	ILK	PA451836	3611	0.906
NULL	Br_J_Cancer_2013_Jul_9_109(1)_14-23.nxml.txt.nlp	23764751	SENT33	24	24	12	12	cisplatin	ASNS	PA449014	440	0.906
NULL	J_Thromb_Haemost_2008_Apr_1_6(4)_583-588.nxml.txt.nlp	18194418	SENT141	20	20	9	9	desmopressin	VWF	PA449237	7450	0.906
NULL	Hum_Genomics_2011_Mar_1_5(3)_170-191.nxml.txt.nlp	21504868	SENT62	25	25	10	10	lipase	FABP4	PA450239	2167	0.906
NULL	Nucleic_Acids_Res_2013_May_5_41(10)_5210-5222.nxml.txt.nlp	23563151	SENT245	4	4	7	7	arsenite	GADD45	PA452638	1647	0.906
NULL	Environ_Health_Perspect_2007_Dec_8_115(Suppl_1)_77-83.nxml.txt.nlp	18174954	SENT99	28	28	9	9	genistein	TTR	PA165109660	7276	0.906
NULL	Acta_Pharmacol_Sin_2012_Jan_28_33(1)_66-74.nxml.txt.nlp	22120966	SENT239	2	2	13	13	genistein	OPG	PA165109660	690	0.906
NULL	Cell_Death_Dis_2014_Apr_24_5(4)_e1197.nxml.txt.nlp	24763054	SENT63	21	21	11	11	doxorubicin	ARC	PA449412	8996;23237	0.906
NULL	Br_J_Cancer_2004_Mar_5_90(Suppl_1)_S11-S14.nxml.txt.nlp	15094759	SENT6	16	16	13	13	anastrozole	aromatase	PA448432	1588	0.906
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT87	23	23	4	4	cisplatin	FasL	PA449014	356	0.906
NULL	Br_J_Cancer_2010_Jul_13_103(2)_186-195.nxml.txt.nlp	20588277	SENT31	17	17	8	8	nutlin-3	MDM2		4193	0.906
NULL	Patient_Prefer_Adherence_2011_Dec_23_6_1-9.nxml.txt.nlp	22272064	SENT3	31	31	8	8	lisinopril	ACE	PA450242	1636	0.906
NULL	Indian_J_Pharmacol_2008_Aug_40(4)_137-143.nxml.txt.nlp	20040945	SENT138	11	11	5	5	irinotecan	UGT1A1	PA450085	54658	0.906
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S18-S30.nxml.txt.nlp	20680104	SENT30	32	32	18	18	oxaliplatin	EGFR	PA131285527	1956	0.906
NULL	Int_J_Breast_Cancer_2011_Sep_6_2011_352182.nxml.txt.nlp	22295219	SENT198	18	18	12	12	trastuzumab	HER2	PA451743	2064	0.906
NULL	J_Breast_Cancer_2011_Jun_18_14(2)_135-139.nxml.txt.nlp	21847409	SENT21	31	31	27	27	letrozole	aromatase	PA450196	1588	0.906
NULL	Acta_Pharmacol_Sin_2010_Nov_18_31(11)_1447-1453.nxml.txt.nlp	20953204	SENT104	18	18	30	30	rimonabant	CB1	PA152407999	1268	0.906
NULL	Chin_J_Cancer_2011_Nov_30(11)_749-756.nxml.txt.nlp	22035855	SENT94	5	5	7	7	tamoxifen	HER2	PA451581	2064	0.906
NULL	J_Geriatr_Cardiol_2013_Sep_10(3)_211-212.nxml.txt.nlp	24133505	SENT6	27	27	1	1	sirolimus	DES	PA451365	1674	0.906
NULL	Oncol_Lett_2013_Mar_8_5(3)_805-812.nxml.txt.nlp	23426281	SENT227	5	5	0	0	gemcitabine	B7-H3	PA449748	80381	0.906
NULL	Br_J_Cancer_2011_Jul_26_105(3)_407-412.nxml.txt.nlp	21730976	SENT71	5	5	19	19	pha-665752	STAT3		6774	0.906
NULL	Pharmaceuticals_(Basel)_2012_Jul_25_5(8)_779-801.nxml.txt.nlp	24280675	SENT79	2	2	14	14	geldanamycin	p23	PA152031327	10728	0.906
NULL	Mol_Cancer_2007_Apr_2_6_26.nxml.txt.nlp	17407576	SENT122	10	10	6	6	cisplatin	p53	PA449014	7157	0.906
NULL	Protein_Cell_2014_Jun_19_5(6)_469-479.nxml.txt.nlp	24748116	SENT50	8	8	4	4	paclitaxel	EB1	PA450761	9167;22919;10982	0.906
NULL	Fibrogenesis_Tissue_Repair_2012_Jul_23_5_11.nxml.txt.nlp	22824096	SENT407	4	4	7	7	thrombin	PAR-1	PA451674	2011;2149	0.906
NULL	Ann_Gen_Psychiatry_2010_Apr_22_9(Suppl_1)_S83.nxml.txt.nlp	NULL	SENT7	30	30	0	0	carbamazepine	AC5	PA448785	111	0.906
NULL	Open_Ophthalmol_J_2013_Feb_1_7_4-10.nxml.txt.nlp	23459241	SENT112	0	0	37	37	ranibizumab	San	PA164746012	80218	0.906
NULL	Endocrinol_Diabetes_Metab_Case_Rep_2014_Mar_1_2014_140001.nxml.txt.nlp	24683487	SENT113	14	14	3	3	cyproheptadine	ACTH	PA164749366	5443	0.906
NULL	Breast_Cancer_(Auckl)_2014_Mar_23_8_51-56.nxml.txt.nlp	24678242	SENT7	24	24	7	7	carboplatin	BRCA1	PA448803	672	0.906
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_13_2012_108626.nxml.txt.nlp	23243426	SENT274	14	14	16	16	carrageenan	ANOVA	PA448814	4858	0.906
NULL	JAKSTAT_2014_Jun_12_3_e29554.nxml.txt.nlp	25105067	SENT50	13	13	3	3	propofol	STAT3	PA451141	6774	0.906
NULL	Thorax_2012_Mar_28_67(3)_229-237.nxml.txt.nlp	21957094	SENT144	0	0	19	19	carbachol	ACL	PA448784	47	0.906
NULL	Eur_J_Neurosci_2009_Apr_29(8)_1604-1614.nxml.txt.nlp	19419423	SENT9	25	25	30	30	ketanserin	5-HT2C	PA131053734	3358	0.906
NULL	J_Immunol_Res_2014_Jan_29_2014_828732.nxml.txt.nlp	24741626	SENT4	5	5	16	16	rituximab	CAMR	PA451261	3028	0.906
NULL	BMB_Rep_2013_Nov_46(11)_544-549.nxml.txt.nlp	24152910	SENT94	2	2	9	9	thrombin	HMGB1	PA451674	3146	0.906
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT164	31	31	18	18	lapatinib	EGFR	PA152241907	1956	0.906
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2751-2762.nxml.txt.nlp	24169358	SENT13	0	0	38	38	fulvestrant	BCAR3	PA164747170	8412	0.906
NULL	Exp_Mol_Med_2012_Dec_17_44(12)_749-755.nxml.txt.nlp	23178275	SENT105	13	13	24	24	glibenclamide	San	PA449782	80218	0.906
NULL	Acta_Neuropathol_Commun_2013_Jul_17_1_39.nxml.txt.nlp	24252174	SENT55	23	23	3	3	erlotinib	Erb	PA134687924	2100	0.906
NULL	J_Oncol_2010_Dec_28_2010_135354.nxml.txt.nlp	21318160	SENT133	34	34	19	19	eltrombopag	MPL	PA165981594	4352	0.906
NULL	J_Cell_Biol_1993_May_2_121(4)_945-955.nxml.txt.nlp	8491785	SENT3	15	15	17	17	thrombin	ADP	PA451674	23038	0.906
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Aug_11_66(Pt_9)_o2276.nxml.txt.nlp	21588631	SENT69	10	10	24	24	ethanol	mol	PA448073	90527	0.906
NULL	Support_Care_Cancer_2012_Jul_27_20(7)_1353-1360.nxml.txt.nlp	22539050	SENT5	11	11	0	0	denosumab	NNT	PA166048634	23530	0.906
NULL	Diabetes_2013_Jun_17_62(6)_1800-1807.nxml.txt.nlp	23704521	SENT238	23	23	11	11	imatinib	SIRT1	PA10804	23411	0.906
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jan_22_67(Pt_2)_o445-o446.nxml.txt.nlp	21523109	SENT80	37	37	19	19	ethanol	mol	PA448073	90527	0.906
NULL	Endocrinol_Diabetes_Metab_Case_Rep_2014_Mar_1_2014_140001.nxml.txt.nlp	24683487	SENT18	21	21	6	6	ketoconazole	ACTH	PA450146	5443	0.906
NULL	Neural_Regen_Res_2013_Sep_15_8(26)_2458-2467.nxml.txt.nlp	25206556	SENT112	2	2	37	37	methimazole	CA1	PA450422	759	0.906
NULL	Ann_Oncol_2011_Mar_8_22(3)_503-514.nxml.txt.nlp	20616198	SENT379	9	9	16	16	fulvestrant	aromatase	PA164747170	1588	0.906
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT12	12	12	2	2	neratinib	HER2	PA165291472	2064	0.906
NULL	Acta_Histochem_Cytochem_2010_May_1_43(2)_61-68.nxml.txt.nlp	20514293	SENT61	15	15	1	1	hyaluronan	LYVE-1	PA165958431	10894	0.906
NULL	Oncoimmunology_2012_May_1_1(3)_372-374.nxml.txt.nlp	22737619	SENT20	23	23	9	9	lenalidomide	IL-2	PA162363968	3558	0.906
NULL	J_Ayurveda_Integr_Med_2013_Apr-Jun_4(2)_99-106.nxml.txt.nlp	23930042	SENT171	28	28	11	11	glipizide	STZ	PA449762	6484	0.906
NULL	J_Appl_Oral_Sci_2013_Mar-Apr_21(2)_118-123.nxml.txt.nlp	23739849	SENT31	11	11	27	27	chlorhexidine	castor	PA164776863	54897	0.906
NULL	Pancreas_2015_Jan_11_44(1)_134-143.nxml.txt.nlp	25243385	SENT341	14	14	25	25	doxorubicin	CD24	PA449412	100133941	0.906
NULL	Br_J_Cancer_2012_Feb_28_106(5)_793-798.nxml.txt.nlp	22315057	SENT59	3	3	8	8	cetuximab	EGFR	PA10040	1956	0.906
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jul_18_65(Pt_8)_o1893.nxml.txt.nlp	21583583	SENT69	10	10	4	4	ethanol	mol	PA448073	90527	0.906
NULL	F1000Prime_Rep_2014_Apr_1_6_21.nxml.txt.nlp	24765526	SENT58	9	9	6	6	tocilizumab	IL-6	PA165292659	3569	0.906
NULL	Braz_J_Med_Biol_Res_2014_Sep_5_47(11)_929-939.nxml.txt.nlp	25296354	SENT106	8	8	23	23	gefitinib	EGFR	PA131301952	1956	0.906
NULL	J_Biol_Inorg_Chem_2012_Apr_5_17(4)_565-571.nxml.txt.nlp	22311114	SENT45	19	19	30	30	l-glutamine	CO2	PA10090	4513	0.906
NULL	Gastric_Cancer_2013_Jul_12_16(3)_345-354.nxml.txt.nlp	22968820	SENT18	20	20	26	26	oxaliplatin	FANCJ	PA131285527	83990	0.906
NULL	Br_J_Pharmacol_2012_Jan_165(2)_380-389.nxml.txt.nlp	21585347	SENT11	25	25	9	9	rosiglitazone	ATGL	PA451283	57104	0.906
NULL	Breast_Cancer_(Auckl)_2012_Feb_20_6_47-66.nxml.txt.nlp	22399860	SENT172	4	4	8	8	tamoxifen	RAD21	PA451581	5885	0.906
NULL	Emerg_Infect_Dis_2003_Jul_9(7)_864-867.nxml.txt.nlp	12890330	SENT70	25	25	28	28	dapsone	DHPS	PA449211	1725	0.906
NULL	Autoimmune_Dis_2012_Dec_6_2012_784364.nxml.txt.nlp	23304459	SENT139	0	0	6	6	mitoxantrone	DMT	PA450526	2039	0.906
NULL	F1000Res_2013_Oct_8_2_173.nxml.txt.nlp	24555085	SENT190	19	19	4	4	hydrocortisone	BDP	PA449905	10620;152926	0.906
NULL	Oncol_Discov_2013_1(4)_10_7243_2052-6199-1-4.nxml.txt.nlp	25383193	SENT194	2	2	12	12	piroxicam	COX	PA450985	1351	0.906
NULL	Pharmaceuticals_(Basel)_2014_Feb_11_7(2)_192-206.nxml.txt.nlp	24521925	SENT177	4	4	1	1	cisplatin	GPD2	PA449014	2820	0.906
NULL	Acta_Pharmacol_Sin_2014_Aug_21_35(8)_1082-1092.nxml.txt.nlp	25047514	SENT80	17	17	26	26	letrozole	aromatase	PA450196	1588	0.906
NULL	J_Biol_Chem_2013_Aug_23_288(34)_24848-24856.nxml.txt.nlp	23843457	SENT221	20	20	3	3	baclofen	KCTD12	PA448533	115207	0.906
NULL	Biosci_Rep_2012_Aug_1_32(Pt_4)_361-374.nxml.txt.nlp	22762204	SENT1062	15	15	3	3	doxorubicin	p27	PA449412	5715;10534	0.906
NULL	Mol_Cancer_2010_Dec_2_9_309.nxml.txt.nlp	21122157	SENT160	10	10	7	7	paclitaxel	IL-6	PA450761	3569	0.906
NULL	BMB_Rep_2013_Mar_46(3)_157-162.nxml.txt.nlp	23527859	SENT110	17	17	40	40	galactose	mol	PA449725	90527	0.906
NULL	N_Am_J_Med_Sci_2011_Jan_3(1)_1-12.nxml.txt.nlp	22540056	SENT66	20	20	2	2	gemcitabine	HuR	PA449748	1994	0.906
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Feb_13_66(Pt_3)_o627.nxml.txt.nlp	21580384	SENT58	19	19	13	13	ethanol	mol	PA448073	90527	0.906
NULL	ScientificWorldJournal_2014_Mar_23_2014_183147.nxml.txt.nlp	24790551	SENT25	24	24	13	13	pantoprazole	NK1	PA450774	11126	0.906
NULL	Core_Evid_2010_Oct_21_5_23-37.nxml.txt.nlp	21042540	SENT161	7	7	38	38	saxagliptin	CYP1A2	PA165958362	1544	0.906
NULL	Gut_Liver_2013_Sep_14_7(5)_585-593.nxml.txt.nlp	24073317	SENT102	4	4	18	18	ribavirin	IFN	PA451241	3439	0.906
NULL	Braz_J_Med_Biol_Res_2014_Sep_5_47(11)_929-939.nxml.txt.nlp	25296354	SENT79	0	0	22	22	gefitinib	EGFR	PA131301952	1956	0.906
NULL	Oncogene_2014_Aug_28_33(35)_4407-4417.nxml.txt.nlp	24469038	SENT244	34	34	7	7	cisplatin	14-3-3	PA449014	10971	0.906
NULL	EMBO_Mol_Med_2012_Jul_18_4(7)_557-560.nxml.txt.nlp	22610822	SENT41	12	12	10	10	resveratrol	SIRT1		23411	0.906
NULL	Mol_Pain_2013_Jun_10_9_27.nxml.txt.nlp	23758830	SENT50	11	11	5	5	tetracaine	ASIC3	PA451638	9311	0.906
NULL	Mol_Cancer_2009_Jun_23_8_39.nxml.txt.nlp	19549337	SENT36	12	12	8	8	flutamide	survivin	PA449685	332	0.906
NULL	Int_J_Biomed_Imaging_2013_Feb_26_2013_230487.nxml.txt.nlp	23533377	SENT153	16	16	9	9	trastuzumab	HER2	PA451743	2064	0.906
NULL	FASEB_J_2013_Jul_27(7)_2880-2892.nxml.txt.nlp	23543682	SENT108	8	8	26	26	choline	ABCA1	PA448976	19	0.906
NULL	Curr_Neuropharmacol_2010_Sep_8(3)_287-304.nxml.txt.nlp	21358978	SENT10	0	0	11	11	agomelatine	5-HT2C	PA165958363	3358	0.906
NULL	Breast_Cancer_Res_2008_Dec_18_10(Suppl_4)_S20.nxml.txt.nlp	19128434	SENT30	37	37	25	25	erlotinib	HER2	PA134687924	2064	0.906
NULL	J_Med_Internet_Res_2013_Jul_12_15(7)_e138.nxml.txt.nlp	23853350	SENT191	18	18	6	6	warfarin	TTR	PA451906	7276	0.906
NULL	Pain_2011_Aug_152(8)_1899-1908.nxml.txt.nlp	21600693	SENT226	22	22	15	15	cangrelor	ADP	PA165945763	23038	0.906
NULL	Front_Oncol_2011_Jun_17_1_10.nxml.txt.nlp	22655230	SENT243	7	7	11	11	olaparib	BRCA1		672	0.906
NULL	Front_Oncol_2013_Oct_31_3_271.nxml.txt.nlp	24199171	SENT370	43	43	21	21	erlotinib	KRAS	PA134687924	3845	0.906
NULL	EMBO_Mol_Med_2012_Sep_20_4(9)_980-991.nxml.txt.nlp	22903875	SENT169	25	25	6	6	paraformaldehyde	BACE1	PA450790	23621	0.906
NULL	Oncogene_2009_Jan_29_28(4)_479-491.nxml.txt.nlp	18978811	SENT252	18	18	30	30	doxycycline	S27	PA449415	6232	0.906
NULL	Aging_Cell_2012_Aug_11(4)_579-587.nxml.txt.nlp	22435726	SENT121	14	14	19	19	etoposide	CD28	PA449552	1493;940	0.906
NULL	Brain_2014_Apr_27_137(4)_1145-1155.nxml.txt.nlp	24578545	SENT232	18	18	5	5	citalopram	MRI	PA449015	78996	0.906
NULL	Autoimmune_Dis_2012_Aug_1_2012_207190.nxml.txt.nlp	22900150	SENT6	4	4	13	13	hyaluronan	CD44	PA165958431	960	0.906
NULL	Arch_Drug_Inf_2011_Mar_4(1)_1-9.nxml.txt.nlp	21572514	SENT207	19	19	13	13	ciprofloxacin	P-gp	PA449009	5243	0.906
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT209	5	5	0	0	perifosine	DR4	PA165291471	8797	0.906
NULL	Ann_Rheum_Dis_2013_Dec_5_72(12)_1897-1904.nxml.txt.nlp	23918035	SENT249	39	39	18	18	tocilizumab	IL-6	PA165292659	3569	0.906
NULL	ISRN_AIDS_2012_Jul_12_2012_485307.nxml.txt.nlp	24052874	SENT98	15	15	7	7	tenofovir	PTH	PA10204	5741	0.906
NULL	Indian_J_Anaesth_2013_Mar-Apr_57(2)_203-204.nxml.txt.nlp	23825828	SENT28	14	14	22	22	succinylcholine	RTS	PA451522	1387	0.906
NULL	Clin_Pharmacol_2009_Sep_7_1_1-6.nxml.txt.nlp	22291481	SENT82	6	6	31	31	fluoxetine	AC1	PA449673	107	0.906
NULL	J_Clin_Biochem_Nutr_2007_Jul_27_41(1)_32-42.nxml.txt.nlp	18392098	SENT612	16	16	4	4	curcumin	PARP	PA151958596	142	0.906
NULL	ScientificWorldJournal_2014_Nov_26_2014_421931.nxml.txt.nlp	25525619	SENT35	4	4	11	11	lercanidipine	GIT	PA164769058	5034	0.906
NULL	Bioinformation_2013_Jan_18_9(2)_89-93.nxml.txt.nlp	23390352	SENT64	8	8	15	15	pioglitazone	PPARG	PA450970	5468	0.906
NULL	J_Adv_Pract_Oncol_2012_Nov_1_Nov-Dec_3(6)_391-394.nxml.txt.nlp	25031970	SENT64	19	19	10	10	pertuzumab	HER2		2064	0.906
NULL	Biomed_Res_Int_2014_May_18_2014_291280.nxml.txt.nlp	24949432	SENT162	38	38	5	5	tamoxifen	MYB	PA451581	4602	0.906
NULL	Nat_Commun_2014_Dec_8_5_5736.nxml.txt.nlp	25484020	SENT724	3	3	0	0	exemestane	TRPA1	PA449563	8989	0.906
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_127043.nxml.txt.nlp	23227093	SENT28	12	12	22	22	lovastatin	RYR	PA450272	6261	0.906
NULL	Mol_Cancer_2014_Jun_24_13_157.nxml.txt.nlp	24958351	SENT4	8	8	15	15	lapatinib	HER2	PA152241907	2064	0.906
NULL	Oncotarget_2014_Jun_26_5(14)_5559-5569.nxml.txt.nlp	24980819	SENT114	17	17	5	5	vemurafenib	p53	PA165946873	7157	0.906
NULL	J_RNAi_Gene_Silencing_2010_May_29_6(1)_386-400.nxml.txt.nlp	20628499	SENT180	0	0	14	14	flavopiridol	Dicer	PA452627	23405	0.906
NULL	Br_J_Cancer_2009_Mar_24_100(6)_870-873.nxml.txt.nlp	19293806	SENT37	17	17	27	27	gemcitabine	CDA	PA449748	978	0.906
NULL	Int_J_Mol_Sci_2014_Sep_16_15(9)_16381-16417.nxml.txt.nlp	25229821	SENT145	0	0	30	30	hydroxychloroquine	TLR9	PA164777036	54106	0.906
NULL	J_Immunol_Res_2014_May_12_2014_897249.nxml.txt.nlp	24901013	SENT36	11	11	23	23	natalizumab	CD4	PA164747191	920	0.906
NULL	Br_J_Cancer_2010_Sep_7_103(6)_837-844.nxml.txt.nlp	20717115	SENT147	33	33	16	16	sorafenib	SHARP	PA7000	23013	0.906
NULL	Front_Neural_Circuits_2015_Jan_12_8_150.nxml.txt.nlp	25628540	SENT201	5	5	33	33	atropine	CA1	PA448505	759	0.906
NULL	Breast_Cancer_(Auckl)_2012_Mar_7_6_67-77.nxml.txt.nlp	22438669	SENT69	13	13	25	25	paclitaxel	HER2	PA450761	2064	0.906
NULL	Cancer_Res_Treat_2014_Jan_15_46(1)_48-54.nxml.txt.nlp	24520223	SENT123	17	17	5	5	bevacizumab	KRAS	PA130232992	3845	0.906
NULL	Diabetes_Care_2012_Feb_16_35(2)_327-333.nxml.txt.nlp	22179958	SENT49	6	6	15	15	metformin	B12	PA450395	7126;4709	0.906
NULL	Oncotarget_2013_Apr_13_4(4)_502-530.nxml.txt.nlp	23594434	SENT511	9	9	25	25	nelfinavir	IL-18	PA450606	3606	0.906
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT231	13	13	4	4	cisplatin	IBP	PA449014	706;50619	0.906
NULL	Diabetes_2013_Mar_14_62(3)_953-964.nxml.txt.nlp	23223176	SENT193	34	34	36	36	paroxetine	PRX	PA450801	9588;57716	0.906
NULL	Mol_Biol_Cell_2012_Nov_1_23(21)_4212-4225.nxml.txt.nlp	22956765	SENT219	16	16	4	4	thrombin	SHP2	PA451674	5781	0.906
NULL	Oncol_Rep_2012_Apr_30_27(4)_923-928.nxml.txt.nlp	22209766	SENT124	20	20	36	36	erlotinib	HER3	PA134687924	2065	0.906
NULL	Acta_Orthop_2009_Aug_7_80(4)_491-498.nxml.txt.nlp	19857181	SENT145	35	35	7	7	estradiol	adiponectin	PA449503	9370	0.906
NULL	Cell_Commun_Signal_2014_Sep_25_12(1)_61.nxml.txt.nlp	NULL	SENT50	23	23	15	15	doxycycline	INPP4B	PA449415	8821	0.906
NULL	Diabetes_Care_2009_Nov_32(Suppl_2)_S184-S188.nxml.txt.nlp	19875549	SENT138	18	18	12	12	ramipril	DREAM	PA451223	30818	0.906
NULL	J_Cancer_2014_Jul_4_5(7)_559-571.nxml.txt.nlp	25057307	SENT284	17	17	24	24	trastuzumab	PTEN	PA451743	5728	0.906
NULL	Endocrinol_Metab_(Seoul)_2014_Sep_25_29(3)_211-216.nxml.txt.nlp	25309777	SENT84	0	0	15	15	axitinib	RET	PA164924493	5979	0.906
NULL	Oncogene_2010_Sep_16_29(37)_5193-5203.nxml.txt.nlp	20581867	SENT119	13	13	7	7	trastuzumab	HRG	PA451743	3084;3273	0.906
NULL	Mol_Cell_Proteomics_2013_Jan_22_12(1)_158-171.nxml.txt.nlp	23090970	SENT42	12	12	8	8	bevacizumab	VEGF-A	PA130232992	7422	0.906
NULL	J_Physiol_2011_Mar_1_589(Pt_5)_1081-1093.nxml.txt.nlp	21224236	SENT142	14	14	2	2	diazoxide	GLP-1	PA449285	100125288	0.906
NULL	J_Radiat_Res_2014_Jul_11_55(4)_613-628.nxml.txt.nlp	24522270	SENT72	8	8	16	16	olaparib	DNA-PKcs		5591	0.906
NULL	Braz_J_Med_Biol_Res_2013_Sep_6_46(9)_746-751.nxml.txt.nlp	24036910	SENT23	10	10	43	43	genistein	HL-1	PA165109660	55600	0.906
NULL	Mol_Cell_Biochem_2012_Apr_3_363(1-2)_135-145.nxml.txt.nlp	22139302	SENT160	26	26	30	30	curcumin	survivin	PA151958596	332	0.906
NULL	J_Cell_Biol_2001_Apr_2_153(1)_207-220.nxml.txt.nlp	11285286	SENT139	7	7	27	27	carbachol	DGK	PA448784	8526;1607	0.906
NULL	Ann_Thorac_Med_2014_Jul-Sep_9(Suppl_1)_S79-S91.nxml.txt.nlp	25077002	SENT279	4	4	6	6	bosentan	STEP	PA10034	84867	0.906
NULL	Nucleic_Acids_Res_2011_Mar_19_39(4)_1266-1279.nxml.txt.nlp	20959290	SENT196	29	29	20	20	doxorubicin	p53	PA449412	7157	0.906
NULL	Clin_Med_Oncol_2008_Jun_11_2_469-470.nxml.txt.nlp	21892319	SENT22	0	0	8	8	trastuzumab	HER2	PA451743	2064	0.906
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT187	19	19	7	7	cisplatin	p53	PA449014	7157	0.906
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT371	10	10	3	3	neratinib	HER2	PA165291472	2064	0.906
NULL	J_Korean_Med_Sci_2009_Jun_15_24(3)_511-512.nxml.txt.nlp	19543518	SENT36	14	14	31	31	clarithromycin	DST	PA449028	667	0.906
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT126	27	27	6	6	perifosine	DR5	PA165291471	8795	0.906
NULL	J_Biol_Chem_2008_Nov_14_283(46)_31679-31689.nxml.txt.nlp	18755684	SENT69	10	10	5	5	iron	FTL	PA450087	2512	0.906
NULL	Curr_Oncol_2006_Feb_13(1)_8-13.nxml.txt.nlp	17576436	SENT115	39	39	31	31	trastuzumab	aromatase	PA451743	1588	0.906
NULL	Front_Immunol_2013_Mar_27_4_76.nxml.txt.nlp	23543707	SENT659	10	10	0	0	alemtuzumab	FCGR3A	PA164783958	2214	0.906
NULL	Exp_Ther_Med_2013_Mar_21_5(3)_987-991.nxml.txt.nlp	23407636	SENT89	7	7	15	15	losartan	IL-8	PA450268	3576	0.906
NULL	Int_J_Nanomedicine_2012_Sep_13_7_4917-4926.nxml.txt.nlp	23028220	SENT225	2	2	17	17	calcein	mol	PA132595336	90527	0.906
NULL	J_Cancer_Res_Clin_Oncol_2013_Feb_10_139(2)_269-280.nxml.txt.nlp	23052698	SENT44	13	13	10	10	anastrozole	aromatase	PA448432	1588	0.906
NULL	J_Hematol_Oncol_2009_Apr_22_2_18.nxml.txt.nlp	19386128	SENT107	43	43	23	23	cetuximab	KRAS	PA10040	3845	0.906
NULL	Case_Rep_Med_2014_Mar_4_2014_923496.nxml.txt.nlp	24715926	SENT116	15	15	1	1	methotrexate	ACR	PA450428	49	0.906
NULL	J_Cell_Mol_Med_2013_Oct_23_17(10)_1207-1217.nxml.txt.nlp	24106980	SENT146	17	17	2	2	doxorubicin	P-gp	PA449412	5243	0.906
NULL	Br_J_Cancer_2013_Mar_19_108(5)_1079-1091.nxml.txt.nlp	23449353	SENT6	33	33	7	7	docetaxel	MIC-1	PA449383	29919;9518	0.906
NULL	J_Mol_Med_2008_Sep_4_86(9)_1045-1056.nxml.txt.nlp	18600309	SENT118	2	2	19	19	salmeterol	IL-8	PA451300	3576	0.906
NULL	Epigenetics_2011_May_6(5)_638-649.nxml.txt.nlp	21593597	SENT96	8	8	21	21	tamoxifen	HER2	PA451581	2064	0.906
NULL	Ann_Lab_Med_2012_Jul_20_32(4)_270-275.nxml.txt.nlp	22779068	SENT105	42	42	35	35	imipenem	ACC-1	PA449968	597	0.906
NULL	Hum_Genomics_2008_Sep_1_3(1)_7-16.nxml.txt.nlp	19129086	SENT195	20	20	12	12	rosiglitazone	CYP2C8	PA451283	1558	0.906
NULL	Front_Neurol_2011_Aug_5_2_48.nxml.txt.nlp	21886636	SENT143	24	24	10	10	vasopressin	AQP2	PA451858	359	0.906
NULL	Indian_J_Crit_Care_Med_2008_Oct-Dec_12(4)_181-189.nxml.txt.nlp	19742267	SENT72	16	16	19	19	alefacept	CD2	PA164748040	914	0.906
NULL	Oncogene_2014_Feb_6_33(6)_713-723.nxml.txt.nlp	23435429	SENT101	21	21	6	6	etoposide	p50	PA449552	958;4790	0.906
NULL	Curr_Opin_Nephrol_Hypertens_2015_Jan_4_24(1)_37-46.nxml.txt.nlp	25427230	SENT183	10	10	16	16	furosemide	UGT	PA449719	7361;7355	0.906
NULL	Int_J_Mol_Sci_2013_Aug_14_14(8)_16719-16731.nxml.txt.nlp	23949634	SENT112	4	4	16	16	thrombin	PAR-1	PA451674	2011;2149	0.906
NULL	Indian_J_Anaesth_2013_May-Jun_57(3)_253-258.nxml.txt.nlp	23983283	SENT46	23	23	8	8	fentanyl	NIBP	PA449599	83696	0.906
NULL	Clinics_(Sao_Paulo)_2011_Aug_66(8)_1457-1462.nxml.txt.nlp	21915500	SENT97	21	21	33	33	rosuvastatin	AST	PA134308647	26503	0.906
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT204	8	8	20	20	phenprocoumon	CYP3A4	PA450921	1576	0.906
NULL	Cancer_Med_2013_Aug_30_2(4)_457-467.nxml.txt.nlp	24156018	SENT171	7	7	0	0	temozolomide	MMP14	PA451609	4323	0.906
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Apr_7_9_12.nxml.txt.nlp	20374640	SENT117	0	0	14	14	ampicillin	TEM	PA448419	64102	0.906
NULL	J_Clin_Exp_Pathol_2012_May_17_Suppl_4_7327.nxml.txt.nlp	25379357	SENT34	8	8	5	5	resveratrol	AMPK		5563	0.906
NULL	Brain_Res_2011_Mar_25_1382(C)_29-36.nxml.txt.nlp	21276431	SENT109	29	29	21	21	ketanserin	5-HT2A	PA131053734	3356	0.906
NULL	Springerplus_2014_Sep_17_3_535.nxml.txt.nlp	25279326	SENT153	15	15	13	13	exemestane	aromatase	PA449563	1588	0.906
NULL	Can_J_Infect_Dis_Med_Microbiol_2014_Nov-Dec_25(6)_327-343.nxml.txt.nlp	25587296	SENT819	9	9	14	14	cimetidine	CYP3A4	PA449001	1576	0.906
NULL	Mol_Biol_Cell_2014_Jul_1_25(13)_2116-2127.nxml.txt.nlp	24807908	SENT165	27	27	41	41	hemin	GAPDH	PA449849	2597	0.906
NULL	Aging_(Albany_NY)_2009_Mar_31_1(4)_412-424.nxml.txt.nlp	20195491	SENT162	9	9	16	16	resveratrol	TXNIP		10628	0.906
NULL	Oncoscience_2014_Dec_15_1(12)_844-853.nxml.txt.nlp	25621299	SENT133	19	19	27	27	sunitinib	CD31	PA162372840	5175	0.906
NULL	Case_Rep_Oncol_2014_Jun_18_7(2)_393-400.nxml.txt.nlp	25076890	SENT7	25	25	13	13	gefitinib	EGFR	PA131301952	1956	0.906
NULL	Pharm_Pract_(Granada)_2009_Mar_15_Jan-Mar_7(1)_54-58.nxml.txt.nlp	25147593	SENT79	30	30	19	19	budesonide	gamma	PA448681	9913	0.906
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT177	2	2	15	15	doxorubicin	B7-H1	PA449412	29126	0.906
NULL	Oncol_Lett_2014_Jul_25_8(1)_62-66.nxml.txt.nlp	24959219	SENT20	9	9	22	22	doxorubicin	CHOP	PA449412	1649	0.906
NULL	Oncotarget_2014_Aug_16_5(17)_7342-7356.nxml.txt.nlp	25277177	SENT8	18	18	15	15	gefitinib	EGFR	PA131301952	1956	0.906
NULL	Mol_Cells_2014_Nov_30_37(11)_819-826.nxml.txt.nlp	25284312	SENT74	16	16	0	0	trypsin	EPO	PA451806	7076;8288;2056	0.906
NULL	BMJ_Open_2014_Sep_17_4(9)_e005651.nxml.txt.nlp	25231491	SENT71	22	22	2	2	ketamine	ENIGMA	PA450144	9260	0.906
NULL	J_Cell_Mol_Med_2014_Aug_6_18(8)_1519-1539.nxml.txt.nlp	25100284	SENT191	10	10	31	31	gemcitabine	EGFR	PA449748	1956	0.906
NULL	Cancer_Manag_Res_2013_Jul_31_5_197-203.nxml.txt.nlp	23940421	SENT101	9	9	6	6	vismodegib	SMO		6608;54498	0.906
NULL	Mol_Cancer_2007_Sep_26_6_61.nxml.txt.nlp	17894897	SENT272	20	20	1	1	etoposide	p53	PA449552	7157	0.906
NULL	J_Breast_Cancer_2013_Mar_31_16(1)_117-121.nxml.txt.nlp	23593092	SENT65	11	11	9	9	exemestane	aromatase	PA449563	1588	0.906
NULL	Hum_Reprod_2014_Oct_10_29(10)_2302-2316.nxml.txt.nlp	25139174	SENT370	0	0	26	26	metformin	StAR	PA450395	6770	0.906
NULL	Reprod_Biol_Endocrinol_2013_May_10_11_36.nxml.txt.nlp	23663257	SENT33	44	44	18	18	estradiol	ghrelin	PA449503	51738	0.906
NULL	Nat_Med_2013_Mar_10_19(3)_313-321.nxml.txt.nlp	23396211	SENT149	5	5	17	17	amlexanox	P65	PA164745310	64689;6857	0.906
NULL	Cancer_Med_2013_Jun_25_2(3)_277-285.nxml.txt.nlp	23930204	SENT182	40	40	4	4	cetuximab	KRAS	PA10040	3845	0.906
NULL	Nucleic_Acids_Res_2011_Nov_25_39(20)_e139.nxml.txt.nlp	21873270	SENT88	47	47	18	18	trypsin	FBS	PA451806	64319;26269	0.906
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_13_2012_636848.nxml.txt.nlp	23258994	SENT273	15	15	2	2	carrageenan	TRPV4	PA448814	59341	0.906
NULL	Br_J_Cancer_2013_May_28_108(10)_2063-2069.nxml.txt.nlp	23591198	SENT123	17	17	4	4	sunitinib	IL-6	PA162372840	3569	0.906
NULL	Oncol_Lett_2014_Oct_22_8(4)_1603-1607.nxml.txt.nlp	25202376	SENT85	21	21	38	38	cisplatin	ERCC1	PA449014	2067	0.906
NULL	Oncol_Rep_2014_Jul_15_32(1)_45-49.nxml.txt.nlp	24841138	SENT94	21	21	9	9	pp2	MMP2		4313	0.906
NULL	Oncol_Rep_2014_Aug_12_32(2)_469-474.nxml.txt.nlp	24926795	SENT33	18	18	3	3	carboplatin	ATP7B	PA448803	540	0.906
NULL	Anal_Bioanal_Chem_2009_Oct_30_395(4)_893-905.nxml.txt.nlp	19484227	SENT242	34	34	19	19	amoxicillin	OTC	PA448406	5009	0.906
NULL	Support_Care_Cancer_2009_Sep_10_17(9)_1177-1185.nxml.txt.nlp	19205755	SENT31	0	0	19	19	ondansetron	CYP2D6	PA450705	1565	0.906
NULL	Scientifica_(Cairo)_2012_Sep_11_2012_927352.nxml.txt.nlp	24278757	SENT345	31	31	19	19	atorvastatin	PCSK9	PA448500	255738	0.906
NULL	Leukemia_2014_Aug_4_28(8)_1573-1585.nxml.txt.nlp	24496300	SENT71	8	8	19	19	levofloxacin	CYP1A2	PA450214	1544	0.906
NULL	Oncogene_2010_Sep_16_29(37)_5193-5203.nxml.txt.nlp	20581867	SENT21	6	6	12	12	trastuzumab	p85	PA451743	5296;5295;54776;23368	0.906
NULL	J_Korean_Med_Sci_2006_Oct_31_21(5)_904-910.nxml.txt.nlp	17043427	SENT54	13	13	0	0	4-methylumbelliferone	NAG	PA154081778	51594;4669	0.906
NULL	Br_J_Cancer_2013_Feb_19_108(3)_512-518.nxml.txt.nlp	23340449	SENT25	23	23	4	4	spermine	ODC	PA164781199	4953;89874	0.906
NULL	Mol_Biol_Cell_2012_Oct_1_23(19)_3882-3898.nxml.txt.nlp	22875989	SENT374	7	7	11	11	metformin	PI3K	PA450395	5290	0.906
NULL	AIDS_Res_Ther_2014_Oct_2_11(1)_32.nxml.txt.nlp	NULL	SENT38	38	38	4	4	nevirapine	CD4	PA450616	920	0.906
NULL	Environ_Health_Perspect_2006_Sep_23_114(9)_1401-1406.nxml.txt.nlp	16966095	SENT24	23	23	39	39	arsenite	p53	PA452638	7157	0.906
NULL	J_Inflamm_(Lond)_2005_Oct_31_2_14.nxml.txt.nlp	16259633	SENT310	0	0	17	17	staurosporine	PKG	PA165109623	5592	0.906
NULL	J_Biomed_Sci_2014_Feb_3_21(1)_10.nxml.txt.nlp	24490900	SENT254	9	9	23	23	alendronate	M-CSF	PA448082	1435	0.906
NULL	Int_J_Biol_Sci_2015_Jan_1_11(1)_48-58.nxml.txt.nlp	25552929	SENT224	14	14	5	5	paclitaxel	TSP-1	PA450761	7057	0.906
NULL	Mol_Cancer_2009_Nov_10_8_99.nxml.txt.nlp	19903356	SENT5	36	36	1	1	imatinib	IGFBP3	PA10804	3486	0.906
NULL	Int_J_Biol_Sci_2012_Jan_20_8(2)_265-271.nxml.txt.nlp	22298954	SENT48	31	31	48	48	l-glutamine	CO2	PA10090	4513	0.906
NULL	Arthritis_Rheum_2010_Dec_62(12)_3666-3676.nxml.txt.nlp	20722027	SENT190	7	7	4	4	sr144528	CB2		1269	0.906
NULL	Clin_Med_Insights_Case_Rep_2012_Jul_16_5_115-118.nxml.txt.nlp	22855635	SENT71	16	16	9	9	cabergoline	A-2	PA448708	27239	0.906
NULL	Oncotarget_2012_Oct_20_3(10)_1236-1245.nxml.txt.nlp	23100449	SENT54	13	13	8	8	doxorubicin	NGAL	PA449412	3934	0.906
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT129	34	34	9	9	trastuzumab	STAT3	PA451743	6774	0.906
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT106	10	10	29	29	curcumin	IL-8	PA151958596	3576	0.906
NULL	J_Hematop_2009_Feb_28_2(2)_113-119.nxml.txt.nlp	19669197	SENT179	3	3	14	14	bortezomib	Bcl-2	PA10252	596	0.906
NULL	Iran_J_Pharm_Res_2014_Winter_13(1)_95-101.nxml.txt.nlp	24734060	SENT33	18	18	28	28	ethanol	mol	PA448073	90527	0.906
NULL	Oncotarget_2011_Mar_23_2(3)_165-177.nxml.txt.nlp	21444946	SENT152	21	21	36	36	erlotinib	EGFR	PA134687924	1956	0.906
NULL	Hum_Genomics_2009_Jan_1_3(2)_128-142.nxml.txt.nlp	19164090	SENT174	39	39	29	29	carboplatin	CD44	PA448803	960	0.906
NULL	Cancer_Immunol_Immunother_2012_Oct_8_61(10)_1713-1720.nxml.txt.nlp	22399057	SENT56	22	22	5	5	plerixafor	CXCL12	PA165958410	6387	0.906
NULL	Eur_J_Clin_Pharmacol_2012_Sep_15_68(9)_1267-1274.nxml.txt.nlp	22418828	SENT30	19	19	5	5	omeprazole	CYP2C19	PA450704	1557	0.906
NULL	Arthritis_Res_Ther_2009_Nov_4_11(6)_R165.nxml.txt.nlp	19889203	SENT356	2	2	17	17	curcumin	MMP3	PA151958596	4314	0.906
NULL	BMJ_2009_Feb_25_338_b438.nxml.txt.nlp	19244302	SENT47	16	16	10	10	anastrozole	aromatase	PA448432	1588	0.906
NULL	Arch_Drug_Inf_2009_Mar_2(1)_8-16.nxml.txt.nlp	19381336	SENT6	33	33	22	22	rifampin	CYP3A4	PA451250	1576	0.906
NULL	Oncotarget_2014_Feb_25_5(5)_1304-1314.nxml.txt.nlp	24675421	SENT66	35	35	6	6	cisplatin	RIP1	PA449014	10928;7386	0.906
NULL	Drug_Des_Devel_Ther_2014_Oct_31_8_2121-2128.nxml.txt.nlp	25382970	SENT80	5	5	15	15	curcumin	TTR	PA151958596	7276	0.906
NULL	Br_J_Cancer_2013_Oct_15_109(8)_2155-2166.nxml.txt.nlp	24045666	SENT258	17	17	14	14	cetuximab	IFN	PA10040	3439	0.906
NULL	Anat_Cell_Biol_2013_Jun_30_46(2)_113-121.nxml.txt.nlp	23869258	SENT45	16	16	28	28	l-glutamine	CO2	PA10090	4513	0.906
NULL	Int_J_Nanomedicine_2012_Nov_29_7_5915-5927.nxml.txt.nlp	23226697	SENT67	27	27	13	13	heparin	FGF1	PA449855	2246	0.906
NULL	Endocrine_2012_Dec_14_42(3)_622-636.nxml.txt.nlp	22695986	SENT201	4	4	23	23	forskolin	PTH	PA146096022	5741	0.906
NULL	Target_Oncol_2013_Mar_30_8(1)_27-33.nxml.txt.nlp	23361373	SENT67	22	22	15	15	gefitinib	EGFR	PA131301952	1956	0.906
NULL	Arthritis_Res_Ther_2010_Jun_2_12(3)_R107.nxml.txt.nlp	20525198	SENT111	5	5	7	7	rolipram	TNF	PA153906323	7124	0.906
NULL	Br_J_Cancer_2010_Jun_8_102(12)_1707-1716.nxml.txt.nlp	20461078	SENT195	24	24	11	11	bortezomib	PARP	PA10252	142	0.906
NULL	Psychiatr_Genet_2013_Aug_28_23(4)_153-162.nxml.txt.nlp	23811784	SENT217	8	8	32	32	clozapine	ARRB2	PA449061	409	0.906
NULL	Gastric_Cancer_2013_Jul_12_16(3)_345-354.nxml.txt.nlp	22968820	SENT168	31	31	15	15	oxaliplatin	FANCJ	PA131285527	83990	0.906
NULL	Open_Cardiovasc_Med_J_2008_Jul_30_2_60-69.nxml.txt.nlp	18949101	SENT16	18	18	9	9	paclitaxel	DES	PA450761	1674	0.906
NULL	Open_AIDS_J_2010_May_14_4_116-122.nxml.txt.nlp	20657827	SENT12	12	12	0	0	methamphetamine	Men	PA450403	8178	0.906
NULL	Drug_Target_Insights_2013_Aug_19_7_27-34.nxml.txt.nlp	24023511	SENT83	13	13	9	9	cyclosporine	P-gp	PA449167	5243	0.906
NULL	Crit_Care_2010_Mar_18_14(2)_R41.nxml.txt.nlp	20298591	SENT86	15	15	0	0	enoxaparin	SAPS	PA449463	8935	0.906
NULL	Oncol_Rep_2013_Oct_22_30(4)_1535-1541.nxml.txt.nlp	23877481	SENT149	19	19	6	6	plerixafor	VEGFR	PA165958410	3791	0.906
NULL	Hum_Genomics_2009_Dec_1_4(2)_91-106.nxml.txt.nlp	20038497	SENT66	0	0	16	16	donepezil	CYP3A4	PA449394	1576	0.906
NULL	Oncologist_2010_Mar_9_15(3)_236-245.nxml.txt.nlp	20215359	SENT10	14	14	30	30	sunitinib	VEGFR	PA162372840	3791	0.906
NULL	Breast_Cancer_Res_Treat_2009_Jul_22_116(2)_371-378.nxml.txt.nlp	18941892	SENT24	34	34	16	16	tamoxifen	aromatase	PA451581	1588	0.906
NULL	Ann_Med_Health_Sci_Res_2012_Jul-Dec_2(2)_191-198.nxml.txt.nlp	23439914	SENT165	18	18	1	1	tamoxifen	P-gp	PA451581	5243	0.906
NULL	J_Cell_Mol_Med_2013_Dec_6_17(12)_1588-1597.nxml.txt.nlp	24199964	SENT35	24	24	33	33	dobutamine	APT	PA449381	653639	0.906
NULL	Int_J_Biol_Sci_2011_Sep_8_7(8)_1077-1092.nxml.txt.nlp	21927577	SENT173	3	3	6	6	irbesartan	AT1	PA450084	9197;185	0.906
NULL	Clin_Interv_Aging_2008_Mar_3(1)_55-70.nxml.txt.nlp	18488879	SENT194	2	2	31	31	bucindolol	BEST	PA165945764	7439	0.906
NULL	Front_Aging_Neurosci_2010_Mar_8_2_5.nxml.txt.nlp	20552045	SENT221	25	25	9	9	exenatide	GLP-1	PA164749238	100125288	0.906
NULL	Sci_Rep_2014_Dec_4_4_7310.nxml.txt.nlp	25472472	SENT207	8	8	2	2	decitabine	CD34	PA164749631	947	0.906
NULL	Cell_Death_Dis_2012_Jun_7_3(6)_e319.nxml.txt.nlp	22673193	SENT48	25	25	4	4	cisplatin	Mcl-1	PA449014	4170	0.906
NULL	Indian_J_Endocrinol_Metab_2013_Nov-Dec_17(6)_996-1004.nxml.txt.nlp	24381874	SENT115	25	25	19	19	bromocriptine	PRL	PA448671	5617	0.906
NULL	Mol_Cancer_2010_Oct_13_9_270.nxml.txt.nlp	20942909	SENT39	27	27	13	13	temozolomide	FADD	PA451609	8772	0.906
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT102	30	30	26	26	isoflurane	HIF-1	PA450106	29072	0.906
NULL	AIDS_Res_Ther_2009_Apr_9_6_3.nxml.txt.nlp	19358725	SENT57	27	27	3	3	fosamprenavir	ATV	PA10084	4683	0.906
NULL	Oncotarget_2014_Dec_4_5(22)_11365-11380.nxml.txt.nlp	25426548	SENT48	16	16	10	10	nutlin-3	p53		7157	0.906
NULL	Breast_Cancer_(Auckl)_2009_Aug_17_3_47-60.nxml.txt.nlp	21556249	SENT48	27	27	24	24	tamoxifen	AF-1	PA451581	3460;5710	0.906
NULL	J_Cancer_Epidemiol_2012_Oct_24_2012_294730.nxml.txt.nlp	23150730	SENT244	21	21	7	7	panitumumab	KRAS	PA162373091	3845	0.906
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1986-2011.nxml.txt.nlp	25268165	SENT68	31	31	9	9	resveratrol	STAT3		6774	0.906
NULL	Oncologist_2012_Nov_17(Suppl_3)_1-6.nxml.txt.nlp	23143667	SENT25	3	3	13	13	cabozantinib	VEGFR	PA165906891	3791	0.906
NULL	Front_Neurosci_2011_Jan_14_4_207.nxml.txt.nlp	21258618	SENT27	18	18	6	6	ethanol	CRF1	PA448073	1394	0.906
NULL	Behav_Brain_Funct_2010_Oct_25_6_64.nxml.txt.nlp	20974001	SENT97	4	4	29	29	l-arginine	ANG	PA448478	283	0.906
NULL	Cancers_(Basel)_2010_Dec_30_3(1)_106-125.nxml.txt.nlp	24212609	SENT26	12	12	2	2	gemcitabine	DCK	PA449748	1633	0.906
NULL	Nucleic_Acids_Res_2011_Dec_31_39(22)_9536-9548.nxml.txt.nlp	21880590	SENT173	13	13	3	3	etoposide	BRCA1	PA449552	672	0.906
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT115	7	7	22	22	doxorubicin	B7-H1	PA449412	29126	0.906
NULL	Pain_Res_Treat_2013_Sep_18_2013_943014.nxml.txt.nlp	24167729	SENT99	30	30	9	9	tramadol	CYP2D6	PA451735	1565	0.906
NULL	J_Hematol_Oncol_2009_Aug_12_2_36.nxml.txt.nlp	19674465	SENT74	4	4	18	18	lenalidomide	IFN	PA162363968	3439	0.906
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_11_2014_274786.nxml.txt.nlp	25505920	SENT164	35	35	9	9	oxaliplatin	ERCC1	PA131285527	2067	0.906
NULL	Front_Neurol_2014_Apr_22_5_57.nxml.txt.nlp	24795694	SENT77	21	21	12	12	fluoxetine	FLAME	PA449673	8837	0.906
NULL	J_Oncol_2012_Feb_6_2012_737981.nxml.txt.nlp	22481932	SENT101	41	41	31	31	paclitaxel	STAT3	PA450761	6774	0.906
NULL	Indian_J_Pharmacol_2014_Jan-Feb_46(1)_3-12.nxml.txt.nlp	24550577	SENT221	23	23	5	5	modafinil	CYP2C9	PA450530	1559	0.906
NULL	AMB_Express_2011_Jul_13_1_16.nxml.txt.nlp	21906371	SENT94	12	12	27	27	fructose	PHB	PA449716	5245	0.906
NULL	Mol_Cancer_2014_Jul_5_13_165.nxml.txt.nlp	24996221	SENT196	14	14	2	2	docetaxel	HMGB1	PA449383	3146	0.906
NULL	Target_Oncol_2013_Jun_27_8(2)_127-136.nxml.txt.nlp	23625191	SENT113	11	11	23	23	panitumumab	KRAS	PA162373091	3845	0.906
NULL	Brain_Res_2012_Jun_12_1459(3)_35-42.nxml.txt.nlp	22560095	SENT383	1	1	9	9	ethanol	p38	PA448073	10598;1432;7965	0.906
NULL	Breast_Cancer_Res_2012_May_2_14(3)_R70.nxml.txt.nlp	22551440	SENT124	25	25	8	8	docetaxel	p53	PA449383	7157	0.906
NULL	Cancer_Metastasis_Rev_2010_Sep_24_29(3)_465-482.nxml.txt.nlp	20730632	SENT260	4	4	14	14	genistein	MEK4	PA165109660	6416	0.906
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT383	24	24	9	9	pp2	TFF3		7033	0.905
NULL	Indian_J_Med_Paediatr_Oncol_2014_Jan-Mar_35(1)_109-110.nxml.txt.nlp	25006299	SENT8	4	4	1	1	gefitinib	EGFR	PA131301952	1956	0.905
NULL	Cancer_Cell_Int_2014_Jun_11_14_49.nxml.txt.nlp	24991192	SENT25	5	5	9	9	berberine	AMPK	PA165860812	5563	0.905
NULL	Pediatr_Nephrol_2009_Jul_20_24(7)_1355-1361.nxml.txt.nlp	19301038	SENT0	24	24	19	19	sevelamer	PTH	PA164781197	5741	0.905
NULL	Ann_Oncol_2011_Aug_27_22(8)_1736-1747.nxml.txt.nlp	21709140	SENT48	12	12	25	25	exemestane	aromatase	PA449563	1588	0.905
NULL	Nat_Med_2013_Nov_27_19(11)_10_1038_nm_3352.nxml.txt.nlp	24162815	SENT184	30	30	27	27	gefitinib	EGFR	PA131301952	1956	0.905
NULL	Diabetes_Care_2008_Nov_31(11)_2169-2176.nxml.txt.nlp	18678611	SENT91	4	4	10	10	rimonabant	adiponectin	PA152407999	9370	0.905
NULL	Br_J_Cancer_2011_Jun_28_105(1)_118-123.nxml.txt.nlp	21654685	SENT154	10	10	12	12	dasatinib	S100beta	PA162372878	6285	0.905
NULL	J_Cell_Biol_2002_Sep_16_158(6)_1051-1066.nxml.txt.nlp	12235123	SENT39	9	9	14	14	staurosporine	DEDD	PA165109623	9191	0.905
NULL	Indian_J_Pharmacol_2014_Sep-Oct_46(5)_547-548.nxml.txt.nlp	25298587	SENT62	19	19	17	17	clarithromycin	CYP3A	PA449028	1574	0.905
NULL	J_Biomed_Biotechnol_2010_Jun_8_2010_757301.nxml.txt.nlp	20625414	SENT74	23	23	32	32	aprotinin	B12	PA448472	7126;4709	0.905
NULL	Nat_Commun_2013_Aug_14_4_2312.nxml.txt.nlp	23942241	SENT233	4	4	19	19	heparin	FGF2	PA449855	2247;2258	0.905
NULL	Front_Neuroenergetics_2014_Apr_3_6_1.nxml.txt.nlp	24765075	SENT496	4	4	12	12	isoflurane	gamma	PA450106	9913	0.905
NULL	Case_Rep_Genet_2014_Jan_22_2014_413743.nxml.txt.nlp	24627811	SENT18	8	8	0	0	warfarin	CYP2C9	PA451906	1559	0.905
NULL	Aging_(Albany_NY)_2010_Dec_20_2(12)_959-968.nxml.txt.nlp	21191146	SENT129	4	4	17	17	cisplatin	LKB1	PA449014	6794	0.905
NULL	Oncologist_2010_Apr_29_15(4)_390-404.nxml.txt.nlp	20350999	SENT133	46	46	29	29	panitumumab	KRAS	PA162373091	3845	0.905
NULL	Open_Biol_2013_Nov_3(11)_130130.nxml.txt.nlp	24258275	SENT306	22	22	8	8	imatinib	p53	PA10804	7157	0.905
NULL	J_Med_Case_Rep_2013_Mar_12_7_65.nxml.txt.nlp	23497724	SENT64	18	18	3	3	vasopressin	ACLS	PA451858	46;2737	0.905
NULL	Oncol_Lett_2013_Jun_29_5(6)_1943-1947.nxml.txt.nlp	23833672	SENT108	2	2	23	23	celecoxib	AKT	PA448871	207	0.905
NULL	J_Histochem_Cytochem_2013_Mar_61(3)_185-198.nxml.txt.nlp	23204112	SENT509	8	8	5	5	fasudil	Rho	PA165946121	29984	0.905
NULL	Arthritis_Res_Ther_2012_May_1_14(3)_R99.nxml.txt.nlp	22546542	SENT72	14	14	1	1	infliximab	CD4	PA452639	920	0.905
NULL	Acta_Pharmacol_Sin_2013_Feb_31_34(2)_231-238.nxml.txt.nlp	23274414	SENT191	21	21	31	31	amiloride	Bcl-2	PA448368	596	0.905
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Nov_13_64(Pt_12)_o2320.nxml.txt.nlp	21581296	SENT59	20	20	7	7	ethanol	mol	PA448073	90527	0.905
NULL	Nucleic_Acids_Res_2006_Jul_4_34(11)_3299-3308.nxml.txt.nlp	16820530	SENT523	12	12	6	6	ethanol	APOBEC-1	PA448073	339	0.905
NULL	Clin_Mol_Allergy_2006_Mar_28_4_5.nxml.txt.nlp	16569217	SENT43	33	33	44	44	colistin	CO2	PA164760862	4513	0.905
NULL	Anesthesiol_Res_Pract_2014_Feb_11_2014_848051.nxml.txt.nlp	24672542	SENT114	3	3	29	29	rocuronium	NMB	PA164754992	10457;4828	0.905
NULL	Br_J_Cancer_2012_Nov_20_107(11)_1853-1863.nxml.txt.nlp	23169338	SENT148	32	32	27	27	cisplatin	BRCA1	PA449014	672	0.905
NULL	Br_J_Cancer_2003_Mar_10_88(5)_788-795.nxml.txt.nlp	12618891	SENT164	20	20	5	5	bosentan	FasL	PA10034	356	0.905
NULL	J_Gen_Physiol_2008_Nov_132(5)_521-535.nxml.txt.nlp	18852303	SENT139	3	3	16	16	trypsin	CAP2	PA451806	5271;10486	0.905
NULL	Arthritis_Res_Ther_2010_Mar_18_12(2)_R44.nxml.txt.nlp	20298547	SENT63	13	13	33	33	ketamine	San	PA450144	80218	0.905
NULL	Br_J_Pharmacol_2014_Apr_28_171(8)_1798-1817.nxml.txt.nlp	24116962	SENT227	16	16	36	36	resveratrol	YY1		7528	0.905
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Sep_9_65(Pt_10)_o2390.nxml.txt.nlp	21577854	SENT78	33	33	25	25	ethanol	mol	PA448073	90527	0.905
NULL	Braz_J_Med_Biol_Res_2012_Sep_21_45(12)_1240-1243.nxml.txt.nlp	22983178	SENT101	27	27	8	8	diclofenac	CB2	PA449293	1269	0.905
NULL	Diabetologia_2009_Oct_14_52(10)_2046-2055.nxml.txt.nlp	19688338	SENT199	36	36	11	11	metformin	GLP-1	PA450395	100125288	0.905
NULL	Virol_J_2011_Nov_28_8_523.nxml.txt.nlp	22122911	SENT176	16	16	13	13	heparin	RANTES	PA449855	6352	0.905
NULL	Mol_Vis_2012_Sep_6_18_2323-2337.nxml.txt.nlp	22977300	SENT182	15	15	8	8	fluorescein	P90	PA164746009	821	0.905
NULL	Cancers_(Basel)_2013_Nov_7_5(4)_1456-1468.nxml.txt.nlp	24213559	SENT693	0	0	9	9	cabozantinib	VEGFR2	PA165906891	3791	0.905
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Jul_19_70(Pt_8)_77-79.nxml.txt.nlp	25249859	SENT14	29	29	1	1	nitrile	mol	PA450636	90527	0.905
NULL	Diabetes_Care_2012_Jan_9_35(1)_4-11.nxml.txt.nlp	22040840	SENT146	23	23	7	7	liraglutide	GLP-1	PA165958364	100125288	0.905
NULL	Cancers_(Basel)_2011_Aug_15_3(3)_3331-3352.nxml.txt.nlp	24212957	SENT242	11	11	32	32	bevacizumab	CD144	PA130232992	1003	0.905
NULL	Cancers_(Basel)_2013_Aug_22_5(3)_1103-1119.nxml.txt.nlp	24202336	SENT91	24	24	32	32	temozolomide	PTEN	PA451609	5728	0.905
NULL	Oncol_Rep_2013_Oct_22_30(4)_1535-1541.nxml.txt.nlp	23877481	SENT41	42	42	23	23	erlotinib	EGF	PA134687924	1950	0.905
NULL	Clinics_(Sao_Paulo)_2014_Jan_69(1)_68-74.nxml.txt.nlp	24473562	SENT93	2	2	7	7	nutlin-3	SOCS-1		8651	0.905
NULL	Mol_Cancer_2010_Oct_13_9_270.nxml.txt.nlp	20942909	SENT39	27	27	11	11	temozolomide	FasL	PA451609	356	0.905
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT71	34	34	24	24	pp2	PP2		4888	0.905
NULL	J_Cardiovasc_Dis_Res_2012_Jan-Mar_3(1)_5-11.nxml.txt.nlp	22346138	SENT143	6	6	19	19	repaglinide	IL-6	PA451234	3569	0.905
NULL	J_Thromb_Thrombolysis_2013_Jul_17_36(1)_31-41.nxml.txt.nlp	23073747	SENT194	22	22	1	1	abciximab	AIDA	PA448006	64853	0.905
NULL	Front_Integr_Neurosci_2011_Oct_14_5_63.nxml.txt.nlp	22016725	SENT338	5	5	37	37	estradiol	NCM	PA449503	57703	0.905
NULL	J_Cell_Mol_Med_2013_Dec_6_17(12)_1588-1597.nxml.txt.nlp	24199964	SENT61	32	32	1	1	dobutamine	APT	PA449381	653639	0.905
NULL	Mol_Cancer_2010_May_19_9_112.nxml.txt.nlp	20482842	SENT270	0	0	27	27	imatinib	p65	PA10804	5970	0.905
NULL	Turk_J_Haematol_2012_Mar_5_29(1)_1-9.nxml.txt.nlp	24744617	SENT52	35	35	2	2	apomorphine	NK-1	PA164781163	27087	0.905
NULL	Br_J_Cancer_2010_Mar_16_102(6)_1061-1067.nxml.txt.nlp	20160719	SENT127	11	11	17	17	resveratrol	SIRT1		23411	0.905
NULL	Gut_2013_Mar_22_62(3)_358-367.nxml.txt.nlp	22442164	SENT123	6	6	19	19	genistein	MARCKS	PA165109660	4082	0.905
NULL	Exp_Ther_Med_2012_Oct_19_4(4)_589-593.nxml.txt.nlp	23170110	SENT31	0	0	8	8	tegafur	DPD	PA452620	1806	0.905
NULL	J_Gen_Physiol_2009_Oct_134(4)_309-322.nxml.txt.nlp	19786584	SENT13	2	2	13	13	glibenclamide	ClC-1	PA449782	1180	0.905
NULL	Ann_Rheum_Dis_2015_Jan_23_74(1)_252-259.nxml.txt.nlp	24152419	SENT40	35	35	11	11	ethanol	TRPV1	PA448073	7442	0.905
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT30	5	5	14	14	atorvastatin	KRAS	PA448500	3845	0.905
NULL	Infection_2013_Sep_14_41(Suppl_2)_91-115.nxml.txt.nlp	24037688	SENT142	19	19	28	28	primaquine	G6PD	PA451103	2539	0.905
NULL	Clin_Med_Insights_Oncol_2012_Feb_28_6_125-135.nxml.txt.nlp	22408376	SENT101	18	18	5	5	panitumumab	BRAF	PA162373091	673	0.905
NULL	Eur_J_Clin_Pharmacol_2014_Oct_8_70(1)_37-45.nxml.txt.nlp	24100471	SENT197	11	11	2	2	pioglitazone	CYP3A4	PA450970	1576	0.905
NULL	Int_J_Mol_Sci_2013_Apr_9_14(4)_7716-7741.nxml.txt.nlp	23571495	SENT147	29	29	23	23	lipase	APOA1	PA450239	335	0.905
NULL	Oxid_Med_Cell_Longev_2013_Nov_28_2013_568093.nxml.txt.nlp	24379901	SENT52	8	8	10	10	resveratrol	SIRT1		23411	0.905
NULL	Blood_Cancer_J_2012_Oct_19_2(10)_e95.nxml.txt.nlp	23085780	SENT174	21	21	17	17	imatinib	ALL	PA10804	613	0.905
NULL	Clin_Drug_Investig_2014_Nov_9_34(2)_107-115.nxml.txt.nlp	24214232	SENT24	30	30	13	13	cinacalcet	IMPACT	PA164776671	55364	0.905
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Jul_9_3(7)_e124.nxml.txt.nlp	25006781	SENT203	9	9	3	3	atorvastatin	SLCO1B1	PA448500	10599	0.905
NULL	Breast_Cancer_Res_2010_Jun_22_12(3)_R39.nxml.txt.nlp	20569502	SENT236	38	38	5	5	tamoxifen	TFF3	PA451581	7033	0.905
NULL	J_Cardiovasc_Dis_Res_2012_Oct-Dec_3(4)_319-322.nxml.txt.nlp	23233778	SENT41	8	8	3	3	erythromycin	CYP3A4	PA449493	1576	0.905
NULL	Core_Evid_2010_Jul_27_5_11-22.nxml.txt.nlp	20694136	SENT23	0	0	31	31	ustekinumab	IL-23	PA166048654	51561	0.905
NULL	Cancer_Gene_Ther_2011_Mar_5_18(3)_176-188.nxml.txt.nlp	21052098	SENT7	20	20	11	11	cisplatin	ING4	PA449014	51147	0.905
NULL	Breast_Cancer_(Auckl)_2014_May_12_8_81-88.nxml.txt.nlp	24855372	SENT16	30	30	27	27	trastuzumab	HER2	PA451743	2064	0.905
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1420-1426.nxml.txt.nlp	24056704	SENT144	0	0	8	8	carbamazepine	CYP3A	PA448785	1574	0.905
NULL	Front_Genet_2012_Nov_12_3_235.nxml.txt.nlp	23162568	SENT168	12	12	5	5	methamphetamine	CYP2D6	PA450403	1565	0.905
NULL	Mol_Cancer_2010_Dec_20_9_317.nxml.txt.nlp	21172025	SENT24	14	14	5	5	tamoxifen	HER2	PA451581	2064	0.905
NULL	Adolesc_Health_Med_Ther_2012_Jun_20_3_85-93.nxml.txt.nlp	24600289	SENT28	0	0	13	13	infliximab	TNF	PA452639	7124	0.905
NULL	Oxid_Med_Cell_Longev_2013_Nov_28_2013_568093.nxml.txt.nlp	24379901	SENT64	7	7	35	35	resveratrol	STZ		6484	0.905
NULL	Front_Mol_Neurosci_2012_Nov_12_5_99.nxml.txt.nlp	23162427	SENT248	5	5	24	24	cocaine	BDNF	PA449072	627	0.905
NULL	Cancer_Metab_2014_Nov_3_2(1)_20.nxml.txt.nlp	NULL	SENT280	27	27	6	6	erlotinib	PDK4	PA134687924	5166	0.905
NULL	Int_J_Biol_Sci_2013_Mar_7_9(3)_279-288.nxml.txt.nlp	23493630	SENT127	23	23	15	15	tocilizumab	IL-21	PA165292659	59067;50616;27189	0.905
NULL	Mar_Drugs_2014_Jun_27_12(7)_3818-3837.nxml.txt.nlp	24979269	SENT222	6	6	29	29	trypsin	CO2	PA451806	4513	0.905
NULL	J_Korean_Med_Sci_2007_Apr_30_22(2)_242-247.nxml.txt.nlp	17449931	SENT54	32	32	7	7	neomycin	GM-CSF	PA450608	1437	0.905
NULL	Arch_Plast_Surg_2012_Sep_12_39(5)_540-545.nxml.txt.nlp	23094252	SENT147	25	25	20	20	remifentanil	TCI	PA451232	6947	0.905
NULL	Ann_Oncol_2011_Aug_27_22(8)_1736-1747.nxml.txt.nlp	21709140	SENT313	7	7	13	13	olaparib	BRCA2		675	0.905
NULL	Br_J_Cancer_2013_Dec_10_109(12)_3067-3072.nxml.txt.nlp	24263065	SENT6	27	27	8	8	irinotecan	BRAF	PA450085	673	0.905
NULL	Arthritis_Res_Ther_2004_Sep_13_6(Suppl_3)_16.nxml.txt.nlp	NULL	SENT10	10	10	2	2	capsaicin	CCL3	PA448776	6348	0.905
NULL	Cancer_Cell_Int_2009_Jan_8_9_3.nxml.txt.nlp	19128511	SENT87	10	10	2	2	oxaliplatin	PI3K	PA131285527	5290	0.905
NULL	Croat_Med_J_2012_Aug_53(4)_314-320.nxml.txt.nlp	22911523	SENT113	14	14	29	29	pertuzumab	HER2		2064	0.905
NULL	Pharmaceuticals_(Basel)_2012_Jun_28_5(7)_674-689.nxml.txt.nlp	24281706	SENT144	1	1	7	7	pertuzumab	EEA1		8411	0.905
NULL	J_Biomed_Sci_2013_Dec_20_20(1)_99.nxml.txt.nlp	24358977	SENT179	26	26	14	14	cisplatin	PTEN	PA449014	5728	0.905
NULL	Br_J_Cancer_2011_May_10_104(10)_1628-1640.nxml.txt.nlp	21505453	SENT45	8	8	26	26	suramin	San	PA10292	80218	0.905
NULL	Mol_Cancer_2014_Jan_13_13_7.nxml.txt.nlp	24418169	SENT40	4	4	12	12	sorafenib	STAT3	PA7000	6774	0.905
NULL	Oncol_Rep_2014_Feb_13_31(2)_581-588.nxml.txt.nlp	24337105	SENT174	13	13	7	7	capsaicin	SERCA2	PA448776	488	0.905
NULL	Vet_Res_Forum_2013_Winter_4(1)_19-24.nxml.txt.nlp	25593681	SENT89	40	40	27	27	diclofenac	B12	PA449293	7126;4709	0.905
NULL	Case_Rep_Med_2011_Mar_2_2011_767610.nxml.txt.nlp	21423546	SENT102	9	9	25	25	thyroglobulin	beta-catenin	PA164754910	1499	0.905
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_7-17.nxml.txt.nlp	17912633	SENT386	28	28	33	33	letrozole	aromatase	PA450196	1588	0.905
NULL	Oncol_Lett_2014_Sep_19_8(3)_1269-1274.nxml.txt.nlp	25120704	SENT4	27	27	5	5	cisplatin	Met	PA449014	79811	0.905
NULL	J_Biol_Chem_2009_Apr_3_284(14)_9558-9565.nxml.txt.nlp	19202191	SENT152	10	10	34	34	camptothecin	CtIP	PA153590860	5932	0.905
NULL	Mol_Syst_Biol_2011_Apr_26_7_486.nxml.txt.nlp	21525872	SENT133	35	35	14	14	imatinib	NDN	PA10804	4692	0.905
NULL	Acta_Pharmacol_Sin_2010_Nov_18_31(11)_1447-1453.nxml.txt.nlp	20953204	SENT125	9	9	2	2	rimonabant	CB1	PA152407999	1268	0.905
NULL	Cardiovasc_Diabetol_2010_Oct_18_9_64.nxml.txt.nlp	20955583	SENT134	15	15	27	27	rosiglitazone	PPARgamma	PA451283	5468	0.905
NULL	Front_Neurosci_2010_Nov_19_4_192.nxml.txt.nlp	21151361	SENT227	22	22	36	36	methamphetamine	spatial	PA450403	219793	0.905
NULL	Oncotarget_2013_Oct_27_4(11)_2080-2095.nxml.txt.nlp	24231268	SENT216	40	40	35	35	nutlin-3	MDM2		4193	0.905
NULL	Indian_J_Pharmacol_2008_Oct_40(Suppl_2)_S211-S221.nxml.txt.nlp	21593975	SENT116	0	0	9	9	pioglitazone	CA1	PA450970	759	0.905
NULL	Oncogene_2014_Jun_26_33(26)_3422-3431.nxml.txt.nlp	23912457	SENT175	42	42	36	36	trastuzumab	HER2	PA451743	2064	0.905
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Oct_31_65(Pt_11)_o2934.nxml.txt.nlp	21578510	SENT48	20	20	14	14	ethanol	mol	PA448073	90527	0.905
NULL	Br_J_Cancer_2009_Oct_6_101(7)_1155-1161.nxml.txt.nlp	19738614	SENT153	14	14	34	34	gemcitabine	MUC4	PA449748	4585	0.905
NULL	Mol_Cancer_2007_Sep_18_6_56.nxml.txt.nlp	17877814	SENT36	17	17	32	32	erlotinib	EGFR	PA134687924	1956	0.905
NULL	J_Headache_Pain_2014_Feb_8_15(1)_7.nxml.txt.nlp	24506953	SENT165	23	23	8	8	capsaicin	TRPV1	PA448776	7442	0.905
NULL	Health_Econ_Rev_2013_Aug_6_3_18.nxml.txt.nlp	23919494	SENT90	39	39	4	4	palivizumab	IMPACT	PA164748781	55364	0.905
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT108	28	28	23	23	phenformin	p53	PA1000	7157	0.905
NULL	Mol_Cancer_2010_Mar_2_9_46.nxml.txt.nlp	20196838	SENT306	16	16	7	7	irinotecan	PXR2	PA450085	51555	0.905
NULL	Chin_J_Cancer_2012_Jul_31(7)_319-326.nxml.txt.nlp	22257382	SENT86	4	4	10	10	cetuximab	EGFR	PA10040	1956	0.905
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT394	5	5	21	21	gw2016	AKT		207	0.905
NULL	Eur_J_Haematol_2008_Feb_80(2)_93-106.nxml.txt.nlp	18081719	SENT46	18	18	6	6	iron	GSTM1	PA450087	2944	0.905
NULL	Diabetes_2009_Jan_58(1)_243-249.nxml.txt.nlp	18840785	SENT178	34	34	43	43	glucose	GIP	PA449773	114897;2771;2695	0.905
NULL	J_Oncol_2012_Jul_30_2012_370272.nxml.txt.nlp	22899920	SENT76	20	20	3	3	rituximab	FDG	PA451261	23583	0.905
NULL	Breast_Cancer_Res_2006_May_31_8(3)_R25.nxml.txt.nlp	16737553	SENT162	27	27	18	18	tamoxifen	GRB7	PA451581	2886	0.905
NULL	Front_Chem_2013_Jul_12_1_10.nxml.txt.nlp	24790939	SENT128	28	28	33	33	hydroquinone	mol	PA449924	90527	0.905
NULL	Basic_Res_Cardiol_2012_Nov_26_107(6)_307.nxml.txt.nlp	23099820	SENT297	4	4	19	19	phenylephrine	ETB	PA450935	1910	0.905
NULL	Breast_Cancer_Res_2011_Sep_13_13(5)_R87.nxml.txt.nlp	21914172	SENT193	39	39	32	32	neratinib	HER2	PA165291472	2064	0.905
NULL	Clin_Ophthalmol_2008_Mar_2(1)_1-14.nxml.txt.nlp	19668384	SENT32	16	16	24	24	bevacizumab	San	PA130232992	80218	0.905
NULL	Eur_J_Med_Res_2013_Dec_13_18(1)_56.nxml.txt.nlp	24330823	SENT44	31	31	17	17	trypsin	PC-3	PA451806	692094	0.905
NULL	Mar_Drugs_2010_Oct_8_8(10)_2578-2596.nxml.txt.nlp	21116407	SENT66	16	16	33	33	creatine	ADP	PA164778930	23038	0.905
NULL	Blood_Cancer_J_2013_Jun_7_3(6)_e120.nxml.txt.nlp	23749045	SENT155	18	18	11	11	bortezomib	IGF1R	PA10252	3480	0.905
NULL	Bone_Marrow_Transplant_2011_Mar_24_46(3)_430-435.nxml.txt.nlp	20498647	SENT25	0	0	18	18	daclizumab	CD25	PA164764446	3669;3559	0.905
NULL	Diabetes_Metab_Syndr_Obes_2010_May_17_3_155-163.nxml.txt.nlp	21437085	SENT9	21	21	17	17	exenatide	GLP-1	PA164749238	100125288	0.905
NULL	Cerebrovasc_Dis_Extra_2013_Jun_11_3(1)_85-94.nxml.txt.nlp	23885261	SENT91	37	37	3	3	alteplase	OCSP	PA164776730	83882	0.905
NULL	Acta_Pharmacol_Sin_2013_Jan_23_34(1)_33-38.nxml.txt.nlp	22820909	SENT99	12	12	21	21	flurbiprofen	ASIC3	PA449683	9311	0.905
NULL	Oncotarget_2013_Nov_19_5(2)_309-325.nxml.txt.nlp	24525395	SENT207	6	6	32	32	curcumin	XIAP	PA151958596	331	0.905
NULL	J_Korean_Med_Sci_2010_Dec_24_25(12)_1792-1797.nxml.txt.nlp	21165296	SENT26	7	7	21	21	vasopressin	AVP	PA451858	114548;551	0.905
NULL	Arthritis_Res_Ther_2007_Oct_10_9(5)_R105.nxml.txt.nlp	17927818	SENT204	4	4	8	8	pp2	RhoA		387	0.905
NULL	Front_Oncol_2013_Apr_4_3_66.nxml.txt.nlp	23577324	SENT137	0	0	18	18	bevacizumab	VEGFR2	PA130232992	3791	0.905
NULL	Breast_Cancer_Res_2008_Jul_24_10(4)_211.nxml.txt.nlp	18671839	SENT137	6	6	22	22	flavopiridol	HER2	PA452627	2064	0.905
NULL	Acta_Pharmacol_Sin_2009_Nov_5_30(11)_1522-1528.nxml.txt.nlp	19890360	SENT70	16	16	4	4	fenoterol	IL-8	PA10079	3576	0.905
NULL	Mol_Cancer_2012_Aug_8_11_53.nxml.txt.nlp	22871047	SENT296	12	12	36	36	cisplatin	HIN-1	PA449014	92304	0.905
NULL	Cell_Cycle_2013_Sep_15_12(18)_3025-3036.nxml.txt.nlp	23974102	SENT5	11	11	18	18	methotrexate	CD4	PA450428	920	0.905
NULL	Asian_J_Androl_2014_Apr_25_Sep-Oct_16(5)_761-766.nxml.txt.nlp	24799635	SENT116	43	43	3	3	fructose	DM2	PA449716	28508	0.905
NULL	Int_J_Cell_Biol_2014_Jan_22_2014_709828.nxml.txt.nlp	24578708	SENT93	2	2	24	24	choline	DAG	PA448976	1605	0.905
NULL	Stroke_Res_Treat_2011_Nov_10_2011_212485.nxml.txt.nlp	22135769	SENT116	9	9	24	24	phenprocoumon	VKORC1	PA450921	79001	0.905
NULL	EMBO_Mol_Med_2012_Jun_13_4(6)_515-527.nxml.txt.nlp	22416035	SENT185	11	11	6	6	olaparib	NOXA		5366	0.905
NULL	Indian_J_Pharm_Sci_2014_Jan-Feb_76(1)_72-77.nxml.txt.nlp	24799741	SENT99	15	15	21	21	glimepiride	CYP2C9	PA449761	1559	0.905
NULL	Oncotarget_2010_May_7_1(1)_59-68.nxml.txt.nlp	20890394	SENT161	25	25	18	18	bortezomib	TRAF3	PA10252	7187	0.905
NULL	J_Cell_Biol_2008_Jul_28_182(2)_367-379.nxml.txt.nlp	18644892	SENT226	0	0	12	12	pp2	PP2		4888	0.905
NULL	J_Thromb_Thrombolysis_2012_Feb_20_33(2)_143-153.nxml.txt.nlp	22183178	SENT21	11	11	16	16	clopidogrel	P2Y12	PA449053	64805	0.905
NULL	Front_Endocrinol_(Lausanne)_2013_Oct_23_4_157.nxml.txt.nlp	24167502	SENT137	23	23	28	28	losartan	AT1	PA450268	9197;185	0.905
NULL	Br_J_Cancer_2012_Jan_3_106(1)_107-115.nxml.txt.nlp	22116303	SENT108	19	19	32	32	vorinostat	AKT	PA164748224	207	0.905
NULL	Indian_J_Endocrinol_Metab_2012_Mar-Apr_16(2)_324-325.nxml.txt.nlp	22470884	SENT11	40	40	29	29	exenatide	DPP4	PA164749238	1803	0.905
NULL	Indian_J_Dermatol_2011_Mar-Apr_56(2)_137-144.nxml.txt.nlp	21716938	SENT107	5	5	0	0	abacavir	HLA-B	PA448004	3106	0.905
NULL	J_Cell_Mol_Med_2014_Mar_22_18(3)_422-433.nxml.txt.nlp	24450475	SENT80	14	14	0	0	glutaraldehyde	CD34	PA449777	947	0.905
NULL	Epigenetics_2012_Nov_1_7(11)_1225-1229.nxml.txt.nlp	23069641	SENT46	30	30	23	23	cisplatin	BRCA1	PA449014	672	0.905
NULL	Acta_Pharmacol_Sin_2011_Jun_3_32(6)_845-852.nxml.txt.nlp	21642952	SENT156	38	38	4	4	prazosin	TRPV1	PA451093	7442	0.905
NULL	Cancer_Cell_Int_2009_Sep_10_9_25.nxml.txt.nlp	19744341	SENT15	3	3	24	24	glucosamine	STAT3	PA164747613	6774	0.905
NULL	Breast_Cancer_Res_2010_Apr_30_12(2)_203.nxml.txt.nlp	20459590	SENT269	16	16	9	9	carboplatin	BRCA2	PA448803	675	0.905
NULL	Antiviral_Res_2009_May_82(2)_A99-A109.nxml.txt.nlp	19176219	SENT1124	25	25	3	3	zalcitabine	OCT2	PA451950	6582;5452	0.905
NULL	Ital_J_Pediatr_2013_Jan_23_39_7.nxml.txt.nlp	23343462	SENT13	17	17	14	14	thalidomide	gamma	PA451644	9913	0.905
NULL	Cancer_Med_2013_Jun_2_2(3)_325-333.nxml.txt.nlp	23930209	SENT151	15	15	24	24	paclitaxel	HER2	PA450761	2064	0.905
NULL	Curr_Oncol_2009_Jul_16(Suppl_2)_S14-S23.nxml.txt.nlp	19672417	SENT42	13	13	1	1	anastrozole	ATAC	PA448432	6375	0.905
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Jul_9_3(7)_e124.nxml.txt.nlp	25006781	SENT38	13	13	37	37	rosuvastatin	OATP1B1	PA134308647	10599	0.905
NULL	Mol_Cancer_2003_Jan_7_2_10.nxml.txt.nlp	12575899	SENT150	18	18	15	15	indomethacin	COX	PA449982	1351	0.905
NULL	Mol_Cancer_2010_Mar_2_9_46.nxml.txt.nlp	20196838	SENT33	3	3	25	25	irinotecan	MRP2	PA450085	100130958;57626;1244	0.905
NULL	Breast_Cancer_Res_2011_Aug_16_13(4)_312.nxml.txt.nlp	21861853	SENT21	11	11	7	7	tamoxifen	CUEDC2	PA451581	79004	0.905
NULL	J_Hematol_Oncol_2011_Apr_25_4_20.nxml.txt.nlp	21518431	SENT160	11	11	4	4	resveratrol	AP-1		2353;3727;2354;3725	0.905
NULL	Br_J_Cancer_2004_Mar_5_90(Suppl_1)_S2-S6.nxml.txt.nlp	15094757	SENT65	33	33	23	23	fulvestrant	AF1	PA164747170	1946	0.905
NULL	Breast_Cancer_Res_2009_Jul_15_11(4)_207.nxml.txt.nlp	19664181	SENT41	20	20	28	28	trastuzumab	PTEN	PA451743	5728	0.905
NULL	Breast_Cancer_Res_Treat_2013_Apr_12_138(2)_427-435.nxml.txt.nlp	23479422	SENT5	11	11	28	28	paclitaxel	HER2	PA450761	2064	0.905
NULL	Breast_Cancer_Res_2006_Nov_6_8(6)_215.nxml.txt.nlp	17096862	SENT70	12	12	4	4	trastuzumab	PTEN	PA451743	5728	0.905
NULL	Mol_Vis_2007_Jul_12_13_1130-1137.nxml.txt.nlp	17653058	SENT168	7	7	24	24	isoflurane	IFN	PA450106	3439	0.905
NULL	Breast_Cancer_Res_2008_Jun_9_10(3)_R52.nxml.txt.nlp	18541018	SENT140	23	23	13	13	fluorescein	CD24	PA164746009	100133941	0.905
NULL	Toxins_(Basel)_2010_Oct_28_2(11)_2584-2592.nxml.txt.nlp	22069565	SENT66	24	24	9	9	warfarin	CYP2C9	PA451906	1559	0.905
NULL	Diabetes_Care_2010_Feb_33(2)_453-455.nxml.txt.nlp	20103562	SENT35	11	11	9	9	liraglutide	GLP-1	PA165958364	100125288	0.905
NULL	Ann_Oncol_2011_Mar_8_22(3)_503-514.nxml.txt.nlp	20616198	SENT135	9	9	13	13	tamoxifen	aromatase	PA451581	1588	0.905
NULL	Nucleic_Acids_Res_2013_Apr_1_41(6)_3723-3733.nxml.txt.nlp	23376931	SENT82	8	8	4	4	phenol	AGO2	PA450913	27161	0.905
NULL	Indian_J_Pharmacol_2013_May-Jun_45(3)_274-277.nxml.txt.nlp	23833372	SENT128	16	16	23	23	colchicine	CA1	PA449092	759	0.905
NULL	Nucleic_Acids_Res_2013_Apr_17_41(7)_4129-4143.nxml.txt.nlp	23420868	SENT97	29	29	1	1	l-glutamine	CD34	PA10090	947	0.905
NULL	Virol_J_2011_Nov_2_8_497.nxml.txt.nlp	22044506	SENT127	31	31	7	7	betaine	LAMP	PA448603	4045;27074	0.905
NULL	J_Korean_Med_Sci_2010_Dec_24_25(12)_1792-1797.nxml.txt.nlp	21165296	SENT26	0	0	9	9	desmopressin	AVP	PA449237	114548;551	0.905
NULL	Acta_Pharmacol_Sin_2012_Dec_29_33(12)_1518-1524.nxml.txt.nlp	23103625	SENT13	4	4	11	11	telmisartan	ACE2	PA451605	59272	0.905
NULL	Endocrinol_Metab_(Seoul)_2013_Dec_12_28(4)_262-274.nxml.txt.nlp	24396690	SENT77	19	19	29	29	liraglutide	GLP-1	PA165958364	100125288	0.905
NULL	Diabetes_2013_Mar_14_62(3)_953-964.nxml.txt.nlp	23223176	SENT163	2	2	33	33	paroxetine	ROS	PA450801	6098	0.905
NULL	Infect_Drug_Resist_2011_Feb_22_4_65-76.nxml.txt.nlp	21694910	SENT97	6	6	20	20	raltegravir	CD4		920	0.905
NULL	Diabetes_2011_Jul_20_60(7)_1872-1881.nxml.txt.nlp	21602511	SENT158	20	20	25	25	metformin	AMPK	PA450395	5563	0.905
NULL	Cell_Cycle_2013_Sep_15_12(18)_3013-3024.nxml.txt.nlp	23974104	SENT74	15	15	11	11	disulfiram	IQGAP1	PA449376	8826	0.905
NULL	Sensors_(Basel)_2013_Mar_6_13(3)_3169-3203.nxml.txt.nlp	23467031	SENT436	19	19	27	27	tamoxifen	aromatase	PA451581	1588	0.905
NULL	Pan_Afr_Med_J_2014_Jul_6_18_205.nxml.txt.nlp	25419332	SENT46	17	17	6	6	rituximab	CHOP	PA451261	1649	0.905
NULL	Braz_J_Med_Biol_Res_2013_Aug_13_46(8)_650-658.nxml.txt.nlp	23969971	SENT188	3	3	16	16	cisplatin	STAT3	PA449014	6774	0.905
NULL	Oncotarget_2013_Aug_25_4(10)_1647-1661.nxml.txt.nlp	24072592	SENT33	15	15	5	5	staurosporine	S6K1	PA165109623	6198	0.905
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Mar_27_66(Pt_4)_m463-m464.nxml.txt.nlp	21580548	SENT95	5	5	12	12	phenol	C42	PA450913	51654	0.905
NULL	Anesthesiol_Res_Pract_2013_Sep_23_2013_297141.nxml.txt.nlp	24174934	SENT181	30	30	13	13	prilocaine	mol	PA451101	90527	0.905
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT37	10	10	31	31	saquinavir	ABCB1	PA451305	5243	0.905
NULL	Cancer_Cell_Int_2014_Jul_2_14_59.nxml.txt.nlp	25120382	SENT97	15	15	17	17	metformin	Met	PA450395	79811	0.905
NULL	Breast_Cancer_Res_2007_Aug_8_9(4)_R50.nxml.txt.nlp	17686159	SENT13	9	9	25	25	gefitinib	AKT	PA131301952	207	0.905
NULL	South_Asian_J_Cancer_2014_Jul-Sep_3(3)_175-178.nxml.txt.nlp	25136526	SENT24	16	16	11	11	cetuximab	EGFR	PA10040	1956	0.905
NULL	J_Hematol_Oncol_2010_Sep_9_3_31.nxml.txt.nlp	20828403	SENT49	40	40	9	9	cisplatin	HER2	PA449014	2064	0.905
NULL	Cancer_Imaging_2012_May_7_12(1)_163-172.nxml.txt.nlp	22571819	SENT94	22	22	8	8	cetuximab	EGFR	PA10040	1956	0.905
NULL	Mol_Cancer_2010_Apr_21_9_83.nxml.txt.nlp	20409325	SENT212	22	22	6	6	doxycycline	MYCN	PA449415	4613	0.905
NULL	Case_Rep_Pediatr_2013_Oct_3_2013_703925.nxml.txt.nlp	24222881	SENT4	0	0	7	7	liraglutide	GLP-1	PA165958364	100125288	0.905
NULL	Toxins_(Basel)_2010_Oct_26_2(11)_2490-2518.nxml.txt.nlp	22069563	SENT207	22	22	13	13	cisplatin	IL-8	PA449014	3576	0.905
NULL	F1000Res_2014_Aug_19_3_198.nxml.txt.nlp	25400908	SENT289	18	18	9	9	lapatinib	ACT	PA152241907	12;11332;9457;641455	0.905
NULL	Breast_Cancer_Res_2007_Dec_17_9(6)_115.nxml.txt.nlp	18190722	SENT66	32	32	7	7	tamoxifen	CYP2D6	PA451581	1565	0.905
NULL	Drugs_R_D_2013_Jun_5_13(2)_153-157.nxml.txt.nlp	23737454	SENT136	25	25	11	11	clopidogrel	P2Y12	PA449053	64805	0.905
NULL	Breast_Cancer_Res_2008_Dec_5_10(6)_R104.nxml.txt.nlp	19061505	SENT225	33	33	11	11	estradiol	JNK	PA449503	5599	0.905
NULL	Int_J_Mol_Sci_2014_Nov_10_15(11)_20607-20637.nxml.txt.nlp	25391045	SENT40	16	16	31	31	atorvastatin	CYP2C9	PA448500	1559	0.905
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT274	17	17	9	9	atorvastatin	PTEN	PA448500	5728	0.905
NULL	Ann_Oncol_2012_Dec_2_23(12)_3007-3016.nxml.txt.nlp	22865781	SENT104	30	30	17	17	lapatinib	PTEN	PA152241907	5728	0.905
NULL	Biologics_2010_Sep_13_4_263-271.nxml.txt.nlp	20859453	SENT101	0	0	36	36	sirolimus	IL-2	PA451365	3558	0.905
NULL	Br_J_Cancer_2013_Feb_5_108(2)_319-326.nxml.txt.nlp	23322198	SENT20	2	2	21	21	sorafenib	VEGFR2	PA7000	3791	0.905
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT90	6	6	12	12	cisplatin	B7-H1	PA449014	29126	0.905
NULL	Ann_Hematol_2014_Apr_1_93(8)_1371-1380.nxml.txt.nlp	24687382	SENT27	5	5	10	10	lenalidomide	CRBN	PA162363968	51185	0.905
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jan_12_67(Pt_2)_o334-o335.nxml.txt.nlp	21523018	SENT78	38	38	20	20	ethanol	mol	PA448073	90527	0.905
NULL	Apoptosis_2008_May_9_13(5)_681-692.nxml.txt.nlp	18392938	SENT29	26	26	0	0	l-glutamine	C10	PA10090	113246	0.905
NULL	J_Carcinog_2012_Oct_27_11_16.nxml.txt.nlp	23230393	SENT56	8	8	15	15	lapatinib	HER-2	PA152241907	2064	0.905
NULL	Pharmaceuticals_(Basel)_2011_Nov_10_4(11)_1488-1502.nxml.txt.nlp	NULL	SENT402	2	2	0	0	geldanamycin	Hsp90	PA152031327	3320	0.905
NULL	Front_Behav_Neurosci_2012_Sep_18_6_61.nxml.txt.nlp	23049505	SENT313	4	4	22	22	donepezil	spatial	PA449394	219793	0.905
NULL	Carcinogenesis_2011_Nov_1_32(11)_1724-1733.nxml.txt.nlp	21890461	SENT242	35	35	42	42	oxygen	ROS	PA450744	6098	0.905
NULL	Int_J_Mol_Imaging_2011_Oct_26_2011_874585.nxml.txt.nlp	21490735	SENT124	11	11	3	3	tamoxifen	FDG	PA451581	23583	0.905
NULL	Neural_Regen_Res_2013_May_25_8(15)_1368-1375.nxml.txt.nlp	25206431	SENT98	2	2	11	11	curcumin	Bcl-2	PA151958596	596	0.905
NULL	Indian_J_Dermatol_2013_May-Jun_58(3)_247c.nxml.txt.nlp	23723524	SENT25	8	8	4	4	doxorubicin	CHOP	PA449412	1649	0.905
NULL	Clin_Med_Insights_Oncol_2012_Feb_28_6_125-135.nxml.txt.nlp	22408376	SENT225	8	8	18	18	panitumumab	KRAS	PA162373091	3845	0.905
NULL	Oncoscience_2014_Aug_21_1(8)_513-521.nxml.txt.nlp	25594058	SENT27	18	18	31	31	docetaxel	EGFR	PA449383	1956	0.905
NULL	J_Infect_Dis_2013_Feb_15_207(4)_656-660.nxml.txt.nlp	23186785	SENT67	15	15	0	0	lumefantrine	C10	PA165111722	113246	0.905
NULL	Oncol_Rep_2015_Jan_23_33(1)_33-39.nxml.txt.nlp	25351453	SENT5	5	5	24	24	l-glutamine	CRT	PA10090	811	0.905
NULL	Viruses_2009_Nov_10_1(3)_873-894.nxml.txt.nlp	21994574	SENT199	34	34	32	32	camptothecin	TOP1	PA153590860	7150	0.905
NULL	Mol_Vis_2014_Mar_30_20_441-457.nxml.txt.nlp	24715760	SENT49	10	10	21	21	geldanamycin	Hsp90	PA152031327	3320	0.905
NULL	Breast_Cancer_Res_2011_Feb_23_13(1)_203.nxml.txt.nlp	21392408	SENT13	20	20	13	13	exemestane	aromatase	PA449563	1588	0.905
NULL	Oncoscience_2014_Mar_12_1(2)_158-166.nxml.txt.nlp	25594008	SENT134	27	27	37	37	dasatinib	ANXA1	PA162372878	301	0.905
NULL	Adv_Ther_2013_Oct_25_30(10)_870-884.nxml.txt.nlp	24158787	SENT210	7	7	14	14	fulvestrant	aromatase	PA164747170	1588	0.905
NULL	Int_J_Biol_Sci_2013_May_8_9(5)_435-443.nxml.txt.nlp	23678293	SENT152	6	6	29	29	imatinib	MTOR	PA10804	2475	0.905
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Sep_19_65(Pt_10)_o2501.nxml.txt.nlp	21577950	SENT61	16	16	29	29	ethanol	mol	PA448073	90527	0.905
NULL	Oncotarget_2011_Aug_30_2(8)_610-626.nxml.txt.nlp	21881167	SENT136	34	34	28	28	doxorubicin	Raf-1	PA449412	5894	0.905
NULL	Cell_Death_Dis_2014_Feb_13_5(2)_e1055.nxml.txt.nlp	24525731	SENT141	6	6	15	15	cisplatin	XRCC1	PA449014	7515	0.905
NULL	Bioinformation_2012_May_15_8(9)_407-411.nxml.txt.nlp	22715309	SENT29	34	34	12	12	thrombin	ZPI	PA451674	51156	0.905
NULL	Case_Rep_Gastrointest_Med_2014_Jul_1_2014_579352.nxml.txt.nlp	25093126	SENT43	14	14	10	10	cyclophosphamide	CHOP	PA449165	1649	0.905
NULL	Br_J_Cancer_2010_Sep_7_103(6)_889-898.nxml.txt.nlp	20664599	SENT12	22	22	30	30	paclitaxel	AKT	PA450761	207	0.905
NULL	Core_Evid_2010_Oct_21_5_23-37.nxml.txt.nlp	21042540	SENT165	1	1	6	6	saxagliptin	P-gp	PA165958362	5243	0.905
NULL	Gut_2012_May_7_61(5)_673-684.nxml.txt.nlp	22315472	SENT303	24	24	16	16	gefitinib	EGFR	PA131301952	1956	0.905
NULL	J_Invest_Dermatol_2012_Sep_19_132(9)_2198-2205.nxml.txt.nlp	22513780	SENT65	18	18	5	5	isotretinoin	CD25	PA450128	3669;3559	0.905
NULL	Eur_J_Med_Res_2010_Jul_26_15(7)_314-318.nxml.txt.nlp	20696644	SENT25	11	11	33	33	hemin	CO2	PA449849	4513	0.905
NULL	Br_J_Cancer_2012_Dec_4_107(12)_1950-1955.nxml.txt.nlp	23169295	SENT97	28	28	17	17	oxaliplatin	ERCC1	PA131285527	2067	0.905
NULL	Breast_Cancer_Res_2005_May_24_7(5)_R589-R597.nxml.txt.nlp	16168102	SENT42	5	5	14	14	trastuzumab	San	PA451743	80218	0.905
NULL	Nat_Neurosci_2014_Jan_8_17(1)_114-120.nxml.txt.nlp	24316890	SENT182	6	6	17	17	vanillin	OR10G4	PA451852	390264	0.905
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Oct_28_65(Pt_11)_o2899.nxml.txt.nlp	21578481	SENT63	22	22	12	12	vanillin	mol	PA451852	90527	0.905
NULL	Neural_Regen_Res_2013_Mar_25_8(9)_825-832.nxml.txt.nlp	25206730	SENT106	0	0	22	22	isoflurane	P2X7	PA450106	5027	0.905
NULL	Indian_J_Anaesth_2009_Oct_53(5)_582-591.nxml.txt.nlp	20640109	SENT84	2	2	11	11	clopidogrel	ADP	PA449053	23038	0.905
NULL	Breast_Cancer_Res_2010_Jul_1_12(4)_R45.nxml.txt.nlp	20594311	SENT204	16	16	33	33	nelfinavir	AKT	PA450606	207	0.905
NULL	ScientificWorldJournal_2013_Dec_24_2013_958724.nxml.txt.nlp	24453930	SENT47	15	15	4	4	bevacizumab	ERM	PA130232992	2119	0.905
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jul_10_68(Pt_8)_o2421.nxml.txt.nlp	22904872	SENT65	16	16	4	4	ethanol	mol	PA448073	90527	0.905
NULL	J_Immunother_Cancer_2014_Jan_27_2_2.nxml.txt.nlp	24829759	SENT97	20	20	16	16	sorafenib	IL-21	PA7000	59067;50616;27189	0.905
NULL	Oncogene_2011_Apr_14_30(15)_1798-1811.nxml.txt.nlp	21170087	SENT148	12	12	2	2	etoposide	p53	PA449552	7157	0.905
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT13	0	0	8	8	phenprocoumon	CYP2C9	PA450921	1559	0.905
NULL	Int_J_Mol_Sci_2014_Nov_21_15(11)_21505-21537.nxml.txt.nlp	25421245	SENT467	0	0	11	11	resveratrol	AMPK		5563	0.905
NULL	Cancer_Immunol_Immunother_2014_Aug_7_63(11)_1189-1197.nxml.txt.nlp	25099367	SENT37	42	42	23	23	thalidomide	FOXP3	PA451644	50943	0.905
NULL	Case_Rep_Genet_2014_Jan_22_2014_413743.nxml.txt.nlp	24627811	SENT72	23	23	8	8	warfarin	VKORC1	PA451906	79001	0.905
NULL	J_Gen_Intern_Med_2009_Nov_18_24(Suppl_2)_389-394.nxml.txt.nlp	19838837	SENT333	3	3	8	8	denosumab	aromatase	PA166048634	1588	0.905
NULL	Exp_Diabetes_Res_2012_May_14_2012_470851.nxml.txt.nlp	22666230	SENT5	19	19	12	12	liraglutide	GLP-1	PA165958364	100125288	0.905
NULL	Breast_Cancer_Res_2009_Nov_17_11(6)_R84.nxml.txt.nlp	19919679	SENT120	34	34	44	44	vinorelbine	HER2	PA451881	2064	0.905
NULL	Int_J_Mol_Sci_2014_Sep_26_15(10)_17204-17220.nxml.txt.nlp	25264738	SENT138	32	32	41	41	sildenafil	MPG	PA451346	4350	0.905
NULL	Ann_Clin_Transl_Neurol_2014_Dec_21_1(12)_996-1005.nxml.txt.nlp	25574474	SENT125	13	13	2	2	riluzole	P-gp	PA451251	5243	0.905
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT422	27	27	13	13	tamoxifen	STAT3	PA451581	6774	0.905
NULL	Cell_Death_Dis_2014_Jul_17_5(7)_e1333.nxml.txt.nlp	25032856	SENT55	23	23	11	11	candesartan	TLR4	PA448765	7099	0.905
NULL	Cancer_Metastasis_Rev_2014_Dec_28_33(1)_161-171.nxml.txt.nlp	24375389	SENT170	23	23	18	18	paclitaxel	CHFR	PA450761	55743	0.905
NULL	Scientifica_(Cairo)_2012_Nov_25_2012_473829.nxml.txt.nlp	24278698	SENT231	33	33	7	7	cisplatin	ATP7B	PA449014	540	0.905
NULL	Ann_Surg_Oncol_2010_Apr_20_17(4)_1168-1176.nxml.txt.nlp	19936839	SENT113	9	9	5	5	cetuximab	KRAS	PA10040	3845	0.905
NULL	Pharm_Pract_(Granada)_2007_Jun_18_Apr-Jun_5(2)_51-58.nxml.txt.nlp	25247008	SENT15	48	48	20	20	varenicline	OTC	PA164781343	5009	0.905
NULL	Cell_Microbiol_2013_Aug_14_15(8)_1385-1400.nxml.txt.nlp	23421931	SENT302	24	24	2	2	fluorescein	MDDC	PA164746009	1541	0.905
NULL	Br_J_Cancer_2013_Aug_6_109(3)_714-722.nxml.txt.nlp	23799849	SENT213	14	14	8	8	cisplatin	MRP8	PA449014	6833;6279;85320	0.905
NULL	Oncotarget_2014_Dec_4_5(22)_11365-11380.nxml.txt.nlp	25426548	SENT48	16	16	7	7	nutlin-3	p53		7157	0.905
NULL	Environ_Health_Perspect_2006_Sep_23_114(9)_1401-1406.nxml.txt.nlp	16966095	SENT119	13	13	9	9	tetracycline	p53	PA451640	7157	0.905
NULL	J_Korean_Med_Sci_2007_Jun_30_22(3)_577-579.nxml.txt.nlp	17596676	SENT47	4	4	14	14	ticlopidine	ADP	PA451686	23038	0.905
NULL	Open_Biochem_J_2012_May_16_6_51-55.nxml.txt.nlp	22654997	SENT172	13	13	8	8	rofecoxib	COX	PA451268	1351	0.905
NULL	Front_Genet_2012_Oct_19_3_180.nxml.txt.nlp	23091478	SENT452	17	17	2	2	cetuximab	KRAS	PA10040	3845	0.905
NULL	Stroke_Res_Treat_2009_Dec_20_2010_386389.nxml.txt.nlp	20700422	SENT199	19	19	13	13	ebselen	JNK	PA161660841	5599	0.905
NULL	Ital_J_Pediatr_2014_Nov_23_40(1)_93.nxml.txt.nlp	NULL	SENT39	0	0	16	16	resveratrol	IL-4		3565	0.905
NULL	J_Korean_Med_Sci_2013_Apr_27_28(4)_527-533.nxml.txt.nlp	23580227	SENT62	17	17	23	23	genistein	TRAIL	PA165109660	8743	0.905
NULL	Cancer_Cell_Int_2005_Aug_24_5_28.nxml.txt.nlp	16120219	SENT168	27	27	20	20	etoposide	p53	PA449552	7157	0.905
NULL	Diabetes_2013_Jun_17_62(6)_1913-1922.nxml.txt.nlp	23349495	SENT201	7	7	19	19	sildenafil	AMPK	PA451346	5563	0.905
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jun_25_67(Pt_7)_o1796.nxml.txt.nlp	21837169	SENT56	23	23	17	17	ethanol	mol	PA448073	90527	0.905
NULL	Arch_Immunol_Ther_Exp_(Warsz)_2007_Oct_1_55(5)_341-345.nxml.txt.nlp	18219765	SENT443	32	32	0	0	methacholine	ATV	PA165958382	4683	0.905
NULL	Clin_Med_Insights_Oncol_2012_Dec_6_6_407-421.nxml.txt.nlp	23239933	SENT6	26	26	9	9	gefitinib	EGFR	PA131301952	1956	0.905
NULL	Eat_Weight_Disord_2014_Jul_29_19(3)_275-283.nxml.txt.nlp	25069836	SENT145	3	3	16	16	metformin	AMPK	PA450395	5563	0.905
NULL	Aging_(Albany_NY)_2013_Feb_21_5(2)_94-95.nxml.txt.nlp	23518473	SENT28	9	9	16	16	resveratrol	SIRT1		23411	0.905
NULL	Acta_Pharmacol_Sin_2014_Aug_21_35(8)_1074-1081.nxml.txt.nlp	25066323	SENT114	0	0	15	15	ribavirin	IFN	PA451241	3439	0.905
NULL	Diabetes_2008_Oct_57(10)_2774-2783.nxml.txt.nlp	18591389	SENT173	17	17	4	4	lipase	ANGPTL4	PA450239	51129	0.905
NULL	Cancer_Cell_Int_2009_Aug_12_9_21.nxml.txt.nlp	19674469	SENT275	20	20	2	2	l-glutamine	PC-3	PA10090	692094	0.905
NULL	Support_Care_Cancer_2012_Mar_20_20(3)_647-652.nxml.txt.nlp	22101611	SENT4	21	21	19	19	rituximab	CHOP	PA451261	1649	0.905
NULL	Aging_Cell_2012_Aug_11(4)_579-587.nxml.txt.nlp	22435726	SENT95	42	42	3	3	etoposide	CD28	PA449552	1493;940	0.905
NULL	Mol_Pain_2013_Nov_28_9_60.nxml.txt.nlp	24283218	SENT266	23	23	2	2	capsaicin	TRPV1	PA448776	7442	0.905
NULL	Acta_Pharmacol_Sin_2009_Sep_17_30(9)_1316-1322.nxml.txt.nlp	19684609	SENT165	14	14	4	4	rosiglitazone	PTEN	PA451283	5728	0.905
NULL	Mol_Cancer_2014_Jul_5_13_165.nxml.txt.nlp	24996221	SENT143	18	18	38	38	docetaxel	LC3	PA449383	84557	0.905
NULL	Cell_Death_Dis_2013_Jun_6_4(6)_e654.nxml.txt.nlp	23744354	SENT183	14	14	19	19	fluorescein	MRP1	PA164746009	4437	0.905
NULL	Exp_Transl_Stroke_Med_2011_Oct_26_3_12.nxml.txt.nlp	22029974	SENT67	18	18	2	2	deferoxamine	HIF-1	PA164746490	29072	0.905
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Nov_7_65(Pt_12)_m1521.nxml.txt.nlp	21578567	SENT64	14	14	9	9	ethanol	mol	PA448073	90527	0.905
NULL	Cancer_Res_Treat_2014_Jan_15_46(1)_98-103.nxml.txt.nlp	24520229	SENT36	29	29	27	27	anastrozole	aromatase	PA448432	1588	0.905
NULL	Mol_Cells_2014_Aug_31_37(8)_585-591.nxml.txt.nlp	25134539	SENT102	5	5	19	19	indacaterol	ADRB2	PA165958348	154	0.905
NULL	Blood_Cancer_J_2012_Mar_23_2(3)_e63.nxml.txt.nlp	22829258	SENT24	41	41	23	23	hydroxyurea	BCS	PA449942	617	0.905
NULL	Acta_Pharmacol_Sin_2012_Oct_17_33(10)_1254-1259.nxml.txt.nlp	22983394	SENT117	29	29	7	7	thrombin	ATIII	PA451674	462	0.905
NULL	Contemp_Oncol_(Pozn)_2012_Feb_29_16(1)_86-89.nxml.txt.nlp	23788860	SENT48	18	18	8	8	cisplatin	DDP	PA449014	1678	0.905
NULL	Breast_Cancer_Res_2011_Jun_10_13(3)_211.nxml.txt.nlp	21672282	SENT74	10	10	3	3	trastuzumab	HER2	PA451743	2064	0.905
NULL	Arthritis_Res_Ther_2009_Apr_23_11(2)_R57.nxml.txt.nlp	19389237	SENT148	18	18	28	28	adalimumab	CD68	PA10004	968	0.905
NULL	Exp_Ther_Med_2013_Jan_1_5(1)_338-342.nxml.txt.nlp	23251295	SENT120	10	10	33	33	everolimus	HK2	PA164746311	3796;3099;29911;3741	0.905
NULL	Case_Rep_Gastroenterol_2011_Oct_7_5(3)_610-616.nxml.txt.nlp	22110423	SENT40	7	7	22	22	mesalazine	DLST	PA450384	1743	0.905
NULL	Exp_Diabetes_Res_2011_Jun_4_2011_489708.nxml.txt.nlp	21747829	SENT188	27	27	7	7	aliskiren	GLP-1	PA143487910	100125288	0.905
NULL	J_Korean_Med_Sci_2009_Jan_29_24(Suppl_1)_S170-S175.nxml.txt.nlp	19194548	SENT132	8	8	20	20	cisplatin	EPO	PA449014	7076;8288;2056	0.905
NULL	Scientifica_(Cairo)_2012_Nov_25_2012_473829.nxml.txt.nlp	24278698	SENT234	24	24	0	0	cisplatin	ATP7A	PA449014	538	0.905
NULL	Breast_Cancer_Res_2010_Oct_22_12(Suppl_2)_S3.nxml.txt.nlp	21050424	SENT184	7	7	31	31	everolimus	HER2	PA164746311	2064	0.905
NULL	Crit_Care_2009_Jun_23_13(3)_R98.nxml.txt.nlp	19549333	SENT26	17	17	3	3	vasopressin	AVP	PA451858	114548;551	0.905
NULL	Genetics_2014_Sep_1_198(1)_17-29.nxml.txt.nlp	25236446	SENT56	21	21	19	19	isoflurane	CO2	PA450106	4513	0.905
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_75-89.nxml.txt.nlp	17912638	SENT169	10	10	1	1	anastrozole	ATAC	PA448432	6375	0.905
NULL	Ann_Rheum_Dis_2014_Oct_29_73(10)_1811-1818.nxml.txt.nlp	23897769	SENT186	11	11	7	7	tocilizumab	IL-6	PA165292659	3569	0.905
NULL	Eur_J_Epidemiol_2009_Sep_2_24(9)_553-572.nxml.txt.nlp	19728115	SENT1547	21	21	14	14	phenprocoumon	CYP2C9	PA450921	1559	0.905
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT223	30	30	16	16	panitumumab	KRAS	PA162373091	3845	0.905
NULL	Eur_Respir_J_2013_Dec_30_42(6)_1484-1494.nxml.txt.nlp	23722616	SENT122	13	13	0	0	tiotropium	TDI	PA164769056	100038246	0.905
NULL	Eur_J_Med_Res_2009_Nov_24_14(Suppl_3)_17-21.nxml.txt.nlp	19959412	SENT31	12	12	30	30	raltegravir	UGT1A3		54659	0.905
NULL	Cancer_Med_2013_Jun_25_2(3)_277-285.nxml.txt.nlp	23930204	SENT195	25	25	16	16	bevacizumab	MAX	PA130232992	4149	0.905
NULL	Clin_Transl_Allergy_2013_Sep_2_3_29.nxml.txt.nlp	24004581	SENT182	6	6	21	21	omalizumab	IL-4	PA164752253	3565	0.905
NULL	Case_Rep_Ophthalmol_Med_2012_Feb_14_2012_894062.nxml.txt.nlp	22606505	SENT35	24	24	18	18	vincristine	CHOP	PA451879	1649	0.905
NULL	Eur_J_Clin_Pharmacol_2009_Dec_8_65(12)_1245-1251.nxml.txt.nlp	19669131	SENT153	14	14	9	9	levodopa	DRD2	PA450213	1813	0.905
NULL	eLife_2014_Apr_30_3_e02208.nxml.txt.nlp	24842996	SENT341	33	33	7	7	hydroxyurea	Spc110	PA449942	26059	0.905
NULL	Cell_Cycle_2013_May_15_12(10)_1492-1500.nxml.txt.nlp	23598717	SENT64	23	23	6	6	doxorubicin	FAK	PA449412	5747	0.905
NULL	Oncotarget_2011_Dec_31_2(12)_894-895.nxml.txt.nlp	22248868	SENT3	9	9	2	2	cetuximab	EGFR	PA10040	1956	0.905
NULL	Int_J_Mol_Sci_2012_Feb_24_13(3)_2578-2589.nxml.txt.nlp	22489112	SENT64	12	12	15	15	maprotiline	GAT1	PA450322	6529	0.905
NULL	Mol_Cell_2014_May_8_54(3)_445-459.nxml.txt.nlp	24746700	SENT505	32	32	21	21	etoposide	BRCA1	PA449552	672	0.905
NULL	Arthritis_Res_Ther_2009_Aug_17_11(4)_R123.nxml.txt.nlp	19686595	SENT177	30	30	15	15	rituximab	CD138	PA451261	6382	0.905
NULL	Nature_2012_Aug_16_488(7411)_384-388.nxml.txt.nlp	22820255	SENT285	7	7	9	9	doxycycline	IL-2	PA449415	3558	0.905
NULL	Breast_Cancer_Res_2013_Oct_29_15(5)_R101.nxml.txt.nlp	24168763	SENT372	14	14	7	7	trastuzumab	PI3K	PA451743	5290	0.905
NULL	Int_J_Med_Sci_2015_Jan_5_12(2)_135-140.nxml.txt.nlp	25589889	SENT77	12	12	3	3	clozapine	NMS	PA449061	129521	0.905
NULL	Oncologist_2010_Mar_9_15(3)_236-245.nxml.txt.nlp	20215359	SENT116	2	2	12	12	temsirolimus	IFN	PA164746890	3439	0.905
NULL	Pan_Afr_Med_J_2012_May_6_12_5.nxml.txt.nlp	22826730	SENT45	16	16	12	12	doxorubicin	CHOP	PA449412	1649	0.905
NULL	Clin_Med_Oncol_2008_Jun_11_2_469-470.nxml.txt.nlp	21892319	SENT22	38	38	23	23	paclitaxel	HER2	PA450761	2064	0.905
NULL	J_Cell_Mol_Med_2013_Dec_6_17(12)_1588-1597.nxml.txt.nlp	24199964	SENT65	15	15	1	1	doxycycline	APT	PA449415	653639	0.905
NULL	Mediators_Inflamm_2010_Jun_21_2010_194896.nxml.txt.nlp	20652055	SENT186	24	24	36	36	berberine	AP-1	PA165860812	2353;3727;2354;3725	0.905
NULL	J_Cell_Biol_2002_Nov_11_159(3)_453-463.nxml.txt.nlp	12427868	SENT225	17	17	27	27	marimastat	TIMP2	PA164748329	7077	0.905
NULL	Br_J_Haematol_2014_Mar_13_164(1)_811-821.nxml.txt.nlp	24328678	SENT143	4	4	10	10	lenalidomide	Aiolos	PA162363968	22806	0.905
NULL	Cancer_Immunol_Immunother_2011_Jul_24_60(7)_943-951.nxml.txt.nlp	21431918	SENT167	19	19	4	4	doxorubicin	CD34	PA449412	947	0.905
NULL	eLife_2013_Nov_5_2_e00969.nxml.txt.nlp	24192036	SENT169	39	39	9	9	vemurafenib	MKK4	PA165946873	6416	0.905
NULL	J_Headache_Pain_2008_Feb_24_9(1)_13-18.nxml.txt.nlp	18217199	SENT110	32	32	4	4	metoprolol	CYP2D6	PA450480	1565	0.905
NULL	Braz_J_Med_Biol_Res_2012_Jul_20_45(10)_935-941.nxml.txt.nlp	22801415	SENT175	7	7	16	16	pioglitazone	ghrelin	PA450970	51738	0.905
NULL	Br_J_Cancer_2010_Oct_12_103(8)_1192-1200.nxml.txt.nlp	20877358	SENT195	26	26	11	11	docetaxel	BRCA2	PA449383	675	0.905
NULL	Ecancermedicalscience_2008_Feb_18_2_75.nxml.txt.nlp	22275966	SENT148	7	7	32	32	gefitinib	NSCL	PA131301952	4807	0.905
NULL	Oncoimmunology_2013_Jun_1_2(6)_e24677.nxml.txt.nlp	23894722	SENT124	33	33	12	12	cetuximab	TLR3	PA10040	7098	0.905
NULL	Anemia_2012_May_23_2012_265790.nxml.txt.nlp	22675615	SENT357	17	17	38	38	infliximab	HOXB4	PA452639	3214	0.905
NULL	Leukemia_2014_Mar_13_28(3)_600-608.nxml.txt.nlp	24240203	SENT135	18	18	10	10	nutlin-3	p53		7157	0.905
NULL	Environ_Health_Perspect_2008_Sep_116(9)_A402a.nxml.txt.nlp	NULL	SENT15	28	28	1	1	iron	HFE	PA450087	3077	0.905
NULL	Scientifica_(Cairo)_2013_Dec_12_2013_635203.nxml.txt.nlp	24416617	SENT497	16	16	2	2	doxorubicin	ABCB5	PA449412	340273	0.905
NULL	Aging_(Albany_NY)_2012_Feb_21_4(2)_133-143.nxml.txt.nlp	22361433	SENT7	18	18	0	0	oxygen	MEF2C	PA450744	4208	0.905
NULL	Int_J_Mol_Sci_2012_Feb_1_13(2)_1512-1523.nxml.txt.nlp	22408405	SENT151	8	8	24	24	olmesartan	LOX-1	PA164742950	4973	0.905
NULL	Arthritis_Res_Ther_2004_Oct_17_6(1)_R7-R14.nxml.txt.nlp	14979933	SENT9	44	44	30	30	naloxone	POMC	PA450586	5443	0.905
NULL	Nat_Commun_2014_Aug_6_5_4602.nxml.txt.nlp	25098764	SENT62	12	12	4	4	chloroquine	TRAF2	PA448948	7186	0.905
NULL	Br_J_Cancer_2010_Jan_5_102(1)_115-123.nxml.txt.nlp	19997099	SENT227	12	12	24	24	cyclophosphamide	GEM	PA449165	2669	0.905
NULL	Diabetes_2013_Oct_17_62(10)_3500-3513.nxml.txt.nlp	23884882	SENT271	4	4	17	17	resveratrol	FOXO1		2308	0.905
NULL	Acta_Pharmacol_Sin_2013_Feb_12_34(2)_255-261.nxml.txt.nlp	23147557	SENT126	29	29	14	14	pioglitazone	CYP2C8	PA450970	1558	0.905
NULL	Oncogene_2014_Aug_21_33(34)_4316-4329.nxml.txt.nlp	24362530	SENT54	18	18	14	14	epirubicin	FOXM1	PA449476	2305	0.905
NULL	Breast_Cancer_Res_2009_Nov_17_11(6)_R84.nxml.txt.nlp	19919679	SENT120	22	22	44	44	docetaxel	HER2	PA449383	2064	0.905
NULL	Front_Neurol_2014_Feb_18_5_17.nxml.txt.nlp	24600432	SENT41	36	36	21	21	levetiracetam	IL-1B	PA450206	3553	0.905
NULL	J_Carcinog_2014_Feb_7_13_1.nxml.txt.nlp	24737949	SENT185	9	9	5	5	nilotinib	KIT	PA165958345	3815	0.905
NULL	Scientifica_(Cairo)_2012_Dec_16_2012_402783.nxml.txt.nlp	24278688	SENT154	14	14	37	37	thrombin	C5a	PA451674	727	0.905
NULL	Oncogene_2013_Sep_12_32(37)_4355-4365.nxml.txt.nlp	23108409	SENT11	7	7	17	17	hyaluronidase	CD44	PA164745713	960	0.905
NULL	Cancers_(Basel)_2014_Mar_26_6(2)_708-722.nxml.txt.nlp	24675568	SENT117	24	24	12	12	erlotinib	JAK2	PA134687924	3717	0.905
NULL	Drugs_Context_2013_May_22_2013_212255.nxml.txt.nlp	24432042	SENT250	18	18	8	8	bromocriptine	GLP-1	PA448671	100125288	0.905
NULL	Ann_Med_Health_Sci_Res_2013_Apr-Jun_3(2)_238-244.nxml.txt.nlp	23919197	SENT126	6	6	12	12	anidulafungin	NAC	PA164742938	22861	0.905
NULL	Chemother_Res_Pract_2012_Aug_29_2012_817297.nxml.txt.nlp	22970367	SENT190	12	12	38	38	afatinib	EGFR	PA165981154	1956	0.905
NULL	Curr_Neuropharmacol_2008_Sep_6(3)_215-234.nxml.txt.nlp	19506722	SENT363	40	40	8	8	citalopram	5-HT6	PA449015	3362	0.905
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_27_2012_829401.nxml.txt.nlp	23259000	SENT139	15	15	3	3	creatine	ANOVA	PA164778930	4858	0.905
NULL	Oncogenesis_2014_Mar_3_3(3)_e90.nxml.txt.nlp	24590311	SENT115	6	6	12	12	imatinib	Hsp90	PA10804	3320	0.905
NULL	Braz_J_Med_Biol_Res_2013_Feb_1_46(2)_171-177.nxml.txt.nlp	23369979	SENT146	13	13	26	26	enalapril	IL-10	PA449456	3586	0.905
NULL	Indian_J_Med_Res_2010_Dec_132(6)_676-682.nxml.txt.nlp	21245614	SENT97	11	11	25	25	zinc	p53	PA451956	7157	0.905
NULL	Oncol_Rep_2012_Apr_16_27(4)_1245-1250.nxml.txt.nlp	22266802	SENT115	4	4	0	0	sulindac	COX	PA451565	1351	0.905
NULL	AIDS_Res_Ther_2013_Dec_13_10_33.nxml.txt.nlp	24330617	SENT45	30	30	21	21	darunavir	CCR5	PA163522472	1234	0.905
NULL	Breast_Cancer_Res_2014_Dec_19_16(6)_499.nxml.txt.nlp	25522654	SENT42	38	38	32	32	estradiol	CYP19A1	PA449503	1588	0.905
NULL	Mol_Vis_2012_Apr_11_18_901-908.nxml.txt.nlp	22539869	SENT209	19	19	23	23	curcumin	HO-1	PA151958596	3162	0.905
NULL	Acta_Pharmacol_Sin_2014_Jun_4_35(6)_752-757.nxml.txt.nlp	24902786	SENT91	25	25	5	5	tamoxifen	STL2	PA451581	1301	0.905
NULL	J_Oncol_2010_Jan_14_2010_740472.nxml.txt.nlp	20130818	SENT122	13	13	7	7	gefitinib	AGO	PA131301952	55294	0.905
NULL	Br_J_Cancer_2013_Nov_26_109(11)_2778-2782.nxml.txt.nlp	24169350	SENT45	9	9	45	45	cisplatin	NACT	PA449014	284111	0.905
NULL	BMB_Rep_2013_Aug_46(8)_410-415.nxml.txt.nlp	23977989	SENT102	33	33	7	7	curcumin	HO-1	PA151958596	3162	0.905
NULL	J_Cell_Biol_1999_Jan_11_144(1)_71-82.nxml.txt.nlp	9885245	SENT165	30	30	12	12	galactose	PRK1	PA449725	5585;84432	0.905
NULL	Br_J_Cancer_2010_Sep_7_103(6)_765-771.nxml.txt.nlp	20700120	SENT14	8	8	2	2	tamoxifen	CYP2D6	PA451581	1565	0.905
NULL	Oncogene_2009_Jan_15_28(2)_157-169.nxml.txt.nlp	18931700	SENT16	26	26	10	10	trastuzumab	NRAS	PA451743	4893	0.905
NULL	Oncotarget_2013_Nov_4_5(1)_161-172.nxml.txt.nlp	24389287	SENT120	3	3	31	31	propranolol	HDM2	PA451145	4193	0.905
NULL	Biologics_2010_Sep_13_4_263-271.nxml.txt.nlp	20859453	SENT78	13	13	32	32	abatacept	CD28	PA164747080	1493;940	0.905
NULL	Breast_Cancer_Res_2013_Oct_8_15(5)_R94.nxml.txt.nlp	24099325	SENT198	22	22	3	3	docetaxel	SATT	PA449383	6509	0.905
NULL	Open_Virol_J_2012_Dec_28_6_204-215.nxml.txt.nlp	23341856	SENT131	7	7	15	15	lopinavir	p53	PA450264	7157	0.905
NULL	Diabetes_2013_Jun_17_62(6)_2141-2150.nxml.txt.nlp	23378610	SENT181	12	12	1	1	betaine	BHMT	PA448603	635	0.905
NULL	Oncotarget_2014_Aug_29_5(17)_7217-7259.nxml.txt.nlp	25277175	SENT301	23	23	13	13	pazopanib	KIT	PA165291492	3815	0.905
NULL	Arch_Med_Sci_2012_Jul_4_8(3)_549-554.nxml.txt.nlp	22852014	SENT28	5	5	24	24	simvastatin	CYP3A4	PA451363	1576	0.905
NULL	Breast_Cancer_Res_2011_Dec_16_13(6)_R131.nxml.txt.nlp	22177475	SENT199	4	4	13	13	lapatinib	AKT	PA152241907	207	0.905
NULL	BMB_Rep_2014_May_47(5)_268-273.nxml.txt.nlp	24286315	SENT91	18	18	29	29	trastuzumab	PTEN	PA451743	5728	0.905
NULL	Oncol_Rep_2013_Apr_23_29(4)_1268-1274.nxml.txt.nlp	23354756	SENT88	25	25	5	5	paclitaxel	SLC25A43	PA450761	203427	0.905
NULL	EMBO_Mol_Med_2010_Mar_2(3)_98-110.nxml.txt.nlp	20201032	SENT263	19	19	21	21	imatinib	IFN	PA10804	3439	0.905
NULL	Biomed_Res_Int_2014_Jun_26_2014_161346.nxml.txt.nlp	25054130	SENT45	13	13	5	5	pentobarbital	STZ	PA450859	6484	0.905
NULL	Oncogene_2014_Mar_20_33(12)_1590-1600.nxml.txt.nlp	23542178	SENT49	17	17	35	35	lapatinib	PIK3CA	PA152241907	5290	0.905
NULL	Arthritis_Res_Ther_2011_Feb_28_13(1)_203.nxml.txt.nlp	21371346	SENT108	20	20	6	6	rosiglitazone	adiponectin	PA451283	9370	0.905
NULL	Curr_Neuropharmacol_2010_Sep_8(3)_287-304.nxml.txt.nlp	21358978	SENT193	35	35	9	9	agomelatine	5-HT2C	PA165958363	3358	0.904
NULL	Environ_Health_Perspect_2006_Sep_23_114(9)_1401-1406.nxml.txt.nlp	16966095	SENT112	10	10	0	0	tetracycline	p53	PA451640	7157	0.904
NULL	Mol_Vis_2012_Oct_5_18_2454-2467.nxml.txt.nlp	23077404	SENT141	11	11	0	0	bevacizumab	VEGF-A	PA130232992	7422	0.904
NULL	Crit_Care_2009_Feb_6_13(1)_R11.nxml.txt.nlp	19196475	SENT39	4	4	16	16	clonidine	IL-6	PA449051	3569	0.904
NULL	Breast_Cancer_Res_2011_Jan_21_13(1)_R9.nxml.txt.nlp	21255398	SENT202	21	21	33	33	cyclophosphamide	RAD21	PA449165	5885	0.904
NULL	Daru_2011_19(4)_306-311.nxml.txt.nlp	22615674	SENT27	0	0	33	33	pentoxifylline	IL-6	PA450864	3569	0.904
NULL	Int_J_Biol_Sci_2013_Apr_22_9(4)_350-360.nxml.txt.nlp	23630447	SENT162	23	23	10	10	doxorubicin	ARC	PA449412	8996;23237	0.904
NULL	Cell_Cycle_2012_Nov_1_11(21)_4069-4078.nxml.txt.nlp	23095523	SENT152	39	39	26	26	imatinib	PERK	PA10804	9451	0.904
NULL	Int_J_Gen_Med_2009_Jul_30_2_91-108.nxml.txt.nlp	20360893	SENT196	43	43	2	2	mitomycin	PC-3	PA450524	692094	0.904
NULL	Clin_Interv_Aging_2008_Mar_3(1)_45-50.nxml.txt.nlp	18488877	SENT30	26	26	9	9	raloxifene	BMD	PA451221	1756;7439	0.904
NULL	Acta_Pharmacol_Sin_2010_Aug_5_31(8)_923-929.nxml.txt.nlp	20686517	SENT45	15	15	34	34	l-glutamine	CO2	PA10090	4513	0.904
NULL	EMBO_Mol_Med_2011_Jan_3(1)_35-49.nxml.txt.nlp	21204267	SENT70	1	1	27	27	doxycycline	PABPN1	PA449415	8106	0.904
NULL	Br_J_Clin_Pharmacol_2011_Oct_72(4)_647-657.nxml.txt.nlp	21518389	SENT190	26	26	37	37	cangrelor	P2Y12	PA165945763	64805	0.904
NULL	Arch_Med_Sci_2014_Aug_29_10(4)_717-724.nxml.txt.nlp	25276156	SENT147	19	19	6	6	carboplatin	VEGFR	PA448803	3791	0.904
NULL	Biosci_Rep_2014_Dec_12_34(6)_e00162.nxml.txt.nlp	25385088	SENT153	18	18	0	0	chymotrypsin	XPA	PA448994	7507	0.904
NULL	Nat_Neurosci_2012_Jun_15(6)_845-852.nxml.txt.nlp	22522402	SENT239	17	17	3	3	paraformaldehyde	PSD95	PA450790	1742	0.904
NULL	Mycobiology_2010_Mar_31_38(1)_58-61.nxml.txt.nlp	23956626	SENT26	0	0	14	14	lipase	TES	PA450239	26136	0.904
NULL	European_J_Org_Chem_2013_Jun_15_2013(16)_3397-3402.nxml.txt.nlp	25191103	SENT97	23	23	10	10	l-alanine	PLP	PA448055	25824;5744	0.904
NULL	Orphanet_J_Rare_Dis_2006_May_19_1_17.nxml.txt.nlp	16722557	SENT174	17	17	2	2	hydroxocobalamin	B12	PA164768689	7126;4709	0.904
NULL	Oncotarget_2010_Nov_22_1(7)_606-619.nxml.txt.nlp	21317456	SENT150	26	26	13	13	doxorubicin	BRCA2	PA449412	675	0.904
NULL	Mol_Cancer_2014_Jul_5_13_165.nxml.txt.nlp	24996221	SENT18	14	14	5	5	docetaxel	HMGB1	PA449383	3146	0.904
NULL	Indian_J_Palliat_Care_2012_Sep-Dec_18(3)_155-161.nxml.txt.nlp	23439674	SENT179	13	13	5	5	gabapentin	NNT	PA449720	23530	0.904
NULL	Korean_Circ_J_2014_Mar_12_44(2)_82-88.nxml.txt.nlp	24653737	SENT38	26	26	32	32	prasugrel	P2Y12	PA154410481	64805	0.904
NULL	J_Headache_Pain_2013_Apr_10_14(1)_33.nxml.txt.nlp	23574808	SENT30	7	7	10	10	capsaicin	CO2	PA448776	4513	0.904
NULL	Br_J_Cancer_1999_Dec_81(8)_1285-1293.nxml.txt.nlp	10604724	SENT2	6	6	21	21	sn-38	p53		7157	0.904
NULL	Cardiovasc_Res_2012_Dec_1_96(3)_552-560.nxml.txt.nlp	22918977	SENT195	14	14	7	7	hydralazine	AT1	PA449894	9197;185	0.904
NULL	Arthritis_Res_Ther_2006_Jul_17_8(4)_R107.nxml.txt.nlp	16846531	SENT168	0	0	19	19	thrombin	CXCL8	PA451674	3576	0.904
NULL	Cancers_(Basel)_2011_Mar_4_3(1)_1081-1110.nxml.txt.nlp	24212654	SENT1410	16	16	4	4	calcein	HER2	PA132595336	2064	0.904
NULL	Breast_Cancer_Res_2003_Oct_31_5(Suppl_1)_62.nxml.txt.nlp	NULL	SENT10	1	1	21	21	tamoxifen	ATAC	PA451581	6375	0.904
NULL	Tumour_Biol_2013_Oct_9_34(5)_2617-2624.nxml.txt.nlp	23657964	SENT37	22	22	30	30	genistein	BTG3	PA165109660	10950	0.904
NULL	Environ_Health_Perspect_2008_Jan_5_116(1)_1-6.nxml.txt.nlp	18197291	SENT86	16	16	34	34	arsenite	SDS	PA452638	51119;10993	0.904
NULL	Mol_Pain_2012_Sep_22_8_71.nxml.txt.nlp	22998838	SENT237	17	17	4	4	paclitaxel	ANOVA	PA450761	4858	0.904
NULL	Front_Cell_Neurosci_2013_Dec_3_7_239.nxml.txt.nlp	24348333	SENT231	10	10	8	8	riluzole	ALS	PA451251	3483	0.904
NULL	J_Cell_Mol_Med_2014_Apr_20_18(4)_709-720.nxml.txt.nlp	24444314	SENT138	6	6	18	18	losartan	AMPK	PA450268	5563	0.904
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT302	23	23	4	4	pemetrexed	UNG	PA10810	7374	0.904
NULL	Exp_Ther_Med_2013_Aug_14_6(2)_574-578.nxml.txt.nlp	24137229	SENT95	12	12	42	42	propranolol	PARP1	PA451145	142	0.904
NULL	Curr_Control_Trials_Cardiovasc_Med_2001_Feb_2_2(1)_20-23.nxml.txt.nlp	11806769	SENT35	44	44	25	25	carvedilol	BEST	PA448817	7439	0.904
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Dec_4_66(Pt_1)_o9.nxml.txt.nlp	21580186	SENT50	21	21	40	40	ethanol	mol	PA448073	90527	0.904
NULL	Avicenna_J_Med_Biotechnol_2011_Jul-Sep_3(3)_109-117.nxml.txt.nlp	23408723	SENT104	15	15	29	29	trypsin	GMF	PA451806	2764	0.904
NULL	Oncoscience_2014_Mar_24_1(3)_196-204.nxml.txt.nlp	25594012	SENT21	9	9	4	4	gefitinib	EGFR	PA131301952	1956	0.904
NULL	Mol_Cell_Biol_2013_Oct_33(20)_4041-4050.nxml.txt.nlp	23959798	SENT527	11	11	18	18	hydroxyurea	MEC1	PA449942	545	0.904
NULL	Int_J_Antimicrob_Agents_2011_Jul_38(1)_39-45.nxml.txt.nlp	21514798	SENT104	10	10	14	14	tigecycline	BSAC	PA164746412	57591	0.904
NULL	Eur_J_Med_Res_2009_Nov_24_14(Suppl_3)_1-3.nxml.txt.nlp	19959410	SENT38	28	28	7	7	darunavir	TRIO	PA163522472	7204	0.904
NULL	Clin_Interv_Aging_2009_May_14_4_197-205.nxml.txt.nlp	19503782	SENT188	24	24	11	11	cytarabine	IL-11	PA449177	3589	0.904
NULL	Br_J_Cancer_2009_Jul_21_101(2)_238-243.nxml.txt.nlp	19568242	SENT19	8	8	14	14	sunitinib	IFN	PA162372840	3439	0.904
NULL	Ann_Oncol_2012_Dec_2_23(12)_3007-3016.nxml.txt.nlp	22865781	SENT113	16	16	10	10	everolimus	PTEN	PA164746311	5728	0.904
NULL	Cancer_Cell_Int_2011_Dec_29_11_44.nxml.txt.nlp	22206574	SENT179	4	4	24	24	sorafenib	Mcl-1	PA7000	4170	0.904
NULL	Aging_(Albany_NY)_2013_Jan_26_4(12)_894-898.nxml.txt.nlp	23525940	SENT26	6	6	10	10	metformin	AMPK	PA450395	5563	0.904
NULL	Mol_Biol_Cell_2012_Jun_15_23(12)_2302-2318.nxml.txt.nlp	22553350	SENT345	9	9	32	32	doxycycline	MARK2	PA449415	2011	0.904
NULL	Clin_Ophthalmol_2014_Sep_29_8_2001-2012.nxml.txt.nlp	25302012	SENT116	5	5	37	37	fluorescein	FAF	PA164746009	8239;2188	0.904
NULL	Case_Rep_Infect_Dis_2013_Jul_7_2013_546578.nxml.txt.nlp	23936695	SENT59	42	42	37	37	paclitaxel	CD4	PA450761	920	0.904
NULL	Front_Neurosci_2010_Jul_19_4_43.nxml.txt.nlp	20700392	SENT142	23	23	2	2	tamoxifen	DCX	PA451581	1641	0.904
NULL	Clin_Exp_Gastroenterol_2012_May_14_5_49-59.nxml.txt.nlp	22649281	SENT87	20	20	8	8	esomeprazole	CYP2C19	PA10075	1557	0.904
NULL	Front_Oncol_2013_Oct_31_3_273.nxml.txt.nlp	24199173	SENT293	16	16	23	23	docetaxel	p53	PA449383	7157	0.904
NULL	Curr_Hematol_Malig_Rep_2013_Mar_8_8(1)_28-36.nxml.txt.nlp	23296408	SENT176	10	10	22	22	imatinib	miR-17-92	PA10804	407975	0.904
NULL	J_Biol_Chem_2012_Apr_27_287(18)_14726-14733.nxml.txt.nlp	22393045	SENT292	17	17	21	21	cisplatin	PTEN	PA449014	5728	0.904
NULL	Child_Adolesc_Psychiatry_Ment_Health_2009_Mar_12_3_9.nxml.txt.nlp	19284622	SENT125	27	27	9	9	ziprasidone	BARS	PA451974	1487	0.904
NULL	Gastric_Cancer_2013_Jul_12_16(3)_345-354.nxml.txt.nlp	22968820	SENT142	4	4	28	28	oxaliplatin	FANCJ	PA131285527	83990	0.904
NULL	Mol_Cancer_2009_Mar_5_8_14.nxml.txt.nlp	19265551	SENT62	5	5	12	12	camptothecin	p53	PA153590860	7157	0.904
NULL	J_Oncol_2012_Apr_10_2012_931071.nxml.txt.nlp	22570654	SENT58	19	19	25	25	plerixafor	CD34	PA165958410	947	0.904
NULL	FEBS_Open_Bio_2012_May_11_2_98-102.nxml.txt.nlp	23650587	SENT268	11	11	0	0	ribavirin	IL28B	PA451241	282617	0.904
NULL	Indian_J_Radiol_Imaging_2012_Oct-Dec_22(4)_257-259.nxml.txt.nlp	23833415	SENT4	1	1	16	16	thrombin	TKR	PA451674	8277	0.904
NULL	Nucleic_Acids_Res_2012_Jun_10_40(11)_4804-4815.nxml.txt.nlp	22328728	SENT162	8	8	15	15	resveratrol	SIRT1		23411	0.904
NULL	Breast_Cancer_Res_2010_Jul_19_12(4)_R51.nxml.txt.nlp	20642837	SENT76	37	37	25	25	hydrocortisone	EGF	PA449905	1950	0.904
NULL	Oncol_Lett_2014_Sep_11_8(3)_1333-1339.nxml.txt.nlp	25120719	SENT145	15	15	26	26	bevacizumab	DR4	PA130232992	8797	0.904
NULL	FEBS_Open_Bio_2012_Aug_22_2_279-283.nxml.txt.nlp	23650611	SENT361	12	12	5	5	raloxifene	IFN	PA451221	3439	0.904
NULL	J_Biol_Eng_2013_May_29_7_14.nxml.txt.nlp	23718629	SENT269	34	34	14	14	nadh	FBA	PA164755085	26273	0.904
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Nov_22_64(Pt_12)_o2409.nxml.txt.nlp	21581378	SENT57	25	25	19	19	ethanol	mol	PA448073	90527	0.904
NULL	Mol_Cancer_2013_Sep_11_12_104.nxml.txt.nlp	24025152	SENT214	22	22	11	11	gemcitabine	STAT3	PA449748	6774	0.904
NULL	Arthritis_Res_Ther_2006_Dec_28_8(1)_R18.nxml.txt.nlp	16507118	SENT29	9	9	20	20	infliximab	IL-15	PA452639	3600	0.904
NULL	Adv_Pharmacol_Sci_2014_Feb_24_2014_809438.nxml.txt.nlp	24707284	SENT286	21	21	40	40	glibenclamide	ANOVA	PA449782	4858	0.904
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT121	4	4	7	7	cisplatin	p53	PA449014	7157	0.904
NULL	Breast_Cancer_Res_2010_Jun_28_12(3)_R43.nxml.txt.nlp	20579400	SENT163	2	2	6	6	fulvestrant	MAPT	PA164747170	4137	0.904
NULL	Lab_Invest_2012_Aug_23_92(8)_1171-1180.nxml.txt.nlp	22525426	SENT58	27	27	7	7	paraformaldehyde	adiponectin	PA450790	9370	0.904
NULL	Diabetes_Metab_Syndr_Obes_2014_Mar_18_7_107-120.nxml.txt.nlp	24672252	SENT35	7	7	21	21	vildagliptin	GLP-1	PA165958346	100125288	0.904
NULL	Oncol_Lett_2013_Jun_29_5(6)_1943-1947.nxml.txt.nlp	23833672	SENT7	3	3	17	17	celecoxib	AKT	PA448871	207	0.904
NULL	Infect_Drug_Resist_2012_Aug_8_5_121-127.nxml.txt.nlp	22893749	SENT38	23	23	12	12	ribavirin	URI	PA451241	8725	0.904
NULL	Clin_Ophthalmol_2010_Oct_21_4_1229-1236.nxml.txt.nlp	21060677	SENT88	15	15	17	17	latanoprost	BAK	PA164774763	578	0.904
NULL	Hum_Genomics_2009_Jan_1_3(2)_169-190.nxml.txt.nlp	19164093	SENT28	10	10	4	4	glipizide	CYP2C9	PA449762	1559	0.904
NULL	Biologics_2012_Dec_17_6_429-464.nxml.txt.nlp	23269860	SENT198	6	6	15	15	tocilizumab	ACR	PA165292659	49	0.904
NULL	Front_Oncol_2014_Apr_9_4_75.nxml.txt.nlp	24782986	SENT191	5	5	14	14	paclitaxel	CD34	PA450761	947	0.904
NULL	Ann_Oncol_2012_Dec_2_23(12)_3007-3016.nxml.txt.nlp	22865781	SENT113	16	16	6	6	everolimus	HER2	PA164746311	2064	0.904
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT258	7	7	5	5	adalimumab	CD36	PA10004	948	0.904
NULL	Oncotarget_2014_Oct_18_5(21)_10206-10221.nxml.txt.nlp	25344914	SENT123	7	7	27	27	vemurafenib	PDGFRB	PA165946873	5159	0.904
NULL	Oncotarget_2014_Jun_26_5(14)_5510-5522.nxml.txt.nlp	24980816	SENT42	6	6	18	18	doxycycline	BSP	PA449415	3381	0.904
NULL	Mol_Cancer_2014_Jan_13_13_7.nxml.txt.nlp	24418169	SENT40	19	19	36	36	sorafenib	STAT3	PA7000	6774	0.904
NULL	Eur_J_Endocrinol_2014_Mar_170(3)_451-459.nxml.txt.nlp	24362411	SENT176	21	21	23	23	metformin	GLP1	PA450395	100125288;2641	0.904
NULL	Ann_Dermatol_2011_Aug_6_23(3)_329-337.nxml.txt.nlp	21909203	SENT81	9	9	18	18	cyclophosphamide	CHOP	PA449165	1649	0.904
NULL	Chemother_Res_Pract_2011_Jun_21_2011_696208.nxml.txt.nlp	22312556	SENT177	8	8	22	22	erlotinib	EGFR	PA134687924	1956	0.904
NULL	Breast_Cancer_Res_2010_Oct_14_12(5)_R84.nxml.txt.nlp	20946630	SENT265	12	12	24	24	choline	Hsp90	PA448976	3320	0.904
NULL	Indian_J_Pharmacol_2009_Dec_41(6)_252-254.nxml.txt.nlp	20407554	SENT37	3	3	16	16	irbesartan	STZ	PA450084	6484	0.904
NULL	Acta_Pharmacol_Sin_2012_Jan_3_33(1)_82-90.nxml.txt.nlp	22212431	SENT222	16	16	4	4	rosiglitazone	PDK4	PA451283	5166	0.904
NULL	J_Inherit_Metab_Dis_2013_Jan_23_36(1)_29-34.nxml.txt.nlp	22729817	SENT97	31	31	18	18	estradiol	GALT	PA449503	2592	0.904
NULL	Diabetes_Care_2011_Jul_17_34(7)_e115-e120.nxml.txt.nlp	21709286	SENT110	5	5	0	0	metformin	AMPK	PA450395	5563	0.904
NULL	Cancer_Cell_Int_2011_Nov_2_11_39.nxml.txt.nlp	22047021	SENT232	24	24	7	7	cyclophosphamide	REV1	PA449165	51455	0.904
NULL	Br_J_Cancer_1999_Aug_80(12)_1945-1954.nxml.txt.nlp	10471043	SENT7	19	19	0	0	penicillamine	HO-1	PA450840	3162	0.904
NULL	Cancer_Res_Treat_2014_Jan_15_46(1)_19-26.nxml.txt.nlp	24520219	SENT92	8	8	2	2	fosaprepitant	NK1	PA165958390	11126	0.904
NULL	Neural_Regen_Res_2013_Mar_25_8(9)_825-832.nxml.txt.nlp	25206730	SENT13	0	0	18	18	isoflurane	P2X7	PA450106	5027	0.904
NULL	J_Cereb_Blood_Flow_Metab_2011_Oct_20_31(10)_2030-2040.nxml.txt.nlp	21505475	SENT203	5	5	21	21	cilostazol	Bcl-2	PA164746334	596	0.904
NULL	Front_Endocrinol_(Lausanne)_2011_Aug_11_2_21.nxml.txt.nlp	22654797	SENT19	23	23	29	29	estradiol	aromatase	PA449503	1588	0.904
NULL	Addict_Sci_Clin_Pract_2010_Dec_5(2)_17-29.nxml.txt.nlp	22002450	SENT144	23	23	9	9	bupropion	DRD2	PA448687	1813	0.904
NULL	J_Occup_Med_Toxicol_2008_Feb_27_3(Suppl_1)_S6.nxml.txt.nlp	18315837	SENT95	10	10	18	18	montelukast	IL-4	PA450546	3565	0.904
NULL	Evid_Based_Complement_Alternat_Med_2011_Feb_14_2011_248231.nxml.txt.nlp	19233878	SENT314	2	2	0	0	rosiglitazone	DBT	PA451283	1629	0.904
NULL	Cancer_Cell_Int_2009_Sep_12_9_26.nxml.txt.nlp	19747396	SENT144	23	23	15	15	warfarin	OPG	PA451906	690	0.904
NULL	Arthritis_Res_Ther_2011_Sep_21_13(5)_239.nxml.txt.nlp	21955617	SENT51	8	8	4	4	naproxen	COX	PA450595	1351	0.904
NULL	Sensors_(Basel)_2012_May_25_12(6)_7015-7032.nxml.txt.nlp	22969334	SENT272	16	16	2	2	oxygen	spatial	PA450744	219793	0.904
NULL	Indian_J_Sex_Transm_Dis_2013_Jul-Dec_34(2)_126-128.nxml.txt.nlp	24339465	SENT17	19	19	3	3	zidovudine	CD4	PA451954	920	0.904
NULL	Oncogenesis_2012_Apr_2_1(4)_e5.nxml.txt.nlp	23552603	SENT235	5	5	16	16	ns-398	cIAP1		329	0.904
NULL	Surg_Res_Pract_2014_Feb_6_2014_801643.nxml.txt.nlp	25379560	SENT12	21	21	10	10	cyclosporine	CD95	PA449167	355	0.904
NULL	Breast_Cancer_Res_2003_Apr_22_5(4)_R82-R87.nxml.txt.nlp	12817998	SENT73	16	16	6	6	estradiol	BP1	PA449503	1748	0.904
NULL	Braz_J_Med_Biol_Res_2013_Apr_12_46(4)_327-338.nxml.txt.nlp	23579631	SENT212	5	5	21	21	estradiol	SON	PA449503	6651	0.904
NULL	Br_J_Cancer_2010_May_11_102(10)_1503-1510.nxml.txt.nlp	20461093	SENT147	5	5	7	7	tamoxifen	aromatase	PA451581	1588	0.904
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT168	33	33	29	29	atorvastatin	RANKL	PA448500	8600	0.904
NULL	Front_Physiol_2011_Jun_14_2_26.nxml.txt.nlp	21716655	SENT224	36	36	28	28	lipase	NEFA	PA450239	4925	0.904
NULL	J_Immunol_Res_2014_Apr_3_2014_796856.nxml.txt.nlp	24804271	SENT78	25	25	21	21	bevacizumab	GM-CSF	PA130232992	1437	0.904
NULL	Int_J_Mol_Sci_2014_Jun_5_15(6)_10116-10135.nxml.txt.nlp	24905409	SENT180	0	0	28	28	curcumin	IL-4	PA151958596	3565	0.904
NULL	Pain_Res_Treat_2012_Mar_1_2012_348043.nxml.txt.nlp	22550578	SENT24	24	24	20	20	capsaicin	TRPV1	PA448776	7442	0.904
NULL	Clin_Exp_Otorhinolaryngol_2011_Mar_17_4(1)_18-23.nxml.txt.nlp	21461058	SENT74	9	9	16	16	bumetanide	NKCC1	PA448682	6558	0.904
NULL	Contemp_Oncol_(Pozn)_2012_Nov_20_16(5)_401-406.nxml.txt.nlp	23788917	SENT154	6	6	19	19	temsirolimus	EGFR	PA164746890	1956	0.904
NULL	Mol_Cancer_2007_Oct_11_6_63.nxml.txt.nlp	17931419	SENT87	13	13	16	16	gefitinib	EGFR	PA131301952	1956	0.904
NULL	Protein_Cell_2014_Jun_19_5(6)_469-479.nxml.txt.nlp	24748116	SENT94	16	16	9	9	paclitaxel	EB1	PA450761	9167;22919;10982	0.904
NULL	Braz_J_Med_Biol_Res_2013_Mar_15_46(3)_299-305.nxml.txt.nlp	23532269	SENT156	0	0	11	11	propofol	TLR4	PA451141	7099	0.904
NULL	Anticancer_Drugs_2015_Feb_22_26(2)_139-147.nxml.txt.nlp	25203626	SENT184	10	10	37	37	sorafenib	PARP1	PA7000	142	0.904
NULL	Gut_2012_May_7_61(5)_673-684.nxml.txt.nlp	22315472	SENT302	18	18	11	11	trastuzumab	PI3K	PA451743	5290	0.904
NULL	Oncogene_2014_Aug_28_33(35)_4396-4406.nxml.txt.nlp	24531714	SENT58	29	29	14	14	nutlin-3	p53		7157	0.904
NULL	Eur_J_Endocrinol_2010_May_162(5)_987-992.nxml.txt.nlp	20164212	SENT6	21	21	3	3	diazoxide	ABCC8	PA449285	6833	0.904
NULL	Br_J_Cancer_2013_Jun_25_108(12)_2470-2477.nxml.txt.nlp	23695024	SENT89	8	8	12	12	sunitinib	IFN	PA162372840	3439	0.904
NULL	Mol_Cancer_2014_Jun_24_13_157.nxml.txt.nlp	24958351	SENT23	9	9	39	39	trastuzumab	EGFR	PA451743	1956	0.904
NULL	Blood_Res_2014_Sep_25_49(3)_148-153.nxml.txt.nlp	25325033	SENT47	43	43	15	15	methotrexate	B2M	PA450428	567	0.904
NULL	Diabetes_Care_2008_Jul_31(7)_1427-1432.nxml.txt.nlp	18390799	SENT120	5	5	14	14	metformin	RBP4	PA450395	5433;5950	0.904
NULL	Acta_Pharmacol_Sin_2010_Nov_18_31(11)_1447-1453.nxml.txt.nlp	20953204	SENT15	0	0	22	22	rimonabant	IL-6	PA152407999	3569	0.904
NULL	Front_Oncol_2013_Nov_18_3_282.nxml.txt.nlp	24303367	SENT239	5	5	16	16	olaparib	PARP		142	0.904
NULL	J_Mol_Signal_2007_Jul_16_2_6.nxml.txt.nlp	17634137	SENT91	21	21	3	3	doxycycline	CLU	PA449415	1191	0.904
NULL	Cell_Cycle_2013_May_15_12(10)_1492-1500.nxml.txt.nlp	23598717	SENT19	21	21	24	24	doxorubicin	ROCK2	PA449412	9475	0.904
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_7-17.nxml.txt.nlp	17912633	SENT368	39	39	29	29	letrozole	AMH	PA450196	268	0.904
NULL	Br_J_Cancer_1996_Apr_73(7)_849-855.nxml.txt.nlp	8611394	SENT12	11	11	1	1	calcein	MDR1	PA132595336	5243	0.904
NULL	Aging_(Albany_NY)_2014_Jul_19_6(9)_755-769.nxml.txt.nlp	25324471	SENT274	9	9	2	2	trypsin	MADA	PA451806	270	0.904
NULL	Front_Immunol_2012_Mar_21_3_57.nxml.txt.nlp	22566938	SENT53	22	22	12	12	vasopressin	IRAP	PA451858	3557	0.904
NULL	Biosci_Rep_2014_Aug_6_34(4)_e00131.nxml.txt.nlp	24975826	SENT162	3	3	11	11	probenecid	TRPM8	PA451106	79054	0.904
NULL	Br_J_Clin_Pharmacol_2012_Apr_7_73(4)_518-535.nxml.txt.nlp	22053916	SENT64	23	23	7	7	pitavastatin	CYP2C9	PA142650384	1559	0.904
NULL	Breast_Cancer_Res_Treat_2014_Sep_25_148(1)_81-90.nxml.txt.nlp	25253174	SENT261	13	13	3	3	metformin	LKB1	PA450395	6794	0.904
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1059-1066.nxml.txt.nlp	21364577	SENT4	23	23	7	7	letrozole	aromatase	PA450196	1588	0.904
NULL	Behav_Brain_Funct_2010_Dec_9_6_72.nxml.txt.nlp	21143898	SENT42	31	31	1	1	methamphetamine	ANOVA	PA450403	4858	0.904
NULL	Crit_Care_2014_Mar_17_18(Suppl_1)_P339.nxml.txt.nlp	NULL	SENT21	8	8	16	16	losartan	T-bet	PA450268	30009	0.904
NULL	J_Radiat_Res_2012_Jul_12_53(4)_551-557.nxml.txt.nlp	22843620	SENT130	12	12	18	18	genistein	PP2	PA165109660	4888	0.904
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_23_2013_941093.nxml.txt.nlp	23864901	SENT245	9	9	11	11	amiodarone	CYP2C9	PA448383	1559	0.904
NULL	Mol_Cancer_2009_Nov_24_8_109.nxml.txt.nlp	19930708	SENT168	1	1	7	7	exemestane	aromatase	PA449563	1588	0.904
NULL	Oncogenesis_2014_Dec_15_3(12)_e133.nxml.txt.nlp	25500906	SENT78	8	8	21	21	trastuzumab	PI3K	PA451743	5290	0.904
NULL	Acta_Pharmacol_Sin_2010_Feb_5_31(2)_137-144.nxml.txt.nlp	20139896	SENT122	5	5	3	3	zileuton	5-LOX	PA451955	240	0.904
NULL	Diabetologia_2010_Jul_2_53(7)_1270-1287.nxml.txt.nlp	20361178	SENT277	6	6	16	16	pioglitazone	adiponectin	PA450970	9370	0.904
NULL	Exp_Diabetes_Res_2012_Jan_29_2012_159874.nxml.txt.nlp	22319521	SENT239	17	17	9	9	telmisartan	Hes1	PA451605	3280	0.904
NULL	Int_Semin_Surg_Oncol_2008_Apr_28_5_9.nxml.txt.nlp	18442393	SENT76	18	18	8	8	tamoxifen	HER-2	PA451581	2064	0.904
NULL	Biomed_Res_Int_2013_Jul_9_2013_580796.nxml.txt.nlp	23936821	SENT23	11	11	21	21	ribavirin	SOC	PA451241	91544	0.904
NULL	Blood_Cancer_J_2013_Oct_18_3(10)_e153.nxml.txt.nlp	24141622	SENT89	21	21	15	15	fludarabine	Mcl-1	PA449655	4170	0.904
NULL	Contemp_Oncol_(Pozn)_2012_Sep_29_16(4)_316-321.nxml.txt.nlp	23788901	SENT114	17	17	13	13	etoposide	STAT3	PA449552	6774	0.904
NULL	Acta_Histochem_Cytochem_2012_Apr_26_45(2)_139-146.nxml.txt.nlp	22685356	SENT106	24	24	4	4	forskolin	AQP2	PA146096022	359	0.904
NULL	Oncologist_2010_Feb_15_15(2)_122-129.nxml.txt.nlp	20156908	SENT131	2	2	5	5	lapatinib	aromatase	PA152241907	1588	0.904
NULL	Eur_J_Clin_Pharmacol_2012_Jan_8_68(1)_29-37.nxml.txt.nlp	21739267	SENT3	7	7	21	21	paroxetine	CYP2D6	PA450801	1565	0.904
NULL	Cancer_Metastasis_Rev_2010_Dec_10_29(4)_581-594.nxml.txt.nlp	20830503	SENT71	18	18	15	15	exemestane	aromatase	PA449563	1588	0.904
NULL	ScientificWorldJournal_2012_Jun_18_2012_564939.nxml.txt.nlp	22778699	SENT134	18	18	10	10	tramadol	IL-6	PA451735	3569	0.904
NULL	J_Cell_Mol_Med_2014_Sep_7_18(9)_1785-1796.nxml.txt.nlp	24909956	SENT194	27	27	8	8	cangrelor	GPR17	PA165945763	2840	0.904
NULL	J_Carcinog_2011_Jun_17_10_16.nxml.txt.nlp	NULL	SENT68	3	3	5	5	resveratrol	p53		7157	0.904
NULL	Bone_Marrow_Transplant_2014_Feb_4_49(2)_201-205.nxml.txt.nlp	24185588	SENT99	8	8	32	32	lenalidomide	CD34	PA162363968	947	0.904
NULL	Br_J_Cancer_2009_Mar_10_100(5)_758-763.nxml.txt.nlp	19259094	SENT140	27	27	3	3	belinostat	MLH1		4292	0.904
NULL	Mol_Cancer_2010_Nov_2_9_289.nxml.txt.nlp	21044322	SENT165	32	32	6	6	docetaxel	RGS10	PA449383	6001	0.904
NULL	Front_Endocrinol_(Lausanne)_2014_Feb_28_5_23.nxml.txt.nlp	24592256	SENT48	9	9	1	1	ramipril	DREAM	PA451223	30818	0.904
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jul_8_65(Pt_8)_o1791.nxml.txt.nlp	21583497	SENT56	17	17	14	14	ethanol	mol	PA448073	90527	0.904
NULL	Cancer_Cell_Int_2013_Mar_4_13_21.nxml.txt.nlp	23497288	SENT220	12	12	10	10	doxorubicin	EWS	PA449412	2130	0.904
NULL	Cancer_Cell_Int_2013_Sep_23_13_94.nxml.txt.nlp	24059699	SENT212	42	42	29	29	bevacizumab	VEGFR1	PA130232992	2321	0.904
NULL	Int_Semin_Surg_Oncol_2006_Sep_18_3_31.nxml.txt.nlp	16981992	SENT30	14	14	1	1	anastrozole	ATAC	PA448432	6375	0.904
NULL	BMB_Rep_2013_Jan_46(1)_59-64.nxml.txt.nlp	23351386	SENT103	6	6	14	14	auranofin	STAT3	PA448510	6774	0.904
NULL	AIDS_Res_Ther_2013_May_1_10_10.nxml.txt.nlp	23634877	SENT12	12	12	23	23	lovastatin	CCL4	PA450272	6351	0.904
NULL	Ecancermedicalscience_2009_Oct_29_3_157.nxml.txt.nlp	22276018	SENT106	43	43	33	33	tamoxifen	HER-2	PA451581	2064	0.904
NULL	Case_Rep_Med_2012_Aug_13_2012_849285.nxml.txt.nlp	22927863	SENT62	6	6	18	18	rituximab	CHOP	PA451261	1649	0.904
NULL	Breast_Cancer_Res_2009_Oct_28_11(5)_211.nxml.txt.nlp	19889200	SENT230	26	26	14	14	tamoxifen	HER2	PA451581	2064	0.904
NULL	Mol_Cancer_2010_Nov_2_9_289.nxml.txt.nlp	21044322	SENT214	30	30	9	9	cisplatin	RGS10	PA449014	6001	0.904
NULL	Genome_Biol_2011_May_25_12(5)_R46.nxml.txt.nlp	21609475	SENT134	15	15	9	9	etoposide	CCND1	PA449552	595	0.904
NULL	Front_Mol_Neurosci_2013_Apr_10_6_7.nxml.txt.nlp	23596389	SENT267	30	30	21	21	furosemide	KCC2	PA449719	57468	0.904
NULL	Behav_Brain_Funct_2013_Dec_30_9_48.nxml.txt.nlp	24377651	SENT35	2	2	22	22	methamphetamine	BAIAP2	PA450403	10458	0.904
NULL	Clin_Med_Insights_Oncol_2011_May_10_5_131-144.nxml.txt.nlp	21695100	SENT113	24	24	34	34	cisplatin	EGFR	PA449014	1956	0.904
NULL	Oncotarget_2011_Dec_24_2(12)_896-917.nxml.txt.nlp	22203527	SENT175	19	19	33	33	lapatinib	survivin	PA152241907	332	0.904
NULL	Fibrogenesis_Tissue_Repair_2011_Aug_2_4_18.nxml.txt.nlp	21810214	SENT232	13	13	3	3	bleomycin	IL-4	PA448645	3565	0.904
NULL	Anat_Cell_Biol_2010_Sep_30_43(3)_194-200.nxml.txt.nlp	21212859	SENT15	12	12	0	0	ethanol	PLP	PA448073	25824;5744	0.904
NULL	Curr_Pharm_Biotechnol_2012_May_13(6)_969-986.nxml.txt.nlp	22039792	SENT177	28	28	25	25	ivermectin	P-gp	PA450133	5243	0.904
NULL	Br_J_Cancer_1996_Jun_73(11)_1356-1361.nxml.txt.nlp	8645579	SENT17	16	16	11	11	hydrocortisone	TNF-alpha	PA449905	7124	0.904
NULL	Front_Oncol_2014_Mar_25_4_54.nxml.txt.nlp	24724051	SENT123	8	8	10	10	everolimus	TORC1	PA164746311	23373	0.904
NULL	Infect_Dis_Ther_2014_Dec_12_3(2)_103-122.nxml.txt.nlp	25388760	SENT240	28	28	4	4	loperamide	P-gp	PA450262	5243	0.904
NULL	Sci_Rep_2015_Jan_6_5_7641.nxml.txt.nlp	25560734	SENT405	32	32	41	41	tamoxifen	CLTC	PA451581	1213	0.904
NULL	Mol_Cancer_2012_Mar_21_11_13.nxml.txt.nlp	22436134	SENT17	15	15	36	36	doxorubicin	HuR	PA449412	1994	0.904
NULL	Neuro_Oncol_2011_Jan_25_13(1)_70-83.nxml.txt.nlp	20978004	SENT259	26	26	3	3	etoposide	CD133	PA449552	8842	0.904
NULL	Clin_Interv_Aging_2010_Dec_3_5_403-416.nxml.txt.nlp	21152242	SENT151	32	32	20	20	telmisartan	ACE	PA451605	1636	0.904
NULL	Nucleic_Acids_Res_2007_Jul_10_35(13)_e93.nxml.txt.nlp	17626049	SENT56	32	32	3	3	galactose	DFF45	PA449725	1676	0.904
NULL	J_Hematol_Oncol_2010_Oct_27_3_42.nxml.txt.nlp	20979652	SENT192	0	0	7	7	bevacizumab	VEGF-A	PA130232992	7422	0.904
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT112	4	4	16	16	doxorubicin	B7-H1	PA449412	29126	0.904
NULL	Cell_Cycle_2013_Sep_15_12(18)_3025-3036.nxml.txt.nlp	23974102	SENT8	12	12	17	17	infliximab	CD4	PA452639	920	0.904
NULL	Eur_J_Clin_Pharmacol_2011_Dec_23_67(12)_1231-1241.nxml.txt.nlp	21698374	SENT299	13	13	4	4	tacrolimus	MDR1	PA451578	5243	0.904
NULL	Mol_Cancer_2013_Nov_11_12_134.nxml.txt.nlp	24215614	SENT33	18	18	32	32	trastuzumab	EGFR	PA451743	1956	0.904
NULL	Exp_Ther_Med_2013_May_15_5(5)_1327-1331.nxml.txt.nlp	23737873	SENT146	6	6	19	19	imidapril	AQP2	PA452640	359	0.904
NULL	Indian_J_Med_Res_2012_Sep_136(3)_460-465.nxml.txt.nlp	23041740	SENT107	0	0	2	2	resveratrol	CYP1A1		1543	0.904
NULL	Alzheimers_Res_Ther_2013_Nov_27_5(6)_51.nxml.txt.nlp	24280275	SENT297	7	7	24	24	flurbiprofen	LRP1	PA449683	10438;4035	0.904
NULL	J_Neuroinflammation_2010_Sep_7_7_51.nxml.txt.nlp	20822529	SENT176	20	20	11	11	hemin	HO-1	PA449849	3162	0.904
NULL	Oncotarget_2014_Aug_29_5(18)_8052-8082.nxml.txt.nlp	25211298	SENT162	0	0	4	4	auranofin	STAT3	PA448510	6774	0.904
NULL	J_Cell_Biol_2001_Oct_29_155(3)_447-458.nxml.txt.nlp	11684709	SENT314	6	6	30	30	pp2	p38		10598;1432;7965	0.904
NULL	Breast_Cancer_Res_2007_Jun_4_9(3)_207.nxml.txt.nlp	17561991	SENT181	42	42	27	27	trastuzumab	HER-2	PA451743	2064	0.904
NULL	Case_Rep_Med_2014_Mar_4_2014_923496.nxml.txt.nlp	24715926	SENT137	20	20	34	34	tocilizumab	IL-6	PA165292659	3569	0.904
NULL	Oncotarget_2011_Dec_31_2(12)_1314-1321.nxml.txt.nlp	22248929	SENT98	4	4	7	7	lapatinib	HER2	PA152241907	2064	0.904
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_79-96.nxml.txt.nlp	19305789	SENT129	12	12	22	22	capsaicin	TRPV1	PA448776	7442	0.904
NULL	Acta_Oncol_2013_May_13_52(4)_776-782.nxml.txt.nlp	23480638	SENT155	17	17	26	26	imatinib	KIT	PA10804	3815	0.904
NULL	Cancer_Biol_Med_2013_Mar_10(1)_16-21.nxml.txt.nlp	23691440	SENT127	16	16	8	8	doxorubicin	Bcl-2	PA449412	596	0.904
NULL	Mol_Cancer_2010_Apr_15_9_77.nxml.txt.nlp	20398291	SENT50	10	10	25	25	geldanamycin	survivin	PA152031327	332	0.904
NULL	Blood_Cancer_J_2014_Feb_28_4(2)_e187.nxml.txt.nlp	24583533	SENT31	13	13	37	37	azacitidine	CD25	PA451996	3669;3559	0.904
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1059-1066.nxml.txt.nlp	21364577	SENT23	18	18	28	28	exemestane	aromatase	PA449563	1588	0.904
NULL	Exp_Ther_Med_2013_Nov_6_6(5)_1089-1095.nxml.txt.nlp	24223627	SENT32	38	38	2	2	epirubicin	NAC	PA449476	22861	0.904
NULL	J_Neurovirol_2011_Feb_19_17(1)_63-69.nxml.txt.nlp	21246320	SENT9	18	18	26	26	memantine	IP-10	PA10364	3627	0.904
NULL	Clin_Mol_Allergy_2007_Jan_25_5_1.nxml.txt.nlp	17254346	SENT214	4	4	7	7	curcumin	IFN	PA151958596	3439	0.904
NULL	Front_Genet_2014_Oct_21_5_372.nxml.txt.nlp	25374583	SENT194	18	18	0	0	hydroxyurea	FANCJ	PA449942	83990	0.904
NULL	J_Physiol_2014_Nov_1_592(21)_4715-4731.nxml.txt.nlp	25172947	SENT91	18	18	11	11	l-arginine	ADP	PA448478	23038	0.904
NULL	EPMA_J_2010_Sep_22_1(3)_377-387.nxml.txt.nlp	23199082	SENT314	4	4	15	15	paclitaxel	KRAS	PA450761	3845	0.904
NULL	Gut_2008_Nov_2_57(11)_1509-1517.nxml.txt.nlp	18596194	SENT187	21	21	11	11	curcumin	p38	PA151958596	10598;1432;7965	0.904
NULL	J_Hematol_Oncol_2012_Oct_10_5_62.nxml.txt.nlp	23050865	SENT97	15	15	10	10	gefitinib	EGFR	PA131301952	1956	0.904
NULL	Autophagy_2012_May_1_8(5)_853-855.nxml.txt.nlp	22617440	SENT68	16	16	7	7	imatinib	MIR30A	PA10804	407029	0.904
NULL	Cancer_Biol_Med_2012_Dec_9(4)_221-233.nxml.txt.nlp	23691482	SENT189	18	18	3	3	calcein	NIR	PA132595336	26155	0.904
NULL	Mol_Cancer_2014_Jun_24_13_157.nxml.txt.nlp	24958351	SENT23	25	25	20	20	lapatinib	HER2	PA152241907	2064	0.904
NULL	Biosci_Rep_2014_Apr_15_34(2)_e00105.nxml.txt.nlp	24617546	SENT125	21	21	12	12	metformin	AMPK	PA450395	5563	0.904
NULL	Iran_Red_Crescent_Med_J_2014_Sep_5_16(9)_e20153.nxml.txt.nlp	25593732	SENT12	0	0	18	18	halothane	CYP2E1	PA449845	1571	0.904
NULL	Int_J_Mol_Sci_2012_Aug_13_13(8)_10091-10112.nxml.txt.nlp	22949849	SENT117	13	13	23	23	ethanol	PPL	PA448073	5493	0.904
NULL	J_Mol_Signal_2008_Dec_2_3_19.nxml.txt.nlp	19055733	SENT49	3	3	21	21	isoproterenol	AKAP12	PA450121	9590	0.904
NULL	JAKSTAT_2013_Jan_1_2(1)_e23820.nxml.txt.nlp	24058799	SENT92	25	25	5	5	imiquimod	IFN	PA449972	3439	0.904
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Sep_30_66(Pt_10)_o2686.nxml.txt.nlp	21587654	SENT54	18	18	12	12	ethanol	mol	PA448073	90527	0.904
NULL	Biomed_Res_Int_2014_Jun_26_2014_483501.nxml.txt.nlp	25057490	SENT145	2	2	9	9	resveratrol	Bcl-2		596	0.904
NULL	Br_J_Cancer_2004_Mar_22_90(6)_1285-1292.nxml.txt.nlp	15026814	SENT200	6	6	14	14	doxorubicin	p53	PA449412	7157	0.904
NULL	Neural_Plast_2014_Mar_17_2014_123026.nxml.txt.nlp	24757568	SENT10	14	14	8	8	fluoxetine	CA3	PA449673	761	0.904
NULL	Aging_(Albany_NY)_2011_Jan_18_3(1)_33-43.nxml.txt.nlp	21248371	SENT126	5	5	19	19	zinc	p53	PA451956	7157	0.904
NULL	Curr_Genomics_2014_Feb_15(1)_18-27.nxml.txt.nlp	24653660	SENT147	40	40	44	44	levodopa	DYT14	PA450213	93984	0.904
NULL	Case_Rep_Psychiatry_2012_Jun_5_2012_496364.nxml.txt.nlp	22934218	SENT51	27	27	17	17	levomepromazine	FGA	PA134687942	2243	0.904
NULL	Open_Cardiovasc_Med_J_2011_Feb_15_5_15-21.nxml.txt.nlp	21660251	SENT23	12	12	25	25	sr144528	CB2		1269	0.904
NULL	Mol_Med_Rep_2015_Jan_22_11(1)_83-90.nxml.txt.nlp	25338529	SENT10	3	3	14	14	octreotide	HO-1	PA450678	3162	0.904
NULL	Biomed_Res_Int_2013_Nov_10_2013_237543.nxml.txt.nlp	24312908	SENT42	23	23	15	15	celecoxib	COX	PA448871	1351	0.904
NULL	Mol_Med_Rep_2015_Jan_16_11(1)_91-98.nxml.txt.nlp	25322694	SENT170	10	10	44	44	cisplatin	LC3	PA449014	84557	0.904
NULL	Front_Oncol_2014_Apr_28_4_90.nxml.txt.nlp	24809021	SENT71	16	16	2	2	etoposide	U87	PA449552	677775;641648	0.904
NULL	Carcinogenesis_2013_Mar_7_34(3)_703-712.nxml.txt.nlp	23222814	SENT121	8	8	24	24	curcumin	ANOVA	PA151958596	4858	0.904
NULL	Br_J_Cancer_2010_Jan_19_102(2)_383-391.nxml.txt.nlp	20010943	SENT140	39	39	17	17	cisplatin	JNK	PA449014	5599	0.904
NULL	Tumour_Biol_2013_Jun_5_34(3)_1371-1380.nxml.txt.nlp	23558965	SENT117	4	4	21	21	gefitinib	EGFR	PA131301952	1956	0.904
NULL	Breast_Cancer_Res_Treat_2013_Jan_6_137(1)_167-174.nxml.txt.nlp	23129173	SENT186	7	7	30	30	letrozole	aromatase	PA450196	1588	0.904
NULL	Oncol_Lett_2013_Apr_28_5(4)_1149-1154.nxml.txt.nlp	23599754	SENT99	5	5	2	2	cisplatin	Dicer	PA449014	23405	0.904
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT287	11	11	6	6	resveratrol	IL-6		3569	0.904
NULL	Indian_J_Pharm_Sci_2009_Nov-Dec_71(6)_622-629.nxml.txt.nlp	20376214	SENT72	15	15	1	1	mannitol	B13	PA450320	4698	0.904
NULL	Clin_Med_Insights_Cardiol_2011_Oct_6_5_103-119.nxml.txt.nlp	22084608	SENT45	4	4	2	2	amiodarone	CYP2C9	PA448383	1559	0.904
NULL	EMBO_Mol_Med_2012_Jul_18_4(7)_557-560.nxml.txt.nlp	22610822	SENT23	26	26	8	8	resveratrol	SIRT1		23411	0.904
NULL	Orphanet_J_Rare_Dis_2008_Jul_7_3_18.nxml.txt.nlp	18606002	SENT350	34	34	6	6	mexiletine	LQT3	PA450488	6331	0.904
NULL	Br_J_Cancer_2012_Jan_31_106(3)_482-489.nxml.txt.nlp	22233925	SENT191	26	26	34	34	carboplatin	PEO1	PA448803	56652	0.904
NULL	Dement_Geriatr_Cogn_Dis_Extra_2014_Nov_15_4(3)_450-456.nxml.txt.nlp	25538729	SENT105	5	5	11	11	donepezil	APOE	PA449394	348	0.904
NULL	J_Cancer_2013_Nov_23_4(9)_736-754.nxml.txt.nlp	24312144	SENT169	9	9	21	21	docetaxel	EGFR	PA449383	1956	0.904
NULL	Ann_Hematol_2015_Aug_3_94_35-43.nxml.txt.nlp	25085377	SENT242	15	15	1	1	rituximab	BAFF	PA451261	10673	0.904
NULL	Nat_Commun_2013_Apr_9_4_1684.nxml.txt.nlp	23575688	SENT49	3	3	19	19	rolipram	CYLD	PA153906323	1540	0.904
NULL	Oncogene_2010_Jul_22_29(29)_4170-4182.nxml.txt.nlp	20498638	SENT31	20	20	3	3	cetuximab	EGFR	PA10040	1956	0.904
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT80	10	10	19	19	delavirdine	CYP3A4	PA449223	1576	0.904
NULL	Oncotarget_2014_Jun_26_5(14)_5510-5522.nxml.txt.nlp	24980816	SENT213	28	28	16	16	doxycycline	BSP	PA449415	3381	0.904
NULL	BMB_Rep_2014_Nov_47(11)_649-654.nxml.txt.nlp	25301019	SENT85	7	7	24	24	l-serine	IL-10	PA451330	3586	0.904
NULL	Int_J_Mol_Sci_2014_Mar_19_15(3)_4837-4855.nxml.txt.nlp	24651458	SENT138	19	19	26	26	staurosporine	PI3K	PA165109623	5290	0.904
NULL	Am_J_Case_Rep_2014_Feb_24_15_85-89.nxml.txt.nlp	24587856	SENT47	20	20	42	42	exemestane	aromatase	PA449563	1588	0.904
NULL	Acta_Pharmacol_Sin_2013_Jan_23_34(1)_33-38.nxml.txt.nlp	22820909	SENT128	5	5	13	13	lidocaine	ASIC2a	PA450226	40	0.904
NULL	Exp_Diabetes_Res_2012_Oct_15_2012_465282.nxml.txt.nlp	23118742	SENT4	17	17	24	24	metformin	FGF21	PA450395	26291	0.904
NULL	Br_J_Pharmacol_2014_Jan_23_171(2)_523-535.nxml.txt.nlp	24372553	SENT18	6	6	18	18	metformin	SIRT1	PA450395	23411	0.904
NULL	Osteoporos_Int_2013_Jan_10_24(1)_227-235.nxml.txt.nlp	22776860	SENT34	12	12	10	10	denosumab	RANK	PA166048634	8792	0.904
NULL	Oncologist_2010_Apr_29_15(4)_390-404.nxml.txt.nlp	20350999	SENT133	44	44	29	29	cetuximab	KRAS	PA10040	3845	0.904
NULL	Clinics_(Sao_Paulo)_2014_Jan_69(1)_68-74.nxml.txt.nlp	24473562	SENT91	44	44	24	24	nutlin-3	SOCS-1		8651	0.904
NULL	Clinics_(Sao_Paulo)_2014_Jan_69(1)_68-74.nxml.txt.nlp	24473562	SENT105	17	17	24	24	nutlin-3	SOCS-1		8651	0.904
NULL	Oncotarget_2013_Nov_23_5(1)_196-210.nxml.txt.nlp	24344116	SENT77	13	13	8	8	doxorubicin	ICAM1	PA449412	3383	0.904
NULL	Front_Endocrinol_(Lausanne)_2013_Nov_11_4_166.nxml.txt.nlp	24273531	SENT244	38	38	41	41	losartan	AT2	PA450268	186	0.904
NULL	ScientificWorldJournal_2013_Sep_21_2013_208309.nxml.txt.nlp	24170980	SENT145	24	24	29	29	lenalidomide	MRP8	PA162363968	6833;6279;85320	0.904
NULL	Osteoporos_Int_2011_Aug_30_22(8)_2337-2345.nxml.txt.nlp	21116816	SENT165	44	44	8	8	fluvastatin	IL-6	PA449688	3569	0.904
NULL	Open_Ophthalmol_J_2013_Feb_1_7_4-10.nxml.txt.nlp	23459241	SENT112	30	30	43	43	bevacizumab	VEGF-A	PA130232992	7422	0.904
NULL	Diagn_Pathol_2014_Aug_9_9(1)_153.nxml.txt.nlp	NULL	SENT27	14	14	38	38	erlotinib	PIK3CA	PA134687924	5290	0.904
NULL	Crit_Care_2012_Jun_7_16(Suppl_2)_A25.nxml.txt.nlp	NULL	SENT94	6	6	8	8	tacrolimus	IL-6	PA451578	3569	0.904
NULL	Scientifica_(Cairo)_2012_Dec_31_2012_205027.nxml.txt.nlp	24278677	SENT411	35	35	20	20	eplerenone	AT1	PA164749044	9197;185	0.904
NULL	Oncol_Lett_2014_Nov_14_8(5)_2086-2092.nxml.txt.nlp	25295095	SENT25	24	24	19	19	gemcitabine	LKB1	PA449748	6794	0.904
NULL	Arthritis_Res_Ther_2008_Apr_16_10(2)_R43.nxml.txt.nlp	18416822	SENT113	32	32	30	30	sr144528	CB2		1269	0.904
NULL	Case_Rep_Oncol_2012_May_23_5(2)_253-259.nxml.txt.nlp	22712013	SENT5	0	0	4	4	erlotinib	EGFR	PA134687924	1956	0.904
NULL	EJNMMI_Res_2011_Jul_29_1_12.nxml.txt.nlp	22214199	SENT185	20	20	14	14	tariquidar	P-gp		5243	0.904
NULL	Int_J_Biol_Sci_2014_Jun_21_10(7)_702-714.nxml.txt.nlp	25013379	SENT156	20	20	17	17	gefitinib	EGFR	PA131301952	1956	0.904
NULL	Breast_Cancer_Res_2004_Aug_5_6(5)_R601-R607.nxml.txt.nlp	15318941	SENT131	40	40	28	28	cisplatin	p27	PA449014	5715;10534	0.904
NULL	Breast_Cancer_Res_2010_Jul_22_12(4)_R53.nxml.txt.nlp	20649975	SENT31	15	15	27	27	tamoxifen	HOXB13	PA451581	10481	0.904
NULL	Eur_J_Endocrinol_2011_Jan_164(1)_69-74.nxml.txt.nlp	20961967	SENT79	16	16	19	19	pioglitazone	adiponectin	PA450970	9370	0.904
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT115	11	11	18	18	sulindac	survivin	PA451565	332	0.904
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT13	3	3	28	28	curcumin	TRAIL	PA151958596	8743	0.904
NULL	Biomed_Res_Int_2013_Aug_6_2013_909613.nxml.txt.nlp	24027765	SENT334	24	24	33	33	hydrocortisone	EEN	PA449905	6455	0.904
NULL	Mol_Cancer_2013_May_1_12_34.nxml.txt.nlp	23634843	SENT4	38	38	40	40	tamoxifen	aromatase	PA451581	1588	0.904
NULL	J_Immunother_Cancer_2014_Jan_27_2_2.nxml.txt.nlp	24829759	SENT170	11	11	7	7	sorafenib	IL-21	PA7000	59067;50616;27189	0.904
NULL	FEBS_Open_Bio_2014_Oct_22_4_905-914.nxml.txt.nlp	25383314	SENT595	2	2	11	11	physostigmine	L-FABP	PA450957	2168	0.904
NULL	Crit_Care_2010_Oct_13_14(5)_R181.nxml.txt.nlp	20942931	SENT15	15	15	1	1	cisplatin	IL-6	PA449014	3569	0.904
NULL	Exp_Ther_Med_2014_Aug_28_8(2)_493-498.nxml.txt.nlp	25009607	SENT80	4	4	23	23	fluorescein	SP-C	PA164746009	6440	0.904
NULL	Breast_Cancer_Res_Treat_2013_Jan_15_137(2)_397-406.nxml.txt.nlp	23242584	SENT193	4	4	18	18	tamoxifen	EGF	PA451581	1950	0.904
NULL	Clin_Pharmacol_2012_Feb_20_4_13-20.nxml.txt.nlp	22427735	SENT101	10	10	2	2	clopidogrel	PON1	PA449053	5444	0.904
NULL	J_Invest_Dermatol_2012_Sep_10_132(9)_2255-2262.nxml.txt.nlp	22572817	SENT139	26	26	6	6	forskolin	MC1R	PA146096022	4157	0.904
NULL	Diabetes_Care_2011_Mar_17_34(3)_730-733.nxml.txt.nlp	21289232	SENT9	0	0	22	22	pioglitazone	IL-10	PA450970	3586	0.904
NULL	Front_Oncol_2013_Nov_27_3_290.nxml.txt.nlp	24350055	SENT89	23	23	4	4	imatinib	PARP-1	PA10804	25976	0.904
NULL	Ann_Rheum_Dis_2014_Sep_2_73(9)_1626-1634.nxml.txt.nlp	24297381	SENT264	10	10	6	6	tocilizumab	IL-6	PA165292659	3569	0.904
NULL	BMB_Rep_2014_Nov_47(11)_649-654.nxml.txt.nlp	25301019	SENT87	5	5	11	11	l-alanine	CCL2	PA448055	6347	0.904
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT38	0	0	7	7	neratinib	EGFR	PA165291472	1956	0.904
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT164	27	27	20	20	atorvastatin	CD14	PA448500	929	0.904
NULL	J_Asthma_Allergy_2008_Sep_19_1_19-29.nxml.txt.nlp	21436982	SENT110	30	30	23	23	fexofenadine	MDC	PA449621	6367	0.904
NULL	Nat_Med_2014_Jul_1_20(7)_715-724.nxml.txt.nlp	24880616	SENT127	9	9	18	18	estradiol	VAMP7	PA449503	6845	0.904
NULL	Eur_J_Clin_Pharmacol_2011_May_9_67(5)_477-482.nxml.txt.nlp	21305273	SENT108	25	25	28	28	dobutamine	DSE	PA449381	29940	0.904
NULL	Mol_Cancer_2008_Jun_5_7_50.nxml.txt.nlp	18534018	SENT72	4	4	19	19	bortezomib	XIAP	PA10252	331	0.904
NULL	Case_Rep_Hematol_2013_Oct_9_2013_458303.nxml.txt.nlp	24224106	SENT37	19	19	13	13	vincristine	CHOP	PA451879	1649	0.904
NULL	Nat_Commun_2014_5_3361.nxml.txt.nlp	24553445	SENT101	8	8	22	22	olaparib	PTEN		5728	0.904
NULL	Cancers_(Basel)_2010_Dec_16_2(4)_2138-2152.nxml.txt.nlp	24281221	SENT25	36	36	18	18	gemcitabine	HIF-1	PA449748	29072	0.904
NULL	Angiogenesis_2010_Dec_7_13(4)_305-315.nxml.txt.nlp	20927579	SENT145	21	21	9	9	resveratrol	p53		7157	0.904
NULL	Arthritis_Res_Ther_2014_Apr_11_16(2)_R93.nxml.txt.nlp	24725461	SENT6	20	20	3	3	estradiol	aromatase	PA449503	1588	0.904
NULL	Clin_Med_Insights_Cardiol_2010_Dec_1_4_117-128.nxml.txt.nlp	21151850	SENT195	5	5	0	0	cilostazol	CYP2C19	PA164746334	1557	0.904
NULL	Oncol_Rep_2014_Feb_13_31(2)_581-588.nxml.txt.nlp	24337105	SENT180	18	18	8	8	capsaicin	CHOP	PA448776	1649	0.904
NULL	J_Cell_Mol_Med_2014_Aug_1_18(8)_1599-1611.nxml.txt.nlp	24889822	SENT235	3	3	22	22	resveratrol	SIRT1		23411	0.904
NULL	J_Int_Soc_Sports_Nutr_2010_Aug_22_7_28.nxml.txt.nlp	20727213	SENT157	7	7	15	15	l-glutamine	AMPK	PA10090	5563	0.904
NULL	J_Infect_Dis_2014_Dec_15_210(12)_2001-2008.nxml.txt.nlp	24994911	SENT34	15	15	22	22	amodiaquine	ACT	PA448404	12;11332;9457;641455	0.904
NULL	Front_Pharmacol_2014_Oct_20_5_230.nxml.txt.nlp	25368579	SENT110	5	5	11	11	berberine	IL-6	PA165860812	3569	0.904
NULL	Cancer_Biol_Med_2012_Mar_9(1)_18-22.nxml.txt.nlp	23691449	SENT51	9	9	2	2	gefitinib	EGFR	PA131301952	1956	0.904
NULL	Oxid_Med_Cell_Longev_2013_Jun_6_2013_891748.nxml.txt.nlp	23840922	SENT199	0	0	10	10	resveratrol	MCP-1		6347	0.904
NULL	Curr_Pharm_Biotechnol_2012_May_13(6)_969-986.nxml.txt.nlp	22039792	SENT387	3	3	10	10	mexiletine	MDR1	PA450488	5243	0.904
NULL	Oncotarget_2014_Aug_29_5(19)_8947-8958.nxml.txt.nlp	25333254	SENT133	2	2	9	9	plerixafor	CXCR7	PA165958410	57007	0.904
NULL	Pharmaceuticals_(Basel)_2012_Aug_30_5(9)_890-898.nxml.txt.nlp	24280696	SENT228	2	2	0	0	geldanamycin	Hsp90	PA152031327	3320	0.904
NULL	Cardiol_Res_Pract_2014_Nov_20_2014_784018.nxml.txt.nlp	25506463	SENT142	9	9	25	25	heparin	ACT	PA449855	12;11332;9457;641455	0.904
NULL	Lab_Invest_2013_Dec_14_93(12)_1265-1275.nxml.txt.nlp	24126890	SENT215	6	6	14	14	celecoxib	IL-6	PA448871	3569	0.904
NULL	Chem_Cent_J_2012_Aug_1_6_78.nxml.txt.nlp	22853321	SENT66	10	10	0	0	ethanol	HC2	PA448073	360184;3053;5682	0.904
NULL	Exp_Mol_Med_2012_Jun_30_44(6)_403-411.nxml.txt.nlp	22510730	SENT126	11	11	9	9	anastrozole	aromatase	PA448432	1588	0.904
NULL	Am_J_Case_Rep_2012_May_23_13_79-85.nxml.txt.nlp	23569495	SENT57	12	12	8	8	doxorubicin	CHOP	PA449412	1649	0.904
NULL	Br_J_Cancer_2012_May_8_106(10)_1682-1688.nxml.txt.nlp	22415229	SENT24	9	9	0	0	estradiol	GPER	PA449503	2852	0.904
NULL	Core_Evid_2011_Mar_17_6_31-42.nxml.txt.nlp	21468241	SENT140	17	17	2	2	ticagrelor	ABCB1	PA165374673	5243	0.904
NULL	Environ_Health_Perspect_2006_Mar_6_114(3)_404-411.nxml.txt.nlp	16507464	SENT207	23	23	8	8	oxazepam	IGFBP1	PA450731	3484	0.904
NULL	Nucleic_Acids_Res_2011_Jun_9_39(11)_4640-4652.nxml.txt.nlp	21310710	SENT321	35	35	19	19	camptothecin	SATB1	PA153590860	6304	0.904
NULL	Cancer_Manag_Res_2011_Jul_13_3_257-266.nxml.txt.nlp	21792334	SENT145	17	17	30	30	cisplatin	HER2	PA449014	2064	0.904
NULL	Arthritis_Res_Ther_2010_Sep_8_12(5)_R167.nxml.txt.nlp	20825639	SENT167	15	15	18	18	resveratrol	AP-1		2353;3727;2354;3725	0.904
NULL	Diabetes_Care_2009_Oct_8_32(10)_1873-1879.nxml.txt.nlp	19587362	SENT67	12	12	4	4	ethanol	ANG	PA448073	283	0.904
NULL	Acta_Pharmacol_Sin_2010_Feb_5_31(2)_184-190.nxml.txt.nlp	20139901	SENT114	20	20	12	12	metformin	SLC22A2	PA450395	6582	0.904
NULL	Front_Physiol_2013_Jul_12_4_178.nxml.txt.nlp	23874303	SENT249	6	6	19	19	aprotinin	EMMPRIN	PA448472	682	0.904
NULL	Oncotarget_2014_Feb_7_5(3)_775-787.nxml.txt.nlp	24519956	SENT112	13	13	8	8	docetaxel	PC3	PA449383	57332;7832;5122	0.904
NULL	J_Headache_Pain_2014_Sep_18_15(Suppl_1)_F28.nxml.txt.nlp	NULL	SENT19	18	18	26	26	verapamil	P-gp	PA451868	5243	0.904
NULL	J_Exp_Med_2000_Mar_6_191(5)_859-870.nxml.txt.nlp	10704466	SENT148	23	23	5	5	arsenite	p38	PA452638	10598;1432;7965	0.904
NULL	J_Clin_Biochem_Nutr_2007_Jan_27_40(1)_13-23.nxml.txt.nlp	18437209	SENT142	16	16	11	11	thrombin	PAR4	PA451674	9002;5074	0.904
NULL	Environ_Health_Perspect_2005_Oct_14_113(10)_1330-1335.nxml.txt.nlp	16203242	SENT114	2	2	15	15	phenylephrine	MLC	PA450935	23209	0.904
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT74	8	8	4	4	trastuzumab	STAT3	PA451743	6774	0.904
NULL	Int_J_Cell_Biol_2013_Mar_19_2013_834684.nxml.txt.nlp	23573093	SENT150	13	13	17	17	aminoglutethimide	CYP11A1	PA448375	1583	0.904
NULL	Infect_Drug_Resist_2014_Aug_19_7_223-228.nxml.txt.nlp	25187730	SENT24	7	7	14	14	ofloxacin	CPX	PA450684	1371;10682;1377	0.904
NULL	Fibrogenesis_Tissue_Repair_2011_Aug_2_4_18.nxml.txt.nlp	21810214	SENT96	18	18	11	11	bleomycin	TLR9	PA448645	54106	0.904
NULL	Ann_Med_Health_Sci_Res_2013_Oct-Dec_3(4)_498-503.nxml.txt.nlp	24379998	SENT86	30	30	16	16	epirubicin	CD4	PA449476	920	0.904
NULL	Breast_Cancer_Res_2005_Jan_26_7(2)_R256-R266.nxml.txt.nlp	15743506	SENT28	14	14	7	7	tamoxifen	aromatase	PA451581	1588	0.904
NULL	Mol_Syst_Biol_2011_Apr_26_7_486.nxml.txt.nlp	21525872	SENT133	35	35	33	33	imatinib	KCNH8	PA10804	131096	0.904
NULL	Acta_Pharmacol_Sin_2009_Nov_12_30(11)_1566-1572.nxml.txt.nlp	19820718	SENT7	26	26	23	23	ketoconazole	P-gp	PA450146	5243	0.904
NULL	Mol_Cancer_2014_Jan_15_13_9.nxml.txt.nlp	24428911	SENT123	8	8	2	2	gefitinib	SRSF2	PA131301952	6427	0.904
NULL	Mol_Biol_Cell_2012_Jun_1_23(11)_2092-2108.nxml.txt.nlp	22513089	SENT222	12	12	32	32	staurosporine	p120	PA165109623	4839;1500;55695;10902	0.904
NULL	Animal_Cells_Syst_(Seoul)_2011_Jun_9_15(2)_95-106.nxml.txt.nlp	21837266	SENT156	4	4	25	25	capsaicin	TRPV4	PA448776	59341	0.904
NULL	JAKSTAT_2014_Jun_12_3_e29554.nxml.txt.nlp	25105067	SENT4	4	4	19	19	propofol	PI3K	PA451141	5290	0.904
NULL	Chin_J_Cancer_2011_Dec_30(12)_815-820.nxml.txt.nlp	22059910	SENT91	29	29	24	24	cetuximab	KRAS	PA10040	3845	0.904
NULL	Oncotarget_2013_Aug_30_4(10)_1698-1711.nxml.txt.nlp	24091605	SENT183	19	19	32	32	gefitinib	SOX2	PA131301952	6657	0.904
NULL	J_Biomed_Biotechnol_2010_Mar_9_2010_525180.nxml.txt.nlp	20300455	SENT135	6	6	0	0	calcein	P-gp	PA132595336	5243	0.904
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT175	14	14	23	23	cisplatin	PUMA	PA449014	27113	0.903
NULL	Oncol_Lett_2013_Feb_7_5(2)_440-446.nxml.txt.nlp	23420122	SENT44	19	19	10	10	sorafenib	EGFR	PA7000	1956	0.903
NULL	Mol_Cancer_2014_Jul_5_13_165.nxml.txt.nlp	24996221	SENT196	14	14	5	5	docetaxel	HMGB1	PA449383	3146	0.903
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT307	8	8	31	31	cisplatin	FasL	PA449014	356	0.903
NULL	J_Gen_Physiol_2012_Jun_139(6)_407-414.nxml.txt.nlp	22641635	SENT111	16	16	35	35	nadh	ADP	PA164755085	23038	0.903
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT88	36	36	18	18	efavirenz	CYP2C19	PA449441	1557	0.903
NULL	Arthritis_Res_Ther_2006_May_5_8(3)_R83.nxml.txt.nlp	16677395	SENT41	9	9	21	21	rituximab	CD154	PA451261	959	0.903
NULL	Gastric_Cancer_2014_Dec_8_17(4)_630-637.nxml.txt.nlp	24318670	SENT193	6	6	2	2	panitumumab	KRAS	PA162373091	3845	0.903
NULL	Ann_Oncol_2014_Oct_18_25(10)_1871-1888.nxml.txt.nlp	25234545	SENT334	25	25	18	18	pertuzumab	HER-2		2064	0.903
NULL	Open_Access_J_Urol_2010_Mar_12_2_35-40.nxml.txt.nlp	24198612	SENT72	13	13	22	22	pazopanib	FLT3	PA165291492	2322	0.903
NULL	Eukaryot_Cell_2014_Aug_13(8)_1077-1084.nxml.txt.nlp	24951438	SENT181	5	5	23	23	doxycycline	RSP5	PA449415	23327	0.903
NULL	Case_Rep_Oncol_Med_2013_Jan_16_2013_320797.nxml.txt.nlp	23401820	SENT39	24	24	18	18	trabectedin	CCL2	PA165958349	6347	0.903
NULL	Br_J_Ophthalmol_2013_May_21_97(5)_617-621.nxml.txt.nlp	23428984	SENT100	12	12	25	25	ranibizumab	PED	PA164746012	8682	0.903
NULL	Clin_Sarcoma_Res_2013_Nov_26_3_13.nxml.txt.nlp	24279994	SENT105	5	5	8	8	pazopanib	VEGFR	PA165291492	3791	0.903
NULL	EMBO_Mol_Med_2012_Mar_4(3)_180-191.nxml.txt.nlp	22174035	SENT140	10	10	36	36	dantrolene	RYR2	PA449208	6262	0.903
NULL	Ann_Dermatol_2011_Oct_31_23(Suppl_2)_S169-S174.nxml.txt.nlp	22148042	SENT104	35	35	11	11	bleomycin	CHOP	PA448645	1649	0.903
NULL	J_Korean_Med_Sci_2012_Sep_22_27(9)_1037-1043.nxml.txt.nlp	22969249	SENT133	18	18	0	0	paricalcitol	CDK2	PA450798	1017	0.903
NULL	Acta_Pharmacol_Sin_2013_Jan_3_34(1)_119-128.nxml.txt.nlp	23202804	SENT219	44	44	28	28	rimonabant	NG2	PA152407999	1464;6048	0.903
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT164	5	5	22	22	curcumin	TRAIL	PA151958596	8743	0.903
NULL	Oncol_Lett_2014_Jan_11_7(1)_156-158.nxml.txt.nlp	24348840	SENT4	7	7	18	18	epirubicin	CHOP	PA449476	1649	0.903
NULL	Harm_Reduct_J_2010_Dec_1_7_29.nxml.txt.nlp	21122129	SENT17	28	28	4	4	buprenorphine	OST	PA448685	1650;23263	0.903
NULL	Aging_(Albany_NY)_2012_Dec_6_4(11)_823-842.nxml.txt.nlp	23235539	SENT319	13	13	0	0	bleomycin	HCA2	PA448645	139081;55811;338442	0.903
NULL	Oncotarget_2013_Mar_23_4(3)_463-473.nxml.txt.nlp	23531874	SENT169	24	24	17	17	erlotinib	EGFR	PA134687924	1956	0.903
NULL	Br_J_Cancer_2012_Nov_6_107(10)_1714-1721.nxml.txt.nlp	23073173	SENT192	0	0	6	6	bicalutamide	RUNX2	PA164746255	860	0.903
NULL	Cancer_Cell_Int_2013_Mar_4_13_21.nxml.txt.nlp	23497288	SENT235	36	36	2	2	doxorubicin	EWS	PA449412	2130	0.903
NULL	Aging_(Albany_NY)_2012_Jan_29_4(1)_28-39.nxml.txt.nlp	22289634	SENT213	17	17	11	11	ethanol	p53	PA448073	7157	0.903
NULL	Br_J_Cancer_2012_Nov_20_107(11)_1844-1852.nxml.txt.nlp	23169337	SENT294	5	5	15	15	bortezomib	AKT	PA10252	207	0.903
NULL	Clin_Pharmacol_2011_Jun_22_3_13-25.nxml.txt.nlp	22287853	SENT182	26	26	42	42	saxagliptin	CYP3A4	PA165958362	1576	0.903
NULL	Acta_Otolaryngol_2010_Nov_30_130(11)_1278-1286.nxml.txt.nlp	20586674	SENT109	16	16	8	8	methimazole	TRPV1	PA450422	7442	0.903
NULL	Ecancermedicalscience_2010_Apr_30_4_ed6.nxml.txt.nlp	24966881	SENT8	33	33	8	8	trastuzumab	PTEN	PA451743	5728	0.903
NULL	Diabetes_Care_2009_Nov_32(Suppl_2)_S223-S231.nxml.txt.nlp	19875556	SENT112	18	18	15	15	liraglutide	GLP-1	PA165958364	100125288	0.903
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT218	13	13	41	41	panitumumab	KRAS	PA162373091	3845	0.903
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_P112.nxml.txt.nlp	NULL	SENT19	18	18	23	23	lumiracoxib	DRB1	PA164769031	129831	0.903
NULL	Mol_Cell_Biochem_2013_Jul_20_383(1-2)_95-102.nxml.txt.nlp	23873331	SENT292	42	42	29	29	paclitaxel	p53	PA450761	7157	0.903
NULL	Breast_Cancer_Res_2006_Nov_27_8(6)_R66.nxml.txt.nlp	17129383	SENT33	9	9	3	3	paclitaxel	HER2	PA450761	2064	0.903
NULL	Cancer_Cell_Int_2011_Aug_19_11_29.nxml.txt.nlp	21854619	SENT137	16	16	10	10	cisplatin	BRCA1	PA449014	672	0.903
NULL	Curr_Biol_2009_Feb_24_19(4)_297-304.nxml.txt.nlp	19217292	SENT392	20	20	12	12	vasopressin	ID2	PA451858	3398	0.903
NULL	Int_J_Mol_Imaging_2012_Oct_17_2012_189254.nxml.txt.nlp	23119157	SENT6	5	5	22	22	ezetimibe	FAST	PA10816	10922	0.903
NULL	Eur_J_Clin_Pharmacol_2013_Mar_11_69(3)_327-339.nxml.txt.nlp	22782539	SENT189	34	34	21	21	dabigatran	IPA		3160	0.903
NULL	Onco_Targets_Ther_2014_Nov_21_7_2143-2146.nxml.txt.nlp	25473295	SENT49	0	0	17	17	sn-38	UGT		7361;7355	0.903
NULL	Asian_J_Androl_2014_Apr_11_Jul-Aug_16(4)_505-510.nxml.txt.nlp	24759577	SENT89	35	35	27	27	estradiol	aromatase	PA449503	1588	0.903
NULL	Chin_J_Cancer_2012_Jul_31(7)_319-326.nxml.txt.nlp	22257382	SENT104	18	18	4	4	erlotinib	EGFR	PA134687924	1956	0.903
NULL	Cancer_2014_Aug_1_120(15)_2343-2351.nxml.txt.nlp	24752945	SENT155	25	25	14	14	cisplatin	ERCC1	PA449014	2067	0.903
NULL	J_Breast_Cancer_2013_Mar_31_16(1)_23-31.nxml.txt.nlp	23593078	SENT150	9	9	25	25	curcumin	DNMT1	PA151958596	1786	0.903
NULL	Curr_Neuropharmacol_2010_Sep_8(3)_243-253.nxml.txt.nlp	21358974	SENT104	10	10	16	16	rimonabant	CB2	PA152407999	1269	0.903
NULL	Mol_Cell_Proteomics_2012_Feb_6_11(2)_M111_015222.nxml.txt.nlp	22147731	SENT409	22	22	13	13	cetuximab	JUN	PA10040	3725	0.903
NULL	Angiogenesis_2012_Sep_27_15(3)_361-376.nxml.txt.nlp	22451299	SENT155	3	3	32	32	resveratrol	CCL2		6347	0.903
NULL	Cancer_Res_Treat_2013_Mar_31_45(1)_55-62.nxml.txt.nlp	23613671	SENT152	7	7	20	20	oxaliplatin	KRAS	PA131285527	3845	0.903
NULL	Brain_2014_Apr_27_137(4)_1145-1155.nxml.txt.nlp	24578545	SENT208	10	10	18	18	citalopram	5-HT1A	PA449015	3350	0.903
NULL	Database_(Oxford)_2014_Nov_19_2014_bau104.nxml.txt.nlp	25414382	SENT45	7	7	16	16	erlotinib	EGFR	PA134687924	1956	0.903
NULL	Infect_Dis_Ther_2013_Dec_2_2(2)_123-144.nxml.txt.nlp	25134476	SENT268	6	6	10	10	amiodarone	DIP	PA448383	23151;1831	0.903
NULL	J_Invest_Dermatol_2012_Nov_21_132(11)_2642-2651.nxml.txt.nlp	22718118	SENT158	17	17	11	11	collagenase	CD11b	PA449107	3684	0.903
NULL	Br_J_Pharmacol_2014_Jan_23_171(2)_523-535.nxml.txt.nlp	24372553	SENT15	10	10	6	6	metformin	SIRT1	PA450395	23411	0.903
NULL	Oncol_Rep_2014_Apr_28_31(4)_1605-1612.nxml.txt.nlp	24481648	SENT129	13	13	29	29	paclitaxel	MRP7	PA450761	89845;1080	0.903
NULL	J_Gynecol_Oncol_2014_Oct_7_25(4)_328-333.nxml.txt.nlp	25142624	SENT91	9	9	5	5	cisplatin	AMH	PA449014	268	0.903
NULL	Leukemia_2015_Jan_26_29(1)_237-241.nxml.txt.nlp	25257991	SENT7	10	10	4	4	vincristine	CHOP	PA451879	1649	0.903
NULL	J_Korean_Assoc_Oral_Maxillofac_Surg_2014_Dec_26_40(6)_291-296.nxml.txt.nlp	25551094	SENT36	30	30	17	17	alendronate	OPG	PA448082	690	0.903
NULL	J_Cell_Sci_2014_May_1_127(9)_2106-2119.nxml.txt.nlp	24569881	SENT393	8	8	20	20	glutaraldehyde	14-3-3	PA449777	10971	0.903
NULL	Evid_Based_Complement_Alternat_Med_2011_Feb_14_2011_429843.nxml.txt.nlp	21869897	SENT136	6	6	31	31	ethanol	CORT	PA448073	1325	0.903
NULL	Cancers_(Basel)_2012_Sep_6_4(3)_873-903.nxml.txt.nlp	24213471	SENT345	21	21	7	7	hyaluronidase	HYAL1	PA164745713	3373	0.903
NULL	Indian_J_Med_Res_2013_Jan_137(1)_125-129.nxml.txt.nlp	23481061	SENT84	14	14	7	7	cisplatin	GSTT1	PA449014	2952	0.903
NULL	Oncol_Rep_2013_Oct_22_30(4)_1535-1541.nxml.txt.nlp	23877481	SENT41	37	37	23	23	cetuximab	EGF	PA10040	1950	0.903
NULL	Clin_Transl_Allergy_2013_Sep_2_3_29.nxml.txt.nlp	24004581	SENT183	13	13	5	5	omalizumab	CD23	PA164752253	2208	0.903
NULL	Cell_Death_Dis_2013_Sep_5_4(9)_e791.nxml.txt.nlp	24008735	SENT215	4	4	0	0	gemcitabine	p53	PA449748	7157	0.903
NULL	Exp_Diabetes_Res_2012_Oct_17_2012_420854.nxml.txt.nlp	23118741	SENT120	3	3	21	21	ezetimibe	JNK	PA10816	5599	0.903
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT195	14	14	19	19	ethanol	CYP3A4	PA448073	1576	0.903
NULL	Diabetes_Care_2010_Mar_15_33(3)_608-613.nxml.txt.nlp	20009095	SENT133	42	42	29	29	rosiglitazone	DREAM	PA451283	30818	0.903
NULL	J_Cancer_Epidemiol_2012_Apr_12_2012_529357.nxml.txt.nlp	22570656	SENT84	0	0	14	14	aprepitant	CYP3A4	PA164747039	1576	0.903
NULL	Exp_Diabetes_Res_2011_Dec_27_2011_604989.nxml.txt.nlp	21253359	SENT50	42	42	13	13	clonidine	GLP-1	PA449051	100125288	0.903
NULL	Arthritis_Res_Ther_2014_Jul_18_16(4)_R153.nxml.txt.nlp	25037855	SENT103	13	13	25	25	adalimumab	LTA	PA10004	4049	0.903
NULL	Clin_Exp_Metastasis_2013_May_15_30(7)_867-876.nxml.txt.nlp	23673558	SENT194	8	8	32	32	vemurafenib	BRAF	PA165946873	673	0.903
NULL	Clinics_(Sao_Paulo)_2012_May_67(5)_419-424.nxml.txt.nlp	22666783	SENT33	7	7	2	2	gefitinib	EGFR	PA131301952	1956	0.903
NULL	Indian_J_Crit_Care_Med_2008_Oct-Dec_12(4)_181-189.nxml.txt.nlp	19742267	SENT102	0	0	19	19	abatacept	CTLA4	PA164747080	1493	0.903
NULL	Biologics_2009_Sep_15_3_419-428.nxml.txt.nlp	19774209	SENT170	4	4	20	20	gefitinib	PTEN	PA131301952	5728	0.903
NULL	Case_Rep_Pediatr_2013_Feb_20_2013_727824.nxml.txt.nlp	23509655	SENT86	19	19	1	1	teicoplanin	BSAC	PA164746244	57591	0.903
NULL	Front_Endocrinol_(Lausanne)_2013_Jun_26_4_75.nxml.txt.nlp	23805127	SENT109	37	37	15	15	gemfibrozil	UGT2B7	PA449750	7364	0.903
NULL	Environ_Health_Perspect_2011_Mar_10_119(3)_357-363.nxml.txt.nlp	21362589	SENT65	33	33	7	7	picrotoxin	RDX	PA164777007	5962	0.903
NULL	Diabetes_Metab_Syndr_Obes_2010_Oct_27_3_363-372.nxml.txt.nlp	21437106	SENT117	32	32	41	41	sitagliptin	GLP-1	PA164748978	100125288	0.903
NULL	Biomed_Res_Int_2014_Jun_25_2014_764981.nxml.txt.nlp	25057499	SENT128	0	0	32	32	sorafenib	TRAIL	PA7000	8743	0.903
NULL	Oncotarget_2012_May_4_3(4)_371-394.nxml.txt.nlp	22564882	SENT311	6	6	13	13	etoposide	CD34	PA449552	947	0.903
NULL	Ann_Surg_Treat_Res_2014_Jun_23_86(6)_334-341.nxml.txt.nlp	24949327	SENT30	25	25	5	5	urokinase	hole	PA451836	80757	0.903
NULL	Oncotarget_2012_Jul_13_3(6)_601-607.nxml.txt.nlp	22802145	SENT22	4	4	13	13	doxorubicin	p53	PA449412	7157	0.903
NULL	Nucleic_Acids_Res_2012_Jul_30_40(13)_6319-6337.nxml.txt.nlp	22467215	SENT422	34	34	4	4	urokinase	survivin	PA451836	332	0.903
NULL	Core_Evid_2009_Jun_15_4_25-36.nxml.txt.nlp	20694062	SENT164	7	7	10	10	febuxostat	FACT	PA165958521	11198	0.903
NULL	Diabetes_2011_Jul_20_60(7)_1990-1999.nxml.txt.nlp	21617181	SENT125	21	21	9	9	geldanamycin	IL-6	PA152031327	3569	0.903
NULL	Curr_Control_Trials_Cardiovasc_Med_2000_Oct_11_1(2)_88-91.nxml.txt.nlp	11714417	SENT80	0	0	14	14	flecainide	LQT3	PA449646	6331	0.903
NULL	Breast_Cancer_Res_Treat_2013_Aug_20_141(1)_43-53.nxml.txt.nlp	23959396	SENT201	35	35	21	21	trastuzumab	HER2	PA451743	2064	0.903
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT245	31	31	39	39	pertuzumab	HER3		2065	0.903
NULL	Oncotarget_2013_Nov_24_4(12)_2430-2438.nxml.txt.nlp	24280348	SENT8	12	12	4	4	gefitinib	EGFR	PA131301952	1956	0.903
NULL	Case_Rep_Rheumatol_2011_Dec_15_2011_185657.nxml.txt.nlp	22937439	SENT57	34	34	29	29	etanercept	TNF-alpha	PA449515	7124	0.903
NULL	Exp_Diabetes_Res_2011_Jun_4_2011_489708.nxml.txt.nlp	21747829	SENT111	18	18	0	0	aliskiren	GLP-1	PA143487910	100125288	0.903
NULL	Cancer_Manag_Res_2013_Nov_21_5_387-400.nxml.txt.nlp	24294007	SENT115	10	10	32	32	vemurafenib	EGFR	PA165946873	1956	0.903
NULL	Breast_Cancer_Res_Treat_2012_Aug_29_135(1)_241-252.nxml.txt.nlp	22872523	SENT161	25	25	9	9	paclitaxel	PLGF	PA450761	5228	0.903
NULL	J_Invest_Dermatol_2014_Feb_10_134(2)_319-325.nxml.txt.nlp	24108405	SENT112	20	20	29	29	vemurafenib	BRAF	PA165946873	673	0.903
NULL	Diabetes_Obes_Metab_2010_Aug_12(8)_700-708.nxml.txt.nlp	20590747	SENT199	3	3	12	12	vildagliptin	PPG	PA165958346	5552	0.903
NULL	Br_J_Cancer_2011_Aug_23_105(5)_649-657.nxml.txt.nlp	21811251	SENT159	31	31	17	17	gefitinib	AKT	PA131301952	207	0.903
NULL	Br_J_Clin_Pharmacol_2013_Aug_23_76(2)_299-315.nxml.txt.nlp	23701319	SENT7	20	20	30	30	alemtuzumab	IL-2	PA164783958	3558	0.903
NULL	J_Immunother_Cancer_2013_Nov_7_1(Suppl_1)_P252.nxml.txt.nlp	NULL	SENT18	9	9	15	15	doxorubicin	CD19	PA449412	930	0.903
NULL	Eur_J_Clin_Pharmacol_2011_Dec_23_67(12)_1231-1241.nxml.txt.nlp	21698374	SENT197	19	19	16	16	tacrolimus	ABCB1	PA451578	5243	0.903
NULL	Int_J_Appl_Basic_Med_Res_2012_Jul-Dec_2(2)_84-91.nxml.txt.nlp	23776818	SENT151	29	29	9	9	oxacillin	OSSA	PA450725	23196	0.903
NULL	J_Invest_Dermatol_2013_Sep_31_133(9)_2247-2254.nxml.txt.nlp	23370537	SENT215	21	21	29	29	etoposide	PUMA	PA449552	27113	0.903
NULL	Emerg_Infect_Dis_2012_Nov_18(11)_1802-1810.nxml.txt.nlp	23092584	SENT39	9	9	2	2	rifampin	DST	PA451250	667	0.903
NULL	Br_J_Cancer_2012_Jun_5_106(12)_1997-2003.nxml.txt.nlp	22596232	SENT115	13	13	8	8	sorafenib	CD133	PA7000	8842	0.903
NULL	J_Inherit_Metab_Dis_2010_Oct_3_33(5)_625-632.nxml.txt.nlp	20814828	SENT75	10	10	19	19	simvastatin	RhoA	PA451363	387	0.903
NULL	J_Med_Internet_Res_2013_Jul_12_15(7)_e138.nxml.txt.nlp	23853350	SENT186	12	12	24	24	warfarin	TTR	PA451906	7276	0.903
NULL	Acta_Pharmacol_Sin_2014_Aug_21_35(8)_1082-1092.nxml.txt.nlp	25047514	SENT182	16	16	14	14	letrozole	aromatase	PA450196	1588	0.903
NULL	Clin_Dev_Immunol_2011_Mar_28_2011_370872.nxml.txt.nlp	21461372	SENT103	18	18	4	4	doxycycline	IL-6	PA449415	3569	0.903
NULL	Cells_2014_Apr_29_3(2)_331-362.nxml.txt.nlp	24785347	SENT61	23	23	11	11	capsaicin	TRPV1	PA448776	7442	0.903
NULL	Oncogene_2013_Sep_26_32(39)_10_1038_onc_2012_491.nxml.txt.nlp	23108394	SENT128	41	41	15	15	epirubicin	FOXM1	PA449476	2305	0.903
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Jun_25_3(6)_e120.nxml.txt.nlp	24964282	SENT269	15	15	7	7	rifampin	CYP3A	PA451250	1574	0.903
NULL	Front_Immunol_2012_Jan_12_2_98.nxml.txt.nlp	22566887	SENT255	0	0	24	24	celecoxib	survivin	PA448871	332	0.903
NULL	Tumour_Biol_2014_Aug_12_35(8)_7807-7819.nxml.txt.nlp	24817012	SENT377	19	19	8	8	gemcitabine	ERCC2	PA449748	2068	0.903
NULL	Nat_Commun_2013_Nov_15_4_2779.nxml.txt.nlp	24240534	SENT227	12	12	20	20	ethanol	CO2	PA448073	4513	0.903
NULL	Pharmaceuticals_(Basel)_2012_Oct_25_5(11)_1160-1176.nxml.txt.nlp	24281306	SENT186	20	20	4	4	indomethacin	ANG	PA449982	283	0.903
NULL	Acta_Pharmacol_Sin_2013_Oct_7_34(10)_1359-1366.nxml.txt.nlp	23933653	SENT16	1	1	7	7	retigabine	KCNQ2	PA144997862	3785	0.903
NULL	Diabetes_2009_Apr_9_58(4)_965-974.nxml.txt.nlp	19136651	SENT258	15	15	35	35	nadh	AMPK	PA164755085	5563	0.903
NULL	Evid_Based_Complement_Alternat_Med_2014_May_8_2014_364819.nxml.txt.nlp	24899907	SENT8	9	9	46	46	tacrolimus	FKBP52	PA451578	2288	0.903
NULL	Mol_Cancer_2014_Jun_27_13_159.nxml.txt.nlp	24972933	SENT180	26	26	36	36	fludarabine	DCK	PA449655	1633	0.903
NULL	Mol_Brain_2014_Aug_21_7_59.nxml.txt.nlp	25139109	SENT27	12	12	16	16	imiquimod	TLR7	PA449972	51284	0.903
NULL	Breast_Cancer_Res_2007_Aug_16_9(4)_305.nxml.txt.nlp	17705882	SENT7	15	15	8	8	letrozole	aromatase	PA450196	1588	0.903
NULL	Int_J_Surg_Oncol_2011_Aug_22_2011_658767.nxml.txt.nlp	22312516	SENT122	13	13	7	7	bevacizumab	EGFR	PA130232992	1956	0.903
NULL	Cancer_Cell_Int_2013_May_15_13_42.nxml.txt.nlp	23672670	SENT212	20	20	5	5	paclitaxel	RAIDD	PA450761	8738	0.903
NULL	Endocrinol_Metab_(Seoul)_2013_Dec_12_28(4)_262-274.nxml.txt.nlp	24396690	SENT156	14	14	2	2	exenatide	GLP-1	PA164749238	100125288	0.903
NULL	Pharmaceuticals_(Basel)_2012_Aug_10_5(8)_802-836.nxml.txt.nlp	24280676	SENT40	29	29	9	9	ribavirin	CNT1	PA451241	9154	0.903
NULL	Case_Rep_Med_2013_Aug_4_2013_373981.nxml.txt.nlp	23983708	SENT11	23	23	19	19	imatinib	KIT	PA10804	3815	0.903
NULL	ScientificWorldJournal_2013_Apr_18_2013_808460.nxml.txt.nlp	23710149	SENT137	36	36	21	21	carrageenan	BOR	PA448814	55143	0.903
NULL	Oncol_Lett_2013_Feb_27_5(2)_435-439.nxml.txt.nlp	23420613	SENT28	17	17	27	27	gefitinib	EGFR	PA131301952	1956	0.903
NULL	Breast_Cancer_Res_2008_Dec_18_10(Suppl_4)_S16.nxml.txt.nlp	19128429	SENT26	13	13	10	10	fulvestrant	aromatase	PA164747170	1588	0.903
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT541	13	13	31	31	olanzapine	PRL	PA450688	5617	0.903
NULL	Exp_Ther_Med_2013_Nov_13_6(5)_1317-1321.nxml.txt.nlp	24223665	SENT170	9	9	1	1	cisplatin	CD133	PA449014	8842	0.903
NULL	Bioinformation_2012_Jan_6_8(1)_13-19.nxml.txt.nlp	22359429	SENT169	20	20	28	28	curcumin	MRP1	PA151958596	4437	0.903
NULL	Curr_Pharm_Biotechnol_2012_May_13(6)_969-986.nxml.txt.nlp	22039792	SENT260	10	10	17	17	omeprazole	MDR1	PA450704	5243	0.903
NULL	Cancers_(Basel)_2013_Nov_26_5(4)_1601-1618.nxml.txt.nlp	24287743	SENT167	16	16	19	19	cetuximab	EGFR	PA10040	1956	0.903
NULL	Eur_J_Epidemiol_2011_Aug_30_26(8)_657-686.nxml.txt.nlp	21877163	SENT941	28	28	14	14	lactulose	CYP2C9	PA164748762	1559	0.903
NULL	Biomed_Res_Int_2014_Jun_30_2014_921296.nxml.txt.nlp	25101299	SENT166	5	5	28	28	bleomycin	BLMH	PA448645	642	0.903
NULL	Arch_Med_Sci_2013_Aug_30_9(4)_731-738.nxml.txt.nlp	24049537	SENT30	25	25	10	10	irinotecan	UGT1A1	PA450085	54658	0.903
NULL	Eur_J_Med_Res_2010_Apr_8_15(4)_145-151.nxml.txt.nlp	20554495	SENT38	8	8	21	21	abacavir	HLA-B	PA448004	3106	0.903
NULL	Biomed_Res_Int_2014_Jan_2_2014_682010.nxml.txt.nlp	24524084	SENT144	7	7	38	38	imatinib	ZAP70	PA10804	7535	0.903
NULL	Br_J_Cancer_2014_Nov_25_111(11)_2091-2102.nxml.txt.nlp	25349971	SENT14	19	19	10	10	imatinib	PTPN18	PA10804	26469	0.903
NULL	Drug_Des_Devel_Ther_2014_Oct_13_8_1851-1867.nxml.txt.nlp	25378905	SENT103	18	18	26	26	docetaxel	BCA-1	PA449383	10563	0.903
NULL	Exp_Ther_Med_2012_Oct_3_4(4)_594-604.nxml.txt.nlp	23170111	SENT27	9	9	33	33	propranolol	HIF1	PA451145	3091	0.903
NULL	Eur_J_Epidemiol_2011_Aug_30_26(8)_657-686.nxml.txt.nlp	21877163	SENT941	30	30	10	10	acenocoumarol	CYP2C9	PA452632	1559	0.903
NULL	Diabetes_2011_Nov_17_60(11)_2691-2700.nxml.txt.nlp	21896928	SENT145	14	14	22	22	resveratrol	SIRT1		23411	0.903
NULL	Mol_Cell_Proteomics_2014_Dec_5_13(12)_3410-3420.nxml.txt.nlp	25193168	SENT46	30	30	5	5	trypsin	E12	PA451806	64100	0.903
NULL	Front_Oncol_2014_Jun_16_4_148.nxml.txt.nlp	24982848	SENT94	7	7	18	18	doxorubicin	p53	PA449412	7157	0.903
NULL	J_Invest_Dermatol_2014_Feb_10_134(2)_319-325.nxml.txt.nlp	24108405	SENT87	16	16	22	22	vemurafenib	NRAS	PA165946873	4893	0.903
NULL	J_Cereb_Blood_Flow_Metab_2014_Oct_23_34(10)_1688-1694.nxml.txt.nlp	25052553	SENT180	46	46	40	40	losartan	AT1	PA450268	9197;185	0.903
NULL	Blood_Cancer_J_2013_Oct_18_3(10)_e153.nxml.txt.nlp	24141622	SENT79	14	14	37	37	fludarabine	HDAC1	PA449655	3065	0.903
NULL	Br_J_Cancer_2003_Mar_10_88(5)_754-759.nxml.txt.nlp	12618886	SENT104	27	27	31	31	amifostine	p53	PA448365	7157	0.903
NULL	Arthritis_Res_Ther_2012_Feb_9_14(Suppl_1)_P48.nxml.txt.nlp	NULL	SENT4	0	0	15	15	abatacept	CD28	PA164747080	1493;940	0.903
NULL	Cancer_Immunol_Immunother_2012_Jul_23_61(7)_1101-1111.nxml.txt.nlp	22193989	SENT232	13	13	28	28	oxaliplatin	PD-L1	PA131285527	29126	0.903
NULL	Breast_Cancer_Res_2007_Jul_5_9(4)_R41.nxml.txt.nlp	17612393	SENT11	8	8	6	6	celecoxib	Bcl-2	PA448871	596	0.903
NULL	Chin_J_Cancer_2012_Feb_31(2)_73-99.nxml.txt.nlp	22098950	SENT20	38	38	28	28	vinblastine	P-gp	PA451877	5243	0.903
NULL	Ann_N_Y_Acad_Sci_2012_Oct_10_1271(1)_10-19.nxml.txt.nlp	23050959	SENT141	4	4	6	6	resveratrol	TNF-alpha		7124	0.903
NULL	Br_J_Cancer_2011_May_24_104(11)_1786-1790.nxml.txt.nlp	21559018	SENT3	28	28	13	13	irinotecan	EGFR	PA450085	1956	0.903
NULL	Virchows_Arch_2012_Feb_16_460(2)_141-149.nxml.txt.nlp	22173329	SENT247	22	22	3	3	irinotecan	BRAF	PA450085	673	0.903
NULL	Neuropsychopharmacology_2009_May_3_34(6)_1504-1513.nxml.txt.nlp	19052543	SENT38	6	6	10	10	cocaine	CB1	PA449072	1268	0.903
NULL	Front_Genet_2012_Nov_5_3_236.nxml.txt.nlp	23133441	SENT18	26	26	0	0	efavirenz	ABCB1	PA449441	5243	0.903
NULL	Exp_Diabetes_Res_2012_Oct_15_2012_465282.nxml.txt.nlp	23118742	SENT131	25	25	29	29	metformin	FGF21	PA450395	26291	0.903
NULL	Asia_Pac_Allergy_2012_Jul_25_2(3)_203-209.nxml.txt.nlp	22872823	SENT35	21	21	11	11	carbamazepine	HLA-B	PA448785	3106	0.903
NULL	Cancers_(Basel)_2010_Sep_17_2(3)_1717-1730.nxml.txt.nlp	24281184	SENT146	31	31	6	6	capecitabine	DPD	PA448771	1806	0.903
NULL	Case_Rep_Hematol_2013_Nov_7_2013_615189.nxml.txt.nlp	24312736	SENT61	20	20	17	17	exemestane	aromatase	PA449563	1588	0.903
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT88	15	15	35	35	methotrexate	MSH2	PA450428	4436	0.903
NULL	Breast_Cancer_(Auckl)_2009_Sep_2_3_61-75.nxml.txt.nlp	19809577	SENT98	13	13	9	9	curcumin	BRCA1	PA151958596	672	0.903
NULL	Oncologist_2010_Nov_4_15(11)_1135-1146.nxml.txt.nlp	21051659	SENT154	26	26	7	7	sunitinib	IFN	PA162372840	3439	0.903
NULL	J_Oncol_2012_Mar_26_2012_986725.nxml.txt.nlp	22545054	SENT147	18	18	10	10	bevacizumab	KDR	PA130232992	3791	0.903
NULL	Arthritis_Rheumatol_2014_Jun_27_66(6)_1574-1582.nxml.txt.nlp	24577881	SENT137	0	0	23	23	hydralazine	ERK	PA449894	5594	0.903
NULL	Case_Rep_Med_2009_Aug_4_2009_148795.nxml.txt.nlp	19721708	SENT69	27	27	7	7	clarithromycin	CCS	PA449028	9973	0.903
NULL	Nat_Commun_2014_Nov_25_5_5548.nxml.txt.nlp	25420520	SENT620	12	12	18	18	cabazitaxel	ERG	PA165958401	2078	0.903
NULL	Pharmaceuticals_(Basel)_2012_Sep_12_5(9)_1008-1020.nxml.txt.nlp	24280702	SENT92	33	33	27	27	geldanamycin	Hsp90	PA152031327	3320	0.903
NULL	Hum_Genomics_2010_Apr_1_4(4)_238-249.nxml.txt.nlp	20511137	SENT106	43	43	41	41	lopinavir	UGT1A1	PA450264	54658	0.903
NULL	Environ_Health_Perspect_2006_Sep_23_114(9)_1401-1406.nxml.txt.nlp	16966095	SENT24	9	9	34	34	arsenite	p53	PA452638	7157	0.903
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1013.nxml.txt.nlp	24457957	SENT140	21	21	31	31	bortezomib	NOXA	PA10252	5366	0.903
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_P43.nxml.txt.nlp	NULL	SENT12	3	3	19	19	abacavir	HLA-B	PA448004	3106	0.903
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT313	9	9	30	30	metformin	HIF-1	PA450395	29072	0.903
NULL	Patient_Prefer_Adherence_2014_Apr_8_8_463-471.nxml.txt.nlp	24748775	SENT7	16	16	14	14	denosumab	RANKL	PA166048634	8600	0.903
NULL	Curr_Neuropharmacol_2014_Jul_12(4)_365-379.nxml.txt.nlp	25342944	SENT46	15	15	32	32	fluoxetine	5-HT1A	PA449673	3350	0.903
NULL	J_Biol_Eng_2009_Oct_16_3_18.nxml.txt.nlp	19835592	SENT56	20	20	12	12	chloramphenicol	CPZ	PA448927	8532	0.903
NULL	Indian_J_Endocrinol_Metab_2013_Jan-Feb_17(1)_19-30.nxml.txt.nlp	23776849	SENT105	13	13	6	6	diazoxide	HADH	PA449285	3033	0.903
NULL	Breast_Cancer_Res_2014_May_28_16(3)_R53.nxml.txt.nlp	24886537	SENT130	10	10	16	16	tamoxifen	aromatase	PA451581	1588	0.903
NULL	Nanoscale_Res_Lett_2014_Apr_1_9(1)_156.nxml.txt.nlp	24685243	SENT19	2	2	14	14	paclitaxel	P-gp	PA450761	5243	0.903
NULL	Exp_Mol_Med_2012_May_31_44(5)_311-318.nxml.txt.nlp	22282402	SENT77	11	11	1	1	cilostazol	MCP-1	PA164746334	6347	0.903
NULL	Behav_Brain_Funct_2007_Apr_28_3_22.nxml.txt.nlp	17466074	SENT161	28	28	35	35	bupropion	COMT	PA448687	1312	0.903
NULL	Pharmaceutics_2011_Nov_18_3(4)_865-913.nxml.txt.nlp	24309312	SENT376	34	34	28	28	albendazole	P-gp	PA164746058	5243	0.903
NULL	Target_Oncol_2013_Mar_30_8(1)_27-33.nxml.txt.nlp	23361373	SENT53	16	16	10	10	carboplatin	EGFR	PA448803	1956	0.903
NULL	Clin_Med_Insights_Oncol_2012_Feb_28_6_125-135.nxml.txt.nlp	22408376	SENT291	5	5	1	1	panitumumab	KRAS	PA162373091	3845	0.903
NULL	Virol_J_2011_Nov_28_8_523.nxml.txt.nlp	22122911	SENT97	23	23	20	20	heparin	RANTES	PA449855	6352	0.903
NULL	Int_J_Cell_Biol_2013_May_16_2013_639401.nxml.txt.nlp	23762063	SENT344	5	5	3	3	resveratrol	AMPK		5563	0.903
NULL	Front_Pharmacol_2014_Nov_28_5_255.nxml.txt.nlp	25506327	SENT198	9	9	11	11	cinacalcet	PTH	PA164776671	5741	0.903
NULL	Environ_Health_Perspect_2002_Aug_110(8)_743-748.nxml.txt.nlp	12153753	SENT10	4	4	7	7	genistein	aromatase	PA165109660	1588	0.903
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Dec_17_3(12)_e152.nxml.txt.nlp	25518025	SENT66	28	28	12	12	oxycodone	CYP3A4	PA450741	1576	0.903
NULL	Chem_Cent_J_2013_Mar_27_7_57.nxml.txt.nlp	23537428	SENT28	16	16	37	37	exemestane	aromatase	PA449563	1588	0.903
NULL	Cell_Death_Dis_2013_Jun_27_4(6)_e694.nxml.txt.nlp	23807223	SENT56	2	2	10	10	chloroquine	JNK	PA448948	5599	0.903
NULL	Br_J_Cancer_2011_Sep_6_105(6)_796-806.nxml.txt.nlp	21847123	SENT147	13	13	32	32	trastuzumab	AKT1	PA451743	207	0.903
NULL	Front_Endocrinol_(Lausanne)_2011_Jan_14_1_12.nxml.txt.nlp	22654789	SENT172	0	0	7	7	vasopressin	AVP	PA451858	114548;551	0.903
NULL	Exp_Ther_Med_2014_May_5_7(5)_1420-1426.nxml.txt.nlp	24940450	SENT119	11	11	23	23	sorafenib	HER-2	PA7000	2064	0.903
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R91.nxml.txt.nlp	22541814	SENT210	29	29	11	11	thrombin	PAR3	PA451674	56288;2151	0.903
NULL	Cell_Death_Dis_2013_Jun_13_4(6)_e665.nxml.txt.nlp	23764846	SENT156	20	20	5	5	sorafenib	BLM	PA7000	641	0.903
NULL	Mol_Cancer_2009_Jun_23_8_39.nxml.txt.nlp	19549337	SENT215	10	10	23	23	resveratrol	AKT		207	0.903
NULL	Diabetes_2009_Feb_58(2)_344-351.nxml.txt.nlp	19008341	SENT168	5	5	7	7	resveratrol	SIRT1		23411	0.903
NULL	Cancer_Cell_Int_2013_Jun_26_13_63.nxml.txt.nlp	23800022	SENT135	2	2	6	6	genistein	XIAP	PA165109660	331	0.903
NULL	Biomed_Res_Int_2014_Jan_20_2014_948427.nxml.txt.nlp	24563867	SENT107	2	2	27	27	buspirone	STZ	PA448689	6484	0.903
NULL	Ann_Hematol_2010_Nov_25_89(11)_1115-1124.nxml.txt.nlp	20499237	SENT119	19	19	5	5	simvastatin	CD5	PA451363	921	0.903
NULL	Clin_Transl_Allergy_2013_Sep_2_3_29.nxml.txt.nlp	24004581	SENT93	9	9	1	1	omalizumab	IL-6	PA164752253	3569	0.903
NULL	Oncol_Lett_2014_Jul_25_8(1)_266-274.nxml.txt.nlp	24959259	SENT96	12	12	26	26	chloroquine	TLR9	PA448948	54106	0.903
NULL	Eur_J_Haematol_2009_Apr_82(4)_277-287.nxml.txt.nlp	19187270	SENT212	17	17	9	9	pha-665752	IL-6		3569	0.903
NULL	Neural_Dev_2013_Mar_7_8_4.nxml.txt.nlp	23497494	SENT118	18	18	5	5	cimetidine	FGFR3	PA449001	2261	0.903
NULL	Cancer_Med_2014_Aug_8_3(4)_747-758.nxml.txt.nlp	24711204	SENT144	22	22	7	7	paclitaxel	C5a	PA450761	727	0.903
NULL	J_Hematol_Oncol_2012_Oct_10_5_62.nxml.txt.nlp	23050865	SENT97	32	32	10	10	paclitaxel	EGFR	PA450761	1956	0.903
NULL	Arch_Med_Sci_2012_Nov_9_8(5)_899-906.nxml.txt.nlp	23185202	SENT171	9	9	7	7	acarbose	PPG	PA448010	5552	0.903
NULL	Oncol_Lett_2013_Feb_9_5(2)_552-558.nxml.txt.nlp	23420128	SENT135	22	22	15	15	imatinib	KIT	PA10804	3815	0.903
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT184	7	7	5	5	pp2	PP1		5540;5464	0.903
NULL	Cancer_Cell_Int_2004_May_17_4_4.nxml.txt.nlp	15147581	SENT93	3	3	15	15	sulindac	EGF	PA451565	1950	0.903
NULL	Lab_Invest_2014_May_10_94(5)_503-516.nxml.txt.nlp	24614199	SENT244	17	17	27	27	curcumin	NAC	PA151958596	22861	0.903
NULL	Breast_Cancer_Res_2011_Feb_8_13(1)_202.nxml.txt.nlp	21392411	SENT162	7	7	18	18	metformin	TWIST1	PA450395	7291	0.903
NULL	Clin_Med_Insights_Womens_Health_2013_Jan_22_6_1-11.nxml.txt.nlp	24665209	SENT55	29	29	22	22	tamoxifen	aromatase	PA451581	1588	0.903
NULL	Adv_Hematol_2014_Apr_3_2014_864058.nxml.txt.nlp	24803933	SENT207	10	10	16	16	curcumin	JAK2	PA151958596	3717	0.903
NULL	J_Hematol_Oncol_2011_Apr_20_4_16.nxml.txt.nlp	21504625	SENT51	14	14	8	8	nutlin-3	MDM4		4194	0.903
NULL	Mol_Cancer_2014_Jun_19_13_154.nxml.txt.nlp	24941944	SENT55	21	21	9	9	carmustine	BRAF	PA448810	673	0.903
NULL	NMR_Biomed_2014_Jul_5_27(7)_760-773.nxml.txt.nlp	24798066	SENT109	24	24	14	14	cyclophosphamide	NACT	PA449165	284111	0.903
NULL	Blood_Cancer_J_2013_May_17_3(5)_e115.nxml.txt.nlp	23686003	SENT40	40	40	16	16	thalidomide	CRBN	PA451644	51185	0.903
NULL	Mol_Cancer_2009_Nov_10_8_99.nxml.txt.nlp	19903356	SENT78	6	6	11	11	imatinib	IGFBP3	PA10804	3486	0.903
NULL	Int_J_Endocrinol_Metab_2013_Jul_1_Summer_11(3)_195-198.nxml.txt.nlp	24348593	SENT78	31	31	21	21	temozolomide	gamma	PA451609	9913	0.903
NULL	Braz_J_Med_Biol_Res_2014_Oct_14_47(12)_1096-1101.nxml.txt.nlp	25387678	SENT42	7	7	13	13	imatinib	p15	PA10804	10923;10573	0.903
NULL	Ann_Clin_Microbiol_Antimicrob_2009_Jan_15_8_2.nxml.txt.nlp	19146672	SENT132	39	39	28	28	isoniazid	EMB	PA450112	133418	0.903
NULL	Front_Oncol_2014_May_14_4_106.nxml.txt.nlp	24860786	SENT256	18	18	21	21	tamoxifen	c-ABL	PA451581	25	0.903
NULL	Chin_J_Cancer_2011_Jul_30(7)_490-496.nxml.txt.nlp	21718595	SENT13	8	8	17	17	oxaliplatin	LC3	PA131285527	84557	0.903
NULL	Mol_Vis_2012_Jul_18_18_1966-1972.nxml.txt.nlp	22876123	SENT149	3	3	17	17	curcumin	IL-5	PA151958596	3567	0.903
NULL	Scientifica_(Cairo)_2012_Nov_25_2012_473829.nxml.txt.nlp	24278698	SENT225	33	33	22	22	cisplatin	ATP7A	PA449014	538	0.903
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Oct_9_66(Pt_11)_o2728.nxml.txt.nlp	21588938	SENT55	18	18	12	12	ethanol	mol	PA448073	90527	0.903
NULL	Br_J_Clin_Pharmacol_2011_Dec_72(6)_921-931.nxml.txt.nlp	21676011	SENT48	0	0	3	3	capsaicin	TRPV1	PA448776	7442	0.903
NULL	Chromatographia_2009_Jun_26_69(Suppl_2)_167-173.nxml.txt.nlp	19554204	SENT133	15	15	0	0	hesperetin	MS2	PA164742902	101	0.903
NULL	EMBO_Mol_Med_2013_Mar_12_5(3)_441-455.nxml.txt.nlp	23401241	SENT37	16	16	7	7	streptozocin	ADAM17	PA451514	6868	0.903
NULL	Int_J_Mol_Sci_2014_Oct_23_15(10)_19265-19280.nxml.txt.nlp	25342321	SENT58	22	22	13	13	cisplatin	CD34	PA449014	947	0.903
NULL	Mol_Cancer_2009_Nov_10_8_99.nxml.txt.nlp	19903356	SENT118	10	10	18	18	imatinib	IGFBP3	PA10804	3486	0.903
NULL	Breast_Cancer_Res_Treat_2014_Nov_24_143(1)_125-133.nxml.txt.nlp	24272078	SENT189	11	11	15	15	exemestane	aromatase	PA449563	1588	0.903
NULL	J_Exp_Med_2003_Aug_4_198(3)_411-421.nxml.txt.nlp	12900517	SENT217	16	16	6	6	rosiglitazone	eotaxin	PA451283	6356	0.903
NULL	Cancers_(Basel)_2010_Jul_27_2(3)_1528-1554.nxml.txt.nlp	24281171	SENT301	26	26	2	2	cisplatin	CD133	PA449014	8842	0.903
NULL	Front_Immunol_2013_May_31_4_129.nxml.txt.nlp	23755052	SENT99	17	17	24	24	anakinra	IL-10	PA10799	3586	0.903
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_4_2013_378657.nxml.txt.nlp	23662132	SENT75	25	25	8	8	saxagliptin	GLP-1	PA165958362	100125288	0.903
NULL	Oncotarget_2014_Oct_18_5(22)_11604-11619.nxml.txt.nlp	25344099	SENT231	18	18	6	6	cisplatin	RYBP	PA449014	23429	0.903
NULL	Chem_Cent_J_2013_Jan_25_7_15.nxml.txt.nlp	23351428	SENT3	15	15	25	25	carbamazepine	STP	PA448785	9322	0.903
NULL	Curr_Oncol_2009_May_16(Suppl_1)_S52-S59.nxml.txt.nlp	19478903	SENT51	31	31	19	19	sorafenib	CYP3A4	PA7000	1576	0.903
NULL	Front_Oncol_2014_Mar_3_4_34.nxml.txt.nlp	24624361	SENT275	37	37	19	19	cisplatin	BRCA1	PA449014	672	0.903
NULL	Ann_Hematol_2014_Sep_10_93(1)_1-11.nxml.txt.nlp	24018623	SENT175	19	19	5	5	lenalidomide	CD34	PA162363968	947	0.903
NULL	EMBO_J_2010_Nov_17_29(22)_3773-3786.nxml.txt.nlp	20924358	SENT73	22	22	20	20	geldanamycin	Hsp90	PA152031327	3320	0.903
NULL	Biologics_2012_Jan_5_6_13-20.nxml.txt.nlp	22291463	SENT116	9	9	16	16	trastuzumab	HER2	PA451743	2064	0.903
NULL	Cancer_Immunol_Immunother_2015_Oct_7_64_61-73.nxml.txt.nlp	25287778	SENT202	16	16	5	5	lenalidomide	IL-2	PA162363968	3558	0.903
NULL	Cancers_(Basel)_2011_May_3_3(2)_2255-2273.nxml.txt.nlp	24212808	SENT106	26	26	14	14	cetuximab	EGFR	PA10040	1956	0.903
NULL	J_Inflamm_(Lond)_2006_Jul_12_3_10.nxml.txt.nlp	16834783	SENT127	0	0	14	14	mometasone	MCP-1	PA450541	6347	0.903
NULL	Diabetes_Obes_Metab_2010_Aug_12(8)_700-708.nxml.txt.nlp	20590747	SENT139	30	30	15	15	voglibose	PPG	PA164752433	5552	0.903
NULL	Mol_Neurodegener_2011_May_4_6_28.nxml.txt.nlp	21542899	SENT279	27	27	3	3	gentamicin	E12	PA449753	64100	0.903
NULL	Curr_Oncol_2006_Feb_13(1)_2-7.nxml.txt.nlp	17576435	SENT20	13	13	21	21	tamoxifen	aromatase	PA451581	1588	0.903
NULL	J_Hematol_Oncol_2013_Aug_13_6_57.nxml.txt.nlp	23938080	SENT190	5	5	19	19	curcumin	p300	PA151958596	2033	0.903
NULL	Cancer_Med_2013_Oct_5_2(5)_625-635.nxml.txt.nlp	24403228	SENT39	29	29	5	5	l-glutamine	PC-3	PA10090	692094	0.903
NULL	Curr_Neuropharmacol_2014_Mar_12(2)_186-192.nxml.txt.nlp	24669211	SENT33	42	42	46	46	metformin	Met	PA450395	79811	0.903
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT77	4	4	23	23	curcumin	Bcl-2	PA151958596	596	0.903
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Mar_27_66(Pt_4)_o924.nxml.txt.nlp	21580734	SENT52	18	18	12	12	ethanol	mol	PA448073	90527	0.903
NULL	Mol_Cancer_2010_Jun_25_9_165.nxml.txt.nlp	20576164	SENT159	5	5	12	12	curcumin	IFN	PA151958596	3439	0.903
NULL	Front_Genet_2014_Oct_31_5_379.nxml.txt.nlp	25400658	SENT1592	2	2	14	14	estradiol	MALAT-1	PA449503	378938	0.903
NULL	J_Biomed_Biotechnol_2011_Jul_6_2011_783528.nxml.txt.nlp	21785566	SENT151	7	7	5	5	lopinavir	P-gp	PA450264	5243	0.903
NULL	Case_Rep_Med_2014_Dec_21_2014_698758.nxml.txt.nlp	25587284	SENT62	14	14	33	33	ertapenem	UTI	PA164777032	259	0.903
NULL	Mol_Biol_Rep_2013_Sep_28_40(10)_5573-5585.nxml.txt.nlp	24078156	SENT267	12	12	2	2	iron	IRP2	PA450087	3658	0.903
NULL	J_Cell_Mol_Med_2013_May_14_17(5)_579-596.nxml.txt.nlp	23490277	SENT208	15	15	8	8	clopidogrel	ADP	PA449053	23038	0.903
NULL	J_Oncol_2011_Oct_12_2011_941876.nxml.txt.nlp	20981352	SENT14	11	11	36	36	cetuximab	EGFR	PA10040	1956	0.903
NULL	Clin_Interv_Aging_2012_Sep_17_7_363-372.nxml.txt.nlp	23049248	SENT57	0	0	15	15	denosumab	RANK	PA166048634	8792	0.903
NULL	Nucleic_Acids_Res_2011_Sep_19_39(16)_7179-7193.nxml.txt.nlp	21596787	SENT283	21	21	4	4	tetracycline	TOM1	PA451640	10043	0.903
NULL	Clin_Exp_Reprod_Med_2014_Sep_30_41(3)_120-124.nxml.txt.nlp	25309856	SENT100	15	15	4	4	estradiol	ADAMTS16	PA449503	170690	0.903
NULL	Ecancermedicalscience_2015_Jan_6_9_497.nxml.txt.nlp	25624878	SENT54	31	31	18	18	cetuximab	KRAS	PA10040	3845	0.903
NULL	J_Invest_Dermatol_2012_May_16_132(5)_1435-1442.nxml.txt.nlp	22336948	SENT68	8	8	27	27	doxycycline	TLSP	PA449415	11012	0.903
NULL	Case_Rep_Med_2012_Dec_25_2012_168785.nxml.txt.nlp	23326271	SENT95	46	46	42	42	bortezomib	EMP	PA10252	10296	0.903
NULL	Biomed_Res_Int_2013_Aug_14_2013_275805.nxml.txt.nlp	24288671	SENT50	16	16	10	10	vincristine	CHOP	PA451879	1649	0.903
NULL	Br_J_Cancer_2001_Aug_85(3)_317-324.nxml.txt.nlp	11487258	SENT3	24	24	1	1	tamoxifen	ATAC	PA451581	6375	0.903
NULL	Cancer_Med_2013_Jun_25_2(3)_277-285.nxml.txt.nlp	23930204	SENT31	29	29	19	19	cetuximab	KRAS	PA10040	3845	0.903
NULL	Br_J_Cancer_2012_Sep_4_107(6)_947-955.nxml.txt.nlp	22892392	SENT5	12	12	1	1	tamoxifen	BCAR4	PA451581	400500	0.903
NULL	Br_J_Cancer_2010_Oct_12_103(8)_1309-1310.nxml.txt.nlp	NULL	SENT29	36	36	19	19	sunitinib	IFN	PA162372840	3439	0.903
NULL	eLife_2013_Nov_5_2_e00969.nxml.txt.nlp	24192036	SENT214	0	0	5	5	vemurafenib	MAP4K5	PA165946873	11183	0.903
NULL	FEBS_Open_Bio_2014_Jan_6_4_77-89.nxml.txt.nlp	24490132	SENT87	44	44	17	17	ebselen	NAC	PA161660841	22861	0.903
NULL	Front_Oncol_2011_Jun_28_1_12.nxml.txt.nlp	22649753	SENT126	5	5	17	17	trastuzumab	HER2	PA451743	2064	0.903
NULL	Exp_Anim_2013_Aug_1_62(3)_255-265.nxml.txt.nlp	23903061	SENT59	18	18	34	34	collagenase	CD11b	PA449107	3684	0.903
NULL	Diagn_Pathol_2013_May_20_8_86.nxml.txt.nlp	23688209	SENT38	10	10	30	30	phosphorus	EMP	PA450954	10296	0.903
NULL	Avicenna_J_Med_2011_Jul-Sep_1(1)_12-17.nxml.txt.nlp	23210004	SENT136	12	12	8	8	docetaxel	GM-CSF	PA449383	1437	0.903
NULL	Ecancermedicalscience_2009_Oct_29_3_157.nxml.txt.nlp	22276018	SENT71	22	22	2	2	gefitinib	HER3	PA131301952	2065	0.903
NULL	Clin_Drug_Investig_2013_Jun_20_33(6)_419-427.nxml.txt.nlp	23605507	SENT150	20	20	8	8	ciprofloxacin	DPI	PA449009	1832	0.903
NULL	Diabetes_Care_2013_Aug_17_36(Suppl_2)_S127-S138.nxml.txt.nlp	23882037	SENT476	22	22	16	16	metformin	GLP-1	PA450395	100125288	0.903
NULL	Oncotarget_2013_Dec_14_5(4)_970-977.nxml.txt.nlp	24448468	SENT129	7	7	3	3	paclitaxel	LZTS1	PA450761	11178	0.903
NULL	Mol_Biol_Rep_2013_Sep_28_40(10)_5573-5585.nxml.txt.nlp	24078156	SENT35	3	3	15	15	iron	FPN1	PA450087	30061	0.903
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT165	13	13	8	8	cisplatin	p53	PA449014	7157	0.903
NULL	Oncoimmunology_2013_May_1_2(5)_e24436.nxml.txt.nlp	23762809	SENT81	8	8	23	23	bevacizumab	IL-6	PA130232992	3569	0.903
NULL	Curr_Cardiol_Rev_2009_Nov_5(4)_251-262.nxml.txt.nlp	21037841	SENT166	41	41	23	23	ibutilide	spatial	PA449958	219793	0.903
NULL	Europace_2014_Aug_19_16(8)_1145-1153.nxml.txt.nlp	24843051	SENT78	15	15	28	28	heparin	ACT	PA449855	12;11332;9457;641455	0.903
NULL	Anal_Chem_2014_Feb_18_86(4)_1988-1996.nxml.txt.nlp	24446580	SENT98	12	12	26	26	trypsin	PPG	PA451806	5552	0.903
NULL	J_Hematol_Oncol_2013_Jul_18_6_53.nxml.txt.nlp	23866964	SENT140	15	15	11	11	temsirolimus	AKT	PA164746890	207	0.903
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_24_2012_673132.nxml.txt.nlp	23133498	SENT114	20	20	6	6	quinidine	P-gp	PA451209	5243	0.903
NULL	Acta_Pharmacol_Sin_2011_Jul_9_32(7)_879-887.nxml.txt.nlp	21552292	SENT24	5	5	8	8	metformin	AMPK	PA450395	5563	0.903
NULL	Mol_Cell_Proteomics_2014_Dec_15_13(12)_3497-3506.nxml.txt.nlp	25225357	SENT48	21	21	4	4	streptomycin	PC-3	PA451512	692094	0.903
NULL	J_Korean_Med_Sci_2011_Dec_29_26(12)_1563-1568.nxml.txt.nlp	22147992	SENT93	14	14	23	23	ekb-569	EGFR		1956	0.903
NULL	Acta_Vet_Scand_2008_Nov_27_50(1)_47.nxml.txt.nlp	19038035	SENT20	18	18	31	31	mephenytoin	CYP2C19	PA450373	1557	0.903
NULL	Oncotarget_2014_Aug_19_5(18)_8703-8715.nxml.txt.nlp	25237928	SENT186	18	18	6	6	glucose	CD44	PA449773	960	0.903
NULL	Arthritis_Res_Ther_2012_May_1_14(3)_R99.nxml.txt.nlp	22546542	SENT59	40	40	26	26	infliximab	CD28	PA452639	1493;940	0.903
NULL	J_Inflamm_(Lond)_2005_Oct_31_2_14.nxml.txt.nlp	16259633	SENT330	6	6	18	18	staurosporine	CCR2	PA165109623	729230	0.903
NULL	Cancer_Immunol_Immunother_2011_Jul_24_60(7)_943-951.nxml.txt.nlp	21431918	SENT145	3	3	13	13	doxorubicin	CD34	PA449412	947	0.903
NULL	Br_J_Cancer_2010_Oct_12_103(8)_1284-1291.nxml.txt.nlp	20859285	SENT94	10	10	5	5	tamoxifen	BCAR4	PA451581	400500	0.903
NULL	Ann_Rheum_Dis_2010_Jun_1_69(6)_964-975.nxml.txt.nlp	20444750	SENT346	10	10	6	6	tocilizumab	IL-6	PA165292659	3569	0.903
NULL	Breast_Cancer_Res_Treat_2013_Jul_5_140(1)_63-71.nxml.txt.nlp	23828499	SENT192	35	35	31	31	trastuzumab	HER2	PA451743	2064	0.903
NULL	Clin_Sarcoma_Res_2013_Mar_7_3_3.nxml.txt.nlp	23497641	SENT156	16	16	10	10	imatinib	TKR	PA10804	8277	0.903
NULL	Oncogene_2010_Nov_18_29(46)_6115-6124.nxml.txt.nlp	20729912	SENT81	2	2	18	18	verapamil	ABCB5	PA451868	340273	0.903
NULL	Cardiovasc_Ther_2009_27(4)_259-274.nxml.txt.nlp	19604248	SENT22	18	18	10	10	clopidogrel	ADP	PA449053	23038	0.903
NULL	Physiol_Rep_2014_Oct_24_2(10)_e12175.nxml.txt.nlp	25344477	SENT195	20	20	28	28	paraformaldehyde	cadherin	PA450790	1015	0.903
NULL	Aust_N_Z_J_Psychiatry_2011_Sep_3_45(9)_712-725.nxml.txt.nlp	21888608	SENT285	0	0	6	6	fluvoxamine	CYP1A2	PA449690	1544	0.903
NULL	Oncotarget_2012_Jul_13_3(6)_601-607.nxml.txt.nlp	22802145	SENT38	27	27	16	16	docetaxel	p53	PA449383	7157	0.903
NULL	Eur_J_Clin_Pharmacol_2014_Oct_8_70(12)_1433-1441.nxml.txt.nlp	25291992	SENT165	27	27	6	6	olanzapine	FES	PA450688	2242	0.903
NULL	J_Oncol_2009_May_6_2009_567486.nxml.txt.nlp	19424511	SENT70	35	35	3	3	cetuximab	EGFR	PA10040	1956	0.903
NULL	Front_Oncol_2014_Jun_12_4_144.nxml.txt.nlp	24971229	SENT81	27	27	17	17	cisplatin	RASSF1	PA449014	11186	0.903
NULL	Indian_J_Pharmacol_2014_Sep-Oct_46(5)_547-548.nxml.txt.nlp	25298587	SENT2	8	8	20	20	ranolazine	CYP3A	PA164746007	1574	0.903
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1051.nxml.txt.nlp	24503543	SENT46	30	30	41	41	thioridazine	FYN	PA451666	2534	0.903
NULL	Proteome_Sci_2010_Jul_9_8_38.nxml.txt.nlp	20618950	SENT162	9	9	33	33	trypsin	PDH	PA451806	54704	0.903
NULL	Proteome_Sci_2009_Mar_31_7_14.nxml.txt.nlp	19331694	SENT121	21	21	35	35	kanamycin	CO2	PA450137	4513	0.903
NULL	J_Adv_Pract_Oncol_2012_Nov_1_Nov-Dec_3(6)_391-394.nxml.txt.nlp	25031970	SENT64	2	2	29	29	pertuzumab	HER2		2064	0.903
NULL	Cancer_Imaging_2012_Sep_28_12(2)_305-309.nxml.txt.nlp	23022887	SENT126	9	9	13	13	olaparib	BRCA1		672	0.903
NULL	Biomed_Res_Int_2014_Apr_23_2014_502542.nxml.txt.nlp	24864249	SENT31	6	6	4	4	rimonabant	CB1	PA152407999	1268	0.903
NULL	Int_J_Mol_Sci_2012_Dec_5_13(12)_16624-16635.nxml.txt.nlp	23443122	SENT11	4	4	13	13	carboplatin	MDR1	PA448803	5243	0.903
NULL	Lipids_Health_Dis_2011_Jan_18_10_8.nxml.txt.nlp	21241519	SENT105	24	24	17	17	simvastatin	ABCB11	PA451363	8647	0.903
NULL	Indian_J_Dermatol_2013_May-Jun_58(3)_227-231.nxml.txt.nlp	23723476	SENT66	14	14	9	9	dapsone	G6PD	PA449211	2539	0.903
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT200	0	0	14	14	erlotinib	AKT	PA134687924	207	0.903
NULL	Br_J_Cancer_2011_Jun_7_104(12)_1848-1853.nxml.txt.nlp	21610704	SENT151	8	8	4	4	panitumumab	KRAS	PA162373091	3845	0.903
NULL	Breast_Cancer_Res_2007_Oct_26_9(5)_306.nxml.txt.nlp	17980055	SENT35	19	19	26	26	tamoxifen	Bcl-2	PA451581	596	0.903
NULL	Evid_Based_Complement_Alternat_Med_2013_Aug_28_2013_516017.nxml.txt.nlp	24066014	SENT127	8	8	25	25	doxorubicin	EDH	PA449412	10804	0.903
NULL	Breast_Cancer_Res_2009_Jul_22_11(4)_R50.nxml.txt.nlp	19624808	SENT24	20	20	7	7	trastuzumab	HER2	PA451743	2064	0.903
NULL	Breast_Cancer_Res_2010_Apr_30_12(2)_203.nxml.txt.nlp	20459590	SENT309	7	7	30	30	cisplatin	BRCA1	PA449014	672	0.903
NULL	ARYA_Atheroscler_2011_Summer_7(2)_78-86.nxml.txt.nlp	22577451	SENT11	26	26	36	36	choline	CRP	PA448976	1401;140913	0.903
NULL	Acta_Neuropathol_Commun_2013_Jul_11_1_34.nxml.txt.nlp	24252661	SENT189	5	5	21	21	paraformaldehyde	CA1	PA450790	759	0.903
NULL	Arch_Med_Sci_2013_Oct_31_9(5)_936-943.nxml.txt.nlp	24273582	SENT103	3	3	21	21	nateglinide	GLP-1	PA450600	100125288	0.903
NULL	Oncol_Rep_2014_Oct_1_32(4)_1683-1694.nxml.txt.nlp	25109354	SENT33	12	12	8	8	bortezomib	HCC	PA10252	84668	0.903
NULL	Front_Immunol_2014_Aug_20_5_348.nxml.txt.nlp	25191322	SENT139	8	8	23	23	galactose	PP13	PA449725	29124	0.903
NULL	Breast_Cancer_Res_2012_Jun_7_14(3)_R89.nxml.txt.nlp	22676470	SENT340	15	15	26	26	geldanamycin	HER2	PA152031327	2064	0.903
NULL	J_Hematol_Oncol_2008_Oct_23_1_19.nxml.txt.nlp	18947412	SENT64	20	20	13	13	alemtuzumab	CD34	PA164783958	947	0.903
NULL	J_Neuroinflammation_2010_Sep_7_7_51.nxml.txt.nlp	20822529	SENT178	16	16	9	9	hemin	p38	PA449849	10598;1432;7965	0.903
NULL	Mol_Cancer_2010_May_20_9_115.nxml.txt.nlp	20487546	SENT280	26	26	16	16	fludarabine	p53	PA449655	7157	0.903
NULL	Front_Neurosci_2014_Dec_8_8_388.nxml.txt.nlp	25538545	SENT154	13	13	16	16	estradiol	aromatase	PA449503	1588	0.903
NULL	Front_Immunol_2013_Mar_27_4_76.nxml.txt.nlp	23543707	SENT218	29	29	4	4	cetuximab	gamma	PA10040	9913	0.903
NULL	EMBO_Mol_Med_2013_Dec_8_5(12)_1821-1834.nxml.txt.nlp	24293316	SENT45	11	11	2	2	doxorubicin	UNC5B	PA449412	219699	0.903
NULL	Mol_Cancer_2010_Apr_12_9_75.nxml.txt.nlp	20385023	SENT149	22	22	25	25	gefitinib	EGFR	PA131301952	1956	0.903
NULL	Br_J_Cancer_2010_Oct_26_103(9)_1380-1390.nxml.txt.nlp	20877355	SENT185	15	15	10	10	doxorubicin	TRAIL	PA449412	8743	0.903
NULL	Cancer_Immunol_Immunother_2012_Jan_17_61(1)_79-88.nxml.txt.nlp	21847632	SENT232	10	10	23	23	berberine	CCND1	PA165860812	595	0.903
NULL	Biosci_Rep_2013_Sep_4_33(5)_e00064.nxml.txt.nlp	23889169	SENT61	15	15	10	10	thrombin	PAR4	PA451674	9002;5074	0.903
NULL	Biomed_Res_Int_2013_Jul_18_2013_603782.nxml.txt.nlp	23971041	SENT138	10	10	23	23	travoprost	BAK	PA164781371	578	0.903
NULL	J_Korean_Med_Sci_2010_Dec_24_25(12)_1766-1770.nxml.txt.nlp	21165292	SENT90	7	7	0	0	sugar	GFR	PA451529	9771	0.903
NULL	Exp_Ther_Med_2012_Sep_12_4(3)_475-480.nxml.txt.nlp	23181121	SENT170	20	20	16	16	doxorubicin	CHOP	PA449412	1649	0.903
NULL	Int_J_Mol_Sci_2014_Nov_28_15(12)_21967-21979.nxml.txt.nlp	25464383	SENT93	5	5	19	19	ethanol	DCX	PA448073	1641	0.903
NULL	Cancer_Imaging_2005_Nov_23_5(Spec_No_A)_S27-S32.nxml.txt.nlp	16361133	SENT138	17	17	25	25	choline	FDG	PA448976	23583	0.903
NULL	Sci_Rep_2015_Jan_6_5_7641.nxml.txt.nlp	25560734	SENT136	18	18	11	11	tamoxifen	CLTC	PA451581	1213	0.903
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT85	20	20	4	4	phenprocoumon	ANOVA	PA450921	4858	0.903
NULL	Cancers_(Basel)_2011_Aug_12_3(3)_3279-3330.nxml.txt.nlp	24212956	SENT1243	31	31	13	13	natalizumab	TPBG	PA164747191	7162	0.903
NULL	Scientifica_(Cairo)_2012_Nov_25_2012_473829.nxml.txt.nlp	24278698	SENT229	8	8	19	19	cisplatin	ATP7B	PA449014	540	0.903
NULL	Breast_Cancer_Res_2010_Jul_6_12(4)_R46.nxml.txt.nlp	20604919	SENT158	31	31	29	29	cetuximab	EGFR	PA10040	1956	0.903
NULL	Ann_Clin_Transl_Neurol_2014_Dec_21_1(12)_996-1005.nxml.txt.nlp	25574474	SENT193	14	14	36	36	riluzole	P-gp	PA451251	5243	0.903
NULL	Exp_Neurobiol_2013_Mar_31_22(1)_51-57.nxml.txt.nlp	23585723	SENT13	0	0	13	13	capsaicin	TRPV1	PA448776	7442	0.903
NULL	Exp_Ther_Med_2013_Dec_14_6(6)_1499-1503.nxml.txt.nlp	24255681	SENT136	11	11	19	19	fluorouracil	S100A3	PA128406956	6274	0.903
NULL	Aging_(Albany_NY)_2014_Oct_28_6(10)_820-834.nxml.txt.nlp	25361036	SENT196	35	35	2	2	resveratrol	PARP-1		25976	0.903
NULL	Lancet_2011_Jun_18_377(9783)_2103-2114.nxml.txt.nlp	21641636	SENT106	28	28	9	9	cetuximab	KRAS	PA10040	3845	0.903
NULL	Breast_Cancer_Res_2012_May_18_14(3)_R78.nxml.txt.nlp	22608253	SENT146	27	27	3	3	letrozole	PDGFRB	PA450196	5159	0.903
NULL	Br_J_Cancer_2009_Jan_13_100(1)_19-23.nxml.txt.nlp	19018262	SENT65	0	0	4	4	lapatinib	EGFR	PA152241907	1956	0.903
NULL	J_Korean_Med_Sci_2006_Jun_21_21(3)_418-424.nxml.txt.nlp	16778382	SENT12	9	9	14	14	hemin	HO-1	PA449849	3162	0.903
NULL	Allergy_Asthma_Clin_Immunol_2013_Oct_3_9(1)_39.nxml.txt.nlp	24219860	SENT44	21	21	13	13	rituximab	BAFF	PA451261	10673	0.903
NULL	Support_Care_Cancer_2014_Dec_14_22(3)_837-846.nxml.txt.nlp	24337717	SENT19	27	27	16	16	itraconazole	CYP3A4	PA450132	1576	0.903
NULL	Br_J_Cancer_2002_Dec_2_87(12)_1411-1416.nxml.txt.nlp	12454770	SENT158	21	21	15	15	tamoxifen	AIB1	PA451581	8202	0.903
NULL	Ann_Hematol_2010_Nov_25_89(11)_1115-1124.nxml.txt.nlp	20499237	SENT100	15	15	5	5	simvastatin	CD5	PA451363	921	0.903
NULL	Breast_Cancer_Res_2011_Mar_14_13(2)_205.nxml.txt.nlp	21457526	SENT114	11	11	8	8	tamoxifen	aromatase	PA451581	1588	0.903
NULL	Biol_Open_2012_Oct_4_1(12)_1215-1225.nxml.txt.nlp	23259056	SENT171	20	20	29	29	l-glutamine	LAMP2	PA10090	3920	0.903
NULL	Breast_Cancer_Res_2014_Sep_11_16(5)_430.nxml.txt.nlp	25212826	SENT12	6	6	2	2	fulvestrant	AKT	PA164747170	207	0.903
NULL	Br_J_Cancer_2006_Feb_13_94(3)_407-426.nxml.txt.nlp	16434996	SENT346	18	18	4	4	genistein	BRCA2	PA165109660	675	0.903
NULL	Clin_Endosc_2013_Nov_19_46(6)_620-626.nxml.txt.nlp	24340254	SENT90	38	38	11	11	cetuximab	EGFR	PA10040	1956	0.903
NULL	J_Biol_Chem_2013_Nov_22_288(47)_34217-34229.nxml.txt.nlp	24106270	SENT271	12	12	21	21	thrombin	RhoG	PA451674	391	0.903
NULL	Exp_Ther_Med_2014_Jun_28_7(6)_1653-1658.nxml.txt.nlp	24926361	SENT164	2	2	11	11	curcumin	p65	PA151958596	5970	0.903
NULL	J_Vet_Med_Sci_2014_Oct_19_76(10)_1339-1345.nxml.txt.nlp	24942113	SENT14	0	0	21	21	losartan	AT2	PA450268	186	0.903
NULL	Int_J_Cell_Biol_2014_Jan_22_2014_709828.nxml.txt.nlp	24578708	SENT108	26	26	5	5	choline	PEMT	PA448976	10400	0.903
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT6	30	30	10	10	imatinib	ABCB1	PA10804	5243	0.903
NULL	Brain_Sci_2014_May_6_4(2)_356-375.nxml.txt.nlp	24961766	SENT210	7	7	13	13	propofol	CA1	PA451141	759	0.903
NULL	Iran_J_Pharm_Res_2014_Spring_13(2)_583-590.nxml.txt.nlp	25237354	SENT28	9	9	19	19	heparin	IL-6	PA449855	3569	0.903
NULL	Cancer_Manag_Res_2014_May_23_6_225-252.nxml.txt.nlp	24904222	SENT59	22	22	14	14	metformin	aromatase	PA450395	1588	0.903
NULL	J_Nutr_Metab_2012_Apr_10_2012_431574.nxml.txt.nlp	22570769	SENT156	21	21	4	4	sertraline	TPH2	PA451333	6999;121278	0.903
NULL	Indian_J_Endocrinol_Metab_2011_Jul-Sep_15(3)_175-181.nxml.txt.nlp	21897893	SENT150	4	4	17	17	denosumab	RANKL	PA166048634	8600	0.903
NULL	J_Breast_Cancer_2013_Jun_28_16(2)_164-170.nxml.txt.nlp	23843848	SENT113	21	21	1	1	doxorubicin	p53	PA449412	7157	0.903
NULL	Br_J_Cancer_2013_Jun_25_108(12)_2485-2494.nxml.txt.nlp	23695022	SENT120	8	8	15	15	vincristine	P-gp	PA451879	5243	0.902
NULL	Eur_J_Pharmacol_2012_May_5_682(1-3)_21-28.nxml.txt.nlp	22381066	SENT139	5	5	13	13	doxycycline	Bcl-2	PA449415	596	0.902
NULL	J_Mol_Psychiatry_2013_Nov_4_1(1)_19.nxml.txt.nlp	25408910	SENT79	37	37	6	6	olanzapine	AC3	PA450688	109	0.902
NULL	J_Clin_Exp_Pathol_2012_May_17_Suppl_4_7327.nxml.txt.nlp	25379357	SENT24	12	12	10	10	resveratrol	SIRT1		23411	0.902
NULL	Cancer_Immunol_Immunother_2011_Jun_25_60(6)_793-808.nxml.txt.nlp	21350947	SENT220	9	9	32	32	sorafenib	IFN	PA7000	3439	0.902
NULL	Mol_Vis_2012_Nov_29_18_2839-2846.nxml.txt.nlp	23233786	SENT123	1	1	26	26	geldanamycin	CB2	PA152031327	1269	0.902
NULL	Open_Biochem_J_2011_Sep_23_5_45-51.nxml.txt.nlp	21966325	SENT125	4	4	13	13	diclofenac	PERK	PA449293	9451	0.902
NULL	Int_J_Breast_Cancer_2012_May_9_2012_415170.nxml.txt.nlp	22649737	SENT71	20	20	9	9	trastuzumab	IGF1R	PA451743	3480	0.902
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT193	20	20	26	26	methotrexate	MSH2	PA450428	4436	0.902
NULL	Mol_Cancer_2009_Jul_15_8_49.nxml.txt.nlp	19604388	SENT153	10	10	5	5	heparin	OPG	PA449855	690	0.902
NULL	Arthritis_Res_Ther_2010_May_28_12(3)_R105.nxml.txt.nlp	20509880	SENT88	26	26	8	8	celecoxib	p38	PA448871	10598;1432;7965	0.902
NULL	Clin_Infect_Dis_2013_Mar_1_56(5)_694-696.nxml.txt.nlp	23175557	SENT24	18	18	23	23	primaquine	ACT	PA451103	12;11332;9457;641455	0.902
NULL	Clin_Interv_Aging_2009_May_14_4_179-186.nxml.txt.nlp	19503779	SENT91	17	17	4	4	ticlopidine	CYP1A2	PA451686	1544	0.902
NULL	Int_J_Surg_Oncol_2012_Jun_12_2012_862879.nxml.txt.nlp	22778941	SENT148	13	13	2	2	cisplatin	BIN1	PA449014	274	0.902
NULL	Cell_Biochem_Biophys_2013_May_28_67(1)_25-43.nxml.txt.nlp	23712866	SENT273	34	34	21	21	etoposide	OTUB1	PA449552	55611	0.902
NULL	J_Gen_Intern_Med_2009_May_21_24(5)_656-664.nxml.txt.nlp	19306050	SENT203	4	4	23	23	warfarin	VKORC1	PA451906	79001	0.902
NULL	Br_J_Cancer_2012_Feb_14_106(4)_685-692.nxml.txt.nlp	22294184	SENT130	22	22	13	13	docetaxel	p38	PA449383	10598;1432;7965	0.902
NULL	J_Cancer_2011_May_1_2_232-261.nxml.txt.nlp	21552384	SENT119	21	21	24	24	exemestane	aromatase	PA449563	1588	0.902
NULL	Cancer_Cell_Int_2005_Jul_24_5_22.nxml.txt.nlp	16042792	SENT131	28	28	4	4	vincristine	MRP1	PA451879	4437	0.902
NULL	Int_J_Alzheimers_Dis_2012_Feb_15_2012_381974.nxml.txt.nlp	22506133	SENT124	31	31	21	21	l-glutamine	B27	PA10090	56246	0.902
NULL	Arthritis_Res_Ther_2006_Apr_28_8(3)_R78.nxml.txt.nlp	16646980	SENT154	22	22	7	7	indomethacin	COX	PA449982	1351	0.902
NULL	Am_J_Cardiovasc_Drugs_2013_Jun_20_13(5)_331-342.nxml.txt.nlp	23784266	SENT226	31	31	24	24	verapamil	P-gp	PA451868	5243	0.902
NULL	Oncotarget_2014_Oct_23_5(22)_11154-11167.nxml.txt.nlp	25525888	SENT180	25	25	14	14	bevacizumab	VEGFR	PA130232992	3791	0.902
NULL	J_Physiol_2014_Nov_15_592(22)_5093-5107.nxml.txt.nlp	25239460	SENT163	6	6	4	4	ketoprofen	COX	PA450149	1351	0.902
NULL	Mol_Cancer_2014_Jan_13_13_7.nxml.txt.nlp	24418169	SENT177	19	19	24	24	sorafenib	SHP-1	PA7000	5777	0.902
NULL	Case_Rep_Pathol_2011_Sep_22_2011_809567.nxml.txt.nlp	22937394	SENT59	9	9	1	1	dapsone	CD4	PA449211	920	0.902
NULL	Trials_2013_Aug_19_14_261.nxml.txt.nlp	23958221	SENT156	27	27	0	0	paclitaxel	HER2	PA450761	2064	0.902
NULL	Oncotarget_2013_Dec_28_5(6)_1475-1490.nxml.txt.nlp	24721996	SENT81	5	5	10	10	celecoxib	CD44	PA448871	960	0.902
NULL	J_Cardiothorac_Surg_2011_Jul_15_6_91.nxml.txt.nlp	21762506	SENT29	13	13	1	1	vasopressin	ACLS	PA451858	46;2737	0.902
NULL	Evid_Based_Complement_Alternat_Med_2012_Sep_25_2012_174916.nxml.txt.nlp	23049604	SENT129	9	9	17	17	curcumin	RANKL	PA151958596	8600	0.902
NULL	Biomed_Res_Int_2014_Jun_26_2014_249780.nxml.txt.nlp	25054134	SENT178	19	19	13	13	ethanol	mol	PA448073	90527	0.902
NULL	Clin_Dev_Immunol_2007_Jan_20_2007_76396.nxml.txt.nlp	18317531	SENT6	35	35	11	11	sertraline	IL-2	PA451333	3558	0.902
NULL	Indian_J_Pharmacol_2008_Oct_40(Suppl_2)_S150-S160.nxml.txt.nlp	21593968	SENT527	9	9	2	2	pioglitazone	IL-4	PA450970	3565	0.902
NULL	Nat_Commun_2013_Sep_27_4_2519.nxml.txt.nlp	24071738	SENT13	28	28	4	4	bortezomib	OTUB1	PA10252	55611	0.902
NULL	Pharmaceuticals_(Basel)_2013_Aug_21_6(8)_988-1038.nxml.txt.nlp	24276379	SENT2898	15	15	11	11	cetuximab	FGFR3	PA10040	2261	0.902
NULL	Arch_Drug_Inf_2008_Dec_1(3)_97-106.nxml.txt.nlp	19639031	SENT141	28	28	22	22	irinotecan	UGT1A1	PA450085	54658	0.902
NULL	Br_J_Cancer_2012_Aug_21_107(5)_793-799.nxml.txt.nlp	22850551	SENT114	20	20	5	5	erlotinib	EGFR	PA134687924	1956	0.902
NULL	Breast_Cancer_(Auckl)_2010_Feb_16_4_1-3.nxml.txt.nlp	20697527	SENT19	10	10	32	32	cyclophosphamide	CTX	PA449165	1593	0.902
NULL	Arthritis_Res_Ther_2008_Oct_17_10(Suppl_2)_S2.nxml.txt.nlp	19007427	SENT159	13	13	11	11	indomethacin	COX	PA449982	1351	0.902
NULL	Clin_Med_Insights_Oncol_2012_Dec_6_6_407-421.nxml.txt.nlp	23239933	SENT145	38	38	33	33	docetaxel	EGFR	PA449383	1956	0.902
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT205	8	8	13	13	atorvastatin	TNF	PA448500	7124	0.902
NULL	Acta_Pharmacol_Sin_2011_Oct_12_32(10)_1259-1265.nxml.txt.nlp	21909126	SENT111	35	35	28	28	fluvastatin	MCP-1	PA449688	6347	0.902
NULL	Oxid_Med_Cell_Longev_2014_Apr_30_2014_149627.nxml.txt.nlp	24876909	SENT113	20	20	35	35	ethanol	PER2	PA448073	8864	0.902
NULL	Cell_Cycle_2013_Dec_15_12(24)_3791-3803.nxml.txt.nlp	24107631	SENT110	17	17	11	11	doxorubicin	YB-1	PA449412	4904	0.902
NULL	Pharmaceuticals_(Basel)_2011_Mar_25_4(4)_567-589.nxml.txt.nlp	NULL	SENT380	5	5	7	7	doxazosin	EGFR	PA449407	1956	0.902
NULL	Oncotarget_2014_Mar_15_5(10)_3055-3065.nxml.txt.nlp	24931391	SENT208	24	24	10	10	hydrocortisone	FBS	PA449905	64319;26269	0.902
NULL	Cancers_(Basel)_2014_Jul_22_6(3)_1540-1552.nxml.txt.nlp	25055117	SENT349	8	8	17	17	crizotinib	Met	PA165946122	79811	0.902
NULL	ARYA_Atheroscler_2012_Winter_7(4)_133-137.nxml.txt.nlp	23205044	SENT73	32	32	2	2	pentoxifylline	p50	PA450864	958;4790	0.902
NULL	Front_Oncol_2014_Sep_23_4_264.nxml.txt.nlp	25295231	SENT175	38	38	21	21	lenalidomide	p53	PA162363968	7157	0.902
NULL	F1000Prime_Rep_2014_Dec_1_6_117.nxml.txt.nlp	25580271	SENT21	14	14	3	3	gefitinib	EGFR	PA131301952	1956	0.902
NULL	J_Gastroenterol_2013_Jan_28_48(1)_1-12.nxml.txt.nlp	23188091	SENT285	16	16	3	3	telaprevir	ITPA	PA165958354	3704	0.902
NULL	Sci_Rep_2014_Nov_28_4_7237.nxml.txt.nlp	25429875	SENT80	11	11	5	5	hesperidin	IRF7	PA449867	3665	0.902
NULL	Br_J_Cancer_2013_May_28_108(10)_2056-2062.nxml.txt.nlp	23660946	SENT63	29	29	10	10	neomycin	ARID1B	PA450608	57492	0.902
NULL	Front_Oncol_2014_Nov_25_4_329.nxml.txt.nlp	25505733	SENT70	0	0	16	16	crizotinib	EGFR	PA165946122	1956	0.902
NULL	Front_Neurosci_2014_Jan_10_7_270.nxml.txt.nlp	24454277	SENT57	3	3	1	1	resveratrol	SIRT1		23411	0.902
NULL	EMBO_Mol_Med_2012_Dec_15_4(12)_1276-1293.nxml.txt.nlp	23065753	SENT364	18	18	13	13	cisplatin	NLRP3	PA449014	114548	0.902
NULL	F1000Res_2013_Oct_8_2_173.nxml.txt.nlp	24555085	SENT281	13	13	21	21	budesonide	CYP3A	PA448681	1574	0.902
NULL	Br_J_Cancer_2012_Apr_24_106(9)_1543-1550.nxml.txt.nlp	22531721	SENT172	18	18	28	28	trastuzumab	CD59	PA451743	966	0.902
NULL	Brain_Sci_2013_Apr_26_3(2)_670-703.nxml.txt.nlp	24961420	SENT135	21	21	3	3	ethanol	AMPK	PA448073	5563	0.902
NULL	Curr_Chem_Genomics_2011_Aug_22_5_62-71.nxml.txt.nlp	21966346	SENT90	22	22	2	2	thalidomide	LSD1	PA451644	23028	0.902
NULL	Oncotarget_2012_Jul_13_3(6)_601-607.nxml.txt.nlp	22802145	SENT29	6	6	29	29	doxorubicin	p53	PA449412	7157	0.902
NULL	Nature_2012_Apr_25_484(7395)_510-513.nxml.txt.nlp	22538615	SENT121	39	39	19	19	mitomycin	CD4	PA450524	920	0.902
NULL	Breast_Cancer_Res_2005_May_24_7(5)_R589-R597.nxml.txt.nlp	16168102	SENT100	7	7	17	17	doxorubicin	HER3	PA449412	2065	0.902
NULL	Oncotarget_2014_Mar_14_5(10)_3029-3038.nxml.txt.nlp	24912489	SENT81	32	32	20	20	everolimus	aromatase	PA164746311	1588	0.902
NULL	Cancer_Med_2013_Jun_25_2(3)_277-285.nxml.txt.nlp	23930204	SENT117	6	6	40	40	bevacizumab	PTEN	PA130232992	5728	0.902
NULL	Arthritis_Res_Ther_2013_Apr_4_15(Suppl_1)_S4.nxml.txt.nlp	23566679	SENT115	28	28	10	10	rituximab	CD27	PA451261	939	0.902
NULL	ScientificWorldJournal_2012_Jun_4_2012_721313.nxml.txt.nlp	22701369	SENT121	35	35	17	17	imatinib	ZNF91	PA10804	7644	0.902
NULL	Chin_J_Cancer_2011_May_30(5)_327-335.nxml.txt.nlp	21527065	SENT20	3	3	12	12	trastuzumab	HER2	PA451743	2064	0.902
NULL	Clin_Ophthalmol_2014_Jun_24_8_1187-1198.nxml.txt.nlp	25028531	SENT5	0	0	16	16	ranibizumab	VEGF-A	PA164746012	7422	0.902
NULL	Am_J_Trop_Med_Hyg_2012_Aug_1_87(2)_231-241.nxml.txt.nlp	22855752	SENT16	15	15	0	0	artemether	ACT	PA165111698	12;11332;9457;641455	0.902
NULL	Nat_Commun_2011_Oct_25_2_513.nxml.txt.nlp	22027593	SENT84	24	24	12	12	nutlin-3	RBM38		55544	0.902
NULL	Cell_Death_Dis_2010_May_13_1(5)_e41.nxml.txt.nlp	21364648	SENT71	1	1	11	11	etoposide	p53	PA449552	7157	0.902
NULL	Cancer_Manag_Res_2013_Jun_7_5_91-101.nxml.txt.nlp	23785245	SENT14	19	19	14	14	gefitinib	EGFR	PA131301952	1956	0.902
NULL	BMB_Rep_2014_Jul_47(7)_376-381.nxml.txt.nlp	24286332	SENT77	5	5	10	10	thrombin	PPG	PA451674	5552	0.902
NULL	J_Clin_Biochem_Nutr_2010_Sep_6_47(2)_121-129.nxml.txt.nlp	20838567	SENT186	26	26	13	13	arsenite	HO-1	PA452638	3162	0.902
NULL	J_Cancer_Prev_2014_Mar_19(1)_39-46.nxml.txt.nlp	25337571	SENT110	35	35	28	28	ethanol	p38	PA448073	10598;1432;7965	0.902
NULL	Osteoporos_Int_2013_May_4_24(10)_2659-2670.nxml.txt.nlp	23644877	SENT226	16	16	27	27	metformin	AMPK	PA450395	5563	0.902
NULL	Int_Neurourol_J_2014_Sep_24_18(3)_115-125.nxml.txt.nlp	25279238	SENT118	30	30	32	32	berberine	CD11b	PA165860812	3684	0.902
NULL	BMB_Rep_2014_Jul_47(7)_388-392.nxml.txt.nlp	24286329	SENT81	4	4	9	9	berberine	AP-1	PA165860812	2353;3727;2354;3725	0.902
NULL	Front_Pharmacol_2014_Nov_25_5_256.nxml.txt.nlp	25505414	SENT111	9	9	33	33	propofol	KCC2	PA451141	57468	0.902
NULL	Clin_Exp_Otorhinolaryngol_2011_Dec_15_4(4)_177-183.nxml.txt.nlp	22232712	SENT11	29	29	13	13	doxycycline	MUC5B	PA449415	727897	0.902
NULL	Iran_J_Basic_Med_Sci_2012_Sep-Oct_15(5)_1106-1110.nxml.txt.nlp	23493185	SENT90	3	3	14	14	scopolamine	CB1	PA451308	1268	0.902
NULL	Anesthesiol_Res_Pract_2012_Nov_24_2012_921405.nxml.txt.nlp	22162685	SENT139	25	25	9	9	lidocaine	NPY	PA450226	4852	0.902
NULL	Diabetes_Metab_Syndr_Obes_2010_May_17_3_155-163.nxml.txt.nlp	21437085	SENT152	6	6	16	16	exenatide	GLP-1	PA164749238	100125288	0.902
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2007_Jan_1_63(Pt_1)_1-8.nxml.txt.nlp	17164520	SENT45	27	27	5	5	trypsin	PTI	PA451806	5269	0.902
NULL	Ann_Surg_Oncol_2010_Apr_20_17(4)_1168-1176.nxml.txt.nlp	19936839	SENT113	13	13	26	26	bevacizumab	KRAS	PA130232992	3845	0.902
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT16	45	45	8	8	capsaicin	p53	PA448776	7157	0.902
NULL	Free_Radic_Res_2012_Aug_14_46(8)_1011-1018.nxml.txt.nlp	22329629	SENT64	41	41	6	6	paraformaldehyde	LC3	PA450790	84557	0.902
NULL	Adv_Hematol_2012_Sep_14_2012_524308.nxml.txt.nlp	21941553	SENT247	18	18	21	21	fludarabine	MCL1	PA449655	4170	0.902
NULL	Mol_Cancer_2014_Aug_22_13(1)_196.nxml.txt.nlp	NULL	SENT291	23	23	6	6	glutaraldehyde	ANGPTL4	PA449777	51129	0.902
NULL	Neural_Regen_Res_2013_Jul_15_8(20)_1853-1862.nxml.txt.nlp	25206494	SENT28	6	6	24	24	ethanol	c-Jun	PA448073	3725	0.902
NULL	Front_Behav_Neurosci_2010_Apr_5_4_14.nxml.txt.nlp	20407577	SENT328	8	8	4	4	cocaine	BDNF	PA449072	627	0.902
NULL	Mol_Cancer_2013_Mar_5_12_17.nxml.txt.nlp	23497256	SENT164	12	12	0	0	sunitinib	p53	PA162372840	7157	0.902
NULL	Nat_Commun_2013_Oct_17_4_2601.nxml.txt.nlp	24131955	SENT79	15	15	32	32	tetracycline	CD37	PA451640	951	0.902
NULL	Breast_Cancer_Res_2012_Jul_20_14(4)_R110.nxml.txt.nlp	22817698	SENT68	14	14	23	23	cisplatin	BRCA1	PA449014	672	0.902
NULL	Diabetes_2013_Sep_15_62(9)_3224-3231.nxml.txt.nlp	23545707	SENT26	43	43	15	15	losartan	ACR	PA450268	49	0.902
NULL	Curr_Genomics_2014_Jun_15(3)_217-230.nxml.txt.nlp	24955029	SENT3	11	11	20	20	oxygen	ROS	PA450744	6098	0.902
NULL	AAPS_J_2011_Dec_22_14(1)_68-78.nxml.txt.nlp	22189899	SENT191	13	13	19	19	rifampin	CYP3A4	PA451250	1576	0.902
NULL	Mar_Drugs_2014_Oct_28_12(11)_5357-5371.nxml.txt.nlp	25353254	SENT362	13	13	0	0	hemin	PI3K	PA449849	5290	0.902
NULL	Ann_Indian_Acad_Neurol_2010_Jan-Mar_13(1)_6-13.nxml.txt.nlp	20436740	SENT263	18	18	14	14	prasugrel	ADP	PA154410481	23038	0.902
NULL	J_Immunother_Cancer_2014_Jan_27_2_2.nxml.txt.nlp	24829759	SENT179	39	39	48	48	sorafenib	IL-21	PA7000	59067;50616;27189	0.902
NULL	Oncol_Lett_2013_Mar_8_5(3)_749-755.nxml.txt.nlp	23426528	SENT95	28	28	11	11	paraformaldehyde	CO2	PA450790	4513	0.902
NULL	Comp_Hepatol_2005_Feb_8_4_2.nxml.txt.nlp	15701172	SENT171	14	14	1	1	ketoconazole	CYP3A	PA450146	1574	0.902
NULL	Int_J_Womens_Health_2012_Oct_10_4_543-549.nxml.txt.nlp	23091400	SENT75	9	9	30	30	resveratrol	aromatase		1588	0.902
NULL	Mol_Cancer_2006_Nov_2_5_53.nxml.txt.nlp	17081294	SENT70	16	16	20	20	doxorubicin	MYC	PA449412	4609	0.902
NULL	Mol_Vis_2007_Jul_12_13_1130-1137.nxml.txt.nlp	17653058	SENT168	9	9	21	21	propofol	IFN	PA451141	3439	0.902
NULL	Front_Oncol_2013_Sep_9_3_235.nxml.txt.nlp	24058902	SENT120	21	21	44	44	pargyline	LSD1	PA450797	23028	0.902
NULL	J_Exp_Med_2003_Aug_4_198(3)_505-512.nxml.txt.nlp	12900524	SENT146	22	22	5	5	heparin	CCL21	PA449855	6366	0.902
NULL	Exp_Ther_Med_2013_Apr_5_5(4)_1259-1263.nxml.txt.nlp	23596498	SENT8	16	16	22	22	propofol	TRPV1	PA451141	7442	0.902
NULL	Ann_Rheum_Dis_2010_Dec_27_70(5)_755-759.nxml.txt.nlp	21187298	SENT166	45	45	22	22	tocilizumab	IL-6	PA165292659	3569	0.902
NULL	Adv_Appl_Bioinform_Chem_2012_Sep_6_5_61-79.nxml.txt.nlp	23055752	SENT139	5	5	20	20	thrombin	DHFR	PA451674	1719	0.902
NULL	Br_J_Cancer_2011_Aug_9_105(4)_469-474.nxml.txt.nlp	21712825	SENT127	24	24	8	8	doxorubicin	UCP2	PA449412	7351	0.902
NULL	Arthritis_Res_Ther_2011_Jan_31_13(1)_R11.nxml.txt.nlp	21281483	SENT29	25	25	0	0	ethanol	CYP2E1	PA448073	1571	0.902
NULL	Int_J_Biol_Sci_2012_Sep_6_8(8)_1109-1120.nxml.txt.nlp	22991499	SENT80	22	22	11	11	trypsin	IFN	PA451806	3439	0.902
NULL	Exp_Ther_Med_2014_Apr_13_7(4)_799-803.nxml.txt.nlp	24669235	SENT76	5	5	11	11	vildagliptin	PPG	PA165958346	5552	0.902
NULL	Arthritis_Res_Ther_2011_Mar_16_13(2)_R44.nxml.txt.nlp	21410959	SENT17	4	4	24	24	glucosamine	RANKL	PA164747613	8600	0.902
NULL	Front_Neural_Circuits_2014_Mar_17_8_21.nxml.txt.nlp	24672433	SENT68	25	25	16	16	haloperidol	5-HT4	PA449841	3360	0.902
NULL	Mol_Cancer_2010_Apr_12_9_75.nxml.txt.nlp	20385023	SENT174	17	17	22	22	gefitinib	PTEN	PA131301952	5728	0.902
NULL	J_Young_Pharm_2010_Jul-Sep_2(3)_273-279.nxml.txt.nlp	21042485	SENT33	21	21	18	18	benzaldehyde	mol	PA448571	90527	0.902
NULL	Front_Endocrinol_(Lausanne)_2014_Aug_18_5_129.nxml.txt.nlp	25183960	SENT97	0	0	24	24	cabergoline	ghrelin	PA448708	51738	0.902
NULL	J_Cell_Mol_Med_2013_Oct_16_17(10)_1261-1270.nxml.txt.nlp	23855452	SENT175	2	2	8	8	gemcitabine	CHK2	PA449748	11200	0.902
NULL	J_Korean_Med_Sci_2013_Feb_29_28(2)_308-314.nxml.txt.nlp	23399960	SENT56	0	0	12	12	gabapentin	IL-10	PA449720	3586	0.902
NULL	J_Biol_Chem_2012_Apr_13_287(16)_12952-12965.nxml.txt.nlp	22371491	SENT63	18	18	5	5	terazosin	CXCL8	PA451612	3576	0.902
NULL	J_Adv_Pharm_Technol_Res_2012_Oct-Dec_3(4)_202-209.nxml.txt.nlp	23378940	SENT168	13	13	5	5	ifosfamide	CYP3A4	PA449964	1576	0.902
NULL	Springerplus_2014_Sep_17_3_535.nxml.txt.nlp	25279326	SENT154	32	32	13	13	exemestane	aromatase	PA449563	1588	0.902
NULL	Int_J_Mol_Sci_2014_Nov_14_15(11)_21028-21044.nxml.txt.nlp	25405735	SENT256	22	22	0	0	estradiol	HSD17B4	PA449503	3295	0.902
NULL	BMB_Rep_2014_Apr_47(4)_221-226.nxml.txt.nlp	24286312	SENT131	24	24	32	32	nutlin-3	p53		7157	0.902
NULL	J_Vet_Pharmacol_Ther_2014_Apr_18_37(2)_161-168.nxml.txt.nlp	24134659	SENT37	4	4	21	21	cyclosporine	GLP	PA449167	342096	0.902
NULL	J_Exp_Med_2000_Mar_6_191(5)_859-870.nxml.txt.nlp	10704466	SENT145	13	13	20	20	arsenite	p38	PA452638	10598;1432;7965	0.902
NULL	Trials_2014_May_10_15_164.nxml.txt.nlp	24884585	SENT105	6	6	28	28	fluorescein	CD34	PA164746009	947	0.902
NULL	Clin_Kidney_J_2013_Aug_6(4)_421-425.nxml.txt.nlp	24422172	SENT78	20	20	0	0	fluorescein	CD46	PA164746009	4179	0.902
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT94	31	31	5	5	dasatinib	ABCG2	PA162372878	9429	0.902
NULL	Mol_Vis_2012_Oct_11_18_2509-2517.nxml.txt.nlp	23112566	SENT174	6	6	24	24	bevacizumab	VEGF-A	PA130232992	7422	0.902
NULL	Breast_Cancer_Res_2004_Oct_6_6(6)_262-268.nxml.txt.nlp	15535857	SENT63	34	34	36	36	tamoxifen	aromatase	PA451581	1588	0.902
NULL	Oncotarget_2013_Nov_24_4(12)_2430-2438.nxml.txt.nlp	24280348	SENT64	7	7	14	14	gefitinib	EGFR	PA131301952	1956	0.902
NULL	Arthritis_Res_Ther_2013_Feb_14_15(1)_R29.nxml.txt.nlp	23406989	SENT63	22	22	1	1	ethanol	ACL	PA448073	47	0.902
NULL	J_Geriatr_Cardiol_2012_Jun_9(2)_180-184.nxml.txt.nlp	22916066	SENT96	23	23	4	4	rosuvastatin	Rho	PA134308647	29984	0.902
NULL	Drugs_R_D_2011_Jun_27_11(2)_113-126.nxml.txt.nlp	21679004	SENT39	18	18	48	48	sunitinib	IFN	PA162372840	3439	0.902
NULL	Eur_J_Clin_Pharmacol_2014_Oct_8_70(1)_37-45.nxml.txt.nlp	24100471	SENT15	4	4	32	32	midazolam	CYP2C19	PA450496	1557	0.902
NULL	Blood_Res_2014_Jun_25_49(2)_85-94.nxml.txt.nlp	25025009	SENT54	18	18	11	11	heparin	VIII	PA449855	1351	0.902
NULL	J_Hematol_Oncol_2013_Feb_17_6_17.nxml.txt.nlp	23414938	SENT173	32	32	19	19	prasugrel	VASP	PA154410481	7408	0.902
NULL	Oncotarget_2014_Oct_24_5(22)_11428-11441.nxml.txt.nlp	25426549	SENT226	11	11	3	3	neomycin	MTAP	PA450608	4507	0.902
NULL	Clin_Med_Insights_Oncol_2012_Feb_28_6_125-135.nxml.txt.nlp	22408376	SENT218	0	0	13	13	panitumumab	KRAS	PA162373091	3845	0.902
NULL	Clin_Ophthalmol_2014_Jan_31_8_335-341.nxml.txt.nlp	24520190	SENT13	21	21	1	1	fluorescein	FAF	PA164746009	8239;2188	0.902
NULL	J_Med_Chem_2014_Feb_13_57(3)_677-685.nxml.txt.nlp	24428777	SENT122	21	21	39	39	geldanamycin	AKT	PA152031327	207	0.902
NULL	Arthritis_Res_Ther_2014_Apr_15_16(2)_R95.nxml.txt.nlp	24735586	SENT202	22	22	8	8	methotrexate	CD19	PA450428	930	0.902
NULL	Nat_Biotechnol_2010_May_28(5)_478-485.nxml.txt.nlp	20458318	SENT44	5	5	32	32	gentamicin	NAG	PA449753	51594;4669	0.902
NULL	Core_Evid_2009_Jun_15_4_171-179.nxml.txt.nlp	20694073	SENT209	3	3	17	17	mirtazapine	STAR	PA450522	6770;2984	0.902
NULL	J_Hematol_Oncol_2011_Jan_21_4_5.nxml.txt.nlp	21255411	SENT166	10	10	2	2	paclitaxel	EGFR	PA450761	1956	0.902
NULL	Int_J_Breast_Cancer_2011_Feb_24_2011_967419.nxml.txt.nlp	22332018	SENT109	18	18	8	8	topotecan	MRP2	PA451729	100130958;57626;1244	0.902
NULL	Acta_Pharmacol_Sin_2010_Nov_18_31(11)_1447-1453.nxml.txt.nlp	20953204	SENT94	12	12	21	21	rimonabant	IL-6	PA152407999	3569	0.902
NULL	J_Clin_Exp_Pathol_2012_May_17_Suppl_4_7327.nxml.txt.nlp	25379357	SENT129	5	5	15	15	metformin	AMPK	PA450395	5563	0.902
NULL	Adv_Hematol_2012_Jan_11_2012_130680.nxml.txt.nlp	22287968	SENT138	15	15	37	37	cyclophosphamide	COP1	PA449165	64326;114769	0.902
NULL	Oncol_Lett_2013_Feb_9_5(2)_552-558.nxml.txt.nlp	23420128	SENT142	28	28	25	25	imatinib	KIT	PA10804	3815	0.902
NULL	Int_J_Mol_Sci_2014_Oct_20_15(10)_19000-19017.nxml.txt.nlp	25334067	SENT197	20	20	12	12	l-tyrosine	F10	PA451822	2159	0.902
NULL	Orphanet_J_Rare_Dis_2010_Jan_29_5_2.nxml.txt.nlp	20113479	SENT375	14	14	29	29	hydroxyurea	RECQL4	PA449942	9401	0.902
NULL	Mol_Cancer_2008_Jun_5_7_50.nxml.txt.nlp	18534018	SENT66	27	27	21	21	bortezomib	NOXA	PA10252	5366	0.902
NULL	J_Biol_Chem_2012_Apr_27_287(18)_14950-14959.nxml.txt.nlp	22393063	SENT120	21	21	6	6	heparin	K19	PA449855	3880	0.902
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1890-1904.nxml.txt.nlp	25268161	SENT67	11	11	21	21	thrombin	KLK5	PA451674	25818	0.902
NULL	Br_J_Cancer_2011_Sep_6_105(6)_814-823.nxml.txt.nlp	21847116	SENT63	30	30	10	10	pha-665752	CO2		4513	0.902
NULL	Mol_Biol_Rep_2013_Jul_11_40(7)_4211-4217.nxml.txt.nlp	23666051	SENT118	18	18	5	5	fexofenadine	SLCO2B1	PA449621	11309	0.902
NULL	Braz_J_Med_Biol_Res_2014_Mar_3_47(3)_245-251.nxml.txt.nlp	24554037	SENT110	20	20	6	6	atorvastatin	IFN	PA448500	3439	0.902
NULL	Front_Behav_Neurosci_2013_Dec_23_7_211.nxml.txt.nlp	24391566	SENT123	14	14	27	27	propranolol	ANOVA	PA451145	4858	0.902
NULL	Cardiovasc_Diabetol_2013_Oct_17_12_150.nxml.txt.nlp	24134550	SENT15	2	2	13	13	metformin	activin	PA450395	83729	0.902
NULL	Trials_2014_Nov_6_15(1)_434.nxml.txt.nlp	NULL	SENT203	33	33	12	12	ofloxacin	Bravo	PA450684	4897	0.902
NULL	J_Thromb_Haemost_2014_Apr_11_12(4)_550-559.nxml.txt.nlp	24460629	SENT116	23	23	30	30	indomethacin	ADP	PA449982	23038	0.902
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Feb_17_68(Pt_3)_o736.nxml.txt.nlp	22412616	SENT66	31	31	4	4	ethanol	mol	PA448073	90527	0.902
NULL	Cancer_Med_2012_Aug_15_1(1)_28-38.nxml.txt.nlp	23342251	SENT218	8	8	6	6	trastuzumab	HER2	PA451743	2064	0.902
NULL	Mol_Pain_2014_Aug_15_10_53.nxml.txt.nlp	25127716	SENT26	26	26	13	13	minocycline	SDH	PA450519	1757;10993	0.902
NULL	Clinics_(Sao_Paulo)_2014_Jul_69(7)_491-496.nxml.txt.nlp	25029582	SENT109	17	17	22	22	methacholine	IL-4	PA165958382	3565	0.902
NULL	Case_Rep_Hematol_2012_Mar_26_2012_746098.nxml.txt.nlp	22928128	SENT67	5	5	1	1	doxorubicin	CHOP	PA449412	1649	0.902
NULL	Genome_Med_2010_Nov_30_2(11)_85.nxml.txt.nlp	21122163	SENT212	16	16	9	9	imatinib	SLC22A1	PA10804	6580	0.902
NULL	Front_Oncol_2014_Mar_25_4_54.nxml.txt.nlp	24724051	SENT325	15	15	12	12	imatinib	BCL6	PA10804	604	0.902
NULL	J_Biol_Chem_2013_Nov_22_288(47)_34217-34229.nxml.txt.nlp	24106270	SENT169	15	15	7	7	thrombin	RhoG	PA451674	391	0.902
NULL	Gut_Liver_2012_Jan_12_6(1)_58-63.nxml.txt.nlp	22375172	SENT39	14	14	1	1	midazolam	ESD	PA450496	2098	0.902
NULL	Drug_Des_Devel_Ther_2014_Oct_14_8_1911-1922.nxml.txt.nlp	25342884	SENT107	21	21	28	28	tamoxifen	aromatase	PA451581	1588	0.902
NULL	Front_Genet_2012_Nov_12_3_235.nxml.txt.nlp	23162568	SENT150	8	8	5	5	methamphetamine	CYP2D6	PA450403	1565	0.902
NULL	J_Biomed_Sci_2013_May_4_20(1)_27.nxml.txt.nlp	23642268	SENT90	20	20	3	3	ampicillin	CNBP	PA448419	7555	0.902
NULL	Cell_Commun_Signal_2013_Feb_20_11_13.nxml.txt.nlp	23425659	SENT224	20	20	5	5	clonazepam	TSPO	PA449050	706	0.902
NULL	Cases_J_2009_Jun_26_2_6384.nxml.txt.nlp	19829800	SENT16	16	16	10	10	vincristine	CHOP	PA451879	1649	0.902
NULL	Indian_J_Endocrinol_Metab_2013_May-Jun_17(3)_413-421.nxml.txt.nlp	23869296	SENT60	34	34	22	22	exenatide	GLP-1	PA164749238	100125288	0.902
NULL	JAKSTAT_2013_Apr_1_2(2)_e23353.nxml.txt.nlp	24058806	SENT69	8	8	0	0	doxorubicin	STAT1	PA449412	6772	0.902
NULL	Brain_2008_Nov_22_131(11)_3072-3080.nxml.txt.nlp	18945724	SENT165	7	7	14	14	rituximab	AQP4	PA451261	361	0.902
NULL	Mol_Cancer_2014_Jan_28_13_17.nxml.txt.nlp	24472312	SENT233	12	12	3	3	ponatinib	Mcl-1	PA165980594	4170	0.902
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT101	15	15	4	4	curcumin	Bcl-2	PA151958596	596	0.902
NULL	F1000Prime_Rep_2014_Dec_1_6_112.nxml.txt.nlp	25580266	SENT65	20	20	2	2	ustekinumab	IL-23	PA166048654	51561	0.902
NULL	Int_Semin_Surg_Oncol_2008_Apr_28_5_9.nxml.txt.nlp	18442393	SENT85	9	9	21	21	tamoxifen	HER2	PA451581	2064	0.902
NULL	Cancer_Imaging_2008_Nov_25_8(1)_199-205.nxml.txt.nlp	19028612	SENT27	6	6	13	13	panitumumab	EGFR	PA162373091	1956	0.902
NULL	Curr_HIV_Res_2014_May_12(3)_174-188.nxml.txt.nlp	24862327	SENT148	25	25	12	12	hemin	MCP-1	PA449849	6347	0.902
NULL	Int_J_Mol_Sci_2014_Mar_20_15(3)_4946-4964.nxml.txt.nlp	24658439	SENT66	7	7	18	18	capsaicin	GBF	PA448776	1316	0.902
NULL	Int_J_Inflam_2011_Nov_30_2011_724080.nxml.txt.nlp	22187661	SENT160	9	9	12	12	losartan	AT1	PA450268	9197;185	0.902
NULL	Indian_J_Pharmacol_2012_Sep-Oct_44(5)_624-628.nxml.txt.nlp	23112426	SENT22	17	17	10	10	nimodipine	P-gp	PA450633	5243	0.902
NULL	Diabetol_Metab_Syndr_2014_Mar_31_6_47.nxml.txt.nlp	24684779	SENT105	3	3	17	17	simvastatin	CD68	PA451363	968	0.902
NULL	Br_J_Cancer_2009_Jul_21_101(2)_238-243.nxml.txt.nlp	19568242	SENT12	5	5	10	10	bevacizumab	IFN	PA130232992	3439	0.902
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT240	5	5	7	7	perifosine	JNK	PA165291471	5599	0.902
NULL	Br_J_Cancer_2009_Jul_21_101(2)_238-243.nxml.txt.nlp	19568242	SENT115	12	12	21	21	sunitinib	IFN	PA162372840	3439	0.902
NULL	Cell_Res_2013_Jul_21_23(7)_915-930.nxml.txt.nlp	23689279	SENT25	19	19	5	5	ethanol	ALDH2	PA448073	217	0.902
NULL	Arthritis_Res_Ther_2010_Dec_17_12(6)_221.nxml.txt.nlp	21205283	SENT126	31	31	0	0	etanercept	ACR	PA449515	49	0.902
NULL	J_Oncol_2012_Jun_19_2012_521215.nxml.txt.nlp	22778735	SENT103	20	20	10	10	cetuximab	EGFR	PA10040	1956	0.902
NULL	Cell_Cycle_2013_May_15_12(10)_1492-1500.nxml.txt.nlp	23598717	SENT19	21	21	0	0	doxorubicin	ROCK1	PA449412	6093	0.902
NULL	J_Cell_Mol_Med_2014_Dec_9_18(12)_2425-2436.nxml.txt.nlp	25297942	SENT195	11	11	8	8	cisplatin	HOTAIR	PA449014	100124700	0.902
NULL	Br_J_Pharmacol_2008_Dec_25_155(7)_1056-1065.nxml.txt.nlp	18724386	SENT254	39	39	37	37	diazoxide	GLP-1	PA449285	100125288	0.902
NULL	Biochim_Biophys_Acta_2014_Jul_1842(7)_959-970.nxml.txt.nlp	24594481	SENT220	6	6	17	17	lipase	FGF21	PA450239	26291	0.902
NULL	J_Oncol_2013_Apr_29_2013_854121.nxml.txt.nlp	23737784	SENT150	17	17	9	9	paclitaxel	HER2	PA450761	2064	0.902
NULL	Cancers_(Basel)_2014_Nov_14_6(4)_2275-2295.nxml.txt.nlp	25405526	SENT523	3	3	19	19	vemurafenib	BRAF	PA165946873	673	0.902
NULL	J_Gen_Physiol_2009_Apr_133(4)_421-438.nxml.txt.nlp	19289574	SENT226	1	1	6	6	glibenclamide	SLC26A9	PA449782	115019	0.902
NULL	Tuberc_Respir_Dis_(Seoul)_2013_Nov_29_75(5)_188-198.nxml.txt.nlp	24348666	SENT103	13	13	33	33	erlotinib	EGFR	PA134687924	1956	0.902
NULL	Basic_Res_Cardiol_2014_Oct_31_109(6)_451.nxml.txt.nlp	25358972	SENT189	2	2	14	14	phenylephrine	FHL2	PA450935	2274	0.902
NULL	Cell_Cycle_2013_Sep_15_12(18)_3025-3036.nxml.txt.nlp	23974102	SENT120	29	29	34	34	infliximab	CD4	PA452639	920	0.902
NULL	Pharmaceuticals_(Basel)_2012_Feb_2_5(2)_114-132.nxml.txt.nlp	24288084	SENT815	6	6	18	18	capsaicin	TRPV1	PA448776	7442	0.902
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Jul_21_9_20.nxml.txt.nlp	20663145	SENT112	36	36	5	5	erythromycin	LBH	PA449493	81606;221491	0.902
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2011_Jun_7_4_29-37.nxml.txt.nlp	22879792	SENT75	0	0	22	22	repaglinide	B12	PA451234	7126;4709	0.902
NULL	Cancers_(Basel)_2014_Oct_24_6(4)_2187-2223.nxml.txt.nlp	25347122	SENT1236	10	10	16	16	olaparib	BRCA2		675	0.902
NULL	J_Hum_Genet_2009_Sep_24_54(9)_516-524.nxml.txt.nlp	19629138	SENT98	9	9	2	2	doxycycline	POLG	PA449415	5428	0.902
NULL	Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.nxml.txt.nlp	24736980	SENT189	8	8	3	3	rosuvastatin	OATP1B1	PA134308647	10599	0.902
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S31-S40.nxml.txt.nlp	20680106	SENT45	16	16	27	27	irinotecan	KRAS	PA450085	3845	0.902
NULL	Acta_Pharmacol_Sin_2011_Nov_10_32(11)_1402-1410.nxml.txt.nlp	21986579	SENT228	6	6	38	38	curcumin	CDK2	PA151958596	1017	0.902
NULL	Evid_Based_Complement_Alternat_Med_2014_May_5_2014_730678.nxml.txt.nlp	24883070	SENT209	13	13	24	24	epirubicin	CCR7	PA449476	1236	0.902
NULL	Mol_Cancer_2013_Oct_8_12_119.nxml.txt.nlp	24103454	SENT188	16	16	11	11	nutlin-3	p53		7157	0.902
NULL	Indian_J_Pharmacol_2014_Sep-Oct_46(5)_547-548.nxml.txt.nlp	25298587	SENT51	32	32	23	23	ranolazine	CYP3A	PA164746007	1574	0.902
NULL	Croat_Med_J_2012_Jun_53(3)_214-223.nxml.txt.nlp	22661134	SENT64	4	4	20	20	reserpine	ACTH	PA451236	5443	0.902
NULL	J_Clin_Exp_Pathol_2012_May_17_Suppl_4_7327.nxml.txt.nlp	25379357	SENT132	12	12	2	2	metformin	AMPK	PA450395	5563	0.902
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT201	4	4	10	10	curcumin	TRAIL	PA151958596	8743	0.902
NULL	Cancer_Microenviron_2013_Jan_22_6(3)_231-240.nxml.txt.nlp	23335094	SENT74	20	20	6	6	simvastatin	PC-3	PA451363	692094	0.902
NULL	Breast_Cancer_Res_2008_Mar_27_10(2)_R27.nxml.txt.nlp	18371219	SENT143	27	27	7	7	paclitaxel	HER2	PA450761	2064	0.902
NULL	Emerg_Infect_Dis_2011_Oct_17(10)_1917-1920.nxml.txt.nlp	22000371	SENT72	3	3	9	9	neomycin	OTC	PA450608	5009	0.902
NULL	Eur_Respir_J_2014_Jul_23_44(1)_23-63.nxml.txt.nlp	24659544	SENT729	0	0	26	26	pyrazinamide	DST	PA451182	667	0.902
NULL	J_Cell_Mol_Med_2014_Dec_9_18(12)_2499-2511.nxml.txt.nlp	24912879	SENT15	9	9	2	2	docetaxel	DACH1	PA449383	1602	0.902
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1522-1532.nxml.txt.nlp	21997136	SENT188	4	4	7	7	irinotecan	EGFR	PA450085	1956	0.902
NULL	Chem_Res_Toxicol_2013_Jun_17_26(6)_878-895.nxml.txt.nlp	23611293	SENT862	19	19	10	10	clozapine	5-HT2A	PA449061	3356	0.902
NULL	Cancers_(Basel)_2010_Dec_22_2(4)_2153-2170.nxml.txt.nlp	21390244	SENT519	7	7	2	2	gefitinib	BAX	PA131301952	581	0.902
NULL	Crit_Care_2004_May_25_8(4)_234-242.nxml.txt.nlp	15312205	SENT153	8	8	15	15	salmeterol	THP1	PA451300	2736	0.902
NULL	Exp_Mol_Med_2012_Feb_29_44(2)_159-166.nxml.txt.nlp	22127053	SENT67	8	8	14	14	simvastatin	RhoA	PA451363	387	0.902
NULL	Oncotarget_2011_Mar_23_2(3)_165-177.nxml.txt.nlp	21444946	SENT177	9	9	3	3	erlotinib	KRAS	PA134687924	3845	0.902
NULL	Cell_Cycle_2012_Dec_15_11(24)_4545-4551.nxml.txt.nlp	23165243	SENT101	43	43	11	11	cisplatin	p63	PA449014	8626	0.902
NULL	Breast_Cancer_Res_2006_Nov_27_8(6)_R66.nxml.txt.nlp	17129383	SENT29	36	36	45	45	doxorubicin	HER2	PA449412	2064	0.902
NULL	Oncogene_2014_Aug_28_33(35)_4407-4417.nxml.txt.nlp	24469038	SENT189	24	24	26	26	cisplatin	gamma	PA449014	9913	0.902
NULL	Mol_Vis_2014_Oct_17_20_1443-1455.nxml.txt.nlp	25352750	SENT189	0	0	13	13	trypsin	CD31	PA451806	5175	0.902
NULL	J_Mol_Signal_2011_Aug_10_6_8.nxml.txt.nlp	21831305	SENT97	12	12	3	3	isoproterenol	AKAP5	PA450121	9495	0.902
NULL	Cancer_Inform_2007_Jan_12_3_275-284.nxml.txt.nlp	19455247	SENT248	15	15	37	37	vinorelbine	EGFR	PA451881	1956	0.902
NULL	Nat_Commun_2011_May_24_2_326.nxml.txt.nlp	21610729	SENT72	10	10	3	3	l-tyrosine	TYR	PA451822	7299	0.902
NULL	Iran_J_Neurol_2013_12(4)_129-135.nxml.txt.nlp	24250922	SENT81	7	7	14	14	trypsin	ANOVA	PA451806	4858	0.902
NULL	Surg_Endosc_2013_Mar_22_27(9)_3271-3279.nxml.txt.nlp	23519491	SENT57	12	12	2	2	propofol	ESD	PA451141	2098	0.902
NULL	Front_Oncol_2014_Sep_15_4_244.nxml.txt.nlp	25309870	SENT101	9	9	29	29	afatinib	EGFR	PA165981154	1956	0.902
NULL	Ann_Oncol_2011_Mar_8_22(3)_503-514.nxml.txt.nlp	20616198	SENT102	10	10	1	1	anastrozole	ATAC	PA448432	6375	0.902
NULL	Am_J_Trop_Med_Hyg_2014_Mar_5_90(3)_530-534.nxml.txt.nlp	24420779	SENT83	10	10	5	5	lopinavir	CYP3A4	PA450264	1576	0.902
NULL	Clinics_(Sao_Paulo)_2012_Sep_67(9)_1093-1099.nxml.txt.nlp	23018309	SENT111	13	13	21	21	sorafenib	Mcl-1	PA7000	4170	0.902
NULL	Exp_Transl_Stroke_Med_2011_Sep_12_3_8.nxml.txt.nlp	21910904	SENT209	27	27	4	4	resveratrol	SIRT1		23411	0.902
NULL	Cancers_(Basel)_2014_Jul_8_6(3)_1487-1499.nxml.txt.nlp	25006835	SENT75	11	11	20	20	cisplatin	AMPK	PA449014	5563	0.902
NULL	Pharmaceutics_2011_Oct_12_3(4)_680-705.nxml.txt.nlp	24309303	SENT56	12	12	19	19	repaglinide	OATP1B3	PA451234	28234	0.902
NULL	Curr_Chem_Genomics_2010_Mar_19_4_9-18.nxml.txt.nlp	20502647	SENT215	11	11	4	4	triciribine	DM1	PA165958661	338023;1760;28509	0.902
NULL	J_Occup_Med_Toxicol_2008_Feb_27_3(Suppl_1)_S6.nxml.txt.nlp	18315837	SENT92	11	11	19	19	pranlukast	IFN	PA134698661	3439	0.902
NULL	Springerplus_2015_Jan_23_4_29.nxml.txt.nlp	25628986	SENT18	18	18	30	30	dapsone	G6PD	PA449211	2539	0.902
NULL	Cell_Commun_Signal_2010_Sep_22_8_27.nxml.txt.nlp	20860841	SENT160	28	28	15	15	hydroxyurea	PP5	PA449942	7980;5536	0.902
NULL	Oncotarget_2011_Mar_7_2(3)_122-134.nxml.txt.nlp	21399234	SENT67	7	7	30	30	erlotinib	Raf-1	PA134687924	5894	0.902
NULL	Br_J_Cancer_2013_Jun_25_108(12)_2495-2504.nxml.txt.nlp	23736031	SENT110	33	33	0	0	paclitaxel	p28	PA450761	246778;5716	0.902
NULL	Clin_Exp_Otorhinolaryngol_2011_Dec_15_4(4)_177-183.nxml.txt.nlp	22232712	SENT133	10	10	19	19	doxycycline	p38	PA449415	10598;1432;7965	0.902
NULL	Front_Oncol_2014_Jun_24_4_160.nxml.txt.nlp	25009801	SENT209	13	13	21	21	cytarabine	p53	PA449177	7157	0.902
NULL	Mar_Drugs_2014_Jun_27_12(7)_3818-3837.nxml.txt.nlp	24979269	SENT209	10	10	18	18	calcein	P-gp	PA132595336	5243	0.902
NULL	J_Inherit_Metab_Dis_2010_Oct_3_33(5)_625-632.nxml.txt.nlp	20814828	SENT111	10	10	19	19	simvastatin	RhoA	PA451363	387	0.902
NULL	Gene_Regul_Syst_Bio_2014_Mar_4_8_63-73.nxml.txt.nlp	24634581	SENT77	7	7	24	24	minocycline	BNIP3	PA450519	664	0.902
NULL	J_Mol_Signal_2011_Aug_10_6_8.nxml.txt.nlp	21831305	SENT91	28	28	12	12	isoproterenol	AKAP12	PA450121	9590	0.902
NULL	Proteins_2013_Aug_1_81(8)_1457-1465.nxml.txt.nlp	23589421	SENT133	18	18	8	8	l-alanine	AGT	PA448055	183;189	0.902
NULL	Arthritis_Res_Ther_2013_Jul_9_15(4)_R73.nxml.txt.nlp	23837669	SENT251	18	18	5	5	colchicine	MICL	PA449092	160364	0.902
NULL	Int_J_Environ_Res_Public_Health_2010_Jan_20_7(1)_269-283.nxml.txt.nlp	20195444	SENT48	18	18	31	31	ethanol	ARG	PA448073	473;27	0.902
NULL	Br_J_Cancer_2003_Mar_10_88(5)_754-759.nxml.txt.nlp	12618886	SENT157	38	38	12	12	amifostine	p53	PA448365	7157	0.902
NULL	Anticancer_Agents_Med_Chem_2012_Feb_12(2)_163-171.nxml.txt.nlp	22043994	SENT182	11	11	3	3	cetuximab	BRAF	PA10040	673	0.902
NULL	Nat_Med_2012_Jul_18(7)_1118-1122.nxml.txt.nlp	22683780	SENT40	19	19	30	30	crizotinib	MET	PA165946122	4233	0.902
NULL	Nat_Med_2011_Jun_22_17(6)_676-683.nxml.txt.nlp	21602801	SENT208	31	31	3	3	gentamicin	HtrA	PA449753	5654	0.902
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Sep_15_68(Pt_10)_o2941.nxml.txt.nlp	23125726	SENT66	12	12	23	23	ethanol	mol	PA448073	90527	0.902
NULL	Curr_Neuropharmacol_2010_Mar_8(1)_26-40.nxml.txt.nlp	20808544	SENT111	11	11	35	35	physostigmine	ACTH	PA450957	5443	0.902
NULL	Cancer_Med_2014_Feb_10_3(1)_134-142.nxml.txt.nlp	24407937	SENT26	0	0	7	7	trastuzumab	HER2	PA451743	2064	0.902
NULL	Chemother_Res_Pract_2011_Dec_18_2011_965826.nxml.txt.nlp	22295208	SENT180	5	5	26	26	azacitidine	ACT	PA451996	12;11332;9457;641455	0.902
NULL	Cancer_Immunol_Immunother_2011_Jun_24_60(6)_771-780.nxml.txt.nlp	21347809	SENT231	4	4	7	7	rituximab	p38	PA451261	10598;1432;7965	0.902
NULL	Oncotarget_2011_Sep_9_2(9)_658-668.nxml.txt.nlp	21911919	SENT109	19	19	9	9	cytarabine	HO-1	PA449177	3162	0.902
NULL	J_Gynecol_Oncol_2014_Jan_8_25(1)_22-29.nxml.txt.nlp	24459577	SENT148	35	35	28	28	lomustine	NACT	PA164749407	284111	0.902
NULL	J_Obes_2011_Jan_17_2011_893629.nxml.txt.nlp	21318056	SENT90	10	10	20	20	clozapine	5-HT2C	PA449061	3358	0.902
NULL	Oncotarget_2012_Oct_20_3(10)_1068-1111.nxml.txt.nlp	23085539	SENT797	3	3	6	6	doxorubicin	p53	PA449412	7157	0.902
NULL	EMBO_Mol_Med_2012_Jun_13_4(6)_515-527.nxml.txt.nlp	22416035	SENT207	13	13	16	16	doxorubicin	p53	PA449412	7157	0.902
NULL	J_Breast_Cancer_2012_Jun_28_15(2)_141-147.nxml.txt.nlp	22807930	SENT124	10	10	7	7	trastuzumab	LDHA	PA451743	3939	0.902
NULL	Cases_J_2009_May_26_2_6567.nxml.txt.nlp	19829827	SENT20	38	38	19	19	capecitabine	IFN	PA448771	3439	0.902
NULL	Mol_Cells_2014_Aug_31_37(8)_585-591.nxml.txt.nlp	25134539	SENT39	33	33	31	31	indacaterol	ADRB2	PA165958348	154	0.902
NULL	Cell_Div_2013_Jul_25_8_10.nxml.txt.nlp	23886499	SENT54	13	13	6	6	tamoxifen	CDK4	PA451581	1019	0.902
NULL	Curr_Pharm_Biotechnol_2012_May_13(6)_969-986.nxml.txt.nlp	22039792	SENT247	30	30	21	21	ivermectin	MDR1	PA450133	5243	0.902
NULL	Br_J_Cancer_2011_Oct_11_105(8)_1114-1122.nxml.txt.nlp	21989215	SENT30	20	20	36	36	bsi-201	PARP-1		25976	0.902
NULL	Arch_Med_Sci_2012_Sep_8_8(4)_589-597.nxml.txt.nlp	23056066	SENT124	0	0	8	8	pitrakinra	IL-4	PA165983754	3565	0.902
NULL	Cell_Commun_Signal_2009_Feb_26_7(Suppl_1)_A99.nxml.txt.nlp	NULL	SENT8	8	8	2	2	thrombin	PAR3	PA451674	56288;2151	0.902
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2675-2684.nxml.txt.nlp	24129246	SENT186	24	24	4	4	doxorubicin	KSR1	PA449412	8844	0.902
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT72	0	0	11	11	metformin	AMPK	PA450395	5563	0.902
NULL	Mol_Cancer_2010_Nov_2_9_289.nxml.txt.nlp	21044322	SENT173	20	20	7	7	cisplatin	RGS10	PA449014	6001	0.902
NULL	Antonie_Van_Leeuwenhoek_2014_Aug_5_106_693-706.nxml.txt.nlp	25090957	SENT155	10	10	36	36	glucosamine	LTA	PA164747613	4049	0.902
NULL	Nat_Commun_2014_Aug_19_5_4701.nxml.txt.nlp	25134715	SENT250	17	17	24	24	l-glutamine	B27	PA10090	56246	0.902
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1066.nxml.txt.nlp	24556681	SENT49	6	6	14	14	ethanol	TLR4	PA448073	7099	0.902
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT80	6	6	17	17	nutlin-3	p53		7157	0.902
NULL	Oncol_Lett_2013_Dec_4_6(6)_1665-1672.nxml.txt.nlp	24273604	SENT136	6	6	14	14	chloroquine	p53	PA448948	7157	0.902
NULL	F1000Res_2014_Mar_31_3_81.nxml.txt.nlp	24795809	SENT38	9	9	24	24	clindamycin	TDI	PA449035	100038246	0.902
NULL	J_Oncol_2009_May_6_2009_567486.nxml.txt.nlp	19424511	SENT114	9	9	5	5	panitumumab	KRAS	PA162373091	3845	0.902
NULL	Mol_Cancer_2010_Apr_23_9_87.nxml.txt.nlp	20416058	SENT150	27	27	18	18	doxorubicin	TRAIL	PA449412	8743	0.902
NULL	Acta_Pharmacol_Sin_2011_Jul_9_32(7)_879-887.nxml.txt.nlp	21552292	SENT173	6	6	13	13	metformin	LKB1	PA450395	6794	0.902
NULL	Theranostics_2014_Jan_29_4(4)_336-365.nxml.txt.nlp	24578720	SENT184	26	26	8	8	doxorubicin	PTEN	PA449412	5728	0.902
NULL	Clinics_(Sao_Paulo)_2011_Aug_66(8)_1457-1462.nxml.txt.nlp	21915500	SENT97	21	21	35	35	rosuvastatin	ALP	PA134308647	6590;10850;27295;80150;470;26033	0.902
NULL	Nucleic_Acids_Res_2005_Jun_8_33(10)_3283-3291.nxml.txt.nlp	15944449	SENT156	22	22	9	9	melphalan	ERCC1	PA450354	2067	0.902
NULL	Target_Oncol_2012_Mar_2_7(1)_55-68.nxml.txt.nlp	22383042	SENT135	8	8	27	27	cyclophosphamide	CD4	PA449165	920	0.902
NULL	J_Med_Life_2011_Nov_14_4(4)_432-439.nxml.txt.nlp	22514580	SENT132	11	11	32	32	maraviroc	CXCR4	PA164768835	7852	0.902
NULL	Clin_Sci_(Lond)_2013_Feb_1_124(Pt_3)_153-164.nxml.txt.nlp	23075334	SENT114	24	24	18	18	resveratrol	SIRT1		23411	0.902
NULL	Front_Neurol_2011_Dec_26_2_83.nxml.txt.nlp	22363312	SENT86	15	15	3	3	clopidogrel	CYP2C19	PA449053	1557	0.902
NULL	ScientificWorldJournal_2012_Sep_17_2012_637953.nxml.txt.nlp	23028251	SENT528	2	2	20	20	genistein	CLB	PA165109660	171425	0.902
NULL	Cancer_Cell_Int_2013_Jan_15_13_3.nxml.txt.nlp	23320839	SENT135	13	13	31	31	sorafenib	ABCC1	PA7000	4363	0.902
NULL	Genome_Biol_Evol_2011_Aug_18_3_985-1005.nxml.txt.nlp	21856648	SENT47	16	16	10	10	estradiol	aromatase	PA449503	1588	0.902
NULL	Clin_Interv_Aging_2014_Dec_30_10_105-115.nxml.txt.nlp	25565793	SENT116	6	6	18	18	denosumab	RANKL	PA166048634	8600	0.902
NULL	Br_J_Cancer_2009_Jul_21_101(2)_350-356.nxml.txt.nlp	19513075	SENT109	34	34	16	16	busulfan	TP53	PA448691	7157	0.902
NULL	Front_Neural_Circuits_2014_Jun_17_8_65.nxml.txt.nlp	24987336	SENT70	34	34	25	25	furosemide	KCC2	PA449719	57468	0.902
NULL	Aging_(Albany_NY)_2009_Mar_31_1(4)_412-424.nxml.txt.nlp	20195491	SENT8	19	19	7	7	resveratrol	TXNIP		10628	0.902
NULL	Oncotarget_2013_Nov_19_5(2)_309-325.nxml.txt.nlp	24525395	SENT304	30	30	47	47	bortezomib	XIAP	PA10252	331	0.902
NULL	J_Hematol_Oncol_2009_Dec_23_2_50.nxml.txt.nlp	20030851	SENT301	19	19	11	11	doxorubicin	CHOP	PA449412	1649	0.902
NULL	Diabetes_2013_Jun_17_62(6)_2141-2150.nxml.txt.nlp	23378610	SENT213	4	4	28	28	betaine	BHMT	PA448603	635	0.902
NULL	Ecancermedicalscience_2009_Oct_29_3_157.nxml.txt.nlp	22276018	SENT106	43	43	29	29	tamoxifen	ADAM9	PA451581	8754	0.902
NULL	Cancer_Cell_2014_Oct_13_26(4)_495-508.nxml.txt.nlp	25314077	SENT249	13	13	5	5	lenalidomide	CD44	PA162363968	960	0.902
NULL	Oncol_Rep_2013_Oct_24_30(4)_1587-1592.nxml.txt.nlp	23900512	SENT117	18	18	12	12	tranylcypromine	NOXA	PA451741	5366	0.902
NULL	Acta_Pharmacol_Sin_2012_Jan_3_33(1)_49-56.nxml.txt.nlp	22212430	SENT183	8	8	0	0	thrombin	A10	PA451674	28870	0.902
NULL	Am_J_Cardiovasc_Drugs_2013_Jun_20_13(5)_331-342.nxml.txt.nlp	23784266	SENT221	27	27	21	21	rivaroxaban	P-gp	PA165958360	5243	0.902
NULL	Clin_Med_Insights_Arthritis_Musculoskelet_Disord_2012_Jan_5_5_1-14.nxml.txt.nlp	22267947	SENT54	12	12	0	0	risedronate	HIP	PA451255	6767;6159;64399;5068	0.902
NULL	Cell_Death_Differ_2010_Oct_30_17(10)_1655-1664.nxml.txt.nlp	20431598	SENT228	37	37	5	5	etoposide	CD4	PA449552	920	0.902
NULL	Front_Behav_Neurosci_2012_Jul_24_6_32.nxml.txt.nlp	22837741	SENT310	9	9	32	32	carbachol	CA1	PA448784	759	0.902
NULL	Mol_Pain_2013_Feb_15_9_3.nxml.txt.nlp	23413875	SENT37	12	12	25	25	resveratrol	TRPA1		8989	0.902
NULL	Exp_Ther_Med_2014_Oct_6_8(4)_1271-1274.nxml.txt.nlp	25187838	SENT108	8	8	18	18	resveratrol	AMPK		5563	0.902
NULL	Mol_Cancer_2013_Mar_5_12_17.nxml.txt.nlp	23497256	SENT154	6	6	15	15	sunitinib	p53	PA162372840	7157	0.902
NULL	Hum_Mol_Genet_2013_Nov_15_22(22)_4602-4615.nxml.txt.nlp	23814040	SENT14	4	4	14	14	l-cysteine	TRMU	PA449173	55687	0.902
NULL	J_Exp_Clin_Cancer_Res_2009_Nov_24_28(1)_144.nxml.txt.nlp	19930704	SENT121	45	45	18	18	carboplatin	P-gp	PA448803	5243	0.902
NULL	Breast_Cancer_Res_Treat_2012_Jun_15_133(3)_1057-1065.nxml.txt.nlp	22418700	SENT174	7	7	15	15	afatinib	EGFR	PA165981154	1956	0.902
NULL	J_Cardiothorac_Surg_2014_Sep_17_9(1)_129.nxml.txt.nlp	NULL	SENT173	31	31	9	9	heparin	ACT	PA449855	12;11332;9457;641455	0.902
NULL	J_Vet_Med_Sci_2014_May_13_76(5)_629-636.nxml.txt.nlp	24419976	SENT154	28	28	11	11	indomethacin	EP4	PA449982	5734	0.902
NULL	Exp_Diabetes_Res_2007_Jun_28_2007_52487.nxml.txt.nlp	17713597	SENT63	0	0	29	29	bevacizumab	VEGF-A	PA130232992	7422	0.902
NULL	NMR_Biomed_2014_Jul_5_27(7)_760-773.nxml.txt.nlp	24798066	SENT108	6	6	1	1	paclitaxel	NACT	PA450761	284111	0.902
NULL	Chin_J_Cancer_2012_Feb_31(2)_73-99.nxml.txt.nlp	22098950	SENT239	12	12	25	25	erlotinib	P-gp	PA134687924	5243	0.902
NULL	Clinics_(Sao_Paulo)_2012_Apr_67(Suppl_1)_91-97.nxml.txt.nlp	22584712	SENT41	28	28	3	3	clopidogrel	HCP5	PA449053	360158;10866	0.902
NULL	Oncotarget_2013_Nov_24_4(12)_2430-2438.nxml.txt.nlp	24280348	SENT189	12	12	16	16	gefitinib	STAT3	PA131301952	6774	0.902
NULL	Cancer_Imaging_2005_Nov_23_5(Spec_No_A)_S113-S119.nxml.txt.nlp	16361126	SENT94	6	6	1	1	doxorubicin	CHOP	PA449412	1649	0.902
NULL	Environ_Health_Perspect_2006_Sep_23_114(9)_1401-1406.nxml.txt.nlp	16966095	SENT165	44	44	13	13	arsenite	p53	PA452638	7157	0.902
NULL	J_Cancer_2014_Jan_5_5(2)_86-97.nxml.txt.nlp	24494026	SENT116	21	21	27	27	cisplatin	KRAS	PA449014	3845	0.902
NULL	Cardiovasc_Ther_2009_27(4)_259-274.nxml.txt.nlp	19604248	SENT139	6	6	15	15	ticagrelor	IPA	PA165374673	3160	0.902
NULL	Biomed_Res_Int_2013_Sep_4_2013_185362.nxml.txt.nlp	24093091	SENT115	22	22	35	35	vincristine	CHOP	PA451879	1649	0.902
NULL	Clin_Med_Insights_Circ_Respir_Pulm_Med_2012_Jun_12_6_27-40.nxml.txt.nlp	22745565	SENT25	8	8	33	33	omalizumab	IL-13	PA164752253	3596	0.902
NULL	Cell_Host_Microbe_2014_Sep_10_16(3)_291-303.nxml.txt.nlp	25211072	SENT86	9	9	17	17	pp2	tetherin		684	0.902
NULL	Arthritis_Res_Ther_2008_Apr_16_10(2)_R43.nxml.txt.nlp	18416822	SENT227	5	5	22	22	sr144528	ERK1		5595	0.902
NULL	Mol_Cells_2014_Mar_31_37(3)_234-240.nxml.txt.nlp	24642709	SENT120	20	20	5	5	cisplatin	HO-1	PA449014	3162	0.902
NULL	Biomed_Res_Int_2013_Nov_28_2013_789184.nxml.txt.nlp	24369535	SENT115	9	9	4	4	simvastatin	CYP3A4	PA451363	1576	0.902
NULL	Cent_European_J_Urol_2011_Dec_9_64(4)_256-257.nxml.txt.nlp	24578906	SENT52	11	11	21	21	doxazosin	CD133	PA449407	8842	0.902
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT210	38	38	13	13	docetaxel	B7-H1	PA449383	29126	0.901
NULL	Anesth_Pain_Med_2014_Sep_9_4(4)_e14221.nxml.txt.nlp	25599022	SENT81	4	4	7	7	propofol	LPO	PA451141	4025	0.901
NULL	J_Hematol_Oncol_2011_Dec_21_4_53.nxml.txt.nlp	22189016	SENT70	12	12	22	22	quinidine	P-gp	PA451209	5243	0.901
NULL	FEBS_Open_Bio_2014_Aug_30_4_763-776.nxml.txt.nlp	25349781	SENT137	23	23	5	5	curcumin	TFEB	PA151958596	7942	0.901
NULL	Front_Oncol_2013_Apr_23_3_86.nxml.txt.nlp	23630663	SENT138	3	3	13	13	afatinib	EGFR	PA165981154	1956	0.901
NULL	Oncotarget_2011_Dec_20_2(12)_1094-1108.nxml.txt.nlp	22190353	SENT205	5	5	24	24	gemcitabine	PUMA	PA449748	27113	0.901
NULL	Cell_Death_Dis_2014_Mar_13_5(3)_e1113.nxml.txt.nlp	24625972	SENT337	18	18	21	21	bleomycin	BI-1	PA448645	7009	0.901
NULL	Int_J_Endocrinol_2014_Jun_25_2014_534904.nxml.txt.nlp	25053942	SENT28	26	26	9	9	amiodarone	AIT	PA448383	160728	0.901
NULL	Int_J_Biol_Sci_2011_May_24_7(5)_673-684.nxml.txt.nlp	21647250	SENT213	31	31	18	18	berberine	AMPK	PA165860812	5563	0.901
NULL	Mol_Cancer_2007_Oct_11_6_63.nxml.txt.nlp	17931419	SENT25	12	12	21	21	gefitinib	EGFR	PA131301952	1956	0.901
NULL	J_Cell_Sci_2013_Nov_15_126(22)_5259-5270.nxml.txt.nlp	24006262	SENT355	15	15	7	7	hyaluronan	CD44	PA165958431	960	0.901
NULL	Ann_Gen_Psychiatry_2014_Jun_13_13_17.nxml.txt.nlp	25053968	SENT124	16	16	11	11	nortriptyline	UST	PA450657	10090	0.901
NULL	Toxins_(Basel)_2010_Mar_31_2(4)_517-551.nxml.txt.nlp	22069598	SENT127	5	5	9	9	curcumin	STAT3	PA151958596	6774	0.901
NULL	Breast_Cancer_Res_2000_Mar_12_2(Suppl_1)_P7_02.nxml.txt.nlp	NULL	SENT8	19	19	39	39	tamoxifen	Bcl-2	PA451581	596	0.901
NULL	Breast_Cancer_Res_Treat_2014_Apr_6_145(1)_33-44.nxml.txt.nlp	24706169	SENT53	5	5	2	2	trastuzumab	HER2	PA451743	2064	0.901
NULL	Gene_Ther_2010_May_18_17(5)_634-642.nxml.txt.nlp	20164856	SENT93	9	9	15	15	fluorescein	CD4	PA164746009	920	0.901
NULL	Alzheimers_Res_Ther_2010_Oct_29_2(5)_31.nxml.txt.nlp	21062519	SENT115	11	11	26	26	estradiol	PSEN1	PA449503	5663	0.901
NULL	Acta_Orthop_2010_Apr_6_81(2)_263-267.nxml.txt.nlp	20148646	SENT161	6	6	13	13	taurine	ATF4	PA451590	468	0.901
NULL	Ann_Hematol_2011_Feb_17_90(2)_173-183.nxml.txt.nlp	20714724	SENT195	2	2	17	17	resveratrol	ZAP-70		7535	0.901
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT280	22	22	7	7	ranibizumab	VEGF-A	PA164746012	7422	0.901
NULL	Mol_Cancer_2009_Nov_10_8_99.nxml.txt.nlp	19903356	SENT150	25	25	18	18	imatinib	IGFBP3	PA10804	3486	0.901
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_2_2012_548486.nxml.txt.nlp	23082082	SENT177	30	30	4	4	trypsin	SRM	PA451806	6723;6725	0.901
NULL	Indian_J_Endocrinol_Metab_2011_Jan-Mar_15(1)_9-17.nxml.txt.nlp	21584160	SENT111	22	22	15	15	liraglutide	PPG	PA165958364	5552	0.901
NULL	Exp_Ther_Med_2013_May_15_5(5)_1327-1331.nxml.txt.nlp	23737873	SENT13	12	12	3	3	imidapril	AQP2	PA452640	359	0.901
NULL	Acta_Neuropathol_2015_Oct_17_129_115-131.nxml.txt.nlp	25322816	SENT264	1	1	4	4	bevacizumab	LDHA	PA130232992	3939	0.901
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2751-2762.nxml.txt.nlp	24169358	SENT13	0	0	17	17	fulvestrant	ABCG2	PA164747170	9429	0.901
NULL	Endocrinology_2014_Oct_22_155(10)_3732-3738.nxml.txt.nlp	25051442	SENT66	20	20	5	5	sibutramine	ARC	PA451344	8996;23237	0.901
NULL	Daru_2012_Aug_30_20(1)_21.nxml.txt.nlp	23351981	SENT33	4	4	20	20	propranolol	P-gp	PA451145	5243	0.901
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT4	14	14	31	31	imatinib	CML	PA10804	613	0.901
NULL	Breast_Cancer_Res_2007_Jul_5_9(4)_R41.nxml.txt.nlp	17612393	SENT161	4	4	15	15	celecoxib	Bcl-2	PA448871	596	0.901
NULL	Brain_Sci_2013_Jun_3_3(2)_877-907.nxml.txt.nlp	24961429	SENT171	15	15	4	4	taurine	ATF6	PA451590	22926	0.901
NULL	Mol_Biol_Rep_2014_Mar_2_41(7)_4213-4222.nxml.txt.nlp	24584661	SENT42	16	16	26	26	estradiol	aromatase	PA449503	1588	0.901
NULL	Indian_J_Med_Res_2014_Aug_140(2)_209-215.nxml.txt.nlp	25297352	SENT103	8	8	5	5	carbamazepine	CLB	PA448785	171425	0.901
NULL	Oncotarget_2012_Aug_9_3(8)_774-782.nxml.txt.nlp	22885298	SENT70	24	24	10	10	tetracycline	IDH1	PA451640	3417	0.901
NULL	Ann_Rheum_Dis_2008_Jul_26_67(7)_917-925.nxml.txt.nlp	17965121	SENT156	34	34	5	5	rituximab	CD138	PA451261	6382	0.901
NULL	Emerg_Infect_Dis_2013_Jul_19(7)_1151-1152.nxml.txt.nlp	23763791	SENT26	30	30	16	16	ethambutol	DST	PA164784021	667	0.901
NULL	Oncotarget_2012_Aug_9_3(8)_774-782.nxml.txt.nlp	22885298	SENT77	29	29	13	13	tetracycline	IDH1	PA451640	3417	0.901
NULL	J_Hematol_Oncol_2012_Oct_11_5_63.nxml.txt.nlp	23057939	SENT109	15	15	29	29	bevacizumab	VEGF-A	PA130232992	7422	0.901
NULL	J_Hematol_Oncol_2010_Oct_27_3_42.nxml.txt.nlp	20979652	SENT141	16	16	25	25	carboplatin	PARP1	PA448803	142	0.901
NULL	J_Cancer_2013_Nov_23_4(9)_736-754.nxml.txt.nlp	24312144	SENT177	8	8	13	13	gefitinib	EGFR	PA131301952	1956	0.901
NULL	JRSM_Cardiovasc_Dis_2012_Sep_24_1(6)_cvd_2012_012015.nxml.txt.nlp	24175073	SENT147	22	22	17	17	clopidogrel	CYP2C19	PA449053	1557	0.901
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_17_2013_549174.nxml.txt.nlp	23843879	SENT101	3	3	23	23	curcumin	NRF2	PA151958596	2551;4780	0.901
NULL	Mol_Vis_2014_Dec_19_20_1680-1694.nxml.txt.nlp	25558172	SENT28	28	28	17	17	ranibizumab	APOE	PA164746012	348	0.901
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT337	24	24	1	1	risperidone	PRL	PA451257	5617	0.901
NULL	Leukemia_2013_Jan_11_27(1)_32-40.nxml.txt.nlp	22781593	SENT234	19	19	21	21	ponatinib	ZNF112	PA165980594	7771	0.901
NULL	Indian_J_Med_Paediatr_Oncol_2012_Oct-Dec_33(4)_195-202.nxml.txt.nlp	23580819	SENT123	25	25	10	10	doxorubicin	CD99	PA449412	4267	0.901
NULL	Int_J_Mol_Sci_2014_Mar_24_15(3)_5140-5162.nxml.txt.nlp	24663085	SENT789	10	10	3	3	cyclophosphamide	LP1	PA449165	6176	0.901
NULL	Pharmaceuticals_(Basel)_2013_Aug_21_6(8)_988-1038.nxml.txt.nlp	24276379	SENT349	20	20	15	15	panitumumab	PIK3CA	PA162373091	5290	0.901
NULL	Cancer_Metab_2013_Jan_23_1_3.nxml.txt.nlp	24280005	SENT362	35	35	42	42	doxycycline	SREBP2	PA449415	6721	0.901
NULL	Diabetes_2009_Apr_2_58(4)_847-854.nxml.txt.nlp	19188436	SENT237	16	16	4	4	metformin	AMPK	PA450395	5563	0.901
NULL	Br_J_Cancer_2011_Aug_9_105(4)_469-474.nxml.txt.nlp	21712825	SENT127	22	22	8	8	cisplatin	UCP2	PA449014	7351	0.901
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jan_8_67(Pt_2)_o240.nxml.txt.nlp	21522934	SENT56	18	18	12	12	ethanol	mol	PA448073	90527	0.901
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT164	27	27	4	4	atorvastatin	RANK	PA448500	8792	0.901
NULL	Arthritis_Res_Ther_2011_Feb_4_13(1)_R14.nxml.txt.nlp	21294864	SENT15	28	28	5	5	indomethacin	IL-17	PA449982	3605	0.901
NULL	Int_J_Breast_Cancer_2011_Sep_6_2011_352182.nxml.txt.nlp	22295219	SENT144	8	8	14	14	trastuzumab	AKT	PA451743	207	0.901
NULL	Cancers_(Basel)_2010_Apr_9_2(2)_397-419.nxml.txt.nlp	24281076	SENT194	2	2	7	7	curcumin	c-Jun	PA151958596	3725	0.901
NULL	Biol_Open_2013_Apr_9_2(6)_535-545.nxml.txt.nlp	23789104	SENT118	19	19	10	10	arsenite	p38	PA452638	10598;1432;7965	0.901
NULL	Evid_Based_Complement_Alternat_Med_2012_Dec_20_2012_908601.nxml.txt.nlp	23326293	SENT8	16	16	28	28	oxaliplatin	EPCAM	PA131285527	4072	0.901
NULL	Oncotarget_2012_May_18_3(5)_525-534.nxml.txt.nlp	22619113	SENT118	12	12	3	3	fludarabine	IL-4	PA449655	3565	0.901
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT57	0	0	19	19	pemetrexed	UNG	PA10810	7374	0.901
NULL	Nucleic_Acids_Res_2012_Jul_30_40(13)_6319-6337.nxml.txt.nlp	22467215	SENT275	11	11	31	31	cisplatin	Bcl-2	PA449014	596	0.901
NULL	Mol_Cancer_2009_Nov_24_8_109.nxml.txt.nlp	19930708	SENT127	22	22	10	10	exemestane	EGFR	PA449563	1956	0.901
NULL	Breast_Cancer_(Auckl)_2010_Feb_16_4_1-3.nxml.txt.nlp	20697527	SENT12	31	31	20	20	cisplatin	FANCD2	PA449014	2177	0.901
NULL	Amino_Acids_2012_Oct_10_43(4)_1751-1759.nxml.txt.nlp	22407485	SENT106	29	29	3	3	carrageenan	ghrelin	PA448814	51738	0.901
NULL	Breast_Cancer_Res_2012_May_4_14(3)_R72.nxml.txt.nlp	22559056	SENT34	17	17	21	21	tamoxifen	CENP-A	PA451581	1058	0.901
NULL	Clin_Epigenetics_2011_May_7_2(2)_249-256.nxml.txt.nlp	22704340	SENT155	15	15	31	31	doxorubicin	GAD1	PA449412	2571	0.901
NULL	Onco_Targets_Ther_2014_Jul_1_7_1185-1193.nxml.txt.nlp	25061320	SENT115	17	17	13	13	paclitaxel	EGFR	PA450761	1956	0.901
NULL	Biomed_Res_Int_2014_May_18_2014_428371.nxml.txt.nlp	24949449	SENT222	27	27	18	18	doxorubicin	Mcl-1	PA449412	4170	0.901
NULL	Cancers_(Basel)_2014_Jul_8_6(3)_1487-1499.nxml.txt.nlp	25006835	SENT75	11	11	17	17	cisplatin	p38	PA449014	10598;1432;7965	0.901
NULL	Subst_Abuse_Rehabil_2013_Nov_6_4_75-82.nxml.txt.nlp	24648790	SENT88	16	16	0	0	chlorpheniramine	OTC	PA448960	5009	0.901
NULL	Oncol_Rep_2014_Aug_16_32(2)_523-529.nxml.txt.nlp	24939415	SENT119	1	1	14	14	bevacizumab	TRN	PA130232992	3842	0.901
NULL	J_Allergy_(Cairo)_2011_Oct_24_2011_457169.nxml.txt.nlp	22121382	SENT194	15	15	23	23	salmeterol	IL-8	PA451300	3576	0.901
NULL	J_Cell_Biol_2003_Aug_18_162(4)_719-730.nxml.txt.nlp	12925712	SENT316	14	14	18	18	phenol	L15	PA450913	6138;91057	0.901
NULL	Br_J_Pharmacol_2014_Feb_24_171(1)_1019-1032.nxml.txt.nlp	24251620	SENT265	18	18	30	30	nifedipine	TRPM3	PA450631	80036	0.901
NULL	Nat_Med_2011_May_1_17(5)_604-609.nxml.txt.nlp	21532597	SENT40	7	7	15	15	daclizumab	CD25	PA164764446	3669;3559	0.901
NULL	J_Health_Popul_Nutr_2007_Jun_25(2)_179-188.nxml.txt.nlp	17985819	SENT69	34	34	5	5	ciprofloxacin	Spn	PA449009	84687	0.901
NULL	Breast_Cancer_Res_2014_May_28_16(3)_R53.nxml.txt.nlp	24886537	SENT130	21	21	16	16	exemestane	aromatase	PA449563	1588	0.901
NULL	Eur_J_Clin_Pharmacol_2010_Nov_29_66(11)_1131-1136.nxml.txt.nlp	20669013	SENT119	18	18	31	31	erythromycin	CYP2C19	PA449493	1557	0.901
NULL	Mol_Cancer_2012_Apr_26_11_26.nxml.txt.nlp	22537224	SENT125	13	13	3	3	chloroquine	CHK1	PA448948	1111	0.901
NULL	Alcohol_Res_2012_34(3)_339-344.nxml.txt.nlp	23134050	SENT8	20	20	6	6	ethanol	ADH1C	PA448073	126	0.901
NULL	Patient_Prefer_Adherence_2011_Dec_23_6_1-9.nxml.txt.nlp	22272064	SENT68	27	27	9	9	telmisartan	ACE	PA451605	1636	0.901
NULL	Mol_Biol_Cell_2014_Jan_1_25(1)_76-86.nxml.txt.nlp	24173717	SENT310	1	1	33	33	paclitaxel	TUBB6	PA450761	84617	0.901
NULL	Breast_Cancer_Res_2002_Sep_10_4(6)_218-221.nxml.txt.nlp	12473166	SENT84	20	20	3	3	tamoxifen	ATAC	PA451581	6375	0.901
NULL	Breast_Cancer_Res_2012_Jun_7_14(3)_R89.nxml.txt.nlp	22676470	SENT161	7	7	1	1	lapatinib	HER2	PA152241907	2064	0.901
NULL	Acta_Pharmacol_Sin_2013_Jan_17_34(1)_157-166.nxml.txt.nlp	23247593	SENT127	21	21	16	16	berberine	IL6	PA165860812	3569	0.901
NULL	ACS_Med_Chem_Lett_2011_Jun_18_2(8)_638-643.nxml.txt.nlp	21841964	SENT72	10	10	16	16	astemizole	CYP2D6	PA448498	1565	0.901
NULL	Neuropsychopharmacology_2009_Apr_2_34(5)_1135-1148.nxml.txt.nlp	18596687	SENT182	28	28	15	15	fluorescein	CRF	PA164746009	1392;10882	0.901
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jun_5_66(Pt_7)_o1565.nxml.txt.nlp	21587808	SENT58	20	20	14	14	ethanol	mol	PA448073	90527	0.901
NULL	Ann_Indian_Acad_Neurol_2010_Oct-Dec_13(4)_241-246.nxml.txt.nlp	21264130	SENT172	12	12	31	31	carbamazepine	KLS	PA448785	6199	0.901
NULL	EMBO_Mol_Med_2012_Oct_30_4(10)_1087-1096.nxml.txt.nlp	22933245	SENT92	14	14	8	8	olaparib	NAMPT		10135	0.901
NULL	Oncol_Rep_2012_Sep_26_28(3)_777-784.nxml.txt.nlp	22751903	SENT140	0	0	7	7	celecoxib	MVD	PA448871	4597	0.901
NULL	J_Adv_Pract_Oncol_2014_May_1_May-Jun_5(3)_211-215.nxml.txt.nlp	25089220	SENT121	18	18	25	25	dacarbazine	BRAF	PA449197	673	0.901
NULL	Cancer_Cell_Int_2014_Jan_23_14_6.nxml.txt.nlp	24456610	SENT31	9	9	23	23	erlotinib	EGFR	PA134687924	1956	0.901
NULL	Curr_Neuropharmacol_2014_Mar_12(2)_186-192.nxml.txt.nlp	24669211	SENT241	25	25	18	18	metformin	Met	PA450395	79811	0.901
NULL	Br_J_Cancer_2011_Aug_23_105(5)_649-657.nxml.txt.nlp	21811251	SENT155	31	31	21	21	gefitinib	IGF1R	PA131301952	3480	0.901
NULL	Curr_Med_Chem_2012_Sep_19(26)_4399-4413.nxml.txt.nlp	22830345	SENT237	21	21	26	26	ketoconazole	CYP3A4	PA450146	1576	0.901
NULL	Cell_Cycle_2012_Nov_15_11(22)_4135-4146.nxml.txt.nlp	22983125	SENT77	7	7	17	17	nadh	p300	PA164755085	2033	0.901
NULL	Mol_Vis_2012_Oct_5_18_2454-2467.nxml.txt.nlp	23077404	SENT240	27	27	14	14	bevacizumab	VEGF-A	PA130232992	7422	0.901
NULL	Ann_Lab_Med_2013_Sep_8_33(5)_349-352.nxml.txt.nlp	24003425	SENT83	19	19	29	29	rifampin	EMB	PA451250	133418	0.901
NULL	Acta_Orthop_2009_Jun_5_80(3)_325-329.nxml.txt.nlp	19626470	SENT84	17	17	34	34	cyclosporine	P-gp	PA449167	5243	0.901
NULL	Indian_J_Endocrinol_Metab_2013_Jul-Aug_17(4)_636-646.nxml.txt.nlp	23961479	SENT146	13	13	4	4	troglitazone	CYP2C9	PA451799	1559	0.901
NULL	Oncotarget_2014_May_27_5(19)_9049-9064.nxml.txt.nlp	24979294	SENT225	35	35	37	37	tamoxifen	aromatase	PA451581	1588	0.901
NULL	EMBO_J_2008_Mar_19_27(6)_852-864.nxml.txt.nlp	18309296	SENT231	17	17	25	25	genistein	MDM2	PA165109660	4193	0.901
NULL	Exp_Diabetes_Res_2009_Jul_7_2009_910783.nxml.txt.nlp	19609456	SENT133	5	5	23	23	rosiglitazone	AMPK	PA451283	5563	0.901
NULL	Leukemia_2013_Jan_11_27(1)_32-40.nxml.txt.nlp	22781593	SENT205	9	9	20	20	ponatinib	ZNF112	PA165980594	7771	0.901
NULL	Adv_Hematol_2012_Mar_26_2012_932658.nxml.txt.nlp	22548067	SENT77	12	12	38	38	cyclophosphamide	CHOP	PA449165	1649	0.901
NULL	Cell_Div_2012_Jul_20_7_18.nxml.txt.nlp	22817864	SENT32	21	21	33	33	geldanamycin	Hsp90	PA152031327	3320	0.901
NULL	J_Inherit_Metab_Dis_2011_Apr_27_34(2)_357-366.nxml.txt.nlp	20978943	SENT239	6	6	39	39	galactose	AMH	PA449725	268	0.901
NULL	Anesth_Essays_Res_2014_Sep-Dec_8(3)_302-306.nxml.txt.nlp	NULL	SENT68	0	0	6	6	propofol	ANOVA	PA451141	4858	0.901
NULL	Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1311-1318.nxml.txt.nlp	25178375	SENT216	9	9	25	25	attapulgite	DAO	PA164781017	26;1610	0.901
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT29	12	12	10	10	lapatinib	HER-2	PA152241907	2064	0.901
NULL	Arthritis_Res_Ther_2012_May_1_14(3)_R99.nxml.txt.nlp	22546542	SENT221	10	10	4	4	infliximab	CD4	PA452639	920	0.901
NULL	Acta_Histochem_Cytochem_2011_Apr_28_44(2)_81-90.nxml.txt.nlp	21614169	SENT302	8	8	2	2	hyaluronan	LYVE-1	PA165958431	10894	0.901
NULL	Case_Rep_Oncol_Med_2014_May_15_2014_608585.nxml.txt.nlp	24959365	SENT7	6	6	8	8	letrozole	aromatase	PA450196	1588	0.901
NULL	J_Antimicrob_Chemother_2014_Dec_20_69(12)_3329-3334.nxml.txt.nlp	25147095	SENT136	17	17	5	5	nevirapine	CD4	PA450616	920	0.901
NULL	J_Carcinog_2011_Dec_22_10_35.nxml.txt.nlp	22279420	SENT125	29	29	20	20	tamoxifen	p53	PA451581	7157	0.901
NULL	Nat_Med_2011_Oct_2_17(10)_1304-1309.nxml.txt.nlp	21963515	SENT205	8	8	18	18	tacrolimus	WNK4	PA451578	65266	0.901
NULL	Evid_Based_Complement_Alternat_Med_2013_Aug_12_2013_982689.nxml.txt.nlp	23997806	SENT233	13	13	0	0	tolbutamide	APE	PA451718	55704;328	0.901
NULL	Mol_Clin_Oncol_2013_Jul_21_1(4)_773-779.nxml.txt.nlp	24649245	SENT6	14	14	0	0	cisplatin	CRT	PA449014	811	0.901
NULL	Oncol_Lett_2014_Nov_14_8(5)_2086-2092.nxml.txt.nlp	25295095	SENT76	8	8	3	3	gemcitabine	LKB1	PA449748	6794	0.901
NULL	Arthritis_Res_2002_May_24_4(Suppl_2)_S34-S40.nxml.txt.nlp	12110156	SENT3	4	4	11	11	etanercept	p75	PA449515	7133;11168	0.901
NULL	J_Oncol_2010_Dec_14_2010_426956.nxml.txt.nlp	20049170	SENT298	29	29	21	21	genistein	CXCL12	PA165109660	6387	0.901
NULL	Gut_Liver_2011_Jun_24_5(2)_160-164.nxml.txt.nlp	21814595	SENT106	27	27	33	33	midazolam	ESD	PA450496	2098	0.901
NULL	Int_J_Mol_Sci_2014_May_12_15(5)_8335-8351.nxml.txt.nlp	24823879	SENT166	3	3	29	29	perifosine	CD34	PA165291471	947	0.901
NULL	Oncotarget_2014_Feb_7_5(3)_775-787.nxml.txt.nlp	24519956	SENT111	13	13	8	8	docetaxel	PC3	PA449383	57332;7832;5122	0.901
NULL	Evid_Based_Complement_Alternat_Med_2011_Mar_1_2011_207034.nxml.txt.nlp	21423686	SENT128	10	10	2	2	clopidogrel	PAC1	PA449053	8624;1316;117	0.901
NULL	Breast_Cancer_Res_2007_Dec_18_9(6)_216.nxml.txt.nlp	18190723	SENT150	33	33	18	18	bevacizumab	VEGFR2	PA130232992	3791	0.901
NULL	Anal_Chem_2011_Feb_15_83(4)_1469-1474.nxml.txt.nlp	21275378	SENT90	13	13	23	23	trypsin	TMT	PA451806	25823	0.901
NULL	J_Gen_Physiol_1992_Apr_1_99(4)_465-489.nxml.txt.nlp	1375958	SENT9	39	39	5	5	forskolin	gamma	PA146096022	9913	0.901
NULL	Mol_Cancer_2013_Sep_11_12_104.nxml.txt.nlp	24025152	SENT198	9	9	13	13	gefitinib	EGFR	PA131301952	1956	0.901
NULL	Drugs_R_D_2014_Sep_31_14(3)_177-184.nxml.txt.nlp	25079671	SENT105	10	10	21	21	miglitol	MCP-1	PA164776726	6347	0.901
NULL	Ann_Rheum_Dis_2014_May_28_73(5)_803-809.nxml.txt.nlp	24473673	SENT215	11	11	7	7	tocilizumab	IL-6	PA165292659	3569	0.901
NULL	Arch_Med_Sci_2012_Nov_9_8(5)_907-917.nxml.txt.nlp	23185203	SENT179	7	7	14	14	metformin	B12	PA450395	7126;4709	0.901
NULL	J_Carcinog_2014_Nov_27_13_13.nxml.txt.nlp	25525412	SENT86	19	19	29	29	leucovorin	EGFR	PA450198	1956	0.901
NULL	Breast_Cancer_Res_2012_Jul_19_14(4)_R109.nxml.txt.nlp	22812567	SENT210	0	0	2	2	gemcitabine	RRM1	PA449748	6240	0.901
NULL	Br_J_Cancer_2013_Apr_16_108(7)_1408-1414.nxml.txt.nlp	23511562	SENT40	16	16	19	19	tamoxifen	aromatase	PA451581	1588	0.901
NULL	Mol_Cancer_2009_Nov_10_8_99.nxml.txt.nlp	19903356	SENT87	13	13	17	17	imatinib	ANOVA	PA10804	4858	0.901
NULL	Mol_Biol_Rep_2013_May_11_40(8)_5013-5026.nxml.txt.nlp	23666059	SENT220	10	10	6	6	resveratrol	p53		7157	0.901
NULL	Asian_J_Androl_2014_Apr_8_May-Jun_16(3)_372-377.nxml.txt.nlp	24759579	SENT139	0	0	29	29	cabozantinib	VEGFR2	PA165906891	3791	0.901
NULL	Breast_Cancer_Res_2010_Mar_5_12(2)_R17.nxml.txt.nlp	20205718	SENT274	9	9	32	32	cisplatin	BRCA1	PA449014	672	0.901
NULL	J_Mater_Sci_Mater_Med_2012_Jul_20_23(7)_1637-1644.nxml.txt.nlp	22528070	SENT7	24	24	12	12	ethanol	PES	PA448073	23481	0.901
NULL	N_Am_J_Med_Sci_2009_Jun_1(1)_16-24.nxml.txt.nlp	22666666	SENT57	0	0	9	9	trypsin	PAR2	PA451806	2150;55065;8856	0.901
NULL	EMBO_Mol_Med_2013_Feb_9_5(2)_309-325.nxml.txt.nlp	23300147	SENT188	10	10	21	21	geldanamycin	HER2	PA152031327	2064	0.901
NULL	Am_J_Trop_Med_Hyg_2011_Jan_5_84(1)_5-14.nxml.txt.nlp	21212194	SENT44	0	0	14	14	albendazole	STH	PA164746058	246744	0.901
NULL	Cancer_Med_2013_Dec_31_2(6)_826-835.nxml.txt.nlp	24403256	SENT198	19	19	10	10	daunorubicin	HDM2	PA449212	4193	0.901
NULL	Cancer_2011_Apr_15_117(8)_1670-1678.nxml.txt.nlp	21472714	SENT169	13	13	18	18	cisplatin	SIRT3	PA449014	23410	0.901
NULL	Front_Oncol_2014_Mar_31_4_63.nxml.txt.nlp	24744989	SENT86	16	16	13	13	tocilizumab	IL-6	PA165292659	3569	0.901
NULL	Cells_2014_Sep_12_3(3)_914-938.nxml.txt.nlp	25222270	SENT712	6	6	10	10	capsaicin	TRPV1	PA448776	7442	0.901
NULL	Indian_J_Pharmacol_2014_Mar-Apr_46(2)_211-215.nxml.txt.nlp	24741196	SENT98	2	2	35	35	carbamazepine	NAC	PA448785	22861	0.901
NULL	Eur_J_Clin_Pharmacol_2012_Jan_8_68(1)_29-37.nxml.txt.nlp	21739267	SENT9	14	14	7	7	aripiprazole	CYP3A4	PA10026	1576	0.901
NULL	FEBS_Open_Bio_2014_Jan_6_4_77-89.nxml.txt.nlp	24490132	SENT202	26	26	1	1	ebselen	GDH	PA161660841	51084;2746	0.901
NULL	Arthritis_Res_Ther_2005_Aug_31_7(5)_208-214.nxml.txt.nlp	16207350	SENT110	12	12	15	15	methotrexate	FasL	PA450428	356	0.901
NULL	Crit_Care_2004_Oct_27_8(6)_R474-R482.nxml.txt.nlp	15566594	SENT34	10	10	17	17	lornoxicam	COX	PA165958395	1351	0.901
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1021.nxml.txt.nlp	24457965	SENT47	48	48	17	17	cisplatin	JNK	PA449014	5599	0.901
NULL	Libyan_J_Med_2007_Jun_1_2(2)_66-72.nxml.txt.nlp	21503256	SENT169	7	7	19	19	tetrabenazine	DIP	PA140222719	23151;1831	0.901
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Jun_14_70(Pt_7)_o778.nxml.txt.nlp	25161565	SENT59	28	28	12	12	ethanol	mol	PA448073	90527	0.901
NULL	Indian_J_Endocrinol_Metab_2013_Oct_17(Suppl1)_S64-S67.nxml.txt.nlp	24251223	SENT48	13	13	7	7	exenatide	GLP-1	PA164749238	100125288	0.901
NULL	Protein_Cell_2014_Jun_19_5(6)_469-479.nxml.txt.nlp	24748116	SENT56	16	16	7	7	paclitaxel	EB1	PA450761	9167;22919;10982	0.901
NULL	Springerplus_2014_Sep_17_3_535.nxml.txt.nlp	25279326	SENT154	32	32	30	30	exemestane	aromatase	PA449563	1588	0.901
NULL	J_Immunotoxicol_2013_Jan_11_10(1)_75-82.nxml.txt.nlp	22967038	SENT85	34	34	9	9	rituximab	IL-2	PA451261	3558	0.901
NULL	Aging_Cell_2012_Aug_11(4)_579-587.nxml.txt.nlp	22435726	SENT114	23	23	2	2	etoposide	CD28	PA449552	1493;940	0.901
NULL	Breast_Cancer_(Dove_Med_Press)_2014_May_2_6_59-71.nxml.txt.nlp	24833917	SENT37	22	22	32	32	raloxifene	aromatase	PA451221	1588	0.901
NULL	Chem_Cent_J_2013_Feb_7_7_27.nxml.txt.nlp	23391345	SENT71	22	22	1	1	ethanol	PF6	PA448073	200162	0.901
NULL	Cell_Tissue_Res_2012_Sep_10_349(3)_635-647.nxml.txt.nlp	22322423	SENT277	24	24	18	18	bevacizumab	VEGF-A	PA130232992	7422	0.901
NULL	Hum_Genomics_2008_Sep_1_3(1)_7-16.nxml.txt.nlp	19129086	SENT149	2	2	21	21	rosiglitazone	CYP2C8	PA451283	1558	0.901
NULL	Stroke_Res_Treat_2011_Nov_10_2011_212485.nxml.txt.nlp	22135769	SENT150	16	16	38	38	clopidogrel	CYP2C19	PA449053	1557	0.901
NULL	Oncol_Lett_2014_Nov_12_8(5)_2203-2208.nxml.txt.nlp	25295109	SENT83	7	7	10	10	celecoxib	GLI1	PA448871	2735	0.901
NULL	Oncotarget_2013_Nov_24_4(12)_2186-2207.nxml.txt.nlp	24327604	SENT130	30	30	4	4	vincristine	MDM2	PA451879	4193	0.901
NULL	Chem_Cent_J_2012_May_30_6_50.nxml.txt.nlp	22647291	SENT178	24	24	12	12	ethanol	mol	PA448073	90527	0.901
NULL	Case_Rep_Gastroenterol_2013_Apr_19_7(1)_195-201.nxml.txt.nlp	23687488	SENT102	5	5	16	16	rituximab	CHOP	PA451261	1649	0.901
NULL	Hum_Genomics_2008_Sep_1_3(1)_7-16.nxml.txt.nlp	19129086	SENT165	14	14	9	9	pioglitazone	CYP2C8	PA450970	1558	0.901
NULL	Breast_Cancer_Res_2014_Oct_31_16(5)_447.nxml.txt.nlp	25358600	SENT319	24	24	6	6	tamoxifen	CXCR4	PA451581	7852	0.901
NULL	J_Cell_Biol_2001_Oct_15_155(2)_207-216.nxml.txt.nlp	11591730	SENT104	25	25	20	20	camptothecin	p53	PA153590860	7157	0.901
NULL	Bioinformation_2012_Jan_6_8(1)_13-19.nxml.txt.nlp	22359429	SENT140	10	10	2	2	curcumin	P-gp	PA151958596	5243	0.901
NULL	Endocrinology_2014_Aug_30_155(8)_2976-2985.nxml.txt.nlp	24877623	SENT10	11	11	38	38	estradiol	StAR	PA449503	6770	0.901
NULL	Diabetes_Care_2010_Jul_31_33(7)_1509-1515.nxml.txt.nlp	20357372	SENT28	0	0	8	8	exenatide	GLP-1	PA164749238	100125288	0.901
NULL	Br_J_Cancer_2010_Oct_12_103(8)_1182-1191.nxml.txt.nlp	20842125	SENT181	0	0	6	6	indomethacin	COX	PA449982	1351	0.901
NULL	Clin_Dev_Immunol_2011_Feb_7_2011_501369.nxml.txt.nlp	21331384	SENT4	28	28	19	19	methylprednisolone	ITM	PA450466	5002	0.901
NULL	Exp_Lung_Res_2013_Oct_1_39(8)_336-348.nxml.txt.nlp	23919450	SENT19	11	11	0	0	thrombin	PAR-1	PA451674	2011;2149	0.901
NULL	Nucleic_Acids_Res_2013_Nov_5_41(20)_e194.nxml.txt.nlp	24013567	SENT217	6	6	21	21	ethanol	OST	PA448073	1650;23263	0.901
NULL	Glycobiology_2012_Jan_26_22(1)_134-145.nxml.txt.nlp	21873605	SENT9	15	15	7	7	heparin	IL-8	PA449855	3576	0.901
NULL	J_Hematol_Oncol_2008_Oct_1_1_16.nxml.txt.nlp	18828924	SENT45	27	27	8	8	lapatinib	HER2	PA152241907	2064	0.901
NULL	J_Immunother_Cancer_2013_Dec_16_1_21.nxml.txt.nlp	24829757	SENT11	37	37	45	45	temozolomide	miR-17-92	PA451609	407975	0.901
NULL	Clin_Ophthalmol_2009_Jun_2_3_175-182.nxml.txt.nlp	19668562	SENT117	17	17	27	27	pegaptanib	VEGF-A	PA164771236	7422	0.901
NULL	Indian_J_Endocrinol_Metab_2013_May-Jun_17(3)_402-412.nxml.txt.nlp	23869295	SENT167	23	23	12	12	clopidogrel	CYP2C19	PA449053	1557	0.901
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT13	33	33	18	18	olanzapine	PRL	PA450688	5617	0.901
NULL	Cell_Commun_Signal_2014_Sep_25_12(1)_61.nxml.txt.nlp	NULL	SENT299	18	18	6	6	doxycycline	INPP4B	PA449415	8821	0.901
NULL	Mol_Pain_2012_Sep_22_8_71.nxml.txt.nlp	22998838	SENT55	9	9	33	33	cisplatin	ANOVA	PA449014	4858	0.901
NULL	Acta_Pharmacol_Sin_2012_May_4_33(5)_710-716.nxml.txt.nlp	22555373	SENT210	4	4	24	24	phenylbutazone	DOM	PA450932	6663	0.901
NULL	Adv_Urol_2010_Jul_20_2010_687043.nxml.txt.nlp	20721275	SENT91	2	2	25	25	pazopanib	FLT3	PA165291492	2322	0.901
NULL	Acta_Pharmacol_Sin_2013_Mar_21_34(3)_373-379.nxml.txt.nlp	23334240	SENT143	20	20	10	10	raloxifene	CYP3A4	PA451221	1576	0.901
NULL	Adv_Hematol_2011_Oct_26_2011_974658.nxml.txt.nlp	20981158	SENT156	22	22	25	25	alemtuzumab	CD52	PA164783958	1043	0.901
NULL	Diabetes_Metab_J_2013_Aug_14_37(4)_240-248.nxml.txt.nlp	23991401	SENT124	10	10	7	7	ezetimibe	NPC1L1	PA10816	29881	0.901
NULL	Front_Oncol_2014_Sep_29_4_256.nxml.txt.nlp	25325013	SENT62	6	6	33	33	afatinib	EGFR	PA165981154	1956	0.901
NULL	Exp_Diabetes_Res_2012_Apr_17_2012_635472.nxml.txt.nlp	22577369	SENT107	25	25	10	10	glimepiride	GLP-1	PA449761	100125288	0.901
NULL	J_Oncol_2010_Jul_20_2010_950201.nxml.txt.nlp	19639033	SENT108	35	35	29	29	trastuzumab	HER2	PA451743	2064	0.901
NULL	ScientificWorldJournal_2013_Dec_14_2013_732340.nxml.txt.nlp	24396306	SENT190	25	25	6	6	gatifloxacin	DPT	PA449738	1805	0.901
NULL	Oncotarget_2013_Dec_24_5(9)_2418-2427.nxml.txt.nlp	24810714	SENT82	7	7	25	25	cisplatin	NAC	PA449014	22861	0.901
NULL	Br_J_Cancer_2010_Oct_12_103(8)_1284-1291.nxml.txt.nlp	20859285	SENT29	13	13	6	6	tamoxifen	BCAR4	PA451581	400500	0.901
NULL	Mar_Drugs_2009_Jul_17_7(3)_331-340.nxml.txt.nlp	19841717	SENT104	6	6	36	36	trabectedin	FDG	PA165958349	23583	0.901
NULL	Cell_Cycle_2013_May_15_12(10)_1492-1500.nxml.txt.nlp	23598717	SENT57	9	9	0	0	doxorubicin	ROCK1	PA449412	6093	0.901
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT333	7	7	38	38	risperidone	PRL	PA451257	5617	0.901
NULL	Int_J_Hypertens_2012_Jan_19_2012_594361.nxml.txt.nlp	22315665	SENT258	22	22	19	19	fasudil	Rho	PA165946121	29984	0.901
NULL	Mol_Cancer_2014_Aug_16_13(1)_193.nxml.txt.nlp	NULL	SENT14	33	33	28	28	cisplatin	RKIP	PA449014	5037	0.901
NULL	Arthritis_Res_Ther_2003_Feb_24_5(Suppl_1)_49.nxml.txt.nlp	NULL	SENT6	11	11	18	18	infliximab	IL-6	PA452639	3569	0.901
NULL	Biomed_Res_Int_2014_Jun_25_2014_203693.nxml.txt.nlp	25089265	SENT205	32	32	27	27	sunitinib	survivin	PA162372840	332	0.901
NULL	Drugs_Context_2012_Nov_26_2012_212243.nxml.txt.nlp	24432032	SENT406	2	2	9	9	cilomilast	IL-8	PA165948031	3576	0.901
NULL	Mol_Vis_2012_Apr_11_18_901-908.nxml.txt.nlp	22539869	SENT80	8	8	34	34	curcumin	HO-1	PA151958596	3162	0.901
NULL	J_Cell_Mol_Med_2013_Jun_4_17(6)_713-722.nxml.txt.nlp	23551576	SENT133	38	38	26	26	cblb502	TLR5		7100	0.901
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT49	0	0	5	5	neratinib	HER2	PA165291472	2064	0.901
NULL	Breast_Cancer_Res_2011_Nov_1_13(6)_227.nxml.txt.nlp	22078026	SENT160	4	4	1	1	trastuzumab	aromatase	PA451743	1588	0.901
NULL	Breast_Cancer_Res_2010_Jun_22_12(3)_R39.nxml.txt.nlp	20569502	SENT212	21	21	9	9	tamoxifen	TFF3	PA451581	7033	0.901
NULL	Mol_Cancer_2010_Aug_23_9_222.nxml.txt.nlp	20731837	SENT138	2	2	9	9	gefitinib	ATM	PA131301952	472	0.901
NULL	Cell_Death_Dis_2013_Jun_13_4(6)_e665.nxml.txt.nlp	23764846	SENT229	14	14	6	6	sorafenib	BLM	PA7000	641	0.901
NULL	Neural_Plast_2007_Jan_1_2007_30585.nxml.txt.nlp	25148070	SENT3530	34	34	14	14	nortriptyline	gamma	PA450657	9913	0.901
NULL	Br_J_Cancer_2012_Oct_9_107(8)_1277-1285.nxml.txt.nlp	22990652	SENT162	0	0	15	15	axitinib	CYP2C19	PA164924493	1557	0.901
NULL	Oncotarget_2013_Aug_8_4(8)_1130-1142.nxml.txt.nlp	24029073	SENT130	22	22	3	3	paclitaxel	NRF2	PA450761	2551;4780	0.901
NULL	Arthritis_Res_Ther_2009_Aug_28_11(4)_R131.nxml.txt.nlp	19715572	SENT126	2	2	7	7	rituximab	CD19	PA451261	930	0.901
NULL	Breast_Cancer_Res_2011_Aug_11_13(3)_R80.nxml.txt.nlp	21834972	SENT189	19	19	6	6	tamoxifen	CDK2	PA451581	1017	0.901
NULL	J_Cell_Sci_2011_Oct_1_124(19)_3344-3355.nxml.txt.nlp	21940797	SENT215	27	27	5	5	arsenite	PABP1	PA452638	26986;26980	0.901
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT446	13	13	16	16	risperidone	PRL	PA451257	5617	0.901
NULL	Cardiol_Res_Pract_2013_Dec_5_2013_637482.nxml.txt.nlp	24381782	SENT207	15	15	45	45	sotalol	NNT	PA451457	23530	0.901
NULL	Adv_Hematol_2012_Nov_20_2012_861060.nxml.txt.nlp	23251161	SENT55	4	4	29	29	lenalidomide	CD4	PA162363968	920	0.901
NULL	J_Hematol_Oncol_2011_Jan_21_4_5.nxml.txt.nlp	21255411	SENT50	19	19	8	8	erlotinib	PTEN	PA134687924	5728	0.901
NULL	Breast_Cancer_Res_2007_Aug_8_9(4)_R50.nxml.txt.nlp	17686159	SENT259	3	3	10	10	trastuzumab	HRG	PA451743	3084;3273	0.901
NULL	Br_J_Pharmacol_2008_Jul_21_154(5)_1079-1093.nxml.txt.nlp	18587449	SENT160	25	25	29	29	bimatoprost	CA2	PA164748867	760	0.901
NULL	Oncotarget_2012_Nov_17_3(12)_1600-1614.nxml.txt.nlp	23307622	SENT6	21	21	9	9	erlotinib	ATG12	PA134687924	9140	0.901
NULL	Biomed_Res_Int_2014_May_28_2014_203601.nxml.txt.nlp	24991539	SENT129	9	9	6	6	panitumumab	EGFR	PA162373091	1956	0.901
NULL	Breast_Cancer_Res_2007_Jun_4_9(3)_207.nxml.txt.nlp	17561991	SENT174	25	25	1	1	trastuzumab	HER-2	PA451743	2064	0.901
NULL	Exp_Lung_Res_2013_Oct_1_39(8)_336-348.nxml.txt.nlp	23919450	SENT186	7	7	11	11	thrombin	PAR-1	PA451674	2011;2149	0.901
NULL	EMBO_J_2008_Oct_22_27(20)_2789-2798.nxml.txt.nlp	18818696	SENT102	22	22	19	19	geldanamycin	Hsp90	PA152031327	3320	0.901
NULL	Brain_2008_Jul_30_131(7)_1722-1735.nxml.txt.nlp	18515320	SENT23	25	25	13	13	oxygen	COX	PA450744	1351	0.901
NULL	Int_J_Alzheimers_Dis_2012_Feb_1_2012_109324.nxml.txt.nlp	22506129	SENT117	2	2	20	20	simvastatin	ZO-1	PA451363	7082	0.901
NULL	Biomed_Res_Int_2014_May_28_2014_365272.nxml.txt.nlp	24982871	SENT35	14	14	20	20	vancomycin	VISA	PA451850	57506	0.901
NULL	J_Hematol_Oncol_2013_Apr_25_6_30.nxml.txt.nlp	23617957	SENT108	4	4	7	7	sorafenib	VEGFR	PA7000	3791	0.901
NULL	Br_J_Cancer_2011_May_10_104(10)_1641-1648.nxml.txt.nlp	21505459	SENT174	16	16	9	9	paclitaxel	PRLR	PA450761	5618	0.901
NULL	Comput_Math_Methods_Med_2014_Feb_3_2014_813067.nxml.txt.nlp	24639887	SENT287	36	36	9	9	doxorubicin	MYBL2	PA449412	4605	0.901
NULL	Int_J_Mol_Sci_2014_Sep_17_15(9)_16430-16457.nxml.txt.nlp	25233127	SENT216	21	21	5	5	ifosfamide	LPO	PA449964	4025	0.901
NULL	Mol_Cancer_2010_Apr_12_9_75.nxml.txt.nlp	20385023	SENT189	36	36	22	22	imatinib	LYN	PA10804	4067	0.901
NULL	Front_Oncol_2014_Sep_23_4_264.nxml.txt.nlp	25295231	SENT177	21	21	26	26	lenalidomide	TP53	PA162363968	7157	0.901
NULL	Exp_Ther_Med_2013_Mar_17_5(3)_797-802.nxml.txt.nlp	23403698	SENT9	31	31	16	16	triciribine	PI3K	PA165958661	5290	0.901
NULL	Br_J_Cancer_2012_Apr_10_106(8)_1367-1373.nxml.txt.nlp	22454081	SENT134	21	21	16	16	trastuzumab	PTEN	PA451743	5728	0.901
NULL	J_Oncol_2011_Oct_27_2011_391564.nxml.txt.nlp	22131990	SENT52	23	23	15	15	cisplatin	HER-2	PA449014	2064	0.901
NULL	F1000_Biol_Rep_2010_Feb_11_2_12.nxml.txt.nlp	20948820	SENT75	29	29	2	2	capsaicin	TRPV1	PA448776	7442	0.901
NULL	Mol_Biol_Cell_2014_Jul_1_25(13)_2116-2127.nxml.txt.nlp	24807908	SENT232	19	19	34	34	hemin	GAPDH	PA449849	2597	0.901
NULL	J_Biol_Chem_2012_Apr_13_287(16)_12952-12965.nxml.txt.nlp	22371491	SENT63	18	18	10	10	terazosin	CCL2	PA451612	6347	0.901
NULL	J_Invest_Dermatol_2012_Jan_18_132(1)_163-169.nxml.txt.nlp	21850019	SENT5	7	7	16	16	imiquimod	CD4	PA449972	920	0.901
NULL	Eur_J_Clin_Pharmacol_2008_Jul_16_64(7)_683-690.nxml.txt.nlp	18415093	SENT150	8	8	16	16	amodiaquine	ACT	PA448404	12;11332;9457;641455	0.901
NULL	Diabetes_Care_2011_Jul_17_34(7)_1678-1680.nxml.txt.nlp	21709302	SENT83	14	14	7	7	ramipril	DREAM	PA451223	30818	0.901
NULL	Hum_Genomics_2009_Jan_1_3(2)_157-168.nxml.txt.nlp	19164092	SENT4	2	2	7	7	lipase	LIPE	PA450239	3991	0.901
NULL	Evid_Based_Complement_Alternat_Med_2013_Oct_10_2013_802784.nxml.txt.nlp	24223618	SENT28	5	5	14	14	clopidogrel	CYP2C19	PA449053	1557	0.901
NULL	Front_Immunol_2013_May_20_4_119.nxml.txt.nlp	23730303	SENT57	13	13	23	23	l-cysteine	San	PA449173	80218	0.901
NULL	Acta_Histochem_Cytochem_2013_Dec_28_46(6)_187-197.nxml.txt.nlp	24610966	SENT147	25	25	19	19	cevimeline	AQP5	PA164754754	362	0.901
NULL	Gut_Liver_2012_Jan_12_6(1)_29-40.nxml.txt.nlp	22375168	SENT89	19	19	12	12	doxorubicin	MDR1	PA449412	5243	0.901
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Apr_23_64(Pt_5)_o881.nxml.txt.nlp	21202365	SENT59	37	37	19	19	ethanol	mol	PA448073	90527	0.901
NULL	Br_J_Cancer_2011_Mar_1_104(5)_750-755.nxml.txt.nlp	21326243	SENT30	15	15	27	27	olaparib	PARP-1		25976	0.901
NULL	J_Biomed_Sci_2013_Dec_20_20(1)_99.nxml.txt.nlp	24358977	SENT218	19	19	13	13	gefitinib	EGFR	PA131301952	1956	0.901
NULL	Nat_Commun_2013_Aug_15_4_2130.nxml.txt.nlp	23945651	SENT185	8	8	2	2	etoposide	ATG5	PA449552	9474	0.901
NULL	Cancer_Med_2014_Jun_14_3(3)_580-591.nxml.txt.nlp	24574330	SENT43	24	24	14	14	pazopanib	IL-6	PA165291492	3569	0.901
NULL	Cell_Res_2009_Aug_19(8)_950-961.nxml.txt.nlp	19546888	SENT67	9	9	0	0	camptothecin	c-Cbl	PA153590860	867	0.901
NULL	Oncol_Lett_2014_May_11_7(5)_1401-1408.nxml.txt.nlp	24765145	SENT155	25	25	16	16	paclitaxel	HIF-1	PA450761	29072	0.901
NULL	Nucleic_Acids_Res_2005_Oct_19_33(18)_5819-5828.nxml.txt.nlp	16237123	SENT38	33	33	11	11	cisplatin	HMGB1	PA449014	3146	0.901
NULL	Crit_Care_2007_Mar_22_11(Suppl_2)_P198.nxml.txt.nlp	NULL	SENT10	6	6	1	1	oxygen	CDP	PA450744	1523	0.901
NULL	Biomed_Res_Int_2013_Dec_31_2013_273498.nxml.txt.nlp	23484100	SENT122	40	40	3	3	genistein	OTC	PA165109660	5009	0.901
NULL	Oncogene_2010_Jun_3_29(22)_3208-3216.nxml.txt.nlp	20383201	SENT89	39	39	23	23	dasatinib	EGF	PA162372878	1950	0.901
NULL	Clin_Sci_(Lond)_2009_Feb_1_116(Pt_3)_265-272.nxml.txt.nlp	18826376	SENT259	10	10	4	4	bevacizumab	VEGF-A	PA130232992	7422	0.901
NULL	Nat_Chem_Biol_2010_Apr_28_6(4)_291-299.nxml.txt.nlp	20190765	SENT159	3	3	28	28	dasatinib	DDR1	PA162372878	780	0.901
NULL	Acta_Pharmacol_Sin_2009_Apr_3_30(4)_478-484.nxml.txt.nlp	19343062	SENT3	9	9	14	14	cyclosporine	CYP3A4	PA449167	1576	0.901
NULL	J_Cell_Mol_Med_2013_Dec_6_17(12)_1588-1597.nxml.txt.nlp	24199964	SENT65	34	34	1	1	dobutamine	APT	PA449381	653639	0.901
NULL	Mol_Pain_2012_Sep_24_8_74.nxml.txt.nlp	23006894	SENT68	22	22	25	25	gabapentin	TNP1	PA449720	7141	0.901
NULL	Front_Neurol_2012_Aug_1_3_120.nxml.txt.nlp	23015798	SENT103	3	3	14	14	isoflurane	RhoA	PA450106	387	0.901
NULL	Mol_Cancer_2012_Apr_5_11_20.nxml.txt.nlp	22480225	SENT632	8	8	0	0	temozolomide	SPARC	PA451609	6678	0.901
NULL	Cancer_Metab_2013_Jan_23_1_3.nxml.txt.nlp	24280005	SENT362	35	35	20	20	doxycycline	SREBP1	PA449415	6720	0.901
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT437	18	18	15	15	olanzapine	PRL	PA450688	5617	0.901
NULL	Acta_Pharmacol_Sin_2012_Jan_3_33(1)_49-56.nxml.txt.nlp	22212430	SENT175	11	11	26	26	thrombin	AP-1	PA451674	2353;3727;2354;3725	0.901
NULL	Patient_Prefer_Adherence_2013_May_7_7_391-400.nxml.txt.nlp	23687442	SENT26	6	6	44	44	fosaprepitant	HEC	PA165958390	10403	0.901
NULL	Evid_Based_Complement_Alternat_Med_2011_Mar_14_2011_635058.nxml.txt.nlp	21437195	SENT228	15	15	2	2	roflumilast	PDE4A	PA165948052	5141	0.901
NULL	J_Headache_Pain_2010_Oct_22_11(5)_431-435.nxml.txt.nlp	20652353	SENT14	8	8	20	20	almotriptan	CYP1A2	PA10246	1544	0.901
NULL	BMJ_2010_Feb_8_340_c693.nxml.txt.nlp	20142325	SENT55	28	28	7	7	tamoxifen	CYP2D6	PA451581	1565	0.901
NULL	Ital_J_Pediatr_2011_Dec_19_37_58.nxml.txt.nlp	22182677	SENT236	2	2	0	0	hydrocortisone	ACTH	PA449905	5443	0.901
NULL	Mol_Cancer_2010_Jun_25_9_165.nxml.txt.nlp	20576164	SENT219	11	11	35	35	curcumin	STAT1	PA151958596	6772	0.901
NULL	Breast_Cancer_Res_2005_Mar_4_7(3)_R345-R352.nxml.txt.nlp	15987429	SENT231	7	7	9	9	carbachol	CARB	PA448784	9482	0.901
NULL	ScientificWorldJournal_2012_Apr_29_2012_327341.nxml.txt.nlp	22649288	SENT211	0	0	27	27	sulindac	MLH1	PA451565	4292	0.901
NULL	Arthritis_Res_Ther_2013_Jan_8_15(1)_R6.nxml.txt.nlp	23298471	SENT30	20	20	12	12	celecoxib	COX	PA448871	1351	0.901
NULL	Clin_Med_Insights_Oncol_2013_Aug_21_7_221-234.nxml.txt.nlp	24179413	SENT61	23	23	29	29	gefitinib	PIK3CA	PA131301952	5290	0.901
NULL	Front_Mol_Neurosci_2009_May_14_2_1.nxml.txt.nlp	19506703	SENT165	2	2	35	35	candesartan	CA1	PA448765	759	0.901
NULL	Cancer_Manag_Res_2012_Jul_26_4_195-205.nxml.txt.nlp	22904641	SENT12	9	9	15	15	amiloride	NHE	PA448368	285335	0.901
NULL	Cancer_Res_Treat_2014_Oct_14_46(4)_323-330.nxml.txt.nlp	25036571	SENT28	30	30	20	20	erlotinib	EGFR	PA134687924	1956	0.901
NULL	F1000Res_2014_Jan_23_3_24.nxml.txt.nlp	24715975	SENT70	18	18	31	31	heparin	BAH	PA449855	444	0.901
NULL	Cancer_Cell_Int_2010_May_11_10_16.nxml.txt.nlp	20459793	SENT141	5	5	18	18	cisplatin	CDKN1A	PA449014	1026	0.901
NULL	Aust_N_Z_J_Psychiatry_2011_Sep_3_45(9)_712-725.nxml.txt.nlp	21888608	SENT286	30	30	11	11	perphenazine	CYP2D6	PA450882	1565	0.901
NULL	Exp_Diabetes_Res_2011_Apr_6_2011_928523.nxml.txt.nlp	21603181	SENT229	30	30	9	9	bromocriptine	NEFA	PA448671	4925	0.901
NULL	Braz_J_Med_Biol_Res_2012_Apr_27_45(6)_510-516.nxml.txt.nlp	22527124	SENT102	8	8	25	25	doxorubicin	IFN	PA449412	3439	0.901
NULL	J_Korean_Med_Sci_2011_Dec_29_26(12)_1563-1568.nxml.txt.nlp	22147992	SENT115	3	3	10	10	ekb-569	AKT		207	0.901
NULL	Mol_Vis_2007_Jul_12_13_1130-1137.nxml.txt.nlp	17653058	SENT168	3	3	41	41	fentanyl	IL-6	PA449599	3569	0.901
NULL	Ann_Lab_Med_2015_Jan_8_35(1)_15-21.nxml.txt.nlp	25553275	SENT60	7	7	0	0	thrombin	Lag	PA451674	3925	0.901
NULL	Br_J_Cancer_2009_Jul_21_101(2)_238-243.nxml.txt.nlp	19568242	SENT139	13	13	22	22	sunitinib	IFN	PA162372840	3439	0.901
NULL	Clin_Pharmacol_2011_Jun_22_3_13-25.nxml.txt.nlp	22287853	SENT190	13	13	5	5	saxagliptin	CYP3A4	PA165958362	1576	0.901
NULL	BMJ_2011_Aug_4_343_d4588.nxml.txt.nlp	21816733	SENT381	4	4	9	9	fluvoxamine	CYP2C19	PA449690	1557	0.901
NULL	Anemia_2012_Aug_12_2012_297641.nxml.txt.nlp	22924125	SENT182	17	17	13	13	deferasirox	EOS	PA164760843	260429	0.901
NULL	Acta_Pharmacol_Sin_2011_Jun_3_32(6)_845-852.nxml.txt.nlp	21642952	SENT33	38	38	12	12	prazosin	TRPV1	PA451093	7442	0.901
NULL	Exp_Neurobiol_2013_Mar_31_22(1)_45-50.nxml.txt.nlp	23585722	SENT161	5	5	0	0	fluoxetine	EPO	PA449673	7076;8288;2056	0.901
NULL	J_Clin_Biochem_Nutr_2007_Jul_27_41(1)_32-42.nxml.txt.nlp	18392098	SENT162	18	18	12	12	curcumin	PARP	PA151958596	142	0.901
NULL	Clin_Ophthalmol_2008_Sep_2(3)_613-621.nxml.txt.nlp	19668762	SENT34	12	12	29	29	travoprost	BAK	PA164781371	578	0.901
NULL	J_Oncol_2012_Aug_9_2012_685213.nxml.txt.nlp	22934113	SENT218	16	16	31	31	octreotide	ACTH	PA450678	5443	0.901
NULL	Br_J_Cancer_2012_Dec_4_107(12)_1950-1955.nxml.txt.nlp	23169295	SENT14	3	3	9	9	oxaliplatin	DPD	PA131285527	1806	0.901
NULL	Cancers_(Basel)_2014_Dec_16_6(4)_2387-2403.nxml.txt.nlp	25521854	SENT200	7	7	21	21	cabozantinib	VEGFR2	PA165906891	3791	0.901
NULL	Environ_Health_Perspect_2005_Apr_14_113(4)_431-439.nxml.txt.nlp	15811834	SENT83	20	20	6	6	paraformaldehyde	PRL	PA450790	5617	0.901
NULL	Evid_Based_Complement_Alternat_Med_2011_Jan_20_2011_713523.nxml.txt.nlp	21318104	SENT117	39	39	0	0	naproxen	SRM	PA450595	6723;6725	0.901
NULL	Clin_Transl_Allergy_2013_Sep_2_3_29.nxml.txt.nlp	24004581	SENT121	36	36	25	25	omalizumab	IL-4	PA164752253	3565	0.901
NULL	Arthritis_Res_2002_Feb_4_4(Suppl_1)_40.nxml.txt.nlp	NULL	SENT4	11	11	5	5	thrombin	PAR4	PA451674	9002;5074	0.901
NULL	Cancers_(Basel)_2011_Oct_14_3(4)_3894-3908.nxml.txt.nlp	24213116	SENT138	13	13	29	29	panitumumab	EGFR	PA162373091	1956	0.901
NULL	EMBO_Mol_Med_2013_Aug_5_5(8)_1213-1226.nxml.txt.nlp	23918228	SENT361	6	6	4	4	cetuximab	EGFR	PA10040	1956	0.901
NULL	Front_Genet_2014_Nov_14_5_391.nxml.txt.nlp	25452763	SENT1173	16	16	4	4	cisplatin	ERCC1	PA449014	2067	0.901
NULL	Arthritis_Res_Ther_2006_Dec_19_8(6)_R187.nxml.txt.nlp	17177994	SENT239	18	18	13	13	etanercept	p75	PA449515	7133;11168	0.901
NULL	Ann_Rheum_Dis_2012_Dec_11_71(12)_2006-2010.nxml.txt.nlp	22887851	SENT156	40	40	17	17	tocilizumab	IL-6	PA165292659	3569	0.901
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Dec_11_67(Pt_1)_o64.nxml.txt.nlp	21522775	SENT48	20	20	14	14	ethanol	mol	PA448073	90527	0.901
NULL	Cell_Death_Dis_2010_Oct_21_1(10)_e86.nxml.txt.nlp	21368859	SENT203	20	20	9	9	doxorubicin	JNK	PA449412	5599	0.901
NULL	Indian_J_Pharmacol_2009_Dec_41(6)_262-267.nxml.txt.nlp	20407557	SENT71	3	3	20	20	ezetimibe	STZ	PA10816	6484	0.901
NULL	Br_J_Pharmacol_2011_Feb_162(4)_989-999.nxml.txt.nlp	21054342	SENT220	10	10	29	29	ketoconazole	CYP2C8	PA450146	1558	0.901
NULL	Ann_Oncol_2013_Aug_12_24(8)_1994-1999.nxml.txt.nlp	23670096	SENT147	18	18	25	25	tamoxifen	AIB1	PA451581	8202	0.901
NULL	Crit_Care_2006_Jul_19_10(4)_R106.nxml.txt.nlp	16859510	SENT104	13	13	1	1	methylprednisolone	OLB	PA450466	26681	0.901
NULL	Nat_Med_2014_Jun_11_20(6)_599-606.nxml.txt.nlp	24813251	SENT91	2	2	10	10	imatinib	YAP1	PA10804	10413	0.901
NULL	Int_J_Biol_Sci_2013_Mar_7_9(3)_279-288.nxml.txt.nlp	23493630	SENT126	13	13	19	19	tocilizumab	IFN	PA165292659	3439	0.901
NULL	Biologics_2009_Oct_12_3_443-457.nxml.txt.nlp	19851470	SENT305	2	2	0	0	denosumab	RANKL	PA166048634	8600	0.901
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT246	26	26	16	16	warfarin	CYP2C9	PA451906	1559	0.901
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT132	18	18	1	1	tenofovir	ABCC10	PA10204	89845	0.901
NULL	Bone_2012_Jan_50(1)_218-225.nxml.txt.nlp	22023931	SENT220	19	19	26	26	iron	FGF23	PA450087	8074	0.901
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_P108.nxml.txt.nlp	NULL	SENT14	4	4	17	17	piperacillin	IL13	PA450975	3596	0.901
NULL	Int_J_Nanomedicine_2012_Sep_13_7_4917-4926.nxml.txt.nlp	23028220	SENT119	7	7	22	22	calcein	mol	PA132595336	90527	0.901
NULL	Cancer_Cell_Int_2011_Nov_2_11_39.nxml.txt.nlp	22047021	SENT150	7	7	2	2	cisplatin	REV3	PA449014	5980	0.901
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1137-1144.nxml.txt.nlp	20234366	SENT151	13	13	3	3	cetuximab	MKP-1	PA10040	1843	0.901
NULL	Ann_Dermatol_2011_Sep_30_23(Suppl_1)_S100-S104.nxml.txt.nlp	22028551	SENT71	25	25	19	19	vincristine	CHOP	PA451879	1649	0.901
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_16_2013_146142.nxml.txt.nlp	23843863	SENT13	15	15	37	37	ns-398	IL8		3576	0.901
NULL	Biomed_Res_Int_2014_Jun_26_2014_875305.nxml.txt.nlp	25054153	SENT56	0	0	11	11	denosumab	RANKL	PA166048634	8600	0.901
NULL	Clin_Psychopharmacol_Neurosci_2012_Apr_30_10(1)_25-33.nxml.txt.nlp	23429852	SENT98	46	46	14	14	haloperidol	SNAP-25	PA449841	6616	0.901
NULL	BMB_Rep_2013_Nov_46(11)_544-549.nxml.txt.nlp	24152910	SENT5	4	4	21	21	thrombin	p38	PA451674	10598;1432;7965	0.901
NULL	Cancer_Biol_Med_2012_Sep_9(3)_202-204.nxml.txt.nlp	23691480	SENT43	7	7	3	3	doxorubicin	CHOP	PA449412	1649	0.901
NULL	Mediators_Inflamm_2000_9(1)_39-43.nxml.txt.nlp	10877454	SENT2	3	3	16	16	roxithromycin	CD80	PA164750505	941	0.901
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_4_2013_378657.nxml.txt.nlp	23662132	SENT298	0	0	10	10	capsaicin	AMPK	PA448776	5563	0.901
NULL	Virol_J_2009_Dec_1_6_213.nxml.txt.nlp	19951438	SENT127	17	17	23	23	etoposide	TRAIL	PA449552	8743	0.901
NULL	Cancer_Med_2013_Jun_23_2(3)_296-304.nxml.txt.nlp	23930206	SENT30	36	36	29	29	gefitinib	EGFR	PA131301952	1956	0.901
NULL	Clinics_(Sao_Paulo)_2014_Jan_69(1)_68-74.nxml.txt.nlp	24473562	SENT26	15	15	34	34	nutlin-3	p53		7157	0.901
NULL	Apoptosis_2013_Aug_23_18(11)_1306-1318.nxml.txt.nlp	23975731	SENT56	24	24	44	44	hydrocortisone	EPO	PA449905	7076;8288;2056	0.901
NULL	Oncotarget_2014_Nov_1_5(19)_9396-9409.nxml.txt.nlp	25238049	SENT102	25	25	3	3	doxycycline	DNA2	PA449415	1763	0.901
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1017.nxml.txt.nlp	24457961	SENT140	18	18	10	10	heparin	EGF	PA449855	1950	0.901
NULL	Oncoimmunology_2012_Nov_1_1(8)_1422-1424.nxml.txt.nlp	23243615	SENT22	21	21	12	12	anastrozole	aromatase	PA448432	1588	0.901
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2007_Dec_12_64(Pt_1)_o247.nxml.txt.nlp	21200812	SENT56	24	24	16	16	ethanol	mol	PA448073	90527	0.901
NULL	Breast_Cancer_(Auckl)_2012_Nov_19_6_191-207.nxml.txt.nlp	23226023	SENT242	29	29	13	13	pertuzumab	HER2		2064	0.901
NULL	Oncoimmunology_2013_Oct_1_2(10)_e27025.nxml.txt.nlp	24353914	SENT181	8	8	21	21	docetaxel	ICOS	PA449383	29851;1493	0.901
NULL	Indian_J_Urol_2007_Apr-Jun_23(2)_91-96.nxml.txt.nlp	19675781	SENT177	14	14	1	1	doxazosin	NNT	PA449407	23530	0.901
NULL	Arthritis_Res_Ther_2011_May_25_13(Suppl_1)_S2.nxml.txt.nlp	21624181	SENT347	12	12	7	7	infliximab	IMPACT	PA452639	55364	0.901
NULL	Genome_Biol_2005_Jul_29_6(8)_228.nxml.txt.nlp	16086858	SENT41	13	13	4	4	daunorubicin	CBR1	PA449212	873	0.901
NULL	J_Mol_Signal_2012_Sep_8_7_15.nxml.txt.nlp	22958338	SENT121	30	30	22	22	pp2	PSD-95		1742	0.901
NULL	Br_J_Cancer_2010_Jun_29_103(1)_18-28.nxml.txt.nlp	20551952	SENT172	16	16	12	12	vatalanib	VEGFR	PA7001	3791	0.901
NULL	Oncotarget_2014_Oct_21_5(22)_11252-11268.nxml.txt.nlp	25361004	SENT117	3	3	20	20	metformin	CLIC1	PA450395	1192	0.9
NULL	J_Headache_Pain_2014_Dec_8_15(1)_85.nxml.txt.nlp	25488888	SENT102	16	16	12	12	zolmitriptan	5-HT1D	PA451975	3352	0.9
NULL	Open_Cardiovasc_Med_J_2011_Feb_24_5_24-34.nxml.txt.nlp	21660248	SENT97	12	12	35	35	orlistat	adiponectin	PA164776864	9370	0.9
NULL	Int_J_Endocrinol_Metab_2013_Dec_21_Winter_11(1)_57-61.nxml.txt.nlp	23853622	SENT39	11	11	22	22	olanzapine	FGA	PA450688	2243	0.9
NULL	J_Skin_Cancer_2013_Feb_24_2013_735282.nxml.txt.nlp	23533766	SENT19	12	12	22	22	dacarbazine	IL-2	PA449197	3558	0.9
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT94	31	31	37	37	dasatinib	ABCG2	PA162372878	9429	0.9
NULL	Oncoscience_2014_Mar_12_1(2)_167-179.nxml.txt.nlp	25126591	SENT226	9	9	2	2	trastuzumab	PI3K	PA451743	5290	0.9
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jun_23_66(Pt_7)_o1753.nxml.txt.nlp	21587969	SENT74	10	10	26	26	benzaldehyde	mol	PA448571	90527	0.9
NULL	BMJ_Open_2014_Feb_27_4(2)_e004071.nxml.txt.nlp	24578536	SENT184	33	33	13	13	warfarin	TTR	PA451906	7276	0.9
NULL	Cent_European_J_Urol_2013_Dec_19_66(4)_394-404.nxml.txt.nlp	24757527	SENT263	32	32	12	12	sunitinib	IFN	PA162372840	3439	0.9
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Oct_20_66(Pt_11)_o2822.nxml.txt.nlp	21589010	SENT65	26	26	18	18	ethanol	mol	PA448073	90527	0.9
NULL	Br_J_Cancer_2006_Dec_4_95(11)_1483-1489.nxml.txt.nlp	17106442	SENT37	12	12	17	17	gefitinib	EGFR	PA131301952	1956	0.9
NULL	Breast_Cancer_Res_2002_Aug_27_4(6)_213-217.nxml.txt.nlp	12473165	SENT3	11	11	2	2	tamoxifen	ATAC	PA451581	6375	0.9
NULL	Breast_Cancer_(Auckl)_2009_Sep_2_3_61-75.nxml.txt.nlp	19809577	SENT20	4	4	22	22	curcumin	BRCA1	PA151958596	672	0.9
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1150.nxml.txt.nlp	24675468	SENT89	16	16	25	25	ethanol	adiponectin	PA448073	9370	0.9
NULL	Scientifica_(Cairo)_2013_Feb_3_2013_125705.nxml.txt.nlp	24278766	SENT270	12	12	23	23	indinavir	RANKL	PA449977	8600	0.9
NULL	Exp_Ther_Med_2014_Aug_10_8(2)_454-458.nxml.txt.nlp	25009600	SENT93	6	6	11	11	genistein	Bcl-2	PA165109660	596	0.9
NULL	Case_Rep_Hematol_2012_Mar_26_2012_746098.nxml.txt.nlp	22928128	SENT67	3	3	1	1	cyclophosphamide	CHOP	PA449165	1649	0.9
NULL	J_Hematol_Oncol_2009_Apr_22_2_18.nxml.txt.nlp	19386128	SENT174	25	25	6	6	cetuximab	KRAS	PA10040	3845	0.9
NULL	Cell_Death_Dis_2010_Oct_21_1(10)_e86.nxml.txt.nlp	21368859	SENT76	20	20	28	28	doxorubicin	JNK	PA449412	5599	0.9
NULL	Acta_Pharmacol_Sin_2012_Dec_29_33(12)_1518-1524.nxml.txt.nlp	23103625	SENT103	15	15	1	1	telmisartan	ACE2	PA451605	59272	0.9
NULL	J_Thorac_Oncol_2014_Jun_30_9(6)_775-783.nxml.txt.nlp	24828661	SENT127	16	16	5	5	erlotinib	Met	PA134687924	79811	0.9
NULL	Br_J_Haematol_2014_Mar_13_164(1)_811-821.nxml.txt.nlp	24328678	SENT142	6	6	11	11	lenalidomide	Aiolos	PA162363968	22806	0.9
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_33-43.nxml.txt.nlp	17912634	SENT124	7	7	15	15	letrozole	HER2	PA450196	2064	0.9
NULL	J_Cell_Biol_1998_Jun_15_141(6)_1349-1356.nxml.txt.nlp	9628891	SENT108	20	20	7	7	potassium	MLCK	PA451047	4638;91807	0.9
NULL	J_Anaesthesiol_Clin_Pharmacol_2012_Jan-Mar_28(1)_106-110.nxml.txt.nlp	22345956	SENT88	22	22	11	11	argatroban	ACT	PA164745516	12;11332;9457;641455	0.9
NULL	Mol_Cancer_2007_Sep_26_6_61.nxml.txt.nlp	17894897	SENT186	8	8	12	12	etoposide	HIF-1	PA449552	29072	0.9
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT80	10	10	17	17	delavirdine	CYP2B6	PA449223	1555	0.9
NULL	Mol_Vis_2007_Jul_12_13_1130-1137.nxml.txt.nlp	17653058	SENT168	3	3	24	24	fentanyl	IFN	PA449599	3439	0.9
NULL	Acta_Pharmacol_Sin_2011_Nov_10_32(11)_1402-1410.nxml.txt.nlp	21986579	SENT130	3	3	17	17	curcumin	p38	PA151958596	10598;1432;7965	0.9
NULL	Front_Physiol_2013_Jul_12_4_178.nxml.txt.nlp	23874303	SENT151	13	13	24	24	aprotinin	EMMPRIN	PA448472	682	0.9
NULL	Eur_J_Neurosci_2008_Apr_1_27(7)_1722-1730.nxml.txt.nlp	18380669	SENT207	20	20	25	25	sr144528	CB1		1268	0.9
NULL	Exp_Ther_Med_2013_Nov_13_6(5)_1317-1321.nxml.txt.nlp	24223665	SENT105	7	7	12	12	curcumin	CD133	PA151958596	8842	0.9
NULL	Cell_Cycle_2013_Dec_15_12(24)_3791-3803.nxml.txt.nlp	24107631	SENT50	16	16	8	8	doxorubicin	YB-1	PA449412	4904	0.9
NULL	EMBO_Mol_Med_2013_Aug_5_5(8)_1213-1226.nxml.txt.nlp	23918228	SENT250	18	18	31	31	cetuximab	EGFR	PA10040	1956	0.9
NULL	Exp_Cell_Res_2011_Apr_15_317(7)_1028-1039.nxml.txt.nlp	21237154	SENT216	31	31	10	10	staurosporine	JIP1	PA165109623	9479	0.9
NULL	Curr_Med_Chem_2013_Aug_20(25)_3103-3115.nxml.txt.nlp	23514419	SENT54	4	4	1	1	vildagliptin	DPPIV	PA165958346	2191;1803	0.9
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT138	25	25	35	35	adalimumab	CD36	PA10004	948	0.9
NULL	Theranostics_2013_Jan_13_3(1)_34-39.nxml.txt.nlp	23382784	SENT125	44	44	30	30	cytarabine	CXCR4	PA449177	7852	0.9
NULL	Adv_Hematol_2012_May_8_2012_393864.nxml.txt.nlp	22851972	SENT28	3	3	13	13	lenalidomide	IL-2	PA162363968	3558	0.9
NULL	Ther_Clin_Risk_Manag_2007_Mar_3(1)_133-148.nxml.txt.nlp	18360621	SENT97	6	6	1	1	adalimumab	STAR	PA10004	6770;2984	0.9
NULL	N_Am_J_Med_Sci_2014_Sep_6(9)_478-480.nxml.txt.nlp	25317394	SENT4	0	0	25	25	phenytoin	CYP2C19	PA450947	1557	0.9
NULL	J_Biomed_Sci_2012_Nov_21_19(1)_99.nxml.txt.nlp	23170833	SENT16	3	3	27	27	atorvastatin	CXCR4	PA448500	7852	0.9
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT116	40	40	6	6	pemetrexed	UNG	PA10810	7374	0.9
NULL	Oncol_Rep_2013_Oct_22_30(4)_1535-1541.nxml.txt.nlp	23877481	SENT129	10	10	3	3	sunitinib	CXCR4	PA162372840	7852	0.9
NULL	J_Geriatr_Cardiol_2012_Jun_9(2)_108-114.nxml.txt.nlp	22916055	SENT135	0	0	13	13	ticagrelor	ADP	PA165374673	23038	0.9
NULL	Structure_2012_May_9_20-540(5-7)_841-849.nxml.txt.nlp	22579251	SENT86	29	29	40	40	bucindolol	EL2	PA165945764	6708	0.9
NULL	Cell_Death_Dis_2014_Mar_13_5(3)_e1118.nxml.txt.nlp	24625977	SENT80	40	40	10	10	etoposide	p53	PA449552	7157	0.9
NULL	Cancer_Cell_Int_2010_Sep_9_10_32.nxml.txt.nlp	20828393	SENT139	27	27	2	2	cisplatin	ATF3	PA449014	467	0.9
NULL	Int_J_Mol_Sci_2014_Mar_5_15(3)_3970-3988.nxml.txt.nlp	24603537	SENT354	11	11	14	14	curcumin	EGFR	PA151958596	1956	0.9
NULL	Mol_Cancer_2014_Jul_5_13_165.nxml.txt.nlp	24996221	SENT7	16	16	11	11	docetaxel	HMGB1	PA449383	3146	0.9
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1420-1426.nxml.txt.nlp	24056704	SENT128	5	5	10	10	ketoconazole	CYP3A	PA450146	1574	0.9
NULL	Biosci_Rep_2012_Aug_1_32(Pt_4)_361-374.nxml.txt.nlp	22762204	SENT142	19	19	26	26	trastuzumab	PTEN	PA451743	5728	0.9
NULL	ASN_Neuro_2011_Apr_7_3(2)_e00056.nxml.txt.nlp	21382016	SENT56	14	14	31	31	glucose	CO2	PA449773	4513	0.9
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT231	17	17	11	11	lapatinib	ADAM17	PA152241907	6868	0.9
NULL	Int_J_Hypertens_2012_Jun_26_2012_124758.nxml.txt.nlp	22792446	SENT218	20	20	16	16	candesartan	AT1	PA448765	9197;185	0.9
NULL	J_Thyroid_Res_2011_Apr_10_2011_895923.nxml.txt.nlp	21603172	SENT181	12	12	3	3	thyroglobulin	IFN	PA164754910	3439	0.9
NULL	Mol_Cancer_2013_Sep_23_12_107.nxml.txt.nlp	24053443	SENT262	8	8	11	11	sunitinib	VEGFR	PA162372840	3791	0.9
NULL	Oncotarget_2014_Dec_1_5(22)_10965-10966.nxml.txt.nlp	25473898	SENT13	25	25	12	12	doxorubicin	STAT6	PA449412	6778	0.9
NULL	Mol_Cancer_2009_Jul_31_8_57.nxml.txt.nlp	19646263	SENT218	8	8	18	18	staurosporine	PC-3	PA165109623	692094	0.9
NULL	Cell_Death_Dis_2014_Feb_27_5(2)_e1093.nxml.txt.nlp	24577091	SENT134	7	7	13	13	curcumin	ALDH1A1	PA151958596	216	0.9
NULL	Cancer_Cell_Int_2011_Aug_19_11_29.nxml.txt.nlp	21854619	SENT209	15	15	10	10	cisplatin	BRCA1	PA449014	672	0.9
NULL	J_Gen_Physiol_2004_Jul_124(1)_1b.nxml.txt.nlp	NULL	SENT1339	14	14	45	45	thrombin	EGF	PA451674	1950	0.9
NULL	J_Histochem_Cytochem_2013_Feb_61(2)_101-115.nxml.txt.nlp	23092791	SENT189	8	8	21	21	heparin	VEGF-A	PA449855	7422	0.9
NULL	Arthritis_Res_Ther_2009_Feb_3_11(1)_R15.nxml.txt.nlp	19192274	SENT224	2	2	8	8	chloroquine	IL-6	PA448948	3569	0.9
NULL	Int_J_Mol_Imaging_2011_Oct_26_2011_874585.nxml.txt.nlp	21490735	SENT176	33	33	19	19	tamoxifen	FDG	PA451581	23583	0.9
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT100	6	6	10	10	pertuzumab	HER2		2064	0.9
NULL	Neuro_Oncol_2011_Jan_25_13(1)_70-83.nxml.txt.nlp	20978004	SENT261	10	10	5	5	etoposide	ABCB1	PA449552	5243	0.9
NULL	Int_J_Chron_Obstruct_Pulmon_Dis_2008_Dec_3(4)_771-780.nxml.txt.nlp	19281092	SENT20	12	12	1	1	tiotropium	TDI	PA164769056	100038246	0.9
NULL	Oncoscience_2014_Jun_1_1(5)_310-325.nxml.txt.nlp	25594026	SENT259	30	30	12	12	decitabine	MBD1	PA164749631	4152	0.9
NULL	Oncogene_2014_Aug_28_33(35)_4407-4417.nxml.txt.nlp	24469038	SENT107	3	3	36	36	arsenite	HEDLS	PA452638	23644	0.9
NULL	J_Immunother_2014_Apr_12_37(3)_180-186.nxml.txt.nlp	24598448	SENT150	20	20	28	28	sorafenib	IL-2	PA7000	3558	0.9
NULL	J_Mol_Signal_2014_Mar_6_9_1.nxml.txt.nlp	24597858	SENT52	28	28	0	0	vasopressin	GRK5	PA451858	2869	0.9
NULL	Oncol_Lett_2014_Mar_16_7(3)_827-833.nxml.txt.nlp	24527090	SENT86	3	3	32	32	cisplatin	IFN	PA449014	3439	0.9
NULL	Oncol_Lett_2013_May_13_5(5)_1677-1681.nxml.txt.nlp	23760084	SENT112	4	4	14	14	sunitinib	NGAL	PA162372840	3934	0.9
NULL	Front_Endocrinol_(Lausanne)_2014_Jan_16_5_1.nxml.txt.nlp	24474947	SENT93	16	16	8	8	estradiol	ESR1	PA449503	2099	0.9
NULL	Br_J_Cancer_2009_Jul_21_101(2)_238-243.nxml.txt.nlp	19568242	SENT143	11	11	17	17	sunitinib	IFN	PA162372840	3439	0.9
NULL	Chemother_Res_Pract_2011_Feb_6_2011_249867.nxml.txt.nlp	22312550	SENT47	19	19	9	9	telithromycin	CAP	PA10202	23476;9200;4012;5269;10580;10487	0.9
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S258-S263.nxml.txt.nlp	21525465	SENT205	18	18	12	12	metformin	GLP-1	PA450395	100125288	0.9
NULL	J_Biol_Chem_2012_Apr_27_287(18)_14644-14658.nxml.txt.nlp	22375002	SENT92	39	39	14	14	gentamicin	B27	PA449753	56246	0.9
NULL	Breast_Cancer_Res_2010_Jun_4_12(3)_R32.nxml.txt.nlp	20525379	SENT312	10	10	18	18	tamoxifen	AGR2	PA451581	10551	0.9
NULL	Breast_Cancer_Res_2014_May_23_16(3)_R50.nxml.txt.nlp	24887458	SENT166	26	26	33	33	lapatinib	HER2	PA152241907	2064	0.9
NULL	Int_J_Nanomedicine_2012_Sep_13_7_4917-4926.nxml.txt.nlp	23028220	SENT218	2	2	17	17	calcein	mol	PA132595336	90527	0.9
NULL	Allergy_Asthma_Immunol_Res_2010_Jul_19_2(3)_177-182.nxml.txt.nlp	20592916	SENT93	12	12	22	22	montelukast	IL-13	PA450546	3596	0.9
NULL	Blood_Cancer_J_2012_Oct_19_2(10)_e95.nxml.txt.nlp	23085780	SENT174	21	21	13	13	imatinib	CML	PA10804	613	0.9
NULL	Arthritis_Res_Ther_2009_Aug_28_11(4)_R131.nxml.txt.nlp	19715572	SENT106	5	5	11	11	rituximab	CD27	PA451261	939	0.9
NULL	Br_J_Cancer_2011_Jan_4_104(1)_91-100.nxml.txt.nlp	21139584	SENT33	5	5	14	14	bortezomib	p53	PA10252	7157	0.9
NULL	Diabetes_2008_Sep_57(9)_2272-2279.nxml.txt.nlp	18519799	SENT294	12	12	2	2	rosiglitazone	PDK4	PA451283	5166	0.9
NULL	Breast_Cancer_Res_2012_Dec_5_14(6)_R153.nxml.txt.nlp	23216744	SENT152	11	11	26	26	auranofin	ESR1	PA448510	2099	0.9
NULL	Pak_J_Med_Sci_2013_Apr_29(2)_519-522.nxml.txt.nlp	24353568	SENT71	34	34	37	37	bevacizumab	VEGF-A	PA130232992	7422	0.9
NULL	J_Hematol_Oncol_2013_Jan_15_6_5.nxml.txt.nlp	23320987	SENT121	22	22	20	20	heparin	PI-PLC	PA449855	2923	0.9
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_7-17.nxml.txt.nlp	17912633	SENT386	28	28	9	9	letrozole	aromatase	PA450196	1588	0.9
NULL	J_Biol_Chem_2009_Jul_10_284(28)_18904-18912.nxml.txt.nlp	19473990	SENT214	17	17	8	8	forskolin	P19	PA146096022	51561	0.9
NULL	Oncologist_2010_Sep_24_15(9)_924-934.nxml.txt.nlp	20736298	SENT28	0	0	31	31	lapatinib	HER-2	PA152241907	2064	0.9
NULL	Oncotarget_2013_Jul_7_4(7)_1065-1074.nxml.txt.nlp	23867252	SENT48	20	20	32	32	trypsin	Hsp90	PA451806	3320	0.9
NULL	Ann_Rheum_Dis_2010_Feb_15_69(2)_387-393.nxml.txt.nlp	19416802	SENT155	10	10	6	6	tocilizumab	IL-6	PA165292659	3569	0.9
NULL	Drugs_2014_Jul_18_74(11)_1209-1231.nxml.txt.nlp	25034361	SENT172	18	18	11	11	dronedarone	P-gp	PA153619853	5243	0.9
NULL	Cancer_Cell_Int_2010_Apr_29_10_12.nxml.txt.nlp	20429927	SENT203	10	10	24	24	bortezomib	RACK1	PA10252	10399	0.9
NULL	Oncotarget_2010_Nov_24_1(7)_583-595.nxml.txt.nlp	21317454	SENT327	13	13	21	21	lovastatin	p53	PA450272	7157	0.9
NULL	Breast_Cancer_Res_2005_Jan_28_7(3)_R284-R290.nxml.txt.nlp	15987423	SENT95	16	16	13	13	tamoxifen	CYP2D6	PA451581	1565	0.9
NULL	Mol_Cancer_2009_Jul_3_8_43.nxml.txt.nlp	19575780	SENT139	11	11	4	4	colchicine	survivin	PA449092	332	0.9
NULL	J_Breast_Cancer_2013_Sep_30_16(3)_274-284.nxml.txt.nlp	24155756	SENT46	18	18	14	14	cyclophosphamide	ACT	PA449165	12;11332;9457;641455	0.9
NULL	Int_J_Med_Sci_2013_Feb_11_10(3)_320-330.nxml.txt.nlp	23423768	SENT90	15	15	10	10	gefitinib	EGFR	PA131301952	1956	0.9
NULL	BMJ_Open_2014_Feb_27_4(2)_e004071.nxml.txt.nlp	24578536	SENT184	41	41	13	13	warfarin	TTR	PA451906	7276	0.9
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1198-1199.nxml.txt.nlp	20179709	SENT26	5	5	17	17	imatinib	KIT	PA10804	3815	0.9
NULL	Indian_J_Pharmacol_2013_Jan-Feb_45(1)_98-99.nxml.txt.nlp	23543750	SENT1	27	27	14	14	olanzapine	BPAD	PA450688	4095	0.9
NULL	Eur_J_Med_Res_2009_Dec_7_14(Suppl_4)_71-77.nxml.txt.nlp	20156730	SENT141	5	5	25	25	tobramycin	gamma	PA451704	9913	0.9
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_79-96.nxml.txt.nlp	19305789	SENT200	5	5	11	11	yohimbine	TRPV1	PA451946	7442	0.9
NULL	Nucl_Recept_Signal_2010_Nov_19_8_e005.nxml.txt.nlp	21383957	SENT31	26	26	9	9	taurine	CYP7A1	PA451590	1581	0.9
NULL	Oncologist_2010_May_28_15(5)_436-446.nxml.txt.nlp	20427383	SENT139	0	0	32	32	sorafenib	KIT	PA7000	3815	0.9
NULL	Clin_Pharmacokinet_2014_Sep_3_53(1)_1-16.nxml.txt.nlp	23999929	SENT51	7	7	34	34	rivaroxaban	E14	PA165958360	4863	0.9
NULL	Breast_Cancer_Res_2011_Jun_7_13(3)_R62.nxml.txt.nlp	21672245	SENT276	15	15	12	12	gefitinib	EGFR	PA131301952	1956	0.9
NULL	Breast_Cancer_Res_2010_Jun_24_12(3)_R41.nxml.txt.nlp	20576088	SENT260	14	14	8	8	paclitaxel	SP1	PA450761	6667	0.9
NULL	Front_Oncol_2013_Sep_11_3_228.nxml.txt.nlp	24062981	SENT275	24	24	30	30	olaparib	BRCA2		675	0.9
NULL	Oncoimmunology_2012_May_1_1(3)_372-374.nxml.txt.nlp	22737619	SENT19	28	28	41	41	lenalidomide	CD4	PA162363968	920	0.9
NULL	Acta_Neuropathol_2013_May_22_125(5)_683-698.nxml.txt.nlp	23429996	SENT217	22	22	6	6	cetuximab	EGFR	PA10040	1956	0.9
NULL	Eur_J_Immunol_2014_Jun_10_44(6)_1759-1769.nxml.txt.nlp	24595810	SENT102	3	3	24	24	fludrocortisone	CCR7	PA164743961	1236	0.9
NULL	Front_Pharmacol_2014_Oct_20_5_230.nxml.txt.nlp	25368579	SENT39	9	9	17	17	berberine	IL-6	PA165860812	3569	0.9
NULL	Mol_Cancer_2006_Oct_6_5_43.nxml.txt.nlp	17026740	SENT371	0	0	6	6	panitumumab	EGFR	PA162373091	1956	0.9
NULL	Acta_Pharmacol_Sin_2011_Nov_10_32(11)_1402-1410.nxml.txt.nlp	21986579	SENT163	29	29	14	14	curcumin	p27	PA151958596	5715;10534	0.9
NULL	Exp_Diabetes_Res_2012_Sep_20_2012_936518.nxml.txt.nlp	23049542	SENT131	19	19	13	13	glucose	HCD	PA449773	1732	0.9
NULL	Clin_Ophthalmol_2009_Jun_2_3_291-295.nxml.txt.nlp	19668581	SENT58	20	20	27	27	travoprost	BAK	PA164781371	578	0.9
NULL	J_Asthma_Allergy_2011_Mar_25_4_19-25.nxml.txt.nlp	21660177	SENT65	7	7	1	1	l-tyrosine	MPL	PA451822	4352	0.9
NULL	Arthritis_Res_Ther_2003_Sep_3_5(6)_R317-R328.nxml.txt.nlp	14680506	SENT153	15	15	4	4	rolipram	IL-10	PA153906323	3586	0.9
NULL	Bone_Marrow_Res_2012_Oct_18_2012_180391.nxml.txt.nlp	23119165	SENT112	24	24	5	5	ciprofloxacin	NOD2	PA449009	64127	0.9
NULL	Med_Sci_Monit_2012_Mar_1_18(3)_PI11-PI15.nxml.txt.nlp	22367138	SENT111	9	9	1	1	omalizumab	TRAIL	PA164752253	8743	0.9
NULL	Br_J_Cancer_2012_Jan_17_106(2)_348-357.nxml.txt.nlp	22146521	SENT116	10	10	3	3	gemcitabine	TP53	PA449748	7157	0.9
NULL	Cardiol_Res_Pract_2013_Jan_31_2013_128795.nxml.txt.nlp	23431496	SENT12	1	1	18	18	clopidogrel	CYP2C19	PA449053	1557	0.9
NULL	Arthritis_Res_Ther_2009_May_19_11(3)_228.nxml.txt.nlp	19497136	SENT128	10	10	3	3	denosumab	RANKL	PA166048634	8600	0.9
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_May_21_3(5)_e115.nxml.txt.nlp	24850445	SENT221	26	26	20	20	trastuzumab	HER-2	PA451743	2064	0.9
NULL	Clin_Cosmet_Investig_Dermatol_2011_Dec_20_4_197-205.nxml.txt.nlp	22253545	SENT25	12	12	29	29	hyaluronidase	JUP	PA164745713	3728	0.9
NULL	Breast_Cancer_(Auckl)_2012_Mar_7_6_67-77.nxml.txt.nlp	22438669	SENT114	7	7	4	4	letrozole	aromatase	PA450196	1588	0.9
NULL	Biomed_Res_Int_2014_Apr_28_2014_274507.nxml.txt.nlp	24877077	SENT49	12	12	26	26	collagenase	CO2	PA449107	4513	0.9
NULL	Scientifica_(Cairo)_2014_Aug_19_2014_901586.nxml.txt.nlp	25215263	SENT101	14	14	5	5	rifampin	CYP3A4	PA451250	1576	0.9
NULL	J_Korean_Med_Sci_2006_Dec_31_21(6)_1005-1011.nxml.txt.nlp	17179677	SENT6	42	42	33	33	busulfan	IL-2	PA448691	3558	0.9
NULL	Eur_J_Clin_Pharmacol_2010_Nov_29_66(11)_1131-1136.nxml.txt.nlp	20669013	SENT14	13	13	1	1	voriconazole	CYP2C19	PA10233	1557	0.9
NULL	Front_Oncol_2014_Sep_22_4_258.nxml.txt.nlp	25295228	SENT42	21	21	5	5	crizotinib	EGFR	PA165946122	1956	0.9
NULL	JAKSTAT_2012_Apr_1_1(2)_83-89.nxml.txt.nlp	24058756	SENT150	13	13	15	15	losartan	AT1	PA450268	9197;185	0.9
NULL	Springerplus_2014_Sep_17_3_535.nxml.txt.nlp	25279326	SENT70	14	14	3	3	tamoxifen	aromatase	PA451581	1588	0.9
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT131	4	4	8	8	adalimumab	CD36	PA10004	948	0.9
NULL	Open_Access_J_Urol_2011_May_10_3_69-82.nxml.txt.nlp	24198638	SENT66	11	11	27	27	efavirenz	CYP2C9	PA449441	1559	0.9
NULL	Cancers_(Basel)_2014_Aug_12_6(3)_1631-1669.nxml.txt.nlp	25119536	SENT1125	26	26	9	9	hydroxyurea	JAK1	PA449942	3716	0.9
NULL	Diabetes_Care_2010_Apr_12_33(4)_861-868.nxml.txt.nlp	20067962	SENT14	17	17	33	33	hyaluronan	TLR4	PA165958431	7099	0.9
NULL	Front_Behav_Neurosci_2014_Oct_30_8_366.nxml.txt.nlp	25400560	SENT100	27	27	2	2	ethanol	GLAST	PA448073	6507	0.9
NULL	Br_J_Cancer_2010_Dec_7_103(12)_1794-1800.nxml.txt.nlp	21063406	SENT131	11	11	20	20	doxorubicin	HER2	PA449412	2064	0.9
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1224-1233.nxml.txt.nlp	22353810	SENT197	15	15	4	4	doxorubicin	MRP-1	PA449412	928	0.9
NULL	Int_J_Mol_Sci_2014_Sep_30_15(10)_17686-17704.nxml.txt.nlp	25272226	SENT101	28	28	12	12	cetuximab	EGFR	PA10040	1956	0.9
NULL	Oncotarget_2014_Jun_19_5(15)_6540-6551.nxml.txt.nlp	25153728	SENT172	6	6	19	19	paclitaxel	HIF-1	PA450761	29072	0.9
NULL	J_Cell_Mol_Med_2014_Jul_30_18(7)_1444-1459.nxml.txt.nlp	24779367	SENT82	28	28	43	43	heparin	EGF	PA449855	1950	0.9
NULL	Pharmaceuticals_(Basel)_2011_Nov_10_4(11)_1488-1502.nxml.txt.nlp	NULL	SENT105	13	13	25	25	cisplatin	HSPCA	PA449014	3324	0.9
NULL	Oncotarget_2014_Jun_1_5(13)_4881-4894.nxml.txt.nlp	24952679	SENT38	19	19	11	11	bortezomib	IRE1	PA10252	2081	0.9
NULL	Indian_J_Med_Res_2012_Dec_136(6)_1051-1053.nxml.txt.nlp	23391805	SENT63	19	19	9	9	carbamazepine	HLA-B	PA448785	3106	0.9
NULL	Clin_Psychopharmacol_Neurosci_2012_Apr_30_10(1)_25-33.nxml.txt.nlp	23429852	SENT124	14	14	21	21	olanzapine	alpha-synuclein	PA450688	6622	0.9
NULL	eLife_2014_Apr_30_3_e02445.nxml.txt.nlp	24843000	SENT614	19	19	11	11	cisplatin	REV1	PA449014	51455	0.9
NULL	Oncotarget_2012_May_19_3(5)_535-545.nxml.txt.nlp	22619121	SENT108	11	11	0	0	topotecan	B-MYB	PA451729	4605	0.9
NULL	J_Invest_Dermatol_2012_Oct_24_132(10)_2440-2450.nxml.txt.nlp	22622430	SENT78	35	35	10	10	temozolomide	IL-8	PA451609	3576	0.9
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jul_23_67(Pt_8)_o2099.nxml.txt.nlp	22091118	SENT60	29	29	7	7	ethanol	mol	PA448073	90527	0.9
NULL	Tanaffos_2013_12(2)_16-21.nxml.txt.nlp	25191457	SENT114	21	21	11	11	pantoprazole	HAP	PA450774	5915;10313	0.9
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1123-1128.nxml.txt.nlp	20354531	SENT139	19	19	1	1	mitomycin	ACT	PA450524	12;11332;9457;641455	0.9
NULL	J_Invest_Dermatol_2014_Jul_134(7)_1786-1788.nxml.txt.nlp	24924756	SENT82	0	0	11	11	aprepitant	CD25	PA164747039	3669;3559	0.9
NULL	Arthritis_Res_2000_Sep_20_2(6)_504-512.nxml.txt.nlp	11056680	SENT64	7	7	1	1	thrombin	PAR1	PA451674	79581;2149	0.9
NULL	Diabetes_Care_2009_Oct_8_32(10)_1873-1879.nxml.txt.nlp	19587362	SENT67	12	12	1	1	ethanol	ANG	PA448073	283	0.9
NULL	Iran_J_Ped_Hematol_Oncol_2014_Mar_15_4(1)_32-38.nxml.txt.nlp	24734162	SENT30	38	38	3	3	azathioprine	TPMT	PA448515	7172	0.9
NULL	Evid_Based_Complement_Alternat_Med_2013_May_16_2013_857929.nxml.txt.nlp	23762164	SENT128	12	12	31	31	doxorubicin	p53	PA449412	7157	0.9
NULL	Oxid_Med_Cell_Longev_2012_Oct_24_2012_906252.nxml.txt.nlp	23150750	SENT377	13	13	0	0	mitomycin	Cocoa	PA450524	57658	0.9
NULL	Evid_Based_Complement_Alternat_Med_2014_Jun_12_2014_807308.nxml.txt.nlp	25024732	SENT135	25	25	11	11	capsaicin	PK2	PA448776	60675	0.9
NULL	Breast_Cancer_(Auckl)_2011_Jul_27_5_175-199.nxml.txt.nlp	21863131	SENT365	19	19	13	13	epirubicin	HER2	PA449476	2064	0.9
NULL	Int_J_Mol_Sci_2014_Sep_22_15(9)_16848-16884.nxml.txt.nlp	25247581	SENT253	0	0	10	10	resveratrol	SIRT1		23411	0.9
NULL	EJC_Suppl_2013_Sep_5_11(2)_3-22.nxml.txt.nlp	NULL	SENT1063	2	2	17	17	anastrozole	ATAC	PA448432	6375	0.9
NULL	Cell_Death_Dis_2010_Oct_21_1(10)_e86.nxml.txt.nlp	21368859	SENT52	13	13	11	11	doxorubicin	TRAIL	PA449412	8743	0.9
NULL	Biomed_Res_Int_2013_Jul_15_2013_458571.nxml.txt.nlp	23956983	SENT178	28	28	3	3	l-serine	SHMT	PA451330	6470	0.9
NULL	Front_Oncol_2013_Nov_18_3_282.nxml.txt.nlp	24303367	SENT224	6	6	22	22	metformin	AMPK	PA450395	5563	0.9
NULL	Ann_Rheum_Dis_2008_Jul_22_68(8)_1303-1309.nxml.txt.nlp	18647851	SENT18	0	0	15	15	adalimumab	MMP13	PA10004	4322	0.9
NULL	ScientificWorldJournal_2012_Sep_10_2012_168953.nxml.txt.nlp	22997489	SENT156	3	3	5	5	tenoxicam	COX	PA131890625	1351	0.9
NULL	Mol_Cancer_2012_Apr_26_11_26.nxml.txt.nlp	22537224	SENT166	5	5	29	29	cisplatin	RAD51	PA449014	5888	0.9
NULL	Breast_Cancer_Res_2011_May_26_13(3)_209.nxml.txt.nlp	21635709	SENT231	11	11	17	17	tamoxifen	aromatase	PA451581	1588	0.9
NULL	Nat_Biotechnol_2010_Jul_27_28(7)_743-747.nxml.txt.nlp	20581846	SENT86	13	13	9	9	imatinib	PP2	PA10804	4888	0.9
NULL	Int_J_Mol_Imaging_2011_Oct_26_2011_874585.nxml.txt.nlp	21490735	SENT98	15	15	7	7	tamoxifen	FDG	PA451581	23583	0.9
NULL	Eur_J_Clin_Pharmacol_2014_May_27_70(8)_975-981.nxml.txt.nlp	24858823	SENT106	8	8	18	18	ciprofloxacin	CYP3A4	PA449009	1576	0.9
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT332	2	2	18	18	olanzapine	PRL	PA450688	5617	0.9
NULL	Oncol_Rep_2014_Apr_28_31(4)_1605-1612.nxml.txt.nlp	24481648	SENT129	13	13	34	34	paclitaxel	MRP7	PA450761	89845;1080	0.9
NULL	Iran_J_Pharm_Res_2014_Spring_13(2)_449-457.nxml.txt.nlp	25237340	SENT44	0	0	17	17	ethanol	Tech	PA448073	57449	0.9
NULL	Pharmaceuticals_(Basel)_2013_Aug_6_6(8)_929-959.nxml.txt.nlp	24276377	SENT102	9	9	3	3	oxaliplatin	CXCR2	PA131285527	3579	0.9
NULL	Crit_Care_2010_Oct_13_14(5)_R181.nxml.txt.nlp	20942931	SENT211	12	12	3	3	cisplatin	IL-6	PA449014	3569	0.9
NULL	J_Radiat_Res_2014_Nov_16_55(6)_1171-1177.nxml.txt.nlp	25129557	SENT48	9	9	17	17	bevacizumab	CRT	PA130232992	811	0.9
NULL	Clin_Cosmet_Investig_Dermatol_2013_Mar_14_6_75-80.nxml.txt.nlp	23515267	SENT84	2	2	13	13	adalimumab	IL-23	PA10004	51561	0.9
NULL	Biomed_Res_Int_2014_Apr_27_2014_459676.nxml.txt.nlp	24864244	SENT73	14	14	44	44	thyroglobulin	B12	PA164754910	7126;4709	0.9
NULL	Onco_Targets_Ther_2014_Jun_6_7_925-935.nxml.txt.nlp	24944516	SENT147	19	19	8	8	sorafenib	CXCR4	PA7000	7852	0.9
NULL	Ann_Rheum_Dis_2008_Sep_11_68(7)_1146-1152.nxml.txt.nlp	18794178	SENT86	17	17	5	5	etanercept	ACR	PA449515	49	0.9
NULL	F1000Prime_Rep_2014_Aug_1_6_65.nxml.txt.nlp	25165564	SENT42	3	3	15	15	alemtuzumab	TP53	PA164783958	7157	0.9
NULL	Arthritis_Res_Ther_2013_Jul_9_15(4)_R73.nxml.txt.nlp	23837669	SENT309	1	1	18	18	colchicine	MICL	PA449092	160364	0.9
NULL	Clin_Exp_Gastroenterol_2011_Dec_12_4_291-296.nxml.txt.nlp	22235173	SENT10	16	16	13	13	cisplatin	ghrelin	PA449014	51738	0.9
NULL	Oncotarget_2012_Jul_31_3(7)_700-708.nxml.txt.nlp	22869096	SENT120	19	19	13	13	l-glutamine	CO2	PA10090	4513	0.9
NULL	J_Invest_Dermatol_2011_Nov_14_131(11)_2281-2288.nxml.txt.nlp	21753781	SENT221	14	14	3	3	calcein	Klk6	PA132595336	3816	0.9
NULL	Clin_Ophthalmol_2011_Apr_26_5_517-525.nxml.txt.nlp	21573041	SENT98	26	26	12	12	latanoprost	BAK	PA164774763	578	0.9
NULL	J_Hematol_Oncol_2013_Jul_9_6_49.nxml.txt.nlp	23837843	SENT281	30	30	16	16	verapamil	P-gp	PA451868	5243	0.9
NULL	J_Biol_Chem_2012_Dec_21_287(52)_43424-43437.nxml.txt.nlp	23118220	SENT386	16	16	7	7	ethanol	RSK2	PA448073	6197	0.9
NULL	Clin_Interv_Aging_2013_Oct_2_8_1329-1337.nxml.txt.nlp	24124355	SENT68	11	11	2	2	zafirlukast	CysLT1	PA451949	10800	0.9
NULL	J_Exp_Med_2000_May_15_191(10)_1745-1754.nxml.txt.nlp	10811867	SENT47	27	27	0	0	l-glutamine	BTK	PA10090	695	0.9
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1420-1426.nxml.txt.nlp	24056704	SENT146	14	14	28	28	ketoconazole	CYP3A	PA450146	1574	0.9
NULL	J_Biol_Chem_2013_Nov_22_288(47)_34217-34229.nxml.txt.nlp	24106270	SENT173	23	23	13	13	abciximab	P2Y12	PA448006	64805	0.9
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Jul_23_3(7)_e126.nxml.txt.nlp	25054314	SENT298	6	6	15	15	docetaxel	OAT	PA449383	4942	0.9
NULL	Case_Rep_Dermatol_2011_Jun_30_3(2)_130-136.nxml.txt.nlp	21743808	SENT5	31	31	18	18	adapalene	EGFR	PA448047	1956	0.9
NULL	Lipids_Health_Dis_2011_Feb_28_10_38.nxml.txt.nlp	21352602	SENT121	27	27	19	19	fenofibrate	PCSK9	PA449594	255738	0.9
NULL	J_Cell_Biol_2001_Apr_2_153(1)_87-100.nxml.txt.nlp	11285276	SENT360	12	12	1	1	collagenase	AP-1	PA449107	2353;3727;2354;3725	0.9
NULL	Cell_Cycle_2013_Nov_15_12(22)_3490-3499.nxml.txt.nlp	24240433	SENT88	28	28	10	10	metformin	TXNIP	PA450395	10628	0.9
NULL	Iran_J_Reprod_Med_2012_Jan_10(1)_33-40.nxml.txt.nlp	25242972	SENT135	11	11	2	2	letrozole	Casper	PA450196	8837	0.9
NULL	Nucleic_Acids_Res_2005_Jun_8_33(10)_3283-3291.nxml.txt.nlp	15944449	SENT114	22	22	15	15	melphalan	XRCC2	PA450354	7516	0.9
NULL	Exp_Ther_Med_2014_Oct_24_8(4)_1092-1096.nxml.txt.nlp	25187802	SENT21	8	8	13	13	carvedilol	TLR4	PA448817	7099	0.9
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT204	3	3	12	12	dasatinib	LYN	PA162372878	4067	0.9
NULL	Breast_Cancer_Res_Treat_2015_Dec_30_149_171-179.nxml.txt.nlp	25547219	SENT2	26	26	16	16	docetaxel	survivin	PA449383	332	0.9
NULL	J_Neurovirol_2013_Jun_4_19(4)_351-358.nxml.txt.nlp	23733308	SENT163	31	31	21	21	mefloquine	SOC	PA450348	91544	0.9
NULL	J_Biol_Chem_2013_Jun_28_288(26)_18716-18731.nxml.txt.nlp	23658023	SENT72	29	29	21	21	mitomycin	P14	PA450524	11102;;6280;56259	0.9
NULL	Biologics_2012_Jul_26_6_233-244.nxml.txt.nlp	22904615	SENT237	3	3	24	24	pertuzumab	HER2		2064	0.9
NULL	Am_J_Cardiovasc_Drugs_2013_Jun_20_13(5)_331-342.nxml.txt.nlp	23784266	SENT223	25	25	16	16	ritonavir	P-gp	PA451260	5243	0.9
NULL	J_Antimicrob_Chemother_2011_Oct_3_66(10)_2235-2239.nxml.txt.nlp	21816764	SENT63	14	14	6	6	minocycline	BSAC	PA450519	57591	0.9
NULL	Calcif_Tissue_Int_2010_Aug_23_87(2)_130-136.nxml.txt.nlp	20571786	SENT194	23	23	6	6	teriparatide	CSA	PA451620	1442;1161	0.9
NULL	Carcinogenesis_2014_Nov_12_35(11)_2485-2494.nxml.txt.nlp	25115442	SENT223	19	19	8	8	heparin	RRH	PA449855	10692	0.9
NULL	Clin_Drug_Investig_2013_Aug_23_33(10)_727-736.nxml.txt.nlp	23975654	SENT43	14	14	27	27	bupropion	CYP3A	PA448687	1574	0.9
NULL	Tuberc_Respir_Dis_(Seoul)_2012_Apr_30_72(4)_343-351.nxml.txt.nlp	23227075	SENT136	18	18	12	12	temsirolimus	EGFR	PA164746890	1956	0.9
NULL	Mol_Cancer_2003_Jan_7_2_10.nxml.txt.nlp	12575899	SENT279	25	25	21	21	sulindac	COX	PA451565	1351	0.9
NULL	Ann_Surg_Oncol_2010_Apr_20_17(4)_1168-1176.nxml.txt.nlp	19936839	SENT86	17	17	39	39	cetuximab	KRAS	PA10040	3845	0.9
NULL	Nucl_Recept_Signal_2009_Jan_16_7_e001.nxml.txt.nlp	19240808	SENT403	12	12	26	26	tamoxifen	SXR	PA451581	8856	0.9
NULL	Cancer_Metastasis_Rev_2010_Dec_10_29(4)_581-594.nxml.txt.nlp	20830503	SENT167	6	6	15	15	exemestane	ARNO	PA449563	9266	0.9
NULL	Mol_Biol_Int_2012_May_24_2012_705948.nxml.txt.nlp	22693671	SENT161	14	14	7	7	cisplatin	RASSF2	PA449014	9770	0.9
NULL	Front_Neurol_2014_Apr_29_5_63.nxml.txt.nlp	24808888	SENT292	15	15	2	2	pilocarpine	ghrelin	PA450962	51738	0.9
NULL	Int_Neurourol_J_2014_Sep_24_18(3)_115-125.nxml.txt.nlp	25279238	SENT158	23	23	12	12	berberine	CA1	PA165860812	759	0.9
NULL	Br_J_Cancer_2013_Aug_6_109(3)_714-722.nxml.txt.nlp	23799849	SENT213	14	14	4	4	cisplatin	MRP1	PA449014	4437	0.9
NULL	Int_J_Surg_Oncol_2012_Jun_12_2012_862879.nxml.txt.nlp	22778941	SENT240	28	28	14	14	cisplatin	PARP1	PA449014	142	0.9
NULL	FEBS_Open_Bio_2014_Jan_6_4_77-89.nxml.txt.nlp	24490132	SENT207	7	7	31	31	ebselen	GDH	PA161660841	51084;2746	0.9
NULL	Oxid_Med_Cell_Longev_2012_Jan_19_2012_390678.nxml.txt.nlp	22315655	SENT167	4	4	6	6	gliclazide	NAC	PA10892	22861	0.9
NULL	J_Biomed_Biotechnol_2010_Jun_7_2010_150960.nxml.txt.nlp	20617134	SENT227	27	27	37	37	irinotecan	KRAS	PA450085	3845	0.9
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_4_2013_378657.nxml.txt.nlp	23662132	SENT495	27	27	3	3	saxagliptin	GLP-1	PA165958362	100125288	0.9
NULL	Acta_Histochem_Cytochem_2014_Aug_29_47(4)_155-164.nxml.txt.nlp	25392569	SENT120	6	6	32	32	diethylstilbestrol	PRL	PA449307	5617	0.9
NULL	Case_Rep_Neurol_2011_Feb_21_3(1)_54-61.nxml.txt.nlp	21490714	SENT83	16	16	11	11	anastrozole	aromatase	PA448432	1588	0.9
NULL	J_Oncol_2014_Mar_26_2014_625060.nxml.txt.nlp	24795759	SENT155	0	0	16	16	denosumab	RANK	PA166048634	8792	0.9
NULL	Evid_Based_Complement_Alternat_Med_2012_Sep_18_2012_674101.nxml.txt.nlp	23028394	SENT159	3	3	15	15	donepezil	CA1	PA449394	759	0.9
NULL	Oxid_Med_Cell_Longev_2013_Nov_28_2013_568093.nxml.txt.nlp	24379901	SENT7	5	5	46	46	resveratrol	SIRT1		23411	0.9
NULL	Cancer_Cell_Int_2013_Feb_8_13_11.nxml.txt.nlp	23394616	SENT231	0	0	6	6	geldanamycin	San	PA152031327	80218	0.9
NULL	Leukemia_2013_Jan_11_27(1)_32-40.nxml.txt.nlp	22781593	SENT166	3	3	10	10	ponatinib	FGFR1	PA165980594	2260	0.9
NULL	Vet_Res_Forum_2013_Winter_4(1)_19-24.nxml.txt.nlp	25593681	SENT84	39	39	26	26	diclofenac	B12	PA449293	7126;4709	0.9
NULL	Diabetes_2009_Feb_58(2)_344-351.nxml.txt.nlp	19008341	SENT55	4	4	22	22	resveratrol	IFN		3439	0.9
NULL	J_Res_Med_Sci_2010_Nov-Dec_15(6)_331-343.nxml.txt.nlp	21526106	SENT208	7	7	16	16	l-arginine	HDEL	PA448478	10945	0.9
NULL	Cancers_(Basel)_2010_Dec_30_3(1)_106-125.nxml.txt.nlp	24212609	SENT87	25	25	11	11	gemcitabine	S100A4	PA449748	6275	0.9
NULL	Br_J_Cancer_2010_Jul_13_103(2)_265-274.nxml.txt.nlp	20551953	SENT328	12	12	23	23	cisplatin	JNK	PA449014	5599	0.9
NULL	Cancers_(Basel)_2013_Aug_22_5(3)_1103-1119.nxml.txt.nlp	24202336	SENT91	24	24	38	38	temozolomide	p16	PA451609	1029	0.9
NULL	Exp_Ther_Med_2013_Nov_18_6(5)_1177-1183.nxml.txt.nlp	24223641	SENT161	5	5	11	11	propofol	BMP2	PA451141	650	0.9
NULL	Cardiovasc_Diabetol_2005_May_15_4_6.nxml.txt.nlp	15892894	SENT60	11	11	24	24	glucose	ANOVA	PA449773	4858	0.9
NULL	Blood_Cancer_J_2014_Oct_31_4(10)_e255.nxml.txt.nlp	25360901	SENT118	0	0	29	29	plerixafor	CD34	PA165958410	947	0.9
NULL	Oncotarget_2013_Dec_4_5(2)_351-362.nxml.txt.nlp	24504051	SENT197	2	2	15	15	nilotinib	ERG	PA165958345	2078	0.9
NULL	Exp_Lung_Res_2013_Oct_1_39(8)_336-348.nxml.txt.nlp	23919450	SENT104	31	31	19	19	thrombin	PAR-1	PA451674	2011;2149	0.9
NULL	Mol_Cancer_2010_Nov_2_9_289.nxml.txt.nlp	21044322	SENT290	25	25	13	13	cisplatin	LPA	PA449014	4018	0.9
NULL	Clin_Exp_Vaccine_Res_2014_Jan_18_3(1)_12-28.nxml.txt.nlp	24427759	SENT290	0	0	11	11	imiquimod	TLR9	PA449972	54106	0.9
NULL	Korean_Circ_J_2013_Sep_30_43(9)_600-606.nxml.txt.nlp	24174960	SENT74	21	21	8	8	abciximab	CD31	PA448006	5175	0.9
NULL	Biomed_Res_Int_2014_Feb_24_2014_540238.nxml.txt.nlp	24707490	SENT136	35	35	20	20	lamotrigine	GluK1	PA450164	2897	0.9
NULL	J_Biol_Chem_2013_Nov_22_288(47)_34217-34229.nxml.txt.nlp	24106270	SENT226	5	5	20	20	thrombin	RhoG	PA451674	391	0.9
NULL	Exp_Ther_Med_2013_Oct_20_6(4)_899-903.nxml.txt.nlp	24137286	SENT9	6	6	30	30	rosuvastatin	MMP2	PA134308647	4313	0.9
NULL	Ann_Indian_Acad_Neurol_2010_Jul-Sep_13(3)_207-210.nxml.txt.nlp	21085534	SENT59	18	18	9	9	infliximab	MRI	PA452639	78996	0.9
NULL	FASEB_J_2010_Jan_24(1)_286-295.nxml.txt.nlp	19720623	SENT91	17	17	1	1	sulfanilamide	SNO	PA451545	6498	0.9
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1542-1553.nxml.txt.nlp	21970874	SENT226	25	25	6	6	pemetrexed	EGFR	PA10810	1956	0.9
NULL	Eur_J_Epidemiol_2009_Sep_2_24(9)_553-572.nxml.txt.nlp	19728115	SENT1537	18	18	13	13	acenocoumarol	CYP2C9	PA452632	1559	0.9
NULL	Indian_J_Med_Res_2014_Jun_139(6)_892-902.nxml.txt.nlp	25109724	SENT7	20	20	32	32	isoniazid	EMB	PA450112	133418	0.9
NULL	Mol_Cancer_2012_Jul_25_11_47.nxml.txt.nlp	22830443	SENT78	6	6	4	4	panitumumab	EGFR	PA162373091	1956	0.9
NULL	Oncol_Lett_2014_Jan_29_7(1)_183-188.nxml.txt.nlp	24348845	SENT145	13	13	5	5	cisplatin	RBM3	PA449014	5935	0.9
NULL	Br_J_Cancer_2003_Jun_16_88(12)_1963-1970.nxml.txt.nlp	12799644	SENT200	13	13	1	1	gemcitabine	TK2	PA449748	7084	0.9
NULL	Lipids_Health_Dis_2011_Dec_30_10_246.nxml.txt.nlp	22208561	SENT127	19	19	4	4	ethanol	HO-1	PA448073	3162	0.9
NULL	Clinics_(Sao_Paulo)_2011_Aug_66(8)_1313-1319.nxml.txt.nlp	21915477	SENT61	9	9	0	0	epirubicin	NACT	PA449476	284111	0.9
NULL	Mol_Cancer_2014_Jun_30_13_160.nxml.txt.nlp	24976026	SENT9	21	21	31	31	bortezomib	GADD153	PA10252	1649	0.9
NULL	Diabetes_Care_2010_Apr_12_33(4)_861-868.nxml.txt.nlp	20067962	SENT216	35	35	25	25	hyaluronan	TLR2	PA165958431	7097	0.9
NULL	Arthritis_Res_Ther_2009_Aug_28_11(4)_R131.nxml.txt.nlp	19715572	SENT16	0	0	5	5	rituximab	CD19	PA451261	930	0.9
NULL	Curr_Neuropharmacol_2013_Jul_11(4)_338-378.nxml.txt.nlp	24381528	SENT664	34	34	22	22	curcumin	ING4	PA151958596	51147	0.9
NULL	Int_J_Biomed_Sci_2007_Sep_3(3)_176-184.nxml.txt.nlp	23675041	SENT113	4	4	0	0	celecoxib	Bcl-2	PA448871	596	0.9
NULL	Indian_J_Pharm_Sci_2014_Jan-Feb_76(1)_72-77.nxml.txt.nlp	24799741	SENT83	38	38	4	4	glimepiride	CYP2C9	PA449761	1559	0.9
NULL	Int_J_Breast_Cancer_2011_Sep_6_2011_352182.nxml.txt.nlp	22295219	SENT268	0	0	13	13	pertuzumab	HER3		2065	0.9
NULL	Acta_Neuropathol_2014_Oct_24_127(2)_203-219.nxml.txt.nlp	24154962	SENT102	20	20	0	0	l-glutamine	U87	PA10090	677775;641648	0.9
NULL	Cancers_(Basel)_2011_May_3_3(2)_2255-2273.nxml.txt.nlp	24212808	SENT106	12	12	16	16	paclitaxel	HER-2	PA450761	2064	0.9
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S120-S127.nxml.txt.nlp	21525442	SENT149	39	39	10	10	acarbose	PPG	PA448010	5552	0.9
NULL	Neuropsychopharmacology_2009_Apr_2_34(5)_1135-1148.nxml.txt.nlp	18596687	SENT264	41	41	6	6	cocaine	CRF	PA449072	1392;10882	0.9
NULL	Mol_Cancer_2007_Aug_21_6_53.nxml.txt.nlp	17711579	SENT219	23	23	4	4	cisplatin	p53	PA449014	7157	0.9
NULL	Chin_J_Cancer_2012_Jun_31(6)_306-314.nxml.txt.nlp	22640627	SENT14	6	6	34	34	rituximab	Bcl-2	PA451261	596	0.9
NULL	Diabetes_Care_2010_Mar_10_33(3)_463-466.nxml.txt.nlp	20007938	SENT116	16	16	26	26	pravastatin	OATP1B1	PA451089	10599	0.9
NULL	Orphanet_J_Rare_Dis_2013_Apr_4_8_51.nxml.txt.nlp	23557332	SENT167	25	25	8	8	galsulfase	ARSB	PA164746235	411	0.9
NULL	F1000_Biol_Rep_2011_Nov_1_3_23.nxml.txt.nlp	22065982	SENT140	8	8	18	18	benzbromarone	URAT1	PA134852920	116085	0.9
NULL	Int_J_Crit_Illn_Inj_Sci_2013_Jan-Mar_3(1)_64-68.nxml.txt.nlp	23724388	SENT112	15	15	10	10	methylprednisolone	FES	PA450466	2242	0.9
NULL	Mol_Vis_2012_May_11_18_1260-1270.nxml.txt.nlp	22665973	SENT226	0	0	12	12	topotecan	HIF-1	PA451729	29072	0.9
NULL	Orphanet_J_Rare_Dis_2012_Apr_19_7_21.nxml.txt.nlp	22515166	SENT6	0	0	12	12	bezafibrate	COX	PA162364313	1351	0.9
NULL	Arthritis_Res_Ther_2009_Aug_24_11(4)_R127.nxml.txt.nlp	19703304	SENT59	21	21	7	7	adalimumab	OASIS	PA10004	90993	0.9
NULL	Nat_Genet_2011_Jan_12_43(1)_27-33.nxml.txt.nlp	21151129	SENT113	1	1	25	25	tamoxifen	FOXA1	PA451581	3169	0.9
NULL	Oncotarget_2013_Apr_8_4(4)_584-599.nxml.txt.nlp	23603840	SENT343	6	6	10	10	vemurafenib	BRAF	PA165946873	673	0.9
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT177	7	7	0	0	atorvastatin	TNF	PA448500	7124	0.9
NULL	J_Korean_Assoc_Oral_Maxillofac_Surg_2014_Dec_26_40(6)_291-296.nxml.txt.nlp	25551094	SENT36	30	30	19	19	alendronate	RANKL	PA448082	8600	0.9
NULL	Front_Pharmacol_2014_Mar_20_5_44.nxml.txt.nlp	24688470	SENT299	17	17	11	11	ethanol	5-HT1B	PA448073	3351	0.9
NULL	Hum_Genomics_2008_Sep_1_3(1)_7-16.nxml.txt.nlp	19129086	SENT192	25	25	19	19	rosiglitazone	SLCO1B1	PA451283	10599	0.9
NULL	Oncol_Lett_2014_May_27_7(5)_1327-1332.nxml.txt.nlp	24765133	SENT69	12	12	30	30	celecoxib	TRAIL	PA448871	8743	0.9
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT23	21	21	9	9	heparin	FGF1	PA449855	2246	0.9
NULL	J_Biomed_Biotechnol_2010_Jun_30_2010_485468.nxml.txt.nlp	20671927	SENT93	27	27	4	4	hyaluronidase	HAS3	PA164745713	3038	0.9
NULL	Int_J_Mol_Sci_2013_Apr_29_14(5)_9338-9364.nxml.txt.nlp	23629668	SENT66	12	12	32	32	bevacizumab	p53	PA130232992	7157	0.9
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT271	5	5	1	1	maraviroc	CCR5	PA164768835	1234	0.9
NULL	J_Vet_Med_Sci_2014_Jun_15_76(6)_813-817.nxml.txt.nlp	24531829	SENT96	7	7	18	18	primaquine	DPT	PA451103	1805	0.9
NULL	Cardiol_Res_Pract_2012_Jun_25_2012_789071.nxml.txt.nlp	22792506	SENT48	20	20	11	11	amiloride	NHE	PA448368	285335	0.9
NULL	Cancer_Cell_Int_2011_Aug_19_11_29.nxml.txt.nlp	21854619	SENT249	27	27	15	15	bleomycin	HDAC	PA448645	9734	0.9
NULL	Arthritis_Res_Ther_2013_May_29_15(3)_R64.nxml.txt.nlp	23718630	SENT181	19	19	0	0	canakinumab	S100A12	PA165958358	6283	0.9
NULL	Breast_Cancer_Res_2011_Mar_1_13(2)_R21.nxml.txt.nlp	21362200	SENT297	29	29	12	12	fulvestrant	PI3K	PA164747170	5290	0.9
NULL	Curr_Neuropharmacol_2009_Dec_7(4)_276-285.nxml.txt.nlp	20514207	SENT60	3	3	16	16	guanidine	GDI1	PA164781028	2664	0.9
NULL	Reprod_Biol_Endocrinol_2013_Feb_25_11_14.nxml.txt.nlp	23442383	SENT74	27	27	39	39	domperidone	DOM	PA134711056	6663	0.9
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_7-17.nxml.txt.nlp	17912633	SENT75	5	5	16	16	anastrozole	aromatase	PA448432	1588	0.9
NULL	J_Midlife_Health_2014_Oct-Dec_5(4)_168-175.nxml.txt.nlp	25540566	SENT304	0	0	26	26	finasteride	EDF	PA449627	3567	0.9
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT52	28	28	23	23	metformin	p53	PA450395	7157	0.9
NULL	Int_J_Mol_Sci_2014_Jun_26_15(7)_11416-11434.nxml.txt.nlp	24972137	SENT91	21	21	6	6	sitagliptin	AMPK	PA164748978	5563	0.9
NULL	Oncotarget_2013_Jul_21_4(8)_1266-1279.nxml.txt.nlp	23907540	SENT162	11	11	5	5	doxycycline	PTEN	PA449415	5728	0.9
NULL	J_Immunol_Res_2014_Apr_9_2014_657625.nxml.txt.nlp	24818168	SENT39	12	12	0	0	arsenite	HLA-G	PA452638	3135	0.9
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Sep_30_66(Pt_10)_o2696.nxml.txt.nlp	21587664	SENT56	24	24	18	18	ethanol	mol	PA448073	90527	0.9
NULL	Colomb_Med_(Cali)_43(4)_305-311.nxml.txt.nlp	24893304	SENT152	45	45	8	8	valganciclovir	CD4	PA10227	920	0.9
NULL	Biosci_Rep_2014_Jun_25_34(3)_e00115.nxml.txt.nlp	24877606	SENT157	15	15	8	8	lovastatin	Rho	PA450272	29984	0.9
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jul_16_67(Pt_8)_o2069.nxml.txt.nlp	22091093	SENT52	24	24	18	18	ethanol	mol	PA448073	90527	0.9
NULL	Br_J_Cancer_2011_Nov_22_105(11)_1635-1639.nxml.txt.nlp	22033275	SENT109	44	44	13	13	everolimus	VEGFR	PA164746311	3791	0.9
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Sep_26_65(Pt_10)_o2518.nxml.txt.nlp	21577965	SENT66	24	24	14	14	ethanol	mol	PA448073	90527	0.9
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT79	12	12	45	45	curcumin	TRAIL	PA151958596	8743	0.9
NULL	Arthritis_Res_Ther_2013_Oct_2_15(5)_R141.nxml.txt.nlp	24286116	SENT15	32	32	22	22	tocilizumab	IL-6	PA165292659	3569	0.9
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Dec_19_66(Pt_1)_o186.nxml.txt.nlp	21580070	SENT55	19	19	7	7	ethanol	mol	PA448073	90527	0.9
NULL	Case_Rep_Oncol_2010_Jul_31_3(2)_282-286.nxml.txt.nlp	21347194	SENT38	12	12	34	34	bevacizumab	KRAS	PA130232992	3845	0.9
NULL	Mol_Cancer_2010_Aug_16_9_217.nxml.txt.nlp	20712901	SENT33	12	12	16	16	curcumin	STAT3	PA151958596	6774	0.9
NULL	Diabetes_2009_Jan_58(1)_174-184.nxml.txt.nlp	18984736	SENT12	17	17	9	9	diazoxide	TRPV2	PA449285	51393	0.9
NULL	Mol_Cancer_2014_Jun_24_13_157.nxml.txt.nlp	24958351	SENT23	9	9	20	20	trastuzumab	HER2	PA451743	2064	0.9
NULL	Cancers_(Basel)_2013_May_27_5(2)_617-638.nxml.txt.nlp	24216994	SENT143	16	16	7	7	curcumin	PC3	PA151958596	57332;7832;5122	0.9
NULL	EMBO_Mol_Med_2012_Mar_4(3)_218-233.nxml.txt.nlp	22294553	SENT276	36	36	8	8	tamoxifen	EGFR	PA451581	1956	0.9
NULL	Nat_Commun_2011_Dec_20_2_592.nxml.txt.nlp	22186888	SENT35	14	14	12	12	amisulpride	DRD2	PA162565877	1813	0.9
NULL	Cancer_Cell_Int_2005_Aug_24_5_28.nxml.txt.nlp	16120219	SENT156	3	3	12	12	etoposide	p53	PA449552	7157	0.9
NULL	Adv_Hematol_2012_Aug_2_2012_842945.nxml.txt.nlp	22919394	SENT15	5	5	14	14	thalidomide	2-21	PA451644	54097	0.9
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_3_2012_908562.nxml.txt.nlp	23082087	SENT183	12	12	6	6	hesperidin	IFN	PA449867	3439	0.9
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT347	27	27	21	21	pp2	PP1		5540;5464	0.9
NULL	Adolesc_Health_Med_Ther_2014_Mar_26_5_35-48.nxml.txt.nlp	24729739	SENT35	20	20	29	29	anakinra	TNF-alpha	PA10799	7124	0.9
NULL	Curr_Heart_Fail_Rep_2014_Sep_5_11(4)_436-444.nxml.txt.nlp	25189801	SENT231	5	5	2	2	sildenafil	PDE5A	PA451346	8654	0.9
NULL	Front_Behav_Neurosci_2014_Oct_30_8_366.nxml.txt.nlp	25400560	SENT100	29	29	2	2	ethanol	GLAST	PA448073	6507	0.9
NULL	J_Oncol_2012_Dec_7_2012_192464.nxml.txt.nlp	22187555	SENT64	5	5	8	8	genistein	EGF	PA165109660	1950	0.9
NULL	Cancer_Immunol_Immunother_2011_Jan_21_60(1)_75-85.nxml.txt.nlp	20857100	SENT162	23	23	30	30	fludarabine	TH1	PA449655	51497	0.9
NULL	Cancer_Inform_2014_Jan_21_13_21-45.nxml.txt.nlp	24526833	SENT97	35	35	14	14	phenol	CO2	PA450913	4513	0.9
NULL	Cardiovasc_Diabetol_2013_Mar_4_12_42.nxml.txt.nlp	23452502	SENT99	24	24	0	0	sevoflurane	PI3K	PA451341	5290	0.9
NULL	Eur_J_Clin_Pharmacol_2012_Jan_8_68(1)_29-37.nxml.txt.nlp	21739267	SENT187	12	12	4	4	fluoxetine	CYP1A2	PA449673	1544	0.9
NULL	Drugs_R_D_2010_Nov_25_10(4)_219-224.nxml.txt.nlp	21171668	SENT21	19	19	32	32	clopidogrel	DES	PA449053	1674	0.9
NULL	J_Biol_Chem_2013_Nov_15_288(46)_33049-33059.nxml.txt.nlp	24089524	SENT24	4	4	11	11	nicotine	GATA6	PA450626	2627	0.9
NULL	Br_J_Clin_Pharmacol_2013_Aug_23_76(2)_299-315.nxml.txt.nlp	23701319	SENT245	15	15	23	23	alemtuzumab	IFN	PA164783958	3439	0.9
NULL	Ann_Oncol_2012_Dec_2_23(12)_3007-3016.nxml.txt.nlp	22865781	SENT170	41	41	4	4	trastuzumab	IGF1R	PA451743	3480	0.9
NULL	Nucleic_Acids_Res_2011_Dec_31_39(22)_9536-9548.nxml.txt.nlp	21880590	SENT228	11	11	27	27	etoposide	BRCA1	PA449552	672	0.9
NULL	Breast_Cancer_Res_2011_Jan_11_13(1)_R3.nxml.txt.nlp	21223569	SENT154	14	14	6	6	etoposide	p53	PA449552	7157	0.9
NULL	Br_J_Cancer_2010_Oct_26_103(9)_1380-1390.nxml.txt.nlp	20877355	SENT180	10	10	3	3	etoposide	FasL	PA449552	356	0.9
NULL	Front_Genet_2012_Nov_5_3_236.nxml.txt.nlp	23133441	SENT59	11	11	1	1	efavirenz	ABCB1	PA449441	5243	0.9
NULL	Breast_Cancer_Res_Treat_2014_Nov_24_143(1)_125-133.nxml.txt.nlp	24272078	SENT189	8	8	15	15	fulvestrant	aromatase	PA164747170	1588	0.9
NULL	ScientificWorldJournal_2012_Feb_1_2012_395741.nxml.txt.nlp	22448131	SENT148	8	8	28	28	protamine	GLUL	PA10366	2752	0.9
NULL	Front_Oncol_2013_Sep_23_3_250.nxml.txt.nlp	24069582	SENT11	21	21	27	27	raloxifene	aromatase	PA451221	1588	0.9
NULL	Diabetes_Care_2009_Apr_8_32(4)_720-725.nxml.txt.nlp	19131464	SENT74	26	26	10	10	metformin	ACR	PA450395	49	0.9
NULL	Acta_Pharmacol_Sin_2014_Sep_25_35(9)_1199-1206.nxml.txt.nlp	25152024	SENT94	27	27	12	12	cisplatin	mig-2	PA449014	10979	0.9
NULL	Biomed_Res_Int_2013_Aug_6_2013_602987.nxml.txt.nlp	24027759	SENT264	20	20	22	22	cisplatin	SMF	PA449014	22993	0.9
NULL	J_Cell_Biol_1975_Dec_1_67(3)_715-724.nxml.txt.nlp	1202020	SENT5	6	6	33	33	glucosamine	mol	PA164747613	90527	0.9
NULL	Curr_Neuropharmacol_2014_Jul_12(4)_365-379.nxml.txt.nlp	25342944	SENT375	6	6	24	24	fluoxetine	TRPC1	PA449673	7220	0.9
NULL	Chonnam_Med_J_2014_Apr_22_50(1)_27-30.nxml.txt.nlp	24855605	SENT48	10	10	6	6	doxorubicin	CHOP	PA449412	1649	0.9
NULL	Ann_Oncol_2011_Dec_17_22(12)_2610-2615.nxml.txt.nlp	21415234	SENT46	2	2	9	9	lapatinib	EGFR	PA152241907	1956	0.9
NULL	Nucleic_Acids_Res_2013_May_5_41(10)_5210-5222.nxml.txt.nlp	23563151	SENT11	4	4	15	15	arsenite	GADD45	PA452638	1647	0.9
NULL	CNS_Neurosci_Ther_2009_Spring_15(1)_32-51.nxml.txt.nlp	19228178	SENT66	0	0	10	10	prazosin	MT3	PA451093	4504	0.9
NULL	Arthritis_Res_Ther_2010_Jan_29_12(1)_R18.nxml.txt.nlp	20113495	SENT158	2	2	7	7	glucosamine	NAPA	PA164747613	9476;8775	0.9
NULL	Oncol_Lett_2013_Oct_24_6(4)_970-976.nxml.txt.nlp	24137447	SENT3	10	10	26	26	tamoxifen	ADM	PA451581	133	0.9
NULL	Case_Rep_Med_2013_Aug_4_2013_373981.nxml.txt.nlp	23983708	SENT11	7	7	19	19	imatinib	KIT	PA10804	3815	0.9
NULL	Cancer_Med_2014_Aug_6_3(4)_988-997.nxml.txt.nlp	24905030	SENT209	22	22	44	44	irinotecan	KRAS	PA450085	3845	0.9
NULL	Scientifica_(Cairo)_2012_Oct_9_2012_821549.nxml.txt.nlp	24278743	SENT338	13	13	22	22	clozapine	5-HT2A	PA449061	3356	0.9
NULL	Breast_Cancer_Res_2009_Sep_29_11(5)_209.nxml.txt.nlp	19818165	SENT164	9	9	24	24	tamoxifen	aromatase	PA451581	1588	0.9
NULL	Curr_Neuropharmacol_2010_Jun_8(2)_84-91.nxml.txt.nlp	21119878	SENT141	8	8	0	0	mannitol	AQP9	PA450320	366;364	0.9
NULL	Int_J_Mol_Sci_2014_Mar_18_15(3)_4747-4779.nxml.txt.nlp	24646914	SENT43	16	16	10	10	ribavirin	IFN	PA451241	3439	0.9
NULL	Ann_Hematol_2014_Apr_1_93(8)_1371-1380.nxml.txt.nlp	24687382	SENT2	24	24	2	2	lenalidomide	CRBN	PA162363968	51185	0.9
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Oct_31_65(Pt_11)_o2959.nxml.txt.nlp	21578530	SENT47	20	20	14	14	ethanol	mol	PA448073	90527	0.9
NULL	F1000Res_2013_Feb_28_2_65.nxml.txt.nlp	24358861	SENT396	3	3	22	22	naloxone	hole	PA450586	80757	0.899
NULL	J_Biol_Chem_2012_Apr_20_287(17)_13868-13876.nxml.txt.nlp	22389490	SENT107	30	30	8	8	capsaicin	TRPV1	PA448776	7442	0.899
NULL	Br_J_Pharmacol_2014_Jan_23_171(2)_523-535.nxml.txt.nlp	24372553	SENT209	7	7	43	43	metformin	SIRT1	PA450395	23411	0.899
NULL	Cardiovasc_Diabetol_2008_Dec_23_7_36.nxml.txt.nlp	19108709	SENT10	16	16	7	7	eptifibatide	JNK1	PA449483	5599	0.899
NULL	Drugs_R_D_2014_Sep_28_14(3)_159-164.nxml.txt.nlp	24973042	SENT32	23	23	14	14	rosiglitazone	CYP3A4	PA451283	1576	0.899
NULL	Breast_Cancer_(Auckl)_2008_Mar_26_1_25-34.nxml.txt.nlp	21655370	SENT32	11	11	1	1	ethanol	GIRK1	PA448073	3760	0.899
NULL	Br_J_Cancer_2012_Aug_21_107(5)_793-799.nxml.txt.nlp	22850551	SENT104	31	31	26	26	gefitinib	EGFR	PA131301952	1956	0.899
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT164	26	26	8	8	erlotinib	PTEN	PA134687924	5728	0.899
NULL	Ann_Coloproctol_2014_Aug_26_30(4)_165-174.nxml.txt.nlp	25210685	SENT142	20	20	33	33	capecitabine	KRAS	PA448771	3845	0.899
NULL	Pharmaceuticals_(Basel)_2011_Jun_30_4(7)_976-991.nxml.txt.nlp	NULL	SENT673	12	12	4	4	methamphetamine	gamma	PA450403	9913	0.899
NULL	Aging_(Albany_NY)_2013_Jun_23_5(7)_515-530.nxml.txt.nlp	24018842	SENT198	10	10	14	14	cilostazol	AMPK	PA164746334	5563	0.899
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT115	10	10	31	31	neratinib	HER2	PA165291472	2064	0.899
NULL	Biol_Open_2014_Nov_21_3(12)_1207-1216.nxml.txt.nlp	25416063	SENT234	16	16	4	4	fluorescein	NANOS2	PA164746009	339345	0.899
NULL	Front_Microbiol_2013_Aug_19_4_241.nxml.txt.nlp	23966991	SENT1150	14	14	4	4	ceftriaxone	xCT	PA448866	23657	0.899
NULL	Oncoimmunology_2013_Dec_1_2(12)_e26663.nxml.txt.nlp	24498552	SENT31	23	23	12	12	melphalan	MICA	PA450354	100507436	0.899
NULL	Clin_Infect_Dis_2013_Aug_15_57(Suppl_2)_S39-S45.nxml.txt.nlp	23884064	SENT102	23	23	33	33	ribavirin	OST	PA451241	1650;23263	0.899
NULL	Biologics_2009_Jul_13_3_215-224.nxml.txt.nlp	19707410	SENT41	8	8	4	4	cetuximab	EGFR	PA10040	1956	0.899
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1717-1723.nxml.txt.nlp	19844230	SENT131	1	1	14	14	sorafenib	GM-CSF	PA7000	1437	0.899
NULL	Br_J_Pharmacol_2011_Nov_164(5)_1522-1533.nxml.txt.nlp	21557728	SENT135	10	10	26	26	suramin	ADP	PA10292	23038	0.899
NULL	Arthritis_Res_Ther_2006_Apr_12_8(Suppl_1)_S3.nxml.txt.nlp	16820042	SENT21	36	36	25	25	colchicine	NALP3	PA449092	114548	0.899
NULL	Cancer_Immunol_Immunother_2015_Oct_7_64_61-73.nxml.txt.nlp	25287778	SENT137	2	2	8	8	lenalidomide	CD25	PA162363968	3669;3559	0.899
NULL	Breast_Cancer_Res_2007_Feb_6_9(1)_R17.nxml.txt.nlp	17280616	SENT4	16	16	18	18	tamoxifen	aromatase	PA451581	1588	0.899
NULL	Hum_Genomics_Proteomics_2010_Aug_3_2010_159761.nxml.txt.nlp	20981231	SENT276	26	26	20	20	lithium	DRD1	PA450243	1812	0.899
NULL	EMBO_Mol_Med_2014_Oct_17_6(10)_1294-1311.nxml.txt.nlp	25231413	SENT146	29	29	23	23	calcein	CD4	PA132595336	920	0.899
NULL	Br_J_Cancer_2014_Mar_4_110(5)_1221-1227.nxml.txt.nlp	24496456	SENT146	24	24	20	20	panitumumab	KRAS	PA162373091	3845	0.899
NULL	Diabetes_2013_Nov_18_62(11)_3958-3959.nxml.txt.nlp	NULL	SENT60	18	18	22	22	amlexanox	TBK1	PA164745310	29110	0.899
NULL	Arthritis_Res_Ther_2014_Jan_13_16(1)_R8.nxml.txt.nlp	24410838	SENT195	16	16	1	1	thrombin	gamma	PA451674	9913	0.899
NULL	Clin_Transl_Allergy_2013_Sep_2_3_29.nxml.txt.nlp	24004581	SENT133	23	23	12	12	omalizumab	IL-4	PA164752253	3565	0.899
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT239	4	4	45	45	perifosine	DR4	PA165291471	8797	0.899
NULL	Anticancer_Agents_Med_Chem_2012_Feb_12(2)_163-171.nxml.txt.nlp	22043994	SENT190	20	20	11	11	cetuximab	BRAF	PA10040	673	0.899
NULL	Blood_Cancer_J_2013_Dec_6_3(12)_e167.nxml.txt.nlp	24317089	SENT146	26	26	10	10	lovastatin	GADD153	PA450272	1649	0.899
NULL	Mol_Cancer_2008_Jun_5_7_50.nxml.txt.nlp	18534018	SENT127	8	8	18	18	bortezomib	p53	PA10252	7157	0.899
NULL	J_Clin_Biochem_Nutr_2007_Nov_30_41(3)_202-210.nxml.txt.nlp	18299717	SENT104	26	26	22	22	indomethacin	GADD45	PA449982	1647	0.899
NULL	Mediators_Inflamm_2011_Jun_7_2011_432080.nxml.txt.nlp	21772662	SENT148	7	7	19	19	rivaroxaban	IL-6	PA165958360	3569	0.899
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT140	15	15	33	33	perifosine	DR5	PA165291471	8795	0.899
NULL	Autophagy_2013_Jan_1_9(1)_20-32.nxml.txt.nlp	23075929	SENT156	19	19	10	10	chloroquine	ATG5	PA448948	9474	0.899
NULL	Curr_Hematol_Malig_Rep_2014_Feb_6_9(1)_9-16.nxml.txt.nlp	24500518	SENT105	22	22	9	9	imatinib	CD34	PA10804	947	0.899
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT15	5	5	11	11	methotrexate	RANKL	PA450428	8600	0.899
NULL	Oncotarget_2013_Apr_16_4(5)_677-690.nxml.txt.nlp	23633472	SENT130	4	4	16	16	doxorubicin	P-gp	PA449412	5243	0.899
NULL	Mol_Cancer_2010_Nov_25_9_305.nxml.txt.nlp	21108789	SENT82	17	17	8	8	temozolomide	PTEN	PA451609	5728	0.899
NULL	Drugs_R_D_2012_Jun_18_12(2)_71-100.nxml.txt.nlp	22715866	SENT130	33	33	11	11	moxifloxacin	SOC	PA450555	91544	0.899
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1046.nxml.txt.nlp	24503538	SENT43	17	17	11	11	oxaliplatin	FGFR4	PA131285527	2264	0.899
NULL	Oncotarget_2013_Nov_22_5(4)_933-943.nxml.txt.nlp	24659749	SENT47	14	14	3	3	nutlin-3	AML2		864	0.899
NULL	Ann_Rheum_Dis_2010_Jan_17_69(1)_88-96.nxml.txt.nlp	19297346	SENT203	11	11	7	7	tocilizumab	IL-6	PA165292659	3569	0.899
NULL	Br_J_Cancer_2010_Feb_2_102(3)_513-519.nxml.txt.nlp	20051960	SENT105	9	9	25	25	trastuzumab	MUC4	PA451743	4585	0.899
NULL	Oncotarget_2013_Apr_13_4(4)_502-530.nxml.txt.nlp	23594434	SENT511	7	7	25	25	disulfiram	IL-18	PA449376	3606	0.899
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Feb_21_65(Pt_3)_o580.nxml.txt.nlp	21582235	SENT51	4	4	34	34	norfloxacin	Ray	PA450654	26751	0.899
NULL	Case_Rep_Med_2012_Feb_16_2012_212381.nxml.txt.nlp	22431927	SENT11	0	0	11	11	tocilizumab	IL-6	PA165292659	3569	0.899
NULL	Biologics_2012_Feb_1_6_31-35.nxml.txt.nlp	22355257	SENT3	11	11	27	27	rituximab	IL-6	PA451261	3569	0.899
NULL	Breast_Cancer_Res_2011_Feb_23_13(1)_203.nxml.txt.nlp	21392408	SENT70	29	29	19	19	tamoxifen	aromatase	PA451581	1588	0.899
NULL	Br_J_Cancer_2013_Jun_25_108(12)_2464-2469.nxml.txt.nlp	23695016	SENT151	27	27	17	17	cisplatin	CRT	PA449014	811	0.899
NULL	Cells_2014_Apr_29_3(2)_331-362.nxml.txt.nlp	24785347	SENT316	21	21	6	6	capsaicin	TRPV1	PA448776	7442	0.899
NULL	Mol_Cancer_2014_Jan_13_13_7.nxml.txt.nlp	24418169	SENT11	2	2	25	25	sorafenib	survivin	PA7000	332	0.899
NULL	Breast_Cancer_Res_2010_Jul_26_12(4)_R55.nxml.txt.nlp	20659323	SENT167	19	19	29	29	doxycycline	BCL2	PA449415	596	0.899
NULL	J_Cell_Mol_Med_2014_Apr_20_18(4)_709-720.nxml.txt.nlp	24444314	SENT36	24	24	7	7	losartan	AMPK	PA450268	5563	0.899
NULL	Br_J_Cancer_2012_Nov_6_107(10)_1714-1721.nxml.txt.nlp	23073173	SENT154	27	27	5	5	bicalutamide	RUNX2	PA164746255	860	0.899
NULL	Br_J_Cancer_2010_May_11_102(10)_1456-1460.nxml.txt.nlp	20461090	SENT105	19	19	22	22	temsirolimus	IFN	PA164746890	3439	0.899
NULL	Clin_Ophthalmol_2010_Apr_26_4_349-358.nxml.txt.nlp	20463804	SENT45	15	15	33	33	latanoprost	C-1	PA164774763	5203	0.899
NULL	Int_J_Mol_Sci_2013_Apr_25_14(5)_9099-9110.nxml.txt.nlp	23698766	SENT140	9	9	5	5	bleomycin	MALAT1	PA448645	378938	0.899
NULL	Biomed_Res_Int_2014_May_13_2014_872139.nxml.txt.nlp	24963489	SENT67	14	14	10	10	paclitaxel	IL-6	PA450761	3569	0.899
NULL	eLife_2013_Nov_19_2_e01157.nxml.txt.nlp	24252875	SENT300	8	8	44	44	zolpidem	PPN	PA451976	64840	0.899
NULL	J_Cell_Biol_2001_May_14_153(4)_785-794.nxml.txt.nlp	11352939	SENT40	28	28	17	17	tetracycline	EPM	PA451640	2054	0.899
NULL	Oxid_Med_Cell_Longev_2013_Nov_10_2013_680414.nxml.txt.nlp	24319532	SENT132	9	9	3	3	minocycline	PARP-1	PA450519	25976	0.899
NULL	Leukemia_2014_May_29_28(5)_1081-1091.nxml.txt.nlp	24166297	SENT255	21	21	11	11	doxycycline	THP1	PA449415	2736	0.899
NULL	Cell_Death_Dis_2014_Jan_30_5(1)_e1038.nxml.txt.nlp	24481452	SENT230	12	12	10	10	raloxifene	NQO1	PA451221	1728	0.899
NULL	Allergy_Asthma_Immunol_Res_2010_Jul_17_2(3)_188-194.nxml.txt.nlp	20592918	SENT68	14	14	9	9	methacholine	IL-13	PA165958382	3596	0.899
NULL	Drug_Healthc_Patient_Saf_2014_Jun_24_6_77-88.nxml.txt.nlp	25018652	SENT112	28	28	36	36	vemurafenib	BRAF	PA165946873	673	0.899
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Aug_20_64(Pt_9)_o1793.nxml.txt.nlp	21201772	SENT56	21	21	8	8	ethanol	mol	PA448073	90527	0.899
NULL	Cancers_(Basel)_2010_Mar_26_2(2)_274-304.nxml.txt.nlp	24281071	SENT1599	6	6	15	15	cisplatin	Bcl-2	PA449014	596	0.899
NULL	J_Cell_Mol_Med_2014_Dec_7_18(12)_2536-2552.nxml.txt.nlp	25287328	SENT172	20	20	12	12	estradiol	PKD1	PA449503	5310	0.899
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jul_17_66(Pt_8)_o2061.nxml.txt.nlp	21588365	SENT47	19	19	13	13	ethanol	mol	PA448073	90527	0.899
NULL	Clin_Pediatr_Endocrinol_2013_Jan_7_22(1)_1-8.nxml.txt.nlp	23966754	SENT66	12	12	4	4	metformin	GLP-1	PA450395	100125288	0.899
NULL	Braz_J_Med_Biol_Res_2012_Jul_27_45(10)_948-954.nxml.txt.nlp	22832600	SENT155	7	7	2	2	tegaserod	5-HT4	PA130413154	3360	0.899
NULL	Target_Oncol_2013_Mar_30_8(1)_27-33.nxml.txt.nlp	23361373	SENT176	8	8	20	20	gefitinib	EGFR	PA131301952	1956	0.899
NULL	Mol_Cancer_2013_Sep_27_12_111.nxml.txt.nlp	24070020	SENT193	41	41	22	22	bezafibrate	FAF	PA162364313	8239;2188	0.899
NULL	Mol_Cells_2014_Dec_31_37(12)_899a-906.nxml.txt.nlp	25431425	SENT204	12	12	7	7	curcumin	EP2	PA151958596	5732;10407	0.899
NULL	Diabetes_2009_Dec_31_58(12)_2851-2862.nxml.txt.nlp	19720788	SENT178	4	4	0	0	forskolin	BiP	PA146096022	3309	0.899
NULL	J_Med_Case_Reports_2011_Oct_10_5_513.nxml.txt.nlp	21985665	SENT31	13	13	32	32	letrozole	aromatase	PA450196	1588	0.899
NULL	J_Gen_Physiol_2013_Aug_142(2)_137-155.nxml.txt.nlp	23858003	SENT439	14	14	23	23	forskolin	TREK-1	PA146096022	3776	0.899
NULL	Tumour_Biol_2012_Jun_21_33(3)_607-615.nxml.txt.nlp	22270450	SENT41	20	20	16	16	afatinib	EGFR	PA165981154	1956	0.899
NULL	Breast_Cancer_Res_2011_Mar_1_13(2)_R21.nxml.txt.nlp	21362200	SENT21	10	10	1	1	fulvestrant	PIK3CA	PA164747170	5290	0.899
NULL	Front_Oncol_2013_Aug_28_3_219.nxml.txt.nlp	24010120	SENT11	12	12	24	24	cetuximab	EGFR	PA10040	1956	0.899
NULL	Oncotarget_2014_Jun_8_5(13)_5040-5053.nxml.txt.nlp	24970815	SENT101	13	13	5	5	cisplatin	PI3K	PA449014	5290	0.899
NULL	Anat_Res_Int_2012_Feb_26_2012_953264.nxml.txt.nlp	22567318	SENT23	10	10	1	1	galactose	EPO	PA449725	7076;8288;2056	0.899
NULL	J_Skin_Cancer_2014_Jul_21_2014_284582.nxml.txt.nlp	25136458	SENT87	24	24	12	12	paclitaxel	CRT	PA450761	811	0.899
NULL	Trials_2013_Aug_19_14_261.nxml.txt.nlp	23958221	SENT156	22	22	0	0	pertuzumab	HER2		2064	0.899
NULL	Nucleic_Acids_Res_2012_Jul_30_40(13)_6319-6337.nxml.txt.nlp	22467215	SENT274	17	17	7	7	cisplatin	Bcl-2	PA449014	596	0.899
NULL	Mol_Cancer_2009_Dec_23_8_129.nxml.txt.nlp	20030852	SENT95	28	28	17	17	curcumin	ABCA1	PA151958596	19	0.899
NULL	Breast_Cancer_Res_2012_Aug_8_14(4)_R116.nxml.txt.nlp	22873525	SENT172	8	8	15	15	trastuzumab	gamma	PA451743	9913	0.899
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_127043.nxml.txt.nlp	23227093	SENT181	19	19	14	14	nifedipine	CYP3A4	PA450631	1576	0.899
NULL	Acta_Pharmacol_Sin_2010_Dec_3_31(12)_1635-1642.nxml.txt.nlp	21127497	SENT159	0	0	25	25	phenylbutazone	UGT	PA450932	7361;7355	0.899
NULL	J_Invest_Dermatol_2012_Oct_24_132(10)_2440-2450.nxml.txt.nlp	22622430	SENT78	24	24	45	45	paclitaxel	IL-8	PA450761	3576	0.899
NULL	Ann_Rheum_Dis_2013_Aug_21_72(8)_1287-1294.nxml.txt.nlp	22915624	SENT226	17	17	28	28	adalimumab	MRI	PA10004	78996	0.899
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT205	8	8	17	17	atorvastatin	RANKL	PA448500	8600	0.899
NULL	Nat_Commun_2013_Oct_25_4_2667.nxml.txt.nlp	24157709	SENT313	30	30	39	39	cisplatin	ETO	PA449014	862	0.899
NULL	Oncogene_2014_Oct_23_33(43)_5109-5120.nxml.txt.nlp	24858043	SENT79	3	3	22	22	pp2	RhoA		387	0.899
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_May_22_66(Pt_6)_o1429.nxml.txt.nlp	21579505	SENT57	20	20	14	14	ethanol	mol	PA448073	90527	0.899
NULL	Oncotarget_2014_Aug_4_5(17)_7776-7787.nxml.txt.nlp	25277200	SENT142	12	12	7	7	carboplatin	ANXA4	PA448803	307	0.899
NULL	Aging_(Albany_NY)_2009_Jun_3_1(6)_515-528.nxml.txt.nlp	20157535	SENT67	32	32	5	5	resveratrol	SIRT1		23411	0.899
NULL	Cancers_(Basel)_2014_Jan_27_6(1)_240-296.nxml.txt.nlp	24473089	SENT2704	22	22	12	12	atorvastatin	NF-kappaB	PA448500	4790	0.899
NULL	Arthritis_Res_Ther_2011_May_25_13(Suppl_1)_S5.nxml.txt.nlp	21624184	SENT238	14	14	9	9	tocilizumab	IL-6	PA165292659	3569	0.899
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1059-1066.nxml.txt.nlp	21364577	SENT51	25	25	19	19	anastrozole	aromatase	PA448432	1588	0.899
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Apr_18_68(Pt_5)_o1402.nxml.txt.nlp	22590290	SENT73	8	8	23	23	ethanol	mol	PA448073	90527	0.899
NULL	Acta_Neuropathol_Commun_2014_Jul_22_2(1)_84.nxml.txt.nlp	NULL	SENT198	5	5	16	16	lenalidomide	IL-6	PA162363968	3569	0.899
NULL	Mol_Cell_Biol_2013_Oct_33(20)_4041-4050.nxml.txt.nlp	23959798	SENT527	11	11	4	4	hydroxyurea	SOD1	PA449942	6647	0.899
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jul_31_66(Pt_8)_o2157.nxml.txt.nlp	21588441	SENT47	24	24	18	18	ethanol	mol	PA448073	90527	0.899
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_105-115.nxml.txt.nlp	17912640	SENT119	17	17	9	9	trastuzumab	HER2	PA451743	2064	0.899
NULL	Clin_Psychopharmacol_Neurosci_2012_Apr_30_10(1)_25-33.nxml.txt.nlp	23429852	SENT98	22	22	41	41	haloperidol	SNAP-25	PA449841	6616	0.899
NULL	J_Cell_Biol_1998_Aug_10_142(3)_625-633.nxml.txt.nlp	9700154	SENT233	16	16	0	0	estradiol	Raf-1	PA449503	5894	0.899
NULL	J_Hematol_Oncol_2010_Nov_26_3_47.nxml.txt.nlp	21108851	SENT192	10	10	13	13	nilotinib	UGT1A1	PA165958345	54658	0.899
NULL	Virol_J_2010_Oct_27_7_285.nxml.txt.nlp	20979618	SENT57	20	20	5	5	ethanol	c-fos	PA448073	2353	0.899
NULL	Neural_Regen_Res_2014_May_15_9(10)_1055-1062.nxml.txt.nlp	25206759	SENT218	25	25	21	21	furosemide	NKCC1	PA449719	6558	0.899
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT83	28	28	21	21	atorvastatin	IL-6	PA448500	3569	0.899
NULL	J_Int_Soc_Prev_Community_Dent_2014_Dec_4(Suppl_3)_S147-S152.nxml.txt.nlp	25625071	SENT116	10	10	8	8	desmopressin	VIII	PA449237	1351	0.899
NULL	Chin_J_Cancer_2011_May_30(5)_293-302.nxml.txt.nlp	21527062	SENT148	21	21	11	11	trastuzumab	HER2	PA451743	2064	0.899
NULL	eLife_2014_Apr_30_3_e02445.nxml.txt.nlp	24843000	SENT236	7	7	11	11	mimosine	BRCA2	PA164752445	675	0.899
NULL	Br_J_Cancer_2010_Sep_7_103(6)_889-898.nxml.txt.nlp	20664599	SENT12	10	10	5	5	paclitaxel	HER-2	PA450761	2064	0.899
NULL	Lancet_2011_Jun_18_377(9783)_2103-2114.nxml.txt.nlp	21641636	SENT4	22	22	17	17	cetuximab	EGFR	PA10040	1956	0.899
NULL	Ethn_Health_2011_Aug_28_16(4-5)_343-359.nxml.txt.nlp	21797722	SENT27	39	39	3	3	hydroxyurea	SCD	PA449942	6319;6584	0.899
NULL	J_Med_Case_Reports_2011_Aug_3_5_345.nxml.txt.nlp	21812958	SENT49	11	11	25	25	temsirolimus	IL-2	PA164746890	3558	0.899
NULL	Acta_Neuropathol_Commun_2014_Oct_21_2(1)_149.nxml.txt.nlp	NULL	SENT345	3	3	20	20	riluzole	gamma	PA451251	9913	0.899
NULL	Indian_J_Anaesth_2011_Mar-Apr_55(2)_104-110.nxml.txt.nlp	21712863	SENT97	15	15	9	9	theophylline	CYP1A2	PA451647	1544	0.899
NULL	Cardiol_Res_Pract_2014_Nov_20_2014_784018.nxml.txt.nlp	25506463	SENT146	1	1	17	17	bivalirudin	ACT	PA10032	12;11332;9457;641455	0.899
NULL	Oncol_Lett_2014_Jun_20_7(6)_1997-2002.nxml.txt.nlp	24932278	SENT121	0	0	18	18	denosumab	RANKL	PA166048634	8600	0.899
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2013_Dec_8_6_75-79.nxml.txt.nlp	24348081	SENT66	14	14	3	3	colesevelam	GLP-1	PA449095	100125288	0.899
NULL	Evid_Based_Complement_Alternat_Med_2013_Aug_22_2013_423164.nxml.txt.nlp	24027594	SENT164	26	26	22	22	berberine	AP-1	PA165860812	2353;3727;2354;3725	0.899
NULL	Orphanet_J_Rare_Dis_2014_Dec_10_9(1)_180.nxml.txt.nlp	NULL	SENT217	14	14	9	9	glucosamine	HGSNAT	PA164747613	138050	0.899
NULL	J_Cardiothorac_Surg_2012_Nov_15_7_123.nxml.txt.nlp	23151309	SENT47	3	3	10	10	heparin	ACT	PA449855	12;11332;9457;641455	0.899
NULL	Clin_Pharmacokinet_2014_Oct_15_53(2)_155-164.nxml.txt.nlp	24127209	SENT29	6	6	22	22	clopidogrel	CYP2C9	PA449053	1559	0.899
NULL	Eur_J_Clin_Pharmacol_2013_Mar_11_69(3)_327-339.nxml.txt.nlp	22782539	SENT33	0	0	4	4	clopidogrel	ADP	PA449053	23038	0.899
NULL	Breast_Cancer_Res_2012_Jul_20_14(4)_R110.nxml.txt.nlp	22817698	SENT19	6	6	15	15	cisplatin	BRCA1	PA449014	672	0.899
NULL	J_Cell_Biol_1997_Jun_30_137(7)_1639-1649.nxml.txt.nlp	9199177	SENT160	9	9	21	21	paraformaldehyde	ZAP-70	PA450790	7535	0.899
NULL	Evid_Based_Complement_Alternat_Med_2014_May_21_2014_375986.nxml.txt.nlp	24963322	SENT165	21	21	4	4	fosinopril	VEGF-A	PA449710	7422	0.899
NULL	Hum_Mol_Genet_2013_Nov_15_22(22)_4602-4615.nxml.txt.nlp	23814040	SENT143	28	28	2	2	l-cysteine	TRMU	PA449173	55687	0.899
NULL	Oncogene_2013_Sep_12_32(37)_4355-4365.nxml.txt.nlp	23108409	SENT29	4	4	21	21	hyaluronan	p38	PA165958431	10598;1432;7965	0.899
NULL	Oncol_Lett_2014_Jun_20_7(6)_1997-2002.nxml.txt.nlp	24932278	SENT33	0	0	21	21	denosumab	RANKL	PA166048634	8600	0.899
NULL	Cancer_Manag_Res_2014_Oct_6_6_389-395.nxml.txt.nlp	25336989	SENT44	31	31	19	19	letrozole	HER2	PA450196	2064	0.899
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT115	13	13	36	36	simvastatin	XIAP	PA451363	331	0.899
NULL	Front_Oncol_2014_May_15_4_112.nxml.txt.nlp	24860788	SENT56	24	24	13	13	imatinib	CD49e	PA10804	3678	0.899
NULL	Surg_Res_Pract_2014_Feb_6_2014_801643.nxml.txt.nlp	25379560	SENT13	15	15	9	9	cyclosporine	CD95	PA449167	355	0.899
NULL	Breast_Cancer_Res_2009_Jun_29_11(3)_R41.nxml.txt.nlp	19563669	SENT184	19	19	11	11	trastuzumab	XIAP	PA451743	331	0.899
NULL	Int_J_Med_Sci_2014_Jan_11_11(3)_240-245.nxml.txt.nlp	24516346	SENT63	31	31	7	7	ethanol	IVD	PA448073	3712	0.899
NULL	Mol_Cancer_2012_Mar_21_11_13.nxml.txt.nlp	22436134	SENT12	16	16	7	7	doxorubicin	HuR	PA449412	1994	0.899
NULL	Neural_Plast_2007_Apr_15_2007_78970.nxml.txt.nlp	18060012	SENT173	7	7	32	32	metyrapone	spatial	PA450486	219793	0.899
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_May_22_66(Pt_6)_o1412.nxml.txt.nlp	21579491	SENT53	25	25	12	12	ethanol	mol	PA448073	90527	0.899
NULL	Oncoimmunology_2014_Jun_3_3_e29030.nxml.txt.nlp	25083328	SENT57	48	48	38	38	temozolomide	IFN	PA451609	3439	0.899
NULL	Front_Behav_Neurosci_2014_Oct_30_8_366.nxml.txt.nlp	25400560	SENT137	28	28	1	1	ethanol	ANOVA	PA448073	4858	0.899
NULL	Acta_Pharmacol_Sin_2010_May_5_31(5)_523-530.nxml.txt.nlp	20364156	SENT119	8	8	2	2	dexmedetomidine	ANOVA	PA449256	4858	0.899
NULL	Mol_Cancer_2008_Jun_5_7_50.nxml.txt.nlp	18534018	SENT106	35	35	24	24	bortezomib	HSP27	PA10252	3315	0.899
NULL	Cancer_Immunol_Immunother_2011_Jan_21_60(1)_75-85.nxml.txt.nlp	20857100	SENT162	23	23	32	32	fludarabine	IFN	PA449655	3439	0.899
NULL	Protein_J_2012_Aug_5_31(6)_511-518.nxml.txt.nlp	22763563	SENT32	13	13	23	23	atorvastatin	CD36	PA448500	948	0.899
NULL	Mol_Cancer_2008_Sep_30_7_73.nxml.txt.nlp	18826597	SENT81	26	26	14	14	doxycycline	c-Myc	PA449415	4609	0.899
NULL	Environ_Health_Perspect_1982_Feb_43_81-88.nxml.txt.nlp	7060548	SENT15	23	23	0	0	cyclophosphamide	DES	PA449165	1674	0.899
NULL	Biosci_Rep_2013_Nov_25_33(6)_e00081.nxml.txt.nlp	24070327	SENT571	7	7	1	1	imatinib	MDR1	PA10804	5243	0.899
NULL	Brain_Struct_Funct_2013_Mar_17_218(2)_421-435.nxml.txt.nlp	22527118	SENT84	4	4	22	22	fluorescein	5-HT1A	PA164746009	3350	0.899
NULL	Exp_Lung_Res_2013_Oct_1_39(8)_336-348.nxml.txt.nlp	23919450	SENT209	5	5	7	7	thrombin	PAR-1	PA451674	2011;2149	0.899
NULL	Acta_Pharmacol_Sin_2012_Aug_23_33(8)_1095-1100.nxml.txt.nlp	22820908	SENT112	23	23	36	36	clarithromycin	CYP2C19	PA449028	1557	0.899
NULL	Pharmaceutics_2011_Nov_18_3(4)_865-913.nxml.txt.nlp	24309312	SENT348	5	5	8	8	everolimus	CYP3A4	PA164746311	1576	0.899
NULL	Ann_Lab_Med_2014_Nov_28_34(6)_439-445.nxml.txt.nlp	25368819	SENT55	29	29	11	11	rifaximin	VAN	PA164752443	10318	0.899
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT144	6	6	19	19	atorvastatin	PTEN	PA448500	5728	0.899
NULL	Mol_Med_Rep_2015_Jan_16_11(1)_189-195.nxml.txt.nlp	25323748	SENT120	5	5	20	20	cisplatin	CHOP	PA449014	1649	0.899
NULL	Exp_Ther_Med_2015_Jan_5_9(1)_84-88.nxml.txt.nlp	25452780	SENT17	0	0	9	9	vildagliptin	DPP4	PA165958346	1803	0.899
NULL	Diabetes_2009_Mar_58(3)_641-651.nxml.txt.nlp	19073764	SENT20	31	31	24	24	exenatide	GLP-1	PA164749238	100125288	0.899
NULL	J_Cell_Mol_Med_2014_May_14_18(5)_811-823.nxml.txt.nlp	24628949	SENT265	12	12	2	2	docetaxel	FOXM1	PA449383	2305	0.899
NULL	Apoptosis_2012_Sep_30_17(9)_989-997.nxml.txt.nlp	22460505	SENT141	3	3	11	11	thioridazine	PI3K	PA451666	5290	0.899
NULL	Front_Immunol_2014_Apr_1_5_131.nxml.txt.nlp	24744755	SENT279	17	17	37	37	imiquimod	IFN	PA449972	3439	0.899
NULL	Mol_Biol_Cell_2014_Apr_1_25(7)_1050-1060.nxml.txt.nlp	24478453	SENT126	28	28	3	3	iodixanol	HRD1	PA164783998	84447	0.899
NULL	Oncotarget_2012_Nov_14_3(12)_1557-1565.nxml.txt.nlp	23238683	SENT92	0	0	5	5	ponatinib	CD34	PA165980594	947	0.899
NULL	J_Headache_Pain_2014_Dec_8_15(1)_85.nxml.txt.nlp	25488888	SENT84	13	13	35	35	zolmitriptan	5-HT1B	PA451975	3351	0.899
NULL	Front_Genet_2012_Nov_12_3_235.nxml.txt.nlp	23162568	SENT170	15	15	7	7	methamphetamine	CYP2D6	PA450403	1565	0.899
NULL	Atten_Defic_Hyperact_Disord_2014_Jul_14_6(3)_175-202.nxml.txt.nlp	25017045	SENT308	28	28	13	13	quetiapine	COMT	PA451201	1312	0.899
NULL	Clin_Infect_Dis_2013_May_1_56(9)_1330-1339.nxml.txt.nlp	23362284	SENT44	31	31	11	11	lamivudine	CD4	PA450163	920	0.899
NULL	J_Cell_Biol_1997_Jun_2_137(5)_1127-1136.nxml.txt.nlp	9166412	SENT122	6	6	31	31	mitomycin	PI3K	PA450524	5290	0.899
NULL	Core_Evid_2010_Jul_27_5_1-10.nxml.txt.nlp	20694135	SENT6	13	13	31	31	carbidopa	COMT	PA448794	1312	0.899
NULL	Clin_Psychopharmacol_Neurosci_2013_Dec_24_11(3)_144-151.nxml.txt.nlp	24465251	SENT13	0	0	25	25	haloperidol	IL-4	PA449841	3565	0.899
NULL	Cases_J_2009_Jul_30_2_7134.nxml.txt.nlp	19829918	SENT31	11	11	4	4	levodopa	LCE	PA450213	79071	0.899
NULL	Arthritis_Res_Ther_2014_Dec_23_16(6)_506.nxml.txt.nlp	25587634	SENT189	0	0	14	14	ustekinumab	IL-23	PA166048654	51561	0.899
NULL	Clin_Interv_Aging_2013_Sep_16_8_1229-1236.nxml.txt.nlp	24072968	SENT83	26	26	20	20	vincristine	CHOP	PA451879	1649	0.899
NULL	J_Biol_Chem_2013_Apr_26_288(17)_11865-11876.nxml.txt.nlp	23449983	SENT277	26	26	36	36	vanillin	CXCL12	PA451852	6387	0.899
NULL	Oncologist_2011_Feb_25_16(2)_155-164.nxml.txt.nlp	21266401	SENT118	19	19	12	12	trastuzumab	HER-2	PA451743	2064	0.899
NULL	Indian_J_Pharmacol_2013_Sep-Oct_45(5)_458-463.nxml.txt.nlp	24130379	SENT146	11	11	22	22	carvedilol	Bcl-2	PA448817	596	0.899
NULL	Biologics_2014_Apr_17_8_169-182.nxml.txt.nlp	24790410	SENT227	11	11	28	28	adalimumab	ACR	PA10004	49	0.899
NULL	Eur_Arch_Psychiatry_Clin_Neurosci_2010_Mar_12_260(2)_101-111.nxml.txt.nlp	19856012	SENT168	32	32	10	10	haloperidol	NR1	PA449841	27158	0.899
NULL	Clin_Drug_Investig_2015_Dec_16_35_141-147.nxml.txt.nlp	25511640	SENT70	9	9	18	18	miglitol	GLP-1	PA164776726	100125288	0.899
NULL	Br_J_Cancer_2010_Oct_26_103(9)_1380-1390.nxml.txt.nlp	20877355	SENT185	6	6	10	10	doxorubicin	TRAIL	PA449412	8743	0.899
NULL	J_Gynecol_Oncol_2013_Jul_4_24(3)_265-272.nxml.txt.nlp	23875077	SENT9	1	1	30	30	thrombin	SMAD2	PA451674	4087	0.899
NULL	Curr_Chem_Genomics_2011_Aug_22_5_62-71.nxml.txt.nlp	21966346	SENT90	26	26	2	2	lenalidomide	LSD1	PA162363968	23028	0.899
NULL	Cardiovasc_Diabetol_2013_May_30_12(Suppl_1)_S2.nxml.txt.nlp	23819752	SENT129	20	20	10	10	pitavastatin	CYP3A4	PA142650384	1576	0.899
NULL	Oncotarget_2014_Jun_1_5(13)_4881-4894.nxml.txt.nlp	24952679	SENT95	6	6	0	0	bortezomib	IRE1	PA10252	2081	0.899
NULL	Breast_Cancer_Res_2012_May_2_14(3)_R70.nxml.txt.nlp	22551440	SENT209	17	17	6	6	docetaxel	p53	PA449383	7157	0.899
NULL	J_Hematol_Oncol_2009_Apr_22_2_18.nxml.txt.nlp	19386128	SENT151	5	5	14	14	cetuximab	KRAS	PA10040	3845	0.899
NULL	Evid_Based_Complement_Alternat_Med_2013_Aug_22_2013_423164.nxml.txt.nlp	24027594	SENT164	3	3	22	22	berberine	AP-1	PA165860812	2353;3727;2354;3725	0.899
NULL	Arthritis_Res_Ther_2013_Dec_30_15(6)_R223.nxml.txt.nlp	24373218	SENT157	16	16	0	0	carprofen	TSP-1	PA164781361	7057	0.899
NULL	Med_Sci_Monit_2013_Dec_23_19_1195-1210.nxml.txt.nlp	24362017	SENT271	40	40	15	15	cisplatin	NOX3	PA449014	50508	0.899
NULL	J_Hematol_Oncol_2010_Mar_13_3_10.nxml.txt.nlp	20226083	SENT28	12	12	1	1	gemcitabine	RRM1	PA449748	6240	0.899
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Feb_23_69(Pt_3)_m165-m166.nxml.txt.nlp	23476507	SENT71	21	21	41	41	phenol	mer	PA450913	10461	0.899
NULL	Cardiovasc_Diabetol_2010_Oct_18_9_64.nxml.txt.nlp	20955583	SENT32	11	11	16	16	rosiglitazone	PPARgamma	PA451283	5468	0.899
NULL	Oncogene_2010_Sep_16_29(37)_5193-5203.nxml.txt.nlp	20581867	SENT125	26	26	11	11	lapatinib	PI3K	PA152241907	5290	0.899
NULL	Br_J_Cancer_2010_Jan_19_102(2)_383-391.nxml.txt.nlp	20010943	SENT113	6	6	0	0	cisplatin	JNK	PA449014	5599	0.899
NULL	Acta_Pharmacol_Sin_2009_Feb_5_30(2)_228-234.nxml.txt.nlp	19122672	SENT103	8	8	13	13	isoflurane	HO-1	PA450106	3162	0.899
NULL	Diabetes_2011_Jul_20_60(7)_1990-1999.nxml.txt.nlp	21617181	SENT200	34	34	13	13	pioglitazone	SOCS3	PA450970	9021	0.899
NULL	Biomed_Res_Int_2014_Jun_26_2014_483501.nxml.txt.nlp	25057490	SENT133	0	0	2	2	resveratrol	p53		7157	0.899
NULL	EPMA_J_2011_Jun_26_2(2)_211-230.nxml.txt.nlp	23199150	SENT246	18	18	12	12	theophylline	PARP-1	PA451647	25976	0.899
NULL	Indian_J_Pharm_Sci_2013_Sep-Oct_75(5)_545-556.nxml.txt.nlp	24403655	SENT209	31	31	10	10	ethanol	mol	PA448073	90527	0.899
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT234	7	7	11	11	metformin	EGFR	PA450395	1956	0.899
NULL	J_Cell_Mol_Med_2013_Oct_23_17(10)_1207-1217.nxml.txt.nlp	24106980	SENT77	10	10	2	2	paclitaxel	PLK1	PA450761	5347	0.899
NULL	Eur_J_Med_Res_2009_Nov_24_14(Suppl_3)_17-21.nxml.txt.nlp	19959412	SENT56	5	5	10	10	midazolam	CYP3A	PA450496	1574	0.899
NULL	Mol_Cancer_2009_Nov_24_8_109.nxml.txt.nlp	19930708	SENT194	16	16	19	19	exemestane	EGFR	PA449563	1956	0.899
NULL	Acta_Pharmacol_Sin_2012_Nov_4_33(11)_1387-1394.nxml.txt.nlp	22659624	SENT128	33	33	13	13	bivalirudin	ACT	PA10032	12;11332;9457;641455	0.899
NULL	Mol_Cancer_2014_Apr_17_13_84.nxml.txt.nlp	24742333	SENT262	45	45	2	2	l-glutamine	PC3	PA10090	57332;7832;5122	0.899
NULL	Eur_J_Med_Chem_2011_Nov_46(11)_5456-5464.nxml.txt.nlp	21940073	SENT88	11	11	2	2	cisplatin	CH1	PA449014	51430	0.899
NULL	Mol_Cells_2014_Mar_31_37(3)_234-240.nxml.txt.nlp	24642709	SENT109	7	7	13	13	cisplatin	NOX4	PA449014	50507	0.899
NULL	Mediators_Inflamm_1996_Oct_5(5)_346-357.nxml.txt.nlp	18475729	SENT8	24	24	8	8	dextran	FMLP	PA449261	2357	0.899
NULL	Front_Neurosci_2011_Jan_14_4_207.nxml.txt.nlp	21258618	SENT104	0	0	21	21	ethanol	HET	PA448073	6294	0.899
NULL	AIDS_Res_Ther_2013_Dec_13_10_29.nxml.txt.nlp	24330529	SENT246	4	4	13	13	lubiprostone	CD4	PA164777012	920	0.899
NULL	Acta_Pharmacol_Sin_2010_Sep_9_31(9)_1181-1188.nxml.txt.nlp	20694025	SENT163	11	11	17	17	erlotinib	EGFR	PA134687924	1956	0.899
NULL	Cancers_(Basel)_2014_Jun_27_6(3)_1382-1393.nxml.txt.nlp	24978439	SENT428	18	18	0	0	trastuzumab	Hsp90	PA451743	3320	0.899
NULL	Adv_Hematol_2009_Jun_22_2009_251915.nxml.txt.nlp	19946423	SENT123	1	1	9	9	hemin	HRI	PA449849	27102	0.899
NULL	Korean_Circ_J_2013_Aug_31_43(8)_541-549.nxml.txt.nlp	24044013	SENT114	25	25	34	34	ticagrelor	CYP2C19	PA165374673	1557	0.899
NULL	Gene_Regul_Syst_Bio_2014_Mar_4_8_63-73.nxml.txt.nlp	24634581	SENT94	11	11	30	30	minocycline	NANOS1	PA450519	340719	0.899
NULL	Front_Neurosci_2014_Mar_26_8_47.nxml.txt.nlp	24723845	SENT102	2	2	5	5	minocycline	PARP-1	PA450519	25976	0.899
NULL	Exp_Ther_Med_2013_Oct_20_6(4)_899-903.nxml.txt.nlp	24137286	SENT10	8	8	36	36	rosuvastatin	c-Jun	PA134308647	3725	0.899
NULL	Biomed_Res_Int_2014_Apr_10_2014_741758.nxml.txt.nlp	24818150	SENT23	11	11	28	28	estradiol	spatial	PA449503	219793	0.899
NULL	Diabetes_Care_2013_Aug_17_36(Suppl_2)_S127-S138.nxml.txt.nlp	23882037	SENT87	27	27	7	7	metformin	GLP-1	PA450395	100125288	0.899
NULL	Evid_Based_Complement_Alternat_Med_2012_May_7_2012_242810.nxml.txt.nlp	22645625	SENT139	23	23	2	2	rifampin	CYP3A4	PA451250	1576	0.899
NULL	Onco_Targets_Ther_2014_Mar_24_7_491-500.nxml.txt.nlp	24711706	SENT62	15	15	10	10	trastuzumab	HER2	PA451743	2064	0.899
NULL	Br_J_Cancer_2012_Nov_20_107(11)_1901-1907.nxml.txt.nlp	23079577	SENT170	9	9	12	12	tamoxifen	aromatase	PA451581	1588	0.899
NULL	Br_J_Cancer_2003_Mar_10_88(5)_754-759.nxml.txt.nlp	12618886	SENT166	19	19	22	22	amifostine	p53	PA448365	7157	0.899
NULL	J_Exp_Clin_Cancer_Res_2009_Jul_10_28(1)_99.nxml.txt.nlp	19591692	SENT6	24	24	34	34	tariquidar	ABCB1		5243	0.899
NULL	Indian_J_Dermatol_2012_Nov-Dec_57(6)_466-474.nxml.txt.nlp	23248365	SENT62	4	4	18	18	tacrolimus	IL-3	PA451578	3562	0.899
NULL	J_Viral_Hepat_2010_Feb_17(2)_139-147.nxml.txt.nlp	19674282	SENT9	8	8	16	16	ribavirin	RVR	PA451241	9975	0.899
NULL	EMBO_Mol_Med_2013_Dec_8_5(12)_1821-1834.nxml.txt.nlp	24293316	SENT52	26	26	12	12	doxorubicin	UNC5B	PA449412	219699	0.899
NULL	J_Neurosci_Rural_Pract_2010_Jul-Dec_1(2)_63-66.nxml.txt.nlp	21808505	SENT24	33	33	12	12	abacavir	gamma	PA448004	9913	0.899
NULL	eLife_2014_May_27_3_e02200.nxml.txt.nlp	24867637	SENT572	12	12	3	3	doxorubicin	p53	PA449412	7157	0.899
NULL	J_Gastroenterol_2013_Feb_22_48(2)_222-237.nxml.txt.nlp	22722906	SENT8	39	39	21	21	ethanol	c-Jun	PA448073	3725	0.899
NULL	J_Invest_Dermatol_2012_Sep_10_132(9)_2255-2262.nxml.txt.nlp	22572817	SENT105	25	25	7	7	forskolin	ASIP	PA146096022	434;56288	0.899
NULL	Open_Access_J_Urol_2010_Aug_12_2_143-154.nxml.txt.nlp	24198622	SENT286	31	31	25	25	cisplatin	CS2	PA449014	64084	0.899
NULL	Br_J_Cancer_2011_Aug_9_105(4)_523-533.nxml.txt.nlp	21792199	SENT219	45	45	8	8	erlotinib	EGFR	PA134687924	1956	0.899
NULL	Curr_Med_Chem_2012_Aug_19(22)_3763-3778.nxml.txt.nlp	22680930	SENT70	25	25	11	11	zileuton	5-LOX	PA451955	240	0.899
NULL	Cancer_Cell_Int_2005_Oct_4_5_30.nxml.txt.nlp	16202168	SENT171	20	20	9	9	sn-38	ABCG2		9429	0.899
NULL	Front_Neurosci_2014_Jan_10_7_270.nxml.txt.nlp	24454277	SENT70	15	15	12	12	resveratrol	SIRT1		23411	0.899
NULL	Tuberc_Respir_Dis_(Seoul)_2013_Nov_29_75(5)_188-198.nxml.txt.nlp	24348666	SENT30	34	34	29	29	gefitinib	EGFR	PA131301952	1956	0.899
NULL	Addict_Sci_Clin_Pract_2010_Dec_5(2)_17-29.nxml.txt.nlp	22002450	SENT136	21	21	11	11	bupropion	CYP2B6	PA448687	1555	0.899
NULL	Appl_Microbiol_Biotechnol_2013_Sep_11_97(22)_9747-9762.nxml.txt.nlp	24022610	SENT28	13	13	35	35	oxygen	AOX1	PA450744	316	0.899
NULL	Int_J_Mol_Sci_2014_Oct_8_15(10)_17974-17999.nxml.txt.nlp	25299695	SENT165	10	10	16	16	curcumin	HO-1	PA151958596	3162	0.899
NULL	Sci_Rep_2015_Jan_14_5_7760.nxml.txt.nlp	25585590	SENT213	2	2	7	7	cyclophosphamide	CD4	PA449165	920	0.899
NULL	Breast_Cancer_(Auckl)_2010_Feb_16_4_1-3.nxml.txt.nlp	20697527	SENT7	26	26	41	41	curcumin	BRCA1	PA151958596	672	0.899
NULL	Emerg_Infect_Dis_2014_Jul_20(7)_1207-1210.nxml.txt.nlp	24963881	SENT53	4	4	15	15	artesunate	USP34	PA165111697	9736	0.899
NULL	J_Oncol_2010_Aug_24_2010_654348.nxml.txt.nlp	20871846	SENT42	24	24	15	15	anastrozole	ATAC	PA448432	6375	0.899
NULL	Front_Genet_2012_Nov_26_3_244.nxml.txt.nlp	23248639	SENT192	16	16	26	26	resveratrol	AMPK		5563	0.899
NULL	Clin_Infect_Dis_2013_May_1_56(9)_1330-1339.nxml.txt.nlp	23362284	SENT159	27	27	10	10	abacavir	HLA-B	PA448004	3106	0.899
NULL	Gut_Liver_2012_Oct_18_6(4)_464-470.nxml.txt.nlp	23170151	SENT135	16	16	44	44	propofol	ESD	PA451141	2098	0.899
NULL	Oncol_Lett_2014_Mar_19_7(3)_674-678.nxml.txt.nlp	24527071	SENT148	10	10	4	4	cisplatin	AKR1C2	PA449014	1646	0.899
NULL	Eur_J_Clin_Pharmacol_2013_Mar_11_69(3)_327-339.nxml.txt.nlp	22782539	SENT230	20	20	10	10	dabigatran	ADP		23038	0.899
NULL	Int_J_Med_Sci_2012_Aug_10_9(6)_472-479.nxml.txt.nlp	22927772	SENT48	24	24	8	8	warfarin	CYP2C9	PA451906	1559	0.899
NULL	Trials_2013_Aug_19_14_261.nxml.txt.nlp	23958221	SENT156	14	14	0	0	pertuzumab	HER2		2064	0.899
NULL	Exp_Diabetes_Res_2012_Mar_15_2012_146194.nxml.txt.nlp	22474415	SENT170	10	10	15	15	valsartan	GLP-1	PA451848	100125288	0.899
NULL	Breast_Cancer_Res_2009_Jul_15_11(4)_207.nxml.txt.nlp	19664181	SENT132	12	12	34	34	gefitinib	EGFR	PA131301952	1956	0.899
NULL	Ulster_Med_J_2008_May_77(2)_106-109.nxml.txt.nlp	18711628	SENT45	0	0	20	20	heparin	ACT	PA449855	12;11332;9457;641455	0.899
NULL	Chem_Commun_(Camb)_2013_Jun_21_49(76)_8441-8443.nxml.txt.nlp	23770604	SENT11	1	1	5	5	geldanamycin	Hsp90	PA152031327	3320	0.899
NULL	Blood_Cancer_J_2012_Jun_22_2(6)_e75.nxml.txt.nlp	22829977	SENT3	40	40	11	11	rituximab	San	PA451261	80218	0.899
NULL	Clin_Epigenetics_2011_Jun_27_2(2)_171-185.nxml.txt.nlp	21949547	SENT94	19	19	7	7	paclitaxel	BAK1	PA450761	578	0.899
NULL	Mol_Cancer_2010_Nov_8_9_291.nxml.txt.nlp	21059223	SENT178	14	14	10	10	paclitaxel	ZNF217	PA450761	7764	0.899
NULL	Reprod_Biol_Endocrinol_2013_Feb_26_11_15.nxml.txt.nlp	23442442	SENT198	3	3	12	12	l-arginine	BAX	PA448478	581	0.899
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Nov_27_66(Pt_12)_o3337.nxml.txt.nlp	21589611	SENT46	19	19	13	13	ethanol	mol	PA448073	90527	0.899
NULL	Core_Evid_2010_Oct_22_5_91-105.nxml.txt.nlp	21468365	SENT180	4	4	26	26	pitavastatin	CYP3A4	PA142650384	1576	0.899
NULL	Indian_J_Ophthalmol_2014_May_62(5)_554-560.nxml.txt.nlp	24881600	SENT21	5	5	13	13	ranibizumab	San	PA164746012	80218	0.899
NULL	Br_J_Haematol_2008_Jun_141(5)_659-671.nxml.txt.nlp	18410446	SENT258	13	13	21	21	cerulenin	JNK	PA164764551	5599	0.899
NULL	Ther_Clin_Risk_Manag_2007_Dec_3(6)_973-974.nxml.txt.nlp	18516313	SENT34	21	21	26	26	etanercept	p75	PA449515	7133;11168	0.899
NULL	Bioinformation_2008_Jun_27_2(9)_384-391.nxml.txt.nlp	18795111	SENT15	0	0	10	10	methotrexate	DHFR	PA450428	1719	0.899
NULL	J_Breast_Cancer_2011_Sep_29_14(3)_167-174.nxml.txt.nlp	22031796	SENT144	24	24	11	11	trastuzumab	HER2	PA451743	2064	0.899
NULL	Br_J_Cancer_2003_Mar_24_88(6)_848-854.nxml.txt.nlp	12644821	SENT5	15	15	1	1	cisplatin	TP53	PA449014	7157	0.899
NULL	J_Korean_Med_Sci_2007_Dec_20_22(6)_1055-1059.nxml.txt.nlp	18162722	SENT120	11	11	23	23	pantoprazole	ESD	PA450774	2098	0.899
NULL	Open_Biol_2014_Jan_4(1)_130138.nxml.txt.nlp	24403013	SENT236	6	6	12	12	etoposide	ETO	PA449552	862	0.899
NULL	Clin_Ophthalmol_2011_Nov_1_5_1575-1583.nxml.txt.nlp	22125404	SENT159	31	31	34	34	travoprost	BAK	PA164781371	578	0.899
NULL	Curr_Neuropharmacol_2013_Dec_11(6)_652-663.nxml.txt.nlp	24396340	SENT193	10	10	28	28	desflurane	TRPA1	PA164749136	8989	0.899
NULL	Oncotarget_2013_Nov_19_5(2)_309-325.nxml.txt.nlp	24525395	SENT304	30	30	45	45	bortezomib	Bcl-2	PA10252	596	0.899
NULL	Cell_Death_Differ_2010_Apr_23_17(4)_699-709.nxml.txt.nlp	19851330	SENT164	18	18	3	3	l-glutamine	PUMA	PA10090	27113	0.899
NULL	Ann_Oncol_2010_Jan_21(1)_133-139.nxml.txt.nlp	20019090	SENT24	5	5	0	0	cyclophosphamide	CHOP	PA449165	1649	0.899
NULL	Eur_J_Clin_Pharmacol_2012_Jan_8_68(1)_29-37.nxml.txt.nlp	21739267	SENT31	24	24	28	28	ketoconazole	CYP3A4	PA450146	1576	0.899
NULL	J_Cardiovasc_Dis_Res_2012_Oct-Dec_3(4)_319-322.nxml.txt.nlp	23233778	SENT64	10	10	2	2	simvastatin	SHARP	PA451363	23013	0.899
NULL	Oncol_Lett_2014_Jan_29_7(1)_183-188.nxml.txt.nlp	24348845	SENT132	19	19	26	26	etoposide	PC3	PA449552	57332;7832;5122	0.899
NULL	AIDS_Res_Ther_2012_May_3_9_13.nxml.txt.nlp	22554313	SENT121	16	16	3	3	efavirenz	CD4	PA449441	920	0.899
NULL	Oncotarget_2014_Feb_8_5(6)_1609-1620.nxml.txt.nlp	24742492	SENT205	22	22	25	25	trastuzumab	HER2	PA451743	2064	0.899
NULL	Biomed_Res_Int_2014_Jan_20_2014_948427.nxml.txt.nlp	24563867	SENT113	2	2	20	20	buspirone	STZ	PA448689	6484	0.899
NULL	Nat_Neurosci_2012_Sep_22_15(9)_1227-1235.nxml.txt.nlp	22820466	SENT142	10	10	16	16	papain	CO2	PA450778	4513	0.899
NULL	Acta_Pharmacol_Sin_2011_Oct_12_32(10)_1259-1265.nxml.txt.nlp	21909126	SENT114	43	43	26	26	rosuvastatin	LOX-1	PA134308647	4973	0.899
NULL	J_Lipid_Res_2012_May_53(5)_1000-1011.nxml.txt.nlp	22368281	SENT291	37	37	5	5	pravastatin	LPA	PA451089	4018	0.899
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT149	31	31	33	33	perifosine	JNK	PA165291471	5599	0.899
NULL	Br_J_Cancer_2006_Feb_13_94(3)_407-426.nxml.txt.nlp	16434996	SENT150	34	34	13	13	fulvestrant	BRCA1	PA164747170	672	0.899
NULL	FEBS_Open_Bio_2013_Jun_20_3_271-278.nxml.txt.nlp	23905009	SENT25	2	2	17	17	geldanamycin	Hsp90	PA152031327	3320	0.899
NULL	Oncol_Rep_2012_Apr_16_27(4)_971-978.nxml.txt.nlp	22266706	SENT12	10	10	17	17	cisplatin	Bcl-2	PA449014	596	0.899
NULL	Oncotarget_2012_May_18_3(5)_525-534.nxml.txt.nlp	22619113	SENT155	4	4	15	15	fludarabine	CD40L	PA449655	959	0.899
NULL	Neural_Dev_2013_Mar_7_8_4.nxml.txt.nlp	23497494	SENT12	28	28	12	12	chlorpheniramine	FOXP2	PA448960	93986	0.899
NULL	Oncotarget_2013_Dec_28_5(6)_1475-1490.nxml.txt.nlp	24721996	SENT171	8	8	13	13	celecoxib	CD133	PA448871	8842	0.899
NULL	J_Cell_Mol_Med_2014_Aug_1_18(8)_1599-1611.nxml.txt.nlp	24889822	SENT243	25	25	7	7	resveratrol	SIRT1		23411	0.899
NULL	Nat_Commun_2014_Aug_18_5_4632.nxml.txt.nlp	25130259	SENT159	32	32	27	27	heparin	EGF	PA449855	1950	0.899
NULL	Comput_Math_Methods_Med_2012_Dec_19_2012_473572.nxml.txt.nlp	23365616	SENT108	18	18	6	6	exemestane	aromatase	PA449563	1588	0.899
NULL	Cancer_Metab_2013_Jan_23_1_3.nxml.txt.nlp	24280005	SENT261	35	35	8	8	ethanol	SREBP2	PA448073	6721	0.899
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT208	14	14	9	9	sulindac	AKT	PA451565	207	0.899
NULL	Acta_Pharmacol_Sin_2013_Sep_5_34(9)_1192-1200.nxml.txt.nlp	23685957	SENT143	6	6	13	13	curcumin	AP-2	PA151958596	7020	0.899
NULL	Breast_Cancer_Res_2011_Jan_24_13(1)_401.nxml.txt.nlp	21349137	SENT31	11	11	19	19	lapatinib	AMPK	PA152241907	5563	0.899
NULL	Eur_J_Clin_Pharmacol_2013_May_14_69(5)_1091-1101.nxml.txt.nlp	23150149	SENT66	15	15	0	0	isoniazid	NAT2	PA450112	10;81539	0.899
NULL	Acta_Pharmacol_Sin_2009_Jul_3_30(7)_889-898.nxml.txt.nlp	19574994	SENT172	23	23	11	11	pp2	EGFR		1956	0.899
NULL	Indian_J_Pharm_Sci_2014_Jan-Feb_76(1)_72-77.nxml.txt.nlp	24799741	SENT117	25	25	8	8	ketoconazole	CYP2C9	PA450146	1559	0.899
NULL	Arthritis_Res_Ther_2011_Feb_23_13(1)_R33.nxml.txt.nlp	21345222	SENT149	0	0	3	3	adalimumab	IL-6	PA10004	3569	0.899
NULL	Clin_Med_Insights_Oncol_2013_Feb_28_7_53-73.nxml.txt.nlp	23492937	SENT137	15	15	22	22	bortezomib	BTD	PA10252	686	0.899
NULL	Theranostics_2014_Aug_15_4(11)_1085-1095.nxml.txt.nlp	25285162	SENT212	3	3	33	33	docetaxel	LC3	PA449383	84557	0.899
NULL	Clin_Med_Insights_Oncol_2012_Apr_3_6_179-187.nxml.txt.nlp	22518088	SENT87	24	24	13	13	trastuzumab	HER2	PA451743	2064	0.899
NULL	Oncol_Lett_2013_Feb_27_5(2)_483-488.nxml.txt.nlp	23420047	SENT182	5	5	1	1	panitumumab	KRAS	PA162373091	3845	0.899
NULL	Front_Immunol_2013_May_24_4_126.nxml.txt.nlp	23745124	SENT258	19	19	4	4	ns-398	COX		1351	0.899
NULL	Acta_Vet_Scand_2008_Jul_4_50(1)_27.nxml.txt.nlp	18601734	SENT146	32	32	21	21	doxorubicin	SMYD2	PA449412	56950	0.899
NULL	Oncotarget_2010_Oct_22_1(7)_530-543.nxml.txt.nlp	21317449	SENT98	10	10	6	6	erlotinib	EGFR	PA134687924	1956	0.899
NULL	Environ_Health_Perspect_2007_Apr_14_115(4)_513-518.nxml.txt.nlp	17450217	SENT174	13	13	37	37	arsenite	GAPDH	PA452638	2597	0.899
NULL	Exp_Cell_Res_2009_Nov_15_315(19)_3433-3441.nxml.txt.nlp	19716819	SENT182	26	26	6	6	hyaluronidase	CD44	PA164745713	960	0.899
NULL	Nucleic_Acids_Res_2012_Jan_9_40(1)_181-195.nxml.txt.nlp	21908405	SENT270	13	13	21	21	bleomycin	53BP1	PA448645	7158	0.899
NULL	Mol_Cancer_2009_Apr_22_8_26.nxml.txt.nlp	19386116	SENT129	8	8	18	18	ritonavir	Bcl-2	PA451260	596	0.899
NULL	J_Adv_Pract_Oncol_2013_Jul_1_Jul-Aug_4(4)_238-250.nxml.txt.nlp	25032004	SENT96	16	16	18	18	tamoxifen	aromatase	PA451581	1588	0.899
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_May_26_66(Pt_6)_o1471.nxml.txt.nlp	21579539	SENT54	20	20	14	14	ethanol	mol	PA448073	90527	0.899
NULL	Oncotarget_2014_Jun_6_5(13)_4935-4944.nxml.txt.nlp	24952732	SENT74	37	37	9	9	doxazosin	PI3K	PA449407	5290	0.899
NULL	Breast_Cancer_Res_2012_Jun_7_14(3)_R89.nxml.txt.nlp	22676470	SENT17	8	8	20	20	trastuzumab	EGFR	PA451743	1956	0.899
NULL	Acta_Pharmacol_Sin_2013_Sep_5_34(9)_1192-1200.nxml.txt.nlp	23685957	SENT137	17	17	26	26	curcumin	AP-2	PA151958596	7020	0.899
NULL	Clin_Proteomics_2014_Dec_11_11(1)_43.nxml.txt.nlp	25593565	SENT215	21	21	2	2	glutaraldehyde	CD4	PA449777	920	0.899
NULL	Antiviral_Res_2009_May_82(2)_A99-A109.nxml.txt.nlp	19176219	SENT283	21	21	8	8	saquinavir	P85	PA451305	8874	0.899
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT118	11	11	2	2	atorvastatin	IL-6	PA448500	3569	0.899
NULL	Mol_Cell_Proteomics_2012_Feb_6_11(2)_M111_015222.nxml.txt.nlp	22147731	SENT40	22	22	19	19	gefitinib	EGFR	PA131301952	1956	0.899
NULL	Mol_Cancer_2014_Jan_13_13_7.nxml.txt.nlp	24418169	SENT256	17	17	4	4	sorafenib	HIF-1	PA7000	29072	0.899
NULL	Pharmaceuticals_(Basel)_2013_Aug_2_6(8)_915-928.nxml.txt.nlp	24276376	SENT127	43	43	38	38	clopidogrel	CAD	PA449053	1677;790	0.899
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1554-1562.nxml.txt.nlp	21970876	SENT145	7	7	3	3	erlotinib	EGFR	PA134687924	1956	0.899
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT60	19	19	30	30	ranibizumab	VEGFR2	PA164746012	3791	0.899
NULL	J_Hematol_Oncol_2013_Aug_19_6_59.nxml.txt.nlp	23958373	SENT211	23	23	11	11	rituximab	BTK	PA451261	695	0.899
NULL	Neural_Regen_Res_2013_May_25_8(15)_1349-1359.nxml.txt.nlp	25206429	SENT110	18	18	4	4	nimodipine	NR1	PA450633	27158	0.899
NULL	Oncogene_2010_Jun_10_29(23)_3335-3348.nxml.txt.nlp	20383197	SENT7	21	21	4	4	trastuzumab	HER2	PA451743	2064	0.899
NULL	J_Cell_Biol_1998_Jan_26_140(2)_335-345.nxml.txt.nlp	9442109	SENT73	3	3	10	10	chloroquine	NHE	PA448948	285335	0.899
NULL	Nucl_Recept_Signal_2006_Jul_7_4_e018.nxml.txt.nlp	16862224	SENT580	3	3	8	8	tamoxifen	SAGE	PA451581	55511	0.899
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1522-1532.nxml.txt.nlp	21997136	SENT217	8	8	5	5	irinotecan	EGFR	PA450085	1956	0.899
NULL	Breast_Cancer_Res_2011_Dec_16_13(6)_R131.nxml.txt.nlp	22177475	SENT275	37	37	21	21	lapatinib	HER2	PA152241907	2064	0.899
NULL	Cancer_Med_2012_Oct_1_1(2)_114-127.nxml.txt.nlp	23342262	SENT309	18	18	8	8	sirolimus	EGFR	PA451365	1956	0.899
NULL	Onco_Targets_Ther_2014_Jun_11_7_969-983.nxml.txt.nlp	24959084	SENT115	11	11	20	20	voriconazole	CYP3A4	PA10233	1576	0.899
NULL	Cancers_(Basel)_2011_Apr_1_3(2)_1844-1860.nxml.txt.nlp	24212785	SENT602	16	16	7	7	cetuximab	NRAS	PA10040	4893	0.899
NULL	Br_J_Cancer_2003_Jun_16_88(12)_1963-1970.nxml.txt.nlp	12799644	SENT216	17	17	9	9	gemcitabine	MRP1	PA449748	4437	0.899
NULL	J_Cell_Biol_2005_Jul_4_170(1)_49-59.nxml.txt.nlp	15983061	SENT179	9	9	12	12	forskolin	HIF1	PA146096022	3091	0.899
NULL	Oncotarget_2010_Nov_22_1(7)_606-619.nxml.txt.nlp	21317456	SENT131	26	26	15	15	doxorubicin	RAD51D	PA449412	5892	0.899
NULL	Exp_Diabetes_Res_2012_Feb_28_2012_481840.nxml.txt.nlp	22474423	SENT196	12	12	26	26	taurine	IRE1	PA451590	2081	0.899
NULL	Oncotarget_2011_Mar_10_2(3)_186-196.nxml.txt.nlp	21406729	SENT124	4	4	2	2	orlistat	FASN	PA164776864	2194	0.899
NULL	Tuberc_Respir_Dis_(Seoul)_2013_Nov_29_75(5)_188-198.nxml.txt.nlp	24348666	SENT49	13	13	2	2	erlotinib	PTEN	PA134687924	5728	0.899
NULL	Mol_Vis_2011_Aug_11_17_2157-2170.nxml.txt.nlp	21850191	SENT220	12	12	9	9	tacrolimus	p50	PA451578	958;4790	0.899
NULL	J_Oncol_2010_Jan_13_2010_314326.nxml.txt.nlp	20111741	SENT50	0	0	9	9	bevacizumab	VEGF-A	PA130232992	7422	0.899
NULL	Mol_Cancer_2013_Oct_8_12_119.nxml.txt.nlp	24103454	SENT189	12	12	8	8	nutlin-3	p53		7157	0.899
NULL	Exp_Diabetes_Res_2012_May_28_2012_924168.nxml.txt.nlp	22693487	SENT37	8	8	23	23	exenatide	GLP-1	PA164749238	100125288	0.899
NULL	Oncotarget_2011_Sep_9_2(9)_658-668.nxml.txt.nlp	21911919	SENT5	17	17	27	27	daunorubicin	HO-1	PA449212	3162	0.899
NULL	J_Korean_Med_Sci_2014_Jan_26_29(1)_53-60.nxml.txt.nlp	24431906	SENT169	25	25	21	21	doxorubicin	CHOP	PA449412	1649	0.899
NULL	Ann_Pediatr_Cardiol_2014_Sep-Dec_7(3)_167-172.nxml.txt.nlp	25298690	SENT45	5	5	26	26	heparin	ACT	PA449855	12;11332;9457;641455	0.899
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jun_25_67(Pt_7)_o1792.nxml.txt.nlp	21837165	SENT59	23	23	17	17	ethanol	mol	PA448073	90527	0.899
NULL	Front_Oncol_2014_Mar_3_4_34.nxml.txt.nlp	24624361	SENT262	12	12	8	8	olaparib	PI3K		5290	0.899
NULL	Ann_Gastroenterol_2015_Jan-Mar_28(1)_55-65.nxml.txt.nlp	25608803	SENT236	5	5	14	14	telaprevir	IL28B	PA165958354	282617	0.899
NULL	Int_J_Mol_Sci_2014_Sep_16_15(9)_16381-16417.nxml.txt.nlp	25229821	SENT2054	16	16	4	4	cyclosporine	IL-18	PA449167	3606	0.899
NULL	Breast_Cancer_Res_2011_Apr_1_13(2)_R35.nxml.txt.nlp	21457545	SENT32	32	32	21	21	erlotinib	EGFR	PA134687924	1956	0.899
NULL	Mol_Pain_2013_Sep_8_9_46.nxml.txt.nlp	24010880	SENT130	19	19	33	33	capsaicin	GluN2B	PA448776	2904	0.899
NULL	Oncotarget_2012_Aug_9_3(8)_774-782.nxml.txt.nlp	22885298	SENT57	5	5	8	8	tetracycline	IDH1	PA451640	3417	0.899
NULL	Apoptosis_2008_May_9_13(5)_681-692.nxml.txt.nlp	18392938	SENT154	17	17	0	0	forskolin	C10	PA146096022	113246	0.899
NULL	Ecancermedicalscience_2011_Dec_1_5_237.nxml.txt.nlp	22276069	SENT34	0	0	8	8	fulvestrant	CEA	PA164747170	5670;1087	0.899
NULL	Front_Pharmacol_2014_Dec_10_5_271.nxml.txt.nlp	25540621	SENT132	8	8	27	27	hesperidin	ghrelin	PA449867	51738	0.899
NULL	Breast_Cancer_Res_2007_Jun_4_9(3)_207.nxml.txt.nlp	17561991	SENT60	32	32	13	13	trastuzumab	HER-2	PA451743	2064	0.899
NULL	ScientificWorldJournal_2013_Dec_29_2013_618495.nxml.txt.nlp	24459439	SENT46	31	31	5	5	phenol	KSA	PA450913	4072	0.899
NULL	Iran_J_Basic_Med_Sci_2012_Nov-Dec_15(6)_1202-1209.nxml.txt.nlp	23653852	SENT160	3	3	5	5	metformin	AMPK	PA450395	5563	0.899
NULL	Front_Behav_Neurosci_2013_Dec_18_7_203.nxml.txt.nlp	24385956	SENT255	32	32	16	16	memantine	spatial	PA10364	219793	0.899
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_11_2014_274786.nxml.txt.nlp	25505920	SENT163	3	3	10	10	oxaliplatin	ERCC1	PA131285527	2067	0.899
NULL	Bone_Marrow_Res_2014_Jul_23_2014_405920.nxml.txt.nlp	25147739	SENT63	3	3	9	9	hyaluronan	IL-8	PA165958431	3576	0.899
NULL	Oncotarget_2014_Jun_8_5(13)_5040-5053.nxml.txt.nlp	24970815	SENT175	14	14	2	2	cisplatin	EGF	PA449014	1950	0.899
NULL	Indian_J_Endocrinol_Metab_2014_Jan-Feb_18(1)_77-82.nxml.txt.nlp	24701434	SENT36	28	28	14	14	metformin	GLP-1	PA450395	100125288	0.899
NULL	Iran_Red_Crescent_Med_J_2014_Sep_5_16(9)_e20153.nxml.txt.nlp	25593732	SENT62	8	8	41	41	halothane	CYP3A4	PA449845	1576	0.899
NULL	Diabetes_Care_2013_Mar_13_36(3)_498-504.nxml.txt.nlp	23139373	SENT22	8	8	12	12	liraglutide	GLP-1	PA165958364	100125288	0.899
NULL	Mol_Cancer_2013_May_24_12_46.nxml.txt.nlp	23705826	SENT357	35	35	17	17	gentamicin	FLT3	PA449753	2322	0.899
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Dec_10_65(Pt_1)_o52.nxml.txt.nlp	21581693	SENT57	20	20	14	14	ethanol	mol	PA448073	90527	0.899
NULL	Front_Oncol_2014_Aug_11_4_204.nxml.txt.nlp	25157335	SENT320	25	25	36	36	ridaforolimus	KRAS	PA165291475	3845	0.899
NULL	Cell_Oncol_(Dordr)_2014_Nov_20_37(6)_421-428.nxml.txt.nlp	25410120	SENT147	14	14	2	2	doxorubicin	P-gp	PA449412	5243	0.899
NULL	Oncol_Rep_2013_Apr_23_29(4)_1268-1274.nxml.txt.nlp	23354756	SENT152	28	28	13	13	epirubicin	SLC25A43	PA449476	203427	0.899
NULL	Arthritis_Res_Ther_2011_Sep_21_13(5)_239.nxml.txt.nlp	21955617	SENT159	21	21	13	13	celecoxib	RANKL	PA448871	8600	0.899
NULL	Br_J_Cancer_2010_Oct_26_103(9)_1380-1390.nxml.txt.nlp	20877355	SENT171	17	17	3	3	vincristine	p75NTR	PA451879	4804	0.899
NULL	J_Cancer_Prev_2013_Sep_18(3)_227-234.nxml.txt.nlp	25337550	SENT72	16	16	3	3	cisplatin	HDAC4	PA449014	9759	0.899
NULL	Int_J_Mol_Sci_2014_Nov_25_15(12)_21703-21722.nxml.txt.nlp	25429431	SENT316	7	7	11	11	olaparib	BRCA1		672	0.899
NULL	Lab_Invest_2014_May_10_94(5)_503-516.nxml.txt.nlp	24614199	SENT224	36	36	25	25	curcumin	RAGE	PA151958596	177	0.899
NULL	Cancer_Manag_Res_2013_Oct_8_5_337-347.nxml.txt.nlp	24204170	SENT75	15	15	2	2	sorafenib	VEGFR2	PA7000	3791	0.899
NULL	Hum_Genomics_2009_Jan_1_3(2)_128-142.nxml.txt.nlp	19164090	SENT188	9	9	20	20	carboplatin	CD44	PA448803	960	0.898
NULL	Breast_Cancer_Res_2012_Jun_14_14(3)_R95.nxml.txt.nlp	22697792	SENT460	25	25	19	19	anastrozole	aromatase	PA448432	1588	0.898
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_17_2013_523484.nxml.txt.nlp	23843878	SENT9	2	2	21	21	curcumin	CYP2E1	PA151958596	1571	0.898
NULL	Br_J_Cancer_2010_Jan_5_102(1)_134-143.nxml.txt.nlp	19920829	SENT179	12	12	8	8	pertuzumab	IL-2		3558	0.898
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT271	29	29	3	3	tenofovir	ABCC10	PA10204	89845	0.898
NULL	Curr_Pharm_Biotechnol_2012_May_13(6)_969-986.nxml.txt.nlp	22039792	SENT75	14	14	24	24	loperamide	P-gp	PA450262	5243	0.898
NULL	Cell_Mol_Life_Sci_2011_Nov_2_68(21)_3573-3587.nxml.txt.nlp	21365278	SENT197	34	34	19	19	iloprost	EP2	PA164746843	5732;10407	0.898
NULL	Cancer_Res_Treat_2013_Mar_31_45(1)_55-62.nxml.txt.nlp	23613671	SENT127	11	11	22	22	oxaliplatin	KRAS	PA131285527	3845	0.898
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_May_22_66(Pt_6)_o1400.nxml.txt.nlp	21579479	SENT47	19	19	13	13	ethanol	mol	PA448073	90527	0.898
NULL	Oncoscience_2014_Aug_7_1(8)_540-549.nxml.txt.nlp	25594061	SENT135	14	14	12	12	erlotinib	EGFR	PA134687924	1956	0.898
NULL	Angiogenesis_2012_Jun_2_15(2)_275-286.nxml.txt.nlp	22382585	SENT25	14	14	10	10	celecoxib	CTX	PA448871	1593	0.898
NULL	Bioinformation_2012_Jan_6_8(1)_13-19.nxml.txt.nlp	22359429	SENT142	11	11	40	40	curcumin	MRP1	PA151958596	4437	0.898
NULL	Adv_Appl_Bioinforma_Chem_2008_Oct_30_1_85-98.nxml.txt.nlp	21918608	SENT172	11	11	0	0	bortezomib	SPARC	PA10252	6678	0.898
NULL	Environ_Health_Perspect_2010_Dec_12_118(12)_1707-1713.nxml.txt.nlp	20705543	SENT142	14	14	4	4	bleomycin	XRCC1	PA448645	7515	0.898
NULL	Curr_Rev_Musculoskelet_Med_2009_Mar_10_2(1)_56-64.nxml.txt.nlp	19468919	SENT78	5	5	15	15	indomethacin	OPG	PA449982	690	0.898
NULL	Exp_Ther_Med_2013_Jul_25_6(1)_109-114.nxml.txt.nlp	23935730	SENT137	15	15	24	24	vincristine	CHOP	PA451879	1649	0.898
NULL	Exp_Ther_Med_2013_Nov_13_6(5)_1317-1321.nxml.txt.nlp	24223665	SENT110	11	11	34	34	cisplatin	CD133	PA449014	8842	0.898
NULL	Nucleic_Acids_Res_2011_Sep_7_39(17)_7465-7476.nxml.txt.nlp	21653549	SENT182	3	3	13	13	etoposide	SC35	PA449552	6427	0.898
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Nov_20_66(Pt_12)_o3256.nxml.txt.nlp	21589540	SENT47	18	18	12	12	ethanol	mol	PA448073	90527	0.898
NULL	Int_J_Biol_Sci_2014_Sep_6_10(9)_1007-1017.nxml.txt.nlp	25210499	SENT91	30	30	11	11	tamoxifen	p63	PA451581	8626	0.898
NULL	J_Cancer_2013_Nov_14_4(9)_703-715.nxml.txt.nlp	24312140	SENT223	24	24	9	9	genistein	BRCA2	PA165109660	675	0.898
NULL	Mol_Cancer_2009_Apr_22_8_26.nxml.txt.nlp	19386116	SENT146	24	24	13	13	ritonavir	AKT	PA451260	207	0.898
NULL	Oxid_Med_Cell_Longev_2013_Apr_21_2013_412576.nxml.txt.nlp	23710286	SENT109	17	17	5	5	curcumin	NQO1	PA151958596	1728	0.898
NULL	Clinics_(Sao_Paulo)_2013_May_68(5)_694-701.nxml.txt.nlp	23778405	SENT152	5	5	8	8	curcumin	MDR1	PA151958596	5243	0.898
NULL	Oncotarget_2011_Mar_10_2(3)_186-196.nxml.txt.nlp	21406729	SENT112	37	37	33	33	orlistat	SREBP1	PA164776864	6720	0.898
NULL	Cell_Death_Dis_2014_Jan_30_5(1)_e1030.nxml.txt.nlp	24481444	SENT7	20	20	13	13	sorafenib	Bcl-2	PA7000	596	0.898
NULL	Mol_Cancer_2009_Nov_10_8_99.nxml.txt.nlp	19903356	SENT46	19	19	22	22	imatinib	IGFBP3	PA10804	3486	0.898
NULL	Front_Immunol_2012_Jan_24_3_3.nxml.txt.nlp	22566889	SENT880	13	13	5	5	rituximab	gamma	PA451261	9913	0.898
NULL	Open_Access_J_Urol_2011_May_10_3_69-82.nxml.txt.nlp	24198638	SENT67	14	14	33	33	warfarin	UGT1A9	PA451906	54600	0.898
NULL	Onco_Targets_Ther_2014_Nov_28_7_2183-2195.nxml.txt.nlp	25506223	SENT91	19	19	27	27	doxorubicin	MICA	PA449412	100507436	0.898
NULL	Ann_Clin_Transl_Neurol_2014_Dec_21_1(12)_996-1005.nxml.txt.nlp	25574474	SENT189	25	25	21	21	elacridar	P-gp		5243	0.898
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT108	0	0	19	19	neratinib	PI3K	PA165291472	5290	0.898
NULL	Open_Virol_J_2010_Apr_8_4_1-6.nxml.txt.nlp	20461227	SENT62	24	24	0	0	l-glutamine	PC3	PA10090	57332;7832;5122	0.898
NULL	Cancer_Res_Treat_2012_Sep_30_44(3)_202-209.nxml.txt.nlp	23091447	SENT156	8	8	5	5	gefitinib	EGFR	PA131301952	1956	0.898
NULL	J_Biol_Chem_2011_Oct_7_286(40)_34998-35006.nxml.txt.nlp	21757733	SENT115	7	7	14	14	forskolin	PLIN1	PA146096022	5346	0.898
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2675-2684.nxml.txt.nlp	24129246	SENT235	22	22	40	40	etoposide	KSR1	PA449552	8844	0.898
NULL	Breast_Cancer_(Auckl)_2012_Mar_7_6_67-77.nxml.txt.nlp	22438669	SENT54	0	0	23	23	lapatinib	HER2	PA152241907	2064	0.898
NULL	Ann_Rheum_Dis_2010_Mar_9_69(4)_631-637.nxml.txt.nlp	20215140	SENT238	11	11	7	7	tocilizumab	IL-6	PA165292659	3569	0.898
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Mar_28_68(Pt_4)_o1219.nxml.txt.nlp	22606156	SENT59	23	23	17	17	ethanol	mol	PA448073	90527	0.898
NULL	Mol_Pain_2012_Sep_22_8_71.nxml.txt.nlp	22998838	SENT14	21	21	4	4	paclitaxel	CB2	PA450761	1269	0.898
NULL	Oxid_Med_Cell_Longev_2011_Oct_15_2011_703676.nxml.txt.nlp	22013498	SENT8	19	19	10	10	resveratrol	IL-6		3569	0.898
NULL	Comput_Struct_Biotechnol_J_2013_Mar_12_4_e201301008.nxml.txt.nlp	24688689	SENT168	22	22	2	2	ethanol	NAT	PA448073	6046	0.898
NULL	Int_J_Biomed_Sci_2007_Sep_3(3)_211-216.nxml.txt.nlp	23675046	SENT88	12	12	24	24	mannitol	ANOVA	PA450320	4858	0.898
NULL	Cancer_Cell_Int_2010_Sep_1_10_30.nxml.txt.nlp	20809984	SENT148	1	1	17	17	estradiol	EGF	PA449503	1950	0.898
NULL	Evid_Based_Complement_Alternat_Med_2014_May_18_2014_156276.nxml.txt.nlp	24963318	SENT68	13	13	39	39	hesperidin	PLP2	PA449867	5355	0.898
NULL	Allergy_Asthma_Immunol_Res_2014_Nov_19_6(6)_548-557.nxml.txt.nlp	25374755	SENT18	5	5	12	12	lovastatin	CCL11	PA450272	6356	0.898
NULL	Oncol_Lett_2013_Feb_7_5(2)_440-446.nxml.txt.nlp	23420122	SENT12	4	4	19	19	sorafenib	EGFR	PA7000	1956	0.898
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT173	8	8	26	26	metformin	HIP	PA450395	6767;6159;64399;5068	0.898
NULL	Cell_Death_Dis_2013_Sep_5_4(9)_e791.nxml.txt.nlp	24008735	SENT44	9	9	21	21	gemcitabine	Bcl-2	PA449748	596	0.898
NULL	Cancer_Biol_Med_2013_Dec_10(4)_214-220.nxml.txt.nlp	24349831	SENT198	14	14	20	20	olaparib	BRCA2		675	0.898
NULL	Clin_Interv_Aging_2010_May_25_5_149-156.nxml.txt.nlp	20517484	SENT133	22	22	13	13	rasagiline	CYP1A2	PA164764584	1544	0.898
NULL	Cancer_Cell_Int_2010_Sep_9_10_32.nxml.txt.nlp	20828393	SENT125	7	7	16	16	cisplatin	ATF3	PA449014	467	0.898
NULL	Biosci_Rep_2012_Dec_1_32(Pt_6)_587-595.nxml.txt.nlp	NULL	SENT372	15	15	3	3	sunitinib	HIF-1	PA162372840	29072	0.898
NULL	Breast_Cancer_Res_2004_Jun_29_6(5)_R488-R498.nxml.txt.nlp	15318931	SENT10	29	29	20	20	estradiol	UGT2B15	PA449503	7366	0.898
NULL	Front_Oncol_2013_Oct_1_3_259.nxml.txt.nlp	24102047	SENT64	17	17	21	21	bevacizumab	HER-2	PA130232992	2064	0.898
NULL	Asian_J_Androl_2014_Apr_25_Sep-Oct_16(5)_761-766.nxml.txt.nlp	24799635	SENT116	43	43	11	11	fructose	DAN	PA449716	5073;4681	0.898
NULL	Clin_Pharmacokinet_2014_Oct_15_53(2)_155-164.nxml.txt.nlp	24127209	SENT29	43	43	20	20	clopidogrel	CYP2B6	PA449053	1555	0.898
NULL	Clin_Mol_Hepatol_2014_Jun_30_20(2)_89-136.nxml.txt.nlp	25032178	SENT334	8	8	18	18	boceprevir	CYP2C	PA165948902	1562	0.898
NULL	Front_Genet_2012_Oct_19_3_220.nxml.txt.nlp	23091481	SENT36	18	18	29	29	bleomycin	p53	PA448645	7157	0.898
NULL	Oncogene_2013_Sep_12_32(37)_4355-4365.nxml.txt.nlp	23108409	SENT25	5	5	28	28	hyaluronan	p38	PA165958431	10598;1432;7965	0.898
NULL	Curr_Cardiol_Rev_2010_Feb_6(1)_62-70.nxml.txt.nlp	21286280	SENT133	4	4	27	27	isoproterenol	ghrelin	PA450121	51738	0.898
NULL	Int_J_Biol_Sci_2014_Jun_3_10(6)_602-613.nxml.txt.nlp	24948873	SENT96	5	5	9	9	dutasteride	SRD5A1	PA164749300	6715	0.898
NULL	Br_J_Cancer_2009_Jun_2_100(11)_1704-1719.nxml.txt.nlp	19436303	SENT77	0	0	8	8	panitumumab	EGFR	PA162373091	1956	0.898
NULL	Front_Physiol_2013_Nov_14_4_323.nxml.txt.nlp	24294204	SENT256	36	36	7	7	metoprolol	UGT1A1	PA450480	54658	0.898
NULL	Cell_J_2012_Dec_22_Winter_13(4)_281-289.nxml.txt.nlp	23507624	SENT20	15	15	31	31	propranolol	IL-17	PA451145	3605	0.898
NULL	Breast_Cancer_Res_2011_Mar_11_13(2)_R29.nxml.txt.nlp	21396094	SENT47	20	20	27	27	fulvestrant	HRG	PA164747170	3084;3273	0.898
NULL	J_Biomed_Biotechnol_2011_Feb_23_2011_187103.nxml.txt.nlp	21403873	SENT275	19	19	8	8	erythromycin	CYP3A4	PA449493	1576	0.898
NULL	Cent_European_J_Urol_2011_Dec_9_64(4)_256-257.nxml.txt.nlp	24578906	SENT15	15	15	4	4	doxazosin	CD133	PA449407	8842	0.898
NULL	J_Carcinog_2014_Feb_20_13_4.nxml.txt.nlp	24737952	SENT193	0	0	3	3	gefitinib	EGFR	PA131301952	1956	0.898
NULL	Clin_Interv_Aging_2015_Jan_14_10_269-275.nxml.txt.nlp	25609939	SENT100	33	33	15	15	galantamine	CYP2D6	PA449726	1565	0.898
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT1690	4	4	2	2	ritonavir	CYP3A4	PA451260	1576	0.898
NULL	Acta_Pharmacol_Sin_2009_Nov_5_30(11)_1522-1528.nxml.txt.nlp	19890360	SENT124	19	19	3	3	fenoterol	IL-8	PA10079	3576	0.898
NULL	Iran_J_Pharm_Res_2013_Summer_12(3)_445-455.nxml.txt.nlp	24250651	SENT35	11	11	1	1	fluorescein	CD4	PA164746009	920	0.898
NULL	Oxid_Med_Cell_Longev_2012_Jun_3_2012_914273.nxml.txt.nlp	22701758	SENT206	3	3	31	31	resveratrol	SIRT1		23411	0.898
NULL	Breast_Cancer_Res_2009_Jun_23_11(Suppl_1)_S19.nxml.txt.nlp	NULL	SENT4	0	0	21	21	neratinib	HER2	PA165291472	2064	0.898
NULL	Am_J_Pathol_2011_Mar_178(3)_1245-1256.nxml.txt.nlp	21356375	SENT34	3	3	6	6	indomethacin	COX	PA449982	1351	0.898
NULL	J_Biol_Chem_2009_Feb_27_284(9)_5645-5653.nxml.txt.nlp	19095655	SENT89	35	35	30	30	phenformin	AMPK	PA1000	5563	0.898
NULL	Neuropsychopharmacology_2009_Jul_25_34(8)_1968-1978.nxml.txt.nlp	19322168	SENT258	45	45	25	25	clozapine	PI3K	PA449061	5290	0.898
NULL	BMJ_Open_2011_Feb_23_1(1)_e000007.nxml.txt.nlp	22021723	SENT260	33	33	7	7	creatine	MRI	PA164778930	78996	0.898
NULL	Exp_Diabetes_Res_2012_Jan_29_2012_159874.nxml.txt.nlp	22319521	SENT143	2	2	17	17	telmisartan	VEGF-A	PA451605	7422	0.898
NULL	Nat_Commun_2013_Nov_26_4_10_1038_ncomms3816.nxml.txt.nlp	24281383	SENT176	9	9	44	44	ethanol	S16	PA448073	6217	0.898
NULL	Exp_Ther_Med_2014_Jun_27_7(6)_1752-1756.nxml.txt.nlp	24926379	SENT61	0	0	19	19	vildagliptin	GLP-1	PA165958346	100125288	0.898
NULL	Anesthesiol_Res_Pract_2012_Nov_24_2012_921405.nxml.txt.nlp	22162685	SENT23	4	4	12	12	lidocaine	NPY	PA450226	4852	0.898
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT392	46	46	25	25	heparin	FGF1	PA449855	2246	0.898
NULL	Breast_Cancer_Res_2012_Jan_6_14(1)_R2.nxml.txt.nlp	22225778	SENT219	20	20	25	25	docetaxel	TNFSF10	PA449383	8743	0.898
NULL	Cancer_Cell_2007_Dec_11_12(6)_514-527.nxml.txt.nlp	18068629	SENT140	12	12	5	5	paclitaxel	THBS2	PA450761	7058	0.898
NULL	Mol_Cancer_2010_Nov_2_9_289.nxml.txt.nlp	21044322	SENT149	30	30	17	17	vincristine	RGS10	PA451879	6001	0.898
NULL	Emerg_Infect_Dis_2012_Nov_18(11)_e2.nxml.txt.nlp	23092736	SENT64	5	5	18	18	ethambutol	DST	PA164784021	667	0.898
NULL	Aging_(Albany_NY)_2009_Mar_28_1(3)_275-277.nxml.txt.nlp	20157515	SENT23	16	16	4	4	etoposide	p65	PA449552	5970	0.898
NULL	Reprod_Biol_Endocrinol_2004_Jun_16_2_31.nxml.txt.nlp	15200680	SENT91	8	8	14	14	tamoxifen	aromatase	PA451581	1588	0.898
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Oct_31_65(Pt_11)_o2919.nxml.txt.nlp	21578497	SENT54	21	21	15	15	ethanol	mol	PA448073	90527	0.898
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1137-1144.nxml.txt.nlp	20234366	SENT140	19	19	10	10	cetuximab	MKP-1	PA10040	1843	0.898
NULL	Blood_Cancer_J_2014_Oct_31_4(10)_e255.nxml.txt.nlp	25360901	SENT39	3	3	6	6	plerixafor	CD34	PA165958410	947	0.898
NULL	Front_Oncol_2014_Sep_15_4_244.nxml.txt.nlp	25309870	SENT86	0	0	19	19	afatinib	EGFR	PA165981154	1956	0.898
NULL	Br_J_Cancer_1995_May_71(5)_907-913.nxml.txt.nlp	7734314	SENT15	22	22	7	7	doxorubicin	MDR1	PA449412	5243	0.898
NULL	Br_J_Cancer_2011_Jul_26_105(3)_372-381.nxml.txt.nlp	21730979	SENT140	4	4	8	8	caffeine	ATR	PA448710	390502;84168;545	0.898
NULL	Ann_Oncol_2011_Mar_8_22(3)_503-514.nxml.txt.nlp	20616198	SENT55	9	9	20	20	letrozole	aromatase	PA450196	1588	0.898
NULL	J_Cancer_2013_Jan_11_4(2)_117-132.nxml.txt.nlp	23386910	SENT282	16	16	9	9	trastuzumab	HER2	PA451743	2064	0.898
NULL	Arthritis_Res_2001_May_18_3(4)_221-227.nxml.txt.nlp	11438040	SENT129	0	0	11	11	clodronate	IL-6	PA10239	3569	0.898
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S272-S275.nxml.txt.nlp	21525467	SENT145	19	19	13	13	metformin	GLP-1	PA450395	100125288	0.898
NULL	Ann_Clin_Microbiol_Antimicrob_2005_Apr_1_4_6.nxml.txt.nlp	15804353	SENT115	2	2	34	34	capreomycin	Met	PA164746226	79811	0.898
NULL	Cerebrovasc_Dis_Extra_2013_Jun_11_3(1)_85-94.nxml.txt.nlp	23885261	SENT91	37	37	9	9	alteplase	TACI	PA164776730	23495	0.898
NULL	Breast_Cancer_Res_2008_Dec_18_10(Suppl_4)_S26.nxml.txt.nlp	19128440	SENT14	13	13	43	43	tamoxifen	ATAC	PA451581	6375	0.898
NULL	Neurosci_Lett_2013_Feb_28_539(C)_16-21.nxml.txt.nlp	23347841	SENT366	36	36	3	3	ethanol	ABCA1	PA448073	19	0.898
NULL	Pharmaceuticals_(Basel)_2011_Nov_11_4(11)_1503-1517.nxml.txt.nlp	NULL	SENT41	23	23	31	31	capsaicin	TRPV1	PA448776	7442	0.898
NULL	Cancer_Cell_Int_2012_Jun_18_12_28.nxml.txt.nlp	22709531	SENT8	18	18	43	43	imatinib	p120ctn	PA10804	1500	0.898
NULL	Clin_Sci_(Lond)_2009_Nov_16_118(Pt_4)_269-279.nxml.txt.nlp	19698082	SENT132	24	24	0	0	ramipril	ACE2	PA451223	59272	0.898
NULL	Exp_Diabetes_Res_2012_May_28_2012_924168.nxml.txt.nlp	22693487	SENT37	11	11	0	0	liraglutide	GLP-1	PA165958364	100125288	0.898
NULL	Br_J_Haematol_2014_Mar_13_164(1)_811-821.nxml.txt.nlp	24328678	SENT208	25	25	15	15	lenalidomide	Aiolos	PA162363968	22806	0.898
NULL	Indian_J_Pharm_Sci_2014_Mar-Apr_76(2)_125-131.nxml.txt.nlp	24843185	SENT156	10	10	15	15	resveratrol	S100B		6285	0.898
NULL	Environ_Health_Perspect_2010_Jul_3_118(7)_936-942.nxml.txt.nlp	20199942	SENT213	19	19	13	13	arsenite	p53	PA452638	7157	0.898
NULL	Mol_Cancer_2010_May_28_9_130.nxml.txt.nlp	20509890	SENT11	13	13	4	4	cisplatin	TGFBI	PA449014	7045	0.898
NULL	Curr_Clin_Pharmacol_2008_Sep_3(3)_198-203.nxml.txt.nlp	18781906	SENT35	17	17	12	12	topiramate	CYP3A4	PA451728	1576	0.898
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_13_2013_874367.nxml.txt.nlp	23843887	SENT46	21	21	40	40	l-glutamine	CO2	PA10090	4513	0.898
NULL	Cancers_(Basel)_2013_May_27_5(2)_617-638.nxml.txt.nlp	24216994	SENT208	23	23	5	5	curcumin	PC3	PA151958596	57332;7832;5122	0.898
NULL	Front_Oncol_2014_Sep_15_4_244.nxml.txt.nlp	25309870	SENT58	9	9	11	11	gefitinib	EGFR	PA131301952	1956	0.898
NULL	Mol_Cancer_2013_May_19_12_43.nxml.txt.nlp	23683438	SENT140	16	16	0	0	s-adenosylmethionine	DNMT1	PA164754994	1786	0.898
NULL	J_Breast_Cancer_2011_Jun_18_14(2)_140-146.nxml.txt.nlp	21847410	SENT172	8	8	19	19	trastuzumab	HER2	PA451743	2064	0.898
NULL	Mol_Neurodegener_2011_Jun_22_6_43.nxml.txt.nlp	21696630	SENT147	9	9	16	16	desmopressin	PKD1	PA449237	5310	0.898
NULL	Oncol_Lett_2013_Feb_9_5(2)_552-558.nxml.txt.nlp	23420128	SENT142	16	16	25	25	imatinib	KIT	PA10804	3815	0.898
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT211	16	16	10	10	bevacizumab	VEGFR2	PA130232992	3791	0.898
NULL	Contemp_Oncol_(Pozn)_2012_Nov_20_16(5)_401-406.nxml.txt.nlp	23788917	SENT162	23	23	10	10	neratinib	EGFR	PA165291472	1956	0.898
NULL	Exp_Ther_Med_2013_Mar_8_5(3)_707-710.nxml.txt.nlp	23404433	SENT98	13	13	16	16	cisplatin	Bcl-2	PA449014	596	0.898
NULL	Cancer_Cell_Int_2008_Mar_18_8_3.nxml.txt.nlp	18348720	SENT104	5	5	40	40	gefitinib	EGFR	PA131301952	1956	0.898
NULL	Br_J_Cancer_2014_Jan_21_110(2)_421-429.nxml.txt.nlp	24300973	SENT203	28	28	1	1	oxaliplatin	DAP3	PA131285527	58512;7818	0.898
NULL	Emerg_Infect_Dis_2015_Jan_21(1)_40-47.nxml.txt.nlp	25530077	SENT142	18	18	5	5	ceftazidime	API	PA448861	5345	0.898
NULL	Clin_Med_Insights_Oncol_2012_Mar_12_6_153-164.nxml.txt.nlp	22550404	SENT81	44	44	28	28	vorinostat	Raf-1	PA164748224	5894	0.898
NULL	Cancer_Immunol_Immunother_2011_Jun_25_60(6)_793-808.nxml.txt.nlp	21350947	SENT224	11	11	21	21	sorafenib	IFN	PA7000	3439	0.898
NULL	Mediators_Inflamm_2010_Oct_5_2010_321061.nxml.txt.nlp	20953358	SENT170	15	15	5	5	methacholine	NOS1	PA165958382	340719;4842	0.898
NULL	Allergy_Asthma_Clin_Immunol_2005_Jun_15_1(2)_65-80.nxml.txt.nlp	20529227	SENT66	13	13	11	11	trypsin	PAR2	PA451806	2150;55065;8856	0.898
NULL	Indian_J_Med_Res_2012_Apr_135(4)_500-505.nxml.txt.nlp	22664497	SENT78	16	16	11	11	estradiol	adiponectin	PA449503	9370	0.898
NULL	Infect_Dis_Obstet_Gynecol_2012_Feb_25_2012_157159.nxml.txt.nlp	22505797	SENT205	16	16	3	3	azithromycin	SPTB	PA448519	6710	0.898
NULL	Exp_Diabetes_Res_2011_Jun_4_2011_489708.nxml.txt.nlp	21747829	SENT157	18	18	0	0	aliskiren	GLP-1	PA143487910	100125288	0.898
NULL	J_Oncol_2010_Feb_22_2010_891059.nxml.txt.nlp	20182637	SENT64	13	13	5	5	cisplatin	PARP-1	PA449014	25976	0.898
NULL	Breast_Cancer_Res_2011_Feb_3_13(1)_R16.nxml.txt.nlp	21291529	SENT145	27	27	18	18	tamoxifen	PHD1	PA451581	112398	0.898
NULL	Eur_J_Clin_Pharmacol_2010_Nov_29_66(11)_1131-1136.nxml.txt.nlp	20669013	SENT140	11	11	8	8	voriconazole	CYP3A4	PA10233	1576	0.898
NULL	Diabetes_2011_Nov_17_60(11)_2691-2700.nxml.txt.nlp	21896928	SENT283	15	15	11	11	resveratrol	SIRT1		23411	0.898
NULL	Oncotarget_2013_Apr_23_4(6)_816-829.nxml.txt.nlp	23615731	SENT115	18	18	0	0	doxycycline	HSF1	PA449415	3297	0.898
NULL	J_Antimicrob_Chemother_2012_Sep_11_67(9)_2213-2221.nxml.txt.nlp	22687893	SENT33	0	0	9	9	efavirenz	CYP3A4	PA449441	1576	0.898
NULL	Mol_Biol_Cell_2014_Jul_1_25(13)_2116-2127.nxml.txt.nlp	24807908	SENT206	11	11	27	27	hemin	NQO1	PA449849	1728	0.898
NULL	Cell_Death_Dis_2013_Jan_31_4(1)_e478.nxml.txt.nlp	23370278	SENT84	3	3	9	9	cisplatin	FANCD2	PA449014	2177	0.898
NULL	Breast_Cancer_Res_2013_Nov_29_15(6)_R114.nxml.txt.nlp	24289103	SENT317	23	23	7	7	tamoxifen	EGFR	PA451581	1956	0.898
NULL	Pharmaceuticals_(Basel)_2013_Aug_2_6(8)_915-928.nxml.txt.nlp	24276376	SENT12	33	33	25	25	aspirin	P2Y12	PA448497	64805	0.898
NULL	Basic_Clin_Neurosci_2013_Autumn_4(4)_323-328.nxml.txt.nlp	25337364	SENT137	15	15	22	22	colchicine	CA1	PA449092	759	0.898
NULL	Br_J_Cancer_2013_Jul_23_109(2)_342-350.nxml.txt.nlp	23807172	SENT21	4	4	31	31	sorafenib	VEGFR2	PA7000	3791	0.898
NULL	Br_J_Cancer_2009_Jul_21_101(2)_238-243.nxml.txt.nlp	19568242	SENT162	12	12	6	6	sunitinib	IFN	PA162372840	3439	0.898
NULL	Acta_Pharmacol_Sin_2011_Aug_11_32(8)_999-1008.nxml.txt.nlp	21743486	SENT148	4	4	18	18	fasudil	JNK	PA165946121	5599	0.898
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT138	9	9	18	18	neratinib	HER3	PA165291472	2065	0.898
NULL	Oxid_Med_Cell_Longev_2013_Apr_21_2013_412576.nxml.txt.nlp	23710286	SENT127	8	8	27	27	curcumin	KEAP1	PA151958596	9817	0.898
NULL	J_Young_Pharm_2010_Jan-Mar_2(1)_54-58.nxml.txt.nlp	21331192	SENT141	17	17	28	28	trypsin	DAI	PA451806	81030	0.898
NULL	Eur_J_Clin_Pharmacol_2008_Feb_26_64(2)_133-157.nxml.txt.nlp	18224312	SENT205	21	21	15	15	warfarin	CYP2C9	PA451906	1559	0.898
NULL	Front_Oncol_2014_Apr_9_4_75.nxml.txt.nlp	24782986	SENT179	11	11	21	21	paclitaxel	Oct4	PA450761	5460	0.898
NULL	Front_Immunol_2013_Mar_27_4_76.nxml.txt.nlp	23543707	SENT218	29	29	10	10	cetuximab	gamma	PA10040	9913	0.898
NULL	Nat_Commun_2014_Dec_8_5_5736.nxml.txt.nlp	25484020	SENT164	11	11	2	2	letrozole	PAR2	PA450196	2150;55065;8856	0.898
NULL	Int_J_Gen_Med_2012_Nov_9_5_935-942.nxml.txt.nlp	23204857	SENT4	9	9	43	43	isoflurane	CA3	PA450106	761	0.898
NULL	Case_Rep_Med_2009_Oct_11_2009_693014.nxml.txt.nlp	19826634	SENT22	17	17	1	1	creatine	CO2	PA164778930	4513	0.898
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Sep_17_64(Pt_10)_o1951.nxml.txt.nlp	21201155	SENT59	27	27	14	14	ethanol	mol	PA448073	90527	0.898
NULL	Mol_Pain_2013_Mar_7_9_11.nxml.txt.nlp	23497285	SENT217	5	5	19	19	remifentanil	ANOVA	PA451232	4858	0.898
NULL	Comput_Math_Methods_Med_2014_Feb_3_2014_813067.nxml.txt.nlp	24639887	SENT230	22	22	33	33	tamoxifen	EMT	PA451581	3702;6581	0.898
NULL	Clin_Psychopharmacol_Neurosci_2013_Dec_24_11(3)_144-151.nxml.txt.nlp	24465251	SENT13	21	21	6	6	quetiapine	IL-4	PA451201	3565	0.898
NULL	Nat_Med_2012_Feb_19_18(3)_446-451.nxml.txt.nlp	22344296	SENT36	11	11	3	3	lopinavir	ATV	PA450264	4683	0.898
NULL	J_Ophthalmol_2012_Feb_28_2012_786870.nxml.txt.nlp	22523653	SENT36	6	6	39	39	bevacizumab	PED	PA130232992	8682	0.898
NULL	Infect_Drug_Resist_2008_Sep_9_1_27-44.nxml.txt.nlp	21694878	SENT193	35	35	22	22	linezolid	VISA	PA450233	57506	0.898
NULL	Indian_J_Med_Paediatr_Oncol_2014_Apr-Jun_35(2)_176-180.nxml.txt.nlp	25197183	SENT35	23	23	4	4	trastuzumab	HER-2	PA451743	2064	0.898
NULL	Biomed_Res_Int_2014_Jun_4_2014_253243.nxml.txt.nlp	24995279	SENT45	35	35	7	7	mitoxantrone	CHOP	PA450526	1649	0.898
NULL	Biologics_2012_Sep_25_6_337-345.nxml.txt.nlp	23055691	SENT52	22	22	17	17	gefitinib	EGFR	PA131301952	1956	0.898
NULL	BMJ_Open_Diabetes_Res_Care_2014_Dec_3_2(1)_e000034.nxml.txt.nlp	25512873	SENT26	42	42	4	4	lipase	ANGPTL4	PA450239	51129	0.898
NULL	Brain_Pathol_2010_Jan_20(1)_17-27.nxml.txt.nlp	19371355	SENT209	29	29	15	15	etoposide	Bcl-2	PA449552	596	0.898
NULL	J_Cell_Biol_1997_Jul_28_138(2)_307-321.nxml.txt.nlp	9230073	SENT143	11	11	16	16	staurosporine	TGN	PA165109623	7038	0.898
NULL	Breast_Cancer_Res_Treat_2014_Dec_21_143(3)_459-467.nxml.txt.nlp	24362951	SENT213	10	10	17	17	fulvestrant	aromatase	PA164747170	1588	0.898
NULL	Breast_Cancer_(Auckl)_2012_Nov_19_6_191-207.nxml.txt.nlp	23226023	SENT244	13	13	18	18	trastuzumab	HER2	PA451743	2064	0.898
NULL	Patient_Prefer_Adherence_2011_Dec_23_6_1-9.nxml.txt.nlp	22272064	SENT67	14	14	22	22	telmisartan	ACE	PA451605	1636	0.898
NULL	Acta_Histochem_Cytochem_2013_Dec_28_46(6)_187-197.nxml.txt.nlp	24610966	SENT376	23	23	1	1	pilocarpine	AQP5	PA450962	362	0.898
NULL	Cancer_Cell_Int_2013_Mar_4_13_21.nxml.txt.nlp	23497288	SENT220	16	16	10	10	etoposide	EWS	PA449552	2130	0.898
NULL	Mol_Biol_Cell_2013_Jul_15_24(14)_2186-2200.nxml.txt.nlp	23699397	SENT86	18	18	45	45	staurosporine	TRAIL	PA165109623	8743	0.898
NULL	Oncotarget_2012_Oct_20_3(10)_1236-1245.nxml.txt.nlp	23100449	SENT76	33	33	27	27	doxorubicin	NGAL	PA449412	3934	0.898
NULL	Aging_(Albany_NY)_2012_Dec_6_4(11)_823-842.nxml.txt.nlp	23235539	SENT328	25	25	9	9	paraformaldehyde	HCA2	PA450790	139081;55811;338442	0.898
NULL	Curr_Colorectal_Cancer_Rep_2012_Mar_14_8(1)_66-81.nxml.txt.nlp	22389639	SENT177	9	9	17	17	curcumin	KAT2B	PA151958596	8850	0.898
NULL	Arthritis_Res_Ther_2007_Sep_23_9(5)_R96.nxml.txt.nlp	17888176	SENT213	31	31	27	27	etanercept	IL-17	PA449515	3605	0.898
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT328	12	12	31	31	risperidone	PRL	PA451257	5617	0.898
NULL	Mol_Biol_Rep_2013_Sep_28_40(10)_5573-5585.nxml.txt.nlp	24078156	SENT9	16	16	5	5	iron	IRP2	PA450087	3658	0.898
NULL	J_Korean_Med_Sci_2007_Apr_30_22(2)_283-289.nxml.txt.nlp	17449938	SENT102	25	25	13	13	minoxidil	Bcl-2	PA450521	596	0.898
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT214	0	0	9	9	nutlin-3	DR4		8797	0.898
NULL	Nat_Commun_2013_Aug_15_4_2130.nxml.txt.nlp	23945651	SENT42	11	11	3	3	etoposide	ATG5	PA449552	9474	0.898
NULL	Breast_Cancer_Res_2010_Oct_20_12(5)_315.nxml.txt.nlp	21062517	SENT16	7	7	1	1	tamoxifen	PI3K	PA451581	5290	0.898
NULL	Mol_Cancer_2010_Dec_20_9_316.nxml.txt.nlp	21172016	SENT342	30	30	10	10	heparin	CO2	PA449855	4513	0.898
NULL	Breast_Cancer_Res_2014_May_28_16(3)_R53.nxml.txt.nlp	24886537	SENT130	12	12	16	16	toremifene	aromatase	PA451731	1588	0.898
NULL	Clin_Med_Insights_Oncol_2012_Mar_19_6_165-178.nxml.txt.nlp	22474408	SENT220	3	3	12	12	fludarabine	GM-CSF	PA449655	1437	0.898
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2013_Sep_1_6_25-37.nxml.txt.nlp	24031162	SENT56	0	0	11	11	metformin	GLP-1	PA450395	100125288	0.898
NULL	J_Thorac_Oncol_2015_Jan_29_10(1)_156-163.nxml.txt.nlp	25247337	SENT70	12	12	5	5	afatinib	TTF	PA165981154	399	0.898
NULL	Pharmaceuticals_(Basel)_2014_Apr_14_7(4)_453-463.nxml.txt.nlp	24736104	SENT131	29	29	5	5	diclofenac	GIT	PA449293	5034	0.898
NULL	Pain_Res_Treat_2011_Aug_14_2011_864605.nxml.txt.nlp	22110933	SENT132	0	0	9	9	gabapentin	PLP	PA449720	25824;5744	0.898
NULL	Acta_Pharmacol_Sin_2010_Jun_4_31(6)_709-717.nxml.txt.nlp	20523342	SENT129	14	14	1	1	glucose	IGF2BP2	PA449773	10644	0.898
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT112	41	41	13	13	cisplatin	MVP	PA449014	9961	0.898
NULL	Support_Care_Cancer_2009_Sep_10_17(9)_1187-1193.nxml.txt.nlp	19205754	SENT88	21	21	36	36	dolasetron	CYP2D6	PA449390	1565	0.898
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT27	15	15	4	4	imatinib	ABCG2	PA10804	9429	0.898
NULL	Diabetes_2011_Nov_17_60(11)_2691-2700.nxml.txt.nlp	21896928	SENT142	11	11	13	13	resveratrol	SIRT1		23411	0.898
NULL	Front_Oncol_2013_Oct_22_3_268.nxml.txt.nlp	24156094	SENT98	26	26	35	35	doxorubicin	CD133	PA449412	8842	0.898
NULL	Br_J_Cancer_2011_Jul_26_105(3)_407-412.nxml.txt.nlp	21730976	SENT100	17	17	27	27	pha-665752	STAT3		6774	0.898
NULL	Breast_Cancer_Res_2010_Oct_14_12(5)_R84.nxml.txt.nlp	20946630	SENT306	29	29	13	13	choline	Hsp90	PA448976	3320	0.898
NULL	Biomed_Res_Int_2013_Dec_30_2013_470217.nxml.txt.nlp	23509726	SENT64	3	3	29	29	ethanol	CO2	PA448073	4513	0.898
NULL	Oncotarget_2014_Oct_18_5(22)_11604-11619.nxml.txt.nlp	25344099	SENT149	6	6	9	9	cisplatin	RYBP	PA449014	23429	0.898
NULL	Clin_Drug_Investig_2013_Aug_23_33(10)_727-736.nxml.txt.nlp	23975654	SENT72	24	24	26	26	bupropion	CYP2D6	PA448687	1565	0.898
NULL	Antibiotics_(Basel)_2014_Jul_1_3(3)_285-316.nxml.txt.nlp	25364574	SENT181	16	16	2	2	ampicillin	IMP-1	PA448419	10642	0.898
NULL	Nat_Med_2014_Jun_11_20(6)_599-606.nxml.txt.nlp	24813251	SENT82	17	17	28	28	imatinib	ABL1	PA10804	25	0.898
NULL	Exp_Brain_Res_2014_Jun_27_232(8)_2637-2644.nxml.txt.nlp	24969614	SENT136	22	22	9	9	palonosetron	NK1	PA10352	11126	0.898
NULL	Oncoimmunology_2013_Oct_1_2(10)_e27025.nxml.txt.nlp	24353914	SENT180	22	22	10	10	docetaxel	CD4	PA449383	920	0.898
NULL	Braz_J_Microbiol_2012_Jun_1_Oct-Dec_43(4)_1291-1301.nxml.txt.nlp	24031955	SENT80	6	6	15	15	moxifloxacin	REC	PA450555	84515	0.898
NULL	Ann_Surg_Treat_Res_2014_Apr_25_86(4)_220-225.nxml.txt.nlp	24783183	SENT6	34	34	10	10	sunitinib	KIT	PA162372840	3815	0.898
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Sep_12_69(Pt_10)_o1525.nxml.txt.nlp	24098214	SENT78	10	10	24	24	ethanol	mol	PA448073	90527	0.898
NULL	Biomed_Res_Int_2013_Jul_31_2013_692071.nxml.txt.nlp	23984399	SENT181	19	19	9	9	paclitaxel	OCT1	PA450761	5451;6580	0.898
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT161	5	5	7	7	perifosine	DR5	PA165291471	8795	0.898
NULL	Core_Evid_2011_Mar_17_6_31-42.nxml.txt.nlp	21468241	SENT259	25	25	11	11	clopidogrel	P2Y12	PA449053	64805	0.898
NULL	Diagn_Pathol_2014_Jan_23_9_19.nxml.txt.nlp	24457059	SENT27	9	9	12	12	cetuximab	EGFR	PA10040	1956	0.898
NULL	Breast_Cancer_Res_2007_Nov_1_9(6)_R75.nxml.txt.nlp	17976236	SENT185	29	29	23	23	trastuzumab	EGFR	PA451743	1956	0.898
NULL	Cell_Res_2013_Jun_21_23(6)_746-758.nxml.txt.nlp	23689277	SENT206	3	3	1	1	resveratrol	SIRT1		23411	0.898
NULL	Target_Oncol_2013_Jun_27_8(2)_127-136.nxml.txt.nlp	23625191	SENT124	43	43	30	30	panitumumab	KRAS	PA162373091	3845	0.898
NULL	Breast_Cancer_Res_2010_Jun_4_12(3)_R32.nxml.txt.nlp	20525379	SENT17	5	5	0	0	fulvestrant	AGR2	PA164747170	10551	0.898
NULL	Biomed_Res_Int_2013_Dec_31_2013_273498.nxml.txt.nlp	23484100	SENT164	31	31	19	19	genistein	OTC	PA165109660	5009	0.898
NULL	Cases_J_2008_Nov_19_1_331.nxml.txt.nlp	19019232	SENT19	22	22	13	13	aspirin	ACE	PA448497	1636	0.898
NULL	Cell_Death_Dis_2013_Oct_3_4(10)_e834.nxml.txt.nlp	24091677	SENT232	19	19	9	9	vinblastine	Bcl-2	PA451877	596	0.898
NULL	Atherosclerosis_2011_Jun_216(2)_342-347.nxml.txt.nlp	21420681	SENT161	15	15	0	0	heparin	HRG	PA449855	3084;3273	0.898
NULL	J_Korean_Med_Sci_2009_Jun_16_24(3)_525-528.nxml.txt.nlp	19543522	SENT14	12	12	6	6	vincristine	CHOP	PA451879	1649	0.898
NULL	Autophagy_2013_Jul_1_9(7)_985-995.nxml.txt.nlp	23584039	SENT150	27	27	12	12	propranolol	PI-PLC	PA451145	2923	0.898
NULL	Neural_Regen_Res_2013_May_25_8(15)_1349-1359.nxml.txt.nlp	25206429	SENT108	12	12	1	1	nimodipine	NR1	PA450633	27158	0.898
NULL	Biomed_Res_Int_2014_May_4_2014_168407.nxml.txt.nlp	24877061	SENT147	24	24	9	9	gemcitabine	IL-10	PA449748	3586	0.898
NULL	Biologics_2009_Jul_13_3_303-318.nxml.txt.nlp	19707417	SENT106	9	9	18	18	adalimumab	ACR	PA10004	49	0.898
NULL	Cancers_(Basel)_2011_Sep_13_3(3)_3506-3524.nxml.txt.nlp	24212966	SENT83	6	6	14	14	gefitinib	EGFR	PA131301952	1956	0.898
NULL	J_Hematol_Oncol_2013_Aug_19_6_59.nxml.txt.nlp	23958373	SENT210	13	13	9	9	ofatumumab	BTK	PA165291493	695	0.898
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT62	24	24	17	17	methotrexate	MSH2	PA450428	4436	0.898
NULL	Clin_Dev_Immunol_2013_Nov_26_2013_325481.nxml.txt.nlp	24371447	SENT141	7	7	17	17	propofol	p47phox	PA451141	653361	0.898
NULL	Br_J_Cancer_2012_Sep_4_107(6)_956-960.nxml.txt.nlp	22892393	SENT114	38	38	33	33	lapatinib	HER2	PA152241907	2064	0.898
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1016.nxml.txt.nlp	24457960	SENT64	22	22	12	12	paclitaxel	TRAIL	PA450761	8743	0.898
NULL	Cell_Logist_2012_Apr_1_2(2)_117-125.nxml.txt.nlp	23162743	SENT134	9	9	0	0	curcumin	PAK1	PA151958596	5585;5058	0.898
NULL	Oncoscience_2014_Oct_22_1(10)_614-623.nxml.txt.nlp	25593991	SENT95	38	38	19	19	panitumumab	KRAS	PA162373091	3845	0.898
NULL	Mol_Cells_2014_Mar_31_37(3)_234-240.nxml.txt.nlp	24642709	SENT124	9	9	7	7	capsaicin	HO-1	PA448776	3162	0.898
NULL	Cancers_(Basel)_2012_Oct_29_4(4)_1146-1160.nxml.txt.nlp	24213502	SENT53	33	33	16	16	raloxifene	STAR	PA451221	6770;2984	0.898
NULL	Cancer_Med_2014_Apr_27_3(2)_245-251.nxml.txt.nlp	24464861	SENT4	13	13	8	8	metformin	HIF1	PA450395	3091	0.898
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Sep_19_65(Pt_10)_o2496.nxml.txt.nlp	21577946	SENT67	15	15	28	28	ethanol	mol	PA448073	90527	0.898
NULL	Clin_Med_Insights_Cardiol_2010_Oct_11_4_89-93.nxml.txt.nlp	20981132	SENT19	0	0	29	29	benazepril	ACS	PA448561	55902;84680	0.898
NULL	J_Aging_Res_2012_Apr_23_2012_753949.nxml.txt.nlp	22619720	SENT219	0	0	29	29	amobarbital	ADP	PA448401	23038	0.898
NULL	Nat_Commun_2013_Sep_20_4_2444.nxml.txt.nlp	24051492	SENT370	40	40	13	13	nutlin-3	p53		7157	0.898
NULL	Cancer_Cell_Int_2014_Jun_11_14_49.nxml.txt.nlp	24991192	SENT98	6	6	10	10	berberine	AMPK	PA165860812	5563	0.898
NULL	Arthritis_Res_Ther_2007_Sep_23_9(5)_R96.nxml.txt.nlp	17888176	SENT49	13	13	7	7	etanercept	OPG	PA449515	690	0.898
NULL	Oncotarget_2014_Nov_11_5(22)_10963-10964.nxml.txt.nlp	25460503	SENT2	12	12	1	1	trastuzumab	HER2	PA451743	2064	0.898
NULL	Breast_Cancer_Res_2003_Aug_14_5(1)_1-7.nxml.txt.nlp	12559038	SENT115	4	4	11	11	camptothecin	SUMO-1	PA153590860	7341	0.898
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT259	10	10	19	19	erlotinib	EGFR	PA134687924	1956	0.898
NULL	Eur_J_Cancer_2014_Sep_50(14)_2367-2374.nxml.txt.nlp	25027307	SENT136	6	6	21	21	tamoxifen	AMH	PA451581	268	0.898
NULL	Cost_Eff_Resour_Alloc_2008_Jan_23_6_2.nxml.txt.nlp	18215255	SENT85	10	10	0	0	isoniazid	IPT	PA450112	54802	0.898
NULL	Oncogene_2010_Sep_9_29(36)_5032-5047.nxml.txt.nlp	20603614	SENT91	22	22	12	12	chloroquine	ARRDC3	PA448948	57561	0.898
NULL	Exp_Ther_Med_2012_Sep_12_4(3)_475-480.nxml.txt.nlp	23181121	SENT163	10	10	6	6	doxorubicin	CHOP	PA449412	1649	0.898
NULL	Indian_J_Nucl_Med_2014_Apr-Jun_29(2)_65-73.nxml.txt.nlp	24761056	SENT146	24	24	11	11	rituximab	CHOP	PA451261	1649	0.898
NULL	Int_J_Endocrinol_2014_Jun_25_2014_534904.nxml.txt.nlp	25053942	SENT102	14	14	3	3	amiodarone	AIT	PA448383	160728	0.898
NULL	Braz_J_Med_Biol_Res_2014_Jan_10_47(1)_60-69.nxml.txt.nlp	24519092	SENT28	23	23	31	31	doxorubicin	zeta	PA449412	9907	0.898
NULL	Indian_Dermatol_Online_J_2013_Oct-Dec_4(4)_365-368.nxml.txt.nlp	24350028	SENT76	25	25	21	21	clarithromycin	P-gp	PA449028	5243	0.898
NULL	Biologics_2010_May_25_4_83-90.nxml.txt.nlp	20531966	SENT143	9	9	21	21	gefitinib	EGFR	PA131301952	1956	0.898
NULL	Endocrinology_2014_Aug_30_155(8)_2976-2985.nxml.txt.nlp	24877623	SENT10	11	11	40	40	estradiol	TSPO	PA449503	706	0.898
NULL	Oxid_Med_Cell_Longev_2012_Aug_8_2012_920932.nxml.txt.nlp	22919442	SENT170	0	0	27	27	creatine	ROS	PA164778930	6098	0.898
NULL	Mol_Cancer_2013_Mar_5_12_17.nxml.txt.nlp	23497256	SENT179	15	15	3	3	sunitinib	HDM2	PA162372840	4193	0.898
NULL	Arthritis_Res_Ther_2012_Feb_15_14(1)_R34.nxml.txt.nlp	22336440	SENT13	33	33	1	1	methotrexate	CXCL13	PA450428	10563	0.898
NULL	Mediators_Inflamm_2010_Jun_21_2010_194896.nxml.txt.nlp	20652055	SENT193	0	0	3	3	berberine	MCP-1	PA165860812	6347	0.898
NULL	Crit_Care_2005_Sep_9_9(2)_212-222.nxml.txt.nlp	15774080	SENT15	2	2	15	15	vasopressin	AVP	PA451858	114548;551	0.898
NULL	J_Cell_Mol_Med_2014_Jan_4_18(1)_38-48.nxml.txt.nlp	24188742	SENT141	32	32	21	21	vincristine	PAX3	PA451879	5077	0.898
NULL	J_Hematol_Oncol_2013_Feb_17_6_17.nxml.txt.nlp	23414938	SENT7	18	18	4	4	prasugrel	P2Y12	PA154410481	64805	0.898
NULL	Cells_2014_May_23_3(2)_517-545.nxml.txt.nlp	24861977	SENT208	24	24	14	14	capsaicin	TRPV1	PA448776	7442	0.898
NULL	Mol_Biotechnol_2011_May_29_48(1)_19-29.nxml.txt.nlp	21046488	SENT91	1	1	14	14	doxycycline	HP1	PA449415	23468	0.898
NULL	Arthritis_Res_Ther_2012_May_1_14(3)_R99.nxml.txt.nlp	22546542	SENT35	14	14	19	19	infliximab	CD4	PA452639	920	0.898
NULL	Osteoporos_Int_2011_Aug_30_22(8)_2337-2345.nxml.txt.nlp	21116816	SENT165	44	44	11	11	fluvastatin	TNF-alpha	PA449688	7124	0.898
NULL	BMB_Rep_2013_Jan_46(1)_59-64.nxml.txt.nlp	23351386	SENT89	14	14	32	32	auranofin	STAT3	PA448510	6774	0.898
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT139	15	15	1	1	tenofovir	ABCC2	PA10204	1244	0.898
NULL	J_Hematol_Oncol_2009_Aug_12_2_36.nxml.txt.nlp	19674465	SENT74	4	4	21	21	lenalidomide	IL-2	PA162363968	3558	0.898
NULL	Biomed_Res_Int_2014_May_18_2014_428371.nxml.txt.nlp	24949449	SENT222	27	27	12	12	doxorubicin	PARP-1	PA449412	25976	0.898
NULL	Mol_Cancer_2013_Sep_11_12_104.nxml.txt.nlp	24025152	SENT205	12	12	19	19	gemcitabine	STAT3	PA449748	6774	0.898
NULL	Cell_Death_Dis_2014_Apr_24_5(4)_e1197.nxml.txt.nlp	24763054	SENT325	24	24	12	12	doxorubicin	ARC	PA449412	8996;23237	0.898
NULL	Oncotarget_2012_Oct_20_3(10)_1236-1245.nxml.txt.nlp	23100449	SENT103	1	1	15	15	doxorubicin	NGAL	PA449412	3934	0.898
NULL	Cancers_(Basel)_2011_Oct_26_3(4)_4010-4023.nxml.txt.nlp	24213122	SENT64	20	20	17	17	fludarabine	STAT1	PA449655	6772	0.898
NULL	Mol_Vis_2014_Dec_31_20_1796-1805.nxml.txt.nlp	25593507	SENT36	1	1	18	18	papain	SIRP	PA450778	140885	0.898
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Mar_15_70(Pt_4)_o450.nxml.txt.nlp	24826152	SENT8	29	29	11	11	phenol	mol	PA450913	90527	0.898
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Nov_8_64(Pt_12)_o2270.nxml.txt.nlp	21581251	SENT62	33	33	27	27	ethanol	mol	PA448073	90527	0.898
NULL	Cell_Res_2011_Mar_11_21(3)_530-545.nxml.txt.nlp	21221130	SENT412	27	27	13	13	thrombin	PAC-1	PA451674	1844	0.898
NULL	Reprod_Biol_Endocrinol_2004_Jul_7_2_55.nxml.txt.nlp	15239837	SENT47	4	4	1	1	letrozole	aromatase	PA450196	1588	0.898
NULL	Target_Oncol_2013_Mar_30_8(1)_27-33.nxml.txt.nlp	23361373	SENT76	7	7	19	19	gemcitabine	EGFR	PA449748	1956	0.898
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Oct_31_65(Pt_11)_o2963.nxml.txt.nlp	21578534	SENT47	20	20	14	14	ethanol	mol	PA448073	90527	0.898
NULL	Clin_Dev_Immunol_2011_Mar_22_2011_790460.nxml.txt.nlp	21603161	SENT410	3	3	7	7	atorvastatin	IFN	PA448500	3439	0.898
NULL	Biologics_2012_Dec_17_6_429-464.nxml.txt.nlp	23269860	SENT246	17	17	27	27	infliximab	ACR	PA452639	49	0.898
NULL	Biomed_Res_Int_2014_Feb_26_2014_710642.nxml.txt.nlp	24707497	SENT15	18	18	11	11	ribavirin	IFN	PA451241	3439	0.898
NULL	Diabetes_Care_2010_Jun_23_33(6)_1300-1303.nxml.txt.nlp	20332351	SENT111	24	24	18	18	metformin	GLP-1	PA450395	100125288	0.898
NULL	Arthritis_Res_Ther_2012_Jul_12_14(4)_R163.nxml.txt.nlp	22784880	SENT31	29	29	14	14	leflunomide	DHODH	PA450192	1723	0.898
NULL	Cancer_Metab_2013_Jul_24_1_16.nxml.txt.nlp	24280319	SENT71	19	19	5	5	doxorubicin	THTR2	PA449412	80704	0.898
NULL	Br_J_Pharmacol_2014_Oct_26_171(20)_4785-4796.nxml.txt.nlp	25074741	SENT34	10	10	24	24	guanfacine	NK1R	PA449825	6869	0.898
NULL	Med_Sci_Monit_2013_Nov_17_19_1006-1012.nxml.txt.nlp	24241246	SENT162	3	3	13	13	rosuvastatin	CD16	PA134308647	2215;2214	0.898
NULL	J_Oncol_2011_Jun_12_2011_542358.nxml.txt.nlp	21772843	SENT166	30	30	36	36	sorafenib	San	PA7000	80218	0.898
NULL	Arthritis_Res_Ther_2012_May_1_14(3)_R99.nxml.txt.nlp	22546542	SENT35	14	14	6	6	infliximab	IL-17	PA452639	3605	0.898
NULL	Pharmaceutics_2012_Jan_31_4(1)_104-129.nxml.txt.nlp	24300183	SENT307	22	22	9	9	lidocaine	SMO	PA450226	6608;54498	0.898
NULL	Sci_Rep_2014_Dec_15_4_7481.nxml.txt.nlp	25500546	SENT424	16	16	2	2	imatinib	p53	PA10804	7157	0.898
NULL	Breast_Cancer_Res_2007_Dec_20_9(Suppl_2)_S20.nxml.txt.nlp	NULL	SENT2	30	30	32	32	tamoxifen	aromatase	PA451581	1588	0.898
NULL	Indian_J_Urol_2009_Oct-Dec_25(4)_427-436.nxml.txt.nlp	19955664	SENT85	33	33	21	21	sunitinib	IFN	PA162372840	3439	0.898
NULL	Curr_Neuropharmacol_2013_Jan_11(1)_53-58.nxml.txt.nlp	23814538	SENT63	16	16	21	21	ketanserin	5-HT2C	PA131053734	3358	0.898
NULL	Arthritis_Res_Ther_2011_Feb_16_13(1)_R25.nxml.txt.nlp	21324169	SENT76	17	17	31	31	tocilizumab	IL-6	PA165292659	3569	0.898
NULL	Crit_Care_2008_Aug_29_12(4)_R112.nxml.txt.nlp	18759980	SENT235	5	5	24	24	thiopental	BTF	PA451664	9774	0.898
NULL	Trials_2013_May_4_14_125.nxml.txt.nlp	23782591	SENT39	29	29	20	20	donepezil	CYP2D6	PA449394	1565	0.898
NULL	Ann_Dermatol_2012_May_26_24(2)_230-232.nxml.txt.nlp	22577282	SENT39	13	13	2	2	phenytoin	CYP2C9	PA450947	1559	0.898
NULL	Chem_Cent_J_2012_Jul_18_6_68.nxml.txt.nlp	22809051	SENT56	22	22	1	1	ethanol	PF6	PA448073	200162	0.898
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1542-1553.nxml.txt.nlp	21970874	SENT259	28	28	15	15	gefitinib	EGF	PA131301952	1950	0.898
NULL	Oncotarget_2013_Apr_13_4(4)_502-530.nxml.txt.nlp	23594434	SENT270	13	13	15	15	ritonavir	AKT	PA451260	207	0.898
NULL	Cancer_Cell_Int_2012_Feb_21_12_5.nxml.txt.nlp	22353776	SENT123	9	9	15	15	ns-398	COX		1351	0.898
NULL	Clinics_(Sao_Paulo)_2012_Mar_67(3)_249-253.nxml.txt.nlp	22473406	SENT108	23	23	9	9	methotrexate	KCS	PA450428	3771	0.898
NULL	Indian_J_Pharm_Sci_2013_Nov-Dec_75(6)_680-687.nxml.txt.nlp	24591743	SENT70	4	4	14	14	gemfibrozil	CYP2C8	PA449750	1558	0.898
NULL	Cell_Commun_Signal_2013_Jan_22_11_6.nxml.txt.nlp	23339737	SENT66	6	6	18	18	pp2	AKT		207	0.898
NULL	Breast_Cancer_Res_2012_Mar_20_14(2)_R53.nxml.txt.nlp	22433433	SENT110	18	18	26	26	doxorubicin	CDK1	PA449412	983	0.898
NULL	Genome_Biol_2008_May_20_9(5)_R83.nxml.txt.nlp	18492237	SENT248	31	31	0	0	paraformaldehyde	CD133	PA450790	8842	0.898
NULL	Diabetologia_2010_Jul_2_53(7)_1270-1287.nxml.txt.nlp	20361178	SENT271	0	0	6	6	pioglitazone	adiponectin	PA450970	9370	0.898
NULL	Case_Rep_Ophthalmol_2014_Dec_10_5(3)_451-454.nxml.txt.nlp	25606038	SENT30	10	10	16	16	anastrozole	aromatase	PA448432	1588	0.898
NULL	Crit_Care_2007_Mar_22_11(Suppl_2)_P31.nxml.txt.nlp	NULL	SENT18	9	9	5	5	dobutamine	p38	PA449381	10598;1432;7965	0.898
NULL	J_Invest_Dermatol_2012_Jan_18_132(1)_163-169.nxml.txt.nlp	21850019	SENT1	0	0	8	8	imiquimod	TLR7	PA449972	51284	0.898
NULL	Ann_Med_2011_Nov_5_43(7)_531-544.nxml.txt.nlp	21815879	SENT117	36	36	4	4	clopidogrel	ADP	PA449053	23038	0.898
NULL	F1000Prime_Rep_2014_Dec_1_6_117.nxml.txt.nlp	25580271	SENT14	15	15	6	6	bevacizumab	EGFR	PA130232992	1956	0.898
NULL	Syst_Synth_Biol_2011_Jun_26_5(1-2)_21-31.nxml.txt.nlp	21949673	SENT82	16	16	6	6	fluorescein	FDG	PA164746009	23583	0.898
NULL	EJC_Suppl_2013_Sep_5_11(2)_299-300.nxml.txt.nlp	NULL	SENT27	3	3	5	5	tamoxifen	aromatase	PA451581	1588	0.898
NULL	Int_J_Mol_Imaging_2011_Oct_26_2011_874585.nxml.txt.nlp	21490735	SENT188	26	26	36	36	tamoxifen	FDG	PA451581	23583	0.898
NULL	Br_J_Cancer_2010_Jun_29_103(1)_61-72.nxml.txt.nlp	20588279	SENT281	8	8	35	35	trastuzumab	RhoB	PA451743	388	0.898
NULL	Gene_Regul_Syst_Bio_2014_Mar_4_8_63-73.nxml.txt.nlp	24634581	SENT89	23	23	31	31	minocycline	MT1-MMP	PA450519	4323	0.898
NULL	Br_J_Cancer_2010_Oct_12_103(8)_1284-1291.nxml.txt.nlp	20859285	SENT15	9	9	0	0	tamoxifen	BCAR4	PA451581	400500	0.898
NULL	Alcohol_Res_Health_2007_30(1)_38-47.nxml.txt.nlp	17718399	SENT173	16	16	6	6	ethanol	ADH	PA448073	551	0.898
NULL	Oncotarget_2011_Aug_30_2(8)_610-626.nxml.txt.nlp	21881167	SENT142	17	17	12	12	doxorubicin	Raf-1	PA449412	5894	0.898
NULL	Eur_J_Clin_Pharmacol_2012_Sep_15_68(9)_1267-1274.nxml.txt.nlp	22418828	SENT150	15	15	30	30	omeprazole	CYP2C19	PA450704	1557	0.898
NULL	Br_J_Cancer_2012_Feb_14_106(4)_619-628.nxml.txt.nlp	22281664	SENT124	10	10	14	14	brivanib	VEGFR	PA164924492	3791	0.898
NULL	Mar_Drugs_2014_Jun_27_12(7)_3818-3837.nxml.txt.nlp	24979269	SENT314	2	2	8	8	nilotinib	ABCB1	PA165958345	5243	0.898
NULL	Br_J_Cancer_2013_Jul_23_109(2)_332-341.nxml.txt.nlp	23807171	SENT57	6	6	34	34	sorafenib	IFN	PA7000	3439	0.898
NULL	Cardiovasc_Diabetol_2013_Mar_23_12_48.nxml.txt.nlp	23522121	SENT174	18	18	14	14	exenatide	NNT	PA164749238	23530	0.898
NULL	J_Korean_Neurosurg_Soc_2014_Jul_31_56(1)_1-4.nxml.txt.nlp	25289117	SENT109	4	4	23	23	curcumin	p38	PA151958596	10598;1432;7965	0.898
NULL	Pharmaceuticals_(Basel)_2014_May_14_7(5)_595-620.nxml.txt.nlp	24830986	SENT346	9	9	19	19	nabumetone	CYP3A4	PA450572	1576	0.898
NULL	Clin_Psychopharmacol_Neurosci_2011_Apr_30_9(1)_36-43.nxml.txt.nlp	23431025	SENT103	46	46	10	10	aripiprazole	FLI	PA10026	2314	0.898
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT232	6	6	17	17	aripiprazole	PRL	PA10026	5617	0.898
NULL	J_Cancer_2011_May_28_2_324-328.nxml.txt.nlp	21716849	SENT44	4	4	0	0	erlotinib	EGFR	PA134687924	1956	0.898
NULL	Mol_Cancer_2012_Apr_5_11_20.nxml.txt.nlp	22480225	SENT253	20	20	2	2	temozolomide	SPARC	PA451609	6678	0.898
NULL	Orphanet_J_Rare_Dis_2013_Oct_17_8_167.nxml.txt.nlp	24135440	SENT18	35	35	13	13	l-tryptophan	GCDH	PA10323	2639	0.898
NULL	Neuropsychopharmacology_2009_Oct_15_34(11)_2376-2389.nxml.txt.nlp	19606083	SENT238	19	19	12	12	desipramine	CA3	PA449233	761	0.898
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT107	11	11	24	24	atorvastatin	IL-6	PA448500	3569	0.898
NULL	J_Oncol_2013_Apr_29_2013_854121.nxml.txt.nlp	23737784	SENT79	11	11	26	26	lapatinib	BCS	PA152241907	617	0.898
NULL	Front_Neurol_2014_Dec_11_5_264.nxml.txt.nlp	25566171	SENT68	0	0	19	19	clozapine	IL-6	PA449061	3569	0.898
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Oct_6_68(Pt_11)_m1337.nxml.txt.nlp	23284328	SENT7	19	19	1	1	urea	mol	PA451831	90527	0.898
NULL	Int_J_Biol_Sci_2014_Aug_23_10(8)_921-939.nxml.txt.nlp	25170305	SENT279	19	19	0	0	nadh	EPO	PA164755085	7076;8288;2056	0.898
NULL	Oncotarget_2014_Jun_8_5(17)_7446-7457.nxml.txt.nlp	25277184	SENT40	6	6	19	19	cisplatin	TRIM8	PA449014	81603	0.898
NULL	J_Clin_Biochem_Nutr_2009_Jan_27_44(1)_79-84.nxml.txt.nlp	19177192	SENT73	10	10	25	25	curcumin	HO-1	PA151958596	3162	0.898
NULL	Korean_Circ_J_2013_Jun_30_43(6)_400-407.nxml.txt.nlp	23882289	SENT114	17	17	4	4	doxorubicin	p38	PA449412	10598;1432;7965	0.898
NULL	Nucleic_Acids_Res_2012_Jul_19_40(13)_5910-5925.nxml.txt.nlp	22434882	SENT299	5	5	0	0	curcumin	HBZ	PA151958596	3050	0.898
NULL	Indian_J_Endocrinol_Metab_2013_May-Jun_17(3)_413-421.nxml.txt.nlp	23869296	SENT60	36	36	22	22	exenatide	GLP-1	PA164749238	100125288	0.898
NULL	Mol_Brain_2014_Sep_3_7_64.nxml.txt.nlp	25182223	SENT119	37	37	4	4	minocycline	FMRP	PA450519	2332	0.898
NULL	Sci_Rep_2014_Dec_12_4_7456.nxml.txt.nlp	25503852	SENT56	21	21	35	35	resveratrol	SIRT1		23411	0.898
NULL	Core_Evid_2011_Mar_17_6_31-42.nxml.txt.nlp	21468241	SENT263	13	13	2	2	ticagrelor	CYP2C19	PA165374673	1557	0.898
NULL	Int_J_Biomed_Sci_2006_Sep_2(3)_260-272.nxml.txt.nlp	23674989	SENT294	38	38	17	17	estradiol	PRG	PA449503	5544	0.898
NULL	Mol_Vis_2011_Feb_1_17_332-340.nxml.txt.nlp	21297899	SENT116	17	17	23	23	telmisartan	DPI	PA451605	1832	0.898
NULL	Case_Rep_Dermatol_2014_Feb_12_6(1)_37-42.nxml.txt.nlp	24707248	SENT56	23	23	7	7	hydrocortisone	CHOP	PA449905	1649	0.898
NULL	Mol_Biol_Cell_2012_Oct_15_23(20)_3936-3947.nxml.txt.nlp	22933571	SENT113	38	38	29	29	galactose	TIM10	PA449725	26519	0.898
NULL	J_Allergy_(Cairo)_2011_Oct_24_2011_457169.nxml.txt.nlp	22121382	SENT194	15	15	21	21	salmeterol	IL-6	PA451300	3569	0.898
NULL	Infect_Drug_Resist_2013_Dec_18_7_1-7.nxml.txt.nlp	24379684	SENT19	17	17	4	4	vancomycin	HAP	PA451850	5915;10313	0.898
NULL	Ann_Indian_Acad_Neurol_2008_Jul-Sep_11(3)_170-178.nxml.txt.nlp	19893664	SENT63	0	0	27	27	heparin	STA	PA449855	2010;2656	0.898
NULL	Nat_Genet_2014_Feb_12_46(2)_166-170.nxml.txt.nlp	24413734	SENT57	11	11	7	7	dasatinib	SRC	PA162372878	6714	0.898
NULL	Chin_J_Cancer_2011_Jun_30(6)_426-432.nxml.txt.nlp	21627865	SENT146	0	0	6	6	verapamil	ABCG2	PA451868	9429	0.898
NULL	J_Ginseng_Res_2011_Jun_35(2)_176-190.nxml.txt.nlp	23717060	SENT340	29	29	22	22	nitroprusside	GMP	PA451406	22978	0.898
NULL	Mucosal_Immunol_2011_Nov_6_4(6)_648-657.nxml.txt.nlp	21734653	SENT283	6	6	30	30	azithromycin	HEC	PA448519	10403	0.898
NULL	Oncotarget_2013_Jul_21_4(8)_1253-1265.nxml.txt.nlp	23896512	SENT1	26	26	18	18	gefitinib	EGFR	PA131301952	1956	0.898
NULL	Acta_Pharmacol_Sin_2014_Jan_16_35(1)_24-32.nxml.txt.nlp	24335837	SENT194	16	16	28	28	paroxetine	Bcl-2	PA450801	596	0.898
NULL	Crit_Care_2011_Feb_3_15(1)_R49.nxml.txt.nlp	21291554	SENT170	27	27	3	3	ceftazidime	CLCR	PA448861	11330	0.898
NULL	Int_J_Breast_Cancer_2011_Sep_6_2011_352182.nxml.txt.nlp	22295219	SENT201	24	24	20	20	erlotinib	EGFR	PA134687924	1956	0.898
NULL	Acta_Pharmacol_Sin_2012_Jan_28_33(1)_66-74.nxml.txt.nlp	22120966	SENT198	8	8	21	21	genistein	RANKL	PA165109660	8600	0.898
NULL	Ann_Hematol_2010_Nov_25_89(11)_1115-1124.nxml.txt.nlp	20499237	SENT8	8	8	23	23	simvastatin	CD38	PA451363	952	0.898
NULL	Oncogene_2010_Sep_16_29(37)_5193-5203.nxml.txt.nlp	20581867	SENT165	11	11	9	9	lapatinib	HER2	PA152241907	2064	0.898
NULL	J_Gen_Physiol_2003_Jul_122(1)_1a-46a.nxml.txt.nlp	NULL	SENT97	27	27	11	11	vasopressin	NKCC2	PA451858	6557	0.898
NULL	Int_J_Mol_Sci_2013_Aug_14_14(8)_16719-16731.nxml.txt.nlp	23949634	SENT20	23	23	8	8	thrombin	ACPP	PA451674	55	0.898
NULL	Acta_Neuropathol_Commun_2014_Mar_7_2_27.nxml.txt.nlp	24606807	SENT308	17	17	34	34	natalizumab	CD4	PA164747191	920	0.898
NULL	Breast_Cancer_Res_2005_Nov_21_7(6)_R1153-R1158.nxml.txt.nlp	16457695	SENT116	20	20	28	28	tamoxifen	EGFR	PA451581	1956	0.898
NULL	Int_Semin_Surg_Oncol_2006_Aug_25_3_22.nxml.txt.nlp	16930493	SENT89	28	28	38	38	cimetidine	PSK	PA449001	9344	0.898
NULL	Indian_J_Endocrinol_Metab_2014_Jul-Aug_18(4)_546-551.nxml.txt.nlp	25143915	SENT5	0	0	18	18	denosumab	RANKL	PA166048634	8600	0.898
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT171	40	40	32	32	cisplatin	MDM2	PA449014	4193	0.898
NULL	Pak_J_Med_Sci_2013_Apr_29(2)_663-665.nxml.txt.nlp	24353600	SENT37	9	9	5	5	bleomycin	DDP	PA448645	1678	0.898
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT167	27	27	5	5	tenofovir	SLC22A6	PA10204	9356	0.898
NULL	Allergy_Asthma_Immunol_Res_2014_Nov_19_6(6)_548-557.nxml.txt.nlp	25374755	SENT91	14	14	21	21	lovastatin	CCL11	PA450272	6356	0.898
NULL	Acta_Pharmacol_Sin_2013_Sep_5_34(9)_1208-1216.nxml.txt.nlp	23852087	SENT129	13	13	9	9	disulfiram	CA9	PA449376	768	0.897
NULL	Breast_Cancer_Res_2008_Feb_1_10(1)_R10.nxml.txt.nlp	18241344	SENT187	43	43	21	21	cisplatin	CD24	PA449014	100133941	0.897
NULL	Cardiovasc_Res_2012_Dec_1_96(3)_552-560.nxml.txt.nlp	22918977	SENT267	8	8	10	10	losartan	JAM-A	PA450268	50848	0.897
NULL	Ecancermedicalscience_2008_Aug_15_2_91.nxml.txt.nlp	22275974	SENT223	17	17	5	5	thalidomide	CD4	PA451644	920	0.897
NULL	Oncotarget_2012_Nov_17_4(1)_18-28.nxml.txt.nlp	23248157	SENT101	14	14	6	6	pargyline	CD133	PA450797	8842	0.897
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT105	13	13	2	2	adalimumab	CD36	PA10004	948	0.897
NULL	EMBO_Mol_Med_2013_Dec_8_5(12)_1821-1834.nxml.txt.nlp	24293316	SENT169	18	18	2	2	doxorubicin	p53	PA449412	7157	0.897
NULL	Breast_Cancer_Res_2011_Apr_21_13(2)_R46.nxml.txt.nlp	21510863	SENT124	0	0	10	10	trastuzumab	HER2	PA451743	2064	0.897
NULL	Oncotarget_2013_Apr_13_4(4)_502-530.nxml.txt.nlp	23594434	SENT298	10	10	4	4	temozolomide	U87	PA451609	677775;641648	0.897
NULL	J_Thromb_Haemost_2007_May_1_5(5)_910-917.nxml.txt.nlp	17362227	SENT158	13	13	27	27	thrombin	ADP	PA451674	23038	0.897
NULL	Int_J_Biomed_Sci_2007_Sep_3(3)_176-184.nxml.txt.nlp	23675041	SENT116	3	3	10	10	celecoxib	Bcl-2	PA448871	596	0.897
NULL	Cancer_Med_2013_Oct_21_2(5)_662-673.nxml.txt.nlp	24403232	SENT256	6	6	16	16	bevacizumab	IFN	PA130232992	3439	0.897
NULL	Clin_Exp_Gastroenterol_2011_Jul_15_4_163-172.nxml.txt.nlp	21904462	SENT87	24	24	9	9	infliximab	OLC	PA452639	26679	0.897
NULL	Mutagenesis_2009_Jul_16_24(4)_309-316.nxml.txt.nlp	19372135	SENT254	10	10	16	16	carboplatin	XPC	PA448803	7508	0.897
NULL	J_Am_Heart_Assoc_2013_Dec_19_2(6)_e000441.nxml.txt.nlp	24252844	SENT250	7	7	17	17	rosiglitazone	gamma	PA451283	9913	0.897
NULL	Cough_2006_Mar_30_2_2.nxml.txt.nlp	16623933	SENT29	11	11	27	27	capsaicin	CB1	PA448776	1268	0.897
NULL	Oncol_Lett_2014_Nov_13_8(5)_2043-2048.nxml.txt.nlp	25289090	SENT78	24	24	33	33	doxorubicin	p53	PA449412	7157	0.897
NULL	Brain_Sci_2013_Jun_3_3(2)_877-907.nxml.txt.nlp	24961429	SENT135	18	18	8	8	taurine	MELAS	PA451590	4219	0.897
NULL	Pharmaceutics_2012_Jan_31_4(1)_104-129.nxml.txt.nlp	24300183	SENT192	31	31	11	11	lidocaine	SMO	PA450226	6608;54498	0.897
NULL	Arthritis_Res_Ther_2010_Apr_29_12(2)_R73.nxml.txt.nlp	20429888	SENT295	7	7	23	23	bortezomib	COL1A2	PA10252	1278	0.897
NULL	Nat_Commun_2014_Nov_25_5_5548.nxml.txt.nlp	25420520	SENT41	11	11	34	34	cabazitaxel	ERG	PA165958401	2078	0.897
NULL	J_Cell_Mol_Med_2013_May_20_17(5)_648-656.nxml.txt.nlp	23601074	SENT30	15	15	8	8	capecitabine	EGFR	PA448771	1956	0.897
NULL	Arch_Med_Sci_2013_Oct_31_9(5)_936-943.nxml.txt.nlp	24273582	SENT103	19	19	42	42	nateglinide	GLP-1	PA450600	100125288	0.897
NULL	Arthritis_Res_Ther_2006_Apr_12_8(Suppl_1)_S4.nxml.txt.nlp	16820043	SENT45	33	33	0	0	pyrazinamide	URAT1	PA451182	116085	0.897
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1023.nxml.txt.nlp	24457967	SENT69	7	7	9	9	saracatinib	PP2		4888	0.897
NULL	Asia_Pac_Allergy_2012_Jul_25_2(3)_203-209.nxml.txt.nlp	22872823	SENT41	11	11	3	3	carbamazepine	HLA-A	PA448785	3105	0.897
NULL	ScientificWorldJournal_2014_Dec_9_2014_808320.nxml.txt.nlp	25548793	SENT8	13	13	10	10	heparin	RAC	PA449855	207	0.897
NULL	Oncogene_2010_Sep_23_29(38)_5286-5298.nxml.txt.nlp	20603611	SENT59	25	25	6	6	pha-665752	Met		79811	0.897
NULL	Chonnam_Med_J_2013_Apr_25_49(1)_31-37.nxml.txt.nlp	23678475	SENT12	3	3	25	25	rosuvastatin	adiponectin	PA134308647	9370	0.897
NULL	Curr_Neuropharmacol_2014_Jul_12(4)_365-379.nxml.txt.nlp	25342944	SENT453	39	39	15	15	fluoxetine	5-HT2B	PA449673	3357	0.897
NULL	Mol_Biol_Cell_2012_Jul_1_23(13)_2412-2423.nxml.txt.nlp	22593212	SENT274	7	7	36	36	paraformaldehyde	p110	PA450790	9733	0.897
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_127043.nxml.txt.nlp	23227093	SENT181	11	11	14	14	lovastatin	CYP3A4	PA450272	1576	0.897
NULL	J_Biol_Chem_2008_Jun_20_283(25)_17194-17204.nxml.txt.nlp	18442977	SENT133	21	21	14	14	ketanserin	5-HT1A	PA131053734	3350	0.897
NULL	J_Gen_Physiol_2013_Dec_142(6)_561-573.nxml.txt.nlp	24277600	SENT250	12	12	26	26	creatine	ADP	PA164778930	23038	0.897
NULL	Int_J_Mol_Sci_2013_Apr_26_14(5)_9182-9204.nxml.txt.nlp	23624607	SENT220	19	19	42	42	gentamicin	CO2	PA449753	4513	0.897
NULL	J_Korean_Med_Sci_2013_Aug_31_28(8)_1238-1243.nxml.txt.nlp	23960454	SENT137	33	33	25	25	amiloride	ASIC3	PA448368	9311	0.897
NULL	J_Breast_Cancer_2013_Jun_28_16(2)_164-170.nxml.txt.nlp	23843848	SENT115	12	12	28	28	doxorubicin	PTEN	PA449412	5728	0.897
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_105-115.nxml.txt.nlp	17912640	SENT264	42	42	40	40	letrozole	aromatase	PA450196	1588	0.897
NULL	Mol_Cancer_2009_Jun_9_8_37.nxml.txt.nlp	19508729	SENT118	10	10	22	22	gemcitabine	HO-1	PA449748	3162	0.897
NULL	Indian_J_Med_Res_2014_Jan_139(1)_117-124.nxml.txt.nlp	24604047	SENT130	10	10	18	18	fluvastatin	p38	PA449688	10598;1432;7965	0.897
NULL	Front_Endocrinol_(Lausanne)_2013_Jan_7_3_180.nxml.txt.nlp	23316185	SENT248	2	2	11	11	glucose	CRF2	PA449773	1395	0.897
NULL	CNS_Neurosci_Ther_2010_Jun_16(3)_e1-e17.nxml.txt.nlp	20406250	SENT85	35	35	9	9	haloperidol	CA3	PA449841	761	0.897
NULL	Cell_Biochem_Biophys_2013_May_28_67(1)_25-43.nxml.txt.nlp	23712866	SENT273	34	34	25	25	etoposide	p53	PA449552	7157	0.897
NULL	J_Biomed_Biotechnol_2010_Jun_6_2010_571343.nxml.txt.nlp	20625496	SENT197	14	14	4	4	carboplatin	ASS1	PA448803	445	0.897
NULL	Case_Rep_Hematol_2013_Jul_7_2013_896394.nxml.txt.nlp	23936694	SENT23	26	26	36	36	cyclophosphamide	aromatase	PA449165	1588	0.897
NULL	Mol_Neurodegener_2011_Aug_16_6_58.nxml.txt.nlp	21846363	SENT130	36	36	25	25	candesartan	AT1	PA448765	9197;185	0.897
NULL	Avicenna_J_Phytomed_2014_Jul-Aug_4(4)_276-286.nxml.txt.nlp	25068142	SENT97	9	9	11	11	lamotrigine	HEG	PA450164	57493	0.897
NULL	Breast_Cancer_Res_2012_Jan_17_14(1)_R12.nxml.txt.nlp	22251451	SENT268	14	14	21	21	tamoxifen	GPER	PA451581	2852	0.897
NULL	Cancer_Cell_Int_2007_Mar_28_7_3.nxml.txt.nlp	17391526	SENT9	28	28	14	14	forskolin	JNK	PA146096022	5599	0.897
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2751-2762.nxml.txt.nlp	24169358	SENT13	0	0	26	26	fulvestrant	RERG	PA164747170	85004	0.897
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Jul_23_3(7)_e126.nxml.txt.nlp	25054314	SENT298	6	6	18	18	docetaxel	OCT1	PA449383	5451;6580	0.897
NULL	AIDS_Res_Ther_2013_May_1_10_10.nxml.txt.nlp	23634877	SENT149	23	23	8	8	lovastatin	CXCL12	PA450272	6387	0.897
NULL	Br_J_Cancer_2010_Dec_7_103(12)_1822-1830.nxml.txt.nlp	21063405	SENT187	11	11	5	5	cisplatin	NBS1	PA449014	55655	0.897
NULL	Drug_Target_Insights_2006_Oct_23_1_5-10.nxml.txt.nlp	21901053	SENT81	4	4	21	21	heparin	INCA	PA449855	440068	0.897
NULL	Oncol_Lett_2014_Sep_19_8(3)_1320-1322.nxml.txt.nlp	25120716	SENT3	18	18	28	28	erlotinib	EGFR	PA134687924	1956	0.897
NULL	Mol_Pain_2012_Sep_22_8_71.nxml.txt.nlp	22998838	SENT112	15	15	1	1	cisplatin	CXCR4	PA449014	7852	0.897
NULL	Br_J_Cancer_1999_Feb_79(5-6)_831-837.nxml.txt.nlp	10070877	SENT8	0	0	35	35	verapamil	MX2	PA451868	4600	0.897
NULL	Endocrinology_2014_Aug_30_155(8)_2976-2985.nxml.txt.nlp	24877623	SENT10	11	11	28	28	estradiol	AC1	PA449503	107	0.897
NULL	Breast_Cancer_Res_Treat_2013_Apr_12_138(2)_427-435.nxml.txt.nlp	23479422	SENT5	13	13	28	28	trastuzumab	HER2	PA451743	2064	0.897
NULL	Acta_Histochem_Cytochem_2012_Apr_26_45(2)_139-146.nxml.txt.nlp	22685356	SENT315	11	11	0	0	forskolin	AQP2	PA146096022	359	0.897
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2675-2684.nxml.txt.nlp	24129246	SENT317	12	12	7	7	etoposide	SIRT1	PA449552	23411	0.897
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT161	3	3	13	13	bevacizumab	VEGF-A	PA130232992	7422	0.897
NULL	J_Hematol_Oncol_2011_Dec_21_4_53.nxml.txt.nlp	22189016	SENT70	14	14	22	22	clarithromycin	P-gp	PA449028	5243	0.897
NULL	Int_J_Alzheimers_Dis_2010_Dec_8_2011_741974.nxml.txt.nlp	21197086	SENT180	8	8	0	0	ramelteon	CYP1A2	PA164744896	1544	0.897
NULL	Arthritis_Res_Ther_2012_May_1_14(3)_R99.nxml.txt.nlp	22546542	SENT13	18	18	11	11	infliximab	IL-17	PA452639	3605	0.897
NULL	Cell_Death_Dis_2013_Oct_3_4(10)_e827.nxml.txt.nlp	24091670	SENT93	11	11	3	3	nilotinib	PI3K	PA165958345	5290	0.897
NULL	Br_J_Cancer_2012_Nov_6_107(10)_1714-1721.nxml.txt.nlp	23073173	SENT219	28	28	11	11	docetaxel	RUNX2	PA449383	860	0.897
NULL	Int_J_Hypertens_2012_Nov_17_2012_121740.nxml.txt.nlp	22164327	SENT34	19	19	0	0	captopril	ACE2	PA448780	59272	0.897
NULL	Mol_Neurobiol_2010_Jun_2_41(2-3)_392-409.nxml.txt.nlp	20437209	SENT294	4	4	11	11	curcumin	COX	PA151958596	1351	0.897
NULL	Reprod_Biol_Endocrinol_2003_Feb_14_1_22.nxml.txt.nlp	12646054	SENT177	26	26	21	21	estradiol	aromatase	PA449503	1588	0.897
NULL	J_Oncol_2010_Dec_28_2010_414676.nxml.txt.nlp	20066160	SENT205	3	3	24	24	pertuzumab	HER2		2064	0.897
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT129	21	21	4	4	capsaicin	p53	PA448776	7157	0.897
NULL	J_Exp_Med_1980_Feb_1_151(2)_314-327.nxml.txt.nlp	6766175	SENT13	11	11	19	19	glutaraldehyde	B10	PA449777	5169	0.897
NULL	Lipids_Health_Dis_2011_Feb_12_10_31.nxml.txt.nlp	21314960	SENT173	10	10	6	6	hemin	HO-1	PA449849	3162	0.897
NULL	Mol_Cancer_2014_Jul_28_13_179.nxml.txt.nlp	25070035	SENT310	28	28	6	6	paraformaldehyde	NY-ESO-1	PA450790	1485	0.897
NULL	EMBO_Mol_Med_2013_Aug_8_5(8)_1227-1246.nxml.txt.nlp	23836498	SENT234	11	11	4	4	doxycycline	HIF-1	PA449415	29072	0.897
NULL	Nucleic_Acids_Res_2011_Dec_31_39(22)_9536-9548.nxml.txt.nlp	21880590	SENT231	25	25	2	2	etoposide	BRCA1	PA449552	672	0.897
NULL	Nat_Commun_2014_Aug_18_5_4632.nxml.txt.nlp	25130259	SENT159	32	32	37	37	heparin	B27	PA449855	56246	0.897
NULL	Eur_J_Neurosci_2008_Nov_28(10)_1941-1955.nxml.txt.nlp	19046377	SENT81	17	17	4	4	paraformaldehyde	E12	PA450790	64100	0.897
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT79	42	42	32	32	curcumin	Bcl-2	PA151958596	596	0.897
NULL	Breast_Cancer_Res_2002_Jul_29_4(5)_202-204.nxml.txt.nlp	12223125	SENT97	21	21	4	4	tamoxifen	ATAC	PA451581	6375	0.897
NULL	Mol_Biol_Cell_2012_Sep_15_23(18)_3707-3721.nxml.txt.nlp	22855535	SENT321	7	7	23	23	azelastine	S23	PA448517	6228	0.897
NULL	Oncol_Rep_2015_Feb_11_33(2)_526-532.nxml.txt.nlp	25501339	SENT134	25	25	12	12	gefitinib	p53	PA131301952	7157	0.897
NULL	Exp_Diabetes_Res_2012_Apr_17_2012_635472.nxml.txt.nlp	22577369	SENT117	19	19	16	16	liraglutide	GLP-1	PA165958364	100125288	0.897
NULL	Br_J_Cancer_2013_Jun_25_108(12)_2464-2469.nxml.txt.nlp	23695016	SENT141	15	15	22	22	carboplatin	CRT	PA448803	811	0.897
NULL	J_Korean_Med_Sci_2014_Jul_11_29(7)_965-972.nxml.txt.nlp	25045229	SENT132	27	27	17	17	metformin	B12	PA450395	7126;4709	0.897
NULL	Adv_Virol_2012_Jul_19_2012_267483.nxml.txt.nlp	22851970	SENT184	25	25	10	10	ribavirin	IL-28B	PA451241	282617	0.897
NULL	J_Immunother_Cancer_2014_Jan_27_2_2.nxml.txt.nlp	24829759	SENT106	14	14	10	10	sorafenib	IL-21	PA7000	59067;50616;27189	0.897
NULL	Arch_Plast_Surg_2014_Nov_3_41(6)_620-629.nxml.txt.nlp	25396172	SENT109	35	35	17	17	triamcinolone	IFN	PA451749	3439	0.897
NULL	Indian_J_Med_Res_2011_Mar_133(3)_308-311.nxml.txt.nlp	21441685	SENT39	18	18	0	0	pyrazinamide	DST	PA451182	667	0.897
NULL	Gut_Liver_2011_Sep_18_5(3)_356-362.nxml.txt.nlp	21927666	SENT24	24	24	15	15	ribavirin	IFN	PA451241	3439	0.897
NULL	Am_J_Physiol_Endocrinol_Metab_2010_Feb_17_298(2)_E278-E286.nxml.txt.nlp	19920213	SENT119	8	8	29	29	pioglitazone	adiponectin	PA450970	9370	0.897
NULL	J_Cell_Biol_1998_Jul_13_142(1)_85-100.nxml.txt.nlp	9660865	SENT40	15	15	21	21	doxycycline	RhoA	PA449415	387	0.897
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Feb_17_68(Pt_3)_o737.nxml.txt.nlp	22412617	SENT68	38	38	4	4	ethanol	mol	PA448073	90527	0.897
NULL	J_Oncol_2013_Feb_17_2013_872957.nxml.txt.nlp	23476648	SENT137	24	24	10	10	cisplatin	SFN	PA449014	25996;2810	0.897
NULL	Case_Rep_Dent_2013_Jul_10_2013_812323.nxml.txt.nlp	23936686	SENT96	18	18	29	29	hyaluronan	LYVE-1	PA165958431	10894	0.897
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Jun_25_3(6)_e120.nxml.txt.nlp	24964282	SENT149	32	32	13	13	rifampin	CYP3A4	PA451250	1576	0.897
NULL	Exp_Mol_Med_2012_Sep_30_44(9)_545-553.nxml.txt.nlp	22809901	SENT77	26	26	10	10	clozapine	adiponectin	PA449061	9370	0.897
NULL	Int_J_Biomed_Sci_2007_Dec_3(4)_251-257.nxml.txt.nlp	23675050	SENT158	18	18	2	2	pergolide	PRL	PA450873	5617	0.897
NULL	Respir_Med_Case_Rep_2013_Oct_26_10_53-55.nxml.txt.nlp	NULL	SENT71	7	7	19	19	abatacept	IL-6	PA164747080	3569	0.897
NULL	J_Hematol_Oncol_2013_Jun_3_6_38.nxml.txt.nlp	23731980	SENT131	37	37	13	13	trastuzumab	HER2	PA451743	2064	0.897
NULL	Mol_Cancer_2009_Nov_10_8_99.nxml.txt.nlp	19903356	SENT123	24	24	9	9	imatinib	IGFBP3	PA10804	3486	0.897
NULL	Oncoimmunology_2012_Nov_1_1(8)_1398-1400.nxml.txt.nlp	23243606	SENT9	5	5	19	19	trastuzumab	HER2	PA451743	2064	0.897
NULL	Int_J_Med_Sci_2015_Jan_1_12(1)_78-82.nxml.txt.nlp	25552922	SENT112	16	16	8	8	tacrolimus	CYP3A5	PA451578	1577	0.897
NULL	Arthritis_Res_Ther_2011_Apr_27_13(2)_111.nxml.txt.nlp	21542890	SENT38	39	39	13	13	methotrexate	IL-18	PA450428	3606	0.897
NULL	Breast_Cancer_(Dove_Med_Press)_2014_May_2_6_59-71.nxml.txt.nlp	24833917	SENT131	18	18	1	1	anastrozole	aromatase	PA448432	1588	0.897
NULL	Nucleic_Acids_Res_2011_Dec_2_39(22)_9549-9558.nxml.txt.nlp	21890893	SENT92	11	11	4	4	resveratrol	SIRT1		23411	0.897
NULL	Arthritis_Res_Ther_2012_Jun_4_14(3)_R133.nxml.txt.nlp	22656185	SENT97	16	16	5	5	ethanol	CD68	PA448073	968	0.897
NULL	J_Invest_Dermatol_2014_Apr_11_134(4)_1083-1090.nxml.txt.nlp	24335898	SENT56	11	11	9	9	nutlin-3	MDM2		4193	0.897
NULL	Br_J_Cancer_2012_Sep_4_107(6)_947-955.nxml.txt.nlp	22892392	SENT13	14	14	0	0	lapatinib	BCAR4	PA152241907	400500	0.897
NULL	J_Cell_Biol_1998_Nov_2_143(3)_601-612.nxml.txt.nlp	9813083	SENT65	13	13	2	2	fluorescein	p24	PA164746009	11261;140767	0.897
NULL	Oncotarget_2014_Mar_13_5(4)_1101-1110.nxml.txt.nlp	24658355	SENT11	26	26	7	7	tamoxifen	MKP-1	PA451581	1843	0.897
NULL	BMJ_2011_Jun_17_342_d3527.nxml.txt.nlp	21685437	SENT133	23	23	19	19	ticagrelor	P2Y12	PA165374673	64805	0.897
NULL	Breast_Cancer_(Auckl)_2014_May_12_8_81-88.nxml.txt.nlp	24855372	SENT75	8	8	15	15	pertuzumab	HER2		2064	0.897
NULL	Ann_Oncol_2010_Mar_18_21(3)_655-661.nxml.txt.nlp	19767314	SENT226	7	7	17	17	lapatinib	HER2	PA152241907	2064	0.897
NULL	Breast_Cancer_Res_2004_Mar_26_6(3)_R252-R263.nxml.txt.nlp	15084249	SENT167	37	37	4	4	tamoxifen	NAT1	PA451581	9;1982	0.897
NULL	Breast_Cancer_(Auckl)_2012_Mar_7_6_67-77.nxml.txt.nlp	22438669	SENT85	28	28	22	22	capecitabine	HER2	PA448771	2064	0.897
NULL	J_Carcinog_2011_Nov_30_10_28.nxml.txt.nlp	22190870	SENT94	21	21	8	8	trastuzumab	PTEN	PA451743	5728	0.897
NULL	J_Exp_Med_1998_Jun_15_187(12)_1985-1993.nxml.txt.nlp	9625758	SENT69	24	24	7	7	neomycin	CD4	PA450608	920	0.897
NULL	Breast_Cancer_Res_2009_Jun_23_11(3)_R39.nxml.txt.nlp	19549321	SENT169	4	4	14	14	vincristine	CK19	PA451879	3880	0.897
NULL	Mol_Cancer_2010_Nov_8_9_291.nxml.txt.nlp	21059223	SENT103	17	17	2	2	daunorubicin	ABCB1	PA449212	5243	0.897
NULL	Scientifica_(Cairo)_2012_Dec_17_2012_502378.nxml.txt.nlp	24278706	SENT103	31	31	10	10	verapamil	P-gp	PA451868	5243	0.897
NULL	J_Breast_Cancer_2014_Dec_26_17(4)_332-338.nxml.txt.nlp	25548580	SENT109	7	7	13	13	capsaicin	TRPV1	PA448776	7442	0.897
NULL	J_Korean_Med_Sci_2014_Jul_11_29(7)_965-972.nxml.txt.nlp	25045229	SENT117	15	15	5	5	metformin	B12	PA450395	7126;4709	0.897
NULL	Indian_J_Anaesth_2014_Jul-Aug_58(4)_423-429.nxml.txt.nlp	25197110	SENT31	9	9	6	6	ondansetron	ODF	PA450705	8600	0.897
NULL	Arthritis_Res_Ther_2008_Sep_9_10(5)_R107.nxml.txt.nlp	18782442	SENT18	20	20	9	9	glucose	HNE	PA449773	1991	0.897
NULL	Eur_J_Clin_Pharmacol_2012_Jan_8_68(1)_29-37.nxml.txt.nlp	21739267	SENT202	3	3	20	20	aripiprazole	CYP2D6	PA10026	1565	0.897
NULL	Breast_Cancer_Res_2011_Mar_11_13(2)_R29.nxml.txt.nlp	21396094	SENT215	27	27	17	17	fulvestrant	HRG	PA164747170	3084;3273	0.897
NULL	Int_J_Endocrinol_2014_Jul_1_2014_685396.nxml.txt.nlp	25097549	SENT30	8	8	4	4	thyroglobulin	TTF-1	PA164754910	7080	0.897
NULL	Biol_Proced_Online_1999_Oct_4_2_1-38.nxml.txt.nlp	12734586	SENT322	7	7	16	16	galactose	GAL4	PA449725	3960	0.897
NULL	Mol_Cancer_2010_Aug_23_9_222.nxml.txt.nlp	20731837	SENT212	8	8	11	11	gefitinib	EGFR	PA131301952	1956	0.897
NULL	Folia_Microbiol_(Praha)_2014_Aug_16_59(6)_543-552.nxml.txt.nlp	25128200	SENT170	16	16	30	30	daptomycin	TDO	PA164768820	6999	0.897
NULL	Br_J_Cancer_2011_May_24_104(11)_1691-1696.nxml.txt.nlp	21540865	SENT137	4	4	24	24	cilengitide	EGFR	PA164924491	1956	0.897
NULL	Br_J_Cancer_2013_Jun_11_108(11)_2272-2280.nxml.txt.nlp	23681187	SENT118	26	26	6	6	celecoxib	COX2	PA448871	4513;5743	0.897
NULL	Cell_J_2012_Dec_22_Winter_13(4)_281-289.nxml.txt.nlp	23507624	SENT20	15	15	25	25	propranolol	IFN	PA451145	3439	0.897
NULL	Mol_Cancer_2010_Apr_23_9_87.nxml.txt.nlp	20416058	SENT146	16	16	26	26	doxorubicin	TRAIL	PA449412	8743	0.897
NULL	Osteoporos_Int_2012_May_19_23(5)_1613-1622.nxml.txt.nlp	21769661	SENT38	0	0	9	9	teriparatide	PTH	PA451620	5741	0.897
NULL	Int_J_Breast_Cancer_2011_Jul_3_2011_912102.nxml.txt.nlp	22295238	SENT139	16	16	0	0	tamoxifen	IRF1	PA451581	3659	0.897
NULL	EPMA_J_2013_Feb_19_4(1)_6.nxml.txt.nlp	23418957	SENT244	23	23	6	6	pertuzumab	HER2		2064	0.897
NULL	EMBO_J_2010_Sep_15_29(18)_3170-3183.nxml.txt.nlp	20676059	SENT427	27	27	10	10	fluoxetine	P15	PA449673	1030;29107	0.897
NULL	J_Mol_Med_(Berl)_2014_May_10_92(7)_709-722.nxml.txt.nlp	24811491	SENT135	30	30	7	7	cetuximab	HER2	PA10040	2064	0.897
NULL	Oncogene_2014_May_8_33(19)_2478-2486.nxml.txt.nlp	23752180	SENT127	28	28	21	21	l-glutamine	FBS	PA10090	64319;26269	0.897
NULL	Arthritis_Res_Ther_2011_Mar_16_13(2)_R44.nxml.txt.nlp	21410959	SENT264	4	4	9	9	glucosamine	RANKL	PA164747613	8600	0.897
NULL	Core_Evid_2010_Oct_21_5_61-76.nxml.txt.nlp	21042543	SENT364	5	5	1	1	panitumumab	KRAS	PA162373091	3845	0.897
NULL	J_Hematol_Oncol_2008_Oct_23_1_19.nxml.txt.nlp	18947412	SENT83	8	8	3	3	alemtuzumab	CD41	PA164783958	3674	0.897
NULL	Breast_Cancer_Res_2012_Mar_9_14(2)_R41.nxml.txt.nlp	22405131	SENT57	33	33	18	18	ethanol	FBS	PA448073	64319;26269	0.897
NULL	Clin_Pediatr_Endocrinol_2007_Aug_8_16(3)_75-80.nxml.txt.nlp	24790349	SENT17	20	20	6	6	octreotide	PHHI	PA450678	6833	0.897
NULL	Mol_Med_Rep_2015_Jan_21_11(1)_59-66.nxml.txt.nlp	25335121	SENT83	20	20	8	8	paraformaldehyde	CO2	PA450790	4513	0.897
NULL	Case_Rep_Dermatol_2014_Mar_7_6(1)_74-79.nxml.txt.nlp	24707255	SENT53	14	14	22	22	dacarbazine	IFN	PA449197	3439	0.897
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT327	13	13	10	10	risperidone	PRL	PA451257	5617	0.897
NULL	Curr_Pharm_Des_2011_Dec_17(35)_3846-3853.nxml.txt.nlp	21933140	SENT146	26	26	1	1	liraglutide	GLP-1	PA165958364	100125288	0.897
NULL	Breast_Cancer_Res_2003_Feb_5_5(2)_113-116.nxml.txt.nlp	12631392	SENT47	11	11	7	7	anastrozole	ATAC	PA448432	6375	0.897
NULL	Mucosal_Immunol_2013_May_19_6(3)_498-510.nxml.txt.nlp	22990622	SENT396	12	12	3	3	dextran	CX3CR1	PA449261	1524	0.897
NULL	Acta_Pharmacol_Sin_2011_Jan_6_32(1)_133-138.nxml.txt.nlp	21131997	SENT104	20	20	6	6	heparin	ACT	PA449855	12;11332;9457;641455	0.897
NULL	Angew_Chem_Int_Ed_Engl_2012_Feb_13_51(7)_1572-1575.nxml.txt.nlp	22213572	SENT34	31	31	10	10	ethanol	CO2	PA448073	4513	0.897
NULL	Arthritis_Res_Ther_2011_Feb_16_13(1)_R25.nxml.txt.nlp	21324169	SENT76	17	17	24	24	tocilizumab	IL-6	PA165292659	3569	0.897
NULL	Arthritis_Res_Ther_2006_Jul_28_8(Suppl_2)_S4.nxml.txt.nlp	16899108	SENT90	27	27	20	20	tocilizumab	IL-6	PA165292659	3569	0.897
NULL	Front_Oncol_2012_Oct_4_2_123.nxml.txt.nlp	23061041	SENT726	12	12	10	10	exemestane	aromatase	PA449563	1588	0.897
NULL	Acta_Pharmacol_Sin_2009_Sep_24_30(9)_1262-1275.nxml.txt.nlp	19701231	SENT129	24	24	8	8	lovastatin	FGA	PA450272	2243	0.897
NULL	Part_Fibre_Toxicol_2013_Aug_13_10_39.nxml.txt.nlp	23937860	SENT32	24	24	6	6	anakinra	IL-6	PA10799	3569	0.897
NULL	Iran_Red_Crescent_Med_J_2014_Sep_5_16(9)_e20153.nxml.txt.nlp	25593732	SENT62	8	8	32	32	halothane	CYP2A6	PA449845	1548	0.897
NULL	Int_J_Biomed_Sci_2006_Jun_2(2)_114-120.nxml.txt.nlp	23674973	SENT100	15	15	0	0	hydrocortisone	IL-10	PA449905	3586	0.897
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT180	3	3	5	5	atorvastatin	RANKL	PA448500	8600	0.897
NULL	Nucleic_Acids_Res_2011_Oct_15_39(19)_8392-8403.nxml.txt.nlp	21764778	SENT20	20	20	0	0	estradiol	SULT1E1	PA449503	6783	0.897
NULL	J_Immunol_Res_2014_May_8_2014_565320.nxml.txt.nlp	24901010	SENT66	19	19	30	30	phenytoin	HLA-B	PA450947	3106	0.897
NULL	Oncotarget_2014_Aug_19_5(18)_8737-8749.nxml.txt.nlp	25228590	SENT24	27	27	16	16	crizotinib	MYCN	PA165946122	4613	0.897
NULL	Sci_Rep_2015_Jan_15_5_7817.nxml.txt.nlp	25588710	SENT15	10	10	17	17	trastuzumab	HER2	PA451743	2064	0.897
NULL	AIDS_Res_Ther_2011_Oct_6_8_36.nxml.txt.nlp	21978457	SENT135	43	43	7	7	zinc	ZIP4	PA451956	55630	0.897
NULL	Acta_Neuropathol_Commun_2014_May_30_2_57.nxml.txt.nlp	24887326	SENT77	34	34	16	16	vardenafil	ABCB1	PA10229	5243	0.897
NULL	Brain_Behav_2012_May_2(3)_270-282.nxml.txt.nlp	22741101	SENT273	15	15	37	37	cerulenin	BACE1	PA164764551	23621	0.897
NULL	Neural_Regen_Res_2014_Mar_15_9(6)_622-629.nxml.txt.nlp	25206865	SENT76	10	10	0	0	vasopressin	c-Jun	PA451858	3725	0.897
NULL	Breast_Cancer_Res_2013_Oct_3_15(5)_R93.nxml.txt.nlp	24088226	SENT107	22	22	6	6	tamoxifen	CYP2D6	PA451581	1565	0.897
NULL	J_Cell_Mol_Med_2014_May_14_18(5)_811-823.nxml.txt.nlp	24628949	SENT15	12	12	8	8	docetaxel	FOXM1	PA449383	2305	0.897
NULL	Br_J_Pharmacol_2014_Jan_23_171(2)_523-535.nxml.txt.nlp	24372553	SENT170	24	24	8	8	metformin	SIRT1	PA450395	23411	0.897
NULL	Arthritis_Res_Ther_2010_Apr_1_12(2)_R60.nxml.txt.nlp	20359365	SENT152	19	19	23	23	bleomycin	SPARC	PA448645	6678	0.897
NULL	Oncotarget_2011_Nov_9_2(11)_850-861.nxml.txt.nlp	22081665	SENT135	16	16	8	8	idarubicin	DNMT3A	PA449961	1788	0.897
NULL	Cell_Death_Dis_2014_Apr_17_5(4)_e1182.nxml.txt.nlp	24743737	SENT91	23	23	32	32	capsaicin	AMPK	PA448776	5563	0.897
NULL	Breast_Cancer_Res_2006_Jul_25_8(4)_R48.nxml.txt.nlp	16869955	SENT33	21	21	6	6	fluorouracil	p53	PA128406956	7157	0.897
NULL	Behav_Neurosci_2014_Aug_16_128(4)_504-522.nxml.txt.nlp	24933661	SENT800	13	13	19	19	scopolamine	CA3	PA451308	761	0.897
NULL	Mol_Cancer_2012_Apr_5_11_20.nxml.txt.nlp	22480225	SENT596	16	16	9	9	temozolomide	U87	PA451609	677775;641648	0.897
NULL	Breast_Cancer_Res_2013_Nov_29_15(6)_R114.nxml.txt.nlp	24289103	SENT237	28	28	15	15	tamoxifen	EGFR	PA451581	1956	0.897
NULL	Cancer_Cell_Int_2005_Feb_9_5_2.nxml.txt.nlp	15703065	SENT136	23	23	18	18	daunorubicin	P-gp	PA449212	5243	0.897
NULL	Breast_Cancer_Res_2007_Aug_8_9(4)_R50.nxml.txt.nlp	17686159	SENT263	16	16	21	21	gefitinib	PI3K	PA131301952	5290	0.897
NULL	Acta_Neuropathol_Commun_2014_May_30_2_57.nxml.txt.nlp	24887326	SENT184	6	6	2	2	vardenafil	ABCB1	PA10229	5243	0.897
NULL	Osteoporos_Int_2015_Sep_19_26_361-372.nxml.txt.nlp	25236877	SENT43	27	27	18	18	teriparatide	DANCE	PA451620	10516	0.897
NULL	Arthritis_Res_Ther_2006_Jul_21_8(4)_R130.nxml.txt.nlp	16859540	SENT169	12	12	20	20	lovastatin	CD59	PA450272	966	0.897
NULL	Mol_Cancer_2008_Mar_26_7_27.nxml.txt.nlp	18366759	SENT210	9	9	37	37	etoposide	HIF-1	PA449552	29072	0.897
NULL	Breast_Cancer_Res_2005_Apr_6_7(3)_119-130.nxml.txt.nlp	15987442	SENT36	31	31	3	3	tamoxifen	AP-1	PA451581	2353;3727;2354;3725	0.897
NULL	Br_J_Cancer_2010_Oct_26_103(9)_1380-1390.nxml.txt.nlp	20877355	SENT191	6	6	2	2	bortezomib	DR4	PA10252	8797	0.897
NULL	Diabetes_Care_2010_Oct_13_33(10)_2250-2253.nxml.txt.nlp	20628086	SENT38	17	17	5	5	rosiglitazone	DREAM	PA451283	30818	0.897
NULL	Acta_Pharmacol_Sin_2014_Aug_21_35(8)_1082-1092.nxml.txt.nlp	25047514	SENT173	44	44	6	6	estradiol	aromatase	PA449503	1588	0.897
NULL	Clin_Interv_Aging_2015_Jan_6_10_157-174.nxml.txt.nlp	25609933	SENT160	35	35	42	42	everolimus	aromatase	PA164746311	1588	0.897
NULL	Clin_Transl_Allergy_2013_Sep_2_3_29.nxml.txt.nlp	24004581	SENT106	29	29	33	33	omalizumab	gamma	PA164752253	9913	0.897
NULL	Diabetes_2013_Nov_18_62(11)_3851-3862.nxml.txt.nlp	23884890	SENT211	2	2	14	14	metformin	AMPK	PA450395	5563	0.897
NULL	Oncoimmunology_2012_Aug_1_1(5)_609-617.nxml.txt.nlp	22934253	SENT111	33	33	39	39	vemurafenib	BRAF	PA165946873	673	0.897
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R91.nxml.txt.nlp	22541814	SENT210	29	29	9	9	thrombin	PAR1	PA451674	79581;2149	0.897
NULL	F1000Res_2013_Mar_5_2_74.nxml.txt.nlp	24358880	SENT235	17	17	12	12	capsaicin	TRPV1	PA448776	7442	0.897
NULL	Mol_Cancer_2009_Dec_3_8_115.nxml.txt.nlp	19958544	SENT172	8	8	14	14	nutlin-3	MDM2		4193	0.897
NULL	Springerplus_2014_Sep_9_3_510.nxml.txt.nlp	25279302	SENT46	11	11	3	3	creatine	CT1	PA164778930	1489;6535	0.897
NULL	Arthritis_Res_Ther_2014_Sep_18_16(Suppl_1)_A50.nxml.txt.nlp	NULL	SENT9	0	0	18	18	eculizumab	C5a	PA164776637	727	0.897
NULL	Cases_J_2009_Jul_30_2_7134.nxml.txt.nlp	19829918	SENT62	12	12	28	28	rasagiline	LCE	PA164764584	79071	0.897
NULL	J_Biol_Inorg_Chem_2014_Oct_17_19(1)_17-27.nxml.txt.nlp	24132751	SENT24	2	2	19	19	cisplatin	CTR1	PA449014	1317	0.897
NULL	Cancer_Cell_Int_2009_Sep_10_9_25.nxml.txt.nlp	19744341	SENT108	0	0	2	2	glucosamine	STAT3	PA164747613	6774	0.897
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT446	31	31	34	34	olanzapine	PRL	PA450688	5617	0.897
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Mar_14_68(Pt_4)_o1061.nxml.txt.nlp	22589928	SENT3	17	17	22	22	formaldehyde	mol	PA449703	90527	0.897
NULL	Br_J_Pharmacol_2011_Nov_164(5)_1522-1533.nxml.txt.nlp	21557728	SENT155	23	23	21	21	cangrelor	P2Y12	PA165945763	64805	0.897
NULL	Cancer_Metastasis_Rev_2014_Dec_28_33(1)_161-171.nxml.txt.nlp	24375389	SENT279	14	14	3	3	paclitaxel	CHFR	PA450761	55743	0.897
NULL	Braz_J_Med_Biol_Res_2013_Aug_13_46(8)_650-658.nxml.txt.nlp	23969971	SENT127	38	38	17	17	cisplatin	STAT3	PA449014	6774	0.897
NULL	Pharmaceuticals_(Basel)_2013_Aug_21_6(8)_988-1038.nxml.txt.nlp	24276379	SENT361	17	17	7	7	cetuximab	EGFR	PA10040	1956	0.897
NULL	Nature_2012_Apr_18_486(7403)_346-352.nxml.txt.nlp	22522925	SENT38	9	9	5	5	trastuzumab	HER2	PA451743	2064	0.897
NULL	Cancers_(Basel)_2012_May_29_4(2)_531-548.nxml.txt.nlp	24213323	SENT117	2	2	12	12	hyaluronan	periostin	PA165958431	10631	0.897
NULL	Int_J_Gen_Med_2012_Nov_12_5_943-951.nxml.txt.nlp	23204858	SENT112	0	0	21	21	fesoterodine	CYP2D6	PA165958376	1565	0.897
NULL	Clinics_(Sao_Paulo)_2010_Aug_65(8)_803b-807.nxml.txt.nlp	20835559	SENT15	10	10	13	13	estradiol	spatial	PA449503	219793	0.897
NULL	Breast_Cancer_Res_2000_Jul_12_2(5)_345-352.nxml.txt.nlp	11250727	SENT45	4	4	19	19	estradiol	aromatase	PA449503	1588	0.897
NULL	Indian_J_Med_Paediatr_Oncol_2014_Apr-Jun_35(2)_140-142.nxml.txt.nlp	25197175	SENT18	40	40	18	18	panitumumab	KRAS	PA162373091	3845	0.897
NULL	Cancers_(Basel)_2013_Jul_26_5(3)_943-958.nxml.txt.nlp	24202328	SENT53	28	28	7	7	hydroxyurea	PARP-1	PA449942	25976	0.897
NULL	Cell_Res_2013_Jun_21_23(6)_746-758.nxml.txt.nlp	23689277	SENT225	17	17	5	5	resveratrol	SOD1		6647	0.897
NULL	Int_J_Endocrinol_2014_Feb_23_2014_397307.nxml.txt.nlp	24707287	SENT169	9	9	13	13	taurine	ACR	PA451590	49	0.897
NULL	Breast_Cancer_Res_2006_Nov_27_8(6)_R66.nxml.txt.nlp	17129383	SENT76	13	13	7	7	paclitaxel	HER2	PA450761	2064	0.897
NULL	Ann_Gen_Psychiatry_2010_Apr_22_9(Suppl_1)_S83.nxml.txt.nlp	NULL	SENT4	9	9	0	0	carbamazepine	AC5	PA448785	111	0.897
NULL	Chin_J_Cancer_2011_Aug_30(8)_508-525.nxml.txt.nlp	21801600	SENT312	25	25	14	14	metformin	AMPK	PA450395	5563	0.897
NULL	EMBO_Mol_Med_2013_Mar_18_5(3)_344-352.nxml.txt.nlp	23417962	SENT130	35	35	33	33	resveratrol	SIRT1		23411	0.897
NULL	Scientifica_(Cairo)_2013_Feb_3_2013_125705.nxml.txt.nlp	24278766	SENT270	14	14	23	23	nelfinavir	RANKL	PA450606	8600	0.897
NULL	Int_J_Mol_Sci_2014_Oct_29_15(11)_19700-19728.nxml.txt.nlp	25356505	SENT191	8	8	10	10	isoproterenol	PP2	PA450121	4888	0.897
NULL	J_Hematol_Oncol_2008_Oct_23_1_19.nxml.txt.nlp	18947412	SENT142	10	10	28	28	alemtuzumab	CD34	PA164783958	947	0.897
NULL	Crit_Care_2008_Mar_13_12(Suppl_2)_P272.nxml.txt.nlp	NULL	SENT7	17	17	0	0	cosyntropin	RAI	PA164749052	10848;6050	0.897
NULL	Br_J_Cancer_2011_Mar_15_104(6)_941-947.nxml.txt.nlp	21407223	SENT161	13	13	25	25	sorafenib	survivin	PA7000	332	0.897
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1699-1708.nxml.txt.nlp	19861960	SENT221	13	13	21	21	dasatinib	mol	PA162372878	90527	0.897
NULL	Cancers_(Basel)_2014_Nov_14_6(4)_2275-2295.nxml.txt.nlp	25405526	SENT201	19	19	28	28	doxorubicin	CHOP	PA449412	1649	0.897
NULL	Ann_Lab_Med_2012_Jul_20_32(4)_270-275.nxml.txt.nlp	22779068	SENT105	42	42	33	33	imipenem	FOX-1	PA449968	54715	0.897
NULL	J_Thyroid_Res_2011_Aug_2_2011_102636.nxml.txt.nlp	21826256	SENT153	0	0	20	20	imatinib	c-ABL	PA10804	25	0.897
NULL	Acta_Neuropathol_2015_Oct_17_129_81-96.nxml.txt.nlp	25322817	SENT160	3	3	21	21	capsaicin	TRPV1	PA448776	7442	0.897
NULL	Biochemistry_2010_Nov_23_49(46)_10006-10012.nxml.txt.nlp	20964302	SENT59	20	20	9	9	trypsin	CO2	PA451806	4513	0.897
NULL	Mol_Biol_Cell_2012_Jul_15_23(14)_2658-2670.nxml.txt.nlp	22621899	SENT233	6	6	22	22	doxycycline	AURKA	PA449415	6790	0.897
NULL	Neural_Regen_Res_2014_Nov_1_9(21)_1897-1901.nxml.txt.nlp	25558239	SENT97	2	2	22	22	diazepam	CA1	PA449283	759	0.897
NULL	Adv_Hematol_2012_Aug_2_2012_842945.nxml.txt.nlp	22919394	SENT156	24	24	18	18	lenalidomide	CRBN	PA162363968	51185	0.897
NULL	J_Mol_Med_2008_Sep_4_86(9)_1045-1056.nxml.txt.nlp	18600309	SENT266	7	7	21	21	curcumin	IL-8	PA151958596	3576	0.897
NULL	BMB_Rep_2014_Jan_47(1)_33-38.nxml.txt.nlp	24209634	SENT116	17	17	2	2	cisplatin	CXCR4	PA449014	7852	0.897
NULL	J_Gen_Physiol_2004_Apr_123(4)_427-439.nxml.txt.nlp	15024039	SENT529	1	1	30	30	genistein	PP2	PA165109660	4888	0.897
NULL	Front_Neurosci_2013_Dec_20_7_256.nxml.txt.nlp	24391536	SENT99	19	19	17	17	rimonabant	CB1	PA152407999	1268	0.897
NULL	Mol_Pain_2012_Sep_22_8_71.nxml.txt.nlp	22998838	SENT55	21	21	30	30	paclitaxel	ANOVA	PA450761	4858	0.897
NULL	Clin_Pharmacokinet_2014_Sep_3_53(1)_1-16.nxml.txt.nlp	23999929	SENT342	3	3	13	13	dabigatran	P-gp		5243	0.897
NULL	Diabetes_2008_Sep_57(9)_2272-2279.nxml.txt.nlp	18519799	SENT153	20	20	30	30	rosiglitazone	PDK4	PA451283	5166	0.897
NULL	Clin_Psychopharmacol_Neurosci_2011_Apr_30_9(1)_36-43.nxml.txt.nlp	23431025	SENT95	11	11	25	25	haloperidol	NAC	PA449841	22861	0.897
NULL	Ann_Rheum_Dis_2008_May_21_68(2)_175-182.nxml.txt.nlp	18495735	SENT139	7	7	26	26	infliximab	CTX	PA452639	1593	0.897
NULL	J_Cancer_Prev_2014_Mar_19(1)_39-46.nxml.txt.nlp	25337571	SENT120	14	14	4	4	ethanol	CDK4	PA448073	1019	0.897
NULL	Curr_Neuropharmacol_2008_Jun_6(2)_151-163.nxml.txt.nlp	19305794	SENT139	10	10	15	15	capsaicin	TRPA1	PA448776	8989	0.897
NULL	Cancer_Cell_Int_2012_Jan_18_12_1.nxml.txt.nlp	22257483	SENT272	2	2	5	5	finasteride	SRD5A1	PA449627	6715	0.897
NULL	Int_J_Mol_Imaging_2011_Oct_26_2011_874585.nxml.txt.nlp	21490735	SENT78	39	39	19	19	glucose	OMG	PA449773	4974	0.897
NULL	Curr_Med_Chem_2011_Dec_18(35)_5476-5482.nxml.txt.nlp	22087839	SENT72	25	25	17	17	irinotecan	CDC25	PA450085	5923	0.897
NULL	Comput_Math_Methods_Med_2014_Feb_3_2014_813067.nxml.txt.nlp	24639887	SENT287	38	38	9	9	etoposide	MYBL2	PA449552	4605	0.897
NULL	Breast_Cancer_Res_2005_Nov_11_7(6)_255-257.nxml.txt.nlp	16457700	SENT37	24	24	21	21	tamoxifen	aromatase	PA451581	1588	0.897
NULL	BMB_Rep_2013_Feb_46(2)_92-96.nxml.txt.nlp	23433111	SENT81	3	3	7	7	etoposide	BRCA1	PA449552	672	0.897
NULL	Br_J_Cancer_2009_Jul_21_101(2)_238-243.nxml.txt.nlp	19568242	SENT118	25	25	12	12	bevacizumab	IFN	PA130232992	3439	0.897
NULL	Cancers_(Basel)_2011_Apr_1_3(2)_1844-1860.nxml.txt.nlp	24212785	SENT128	19	19	26	26	bevacizumab	ACRC	PA130232992	93953	0.897
NULL	Mol_Cancer_2012_Jul_25_11_47.nxml.txt.nlp	22830443	SENT54	26	26	2	2	panitumumab	EGFR	PA162373091	1956	0.897
NULL	Biomed_Res_Int_2014_Jun_25_2014_203693.nxml.txt.nlp	25089265	SENT203	1	1	12	12	sorafenib	survivin	PA7000	332	0.897
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT113	9	9	32	32	neratinib	HER2	PA165291472	2064	0.897
NULL	Int_J_Endocrinol_2014_Aug_11_2014_312452.nxml.txt.nlp	25183970	SENT159	25	25	7	7	liraglutide	PI3K	PA165958364	5290	0.897
NULL	Curr_Opin_Pharmacol_2013_Aug_13(4)_497-503.nxml.txt.nlp	23664091	SENT306	9	9	7	7	gefitinib	EGFR	PA131301952	1956	0.897
NULL	Oncol_Rep_2014_Apr_28_31(4)_1605-1612.nxml.txt.nlp	24481648	SENT114	5	5	22	22	ponatinib	MRP7	PA165980594	89845;1080	0.897
NULL	Mol_Cancer_2009_Aug_25_8_66.nxml.txt.nlp	19706164	SENT90	12	12	21	21	celecoxib	FBS	PA448871	64319;26269	0.897
NULL	Int_J_Biol_Sci_2015_Jan_1_11(1)_48-58.nxml.txt.nlp	25552929	SENT210	19	19	2	2	paclitaxel	TSP-1	PA450761	7057	0.897
NULL	Am_J_Trop_Med_Hyg_2012_Nov_7_87(5_Suppl)_137-143.nxml.txt.nlp	23136289	SENT141	7	7	33	33	amoxicillin	PKR	PA448406	5610	0.897
NULL	Oncogene_2009_Apr_23_28(16)_1821-1832.nxml.txt.nlp	19305428	SENT176	2	2	7	7	pp2	San		80218	0.897
NULL	Oncol_Lett_2013_May_22_5(5)_1541-1545.nxml.txt.nlp	23760395	SENT175	3	3	10	10	mefloquine	PC3	PA450348	57332;7832;5122	0.897
NULL	Crit_Care_2011_Nov_30_15(6)_R289.nxml.txt.nlp	22129171	SENT175	15	15	10	10	dipyridamole	IL-6	PA449367	3569	0.897
NULL	Acta_Pharmacol_Sin_2012_May_16_33(5)_682-690.nxml.txt.nlp	22504904	SENT130	15	15	19	19	celecoxib	STAT3	PA448871	6774	0.897
NULL	Int_J_Mol_Sci_2012_Feb_1_13(2)_1512-1523.nxml.txt.nlp	22408405	SENT62	20	20	42	42	olmesartan	LOX-1	PA164742950	4973	0.897
NULL	Nature_2012_Jan_25_482(7384)_232-236.nxml.txt.nlp	22278056	SENT14	38	38	16	16	suramin	AP-1	PA10292	2353;3727;2354;3725	0.897
NULL	Int_J_Environ_Res_Public_Health_2012_Aug_3_9(8)_2788-2800.nxml.txt.nlp	23066397	SENT201	12	12	3	3	phenol	CYP2E1	PA450913	1571	0.897
NULL	Lipids_Health_Dis_2011_Feb_28_10_38.nxml.txt.nlp	21352602	SENT75	3	3	32	32	atorvastatin	PCSK9	PA448500	255738	0.897
NULL	Int_J_Mol_Sci_2014_Nov_7_15(11)_20500-20517.nxml.txt.nlp	25387078	SENT151	23	23	11	11	sorafenib	Bcl-2	PA7000	596	0.897
NULL	J_Hematol_Oncol_2013_May_16_6_36.nxml.txt.nlp	23680477	SENT184	0	0	20	20	alvespimycin	Hsp90	PA165291491	3320	0.897
NULL	J_Adv_Pract_Oncol_2012_Sep_1_Sep-Oct_3(5)_343-344.nxml.txt.nlp	25031965	SENT78	14	14	17	17	capecitabine	DPD	PA448771	1806	0.897
NULL	Cancer_Res_Treat_2012_Dec_31_44(4)_251-261.nxml.txt.nlp	23341789	SENT181	9	9	7	7	tetracycline	p53	PA451640	7157	0.897
NULL	J_Thromb_Thrombolysis_2011_Nov_26_32(4)_459-466.nxml.txt.nlp	21706290	SENT128	7	7	23	23	tirofiban	CYP2C19	PA451698	1557	0.897
NULL	J_Thromb_Haemost_2011_Oct_9(10)_2050-2056.nxml.txt.nlp	21794076	SENT83	2	2	12	12	prasugrel	P2Y12	PA154410481	64805	0.897
NULL	Mol_Biol_Cell_2013_Aug_1_24(15)_2477-2490.nxml.txt.nlp	23761072	SENT151	19	19	35	35	arsenite	CHOP	PA452638	1649	0.897
NULL	Cancer_Cell_Int_2010_Sep_9_10_32.nxml.txt.nlp	20828393	SENT49	7	7	14	14	cisplatin	ATF3	PA449014	467	0.897
NULL	Breast_Cancer_Res_2012_Apr_4_14(2)_R57.nxml.txt.nlp	22475046	SENT44	13	13	1	1	anastrozole	ATAC	PA448432	6375	0.897
NULL	Oncotarget_2013_Dec_18_5(2)_375-385.nxml.txt.nlp	24495868	SENT57	14	14	28	28	flavopiridol	CD34	PA452627	947	0.897
NULL	Oncogene_2009_Apr_2_28(13)_1616-1625.nxml.txt.nlp	19219073	SENT100	16	16	23	23	nutlin-3	MDM2		4193	0.897
NULL	Ann_Hematol_2011_Feb_17_90(2)_173-183.nxml.txt.nlp	20714724	SENT107	36	36	22	22	resveratrol	CD19		930	0.897
NULL	Clinicoecon_Outcomes_Res_2014_Oct_17_6_451-461.nxml.txt.nlp	25378939	SENT78	23	23	11	11	linezolid	HAP	PA450233	5915;10313	0.897
NULL	EMBO_Mol_Med_2011_Jul_3(7)_367-369.nxml.txt.nlp	21591260	SENT41	30	30	26	26	thrombin	PAR1	PA451674	79581;2149	0.897
NULL	Case_Rep_Psychiatry_2014_Sep_24_2014_659715.nxml.txt.nlp	25328745	SENT68	33	33	17	17	venlafaxine	CYP2C19	PA451866	1557	0.897
NULL	ARYA_Atheroscler_2011_Summer_7(2)_78-86.nxml.txt.nlp	22577451	SENT11	4	4	36	36	choline	CRP	PA448976	1401;140913	0.897
NULL	Acta_Pharmacol_Sin_2009_Nov_5_30(11)_1522-1528.nxml.txt.nlp	19890360	SENT74	14	14	28	28	fenoterol	CD14	PA10079	929	0.897
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_33-43.nxml.txt.nlp	17912634	SENT166	10	10	1	1	tamoxifen	aromatase	PA451581	1588	0.897
NULL	Cell_Commun_Signal_2005_Aug_9_3_10.nxml.txt.nlp	16091148	SENT222	3	3	27	27	isoproterenol	San	PA450121	80218	0.897
NULL	F1000Prime_Rep_2014_Dec_1_6_117.nxml.txt.nlp	25580271	SENT5	16	16	20	20	bevacizumab	EGFR	PA130232992	1956	0.897
NULL	Int_J_Gen_Med_2011_Jul_13_4_529-533.nxml.txt.nlp	21845061	SENT5	42	42	15	15	ribavirin	HIC	PA451241	29969	0.897
NULL	Cancer_Cell_Int_2006_Oct_2_6_22.nxml.txt.nlp	17014709	SENT169	44	44	17	17	imatinib	PDGFA	PA10804	5154	0.897
NULL	Oncotarget_2013_Nov_22_5(4)_933-943.nxml.txt.nlp	24659749	SENT108	42	42	29	29	nutlin-3	AML2		864	0.897
NULL	J_Mol_Signal_2011_Jul_20_6_7.nxml.txt.nlp	21774804	SENT257	13	13	33	33	dasatinib	CD166	PA162372878	214	0.897
NULL	Oncotarget_2014_Jun_8_5(13)_5040-5053.nxml.txt.nlp	24970815	SENT151	9	9	2	2	cisplatin	EGFR	PA449014	1956	0.897
NULL	Oncotarget_2011_Aug_30_2(8)_610-626.nxml.txt.nlp	21881167	SENT189	20	20	11	11	doxorubicin	Raf-1	PA449412	5894	0.897
NULL	Front_Immunol_2012_Mar_12_3_20.nxml.txt.nlp	22566904	SENT400	12	12	3	3	imatinib	SOCS1	PA10804	8651	0.897
NULL	FEBS_Open_Bio_2014_Jan_6_4_77-89.nxml.txt.nlp	24490132	SENT180	26	26	16	16	ebselen	NAC	PA161660841	22861	0.897
NULL	Ann_Rheum_Dis_2008_May_21_68(2)_175-182.nxml.txt.nlp	18495735	SENT139	7	7	13	13	infliximab	IL-6	PA452639	3569	0.897
NULL	Case_Rep_Infect_Dis_2012_Dec_23_2012_176864.nxml.txt.nlp	23320209	SENT30	12	12	31	31	meropenem	HCAP	PA164764445	117159;9126	0.897
NULL	Oxid_Med_Cell_Longev_2013_Sep_24_2013_102741.nxml.txt.nlp	24205431	SENT179	2	2	43	43	hesperidin	Bcl-2	PA449867	596	0.897
NULL	Indian_J_Nephrol_2013_Jul-Aug_23(4)_287-291.nxml.txt.nlp	23960346	SENT128	3	3	8	8	rituximab	CHOP	PA451261	1649	0.897
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_127043.nxml.txt.nlp	23227093	SENT180	9	9	14	14	nifedipine	CYP3A4	PA450631	1576	0.897
NULL	Oxid_Med_Cell_Longev_2011_Nov_24_2011_467180.nxml.txt.nlp	22191013	SENT89	21	21	3	3	methamphetamine	GAPDH	PA450403	2597	0.897
NULL	Nat_Commun_2014_Nov_25_5_5548.nxml.txt.nlp	25420520	SENT41	11	11	1	1	cabazitaxel	ERG	PA165958401	2078	0.897
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT170	13	13	8	8	neratinib	HER2	PA165291472	2064	0.897
NULL	Diabetes_2009_Jun_26_58(6)_1457-1462.nxml.txt.nlp	19324939	SENT29	31	31	11	11	vasopressin	SSTR2	PA451858	6752	0.897
NULL	Endocrinology_2014_Oct_22_155(10)_3732-3738.nxml.txt.nlp	25051442	SENT66	20	20	6	6	sibutramine	POMC	PA451344	5443	0.897
NULL	Mol_Cancer_2009_Nov_10_8_99.nxml.txt.nlp	19903356	SENT91	10	10	2	2	imatinib	IGFBP3	PA10804	3486	0.897
NULL	Br_J_Cancer_2010_Jun_8_102(12)_1707-1716.nxml.txt.nlp	20461078	SENT136	1	1	34	34	bortezomib	TRAIL	PA10252	8743	0.897
NULL	Allergy_Asthma_Immunol_Res_2010_Apr_24_2(2)_87-101.nxml.txt.nlp	20358022	SENT219	23	23	10	10	lidocaine	IL-5	PA450226	3567	0.897
NULL	Curr_Neuropharmacol_2013_Dec_11(6)_652-663.nxml.txt.nlp	24396340	SENT193	8	8	18	18	enflurane	TRPV1	PA449461	7442	0.897
NULL	Diabetes_Care_2012_Feb_16_35(2)_327-333.nxml.txt.nlp	22179958	SENT10	13	13	1	1	metformin	B12	PA450395	7126;4709	0.897
NULL	COPD_2014_Jun_2_11(3)_310-318.nxml.txt.nlp	24295402	SENT51	9	9	23	23	trypsin	CD34	PA451806	947	0.897
NULL	Br_J_Cancer_2009_Jan_13_100(1)_19-23.nxml.txt.nlp	19018262	SENT66	2	2	6	6	gefitinib	EGFR	PA131301952	1956	0.897
NULL	Croat_Med_J_2013_Apr_54(2)_171-179.nxml.txt.nlp	23630144	SENT144	12	12	19	19	taurine	STZ	PA451590	6484	0.897
NULL	J_Hematol_Oncol_2008_Oct_1_1_16.nxml.txt.nlp	18828924	SENT66	9	9	23	23	bevacizumab	HER2	PA130232992	2064	0.897
NULL	Anat_Cell_Biol_2012_Jun_30_45(2)_73-78.nxml.txt.nlp	22822460	SENT85	17	17	26	26	paclitaxel	HIF-1	PA450761	29072	0.897
NULL	Mol_Cancer_2008_Jul_24_7_64.nxml.txt.nlp	18652674	SENT134	18	18	4	4	doxorubicin	XIAP	PA449412	331	0.897
NULL	Drug_Target_Insights_2013_Aug_19_7_27-34.nxml.txt.nlp	24023511	SENT40	20	20	9	9	vinblastine	P-gp	PA451877	5243	0.897
NULL	Free_Radic_Biol_Med_2014_Mar_68(100)_87-100.nxml.txt.nlp	24333634	SENT282	16	16	40	40	hemin	LIP	PA449849	23049	0.897
NULL	Int_J_Breast_Cancer_2012_May_8_2012_764570.nxml.txt.nlp	22645687	SENT30	9	9	11	11	tamoxifen	aromatase	PA451581	1588	0.897
NULL	Clin_Interv_Aging_2009_May_14_4_109-113.nxml.txt.nlp	19503773	SENT22	17	17	10	10	levodopa	COMT	PA450213	1312	0.897
NULL	Clin_Mol_Allergy_2011_Jul_26_9_11.nxml.txt.nlp	21791043	SENT57	16	16	5	5	omalizumab	CD4	PA164752253	920	0.897
NULL	Rare_Tumors_2010_Jun_30_2(2)_e34.nxml.txt.nlp	21139836	SENT98	18	18	8	8	alemtuzumab	CD52	PA164783958	1043	0.897
NULL	Front_Neurol_2011_Dec_26_2_83.nxml.txt.nlp	22363312	SENT111	15	15	8	8	clopidogrel	LTA	PA449053	4049	0.897
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT50	0	0	2	2	resveratrol	IL-6		3569	0.897
NULL	J_Mol_Signal_2011_May_16_6_4.nxml.txt.nlp	21575178	SENT170	17	17	13	13	forskolin	HSP27	PA146096022	3315	0.897
NULL	J_Cardiothorac_Surg_2011_Jul_15_6_91.nxml.txt.nlp	21762506	SENT29	13	13	21	21	vasopressin	ACLS	PA451858	46;2737	0.897
NULL	Breast_Cancer_Res_2008_Dec_18_10(Suppl_4)_S20.nxml.txt.nlp	19128434	SENT30	28	28	25	25	trastuzumab	HER2	PA451743	2064	0.897
NULL	Br_J_Cancer_2010_Jan_5_102(1)_104-114.nxml.txt.nlp	20051961	SENT286	26	26	3	3	paclitaxel	PC3	PA450761	57332;7832;5122	0.897
NULL	Curr_Oncol_2006_Feb_13(1)_2-7.nxml.txt.nlp	17576435	SENT21	14	14	7	7	tamoxifen	HER2	PA451581	2064	0.897
NULL	Acta_Pharmacol_Sin_2014_Jul_9_35(7)_889-898.nxml.txt.nlp	24909515	SENT223	15	15	3	3	bromocriptine	DRD2	PA448671	1813	0.897
NULL	Psychiatry_Investig_2010_Dec_30_7(4)_236-242.nxml.txt.nlp	21253406	SENT59	14	14	25	25	citalopram	STAR	PA449015	6770;2984	0.897
NULL	Evid_Based_Complement_Alternat_Med_2012_Sep_4_2012_967182.nxml.txt.nlp	22988478	SENT40	32	32	28	28	probenecid	OAT1	PA451106	9356	0.897
NULL	Breast_Cancer_Res_2011_Nov_1_13(6)_224.nxml.txt.nlp	22114931	SENT68	15	15	38	38	tamoxifen	aromatase	PA451581	1588	0.897
NULL	J_Cell_Biol_1984_Mar_1_98(3)_1048-1053.nxml.txt.nlp	6321514	SENT6	13	13	28	28	chloroquine	EGF	PA448948	1950	0.897
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT219	42	42	5	5	heparin	FGF1	PA449855	2246	0.897
NULL	J_Immunol_Res_2014_Apr_10_2014_268479.nxml.txt.nlp	24818166	SENT159	14	14	41	41	gemcitabine	CD22	PA449748	933	0.897
NULL	Clin_Pharmacol_2011_Jun_22_3_13-25.nxml.txt.nlp	22287853	SENT190	7	7	5	5	diltiazem	CYP3A4	PA449334	1576	0.897
NULL	Neuropsychopharmacology_2012_Feb_2_37(3)_641-650.nxml.txt.nlp	22048466	SENT130	10	10	6	6	varenicline	CHRNB2	PA164781343	1141	0.897
NULL	Indian_J_Med_Res_2012_Dec_136(6)_926-941.nxml.txt.nlp	23391788	SENT137	13	13	9	9	cangrelor	P2Y12	PA165945763	64805	0.897
NULL	Eur_J_Haematol_2014_Nov_28_93(5)_369-376.nxml.txt.nlp	24797664	SENT126	25	25	14	14	thrombin	FVIII	PA451674	2157	0.897
NULL	Oncotarget_2012_May_4_3(4)_395-398.nxml.txt.nlp	22565037	SENT9	31	31	9	9	trastuzumab	CD44	PA451743	960	0.897
NULL	Eur_J_Clin_Pharmacol_2014_Oct_8_70(1)_37-45.nxml.txt.nlp	24100471	SENT15	11	11	38	38	rosuvastatin	OATP1B1	PA134308647	10599	0.897
NULL	Onco_Targets_Ther_2014_Jun_11_7_969-983.nxml.txt.nlp	24959084	SENT115	27	27	4	4	carbamazepine	CYP3A4	PA448785	1576	0.897
NULL	ScientificWorldJournal_2012_Apr_1_2012_381434.nxml.txt.nlp	22545017	SENT384	25	25	12	12	aprepitant	NK-1	PA164747039	27087	0.896
NULL	Exp_Ther_Med_2013_Apr_29_5(4)_1093-1096.nxml.txt.nlp	23596475	SENT79	8	8	29	29	ketamine	IL-6	PA450144	3569	0.896
NULL	Biosci_Rep_2014_Aug_6_34(4)_e00131.nxml.txt.nlp	24975826	SENT147	19	19	13	13	pp2	PP2		4888	0.896
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT109	5	5	0	0	imatinib	ABCG2	PA10804	9429	0.896
NULL	Int_J_Mol_Sci_2014_Sep_2_15(9)_15512-15529.nxml.txt.nlp	25184950	SENT81	15	15	23	23	resveratrol	IL-10		3586	0.896
NULL	J_Immunother_Cancer_2014_Jan_27_2_2.nxml.txt.nlp	24829759	SENT169	3	3	40	40	sorafenib	IFN	PA7000	3439	0.896
NULL	Colorectal_Dis_2012_Feb_14(2)_e31-e47.nxml.txt.nlp	21848897	SENT136	6	6	18	18	panitumumab	KRAS	PA162373091	3845	0.896
NULL	Oxid_Med_Cell_Longev_2013_Jun_2_2013_793525.nxml.txt.nlp	23819014	SENT124	13	13	8	8	resveratrol	PI3K		5290	0.896
NULL	Leukemia_2013_Apr_14_27(4)_803-812.nxml.txt.nlp	23238589	SENT117	5	5	10	10	imatinib	IFN	PA10804	3439	0.896
NULL	J_Cardiothorac_Surg_2014_Sep_17_9(1)_129.nxml.txt.nlp	NULL	SENT170	20	20	12	12	heparin	ACT	PA449855	12;11332;9457;641455	0.896
NULL	Cancer_Gene_Ther_2014_May_2_21(5)_181-187.nxml.txt.nlp	24787239	SENT85	3	3	10	10	erlotinib	EGFR	PA134687924	1956	0.896
NULL	Nat_Commun_2013_Aug_15_4_2130.nxml.txt.nlp	23945651	SENT42	13	13	21	21	cisplatin	ATG5	PA449014	9474	0.896
NULL	Mol_Cancer_2010_Dec_2_9_309.nxml.txt.nlp	21122157	SENT170	10	10	7	7	paclitaxel	IL-6	PA450761	3569	0.896
NULL	Pak_J_Med_Sci_2013_Nov-Dec_29(6)_1459-1461.nxml.txt.nlp	24550976	SENT39	6	6	25	25	heparin	ACT	PA449855	12;11332;9457;641455	0.896
NULL	Diabetes_Obes_Metab_2011_Nov_13(11)_982-989.nxml.txt.nlp	21615670	SENT100	11	11	20	20	exenatide	PPG	PA164749238	5552	0.896
NULL	Clin_Med_Insights_Case_Rep_2011_Dec_4_4_73-77.nxml.txt.nlp	22174593	SENT74	25	25	15	15	warfarin	CYP2C9	PA451906	1559	0.896
NULL	Cancer_Immunol_Immunother_2011_Jun_25_60(6)_793-808.nxml.txt.nlp	21350947	SENT59	22	22	19	19	sorafenib	IFN	PA7000	3439	0.896
NULL	J_Adv_Pharm_Technol_Res_2014_Jan-Mar_5(1)_21-27.nxml.txt.nlp	24696814	SENT46	24	24	7	7	ethanol	mol	PA448073	90527	0.896
NULL	Acta_Pharmacol_Sin_2014_Aug_7_35(8)_1015-1022.nxml.txt.nlp	24998256	SENT27	18	18	4	4	ethanol	ALDH2	PA448073	217	0.896
NULL	Front_Oncol_2014_Jun_18_4_153.nxml.txt.nlp	24995158	SENT546	36	36	18	18	doxorubicin	JNK	PA449412	5599	0.896
NULL	Oncotarget_2012_Sep_11_3(9)_1026-1035.nxml.txt.nlp	22976441	SENT103	26	26	14	14	etoposide	CKI	PA449552	1119	0.896
NULL	Crit_Care_2004_Mar_15_8(Suppl_1)_P259.nxml.txt.nlp	NULL	SENT7	14	14	1	1	hydrocortisone	ACTH	PA449905	5443	0.896
NULL	Indian_J_Ophthalmol_2011_Jul-Aug_59(4)_273-277.nxml.txt.nlp	21666310	SENT54	17	17	25	25	doxorubicin	CHOP	PA449412	1649	0.896
NULL	Diabetes_2013_Oct_17_62(10)_3500-3513.nxml.txt.nlp	23884882	SENT269	17	17	6	6	resveratrol	NKX6-2		84504	0.896
NULL	Br_J_Haematol_2014_Mar_13_164(1)_811-821.nxml.txt.nlp	24328678	SENT102	4	4	21	21	lenalidomide	Aiolos	PA162363968	22806	0.896
NULL	J_Gen_Physiol_2013_Feb_141(2)_165-178.nxml.txt.nlp	23359281	SENT317	15	15	21	21	thrombin	CPI-17	PA451674	94274	0.896
NULL	Mol_Pain_2013_Jul_31_9_38.nxml.txt.nlp	23898828	SENT9	11	11	36	36	losartan	p38	PA450268	10598;1432;7965	0.896
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT308	14	14	21	21	ranibizumab	VEGF-A	PA164746012	7422	0.896
NULL	Int_J_Biol_Sci_2014_Nov_26_10(10)_1193-1202.nxml.txt.nlp	25516717	SENT38	42	42	9	9	camptothecin	SIRT1	PA153590860	23411	0.896
NULL	Cardiovasc_Ther_2009_27(4)_259-274.nxml.txt.nlp	19604248	SENT5	17	17	8	8	ticagrelor	P2Y12	PA165374673	64805	0.896
NULL	J_Cell_Mol_Med_2014_Aug_6_18(8)_1519-1539.nxml.txt.nlp	25100284	SENT174	19	19	24	24	gefitinib	EGFR	PA131301952	1956	0.896
NULL	Cancers_(Basel)_2012_Oct_12_4(4)_989-1035.nxml.txt.nlp	24213498	SENT447	36	36	30	30	gemcitabine	CXCR4	PA449748	7852	0.896
NULL	J_Hematol_Oncol_2009_Apr_22_2_18.nxml.txt.nlp	19386128	SENT60	18	18	22	22	panitumumab	EGFR	PA162373091	1956	0.896
NULL	Biol_Open_2014_Nov_28_3(12)_1236-1244.nxml.txt.nlp	25432513	SENT226	23	23	25	25	hydroxyurea	gamma	PA449942	9913	0.896
NULL	J_Biol_Chem_2013_Dec_6_288(49)_35387-35395.nxml.txt.nlp	24142790	SENT166	8	8	24	24	meclizine	PCYT2	PA450338	5833	0.896
NULL	Indian_J_Med_Res_2014_Aug_140(2)_209-215.nxml.txt.nlp	25297352	SENT103	12	12	5	5	phenytoin	CLB	PA450947	171425	0.896
NULL	Nucleic_Acids_Res_2012_Sep_4_40(16)_8119-8128.nxml.txt.nlp	22669903	SENT174	41	41	29	29	thrombin	TGT	PA451674	9097;81890	0.896
NULL	Ann_R_Coll_Surg_Engl_2012_Sep_94(6)_e189-e190.nxml.txt.nlp	22943317	SENT24	5	5	13	13	rituximab	ABO	PA451261	28	0.896
NULL	Carcinogenesis_2010_Dec_27_31(12)_2049-2057.nxml.txt.nlp	20876285	SENT127	30	30	23	23	tamoxifen	HER2	PA451581	2064	0.896
NULL	Exp_Ther_Med_2013_Jul_8_6(1)_241-247.nxml.txt.nlp	23935754	SENT63	25	25	16	16	trypsin	CO2	PA451806	4513	0.896
NULL	J_Neuroinflammation_2011_Aug_5_8_91.nxml.txt.nlp	21819568	SENT207	11	11	23	23	pioglitazone	ANOVA	PA450970	4858	0.896
NULL	Cancer_2011_Apr_15_117(8)_1670-1678.nxml.txt.nlp	21472714	SENT169	13	13	4	4	cisplatin	SIRT3	PA449014	23410	0.896
NULL	Contemp_Oncol_(Pozn)_2012_Nov_20_16(5)_401-406.nxml.txt.nlp	23788917	SENT154	8	8	21	21	everolimus	HER2	PA164746311	2064	0.896
NULL	Mol_Cancer_2014_Jul_5_13_165.nxml.txt.nlp	24996221	SENT252	18	18	8	8	docetaxel	HMGB1	PA449383	3146	0.896
NULL	ScientificWorldJournal_2014_Jan_30_2014_910590.nxml.txt.nlp	24672390	SENT116	11	11	7	7	ethanol	CO2	PA448073	4513	0.896
NULL	Sci_Rep_2014_Dec_9_4_7380.nxml.txt.nlp	25490312	SENT32	15	15	2	2	kanamycin	ING4	PA450137	51147	0.896
NULL	Curr_Cardiol_Rev_2009_Aug_5(3)_166-176.nxml.txt.nlp	20676275	SENT197	12	12	19	19	terfenadine	HERG	PA451619	3757	0.896
NULL	Oxid_Med_Cell_Longev_2012_Jun_3_2012_914273.nxml.txt.nlp	22701758	SENT203	23	23	26	26	resveratrol	SIRT1		23411	0.896
NULL	J_Cell_Biol_2000_Jan_24_148(2)_325-332.nxml.txt.nlp	10648565	SENT58	23	23	10	10	ethanol	p65	PA448073	5970	0.896
NULL	Front_Neurosci_2014_Jun_3_8_128.nxml.txt.nlp	24917782	SENT17	14	14	32	32	ethanol	MC4R	PA448073	4160	0.896
NULL	Endocr_Relat_Cancer_2014_Apr_21(2)_355-369.nxml.txt.nlp	24481325	SENT10	0	0	15	15	tamoxifen	GPER	PA451581	2852	0.896
NULL	Aging_(Albany_NY)_2014_May_17_6(5)_369-379.nxml.txt.nlp	24860943	SENT79	14	14	32	32	l-arginine	S6K1	PA448478	6198	0.896
NULL	Aging_(Albany_NY)_2014_Jan_14_6(1)_70-81.nxml.txt.nlp	24429382	SENT202	23	23	6	6	etoposide	WRN	PA449552	7486	0.896
NULL	Acta_Pharmacol_Sin_2012_May_16_33(5)_682-690.nxml.txt.nlp	22504904	SENT125	0	0	8	8	celecoxib	STAT3	PA448871	6774	0.896
NULL	J_Mol_Med_(Berl)_2014_Jan_10_92(5)_497-507.nxml.txt.nlp	24408111	SENT14	0	0	8	8	pioglitazone	HIF-1	PA450970	29072	0.896
NULL	Protein_Eng_Des_Sel_2014_Apr_28_27(4)_97-109.nxml.txt.nlp	24586053	SENT238	20	20	37	37	trastuzumab	CEA	PA451743	5670;1087	0.896
NULL	J_Int_AIDS_Soc_2011_Nov_15_14_55.nxml.txt.nlp	22085598	SENT194	11	11	21	21	raltegravir	CCR5		1234	0.896
NULL	Ann_Clin_Microbiol_Antimicrob_2005_Sep_13_4_13.nxml.txt.nlp	16159399	SENT206	24	24	11	11	ribavirin	IFN	PA451241	3439	0.896
NULL	Br_J_Pharmacol_2008_Oct_18_155(4)_596-605.nxml.txt.nlp	18852694	SENT177	5	5	21	21	fenofibrate	SREBP2	PA449594	6721	0.896
NULL	Diabetes_2009_Apr_23_58(4)_894-905.nxml.txt.nlp	19168596	SENT89	0	0	7	7	paraformaldehyde	INS-1	PA450790	2305	0.896
NULL	Aging_(Albany_NY)_2011_Apr_6_3(4)_444-449.nxml.txt.nlp	21483037	SENT4	4	4	7	7	resveratrol	SIRT1		23411	0.896
NULL	Evid_Based_Complement_Alternat_Med_2011_Jan_4_2011_729412.nxml.txt.nlp	19592476	SENT74	3	3	19	19	fenofibrate	2-19	PA449594	60343	0.896
NULL	Clin_Ophthalmol_2014_Jun_28_8_1241-1252.nxml.txt.nlp	25061271	SENT36	10	10	20	20	timolol	BAK	PA451690	578	0.896
NULL	Breast_Cancer_Res_2008_Dec_18_10(Suppl_4)_S18.nxml.txt.nlp	19128431	SENT32	34	34	5	5	tamoxifen	HER2	PA451581	2064	0.896
NULL	Indian_J_Occup_Environ_Med_2008_Dec_12(3)_136-138.nxml.txt.nlp	20040973	SENT37	45	45	25	25	fluorescein	ERG	PA164746009	2078	0.896
NULL	Environ_Toxicol_Chem_2014_Oct_25_33(10)_2363-2367.nxml.txt.nlp	25043914	SENT86	22	22	12	12	galactose	ARNT	PA449725	405	0.896
NULL	J_Int_Soc_Sports_Nutr_2009_Feb_19_6_6.nxml.txt.nlp	19228401	SENT20	0	0	28	28	creatine	ADP	PA164778930	23038	0.896
NULL	Mol_Pain_2012_Sep_22_8_71.nxml.txt.nlp	22998838	SENT55	9	9	30	30	cisplatin	ANOVA	PA449014	4858	0.896
NULL	Emerg_Med_Int_2014_Feb_20_2014_935474.nxml.txt.nlp	24696784	SENT20	6	6	22	22	rivaroxaban	CYP2J2	PA165958360	1573	0.896
NULL	Oncotarget_2014_Mar_12_5(5)_1363-1381.nxml.txt.nlp	24658058	SENT314	0	0	6	6	imiquimod	San	PA449972	80218	0.896
NULL	Curr_Opin_Oncol_2014_Jul_6_26(4)_428-433.nxml.txt.nlp	24840521	SENT159	22	22	19	19	olaparib	PARP		142	0.896
NULL	Lipids_Health_Dis_2011_Jan_18_10_8.nxml.txt.nlp	21241519	SENT105	24	24	15	15	simvastatin	ABCG8	PA451363	64241	0.896
NULL	Cancer_Res_Treat_2013_Mar_31_45(1)_55-62.nxml.txt.nlp	23613671	SENT127	13	13	22	22	irinotecan	KRAS	PA450085	3845	0.896
NULL	Cancers_(Basel)_2014_Oct_24_6(4)_2187-2223.nxml.txt.nlp	25347122	SENT699	10	10	35	35	cyclophosphamide	MA5	PA449165	29944	0.896
NULL	Oncotarget_2014_Oct_18_5(22)_11604-11619.nxml.txt.nlp	25344099	SENT151	7	7	1	1	cisplatin	RYBP	PA449014	23429	0.896
NULL	Oncotarget_2013_Jul_7_4(7)_1065-1074.nxml.txt.nlp	23867252	SENT64	3	3	20	20	geldanamycin	Hsp90	PA152031327	3320	0.896
NULL	J_Gynecol_Oncol_2013_Jul_4_24(3)_273-279.nxml.txt.nlp	23875078	SENT118	9	9	24	24	paclitaxel	COX	PA450761	1351	0.896
NULL	Nat_Med_2010_Jun_23_16(6)_671-677.nxml.txt.nlp	20495567	SENT62	5	5	15	15	sorafenib	EGFR	PA7000	1956	0.896
NULL	Breast_Cancer_Res_2010_Jun_4_12(3)_R32.nxml.txt.nlp	20525379	SENT223	15	15	8	8	fulvestrant	AGR2	PA164747170	10551	0.896
NULL	Br_J_Pharmacol_2011_Feb_162(4)_989-999.nxml.txt.nlp	21054342	SENT220	5	5	22	22	omeprazole	CYP2C8	PA450704	1558	0.896
NULL	Arthritis_Res_Ther_2007_Oct_9_9(5)_R104.nxml.txt.nlp	17925024	SENT28	43	43	31	31	glucosamine	p38	PA164747613	10598;1432;7965	0.896
NULL	Int_J_Hypertens_2014_Oct_23_2014_641587.nxml.txt.nlp	25405024	SENT28	27	27	13	13	vasopressin	AVP	PA451858	114548;551	0.896
NULL	J_Invest_Dermatol_2014_Jul_31_134(7)_1903-1911.nxml.txt.nlp	24487305	SENT104	4	4	31	31	chloroquine	IL-9	PA448948	3578	0.896
NULL	Br_J_Cancer_2012_Nov_6_107(10)_1745-1753.nxml.txt.nlp	23099808	SENT14	44	44	19	19	gefitinib	EGFR	PA131301952	1956	0.896
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT18	32	32	9	9	glucosamine	FGF1	PA164747613	2246	0.896
NULL	Anesthesiol_Res_Pract_2013_Sep_23_2013_297141.nxml.txt.nlp	24174934	SENT236	0	0	20	20	bupivacaine	mol	PA135057240	90527	0.896
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT254	0	0	14	14	pemetrexed	UNG	PA10810	7374	0.896
NULL	Front_Neurol_2014_Jul_7_5_119.nxml.txt.nlp	25071707	SENT26	28	28	12	12	thrombin	VCAM1	PA451674	7412	0.896
NULL	Allergy_Asthma_Clin_Immunol_2013_Oct_3_9(1)_39.nxml.txt.nlp	24219860	SENT58	6	6	13	13	rituximab	BAFF	PA451261	10673	0.896
NULL	Ann_Hematol_2014_Sep_10_93(1)_1-11.nxml.txt.nlp	24018623	SENT130	10	10	22	22	lenalidomide	MDM2	PA162363968	4193	0.896
NULL	J_RNAi_Gene_Silencing_2009_Mar_9_5(1)_321-330.nxml.txt.nlp	19771229	SENT214	17	17	28	28	gemcitabine	RRM2	PA449748	6241	0.896
NULL	Front_Hum_Neurosci_2011_Sep_21_5_90.nxml.txt.nlp	21960965	SENT306	12	12	26	26	diazepam	gamma	PA449283	9913	0.896
NULL	Nat_Genet_2013_May_24_45(5)_10_1038_ng_2591.nxml.txt.nlp	23525077	SENT204	22	22	14	14	trastuzumab	ERBB2	PA451743	2064	0.896
NULL	Mol_Cancer_2013_Sep_11_12_104.nxml.txt.nlp	24025152	SENT6	14	14	22	22	gemcitabine	EGFR	PA449748	1956	0.896
NULL	Br_J_Cancer_2010_Jan_5_102(1)_104-114.nxml.txt.nlp	20051961	SENT276	15	15	3	3	curcumin	PC3	PA151958596	57332;7832;5122	0.896
NULL	Crit_Care_1999_Nov_8_3(6)_R107-R111.nxml.txt.nlp	NULL	SENT74	16	16	8	8	propranolol	IL-10	PA451145	3586	0.896
NULL	J_Cell_Biol_1995_May_1_129(3)_831-842.nxml.txt.nlp	7537275	SENT4	16	16	3	3	thrombin	p85	PA451674	5296;5295;54776;23368	0.896
NULL	J_Mol_Med_(Berl)_2014_Jan_10_92(5)_497-507.nxml.txt.nlp	24408111	SENT175	0	0	2	2	pioglitazone	HIF-1	PA450970	29072	0.896
NULL	Mol_Cell_Biochem_2014_Oct_9_385(1-2)_265-275.nxml.txt.nlp	24104452	SENT229	9	9	23	23	bortezomib	U87	PA10252	677775;641648	0.896
NULL	Ann_Gen_Psychiatry_2009_Jul_27_8_16.nxml.txt.nlp	19635147	SENT80	19	19	5	5	paroxetine	CYP2D6	PA450801	1565	0.896
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_39-54.nxml.txt.nlp	19305787	SENT209	11	11	4	4	ethanol	NR1	PA448073	27158	0.896
NULL	Cancer_Manag_Res_2014_Jan_28_6_39-51.nxml.txt.nlp	24501545	SENT134	37	37	41	41	theophylline	CYP1A2	PA451647	1544	0.896
NULL	Acta_Pharmacol_Sin_2013_Feb_31_34(2)_231-238.nxml.txt.nlp	23274414	SENT14	4	4	22	22	amiloride	Bcl-2	PA448368	596	0.896
NULL	F1000Prime_Rep_2014_Dec_1_6_117.nxml.txt.nlp	25580271	SENT66	33	33	38	38	cisplatin	EGFR	PA449014	1956	0.896
NULL	Arch_Drug_Inf_2011_Mar_4(1)_1-9.nxml.txt.nlp	21572514	SENT156	12	12	0	0	quinidine	P-gp	PA451209	5243	0.896
NULL	Nat_Neurosci_2012_Sep_5_15(9)_1245-1254.nxml.txt.nlp	22864611	SENT75	8	8	2	2	clozapine	HDAC2	PA449061	3066	0.896
NULL	Arthritis_Res_Ther_2010_Sep_8_12(5)_R167.nxml.txt.nlp	20825639	SENT172	4	4	11	11	resveratrol	AP-1		2353;3727;2354;3725	0.896
NULL	Ann_Rheum_Dis_2014_Jan_13_73(1)_95-100.nxml.txt.nlp	23765873	SENT209	11	11	7	7	tocilizumab	IL-6	PA165292659	3569	0.896
NULL	Eur_J_Clin_Pharmacol_2010_Nov_29_66(11)_1131-1136.nxml.txt.nlp	20669013	SENT119	18	18	38	38	erythromycin	CYP2C19	PA449493	1557	0.896
NULL	Amino_Acids_2012_Oct_10_43(4)_1751-1759.nxml.txt.nlp	22407485	SENT73	42	42	21	21	carrageenan	ghrelin	PA448814	51738	0.896
NULL	Evid_Based_Complement_Alternat_Med_2013_May_27_2013_582493.nxml.txt.nlp	23781264	SENT41	12	12	4	4	ethanol	CO2	PA448073	4513	0.896
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S279-S284.nxml.txt.nlp	21525469	SENT97	11	11	7	7	liraglutide	GLP-1	PA165958364	100125288	0.896
NULL	Int_J_Surg_Oncol_2012_Aug_27_2012_180574.nxml.txt.nlp	22970358	SENT26	4	4	18	18	tamoxifen	ATAC	PA451581	6375	0.896
NULL	Indian_J_Med_Paediatr_Oncol_2014_Apr-Jun_35(2)_140-142.nxml.txt.nlp	25197175	SENT7	4	4	11	11	erlotinib	EGFR	PA134687924	1956	0.896
NULL	Brain_Res_2012_Feb_3_1436(C)_111-121.nxml.txt.nlp	22200378	SENT127	16	16	19	19	probenecid	MRP1	PA451106	4437	0.896
NULL	Cancer_Res_Treat_2013_Mar_31_45(1)_55-62.nxml.txt.nlp	23613671	SENT13	3	3	25	25	oxaliplatin	KRAS	PA131285527	3845	0.896
NULL	Front_Oncol_2014_Apr_8_4_71.nxml.txt.nlp	24782983	SENT360	15	15	19	19	cisplatin	PTEN	PA449014	5728	0.896
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1013.nxml.txt.nlp	24457957	SENT89	7	7	20	20	orlistat	NOXA	PA164776864	5366	0.896
NULL	Int_J_Nanomedicine_2012_Oct_25_7_5565-5575.nxml.txt.nlp	23118538	SENT29	2	2	9	9	fenofibrate	CO2	PA449594	4513	0.896
NULL	Biomed_Res_Int_2014_Feb_23_2014_168949.nxml.txt.nlp	24707474	SENT145	6	6	10	10	lapatinib	HDAC7	PA152241907	51564	0.896
NULL	Cardiol_Res_Pract_2013_Feb_19_2013_195456.nxml.txt.nlp	23533940	SENT63	0	0	15	15	ticagrelor	ADP	PA165374673	23038	0.896
NULL	Cancer_Biol_Med_2012_Mar_9(1)_18-22.nxml.txt.nlp	23691449	SENT41	13	13	5	5	imatinib	EGFR	PA10804	1956	0.896
NULL	Behav_Sci_(Basel)_2012_Jun_21_2(2)_135-171.nxml.txt.nlp	23077729	SENT194	2	2	27	27	tetracycline	P21	PA451640	1026;9338	0.896
NULL	Diabetes_2011_Jun_21_60(6)_1770-1778.nxml.txt.nlp	21562078	SENT201	3	3	18	18	metformin	STZ	PA450395	6484	0.896
NULL	Chemother_Res_Pract_2012_Aug_29_2012_817297.nxml.txt.nlp	22970367	SENT125	17	17	26	26	erlotinib	AXL	PA134687924	558	0.896
NULL	Pharmaceuticals_(Basel)_2012_Aug_10_5(8)_802-836.nxml.txt.nlp	24280676	SENT25	18	18	14	14	gemcitabine	CNT2	PA449748	9153	0.896
NULL	Int_J_Chron_Obstruct_Pulmon_Dis_2006_Dec_1(4)_373-379.nxml.txt.nlp	18044094	SENT49	20	20	15	15	cilomilast	PDE4D	PA165948031	5144	0.896
NULL	Cancer_Manag_Res_2013_Nov_21_5_387-400.nxml.txt.nlp	24294007	SENT116	12	12	31	31	vemurafenib	BRAF	PA165946873	673	0.896
NULL	Oncol_Lett_2014_Aug_16_8(2)_673-678.nxml.txt.nlp	25009649	SENT36	0	0	27	27	ethanol	San	PA448073	80218	0.896
NULL	Open_Biochem_J_2011_Sep_23_5_45-51.nxml.txt.nlp	21966325	SENT119	17	17	7	7	diclofenac	IRE1	PA449293	2081	0.896
NULL	Oncotarget_2014_Jun_3_5(13)_4920-4928.nxml.txt.nlp	24952482	SENT130	4	4	11	11	crizotinib	ALK	PA165946122	238	0.896
NULL	Ann_Surg_Treat_Res_2014_Feb_22_86(2)_68-75.nxml.txt.nlp	24761411	SENT169	4	4	14	14	resveratrol	survivin		332	0.896
NULL	Mol_Biol_Cell_2014_Jul_1_25(13)_2116-2127.nxml.txt.nlp	24807908	SENT70	23	23	31	31	hemin	p52	PA449849	11168;4791	0.896
NULL	J_Gen_Physiol_2012_Nov_140(5)_541-555.nxml.txt.nlp	23109716	SENT21	5	5	12	12	capsaicin	TRPV1	PA448776	7442	0.896
NULL	Acta_Pharmacol_Sin_2014_Jan_9_35(1)_1-10.nxml.txt.nlp	24317012	SENT69	17	17	6	6	doxorubicin	MRP1	PA449412	4437	0.896
NULL	Front_Oncol_2014_Mar_6_4_40.nxml.txt.nlp	24639951	SENT542	5	5	15	15	lapatinib	AXL	PA152241907	558	0.896
NULL	J_Med_Econ_2013_Jul_24_16(7)_917-925.nxml.txt.nlp	23663091	SENT19	2	2	20	20	aripiprazole	SOC	PA10026	91544	0.896
NULL	J_Oncol_2009_Jun_22_2009_849051.nxml.txt.nlp	19584908	SENT71	22	22	5	5	irinotecan	EGFR	PA450085	1956	0.896
NULL	Clin_Psychopharmacol_Neurosci_2011_Apr_30_9(1)_36-43.nxml.txt.nlp	23431025	SENT125	10	10	29	29	aripiprazole	CA1	PA10026	759	0.896
NULL	ScientificWorldJournal_2013_Jun_24_2013_534807.nxml.txt.nlp	23864826	SENT84	28	28	5	5	fluoxetine	ANOVA	PA449673	4858	0.896
NULL	Oncotarget_2014_Sep_16_5(20)_9980-9991.nxml.txt.nlp	25296971	SENT126	5	5	39	39	oxaliplatin	E2F1	PA131285527	1869	0.896
NULL	Biosci_Rep_2012_Dec_6_33(1)_e00006.nxml.txt.nlp	23050906	SENT12	9	9	5	5	lovastatin	DHCR24	PA450272	1718	0.896
NULL	Endocrine_2012_Dec_14_42(3)_622-636.nxml.txt.nlp	22695986	SENT237	6	6	8	8	forskolin	PTH	PA146096022	5741	0.896
NULL	Oncogene_2014_Sep_18_33(38)_4685-4696.nxml.txt.nlp	24121268	SENT115	2	2	24	24	bortezomib	p53	PA10252	7157	0.896
NULL	Pharmaceuticals_(Basel)_2011_Jan_12_4(1)_187-201.nxml.txt.nlp	NULL	SENT165	9	9	22	22	l-arginine	NOS2	PA448478	339345;4843	0.896
NULL	J_Immunol_Res_2014_Mar_9_2014_549315.nxml.txt.nlp	24741606	SENT184	3	3	17	17	rituximab	ABO	PA451261	28	0.896
NULL	Oncotarget_2011_Mar_10_2(3)_186-196.nxml.txt.nlp	21406729	SENT115	23	23	19	19	orlistat	SREBP1	PA164776864	6720	0.896
NULL	J_Cell_Biol_1998_Jan_26_140(2)_335-345.nxml.txt.nlp	9442109	SENT172	4	4	7	7	chloroquine	NHE	PA448948	285335	0.896
NULL	Breast_Cancer_Res_2004_Nov_7_6(1)_39-52.nxml.txt.nlp	14680484	SENT207	0	0	16	16	trastuzumab	HER-2	PA451743	2064	0.896
NULL	Cancer_Metab_2013_Aug_14_1_18.nxml.txt.nlp	24280377	SENT237	13	13	23	23	creatine	ADP	PA164778930	23038	0.896
NULL	Biochemistry_2008_Aug_19_47(33)_8689-8696.nxml.txt.nlp	18642884	SENT60	15	15	2	2	nadh	XMP	PA164755085	2013	0.896
NULL	Nucleic_Acids_Res_2011_Mar_23_39(4)_1526-1537.nxml.txt.nlp	20972225	SENT193	30	30	6	6	tetracycline	BCS	PA451640	617	0.896
NULL	Environ_Health_Perspect_2009_Jul_23_117(7)_1155-1161.nxml.txt.nlp	19654927	SENT23	19	19	34	34	estradiol	AF1	PA449503	1946	0.896
NULL	Mol_Cancer_2014_Jun_20_13_155.nxml.txt.nlp	24950741	SENT156	13	13	28	28	bortezomib	StAR	PA10252	6770	0.896
NULL	Nat_Genet_2011_Dec_25_44(2)_165-169.nxml.txt.nlp	22197930	SENT12	15	15	2	2	temozolomide	MAP3K9	PA451609	4293	0.896
NULL	Int_J_Mol_Imaging_2011_Oct_12_2011_694179.nxml.txt.nlp	22013519	SENT108	6	6	21	21	zolmitriptan	5-HT1B	PA451975	3351	0.896
NULL	Diabetes_Care_2012_Jun_11_35(6)_1225-1231.nxml.txt.nlp	22432104	SENT208	25	25	12	12	metformin	GLP-1	PA450395	100125288	0.896
NULL	Alcohol_Res_2012_34(4)_459-467.nxml.txt.nlp	23584112	SENT114	30	30	5	5	naloxone	ACTH	PA450586	5443	0.896
NULL	J_Biol_Chem_2013_Nov_22_288(47)_34217-34229.nxml.txt.nlp	24106270	SENT217	14	14	8	8	thrombin	RhoG	PA451674	391	0.896
NULL	Mol_Cancer_2009_Nov_24_8_109.nxml.txt.nlp	19930708	SENT101	24	24	1	1	estradiol	aromatase	PA449503	1588	0.896
NULL	Int_J_Hypertens_2012_Dec_17_2012_242786.nxml.txt.nlp	23316343	SENT144	7	7	10	10	eplerenone	MRB	PA164749044	54538	0.896
NULL	Mol_Pain_2012_Sep_22_8_71.nxml.txt.nlp	22998838	SENT112	23	23	1	1	paclitaxel	CXCR4	PA450761	7852	0.896
NULL	Gene_Regul_Syst_Bio_2014_Mar_4_8_63-73.nxml.txt.nlp	24634581	SENT132	8	8	11	11	minocycline	MT1-MMP	PA450519	4323	0.896
NULL	Biologics_2012_Dec_17_6_429-464.nxml.txt.nlp	23269860	SENT12	6	6	15	15	tocilizumab	ACR	PA165292659	49	0.896
NULL	EMBO_J_2009_Mar_18_28(6)_663-676.nxml.txt.nlp	19214186	SENT371	15	15	12	12	oxaliplatin	p53	PA131285527	7157	0.896
NULL	Diabetes_2013_Jul_14_62(7)_2500-2508.nxml.txt.nlp	23454692	SENT257	12	12	17	17	daclizumab	CD4	PA164764446	920	0.896
NULL	Breast_Cancer_Res_2013_Oct_18_15(5)_R97.nxml.txt.nlp	24135425	SENT20	30	30	34	34	pertuzumab	DM1		338023;1760;28509	0.896
NULL	J_Immunol_Res_2014_Jul_16_2014_696812.nxml.txt.nlp	25133198	SENT159	19	19	7	7	rifaximin	TLR2	PA164752443	7097	0.896
NULL	Oncogene_2014_Feb_6_33(6)_713-723.nxml.txt.nlp	23435429	SENT101	21	21	8	8	etoposide	p65	PA449552	5970	0.896
NULL	Indian_J_Psychol_Med_2013_Jul-Sep_35(3)_290-298.nxml.txt.nlp	24249933	SENT28	3	3	10	10	buspirone	5-HT1A	PA448689	3350	0.896
NULL	Front_Immunol_2014_Apr_23_5_187.nxml.txt.nlp	24795729	SENT148	14	14	11	11	pimozide	PI3K	PA450965	5290	0.896
NULL	Oncotarget_2014_Jun_1_5(13)_4881-4894.nxml.txt.nlp	24952679	SENT191	24	24	9	9	dasatinib	IRE1	PA162372878	2081	0.896
NULL	Mol_Cancer_2010_Dec_20_9_317.nxml.txt.nlp	21172025	SENT34	15	15	19	19	tamoxifen	HER2	PA451581	2064	0.896
NULL	Biomed_Res_Int_2013_Jun_6_2013_928271.nxml.txt.nlp	23841099	SENT56	13	13	10	10	ticagrelor	P2Y12	PA165374673	64805	0.896
NULL	Cancers_(Basel)_2010_May_28_2(2)_1040-1065.nxml.txt.nlp	24281106	SENT97	28	28	23	23	gefitinib	EGFR	PA131301952	1956	0.896
NULL	JAKSTAT_2013_Jul_1_2(3)_e24812.nxml.txt.nlp	24069562	SENT61	21	21	8	8	pp2	STAT3		6774	0.896
NULL	Clin_Transl_Allergy_2013_Sep_2_3_29.nxml.txt.nlp	24004581	SENT82	24	24	13	13	omalizumab	IL-4	PA164752253	3565	0.896
NULL	J_Med_Internet_Res_2011_Jan_24_13(1)_e12.nxml.txt.nlp	21266318	SENT122	21	21	40	40	mitoxantrone	DMT	PA450526	2039	0.896
NULL	J_Cell_Biol_2001_Nov_12_155(4)_637-648.nxml.txt.nlp	11696559	SENT190	30	30	20	20	etoposide	Bcl-2	PA449552	596	0.896
NULL	Indian_J_Endocrinol_Metab_2014_Jan-Feb_18(1)_23-31.nxml.txt.nlp	24701426	SENT135	5	5	18	18	methimazole	TFI	PA450422	7035	0.896
NULL	Front_Oncol_2013_Oct_1_3_237.nxml.txt.nlp	24098868	SENT225	5	5	12	12	olaparib	VEGFR		3791	0.896
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Jan_12_69(Pt_2)_o223.nxml.txt.nlp	23424504	SENT4	16	16	1	1	phenol	mol	PA450913	90527	0.896
NULL	J_Cell_Biol_2001_Jun_11_153(6)_1277-1286.nxml.txt.nlp	11402070	SENT70	15	15	0	0	glutaraldehyde	CD44	PA449777	960	0.896
NULL	J_Hematol_Oncol_2009_Apr_22_2_18.nxml.txt.nlp	19386128	SENT93	38	38	31	31	cetuximab	KRAS	PA10040	3845	0.896
NULL	Indian_J_Med_Res_2012_Mar_135(3)_359-364.nxml.txt.nlp	22561623	SENT115	14	14	3	3	cefotetan	ACC-1	PA164784033	597	0.896
NULL	Oncogene_2014_Jul_24_33(30)_3927-3938.nxml.txt.nlp	23995784	SENT248	7	7	13	13	doxycycline	FOXO1	PA449415	2308	0.896
NULL	J_Cell_Mol_Med_2014_May_14_18(5)_811-823.nxml.txt.nlp	24628949	SENT17	6	6	14	14	docetaxel	FOXM1	PA449383	2305	0.896
NULL	Diabetes_2013_Jun_17_62(6)_1800-1807.nxml.txt.nlp	23704521	SENT238	23	23	9	9	imatinib	p53	PA10804	7157	0.896
NULL	Springerplus_2013_Jan_11_2_5.nxml.txt.nlp	23520572	SENT129	26	26	12	12	tamoxifen	aromatase	PA451581	1588	0.896
NULL	J_Vet_Med_Sci_2014_Jun_15_76(6)_813-817.nxml.txt.nlp	24531829	SENT145	20	20	2	2	primaquine	DPT	PA451103	1805	0.896
NULL	N_Am_J_Med_Sci_2013_Jul_5(7)_432-437.nxml.txt.nlp	24020054	SENT63	26	26	20	20	vincristine	CHOP	PA451879	1649	0.896
NULL	J_Hematol_Oncol_2008_Oct_23_1_19.nxml.txt.nlp	18947412	SENT35	15	15	11	11	alemtuzumab	CD52	PA164783958	1043	0.896
NULL	Chin_J_Cancer_2012_Feb_31(2)_73-99.nxml.txt.nlp	22098950	SENT99	17	17	9	9	mitoxantrone	CD34	PA450526	947	0.896
NULL	Biomed_Res_Int_2013_Dec_31_2013_795103.nxml.txt.nlp	23710462	SENT166	12	12	9	9	fenofibrate	adiponectin	PA449594	9370	0.896
NULL	Breast_Cancer_Res_2009_Sep_16_11(5)_R69.nxml.txt.nlp	19758440	SENT200	30	30	8	8	trastuzumab	HER2	PA451743	2064	0.896
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT278	31	31	34	34	neratinib	HER2	PA165291472	2064	0.896
NULL	Oncotarget_2012_Jan_31_3(1)_107-111.nxml.txt.nlp	22403741	SENT45	27	27	16	16	cisplatin	p53	PA449014	7157	0.896
NULL	Neurosci_Lett_2010_Dec_10_486(2-13)_78-83.nxml.txt.nlp	20816723	SENT420	19	19	1	1	streptozocin	Beta3	PA451514	27319	0.896
NULL	Exp_Mol_Med_2012_Sep_30_44(9)_536-544.nxml.txt.nlp	22771771	SENT56	6	6	13	13	ns-398	p16		1029	0.896
NULL	Indian_Dermatol_Online_J_2013_Oct-Dec_4(4)_340-343.nxml.txt.nlp	24350021	SENT111	33	33	18	18	isotretinoin	GJB3	PA450128	2707	0.896
NULL	Neural_Plast_2012_May_20_2012_569149.nxml.txt.nlp	22685677	SENT146	37	37	4	4	staurosporine	iPLA2	PA165109623	8398	0.896
NULL	Breast_Cancer_Res_2002_Aug_27_4(6)_213-217.nxml.txt.nlp	12473165	SENT141	12	12	31	31	tamoxifen	ATAC	PA451581	6375	0.896
NULL	Cell_Death_Dis_2014_Jul_3_5(7)_e1311.nxml.txt.nlp	24991763	SENT348	20	20	3	3	ketamine	PSD95	PA450144	1742	0.896
NULL	Pharmaceuticals_(Basel)_2012_Aug_10_5(8)_802-836.nxml.txt.nlp	24280676	SENT90	34	34	10	10	ribavirin	CNT2	PA451241	9153	0.896
NULL	Oncotarget_2014_Apr_30_5(22)_11193-11208.nxml.txt.nlp	25008202	SENT232	7	7	21	21	sorafenib	Mcl-1	PA7000	4170	0.896
NULL	Braz_J_Med_Biol_Res_2014_Jan_10_47(1)_60-69.nxml.txt.nlp	24519092	SENT172	7	7	0	0	doxorubicin	YWHAZ	PA449412	7534	0.896
NULL	Cardiovasc_Diabetol_2006_Sep_26_5_20.nxml.txt.nlp	17002798	SENT114	23	23	7	7	cholestyramine	CAD	PA448974	1677;790	0.896
NULL	Front_Oncol_2013_Sep_11_3_228.nxml.txt.nlp	24062981	SENT189	19	19	3	3	topotecan	PARP1	PA451729	142	0.896
NULL	Thorax_2014_Jul_24_69(7)_638-647.nxml.txt.nlp	24567297	SENT86	15	15	21	21	doxycycline	TRAIL	PA449415	8743	0.896
NULL	Toxins_(Basel)_2010_Mar_31_2(4)_517-551.nxml.txt.nlp	22069598	SENT172	6	6	29	29	genistein	HER-2	PA165109660	2064	0.896
NULL	J_Korean_Med_Sci_2010_Dec_24_25(12)_1766-1770.nxml.txt.nlp	21165292	SENT67	21	21	3	3	glucose	GFR	PA449773	9771	0.896
NULL	J_Cell_Biol_2001_May_14_153(4)_785-794.nxml.txt.nlp	11352939	SENT46	11	11	5	5	tetracycline	EGF	PA451640	1950	0.896
NULL	Exp_Ther_Med_2014_Nov_15_8(5)_1581-1584.nxml.txt.nlp	25289063	SENT9	14	14	3	3	propylthiouracil	DRB1	PA451156	129831	0.896
NULL	Oncotarget_2013_Jun_4_4(5)_772-784.nxml.txt.nlp	23800712	SENT131	47	47	27	27	dasatinib	PIK3CA	PA162372878	5290	0.896
NULL	Pain_2011_Aug_152(8)_1899-1908.nxml.txt.nlp	21600693	SENT539	30	30	5	5	cangrelor	ADP	PA165945763	23038	0.896
NULL	J_Ginseng_Res_2011_Nov_35(4)_471-478.nxml.txt.nlp	23717094	SENT202	4	4	17	17	ethanol	CaCC	PA448073	1179	0.896
NULL	Front_Neural_Circuits_2013_Sep_20_7_148.nxml.txt.nlp	24065892	SENT250	3	3	10	10	scopolamine	MOB	PA451308	259230	0.896
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT278	10	10	13	13	lapatinib	HER2	PA152241907	2064	0.896
NULL	Oncogene_2010_Jan_7_29(1)_81-92.nxml.txt.nlp	19784067	SENT104	9	9	15	15	cisplatin	BRG1	PA449014	6597	0.896
NULL	Front_Oncol_2013_Sep_6_3_218.nxml.txt.nlp	24032106	SENT122	15	15	37	37	cytarabine	NPM1	PA449177	4869	0.896
NULL	Allergy_Rhinol_(Providence)_2013_Apr_2_Spring_4(1)_e13-e16.nxml.txt.nlp	23772319	SENT145	8	8	1	1	cetuximab	EGFR	PA10040	1956	0.896
NULL	Br_J_Cancer_2002_Jan_21_86(2)_218-221.nxml.txt.nlp	11870509	SENT72	8	8	22	22	tamoxifen	BRCA1	PA451581	672	0.896
NULL	Front_Genet_2012_Nov_5_3_236.nxml.txt.nlp	23133441	SENT318	13	13	5	5	tacrolimus	MDR1	PA451578	5243	0.896
NULL	Clin_Pharmacokinet_2014_Oct_15_53(2)_155-164.nxml.txt.nlp	24127209	SENT29	6	6	20	20	clopidogrel	CYP2B6	PA449053	1555	0.896
NULL	Mar_Drugs_2014_Sep_30_12(10)_5089-5122.nxml.txt.nlp	25272328	SENT336	6	6	15	15	s-adenosylmethionine	DPD	PA164754994	1806	0.896
NULL	Breast_Cancer_Res_2007_Dec_20_9(Suppl_2)_S11.nxml.txt.nlp	NULL	SENT19	17	17	12	12	tamoxifen	IMPACT	PA451581	55364	0.896
NULL	BMB_Rep_2014_Jan_47(1)_33-38.nxml.txt.nlp	24209634	SENT112	28	28	21	21	cisplatin	CXCR4	PA449014	7852	0.896
NULL	Aging_(Albany_NY)_2014_Aug_13_6(8)_661-674.nxml.txt.nlp	25239871	SENT172	28	28	9	9	resveratrol	p65		5970	0.896
NULL	Front_Endocrinol_(Lausanne)_2013_Mar_12_4_26.nxml.txt.nlp	23486926	SENT830	1	1	14	14	vasopressin	AVP	PA451858	114548;551	0.896
NULL	Ther_Clin_Risk_Manag_2007_Aug_3(4)_591-604.nxml.txt.nlp	18472981	SENT211	19	19	8	8	ethanol	castor	PA448073	54897	0.896
NULL	Acta_Pharmacol_Sin_2012_Oct_3_33(10)_1311-1318.nxml.txt.nlp	22941289	SENT126	4	4	9	9	sorafenib	VEGFR2	PA7000	3791	0.896
NULL	Mol_Cancer_2008_Sep_30_7_73.nxml.txt.nlp	18826597	SENT81	26	26	2	2	doxycycline	TCF-4	PA449415	6934	0.896
NULL	Arch_Med_Sci_2013_Oct_31_9(5)_936-943.nxml.txt.nlp	24273582	SENT37	44	44	39	39	glibenclamide	SUR2	PA449782	10060	0.896
NULL	Biologics_2012_Feb_1_6_31-35.nxml.txt.nlp	22355257	SENT85	11	11	40	40	rituximab	IL-7	PA451261	3574	0.896
NULL	Mar_Drugs_2009_Jul_17_7(3)_331-340.nxml.txt.nlp	19841717	SENT46	29	29	21	21	trabectedin	FDG	PA165958349	23583	0.896
NULL	Environ_Health_Perspect_2008_Mar_26_116(3)_322-328.nxml.txt.nlp	18335098	SENT142	20	20	28	28	estradiol	PMI	PA449503	8834;5373	0.896
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2675-2684.nxml.txt.nlp	24129246	SENT235	22	22	42	42	etoposide	p53	PA449552	7157	0.896
NULL	Scientifica_(Cairo)_2012_Dec_17_2012_502378.nxml.txt.nlp	24278706	SENT103	34	34	24	24	quinidine	P-gp	PA451209	5243	0.896
NULL	Bioimpacts_2014_Mar_28_4(1)_3-14.nxml.txt.nlp	24790893	SENT141	3	3	37	37	cetuximab	EGFR	PA10040	1956	0.896
NULL	Arthritis_Res_Ther_2011_Feb_16_13(1)_R25.nxml.txt.nlp	21324169	SENT76	17	17	37	37	tocilizumab	IL-6	PA165292659	3569	0.896
NULL	Support_Care_Cancer_2014_Oct_19_22(2)_469-477.nxml.txt.nlp	24141698	SENT142	26	26	39	39	dolasetron	HEC	PA449390	10403	0.896
NULL	Onco_Targets_Ther_2014_Mar_20_7_457-467.nxml.txt.nlp	24672248	SENT90	7	7	17	17	imatinib	PDGFRA	PA10804	5156	0.896
NULL	Oncotarget_2014_Mar_15_5(10)_3055-3065.nxml.txt.nlp	24931391	SENT208	24	24	6	6	hydrocortisone	F12	PA449905	2161	0.896
NULL	Cell_Commun_Signal_2010_Sep_22_8_27.nxml.txt.nlp	20860841	SENT160	28	28	7	7	hydroxyurea	CHK1	PA449942	1111	0.896
NULL	Oncoimmunology_2014_Jun_25_3_e29380.nxml.txt.nlp	25114834	SENT19	27	27	37	37	axitinib	VEGFR	PA164924493	3791	0.896
NULL	Oncogene_2014_Feb_6_33(6)_713-723.nxml.txt.nlp	23435429	SENT264	40	40	10	10	etoposide	BRCA1	PA449552	672	0.896
NULL	Pain_Res_Treat_2013_Jan_30_2013_217864.nxml.txt.nlp	23431433	SENT93	7	7	12	12	amiloride	NHE	PA448368	285335	0.896
NULL	Front_Physiol_2011_Dec_20_2_103.nxml.txt.nlp	22194726	SENT300	15	15	7	7	hyaluronan	CD44	PA165958431	960	0.896
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Oct_29_6_169-177.nxml.txt.nlp	25378949	SENT84	16	16	6	6	lapatinib	HER2	PA152241907	2064	0.896
NULL	Neuropsychopharmacology_2009_May_3_34(6)_1504-1513.nxml.txt.nlp	19052543	SENT34	13	13	4	4	cocaine	CB1	PA449072	1268	0.896
NULL	Clin_Pharmacol_2013_Apr_19_5_67-83.nxml.txt.nlp	23650452	SENT178	30	30	21	21	clopidogrel	P2Y12	PA449053	64805	0.896
NULL	Breast_Cancer_Res_2012_Feb_6_14(1)_R22.nxml.txt.nlp	22309939	SENT312	14	14	2	2	trastuzumab	PLK1	PA451743	5347	0.896
NULL	Front_Physiol_2013_Nov_14_4_323.nxml.txt.nlp	24294204	SENT94	32	32	8	8	bisoprolol	CYP2C19	PA448641	1557	0.896
NULL	J_Adv_Pharm_Technol_Res_2012_Oct-Dec_3(4)_202-209.nxml.txt.nlp	23378940	SENT168	30	30	5	5	aprepitant	CYP3A4	PA164747039	1576	0.896
NULL	Cardiol_Res_Pract_2013_Feb_19_2013_195456.nxml.txt.nlp	23533940	SENT132	25	25	7	7	clopidogrel	CYP3A4	PA449053	1576	0.896
NULL	Eur_J_Epidemiol_2007_Nov_23_22(11)_819-829.nxml.txt.nlp	17955331	SENT706	19	19	10	10	acenocoumarol	CYP2C9	PA452632	1559	0.896
NULL	Eur_J_Clin_Pharmacol_2010_Nov_29_66(11)_1131-1136.nxml.txt.nlp	20669013	SENT139	15	15	24	24	voriconazole	CYP3A4	PA10233	1576	0.896
NULL	Br_J_Cancer_2009_Jul_7_101(1)_166-173.nxml.txt.nlp	19513072	SENT150	12	12	43	43	bortezomib	UBE2C	PA10252	11065	0.896
NULL	Mol_Cancer_2009_Nov_24_8_109.nxml.txt.nlp	19930708	SENT128	18	18	7	7	exemestane	EGFR	PA449563	1956	0.896
NULL	Indian_J_Anaesth_2012_Jan-Feb_56(1)_89-90.nxml.txt.nlp	22529433	SENT14	16	16	26	26	fentanyl	CO2	PA449599	4513	0.896
NULL	Diabetol_Metab_Syndr_2014_Sep_23_6(1)_102.nxml.txt.nlp	NULL	SENT194	8	8	11	11	atorvastatin	RAGE	PA448500	177	0.896
NULL	Korean_J_Anesthesiol_2013_Jan_21_64(1)_54-60.nxml.txt.nlp	23372887	SENT163	4	4	17	17	hydrocortisone	CRT	PA449905	811	0.896
NULL	Neuroscience_2009_Jun_30_161(2-3)_572-577.nxml.txt.nlp	19327387	SENT497	7	7	10	10	capsaicin	NAPE-PLD	PA448776	222236	0.896
NULL	Mol_Cancer_2009_Oct_8_8_83.nxml.txt.nlp	19814803	SENT164	16	16	23	23	triciribine	AKT	PA165958661	207	0.896
NULL	Case_Rep_Gastroenterol_2010_Jul_26_4(2)_250-260.nxml.txt.nlp	20805952	SENT112	5	5	22	22	sunitinib	KIT	PA162372840	3815	0.896
NULL	Front_Behav_Neurosci_2010_Apr_5_4_14.nxml.txt.nlp	20407577	SENT257	0	0	16	16	doxycycline	NAC-1	PA449415	112939	0.896
NULL	Toxins_(Basel)_2010_Oct_26_2(11)_2490-2518.nxml.txt.nlp	22069563	SENT118	30	30	1	1	cisplatin	p53	PA449014	7157	0.896
NULL	Biol_Proced_Online_2003_Feb_17_5_43-52.nxml.txt.nlp	12734557	SENT133	6	6	3	3	bupivacaine	IFNA6	PA135057240	3443	0.896
NULL	Bioinorg_Chem_Appl_2014_Sep_15_2014_718175.nxml.txt.nlp	25332694	SENT44	14	14	28	28	ethanol	mol	PA448073	90527	0.896
NULL	Nucleic_Acids_Res_2011_Mar_15_39(4)_1595-1609.nxml.txt.nlp	21078679	SENT361	10	10	22	22	vinblastine	p53	PA451877	7157	0.896
NULL	J_Cancer_2013_Jan_11_4(2)_117-132.nxml.txt.nlp	23386910	SENT286	7	7	14	14	trastuzumab	HER-2	PA451743	2064	0.896
NULL	J_Immunother_Cancer_2014_Jan_27_2_2.nxml.txt.nlp	24829759	SENT9	20	20	14	14	sorafenib	IL-21	PA7000	59067;50616;27189	0.896
NULL	Clinics_(Sao_Paulo)_2012_Apr_67(Suppl_1)_91-97.nxml.txt.nlp	22584712	SENT41	28	28	21	21	clopidogrel	CYP2C19	PA449053	1557	0.896
NULL	Cell_Commun_Signal_2003_Nov_24_1_5.nxml.txt.nlp	14636425	SENT222	11	11	5	5	heparin	CCN5	PA449855	8839	0.896
NULL	Br_J_Cancer_2012_Jul_10_107(2)_230-233.nxml.txt.nlp	22735900	SENT47	8	8	4	4	paroxetine	CYP2D6	PA450801	1565	0.896
NULL	J_Cell_Biol_1988_Feb_1_106(2)_415-422.nxml.txt.nlp	2448314	SENT13	14	14	9	9	heparin	SMC	PA449855	54808	0.896
NULL	Thorax_2014_Jul_24_69(7)_638-647.nxml.txt.nlp	24567297	SENT86	42	42	12	12	doxycycline	TRAIL	PA449415	8743	0.896
NULL	Int_J_Biol_Sci_2012_Sep_6_8(8)_1109-1120.nxml.txt.nlp	22991499	SENT212	12	12	16	16	l-arginine	ARG	PA448478	473;27	0.896
NULL	Int_J_Mol_Sci_2012_Dec_5_13(12)_16624-16635.nxml.txt.nlp	23443122	SENT77	26	26	13	13	vincristine	P-gp	PA451879	5243	0.896
NULL	Acta_Histochem_Cytochem_2006_Dec_28_39(6)_163-172.nxml.txt.nlp	17327903	SENT16	19	19	5	5	staurosporine	ERK	PA165109623	5594	0.896
NULL	J_Cardiovasc_Magn_Reson_2009_Jun_28_11(1)_20.nxml.txt.nlp	19558722	SENT238	17	17	2	2	iron	CIC	PA450087	23152	0.896
NULL	Iran_J_Pharm_Res_2013_Winter_12(1)_141-146.nxml.txt.nlp	24250582	SENT109	15	15	0	0	isoniazid	NAC	PA450112	22861	0.896
NULL	Arthritis_Res_Ther_2008_Jan_31_10(1)_R16.nxml.txt.nlp	18234118	SENT154	5	5	17	17	infliximab	HO-1	PA452639	3162	0.896
NULL	Hum_Mol_Genet_2013_Nov_15_22(22)_4616-4626.nxml.txt.nlp	23814041	SENT166	2	2	8	8	simvastatin	neuroserpin	PA451363	5274	0.896
NULL	J_Med_Case_Reports_2011_Aug_16_5_386.nxml.txt.nlp	21846347	SENT97	46	46	20	20	octreotide	SSTR1	PA450678	6751	0.896
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT330	16	16	12	12	resveratrol	IL-6		3569	0.896
NULL	Br_J_Cancer_2010_Jan_5_102(1)_80-86.nxml.txt.nlp	19920817	SENT27	23	23	17	17	sunitinib	IFN	PA162372840	3439	0.896
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_105-115.nxml.txt.nlp	17912640	SENT44	29	29	23	23	tamoxifen	EGFR	PA451581	1956	0.896
NULL	Diabetes_Care_2010_Feb_33(2)_e20-e25.nxml.txt.nlp	20103551	SENT65	31	31	8	8	exenatide	GLP-1	PA164749238	100125288	0.896
NULL	Mol_Cancer_2010_May_20_9_115.nxml.txt.nlp	20487546	SENT153	7	7	30	30	fludarabine	MYC	PA449655	4609	0.896
NULL	Cardiovasc_Diabetol_2013_May_30_12(Suppl_1)_S2.nxml.txt.nlp	23819752	SENT129	14	14	10	10	rosuvastatin	CYP3A4	PA134308647	1576	0.896
NULL	Exp_Ther_Med_2013_Apr_11_5(4)_1147-1152.nxml.txt.nlp	23599738	SENT24	21	21	11	11	fentanyl	OPRM1	PA449599	4988	0.896
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1699-1708.nxml.txt.nlp	19861960	SENT70	28	28	35	35	dasatinib	mol	PA162372878	90527	0.896
NULL	J_Korean_Med_Sci_2013_Apr_27_28(4)_527-533.nxml.txt.nlp	23580227	SENT161	15	15	21	21	genistein	TRAIL	PA165109660	8743	0.896
NULL	Mol_Biol_Rep_2014_Jan_18_41(4)_2419-2425.nxml.txt.nlp	24443228	SENT266	3	3	17	17	sertraline	Gen	PA451333	348654	0.896
NULL	Diabetes_2013_Jun_17_62(6)_1843-1854.nxml.txt.nlp	23349486	SENT193	12	12	24	24	pioglitazone	IL-6	PA450970	3569	0.896
NULL	Breast_Cancer_Res_2008_Aug_29_10(4)_304.nxml.txt.nlp	18828866	SENT15	12	12	3	3	doxorubicin	CD44	PA449412	960	0.896
NULL	Cancer_Med_2013_Dec_31_2(6)_950-963.nxml.txt.nlp	24403269	SENT219	8	8	0	0	cisplatin	RAB25	PA449014	57111	0.896
NULL	Breast_Cancer_Res_2010_Jun_22_12(3)_R39.nxml.txt.nlp	20569502	SENT201	18	18	9	9	tamoxifen	IGFBP5	PA451581	3488	0.896
NULL	Drug_Target_Insights_2013_Aug_19_7_27-34.nxml.txt.nlp	24023511	SENT64	11	11	21	21	paclitaxel	P-gp	PA450761	5243	0.896
NULL	Oncotarget_2012_Nov_14_3(12)_1557-1565.nxml.txt.nlp	23238683	SENT103	8	8	6	6	ponatinib	CRKL	PA165980594	1399	0.896
NULL	Mol_Cancer_2014_Jun_5_13_143.nxml.txt.nlp	24898067	SENT37	2	2	15	15	trastuzumab	DM1	PA451743	338023;1760;28509	0.896
NULL	J_Cell_Biol_1998_Jan_26_140(2)_335-345.nxml.txt.nlp	9442109	SENT171	22	22	8	8	chloroquine	NHE	PA448948	285335	0.896
NULL	Iran_J_Ped_Hematol_Oncol_2014_Mar_15_4(1)_32-38.nxml.txt.nlp	24734162	SENT114	10	10	5	5	mercaptopurine	TPMT	PA450379	7172	0.896
NULL	Clin_Med_Insights_Oncol_2011_Sep_21_5_315-323.nxml.txt.nlp	22084620	SENT147	9	9	11	11	gemcitabine	IFN	PA449748	3439	0.896
NULL	Cancer_Cell_Int_2010_May_11_10_16.nxml.txt.nlp	20459793	SENT86	18	18	33	33	cisplatin	ABCC6	PA449014	368	0.896
NULL	Case_Rep_Dermatol_2011_Oct_11_3(3)_223-227.nxml.txt.nlp	22135629	SENT66	5	5	17	17	paclitaxel	HER2	PA450761	2064	0.896
NULL	Springerplus_2015_Jan_23_4_29.nxml.txt.nlp	25628986	SENT63	16	16	12	12	dapsone	G6PD	PA449211	2539	0.896
NULL	Indian_J_Pharmacol_2009_Dec_41(6)_262-267.nxml.txt.nlp	20407557	SENT251	13	13	24	24	ezetimibe	STZ	PA10816	6484	0.896
NULL	Ann_Med_Health_Sci_Res_2012_Jul-Dec_2(2)_152-156.nxml.txt.nlp	23440669	SENT95	16	16	8	8	rosiglitazone	CYP3A4	PA451283	1576	0.896
NULL	Front_Neurosci_2014_Feb_14_8_23.nxml.txt.nlp	24592205	SENT182	5	5	34	34	capsaicin	TRPV1	PA448776	7442	0.896
NULL	Mol_Cancer_2012_Aug_8_11_53.nxml.txt.nlp	22871047	SENT296	10	10	4	4	paclitaxel	HIN-1	PA450761	92304	0.896
NULL	Cell_Commun_Signal_2011_May_15_9_13.nxml.txt.nlp	21569639	SENT331	7	7	18	18	quinacrine	AKT	PA164745551	207	0.896
NULL	J_Cereb_Blood_Flow_Metab_2012_Jan_12_32(1)_17-22.nxml.txt.nlp	21989481	SENT104	2	2	14	14	oxygen	UBC9	PA450744	7329	0.896
NULL	Cancer_Cell_Int_2011_Jun_1_11_15.nxml.txt.nlp	21631944	SENT190	6	6	18	18	etoposide	MICA	PA449552	100507436	0.896
NULL	Front_Pharmacol_2014_May_30_5_132.nxml.txt.nlp	24910615	SENT106	5	5	15	15	estradiol	PDE7B	PA449503	27115	0.896
NULL	Indian_J_Anaesth_2011_Jul-Aug_55(4)_435-437.nxml.txt.nlp	22013281	SENT40	14	14	25	25	fentanyl	sit	PA449599	55733	0.896
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT236	21	21	9	9	cisplatin	IBP	PA449014	706;50619	0.896
NULL	J_Oncol_2010_Jan_13_2010_314326.nxml.txt.nlp	20111741	SENT102	15	15	1	1	ekb-569	EGFR		1956	0.896
NULL	Br_J_Cancer_2009_Jul_21_101(2)_269-277.nxml.txt.nlp	19603033	SENT152	32	32	27	27	cisplatin	XIAP	PA449014	331	0.896
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT352	23	23	17	17	pp2	PP1		5540;5464	0.896
NULL	Avicenna_J_Phytomed_2014_Jul-Aug_4(4)_276-286.nxml.txt.nlp	25068142	SENT98	9	9	11	11	lamotrigine	HEG	PA450164	57493	0.896
NULL	Biochem_Res_Int_2010_Aug_4_2010_549572.nxml.txt.nlp	21188077	SENT30	25	25	2	2	l-tyrosine	TAT	PA451822	6898	0.896
NULL	Int_J_Endocrinol_2014_Mar_11_2014_927317.nxml.txt.nlp	24738001	SENT80	10	10	2	2	exenatide	GLP-1	PA164749238	100125288	0.896
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT142	13	13	0	0	dasatinib	ABCG2	PA162372878	9429	0.896
NULL	Mol_Brain_2013_Nov_13_6_47.nxml.txt.nlp	24284042	SENT87	3	3	18	18	trypsin	Alix	PA451806	10015	0.896
NULL	Cell_Death_Dis_2014_Jul_3_5(7)_e1311.nxml.txt.nlp	24991763	SENT63	10	10	4	4	ketamine	GluN1	PA450144	2902	0.896
NULL	Case_Rep_Transplant_2011_Jan_5_2011_210178.nxml.txt.nlp	23213600	SENT39	40	40	21	21	tacrolimus	CYP3A	PA451578	1574	0.896
NULL	Eur_J_Med_Res_2011_Nov_10_16(11)_484-490.nxml.txt.nlp	22027641	SENT144	13	13	15	15	acetazolamide	CO2	PA448018	4513	0.896
NULL	Int_J_Mol_Sci_2012_Sep_25_13(10)_12153-12168.nxml.txt.nlp	23202889	SENT512	6	6	2	2	panitumumab	KRAS	PA162373091	3845	0.896
NULL	Oncogene_2014_Jul_24_33(30)_3959-3969.nxml.txt.nlp	24096481	SENT25	27	27	4	4	doxorubicin	p53	PA449412	7157	0.896
NULL	Nat_Med_2013_Dec_10_19(12)_10_1038_nm_3385.nxml.txt.nlp	24216752	SENT164	13	13	6	6	thrombin	PAR4	PA451674	9002;5074	0.896
NULL	Mol_Cell_Biochem_2014_Jul_26_396(1-2)_221-228.nxml.txt.nlp	25063218	SENT220	5	5	14	14	resveratrol	AP-1		2353;3727;2354;3725	0.896
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1063.nxml.txt.nlp	24556678	SENT45	0	0	2	2	thioridazine	c-FLIP	PA451666	8837	0.896
NULL	Acta_Pharmacol_Sin_2012_Dec_29_33(12)_1518-1524.nxml.txt.nlp	23103625	SENT124	13	13	6	6	telmisartan	ACE2	PA451605	59272	0.896
NULL	Acta_Neuropathol_2015_Oct_17_129_81-96.nxml.txt.nlp	25322817	SENT272	10	10	18	18	capsaicin	TRPV1	PA448776	7442	0.896
NULL	Orphanet_J_Rare_Dis_2013_Sep_13_8_142.nxml.txt.nlp	24034279	SENT47	13	13	0	0	vasopressin	ACTH	PA451858	5443	0.896
NULL	J_Cell_Biol_1998_Nov_2_143(3)_837-847.nxml.txt.nlp	9813101	SENT262	3	3	14	14	paraformaldehyde	CD44	PA450790	960	0.896
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1554-1562.nxml.txt.nlp	21970876	SENT206	5	5	16	16	afatinib	EGFR	PA165981154	1956	0.896
NULL	Mol_Vis_2014_Nov_4_20_1518-1526.nxml.txt.nlp	25489225	SENT159	7	7	14	14	fenofibrate	IL-17	PA449594	3605	0.896
NULL	Indian_J_Pharmacol_2013_Mar-Apr_45(2)_121-125.nxml.txt.nlp	23716885	SENT147	26	26	6	6	aripiprazole	CYP3A4	PA10026	1576	0.896
NULL	Oncotarget_2013_Aug_6_4(9)_1399-1415.nxml.txt.nlp	24009080	SENT69	29	29	23	23	doxycycline	p53	PA449415	7157	0.896
NULL	Cells_2014_May_23_3(2)_517-545.nxml.txt.nlp	24861977	SENT207	14	14	28	28	capsaicin	TRPV1	PA448776	7442	0.896
NULL	Ann_Indian_Acad_Neurol_2009_Apr-Jun_12(2)_89-98.nxml.txt.nlp	20142853	SENT202	15	15	28	28	carbamazepine	MRP5	PA448785	10057	0.896
NULL	Orphanet_J_Rare_Dis_2007_Jan_4_2_1.nxml.txt.nlp	17204147	SENT8	15	15	6	6	trypsin	PRSS1	PA451806	5644	0.896
NULL	EMBO_Mol_Med_2013_Dec_8_5(12)_1821-1834.nxml.txt.nlp	24293316	SENT45	11	11	0	0	doxorubicin	UNC5A	PA449412	90249	0.896
NULL	Iran_J_Pharm_Res_2015_Winter_14(1)_321-328.nxml.txt.nlp	25561938	SENT9	15	15	11	11	forskolin	VASP	PA146096022	7408	0.896
NULL	Clin_Ophthalmol_2011_Feb_11_5_167-170.nxml.txt.nlp	21383944	SENT65	28	28	14	14	ranibizumab	hole	PA164746012	80757	0.896
NULL	J_Nutr_Metab_2012_Apr_10_2012_431574.nxml.txt.nlp	22570769	SENT156	23	23	4	4	fluoxetine	TPH2	PA449673	6999;121278	0.896
NULL	Diabetes_2009_Aug_15_58(8)_1893-1901.nxml.txt.nlp	19528375	SENT11	3	3	26	26	metformin	AMPK	PA450395	5563	0.896
NULL	Br_J_Cancer_2009_Sep_15_101(6)_957-966.nxml.txt.nlp	19738618	SENT148	21	21	34	34	dexrazoxane	THBS-1	PA449259	7057	0.896
NULL	Oncotarget_2014_Nov_11_5(22)_10963-10964.nxml.txt.nlp	25460503	SENT6	21	21	28	28	trastuzumab	ADAM10	PA451743	102	0.896
NULL	Aging_(Albany_NY)_2011_Jan_18_3(1)_33-43.nxml.txt.nlp	21248371	SENT119	4	4	19	19	zinc	VHL	PA451956	7428	0.896
NULL	Cancer_Cell_Int_2009_Jan_8_9_3.nxml.txt.nlp	19128511	SENT87	10	10	27	27	oxaliplatin	PI3K	PA131285527	5290	0.896
NULL	J_Cell_Mol_Med_2014_Dec_9_18(12)_2499-2511.nxml.txt.nlp	24912879	SENT246	19	19	7	7	docetaxel	DACH1	PA449383	1602	0.896
NULL	Oncol_Lett_2014_Jun_2_7(6)_1889-1894.nxml.txt.nlp	24932254	SENT115	23	23	11	11	irinotecan	OCT1	PA450085	5451;6580	0.896
NULL	J_Oncol_2009_Oct_7_2009_854127.nxml.txt.nlp	19830244	SENT159	20	20	13	13	bevacizumab	EGFR	PA130232992	1956	0.896
NULL	Mediators_Inflamm_1999_8(6)_287-294.nxml.txt.nlp	10815617	SENT14	2	2	20	20	forskolin	COX	PA146096022	1351	0.896
NULL	Eur_J_Clin_Pharmacol_2010_Nov_29_66(11)_1131-1136.nxml.txt.nlp	20669013	SENT135	18	18	3	3	voriconazole	CYP2C19	PA10233	1557	0.896
NULL	J_Carcinog_2013_Dec_31_12_22.nxml.txt.nlp	24574860	SENT50	14	14	29	29	cetuximab	KRAS	PA10040	3845	0.896
NULL	Oncotarget_2011_Jun_15_2(6)_518-524.nxml.txt.nlp	21680956	SENT96	1	1	5	5	pimozide	STAT3	PA450965	6774	0.896
NULL	Oxid_Med_Cell_Longev_2013_Nov_28_2013_568093.nxml.txt.nlp	24379901	SENT137	0	0	19	19	resveratrol	SIRT1		23411	0.896
NULL	Int_J_Mol_Sci_2010_Oct_25_11(10)_4165-4174.nxml.txt.nlp	21152328	SENT88	14	14	6	6	ethanol	mol	PA448073	90527	0.896
NULL	Arch_Plast_Surg_2012_Sep_12_39(5)_540-545.nxml.txt.nlp	23094252	SENT69	15	15	12	12	remifentanil	TCI	PA451232	6947	0.896
NULL	Drug_Des_Devel_Ther_2014_Sep_23_8_1527-1538.nxml.txt.nlp	25284985	SENT132	14	14	34	34	celecoxib	IFN	PA448871	3439	0.896
NULL	Oncotarget_2012_Dec_31_3(12)_1653-1668.nxml.txt.nlp	23391506	SENT170	19	19	8	8	temozolomide	U87	PA451609	677775;641648	0.896
NULL	Drugs_R_D_2014_Sep_31_14(3)_177-184.nxml.txt.nlp	25079671	SENT170	1	1	9	9	miglitol	MCP-1	PA164776726	6347	0.896
NULL	J_Hematol_Oncol_2013_Nov_5_6_83.nxml.txt.nlp	24283248	SENT8	6	6	19	19	nutlin-3	TP53		7157	0.895
NULL	Mar_Drugs_2009_Jul_17_7(3)_331-340.nxml.txt.nlp	19841717	SENT104	6	6	9	9	trabectedin	FDG	PA165958349	23583	0.895
NULL	Curr_Pharm_Des_2011_Dec_17(35)_3846-3853.nxml.txt.nlp	21933140	SENT146	34	34	1	1	exenatide	GLP-1	PA164749238	100125288	0.895
NULL	Breast_Cancer_Res_2012_Jul_23_14(4)_R112.nxml.txt.nlp	22824341	SENT241	17	17	22	22	doxorubicin	RANK	PA449412	8792	0.895
NULL	Bioinformation_2008_Dec_31_3(5)_198-204.nxml.txt.nlp	19255634	SENT78	16	16	3	3	hyperforin	CYP3A4	PA165985514	1576	0.895
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_May_22_66(Pt_6)_o1398.nxml.txt.nlp	21579477	SENT47	18	18	12	12	ethanol	mol	PA448073	90527	0.895
NULL	Br_J_Clin_Pharmacol_2013_Aug_23_76(2)_299-315.nxml.txt.nlp	23701319	SENT94	12	12	21	21	bevacizumab	IFN	PA130232992	3439	0.895
NULL	J_Cell_Mol_Med_2013_Nov_23_17(11)_1422-1433.nxml.txt.nlp	24112466	SENT235	15	15	9	9	erlotinib	EGFR	PA134687924	1956	0.895
NULL	J_Biol_Chem_2008_Oct_31_283(44)_29841-29846.nxml.txt.nlp	18765669	SENT40	8	8	13	13	suramin	P2X1	PA10292	5023	0.895
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT247	23	23	14	14	cisplatin	MDM2	PA449014	4193	0.895
NULL	Exp_Diabetes_Res_2011_Dec_27_2011_604989.nxml.txt.nlp	21253359	SENT187	38	38	32	32	clonidine	GLP-1	PA449051	100125288	0.895
NULL	Oncol_Lett_2014_Mar_19_7(3)_797-798.nxml.txt.nlp	24520296	SENT58	38	38	13	13	methotrexate	OATP1	PA450428	4945;53919	0.895
NULL	Clin_Ophthalmol_2009_Jun_2_3_199-210.nxml.txt.nlp	19668566	SENT182	13	13	0	0	diclofenac	Rho	PA449293	29984	0.895
NULL	Breast_Cancer_Res_2011_Jan_24_13(1)_401.nxml.txt.nlp	21349137	SENT39	37	37	7	7	lapatinib	AMPK	PA152241907	5563	0.895
NULL	Evid_Based_Complement_Alternat_Med_2012_May_7_2012_242810.nxml.txt.nlp	22645625	SENT328	10	10	30	30	rifampin	CYP3A4	PA451250	1576	0.895
NULL	Arch_Public_Health_2011_Dec_5_69(1)_8.nxml.txt.nlp	22958637	SENT132	11	11	23	23	warfarin	VKORC1	PA451906	79001	0.895
NULL	J_Hematol_Oncol_2009_Apr_22_2_18.nxml.txt.nlp	19386128	SENT161	19	19	12	12	cetuximab	KRAS	PA10040	3845	0.895
NULL	Diabetes_2011_Nov_17_60(11)_2730-2739.nxml.txt.nlp	21926273	SENT194	25	25	10	10	lipase	S14	PA450239	5714;6208;7069	0.895
NULL	Nat_Med_2011_Oct_9_17(11)_1448-1455.nxml.txt.nlp	21983856	SENT104	3	3	29	29	fluoxetine	GAD65	PA449673	2572	0.895
NULL	Mol_Vis_2010_Sep_2_16_1781-1790.nxml.txt.nlp	20824160	SENT209	26	26	5	5	forskolin	ZO-1	PA146096022	7082	0.895
NULL	Niger_Med_J_2013_Mar-Apr_54(2)_100-106.nxml.txt.nlp	23798795	SENT121	19	19	11	11	indomethacin	PTEN	PA449982	5728	0.895
NULL	Breast_Cancer_Res_2011_Jun_29_13(3)_R70.nxml.txt.nlp	21707964	SENT193	42	42	27	27	tamoxifen	HER2	PA451581	2064	0.895
NULL	Evid_Based_Complement_Alternat_Med_2013_May_22_2013_921012.nxml.txt.nlp	23762167	SENT121	18	18	26	26	glucose	AMPK	PA449773	5563	0.895
NULL	Mol_Cancer_2009_Jul_3_8_43.nxml.txt.nlp	19575780	SENT256	13	13	8	8	colchicine	survivin	PA449092	332	0.895
NULL	Indian_J_Pharm_Sci_2014_Jul-Aug_76(4)_299-307.nxml.txt.nlp	25284927	SENT119	4	4	22	22	carrageenan	2-19	PA448814	60343	0.895
NULL	Biomed_Res_Int_2014_Jan_29_2014_831845.nxml.txt.nlp	24605337	SENT93	14	14	1	1	bupivacaine	S6K1	PA135057240	6198	0.895
NULL	Breast_Cancer_Res_2012_Jan_6_14(1)_R2.nxml.txt.nlp	22225778	SENT219	20	20	27	27	docetaxel	TLR6	PA449383	10333	0.895
NULL	Nat_Commun_2013_Sep_4_4_2338.nxml.txt.nlp	24005565	SENT552	15	15	3	3	cisplatin	HELQ	PA449014	113510	0.895
NULL	Diabetes_2011_Jan_60(1)_28-29.nxml.txt.nlp	21193737	SENT32	15	15	9	9	tolbutamide	TRPM2	PA451718	7226	0.895
NULL	Cells_2014_Apr_4_3(2)_199-235.nxml.txt.nlp	24709958	SENT330	11	11	4	4	gefitinib	EGFR	PA131301952	1956	0.895
NULL	Front_Oncol_2013_Oct_31_3_271.nxml.txt.nlp	24199171	SENT137	36	36	22	22	vemurafenib	BRAF	PA165946873	673	0.895
NULL	Psychiatry_Investig_2012_Jun_22_9(2)_166-173.nxml.txt.nlp	22707968	SENT61	3	3	15	15	memantine	ANOVA	PA10364	4858	0.895
NULL	An_Bras_Dermatol_2014_Mar-Apr_89(2)_301-310.nxml.txt.nlp	24770508	SENT198	37	37	40	40	nilotinib	KIT	PA165958345	3815	0.895
NULL	Clin_Psychopharmacol_Neurosci_2011_Aug_31_9(2)_45-53.nxml.txt.nlp	23429653	SENT34	30	30	9	9	quetiapine	TMAP	PA451201	26586	0.895
NULL	Arch_Med_Sci_2013_Apr_20_9(2)_332-339.nxml.txt.nlp	23671446	SENT133	2	2	19	19	midazolam	p38	PA450496	10598;1432;7965	0.895
NULL	Mol_Cancer_2013_Nov_11_12_134.nxml.txt.nlp	24215614	SENT172	11	11	23	23	trastuzumab	HRG	PA451743	3084;3273	0.895
NULL	Trials_2014_May_1_15_151.nxml.txt.nlp	24885437	SENT131	13	13	6	6	clopidogrel	P2Y12	PA449053	64805	0.895
NULL	Indian_J_Pharm_Sci_2013_Nov-Dec_75(6)_680-687.nxml.txt.nlp	24591743	SENT39	16	16	25	25	gemfibrozil	CYP2C8	PA449750	1558	0.895
NULL	Ther_Clin_Risk_Manag_2006_Jun_2(2)_187-192.nxml.txt.nlp	18360592	SENT49	42	42	30	30	sertraline	5-HT2A	PA451333	3356	0.895
NULL	Br_J_Cancer_2013_Sep_3_109(5)_1157-1164.nxml.txt.nlp	23942075	SENT144	12	12	8	8	lapatinib	HER2	PA152241907	2064	0.895
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT215	6	6	8	8	perifosine	JNK	PA165291471	5599	0.895
NULL	Acta_Pharmacol_Sin_2012_May_4_33(5)_710-716.nxml.txt.nlp	22555373	SENT210	4	4	33	33	phenylbutazone	DOM	PA450932	6663	0.895
NULL	J_Cancer_2011_May_1_2_232-261.nxml.txt.nlp	21552384	SENT119	33	33	24	24	exemestane	aromatase	PA449563	1588	0.895
NULL	Nat_Chem_Biol_2010_Apr_28_6(4)_291-299.nxml.txt.nlp	20190765	SENT129	16	16	28	28	dasatinib	EGFR	PA162372878	1956	0.895
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT232	20	20	0	0	doxorubicin	ABCB1	PA449412	5243	0.895
NULL	Toxins_(Basel)_2010_Jun_9_2(6)_1381-1398.nxml.txt.nlp	22069643	SENT131	9	9	3	3	cyclosporine	OAT10	PA449167	9390	0.895
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Apr_18_68(Pt_5)_o1402.nxml.txt.nlp	22590290	SENT73	27	27	4	4	ethanol	mol	PA448073	90527	0.895
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1542-1553.nxml.txt.nlp	21970874	SENT259	28	28	9	9	gefitinib	c-fos	PA131301952	2353	0.895
NULL	JAKSTAT_2014_Jun_12_3_e29554.nxml.txt.nlp	25105067	SENT56	34	34	4	4	propofol	STAT3	PA451141	6774	0.895
NULL	South_Asian_J_Cancer_2014_Jul-Sep_3(3)_182-184.nxml.txt.nlp	25136528	SENT82	24	24	9	9	clarithromycin	CYP3A4	PA449028	1576	0.895
NULL	Reprod_Biol_Endocrinol_2013_May_10_11_36.nxml.txt.nlp	23663257	SENT100	42	42	35	35	estradiol	ghrelin	PA449503	51738	0.895
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Jun_7_64(Pt_7)_o1211.nxml.txt.nlp	21202850	SENT72	30	30	10	10	ethanol	mol	PA448073	90527	0.895
NULL	Acta_Naturae_2012_Oct-Dec_4(4)_73-77.nxml.txt.nlp	23346382	SENT9	12	12	29	29	nadh	GMP	PA164755085	22978	0.895
NULL	Nat_Med_2011_May_1_17(5)_604-609.nxml.txt.nlp	21532597	SENT228	37	37	11	11	daclizumab	IL-17	PA164764446	3605	0.895
NULL	Ann_Surg_Oncol_2010_Feb_20_17(2)_354-355.nxml.txt.nlp	19936842	SENT41	5	5	1	1	panitumumab	KRAS	PA162373091	3845	0.895
NULL	Cell_Death_Dis_2014_Jan_16_5(1)_e1000.nxml.txt.nlp	24434508	SENT292	19	19	25	25	doxorubicin	p53	PA449412	7157	0.895
NULL	Case_Rep_Transplant_2011_Jan_5_2011_210178.nxml.txt.nlp	23213600	SENT69	35	35	20	20	efavirenz	CYP3A4	PA449441	1576	0.895
NULL	Eur_J_Epidemiol_2011_Aug_30_26(8)_657-686.nxml.txt.nlp	21877163	SENT941	30	30	14	14	acenocoumarol	CYP2C9	PA452632	1559	0.895
NULL	J_Med_Case_Reports_2011_Oct_10_5_513.nxml.txt.nlp	21985665	SENT31	13	13	10	10	letrozole	aromatase	PA450196	1588	0.895
NULL	Ann_Rheum_Dis_2011_Oct_19_71(3)_351-357.nxml.txt.nlp	22012969	SENT185	17	17	12	12	rituximab	ACPA	PA451261	5657	0.895
NULL	Front_Oncol_2014_Apr_22_4_86.nxml.txt.nlp	24795863	SENT673	9	9	13	13	olaparib	BRCA1		672	0.895
NULL	Curr_Neuropharmacol_2013_Jan_11(1)_53-58.nxml.txt.nlp	23814538	SENT63	16	16	19	19	ketanserin	5-HT2A	PA131053734	3356	0.895
NULL	Br_J_Cancer_2012_May_8_106(10)_1587-1590.nxml.txt.nlp	22568998	SENT78	19	19	22	22	sunitinib	IFN	PA162372840	3439	0.895
NULL	Biomed_Res_Int_2014_Jun_25_2014_203693.nxml.txt.nlp	25089265	SENT336	20	20	5	5	sorafenib	San	PA7000	80218	0.895
NULL	Cancer_Cell_Int_2011_Aug_19_11_29.nxml.txt.nlp	21854619	SENT207	18	18	3	3	cisplatin	BRCA1	PA449014	672	0.895
NULL	Int_J_Breast_Cancer_2012_May_9_2012_415170.nxml.txt.nlp	22649737	SENT69	7	7	3	3	trastuzumab	HER2	PA451743	2064	0.895
NULL	J_Biol_Chem_2013_Feb_8_288(6)_3918-3928.nxml.txt.nlp	23239877	SENT174	27	27	37	37	thrombin	ADP	PA451674	23038	0.895
NULL	Aging_(Albany_NY)_2009_Sep_10_1(9)_803-817.nxml.txt.nlp	20157568	SENT38	25	25	10	10	doxycycline	TTP	PA449415	7538;11093	0.895
NULL	Nat_Biotechnol_2012_Jul_10_30(7)_10_1038_nbt_2287.nxml.txt.nlp	22781695	SENT101	7	7	33	33	clodronate	gamma	PA10239	9913	0.895
NULL	J_Oncol_2011_Jun_12_2011_542358.nxml.txt.nlp	21772843	SENT364	40	40	20	20	doxorubicin	p53	PA449412	7157	0.895
NULL	Breast_Cancer_Res_2005_Jan_12_7(2)_45-47.nxml.txt.nlp	15743509	SENT15	25	25	21	21	tamoxifen	aromatase	PA451581	1588	0.895
NULL	Indian_J_Pharm_Sci_2013_Nov-Dec_75(6)_680-687.nxml.txt.nlp	24591743	SENT34	6	6	28	28	gemfibrozil	CYP2C9	PA449750	1559	0.895
NULL	Breast_Cancer_Res_2009_Jun_23_11(Suppl_1)_S19.nxml.txt.nlp	NULL	SENT4	0	0	16	16	neratinib	EGFR	PA165291472	1956	0.895
NULL	Cancer_Med_2014_Jun_12_3(3)_572-579.nxml.txt.nlp	24574334	SENT29	3	3	26	26	sorafenib	EGFR	PA7000	1956	0.895
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT59	6	6	18	18	resveratrol	p53		7157	0.895
NULL	Diabetes_2009_Apr_9_58(4)_965-974.nxml.txt.nlp	19136651	SENT121	29	29	24	24	nadh	NQO1	PA164755085	1728	0.895
NULL	Breast_Cancer_Res_2011_Jun_29_13(3)_R70.nxml.txt.nlp	21707964	SENT193	42	42	35	35	tamoxifen	AKT	PA451581	207	0.895
NULL	EPMA_J_2012_Sep_27_3(1)_10.nxml.txt.nlp	23016735	SENT117	32	32	21	21	warfarin	CYP2C9	PA451906	1559	0.895
NULL	Case_Rep_Hematol_2013_Dec_18_2013_703027.nxml.txt.nlp	24455336	SENT72	14	14	22	22	desmopressin	FVIII	PA449237	2157	0.895
NULL	Eur_J_Clin_Pharmacol_2010_Nov_29_66(11)_1131-1136.nxml.txt.nlp	20669013	SENT123	18	18	13	13	voriconazole	CYP3A4	PA10233	1576	0.895
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT78	21	21	13	13	pemetrexed	UNG	PA10810	7374	0.895
NULL	Case_Rep_Oncol_Med_2013_Sep_26_2013_234391.nxml.txt.nlp	24191208	SENT62	11	11	15	15	topotecan	HER2	PA451729	2064	0.895
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT198	15	15	23	23	adalimumab	DPI	PA10004	1832	0.895
NULL	Curr_Gerontol_Geriatr_Res_2012_Mar_20_2012_463909.nxml.txt.nlp	22545043	SENT66	40	40	22	22	memantine	spatial	PA10364	219793	0.895
NULL	Psychiatr_Genet_2013_Aug_28_23(4)_153-162.nxml.txt.nlp	23811784	SENT213	27	27	15	15	clozapine	CLINT1	PA449061	9685	0.895
NULL	Mol_Cell_Biochem_2014_Jul_26_396(1-2)_221-228.nxml.txt.nlp	25063218	SENT152	7	7	25	25	resveratrol	EGFR		1956	0.895
NULL	J_Oncol_2012_Apr_10_2012_931071.nxml.txt.nlp	22570654	SENT58	19	19	10	10	plerixafor	CD34	PA165958410	947	0.895
NULL	Cell_Cycle_2012_Nov_1_11(21)_3983-3996.nxml.txt.nlp	22987153	SENT123	8	8	2	2	cisplatin	RAD51	PA449014	5888	0.895
NULL	Cells_2014_May_23_3(2)_517-545.nxml.txt.nlp	24861977	SENT281	18	18	10	10	capsaicin	TRPV1	PA448776	7442	0.895
NULL	Clin_Med_Insights_Oncol_2013_Jun_3_7_103-122.nxml.txt.nlp	23843721	SENT133	0	0	12	12	trastuzumab	PTEN	PA451743	5728	0.895
NULL	Diabetes_2008_Sep_57(9)_2272-2279.nxml.txt.nlp	18519799	SENT153	20	20	9	9	rosiglitazone	PDK4	PA451283	5166	0.895
NULL	Virol_J_2011_Nov_28_8_523.nxml.txt.nlp	22122911	SENT170	20	20	26	26	heparin	RANTES	PA449855	6352	0.895
NULL	Mol_Cancer_2010_Aug_23_9_222.nxml.txt.nlp	20731837	SENT274	15	15	10	10	gefitinib	EGFR	PA131301952	1956	0.895
NULL	Mol_Vis_2012_Nov_29_18_2839-2846.nxml.txt.nlp	23233786	SENT119	0	0	26	26	geldanamycin	Hsp90	PA152031327	3320	0.895
NULL	J_Mol_Signal_2011_Jul_20_6_7.nxml.txt.nlp	21774804	SENT9	11	11	31	31	dasatinib	CD166	PA162372878	214	0.895
NULL	Biol_Open_2014_May_2_3(6)_418-430.nxml.txt.nlp	24795145	SENT6	17	17	0	0	etoposide	RanBPM	PA449552	10048	0.895
NULL	Cancer_Immunol_Immunother_2013_Jul_20_62(9)_1533-1545.nxml.txt.nlp	23873089	SENT102	29	29	9	9	ixabepilone	CD69		969	0.895
NULL	J_Carcinog_2013_Dec_31_12_22.nxml.txt.nlp	24574860	SENT46	11	11	7	7	gefitinib	EGFR	PA131301952	1956	0.895
NULL	Open_Cardiovasc_Med_J_2014_Feb_7_8_12-17.nxml.txt.nlp	24653785	SENT111	25	25	8	8	lovastatin	CYP3A4	PA450272	1576	0.895
NULL	Cancer_Gene_Ther_2013_Jan_9_20(1)_10_1038_cgt_2012_75.nxml.txt.nlp	23138870	SENT102	36	36	28	28	docetaxel	PC3	PA449383	57332;7832;5122	0.895
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT83	13	13	8	8	cisplatin	ERCC1	PA449014	2067	0.895
NULL	Case_Rep_Rheumatol_2013_Dec_17_2013_923497.nxml.txt.nlp	24455384	SENT48	24	24	5	5	etanercept	IL18	PA449515	3606	0.895
NULL	J_Med_Case_Reports_2011_Mar_28_5_117.nxml.txt.nlp	21443773	SENT20	17	17	3	3	vildagliptin	GLP-1	PA165958346	100125288	0.895
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT175	14	14	18	18	cisplatin	p53	PA449014	7157	0.895
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_12_2013_946451.nxml.txt.nlp	23843890	SENT245	21	21	19	19	metformin	AMPK	PA450395	5563	0.895
NULL	Arthritis_Res_Ther_2005_Sep_15_7(6)_R1281-R1288.nxml.txt.nlp	16277681	SENT37	2	2	8	8	tocilizumab	IL-6	PA165292659	3569	0.895
NULL	Mol_Cancer_2012_May_14_11_33.nxml.txt.nlp	22583829	SENT151	30	30	12	12	cisplatin	IL-8	PA449014	3576	0.895
NULL	Allergy_Asthma_Immunol_Res_2014_Nov_19_6(6)_548-557.nxml.txt.nlp	25374755	SENT91	14	14	23	23	lovastatin	CCL24	PA450272	6369	0.895
NULL	Oncotarget_2014_Jun_19_5(15)_6540-6551.nxml.txt.nlp	25153728	SENT142	15	15	29	29	paclitaxel	PI3K	PA450761	5290	0.895
NULL	Diabetes_2011_Jul_20_60(7)_1990-1999.nxml.txt.nlp	21617181	SENT126	0	0	12	12	geldanamycin	IL-6	PA152031327	3569	0.895
NULL	Environ_Health_Perspect_2010_Jul_3_118(7)_936-942.nxml.txt.nlp	20199942	SENT170	44	44	5	5	arsenite	NKRF	PA452638	55922	0.895
NULL	Acta_Pharmacol_Sin_2011_Jun_23_32(6)_765-780.nxml.txt.nlp	21602835	SENT145	19	19	11	11	diazoxide	SUR1	PA449285	6833	0.895
NULL	Breast_Cancer_Res_2011_Dec_16_13(6)_R131.nxml.txt.nlp	22177475	SENT275	37	37	23	23	lapatinib	AKT	PA152241907	207	0.895
NULL	Cell_Death_Dis_2012_Jun_21_3(6)_e330.nxml.txt.nlp	22717585	SENT321	16	16	25	25	simvastatin	Bcl-2	PA451363	596	0.895
NULL	Exp_Diabetes_Res_2012_Mar_4_2012_653678.nxml.txt.nlp	22474428	SENT100	18	18	10	10	pioglitazone	LPO	PA450970	4025	0.895
NULL	Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.nxml.txt.nlp	24736980	SENT9	11	11	19	19	rosuvastatin	OATP1B1	PA134308647	10599	0.895
NULL	J_Hematol_Oncol_2009_Apr_22_2_18.nxml.txt.nlp	19386128	SENT107	43	43	14	14	cetuximab	KRAS	PA10040	3845	0.895
NULL	Cases_J_2009_Jul_30_2_7134.nxml.txt.nlp	19829918	SENT16	21	21	12	12	benserazide	DDC		1644	0.895
NULL	Front_Hum_Neurosci_2014_Sep_19_8_738.nxml.txt.nlp	25285076	SENT136	12	12	34	34	oxygen	San	PA450744	80218	0.895
NULL	Br_J_Cancer_2010_Nov_9_103(11)_1692-1697.nxml.txt.nlp	21063402	SENT131	19	19	22	22	doxycycline	TRAIL	PA449415	8743	0.895
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Aug_27_67(Pt_9)_o2443.nxml.txt.nlp	22059014	SENT60	9	9	26	26	ethanol	mol	PA448073	90527	0.895
NULL	Mol_Cancer_2008_Mar_6_7_24.nxml.txt.nlp	18325101	SENT21	44	44	20	20	cisplatin	BRCA1	PA449014	672	0.895
NULL	Int_J_Circumpolar_Health_2013_Aug_5_72_10_3402_ijch_v72i0_20854.nxml.txt.nlp	23984273	SENT120	21	21	15	15	cefotaxime	19A	PA448852	57823	0.895
NULL	Behav_Neurol_2014_Nov_16_2014_360978.nxml.txt.nlp	25477708	SENT111	18	18	6	6	nicotine	spatial	PA450626	219793	0.895
NULL	Clin_Psychopharmacol_Neurosci_2014_Apr_24_12(1)_54-64.nxml.txt.nlp	24851122	SENT121	16	16	5	5	methamphetamine	MAPK4	PA450403	5596	0.895
NULL	Case_Rep_Gastroenterol_2011_Jul_9_5(2)_378-385.nxml.txt.nlp	21769291	SENT40	27	27	18	18	metformin	CEA	PA450395	5670;1087	0.895
NULL	Int_J_Mol_Sci_2014_May_8_15(5)_8106-8121.nxml.txt.nlp	24815071	SENT60	7	7	0	0	atorvastatin	LC3	PA448500	84557	0.895
NULL	Glycobiology_2010_Jan_9_20(1)_24-32.nxml.txt.nlp	19741058	SENT160	8	8	19	19	imiglucerase	CD206	PA164742934	4360	0.895
NULL	Mol_Cell_Biochem_2014_Jul_26_396(1-2)_221-228.nxml.txt.nlp	25063218	SENT97	9	9	17	17	resveratrol	EGFR		1956	0.895
NULL	Cell_Death_Dis_2010_Nov_18_1(11)_e102.nxml.txt.nlp	21368867	SENT148	14	14	7	7	gentamicin	CLIMP-63	PA449753	10970	0.895
NULL	Cancer_Gene_Ther_2013_Jan_9_20(1)_10_1038_cgt_2012_75.nxml.txt.nlp	23138870	SENT164	15	15	31	31	vinblastine	CD31	PA451877	5175	0.895
NULL	Case_Rep_Oncol_2012_Sep_21_5(3)_627-632.nxml.txt.nlp	23275777	SENT69	13	13	5	5	sunitinib	ABCG2	PA162372840	9429	0.895
NULL	Biochemistry_2011_May_3_50(17)_3408-3410.nxml.txt.nlp	21425834	SENT46	30	30	15	15	nadh	VDAC2	PA164755085	7417	0.895
NULL	Daru_2011_19(2)_138-144.nxml.txt.nlp	22615650	SENT11	6	6	20	20	heparin	FGF20	PA449855	26281	0.895
NULL	Exp_Ther_Med_2012_Sep_7_4(3)_452-458.nxml.txt.nlp	23181117	SENT6	22	22	20	20	cisplatin	HAI	PA449014	6692;6768	0.895
NULL	Avicenna_J_Med_2011_Oct-Dec_1(2)_52-54.nxml.txt.nlp	23210009	SENT45	13	13	22	22	erlotinib	EGFR	PA134687924	1956	0.895
NULL	Arthritis_Res_Ther_2009_Jun_29_11(3)_R100.nxml.txt.nlp	19563672	SENT14	7	7	20	20	infliximab	IFN	PA452639	3439	0.895
NULL	Cancer_Res_Treat_2012_Jun_30_44(2)_74-84.nxml.txt.nlp	22802745	SENT257	9	9	20	20	neratinib	EGFR	PA165291472	1956	0.895
NULL	Biologics_2013_Dec_9_8_1-12.nxml.txt.nlp	24353404	SENT101	17	17	1	1	tocilizumab	IL-6	PA165292659	3569	0.895
NULL	Cardiovasc_Diabetol_2013_Nov_12_12_169.nxml.txt.nlp	24215514	SENT307	41	41	27	27	valsartan	AT2	PA451848	186	0.895
NULL	Oncotarget_2014_Aug_29_5(19)_8947-8958.nxml.txt.nlp	25333254	SENT128	33	33	18	18	plerixafor	CD49d	PA165958410	3676	0.895
NULL	Emerg_Infect_Dis_2012_Nov_18(11)_e2.nxml.txt.nlp	23092736	SENT64	7	7	18	18	pyrazinamide	DST	PA451182	667	0.895
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jun_24_65(Pt_7)_o1668.nxml.txt.nlp	21582928	SENT60	13	13	30	30	ethanol	mol	PA448073	90527	0.895
NULL	Angiogenesis_2013_Apr_10_16(2)_373-386.nxml.txt.nlp	23143659	SENT224	7	7	19	19	vinblastine	LDM	PA451877	1595	0.895
NULL	Int_J_Mol_Sci_2014_Oct_8_15(10)_17974-17999.nxml.txt.nlp	25299695	SENT161	22	22	5	5	curcumin	HO-1	PA151958596	3162	0.895
NULL	Breast_Cancer_Res_Treat_2014_Jan_30_144(1)_133-142.nxml.txt.nlp	24477976	SENT228	8	8	12	12	olaparib	BRCA1		672	0.895
NULL	Chemother_Res_Pract_2012_Aug_29_2012_817297.nxml.txt.nlp	22970367	SENT126	25	25	4	4	erlotinib	AXL	PA134687924	558	0.895
NULL	Biomed_Res_Int_2013_Jul_7_2013_692751.nxml.txt.nlp	23936834	SENT137	4	4	7	7	naloxone	mol	PA450586	90527	0.895
NULL	Braz_J_Med_Biol_Res_2014_Sep_5_47(11)_929-939.nxml.txt.nlp	25296354	SENT119	16	16	27	27	afatinib	EGFR	PA165981154	1956	0.895
NULL	Acta_Pharmacol_Sin_2010_Jul_28_31(7)_867-873.nxml.txt.nlp	20581857	SENT159	17	17	2	2	docetaxel	PDCD4	PA449383	27250	0.895
NULL	Breast_Cancer_Res_2010_Jun_22_12(3)_R39.nxml.txt.nlp	20569502	SENT163	17	17	6	6	tamoxifen	TFF3	PA451581	7033	0.895
NULL	Autophagy_2012_Jul_1_8(7)_1045-1057.nxml.txt.nlp	22647547	SENT176	32	32	9	9	gentamicin	MIR30B	PA449753	407030	0.895
NULL	Acta_Myol_2011_Oct_30(2)_153a.nxml.txt.nlp	NULL	SENT6	33	33	12	12	bezafibrate	Q10	PA162364313	27161	0.895
NULL	Arthritis_Res_Ther_2007_Jun_29_9(Suppl_1)_S7.nxml.txt.nlp	17634146	SENT66	16	16	26	26	denosumab	aromatase	PA166048634	1588	0.895
NULL	J_Oncol_2012_Nov_10_2012_358472.nxml.txt.nlp	22131994	SENT89	0	0	13	13	sorafenib	VEGFR3	PA7000	2324	0.895
NULL	Cerebrovasc_Dis_Extra_2014_Mar_28_4(1)_69-76.nxml.txt.nlp	24803915	SENT91	11	11	14	14	clopidogrel	MRI	PA449053	78996	0.895
NULL	Front_Immunol_2012_Nov_16_3_343.nxml.txt.nlp	23162557	SENT169	15	15	7	7	hyaluronan	CD44	PA165958431	960	0.895
NULL	Hum_Genomics_2010_Oct_1_5(1)_61-72.nxml.txt.nlp	21106490	SENT64	7	7	32	32	midazolam	CYP3A	PA450496	1574	0.895
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_127043.nxml.txt.nlp	23227093	SENT170	18	18	9	9	lovastatin	P-gp	PA450272	5243	0.895
NULL	Trials_2012_Dec_13_13_239.nxml.txt.nlp	23237631	SENT199	33	33	43	43	amiodarone	VKORC1	PA448383	79001	0.895
NULL	Patient_Prefer_Adherence_2014_Apr_8_8_463-471.nxml.txt.nlp	24748775	SENT141	5	5	3	3	denosumab	RANKL	PA166048634	8600	0.895
NULL	Int_J_Cell_Biol_2009_Apr_14_2009_243532.nxml.txt.nlp	20414334	SENT22	19	19	10	10	cisplatin	YB-1	PA449014	4904	0.895
NULL	Oncogene_2010_Jun_3_29(22)_3208-3216.nxml.txt.nlp	20383201	SENT87	10	10	5	5	dasatinib	EGF	PA162372878	1950	0.895
NULL	Cancer_Biol_Med_2012_Mar_9(1)_1-8.nxml.txt.nlp	23691447	SENT170	14	14	2	2	lipase	LPA	PA450239	4018	0.895
NULL	Oncotarget_2010_May_27_1(2)_89-103.nxml.txt.nlp	20671809	SENT211	3	3	14	14	etoposide	CD34	PA449552	947	0.895
NULL	Mol_Cancer_2010_Nov_2_9_289.nxml.txt.nlp	21044322	SENT165	26	26	8	8	vincristine	RGS17	PA451879	26575	0.895
NULL	J_Cell_Sci_2014_Aug_1_127(15)_3233-3239.nxml.txt.nlp	24928904	SENT28	0	0	6	6	doxycycline	LKB1	PA449415	6794	0.895
NULL	Curr_Chem_Genomics_2011_Aug_22_5_62-71.nxml.txt.nlp	21966346	SENT90	16	16	2	2	pargyline	LSD1	PA450797	23028	0.895
NULL	Oncotarget_2013_Dec_18_5(2)_375-385.nxml.txt.nlp	24495868	SENT143	10	10	29	29	flavopiridol	CD34	PA452627	947	0.895
NULL	J_Cell_Biol_1998_Apr_6_141(1)_71-84.nxml.txt.nlp	9531549	SENT342	11	11	0	0	kanamycin	LEU2	PA450137	8847	0.895
NULL	Biomed_Res_Int_2014_Jan_20_2014_948427.nxml.txt.nlp	24563867	SENT163	7	7	21	21	buspirone	STZ	PA448689	6484	0.895
NULL	Curr_Neuropharmacol_2008_Dec_6(4)_293-310.nxml.txt.nlp	19587851	SENT259	27	27	34	34	ketanserin	5-HT2A	PA131053734	3356	0.895
NULL	Case_Rep_Nephrol_Urol_2013_Mar_7_3(1)_22-27.nxml.txt.nlp	23569460	SENT51	12	12	20	20	gentamicin	ISPD	PA449753	729920	0.895
NULL	Arthritis_Res_Ther_2005_Dec_1_7(1)_R149-R155.nxml.txt.nlp	15642135	SENT138	18	18	10	10	infliximab	OPG	PA452639	690	0.895
NULL	Biomed_Res_Int_2013_Nov_26_2013_843657.nxml.txt.nlp	24371833	SENT25	0	0	15	15	exenatide	GLP-1	PA164749238	100125288	0.895
NULL	BMB_Rep_2013_Jun_46(6)_295-304.nxml.txt.nlp	23790972	SENT69	11	11	20	20	flurbiprofen	ASIC3	PA449683	9311	0.895
NULL	Front_Immunol_2014_Apr_1_5_131.nxml.txt.nlp	24744755	SENT510	29	29	16	16	efalizumab	TNF-alpha	PA164748817	7124	0.895
NULL	Cancer_Cell_Int_2011_Aug_19_11_29.nxml.txt.nlp	21854619	SENT220	11	11	37	37	cisplatin	HDAC	PA449014	9734	0.895
NULL	Mol_Cancer_2009_Nov_10_8_99.nxml.txt.nlp	19903356	SENT99	29	29	3	3	imatinib	IGFBP3	PA10804	3486	0.895
NULL	Oxid_Med_Cell_Longev_2012_May_15_2012_984219.nxml.txt.nlp	22666523	SENT325	33	33	14	14	resveratrol	miR-17-92		407975	0.895
NULL	J_Adv_Pract_Oncol_2012_Nov_1_Nov-Dec_3(6)_391-394.nxml.txt.nlp	25031970	SENT64	19	19	29	29	pertuzumab	HER2		2064	0.895
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jun_27_68(Pt_7)_o2237.nxml.txt.nlp	22798893	SENT75	4	4	28	28	piperazine	mol	PA450977	90527	0.895
NULL	J_Cardiovasc_Dis_Res_2010_Oct-Dec_1(4)_165-170.nxml.txt.nlp	21264179	SENT118	39	39	44	44	fasudil	ROCK1	PA165946121	6093	0.895
NULL	Lipids_Health_Dis_2011_Jan_18_10_8.nxml.txt.nlp	21241519	SENT157	4	4	24	24	simvastatin	SR-BI	PA451363	949	0.895
NULL	Cell_Commun_Signal_2013_Dec_23_11_100.nxml.txt.nlp	24364863	SENT338	7	7	27	27	nystatin	PP2	PA450666	4888	0.895
NULL	J_Cell_Biol_2002_Mar_18_156(6)_993-1001.nxml.txt.nlp	11901166	SENT118	30	30	13	13	tetracycline	CSR1	PA451640	51435	0.895
NULL	Case_Rep_Hematol_2013_Feb_6_2013_541783.nxml.txt.nlp	23476834	SENT36	1	1	18	18	pyrimethamine	CHOP	PA451193	1649	0.895
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT201	4	4	23	23	curcumin	TRAIL	PA151958596	8743	0.895
NULL	Clin_Med_Insights_Oncol_2011_Sep_21_5_315-323.nxml.txt.nlp	22084620	SENT126	4	4	29	29	gemcitabine	TRAIL	PA449748	8743	0.895
NULL	Clin_Ophthalmol_2011_Feb_28_5_269-274.nxml.txt.nlp	21468332	SENT16	3	3	24	24	ketorolac	BAK	PA450150	578	0.895
NULL	Oncol_Lett_2013_Aug_17_6(2)_295-305.nxml.txt.nlp	24137320	SENT333	6	6	26	26	tamoxifen	TIMP3	PA451581	7078	0.895
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT147	7	7	0	0	doxorubicin	SLK	PA449412	9748;2534	0.895
NULL	Arthritis_Res_Ther_2007_Jun_29_9(Suppl_1)_S3.nxml.txt.nlp	17634142	SENT127	20	20	4	4	denosumab	CTX	PA166048634	1593	0.895
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT10	23	23	1	1	phenprocoumon	VKORC1	PA450921	79001	0.895
NULL	J_Indian_Soc_Periodontol_2014_May-Jun_18(3)_390-394.nxml.txt.nlp	25024557	SENT140	21	21	7	7	desmopressin	VIII	PA449237	1351	0.895
NULL	Diabetes_2011_Mar_21_60(3)_848-856.nxml.txt.nlp	21270238	SENT57	29	29	11	11	ketamine	STZ	PA450144	6484	0.895
NULL	Br_J_Haematol_2014_Jan_28_164(2)_233-244.nxml.txt.nlp	24206017	SENT245	9	9	14	14	lenalidomide	CRBN	PA162363968	51185	0.895
NULL	Oncotarget_2013_Oct_19_4(11)_2045-2056.nxml.txt.nlp	24185104	SENT99	19	19	4	4	cisplatin	14-3-3	PA449014	10971	0.895
NULL	Oncologist_2011_Feb_25_16(2)_155-164.nxml.txt.nlp	21266401	SENT158	13	13	3	3	trastuzumab	HER-2	PA451743	2064	0.895
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT223	5	5	20	20	nilotinib	ABCB1	PA165958345	5243	0.895
NULL	Cancer_Growth_Metastasis_2014_Aug_10_7_33-42.nxml.txt.nlp	25187738	SENT182	0	0	11	11	denosumab	RANKL	PA166048634	8600	0.895
NULL	Ann_Clin_Microbiol_Antimicrob_2014_Nov_7_13(1)_52.nxml.txt.nlp	NULL	SENT173	0	0	18	18	tigecycline	CABP	PA164746412	6277	0.895
NULL	Anal_Bioanal_Chem_2011_Sep_14_401(4)_1109-1125.nxml.txt.nlp	21755271	SENT327	11	11	5	5	imatinib	ABL	PA10804	4547	0.895
NULL	Mol_Med_Rep_2015_Jan_22_11(1)_83-90.nxml.txt.nlp	25338529	SENT160	10	10	13	13	octreotide	HO-1	PA450678	3162	0.895
NULL	Cardiovasc_Res_2012_Dec_1_96(3)_552-560.nxml.txt.nlp	22918977	SENT64	25	25	5	5	hydralazine	ANG	PA449894	283	0.895
NULL	Arthritis_Res_Ther_2014_Jan_16_16(1)_R12.nxml.txt.nlp	24428870	SENT105	13	13	3	3	methotrexate	survivin	PA450428	332	0.895
NULL	Front_Neurosci_2014_Jan_10_7_270.nxml.txt.nlp	24454277	SENT177	3	3	0	0	resveratrol	SIRT1		23411	0.895
NULL	Br_J_Cancer_2013_Apr_16_108(7)_1408-1414.nxml.txt.nlp	23511562	SENT39	24	24	29	29	tamoxifen	aromatase	PA451581	1588	0.895
NULL	Front_Oncol_2013_Nov_14_3_279.nxml.txt.nlp	24294592	SENT80	10	10	24	24	gemcitabine	PARP-1	PA449748	25976	0.895
NULL	J_Adv_Pharm_Technol_Res_2011_Apr-Jun_2(2)_81-87.nxml.txt.nlp	22171298	SENT4	9	9	28	28	itraconazole	BCS	PA450132	617	0.895
NULL	Blood_Cancer_J_2014_Feb_28_4(2)_e187.nxml.txt.nlp	24583533	SENT30	30	30	13	13	azacitidine	CD34	PA451996	947	0.895
NULL	J_Cardiovasc_Dis_Res_2010_Oct-Dec_1(4)_171-176.nxml.txt.nlp	21264180	SENT111	18	18	7	7	resveratrol	AMPK		5563	0.895
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT324	10	10	6	6	risperidone	PRL	PA451257	5617	0.895
NULL	Biologics_2014_Apr_23_8_183-192.nxml.txt.nlp	24790411	SENT87	3	3	17	17	afatinib	HER2	PA165981154	2064	0.895
NULL	Biol_Open_2013_Dec_18_3(1)_103-107.nxml.txt.nlp	24357231	SENT86	4	4	7	7	arsenite	G3BP	PA452638	10146	0.895
NULL	BMB_Rep_2014_Nov_47(11)_649-654.nxml.txt.nlp	25301019	SENT130	18	18	13	13	l-serine	T1R3	PA451330	83756	0.895
NULL	Cell_Death_Dis_2014_Feb_13_5(2)_e1055.nxml.txt.nlp	24525731	SENT330	19	19	26	26	cisplatin	XRCC1	PA449014	7515	0.895
NULL	Oncogene_2010_Mar_11_29(10)_1509-1518.nxml.txt.nlp	19946334	SENT149	11	11	5	5	bortezomib	pS2	PA10252	7031	0.895
NULL	Oxid_Med_Cell_Longev_2012_May_28_2012_632959.nxml.txt.nlp	22690272	SENT61	5	5	11	11	curcumin	PSA	PA151958596	29968;9520;354	0.895
NULL	Biol_Open_2013_Aug_14_2(10)_1013-1021.nxml.txt.nlp	24167711	SENT178	18	18	14	14	ethanol	EVL	PA448073	51466	0.895
NULL	Arthritis_Res_2000_Sep_20_2(6)_504-512.nxml.txt.nlp	11056680	SENT62	7	7	0	0	thrombin	PAR-1	PA451674	2011;2149	0.895
NULL	Br_J_Cancer_2014_Jan_7_110(1)_55-62.nxml.txt.nlp	24263064	SENT137	14	14	37	37	gefitinib	EGFR	PA131301952	1956	0.895
NULL	Adipocyte_2013_Jan_1_2(1)_17-27.nxml.txt.nlp	23599907	SENT108	20	20	10	10	glucose	IRAP	PA449773	3557	0.895
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1059-1066.nxml.txt.nlp	21364577	SENT59	16	16	9	9	letrozole	aromatase	PA450196	1588	0.895
NULL	Clin_Drug_Investig_2014_Nov_9_34(2)_107-115.nxml.txt.nlp	24214232	SENT208	30	30	13	13	cinacalcet	IMPACT	PA164776671	55364	0.895
NULL	Indian_J_Pharm_Sci_2014_Jan-Feb_76(1)_72-77.nxml.txt.nlp	24799741	SENT117	27	27	8	8	metronidazole	CYP2C9	PA450484	1559	0.895
NULL	J_Biomed_Sci_2014_Feb_3_21(1)_10.nxml.txt.nlp	24490900	SENT254	9	9	21	21	alendronate	RANKL	PA448082	8600	0.895
NULL	Diabetologia_2010_Jan_6_53(1)_1-6.nxml.txt.nlp	19894028	SENT99	23	23	19	19	sitagliptin	HIP	PA164748978	6767;6159;64399;5068	0.895
NULL	Mol_Syst_Biol_2009_Jul_28_5_288.nxml.txt.nlp	19638969	SENT229	34	34	39	39	resveratrol	HuR		1994	0.895
NULL	Exp_Ther_Med_2013_Jan_10_5(1)_287-291.nxml.txt.nlp	23251285	SENT115	9	9	29	29	aspirin	APS	PA448497	10603	0.895
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT172	38	38	22	22	dasatinib	PP2	PA162372878	4888	0.895
NULL	Cancer_Cell_Int_2014_Aug_16_14_74.nxml.txt.nlp	25187756	SENT183	30	30	5	5	lovastatin	survivin	PA450272	332	0.895
NULL	Acta_Naturae_2011_Jul-Sep_3(3)_12-28.nxml.txt.nlp	22649690	SENT307	1	1	10	10	raltegravir	CYP3A4		1576	0.895
NULL	EMBO_Mol_Med_2011_Jul_3(7)_410-427.nxml.txt.nlp	21567994	SENT169	21	21	3	3	probucol	SOD2	PA451107	6648	0.895
NULL	Front_Immunol_2012_Jan_2_2_82.nxml.txt.nlp	22566871	SENT717	9	9	4	4	infliximab	CX3CR1	PA452639	1524	0.895
NULL	Breast_Cancer_(Auckl)_2011_Jun_1_5_117-130.nxml.txt.nlp	21695096	SENT18	36	36	28	28	methotrexate	spatial	PA450428	219793	0.895
NULL	Biomed_Opt_Express_2010_Jul_14_1(1)_59-73.nxml.txt.nlp	21258446	SENT74	24	24	5	5	ethanol	CARS	PA448073	833	0.895
NULL	Braz_J_Med_Biol_Res_2014_May_9_47(6)_478-482.nxml.txt.nlp	24770568	SENT80	20	20	36	36	cisplatin	CD133	PA449014	8842	0.895
NULL	Breast_Cancer_Res_Treat_2014_Jul_8_146(3)_557-566.nxml.txt.nlp	25001612	SENT353	13	13	6	6	temozolomide	PARP1	PA451609	142	0.895
NULL	Indian_J_Endocrinol_Metab_2013_Oct_17(Suppl1)_S301-S303.nxml.txt.nlp	24251194	SENT9	0	0	7	7	liraglutide	GLP-1	PA165958364	100125288	0.895
NULL	J_Equine_Sci_2014_Apr_22_25(1)_7-13.nxml.txt.nlp	24834008	SENT39	15	15	26	26	genistein	MEK1	PA165109660	5604	0.895
NULL	Clin_Exp_Otorhinolaryngol_2012_Sep_27_5(3)_117-121.nxml.txt.nlp	22977707	SENT103	9	9	14	14	kanamycin	NKCC1	PA450137	6558	0.895
NULL	Eur_J_Nutr_2009_Jun_24_48(4)_229-234.nxml.txt.nlp	19238310	SENT20	4	4	18	18	capsaicin	GLP-1	PA448776	100125288	0.895
NULL	Diabetes_Metab_J_2013_Oct_17_37(5)_315-325.nxml.txt.nlp	24199159	SENT197	6	6	10	10	resveratrol	AMPK		5563	0.895
NULL	J_Clin_Biochem_Nutr_2007_Jul_27_41(1)_43-49.nxml.txt.nlp	18392105	SENT72	15	15	1	1	pentobarbital	P18	PA450859	7975;10168	0.895
NULL	Br_J_Cancer_2004_Mar_22_90(6)_1285-1292.nxml.txt.nlp	15026814	SENT42	43	43	18	18	cisplatin	p53	PA449014	7157	0.895
NULL	Cancer_Cell_Int_2008_Mar_18_8_3.nxml.txt.nlp	18348720	SENT69	25	25	28	28	gefitinib	EGFR	PA131301952	1956	0.895
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT133	4	4	10	10	chloroquine	BMPR-II	PA448948	659	0.895
NULL	Oncoimmunology_2013_Oct_1_2(10)_e27025.nxml.txt.nlp	24353914	SENT80	0	0	11	11	docetaxel	CD4	PA449383	920	0.895
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Dec_8_69(Pt_1)_o49.nxml.txt.nlp	23476432	SENT65	15	15	4	4	ethanol	mol	PA448073	90527	0.895
NULL	J_Gen_Physiol_2013_Jan_141(1)_1-2.nxml.txt.nlp	23277473	SENT16	13	13	0	0	phenylephrine	CYB5R3	PA450935	1727	0.895
NULL	Acta_Pharmacol_Sin_2009_Jul_3_30(7)_1025-1032.nxml.txt.nlp	19575006	SENT164	19	19	3	3	perifosine	JNK	PA165291471	5599	0.895
NULL	Eur_J_Epidemiol_2011_Aug_30_26(8)_657-686.nxml.txt.nlp	21877163	SENT941	19	19	10	10	acenocoumarol	CYP2C9	PA452632	1559	0.895
NULL	Cancer_Cell_Int_2014_Jul_2_14_59.nxml.txt.nlp	25120382	SENT200	29	29	31	31	metformin	Met	PA450395	79811	0.895
NULL	Case_Rep_Dent_2011_Jul_7_2011_357518.nxml.txt.nlp	22567436	SENT32	21	21	7	7	thyroglobulin	CDX2	PA164754910	1045	0.895
NULL	Biomed_Res_Int_2014_Jan_29_2014_831845.nxml.txt.nlp	24605337	SENT109	6	6	2	2	bupivacaine	S6K1	PA135057240	6198	0.895
NULL	Indian_Dermatol_Online_J_2014_Jul-Sep_5(3)_374-377.nxml.txt.nlp	25165678	SENT15	2	2	28	28	pentoxifylline	solo	PA450864	55701	0.895
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Oct_31_65(Pt_11)_o2935.nxml.txt.nlp	21578511	SENT58	26	26	20	20	ethanol	mol	PA448073	90527	0.895
NULL	J_Cell_Mol_Med_2014_Mar_10_18(3)_514-529.nxml.txt.nlp	24410795	SENT233	34	34	36	36	resveratrol	SIRT1		23411	0.895
NULL	Oncoimmunology_2012_May_1_1(3)_279-286.nxml.txt.nlp	22737603	SENT114	18	18	21	21	doxorubicin	ANOVA	PA449412	4858	0.895
NULL	Gene_Regul_Syst_Bio_2014_Mar_4_8_63-73.nxml.txt.nlp	24634581	SENT139	3	3	33	33	minocycline	NANOS1	PA450519	340719	0.895
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT90	33	33	11	11	erlotinib	AKT	PA134687924	207	0.895
NULL	Pharmaceuticals_(Basel)_2013_Apr_8_6(4)_500-509.nxml.txt.nlp	24276120	SENT231	10	10	1	1	bumetanide	GPR35	PA448682	2859	0.895
NULL	J_Hematol_Oncol_2014_Aug_1_7_52.nxml.txt.nlp	25085632	SENT155	10	10	25	25	sunitinib	EGFR	PA162372840	1956	0.895
NULL	Curr_HIV_Res_2014_May_12(3)_174-188.nxml.txt.nlp	24862327	SENT147	25	25	19	19	hemin	HO-1	PA449849	3162	0.895
NULL	Trials_2012_Sep_8_13_160.nxml.txt.nlp	22958580	SENT44	26	26	17	17	succinylcholine	MVD	PA451522	4597	0.895
NULL	Behav_Brain_Funct_2014_Jun_16_10_21.nxml.txt.nlp	24934302	SENT246	36	36	28	28	methamphetamine	gamma	PA450403	9913	0.895
NULL	Oncol_Lett_2013_Feb_30_5(2)_588-592.nxml.txt.nlp	23420263	SENT13	13	13	17	17	lenalidomide	NKX2-1	PA162363968	7080	0.895
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT123	10	10	3	3	metformin	HIF-1	PA450395	29072	0.895
NULL	Br_J_Cancer_2012_Jan_3_106(1)_107-115.nxml.txt.nlp	22116303	SENT123	30	30	17	17	vorinostat	AKT	PA164748224	207	0.895
NULL	Ann_Hematol_2011_Feb_17_90(2)_173-183.nxml.txt.nlp	20714724	SENT95	11	11	41	41	resveratrol	BAX		581	0.895
NULL	Nat_Chem_Biol_2010_Apr_28_6(4)_291-299.nxml.txt.nlp	20190765	SENT77	30	30	21	21	dasatinib	EGFR	PA162372878	1956	0.895
NULL	Basic_Clin_Neurosci_2014_Winter_5(1)_74-79.nxml.txt.nlp	25436087	SENT14	4	4	24	24	fluoxetine	AQP4	PA449673	361	0.895
NULL	Mol_Cancer_2013_Mar_7_12_19.nxml.txt.nlp	23497317	SENT275	31	31	13	13	gentamicin	KIT	PA449753	3815	0.895
NULL	Clin_Ophthalmol_2011_Feb_11_5_167-170.nxml.txt.nlp	21383944	SENT14	16	16	7	7	ranibizumab	hole	PA164746012	80757	0.895
NULL	Indian_J_Radiol_Imaging_2010_Feb_20(1)_13-19.nxml.txt.nlp	20351986	SENT184	9	9	25	25	furosemide	FDG	PA449719	23583	0.895
NULL	Biochem_Res_Int_2012_Jun_25_2012_518437.nxml.txt.nlp	22792465	SENT202	4	4	13	13	doxycycline	RGS5	PA449415	8490	0.895
NULL	Biomed_Res_Int_2013_Nov_10_2013_237543.nxml.txt.nlp	24312908	SENT42	26	26	15	15	indomethacin	COX	PA449982	1351	0.895
NULL	Br_J_Cancer_2012_Apr_10_106(8)_1367-1373.nxml.txt.nlp	22454081	SENT167	31	31	9	9	trastuzumab	IGF1R	PA451743	3480	0.895
NULL	Ann_Oncol_2013_Nov_12_24(11)_2892-2897.nxml.txt.nlp	24030098	SENT73	11	11	7	7	doxorubicin	CHOP	PA449412	1649	0.895
NULL	Oncotarget_2010_Jun_7_1(2)_104-119.nxml.txt.nlp	21297223	SENT242	24	24	2	2	berberine	IL-9	PA165860812	3578	0.895
NULL	Emerg_Infect_Dis_2012_Jan_18(1)_113-116.nxml.txt.nlp	22260877	SENT11	27	27	40	40	rifampin	CA1	PA451250	759	0.895
NULL	J_Gastroenterol_2014_Feb_6_49(12)_1578-1587.nxml.txt.nlp	24499826	SENT106	12	12	5	5	sorafenib	CLIP	PA7000	5443;6249;7461	0.895
NULL	Sci_Rep_2014_Dec_3_4_7294.nxml.txt.nlp	25465236	SENT58	9	9	25	25	axitinib	TYK2	PA164924493	7297	0.895
NULL	EPMA_J_2010_Sep_25_1(3)_495-502.nxml.txt.nlp	23199091	SENT113	12	12	35	35	epirubicin	DPD	PA449476	1806	0.895
NULL	Int_J_Vasc_Med_2012_Jan_4_2012_657025.nxml.txt.nlp	22347626	SENT5	16	16	2	2	pitavastatin	PTX3	PA142650384	5806	0.895
NULL	Iran_Red_Crescent_Med_J_2014_Aug_5_16(8)_e6915.nxml.txt.nlp	25389496	SENT109	8	8	15	15	simvastatin	adiponectin	PA451363	9370	0.895
NULL	J_Adv_Pract_Oncol_2012_Jul_1_Jul-Aug_3(4)_249-257.nxml.txt.nlp	25031953	SENT37	1	1	13	13	calcidiol	PTH	PA164745614	5741	0.895
NULL	Acta_Pharmacol_Sin_2012_Jan_28_33(1)_75-81.nxml.txt.nlp	22120969	SENT141	7	7	14	14	exenatide	GLP-1	PA164749238	100125288	0.895
NULL	Biologics_2012_Oct_25_6_371-378.nxml.txt.nlp	23118526	SENT185	3	3	16	16	alefacept	CD4	PA164748040	920	0.895
NULL	Biomed_Res_Int_2014_Feb_6_2014_323594.nxml.txt.nlp	24689036	SENT200	7	7	14	14	raloxifene	PC3	PA451221	57332;7832;5122	0.895
NULL	Am_J_Trop_Med_Hyg_2012_Aug_1_87(2)_231-241.nxml.txt.nlp	22855752	SENT16	32	32	0	0	lumefantrine	ACT	PA165111722	12;11332;9457;641455	0.895
NULL	Acta_Pharmacol_Sin_2012_May_2_33(5)_615-624.nxml.txt.nlp	22465948	SENT13	15	15	12	12	estradiol	PRG	PA449503	5544	0.895
NULL	J_Korean_Med_Sci_2011_Aug_27_26(8)_1007-1013.nxml.txt.nlp	21860550	SENT148	14	14	0	0	tamoxifen	CYP2D6	PA451581	1565	0.895
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT287	24	24	11	11	ranibizumab	VEGFR1	PA164746012	2321	0.895
NULL	Br_J_Cancer_2010_Dec_7_103(12)_1765-1772.nxml.txt.nlp	21139621	SENT13	28	28	22	22	cetuximab	EGFR	PA10040	1956	0.895
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT222	0	0	5	5	chloroquine	BMPR-II	PA448948	659	0.895
NULL	Oncogenesis_2014_Dec_15_3(12)_e133.nxml.txt.nlp	25500906	SENT12	13	13	9	9	trastuzumab	MPZL1	PA451743	9019	0.895
NULL	Chonnam_Med_J_2013_Apr_25_49(1)_31-37.nxml.txt.nlp	23678475	SENT79	8	8	27	27	rosuvastatin	adiponectin	PA134308647	9370	0.895
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1411-1419.nxml.txt.nlp	24077634	SENT142	4	4	2	2	metformin	AMPK	PA450395	5563	0.895
NULL	Breast_Cancer_Res_2005_Jul_18_7(5)_187-189.nxml.txt.nlp	16168136	SENT45	23	23	7	7	tamoxifen	HER2	PA451581	2064	0.895
NULL	Curr_Cardiol_Rev_2010_Nov_6(4)_291-297.nxml.txt.nlp	22043205	SENT94	8	8	10	10	candesartan	AT1	PA448765	9197;185	0.895
NULL	Br_J_Cancer_2012_Jun_5_106(12)_1997-2003.nxml.txt.nlp	22596232	SENT10	4	4	18	18	sorafenib	JNK	PA7000	5599	0.895
NULL	EJNMMI_Res_2011_Nov_10_1_25.nxml.txt.nlp	22214344	SENT102	11	11	24	24	carbidopa	COMT	PA448794	1312	0.895
NULL	Oncoimmunology_2012_Jul_1_1(4)_493-506.nxml.txt.nlp	22754768	SENT148	26	26	16	16	paclitaxel	CD40L	PA450761	959	0.895
NULL	Mol_Cancer_2010_Apr_21_9_83.nxml.txt.nlp	20409325	SENT94	32	32	26	26	doxycycline	MYCN	PA449415	4613	0.895
NULL	J_Oncol_2012_Aug_9_2012_685213.nxml.txt.nlp	22934113	SENT137	17	17	8	8	cabergoline	PRL	PA448708	5617	0.895
NULL	Hum_Genomics_2010_Apr_1_4(4)_238-249.nxml.txt.nlp	20511137	SENT68	0	0	42	42	irinotecan	CYP3A4	PA450085	1576	0.895
NULL	Oncol_Rep_2014_Apr_28_31(4)_1605-1612.nxml.txt.nlp	24481648	SENT95	27	27	13	13	vincristine	MRP7	PA451879	89845;1080	0.895
NULL	J_Cell_Biol_2004_Dec_6_167(5)_851-862.nxml.txt.nlp	15569712	SENT53	0	0	23	23	staurosporine	ICAD	PA165109623	1676	0.895
NULL	Daru_2012_Sep_3_20(1)_24.nxml.txt.nlp	23351176	SENT152	4	4	15	15	itopride	EPO	PA152432599	7076;8288;2056	0.895
NULL	Environ_Health_Perspect_2007_Dec_8_115(Suppl_1)_77-83.nxml.txt.nlp	18174954	SENT78	15	15	11	11	genistein	TPO	PA165109660	7066;7173	0.895
NULL	Breast_Cancer_Res_2007_Oct_10_9(5)_R69.nxml.txt.nlp	17925034	SENT78	14	14	3	3	pp2	HC11		6347	0.895
NULL	Acta_Physiol_(Oxf)_2007_Sep_191(1)_43-57.nxml.txt.nlp	17524066	SENT148	21	21	0	0	nifedipine	PES	PA450631	23481	0.895
NULL	Cell_Death_Dis_2014_Jan_16_5(1)_e1000.nxml.txt.nlp	24434508	SENT70	28	28	6	6	etoposide	p53	PA449552	7157	0.895
NULL	Mol_Cancer_2007_Oct_11_6_63.nxml.txt.nlp	17931419	SENT109	10	10	2	2	cetuximab	HIF-1	PA10040	29072	0.895
NULL	Case_Rep_Med_2010_Dec_20_2010_782595.nxml.txt.nlp	21209730	SENT86	29	29	14	14	imatinib	FIP1L1	PA10804	81608	0.895
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1046.nxml.txt.nlp	24503538	SENT83	20	20	40	40	doxorubicin	FGFR4	PA449412	2264	0.895
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT175	19	19	3	3	erlotinib	CYP3A	PA134687924	1574	0.895
NULL	EMBO_Mol_Med_2013_Dec_8_5(12)_1821-1834.nxml.txt.nlp	24293316	SENT51	25	25	16	16	doxorubicin	UNC5B	PA449412	219699	0.895
NULL	Front_Oncol_2014_Sep_22_4_258.nxml.txt.nlp	25295228	SENT210	19	19	29	29	cisplatin	EGFR	PA449014	1956	0.895
NULL	Hum_Mol_Genet_2013_Nov_15_22(22)_4616-4626.nxml.txt.nlp	23814041	SENT185	17	17	25	25	simvastatin	neuroserpin	PA451363	5274	0.895
NULL	Mol_Cytogenet_2014_Jul_15_7_47.nxml.txt.nlp	25071866	SENT82	24	24	35	35	l-glutamine	CO2	PA10090	4513	0.895
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Aug_16_70(Pt_9)_o1015-o1016.nxml.txt.nlp	25309199	SENT102	9	9	34	34	ethanol	mol	PA448073	90527	0.895
NULL	Chin_J_Cancer_2012_Feb_31(2)_73-99.nxml.txt.nlp	22098950	SENT210	31	31	40	40	nilotinib	CD34	PA165958345	947	0.895
NULL	Oncoimmunology_2012_Nov_1_1(8)_1376-1386.nxml.txt.nlp	23243601	SENT99	0	0	20	20	lenalidomide	IRF4	PA162363968	3662	0.895
NULL	Cerebrovasc_Dis_Extra_2013_Jun_11_3(1)_85-94.nxml.txt.nlp	23885261	SENT131	16	16	5	5	alteplase	TACI	PA164776730	23495	0.895
NULL	FEBS_Open_Bio_2014_Jul_8_4_672-682.nxml.txt.nlp	25180151	SENT205	9	9	0	0	nadh	ADP	PA164755085	23038	0.895
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Oct_29_67(Pt_11)_o3069-o3070.nxml.txt.nlp	22220078	SENT65	32	32	24	24	ethanol	mol	PA448073	90527	0.895
NULL	J_Cell_Biol_1998_May_4_141(3)_715-726.nxml.txt.nlp	9566971	SENT237	23	23	5	5	heparin	ARIA	PA449855	641700	0.895
NULL	Environ_Health_Perspect_2013_Sep_14_121(9)_1002-1010.nxml.txt.nlp	23771518	SENT95	15	15	7	7	propiconazole	aromatase	PA165107991	1588	0.895
NULL	Oncotarget_2013_Nov_22_5(4)_933-943.nxml.txt.nlp	24659749	SENT93	2	2	17	17	nutlin-3	p53		7157	0.895
NULL	Ann_Gastroenterol_2012_25(3)_207-217.nxml.txt.nlp	24713803	SENT154	0	0	16	16	metformin	DM2	PA450395	28508	0.895
NULL	BMB_Rep_2013_Aug_46(8)_410-415.nxml.txt.nlp	23977989	SENT6	0	0	31	31	curcumin	HO-1	PA151958596	3162	0.895
NULL	Indian_J_Hum_Genet_2014_Apr-Jun_20(2)_175-184.nxml.txt.nlp	25400347	SENT89	13	13	3	3	warfarin	CYP2C9	PA451906	1559	0.895
NULL	Arthritis_Res_Ther_2005_Feb_17_7(Suppl_1)_P21.nxml.txt.nlp	NULL	SENT15	21	21	24	24	abatacept	IL-2	PA164747080	3558	0.895
NULL	Cancers_(Basel)_2014_Apr_16_6(2)_926-957.nxml.txt.nlp	24743778	SENT1751	11	11	5	5	ponatinib	FGFR4	PA165980594	2264	0.895
NULL	Curr_Neuropharmacol_2010_Mar_8(1)_41-61.nxml.txt.nlp	20808545	SENT296	13	13	2	2	pravastatin	CTX	PA451089	1593	0.895
NULL	Oncotarget_2013_Jul_21_4(8)_1253-1265.nxml.txt.nlp	23896512	SENT1	28	28	18	18	erlotinib	EGFR	PA134687924	1956	0.895
NULL	Acta_Pharmacol_Sin_2014_Sep_4_35(9)_1157-1166.nxml.txt.nlp	25088002	SENT103	5	5	11	11	curcumin	STAT3	PA151958596	6774	0.895
NULL	Cancers_(Basel)_2012_Nov_2_4(4)_1161-1179.nxml.txt.nlp	24213503	SENT1045	11	11	9	9	plerixafor	CXCR4	PA165958410	7852	0.895
NULL	J_Oncol_2009_Mar_24_2009_491985.nxml.txt.nlp	19325924	SENT114	13	13	8	8	genistein	CXCR4	PA165109660	7852	0.895
NULL	Biol_Open_2014_Jul_25_3(8)_741-758.nxml.txt.nlp	25063196	SENT490	23	23	11	11	ethanol	NF1	PA448073	4763	0.895
NULL	J_Hematol_Oncol_2010_Mar_13_3_10.nxml.txt.nlp	20226083	SENT31	7	7	21	21	docetaxel	BRCA1	PA449383	672	0.895
NULL	Front_Oncol_2011_Jun_17_1_10.nxml.txt.nlp	22655230	SENT1104	7	7	11	11	olaparib	BRCA1		672	0.895
NULL	Diabetes_2013_Sep_15_62(9)_3232-3240.nxml.txt.nlp	23835329	SENT21	12	12	17	17	olanzapine	AAP	PA450688	5345	0.895
NULL	J_Invest_Dermatol_2013_Dec_7_133(12)_10_1038_jid_2013_222.nxml.txt.nlp	23652797	SENT26	25	25	0	0	l-tryptophan	IFN	PA10323	3439	0.895
NULL	J_Cell_Sci_2013_Sep_1_126(17)_3873-3883.nxml.txt.nlp	23843614	SENT229	21	21	11	11	forskolin	PICK1	PA146096022	9463	0.895
NULL	Pharmaceuticals_(Basel)_2013_Feb_7_6(2)_269-286.nxml.txt.nlp	24275951	SENT914	35	35	24	24	cisplatin	Mcl-1	PA449014	4170	0.895
NULL	Oncotarget_2013_Jun_4_4(5)_772-784.nxml.txt.nlp	23800712	SENT131	45	45	27	27	erlotinib	PIK3CA	PA134687924	5290	0.895
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_16_2014_926087.nxml.txt.nlp	25478000	SENT96	9	9	16	16	ezetimibe	PCSK9	PA10816	255738	0.895
NULL	Endocr_Relat_Cancer_2014_Apr_21(2)_175-187.nxml.txt.nlp	24280133	SENT117	22	22	29	29	doxycycline	SOCS2	PA449415	8835	0.895
NULL	Br_J_Cancer_1998_May_77(10)_1645-1652.nxml.txt.nlp	9635842	SENT9	36	36	38	38	topotecan	TPT	PA451729	23590;6469	0.895
NULL	Int_J_Environ_Res_Public_Health_2010_May_27_7(5)_1872-1888.nxml.txt.nlp	20622998	SENT260	17	17	10	10	naltrexone	OPRM1	PA450588	4988	0.895
NULL	Front_Immunol_2013_Nov_7_4_360.nxml.txt.nlp	24223576	SENT179	7	7	0	0	imiquimod	CCR7	PA449972	1236	0.895
NULL	Basic_Clin_Neurosci_2014_Winter_5(1)_66-73.nxml.txt.nlp	25436086	SENT126	2	2	15	15	lidocaine	LHA	PA450226	1081	0.894
NULL	EPMA_J_2013_Feb_19_4(1)_6.nxml.txt.nlp	23418957	SENT69	4	4	8	8	paclitaxel	aromatase	PA450761	1588	0.894
NULL	Breast_Cancer_Res_2011_Jan_20_13(1)_R8.nxml.txt.nlp	21251330	SENT37	39	39	31	31	exemestane	aromatase	PA449563	1588	0.894
NULL	Mol_Cell_Biochem_2014_Jul_26_396(1-2)_221-228.nxml.txt.nlp	25063218	SENT162	5	5	3	3	resveratrol	EGFR		1956	0.894
NULL	Clinics_(Sao_Paulo)_2014_Jan_69(1)_68-74.nxml.txt.nlp	24473562	SENT131	7	7	2	2	nutlin-3	p53		7157	0.894
NULL	Front_Comput_Neurosci_2013_Apr_5_7_22.nxml.txt.nlp	23576979	SENT16	11	11	24	24	ketamine	HCN1	PA450144	348980	0.894
NULL	Acta_Naturae_2012_Jan-Mar_4(1)_93-100.nxml.txt.nlp	22708069	SENT65	8	8	18	18	methotrexate	FVIII	PA450428	2157	0.894
NULL	Clin_J_Gastroenterol_2014_Jun_6_7(4)_355-360.nxml.txt.nlp	25132867	SENT3	6	6	19	19	ribavirin	IFN	PA451241	3439	0.894
NULL	Nat_Commun_2013_Aug_15_4_2130.nxml.txt.nlp	23945651	SENT62	6	6	1	1	etoposide	ATG5	PA449552	9474	0.894
NULL	Ann_Surg_Oncol_2009_Aug_10_16(8)_2086-2088.nxml.txt.nlp	19513600	SENT72	29	29	10	10	cetuximab	gamma	PA10040	9913	0.894
NULL	Mol_Cancer_2012_Apr_26_11_24.nxml.txt.nlp	22537161	SENT126	32	32	10	10	atropine	MUC4	PA448505	4585	0.894
NULL	Clin_Med_Oncol_2008_Jul_8_2_471-475.nxml.txt.nlp	21892320	SENT47	39	39	22	22	thalidomide	GM-CSF	PA451644	1437	0.894
NULL	Indian_J_Pharm_Sci_2013_Jan-Feb_75(1)_94-98.nxml.txt.nlp	23901167	SENT30	10	10	28	28	phenacetin	CYP2C9	PA450897	1559	0.894
NULL	Neuro_Oncol_2010_Mar_6_12(3)_233-242.nxml.txt.nlp	20167811	SENT156	12	12	4	4	bevacizumab	U87	PA130232992	677775;641648	0.894
NULL	Oncogene_2010_Sep_16_29(37)_5159-5170.nxml.txt.nlp	20562917	SENT26	23	23	2	2	gefitinib	CXCL14	PA131301952	9547	0.894
NULL	J_Hematol_Oncol_2010_May_2_3_18.nxml.txt.nlp	20433767	SENT178	9	9	23	23	gefitinib	EGFR	PA131301952	1956	0.894
NULL	Braz_J_Med_Biol_Res_2013_May_10_46(5)_433-439.nxml.txt.nlp	23681290	SENT49	8	8	14	14	bezafibrate	BAFF	PA162364313	10673	0.894
NULL	Acta_Pharmacol_Sin_2013_Jan_5_34(1)_24-32.nxml.txt.nlp	23123646	SENT101	19	19	5	5	diazoxide	SUR1	PA449285	6833	0.894
NULL	Cancer_Cell_Int_2005_Aug_23_5_27.nxml.txt.nlp	16117829	SENT158	10	10	5	5	doxycycline	p53	PA449415	7157	0.894
NULL	Oncotarget_2012_May_4_3(4)_395-398.nxml.txt.nlp	22565037	SENT9	29	29	11	11	metformin	CD24	PA450395	100133941	0.894
NULL	Br_J_Cancer_2013_Feb_5_108(2)_334-341.nxml.txt.nlp	23257893	SENT235	2	2	9	9	sorafenib	NOXA	PA7000	5366	0.894
NULL	Chem_Rev_2014_Jun_11_114(11)_5753-5774.nxml.txt.nlp	24758331	SENT121	26	26	36	36	doxorubicin	P-gp	PA449412	5243	0.894
NULL	Ann_Oncol_2012_Nov_22_23(11)_2782-2790.nxml.txt.nlp	22730099	SENT25	8	8	14	14	anastrozole	aromatase	PA448432	1588	0.894
NULL	Case_Rep_Gastroenterol_2011_Oct_7_5(3)_610-616.nxml.txt.nlp	22110423	SENT65	18	18	46	46	mesalazine	DLST	PA450384	1743	0.894
NULL	Case_Rep_Obstet_Gynecol_2014_Mar_24_2014_549619.nxml.txt.nlp	24782935	SENT87	3	3	18	18	rituximab	CHOP	PA451261	1649	0.894
NULL	Br_J_Cancer_2013_Sep_3_109(5)_1243-1251.nxml.txt.nlp	23922111	SENT165	25	25	17	17	bevacizumab	EGFL7	PA130232992	51162	0.894
NULL	Evid_Based_Complement_Alternat_Med_2011_Aug_11_2011_237941.nxml.txt.nlp	19887507	SENT179	41	41	11	11	metformin	STZ	PA450395	6484	0.894
NULL	Acta_Pharmacol_Sin_2010_Jul_28_31(7)_867-873.nxml.txt.nlp	20581857	SENT112	14	14	0	0	docetaxel	PDCD4	PA449383	27250	0.894
NULL	Oncotarget_2010_Oct_30_1(7)_639-650.nxml.txt.nlp	21317459	SENT5	26	26	16	16	nutlin-3	p53		7157	0.894
NULL	Case_Rep_Gastroenterol_2012_May_3_6(2)_223-231.nxml.txt.nlp	22679409	SENT107	17	17	8	8	azathioprine	DIP	PA448515	23151;1831	0.894
NULL	AMIA_Jt_Summits_Transl_Sci_Proc_2012_Mar_19_2012_25-34.nxml.txt.nlp	22779044	SENT161	7	7	3	3	ethanol	PPARD	PA448073	5467	0.894
NULL	Breast_Cancer_Res_2002_May_10_4(4)_165-168.nxml.txt.nlp	12100742	SENT52	32	32	23	23	tamoxifen	EGF	PA451581	1950	0.894
NULL	Br_J_Pharmacol_2011_Mar_162(5)_1074-1082.nxml.txt.nlp	20973779	SENT24	25	25	14	14	verapamil	BTZ	PA451868	22794	0.894
NULL	Breast_Cancer_Res_Treat_2012_Jul_24_134(1)_13-20.nxml.txt.nlp	22198412	SENT217	9	9	16	16	pazopanib	HER2	PA165291492	2064	0.894
NULL	Cancer_Metab_2014_May_28_2(Suppl_1)_P73.nxml.txt.nlp	NULL	SENT16	13	13	26	26	metformin	IL-8	PA450395	3576	0.894
NULL	J_Cell_Mol_Med_2014_Sep_7_18(9)_1785-1796.nxml.txt.nlp	24909956	SENT242	25	25	8	8	cangrelor	GPR17	PA165945763	2840	0.894
NULL	Cancers_(Basel)_2012_Apr_5_4(2)_354-378.nxml.txt.nlp	24213315	SENT156	7	7	19	19	etoposide	TRAIL	PA449552	8743	0.894
NULL	Braz_J_Med_Biol_Res_2012_Jul_20_45(10)_935-941.nxml.txt.nlp	22801415	SENT175	7	7	19	19	pioglitazone	adiponectin	PA450970	9370	0.894
NULL	Aging_(Albany_NY)_2009_Oct_13_1(10)_842-844.nxml.txt.nlp	20157556	SENT30	13	13	4	4	nutlin-3	SIRT1		23411	0.894
NULL	Mol_Cancer_2010_Aug_23_9_222.nxml.txt.nlp	20731837	SENT102	0	0	2	2	cetuximab	EGFR	PA10040	1956	0.894
NULL	Oncotarget_2014_Nov_12_5(20)_9626-9640.nxml.txt.nlp	25275299	SENT78	19	19	33	33	thrombin	LPA	PA451674	4018	0.894
NULL	Breast_Cancer_Res_2007_Aug_31_9(4)_R56.nxml.txt.nlp	17764562	SENT229	39	39	19	19	paclitaxel	gamma	PA450761	9913	0.894
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT64	22	22	15	15	methotrexate	MSH2	PA450428	4436	0.894
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1196-1204.nxml.txt.nlp	22315058	SENT146	18	18	6	6	lapatinib	HER2	PA152241907	2064	0.894
NULL	Int_J_Gen_Med_2009_Dec_29_2_209-217.nxml.txt.nlp	20360906	SENT139	25	25	28	28	lisuride	PRL	PA164749019	5617	0.894
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1709-1716.nxml.txt.nlp	19844235	SENT190	15	15	31	31	gemcitabine	B7-H3	PA449748	80381	0.894
NULL	Cancer_Res_Treat_2013_Mar_31_45(1)_55-62.nxml.txt.nlp	23613671	SENT14	13	13	45	45	oxaliplatin	KRAS	PA131285527	3845	0.894
NULL	Ann_Gen_Psychiatry_2008_Aug_18_7_11.nxml.txt.nlp	18706108	SENT142	2	2	11	11	ethanol	CD50	PA448073	3385	0.894
NULL	Int_J_Nanomedicine_2012_Sep_14_7_4983-4994.nxml.txt.nlp	23028226	SENT222	15	15	35	35	chymotrypsin	GLP-1	PA448994	100125288	0.894
NULL	Int_J_Biol_Sci_2014_Jan_11_10(2)_142-148.nxml.txt.nlp	24520212	SENT118	15	15	7	7	cisplatin	WWOX	PA449014	51741	0.894
NULL	Front_Oncol_2014_Sep_15_4_248.nxml.txt.nlp	25309873	SENT140	10	10	6	6	gefitinib	EGFR	PA131301952	1956	0.894
NULL	Cancer_Cell_Int_2013_Jun_26_13_64.nxml.txt.nlp	23802572	SENT35	0	0	17	17	curcumin	PARP-1	PA151958596	25976	0.894
NULL	Acta_Pharmacol_Sin_2013_Jan_3_34(1)_167-175.nxml.txt.nlp	23202799	SENT119	22	22	12	12	paraformaldehyde	CO2	PA450790	4513	0.894
NULL	Chem_Cent_J_2012_May_30_6_50.nxml.txt.nlp	22647291	SENT178	24	24	6	6	ethanol	mol	PA448073	90527	0.894
NULL	Hum_Mol_Genet_2013_Nov_15_22(22)_4616-4626.nxml.txt.nlp	23814041	SENT165	4	4	16	16	simvastatin	neuroserpin	PA451363	5274	0.894
NULL	Exp_Ther_Med_2013_Jul_25_6(1)_109-114.nxml.txt.nlp	23935730	SENT150	17	17	13	13	doxorubicin	CHOP	PA449412	1649	0.894
NULL	Eur_J_Med_Res_2009_Nov_24_14(Suppl_3)_36-42.nxml.txt.nlp	19959415	SENT34	28	28	14	14	abacavir	gamma	PA448004	9913	0.894
NULL	Clin_Med_Insights_Oncol_2011_Nov_9_5_365-379.nxml.txt.nlp	22174597	SENT167	18	18	3	3	imatinib	KIT	PA10804	3815	0.894
NULL	Int_J_Mol_Sci_2014_Mar_5_15(3)_3970-3988.nxml.txt.nlp	24603537	SENT2	8	8	16	16	curcumin	MCH	PA151958596	5367	0.894
NULL	Eur_J_Clin_Pharmacol_2011_Dec_23_67(12)_1231-1241.nxml.txt.nlp	21698374	SENT182	20	20	11	11	tacrolimus	CYP3A5	PA451578	1577	0.894
NULL	Breast_Cancer_Res_2005_Mar_4_7(3)_R345-R352.nxml.txt.nlp	15987429	SENT231	7	7	25	25	carbachol	PIR	PA448784	8544	0.894
NULL	Indian_J_Pharm_Sci_2009_Nov-Dec_71(6)_622-629.nxml.txt.nlp	20376214	SENT80	17	17	1	1	mannitol	B13	PA450320	4698	0.894
NULL	Oncol_Rep_2012_Apr_30_27(4)_923-928.nxml.txt.nlp	22209766	SENT125	14	14	2	2	erlotinib	EGFR	PA134687924	1956	0.894
NULL	Aging_(Albany_NY)_2010_Sep_18_2(9)_535-537.nxml.txt.nlp	20876940	SENT13	8	8	29	29	doxorubicin	MTOR	PA449412	2475	0.894
NULL	Curr_Clin_Pharmacol_2014_May_9(2)_130-138.nxml.txt.nlp	24218995	SENT262	8	8	1	1	salmeterol	Gen	PA451300	348654	0.894
NULL	Tuberc_Respir_Dis_(Seoul)_2013_Aug_30_75(2)_75-78.nxml.txt.nlp	24023561	SENT57	9	9	5	5	azithromycin	CAP	PA448519	23476;9200;4012;5269;10580;10487	0.894
NULL	Indian_J_Anaesth_2014_Jul-Aug_58(4)_423-429.nxml.txt.nlp	25197110	SENT43	9	9	19	19	ondansetron	ODF	PA450705	8600	0.894
NULL	Korean_J_Anesthesiol_2013_Feb_15_64(2)_105-111.nxml.txt.nlp	23459312	SENT54	15	15	4	4	heparin	ACT	PA449855	12;11332;9457;641455	0.894
NULL	Med_Sci_Monit_2012_May_1_18(5)_BR181-BR187.nxml.txt.nlp	22534700	SENT41	17	17	6	6	alendronate	ghrelin	PA448082	51738	0.894
NULL	Exp_Diabetes_Res_2012_Oct_19_2012_628978.nxml.txt.nlp	22028701	SENT267	6	6	15	15	glucose	AMPK	PA449773	5563	0.894
NULL	Mol_Cell_Proteomics_2014_May_17_13(5)_1273-1285.nxml.txt.nlp	24637012	SENT216	5	5	21	21	ergotamine	5-HT2A	PA164747651	3356	0.894
NULL	Acta_Pharmacol_Sin_2011_Oct_15_32(10)_1303-1308.nxml.txt.nlp	21841812	SENT162	4	4	9	9	losartan	CYP2C9	PA450268	1559	0.894
NULL	Acta_Pharmacol_Sin_2012_Jan_12_33(1)_27-33.nxml.txt.nlp	22158109	SENT186	15	15	29	29	isoflurane	AMPK	PA450106	5563	0.894
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_25_2013_650134.nxml.txt.nlp	23878602	SENT113	12	12	29	29	galactose	mol	PA449725	90527	0.894
NULL	Ann_Dermatol_2011_Dec_27_23(Suppl_3)_S290-S295.nxml.txt.nlp	22346260	SENT21	2	2	16	16	dapsone	EED	PA449211	8726	0.894
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT407	5	5	1	1	panitumumab	KRAS	PA162373091	3845	0.894
NULL	Cancer_Cell_Int_2012_Jul_18_12_34.nxml.txt.nlp	22809533	SENT84	13	13	19	19	cisplatin	HK1	PA449014	3098;51361;3739	0.894
NULL	Br_J_Cancer_2013_Jun_25_108(12)_2464-2469.nxml.txt.nlp	23695016	SENT164	14	14	20	20	carboplatin	CRT	PA448803	811	0.894
NULL	Arthritis_Res_Ther_2012_Jun_12_14(3)_R142.nxml.txt.nlp	22691272	SENT139	11	11	29	29	mianserin	IFN	PA134687937	3439	0.894
NULL	Exp_Diabetes_Res_2012_May_28_2012_924168.nxml.txt.nlp	22693487	SENT5	3	3	6	6	liraglutide	GLP-1	PA165958364	100125288	0.894
NULL	J_Gastrointest_Cancer_2013_Aug_7_44(4)_385-392.nxml.txt.nlp	23921604	SENT23	3	3	23	23	imatinib	CML	PA10804	613	0.894
NULL	Int_J_Biol_Sci_2014_Jun_3_10(6)_602-613.nxml.txt.nlp	24948873	SENT92	17	17	6	6	bicalutamide	PC3	PA164746255	57332;7832;5122	0.894
NULL	Mol_Cancer_2012_Mar_21_11_13.nxml.txt.nlp	22436134	SENT76	2	2	6	6	doxorubicin	HuR	PA449412	1994	0.894
NULL	Clin_Dev_Immunol_2011_Dec_29_2011_160250.nxml.txt.nlp	22242035	SENT208	2	2	11	11	cyclophosphamide	IFN	PA449165	3439	0.894
NULL	Cell_Death_Dis_2010_Nov_18_1(11)_e102.nxml.txt.nlp	21368867	SENT70	4	4	19	19	gentamicin	CLIMP-63	PA449753	10970	0.894
NULL	Ann_Oncol_2011_Aug_27_22(8)_1736-1747.nxml.txt.nlp	21709140	SENT313	7	7	11	11	olaparib	BRCA1		672	0.894
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT173	18	18	6	6	sulindac	AKT	PA451565	207	0.894
NULL	Autophagy_2012_Dec_1_8(12)_1724-1740.nxml.txt.nlp	22948227	SENT129	12	12	8	8	doxycycline	MAPK15	PA449415	225689	0.894
NULL	Indian_J_Endocrinol_Metab_2012_Jul-Aug_16(4)_525-527.nxml.txt.nlp	22837910	SENT24	15	15	20	20	liraglutide	GLP-1	PA165958364	100125288	0.894
NULL	J_Korean_Med_Sci_2007_Apr_30_22(2)_283-289.nxml.txt.nlp	17449938	SENT102	20	20	13	13	minoxidil	Bcl-2	PA450521	596	0.894
NULL	Nat_Commun_2013_Sep_4_4_2338.nxml.txt.nlp	24005565	SENT552	34	34	3	3	olaparib	HELQ		113510	0.894
NULL	Cancers_(Basel)_2010_Mar_22_2(1)_190-208.nxml.txt.nlp	24281040	SENT50	5	5	24	24	erlotinib	EGFR	PA134687924	1956	0.894
NULL	Neural_Regen_Res_2013_May_25_8(15)_1368-1375.nxml.txt.nlp	25206431	SENT95	0	0	10	10	curcumin	Bcl-2	PA151958596	596	0.894
NULL	Biomed_Res_Int_2013_Jul_31_2013_692071.nxml.txt.nlp	23984399	SENT21	41	41	27	27	sorafenib	SLC22A1	PA7000	6580	0.894
NULL	Mol_Vis_2012_Nov_29_18_2839-2846.nxml.txt.nlp	23233786	SENT9	0	0	5	5	geldanamycin	Hsp90	PA152031327	3320	0.894
NULL	AAPS_J_2014_Jun_11_16(5)_1029-1037.nxml.txt.nlp	24917180	SENT172	11	11	9	9	tariquidar	P-gp		5243	0.894
NULL	Mol_Cancer_2014_Feb_4_13_21.nxml.txt.nlp	24495750	SENT278	31	31	12	12	oxaliplatin	San	PA131285527	80218	0.894
NULL	Genome_Med_2010_Aug_11_2(8)_53.nxml.txt.nlp	20701793	SENT60	5	5	8	8	sunitinib	VEGFR	PA162372840	3791	0.894
NULL	Clin_Exp_Otorhinolaryngol_2012_Sep_27_5(3)_132-138.nxml.txt.nlp	22977709	SENT9	16	16	9	9	fluorescein	P18	PA164746009	7975;10168	0.894
NULL	Onco_Targets_Ther_2014_Sep_9_7_1571-1582.nxml.txt.nlp	25228815	SENT111	8	8	19	19	sunitinib	VEGFR1	PA162372840	2321	0.894
NULL	Chem_Cent_J_2012_Aug_1_6_78.nxml.txt.nlp	22853321	SENT62	10	10	0	0	ethanol	PC5	PA448073	5125	0.894
NULL	Breast_Cancer_Res_2008_Dec_9_10(Suppl_1)_S3.nxml.txt.nlp	19091007	SENT164	6	6	0	0	estradiol	FES	PA449503	2242	0.894
NULL	J_Cell_Biol_2002_Sep_16_158(6)_1067-1078.nxml.txt.nlp	12235124	SENT72	27	27	6	6	galactose	TCF4	PA449725	6925	0.894
NULL	Acta_Neuropathol_Commun_2014_Jul_17_2(1)_74.nxml.txt.nlp	NULL	SENT217	12	12	33	33	estradiol	p53	PA449503	7157	0.894
NULL	Exp_Diabetes_Res_2012_Feb_19_2012_749812.nxml.txt.nlp	22454628	SENT133	11	11	18	18	metformin	AMPK	PA450395	5563	0.894
NULL	Case_Rep_Gastrointest_Med_2014_Jul_1_2014_579352.nxml.txt.nlp	25093126	SENT43	18	18	10	10	vincristine	CHOP	PA451879	1649	0.894
NULL	Arthritis_Res_Ther_2003_Sep_12_5(Suppl_3)_38.nxml.txt.nlp	NULL	SENT3	12	12	23	23	diclofenac	gamma	PA449293	9913	0.894
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2007_Dec_6_64(Pt_1)_m12.nxml.txt.nlp	21200479	SENT54	17	17	3	3	ethanol	mol	PA448073	90527	0.894
NULL	Int_J_Biol_Sci_2013_Apr_22_9(4)_350-360.nxml.txt.nlp	23630447	SENT162	28	28	18	18	doxorubicin	ARC	PA449412	8996;23237	0.894
NULL	J_Thromb_Haemost_2011_Oct_9(10)_2103-2105.nxml.txt.nlp	21812912	SENT32	0	0	13	13	ticagrelor	PAR-1	PA165374673	2011;2149	0.894
NULL	Clin_Sci_(Lond)_2013_Feb_1_124(Pt_3)_153-164.nxml.txt.nlp	23075334	SENT117	5	5	9	9	resveratrol	AMPK		5563	0.894
NULL	J_Mol_Med_2011_Jul_23_89(7)_667-676.nxml.txt.nlp	21431325	SENT192	21	21	2	2	resveratrol	SIRT1		23411	0.894
NULL	Cancers_(Basel)_2012_Sep_6_4(3)_873-903.nxml.txt.nlp	24213471	SENT976	14	14	2	2	hyaluronan	CD44	PA165958431	960	0.894
NULL	Arthritis_Res_Ther_2010_Apr_29_12(2)_R73.nxml.txt.nlp	20429888	SENT250	15	15	6	6	bortezomib	c-Jun	PA10252	3725	0.894
NULL	J_Hematol_Oncol_2013_Jan_15_6_5.nxml.txt.nlp	23320987	SENT135	27	27	2	2	heparin	PI-PLC	PA449855	2923	0.894
NULL	Mol_Cancer_2009_Nov_10_8_99.nxml.txt.nlp	19903356	SENT55	10	10	4	4	imatinib	IGFBP3	PA10804	3486	0.894
NULL	Evid_Based_Complement_Alternat_Med_2013_May_16_2013_857929.nxml.txt.nlp	23762164	SENT205	9	9	30	30	doxorubicin	p53	PA449412	7157	0.894
NULL	Int_J_Biol_Sci_2012_Feb_9_8(3)_310-327.nxml.txt.nlp	22355267	SENT47	23	23	36	36	simvastatin	PCSK9	PA451363	255738	0.894
NULL	Exp_Ther_Med_2013_Nov_13_6(5)_1317-1321.nxml.txt.nlp	24223665	SENT100	26	26	14	14	cisplatin	CD133	PA449014	8842	0.894
NULL	Oncogene_2011_Apr_14_30(15)_1798-1811.nxml.txt.nlp	21170087	SENT148	12	12	10	10	etoposide	MDM2	PA449552	4193	0.894
NULL	Cancer_Cell_Int_2006_Aug_9_6_20.nxml.txt.nlp	16899133	SENT186	8	8	27	27	l-leucine	p27	PA450197	5715;10534	0.894
NULL	J_Korean_Med_Sci_2013_Apr_27_28(4)_527-533.nxml.txt.nlp	23580227	SENT168	10	10	16	16	genistein	TRAIL	PA165109660	8743	0.894
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1033-1038.nxml.txt.nlp	22374460	SENT187	26	26	4	4	gemcitabine	HER2	PA449748	2064	0.894
NULL	Oxid_Med_Cell_Longev_2013_Nov_28_2013_568093.nxml.txt.nlp	24379901	SENT5	6	6	24	24	resveratrol	SIRT1		23411	0.894
NULL	Front_Neurosci_2012_May_30_6_77.nxml.txt.nlp	22661925	SENT156	11	11	34	34	ethanol	DCX	PA448073	1641	0.894
NULL	Breast_Cancer_Res_2005_Jun_17_7(Suppl_2)_S_13.nxml.txt.nlp	NULL	SENT8	15	15	18	18	tamoxifen	aromatase	PA451581	1588	0.894
NULL	Cancer_Immunol_Immunother_2012_Oct_8_61(10)_1713-1720.nxml.txt.nlp	22399057	SENT127	24	24	21	21	plerixafor	CXCR4	PA165958410	7852	0.894
NULL	Leukemia_2012_Sep_19_26(9)_2114-2123.nxml.txt.nlp	22425892	SENT182	4	4	17	17	bortezomib	p38	PA10252	10598;1432;7965	0.894
NULL	Biomed_Res_Int_2014_Jan_16_2014_706302.nxml.txt.nlp	24551852	SENT65	18	18	0	0	ethanol	CYP2E1	PA448073	1571	0.894
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT327	26	26	35	35	pegaptanib	VEGF-A	PA164771236	7422	0.894
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_11_2014_274786.nxml.txt.nlp	25505920	SENT247	14	14	3	3	cisplatin	ERCC1	PA449014	2067	0.894
NULL	Indian_J_Pharmacol_2014_Jan-Feb_46(1)_3-12.nxml.txt.nlp	24550577	SENT222	28	28	25	25	clarithromycin	P-gp	PA449028	5243	0.894
NULL	Cholesterol_2014_Nov_18_2014_720507.nxml.txt.nlp	25478215	SENT70	7	7	18	18	atorvastatin	ANOVA	PA448500	4858	0.894
NULL	J_Antimicrob_Chemother_2013_Jan_30_68(1)_17-22.nxml.txt.nlp	22941900	SENT59	7	7	16	16	doxycycline	BSAC	PA449415	57591	0.894
NULL	Cell_Death_Dis_2010_Nov_18_1(11)_e102.nxml.txt.nlp	21368867	SENT152	8	8	11	11	gentamicin	14-3-3	PA449753	10971	0.894
NULL	Contemp_Oncol_(Pozn)_2012_Sep_29_16(4)_345-349.nxml.txt.nlp	23788907	SENT71	10	10	14	14	tamoxifen	aromatase	PA451581	1588	0.894
NULL	Int_J_Biomed_Sci_2007_Dec_3(4)_251-257.nxml.txt.nlp	23675050	SENT158	14	14	2	2	bromocriptine	PRL	PA448671	5617	0.894
NULL	J_Vet_Med_Sci_2013_Nov_12_75(11)_1539-1542.nxml.txt.nlp	23856759	SENT43	5	5	22	22	ampicillin	OTC	PA448419	5009	0.894
NULL	Int_J_Mol_Sci_2014_Jun_3_15(6)_9924-9944.nxml.txt.nlp	24897026	SENT181	6	6	4	4	metformin	AMPK	PA450395	5563	0.894
NULL	Int_J_Mol_Sci_2014_Nov_25_15(12)_21703-21722.nxml.txt.nlp	25429431	SENT316	7	7	13	13	olaparib	BRCA2		675	0.894
NULL	Sensors_(Basel)_2013_Jun_14_13(6)_7668-7679.nxml.txt.nlp	23771156	SENT130	0	0	17	17	procaine	mol	PA451110	90527	0.894
NULL	Br_J_Pharmacol_2011_May_163(2)_261-271.nxml.txt.nlp	21054345	SENT193	11	11	0	0	rolipram	GLP-1	PA153906323	100125288	0.894
NULL	Arthritis_Res_Ther_2010_Apr_29_12(2)_R73.nxml.txt.nlp	20429888	SENT271	6	6	34	34	bortezomib	COL1A2	PA10252	1278	0.894
NULL	Clin_Ophthalmol_2014_Jun_26_8_1213-1219.nxml.txt.nlp	25061267	SENT106	13	13	3	3	proparacaine	PRK	PA164776849	1263	0.894
NULL	Cancers_(Basel)_2014_Apr_16_6(2)_926-957.nxml.txt.nlp	24743778	SENT1602	0	0	2	2	celecoxib	STAT3	PA448871	6774	0.894
NULL	Oncotarget_2014_Jul_25_5(21)_10460-10472.nxml.txt.nlp	25361005	SENT9	12	12	4	4	everolimus	AKT	PA164746311	207	0.894
NULL	Eur_J_Clin_Pharmacol_2011_Dec_23_67(12)_1231-1241.nxml.txt.nlp	21698374	SENT297	14	14	6	6	tacrolimus	MDR1	PA451578	5243	0.894
NULL	J_Clin_Biochem_Nutr_2007_Jul_27_41(1)_32-42.nxml.txt.nlp	18392098	SENT144	8	8	2	2	curcumin	ROS	PA151958596	6098	0.894
NULL	Aging_(Albany_NY)_2012_Apr_16_4(4)_247-255.nxml.txt.nlp	22511639	SENT82	12	12	41	41	metformin	CH1	PA450395	51430	0.894
NULL	Oncogene_2010_Sep_23_29(38)_5299-5310.nxml.txt.nlp	20622903	SENT71	7	7	3	3	melphalan	HMGB1	PA450354	3146	0.894
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Jun_27_5_15.nxml.txt.nlp	16803618	SENT13	21	21	26	26	erythromycin	LTA	PA449493	4049	0.894
NULL	Cancer_Cell_Int_2013_Jun_26_13_63.nxml.txt.nlp	23800022	SENT212	4	4	10	10	genistein	ATF3	PA165109660	467	0.894
NULL	Evid_Based_Complement_Alternat_Med_2011_Mar_14_2011_635058.nxml.txt.nlp	21437195	SENT228	15	15	4	4	roflumilast	PDE4B	PA165948052	5142	0.894
NULL	Oncotarget_2011_Dec_31_2(12)_894-895.nxml.txt.nlp	22248868	SENT13	13	13	7	7	cetuximab	EGFR	PA10040	1956	0.894
NULL	Int_J_Breast_Cancer_2011_Feb_14_2011_618757.nxml.txt.nlp	22332014	SENT150	10	10	6	6	tamoxifen	ATAC	PA451581	6375	0.894
NULL	Int_J_Mol_Sci_2014_Sep_9_15(9)_15924-15950.nxml.txt.nlp	25207602	SENT116	0	0	14	14	agomelatine	5-HT2C	PA165958363	3358	0.894
NULL	Oncotarget_2014_Aug_25_5(17)_7945-7959.nxml.txt.nlp	25277206	SENT373	7	7	13	13	pazopanib	VEGFR	PA165291492	3791	0.894
NULL	J_Carcinog_2013_May_20_12_8.nxml.txt.nlp	23858296	SENT372	15	15	11	11	cyclosporine	HIF1	PA449167	3091	0.894
NULL	J_Cardiothorac_Surg_2013_May_13_8_127.nxml.txt.nlp	23668669	SENT41	14	14	1	1	sufentanil	EDA	PA451527	1896	0.894
NULL	Nat_Commun_2011_Sep_27_2_483.nxml.txt.nlp	21952217	SENT24	15	15	27	27	artemisinin	FPP	PA165111696	4488;60529	0.894
NULL	Curr_Control_Trials_Cardiovasc_Med_2001_Feb_8_2(1)_45-53.nxml.txt.nlp	11806772	SENT88	0	0	12	12	tacrolimus	FKBP-12	PA451578	2280	0.894
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT148	26	26	43	43	calcein	CO2	PA132595336	4513	0.894
NULL	J_Cell_Mol_Med_2013_Sep_11_17(9)_1160-1172.nxml.txt.nlp	23844832	SENT174	26	26	3	3	gefitinib	EGF	PA131301952	1950	0.894
NULL	Mol_Cancer_2009_Nov_10_8_99.nxml.txt.nlp	19903356	SENT113	27	27	3	3	imatinib	IGFBP3	PA10804	3486	0.894
NULL	Blood_Cancer_J_2014_Aug_22_4(8)_e240.nxml.txt.nlp	25148222	SENT359	24	24	14	14	pimozide	IL-3	PA450965	3562	0.894
NULL	JRSM_Cardiovasc_Dis_2012_Sep_24_1(6)_cvd_2012_012015.nxml.txt.nlp	24175073	SENT93	13	13	20	20	clopidogrel	HPR	PA449053	3250	0.894
NULL	Arthritis_Res_Ther_2009_Feb_3_11(1)_R15.nxml.txt.nlp	19192274	SENT223	8	8	30	30	azathioprine	IL-6	PA448515	3569	0.894
NULL	Oncotarget_2012_Dec_30_3(12)_1505-1521.nxml.txt.nlp	23455493	SENT260	15	15	24	24	berberine	NGAL	PA165860812	3934	0.894
NULL	Acta_Pharmacol_Sin_2011_Jan_6_32(1)_133-138.nxml.txt.nlp	21131997	SENT49	21	21	2	2	protamine	ACT	PA10366	12;11332;9457;641455	0.894
NULL	Br_J_Cancer_2011_Aug_9_105(4)_469-474.nxml.txt.nlp	21712825	SENT127	24	24	6	6	doxorubicin	UCP1	PA449412	7350	0.894
NULL	Mol_Cancer_2010_Jun_25_9_165.nxml.txt.nlp	20576164	SENT210	3	3	6	6	curcumin	STAT3	PA151958596	6774	0.894
NULL	Breast_Cancer_Res_2010_Mar_5_12(2)_R16.nxml.txt.nlp	20205716	SENT9	16	16	7	7	lovastatin	G3BP1	PA450272	10146	0.894
NULL	J_Int_AIDS_Soc_2010_Nov_8_13(Suppl_4)_P92.nxml.txt.nlp	NULL	SENT19	10	10	5	5	didanosine	DDX	PA449301	8644	0.894
NULL	Allergy_Asthma_Immunol_Res_2013_Jan_29_5(1)_55-58.nxml.txt.nlp	23277879	SENT38	14	14	21	21	ketoprofen	IPA	PA450149	3160	0.894
NULL	Trials_2014_May_1_15_151.nxml.txt.nlp	24885437	SENT6	27	27	12	12	clopidogrel	P2Y12	PA449053	64805	0.894
NULL	Br_J_Cancer_2010_Jun_29_103(1)_61-72.nxml.txt.nlp	20588279	SENT223	12	12	44	44	trastuzumab	HER-2	PA451743	2064	0.894
NULL	Braz_J_Med_Biol_Res_2013_Aug_13_46(8)_650-658.nxml.txt.nlp	23969971	SENT180	10	10	19	19	oxaliplatin	STAT3	PA131285527	6774	0.894
NULL	Oncol_Rep_2013_Oct_22_30(4)_1535-1541.nxml.txt.nlp	23877481	SENT149	19	19	24	24	plerixafor	EGFR	PA165958410	1956	0.894
NULL	Biomed_Res_Int_2014_Jun_2_2014_946492.nxml.txt.nlp	24991574	SENT72	16	16	20	20	olmesartan	adiponectin	PA164742950	9370	0.894
NULL	Mol_Cancer_2009_Jul_31_8_57.nxml.txt.nlp	19646263	SENT209	19	19	47	47	staurosporine	IL-8	PA165109623	3576	0.894
NULL	Breast_Cancer_Res_2009_Nov_26_11(6)_111.nxml.txt.nlp	20017885	SENT18	6	6	19	19	olaparib	BRCA2		675	0.894
NULL	Br_J_Haematol_2014_Mar_6_164(6)_759-766.nxml.txt.nlp	24387053	SENT129	7	7	27	27	rituximab	ADAMTS13	PA451261	11093	0.894
NULL	Breast_Cancer_Res_2007_Jul_22_9(4)_R45.nxml.txt.nlp	17659092	SENT124	25	25	1	1	doxorubicin	FDG	PA449412	23583	0.894
NULL	Acta_Pharmacol_Sin_2012_May_4_33(5)_710-716.nxml.txt.nlp	22555373	SENT118	13	13	16	16	diazepam	DOM	PA449283	6663	0.894
NULL	Korean_Circ_J_2014_Mar_12_44(2)_97-104.nxml.txt.nlp	24653739	SENT138	17	17	3	3	bosentan	Bcl-2	PA10034	596	0.894
NULL	Osteoporos_Int_2012_May_19_23(5)_1613-1622.nxml.txt.nlp	21769661	SENT163	14	14	5	5	teriparatide	VCF	PA451620	7413	0.894
NULL	Br_J_Cancer_2011_Dec_6_105(12)_1850-1855.nxml.txt.nlp	22095231	SENT22	24	24	4	4	gefitinib	EGFR	PA131301952	1956	0.894
NULL	Blood_Cancer_J_2013_Mar_1_3(3)_e103.nxml.txt.nlp	23454896	SENT93	28	28	38	38	bortezomib	ATF6	PA10252	22926	0.894
NULL	Clin_Drug_Investig_2013_Aug_23_33(10)_727-736.nxml.txt.nlp	23975654	SENT80	16	16	10	10	ketoconazole	CYP2C9	PA450146	1559	0.894
NULL	Eur_J_Clin_Pharmacol_2013_May_14_69(5)_1091-1101.nxml.txt.nlp	23150149	SENT29	0	0	26	26	isoniazid	NAT2	PA450112	10;81539	0.894
NULL	Ann_Rheum_Dis_2008_Nov_14_67(11)_1516-1523.nxml.txt.nlp	18625622	SENT46	28	28	9	9	tocilizumab	CRP	PA165292659	1401;140913	0.894
NULL	Anat_Cell_Biol_2010_Sep_30_43(3)_194-200.nxml.txt.nlp	21212859	SENT84	5	5	24	24	ethanol	PLP	PA448073	25824;5744	0.894
NULL	Oncotarget_2013_Aug_30_4(10)_1698-1711.nxml.txt.nlp	24091605	SENT183	19	19	34	34	gefitinib	POU5F1	PA131301952	5460	0.894
NULL	Scientifica_(Cairo)_2012_Dec_16_2012_402783.nxml.txt.nlp	24278688	SENT184	8	8	2	2	thrombin	PAR4	PA451674	9002;5074	0.894
NULL	J_Oncol_2012_Aug_9_2012_685213.nxml.txt.nlp	22934113	SENT137	19	19	22	22	bromocriptine	PRL	PA448671	5617	0.894
NULL	Biologics_2012_Feb_1_6_31-35.nxml.txt.nlp	22355257	SENT85	11	11	36	36	rituximab	IL-2	PA451261	3558	0.894
NULL	Adolesc_Health_Med_Ther_2013_Aug_27_4_79-87.nxml.txt.nlp	24600298	SENT61	24	24	6	6	raltegravir	UGT1A1		54658	0.894
NULL	Eur_J_Med_Res_2010_Nov_30_15(12)_533-543.nxml.txt.nlp	21163728	SENT33	17	17	19	19	vancomycin	VISA	PA451850	57506	0.894
NULL	Curr_Neuropharmacol_2013_Mar_11(2)_218-230.nxml.txt.nlp	23997756	SENT465	7	7	28	28	phencyclidine	c-fos	PA128406980	2353	0.894
NULL	Cancers_(Basel)_2011_Apr_19_3(2)_2080-2105.nxml.txt.nlp	24212797	SENT139	42	42	25	25	panitumumab	KRAS	PA162373091	3845	0.894
NULL	Acta_Neuropathol_Commun_2014_Sep_4_2(1)_93.nxml.txt.nlp	NULL	SENT340	39	39	21	21	tamoxifen	STAT3	PA451581	6774	0.894
NULL	J_Hematol_Oncol_2013_Jan_15_6_5.nxml.txt.nlp	23320987	SENT138	28	28	26	26	heparin	PI-PLC	PA449855	2923	0.894
NULL	Acta_Pharmacol_Sin_2010_Nov_18_31(11)_1447-1453.nxml.txt.nlp	20953204	SENT170	8	8	2	2	rimonabant	CB1	PA152407999	1268	0.894
NULL	J_Korean_Med_Sci_2010_Apr_19_25(4)_557-563.nxml.txt.nlp	20357998	SENT159	21	21	3	3	rosiglitazone	MCP-1	PA451283	6347	0.894
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_315-322.nxml.txt.nlp	20049735	SENT176	34	34	16	16	fluorescein	RAD51	PA164746009	5888	0.894
NULL	Comp_Hepatol_2005_Feb_8_4_2.nxml.txt.nlp	15701172	SENT113	8	8	14	14	ketoconazole	CYP3A	PA450146	1574	0.894
NULL	Indian_J_Med_Res_2011_Apr_133(4)_434-441.nxml.txt.nlp	21537099	SENT12	26	26	16	16	lansoprazole	EGF	PA450180	1950	0.894
NULL	Mol_Cancer_2010_Jun_25_9_165.nxml.txt.nlp	20576164	SENT30	7	7	15	15	curcumin	STAT3	PA151958596	6774	0.894
NULL	Diabetes_2009_Jun_31_58(6)_1434-1439.nxml.txt.nlp	19336679	SENT27	22	22	8	8	metformin	SLC22A1	PA450395	6580	0.894
NULL	Breast_Cancer_Res_2002_Apr_4_4(3)_85-89.nxml.txt.nlp	12052249	SENT41	28	28	3	3	tamoxifen	CYP3A4	PA451581	1576	0.894
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT109	16	16	5	5	trastuzumab	HER2	PA451743	2064	0.894
NULL	Cell_Death_Dis_2013_Oct_3_4(10)_e827.nxml.txt.nlp	24091670	SENT37	10	10	2	2	nilotinib	PI3K	PA165958345	5290	0.894
NULL	Mol_Cells_2014_Mar_31_37(3)_234-240.nxml.txt.nlp	24642709	SENT16	4	4	15	15	capsaicin	HO-1	PA448776	3162	0.894
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Nov_5_67(Pt_12)_o3175.nxml.txt.nlp	22199699	SENT65	23	23	6	6	ethanol	mol	PA448073	90527	0.894
NULL	Breast_Cancer_Res_2008_Aug_5_10(4)_R68.nxml.txt.nlp	18681966	SENT237	26	26	32	32	paclitaxel	PRLR	PA450761	5618	0.894
NULL	Mol_Cancer_2007_Oct_25_6_67.nxml.txt.nlp	17958915	SENT109	10	10	16	16	nilotinib	CD19	PA165958345	930	0.894
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT287	15	15	18	18	chloroquine	BMPR-II	PA448948	659	0.894
NULL	Clin_Cosmet_Investig_Dermatol_2013_Sep_26_6_233-244.nxml.txt.nlp	24101875	SENT104	5	5	0	0	sunitinib	IFN	PA162372840	3439	0.894
NULL	J_Indian_Soc_Periodontol_2014_May-Jun_18(3)_282-288.nxml.txt.nlp	25024538	SENT87	28	28	9	9	denosumab	RANKL	PA166048634	8600	0.894
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT106	24	24	34	34	l-leucine	S6K1	PA450197	6198	0.894
NULL	Acta_Pharmacol_Sin_2013_Jun_20_34(6)_732-740.nxml.txt.nlp	23685952	SENT184	12	12	7	7	bevacizumab	U87	PA130232992	677775;641648	0.894
NULL	Oxid_Med_Cell_Longev_2013_Jun_2_2013_793525.nxml.txt.nlp	23819014	SENT158	9	9	2	2	resveratrol	SGBS		2719	0.894
NULL	J_Oncol_2012_Mar_8_2012_723541.nxml.txt.nlp	22481931	SENT185	34	34	22	22	heparin	COX2	PA449855	4513;5743	0.894
NULL	Evid_Based_Complement_Alternat_Med_2012_Feb_12_2012_472897.nxml.txt.nlp	22454667	SENT184	0	0	9	9	cilomilast	PDE4A	PA165948031	5141	0.894
NULL	J_Breast_Cancer_2011_Sep_29_14(3)_247-250.nxml.txt.nlp	22031809	SENT45	9	9	6	6	anastrozole	aromatase	PA448432	1588	0.894
NULL	J_Biol_Chem_2010_Aug_20_285(34)_25928-25940.nxml.txt.nlp	20547488	SENT26	17	17	23	23	cisplatin	p38	PA449014	10598;1432;7965	0.894
NULL	Breast_Cancer_Res_2011_Aug_16_13(4)_312.nxml.txt.nlp	21861853	SENT20	17	17	1	1	tamoxifen	CUEDC2	PA451581	79004	0.894
NULL	J_Exp_Clin_Cancer_Res_2009_Jul_3_28(1)_97.nxml.txt.nlp	19575783	SENT149	22	22	4	4	cisplatin	HER2	PA449014	2064	0.894
NULL	Nat_Med_2010_Feb_24_16(2)_214-218.nxml.txt.nlp	20098429	SENT72	16	16	0	0	cisplatin	LAPTM4B	PA449014	55353	0.894
NULL	Basic_Clin_Neurosci_2014_Winter_5(1)_74-79.nxml.txt.nlp	25436087	SENT85	3	3	10	10	fluoxetine	EPAC	PA449673	10411	0.894
NULL	Infect_Drug_Resist_2010_Mar_11_3_45-51.nxml.txt.nlp	21694893	SENT115	20	20	16	16	astemizole	CYP3A4	PA448498	1576	0.894
NULL	Pharmaceuticals_(Basel)_2011_Jan_28_4(2)_366-381.nxml.txt.nlp	NULL	SENT171	37	37	26	26	naltrexone	ACTH	PA450588	5443	0.894
NULL	Oncol_Lett_2015_Jan_4_9(1)_91-95.nxml.txt.nlp	25435939	SENT73	14	14	8	8	vincristine	NACT	PA451879	284111	0.894
NULL	Oncotarget_2014_Jun_22_5(13)_4581-4602.nxml.txt.nlp	25015035	SENT400	16	16	13	13	doxorubicin	p53	PA449412	7157	0.894
NULL	Front_Physiol_2011_Dec_20_2_103.nxml.txt.nlp	22194726	SENT300	15	15	0	0	hyaluronan	LYVE-1	PA165958431	10894	0.894
NULL	J_RNAi_Gene_Silencing_2006_Feb_28_2(1)_136-145.nxml.txt.nlp	19771215	SENT183	19	19	0	0	etoposide	Bcl-2	PA449552	596	0.894
NULL	Environ_Health_Perspect_2009_Feb_8_117(2)_175-180.nxml.txt.nlp	19270784	SENT200	21	21	4	4	cisplatin	BPA	PA449014	667	0.894
NULL	Adv_Hematol_2012_May_8_2012_393864.nxml.txt.nlp	22851972	SENT30	5	5	20	20	lenalidomide	AP-1	PA162363968	2353;3727;2354;3725	0.894
NULL	J_Oncol_2013_Apr_29_2013_854121.nxml.txt.nlp	23737784	SENT151	27	27	16	16	trastuzumab	c-Myc	PA451743	4609	0.894
NULL	Cell_Commun_Signal_2009_Feb_26_7(Suppl_1)_A63.nxml.txt.nlp	NULL	SENT19	28	28	13	13	pp2	GRHL3		57822	0.894
NULL	Acta_Pharmacol_Sin_2009_Sep_24_30(9)_1262-1275.nxml.txt.nlp	19701231	SENT173	19	19	11	11	lovastatin	LRH-1	PA450272	2494	0.894
NULL	Br_J_Cancer_2011_Jul_26_105(3)_382-392.nxml.txt.nlp	21750552	SENT134	38	38	19	19	sorafenib	EGFR	PA7000	1956	0.894
NULL	J_Oncol_2010_Apr_8_2010_785934.nxml.txt.nlp	20396391	SENT54	15	15	1	1	pemetrexed	B12	PA10810	7126;4709	0.894
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_P112.nxml.txt.nlp	NULL	SENT19	9	9	12	12	ximelagatran	HLA-DRB1	PA161748474	3123	0.894
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT142	7	7	3	3	sitagliptin	HIP	PA164748978	6767;6159;64399;5068	0.894
NULL	Ann_Med_Health_Sci_Res_2012_Jul-Dec_2(2)_191-198.nxml.txt.nlp	23439914	SENT166	7	7	1	1	valspodar	P-gp		5243	0.894
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_11_2014_274786.nxml.txt.nlp	25505920	SENT251	10	10	36	36	oxaliplatin	ERCC1	PA131285527	2067	0.894
NULL	Cancers_(Basel)_2010_Mar_25_2(2)_209-232.nxml.txt.nlp	24281068	SENT219	32	32	22	22	docetaxel	p53	PA449383	7157	0.894
NULL	Oncogene_2010_Sep_16_29(37)_5193-5203.nxml.txt.nlp	20581867	SENT11	15	15	6	6	lapatinib	HRG	PA152241907	3084;3273	0.894
NULL	Oncotarget_2013_Nov_19_5(2)_309-325.nxml.txt.nlp	24525395	SENT303	32	32	44	44	sorafenib	Hsp90	PA7000	3320	0.894
NULL	Mol_Cancer_2013_Mar_2_12_16.nxml.txt.nlp	23452820	SENT93	31	31	17	17	chloroquine	BECN1	PA448948	8678	0.894
NULL	Arthritis_Res_Ther_2005_Mar_16_7(Suppl_2)_S21-S25.nxml.txt.nlp	15833145	SENT93	27	27	13	13	abatacept	ACR	PA164747080	49	0.894
NULL	AIDS_Res_Ther_2013_Sep_3_10_22.nxml.txt.nlp	24004690	SENT42	9	9	17	17	emtricitabine	CD4	PA10069	920	0.894
NULL	J_Cell_Mol_Med_2014_Feb_8_18(2)_197-207.nxml.txt.nlp	24400890	SENT94	31	31	9	9	ethanol	TLR4	PA448073	7099	0.894
NULL	Int_J_Endocrinol_Metab_2013_Jul_1_Summer_11(3)_184-190.nxml.txt.nlp	24348591	SENT161	19	19	10	10	liraglutide	INS-1	PA165958364	2305	0.894
NULL	Trials_2013_Aug_19_14_261.nxml.txt.nlp	23958221	SENT165	20	20	3	3	carboplatin	HER2	PA448803	2064	0.894
NULL	Mol_Cancer_2009_Jun_8_8_34.nxml.txt.nlp	19500427	SENT233	25	25	5	5	gemcitabine	p53	PA449748	7157	0.894
NULL	Acta_Pharmacol_Sin_2009_Jul_22_30(7)_956-964.nxml.txt.nlp	19543298	SENT5	7	7	27	27	atorvastatin	SLCO2B1	PA448500	11309	0.894
NULL	Cardiovasc_Ultrasound_2009_Feb_7_7_5.nxml.txt.nlp	19200398	SENT73	6	6	14	14	dobutamine	ANOVA	PA449381	4858	0.894
NULL	Indian_J_Dermatol_2008_53(3)_149-153.nxml.txt.nlp	19882018	SENT64	6	6	22	22	isoniazid	EMB	PA450112	133418	0.894
NULL	Braz_J_Med_Biol_Res_2012_Jul_27_45(10)_948-954.nxml.txt.nlp	22832600	SENT15	0	0	3	3	fluoxetine	5-HT4	PA449673	3360	0.894
NULL	Environ_Health_Perspect_2013_Oct_1_121(10)_A298-A303.nxml.txt.nlp	24218659	SENT151	18	18	20	20	diethylstilbestrol	DES	PA449307	1674	0.894
NULL	Gene_Regul_Syst_Bio_2014_Mar_4_8_63-73.nxml.txt.nlp	24634581	SENT136	11	11	4	4	minocycline	MT1-MMP	PA450519	4323	0.894
NULL	J_Int_Soc_Sports_Nutr_2010_Feb_4_7_9.nxml.txt.nlp	20205771	SENT36	27	27	13	13	trypsin	CO2	PA451806	4513	0.894
NULL	Cancer_Microenviron_2009_Sep_26_2(Suppl_1)_19-204.nxml.txt.nlp	NULL	SENT6591	0	0	10	10	docetaxel	MDR1	PA449383	5243	0.894
NULL	Braz_J_Med_Biol_Res_2013_Feb_1_46(2)_171-177.nxml.txt.nlp	23369979	SENT146	23	23	26	26	enalapril	IL-10	PA449456	3586	0.894
NULL	Gene_Ther_2010_Aug_1_17(8)_1042-1051.nxml.txt.nlp	20596059	SENT18	0	0	12	12	bevacizumab	VEGF-A	PA130232992	7422	0.894
NULL	Mol_Cancer_2010_Aug_20_9_220.nxml.txt.nlp	20727180	SENT137	8	8	15	15	nicotine	p53	PA450626	7157	0.894
NULL	Cancers_(Basel)_2014_May_16_6(2)_1180-1194.nxml.txt.nlp	24840048	SENT125	12	12	28	28	pazopanib	VEGFR	PA165291492	3791	0.894
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1126-1134.nxml.txt.nlp	21364592	SENT23	17	17	33	33	tegafur	CYP2A6	PA452620	1548	0.894
NULL	Mol_Cancer_2010_May_18_9_110.nxml.txt.nlp	20482802	SENT159	8	8	45	45	bortezomib	CHOP	PA10252	1649	0.894
NULL	Oncotarget_2012_Oct_20_3(10)_1068-1111.nxml.txt.nlp	23085539	SENT849	28	28	19	19	paclitaxel	EGFR	PA450761	1956	0.894
NULL	Environ_Health_Perspect_2006_Sep_23_114(9)_1401-1406.nxml.txt.nlp	16966095	SENT39	9	9	25	25	arsenite	p53	PA452638	7157	0.894
NULL	J_Cell_Biol_1978_Jun_1_77(3)_774-788.nxml.txt.nlp	308066	SENT6	25	25	7	7	thrombin	EGF	PA451674	1950	0.894
NULL	Gene_Regul_Syst_Bio_2014_Mar_4_8_63-73.nxml.txt.nlp	24634581	SENT121	2	2	10	10	minocycline	STAT3	PA450519	6774	0.894
NULL	J_Oncol_2012_Feb_6_2012_737981.nxml.txt.nlp	22481932	SENT83	24	24	6	6	cyclophosphamide	MUC16	PA449165	94025	0.894
NULL	Breast_Cancer_Res_2004_Aug_5_6(5)_R601-R607.nxml.txt.nlp	15318941	SENT131	20	20	28	28	teniposide	p27	PA451611	5715;10534	0.894
NULL	Diabetes_2011_Jun_21_60(6)_1770-1778.nxml.txt.nlp	21562078	SENT202	10	10	6	6	metformin	AMPK	PA450395	5563	0.894
NULL	J_Korean_Med_Sci_2009_Oct_24_24(5)_910-917.nxml.txt.nlp	19794992	SENT156	26	26	8	8	trastuzumab	HER2	PA451743	2064	0.894
NULL	Int_J_Genomics_2014_Jan_30_2014_820248.nxml.txt.nlp	24616890	SENT176	18	18	26	26	cisplatin	MSH2	PA449014	4436	0.894
NULL	Biosci_Rep_2012_Aug_1_32(Pt_4)_361-374.nxml.txt.nlp	22762204	SENT164	30	30	3	3	carboplatin	BRCA1	PA448803	672	0.894
NULL	Br_J_Haematol_2014_Mar_13_164(1)_811-821.nxml.txt.nlp	24328678	SENT162	9	9	2	2	lenalidomide	Aiolos	PA162363968	22806	0.894
NULL	Cell_Cycle_2013_Feb_15_12(4)_625-634.nxml.txt.nlp	23324396	SENT188	10	10	1	1	doxycycline	p53	PA449415	7157	0.894
NULL	J_Hematol_Oncol_2013_Jun_3_6_38.nxml.txt.nlp	23731980	SENT55	23	23	31	31	doxorubicin	HER2	PA449412	2064	0.894
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT189	17	17	4	4	tacrolimus	STAT3	PA451578	6774	0.894
NULL	Oncoimmunology_2013_Mar_1_2(3)_e24567.nxml.txt.nlp	23802090	SENT11	5	5	23	23	trastuzumab	DM1	PA451743	338023;1760;28509	0.894
NULL	J_Invest_Dermatol_2014_Jul_31_134(7)_1903-1911.nxml.txt.nlp	24487305	SENT60	6	6	17	17	chloroquine	IL-9	PA448948	3578	0.894
NULL	Angiogenesis_2010_Dec_7_13(4)_305-315.nxml.txt.nlp	20927579	SENT182	12	12	2	2	resveratrol	THBS1		7057	0.894
NULL	Int_J_Endocrinol_2010_Mar_2_2010_621687.nxml.txt.nlp	20204178	SENT123	19	19	33	33	paricalcitol	PTH	PA450798	5741	0.894
NULL	Clin_Mol_Allergy_2011_Jul_26_9_11.nxml.txt.nlp	21791043	SENT13	18	18	5	5	omalizumab	CD4	PA164752253	920	0.894
NULL	Int_J_Mol_Sci_2012_Feb_1_13(2)_1512-1523.nxml.txt.nlp	22408405	SENT62	20	20	25	25	olmesartan	LOX-1	PA164742950	4973	0.894
NULL	Curr_Pharm_Des_2012_Apr_18(10)_1434-1445.nxml.txt.nlp	22300258	SENT225	11	11	42	42	ezetimibe	NPC1	PA10816	4864	0.894
NULL	Blood_Cancer_J_2012_Sep_7_2(9)_e89.nxml.txt.nlp	22961061	SENT68	24	24	44	44	thalidomide	FGFR3	PA451644	2261	0.894
NULL	Cancer_Imaging_2005_Nov_23_5(Spec_No_A)_S113-S119.nxml.txt.nlp	16361126	SENT94	14	14	1	1	rituximab	CHOP	PA451261	1649	0.894
NULL	Front_Neuroengineering_2008_Dec_12_1_2.nxml.txt.nlp	19129909	SENT105	6	6	24	24	nadh	GDH	PA164755085	51084;2746	0.894
NULL	Cell_Death_Dis_2013_Oct_3_4(10)_e828.nxml.txt.nlp	24091671	SENT91	29	29	10	10	cetuximab	CD44	PA10040	960	0.894
NULL	ISRN_AIDS_2014_Apr_10_2014_674906.nxml.txt.nlp	25006528	SENT108	15	15	18	18	etravirine	DUET	PA166014703	8997	0.894
NULL	Toxins_(Basel)_2010_Oct_28_2(11)_2584-2592.nxml.txt.nlp	22069565	SENT264	19	19	10	10	acenocoumarol	CYP2C9	PA452632	1559	0.894
NULL	J_Biomed_Sci_2012_Nov_21_19(1)_99.nxml.txt.nlp	23170833	SENT162	8	8	15	15	atorvastatin	CXCR4	PA448500	7852	0.894
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT106	13	13	41	41	celecoxib	IL-6	PA448871	3569	0.894
NULL	Breast_Cancer_Res_2010_Jul_22_12(4)_R53.nxml.txt.nlp	20649975	SENT163	2	2	18	18	estradiol	aromatase	PA449503	1588	0.894
NULL	Drug_Des_Devel_Ther_2014_Oct_31_8_2121-2128.nxml.txt.nlp	25382970	SENT87	24	24	19	19	curcumin	LC3	PA151958596	84557	0.894
NULL	Evid_Based_Complement_Alternat_Med_2011_Feb_14_2011_429843.nxml.txt.nlp	21869897	SENT103	38	38	34	34	ethanol	CEA	PA448073	5670;1087	0.894
NULL	BMJ_2009_Feb_25_338_b438.nxml.txt.nlp	19244302	SENT47	14	14	10	10	exemestane	aromatase	PA449563	1588	0.894
NULL	Clin_Med_Insights_Cardiol_2011_Oct_6_5_103-119.nxml.txt.nlp	22084608	SENT40	41	41	34	34	dronedarone	CYP3A4	PA153619853	1576	0.894
NULL	Curr_Pharm_Des_2011_Feb_17(6)_578-590.nxml.txt.nlp	21391908	SENT177	31	31	14	14	nutlin-3	p53		7157	0.894
NULL	Mol_Pain_2013_Jun_10_9_27.nxml.txt.nlp	23758830	SENT13	17	17	3	3	tetracaine	ASIC3	PA451638	9311	0.894
NULL	Cancer_Med_2014_Aug_6_3(4)_988-997.nxml.txt.nlp	24905030	SENT187	13	13	6	6	cetuximab	IGF1R	PA10040	3480	0.894
NULL	Eur_J_Clin_Pharmacol_2012_Jan_8_68(1)_29-37.nxml.txt.nlp	21739267	SENT187	12	12	6	6	fluoxetine	CYP2C19	PA449673	1557	0.894
NULL	Springerplus_2014_Sep_17_3_535.nxml.txt.nlp	25279326	SENT153	15	15	5	5	exemestane	aromatase	PA449563	1588	0.894
NULL	Aging_(Albany_NY)_2010_Jul_17_2(7)_415-431.nxml.txt.nlp	20634564	SENT25	0	0	10	10	resveratrol	SIRT1		23411	0.894
NULL	Oncotarget_2014_Jun_8_5(13)_5040-5053.nxml.txt.nlp	24970815	SENT218	28	28	2	2	cisplatin	BBC3	PA449014	27113	0.894
NULL	Nat_Commun_2014_Nov_21_5_5383.nxml.txt.nlp	25415230	SENT773	19	19	6	6	bicalutamide	NEAT1	PA164746255	283131	0.894
NULL	Front_Immunol_2012_Jun_11_3_144.nxml.txt.nlp	22701453	SENT191	6	6	15	15	imiquimod	IFN	PA449972	3439	0.894
NULL	Cancer_Cell_Int_2009_Sep_10_9_25.nxml.txt.nlp	19744341	SENT169	6	6	11	11	glucosamine	STAT3	PA164747613	6774	0.894
NULL	Diabetes_2008_Oct_57(10)_2784-2793.nxml.txt.nlp	18599521	SENT132	4	4	11	11	simvastatin	Rho	PA451363	29984	0.894
NULL	Mol_Biol_Cell_2012_Nov_1_23(21)_4188-4202.nxml.txt.nlp	22973054	SENT269	7	7	17	17	forskolin	IL-8	PA146096022	3576	0.894
NULL	ASN_Neuro_2009_Aug_26_1(3)_e00015.nxml.txt.nlp	19663807	SENT239	39	39	32	32	thrombin	MT1-MMP	PA451674	4323	0.894
NULL	J_Mol_Signal_2012_May_14_7_4.nxml.txt.nlp	22583680	SENT188	3	3	16	16	rolipram	AKAP5	PA153906323	9495	0.894
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT146	7	7	15	15	curcumin	TRAIL	PA151958596	8743	0.894
NULL	Cell_Death_Dis_2012_Nov_15_3(11)_e422.nxml.txt.nlp	23152058	SENT11	27	27	3	3	cisplatin	GPX1	PA449014	2876	0.894
NULL	Ther_Clin_Risk_Manag_2006_Sep_2(3)_235-249.nxml.txt.nlp	18360599	SENT303	14	14	8	8	alendronate	PTH	PA448082	5741	0.894
NULL	J_Med_Case_Reports_2011_Feb_27_5_84.nxml.txt.nlp	21352580	SENT27	4	4	11	11	bevacizumab	San	PA130232992	80218	0.894
NULL	AIDS_Res_Treat_2013_Mar_7_2013_249171.nxml.txt.nlp	23533730	SENT135	13	13	26	26	stavudine	MDC	PA451494	6367	0.894
NULL	Clin_Interv_Aging_2009_May_14_4_197-205.nxml.txt.nlp	19503782	SENT188	19	19	11	11	idarubicin	IL-11	PA449961	3589	0.894
NULL	Br_J_Cancer_2011_Jul_26_105(3)_382-392.nxml.txt.nlp	21750552	SENT47	39	39	21	21	sorafenib	EGFR	PA7000	1956	0.894
NULL	Anc_Sci_Life_2011_Jan-Mar_30(3)_78-83.nxml.txt.nlp	22557432	SENT9	31	31	18	18	diazepam	ASM	PA449283	6609;283120	0.894
NULL	Curr_Neuropharmacol_2008_Jun_6(2)_125-150.nxml.txt.nlp	19305793	SENT759	8	8	17	17	naloxone	ORL1	PA450586	4987	0.894
NULL	J_Med_Case_Reports_2011_Oct_21_5_518.nxml.txt.nlp	22017919	SENT72	4	4	21	21	thrombin	HAP	PA451674	5915;10313	0.894
NULL	Breast_Cancer_Res_Treat_2014_Nov_11_148(3)_563-570.nxml.txt.nlp	25385180	SENT58	3	3	10	10	trastuzumab	PTH	PA451743	5741	0.894
NULL	Evid_Based_Complement_Alternat_Med_2013_Aug_12_2013_982689.nxml.txt.nlp	23997806	SENT232	15	15	6	6	tolbutamide	APE	PA451718	55704;328	0.894
NULL	Front_Endocrinol_(Lausanne)_2014_Feb_25_5_22.nxml.txt.nlp	24611062	SENT110	12	12	5	5	estradiol	PTEN	PA449503	5728	0.894
NULL	Oncogene_2010_Mar_11_29(10)_1509-1518.nxml.txt.nlp	19946334	SENT160	7	7	4	4	tamoxifen	aromatase	PA451581	1588	0.894
NULL	Oncogene_2014_Apr_3_33(14)_1828-1839.nxml.txt.nlp	23624914	SENT158	9	9	3	3	doxycycline	survivin	PA449415	332	0.894
NULL	Genet_Mol_Biol_2009_Mar_1_Jan-Mar_32(1)_144-150.nxml.txt.nlp	21637660	SENT125	19	19	26	26	etoposide	RUNX1	PA449552	861	0.894
NULL	Acta_Pharmacol_Sin_2013_Jun_8_34(6)_830-836.nxml.txt.nlp	23564080	SENT134	14	14	2	2	simvastatin	HMGB1	PA451363	3146	0.894
NULL	Cell_Commun_Signal_2013_Oct_3_11_76.nxml.txt.nlp	24090154	SENT212	10	10	23	23	doxycycline	PARP-1	PA449415	25976	0.894
NULL	J_Gynecol_Oncol_2013_Jul_4_24(3)_273-279.nxml.txt.nlp	23875078	SENT124	14	14	7	7	doxorubicin	MDR1	PA449412	5243	0.894
NULL	Nat_Chem_Biol_2013_Feb_9_9(2)_112-118.nxml.txt.nlp	23222885	SENT124	24	24	16	16	geldanamycin	Hsp90	PA152031327	3320	0.894
NULL	Appl_Microbiol_Biotechnol_2014_Feb_18_98(8)_3829-3840.nxml.txt.nlp	24535257	SENT35	24	24	7	7	ethanol	PE-2	PA448073	2077	0.894
NULL	J_Int_Soc_Sports_Nutr_2009_Feb_19_6_6.nxml.txt.nlp	19228401	SENT165	8	8	27	27	creatine	CEE	PA164778930	51608	0.894
NULL	Int_J_Mol_Sci_2014_Oct_27_15(11)_19516-19534.nxml.txt.nlp	25350114	SENT688	3	3	1	1	ekb-569	EGFR		1956	0.894
NULL	Cancer_Cell_Int_2010_Sep_9_10_32.nxml.txt.nlp	20828393	SENT52	16	16	5	5	cisplatin	ATF3	PA449014	467	0.894
NULL	Cancer_Cell_Int_2006_Aug_9_6_20.nxml.txt.nlp	16899133	SENT186	17	17	27	27	l-methionine	p27	PA450423	5715;10534	0.894
NULL	Oxid_Med_Cell_Longev_2012_Jan_19_2012_390678.nxml.txt.nlp	22315655	SENT162	4	4	6	6	gliclazide	NAC	PA10892	22861	0.894
NULL	Front_Oncol_2014_Jun_18_4_153.nxml.txt.nlp	24995158	SENT537	34	34	27	27	noscapine	c-Jun		3725	0.894
NULL	Mol_Cancer_2008_Mar_6_7_24.nxml.txt.nlp	18325101	SENT74	37	37	16	16	cisplatin	FANCD2	PA449014	2177	0.894
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Oct_28_65(Pt_11)_o2898.nxml.txt.nlp	21578480	SENT59	23	23	13	13	vanillin	mol	PA451852	90527	0.894
NULL	Leukemia_2013_Jan_11_27(1)_32-40.nxml.txt.nlp	22781593	SENT234	19	19	32	32	ponatinib	BBC2	PA165980594	572	0.894
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1542-1553.nxml.txt.nlp	21970874	SENT226	27	27	6	6	carboplatin	EGFR	PA448803	1956	0.894
NULL	J_Immunol_Res_2014_Jul_21_2014_297073.nxml.txt.nlp	25143957	SENT232	21	21	13	13	hydrocortisone	HLA-G	PA449905	3135	0.894
NULL	Cancers_(Basel)_2010_May_26_2(2)_913-954.nxml.txt.nlp	24281100	SENT2943	23	23	8	8	cyclophosphamide	p53	PA449165	7157	0.894
NULL	Oncoimmunology_2014_May_29_3_e28925.nxml.txt.nlp	25083322	SENT7	0	0	10	10	dasatinib	CD4	PA162372878	920	0.894
NULL	Biologics_2009_Jul_13_3_289-301.nxml.txt.nlp	19707416	SENT213	17	17	24	24	vinorelbine	HER2	PA451881	2064	0.894
NULL	J_Mol_Signal_2009_Sep_2_4_6.nxml.txt.nlp	19725972	SENT41	21	21	4	4	ethanol	RCAN1	PA448073	1827	0.894
NULL	Br_J_Cancer_2010_Mar_16_102(6)_1003-1009.nxml.txt.nlp	20179710	SENT134	10	10	15	15	cyclophosphamide	CYP2C19	PA449165	1557	0.894
NULL	Int_J_Endocrinol_Metab_2013_Dec_21_Winter_11(1)_57-61.nxml.txt.nlp	23853622	SENT52	0	0	12	12	bromocriptine	PRL	PA448671	5617	0.894
NULL	Cancer_Med_2013_Dec_2_2(6)_881-888.nxml.txt.nlp	24403261	SENT215	9	9	5	5	panitumumab	KRAS	PA162373091	3845	0.894
NULL	Sci_Rep_2014_Dec_12_4_7467.nxml.txt.nlp	25502280	SENT330	4	4	17	17	taurine	NF-kappaB	PA451590	4790	0.894
NULL	Int_J_Biochem_Cell_Biol_2013_Aug_45(8)_1776-1783.nxml.txt.nlp	23726972	SENT59	8	8	0	0	fluvastatin	Rho	PA449688	29984	0.894
NULL	Mol_Cancer_2014_Jun_19_13_154.nxml.txt.nlp	24941944	SENT13	40	40	21	21	temozolomide	NRAS	PA451609	4893	0.894
NULL	J_Cell_Biol_1997_Jun_30_137(7)_1663-1681.nxml.txt.nlp	9199179	SENT197	14	14	3	3	trypsin	RGDS	PA451806	5900	0.894
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_P104.nxml.txt.nlp	NULL	SENT18	8	8	1	1	darunavir	DPT	PA163522472	1805	0.894
NULL	Arch_Gynecol_Obstet_2012_May_30_285(5)_1447-1453.nxml.txt.nlp	22127553	SENT9	3	3	0	0	paclitaxel	TEC	PA450761	7006	0.894
NULL	J_Hematol_Oncol_2009_Jan_21_2_2.nxml.txt.nlp	19159467	SENT57	26	26	5	5	cetuximab	EGFR	PA10040	1956	0.894
NULL	Biomed_Res_Int_2013_Jan_16_2013_937936.nxml.txt.nlp	23509814	SENT139	12	12	23	23	sirolimus	MCP-1	PA451365	6347	0.894
NULL	Neural_Dev_2012_Dec_8_7_39.nxml.txt.nlp	23217170	SENT306	5	5	13	13	tamoxifen	E12	PA451581	64100	0.894
NULL	Oncol_Rep_2012_Apr_12_27(4)_1027-1034.nxml.txt.nlp	22245869	SENT156	25	25	15	15	paclitaxel	AKT2	PA450761	208	0.894
NULL	Adv_Hematol_2010_Dec_30_2010_627401.nxml.txt.nlp	21234094	SENT107	12	12	6	6	vincristine	CHOP	PA451879	1649	0.894
NULL	Br_J_Cancer_2012_Nov_6_107(10)_1714-1721.nxml.txt.nlp	23073173	SENT114	27	27	9	9	bicalutamide	RUNX2	PA164746255	860	0.894
NULL	Front_Neural_Circuits_2014_Apr_23_8_37.nxml.txt.nlp	24795570	SENT172	1	1	24	24	tamoxifen	STOP	PA451581	4135	0.894
NULL	Hum_Genomics_2010_Oct_1_5(1)_61-72.nxml.txt.nlp	21106490	SENT87	17	17	14	14	midazolam	CYP3A4	PA450496	1576	0.894
NULL	Oncogene_2010_Sep_16_29(37)_5159-5170.nxml.txt.nlp	20562917	SENT217	9	9	3	3	gefitinib	BRAK	PA131301952	9547	0.894
NULL	Biologics_2012_Jul_26_6_233-244.nxml.txt.nlp	22904615	SENT253	9	9	13	13	olaparib	BRCA1		672	0.894
NULL	Cancer_Immunol_Immunother_2012_Jan_17_61(1)_79-88.nxml.txt.nlp	21847632	SENT232	10	10	19	19	berberine	AP-1	PA165860812	2353;3727;2354;3725	0.894
NULL	Int_J_Mol_Sci_2014_Oct_10_15(10)_18221-18252.nxml.txt.nlp	25310649	SENT323	20	20	26	26	agomelatine	5-HT2C	PA165958363	3358	0.894
NULL	Oncotarget_2011_Dec_31_2(12)_1314-1321.nxml.txt.nlp	22248929	SENT140	13	13	2	2	lapatinib	HER3	PA152241907	2065	0.894
NULL	J_Biomed_Biotechnol_2010_Jun_6_2010_571343.nxml.txt.nlp	20625496	SENT188	16	16	2	2	cisplatin	HSPD1	PA449014	3329	0.894
NULL	Angiogenesis_2012_Dec_28_15(4)_623-641.nxml.txt.nlp	22843200	SENT167	26	26	41	41	sunitinib	NG2	PA162372840	1464;6048	0.894
NULL	Oncoscience_2014_Mar_12_1(2)_158-166.nxml.txt.nlp	25594008	SENT62	14	14	10	10	dasatinib	PTRF	PA162372878	284119	0.894
NULL	Front_Neurol_2013_May_15_4_53.nxml.txt.nlp	23720649	SENT266	11	11	1	1	geldanamycin	Hsp90	PA152031327	3320	0.894
NULL	Dement_Geriatr_Cogn_Dis_Extra_2014_Nov_15_4(3)_450-456.nxml.txt.nlp	25538729	SENT89	21	21	15	15	donepezil	APOE	PA449394	348	0.894
NULL	Breast_Cancer_(Dove_Med_Press)_2013_Aug_22_5_73-78.nxml.txt.nlp	24648760	SENT4	16	16	13	13	tamoxifen	UGT2B7	PA451581	7364	0.894
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT142	18	18	10	10	sulindac	survivin	PA451565	332	0.894
NULL	Acta_Pharmacol_Sin_2013_Sep_5_34(9)_1208-1216.nxml.txt.nlp	23852087	SENT122	21	21	11	11	disulfiram	HIF-1	PA449376	29072	0.893
NULL	Blood_Res_2014_Sep_25_49(3)_148-153.nxml.txt.nlp	25325033	SENT47	45	45	15	15	cytarabine	B2M	PA449177	567	0.893
NULL	Clin_Pharmacol_2013_Apr_19_5_67-83.nxml.txt.nlp	23650452	SENT4	10	10	15	15	ticagrelor	P2Y12	PA165374673	64805	0.893
NULL	Front_Immunol_2013_Mar_8_4_50.nxml.txt.nlp	23483669	SENT200	9	9	12	12	metformin	NLRP3	PA450395	114548	0.893
NULL	Respir_Med_Case_Rep_2013_Aug_8_10_27-30.nxml.txt.nlp	NULL	SENT46	4	4	17	17	everolimus	DLST	PA164746311	1743	0.893
NULL	Acta_Pharmacol_Sin_2010_Sep_2_31(9)_1172-1180.nxml.txt.nlp	20676117	SENT182	6	6	12	12	bsi-201	PARP1		142	0.893
NULL	Acta_Pharmacol_Sin_2014_Sep_4_35(9)_1157-1166.nxml.txt.nlp	25088002	SENT102	15	15	20	20	curcumin	p300	PA151958596	2033	0.893
NULL	Br_J_Haematol_2014_Mar_13_164(1)_811-821.nxml.txt.nlp	24328678	SENT259	15	15	0	0	lenalidomide	Aiolos	PA162363968	22806	0.893
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Feb_17_68(Pt_3)_o712-o713.nxml.txt.nlp	22412597	SENT79	24	24	7	7	ethanol	mol	PA448073	90527	0.893
NULL	FEBS_Open_Bio_2014_Oct_22_4_905-914.nxml.txt.nlp	25383314	SENT162	19	19	6	6	atropine	L-FABP	PA448505	2168	0.893
NULL	Br_J_Pharmacol_2013_Jun_27_169(4)_736-747.nxml.txt.nlp	23489111	SENT105	13	13	4	4	granisetron	5-HT3B	PA449809	9177	0.893
NULL	Drug_Target_Insights_2007_Mar_6_2_71-81.nxml.txt.nlp	21901064	SENT160	7	7	4	4	verapamil	P-gp	PA451868	5243	0.893
NULL	Front_Neurosci_2011_Dec_5_5_131.nxml.txt.nlp	22164129	SENT95	26	26	6	6	allopregnanolone	TSPO	PA142320763	706	0.893
NULL	Cancers_(Basel)_2010_Dec_30_3(1)_106-125.nxml.txt.nlp	24212609	SENT23	20	20	12	12	gemcitabine	CNT3	PA449748	64078	0.893
NULL	Korean_J_Anesthesiol_2013_Jan_21_64(1)_54-60.nxml.txt.nlp	23372887	SENT163	4	4	27	27	hydrocortisone	CRT	PA449905	811	0.893
NULL	Case_Rep_Oncol_2010_Apr_22_3(2)_98-105.nxml.txt.nlp	20740181	SENT54	14	14	22	22	erlotinib	EGFR	PA134687924	1956	0.893
NULL	Front_Immunol_2013_Nov_7_4_360.nxml.txt.nlp	24223576	SENT181	7	7	0	0	imiquimod	IL-6	PA449972	3569	0.893
NULL	Breast_Cancer_Res_2011_Feb_23_13(1)_203.nxml.txt.nlp	21392408	SENT107	21	21	35	35	tamoxifen	aromatase	PA451581	1588	0.893
NULL	Drugs_Aging_2014_May_6_31(6)_413-424.nxml.txt.nlp	24797286	SENT37	0	0	15	15	denosumab	RANK	PA166048634	8792	0.893
NULL	Allergy_Asthma_Immunol_Res_2014_Nov_19_6(6)_548-557.nxml.txt.nlp	25374755	SENT18	5	5	14	14	lovastatin	CCL24	PA450272	6369	0.893
NULL	Nutr_J_2014_Jan_24_13_11.nxml.txt.nlp	24461029	SENT137	15	15	42	42	curcumin	CTR	PA151958596	799	0.893
NULL	Oncotarget_2013_Mar_23_4(3)_463-473.nxml.txt.nlp	23531874	SENT186	31	31	35	35	erlotinib	EGFR	PA134687924	1956	0.893
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_May_29_65(Pt_6)_o1402.nxml.txt.nlp	21583247	SENT60	26	26	7	7	ethanol	mol	PA448073	90527	0.893
NULL	Oncogene_2009_Feb_5_28(5)_742-751.nxml.txt.nlp	19043454	SENT116	13	13	10	10	doxorubicin	TOP2A	PA449412	7153	0.893
NULL	Nat_Commun_2013_Apr_9_4_1684.nxml.txt.nlp	23575688	SENT125	15	15	11	11	forskolin	JNK2	PA146096022	5601	0.893
NULL	Drug_Target_Insights_2012_Aug_6_6_19-39.nxml.txt.nlp	22915839	SENT113	19	19	12	12	doxorubicin	Hsp90	PA449412	3320	0.893
NULL	Oncologist_2010_Sep_26_15(9)_944-953.nxml.txt.nlp	20798196	SENT23	22	22	38	38	letrozole	HER-2	PA450196	2064	0.893
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_May_23_65(Pt_6)_o1364-o1365.nxml.txt.nlp	21583215	SENT4	3	3	30	30	metoprolol	mol	PA450480	90527	0.893
NULL	Br_J_Cancer_1981_Aug_44(2)_201-207.nxml.txt.nlp	6168277	SENT4	6	6	8	8	bleomycin	BLM	PA448645	641	0.893
NULL	Int_J_Mol_Sci_2012_Sep_26_13(10)_12336-12348.nxml.txt.nlp	23202901	SENT58	6	6	23	23	phenol	P90	PA450913	821	0.893
NULL	Int_J_Mol_Sci_2014_Nov_4_15(11)_20054-20071.nxml.txt.nlp	25375189	SENT725	0	0	10	10	berberine	Rho	PA165860812	29984	0.893
NULL	J_Biol_Chem_2009_Jul_24_284(30)_20011-20021.nxml.txt.nlp	19473976	SENT193	29	29	4	4	trypsin	MCT1	PA451806	6566	0.893
NULL	Int_J_Med_Sci_2015_Jan_1_12(1)_63-71.nxml.txt.nlp	25552920	SENT119	15	15	19	19	berberine	PC-3	PA165860812	692094	0.893
NULL	Breast_Cancer_Res_2006_Nov_6_8(6)_215.nxml.txt.nlp	17096862	SENT74	28	28	6	6	trastuzumab	HER2	PA451743	2064	0.893
NULL	Angiogenesis_2012_Dec_28_15(4)_623-641.nxml.txt.nlp	22843200	SENT167	26	26	36	36	sunitinib	CD31	PA162372840	5175	0.893
NULL	Mol_Cancer_2012_Dec_12_11_91.nxml.txt.nlp	23234355	SENT83	13	13	6	6	erlotinib	EGFR	PA134687924	1956	0.893
NULL	Nanoscale_Res_Lett_2010_Feb_11_5(4)_761-768.nxml.txt.nlp	20672132	SENT46	22	22	4	4	ethanol	TEM	PA448073	64102	0.893
NULL	Br_J_Cancer_2012_May_8_106(10)_1638-1647.nxml.txt.nlp	22498643	SENT59	5	5	19	19	deferoxamine	HIF-1	PA164746490	29072	0.893
NULL	Angiogenesis_2012_Sep_27_15(3)_361-376.nxml.txt.nlp	22451299	SENT155	3	3	24	24	resveratrol	CXCL1		2919	0.893
NULL	BMB_Rep_2013_Aug_46(8)_410-415.nxml.txt.nlp	23977989	SENT6	0	0	34	34	curcumin	HO-1	PA151958596	3162	0.893
NULL	Arthritis_Res_Ther_2014_Sep_26_16(5)_429.nxml.txt.nlp	25606593	SENT106	0	0	16	16	tocilizumab	ADAMTS5	PA165292659	11096	0.893
NULL	Exp_Ther_Med_2012_Sep_12_4(3)_475-480.nxml.txt.nlp	23181121	SENT163	12	12	6	6	vincristine	CHOP	PA451879	1649	0.893
NULL	Onco_Targets_Ther_2014_Sep_9_7_1571-1582.nxml.txt.nlp	25228815	SENT105	4	4	2	2	sunitinib	VEGFR1	PA162372840	2321	0.893
NULL	Breast_Cancer_Res_2011_May_26_13(3)_209.nxml.txt.nlp	21635709	SENT12	14	14	8	8	tamoxifen	aromatase	PA451581	1588	0.893
NULL	Blood_Cancer_J_2012_Sep_14_2(9)_e90.nxml.txt.nlp	22983433	SENT31	23	23	9	9	bortezomib	CT7	PA10252	9947	0.893
NULL	Indian_J_Anaesth_2011_May-Jun_55(3)_271-273.nxml.txt.nlp	21808400	SENT64	5	5	9	9	diclofenac	COX	PA449293	1351	0.893
NULL	Mol_Cancer_2012_Sep_21_11_72.nxml.txt.nlp	22995644	SENT44	23	23	29	29	imatinib	PRL-3	PA10804	11156	0.893
NULL	Aliment_Pharmacol_Ther_2012_Apr_22_35(7)_745-767.nxml.txt.nlp	22356640	SENT163	33	33	11	11	tegaserod	5-HT4	PA130413154	3360	0.893
NULL	Biol_Proced_Online_2002_Dec_9_4_94-104.nxml.txt.nlp	12734563	SENT123	11	11	21	21	trypsin	mol	PA451806	90527	0.893
NULL	Cancers_(Basel)_2014_Jun_27_6(3)_1363-1381.nxml.txt.nlp	24978438	SENT220	11	11	0	0	melphalan	CD138	PA450354	6382	0.893
NULL	Biochem_Biophys_Res_Commun_2009_May_22_383(1)_63-67.nxml.txt.nlp	19332024	SENT107	28	28	24	24	lipase	CES1	PA450239	1066	0.893
NULL	Breast_Cancer_Res_2008_Jul_24_10(4)_211.nxml.txt.nlp	18671839	SENT81	4	4	24	24	bortezomib	AP-1	PA10252	2353;3727;2354;3725	0.893
NULL	Biologics_2012_Jul_26_6_233-244.nxml.txt.nlp	22904615	SENT253	9	9	15	15	olaparib	BRCA2		675	0.893
NULL	J_Invest_Dermatol_2013_Sep_31_133(9)_2247-2254.nxml.txt.nlp	23370537	SENT67	8	8	14	14	etoposide	PUMA	PA449552	27113	0.893
NULL	Mol_Cell_Biochem_2014_Feb_13_391(1-2)_27-35.nxml.txt.nlp	24522554	SENT238	5	5	12	12	resveratrol	AP-1		2353;3727;2354;3725	0.893
NULL	Clin_Ophthalmol_2011_Apr_18_5_495-502.nxml.txt.nlp	21573098	SENT117	12	12	24	24	gatifloxacin	BAK	PA449738	578	0.893
NULL	Arthritis_Res_Ther_2009_Feb_23_11(1)_216.nxml.txt.nlp	19291269	SENT91	20	20	1	1	etanercept	ACR	PA449515	49	0.893
NULL	J_Mol_Signal_2010_May_10_5_4.nxml.txt.nlp	20459745	SENT111	12	12	3	3	cisplatin	p53	PA449014	7157	0.893
NULL	Mol_Biol_Cell_2012_May_15_23(10)_1928-1942.nxml.txt.nlp	22438580	SENT253	13	13	5	5	galactose	GAL	PA449725	51083	0.893
NULL	Scientifica_(Cairo)_2012_Dec_17_2012_502378.nxml.txt.nlp	24278706	SENT103	29	29	10	10	amiodarone	P-gp	PA448383	5243	0.893
NULL	Ann_Rheum_Dis_2009_Oct_17_68(10)_1580-1584.nxml.txt.nlp	19019888	SENT180	36	36	19	19	tocilizumab	IL-6	PA165292659	3569	0.893
NULL	Oncotarget_2014_Sep_3_5(19)_8879-8892.nxml.txt.nlp	25294809	SENT316	27	27	7	7	etoposide	p53	PA449552	7157	0.893
NULL	Adv_Pharmacol_Sci_2014_Feb_24_2014_809438.nxml.txt.nlp	24707284	SENT298	21	21	40	40	glibenclamide	ANOVA	PA449782	4858	0.893
NULL	Mol_Neurodegener_2011_Aug_8_6_57.nxml.txt.nlp	21819629	SENT251	11	11	17	17	arsenite	TDP-43	PA452638	23435	0.893
NULL	Breast_Cancer_Res_2007_Jun_7_9(3)_R37.nxml.txt.nlp	17555561	SENT23	11	11	5	5	anastrozole	aromatase	PA448432	1588	0.893
NULL	Cell_Cycle_2013_May_15_12(10)_1492-1500.nxml.txt.nlp	23598717	SENT97	20	20	15	15	doxorubicin	ROCK1	PA449412	6093	0.893
NULL	Nature_2012_Apr_25_484(7395)_524-528.nxml.txt.nlp	22538616	SENT128	17	17	7	7	vancomycin	PD1	PA451850	9825;6622;5133	0.893
NULL	J_Mol_Model_2011_Nov_1_17(11)_2973-2987.nxml.txt.nlp	21360176	SENT40	8	8	4	4	paclitaxel	spatial	PA450761	219793	0.893
NULL	Virchows_Arch_2011_Jan_13_458(1)_55-64.nxml.txt.nlp	20941507	SENT230	8	8	12	12	olaparib	BRCA1		672	0.893
NULL	Neuropsychopharmacology_2009_May_22_34(6)_1482-1493.nxml.txt.nlp	18946467	SENT116	5	5	15	15	ethanol	ANOVA	PA448073	4858	0.893
NULL	Cardiovasc_Diabetol_2013_Nov_12_12_169.nxml.txt.nlp	24215514	SENT107	7	7	23	23	candesartan	ANG	PA448765	283	0.893
NULL	Front_Oncol_2013_Apr_29_3_99.nxml.txt.nlp	23641363	SENT16	20	20	30	30	decitabine	IL-2	PA164749631	3558	0.893
NULL	Front_Endocrinol_(Lausanne)_2013_Jun_14_4_72.nxml.txt.nlp	23785354	SENT53	25	25	9	9	estradiol	LOX	PA449503	4015	0.893
NULL	Mol_Biol_Cell_2012_Nov_1_23(21)_4212-4225.nxml.txt.nlp	22956765	SENT172	14	14	1	1	thrombin	SHP2	PA451674	5781	0.893
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT53	38	38	24	24	pertuzumab	HER3		2065	0.893
NULL	J_Invest_Dermatol_2012_Sep_19_132(9)_2198-2205.nxml.txt.nlp	22513780	SENT65	18	18	3	3	isotretinoin	CD4	PA450128	920	0.893
NULL	Cancer_Metastasis_Rev_2010_Dec_10_29(4)_581-594.nxml.txt.nlp	20830503	SENT66	4	4	9	9	tamoxifen	CYP2D6	PA451581	1565	0.893
NULL	Ann_Oncol_2011_Mar_8_22(3)_503-514.nxml.txt.nlp	20616198	SENT191	24	24	9	9	letrozole	aromatase	PA450196	1588	0.893
NULL	Oncoscience_2014_Mar_12_1(2)_158-166.nxml.txt.nlp	25594008	SENT97	21	21	2	2	dasatinib	ANXA1	PA162372878	301	0.893
NULL	Infect_Dis_Ther_2013_Dec_2_2(2)_123-144.nxml.txt.nlp	25134476	SENT271	19	19	4	4	clofazimine	DIP	PA164748759	23151;1831	0.893
NULL	Br_J_Cancer_2012_Aug_21_107(5)_823-830.nxml.txt.nlp	22836512	SENT164	18	18	13	13	gefitinib	EGFR	PA131301952	1956	0.893
NULL	J_Inherit_Metab_Dis_2010_Oct_3_33(5)_625-632.nxml.txt.nlp	20814828	SENT79	2	2	9	9	simvastatin	RhoA	PA451363	387	0.893
NULL	Mol_Cell_Proteomics_2014_May_17_13(5)_1273-1285.nxml.txt.nlp	24637012	SENT233	11	11	0	0	ergotamine	5-HT2A	PA164747651	3356	0.893
NULL	Evid_Based_Complement_Alternat_Med_2013_May_22_2013_921012.nxml.txt.nlp	23762167	SENT125	11	11	4	4	glucose	AMPK	PA449773	5563	0.893
NULL	Open_Microbiol_J_2008_Jun_19_2_89-93.nxml.txt.nlp	19088917	SENT35	36	36	9	9	spectinomycin	SEM1	PA164781342	7979	0.893
NULL	Exp_Diabetes_Res_2012_Jan_29_2012_159874.nxml.txt.nlp	22319521	SENT242	16	16	8	8	telmisartan	Hes1	PA451605	3280	0.893
NULL	Breast_Cancer_Res_2007_Aug_8_9(4)_R50.nxml.txt.nlp	17686159	SENT277	25	25	20	20	gefitinib	EGFR	PA131301952	1956	0.893
NULL	Oncol_Lett_2014_May_11_7(5)_1401-1408.nxml.txt.nlp	24765145	SENT108	3	3	17	17	paclitaxel	PI3K	PA450761	5290	0.893
NULL	Front_Physiol_2013_Jul_24_4_181.nxml.txt.nlp	23898301	SENT242	0	0	4	4	dihydroergotamine	PAG	PA164743028	55824	0.893
NULL	Oncol_Rep_2014_Aug_12_32(2)_469-474.nxml.txt.nlp	24926795	SENT33	16	16	3	3	cisplatin	ATP7B	PA449014	540	0.893
NULL	Mol_Cancer_2008_Jun_30_7_60.nxml.txt.nlp	18590557	SENT168	13	13	22	22	etoposide	TRAIL	PA449552	8743	0.893
NULL	Mol_Cancer_2012_Mar_21_11_13.nxml.txt.nlp	22436134	SENT15	13	13	2	2	doxorubicin	HuR	PA449412	1994	0.893
NULL	Br_J_Cancer_2010_Mar_2_102(5)_815-826.nxml.txt.nlp	20145614	SENT231	26	26	5	5	fluorescein	CD24	PA164746009	100133941	0.893
NULL	Environ_Health_Perspect_2005_Oct_14_113(10)_1330-1335.nxml.txt.nlp	16203242	SENT221	10	10	5	5	phenylephrine	SMC	PA450935	54808	0.893
NULL	Br_J_Cancer_2010_Jan_5_102(1)_80-86.nxml.txt.nlp	19920817	SENT83	19	19	23	23	sunitinib	IFN	PA162372840	3439	0.893
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jun_30_68(Pt_7)_o2275-o2276.nxml.txt.nlp	22798921	SENT10	10	10	4	4	phenol	mol	PA450913	90527	0.893
NULL	Ann_Hematol_2010_Mar_2_89(3)_283-289.nxml.txt.nlp	19727725	SENT153	9	9	22	22	rituximab	CD55	PA451261	1604	0.893
NULL	J_Cancer_Res_Clin_Oncol_2015_Aug_3_141_61-68.nxml.txt.nlp	25086987	SENT21	0	0	30	30	erlotinib	EGFR	PA134687924	1956	0.893
NULL	Bioimpacts_2014_Jun_29_4(2)_55-67.nxml.txt.nlp	25035848	SENT47	3	3	9	9	nadh	ADP	PA164755085	23038	0.893
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT143	16	16	14	14	erlotinib	CYP3A	PA134687924	1574	0.893
NULL	Br_J_Cancer_2010_Mar_2_102(5)_815-826.nxml.txt.nlp	20145614	SENT195	13	13	28	28	tamoxifen	aromatase	PA451581	1588	0.893
NULL	Cancer_Cell_Int_2014_Feb_4_14_13.nxml.txt.nlp	24495648	SENT127	21	21	3	3	doxorubicin	p65	PA449412	5970	0.893
NULL	Semin_Immunopathol_2013_May_10_35(3)_351-373.nxml.txt.nlp	23572207	SENT371	24	24	18	18	bortezomib	XBP1	PA10252	7494	0.893
NULL	Int_J_Vasc_Med_2012_Sep_19_2012_271030.nxml.txt.nlp	21941658	SENT28	8	8	11	11	lipase	APOE	PA450239	348	0.893
NULL	Iran_J_Reprod_Med_2014_Apr_12(4)_257-262.nxml.txt.nlp	24976820	SENT31	29	29	7	7	protamine	TNP2	PA10366	7142	0.893
NULL	Ann_Rheum_Dis_2010_Oct_27_70(2)_299-304.nxml.txt.nlp	20980704	SENT108	18	18	11	11	infliximab	FCGR3B	PA452639	2215	0.893
NULL	Front_Physiol_2011_Jun_30_2_33.nxml.txt.nlp	21747769	SENT230	0	0	7	7	berberine	KCNQ1	PA165860812	3784	0.893
NULL	Oncotarget_2011_Jun_15_2(6)_518-524.nxml.txt.nlp	21680956	SENT96	3	3	5	5	pyrimethamine	STAT3	PA451193	6774	0.893
NULL	J_Thromb_Haemost_2014_May_22_12(5)_748-760.nxml.txt.nlp	24612393	SENT160	15	15	17	17	abciximab	RGDS	PA448006	5900	0.893
NULL	Front_Neurosci_2011_Feb_22_5_20.nxml.txt.nlp	21373362	SENT966	10	10	4	4	cyclophosphamide	fractalkine	PA449165	6376	0.893
NULL	Front_Oncol_2013_Sep_23_3_250.nxml.txt.nlp	24069582	SENT114	5	5	22	22	anastrozole	aromatase	PA448432	1588	0.893
NULL	Front_Immunol_2012_May_7_3_101.nxml.txt.nlp	22783250	SENT244	3	3	17	17	papain	IL-13	PA450778	3596	0.893
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Dec_4_67(Pt_1)_o32.nxml.txt.nlp	21522744	SENT58	23	23	17	17	ethanol	mol	PA448073	90527	0.893
NULL	Iran_Red_Crescent_Med_J_2014_Sep_5_16(9)_e20153.nxml.txt.nlp	25593732	SENT12	2	2	18	18	enflurane	CYP2E1	PA449461	1571	0.893
NULL	Braz_J_Med_Biol_Res_2012_Jul_27_45(10)_948-954.nxml.txt.nlp	22832600	SENT117	0	0	13	13	tegaserod	5-HT4	PA130413154	3360	0.893
NULL	Cell_Cycle_2013_May_1_12(9)_1371-1384.nxml.txt.nlp	23574725	SENT18	16	16	26	26	metformin	MCT4	PA450395	9122;9123	0.893
NULL	Cell_Death_Dis_2014_Feb_13_5(2)_e1055.nxml.txt.nlp	24525731	SENT93	22	22	10	10	cisplatin	TXNL1	PA449014	9352	0.893
NULL	Cell_Cycle_2012_Nov_15_11(22)_4111.nxml.txt.nlp	23099921	SENT12	30	30	8	8	cisplatin	DNA2	PA449014	1763	0.893
NULL	J_Young_Pharm_2010_Oct-Dec_2(4)_428-429.nxml.txt.nlp	21264109	SENT5	8	8	35	35	metformin	B12	PA450395	7126;4709	0.893
NULL	Cancer_Metab_2013_Dec_23_1_23.nxml.txt.nlp	24359630	SENT153	21	21	5	5	glucose	CO2	PA449773	4513	0.893
NULL	Exp_Hematol_Oncol_2012_Sep_11_1_27.nxml.txt.nlp	23210501	SENT68	2	2	20	20	lenalidomide	p53	PA162363968	7157	0.893
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT165	20	20	5	5	neratinib	EGFR	PA165291472	1956	0.893
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT92	1	1	8	8	methotrexate	MLH1	PA450428	4292	0.893
NULL	Cancer_Med_2014_Jun_19_3(3)_555-564.nxml.txt.nlp	24648042	SENT132	30	30	3	3	cyclophosphamide	SF3B1	PA449165	23451	0.893
NULL	Breast_Cancer_Res_2009_Oct_28_11(5)_211.nxml.txt.nlp	19889200	SENT123	13	13	7	7	tamoxifen	ARNO	PA451581	9266	0.893
NULL	Genome_Biol_2004_Jul_22_5(8)_R54.nxml.txt.nlp	15287976	SENT24	26	26	21	21	ribavirin	IFN	PA451241	3439	0.893
NULL	Br_J_Cancer_2011_Jul_26_105(3)_372-381.nxml.txt.nlp	21730979	SENT76	6	6	2	2	hydroxyurea	CHK1	PA449942	1111	0.893
NULL	J_Cell_Mol_Med_2014_Aug_6_18(8)_1519-1539.nxml.txt.nlp	25100284	SENT26	0	0	31	31	afatinib	EGFR	PA165981154	1956	0.893
NULL	Clin_Pharmacokinet_2014_Jun_27_53(8)_741-751.nxml.txt.nlp	24968986	SENT250	23	23	42	42	docetaxel	OATP1B1	PA449383	10599	0.893
NULL	Mol_Cancer_2014_Feb_4_13_21.nxml.txt.nlp	24495750	SENT146	27	27	7	7	oxaliplatin	Mcl-1	PA131285527	4170	0.893
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT149	5	5	33	33	perifosine	JNK	PA165291471	5599	0.893
NULL	Oncotarget_2014_Feb_7_5(3)_775-787.nxml.txt.nlp	24519956	SENT101	22	22	18	18	dasatinib	PC3	PA162372878	57332;7832;5122	0.893
NULL	Biologics_2014_Nov_14_8_269-280.nxml.txt.nlp	25484574	SENT95	16	16	10	10	doxorubicin	SNF2	PA449412	6595;6597	0.893
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_16_2013_846039.nxml.txt.nlp	23843885	SENT29	28	28	17	17	lipase	gamma	PA450239	9913	0.893
NULL	Toxins_(Basel)_2010_Oct_26_2(11)_2490-2518.nxml.txt.nlp	22069563	SENT230	8	8	3	3	cisplatin	TLR9	PA449014	54106	0.893
NULL	Mol_Cancer_2010_Dec_20_9_317.nxml.txt.nlp	21172025	SENT236	24	24	12	12	tamoxifen	EVL	PA451581	51466	0.893
NULL	J_Young_Pharm_2010_Jul-Sep_2(3)_326-331.nxml.txt.nlp	21042495	SENT127	33	33	28	28	rosuvastatin	CYP2C9	PA134308647	1559	0.893
NULL	Oncol_Lett_2014_Jul_16_8(1)_211-217.nxml.txt.nlp	24959248	SENT7	18	18	26	26	cisplatin	ALDOA	PA449014	226	0.893
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT280	9	9	3	3	acetaminophen	IL-10	PA448015	3586	0.893
NULL	Cancer_Cell_Int_2005_Aug_24_5_28.nxml.txt.nlp	16120219	SENT168	27	27	13	13	etoposide	p53	PA449552	7157	0.893
NULL	Acta_Pharmacol_Sin_2010_May_12_31(5)_578-584.nxml.txt.nlp	20383171	SENT201	6	6	39	39	berberine	ORP150	PA165860812	10525	0.893
NULL	Breast_Cancer_Res_2012_Jun_19_14(3)_209.nxml.txt.nlp	22713170	SENT32	0	0	8	8	trastuzumab	HER2	PA451743	2064	0.893
NULL	Oncotarget_2014_Aug_16_5(17)_7342-7356.nxml.txt.nlp	25277177	SENT186	28	28	25	25	gefitinib	EGFR	PA131301952	1956	0.893
NULL	Curr_Neuropharmacol_2013_Mar_11(2)_171-185.nxml.txt.nlp	23997752	SENT281	11	11	42	42	reboxetine	GDNF	PA144614921	2668	0.893
NULL	Biochem_Res_Int_2012_Feb_12_2012_346972.nxml.txt.nlp	22400115	SENT53	17	17	0	0	hyaluronan	LYVE-1	PA165958431	10894	0.893
NULL	Colorectal_Dis_2012_Feb_14(2)_e31-e47.nxml.txt.nlp	21848897	SENT37	0	0	11	11	cetuximab	EGFR	PA10040	1956	0.893
NULL	Clin_Med_Insights_Oncol_2012_Feb_28_6_125-135.nxml.txt.nlp	22408376	SENT18	19	19	15	15	panitumumab	EGFR	PA162373091	1956	0.893
NULL	Mol_Biol_Cell_2013_Dec_15_24(24)_3939-3944.nxml.txt.nlp	24152728	SENT102	5	5	22	22	tamoxifen	CCN2	PA451581	1490	0.893
NULL	Diabetol_Metab_Syndr_2014_Sep_23_6(1)_102.nxml.txt.nlp	NULL	SENT191	6	6	12	12	atorvastatin	RAGE	PA448500	177	0.893
NULL	Croat_Med_J_2013_Apr_54(2)_171-179.nxml.txt.nlp	23630144	SENT131	7	7	0	0	taurine	STZ	PA451590	6484	0.893
NULL	J_RNAi_Gene_Silencing_2010_May_29_6(1)_386-400.nxml.txt.nlp	20628499	SENT66	17	17	2	2	l-glutamine	ACH2	PA10090	641371	0.893
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT174	22	22	8	8	perifosine	DR4	PA165291471	8797	0.893
NULL	F1000_Med_Rep_2012_Feb_1_4_4.nxml.txt.nlp	22312414	SENT16	32	32	35	35	vancomycin	VISA	PA451850	57506	0.893
NULL	Braz_J_Med_Biol_Res_2012_Jul_20_45(10)_935-941.nxml.txt.nlp	22801415	SENT148	13	13	5	5	pioglitazone	adiponectin	PA450970	9370	0.893
NULL	Pharmaceuticals_(Basel)_2012_Aug_30_5(9)_890-898.nxml.txt.nlp	24280696	SENT299	11	11	21	21	fludarabine	TP53	PA449655	7157	0.893
NULL	Biologics_2012_Apr_12_6_89-99.nxml.txt.nlp	22532777	SENT182	15	15	12	12	denosumab	RANKL	PA166048634	8600	0.893
NULL	Mol_Cancer_2014_Jun_24_13_157.nxml.txt.nlp	24958351	SENT60	33	33	9	9	lapatinib	HER2	PA152241907	2064	0.893
NULL	Oncogene_2014_Mar_6_33(10)_1316-1324.nxml.txt.nlp	23474758	SENT90	9	9	20	20	paclitaxel	AXL	PA450761	558	0.893
NULL	ScientificWorldJournal_2014_Dec_9_2014_808320.nxml.txt.nlp	25548793	SENT91	8	8	10	10	heparin	RAC	PA449855	207	0.893
NULL	Open_Cardiovasc_Med_J_2009_Mar_20_3_8-14.nxml.txt.nlp	19430573	SENT65	13	13	4	4	heparin	CEA	PA449855	5670;1087	0.893
NULL	Br_J_Cancer_2004_May_4_90(9)_1733-1739.nxml.txt.nlp	15150604	SENT52	10	10	4	4	aminoglutethimide	aromatase	PA448375	1588	0.893
NULL	F1000_Biol_Rep_2009_Mar_24_1_23.nxml.txt.nlp	20948663	SENT13	28	28	2	2	paroxetine	ABCB1	PA450801	5243	0.893
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2675-2684.nxml.txt.nlp	24129246	SENT172	23	23	28	28	etoposide	p53	PA449552	7157	0.893
NULL	Exp_Ther_Med_2014_Dec_3_8(6)_1825-1830.nxml.txt.nlp	25371739	SENT24	33	33	17	17	sulfamethoxazole	DHPS	PA451544	1725	0.893
NULL	Oncol_Rep_2013_Mar_8_29(3)_917-924.nxml.txt.nlp	23314174	SENT129	9	9	7	7	sorafenib	HIF-1	PA7000	29072	0.893
NULL	J_Korean_Med_Sci_2010_Aug_21_25(8)_1222-1227.nxml.txt.nlp	20676337	SENT152	26	26	18	18	propofol	LPA	PA451141	4018	0.893
NULL	J_Hematol_Oncol_2009_Feb_23_2_9.nxml.txt.nlp	19236713	SENT35	17	17	1	1	cetuximab	KRAS	PA10040	3845	0.893
NULL	J_Cell_Biol_2002_May_28_157(5)_761-770.nxml.txt.nlp	12034770	SENT10	28	28	0	0	doxycycline	TFF1	PA449415	7031	0.893
NULL	Gut_Liver_2012_Oct_18_6(4)_464-470.nxml.txt.nlp	23170151	SENT28	6	6	27	27	propofol	ESD	PA451141	2098	0.893
NULL	Cell_Cycle_2013_May_15_12(10)_1625-1636.nxml.txt.nlp	23624835	SENT67	20	20	2	2	hydroxyurea	ELG1	PA449942	79915	0.893
NULL	Ann_Gastroenterol_2012_25(3)_207-217.nxml.txt.nlp	24713803	SENT139	30	30	18	18	losartan	DM2	PA450268	28508	0.893
NULL	Mol_Vis_2011_Dec_6_17_3147-3155.nxml.txt.nlp	22171161	SENT148	4	4	9	9	diclofenac	COX	PA449293	1351	0.893
NULL	Nat_Neurosci_2013_Dec_20_16(12)_10_1038_nn_3553.nxml.txt.nlp	24141309	SENT93	1	1	13	13	tamoxifen	P21	PA451581	1026;9338	0.893
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1063.nxml.txt.nlp	24556678	SENT233	10	10	8	8	thioridazine	Mcl-1	PA451666	4170	0.893
NULL	Cancer_Cell_Int_2010_Sep_9_10_32.nxml.txt.nlp	20828393	SENT191	16	16	22	22	cisplatin	ATF3	PA449014	467	0.893
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT214	5	5	20	20	mitoxantrone	B7-H1	PA450526	29126	0.893
NULL	Exp_Ther_Med_2013_Apr_5_5(4)_1259-1263.nxml.txt.nlp	23596498	SENT25	10	10	27	27	capsaicin	TRPV1	PA448776	7442	0.893
NULL	Hum_Genomics_Proteomics_2010_Aug_3_2010_159761.nxml.txt.nlp	20981231	SENT182	17	17	11	11	lithium	C8orf33	PA450243	65265	0.893
NULL	J_Korean_Med_Sci_2009_Jun_12_24(3)_453-460.nxml.txt.nlp	19543509	SENT42	11	11	20	20	l-glutamine	CO2	PA10090	4513	0.893
NULL	Case_Rep_Rheumatol_2013_Dec_17_2013_923497.nxml.txt.nlp	24455384	SENT54	28	28	15	15	tocilizumab	IL6	PA165292659	3569	0.893
NULL	J_Korean_Assoc_Oral_Maxillofac_Surg_2014_Dec_26_40(6)_291-296.nxml.txt.nlp	25551094	SENT126	4	4	25	25	alendronate	OPG	PA448082	690	0.893
NULL	Ann_Surg_Treat_Res_2014_Feb_22_86(2)_68-75.nxml.txt.nlp	24761411	SENT49	5	5	8	8	oxaliplatin	survivin	PA131285527	332	0.893
NULL	J_Cell_Biol_1999_Feb_22_144(4)_789-801.nxml.txt.nlp	10037799	SENT56	28	28	6	6	ethanol	CD44	PA448073	960	0.893
NULL	Front_Comput_Neurosci_2013_Apr_5_7_22.nxml.txt.nlp	23576979	SENT441	11	11	0	0	ketamine	HCN1	PA450144	348980	0.893
NULL	Front_Immunol_2012_Feb_6_3_11.nxml.txt.nlp	22566897	SENT117	9	9	26	26	bleomycin	IL-17	PA448645	3605	0.893
NULL	J_Hematol_Oncol_2013_Oct_12_6_78.nxml.txt.nlp	24283803	SENT46	14	14	21	21	daunorubicin	STAT3	PA449212	6774	0.893
NULL	Drug_Target_Insights_2012_Aug_6_6_19-39.nxml.txt.nlp	22915839	SENT32	30	30	45	45	kanamycin	CO2	PA450137	4513	0.893
NULL	Psychiatry_Investig_2013_Dec_16_10(4)_425-427.nxml.txt.nlp	24474994	SENT41	11	11	24	24	quetiapine	CYP2D6	PA451201	1565	0.893
NULL	Front_Endocrinol_(Lausanne)_2015_Jan_9_5_235.nxml.txt.nlp	25620956	SENT109	17	17	39	39	glucosamine	IL6	PA164747613	3569	0.893
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Sep_11_66(Pt_10)_o2550.nxml.txt.nlp	21587538	SENT55	18	18	12	12	ethanol	mol	PA448073	90527	0.893
NULL	Aging_(Albany_NY)_2011_Dec_12_3(11)_1063-1077.nxml.txt.nlp	22170748	SENT56	14	14	10	10	metformin	AMPK	PA450395	5563	0.893
NULL	Cancer_Cell_2007_Dec_11_12(6)_514-527.nxml.txt.nlp	18068629	SENT152	19	19	3	3	paclitaxel	TGFBI	PA450761	7045	0.893
NULL	J_Hematol_Oncol_2013_Jul_18_6_53.nxml.txt.nlp	23866964	SENT7	4	4	23	23	temsirolimus	MTOR	PA164746890	2475	0.893
NULL	Case_Rep_Ophthalmol_2010_Dec_8_1(2)_110-113.nxml.txt.nlp	21373383	SENT15	12	12	1	1	ranibizumab	PED	PA164746012	8682	0.893
NULL	Am_J_Case_Rep_2014_Feb_24_15_85-89.nxml.txt.nlp	24587856	SENT72	36	36	19	19	exemestane	aromatase	PA449563	1588	0.893
NULL	Open_Biol_2014_May_4(5)_140045.nxml.txt.nlp	24850912	SENT180	15	15	7	7	azithromycin	L22	PA448519	6146	0.893
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Oct_25_64(Pt_11)_o2199.nxml.txt.nlp	21581057	SENT62	23	23	6	6	ethanol	mol	PA448073	90527	0.893
NULL	Indian_J_Pharm_Sci_2014_Mar-Apr_76(2)_125-131.nxml.txt.nlp	24843185	SENT144	21	21	10	10	resveratrol	CA3		761	0.893
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1135-1143.nxml.txt.nlp	21364580	SENT208	18	18	25	25	pertuzumab	ERBB2		2064	0.893
NULL	Clin_Ophthalmol_2013_Dec_21_7_7-14.nxml.txt.nlp	23293509	SENT97	37	37	12	12	tafluprost	BAK	PA165958432	578	0.893
NULL	Subst_Abuse_Treat_Prev_Policy_2009_Feb_5_4_1.nxml.txt.nlp	19196468	SENT214	21	21	16	16	buprenorphine	HMP	PA448685	10989	0.893
NULL	Acta_Pharmacol_Sin_2010_May_12_31(5)_578-584.nxml.txt.nlp	20383171	SENT14	17	17	23	23	berberine	JNK	PA165860812	5599	0.893
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Jul_23_3(7)_e126.nxml.txt.nlp	25054314	SENT211	9	9	3	3	telmisartan	OATP1B3	PA451605	28234	0.893
NULL	Nucleic_Acids_Res_2010_Oct_21_38(18)_6148-6158.nxml.txt.nlp	20494979	SENT308	24	24	38	38	paclitaxel	HLJ1	PA450761	11080	0.893
NULL	Front_Behav_Neurosci_2011_Sep_8_5_56.nxml.txt.nlp	21927600	SENT878	8	8	3	3	trastuzumab	DARPP-32	PA451743	84152	0.893
NULL	Indian_J_Pharm_Sci_2008_Nov-Dec_70(6)_745-753.nxml.txt.nlp	21369435	SENT75	7	7	42	42	ketoprofen	San	PA450149	80218	0.893
NULL	Blood_Cancer_J_2012_Oct_19_2(10)_e95.nxml.txt.nlp	23085780	SENT153	12	12	45	45	imatinib	CML	PA10804	613	0.893
NULL	Int_J_Vasc_Med_2012_Aug_21_2012_648167.nxml.txt.nlp	22957259	SENT85	2	2	18	18	atorvastatin	MCP-1	PA448500	6347	0.893
NULL	Br_J_Cancer_2011_Jul_26_105(3)_366-371.nxml.txt.nlp	21750556	SENT139	26	26	14	14	trastuzumab	T-bet	PA451743	30009	0.893
NULL	Drugs_Context_2012_Nov_19_2012_212242.nxml.txt.nlp	24432031	SENT128	4	4	15	15	cisplatin	IL-2	PA449014	3558	0.893
NULL	Drug_Target_Insights_2013_Aug_19_7_27-34.nxml.txt.nlp	24023511	SENT84	11	11	4	4	erythromycin	P-gp	PA449493	5243	0.893
NULL	Breast_Cancer_Res_2011_Apr_14_13(2)_R43.nxml.txt.nlp	21492444	SENT46	33	33	25	25	tamoxifen	PTEN	PA451581	5728	0.893
NULL	Clin_Pharmacokinet_2014_Sep_3_53(1)_1-16.nxml.txt.nlp	23999929	SENT275	23	23	16	16	rivaroxaban	P-gp	PA165958360	5243	0.893
NULL	Indian_J_Med_Res_2012_Sep_136(3)_391-403.nxml.txt.nlp	23041732	SENT185	9	9	16	16	bevacizumab	HCC	PA130232992	84668	0.893
NULL	Mol_Cancer_2010_Apr_15_9_77.nxml.txt.nlp	20398291	SENT123	5	5	13	13	geldanamycin	survivin	PA152031327	332	0.893
NULL	Ayu_2013_Oct-Dec_34(4)_421-429.nxml.txt.nlp	24696581	SENT187	18	18	27	27	scopolamine	IL-10	PA451308	3586	0.893
NULL	Gene_Ther_2011_Jul_17_18(7)_637-645.nxml.txt.nlp	21412286	SENT130	26	26	44	44	diazepam	ERG	PA449283	2078	0.893
NULL	Nucleic_Acids_Res_2013_Apr_18_41(7)_4144-4158.nxml.txt.nlp	23423352	SENT178	29	29	10	10	galactose	GAL	PA449725	51083	0.893
NULL	Aging_(Albany_NY)_2009_Jan_7_1(1)_1-5.nxml.txt.nlp	20157590	SENT88	18	18	26	26	metformin	AMPK	PA450395	5563	0.893
NULL	J_Ophthalmic_Inflamm_Infect_2012_Feb_4_2(3)_149-152.nxml.txt.nlp	22311604	SENT69	28	28	7	7	gentamicin	CD4	PA449753	920	0.893
NULL	Eur_J_Neurosci_2008_Apr_1_27(7)_1722-1730.nxml.txt.nlp	18380669	SENT207	20	20	17	17	sr144528	CB2		1269	0.893
NULL	Exp_Ther_Med_2012_Oct_3_4(4)_594-604.nxml.txt.nlp	23170111	SENT99	27	27	14	14	propranolol	JNK	PA451145	5599	0.893
NULL	Diabetes_Obes_Metab_2010_Aug_12(8)_700-708.nxml.txt.nlp	20590747	SENT191	11	11	32	32	vildagliptin	PPG	PA165958346	5552	0.893
NULL	Diabetes_Metab_Syndr_Obes_2014_Jun_24_7_229-239.nxml.txt.nlp	25018644	SENT104	20	20	8	8	sitagliptin	GLP-1	PA164748978	100125288	0.893
NULL	Oncol_Lett_2014_Mar_7_7(3)_866-870.nxml.txt.nlp	24527094	SENT16	27	27	12	12	cisplatin	BRCA1	PA449014	672	0.893
NULL	Biologics_2010_Feb_4_4_19-31.nxml.txt.nlp	20161982	SENT104	29	29	12	12	imatinib	KIT	PA10804	3815	0.893
NULL	F1000Prime_Rep_2013_Jul_1_5_24.nxml.txt.nlp	23864931	SENT83	26	26	28	28	boceprevir	BOC	PA165948902	91653	0.893
NULL	J_Headache_Pain_2014_Feb_8_15(1)_7.nxml.txt.nlp	24506953	SENT204	0	0	11	11	naratriptan	5-HT1D	PA450597	3352	0.893
NULL	Front_Genet_2014_Jul_16_5_201.nxml.txt.nlp	25076963	SENT1212	22	22	10	10	arsenite	RECK	PA452638	8434	0.893
NULL	Biosci_Rep_2012_Aug_1_32(Pt_4)_361-374.nxml.txt.nlp	22762204	SENT164	37	37	3	3	etoposide	BRCA1	PA449552	672	0.893
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jan_12_67(Pt_2)_o365.nxml.txt.nlp	21523043	SENT56	21	21	9	9	ethanol	mol	PA448073	90527	0.893
NULL	Mol_Cancer_2014_Jul_5_13_165.nxml.txt.nlp	24996221	SENT220	38	38	20	20	docetaxel	HMGB1	PA449383	3146	0.893
NULL	Mol_Biol_Cell_2012_Jul_1_23(13)_2560-2570.nxml.txt.nlp	22593210	SENT104	1	1	9	9	galactose	NUF2	PA449725	83540	0.893
NULL	Cells_2014_Jun_11_3(2)_616-626.nxml.txt.nlp	24921186	SENT62	40	40	11	11	capsaicin	TRPV1	PA448776	7442	0.893
NULL	Eur_J_Immunol_2014_Jun_10_44(6)_1759-1769.nxml.txt.nlp	24595810	SENT80	29	29	33	33	fludrocortisone	CXCR4	PA164743961	7852	0.893
NULL	Vet_Res_2013_Sep_9_44(1)_82.nxml.txt.nlp	24016341	SENT183	25	25	7	7	imiquimod	IL-6	PA449972	3569	0.893
NULL	Mol_Cancer_2012_May_14_11_34.nxml.txt.nlp	22583868	SENT168	12	12	8	8	resveratrol	JNK		5599	0.893
NULL	Acta_Pharmacol_Sin_2012_Dec_27_33(12)_1469-1476.nxml.txt.nlp	22922343	SENT91	23	23	1	1	zolpidem	ANOVA	PA451976	4858	0.893
NULL	Cardiovasc_J_Afr_2009_Apr_20(2)_122-125.nxml.txt.nlp	19421648	SENT31	18	18	23	23	vancomycin	DBL	PA451850	4168	0.893
NULL	Mol_Cancer_2012_Jun_26_11_43.nxml.txt.nlp	22731636	SENT124	18	18	7	7	pp2	PP2		4888	0.893
NULL	Br_J_Cancer_2013_Aug_6_109(3)_686-693.nxml.txt.nlp	23839492	SENT143	16	16	3	3	everolimus	IL-8	PA164746311	3576	0.893
NULL	Clin_Epidemiol_2014_May_13_6_169-182.nxml.txt.nlp	24872723	SENT119	10	10	15	15	fluconazole	CD4	PA449653	920	0.893
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT248	2	2	15	15	atorvastatin	KRAS	PA448500	3845	0.893
NULL	Oncol_Lett_2014_Nov_14_8(5)_2086-2092.nxml.txt.nlp	25295095	SENT111	19	19	15	15	gemcitabine	LKB1	PA449748	6794	0.893
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Aug_20_64(Pt_9)_o1793.nxml.txt.nlp	21201772	SENT56	21	21	16	16	ethanol	mol	PA448073	90527	0.893
NULL	Oncotarget_2011_Mar_10_2(3)_186-196.nxml.txt.nlp	21406729	SENT115	23	23	7	7	orlistat	FLIP	PA164776864	8837	0.893
NULL	Exp_Mol_Med_2012_Feb_29_44(2)_81-88.nxml.txt.nlp	22257883	SENT76	1	1	19	19	glucose	PERK	PA449773	9451	0.893
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Aug_18_66(Pt_9)_o2302.nxml.txt.nlp	21588652	SENT57	26	26	7	7	ethanol	mol	PA448073	90527	0.893
NULL	J_Gastroenterol_2013_Feb_22_48(2)_222-237.nxml.txt.nlp	22722906	SENT303	27	27	44	44	ethanol	JNK	PA448073	5599	0.893
NULL	Cancer_Immunol_Immunother_2011_Jan_21_60(1)_75-85.nxml.txt.nlp	20857100	SENT226	13	13	22	22	fludarabine	IFN	PA449655	3439	0.893
NULL	Breast_Cancer_Res_Treat_2013_Oct_8_141(3)_437-446.nxml.txt.nlp	24101324	SENT171	19	19	22	22	docetaxel	PIK3CA	PA449383	5290	0.893
NULL	Arthritis_Res_2001_Sep_18_3(6)_381-388.nxml.txt.nlp	11714393	SENT154	12	12	1	1	collagenase	AP-1	PA449107	2353;3727;2354;3725	0.893
NULL	Cell_Biol_Int_Rep_(2010)_2012_Jun_21_19(1)_e00017.nxml.txt.nlp	23124518	SENT4	6	6	14	14	etoposide	DR5	PA449552	8795	0.893
NULL	Br_J_Cancer_2010_Feb_2_102(3)_520-529.nxml.txt.nlp	20029417	SENT135	23	23	7	7	trastuzumab	IL-21	PA451743	59067;50616;27189	0.893
NULL	Nat_Commun_2014_Nov_19_5_5479.nxml.txt.nlp	25407222	SENT93	5	5	16	16	dextran	YTS	PA449261	8565	0.893
NULL	Nat_Med_2010_Jun_23_16(6)_671-677.nxml.txt.nlp	20495567	SENT111	25	25	35	35	sorafenib	MCL1	PA7000	4170	0.893
NULL	Acta_Pharmacol_Sin_2011_Aug_18_32(8)_1078-1084.nxml.txt.nlp	21765448	SENT143	22	22	14	14	iptakalim	KCNJ11	PA165949694	3767	0.893
NULL	Evid_Based_Complement_Alternat_Med_2013_Aug_12_2013_982689.nxml.txt.nlp	23997806	SENT12	13	13	0	0	tolbutamide	APE	PA451718	55704;328	0.893
NULL	Br_J_Cancer_1997_75(11)_1559-1566.nxml.txt.nlp	9184169	SENT9	24	24	13	13	genistein	p53	PA165109660	7157	0.893
NULL	Adolesc_Health_Med_Ther_2014_Mar_26_5_35-48.nxml.txt.nlp	24729739	SENT35	33	33	29	29	abatacept	TNF-alpha	PA164747080	7124	0.893
NULL	Biomed_Res_Int_2013_Jul_15_2013_386074.nxml.txt.nlp	23956980	SENT27	3	3	16	16	clopidogrel	San	PA449053	80218	0.893
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Mar_14_65(Pt_4)_o756.nxml.txt.nlp	21582487	SENT61	32	32	11	11	ethanol	mol	PA448073	90527	0.893
NULL	Emerg_Infect_Dis_2011_Mar_17(3)_432-440.nxml.txt.nlp	21392434	SENT130	33	33	12	12	rifampin	DST	PA451250	667	0.893
NULL	Mol_Cancer_2013_May_24_12_46.nxml.txt.nlp	23705826	SENT357	35	35	13	13	gentamicin	KIT	PA449753	3815	0.893
NULL	Diabetes_Care_2009_Apr_32(4)_531-540.nxml.txt.nlp	19336638	SENT18	18	18	27	27	clopidogrel	ADP	PA449053	23038	0.893
NULL	Oncogene_2013_Oct_17_32(42)_5101-5110.nxml.txt.nlp	23208508	SENT271	37	37	21	21	metformin	PC-3	PA450395	692094	0.893
NULL	Biomed_Res_Int_2013_Aug_6_2013_602987.nxml.txt.nlp	24027759	SENT274	20	20	10	10	paclitaxel	SMF	PA450761	22993	0.893
NULL	Diabetes_Care_2013_Aug_17_36(Suppl_2)_S127-S138.nxml.txt.nlp	23882037	SENT388	14	14	26	26	metformin	GLP-1	PA450395	100125288	0.893
NULL	Indian_J_Nucl_Med_2015_Jan-Mar_30(1)_42-46.nxml.txt.nlp	25589805	SENT108	12	12	21	21	octreotide	SSTR2	PA450678	6752	0.893
NULL	AMB_Express_2012_Apr_26_2_25.nxml.txt.nlp	22537922	SENT15	17	17	3	3	isoniazid	INA	PA450112	9118	0.893
NULL	ScientificWorldJournal_2014_May_19_2014_567148.nxml.txt.nlp	24971383	SENT262	5	5	19	19	epirubicin	MRP-1	PA449476	928	0.893
NULL	Oncotarget_2014_Jul_9_5(21)_10446-10459.nxml.txt.nlp	25431953	SENT5	17	17	24	24	temozolomide	FTM	PA451609	23322	0.893
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT535	31	31	25	25	pp2	PP1		5540;5464	0.893
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT134	15	15	17	17	trastuzumab	STAT3	PA451743	6774	0.893
NULL	Cancer_Res_Treat_2014_Oct_14_46(4)_323-330.nxml.txt.nlp	25036571	SENT28	28	28	20	20	gefitinib	EGFR	PA131301952	1956	0.893
NULL	Acta_Pharmacol_Sin_2012_Aug_23_33(8)_1095-1100.nxml.txt.nlp	22820908	SENT114	30	30	10	10	ilaprazole	CYP3A	PA165947499	1574	0.893
NULL	Diabetes_2013_May_16_62(5)_1689-1696.nxml.txt.nlp	23274908	SENT217	13	13	26	26	tolbutamide	KCNJ11	PA451718	3767	0.893
NULL	J_Thromb_Thrombolysis_2011_Nov_26_32(4)_459-466.nxml.txt.nlp	21706290	SENT224	13	13	2	2	ticagrelor	CYP2C19	PA165374673	1557	0.893
NULL	Oncogene_2009_Apr_23_28(16)_1821-1832.nxml.txt.nlp	19305428	SENT77	5	5	7	7	erlotinib	PP2	PA134687924	4888	0.893
NULL	Oncogenesis_2012_Apr_2_1(4)_e5.nxml.txt.nlp	23552603	SENT242	23	23	17	17	celecoxib	BIM	PA448871	10018	0.893
NULL	Breast_Cancer_(Auckl)_2011_Jul_27_5_175-199.nxml.txt.nlp	21863131	SENT384	7	7	11	11	olaparib	BRCA1		672	0.893
NULL	Exp_Diabetes_Res_2012_Mar_15_2012_146194.nxml.txt.nlp	22474415	SENT117	11	11	16	16	valsartan	GLP-1	PA451848	100125288	0.893
NULL	Clin_Exp_Otorhinolaryngol_2012_Sep_27_5(3)_117-121.nxml.txt.nlp	22977707	SENT94	6	6	14	14	kanamycin	KCC2	PA450137	57468	0.893
NULL	Mol_Vis_2014_May_2_20_616-628.nxml.txt.nlp	24826069	SENT184	7	7	13	13	fluorescein	CD11b	PA164746009	3684	0.893
NULL	Eur_J_Endocrinol_2011_Jan_164(1)_69-74.nxml.txt.nlp	20961967	SENT76	16	16	3	3	metformin	OPG	PA450395	690	0.893
NULL	Br_J_Cancer_2012_Jan_3_106(1)_53-60.nxml.txt.nlp	22068817	SENT212	1	1	16	16	cetuximab	KRAS	PA10040	3845	0.893
NULL	Indian_J_Endocrinol_Metab_2013_Oct_17(Suppl1)_S64-S67.nxml.txt.nlp	24251223	SENT48	11	11	7	7	liraglutide	GLP-1	PA165958364	100125288	0.893
NULL	Nat_Commun_2014_Dec_8_5_5736.nxml.txt.nlp	25484020	SENT89	18	18	26	26	exemestane	TRPA1	PA449563	8989	0.893
NULL	Arthritis_Rheum_2013_Sep_26_65(9)_2290-2300.nxml.txt.nlp	23740547	SENT242	8	8	29	29	doxycycline	osterix	PA449415	121340	0.893
NULL	Clin_Endocrinol_(Oxf)_2014_Jan_1_81(2)_289-293.nxml.txt.nlp	24735400	SENT79	23	23	7	7	metyrapone	ACTH	PA450486	5443	0.893
NULL	Oncol_Lett_2014_Nov_14_8(5)_2086-2092.nxml.txt.nlp	25295095	SENT131	21	21	5	5	gemcitabine	LKB1	PA449748	6794	0.893
NULL	Cancer_Med_2014_Jun_19_3(3)_555-564.nxml.txt.nlp	24648042	SENT107	44	44	12	12	fludarabine	PI3K	PA449655	5290	0.893
NULL	Calcif_Tissue_Int_2010_Nov_20_87(5)_375-384.nxml.txt.nlp	20725827	SENT224	15	15	3	3	teriparatide	DANCE	PA451620	10516	0.893
NULL	J_Mol_Signal_2008_Dec_1_3_18.nxml.txt.nlp	19046439	SENT84	14	14	42	42	metformin	CDK2	PA450395	1017	0.893
NULL	Cancers_(Basel)_2014_Apr_9_6(2)_829-859.nxml.txt.nlp	24722453	SENT1691	1	1	3	3	evodiamine	STAT3	PA165860788	6774	0.893
NULL	Acta_Pharmacol_Sin_2009_Apr_3_30(4)_478-484.nxml.txt.nlp	19343062	SENT100	29	29	4	4	nevirapine	CYP3A4	PA450616	1576	0.893
NULL	Evid_Based_Complement_Alternat_Med_2013_May_26_2013_349790.nxml.txt.nlp	23762123	SENT123	20	20	13	13	rosiglitazone	TLSP	PA451283	11012	0.893
NULL	Archaea_2013_Feb_21_2013_732864.nxml.txt.nlp	23533331	SENT230	8	8	0	0	arsenite	ArsB	PA452638	57152	0.893
NULL	Reprod_Biol_Endocrinol_2013_Feb_26_11_15.nxml.txt.nlp	23442442	SENT141	20	20	6	6	l-arginine	BCL2	PA448478	596	0.893
NULL	ScientificWorldJournal_2013_Sep_26_2013_608415.nxml.txt.nlp	24191141	SENT136	14	14	30	30	ritonavir	APOC3	PA451260	345	0.893
NULL	Indian_J_Endocrinol_Metab_2013_Jul-Aug_17(4)_693-696.nxml.txt.nlp	23961488	SENT25	1	1	22	22	cosyntropin	ACTH	PA164749052	5443	0.893
NULL	Mol_Cancer_2009_Nov_10_8_99.nxml.txt.nlp	19903356	SENT81	6	6	31	31	imatinib	IGFBP3	PA10804	3486	0.893
NULL	Biomed_Res_Int_2014_Apr_10_2014_580852.nxml.txt.nlp	24812624	SENT128	16	16	4	4	resveratrol	PTEN		5728	0.893
NULL	Cancers_(Basel)_2014_Sep_5_6(3)_1769-1792.nxml.txt.nlp	25198391	SENT775	16	16	4	4	doxorubicin	MDR1	PA449412	5243	0.893
NULL	Biomed_Res_Int_2014_Feb_6_2014_323594.nxml.txt.nlp	24689036	SENT242	15	15	8	8	raloxifene	EGFR	PA451221	1956	0.893
NULL	Environ_Health_Perspect_2010_Dec_19_118(12)_1775-1781.nxml.txt.nlp	21126941	SENT193	10	10	7	7	malathion	PON1	PA164748092	5444	0.893
NULL	Mucosal_Immunol_2013_Nov_10_6(6)_1179-1190.nxml.txt.nlp	23571504	SENT123	28	28	30	30	auranofin	TRX	PA448510	7295	0.893
NULL	J_Clin_Biochem_Nutr_2007_Nov_30_41(3)_160-168.nxml.txt.nlp	18299710	SENT11	27	27	10	10	ecabet	IL-8	PA165958350	3576	0.893
NULL	Int_J_Biomed_Sci_2007_Jun_3(2)_123-130.nxml.txt.nlp	23675034	SENT43	18	18	45	45	ranitidine	RAN	PA451224	5901	0.893
NULL	Gut_2015_Jan_19_64(1)_111-120.nxml.txt.nlp	24647007	SENT40	34	34	2	2	capecitabine	DPYD	PA448771	1806	0.893
NULL	Breast_Cancer_Res_2008_Jul_8_10(4)_R56.nxml.txt.nlp	18611244	SENT46	31	31	20	20	neomycin	aromatase	PA450608	1588	0.893
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Oct_15_70(Pt_11)_337-340.nxml.txt.nlp	25484739	SENT42	23	23	2	2	nitrile	hole	PA450636	80757	0.893
NULL	J_Adv_Pharm_Technol_Res_2012_Oct-Dec_3(4)_202-209.nxml.txt.nlp	23378940	SENT166	2	2	9	9	fosaprepitant	CYP2C9	PA165958390	1559	0.893
NULL	Genome_Announc_2014_Jul_10_2(4)_e00647-14.nxml.txt.nlp	25013137	SENT26	31	31	21	21	teicoplanin	DMT	PA164746244	2039	0.893
NULL	EMBO_Mol_Med_2010_May_2(5)_143-145.nxml.txt.nlp	20461736	SENT24	16	16	18	18	gefitinib	KRAS	PA131301952	3845	0.893
NULL	Cancer_Manag_Res_2011_Aug_10_3_273-285.nxml.txt.nlp	21931501	SENT53	0	0	3	3	pazopanib	VEGFR	PA165291492	3791	0.893
NULL	Acta_Pharmacol_Sin_2009_Oct_21_30(10)_1392-1398.nxml.txt.nlp	19767766	SENT97	15	15	26	26	atorvastatin	p38	PA448500	10598;1432;7965	0.893
NULL	J_Biomed_Biotechnol_2006_Oct_16_2006_97287.nxml.txt.nlp	17489020	SENT164	3	3	16	16	perindopril	6A3-5	PA450877	57492	0.893
NULL	Mol_Cell_Biochem_2014_Oct_9_385(1-2)_265-275.nxml.txt.nlp	24104452	SENT141	19	19	8	8	bortezomib	LC3	PA10252	84557	0.893
NULL	Br_J_Pharmacol_2014_Sep_28_171(18)_4255-4272.nxml.txt.nlp	24846338	SENT54	17	17	27	27	ondansetron	5-HT7	PA450705	3363	0.893
NULL	Cancer_Med_2014_Jun_19_3(3)_555-564.nxml.txt.nlp	24648042	SENT135	20	20	2	2	rituximab	NOTCH1	PA451261	4851	0.893
NULL	J_Korean_Med_Sci_2007_Jun_30_22(3)_557-559.nxml.txt.nlp	17596671	SENT18	26	26	14	14	warfarin	CYP2C9	PA451906	1559	0.893
NULL	Ann_Clin_Transl_Neurol_2014_Dec_21_1(12)_996-1005.nxml.txt.nlp	25574474	SENT124	40	40	5	5	riluzole	P-gp	PA451251	5243	0.893
NULL	Ann_Indian_Acad_Neurol_2010_Jul-Sep_13(3)_207-210.nxml.txt.nlp	21085534	SENT61	4	4	8	8	infliximab	MRI	PA452639	78996	0.893
NULL	Int_J_Med_Sci_2013_Mar_13_10(5)_522-531.nxml.txt.nlp	23532711	SENT70	31	31	7	7	heparin	EGF	PA449855	1950	0.893
NULL	Thorax_2012_Oct_12_67(10)_891-900.nxml.txt.nlp	22693178	SENT162	38	38	8	8	capsaicin	TRPV1	PA448776	7442	0.893
NULL	Front_Physiol_2013_May_20_4_101.nxml.txt.nlp	23730288	SENT142	37	37	3	3	allopurinol	HL-1	PA448320	55600	0.893
NULL	Br_J_Cancer_2013_Oct_15_109(8)_2175-2188.nxml.txt.nlp	24045662	SENT9	30	30	6	6	methotrexate	GGH	PA450428	8836	0.893
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2675-2684.nxml.txt.nlp	24129246	SENT317	12	12	5	5	etoposide	DBC1	PA449552	57805;1620	0.893
NULL	J_Lipid_Res_2014_Dec_55(12)_2479-2490.nxml.txt.nlp	25325755	SENT46	14	14	39	39	l-glutamine	CO2	PA10090	4513	0.893
NULL	Mol_Immunol_2009_Apr_46(7)_1424-1431.nxml.txt.nlp	19185921	SENT416	29	29	2	2	oxygen	CDR1	PA450744	1038	0.893
NULL	Oncotarget_2013_Nov_19_5(2)_309-325.nxml.txt.nlp	24525395	SENT207	6	6	26	26	curcumin	STAT3	PA151958596	6774	0.893
NULL	Int_J_Vasc_Med_2014_Jul_22_2014_659617.nxml.txt.nlp	25140254	SENT153	7	7	39	39	isoflurane	AVP	PA450106	114548;551	0.893
NULL	Oncoimmunology_2014_Jan_17_3_e27574.nxml.txt.nlp	24800167	SENT27	18	18	9	9	cyclophosphamide	TH1	PA449165	51497	0.893
NULL	Oncogene_2009_Feb_5_28(5)_742-751.nxml.txt.nlp	19043454	SENT116	15	15	10	10	etoposide	TOP2A	PA449552	7153	0.893
NULL	Leukemia_2013_Apr_14_27(4)_803-812.nxml.txt.nlp	23238589	SENT159	22	22	34	34	nilotinib	IFN	PA165958345	3439	0.893
NULL	Int_J_Cell_Biol_2013_Nov_17_2013_769536.nxml.txt.nlp	24348564	SENT90	30	30	11	11	estradiol	HSD1	PA449503	26871	0.893
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT119	44	44	5	5	perifosine	DR4	PA165291471	8797	0.893
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Apr_30_65(Pt_5)_m594.nxml.txt.nlp	21583816	SENT52	21	21	7	7	ethanol	mol	PA448073	90527	0.893
NULL	Int_J_Hypertens_2012_Dec_4_2012_789671.nxml.txt.nlp	23304452	SENT317	3	3	9	9	vasopressin	IRAP	PA451858	3557	0.893
NULL	J_Mol_Signal_2011_Jul_20_6_7.nxml.txt.nlp	21774804	SENT50	43	43	8	8	curcumin	p53	PA151958596	7157	0.893
NULL	Breast_Cancer_Res_Treat_2013_Jun_5_139(3)_649-655.nxml.txt.nlp	23736997	SENT162	15	15	12	12	tamoxifen	aromatase	PA451581	1588	0.893
NULL	Diabetes_2009_Aug_15_58(8)_1893-1901.nxml.txt.nlp	19528375	SENT125	8	8	3	3	metformin	AMPK	PA450395	5563	0.893
NULL	Oncotarget_2013_Nov_19_5(2)_309-325.nxml.txt.nlp	24525395	SENT94	1	1	24	24	flavopiridol	Mcl-1	PA452627	4170	0.893
NULL	Cell_Cycle_2013_May_15_12(10)_1492-1500.nxml.txt.nlp	23598717	SENT5	3	3	5	5	doxorubicin	ROCK1	PA449412	6093	0.893
NULL	Cancers_(Basel)_2011_Mar_4_3(1)_1111-1128.nxml.txt.nlp	24212655	SENT138	11	11	2	2	temozolomide	ABCG2	PA451609	9429	0.893
NULL	Cancer_Gene_Ther_2011_Oct_26_18(10)_751-759.nxml.txt.nlp	21869826	SENT38	28	28	47	47	l-glutamine	CO2	PA10090	4513	0.893
NULL	Cancer_Immunol_Immunother_2013_Aug_27_62(10)_1637-1648.nxml.txt.nlp	23982484	SENT41	5	5	10	10	lenalidomide	STAT3	PA162363968	6774	0.893
NULL	Mol_Cancer_2012_Sep_25_11_73.nxml.txt.nlp	23009336	SENT115	31	31	27	27	erlotinib	EGFR	PA134687924	1956	0.893
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT121	41	41	32	32	pp2	PP2		4888	0.893
NULL	Cancers_(Basel)_2014_Feb_10_6(1)_376-395.nxml.txt.nlp	24518612	SENT186	6	6	2	2	temozolomide	STAT3	PA451609	6774	0.893
NULL	Oncol_Lett_2014_Nov_10_8(5)_2333-2339.nxml.txt.nlp	25295120	SENT87	17	17	13	13	sorafenib	ADM	PA7000	133	0.893
NULL	Evid_Based_Complement_Alternat_Med_2013_Nov_26_2013_156574.nxml.txt.nlp	24379885	SENT152	38	38	24	24	nifedipine	CYP3A4	PA450631	1576	0.893
NULL	Behav_Brain_Funct_2009_Jun_4_5_23.nxml.txt.nlp	19497110	SENT54	3	3	29	29	ethanol	P35	PA448073	2220	0.893
NULL	J_Oncol_2013_Apr_29_2013_854121.nxml.txt.nlp	23737784	SENT150	15	15	9	9	trastuzumab	HER2	PA451743	2064	0.893
NULL	Cancers_(Basel)_2010_Apr_20_2(2)_611-623.nxml.txt.nlp	24281084	SENT343	3	3	13	13	l-tryptophan	NK1	PA10323	11126	0.893
NULL	J_Cell_Sci_2014_Nov_1_127(21)_4728-4739.nxml.txt.nlp	25179605	SENT359	6	6	20	20	paraformaldehyde	LAMP1	PA450790	3916	0.893
NULL	Br_J_Pharmacol_2012_Jan_165(2)_390-400.nxml.txt.nlp	21671897	SENT185	22	22	10	10	suramin	P2X2	PA10292	22953	0.893
NULL	Biomed_Res_Int_2014_Jan_15_2014_859871.nxml.txt.nlp	24527460	SENT110	14	14	1	1	oxaliplatin	IL-4	PA131285527	3565	0.893
NULL	Neuropsychopharmacology_2009_Sep_13_34(10)_2197-2207.nxml.txt.nlp	19440190	SENT161	19	19	2	2	fluoxetine	EPM	PA449673	2054	0.893
NULL	Breast_Cancer_Res_2008_Mar_31_10(2)_205.nxml.txt.nlp	18394187	SENT128	16	16	2	2	tamoxifen	ADAM9	PA451581	8754	0.893
NULL	Patient_Prefer_Adherence_2011_Jul_19_5_369-374.nxml.txt.nlp	21845036	SENT144	12	12	8	8	fluconazole	CDR1	PA449653	1038	0.893
NULL	Indian_J_Pharmacol_2014_Sep-Oct_46(5)_557-559.nxml.txt.nlp	25298592	SENT17	30	30	17	17	thalidomide	gamma	PA451644	9913	0.893
NULL	Br_J_Cancer_2013_Feb_19_108(3)_557-563.nxml.txt.nlp	23361053	SENT13	26	26	23	23	tamoxifen	PAK1	PA451581	5585;5058	0.893
NULL	Mol_Cancer_2009_Aug_25_8_66.nxml.txt.nlp	19706164	SENT119	7	7	38	38	celecoxib	p53	PA448871	7157	0.893
NULL	Acta_Pharmacol_Sin_2009_Jul_22_30(7)_956-964.nxml.txt.nlp	19543298	SENT169	16	16	34	34	simvastatin	NPC1L1	PA451363	29881	0.893
NULL	Oxid_Med_Cell_Longev_2011_Aug_4_2011_471590.nxml.txt.nlp	21904644	SENT188	7	7	1	1	probucol	CA1	PA451107	759	0.893
NULL	Clin_Ophthalmol_2014_Jan_31_8_335-341.nxml.txt.nlp	24520190	SENT7	3	3	13	13	fluorescein	FAF	PA164746009	8239;2188	0.893
NULL	Exp_Lung_Res_2013_Oct_1_39(8)_336-348.nxml.txt.nlp	23919450	SENT165	8	8	16	16	thrombin	cadherin	PA451674	1015	0.893
NULL	Int_J_Mol_Sci_2014_Mar_12_15(3)_4356-4392.nxml.txt.nlp	24625663	SENT1893	7	7	11	11	doxorubicin	Bcl-2	PA449412	596	0.893
NULL	Case_Rep_Nephrol_Urol_2014_Apr_12_4(1)_75-81.nxml.txt.nlp	24847349	SENT24	15	15	7	7	amiodarone	APT	PA448383	653639	0.893
NULL	Pain_2012_Apr_153(4)_775-783.nxml.txt.nlp	22325744	SENT438	0	0	13	13	naloxone	P21	PA450586	1026;9338	0.893
NULL	J_Exp_Med_2000_May_15_191(10)_1709-1720.nxml.txt.nlp	10811864	SENT49	28	28	3	3	neomycin	Bcl-2	PA450608	596	0.893
NULL	Breast_Cancer_(Auckl)_2014_Mar_23_8_51-56.nxml.txt.nlp	24678242	SENT5	34	34	6	6	carboplatin	BRCA1	PA448803	672	0.893
NULL	Cancer_Med_2013_Aug_29_2(4)_478-487.nxml.txt.nlp	24156020	SENT88	16	16	4	4	gemcitabine	CD4	PA449748	920	0.893
NULL	Scientifica_(Cairo)_2012_Dec_31_2012_205027.nxml.txt.nlp	24278677	SENT411	28	28	20	20	aliskiren	AT1	PA143487910	9197;185	0.893
NULL	Case_Rep_Oncol_Med_2014_Sep_14_2014_532924.nxml.txt.nlp	25298899	SENT63	25	25	3	3	leucovorin	NAC	PA450198	22861	0.893
NULL	J_Neuroinflammation_2010_Sep_7_7_51.nxml.txt.nlp	20822529	SENT187	21	21	12	12	hemin	p38	PA449849	10598;1432;7965	0.893
NULL	Arch_Toxicol_2009_Jun_27_83(6)_609-617.nxml.txt.nlp	18754102	SENT6	2	2	16	16	curcumin	gamma	PA151958596	9913	0.893
NULL	Acta_Naturae_2010_Oct-Dec_2(4)_82-94.nxml.txt.nlp	22649668	SENT82	11	11	19	19	ketamine	SAGE	PA450144	55511	0.893
NULL	J_Mol_Signal_2011_Jul_20_6_7.nxml.txt.nlp	21774804	SENT9	11	11	27	27	dasatinib	CD44	PA162372878	960	0.893
NULL	Case_Rep_Hematol_2014_May_8_2014_272458.nxml.txt.nlp	24900929	SENT27	4	4	38	38	fludarabine	CD34	PA449655	947	0.893
NULL	Adv_Hematol_2012_Mar_8_2012_856341.nxml.txt.nlp	22496694	SENT92	3	3	16	16	rivaroxaban	P-gp	PA165958360	5243	0.893
NULL	Breast_Cancer_Res_2007_Aug_8_9(4)_R50.nxml.txt.nlp	17686159	SENT234	28	28	24	24	gefitinib	EGFR	PA131301952	1956	0.893
NULL	Anat_Cell_Biol_2010_Sep_30_43(3)_194-200.nxml.txt.nlp	21212859	SENT15	17	17	29	29	ethanol	PLP	PA448073	25824;5744	0.893
NULL	Br_J_Cancer_2011_Oct_25_105(9)_1331-1337.nxml.txt.nlp	21970881	SENT135	9	9	21	21	olmesartan	MVD	PA164742950	4597	0.893
NULL	Chin_J_Cancer_2011_Jul_30(7)_463-471.nxml.txt.nlp	21718592	SENT73	23	23	1	1	olaparib	PARP1		142	0.893
NULL	Acta_Pharmacol_Sin_2011_Nov_10_32(11)_1402-1410.nxml.txt.nlp	21986579	SENT228	6	6	40	40	curcumin	CDK4	PA151958596	1019	0.893
NULL	Exp_Ther_Med_2014_Feb_13_7(2)_513-517.nxml.txt.nlp	24396436	SENT84	24	24	0	0	trypsin	TFPI-2	PA451806	7980	0.893
NULL	Int_J_Genomics_2014_Jan_29_2014_894296.nxml.txt.nlp	24616891	SENT186	37	37	15	15	ethanol	PC2	PA448073	5126;5311;8535	0.893
NULL	Clin_Psychopharmacol_Neurosci_2013_Aug_26_11(2)_60-66.nxml.txt.nlp	24023549	SENT26	5	5	27	27	aripiprazole	5-HT1A	PA10026	3350	0.893
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jun_11_67(Pt_7)_o1607.nxml.txt.nlp	21837015	SENT8	5	5	1	1	urea	mol	PA451831	90527	0.893
NULL	Br_J_Cancer_2013_Jun_25_108(12)_2485-2494.nxml.txt.nlp	23695022	SENT135	28	28	15	15	vincristine	CD31	PA451879	5175	0.893
NULL	Emerg_Infect_Dis_2014_Aug_20(8)_1280-1286.nxml.txt.nlp	25061906	SENT22	18	18	11	11	sulfadoxine	DHPS	PA451540	1725	0.893
NULL	Bone_Marrow_Transplant_2011_Mar_24_46(3)_430-435.nxml.txt.nlp	20498647	SENT103	12	12	18	18	daclizumab	IL-2	PA164764446	3558	0.893
NULL	Curr_Neuropharmacol_2008_Sep_6(3)_215-234.nxml.txt.nlp	19506722	SENT450	15	15	21	21	fluvoxamine	5-HT2A	PA449690	3356	0.893
NULL	Mol_Biol_Rep_2013_Sep_28_40(10)_5573-5585.nxml.txt.nlp	24078156	SENT273	40	40	11	11	iron	FPN1	PA450087	30061	0.893
NULL	Mol_Cancer_2010_Apr_23_9_87.nxml.txt.nlp	20416058	SENT197	28	28	9	9	doxorubicin	FADD	PA449412	8772	0.892
NULL	Case_Rep_Oncol_2013_Mar_29_6(1)_189-196.nxml.txt.nlp	23626560	SENT16	3	3	10	10	gefitinib	EGFR	PA131301952	1956	0.892
NULL	Curr_Neuropharmacol_2013_Mar_11(2)_160-170.nxml.txt.nlp	23997751	SENT129	6	6	33	33	haloperidol	5-HT2C	PA449841	3358	0.892
NULL	Br_J_Cancer_2013_May_14_108(9)_1807-1809.nxml.txt.nlp	23612454	SENT45	38	38	32	32	trastuzumab	PIK3CA	PA451743	5290	0.892
NULL	Oncotarget_2014_Dec_4_5(22)_11365-11380.nxml.txt.nlp	25426548	SENT47	14	14	24	24	nutlin-3	p53		7157	0.892
NULL	Allergy_Asthma_Immunol_Res_2009_Oct_25_1(1)_30-35.nxml.txt.nlp	20224667	SENT84	19	19	6	6	aspirin	PPARG	PA448497	5468	0.892
NULL	Curr_Neuropharmacol_2013_Mar_11(2)_160-170.nxml.txt.nlp	23997751	SENT46	9	9	3	3	mianserin	5-HT2C	PA134687937	3358	0.892
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Dec_17_3(12)_e152.nxml.txt.nlp	25518025	SENT72	22	22	18	18	itraconazole	CYP3A	PA450132	1574	0.892
NULL	Biol_Open_2014_Nov_21_3(12)_1207-1216.nxml.txt.nlp	25416063	SENT302	19	19	2	2	paraformaldehyde	DAZL	PA450790	1618	0.892
NULL	Ann_Oncol_2012_Dec_2_23(12)_3007-3016.nxml.txt.nlp	22865781	SENT171	32	32	6	6	trastuzumab	IGF1R	PA451743	3480	0.892
NULL	J_Signal_Transduct_2011_Jun_7_2011_982879.nxml.txt.nlp	21776391	SENT182	23	23	3	3	erlotinib	EGFR	PA134687924	1956	0.892
NULL	Biomed_Res_Int_2014_Jan_20_2014_948427.nxml.txt.nlp	24563867	SENT188	23	23	5	5	buspirone	COB	PA448689	4519	0.892
NULL	Arthritis_Res_Ther_2008_Mar_17_10(2)_R33.nxml.txt.nlp	18346273	SENT164	43	43	9	9	infliximab	IFN	PA452639	3439	0.892
NULL	J_Biomed_Biotechnol_2010_May_23_2010_798467.nxml.txt.nlp	20508851	SENT32	12	12	7	7	gemcitabine	CTX	PA449748	1593	0.892
NULL	Indian_J_Hum_Genet_2014_Apr-Jun_20(2)_175-184.nxml.txt.nlp	25400347	SENT137	30	30	7	7	warfarin	CYP2C9	PA451906	1559	0.892
NULL	Biochim_Biophys_Acta_2014_Jun_1841(6)_906-917.nxml.txt.nlp	24657704	SENT211	22	22	0	0	l-arginine	ATGL	PA448478	57104	0.892
NULL	Mol_Vis_2014_Dec_19_20_1680-1694.nxml.txt.nlp	25558172	SENT28	28	28	14	14	ranibizumab	HTRA1	PA164746012	5654	0.892
NULL	Eur_J_Clin_Pharmacol_2010_Nov_29_66(11)_1131-1136.nxml.txt.nlp	20669013	SENT121	12	12	23	23	voriconazole	CYP3A4	PA10233	1576	0.892
NULL	Breast_Cancer_2013_Mar_1_20(4)_302-309.nxml.txt.nlp	23456736	SENT157	12	12	5	5	tegafur	GBL	PA452620	64223	0.892
NULL	Acta_Pharmacol_Sin_2012_Dec_5_33(12)_1502-1510.nxml.txt.nlp	23123644	SENT126	0	0	7	7	losartan	AT1	PA450268	9197;185	0.892
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R91.nxml.txt.nlp	22541814	SENT17	22	22	1	1	pp2	HO-1		3162	0.892
NULL	Biologics_2012_Apr_12_6_89-99.nxml.txt.nlp	22532777	SENT35	11	11	23	23	denosumab	RANKL	PA166048634	8600	0.892
NULL	Onco_Targets_Ther_2014_May_28_7_841-852.nxml.txt.nlp	24920926	SENT4	0	0	8	8	gefitinib	EGFR	PA131301952	1956	0.892
NULL	Infect_Drug_Resist_2010_Apr_26_3_15-23.nxml.txt.nlp	21694890	SENT68	13	13	3	3	raltegravir	CD4		920	0.892
NULL	Cancers_(Basel)_2014_Nov_14_6(4)_2275-2295.nxml.txt.nlp	25405526	SENT231	18	18	14	14	carboplatin	CHOP	PA448803	1649	0.892
NULL	Breast_Cancer_Res_2010_May_18_12(Suppl_1)_P20.nxml.txt.nlp	NULL	SENT15	12	12	20	20	hydroxyurea	PLU-1	PA449942	10765	0.892
NULL	Eur_J_Clin_Pharmacol_2007_Apr_21_63(4)_335-343.nxml.txt.nlp	17318526	SENT224	6	6	34	34	acenocoumarol	CYP2C9	PA452632	1559	0.892
NULL	Biosci_Rep_2014_Dec_12_34(6)_e00160.nxml.txt.nlp	25495645	SENT94	23	23	1	1	fenofibrate	ANGPTL3	PA449594	27329	0.892
NULL	Int_J_Biol_Sci_2013_Apr_22_9(4)_350-360.nxml.txt.nlp	23630447	SENT142	24	24	6	6	doxorubicin	MDR1	PA449412	5243	0.892
NULL	Physiol_Rep_2014_Sep_28_2(9)_e12158.nxml.txt.nlp	25263207	SENT311	8	8	4	4	forskolin	MRP4	PA146096022	10257	0.892
NULL	J_Gen_Physiol_2000_Jun_1_115(6)_685-696.nxml.txt.nlp	10828243	SENT159	23	23	14	14	genistein	OLF	PA165109660	83857	0.892
NULL	Cell_Cycle_2013_May_15_12(10)_1492-1500.nxml.txt.nlp	23598717	SENT105	10	10	22	22	doxorubicin	ROCK1	PA449412	6093	0.892
NULL	Eur_J_Med_Res_2010_Feb_26_15(2)_47-53.nxml.txt.nlp	20452883	SENT140	42	42	10	10	etomidate	ESG	PA164743987	7089;7088;7090;7091	0.892
NULL	Int_J_Mol_Sci_2014_Mar_27_15(4)_5337-5349.nxml.txt.nlp	24681582	SENT108	25	25	9	9	ethanol	mol	PA448073	90527	0.892
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT537	26	26	20	20	pp2	PP1		5540;5464	0.892
NULL	Int_J_Breast_Cancer_2011_Sep_6_2011_352182.nxml.txt.nlp	22295219	SENT188	3	3	16	16	trastuzumab	p27	PA451743	5715;10534	0.892
NULL	Case_Rep_Oncol_2012_Mar_17_5(1)_125-133.nxml.txt.nlp	22666200	SENT76	36	36	21	21	trastuzumab	ACTH	PA451743	5443	0.892
NULL	Front_Mol_Neurosci_2012_Sep_6_5_91.nxml.txt.nlp	22973190	SENT466	3	3	19	19	ethanol	CRF1	PA448073	1394	0.892
NULL	Sensors_(Basel)_2010_May_25_10(5)_5074-5089.nxml.txt.nlp	22399925	SENT133	11	11	37	37	oxygen	CO2	PA450744	4513	0.892
NULL	Pain_Res_Treat_2013_Jan_30_2013_217864.nxml.txt.nlp	23431433	SENT77	10	10	3	3	amiloride	NHE	PA448368	285335	0.892
NULL	Oncotarget_2014_Aug_29_5(17)_7217-7259.nxml.txt.nlp	25277175	SENT301	23	23	15	15	pazopanib	CSF1R	PA165291492	1436	0.892
NULL	Drug_Des_Devel_Ther_2014_Sep_23_8_1527-1538.nxml.txt.nlp	25284985	SENT131	5	5	37	37	celecoxib	IFN	PA448871	3439	0.892
NULL	Infect_Dis_Ther_2013_Dec_8_2(2)_95-110.nxml.txt.nlp	25134474	SENT145	7	7	13	13	ceftriaxone	CABP	PA448866	6277	0.892
NULL	Alzheimers_Res_Ther_2011_Dec_20_3(6)_36.nxml.txt.nlp	22236739	SENT78	29	29	15	15	pioglitazone	TOMM40	PA450970	10452	0.892
NULL	Hum_Genomics_2010_Apr_1_4(4)_238-249.nxml.txt.nlp	20511137	SENT105	9	9	19	19	sn-38	UGT1A1		54658	0.892
NULL	Reprod_Biol_Endocrinol_2013_Feb_26_11_15.nxml.txt.nlp	23442442	SENT198	3	3	10	10	l-arginine	BCL2	PA448478	596	0.892
NULL	Breast_Cancer_Res_Treat_2009_Jul_22_116(2)_371-378.nxml.txt.nlp	18941892	SENT124	11	11	1	1	estradiol	aromatase	PA449503	1588	0.892
NULL	Br_J_Cancer_2012_Feb_14_106(4)_685-692.nxml.txt.nlp	22294184	SENT251	2	2	8	8	lovastatin	p27	PA450272	5715;10534	0.892
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT133	25	25	37	37	dasatinib	LYN	PA162372878	4067	0.892
NULL	Oncotarget_2014_Feb_7_5(3)_775-787.nxml.txt.nlp	24519956	SENT113	13	13	8	8	docetaxel	PC3	PA449383	57332;7832;5122	0.892
NULL	J_Mol_Signal_2014_Mar_6_9_1.nxml.txt.nlp	24597858	SENT107	7	7	12	12	metoprolol	EGFR	PA450480	1956	0.892
NULL	Br_J_Cancer_2012_Aug_21_107(5)_823-830.nxml.txt.nlp	22836512	SENT164	26	26	13	13	crizotinib	EGFR	PA165946122	1956	0.892
NULL	Exp_Ther_Med_2015_Feb_3_9(2)_585-590.nxml.txt.nlp	25574239	SENT9	8	8	34	34	indomethacin	COX	PA449982	1351	0.892
NULL	Nucleic_Acids_Res_2011_Dec_2_39(22)_9731-9745.nxml.txt.nlp	21890904	SENT193	10	10	21	21	galactose	U3A	PA449725	692232	0.892
NULL	Breast_Cancer_Res_2012_Jun_14_14(3)_R95.nxml.txt.nlp	22697792	SENT460	30	30	19	19	exemestane	aromatase	PA449563	1588	0.892
NULL	Arthritis_Res_Ther_2008_Mar_17_10(2)_R33.nxml.txt.nlp	18346273	SENT13	23	23	3	3	infliximab	HMGB1	PA452639	3146	0.892
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT160	10	10	1	1	lapatinib	HER2	PA152241907	2064	0.892
NULL	Oncol_Lett_2014_Mar_2_7(3)_791-796.nxml.txt.nlp	24527087	SENT134	8	8	24	24	imatinib	CD34	PA10804	947	0.892
NULL	Ann_Surg_Treat_Res_2014_Feb_22_86(2)_68-75.nxml.txt.nlp	24761411	SENT152	5	5	8	8	oxaliplatin	survivin	PA131285527	332	0.892
NULL	Biomed_Res_Int_2014_Jan_20_2014_948427.nxml.txt.nlp	24563867	SENT93	3	3	26	26	buspirone	STZ	PA448689	6484	0.892
NULL	Hum_Genomics_2010_Feb_1_4(3)_194-201.nxml.txt.nlp	20368140	SENT51	2	2	10	10	collagenase	MMP1	PA449107	4312	0.892
NULL	Diabetes_Care_2011_Sep_19_34(9)_2108-2112.nxml.txt.nlp	21788628	SENT157	25	25	10	10	rosiglitazone	DREAM	PA451283	30818	0.892
NULL	Hum_Genomics_2010_Apr_1_4(4)_238-249.nxml.txt.nlp	20511137	SENT49	27	27	30	30	atazanavir	UGT1A1	PA10251	54658	0.892
NULL	Korean_Circ_J_2013_Oct_30_43(10)_699-701.nxml.txt.nlp	24255655	SENT66	3	3	13	13	amiodarone	APT	PA448383	653639	0.892
NULL	Lancet_2011_Jun_18_377(9783)_2103-2114.nxml.txt.nlp	21641636	SENT290	16	16	20	20	cetuximab	KRAS	PA10040	3845	0.892
NULL	Acta_Pharmacol_Sin_2009_Sep_24_30(9)_1262-1275.nxml.txt.nlp	19701231	SENT10	16	16	9	9	lovastatin	LRP10	PA450272	26020	0.892
NULL	Biologics_2010_Aug_9_4_173-185.nxml.txt.nlp	20714355	SENT40	21	21	18	18	cetuximab	EGFR	PA10040	1956	0.892
NULL	ScientificWorldJournal_2014_Dec_11_2014_194652.nxml.txt.nlp	25580452	SENT61	26	26	29	29	benzaldehyde	mol	PA448571	90527	0.892
NULL	Chin_J_Cancer_2012_Feb_31(2)_58-72.nxml.txt.nlp	22098952	SENT238	14	14	3	3	vincristine	MRP7	PA451879	89845;1080	0.892
NULL	J_Adv_Pharm_Technol_Res_2011_Apr-Jun_2(2)_81-87.nxml.txt.nlp	22171298	SENT4	14	14	28	28	carbamazepine	BCS	PA448785	617	0.892
NULL	NMR_Biomed_2014_Jul_5_27(7)_760-773.nxml.txt.nlp	24798066	SENT109	24	24	4	4	cyclophosphamide	TP1	PA449165	7011	0.892
NULL	Oncotarget_2013_Nov_19_5(2)_309-325.nxml.txt.nlp	24525395	SENT207	6	6	19	19	curcumin	AKT	PA151958596	207	0.892
NULL	Indian_J_Pharm_Sci_2014_Jan-Feb_76(1)_72-77.nxml.txt.nlp	24799741	SENT117	13	13	19	19	diclofenac	CYP2C9	PA449293	1559	0.892
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT351	17	17	5	5	heparin	FGF2	PA449855	2247;2258	0.892
NULL	Exp_Transl_Stroke_Med_2011_Sep_12_3_8.nxml.txt.nlp	21910904	SENT65	25	25	11	11	nadh	SIRT1	PA164755085	23411	0.892
NULL	Br_J_Haematol_2008_Aug_28_142(4)_505-514.nxml.txt.nlp	18510682	SENT149	32	32	21	21	alemtuzumab	B19	PA164783958	59271	0.892
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT104	0	0	16	16	pertuzumab	HRG		3084;3273	0.892
NULL	Br_J_Cancer_2011_Mar_1_104(5)_769-780.nxml.txt.nlp	21304529	SENT176	20	20	1	1	oxaliplatin	ANOVA	PA131285527	4858	0.892
NULL	Epilepsia_2012_Jun_21_53(Suppl_1)_18-25.nxml.txt.nlp	22612805	SENT116	7	7	16	16	furosemide	CA1	PA449719	759	0.892
NULL	BMB_Rep_2014_Nov_47(11)_649-654.nxml.txt.nlp	25301019	SENT87	7	7	11	11	l-serine	CCL2	PA451330	6347	0.892
NULL	Drugs_R_D_2010_Sep_27_10(3)_203-210.nxml.txt.nlp	20945949	SENT11	26	26	43	43	boceprevir	SOC	PA165948902	91544	0.892
NULL	Arthritis_Res_Ther_2013_Dec_19_15(6)_R218.nxml.txt.nlp	24351550	SENT47	30	30	6	6	metformin	AMPK	PA450395	5563	0.892
NULL	Mol_Cancer_2009_Jun_8_8_34.nxml.txt.nlp	19500427	SENT175	16	16	5	5	gemcitabine	FBXO5	PA449748	26271	0.892
NULL	Anticancer_Agents_Med_Chem_2012_Feb_12(2)_163-171.nxml.txt.nlp	22043994	SENT192	9	9	29	29	cetuximab	BRAF	PA10040	673	0.892
NULL	Diabetes_Care_2010_Oct_13_33(10)_2250-2253.nxml.txt.nlp	20628086	SENT23	32	32	14	14	glucose	DREAM	PA449773	30818	0.892
NULL	Nat_Chem_Biol_2010_Apr_28_6(4)_291-299.nxml.txt.nlp	20190765	SENT190	8	8	27	27	dasatinib	AKT	PA162372878	207	0.892
NULL	Mol_Syst_Biol_2009_Jul_28_5_288.nxml.txt.nlp	19638969	SENT14	8	8	19	19	resveratrol	HuR		1994	0.892
NULL	J_Mol_Signal_2010_May_10_5_4.nxml.txt.nlp	20459745	SENT141	7	7	3	3	cisplatin	CTR1	PA449014	1317	0.892
NULL	Onco_Targets_Ther_2014_Sep_18_7_1619-1624.nxml.txt.nlp	25258542	SENT58	18	18	12	12	cetuximab	EGF	PA10040	1950	0.892
NULL	J_Vet_Med_Sci_2014_Mar_5_76(3)_431-433.nxml.txt.nlp	24189617	SENT16	0	0	7	7	ketoconazole	CYP3A	PA450146	1574	0.892
NULL	Eur_J_Epidemiol_2009_Sep_2_24(9)_553-572.nxml.txt.nlp	19728115	SENT1547	19	19	10	10	acenocoumarol	CYP2C9	PA452632	1559	0.892
NULL	J_Biomed_Biotechnol_2010_May_23_2010_798467.nxml.txt.nlp	20508851	SENT216	24	24	13	13	gemcitabine	CTX	PA449748	1593	0.892
NULL	Hum_Genomics_2008_Sep_1_3(1)_53-70.nxml.txt.nlp	19129090	SENT194	44	44	6	6	perifosine	DGKE	PA165291471	8526	0.892
NULL	Clinics_(Sao_Paulo)_2013_May_68(5)_694-701.nxml.txt.nlp	23778405	SENT40	15	15	22	22	vincristine	DDP	PA451879	1678	0.892
NULL	Ann_Oncol_2010_Oct_19_21(10)_1952-1960.nxml.txt.nlp	20305037	SENT166	12	12	4	4	cetuximab	KRAS	PA10040	3845	0.892
NULL	Adv_Pharmacol_Sci_2014_Jan_15_2014_132034.nxml.txt.nlp	24527029	SENT109	0	0	11	11	fluoxetine	CYP2D6	PA449673	1565	0.892
NULL	Curr_Neuropharmacol_2013_Dec_11(6)_652-663.nxml.txt.nlp	24396340	SENT82	1	1	18	18	paclitaxel	TRPV1	PA450761	7442	0.892
NULL	Am_J_Trop_Med_Hyg_2014_Oct_1_91(4)_854-861.nxml.txt.nlp	25071003	SENT18	23	23	9	9	primaquine	G6PD	PA451103	2539	0.892
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Jul_23_3(7)_e126.nxml.txt.nlp	25054314	SENT24	23	23	2	2	docetaxel	OATP1B3	PA449383	28234	0.892
NULL	Clin_Med_Insights_Womens_Health_2013_Jan_22_6_1-11.nxml.txt.nlp	24665209	SENT43	17	17	5	5	exemestane	aromatase	PA449563	1588	0.892
NULL	Eur_J_Clin_Pharmacol_2008_Feb_26_64(2)_133-157.nxml.txt.nlp	18224312	SENT77	11	11	6	6	tolbutamide	CYP2C9	PA451718	1559	0.892
NULL	EPMA_J_2015_Jan_22_6(1)_1.nxml.txt.nlp	25628770	SENT342	14	14	2	2	cetuximab	KRAS	PA10040	3845	0.892
NULL	Cost_Eff_Resour_Alloc_2006_May_31_4_9.nxml.txt.nlp	16737538	SENT128	23	23	1	1	rofecoxib	OTC	PA451268	5009	0.892
NULL	J_Biol_Chem_2008_May_23_283(21)_14845-14856.nxml.txt.nlp	18356157	SENT159	14	14	6	6	paraformaldehyde	SNAP45	PA450790	6618	0.892
NULL	Biologics_2013_Mar_3_7_61-68.nxml.txt.nlp	23493885	SENT50	36	36	26	26	gefitinib	AKT	PA131301952	207	0.892
NULL	Br_J_Cancer_2013_Jul_23_109(2)_342-350.nxml.txt.nlp	23807172	SENT243	15	15	25	25	sorafenib	NAC	PA7000	22861	0.892
NULL	Pharm_Pract_(Granada)_2011_Mar_15_Jan-Mar_9(1)_1-10.nxml.txt.nlp	25132883	SENT167	33	33	45	45	warfarin	SPAF	PA451906	166378	0.892
NULL	Cancers_(Basel)_2010_Dec_30_3(1)_106-125.nxml.txt.nlp	24212609	SENT21	3	3	39	39	gemcitabine	SLC29A1	PA449748	2030	0.892
NULL	Clinics_(Sao_Paulo)_2013_Feb_68(2)_253-262.nxml.txt.nlp	23525324	SENT238	30	30	9	9	genistein	Gen	PA165109660	348654	0.892
NULL	Mol_Cancer_2014_Jun_5_13_143.nxml.txt.nlp	24898067	SENT190	25	25	20	20	gefitinib	HER-2	PA131301952	2064	0.892
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT3	5	5	24	24	curcumin	PC-3	PA151958596	692094	0.892
NULL	Ther_Clin_Risk_Manag_2006_Mar_2(1)_19-24.nxml.txt.nlp	18360578	SENT35	15	15	6	6	oxybutynin	CYP3A4	PA164746030	1576	0.892
NULL	BMB_Rep_2014_May_47(5)_274-279.nxml.txt.nlp	24286313	SENT73	11	11	31	31	bortezomib	GAPDH	PA10252	2597	0.892
NULL	J_Cell_Mol_Med_2014_May_14_18(5)_811-823.nxml.txt.nlp	24628949	SENT229	38	38	9	9	docetaxel	FOXM1	PA449383	2305	0.892
NULL	Oncotarget_2014_Dec_4_5(22)_11365-11380.nxml.txt.nlp	25426548	SENT35	22	22	20	20	nutlin-3	MDM2		4193	0.892
NULL	Indian_J_Pharmacol_2013_Jan-Feb_45(1)_54-60.nxml.txt.nlp	23543867	SENT145	12	12	27	27	terlipressin	NAC	PA164781020	22861	0.892
NULL	J_Int_Soc_Sports_Nutr_2008_Sep_17_5(Suppl_1)_P4.nxml.txt.nlp	NULL	SENT10	1	1	16	16	creatine	ANOVA	PA164778930	4858	0.892
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT53	33	33	18	18	trastuzumab	HER3	PA451743	2065	0.892
NULL	Aging_(Albany_NY)_2012_Jul_22_4(7)_480-498.nxml.txt.nlp	22837425	SENT10	8	8	27	27	metformin	AMPK	PA450395	5563	0.892
NULL	Braz_J_Med_Biol_Res_2014_Oct_14_47(12)_1068-1074.nxml.txt.nlp	25387674	SENT74	0	0	31	31	taurine	HCS	PA451590	3141;54205	0.892
NULL	Exp_Mol_Med_2012_Sep_30_44(9)_536-544.nxml.txt.nlp	22771771	SENT32	26	26	33	33	ns-398	COX		1351	0.892
NULL	Front_Oncol_2014_Mar_3_4_34.nxml.txt.nlp	24624361	SENT331	21	21	25	25	olaparib	BRCA1		672	0.892
NULL	Cancer_2014_Aug_1_120(15)_2343-2351.nxml.txt.nlp	24752945	SENT155	27	27	14	14	gemcitabine	ERCC1	PA449748	2067	0.892
NULL	J_Cell_Biol_1986_Jul_1_103(1)_87-94.nxml.txt.nlp	3013901	SENT9	9	9	18	18	glutaraldehyde	EGF	PA449777	1950	0.892
NULL	Br_J_Cancer_2011_Aug_23_105(5)_649-657.nxml.txt.nlp	21811251	SENT155	31	31	19	19	gefitinib	IGF1R	PA131301952	3480	0.892
NULL	Biomed_Res_Int_2014_Feb_13_2014_309151.nxml.txt.nlp	24683546	SENT174	22	22	9	9	rosiglitazone	STZ	PA451283	6484	0.892
NULL	Biologics_2012_Jan_5_6_13-20.nxml.txt.nlp	22291463	SENT110	10	10	26	26	carboplatin	CA125	PA448803	4077;94025	0.892
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1059-1066.nxml.txt.nlp	21364577	SENT74	29	29	16	16	letrozole	BCS	PA450196	617	0.892
NULL	Cancer_Manag_Res_2013_Nov_21_5_387-400.nxml.txt.nlp	24294007	SENT115	10	10	22	22	vemurafenib	EGFR	PA165946873	1956	0.892
NULL	Cardiovasc_Res_2014_Mar_1_101(3)_513-521.nxml.txt.nlp	24323316	SENT129	7	7	2	2	maraviroc	CCR5	PA164768835	1234	0.892
NULL	Indian_J_Pharmacol_2014_Jan-Feb_46(1)_3-12.nxml.txt.nlp	24550577	SENT222	32	32	25	25	azithromycin	P-gp	PA448519	5243	0.892
NULL	Mol_Pain_2014_Apr_18_10_27.nxml.txt.nlp	24742127	SENT269	19	19	6	6	paclitaxel	CB1	PA450761	1268	0.892
NULL	Indian_J_Endocrinol_Metab_2013_Jul-Aug_17(4)_636-646.nxml.txt.nlp	23961479	SENT240	13	13	6	6	atorvastatin	SGS	PA448500	2200	0.892
NULL	Biosci_Rep_2013_Nov_25_33(6)_e00081.nxml.txt.nlp	24070327	SENT195	34	34	28	28	idarubicin	survivin	PA449961	332	0.892
NULL	Cells_2014_Apr_4_3(2)_199-235.nxml.txt.nlp	24709958	SENT350	6	6	24	24	sunitinib	KIT	PA162372840	3815	0.892
NULL	Breast_Cancer_Res_2005_May_24_7(5)_R589-R597.nxml.txt.nlp	16168102	SENT144	9	9	17	17	trastuzumab	FAK	PA451743	5747	0.892
NULL	Biomed_Res_Int_2013_Dec_5_2013_642848.nxml.txt.nlp	24381940	SENT165	5	5	8	8	cisplatin	IL-6	PA449014	3569	0.892
NULL	Evid_Based_Complement_Alternat_Med_2011_Feb_14_2011_248231.nxml.txt.nlp	19233878	SENT290	29	29	6	6	rosiglitazone	AS160	PA451283	9882	0.892
NULL	Ann_Neurosci_2012_Oct_19(4)_151-157.nxml.txt.nlp	25205989	SENT222	5	5	10	10	estradiol	5-HT1A	PA449503	3350	0.892
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Dec_18_67(Pt_1)_o193.nxml.txt.nlp	21522695	SENT62	10	10	21	21	ethanol	mol	PA448073	90527	0.892
NULL	Exp_Ther_Med_2013_Feb_13_5(2)_581-585.nxml.txt.nlp	23403473	SENT93	5	5	36	36	etanercept	p38	PA449515	10598;1432;7965	0.892
NULL	J_Neurol_2011_Oct_3_258(10)_1820-1826.nxml.txt.nlp	21461958	SENT112	30	30	1	1	amitriptyline	DM1	PA448385	338023;1760;28509	0.892
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT88	2	2	10	10	atorvastatin	IL-6	PA448500	3569	0.892
NULL	Eur_J_Med_Res_2009_Dec_7_14(Suppl_4)_71-77.nxml.txt.nlp	20156730	SENT140	19	19	7	7	tobramycin	PARI	PA451704	55010	0.892
NULL	Br_J_Cancer_2001_Aug_85(3)_317-324.nxml.txt.nlp	11487258	SENT3	20	20	1	1	tamoxifen	ATAC	PA451581	6375	0.892
NULL	Mol_Cell_Proteomics_2012_Feb_6_11(2)_M111_015222.nxml.txt.nlp	22147731	SENT386	35	35	3	3	cetuximab	GFPT2	PA10040	9945	0.892
NULL	Exp_Ther_Med_2013_Oct_20_6(4)_899-903.nxml.txt.nlp	24137286	SENT10	8	8	28	28	rosuvastatin	p38	PA134308647	10598;1432;7965	0.892
NULL	Aging_(Albany_NY)_2012_Apr_16_4(4)_247-255.nxml.txt.nlp	22511639	SENT83	34	34	15	15	metformin	CH1	PA450395	51430	0.892
NULL	J_Cell_Mol_Med_2013_Nov_9_17(11)_1484-1493.nxml.txt.nlp	24015932	SENT122	26	26	3	3	berberine	PAO	PA165860812	196743;54498	0.892
NULL	Front_Oncol_2014_Apr_2_4_70.nxml.txt.nlp	24765614	SENT137	16	16	9	9	sunitinib	CT26	PA162372840	168400	0.892
NULL	Int_J_Biol_Sci_2013_Aug_27_9(8)_842-852.nxml.txt.nlp	23983617	SENT214	40	40	27	27	heparin	PPX	PA449855	5531	0.892
NULL	Br_J_Ophthalmol_2008_Sep_22_92(9)_1275-1282.nxml.txt.nlp	18723745	SENT152	18	18	22	22	latanoprost	BAK	PA164774763	578	0.892
NULL	Cancers_(Basel)_2011_Apr_8_3(2)_1899-1928.nxml.txt.nlp	24212788	SENT254	27	27	9	9	paclitaxel	NRP1	PA450761	8829	0.892
NULL	Exp_Diabetes_Res_2012_Oct_26_2012_820989.nxml.txt.nlp	22110480	SENT101	8	8	18	18	rosiglitazone	LYRM1	PA451283	57149	0.892
NULL	Nat_Commun_2013_Nov_29_4_2869.nxml.txt.nlp	24287629	SENT152	7	7	16	16	collagenase	FBS	PA449107	64319;26269	0.892
NULL	Oncotarget_2014_Mar_16_5(12)_4087-4102.nxml.txt.nlp	24961479	SENT195	6	6	10	10	hemin	PC3	PA449849	57332;7832;5122	0.892
NULL	Case_Rep_Rheumatol_2014_Apr_15_2014_386328.nxml.txt.nlp	24839573	SENT45	15	15	27	27	tocilizumab	IL-6	PA165292659	3569	0.892
NULL	Croat_Med_J_2013_Apr_54(2)_171-179.nxml.txt.nlp	23630144	SENT105	26	26	19	19	taurine	STZ	PA451590	6484	0.892
NULL	Neural_Regen_Res_2014_Apr_15_9(8)_828-836.nxml.txt.nlp	25206896	SENT131	14	14	22	22	trypsin	p75	PA451806	7133;11168	0.892
NULL	Breast_Cancer_Res_2010_Jun_28_12(3)_R44.nxml.txt.nlp	20584310	SENT209	17	17	24	24	doxycycline	AKT	PA449415	207	0.892
NULL	J_Oncol_2009_Mar_24_2009_491985.nxml.txt.nlp	19325924	SENT186	24	24	16	16	genistein	IL-6	PA165109660	3569	0.892
NULL	Oncogene_2010_Jan_7_29(1)_81-92.nxml.txt.nlp	19784067	SENT18	19	19	13	13	cisplatin	MITF	PA449014	4286	0.892
NULL	Pharm_Methods_2011_Jul-Sep_2(3)_178-183.nxml.txt.nlp	23781452	SENT19	12	12	0	0	tenoxicam	LOR	PA131890625	4014	0.892
NULL	J_Oncol_2010_May_24_2010_729725.nxml.txt.nlp	20508816	SENT79	8	8	26	26	lenalidomide	IL-6	PA162363968	3569	0.892
NULL	Int_J_Med_Sci_2012_Nov_7_9(10)_881-893.nxml.txt.nlp	23155362	SENT28	18	18	13	13	anastrozole	aromatase	PA448432	1588	0.892
NULL	Med_Sci_Monit_2013_Nov_29_19_1080-1088.nxml.txt.nlp	24287619	SENT228	12	12	0	0	estradiol	ACL	PA449503	47	0.892
NULL	Case_Rep_Hematol_2013_Jun_11_2013_680459.nxml.txt.nlp	23840983	SENT12	13	13	1	1	cyanocobalamin	B12	PA451892	7126;4709	0.892
NULL	F1000_Biol_Rep_2010_Feb_11_2_12.nxml.txt.nlp	20948820	SENT33	29	29	19	19	capsaicin	P2X3	PA448776	5024	0.892
NULL	Arthritis_Res_Ther_2012_Jun_12_14(3)_R142.nxml.txt.nlp	22691272	SENT40	13	13	38	38	mianserin	IL-6	PA134687937	3569	0.892
NULL	Eur_Heart_J_2013_Apr_1_34(13)_982-992.nxml.txt.nlp	23100282	SENT148	10	10	17	17	simvastatin	LPA	PA451363	4018	0.892
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT57	28	28	5	5	cisplatin	MVP	PA449014	9961	0.892
NULL	Acta_Pharmacol_Sin_2012_Jun_14_33(6)_832-838.nxml.txt.nlp	22580740	SENT13	6	6	8	8	doxorubicin	ADM	PA449412	133	0.892
NULL	Arthritis_Res_Ther_2013_Oct_30_15(5)_R171.nxml.txt.nlp	24286269	SENT77	31	31	8	8	rituximab	GML	PA451261	2765	0.892
NULL	Int_J_Environ_Res_Public_Health_2011_Jun_8_8(6)_2090-2108.nxml.txt.nlp	21776218	SENT210	24	24	14	14	arsenite	KCNE1	PA452638	3753	0.892
NULL	Mol_Biol_Cell_2014_Mar_15_25(6)_739-752.nxml.txt.nlp	24430869	SENT154	9	9	19	19	pp2	EGF		1950	0.892
NULL	Oncotarget_2012_May_23_3(5)_518-524.nxml.txt.nlp	22643838	SENT73	11	11	16	16	imatinib	MYL	PA10804	5371	0.892
NULL	Breast_Cancer_Res_2010_Dec_20_12(Suppl_4)_S18.nxml.txt.nlp	21172080	SENT18	16	16	9	9	tamoxifen	CYP2D6	PA451581	1565	0.892
NULL	Mol_Cancer_2010_Apr_30_9_96.nxml.txt.nlp	20433742	SENT20	33	33	22	22	methotrexate	TYMS	PA450428	7298	0.892
NULL	Br_J_Pharmacol_2014_May_171(10)_2659-2670.nxml.txt.nlp	24116661	SENT20	3	3	25	25	naringenin	TRPP2	PA151958361	5311	0.892
NULL	Ann_Surg_Oncol_2010_Apr_20_17(4)_1168-1176.nxml.txt.nlp	19936839	SENT76	5	5	14	14	panitumumab	KRAS	PA162373091	3845	0.892
NULL	Nucleic_Acids_Res_2012_Jul_5_40(13)_5988-6000.nxml.txt.nlp	22492511	SENT131	21	21	31	31	flavopiridol	MYB	PA452627	4602	0.892
NULL	Acta_Neuropathol_2010_Nov_17_120(5)_567-584.nxml.txt.nlp	20714900	SENT267	17	17	7	7	temozolomide	MSH6	PA451609	2956	0.892
NULL	Mol_Cancer_2010_Aug_16_9_217.nxml.txt.nlp	20712901	SENT64	6	6	9	9	curcumin	STAT3	PA151958596	6774	0.892
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT277	16	16	20	20	metformin	HIF-1	PA450395	29072	0.892
NULL	Hum_Mol_Genet_2013_Jun_1_22(11)_2247-2262.nxml.txt.nlp	23424202	SENT174	4	4	24	24	apomorphine	AMPH	PA164781163	273	0.892
NULL	Contemp_Oncol_(Pozn)_2012_Nov_20_16(5)_401-406.nxml.txt.nlp	23788917	SENT124	19	19	25	25	erlotinib	EGFR	PA134687924	1956	0.892
NULL	Pharmaceutics_2013_Dec_19_6(1)_1-25.nxml.txt.nlp	24662363	SENT274	20	20	5	5	doxorubicin	DC8	PA449412	25936	0.892
NULL	Reprod_Biol_Endocrinol_2003_Oct_9_1_74.nxml.txt.nlp	14613550	SENT13	12	12	6	6	tolmetin	COX	PA451721	1351	0.892
NULL	EMBO_J_2014_Feb_3_33(3)_181-197.nxml.txt.nlp	24442637	SENT176	27	27	5	5	camptothecin	FAT1	PA153590860	2195	0.892
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT163	15	15	7	7	heparin	FGF1	PA449855	2246	0.892
NULL	Nucleic_Acids_Res_2005_Jun_8_33(10)_3283-3291.nxml.txt.nlp	15944449	SENT156	22	22	13	13	melphalan	XRCC3	PA450354	7517	0.892
NULL	Ann_Surg_Oncol_2012_Dec_6_19(13)_4287-4299.nxml.txt.nlp	22766981	SENT20	32	32	25	25	cetuximab	VEGF-A	PA10040	7422	0.892
NULL	Diabetes_Metab_J_2013_Oct_17_37(5)_315-325.nxml.txt.nlp	24199159	SENT194	10	10	41	41	resveratrol	SIRT1		23411	0.892
NULL	Front_Oncol_2013_Sep_11_3_228.nxml.txt.nlp	24062981	SENT189	19	19	24	24	topotecan	PARP1	PA451729	142	0.892
NULL	Cancer_Imaging_2005_Nov_23_5(Spec_No_A)_S27-S32.nxml.txt.nlp	16361133	SENT164	15	15	7	7	trastuzumab	HER2	PA451743	2064	0.892
NULL	Oncotarget_2013_Nov_4_5(1)_161-172.nxml.txt.nlp	24389287	SENT30	0	0	16	16	propranolol	p53	PA451145	7157	0.892
NULL	Cancer_Biol_Med_2013_Dec_10(4)_214-220.nxml.txt.nlp	24349831	SENT198	14	14	18	18	olaparib	BRCA1		672	0.892
NULL	Cell_Death_Dis_2013_Oct_3_4(10)_e828.nxml.txt.nlp	24091671	SENT269	8	8	0	0	cetuximab	CD44	PA10040	960	0.892
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT196	43	43	34	34	cetuximab	KRAS	PA10040	3845	0.892
NULL	Indian_J_Pharmacol_2012_Nov-Dec_44(6)_744-748.nxml.txt.nlp	23248405	SENT155	6	6	26	26	clopidogrel	P2Y12	PA449053	64805	0.892
NULL	J_Physiol_2011_Dec_1_589(Pt_23)_5561-5579.nxml.txt.nlp	22005672	SENT231	11	11	27	27	methysergide	c-fos	PA164743265	2353	0.892
NULL	Int_J_Surg_Oncol_2012_Sep_4_2012_761364.nxml.txt.nlp	22988495	SENT243	21	21	17	17	raloxifene	aromatase	PA451221	1588	0.892
NULL	Lab_Invest_2012_Jun_26_92(6)_827-841.nxml.txt.nlp	22449800	SENT233	19	19	24	24	curcumin	RAGE	PA151958596	177	0.892
NULL	Daru_2013_Dec_20_21(1)_78.nxml.txt.nlp	24359941	SENT9	41	41	25	25	gentamicin	EPO	PA449753	7076;8288;2056	0.892
NULL	Structure_2012_May_9_20-540(5-7)_841-849.nxml.txt.nlp	22579251	SENT86	43	43	16	16	dobutamine	EL2	PA449381	6708	0.892
NULL	Breast_Cancer_Res_Treat_2014_Jan_9_143(3)_493-505.nxml.txt.nlp	24402830	SENT122	19	19	2	2	lapatinib	TTR	PA152241907	7276	0.892
NULL	J_RNAi_Gene_Silencing_2010_May_29_6(1)_386-400.nxml.txt.nlp	20628499	SENT65	27	27	4	4	l-glutamine	Dicer	PA10090	23405	0.892
NULL	Clin_Med_Insights_Oncol_2012_Jan_5_6_53-66.nxml.txt.nlp	22253555	SENT6	16	16	24	24	vemurafenib	BRAF	PA165946873	673	0.892
NULL	Indian_J_Pharm_Sci_2013_Jan-Feb_75(1)_31-35.nxml.txt.nlp	23901158	SENT49	14	14	8	8	dicloxacillin	DCX	PA164749649	1641	0.892
NULL	Cancer_Inform_2014_Jan_21_13_21-45.nxml.txt.nlp	24526833	SENT348	2	2	11	11	tamoxifen	STAT3	PA451581	6774	0.892
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT418	18	18	4	4	cetuximab	KRAS	PA10040	3845	0.892
NULL	Evid_Based_Complement_Alternat_Med_2013_Oct_22_2013_213976.nxml.txt.nlp	24250713	SENT63	22	22	28	28	amiodarone	ANOVA	PA448383	4858	0.892
NULL	Oncol_Rep_2013_Apr_23_29(4)_1268-1274.nxml.txt.nlp	23354756	SENT169	7	7	0	0	paclitaxel	SLC25A43	PA450761	203427	0.892
NULL	Front_Genet_2014_Nov_14_5_391.nxml.txt.nlp	25452763	SENT317	8	8	4	4	cisplatin	ERCC1	PA449014	2067	0.892
NULL	Open_Access_J_Urol_2011_May_10_3_69-82.nxml.txt.nlp	24198638	SENT67	16	16	31	31	phenprocoumon	UGT1A1	PA450921	54658	0.892
NULL	Oncogene_2009_Feb_5_28(5)_625-637.nxml.txt.nlp	19015636	SENT36	3	3	10	10	doxycycline	GLI2	PA449415	2736	0.892
NULL	J_Biomed_Biotechnol_2010_Jun_6_2010_571343.nxml.txt.nlp	20625496	SENT188	16	16	25	25	cisplatin	HSPD1	PA449014	3329	0.892
NULL	J_Adv_Pharm_Technol_Res_2012_Oct-Dec_3(4)_202-209.nxml.txt.nlp	23378940	SENT86	11	11	28	28	tropisetron	GIT	PA161925594	5034	0.892
NULL	J_Gen_Physiol_2009_Apr_133(4)_421-438.nxml.txt.nlp	19289574	SENT300	4	4	20	20	forskolin	SLC26A9	PA146096022	115019	0.892
NULL	Oncotarget_2013_Jul_31_4(10)_1572-1581.nxml.txt.nlp	24197907	SENT100	22	22	16	16	cisplatin	53BP1	PA449014	7158	0.892
NULL	Evid_Based_Complement_Alternat_Med_2013_May_28_2013_629750.nxml.txt.nlp	23781265	SENT28	7	7	26	26	capsaicin	PERK	PA448776	9451	0.892
NULL	Mol_Vis_2011_Aug_11_17_2157-2170.nxml.txt.nlp	21850191	SENT201	6	6	8	8	tacrolimus	p50	PA451578	958;4790	0.892
NULL	Diabetes_2011_Jun_21_60(6)_1797-1804.nxml.txt.nlp	21536946	SENT124	11	11	16	16	diazoxide	SUR1	PA449285	6833	0.892
NULL	Eur_J_Clin_Pharmacol_2008_Feb_26_64(2)_133-157.nxml.txt.nlp	18224312	SENT65	23	23	6	6	mephenytoin	CYP2C19	PA450373	1557	0.892
NULL	Exp_Ther_Med_2013_Mar_21_5(3)_987-991.nxml.txt.nlp	23407636	SENT100	16	16	34	34	losartan	IL-8	PA450268	3576	0.892
NULL	J_Antimicrob_Chemother_2009_Oct_13_64(4)_829-836.nxml.txt.nlp	19679597	SENT17	23	23	1	1	fosfomycin	SMF	PA164748039	22993	0.892
NULL	Br_J_Cancer_2012_Feb_14_106(4)_685-692.nxml.txt.nlp	22294184	SENT197	4	4	11	11	docetaxel	p38	PA449383	10598;1432;7965	0.892
NULL	Mol_Cancer_2010_Jun_27_9_168.nxml.txt.nlp	20579391	SENT70	3	3	22	22	imatinib	TEC	PA10804	7006	0.892
NULL	Breast_Cancer_Res_2012_Mar_20_14(2)_R53.nxml.txt.nlp	22433433	SENT317	9	9	21	21	paclitaxel	CCNE1	PA450761	898	0.892
NULL	Br_J_Pharmacol_2011_May_163(2)_261-271.nxml.txt.nlp	21054345	SENT251	16	16	6	6	rolipram	GLP-1	PA153906323	100125288	0.892
NULL	Br_J_Cancer_2014_Apr_15_110(8)_2144-2158.nxml.txt.nlp	24667650	SENT228	16	16	10	10	tamoxifen	BCAS2	PA451581	10286	0.892
NULL	Lipids_Health_Dis_2011_Jan_18_10_8.nxml.txt.nlp	21241519	SENT157	4	4	29	29	simvastatin	ABCB4	PA451363	5244	0.892
NULL	Br_J_Cancer_2010_Jan_19_102(2)_294-300.nxml.txt.nlp	19953095	SENT161	34	34	22	22	tamoxifen	ESR1	PA451581	2099	0.892
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R91.nxml.txt.nlp	22541814	SENT41	18	18	7	7	thrombin	HO-1	PA451674	3162	0.892
NULL	Arthritis_Res_Ther_2008_Mar_17_10(2)_R33.nxml.txt.nlp	18346273	SENT45	22	22	6	6	infliximab	HMGB1	PA452639	3146	0.892
NULL	J_Carcinog_2011_Nov_30_10_28.nxml.txt.nlp	22190870	SENT116	5	5	14	14	trastuzumab	CDK2	PA451743	1017	0.892
NULL	Front_Immunol_2012_May_7_3_101.nxml.txt.nlp	22783250	SENT251	25	25	7	7	papain	CD90	PA450778	7070	0.892
NULL	Diabetes_Metab_J_2012_Oct_18_36(5)_336-344.nxml.txt.nlp	23130317	SENT114	17	17	12	12	exenatide	GLP-1	PA164749238	100125288	0.892
NULL	Balkan_J_Med_Genet_2011_Jun_25_14(1)_25-30.nxml.txt.nlp	24052699	SENT81	5	5	23	23	carbamazepine	ABCC1	PA448785	4363	0.892
NULL	J_Biomed_Biotechnol_2010_Nov_1_2010_617521.nxml.txt.nlp	19888437	SENT86	4	4	11	11	lovastatin	MRP1	PA450272	4437	0.892
NULL	Cancer_Cell_Int_2012_Jul_4_12_19.nxml.txt.nlp	22631225	SENT305	13	13	5	5	heparin	PPIA	PA449855	5478	0.892
NULL	ScientificWorldJournal_2014_Mar_12_2014_731462.nxml.txt.nlp	24715817	SENT169	7	7	29	29	diclofenac	IL-6	PA449293	3569	0.892
NULL	Breast_Cancer_Res_2008_Dec_3_10(6)_R101.nxml.txt.nlp	19055754	SENT30	26	26	32	32	cetuximab	EGFR	PA10040	1956	0.892
NULL	Mol_Cancer_2010_Mar_25_9_68.nxml.txt.nlp	20338046	SENT192	29	29	22	22	doxorubicin	GSTP1	PA449412	2950	0.892
NULL	Patient_Prefer_Adherence_2008_Feb_2_2_167-175.nxml.txt.nlp	19920959	SENT181	35	35	17	17	clopidogrel	DES	PA449053	1674	0.892
NULL	Oncogene_2013_Sep_26_32(39)_10_1038_onc_2012_491.nxml.txt.nlp	23108394	SENT103	41	41	35	35	epirubicin	BRIP1	PA449476	64979;83990	0.892
NULL	Br_J_Cancer_2006_Feb_13_94(3)_407-426.nxml.txt.nlp	16434996	SENT9	28	28	13	13	genistein	BRCA1	PA165109660	672	0.892
NULL	Braz_J_Microbiol_2014_Oct_9_45(3)_1007-1015.nxml.txt.nlp	25477937	SENT149	4	4	13	13	trypsin	AG1	PA451806	100132406	0.892
NULL	Virol_J_2010_Oct_20_7_279.nxml.txt.nlp	20961433	SENT381	9	9	4	4	trypsin	VLP	PA451806	391104	0.892
NULL	Ann_Rheum_Dis_2009_Dec_1_68(12)_1819-1826.nxml.txt.nlp	19054822	SENT20	17	17	20	20	abatacept	CDP	PA164747080	1523	0.892
NULL	Front_Genet_2013_Aug_29_4_163.nxml.txt.nlp	24009622	SENT171	6	6	16	16	ethanol	ABCG2	PA448073	9429	0.892
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT281	17	17	9	9	atorvastatin	PTEN	PA448500	5728	0.892
NULL	Pharm_Pract_(Granada)_2011_Mar_15_Jan-Mar_9(1)_1-10.nxml.txt.nlp	25132883	SENT155	15	15	7	7	enoxaparin	SPAF	PA449463	166378	0.892
NULL	Gut_Liver_2013_Sep_14_7(5)_505-512.nxml.txt.nlp	24073306	SENT158	2	2	24	24	dextran	ghrelin	PA449261	51738	0.892
NULL	Cell_Commun_Signal_2013_Jan_11_11_2.nxml.txt.nlp	23305203	SENT158	28	28	4	4	forskolin	TIMAP	PA146096022	26051	0.892
NULL	Front_Oncol_2014_Jun_18_4_153.nxml.txt.nlp	24995158	SENT242	0	0	10	10	paclitaxel	JNK	PA450761	5599	0.892
NULL	Breast_Cancer_Res_2013_Sep_23_15(5)_R86.nxml.txt.nlp	24060333	SENT61	24	24	12	12	tamoxifen	aromatase	PA451581	1588	0.892
NULL	J_Clin_Biochem_Nutr_2009_Jul_30_45(1)_9-13.nxml.txt.nlp	19590701	SENT39	9	9	11	11	lansoprazole	HO-1	PA450180	3162	0.892
NULL	Biologics_2009_Jul_13_3_289-301.nxml.txt.nlp	19707416	SENT152	14	14	20	20	lapatinib	HER2	PA152241907	2064	0.892
NULL	J_Mol_Med_(Berl)_2013_Aug_17_91(11)_1257-1271.nxml.txt.nlp	23955016	SENT186	12	12	30	30	thrombin	p38	PA451674	10598;1432;7965	0.892
NULL	Exp_Diabetes_Res_2008_Jan_4_2008_704045.nxml.txt.nlp	19132099	SENT14	18	18	8	8	berberine	STZ	PA165860812	6484	0.892
NULL	Acta_Vet_Scand_2001_Jun_30_42(2)_295-302.nxml.txt.nlp	11503375	SENT90	7	7	28	28	ampicillin	spatial	PA448419	219793	0.892
NULL	Breast_Cancer_Res_Treat_2015_Dec_30_149_171-179.nxml.txt.nlp	25547219	SENT22	23	23	13	13	trastuzumab	HER2	PA451743	2064	0.892
NULL	Nucleic_Acids_Res_2005_Aug_2_33(13)_4345-4356.nxml.txt.nlp	16077030	SENT102	27	27	2	2	l-glutamine	CD4	PA10090	920	0.892
NULL	Breast_Cancer_Res_2011_Dec_16_13(6)_R131.nxml.txt.nlp	22177475	SENT12	15	15	46	46	gefitinib	AKT	PA131301952	207	0.892
NULL	Front_Genet_2012_Nov_22_3_249.nxml.txt.nlp	23189085	SENT189	23	23	8	8	vincristine	CYP3A5	PA451879	1577	0.892
NULL	Curr_Neuropharmacol_2008_Sep_6(3)_215-234.nxml.txt.nlp	19506722	SENT628	15	15	9	9	fluoxetine	5-HT1B	PA449673	3351	0.892
NULL	Subst_Abuse_Treat_Prev_Policy_2007_Oct_31_2_32.nxml.txt.nlp	17974020	SENT283	31	31	2	2	methamphetamine	NMU	PA450403	10874	0.892
NULL	Arch_Gynecol_Obstet_2012_May_30_285(5)_1447-1453.nxml.txt.nlp	22127553	SENT28	6	6	2	2	epirubicin	TEC	PA449476	7006	0.892
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jan_21_68(Pt_2)_o487.nxml.txt.nlp	22347090	SENT58	13	13	3	3	ethanol	mol	PA448073	90527	0.892
NULL	Mol_Cancer_2012_Aug_8_11_53.nxml.txt.nlp	22871047	SENT305	12	12	8	8	paclitaxel	ES2	PA450761	8220	0.892
NULL	Allergy_Asthma_Immunol_Res_2014_Nov_19_6(6)_548-557.nxml.txt.nlp	25374755	SENT112	2	2	9	9	lovastatin	L10	PA450272	6134	0.892
NULL	J_Oncol_2012_Jul_14_2012_193436.nxml.txt.nlp	21804824	SENT107	7	7	15	15	erlotinib	EGFR	PA134687924	1956	0.892
NULL	F1000_Med_Rep_2012_Feb_1_4_4.nxml.txt.nlp	22312414	SENT16	18	18	35	35	vancomycin	VISA	PA451850	57506	0.892
NULL	Mol_Cancer_2009_Nov_10_8_99.nxml.txt.nlp	19903356	SENT52	5	5	29	29	imatinib	IGFBP3	PA10804	3486	0.892
NULL	Exp_Ther_Med_2014_Aug_11_8(2)_533-538.nxml.txt.nlp	25009615	SENT20	17	17	0	0	thrombin	PAR-1	PA451674	2011;2149	0.892
NULL	Eur_J_Haematol_2014_Feb_25_92(2)_127-136.nxml.txt.nlp	24118452	SENT86	33	33	25	25	anagrelide	CRT	PA164742986	811	0.892
NULL	Acta_Pharmacol_Sin_2009_Oct_21_30(10)_1392-1398.nxml.txt.nlp	19767766	SENT128	0	0	46	46	atorvastatin	p38	PA448500	10598;1432;7965	0.892
NULL	J_Hematol_Oncol_2009_Jan_21_2_2.nxml.txt.nlp	19159467	SENT79	14	14	3	3	erlotinib	EGFR	PA134687924	1956	0.892
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT60	17	17	10	10	atorvastatin	TNF	PA448500	7124	0.892
NULL	J_Lipid_Res_2014_Dec_55(12)_2479-2490.nxml.txt.nlp	25325755	SENT126	0	0	4	4	indomethacin	COX	PA449982	1351	0.892
NULL	Diabetes_2009_Feb_58(2)_352-359.nxml.txt.nlp	19011168	SENT17	0	0	18	18	exenatide	GLP-1	PA164749238	100125288	0.892
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Sep_19_65(Pt_10)_o2494.nxml.txt.nlp	21577944	SENT58	11	11	6	6	ethanol	mol	PA448073	90527	0.892
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT797	27	27	3	3	metformin	OCT1	PA450395	5451;6580	0.892
NULL	EPMA_J_2010_Sep_20_1(3)_421-437.nxml.txt.nlp	23199086	SENT273	32	32	18	18	epirubicin	HER2	PA449476	2064	0.892
NULL	Biology_(Basel)_2012_Dec_31_2(1)_40-63.nxml.txt.nlp	24832651	SENT54	22	22	39	39	hydroxyurea	BRCA1	PA449942	672	0.892
NULL	Br_J_Haematol_2008_Aug_28_142(4)_505-514.nxml.txt.nlp	18510682	SENT150	0	0	9	9	tacrolimus	B19	PA451578	59271	0.892
NULL	J_Biol_Chem_2012_Apr_27_287(18)_14644-14658.nxml.txt.nlp	22375002	SENT708	10	10	16	16	rolipram	PDE4D	PA153906323	5144	0.892
NULL	Case_Rep_Oncol_2013_Jan_8_6(1)_15-20.nxml.txt.nlp	23466741	SENT13	35	35	24	24	erlotinib	EGFR	PA134687924	1956	0.892
NULL	Braz_J_Microbiol_2009_Dec_1_Oct-Dec_40(4)_747-756.nxml.txt.nlp	24031421	SENT93	3	3	18	18	lipase	mol	PA450239	90527	0.892
NULL	Diabetes_2009_Dec_31_58(12)_2851-2862.nxml.txt.nlp	19720788	SENT268	28	28	13	13	forskolin	GADD34	PA146096022	23645	0.892
NULL	Nat_Commun_2014_Dec_19_5_5812.nxml.txt.nlp	25524025	SENT99	19	19	14	14	doxorubicin	p53	PA449412	7157	0.892
NULL	Diabetes_Care_2009_Oct_32(10)_1941-1943.nxml.txt.nlp	19794006	SENT28	0	0	13	13	simvastatin	adiponectin	PA451363	9370	0.892
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_27_2014_715937.nxml.txt.nlp	25525447	SENT168	3	3	9	9	amiodarone	KCNB1	PA448383	3745	0.892
NULL	J_Oral_Pathol_Med_2013_Jul_18_42(6)_499-506.nxml.txt.nlp	23331485	SENT183	10	10	7	7	indomethacin	COX	PA449982	1351	0.892
NULL	Cancer_Cell_Int_2009_Feb_17_9_4.nxml.txt.nlp	19222856	SENT224	29	29	9	9	doxorubicin	p53	PA449412	7157	0.892
NULL	Oncol_Rep_2013_Sep_1_30(3)_1045-1052.nxml.txt.nlp	23817662	SENT137	35	35	6	6	erlotinib	EGFR	PA134687924	1956	0.892
NULL	Reprod_Biol_Endocrinol_2003_Apr_28_1_39.nxml.txt.nlp	12737634	SENT32	8	8	4	4	choline	BSP	PA448976	3381	0.892
NULL	Curr_Clin_Pharmacol_2008_Sep_3(3)_198-203.nxml.txt.nlp	18781906	SENT35	2	2	12	12	carbamazepine	CYP3A4	PA448785	1576	0.892
NULL	Mol_Cancer_2009_Nov_10_8_99.nxml.txt.nlp	19903356	SENT99	9	9	3	3	imatinib	IGFBP3	PA10804	3486	0.892
NULL	Mol_Cancer_2013_Sep_11_12_104.nxml.txt.nlp	24025152	SENT223	19	19	3	3	gemcitabine	STAT3	PA449748	6774	0.892
NULL	J_Hematol_Oncol_2014_Aug_1_7_52.nxml.txt.nlp	25085632	SENT13	10	10	15	15	sunitinib	EGFR	PA162372840	1956	0.892
NULL	Arthritis_Res_Ther_2009_Apr_23_11(2)_R57.nxml.txt.nlp	19389237	SENT147	21	21	30	30	adalimumab	CD68	PA10004	968	0.892
NULL	Br_J_Cancer_2009_May_19_100(10)_1540-1548.nxml.txt.nlp	19384300	SENT120	1	1	41	41	trypsin	TATI	PA451806	6690	0.892
NULL	Br_J_Cancer_2003_Jun_2_88(11)_1785-1792.nxml.txt.nlp	12771996	SENT95	13	13	8	8	staurosporine	p53	PA165109623	7157	0.892
NULL	Br_J_Cancer_2009_Nov_3_101(9)_1620-1629.nxml.txt.nlp	19809428	SENT5	0	0	40	40	geldanamycin	PC3	PA152031327	57332;7832;5122	0.892
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_15_2012_769508.nxml.txt.nlp	22203879	SENT103	19	19	3	3	l-glutamine	IFN	PA10090	3439	0.892
NULL	Biomed_Res_Int_2014_May_4_2014_171892.nxml.txt.nlp	24883302	SENT155	21	21	23	23	fulvestrant	PI3K	PA164747170	5290	0.892
NULL	EMBO_Mol_Med_2010_Oct_2(10)_388-400.nxml.txt.nlp	20878915	SENT277	22	22	17	17	rosiglitazone	p53	PA451283	7157	0.892
NULL	BMB_Rep_2013_Nov_46(11)_544-549.nxml.txt.nlp	24152910	SENT19	32	32	4	4	thrombin	PAR-1	PA451674	2011;2149	0.892
NULL	Acta_Pharmacol_Sin_2011_Oct_15_32(10)_1233-1238.nxml.txt.nlp	21841815	SENT12	6	6	16	16	mecamylamine	CTX	PA450334	1593	0.892
NULL	Clin_Endosc_2011_Sep_30_44(1)_22-26.nxml.txt.nlp	22741108	SENT27	18	18	25	25	midazolam	ESD	PA450496	2098	0.892
NULL	Biosci_Rep_2013_Jun_5_33(3)_e00041.nxml.txt.nlp	23577625	SENT19	2	2	0	0	disulfiram	DDC	PA449376	1644	0.892
NULL	J_Cell_Biol_2004_Jan_5_164(1)_111-122.nxml.txt.nlp	14709544	SENT44	14	14	36	36	forskolin	BMP2	PA146096022	650	0.892
NULL	Front_Physiol_2013_May_20_4_101.nxml.txt.nlp	23730288	SENT64	28	28	3	3	allopurinol	HL-1	PA448320	55600	0.892
NULL	Diabetes_Care_2010_Apr_12_33(4)_861-868.nxml.txt.nlp	20067962	SENT216	35	35	27	27	hyaluronan	TLR4	PA165958431	7099	0.892
NULL	Core_Evid_2011_Mar_17_6_31-42.nxml.txt.nlp	21468241	SENT94	18	18	6	6	clopidogrel	IPA	PA449053	3160	0.892
NULL	Int_J_Endocrinol_2010_Aug_19_2010_320721.nxml.txt.nlp	20016682	SENT64	9	9	3	3	atorvastatin	CYP3A4	PA448500	1576	0.892
NULL	J_Gynecol_Oncol_2012_Jul_2_23(3)_139-140.nxml.txt.nlp	NULL	SENT26	24	24	19	19	paclitaxel	EZH2	PA450761	2146	0.892
NULL	Breast_Cancer_Res_2007_Mar_2_9(2)_205.nxml.txt.nlp	NULL	SENT128	24	24	10	10	lapatinib	survivin	PA152241907	332	0.892
NULL	Alcohol_Res_Health_2007_30(1)_5-13.nxml.txt.nlp	17718394	SENT174	6	6	20	20	ethanol	ALDH2	PA448073	217	0.892
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT236	27	27	48	48	metformin	LKB1	PA450395	6794	0.892
NULL	J_Gen_Physiol_2010_Apr_135(4)_333-353.nxml.txt.nlp	20231374	SENT427	4	4	14	14	amitriptyline	P2X4	PA448385	5025	0.892
NULL	Cancer_Immunol_Immunother_2013_Aug_27_62(10)_1637-1648.nxml.txt.nlp	23982484	SENT16	9	9	22	22	lenalidomide	IL-6	PA162363968	3569	0.892
NULL	Biologics_2010_May_25_4_119-129.nxml.txt.nlp	20531968	SENT5	0	0	16	16	ustekinumab	IL-23	PA166048654	51561	0.892
NULL	J_Hematol_Oncol_2013_Jun_3_6_38.nxml.txt.nlp	23731980	SENT55	23	23	7	7	doxorubicin	San	PA449412	80218	0.892
NULL	Mol_Pain_2013_Feb_15_9_3.nxml.txt.nlp	23413875	SENT8	19	19	34	34	resveratrol	TRPV1		7442	0.892
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT94	40	40	5	5	imatinib	ABCG2	PA10804	9429	0.892
NULL	Clin_Exp_Otorhinolaryngol_2011_Dec_15_4(4)_177-183.nxml.txt.nlp	22232712	SENT18	7	7	20	20	doxycycline	p38	PA449415	10598;1432;7965	0.892
NULL	Indian_J_Med_Res_2011_Sep_134(3)_295-301.nxml.txt.nlp	21985811	SENT123	45	45	11	11	phenytoin	CYP2C9	PA450947	1559	0.892
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Sep_30_67(Pt_10)_o2720.nxml.txt.nlp	22065500	SENT68	13	13	24	24	ethanol	mol	PA448073	90527	0.892
NULL	Oncotarget_2013_Jul_14_4(8)_1185-1198.nxml.txt.nlp	23852390	SENT222	2	2	12	12	bortezomib	TRAIL	PA10252	8743	0.892
NULL	J_Oncol_2012_Sep_5_2012_128608.nxml.txt.nlp	21904549	SENT170	11	11	14	14	sunitinib	FLT3	PA162372840	2322	0.892
NULL	Anat_Cell_Biol_2011_Sep_29_44(3)_218-225.nxml.txt.nlp	22025974	SENT109	0	0	10	10	rosiglitazone	BDNF	PA451283	627	0.892
NULL	AMB_Express_2014_Mar_20_4_31.nxml.txt.nlp	24949266	SENT112	15	15	47	47	glucose	S3A	PA449773	6189	0.892
NULL	Int_J_Alzheimers_Dis_2010_Dec_27_2011_231595.nxml.txt.nlp	21234401	SENT106	4	4	32	32	iron	APP	PA450087	351	0.892
NULL	JAKSTAT_2013_Jan_1_2(1)_e23576.nxml.txt.nlp	24058797	SENT51	20	20	15	15	staurosporine	IFN	PA165109623	3439	0.892
NULL	Aging_(Albany_NY)_2014_Jan_14_6(1)_70-81.nxml.txt.nlp	24429382	SENT171	15	15	5	5	etoposide	WRN	PA449552	7486	0.892
NULL	Adv_Bioinformatics_2012_Dec_19_2012_705435.nxml.txt.nlp	23316227	SENT86	25	25	16	16	resveratrol	SIRT1		23411	0.892
NULL	Virulence_2014_Jan_1_5(1)_36-44.nxml.txt.nlp	23774844	SENT142	24	24	9	9	thrombin	PAR1	PA451674	79581;2149	0.892
NULL	Br_J_Clin_Pharmacol_2014_Nov_20_78(5)_1050-1057.nxml.txt.nlp	24962564	SENT14	22	22	5	5	ketoconazole	CYP3A4	PA450146	1576	0.892
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT160	12	12	1	1	pertuzumab	HER2		2064	0.892
NULL	Cancer_Cell_Int_2011_Aug_19_11_29.nxml.txt.nlp	21854619	SENT222	14	14	22	22	cisplatin	BRCA1	PA449014	672	0.892
NULL	Korean_J_Anesthesiol_2013_Dec_26_65(6)_501-507.nxml.txt.nlp	24427455	SENT50	27	27	14	14	rocuronium	NMB	PA164754992	10457;4828	0.892
NULL	Breast_Cancer_Res_2011_Jan_20_13(1)_R8.nxml.txt.nlp	21251330	SENT37	34	34	31	31	anastrozole	aromatase	PA448432	1588	0.892
NULL	Oncol_Lett_2013_Sep_28_6(3)_795-800.nxml.txt.nlp	24137413	SENT11	28	28	16	16	paclitaxel	HIF-1	PA450761	29072	0.892
NULL	Front_Oncol_2014_Sep_15_4_244.nxml.txt.nlp	25309870	SENT133	17	17	10	10	afatinib	EGFR	PA165981154	1956	0.892
NULL	Chemother_Res_Pract_2011_Apr_7_2011_393976.nxml.txt.nlp	22312553	SENT39	18	18	12	12	artemether	CYP3A4	PA165111698	1576	0.892
NULL	Onco_Targets_Ther_2014_May_28_7_841-852.nxml.txt.nlp	24920926	SENT64	30	30	40	40	pemetrexed	EGFR	PA10810	1956	0.892
NULL	ScientificWorldJournal_2014_Dec_9_2014_808320.nxml.txt.nlp	25548793	SENT43	12	12	19	19	heparin	RAC	PA449855	207	0.892
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_91-103.nxml.txt.nlp	17912639	SENT101	16	16	5	5	tamoxifen	HER2	PA451581	2064	0.892
NULL	Acta_Pharmacol_Sin_2012_May_16_33(5)_682-690.nxml.txt.nlp	22504904	SENT236	10	10	0	0	celecoxib	IL-6	PA448871	3569	0.892
NULL	J_Gynecol_Oncol_2013_Jul_4_24(3)_273-279.nxml.txt.nlp	23875078	SENT108	3	3	5	5	paclitaxel	COX	PA450761	1351	0.892
NULL	Evid_Based_Complement_Alternat_Med_2014_Jul_13_2014_478290.nxml.txt.nlp	25126099	SENT65	28	28	43	43	gentamicin	CO2	PA449753	4513	0.892
NULL	Nat_Commun_2014_Dec_8_5_5736.nxml.txt.nlp	25484020	SENT36	9	9	20	20	anastrozole	TRPA1	PA448432	8989	0.892
NULL	Front_Neurol_2013_May_15_4_53.nxml.txt.nlp	23720649	SENT271	7	7	4	4	geldanamycin	Hsp90	PA152031327	3320	0.892
NULL	Front_Genet_2014_Nov_14_5_391.nxml.txt.nlp	25452763	SENT259	9	9	3	3	cisplatin	ERCC2	PA449014	2068	0.892
NULL	Arch_Med_Sci_2012_Sep_8_8(4)_589-597.nxml.txt.nlp	23056066	SENT129	0	0	9	9	daclizumab	CD25	PA164764446	3669;3559	0.892
NULL	Biologics_2012_Dec_17_6_429-464.nxml.txt.nlp	23269860	SENT246	17	17	24	24	infliximab	ACR	PA452639	49	0.892
NULL	Mol_Vis_2012_Apr_11_18_901-908.nxml.txt.nlp	22539869	SENT170	9	9	27	27	curcumin	p38	PA151958596	10598;1432;7965	0.892
NULL	Indian_J_Pharmacol_2014_Nov-Dec_46(6)_627-632.nxml.txt.nlp	25538335	SENT106	6	6	9	9	metformin	Q10	PA450395	27161	0.892
NULL	Curr_Pharm_Des_2011_Feb_17(6)_578-590.nxml.txt.nlp	21391908	SENT245	7	7	13	13	imatinib	p38	PA10804	10598;1432;7965	0.892
NULL	ARYA_Atheroscler_2011_Summer_7(2)_78-86.nxml.txt.nlp	22577451	SENT11	4	4	40	40	choline	TNF	PA448976	7124	0.892
NULL	Indian_Dermatol_Online_J_2014_Dec_5(Suppl_2)_S76-S86.nxml.txt.nlp	25593813	SENT286	8	8	3	3	carbamazepine	HLA-B	PA448785	3106	0.892
NULL	J_Breast_Cancer_2011_Mar_31_14(1)_46-51.nxml.txt.nlp	21847394	SENT118	28	28	12	12	trastuzumab	HER2	PA451743	2064	0.892
NULL	Clin_Med_Insights_Cardiol_2014_Nov_13_8_93-102.nxml.txt.nlp	25452701	SENT51	11	11	6	6	heparin	ACT	PA449855	12;11332;9457;641455	0.892
NULL	Blood_Cancer_J_2014_Aug_22_4(8)_e240.nxml.txt.nlp	25148222	SENT210	0	0	29	29	pimozide	SYK	PA450965	6850	0.892
NULL	Front_Neural_Circuits_2013_Sep_3_7_139.nxml.txt.nlp	24027498	SENT206	6	6	15	15	taurine	Ray	PA451590	26751	0.892
NULL	Infect_Dis_Obstet_Gynecol_2012_Feb_25_2012_157159.nxml.txt.nlp	22505797	SENT205	26	26	3	3	metronidazole	SPTB	PA450484	6710	0.892
NULL	Mol_Cancer_2008_Mar_26_7_27.nxml.txt.nlp	18366759	SENT79	7	7	10	10	etoposide	BAX	PA449552	581	0.892
NULL	J_Hematol_Oncol_2014_Apr_28_7_37.nxml.txt.nlp	24775308	SENT192	6	6	8	8	imatinib	JAK2	PA10804	3717	0.891
NULL	Breast_Cancer_Res_2011_Jun_29_13(3)_R70.nxml.txt.nlp	21707964	SENT189	12	12	29	29	tamoxifen	FOXM1	PA451581	2305	0.891
NULL	Lab_Anim_Res_2013_Jun_24_29(2)_84-95.nxml.txt.nlp	23825481	SENT133	34	34	30	30	nifedipine	INS-1	PA450631	2305	0.891
NULL	Breast_Cancer_Res_2008_Dec_18_10(Suppl_4)_S22.nxml.txt.nlp	19128436	SENT41	4	4	2	2	aminoglutethimide	aromatase	PA448375	1588	0.891
NULL	Exp_Ther_Med_2013_Nov_13_6(5)_1317-1321.nxml.txt.nlp	24223665	SENT6	33	33	29	29	cisplatin	CD133	PA449014	8842	0.891
NULL	Asian_J_Androl_2014_Jan_17_Mar-Apr_16(2)_274-279.nxml.txt.nlp	24457841	SENT114	11	11	16	16	finasteride	PC3	PA449627	57332;7832;5122	0.891
NULL	Cancer_Cell_Int_2013_Jun_26_13_64.nxml.txt.nlp	23802572	SENT93	11	11	17	17	curcumin	Bcl-2	PA151958596	596	0.891
NULL	Mol_Cancer_2009_Apr_16_8_24.nxml.txt.nlp	19371427	SENT14	11	11	22	22	cisplatin	CHK1	PA449014	1111	0.891
NULL	Cell_Oncol_(Dordr)_2011_Apr_19_34(2)_71-88.nxml.txt.nlp	21336636	SENT74	23	23	5	5	cisplatin	BRCA1	PA449014	672	0.891
NULL	Clin_Epigenetics_2011_Dec_5_3(1)_8.nxml.txt.nlp	22414275	SENT182	17	17	12	12	ribavirin	ESR1	PA451241	2099	0.891
NULL	Semin_Immunopathol_2013_Jan_26_35(1)_39-52.nxml.txt.nlp	22829332	SENT197	12	12	18	18	etoposide	CHOP	PA449552	1649	0.891
NULL	Indian_J_Pharm_Sci_2014_Mar-Apr_76(2)_163-166.nxml.txt.nlp	24843190	SENT28	37	37	21	21	ethanol	mol	PA448073	90527	0.891
NULL	FASEB_J_2014_Sep_28(9)_3906-3918.nxml.txt.nlp	24858279	SENT110	14	14	0	0	glutaraldehyde	CTR	PA449777	799	0.891
NULL	Oncogene_2013_Sep_12_32(37)_4355-4365.nxml.txt.nlp	23108409	SENT84	14	14	5	5	hyaluronan	CD44	PA165958431	960	0.891
NULL	Ann_Clin_Transl_Neurol_2014_Dec_21_1(12)_996-1005.nxml.txt.nlp	25574474	SENT119	30	30	20	20	riluzole	P-gp	PA451251	5243	0.891
NULL	Curr_Cardiol_Rev_2009_Aug_5(3)_166-176.nxml.txt.nlp	20676275	SENT156	25	25	14	14	ibutilide	HERG	PA449958	3757	0.891
NULL	J_Cell_Biol_1998_Jul_13_142(1)_153-165.nxml.txt.nlp	9660870	SENT209	12	12	22	22	colchicine	B10	PA449092	5169	0.891
NULL	Int_J_Biol_Sci_2011_May_19_7(5)_645-650.nxml.txt.nlp	21647332	SENT81	9	9	2	2	metformin	AMPK	PA450395	5563	0.891
NULL	Braz_J_Med_Biol_Res_2013_Mar_15_46(3)_299-305.nxml.txt.nlp	23532269	SENT184	7	7	14	14	propofol	CD14	PA451141	929	0.891
NULL	Curr_Oncol_2010_Feb_17(1)_81-86.nxml.txt.nlp	20179808	SENT57	45	45	43	43	exemestane	aromatase	PA449563	1588	0.891
NULL	Br_J_Haematol_2009_Nov_2_147(3)_396-410.nxml.txt.nlp	19758122	SENT11	30	30	18	18	chlorambucil	p53	PA448926	7157	0.891
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT137	26	26	33	33	saquinavir	CYP3A	PA451305	1574	0.891
NULL	Clin_Interv_Aging_2013_Jul_16_8_889-897.nxml.txt.nlp	23898224	SENT62	4	4	13	13	gemcitabine	SIRT1	PA449748	23411	0.891
NULL	Br_J_Cancer_2012_Sep_4_107(6)_947-955.nxml.txt.nlp	22892392	SENT252	35	35	17	17	lapatinib	EGF	PA152241907	1950	0.891
NULL	Ann_Oncol_2011_Jan_13_22(1)_215-223.nxml.txt.nlp	20627875	SENT92	13	13	18	18	etoposide	DAC	PA449552	13	0.891
NULL	Breast_Cancer_Res_2011_Jan_24_13(1)_401.nxml.txt.nlp	21349137	SENT38	0	0	4	4	lapatinib	AMPK	PA152241907	5563	0.891
NULL	Eur_J_Clin_Pharmacol_2011_May_9_67(5)_477-482.nxml.txt.nlp	21305273	SENT108	25	25	12	12	dobutamine	ADRB1	PA449381	153	0.891
NULL	Cancer_Cell_Int_2013_Mar_4_13_21.nxml.txt.nlp	23497288	SENT59	24	24	3	3	cyclophosphamide	EWS	PA449165	2130	0.891
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Dec_10_3(12)_e151.nxml.txt.nlp	25494035	SENT235	8	8	2	2	rosuvastatin	OATP1B1	PA134308647	10599	0.891
NULL	J_Biomed_Biotechnol_2011_Dec_6_2011_856985.nxml.txt.nlp	21188173	SENT280	20	20	29	29	letrozole	San	PA450196	80218	0.891
NULL	Cancers_(Basel)_2014_Nov_25_6(4)_2313-2329.nxml.txt.nlp	25534569	SENT170	3	3	0	0	cabozantinib	HGF	PA165906891	3569;6654;3082	0.891
NULL	EMBO_Mol_Med_2012_Feb_4(2)_93-108.nxml.txt.nlp	22246988	SENT98	31	31	6	6	tetracycline	ATF3	PA451640	467	0.891
NULL	Indian_J_Anaesth_2014_Jul-Aug_58(4)_423-429.nxml.txt.nlp	25197110	SENT35	13	13	4	4	ondansetron	ODF	PA450705	8600	0.891
NULL	Br_J_Cancer_2013_Dec_10_109(12)_2954-2958.nxml.txt.nlp	24231949	SENT81	7	7	14	14	nutlin-3	p53		7157	0.891
NULL	Front_Neurosci_2011_Jul_26_5_92.nxml.txt.nlp	21845173	SENT65	29	29	4	4	naloxone	ANOVA	PA450586	4858	0.891
NULL	Int_J_Impot_Res_2010_Mar_26_22(2)_120-126.nxml.txt.nlp	19940852	SENT82	1	1	21	21	forskolin	mol	PA146096022	90527	0.891
NULL	Mol_Cancer_2006_Oct_6_5_43.nxml.txt.nlp	17026740	SENT369	0	0	3	3	cetuximab	EGFR	PA10040	1956	0.891
NULL	Br_J_Cancer_2013_Feb_5_108(2)_469-476.nxml.txt.nlp	23169292	SENT27	25	25	6	6	gemcitabine	KRAS	PA449748	3845	0.891
NULL	Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.nxml.txt.nlp	24736980	SENT242	11	11	1	1	rosuvastatin	OATP1B1	PA134308647	10599	0.891
NULL	Exp_Diabetes_Res_2011_Jun_4_2011_489708.nxml.txt.nlp	21747829	SENT188	15	15	31	31	aliskiren	GLP-1	PA143487910	100125288	0.891
NULL	Aging_(Albany_NY)_2013_Mar_8_5(3)_142-143.nxml.txt.nlp	23474671	SENT19	18	18	21	21	resveratrol	SIRT1		23411	0.891
NULL	Diabetes_2013_May_16_62(5)_1443-1452.nxml.txt.nlp	23274909	SENT94	22	22	29	29	carbachol	GLP-1	PA448784	100125288	0.891
NULL	Cardiovasc_Diabetol_2005_May_15_4_6.nxml.txt.nlp	15892894	SENT60	6	6	29	29	telmisartan	ANOVA	PA451605	4858	0.891
NULL	Infect_Drug_Resist_2010_Apr_22_3_5-14.nxml.txt.nlp	21694889	SENT105	6	6	28	28	vancomycin	VISA	PA451850	57506	0.891
NULL	Environ_Health_Perspect_2012_Apr_3_120(4)_583-589.nxml.txt.nlp	22476201	SENT17	40	40	14	14	arsenite	NRF2	PA452638	2551;4780	0.891
NULL	Antimicrob_Agents_Chemother_2014_Dec_58(12)_7340-7346.nxml.txt.nlp	25267661	SENT202	26	26	2	2	primaquine	CYP3A4	PA451103	1576	0.891
NULL	J_Oncol_2011_Jun_13_2011_125467.nxml.txt.nlp	21772841	SENT89	17	17	9	9	gefitinib	EGFR	PA131301952	1956	0.891
NULL	J_Exp_Med_2003_Aug_4_198(3)_505-512.nxml.txt.nlp	12900524	SENT122	14	14	3	3	dextran	CXCL13	PA449261	10563	0.891
NULL	Environ_Health_Perspect_2006_Sep_23_114(9)_1401-1406.nxml.txt.nlp	16966095	SENT178	8	8	20	20	arsenite	p53	PA452638	7157	0.891
NULL	Aging_(Albany_NY)_2013_Jan_26_4(12)_894-898.nxml.txt.nlp	23525940	SENT39	11	11	14	14	metformin	AMPK	PA450395	5563	0.891
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1063.nxml.txt.nlp	24556678	SENT66	29	29	17	17	thioridazine	Mcl-1	PA451666	4170	0.891
NULL	BMJ_2013_Feb_5_346_e5793.nxml.txt.nlp	23386361	SENT69	12	12	6	6	warfarin	VKORC1	PA451906	79001	0.891
NULL	Int_J_Endocrinol_2010_Feb_10_2010_625852.nxml.txt.nlp	20169119	SENT118	8	8	28	28	paricalcitol	PTH	PA450798	5741	0.891
NULL	J_Invest_Dermatol_2013_Aug_133(8)_1928-1929.nxml.txt.nlp	23856932	SENT39	18	18	30	30	vemurafenib	STAT3	PA165946873	6774	0.891
NULL	Ann_Med_2014_Nov_21_46(7)_475-489.nxml.txt.nlp	25045928	SENT184	12	12	17	17	cilostazol	P2Y12	PA164746334	64805	0.891
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_79-85.nxml.txt.nlp	23864840	SENT106	12	12	10	10	afatinib	EGFR	PA165981154	1956	0.891
NULL	Mol_Cell_Biochem_2012_Apr_3_363(1-2)_135-145.nxml.txt.nlp	22139302	SENT179	7	7	5	5	curcumin	survivin	PA151958596	332	0.891
NULL	Nat_Med_2013_Jun_26_19(6)_713-721.nxml.txt.nlp	23708291	SENT119	28	28	24	24	celecoxib	COX2	PA448871	4513;5743	0.891
NULL	Indian_J_Anaesth_2009_Oct_53(5)_582-591.nxml.txt.nlp	20640109	SENT53	3	3	22	22	clopidogrel	ADP	PA449053	23038	0.891
NULL	Cancers_(Basel)_2013_Jul_26_5(3)_943-958.nxml.txt.nlp	24202328	SENT853	10	10	14	14	olaparib	BRCA1		672	0.891
NULL	Biomed_Res_Int_2014_Aug_4_2014_459452.nxml.txt.nlp	25162013	SENT241	4	4	16	16	isoniazid	mol	PA450112	90527	0.891
NULL	Br_J_Cancer_2012_Jan_31_106(3)_496-507.nxml.txt.nlp	22240799	SENT213	15	15	13	13	cisplatin	GADD34	PA449014	23645	0.891
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT188	0	0	44	44	curcumin	XIAP	PA151958596	331	0.891
NULL	Biomed_Imaging_Interv_J_2011_Oct_1_7(4)_e25.nxml.txt.nlp	22279502	SENT46	0	0	8	8	oxaliplatin	CRT	PA131285527	811	0.891
NULL	Acta_Histochem_Cytochem_2014_Jun_28_47(3)_103-112.nxml.txt.nlp	25320407	SENT246	13	13	21	21	estradiol	SF-1	PA449503	2516	0.891
NULL	Front_Zool_2013_Dec_27_10_81.nxml.txt.nlp	24373523	SENT74	22	22	29	29	oxygen	CO2	PA450744	4513	0.891
NULL	Exp_Cell_Res_2008_Oct_1_314(16)_3075-3080.nxml.txt.nlp	18692496	SENT35	22	22	1	1	l-glutamine	INS-1	PA10090	2305	0.891
NULL	Mol_Biol_Cell_2014_Jan_1_25(1)_76-86.nxml.txt.nlp	24173717	SENT229	8	8	27	27	colchicine	IL-1B	PA449092	3553	0.891
NULL	Acta_Pharmacol_Sin_2012_Jan_12_33(1)_27-33.nxml.txt.nlp	22158109	SENT18	6	6	23	23	propofol	AMPK	PA451141	5563	0.891
NULL	Acta_Pharmacol_Sin_2012_Dec_29_33(12)_1518-1524.nxml.txt.nlp	23103625	SENT12	2	2	19	19	telmisartan	ACE	PA451605	1636	0.891
NULL	Hum_Genomics_2010_Apr_1_4(4)_238-249.nxml.txt.nlp	20511137	SENT119	6	6	9	9	sorafenib	UGT1A1	PA7000	54658	0.891
NULL	Adv_Hematol_2012_Mar_25_2012_302570.nxml.txt.nlp	22536253	SENT111	8	8	16	16	rituximab	CD22	PA451261	933	0.891
NULL	Oncogene_2014_Jul_24_33(30)_3959-3969.nxml.txt.nlp	24096481	SENT47	17	17	24	24	nutlin-3	p53		7157	0.891
NULL	Arthritis_Res_Ther_2014_Apr_30_16(2)_R90.nxml.txt.nlp	25167216	SENT100	28	28	6	6	tocilizumab	STEPP	PA165292659	222659	0.891
NULL	Br_J_Cancer_2004_May_4_90(9)_1733-1739.nxml.txt.nlp	15150604	SENT44	7	7	4	4	anastrozole	aromatase	PA448432	1588	0.891
NULL	Br_J_Cancer_2011_Mar_15_104(6)_893-898.nxml.txt.nlp	21364594	SENT114	24	24	13	13	capecitabine	miR-137	PA448771	406928	0.891
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT134	12	12	16	16	chloroquine	BMPR-II	PA448948	659	0.891
NULL	Front_Neurosci_2014_Dec_8_8_388.nxml.txt.nlp	25538545	SENT144	10	10	13	13	estradiol	5-HT2A	PA449503	3356	0.891
NULL	Core_Evid_2011_Feb_8_6_23-29.nxml.txt.nlp	21468240	SENT43	17	17	31	31	plerixafor	CD34	PA165958410	947	0.891
NULL	Clinics_(Sao_Paulo)_2014_Jun_69(6)_426-432.nxml.txt.nlp	24964308	SENT43	38	38	27	27	bezafibrate	IL-6	PA162364313	3569	0.891
NULL	Exp_Diabetes_Res_2012_Apr_17_2012_635472.nxml.txt.nlp	22577369	SENT73	10	10	7	7	exenatide	GLP-1	PA164749238	100125288	0.891
NULL	Br_J_Cancer_2009_Mar_10_100(5)_834-839.nxml.txt.nlp	19174821	SENT108	24	24	19	19	sulfamethoxazole	TMP	PA451544	2012	0.891
NULL	Cell_Death_Dis_2014_Apr_24_5(4)_e1197.nxml.txt.nlp	24763054	SENT103	23	23	15	15	doxorubicin	ARC	PA449412	8996;23237	0.891
NULL	Mol_Biol_Rep_2013_May_11_40(8)_5013-5026.nxml.txt.nlp	23666059	SENT36	14	14	6	6	resveratrol	p53		7157	0.891
NULL	Oxid_Med_Cell_Longev_2012_Nov_14_2012_856085.nxml.txt.nlp	23213350	SENT234	2	2	23	23	losartan	p47phox	PA450268	653361	0.891
NULL	Aging_(Albany_NY)_2010_Dec_31_2(12)_924-935.nxml.txt.nlp	21212465	SENT99	32	32	27	27	etoposide	p53	PA449552	7157	0.891
NULL	Oncol_Rep_2015_Feb_11_33(2)_526-532.nxml.txt.nlp	25501339	SENT26	30	30	16	16	gefitinib	PI3K	PA131301952	5290	0.891
NULL	Clin_Epigenetics_2011_Jun_27_2(2)_171-185.nxml.txt.nlp	21949547	SENT62	32	32	17	17	doxorubicin	MRP1	PA449412	4437	0.891
NULL	J_Biol_Chem_2009_Sep_4_284(36)_24443-24452.nxml.txt.nlp	19561358	SENT17	17	17	4	4	mitomycin	FANCI	PA450524	55215	0.891
NULL	Crit_Rev_Toxicol_2013_Feb_25_43(2)_119-153.nxml.txt.nlp	23346981	SENT265	21	21	19	19	hydroquinone	CYP2E1	PA449924	1571	0.891
NULL	Br_J_Haematol_2014_Mar_13_164(1)_811-821.nxml.txt.nlp	24328678	SENT130	19	19	42	42	lenalidomide	Aiolos	PA162363968	22806	0.891
NULL	Cell_Logist_2012_Apr_1_2(2)_117-125.nxml.txt.nlp	23162743	SENT88	4	4	16	16	pp2	RAC		207	0.891
NULL	Int_J_Mol_Sci_2014_Oct_8_15(10)_17974-17999.nxml.txt.nlp	25299695	SENT112	2	2	14	14	curcumin	HO-2	PA151958596	3163	0.891
NULL	Mol_Cancer_2007_Mar_7_6_18.nxml.txt.nlp	17343740	SENT182	3	3	16	16	pamidronate	PC3	PA450767	57332;7832;5122	0.891
NULL	Curr_Health_Sci_J_2014_Dec_29_Jan-Mar_40(1)_62-66.nxml.txt.nlp	24791209	SENT80	18	18	13	13	azathioprine	ACE	PA448515	1636	0.891
NULL	J_Brachial_Plex_Peripher_Nerve_Inj_2008_Mar_19_3_8.nxml.txt.nlp	18353188	SENT205	30	30	17	17	capsaicin	SSeCKS	PA448776	9590	0.891
NULL	Endocrinol_Metab_(Seoul)_2014_Jun_26_29(2)_105-111.nxml.txt.nlp	25031882	SENT14	3	3	12	12	heparin	FGF19	PA449855	9965	0.891
NULL	Int_J_Mol_Sci_2014_May_8_15(5)_8106-8121.nxml.txt.nlp	24815071	SENT8	3	3	27	27	atorvastatin	LC3	PA448500	84557	0.891
NULL	Diabetes_Care_2009_Oct_8_32(10)_1796-1801.nxml.txt.nlp	19587369	SENT184	13	13	5	5	rosiglitazone	DREAM	PA451283	30818	0.891
NULL	J_Physiol_2009_Feb_15_587(Pt_4)_731-744.nxml.txt.nlp	19074966	SENT88	6	6	1	1	taurine	PAT1	PA451590	10513;206358	0.891
NULL	J_Adv_Pharm_Technol_Res_2012_Oct-Dec_3(4)_202-209.nxml.txt.nlp	23378940	SENT86	9	9	28	28	granisetron	GIT	PA449809	5034	0.891
NULL	Breast_Cancer_Res_2011_Nov_1_13(6)_224.nxml.txt.nlp	22114931	SENT129	34	34	30	30	lapatinib	HER2	PA152241907	2064	0.891
NULL	Curr_Oncol_2009_Jan_16(1)_27-48.nxml.txt.nlp	19229369	SENT268	20	20	35	35	docetaxel	KRAS	PA449383	3845	0.891
NULL	Cancer_Cell_Int_2005_Aug_23_5_27.nxml.txt.nlp	16117829	SENT195	19	19	27	27	doxycycline	p53	PA449415	7157	0.891
NULL	Oncol_Lett_2014_Jan_18_7(1)_131-136.nxml.txt.nlp	24348834	SENT37	9	9	21	21	spectinomycin	EGFR	PA164781342	1956	0.891
NULL	Saudi_J_Anaesth_2013_Jan-Mar_7(1)_80-82.nxml.txt.nlp	23717238	SENT16	25	25	18	18	bupivacaine	PTN	PA135057240	5764	0.891
NULL	J_Immunol_Res_2014_Jul_21_2014_297073.nxml.txt.nlp	25143957	SENT234	3	3	13	13	cyclosporine	HLA-G	PA449167	3135	0.891
NULL	Exp_Ther_Med_2013_Mar_24_5(3)_902-906.nxml.txt.nlp	23408108	SENT7	21	21	9	9	anastrozole	aromatase	PA448432	1588	0.891
NULL	Pharmaceuticals_(Basel)_2014_May_14_7(5)_621-633.nxml.txt.nlp	24830987	SENT216	22	22	32	32	ethanol	FDG	PA448073	23583	0.891
NULL	Cases_J_2009_Jul_30_2_7134.nxml.txt.nlp	19829918	SENT56	25	25	35	35	levodopa	LCE	PA450213	79071	0.891
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT12	17	17	25	25	neratinib	HRG	PA165291472	3084;3273	0.891
NULL	Exp_Ther_Med_2013_Jul_25_6(1)_109-114.nxml.txt.nlp	23935730	SENT142	33	33	29	29	doxorubicin	CHOP	PA449412	1649	0.891
NULL	Breast_Cancer_(Auckl)_2009_Apr_7_3_23-34.nxml.txt.nlp	21556247	SENT125	7	7	14	14	celecoxib	AKT	PA448871	207	0.891
NULL	Exp_Diabetes_Res_2012_Nov_12_2012_618923.nxml.txt.nlp	23197974	SENT160	11	11	24	24	telmisartan	STZ	PA451605	6484	0.891
NULL	Arch_Toxicol_2014_Nov_5_88(12)_2135-2190.nxml.txt.nlp	25370008	SENT1020	1	1	6	6	4-methylumbelliferone	UGT	PA154081778	7361;7355	0.891
NULL	J_Mol_Signal_2008_Dec_2_3_19.nxml.txt.nlp	19055733	SENT58	16	16	2	2	isoproterenol	AKAP5	PA450121	9495	0.891
NULL	Br_J_Cancer_2014_Dec_9_111(12)_2379-2380.nxml.txt.nlp	24619075	SENT12	28	28	15	15	irinotecan	KRAS	PA450085	3845	0.891
NULL	Infect_Dis_Ther_2014_Dec_12_3(2)_103-122.nxml.txt.nlp	25388760	SENT240	31	31	4	4	tipranavir	P-gp	PA163522473	5243	0.891
NULL	Cells_2014_Apr_4_3(2)_199-235.nxml.txt.nlp	24709958	SENT336	20	20	12	12	erlotinib	PTEN	PA134687924	5728	0.891
NULL	Ther_Clin_Risk_Manag_2007_Jun_3(3)_467-474.nxml.txt.nlp	18488080	SENT122	15	15	18	18	ciprofloxacin	CYP1A2	PA449009	1544	0.891
NULL	Eur_J_Med_Res_2010_Feb_26_15(2)_47-53.nxml.txt.nlp	20452883	SENT82	32	32	13	13	fentanyl	ESG	PA449599	7089;7088;7090;7091	0.891
NULL	Drug_Des_Devel_Ther_2014_Dec_1_8_2391-2400.nxml.txt.nlp	25489237	SENT175	6	6	13	13	liraglutide	GLP-1	PA165958364	100125288	0.891
NULL	Nat_Commun_2014_Dec_1_5_5472.nxml.txt.nlp	25434649	SENT503	10	10	30	30	minocycline	CD68	PA450519	968	0.891
NULL	Cent_European_J_Urol_2011_Dec_9_64(4)_256-257.nxml.txt.nlp	24578906	SENT13	24	24	7	7	doxazosin	CD133	PA449407	8842	0.891
NULL	Oncotarget_2013_Dec_18_5(3)_634-648.nxml.txt.nlp	24504138	SENT177	21	21	8	8	bortezomib	Bcl-2	PA10252	596	0.891
NULL	Clin_Mol_Hepatol_2013_Dec_28_19(4)_325-348.nxml.txt.nlp	24459637	SENT246	0	0	32	32	metformin	AMPK	PA450395	5563	0.891
NULL	Asian_J_Androl_2014_Apr_18_May-Jun_16(3)_387-400.nxml.txt.nlp	24759590	SENT56	21	21	11	11	eplerenone	ACTH	PA164749044	5443	0.891
NULL	Diabetes_Care_2011_Jul_17_34(7)_e115-e120.nxml.txt.nlp	21709286	SENT108	15	15	3	3	metformin	AMPK	PA450395	5563	0.891
NULL	Cancer_Cell_Int_2014_Jul_2_14_59.nxml.txt.nlp	25120382	SENT132	16	16	18	18	metformin	Met	PA450395	79811	0.891
NULL	Acta_Pharmacol_Sin_2011_Jul_13_32(7)_967-972.nxml.txt.nlp	21666702	SENT149	17	17	3	3	ticlopidine	P-gp	PA451686	5243	0.891
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT258	11	11	28	28	pp2	PP2		4888	0.891
NULL	Antiviral_Res_2009_May_82(2)_A99-A109.nxml.txt.nlp	19176219	SENT180	5	5	13	13	lamivudine	OCT2	PA450163	6582;5452	0.891
NULL	Mol_Biol_Cell_2014_Jan_1_25(1)_145-159.nxml.txt.nlp	24196833	SENT291	33	33	6	6	staurosporine	Fis1	PA165109623	51024	0.891
NULL	Oncotarget_2014_Oct_21_5(22)_11252-11268.nxml.txt.nlp	25361004	SENT37	22	22	9	9	metformin	CLIC1	PA450395	1192	0.891
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_16_2012_395912.nxml.txt.nlp	23118789	SENT148	17	17	0	0	naringenin	UGT1A3	PA151958361	54659	0.891
NULL	ISRN_Obes_2012_Nov_18_2012_437198.nxml.txt.nlp	24527263	SENT150	22	22	3	3	nadh	CLOCK	PA164755085	9575	0.891
NULL	Appl_Microbiol_Biotechnol_2014_Feb_18_98(8)_3829-3840.nxml.txt.nlp	24535257	SENT219	32	32	13	13	ethanol	CAT-1	PA448073	6541	0.891
NULL	Neural_Regen_Res_2013_May_5_8(13)_1180-1189.nxml.txt.nlp	25206412	SENT79	10	10	4	4	fasudil	RhoA	PA165946121	387	0.891
NULL	Front_Neurol_2014_Jul_1_5_111.nxml.txt.nlp	25071699	SENT156	18	18	1	1	pilocarpine	MRI	PA450962	78996	0.891
NULL	Can_J_Infect_Dis_Med_Microbiol_2014_Nov-Dec_25(6)_311-320.nxml.txt.nlp	25587293	SENT406	11	11	3	3	telaprevir	CYP3A	PA165958354	1574	0.891
NULL	Environ_Health_Perspect_2011_Apr_16_119(4)_534-541.nxml.txt.nlp	21081300	SENT199	10	10	33	33	genistein	COX	PA165109660	1351	0.891
NULL	Int_J_Biomater_2013_Sep_15_2013_252531.nxml.txt.nlp	24159333	SENT224	19	19	29	29	trastuzumab	PLK1	PA451743	5347	0.891
NULL	Tuberc_Respir_Dis_(Seoul)_2014_Nov_28_77(5)_227-229.nxml.txt.nlp	25473412	SENT59	36	36	4	4	imipenem	RGM	PA449968	56963	0.891
NULL	Oncotarget_2013_Nov_24_4(12)_2430-2438.nxml.txt.nlp	24280348	SENT109	19	19	16	16	gefitinib	STAT3	PA131301952	6774	0.891
NULL	Osteoporos_Int_2012_Jun_20_23(6)_1737-1745.nxml.txt.nlp	21932114	SENT156	19	19	6	6	risedronate	PTH	PA451255	5741	0.891
NULL	J_Oncol_2012_Jun_19_2012_521215.nxml.txt.nlp	22778735	SENT262	33	33	14	14	cetuximab	EGFR	PA10040	1956	0.891
NULL	Eur_J_Clin_Pharmacol_2010_Nov_29_66(11)_1131-1136.nxml.txt.nlp	20669013	SENT108	6	6	14	14	erythromycin	CYP2C19	PA449493	1557	0.891
NULL	Cancer_Biol_Med_2012_Mar_9(1)_34-37.nxml.txt.nlp	23691452	SENT162	14	14	8	8	azacitidine	TET2	PA451996	54790	0.891
NULL	Mol_Cancer_2010_Mar_2_9_46.nxml.txt.nlp	20196838	SENT202	6	6	13	13	irinotecan	CYP3A4	PA450085	1576	0.891
NULL	Neural_Plast_2013_Aug_18_2013_683909.nxml.txt.nlp	24024041	SENT177	17	17	2	2	fluoxetine	NPAS4	PA449673	266743	0.891
NULL	Eur_J_Med_Res_2014_Sep_16_19(1)_50.nxml.txt.nlp	25223338	SENT49	16	16	40	40	docetaxel	TUBB3	PA449383	10381	0.891
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT311	13	13	24	24	quetiapine	PRL	PA451201	5617	0.891
NULL	EJC_Suppl_2013_Sep_5_11(2)_278-280.nxml.txt.nlp	NULL	SENT91	3	3	7	7	vemurafenib	BRAF	PA165946873	673	0.891
NULL	Infect_Drug_Resist_2009_Apr_24_2_13-26.nxml.txt.nlp	21694884	SENT6	6	6	12	12	lamivudine	TDF	PA450163	6736	0.891
NULL	Br_J_Cancer_2004_May_4_90(9)_1733-1739.nxml.txt.nlp	15150604	SENT137	21	21	9	9	aminoglutethimide	aromatase	PA448375	1588	0.891
NULL	J_Anaesthesiol_Clin_Pharmacol_2012_Oct-Dec_28(4)_510-513.nxml.txt.nlp	23225936	SENT30	25	25	4	4	fentanyl	CSE	PA449599	1433	0.891
NULL	Mol_Neurobiol_2010_Jun_2_41(2-3)_392-409.nxml.txt.nlp	20437209	SENT318	3	3	13	13	curcumin	COX	PA151958596	1351	0.891
NULL	Bioinformation_2012_Jan_6_8(1)_13-19.nxml.txt.nlp	22359429	SENT169	8	8	28	28	curcumin	MRP1	PA151958596	4437	0.891
NULL	J_Cell_Mol_Med_2015_Jan_11_19(1)_92-102.nxml.txt.nlp	25388834	SENT204	4	4	7	7	metformin	LOX-1	PA450395	4973	0.891
NULL	Curr_Med_Chem_2014_May_21(14)_1595-1606.nxml.txt.nlp	23992330	SENT75	23	23	19	19	erlotinib	EGFR	PA134687924	1956	0.891
NULL	J_Geriatr_Cardiol_2014_Mar_11(1)_63-73.nxml.txt.nlp	24748884	SENT10	6	6	19	19	fenoldopam	PKD	PA164784034	5587	0.891
NULL	Mol_Cancer_2007_Aug_21_6_53.nxml.txt.nlp	17711579	SENT236	11	11	4	4	cisplatin	DICER1	PA449014	23405	0.891
NULL	Br_J_Cancer_2012_Nov_6_107(10)_1737-1744.nxml.txt.nlp	23037715	SENT108	34	34	23	23	chlorpromazine	PC-3	PA448964	692094	0.891
NULL	Acta_Pharmacol_Sin_2009_Jun_11_30(6)_723-739.nxml.txt.nlp	19434058	SENT168	16	16	12	12	tranylcypromine	CYP2A6	PA451741	1548	0.891
NULL	Int_J_Vasc_Med_2013_Jun_26_2013_456852.nxml.txt.nlp	23878738	SENT70	29	29	9	9	indomethacin	ANOVA	PA449982	4858	0.891
NULL	Lipids_Health_Dis_2011_Feb_28_10_38.nxml.txt.nlp	21352602	SENT139	15	15	28	28	fenofibrate	PCSK9	PA449594	255738	0.891
NULL	Cancers_(Basel)_2011_Sep_13_3(3)_3506-3524.nxml.txt.nlp	24212966	SENT104	12	12	19	19	cetuximab	EGFR	PA10040	1956	0.891
NULL	Breast_Cancer_Res_2011_Mar_14_13(2)_205.nxml.txt.nlp	21457526	SENT21	3	3	8	8	anastrozole	aromatase	PA448432	1588	0.891
NULL	J_Health_Popul_Nutr_2007_Jun_25(2)_179-188.nxml.txt.nlp	17985819	SENT69	29	29	5	5	erythromycin	Spn	PA449493	84687	0.891
NULL	Acta_Orthop_2013_Dec_2_84(6)_509-516.nxml.txt.nlp	24171687	SENT201	0	0	22	22	gentamicin	TKR	PA449753	8277	0.891
NULL	Oncoimmunology_2013_Oct_1_2(10)_e27025.nxml.txt.nlp	24353914	SENT180	20	20	10	10	vinorelbine	CD4	PA451881	920	0.891
NULL	Oncotarget_2013_Aug_21_4(9)_1484-1495.nxml.txt.nlp	23986086	SENT172	44	44	17	17	metformin	PIK3CA	PA450395	5290	0.891
NULL	J_Neuroinflammation_2011_Aug_5_8_91.nxml.txt.nlp	21819568	SENT247	20	20	12	12	pioglitazone	CD68	PA450970	968	0.891
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Apr_7_9_12.nxml.txt.nlp	20374640	SENT118	22	22	6	6	ampicillin	TEM	PA448419	64102	0.891
NULL	Arthritis_Res_Ther_2007_May_30_9(3)_212.nxml.txt.nlp	17561993	SENT116	27	27	17	17	capsaicin	CCL3	PA448776	6348	0.891
NULL	Oncotarget_2013_Aug_30_4(10)_1698-1711.nxml.txt.nlp	24091605	SENT183	19	19	30	30	gefitinib	NANOG	PA131301952	79923	0.891
NULL	J_Oncol_2012_Oct_22_2012_391629.nxml.txt.nlp	23133451	SENT121	29	29	21	21	sunitinib	FDG	PA162372840	23583	0.891
NULL	Chemother_Res_Pract_2012_Dec_20_2012_743193.nxml.txt.nlp	23320171	SENT122	16	16	7	7	docetaxel	HER2	PA449383	2064	0.891
NULL	J_Inflamm_(Lond)_2005_Oct_31_2_14.nxml.txt.nlp	16259633	SENT223	0	0	16	16	staurosporine	CCR2	PA165109623	729230	0.891
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT158	31	31	34	34	metformin	HIF-1	PA450395	29072	0.891
NULL	Int_J_Gen_Med_2010_Nov_19_3_379-382.nxml.txt.nlp	21189835	SENT60	15	15	4	4	atorvastatin	JBS	PA448500	3719	0.891
NULL	Br_J_Cancer_2011_May_10_104(10)_1587-1593.nxml.txt.nlp	21487405	SENT37	16	16	21	21	docetaxel	PTEN	PA449383	5728	0.891
NULL	Front_Immunol_2014_Aug_12_5_368.nxml.txt.nlp	25161652	SENT40	10	10	16	16	ustekinumab	p40	PA166048654	3921;339541;10314	0.891
NULL	Clin_Med_Insights_Cardiol_2011_Oct_6_5_103-119.nxml.txt.nlp	22084608	SENT41	12	12	6	6	diltiazem	CYP3A4	PA449334	1576	0.891
NULL	Eur_J_Clin_Pharmacol_2014_Oct_8_70(12)_1433-1441.nxml.txt.nlp	25291992	SENT173	13	13	22	22	risperidone	CPZ	PA451257	8532	0.891
NULL	Br_J_Cancer_2012_Jan_3_106(1)_18-24.nxml.txt.nlp	22108516	SENT140	19	19	11	11	cetuximab	KRAS	PA10040	3845	0.891
NULL	Asian_J_Androl_2014_Feb_18_Mar-Apr_16(2)_319-324.nxml.txt.nlp	24556744	SENT28	41	41	2	2	l-glutamine	PC3	PA10090	57332;7832;5122	0.891
NULL	Acta_Crystallogr_Sect_F_Struct_Biol_Cryst_Commun_2009_Sep_25_65(Pt_10)_1030-1034.nxml.txt.nlp	19851015	SENT26	13	13	18	18	oxaliplatin	p53	PA131285527	7157	0.891
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT53	11	11	1	1	indinavir	SLK	PA449977	9748;2534	0.891
NULL	Acta_Pharmacol_Sin_2012_Jan_28_33(1)_66-74.nxml.txt.nlp	22120966	SENT233	2	2	15	15	genistein	RANKL	PA165109660	8600	0.891
NULL	J_Nat_Prod_2011_Apr_25_74(4)_567-573.nxml.txt.nlp	21348461	SENT53	30	30	9	9	verapamil	MDR1	PA451868	5243	0.891
NULL	J_Immunother_Cancer_2014_Jan_27_2_2.nxml.txt.nlp	24829759	SENT120	19	19	13	13	sorafenib	IL-21	PA7000	59067;50616;27189	0.891
NULL	Oncol_Lett_2014_Jun_9_7(6)_2053-2058.nxml.txt.nlp	24932288	SENT30	0	0	9	9	celecoxib	COX	PA448871	1351	0.891
NULL	Cell_Commun_Signal_2013_Nov_11_11_86.nxml.txt.nlp	24215724	SENT614	18	18	6	6	thrombin	P2X1	PA451674	5023	0.891
NULL	BMB_Rep_2013_Mar_46(3)_157-162.nxml.txt.nlp	23527859	SENT110	42	42	9	9	galactose	mol	PA449725	90527	0.891
NULL	Oncol_Lett_2014_Mar_19_7(3)_674-678.nxml.txt.nlp	24527071	SENT106	12	12	5	5	cisplatin	AKR1C2	PA449014	1646	0.891
NULL	Cancer_Cell_Int_2010_Sep_9_10_32.nxml.txt.nlp	20828393	SENT12	14	14	4	4	cisplatin	ATF3	PA449014	467	0.891
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT1051	0	0	8	8	tenofovir	OAT1	PA10204	9356	0.891
NULL	Cancer_Imaging_2012_Sep_28_12(2)_305-309.nxml.txt.nlp	23022887	SENT126	9	9	15	15	olaparib	BRCA2		675	0.891
NULL	Front_Oncol_2014_Apr_9_4_75.nxml.txt.nlp	24782986	SENT17	5	5	18	18	paclitaxel	CD117	PA450761	3815	0.891
NULL	Acta_Pharmacol_Sin_2010_Nov_18_31(11)_1447-1453.nxml.txt.nlp	20953204	SENT195	9	9	2	2	rimonabant	CB1	PA152407999	1268	0.891
NULL	Scientifica_(Cairo)_2012_Jul_8_2012_128382.nxml.txt.nlp	24278667	SENT178	34	34	29	29	ribavirin	IFN	PA451241	3439	0.891
NULL	Int_J_Mol_Sci_2014_Jun_3_15(6)_9924-9944.nxml.txt.nlp	24897026	SENT181	6	6	32	32	metformin	SREBP-1c	PA450395	6720	0.891
NULL	Biomed_Res_Int_2013_Sep_4_2013_185362.nxml.txt.nlp	24093091	SENT115	40	40	35	35	epirubicin	CHOP	PA449476	1649	0.891
NULL	Evid_Based_Complement_Alternat_Med_2012_Dec_20_2012_908601.nxml.txt.nlp	23326293	SENT69	1	1	32	32	trypsin	CD44	PA451806	960	0.891
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1137-1144.nxml.txt.nlp	20234366	SENT145	6	6	10	10	cetuximab	BRAF	PA10040	673	0.891
NULL	Int_J_Breast_Cancer_2011_Sep_6_2011_352182.nxml.txt.nlp	22295219	SENT134	17	17	12	12	lapatinib	PTEN	PA152241907	5728	0.891
NULL	Chin_J_Cancer_2012_Jun_31(6)_306-314.nxml.txt.nlp	22640627	SENT23	6	6	37	37	rituximab	Bcl-2	PA451261	596	0.891
NULL	Clinics_(Sao_Paulo)_2014_Jan_69(1)_68-74.nxml.txt.nlp	24473562	SENT89	14	14	39	39	nutlin-3	SOCS-1		8651	0.891
NULL	J_Oncol_2012_Apr_1_2012_370385.nxml.txt.nlp	22545048	SENT40	3	3	5	5	tamoxifen	aromatase	PA451581	1588	0.891
NULL	Oncoscience_2014_Oct_5_1(10)_624-633.nxml.txt.nlp	25593992	SENT75	31	31	13	13	doxycycline	PCTAIRE1	PA449415	5127	0.891
NULL	Crit_Care_2013_Mar_19_17(Suppl_2)_P228.nxml.txt.nlp	NULL	SENT10	5	5	13	13	dobutamine	ANOVA	PA449381	4858	0.891
NULL	Oncol_Lett_2013_Mar_11_5(3)_1010-1016.nxml.txt.nlp	23426784	SENT10	21	21	24	24	midazolam	TRPM7	PA450496	54822	0.891
NULL	J_Gynecol_Oncol_2013_Jul_4_24(3)_273-279.nxml.txt.nlp	23875078	SENT122	15	15	25	25	doxorubicin	P-gp	PA449412	5243	0.891
NULL	Nucleic_Acids_Res_2011_Nov_16_39(21)_9376-9389.nxml.txt.nlp	21846775	SENT35	42	42	1	1	phenol	APE	PA450913	55704;328	0.891
NULL	Exp_Ther_Med_2013_Feb_13_5(2)_581-585.nxml.txt.nlp	23403473	SENT93	27	27	10	10	etanercept	p38	PA449515	10598;1432;7965	0.891
NULL	Arthritis_Res_Ther_2006_Apr_12_8(Suppl_1)_S3.nxml.txt.nlp	16820042	SENT21	36	36	6	6	colchicine	MSU	PA449092	593	0.891
NULL	Ann_Surg_Oncol_2014_Sep_25_21(2)_597-604.nxml.txt.nlp	24065387	SENT222	5	5	1	1	cetuximab	EGFR	PA10040	1956	0.891
NULL	Oncotarget_2011_Dec_31_2(12)_935-947.nxml.txt.nlp	22249213	SENT227	18	18	4	4	paclitaxel	MCAK	PA450761	11004	0.891
NULL	Front_Oncol_2014_Sep_15_4_244.nxml.txt.nlp	25309870	SENT71	22	22	27	27	gefitinib	EGFR	PA131301952	1956	0.891
NULL	Cancer_Med_2013_Jun_25_2(3)_277-285.nxml.txt.nlp	23930204	SENT117	6	6	19	19	bevacizumab	PTEN	PA130232992	5728	0.891
NULL	Nat_Med_2013_Mar_10_19(3)_313-321.nxml.txt.nlp	23396211	SENT368	38	38	47	47	amlexanox	TBK1	PA164745310	29110	0.891
NULL	Oncotarget_2013_Feb_26_4(2)_298-309.nxml.txt.nlp	23593653	SENT61	9	9	16	16	quinacrine	CDH13	PA164745551	1012	0.891
NULL	Mediators_Inflamm_2011_Jun_28_2011_949072.nxml.txt.nlp	21772670	SENT142	12	12	4	4	estradiol	APOE	PA449503	348	0.891
NULL	Biosci_Rep_2013_Sep_17_33(5)_e00068.nxml.txt.nlp	23919527	SENT215	37	37	28	28	guanidine	CXCL8	PA164781028	3576	0.891
NULL	Core_Evid_2010_Jul_27_5_1-10.nxml.txt.nlp	20694135	SENT16	19	19	0	0	entacapone	CLE	PA164748726	51637	0.891
NULL	Autophagy_2012_May_1_8(5)_853-855.nxml.txt.nlp	22617440	SENT53	20	20	9	9	imatinib	ATG5	PA10804	9474	0.891
NULL	BMB_Rep_2013_Mar_46(3)_157-162.nxml.txt.nlp	23527859	SENT110	42	42	15	15	galactose	mol	PA449725	90527	0.891
NULL	Osteoporos_Int_2013_Jan_24_24(1)_219-226.nxml.txt.nlp	23093347	SENT27	18	18	16	16	teriparatide	PTH	PA451620	5741	0.891
NULL	Clin_Ophthalmol_2011_Jun_9_5_771-781.nxml.txt.nlp	21750610	SENT54	19	19	7	7	ranibizumab	CRT	PA164746012	811	0.891
NULL	Front_Synaptic_Neurosci_2014_Sep_5_6_18.nxml.txt.nlp	25249974	SENT51	20	20	11	11	lipase	DAG	PA450239	1605	0.891
NULL	J_Med_Chem_2014_Jan_23_57(2)_449-461.nxml.txt.nlp	24387105	SENT303	24	24	0	0	benzaldehyde	ALDH3A1	PA448571	218	0.891
NULL	Behav_Brain_Funct_2005_Jul_15_1_9.nxml.txt.nlp	16022733	SENT175	10	10	16	16	atomoxetine	NET1	PA134688071	55119;10276	0.891
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT144	10	10	20	20	pertuzumab	HRG		3084;3273	0.891
NULL	Oncotarget_2013_Oct_19_4(11)_2045-2056.nxml.txt.nlp	24185104	SENT101	20	20	9	9	cisplatin	14-3-3	PA449014	10971	0.891
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT91	24	24	21	21	resveratrol	TRAIL		8743	0.891
NULL	Environ_Health_Perspect_2010_Dec_12_118(12)_1707-1713.nxml.txt.nlp	20705543	SENT81	17	17	3	3	bleomycin	XRCC1	PA448645	7515	0.891
NULL	J_Int_Soc_Sports_Nutr_2010_Dec_15_7_39.nxml.txt.nlp	21156078	SENT167	4	4	1	1	choline	CRAM	PA448976	56896	0.891
NULL	Neural_Regen_Res_2013_Mar_25_8(9)_825-832.nxml.txt.nlp	25206730	SENT114	13	13	10	10	isoflurane	P2X7	PA450106	5027	0.891
NULL	J_Mol_Med_(Berl)_2014_May_10_92(7)_709-722.nxml.txt.nlp	24811491	SENT228	6	6	2	2	panitumumab	KRAS	PA162373091	3845	0.891
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT314	24	24	1	1	quetiapine	PRL	PA451201	5617	0.891
NULL	Mol_Pain_2013_Jun_10_9_27.nxml.txt.nlp	23758830	SENT187	28	28	11	11	tetracaine	ASIC1	PA451638	41	0.891
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_127043.nxml.txt.nlp	23227093	SENT5	20	20	4	4	lovastatin	RYR	PA450272	6261	0.891
NULL	Nat_Commun_2013_Oct_1_4_2516.nxml.txt.nlp	24084631	SENT643	9	9	12	12	losartan	CCN2	PA450268	1490	0.891
NULL	Breast_Cancer_Res_2014_Sep_11_16(5)_430.nxml.txt.nlp	25212826	SENT265	0	0	4	4	fulvestrant	AKT	PA164747170	207	0.891
NULL	Virulence_2014_Jan_1_5(1)_206-212.nxml.txt.nlp	24200870	SENT105	0	0	36	36	ceftazidime	VIM	PA448861	7431	0.891
NULL	Case_Rep_Hematol_2014_Dec_11_2014_587912.nxml.txt.nlp	25574404	SENT22	29	29	20	20	busulfan	HLA-A	PA448691	3105	0.891
NULL	Arthritis_Res_Ther_2005_Feb_18_7(3)_R476-R484.nxml.txt.nlp	15899034	SENT5	6	6	9	9	thrombin	Rho	PA451674	29984	0.891
NULL	J_Cell_Biol_2008_Jul_14_182(1)_197-213.nxml.txt.nlp	18625847	SENT200	8	8	16	16	nutlin-3	JNK		5599	0.891
NULL	Tob_Control_2009_Feb_13_18(1)_34-42.nxml.txt.nlp	18845621	SENT274	19	19	44	44	bupropion	CYP2B6	PA448687	1555	0.891
NULL	EPMA_J_2010_Mar_13_1(1)_138-163.nxml.txt.nlp	23199048	SENT286	15	15	2	2	liraglutide	GLP-1	PA165958364	100125288	0.891
NULL	Evid_Based_Complement_Alternat_Med_2015_Jan_6_2015_736431.nxml.txt.nlp	25632290	SENT111	15	15	8	8	doxorubicin	P-gp	PA449412	5243	0.891
NULL	Parasit_Vectors_2014_Apr_24_7_197.nxml.txt.nlp	24761813	SENT99	6	6	9	9	l-cysteine	mol	PA449173	90527	0.891
NULL	Cancer_Cell_Int_2013_Jan_15_13_3.nxml.txt.nlp	23320839	SENT135	13	13	29	29	sorafenib	ABCB1	PA7000	5243	0.891
NULL	Oncotarget_2012_Jan_28_3(1)_78-83.nxml.txt.nlp	22289679	SENT22	10	10	5	5	paclitaxel	PLK2	PA450761	10769	0.891
NULL	Indian_J_Med_Res_2013_Jan_137(1)_203-209.nxml.txt.nlp	23481074	SENT132	13	13	3	3	acenocoumarol	CYP4F2	PA452632	8529	0.891
NULL	Aging_(Albany_NY)_2013_Apr_14_5(4)_288-303.nxml.txt.nlp	23596277	SENT192	24	24	16	16	l-glutamine	FBS	PA10090	64319;26269	0.891
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R91.nxml.txt.nlp	22541814	SENT41	5	5	35	35	thrombin	HO-1	PA451674	3162	0.891
NULL	Mol_Cancer_2009_Nov_10_8_99.nxml.txt.nlp	19903356	SENT41	0	0	4	4	imatinib	IGFBP3	PA10804	3486	0.891
NULL	Exp_Ther_Med_2015_Feb_16_9(2)_631-635.nxml.txt.nlp	25574246	SENT98	2	2	10	10	valsartan	TRPC3	PA451848	7222	0.891
NULL	Exp_Diabetes_Res_2012_Oct_15_2012_465282.nxml.txt.nlp	23118742	SENT28	17	17	26	26	metformin	AMPK	PA450395	5563	0.891
NULL	Brain_Sci_2013_Jun_3_3(2)_877-907.nxml.txt.nlp	24961429	SENT172	4	4	20	20	taurine	IRE1	PA451590	2081	0.891
NULL	Cancer_Cell_Int_2004_Aug_17_4_5.nxml.txt.nlp	15315711	SENT106	29	29	0	0	genistein	PC3	PA165109660	57332;7832;5122	0.891
NULL	EMBO_Rep_2013_Dec_1_14(12)_1127-1135.nxml.txt.nlp	24176932	SENT102	5	5	11	11	valinomycin	PINK1	PA151917011	65018	0.891
NULL	Evid_Based_Complement_Alternat_Med_2011_Jan_4_2011_392627.nxml.txt.nlp	19542183	SENT130	30	30	5	5	phenylephrine	mol	PA450935	90527	0.891
NULL	J_Gynecol_Oncol_2013_Jul_4_24(3)_273-279.nxml.txt.nlp	23875078	SENT108	3	3	18	18	paclitaxel	P-gp	PA450761	5243	0.891
NULL	Diabetes_2008_Sep_57(9)_2272-2279.nxml.txt.nlp	18519799	SENT139	8	8	17	17	rosiglitazone	PDK2	PA451283	5164	0.891
NULL	Oncol_Rep_2014_Feb_13_31(2)_581-588.nxml.txt.nlp	24337105	SENT148	9	9	5	5	capsaicin	Bcl-2	PA448776	596	0.891
NULL	J_Antimicrob_Chemother_2014_Mar_13_69(3)_651-663.nxml.txt.nlp	24235095	SENT104	15	15	23	23	pentamidine	AQP2	PA450850	359	0.891
NULL	Breast_Cancer_Res_Treat_2014_Apr_6_145(1)_33-44.nxml.txt.nlp	24706169	SENT124	16	16	10	10	trastuzumab	HER2	PA451743	2064	0.891
NULL	BMB_Rep_2014_May_47(5)_274-279.nxml.txt.nlp	24286313	SENT66	3	3	18	18	bortezomib	CD138	PA10252	6382	0.891
NULL	Arthritis_Res_Ther_2011_Apr_4_13(2)_R56.nxml.txt.nlp	21463515	SENT19	15	15	26	26	infliximab	IL-6	PA452639	3569	0.891
NULL	EMBO_Mol_Med_2013_Dec_8_5(12)_1821-1834.nxml.txt.nlp	24293316	SENT52	26	26	10	10	doxorubicin	UNC5A	PA449412	90249	0.891
NULL	Pharmaceuticals_(Basel)_2011_Jan_26_4(2)_285-342.nxml.txt.nlp	NULL	SENT189	18	18	12	12	milnacipran	5-HTT	PA164752812	6532	0.891
NULL	Breast_Cancer_Res_Treat_2013_Oct_8_141(3)_437-446.nxml.txt.nlp	24101324	SENT171	13	13	22	22	pertuzumab	PIK3CA		5290	0.891
NULL	Crit_Care_2011_Feb_3_15(1)_R49.nxml.txt.nlp	21291554	SENT170	33	33	3	3	vancomycin	CLCR	PA451850	11330	0.891
NULL	J_Cell_Biol_2002_Jun_10_157(6)_1017-1028.nxml.txt.nlp	12058017	SENT166	32	32	25	25	lovastatin	COD1	PA450272	25839	0.891
NULL	Exp_Ther_Med_2013_Nov_13_6(5)_1317-1321.nxml.txt.nlp	24223665	SENT106	28	28	24	24	cisplatin	CD133	PA449014	8842	0.891
NULL	Age_(Dordr)_2013_Feb_4_35(1)_129-138.nxml.txt.nlp	22139381	SENT119	32	32	23	23	medroxyprogesterone	CEE	PA450344	51608	0.891
NULL	Int_J_Cell_Biol_2014_Jan_22_2014_156020.nxml.txt.nlp	24587804	SENT48	0	0	3	3	metformin	AMPK	PA450395	5563	0.891
NULL	J_Cell_Biol_2000_Aug_7_150(3)_475-488.nxml.txt.nlp	10931861	SENT208	2	2	10	10	staurosporine	p115	PA165109623	8615;393	0.891
NULL	Diabetes_Care_2009_Apr_29_32(4)_541-546.nxml.txt.nlp	19114614	SENT100	3	3	0	0	simvastatin	Men	PA451363	8178	0.891
NULL	Clin_Interv_Aging_2012_Dec_30_7_1-13.nxml.txt.nlp	22291468	SENT131	20	20	5	5	dronedarone	CYP3A4	PA153619853	1576	0.891
NULL	Crit_Care_2011_Oct_26_15(5)_R257.nxml.txt.nlp	22030215	SENT257	17	17	26	26	dexmedetomidine	SAPS	PA449256	8935	0.891
NULL	Breast_Cancer_Res_Treat_2014_Apr_9_145(1)_73-82.nxml.txt.nlp	24715380	SENT120	38	38	28	28	tamoxifen	CXCL10	PA451581	3627	0.891
NULL	J_Mol_Recognit_2013_Dec_11_26(12)_679-688.nxml.txt.nlp	24277613	SENT57	3	3	23	23	tetracycline	ACC2	PA451640	32	0.891
NULL	Oxid_Med_Cell_Longev_2008_Oct-Dec_1(1)_39-45.nxml.txt.nlp	19794907	SENT43	12	12	27	27	taurine	ALAD	PA451590	210	0.891
NULL	Br_J_Cancer_2013_Mar_19_108(5)_1079-1091.nxml.txt.nlp	23449353	SENT170	16	16	9	9	docetaxel	MIC-1	PA449383	29919;9518	0.891
NULL	Dermatoendocrinol_2012_Jul_1_4(3)_253-258.nxml.txt.nlp	23467280	SENT147	2	2	5	5	hyaluronan	CD44	PA165958431	960	0.891
NULL	Front_Oncol_2013_Sep_23_3_250.nxml.txt.nlp	24069582	SENT11	19	19	27	27	tamoxifen	aromatase	PA451581	1588	0.891
NULL	Iran_J_Ped_Hematol_Oncol_2014_Jul_20_4(3)_118-126.nxml.txt.nlp	25254091	SENT112	14	14	21	21	vinblastine	ABCA2	PA451877	20	0.891
NULL	Br_J_Pharmacol_2010_Sep_161(2)_288-307.nxml.txt.nlp	20735416	SENT125	28	28	40	40	pentobarbital	c-fos	PA450859	2353	0.891
NULL	Oncotarget_2012_Aug_10_3(8)_744-758.nxml.txt.nlp	22889873	SENT46	2	2	10	10	lapatinib	EGFR	PA152241907	1956	0.891
NULL	Int_J_Mol_Sci_2014_Sep_23_15(9)_16911-16935.nxml.txt.nlp	25250910	SENT60	20	20	27	27	ethosuximide	gamma	PA449533	9913	0.891
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1449-1456.nxml.txt.nlp	24077631	SENT27	42	42	24	24	tolbutamide	CYP2C9	PA451718	1559	0.891
NULL	Mol_Cancer_2014_Feb_24_13_35.nxml.txt.nlp	24565101	SENT173	47	47	5	5	doxorubicin	p65	PA449412	5970	0.891
NULL	Indian_J_Pharmacol_2008_Oct_40(Suppl_2)_S211-S221.nxml.txt.nlp	21593975	SENT115	0	0	20	20	pioglitazone	CA1	PA450970	759	0.891
NULL	Psychiatry_Investig_2009_Sep_3_6(3)_222-225.nxml.txt.nlp	20046399	SENT14	4	4	22	22	risperidone	DRD2	PA451257	1813	0.891
NULL	Carcinogenesis_2014_Sep_1_35(9)_1983-1992.nxml.txt.nlp	24692066	SENT509	21	21	3	3	docetaxel	CXCR4	PA449383	7852	0.891
NULL	F1000Prime_Rep_2014_Aug_1_6_68.nxml.txt.nlp	25165567	SENT108	0	0	2	2	fluvoxamine	CYP1A2	PA449690	1544	0.891
NULL	Br_J_Cancer_2003_Mar_24_88(6)_848-854.nxml.txt.nlp	12644821	SENT5	15	15	8	8	cisplatin	TP53	PA449014	7157	0.891
NULL	Breast_Cancer_Res_2002_Aug_27_4(6)_213-217.nxml.txt.nlp	12473165	SENT17	11	11	27	27	tamoxifen	aromatase	PA451581	1588	0.891
NULL	Biomed_Res_Int_2014_Aug_6_2014_967826.nxml.txt.nlp	25165721	SENT77	25	25	17	17	cisplatin	p53	PA449014	7157	0.891
NULL	Breast_Cancer_Res_2005_Nov_11_7(6)_255-257.nxml.txt.nlp	16457700	SENT63	28	28	25	25	tamoxifen	aromatase	PA451581	1588	0.891
NULL	Drug_Healthc_Patient_Saf_2012_Nov_29_4_173-180.nxml.txt.nlp	23236256	SENT67	5	5	12	12	sertindole	FGA	PA164784002	2243	0.891
NULL	EMBO_Mol_Med_2012_Jul_18_4(7)_557-560.nxml.txt.nlp	22610822	SENT35	33	33	26	26	resveratrol	SIRT1		23411	0.891
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT97	3	3	10	10	neratinib	HER2	PA165291472	2064	0.891
NULL	Nucleic_Acids_Res_2013_May_5_41(10)_5210-5222.nxml.txt.nlp	23563151	SENT212	24	24	11	11	arsenite	MDM2	PA452638	4193	0.891
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jul_6_67(Pt_8)_o1934.nxml.txt.nlp	22090978	SENT75	21	21	12	12	ethanol	mol	PA448073	90527	0.891
NULL	Clin_Exp_Reprod_Med_2012_Dec_31_39(4)_153-160.nxml.txt.nlp	23346525	SENT55	6	6	48	48	hyaluronidase	CO2	PA164745713	4513	0.891
NULL	Exp_Lung_Res_2013_Oct_1_39(8)_336-348.nxml.txt.nlp	23919450	SENT89	0	0	8	8	thrombin	PAR-1	PA451674	2011;2149	0.891
NULL	Ann_Hematol_2011_May_12_90(5)_557-568.nxml.txt.nlp	20938660	SENT213	18	18	10	10	plerixafor	CD34	PA165958410	947	0.891
NULL	J_Mol_Signal_2010_Jul_1_5_7.nxml.txt.nlp	20594350	SENT21	23	23	0	0	etoposide	CARP-1	PA449552	55749	0.891
NULL	J_Gynecol_Oncol_2013_Jan_8_24(1)_66-82.nxml.txt.nlp	23346316	SENT71	24	24	34	34	olaparib	BRCA2		675	0.891
NULL	Cell_Microbiol_2010_Jun_20_12(6)_725-739.nxml.txt.nlp	20039882	SENT65	13	13	20	20	papain	SERA	PA450778	26227	0.891
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Feb_17_6_29-36.nxml.txt.nlp	24648767	SENT43	13	13	20	20	tamoxifen	BRCA2	PA451581	675	0.891
NULL	Front_Pharmacol_2014_Dec_10_5_271.nxml.txt.nlp	25540621	SENT96	6	6	13	13	fenfluramine	ghrelin	PA449592	51738	0.891
NULL	Br_J_Cancer_2010_May_11_102(10)_1456-1460.nxml.txt.nlp	20461090	SENT130	21	21	6	6	temsirolimus	IFN	PA164746890	3439	0.891
NULL	Mol_Cancer_2012_Aug_24_11_61.nxml.txt.nlp	22917467	SENT221	34	34	5	5	paclitaxel	B27	PA450761	56246	0.891
NULL	Cell_Death_Dis_2012_Jun_21_3(6)_e330.nxml.txt.nlp	22717585	SENT66	0	0	31	31	simvastatin	Mcl-1	PA451363	4170	0.891
NULL	Cardiovasc_Ther_2012_Jun_19_30(3)_e146-e155.nxml.txt.nlp	21167014	SENT75	23	23	21	21	exenatide	GLP-1	PA164749238	100125288	0.891
NULL	Oncotarget_2013_Nov_23_5(1)_196-210.nxml.txt.nlp	24344116	SENT115	8	8	4	4	doxorubicin	p53	PA449412	7157	0.891
NULL	Acta_Pharmacol_Sin_2014_Jun_5_35(6)_727-737.nxml.txt.nlp	24793312	SENT14	34	34	19	19	telmisartan	Bcl-2	PA451605	596	0.891
NULL	Br_J_Cancer_2010_Oct_12_103(8)_1284-1291.nxml.txt.nlp	20859285	SENT13	14	14	3	3	tamoxifen	ERBB2	PA451581	2064	0.891
NULL	Patient_Prefer_Adherence_2013_Apr_26_7_369-377.nxml.txt.nlp	23641151	SENT41	19	19	12	12	ustekinumab	p40	PA166048654	3921;339541;10314	0.891
NULL	Crit_Care_2010_Jul_30_14(4)_R143.nxml.txt.nlp	20673352	SENT172	22	22	11	11	simvastatin	MCP-1	PA451363	6347	0.891
NULL	Breast_Cancer_Res_2011_Dec_16_13(6)_R131.nxml.txt.nlp	22177475	SENT12	11	11	36	36	lapatinib	HER2	PA152241907	2064	0.891
NULL	Clin_Drug_Investig_2014_Nov_9_34(2)_107-115.nxml.txt.nlp	24214232	SENT10	13	13	4	4	paricalcitol	IMPACT	PA450798	55364	0.891
NULL	Cancer_Med_2013_Jun_25_2(3)_277-285.nxml.txt.nlp	23930204	SENT159	11	11	1	1	bevacizumab	PTEN	PA130232992	5728	0.891
NULL	Exp_Ther_Med_2013_Apr_5_5(4)_1259-1263.nxml.txt.nlp	23596498	SENT98	4	4	23	23	propofol	TRPV1	PA451141	7442	0.891
NULL	Int_J_Genomics_2014_Oct_21_2014_312102.nxml.txt.nlp	25401099	SENT12	29	29	0	0	heparin	EGFR	PA449855	1956	0.891
NULL	Neuropsychopharmacology_2009_Apr_2_34(5)_1135-1148.nxml.txt.nlp	18596687	SENT174	29	29	16	16	cocaine	CRF	PA449072	1392;10882	0.891
NULL	Mol_Cancer_2013_Sep_11_12_104.nxml.txt.nlp	24025152	SENT234	2	2	23	23	gemcitabine	STAT3	PA449748	6774	0.891
NULL	Breast_Cancer_Res_Treat_2013_Jun_5_139(3)_649-655.nxml.txt.nlp	23736997	SENT151	29	29	2	2	tamoxifen	CYP2C19	PA451581	1557	0.891
NULL	J_Thromb_Thrombolysis_2012_Feb_20_33(2)_143-153.nxml.txt.nlp	22183178	SENT20	10	10	2	2	cangrelor	P2Y12	PA165945763	64805	0.891
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jun_18_67(Pt_7)_o1665.nxml.txt.nlp	21837064	SENT58	10	10	26	26	ethanol	mol	PA448073	90527	0.891
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT93	26	26	9	9	cisplatin	p53	PA449014	7157	0.891
NULL	J_Oncol_2013_Aug_20_2013_732047.nxml.txt.nlp	24027583	SENT109	22	22	4	4	bevacizumab	HER2	PA130232992	2064	0.891
NULL	J_Cell_Biol_1998_Aug_24_142(4)_923-936.nxml.txt.nlp	9722606	SENT117	29	29	23	23	fluorescein	TGN	PA164746009	7038	0.891
NULL	Cancer_Res_Treat_2011_Sep_30_43(3)_148-153.nxml.txt.nlp	22022291	SENT120	7	7	14	14	sn-38	UGT1A1		54658	0.891
NULL	Basic_Clin_Neurosci_2014_Winter_5(1)_31-41.nxml.txt.nlp	25436082	SENT136	36	36	12	12	bupropion	ANOVA	PA448687	4858	0.891
NULL	Anat_Cell_Biol_2011_Sep_29_44(3)_194-203.nxml.txt.nlp	22025971	SENT188	2	2	12	12	resveratrol	AMPK		5563	0.891
NULL	J_Hematol_Oncol_2008_Oct_1_1_16.nxml.txt.nlp	18828924	SENT105	45	45	39	39	trastuzumab	HER2	PA451743	2064	0.891
NULL	Scientifica_(Cairo)_2012_Oct_14_2012_428139.nxml.txt.nlp	24278693	SENT117	16	16	7	7	irinotecan	OCT1	PA450085	5451;6580	0.891
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jun_16_68(Pt_7)_o2122.nxml.txt.nlp	22798798	SENT74	22	22	6	6	ethanol	mol	PA448073	90527	0.891
NULL	Oncoimmunology_2012_Nov_1_1(8)_1305-1312.nxml.txt.nlp	23243594	SENT15	14	14	2	2	l-arginine	ARG	PA448478	473;27	0.891
NULL	Multidiscip_Respir_Med_2014_Oct_15_9(1)_50.nxml.txt.nlp	25364503	SENT266	4	4	16	16	formoterol	FEV	PA134687907	54738	0.891
NULL	Anticancer_Drugs_2015_Jan_28_26(1)_46-55.nxml.txt.nlp	25099621	SENT81	16	16	6	6	doxorubicin	KE-3	PA449412	6222	0.89
NULL	Mol_Cancer_2014_Jun_26_13_158.nxml.txt.nlp	24965046	SENT138	19	19	39	39	sorafenib	VEGFR	PA7000	3791	0.89
NULL	Oncol_Lett_2013_Oct_24_6(4)_985-989.nxml.txt.nlp	24137450	SENT130	19	19	28	28	etoposide	ADM	PA449552	133	0.89
NULL	Oncotarget_2011_Mar_23_2(3)_259-264.nxml.txt.nlp	21436470	SENT66	17	17	12	12	cisplatin	p63	PA449014	8626	0.89
NULL	J_Inflamm_(Lond)_2008_Jul_29_5_11.nxml.txt.nlp	18664275	SENT86	14	14	0	0	clarithromycin	IL-8	PA449028	3576	0.89
NULL	Diabetes_Care_2009_Oct_32(10)_1941-1943.nxml.txt.nlp	19794006	SENT28	4	4	13	13	pravastatin	adiponectin	PA451089	9370	0.89
NULL	Curr_Neuropharmacol_2013_May_11(3)_263-275.nxml.txt.nlp	24179463	SENT130	17	17	11	11	citalopram	CB1	PA449015	1268	0.89
NULL	Brain_Sci_2013_Jun_3_3(2)_877-907.nxml.txt.nlp	24961429	SENT187	0	0	3	3	taurine	IRE1	PA451590	2081	0.89
NULL	Arch_Drug_Inf_2011_Mar_4(1)_1-9.nxml.txt.nlp	21572514	SENT36	3	3	11	11	trimethoprim	P-gp	PA451788	5243	0.89
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jan_12_67(Pt_2)_o336.nxml.txt.nlp	21523019	SENT73	33	33	15	15	ethanol	mol	PA448073	90527	0.89
NULL	Mol_Cell_Biochem_2014_Jun_19_395(1-2)_109-116.nxml.txt.nlp	24942236	SENT51	18	18	37	37	neomycin	CO2	PA450608	4513	0.89
NULL	Cent_European_J_Urol_2013_Dec_19_66(4)_394-404.nxml.txt.nlp	24757527	SENT177	29	29	40	40	temsirolimus	MARK	PA164746890	4139	0.89
NULL	Brain_Sci_2013_Jun_14_3(2)_941-963.nxml.txt.nlp	24961432	SENT940	4	4	13	13	ethanol	CA1	PA448073	759	0.89
NULL	Ann_Rheum_Dis_2008_Nov_14_67(11)_1516-1523.nxml.txt.nlp	18625622	SENT18	0	0	23	23	tocilizumab	TNF	PA165292659	7124	0.89
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Jul_23_3(7)_e126.nxml.txt.nlp	25054314	SENT24	23	23	17	17	docetaxel	MRP2	PA449383	100130958;57626;1244	0.89
NULL	Mol_Cancer_2014_Jan_28_13_17.nxml.txt.nlp	24472312	SENT229	9	9	4	4	ponatinib	survivin	PA165980594	332	0.89
NULL	J_Gynecol_Oncol_2013_Jan_8_24(1)_66-82.nxml.txt.nlp	23346316	SENT53	14	14	27	27	bevacizumab	BBP	PA130232992	83941	0.89
NULL	Mediators_Inflamm_1996_Feb_5(1)_62-68.nxml.txt.nlp	18475700	SENT10	4	4	15	15	ng-monomethyl-l-arginine	IFN		3439	0.89
NULL	Oncotarget_2011_Mar_10_2(3)_186-196.nxml.txt.nlp	21406729	SENT112	37	37	10	10	orlistat	FASN	PA164776864	2194	0.89
NULL	Curr_Neuropharmacol_2009_Mar_7(1)_50-59.nxml.txt.nlp	19721817	SENT118	24	24	11	11	carbachol	c-fos	PA448784	2353	0.89
NULL	Aging_(Albany_NY)_2012_Jul_22_4(7)_480-498.nxml.txt.nlp	22837425	SENT24	40	40	34	34	metformin	AMPK	PA450395	5563	0.89
NULL	Comb_Chem_High_Throughput_Screen_2010_Feb_13(2)_188-206.nxml.txt.nlp	20053163	SENT245	24	24	11	11	itraconazole	CYP3A4	PA450132	1576	0.89
NULL	Diabetes_Care_2010_Apr_12_33(4)_730-732.nxml.txt.nlp	20067974	SENT44	38	38	2	2	glimepiride	GLP-1	PA449761	100125288	0.89
NULL	Acta_Pharmacol_Sin_2012_May_16_33(5)_682-690.nxml.txt.nlp	22504904	SENT126	3	3	12	12	celecoxib	STAT3	PA448871	6774	0.89
NULL	J_Hematol_Oncol_2008_Oct_23_1_19.nxml.txt.nlp	18947412	SENT64	20	20	4	4	alemtuzumab	CD34	PA164783958	947	0.89
NULL	J_Neuroinflammation_2010_Sep_7_7_51.nxml.txt.nlp	20822529	SENT13	2	2	7	7	hemin	HO-1	PA449849	3162	0.89
NULL	J_Clin_Biochem_Nutr_2011_Mar_26_48(2)_126-133.nxml.txt.nlp	21373265	SENT119	1	1	28	28	lansoprazole	HO-1	PA450180	3162	0.89
NULL	Cells_2014_Apr_29_3(2)_331-362.nxml.txt.nlp	24785347	SENT157	9	9	21	21	capsaicin	TRPV1	PA448776	7442	0.89
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT66	5	5	14	14	cetuximab	EGFR	PA10040	1956	0.89
NULL	Oxid_Med_Cell_Longev_2013_Jul_9_2013_574029.nxml.txt.nlp	23936610	SENT253	4	4	23	23	resveratrol	CD40		958	0.89
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT146	19	19	24	24	gefitinib	PI3K	PA131301952	5290	0.89
NULL	Front_Immunol_2012_Jan_24_3_3.nxml.txt.nlp	22566889	SENT1798	15	15	4	4	rituximab	CD55	PA451261	1604	0.89
NULL	Cancer_Med_2014_Apr_5_3(2)_337-348.nxml.txt.nlp	24500884	SENT59	10	10	1	1	fluorescein	INPP4B	PA164746009	8821	0.89
NULL	Iran_J_Basic_Med_Sci_2012_Sep-Oct_15(5)_1102-1105.nxml.txt.nlp	23492757	SENT50	22	22	7	7	celecoxib	IL-10	PA448871	3586	0.89
NULL	Mol_Cell_Proteomics_2012_Feb_6_11(2)_M111_015222.nxml.txt.nlp	22147731	SENT40	24	24	19	19	cetuximab	EGFR	PA10040	1956	0.89
NULL	J_Neuroinflammation_2011_Aug_5_8_91.nxml.txt.nlp	21819568	SENT152	16	16	28	28	pioglitazone	ANOVA	PA450970	4858	0.89
NULL	J_Cancer_Res_Clin_Oncol_2010_May_11_136(5)_737-743.nxml.txt.nlp	19904559	SENT40	13	13	21	21	irinotecan	IFL	PA450085	3439	0.89
NULL	Breast_Cancer_Res_Treat_2013_Jun_5_139(3)_649-655.nxml.txt.nlp	23736997	SENT160	10	10	32	32	tamoxifen	aromatase	PA451581	1588	0.89
NULL	Cancer_Growth_Metastasis_2013_Nov_27_6_61-80.nxml.txt.nlp	24665208	SENT285	0	0	18	18	cabozantinib	VEGFR2	PA165906891	3791	0.89
NULL	Oncotarget_2011_Dec_22_2(12)_1176-1190.nxml.txt.nlp	22202492	SENT26	8	8	5	5	darapladib	PLA2G7	PA165884699	7941	0.89
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT119	10	10	2	2	doxorubicin	IBP	PA449412	706;50619	0.89
NULL	Cardiol_Ther_2013_Jun_7_2(1)_57-68.nxml.txt.nlp	25135289	SENT62	7	7	2	2	thrombin	PAR-1	PA451674	2011;2149	0.89
NULL	J_Oncol_2012_Feb_6_2012_737981.nxml.txt.nlp	22481932	SENT101	18	18	31	31	paclitaxel	STAT3	PA450761	6774	0.89
NULL	J_Oncol_2009_Mar_10_2009_831626.nxml.txt.nlp	20300583	SENT96	38	38	8	8	cetuximab	KRAS	PA10040	3845	0.89
NULL	Cell_Death_Differ_2010_Oct_30_17(10)_1624-1635.nxml.txt.nlp	20431602	SENT167	5	5	15	15	paclitaxel	Mcl-1	PA450761	4170	0.89
NULL	Nat_Commun_2014_Nov_25_5_5548.nxml.txt.nlp	25420520	SENT665	31	31	16	16	cabazitaxel	ERG	PA165958401	2078	0.89
NULL	BMJ_2010_Feb_8_340_c693.nxml.txt.nlp	20142325	SENT261	20	20	17	17	fluoxetine	CYP2D6	PA449673	1565	0.89
NULL	J_Vet_Med_Sci_2014_Feb_8_76(2)_173-182.nxml.txt.nlp	24107430	SENT189	19	19	9	9	yohimbine	AVP	PA451946	114548;551	0.89
NULL	Oncol_Lett_2013_Jun_3_5(6)_1760-1764.nxml.txt.nlp	23833637	SENT116	6	6	23	23	gemcitabine	p17	PA449748	54107	0.89
NULL	J_Am_Heart_Assoc_2013_Apr_24_2(2)_e000131.nxml.txt.nlp	23537811	SENT56	33	33	15	15	clopidogrel	CYP2C19	PA449053	1557	0.89
NULL	Eur_J_Clin_Pharmacol_2012_Jan_7_68(1)_55-64.nxml.txt.nlp	21735164	SENT25	17	17	8	8	oxymorphone	CYP3A4	PA450748	1576	0.89
NULL	Mol_Vis_2014_Mar_30_20_441-457.nxml.txt.nlp	24715760	SENT49	10	10	23	23	geldanamycin	HIF-1	PA152031327	29072	0.89
NULL	Autoimmune_Dis_2013_Sep_26_2013_827254.nxml.txt.nlp	24187614	SENT221	14	14	1	1	rituximab	IL-6	PA451261	3569	0.89
NULL	J_Gen_Physiol_2000_Jun_1_115(6)_799-814.nxml.txt.nlp	10828252	SENT87	12	12	7	7	spermine	IRK1	PA164781199	3759	0.89
NULL	Oncotarget_2013_Feb_26_4(2)_298-309.nxml.txt.nlp	23593653	SENT151	13	13	20	20	etoposide	DNMT1	PA449552	1786	0.89
NULL	Cancer_Cell_Int_2011_Nov_2_11_39.nxml.txt.nlp	22047021	SENT151	12	12	17	17	cisplatin	REV3	PA449014	5980	0.89
NULL	Mol_Cancer_2009_Jun_9_8_37.nxml.txt.nlp	19508729	SENT118	10	10	2	2	gemcitabine	HO-1	PA449748	3162	0.89
NULL	EJC_Suppl_2013_Sep_5_11(2)_3-22.nxml.txt.nlp	NULL	SENT376	16	16	23	23	trastuzumab	HER2	PA451743	2064	0.89
NULL	Pharmaceuticals_(Basel)_2013_Mar_14_6(3)_295-319.nxml.txt.nlp	23894227	SENT362	17	17	6	6	trypsin	PC3	PA451806	57332;7832;5122	0.89
NULL	Cell_Cycle_2013_Dec_15_12(24)_3791-3803.nxml.txt.nlp	24107631	SENT44	13	13	5	5	doxorubicin	YB-1	PA449412	4904	0.89
NULL	Cell_Death_Dis_2014_Feb_27_5(2)_e1082.nxml.txt.nlp	24577080	SENT201	21	21	31	31	isoproterenol	ANOVA	PA450121	4858	0.89
NULL	J_Cell_Biol_1998_Nov_16_143(4)_973-990.nxml.txt.nlp	9817755	SENT325	27	27	12	12	chloroquine	TGN38	PA448948	10618	0.89
NULL	Br_J_Dermatol_2009_Feb_160(2)_438-441.nxml.txt.nlp	19016697	SENT107	24	24	14	14	methotrexate	ATIC	PA450428	471	0.89
NULL	Breast_Cancer_Res_2012_Jun_19_14(3)_311.nxml.txt.nlp	22713135	SENT34	26	26	16	16	letrozole	PIK3CA	PA450196	5290	0.89
NULL	Cell_Cycle_2012_Nov_15_11(22)_4111.nxml.txt.nlp	23099921	SENT12	39	39	8	8	camptothecin	DNA2	PA153590860	1763	0.89
NULL	Ann_Rheum_Dis_2014_Jan_31_73(1)_69-74.nxml.txt.nlp	23904473	SENT232	11	11	7	7	tocilizumab	IL-6	PA165292659	3569	0.89
NULL	Neuropsychopharmacology_2009_Jul_11_34(8)_1946-1957.nxml.txt.nlp	19279569	SENT130	11	11	20	20	cocaine	DOR	PA449072	58476	0.89
NULL	Exp_Diabetes_Res_2012_Apr_17_2012_635472.nxml.txt.nlp	22577369	SENT69	24	24	18	18	liraglutide	GLP-1	PA165958364	100125288	0.89
NULL	J_Biol_Eng_2009_Oct_16_3_18.nxml.txt.nlp	19835592	SENT56	18	18	12	12	ofloxacin	CPZ	PA450684	8532	0.89
NULL	Pharmaceutics_2011_Sep_14_3(3)_615-635.nxml.txt.nlp	24310600	SENT82	19	19	2	2	imatinib	ABCG2	PA10804	9429	0.89
NULL	Br_J_Cancer_2012_Feb_14_106(4)_685-692.nxml.txt.nlp	22294184	SENT163	8	8	2	2	docetaxel	survivin	PA449383	332	0.89
NULL	Acta_Pharmacol_Sin_2013_Jan_23_34(1)_33-38.nxml.txt.nlp	22820909	SENT86	3	3	11	11	amiloride	ASIC3	PA448368	9311	0.89
NULL	Nucleic_Acids_Res_2005_Jun_8_33(10)_3283-3291.nxml.txt.nlp	15944449	SENT156	22	22	11	11	melphalan	XRCC2	PA450354	7516	0.89
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT382	2	2	13	13	cetuximab	KRAS	PA10040	3845	0.89
NULL	Nucleic_Acids_Res_2011_Aug_29_39(15)_6620-6632.nxml.txt.nlp	21531700	SENT223	5	5	0	0	doxycycline	MYC	PA449415	4609	0.89
NULL	F1000Res_2013_Jul_9_2_150.nxml.txt.nlp	24627787	SENT18	9	9	28	28	clozapine	DIP	PA449061	23151;1831	0.89
NULL	Tuberc_Respir_Dis_(Seoul)_2013_Sep_30_75(3)_95-103.nxml.txt.nlp	24101933	SENT26	23	23	15	15	erlotinib	CD56	PA134687924	4684	0.89
NULL	Br_J_Pharmacol_2012_Jan_165(2)_390-400.nxml.txt.nlp	21671897	SENT256	21	21	11	11	suramin	P2X4	PA10292	5025	0.89
NULL	Mol_Cancer_2010_Jun_25_9_165.nxml.txt.nlp	20576164	SENT210	3	3	10	10	curcumin	IFN	PA151958596	3439	0.89
NULL	Clin_Drug_Investig_2015_Dec_16_35_141-147.nxml.txt.nlp	25511640	SENT71	25	25	5	5	miglitol	GLP-1	PA164776726	100125288	0.89
NULL	Br_J_Cancer_2011_May_24_104(11)_1786-1790.nxml.txt.nlp	21559018	SENT101	12	12	34	34	decitabine	EGFR	PA164749631	1956	0.89
NULL	Diabetes_2011_Jun_21_60(6)_1770-1778.nxml.txt.nlp	21562078	SENT147	16	16	12	12	metformin	HL-1	PA450395	55600	0.89
NULL	Environ_Health_Perspect_2006_Sep_23_114(9)_1401-1406.nxml.txt.nlp	16966095	SENT165	44	44	39	39	arsenite	p53	PA452638	7157	0.89
NULL	Aging_(Albany_NY)_2009_Mar_31_1(4)_412-424.nxml.txt.nlp	20195491	SENT123	2	2	8	8	resveratrol	AMPK		5563	0.89
NULL	Cancer_Immunol_Immunother_2012_Jul_23_61(7)_1101-1111.nxml.txt.nlp	22193989	SENT37	7	7	26	26	oxaliplatin	PD-L2	PA131285527	80380	0.89
NULL	Cost_Eff_Resour_Alloc_2004_Apr_15_2_2.nxml.txt.nlp	15086954	SENT9	33	33	24	24	nateglinide	PPG	PA450600	5552	0.89
NULL	Arthritis_Res_Ther_2003_Dec_2_5(Suppl_4)_S12-S16.nxml.txt.nlp	15180892	SENT75	22	22	32	32	doxorubicin	CHOP	PA449412	1649	0.89
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT37	28	28	31	31	saquinavir	ABCB1	PA451305	5243	0.89
NULL	Oncotarget_2014_Sep_16_5(20)_10034-10047.nxml.txt.nlp	25296981	SENT179	43	43	24	24	doxorubicin	CHK1	PA449412	1111	0.89
NULL	Ann_Rheum_Dis_2008_May_21_68(2)_175-182.nxml.txt.nlp	18495735	SENT66	5	5	14	14	infliximab	IL-6	PA452639	3569	0.89
NULL	Breast_Cancer_(Auckl)_2014_May_12_8_81-88.nxml.txt.nlp	24855372	SENT16	9	9	17	17	pertuzumab	HER2		2064	0.89
NULL	Cancer_Imaging_2008_Nov_25_8(1)_199-205.nxml.txt.nlp	19028612	SENT125	19	19	12	12	sorafenib	EGFR	PA7000	1956	0.89
NULL	Psychiatr_Genet_2013_Aug_28_23(4)_153-162.nxml.txt.nlp	23811784	SENT156	7	7	16	16	clozapine	HTR2A	PA449061	3356	0.89
NULL	Cancer_Cell_Int_2013_Mar_4_13_21.nxml.txt.nlp	23497288	SENT231	0	0	6	6	etoposide	San	PA449552	80218	0.89
NULL	Clin_Exp_Gastroenterol_2011_Jul_15_4_163-172.nxml.txt.nlp	21904462	SENT26	0	0	12	12	adalimumab	p55	PA10004	6624;2078;8503;5718	0.89
NULL	Br_J_Cancer_2013_Oct_15_109(8)_2175-2188.nxml.txt.nlp	24045662	SENT9	30	30	20	20	methotrexate	GGH	PA450428	8836	0.89
NULL	Arthritis_Res_Ther_2013_Feb_20_15(1)_R31.nxml.txt.nlp	23421940	SENT178	16	16	22	22	nitroprusside	STAT3	PA451406	6774	0.89
NULL	Curr_Cardiol_Rev_2009_Aug_5(3)_166-176.nxml.txt.nlp	20676275	SENT182	4	4	13	13	levofloxacin	HERG	PA450214	3757	0.89
NULL	Curr_Rheumatol_Rep_2011_Aug_19_13(4)_353-359.nxml.txt.nlp	21503693	SENT93	7	7	24	24	methotrexate	IL-8	PA450428	3576	0.89
NULL	Clin_Interv_Aging_2012_Dec_30_7_1-13.nxml.txt.nlp	22291468	SENT267	24	24	15	15	telithromycin	CYP3A4	PA10202	1576	0.89
NULL	J_Biomed_Biotechnol_2007_Dec_27_2007_54327.nxml.txt.nlp	17497024	SENT38	10	10	1	1	thrombin	CD11b	PA451674	3684	0.89
NULL	Eur_J_Clin_Pharmacol_2010_Feb_17_66(2)_165-170.nxml.txt.nlp	19838691	SENT28	16	16	25	25	zidovudine	UGT2B7	PA451954	7364	0.89
NULL	Oncologist_2011_Jan_6_16(1)_5-24.nxml.txt.nlp	21212434	SENT196	18	18	29	29	dacarbazine	IFN	PA449197	3439	0.89
NULL	Gut_Liver_2013_Sep_11_7(5)_560-568.nxml.txt.nlp	24073314	SENT161	37	37	10	10	lansoprazole	ATP4A	PA450180	495	0.89
NULL	Bioinformation_2012_Jan_6_8(1)_13-19.nxml.txt.nlp	22359429	SENT94	16	16	3	3	curcumin	MRP1	PA151958596	4437	0.89
NULL	Oncotarget_2013_Jul_7_4(7)_1065-1074.nxml.txt.nlp	23867252	SENT49	10	10	4	4	trypsin	Hsp90	PA451806	3320	0.89
NULL	Front_Chem_2014_Mar_14_2_12.nxml.txt.nlp	24790981	SENT16	22	22	15	15	curcumin	GATA4	PA151958596	2626	0.89
NULL	Br_J_Cancer_2013_May_14_108(9)_1862-1869.nxml.txt.nlp	23579219	SENT138	27	27	15	15	cetuximab	ANXA11	PA10040	311	0.89
NULL	Oncotarget_2014_Oct_21_5(22)_11709-11722.nxml.txt.nlp	25365944	SENT227	16	16	27	27	metformin	Rho	PA450395	29984	0.89
NULL	Cell_Death_Dis_2012_Nov_15_3(11)_e422.nxml.txt.nlp	23152058	SENT317	22	22	7	7	cisplatin	ZNF143	PA449014	7702	0.89
NULL	Br_J_Cancer_2013_Sep_3_109(5)_1214-1222.nxml.txt.nlp	23922104	SENT176	22	22	31	31	dasatinib	TP53	PA162372878	7157	0.89
NULL	Oncotarget_2013_Nov_15_5(6)_1458-1474.nxml.txt.nlp	24681547	SENT149	1	1	13	13	celecoxib	CDH11	PA448871	1009	0.89
NULL	J_Cell_Biol_2004_Jun_21_165(6)_893-902.nxml.txt.nlp	15197174	SENT128	6	6	20	20	trifluoperazine	ADAM10	PA451771	102	0.89
NULL	Avicenna_J_Med_Biotechnol_2012_Jan-Mar_4(1)_35-39.nxml.txt.nlp	23407847	SENT56	36	36	10	10	nadh	CO2	PA164755085	4513	0.89
NULL	J_Cell_Biol_1998_Jan_26_140(2)_283-293.nxml.txt.nlp	9442104	SENT188	24	24	19	19	galactose	CLN3	PA449725	1201	0.89
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1554-1562.nxml.txt.nlp	21970876	SENT145	9	9	3	3	gefitinib	EGFR	PA131301952	1956	0.89
NULL	Anat_Cell_Biol_2011_Mar_31_44(1)_14-24.nxml.txt.nlp	21519545	SENT12	26	26	15	15	cyclophosphamide	CK8	PA449165	3856	0.89
NULL	Indian_J_Ophthalmol_2014_Jun_62(6)_671-674.nxml.txt.nlp	25005192	SENT89	34	34	41	41	candesartan	CRA	PA448765	51747;10903	0.89
NULL	Br_J_Cancer_2010_Jun_29_103(1)_61-72.nxml.txt.nlp	20588279	SENT312	0	0	12	12	trastuzumab	AKT	PA451743	207	0.89
NULL	Korean_J_Anesthesiol_2013_Dec_26_65(6)_501-507.nxml.txt.nlp	24427455	SENT50	0	0	14	14	rocuronium	NMB	PA164754992	10457;4828	0.89
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT174	22	22	10	10	perifosine	DR5	PA165291471	8795	0.89
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Apr_21_68(Pt_5)_o1453-o1454.nxml.txt.nlp	22590331	SENT69	7	7	18	18	nitazoxanide	TIZ	PA164754874	171392	0.89
NULL	J_Hematol_Oncol_2012_Sep_18_5_57.nxml.txt.nlp	22989009	SENT171	15	15	9	9	nutlin-3	HDM2		4193	0.89
NULL	Ann_Clin_Transl_Neurol_2014_Dec_21_1(12)_996-1005.nxml.txt.nlp	25574474	SENT199	29	29	18	18	elacridar	P-gp		5243	0.89
NULL	Dermatoendocrinol_2013_Apr_1_5(2)_252-263.nxml.txt.nlp	24194965	SENT208	27	27	9	9	metformin	IL-6	PA450395	3569	0.89
NULL	Indian_J_Pharmacol_2008_Oct_40(Suppl_2)_S97-S112.nxml.txt.nlp	21593984	SENT663	7	7	14	14	propranolol	HYD	PA451145	51366	0.89
NULL	Breast_Cancer_Res_2010_May_18_12(Suppl_1)_P45.nxml.txt.nlp	NULL	SENT10	25	25	1	1	tamoxifen	FKBPL	PA451581	63943	0.89
NULL	Open_AIDS_J_2011_Apr_22_5_44-50.nxml.txt.nlp	21643422	SENT45	35	35	43	43	ritonavir	ATV	PA451260	4683	0.89
NULL	Br_J_Cancer_2011_Jun_28_105(1)_53-57.nxml.txt.nlp	21654688	SENT158	0	0	6	6	irinotecan	UGT1A1	PA450085	54658	0.89
NULL	Orphanet_J_Rare_Dis_2013_Apr_4_8_51.nxml.txt.nlp	23557332	SENT167	32	32	8	8	galsulfase	ARSB	PA164746235	411	0.89
NULL	Clin_Pharmacol_2011_Jun_22_3_13-25.nxml.txt.nlp	22287853	SENT187	15	15	20	20	saxagliptin	CYP3A4	PA165958362	1576	0.89
NULL	Case_Rep_Oncol_2011_Nov_11_4(3)_531-533.nxml.txt.nlp	22171218	SENT49	6	6	1	1	sunitinib	VEGFR	PA162372840	3791	0.89
NULL	Mol_Cancer_2006_Oct_17_5_45.nxml.txt.nlp	17044934	SENT13	9	9	17	17	resveratrol	COX		1351	0.89
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT95	5	5	20	20	celecoxib	survivin	PA448871	332	0.89
NULL	Oncotarget_2013_Dec_28_5(6)_1475-1490.nxml.txt.nlp	24721996	SENT82	2	2	7	7	celecoxib	CD133	PA448871	8842	0.89
NULL	Br_J_Cancer_2009_Jul_21_101(2)_238-243.nxml.txt.nlp	19568242	SENT174	12	12	6	6	sunitinib	IFN	PA162372840	3439	0.89
NULL	J_Hematol_Oncol_2009_Apr_22_2_18.nxml.txt.nlp	19386128	SENT170	18	18	35	35	cetuximab	KRAS	PA10040	3845	0.89
NULL	Pharmaceuticals_(Basel)_2014_May_14_7(5)_621-633.nxml.txt.nlp	24830987	SENT216	22	22	13	13	ethanol	FDG	PA448073	23583	0.89
NULL	Cancer_Cell_Int_2011_Mar_2_11_5.nxml.txt.nlp	21366897	SENT134	10	10	19	19	cisplatin	p53	PA449014	7157	0.89
NULL	Exp_Ther_Med_2013_Apr_5_5(4)_1259-1263.nxml.txt.nlp	23596498	SENT5	5	5	12	12	propofol	TRPV1	PA451141	7442	0.89
NULL	Evid_Based_Complement_Alternat_Med_2011_Mar_13_2011_913898.nxml.txt.nlp	21785639	SENT155	1	1	10	10	nifedipine	CYP3A4	PA450631	1576	0.89
NULL	Br_J_Cancer_2011_Jul_12_105(2)_255-262.nxml.txt.nlp	21694725	SENT21	24	24	5	5	panitumumab	KRAS	PA162373091	3845	0.89
NULL	Oncol_Lett_2013_Feb_9_5(2)_552-558.nxml.txt.nlp	23420128	SENT33	20	20	12	12	imatinib	KIT	PA10804	3815	0.89
NULL	Front_Syst_Neurosci_2014_Jul_1_8_114.nxml.txt.nlp	25071473	SENT252	11	11	0	0	ketamine	HCN1	PA450144	348980	0.89
NULL	Curr_Neuropharmacol_2014_Jul_12(4)_308-323.nxml.txt.nlp	25342939	SENT217	1	1	30	30	nifedipine	NKCC1	PA450631	6558	0.89
NULL	Diabetes_Care_2013_Aug_11_36(8)_2408-2414.nxml.txt.nlp	23536583	SENT110	5	5	34	34	rosiglitazone	adiponectin	PA451283	9370	0.89
NULL	Arthritis_Res_Ther_2004_Jun_22_6(4)_178-180.nxml.txt.nlp	15225363	SENT9	16	16	29	29	cyclophosphamide	IFN	PA449165	3439	0.89
NULL	EPMA_J_2012_Sep_27_3(1)_10.nxml.txt.nlp	23016735	SENT137	30	30	20	20	warfarin	CYP2C9	PA451906	1559	0.89
NULL	Cancer_2014_Aug_1_120(15)_2343-2351.nxml.txt.nlp	24752945	SENT155	25	25	16	16	cisplatin	RRM1	PA449014	6240	0.89
NULL	Oncol_Lett_2014_Jun_2_7(6)_1889-1894.nxml.txt.nlp	24932254	SENT28	19	19	8	8	cisplatin	OCT1	PA449014	5451;6580	0.89
NULL	Oncotarget_2011_Mar_27_2(3)_209-221.nxml.txt.nlp	21444945	SENT161	13	13	20	20	bortezomib	p53	PA10252	7157	0.89
NULL	Nucleic_Acids_Res_2013_Apr_14_41(8)_4495-4506.nxml.txt.nlp	23502002	SENT420	32	32	27	27	urokinase	c-Myc	PA451836	4609	0.89
NULL	Mol_Biol_Cell_2013_Dec_15_24(24)_3939-3944.nxml.txt.nlp	24152728	SENT88	7	7	13	13	tamoxifen	CCN2	PA451581	1490	0.89
NULL	EPMA_J_2010_Mar_13_1(1)_138-163.nxml.txt.nlp	23199048	SENT286	8	8	2	2	exenatide	GLP-1	PA164749238	100125288	0.89
NULL	Breast_Cancer_Res_2005_May_27_7(Suppl_1)_S16.nxml.txt.nlp	NULL	SENT5	6	6	26	26	anastrozole	BCS	PA448432	617	0.89
NULL	Infect_Drug_Resist_2011_Jan_12_4_11-18.nxml.txt.nlp	21694905	SENT134	9	9	23	23	fluvastatin	RVR	PA449688	9975	0.89
NULL	Clin_Ophthalmol_2014_May_23_8_1031-1038.nxml.txt.nlp	24920879	SENT106	12	12	20	20	bimatoprost	BAK	PA164748867	578	0.89
NULL	Scientifica_(Cairo)_2013_Dec_12_2013_635203.nxml.txt.nlp	24416617	SENT405	9	9	37	37	sorafenib	FLT3	PA7000	2322	0.89
NULL	Int_J_Mol_Sci_2014_Oct_29_15(11)_19700-19728.nxml.txt.nlp	25356505	SENT191	8	8	12	12	isoproterenol	EGFR	PA450121	1956	0.89
NULL	Arch_Gynecol_Obstet_2012_May_30_285(5)_1447-1453.nxml.txt.nlp	22127553	SENT29	36	36	17	17	epirubicin	TEC	PA449476	7006	0.89
NULL	Eur_J_Endocrinol_2013_Apr_168(4)_557-564.nxml.txt.nlp	23345197	SENT50	8	8	17	17	diazoxide	SUR1	PA449285	6833	0.89
NULL	J_Korean_Med_Sci_2007_Sep_30_22(Suppl)_S167-S170.nxml.txt.nlp	17923747	SENT61	21	21	9	9	rituximab	B19	PA451261	59271	0.89
NULL	Clin_Sci_(Lond)_2011_Apr_1_120(Pt_8)_335-345.nxml.txt.nlp	21091432	SENT133	5	5	42	42	ramipril	ACE2	PA451223	59272	0.89
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Feb_21_65(Pt_3)_o578.nxml.txt.nlp	21582233	SENT75	15	15	6	6	ethanol	mol	PA448073	90527	0.89
NULL	Adipocyte_2012_Jul_1_1(3)_142-183.nxml.txt.nlp	23700523	SENT90	14	14	33	33	lipase	gamma	PA450239	9913	0.89
NULL	J_Neurosci_Methods_2009_Oct_15_183(2)_107-113.nxml.txt.nlp	19524611	SENT95	14	14	34	34	carbachol	DSI	PA448784	5034	0.89
NULL	Mol_Cells_2014_Mar_31_37(3)_234-240.nxml.txt.nlp	24642709	SENT109	7	7	22	22	cisplatin	NOX4	PA449014	50507	0.89
NULL	J_Vet_Med_Sci_2014_Oct_16_76(10)_1383-1387.nxml.txt.nlp	24931645	SENT72	5	5	12	12	sitagliptin	GLP-1	PA164748978	100125288	0.89
NULL	Am_J_Clin_Nutr_2011_Jul_94(1)_359S-365S.nxml.txt.nlp	21593496	SENT312	13	13	6	6	hydroxocobalamin	B12	PA164768689	7126;4709	0.89
NULL	Breast_Cancer_Res_2008_Jul_24_10(4)_211.nxml.txt.nlp	18671839	SENT197	3	3	14	14	gefitinib	EGFR	PA131301952	1956	0.89
NULL	Chin_J_Cancer_2012_Aug_31(8)_373-380.nxml.txt.nlp	22739266	SENT11	19	19	8	8	cytarabine	XRCC3	PA449177	7517	0.89
NULL	Diabetes_2009_Aug_28_58(8)_1816-1825.nxml.txt.nlp	19401425	SENT169	20	20	25	25	nimodipine	GLP-1	PA450633	100125288	0.89
NULL	Br_J_Cancer_2012_Oct_9_107(8)_1207-1212.nxml.txt.nlp	23047591	SENT95	0	0	11	11	metformin	AMPK	PA450395	5563	0.89
NULL	Br_J_Pharmacol_2013_Mar_25_168(6)_1445-1455.nxml.txt.nlp	23121507	SENT228	8	8	12	12	nifedipine	TRPM3	PA450631	80036	0.89
NULL	Arthritis_Res_Ther_2013_Dec_30_15(6)_R223.nxml.txt.nlp	24373218	SENT262	10	10	0	0	carprofen	TSP-1	PA164781361	7057	0.89
NULL	Oxid_Med_Cell_Longev_2013_Nov_28_2013_568093.nxml.txt.nlp	24379901	SENT79	0	0	19	19	resveratrol	AMPK		5563	0.89
NULL	Br_J_Cancer_2009_Jul_21_101(2)_238-243.nxml.txt.nlp	19568242	SENT122	13	13	18	18	bevacizumab	IFN	PA130232992	3439	0.89
NULL	Biologics_2012_Feb_1_6_31-35.nxml.txt.nlp	22355257	SENT66	33	33	20	20	rituximab	IL-7	PA451261	3574	0.89
NULL	Arthritis_Res_Ther_2003_Nov_8_5(1)_12-24.nxml.txt.nlp	12716443	SENT65	1	1	21	21	alendronate	Rho	PA448082	29984	0.89
NULL	Anticancer_Drugs_2015_Jan_28_26(1)_46-55.nxml.txt.nlp	25099621	SENT106	0	0	22	22	doxorubicin	p38	PA449412	10598;1432;7965	0.89
NULL	Biomed_Res_Int_2014_Jan_20_2014_948427.nxml.txt.nlp	24563867	SENT122	30	30	8	8	glucose	5-HT1A	PA449773	3350	0.89
NULL	Ann_Saudi_Med_2010_Mar-Apr_30(2)_109-114.nxml.txt.nlp	20220259	SENT51	29	29	4	4	ribavirin	HVR1	PA451241	7433	0.89
NULL	Cardiovasc_Diabetol_2013_May_4_12_73.nxml.txt.nlp	23642288	SENT15	3	3	22	22	acarbose	GLP-1	PA448010	100125288	0.89
NULL	Mol_Cancer_2012_Mar_21_11_13.nxml.txt.nlp	22436134	SENT158	18	18	13	13	doxorubicin	HuR	PA449412	1994	0.89
NULL	AIDS_Res_Ther_2014_May_19_11_13.nxml.txt.nlp	24894206	SENT315	21	21	33	33	methamphetamine	IL-8	PA450403	3576	0.89
NULL	Sci_Rep_2014_Dec_3_4_7298.nxml.txt.nlp	25466238	SENT60	25	25	18	18	chloroquine	UCHL1	PA448948	7345	0.89
NULL	Cancer_Imaging_2013_Jul_22_13(3)_306-313.nxml.txt.nlp	23876444	SENT257	5	5	9	9	vemurafenib	BRAF	PA165946873	673	0.89
NULL	Oncoimmunology_2012_Oct_1_1(7)_1027-1037.nxml.txt.nlp	23170251	SENT210	10	10	15	15	imatinib	IFN	PA10804	3439	0.89
NULL	ScientificWorldJournal_2013_Feb_13_2013_292687.nxml.txt.nlp	23476127	SENT181	11	11	20	20	dexmedetomidine	NGAL	PA449256	3934	0.89
NULL	Cancer_Res_Treat_2011_Jun_30_43(2)_89-95.nxml.txt.nlp	21811424	SENT50	7	7	12	12	tamoxifen	aromatase	PA451581	1588	0.89
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT106	41	41	38	38	methotrexate	MSH2	PA450428	4436	0.89
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1137-1144.nxml.txt.nlp	20234366	SENT159	11	11	19	19	bevacizumab	BRAF	PA130232992	673	0.89
NULL	Case_Rep_Gastroenterol_2014_Apr_10_8(1)_134-140.nxml.txt.nlp	24847196	SENT76	18	18	11	11	vincristine	CHOP	PA451879	1649	0.89
NULL	Ann_Dermatol_2014_Aug_31_26(4)_517-520.nxml.txt.nlp	25143685	SENT35	9	9	14	14	tazarotene	TIG3	PA164746821	5920	0.89
NULL	Eur_J_Clin_Pharmacol_2010_Nov_29_66(11)_1131-1136.nxml.txt.nlp	20669013	SENT14	6	6	1	1	erythromycin	CYP2C19	PA449493	1557	0.89
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT160	7	7	12	12	cisplatin	p53	PA449014	7157	0.89
NULL	Front_Oncol_2014_Sep_23_4_263.nxml.txt.nlp	25295230	SENT203	7	7	9	9	imatinib	FLT3	PA10804	2322	0.89
NULL	Ann_Med_2011_Nov_5_43(7)_531-544.nxml.txt.nlp	21815879	SENT105	12	12	17	17	cilostazol	P2Y12	PA164746334	64805	0.89
NULL	Nat_Commun_2013_Nov_12_4_2760.nxml.txt.nlp	24217681	SENT176	2	2	30	30	pentobarbital	CA1	PA450859	759	0.89
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Feb_10_68(Pt_3)_o661.nxml.txt.nlp	22412563	SENT3	15	15	33	33	artemisinin	mol	PA165111696	90527	0.89
NULL	J_Headache_Pain_2013_Mar_12_14(1)_25.nxml.txt.nlp	23566208	SENT29	35	35	7	7	levetiracetam	LEP	PA450206	3952	0.89
NULL	Br_J_Cancer_2012_Jan_3_106(1)_6-13.nxml.txt.nlp	22215104	SENT52	0	0	22	22	lapatinib	HER2	PA152241907	2064	0.89
NULL	Front_Immunol_2012_May_7_3_101.nxml.txt.nlp	22783250	SENT244	3	3	12	12	papain	IL-5	PA450778	3567	0.89
NULL	Cancer_Metastasis_Rev_2010_Dec_10_29(4)_581-594.nxml.txt.nlp	20830503	SENT341	9	9	28	28	tamoxifen	ATAC	PA451581	6375	0.89
NULL	Clin_Med_Insights_Cardiol_2013_Aug_11_7_127-140.nxml.txt.nlp	23997577	SENT84	0	0	9	9	dronedarone	CYP2D6	PA153619853	1565	0.89
NULL	J_Cell_Mol_Med_2014_Dec_9_18(12)_2499-2511.nxml.txt.nlp	24912879	SENT245	21	21	7	7	docetaxel	DACH1	PA449383	1602	0.89
NULL	Mol_Biol_Rep_2013_May_11_40(8)_5013-5026.nxml.txt.nlp	23666059	SENT335	6	6	16	16	resveratrol	p53		7157	0.89
NULL	Int_Neurourol_J_2014_Sep_24_18(3)_115-125.nxml.txt.nlp	25279238	SENT128	31	31	10	10	berberine	PI3K	PA165860812	5290	0.89
NULL	Int_J_Med_Sci_2013_Jan_3_10(2)_141-147.nxml.txt.nlp	23329885	SENT32	5	5	20	20	creatine	AGAT	PA164778930	2628	0.89
NULL	Mol_Cancer_2014_Aug_15_13(1)_192.nxml.txt.nlp	NULL	SENT317	7	7	2	2	trastuzumab	ERBB2	PA451743	2064	0.89
NULL	Endocr_Relat_Cancer_2014_Apr_21(2)_355-369.nxml.txt.nlp	24481325	SENT10	0	0	19	19	tamoxifen	GPER	PA451581	2852	0.89
NULL	Acta_Neuropathol_2012_Feb_19_123(2)_247-258.nxml.txt.nlp	22009304	SENT235	24	24	38	38	tamoxifen	flower	PA451581	11094	0.89
NULL	Int_J_Gen_Med_2013_Dec_27_7_43-47.nxml.txt.nlp	24403843	SENT78	6	6	9	9	roxithromycin	ACR	PA164750505	49	0.89
NULL	Curr_Neuropharmacol_2009_Sep_7(3)_160-179.nxml.txt.nlp	20190959	SENT258	43	43	32	32	suramin	CA3	PA10292	761	0.89
NULL	Cancer_Cell_Int_2009_Sep_10_9_25.nxml.txt.nlp	19744341	SENT103	11	11	40	40	glucosamine	STAT3	PA164747613	6774	0.89
NULL	Biomed_Res_Int_2014_Jan_27_2014_696107.nxml.txt.nlp	24587987	SENT196	8	8	14	14	ebselen	NAC	PA161660841	22861	0.89
NULL	Patient_Prefer_Adherence_2009_Nov_3_3_51-59.nxml.txt.nlp	19936145	SENT131	12	12	7	7	tolcapone	COMT	PA451720	1312	0.89
NULL	AIDS_Res_Ther_2009_Feb_5_6_2.nxml.txt.nlp	19196474	SENT96	29	29	1	1	enfuvirtide	ANOVA	PA164744517	4858	0.89
NULL	Breast_Cancer_Res_2012_Mar_16_14(2)_206.nxml.txt.nlp	22423895	SENT161	16	16	2	2	sunitinib	FDG	PA162372840	23583	0.89
NULL	Oncol_Rep_2013_Oct_22_30(4)_1535-1541.nxml.txt.nlp	23877481	SENT106	2	2	16	16	gefitinib	EGFR	PA131301952	1956	0.89
NULL	J_Thromb_Haemost_2011_Oct_9(10)_2103-2105.nxml.txt.nlp	21812912	SENT44	19	19	10	10	ticagrelor	P2Y12	PA165374673	64805	0.89
NULL	Int_J_Mol_Sci_2014_Nov_21_15(11)_21505-21537.nxml.txt.nlp	25421245	SENT224	10	10	4	4	capsaicin	UCP2	PA448776	7351	0.89
NULL	Breast_Cancer_Res_Treat_2013_Aug_20_141(1)_43-53.nxml.txt.nlp	23959396	SENT28	27	27	12	12	trastuzumab	HER3	PA451743	2065	0.89
NULL	Ann_Lab_Med_2012_Jul_20_32(4)_298-303.nxml.txt.nlp	22779073	SENT40	19	19	37	37	isoniazid	EMB	PA450112	133418	0.89
NULL	Br_J_Cancer_2012_May_8_106(10)_1689-1696.nxml.txt.nlp	22531631	SENT30	30	30	0	0	l-glutamine	PC-3	PA10090	692094	0.89
NULL	Indian_J_Med_Res_2011_Sep_134(3)_295-301.nxml.txt.nlp	21985811	SENT123	45	45	15	15	phenytoin	ABCB1	PA450947	5243	0.89
NULL	Diabetes_Care_2009_Sep_28_32(9)_1649-1655.nxml.txt.nlp	19478198	SENT105	14	14	6	6	saxagliptin	PPG	PA165958362	5552	0.89
NULL	Biosci_Rep_2012_Aug_1_32(Pt_4)_361-374.nxml.txt.nlp	22762204	SENT948	9	9	4	4	cisplatin	p27	PA449014	5715;10534	0.89
NULL	Curr_Neuropharmacol_2013_Dec_11(6)_652-663.nxml.txt.nlp	24396340	SENT81	0	0	22	22	paclitaxel	TRPV4	PA450761	59341	0.89
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT189	17	17	6	6	tacrolimus	IL-6	PA451578	3569	0.89
NULL	Indian_J_Dermatol_2013_Jan-Feb_58(1)_61-64.nxml.txt.nlp	23372216	SENT99	8	8	12	12	fluvoxamine	CYP3A4	PA449690	1576	0.89
NULL	Oncol_Rep_2012_Apr_30_27(4)_923-928.nxml.txt.nlp	22209766	SENT140	6	6	10	10	erlotinib	EGFR	PA134687924	1956	0.89
NULL	Oxid_Med_Cell_Longev_2011_Aug_17_2011_450317.nxml.txt.nlp	21904643	SENT201	26	26	33	33	l-leucine	DTNB	PA450197	1838	0.89
NULL	Clinics_(Sao_Paulo)_2014_Apr_69(4)_225-233.nxml.txt.nlp	24714829	SENT128	14	14	31	31	lactulose	adiponectin	PA164748762	9370	0.89
NULL	J_Immunother_Cancer_2014_Jan_27_2_2.nxml.txt.nlp	24829759	SENT106	30	30	39	39	sorafenib	IL-21	PA7000	59067;50616;27189	0.89
NULL	Ann_Clin_Transl_Neurol_2014_Mar_4_1(3)_199-208.nxml.txt.nlp	25356398	SENT157	14	14	2	2	reserpine	ANOVA	PA451236	4858	0.89
NULL	Nucl_Recept_Signal_2009_Jan_16_7_e001.nxml.txt.nlp	19240808	SENT208	7	7	0	0	midazolam	SFN	PA450496	25996;2810	0.89
NULL	Br_J_Cancer_2013_Mar_19_108(5)_1052-1060.nxml.txt.nlp	23422754	SENT177	29	29	18	18	bevacizumab	VEGF-A	PA130232992	7422	0.89
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT148	7	7	0	0	doxorubicin	B7-H1	PA449412	29126	0.89
NULL	J_Invest_Dermatol_2012_May_16_132(5)_1435-1442.nxml.txt.nlp	22336948	SENT67	7	7	23	23	doxycycline	TLSP	PA449415	11012	0.89
NULL	Bioimpacts_2014_Sep_21_4(3)_113-116.nxml.txt.nlp	25337463	SENT95	44	44	24	24	lipase	MCU	PA450239	90550	0.89
NULL	Indian_J_Pharm_Sci_2014_Jan-Feb_76(1)_72-77.nxml.txt.nlp	24799741	SENT117	15	15	8	8	imipramine	CYP2C9	PA449969	1559	0.89
NULL	Iran_J_Public_Health_2012_Nov_1_41(11)_1-9.nxml.txt.nlp	23304670	SENT204	14	14	11	11	letrozole	aromatase	PA450196	1588	0.89
NULL	Oncotarget_2013_Dec_28_5(6)_1475-1490.nxml.txt.nlp	24721996	SENT206	1	1	8	8	celecoxib	CD44	PA448871	960	0.89
NULL	Case_Rep_Oncol_Med_2013_Apr_11_2013_485025.nxml.txt.nlp	23878753	SENT96	9	9	27	27	thyroglobulin	VEGFR2	PA164754910	3791	0.89
NULL	Cancer_Cell_Int_2012_Jul_4_12_19.nxml.txt.nlp	22631225	SENT181	34	34	31	31	heparin	PPIA	PA449855	5478	0.89
NULL	Nat_Commun_2013_Nov_26_4_10_1038_ncomms3816.nxml.txt.nlp	24281383	SENT170	13	13	47	47	allopregnanolone	S15	PA142320763	6209	0.89
NULL	Oncogenesis_2012_Apr_16_1(4)_e7.nxml.txt.nlp	23552604	SENT37	16	16	6	6	etoposide	CEACAM1	PA449552	634	0.89
NULL	Breast_Cancer_Res_2004_Nov_7_6(1)_39-52.nxml.txt.nlp	14680484	SENT243	9	9	5	5	tamoxifen	STAR	PA451581	6770;2984	0.89
NULL	Curr_Med_Chem_2013_Apr_20(10)_1241-1285.nxml.txt.nlp	23409712	SENT959	28	28	19	19	capsaicin	TRPV1	PA448776	7442	0.89
NULL	Front_Immunol_2013_May_16_4_110.nxml.txt.nlp	23720659	SENT156	24	24	12	12	fluorouracil	RAG2	PA128406956	5897	0.89
NULL	Croat_Med_J_2013_Apr_54(2)_171-179.nxml.txt.nlp	23630144	SENT166	24	24	14	14	taurine	AT2	PA451590	186	0.89
NULL	J_Cell_Biol_1999_Feb_22_144(4)_789-801.nxml.txt.nlp	10037799	SENT56	28	28	4	4	ethanol	LYVE-1	PA448073	10894	0.89
NULL	J_Antimicrob_Chemother_2014_Mar_13_69(3)_651-663.nxml.txt.nlp	24235095	SENT104	15	15	28	28	pentamidine	AQP3	PA450850	360	0.89
NULL	Oncoimmunology_2014_Jun_18_3_e29126.nxml.txt.nlp	25083331	SENT22	14	14	34	34	vemurafenib	CD4	PA165946873	920	0.89
NULL	Br_J_Cancer_2011_Sep_6_105(6)_796-806.nxml.txt.nlp	21847123	SENT167	9	9	24	24	lapatinib	AKT1	PA152241907	207	0.89
NULL	Evid_Based_Complement_Alternat_Med_2012_Aug_29_2012_149256.nxml.txt.nlp	22973399	SENT184	6	6	23	23	imipramine	GDNF	PA449969	2668	0.89
NULL	Br_J_Cancer_2010_Oct_12_103(8)_1284-1291.nxml.txt.nlp	20859285	SENT93	6	6	2	2	tamoxifen	BCAR4	PA451581	400500	0.89
NULL	Neuro_Oncol_2011_Nov_22_13(11)_1178-1191.nxml.txt.nlp	21940738	SENT175	10	10	0	0	imatinib	SOX2	PA10804	6657	0.89
NULL	Biomed_Res_Int_2014_Jan_20_2014_948427.nxml.txt.nlp	24563867	SENT109	3	3	27	27	buspirone	STZ	PA448689	6484	0.89
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2011_Mar_14_4_13-24.nxml.txt.nlp	22879790	SENT138	33	33	28	28	exenatide	PPG	PA164749238	5552	0.89
NULL	Breast_Cancer_Res_2011_Feb_4_13(1)_R17.nxml.txt.nlp	21294885	SENT48	5	5	16	16	trastuzumab	San	PA451743	80218	0.89
NULL	Curr_Genomics_2014_Jun_15(3)_190-202.nxml.txt.nlp	24955027	SENT550	11	11	24	24	cabozantinib	VEGFR2	PA165906891	3791	0.89
NULL	Mol_Biol_Cell_2014_Mar_15_25(6)_739-752.nxml.txt.nlp	24430869	SENT154	9	9	14	14	pp2	EGFR		1956	0.89
NULL	J_Community_Hosp_Intern_Med_Perspect_2012_Oct_15_2(3)_10_3402_jchimp_v2i3_19081.nxml.txt.nlp	23882374	SENT68	3	3	10	10	liraglutide	GLP-1	PA165958364	100125288	0.89
NULL	Infect_Drug_Resist_2009_Apr_24_2_13-26.nxml.txt.nlp	21694884	SENT291	5	5	16	16	tenofovir	LAM	PA10204	7249;7248	0.89
NULL	Mol_Cancer_2010_Jun_27_9_168.nxml.txt.nlp	20579391	SENT179	5	5	20	20	dasatinib	SVEP1	PA162372878	79987	0.89
NULL	Clin_Ophthalmol_2011_Nov_1_5_1575-1583.nxml.txt.nlp	22125404	SENT156	14	14	16	16	travoprost	BAK	PA164781371	578	0.89
NULL	F1000_Med_Rep_2012_Feb_1_4_4.nxml.txt.nlp	22312414	SENT114	0	0	18	18	vancomycin	VISA	PA451850	57506	0.89
NULL	J_Oncol_2012_Feb_6_2012_737981.nxml.txt.nlp	22481932	SENT83	24	24	11	11	cyclophosphamide	MUC16	PA449165	94025	0.89
NULL	Endocr_Relat_Cancer_2014_Apr_21(2)_175-187.nxml.txt.nlp	24280133	SENT117	22	22	16	16	doxycycline	SOCS2	PA449415	8835	0.89
NULL	Cancer_Cell_Int_2012_Jul_18_12_34.nxml.txt.nlp	22809533	SENT95	10	10	14	14	cisplatin	HK1	PA449014	3098;51361;3739	0.89
NULL	Int_J_Cell_Biol_2009_Dec_30_2009_750482.nxml.txt.nlp	20130821	SENT51	21	21	9	9	trypsin	L15	PA451806	6138;91057	0.89
NULL	Cancer_Manag_Res_2014_Sep_10_6_349-356.nxml.txt.nlp	25228821	SENT50	1	1	28	28	vemurafenib	BRAF	PA165946873	673	0.89
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_105-115.nxml.txt.nlp	17912640	SENT122	3	3	14	14	letrozole	HER2	PA450196	2064	0.89
NULL	Br_J_Cancer_2010_Jan_5_102(1)_80-86.nxml.txt.nlp	19920817	SENT105	11	11	15	15	sunitinib	IFN	PA162372840	3439	0.89
NULL	Indian_J_Urol_2015_Jan-Mar_31(1)_15-21.nxml.txt.nlp	25624570	SENT139	18	18	12	12	papaverine	STZ	PA164745550	6484	0.89
NULL	Cancers_(Basel)_2014_Mar_26_6(2)_708-722.nxml.txt.nlp	24675568	SENT107	27	27	1	1	afatinib	STAT3	PA165981154	6774	0.89
NULL	Enzyme_Res_2009_Nov_1_2010_165878.nxml.txt.nlp	21048860	SENT189	17	17	10	10	asparaginase	NAC	PA448492	22861	0.89
NULL	Mol_Brain_2013_Apr_9_6_16.nxml.txt.nlp	23570271	SENT235	7	7	5	5	sulindac	COX	PA451565	1351	0.89
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT164	13	13	3	3	cisplatin	p53	PA449014	7157	0.89
NULL	Mol_Cancer_2010_Jun_27_9_168.nxml.txt.nlp	20579391	SENT179	5	5	34	34	dasatinib	TTK	PA162372878	7272	0.89
NULL	Dent_Res_J_(Isfahan)_2009_Spring_6(1)_29-37.nxml.txt.nlp	21528027	SENT127	14	14	3	3	ethanol	PLP	PA448073	25824;5744	0.89
NULL	Genetics_2014_Jun_20_197(2)_611-623.nxml.txt.nlp	24653001	SENT11	15	15	27	27	camptothecin	TEL1	PA153590860	472	0.89
NULL	Hum_Genomics_2011_Oct_1_5(6)_569-576.nxml.txt.nlp	22155604	SENT22	36	36	21	21	ethanol	ADH1B	PA448073	125	0.89
NULL	J_Geriatr_Cardiol_2013_Mar_10(1)_21-27.nxml.txt.nlp	23610570	SENT58	24	24	40	40	theophylline	PAC-1	PA451647	1844	0.89
NULL	Biologics_2009_Sep_15_3_419-428.nxml.txt.nlp	19774209	SENT170	37	37	33	33	everolimus	EGFR	PA164746311	1956	0.89
NULL	J_Neural_Transm_2014_Mar_27_121(10)_1221-1232.nxml.txt.nlp	24671607	SENT5	2	2	12	12	sertraline	PSD-95	PA451333	1742	0.89
NULL	Cell_Commun_Signal_2004_Sep_10_2_9.nxml.txt.nlp	15361251	SENT181	9	9	0	0	heparin	CCN3	PA449855	4856	0.89
NULL	Mol_Cancer_2009_Aug_25_8_66.nxml.txt.nlp	19706164	SENT36	16	16	4	4	rofecoxib	COX	PA451268	1351	0.89
NULL	JAKSTAT_2013_Jan_1_2(1)_e23820.nxml.txt.nlp	24058799	SENT92	25	25	17	17	imiquimod	CXCL9	PA449972	4283	0.89
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_127043.nxml.txt.nlp	23227093	SENT28	32	32	22	22	nifedipine	RYR	PA450631	6261	0.89
NULL	Emerg_Infect_Dis_2012_Jan_18(1)_113-116.nxml.txt.nlp	22260877	SENT11	25	25	42	42	isoniazid	CA4	PA450112	762	0.89
NULL	Environ_Health_Perspect_2008_Jul_26_116(7)_854-862.nxml.txt.nlp	18629305	SENT336	41	41	28	28	ebselen	NAC	PA161660841	22861	0.89
NULL	J_Mol_Signal_2008_Mar_31_3_8.nxml.txt.nlp	18377662	SENT129	7	7	33	33	pp2	KDR		3791	0.89
NULL	Mol_Vis_2012_Jul_11_18_1881-1884.nxml.txt.nlp	22876112	SENT119	9	9	31	31	hyaluronan	NFkappaB	PA165958431	4790	0.89
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Jun_27_5_15.nxml.txt.nlp	16803618	SENT181	12	12	0	0	flucloxacillin	LTA	PA164781042	4049	0.89
NULL	Expert_Rev_Anti_Infect_Ther_2013_Dec_11_11(12)_1303-1332.nxml.txt.nlp	24191955	SENT89	12	12	3	3	azithromycin	San	PA448519	80218	0.89
NULL	EMBO_Mol_Med_2010_Jul_2(7)_247-257.nxml.txt.nlp	20597104	SENT136	30	30	27	27	losartan	AT1	PA450268	9197;185	0.89
NULL	Mol_Pain_2013_Jan_2_9_1.nxml.txt.nlp	23279936	SENT117	16	16	6	6	capsaicin	TRPV1	PA448776	7442	0.89
NULL	Breast_Cancer_Res_2012_Jun_19_14(3)_311.nxml.txt.nlp	22713135	SENT34	28	28	16	16	everolimus	PIK3CA	PA164746311	5290	0.89
NULL	Mol_Cancer_2010_May_20_9_115.nxml.txt.nlp	20487546	SENT168	7	7	30	30	fludarabine	MYC	PA449655	4609	0.89
NULL	Pharmaceutics_2011_Oct_12_3(4)_680-705.nxml.txt.nlp	24309303	SENT129	18	18	28	28	metformin	MATE1	PA450395	55244	0.89
NULL	Br_J_Cancer_2010_Oct_12_103(8)_1297-1304.nxml.txt.nlp	20842126	SENT16	0	0	12	12	taurine	SMO	PA451590	6608;54498	0.89
NULL	Hum_Genomics_Proteomics_2010_Aug_3_2010_159761.nxml.txt.nlp	20981231	SENT193	32	32	12	12	lithium	INPP1	PA450243	3628	0.89
NULL	Breast_Cancer_Res_2011_Feb_23_13(1)_203.nxml.txt.nlp	21392408	SENT145	9	9	5	5	letrozole	aromatase	PA450196	1588	0.89
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Aug_29_65(Pt_9)_m1142-m1143.nxml.txt.nlp	21577477	SENT5	23	23	36	36	sparteine	mol	PA452610	90527	0.89
NULL	Clin_Interv_Aging_2013_Jul_16_8_889-897.nxml.txt.nlp	23898224	SENT69	20	20	35	35	gemcitabine	PARP-1	PA449748	25976	0.89
NULL	Oncotarget_2014_Nov_2_5(21)_10222-10236.nxml.txt.nlp	25400118	SENT98	5	5	18	18	neratinib	HER2	PA165291472	2064	0.89
NULL	Biosci_Rep_2012_Dec_20_33(1)_e00011.nxml.txt.nlp	23137297	SENT256	29	29	13	13	heparin	RPSA	PA449855	3921	0.89
NULL	J_Carcinog_2011_Nov_30_10_28.nxml.txt.nlp	22190870	SENT166	41	41	12	12	trastuzumab	PIK3CA	PA451743	5290	0.89
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Dec_10_3(12)_e151.nxml.txt.nlp	25494035	SENT260	11	11	4	4	pravastatin	SLCO1B1	PA451089	10599	0.89
NULL	Oncotarget_2012_Sep_11_3(9)_1026-1035.nxml.txt.nlp	22976441	SENT89	4	4	9	9	etoposide	ATM	PA449552	472	0.89
NULL	Int_J_Med_Sci_2012_Nov_7_9(10)_881-893.nxml.txt.nlp	23155362	SENT28	8	8	13	13	tamoxifen	aromatase	PA451581	1588	0.89
NULL	Blood_Cancer_J_2013_Oct_4_3(10)_e150.nxml.txt.nlp	24096714	SENT157	35	35	13	13	bortezomib	IFNG	PA10252	3458	0.89
NULL	Mol_Cancer_2010_Aug_25_9_225.nxml.txt.nlp	20738848	SENT105	24	24	7	7	doxorubicin	RhoH	PA449412	399	0.89
NULL	Biomed_Res_Int_2013_Jul_31_2013_692071.nxml.txt.nlp	23984399	SENT200	0	0	6	6	erlotinib	OCT1	PA134687924	5451;6580	0.89
NULL	Curr_Chem_Genomics_2011_Jul_4_5_30-41.nxml.txt.nlp	21760877	SENT60	13	13	4	4	nadh	GAPDHS	PA164755085	26330	0.89
NULL	Cell_Death_Dis_2014_Feb_13_5(2)_e1055.nxml.txt.nlp	24525731	SENT115	13	13	30	30	irinotecan	XRCC1	PA450085	7515	0.89
NULL	Front_Endocrinol_(Lausanne)_2013_Jan_7_3_180.nxml.txt.nlp	23316185	SENT67	30	30	15	15	glucose	CRF	PA449773	1392;10882	0.89
NULL	Drug_Healthc_Patient_Saf_2013_Mar_8_5_49-55.nxml.txt.nlp	23526112	SENT45	0	0	9	9	tiotropium	DPI	PA164769056	1832	0.89
NULL	Cell_Death_Differ_2010_Oct_30_17(10)_1624-1635.nxml.txt.nlp	20431602	SENT279	29	29	2	2	paclitaxel	Bcl-2	PA450761	596	0.89
NULL	Diabetes_Care_2013_Aug_17_36(Suppl_2)_S245-S252.nxml.txt.nlp	23882053	SENT87	25	25	10	10	exenatide	GLP-1	PA164749238	100125288	0.89
NULL	Breast_Cancer_Res_2010_Mar_8_12(2)_R18.nxml.txt.nlp	20211017	SENT52	18	18	4	4	hydrocortisone	F12	PA449905	2161	0.89
NULL	Pharmaceuticals_(Basel)_2011_Nov_11_4(11)_1503-1517.nxml.txt.nlp	NULL	SENT17	19	19	0	0	capsaicin	TRPV1	PA448776	7442	0.89
NULL	J_Biomed_Sci_2014_Feb_3_21(1)_10.nxml.txt.nlp	24490900	SENT96	10	10	17	17	alendronate	RANKL	PA448082	8600	0.89
NULL	Cell_Commun_Signal_2010_Jun_24_8_14.nxml.txt.nlp	20576134	SENT50	31	31	4	4	heparin	FRS2	PA449855	10818	0.89
NULL	Oncotarget_2014_Jun_30_5(14)_5624-5636.nxml.txt.nlp	25015549	SENT164	19	19	0	0	ethanol	PC-3	PA448073	692094	0.89
NULL	Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_1029-1037.nxml.txt.nlp	25049660	SENT126	20	20	8	8	l-cysteine	MC1R	PA449173	4157	0.89
NULL	Arch_Toxicol_2014_Nov_5_88(12)_2135-2190.nxml.txt.nlp	25370008	SENT1035	19	19	16	16	4-methylumbelliferone	UGT	PA154081778	7361;7355	0.89
NULL	Oncoimmunology_2013_May_1_2(5)_e23850.nxml.txt.nlp	23762785	SENT40	48	48	38	38	denosumab	RANKL	PA166048634	8600	0.89
NULL	Biologics_2009_Jul_13_3_215-224.nxml.txt.nlp	19707410	SENT104	17	17	4	4	cetuximab	EGFR	PA10040	1956	0.89
NULL	Int_J_Biol_Sci_2011_May_24_7(5)_673-684.nxml.txt.nlp	21647250	SENT204	30	30	5	5	berberine	SREBP-1c	PA165860812	6720	0.89
NULL	Ann_Hematol_2014_Mar_18_93(8)_1335-1344.nxml.txt.nlp	24638841	SENT92	22	22	19	19	doxorubicin	CHOP	PA449412	1649	0.89
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jul_15_65(Pt_8)_o1857.nxml.txt.nlp	21583555	SENT49	15	15	41	41	benzaldehyde	mol	PA448571	90527	0.89
NULL	Breast_Cancer_Res_2007_Jul_5_9(4)_R41.nxml.txt.nlp	17612393	SENT159	37	37	17	17	celecoxib	Bcl-2	PA448871	596	0.89
NULL	Respir_Med_Case_Rep_2013_Oct_26_10_53-55.nxml.txt.nlp	NULL	SENT71	5	5	9	9	ustekinumab	IL-17	PA166048654	3605	0.89
NULL	Diabetes_Care_2010_Nov_33(11)_2399-2405.nxml.txt.nlp	20980427	SENT16	12	12	4	4	ranibizumab	CRT	PA164746012	811	0.89
NULL	Neural_Regen_Res_2014_May_15_9(10)_1055-1062.nxml.txt.nlp	25206759	SENT174	5	5	0	0	fluorescein	KCC2	PA164746009	57468	0.89
NULL	Comp_Hepatol_2004_Jan_14_3(Suppl_1)_S31.nxml.txt.nlp	14960183	SENT19	13	13	3	3	ethanol	TNF-alpha	PA448073	7124	0.89
NULL	Curr_Neuropharmacol_2009_Mar_7(1)_37-49.nxml.txt.nlp	19721816	SENT187	12	12	5	5	capsaicin	ghrelin	PA448776	51738	0.89
NULL	F1000Res_2014_Aug_19_3_198.nxml.txt.nlp	25400908	SENT174	12	12	18	18	trastuzumab	HER2	PA451743	2064	0.89
NULL	J_Immunother_Cancer_2013_Nov_7_1(Suppl_1)_P31.nxml.txt.nlp	NULL	SENT9	7	7	15	15	fludarabine	IL-2	PA449655	3558	0.89
NULL	Exp_Transl_Stroke_Med_2014_Jun_21_6_8.nxml.txt.nlp	24991402	SENT105	17	17	6	6	chloroquine	ANOVA	PA448948	4858	0.89
NULL	Aging_(Albany_NY)_2011_Jan_18_3(1)_33-43.nxml.txt.nlp	21248371	SENT123	20	20	33	33	zinc	HIPK2	PA451956	28996	0.89
NULL	J_Infect_Dis_2011_Jun_15_203(12)_1775-1783.nxml.txt.nlp	21606536	SENT123	10	10	0	0	galactose	SNA	PA449725	6615	0.89
NULL	Indian_J_Endocrinol_Metab_2015_Jan-Feb_19(1)_182-187.nxml.txt.nlp	25593851	SENT68	5	5	10	10	metformin	GLP-1	PA450395	100125288	0.89
NULL	Int_J_Biol_Sci_2012_Oct_24_8(9)_1227-1236.nxml.txt.nlp	23136551	SENT72	15	15	18	18	tocilizumab	IL-6	PA165292659	3569	0.89
NULL	Behav_Brain_Funct_2007_Jul_25_3_34.nxml.txt.nlp	17651483	SENT229	24	24	9	9	clozapine	DRD2	PA449061	1813	0.89
NULL	Mol_Cancer_2009_Dec_3_8_115.nxml.txt.nlp	19958544	SENT74	14	14	32	32	nutlin-3	PUMA		27113	0.89
NULL	J_Korean_Med_Sci_2010_Aug_21_25(8)_1222-1227.nxml.txt.nlp	20676337	SENT122	5	5	14	14	propofol	LPA	PA451141	4018	0.89
NULL	Leukemia_2013_Apr_14_27(4)_803-812.nxml.txt.nlp	23238589	SENT159	24	24	34	34	nilotinib	IFN	PA165958345	3439	0.89
NULL	Oncogene_2014_Jul_24_33(30)_3927-3938.nxml.txt.nlp	23995784	SENT40	14	14	22	22	doxycycline	EWS	PA449415	2130	0.89
NULL	Genome_Med_2010_Aug_11_2(8)_53.nxml.txt.nlp	20701793	SENT133	39	39	14	14	paclitaxel	CERT	PA450761	10087	0.89
NULL	Iran_Red_Crescent_Med_J_2013_Jun_5_15(6)_477-482.nxml.txt.nlp	24349745	SENT63	23	23	1	1	ethanol	IFN	PA448073	3439	0.89
NULL	Amyloid_2014_Sep_11_21(3)_175-184.nxml.txt.nlp	24918964	SENT128	23	23	11	11	anakinra	p65	PA10799	5970	0.89
NULL	Cardiovasc_Diabetol_2013_Nov_12_12_169.nxml.txt.nlp	24215514	SENT107	7	7	16	16	candesartan	ANG	PA448765	283	0.89
NULL	Angiogenesis_2012_Sep_27_15(3)_361-376.nxml.txt.nlp	22451299	SENT155	3	3	17	17	resveratrol	CXCL8		3576	0.89
NULL	Cardiovasc_Diabetol_2013_Oct_17_12_150.nxml.txt.nlp	24134550	SENT16	17	17	4	4	pioglitazone	activin	PA450970	83729	0.89
NULL	Mol_Biol_Cell_2014_Jan_1_25(1)_76-86.nxml.txt.nlp	24173717	SENT311	13	13	7	7	paclitaxel	TUBB6	PA450761	84617	0.89
NULL	Oxid_Med_Cell_Longev_2013_Apr_21_2013_412576.nxml.txt.nlp	23710286	SENT110	14	14	42	42	curcumin	NRF1	PA151958596	4899;4779	0.89
NULL	J_Hum_Genet_2013_Jun_2_58(6)_306-312.nxml.txt.nlp	23635953	SENT70	18	18	23	23	estradiol	TCL1A	PA449503	8115	0.89
NULL	Evid_Based_Complement_Alternat_Med_2011_Mar_13_2011_913898.nxml.txt.nlp	21785639	SENT184	6	6	24	24	curcumin	CYP3A4	PA151958596	1576	0.89
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_23_2013_185158.nxml.txt.nlp	23864881	SENT196	9	9	26	26	vorinostat	p27	PA164748224	5715;10534	0.889
NULL	Oncol_Lett_2013_Oct_24_6(4)_970-976.nxml.txt.nlp	24137447	SENT3	15	15	26	26	doxorubicin	ADM	PA449412	133	0.889
NULL	Eur_J_Nutr_2009_Jun_24_48(4)_229-234.nxml.txt.nlp	19238310	SENT155	16	16	32	32	capsaicin	ghrelin	PA448776	51738	0.889
NULL	Cell_Death_Dis_2012_Jul_5_3(7)_e342.nxml.txt.nlp	22764101	SENT111	0	0	16	16	chloroquine	LC3	PA448948	84557	0.889
NULL	Br_J_Cancer_2011_Jul_26_105(3)_403-406.nxml.txt.nlp	21730978	SENT25	19	19	24	24	cetuximab	KRAS	PA10040	3845	0.889
NULL	Drug_Des_Devel_Ther_2014_Oct_31_8_2121-2128.nxml.txt.nlp	25382970	SENT88	4	4	10	10	curcumin	TTR	PA151958596	7276	0.889
NULL	Int_J_Surg_Oncol_2012_Jun_12_2012_862879.nxml.txt.nlp	22778941	SENT68	10	10	3	3	cisplatin	ATP7B	PA449014	540	0.889
NULL	Clin_Ophthalmol_2011_Jan_6_5_37-44.nxml.txt.nlp	21386919	SENT21	7	7	21	21	bevacizumab	VEGF-A	PA130232992	7422	0.889
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1137-1144.nxml.txt.nlp	20234366	SENT118	15	15	7	7	cetuximab	KRAS	PA10040	3845	0.889
NULL	Breast_Cancer_Res_2007_Jul_5_9(4)_R41.nxml.txt.nlp	17612393	SENT156	7	7	28	28	celecoxib	Bcl-2	PA448871	596	0.889
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Feb_15_5_3.nxml.txt.nlp	16480505	SENT177	19	19	24	24	cyclosporine	CYP3A4	PA449167	1576	0.889
NULL	Breast_Cancer_Res_Treat_2014_Jan_9_143(3)_493-505.nxml.txt.nlp	24402830	SENT122	21	21	2	2	capecitabine	TTR	PA448771	7276	0.889
NULL	Breast_Cancer_Res_2010_Aug_16_12(4)_R63.nxml.txt.nlp	20712882	SENT225	14	14	9	9	trastuzumab	PTEN	PA451743	5728	0.889
NULL	Indian_J_Crit_Care_Med_2014_Aug_18(8)_518-526.nxml.txt.nlp	25136191	SENT125	22	22	3	3	cisplatin	IL-18	PA449014	3606	0.889
NULL	J_Infect_Dis_2011_Oct_1_204(7)_1104-1114.nxml.txt.nlp	21881126	SENT173	21	21	29	29	chloroquine	MxA	PA448948	4599	0.889
NULL	J_Hematol_Oncol_2008_Aug_11_1_11.nxml.txt.nlp	18694493	SENT58	11	11	13	13	sunitinib	IFN	PA162372840	3439	0.889
NULL	Pharmaceuticals_(Basel)_2013_Aug_2_6(8)_915-928.nxml.txt.nlp	24276376	SENT100	1	1	26	26	thrombin	PAR-1	PA451674	2011;2149	0.889
NULL	Mol_Cancer_2009_Nov_10_8_99.nxml.txt.nlp	19903356	SENT55	10	10	19	19	imatinib	IGFBP3	PA10804	3486	0.889
NULL	Biochim_Biophys_Acta_2014_Jul_1842(7)_959-970.nxml.txt.nlp	24594481	SENT312	31	31	11	11	lipase	FGF21	PA450239	26291	0.889
NULL	Evid_Based_Complement_Alternat_Med_2012_Dec_20_2012_908601.nxml.txt.nlp	23326293	SENT8	16	16	23	23	oxaliplatin	CD90	PA131285527	7070	0.889
NULL	J_Cancer_Prev_2013_Dec_18(4)_313-321.nxml.txt.nlp	25337560	SENT136	26	26	13	13	estradiol	PTEN	PA449503	5728	0.889
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2007_Dec_6_64(Pt_1)_m88-m89.nxml.txt.nlp	21200656	SENT63	31	31	2	2	ethanol	NO3	PA448073	4681	0.889
NULL	Breast_Cancer_Res_2011_Apr_20_13(2)_307.nxml.txt.nlp	21575280	SENT21	23	23	10	10	tamoxifen	FOXA1	PA451581	3169	0.889
NULL	Cardiol_Res_Pract_2010_Oct_7_2011_963517.nxml.txt.nlp	20953380	SENT65	1	1	22	22	olmesartan	adiponectin	PA164742950	9370	0.889
NULL	Front_Immunol_2013_Nov_7_4_360.nxml.txt.nlp	24223576	SENT223	20	20	24	24	imiquimod	IRF5	PA449972	3663	0.889
NULL	Mol_Neurobiol_2010_Jun_2_41(2-3)_392-409.nxml.txt.nlp	20437209	SENT402	8	8	6	6	pioglitazone	PPARgamma	PA450970	5468	0.889
NULL	Acta_Pharmacol_Sin_2009_Apr_9_30(4)_451-457.nxml.txt.nlp	19270722	SENT119	5	5	24	24	imatinib	P-gp	PA10804	5243	0.889
NULL	Clin_Drug_Investig_2013_Aug_23_33(10)_727-736.nxml.txt.nlp	23975654	SENT43	8	8	16	16	omeprazole	CYP2B6	PA450704	1555	0.889
NULL	Bone_Marrow_Transplant_2012_Feb_28_47(2)_203-211.nxml.txt.nlp	21441963	SENT37	25	25	0	0	cyclophosphamide	NMA	PA449165	25805	0.889
NULL	EMBO_J_2010_Aug_18_29(16)_2772-2787.nxml.txt.nlp	20664520	SENT321	26	26	16	16	forskolin	RXFP1	PA146096022	59350	0.889
NULL	Biosensors_(Basel)_2012_Sep_10_2(3)_318-340.nxml.txt.nlp	25585933	SENT697	21	21	4	4	bleomycin	p53	PA448645	7157	0.889
NULL	Arthritis_Res_Ther_2007_Mar_12_9(2)_R28.nxml.txt.nlp	17352828	SENT67	24	24	11	11	anakinra	MSU	PA10799	593	0.889
NULL	Nat_Commun_2013_Apr_9_4_1684.nxml.txt.nlp	23575688	SENT249	13	13	3	3	rolipram	PDE4B	PA153906323	5142	0.889
NULL	Acta_Pharmacol_Sin_2010_Aug_5_31(8)_938-943.nxml.txt.nlp	20686519	SENT196	7	7	4	4	reserpine	GML	PA451236	2765	0.889
NULL	Behav_Brain_Funct_2014_Oct_2_10(1)_35.nxml.txt.nlp	NULL	SENT110	23	23	9	9	risperidone	FTO	PA451257	79068	0.889
NULL	Case_Rep_Oncol_2011_Jan_18_4(1)_19-24.nxml.txt.nlp	21526002	SENT5	12	12	15	15	trastuzumab	HER-2	PA451743	2064	0.889
NULL	Front_Immunol_2012_May_7_3_101.nxml.txt.nlp	22783250	SENT244	3	3	14	14	papain	IL-9	PA450778	3578	0.889
NULL	Eur_J_Clin_Pharmacol_2011_May_9_67(5)_477-482.nxml.txt.nlp	21305273	SENT14	27	27	1	1	dobutamine	ADRB1	PA449381	153	0.889
NULL	J_Hematol_Oncol_2011_Jan_21_4_5.nxml.txt.nlp	21255411	SENT229	15	15	24	24	paclitaxel	EGFR	PA450761	1956	0.889
NULL	Int_J_Mol_Sci_2014_Mar_20_15(3)_4965-4976.nxml.txt.nlp	24658440	SENT72	0	0	23	23	etanercept	CD19	PA449515	930	0.889
NULL	Oncol_Rep_2013_Jun_2_29(6)_2095-2100.nxml.txt.nlp	23563900	SENT31	0	0	41	41	sorafenib	p38	PA7000	10598;1432;7965	0.889
NULL	J_Korean_Med_Sci_2014_Jan_26_29(1)_53-60.nxml.txt.nlp	24431906	SENT144	26	26	19	19	rituximab	CHOP	PA451261	1649	0.889
NULL	Am_J_Case_Rep_2014_Feb_24_15_85-89.nxml.txt.nlp	24587856	SENT92	6	6	13	13	exemestane	aromatase	PA449563	1588	0.889
NULL	Behav_Brain_Funct_2013_May_3_9_17.nxml.txt.nlp	23642235	SENT187	23	23	8	8	baclofen	AT1	PA448533	9197;185	0.889
NULL	Lipids_Health_Dis_2011_Feb_28_10_38.nxml.txt.nlp	21352602	SENT122	3	3	23	23	fenofibrate	PCSK9	PA449594	255738	0.889
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT91	5	5	26	26	pp2	PP2		4888	0.889
NULL	Acta_Pharmacol_Sin_2014_Sep_25_35(9)_1199-1206.nxml.txt.nlp	25152024	SENT174	24	24	5	5	cisplatin	mig-2	PA449014	10979	0.889
NULL	Cancers_(Basel)_2013_May_27_5(2)_617-638.nxml.txt.nlp	24216994	SENT186	12	12	24	24	curcumin	PC3	PA151958596	57332;7832;5122	0.889
NULL	Br_J_Cancer_2012_Apr_24_106(9)_1543-1550.nxml.txt.nlp	22531721	SENT127	25	25	8	8	trastuzumab	CD59	PA451743	966	0.889
NULL	Mol_Cancer_2007_Oct_11_6_63.nxml.txt.nlp	17931419	SENT90	2	2	24	24	cetuximab	EGFR	PA10040	1956	0.889
NULL	Iran_J_Pharm_Res_2013_Summer_12(3)_457-469.nxml.txt.nlp	24250652	SENT208	18	18	20	20	indomethacin	COX	PA449982	1351	0.889
NULL	Front_Pharmacol_2014_Dec_18_5_280.nxml.txt.nlp	25566076	SENT456	25	25	5	5	fentanyl	GRK3	PA449599	157	0.889
NULL	Oncoscience_2013_Dec_11_1(1)_21-29.nxml.txt.nlp	25593981	SENT114	5	5	14	14	disulfiram	JNK	PA449376	5599	0.889
NULL	Eur_J_Cancer_2014_Sep_50(14)_2367-2374.nxml.txt.nlp	25027307	SENT127	14	14	10	10	estradiol	AMH	PA449503	268	0.889
NULL	J_Clin_Biochem_Nutr_2008_May_29_42(3)_197-203.nxml.txt.nlp	18545641	SENT88	18	18	32	32	curcumin	JNK	PA151958596	5599	0.889
NULL	Ann_Dermatol_2011_Dec_27_23(Suppl_3)_S290-S295.nxml.txt.nlp	22346260	SENT92	11	11	17	17	dapsone	EED	PA449211	8726	0.889
NULL	Lancet_2010_Sep_4_376(9743)_794-801.nxml.txt.nlp	20800271	SENT62	7	7	3	3	heparin	CFHR5	PA449855	81494	0.889
NULL	Mol_Cancer_2013_Sep_27_12_111.nxml.txt.nlp	24070020	SENT511	31	31	20	20	indomethacin	FAF	PA449982	8239;2188	0.889
NULL	Cell_Death_Dis_2013_Jan_31_4(1)_e478.nxml.txt.nlp	23370278	SENT319	19	19	29	29	cisplatin	DNA-PKcs	PA449014	5591	0.889
NULL	J_Cardiothorac_Surg_2010_Aug_21_5_66.nxml.txt.nlp	20727201	SENT41	11	11	21	21	collagenase	MMP9	PA449107	4318	0.889
NULL	Acta_Pharmacol_Sin_2013_Sep_5_34(9)_1192-1200.nxml.txt.nlp	23685957	SENT126	20	20	8	8	curcumin	Bcl-2	PA151958596	596	0.889
NULL	F1000Prime_Rep_2014_Dec_1_6_117.nxml.txt.nlp	25580271	SENT76	10	10	15	15	bevacizumab	EGFR	PA130232992	1956	0.889
NULL	J_Viral_Hepat_2012_Feb_19(2)_94-102.nxml.txt.nlp	22239499	SENT150	28	28	12	12	ribavirin	RVR	PA451241	9975	0.889
NULL	Theranostics_2014_Jan_29_4(4)_336-365.nxml.txt.nlp	24578720	SENT423	12	12	4	4	everolimus	PI3K	PA164746311	5290	0.889
NULL	F1000_Med_Rep_2009_May_8_1_34.nxml.txt.nlp	20948746	SENT18	0	0	6	6	cladribine	DMT	PA449027	2039	0.889
NULL	Biologics_2010_May_25_4_91-101.nxml.txt.nlp	20531964	SENT229	19	19	3	3	temsirolimus	PTEN	PA164746890	5728	0.889
NULL	Oncol_Rep_2013_Apr_23_29(4)_1268-1274.nxml.txt.nlp	23354756	SENT171	28	28	9	9	trastuzumab	SLC25A43	PA451743	203427	0.889
NULL	J_Gynecol_Oncol_2012_Jan_9_23(1)_35-42.nxml.txt.nlp	22355465	SENT164	39	39	18	18	cisplatin	CDK1	PA449014	983	0.889
NULL	Br_J_Pharmacol_2008_Dec_25_155(7)_1056-1065.nxml.txt.nlp	18724386	SENT254	39	39	45	45	diazoxide	GLP-1	PA449285	100125288	0.889
NULL	J_Invest_Dermatol_2012_Nov_14_132(11)_2601-2609.nxml.txt.nlp	22696056	SENT60	22	22	12	12	phenol	ATF6	PA450913	22926	0.889
NULL	Front_Cell_Neurosci_2013_Dec_30_7_273.nxml.txt.nlp	24415999	SENT170	14	14	21	21	suramin	P2X2	PA10292	22953	0.889
NULL	Indian_J_Dermatol_2012_Nov-Dec_57(6)_466-474.nxml.txt.nlp	23248365	SENT62	4	4	20	20	tacrolimus	IL-4	PA451578	3565	0.889
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT115	3	3	12	12	trastuzumab	HER3	PA451743	2065	0.889
NULL	Adv_Ther_2014_Sep_23_31(9)_986-999.nxml.txt.nlp	25245811	SENT237	8	8	13	13	liraglutide	GLP-1	PA165958364	100125288	0.889
NULL	Gut_Liver_2013_Sep_14_7(5)_552-559.nxml.txt.nlp	24073313	SENT19	1	1	7	7	celecoxib	EGFR	PA448871	1956	0.889
NULL	An_Bras_Dermatol_2013_Nov-Dec_88(6_Suppl_1)_93-96.nxml.txt.nlp	24346890	SENT61	0	0	12	12	thalidomide	ENL	PA451644	4298	0.889
NULL	Acta_Vet_Scand_2008_Jul_4_50(1)_27.nxml.txt.nlp	18601734	SENT146	32	32	15	15	doxorubicin	CLPTM1	PA449412	1209	0.889
NULL	Patient_Prefer_Adherence_2011_Dec_23_6_1-9.nxml.txt.nlp	22272064	SENT119	16	16	13	13	telmisartan	ACE	PA451605	1636	0.889
NULL	Breast_Cancer_Res_2011_Oct_12_13(5)_220.nxml.txt.nlp	22018398	SENT197	26	26	14	14	vinorelbine	STAT3	PA451881	6774	0.889
NULL	J_Cell_Biol_2001_Dec_24_155(7)_1333-1344.nxml.txt.nlp	11748248	SENT533	12	12	1	1	collagenase	AP-1	PA449107	2353;3727;2354;3725	0.889
NULL	Nat_Commun_2011_Jul_5_2_380.nxml.txt.nlp	21730960	SENT3	13	13	32	32	fluorescein	PGRMC1	PA164746009	10857	0.889
NULL	Front_Synaptic_Neurosci_2010_Feb_22_2_1.nxml.txt.nlp	21423487	SENT146	6	6	26	26	baclofen	CA3	PA448533	761	0.889
NULL	Ann_Clin_Microbiol_Antimicrob_2005_Apr_1_4_6.nxml.txt.nlp	15804353	SENT103	37	37	39	39	metronidazole	Met	PA450484	79811	0.889
NULL	FASEB_J_2013_Jun_27(6)_2328-2341.nxml.txt.nlp	23447581	SENT853	6	6	14	14	ns-398	PGHS-1		5742	0.889
NULL	J_Inflamm_(Lond)_2005_Oct_31_2_14.nxml.txt.nlp	16259633	SENT223	0	0	33	33	staurosporine	CCR1	PA165109623	1230	0.889
NULL	Curr_Neuropharmacol_2007_Dec_5(4)_232-243.nxml.txt.nlp	19305740	SENT413	20	20	18	18	pioglitazone	PPARgamma	PA450970	5468	0.889
NULL	J_Ginseng_Res_2011_Nov_35(4)_471-478.nxml.txt.nlp	23717094	SENT103	10	10	8	8	ethanol	CaCC	PA448073	1179	0.889
NULL	Oncotarget_2013_Apr_13_4(4)_502-530.nxml.txt.nlp	23594434	SENT270	11	11	26	26	nelfinavir	PTEN	PA450606	5728	0.889
NULL	Nucleic_Acids_Res_2011_Oct_9_39(19)_8416-8429.nxml.txt.nlp	21745815	SENT222	32	32	0	0	l-lysine	LIG4	PA450280	3981	0.889
NULL	Nat_Med_2010_Nov_24_16(11)_1299-1304.nxml.txt.nlp	20972434	SENT32	9	9	16	16	colchicine	ASM	PA449092	6609;283120	0.889
NULL	Mol_Cell_Proteomics_2012_Feb_6_11(2)_M111_015222.nxml.txt.nlp	22147731	SENT215	34	34	16	16	cetuximab	EGF	PA10040	1950	0.889
NULL	Front_Neurosci_2011_Jan_14_4_207.nxml.txt.nlp	21258618	SENT164	6	6	11	11	ethanol	AC7	PA448073	113	0.889
NULL	Cancer_Metab_2014_May_28_2(Suppl_1)_P72.nxml.txt.nlp	NULL	SENT4	3	3	9	9	l-carnitine	Q10	PA450154	27161	0.889
NULL	Cancer_Inform_2007_Jan_12_3_275-284.nxml.txt.nlp	19455247	SENT25	32	32	11	11	erlotinib	EGFR	PA134687924	1956	0.889
NULL	Nat_Genet_2011_Feb_26_43(2)_117-120.nxml.txt.nlp	21186350	SENT79	17	17	8	8	metformin	AMPK	PA450395	5563	0.889
NULL	Ann_Hematol_2010_Sep_13_89(9)_861-871.nxml.txt.nlp	20387067	SENT226	15	15	7	7	dasatinib	CD34	PA162372878	947	0.889
NULL	J_Oncol_2012_Sep_5_2012_128608.nxml.txt.nlp	21904549	SENT182	3	3	19	19	semaxanib	FLT3	PA131887911	2322	0.889
NULL	J_Clin_Biochem_Nutr_2009_Sep_28_45(2)_178-184.nxml.txt.nlp	19794926	SENT234	4	4	12	12	hyaluronan	EGFR	PA165958431	1956	0.889
NULL	J_Mol_Signal_2014_Mar_6_9_1.nxml.txt.nlp	24597858	SENT52	28	28	2	2	vasopressin	GRK6	PA451858	2870	0.889
NULL	Mol_Cancer_2010_Oct_12_9_269.nxml.txt.nlp	20939893	SENT143	19	19	7	7	isoproterenol	STAT3	PA450121	6774	0.889
NULL	Mol_Cancer_2007_Sep_18_6_56.nxml.txt.nlp	17877814	SENT3	25	25	3	3	gefitinib	EGFR	PA131301952	1956	0.889
NULL	Oncoimmunology_2013_Dec_1_2(12)_e27058.nxml.txt.nlp	24498564	SENT62	34	34	23	23	cyclophosphamide	THBS1	PA449165	7057	0.889
NULL	Indian_J_Med_Res_2013_Jan_137(1)_203-209.nxml.txt.nlp	23481074	SENT96	4	4	9	9	coumarin	CYP2C9	PA134521193	1559	0.889
NULL	Drugs_R_D_2011_Mar_27_11(1)_37-51.nxml.txt.nlp	21410294	SENT36	35	35	20	20	itraconazole	CYP3A4	PA450132	1576	0.889
NULL	Front_Endocrinol_(Lausanne)_2013_Jun_26_4_75.nxml.txt.nlp	23805127	SENT216	3	3	17	17	oxazepam	UGT2B15	PA450731	7366	0.889
NULL	Lab_Invest_2011_Jan_9_91(1)_138-146.nxml.txt.nlp	20697379	SENT8	17	17	24	24	thyroglobulin	p63	PA164754910	8626	0.889
NULL	Br_J_Cancer_2013_Feb_19_108(3)_557-563.nxml.txt.nlp	23361053	SENT174	19	19	35	35	tamoxifen	PAK1	PA451581	5585;5058	0.889
NULL	Oncol_Lett_2013_Mar_28_5(3)_935-942.nxml.txt.nlp	23426424	SENT10	30	30	22	22	cisplatin	ERCC1	PA449014	2067	0.889
NULL	J_Biol_Chem_2012_Apr_13_287(16)_12952-12965.nxml.txt.nlp	22371491	SENT271	2	2	15	15	terazosin	CXCR2	PA451612	3579	0.889
NULL	AIDS_Res_Ther_2008_Mar_28_5_5.nxml.txt.nlp	18373851	SENT19	0	0	13	13	ritonavir	ATV	PA451260	4683	0.889
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT170	21	21	16	16	cisplatin	IBP	PA449014	706;50619	0.889
NULL	Front_Cell_Neurosci_2014_Jul_18_8_185.nxml.txt.nlp	25100946	SENT404	19	19	37	37	pp2	PP2		4888	0.889
NULL	Eur_J_Clin_Pharmacol_2007_Apr_21_63(4)_335-343.nxml.txt.nlp	17318526	SENT232	31	31	27	27	warfarin	GGCX	PA451906	2677	0.889
NULL	J_Thromb_Thrombolysis_2012_Feb_20_33(2)_143-153.nxml.txt.nlp	22183178	SENT250	14	14	3	3	ticagrelor	CYP2C19	PA165374673	1557	0.889
NULL	Cancers_(Basel)_2013_Jul_26_5(3)_943-958.nxml.txt.nlp	24202328	SENT842	7	7	11	11	olaparib	BRCA1		672	0.889
NULL	J_Immunol_Res_2014_Apr_28_2014_286170.nxml.txt.nlp	24868562	SENT67	28	28	18	18	docetaxel	IL-2	PA449383	3558	0.889
NULL	Breast_Cancer_Res_2007_Feb_6_9(1)_R17.nxml.txt.nlp	17280616	SENT87	3	3	40	40	neomycin	MELK	PA450608	9833	0.889
NULL	Mol_Clin_Oncol_2013_Sep_24_1(5)_918-924.nxml.txt.nlp	24649271	SENT96	6	6	8	8	gemcitabine	EGFR	PA449748	1956	0.889
NULL	Mol_Cancer_2012_Jul_25_11_47.nxml.txt.nlp	22830443	SENT152	20	20	6	6	panitumumab	EGFR	PA162373091	1956	0.889
NULL	Asian-Australas_J_Anim_Sci_2012_Feb_1_25(2)_207-212.nxml.txt.nlp	25049553	SENT120	25	25	46	46	phosphorus	CO2	PA450954	4513	0.889
NULL	Diabetes_Care_2013_Aug_17_36(Suppl_2)_S245-S252.nxml.txt.nlp	23882053	SENT72	18	18	13	13	liraglutide	GLP-1	PA165958364	100125288	0.889
NULL	Hum_Genomics_2013_Oct_30_7(1)_22.nxml.txt.nlp	24172014	SENT187	9	9	0	0	trypsin	SERPINB11	PA451806	89778	0.889
NULL	Exp_Ther_Med_2013_Oct_20_6(4)_899-903.nxml.txt.nlp	24137286	SENT91	7	7	23	23	rosuvastatin	MMP9	PA134308647	4318	0.889
NULL	Exp_Diabetes_Res_2012_Oct_15_2012_465282.nxml.txt.nlp	23118742	SENT8	31	31	24	24	metformin	FGF21	PA450395	26291	0.889
NULL	Breast_Cancer_Res_2010_Jun_24_12(3)_R41.nxml.txt.nlp	20576088	SENT153	14	14	7	7	paclitaxel	BCL2L1	PA450761	598	0.889
NULL	Asian-Australas_J_Anim_Sci_2013_Feb_26(2)_233-240.nxml.txt.nlp	25049781	SENT80	13	13	6	6	l-carnitine	HGB	PA450154	114757	0.889
NULL	Diabetes_Care_2009_Feb_32(2)_e13-e19.nxml.txt.nlp	19171729	SENT67	21	21	10	10	rosiglitazone	DREAM	PA451283	30818	0.889
NULL	Oncotarget_2014_Oct_16_5(20)_9546-9563.nxml.txt.nlp	25337673	SENT190	25	25	17	17	gefitinib	AXL	PA131301952	558	0.889
NULL	Front_Immunol_2012_Jan_12_2_98.nxml.txt.nlp	22566887	SENT154	4	4	24	24	anakinra	IL-8	PA10799	3576	0.889
NULL	Cell_Commun_Signal_2011_May_15_9_13.nxml.txt.nlp	21569639	SENT293	5	5	23	23	quinacrine	BAX	PA164745551	581	0.889
NULL	Breast_Cancer_Res_2011_Feb_8_13(1)_202.nxml.txt.nlp	21392411	SENT162	7	7	16	16	metformin	ZEB1	PA450395	6935	0.889
NULL	Mol_Cancer_2010_Nov_8_9_291.nxml.txt.nlp	21059223	SENT103	17	17	27	27	daunorubicin	ABCB1	PA449212	5243	0.889
NULL	Breast_Cancer_(Auckl)_2010_May_7_4_23-33.nxml.txt.nlp	20697530	SENT162	15	15	6	6	cyclophosphamide	XRCC1	PA449165	7515	0.889
NULL	Sci_Rep_2014_Dec_15_4_7481.nxml.txt.nlp	25500546	SENT424	16	16	4	4	imatinib	SIRT1	PA10804	23411	0.889
NULL	Br_J_Cancer_2010_Oct_12_103(8)_1192-1200.nxml.txt.nlp	20877358	SENT195	26	26	6	6	docetaxel	BRCA1	PA449383	672	0.889
NULL	Breast_Cancer_Res_2011_Jan_28_13(1)_R11.nxml.txt.nlp	21276249	SENT273	17	17	26	26	tamoxifen	PRLR	PA451581	5618	0.889
NULL	Cancer_Med_2014_Feb_7_3(1)_124-133.nxml.txt.nlp	24403130	SENT206	38	38	44	44	bevacizumab	KRAS	PA130232992	3845	0.889
NULL	Nat_Commun_2012_Jan_10_3_614.nxml.txt.nlp	22233624	SENT128	17	17	0	0	l-glutamine	C32	PA10090	51192	0.889
NULL	Int_J_Mol_Sci_2013_Apr_29_14(5)_9338-9364.nxml.txt.nlp	23629668	SENT166	11	11	25	25	sunitinib	IL-8	PA162372840	3576	0.889
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT447	33	33	24	24	risperidone	PRL	PA451257	5617	0.889
NULL	Oncotarget_2013_Jun_29_4(9)_1338-1348.nxml.txt.nlp	23907514	SENT121	11	11	24	24	doxorubicin	PSMA5	PA449412	5686	0.889
NULL	Oncol_Lett_2014_Apr_12_7(4)_1049-1052.nxml.txt.nlp	24944667	SENT52	24	24	6	6	irinotecan	GEM	PA450085	2669	0.889
NULL	J_Gen_Physiol_2000_Jun_1_115(6)_685-696.nxml.txt.nlp	10828243	SENT6	8	8	37	37	genistein	OLF	PA165109660	83857	0.889
NULL	J_Neuroinflammation_2010_Sep_7_7_51.nxml.txt.nlp	20822529	SENT199	19	19	12	12	hemin	HO-1	PA449849	3162	0.889
NULL	Chem_Cent_J_2013_Jul_8_7_112.nxml.txt.nlp	23829861	SENT77	24	24	16	16	doxorubicin	PC-3	PA449412	692094	0.889
NULL	Front_Neurosci_2011_Jan_14_4_207.nxml.txt.nlp	21258618	SENT105	13	13	4	4	ethanol	AC7	PA448073	113	0.889
NULL	Nucleic_Acids_Res_2011_Dec_31_39(22)_9536-9548.nxml.txt.nlp	21880590	SENT228	20	20	8	8	etoposide	BRCA1	PA449552	672	0.889
NULL	Fibrogenesis_Tissue_Repair_2011_Jan_13_4_3.nxml.txt.nlp	21232095	SENT191	20	20	9	9	celecoxib	COX	PA448871	1351	0.889
NULL	Curr_Pharm_Des_2011_Feb_17(6)_578-590.nxml.txt.nlp	21391908	SENT178	21	21	15	15	nutlin-3	MDM2		4193	0.889
NULL	J_Ophthalmic_Inflamm_Infect_2013_Feb_11_3_31.nxml.txt.nlp	23514571	SENT21	14	14	2	2	ethanol	PRK	PA448073	1263	0.889
NULL	Diabetes_Care_2009_Jan_32(Suppl_1)_S13-S61.nxml.txt.nlp	19118286	SENT2163	12	12	6	6	ramipril	DREAM	PA451223	30818	0.889
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT170	4	4	25	25	chloroquine	BMPR-II	PA448948	659	0.889
NULL	Arthritis_Res_2001_Jan_26_3(Suppl_A)_P094.nxml.txt.nlp	NULL	SENT11	34	34	26	26	infliximab	OPG	PA452639	690	0.889
NULL	Br_J_Cancer_2010_Jan_5_102(1)_80-86.nxml.txt.nlp	19920817	SENT7	18	18	16	16	sunitinib	IFN	PA162372840	3439	0.889
NULL	Environ_Health_Perspect_2010_Jul_3_118(7)_936-942.nxml.txt.nlp	20199942	SENT170	32	32	11	11	arsenite	mot-2	PA452638	3313	0.889
NULL	Oncol_Lett_2014_Jan_11_7(1)_156-158.nxml.txt.nlp	24348840	SENT4	9	9	18	18	vindesine	CHOP	PA10232	1649	0.889
NULL	Indian_J_Med_Res_2013_Mar_137(3)_527-532.nxml.txt.nlp	23640560	SENT118	20	20	8	8	doxorubicin	PARP-1	PA449412	25976	0.889
NULL	Breast_Cancer_Res_2011_Feb_23_13(1)_203.nxml.txt.nlp	21392408	SENT145	9	9	13	13	letrozole	aromatase	PA450196	1588	0.889
NULL	J_Med_Internet_Res_2013_Jul_12_15(7)_e138.nxml.txt.nlp	23853350	SENT186	12	12	17	17	warfarin	TTR	PA451906	7276	0.889
NULL	Cancer_Cell_Int_2010_May_11_10_16.nxml.txt.nlp	20459793	SENT86	18	18	29	29	cisplatin	ABCC1	PA449014	4363	0.889
NULL	Open_Biol_2014_May_4(5)_140065.nxml.txt.nlp	24850914	SENT162	30	30	18	18	bortezomib	USP15	PA10252	9958	0.889
NULL	Diabetes_2011_Jun_21_60(6)_1770-1778.nxml.txt.nlp	21562078	SENT74	20	20	0	0	s-adenosylmethionine	AMPK	PA164754994	5563	0.889
NULL	Mol_Biol_Cell_2013_Jul_15_24(14)_2285-2298.nxml.txt.nlp	23720763	SENT135	17	17	27	27	nystatin	CPZ	PA450666	8532	0.889
NULL	Comp_Funct_Genomics_2012_May_14_2012_178525.nxml.txt.nlp	22666083	SENT187	12	12	5	5	gemcitabine	HuR	PA449748	1994	0.889
NULL	Endocrine_2012_Dec_14_42(3)_622-636.nxml.txt.nlp	22695986	SENT67	6	6	4	4	forskolin	PTH	PA146096022	5741	0.889
NULL	Ther_Clin_Risk_Manag_2006_Mar_2(1)_77-86.nxml.txt.nlp	18360583	SENT112	20	20	12	12	alendronate	PTH	PA448082	5741	0.889
NULL	EMBO_Mol_Med_2011_Jul_3(7)_410-427.nxml.txt.nlp	21567994	SENT236	2	2	39	39	probucol	HMOX2	PA451107	3163	0.889
NULL	Mol_Vis_2007_Jan_19_13_47-56.nxml.txt.nlp	17277743	SENT28	20	20	6	6	heparin	VEGF-A	PA449855	7422	0.889
NULL	F1000_Biol_Rep_2009_Sep_8_1_70.nxml.txt.nlp	20948617	SENT8	24	24	30	30	ustekinumab	IL-23	PA166048654	51561	0.889
NULL	Pharmaceutics_2012_Jan_31_4(1)_104-129.nxml.txt.nlp	24300183	SENT237	34	34	11	11	fluorescein	SMO	PA164746009	6608;54498	0.889
NULL	Br_J_Cancer_2012_Jul_10_107(2)_300-307.nxml.txt.nlp	22653145	SENT154	18	18	10	10	cisplatin	NAC1	PA449014	112939;6323	0.889
NULL	J_Cancer_2011_May_1_2_232-261.nxml.txt.nlp	21552384	SENT98	30	30	32	32	tamoxifen	aromatase	PA451581	1588	0.889
NULL	Breast_Cancer_Res_2011_Jan_11_13(1)_R3.nxml.txt.nlp	21223569	SENT5	8	8	36	36	estradiol	p53	PA449503	7157	0.889
NULL	J_Biol_Inorg_Chem_2014_Oct_17_19(1)_17-27.nxml.txt.nlp	24132751	SENT22	5	5	18	18	cisplatin	CTR1	PA449014	1317	0.889
NULL	Ther_Clin_Risk_Manag_2007_Dec_3(6)_1009-1020.nxml.txt.nlp	18516316	SENT49	3	3	19	19	palonosetron	HEC	PA10352	10403	0.889
NULL	Breast_Cancer_Res_2004_Mar_11_6(3)_109-118.nxml.txt.nlp	15084231	SENT90	18	18	13	13	tamoxifen	AIB1	PA451581	8202	0.889
NULL	Br_J_Ophthalmol_2008_Sep_22_92(9)_1275-1282.nxml.txt.nlp	18723745	SENT123	12	12	25	25	latanoprost	BAK	PA164774763	578	0.889
NULL	Core_Evid_2013_Sep_30_8_69-78.nxml.txt.nlp	24115917	SENT19	5	5	21	21	lapatinib	HER-2	PA152241907	2064	0.889
NULL	Osteoporos_Int_2012_Jan_3_23(1)_327-337.nxml.txt.nlp	21892677	SENT213	18	18	15	15	denosumab	RANKL	PA166048634	8600	0.889
NULL	Mol_Cancer_2012_Sep_19_11_70.nxml.txt.nlp	22992329	SENT28	24	24	5	5	gefitinib	EGFR	PA131301952	1956	0.889
NULL	J_Korean_Neurosurg_Soc_2014_Jul_31_56(1)_1-4.nxml.txt.nlp	25289117	SENT82	4	4	23	23	curcumin	p38	PA151958596	10598;1432;7965	0.889
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1046.nxml.txt.nlp	24503538	SENT83	22	22	40	40	cyclophosphamide	FGFR4	PA449165	2264	0.889
NULL	Mol_Cancer_2007_Oct_22_6_66.nxml.txt.nlp	17953743	SENT148	7	7	3	3	cisplatin	TRAIL	PA449014	8743	0.889
NULL	Gut_Liver_2013_Sep_14_7(5)_576-584.nxml.txt.nlp	24073316	SENT24	16	16	38	38	epirubicin	HAI	PA449476	6692;6768	0.889
NULL	Oncotarget_2013_Nov_7_4(12)_2550-2566.nxml.txt.nlp	24334291	SENT139	25	25	16	16	dasatinib	AMPK	PA162372878	5563	0.889
NULL	Case_Reports_Hepatol_2013_Dec_14_2013_807537.nxml.txt.nlp	25379301	SENT80	5	5	32	32	infliximab	TH1	PA452639	51497	0.889
NULL	Acta_Pharmacol_Sin_2011_Oct_15_32(10)_1225-1232.nxml.txt.nlp	21841809	SENT138	19	19	28	28	aripiprazole	5-HT1A	PA10026	3350	0.889
NULL	Breast_Cancer_Res_2002_Jan_14_4(2)_65-69.nxml.txt.nlp	11879566	SENT72	20	20	11	11	estradiol	IL-6	PA449503	3569	0.889
NULL	Mol_Pain_2014_Apr_18_10_27.nxml.txt.nlp	24742127	SENT16	12	12	20	20	paclitaxel	CD11b	PA450761	3684	0.889
NULL	Oncol_Lett_2014_Oct_30_8(4)_1447-1454.nxml.txt.nlp	25202348	SENT100	6	6	15	15	everolimus	UBC	PA164746311	7316	0.889
NULL	Eur_J_Clin_Microbiol_Infect_Dis_2014_Feb_23_33(6)_879-910.nxml.txt.nlp	24563274	SENT164	20	20	9	9	cefotaxime	19A	PA448852	57823	0.889
NULL	Support_Care_Cancer_2012_Jul_6_20(7)_1533-1540.nxml.txt.nlp	21822636	SENT59	25	25	28	28	fulvestrant	aromatase	PA164747170	1588	0.889
NULL	Br_J_Clin_Pharmacol_2013_Aug_23_76(2)_299-315.nxml.txt.nlp	23701319	SENT94	8	8	21	21	basiliximab	IFN	PA164747126	3439	0.889
NULL	J_Neurosci_Rural_Pract_2014_Nov_5(Suppl_1)_S7-S12.nxml.txt.nlp	25540548	SENT68	25	25	10	10	clobazam	CLB	PA10888	171425	0.889
NULL	Indian_J_Anaesth_2014_Mar-Apr_58(2)_154-159.nxml.txt.nlp	24963179	SENT72	9	9	30	30	dexmedetomidine	ANOVA	PA449256	4858	0.889
NULL	Ann_Rheum_Dis_2008_Jul_26_67(7)_917-925.nxml.txt.nlp	17965121	SENT232	26	26	15	15	rituximab	CD55	PA451261	1604	0.889
NULL	Indian_J_Anaesth_2013_Jan-Feb_57(1)_91-92.nxml.txt.nlp	23716783	SENT18	3	3	11	11	rocuronium	NMB	PA164754992	10457;4828	0.889
NULL	Breast_Cancer_Res_2010_Oct_22_12(Suppl_2)_S2.nxml.txt.nlp	21050423	SENT99	20	20	9	9	epirubicin	MSH2	PA449476	4436	0.889
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1021.nxml.txt.nlp	24457965	SENT234	35	35	26	26	cisplatin	JNK	PA449014	5599	0.889
NULL	Oncogene_2010_Jun_10_29(23)_3335-3348.nxml.txt.nlp	20383197	SENT121	16	16	28	28	lapatinib	VEGFR	PA152241907	3791	0.889
NULL	Acta_Pharmacol_Sin_2009_Nov_5_30(11)_1522-1528.nxml.txt.nlp	19890360	SENT140	11	11	23	23	fenoterol	CD14	PA10079	929	0.889
NULL	J_Hematol_Oncol_2013_Jan_15_6_5.nxml.txt.nlp	23320987	SENT195	19	19	16	16	heparin	PI-PLC	PA449855	2923	0.889
NULL	J_Clin_Biochem_Nutr_2009_Sep_28_45(2)_163-170.nxml.txt.nlp	19794924	SENT403	14	14	24	24	paraformaldehyde	TRAIL	PA450790	8743	0.889
NULL	Int_J_Vasc_Med_2011_Jun_30_2011_250518.nxml.txt.nlp	21761004	SENT56	13	13	30	30	clopidogrel	ADP	PA449053	23038	0.889
NULL	Int_J_Biol_Sci_2011_Nov_5_8(1)_1-14.nxml.txt.nlp	22211100	SENT239	9	9	28	28	gemcitabine	PI3K	PA449748	5290	0.889
NULL	Oncotarget_2014_Aug_31_5(19)_9239-9255.nxml.txt.nlp	25238453	SENT313	22	22	0	0	paraformaldehyde	EGFR	PA450790	1956	0.889
NULL	Acta_Pharmacol_Sin_2013_May_8_34(5)_699-709.nxml.txt.nlp	23564084	SENT181	10	10	12	12	vorinostat	HDAC1	PA164748224	3065	0.889
NULL	Biologics_2010_May_25_4_91-101.nxml.txt.nlp	20531964	SENT229	19	19	5	5	temsirolimus	HIF-1	PA164746890	29072	0.889
NULL	Environ_Health_Perspect_2006_Sep_23_114(9)_1401-1406.nxml.txt.nlp	16966095	SENT48	31	31	5	5	arsenite	p53	PA452638	7157	0.889
NULL	Mol_Cancer_2010_May_20_9_115.nxml.txt.nlp	20487546	SENT35	13	13	23	23	fludarabine	p53	PA449655	7157	0.889
NULL	Ther_Clin_Risk_Manag_2006_Mar_2(1)_59-75.nxml.txt.nlp	18360582	SENT223	0	0	15	15	telithromycin	CYP3A4	PA10202	1576	0.889
NULL	Adv_Biomed_Res_2014_Sep_8_3_189.nxml.txt.nlp	25298958	SENT6	18	18	37	37	amoxicillin	NAC	PA448406	22861	0.889
NULL	Mol_Syst_Biol_2010_Oct_19_6_420.nxml.txt.nlp	20959818	SENT84	17	17	11	11	galactose	GAL	PA449725	51083	0.889
NULL	Cancer_Cell_Int_2014_Feb_28_14_18.nxml.txt.nlp	24576043	SENT104	3	3	5	5	flavopiridol	CDK8	PA452627	1024	0.889
NULL	Eur_J_Epidemiol_2007_Nov_23_22(11)_819-829.nxml.txt.nlp	17955331	SENT696	20	20	13	13	phenprocoumon	CYP2C9	PA450921	1559	0.889
NULL	Clin_Mol_Allergy_2008_May_20_6_4.nxml.txt.nlp	18489791	SENT152	4	4	29	29	omalizumab	CD23	PA164752253	2208	0.889
NULL	Case_Rep_Ophthalmol_2014_Jan_7_5(1)_6-10.nxml.txt.nlp	24575032	SENT55	19	19	13	13	erlotinib	EGFR	PA134687924	1956	0.889
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT185	2	2	32	32	perifosine	NAC	PA165291471	22861	0.889
NULL	J_Hematol_Oncol_2011_Mar_9_4_9.nxml.txt.nlp	21388537	SENT42	5	5	11	11	cytarabine	UGT1A1	PA449177	54658	0.889
NULL	Cell_Biol_Int_Rep_(2010)_2012_Jun_21_19(1)_e00017.nxml.txt.nlp	23124518	SENT132	4	4	12	12	etoposide	TRAIL-R2	PA449552	8795	0.889
NULL	Br_J_Cancer_2011_Jul_26_105(3)_407-412.nxml.txt.nlp	21730976	SENT76	2	2	16	16	pha-665752	STAT3		6774	0.889
NULL	Braz_J_Med_Biol_Res_2013_Mar_15_46(3)_299-305.nxml.txt.nlp	23532269	SENT184	7	7	16	16	propofol	TLR4	PA451141	7099	0.889
NULL	AIDS_Res_Ther_2013_May_1_10_10.nxml.txt.nlp	23634877	SENT156	14	14	5	5	atorvastatin	CCL4	PA448500	6351	0.889
NULL	Cancer_Microenviron_2009_Sep_26_2(Suppl_1)_19-204.nxml.txt.nlp	NULL	SENT1397	5	5	16	16	staurosporine	VDAC3	PA165109623	7419	0.889
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT173	8	8	4	4	metformin	HIP	PA450395	6767;6159;64399;5068	0.889
NULL	Cancer_Med_2013_Jun_25_2(3)_277-285.nxml.txt.nlp	23930204	SENT31	33	33	19	19	irinotecan	KRAS	PA450085	3845	0.889
NULL	Acta_Naturae_2012_Jan-Mar_4(1)_82-85.nxml.txt.nlp	22708067	SENT35	32	32	25	25	erlotinib	EGFR	PA134687924	1956	0.889
NULL	Curr_Genomics_2014_Jun_15(3)_217-230.nxml.txt.nlp	24955029	SENT129	5	5	26	26	oxygen	ROS	PA450744	6098	0.889
NULL	Hum_Mol_Genet_2013_Jun_1_22(11)_2247-2262.nxml.txt.nlp	23424202	SENT308	34	34	8	8	fluoxetine	AMPH	PA449673	273	0.889
NULL	Acta_Pharmacol_Sin_2010_Sep_16_31(9)_1133-1140.nxml.txt.nlp	20711219	SENT90	7	7	1	1	infliximab	ACR	PA452639	49	0.889
NULL	Mol_Imaging_Biol_2009_Jul_31_11(4)_241-245.nxml.txt.nlp	19333655	SENT108	6	6	4	4	aprepitant	NK1	PA164747039	11126	0.889
NULL	Cell_Death_Dis_2012_Mar_1_3(3)_e275.nxml.txt.nlp	22378068	SENT66	12	12	0	0	metformin	AMPK	PA450395	5563	0.889
NULL	J_Biomed_Sci_2014_Feb_3_21(1)_10.nxml.txt.nlp	24490900	SENT96	10	10	21	21	alendronate	M-CSF	PA448082	1435	0.889
NULL	Diabetes_Care_2013_Jun_15_36(6)_1765-1771.nxml.txt.nlp	23704676	SENT234	12	12	16	16	metformin	B12	PA450395	7126;4709	0.889
NULL	Front_Neurosci_2014_Nov_25_8_366.nxml.txt.nlp	25505376	SENT133	6	6	1	1	nadh	ADP	PA164755085	23038	0.889
NULL	Drug_Saf_2014_Feb_19_37(4)_201-211.nxml.txt.nlp	24550106	SENT310	5	5	12	12	fluvoxamine	CYP2C19	PA449690	1557	0.889
NULL	J_Hematol_Oncol_2008_Oct_1_1_16.nxml.txt.nlp	18828924	SENT122	7	7	13	13	tanespimycin	HER2	PA165291490	2064	0.889
NULL	Drug_Des_Devel_Ther_2014_Oct_8_8_1765-1780.nxml.txt.nlp	25336920	SENT70	21	21	9	9	fluorescein	p65	PA164746009	5970	0.889
NULL	Oncotarget_2013_Nov_26_4(12)_2502-2511.nxml.txt.nlp	24318446	SENT142	13	13	26	26	doxycycline	PHGDH	PA449415	26227	0.889
NULL	Breast_Cancer_Res_2007_Aug_8_9(4)_R50.nxml.txt.nlp	17686159	SENT246	26	26	37	37	gefitinib	HRG	PA131301952	3084;3273	0.889
NULL	Cancer_Med_2013_Dec_31_2(6)_826-835.nxml.txt.nlp	24403256	SENT218	11	11	7	7	daunorubicin	p53	PA449212	7157	0.889
NULL	J_Cancer_2014_Jan_5_5(2)_86-97.nxml.txt.nlp	24494026	SENT101	24	24	27	27	erlotinib	EGFR	PA134687924	1956	0.889
NULL	Oncotarget_2014_Mar_15_5(10)_3055-3065.nxml.txt.nlp	24931391	SENT263	0	0	15	15	dextran	FBS	PA449261	64319;26269	0.889
NULL	Breast_Cancer_Res_2008_Dec_5_10(6)_R104.nxml.txt.nlp	19061505	SENT225	33	33	21	21	estradiol	c-Jun	PA449503	3725	0.889
NULL	Eur_J_Clin_Pharmacol_2013_Mar_24_69(3)_489-497.nxml.txt.nlp	22918614	SENT242	13	13	4	4	phenytoin	CYP2C	PA450947	1562	0.889
NULL	BMB_Rep_2014_May_47(5)_274-279.nxml.txt.nlp	24286313	SENT80	16	16	8	8	bortezomib	CD138	PA10252	6382	0.889
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT3	5	5	20	20	curcumin	TRAIL	PA151958596	8743	0.889
NULL	Biologics_2009_Jul_13_3_289-301.nxml.txt.nlp	19707416	SENT187	14	14	29	29	docetaxel	HER2	PA449383	2064	0.889
NULL	Springerplus_2015_Jan_23_4_29.nxml.txt.nlp	25628986	SENT47	4	4	10	10	dapsone	G6PD	PA449211	2539	0.889
NULL	J_Hematol_Oncol_2008_Oct_1_1_16.nxml.txt.nlp	18828924	SENT234	7	7	32	32	vinorelbine	HER2	PA451881	2064	0.889
NULL	J_Invest_Dermatol_2012_Sep_17_132(9)_2148-2157.nxml.txt.nlp	22592159	SENT133	19	19	27	27	tetracycline	AREG	PA451640	374	0.889
NULL	BMJ_2013_Feb_5_346_e5793.nxml.txt.nlp	23386361	SENT13	27	27	40	40	trastuzumab	HER-2	PA451743	2064	0.889
NULL	Front_Oncol_2013_Oct_1_3_237.nxml.txt.nlp	24098868	SENT329	24	24	28	28	olaparib	BRCA1		672	0.889
NULL	Cell_Death_Dis_2014_Jan_30_5(1)_e1033.nxml.txt.nlp	24481447	SENT129	7	7	14	14	pioglitazone	CDK5	PA450970	1020	0.889
NULL	Adolesc_Health_Med_Ther_2012_Jun_20_3_85-93.nxml.txt.nlp	24600289	SENT65	10	10	1	1	adalimumab	ACR	PA10004	49	0.889
NULL	Cancer_Cell_Int_2011_Nov_17_11_40.nxml.txt.nlp	22088142	SENT151	25	25	9	9	doxorubicin	EGFR	PA449412	1956	0.889
NULL	Mol_Cancer_2010_Aug_20_9_220.nxml.txt.nlp	20727180	SENT219	10	10	18	18	nicotine	p53	PA450626	7157	0.889
NULL	Semin_Immunopathol_2013_Jan_26_35(1)_39-52.nxml.txt.nlp	22829332	SENT197	35	35	18	18	fludarabine	CHOP	PA449655	1649	0.889
NULL	Cancer_Cell_Int_2010_May_11_10_16.nxml.txt.nlp	20459793	SENT140	15	15	1	1	cisplatin	ABCC6	PA449014	368	0.889
NULL	Int_J_Mol_Sci_2007_Feb_23_8(2)_136-144.nxml.txt.nlp	NULL	SENT114	6	6	28	28	nitrogen	MCH	PA450643	5367	0.889
NULL	JAKSTAT_2014_Jun_12_3_e29554.nxml.txt.nlp	25105067	SENT9	0	0	4	4	propofol	STAT3	PA451141	6774	0.889
NULL	F1000Prime_Rep_2014_Dec_1_6_117.nxml.txt.nlp	25580271	SENT66	35	35	38	38	gemcitabine	EGFR	PA449748	1956	0.889
NULL	Cases_J_2009_Oct_30_2_177.nxml.txt.nlp	20062761	SENT72	22	22	6	6	octreotide	Sancho	PA450678	91151	0.889
NULL	Nat_Genet_2011_Jan_12_43(1)_27-33.nxml.txt.nlp	21151129	SENT158	12	12	5	5	tamoxifen	FOXA1	PA451581	3169	0.889
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT170	16	16	9	9	phenprocoumon	CYP2C9	PA450921	1559	0.889
NULL	Eur_J_Med_Res_2014_Nov_22_19(1)_64.nxml.txt.nlp	25416032	SENT100	22	22	16	16	vincristine	CHOP	PA451879	1649	0.889
NULL	Ann_Neurosci_2011_Apr_18(2)_48-55.nxml.txt.nlp	25205921	SENT227	23	23	3	3	forskolin	SOD1	PA146096022	6647	0.889
NULL	Cell_Death_Dis_2013_Oct_3_4(10)_e828.nxml.txt.nlp	24091671	SENT91	29	29	7	7	cetuximab	CD54	PA10040	3383	0.889
NULL	Mol_Cancer_2012_Aug_8_11_53.nxml.txt.nlp	22871047	SENT305	12	12	6	6	paclitaxel	HIN-1	PA450761	92304	0.889
NULL	Diabetes_Metab_J_2012_Oct_18_36(5)_328-335.nxml.txt.nlp	23130316	SENT144	11	11	21	21	rosiglitazone	PDK4	PA451283	5166	0.889
NULL	Oncoscience_2014_Oct_22_1(10)_614-623.nxml.txt.nlp	25593991	SENT95	36	36	9	9	cetuximab	NRAS	PA10040	4893	0.889
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT202	20	20	9	9	nutlin-3	TRAIL		8743	0.889
NULL	Asia_Pac_Allergy_2013_Oct_31_3(4)_215-223.nxml.txt.nlp	24260726	SENT100	10	10	29	29	phenytoin	HLA-B	PA450947	3106	0.889
NULL	Front_Chem_2014_Dec_23_2_113.nxml.txt.nlp	25566531	SENT158	3	3	11	11	curcumin	ACOX1	PA151958596	51	0.889
NULL	Pharmaceuticals_(Basel)_2011_Nov_10_4(11)_1488-1502.nxml.txt.nlp	NULL	SENT290	18	18	0	0	trastuzumab	Hsp90	PA451743	3320	0.889
NULL	Nucleic_Acids_Res_2011_Sep_28_39(17)_7858-7867.nxml.txt.nlp	21715374	SENT119	26	26	1	1	thrombin	TGT	PA451674	9097;81890	0.889
NULL	Acta_Histochem_Cytochem_2013_Dec_28_46(6)_187-197.nxml.txt.nlp	24610966	SENT4	8	8	36	36	pilocarpine	AQP5	PA450962	362	0.889
NULL	Cancer_Med_2012_Aug_15_1(1)_28-38.nxml.txt.nlp	23342251	SENT218	27	27	20	20	trastuzumab	HER2	PA451743	2064	0.889
NULL	Biomed_Res_Int_2013_Jul_31_2013_692071.nxml.txt.nlp	23984399	SENT182	22	22	31	31	irinotecan	OCT1	PA450085	5451;6580	0.889
NULL	Oncol_Lett_2014_Jul_16_8(1)_211-217.nxml.txt.nlp	24959248	SENT6	18	18	29	29	cisplatin	ALDOA	PA449014	226	0.889
NULL	Core_Evid_2011_Feb_8_6_23-29.nxml.txt.nlp	21468240	SENT32	25	25	11	11	plerixafor	CD34	PA165958410	947	0.889
NULL	Oncotarget_2010_Nov_22_1(7)_606-619.nxml.txt.nlp	21317456	SENT154	12	12	5	5	doxorubicin	BRCA2	PA449412	675	0.889
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT79	2	2	13	13	atorvastatin	IL-6	PA448500	3569	0.889
NULL	Int_J_Biol_Sci_2014_Jun_21_10(7)_702-714.nxml.txt.nlp	25013379	SENT141	23	23	6	6	gefitinib	EGFR	PA131301952	1956	0.889
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT29	26	26	35	35	atorvastatin	IL-6	PA448500	3569	0.889
NULL	eLife_2014_Apr_30_3_e02445.nxml.txt.nlp	24843000	SENT614	19	19	13	13	cisplatin	RAD51	PA449014	5888	0.889
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT47	4	4	20	20	curcumin	TRAIL	PA151958596	8743	0.889
NULL	Int_J_Breast_Cancer_2011_Sep_6_2011_352182.nxml.txt.nlp	22295219	SENT73	3	3	11	11	trastuzumab	HER2	PA451743	2064	0.889
NULL	Case_Rep_Oncol_2010_Apr_22_3(2)_98-105.nxml.txt.nlp	20740181	SENT69	15	15	18	18	erlotinib	EGFR	PA134687924	1956	0.889
NULL	J_Mol_Signal_2010_May_10_5_4.nxml.txt.nlp	20459745	SENT58	7	7	5	5	cisplatin	p53	PA449014	7157	0.889
NULL	J_Gastroenterol_2014_Dec_24_49(12)_1536-1547.nxml.txt.nlp	24366288	SENT31	11	11	16	16	rabeprazole	CYP2C19	PA451216	1557	0.889
NULL	Br_J_Cancer_2011_Jul_26_105(3)_420-427.nxml.txt.nlp	21730982	SENT193	22	22	9	9	cisplatin	EGFR	PA449014	1956	0.889
NULL	Acta_Pharmacol_Sin_2011_Jul_9_32(7)_879-887.nxml.txt.nlp	21552292	SENT25	5	5	15	15	metformin	AMPK	PA450395	5563	0.889
NULL	Breast_Cancer_Res_2005_Jun_17_7(Suppl_2)_S_13.nxml.txt.nlp	NULL	SENT8	25	25	18	18	letrozole	aromatase	PA450196	1588	0.889
NULL	Breast_Cancer_Res_2008_Apr_29_10(2)_206.nxml.txt.nlp	18492214	SENT122	9	9	1	1	exemestane	aromatase	PA449563	1588	0.889
NULL	J_Thromb_Haemost_2014_May_22_12(5)_726-735.nxml.txt.nlp	24581425	SENT190	3	3	9	9	thrombin	ARF6	PA451674	382	0.889
NULL	Clin_Ophthalmol_2010_Nov_23_4_1355-1359.nxml.txt.nlp	21179218	SENT70	8	8	38	38	latanoprost	BAK	PA164774763	578	0.889
NULL	Front_Immunol_2012_May_7_3_101.nxml.txt.nlp	22783250	SENT251	25	25	35	35	papain	IL-13	PA450778	3596	0.889
NULL	Nat_Commun_2014_Dec_8_5_5736.nxml.txt.nlp	25484020	SENT233	11	11	21	21	exemestane	PAR2	PA449563	2150;55065;8856	0.889
NULL	J_Immunol_Res_2014_Jul_21_2014_297073.nxml.txt.nlp	25143957	SENT63	28	28	9	9	glucosamine	KIR2DL4	PA164747613	3805	0.889
NULL	Oxid_Med_Cell_Longev_2013_May_25_2013_120305.nxml.txt.nlp	23766848	SENT179	18	18	6	6	hemin	FECH	PA449849	2235	0.889
NULL	Oncotarget_2011_Dec_31_2(12)_1314-1321.nxml.txt.nlp	22248929	SENT62	13	13	28	28	lapatinib	HER3	PA152241907	2065	0.889
NULL	Drugs_R_D_2010_Sep_27_10(3)_179-202.nxml.txt.nlp	20945948	SENT421	28	28	5	5	telaprevir	RVR	PA165958354	9975	0.889
NULL	Cancer_Imaging_2008_Nov_25_8(1)_199-205.nxml.txt.nlp	19028612	SENT125	21	21	12	12	sunitinib	EGFR	PA162372840	1956	0.889
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Dec_8_67(Pt_1)_o50.nxml.txt.nlp	21522760	SENT48	18	18	12	12	ethanol	mol	PA448073	90527	0.889
NULL	Ann_Gastroenterol_2012_25(3)_207-217.nxml.txt.nlp	24713803	SENT139	39	39	18	18	metformin	DM2	PA450395	28508	0.889
NULL	Clin_Ophthalmol_2014_Jun_26_8_1213-1219.nxml.txt.nlp	25061267	SENT4	0	0	27	27	tetracaine	PRK	PA451638	1263	0.889
NULL	Front_Physiol_2013_Nov_14_4_323.nxml.txt.nlp	24294204	SENT256	36	36	2	2	metoprolol	ADRB1	PA450480	153	0.889
NULL	Cancer_Med_2013_Feb_3_2(1)_76-85.nxml.txt.nlp	24133630	SENT353	13	13	21	21	vemurafenib	ABCB1	PA165946873	5243	0.889
NULL	Evid_Based_Complement_Alternat_Med_2011_Feb_14_2011_429843.nxml.txt.nlp	21869897	SENT189	25	25	14	14	ethanol	CEA	PA448073	5670;1087	0.889
NULL	Oncotarget_2012_Aug_9_3(8)_774-782.nxml.txt.nlp	22885298	SENT74	31	31	8	8	tetracycline	IDH1	PA451640	3417	0.889
NULL	J_Clin_Biochem_Nutr_2008_Jul_1_43(1)_6-12.nxml.txt.nlp	18648659	SENT25	6	6	31	31	oxygen	ROS	PA450744	6098	0.889
NULL	Cancer_Manag_Res_2013_Nov_21_5_387-400.nxml.txt.nlp	24294007	SENT134	15	15	19	19	panitumumab	KRAS	PA162373091	3845	0.889
NULL	Cancer_Immunol_Immunother_2012_Jul_23_61(7)_1101-1111.nxml.txt.nlp	22193989	SENT232	13	13	21	21	oxaliplatin	IFN	PA131285527	3439	0.889
NULL	Crit_Care_2010_Oct_13_14(5)_R181.nxml.txt.nlp	20942931	SENT209	30	30	18	18	cisplatin	IL-6	PA449014	3569	0.889
NULL	Breast_Cancer_Res_2007_Aug_8_9(4)_R50.nxml.txt.nlp	17686159	SENT262	18	18	11	11	trastuzumab	HRG	PA451743	3084;3273	0.889
NULL	Br_J_Cancer_2010_Jan_19_102(2)_325-331.nxml.txt.nlp	20051959	SENT107	27	27	7	7	neomycin	MRGBP	PA450608	55257	0.889
NULL	Mol_Pain_2013_Mar_26_9_14.nxml.txt.nlp	23531341	SENT3	4	4	14	14	metformin	AMPK	PA450395	5563	0.889
NULL	Int_J_Cell_Biol_2013_Apr_30_2013_231279.nxml.txt.nlp	23737792	SENT56	1	1	7	7	thrombin	San	PA451674	80218	0.889
NULL	Front_Neurol_2011_Dec_16_2_72.nxml.txt.nlp	22203815	SENT199	23	23	5	5	protamine	CD4	PA10366	920	0.889
NULL	Oncol_Lett_2013_Jun_16_5(6)_1854-1858.nxml.txt.nlp	23833655	SENT28	10	10	0	0	paclitaxel	EGFR	PA450761	1956	0.889
NULL	Eur_J_Med_Res_2010_Apr_8_15(4)_162-168.nxml.txt.nlp	20564833	SENT42	39	39	21	21	l-glutamine	CD95	PA10090	355	0.889
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Nov_18_65(Pt_12)_o3103.nxml.txt.nlp	21578830	SENT66	43	43	17	17	ethanol	mol	PA448073	90527	0.889
NULL	J_Adv_Pract_Oncol_2013_Jul_1_Jul-Aug_4(4)_263-268.nxml.txt.nlp	25032007	SENT49	6	6	10	10	voriconazole	CYP2B6	PA10233	1555	0.889
NULL	Cell_Commun_Signal_2014_Jan_30_12_8.nxml.txt.nlp	24479879	SENT60	7	7	30	30	dextran	NFAT1	PA449261	4773	0.889
NULL	Cell_Commun_Signal_2004_Jun_30_2_6.nxml.txt.nlp	15228623	SENT148	27	27	14	14	flunarizine	TTN	PA164776636	7273	0.889
NULL	J_Gynecol_Oncol_2012_Jul_2_23(3)_139-140.nxml.txt.nlp	NULL	SENT26	26	26	7	7	docetaxel	EZH2	PA449383	2146	0.889
NULL	Aging_(Albany_NY)_2010_Jun_28_2(6)_353-360.nxml.txt.nlp	20606253	SENT105	13	13	11	11	resveratrol	AMPK		5563	0.889
NULL	BMB_Rep_2013_Jan_46(1)_59-64.nxml.txt.nlp	23351386	SENT41	20	20	11	11	auranofin	STAT3	PA448510	6774	0.889
NULL	eLife_2013_Nov_5_2_e00969.nxml.txt.nlp	24192036	SENT350	13	13	29	29	vemurafenib	JNK	PA165946873	5599	0.889
NULL	Breast_Cancer_Res_2011_Jun_29_13(3)_R70.nxml.txt.nlp	21707964	SENT189	12	12	25	25	tamoxifen	14-3-3	PA451581	10971	0.889
NULL	Crit_Care_2008_Feb_2_12(1)_R11.nxml.txt.nlp	18252006	SENT172	24	24	34	34	vasopressin	ACTH	PA451858	5443	0.889
NULL	Cells_2014_Apr_4_3(2)_199-235.nxml.txt.nlp	24709958	SENT1163	8	8	2	2	cetuximab	EGFR	PA10040	1956	0.889
NULL	Hum_Genomics_2009_Jan_1_3(2)_121-127.nxml.txt.nlp	19164089	SENT45	17	17	0	0	ethanol	ALDH1A1	PA448073	216	0.889
NULL	Chem_Rev_2013_Oct_9_113(10)_7769-7792.nxml.txt.nlp	23808632	SENT65	0	0	3	3	arsenite	PDH	PA452638	54704	0.889
NULL	Br_J_Cancer_2009_Oct_6_101(7)_1044-1050.nxml.txt.nlp	19738609	SENT134	0	0	10	10	vorinostat	HDAC6	PA164748224	10013	0.889
NULL	Oncol_Lett_2013_Sep_3_6(3)_725-727.nxml.txt.nlp	24137399	SENT54	18	18	15	15	cisplatin	PARP-1	PA449014	25976	0.889
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT115	3	3	20	20	trastuzumab	HER3	PA451743	2065	0.889
NULL	Biomed_Res_Int_2013_Jun_18_2013_104315.nxml.txt.nlp	23853765	SENT110	37	37	12	12	pitrakinra	IL-4	PA165983754	3565	0.889
NULL	Nat_Commun_2013_Oct_1_4_2516.nxml.txt.nlp	24084631	SENT84	20	20	12	12	losartan	AT1	PA450268	9197;185	0.889
NULL	Front_Immunol_2012_Mar_15_3_46.nxml.txt.nlp	22566928	SENT54	23	23	31	31	pp2	mol		90527	0.889
NULL	FASEB_J_2014_Nov_28(11)_4610-4616.nxml.txt.nlp	25145629	SENT92	18	18	11	11	carbachol	PER2	PA448784	8864	0.889
NULL	Nat_Commun_2013_Apr_3_4_1652.nxml.txt.nlp	23552067	SENT419	15	15	9	9	ketamine	CA1	PA450144	759	0.889
NULL	Int_J_Gen_Med_2009_Jul_30_2_129-140.nxml.txt.nlp	20360896	SENT19	18	18	11	11	exemestane	aromatase	PA449563	1588	0.889
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT8	7	7	17	17	nutlin-3	p53		7157	0.889
NULL	Cardiovasc_Diabetol_2013_May_4_12_73.nxml.txt.nlp	23642288	SENT16	5	5	16	16	acarbose	GLP-1	PA448010	100125288	0.889
NULL	Mol_Cancer_2009_Nov_10_8_99.nxml.txt.nlp	19903356	SENT87	13	13	6	6	imatinib	IGFBP3	PA10804	3486	0.889
NULL	AIDS_Res_Ther_2013_May_1_10_10.nxml.txt.nlp	23634877	SENT152	10	10	3	3	atorvastatin	CXCR4	PA448500	7852	0.888
NULL	Breast_Cancer_Res_2002_Jul_29_4(5)_202-204.nxml.txt.nlp	12223125	SENT97	21	21	40	40	tamoxifen	ATAC	PA451581	6375	0.888
NULL	Gut_Liver_2011_Jun_24_5(2)_171-180.nxml.txt.nlp	21814597	SENT29	30	30	42	42	imatinib	PDGFA	PA10804	5154	0.888
NULL	AAPS_J_2014_Jun_11_16(5)_1029-1037.nxml.txt.nlp	24917180	SENT7	7	7	3	3	quinidine	P-gp	PA451209	5243	0.888
NULL	Iran_J_Pharm_Res_2014_Winter_13(Suppl)_3-14.nxml.txt.nlp	24711824	SENT4	3	3	27	27	fluoxetine	zeta	PA449673	9907	0.888
NULL	Int_J_Mol_Sci_2012_Feb_24_13(3)_2578-2589.nxml.txt.nlp	22489112	SENT64	10	10	17	17	desipramine	GAT3	PA449233	6538	0.888
NULL	F1000Prime_Rep_2014_Dec_1_6_117.nxml.txt.nlp	25580271	SENT14	15	15	23	23	bevacizumab	EGFR	PA130232992	1956	0.888
NULL	ScientificWorldJournal_2013_Oct_27_2013_549091.nxml.txt.nlp	24288493	SENT130	10	10	5	5	vancomycin	MRS	PA451850	8011	0.888
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_13_2013_468537.nxml.txt.nlp	23956772	SENT141	4	4	32	32	etoposide	BAX	PA449552	581	0.888
NULL	Nucleic_Acids_Res_2012_Jul_19_40(13)_5910-5925.nxml.txt.nlp	22434882	SENT300	19	19	6	6	curcumin	HBZ	PA151958596	3050	0.888
NULL	Br_J_Cancer_1998_77(2)_201-209.nxml.txt.nlp	9460989	SENT11	36	36	8	8	melphalan	MRP1	PA450354	4437	0.888
NULL	J_Biol_Chem_2009_Aug_7_284(32)_21347-21359.nxml.txt.nlp	19520849	SENT168	17	17	24	24	s-adenosylmethionine	PRMT5	PA164754994	10419	0.888
NULL	Environ_Health_Perspect_2006_Sep_23_114(9)_1401-1406.nxml.txt.nlp	16966095	SENT189	4	4	26	26	arsenite	p53	PA452638	7157	0.888
NULL	Braz_J_Med_Biol_Res_2013_Mar_15_46(3)_299-305.nxml.txt.nlp	23532269	SENT12	4	4	14	14	propofol	CD14	PA451141	929	0.888
NULL	Cardiovasc_Res_2012_Mar_15_93(4)_674-681.nxml.txt.nlp	22166712	SENT72	29	29	11	11	clopidogrel	CYP3A4	PA449053	1576	0.888
NULL	Endocrinology_2014_Oct_22_155(10)_3732-3738.nxml.txt.nlp	25051442	SENT118	30	30	13	13	sibutramine	POMC	PA451344	5443	0.888
NULL	Biomed_Res_Int_2013_Apr_15_2013_378380.nxml.txt.nlp	23691500	SENT85	10	10	12	12	chlorpromazine	CPZ	PA448964	8532	0.888
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S279-S284.nxml.txt.nlp	21525469	SENT94	20	20	14	14	exenatide	GLP-1	PA164749238	100125288	0.888
NULL	J_Cell_Mol_Med_2013_Feb_10_17(2)_233-241.nxml.txt.nlp	23301673	SENT162	18	18	25	25	cisplatin	REN	PA449014	5972;147040	0.888
NULL	Diabetes_2009_Feb_58(2)_329-336.nxml.txt.nlp	19171749	SENT112	27	27	37	37	imatinib	JNK	PA10804	5599	0.888
NULL	Mol_Cancer_2010_Aug_23_9_222.nxml.txt.nlp	20731837	SENT89	4	4	9	9	gefitinib	ATM	PA131301952	472	0.888
NULL	Adv_Urol_2012_Oct_26_2012_812398.nxml.txt.nlp	22110495	SENT63	30	30	4	4	cisplatin	EGFR	PA449014	1956	0.888
NULL	J_Allergy_(Cairo)_2012_Dec_17_2012_604854.nxml.txt.nlp	23316250	SENT134	0	0	2	2	metformin	PTEN	PA450395	5728	0.888
NULL	Diabetes_Care_2012_Jan_13_35(Suppl_1)_S11-S63.nxml.txt.nlp	22187469	SENT1913	22	22	7	7	rosiglitazone	DREAM	PA451283	30818	0.888
NULL	J_Cancer_2013_Aug_28_4(7)_585-596.nxml.txt.nlp	24069069	SENT153	6	6	17	17	verteporfin	p62	PA451871	8878;10657;23636	0.888
NULL	Eur_J_Nucl_Med_Mol_Imaging_2010_Feb_18_37(2)_250-259.nxml.txt.nlp	19763566	SENT43	1	1	16	16	cetuximab	EGFR	PA10040	1956	0.888
NULL	Br_J_Cancer_2009_Jul_21_101(2)_269-277.nxml.txt.nlp	19603033	SENT125	9	9	22	22	cisplatin	MLH1	PA449014	4292	0.888
NULL	Eur_J_Haematol_2013_Feb_22_90(2)_89-98.nxml.txt.nlp	23181448	SENT135	3	3	19	19	nilotinib	KIT	PA165958345	3815	0.888
NULL	Am_J_Case_Rep_2012_May_23_13_79-85.nxml.txt.nlp	23569495	SENT97	17	17	11	11	vincristine	CHOP	PA451879	1649	0.888
NULL	Ann_Rheum_Dis_2011_Oct_19_71(3)_351-357.nxml.txt.nlp	22012969	SENT146	11	11	6	6	rituximab	ACPA	PA451261	5657	0.888
NULL	Acta_Naturae_2013_Apr-Jun_5(2)_90-99.nxml.txt.nlp	23819040	SENT187	37	37	15	15	staurosporine	IGF1R	PA165109623	3480	0.888
NULL	J_Cell_Mol_Med_2014_Jan_4_18(1)_38-48.nxml.txt.nlp	24188742	SENT143	32	32	21	21	vincristine	PAX3	PA451879	5077	0.888
NULL	Diabetes_2011_Nov_17_60(11)_2701-2709.nxml.txt.nlp	21885869	SENT207	28	28	19	19	yohimbine	PPG	PA451946	5552	0.888
NULL	Chonnam_Med_J_2013_Apr_25_49(1)_31-37.nxml.txt.nlp	23678475	SENT87	22	22	8	8	atorvastatin	adiponectin	PA448500	9370	0.888
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Oct_31_65(Pt_11)_o2938.nxml.txt.nlp	21578514	SENT51	25	25	19	19	ethanol	mol	PA448073	90527	0.888
NULL	Environ_Health_Perspect_2008_Feb_8_116(2)_158-164.nxml.txt.nlp	18288312	SENT57	23	23	9	9	arsenite	MRP1	PA452638	4437	0.888
NULL	Mol_Biol_Cell_2013_Jul_15_24(14)_2269-2284.nxml.txt.nlp	23676666	SENT215	34	34	7	7	isoproterenol	PI4KII	PA450121	55361	0.888
NULL	Anal_Bioanal_Chem_2010_Aug_2_397(8)_3195-3202.nxml.txt.nlp	20361179	SENT100	8	8	1	1	trypsin	PSD-95	PA451806	1742	0.888
NULL	Front_Immunol_2012_Jul_12_3_175.nxml.txt.nlp	22807925	SENT121	24	24	11	11	heparin	CCL5	PA449855	6352	0.888
NULL	Indian_J_Psychiatry_2010_Jan_52(Suppl1)_S317-S340.nxml.txt.nlp	21836703	SENT110	5	5	12	12	thiothixene	TFP	PA451669	7034	0.888
NULL	Ann_Oncol_2011_Mar_8_22(3)_503-514.nxml.txt.nlp	20616198	SENT379	12	12	16	16	exemestane	aromatase	PA449563	1588	0.888
NULL	J_Obes_2011_Dec_22_2011_252817.nxml.txt.nlp	21318055	SENT9	0	0	28	28	metformin	AMPK	PA450395	5563	0.888
NULL	Breast_Cancer_Res_2011_Jan_28_13(1)_R11.nxml.txt.nlp	21276249	SENT273	33	33	26	26	tamoxifen	PRLR	PA451581	5618	0.888
NULL	Br_J_Cancer_2009_Oct_6_101(7)_1155-1161.nxml.txt.nlp	19738614	SENT82	14	14	25	25	gemcitabine	MUC4	PA449748	4585	0.888
NULL	Acta_Pharmacol_Sin_2013_Mar_11_34(3)_403-413.nxml.txt.nlp	23396374	SENT47	19	19	25	25	triciribine	AKT	PA165958661	207	0.888
NULL	Pain_Res_Treat_2012_Nov_4_2012_426130.nxml.txt.nlp	23213512	SENT278	3	3	1	1	amitriptyline	NNT	PA448385	23530	0.888
NULL	Br_J_Clin_Pharmacol_2013_Aug_23_76(2)_299-315.nxml.txt.nlp	23701319	SENT94	10	10	21	21	daclizumab	IFN	PA164764446	3439	0.888
NULL	Acta_Pharmacol_Sin_2014_Aug_7_35(8)_1023-1030.nxml.txt.nlp	24998255	SENT106	3	3	16	16	octreotide	STAT3	PA450678	6774	0.888
NULL	Acta_Pharmacol_Sin_2014_Jun_5_35(6)_727-737.nxml.txt.nlp	24793312	SENT15	34	34	17	17	telmisartan	B27	PA451605	56246	0.888
NULL	Oncogene_2009_Dec_17_28(50)_4469-4479.nxml.txt.nlp	19855428	SENT92	6	6	4	4	caffeine	ATR	PA448710	390502;84168;545	0.888
NULL	Int_J_Bipolar_Disord_2013_Jul_4_1_10.nxml.txt.nlp	25505677	SENT88	24	24	1	1	quetiapine	NNT	PA451201	23530	0.888
NULL	Biologics_2012_Jul_13_6_221-231.nxml.txt.nlp	22904614	SENT186	5	5	1	1	panitumumab	KRAS	PA162373091	3845	0.888
NULL	Adv_Hematol_2010_May_16_2010_672137.nxml.txt.nlp	20490274	SENT14	38	38	18	18	idarubicin	AIDA	PA449961	64853	0.888
NULL	Oncotarget_2013_Nov_19_5(2)_309-325.nxml.txt.nlp	24525395	SENT282	19	19	37	37	hyperforin	p53	PA165985514	7157	0.888
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2008_Sep_1_64(Pt_9)_933-940.nxml.txt.nlp	18703841	SENT182	29	29	5	5	nadh	MRF	PA164755085	745	0.888
NULL	Indian_J_Nephrol_2011_Oct-Dec_21(4)_258-263.nxml.txt.nlp	22022086	SENT62	44	44	9	9	azathioprine	IL-2	PA448515	3558	0.888
NULL	Biomed_Res_Int_2013_May_22_2013_430791.nxml.txt.nlp	23762845	SENT181	20	20	27	27	fasudil	SDH	PA165946121	1757;10993	0.888
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT98	6	6	23	23	trastuzumab	STAT3	PA451743	6774	0.888
NULL	Exp_Diabetes_Res_2011_Dec_27_2011_604989.nxml.txt.nlp	21253359	SENT50	9	9	44	44	clonidine	GLP-1	PA449051	100125288	0.888
NULL	Breast_Cancer_Res_2012_Mar_9_14(2)_R41.nxml.txt.nlp	22405131	SENT57	33	33	26	26	ethanol	FBS	PA448073	64319;26269	0.888
NULL	J_Invest_Dermatol_2012_May_16_132(5)_1435-1442.nxml.txt.nlp	22336948	SENT97	3	3	23	23	doxycycline	TLSP	PA449415	11012	0.888
NULL	Ann_Clin_Microbiol_Antimicrob_2005_Sep_13_4_13.nxml.txt.nlp	16159399	SENT258	11	11	7	7	lamivudine	IFN	PA450163	3439	0.888
NULL	Biomed_Res_Int_2013_Jun_19_2013_230805.nxml.txt.nlp	23862137	SENT164	31	31	0	0	heparin	OPG	PA449855	690	0.888
NULL	Int_J_Breast_Cancer_2011_Sep_6_2011_352182.nxml.txt.nlp	22295219	SENT52	19	19	26	26	trastuzumab	CDK2	PA451743	1017	0.888
NULL	Biochem_Res_Int_2012_Mar_4_2012_685267.nxml.txt.nlp	22496978	SENT251	10	10	19	19	thrombin	HSPC	PA451674	5688	0.888
NULL	Braz_J_Med_Biol_Res_2013_Mar_19_46(3)_207-216.nxml.txt.nlp	23558859	SENT22	10	10	24	24	trastuzumab	HER2	PA451743	2064	0.888
NULL	Mol_Cell_Proteomics_2013_Oct_22_12(10)_2791-2803.nxml.txt.nlp	23793018	SENT323	31	31	16	16	galactose	GAL	PA449725	51083	0.888
NULL	J_Inherit_Metab_Dis_2011_Apr_29_34(2)_315-325.nxml.txt.nlp	20668944	SENT208	2	2	6	6	bezafibrate	CPT2	PA162364313	1376	0.888
NULL	J_Vet_Med_Sci_2014_Aug_15_76(8)_1119-1127.nxml.txt.nlp	24829081	SENT133	25	25	19	19	trypsin	IL-8	PA451806	3576	0.888
NULL	Clin_Pharmacokinet_2014_Sep_3_53(1)_1-16.nxml.txt.nlp	23999929	SENT278	7	7	16	16	erythromycin	CYP3A4	PA449493	1576	0.888
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Jul_23_3(7)_e126.nxml.txt.nlp	25054314	SENT61	29	29	7	7	docetaxel	OATP1B3	PA449383	28234	0.888
NULL	Br_J_Cancer_2011_Aug_23_105(5)_698-708.nxml.txt.nlp	21811256	SENT27	20	20	35	35	tamoxifen	aromatase	PA451581	1588	0.888
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT6	6	6	19	19	gefitinib	KRAS	PA131301952	3845	0.888
NULL	Arthritis_Res_Ther_2013_Jul_9_15(4)_R73.nxml.txt.nlp	23837669	SENT262	3	3	13	13	colchicine	MSU	PA449092	593	0.888
NULL	Cell_Mol_Life_Sci_2012_Mar_2_69(6)_963-979.nxml.txt.nlp	21964925	SENT47	31	31	3	3	etoposide	PI3	PA449552	5266	0.888
NULL	Arch_Med_Sci_2012_May_9_8(2)_375-388.nxml.txt.nlp	22662015	SENT256	36	36	26	26	erythromycin	CYP3A4	PA449493	1576	0.888
NULL	Environ_Health_2011_Mar_18_10_20.nxml.txt.nlp	21418576	SENT164	9	9	11	11	diethylstilbestrol	DES	PA449307	1674	0.888
NULL	Mol_Biol_Int_2011_Feb_24_2011_137459.nxml.txt.nlp	22091395	SENT93	8	8	17	17	arsenite	TIA1	PA452638	7072	0.888
NULL	Eur_J_Clin_Pharmacol_2011_May_8_67(5)_493-506.nxml.txt.nlp	21140139	SENT154	18	18	10	10	fluoxetine	CYP2D6	PA449673	1565	0.888
NULL	Cancers_(Basel)_2013_Jul_4_5(3)_838-856.nxml.txt.nlp	24202322	SENT204	3	3	20	20	etoposide	p53	PA449552	7157	0.888
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_4_2013_378657.nxml.txt.nlp	23662132	SENT495	25	25	15	15	vildagliptin	GLP-1	PA165958346	100125288	0.888
NULL	Nat_Biotechnol_2011_Jul_17_29(8)_757-761.nxml.txt.nlp	21765402	SENT148	32	32	3	3	kanamycin	NIR	PA450137	26155	0.888
NULL	Br_J_Cancer_2006_Dec_4_95(11)_1483-1489.nxml.txt.nlp	17106442	SENT162	4	4	11	11	gefitinib	EGFR	PA131301952	1956	0.888
NULL	Br_J_Cancer_2013_Aug_6_109(3)_739-746.nxml.txt.nlp	23828517	SENT8	14	14	27	27	gemcitabine	PTX3	PA449748	5806	0.888
NULL	Front_Physiol_2013_May_20_4_101.nxml.txt.nlp	23730288	SENT145	38	38	8	8	allopurinol	HL-1	PA448320	55600	0.888
NULL	Front_Oncol_2013_Apr_30_3_106.nxml.txt.nlp	23641364	SENT106	12	12	10	10	tocilizumab	IL-6	PA165292659	3569	0.888
NULL	Cancers_(Basel)_2013_Nov_26_5(4)_1601-1618.nxml.txt.nlp	24287743	SENT206	9	9	7	7	gefitinib	EGFR	PA131301952	1956	0.888
NULL	Int_J_Health_Geogr_2011_Feb_28_10_17.nxml.txt.nlp	21356088	SENT4	7	7	2	2	ciprofloxacin	spatial	PA449009	219793	0.888
NULL	Oncol_Lett_2014_Apr_12_7(4)_1049-1052.nxml.txt.nlp	24944667	SENT22	4	4	6	6	gemcitabine	GEM	PA449748	2669	0.888
NULL	J_Headache_Pain_2012_Mar_27_13(2)_103-111.nxml.txt.nlp	22200764	SENT97	0	0	20	20	sumatriptan	5-HT1B	PA451566	3351	0.888
NULL	EMBO_Mol_Med_2013_Aug_4_5(8)_1247-1262.nxml.txt.nlp	23737459	SENT4	24	24	11	11	nilotinib	parkin	PA165958345	5071	0.888
NULL	Mol_Cell_Proteomics_2014_May_20_13(5)_1184-1197.nxml.txt.nlp	24556848	SENT192	28	28	5	5	staurosporine	PARP1	PA165109623	142	0.888
NULL	Arthritis_Res_Ther_2005_Feb_18_7(3)_R476-R484.nxml.txt.nlp	15899034	SENT104	29	29	31	31	thrombin	Rho	PA451674	29984	0.888
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT137	28	28	33	33	atazanavir	CYP3A	PA10251	1574	0.888
NULL	J_Cell_Biol_1988_Feb_1_106(2)_415-422.nxml.txt.nlp	2448314	SENT9	12	12	28	28	heparin	SMC	PA449855	54808	0.888
NULL	J_Adv_Pract_Oncol_2012_Nov_1_Nov-Dec_3(6)_391-394.nxml.txt.nlp	25031970	SENT68	13	13	2	2	pertuzumab	HER2		2064	0.888
NULL	Oncoimmunology_2013_Jan_1_2(1)_e22246.nxml.txt.nlp	23482454	SENT17	15	15	32	32	cyclophosphamide	GM-CSF	PA449165	1437	0.888
NULL	Oncol_Rep_2014_Mar_14_31(3)_1035-1042.nxml.txt.nlp	24424445	SENT58	31	31	2	2	etoposide	CD133	PA449552	8842	0.888
NULL	J_Cell_Biol_1998_Jan_26_140(2)_335-345.nxml.txt.nlp	9442109	SENT207	4	4	7	7	chloroquine	NHE	PA448948	285335	0.888
NULL	J_Int_AIDS_Soc_2012_Oct_22_15(Suppl_3)_18438.nxml.txt.nlp	NULL	SENT350	21	21	3	3	glimepiride	CD4	PA449761	920	0.888
NULL	Br_J_Cancer_2013_Dec_10_109(12)_2954-2958.nxml.txt.nlp	24231949	SENT65	5	5	19	19	nutlin-3	p53		7157	0.888
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Aug_27_67(Pt_9)_o2453.nxml.txt.nlp	22059021	SENT47	23	23	17	17	ethanol	mol	PA448073	90527	0.888
NULL	Br_J_Cancer_2013_May_14_108(9)_1862-1869.nxml.txt.nlp	23579219	SENT25	7	7	10	10	cetuximab	ANXA11	PA10040	311	0.888
NULL	Nat_Med_2013_Dec_10_19(12)_10_1038_nm_3385.nxml.txt.nlp	24216752	SENT114	19	19	22	22	thrombin	PAR1	PA451674	79581;2149	0.888
NULL	Mol_Cancer_2009_Aug_25_8_66.nxml.txt.nlp	19706164	SENT159	31	31	11	11	celecoxib	LC3	PA448871	84557	0.888
NULL	Case_Rep_Rheumatol_2012_Dec_24_2012_270315.nxml.txt.nlp	23424706	SENT86	15	15	7	7	tocilizumab	IL-6	PA165292659	3569	0.888
NULL	Eur_J_Clin_Pharmacol_2012_Jan_8_68(1)_29-37.nxml.txt.nlp	21739267	SENT187	10	10	4	4	citalopram	CYP1A2	PA449015	1544	0.888
NULL	J_Biomed_Biotechnol_2010_Mar_3_2010_289360.nxml.txt.nlp	20204129	SENT161	9	9	22	22	triamcinolone	MMP9	PA451749	4318	0.888
NULL	Cell_Cycle_2013_Sep_15_12(18)_3013-3024.nxml.txt.nlp	23974104	SENT157	44	44	19	19	doxorubicin	CD44	PA449412	960	0.888
NULL	Diabetes_Care_2010_Jul_31_33(7)_1607-1609.nxml.txt.nlp	20357375	SENT53	6	6	11	11	sitagliptin	CD34	PA164748978	947	0.888
NULL	Cancer_Res_Treat_2012_Sep_30_44(3)_195-201.nxml.txt.nlp	23091446	SENT99	10	10	22	22	irinotecan	MKP-1	PA450085	1843	0.888
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2751-2762.nxml.txt.nlp	24169358	SENT13	0	0	7	7	fulvestrant	GPER	PA164747170	2852	0.888
NULL	Arthritis_Res_Ther_2006_Jul_3_8(4)_216.nxml.txt.nlp	16879719	SENT107	37	37	7	7	sulfasalazine	ACR	PA451547	49	0.888
NULL	J_Obes_2010_Oct_31_2010_892081.nxml.txt.nlp	21052532	SENT85	36	36	20	20	glucose	adiponectin	PA449773	9370	0.888
NULL	Semin_Immunopathol_2013_Jan_26_35(1)_39-52.nxml.txt.nlp	22829332	SENT197	5	5	18	18	vinblastine	CHOP	PA451877	1649	0.888
NULL	Breast_Cancer_Res_2012_May_23_14(3)_R83.nxml.txt.nlp	22621334	SENT184	13	13	5	5	trastuzumab	HER2	PA451743	2064	0.888
NULL	Ther_Clin_Risk_Manag_2006_Jun_2(2)_187-192.nxml.txt.nlp	18360592	SENT49	40	40	30	30	fluoxetine	5-HT2A	PA449673	3356	0.888
NULL	Inflammation_2014_Apr_6_37(5)_1476-1485.nxml.txt.nlp	24706026	SENT2	5	5	22	22	curcumin	GATA3	PA151958596	2625	0.888
NULL	Cells_2013_Jul_18_2(3)_545-573.nxml.txt.nlp	24709797	SENT285	7	7	9	9	decitabine	DAC	PA164749631	13	0.888
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2014_Sep_27_70(Pt_10)_2740-2753.nxml.txt.nlp	25286857	SENT9	25	25	9	9	bsi-201	TNKS2		80351	0.888
NULL	J_Cell_Biol_1998_Jan_26_140(2)_315-323.nxml.txt.nlp	9442107	SENT134	20	20	11	11	calcein	CD4	PA132595336	920	0.888
NULL	Anal_Bioanal_Chem_2012_Feb_16_402(4)_1611-1623.nxml.txt.nlp	22173207	SENT209	12	12	0	0	oseltamivir	SRM	PA450721	6723;6725	0.888
NULL	Clin_Med_Insights_Cardiol_2010_Dec_1_4_117-128.nxml.txt.nlp	21151850	SENT53	7	7	16	16	clopidogrel	ADP	PA449053	23038	0.888
NULL	Biol_Proced_Online_2003_Oct_24_5_211-221.nxml.txt.nlp	14615818	SENT328	19	19	4	4	procainamide	CD4	PA451108	920	0.888
NULL	Clin_Interv_Aging_2009_May_14_4_197-205.nxml.txt.nlp	19503782	SENT291	13	13	29	29	daunorubicin	MDR1	PA449212	5243	0.888
NULL	Curr_Neuropharmacol_2013_Jan_11(1)_114-127.nxml.txt.nlp	23814544	SENT159	9	9	5	5	tariquidar	P-gp		5243	0.888
NULL	J_Thorac_Oncol_2015_Jan_29_10(1)_156-163.nxml.txt.nlp	25247337	SENT295	6	6	16	16	cisplatin	EGFR	PA449014	1956	0.888
NULL	Clin_Med_Insights_Cardiol_2010_Dec_1_4_117-128.nxml.txt.nlp	21151850	SENT266	13	13	2	2	ticagrelor	CYP2C19	PA165374673	1557	0.888
NULL	Scientifica_(Cairo)_2014_Aug_19_2014_901586.nxml.txt.nlp	25215263	SENT101	10	10	5	5	clarithromycin	CYP3A4	PA449028	1576	0.888
NULL	Br_J_Cancer_2013_Feb_19_108(3)_570-578.nxml.txt.nlp	23299527	SENT69	24	24	11	11	phenol	CO2	PA450913	4513	0.888
NULL	Cancer_Microenviron_2008_Dec_19_1(1)_85-91.nxml.txt.nlp	19308687	SENT123	9	9	4	4	collagenase	EGF	PA449107	1950	0.888
NULL	Oncogenesis_2012_Apr_2_1(4)_e5.nxml.txt.nlp	23552603	SENT235	3	3	16	16	celecoxib	cIAP1	PA448871	329	0.888
NULL	Biologics_2012_Apr_11_6_83-87.nxml.txt.nlp	22532776	SENT41	10	10	24	24	fluorescein	CD56	PA164746009	4684	0.888
NULL	Arthritis_Res_2000_Nov_15_1(Suppl_1)_S47.nxml.txt.nlp	NULL	SENT5	15	15	30	30	etanercept	ACR	PA449515	49	0.888
NULL	Acta_Pharmacol_Sin_2010_Jul_28_31(7)_867-873.nxml.txt.nlp	20581857	SENT215	27	27	13	13	docetaxel	PDCD4	PA449383	27250	0.888
NULL	EMBO_Mol_Med_2012_Sep_7_4(9)_896-909.nxml.txt.nlp	22887866	SENT281	2	2	17	17	metformin	c-Myc	PA450395	4609	0.888
NULL	Mol_Immunol_2009_Apr_46(7)_1561-1567.nxml.txt.nlp	19200600	SENT66	9	9	3	3	papain	HC1	PA450778	342358	0.888
NULL	Br_J_Cancer_2012_Oct_9_107(8)_1277-1285.nxml.txt.nlp	22990652	SENT164	21	21	23	23	axitinib	CYP2C8	PA164924493	1558	0.888
NULL	J_Immunol_Res_2014_May_12_2014_897249.nxml.txt.nlp	24901013	SENT259	27	27	6	6	natalizumab	PTEN	PA164747191	5728	0.888
NULL	Indian_J_Psychiatry_2007_Oct-Dec_49(4)_271-276.nxml.txt.nlp	20680140	SENT67	24	24	7	7	risperidone	spatial	PA451257	219793	0.888
NULL	Cancers_(Basel)_2013_Apr_2_5(2)_320-333.nxml.txt.nlp	24216979	SENT131	15	15	2	2	imatinib	HIF1	PA10804	3091	0.888
NULL	Crit_Care_2011_Aug_11_15(4)_226.nxml.txt.nlp	21892977	SENT30	0	0	15	15	vasopressin	ACTH	PA451858	5443	0.888
NULL	Front_Genet_2014_Jun_2_5_162.nxml.txt.nlp	24917882	SENT997	11	11	0	0	cetuximab	KRAS	PA10040	3845	0.888
NULL	Curr_Mol_Med_2014_Jun_14(5)_603-615.nxml.txt.nlp	24894176	SENT86	5	5	18	18	doxorubicin	BI-1	PA449412	7009	0.888
NULL	Pharmaceuticals_(Basel)_2011_Sep_1_4(9)_1196-1215.nxml.txt.nlp	NULL	SENT170	35	35	38	38	timolol	ADRB1	PA451690	153	0.888
NULL	Mol_Cancer_2010_Mar_2_9_46.nxml.txt.nlp	20196838	SENT33	3	3	18	18	irinotecan	MDR1	PA450085	5243	0.888
NULL	J_Cell_Mol_Med_2014_Oct_11_18(10)_2031-2043.nxml.txt.nlp	25109475	SENT39	12	12	43	43	valsartan	AMPK	PA451848	5563	0.888
NULL	Oncoimmunology_2013_Sep_1_2(9)_e25595.nxml.txt.nlp	24319634	SENT90	33	33	22	22	doxorubicin	TLR7	PA449412	51284	0.888
NULL	Br_J_Cancer_1996_Jul_74(2)_187-193.nxml.txt.nlp	8688320	SENT15	19	19	6	6	daunorubicin	P-gp	PA449212	5243	0.888
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT227	5	5	8	8	atorvastatin	RANKL	PA448500	8600	0.888
NULL	Indian_J_Ophthalmol_2011_Mar-Apr_59(2)_137-141.nxml.txt.nlp	21350283	SENT49	27	27	30	30	cyanocobalamin	B12	PA451892	7126;4709	0.888
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT328	12	12	40	40	risperidone	PRL	PA451257	5617	0.888
NULL	Mediators_Inflamm_2001_Jun_10(3)_109-115.nxml.txt.nlp	11545247	SENT0	24	24	13	13	risperidone	TNF-alpha	PA451257	7124	0.888
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT118	16	16	40	40	sulindac	NAC	PA451565	22861	0.888
NULL	J_Carcinog_2011_Nov_30_10_29.nxml.txt.nlp	22190871	SENT163	35	35	16	16	lapatinib	AKT	PA152241907	207	0.888
NULL	Mol_Biol_Cell_2014_Mar_15_25(6)_811-827.nxml.txt.nlp	24430873	SENT316	35	35	30	30	paraformaldehyde	FMNL2	PA450790	114793	0.888
NULL	Mol_Cancer_2008_Mar_6_7_24.nxml.txt.nlp	18325101	SENT155	23	23	5	5	cisplatin	BRCA1	PA449014	672	0.888
NULL	Breast_Cancer_Res_Treat_2014_Jan_30_144(1)_133-142.nxml.txt.nlp	24477976	SENT228	8	8	14	14	olaparib	BRCA2		675	0.888
NULL	Mol_Cancer_2007_Sep_18_6_56.nxml.txt.nlp	17877814	SENT99	6	6	3	3	erlotinib	EGFR	PA134687924	1956	0.888
NULL	Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_1029-1037.nxml.txt.nlp	25049660	SENT233	26	26	3	3	l-cysteine	MC1R	PA449173	4157	0.888
NULL	Nat_Commun_2014_5_3128.nxml.txt.nlp	24451681	SENT37	23	23	18	18	methotrexate	DHFR	PA450428	1719	0.888
NULL	Cancer_Manag_Res_2013_Jun_11_5_103-115.nxml.txt.nlp	23807861	SENT63	19	19	30	30	bevacizumab	VEGF-A	PA130232992	7422	0.888
NULL	Chemother_Res_Pract_2012_Dec_20_2012_743193.nxml.txt.nlp	23320171	SENT119	5	5	12	12	letrozole	HER2	PA450196	2064	0.888
NULL	Breast_Cancer_Res_2014_May_30_16(3)_R55.nxml.txt.nlp	24886669	SENT222	21	21	9	9	doxorubicin	survivin	PA449412	332	0.888
NULL	Oncotarget_2012_Nov_29_4(1)_29-34.nxml.txt.nlp	23237847	SENT117	10	10	25	25	phenol	AKT1	PA450913	207	0.888
NULL	Mol_Cancer_2010_Mar_2_9_47.nxml.txt.nlp	20196847	SENT80	3	3	7	7	paclitaxel	SFN	PA450761	25996;2810	0.888
NULL	Target_Oncol_2013_Mar_30_8(1)_27-33.nxml.txt.nlp	23361373	SENT34	4	4	10	10	gefitinib	EGFR	PA131301952	1956	0.888
NULL	Oxid_Med_Cell_Longev_2013_Nov_28_2013_568093.nxml.txt.nlp	24379901	SENT52	8	8	41	41	resveratrol	SIRT1		23411	0.888
NULL	Front_Synaptic_Neurosci_2014_Sep_25_6_21.nxml.txt.nlp	25309421	SENT78	24	24	7	7	choline	HDB	PA448976	26512	0.888
NULL	Hum_Genomics_2008_Sep_1_3(1)_7-16.nxml.txt.nlp	19129086	SENT35	23	23	10	10	pravastatin	SLCO1B1	PA451089	10599	0.888
NULL	EMBO_Mol_Med_2012_Jun_13_4(6)_515-527.nxml.txt.nlp	22416035	SENT150	16	16	21	21	olaparib	p53		7157	0.888
NULL	Breast_Cancer_Res_2010_Jun_28_12(3)_R43.nxml.txt.nlp	20579400	SENT102	36	36	11	11	doxorubicin	MTS	PA449412	1678	0.888
NULL	Oncol_Rep_2013_Sep_1_30(3)_1045-1052.nxml.txt.nlp	23817662	SENT148	31	31	14	14	gefitinib	EGFR	PA131301952	1956	0.888
NULL	Acta_Pharmacol_Sin_2012_May_4_33(5)_710-716.nxml.txt.nlp	22555373	SENT210	4	4	28	28	phenylbutazone	DOM	PA450932	6663	0.888
NULL	Br_J_Cancer_2012_Nov_20_107(11)_1844-1852.nxml.txt.nlp	23169337	SENT294	5	5	22	22	bortezomib	AKT	PA10252	207	0.888
NULL	Indian_J_Pharm_Sci_2014_Mar-Apr_76(2)_157-163.nxml.txt.nlp	24843189	SENT45	20	20	34	34	carbamazepine	ANOVA	PA448785	4858	0.888
NULL	Int_J_Breast_Cancer_2011_Feb_24_2011_967419.nxml.txt.nlp	22332018	SENT142	34	34	19	19	topotecan	p53	PA451729	7157	0.888
NULL	Oncogenesis_2012_Apr_2_1(4)_e5.nxml.txt.nlp	23552603	SENT84	3	3	19	19	ns-398	IL-6		3569	0.888
NULL	Case_Rep_Oncol_2013_Jan_30_6(1)_78-83.nxml.txt.nlp	23467479	SENT31	20	20	4	4	heparin	IL-2	PA449855	3558	0.888
NULL	Indian_J_Pharmacol_2014_Mar-Apr_46(2)_211-215.nxml.txt.nlp	24741196	SENT98	2	2	44	44	carbamazepine	NAC	PA448785	22861	0.888
NULL	Cardiol_Res_Pract_2011_Aug_15_2011_156146.nxml.txt.nlp	21876822	SENT33	17	17	39	39	glibenclamide	KIR	PA449782	2669	0.888
NULL	Nat_Med_2014_Jul_8_20(7)_764-768.nxml.txt.nlp	24908571	SENT168	28	28	13	13	heparin	EGF	PA449855	1950	0.888
NULL	J_Cancer_2013_Aug_28_4(7)_585-596.nxml.txt.nlp	24069069	SENT111	19	19	9	9	verteporfin	p53	PA451871	7157	0.888
NULL	Front_Oncol_2014_May_14_4_106.nxml.txt.nlp	24860786	SENT269	42	42	30	30	tamoxifen	HRPAP20	PA451581	29078	0.888
NULL	Drug_Des_Devel_Ther_2014_Oct_6_8_1723-1731.nxml.txt.nlp	25336916	SENT134	33	33	21	21	valsartan	CLCR	PA451848	11330	0.888
NULL	Clin_Dev_Immunol_2013_May_22_2013_701305.nxml.txt.nlp	23762095	SENT149	13	13	29	29	vinblastine	BCL2A1	PA451877	597	0.888
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT373	24	24	9	9	pp2	TFF3		7033	0.888
NULL	Nucleic_Acids_Res_2005_Jun_9_33(10)_3323-3330.nxml.txt.nlp	15947132	SENT152	22	22	10	10	cisplatin	MSH2	PA449014	4436	0.888
NULL	J_Thorac_Oncol_2014_Apr_21_9(4)_483-487.nxml.txt.nlp	24736070	SENT155	17	17	9	9	gefitinib	EGFR	PA131301952	1956	0.888
NULL	Acta_Pharmacol_Sin_2013_Jun_20_34(6)_732-740.nxml.txt.nlp	23685952	SENT169	18	18	3	3	paclitaxel	P-gp	PA450761	5243	0.888
NULL	Open_Biochem_J_2011_Sep_23_5_45-51.nxml.txt.nlp	21966325	SENT200	14	14	5	5	diclofenac	CHOP	PA449293	1649	0.888
NULL	Adv_Hematol_2012_Jan_18_2012_195484.nxml.txt.nlp	22312366	SENT22	3	3	30	30	rituximab	CHOP	PA451261	1649	0.888
NULL	Nat_Commun_2013_Apr_9_4_1684.nxml.txt.nlp	23575688	SENT132	8	8	18	18	forskolin	CYLD	PA146096022	1540	0.888
NULL	Br_J_Cancer_2011_Jul_26_105(3)_420-427.nxml.txt.nlp	21730982	SENT211	23	23	11	11	gefitinib	EGFR	PA131301952	1956	0.888
NULL	Diagn_Pathol_2006_Aug_15_1_19.nxml.txt.nlp	16911776	SENT186	46	46	1	1	erlotinib	EGFR	PA134687924	1956	0.888
NULL	Environ_Health_Perspect_1985_Sep_61_111-121.nxml.txt.nlp	3905370	SENT4	22	22	6	6	estradiol	DES	PA449503	1674	0.888
NULL	Int_J_Mol_Sci_2014_Sep_25_15(9)_17065-17076.nxml.txt.nlp	25257528	SENT6	14	14	30	30	decitabine	SMG1	PA164749631	23049	0.888
NULL	Cell_Death_Differ_2010_Oct_30_17(10)_1655-1664.nxml.txt.nlp	20431598	SENT61	36	36	7	7	etoposide	CD4	PA449552	920	0.888
NULL	Cancer_Med_2014_Oct_2_3(5)_1385-1395.nxml.txt.nlp	24890702	SENT147	9	9	5	5	panitumumab	KRAS	PA162373091	3845	0.888
NULL	Br_J_Pharmacol_2008_Nov_11_155(6)_896-905.nxml.txt.nlp	18695641	SENT134	11	11	46	46	genistein	CTX	PA165109660	1593	0.888
NULL	J_Cancer_2013_Jan_11_4(2)_117-132.nxml.txt.nlp	23386910	SENT227	8	8	34	34	trastuzumab	PI3K	PA451743	5290	0.888
NULL	Diabetes_2009_Jan_58(1)_174-184.nxml.txt.nlp	18984736	SENT11	14	14	25	25	tranilast	TRPV2	PA131890628	51393	0.888
NULL	Int_J_Alzheimers_Dis_2012_Feb_15_2012_381974.nxml.txt.nlp	22506133	SENT126	24	24	30	30	l-glutamine	B27	PA10090	56246	0.888
NULL	Eur_J_Histochem_2011_Dec_2_55(4)_e41.nxml.txt.nlp	22297447	SENT87	20	20	36	36	ethanol	LSM5	PA448073	23658	0.888
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1153-1159.nxml.txt.nlp	22353811	SENT123	36	36	13	13	thalidomide	IL-8	PA451644	3576	0.888
NULL	Mol_Med_Rep_2015_Jan_16_11(1)_91-98.nxml.txt.nlp	25322694	SENT103	20	20	13	13	cisplatin	LC3	PA449014	84557	0.888
NULL	Cancer_Cell_2015_Jan_12_27(1)_85-96.nxml.txt.nlp	25500121	SENT30	18	18	7	7	vemurafenib	BRAF	PA165946873	673	0.888
NULL	Biomed_Imaging_Interv_J_2008_Jul_1_4(3)_e38.nxml.txt.nlp	21611004	SENT147	25	25	21	21	anastrozole	aromatase	PA448432	1588	0.888
NULL	Oncotarget_2013_Jul_7_4(7)_1065-1074.nxml.txt.nlp	23867252	SENT48	20	20	7	7	trypsin	Hsp90	PA451806	3320	0.888
NULL	Exp_Ther_Med_2013_Jan_22_5(1)_247-252.nxml.txt.nlp	23251277	SENT91	15	15	5	5	alendronate	GAPDH	PA448082	2597	0.888
NULL	J_Cell_Mol_Med_2014_Dec_7_18(12)_2536-2552.nxml.txt.nlp	25287328	SENT326	35	35	12	12	tamoxifen	PKD1	PA451581	5310	0.888
NULL	Int_J_Gen_Med_2012_Jun_18_5_535-540.nxml.txt.nlp	22807641	SENT17	6	6	20	20	pitavastatin	adiponectin	PA142650384	9370	0.888
NULL	Scientifica_(Cairo)_2012_Nov_25_2012_473829.nxml.txt.nlp	24278698	SENT307	0	0	5	5	cimetidine	OCT2	PA449001	6582;5452	0.888
NULL	Eur_J_Clin_Pharmacol_2013_Mar_11_69(3)_327-339.nxml.txt.nlp	22782539	SENT280	22	22	3	3	clopidogrel	CYP3A4	PA449053	1576	0.888
NULL	J_Mol_Med_(Berl)_2014_May_10_92(7)_709-722.nxml.txt.nlp	24811491	SENT80	29	29	0	0	panitumumab	KRAS	PA162373091	3845	0.888
NULL	Brain_Behav_2012_Jan_2(1)_22-31.nxml.txt.nlp	22574271	SENT91	1	1	9	9	ethanol	ANOVA	PA448073	4858	0.888
NULL	Trials_2012_Aug_3_13_130.nxml.txt.nlp	22862827	SENT173	4	4	1	1	aprepitant	NK1	PA164747039	11126	0.888
NULL	J_Clin_Biochem_Nutr_2010_Mar_27_46(2)_126-134.nxml.txt.nlp	20216945	SENT42	20	20	13	13	taurine	NAC	PA451590	22861	0.888
NULL	Curr_Neuropharmacol_2010_Dec_8(4)_409-421.nxml.txt.nlp	21629447	SENT246	2	2	0	0	hydrocortisone	ACTH	PA449905	5443	0.888
NULL	Oncotarget_2013_Nov_24_4(12)_2186-2207.nxml.txt.nlp	24327604	SENT238	19	19	2	2	melphalan	B7-H1	PA450354	29126	0.888
NULL	Biologics_2010_Aug_9_4_173-185.nxml.txt.nlp	20714355	SENT3	0	0	7	7	cetuximab	EGFR	PA10040	1956	0.888
NULL	Acta_Pharmacol_Sin_2009_Sep_24_30(9)_1262-1275.nxml.txt.nlp	19701231	SENT226	39	39	27	27	lovastatin	RTN3	PA450272	10313	0.888
NULL	Cancer_Cell_Int_2014_Jun_13_14_51.nxml.txt.nlp	24959102	SENT11	9	9	6	6	celecoxib	5-LOX	PA448871	240	0.888
NULL	Curr_Oncol_2010_Feb_17(1)_81-86.nxml.txt.nlp	20179808	SENT116	16	16	12	12	paroxetine	CYP2D6	PA450801	1565	0.888
NULL	Theranostics_2013_Jan_15_3(1)_47-75.nxml.txt.nlp	23382786	SENT89	36	36	3	3	bleomycin	CXCR4	PA448645	7852	0.888
NULL	Oncol_Lett_2014_Nov_12_8(5)_2203-2208.nxml.txt.nlp	25295109	SENT176	27	27	7	7	celecoxib	GLI1	PA448871	2735	0.888
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jan_18_68(Pt_2)_o446.nxml.txt.nlp	22347057	SENT4	0	0	13	13	gliclazide	mol	PA10892	90527	0.888
NULL	Crit_Care_2008_Nov_12_12(6)_235.nxml.txt.nlp	19040780	SENT177	25	25	13	13	nifedipine	CYP3A4	PA450631	1576	0.888
NULL	Int_J_Endocrinol_Metab_2013_Dec_21_Winter_11(1)_57-61.nxml.txt.nlp	23853622	SENT31	8	8	2	2	fluphenazine	FGA	PA449676	2243	0.888
NULL	J_Thromb_Thrombolysis_2012_Feb_20_33(2)_143-153.nxml.txt.nlp	22183178	SENT66	8	8	17	17	cangrelor	P2Y12	PA165945763	64805	0.888
NULL	Arthritis_Res_Ther_2011_Jul_28_13(4)_235.nxml.txt.nlp	21861862	SENT54	0	0	6	6	denosumab	RANKL	PA166048634	8600	0.888
NULL	Oncol_Lett_2014_Jun_8_7(6)_1903-1910.nxml.txt.nlp	24932256	SENT161	8	8	26	26	cisplatin	Bcl-2	PA449014	596	0.888
NULL	Cardiovasc_Psychiatry_Neurol_2013_Jan_15_2013_530356.nxml.txt.nlp	23401746	SENT126	9	9	4	4	natalizumab	IFN	PA164747191	3439	0.888
NULL	Breast_Cancer_Res_2004_Oct_6_6(6)_269-274.nxml.txt.nlp	15535858	SENT132	12	12	9	9	tamoxifen	aromatase	PA451581	1588	0.888
NULL	Oncol_Lett_2013_Dec_4_6(6)_1665-1672.nxml.txt.nlp	24273604	SENT142	7	7	10	10	chloroquine	TLR9	PA448948	54106	0.888
NULL	Oncogenesis_2012_Apr_2_1(4)_e5.nxml.txt.nlp	23552603	SENT234	20	20	34	34	celecoxib	BAX	PA448871	581	0.888
NULL	Chem_Rev_2014_Jun_11_114(11)_5753-5774.nxml.txt.nlp	24758331	SENT121	22	22	5	5	geldanamycin	P-gp	PA152031327	5243	0.888
NULL	DNA_Res_2011_Dec_6_18(6)_423-434.nxml.txt.nlp	21900213	SENT218	41	41	35	35	galactose	GAL	PA449725	51083	0.888
NULL	J_Adv_Pharm_Technol_Res_2010_Jul-Sep_1(3)_320-325.nxml.txt.nlp	22247864	SENT32	29	29	7	7	ethanol	mol	PA448073	90527	0.888
NULL	Int_J_Mol_Sci_2012_Feb_10_13(2)_1886-1918.nxml.txt.nlp	22408430	SENT240	5	5	16	16	sorafenib	VEGFR	PA7000	3791	0.888
NULL	Diabetes_Obes_Metab_2012_Dec_19_14(12)_1097-1103.nxml.txt.nlp	22734440	SENT162	7	7	10	10	exenatide	GLP-1	PA164749238	100125288	0.888
NULL	J_Biomed_Biotechnol_2011_Dec_6_2011_856985.nxml.txt.nlp	21188173	SENT263	21	21	23	23	tamoxifen	aromatase	PA451581	1588	0.888
NULL	Br_J_Haematol_2008_Jun_141(5)_659-671.nxml.txt.nlp	18410446	SENT74	7	7	20	20	cerulenin	Apo2	PA164764551	8797	0.888
NULL	Br_J_Cancer_2011_Jan_4_104(1)_91-100.nxml.txt.nlp	21139584	SENT65	11	11	25	25	fluorescein	San	PA164746009	80218	0.888
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Jul_31_64(Pt_8)_o1626.nxml.txt.nlp	21203316	SENT56	27	27	14	14	ethanol	mol	PA448073	90527	0.888
NULL	Ther_Clin_Risk_Manag_2006_Dec_2(4)_435-445.nxml.txt.nlp	18360654	SENT101	21	21	13	13	erlotinib	CA4	PA134687924	762	0.888
NULL	Arch_Med_Sci_2013_Oct_31_9(5)_936-943.nxml.txt.nlp	24273582	SENT103	19	19	13	13	nateglinide	GLP-1	PA450600	100125288	0.888
NULL	Diabetes_2011_Jun_21_60(6)_1770-1778.nxml.txt.nlp	21562078	SENT298	4	4	2	2	metformin	AMPK	PA450395	5563	0.888
NULL	Oxid_Med_Cell_Longev_2013_Dec_5_2013_963520.nxml.txt.nlp	24381719	SENT214	8	8	10	10	telmisartan	BDNF	PA451605	627	0.888
NULL	Arthritis_Res_Ther_2004_Feb_24_6(Suppl_1)_24.nxml.txt.nlp	NULL	SENT13	17	17	6	6	etanercept	OPG	PA449515	690	0.888
NULL	J_Med_Case_Reports_2011_Aug_16_5_386.nxml.txt.nlp	21846347	SENT97	46	46	41	41	octreotide	SSTR1	PA450678	6751	0.888
NULL	Br_J_Cancer_2012_May_22_106(11)_1722-1727.nxml.txt.nlp	22568966	SENT29	14	14	9	9	panitumumab	EGFR	PA162373091	1956	0.888
NULL	Br_J_Haematol_2011_Jun_153(5)_634-643.nxml.txt.nlp	21477209	SENT160	12	12	3	3	etoposide	TP53	PA449552	7157	0.888
NULL	Br_J_Cancer_2013_Jul_23_109(2)_342-350.nxml.txt.nlp	23807172	SENT183	5	5	21	21	sorafenib	Mcl-1	PA7000	4170	0.888
NULL	Biomed_Res_Int_2014_Apr_28_2014_549742.nxml.txt.nlp	24877113	SENT137	20	20	26	26	bevacizumab	BMP4	PA130232992	652	0.888
NULL	Front_Physiol_2011_Jun_14_2_26.nxml.txt.nlp	21716655	SENT224	1	1	28	28	lipase	NEFA	PA450239	4925	0.888
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT185	11	11	15	15	cisplatin	p53	PA449014	7157	0.888
NULL	Cancer_Cell_Int_2005_Jun_1_5_18.nxml.txt.nlp	15929791	SENT48	29	29	9	9	bortezomib	p53	PA10252	7157	0.888
NULL	Cell_Death_Dis_2014_Mar_13_5(3)_e1113.nxml.txt.nlp	24625972	SENT87	35	35	15	15	bleomycin	BI-1	PA448645	7009	0.888
NULL	Blood_Cancer_J_2014_Feb_7_4(2)_e180.nxml.txt.nlp	24510029	SENT22	43	43	6	6	rituximab	CD19	PA451261	930	0.888
NULL	Breast_Cancer_Res_2005_Jul_20_7(5)_205-211.nxml.txt.nlp	16168139	SENT123	11	11	15	15	gefitinib	HER2	PA131301952	2064	0.888
NULL	Breast_Cancer_Res_Treat_2013_Jan_13_137(2)_471-482.nxml.txt.nlp	23239151	SENT206	10	10	2	2	trastuzumab	HER2	PA451743	2064	0.888
NULL	Br_J_Cancer_2014_Aug_12_111(4)_640-645.nxml.txt.nlp	24642617	SENT114	7	7	24	24	vemurafenib	BRAF	PA165946873	673	0.888
NULL	Cell_Death_Dis_2012_Jun_7_3(6)_e319.nxml.txt.nlp	22673193	SENT7	12	12	4	4	cisplatin	Mcl-1	PA449014	4170	0.888
NULL	Biol_Open_2012_Oct_4_1(12)_1215-1225.nxml.txt.nlp	23259056	SENT190	6	6	14	14	l-glutamine	S6K1	PA10090	6198	0.888
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Nov_7_65(Pt_12)_o3013.nxml.txt.nlp	21578750	SENT58	24	24	6	6	ethanol	mol	PA448073	90527	0.888
NULL	Biomed_Res_Int_2014_May_13_2014_872139.nxml.txt.nlp	24963489	SENT67	14	14	18	18	paclitaxel	TLR4	PA450761	7099	0.888
NULL	Arthritis_Res_Ther_2012_Sep_24_14(5)_R200.nxml.txt.nlp	23006144	SENT132	8	8	1	1	alefacept	IL-20	PA164748040	27190;50604	0.888
NULL	J_Immune_Based_Ther_Vaccines_2005_May_18_3_3.nxml.txt.nlp	15904525	SENT72	35	35	18	18	saquinavir	GM-CSF	PA451305	1437	0.888
NULL	Neural_Regen_Res_2014_Mar_15_9(6)_622-629.nxml.txt.nlp	25206865	SENT68	26	26	4	4	vasopressin	p38	PA451858	10598;1432;7965	0.888
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1196-1204.nxml.txt.nlp	22315058	SENT181	25	25	2	2	gefitinib	EGF	PA131301952	1950	0.888
NULL	Virol_J_2010_Oct_20_7_279.nxml.txt.nlp	20961433	SENT382	10	10	4	4	trypsin	VLP	PA451806	391104	0.888
NULL	Breast_Cancer_Res_2012_Jun_13_14(3)_R93.nxml.txt.nlp	22694844	SENT27	1	1	8	8	trastuzumab	HER2	PA451743	2064	0.888
NULL	Case_Rep_Oncol_2014_Jun_18_7(2)_393-400.nxml.txt.nlp	25076890	SENT37	18	18	13	13	sorafenib	EGFR	PA7000	1956	0.888
NULL	EMBO_Mol_Med_2012_Dec_15_4(12)_1276-1293.nxml.txt.nlp	23065753	SENT399	20	20	13	13	cisplatin	DPI	PA449014	1832	0.888
NULL	Nat_Commun_2013_Sep_17_4_2464.nxml.txt.nlp	24043118	SENT121	33	33	16	16	estradiol	EGR2	PA449503	1959	0.888
NULL	Anesth_Pain_Med_2013_Dec_27_4(1)_e11906.nxml.txt.nlp	24660144	SENT37	37	37	12	12	methylprednisolone	VIII	PA450466	1351	0.888
NULL	J_Cell_Mol_Med_2014_Apr_20_18(4)_709-720.nxml.txt.nlp	24444314	SENT36	24	24	15	15	losartan	AMPK	PA450268	5563	0.888
NULL	Diabetes_Care_2010_Feb_33(2)_428-433.nxml.txt.nlp	20103558	SENT81	32	32	28	28	sitagliptin	HIP	PA164748978	6767;6159;64399;5068	0.888
NULL	Br_J_Cancer_2011_Dec_6_105(12)_1920-1926.nxml.txt.nlp	22095222	SENT78	25	25	38	38	gefitinib	EGFR	PA131301952	1956	0.888
NULL	Int_J_Mol_Sci_2012_Sep_20_13(9)_12000-12016.nxml.txt.nlp	23109896	SENT54	21	21	13	13	erlotinib	EGFR	PA134687924	1956	0.888
NULL	Ann_Med_Health_Sci_Res_2012_Jul-Dec_2(2)_191-198.nxml.txt.nlp	23439914	SENT165	7	7	1	1	verapamil	P-gp	PA451868	5243	0.888
NULL	J_Oncol_2012_Jan_26_2012_750270.nxml.txt.nlp	22363346	SENT210	5	5	20	20	gefitinib	EGFR	PA131301952	1956	0.888
NULL	Curr_Neuropharmacol_2010_Sep_8(3)_254-267.nxml.txt.nlp	21358975	SENT191	12	12	32	32	felbamate	CYP3A4	PA449590	1576	0.888
NULL	J_Org_Chem_2011_Aug_19_76(16)_6703-6714.nxml.txt.nlp	21739961	SENT168	34	34	16	16	ethanol	mol	PA448073	90527	0.888
NULL	Trials_2012_Dec_13_13_239.nxml.txt.nlp	23237631	SENT199	33	33	41	41	amiodarone	CYP2C9	PA448383	1559	0.888
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT94	5	5	26	26	curcumin	TRAIL	PA151958596	8743	0.888
NULL	Basic_Clin_Neurosci_2014_Summer_5(3)_182-190.nxml.txt.nlp	25337378	SENT124	15	15	9	9	bupropion	mol	PA448687	90527	0.888
NULL	J_Korean_Med_Sci_2013_Aug_31_28(8)_1238-1243.nxml.txt.nlp	23960454	SENT93	1	1	8	8	amiloride	ASIC3	PA448368	9311	0.888
NULL	Front_Neurosci_2012_May_30_6_77.nxml.txt.nlp	22661925	SENT183	8	8	11	11	ethanol	HEC	PA448073	10403	0.888
NULL	J_Mol_Signal_2010_May_10_5_4.nxml.txt.nlp	20459745	SENT109	14	14	8	8	cisplatin	p53	PA449014	7157	0.888
NULL	Br_J_Haematol_2007_Sep_26_138(6)_676-686.nxml.txt.nlp	17655728	SENT182	2	2	14	14	desmopressin	VIII	PA449237	1351	0.888
NULL	Int_J_Gen_Med_2013_Dec_4_6_877-895.nxml.txt.nlp	24403842	SENT58	11	11	22	22	metformin	PPG	PA450395	5552	0.888
NULL	eLife_2013_Nov_5_2_e00969.nxml.txt.nlp	24192036	SENT104	6	6	0	0	vemurafenib	BIM	PA165946873	10018	0.888
NULL	Int_J_Mol_Sci_2014_Oct_7_15(10)_17901-17919.nxml.txt.nlp	25295482	SENT68	12	12	21	21	thrombin	ADP	PA451674	23038	0.888
NULL	Indian_J_Med_Res_2013_Jan_137(1)_203-209.nxml.txt.nlp	23481074	SENT132	13	13	5	5	acenocoumarol	CYP2C18	PA452632	1562	0.888
NULL	Contemp_Oncol_(Pozn)_2013_Apr_29_17(2)_128-133.nxml.txt.nlp	23788978	SENT44	26	26	21	21	oxymorphone	CYP2D6	PA450748	1565	0.888
NULL	Diabetol_Metab_Syndr_2014_Mar_31_6_48.nxml.txt.nlp	24684803	SENT145	14	14	38	38	metformin	STEP	PA450395	84867	0.888
NULL	J_Mol_Signal_2011_May_16_6_4.nxml.txt.nlp	21575178	SENT220	41	41	37	37	arsenite	HSP27	PA452638	3315	0.888
NULL	Nucleic_Acids_Res_2011_Aug_29_39(15)_6620-6632.nxml.txt.nlp	21531700	SENT214	16	16	3	3	doxycycline	MYC	PA449415	4609	0.888
NULL	BMB_Rep_2013_Nov_46(11)_544-549.nxml.txt.nlp	24152910	SENT51	10	10	24	24	thrombin	PAR-1	PA451674	2011;2149	0.888
NULL	Case_Rep_Otolaryngol_2014_Aug_25_2014_902071.nxml.txt.nlp	25243089	SENT72	5	5	13	13	desmopressin	VWF	PA449237	7450	0.888
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Mar_29_70(Pt_4)_o497-o498.nxml.txt.nlp	24826186	SENT4	25	25	1	1	piperazine	mol	PA450977	90527	0.888
NULL	J_Hematol_Oncol_2010_Sep_9_3_31.nxml.txt.nlp	20828403	SENT49	37	37	9	9	capecitabine	HER2	PA448771	2064	0.888
NULL	Acta_Pharmacol_Sin_2013_Sep_5_34(9)_1192-1200.nxml.txt.nlp	23685957	SENT137	4	4	26	26	curcumin	AP-2	PA151958596	7020	0.888
NULL	Acta_Pharmacol_Sin_2010_Nov_18_31(11)_1447-1453.nxml.txt.nlp	20953204	SENT98	5	5	13	13	rimonabant	PI3K	PA152407999	5290	0.888
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1149.nxml.txt.nlp	24675467	SENT293	15	15	44	44	chloroquine	p62	PA448948	8878;10657;23636	0.888
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT125	6	6	28	28	atorvastatin	AKT	PA448500	207	0.888
NULL	Clin_Interv_Aging_2010_Dec_3_5_403-416.nxml.txt.nlp	21152242	SENT54	23	23	20	20	perindopril	ACE	PA450877	1636	0.888
NULL	Nucleic_Acids_Res_2014_Jan_1_42(1)_643-660.nxml.txt.nlp	24097436	SENT212	41	41	7	7	galactose	TRAMP	PA449725	8718;23471;9189	0.888
NULL	Acta_Pharmacol_Sin_2013_Sep_5_34(9)_1192-1200.nxml.txt.nlp	23685957	SENT205	25	25	16	16	curcumin	AKT	PA151958596	207	0.888
NULL	Oncotarget_2014_Nov_3_5(20)_10127-10139.nxml.txt.nlp	25333256	SENT7	4	4	1	1	vemurafenib	BRAF	PA165946873	673	0.888
NULL	Cancer_Cell_2013_Nov_11_24(5)_617-630.nxml.txt.nlp	24229709	SENT549	23	23	7	7	tamoxifen	p110	PA451581	9733	0.888
NULL	Acta_Oncol_2014_Oct_9_53(10)_1347-1355.nxml.txt.nlp	24909504	SENT118	36	36	1	1	doxorubicin	TP53	PA449412	7157	0.888
NULL	Exp_Diabetes_Res_2011_Apr_6_2011_928523.nxml.txt.nlp	21603181	SENT152	9	9	20	20	haloperidol	DRD2	PA449841	1813	0.888
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT126	17	17	32	32	glucose	PP2	PA449773	4888	0.888
NULL	Oncotarget_2014_Mar_14_5(10)_3029-3038.nxml.txt.nlp	24912489	SENT102	32	32	16	16	letrozole	aromatase	PA450196	1588	0.888
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT184	9	9	4	4	heparin	FGF1	PA449855	2246	0.888
NULL	Diabetes_Care_2009_Oct_32(10)_1753-1768.nxml.txt.nlp	19794001	SENT161	8	8	3	3	sirolimus	IL2	PA451365	3558	0.888
NULL	Clin_Med_Insights_Oncol_2012_May_16_6_205-217.nxml.txt.nlp	22654526	SENT248	10	10	17	17	pravastatin	EGFR	PA451089	1956	0.888
NULL	Oncotarget_2011_Jun_15_2(6)_518-524.nxml.txt.nlp	21680956	SENT73	10	10	18	18	pimozide	CD34	PA450965	947	0.888
NULL	Int_J_Mol_Sci_2013_Apr_26_14(5)_9111-9125.nxml.txt.nlp	23624604	SENT88	31	31	9	9	iron	MRI	PA450087	78996	0.888
NULL	Infect_Dis_Ther_2014_Dec_24_3(2)_83-102.nxml.txt.nlp	25134686	SENT21	12	12	15	15	maraviroc	CRA	PA164768835	51747;10903	0.888
NULL	Cell_Res_2010_Apr_26_20(4)_434-444.nxml.txt.nlp	20101261	SENT66	15	15	36	36	rosiglitazone	UCP1	PA451283	7350	0.888
NULL	Mol_Vis_2014_Dec_19_20_1680-1694.nxml.txt.nlp	25558172	SENT28	28	28	11	11	ranibizumab	ARMS2	PA164746012	387715	0.888
NULL	BMB_Rep_2013_Aug_46(8)_410-415.nxml.txt.nlp	23977989	SENT20	0	0	21	21	curcumin	AP-1	PA151958596	2353;3727;2354;3725	0.888
NULL	J_Gen_Physiol_2004_Aug_124(2)_125-137.nxml.txt.nlp	15277574	SENT302	7	7	34	34	glibenclamide	CFTR	PA449782	1080	0.888
NULL	Br_J_Pharmacol_2014_Sep_28_171(18)_4255-4272.nxml.txt.nlp	24846338	SENT96	33	33	40	40	pargyline	5-HT1A	PA450797	3350	0.888
NULL	Am_J_Transplant_2013_Mar_21_13(3)_760-769.nxml.txt.nlp	23279614	SENT20	39	39	2	2	tacrolimus	OPTN	PA451578	10133	0.888
NULL	Front_Mol_Neurosci_2013_Mar_21_6_5.nxml.txt.nlp	23518818	SENT211	8	8	22	22	capsaicin	TRPV1	PA448776	7442	0.888
NULL	Exp_Ther_Med_2014_Feb_25_7(2)_397-400.nxml.txt.nlp	24396413	SENT38	35	35	19	19	isoniazid	LOX	PA450112	4015	0.888
NULL	Acta_Neuropathol_2010_Nov_17_120(5)_567-584.nxml.txt.nlp	20714900	SENT383	14	14	33	33	temozolomide	EGFR	PA451609	1956	0.888
NULL	Cardiovasc_Diabetol_2007_Oct_24_6_32.nxml.txt.nlp	17958881	SENT62	3	3	16	16	glucose	ADA	PA449773	100	0.888
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT257	8	8	18	18	tacrolimus	RANKL	PA451578	8600	0.888
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT175	14	14	3	3	cisplatin	Bcl-2	PA449014	596	0.888
NULL	Breast_Cancer_Res_2012_Jun_19_14(3)_209.nxml.txt.nlp	22713170	SENT52	0	0	21	21	pertuzumab	EGFR		1956	0.888
NULL	Pharmaceuticals_(Basel)_2014_Sep_4_7(9)_913-942.nxml.txt.nlp	25192192	SENT109	21	21	8	8	resveratrol	UCP2		7351	0.888
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1018.nxml.txt.nlp	24457962	SENT70	2	2	12	12	erlotinib	EGFR	PA134687924	1956	0.888
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT94	5	5	18	18	atorvastatin	survivin	PA448500	332	0.888
NULL	Br_J_Cancer_2004_Mar_22_90(6)_1285-1292.nxml.txt.nlp	15026814	SENT15	10	10	7	7	doxorubicin	p53	PA449412	7157	0.888
NULL	BMJ_2011_Aug_4_343_d4588.nxml.txt.nlp	21816733	SENT311	13	13	16	16	clopidogrel	CYP2C19	PA449053	1557	0.888
NULL	Arthritis_Res_Ther_2007_Oct_10_9(5)_R105.nxml.txt.nlp	17927818	SENT132	12	12	27	27	pp2	PP2		4888	0.888
NULL	Breast_Cancer_Res_2011_Jan_11_13(1)_R3.nxml.txt.nlp	21223569	SENT154	14	14	19	19	etoposide	PUMA	PA449552	27113	0.888
NULL	Oncol_Rep_2012_Apr_30_27(4)_1177-1187.nxml.txt.nlp	22209971	SENT80	26	26	3	3	ethanol	ABCG2	PA448073	9429	0.888
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT40	15	15	38	38	metformin	AKT	PA450395	207	0.888
NULL	F1000Res_2014_Aug_19_3_198.nxml.txt.nlp	25400908	SENT259	8	8	2	2	tamoxifen	IMPACT	PA451581	55364	0.888
NULL	Oncotarget_2013_Nov_7_4(12)_2550-2566.nxml.txt.nlp	24334291	SENT40	14	14	11	11	dasatinib	CD38	PA162372878	952	0.888
NULL	Environ_Health_Perspect_2002_Jun_110(Suppl_3)_349-353.nxml.txt.nlp	12060828	SENT8	6	6	27	27	genistein	TPO	PA165109660	7066;7173	0.888
NULL	Clin_Epidemiol_2014_May_13_6_169-182.nxml.txt.nlp	24872723	SENT182	21	21	5	5	fluconazole	CD4	PA449653	920	0.888
NULL	Nucleic_Acids_Res_2011_Nov_18_39(20)_8881-8890.nxml.txt.nlp	21768123	SENT63	46	46	0	0	heparin	MBNL1	PA449855	4154	0.888
NULL	Hum_Mol_Genet_2013_Nov_15_22(22)_4616-4626.nxml.txt.nlp	23814041	SENT157	10	10	4	4	doxycycline	neuroserpin	PA449415	5274	0.888
NULL	Br_J_Cancer_2010_Feb_16_102(4)_658-664.nxml.txt.nlp	20104222	SENT150	11	11	8	8	sunitinib	IFN	PA162372840	3439	0.888
NULL	J_Hematol_Oncol_2011_Mar_22_4_10.nxml.txt.nlp	21418662	SENT94	10	10	17	17	omalizumab	MCAD	PA164752253	34	0.888
NULL	J_Hematol_Oncol_2013_Jul_18_6_53.nxml.txt.nlp	23866964	SENT227	8	8	13	13	temsirolimus	HDAC2	PA164746890	3066	0.888
NULL	Case_Rep_Gastrointest_Med_2014_Mar_4_2014_494098.nxml.txt.nlp	24711933	SENT48	19	19	1	1	olmesartan	DQ2	PA164742950	1861	0.888
NULL	Curr_Med_Chem_2013_Jun_20(19)_2415-2437.nxml.txt.nlp	23394552	SENT86	12	12	35	35	diclofenac	COX	PA449293	1351	0.888
NULL	Cancers_(Basel)_2010_Jul_27_2(3)_1528-1554.nxml.txt.nlp	24281171	SENT325	23	23	18	18	doxorubicin	ABCB5	PA449412	340273	0.888
NULL	Cell_Cycle_2012_Nov_1_11(21)_3983-3996.nxml.txt.nlp	22987153	SENT179	7	7	19	19	cisplatin	FANCD2	PA449014	2177	0.888
NULL	Oncogene_2014_Feb_6_33(6)_713-723.nxml.txt.nlp	23435429	SENT101	23	23	8	8	camptothecin	p65	PA153590860	5970	0.888
NULL	Emerg_Infect_Dis_2012_Aug_18(8)_1383-1385.nxml.txt.nlp	22840532	SENT21	21	21	32	32	meropenem	API	PA164764445	5345	0.888
NULL	Support_Care_Cancer_2012_Jul_27_20(7)_1353-1360.nxml.txt.nlp	22539050	SENT224	15	15	7	7	denosumab	NNT	PA166048634	23530	0.888
NULL	Int_J_Mol_Sci_2014_Oct_27_15(11)_19444-19457.nxml.txt.nlp	25350110	SENT158	10	10	2	2	isoflurane	EAAC1	PA450106	6505	0.888
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT86	30	30	6	6	imatinib	ABCG2	PA10804	9429	0.888
NULL	Cancer_Cell_Int_2010_Apr_29_10_12.nxml.txt.nlp	20429927	SENT166	16	16	2	2	bortezomib	HRI	PA10252	27102	0.888
NULL	Clin_Med_Insights_Oncol_2012_May_16_6_205-217.nxml.txt.nlp	22654526	SENT248	12	12	17	17	lovastatin	EGFR	PA450272	1956	0.888
NULL	J_Psychopharmacol_2010_Jan_24(1)_27-38.nxml.txt.nlp	19204064	SENT363	15	15	32	32	morphine	NK1	PA450550	11126	0.888
NULL	Clin_Mol_Allergy_2007_Jan_25_5_1.nxml.txt.nlp	17254346	SENT228	6	6	12	12	curcumin	IFN	PA151958596	3439	0.888
NULL	Ann_N_Y_Acad_Sci_2013_Apr_6_1281(1)_36-50.nxml.txt.nlp	23387439	SENT273	2	2	31	31	liraglutide	c-Jun	PA165958364	3725	0.888
NULL	Neuropsychopharmacology_2009_Sep_20_34(10)_2275-2284.nxml.txt.nlp	19458612	SENT166	11	11	3	3	escitalopram	5-HT1A	PA10074	3350	0.888
NULL	Curr_Neuropharmacol_2013_May_11(3)_263-275.nxml.txt.nlp	24179463	SENT131	9	9	15	15	tranylcypromine	CB1	PA451741	1268	0.888
NULL	Br_J_Cancer_2013_Sep_3_109(5)_1079-1084.nxml.txt.nlp	23928659	SENT81	28	28	5	5	docetaxel	DES	PA449383	1674	0.888
NULL	Adv_Hematol_2012_Jun_19_2012_851674.nxml.txt.nlp	22778745	SENT224	24	24	11	11	nimesulide	COX	PA137179528	1351	0.888
NULL	Breast_Cancer_Res_2005_Nov_11_7(6)_255-257.nxml.txt.nlp	16457700	SENT10	36	36	30	30	tamoxifen	aromatase	PA451581	1588	0.888
NULL	Clin_Exp_Gastroenterol_2011_Sep_14_4_213-220.nxml.txt.nlp	22016582	SENT79	12	12	3	3	esomeprazole	CYP2C19	PA10075	1557	0.888
NULL	Br_J_Cancer_2013_Jul_23_109(2)_433-443.nxml.txt.nlp	23807168	SENT37	24	24	36	36	glucose	FBS	PA449773	64319;26269	0.887
NULL	Cancer_Res_Treat_2014_Jan_15_46(1)_48-54.nxml.txt.nlp	24520223	SENT20	7	7	0	0	bevacizumab	KRAS	PA130232992	3845	0.887
NULL	Oncotarget_2013_Jul_21_4(8)_1266-1279.nxml.txt.nlp	23907540	SENT165	13	13	5	5	doxycycline	PTEN	PA449415	5728	0.887
NULL	Cancers_(Basel)_2011_Sep_28_3(4)_3740-3761.nxml.txt.nlp	24213109	SENT198	0	0	25	25	trabectedin	CCL2	PA165958349	6347	0.887
NULL	Br_J_Cancer_2009_Mar_24_100(6)_941-949.nxml.txt.nlp	19240716	SENT160	29	29	4	4	pertuzumab	EGFR		1956	0.887
NULL	Cancer_Metab_2013_Feb_4_1_7.nxml.txt.nlp	24280108	SENT182	25	25	13	13	doxycycline	DMK	PA449415	1760	0.887
NULL	Scientifica_(Cairo)_2012_Nov_25_2012_473829.nxml.txt.nlp	24278698	SENT232	8	8	5	5	cisplatin	ATP7A	PA449014	538	0.887
NULL	Mol_Cancer_2012_Jul_12_11_45.nxml.txt.nlp	22788833	SENT146	21	21	9	9	cisplatin	EGFR	PA449014	1956	0.887
NULL	Exp_Hematol_Oncol_2014_Jan_11_3_2.nxml.txt.nlp	24410791	SENT144	7	7	3	3	erlotinib	AKT	PA134687924	207	0.887
NULL	J_Vis_Exp_2011_Jun_17_(52)_2599.nxml.txt.nlp	21712797	SENT167	37	37	11	11	bromocriptine	5-HT1A	PA448671	3350	0.887
NULL	Indian_J_Endocrinol_Metab_2013_Oct_17(Suppl1)_S349-S354.nxml.txt.nlp	24251211	SENT106	1	1	7	7	lipase	adiponectin	PA450239	9370	0.887
NULL	Crit_Care_2011_Apr_20_15(2)_221.nxml.txt.nlp	21586104	SENT181	2	2	10	10	fenofibrate	adiponectin	PA449594	9370	0.887
NULL	J_Mol_Med_2009_Oct_8_87(10)_971-980.nxml.txt.nlp	19669106	SENT136	24	24	8	8	methimazole	TPO	PA450422	7066;7173	0.887
NULL	Breast_Cancer_Res_Treat_2013_Jan_8_137(2)_457-464.nxml.txt.nlp	23224144	SENT31	0	0	7	7	lapatinib	aromatase	PA152241907	1588	0.887
NULL	Nucleic_Acids_Res_2005_Aug_12_33(14)_4584-4592.nxml.txt.nlp	16100380	SENT126	10	10	27	27	paromomycin	GCN2	PA164784023	440275	0.887
NULL	Contemp_Oncol_(Pozn)_2012_Nov_20_16(5)_401-406.nxml.txt.nlp	23788917	SENT154	6	6	21	21	temsirolimus	HER2	PA164746890	2064	0.887
NULL	Acta_Pharmacol_Sin_2012_Jun_14_33(6)_832-838.nxml.txt.nlp	22580740	SENT13	6	6	13	13	doxorubicin	GEM	PA449412	2669	0.887
NULL	Breast_Cancer_Res_Treat_2013_Apr_12_138(2)_427-435.nxml.txt.nlp	23479422	SENT25	0	0	7	7	lapatinib	EGFR	PA152241907	1956	0.887
NULL	Clin_Med_Insights_Circ_Respir_Pulm_Med_2012_Jun_12_6_27-40.nxml.txt.nlp	22745565	SENT25	8	8	35	35	omalizumab	IL-5	PA164752253	3567	0.887
NULL	Oncotarget_2014_Feb_25_5(5)_1304-1314.nxml.txt.nlp	24675421	SENT32	26	26	21	21	cisplatin	RIP1	PA449014	10928;7386	0.887
NULL	Indian_J_Pharm_Sci_2013_Jul-Aug_75(4)_463-475.nxml.txt.nlp	24302802	SENT103	19	19	6	6	ethanol	mol	PA448073	90527	0.887
NULL	Oncotarget_2013_Dec_5_5(1)_49-66.nxml.txt.nlp	24393708	SENT226	3	3	26	26	imatinib	KIT	PA10804	3815	0.887
NULL	Case_Rep_Med_2010_Feb_28_2010_352417.nxml.txt.nlp	20204071	SENT55	15	15	6	6	colchicine	COPE	PA449092	11316	0.887
NULL	Leukemia_2013_Apr_14_27(4)_803-812.nxml.txt.nlp	23238589	SENT36	24	24	18	18	imatinib	IFN	PA10804	3439	0.887
NULL	Ann_Rheum_Dis_2009_Feb_68(2)_296.nxml.txt.nlp	NULL	SENT5	4	4	0	0	tocilizumab	IL-6	PA165292659	3569	0.887
NULL	Cancer_Immunol_Immunother_2012_Jul_23_61(7)_1101-1111.nxml.txt.nlp	22193989	SENT195	5	5	16	16	oxaliplatin	STAT3	PA131285527	6774	0.887
NULL	Clin_Ophthalmol_2014_Dec_30_9_33-41.nxml.txt.nlp	25565766	SENT9	0	0	6	6	mitomycin	PRK	PA450524	1263	0.887
NULL	Adv_Hematol_2010_May_16_2010_672137.nxml.txt.nlp	20490274	SENT14	29	29	18	18	mitoxantrone	AIDA	PA450526	64853	0.887
NULL	Cell_Death_Dis_2014_Mar_13_5(3)_e1113.nxml.txt.nlp	24625972	SENT351	18	18	13	13	bleomycin	BI-1	PA448645	7009	0.887
NULL	J_Gen_Physiol_2003_Jul_122(1)_45-61.nxml.txt.nlp	12835470	SENT94	1	1	5	5	capsaicin	VR1	PA448776	56664	0.887
NULL	J_Gen_Physiol_2000_Jun_1_115(6)_685-696.nxml.txt.nlp	10828243	SENT120	7	7	3	3	genistein	OLF	PA165109660	83857	0.887
NULL	Front_Endocrinol_(Lausanne)_2013_Nov_11_4_166.nxml.txt.nlp	24273531	SENT248	12	12	7	7	losartan	ANG	PA450268	283	0.887
NULL	JAKSTAT_2012_Apr_1_1(2)_55-64.nxml.txt.nlp	24058751	SENT140	1	1	26	26	flavopiridol	STAT3	PA452627	6774	0.887
NULL	Mol_Cancer_2010_Jun_7_9_139.nxml.txt.nlp	20529262	SENT4	0	0	11	11	cetuximab	EGFR	PA10040	1956	0.887
NULL	Mol_Cancer_2010_Nov_2_9_289.nxml.txt.nlp	21044322	SENT290	25	25	11	11	cisplatin	RGS17	PA449014	26575	0.887
NULL	J_Cancer_2013_Mar_15_4(3)_241-250.nxml.txt.nlp	23459666	SENT90	19	19	27	27	cetuximab	KRAS	PA10040	3845	0.887
NULL	AIDS_Res_Treat_2012_Mar_11_2012_312564.nxml.txt.nlp	22496970	SENT42	10	10	25	25	vincristine	APCA	PA451879	773	0.887
NULL	Cogn_Neurodyn_2012_Apr_13_6(2)_169-183.nxml.txt.nlp	22511913	SENT352	26	26	11	11	ketamine	MST	PA450144	55154;4357;4294	0.887
NULL	Clin_Mol_Allergy_2007_Jan_25_5_1.nxml.txt.nlp	17254346	SENT227	5	5	11	11	curcumin	STAT3	PA151958596	6774	0.887
NULL	Acta_Neuropathol_2010_Nov_17_120(5)_567-584.nxml.txt.nlp	20714900	SENT268	12	12	7	7	temozolomide	MSH6	PA451609	2956	0.887
NULL	Int_J_Endocrinol_2014_Jan_16_2014_412354.nxml.txt.nlp	24550985	SENT98	11	11	8	8	buserelin	CB1	PA10253	1268	0.887
NULL	Exp_Diabetes_Res_2011_Jun_20_2011_601047.nxml.txt.nlp	21747830	SENT88	30	30	24	24	exenatide	GLP-1	PA164749238	100125288	0.887
NULL	Arch_Osteoporos_2013_Oct_11_8(1-2)_136.nxml.txt.nlp	24113837	SENT3087	19	19	29	29	teriparatide	PTH	PA451620	5741	0.887
NULL	Acta_Pharmacol_Sin_2009_Jun_5_30(6)_702-714.nxml.txt.nlp	19498416	SENT119	0	0	12	12	galantamine	PI3K	PA449726	5290	0.887
NULL	Cancer_Res_Treat_2014_Jul_15_46(3)_234-242.nxml.txt.nlp	25038758	SENT26	17	17	8	8	paclitaxel	P-gp	PA450761	5243	0.887
NULL	Mol_Cancer_2007_Aug_21_6_53.nxml.txt.nlp	17711579	SENT15	9	9	0	0	cisplatin	NEO1	PA449014	4756	0.887
NULL	Br_J_Haematol_2014_Mar_28_164(6)_858-866.nxml.txt.nlp	24372446	SENT95	22	22	4	4	rituximab	PEX	PA451261	5251	0.887
NULL	Psychiatry_Investig_2012_Dec_12_9(4)_422-424.nxml.txt.nlp	23251210	SENT14	22	22	15	15	perphenazine	CYP2D6	PA450882	1565	0.887
NULL	Br_J_Pharmacol_2014_Jan_23_171(2)_523-535.nxml.txt.nlp	24372553	SENT220	0	0	4	4	metformin	AMPK	PA450395	5563	0.887
NULL	Int_J_Hypertens_2012_Feb_22_2012_127910.nxml.txt.nlp	22518279	SENT231	17	17	21	21	ns-398	COX		1351	0.887
NULL	Breast_Cancer_Res_2008_Dec_18_10(Suppl_4)_S26.nxml.txt.nlp	19128440	SENT14	10	10	43	43	anastrozole	ATAC	PA448432	6375	0.887
NULL	Breast_Cancer_Res_2007_Oct_26_9(5)_112.nxml.txt.nlp	17980056	SENT96	17	17	27	27	tamoxifen	HER2	PA451581	2064	0.887
NULL	Breast_Cancer_(Auckl)_2008_Mar_26_1_25-34.nxml.txt.nlp	21655370	SENT3	11	11	1	1	ethanol	GIRK1	PA448073	3760	0.887
NULL	Cell_Commun_Signal_2004_Jun_25_2_5.nxml.txt.nlp	15219238	SENT156	0	0	17	17	2-methoxyestradiol	JNK	PA134967247	5599	0.887
NULL	Mol_Imaging_Biol_2013_Apr_11_15(2)_136-147.nxml.txt.nlp	22886728	SENT81	8	8	32	32	orlistat	FDG	PA164776864	23583	0.887
NULL	J_Radiat_Res_2014_Jan_14_55(1)_113-120.nxml.txt.nlp	23772086	SENT230	21	21	10	10	sorafenib	HCC	PA7000	84668	0.887
NULL	Orphanet_J_Rare_Dis_2014_Nov_15_9(1)_161.nxml.txt.nlp	NULL	SENT206	22	22	0	0	creatine	Met	PA164778930	79811	0.887
NULL	GMS_Curr_Top_Otorhinolaryngol_Head_Neck_Surg_2004_Dec_28_3_Doc04.nxml.txt.nlp	22073046	SENT212	13	13	0	0	nedocromil	IL-4	PA450601	3565	0.887
NULL	Biomed_Res_Int_2014_Jun_26_2014_161346.nxml.txt.nlp	25054130	SENT228	7	7	21	21	curcumin	STZ	PA151958596	6484	0.887
NULL	Korean_J_Anesthesiol_2013_Jan_21_64(1)_47-53.nxml.txt.nlp	23372886	SENT96	23	23	5	5	bupivacaine	IGK	PA135057240	50802	0.887
NULL	Crit_Care_2005_Nov_4_9(6)_561-565.nxml.txt.nlp	16356239	SENT115	2	2	27	27	propranolol	IL-6	PA451145	3569	0.887
NULL	Anal_Chem_2014_Feb_18_86(4)_1988-1996.nxml.txt.nlp	24446580	SENT98	12	12	32	32	trypsin	PPG	PA451806	5552	0.887
NULL	Front_Physiol_2011_Jun_14_2_26.nxml.txt.nlp	21716655	SENT224	36	36	21	21	lipase	SCAD	PA450239	35	0.887
NULL	Br_J_Dermatol_2009_Feb_160(2)_438-441.nxml.txt.nlp	19016697	SENT107	24	24	10	10	methotrexate	GGH	PA450428	8836	0.887
NULL	Oncotarget_2013_Nov_24_4(12)_2430-2438.nxml.txt.nlp	24280348	SENT27	5	5	31	31	gefitinib	STAT3	PA131301952	6774	0.887
NULL	J_Cancer_Res_Clin_Oncol_2013_Aug_7_139(10)_1667-1672.nxml.txt.nlp	23918349	SENT138	8	8	1	1	hydrocortisone	STEPP	PA449905	222659	0.887
NULL	Biomed_Res_Int_2013_Jul_22_2013_408573.nxml.txt.nlp	23971034	SENT200	9	9	38	38	doxorubicin	CBR1	PA449412	873	0.887
NULL	Int_J_Biol_Sci_2015_Jan_1_11(2)_144-155.nxml.txt.nlp	25561897	SENT242	22	22	10	10	cisplatin	POLB	PA449014	5423	0.887
NULL	Oncogenesis_2012_Apr_2_1(4)_e5.nxml.txt.nlp	23552603	SENT291	4	4	10	10	celecoxib	p65	PA448871	5970	0.887
NULL	Front_Oncol_2013_Sep_23_3_250.nxml.txt.nlp	24069582	SENT11	38	38	27	27	exemestane	aromatase	PA449563	1588	0.887
NULL	Case_Rep_Rheumatol_2011_Dec_15_2011_185657.nxml.txt.nlp	22937439	SENT57	21	21	29	29	etanercept	TNF-alpha	PA449515	7124	0.887
NULL	Biol_Open_2012_May_21_1(7)_629-639.nxml.txt.nlp	23125914	SENT1082	16	16	0	0	creatine	p53	PA164778930	7157	0.887
NULL	J_Cell_Biol_1980_Feb_1_84(2)_294-297.nxml.txt.nlp	7380884	SENT6	13	13	4	4	creatine	CMIP	PA164778930	80790	0.887
NULL	Gynecol_Oncol_Case_Rep_2013_Jul_1_6_7-9.nxml.txt.nlp	24371706	SENT59	14	14	21	21	bevacizumab	VEGF-A	PA130232992	7422	0.887
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1522-1532.nxml.txt.nlp	21997136	SENT152	13	13	23	23	gefitinib	ABCG2	PA131301952	9429	0.887
NULL	Aging_(Albany_NY)_2013_Jan_29_5(1)_3-17.nxml.txt.nlp	23363843	SENT51	1	1	15	15	etoposide	p53	PA449552	7157	0.887
NULL	Arthritis_Res_Ther_2010_Jan_29_12(1)_R18.nxml.txt.nlp	20113495	SENT178	2	2	7	7	glucosamine	NAPA	PA164747613	9476;8775	0.887
NULL	Anesth_Pain_Med_2012_Sep_13_Autumn_2(2)_60-65.nxml.txt.nlp	24223339	SENT173	11	11	23	23	aprotinin	BART	PA448472	7809;23568	0.887
NULL	BMJ_Open_2013_Nov_4_3(11)_e003995.nxml.txt.nlp	24189085	SENT80	33	33	21	21	orlistat	GLP-1	PA164776864	100125288	0.887
NULL	Oncotarget_2013_Feb_27_4(2)_329-345.nxml.txt.nlp	23593654	SENT82	18	18	15	15	staurosporine	RSK1	PA165109623	6195	0.887
NULL	J_Cardiovasc_Dis_Res_2010_Jul-Sep_1(3)_116-121.nxml.txt.nlp	21187864	SENT70	19	19	12	12	oxygen	MET	PA450744	4233	0.887
NULL	Breast_Cancer_Res_2007_Aug_16_9(4)_305.nxml.txt.nlp	17705882	SENT7	11	11	8	8	exemestane	aromatase	PA449563	1588	0.887
NULL	Oncol_Lett_2013_Feb_7_5(2)_440-446.nxml.txt.nlp	23420122	SENT212	9	9	18	18	sorafenib	KRAS	PA7000	3845	0.887
NULL	Drugs_R_D_2014_Dec_6_14(4)_315-324.nxml.txt.nlp	25480348	SENT107	25	25	3	3	alfacalcidol	BMD	PA164746469	1756;7439	0.887
NULL	Core_Evid_2011_Mar_17_6_31-42.nxml.txt.nlp	21468241	SENT94	14	14	6	6	ticagrelor	IPA	PA165374673	3160	0.887
NULL	J_Org_Chem_2011_Aug_19_76(16)_6703-6714.nxml.txt.nlp	21739961	SENT168	34	34	6	6	ethanol	mol	PA448073	90527	0.887
NULL	Front_Neuroenergetics_2014_Jan_9_5_13.nxml.txt.nlp	24409143	SENT229	19	19	29	29	propofol	FDG	PA451141	23583	0.887
NULL	J_Cell_Mol_Med_2013_May_20_17(5)_648-656.nxml.txt.nlp	23601074	SENT122	2	2	8	8	gefitinib	AKT	PA131301952	207	0.887
NULL	Viruses_2014_Mar_14_6(3)_1294-1316.nxml.txt.nlp	24638204	SENT177	27	27	37	37	galactose	SP-D	PA449725	6441	0.887
NULL	J_Korean_Med_Sci_2010_Feb_19_25(2)_333-335.nxml.txt.nlp	20119596	SENT66	14	14	19	19	aripiprazole	5-HT1A	PA10026	3350	0.887
NULL	Osteoporos_Int_2014_Mar_6_25(9)_2159-2171.nxml.txt.nlp	24599274	SENT350	15	15	20	20	risedronate	IMPACT	PA451255	55364	0.887
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT115	40	40	23	23	neratinib	HER2	PA165291472	2064	0.887
NULL	Neural_Dev_2009_Dec_2_4_42.nxml.txt.nlp	19954518	SENT107	24	24	8	8	paraformaldehyde	P18	PA450790	7975;10168	0.887
NULL	Mol_Cancer_2014_Jan_13_13_7.nxml.txt.nlp	24418169	SENT177	5	5	24	24	sorafenib	SHP-1	PA7000	5777	0.887
NULL	Aging_(Albany_NY)_2012_Jun_11_4(6)_402-416.nxml.txt.nlp	22691943	SENT35	20	20	10	10	tamoxifen	SIRT1	PA451581	23411	0.887
NULL	Cancers_(Basel)_2013_May_27_5(2)_617-638.nxml.txt.nlp	24216994	SENT159	25	25	18	18	curcumin	PC3	PA151958596	57332;7832;5122	0.887
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Feb_20_69(Pt_3)_o398-o399.nxml.txt.nlp	23476581	SENT79	12	12	23	23	ethanol	mol	PA448073	90527	0.887
NULL	Exp_Ther_Med_2013_May_15_5(5)_1327-1331.nxml.txt.nlp	23737873	SENT191	15	15	5	5	imidapril	AQP2	PA452640	359	0.887
NULL	Front_Physiol_2013_May_20_4_101.nxml.txt.nlp	23730288	SENT142	37	37	8	8	allopurinol	HL-1	PA448320	55600	0.887
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1224-1233.nxml.txt.nlp	22353810	SENT198	2	2	31	31	doxorubicin	MRP-1	PA449412	928	0.887
NULL	Mol_Cancer_2013_Sep_11_12_104.nxml.txt.nlp	24025152	SENT124	9	9	4	4	gemcitabine	STAT3	PA449748	6774	0.887
NULL	Oncotarget_2014_Oct_9_5(20)_9564-9576.nxml.txt.nlp	25333255	SENT135	21	21	25	25	imatinib	CD34	PA10804	947	0.887
NULL	Environ_Health_Perspect_2005_Aug_15_113(8)_1009-1014.nxml.txt.nlp	16079071	SENT218	2	2	17	17	losartan	p38	PA450268	10598;1432;7965	0.887
NULL	Sensors_(Basel)_2011_Jan_25_11(2)_1328-1344.nxml.txt.nlp	22319354	SENT43	14	14	20	20	ethanol	mol	PA448073	90527	0.887
NULL	J_Exp_Med_1994_Jul_1_180(1)_383-387.nxml.txt.nlp	7516415	SENT1	9	9	23	23	hyaluronan	CD44	PA165958431	960	0.887
NULL	Front_Syst_Neurosci_2014_Apr_21_8_60.nxml.txt.nlp	24795576	SENT136	5	5	15	15	estradiol	ADX	PA449503	2230	0.887
NULL	Breast_Cancer_(Auckl)_2014_Jul_29_8_103-108.nxml.txt.nlp	25125980	SENT29	20	20	24	24	trastuzumab	HER2	PA451743	2064	0.887
NULL	Oncotarget_2012_Oct_20_3(10)_1068-1111.nxml.txt.nlp	23085539	SENT135	12	12	18	18	vemurafenib	BRAF	PA165946873	673	0.887
NULL	J_Biomed_Biotechnol_2006_May_25_2006_62079.nxml.txt.nlp	17047309	SENT166	15	15	30	30	chloroquine	p62	PA448948	8878;10657;23636	0.887
NULL	Cell_Commun_Signal_2014_Oct_5_12(1)_54.nxml.txt.nlp	NULL	SENT110	31	31	8	8	doxycycline	MRCK	PA449415	8476	0.887
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Sep_30_67(Pt_10)_o2776.nxml.txt.nlp	22065516	SENT73	23	23	12	12	ethanol	mol	PA448073	90527	0.887
NULL	Indian_J_Pharmacol_2012_Nov-Dec_44(6)_759-764.nxml.txt.nlp	23248408	SENT97	15	15	3	3	sitagliptin	GLP-1	PA164748978	100125288	0.887
NULL	Cancer_Manag_Res_2011_Aug_10_3_273-285.nxml.txt.nlp	21931501	SENT67	4	4	15	15	pazopanib	VEGFR2	PA165291492	3791	0.887
NULL	Oncologist_2010_Feb_15_15(2)_122-129.nxml.txt.nlp	20156908	SENT31	38	38	34	34	anastrozole	aromatase	PA448432	1588	0.887
NULL	Exp_Ther_Med_2013_Mar_8_5(3)_707-710.nxml.txt.nlp	23404433	SENT147	8	8	15	15	cisplatin	Bcl-2	PA449014	596	0.887
NULL	Breast_Cancer_(Auckl)_2009_Sep_2_3_61-75.nxml.txt.nlp	19809577	SENT145	16	16	21	21	curcumin	BRCA1	PA151958596	672	0.887
NULL	Br_J_Cancer_2013_Oct_15_109(8)_2155-2166.nxml.txt.nlp	24045666	SENT258	17	17	5	5	cetuximab	IFN	PA10040	3439	0.887
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT53	38	38	16	16	pertuzumab	HER2		2064	0.887
NULL	Arthritis_Res_Ther_2009_May_19_11(3)_225.nxml.txt.nlp	19490600	SENT188	0	0	17	17	abatacept	CD80	PA164747080	941	0.887
NULL	FASEB_J_2008_Nov_22(11)_4005-4010.nxml.txt.nlp	18753249	SENT11	4	4	2	2	naproxen	COX	PA450595	1351	0.887
NULL	J_Int_Soc_Sports_Nutr_2011_Nov_7_8(Suppl_1)_P15.nxml.txt.nlp	NULL	SENT5	0	0	14	14	resveratrol	IL-6		3569	0.887
NULL	J_Thromb_Haemost_2011_Oct_9(10)_2103-2105.nxml.txt.nlp	21812912	SENT71	12	12	30	30	ticagrelor	mol	PA165374673	90527	0.887
NULL	Ann_Med_Health_Sci_Res_2014_Jul-Aug_4(4)_466-471.nxml.txt.nlp	25221689	SENT153	11	11	26	26	piperaquine	CYP3A4	PA166104279	1576	0.887
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Feb_17_68(Pt_3)_o715-o716.nxml.txt.nlp	22412599	SENT4	25	25	1	1	piperazine	mol	PA450977	90527	0.887
NULL	EMBO_Mol_Med_2012_Aug_16_4(8)_743-760.nxml.txt.nlp	22593025	SENT200	21	21	36	36	paclitaxel	EGFR	PA450761	1956	0.887
NULL	EMBO_Mol_Med_2013_Feb_9_5(2)_309-325.nxml.txt.nlp	23300147	SENT214	21	21	29	29	geldanamycin	HER2	PA152031327	2064	0.887
NULL	Colomb_Med_(Cali)_43(3)_235-243.nxml.txt.nlp	24893199	SENT178	7	7	1	1	doxycycline	AKT	PA449415	207	0.887
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT210	20	20	6	6	cisplatin	p53	PA449014	7157	0.887
NULL	Clin_Ophthalmol_2008_Jun_2(2)_355-368.nxml.txt.nlp	19668727	SENT43	7	7	26	26	nepafenac	COX1	PA165958407	4512;5742	0.887
NULL	Exp_Brain_Res_2014_Jun_27_232(8)_2637-2644.nxml.txt.nlp	24969614	SENT169	9	9	30	30	palonosetron	NK1	PA10352	11126	0.887
NULL	Br_J_Cancer_2013_May_28_108(10)_1957-1963.nxml.txt.nlp	23640393	SENT25	10	10	3	3	cisplatin	NACT	PA449014	284111	0.887
NULL	J_Immunother_Cancer_2014_Jan_27_2_2.nxml.txt.nlp	24829759	SENT179	16	16	48	48	sorafenib	IL-21	PA7000	59067;50616;27189	0.887
NULL	Evid_Based_Complement_Alternat_Med_2011_Feb_20_2011_541209.nxml.txt.nlp	21799681	SENT100	17	17	8	8	curcumin	P21	PA151958596	1026;9338	0.887
NULL	ScientificWorldJournal_2013_Apr_30_2013_823289.nxml.txt.nlp	23737729	SENT150	11	11	23	23	diazepam	SNK	PA449283	10769	0.887
NULL	Case_Rep_Neurol_2010_Nov_12_2(3)_139-144.nxml.txt.nlp	21113284	SENT68	37	37	15	15	methotrexate	San	PA450428	80218	0.887
NULL	Int_J_Biol_Sci_2013_Aug_9_9(7)_743-752.nxml.txt.nlp	23983607	SENT117	20	20	17	17	nutlin-3	MDM2		4193	0.887
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT109	16	16	21	21	trastuzumab	MUC1	PA451743	4582	0.887
NULL	Drug_Target_Insights_2013_Aug_19_7_27-34.nxml.txt.nlp	24023511	SENT83	25	25	9	9	erythromycin	P-gp	PA449493	5243	0.887
NULL	Biologics_2009_Sep_15_3_419-428.nxml.txt.nlp	19774209	SENT15	8	8	24	24	erlotinib	EGFR	PA134687924	1956	0.887
NULL	Mol_Cancer_2010_Aug_16_9_217.nxml.txt.nlp	20712901	SENT64	6	6	12	12	curcumin	JAK2	PA151958596	3717	0.887
NULL	J_Antimicrob_Chemother_2014_Mar_13_69(3)_651-663.nxml.txt.nlp	24235095	SENT21	20	20	15	15	pentamidine	AQP3	PA450850	360	0.887
NULL	Mol_Pain_2013_Jun_10_9_27.nxml.txt.nlp	23758830	SENT13	17	17	8	8	tetracaine	ASIC1	PA451638	41	0.887
NULL	Leukemia_2013_Dec_27_27(12)_2322-2331.nxml.txt.nlp	24072044	SENT229	15	15	19	19	plerixafor	CXCL12	PA165958410	6387	0.887
NULL	Arthritis_Res_Ther_2010_Aug_13_12(4)_134.nxml.txt.nlp	20735865	SENT9	2	2	7	7	methotrexate	MTHFR	PA450428	4524	0.887
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Sep_16_65(Pt_10)_o2480.nxml.txt.nlp	21577931	SENT72	23	23	6	6	ethanol	mol	PA448073	90527	0.887
NULL	Nat_Commun_2014_Dec_12_5_5775.nxml.txt.nlp	25503391	SENT557	31	31	8	8	chloroquine	PC3	PA448948	57332;7832;5122	0.887
NULL	Environ_Health_Perspect_2013_Apr_1_121(4)_a104-a106.nxml.txt.nlp	23548368	SENT48	10	10	12	12	diethylstilbestrol	DES	PA449307	1674	0.887
NULL	Breast_Cancer_Res_2010_May_18_12(Suppl_1)_P20.nxml.txt.nlp	NULL	SENT15	12	12	15	15	hydroxyurea	CDKN1A	PA449942	1026	0.887
NULL	Oxid_Med_Cell_Longev_2008_Oct-Dec_1(1)_39-45.nxml.txt.nlp	19794907	SENT51	29	29	42	42	taurine	MCH	PA451590	5367	0.887
NULL	Cancer_Metastasis_Rev_2007_Dec_24_26(3-4)_489-502.nxml.txt.nlp	17717633	SENT1467	15	15	0	0	hyaluronan	LYVE-1	PA165958431	10894	0.887
NULL	J_Radiat_Res_2012_Jul_12_53(4)_551-557.nxml.txt.nlp	22843620	SENT141	34	34	38	38	pp2	EGFR		1956	0.887
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT51	17	17	3	3	trastuzumab	STAT3	PA451743	6774	0.887
NULL	ScientificWorldJournal_2012_Aug_2_2012_940613.nxml.txt.nlp	22919361	SENT158	12	12	8	8	naloxone	PAG	PA450586	55824	0.887
NULL	Ann_Clin_Microbiol_Antimicrob_2011_Jul_21_10_30.nxml.txt.nlp	21774834	SENT253	22	22	13	13	oxacillin	VISA	PA450725	57506	0.887
NULL	Environ_Microbiol_2012_Jun_14(6)_1444-1453.nxml.txt.nlp	22429517	SENT53	9	9	14	14	piperacillin	TMT	PA450975	25823	0.887
NULL	Br_J_Cancer_2011_Sep_27_105(7)_1012-1022.nxml.txt.nlp	21863032	SENT24	6	6	13	13	nutlin-3	MDM2		4193	0.887
NULL	Cardiol_Res_Pract_2013_Feb_19_2013_195456.nxml.txt.nlp	23533940	SENT61	0	0	5	5	ticagrelor	ADP	PA165374673	23038	0.887
NULL	Endocrine_2012_Dec_14_42(3)_622-636.nxml.txt.nlp	22695986	SENT64	6	6	4	4	forskolin	PTH	PA146096022	5741	0.887
NULL	Front_Oncol_2014_Oct_21_4_285.nxml.txt.nlp	25374842	SENT703	9	9	0	0	nutlin-3	HDM2		4193	0.887
NULL	Chem_Cent_J_2013_Sep_4_7_147.nxml.txt.nlp	24006941	SENT94	7	7	33	33	lipase	LOX	PA450239	4015	0.887
NULL	J_Cardiothorac_Surg_2009_Nov_4_4_60.nxml.txt.nlp	19889206	SENT105	21	21	6	6	thrombin	hole	PA451674	80757	0.887
NULL	Evid_Based_Complement_Alternat_Med_2012_Dec_20_2012_908601.nxml.txt.nlp	23326293	SENT187	8	8	20	20	oxaliplatin	EMT	PA131285527	3702;6581	0.887
NULL	J_Cardiothorac_Surg_2014_Feb_11_9_32.nxml.txt.nlp	24512988	SENT33	7	7	14	14	heparin	ANOVA	PA449855	4858	0.887
NULL	Cell_Death_Dis_2012_Jun_7_3(6)_e319.nxml.txt.nlp	22673193	SENT8	8	8	2	2	cisplatin	Mcl-1	PA449014	4170	0.887
NULL	J_Cardiothorac_Surg_2014_May_9_9_81.nxml.txt.nlp	24885948	SENT183	5	5	3	3	sorafenib	c-Raf	PA7000	5894	0.887
NULL	Br_J_Cancer_2009_Jul_7_101(1)_48-54.nxml.txt.nlp	19513067	SENT121	15	15	32	32	imatinib	HER-2	PA10804	2064	0.887
NULL	Eur_J_Clin_Pharmacol_2014_Oct_8_70(1)_37-45.nxml.txt.nlp	24100471	SENT15	6	6	28	28	pioglitazone	CYP3A4	PA450970	1576	0.887
NULL	J_Cachexia_Sarcopenia_Muscle_2010_Sep_26_1(1)_43-128.nxml.txt.nlp	22477519	SENT746	14	14	1	1	fenfluramine	MC4R	PA449592	4160	0.887
NULL	Daru_2012_Nov_28_20(1)_81.nxml.txt.nlp	23351280	SENT343	6	6	2	2	diazepam	MARK	PA449283	4139	0.887
NULL	Cancers_(Basel)_2011_Sep_28_3(4)_3740-3761.nxml.txt.nlp	24213109	SENT198	0	0	23	23	trabectedin	IL-6	PA165958349	3569	0.887
NULL	Hematol_Rep_2011_Oct_28_3(3_Suppl)_e3.nxml.txt.nlp	22586511	SENT26	23	23	32	32	doxorubicin	CHOP	PA449412	1649	0.887
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1046.nxml.txt.nlp	24503538	SENT77	1	1	38	38	oxaliplatin	FGFR4	PA131285527	2264	0.887
NULL	Int_J_Mol_Sci_2012_Aug_15_13(8)_10143-10153.nxml.txt.nlp	22949852	SENT312	4	4	6	6	diethylstilbestrol	DES	PA449307	1674	0.887
NULL	J_Korean_Med_Sci_2008_Aug_25_23(4)_685-690.nxml.txt.nlp	18756058	SENT86	14	14	19	19	olanzapine	ghrelin	PA450688	51738	0.887
NULL	Cancers_(Basel)_2012_Nov_8_4(4)_1180-1211.nxml.txt.nlp	24213504	SENT51	4	4	17	17	cetuximab	EGFR	PA10040	1956	0.887
NULL	Breast_Cancer_Res_2007_May_25_9(3)_R32.nxml.txt.nlp	17531096	SENT69	41	41	38	38	trastuzumab	aromatase	PA451743	1588	0.887
NULL	Nucleic_Acids_Res_2013_Nov_5_41(20)_e191.nxml.txt.nlp	24013564	SENT96	27	27	4	4	fluorescein	HEX	PA164746009	3087	0.887
NULL	J_Korean_Med_Sci_2012_Sep_22_27(9)_1037-1043.nxml.txt.nlp	22969249	SENT114	4	4	11	11	paricalcitol	STAT3	PA450798	6774	0.887
NULL	Br_J_Pharmacol_2014_Feb_24_171(1)_1019-1032.nxml.txt.nlp	24251620	SENT48	22	22	13	13	nitrendipine	TRPM3	PA146096020	80036	0.887
NULL	Emerg_Infect_Dis_2011_Oct_17(10)_1917-1920.nxml.txt.nlp	22000371	SENT76	11	11	29	29	neomycin	OTC	PA450608	5009	0.887
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT195	29	29	19	19	lidocaine	CYP3A4	PA450226	1576	0.887
NULL	Diabetologia_2010_Apr_26_53(4)_606-613.nxml.txt.nlp	20101384	SENT142	3	3	10	10	acarbose	GLP-1	PA448010	100125288	0.887
NULL	Ann_Rheum_Dis_2013_Aug_21_72(8)_1287-1294.nxml.txt.nlp	22915624	SENT186	8	8	27	27	abatacept	MRI	PA164747080	78996	0.887
NULL	Oncotarget_2012_Sep_28_3(10)_1169-1181.nxml.txt.nlp	23045411	SENT108	10	10	0	0	doxorubicin	JIP1	PA449412	9479	0.887
NULL	Biomed_Res_Int_2014_Jan_20_2014_948427.nxml.txt.nlp	24563867	SENT124	3	3	21	21	buspirone	5-HT1A	PA448689	3350	0.887
NULL	Clin_Med_Insights_Cardiol_2011_Oct_6_5_103-119.nxml.txt.nlp	22084608	SENT45	12	12	2	2	warfarin	CYP2C9	PA451906	1559	0.887
NULL	Cancer_Med_2014_Dec_13_3(6)_1579-1594.nxml.txt.nlp	25124282	SENT285	18	18	4	4	olaparib	PARP2		10038	0.887
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Nov_20_64(Pt_12)_o2370.nxml.txt.nlp	21581342	SENT55	20	20	14	14	ethanol	mol	PA448073	90527	0.887
NULL	J_Carcinog_2013_Aug_8_12_16.nxml.txt.nlp	24082825	SENT99	19	19	8	8	phenformin	LKB1	PA1000	6794	0.887
NULL	J_Int_AIDS_Soc_2011_Dec_28_14_61.nxml.txt.nlp	22204313	SENT51	4	4	25	25	zidovudine	CD4	PA451954	920	0.887
NULL	Oncotarget_2014_Aug_19_5(18)_8737-8749.nxml.txt.nlp	25228590	SENT32	22	22	9	9	crizotinib	MYCN	PA165946122	4613	0.887
NULL	Cardiol_Res_Pract_2011_Apr_26_2011_874802.nxml.txt.nlp	21577272	SENT128	9	9	25	25	valsartan	AT1	PA451848	9197;185	0.887
NULL	Biomed_Res_Int_2014_Jun_25_2014_203693.nxml.txt.nlp	25089265	SENT286	6	6	43	43	cabozantinib	AXL	PA165906891	558	0.887
NULL	Diabetes_2008_Sep_57(9)_2272-2279.nxml.txt.nlp	18519799	SENT134	29	29	32	32	rosiglitazone	PDK4	PA451283	5166	0.887
NULL	J_Med_Chem_2014_Feb_27_57(4)_1557-1572.nxml.txt.nlp	24471976	SENT141	30	30	4	4	ropinirole	ANOVA	PA164749035	4858	0.887
NULL	Arthritis_Res_Ther_2014_Apr_15_16(2)_R95.nxml.txt.nlp	24735586	SENT225	23	23	16	16	rituximab	CD27	PA451261	939	0.887
NULL	Oncotarget_2012_Jul_13_3(6)_601-607.nxml.txt.nlp	22802145	SENT38	29	29	16	16	vinblastine	p53	PA451877	7157	0.887
NULL	Int_J_Fertil_Steril_2014_Nov_1_Oct-Dec_8(3)_255-260.nxml.txt.nlp	25379153	SENT110	14	14	11	11	letrozole	aromatase	PA450196	1588	0.887
NULL	Diabetes_Care_2011_Jun_20_34(6)_1265-1269.nxml.txt.nlp	21515846	SENT148	22	22	7	7	rosiglitazone	DREAM	PA451283	30818	0.887
NULL	J_Oncol_2012_Apr_10_2012_931071.nxml.txt.nlp	22570654	SENT50	11	11	5	5	plerixafor	CD34	PA165958410	947	0.887
NULL	Br_J_Cancer_1998_77(2)_201-209.nxml.txt.nlp	9460989	SENT11	25	25	8	8	chlorambucil	MRP1	PA448926	4437	0.887
NULL	Cancer_Cell_Int_2011_Nov_17_11_40.nxml.txt.nlp	22088142	SENT86	29	29	8	8	doxorubicin	MRP3	PA449412	8714	0.887
NULL	Br_J_Cancer_2011_Mar_15_104(6)_941-947.nxml.txt.nlp	21407223	SENT164	15	15	7	7	sorafenib	survivin	PA7000	332	0.887
NULL	Br_J_Cancer_2013_Jul_9_109(1)_68-75.nxml.txt.nlp	23807173	SENT157	18	18	13	13	cisplatin	ERCC1	PA449014	2067	0.887
NULL	Cell_Res_2009_Aug_19(8)_950-961.nxml.txt.nlp	19546888	SENT67	9	9	2	2	camptothecin	Cbl-b	PA153590860	868	0.887
NULL	Cancer_Med_2014_Oct_10_3(5)_1275-1283.nxml.txt.nlp	24913924	SENT210	12	12	16	16	vemurafenib	BRAF	PA165946873	673	0.887
NULL	J_Exp_Med_2003_Aug_4_198(3)_505-512.nxml.txt.nlp	12900524	SENT130	24	24	22	22	dextran	CCL21	PA449261	6366	0.887
NULL	Oncoimmunology_2013_Oct_1_2(10)_e27025.nxml.txt.nlp	24353914	SENT110	43	43	12	12	vinorelbine	CD4	PA451881	920	0.887
NULL	Biomed_Res_Int_2013_Feb_28_2013_215283.nxml.txt.nlp	23555077	SENT69	39	39	29	29	ethanol	ATK	PA448073	695	0.887
NULL	Int_J_Pediatr_2009_May_27_2009_424192.nxml.txt.nlp	20041017	SENT46	38	38	31	31	sumatriptan	TNF-alpha	PA451566	7124	0.887
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Dec_10_3(12)_e151.nxml.txt.nlp	25494035	SENT71	6	6	30	30	rosuvastatin	OATP1B1	PA134308647	10599	0.887
NULL	Apoptosis_2013_May_13_18(5)_639-651.nxml.txt.nlp	23404198	SENT42	25	25	10	10	l-glutamine	CO2	PA10090	4513	0.887
NULL	J_Hematol_Oncol_2013_Mar_27_6_23.nxml.txt.nlp	23531342	SENT165	35	35	31	31	bortezomib	p53	PA10252	7157	0.887
NULL	J_Mol_Signal_2011_Jul_20_6_7.nxml.txt.nlp	21774804	SENT9	11	11	29	29	dasatinib	CD133	PA162372878	8842	0.887
NULL	Mol_Cancer_2007_Oct_11_6_63.nxml.txt.nlp	17931419	SENT90	2	2	15	15	cetuximab	EGFR	PA10040	1956	0.887
NULL	J_Hematol_Oncol_2013_Jul_9_6_49.nxml.txt.nlp	23837843	SENT223	3	3	9	9	verapamil	Rho	PA451868	29984	0.887
NULL	Front_Neurol_2011_Dec_26_2_83.nxml.txt.nlp	22363312	SENT729	11	11	3	3	clopidogrel	CYP2C19	PA449053	1557	0.887
NULL	J_Biol_Chem_2013_Feb_8_288(6)_3918-3928.nxml.txt.nlp	23239877	SENT107	22	22	25	25	thrombin	PAR1	PA451674	79581;2149	0.887
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_11_2013_987612.nxml.txt.nlp	23840275	SENT242	15	15	1	1	geldanamycin	p53	PA152031327	7157	0.887
NULL	Fibrogenesis_Tissue_Repair_2010_Nov_24_3_23.nxml.txt.nlp	21106092	SENT29	3	3	14	14	fluorescein	CysLT1	PA164746009	10800	0.887
NULL	Structure_2013_Jun_4_21(6)_1051-1058.nxml.txt.nlp	23665170	SENT399	12	12	22	22	oxygen	hole	PA450744	80757	0.887
NULL	Br_J_Cancer_2010_Jan_19_102(2)_268-275.nxml.txt.nlp	20010948	SENT22	20	20	13	13	bevacizumab	EGFR	PA130232992	1956	0.887
NULL	J_Vet_Med_Sci_2014_Jun_15_76(6)_813-817.nxml.txt.nlp	24531829	SENT115	13	13	20	20	primaquine	DPT	PA451103	1805	0.887
NULL	Semin_Immunol_2011_Feb_23(1)_28-41.nxml.txt.nlp	21295490	SENT246	6	6	17	17	ustekinumab	CD11c	PA166048654	3687	0.887
NULL	J_Gen_Physiol_2012_May_139(5)_371-388.nxml.txt.nlp	22508847	SENT40	23	23	3	3	thrombin	GluA2	PA451674	2891	0.887
NULL	Aging_(Albany_NY)_2012_Mar_12_4(3)_146-158.nxml.txt.nlp	22436213	SENT61	7	7	23	23	resveratrol	AMPK		5563	0.887
NULL	Br_J_Cancer_2010_Jan_19_102(2)_268-275.nxml.txt.nlp	20010948	SENT197	19	19	4	4	sorafenib	EPO	PA7000	7076;8288;2056	0.887
NULL	Chem_Cent_J_2012_Aug_1_6_78.nxml.txt.nlp	22853321	SENT68	10	10	0	0	ethanol	HC5	PA448073	5689;122950	0.887
NULL	ScientificWorldJournal_2014_Nov_27_2014_837543.nxml.txt.nlp	25544963	SENT286	15	15	8	8	imatinib	SLCO1B3	PA10804	28234	0.887
NULL	Indian_J_Ophthalmol_2014_Jan_62(1)_74-81.nxml.txt.nlp	24492505	SENT151	0	0	3	3	daclizumab	IL-2	PA164764446	3558	0.887
NULL	Exp_Ther_Med_2014_Apr_10_7(4)_791-798.nxml.txt.nlp	24669234	SENT58	10	10	25	25	paraformaldehyde	San	PA450790	80218	0.887
NULL	J_Adv_Pharm_Technol_Res_2014_Oct-Dec_5(4)_185-190.nxml.txt.nlp	25364697	SENT178	15	15	31	31	carvedilol	CYP3A	PA448817	1574	0.887
NULL	Onco_Targets_Ther_2014_Jun_9_7_947-956.nxml.txt.nlp	24959081	SENT56	9	9	18	18	fluorescein	CD25	PA164746009	3669;3559	0.887
NULL	Int_J_Surg_Oncol_2012_Sep_4_2012_761364.nxml.txt.nlp	22988495	SENT257	11	11	3	3	exemestane	aromatase	PA449563	1588	0.887
NULL	Environ_Health_Perspect_2013_Mar_1_121(3)_a97.nxml.txt.nlp	23454847	SENT25	11	11	5	5	estradiol	JNK	PA449503	5599	0.887
NULL	Neural_Regen_Res_2014_Mar_15_9(6)_622-629.nxml.txt.nlp	25206865	SENT119	8	8	15	15	vasopressin	p38	PA451858	10598;1432;7965	0.887
NULL	J_Cancer_2012_Aug_24_3_354-361.nxml.txt.nlp	22962562	SENT178	6	6	8	8	chlorambucil	CLB	PA448926	171425	0.887
NULL	J_Int_AIDS_Soc_2012_Oct_22_15(Suppl_3)_10_7448_IAS_15_5_18440.nxml.txt.nlp	NULL	SENT908	8	8	0	0	cefixime	Men	PA164768821	8178	0.887
NULL	Br_J_Cancer_2011_Jan_4_104(1)_91-100.nxml.txt.nlp	21139584	SENT133	5	5	17	17	geldanamycin	Hsp90	PA152031327	3320	0.887
NULL	Cell_Death_Dis_2010_May_13_1(5)_e41.nxml.txt.nlp	21364648	SENT72	8	8	24	24	etoposide	p53	PA449552	7157	0.887
NULL	Clinics_(Sao_Paulo)_2013_Feb_68(2)_253-262.nxml.txt.nlp	23525324	SENT221	29	29	8	8	genistein	Gen	PA165109660	348654	0.887
NULL	Front_Neurosci_2011_Jan_14_4_207.nxml.txt.nlp	21258618	SENT164	6	6	13	13	ethanol	CRF1	PA448073	1394	0.887
NULL	Ann_Hematol_2014_Apr_1_93(8)_1371-1380.nxml.txt.nlp	24687382	SENT187	15	15	33	33	lenalidomide	CCND1	PA162363968	595	0.887
NULL	Diabetes_Care_2013_Jul_12_36(7)_1913-1918.nxml.txt.nlp	23359361	SENT152	11	11	6	6	sitagliptin	GLP-1	PA164748978	100125288	0.887
NULL	Br_J_Cancer_2000_Jun_82(11)_1851-1859.nxml.txt.nlp	10839301	SENT9	20	20	27	27	topotecan	CD95	PA451729	355	0.887
NULL	Clinics_(Sao_Paulo)_2012_Aug_67(8)_931-937.nxml.txt.nlp	22948462	SENT148	3	3	16	16	bevacizumab	ERG	PA130232992	2078	0.887
NULL	Int_J_Biol_Sci_2012_Oct_17_8(8)_1197-1205.nxml.txt.nlp	23091417	SENT69	15	15	45	45	captopril	ACE2	PA448780	59272	0.887
NULL	Eur_J_Clin_Pharmacol_2011_May_8_67(5)_493-506.nxml.txt.nlp	21140139	SENT42	19	19	15	15	ketoconazole	CYP3A4	PA450146	1576	0.887
NULL	Leukemia_2014_Sep_30_28(9)_1918-1922.nxml.txt.nlp	24791858	SENT53	21	21	14	14	imatinib	JAK2	PA10804	3717	0.887
NULL	Front_Oncol_2011_Jun_17_1_10.nxml.txt.nlp	22655230	SENT134	12	12	24	24	gefitinib	EGFR	PA131301952	1956	0.887
NULL	Curr_Hematol_Malig_Rep_2012_Sep_27_7(3)_235-240.nxml.txt.nlp	22538464	SENT33	23	23	12	12	etoposide	CHOP	PA449552	1649	0.887
NULL	F1000Res_2014_Aug_19_3_198.nxml.txt.nlp	25400908	SENT289	18	18	22	22	lapatinib	ACT	PA152241907	12;11332;9457;641455	0.887
NULL	Drug_Target_Insights_2007_Aug_17_2_197-207.nxml.txt.nlp	21901074	SENT127	7	7	42	42	minocycline	U87	PA450519	677775;641648	0.887
NULL	Cell_Death_Dis_2014_Jan_9_5(1)_e986.nxml.txt.nlp	24407239	SENT138	32	32	19	19	fludarabine	STAT1	PA449655	6772	0.887
NULL	Exp_Diabetes_Res_2011_Nov_30_2011_162092.nxml.txt.nlp	22203828	SENT35	34	34	10	10	sitagliptin	GLP-1	PA164748978	100125288	0.887
NULL	Arthritis_Res_Ther_2011_Sep_30_13(5)_242.nxml.txt.nlp	21996023	SENT154	31	31	7	7	methotrexate	BEST	PA450428	7439	0.887
NULL	Br_J_Cancer_2013_Feb_19_108(3)_587-596.nxml.txt.nlp	23322202	SENT258	20	20	25	25	bevacizumab	VEGF-A	PA130232992	7422	0.887
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_75-89.nxml.txt.nlp	17912638	SENT217	23	23	7	7	anastrozole	ATAC	PA448432	6375	0.887
NULL	FASEB_J_2008_Nov_22(11)_4005-4010.nxml.txt.nlp	18753249	SENT119	18	18	26	26	rofecoxib	COX	PA451268	1351	0.887
NULL	Structure_2013_Sep_3_21(9)_1648-1658.nxml.txt.nlp	23932590	SENT112	20	20	11	11	mitomycin	FANCD2	PA450524	2177	0.887
NULL	Support_Care_Cancer_2009_Sep_10_17(9)_1187-1193.nxml.txt.nlp	19205754	SENT183	27	27	20	20	ondansetron	NK-1	PA450705	27087	0.887
NULL	J_Ayurveda_Integr_Med_2010_Oct-Dec_1(4)_287-291.nxml.txt.nlp	21731376	SENT82	31	31	15	15	loperamide	castor	PA450262	54897	0.887
NULL	Breast_Cancer_(Auckl)_2012_Mar_7_6_67-77.nxml.txt.nlp	22438669	SENT114	0	0	4	4	lapatinib	aromatase	PA152241907	1588	0.887
NULL	Nat_Med_2010_Sep_22_16(9)_998-1000.nxml.txt.nlp	20729864	SENT30	16	16	25	25	sorafenib	LRRK2	PA7000	120892	0.887
NULL	Endocrinol_Metab_(Seoul)_2013_Dec_12_28(4)_262-274.nxml.txt.nlp	24396690	SENT164	7	7	31	31	exenatide	GLP-1	PA164749238	100125288	0.887
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Mar_28_68(Pt_4)_o1220.nxml.txt.nlp	22606157	SENT57	19	19	13	13	ethanol	mol	PA448073	90527	0.887
NULL	Arthritis_Res_Ther_2007_Oct_9_9(5)_R104.nxml.txt.nlp	17925024	SENT149	23	23	14	14	glucosamine	p38	PA164747613	10598;1432;7965	0.887
NULL	Exp_Lung_Res_2013_Oct_1_39(8)_336-348.nxml.txt.nlp	23919450	SENT112	5	5	0	0	argatroban	PAR-1	PA164745516	2011;2149	0.887
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT138	9	9	14	14	neratinib	EGFR	PA165291472	1956	0.887
NULL	Curr_Opin_Nephrol_Hypertens_2015_Jan_4_24(1)_37-46.nxml.txt.nlp	25427230	SENT183	8	8	16	16	gemfibrozil	UGT	PA449750	7361;7355	0.887
NULL	Oncotarget_2013_Oct_19_4(11)_2045-2056.nxml.txt.nlp	24185104	SENT144	31	31	13	13	cisplatin	p38	PA449014	10598;1432;7965	0.887
NULL	Cancer_Cell_Int_2011_Nov_2_11_39.nxml.txt.nlp	22047021	SENT415	16	16	4	4	cisplatin	REV3	PA449014	5980	0.887
NULL	Aging_(Albany_NY)_2014_Oct_28_6(10)_820-834.nxml.txt.nlp	25361036	SENT239	6	6	14	14	resveratrol	PARP-1		25976	0.887
NULL	J_Oncol_2010_Dec_15_2010_821717.nxml.txt.nlp	20049172	SENT267	29	29	18	18	paclitaxel	TUBB3	PA450761	10381	0.887
NULL	Mult_Scler_Int_2013_Jan_10_2013_231345.nxml.txt.nlp	23365753	SENT33	30	30	18	18	azathioprine	IFN	PA448515	3439	0.887
NULL	Acta_Pharmacol_Sin_2010_Feb_5_31(2)_184-190.nxml.txt.nlp	20139901	SENT44	33	33	20	20	metformin	SLC22A2	PA450395	6582	0.887
NULL	Open_Access_J_Urol_2011_May_10_3_69-82.nxml.txt.nlp	24198638	SENT35	26	26	37	37	sorafenib	Raf-1	PA7000	5894	0.887
NULL	Oncol_Lett_2015_Feb_3_9(2)_757-761.nxml.txt.nlp	25621047	SENT157	22	22	13	13	olaparib	RAD51		5888	0.887
NULL	J_Cancer_Prev_2014_Mar_19(1)_39-46.nxml.txt.nlp	25337571	SENT97	29	29	17	17	ethanol	p53	PA448073	7157	0.887
NULL	Ann_N_Y_Acad_Sci_2012_Oct_10_1271(1)_20-32.nxml.txt.nlp	23050960	SENT132	4	4	16	16	vorinostat	LC3	PA164748224	84557	0.887
NULL	Br_J_Cancer_2014_Nov_25_111(11)_2091-2102.nxml.txt.nlp	25349971	SENT243	11	11	16	16	imatinib	KIT	PA10804	3815	0.887
NULL	Int_J_Biol_Sci_2013_Mar_7_9(3)_279-288.nxml.txt.nlp	23493630	SENT194	3	3	15	15	tocilizumab	IL-21	PA165292659	59067;50616;27189	0.887
NULL	Acta_Pharmacol_Sin_2010_Apr_15_31(4)_421-428.nxml.txt.nlp	20228827	SENT45	25	25	31	31	phenylephrine	mol	PA450935	90527	0.887
NULL	Oncol_Lett_2014_May_11_7(5)_1401-1408.nxml.txt.nlp	24765145	SENT109	24	24	7	7	paclitaxel	PI3K	PA450761	5290	0.887
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT134	13	13	20	20	tenofovir	ABCB1	PA10204	5243	0.887
NULL	Endocrinol_Metab_(Seoul)_2014_Sep_25_29(3)_356-362.nxml.txt.nlp	25309795	SENT8	13	13	9	9	hemin	HO-1	PA449849	3162	0.887
NULL	ScientificWorldJournal_2013_Jun_24_2013_534807.nxml.txt.nlp	23864826	SENT193	1	1	34	34	diazepam	SNK	PA449283	10769	0.887
NULL	Carcinogenesis_2010_Dec_27_31(12)_2049-2057.nxml.txt.nlp	20876285	SENT202	12	12	6	6	tamoxifen	HER2	PA451581	2064	0.887
NULL	J_Headache_Pain_2011_Aug_25_12(4)_399-403.nxml.txt.nlp	21437713	SENT17	11	11	16	16	naratriptan	OTC	PA450597	5009	0.887
NULL	Cardiol_Res_Pract_2011_Aug_15_2011_156146.nxml.txt.nlp	21876822	SENT182	15	15	3	3	oxygen	eNOS	PA450744	4846	0.887
NULL	Acta_Pharmacol_Sin_2013_Apr_11_34(4)_570-580.nxml.txt.nlp	23396375	SENT186	3	3	21	21	tegafur	DPD	PA452620	1806	0.887
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1522-1532.nxml.txt.nlp	21997136	SENT256	6	6	3	3	lapatinib	EGFR	PA152241907	1956	0.887
NULL	Chonnam_Med_J_2013_Apr_25_49(1)_31-37.nxml.txt.nlp	23678475	SENT120	10	10	32	32	rosuvastatin	adiponectin	PA134308647	9370	0.887
NULL	Br_J_Cancer_2010_Jun_8_102(12)_1699-1706.nxml.txt.nlp	20485286	SENT160	10	10	25	25	sunitinib	CYP3A	PA162372840	1574	0.887
NULL	J_Gen_Intern_Med_2009_Nov_18_24(Suppl_2)_389-394.nxml.txt.nlp	19838837	SENT57	20	20	7	7	denosumab	RANKL	PA166048634	8600	0.887
NULL	Exp_Mol_Med_2012_Sep_30_44(9)_545-553.nxml.txt.nlp	22809901	SENT67	15	15	11	11	quetiapine	PRDM16	PA451201	63976	0.887
NULL	Mol_Biol_Cell_2012_Jul_1_23(13)_2571-2582.nxml.txt.nlp	22573884	SENT94	12	12	8	8	dextran	EEA1	PA449261	8411	0.887
NULL	Int_Semin_Surg_Oncol_2006_Sep_18_3_31.nxml.txt.nlp	16981992	SENT30	17	17	1	1	tamoxifen	ATAC	PA451581	6375	0.887
NULL	Br_J_Cancer_2012_Jan_3_106(1)_107-115.nxml.txt.nlp	22116303	SENT111	7	7	22	22	vorinostat	AKT	PA164748224	207	0.887
NULL	Arthritis_Res_Ther_2014_Apr_11_16(2)_R93.nxml.txt.nlp	24725461	SENT45	26	26	23	23	letrozole	aromatase	PA450196	1588	0.887
NULL	Br_J_Cancer_2010_Nov_2_103(11)_1671-1679.nxml.txt.nlp	21045835	SENT183	38	38	24	24	gemcitabine	CXCR4	PA449748	7852	0.887
NULL	Hum_Genet_2014_Nov_19_133(4)_463-469.nxml.txt.nlp	24241281	SENT123	32	32	16	16	cetuximab	KRAS	PA10040	3845	0.887
NULL	Core_Evid_2011_Mar_17_6_31-42.nxml.txt.nlp	21468241	SENT148	28	28	8	8	ticagrelor	ADP	PA165374673	23038	0.887
NULL	Braz_J_Med_Biol_Res_2013_Dec_2_46(12)_1000-1006.nxml.txt.nlp	24345907	SENT6	17	17	4	4	vasopressin	SON	PA451858	6651	0.887
NULL	Nucleic_Acids_Res_2011_Jun_15_39(11)_4890-4899.nxml.txt.nlp	21325266	SENT132	18	18	44	44	thyroglobulin	B12	PA164754910	7126;4709	0.887
NULL	J_Gynecol_Oncol_2013_Jan_8_24(1)_66-82.nxml.txt.nlp	23346316	SENT6	10	10	19	19	bevacizumab	ADP	PA130232992	23038	0.887
NULL	Nucleic_Acids_Res_2013_Dec_21_41(22)_10283-10297.nxml.txt.nlp	24005041	SENT37	11	11	27	27	mitomycin	FANCD2	PA450524	2177	0.887
NULL	Clin_Pract_2013_Jan_25_3(1)_e2.nxml.txt.nlp	24765495	SENT58	25	25	20	20	l-arginine	CTLN1	PA448478	445	0.887
NULL	J_Vet_Med_Sci_2014_Oct_19_76(10)_1339-1345.nxml.txt.nlp	24942113	SENT172	5	5	21	21	losartan	AT2	PA450268	186	0.887
NULL	Br_J_Haematol_2014_Jul_25_166(1)_77-83.nxml.txt.nlp	24661044	SENT21	12	12	6	6	vincristine	CHOP	PA451879	1649	0.887
NULL	Chin_J_Cancer_2012_Aug_31(8)_373-380.nxml.txt.nlp	22739266	SENT104	11	11	2	2	cytarabine	XRCC3	PA449177	7517	0.887
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_May_22_66(Pt_6)_o1412.nxml.txt.nlp	21579491	SENT53	25	25	6	6	ethanol	mol	PA448073	90527	0.887
NULL	Ital_J_Pediatr_2014_Jun_7_40_55.nxml.txt.nlp	24906390	SENT151	3	3	1	1	denosumab	OPG	PA166048634	690	0.887
NULL	Acta_Naturae_2013_Oct-Dec_5(4)_83-93.nxml.txt.nlp	24455187	SENT141	8	8	27	27	methotrexate	7SL	PA450428	6029	0.887
NULL	Aging_(Albany_NY)_2009_Mar_31_1(4)_412-424.nxml.txt.nlp	20195491	SENT121	0	0	21	21	resveratrol	TXNIP		10628	0.887
NULL	J_Gastroenterol_2013_Jan_24_48(1)_13-21.nxml.txt.nlp	23090000	SENT146	24	24	6	6	telbivudine	IFN	PA164760861	3439	0.887
NULL	Scientifica_(Cairo)_2012_Nov_25_2012_473829.nxml.txt.nlp	24278698	SENT234	14	14	0	0	cisplatin	ATP7A	PA449014	538	0.887
NULL	Amyloid_2014_Sep_11_21(3)_175-184.nxml.txt.nlp	24918964	SENT106	11	11	3	3	anakinra	TTR	PA10799	7276	0.887
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_27_2014_715937.nxml.txt.nlp	25525447	SENT168	3	3	7	7	amiodarone	SCN2A	PA448383	6326	0.887
NULL	Biomed_Res_Int_2014_Jan_20_2014_948427.nxml.txt.nlp	24563867	SENT216	23	23	5	5	buspirone	COB	PA448689	4519	0.887
NULL	Int_J_Cell_Biol_2014_Jan_22_2014_156020.nxml.txt.nlp	24587804	SENT48	0	0	9	9	metformin	PGC1	PA450395	10891	0.887
NULL	Nat_Commun_2013_Sep_4_4_2338.nxml.txt.nlp	24005565	SENT552	28	28	3	3	camptothecin	HELQ	PA153590860	113510	0.887
NULL	Eur_J_Clin_Pharmacol_2012_Jan_8_68(1)_29-37.nxml.txt.nlp	21739267	SENT210	2	2	19	19	aripiprazole	CYP2D6	PA10026	1565	0.887
NULL	Clin_Drug_Investig_2014_Nov_9_34(2)_107-115.nxml.txt.nlp	24214232	SENT43	37	37	12	12	cinacalcet	IMPACT	PA164776671	55364	0.887
NULL	Br_J_Cancer_1995_Oct_72(4)_1013-1015.nxml.txt.nlp	7547213	SENT4	0	0	6	6	buspirone	5-HT1A	PA448689	3350	0.887
NULL	Iran_J_Pharm_Res_2014_Autumn_13(4)_1241-1247.nxml.txt.nlp	25587313	SENT52	35	35	20	20	vancomycin	ANOVA	PA451850	4858	0.887
NULL	Patient_Prefer_Adherence_2013_Jun_19_7_531-542.nxml.txt.nlp	23814462	SENT5	17	17	2	2	efavirenz	CD4	PA449441	920	0.887
NULL	Cell_Death_Dis_2014_Feb_27_5(2)_e1088.nxml.txt.nlp	24577086	SENT80	16	16	24	24	metformin	Bcl-2	PA450395	596	0.887
NULL	Int_J_Biomed_Sci_2006_Dec_2(4)_333-336.nxml.txt.nlp	23675001	SENT57	2	2	8	8	telmisartan	NEFA	PA451605	4925	0.887
NULL	J_Invest_Dermatol_2012_Jun_8_132(6)_1605-1614.nxml.txt.nlp	22402440	SENT274	12	12	23	23	bleomycin	IL-6	PA448645	3569	0.887
NULL	Ital_J_Pediatr_2013_Jun_5_39_37.nxml.txt.nlp	23738960	SENT21	1	1	19	19	bumetanide	NKCC1	PA448682	6558	0.887
NULL	J_Cell_Mol_Med_2014_May_14_18(5)_811-823.nxml.txt.nlp	24628949	SENT16	12	12	2	2	docetaxel	FOXM1	PA449383	2305	0.887
NULL	Cell_Cycle_2013_Dec_15_12(24)_3791-3803.nxml.txt.nlp	24107631	SENT43	14	14	8	8	doxorubicin	YB-1	PA449412	4904	0.887
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Feb_4_68(Pt_3)_o589-o590.nxml.txt.nlp	22412505	SENT4	20	20	1	1	piperazine	mol	PA450977	90527	0.887
NULL	Cancer_Imaging_2008_Nov_25_8(1)_199-205.nxml.txt.nlp	19028612	SENT107	9	9	5	5	sorafenib	VEGFR	PA7000	3791	0.887
NULL	Case_Rep_Otolaryngol_2013_Feb_14_2013_875607.nxml.txt.nlp	23476859	SENT17	30	30	17	17	temozolomide	gamma	PA451609	9913	0.887
NULL	J_Cell_Biol_2003_Aug_18_162(4)_673-682.nxml.txt.nlp	12913111	SENT78	12	12	5	5	doxycycline	L12	PA449415	26156;6136	0.887
NULL	Neuroscience_2009_Jun_30_161(2-3)_572-577.nxml.txt.nlp	19327387	SENT59	8	8	16	16	capsaicin	TRPV1	PA448776	7442	0.887
NULL	eLife_2014_Apr_30_3_e02445.nxml.txt.nlp	24843000	SENT236	7	7	14	14	mimosine	RAD51	PA164752445	5888	0.887
NULL	Exp_Ther_Med_2013_Jan_1_5(1)_338-342.nxml.txt.nlp	23251295	SENT92	29	29	22	22	everolimus	HK2	PA164746311	3796;3099;29911;3741	0.887
NULL	Curr_Pharm_Des_2011_Apr_17(10)_985-989.nxml.txt.nlp	21524255	SENT58	21	21	14	14	vasopressin	PAC1	PA451858	8624;1316;117	0.887
NULL	Extremophiles_2009_Sep_5_13(5)_769-783.nxml.txt.nlp	19579003	SENT106	20	20	33	33	lipase	mol	PA450239	90527	0.887
NULL	Am_J_Trop_Med_Hyg_2014_Sep_3_91(3)_439.nxml.txt.nlp	25187668	SENT19	14	14	17	17	doxycycline	CD4	PA449415	920	0.886
NULL	Alzheimers_Res_Ther_2010_Oct_29_2(5)_31.nxml.txt.nlp	21062519	SENT65	5	5	15	15	simvastatin	PSEN1	PA451363	5663	0.886
NULL	Patient_Prefer_Adherence_2010_Sep_7_4_313-324.nxml.txt.nlp	20859458	SENT50	20	20	2	2	metformin	AMIGO	PA450395	57463	0.886
NULL	Cancers_(Basel)_2014_Aug_12_6(3)_1631-1669.nxml.txt.nlp	25119536	SENT101	10	10	23	23	imatinib	CXCR4	PA10804	7852	0.886
NULL	J_Cell_Biol_2001_Apr_2_153(1)_207-220.nxml.txt.nlp	11285286	SENT127	23	23	1	1	carbachol	DGK	PA448784	8526;1607	0.886
NULL	Oncoscience_2014_Mar_12_1(2)_158-166.nxml.txt.nlp	25594008	SENT126	12	12	6	6	dasatinib	PTRF	PA162372878	284119	0.886
NULL	J_Immunother_2014_Apr_12_37(3)_180-186.nxml.txt.nlp	24598448	SENT16	4	4	1	1	sorafenib	IL-2	PA7000	3558	0.886
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Sep_9_65(Pt_10)_o2390.nxml.txt.nlp	21577854	SENT78	33	33	15	15	ethanol	mol	PA448073	90527	0.886
NULL	J_Carcinog_2012_Sep_13_11_15.nxml.txt.nlp	23230392	SENT127	15	15	19	19	panitumumab	EGFR	PA162373091	1956	0.886
NULL	Environ_Toxicol_Chem_2014_Oct_25_33(10)_2363-2367.nxml.txt.nlp	25043914	SENT82	18	18	7	7	galactose	ARNT	PA449725	405	0.886
NULL	Breast_Cancer_Res_2005_Dec_7_7(1)_R156-R163.nxml.txt.nlp	15642164	SENT141	20	20	26	26	letrozole	aromatase	PA450196	1588	0.886
NULL	Genome_Biol_2003_Jan_30_4(2)_305.nxml.txt.nlp	12620114	SENT145	42	42	37	37	geldanamycin	Hsp90	PA152031327	3320	0.886
NULL	Oncotarget_2013_Apr_10_4(4)_622-635.nxml.txt.nlp	23599172	SENT76	8	8	13	13	lapatinib	EGF	PA152241907	1950	0.886
NULL	Diabetes_2013_Oct_17_62(10)_3500-3513.nxml.txt.nlp	23884882	SENT204	2	2	14	14	resveratrol	PDX1		8050;3651	0.886
NULL	Org_Med_Chem_Lett_2014_Feb_28_4_1.nxml.txt.nlp	24576663	SENT65	10	10	25	25	ethanol	mol	PA448073	90527	0.886
NULL	BMB_Rep_2013_Aug_46(8)_410-415.nxml.txt.nlp	23977989	SENT214	1	1	18	18	curcumin	AP-1	PA151958596	2353;3727;2354;3725	0.886
NULL	Br_J_Cancer_2010_Feb_16_102(4)_658-664.nxml.txt.nlp	20104222	SENT133	21	21	18	18	sunitinib	IFN	PA162372840	3439	0.886
NULL	Oncotarget_2014_Jun_7_5(14)_5257-5271.nxml.txt.nlp	24913448	SENT55	6	6	12	12	nilotinib	CRKL	PA165958345	1399	0.886
NULL	Mol_Cell_Biochem_2013_Jun_13_378(1-2)_229-236.nxml.txt.nlp	23483428	SENT144	29	29	37	37	methotrexate	DHFR	PA450428	1719	0.886
NULL	Cancers_(Basel)_2014_Aug_12_6(3)_1631-1669.nxml.txt.nlp	25119536	SENT368	4	4	0	0	pha-665752	Met		79811	0.886
NULL	Case_Rep_Hematol_2014_May_8_2014_272458.nxml.txt.nlp	24900929	SENT27	13	13	38	38	etoposide	CD34	PA449552	947	0.886
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT295	2	2	21	21	atorvastatin	PIK3CA	PA448500	5290	0.886
NULL	Anat_Cell_Biol_2011_Sep_29_44(3)_169-175.nxml.txt.nlp	22025968	SENT53	11	11	3	3	ethanol	CLU	PA448073	1191	0.886
NULL	Mol_Cancer_2007_Sep_18_6_56.nxml.txt.nlp	17877814	SENT173	40	40	4	4	erlotinib	EGFR	PA134687924	1956	0.886
NULL	Oncol_Rep_2013_Jun_2_29(6)_2095-2100.nxml.txt.nlp	23563900	SENT122	21	21	3	3	sorafenib	EGFR	PA7000	1956	0.886
NULL	Neuropsychopharmacology_2009_Jul_25_34(8)_1968-1978.nxml.txt.nlp	19322168	SENT226	3	3	14	14	clozapine	PI3K	PA449061	5290	0.886
NULL	Br_J_Pharmacol_2008_Oct_18_155(4)_596-605.nxml.txt.nlp	18852694	SENT20	4	4	23	23	fenofibrate	SREBP2	PA449594	6721	0.886
NULL	Front_Cell_Neurosci_2014_Jul_28_8_209.nxml.txt.nlp	25120433	SENT11	2	2	11	11	potassium	KCNT1	PA451047	57582	0.886
NULL	Cardiovasc_Diabetol_2013_Oct_17_12_150.nxml.txt.nlp	24134550	SENT34	41	41	24	24	pioglitazone	activin	PA450970	83729	0.886
NULL	J_Cancer_2014_Jul_4_5(7)_559-571.nxml.txt.nlp	25057307	SENT249	29	29	13	13	lapatinib	HER2	PA152241907	2064	0.886
NULL	Oncotarget_2014_Jun_7_5(14)_5257-5271.nxml.txt.nlp	24913448	SENT88	5	5	31	31	nilotinib	LASP1	PA165958345	3927	0.886
NULL	FEBS_Open_Bio_2013_Dec_30_4_96-104.nxml.txt.nlp	24490130	SENT561	7	7	0	0	cisplatin	BRCA1	PA449014	672	0.886
NULL	Br_J_Cancer_2012_Jan_3_106(1)_6-13.nxml.txt.nlp	22215104	SENT20	1	1	27	27	trastuzumab	HER2	PA451743	2064	0.886
NULL	Cardiol_Res_Pract_2011_Apr_26_2011_874802.nxml.txt.nlp	21577272	SENT80	12	12	1	1	dronedarone	CYP3A4	PA153619853	1576	0.886
NULL	Patient_Prefer_Adherence_2011_Dec_23_6_1-9.nxml.txt.nlp	22272064	SENT122	9	9	6	6	telmisartan	ACE	PA451605	1636	0.886
NULL	J_Korean_Med_Sci_2009_Jun_12_24(3)_448-452.nxml.txt.nlp	19543508	SENT104	16	16	21	21	gefitinib	EGFR	PA131301952	1956	0.886
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1495-1502.nxml.txt.nlp	21989186	SENT21	2	2	29	29	panitumumab	KRAS	PA162373091	3845	0.886
NULL	Mol_Cancer_2007_Oct_11_6_63.nxml.txt.nlp	17931419	SENT57	15	15	12	12	cetuximab	EGFR	PA10040	1956	0.886
NULL	Exp_Lung_Res_2013_Oct_1_39(8)_336-348.nxml.txt.nlp	23919450	SENT204	5	5	17	17	thrombin	PAR-1	PA451674	2011;2149	0.886
NULL	EMBO_Mol_Med_2013_Jul_30_5(7)_932-948.nxml.txt.nlp	23723167	SENT77	23	23	3	3	pilocarpine	MMP13	PA450962	4322	0.886
NULL	Br_J_Cancer_1998_77(2)_201-209.nxml.txt.nlp	9460989	SENT11	32	32	8	8	melphalan	MRP1	PA450354	4437	0.886
NULL	Front_Microbiol_2014_Mar_14_5_99.nxml.txt.nlp	24672516	SENT86	30	30	20	20	caspofungin	TLR2	PA164743013	7097	0.886
NULL	JAKSTAT_2013_Jan_1_2(1)_e23576.nxml.txt.nlp	24058797	SENT58	22	22	16	16	staurosporine	IFN	PA165109623	3439	0.886
NULL	Breast_Cancer_Res_2004_Mar_26_6(3)_R252-R263.nxml.txt.nlp	15084249	SENT178	21	21	0	0	tamoxifen	NAT1	PA451581	9;1982	0.886
NULL	J_Hematol_Oncol_2008_Oct_1_1_16.nxml.txt.nlp	18828924	SENT117	22	22	17	17	trastuzumab	HER2	PA451743	2064	0.886
NULL	Br_J_Cancer_2009_Jul_7_101(1)_116-123.nxml.txt.nlp	19491899	SENT18	15	15	11	11	irinotecan	CRT	PA450085	811	0.886
NULL	Acta_Pharmacol_Sin_2010_Jul_28_31(7)_867-873.nxml.txt.nlp	20581857	SENT212	5	5	0	0	docetaxel	PDCD4	PA449383	27250	0.886
NULL	Korean_Circ_J_2013_Jun_30_43(6)_400-407.nxml.txt.nlp	23882289	SENT144	25	25	10	10	doxorubicin	survivin	PA449412	332	0.886
NULL	Cell_Death_Differ_2010_Apr_23_17(4)_699-709.nxml.txt.nlp	19851330	SENT295	3	3	25	25	tetracycline	PUMA	PA451640	27113	0.886
NULL	Leukemia_2013_Jan_11_27(1)_32-40.nxml.txt.nlp	22781593	SENT33	4	4	12	12	ponatinib	FGFR1	PA165980594	2260	0.886
NULL	Cancers_(Basel)_2013_Jul_24_5(3)_901-918.nxml.txt.nlp	24202326	SENT7	24	24	34	34	bortezomib	CDC7	PA10252	8317	0.886
NULL	Arthritis_Res_Ther_2012_May_1_14(3)_R99.nxml.txt.nlp	22546542	SENT12	24	24	1	1	infliximab	CD4	PA452639	920	0.886
NULL	Pharmaceutics_2011_Nov_18_3(4)_865-913.nxml.txt.nlp	24309312	SENT532	15	15	10	10	nifedipine	CYP3A4	PA450631	1576	0.886
NULL	Front_Immunol_2012_Jan_24_3_3.nxml.txt.nlp	22566889	SENT109	14	14	28	28	rituximab	IL-2	PA451261	3558	0.886
NULL	Arthritis_Res_Ther_2011_Feb_28_13(1)_205.nxml.txt.nlp	21371351	SENT180	8	8	6	6	rituximab	BAFF	PA451261	10673	0.886
NULL	Oncogene_2010_Nov_18_29(46)_6115-6124.nxml.txt.nlp	20729912	SENT84	26	26	12	12	doxorubicin	ABCB5	PA449412	340273	0.886
NULL	Braz_J_Med_Biol_Res_2014_Sep_5_47(11)_929-939.nxml.txt.nlp	25296354	SENT144	18	18	9	9	erlotinib	EGFR	PA134687924	1956	0.886
NULL	Ther_Clin_Risk_Manag_2005_Mar_1(1)_3-13.nxml.txt.nlp	18360537	SENT61	21	21	12	12	verapamil	CYP3A4	PA451868	1576	0.886
NULL	J_Oncol_2012_Aug_25_2012_782020.nxml.txt.nlp	21876694	SENT213	18	18	8	8	cyclophosphamide	VEGFR2	PA449165	3791	0.886
NULL	Front_Genet_2012_Nov_5_3_236.nxml.txt.nlp	23133441	SENT66	17	17	3	3	efavirenz	ABCB1	PA449441	5243	0.886
NULL	Clin_Ophthalmol_2008_Jun_2(2)_355-368.nxml.txt.nlp	19668727	SENT214	12	12	3	3	nepafenac	PRK	PA165958407	1263	0.886
NULL	Oxid_Med_Cell_Longev_2013_Jun_6_2013_891748.nxml.txt.nlp	23840922	SENT280	6	6	10	10	resveratrol	NQO1		1728	0.886
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Apr_15_6_37-41.nxml.txt.nlp	24833915	SENT4	16	16	36	36	pertuzumab	HER2		2064	0.886
NULL	J_Ginseng_Res_2011_Sep_35(3)_315-324.nxml.txt.nlp	23717075	SENT271	17	17	5	5	docetaxel	NF-kappaB	PA449383	4790	0.886
NULL	J_Cell_Mol_Med_2014_Aug_28_18(8)_1655-1666.nxml.txt.nlp	24975047	SENT81	43	43	15	15	paraformaldehyde	TMEM106A	PA450790	113277	0.886
NULL	Exp_Cell_Res_2011_May_1_317(8)_1093-1107.nxml.txt.nlp	21320486	SENT252	8	8	20	20	bortezomib	APPL1	PA10252	26060	0.886
NULL	Appl_Clin_Genet_2010_Oct_29_3_85-101.nxml.txt.nlp	23776354	SENT136	27	27	31	31	imatinib	PDGFRA	PA10804	5156	0.886
NULL	Eur_Respir_J_2012_Nov_26_40(5)_1106-1114.nxml.txt.nlp	23060624	SENT186	35	35	20	20	tiotropium	TDI	PA164769056	100038246	0.886
NULL	Springerplus_2013_Jan_25_2_23.nxml.txt.nlp	23805410	SENT85	25	25	8	8	paraformaldehyde	CO2	PA450790	4513	0.886
NULL	Ann_Clin_Microbiol_Antimicrob_2015_Jan_16_14(1)_4.nxml.txt.nlp	NULL	SENT39	14	14	3	3	clavulanate	CTX	PA164742987	1593	0.886
NULL	Open_Orthop_J_2008_Oct_24_2_137-144.nxml.txt.nlp	19478889	SENT163	9	9	0	0	heparin	GPC3	PA449855	2719	0.886
NULL	Vet_Res_2013_Oct_2_44(1)_89.nxml.txt.nlp	24088531	SENT231	39	39	20	20	hemin	HO-1	PA449849	3162	0.886
NULL	CNS_Neurosci_Ther_2009_Jun_15(2)_157-182.nxml.txt.nlp	19298613	SENT468	17	17	26	26	nadh	Q10	PA164755085	27161	0.886
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R91.nxml.txt.nlp	22541814	SENT210	29	29	25	25	thrombin	HO-1	PA451674	3162	0.886
NULL	Nature_2009_Apr_2_458(7238)_591-596.nxml.txt.nlp	19234442	SENT76	23	23	10	10	etoposide	JNK1	PA449552	5599	0.886
NULL	Mol_Cancer_2008_May_21_7_42.nxml.txt.nlp	18492291	SENT4	0	0	14	14	gefitinib	EGFR	PA131301952	1956	0.886
NULL	Biology_(Basel)_2012_Dec_13_1(3)_869-879.nxml.txt.nlp	24832521	SENT55	27	27	34	34	forskolin	CCR5	PA146096022	1234	0.886
NULL	Biosci_Rep_2012_Aug_1_32(Pt_4)_361-374.nxml.txt.nlp	22762204	SENT182	23	23	12	12	paclitaxel	LATS2	PA450761	26524	0.886
NULL	Mol_Cancer_2010_May_20_9_115.nxml.txt.nlp	20487546	SENT168	7	7	38	38	fludarabine	IPA	PA449655	3160	0.886
NULL	Indian_J_Pharmacol_2014_Jul-Aug_46(4)_404-408.nxml.txt.nlp	25097278	SENT28	27	27	33	33	ketorolac	COX	PA450150	1351	0.886
NULL	Reprod_Biol_Endocrinol_2003_Nov_10_1_94.nxml.txt.nlp	14613530	SENT76	8	8	16	16	estradiol	IL-8	PA449503	3576	0.886
NULL	Nucleic_Acids_Res_2005_Mar_22_33(5)_1722-1736.nxml.txt.nlp	15784612	SENT13	27	27	5	5	chloramphenicol	ENO1	PA448927	2023	0.886
NULL	Arthritis_Res_Ther_2005_Aug_31_7(5)_208-214.nxml.txt.nlp	16207350	SENT111	0	0	5	5	methotrexate	FasL	PA450428	356	0.886
NULL	Cancer_Med_2013_Aug_30_2(4)_457-467.nxml.txt.nlp	24156018	SENT156	0	0	14	14	temozolomide	MMP14	PA451609	4323	0.886
NULL	J_Hematol_Oncol_2008_Oct_1_1_16.nxml.txt.nlp	18828924	SENT79	29	29	21	21	trastuzumab	HER2	PA451743	2064	0.886
NULL	J_Hematol_Oncol_2014_Aug_1_7_52.nxml.txt.nlp	25085632	SENT13	10	10	17	17	sunitinib	KRAS	PA162372840	3845	0.886
NULL	Breast_Cancer_(Auckl)_2009_Sep_2_3_61-75.nxml.txt.nlp	19809577	SENT149	8	8	18	18	curcumin	BRCA1	PA151958596	672	0.886
NULL	J_Hematol_Oncol_2014_Apr_4_7_30.nxml.txt.nlp	24708874	SENT51	30	30	5	5	sulfasalazine	xCT	PA451547	23657	0.886
NULL	Ther_Clin_Risk_Manag_2007_Jun_3(3)_363-379.nxml.txt.nlp	18488081	SENT5	17	17	28	28	rabeprazole	CYP2C19	PA451216	1557	0.886
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Dec_17_3(12)_e152.nxml.txt.nlp	25518025	SENT57	14	14	7	7	oxymorphone	CYP3A4	PA450748	1576	0.886
NULL	Breast_Cancer_Res_2010_Jul_22_12(4)_R53.nxml.txt.nlp	20649975	SENT29	23	23	10	10	tamoxifen	HOXB13	PA451581	10481	0.886
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2007_Dec_6_64(Pt_1)_o119.nxml.txt.nlp	21200682	SENT70	19	19	11	11	ethanol	mol	PA448073	90527	0.886
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1063.nxml.txt.nlp	24556678	SENT50	4	4	7	7	thioridazine	c-FLIP	PA451666	8837	0.886
NULL	Mol_Cancer_2012_Dec_12_11_91.nxml.txt.nlp	23234355	SENT196	37	37	23	23	erlotinib	EGFR	PA134687924	1956	0.886
NULL	J_Korean_Med_Sci_2013_Apr_27_28(4)_527-533.nxml.txt.nlp	23580227	SENT55	15	15	21	21	genistein	TRAIL	PA165109660	8743	0.886
NULL	Breast_Cancer_Res_2007_Aug_8_9(4)_R50.nxml.txt.nlp	17686159	SENT13	5	5	14	14	trastuzumab	HRG	PA451743	3084;3273	0.886
NULL	Diabetes_Care_2009_Apr_32(4)_531-540.nxml.txt.nlp	19336638	SENT186	4	4	13	13	clopidogrel	ADP	PA449053	23038	0.886
NULL	Clin_Med_Insights_Oncol_2012_Feb_28_6_125-135.nxml.txt.nlp	22408376	SENT148	7	7	20	20	panitumumab	KRAS	PA162373091	3845	0.886
NULL	Clin_Ophthalmol_2008_Jun_2(2)_355-368.nxml.txt.nlp	19668727	SENT81	16	16	34	34	bromfenac	COX2	PA448670	4513;5743	0.886
NULL	Br_J_Cancer_2011_Oct_25_105(9)_1260-1266.nxml.txt.nlp	21989185	SENT25	5	5	7	7	tamoxifen	aromatase	PA451581	1588	0.886
NULL	Mol_Biol_Cell_2014_Jul_1_25(13)_2116-2127.nxml.txt.nlp	24807908	SENT214	10	10	34	34	hemin	NQO1	PA449849	1728	0.886
NULL	Ann_Saudi_Med_2011_May-Jun_31(3)_279-283.nxml.txt.nlp	21623058	SENT23	28	28	16	16	basiliximab	CD52	PA164747126	1043	0.886
NULL	J_Inherit_Metab_Dis_2012_Jan_10_35(1)_141-149.nxml.txt.nlp	21556832	SENT185	32	32	41	41	creatine	CRTR	PA164778930	6535	0.886
NULL	Curr_Neuropharmacol_2011_Dec_9(4)_530-552.nxml.txt.nlp	22654714	SENT143	11	11	24	24	lithium	BDNF	PA450243	627	0.886
NULL	Mol_Vis_2011_Feb_1_17_332-340.nxml.txt.nlp	21297899	SENT179	0	0	12	12	benazepril	DPI	PA448561	1832	0.886
NULL	Blood_Res_2014_Mar_24_49(1)_36-41.nxml.txt.nlp	24724065	SENT107	37	37	33	33	doxorubicin	CHOP	PA449412	1649	0.886
NULL	Arthritis_Res_Ther_2005_Feb_21_7(3)_R439-R444.nxml.txt.nlp	15899030	SENT3	4	4	41	41	infliximab	TP2	PA452639	7015;7142	0.886
NULL	Front_Oncol_2014_Oct_13_4_229.nxml.txt.nlp	25353005	SENT72	21	21	7	7	trastuzumab	EGFR	PA451743	1956	0.886
NULL	Drugs_Context_2012_Nov_19_2012_212242.nxml.txt.nlp	24432031	SENT231	8	8	12	12	dacarbazine	IFN	PA449197	3439	0.886
NULL	Target_Oncol_2012_Mar_2_7(1)_55-68.nxml.txt.nlp	22383042	SENT135	8	8	18	18	cyclophosphamide	IL-7	PA449165	3574	0.886
NULL	J_Cancer_2013_Mar_15_4(3)_262-269.nxml.txt.nlp	23459716	SENT34	16	16	5	5	oxaliplatin	PSM	PA131285527	2346	0.886
NULL	Indian_J_Psychiatry_2008_Apr-Jun_50(2)_135-137.nxml.txt.nlp	19742212	SENT42	21	21	7	7	metformin	B12	PA450395	7126;4709	0.886
NULL	Cancers_(Basel)_2010_Nov_29_2(4)_2026-2043.nxml.txt.nlp	24281216	SENT38	0	0	20	20	erlotinib	EGFR	PA134687924	1956	0.886
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT109	11	11	31	31	glucose	PP2	PA449773	4888	0.886
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT133	4	4	22	22	chloroquine	BMPR-II	PA448948	659	0.886
NULL	Chemother_Res_Pract_2011_Feb_6_2011_249867.nxml.txt.nlp	22312550	SENT47	22	22	9	9	clarithromycin	CAP	PA449028	23476;9200;4012;5269;10580;10487	0.886
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_79-96.nxml.txt.nlp	19305789	SENT168	12	12	4	4	capsaicin	TRPV1	PA448776	7442	0.886
NULL	Orphanet_J_Rare_Dis_2013_Aug_6_8_116.nxml.txt.nlp	23915644	SENT246	9	9	20	20	paricalcitol	CD74	PA450798	972	0.886
NULL	J_Biomed_Biotechnol_2011_Jul_6_2011_783528.nxml.txt.nlp	21785566	SENT148	25	25	9	9	saquinavir	CYP3A4	PA451305	1576	0.886
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1495-1502.nxml.txt.nlp	21989186	SENT71	20	20	10	10	panitumumab	HSI	PA162373091	57016	0.886
NULL	J_Korean_Med_Sci_2013_Feb_29_28(2)_308-314.nxml.txt.nlp	23399960	SENT33	18	18	10	10	gabapentin	IL-10	PA449720	3586	0.886
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT65	19	19	1	1	pemetrexed	UNG	PA10810	7374	0.886
NULL	BMJ_Open_2014_Feb_27_4(2)_e004071.nxml.txt.nlp	24578536	SENT59	0	0	17	17	warfarin	TTR	PA451906	7276	0.886
NULL	Nucleic_Acids_Res_2011_Dec_31_39(22)_9536-9548.nxml.txt.nlp	21880590	SENT175	27	27	19	19	etoposide	BRCA1	PA449552	672	0.886
NULL	Cardiovasc_Diabetol_2013_Mar_23_12_48.nxml.txt.nlp	23522121	SENT36	5	5	1	1	exenatide	GLP-1	PA164749238	100125288	0.886
NULL	Adv_Ther_2014_May_13_31(5)_473-493.nxml.txt.nlp	24821599	SENT140	5	5	9	9	rivaroxaban	TTR	PA165958360	7276	0.886
NULL	Breast_Cancer_Res_2005_Nov_11_7(6)_255-257.nxml.txt.nlp	16457700	SENT59	31	31	21	21	tamoxifen	aromatase	PA451581	1588	0.886
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT145	11	11	24	24	lapatinib	HER2	PA152241907	2064	0.886
NULL	Exp_Diabetes_Res_2012_Nov_14_2012_386524.nxml.txt.nlp	23213322	SENT99	16	16	37	37	rosiglitazone	adiponectin	PA451283	9370	0.886
NULL	Springerplus_2015_Jan_23_4_29.nxml.txt.nlp	25628986	SENT39	22	22	6	6	dapsone	G6PD	PA449211	2539	0.886
NULL	Braz_J_Microbiol_2011_Dec_1_Oct-Dec_42(4)_1300-1307.nxml.txt.nlp	24031756	SENT30	25	25	43	43	miconazole	OTC	PA450494	5009	0.886
NULL	Br_J_Pharmacol_2008_Dec_25_155(7)_1056-1065.nxml.txt.nlp	18724386	SENT254	28	28	10	10	nitrendipine	GLP-1	PA146096020	100125288	0.886
NULL	Br_J_Cancer_1999_Mar_79(7-8)_1104-1110.nxml.txt.nlp	10098743	SENT5	33	33	36	36	cisplatin	c-Jun	PA449014	3725	0.886
NULL	Mol_Biol_Rep_2013_May_11_40(8)_5013-5026.nxml.txt.nlp	23666059	SENT13	18	18	5	5	resveratrol	p53		7157	0.886
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_13_2012_636848.nxml.txt.nlp	23258994	SENT206	4	4	18	18	carrageenan	TRPV4	PA448814	59341	0.886
NULL	J_Cell_Mol_Med_2013_Jan_10_17(1)_30-54.nxml.txt.nlp	23301832	SENT229	9	9	21	21	docetaxel	CD44	PA449383	960	0.886
NULL	Int_J_Mol_Sci_2012_Feb_1_13(2)_1512-1523.nxml.txt.nlp	22408405	SENT62	33	33	42	42	olmesartan	LOX-1	PA164742950	4973	0.886
NULL	BMB_Rep_2013_Nov_46(11)_544-549.nxml.txt.nlp	24152910	SENT81	4	4	32	32	thrombin	HMGB1	PA451674	3146	0.886
NULL	Indian_J_Anaesth_2014_Sep-Oct_58(5)_515-523.nxml.txt.nlp	25535411	SENT175	0	0	14	14	thrombin	VIII	PA451674	1351	0.886
NULL	Br_J_Cancer_2010_Dec_7_103(12)_1783-1787.nxml.txt.nlp	21081929	SENT107	27	27	17	17	rituximab	TRAIL-R2	PA451261	8795	0.886
NULL	Bioinorg_Chem_Appl_2013_Dec_8_2013_360142.nxml.txt.nlp	24382950	SENT58	13	13	2	2	ethanol	COD	PA448073	6628	0.886
NULL	Mol_Cancer_2014_Jan_13_13_7.nxml.txt.nlp	24418169	SENT204	24	24	21	21	sorafenib	survivin	PA7000	332	0.886
NULL	Acta_Pharmacol_Sin_2011_Jun_3_32(6)_817-823.nxml.txt.nlp	21642950	SENT144	17	17	4	4	propofol	HCN4	PA451141	10021	0.886
NULL	Front_Pharmacol_2014_Mar_21_5_46.nxml.txt.nlp	24711793	SENT150	2	2	9	9	vasopressin	RXFP3	PA451858	51289	0.886
NULL	Am_J_Case_Rep_2012_May_23_13_79-85.nxml.txt.nlp	23569495	SENT97	15	15	11	11	doxorubicin	CHOP	PA449412	1649	0.886
NULL	Nat_Neurosci_2013_Dec_27_16(12)_1745-1753.nxml.txt.nlp	24162653	SENT172	16	16	9	9	etoposide	EZH2	PA449552	2146	0.886
NULL	Osteoporos_Int_2012_Feb_4_23(Suppl_1)_S1-S23.nxml.txt.nlp	22311111	SENT363	4	4	18	18	raloxifene	STAR	PA451221	6770;2984	0.886
NULL	Nat_Commun_2014_Dec_8_5_5736.nxml.txt.nlp	25484020	SENT27	32	32	23	23	capsaicin	TRPV1	PA448776	7442	0.886
NULL	Br_J_Cancer_2013_May_28_108(10)_1957-1963.nxml.txt.nlp	23640393	SENT25	7	7	17	17	bleomycin	NACT	PA448645	284111	0.886
NULL	Oncol_Rep_2012_Sep_26_28(3)_777-784.nxml.txt.nlp	22751903	SENT13	0	0	18	18	celecoxib	MVD	PA448871	4597	0.886
NULL	J_Appl_Oral_Sci_2010_Nov-Dec_18(6)_630-634.nxml.txt.nlp	21308296	SENT61	34	34	41	41	ketorolac	ETO	PA450150	862	0.886
NULL	Oncotarget_2013_Nov_19_5(1)_95-102.nxml.txt.nlp	24395633	SENT67	0	0	2	2	sirolimus	CD8A	PA451365	925	0.886
NULL	Ayu_2014_Jan-Mar_35(1)_85-89.nxml.txt.nlp	25364206	SENT141	9	9	7	7	doxycycline	MMP2	PA449415	4313	0.886
NULL	AMB_Express_2011_May_27_1_8.nxml.txt.nlp	21906340	SENT8	11	11	14	14	hydroquinone	mol	PA449924	90527	0.886
NULL	Oncologist_2011_Jan_6_16(1)_5-24.nxml.txt.nlp	21212434	SENT195	17	17	12	12	temozolomide	IFN	PA451609	3439	0.886
NULL	EMBO_J_2010_Nov_17_29(22)_3773-3786.nxml.txt.nlp	20924358	SENT88	5	5	32	32	novobiocin	Hsp90	PA164768819	3320	0.886
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2011_Sep_13_4_47-62.nxml.txt.nlp	22879794	SENT343	18	18	3	3	liraglutide	GLP-1	PA165958364	100125288	0.886
NULL	Front_Oncol_2013_Aug_13_3_208.nxml.txt.nlp	23986880	SENT108	41	41	13	13	docetaxel	mol	PA449383	90527	0.886
NULL	ACS_Catal_2014_Feb_7_4(2)_546-552.nxml.txt.nlp	24634794	SENT78	44	44	16	16	hemin	TTN	PA449849	7273	0.886
NULL	J_Lipid_Res_2012_Nov_53(11)_2355-2363.nxml.txt.nlp	22956783	SENT44	8	8	26	26	isoflurane	CO2	PA450106	4513	0.886
NULL	Basic_Res_Cardiol_2012_Mar_11_107(2)_245.nxml.txt.nlp	22234702	SENT165	15	15	0	0	caffeine	PTIP	PA448710	22976	0.886
NULL	Cancer_Med_2013_Jun_25_2(3)_277-285.nxml.txt.nlp	23930204	SENT51	7	7	26	26	bevacizumab	PTEN	PA130232992	5728	0.886
NULL	Adv_Hematol_2012_Mar_25_2012_302570.nxml.txt.nlp	22536253	SENT301	4	4	33	33	coumarin	Hsp90	PA134521193	3320	0.886
NULL	Clin_Sci_(Lond)_2011_Nov_1_121(Pt_10)_449-458.nxml.txt.nlp	21671887	SENT181	9	9	16	16	atorvastatin	AMPK	PA448500	5563	0.886
NULL	Psychiatry_Investig_2010_Sep_9_7(3)_220-223.nxml.txt.nlp	20927312	SENT20	18	18	15	15	aripiprazole	5-HT1A	PA10026	3350	0.886
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT344	10	10	28	28	risperidone	PRL	PA451257	5617	0.886
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Dec_17_3(12)_e152.nxml.txt.nlp	25518025	SENT41	6	6	3	3	ketoconazole	CYP3A	PA450146	1574	0.886
NULL	Adv_Appl_Bioinforma_Chem_2008_Oct_30_1_85-98.nxml.txt.nlp	21918608	SENT168	14	14	6	6	bortezomib	SPARC	PA10252	6678	0.886
NULL	Clin_Med_Insights_Oncol_2013_Aug_21_7_221-234.nxml.txt.nlp	24179413	SENT92	28	28	13	13	cetuximab	EGFR	PA10040	1956	0.886
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_75-89.nxml.txt.nlp	17912638	SENT381	40	40	38	38	exemestane	aromatase	PA449563	1588	0.886
NULL	J_Heart_Lung_Transplant_2010_Jun_29(6)_610-615.nxml.txt.nlp	20227301	SENT19	6	6	0	0	sildenafil	RAC	PA451346	207	0.886
NULL	Br_J_Pharmacol_2008_Dec_25_155(7)_1056-1065.nxml.txt.nlp	18724386	SENT139	17	17	11	11	diazoxide	GPR119	PA449285	139760	0.886
NULL	Cancer_Cell_Int_2011_Dec_29_11_44.nxml.txt.nlp	22206574	SENT113	27	27	10	10	sorafenib	p65	PA7000	5970	0.886
NULL	Mol_Cancer_2010_Apr_29_9_95.nxml.txt.nlp	20429933	SENT64	16	16	19	19	cisplatin	p53	PA449014	7157	0.886
NULL	Core_Evid_2011_Feb_8_6_23-29.nxml.txt.nlp	21468240	SENT56	34	34	18	18	plerixafor	CD34	PA165958410	947	0.886
NULL	BMB_Rep_2014_May_47(5)_274-279.nxml.txt.nlp	24286313	SENT68	16	16	8	8	bortezomib	CD138	PA10252	6382	0.886
NULL	Breast_Cancer_Res_2007_Dec_20_9(Suppl_2)_S13.nxml.txt.nlp	NULL	SENT49	31	31	2	2	anastrozole	IMPACT	PA448432	55364	0.886
NULL	Cancer_Metastasis_Rev_2011_Dec_20_30(3-4)_465-480.nxml.txt.nlp	22012553	SENT251	23	23	2	2	indomethacin	EP2	PA449982	5732;10407	0.886
NULL	J_Cell_Biol_2001_Nov_26_155(5)_845-858.nxml.txt.nlp	11724824	SENT389	11	11	0	0	heparin	CD44	PA449855	960	0.886
NULL	Neural_Regen_Res_2013_Jul_15_8(20)_1853-1862.nxml.txt.nlp	25206494	SENT136	31	31	16	16	ethanol	p53	PA448073	7157	0.886
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT224	21	21	15	15	chloroquine	BMPR-II	PA448948	659	0.886
NULL	Ann_Indian_Acad_Neurol_2008_Jan-Mar_11(1)_13-19.nxml.txt.nlp	19966973	SENT114	3	3	16	16	curcumin	TNF	PA151958596	7124	0.886
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT1261	26	26	10	10	elacridar	ABCB1		5243	0.886
NULL	Br_J_Cancer_2003_Mar_10_88(5)_754-759.nxml.txt.nlp	12618886	SENT61	10	10	29	29	amifostine	p53	PA448365	7157	0.886
NULL	Biomed_Res_Int_2013_Dec_5_2013_642848.nxml.txt.nlp	24381940	SENT165	11	11	8	8	cisplatin	IL-6	PA449014	3569	0.886
NULL	Br_J_Cancer_2013_Apr_16_108(7)_1408-1414.nxml.txt.nlp	23511562	SENT119	8	8	5	5	tamoxifen	aromatase	PA451581	1588	0.886
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT202	10	10	18	18	bevacizumab	VEGFR1	PA130232992	2321	0.886
NULL	EMBO_Mol_Med_2013_Feb_9_5(2)_309-325.nxml.txt.nlp	23300147	SENT278	16	16	1	1	geldanamycin	Hsp90	PA152031327	3320	0.886
NULL	Ann_Gen_Psychiatry_2013_Aug_13_12_26.nxml.txt.nlp	23941527	SENT146	32	32	23	23	nefazodone	NMA	PA450603	25805	0.886
NULL	Anesthesiol_Res_Pract_2013_Jul_29_2013_236089.nxml.txt.nlp	23983684	SENT57	15	15	6	6	dexmedetomidine	NNT	PA449256	23530	0.886
NULL	Arthritis_Res_2002_Nov_23_4(3)_157-164.nxml.txt.nlp	12010565	SENT190	16	16	5	5	collagenase	AP-1	PA449107	2353;3727;2354;3725	0.886
NULL	Virol_J_2009_Dec_1_6_213.nxml.txt.nlp	19951438	SENT189	15	15	38	38	mitomycin	TRAIL	PA450524	8743	0.886
NULL	Curr_Pharm_Biotechnol_2012_May_13(6)_969-986.nxml.txt.nlp	22039792	SENT222	20	20	26	26	ivermectin	P-gp	PA450133	5243	0.886
NULL	J_Lipid_Res_2013_May_54(5)_1410-1420.nxml.txt.nlp	23419260	SENT153	14	14	24	24	tetracycline	IDOL	PA451640	29116	0.886
NULL	Oncotarget_2011_Sep_22_2(9)_713-727.nxml.txt.nlp	21946665	SENT203	12	12	5	5	imatinib	IFN	PA10804	3439	0.886
NULL	Front_Oncol_2014_May_14_4_106.nxml.txt.nlp	24860786	SENT159	19	19	9	9	doxorubicin	p53	PA449412	7157	0.886
NULL	Eur_J_Clin_Pharmacol_2010_Nov_29_66(11)_1131-1136.nxml.txt.nlp	20669013	SENT139	33	33	12	12	voriconazole	CYP2C19	PA10233	1557	0.886
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT50	5	5	18	18	nifedipine	CYP3A	PA450631	1574	0.886
NULL	J_Exp_Clin_Cancer_Res_2009_Nov_24_28(1)_144.nxml.txt.nlp	19930704	SENT121	24	24	3	3	vincristine	P-gp	PA451879	5243	0.886
NULL	Cancer_Med_2013_Feb_3_2(1)_76-85.nxml.txt.nlp	24133630	SENT191	26	26	3	3	vemurafenib	AKT	PA165946873	207	0.886
NULL	eLife_2014_May_7_3_e02444.nxml.txt.nlp	24894464	SENT522	29	29	0	0	bexarotene	ABCA1	PA164752250	19	0.886
NULL	Breast_Cancer_Res_2004_Mar_26_6(3)_R252-R263.nxml.txt.nlp	15084249	SENT163	29	29	6	6	tamoxifen	CYP2B6	PA451581	1555	0.886
NULL	Arthritis_Res_Ther_2009_Jan_30_11(1)_210.nxml.txt.nlp	19232069	SENT70	15	15	40	40	tocilizumab	RANKL	PA165292659	8600	0.886
NULL	J_Korean_Med_Sci_2010_Apr_19_25(4)_557-563.nxml.txt.nlp	20357998	SENT99	28	28	8	8	cisplatin	IL-10	PA449014	3586	0.886
NULL	J_Invest_Dermatol_2012_Nov_21_132(11)_2642-2651.nxml.txt.nlp	22718118	SENT158	17	17	44	44	collagenase	IFN	PA449107	3439	0.886
NULL	Colomb_Med_(Cali)_43(4)_305-311.nxml.txt.nlp	24893304	SENT152	43	43	25	25	ganciclovir	CD4	PA449733	920	0.886
NULL	Cilia_2013_Jan_3_2_1.nxml.txt.nlp	23351214	SENT52	8	8	2	2	forskolin	MCHR1	PA146096022	2847	0.886
NULL	Am_J_Rhinol_Allergy_2012_Jan-Feb_26(1)_e20-e22.nxml.txt.nlp	22391072	SENT20	5	5	10	10	aspirin	CRS	PA448497	1403	0.886
NULL	Arch_Med_Sci_2013_Oct_31_9(5)_916-921.nxml.txt.nlp	24273579	SENT143	9	9	0	0	bleomycin	AQP1	PA448645	358	0.886
NULL	Curr_Oncol_2009_Jul_16(Suppl_2)_S14-S23.nxml.txt.nlp	19672417	SENT197	3	3	5	5	tamoxifen	aromatase	PA451581	1588	0.886
NULL	Br_J_Cancer_1995_Oct_72(4)_1013-1015.nxml.txt.nlp	7547213	SENT6	21	21	14	14	cisplatin	5-HT1A	PA449014	3350	0.886
NULL	Front_Behav_Neurosci_2009_Jun_29_3_10.nxml.txt.nlp	19587848	SENT1395	3	3	5	5	diethylstilbestrol	DES	PA449307	1674	0.886
NULL	Iran_J_Public_Health_2012_Jan_31_41(1)_37-44.nxml.txt.nlp	23113120	SENT161	15	15	2	2	imatinib	survivin	PA10804	332	0.886
NULL	Front_Neurol_2011_Dec_16_2_72.nxml.txt.nlp	22203815	SENT190	5	5	25	25	protamine	IL-17	PA10366	3605	0.886
NULL	Biol_Proced_Online_2002_Apr_8_3_70-78.nxml.txt.nlp	12734577	SENT136	5	5	16	16	atropine	mol	PA448505	90527	0.886
NULL	Nat_Commun_2014_Dec_8_5_5736.nxml.txt.nlp	25484020	SENT652	5	5	18	18	letrozole	TRPA1	PA450196	8989	0.886
NULL	Parasit_Vectors_2013_Oct_1_6_287.nxml.txt.nlp	24289745	SENT12	9	9	12	12	albendazole	gamma	PA164746058	9913	0.886
NULL	Exp_Cell_Res_2011_Apr_15_317(7)_1028-1039.nxml.txt.nlp	21237154	SENT115	14	14	26	26	staurosporine	JIP1	PA165109623	9479	0.886
NULL	BMJ_Open_2014_Oct_31_4(10)_e005781.nxml.txt.nlp	25361837	SENT271	3	3	8	8	abciximab	ADP	PA448006	23038	0.886
NULL	Indian_J_Pharm_Sci_2014_Jan-Feb_76(1)_72-77.nxml.txt.nlp	24799741	SENT83	28	28	4	4	glipizide	CYP2C9	PA449762	1559	0.886
NULL	Front_Syst_Neurosci_2014_Mar_10_8_27.nxml.txt.nlp	24653682	SENT134	40	40	21	21	baclofen	ANOVA	PA448533	4858	0.886
NULL	Neuropsychopharmacology_2009_May_8_34(6)_1454-1466.nxml.txt.nlp	18843265	SENT306	20	20	5	5	haloperidol	GLAST	PA449841	6507	0.886
NULL	Int_J_Biochem_Cell_Biol_2013_Feb_45(2)_283-291.nxml.txt.nlp	23085378	SENT118	0	0	12	12	finasteride	aromatase	PA449627	1588	0.886
NULL	Br_J_Cancer_2010_Feb_16_102(4)_658-664.nxml.txt.nlp	20104222	SENT30	13	13	16	16	sunitinib	IFN	PA162372840	3439	0.886
NULL	Cells_2014_Apr_8_3(2)_258-287.nxml.txt.nlp	24717323	SENT184	18	18	4	4	capsaicin	TRPV1	PA448776	7442	0.886
NULL	Core_Evid_2010_Oct_21_5_61-76.nxml.txt.nlp	21042543	SENT259	36	36	32	32	panitumumab	EGFR	PA162373091	1956	0.886
NULL	Br_J_Cancer_2010_Oct_12_103(8)_1139-1143.nxml.txt.nlp	20877357	SENT55	24	24	4	4	temozolomide	MSH6	PA451609	2956	0.886
NULL	Oncol_Lett_2013_Aug_17_6(2)_295-305.nxml.txt.nlp	24137320	SENT166	14	14	8	8	tamoxifen	aromatase	PA451581	1588	0.886
NULL	Anticancer_Agents_Med_Chem_2010_Oct_10(8)_617-624.nxml.txt.nlp	21182469	SENT56	23	23	29	29	tamoxifen	ABCC11	PA451581	85320	0.886
NULL	eLife_2014_May_6_3_e02482.nxml.txt.nlp	24843002	SENT215	33	33	15	15	etoposide	SETD2	PA449552	29072	0.886
NULL	J_Korean_Med_Sci_2007_Dec_20_22(6)_946-951.nxml.txt.nlp	18162704	SENT32	24	24	7	7	acetazolamide	SCN4A	PA448018	6329	0.886
NULL	Diabetes_Metab_J_2012_Oct_18_36(5)_336-344.nxml.txt.nlp	23130317	SENT114	19	19	12	12	liraglutide	GLP-1	PA165958364	100125288	0.886
NULL	ISRN_Otolaryngol_2012_Nov_14_2012_797619.nxml.txt.nlp	23762619	SENT194	9	9	15	15	gefitinib	EGF	PA131301952	1950	0.886
NULL	Breast_Cancer_Res_2010_Oct_20_12(5)_315.nxml.txt.nlp	21062517	SENT45	16	16	9	9	tamoxifen	PI3K	PA451581	5290	0.886
NULL	Behav_Sci_(Basel)_2012_Jun_21_2(2)_135-171.nxml.txt.nlp	23077729	SENT135	25	25	12	12	vasopressin	CORT	PA451858	1325	0.886
NULL	Toxins_(Basel)_2010_Oct_28_2(11)_2584-2592.nxml.txt.nlp	22069565	SENT144	10	10	5	5	warfarin	CYP2C9	PA451906	1559	0.886
NULL	Nucleic_Acids_Res_2013_Nov_27_41(21)_9786-9799.nxml.txt.nlp	23982513	SENT104	4	4	9	9	arsenite	TIAR	PA452638	7073	0.886
NULL	Clin_Pharmacol_2010_Sep_6_2_155-162.nxml.txt.nlp	22291500	SENT110	35	35	22	22	clopidogrel	Ray	PA449053	26751	0.886
NULL	Int_J_Endocrinol_Metab_2013_Apr_1_Spring_11(2)_95-101.nxml.txt.nlp	23825980	SENT43	3	3	6	6	galactose	mol	PA449725	90527	0.886
NULL	Mol_Cell_Biochem_2014_Oct_9_385(1-2)_265-275.nxml.txt.nlp	24104452	SENT117	15	15	1	1	bortezomib	U87	PA10252	677775;641648	0.886
NULL	AMB_Express_2012_Dec_13_2_67.nxml.txt.nlp	23237525	SENT208	32	32	6	6	mupirocin	CEN1	PA164764568	1068	0.886
NULL	Arthritis_Res_Ther_2006_Jul_21_8(4)_R130.nxml.txt.nlp	16859540	SENT185	23	23	44	44	atorvastatin	CD59	PA448500	966	0.886
NULL	Arch_Gynecol_Obstet_2012_Aug_23_286(2)_389-393.nxml.txt.nlp	22441658	SENT150	13	13	20	20	hyaluronan	CO2	PA165958431	4513	0.886
NULL	J_Hematol_Oncol_2008_Aug_14_1_12.nxml.txt.nlp	18702822	SENT169	15	15	11	11	trastuzumab	TOP2A	PA451743	7153	0.886
NULL	Diabetes_2013_May_16_62(5)_1409-1416.nxml.txt.nlp	23193189	SENT215	10	10	31	31	lipase	HSL	PA450239	3991	0.886
NULL	Ann_Oncol_2010_Oct_19_21(10)_1952-1960.nxml.txt.nlp	20305037	SENT146	9	9	4	4	cetuximab	EGFR	PA10040	1956	0.886
NULL	Eur_J_Clin_Pharmacol_2008_Feb_26_64(2)_133-157.nxml.txt.nlp	18224312	SENT59	16	16	10	10	tramadol	CYP2D6	PA451735	1565	0.886
NULL	Neural_Regen_Res_2013_Jul_5_8(19)_1803-1813.nxml.txt.nlp	25206477	SENT156	5	5	9	9	cilostazol	spatial	PA164746334	219793	0.886
NULL	Oncogene_2009_Apr_23_28(16)_1821-1832.nxml.txt.nlp	19305428	SENT70	3	3	6	6	erlotinib	EGFR	PA134687924	1956	0.886
NULL	Acta_Pharmacol_Sin_2013_Feb_31_34(2)_301-308.nxml.txt.nlp	23274410	SENT147	17	17	7	7	gemcitabine	survivin	PA449748	332	0.886
NULL	J_Cardiovasc_Dis_Res_2011_Jan-Mar_2(1)_61-67.nxml.txt.nlp	21716755	SENT80	5	5	16	16	estradiol	ERBA	PA449503	7067	0.886
NULL	Br_J_Cancer_2010_Oct_26_103(9)_1380-1390.nxml.txt.nlp	20877355	SENT182	25	25	4	4	vincristine	TRAIL	PA451879	8743	0.886
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jan_12_67(Pt_2)_o365.nxml.txt.nlp	21523043	SENT56	21	21	3	3	ethanol	mol	PA448073	90527	0.886
NULL	J_Hum_Genet_2013_Jun_2_58(6)_306-312.nxml.txt.nlp	23635953	SENT15	10	10	19	19	tamoxifen	aromatase	PA451581	1588	0.886
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT173	18	18	14	14	sitagliptin	HIP	PA164748978	6767;6159;64399;5068	0.886
NULL	Case_Rep_Dermatol_2011_Oct_11_3(3)_223-227.nxml.txt.nlp	22135629	SENT11	7	7	19	19	paclitaxel	HER2	PA450761	2064	0.886
NULL	Breast_Cancer_Res_2009_Oct_7_11(5)_R73.nxml.txt.nlp	19811637	SENT198	5	5	8	8	trastuzumab	aromatase	PA451743	1588	0.886
NULL	Leukemia_2013_Apr_14_27(4)_803-812.nxml.txt.nlp	23238589	SENT53	7	7	26	26	imatinib	IFN	PA10804	3439	0.886
NULL	Mol_Cancer_2010_Nov_8_9_291.nxml.txt.nlp	21059223	SENT178	30	30	10	10	paclitaxel	ZNF217	PA450761	7764	0.886
NULL	Cells_2014_Apr_8_3(2)_258-287.nxml.txt.nlp	24717323	SENT103	14	14	7	7	capsaicin	TRPV1	PA448776	7442	0.886
NULL	J_Res_Med_Sci_2012_Oct_17(10)_928-933.nxml.txt.nlp	23825991	SENT137	32	32	18	18	tretinoin	CO2	PA451746	4513	0.886
NULL	Oncoimmunology_2014_Apr_25_3_e28518.nxml.txt.nlp	25071979	SENT157	5	5	11	11	oxaliplatin	HMGB1	PA131285527	3146	0.886
NULL	Br_J_Cancer_2003_Mar_10_88(5)_754-759.nxml.txt.nlp	12618886	SENT161	22	22	36	36	amifostine	p53	PA448365	7157	0.886
NULL	Alcohol_Res_2013_35(1)_97-113.nxml.txt.nlp	24313169	SENT200	12	12	2	2	ethanol	ACSS2	PA448073	55902	0.886
NULL	Oncogene_2010_Sep_16_29(37)_5193-5203.nxml.txt.nlp	20581867	SENT125	28	28	11	11	trastuzumab	PI3K	PA451743	5290	0.886
NULL	Drugs_R_D_2010_Nov_25_10(4)_219-224.nxml.txt.nlp	21171668	SENT2	5	5	18	18	clopidogrel	DES	PA449053	1674	0.886
NULL	Oncotarget_2014_Aug_29_5(18)_8052-8082.nxml.txt.nlp	25211298	SENT497	28	28	24	24	celecoxib	COX	PA448871	1351	0.886
NULL	Diabetol_Metab_Syndr_2014_Mar_31_6_47.nxml.txt.nlp	24684779	SENT105	0	0	17	17	pioglitazone	CD68	PA450970	968	0.886
NULL	Cancer_Metab_2013_Feb_4_1_7.nxml.txt.nlp	24280108	SENT160	10	10	2	2	glucose	NAC	PA449773	22861	0.886
NULL	J_Cell_Mol_Med_2013_Oct_23_17(10)_1207-1217.nxml.txt.nlp	24106980	SENT134	22	22	15	15	paclitaxel	PTEN	PA450761	5728	0.886
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_24_2012_673132.nxml.txt.nlp	23133498	SENT125	16	16	10	10	carbamazepine	CYP3A	PA448785	1574	0.886
NULL	Cardiovasc_Diabetol_2010_Oct_18_9_64.nxml.txt.nlp	20955583	SENT134	17	17	27	27	losartan	PPARgamma	PA450268	5468	0.886
NULL	Neural_Dev_2013_Mar_7_8_4.nxml.txt.nlp	23497494	SENT118	16	16	5	5	chlorpheniramine	FGFR3	PA448960	2261	0.886
NULL	Breast_Cancer_Res_2011_Mar_1_13(2)_R21.nxml.txt.nlp	21362200	SENT154	5	5	15	15	estradiol	p110	PA449503	9733	0.886
NULL	Lab_Invest_2010_Nov_28_90(11)_1573-1581.nxml.txt.nlp	20585312	SENT145	28	28	0	0	telmisartan	ATR1	PA451605	6519	0.886
NULL	Eur_J_Clin_Pharmacol_2013_May_14_69(5)_1091-1101.nxml.txt.nlp	23150149	SENT88	29	29	14	14	glucose	ALP	PA449773	6590;10850;27295;80150;470;26033	0.886
NULL	Oxid_Med_Cell_Longev_2013_Jun_2_2013_793525.nxml.txt.nlp	23819014	SENT147	11	11	19	19	resveratrol	ROS		6098	0.886
NULL	Int_J_Med_Sci_2012_Dec_28_10(2)_110-118.nxml.txt.nlp	23329881	SENT54	9	9	28	28	docetaxel	NACT	PA449383	284111	0.886
NULL	Cancers_(Basel)_2010_Feb_23_2(1)_88-113.nxml.txt.nlp	24281034	SENT1438	8	8	0	0	cetuximab	KRAS	PA10040	3845	0.886
NULL	Int_J_Endocrinol_Metab_2013_Dec_21_Winter_11(1)_57-61.nxml.txt.nlp	23853622	SENT38	9	9	20	20	risperidone	PRL	PA451257	5617	0.886
NULL	Biomed_Res_Int_2014_Jan_2_2014_865741.nxml.txt.nlp	24516856	SENT119	29	29	8	8	genistein	VCL	PA165109660	7414	0.886
NULL	Evid_Based_Complement_Alternat_Med_2011_Mar_1_2011_207034.nxml.txt.nlp	21423686	SENT128	10	10	0	0	clopidogrel	CD62P	PA449053	6403	0.886
NULL	Cancer_Med_2013_Feb_3_2(1)_11-20.nxml.txt.nlp	24133623	SENT22	31	31	12	12	cetuximab	KRAS	PA10040	3845	0.886
NULL	Indian_J_Pharm_Sci_2013_Sep-Oct_75(5)_523-532.nxml.txt.nlp	24403652	SENT39	16	16	4	4	cholestyramine	ATV	PA448974	4683	0.886
NULL	Virol_J_2011_Nov_28_8_523.nxml.txt.nlp	22122911	SENT133	6	6	33	33	heparin	RANTES	PA449855	6352	0.886
NULL	J_Exp_Clin_Cancer_Res_2009_Jul_3_28(1)_97.nxml.txt.nlp	19575783	SENT122	0	0	8	8	trastuzumab	HER2	PA451743	2064	0.886
NULL	Anc_Sci_Life_2013_Oct-Dec_33(2)_131-138.nxml.txt.nlp	25284948	SENT83	30	30	5	5	loperamide	castor	PA450262	54897	0.886
NULL	Mol_Biol_Cell_2013_Dec_15_24(24)_3939-3944.nxml.txt.nlp	24152728	SENT73	20	20	37	37	tamoxifen	CCN2	PA451581	1490	0.886
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT305	17	17	29	29	paliperidone	PRL	PA163518919	5617	0.886
NULL	Drugs_R_D_2014_Sep_31_14(3)_177-184.nxml.txt.nlp	25079671	SENT114	20	20	3	3	acarbose	STOP	PA448010	4135	0.886
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT533	27	27	21	21	pp2	PP1		5540;5464	0.886
NULL	Cell_Res_2011_Mar_11_21(3)_530-545.nxml.txt.nlp	21221130	SENT410	31	31	17	17	thrombin	PAC-1	PA451674	1844	0.886
NULL	Front_Oncol_2013_Oct_1_3_259.nxml.txt.nlp	24102047	SENT96	41	41	23	23	paclitaxel	EGFR	PA450761	1956	0.886
NULL	Oncol_Lett_2014_May_4_7(5)_1352-1362.nxml.txt.nlp	24765137	SENT155	35	35	10	10	doxorubicin	Bcl-2	PA449412	596	0.886
NULL	Mol_Cancer_2010_Aug_16_9_217.nxml.txt.nlp	20712901	SENT9	16	16	11	11	curcumin	STAT3	PA151958596	6774	0.886
NULL	Nat_Commun_2012_Sep_4_3_1034.nxml.txt.nlp	22948816	SENT217	17	17	1	1	clopidogrel	P2Y12	PA449053	64805	0.886
NULL	Br_J_Cancer_2011_Jul_12_105(2)_212-220.nxml.txt.nlp	21694723	SENT138	0	0	3	3	curcumin	STAT3	PA151958596	6774	0.886
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT133	2	2	9	9	phenformin	CCL16	PA1000	6360	0.886
NULL	Patient_Prefer_Adherence_2011_Dec_23_6_1-9.nxml.txt.nlp	22272064	SENT63	21	21	30	30	telmisartan	ACE	PA451605	1636	0.886
NULL	Mol_Cancer_2008_Mar_6_7_24.nxml.txt.nlp	18325101	SENT76	9	9	11	11	cisplatin	FANCD2	PA449014	2177	0.886
NULL	Oncoimmunology_2013_Aug_1_2(8)_e25476.nxml.txt.nlp	24175153	SENT33	23	23	32	32	decitabine	IRF8	PA164749631	3394	0.886
NULL	Front_Genet_2014_Jan_17_4_310.nxml.txt.nlp	24478790	SENT228	12	12	1	1	trypsin	PAPSS1	PA451806	9061	0.886
NULL	Physiology_(Bethesda)_2014_Mar_29(2)_99-107.nxml.txt.nlp	24583766	SENT62	5	5	19	19	berberine	ADP	PA165860812	23038	0.886
NULL	Drug_Saf_2014_Feb_19_37(4)_201-211.nxml.txt.nlp	24550106	SENT152	15	15	27	27	theophylline	CYP2C19	PA451647	1557	0.886
NULL	Alcohol_Alcohol_2009_Sep_19_Nov-Dec_44(6)_547-554.nxml.txt.nlp	19767625	SENT82	4	4	31	31	ethanol	ANOVA	PA448073	4858	0.886
NULL	Eur_J_Clin_Pharmacol_2011_May_8_67(5)_493-506.nxml.txt.nlp	21140139	SENT288	22	22	12	12	oxycodone	CYP3A4	PA450741	1576	0.886
NULL	J_Korean_Med_Sci_2013_Apr_27_28(4)_527-533.nxml.txt.nlp	23580227	SENT142	8	8	25	25	genistein	DR5	PA165109660	8795	0.886
NULL	Br_J_Cancer_1996_Aug_74(3)_387-393.nxml.txt.nlp	8695353	SENT12	16	16	5	5	cisplatin	c-myb	PA449014	4602	0.886
NULL	Br_J_Cancer_1996_Oct_74(7)_1037-1045.nxml.txt.nlp	8855971	SENT8	6	6	11	11	cisplatin	CH1	PA449014	51430	0.886
NULL	Biochemistry_2008_Aug_19_47(33)_8689-8696.nxml.txt.nlp	18642884	SENT60	15	15	4	4	nadh	GMP	PA164755085	22978	0.886
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT190	35	35	24	24	perifosine	NAC	PA165291471	22861	0.886
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2675-2684.nxml.txt.nlp	24129246	SENT305	16	16	10	10	etoposide	DBC1	PA449552	57805;1620	0.886
NULL	Int_J_Med_Sci_2012_Dec_28_10(2)_110-118.nxml.txt.nlp	23329881	SENT54	11	11	28	28	epirubicin	NACT	PA449476	284111	0.886
NULL	Semin_Cancer_Biol_2014_Jun_26(100)_89-98.nxml.txt.nlp	24316494	SENT49	33	33	23	23	basiliximab	IFN	PA164747126	3439	0.886
NULL	Leukemia_2014_Aug_4_28(8)_1573-1585.nxml.txt.nlp	24496300	SENT71	6	6	19	19	ofloxacin	CYP1A2	PA450684	1544	0.886
NULL	Support_Care_Cancer_2012_May_1_20(5)_941-949.nxml.txt.nlp	21533811	SENT30	31	31	40	40	granisetron	HEC	PA449809	10403	0.886
NULL	J_Biol_Chem_2013_Dec_6_288(49)_35387-35395.nxml.txt.nlp	24142790	SENT166	8	8	6	6	meclizine	PCYT2	PA450338	5833	0.886
NULL	Indian_J_Crit_Care_Med_2013_May-Jun_17(3)_129-134.nxml.txt.nlp	24082608	SENT60	12	12	4	4	colistin	CRA	PA164760862	51747;10903	0.886
NULL	J_Hum_Genet_2013_Jun_23_58(6)_339-345.nxml.txt.nlp	23697979	SENT14	22	22	4	4	ticlopidine	ADP	PA451686	23038	0.886
NULL	Cancer_Biol_Med_2012_Jun_9(2)_141-143.nxml.txt.nlp	23691471	SENT78	19	19	7	7	docetaxel	NF-kappaB	PA449383	4790	0.886
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT369	14	14	24	24	resveratrol	p300		2033	0.886
NULL	EMBO_Mol_Med_2013_Dec_8_5(12)_1821-1834.nxml.txt.nlp	24293316	SENT38	31	31	10	10	doxorubicin	GAPDH	PA449412	2597	0.886
NULL	Acta_Pharmacol_Sin_2012_Jan_28_33(1)_75-81.nxml.txt.nlp	22120969	SENT14	9	9	13	13	sitagliptin	GLP-1	PA164748978	100125288	0.886
NULL	Target_Oncol_2013_Jun_27_8(2)_127-136.nxml.txt.nlp	23625191	SENT152	6	6	2	2	panitumumab	KRAS	PA162373091	3845	0.886
NULL	Evid_Based_Complement_Alternat_Med_2013_May_22_2013_921012.nxml.txt.nlp	23762167	SENT128	7	7	15	15	glucose	AMPK	PA449773	5563	0.886
NULL	Pharmaceuticals_(Basel)_2014_Mar_5_7(3)_311-338.nxml.txt.nlp	24603603	SENT70	14	14	1	1	cetuximab	EGFR	PA10040	1956	0.886
NULL	Cancer_Res_Treat_2014_Jan_15_46(1)_48-54.nxml.txt.nlp	24520223	SENT163	7	7	14	14	oxaliplatin	KRAS	PA131285527	3845	0.886
NULL	Acta_Pharmacol_Sin_2012_Jan_3_33(1)_49-56.nxml.txt.nlp	22212430	SENT112	2	2	16	16	thrombin	A10	PA451674	28870	0.886
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Mar_24_68(Pt_4)_o1147-o1148.nxml.txt.nlp	22606094	SENT4	24	24	1	1	piperazine	mol	PA450977	90527	0.886
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_P23.nxml.txt.nlp	NULL	SENT16	7	7	3	3	isoniazid	DAO	PA450112	26;1610	0.886
NULL	Cells_2014_Aug_5_3(3)_802-823.nxml.txt.nlp	25100020	SENT188	37	37	0	0	tamoxifen	Dicer	PA451581	23405	0.886
NULL	Front_Endocrinol_(Lausanne)_2014_Feb_26_5_17.nxml.txt.nlp	24616713	SENT96	12	12	9	9	vasopressin	OXT	PA451858	5020	0.886
NULL	Biol_Open_2013_Aug_6_2(10)_1022-1031.nxml.txt.nlp	24167712	SENT287	6	6	37	37	doxycycline	PLK1	PA449415	5347	0.886
NULL	Diabetes_Care_2011_Apr_21_34(4)_845-851.nxml.txt.nlp	21330640	SENT134	11	11	3	3	rosiglitazone	DREAM	PA451283	30818	0.886
NULL	Stroke_Res_Treat_2012_Sep_15_2012_809417.nxml.txt.nlp	21941688	SENT116	19	19	37	37	tacrolimus	CA1	PA451578	759	0.886
NULL	Oncol_Lett_2014_Jan_12_7(1)_17-22.nxml.txt.nlp	24348813	SENT112	0	0	13	13	curcumin	COX	PA151958596	1351	0.886
NULL	Aging_(Albany_NY)_2012_Mar_4_4(3)_144-145.nxml.txt.nlp	22388573	SENT25	28	28	11	11	resveratrol	AMPK		5563	0.886
NULL	J_Mol_Signal_2011_Jul_20_6_7.nxml.txt.nlp	21774804	SENT287	3	3	12	12	dasatinib	EGFR	PA162372878	1956	0.886
NULL	Pharmaceuticals_(Basel)_2013_Apr_17_6(4)_557-578.nxml.txt.nlp	24276125	SENT206	11	11	40	40	saracatinib	IL-2		3558	0.886
NULL	Br_J_Cancer_2011_Aug_23_105(5)_649-657.nxml.txt.nlp	21811251	SENT151	25	25	37	37	gefitinib	IGF1R	PA131301952	3480	0.886
NULL	Can_J_Anaesth_2011_Feb_31_58(2)_206-215.nxml.txt.nlp	21194017	SENT260	4	4	33	33	etomidate	gamma	PA164743987	9913	0.886
NULL	Extremophiles_2009_Nov_23_13(6)_885-894.nxml.txt.nlp	19701714	SENT138	23	23	42	42	ethanol	CO2	PA448073	4513	0.886
NULL	Pharmaceuticals_(Basel)_2014_Sep_4_7(9)_913-942.nxml.txt.nlp	25192192	SENT105	5	5	0	0	resveratrol	AMPK		5563	0.886
NULL	Clin_Psychopharmacol_Neurosci_2013_Dec_24_11(3)_144-151.nxml.txt.nlp	24465251	SENT41	2	2	11	11	haloperidol	IL-10	PA449841	3586	0.886
NULL	Chin_J_Cancer_2012_Mar_31(3)_150-158.nxml.txt.nlp	22360854	SENT6	14	14	10	10	mitoxantrone	ABCG2	PA450526	9429	0.886
NULL	Arch_Med_Sci_2012_Jul_4_8(3)_533-541.nxml.txt.nlp	22852012	SENT221	20	20	26	26	dasatinib	KIT	PA162372878	3815	0.886
NULL	Aging_(Albany_NY)_2013_Jun_23_5(7)_515-530.nxml.txt.nlp	24018842	SENT230	17	17	5	5	tetracycline	NOX2	PA451640	1536	0.886
NULL	Exp_Hematol_Oncol_2012_Jun_18_1_14.nxml.txt.nlp	23210689	SENT107	36	36	30	30	imatinib	PDGFRA	PA10804	5156	0.886
NULL	J_Immunother_2014_Apr_12_37(3)_180-186.nxml.txt.nlp	24598448	SENT5	13	13	7	7	sorafenib	IL-2	PA7000	3558	0.886
NULL	Int_J_Mol_Sci_2014_Mar_12_15(3)_4356-4392.nxml.txt.nlp	24625663	SENT122	28	28	36	36	paclitaxel	CERT	PA450761	10087	0.886
NULL	Arthritis_Res_Ther_2011_Feb_16_13(1)_R25.nxml.txt.nlp	21324169	SENT176	10	10	13	13	adalimumab	TNF	PA10004	7124	0.886
NULL	Pharmaceutics_2011_Oct_12_3(4)_680-705.nxml.txt.nlp	24309303	SENT1025	30	30	8	8	repaglinide	OATP1B3	PA451234	28234	0.886
NULL	Case_Rep_Endocrinol_2013_Sep_8_2013_415810.nxml.txt.nlp	24083038	SENT62	11	11	13	13	sulfamethoxazole	CYP2C9	PA451544	1559	0.886
NULL	Pain_2012_Apr_153(4)_775-783.nxml.txt.nlp	22325744	SENT435	5	5	19	19	naloxone	P21	PA450586	1026;9338	0.886
NULL	Nat_Neurosci_2013_Apr_17_16(4)_464-472.nxml.txt.nlp	23502536	SENT191	15	15	8	8	fluoxetine	GluA1	PA449673	2890	0.886
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT110	3	3	13	13	atorvastatin	IL-6	PA448500	3569	0.886
NULL	FASEB_J_2008_Nov_22(11)_4005-4010.nxml.txt.nlp	18753249	SENT11	6	6	2	2	diclofenac	COX	PA449293	1351	0.886
NULL	Front_Oncol_2013_Sep_11_3_228.nxml.txt.nlp	24062981	SENT276	24	24	30	30	olaparib	BRCA2		675	0.886
NULL	Ann_Pediatr_Cardiol_2008_Jan-Jun_1(1)_18-26.nxml.txt.nlp	20300233	SENT178	8	8	2	2	mexiletine	SCN5A	PA450488	6331	0.886
NULL	J_Hematol_Oncol_2008_Oct_23_1_19.nxml.txt.nlp	18947412	SENT10	33	33	5	5	alemtuzumab	CD34	PA164783958	947	0.886
NULL	J_Cancer_Epidemiol_2012_Aug_9_2012_957467.nxml.txt.nlp	22927849	SENT138	14	14	19	19	s-adenosylmethionine	MTHFR	PA164754994	4524	0.886
NULL	Br_J_Cancer_1991_Aug_64(2)_215-220.nxml.txt.nlp	1892748	SENT9	28	28	35	35	carboplatin	CHIP	PA448803	10273	0.886
NULL	Genome_Med_2010_Nov_30_2(11)_85.nxml.txt.nlp	21122163	SENT211	18	18	5	5	imatinib	IFN	PA10804	3439	0.886
NULL	Oncogene_2010_Jan_7_29(1)_81-92.nxml.txt.nlp	19784067	SENT263	21	21	14	14	cisplatin	BRG1	PA449014	6597	0.886
NULL	Clin_Pharmacol_2013_Apr_19_5_67-83.nxml.txt.nlp	23650452	SENT49	22	22	8	8	clopidogrel	LTA	PA449053	4049	0.886
NULL	Oncol_Lett_2013_Mar_8_5(3)_805-812.nxml.txt.nlp	23426281	SENT27	26	26	17	17	gemcitabine	B7-H3	PA449748	80381	0.886
NULL	Breast_Cancer_Res_Treat_2014_Jan_9_143(3)_493-505.nxml.txt.nlp	24402830	SENT29	0	0	8	8	lapatinib	HER2	PA152241907	2064	0.886
NULL	Front_Cell_Neurosci_2014_Jan_29_8_11.nxml.txt.nlp	24523671	SENT190	16	16	7	7	ethanol	GluA3	PA448073	2892	0.886
NULL	Cancers_(Basel)_2011_Apr_1_3(2)_1844-1860.nxml.txt.nlp	24212785	SENT43	33	33	30	30	cetuximab	ACRC	PA10040	93953	0.886
NULL	Oncotarget_2014_Oct_21_5(22)_11180-11192.nxml.txt.nlp	25361003	SENT130	33	33	36	36	doxycycline	NTRK1	PA449415	4914	0.886
NULL	Onco_Targets_Ther_2014_Nov_21_7_2143-2146.nxml.txt.nlp	25473295	SENT31	13	13	22	22	cetuximab	KRAS	PA10040	3845	0.886
NULL	Cancer_Cell_2007_Dec_11_12(6)_514-527.nxml.txt.nlp	18068629	SENT194	26	26	7	7	paclitaxel	TGFBI	PA450761	7045	0.886
NULL	Pain_2012_Apr_153(4)_775-783.nxml.txt.nlp	22325744	SENT442	9	9	15	15	naloxone	P35	PA450586	2220	0.886
NULL	J_Cell_Biol_2002_Jun_24_157(7)_1151-1160.nxml.txt.nlp	12082077	SENT102	23	23	17	17	trypsin	COX	PA451806	1351	0.886
NULL	Acta_Pharmacol_Sin_2009_Feb_5_30(2)_228-234.nxml.txt.nlp	19122672	SENT25	4	4	20	20	isoflurane	HO-1	PA450106	3162	0.886
NULL	Osteoporos_Int_2012_Jan_3_23(1)_327-337.nxml.txt.nlp	21892677	SENT41	45	45	7	7	denosumab	RANKL	PA166048634	8600	0.886
NULL	Nat_Chem_Biol_2010_Apr_28_6(4)_291-299.nxml.txt.nlp	20190765	SENT121	8	8	29	29	dasatinib	EGFR	PA162372878	1956	0.886
NULL	Int_J_Mol_Sci_2014_Oct_8_15(10)_17974-17999.nxml.txt.nlp	25299695	SENT103	11	11	16	16	curcumin	HO-1	PA151958596	3162	0.886
NULL	Clin_Liver_Dis_2013_May_17(2)_161-189.nxml.txt.nlp	23540496	SENT158	29	29	8	8	budesonide	CYP3A4	PA448681	1576	0.886
NULL	Breast_Cancer_Res_Treat_2014_Apr_9_145(1)_73-82.nxml.txt.nlp	24715380	SENT84	8	8	4	4	tamoxifen	CXCL10	PA451581	3627	0.886
NULL	Radiol_Res_Pract_2012_Jun_20_2012_268483.nxml.txt.nlp	22919485	SENT17	34	34	24	24	acetazolamide	CO2	PA448018	4513	0.886
NULL	Exp_Mol_Med_2012_Aug_31_44(8)_473-482.nxml.txt.nlp	22627808	SENT84	12	12	1	1	lapatinib	HER3	PA152241907	2065	0.886
NULL	Diabetes_2013_Jun_17_62(6)_1843-1854.nxml.txt.nlp	23349486	SENT235	26	26	37	37	hyaluronan	MCP-1	PA165958431	6347	0.886
NULL	Oncotarget_2010_Oct_25_1(7)_497-514.nxml.txt.nlp	21165163	SENT324	14	14	21	21	cetuximab	EGFR	PA10040	1956	0.886
NULL	Oncotarget_2014_Aug_29_5(19)_8947-8958.nxml.txt.nlp	25333254	SENT128	33	33	16	16	plerixafor	CXCR4	PA165958410	7852	0.885
NULL	J_Exp_Med_2003_Aug_4_198(3)_505-512.nxml.txt.nlp	12900524	SENT130	24	24	9	9	dextran	CCL21	PA449261	6366	0.885
NULL	Br_J_Pharmacol_2014_Jan_23_171(2)_523-535.nxml.txt.nlp	24372553	SENT109	4	4	12	12	metformin	SIRT1	PA450395	23411	0.885
NULL	eLife_2014_May_7_3_e02669.nxml.txt.nlp	24843006	SENT400	22	22	11	11	tamoxifen	NeuN	PA451581	146713	0.885
NULL	Pharmaceutics_2011_Nov_18_3(4)_865-913.nxml.txt.nlp	24309312	SENT163	10	10	44	44	raltegravir	CYP3A4		1576	0.885
NULL	Clinics_(Sao_Paulo)_2012_Jun_67(6)_693-696.nxml.txt.nlp	22760915	SENT47	23	23	6	6	mannitol	EOS	PA450320	260429	0.885
NULL	Acta_Pharmacol_Sin_2010_Oct_27_31(10)_1389-1394.nxml.txt.nlp	20871620	SENT29	6	6	24	24	carbachol	IL-6	PA448784	3569	0.885
NULL	Front_Oncol_2014_Apr_9_4_75.nxml.txt.nlp	24782986	SENT199	21	21	8	8	paclitaxel	Oct4	PA450761	5460	0.885
NULL	Bone_Marrow_Transplant_2011_Mar_24_46(3)_430-435.nxml.txt.nlp	20498647	SENT144	5	5	1	1	daclizumab	IL-2	PA164764446	3558	0.885
NULL	Eur_J_Haematol_2014_Feb_25_92(2)_127-136.nxml.txt.nlp	24118452	SENT18	11	11	7	7	anagrelide	CRT	PA164742986	811	0.885
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Mar_13_66(Pt_4)_o816.nxml.txt.nlp	21580648	SENT70	22	22	6	6	ethanol	mol	PA448073	90527	0.885
NULL	Osteoporos_Int_2011_Jan_1_22(1)_27-35.nxml.txt.nlp	20358360	SENT74	35	35	29	29	letrozole	aromatase	PA450196	1588	0.885
NULL	Neural_Regen_Res_2013_Mar_25_8(9)_825-832.nxml.txt.nlp	25206730	SENT90	2	2	7	7	isoflurane	P2X7	PA450106	5027	0.885
NULL	Braz_J_Med_Biol_Res_2013_Aug_16_46(8)_700-707.nxml.txt.nlp	23969977	SENT25	4	4	21	21	estradiol	aromatase	PA449503	1588	0.885
NULL	Kidney_Int_Suppl_(2011)_2013_Dec_27_3(4)_392-409.nxml.txt.nlp	NULL	SENT770	22	22	7	7	everolimus	NGAL	PA164746311	3934	0.885
NULL	Case_Rep_Infect_Dis_2012_Dec_23_2012_176864.nxml.txt.nlp	23320209	SENT30	10	10	31	31	linezolid	HCAP	PA450233	117159;9126	0.885
NULL	Biomed_Res_Int_2013_Apr_21_2013_759057.nxml.txt.nlp	23710458	SENT31	17	17	14	14	gefitinib	EGFR	PA131301952	1956	0.885
NULL	Mol_Cancer_2010_May_27_9_124.nxml.txt.nlp	20504375	SENT119	42	42	2	2	doxycycline	HOXB13	PA449415	10481	0.885
NULL	Br_J_Cancer_2012_Feb_14_106(4)_685-692.nxml.txt.nlp	22294184	SENT246	2	2	14	14	lovastatin	Mcl-1	PA450272	4170	0.885
NULL	Biologics_2012_Jun_20_6_147-154.nxml.txt.nlp	22807625	SENT44	0	0	6	6	pertuzumab	EGFR		1956	0.885
NULL	Pharmaceuticals_(Basel)_2012_Aug_10_5(8)_802-836.nxml.txt.nlp	24280676	SENT90	27	27	23	23	gemcitabine	CNT2	PA449748	9153	0.885
NULL	An_Bras_Dermatol_2013_May-Jun_88(3)_329-343.nxml.txt.nlp	23793209	SENT156	12	12	9	9	simvastatin	NF1	PA451363	4763	0.885
NULL	Acta_Pharmacol_Sin_2009_Apr_3_30(4)_478-484.nxml.txt.nlp	19343062	SENT145	12	12	15	15	cyclosporine	CYP3A4	PA449167	1576	0.885
NULL	Int_J_Med_Sci_2015_Jan_1_12(1)_78-82.nxml.txt.nlp	25552922	SENT112	16	16	24	24	tacrolimus	CYP3A5	PA451578	1577	0.885
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT106	26	26	34	34	l-methionine	S6K1	PA450423	6198	0.885
NULL	Br_J_Ophthalmol_2014_Aug_2_98(8)_1023-1027.nxml.txt.nlp	24695688	SENT30	24	24	13	13	tacrolimus	castor	PA451578	54897	0.885
NULL	Biologics_2011_Aug_9_5_87-94.nxml.txt.nlp	21847344	SENT91	26	26	8	8	trastuzumab	B27	PA451743	56246	0.885
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT310	34	34	6	6	quetiapine	PRL	PA451201	5617	0.885
NULL	Front_Immunol_2013_May_15_4_116.nxml.txt.nlp	23720663	SENT1590	9	9	1	1	temozolomide	CD4	PA451609	920	0.885
NULL	Oncotarget_2012_Aug_9_3(8)_774-782.nxml.txt.nlp	22885298	SENT34	25	25	22	22	tetracycline	IDH1	PA451640	3417	0.885
NULL	Breast_Cancer_(Auckl)_2011_Jul_27_5_175-199.nxml.txt.nlp	21863131	SENT384	7	7	13	13	olaparib	BRCA2		675	0.885
NULL	Mol_Biol_Cell_2014_Mar_15_25(6)_948-964.nxml.txt.nlp	24451262	SENT438	24	24	6	6	paraformaldehyde	TPC1	PA450790	53373	0.885
NULL	Oncotarget_2013_Nov_26_4(12)_2502-2511.nxml.txt.nlp	24318446	SENT142	13	13	28	28	doxycycline	GAPDH	PA449415	2597	0.885
NULL	Cell_Cycle_2013_Aug_15_12(16)_2625-2635.nxml.txt.nlp	23907123	SENT121	12	12	37	37	ethanol	p27	PA448073	5715;10534	0.885
NULL	Mol_Cancer_2008_Jun_5_7_50.nxml.txt.nlp	18534018	SENT128	20	20	7	7	bortezomib	Mcl-1	PA10252	4170	0.885
NULL	Breast_Cancer_Res_2008_Dec_3_10(6)_R101.nxml.txt.nlp	19055754	SENT30	28	28	32	32	bevacizumab	EGFR	PA130232992	1956	0.885
NULL	Br_J_Haematol_2014_Jan_28_164(2)_233-244.nxml.txt.nlp	24206017	SENT248	20	20	7	7	lenalidomide	CRBN	PA162363968	51185	0.885
NULL	Int_J_Breast_Cancer_2012_Feb_26_2012_740353.nxml.txt.nlp	22500240	SENT112	26	26	13	13	tamoxifen	DES	PA451581	1674	0.885
NULL	eLife_2013_Nov_5_2_e00969.nxml.txt.nlp	24192036	SENT169	39	39	12	12	vemurafenib	MAP4K5	PA165946873	11183	0.885
NULL	Cancer_Cell_Int_2014_Jan_29_14_10.nxml.txt.nlp	24472145	SENT10	25	25	42	42	cisplatin	HER-2	PA449014	2064	0.885
NULL	Oncotarget_2010_May_27_1(2)_89-103.nxml.txt.nlp	20671809	SENT214	6	6	15	15	perifosine	PDK1	PA165291471	5170;5163	0.885
NULL	Breast_Cancer_Res_2012_May_23_14(3)_R85.nxml.txt.nlp	22621393	SENT342	29	29	20	20	tamoxifen	JMJD6	PA451581	23210	0.885
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT173	24	24	27	27	bevacizumab	PlGF-2	PA130232992	5228	0.885
NULL	BMJ_2009_Feb_25_338_b438.nxml.txt.nlp	19244302	SENT46	25	25	21	21	anastrozole	aromatase	PA448432	1588	0.885
NULL	Arthritis_Res_Ther_2013_Jan_16_15(1)_R13.nxml.txt.nlp	23324173	SENT169	23	23	1	1	neomycin	ST2	PA450608	9173;6761	0.885
NULL	Biomed_Res_Int_2013_May_16_2013_749203.nxml.txt.nlp	23862155	SENT130	8	8	4	4	erlotinib	EGFR	PA134687924	1956	0.885
NULL	Cancer_Cell_Int_2012_Aug_1_12_35.nxml.txt.nlp	22853623	SENT154	6	6	18	18	cisplatin	survivin	PA449014	332	0.885
NULL	Clin_Mol_Allergy_2011_Jul_26_9_11.nxml.txt.nlp	21791043	SENT56	16	16	27	27	omalizumab	CD4	PA164752253	920	0.885
NULL	J_Mol_Signal_2008_Dec_1_3_18.nxml.txt.nlp	19046439	SENT187	8	8	14	14	metformin	AMPK	PA450395	5563	0.885
NULL	Int_J_Biomed_Sci_2014_Sep_10(3)_146-157.nxml.txt.nlp	25324695	SENT23	8	8	32	32	lovastatin	LFA-1	PA450272	3683;3689	0.885
NULL	Nat_Med_2011_Dec_11_18(1)_74-82.nxml.txt.nlp	22157681	SENT236	16	16	5	5	gefitinib	APAF-1	PA131301952	317	0.885
NULL	Int_J_Biol_Sci_2013_Nov_16_9(10)_1070-1078.nxml.txt.nlp	24250252	SENT156	24	24	38	38	lipase	gamma	PA450239	9913	0.885
NULL	Oncogene_2014_Jun_26_33(26)_3422-3431.nxml.txt.nlp	23912457	SENT19	0	0	21	21	trastuzumab	PTEN	PA451743	5728	0.885
NULL	Cancers_(Basel)_2014_May_16_6(2)_1180-1194.nxml.txt.nlp	24840048	SENT46	28	28	6	6	cisplatin	Bcl-2	PA449014	596	0.885
NULL	Core_Evid_2009_Jun_15_4_131-147.nxml.txt.nlp	20694070	SENT177	10	10	27	27	raltegravir	CD4		920	0.885
NULL	ScientificWorldJournal_2012_Dec_27_2012_740308.nxml.txt.nlp	23346021	SENT130	2	2	15	15	ethanol	IL-13	PA448073	3596	0.885
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT78	21	21	8	8	pemetrexed	UNG	PA10810	7374	0.885
NULL	Oncol_Lett_2013_Jul_29_6(1)_118-124.nxml.txt.nlp	23946788	SENT90	12	12	8	8	tamoxifen	HER-2	PA451581	2064	0.885
NULL	Oncotarget_2010_May_1_1(1)_6-8.nxml.txt.nlp	21293050	SENT26	29	29	40	40	bortezomib	KIT	PA10252	3815	0.885
NULL	Croat_Med_J_2012_Jun_53(3)_214-223.nxml.txt.nlp	22661134	SENT58	3	3	16	16	clonidine	ACTH	PA449051	5443	0.885
NULL	Clin_Psychopharmacol_Neurosci_2013_Aug_26_11(2)_60-66.nxml.txt.nlp	24023549	SENT26	22	22	27	27	risperidone	5-HT1A	PA451257	3350	0.885
NULL	Oncotarget_2012_Nov_17_3(12)_1600-1614.nxml.txt.nlp	23307622	SENT83	39	39	7	7	paclitaxel	ATG12	PA450761	9140	0.885
NULL	Ann_Gen_Psychiatry_2009_Jul_27_8_16.nxml.txt.nlp	19635147	SENT80	19	19	7	7	paroxetine	CYP3A4	PA450801	1576	0.885
NULL	Indian_J_Pharmacol_2008_Aug_40(4)_183-185.nxml.txt.nlp	20040954	SENT7	41	41	30	30	glibenclamide	flower	PA449782	11094	0.885
NULL	Oncotarget_2011_Sep_9_2(9)_658-668.nxml.txt.nlp	21911919	SENT114	10	10	2	2	daunorubicin	HO-1	PA449212	3162	0.885
NULL	Biomed_Res_Int_2014_Jun_25_2014_203693.nxml.txt.nlp	25089265	SENT286	6	6	46	46	cabozantinib	TIE-2	PA165906891	7010	0.885
NULL	Case_Rep_Ophthalmol_Med_2012_Dec_18_2012_379132.nxml.txt.nlp	23320223	SENT45	2	2	10	10	erlotinib	EGFR	PA134687924	1956	0.885
NULL	Drug_Healthc_Patient_Saf_2012_Jun_6_4_39-54.nxml.txt.nlp	22792008	SENT201	8	8	13	13	phenytoin	UGT	PA450947	7361;7355	0.885
NULL	Cancer_Cell_Int_2010_Apr_29_10_12.nxml.txt.nlp	20429927	SENT203	10	10	26	26	bortezomib	TRAF2	PA10252	7186	0.885
NULL	J_Cell_Biol_1998_Jul_27_142(2)_537-544.nxml.txt.nlp	9679150	SENT160	23	23	6	6	staurosporine	Bcl-2	PA165109623	596	0.885
NULL	Acta_Pharmacol_Sin_2009_Mar_5_30(3)_307-313.nxml.txt.nlp	19262554	SENT26	10	10	13	13	losartan	AT1	PA450268	9197;185	0.885
NULL	Eur_J_Immunol_2014_Jun_10_44(6)_1759-1769.nxml.txt.nlp	24595810	SENT91	7	7	17	17	fludrocortisone	CD4	PA164743961	920	0.885
NULL	J_Bras_Pneumol_2013_Jun-Aug_39(4)_495-512.nxml.txt.nlp	24068273	SENT350	21	21	12	12	azithromycin	APE	PA448519	55704;328	0.885
NULL	J_Hematol_Oncol_2013_Jan_15_6_5.nxml.txt.nlp	23320987	SENT138	28	28	10	10	heparin	PI-PLC	PA449855	2923	0.885
NULL	Mol_Cancer_2008_Sep_12_7_69.nxml.txt.nlp	18789131	SENT171	16	16	31	31	pp2	EGFR		1956	0.885
NULL	Breast_Cancer_Res_2011_Jan_11_13(1)_R3.nxml.txt.nlp	21223569	SENT185	18	18	31	31	etoposide	p53	PA449552	7157	0.885
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Nov_6_66(Pt_12)_o3054-o3055.nxml.txt.nlp	21589366	SENT76	10	10	22	22	ethanol	mol	PA448073	90527	0.885
NULL	Cancers_(Basel)_2011_Apr_1_3(2)_1844-1860.nxml.txt.nlp	24212785	SENT55	11	11	19	19	cetuximab	EGFR	PA10040	1956	0.885
NULL	Case_Rep_Genet_2011_Jul_6_2011_913020.nxml.txt.nlp	23074682	SENT62	7	7	18	18	hydroxyprogesterone	ACTH	PA449932	5443	0.885
NULL	Front_Oncol_2014_May_20_4_111.nxml.txt.nlp	24904826	SENT160	24	24	28	28	olaparib	BRCA1		672	0.885
NULL	Oncol_Rep_2013_Jun_22_29(6)_2479-2485.nxml.txt.nlp	23525656	SENT31	2	2	19	19	imatinib	KIT	PA10804	3815	0.885
NULL	Lipids_Health_Dis_2011_Jan_18_10_8.nxml.txt.nlp	21241519	SENT105	24	24	7	7	simvastatin	ABCG1	PA451363	9619	0.885
NULL	Br_J_Cancer_2010_Oct_12_103(8)_1284-1291.nxml.txt.nlp	20859285	SENT164	9	9	4	4	tamoxifen	ERBB2	PA451581	2064	0.885
NULL	Acta_Pharmacol_Sin_2009_Jul_22_30(7)_956-964.nxml.txt.nlp	19543298	SENT169	21	21	34	34	ezetimibe	NPC1L1	PA10816	29881	0.885
NULL	Diabetes_Care_2009_Sep_32(9)_e104-e111.nxml.txt.nlp	19717816	SENT127	32	32	17	17	exenatide	GLP-1	PA164749238	100125288	0.885
NULL	Braz_J_Microbiol_2014_Mar_10_44(4)_1089-1095.nxml.txt.nlp	24688497	SENT54	3	3	16	16	lipase	mol	PA450239	90527	0.885
NULL	Br_J_Cancer_2011_Jul_26_105(3)_372-381.nxml.txt.nlp	21730979	SENT240	20	20	25	25	hydroxyurea	PARP	PA449942	142	0.885
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Sep_14_67(Pt_10)_o2575.nxml.txt.nlp	22058741	SENT57	28	28	22	22	ethanol	mol	PA448073	90527	0.885
NULL	Am_J_Case_Rep_2014_Apr_14_15_152-154.nxml.txt.nlp	24753783	SENT46	46	46	43	43	sitagliptin	DPP4	PA164748978	1803	0.885
NULL	Cancer_Cell_Int_2011_Aug_19_11_29.nxml.txt.nlp	21854619	SENT14	7	7	4	4	platinum	HDAC	PA150595617	9734	0.885
NULL	J_Nat_Prod_2011_Apr_25_74(4)_567-573.nxml.txt.nlp	21348461	SENT53	41	41	9	9	calcein	MDR1	PA132595336	5243	0.885
NULL	J_Mol_Psychiatry_2013_Nov_4_1(1)_19.nxml.txt.nlp	25408910	SENT81	9	9	25	25	olanzapine	CTCF	PA450688	10664	0.885
NULL	Oncoscience_2014_Oct_22_1(10)_614-623.nxml.txt.nlp	25593991	SENT132	13	13	34	34	carboplatin	TP53	PA448803	7157	0.885
NULL	Front_Aging_Neurosci_2010_May_18_2_20.nxml.txt.nlp	20589102	SENT63	16	16	5	5	naproxen	COX	PA450595	1351	0.885
NULL	Br_J_Cancer_1998_Jun_77(11)_1880-1883.nxml.txt.nlp	9667663	SENT11	19	19	4	4	guanidine	BRCA1	PA164781028	672	0.885
NULL	Clin_Interv_Aging_2013_Jul_16_8_889-897.nxml.txt.nlp	23898224	SENT20	38	38	32	32	gemcitabine	SIRT1	PA449748	23411	0.885
NULL	Front_Oncol_2014_Jun_18_4_153.nxml.txt.nlp	24995158	SENT529	24	24	19	19	paclitaxel	CLIP-170	PA450761	6249	0.885
NULL	J_Breast_Cancer_2012_Mar_28_15(1)_79-86.nxml.txt.nlp	22493632	SENT25	11	11	13	13	tamoxifen	aromatase	PA451581	1588	0.885
NULL	Int_Neurourol_J_2014_Sep_24_18(3)_115-125.nxml.txt.nlp	25279238	SENT163	6	6	11	11	berberine	Bcl-2	PA165860812	596	0.885
NULL	J_Signal_Transduct_2011_Jun_7_2011_982879.nxml.txt.nlp	21776391	SENT151	17	17	29	29	cetuximab	PI3K	PA10040	5290	0.885
NULL	Clin_Med_Insights_Blood_Disord_2013_Nov_14_6_23-27.nxml.txt.nlp	25512717	SENT112	34	34	28	28	vindesine	CHOP	PA10232	1649	0.885
NULL	J_Brachial_Plex_Peripher_Nerve_Inj_2008_Mar_19_3_8.nxml.txt.nlp	18353188	SENT212	3	3	24	24	capsaicin	SSeCKS	PA448776	9590	0.885
NULL	Hum_Genomics_2008_Sep_1_3(1)_7-16.nxml.txt.nlp	19129086	SENT151	0	0	7	7	rosiglitazone	CYP2C8	PA451283	1558	0.885
NULL	Nucleic_Acids_Res_2013_Apr_17_41(7)_4129-4143.nxml.txt.nlp	23420868	SENT265	20	20	16	16	hemin	SHP2	PA449849	5781	0.885
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT79	42	42	26	26	curcumin	DR5	PA151958596	8795	0.885
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT113	3	3	10	10	tenofovir	SLC22A8	PA10204	9376	0.885
NULL	J_Cell_Mol_Med_2014_Apr_20_18(4)_709-720.nxml.txt.nlp	24444314	SENT107	23	23	28	28	losartan	Met	PA450268	79811	0.885
NULL	Evid_Based_Complement_Alternat_Med_2013_Aug_12_2013_982689.nxml.txt.nlp	23997806	SENT228	18	18	8	8	tolbutamide	APE	PA451718	55704;328	0.885
NULL	Acta_Vet_Scand_2011_Mar_7_53(1)_16.nxml.txt.nlp	21375785	SENT204	27	27	7	7	oxygen	CA-II	PA450744	760	0.885
NULL	Arthritis_Res_Ther_2010_Jul_5_12(4)_R128.nxml.txt.nlp	20602758	SENT60	14	14	2	2	fluorescein	CD204	PA164746009	4481	0.885
NULL	J_Cell_Biol_2003_Sep_29_162(7)_1197-1209.nxml.txt.nlp	14517203	SENT36	22	22	16	16	hydroxyurea	BLM	PA449942	641	0.885
NULL	Nat_Commun_2012_Dec_27_3_1316.nxml.txt.nlp	23271650	SENT531	20	20	2	2	tamoxifen	P60	PA451581	7984	0.885
NULL	Br_J_Cancer_2009_Nov_3_101(9)_1620-1629.nxml.txt.nlp	19809428	SENT33	34	34	10	10	etoposide	CXCL8	PA449552	3576	0.885
NULL	Arch_Gynecol_Obstet_2013_Mar_8_287(3)_563-570.nxml.txt.nlp	23135210	SENT38	44	44	8	8	camptothecin	MRP2	PA153590860	100130958;57626;1244	0.885
NULL	J_Hematol_Oncol_2013_Jan_4_6_1.nxml.txt.nlp	23286345	SENT89	4	4	23	23	trastuzumab	FCGR3A	PA451743	2214	0.885
NULL	Clinics_(Sao_Paulo)_2010_Sep_65(9)_885-894.nxml.txt.nlp	21049217	SENT36	19	19	31	31	clozapine	5-HT2C	PA449061	3358	0.885
NULL	Mol_Cancer_2009_Aug_25_8_66.nxml.txt.nlp	19706164	SENT230	12	12	21	21	oxygen	p53	PA450744	7157	0.885
NULL	Bioinformation_2012_Jun_16_8(11)_523-528.nxml.txt.nlp	22829723	SENT12	25	25	5	5	rimonabant	CB1	PA152407999	1268	0.885
NULL	Epigenetics_2012_Nov_1_7(11)_1225-1229.nxml.txt.nlp	23069641	SENT38	8	8	20	20	cisplatin	BRCA1	PA449014	672	0.885
NULL	Front_Neurosci_2012_May_30_6_77.nxml.txt.nlp	22661925	SENT226	6	6	15	15	ethanol	NeuN	PA448073	146713	0.885
NULL	Oncotarget_2014_Feb_25_5(5)_1304-1314.nxml.txt.nlp	24675421	SENT66	35	35	16	16	cisplatin	JNK	PA449014	5599	0.885
NULL	Drugs_R_D_2011_Jun_27_11(2)_101-111.nxml.txt.nlp	21679003	SENT12	26	26	14	14	bevacizumab	BRAF	PA130232992	673	0.885
NULL	Indian_J_Psychiatry_2010_Jan_52(Suppl1)_S200-S209.nxml.txt.nlp	21836679	SENT152	19	19	16	16	clonidine	ACTH	PA449051	5443	0.885
NULL	J_Biomed_Biotechnol_2011_Dec_30_2011_758736.nxml.txt.nlp	21253525	SENT102	15	15	23	23	doxorubicin	ANOVA	PA449412	4858	0.885
NULL	Mol_Cancer_2010_Jun_27_9_168.nxml.txt.nlp	20579391	SENT179	5	5	27	27	dasatinib	MMP1	PA162372878	4312	0.885
NULL	Gut_Liver_2011_Dec_21_5(4)_397-405.nxml.txt.nlp	22195236	SENT7	9	9	0	0	hyaluronan	CD44	PA165958431	960	0.885
NULL	Diabetes_Care_2009_Apr_32(4)_531-540.nxml.txt.nlp	19336638	SENT23	2	2	9	9	ticlopidine	ADP	PA451686	23038	0.885
NULL	Front_Genet_2012_Nov_12_3_235.nxml.txt.nlp	23162568	SENT168	15	15	5	5	methamphetamine	CYP2D6	PA450403	1565	0.885
NULL	Int_J_Endocrinol_2012_Apr_10_2012_268957.nxml.txt.nlp	22550484	SENT448	9	9	19	19	cabergoline	PRL	PA448708	5617	0.885
NULL	Biomed_Res_Int_2013_May_9_2013_341218.nxml.txt.nlp	23762839	SENT138	9	9	25	25	voriconazole	ANOVA	PA10233	4858	0.885
NULL	Clin_Pharmacokinet_2014_Sep_3_53(1)_1-16.nxml.txt.nlp	23999929	SENT278	28	28	18	18	rivaroxaban	P-gp	PA165958360	5243	0.885
NULL	Mol_Cancer_2010_May_18_9_110.nxml.txt.nlp	20482802	SENT183	5	5	33	33	bortezomib	CHOP	PA10252	1649	0.885
NULL	J_Hematol_Oncol_2013_Jun_3_6_38.nxml.txt.nlp	23731980	SENT100	18	18	10	10	pertuzumab	HER2		2064	0.885
NULL	Cell_Death_Dis_2014_Feb_27_5(2)_e1088.nxml.txt.nlp	24577086	SENT308	22	22	11	11	metformin	MDC	PA450395	6367	0.885
NULL	Mol_Biol_Cell_2012_Jun_1_23(11)_2226-2234.nxml.txt.nlp	22493319	SENT129	9	9	15	15	etoposide	FOXO3	PA449552	2309	0.885
NULL	Oncol_Lett_2013_Feb_9_5(2)_552-558.nxml.txt.nlp	23420128	SENT6	5	5	10	10	imatinib	KIT	PA10804	3815	0.885
NULL	J_Cell_Mol_Med_2014_Oct_11_18(10)_2031-2043.nxml.txt.nlp	25109475	SENT319	5	5	16	16	valsartan	AMPK	PA451848	5563	0.885
NULL	J_Ophthalmol_2011_Oct_20_2011_252549.nxml.txt.nlp	22046503	SENT114	8	8	19	19	ranibizumab	HTRA1	PA164746012	5654	0.885
NULL	Biomed_Res_Int_2014_Jan_20_2014_948427.nxml.txt.nlp	24563867	SENT194	23	23	5	5	buspirone	COB	PA448689	4519	0.885
NULL	Ann_Gastroenterol_2014_27(3)_200-206.nxml.txt.nlp	24976114	SENT83	8	8	4	4	thrombin	PAR4	PA451674	9002;5074	0.885
NULL	J_Cell_Mol_Med_2013_Oct_23_17(10)_1207-1217.nxml.txt.nlp	24106980	SENT161	14	14	21	21	paclitaxel	CD24	PA450761	100133941	0.885
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT269	5	5	20	20	tacrolimus	IL-6	PA451578	3569	0.885
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT147	0	0	12	12	neratinib	HER2	PA165291472	2064	0.885
NULL	Cell_Death_Dis_2010_Nov_4_1(11)_e93.nxml.txt.nlp	21368869	SENT10	8	8	2	2	imatinib	RSK	PA10804	6195;6196;6197	0.885
NULL	Ann_Rheum_Dis_2008_Aug_29_67(8)_1096-1103.nxml.txt.nlp	18055472	SENT122	13	13	15	15	infliximab	ACR	PA452639	49	0.885
NULL	Carcinogenesis_2014_May_13_35(5)_1055-1066.nxml.txt.nlp	24419232	SENT282	0	0	2	2	metformin	AMPK	PA450395	5563	0.885
NULL	Oncotarget_2013_Aug_21_4(9)_1484-1495.nxml.txt.nlp	23986086	SENT14	42	42	15	15	metformin	PIK3CA	PA450395	5290	0.885
NULL	Ther_Clin_Risk_Manag_2007_Jun_3(3)_467-474.nxml.txt.nlp	18488080	SENT121	13	13	3	3	rasagiline	CYP1A2	PA164764584	1544	0.885
NULL	Nucleic_Acids_Res_2012_Sep_7_40(16)_7705-7717.nxml.txt.nlp	22684509	SENT103	27	27	4	4	chloramphenicol	PAD1	PA448927	29943	0.885
NULL	J_Hematol_Oncol_2010_May_2_3_18.nxml.txt.nlp	20433767	SENT123	23	23	11	11	vinorelbine	EGFR	PA451881	1956	0.885
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT156	14	14	21	21	trastuzumab	HER3	PA451743	2065	0.885
NULL	Scientifica_(Cairo)_2012_Dec_23_2012_857516.nxml.txt.nlp	24278747	SENT288	31	31	20	20	celecoxib	CHOP	PA448871	1649	0.885
NULL	J_Cell_Mol_Med_2014_Dec_6_18(12)_2404-2416.nxml.txt.nlp	25284615	SENT90	10	10	14	14	fluorescein	SP-C	PA164746009	6440	0.885
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT168	2	2	19	19	tacrolimus	OPG	PA451578	690	0.885
NULL	Case_Rep_Anesthesiol_2011_Jan_5_2011_204538.nxml.txt.nlp	22606382	SENT27	18	18	27	27	sildenafil	PTPA	PA451346	5524	0.885
NULL	Mol_Cancer_2004_Nov_17_3_31.nxml.txt.nlp	15548330	SENT290	13	13	18	18	etoposide	PC-3	PA449552	692094	0.885
NULL	Crit_Care_1999_Nov_8_3(6)_R107-R111.nxml.txt.nlp	NULL	SENT71	16	16	4	4	propranolol	IL-10	PA451145	3586	0.885
NULL	Ann_Oncol_2011_Aug_27_22(8)_1736-1747.nxml.txt.nlp	21709140	SENT48	21	21	25	25	exemestane	aromatase	PA449563	1588	0.885
NULL	Exp_Diabetes_Res_2011_Jun_22_2011_279530.nxml.txt.nlp	21747825	SENT164	6	6	0	0	exenatide	GLP-1	PA164749238	100125288	0.885
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT148	3	3	7	7	lopinavir	SLC22A8	PA450264	9376	0.885
NULL	Br_J_Pharmacol_2014_Oct_26_171(20)_4785-4796.nxml.txt.nlp	25074741	SENT241	30	30	15	15	guanfacine	NK1R	PA449825	6869	0.885
NULL	J_Oncol_2013_Feb_17_2013_872957.nxml.txt.nlp	23476648	SENT136	19	19	31	31	cisplatin	SFN	PA449014	25996;2810	0.885
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT434	26	26	11	11	forskolin	AMPK	PA146096022	5563	0.885
NULL	Br_J_Cancer_2013_Jul_9_109(1)_68-75.nxml.txt.nlp	23807173	SENT214	6	6	11	11	cisplatin	ANOVA	PA449014	4858	0.885
NULL	J_Gynecol_Oncol_2012_Jul_2_23(3)_139-140.nxml.txt.nlp	NULL	SENT26	26	26	19	19	docetaxel	EZH2	PA449383	2146	0.885
NULL	Adv_Hematol_2012_Aug_2_2012_842945.nxml.txt.nlp	22919394	SENT160	31	31	18	18	lenalidomide	CRBN	PA162363968	51185	0.885
NULL	F1000Res_2013_Feb_28_2_65.nxml.txt.nlp	24358861	SENT132	9	9	7	7	naloxone	TLR4	PA450586	7099	0.885
NULL	Oncoimmunology_2014_Jun_25_3_e29351.nxml.txt.nlp	25083341	SENT44	15	15	4	4	cyclophosphamide	CD4	PA449165	920	0.885
NULL	Acta_Pharmacol_Sin_2009_Feb_5_30(2)_228-234.nxml.txt.nlp	19122672	SENT125	9	9	27	27	isoflurane	HO-1	PA450106	3162	0.885
NULL	Br_J_Cancer_2011_Jul_26_105(3)_393-402.nxml.txt.nlp	21750550	SENT179	13	13	17	17	etodolac	SNAIL	PA449550	6615	0.885
NULL	J_Mol_Med_(Berl)_2014_May_10_92(7)_709-722.nxml.txt.nlp	24811491	SENT70	17	17	3	3	cetuximab	HER2	PA10040	2064	0.885
NULL	Arthritis_Res_Ther_2013_May_29_15(3)_R64.nxml.txt.nlp	23718630	SENT185	5	5	0	0	anakinra	S100A12	PA10799	6283	0.885
NULL	Br_J_Cancer_2010_Oct_12_103(8)_1309-1310.nxml.txt.nlp	NULL	SENT14	24	24	19	19	sunitinib	IFN	PA162372840	3439	0.885
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT20	32	32	13	13	etoposide	PDK1	PA449552	5170;5163	0.885
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Oct_23_66(Pt_11)_o2941.nxml.txt.nlp	21589111	SENT48	18	18	12	12	ethanol	mol	PA448073	90527	0.885
NULL	Clin_Sci_(Lond)_2012_May_1_122(Pt_9)_421-428.nxml.txt.nlp	22092038	SENT178	26	26	11	11	doxycycline	AP-1	PA449415	2353;3727;2354;3725	0.885
NULL	Carcinogenesis_2014_May_13_35(5)_1055-1066.nxml.txt.nlp	24419232	SENT263	5	5	19	19	metformin	CD31	PA450395	5175	0.885
NULL	Osteoporos_Int_2012_Jan_3_23(1)_327-337.nxml.txt.nlp	21892677	SENT13	21	21	18	18	denosumab	RANKL	PA166048634	8600	0.885
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_75-89.nxml.txt.nlp	17912638	SENT577	15	15	32	32	anastrozole	ATAC	PA448432	6375	0.885
NULL	Br_J_Cancer_2013_Dec_10_109(12)_3034-3041.nxml.txt.nlp	24178758	SENT142	37	37	16	16	tamoxifen	BiP	PA451581	3309	0.885
NULL	Indian_J_Ophthalmol_2007_Nov-Dec_55(6)_482-483.nxml.txt.nlp	17951917	SENT16	35	35	6	6	cefazolin	API	PA448839	5345	0.885
NULL	Chem_Commun_(Camb)_2013_Jun_21_49(76)_8441-8443.nxml.txt.nlp	23770604	SENT10	1	1	14	14	geldanamycin	Hsp90	PA152031327	3320	0.885
NULL	eLife_2014_May_7_3_e02669.nxml.txt.nlp	24843006	SENT400	33	33	11	11	tamoxifen	NeuN	PA451581	146713	0.885
NULL	Cancers_(Basel)_2012_Oct_29_4(4)_1146-1160.nxml.txt.nlp	24213502	SENT183	24	24	28	28	tamoxifen	aromatase	PA451581	1588	0.885
NULL	Breast_Cancer_Res_Treat_2013_Aug_20_141(1)_43-53.nxml.txt.nlp	23959396	SENT192	32	32	21	21	trastuzumab	HER3	PA451743	2065	0.885
NULL	Breast_Cancer_Res_2009_Sep_16_11(5)_R69.nxml.txt.nlp	19758440	SENT200	32	32	8	8	lapatinib	HER2	PA152241907	2064	0.885
NULL	Biomed_Res_Int_2013_Aug_29_2013_560141.nxml.txt.nlp	24073410	SENT161	23	23	9	9	estradiol	SLPI	PA449503	6590	0.885
NULL	Br_J_Pharmacol_2010_Mar_8_159(5)_1092-1105.nxml.txt.nlp	20148890	SENT54	23	23	25	25	ticlopidine	P2Y12	PA451686	64805	0.885
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_May_14_65(Pt_6)_o1266.nxml.txt.nlp	21583130	SENT51	13	13	31	31	ethanol	mol	PA448073	90527	0.885
NULL	Cancer_Cell_Int_2013_Jun_26_13_64.nxml.txt.nlp	23802572	SENT128	0	0	11	11	curcumin	Bcl-2	PA151958596	596	0.885
NULL	FEBS_J_2012_May_279(10)_1857-1870.nxml.txt.nlp	22420714	SENT46	0	0	7	7	capsaicin	TRPV1	PA448776	7442	0.885
NULL	Biomed_Res_Int_2014_Jan_16_2014_706302.nxml.txt.nlp	24551852	SENT22	24	24	0	0	ethanol	CYP2E1	PA448073	1571	0.885
NULL	Front_Cell_Neurosci_2014_Jan_29_8_11.nxml.txt.nlp	24523671	SENT190	16	16	9	9	ethanol	GluA4	PA448073	2893	0.885
NULL	J_Nucleic_Acids_2009_Dec_15_2010_593408.nxml.txt.nlp	20814427	SENT273	31	31	8	8	berberine	PC-3	PA165860812	692094	0.885
NULL	Oncotarget_2011_Nov_9_2(11)_850-861.nxml.txt.nlp	22081665	SENT0	17	17	7	7	daunorubicin	DNMT3A	PA449212	1788	0.885
NULL	Cancer_Imaging_2013_May_2_13(2)_197-211.nxml.txt.nlp	23649384	SENT89	15	15	18	18	imatinib	FDG	PA10804	23583	0.885
NULL	Cancer_Cell_Int_2010_Sep_9_10_32.nxml.txt.nlp	20828393	SENT189	6	6	13	13	cisplatin	ATF3	PA449014	467	0.885
NULL	Br_J_Cancer_2011_Sep_6_105(6)_807-813.nxml.txt.nlp	21847121	SENT86	31	31	11	11	gefitinib	HER3	PA131301952	2065	0.885
NULL	Int_J_Gen_Med_2012_Jun_18_5_535-540.nxml.txt.nlp	22807641	SENT81	7	7	17	17	pitavastatin	adiponectin	PA142650384	9370	0.885
NULL	Clin_Pharmacol_2009_Sep_7_1_1-6.nxml.txt.nlp	22291481	SENT82	6	6	16	16	fluoxetine	PDE4B	PA449673	5142	0.885
NULL	Cell_Death_Dis_2014_Feb_27_5(2)_e1088.nxml.txt.nlp	24577086	SENT346	5	5	21	21	metformin	LC3	PA450395	84557	0.885
NULL	Rare_Tumors_2010_Dec_31_2(4)_e58.nxml.txt.nlp	21234250	SENT66	0	0	17	17	nilotinib	KIT	PA165958345	3815	0.885
NULL	Acta_Pharmacol_Sin_2011_Jun_23_32(6)_765-780.nxml.txt.nlp	21602835	SENT149	5	5	0	0	diazoxide	SUR1	PA449285	6833	0.885
NULL	Apoptosis_2012_Sep_30_17(9)_989-997.nxml.txt.nlp	22460505	SENT136	4	4	14	14	thioridazine	p53	PA451666	7157	0.885
NULL	Oncotarget_2013_Nov_24_4(12)_2186-2207.nxml.txt.nlp	24327604	SENT121	38	38	43	43	vincristine	P-gp	PA451879	5243	0.885
NULL	Mol_Cell_Proteomics_2012_Feb_6_11(2)_M111_015222.nxml.txt.nlp	22147731	SENT34	12	12	4	4	cetuximab	PIK3CA	PA10040	5290	0.885
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Mar_14_68(Pt_4)_o1044.nxml.txt.nlp	22589914	SENT63	15	15	6	6	ethanol	mol	PA448073	90527	0.885
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT520	37	37	43	43	iloperidone	PRL	PA161199368	5617	0.885
NULL	ISRN_AIDS_2012_Jul_12_2012_485307.nxml.txt.nlp	24052874	SENT99	9	9	1	1	tenofovir	PTH	PA10204	5741	0.885
NULL	Cancers_(Basel)_2012_Jun_5_4(2)_549-565.nxml.txt.nlp	24213324	SENT442	3	3	15	15	sorafenib	SHARP	PA7000	23013	0.885
NULL	HSR_Proc_Intensive_Care_Cardiovasc_Anesth_2010_2(2)_81-91.nxml.txt.nlp	23440622	SENT134	3	3	13	13	clopidogrel	P2Y12	PA449053	64805	0.885
NULL	Oncol_Lett_2014_Nov_14_8(5)_2086-2092.nxml.txt.nlp	25295095	SENT86	14	14	10	10	gemcitabine	LKB1	PA449748	6794	0.885
NULL	Pharmaceuticals_(Basel)_2013_Apr_8_6(4)_500-509.nxml.txt.nlp	24276120	SENT231	12	12	1	1	furosemide	GPR35	PA449719	2859	0.885
NULL	Cancer_Metastasis_Rev_2013_Jun_6_32(1-2)_179-188.nxml.txt.nlp	23129208	SENT188	11	11	8	8	trastuzumab	HER2	PA451743	2064	0.885
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Mar_17_66(Pt_4)_o864-o865.nxml.txt.nlp	21580687	SENT73	36	36	25	25	ethanol	mol	PA448073	90527	0.885
NULL	Arthritis_Res_Ther_2012_Jun_12_14(3)_R142.nxml.txt.nlp	22691272	SENT139	11	11	18	18	mianserin	IL-17	PA134687937	3605	0.885
NULL	Oncogene_2013_Sep_12_32(37)_4355-4365.nxml.txt.nlp	23108409	SENT25	5	5	15	15	hyaluronan	HAS2	PA165958431	3037	0.885
NULL	Ther_Clin_Risk_Manag_2007_Aug_3(4)_675-684.nxml.txt.nlp	18472990	SENT207	0	0	12	12	linezolid	VISA	PA450233	57506	0.885
NULL	Br_J_Cancer_2004_Mar_8_90(5)_1059-1068.nxml.txt.nlp	14997208	SENT155	27	27	8	8	remikiren	AT2	PA164774779	186	0.885
NULL	Biol_Open_2012_May_21_1(7)_629-639.nxml.txt.nlp	23125914	SENT53	41	41	12	12	doxycycline	PITX1	PA449415	5307	0.885
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1420-1426.nxml.txt.nlp	24056704	SENT125	0	0	20	20	ketoconazole	CYP3A	PA450146	1574	0.885
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_19_2013_642920.nxml.txt.nlp	23861709	SENT152	21	21	8	8	choline	p53	PA448976	7157	0.885
NULL	J_Biomed_Sci_2012_Nov_21_19(1)_99.nxml.txt.nlp	23170833	SENT11	17	17	10	10	atorvastatin	CXCR4	PA448500	7852	0.885
NULL	Aging_(Albany_NY)_2012_Dec_29_5(1)_37-50.nxml.txt.nlp	23449538	SENT79	9	9	18	18	tamoxifen	E2F1	PA451581	1869	0.885
NULL	Breast_Cancer_Res_2006_May_31_8(3)_R25.nxml.txt.nlp	16737553	SENT162	27	27	13	13	tamoxifen	CD68	PA451581	968	0.885
NULL	Br_J_Cancer_2011_Jul_12_105(2)_212-220.nxml.txt.nlp	21694723	SENT192	6	6	11	11	curcumin	STAT3	PA151958596	6774	0.885
NULL	Oncoscience_2014_Aug_7_1(8)_540-549.nxml.txt.nlp	25594061	SENT70	13	13	21	21	erlotinib	KRAS	PA134687924	3845	0.885
NULL	Nat_Commun_2012_Feb_14_3_672.nxml.txt.nlp	22334075	SENT385	10	10	8	8	lovastatin	PPARgamma	PA450272	5468	0.885
NULL	Br_J_Cancer_2011_Aug_23_105(5)_649-657.nxml.txt.nlp	21811251	SENT185	18	18	25	25	gefitinib	IGF1R	PA131301952	3480	0.885
NULL	Cancer_Cell_Int_2004_Aug_17_4_5.nxml.txt.nlp	15315711	SENT11	12	12	24	24	genistein	CPP32	PA165109660	836	0.885
NULL	J_Clin_Biochem_Nutr_2007_Jul_27_41(1)_32-42.nxml.txt.nlp	18392098	SENT145	29	29	14	14	curcumin	ROS	PA151958596	6098	0.885
NULL	Exp_Diabetes_Res_2012_May_14_2012_470851.nxml.txt.nlp	22666230	SENT49	2	2	11	11	exenatide	GLP-1	PA164749238	100125288	0.885
NULL	eLife_2014_May_27_3_e02510.nxml.txt.nlp	24867642	SENT71	19	19	12	12	tamoxifen	Dicer	PA451581	23405	0.885
NULL	Case_Rep_Rheumatol_2011_Dec_15_2011_185657.nxml.txt.nlp	22937439	SENT13	13	13	10	10	etanercept	TNF-alpha	PA449515	7124	0.885
NULL	Int_J_Nanomedicine_2008_Sep_3(3)_359-372.nxml.txt.nlp	18990945	SENT2	5	5	19	19	methylprednisolone	CDP	PA450466	1523	0.885
NULL	J_Biomed_Biotechnol_2006_May_25_2006_62079.nxml.txt.nlp	17047309	SENT166	15	15	9	9	chloroquine	p62	PA448948	8878;10657;23636	0.885
NULL	Br_J_Cancer_2012_Feb_28_106(5)_916-922.nxml.txt.nlp	22333602	SENT13	19	19	25	25	doxorubicin	TOP2A	PA449412	7153	0.885
NULL	J_Biol_Chem_2013_Nov_22_288(47)_34217-34229.nxml.txt.nlp	24106270	SENT387	12	12	7	7	thrombin	RhoG	PA451674	391	0.885
NULL	Arthritis_Res_Ther_2013_Dec_4_15(6)_R207.nxml.txt.nlp	24299175	SENT162	21	21	4	4	rituximab	CD319	PA451261	57823	0.885
NULL	Cancers_(Basel)_2013_Aug_9_5(3)_998-1019.nxml.txt.nlp	24202331	SENT72	29	29	23	23	docetaxel	PC3	PA449383	57332;7832;5122	0.885
NULL	N_Am_J_Med_Sci_2013_Jun_5(6)_386-391.nxml.txt.nlp	23923114	SENT121	7	7	3	3	vemurafenib	BRAF	PA165946873	673	0.885
NULL	Cancer_Cell_Int_2013_Feb_8_13_11.nxml.txt.nlp	23394616	SENT186	36	36	26	26	geldanamycin	FOXO3	PA152031327	2309	0.885
NULL	Acta_Pharmacol_Sin_2010_Jul_28_31(7)_775-783.nxml.txt.nlp	20581849	SENT209	0	0	14	14	agomelatine	5-HT2C	PA165958363	3358	0.885
NULL	Biomed_Res_Int_2014_Jun_25_2014_203693.nxml.txt.nlp	25089265	SENT286	6	6	37	37	cabozantinib	KIT	PA165906891	3815	0.885
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1033-1038.nxml.txt.nlp	22374460	SENT61	17	17	10	10	trastuzumab	HER2	PA451743	2064	0.885
NULL	Blood_Cancer_J_2012_Sep_14_2(9)_e90.nxml.txt.nlp	22983433	SENT31	21	21	9	9	melphalan	CT7	PA450354	9947	0.885
NULL	J_Immunol_Res_2014_Jan_19_2014_103780.nxml.txt.nlp	24741572	SENT146	0	0	25	25	salmeterol	ADP	PA451300	23038	0.885
NULL	Mol_Cancer_2010_Apr_23_9_87.nxml.txt.nlp	20416058	SENT11	6	6	19	19	doxorubicin	TRAIL	PA449412	8743	0.885
NULL	Oncotarget_2013_Nov_4_5(1)_161-172.nxml.txt.nlp	24389287	SENT145	30	30	2	2	propranolol	p53	PA451145	7157	0.885
NULL	Curr_Control_Trials_Cardiovasc_Med_2001_Feb_2_2(1)_20-23.nxml.txt.nlp	11806769	SENT74	22	22	10	10	bucindolol	BEST	PA165945764	7439	0.885
NULL	Cancers_(Basel)_2013_Aug_9_5(3)_998-1019.nxml.txt.nlp	24202331	SENT72	29	29	11	11	docetaxel	PC3	PA449383	57332;7832;5122	0.885
NULL	Cancers_(Basel)_2014_Aug_5_6(3)_1597-1614.nxml.txt.nlp	25099886	SENT719	0	0	20	20	methotrexate	MSH2	PA450428	4436	0.885
NULL	Ann_Oncol_2013_Sep_4_24(9)_2206-2223.nxml.txt.nlp	23917950	SENT245	10	10	15	15	tamoxifen	aromatase	PA451581	1588	0.885
NULL	J_Headache_Pain_2014_Sep_18_15(Suppl_1)_E6.nxml.txt.nlp	NULL	SENT11	18	18	36	36	bupivacaine	SPG	PA135057240	55764	0.885
NULL	Clin_Ophthalmol_2014_Jun_26_8_1213-1219.nxml.txt.nlp	25061267	SENT18	1	1	13	13	tetracaine	PRK	PA451638	1263	0.885
NULL	Breast_Cancer_Res_2011_Mar_11_13(2)_R29.nxml.txt.nlp	21396094	SENT215	33	33	17	17	trastuzumab	HRG	PA451743	3084;3273	0.885
NULL	Mediators_Inflamm_1998_7(3)_169-173.nxml.txt.nlp	9705604	SENT8	35	35	24	24	octreotide	IL-6	PA450678	3569	0.885
NULL	Clin_Ophthalmol_2008_Jun_2(2)_355-368.nxml.txt.nlp	19668727	SENT81	11	11	26	26	amfenac	COX1	PA166049186	4512;5742	0.885
NULL	Lab_Invest_2011_Apr_14_91(4)_598-608.nxml.txt.nlp	21321535	SENT133	6	6	20	20	sorafenib	CD4	PA7000	920	0.885
NULL	Mol_Cancer_2014_Jan_28_13_17.nxml.txt.nlp	24472312	SENT129	13	13	3	3	ponatinib	Mcl-1	PA165980594	4170	0.885
NULL	Biomed_Res_Int_2013_Dec_4_2013_685308.nxml.txt.nlp	23509762	SENT213	7	7	14	14	doxorubicin	HIF-1	PA449412	29072	0.885
NULL	Arthritis_Res_Ther_2011_Feb_8_13(1)_R17.nxml.txt.nlp	21303509	SENT213	40	40	1	1	leflunomide	FSTL1	PA450192	11167	0.885
NULL	Front_Genet_2012_Oct_19_3_220.nxml.txt.nlp	23091481	SENT2	20	20	17	17	bleomycin	gamma	PA448645	9913	0.885
NULL	Clin_Interv_Aging_2013_Mar_26_8_347-352.nxml.txt.nlp	23569367	SENT99	24	24	7	7	levodopa	GRK6	PA450213	2870	0.885
NULL	Ther_Clin_Risk_Manag_2007_Mar_3(1)_71-97.nxml.txt.nlp	18360617	SENT270	24	24	17	17	micafungin	CYP3A	PA164781026	1574	0.885
NULL	Biomed_Res_Int_2014_May_14_2014_494835.nxml.txt.nlp	24949455	SENT38	16	16	37	37	trypsin	CO2	PA451806	4513	0.885
NULL	Br_J_Cancer_2000_Jun_82(11)_1851-1859.nxml.txt.nlp	10839301	SENT8	26	26	4	4	bleomycin	CD95	PA448645	355	0.885
NULL	Curr_Med_Chem_2011_Dec_18(35)_5476-5482.nxml.txt.nlp	22087839	SENT130	16	16	10	10	cisplatin	p53	PA449014	7157	0.885
NULL	Mol_Cancer_2010_Dec_2_9_309.nxml.txt.nlp	21122157	SENT334	19	19	13	13	paclitaxel	IL-6	PA450761	3569	0.885
NULL	J_Cell_Biol_2003_Dec_22_163(6)_1385-1395.nxml.txt.nlp	14676308	SENT269	15	15	2	2	thrombin	Rho	PA451674	29984	0.885
NULL	Breast_Cancer_Res_2011_Mar_4_13(2)_R23.nxml.txt.nlp	21375726	SENT209	31	31	9	9	tamoxifen	ERBB2	PA451581	2064	0.885
NULL	Exp_Ther_Med_2013_Jul_25_6(1)_109-114.nxml.txt.nlp	23935730	SENT150	19	19	13	13	vincristine	CHOP	PA451879	1649	0.885
NULL	Alcohol_Res_Health_2007_30(1)_38-47.nxml.txt.nlp	17718399	SENT76	33	33	3	3	ethanol	ADH1B	PA448073	125	0.885
NULL	Clin_Med_Insights_Oncol_2012_Feb_28_6_125-135.nxml.txt.nlp	22408376	SENT192	9	9	23	23	cetuximab	KRAS	PA10040	3845	0.885
NULL	Mol_Cancer_2010_Jun_25_9_165.nxml.txt.nlp	20576164	SENT219	11	11	29	29	curcumin	STAT1	PA151958596	6772	0.885
NULL	Exp_Diabetes_Res_2011_Apr_6_2011_928523.nxml.txt.nlp	21603181	SENT217	31	31	13	13	haloperidol	NEFA	PA449841	4925	0.885
NULL	Autophagy_2013_May_1_9(5)_789-790.nxml.txt.nlp	23388383	SENT25	20	20	15	15	docetaxel	NRP2	PA449383	8828;4753	0.885
NULL	Indian_J_Psychiatry_2014_Jan_56(Suppl_1)_S63-S96.nxml.txt.nlp	NULL	SENT818	22	22	36	36	clozapine	OGC	PA449061	8402	0.885
NULL	J_Hematol_Oncol_2009_Feb_23_2_10.nxml.txt.nlp	19236716	SENT72	27	27	2	2	imatinib	LYN	PA10804	4067	0.885
NULL	Chin_J_Cancer_2011_Sep_30(9)_645-654.nxml.txt.nlp	21880186	SENT131	27	27	1	1	methotrexate	NACT	PA450428	284111	0.885
NULL	Allergy_Asthma_Clin_Immunol_2007_Mar_15_3(1)_24-30.nxml.txt.nlp	20525150	SENT79	16	16	27	27	meloxicam	COX	PA450353	1351	0.885
NULL	J_Headache_Pain_2009_Apr_27_10(2)_105-110.nxml.txt.nlp	19172228	SENT137	6	6	20	20	sumatriptan	c-fos	PA451566	2353	0.885
NULL	J_Exp_Clin_Cancer_Res_2009_Jul_10_28(1)_99.nxml.txt.nlp	19591692	SENT122	16	16	11	11	elacridar	ABCG2		9429	0.885
NULL	J_Korean_Med_Sci_2006_Jun_21_21(3)_418-424.nxml.txt.nlp	16778382	SENT158	11	11	5	5	hemin	INS-1	PA449849	2305	0.885
NULL	Mol_Cancer_2012_May_14_11_33.nxml.txt.nlp	22583829	SENT172	20	20	33	33	cisplatin	TLR4	PA449014	7099	0.885
NULL	Eur_J_Epidemiol_2011_Aug_30_26(8)_657-686.nxml.txt.nlp	21877163	SENT942	19	19	10	10	acenocoumarol	CYP2C9	PA452632	1559	0.885
NULL	Eur_J_Pediatr_2014_Sep_26_173(2)_131-139.nxml.txt.nlp	24068459	SENT224	0	0	8	8	pentoxifylline	TNF-alpha	PA450864	7124	0.885
NULL	Core_Evid_2007_Nov_30_2(2)_81-88.nxml.txt.nlp	21221177	SENT89	21	21	11	11	irinotecan	EGFR	PA450085	1956	0.885
NULL	Cancers_(Basel)_2012_Apr_5_4(2)_354-378.nxml.txt.nlp	24213315	SENT153	18	18	30	30	etoposide	TRAIL	PA449552	8743	0.885
NULL	Oncotarget_2013_Nov_23_5(1)_196-210.nxml.txt.nlp	24344116	SENT77	13	13	11	11	doxorubicin	TNFAIP3	PA449412	7128	0.885
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT265	17	17	4	4	aripiprazole	PRL	PA10026	5617	0.885
NULL	Aging_(Albany_NY)_2011_Apr_4_3(4)_348-362.nxml.txt.nlp	21483040	SENT106	38	38	5	5	metformin	BRCA1	PA450395	672	0.885
NULL	Evid_Based_Complement_Alternat_Med_2011_Mar_17_2011_726723.nxml.txt.nlp	21584252	SENT145	8	8	25	25	glibenclamide	adiponectin	PA449782	9370	0.885
NULL	Br_J_Cancer_2011_Sep_6_105(6)_796-806.nxml.txt.nlp	21847123	SENT128	22	22	16	16	trastuzumab	HEY1	PA451743	23462	0.885
NULL	ISRN_Oxidative_Med_2013_2013_831596.nxml.txt.nlp	25506596	SENT158	17	17	7	7	hemin	TLR4	PA449849	7099	0.885
NULL	FEBS_Open_Bio_2014_Aug_30_4_763-776.nxml.txt.nlp	25349781	SENT141	15	15	21	21	curcumin	LKB1	PA151958596	6794	0.885
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2011_Jan_12_4_1-12.nxml.txt.nlp	22879789	SENT46	5	5	14	14	metformin	GLP	PA450395	342096	0.885
NULL	Br_J_Cancer_2011_Jan_4_104(1)_91-100.nxml.txt.nlp	21139584	SENT155	16	16	44	44	bortezomib	p53	PA10252	7157	0.885
NULL	Patient_Prefer_Adherence_2008_Feb_2_2_167-175.nxml.txt.nlp	19920959	SENT40	3	3	21	21	clopidogrel	DES	PA449053	1674	0.885
NULL	Breast_Cancer_Res_2008_May_16_10(3)_R46.nxml.txt.nlp	18485221	SENT23	13	13	15	15	tamoxifen	aromatase	PA451581	1588	0.885
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S18-S30.nxml.txt.nlp	20680104	SENT144	16	16	9	9	cetuximab	EGFR	PA10040	1956	0.885
NULL	Br_J_Dermatol_2009_Feb_160(2)_438-441.nxml.txt.nlp	19016697	SENT107	24	24	12	12	methotrexate	MTHFR	PA450428	4524	0.885
NULL	Int_J_Biomed_Sci_2007_Jun_3(2)_104-111.nxml.txt.nlp	23675031	SENT173	8	8	23	23	suramin	CD95	PA10292	355	0.885
NULL	Angew_Chem_Int_Ed_Engl_2013_Feb_11_52(7)_1990-1993.nxml.txt.nlp	23296685	SENT13	2	2	35	35	copper	Met	PA449114	79811	0.885
NULL	Biomed_Res_Int_2013_Dec_31_2013_952416.nxml.txt.nlp	23509820	SENT56	24	24	10	10	ethanol	CO2	PA448073	4513	0.885
NULL	Mol_Cancer_2009_Jun_9_8_37.nxml.txt.nlp	19508729	SENT41	16	16	4	4	gemcitabine	HO-1	PA449748	3162	0.885
NULL	Int_J_Mol_Sci_2012_Feb_24_13(3)_2578-2589.nxml.txt.nlp	22489112	SENT64	8	8	17	17	amitriptyline	GAT3	PA448385	6538	0.885
NULL	Cerebellum_2012_Sep_24_11(3)_651-665.nxml.txt.nlp	20734177	SENT128	20	20	11	11	pp2	PP1		5540;5464	0.885
NULL	Clin_Exp_Gastroenterol_2012_May_14_5_49-59.nxml.txt.nlp	22649281	SENT87	20	20	10	10	esomeprazole	CYP3A4	PA10075	1576	0.885
NULL	J_Oncol_2010_May_4_2010_373491.nxml.txt.nlp	20454582	SENT47	16	16	0	0	ethanol	TRG	PA448073	6965	0.885
NULL	J_Cell_Biol_1997_Jun_30_137(7)_1639-1649.nxml.txt.nlp	9199177	SENT160	9	9	14	14	paraformaldehyde	ZAP-70	PA450790	7535	0.885
NULL	Mol_Cancer_2012_Apr_26_11_26.nxml.txt.nlp	22537224	SENT180	28	28	17	17	cisplatin	CHK1	PA449014	1111	0.885
NULL	Cardiovasc_Toxicol_2013_Jun_24_13(2)_161-167.nxml.txt.nlp	23264063	SENT36	6	6	9	9	ethanol	hole	PA448073	80757	0.885
NULL	Cancer_Microenviron_2009_Sep_26_2(Suppl_1)_19-204.nxml.txt.nlp	NULL	SENT2221	13	13	28	28	thrombin	IL-8	PA451674	3576	0.885
NULL	Oncotarget_2010_Oct_22_1(7)_530-543.nxml.txt.nlp	21317449	SENT95	0	0	20	20	cetuximab	EGFR	PA10040	1956	0.885
NULL	Korean_Circ_J_2014_Mar_12_44(2)_97-104.nxml.txt.nlp	24653739	SENT160	18	18	3	3	bosentan	IL-6	PA10034	3569	0.885
NULL	Adv_Hematol_2012_Jul_24_2012_513702.nxml.txt.nlp	22888354	SENT92	21	21	9	9	lenalidomide	IL-2	PA162363968	3558	0.885
NULL	J_Immunol_Res_2014_May_12_2014_897249.nxml.txt.nlp	24901013	SENT175	13	13	7	7	natalizumab	E2F1	PA164747191	1869	0.885
NULL	Exp_Lung_Res_2013_Oct_1_39(8)_336-348.nxml.txt.nlp	23919450	SENT166	13	13	8	8	argatroban	PAR-1	PA164745516	2011;2149	0.885
NULL	Cell_Death_Differ_2010_Oct_30_17(10)_1624-1635.nxml.txt.nlp	20431602	SENT104	4	4	15	15	paclitaxel	Bcl-2	PA450761	596	0.885
NULL	Br_J_Clin_Pharmacol_2011_Oct_72(4)_647-657.nxml.txt.nlp	21518389	SENT214	39	39	44	44	cangrelor	P2Y12	PA165945763	64805	0.885
NULL	Acta_Pharmacol_Sin_2010_Nov_18_31(11)_1447-1453.nxml.txt.nlp	20953204	SENT92	9	9	6	6	rimonabant	CB1	PA152407999	1268	0.885
NULL	Onco_Targets_Ther_2014_Jun_11_7_969-983.nxml.txt.nlp	24959084	SENT115	15	15	20	20	atazanavir	CYP3A4	PA10251	1576	0.885
NULL	Breast_Cancer_Res_2005_May_24_7(5)_R589-R597.nxml.txt.nlp	16168102	SENT214	13	13	2	2	doxorubicin	HER3	PA449412	2065	0.885
NULL	Oncogene_2009_Jan_15_28(2)_157-169.nxml.txt.nlp	18931700	SENT106	19	19	7	7	geldanamycin	CDK4	PA152031327	1019	0.885
NULL	Diabetes_2008_Sep_57(9)_2332-2340.nxml.txt.nlp	18567824	SENT164	22	22	16	16	atropine	ghrelin	PA448505	51738	0.885
NULL	Biol_Open_2014_Nov_13_3(12)_1164-1172.nxml.txt.nlp	25395667	SENT354	0	0	10	10	ketoconazole	FAAH	PA450146	79152;2166	0.885
NULL	F1000Res_2014_Jul_1_3_149.nxml.txt.nlp	25352980	SENT114	4	4	10	10	galactose	ARG1	PA449725	383;64129	0.885
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT210	36	36	13	13	cisplatin	B7-H1	PA449014	29126	0.885
NULL	Drugs_R_D_2014_Sep_31_14(3)_177-184.nxml.txt.nlp	25079671	SENT13	10	10	22	22	miglitol	MCP-1	PA164776726	6347	0.885
NULL	Nat_Commun_2013_Sep_17_4_2464.nxml.txt.nlp	24043118	SENT580	15	15	12	12	estradiol	FGFR2	PA449503	2263	0.885
NULL	Indian_J_Pharm_Sci_2014_Jan-Feb_76(1)_72-77.nxml.txt.nlp	24799741	SENT117	15	15	19	19	imipramine	CYP2C9	PA449969	1559	0.885
NULL	Cells_2012_Oct_10_1(4)_711-737.nxml.txt.nlp	24710527	SENT241	10	10	18	18	etoposide	XIAP	PA449552	331	0.885
NULL	Acta_Pharmacol_Sin_2011_Jun_3_32(6)_845-852.nxml.txt.nlp	21642952	SENT127	9	9	26	26	capsaicin	TRPV1	PA448776	7442	0.885
NULL	Evid_Based_Complement_Alternat_Med_2012_Aug_8_2012_568273.nxml.txt.nlp	21860653	SENT114	22	22	15	15	carrageenan	Hua	PA448814	1994	0.885
NULL	Am_J_Transplant_2014_Jun_14_14(6)_1290-1299.nxml.txt.nlp	24731050	SENT111	23	23	11	11	rituximab	CD40	PA451261	958	0.885
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT616	41	41	8	8	aripiprazole	PRL	PA10026	5617	0.885
NULL	Br_J_Cancer_2012_May_8_106(10)_1587-1590.nxml.txt.nlp	22568998	SENT98	7	7	17	17	sunitinib	REL	PA162372840	5966	0.885
NULL	Oncogene_2014_Sep_11_33(37)_4579-4588.nxml.txt.nlp	24662835	SENT119	5	5	11	11	tamoxifen	MAGEA2	PA451581	4101;266740	0.885
NULL	Ann_Dermatol_2014_Dec_26_26(6)_706-712.nxml.txt.nlp	25473222	SENT117	19	19	0	0	isotretinoin	EPO	PA450128	7076;8288;2056	0.885
NULL	Med_Sci_Monit_2013_Sep_9_19_751-756.nxml.txt.nlp	24019010	SENT140	28	28	3	3	entecavir	LAM	PA164784025	7249;7248	0.885
NULL	Indian_J_Urol_2009_Apr-Jun_25(2)_186-189.nxml.txt.nlp	19672343	SENT49	37	37	8	8	chlorambucil	GTS	PA448926	2973	0.885
NULL	J_Carcinog_2014_Nov_27_13_13.nxml.txt.nlp	25525412	SENT109	32	32	17	17	cetuximab	KRAS	PA10040	3845	0.885
NULL	Nat_Neurosci_2014_Jul_25_17(7)_943-952.nxml.txt.nlp	24859199	SENT127	2	2	19	19	doxycycline	DCX	PA449415	1641	0.885
NULL	Case_Rep_Oncol_2014_Mar_26_7(1)_204-209.nxml.txt.nlp	24803896	SENT31	26	26	16	16	trabectedin	MRCL	PA165958349	348174	0.885
NULL	Pharmaceuticals_(Basel)_2014_Apr_10_7(4)_433-452.nxml.txt.nlp	24727459	SENT439	8	8	4	4	lopinavir	MRP2	PA450264	100130958;57626;1244	0.885
NULL	Ther_Clin_Risk_Manag_2006_Dec_2(4)_389-400.nxml.txt.nlp	18360651	SENT162	20	20	12	12	infliximab	IMPACT	PA452639	55364	0.885
NULL	Mol_Vis_2011_Aug_11_17_2157-2170.nxml.txt.nlp	21850191	SENT205	12	12	9	9	tacrolimus	p50	PA451578	958;4790	0.885
NULL	Ann_Oncol_2011_Mar_8_22(3)_503-514.nxml.txt.nlp	20616198	SENT307	6	6	25	25	tamoxifen	ATAC	PA451581	6375	0.885
NULL	Arthritis_Res_2002_Sep_16_4(6)_R12.nxml.txt.nlp	12453315	SENT133	8	8	14	14	methotrexate	CRP	PA450428	1401;140913	0.885
NULL	Nat_Commun_2014_Nov_25_5_5548.nxml.txt.nlp	25420520	SENT38	42	42	20	20	cabazitaxel	ERG	PA165958401	2078	0.885
NULL	Clin_Med_Oncol_2008_Jun_11_2_469-470.nxml.txt.nlp	21892319	SENT22	33	33	23	23	cyclophosphamide	HER2	PA449165	2064	0.885
NULL	Mol_Neurodegener_2011_Aug_8_6_57.nxml.txt.nlp	21819629	SENT248	27	27	17	17	arsenite	JNK	PA452638	5599	0.885
NULL	Exp_Neurobiol_2013_Mar_31_22(1)_51-57.nxml.txt.nlp	23585723	SENT106	4	4	12	12	capsaicin	TRPV1	PA448776	7442	0.885
NULL	Clin_Med_Insights_Oncol_2012_Dec_6_6_407-421.nxml.txt.nlp	23239933	SENT62	21	21	18	18	gefitinib	EGFR	PA131301952	1956	0.885
NULL	Evid_Based_Complement_Alternat_Med_2014_May_21_2014_375986.nxml.txt.nlp	24963322	SENT239	8	8	21	21	ethanol	VEGF-A	PA448073	7422	0.885
NULL	Physiol_Rep_2014_Sep_28_2(9)_e12155.nxml.txt.nlp	25263205	SENT523	18	18	6	6	bleomycin	CD73	PA448645	4907	0.885
NULL	J_Oncol_2009_May_6_2009_567486.nxml.txt.nlp	19424511	SENT70	31	31	3	3	bevacizumab	EGFR	PA130232992	1956	0.885
NULL	Br_J_Cancer_2013_Jun_25_108(12)_2505-2515.nxml.txt.nlp	23736036	SENT222	22	22	6	6	capecitabine	MTHFR	PA448771	4524	0.885
NULL	Colorectal_Dis_2012_Feb_14(2)_e31-e47.nxml.txt.nlp	21848897	SENT149	2	2	34	34	panitumumab	KRAS	PA162373091	3845	0.884
NULL	Virol_J_2010_Jan_22_7_16.nxml.txt.nlp	20096105	SENT151	26	26	22	22	doxorubicin	p53	PA449412	7157	0.884
NULL	Br_J_Cancer_2013_Dec_10_109(12)_2965-2972.nxml.txt.nlp	24149178	SENT32	33	33	15	15	doxorubicin	HER2	PA449412	2064	0.884
NULL	Oncotarget_2012_Oct_20_3(10)_1068-1111.nxml.txt.nlp	23085539	SENT122	0	0	4	4	sorafenib	VEGFR	PA7000	3791	0.884
NULL	Biomed_Res_Int_2013_Dec_30_2013_396839.nxml.txt.nlp	24490159	SENT173	6	6	14	14	denosumab	RANKL	PA166048634	8600	0.884
NULL	Arthritis_Res_Ther_2008_Mar_17_10(2)_R33.nxml.txt.nlp	18346273	SENT132	12	12	17	17	infliximab	HMGB1	PA452639	3146	0.884
NULL	Biol_Open_2014_Sep_12_3(10)_937-946.nxml.txt.nlp	25217618	SENT127	16	16	28	28	niclosamide	SOST	PA165958408	50964	0.884
NULL	Adipocyte_2014_Jul_1_3(3)_190-196.nxml.txt.nlp	25068085	SENT13	29	29	0	0	lipase	adiponectin	PA450239	9370	0.884
NULL	Cardiol_Res_Pract_2013_Jan_31_2013_128795.nxml.txt.nlp	23431496	SENT124	24	24	27	27	clopidogrel	CYP2C19	PA449053	1557	0.884
NULL	Exp_Ther_Med_2012_Sep_27_4(3)_503-506.nxml.txt.nlp	23181126	SENT73	7	7	18	18	naloxone	ETB	PA450586	1910	0.884
NULL	Oncol_Lett_2013_Feb_7_5(2)_440-446.nxml.txt.nlp	23420122	SENT99	20	20	8	8	sorafenib	EGFR	PA7000	1956	0.884
NULL	Front_Microbiol_2013_Aug_19_4_241.nxml.txt.nlp	23966991	SENT2017	14	14	8	8	rifampin	gamma	PA451250	9913	0.884
NULL	Evid_Based_Complement_Alternat_Med_2013_May_13_2013_506324.nxml.txt.nlp	23818927	SENT102	0	0	33	33	doxorubicin	MM1	PA449412	23654	0.884
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_May_7_67(Pt_6)_m708-m709.nxml.txt.nlp	21754609	SENT63	12	12	40	40	ethanol	mol	PA448073	90527	0.884
NULL	Acta_Pharmacol_Sin_2014_Jun_4_35(6)_792-805.nxml.txt.nlp	24902787	SENT34	23	23	6	6	paroxetine	CYP2D6	PA450801	1565	0.884
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_127043.nxml.txt.nlp	23227093	SENT7	14	14	5	5	lovastatin	RYR	PA450272	6261	0.884
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT88	36	36	24	24	efavirenz	CYP3A4	PA449441	1576	0.884
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT139	28	28	35	35	etravirine	CYP3A	PA166014703	1574	0.884
NULL	Case_Rep_Dent_2013_Jul_10_2013_812323.nxml.txt.nlp	23936686	SENT96	34	34	13	13	hyaluronan	LYVE-1	PA165958431	10894	0.884
NULL	Breast_Cancer_Res_2012_Apr_10_14(2)_306.nxml.txt.nlp	22494569	SENT37	6	6	9	9	cisplatin	BRCA1	PA449014	672	0.884
NULL	Core_Evid_2011_Feb_8_6_23-29.nxml.txt.nlp	21468240	SENT22	0	0	17	17	plerixafor	CXCR4	PA165958410	7852	0.884
NULL	Brain_Sci_2013_Jun_3_3(2)_877-907.nxml.txt.nlp	24961429	SENT171	15	15	6	6	taurine	ATF6	PA451590	22926	0.884
NULL	Evid_Based_Complement_Alternat_Med_2014_Oct_19_2014_628712.nxml.txt.nlp	25389442	SENT10	35	35	13	13	erlotinib	PTEN	PA134687924	5728	0.884
NULL	Bioconjug_Chem_2011_Oct_19_22(10)_2048-2059.nxml.txt.nlp	21877749	SENT36	5	5	27	27	trastuzumab	HER2	PA451743	2064	0.884
NULL	Cell_Death_Dis_2013_Oct_3_4(10)_e828.nxml.txt.nlp	24091671	SENT271	23	23	15	15	cetuximab	CD44	PA10040	960	0.884
NULL	BMJ_Open_2014_Feb_27_4(2)_e004071.nxml.txt.nlp	24578536	SENT151	9	9	18	18	warfarin	TTR	PA451906	7276	0.884
NULL	Drugs_Context_2012_Nov_19_2012_212242.nxml.txt.nlp	24432031	SENT128	6	6	20	20	dacarbazine	IFN	PA449197	3439	0.884
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT164	31	31	11	11	lapatinib	HER2	PA152241907	2064	0.884
NULL	Int_J_Mol_Sci_2014_Mar_5_15(3)_3970-3988.nxml.txt.nlp	24603537	SENT244	9	9	3	3	curcumin	MCH	PA151958596	5367	0.884
NULL	Mol_Cell_Biochem_2015_Oct_8_398(1-2)_165-173.nxml.txt.nlp	25292312	SENT110	24	24	12	12	bortezomib	HIF-1	PA10252	29072	0.884
NULL	Aging_(Albany_NY)_2009_Sep_25_1(10)_845-854.nxml.txt.nlp	20157557	SENT200	14	14	10	10	doxorubicin	p53	PA449412	7157	0.884
NULL	Pain_Res_Treat_2011_Aug_14_2011_864605.nxml.txt.nlp	22110933	SENT127	8	8	26	26	mirtazapine	PLP	PA450522	25824;5744	0.884
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT189	17	17	13	13	methotrexate	DHFR	PA450428	1719	0.884
NULL	Cancer_Immunol_Immunother_2013_Aug_27_62(10)_1637-1648.nxml.txt.nlp	23982484	SENT237	17	17	8	8	lenalidomide	IFN	PA162363968	3439	0.884
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT172	10	10	3	3	cisplatin	p53	PA449014	7157	0.884
NULL	AIDS_Res_Ther_2015_Jan_17_12(1)_2.nxml.txt.nlp	NULL	SENT34	32	32	22	22	zidovudine	CD4	PA451954	920	0.884
NULL	J_Cardiothorac_Surg_2012_Jun_28_7_61.nxml.txt.nlp	22741616	SENT88	19	19	11	11	amiodarone	NAC	PA448383	22861	0.884
NULL	Breast_Cancer_Res_2007_Apr_13_9(2)_103.nxml.txt.nlp	17433116	SENT22	6	6	27	27	tamoxifen	CYP2D6	PA451581	1565	0.884
NULL	Int_J_Womens_Health_2012_Aug_24_4_427-431.nxml.txt.nlp	23071411	SENT38	23	23	19	19	fluconazole	aromatase	PA449653	1588	0.884
NULL	Cancer_Cell_Int_2014_Jan_29_14_10.nxml.txt.nlp	24472145	SENT179	6	6	14	14	paclitaxel	HER-2	PA450761	2064	0.884
NULL	Oncotarget_2011_Mar_10_2(3)_186-196.nxml.txt.nlp	21406729	SENT115	23	23	5	5	orlistat	FADD	PA164776864	8772	0.884
NULL	Comp_Funct_Genomics_2008_Jun_9_2008_634283.nxml.txt.nlp	18551189	SENT165	22	22	7	7	bleomycin	RAD21	PA448645	5885	0.884
NULL	Diabetes_2009_Feb_58(2)_352-359.nxml.txt.nlp	19011168	SENT174	22	22	6	6	exenatide	GLP-1	PA164749238	100125288	0.884
NULL	F1000Res_2013_Jul_9_2_150.nxml.txt.nlp	24627787	SENT54	24	24	18	18	olanzapine	DIP	PA450688	23151;1831	0.884
NULL	Exp_Ther_Med_2013_Nov_13_6(5)_1317-1321.nxml.txt.nlp	24223665	SENT106	18	18	24	24	curcumin	CD133	PA151958596	8842	0.884
NULL	Curr_Neuropharmacol_2008_Sep_6(3)_215-234.nxml.txt.nlp	19506722	SENT156	1	1	33	33	fluoxetine	5-HT7	PA449673	3363	0.884
NULL	Ann_Oncol_2011_Mar_8_22(3)_503-514.nxml.txt.nlp	20616198	SENT66	10	10	30	30	aminoglutethimide	aromatase	PA448375	1588	0.884
NULL	Diabetes_Metab_J_2012_Aug_20_36(4)_293-299.nxml.txt.nlp	22950061	SENT112	15	15	24	24	metformin	NPY	PA450395	4852	0.884
NULL	Cancer_Res_Treat_2013_Dec_31_45(4)_251-262.nxml.txt.nlp	24453997	SENT141	7	7	1	1	cisplatin	ASS1	PA449014	445	0.884
NULL	Indian_J_Dermatol_2014_Nov-Dec_59(6)_632a.nxml.txt.nlp	25484418	SENT37	3	3	19	19	bevacizumab	VEGFR	PA130232992	3791	0.884
NULL	Indian_J_Pharm_Sci_2008_Mar-Apr_70(2)_208-215.nxml.txt.nlp	20046714	SENT39	24	24	4	4	ethanol	mol	PA448073	90527	0.884
NULL	Environ_Health_Perspect_2010_Mar_14_118(3)_331-337.nxml.txt.nlp	20064782	SENT86	28	28	10	10	gentamicin	F12	PA449753	2161	0.884
NULL	Semin_Immunopathol_2012_Jan_4_34(1)_93-106.nxml.txt.nlp	21845431	SENT188	15	15	4	4	thrombin	PAR-1	PA451674	2011;2149	0.884
NULL	Mol_Med_Rep_2015_Feb_5_11(2)_805-814.nxml.txt.nlp	25373883	SENT109	11	11	4	4	colchicine	APE	PA449092	55704;328	0.884
NULL	J_Immunol_Res_2014_Apr_28_2014_286170.nxml.txt.nlp	24868562	SENT154	8	8	19	19	docetaxel	IFN	PA449383	3439	0.884
NULL	Environ_Health_Perspect_2012_Jul_18_120(7)_990-996.nxml.txt.nlp	22510978	SENT219	23	23	25	25	diethylstilbestrol	DES	PA449307	1674	0.884
NULL	Int_J_Mol_Imaging_2011_Oct_26_2011_874585.nxml.txt.nlp	21490735	SENT150	23	23	4	4	doxorubicin	FDG	PA449412	23583	0.884
NULL	Cardiovasc_Diabetol_2013_Mar_4_12_42.nxml.txt.nlp	23452502	SENT220	0	0	5	5	exenatide	GLP1	PA164749238	100125288;2641	0.884
NULL	Clin_Interv_Aging_2012_Dec_30_7_1-13.nxml.txt.nlp	22291468	SENT267	20	20	15	15	itraconazole	CYP3A4	PA450132	1576	0.884
NULL	Cancers_(Basel)_2011_May_3_3(2)_2255-2273.nxml.txt.nlp	24212808	SENT106	28	28	16	16	trastuzumab	HER-2	PA451743	2064	0.884
NULL	Mol_Cancer_2014_Feb_20_13_31.nxml.txt.nlp	24555568	SENT5	38	38	25	25	temozolomide	NKCC1	PA451609	6558	0.884
NULL	Ann_Gen_Psychiatry_2013_Dec_12_12_40.nxml.txt.nlp	24330737	SENT134	6	6	22	22	clozapine	HAK	PA449061	115701	0.884
NULL	Eur_J_Med_Res_2009_Dec_7_14(Suppl_4)_108-111.nxml.txt.nlp	20156738	SENT75	21	21	4	4	budesonide	FKBP51	PA448681	2289	0.884
NULL	Exp_Mol_Med_2012_Aug_31_44(8)_473-482.nxml.txt.nlp	22627808	SENT134	0	0	28	28	lapatinib	HRG	PA152241907	3084;3273	0.884
NULL	Biomed_Res_Int_2014_Jan_2_2014_682010.nxml.txt.nlp	24524084	SENT115	9	9	18	18	imatinib	LCK	PA10804	3932	0.884
NULL	Gut_2008_Jul_4_57(7)_923-929.nxml.txt.nlp	18252749	SENT201	18	18	13	13	capsaicin	TRPV1	PA448776	7442	0.884
NULL	Blood_Cancer_J_2013_Jun_7_3(6)_e120.nxml.txt.nlp	23749045	SENT86	4	4	10	10	imatinib	JAG2	PA10804	3714	0.884
NULL	Breast_Cancer_Res_2008_Dec_4_10(6)_R103.nxml.txt.nlp	19055788	SENT151	31	31	28	28	tamoxifen	CDH1	PA451581	51343;999	0.884
NULL	Breast_Cancer_Res_2011_Jan_24_13(1)_401.nxml.txt.nlp	21349137	SENT39	3	3	7	7	lapatinib	AMPK	PA152241907	5563	0.884
NULL	Reprod_Biol_Endocrinol_2003_Oct_9_1_74.nxml.txt.nlp	14613550	SENT196	13	13	8	8	indomethacin	COX	PA449982	1351	0.884
NULL	Am_J_Case_Rep_2014_Dec_9_15_550-553.nxml.txt.nlp	25488633	SENT90	17	17	4	4	methotrexate	B12	PA450428	7126;4709	0.884
NULL	J_Korean_Med_Sci_2014_Jul_11_29(7)_965-972.nxml.txt.nlp	25045229	SENT165	19	19	4	4	metformin	B12	PA450395	7126;4709	0.884
NULL	J_Lipid_Res_2014_Mar_55(3)_385-397.nxml.txt.nlp	24347527	SENT14	14	14	25	25	lipase	IL-4	PA450239	3565	0.884
NULL	J_Hum_Genet_2013_Jun_23_58(6)_339-345.nxml.txt.nlp	23697979	SENT27	7	7	10	10	clopidogrel	ADP	PA449053	23038	0.884
NULL	Basic_Res_Cardiol_2011_Nov_5_106(6)_1269-1281.nxml.txt.nlp	22057716	SENT51	10	10	37	37	ketamine	EDA	PA450144	1896	0.884
NULL	Neural_Regen_Res_2013_Jul_15_8(20)_1853-1862.nxml.txt.nlp	25206494	SENT179	3	3	8	8	ethanol	p53	PA448073	7157	0.884
NULL	Ther_Clin_Risk_Manag_2006_Dec_2(4)_337-346.nxml.txt.nlp	18360646	SENT65	2	2	31	31	brimonidine	BAK	PA448665	578	0.884
NULL	Ann_Oncol_2011_Jul_6_22(7)_1561-1570.nxml.txt.nlp	21135055	SENT302	7	7	13	13	olaparib	BRCA2		675	0.884
NULL	Oncotarget_2014_Jun_26_5(14)_5559-5569.nxml.txt.nlp	24980819	SENT184	27	27	34	34	vemurafenib	p53	PA165946873	7157	0.884
NULL	Biochim_Biophys_Acta_2014_Jul_1842(7)_959-970.nxml.txt.nlp	24594481	SENT812	34	34	18	18	lipase	HSL	PA450239	3991	0.884
NULL	Viruses_2014_Aug_12_6(8)_3080-3096.nxml.txt.nlp	25118638	SENT40	24	24	10	10	heparin	B27	PA449855	56246	0.884
NULL	Int_J_Mol_Sci_2007_Mar_13_8(3)_229-240.nxml.txt.nlp	NULL	SENT140	11	11	24	24	acetazolamide	AQP1	PA448018	358	0.884
NULL	Front_Oncol_2014_Sep_15_4_244.nxml.txt.nlp	25309870	SENT105	23	23	15	15	afatinib	EGFR	PA165981154	1956	0.884
NULL	Br_J_Cancer_2009_Mar_10_100(5)_732-738.nxml.txt.nlp	19259093	SENT20	18	18	8	8	cisplatin	ERCC1	PA449014	2067	0.884
NULL	Onco_Targets_Ther_2014_Sep_9_7_1571-1582.nxml.txt.nlp	25228815	SENT160	3	3	7	7	sunitinib	VEGFR2	PA162372840	3791	0.884
NULL	Curr_Chem_Genomics_2010_Mar_1_4_1-8.nxml.txt.nlp	20448812	SENT120	28	28	47	47	bosentan	OATP1B3	PA10034	28234	0.884
NULL	J_Orthop_Sci_2014_May_13_19(4)_521-528.nxml.txt.nlp	24819307	SENT51	8	8	0	0	iron	MSC	PA450087	9242	0.884
NULL	Nucleic_Acids_Res_2011_Sep_28_39(17)_7858-7867.nxml.txt.nlp	21715374	SENT105	8	8	24	24	thrombin	TGT	PA451674	9097;81890	0.884
NULL	J_Exp_Med_1962_Feb_28_115(3)_641-653.nxml.txt.nlp	13862910	SENT4	8	8	14	14	papain	S20	PA450778	6224	0.884
NULL	Int_J_Med_Chem_2012_Dec_13_2012_530392.nxml.txt.nlp	25379286	SENT274	12	12	7	7	ethanol	mol	PA448073	90527	0.884
NULL	J_Cardiothorac_Surg_2014_May_2_9_77.nxml.txt.nlp	24885502	SENT38	11	11	7	7	thyroglobulin	CEA	PA164754910	5670;1087	0.884
NULL	Indian_J_Med_Res_2012_Aug_136(2)_249-259.nxml.txt.nlp	22960892	SENT35	15	15	26	26	irinotecan	UGT1A1	PA450085	54658	0.884
NULL	J_Gen_Physiol_1992_Apr_1_99(4)_531-544.nxml.txt.nlp	1597677	SENT5	22	22	17	17	tetracaine	gamma	PA451638	9913	0.884
NULL	Blood_Cancer_J_2013_Aug_9_3(8)_e131.nxml.txt.nlp	23933705	SENT207	7	7	23	23	rituximab	San	PA451261	80218	0.884
NULL	Eur_J_Epidemiol_2007_Nov_23_22(11)_819-829.nxml.txt.nlp	17955331	SENT696	18	18	13	13	acenocoumarol	CYP2C9	PA452632	1559	0.884
NULL	Br_J_Cancer_2013_Sep_3_109(5)_1157-1164.nxml.txt.nlp	23942075	SENT144	14	14	8	8	trastuzumab	HER2	PA451743	2064	0.884
NULL	Int_J_Biol_Sci_2014_Jun_21_10(7)_702-714.nxml.txt.nlp	25013379	SENT156	20	20	5	5	gefitinib	ADAM17	PA131301952	6868	0.884
NULL	Adv_Virol_2012_Oct_29_2012_186512.nxml.txt.nlp	22312362	SENT123	17	17	3	3	iodine	NIS	PA450049	6528	0.884
NULL	Reprod_Biol_Endocrinol_2003_Oct_7_1_66.nxml.txt.nlp	14609433	SENT252	26	26	34	34	cisplatin	p53	PA449014	7157	0.884
NULL	Br_J_Pharmacol_2008_Oct_18_155(4)_596-605.nxml.txt.nlp	18852694	SENT139	8	8	12	12	fenofibrate	SREBP2	PA449594	6721	0.884
NULL	FEBS_Open_Bio_2014_Aug_30_4_763-776.nxml.txt.nlp	25349781	SENT102	24	24	28	28	curcumin	LC3	PA151958596	84557	0.884
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_105-115.nxml.txt.nlp	17912640	SENT105	8	8	10	10	tamoxifen	aromatase	PA451581	1588	0.884
NULL	J_Antimicrob_Chemother_2011_Jun_25_66(6)_1332-1339.nxml.txt.nlp	21441248	SENT10	3	3	36	36	nevirapine	CYP2B6	PA450616	1555	0.884
NULL	Breast_Cancer_Res_2004_Mar_26_6(3)_R252-R263.nxml.txt.nlp	15084249	SENT163	29	29	8	8	tamoxifen	FMO5	PA451581	2330	0.884
NULL	Mol_Cancer_2010_Oct_12_9_269.nxml.txt.nlp	20939893	SENT143	19	19	9	9	isoproterenol	c-Jun	PA450121	3725	0.884
NULL	Lab_Invest_2012_Jun_26_92(6)_827-841.nxml.txt.nlp	22449800	SENT267	6	6	15	15	curcumin	AP-1	PA151958596	2353;3727;2354;3725	0.884
NULL	Br_J_Cancer_2012_Jan_17_106(2)_348-357.nxml.txt.nlp	22146521	SENT118	12	12	7	7	gemcitabine	TP53	PA449748	7157	0.884
NULL	EMBO_J_2013_May_29_32(11)_1514-1528.nxml.txt.nlp	23524851	SENT441	15	15	5	5	staurosporine	SENP3	PA165109623	26168	0.884
NULL	Nat_Genet_2011_Jan_12_43(1)_27-33.nxml.txt.nlp	21151129	SENT158	12	12	34	34	tamoxifen	FOXA1	PA451581	3169	0.884
NULL	J_Korean_Med_Sci_2008_Aug_25_23(4)_685-690.nxml.txt.nlp	18756058	SENT86	14	14	7	7	olanzapine	ghrelin	PA450688	51738	0.884
NULL	J_Cell_Biol_2008_Jul_14_182(1)_77-88.nxml.txt.nlp	18606852	SENT506	13	13	6	6	noscapine	c-Jun		3725	0.884
NULL	Br_J_Cancer_1995_Apr_71(4)_854-856.nxml.txt.nlp	7710954	SENT10	29	29	31	31	tamoxifen	TMX	PA451581	81542	0.884
NULL	Mediators_Inflamm_1998_7(3)_169-173.nxml.txt.nlp	9705604	SENT8	35	35	26	26	octreotide	IL-10	PA450678	3586	0.884
NULL	Oxid_Med_Cell_Longev_2012_May_15_2012_890826.nxml.txt.nlp	22666522	SENT50	39	39	3	3	nadh	AST	PA164755085	26503	0.884
NULL	Indian_J_Med_Res_2011_Apr_133(4)_434-441.nxml.txt.nlp	21537099	SENT103	30	30	40	40	lansoprazole	EGF	PA450180	1950	0.884
NULL	Colorectal_Dis_2012_Feb_14(2)_e31-e47.nxml.txt.nlp	21848897	SENT41	13	13	7	7	cetuximab	KRAS	PA10040	3845	0.884
NULL	Mol_Cancer_2013_Nov_11_12_134.nxml.txt.nlp	24215614	SENT303	14	14	7	7	trastuzumab	PI3K	PA451743	5290	0.884
NULL	Acta_Pharmacol_Sin_2011_Oct_15_32(10)_1303-1308.nxml.txt.nlp	21841812	SENT131	2	2	18	18	losartan	CYP2C9	PA450268	1559	0.884
NULL	Breast_Cancer_Res_2012_May_3_14(3)_R71.nxml.txt.nlp	22554015	SENT274	20	20	12	12	trastuzumab	HER2	PA451743	2064	0.884
NULL	Oncotarget_2014_Jun_19_5(15)_6540-6551.nxml.txt.nlp	25153728	SENT172	11	11	19	19	paclitaxel	HIF-1	PA450761	29072	0.884
NULL	Br_J_Pharmacol_2012_Apr_165(8)_2611-2619.nxml.txt.nlp	21718301	SENT198	6	6	4	4	rimonabant	GPR55	PA152407999	9290	0.884
NULL	Front_Immunol_2013_May_15_4_116.nxml.txt.nlp	23720663	SENT15	9	9	32	32	cyclophosphamide	CD25	PA449165	3669;3559	0.884
NULL	Nat_Commun_2013_4_10_1038_ncomms3472.nxml.txt.nlp	24045463	SENT205	5	5	26	26	propranolol	FDG	PA451145	23583	0.884
NULL	J_Adv_Pharm_Technol_Res_2014_Jan-Mar_5(1)_21-27.nxml.txt.nlp	24696814	SENT56	40	40	31	31	ethanol	mol	PA448073	90527	0.884
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1063.nxml.txt.nlp	24556678	SENT163	39	39	16	16	thioridazine	NAC	PA451666	22861	0.884
NULL	Br_J_Cancer_2011_Nov_22_105(11)_1654-1662.nxml.txt.nlp	22045187	SENT132	37	37	22	22	irinotecan	ABCC1	PA450085	4363	0.884
NULL	Cancers_(Basel)_2014_Oct_24_6(4)_2187-2223.nxml.txt.nlp	25347122	SENT364	14	14	34	34	paclitaxel	PI3K	PA450761	5290	0.884
NULL	J_Hematol_Oncol_2013_Jul_18_6_53.nxml.txt.nlp	23866964	SENT141	3	3	16	16	temsirolimus	MTOR	PA164746890	2475	0.884
NULL	Oncol_Lett_2014_Nov_12_8(5)_2203-2208.nxml.txt.nlp	25295109	SENT176	27	27	5	5	celecoxib	SMO	PA448871	6608;54498	0.884
NULL	F1000Res_2013_Oct_3_2_202.nxml.txt.nlp	24795806	SENT119	4	4	1	1	panitumumab	EGFR	PA162373091	1956	0.884
NULL	J_Neuroinflammation_2011_Feb_4_8_10.nxml.txt.nlp	21294877	SENT191	27	27	9	9	capsaicin	TAC1	PA448776	6863	0.884
NULL	Oxid_Med_Cell_Longev_2010_Nov-Dec_3(6)_361-373.nxml.txt.nlp	21311214	SENT298	5	5	18	18	rosiglitazone	AMPK	PA451283	5563	0.884
NULL	Eur_J_Clin_Pharmacol_2012_Jan_7_68(1)_55-64.nxml.txt.nlp	21735164	SENT125	18	18	41	41	oxymorphone	ANOVA	PA450748	4858	0.884
NULL	Oncotarget_2012_Nov_17_3(12)_1600-1614.nxml.txt.nlp	23307622	SENT60	11	11	6	6	trastuzumab	ATG12	PA451743	9140	0.884
NULL	Int_J_Mol_Sci_2014_Dec_2_15(12)_22128-22141.nxml.txt.nlp	25474084	SENT6	30	30	21	21	cisplatin	PUMA	PA449014	27113	0.884
NULL	J_Cell_Biol_1998_Jan_26_140(2)_335-345.nxml.txt.nlp	9442109	SENT331	13	13	8	8	chloroquine	NHE	PA448948	285335	0.884
NULL	Br_J_Cancer_2012_Jan_3_106(1)_18-24.nxml.txt.nlp	22108516	SENT131	18	18	32	32	irinotecan	NFKB1	PA450085	4790	0.884
NULL	Acta_Pharmacol_Sin_2010_Dec_22_31(12)_1576-1582.nxml.txt.nlp	21102485	SENT188	11	11	3	3	ethanol	p85	PA448073	5296;5295;54776;23368	0.884
NULL	Oncotarget_2013_Nov_24_4(12)_2186-2207.nxml.txt.nlp	24327604	SENT130	34	34	17	17	etoposide	p53	PA449552	7157	0.884
NULL	Br_J_Cancer_2010_Jun_29_103(1)_61-72.nxml.txt.nlp	20588279	SENT270	26	26	21	21	trastuzumab	RhoB	PA451743	388	0.884
NULL	Neuropsychopharmacology_2009_Apr_2_34(5)_1135-1148.nxml.txt.nlp	18596687	SENT333	13	13	0	0	cocaine	CRF	PA449072	1392;10882	0.884
NULL	Breast_Cancer_Res_2011_Nov_1_13(6)_224.nxml.txt.nlp	22114931	SENT99	9	9	14	14	letrozole	TORC1	PA450196	23373	0.884
NULL	Case_Rep_Dermatol_2011_Jun_30_3(2)_130-136.nxml.txt.nlp	21743808	SENT15	29	29	16	16	adapalene	EGFR	PA448047	1956	0.884
NULL	Case_Rep_Ophthalmol_Med_2013_Sep_12_2013_213124.nxml.txt.nlp	24109538	SENT7	18	18	8	8	gefitinib	EGFR	PA131301952	1956	0.884
NULL	Cell_Death_Dis_2014_Jan_16_5(1)_e1000.nxml.txt.nlp	24434508	SENT56	19	19	7	7	etoposide	p53	PA449552	7157	0.884
NULL	Braz_J_Med_Biol_Res_2013_Aug_13_46(8)_650-658.nxml.txt.nlp	23969971	SENT173	27	27	15	15	cisplatin	STAT3	PA449014	6774	0.884
NULL	J_Immunol_Res_2014_Jul_16_2014_696812.nxml.txt.nlp	25133198	SENT125	23	23	5	5	rifaximin	TLR2	PA164752443	7097	0.884
NULL	J_Exp_Clin_Cancer_Res_2009_Nov_24_28(1)_144.nxml.txt.nlp	19930704	SENT121	24	24	18	18	vincristine	P-gp	PA451879	5243	0.884
NULL	Cardiovasc_Diabetol_2010_Nov_16_9_76.nxml.txt.nlp	21080957	SENT282	19	19	17	17	exenatide	GLP-1	PA164749238	100125288	0.884
NULL	Evid_Based_Complement_Alternat_Med_2013_Aug_12_2013_982689.nxml.txt.nlp	23997806	SENT181	29	29	15	15	tolbutamide	APE	PA451718	55704;328	0.884
NULL	Arthritis_Res_Ther_2009_Jun_29_11(3)_R100.nxml.txt.nlp	19563672	SENT148	28	28	13	13	infliximab	IFN	PA452639	3439	0.884
NULL	Angiogenesis_2010_Dec_7_13(4)_305-315.nxml.txt.nlp	20927579	SENT172	2	2	20	20	resveratrol	p53		7157	0.884
NULL	ScientificWorldJournal_2012_Apr_26_2012_358102.nxml.txt.nlp	22645419	SENT158	16	16	10	10	captopril	PRL	PA448780	5617	0.884
NULL	Clin_Interv_Aging_2009_Jun_9_4_241-250.nxml.txt.nlp	19554095	SENT93	21	21	14	14	denosumab	aromatase	PA166048634	1588	0.884
NULL	Breast_Cancer_Res_2007_Aug_10_9(4)_R52.nxml.txt.nlp	17692126	SENT274	25	25	9	9	letrozole	aromatase	PA450196	1588	0.884
NULL	Ann_Hematol_2014_Apr_1_93(8)_1371-1380.nxml.txt.nlp	24687382	SENT20	30	30	24	24	lenalidomide	CRBN	PA162363968	51185	0.884
NULL	Diagn_Pathol_2013_Nov_25_8_192.nxml.txt.nlp	24274261	SENT89	10	10	6	6	cisplatin	IL-2	PA449014	3558	0.884
NULL	Eur_J_Endocrinol_2013_Aug_169(2)_187-201.nxml.txt.nlp	23704713	SENT68	17	17	9	9	vildagliptin	DPP4	PA165958346	1803	0.884
NULL	J_Cell_Biol_2001_Feb_19_152(4)_729-740.nxml.txt.nlp	11266464	SENT5	32	32	34	34	bleomycin	BLM	PA448645	641	0.884
NULL	J_Adv_Pract_Oncol_2013_Jul_1_Jul-Aug_4(4)_263-268.nxml.txt.nlp	25032007	SENT42	19	19	13	13	fosphenytoin	CYP3A4	PA164746820	1576	0.884
NULL	J_Oncol_2013_Apr_29_2013_854121.nxml.txt.nlp	23737784	SENT120	22	22	27	27	lapatinib	HER2	PA152241907	2064	0.884
NULL	Mol_Cancer_2010_Nov_2_9_289.nxml.txt.nlp	21044322	SENT173	20	20	9	9	cisplatin	RGS17	PA449014	26575	0.884
NULL	Oncol_Lett_2014_Jul_16_8(1)_211-217.nxml.txt.nlp	24959248	SENT119	4	4	34	34	cisplatin	ANGPTL4	PA449014	51129	0.884
NULL	J_Occup_Med_Toxicol_2008_Feb_27_3(Suppl_1)_S6.nxml.txt.nlp	18315837	SENT91	7	7	30	30	pranlukast	IL-2	PA134698661	3558	0.884
NULL	Mol_Vis_2011_Aug_11_17_2157-2170.nxml.txt.nlp	21850191	SENT229	20	20	8	8	tacrolimus	p50	PA451578	958;4790	0.884
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jun_24_65(Pt_7)_o1668.nxml.txt.nlp	21582928	SENT60	34	34	9	9	ethanol	mol	PA448073	90527	0.884
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_3_2013_718380.nxml.txt.nlp	23861711	SENT207	3	3	17	17	sunitinib	EGFR	PA162372840	1956	0.884
NULL	Biomed_Res_Int_2013_Dec_17_2013_312709.nxml.txt.nlp	24455685	SENT116	28	28	8	8	ethanol	activin	PA448073	83729	0.884
NULL	Ther_Clin_Risk_Manag_2005_Mar_1(1)_3-13.nxml.txt.nlp	18360537	SENT92	22	22	6	6	clarithromycin	CYP3A	PA449028	1574	0.884
NULL	Int_J_Gen_Med_2013_Dec_27_7_43-47.nxml.txt.nlp	24403843	SENT77	8	8	11	11	roxithromycin	ACR	PA164750505	49	0.884
NULL	Cell_Death_Dis_2010_Nov_18_1(11)_e102.nxml.txt.nlp	21368867	SENT292	15	15	21	21	gentamicin	CLIMP-63	PA449753	10970	0.884
NULL	Exp_Cell_Res_2011_Apr_15_317(7)_1028-1039.nxml.txt.nlp	21237154	SENT250	25	25	14	14	staurosporine	JNK	PA165109623	5599	0.884
NULL	Diabetes_Metab_Syndr_Obes_2010_May_17_3_155-163.nxml.txt.nlp	21437085	SENT153	6	6	16	16	liraglutide	GLP-1	PA165958364	100125288	0.884
NULL	Drugs_R_D_2014_Sep_31_14(3)_177-184.nxml.txt.nlp	25079671	SENT151	10	10	21	21	miglitol	IL-6	PA164776726	3569	0.884
NULL	Diabetes_2009_Aug_28_58(8)_1757-1765.nxml.txt.nlp	19478146	SENT68	8	8	32	32	ethanol	mol	PA448073	90527	0.884
NULL	Anticancer_Agents_Med_Chem_2014_Oct_14(8)_1121-1127.nxml.txt.nlp	24893730	SENT136	8	8	29	29	vorinostat	EGFR	PA164748224	1956	0.884
NULL	EMBO_Mol_Med_2012_Apr_4(4)_298-312.nxml.txt.nlp	22331558	SENT166	19	19	4	4	etoposide	SIRT1	PA449552	23411	0.884
NULL	Cell_Death_Dis_2014_Feb_27_5(2)_e1082.nxml.txt.nlp	24577080	SENT201	21	21	10	10	isoproterenol	DJ-1	PA450121	11315	0.884
NULL	Ayu_2012_Jan-Mar_33(1)_38-43.nxml.txt.nlp	23049182	SENT60	29	29	16	16	pyrazinamide	AKT	PA451182	207	0.884
NULL	Oxid_Med_Cell_Longev_2012_Jun_3_2012_914273.nxml.txt.nlp	22701758	SENT235	7	7	29	29	resveratrol	IL-6		3569	0.884
NULL	Acta_Pharmacol_Sin_2014_Jul_3_35(7)_945-956.nxml.txt.nlp	24989254	SENT56	21	21	32	32	doxycycline	GDNF	PA449415	2668	0.884
NULL	Ann_Rheum_Dis_2008_Aug_29_67(8)_1096-1103.nxml.txt.nlp	18055472	SENT191	29	29	9	9	infliximab	ACR	PA452639	49	0.884
NULL	Mol_Cancer_2013_Mar_5_12_17.nxml.txt.nlp	23497256	SENT127	17	17	4	4	sunitinib	CD11b	PA162372840	3684	0.884
NULL	AAPS_J_2011_Jun_1_13(3)_405-416.nxml.txt.nlp	21630127	SENT252	15	15	33	33	omeprazole	OATP1B1	PA450704	10599	0.884
NULL	Cancers_(Basel)_2014_Nov_25_6(4)_2313-2329.nxml.txt.nlp	25534569	SENT82	23	23	36	36	cabozantinib	HGF	PA165906891	3569;6654;3082	0.884
NULL	Diabetes_2013_Jun_17_62(6)_1800-1807.nxml.txt.nlp	23704521	SENT139	7	7	18	18	metformin	SIRT1	PA450395	23411	0.884
NULL	Cancers_(Basel)_2014_Oct_24_6(4)_2187-2223.nxml.txt.nlp	25347122	SENT1236	10	10	14	14	olaparib	BRCA1		672	0.884
NULL	AIDS_Res_Ther_2013_Dec_13_10_33.nxml.txt.nlp	24330617	SENT45	24	24	21	21	maraviroc	CCR5	PA164768835	1234	0.884
NULL	eLife_2014_Apr_15_3_e01694.nxml.txt.nlp	24737860	SENT635	20	20	18	18	nutlin-3	MDM2		4193	0.884
NULL	Cancers_(Basel)_2010_Dec_30_3(1)_106-125.nxml.txt.nlp	24212609	SENT49	22	22	2	2	gemcitabine	MUC4	PA449748	4585	0.884
NULL	Nat_Commun_2013_Nov_12_4_2760.nxml.txt.nlp	24217681	SENT68	22	22	35	35	pirenzepine	CA1	PA10159	759	0.884
NULL	J_Korean_Med_Sci_2013_Apr_27_28(4)_527-533.nxml.txt.nlp	23580227	SENT48	26	26	32	32	genistein	TRAIL	PA165109660	8743	0.884
NULL	Environ_Health_Perspect_2009_Nov_26_117(11)_1737-1744.nxml.txt.nlp	20049126	SENT199	11	11	4	4	arsenite	NAC	PA452638	22861	0.884
NULL	Breast_Cancer_Res_2007_Aug_8_9(4)_R50.nxml.txt.nlp	17686159	SENT259	7	7	10	10	gefitinib	HRG	PA131301952	3084;3273	0.884
NULL	Front_Oncol_2014_May_19_4_113.nxml.txt.nlp	24904827	SENT87	24	24	2	2	potassium	AGO2	PA451047	27161	0.884
NULL	J_Biol_Chem_2013_Jan_25_288(4)_2721-2733.nxml.txt.nlp	23209292	SENT124	4	4	0	0	heparin	FGF1	PA449855	2246	0.884
NULL	J_Gen_Physiol_2000_Jun_1_115(6)_685-696.nxml.txt.nlp	10828243	SENT8	12	12	26	26	genistein	OLF	PA165109660	83857	0.884
NULL	Ther_Clin_Risk_Manag_2007_Jun_3(3)_411-420.nxml.txt.nlp	18488075	SENT206	36	36	10	10	alefacept	CD4	PA164748040	920	0.884
NULL	Lab_Invest_2011_Jun_14_91(6)_852-858.nxml.txt.nlp	21403643	SENT15	18	18	3	3	tenofovir	MRP4	PA10204	10257	0.884
NULL	Br_J_Cancer_2010_Feb_16_102(4)_658-664.nxml.txt.nlp	20104222	SENT138	22	22	19	19	sunitinib	IFN	PA162372840	3439	0.884
NULL	Mol_Cancer_2008_Jun_5_7_50.nxml.txt.nlp	18534018	SENT72	4	4	21	21	bortezomib	survivin	PA10252	332	0.884
NULL	Ann_Rheum_Dis_2008_Aug_29_67(8)_1096-1103.nxml.txt.nlp	18055472	SENT119	18	18	8	8	infliximab	ACR	PA452639	49	0.884
NULL	Chemother_Res_Pract_2011_Feb_27_2011_175054.nxml.txt.nlp	22295203	SENT67	24	24	11	11	cisplatin	MTD	PA449014	4493	0.884
NULL	Acta_Odontol_Scand_2013_Mar_8_71(2)_312-316.nxml.txt.nlp	22564045	SENT8	0	0	2	2	benzbromarone	URAT1	PA134852920	116085	0.884
NULL	Adv_Hematol_2009_Oct_20_2009_689639.nxml.txt.nlp	19960046	SENT24	14	14	5	5	l-cysteine	NAC	PA449173	22861	0.884
NULL	Nucleic_Acids_Res_2012_Apr_16_40(8)_3511-3523.nxml.txt.nlp	22180533	SENT244	24	24	12	12	doxycycline	E2F7	PA449415	144455	0.884
NULL	Diabetes_Care_2010_Nov_33(11)_2399-2405.nxml.txt.nlp	20980427	SENT150	3	3	15	15	ranibizumab	CRT	PA164746012	811	0.884
NULL	Cell_Host_Microbe_2014_Sep_10_16(3)_291-303.nxml.txt.nlp	25211072	SENT86	3	3	17	17	genistein	tetherin	PA165109660	684	0.884
NULL	Arthritis_Res_Ther_2009_Feb_3_11(1)_R15.nxml.txt.nlp	19192274	SENT223	20	20	30	30	methylprednisolone	IL-6	PA450466	3569	0.884
NULL	EJC_Suppl_2013_Sep_5_11(2)_274.nxml.txt.nlp	NULL	SENT15	11	11	16	16	cetuximab	EGFR	PA10040	1956	0.884
NULL	J_Hematol_Oncol_2009_Feb_23_2_9.nxml.txt.nlp	19236713	SENT313	7	7	24	24	sorafenib	SHARP	PA7000	23013	0.884
NULL	Mol_Brain_2014_Mar_5_7_15.nxml.txt.nlp	24594013	SENT237	33	33	3	3	physostigmine	C-1	PA450957	5203	0.884
NULL	Brain_Sci_2013_Apr_26_3(2)_670-703.nxml.txt.nlp	24961420	SENT41	14	14	42	42	ethanol	Bcl-2	PA448073	596	0.884
NULL	Br_J_Cancer_2012_Jun_5_106(12)_1960-1966.nxml.txt.nlp	22596237	SENT15	21	21	14	14	saracatinib	PC3		57332;7832;5122	0.884
NULL	Am_J_Trop_Med_Hyg_2012_Nov_7_87(5)_783-784.nxml.txt.nlp	23136171	SENT16	9	9	39	39	chloroquine	ACT	PA448948	12;11332;9457;641455	0.884
NULL	Arthritis_Res_Ther_2005_Jan_21_7(2)_55-61.nxml.txt.nlp	15743490	SENT106	6	6	37	37	simvastatin	CD40	PA451363	958	0.884
NULL	JRSM_Cardiovasc_Dis_2012_Sep_24_1(6)_cvd_2012_012015.nxml.txt.nlp	24175073	SENT171	28	28	19	19	ticagrelor	ABCB1	PA165374673	5243	0.884
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jun_24_65(Pt_7)_o1670.nxml.txt.nlp	21582930	SENT63	12	12	7	7	ethanol	mol	PA448073	90527	0.884
NULL	Diabetes_Care_2011_Jul_17_34(7)_e115-e120.nxml.txt.nlp	21709286	SENT92	12	12	5	5	metformin	AMPK	PA450395	5563	0.884
NULL	Front_Behav_Neurosci_2010_Apr_5_4_14.nxml.txt.nlp	20407577	SENT65	15	15	8	8	cocaine	hole	PA449072	80757	0.884
NULL	Int_J_Mol_Sci_2014_Sep_11_15(9)_15994-16011.nxml.txt.nlp	25216334	SENT166	5	5	2	2	sunitinib	VEGFR	PA162372840	3791	0.884
NULL	Arch_Med_Sci_2013_Aug_30_9(4)_739-744.nxml.txt.nlp	24049538	SENT122	37	37	21	21	candesartan	PC-3	PA448765	692094	0.884
NULL	Indian_J_Endocrinol_Metab_2012_Sep-Oct_16(5)_769-776.nxml.txt.nlp	23087862	SENT121	23	23	8	8	glucose	IL-6	PA449773	3569	0.884
NULL	Oncotarget_2014_Oct_18_5(22)_11604-11619.nxml.txt.nlp	25344099	SENT145	8	8	3	3	cisplatin	RYBP	PA449014	23429	0.884
NULL	Osteoporos_Int_2014_Oct_10_25(3)_1173-1180.nxml.txt.nlp	24108429	SENT58	1	1	19	19	teriparatide	PTH	PA451620	5741	0.884
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT133	25	25	9	9	perifosine	DR5	PA165291471	8795	0.884
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT29	30	30	16	16	celecoxib	IL-6	PA448871	3569	0.884
NULL	Sci_Rep_2014_Nov_28_4_7237.nxml.txt.nlp	25429875	SENT86	9	9	20	20	hesperidin	p38	PA449867	10598;1432;7965	0.884
NULL	Biomed_Res_Int_2014_Jan_20_2014_948427.nxml.txt.nlp	24563867	SENT159	7	7	18	18	buspirone	STZ	PA448689	6484	0.884
NULL	J_Biol_Chem_2010_Apr_23_285(17)_12979-12989.nxml.txt.nlp	20189985	SENT223	22	22	11	11	forskolin	IP3R2	PA146096022	3709	0.884
NULL	Acta_Pharmacol_Sin_2010_Jul_28_31(7)_867-873.nxml.txt.nlp	20581857	SENT154	31	31	17	17	docetaxel	PC3	PA449383	57332;7832;5122	0.884
NULL	Diabetes_2009_Jan_58(1)_243-249.nxml.txt.nlp	18840785	SENT208	31	31	4	4	vildagliptin	GLP-1	PA165958346	100125288	0.884
NULL	Adv_Pharmacol_Sci_2014_Feb_24_2014_809438.nxml.txt.nlp	24707284	SENT319	21	21	40	40	glibenclamide	ANOVA	PA449782	4858	0.884
NULL	Front_Neuroanat_2014_Oct_9_8_112.nxml.txt.nlp	25346662	SENT52	15	15	13	13	colchicine	SDH	PA449092	1757;10993	0.884
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1542-1553.nxml.txt.nlp	21970874	SENT259	28	28	25	25	gefitinib	EGFR	PA131301952	1956	0.884
NULL	Lipids_Health_Dis_2011_Jan_18_10_8.nxml.txt.nlp	21241519	SENT105	24	24	11	11	simvastatin	SR-BI	PA451363	949	0.884
NULL	Cell_Cycle_2012_Dec_15_11(24)_4499-4506.nxml.txt.nlp	23114620	SENT87	8	8	25	25	choline	LPA	PA448976	4018	0.884
NULL	Mediators_Inflamm_1998_7(6)_417-420.nxml.txt.nlp	9927235	SENT3	21	21	32	32	heparin	C3a	PA449855	718	0.884
NULL	Nucleic_Acids_Res_2012_Apr_16_40(8)_3511-3523.nxml.txt.nlp	22180533	SENT250	24	24	12	12	doxycycline	E2F7	PA449415	144455	0.884
NULL	Indian_J_Pharm_Sci_2013_Jan-Feb_75(1)_16-22.nxml.txt.nlp	23901156	SENT53	13	13	6	6	ethanol	mol	PA448073	90527	0.884
NULL	Eur_J_Med_Res_2011_Apr_28_16(4)_139-144.nxml.txt.nlp	21486727	SENT71	23	23	3	3	voriconazole	CYP2C19	PA10233	1557	0.884
NULL	Pharmaceuticals_(Basel)_2013_Aug_2_6(8)_915-928.nxml.txt.nlp	24276376	SENT186	20	20	26	26	clopidogrel	PAR-1	PA449053	2011;2149	0.884
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1449-1456.nxml.txt.nlp	24077631	SENT103	1	1	35	35	tolbutamide	CYP2C9	PA451718	1559	0.884
NULL	Adv_Ther_2013_Oct_25_30(10)_870-884.nxml.txt.nlp	24158787	SENT212	2	2	14	14	anastrozole	aromatase	PA448432	1588	0.884
NULL	Cancer_Med_2013_Aug_30_2(4)_457-467.nxml.txt.nlp	24156018	SENT115	18	18	12	12	marimastat	U87	PA164748329	677775;641648	0.884
NULL	J_Cell_Mol_Med_2014_May_14_18(5)_811-823.nxml.txt.nlp	24628949	SENT194	16	16	7	7	docetaxel	FOXM1	PA449383	2305	0.884
NULL	J_Hematol_Oncol_2013_Jun_3_6_38.nxml.txt.nlp	23731980	SENT111	15	15	18	18	trastuzumab	aromatase	PA451743	1588	0.884
NULL	Breast_Cancer_Res_2010_Mar_8_12(2)_R18.nxml.txt.nlp	20211017	SENT50	22	22	28	28	hydrocortisone	EGF	PA449905	1950	0.884
NULL	Oncotarget_2012_Nov_17_3(12)_1600-1614.nxml.txt.nlp	23307622	SENT61	21	21	31	31	trastuzumab	ATG12	PA451743	9140	0.884
NULL	Biomed_Res_Int_2013_Jun_13_2013_851428.nxml.txt.nlp	23841096	SENT36	33	33	3	3	l-serine	SHMT	PA451330	6470	0.884
NULL	Alcohol_Clin_Exp_Res_2014_Mar_11_38(3)_657-671.nxml.txt.nlp	24117525	SENT141	1	1	23	23	ethanol	MCP-1	PA448073	6347	0.884
NULL	Front_Immunol_2012_Jul_18_3_198.nxml.txt.nlp	22826708	SENT47	25	25	34	34	alemtuzumab	IL-2	PA164783958	3558	0.884
NULL	Evid_Based_Complement_Alternat_Med_2014_May_8_2014_364819.nxml.txt.nlp	24899907	SENT113	7	7	27	27	tacrolimus	FKBP52	PA451578	2288	0.884
NULL	Oncol_Lett_2014_Jul_25_8(1)_313-316.nxml.txt.nlp	24959268	SENT79	3	3	22	22	sulindac	JNK1	PA451565	5599	0.884
NULL	Br_J_Cancer_2010_Sep_7_103(6)_765-771.nxml.txt.nlp	20700120	SENT39	27	27	18	18	tamoxifen	CYP2D6	PA451581	1565	0.884
NULL	Biomed_Res_Int_2014_Apr_28_2014_549742.nxml.txt.nlp	24877113	SENT94	14	14	5	5	temozolomide	mGlu3	PA451609	2913	0.884
NULL	Mol_Cancer_2014_Jan_13_13_7.nxml.txt.nlp	24418169	SENT213	20	20	30	30	sorafenib	STAT3	PA7000	6774	0.884
NULL	J_Vet_Med_Sci_2014_Jun_15_76(6)_813-817.nxml.txt.nlp	24531829	SENT115	13	13	8	8	primaquine	DPT	PA451103	1805	0.884
NULL	Hum_Mol_Genet_2011_Oct_1_20(19)_3876-3883.nxml.txt.nlp	21729881	SENT318	12	12	1	1	warfarin	CYP4F2	PA451906	8529	0.884
NULL	Oncoimmunology_2014_Jan_17_3_e27574.nxml.txt.nlp	24800167	SENT20	3	3	20	20	cyclophosphamide	IFN	PA449165	3439	0.884
NULL	Oncol_Rep_2014_Sep_11_32(3)_901-905.nxml.txt.nlp	25017515	SENT86	20	20	14	14	celecoxib	PDK1	PA448871	5170;5163	0.884
NULL	Oncol_Lett_2014_May_11_7(5)_1401-1408.nxml.txt.nlp	24765145	SENT34	20	20	17	17	paclitaxel	PI3K	PA450761	5290	0.884
NULL	Cerebellum_2011_Jun_16_10(2)_296-299.nxml.txt.nlp	21321808	SENT53	36	36	22	22	acetazolamide	EA2	PA448018	773	0.884
NULL	ScientificWorldJournal_2014_Mar_24_2014_280928.nxml.txt.nlp	24790559	SENT60	18	18	8	8	ethanol	castor	PA448073	54897	0.884
NULL	Oncotarget_2013_Apr_13_4(4)_502-530.nxml.txt.nlp	23594434	SENT270	13	13	26	26	ritonavir	PTEN	PA451260	5728	0.884
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jan_12_67(Pt_2)_o334-o335.nxml.txt.nlp	21523018	SENT78	38	38	27	27	ethanol	mol	PA448073	90527	0.884
NULL	Allergy_Asthma_Immunol_Res_2014_Sep_28_6(5)_401-408.nxml.txt.nlp	25228996	SENT110	4	4	24	24	capsaicin	TRPV1	PA448776	7442	0.884
NULL	Nat_Genet_2011_Feb_26_43(2)_117-120.nxml.txt.nlp	21186350	SENT29	5	5	33	33	metformin	AMPK	PA450395	5563	0.884
NULL	Arthritis_Care_Res_(Hoboken)_2014_Mar_24_66(3)_344-354.nxml.txt.nlp	23983039	SENT35	0	0	14	14	tocilizumab	IL-6	PA165292659	3569	0.884
NULL	Am_J_Clin_Nutr_2011_Jul_18_94(1)_348S-358S.nxml.txt.nlp	21593511	SENT467	13	13	6	6	hydroxocobalamin	B12	PA164768689	7126;4709	0.884
NULL	Cardiovasc_Ther_2009_27(4)_259-274.nxml.txt.nlp	19604248	SENT139	6	6	20	20	ticagrelor	IPA	PA165374673	3160	0.884
NULL	J_Cell_Biol_1997_May_19_137(4)_835-845.nxml.txt.nlp	9151686	SENT286	10	10	32	32	paraformaldehyde	TGN	PA450790	7038	0.884
NULL	Oncotarget_2012_May_4_3(4)_395-398.nxml.txt.nlp	22565037	SENT29	39	39	32	32	metformin	CD44	PA450395	960	0.884
NULL	Scientifica_(Cairo)_2013_Dec_10_2013_691251.nxml.txt.nlp	24386592	SENT194	9	9	5	5	epirubicin	SIRT6	PA449476	51548	0.884
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT110	17	17	31	31	vinorelbine	PTEN	PA451881	5728	0.884
NULL	Acta_Pharmacol_Sin_2009_Aug_6_30(8)_1204-1210.nxml.txt.nlp	19578385	SENT205	12	12	3	3	ibandronate	CTX	PA10270	1593	0.884
NULL	Front_Oncol_2014_Apr_9_4_75.nxml.txt.nlp	24782986	SENT178	15	15	27	27	paclitaxel	CD117	PA450761	3815	0.884
NULL	Cell_Biol_Int_Rep_(2010)_2012_Jun_21_19(1)_e00017.nxml.txt.nlp	23124518	SENT166	4	4	8	8	etoposide	TRAIL	PA449552	8743	0.884
NULL	Mol_Cancer_2010_Apr_15_9_77.nxml.txt.nlp	20398291	SENT47	26	26	15	15	geldanamycin	survivin	PA152031327	332	0.884
NULL	Oncotarget_2014_Oct_21_5(22)_11252-11268.nxml.txt.nlp	25361004	SENT213	0	0	8	8	metformin	CLIC1	PA450395	1192	0.884
NULL	Reprod_Biol_Endocrinol_2013_Feb_26_11_15.nxml.txt.nlp	23442442	SENT141	2	2	6	6	l-arginine	BCL2	PA448478	596	0.884
NULL	Carcinogenesis_2014_May_13_35(5)_1055-1066.nxml.txt.nlp	24419232	SENT272	10	10	21	21	metformin	CD34	PA450395	947	0.884
NULL	Cancer_Metastasis_Rev_2010_Dec_10_29(4)_581-594.nxml.txt.nlp	20830503	SENT280	16	16	5	5	tamoxifen	STA	PA451581	2010;2656	0.884
NULL	Int_J_Mol_Sci_2013_Aug_14_14(8)_16719-16731.nxml.txt.nlp	23949634	SENT98	15	15	17	17	thrombin	PAR-1	PA451674	2011;2149	0.884
NULL	Exp_Cell_Res_2011_Apr_15_317(7)_1028-1039.nxml.txt.nlp	21237154	SENT138	13	13	6	6	staurosporine	JIP1	PA165109623	9479	0.884
NULL	Onco_Targets_Ther_2014_Dec_4_7_2249-2255.nxml.txt.nlp	25587220	SENT95	19	19	34	34	doxorubicin	MRP1	PA449412	4437	0.884
NULL	Front_Endocrinol_(Lausanne)_2013_Jan_2_3_174.nxml.txt.nlp	23293631	SENT175	17	17	8	8	creatine	URP	PA164778930	8233;90226;257313;25972	0.884
NULL	J_Mol_Signal_2006_Dec_6_1_8.nxml.txt.nlp	17224083	SENT9	17	17	24	24	thrombin	Rho	PA451674	29984	0.884
NULL	BioData_Min_2011_Jun_14_4_15.nxml.txt.nlp	21672238	SENT32	5	5	0	0	geldanamycin	Hsp90	PA152031327	3320	0.884
NULL	EJC_Suppl_2013_Sep_5_11(2)_3-22.nxml.txt.nlp	NULL	SENT261	23	23	12	12	gemcitabine	ACT	PA449748	12;11332;9457;641455	0.884
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT349	27	27	21	21	pp2	PP1		5540;5464	0.884
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT108	14	14	24	24	trastuzumab	MUC1	PA451743	4582	0.884
NULL	FEBS_Open_Bio_2014_Jul_5_4_659-671.nxml.txt.nlp	25161875	SENT444	1	1	18	18	cisplatin	XIAP	PA449014	331	0.884
NULL	Oncotarget_2012_Oct_20_3(10)_1236-1245.nxml.txt.nlp	23100449	SENT73	17	17	7	7	doxorubicin	NGAL	PA449412	3934	0.884
NULL	Clin_Ophthalmol_2012_Dec_13_6_1-4.nxml.txt.nlp	22259229	SENT72	4	4	12	12	travoprost	BAK	PA164781371	578	0.884
NULL	Breast_Cancer_Res_2004_Nov_7_6(1)_39-52.nxml.txt.nlp	14680484	SENT174	6	6	2	2	tamoxifen	STAR	PA451581	6770;2984	0.884
NULL	J_Cell_Mol_Med_2014_Oct_11_18(10)_2031-2043.nxml.txt.nlp	25109475	SENT149	26	26	13	13	valsartan	LKB1	PA451848	6794	0.884
NULL	Nat_Commun_2013_Sep_17_4_2464.nxml.txt.nlp	24043118	SENT204	7	7	16	16	estradiol	FGF10	PA449503	2255	0.884
NULL	Acta_Pharmacol_Sin_2013_Jan_17_34(1)_157-166.nxml.txt.nlp	23247593	SENT154	5	5	30	30	berberine	IL-6	PA165860812	3569	0.884
NULL	Mol_Biol_Cell_2012_May_15_23(10)_1860-1873.nxml.txt.nlp	22456507	SENT384	13	13	4	4	paraformaldehyde	LC3	PA450790	84557	0.884
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT87	7	7	3	3	trastuzumab	STAT3	PA451743	6774	0.884
NULL	Br_J_Dermatol_2014_Feb_18_170(1)_342-351.nxml.txt.nlp	24547721	SENT132	14	14	4	4	omeprazole	CLE	PA450704	51637	0.884
NULL	AIDS_Res_Ther_2011_Oct_6_8_36.nxml.txt.nlp	21978457	SENT125	11	11	22	22	zinc	TNF	PA451956	7124	0.884
NULL	Br_J_Cancer_2014_Jan_21_110(2)_330-340.nxml.txt.nlp	24281000	SENT15	20	20	3	3	paclitaxel	CHKA	PA450761	1119	0.884
NULL	J_Hum_Genet_2013_Jun_23_58(6)_339-345.nxml.txt.nlp	23697979	SENT35	3	3	6	6	clopidogrel	CYP2C19	PA449053	1557	0.884
NULL	Eur_J_Med_Res_2009_Nov_24_14(Suppl_3)_17-21.nxml.txt.nlp	19959412	SENT31	12	12	32	32	raltegravir	UGT1A9		54600	0.884
NULL	Aging_Cell_2012_Aug_11(4)_579-587.nxml.txt.nlp	22435726	SENT95	42	42	8	8	etoposide	CD28	PA449552	1493;940	0.884
NULL	J_Vis_Exp_2010_Jan_12_(35)_1701.nxml.txt.nlp	20068548	SENT12	13	13	24	24	carbenicillin	KLRG1	PA448788	10219	0.884
NULL	Exp_Ther_Med_2013_Apr_5_5(4)_1259-1263.nxml.txt.nlp	23596498	SENT12	4	4	7	7	propofol	TRPV1	PA451141	7442	0.884
NULL	Cancers_(Basel)_2014_Apr_16_6(2)_926-957.nxml.txt.nlp	24743778	SENT337	0	0	32	32	curcumin	STAT3	PA151958596	6774	0.884
NULL	Front_Physiol_2011_Jun_14_2_26.nxml.txt.nlp	21716655	SENT224	1	1	21	21	lipase	SCAD	PA450239	35	0.884
NULL	Endocrinol_Metab_(Seoul)_2014_Sep_25_29(3)_211-216.nxml.txt.nlp	25309777	SENT81	6	6	14	14	sunitinib	MTC	PA162372840	4914	0.884
NULL	Nucleic_Acids_Res_2007_Jan_7_35(2)_e9.nxml.txt.nlp	17158148	SENT37	2	2	20	20	neomycin	RAD18	PA450608	56852	0.884
NULL	Mediators_Inflamm_2000_9(1)_39-43.nxml.txt.nlp	10877454	SENT2	3	3	18	18	roxithromycin	CD86	PA164750505	942	0.884
NULL	J_Nat_Sci_Biol_Med_2011_Jul-Dec_2(2)_180-184.nxml.txt.nlp	22346232	SENT29	25	25	10	10	linezolid	SGB	PA450233	2719	0.884
NULL	Pharmaceutics_2011_Sep_14_3(3)_615-635.nxml.txt.nlp	24310600	SENT84	15	15	28	28	irinotecan	ABCG2	PA450085	9429	0.884
NULL	Breast_Cancer_(Auckl)_2014_May_12_8_81-88.nxml.txt.nlp	24855372	SENT3	8	8	19	19	trastuzumab	HER2	PA451743	2064	0.884
NULL	Nat_Commun_2014_Jun_9_5_4088.nxml.txt.nlp	24909826	SENT301	10	10	29	29	mitomycin	EGF	PA450524	1950	0.884
NULL	Chin_J_Cancer_2012_Feb_31(2)_110-118.nxml.txt.nlp	22098951	SENT27	20	20	37	37	imatinib	P-gp	PA10804	5243	0.884
NULL	Cancers_(Basel)_2013_Mar_11_5(1)_255-280.nxml.txt.nlp	24216707	SENT17	44	44	17	17	calcidiol	CYP2R1	PA164745614	120227	0.884
NULL	Acta_Pharmacol_Sin_2009_Nov_5_30(11)_1522-1528.nxml.txt.nlp	19890360	SENT134	6	6	18	18	fenoterol	CD14	PA10079	929	0.884
NULL	Curr_Chem_Genomics_2010_Mar_1_4_1-8.nxml.txt.nlp	20448812	SENT9	5	5	22	22	piperazine	OATP1B3	PA450977	28234	0.884
NULL	Acta_Pharmacol_Sin_2013_Jan_3_34(1)_119-128.nxml.txt.nlp	23202804	SENT219	44	44	22	22	rimonabant	NG2	PA152407999	1464;6048	0.884
NULL	Molecules_2012_Dec_11_17(12)_14795-14809.nxml.txt.nlp	23519253	SENT227	12	12	3	3	curcumin	NFkappaB	PA151958596	4790	0.884
NULL	Mol_Biol_Int_2014_Oct_19_2014_574850.nxml.txt.nlp	25386362	SENT138	38	38	12	12	hydroxyurea	MCM5	PA449942	4174	0.884
NULL	J_Hematol_Oncol_2013_Dec_17_6_93.nxml.txt.nlp	24341609	SENT127	10	10	17	17	gefitinib	IGF1R	PA131301952	3480	0.884
NULL	Clin_Med_Insights_Oncol_2013_May_20_7_87-102.nxml.txt.nlp	23761989	SENT258	15	15	6	6	belinostat	RAD23B		5887	0.884
NULL	Clin_Med_Insights_Oncol_2012_Mar_19_6_165-178.nxml.txt.nlp	22474408	SENT220	5	5	12	12	cytarabine	GM-CSF	PA449177	1437	0.884
NULL	Arch_Med_Sci_2012_May_9_8(2)_375-388.nxml.txt.nlp	22662015	SENT256	38	38	26	26	ketoconazole	CYP3A4	PA450146	1576	0.884
NULL	Scientifica_(Cairo)_2012_Oct_9_2012_159680.nxml.txt.nlp	24278674	SENT64	3	3	20	20	l-cysteine	PAG	PA449173	55824	0.884
NULL	Oncotarget_2013_Dec_7_5(2)_363-374.nxml.txt.nlp	24495907	SENT275	18	18	10	10	temozolomide	CD133	PA451609	8842	0.884
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT74	20	20	18	18	pertuzumab	HER2		2064	0.884
NULL	Brain_Behav_2011_Nov_1(2)_63-69.nxml.txt.nlp	22399085	SENT124	9	9	7	7	pioglitazone	PPARgamma	PA450970	5468	0.884
NULL	Pharmaceuticals_(Basel)_2013_Apr_17_6(4)_557-578.nxml.txt.nlp	24276125	SENT124	4	4	14	14	ustekinumab	IL-23	PA166048654	51561	0.884
NULL	Amyloid_2014_Sep_11_21(3)_175-184.nxml.txt.nlp	24918964	SENT197	1	1	17	17	anakinra	TTR	PA10799	7276	0.884
NULL	Breast_Cancer_Res_2012_Mar_14_14(2)_R46.nxml.txt.nlp	22417870	SENT28	12	12	3	3	trastuzumab	HER2	PA451743	2064	0.884
NULL	Clin_Drug_Investig_2015_Dec_16_35_141-147.nxml.txt.nlp	25511640	SENT92	6	6	13	13	miglitol	GLP-1	PA164776726	100125288	0.884
NULL	J_Gen_Physiol_2000_Jun_1_115(6)_685-696.nxml.txt.nlp	10828243	SENT6	16	16	33	33	genistein	OLF	PA165109660	83857	0.884
NULL	Biomed_Res_Int_2014_Jan_20_2014_948427.nxml.txt.nlp	24563867	SENT103	3	3	29	29	buspirone	STZ	PA448689	6484	0.884
NULL	Chonnam_Med_J_2013_Apr_25_49(1)_31-37.nxml.txt.nlp	23678475	SENT103	34	34	8	8	rosuvastatin	adiponectin	PA134308647	9370	0.884
NULL	Reprod_Biol_Endocrinol_2013_Jun_19_11_53.nxml.txt.nlp	23782518	SENT138	10	10	34	34	cisplatin	CXCR4	PA449014	7852	0.884
NULL	Int_J_Mol_Imaging_2011_Oct_26_2011_874585.nxml.txt.nlp	21490735	SENT124	11	11	30	30	tamoxifen	FDG	PA451581	23583	0.883
NULL	Oncoscience_2014_Mar_12_1(2)_158-166.nxml.txt.nlp	25594008	SENT134	27	27	39	39	dasatinib	ANXA2	PA162372878	302	0.883
NULL	Br_J_Cancer_2013_Feb_19_108(3)_557-563.nxml.txt.nlp	23361053	SENT43	28	28	15	15	tamoxifen	PAK1	PA451581	5585;5058	0.883
NULL	Chin_J_Cancer_2012_Feb_31(2)_110-118.nxml.txt.nlp	22098951	SENT126	13	13	17	17	vincristine	P-gp	PA451879	5243	0.883
NULL	Acta_Pharmacol_Sin_2012_Aug_23_33(8)_1095-1100.nxml.txt.nlp	22820908	SENT111	4	4	21	21	clarithromycin	CYP2C19	PA449028	1557	0.883
NULL	Int_J_Nanomedicine_2012_Oct_25_7_5565-5575.nxml.txt.nlp	23118538	SENT27	21	21	5	5	fenofibrate	CO2	PA449594	4513	0.883
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1059-1066.nxml.txt.nlp	21364577	SENT3	15	15	10	10	letrozole	aromatase	PA450196	1588	0.883
NULL	Evid_Based_Complement_Alternat_Med_2014_Jan_9_2014_506735.nxml.txt.nlp	24523822	SENT85	7	7	5	5	fluoxetine	GTS	PA449673	2973	0.883
NULL	Br_J_Cancer_2012_Sep_4_107(6)_947-955.nxml.txt.nlp	22892392	SENT43	26	26	13	13	tamoxifen	ERBB2	PA451581	2064	0.883
NULL	Biomed_Res_Int_2014_Jan_23_2014_312647.nxml.txt.nlp	24587984	SENT134	5	5	11	11	infliximab	ABCA1	PA452639	19	0.883
NULL	Sci_Rep_2015_Jan_6_5_7636.nxml.txt.nlp	25560045	SENT42	26	26	13	13	ethanol	NO3	PA448073	4681	0.883
NULL	J_Oncol_2012_Jun_19_2012_521215.nxml.txt.nlp	22778735	SENT236	3	3	14	14	afatinib	EGFR	PA165981154	1956	0.883
NULL	Ann_Oncol_2011_Aug_27_22(8)_1736-1747.nxml.txt.nlp	21709140	SENT48	14	14	25	25	anastrozole	aromatase	PA448432	1588	0.883
NULL	J_Invest_Dermatol_2012_May_1_132(5)_1513-1516.nxml.txt.nlp	22377761	SENT15	3	3	18	18	tamoxifen	ADAM10	PA451581	102	0.883
NULL	Curr_Neuropharmacol_2008_Dec_6(4)_311-321.nxml.txt.nlp	19587852	SENT363	14	14	7	7	fluoxetine	DARPP-32	PA449673	84152	0.883
NULL	Nat_Commun_2014_Nov_25_5_5548.nxml.txt.nlp	25420520	SENT112	18	18	25	25	docetaxel	TMPRSS2	PA449383	7113	0.883
NULL	J_Oncol_2012_Apr_10_2012_931071.nxml.txt.nlp	22570654	SENT74	16	16	8	8	plerixafor	CD34	PA165958410	947	0.883
NULL	Blood_Cancer_J_2014_Jan_17_4(1)_e175.nxml.txt.nlp	24442204	SENT86	12	12	5	5	bortezomib	MAFB	PA10252	9935	0.883
NULL	Hum_Genomics_2008_Sep_1_3(1)_7-16.nxml.txt.nlp	19129086	SENT10	21	21	3	3	rosiglitazone	CYP2C8	PA451283	1558	0.883
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT82	18	18	8	8	nutlin-3	p53		7157	0.883
NULL	Breast_Cancer_Res_2014_May_5_16(3)_R45.nxml.txt.nlp	24887236	SENT283	15	15	10	10	lapatinib	PI3K	PA152241907	5290	0.883
NULL	Arthritis_Res_Ther_2008_Jan_18_10(1)_R8.nxml.txt.nlp	18205921	SENT34	32	32	4	4	vardenafil	MRP5	PA10229	10057	0.883
NULL	Diabetes_2011_Jun_21_60(6)_1734-1742.nxml.txt.nlp	21498783	SENT86	21	21	3	3	lipase	DAG	PA450239	1605	0.883
NULL	Breast_Cancer_Res_2010_Aug_23_12(4)_R64.nxml.txt.nlp	20731819	SENT58	22	22	12	12	tamoxifen	CYP2D6	PA451581	1565	0.883
NULL	Breast_Cancer_Res_2008_Feb_28_10(1)_R20.nxml.txt.nlp	18307763	SENT108	16	16	45	45	trastuzumab	HER2	PA451743	2064	0.883
NULL	Front_Oncol_2013_Oct_22_3_268.nxml.txt.nlp	24156094	SENT98	26	26	18	18	doxorubicin	CD133	PA449412	8842	0.883
NULL	Pharmaceuticals_(Basel)_2012_Jan_5_5(1)_79-93.nxml.txt.nlp	24288044	SENT16	14	14	9	9	trastuzumab	HER2	PA451743	2064	0.883
NULL	Open_AIDS_J_2011_Jul_11_5_62-66.nxml.txt.nlp	21772932	SENT14	13	13	36	36	fosamprenavir	CD4	PA10084	920	0.883
NULL	Front_Genet_2014_Aug_7_5_224.nxml.txt.nlp	25147554	SENT634	5	5	13	13	ethanol	GLI2	PA448073	2736	0.883
NULL	J_Biol_Chem_2008_Oct_31_283(44)_29841-29846.nxml.txt.nlp	18765669	SENT202	9	9	18	18	suramin	P2X1	PA10292	5023	0.883
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Oct_15_64(Pt_11)_o2118-o2119.nxml.txt.nlp	21580981	SENT66	23	23	9	9	ethanol	mol	PA448073	90527	0.883
NULL	Int_J_Breast_Cancer_2012_Oct_15_2012_809291.nxml.txt.nlp	22295251	SENT197	35	35	16	16	irinotecan	EGFR	PA450085	1956	0.883
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Oct_22_67(Pt_11)_o2984.nxml.txt.nlp	22220004	SENT3	30	30	3	3	phenol	mol	PA450913	90527	0.883
NULL	J_Exp_Bot_2011_Oct_4_62(14)_4787-4803.nxml.txt.nlp	21821598	SENT32	26	26	20	20	mannitol	M6PR	PA450320	4074	0.883
NULL	EMBO_Mol_Med_2012_Oct_30_4(10)_1087-1096.nxml.txt.nlp	22933245	SENT7	14	14	6	6	olaparib	NAMPT		10135	0.883
NULL	Cancer_Microenviron_2013_Jan_22_6(3)_231-240.nxml.txt.nlp	23335094	SENT84	12	12	7	7	simvastatin	PC-3	PA451363	692094	0.883
NULL	Mol_Cancer_2014_Jun_3_13_137.nxml.txt.nlp	24889938	SENT281	44	44	16	16	heparin	B27	PA449855	56246	0.883
NULL	Arthritis_Res_Ther_2008_Mar_17_10(2)_R33.nxml.txt.nlp	18346273	SENT58	10	10	6	6	infliximab	IL-15	PA452639	3600	0.883
NULL	J_Cancer_Prev_2013_Jun_18(2)_186-191.nxml.txt.nlp	25337545	SENT95	7	7	12	12	curcumin	STAT3	PA151958596	6774	0.883
NULL	Mol_Vis_2012_Apr_11_18_901-908.nxml.txt.nlp	22539869	SENT124	17	17	8	8	curcumin	HO-1	PA151958596	3162	0.883
NULL	Cancer_Cell_Int_2010_Apr_29_10_12.nxml.txt.nlp	20429927	SENT177	34	34	10	10	bortezomib	HRI	PA10252	27102	0.883
NULL	Int_J_Nanomedicine_2012_Oct_25_7_5565-5575.nxml.txt.nlp	23118538	SENT2	11	11	24	24	fenofibrate	CO2	PA449594	4513	0.883
NULL	Eur_J_Clin_Pharmacol_2012_May_21_68(5)_553-560.nxml.txt.nlp	22189672	SENT197	9	9	5	5	alprazolam	CYP2D6	PA448333	1565	0.883
NULL	Breast_Cancer_Res_2011_Aug_31_13(4)_R84.nxml.txt.nlp	21884573	SENT234	47	47	39	39	lapatinib	FAK	PA152241907	5747	0.883
NULL	Anesth_Pain_Med_2013_Dec_27_4(1)_e11906.nxml.txt.nlp	24660144	SENT82	22	22	15	15	rituximab	FVIII	PA451261	2157	0.883
NULL	Oncotarget_2014_Jun_8_5(13)_5040-5053.nxml.txt.nlp	24970815	SENT202	27	27	7	7	cisplatin	BBC3	PA449014	27113	0.883
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_105-115.nxml.txt.nlp	17912640	SENT57	18	18	6	6	trastuzumab	EGFR	PA451743	1956	0.883
NULL	Br_J_Cancer_2012_Jun_5_106(12)_1901-1906.nxml.txt.nlp	22596239	SENT49	6	6	10	10	imatinib	CXCR4	PA10804	7852	0.883
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT38	20	20	11	11	liraglutide	GLP-1	PA165958364	100125288	0.883
NULL	Adv_Hematol_2012_May_8_2012_393864.nxml.txt.nlp	22851972	SENT20	39	39	21	21	fludarabine	TP53	PA449655	7157	0.883
NULL	Acta_Pharmacol_Sin_2010_Nov_18_31(11)_1447-1453.nxml.txt.nlp	20953204	SENT11	17	17	22	22	rimonabant	IL-6	PA152407999	3569	0.883
NULL	Nucleic_Acids_Res_2011_Dec_31_39(22)_9536-9548.nxml.txt.nlp	21880590	SENT160	19	19	12	12	etoposide	BRCA1	PA449552	672	0.883
NULL	J_Biomed_Biotechnol_2010_Jun_7_2010_150960.nxml.txt.nlp	20617134	SENT224	28	28	35	35	paclitaxel	KRAS	PA450761	3845	0.883
NULL	J_Exp_Clin_Cancer_Res_2008_Sep_12_27(1)_37.nxml.txt.nlp	18789152	SENT26	0	0	12	12	docetaxel	p53	PA449383	7157	0.883
NULL	Acta_Pharmacol_Sin_2011_Mar_31_32(3)_295-302.nxml.txt.nlp	21278785	SENT156	5	5	10	10	evodiamine	IL-6	PA165860788	3569	0.883
NULL	Clin_Drug_Investig_2015_Dec_4_35_45-51.nxml.txt.nlp	25471740	SENT32	20	20	31	31	atorvastatin	CYP3A4	PA448500	1576	0.883
NULL	Core_Evid_2010_Oct_21_5_77-90.nxml.txt.nlp	21042544	SENT177	3	3	6	6	aprepitant	CYP3A4	PA164747039	1576	0.883
NULL	Int_J_Mol_Sci_2014_Jun_5_15(6)_10083-10100.nxml.txt.nlp	24905407	SENT22	22	22	7	7	tetracycline	TRB	PA451640	6957	0.883
NULL	Br_J_Cancer_2009_Mar_10_100(5)_758-763.nxml.txt.nlp	19259094	SENT27	19	19	13	13	decitabine	HDAC	PA164749631	9734	0.883
NULL	ACS_Med_Chem_Lett_2011_May_16_2(7)_549-554.nxml.txt.nlp	21765967	SENT84	14	14	17	17	maraviroc	CCR5	PA164768835	1234	0.883
NULL	J_Gastrointest_Cancer_2013_Aug_7_44(4)_385-392.nxml.txt.nlp	23921604	SENT174	4	4	12	12	imatinib	PDGFRA	PA10804	5156	0.883
NULL	J_Breast_Cancer_2011_Sep_29_14(3)_167-174.nxml.txt.nlp	22031796	SENT56	10	10	15	15	doxorubicin	HSP27	PA449412	3315	0.883
NULL	Exp_Ther_Med_2012_Sep_8_4(3)_435-441.nxml.txt.nlp	23181114	SENT161	16	16	10	10	methotrexate	CD133	PA450428	8842	0.883
NULL	Mol_Microbiol_2014_May_28_92(3)_453-470.nxml.txt.nlp	24533860	SENT99	43	43	35	35	tetracycline	HMI	PA451640	3160	0.883
NULL	Arch_Med_Sci_2013_Oct_31_9(5)_936-943.nxml.txt.nlp	24273582	SENT37	44	44	37	37	glibenclamide	SUR1	PA449782	6833	0.883
NULL	Oncol_Lett_2014_Jan_12_7(1)_17-22.nxml.txt.nlp	24348813	SENT120	13	13	17	17	curcumin	EGFR	PA151958596	1956	0.883
NULL	Acta_Pharmacol_Sin_2009_Sep_24_30(9)_1323-1329.nxml.txt.nlp	19701237	SENT143	20	20	10	10	clarithromycin	CYP3A	PA449028	1574	0.883
NULL	Alcohol_Res_2012_34(3)_367-374.nxml.txt.nlp	23134054	SENT97	12	12	31	31	ethanol	PPOX	PA448073	3060;5498	0.883
NULL	Br_J_Clin_Pharmacol_2013_Aug_23_76(2)_299-315.nxml.txt.nlp	23701319	SENT94	6	6	21	21	etanercept	IFN	PA449515	3439	0.883
NULL	Eur_J_Neurosci_2008_Jun_27(12)_3151-3160.nxml.txt.nlp	18598259	SENT253	8	8	25	25	capsaicin	TRPA1	PA448776	8989	0.883
NULL	Exp_Ther_Med_2014_Nov_29_8(5)_1473-1478.nxml.txt.nlp	25289044	SENT124	19	19	5	5	heparin	AZU	PA449855	566	0.883
NULL	J_Med_Life_2011_Feb_15_4(1)_11-20.nxml.txt.nlp	21505570	SENT193	0	0	6	6	ketorolac	COX1	PA450150	4512;5742	0.883
NULL	Database_(Oxford)_2014_Dec_23_2014_bau124.nxml.txt.nlp	25539768	SENT320	11	11	21	21	gefitinib	LKB1	PA131301952	6794	0.883
NULL	FEBS_Open_Bio_2013_Dec_30_4_96-104.nxml.txt.nlp	24490130	SENT140	11	11	17	17	cisplatin	BRCA1	PA449014	672	0.883
NULL	Acta_Pharmacol_Sin_2009_Oct_21_30(10)_1392-1398.nxml.txt.nlp	19767766	SENT142	34	34	26	26	atorvastatin	p38	PA448500	10598;1432;7965	0.883
NULL	Breast_Cancer_Res_2005_Jan_12_7(2)_48-51.nxml.txt.nlp	15743510	SENT84	15	15	34	34	tamoxifen	ATAC	PA451581	6375	0.883
NULL	Diabetes_Care_2010_Aug_27_33(8)_1734-1737.nxml.txt.nlp	20424219	SENT61	8	8	18	18	exenatide	adiponectin	PA164749238	9370	0.883
NULL	Tuberc_Respir_Dis_(Seoul)_2013_Nov_29_75(5)_188-198.nxml.txt.nlp	24348666	SENT129	7	7	26	26	gefitinib	CD133	PA131301952	8842	0.883
NULL	Front_Microbiol_2012_Mar_12_3_74.nxml.txt.nlp	22416241	SENT537	15	15	2	2	efalizumab	TNF-alpha	PA164748817	7124	0.883
NULL	J_Hematol_Oncol_2008_Aug_11_1_11.nxml.txt.nlp	18694493	SENT141	15	15	11	11	sunitinib	IL-2	PA162372840	3558	0.883
NULL	J_Biomed_Biotechnol_2011_Dec_6_2011_856985.nxml.txt.nlp	21188173	SENT206	8	8	12	12	tamoxifen	HDAC2	PA451581	3066	0.883
NULL	Drug_Healthc_Patient_Saf_2012_Nov_29_4_173-180.nxml.txt.nlp	23236256	SENT67	0	0	12	12	olanzapine	FGA	PA450688	2243	0.883
NULL	Diabetes_Care_2013_Jul_12_36(7)_1913-1918.nxml.txt.nlp	23359361	SENT218	13	13	25	25	metformin	GLP-1	PA450395	100125288	0.883
NULL	Curr_Med_Chem_2013_Jun_20(19)_2415-2437.nxml.txt.nlp	23394552	SENT274	15	15	24	24	ethanol	GPD	PA448073	2532	0.883
NULL	Diabetes_2009_Jan_58(1)_243-249.nxml.txt.nlp	18840785	SENT104	23	23	36	36	vildagliptin	GLP-1	PA165958346	100125288	0.883
NULL	Pharmaceuticals_(Basel)_2013_Nov_11_6(11)_1429-1450.nxml.txt.nlp	24287465	SENT264	18	18	26	26	vemurafenib	GLI2	PA165946873	2736	0.883
NULL	Mol_Cancer_2010_Apr_12_9_75.nxml.txt.nlp	20385023	SENT309	10	10	32	32	cetuximab	PTEN	PA10040	5728	0.883
NULL	Breast_Cancer_Res_2007_Dec_20_9(Suppl_2)_S13.nxml.txt.nlp	NULL	SENT49	11	11	2	2	tamoxifen	IMPACT	PA451581	55364	0.883
NULL	Arthritis_Res_Ther_2005_May_18_7(Suppl_3)_S19-S25.nxml.txt.nlp	15960818	SENT226	9	9	5	5	doxorubicin	CHOP	PA449412	1649	0.883
NULL	Ann_Hematol_2010_Sep_13_89(9)_861-871.nxml.txt.nlp	20387067	SENT225	0	0	22	22	dasatinib	KIT	PA162372878	3815	0.883
NULL	Cells_2012_Jul_6_1(3)_284-312.nxml.txt.nlp	24710477	SENT300	4	4	8	8	lapatinib	Mcl-1	PA152241907	4170	0.883
NULL	Arthritis_Res_Ther_2012_May_1_14(3)_R99.nxml.txt.nlp	22546542	SENT122	13	13	3	3	infliximab	IL-6	PA452639	3569	0.883
NULL	J_Allergy_(Cairo)_2011_Dec_11_2011_742710.nxml.txt.nlp	22220184	SENT177	21	21	7	7	isoproterenol	ASM	PA450121	6609;283120	0.883
NULL	J_Med_Genet_2010_Aug_18_47(8)_507-512.nxml.txt.nlp	19542079	SENT105	15	15	5	5	s-adenosylmethionine	B12	PA164754994	7126;4709	0.883
NULL	Curr_Neuropharmacol_2008_Sep_6(3)_215-234.nxml.txt.nlp	19506722	SENT156	1	1	6	6	fluoxetine	5-HT7	PA449673	3363	0.883
NULL	Diabetes_Care_2009_Sep_28_32(9)_1649-1655.nxml.txt.nlp	19478198	SENT165	36	36	15	15	saxagliptin	PPG	PA165958362	5552	0.883
NULL	Carcinogenesis_2014_May_13_35(5)_1055-1066.nxml.txt.nlp	24419232	SENT317	15	15	22	22	resveratrol	CYP1B1		1545	0.883
NULL	Acta_Pharmacol_Sin_2011_Oct_12_32(10)_1259-1265.nxml.txt.nlp	21909126	SENT136	15	15	22	22	fluvastatin	p38	PA449688	10598;1432;7965	0.883
NULL	Breast_Cancer_Res_2009_Jan_16_11(1)_201.nxml.txt.nlp	19216727	SENT152	33	33	9	9	trastuzumab	HER2	PA451743	2064	0.883
NULL	Acta_Pharmacol_Sin_2010_Jul_21_31(7)_855-860.nxml.txt.nlp	20562904	SENT12	15	15	7	7	fluconazole	CDR2	PA449653	1039	0.883
NULL	Indian_J_Pharmacol_2012_Nov-Dec_44(6)_737-743.nxml.txt.nlp	23248404	SENT73	4	4	20	20	ketamine	BS4	PA450144	51667	0.883
NULL	Acta_Pharmacol_Sin_2013_Sep_5_34(9)_1192-1200.nxml.txt.nlp	23685957	SENT126	20	20	10	10	curcumin	FasL	PA151958596	356	0.883
NULL	Virol_J_2011_May_25_8_258.nxml.txt.nlp	21609495	SENT34	16	16	9	9	ribavirin	IFN	PA451241	3439	0.883
NULL	Front_Immunol_2012_Jan_6_2_93.nxml.txt.nlp	22566882	SENT167	11	11	1	1	thrombin	MMRN1	PA451674	22915	0.883
NULL	J_RNAi_Gene_Silencing_2009_Mar_9_5(1)_321-330.nxml.txt.nlp	19771229	SENT229	20	20	4	4	hydroxyurea	RRM2	PA449942	6241	0.883
NULL	Br_J_Pharmacol_2014_Jan_23_171(2)_523-535.nxml.txt.nlp	24372553	SENT14	2	2	8	8	metformin	SIRT1	PA450395	23411	0.883
NULL	Environ_Health_Perspect_2005_Apr_14_113(4)_431-439.nxml.txt.nlp	15811834	SENT83	24	24	6	6	glutaraldehyde	PRL	PA449777	5617	0.883
NULL	Clin_Cosmet_Investig_Dermatol_2011_Jul_1_4_93-99.nxml.txt.nlp	21760744	SENT99	13	13	3	3	acitretin	IL-17	PA448039	3605	0.883
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT147	12	12	7	7	trastuzumab	STAT3	PA451743	6774	0.883
NULL	Cell_Death_Dis_2013_Jul_25_4(7)_e740.nxml.txt.nlp	23887631	SENT11	8	8	0	0	doxorubicin	CD133	PA449412	8842	0.883
NULL	Br_J_Cancer_1997_76(8)_1029-1034.nxml.txt.nlp	9376262	SENT17	18	18	29	29	daunorubicin	CD34	PA449212	947	0.883
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_P42.nxml.txt.nlp	NULL	SENT14	21	21	17	17	amoxicillin	IFN	PA448406	3439	0.883
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1047.nxml.txt.nlp	24503539	SENT27	36	36	4	4	staurosporine	SIRT3	PA165109623	23410	0.883
NULL	Exp_Diabetes_Res_2012_Jan_29_2012_159874.nxml.txt.nlp	22319521	SENT136	3	3	10	10	telmisartan	Hes1	PA451605	3280	0.883
NULL	Environ_Health_Perspect_2009_Feb_8_117(2)_175-180.nxml.txt.nlp	19270784	SENT207	21	21	4	4	cisplatin	BPA	PA449014	667	0.883
NULL	Mol_Cancer_2013_Sep_11_12_104.nxml.txt.nlp	24025152	SENT50	23	23	30	30	gemcitabine	STAT3	PA449748	6774	0.883
NULL	J_Gastroenterol_Hepatol_2014_Dec_18_29(12)_1996-2005.nxml.txt.nlp	24910341	SENT123	38	38	43	43	ribavirin	IL28B	PA451241	282617	0.883
NULL	Br_J_Cancer_2011_Jul_12_105(2)_212-220.nxml.txt.nlp	21694723	SENT239	25	25	9	9	curcumin	CD133	PA151958596	8842	0.883
NULL	Exp_Ther_Med_2014_Oct_23_8(4)_1318-1324.nxml.txt.nlp	25187847	SENT86	5	5	10	10	ranitidine	IL-6	PA451224	3569	0.883
NULL	Br_J_Cancer_2004_Mar_5_90(Suppl_1)_S7-S10.nxml.txt.nlp	15094758	SENT96	18	18	26	26	midazolam	CYP3A4	PA450496	1576	0.883
NULL	Curr_Cardiol_Rev_2009_Aug_5(3)_166-176.nxml.txt.nlp	20676275	SENT182	6	6	13	13	ciprofloxacin	HERG	PA449009	3757	0.883
NULL	Cancer_Cell_Int_2011_Nov_2_11_39.nxml.txt.nlp	22047021	SENT417	27	27	21	21	cisplatin	REV3	PA449014	5980	0.883
NULL	Eur_J_Med_Res_2009_Nov_24_14(Suppl_3)_36-42.nxml.txt.nlp	19959415	SENT34	23	23	14	14	lamivudine	gamma	PA450163	9913	0.883
NULL	Eur_J_Epidemiol_2009_Sep_2_24(9)_553-572.nxml.txt.nlp	19728115	SENT1536	19	19	14	14	acenocoumarol	CYP2C9	PA452632	1559	0.883
NULL	Br_J_Cancer_2011_Sep_6_105(6)_807-813.nxml.txt.nlp	21847121	SENT86	29	29	7	7	pha-665752	EGFR		1956	0.883
NULL	Br_J_Cancer_2009_Sep_15_101(6)_957-966.nxml.txt.nlp	19738618	SENT184	14	14	34	34	heparin	IL-8	PA449855	3576	0.883
NULL	Eur_J_Neurosci_2008_Sep_28(6)_1146-1156.nxml.txt.nlp	18783372	SENT271	38	38	45	45	clotrimazole	TRPM2	PA449057	7226	0.883
NULL	J_Cell_Biol_2001_Aug_20_154(4)_763-774.nxml.txt.nlp	11514590	SENT257	12	12	4	4	colchicine	EGF	PA449092	1950	0.883
NULL	Ther_Clin_Risk_Manag_2006_Jun_2(2)_129-158.nxml.txt.nlp	18360588	SENT157	3	3	6	6	voriconazole	CYP3A4	PA10233	1576	0.883
NULL	Ther_Clin_Risk_Manag_2007_Jun_3(2)_341-348.nxml.txt.nlp	18360643	SENT111	27	27	19	19	erlotinib	EGFR	PA134687924	1956	0.883
NULL	Oncotarget_2014_Mar_13_5(4)_1101-1110.nxml.txt.nlp	24658355	SENT169	10	10	5	5	tamoxifen	MKP-2	PA451581	1846	0.883
NULL	Br_J_Cancer_2013_Mar_19_108(5)_1052-1060.nxml.txt.nlp	23422754	SENT23	9	9	1	1	bevacizumab	VEGF-A	PA130232992	7422	0.883
NULL	Br_J_Cancer_2010_Nov_2_103(11)_1671-1679.nxml.txt.nlp	21045835	SENT138	10	10	1	1	gemcitabine	CXCR4	PA449748	7852	0.883
NULL	Oncogene_2014_Aug_28_33(35)_4396-4406.nxml.txt.nlp	24531714	SENT73	32	32	15	15	hydroxyurea	PUMA	PA449942	27113	0.883
NULL	Paediatr_Drugs_2014_Feb_27_16(3)_199-211.nxml.txt.nlp	24574047	SENT123	5	5	30	30	doxylamine	PLP	PA449419	25824;5744	0.883
NULL	Comput_Struct_Biotechnol_J_2013_Apr_5_5_e201302012.nxml.txt.nlp	24688705	SENT93	13	13	24	24	glucosamine	TLR4	PA164747613	7099	0.883
NULL	Mol_Cancer_2014_Jun_24_13_157.nxml.txt.nlp	24958351	SENT152	18	18	30	30	lapatinib	AKT	PA152241907	207	0.883
NULL	Eur_J_Epidemiol_2009_Sep_2_24(9)_553-572.nxml.txt.nlp	19728115	SENT1537	20	20	13	13	phenprocoumon	CYP2C9	PA450921	1559	0.883
NULL	Emerg_Infect_Dis_2011_Mar_17(3)_495-497.nxml.txt.nlp	21392442	SENT17	16	16	1	1	ethambutol	DST	PA164784021	667	0.883
NULL	Cancer_Res_Treat_2014_Jan_15_46(1)_81-92.nxml.txt.nlp	24520227	SENT183	8	8	4	4	paclitaxel	COX	PA450761	1351	0.883
NULL	Front_Neurosci_2014_Feb_14_8_23.nxml.txt.nlp	24592205	SENT165	12	12	41	41	capsaicin	TRPV1	PA448776	7442	0.883
NULL	Cancer_Cell_Int_2011_Nov_17_11_40.nxml.txt.nlp	22088142	SENT180	22	22	11	11	doxorubicin	EGFR	PA449412	1956	0.883
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT108	9	9	35	35	pp2	EGFR		1956	0.883
NULL	Oncol_Rep_2013_Apr_23_29(4)_1268-1274.nxml.txt.nlp	23354756	SENT10	19	19	4	4	epirubicin	SLC25A43	PA449476	203427	0.883
NULL	Daru_2012_Dec_23_20(1)_98.nxml.txt.nlp	23351237	SENT114	0	0	6	6	estradiol	spatial	PA449503	219793	0.883
NULL	Acta_Neuropathol_Commun_2014_May_30_2_57.nxml.txt.nlp	24887326	SENT34	20	20	15	15	vincristine	ABCB1	PA451879	5243	0.883
NULL	Clin_Med_Insights_Oncol_2012_Mar_19_6_165-178.nxml.txt.nlp	22474408	SENT43	15	15	30	30	fludarabine	TP53	PA449655	7157	0.883
NULL	Evid_Based_Complement_Alternat_Med_2012_Feb_12_2012_472897.nxml.txt.nlp	22454667	SENT184	0	0	11	11	cilomilast	PDE4B	PA165948031	5142	0.883
NULL	Biologics_2014_Nov_14_8_269-280.nxml.txt.nlp	25484574	SENT8	18	18	13	13	doxorubicin	SNF2	PA449412	6595;6597	0.883
NULL	Pharmaceuticals_(Basel)_2011_Oct_25_4(11)_1400-1422.nxml.txt.nlp	NULL	SENT76	9	9	21	21	hydroquinone	Hsp90	PA449924	3320	0.883
NULL	Int_J_Mol_Sci_2014_Jun_5_15(6)_10083-10100.nxml.txt.nlp	24905407	SENT78	11	11	7	7	estradiol	STP	PA449503	9322	0.883
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_11_2014_274786.nxml.txt.nlp	25505920	SENT241	23	23	17	17	oxaliplatin	ERCC1	PA131285527	2067	0.883
NULL	Acta_Pharmacol_Sin_2012_Jan_28_33(1)_75-81.nxml.txt.nlp	22120969	SENT147	30	30	5	5	exenatide	GLP-1	PA164749238	100125288	0.883
NULL	N_Am_J_Med_Sci_2011_Jan_3(1)_1-12.nxml.txt.nlp	22540056	SENT82	16	16	37	37	gemcitabine	CRT	PA449748	811	0.883
NULL	Oncotarget_2013_Aug_30_4(10)_1698-1711.nxml.txt.nlp	24091605	SENT180	5	5	7	7	hyaluronan	NANOG	PA165958431	79923	0.883
NULL	Osteoporos_Int_2007_Jan_15_18(1)_25-34.nxml.txt.nlp	17106785	SENT105	26	26	5	5	alendronate	PROC	PA448082	5624	0.883
NULL	Oncotarget_2014_Dec_4_5(22)_11365-11380.nxml.txt.nlp	25426548	SENT141	22	22	33	33	nutlin-3	p53		7157	0.883
NULL	Breast_Cancer_Res_2002_Sep_10_4(6)_218-221.nxml.txt.nlp	12473166	SENT84	20	20	39	39	tamoxifen	ATAC	PA451581	6375	0.883
NULL	Neuro_Oncol_2013_Sep_30_15(9)_1200-1211.nxml.txt.nlp	23723255	SENT43	30	30	0	0	streptomycin	U87	PA451512	677775;641648	0.883
NULL	Curr_Neuropharmacol_2014_Jul_12(4)_365-379.nxml.txt.nlp	25342944	SENT453	39	39	13	13	fluoxetine	5-HT2A	PA449673	3356	0.883
NULL	Behav_Brain_Funct_2009_Jun_4_5_23.nxml.txt.nlp	19497110	SENT135	22	22	28	28	ethanol	P90	PA448073	821	0.883
NULL	Exp_Ther_Med_2014_Nov_17_8(5)_1484-1488.nxml.txt.nlp	25289046	SENT3	25	25	19	19	cisplatin	ECRG2	PA449014	84651	0.883
NULL	Nucleic_Acids_Res_2013_Apr_17_41(7)_4129-4143.nxml.txt.nlp	23420868	SENT282	26	26	6	6	hemin	SHP2	PA449849	5781	0.883
NULL	Diabetes_2013_Sep_15_62(9)_3232-3240.nxml.txt.nlp	23835329	SENT160	24	24	2	2	olanzapine	GLP-1	PA450688	100125288	0.883
NULL	Osteoporos_Int_2011_Jan_1_22(1)_27-35.nxml.txt.nlp	20358360	SENT74	38	38	29	29	exemestane	aromatase	PA449563	1588	0.883
NULL	Diabetologia_2010_Jun_27_53(6)_1142-1150.nxml.txt.nlp	20349036	SENT24	6	6	21	21	spermine	AMPK	PA164781199	5563	0.883
NULL	Anal_Chem_2014_Feb_18_86(4)_1988-1996.nxml.txt.nlp	24446580	SENT97	29	29	15	15	trypsin	PPG	PA451806	5552	0.883
NULL	Exp_Ther_Med_2014_Oct_31_8(4)_1185-1190.nxml.txt.nlp	25187821	SENT123	6	6	11	11	mannitol	GLP-1	PA450320	100125288	0.883
NULL	Oncotarget_2014_Jun_3_5(13)_4920-4928.nxml.txt.nlp	24952482	SENT132	7	7	25	25	crizotinib	ALK	PA165946122	238	0.883
NULL	Br_J_Cancer_2012_Nov_20_107(11)_1853-1863.nxml.txt.nlp	23169338	SENT202	16	16	35	35	cisplatin	DNAJB11	PA449014	51726	0.883
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_11_2014_274786.nxml.txt.nlp	25505920	SENT164	35	35	26	26	oxaliplatin	ERCC1	PA131285527	2067	0.883
NULL	Pharmaceuticals_(Basel)_2013_Aug_21_6(8)_988-1038.nxml.txt.nlp	24276379	SENT250	0	0	7	7	sn-38	UGT1A		7361;54658	0.883
NULL	eLife_2013_Nov_5_2_e00969.nxml.txt.nlp	24192036	SENT165	11	11	4	4	vemurafenib	MAP2K4	PA165946873	6416	0.883
NULL	Nat_Commun_2013_Sep_20_4_2444.nxml.txt.nlp	24051492	SENT370	40	40	6	6	nutlin-3	PER2		8864	0.883
NULL	BioDrugs_2014_Aug_18_28(1)_27-39.nxml.txt.nlp	23955284	SENT415	17	17	9	9	docetaxel	survivin	PA449383	332	0.883
NULL	Mol_Cancer_2009_Mar_20_8_21.nxml.txt.nlp	19298677	SENT91	4	4	13	13	curcumin	EGFR	PA151958596	1956	0.883
NULL	Br_J_Cancer_2013_Jul_9_109(1)_68-75.nxml.txt.nlp	23807173	SENT185	28	28	21	21	cisplatin	ERCC1	PA449014	2067	0.883
NULL	Oncotarget_2013_Nov_15_5(6)_1458-1474.nxml.txt.nlp	24681547	SENT248	5	5	10	10	celecoxib	CDH11	PA448871	1009	0.883
NULL	Nat_Med_2011_May_1_17(5)_604-609.nxml.txt.nlp	21532597	SENT228	37	37	6	6	daclizumab	IL-2	PA164764446	3558	0.883
NULL	Arthritis_Res_Ther_2010_May_28_12(3)_R105.nxml.txt.nlp	20509880	SENT183	16	16	12	12	celecoxib	p38	PA448871	10598;1432;7965	0.883
NULL	Int_J_Mol_Sci_2014_Oct_20_15(10)_18919-18940.nxml.txt.nlp	25334063	SENT366	1	1	24	24	curcumin	JNK	PA151958596	5599	0.883
NULL	Biochim_Biophys_Acta_2014_Jul_1842(7)_959-970.nxml.txt.nlp	24594481	SENT24	1	1	8	8	lipase	FGF21	PA450239	26291	0.883
NULL	Oncoimmunology_2013_Oct_1_2(10)_e27025.nxml.txt.nlp	24353914	SENT173	12	12	19	19	cisplatin	CD4	PA449014	920	0.883
NULL	Br_J_Cancer_2013_Dec_10_109(12)_3067-3072.nxml.txt.nlp	24263065	SENT38	25	25	12	12	cetuximab	BRAF	PA10040	673	0.883
NULL	Breast_Cancer_Res_2011_Jan_17_13(1)_R5.nxml.txt.nlp	21241485	SENT216	9	9	33	33	tamoxifen	Brn-3b	PA451581	5458	0.883
NULL	Biomed_Res_Int_2014_Jun_29_2014_974309.nxml.txt.nlp	25093192	SENT113	10	10	36	36	bortezomib	GAPDH	PA10252	2597	0.883
NULL	Oncogene_2009_Jan_15_28(2)_157-169.nxml.txt.nlp	18931700	SENT16	26	26	12	12	trastuzumab	BRAF	PA451743	673	0.883
NULL	Hum_Genomics_Proteomics_2010_Apr_13_2010_164906.nxml.txt.nlp	20981232	SENT250	11	11	4	4	thrombin	Rho	PA451674	29984	0.883
NULL	Cancer_Metab_2013_Dec_23_1_23.nxml.txt.nlp	24359630	SENT164	12	12	17	17	glucose	CO2	PA449773	4513	0.883
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2014_Jun_29_70(Pt_7)_1922-1933.nxml.txt.nlp	25004969	SENT186	24	24	27	27	cycloserine	PLP	PA164764600	25824;5744	0.883
NULL	Cardiovasc_Ther_2009_27(4)_259-274.nxml.txt.nlp	19604248	SENT49	0	0	37	37	ticagrelor	ADP	PA165374673	23038	0.883
NULL	J_Cell_Biol_2000_Dec_11_151(6)_1295-1304.nxml.txt.nlp	11121443	SENT445	16	16	0	0	creatine	p53	PA164778930	7157	0.883
NULL	J_Cancer_2014_Jul_4_5(7)_559-571.nxml.txt.nlp	25057307	SENT230	14	14	18	18	tamoxifen	CD44	PA451581	960	0.883
NULL	Mol_Cancer_2010_Aug_4_9_208.nxml.txt.nlp	20684776	SENT104	17	17	7	7	doxorubicin	p53	PA449412	7157	0.883
NULL	Clin_Interv_Aging_2012_Dec_30_7_1-13.nxml.txt.nlp	22291468	SENT268	18	18	11	11	carbamazepine	CYP3A4	PA448785	1576	0.883
NULL	Mol_Pain_2013_Nov_27_9_59.nxml.txt.nlp	24279796	SENT236	39	39	15	15	isoflurane	STZ	PA450106	6484	0.883
NULL	Case_Rep_Oncol_Med_2012_Sep_11_2012_726424.nxml.txt.nlp	22997596	SENT11	27	27	29	29	rituximab	CHOP	PA451261	1649	0.883
NULL	Diabetes_Care_2013_Jul_12_36(7)_2126-2132.nxml.txt.nlp	23645884	SENT48	26	26	28	28	exenatide	GLP-1	PA164749238	100125288	0.883
NULL	Mol_Vis_2014_May_2_20_616-628.nxml.txt.nlp	24826069	SENT139	7	7	13	13	fluorescein	CD11b	PA164746009	3684	0.883
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT17	0	0	7	7	lapatinib	EGFR	PA152241907	1956	0.883
NULL	Ther_Clin_Risk_Manag_2006_Dec_2(4)_337-346.nxml.txt.nlp	18360646	SENT196	10	10	21	21	brimonidine	BAK	PA448665	578	0.883
NULL	Clin_Interv_Aging_2012_Sep_17_7_363-372.nxml.txt.nlp	23049248	SENT57	20	20	9	9	denosumab	RANKL	PA166048634	8600	0.883
NULL	Arthritis_Res_Ther_2006_Nov_1_8(6)_R166.nxml.txt.nlp	17078892	SENT373	6	6	22	22	etanercept	CD4	PA449515	920	0.883
NULL	Clin_Med_Insights_Womens_Health_2013_Jan_22_6_1-11.nxml.txt.nlp	24665209	SENT213	32	32	23	23	tamoxifen	aromatase	PA451581	1588	0.883
NULL	EPMA_J_2010_Jun_29_1(2)_293-303.nxml.txt.nlp	21124753	SENT352	14	14	4	4	donepezil	CYP2D6	PA449394	1565	0.883
NULL	J_Oncol_2009_Jun_22_2009_849051.nxml.txt.nlp	19584908	SENT71	24	24	5	5	cetuximab	EGFR	PA10040	1956	0.883
NULL	Nanoscale_Res_Lett_2012_Jan_5_7(1)_5.nxml.txt.nlp	22221320	SENT42	27	27	2	2	ethanol	ITO	PA448073	3160	0.883
NULL	Diabetes_2013_Oct_17_62(10)_3500-3513.nxml.txt.nlp	23884882	SENT204	2	2	26	26	resveratrol	FOXO1		2308	0.883
NULL	Br_J_Cancer_2012_Sep_4_107(6)_947-955.nxml.txt.nlp	22892392	SENT175	31	31	28	28	lapatinib	ERBB2	PA152241907	2064	0.883
NULL	Patient_Prefer_Adherence_2008_Feb_2_2_387-392.nxml.txt.nlp	19920986	SENT20	2	2	11	11	methotrexate	gamma	PA450428	9913	0.883
NULL	Cardiol_Res_Pract_2013_Jan_31_2013_128795.nxml.txt.nlp	23431496	SENT154	44	44	20	20	clopidogrel	CYP2C19	PA449053	1557	0.883
NULL	Mol_Cancer_2014_Aug_22_13(1)_195.nxml.txt.nlp	NULL	SENT100	15	15	7	7	cisplatin	TBL1XR1	PA449014	79718	0.883
NULL	Front_Behav_Neurosci_2014_Dec_16_8_437.nxml.txt.nlp	25566005	SENT149	34	34	1	1	menthol	ANOVA	PA164776605	4858	0.883
NULL	Biomed_Res_Int_2014_Jun_25_2014_539151.nxml.txt.nlp	25057494	SENT116	0	0	12	12	warfarin	VKORC1	PA451906	79001	0.883
NULL	Breast_Cancer_Res_2007_Aug_8_9(4)_R50.nxml.txt.nlp	17686159	SENT202	4	4	22	22	gefitinib	HRG	PA131301952	3084;3273	0.883
NULL	Front_Hum_Neurosci_2013_Apr_9_7_136.nxml.txt.nlp	23576977	SENT33	29	29	21	21	propofol	gamma	PA451141	9913	0.883
NULL	Br_J_Cancer_2012_May_8_106(10)_1587-1590.nxml.txt.nlp	22568998	SENT79	15	15	18	18	sunitinib	IFN	PA162372840	3439	0.883
NULL	Comp_Hepatol_2005_Feb_8_4_2.nxml.txt.nlp	15701172	SENT259	7	7	18	18	ketoconazole	CYP3A4	PA450146	1576	0.883
NULL	Cancer_Cell_Int_2009_Sep_10_9_25.nxml.txt.nlp	19744341	SENT154	23	23	4	4	glucosamine	PC-3	PA164747613	692094	0.883
NULL	Oncogene_2010_Jul_8_29(27)_3896-3907.nxml.txt.nlp	20453888	SENT336	3	3	25	25	trastuzumab	p27	PA451743	5715;10534	0.883
NULL	Biomed_Res_Int_2013_Aug_7_2013_546318.nxml.txt.nlp	23986907	SENT97	6	6	0	0	cetuximab	KRAS	PA10040	3845	0.883
NULL	Front_Neurosci_2013_Jan_31_7_3.nxml.txt.nlp	23386808	SENT15	21	21	17	17	capsaicin	TRPV1	PA448776	7442	0.883
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT29	30	30	18	18	celecoxib	survivin	PA448871	332	0.883
NULL	Breast_Cancer_Res_Treat_2013_May_12_139(1)_107-113.nxml.txt.nlp	23580070	SENT5	14	14	8	8	trastuzumab	HER2	PA451743	2064	0.883
NULL	Acta_Pharmacol_Sin_2014_Aug_30_35(8)_1045-1054.nxml.txt.nlp	24976155	SENT5	34	34	39	39	resveratrol	SIRT1		23411	0.883
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT198	18	18	32	32	tacrolimus	IL-6	PA451578	3569	0.883
NULL	Oncotarget_2014_Aug_16_5(18)_8637-8650.nxml.txt.nlp	25226617	SENT114	9	9	5	5	dasatinib	JAK2	PA162372878	3717	0.883
NULL	Antonie_Van_Leeuwenhoek_2013_Jul_26_104(5)_703-714.nxml.txt.nlp	23887884	SENT28	18	18	23	23	ethanol	CO2	PA448073	4513	0.883
NULL	Eur_J_Endocrinol_2011_Jan_164(1)_69-74.nxml.txt.nlp	20961967	SENT101	2	2	7	7	pioglitazone	adiponectin	PA450970	9370	0.883
NULL	EMBO_Mol_Med_2010_May_2(5)_172-187.nxml.txt.nlp	20432503	SENT125	30	30	7	7	indomethacin	CD14	PA449982	929	0.883
NULL	Mol_Cancer_2007_Jan_14_6_5.nxml.txt.nlp	17222355	SENT43	41	41	11	11	hydrocortisone	F12	PA449905	2161	0.883
NULL	J_Cell_Biol_2001_Apr_16_153(2)_367-380.nxml.txt.nlp	11309417	SENT805	11	11	3	3	fluorescein	BLM	PA164746009	641	0.883
NULL	Arch_Gynecol_Obstet_2009_Oct_31_280(4)_529-538.nxml.txt.nlp	19644696	SENT123	27	27	10	10	estradiol	TIAR	PA449503	7073	0.883
NULL	ISRN_Obes_2012_Nov_18_2012_437198.nxml.txt.nlp	24527263	SENT150	22	22	7	7	nadh	NPAS2	PA164755085	4862	0.883
NULL	Acta_Pharmacol_Sin_2012_Apr_12_33(4)_542-550.nxml.txt.nlp	22407228	SENT102	9	9	17	17	perifosine	JNK	PA165291471	5599	0.883
NULL	Cancer_Cell_Int_2011_Nov_17_11_40.nxml.txt.nlp	22088142	SENT84	6	6	10	10	gemcitabine	MRP2	PA449748	100130958;57626;1244	0.883
NULL	Breast_Cancer_Res_2005_May_24_7(5)_R589-R597.nxml.txt.nlp	16168102	SENT112	37	37	12	12	doxorubicin	FAK	PA449412	5747	0.883
NULL	Breast_Cancer_Res_2011_Apr_15_13(2)_R44.nxml.txt.nlp	21496232	SENT37	36	36	6	6	trastuzumab	HER2	PA451743	2064	0.883
NULL	Indian_J_Endocrinol_Metab_2011_Jan-Mar_15(1)_9-17.nxml.txt.nlp	21584160	SENT185	5	5	8	8	liraglutide	GLP-1	PA165958364	100125288	0.883
NULL	Indian_J_Med_Res_2012_Sep_136(3)_391-403.nxml.txt.nlp	23041732	SENT168	16	16	45	45	doxorubicin	HCC	PA449412	84668	0.883
NULL	J_Antimicrob_Chemother_2014_Mar_13_69(3)_651-663.nxml.txt.nlp	24235095	SENT21	20	20	13	13	pentamidine	AQP2	PA450850	359	0.883
NULL	Breast_Cancer_Res_2006_Nov_6_8(6)_215.nxml.txt.nlp	17096862	SENT106	8	8	29	29	lapatinib	survivin	PA152241907	332	0.883
NULL	Oncogenesis_2012_Apr_2_1(4)_e5.nxml.txt.nlp	23552603	SENT241	21	21	29	29	celecoxib	Bcl-2	PA448871	596	0.883
NULL	Acta_Pharmacol_Sin_2013_Mar_11_34(3)_403-413.nxml.txt.nlp	23396374	SENT47	19	19	6	6	triciribine	p38	PA165958661	10598;1432;7965	0.883
NULL	Cell_Death_Dis_2013_Oct_3_4(10)_e828.nxml.txt.nlp	24091671	SENT269	8	8	2	2	cetuximab	CD54	PA10040	3383	0.883
NULL	Oncotarget_2013_Nov_24_4(12)_2186-2207.nxml.txt.nlp	24327604	SENT121	40	40	43	43	doxorubicin	P-gp	PA449412	5243	0.883
NULL	Clin_Med_Oncol_2008_Jun_11_2_469-470.nxml.txt.nlp	21892319	SENT5	13	13	25	25	trastuzumab	HER-2	PA451743	2064	0.883
NULL	Breast_Cancer_Res_2011_Jun_29_13(3)_R70.nxml.txt.nlp	21707964	SENT121	2	2	38	38	tamoxifen	14-3-3	PA451581	10971	0.883
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Jul_31_64(Pt_8)_o1626.nxml.txt.nlp	21203316	SENT56	27	27	7	7	ethanol	mol	PA448073	90527	0.883
NULL	Nat_Commun_2013_Apr_23_4_1758.nxml.txt.nlp	23612299	SENT34	9	9	6	6	isoproterenol	SOD1	PA450121	6647	0.883
NULL	Oncol_Lett_2013_Dec_4_6(6)_1665-1672.nxml.txt.nlp	24273604	SENT9	9	9	27	27	chloroquine	TLR9	PA448948	54106	0.883
NULL	Acta_Pharmacol_Sin_2012_May_16_33(5)_682-690.nxml.txt.nlp	22504904	SENT172	22	22	29	29	celecoxib	STAT3	PA448871	6774	0.883
NULL	Nat_Commun_2013_Aug_15_4_2130.nxml.txt.nlp	23945651	SENT224	23	23	27	27	etoposide	ATG5	PA449552	9474	0.883
NULL	J_Hematol_Oncol_2010_Sep_9_3_31.nxml.txt.nlp	20828403	SENT42	0	0	6	6	trastuzumab	HER2	PA451743	2064	0.883
NULL	Breast_Cancer_Res_2011_Mar_14_13(2)_205.nxml.txt.nlp	21457526	SENT44	13	13	10	10	tamoxifen	aromatase	PA451581	1588	0.883
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R91.nxml.txt.nlp	22541814	SENT187	24	24	19	19	thrombin	PP2	PA451674	4888	0.883
NULL	Front_Oncol_2014_Apr_9_4_75.nxml.txt.nlp	24782986	SENT178	15	15	22	22	paclitaxel	CA125	PA450761	4077;94025	0.883
NULL	Crit_Care_2010_Oct_13_14(5)_R181.nxml.txt.nlp	20942931	SENT235	26	26	11	11	furosemide	IL-6	PA449719	3569	0.883
NULL	Biomed_Res_Int_2013_Sep_4_2013_185362.nxml.txt.nlp	24093091	SENT150	4	4	8	8	rituximab	CHOP	PA451261	1649	0.883
NULL	Core_Evid_2011_Mar_17_6_31-42.nxml.txt.nlp	21468241	SENT23	0	0	9	9	ticagrelor	P2Y12	PA165374673	64805	0.883
NULL	EJNMMI_Res_2011_Jul_29_1_12.nxml.txt.nlp	22214199	SENT23	5	5	18	18	loperamide	P-gp	PA450262	5243	0.883
NULL	Nat_Commun_2014_Dec_8_5_5736.nxml.txt.nlp	25484020	SENT662	5	5	18	18	letrozole	TRPA1	PA450196	8989	0.883
NULL	Nat_Genet_2013_Oct_5_45(10)_1141-1149.nxml.txt.nlp	23917401	SENT341	25	25	17	17	erlotinib	EGFR	PA134687924	1956	0.883
NULL	Arthritis_Res_Ther_2009_Jan_30_11(1)_206.nxml.txt.nlp	19232066	SENT171	0	0	13	13	abatacept	CD28	PA164747080	1493;940	0.883
NULL	Br_J_Cancer_2014_Oct_14_111(8)_1476-1481.nxml.txt.nlp	25211660	SENT135	3	3	13	13	vismodegib	SUFU		51684	0.883
NULL	J_Cell_Mol_Med_2014_Mar_10_18(3)_514-529.nxml.txt.nlp	24410795	SENT301	29	29	31	31	resveratrol	SIRT1		23411	0.883
NULL	FEBS_Open_Bio_2014_May_2_4_450-457.nxml.txt.nlp	24918060	SENT120	24	24	5	5	sulfasalazine	RAC3	PA451547	5881;8202	0.883
NULL	Br_J_Cancer_2012_Jun_5_106(12)_1997-2003.nxml.txt.nlp	22596232	SENT94	9	9	11	11	sorafenib	JNK	PA7000	5599	0.883
NULL	Acta_Pharmacol_Sin_2012_Jan_3_33(1)_49-56.nxml.txt.nlp	22212430	SENT90	41	41	16	16	thrombin	A10	PA451674	28870	0.883
NULL	Br_J_Cancer_2010_Oct_12_103(8)_1182-1191.nxml.txt.nlp	20842125	SENT190	3	3	14	14	indomethacin	COX	PA449982	1351	0.883
NULL	Biologics_2009_Sep_15_3_419-428.nxml.txt.nlp	19774209	SENT170	39	39	20	20	cetuximab	PTEN	PA10040	5728	0.883
NULL	Oncol_Lett_2014_Jul_25_8(1)_62-66.nxml.txt.nlp	24959219	SENT20	7	7	22	22	cyclophosphamide	CHOP	PA449165	1649	0.883
NULL	Eur_J_Epidemiol_2009_Sep_2_24(9)_553-572.nxml.txt.nlp	19728115	SENT1536	19	19	10	10	acenocoumarol	CYP2C9	PA452632	1559	0.883
NULL	Mol_Biol_Cell_2013_Jul_15_24(14)_2186-2200.nxml.txt.nlp	23699397	SENT90	23	23	7	7	doxorubicin	TRAIL	PA449412	8743	0.883
NULL	Diabetes_2013_Oct_17_62(10)_3547-3552.nxml.txt.nlp	23863812	SENT8	13	13	17	17	valsartan	adiponectin	PA451848	9370	0.883
NULL	Acta_Pharmacol_Sin_2012_Jul_18_33(7)_861-872.nxml.txt.nlp	22705730	SENT247	8	8	14	14	atorvastatin	PDK1	PA448500	5170;5163	0.883
NULL	Exp_Diabetes_Res_2012_Oct_15_2012_465282.nxml.txt.nlp	23118742	SENT28	5	5	19	19	metformin	FGF21	PA450395	26291	0.883
NULL	Drugs_2014_Jul_18_74(11)_1209-1231.nxml.txt.nlp	25034361	SENT172	14	14	11	11	verapamil	P-gp	PA451868	5243	0.883
NULL	Anat_Cell_Biol_2011_Sep_29_44(3)_169-175.nxml.txt.nlp	22025968	SENT59	29	29	0	0	ethanol	CLU	PA448073	1191	0.883
NULL	Mol_Cancer_2009_Dec_23_8_129.nxml.txt.nlp	20030852	SENT157	7	7	14	14	curcumin	CXCL1	PA151958596	2919	0.883
NULL	Mol_Immunol_2009_Apr_46(7)_1424-1431.nxml.txt.nlp	19185921	SENT416	33	33	2	2	nitrogen	CDR1	PA450643	1038	0.883
NULL	Cancer_Immunol_Immunother_2012_Oct_8_61(10)_1713-1720.nxml.txt.nlp	22399057	SENT6	41	41	29	29	plerixafor	CXCR4	PA165958410	7852	0.883
NULL	Arthritis_Res_Ther_2014_Apr_11_16(2)_R93.nxml.txt.nlp	24725461	SENT136	18	18	27	27	fluorescein	aromatase	PA164746009	1588	0.883
NULL	Oncogenesis_2012_Apr_2_1(4)_e5.nxml.txt.nlp	23552603	SENT241	23	23	29	29	ns-398	Bcl-2		596	0.883
NULL	Lipids_Health_Dis_2011_Feb_23_10_36.nxml.txt.nlp	21345233	SENT56	9	9	32	32	hesperetin	EIF3H	PA164742902	8667	0.883
NULL	Clin_Dev_Immunol_2013_Sep_22_2013_317682.nxml.txt.nlp	24171032	SENT9	12	12	2	2	hyaluronan	IL-6	PA165958431	3569	0.883
NULL	Evid_Based_Complement_Alternat_Med_2004_Sep_1(2)_207-209.nxml.txt.nlp	15480447	SENT43	7	7	29	29	cisplatin	HER-2	PA449014	2064	0.883
NULL	Cancer_Res_Treat_2014_Jan_15_46(1)_48-54.nxml.txt.nlp	24520223	SENT136	14	14	4	4	bevacizumab	KRAS	PA130232992	3845	0.883
NULL	Indian_J_Pharm_Sci_2012_Nov-Dec_74(6)_592-596.nxml.txt.nlp	23798790	SENT108	16	16	7	7	ivermectin	mol	PA450133	90527	0.883
NULL	Arthritis_Res_Ther_2010_May_5_12(3)_R75.nxml.txt.nlp	20444266	SENT106	24	24	33	33	methotrexate	HLA-DRB1	PA450428	3123	0.883
NULL	Arthritis_Res_Ther_2014_May_29_16(3)_R118.nxml.txt.nlp	24887143	SENT70	23	23	10	10	mitomycin	CD4	PA450524	920	0.883
NULL	Int_J_Med_Sci_2014_Sep_6_11(11)_1185-1200.nxml.txt.nlp	25249787	SENT147	11	11	0	0	liraglutide	GLP-1	PA165958364	100125288	0.883
NULL	Cancer_Cell_Int_2013_Sep_23_13_94.nxml.txt.nlp	24059699	SENT104	29	29	10	10	bevacizumab	NRP1	PA130232992	8829	0.883
NULL	Arch_Drug_Inf_2008_Sep_1(2)_50-55.nxml.txt.nlp	19915714	SENT57	0	0	25	25	fentanyl	API	PA449599	5345	0.883
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT147	12	12	23	23	trastuzumab	AKT	PA451743	207	0.883
NULL	Breast_Cancer_Res_2004_Mar_26_6(3)_R252-R263.nxml.txt.nlp	15084249	SENT26	3	3	13	13	tamoxifen	FMO1	PA451581	2326	0.883
NULL	Arch_Virol_2014_Jul_16_159(1)_29-37.nxml.txt.nlp	23857507	SENT195	26	26	19	19	lamivudine	LAM	PA450163	7249;7248	0.883
NULL	J_Korean_Med_Sci_1998_Dec_13(6)_685-688.nxml.txt.nlp	9886182	SENT13	22	22	27	27	paclitaxel	GM-CSF	PA450761	1437	0.883
NULL	Leukemia_2014_Mar_20_28(3)_554-565.nxml.txt.nlp	24280866	SENT142	0	0	6	6	imatinib	BCL2	PA10804	596	0.883
NULL	Cent_European_J_Urol_2013_Aug_13_66(2)_144-149.nxml.txt.nlp	24579014	SENT41	21	21	34	34	doxorubicin	survivin	PA449412	332	0.883
NULL	Mol_Cancer_2010_Aug_23_9_222.nxml.txt.nlp	20731837	SENT79	22	22	29	29	gefitinib	ATM	PA131301952	472	0.883
NULL	Cell_Tissue_Res_2013_May_18_352(2)_191-198.nxml.txt.nlp	23329124	SENT43	0	0	13	13	methotrexate	IL-11	PA450428	3589	0.883
NULL	Breast_Cancer_Res_2005_Jul_20_7(5)_205-211.nxml.txt.nlp	16168139	SENT110	28	28	2	2	tamoxifen	aromatase	PA451581	1588	0.883
NULL	Oncogene_2013_Sep_26_32(39)_10_1038_onc_2012_491.nxml.txt.nlp	23108394	SENT123	42	42	4	4	epirubicin	FOXM1	PA449476	2305	0.883
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_16_2013_146142.nxml.txt.nlp	23843863	SENT13	15	15	40	40	ns-398	SAA1		6288	0.883
NULL	Pharmaceuticals_(Basel)_2014_Apr_10_7(4)_433-452.nxml.txt.nlp	24727459	SENT42	6	6	19	19	quinidine	P-gp	PA451209	5243	0.883
NULL	J_Allergy_(Cairo)_2011_Oct_24_2011_457169.nxml.txt.nlp	22121382	SENT220	13	13	24	24	salmeterol	IL-8	PA451300	3576	0.883
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2010_Aug_3_3_43-51.nxml.txt.nlp	22879786	SENT84	16	16	22	22	pioglitazone	CYP2C8	PA450970	1558	0.883
NULL	Cell_Death_Dis_2014_Jul_10_5(7)_e1318.nxml.txt.nlp	25010984	SENT9	22	22	12	12	nutlin-3	RITA		55422;84934	0.883
NULL	Clin_Med_Insights_Arthritis_Musculoskelet_Disord_2012_Jan_5_5_1-14.nxml.txt.nlp	22267947	SENT122	33	33	30	30	risedronate	HIP	PA451255	6767;6159;64399;5068	0.883
NULL	Oncol_Rep_2013_Apr_23_29(4)_1268-1274.nxml.txt.nlp	23354756	SENT148	20	20	6	6	trastuzumab	SLC25A43	PA451743	203427	0.883
NULL	Case_Rep_Oncol_Med_2013_Jul_30_2013_496351.nxml.txt.nlp	23984138	SENT19	0	0	8	8	denosumab	RANKL	PA166048634	8600	0.883
NULL	Ann_Oncol_2014_Oct_18_25(10)_1871-1888.nxml.txt.nlp	25234545	SENT323	3	3	14	14	everolimus	aromatase	PA164746311	1588	0.883
NULL	J_Hematol_Oncol_2013_Jan_17_6_8.nxml.txt.nlp	23327547	SENT84	15	15	5	5	sulindac	JNK1	PA451565	5599	0.883
NULL	Iran_J_Pharm_Res_2013_Summer_12(3)_457-469.nxml.txt.nlp	24250652	SENT13	20	20	13	13	indomethacin	spatial	PA449982	219793	0.883
NULL	Acta_Pharmacol_Sin_2011_Mar_31_32(3)_393-398.nxml.txt.nlp	21278781	SENT3	21	21	14	14	cisplatin	ALKBH2	PA449014	121642	0.883
NULL	Reprod_Biol_Endocrinol_2013_Jun_19_11_53.nxml.txt.nlp	23782518	SENT72	5	5	27	27	paclitaxel	ABCG2	PA450761	9429	0.883
NULL	Braz_J_Med_Biol_Res_2014_Oct_14_47(12)_1068-1074.nxml.txt.nlp	25387674	SENT98	28	28	2	2	taurine	HCS	PA451590	3141;54205	0.883
NULL	EMBO_J_2010_Aug_18_29(16)_2772-2787.nxml.txt.nlp	20664520	SENT322	28	28	18	18	forskolin	RXFP1	PA146096022	59350	0.883
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT207	11	11	21	21	perifosine	DR4	PA165291471	8797	0.883
NULL	J_Korean_Med_Sci_2014_Jul_11_29(7)_965-972.nxml.txt.nlp	25045229	SENT119	24	24	12	12	metformin	B12	PA450395	7126;4709	0.883
NULL	Acta_Pharmacol_Sin_2012_May_26_33(5)_652-659.nxml.txt.nlp	22447224	SENT36	5	5	18	18	ethanol	adiponectin	PA448073	9370	0.883
NULL	J_Young_Pharm_2011_Oct-Dec_3(4)_259-266.nxml.txt.nlp	22224031	SENT143	37	37	1	1	cephalexin	ANOVA	PA448883	4858	0.883
NULL	Eur_J_Clin_Pharmacol_2011_May_8_67(5)_493-506.nxml.txt.nlp	21140139	SENT249	11	11	4	4	oxycodone	CYP3A4	PA450741	1576	0.883
NULL	Cancer_Immunol_Immunother_2011_Jan_21_60(1)_75-85.nxml.txt.nlp	20857100	SENT162	23	23	39	39	fludarabine	IL-2	PA449655	3558	0.883
NULL	Cardiovasc_Res_2012_Mar_15_93(4)_674-681.nxml.txt.nlp	22166712	SENT72	24	24	11	11	ketoconazole	CYP3A4	PA450146	1576	0.883
NULL	Genetics_2013_Jan_193(1)_1-50.nxml.txt.nlp	23275493	SENT260	33	33	24	24	choline	DAG	PA448976	1605	0.883
NULL	Cancer_Cell_Int_2006_Aug_9_6_20.nxml.txt.nlp	16899133	SENT141	16	16	36	36	triciribine	p27	PA165958661	5715;10534	0.883
NULL	Br_J_Cancer_2012_Jan_3_106(1)_18-24.nxml.txt.nlp	22108516	SENT131	18	18	36	36	irinotecan	TDP1	PA450085	55775	0.883
NULL	Front_Cell_Neurosci_2014_Jul_28_8_209.nxml.txt.nlp	25120433	SENT988	11	11	0	0	quinidine	KCNT1	PA451209	57582	0.883
NULL	J_Mammary_Gland_Biol_Neoplasia_2010_Mar_27_15(1)_5-17.nxml.txt.nlp	20101446	SENT179	17	17	0	0	tamoxifen	HuR	PA451581	1994	0.883
NULL	Nucleic_Acids_Res_2005_Jun_8_33(10)_3283-3291.nxml.txt.nlp	15944449	SENT114	22	22	13	13	melphalan	ERCC1	PA450354	2067	0.883
NULL	Oncotarget_2013_Nov_24_4(12)_2186-2207.nxml.txt.nlp	24327604	SENT286	22	22	7	7	bortezomib	CD138	PA10252	6382	0.883
NULL	J_Exerc_Rehabil_2014_Apr_30_10(2)_60-68.nxml.txt.nlp	24877039	SENT24	12	12	22	22	candesartan	adiponectin	PA448765	9370	0.883
NULL	Breast_Cancer_Res_2004_May_7_6(4)_R352-R365.nxml.txt.nlp	15217502	SENT174	11	11	0	0	estradiol	CYP1A2	PA449503	1544	0.883
NULL	Curr_Opin_Genet_Dev_2014_Feb_24(100)_114-119.nxml.txt.nlp	24607840	SENT188	15	15	25	25	afatinib	EGFR	PA165981154	1956	0.883
NULL	Oxid_Med_Cell_Longev_2014_Apr_30_2014_149627.nxml.txt.nlp	24876909	SENT222	10	10	8	8	geldanamycin	Hsp90	PA152031327	3320	0.883
NULL	Cell_Commun_Signal_2014_Sep_25_12(1)_61.nxml.txt.nlp	NULL	SENT166	15	15	3	3	doxycycline	PC-3	PA449415	692094	0.883
NULL	Mol_Cancer_2008_Jun_3_7_47.nxml.txt.nlp	18519000	SENT180	17	17	9	9	gefitinib	EGFR	PA131301952	1956	0.883
NULL	Indian_J_Med_Res_2014_Jan_139(1)_117-124.nxml.txt.nlp	24604047	SENT160	24	24	27	27	fluvastatin	PI3K	PA449688	5290	0.883
NULL	J_Mol_Med_2008_Sep_4_86(9)_1045-1056.nxml.txt.nlp	18600309	SENT266	7	7	32	32	curcumin	p38	PA151958596	10598;1432;7965	0.883
NULL	Drugs_R_D_2010_Sep_27_10(3)_203-210.nxml.txt.nlp	20945949	SENT142	11	11	41	41	ribavirin	RVR	PA451241	9975	0.883
NULL	J_Cardiothorac_Surg_2012_Sep_27_7_97.nxml.txt.nlp	23013706	SENT163	29	29	16	16	warfarin	VKORC1	PA451906	79001	0.883
NULL	J_Invest_Dermatol_2012_Nov_14_132(11)_2601-2609.nxml.txt.nlp	22696056	SENT60	22	22	2	2	phenol	IRE1	PA450913	2081	0.883
NULL	Biomed_Res_Int_2014_May_18_2014_690103.nxml.txt.nlp	24949464	SENT133	34	34	8	8	cisplatin	PRKCD	PA449014	5580	0.882
NULL	Braz_J_Med_Biol_Res_2011_Dec_9_45(1)_13-19.nxml.txt.nlp	22147192	SENT56	38	38	5	5	paraformaldehyde	P28	PA450790	9446;7802;9527	0.882
NULL	Mar_Drugs_2014_Jun_27_12(7)_3818-3837.nxml.txt.nlp	24979269	SENT34	15	15	7	7	calcein	P-gp	PA132595336	5243	0.882
NULL	Mol_Cancer_2012_Mar_21_11_13.nxml.txt.nlp	22436134	SENT117	19	19	9	9	doxorubicin	CTRL	PA449412	1506	0.882
NULL	Ther_Clin_Risk_Manag_2006_Dec_2(4)_365-375.nxml.txt.nlp	18360649	SENT114	12	12	14	14	methotrexate	ACR	PA450428	49	0.882
NULL	Oncol_Lett_2014_Mar_16_7(3)_827-833.nxml.txt.nlp	24527090	SENT79	31	31	24	24	cisplatin	IFN	PA449014	3439	0.882
NULL	Front_Oncol_2014_Jun_18_4_153.nxml.txt.nlp	24995158	SENT175	4	4	12	12	doxorubicin	AP-1	PA449412	2353;3727;2354;3725	0.882
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT161	7	7	18	18	dasatinib	CSK	PA162372878	1445	0.882
NULL	Oncotarget_2012_Dec_30_3(12)_1505-1521.nxml.txt.nlp	23455493	SENT318	13	13	3	3	doxorubicin	NGAL	PA449412	3934	0.882
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT29	30	30	35	35	celecoxib	IL-6	PA448871	3569	0.882
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT163	14	14	4	4	doxorubicin	SLK	PA449412	9748;2534	0.882
NULL	Arthritis_Res_Ther_2013_Nov_29_15(6)_221.nxml.txt.nlp	24289848	SENT139	4	4	13	13	ginseng	Q10	PA164781150	27161	0.882
NULL	Br_J_Cancer_2009_Jul_21_101(2)_312-319.nxml.txt.nlp	19568237	SENT108	23	23	21	21	pp2	PP1		5540;5464	0.882
NULL	Exp_Lung_Res_2013_Oct_1_39(8)_336-348.nxml.txt.nlp	23919450	SENT208	18	18	1	1	thrombin	PAR-1	PA451674	2011;2149	0.882
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Dec_17_3(12)_e152.nxml.txt.nlp	25518025	SENT46	19	19	11	11	itraconazole	CYP3A4	PA450132	1576	0.882
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_39-54.nxml.txt.nlp	19305787	SENT237	0	0	27	27	ethanol	DARPP-32	PA448073	84152	0.882
NULL	Int_J_Endocrinol_2014_Mar_12_2014_847827.nxml.txt.nlp	24744784	SENT142	6	6	31	31	geldanamycin	IL-6	PA152031327	3569	0.882
NULL	Core_Evid_2011_Mar_17_6_31-42.nxml.txt.nlp	21468241	SENT76	12	12	22	22	clopidogrel	P2Y12	PA449053	64805	0.882
NULL	Br_J_Ophthalmol_2012_Jul_26_96(7)_1023-1028.nxml.txt.nlp	22539748	SENT138	34	34	13	13	ranibizumab	REC	PA164746012	84515	0.882
NULL	Br_J_Cancer_2012_May_22_106(11)_1742-1752.nxml.txt.nlp	22538973	SENT187	20	20	9	9	imatinib	IFN	PA10804	3439	0.882
NULL	Acta_Histochem_Cytochem_2006_Jul_1_39(3)_61-67.nxml.txt.nlp	17327925	SENT31	22	22	26	26	cisplatin	p53	PA449014	7157	0.882
NULL	ScientificWorldJournal_2013_Nov_5_2013_383574.nxml.txt.nlp	24298214	SENT132	4	4	24	24	genistein	TPC	PA165109660	8030;60386	0.882
NULL	Clin_Exp_Reprod_Med_2011_Mar_31_38(1)_18-23.nxml.txt.nlp	22384413	SENT49	15	15	17	17	diethylstilbestrol	DES	PA449307	1674	0.882
NULL	Evid_Based_Complement_Alternat_Med_2014_May_18_2014_156276.nxml.txt.nlp	24963318	SENT68	13	13	36	36	hesperidin	PLP1	PA449867	5354	0.882
NULL	J_Antimicrob_Chemother_2008_Nov_13_62(5)_1086-1093.nxml.txt.nlp	18703526	SENT86	23	23	17	17	ceftazidime	CTX	PA448861	1593	0.882
NULL	Mol_Biol_Rep_2013_May_11_40(8)_5013-5026.nxml.txt.nlp	23666059	SENT201	17	17	33	33	resveratrol	CDC2		5424	0.882
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_May_29_65(Pt_6)_m697.nxml.txt.nlp	21583052	SENT3	39	39	13	13	phenol	NO3	PA450913	4681	0.882
NULL	Nucleic_Acids_Res_2012_Jun_10_40(11)_4804-4815.nxml.txt.nlp	22328728	SENT219	17	17	9	9	hemin	SIRT1	PA449849	23411	0.882
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT210	38	38	23	23	docetaxel	B7-H1	PA449383	29126	0.882
NULL	EMBO_Mol_Med_2012_Jun_13_4(6)_515-527.nxml.txt.nlp	22416035	SENT177	3	3	14	14	olaparib	p53		7157	0.882
NULL	Nucleic_Acids_Res_2012_Apr_16_40(8)_3511-3523.nxml.txt.nlp	22180533	SENT199	13	13	5	5	hydroxyurea	E2F1	PA449942	1869	0.882
NULL	Mol_Cancer_2009_Nov_10_8_99.nxml.txt.nlp	19903356	SENT89	16	16	7	7	imatinib	IGFBP3	PA10804	3486	0.882
NULL	BMJ_Open_2013_Feb_14_3(2)_e002577.nxml.txt.nlp	23418302	SENT79	36	36	18	18	morphine	PCA	PA450550	28982	0.882
NULL	Nat_Biotechnol_2013_Jul_30_31(7)_630-637.nxml.txt.nlp	23811600	SENT180	15	15	3	3	crizotinib	FES	PA165946122	2242	0.882
NULL	Glob_Health_Action_2014_May_22_7_10_3402_gha_v7_24303.nxml.txt.nlp	24857613	SENT212	35	35	20	20	amoxicillin	PTB	PA448406	58155	0.882
NULL	Oncotarget_2010_Nov_22_1(7)_606-619.nxml.txt.nlp	21317456	SENT131	26	26	6	6	doxorubicin	RAD51D	PA449412	5892	0.882
NULL	Nucleic_Acids_Res_2012_Jun_22_40(11)_4861-4878.nxml.txt.nlp	22362753	SENT245	27	27	18	18	trypsin	NPM	PA451806	4869	0.882
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_75-89.nxml.txt.nlp	17912638	SENT381	4	4	38	38	exemestane	aromatase	PA449563	1588	0.882
NULL	J_Korean_Med_Sci_2006_Jun_21_21(3)_418-424.nxml.txt.nlp	16778382	SENT12	9	9	6	6	hemin	INS-1	PA449849	2305	0.882
NULL	Chem_Cent_J_2012_Aug_1_6_78.nxml.txt.nlp	22853321	SENT60	10	10	0	0	ethanol	PC2	PA448073	5126;5311;8535	0.882
NULL	Br_J_Cancer_2012_Jan_3_106(1)_18-24.nxml.txt.nlp	22108516	SENT131	18	18	38	38	irinotecan	XRCC1	PA450085	7515	0.882
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2008_Jun_1_64(Pt_6)_611-619.nxml.txt.nlp	18560148	SENT191	10	10	36	36	heparin	IP-10	PA449855	3627	0.882
NULL	Ann_Rheum_Dis_2011_Aug_17_70(12)_2148-2151.nxml.txt.nlp	21852254	SENT126	12	12	8	8	tocilizumab	IL-6	PA165292659	3569	0.882
NULL	Breast_Cancer_Res_2012_May_2_14(3)_R70.nxml.txt.nlp	22551440	SENT252	14	14	28	28	docetaxel	TP53	PA449383	7157	0.882
NULL	Cancer_Res_Treat_2012_Sep_30_44(3)_202-209.nxml.txt.nlp	23091447	SENT30	4	4	18	18	gefitinib	EGFR	PA131301952	1956	0.882
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_May_11_69(Pt_6)_o863-o864.nxml.txt.nlp	23795045	SENT73	35	35	9	9	ethanol	mol	PA448073	90527	0.882
NULL	Front_Immunol_2012_Mar_21_3_57.nxml.txt.nlp	22566938	SENT53	22	22	16	16	vasopressin	IRAP	PA451858	3557	0.882
NULL	Mol_Cancer_2012_Jun_26_11_43.nxml.txt.nlp	22731636	SENT131	12	12	6	6	pp2	p38		10598;1432;7965	0.882
NULL	Indian_J_Ophthalmol_2013_May_61(5)_213-217.nxml.txt.nlp	23314254	SENT77	24	24	16	16	ranibizumab	San	PA164746012	80218	0.882
NULL	Clinics_(Sao_Paulo)_2010_Jan_65(1)_29-34.nxml.txt.nlp	20126343	SENT105	1	1	17	17	propofol	LPSB	PA451141	8991	0.882
NULL	Arch_Med_Sci_2012_Jul_4_8(3)_533-541.nxml.txt.nlp	22852012	SENT214	11	11	2	2	hydroxyurea	IFN	PA449942	3439	0.882
NULL	Oncotarget_2010_Oct_25_1(7)_497-514.nxml.txt.nlp	21165163	SENT322	22	22	33	33	erlotinib	EGFR	PA134687924	1956	0.882
NULL	Breast_Cancer_Res_2002_Jun_21_4(5)_R9.nxml.txt.nlp	12223126	SENT114	33	33	8	8	tamoxifen	FasL	PA451581	356	0.882
NULL	Arthritis_Res_Ther_2009_Jun_29_11(3)_R100.nxml.txt.nlp	19563672	SENT224	17	17	30	30	etanercept	IFN	PA449515	3439	0.882
NULL	Acta_Pharmacol_Sin_2012_May_4_33(5)_644-651.nxml.txt.nlp	22555371	SENT134	3	3	20	20	sulodexide	CRF	PA164746343	1392;10882	0.882
NULL	Cancers_(Basel)_2011_May_9_3(2)_2286-2301.nxml.txt.nlp	24212810	SENT184	3	3	7	7	sorafenib	VEGFR2	PA7000	3791	0.882
NULL	Breast_Cancer_Res_2010_Jun_28_12(3)_R43.nxml.txt.nlp	20579400	SENT265	10	10	17	17	tamoxifen	MAPT	PA451581	4137	0.882
NULL	Br_J_Cancer_2013_Feb_19_108(3)_557-563.nxml.txt.nlp	23361053	SENT56	21	21	5	5	letrozole	aromatase	PA450196	1588	0.882
NULL	Ann_Indian_Acad_Neurol_2009_Oct-Dec_12(4)_273-282.nxml.txt.nlp	20182575	SENT39	25	25	5	5	natalizumab	IFN	PA164747191	3439	0.882
NULL	J_Gen_Physiol_2004_Apr_123(4)_427-439.nxml.txt.nlp	15024039	SENT436	9	9	31	31	genistein	EGFR	PA165109660	1956	0.882
NULL	Crit_Care_2008_Mar_13_12(Suppl_2)_P303.nxml.txt.nlp	NULL	SENT11	5	5	7	7	heparin	ACT	PA449855	12;11332;9457;641455	0.882
NULL	J_Headache_Pain_2013_Feb_21_14(Suppl_1)_P124.nxml.txt.nlp	NULL	SENT13	11	11	18	18	capsaicin	ANOVA	PA448776	4858	0.882
NULL	Mol_Cancer_2011_Sep_7_10_109.nxml.txt.nlp	21899742	SENT300	6	6	25	25	etoposide	TRAIL	PA449552	8743	0.882
NULL	Br_J_Haematol_2008_Mar_3_144(5)_677-685.nxml.txt.nlp	19055662	SENT87	17	17	13	13	doxorubicin	CHOP	PA449412	1649	0.882
NULL	J_Exp_Med_1998_Jun_1_187(11)_1885-1892.nxml.txt.nlp	9607928	SENT163	8	8	18	18	thalidomide	CD4	PA451644	920	0.882
NULL	Mol_Cancer_2010_Apr_30_9_96.nxml.txt.nlp	20433742	SENT20	33	33	16	16	methotrexate	DHFR	PA450428	1719	0.882
NULL	Exp_Hematol_Oncol_2012_Sep_6_1_26.nxml.txt.nlp	23210433	SENT122	13	13	7	7	eculizumab	BCS	PA164776637	617	0.882
NULL	F1000_Med_Rep_2009_Jan_21_1_3.nxml.txt.nlp	20948751	SENT34	12	12	27	27	hydrocortisone	ACTH	PA449905	5443	0.882
NULL	Nucleic_Acids_Res_2011_Dec_31_39(22)_9536-9548.nxml.txt.nlp	21880590	SENT175	27	27	5	5	etoposide	BRCA1	PA449552	672	0.882
NULL	Nat_Med_2011_Sep_11_17(10)_1235-1241.nxml.txt.nlp	21909103	SENT124	4	4	15	15	denosumab	RANKL	PA166048634	8600	0.882
NULL	Anticancer_Agents_Med_Chem_2012_Feb_12(2)_163-171.nxml.txt.nlp	22043994	SENT192	9	9	26	26	cetuximab	KRAS	PA10040	3845	0.882
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT202	5	5	11	11	tacrolimus	RANKL	PA451578	8600	0.882
NULL	J_Mol_Signal_2013_Mar_25_8_3.nxml.txt.nlp	23531275	SENT241	27	27	29	29	thrombin	LPA	PA451674	4018	0.882
NULL	Cancers_(Basel)_2010_May_28_2(2)_1027-1039.nxml.txt.nlp	24281105	SENT50	10	10	21	21	vatalanib	VEGFR1	PA7001	2321	0.882
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jul_23_67(Pt_8)_o2099.nxml.txt.nlp	22091118	SENT60	29	29	18	18	ethanol	mol	PA448073	90527	0.882
NULL	Breast_Cancer_Res_2007_Aug_8_9(4)_R50.nxml.txt.nlp	17686159	SENT13	9	9	23	23	gefitinib	HRG	PA131301952	3084;3273	0.882
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1150.nxml.txt.nlp	24675468	SENT121	17	17	0	0	ethanol	AMPK	PA448073	5563	0.882
NULL	Acta_Pharmacol_Sin_2009_Oct_5_30(10)_1428-1435.nxml.txt.nlp	19801997	SENT145	9	9	29	29	artemether	JNK	PA165111698	5599	0.882
NULL	Int_J_Nanomedicine_2012_Sep_24_7_5109-5117.nxml.txt.nlp	23055723	SENT127	20	20	29	29	resveratrol	Q10		27161	0.882
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Oct_28_65(Pt_11)_o2899.nxml.txt.nlp	21578481	SENT63	15	15	28	28	ethanol	mol	PA448073	90527	0.882
NULL	Oncogene_2013_Oct_17_32(42)_5058-5065.nxml.txt.nlp	23160381	SENT81	16	16	29	29	docetaxel	p38	PA449383	10598;1432;7965	0.882
NULL	Croat_Med_J_2012_Jun_53(3)_224-233.nxml.txt.nlp	22661135	SENT67	0	0	10	10	bromocriptine	PRL	PA448671	5617	0.882
NULL	Arthritis_Res_Ther_2013_Jul_9_15(4)_R73.nxml.txt.nlp	23837669	SENT263	6	6	14	14	colchicine	MSU	PA449092	593	0.882
NULL	Crit_Care_2011_Oct_25_15(5)_R255.nxml.txt.nlp	22026977	SENT138	9	9	19	19	dobutamine	AVP	PA449381	114548;551	0.882
NULL	Oncotarget_2012_Oct_20_3(10)_1068-1111.nxml.txt.nlp	23085539	SENT532	23	23	27	27	irinotecan	HER2	PA450085	2064	0.882
NULL	AIDS_Res_Ther_2013_May_1_10_10.nxml.txt.nlp	23634877	SENT156	14	14	7	7	atorvastatin	CCL5	PA448500	6352	0.882
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Mar_27_66(Pt_4)_o922.nxml.txt.nlp	21580732	SENT56	19	19	13	13	ethanol	mol	PA448073	90527	0.882
NULL	J_Lipid_Res_2011_May_52(5)_873-884.nxml.txt.nlp	21324916	SENT265	7	7	36	36	bezafibrate	ACO	PA162364313	55554	0.882
NULL	Cancer_Med_2012_Oct_1_1(2)_114-127.nxml.txt.nlp	23342262	SENT184	0	0	10	10	cetuximab	EGFR	PA10040	1956	0.882
NULL	Cancer_Imaging_2010_Jul_6_10(1)_144-152.nxml.txt.nlp	20605761	SENT78	18	18	28	28	pertuzumab	HER2		2064	0.882
NULL	Nucleic_Acids_Res_2010_Oct_28_38(19)_6418-6432.nxml.txt.nlp	20511593	SENT177	17	17	10	10	collagenase	AP-1	PA449107	2353;3727;2354;3725	0.882
NULL	Endocrinol_Metab_(Seoul)_2014_Sep_25_29(3)_363-370.nxml.txt.nlp	25309796	SENT154	23	23	7	7	metformin	PAK1	PA450395	5585;5058	0.882
NULL	Mol_Cancer_2010_Aug_23_9_222.nxml.txt.nlp	20731837	SENT121	22	22	9	9	gefitinib	ATM	PA131301952	472	0.882
NULL	Diabetes_Care_2012_Feb_16_35(2)_327-333.nxml.txt.nlp	22179958	SENT113	4	4	7	7	metformin	B12	PA450395	7126;4709	0.882
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_May_7_67(Pt_6)_o1313-o1314.nxml.txt.nlp	21754713	SENT75	22	22	6	6	ethanol	mol	PA448073	90527	0.882
NULL	Biomed_Res_Int_2013_Aug_6_2013_602987.nxml.txt.nlp	24027759	SENT308	24	24	21	21	cisplatin	SMF	PA449014	22993	0.882
NULL	Breast_Cancer_Res_2014_Oct_31_16(5)_447.nxml.txt.nlp	25358600	SENT319	24	24	8	8	tamoxifen	CXCR7	PA451581	57007	0.882
NULL	Int_J_Biol_Sci_2014_Jun_10_10(7)_654-663.nxml.txt.nlp	25013375	SENT116	12	12	25	25	nelfinavir	CDK6	PA450606	1021	0.882
NULL	Clin_Dev_Immunol_2013_Sep_22_2013_317682.nxml.txt.nlp	24171032	SENT23	12	12	3	3	hyaluronan	IL-6	PA165958431	3569	0.882
NULL	Mol_Med_Rep_2015_Feb_5_11(2)_805-814.nxml.txt.nlp	25373883	SENT148	11	11	4	4	colchicine	APE	PA449092	55704;328	0.882
NULL	Indian_J_Pharm_Sci_2013_May-Jun_75(3)_251-261.nxml.txt.nlp	24082340	SENT167	10	10	16	16	cisplatin	HER2	PA449014	2064	0.882
NULL	Nucleic_Acids_Res_2012_Apr_16_40(8)_3511-3523.nxml.txt.nlp	22180533	SENT142	3	3	14	14	doxycycline	E2F7	PA449415	144455	0.882
NULL	Diabetes_Care_2011_Jul_17_34(7)_1601-1604.nxml.txt.nlp	21709296	SENT80	22	22	7	7	rosiglitazone	DREAM	PA451283	30818	0.882
NULL	ScientificWorldJournal_2012_May_1_2012_520524.nxml.txt.nlp	22623908	SENT134	7	7	10	10	praziquantel	IL-4	PA164764583	3565	0.882
NULL	Cancer_Cell_Int_2013_Oct_22_13_103.nxml.txt.nlp	24148306	SENT7	29	29	2	2	etoposide	PRL	PA449552	5617	0.882
NULL	Int_J_Hypertens_2012_Feb_26_2012_957235.nxml.txt.nlp	22518298	SENT147	9	9	33	33	hemin	HO-1	PA449849	3162	0.882
NULL	Acta_Pharmacol_Sin_2009_Sep_17_30(9)_1316-1322.nxml.txt.nlp	19684609	SENT16	20	20	3	3	rosiglitazone	PTEN	PA451283	5728	0.882
NULL	Arthritis_Res_Ther_2012_May_1_14(3)_R99.nxml.txt.nlp	22546542	SENT215	10	10	16	16	infliximab	IL-17	PA452639	3605	0.882
NULL	Mol_Cancer_2008_Mar_26_7_27.nxml.txt.nlp	18366759	SENT277	13	13	9	9	etoposide	p53	PA449552	7157	0.882
NULL	Exp_Ther_Med_2013_May_15_5(5)_1327-1331.nxml.txt.nlp	23737873	SENT28	41	41	20	20	imidapril	AVP	PA452640	114548;551	0.882
NULL	Oncotarget_2014_Mar_13_5(4)_1101-1110.nxml.txt.nlp	24658355	SENT118	5	5	0	0	tamoxifen	MKP-2	PA451581	1846	0.882
NULL	Eur_J_Med_Res_2010_Mar_30_15(3)_97-101.nxml.txt.nlp	20452893	SENT90	28	28	13	13	ribavirin	CCR5	PA451241	1234	0.882
NULL	Br_J_Cancer_2014_Oct_14_111(8)_1552-1561.nxml.txt.nlp	25117814	SENT148	18	18	8	8	doxorubicin	XIAP	PA449412	331	0.882
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT216	2	2	21	21	cisplatin	MDM2	PA449014	4193	0.882
NULL	Oncol_Lett_2014_May_24_7(5)_1333-1340.nxml.txt.nlp	24765134	SENT54	7	7	17	17	celecoxib	CRMP1	PA448871	1400	0.882
NULL	Cancer_Manag_Res_2012_May_28_4_137-149.nxml.txt.nlp	22740774	SENT130	11	11	18	18	bevacizumab	San	PA130232992	80218	0.882
NULL	Cell_Commun_Signal_2013_Oct_1_11_73.nxml.txt.nlp	24083678	SENT148	2	2	9	9	sulindac	p65	PA451565	5970	0.882
NULL	Cancer_Cell_Int_2014_Jul_2_14_59.nxml.txt.nlp	25120382	SENT204	26	26	28	28	metformin	Met	PA450395	79811	0.882
NULL	Oncotarget_2014_Nov_2_5(21)_10222-10236.nxml.txt.nlp	25400118	SENT224	26	26	38	38	trastuzumab	HER2	PA451743	2064	0.882
NULL	Mucosal_Immunol_2014_Mar_24_7(2)_335-347.nxml.txt.nlp	23881354	SENT314	27	27	13	13	galantamine	NRX	PA449726	64359	0.882
NULL	Sci_Rep_2015_Jan_6_5_7642.nxml.txt.nlp	25560837	SENT919	28	28	24	24	rimonabant	CB1	PA152407999	1268	0.882
NULL	Exp_Ther_Med_2013_Jul_25_6(1)_109-114.nxml.txt.nlp	23935730	SENT142	35	35	29	29	vincristine	CHOP	PA451879	1649	0.882
NULL	J_Hematol_Oncol_2011_Dec_21_4_53.nxml.txt.nlp	22189016	SENT70	18	18	7	7	amiodarone	P-gp	PA448383	5243	0.882
NULL	Front_Behav_Neurosci_2009_Jun_29_3_10.nxml.txt.nlp	19587848	SENT1325	8	8	10	10	diethylstilbestrol	DES	PA449307	1674	0.882
NULL	Clin_Med_Insights_Oncol_2013_Feb_28_7_53-73.nxml.txt.nlp	23492937	SENT360	29	29	21	21	bortezomib	Mcl-1	PA10252	4170	0.882
NULL	Br_J_Cancer_1996_Nov_74(10)_1545-1552.nxml.txt.nlp	8932333	SENT14	4	4	21	21	epirubicin	P85	PA449476	8874	0.882
NULL	J_Adv_Pract_Oncol_2013_Jul_1_Jul-Aug_4(4)_263-268.nxml.txt.nlp	25032007	SENT47	2	2	4	4	voriconazole	CYP3A4	PA10233	1576	0.882
NULL	Clin_Med_Insights_Circ_Respir_Pulm_Med_2012_Jun_12_6_27-40.nxml.txt.nlp	22745565	SENT188	23	23	11	11	omalizumab	ACT	PA164752253	12;11332;9457;641455	0.882
NULL	Biomed_Res_Int_2014_Aug_6_2014_621827.nxml.txt.nlp	25165710	SENT13	17	17	12	12	dexmedetomidine	CD68	PA449256	968	0.882
NULL	Cent_European_J_Urol_2013_Nov_18_66(3)_344-349.nxml.txt.nlp	24707382	SENT8	34	34	4	4	methylprednisolone	ABO	PA450466	28	0.882
NULL	Thorax_2014_Jul_24_69(7)_638-647.nxml.txt.nlp	24567297	SENT82	13	13	10	10	doxycycline	TRAIL	PA449415	8743	0.882
NULL	Int_J_Mol_Sci_2014_Dec_15_15(12)_23307-23331.nxml.txt.nlp	25517035	SENT149	7	7	13	13	dicumarol	NQO1	PA449298	1728	0.882
NULL	J_Oncol_2009_Jun_22_2009_849051.nxml.txt.nlp	19584908	SENT144	28	28	6	6	erlotinib	EGFR	PA134687924	1956	0.882
NULL	Osteoarthritis_Cartilage_2013_Sep_21(9)_1336-1345.nxml.txt.nlp	23973148	SENT185	11	11	5	5	celecoxib	MIA	PA448871	8190	0.882
NULL	Child_Adolesc_Psychiatry_Ment_Health_2009_Mar_12_3_9.nxml.txt.nlp	19284622	SENT42	28	28	22	22	haloperidol	PES	PA449841	23481	0.882
NULL	Arthritis_Res_Ther_2010_Mar_19_12(2)_R48.nxml.txt.nlp	20302641	SENT45	0	0	19	19	methotrexate	CD4	PA450428	920	0.882
NULL	Anticancer_Agents_Med_Chem_2012_Feb_12(2)_163-171.nxml.txt.nlp	22043994	SENT173	28	28	8	8	cetuximab	BRAF	PA10040	673	0.882
NULL	Arthritis_Res_Ther_2012_Aug_15_14(4)_R186.nxml.txt.nlp	22894827	SENT147	22	22	7	7	etanercept	ACTH	PA449515	5443	0.882
NULL	Ann_Surg_Oncol_2010_Jul_24_17(7)_1964-1965.nxml.txt.nlp	20180030	SENT9	7	7	1	1	cyclophosphamide	NAC	PA449165	22861	0.882
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT16	18	18	8	8	capsaicin	p53	PA448776	7157	0.882
NULL	Open_Biochem_J_2008_Sep_27_2_121-128.nxml.txt.nlp	19238186	SENT245	9	9	30	30	paclitaxel	San	PA450761	80218	0.882
NULL	J_Hypertens_2014_Dec_12_32(12)_2488-2498.nxml.txt.nlp	25144296	SENT151	0	0	12	12	candesartan	AT-1	PA448765	9197	0.882
NULL	Angiogenesis_2010_Dec_7_13(4)_305-315.nxml.txt.nlp	20927579	SENT172	2	2	6	6	resveratrol	HIF-1		29072	0.882
NULL	Oncol_Lett_2014_Nov_13_8(5)_2043-2048.nxml.txt.nlp	25289090	SENT106	13	13	24	24	doxorubicin	p53	PA449412	7157	0.882
NULL	Arthritis_Res_Ther_2003_Dec_2_5(Suppl_4)_S12-S16.nxml.txt.nlp	15180892	SENT81	4	4	0	0	doxorubicin	CHOP	PA449412	1649	0.882
NULL	Pharmaceutics_2011_Jul_13_3(3)_425-439.nxml.txt.nlp	24310588	SENT15	19	19	8	8	diazepam	OTC	PA449283	5009	0.882
NULL	Front_Neurosci_2014_Jun_3_8_128.nxml.txt.nlp	24917782	SENT62	11	11	5	5	ethanol	POMC	PA448073	5443	0.882
NULL	Breast_Cancer_Res_2010_Jun_28_12(3)_R43.nxml.txt.nlp	20579400	SENT178	6	6	10	10	estradiol	MAPT	PA449503	4137	0.882
NULL	J_Cancer_2014_Jan_5_5(2)_86-97.nxml.txt.nlp	24494026	SENT226	0	0	12	12	lopinavir	p53	PA450264	7157	0.882
NULL	Cell_Death_Dis_2013_Jul_11_4(7)_e719.nxml.txt.nlp	23846221	SENT64	24	24	22	22	cisplatin	TRAIL	PA449014	8743	0.882
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT185	33	33	15	15	cisplatin	p53	PA449014	7157	0.882
NULL	Breast_Cancer_Res_2010_Nov_16_12(6)_R96.nxml.txt.nlp	21080941	SENT232	0	0	2	2	lapatinib	EGFR	PA152241907	1956	0.882
NULL	Cancer_Cell_Int_2009_Sep_10_9_25.nxml.txt.nlp	19744341	SENT195	23	23	14	14	glucosamine	EGF	PA164747613	1950	0.882
NULL	Eur_J_Epidemiol_2007_Nov_23_22(11)_819-829.nxml.txt.nlp	17955331	SENT706	21	21	14	14	phenprocoumon	CYP2C9	PA450921	1559	0.882
NULL	Biomed_Res_Int_2013_Dec_4_2013_764706.nxml.txt.nlp	24369016	SENT95	12	12	17	17	doxorubicin	HER-2	PA449412	2064	0.882
NULL	J_Headache_Pain_2014_Dec_8_15(1)_85.nxml.txt.nlp	25488888	SENT102	2	2	10	10	naratriptan	5-HT1B	PA450597	3351	0.882
NULL	Ann_Indian_Acad_Neurol_2009_Apr-Jun_12(2)_89-98.nxml.txt.nlp	20142853	SENT202	19	19	26	26	tiagabine	MRP2	PA451682	100130958;57626;1244	0.882
NULL	Diabetes_2009_Dec_31_58(12)_2851-2862.nxml.txt.nlp	19720788	SENT169	4	4	23	23	forskolin	XBP1	PA146096022	7494	0.882
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1063.nxml.txt.nlp	24556678	SENT105	5	5	12	12	thioridazine	TRAIL	PA451666	8743	0.882
NULL	Eur_J_Med_Res_2009_Sep_1_14(9)_369-377.nxml.txt.nlp	19748856	SENT185	21	21	16	16	lidocaine	CYP1A2	PA450226	1544	0.882
NULL	Oncol_Lett_2013_Mar_8_5(3)_805-812.nxml.txt.nlp	23426281	SENT199	25	25	9	9	gemcitabine	B7-H3	PA449748	80381	0.882
NULL	Adv_Hematol_2012_Feb_16_2012_535709.nxml.txt.nlp	22400031	SENT81	1	1	14	14	imatinib	MPN	PA10804	83886	0.882
NULL	J_Korean_Med_Sci_1996_Jun_11(3)_250-257.nxml.txt.nlp	8843008	SENT12	8	8	28	28	nitroprusside	NIF	PA451406	6280	0.882
NULL	Curr_Med_Chem_2012_Sep_19(26)_4399-4413.nxml.txt.nlp	22830345	SENT237	28	28	19	19	rifampin	CYP3A4	PA451250	1576	0.882
NULL	Nat_Genet_2011_Feb_26_43(2)_117-120.nxml.txt.nlp	21186350	SENT165	22	22	1	1	metformin	AMPK	PA450395	5563	0.882
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT185	2	2	24	24	perifosine	DR5	PA165291471	8795	0.882
NULL	Front_Syst_Neurosci_2014_Dec_22_8_238.nxml.txt.nlp	25565991	SENT2417	7	7	4	4	rimonabant	CB1	PA152407999	1268	0.882
NULL	Antibiotics_(Basel)_2014_Jul_1_3(3)_285-316.nxml.txt.nlp	25364574	SENT181	24	24	2	2	imipenem	IMP-1	PA449968	10642	0.882
NULL	J_Biol_Eng_2009_Oct_16_3_18.nxml.txt.nlp	19835592	SENT56	16	16	12	12	ciprofloxacin	CPZ	PA449009	8532	0.882
NULL	J_Oncol_2010_Apr_11_2010_251231.nxml.txt.nlp	20414333	SENT214	3	3	17	17	2-methoxyestradiol	HIF1	PA134967247	3091	0.882
NULL	J_Headache_Pain_2013_Aug_13_14(1)_71.nxml.txt.nlp	23941062	SENT58	0	0	31	31	carrageenan	TRPA1	PA448814	8989	0.882
NULL	Eur_J_Clin_Pharmacol_2012_Sep_15_68(9)_1267-1274.nxml.txt.nlp	22418828	SENT182	11	11	5	5	pantoprazole	CYP2C19	PA450774	1557	0.882
NULL	J_Cell_Biol_2000_Jul_10_150(1)_213-224.nxml.txt.nlp	10893269	SENT87	35	35	8	8	sulfinpyrazone	AP-1	PA451550	2353;3727;2354;3725	0.882
NULL	Oncotarget_2011_Dec_31_2(12)_894-895.nxml.txt.nlp	22248868	SENT3	22	22	2	2	gefitinib	EGFR	PA131301952	1956	0.882
NULL	Indian_J_Med_Res_2012_Aug_136(2)_249-259.nxml.txt.nlp	22960892	SENT117	14	14	18	18	irinotecan	UGT1A1	PA450085	54658	0.882
NULL	Acta_Pharmacol_Sin_2011_Jul_9_32(7)_879-887.nxml.txt.nlp	21552292	SENT105	29	29	11	11	metformin	AKT	PA450395	207	0.882
NULL	Addict_Sci_Clin_Pract_2010_Dec_5(2)_17-29.nxml.txt.nlp	22002450	SENT50	34	34	20	20	hydromorphone	CYP2D6	PA449918	1565	0.882
NULL	Evid_Based_Complement_Alternat_Med_2011_Mar_13_2011_913898.nxml.txt.nlp	21785639	SENT201	24	24	21	21	curcumin	CYP3A4	PA151958596	1576	0.882
NULL	Mol_Vis_2010_Sep_12_16_1854-1863.nxml.txt.nlp	21031018	SENT117	10	10	4	4	choline	Caspr	PA448976	8506	0.882
NULL	Cell_Commun_Signal_2009_Feb_26_7(Suppl_1)_A99.nxml.txt.nlp	NULL	SENT8	8	8	4	4	thrombin	PAR4	PA451674	9002;5074	0.882
NULL	Biologics_2010_May_25_4_91-101.nxml.txt.nlp	20531964	SENT3	33	33	29	29	sunitinib	VEGFR	PA162372840	3791	0.882
NULL	Front_Public_Health_2013_Nov_14_1_50.nxml.txt.nlp	24350219	SENT82	35	35	10	10	hydrocortisone	CO2	PA449905	4513	0.882
NULL	Breast_Cancer_Res_2011_Jun_29_13(3)_R70.nxml.txt.nlp	21707964	SENT184	42	42	25	25	tamoxifen	FOXM1	PA451581	2305	0.882
NULL	J_Mol_Signal_2011_Aug_10_6_8.nxml.txt.nlp	21831305	SENT91	28	28	8	8	isoproterenol	AKAP5	PA450121	9495	0.882
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT174	40	40	43	43	metformin	HIF-1	PA450395	29072	0.882
NULL	EMBO_J_2009_Jun_17_28(12)_1679-1680.nxml.txt.nlp	19532144	SENT22	21	21	32	32	galactose	GAL	PA449725	51083	0.882
NULL	Clinics_(Sao_Paulo)_2013_May_68(5)_694-701.nxml.txt.nlp	23778405	SENT173	3	3	11	11	curcumin	P-gp	PA151958596	5243	0.882
NULL	Blood_Res_2013_Jun_25_48(2)_115-120.nxml.txt.nlp	23826580	SENT19	21	21	15	15	vincristine	CHOP	PA451879	1649	0.882
NULL	Pain_Res_Treat_2012_Apr_23_2012_295926.nxml.txt.nlp	22577544	SENT53	10	10	22	22	ketoprofen	ARC	PA450149	8996;23237	0.882
NULL	Cardiovasc_Ther_2012_Jun_19_30(3)_e146-e155.nxml.txt.nlp	21167014	SENT172	20	20	22	22	exenatide	GLP-1	PA164749238	100125288	0.882
NULL	Front_Oncol_2013_Oct_1_3_259.nxml.txt.nlp	24102047	SENT64	17	17	12	12	bevacizumab	HER-2	PA130232992	2064	0.882
NULL	J_Oncol_2009_Mar_24_2009_491985.nxml.txt.nlp	19325924	SENT179	3	3	15	15	genistein	CXCL12	PA165109660	6387	0.882
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1563-1573.nxml.txt.nlp	22015557	SENT126	6	6	16	16	sunitinib	c-Myc	PA162372840	4609	0.882
NULL	Neuropsychopharmacology_2009_Sep_3_34(10)_2227-2236.nxml.txt.nlp	19494805	SENT46	28	28	1	1	bupropion	STAR	PA448687	6770;2984	0.882
NULL	Biologics_2010_May_25_4_83-90.nxml.txt.nlp	20531966	SENT80	10	10	18	18	gefitinib	EGFR	PA131301952	1956	0.882
NULL	Biomed_Res_Int_2013_Aug_18_2013_946206.nxml.txt.nlp	24024216	SENT236	27	27	3	3	nadh	PDK1	PA164755085	5170;5163	0.882
NULL	Cerebrum_2011_Jul_21_2011_11.nxml.txt.nlp	23447780	SENT48	14	14	33	33	chloroquine	CLN3	PA448948	1201	0.882
NULL	Oncol_Rep_2014_Feb_13_31(2)_581-588.nxml.txt.nlp	24337105	SENT125	10	10	0	0	capsaicin	ATF4	PA448776	468	0.882
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jul_14_66(Pt_8)_o1996.nxml.txt.nlp	21588310	SENT73	43	43	24	24	ethanol	mol	PA448073	90527	0.882
NULL	Cancer_Cell_Int_2003_Jul_23_3_12.nxml.txt.nlp	12914669	SENT54	10	10	20	20	doxycycline	PP1	PA449415	5540;5464	0.882
NULL	Nanoscale_Res_Lett_2013_Nov_6_8(1)_465.nxml.txt.nlp	24195721	SENT67	16	16	4	4	oxygen	CO2	PA450744	4513	0.882
NULL	EMBO_Mol_Med_2012_Apr_4(4)_298-312.nxml.txt.nlp	22331558	SENT61	27	27	10	10	mi-63	p53		7157	0.882
NULL	Infect_Dis_Ther_2013_Dec_2_2(2)_123-144.nxml.txt.nlp	25134476	SENT127	36	36	3	3	ethionamide	DST	PA164768738	667	0.882
NULL	Ann_Hematol_2014_Sep_10_93(1)_1-11.nxml.txt.nlp	24018623	SENT134	22	22	9	9	lenalidomide	MDM2	PA162363968	4193	0.882
NULL	Breast_Cancer_Res_2003_Jul_28_5(5)_276-279.nxml.txt.nlp	12927039	SENT77	10	10	4	4	tamoxifen	aromatase	PA451581	1588	0.882
NULL	Pharmaceutics_2011_Nov_18_3(4)_865-913.nxml.txt.nlp	24309312	SENT286	12	12	2	2	atorvastatin	CYP3A4	PA448500	1576	0.882
NULL	Neural_Dev_2013_Mar_7_8_4.nxml.txt.nlp	23497494	SENT123	14	14	0	0	chlorpheniramine	FGFR1	PA448960	2260	0.882
NULL	Br_J_Cancer_2010_Oct_26_103(9)_1331-1334.nxml.txt.nlp	20877352	SENT84	47	47	3	3	trastuzumab	GM-CSF	PA451743	1437	0.882
NULL	Indian_J_Urol_2007_Apr-Jun_23(2)_91-96.nxml.txt.nlp	19675781	SENT176	22	22	2	2	doxazosin	NNT	PA449407	23530	0.882
NULL	Nucleic_Acids_Res_2012_Apr_16_40(8)_3511-3523.nxml.txt.nlp	22180533	SENT244	24	24	14	14	doxycycline	E2F7	PA449415	144455	0.882
NULL	Br_J_Cancer_2012_Sep_4_107(6)_947-955.nxml.txt.nlp	22892392	SENT8	12	12	9	9	lapatinib	BCAR4	PA152241907	400500	0.882
NULL	Diabetes_Metab_Syndr_Obes_2010_Mar_29_3_31-41.nxml.txt.nlp	21437074	SENT21	7	7	10	10	pramlintide	GLP-1	PA164781394	100125288	0.882
NULL	N_Am_J_Med_Sci_2011_Oct_3(10)_441-450.nxml.txt.nlp	22363081	SENT122	31	31	19	19	erlotinib	EGFR	PA134687924	1956	0.882
NULL	Chin_J_Cancer_2012_Feb_31(2)_73-99.nxml.txt.nlp	22098950	SENT240	0	0	19	19	lapatinib	EGFR	PA152241907	1956	0.882
NULL	Cancers_(Basel)_2011_Apr_1_3(2)_1844-1860.nxml.txt.nlp	24212785	SENT463	6	6	2	2	panitumumab	KRAS	PA162373091	3845	0.882
NULL	Trials_2013_Dec_10_14_424.nxml.txt.nlp	24325953	SENT52	7	7	21	21	bupivacaine	TAP	PA135057240	8615;2317;10482;23541	0.882
NULL	J_Inherit_Metab_Dis_2010_Oct_3_33(5)_625-632.nxml.txt.nlp	20814828	SENT109	11	11	34	34	simvastatin	RhoA	PA451363	387	0.882
NULL	Br_J_Cancer_2010_Nov_2_103(11)_1671-1679.nxml.txt.nlp	21045835	SENT174	7	7	35	35	gemcitabine	Bcl-2	PA449748	596	0.882
NULL	J_Korean_Med_Sci_2009_Jun_16_24(3)_525-528.nxml.txt.nlp	19543522	SENT15	21	21	23	23	rituximab	CHOP	PA451261	1649	0.882
NULL	Arch_Drug_Inf_2011_Mar_4(1)_1-9.nxml.txt.nlp	21572514	SENT156	12	12	16	16	quinidine	PEPT1	PA451209	6564	0.882
NULL	Acta_Pharmacol_Sin_2013_Apr_5_34(4)_581.nxml.txt.nlp	NULL	SENT6	0	0	2	2	celecoxib	STAT3	PA448871	6774	0.882
NULL	Cell_Commun_Signal_2011_May_20_9_14.nxml.txt.nlp	21599982	SENT19	14	14	30	30	pp2	STAT3		6774	0.882
NULL	Ann_Oncol_2011_Mar_8_22(3)_503-514.nxml.txt.nlp	20616198	SENT5	23	23	15	15	anastrozole	aromatase	PA448432	1588	0.882
NULL	Br_J_Cancer_2012_Feb_14_106(4)_646-650.nxml.txt.nlp	22240794	SENT89	32	32	20	20	sunitinib	IFN	PA162372840	3439	0.882
NULL	Oncotarget_2014_Mar_26_5(21)_10342-10355.nxml.txt.nlp	25431950	SENT124	15	15	4	4	doxycycline	EZH2	PA449415	2146	0.882
NULL	Cell_Commun_Signal_2014_Oct_5_12(1)_54.nxml.txt.nlp	NULL	SENT110	31	31	20	20	doxycycline	ROCK2	PA449415	9475	0.882
NULL	J_Cell_Biol_2008_Jul_28_182(2)_381-393.nxml.txt.nlp	18663145	SENT214	29	29	8	8	trypsin	GIV	PA451806	55704	0.882
NULL	Acta_Pharmacol_Sin_2012_Jan_12_33(1)_27-33.nxml.txt.nlp	22158109	SENT172	7	7	10	10	propofol	AMPK	PA451141	5563	0.882
NULL	J_Ginseng_Res_2011_Sep_35(3)_315-324.nxml.txt.nlp	23717075	SENT272	13	13	24	24	docetaxel	NF-kappaB	PA449383	4790	0.882
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Apr_18_68(Pt_5)_o1406.nxml.txt.nlp	22590294	SENT4	17	17	1	1	phenol	mol	PA450913	90527	0.882
NULL	Oxid_Med_Cell_Longev_2012_Sep_16_2012_728547.nxml.txt.nlp	23029599	SENT57	9	9	4	4	resveratrol	SIRT1		23411	0.882
NULL	J_Invest_Dermatol_2014_Jan_134(1)_10_1038_jid_2013_372.nxml.txt.nlp	24352079	SENT42	9	9	27	27	verteporfin	BRAF	PA451871	673	0.882
NULL	Behav_Brain_Funct_2008_Aug_15_4_37.nxml.txt.nlp	18702828	SENT129	24	24	13	13	methamphetamine	FZD3	PA450403	7976;8326	0.882
NULL	Cell_Biol_Int_Rep_(2010)_2012_Jun_21_19(1)_e00017.nxml.txt.nlp	23124518	SENT6	25	25	22	22	etoposide	TRAIL	PA449552	8743	0.882
NULL	Iran_J_Pharm_Res_2014_Summer_13(3)_919-926.nxml.txt.nlp	25276192	SENT114	24	24	8	8	doxorubicin	p53	PA449412	7157	0.882
NULL	BMB_Rep_2014_Jan_47(1)_33-38.nxml.txt.nlp	24209634	SENT279	9	9	1	1	docetaxel	CXCR4	PA449383	7852	0.882
NULL	Cell_Cycle_2013_Sep_15_12(18)_3013-3024.nxml.txt.nlp	23974104	SENT157	12	12	19	19	doxorubicin	CD44	PA449412	960	0.882
NULL	Acta_Pharmacol_Sin_2014_Jun_5_35(6)_814-824.nxml.txt.nlp	24793310	SENT183	17	17	9	9	geldanamycin	Hsp90	PA152031327	3320	0.882
NULL	Curr_Pain_Headache_Rep_2011_Aug_12_15(4)_271-279.nxml.txt.nlp	21479998	SENT39	17	17	3	3	ranitidine	CYP2D6	PA451224	1565	0.882
NULL	Virol_J_2010_Nov_20_7_332.nxml.txt.nlp	21092135	SENT151	8	8	3	3	topotecan	TOP1	PA451729	7150	0.882
NULL	Ann_Oncol_2014_Oct_18_25(10)_1871-1888.nxml.txt.nlp	25234545	SENT203	31	31	13	13	everolimus	aromatase	PA164746311	1588	0.882
NULL	Oncol_Lett_2013_Aug_25_6(2)_407-414.nxml.txt.nlp	24137337	SENT180	5	5	17	17	cisapride	HERG	PA449011	3757	0.882
NULL	Br_J_Pharmacol_2010_Sep_161(2)_288-307.nxml.txt.nlp	20735416	SENT125	26	26	40	40	propofol	c-fos	PA451141	2353	0.882
NULL	Contemp_Oncol_(Pozn)_2012_Jan_4_16(6)_461-466.nxml.txt.nlp	23788931	SENT76	37	37	31	31	vincristine	CHOP	PA451879	1649	0.882
NULL	Cell_Commun_Signal_2013_Feb_20_11_13.nxml.txt.nlp	23425659	SENT119	22	22	5	5	clonazepam	IL-6	PA449050	3569	0.882
NULL	BMB_Rep_2014_Jun_47(6)_299-310.nxml.txt.nlp	24856830	SENT168	23	23	7	7	cisplatin	STAG2	PA449014	10735	0.882
NULL	Cancer_Immunol_Immunother_2013_Aug_27_62(10)_1637-1648.nxml.txt.nlp	23982484	SENT157	29	29	23	23	lenalidomide	IL-6	PA162363968	3569	0.882
NULL	Ann_Rheum_Dis_2008_Apr_20_67(4)_511-517.nxml.txt.nlp	17644552	SENT68	25	25	6	6	infliximab	IL-6	PA452639	3569	0.882
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT38	20	20	38	38	liraglutide	GLP-1	PA165958364	100125288	0.882
NULL	Mol_Cancer_2010_Jun_25_9_165.nxml.txt.nlp	20576164	SENT32	8	8	26	26	curcumin	STAT3	PA151958596	6774	0.882
NULL	Front_Oncol_2014_Nov_25_4_329.nxml.txt.nlp	25505733	SENT94	15	15	18	18	docetaxel	KRAS	PA449383	3845	0.882
NULL	Oncotarget_2014_Jun_3_5(13)_4920-4928.nxml.txt.nlp	24952482	SENT103	15	15	22	22	crizotinib	HGF	PA165946122	3569;6654;3082	0.882
NULL	Biomed_Res_Int_2013_Jul_31_2013_692071.nxml.txt.nlp	23984399	SENT174	13	13	11	11	quinidine	OCT1	PA451209	5451;6580	0.882
NULL	Oncogene_2011_Apr_21_30(16)_1855-1867.nxml.txt.nlp	21151168	SENT260	10	10	20	20	ethanol	IL3	PA448073	3562	0.882
NULL	Cancers_(Basel)_2013_May_27_5(2)_617-638.nxml.txt.nlp	24216994	SENT340	12	12	6	6	curcumin	MMP9	PA151958596	4318	0.882
NULL	Int_J_Gen_Med_2012_Nov_9_5_935-942.nxml.txt.nlp	23204857	SENT151	5	5	10	10	naloxone	AIDA	PA450586	64853	0.882
NULL	Acta_Pharmacol_Sin_2013_Jan_19_34(1)_146-156.nxml.txt.nlp	23160340	SENT60	30	30	16	16	methotrexate	CYP3A4	PA450428	1576	0.882
NULL	J_Korean_Med_Sci_2013_Apr_27_28(4)_527-533.nxml.txt.nlp	23580227	SENT91	5	5	24	24	genistein	TRAIL	PA165109660	8743	0.882
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_14_2012_617085.nxml.txt.nlp	23097677	SENT196	5	5	0	0	decitabine	DNMT1	PA164749631	1786	0.882
NULL	Toxins_(Basel)_2010_Oct_28_2(11)_2584-2592.nxml.txt.nlp	22069565	SENT264	21	21	14	14	phenprocoumon	CYP2C9	PA450921	1559	0.882
NULL	Aging_(Albany_NY)_2009_May_22_1(6)_557-572.nxml.txt.nlp	20195383	SENT16	12	12	7	7	creatine	gamma	PA164778930	9913	0.882
NULL	Oncol_Rep_2013_Apr_23_29(4)_1268-1274.nxml.txt.nlp	23354756	SENT12	13	13	5	5	paclitaxel	SLC25A43	PA450761	203427	0.882
NULL	Lab_Invest_2011_Apr_14_91(4)_598-608.nxml.txt.nlp	21321535	SENT133	6	6	28	28	sorafenib	CD25	PA7000	3669;3559	0.882
NULL	Biomed_Res_Int_2013_Oct_10_2013_541947.nxml.txt.nlp	24224169	SENT126	4	4	26	26	thyroglobulin	B12	PA164754910	7126;4709	0.882
NULL	J_Exp_Clin_Cancer_Res_2009_Jul_10_28(1)_99.nxml.txt.nlp	19591692	SENT122	16	16	9	9	elacridar	ABCB1		5243	0.882
NULL	Case_Rep_Gastrointest_Med_2013_Mar_27_2013_386263.nxml.txt.nlp	23607002	SENT62	7	7	20	20	sorafenib	BRAF	PA7000	673	0.882
NULL	Infect_Dis_Obstet_Gynecol_2012_Feb_28_2012_137192.nxml.txt.nlp	22536010	SENT128	12	12	16	16	carbamazepine	CYP3A	PA448785	1574	0.882
NULL	EMBO_Mol_Med_2012_Sep_7_4(9)_896-909.nxml.txt.nlp	22887866	SENT147	0	0	9	9	lovastatin	SREBF1	PA450272	6720	0.882
NULL	Br_J_Cancer_2011_Jan_4_104(1)_91-100.nxml.txt.nlp	21139584	SENT133	35	35	8	8	geldanamycin	Hsp90	PA152031327	3320	0.882
NULL	Amino_Acids_2012_May_25_42(5)_1529-1539.nxml.txt.nlp	21437784	SENT66	6	6	12	12	taurine	STZ	PA451590	6484	0.882
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_11_2014_274786.nxml.txt.nlp	25505920	SENT186	13	13	7	7	dasatinib	CYP3A	PA162372878	1574	0.882
NULL	Carcinogenesis_2014_Sep_3_35(9)_1968-1976.nxml.txt.nlp	24590896	SENT274	6	6	13	13	metformin	AMPK	PA450395	5563	0.882
NULL	Gut_Liver_2012_Jul_2_6(3)_316-320.nxml.txt.nlp	22844558	SENT127	29	29	41	41	warfarin	ESD	PA451906	2098	0.882
NULL	Br_J_Cancer_2013_Jul_23_109(2)_351-359.nxml.txt.nlp	23799854	SENT16	8	8	5	5	paclitaxel	BLT2	PA450761	56413	0.882
NULL	Clin_Transl_Allergy_2013_Sep_2_3_29.nxml.txt.nlp	24004581	SENT202	3	3	16	16	omalizumab	IL-4	PA164752253	3565	0.882
NULL	Clin_Pharmacokinet_2014_Sep_3_53(1)_1-16.nxml.txt.nlp	23999929	SENT129	18	18	14	14	rivaroxaban	CLCR	PA165958360	11330	0.882
NULL	Br_J_Cancer_1995_Feb_71(2)_294-299.nxml.txt.nlp	7841043	SENT10	9	9	18	18	tamoxifen	P-gp	PA451581	5243	0.882
NULL	Arthritis_Res_Ther_2014_Sep_26_16(5)_429.nxml.txt.nlp	25606593	SENT134	2	2	16	16	simvastatin	RhoA	PA451363	387	0.882
NULL	Hum_Genomics_2009_Jan_1_3(2)_169-190.nxml.txt.nlp	19164093	SENT28	12	12	4	4	tolbutamide	CYP2C9	PA451718	1559	0.882
NULL	Int_Semin_Surg_Oncol_2006_Aug_25_3_22.nxml.txt.nlp	16930493	SENT73	11	11	21	21	cimetidine	PSK	PA449001	9344	0.882
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT15	25	25	8	8	simvastatin	survivin	PA451363	332	0.882
NULL	Brief_Bioinform_2014_Jul_31_15(4)_648-659.nxml.txt.nlp	23376192	SENT127	12	12	3	3	cyclophosphamide	CYP3A4	PA449165	1576	0.882
NULL	Curr_Oncol_2009_Jul_16(Suppl_2)_S14-S23.nxml.txt.nlp	19672417	SENT42	15	15	1	1	tamoxifen	ATAC	PA451581	6375	0.882
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Nov_19_67(Pt_12)_o3364.nxml.txt.nlp	22199858	SENT64	24	24	6	6	ethanol	mol	PA448073	90527	0.882
NULL	J_Cell_Biol_2001_Mar_19_152(6)_1135-1144.nxml.txt.nlp	11257115	SENT166	4	4	14	14	lipase	DAG	PA450239	1605	0.882
NULL	Bone_Marrow_Transplant_2011_Mar_24_46(3)_430-435.nxml.txt.nlp	20498647	SENT25	26	26	18	18	infliximab	CD25	PA452639	3669;3559	0.882
NULL	Eur_J_Dent_2009_Jul_3(3)_240-249.nxml.txt.nlp	19756201	SENT76	17	17	44	44	cisplatin	CD44	PA449014	960	0.882
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT124	9	9	41	41	sitagliptin	HIP	PA164748978	6767;6159;64399;5068	0.882
NULL	Curr_Neuropharmacol_2010_Dec_8(4)_409-421.nxml.txt.nlp	21629447	SENT193	17	17	9	9	flunarizine	LGS	PA164776636	51557	0.882
NULL	Clin_Infect_Dis_2013_Mar_1_56(5)_694-696.nxml.txt.nlp	23175557	SENT24	18	18	9	9	primaquine	G6PD	PA451103	2539	0.882
NULL	J_Res_Med_Sci_2010_Nov-Dec_15(6)_331-343.nxml.txt.nlp	21526106	SENT27	7	7	26	26	l-arginine	HDEL	PA448478	10945	0.882
NULL	Calcif_Tissue_Int_2014_Aug_21_94(2)_170-175.nxml.txt.nlp	23963633	SENT122	21	21	26	26	teriparatide	PTH	PA451620	5741	0.882
NULL	Br_J_Cancer_2010_Jan_19_102(2)_268-275.nxml.txt.nlp	20010948	SENT22	16	16	13	13	erlotinib	EGFR	PA134687924	1956	0.882
NULL	Clin_Exp_Otorhinolaryngol_2012_Sep_27_5(3)_117-121.nxml.txt.nlp	22977707	SENT117	19	19	31	31	kanamycin	NKCC1	PA450137	6558	0.882
NULL	Breast_Cancer_Res_2008_Jan_8_10(1)_R2.nxml.txt.nlp	18182100	SENT216	26	26	9	9	tamoxifen	HER3	PA451581	2065	0.882
NULL	Biomed_Res_Int_2013_Dec_10_2013_565218.nxml.txt.nlp	24386638	SENT242	18	18	35	35	imipramine	DIO3	PA449969	1735	0.882
NULL	Oncotarget_2014_Feb_7_5(3)_775-787.nxml.txt.nlp	24519956	SENT121	40	40	35	35	docetaxel	PC3	PA449383	57332;7832;5122	0.882
NULL	Ther_Clin_Risk_Manag_2006_Jun_2(2)_129-158.nxml.txt.nlp	18360588	SENT140	3	3	5	5	voriconazole	CYP3A4	PA10233	1576	0.882
NULL	Front_Neurosci_2012_May_30_6_77.nxml.txt.nlp	22661925	SENT304	3	3	26	26	ethanol	DCX	PA448073	1641	0.882
NULL	Bone_Marrow_Res_2011_Jul_13_2011_303487.nxml.txt.nlp	22046559	SENT281	7	7	23	23	fludarabine	CD34	PA449655	947	0.882
NULL	Br_J_Cancer_2010_Nov_2_103(11)_1671-1679.nxml.txt.nlp	21045835	SENT117	28	28	5	5	gemcitabine	CXCR4	PA449748	7852	0.882
NULL	Core_Evid_2011_Mar_17_6_31-42.nxml.txt.nlp	21468241	SENT263	13	13	4	4	ticagrelor	ABCB1	PA165374673	5243	0.882
NULL	Arthritis_Res_Ther_2003_Dec_2_5(Suppl_4)_S12-S16.nxml.txt.nlp	15180892	SENT75	30	30	18	18	rituximab	CHOP	PA451261	1649	0.882
NULL	J_Cell_Biol_2002_Sep_16_158(6)_1119-1131.nxml.txt.nlp	12221069	SENT34	40	40	34	34	amiloride	Rho	PA448368	29984	0.882
NULL	Mol_Biol_Rep_2013_May_11_40(8)_5013-5026.nxml.txt.nlp	23666059	SENT34	8	8	33	33	resveratrol	p53		7157	0.882
NULL	Br_J_Cancer_2012_Jan_3_106(1)_18-24.nxml.txt.nlp	22108516	SENT131	18	18	34	34	irinotecan	PARP1	PA450085	142	0.882
NULL	Int_J_Mol_Sci_2014_Nov_21_15(11)_21433-21454.nxml.txt.nlp	25421240	SENT99	4	4	21	21	pp2	EGF		1950	0.882
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT105	16	16	23	23	pp2	PP2		4888	0.882
NULL	J_Korean_Med_Sci_2010_May_16_25(5)_716-722.nxml.txt.nlp	20436707	SENT11	5	5	20	20	simvastatin	DES	PA451363	1674	0.882
NULL	Exp_Ther_Med_2013_Nov_13_6(5)_1317-1321.nxml.txt.nlp	24223665	SENT110	11	11	20	20	cisplatin	CD133	PA449014	8842	0.882
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT178	36	36	16	16	adalimumab	CD36	PA10004	948	0.882
NULL	J_Hematol_Oncol_2013_Jul_10_6_50.nxml.txt.nlp	23841999	SENT15	4	4	0	0	erlotinib	EGF	PA134687924	1950	0.882
NULL	Biosensors_(Basel)_2012_Sep_10_2(3)_318-340.nxml.txt.nlp	25585933	SENT215	11	11	20	20	bleomycin	p53	PA448645	7157	0.882
NULL	Br_J_Pharmacol_2012_Jan_165(2)_390-400.nxml.txt.nlp	21671897	SENT185	22	22	6	6	suramin	P2X1	PA10292	5023	0.882
NULL	Oncotarget_2012_Sep_28_3(10)_1169-1181.nxml.txt.nlp	23045411	SENT15	16	16	2	2	doxorubicin	JIP1	PA449412	9479	0.882
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1148-1152.nxml.txt.nlp	22343623	SENT25	18	18	10	10	gefitinib	EGFR	PA131301952	1956	0.882
NULL	Clin_Med_Insights_Oncol_2012_May_16_6_205-217.nxml.txt.nlp	22654526	SENT248	19	19	17	17	erlotinib	EGFR	PA134687924	1956	0.882
NULL	Iran_J_Pharm_Res_2014_Autumn_13(4)_1263-1277.nxml.txt.nlp	25587316	SENT215	8	8	22	22	penicillamine	CHP	PA450840	11261	0.882
NULL	Oncotarget_2013_Nov_24_4(12)_2430-2438.nxml.txt.nlp	24280348	SENT65	25	25	19	19	gefitinib	EGFR	PA131301952	1956	0.882
NULL	Breast_Cancer_Res_2005_Jan_26_7(2)_R256-R266.nxml.txt.nlp	15743506	SENT29	38	38	10	10	methotrexate	HER-2	PA450428	2064	0.882
NULL	Cancer_Cell_Int_2013_Nov_14_13_114.nxml.txt.nlp	24228711	SENT252	19	19	25	25	curcumin	WT1	PA151958596	7490	0.882
NULL	J_Cell_Mol_Med_2014_May_14_18(5)_811-823.nxml.txt.nlp	24628949	SENT246	26	26	19	19	docetaxel	FOXM1	PA449383	2305	0.882
NULL	Ann_Hematol_2014_Sep_10_93(1)_1-11.nxml.txt.nlp	24018623	SENT147	4	4	22	22	lenalidomide	SPARC	PA162363968	6678	0.882
NULL	Carcinogenesis_2014_May_13_35(5)_1055-1066.nxml.txt.nlp	24419232	SENT14	0	0	14	14	metformin	AMPK	PA450395	5563	0.882
NULL	Case_Rep_Oncol_2011_Dec_7_4(3)_564-568.nxml.txt.nlp	22220151	SENT42	17	17	9	9	gefitinib	EGFR	PA131301952	1956	0.882
NULL	Oncotarget_2010_Oct_9_1(6)_387-395.nxml.txt.nlp	21311095	SENT127	13	13	1	1	oxaliplatin	IL-4	PA131285527	3565	0.882
NULL	Front_Neurosci_2013_Jan_31_7_3.nxml.txt.nlp	23386808	SENT201	34	34	19	19	capsaicin	TRPV1	PA448776	7442	0.882
NULL	J_Korean_Med_Sci_2005_Jun_30_20(3)_456-460.nxml.txt.nlp	15953869	SENT110	30	30	15	15	lipase	HSL	PA450239	3991	0.882
NULL	Br_J_Cancer_2011_Sep_6_105(6)_778-786.nxml.txt.nlp	21847128	SENT173	17	17	19	19	zoledronate	IL-2	PA10235	3558	0.882
NULL	Reprod_Biol_Endocrinol_2013_Feb_26_11_15.nxml.txt.nlp	23442442	SENT140	5	5	14	14	l-arginine	BCL2	PA448478	596	0.882
NULL	Evid_Based_Complement_Alternat_Med_2013_Mar_4_2013_957078.nxml.txt.nlp	23533531	SENT50	11	11	29	29	oxaliplatin	DDP	PA131285527	1678	0.882
NULL	Mol_Cancer_2012_Mar_21_11_13.nxml.txt.nlp	22436134	SENT10	8	8	1	1	doxorubicin	HuR	PA449412	1994	0.882
NULL	Br_J_Cancer_2009_Jul_21_101(2)_357-362.nxml.txt.nlp	19536092	SENT156	9	9	21	21	irinotecan	UGT	PA450085	7361;7355	0.882
NULL	Oncotarget_2014_Feb_19_5(8)_2085-2095.nxml.txt.nlp	24742694	SENT296	20	20	28	28	suramin	SIRT1	PA10292	23411	0.882
NULL	Cancer_Med_2012_Aug_15_1(1)_28-38.nxml.txt.nlp	23342251	SENT218	27	27	17	17	trastuzumab	HER2	PA451743	2064	0.882
NULL	Mol_Cancer_2013_May_24_12_47.nxml.txt.nlp	23705854	SENT223	8	8	13	13	celecoxib	P-gp	PA448871	5243	0.882
NULL	Br_J_Cancer_2009_Nov_3_101(9)_1613-1619.nxml.txt.nlp	19773750	SENT158	32	32	7	7	ethanol	aromatase	PA448073	1588	0.882
NULL	Acta_Pharmacol_Sin_2010_May_12_31(5)_578-584.nxml.txt.nlp	20383171	SENT157	11	11	22	22	berberine	PERK	PA165860812	9451	0.882
NULL	Biologics_2010_May_25_4_91-101.nxml.txt.nlp	20531964	SENT3	35	35	29	29	sorafenib	VEGFR	PA7000	3791	0.882
NULL	Iran_J_Pharm_Res_2014_Winter_13(Suppl)_35-42.nxml.txt.nlp	24711827	SENT193	28	28	19	19	indomethacin	ADP	PA449982	23038	0.882
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_May_12_66(Pt_6)_o1324-o1325.nxml.txt.nlp	21579416	SENT66	20	20	15	15	ethanol	mol	PA448073	90527	0.882
NULL	J_Biol_Chem_2013_May_31_288(22)_15699-15711.nxml.txt.nlp	23592792	SENT64	17	17	31	31	phenol	CO2	PA450913	4513	0.882
NULL	Oncol_Lett_2013_Mar_19_5(3)_923-928.nxml.txt.nlp	23426648	SENT108	35	35	0	0	sc-560	MVD		4597	0.882
NULL	Curr_Control_Trials_Cardiovasc_Med_2001_Oct_16_2(6)_271-277.nxml.txt.nlp	11806813	SENT62	26	26	6	6	enalapril	IL-6	PA449456	3569	0.881
NULL	BMB_Rep_2014_May_47(5)_268-273.nxml.txt.nlp	24286315	SENT368	8	8	12	12	trastuzumab	mol	PA451743	90527	0.881
NULL	J_Invest_Dermatol_2013_Sep_31_133(9)_2247-2254.nxml.txt.nlp	23370537	SENT67	34	34	14	14	chloroquine	PUMA	PA448948	27113	0.881
NULL	J_Mol_Signal_2011_Aug_10_6_8.nxml.txt.nlp	21831305	SENT97	12	12	0	0	isoproterenol	AKAP12	PA450121	9590	0.881
NULL	J_Neurochem_2013_Jul_20_126(2)_223-233.nxml.txt.nlp	23638840	SENT60	25	25	13	13	l-glutamine	B27	PA10090	56246	0.881
NULL	Cancer_Cell_Int_2006_Mar_30_6_9.nxml.txt.nlp	16573823	SENT243	19	19	2	2	lovastatin	CT50	PA450272	93273	0.881
NULL	Breast_Cancer_Res_Treat_2013_Jun_30_139(2)_441-451.nxml.txt.nlp	23715630	SENT19	24	24	34	34	tamoxifen	aromatase	PA451581	1588	0.881
NULL	EMBO_J_2013_Feb_20_32(4)_511-523.nxml.txt.nlp	23241948	SENT241	23	23	15	15	kanamycin	CAB2	PA450137	93210	0.881
NULL	Nat_Neurosci_2014_Jul_25_17(7)_943-952.nxml.txt.nlp	24859199	SENT282	10	10	36	36	doxycycline	P56	PA449415	8999	0.881
NULL	Br_J_Cancer_2013_Apr_16_108(7)_1449-1459.nxml.txt.nlp	23511563	SENT198	24	24	8	8	gemcitabine	CD24	PA449748	100133941	0.881
NULL	Eur_J_Nucl_Med_Mol_Imaging_2008_May_22_35(5)_1008-1018.nxml.txt.nlp	18157531	SENT157	4	4	29	29	trastuzumab	HER2	PA451743	2064	0.881
NULL	Br_J_Cancer_1990_Dec_62(6)_891-896.nxml.txt.nlp	2124136	SENT10	33	33	10	10	mitomycin	HAI	PA450524	6692;6768	0.881
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT94	24	24	7	7	curcumin	TRAIL	PA151958596	8743	0.881
NULL	Aging_(Albany_NY)_2012_Jul_22_4(7)_480-498.nxml.txt.nlp	22837425	SENT19	12	12	15	15	metformin	AMPK	PA450395	5563	0.881
NULL	Alzheimers_Res_Ther_2010_Oct_29_2(5)_31.nxml.txt.nlp	21062519	SENT71	15	15	2	2	simvastatin	PSEN1	PA451363	5663	0.881
NULL	Br_J_Cancer_1996_Mar_73(6)_735-743.nxml.txt.nlp	8611373	SENT8	5	5	33	33	tamoxifen	pS2	PA451581	7031	0.881
NULL	Int_J_Biomed_Sci_2014_Sep_10(3)_146-157.nxml.txt.nlp	25324695	SENT131	0	0	10	10	pravastatin	RANTES	PA451089	6352	0.881
NULL	Oncotarget_2010_Nov_22_1(7)_606-619.nxml.txt.nlp	21317456	SENT155	23	23	3	3	doxorubicin	BRCA2	PA449412	675	0.881
NULL	Infection_2013_Sep_14_41(Suppl_2)_91-115.nxml.txt.nlp	24037688	SENT142	17	17	28	28	clindamycin	G6PD	PA449035	2539	0.881
NULL	Iran_J_Pharm_Res_2014_Spring_13(2)_683-693.nxml.txt.nlp	25237365	SENT14	28	28	21	21	tranilast	CXCL12	PA131890628	6387	0.881
NULL	AIDS_Res_Treat_2011_Jun_7_2011_354908.nxml.txt.nlp	21716719	SENT216	6	6	0	0	tenofovir	OAT1	PA10204	9356	0.881
NULL	Cardiol_Res_Pract_2013_Feb_21_2013_127270.nxml.txt.nlp	23509665	SENT173	37	37	23	23	prasugrel	ADP	PA154410481	23038	0.881
NULL	Evid_Based_Complement_Alternat_Med_2014_Oct_19_2014_628712.nxml.txt.nlp	25389442	SENT122	26	26	5	5	erlotinib	PTEN	PA134687924	5728	0.881
NULL	Br_J_Clin_Pharmacol_2013_Aug_23_76(2)_299-315.nxml.txt.nlp	23701319	SENT150	3	3	22	22	rituximab	IL-13	PA451261	3596	0.881
NULL	Oncoimmunology_2013_Sep_1_2(9)_e25737.nxml.txt.nlp	24327935	SENT13	9	9	14	14	bleomycin	BLM	PA448645	641	0.881
NULL	Cardiol_Res_Pract_2013_Feb_21_2013_127270.nxml.txt.nlp	23509665	SENT69	11	11	38	38	prasugrel	NNT	PA154410481	23530	0.881
NULL	Biologics_2010_Nov_9_4_289-298.nxml.txt.nlp	21116327	SENT29	38	38	19	19	panitumumab	EGF	PA162373091	1950	0.881
NULL	Mol_Cancer_2012_Mar_21_11_13.nxml.txt.nlp	22436134	SENT14	4	4	38	38	doxorubicin	HuR	PA449412	1994	0.881
NULL	Int_J_Mol_Sci_2012_Sep_5_13(9)_11012-11026.nxml.txt.nlp	23109835	SENT136	14	14	2	2	cisplatin	DDB2	PA449014	1643	0.881
NULL	J_Oncol_2010_May_24_2010_729725.nxml.txt.nlp	20508816	SENT204	27	27	18	18	bevacizumab	MVD	PA130232992	4597	0.881
NULL	Diabetes_2009_Dec_31_58(12)_2851-2862.nxml.txt.nlp	19720788	SENT182	5	5	1	1	forskolin	BiP	PA146096022	3309	0.881
NULL	Oxid_Med_Cell_Longev_2011_Sep_8_2011_293769.nxml.txt.nlp	21912722	SENT246	5	5	32	32	sildenafil	PKG	PA451346	5592	0.881
NULL	Mol_Immunol_2009_Mar_46(6)_1149-1162.nxml.txt.nlp	19100624	SENT595	23	23	7	7	chlorpromazine	C5L2	PA448964	27202	0.881
NULL	Cancers_(Basel)_2011_Apr_1_3(2)_1861-1876.nxml.txt.nlp	24212786	SENT973	11	11	5	5	erlotinib	EGFR	PA134687924	1956	0.881
NULL	Oncotarget_2013_Nov_24_4(12)_2430-2438.nxml.txt.nlp	24280348	SENT45	7	7	14	14	gefitinib	EGFR	PA131301952	1956	0.881
NULL	Acta_Pharmacol_Sin_2010_Aug_5_31(8)_938-943.nxml.txt.nlp	20686519	SENT132	8	8	1	1	reserpine	GML	PA451236	2765	0.881
NULL	Int_J_Gen_Med_2013_Dec_4_6_877-895.nxml.txt.nlp	24403842	SENT55	28	28	36	36	exenatide	GLP-1	PA164749238	100125288	0.881
NULL	Mol_Pain_2013_Jun_10_9_27.nxml.txt.nlp	23758830	SENT176	13	13	3	3	tetracaine	ASIC3	PA451638	9311	0.881
NULL	J_Gastroenterol_2014_Jun_19_49(6)_1001-1010.nxml.txt.nlp	23780559	SENT118	25	25	16	16	genistein	HCN	PA165109660	378938	0.881
NULL	J_Biomed_Sci_2014_Apr_17_21(1)_30.nxml.txt.nlp	24742230	SENT137	21	21	36	36	lovastatin	Bcl-2	PA450272	596	0.881
NULL	Biomed_Res_Int_2014_Jan_12_2014_276918.nxml.txt.nlp	24524073	SENT98	13	13	33	33	sertraline	CYP2D6	PA451333	1565	0.881
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Feb_17_6_29-36.nxml.txt.nlp	24648767	SENT43	13	13	18	18	tamoxifen	BRCA1	PA451581	672	0.881
NULL	J_Hematol_Oncol_2010_May_2_3_18.nxml.txt.nlp	20433767	SENT133	1	1	10	10	cetuximab	EGFR	PA10040	1956	0.881
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT258	9	9	18	18	risperidone	PRL	PA451257	5617	0.881
NULL	Breast_Cancer_Res_2011_Mar_14_13(2)_205.nxml.txt.nlp	21457526	SENT175	33	33	5	5	anastrozole	ATAC	PA448432	6375	0.881
NULL	J_Int_Soc_Sports_Nutr_2009_Feb_19_6_6.nxml.txt.nlp	19228401	SENT20	11	11	28	28	creatine	ADP	PA164778930	23038	0.881
NULL	J_Mol_Med_(Berl)_2012_Apr_30_90(4)_401-411.nxml.txt.nlp	22038171	SENT112	33	33	13	13	tetracycline	PTH	PA451640	5741	0.881
NULL	Environ_Health_Perspect_2008_Jan_5_116(1)_1-6.nxml.txt.nlp	18197291	SENT135	15	15	23	23	arsenite	p85	PA452638	5296;5295;54776;23368	0.881
NULL	Iran_J_Basic_Med_Sci_2012_May-Jun_15(3)_795-802.nxml.txt.nlp	23493622	SENT154	11	11	25	25	capsaicin	EPM	PA448776	2054	0.881
NULL	J_Cell_Biol_1998_Jan_26_140(2)_419-430.nxml.txt.nlp	9442117	SENT73	37	37	3	3	ethanol	TSP2	PA448073	7058	0.881
NULL	Eur_J_Neurosci_2010_Jul_32(1)_29-40.nxml.txt.nlp	20608967	SENT293	15	15	23	23	cyclothiazide	NG2	PA449168	1464;6048	0.881
NULL	Cancer_Causes_Control_2012_Jan_21_23(1)_207-211.nxml.txt.nlp	22015647	SENT1	8	8	10	10	diethylstilbestrol	DES	PA449307	1674	0.881
NULL	J_Signal_Transduct_2010_Sep_1_2010_643642.nxml.txt.nlp	21637354	SENT112	38	38	4	4	pp2	ghrelin		51738	0.881
NULL	Int_J_Biomed_Sci_2014_Dec_10(4)_229-235.nxml.txt.nlp	25598752	SENT6	25	25	8	8	abatacept	ADAM17	PA164747080	6868	0.881
NULL	Clin_Med_Insights_Oncol_2012_Feb_28_6_125-135.nxml.txt.nlp	22408376	SENT266	6	6	2	2	panitumumab	KRAS	PA162373091	3845	0.881
NULL	Eur_J_Nucl_Med_Mol_Imaging_2005_Feb_4_32(2)_153-162.nxml.txt.nlp	15690223	SENT226	6	6	10	10	imatinib	FDG	PA10804	23583	0.881
NULL	Oncotarget_2014_Feb_25_5(5)_1304-1314.nxml.txt.nlp	24675421	SENT53	1	1	21	21	cisplatin	RIP1	PA449014	10928;7386	0.881
NULL	Anticancer_Agents_Med_Chem_2010_Oct_10(8)_617-624.nxml.txt.nlp	21182469	SENT165	17	17	13	13	pemetrexed	ABCC11	PA10810	85320	0.881
NULL	Biomed_Res_Int_2013_Aug_6_2013_602987.nxml.txt.nlp	24027759	SENT308	26	26	21	21	doxorubicin	SMF	PA449412	22993	0.881
NULL	Int_J_Nanomedicine_2009_Apr_1_4_27-35.nxml.txt.nlp	19421368	SENT176	10	10	22	22	genistein	IL-2	PA165109660	3558	0.881
NULL	Mol_Biol_Cell_2012_Nov_15_23(22)_4335-4346.nxml.txt.nlp	22993211	SENT306	27	27	7	7	galactose	DHFR	PA449725	1719	0.881
NULL	J_Oncol_2010_Jun_27_2010_757908.nxml.txt.nlp	20652061	SENT132	11	11	34	34	choline	HIF-1	PA448976	29072	0.881
NULL	J_Exp_Bot_2012_May_15_63(8)_2961-2970.nxml.txt.nlp	22345639	SENT218	28	28	36	36	arsenite	ANOVA	PA452638	4858	0.881
NULL	Exp_Ther_Med_2013_Apr_5_5(4)_1259-1263.nxml.txt.nlp	23596498	SENT26	3	3	10	10	propofol	TRPV1	PA451141	7442	0.881
NULL	Clin_Mol_Allergy_2007_Jan_25_5_1.nxml.txt.nlp	17254346	SENT212	19	19	0	0	curcumin	IFN	PA151958596	3439	0.881
NULL	Eur_J_Epidemiol_2009_Sep_2_24(9)_553-572.nxml.txt.nlp	19728115	SENT1537	18	18	9	9	acenocoumarol	CYP2C9	PA452632	1559	0.881
NULL	Int_J_Biol_Sci_2011_Nov_5_8(1)_1-14.nxml.txt.nlp	22211100	SENT170	8	8	25	25	evodiamine	Bcl-2	PA165860788	596	0.881
NULL	Int_J_Mol_Sci_2014_Sep_23_15(9)_16975-16997.nxml.txt.nlp	25250913	SENT1108	6	6	23	23	iloprost	Rho	PA164746843	29984	0.881
NULL	Br_J_Pharmacol_2014_May_171(10)_2659-2670.nxml.txt.nlp	24116661	SENT285	0	0	15	15	naringenin	TRPP2	PA151958361	5311	0.881
NULL	J_Korean_Med_Sci_2008_Aug_25_23(4)_685-690.nxml.txt.nlp	18756058	SENT59	24	24	17	17	olanzapine	ghrelin	PA450688	51738	0.881
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT96	9	9	27	27	atorvastatin	survivin	PA448500	332	0.881
NULL	Br_J_Pharmacol_2010_Sep_161(2)_308-320.nxml.txt.nlp	20735417	SENT241	18	18	24	24	rimonabant	GPR55	PA152407999	9290	0.881
NULL	Mol_Biol_Cell_2013_Aug_15_24(16)_2582-2592.nxml.txt.nlp	23783032	SENT114	24	24	11	11	bortezomib	FANCL	PA10252	55120	0.881
NULL	Nat_Med_2013_Mar_3_19(3)_295-304.nxml.txt.nlp	23377280	SENT82	39	39	21	21	erlotinib	EGFR	PA134687924	1956	0.881
NULL	Comp_Hepatol_2004_Jan_14_3(Suppl_1)_S37.nxml.txt.nlp	14960189	SENT24	5	5	22	22	collagenase	TNF-alpha	PA449107	7124	0.881
NULL	Acta_Pharmacol_Sin_2010_Aug_5_31(8)_938-943.nxml.txt.nlp	20686519	SENT133	8	8	1	1	reserpine	GML	PA451236	2765	0.881
NULL	J_Korean_Assoc_Oral_Maxillofac_Surg_2014_Dec_26_40(6)_291-296.nxml.txt.nlp	25551094	SENT126	4	4	22	22	alendronate	M-CSF	PA448082	1435	0.881
NULL	Exp_Ther_Med_2014_Nov_26_8(5)_1611-1615.nxml.txt.nlp	25289068	SENT112	22	22	3	3	mitoxantrone	P-gp	PA450526	5243	0.881
NULL	Br_J_Cancer_2013_Jul_9_109(1)_68-75.nxml.txt.nlp	23807173	SENT211	6	6	11	11	cisplatin	ANOVA	PA449014	4858	0.881
NULL	Clin_Pediatr_Endocrinol_2007_May_17_16(2)_37-44.nxml.txt.nlp	24790343	SENT91	20	20	25	25	estradiol	aromatase	PA449503	1588	0.881
NULL	Case_Rep_Transplant_2011_Jan_5_2011_210178.nxml.txt.nlp	23213600	SENT69	35	35	37	37	efavirenz	CYP3A	PA449441	1574	0.881
NULL	ScientificWorldJournal_2012_Apr_26_2012_215231.nxml.txt.nlp	22629121	SENT29	16	16	7	7	cyclophosphamide	CHOP	PA449165	1649	0.881
NULL	Biosci_Rep_2013_Oct_31_33(5)_e00078.nxml.txt.nlp	24073800	SENT164	22	22	8	8	capsaicin	TRPV1	PA448776	7442	0.881
NULL	Exp_Diabetes_Res_2012_Oct_15_2012_465282.nxml.txt.nlp	23118742	SENT151	12	12	3	3	metformin	FGF21	PA450395	26291	0.881
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT107	11	11	5	5	atorvastatin	IL-6	PA448500	3569	0.881
NULL	Iran_J_Basic_Med_Sci_2011_Nov-Dec_14(6)_485-498.nxml.txt.nlp	23493821	SENT122	18	18	12	12	tacrolimus	CYP3A5	PA451578	1577	0.881
NULL	Mol_Cells_2014_Sep_30_37(9)_699-704.nxml.txt.nlp	25245523	SENT118	19	19	26	26	doxorubicin	CTX	PA449412	1593	0.881
NULL	BMJ_2011_Jun_17_342_d3527.nxml.txt.nlp	21685437	SENT14	37	37	34	34	ticagrelor	P2Y12	PA165374673	64805	0.881
NULL	Int_J_Ion_Mobil_Spectrom_2009_Aug_1_12(3)_91-102.nxml.txt.nlp	20835390	SENT127	24	24	28	28	glucosamine	mol	PA164747613	90527	0.881
NULL	Clin_Pharmacol_2012_Feb_20_4_13-20.nxml.txt.nlp	22427735	SENT100	17	17	9	9	clopidogrel	CYP2C19	PA449053	1557	0.881
NULL	Acta_Pharmacol_Sin_2011_Feb_4_32(2)_230-238.nxml.txt.nlp	21293475	SENT118	31	31	10	10	troglitazone	aP2	PA451799	2167	0.881
NULL	Breast_Cancer_Res_2009_Oct_12_11(5)_R74.nxml.txt.nlp	19821999	SENT26	0	0	31	31	bortezomib	Bcl-2	PA10252	596	0.881
NULL	Contemp_Oncol_(Pozn)_2012_Jan_4_16(6)_461-466.nxml.txt.nlp	23788931	SENT76	35	35	31	31	doxorubicin	CHOP	PA449412	1649	0.881
NULL	Clin_Med_Insights_Oncol_2011_Sep_21_5_315-323.nxml.txt.nlp	22084620	SENT232	3	3	5	5	gemcitabine	IFN	PA449748	3439	0.881
NULL	Acta_Pharmacol_Sin_2014_Jun_4_35(6)_752-757.nxml.txt.nlp	24902786	SENT96	10	10	25	25	letrozole	STL2	PA450196	1301	0.881
NULL	Br_J_Cancer_2012_Oct_9_107(8)_1327-1336.nxml.txt.nlp	22990650	SENT109	20	20	16	16	cisplatin	FGF1	PA449014	2246	0.881
NULL	Indian_J_Anaesth_2012_Jul-Aug_56(4)_430-431.nxml.txt.nlp	23087482	SENT3	0	0	12	12	heparin	ACT	PA449855	12;11332;9457;641455	0.881
NULL	Acta_Pharmacol_Sin_2010_Jul_28_31(7)_867-873.nxml.txt.nlp	20581857	SENT17	13	13	0	0	docetaxel	PDCD4	PA449383	27250	0.881
NULL	J_Histochem_Cytochem_2013_Feb_61(2)_101-115.nxml.txt.nlp	23092791	SENT188	12	12	7	7	heparin	VEGF-A	PA449855	7422	0.881
NULL	Cancer_Imaging_2008_Nov_25_8(1)_199-205.nxml.txt.nlp	19028612	SENT118	3	3	6	6	bevacizumab	EGFR	PA130232992	1956	0.881
NULL	Indian_J_Urol_2009_Apr-Jun_25(2)_186-189.nxml.txt.nlp	19672343	SENT49	39	39	8	8	methotrexate	GTS	PA450428	2973	0.881
NULL	Indian_J_Crit_Care_Med_2008_Oct-Dec_12(4)_181-189.nxml.txt.nlp	19742267	SENT111	4	4	7	7	alefacept	CD2	PA164748040	914	0.881
NULL	Mol_Cancer_2008_Mar_26_7_27.nxml.txt.nlp	18366759	SENT78	8	8	12	12	etoposide	HIF-1	PA449552	29072	0.881
NULL	Br_J_Cancer_2009_May_19_100(10)_1523-1529.nxml.txt.nlp	19401686	SENT81	4	4	10	10	tanespimycin	HER-2	PA165291490	2064	0.881
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT75	7	7	21	21	curcumin	TRAIL	PA151958596	8743	0.881
NULL	Oncotarget_2011_Sep_9_2(9)_658-668.nxml.txt.nlp	21911919	SENT65	2	2	4	4	daunorubicin	HO-1	PA449212	3162	0.881
NULL	Br_J_Cancer_2004_Mar_22_90(6)_1285-1292.nxml.txt.nlp	15026814	SENT194	13	13	16	16	doxorubicin	p53	PA449412	7157	0.881
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT134	13	13	0	0	tenofovir	ABCB1	PA10204	5243	0.881
NULL	Cancer_Cell_Int_2014_Jul_2_14_59.nxml.txt.nlp	25120382	SENT93	15	15	17	17	metformin	Met	PA450395	79811	0.881
NULL	Sci_Rep_2014_Dec_8_4_7355.nxml.txt.nlp	25483453	SENT12	21	21	35	35	tamoxifen	aromatase	PA451581	1588	0.881
NULL	Exp_Hematol_2008_Sep_36(9-2)_1167-1175.nxml.txt.nlp	18550257	SENT65	30	30	23	23	l-glutamine	M-CSF	PA10090	1435	0.881
NULL	J_Cell_Biol_2002_Jun_24_157(7)_1151-1160.nxml.txt.nlp	12082077	SENT100	15	15	3	3	trypsin	COX	PA451806	1351	0.881
NULL	Oncogene_2010_Jun_24_29(25)_3639-3649.nxml.txt.nlp	20453883	SENT272	15	15	7	7	doxycycline	HIF-1	PA449415	29072	0.881
NULL	Curr_Oncol_2009_Jul_16(Suppl_2)_S1-S13.nxml.txt.nlp	19672416	SENT243	12	12	10	10	paroxetine	CYP2D6	PA450801	1565	0.881
NULL	Indian_J_Pharm_Sci_2014_Jan-Feb_76(1)_72-77.nxml.txt.nlp	24799741	SENT117	17	17	8	8	phenytoin	CYP2C9	PA450947	1559	0.881
NULL	J_Oncol_2012_Nov_1_2012_707156.nxml.txt.nlp	23193402	SENT60	23	23	5	5	iodine	NIS	PA450049	6528	0.881
NULL	Arthritis_Res_Ther_2005_Mar_30_7(3)_111-113.nxml.txt.nlp	15899059	SENT13	31	31	41	41	adalimumab	IL-6	PA10004	3569	0.881
NULL	Indian_J_Hum_Genet_2014_Apr-Jun_20(2)_175-184.nxml.txt.nlp	25400347	SENT136	10	10	0	0	warfarin	CYP2C9	PA451906	1559	0.881
NULL	Breast_Cancer_Res_2010_Mar_19_12(2)_104.nxml.txt.nlp	20346095	SENT30	21	21	3	3	tamoxifen	BRCA1	PA451581	672	0.881
NULL	Nat_Genet_2011_Jan_12_43(1)_27-33.nxml.txt.nlp	21151129	SENT112	23	23	18	18	tamoxifen	FOXA1	PA451581	3169	0.881
NULL	Cancer_2011_Apr_15_117(8)_1670-1678.nxml.txt.nlp	21472714	SENT167	18	18	6	6	cisplatin	SIRT3	PA449014	23410	0.881
NULL	Indian_J_Pharmacol_2008_Oct_40(Suppl_2)_S97-S112.nxml.txt.nlp	21593984	SENT465	10	10	21	21	benazepril	STZ	PA448561	6484	0.881
NULL	Genome_Biol_2003_Sep_11_4(10)_R69.nxml.txt.nlp	14519204	SENT92	19	19	10	10	tetracycline	MYC	PA451640	4609	0.881
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_3_2014_473213.nxml.txt.nlp	25538791	SENT110	26	26	0	0	fexofenadine	MDR1	PA449621	5243	0.881
NULL	Am_J_Cardiovasc_Drugs_2014_Oct_31_14(2)_79-87.nxml.txt.nlp	24174174	SENT28	2	2	22	22	pravastatin	adiponectin	PA451089	9370	0.881
NULL	Pharmaceutics_2011_Jul_13_3(3)_425-439.nxml.txt.nlp	24310588	SENT15	15	15	8	8	oxycodone	OTC	PA450741	5009	0.881
NULL	Breast_Cancer_Res_2011_Jun_10_13(3)_211.nxml.txt.nlp	21672282	SENT75	6	6	14	14	trastuzumab	HER2	PA451743	2064	0.881
NULL	Clin_Med_Case_Rep_2009_Jul_31_2_43-49.nxml.txt.nlp	24179373	SENT94	41	41	9	9	hydrocortisone	CD33	PA449905	945	0.881
NULL	Pharmaceutics_2011_Sep_14_3(3)_615-635.nxml.txt.nlp	24310600	SENT641	25	25	10	10	elacridar	ABCB1		5243	0.881
NULL	Breast_Cancer_Res_2001_Mar_26_3(3)_180-182.nxml.txt.nlp	11305952	SENT24	19	19	12	12	exemestane	aromatase	PA449563	1588	0.881
NULL	Biologics_2012_Feb_1_6_31-35.nxml.txt.nlp	22355257	SENT63	26	26	13	13	rituximab	IL-7	PA451261	3574	0.881
NULL	Nucleic_Acids_Res_2013_May_5_41(10)_5210-5222.nxml.txt.nlp	23563151	SENT86	30	30	6	6	arsenite	GADD45	PA452638	1647	0.881
NULL	NMR_Biomed_2013_Oct_7_26(10)_1258-1270.nxml.txt.nlp	23564602	SENT54	10	10	36	36	estradiol	MRI	PA449503	78996	0.881
NULL	Viruses_2014_Feb_10_6(2)_709-726.nxml.txt.nlp	24517971	SENT391	10	10	8	8	maraviroc	CCR5	PA164768835	1234	0.881
NULL	Ecancermedicalscience_2009_Oct_29_3_157.nxml.txt.nlp	22276018	SENT416	12	12	31	31	tamoxifen	ATAC	PA451581	6375	0.881
NULL	Eur_J_Med_Res_2014_Sep_16_19(1)_50.nxml.txt.nlp	25223338	SENT49	16	16	38	38	docetaxel	ERCC1	PA449383	2067	0.881
NULL	Ann_Dermatol_2014_Aug_31_26(4)_517-520.nxml.txt.nlp	25143685	SENT25	32	32	11	11	tazarotene	TIG3	PA164746821	5920	0.881
NULL	Eur_J_Med_Res_2011_Feb_24_16(2)_71-75.nxml.txt.nlp	21463985	SENT122	19	19	10	10	vinblastine	HAI	PA451877	6692;6768	0.881
NULL	Acta_Pharmacol_Sin_2012_Jan_3_33(1)_49-56.nxml.txt.nlp	22212430	SENT97	4	4	17	17	thrombin	PAR-1	PA451674	2011;2149	0.881
NULL	Mol_Biol_Cell_2012_Mar_15_23(6)_996-1009.nxml.txt.nlp	22278744	SENT86	26	26	3	3	forskolin	14-3-3	PA146096022	10971	0.881
NULL	Autophagy_2013_Mar_1_9(3)_317-327.nxml.txt.nlp	23242206	SENT96	5	5	21	21	chloroquine	CASP3	PA448948	836	0.881
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2010_Aug_3_3_43-51.nxml.txt.nlp	22879786	SENT84	26	26	22	22	rifampin	CYP2C8	PA451250	1558	0.881
NULL	Curr_Opin_Organ_Transplant_2015_Feb_8_20(1)_94-102.nxml.txt.nlp	25565444	SENT68	11	11	1	1	alemtuzumab	SPK	PA164783958	55872;8189	0.881
NULL	Cell_Commun_Signal_2011_May_15_9_13.nxml.txt.nlp	21569639	SENT320	43	43	23	23	quinacrine	p53	PA164745551	7157	0.881
NULL	Islets_2012_Jan_1_4(1)_64-70.nxml.txt.nlp	22504862	SENT202	30	30	8	8	dipyridamole	GMP	PA449367	22978	0.881
NULL	J_Occup_Med_Toxicol_2008_Feb_27_3(Suppl_1)_S6.nxml.txt.nlp	18315837	SENT95	10	10	26	26	montelukast	IFN	PA450546	3439	0.881
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_May_22_66(Pt_6)_o1414.nxml.txt.nlp	21579493	SENT58	25	25	6	6	ethanol	mol	PA448073	90527	0.881
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_4_2013_378657.nxml.txt.nlp	23662132	SENT382	6	6	9	9	genistein	AMPK	PA165109660	5563	0.881
NULL	Cancers_(Basel)_2014_Apr_16_6(2)_926-957.nxml.txt.nlp	24743778	SENT990	18	18	0	0	tamoxifen	STAT3	PA451581	6774	0.881
NULL	Blood_Cancer_J_2013_Mar_1_3(3)_e103.nxml.txt.nlp	23454896	SENT89	5	5	9	9	ritonavir	AKT	PA451260	207	0.881
NULL	J_Cell_Biol_1965_Jan_1_24(1)_31-37.nxml.txt.nlp	14286295	SENT5	8	8	26	26	aluminium	P31	PA164760864	529	0.881
NULL	Acta_Pharmacol_Sin_2013_Sep_5_34(9)_1192-1200.nxml.txt.nlp	23685957	SENT127	0	0	8	8	curcumin	FasL	PA151958596	356	0.881
NULL	Evid_Based_Complement_Alternat_Med_2013_Aug_22_2013_423164.nxml.txt.nlp	24027594	SENT236	9	9	0	0	berberine	AP-1	PA165860812	2353;3727;2354;3725	0.881
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Mar_9_67(Pt_4)_o815.nxml.txt.nlp	21754101	SENT64	22	22	14	14	ethanol	mol	PA448073	90527	0.881
NULL	Ther_Clin_Risk_Manag_2007_Jun_3(2)_333-339.nxml.txt.nlp	18360642	SENT86	18	18	22	22	cyclophosphamide	NNT	PA449165	23530	0.881
NULL	Exp_Diabetes_Res_2011_Jun_22_2011_279530.nxml.txt.nlp	21747825	SENT164	8	8	0	0	liraglutide	GLP-1	PA165958364	100125288	0.881
NULL	Int_J_Biomed_Sci_2007_Jun_3(2)_123-130.nxml.txt.nlp	23675034	SENT44	16	16	34	34	ranitidine	RAN	PA451224	5901	0.881
NULL	Clin_Interv_Aging_2014_Apr_8_9_593-601.nxml.txt.nlp	24748777	SENT137	4	4	17	17	denosumab	RANKL	PA166048634	8600	0.881
NULL	Br_J_Cancer_2012_May_22_106(11)_1779-1789.nxml.txt.nlp	22549178	SENT31	6	6	11	11	pertuzumab	HER2		2064	0.881
NULL	Front_Oncol_2014_Sep_23_4_264.nxml.txt.nlp	25295231	SENT99	18	18	2	2	lenalidomide	p53	PA162363968	7157	0.881
NULL	Nucleic_Acids_Res_2012_Jul_30_40(13)_6319-6337.nxml.txt.nlp	22467215	SENT274	28	28	7	7	cisplatin	Bcl-2	PA449014	596	0.881
NULL	Brain_Sci_2013_Mar_7_3(1)_215-238.nxml.txt.nlp	23667741	SENT78	21	21	11	11	glibenclamide	CTR	PA449782	799	0.881
NULL	Cell_Death_Dis_2010_Nov_18_1(11)_e102.nxml.txt.nlp	21368867	SENT337	18	18	12	12	gentamicin	14-3-3	PA449753	10971	0.881
NULL	Diabetes_Care_2013_Aug_17_36(Suppl_2)_S145-S148.nxml.txt.nlp	23882039	SENT101	6	6	33	33	exenatide	GLP-1	PA164749238	100125288	0.881
NULL	Br_J_Cancer_2010_Nov_9_103(10)_1554-1561.nxml.txt.nlp	20959830	SENT164	13	13	19	19	axitinib	VEGFR	PA164924493	3791	0.881
NULL	Mucosal_Immunol_2014_Mar_24_7(2)_335-347.nxml.txt.nlp	23881354	SENT335	5	5	7	7	galantamine	GAL	PA449726	51083	0.881
NULL	Leukemia_2014_Apr_14_28(4)_961-964.nxml.txt.nlp	24418991	SENT46	9	9	30	30	nilotinib	P-gp	PA165958345	5243	0.881
NULL	Oxid_Med_Cell_Longev_2012_Jun_3_2012_914273.nxml.txt.nlp	22701758	SENT235	7	7	20	20	resveratrol	CD4		920	0.881
NULL	Clin_Interv_Aging_2012_Jul_12_7_235-247.nxml.txt.nlp	22866001	SENT131	34	34	45	45	alendronate	PTH	PA448082	5741	0.881
NULL	Cancer_Inform_2014_Oct_14_13(Suppl_1)_103-111.nxml.txt.nlp	25392688	SENT225	23	23	31	31	domperidone	CYP3A5	PA134711056	1577	0.881
NULL	Cancer_Manag_Res_2014_Jun_6_6_267-278.nxml.txt.nlp	24944518	SENT135	31	31	0	0	finasteride	PC3	PA449627	57332;7832;5122	0.881
NULL	J_Clin_Biochem_Nutr_2011_May_13_48(3)_237-244.nxml.txt.nlp	21562645	SENT163	15	15	27	27	resveratrol	AMPK		5563	0.881
NULL	Eur_J_Clin_Pharmacol_2012_Sep_15_68(9)_1267-1274.nxml.txt.nlp	22418828	SENT34	13	13	10	10	pantoprazole	CYP2C19	PA450774	1557	0.881
NULL	Nat_Chem_Biol_2013_Sep_7_9(9)_557-564.nxml.txt.nlp	23831757	SENT77	26	26	36	36	itraconazole	A20	PA450132	7128;28935	0.881
NULL	Nat_Med_2011_Dec_4_18(1)_111-119.nxml.txt.nlp	22138751	SENT59	29	29	18	18	doxycycline	TERT	PA449415	7015	0.881
NULL	Orphanet_J_Rare_Dis_2013_Feb_12_8_23.nxml.txt.nlp	23398819	SENT168	32	32	20	20	creatine	BTHS	PA164778930	6901	0.881
NULL	Environ_Health_Perspect_2006_May_13_114(5)_740-745.nxml.txt.nlp	16675430	SENT35	9	9	2	2	estradiol	CYP1B1	PA449503	1545	0.881
NULL	Front_Oncol_2014_Jun_18_4_153.nxml.txt.nlp	24995158	SENT175	4	4	9	9	doxorubicin	c-Jun	PA449412	3725	0.881
NULL	Biomed_Eng_Online_2013_Dec_4_12_125.nxml.txt.nlp	24304500	SENT128	18	18	33	33	ethanol	ADM	PA448073	133	0.881
NULL	Case_Rep_Transplant_2013_Aug_28_2013_969186.nxml.txt.nlp	24066254	SENT23	12	12	3	3	tacrolimus	IL-2	PA451578	3558	0.881
NULL	Curr_Med_Chem_2011_Jun_18(18)_2686-2714.nxml.txt.nlp	21649578	SENT608	22	22	16	16	carboplatin	PI3K	PA448803	5290	0.881
NULL	Indian_J_Med_Paediatr_Oncol_2014_Apr-Jun_35(2)_140-142.nxml.txt.nlp	25197175	SENT61	26	26	15	15	panitumumab	NRAS	PA162373091	4893	0.881
NULL	J_Neural_Transm_2014_Feb_19_121(7)_707-715.nxml.txt.nlp	24549572	SENT206	16	16	27	27	clonazepam	CB1	PA449050	1268	0.881
NULL	J_Res_Med_Sci_2010_Nov-Dec_15(6)_348-358.nxml.txt.nlp	21526108	SENT34	16	16	0	0	thrombin	PAR-1	PA451674	2011;2149	0.881
NULL	Exp_Diabetes_Res_2012_Oct_26_2012_820989.nxml.txt.nlp	22110480	SENT88	18	18	5	5	rosiglitazone	LYRM1	PA451283	57149	0.881
NULL	Exp_Anim_2014_Apr_26_63(2)_257-267.nxml.txt.nlp	24770651	SENT94	2	2	14	14	perindopril	apelin	PA450877	8862	0.881
NULL	Carcinogenesis_2010_Dec_23_31(12)_2111-2117.nxml.txt.nlp	20732909	SENT56	33	33	25	25	dextran	SN1	PA449261	10991	0.881
NULL	Br_J_Cancer_2011_Mar_1_104(5)_741-745.nxml.txt.nlp	21266975	SENT91	0	0	8	8	everolimus	TORC1	PA164746311	23373	0.881
NULL	J_Anim_Sci_Biotechnol_2013_Jul_30_4(1)_27.nxml.txt.nlp	23899038	SENT197	3	3	34	34	l-cysteine	IFN	PA449173	3439	0.881
NULL	Korean_Circ_J_2013_Aug_31_43(8)_541-549.nxml.txt.nlp	24044013	SENT104	39	39	24	24	ticagrelor	CYP2C19	PA165374673	1557	0.881
NULL	Leukemia_2014_Mar_13_28(3)_629-641.nxml.txt.nlp	24263804	SENT367	22	22	6	6	imatinib	PAK2	PA10804	5062	0.881
NULL	Acta_Physiol_(Oxf)_2012_Feb_204(2)_227-237.nxml.txt.nlp	21624095	SENT191	17	17	7	7	propofol	TRPC5	PA451141	7224	0.881
NULL	Mol_Cancer_2004_Nov_17_3_31.nxml.txt.nlp	15548330	SENT290	13	13	34	34	etoposide	PC-3	PA449552	692094	0.881
NULL	Autophagy_2013_Jan_1_9(1)_20-32.nxml.txt.nlp	23075929	SENT87	27	27	16	16	chloroquine	PC-3	PA448948	692094	0.881
NULL	Breast_Cancer_Res_2012_Feb_14_14(1)_R30.nxml.txt.nlp	22333315	SENT17	12	12	18	18	celecoxib	CXCL9	PA448871	4283	0.881
NULL	Mol_Cancer_2007_Mar_7_6_18.nxml.txt.nlp	17343740	SENT245	37	37	6	6	pamidronate	CD44	PA450767	960	0.881
NULL	Adv_Pharmacol_Sci_2013_May_12_2013_313858.nxml.txt.nlp	23737767	SENT101	19	19	14	14	abatacept	ACR	PA164747080	49	0.881
NULL	Drug_Saf_2014_Feb_19_37(4)_201-211.nxml.txt.nlp	24550106	SENT116	26	26	39	39	moclobemide	CYP2C19	PA452615	1557	0.881
NULL	Ther_Clin_Risk_Manag_2006_Jun_2(2)_129-158.nxml.txt.nlp	18360588	SENT213	7	7	11	11	vinorelbine	CYP3A4	PA451881	1576	0.881
NULL	Am_J_Trop_Med_Hyg_2012_Sep_5_87(3)_437-446.nxml.txt.nlp	22848096	SENT13	19	19	8	8	pyrimethamine	ACT	PA451193	12;11332;9457;641455	0.881
NULL	Oncol_Rep_2013_Oct_24_30(4)_1587-1592.nxml.txt.nlp	23900512	SENT120	18	18	26	26	tranylcypromine	NOXA	PA451741	5366	0.881
NULL	Curr_Chem_Genomics_2011_Aug_22_5_62-71.nxml.txt.nlp	21966346	SENT90	11	11	2	2	tranylcypromine	LSD1	PA451741	23028	0.881
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jun_26_66(Pt_7)_o1807.nxml.txt.nlp	21588016	SENT60	26	26	14	14	ethanol	mol	PA448073	90527	0.881
NULL	Mol_Immunol_2009_Mar_46(6)_1149-1162.nxml.txt.nlp	19100624	SENT212	22	22	31	31	chlorpromazine	C5L2	PA448964	27202	0.881
NULL	Breast_Cancer_Res_2013_Oct_18_15(5)_R97.nxml.txt.nlp	24135425	SENT20	28	28	34	34	lapatinib	DM1	PA152241907	338023;1760;28509	0.881
NULL	Mol_Cancer_2008_Apr_7_7_29.nxml.txt.nlp	18394172	SENT35	22	22	1	1	docetaxel	BRCA1	PA449383	672	0.881
NULL	Br_J_Cancer_2014_Jan_7_110(1)_55-62.nxml.txt.nlp	24263064	SENT28	23	23	28	28	gefitinib	EGFR	PA131301952	1956	0.881
NULL	J_Med_Life_2011_Feb_15_4(1)_11-20.nxml.txt.nlp	21505570	SENT208	19	19	12	12	flurbiprofen	FAAH	PA449683	79152;2166	0.881
NULL	Arthritis_Res_Ther_2005_Mar_16_7(Suppl_2)_S4-S14.nxml.txt.nlp	15833146	SENT223	6	6	32	32	sulfasalazine	IL-4	PA451547	3565	0.881
NULL	J_Allergy_(Cairo)_2011_Oct_24_2011_457169.nxml.txt.nlp	22121382	SENT220	13	13	22	22	salmeterol	IL-6	PA451300	3569	0.881
NULL	Acta_Diabetol_2012_Aug_11_49(4)_277-289.nxml.txt.nlp	21833779	SENT169	26	26	23	23	carbachol	ANOVA	PA448784	4858	0.881
NULL	Oncogene_2009_Jan_15_28(2)_279-288.nxml.txt.nlp	18836480	SENT66	8	8	38	38	pp2	PP2		4888	0.881
NULL	Target_Oncol_2013_Mar_30_8(1)_27-33.nxml.txt.nlp	23361373	SENT67	22	22	11	11	gefitinib	EGFR	PA131301952	1956	0.881
NULL	J_Infect_Dis_2012_Apr_15_205(8)_1278-1286.nxml.txt.nlp	22396598	SENT177	17	17	23	23	atovaquone	DHODH	PA448502	1723	0.881
NULL	Oncotarget_2014_Aug_19_5(18)_8703-8715.nxml.txt.nlp	25237928	SENT55	19	19	0	0	glucose	CD44	PA449773	960	0.881
NULL	Clin_Interv_Aging_2013_Jan_31_8_103-110.nxml.txt.nlp	23386786	SENT107	5	5	23	23	atorvastatin	IL-6	PA448500	3569	0.881
NULL	Oncologist_2011_Jan_6_16(1)_5-24.nxml.txt.nlp	21212434	SENT196	13	13	25	25	vincristine	IFN	PA451879	3439	0.881
NULL	Front_Oncol_2013_Apr_23_3_86.nxml.txt.nlp	23630663	SENT104	0	0	20	20	trastuzumab	DM1	PA451743	338023;1760;28509	0.881
NULL	Nucleic_Acids_Res_2013_May_20_41(9)_e104.nxml.txt.nlp	23519618	SENT98	35	35	26	26	etoposide	TPT	PA449552	23590;6469	0.881
NULL	Mol_Cancer_2012_Jun_18_11_41.nxml.txt.nlp	22709873	SENT293	13	13	15	15	lapatinib	RB1CC1	PA152241907	9821	0.881
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT22	10	10	3	3	gefitinib	KRAS	PA131301952	3845	0.881
NULL	Chonnam_Med_J_2014_Apr_22_50(1)_27-30.nxml.txt.nlp	24855605	SENT48	12	12	6	6	vincristine	CHOP	PA451879	1649	0.881
NULL	Angiogenesis_2010_Dec_7_13(4)_305-315.nxml.txt.nlp	20927579	SENT216	3	3	39	39	resveratrol	TSP1		7057	0.881
NULL	Aging_(Albany_NY)_2010_Oct_31_2(10)_669-677.nxml.txt.nlp	21076179	SENT96	16	16	30	30	vorinostat	PKR	PA164748224	5610	0.881
NULL	Crit_Care_2010_Oct_13_14(5)_R181.nxml.txt.nlp	20942931	SENT209	30	30	4	4	cisplatin	IL-6	PA449014	3569	0.881
NULL	J_Gynecol_Oncol_2013_Jan_8_24(1)_66-82.nxml.txt.nlp	23346316	SENT71	24	24	5	5	olaparib	BRCA1		672	0.881
NULL	Int_J_Hypertens_2013_Feb_14_2013_782861.nxml.txt.nlp	23476748	SENT31	41	41	37	37	losartan	AT1	PA450268	9197;185	0.881
NULL	F1000Res_2013_Oct_3_2_202.nxml.txt.nlp	24795806	SENT139	16	16	6	6	cidofovir	EGFR	PA448997	1956	0.881
NULL	Eur_Respir_J_2012_Apr_39(4)_807-819.nxml.txt.nlp	22467723	SENT208	14	14	40	40	isoniazid	DST	PA450112	667	0.881
NULL	Clin_Pract_2012_Nov_13_2(4)_e82.nxml.txt.nlp	24765481	SENT74	11	11	4	4	octreotide	ACTH	PA450678	5443	0.881
NULL	Mol_Pain_2012_Sep_24_8_74.nxml.txt.nlp	23006894	SENT68	40	40	25	25	amitriptyline	TNP1	PA448385	7141	0.881
NULL	Diabetes_2008_Sep_57(9)_2288-2295.nxml.txt.nlp	18535187	SENT122	6	6	14	14	pioglitazone	mol	PA450970	90527	0.881
NULL	Oncologist_2010_Sep_26_15(9)_944-953.nxml.txt.nlp	20798196	SENT30	28	28	21	21	anastrozole	aromatase	PA448432	1588	0.881
NULL	Pharmaceuticals_(Basel)_2012_Aug_10_5(8)_802-836.nxml.txt.nlp	24280676	SENT40	29	29	23	23	ribavirin	CNT2	PA451241	9153	0.881
NULL	Oncogenesis_2014_Dec_15_3(12)_e133.nxml.txt.nlp	25500906	SENT28	14	14	9	9	trastuzumab	PI3K	PA451743	5290	0.881
NULL	J_Oncol_2009_Mar_24_2009_491985.nxml.txt.nlp	19325924	SENT179	3	3	13	13	genistein	CXCR4	PA165109660	7852	0.881
NULL	Biomed_Eng_Online_2007_Apr_20_6_14.nxml.txt.nlp	17448235	SENT38	25	25	21	21	nadh	ADP	PA164755085	23038	0.881
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Mar_24_68(Pt_4)_o1159.nxml.txt.nlp	22606104	SENT53	8	8	27	27	ethanol	CO2	PA448073	4513	0.881
NULL	Evid_Based_Complement_Alternat_Med_2011_Jan_20_2011_713523.nxml.txt.nlp	21318104	SENT119	21	21	0	0	naproxen	SRM	PA450595	6723;6725	0.881
NULL	Sleep_Disord_2014_Feb_5_2014_527109.nxml.txt.nlp	24649369	SENT66	40	40	8	8	zolpidem	CYP2C19	PA451976	1557	0.881
NULL	Clin_Ophthalmol_2014_Jun_3_8_1057-1064.nxml.txt.nlp	24940042	SENT35	38	38	7	7	bevacizumab	CST	PA130232992	9514	0.881
NULL	Clin_Interv_Aging_2010_Dec_3_5_403-416.nxml.txt.nlp	21152242	SENT50	27	27	24	24	trandolapril	ACE	PA451737	1636	0.881
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT53	10	10	1	1	tenofovir	MRP7	PA10204	89845;1080	0.881
NULL	Indian_J_Pharm_Sci_2013_Jan-Feb_75(1)_94-98.nxml.txt.nlp	23901167	SENT30	8	8	28	28	tolbutamide	CYP2C9	PA451718	1559	0.881
NULL	Br_J_Haematol_2014_Jan_28_164(2)_233-244.nxml.txt.nlp	24206017	SENT21	28	28	11	11	lenalidomide	CRBN	PA162363968	51185	0.881
NULL	Mol_Cancer_2012_Dec_12_11_91.nxml.txt.nlp	23234355	SENT184	9	9	47	47	gefitinib	NKG2D	PA131301952	22914	0.881
NULL	Mol_Cancer_2010_May_26_9_123.nxml.txt.nlp	20504344	SENT127	14	14	30	30	fludarabine	p53	PA449655	7157	0.881
NULL	Emerg_Infect_Dis_2014_Aug_20(8)_1280-1286.nxml.txt.nlp	25061906	SENT22	18	18	5	5	sulfadoxine	DHFR	PA451540	1719	0.881
NULL	Br_J_Cancer_2011_Aug_23_105(5)_698-708.nxml.txt.nlp	21811256	SENT27	20	20	39	39	tamoxifen	aromatase	PA451581	1588	0.881
NULL	Nucleic_Acids_Res_2012_Jul_20_40(13)_6270-6289.nxml.txt.nlp	22434888	SENT325	17	17	9	9	galactose	Spc97p	PA449725	10844	0.881
NULL	Br_J_Cancer_1991_Aug_64(2)_215-220.nxml.txt.nlp	1892748	SENT9	21	21	35	35	cisplatin	CHIP	PA449014	10273	0.881
NULL	Eur_J_Clin_Pharmacol_2013_May_14_69(5)_1091-1101.nxml.txt.nlp	23150149	SENT88	29	29	12	12	glucose	AST	PA449773	26503	0.881
NULL	Front_Oncol_2013_Oct_1_3_237.nxml.txt.nlp	24098868	SENT289	32	32	18	18	temozolomide	PTEN	PA451609	5728	0.881
NULL	Br_J_Pharmacol_2008_Oct_18_155(4)_596-605.nxml.txt.nlp	18852694	SENT177	5	5	14	14	fenofibrate	SREBP2	PA449594	6721	0.881
NULL	BMB_Rep_2014_Jul_47(7)_388-392.nxml.txt.nlp	24286329	SENT9	4	4	22	22	berberine	AP-1	PA165860812	2353;3727;2354;3725	0.881
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Feb_6_66(Pt_3)_o541.nxml.txt.nlp	21580312	SENT56	5	5	19	19	l-asparagine	C10	PA164776968	113246	0.881
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT57	12	12	6	6	metformin	EGFR	PA450395	1956	0.881
NULL	AAPS_J_2013_Aug_20_15(4)_1119-1127.nxml.txt.nlp	23959685	SENT163	20	20	28	28	ketoprofen	CPE	PA450149	1363	0.881
NULL	Curr_Neuropharmacol_2009_Dec_7(4)_276-285.nxml.txt.nlp	20514207	SENT60	3	3	15	15	guanidine	Rho	PA164781028	29984	0.881
NULL	Br_J_Cancer_2004_Mar_22_90(6)_1285-1292.nxml.txt.nlp	15026814	SENT154	34	34	23	23	doxorubicin	p53	PA449412	7157	0.881
NULL	Breast_Cancer_Res_2013_Oct_3_15(5)_R93.nxml.txt.nlp	24088226	SENT0	25	25	15	15	tamoxifen	CYP2D6	PA451581	1565	0.881
NULL	Int_J_Appl_Basic_Med_Res_2012_Jul-Dec_2(2)_77-83.nxml.txt.nlp	23776817	SENT181	27	27	23	23	rifampin	CYP3A4	PA451250	1576	0.881
NULL	Clin_Sci_(Lond)_2013_Feb_1_124(Pt_3)_153-164.nxml.txt.nlp	23075334	SENT115	7	7	17	17	resveratrol	LKB1		6794	0.881
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_May_11_67(Pt_6)_o1372-o1373.nxml.txt.nlp	21754763	SENT78	22	22	6	6	ethanol	mol	PA448073	90527	0.881
NULL	Scientifica_(Cairo)_2013_Apr_17_2013_217513.nxml.txt.nlp	24278769	SENT187	10	10	22	22	cyclosporine	PPIase	PA449167	2281;2289;8468;2286;2287	0.881
NULL	Breast_Cancer_Res_2005_Mar_4_7(3)_R345-R352.nxml.txt.nlp	15987429	SENT134	11	11	20	20	indomethacin	COX	PA449982	1351	0.881
NULL	AIDS_Res_Ther_2013_May_1_10_10.nxml.txt.nlp	23634877	SENT156	14	14	3	3	atorvastatin	CCL3	PA448500	6348	0.881
NULL	Oncotarget_2014_Oct_29_5(22)_11168-11179.nxml.txt.nlp	25426553	SENT82	4	4	1	1	carboplatin	PI3K	PA448803	5290	0.881
NULL	Br_J_Cancer_2010_Feb_16_102(4)_658-664.nxml.txt.nlp	20104222	SENT56	13	13	10	10	sunitinib	IFN	PA162372840	3439	0.881
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT10	7	7	18	18	perifosine	JNK	PA165291471	5599	0.881
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Apr_29_67(Pt_5)_o1248-o1249.nxml.txt.nlp	21754540	SENT72	22	22	6	6	ethanol	mol	PA448073	90527	0.881
NULL	Front_Neuroanat_2011_Aug_26_5_50.nxml.txt.nlp	21904525	SENT1876	12	12	5	5	fluoxetine	DARPP-32	PA449673	84152	0.881
NULL	Evid_Based_Complement_Alternat_Med_2011_Mar_1_2011_207034.nxml.txt.nlp	21423686	SENT112	19	19	27	27	clopidogrel	CYP2C19	PA449053	1557	0.881
NULL	Arthritis_Res_Ther_2005_Jan_21_7(2)_55-61.nxml.txt.nlp	15743490	SENT106	6	6	35	35	simvastatin	CD83	PA451363	9308	0.881
NULL	Cancer_Cell_Int_2013_Jan_15_13_3.nxml.txt.nlp	23320839	SENT135	7	7	35	35	gefitinib	ABCC3	PA131301952	8714	0.881
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT107	9	9	20	20	trastuzumab	HER2	PA451743	2064	0.881
NULL	Leukemia_2013_Feb_3_27(2)_315-324.nxml.txt.nlp	22751450	SENT192	6	6	9	9	sorafenib	Mcl-1	PA7000	4170	0.881
NULL	Breast_Cancer_Res_2014_Sep_11_16(5)_430.nxml.txt.nlp	25212826	SENT15	7	7	22	22	fulvestrant	AKT	PA164747170	207	0.881
NULL	Breast_Cancer_Res_2002_Jun_21_4(5)_R9.nxml.txt.nlp	12223126	SENT116	4	4	8	8	tamoxifen	FasL	PA451581	356	0.881
NULL	Curr_Pain_Headache_Rep_2011_Aug_12_15(4)_271-279.nxml.txt.nlp	21479998	SENT149	20	20	10	10	oxymorphone	CYP3A4	PA450748	1576	0.881
NULL	Br_J_Cancer_2011_Aug_9_105(4)_523-533.nxml.txt.nlp	21792199	SENT257	12	12	18	18	erlotinib	EGF	PA134687924	1950	0.881
NULL	Oncogene_2009_Aug_27_28(34)_3022-3032.nxml.txt.nlp	19543317	SENT160	21	21	17	17	etoposide	BMI1	PA449552	648	0.881
NULL	Fibrogenesis_Tissue_Repair_2012_Apr_13_5_5.nxml.txt.nlp	22502865	SENT72	2	2	9	9	troglitazone	CCN2	PA451799	1490	0.881
NULL	Mol_Biol_Cell_2013_Dec_15_24(24)_3939-3944.nxml.txt.nlp	24152728	SENT106	5	5	22	22	tamoxifen	CCN2	PA451581	1490	0.881
NULL	Acta_Pharmacol_Sin_2011_Nov_19_32(11)_1387-1396.nxml.txt.nlp	21927014	SENT34	10	10	23	23	oxaliplatin	p53	PA131285527	7157	0.881
NULL	Case_Rep_Hematol_2014_Feb_10_2014_641483.nxml.txt.nlp	24660077	SENT77	38	38	19	19	rituximab	CHOP	PA451261	1649	0.881
NULL	Cardiol_Res_Pract_2013_Feb_19_2013_195456.nxml.txt.nlp	23533940	SENT78	6	6	3	3	cangrelor	P2Y12	PA165945763	64805	0.881
NULL	Iran_J_Reprod_Med_2012_Mar_10(2)_77-82.nxml.txt.nlp	25242977	SENT71	22	22	17	17	l-carnitine	F10	PA450154	2159	0.881
NULL	J_Biomed_Biotechnol_2010_Jun_7_2010_150960.nxml.txt.nlp	20617134	SENT224	21	21	35	35	cisplatin	KRAS	PA449014	3845	0.881
NULL	Nat_Commun_2013_Nov_15_4_2779.nxml.txt.nlp	24240534	SENT227	6	6	20	20	ethanol	CO2	PA448073	4513	0.881
NULL	Pharmaceutics_2012_Jan_31_4(1)_104-129.nxml.txt.nlp	24300183	SENT307	33	33	9	9	lidocaine	SMO	PA450226	6608;54498	0.881
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_39-54.nxml.txt.nlp	19305787	SENT237	0	0	25	25	ethanol	NR1	PA448073	27158	0.881
NULL	Mol_Biol_Cell_2013_Jun_15_24(12)_1996-2007.nxml.txt.nlp	23637462	SENT291	14	14	7	7	paraformaldehyde	p75	PA450790	7133;11168	0.881
NULL	Oncogene_2010_Sep_16_29(37)_5135-5145.nxml.txt.nlp	20622897	SENT76	18	18	21	21	cetuximab	STAT3	PA10040	6774	0.881
NULL	Mol_Cancer_2012_Dec_12_11_91.nxml.txt.nlp	23234355	SENT192	9	9	13	13	erlotinib	EGFR	PA134687924	1956	0.881
NULL	J_Inherit_Metab_Dis_2012_Jan_10_35(1)_141-149.nxml.txt.nlp	21556832	SENT187	23	23	1	1	creatine	CRTR	PA164778930	6535	0.881
NULL	Cancer_Manag_Res_2014_Mar_24_6_149-170.nxml.txt.nlp	24711712	SENT116	6	6	2	2	choline	IDH1	PA448976	3417	0.881
NULL	Nat_Med_2011_Oct_2_17(10)_1304-1309.nxml.txt.nlp	21963515	SENT36	0	0	23	23	tacrolimus	SPAK	PA451578	27347	0.881
NULL	J_Cell_Mol_Med_2013_Oct_23_17(10)_1207-1217.nxml.txt.nlp	24106980	SENT146	21	21	2	2	vinblastine	P-gp	PA451877	5243	0.881
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1709-1716.nxml.txt.nlp	19844235	SENT140	4	4	34	34	gemcitabine	B7-H3	PA449748	80381	0.881
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT90	14	14	20	20	cisplatin	XPA	PA449014	7507	0.881
NULL	Cancers_(Basel)_2010_Mar_30_2(2)_338-363.nxml.txt.nlp	24281073	SENT151	27	27	8	8	doxorubicin	GST5	PA449412	2947	0.881
NULL	Clin_Sci_(Lond)_2011_Nov_1_121(Pt_10)_449-458.nxml.txt.nlp	21671887	SENT183	30	30	38	38	phenylephrine	AMPK	PA450935	5563	0.881
NULL	Clin_Med_Insights_Oncol_2012_Dec_20_7_1-12.nxml.txt.nlp	23362372	SENT36	2	2	12	12	cabazitaxel	CYP3A	PA165958401	1574	0.881
NULL	Orphanet_J_Rare_Dis_2014_Mar_12_9_34.nxml.txt.nlp	24618404	SENT137	16	16	4	4	choline	CNTF	PA448976	1270	0.881
NULL	Aging_(Albany_NY)_2009_Mar_31_1(4)_412-424.nxml.txt.nlp	20195491	SENT158	5	5	10	10	resveratrol	TXNIP		10628	0.881
NULL	Oncoimmunology_2012_Mar_1_1(2)_179-188.nxml.txt.nlp	22720239	SENT44	41	41	38	38	etoposide	EGFR	PA449552	1956	0.881
NULL	Pharmacogn_Rev_2011_Jan-Jun_5(9)_1-12.nxml.txt.nlp	22096313	SENT156	0	0	18	18	estradiol	aromatase	PA449503	1588	0.881
NULL	J_Biol_Chem_2008_May_30_283(22)_15440-15450.nxml.txt.nlp	18385140	SENT161	4	4	20	20	trypsin	PTPMT1	PA451806	114971	0.881
NULL	Biomed_Imaging_Interv_J_2008_Jul_1_4(3)_e38.nxml.txt.nlp	21611004	SENT147	29	29	21	21	exemestane	aromatase	PA449563	1588	0.881
NULL	Evid_Based_Complement_Alternat_Med_2014_May_8_2014_364819.nxml.txt.nlp	24899907	SENT65	6	6	3	3	tacrolimus	FKBP52	PA451578	2288	0.881
NULL	Asian_J_Androl_2015_Aug_15_Jan-Feb_17(1)_143-148.nxml.txt.nlp	25155105	SENT28	38	38	15	15	udenafil	SEP	PA164776753	79258;5364	0.881
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_O3.nxml.txt.nlp	NULL	SENT21	3	3	12	12	amoxicillin	HLA-DRB1	PA448406	3123	0.881
NULL	Br_J_Cancer_2003_Mar_24_88(6)_910-917.nxml.txt.nlp	12644829	SENT80	7	7	23	23	tetracycline	TRAIL	PA451640	8743	0.881
NULL	Curr_Neuropharmacol_2010_Jun_8(2)_122-127.nxml.txt.nlp	21119883	SENT46	10	10	19	19	capsaicin	TRPV1	PA448776	7442	0.881
NULL	J_Cell_Mol_Med_2014_Dec_7_18(12)_2536-2552.nxml.txt.nlp	25287328	SENT149	7	7	0	0	estradiol	PKD1	PA449503	5310	0.881
NULL	Ann_Oncol_2010_Feb_21(2)_217-222.nxml.txt.nlp	20110292	SENT114	21	21	34	34	erlotinib	PSPH	PA134687924	5723	0.881
NULL	EMBO_Mol_Med_2013_May_22_5(5)_776-794.nxml.txt.nlp	23606583	SENT183	44	44	42	42	maraviroc	CCL5	PA164768835	6352	0.881
NULL	Curr_Chem_Genomics_2010_Mar_1_4_1-8.nxml.txt.nlp	20448812	SENT120	28	28	42	42	bosentan	OATP1B1	PA10034	10599	0.881
NULL	Adipocyte_2012_Oct_1_1(4)_256-258.nxml.txt.nlp	23700542	SENT9	19	19	8	8	resveratrol	AMPK		5563	0.881
NULL	Oncotarget_2014_Jan_11_5(3)_693-703.nxml.txt.nlp	24525337	SENT167	33	33	27	27	resveratrol	p53		7157	0.881
NULL	Int_J_Biomed_Imaging_2013_Feb_26_2013_230487.nxml.txt.nlp	23533377	SENT161	27	27	15	15	panitumumab	HER2	PA162373091	2064	0.881
NULL	J_Cell_Sci_2013_Nov_15_126(22)_5259-5270.nxml.txt.nlp	24006262	SENT674	7	7	1	1	hyaluronan	LYVE-1	PA165958431	10894	0.881
NULL	Mol_Cancer_2007_Sep_26_6_61.nxml.txt.nlp	17894897	SENT272	20	20	3	3	etoposide	HIF-1	PA449552	29072	0.881
NULL	Clin_Med_Insights_Cardiol_2010_Dec_1_4_117-128.nxml.txt.nlp	21151850	SENT266	13	13	4	4	ticagrelor	ABCB1	PA165374673	5243	0.881
NULL	Crit_Care_2009_Mar_13_13(Suppl_1)_P328.nxml.txt.nlp	NULL	SENT5	17	17	0	0	cosyntropin	RAI	PA164749052	10848;6050	0.881
NULL	Eur_J_Clin_Pharmacol_2010_Jun_31_66(6)_579-590.nxml.txt.nlp	20354687	SENT291	14	14	6	6	tacrolimus	MDR1	PA451578	5243	0.881
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT20	12	12	30	30	trastuzumab	HER2	PA451743	2064	0.881
NULL	J_Biol_2003_Sep_24_2(4)_28.nxml.txt.nlp	14511394	SENT150	21	21	14	14	phenformin	AMPK	PA1000	5563	0.881
NULL	Glycoconj_J_2011_Oct_6_28(7)_481-492.nxml.txt.nlp	21894462	SENT234	10	10	3	3	galactose	UGT	PA449725	7361;7355	0.881
NULL	Aging_(Albany_NY)_2009_Feb_11_1(2)_234-244.nxml.txt.nlp	20157512	SENT4	6	6	12	12	indomethacin	COX	PA449982	1351	0.881
NULL	Bone_Marrow_Transplant_2011_Mar_24_46(3)_430-435.nxml.txt.nlp	20498647	SENT25	2	2	20	20	infliximab	IL2	PA452639	3558	0.881
NULL	J_Oncol_2009_May_6_2009_567486.nxml.txt.nlp	19424511	SENT157	21	21	17	17	sunitinib	IFN	PA162372840	3439	0.881
NULL	Int_J_Endocrinol_2011_Mar_6_2011_415719.nxml.txt.nlp	21461394	SENT67	3	3	24	24	cinacalcet	PTH	PA164776671	5741	0.881
NULL	Clinics_(Sao_Paulo)_2013_Feb_68(2)_253-262.nxml.txt.nlp	23525324	SENT217	29	29	8	8	genistein	Gen	PA165109660	348654	0.881
NULL	Mol_Biol_Cell_2013_Sep_15_24(18)_2795-2806.nxml.txt.nlp	23904266	SENT97	23	23	9	9	hydroxyurea	GRK2	PA449942	156	0.881
NULL	Front_Oncol_2014_May_20_4_111.nxml.txt.nlp	24904826	SENT160	24	24	30	30	olaparib	BRCA2		675	0.881
NULL	Clin_Ophthalmol_2009_Jun_2_3_175-182.nxml.txt.nlp	19668562	SENT113	3	3	24	24	bevacizumab	San	PA130232992	80218	0.881
NULL	Nat_Genet_2011_Jan_12_43(1)_27-33.nxml.txt.nlp	21151129	SENT74	4	4	0	0	tamoxifen	FOXA1	PA451581	3169	0.881
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S279-S284.nxml.txt.nlp	21525469	SENT94	18	18	14	14	liraglutide	GLP-1	PA165958364	100125288	0.881
NULL	J_Immunother_Cancer_2014_Nov_6_2(Suppl_3)_P13.nxml.txt.nlp	NULL	SENT4	10	10	15	15	cetuximab	EGFR	PA10040	1956	0.881
NULL	Ecancermedicalscience_2010_Feb_3_4_164.nxml.txt.nlp	22276026	SENT805	12	12	10	10	erlotinib	EGFR	PA134687924	1956	0.881
NULL	Evid_Based_Complement_Alternat_Med_2012_May_7_2012_242810.nxml.txt.nlp	22645625	SENT323	15	15	26	26	rifampin	CYP3A4	PA451250	1576	0.881
NULL	Eur_J_Epidemiol_2007_Nov_23_22(11)_819-829.nxml.txt.nlp	17955331	SENT706	19	19	14	14	acenocoumarol	CYP2C9	PA452632	1559	0.881
NULL	Theranostics_2013_Jan_15_3(1)_47-75.nxml.txt.nlp	23382786	SENT349	11	11	24	24	chloroquine	CXCR4	PA448948	7852	0.881
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT163	0	0	2	2	metformin	ADP	PA450395	23038	0.881
NULL	Saudi_J_Anaesth_2013_Jan-Mar_7(1)_14-17.nxml.txt.nlp	23717225	SENT39	28	28	9	9	hydrocortisone	CO2	PA449905	4513	0.881
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT221	6	6	11	11	perifosine	DR5	PA165291471	8795	0.881
NULL	Archaea_2010_Dec_23_2010_690737.nxml.txt.nlp	21234345	SENT14	28	28	9	9	betaine	C-1	PA448603	5203	0.881
NULL	Int_J_Mol_Sci_2014_Sep_23_15(9)_16911-16935.nxml.txt.nlp	25250910	SENT107	3	3	28	28	potassium	mol	PA451047	90527	0.881
NULL	Front_Physiol_2013_May_20_4_101.nxml.txt.nlp	23730288	SENT145	38	38	3	3	allopurinol	HL-1	PA448320	55600	0.881
NULL	Iran_J_Basic_Med_Sci_2012_Jul-Aug_15(4)_997-1002.nxml.txt.nlp	23493662	SENT102	29	29	13	13	triamcinolone	HDL2	PA451749	57338	0.881
NULL	Cells_2014_Apr_8_3(2)_258-287.nxml.txt.nlp	24717323	SENT101	25	25	5	5	capsaicin	TRPV1	PA448776	7442	0.881
NULL	Oncogene_2011_Apr_21_30(16)_1855-1867.nxml.txt.nlp	21151168	SENT258	13	13	28	28	ethanol	IL3	PA448073	3562	0.881
NULL	Chin_J_Cancer_2011_May_30(5)_287-292.nxml.txt.nlp	21527061	SENT98	33	33	11	11	crizotinib	EML4	PA165946122	27436	0.881
NULL	Oncogene_2010_Sep_23_29(38)_5299-5310.nxml.txt.nlp	20622903	SENT101	13	13	4	4	oxaliplatin	HMGB1	PA131285527	3146	0.881
NULL	Int_J_Biol_Sci_2014_Feb_20_10(3)_268-277.nxml.txt.nlp	24644425	SENT107	0	0	9	9	metformin	p62	PA450395	8878;10657;23636	0.881
NULL	Mol_Cell_Biochem_2014_Oct_9_385(1-2)_265-275.nxml.txt.nlp	24104452	SENT147	4	4	16	16	bortezomib	U87	PA10252	677775;641648	0.881
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_75-89.nxml.txt.nlp	17912638	SENT381	40	40	2	2	exemestane	aromatase	PA449563	1588	0.881
NULL	Cancers_(Basel)_2013_Jul_26_5(3)_943-958.nxml.txt.nlp	24202328	SENT842	7	7	13	13	olaparib	BRCA2		675	0.881
NULL	Mol_Cancer_2010_May_28_9_130.nxml.txt.nlp	20509890	SENT94	4	4	10	10	etoposide	TGFBI	PA449552	7045	0.881
NULL	Braz_J_Med_Biol_Res_2014_Feb_17_47(2)_101-109.nxml.txt.nlp	24519125	SENT210	26	26	20	20	isoproterenol	IL-6	PA450121	3569	0.881
NULL	Behav_Brain_Funct_2008_Aug_15_4_37.nxml.txt.nlp	18702828	SENT135	18	18	5	5	methamphetamine	FZD3	PA450403	7976;8326	0.881
NULL	EMBO_Mol_Med_2012_Jan_4(1)_52-67.nxml.txt.nlp	22174013	SENT235	18	18	16	16	tamoxifen	NR2E3	PA451581	10002	0.881
NULL	Cancer_Cell_Int_2011_Aug_19_11_29.nxml.txt.nlp	21854619	SENT157	31	31	4	4	cisplatin	BRCA1	PA449014	672	0.881
NULL	J_Cell_Biol_2000_Jul_10_150(1)_155-164.nxml.txt.nlp	10893264	SENT114	8	8	29	29	choline	CD95	PA448976	355	0.881
NULL	Evid_Based_Complement_Alternat_Med_2012_May_7_2012_242810.nxml.txt.nlp	22645625	SENT194	13	13	16	16	rifampin	CYP3A4	PA451250	1576	0.881
NULL	Oncotarget_2013_Feb_26_4(2)_298-309.nxml.txt.nlp	23593653	SENT62	6	6	13	13	quinacrine	p16	PA164745551	1029	0.88
NULL	Breast_Cancer_Res_2010_Jun_24_12(3)_R41.nxml.txt.nlp	20576088	SENT245	4	4	14	14	paclitaxel	MT3	PA450761	4504	0.88
NULL	Ann_Hematol_2010_Nov_25_89(11)_1115-1124.nxml.txt.nlp	20499237	SENT119	25	25	2	2	cladribine	CD19	PA449027	930	0.88
NULL	Environ_Health_Perspect_1983_Apr_50_163-168.nxml.txt.nlp	6135607	SENT5	9	9	20	20	pentobarbital	PHB	PA450859	5245	0.88
NULL	Patient_Prefer_Adherence_2014_Apr_8_8_463-471.nxml.txt.nlp	24748775	SENT67	2	2	43	43	denosumab	OPG	PA166048634	690	0.88
NULL	Cardiol_Res_Pract_2012_Jan_5_2012_909154.nxml.txt.nlp	22347666	SENT235	13	13	2	2	clopidogrel	P2Y12	PA449053	64805	0.88
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Mar_10_66(Pt_4)_o790.nxml.txt.nlp	21580629	SENT58	18	18	4	4	ethanol	mol	PA448073	90527	0.88
NULL	Biomed_Res_Int_2014_Jan_29_2014_196249.nxml.txt.nlp	24605321	SENT172	20	20	8	8	bortezomib	ORP150	PA10252	10525	0.88
NULL	Nat_Med_2011_Dec_11_18(1)_74-82.nxml.txt.nlp	22157681	SENT111	17	17	0	0	erlotinib	PTEN	PA134687924	5728	0.88
NULL	Ann_Oncol_2011_Dec_17_22(12)_2610-2615.nxml.txt.nlp	21415234	SENT46	2	2	11	11	lapatinib	HER2	PA152241907	2064	0.88
NULL	Oncotarget_2013_Jun_4_4(5)_772-784.nxml.txt.nlp	23800712	SENT204	11	11	0	0	cetuximab	EGFR	PA10040	1956	0.88
NULL	Br_J_Cancer_2011_Nov_22_105(11)_1628-1634.nxml.txt.nlp	22009028	SENT70	41	41	0	0	flutamide	Men	PA449685	8178	0.88
NULL	J_Immunol_Methods_2009_Jan_1_340(1)_11-24.nxml.txt.nlp	18929568	SENT143	2	2	30	30	dasatinib	CD4	PA162372878	920	0.88
NULL	Diabetes_2008_Sep_57(9)_2288-2295.nxml.txt.nlp	18535187	SENT11	4	4	12	12	pioglitazone	mol	PA450970	90527	0.88
NULL	Cancers_(Basel)_2010_Aug_18_2(3)_1576-1596.nxml.txt.nlp	24281174	SENT223	5	5	36	36	etoposide	CD123	PA449552	3563	0.88
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT12	17	17	11	11	neratinib	HER2	PA165291472	2064	0.88
NULL	Arthritis_Res_Ther_2006_May_11_8(3)_209.nxml.txt.nlp	16712713	SENT80	20	20	16	16	aspirin	COX	PA448497	1351	0.88
NULL	Cell_Biol_Int_Rep_(2010)_2012_Jun_21_19(1)_e00017.nxml.txt.nlp	23124518	SENT137	1	1	5	5	etoposide	TRAIL-R2	PA449552	8795	0.88
NULL	Arch_Med_Sci_2012_May_9_8(2)_375-388.nxml.txt.nlp	22662015	SENT256	40	40	26	26	lansoprazole	CYP3A4	PA450180	1576	0.88
NULL	J_Cancer_2013_Sep_10_4(8)_614-625.nxml.txt.nlp	24155773	SENT207	35	35	15	15	etoposide	CRM1	PA449552	7514	0.88
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_15_2012_726025.nxml.txt.nlp	23118796	SENT49	14	14	24	24	l-glutamine	FBS	PA10090	64319;26269	0.88
NULL	Cardiol_Ther_2013_Jun_26_2(1)_69-84.nxml.txt.nlp	25135290	SENT104	5	5	13	13	paclitaxel	DES	PA450761	1674	0.88
NULL	J_Cell_Biol_1998_Jan_26_140(2)_335-345.nxml.txt.nlp	9442109	SENT206	12	12	30	30	chloroquine	NHE	PA448948	285335	0.88
NULL	JRSM_Cardiovasc_Dis_2012_Sep_24_1(6)_cvd_2012_012015.nxml.txt.nlp	24175073	SENT36	11	11	8	8	clopidogrel	CYP2C19	PA449053	1557	0.88
NULL	J_Geriatr_Cardiol_2013_Sep_10(3)_272-280.nxml.txt.nlp	24133516	SENT225	42	42	29	29	carbachol	SM22	PA448784	6876	0.88
NULL	Breast_Cancer_Res_2001_Oct_1_3(6)_361-364.nxml.txt.nlp	11737886	SENT61	15	15	2	2	cyclophosphamide	p53	PA449165	7157	0.88
NULL	Br_J_Cancer_2010_Jun_29_103(1)_61-72.nxml.txt.nlp	20588279	SENT34	5	5	24	24	trastuzumab	HER-2	PA451743	2064	0.88
NULL	Cancer_Med_2012_Oct_16_1(2)_207-217.nxml.txt.nlp	23342270	SENT204	16	16	32	32	saracatinib	PIK3CA		5290	0.88
NULL	Mol_Cancer_2008_Oct_23_7_82.nxml.txt.nlp	18947424	SENT279	25	25	7	7	doxazosin	EGF	PA449407	1950	0.88
NULL	Arthritis_Res_Ther_2011_Sep_30_13(5)_242.nxml.txt.nlp	21996023	SENT154	36	36	7	7	infliximab	BEST	PA452639	7439	0.88
NULL	Oncotarget_2014_Nov_8_5(21)_10280-10292.nxml.txt.nlp	25373733	SENT3	16	16	21	21	bevacizumab	HIF-1	PA130232992	29072	0.88
NULL	J_Cancer_2013_Sep_27_4(8)_662-670.nxml.txt.nlp	24155778	SENT49	14	14	0	0	cisplatin	UCHL1	PA449014	7345	0.88
NULL	Mol_Pain_2013_Jan_2_9_1.nxml.txt.nlp	23279936	SENT136	30	30	20	20	capsaicin	TRPV1	PA448776	7442	0.88
NULL	Oncol_Lett_2014_May_4_7(5)_1352-1362.nxml.txt.nlp	24765137	SENT155	37	37	10	10	cisplatin	Bcl-2	PA449014	596	0.88
NULL	Ther_Clin_Risk_Manag_2006_Dec_2(4)_389-400.nxml.txt.nlp	18360651	SENT149	19	19	7	7	infliximab	IMPACT	PA452639	55364	0.88
NULL	Endocrinol_Diabetes_Metab_Case_Rep_2014_Mar_1_2014_140001.nxml.txt.nlp	24683487	SENT62	3	3	18	18	cabergoline	ACTH	PA448708	5443	0.88
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1145.nxml.txt.nlp	24675463	SENT162	9	9	5	5	cetuximab	EGFR	PA10040	1956	0.88
NULL	Breast_Cancer_Res_2012_May_4_14(3)_R72.nxml.txt.nlp	22559056	SENT34	17	17	9	9	tamoxifen	CENP-A	PA451581	1058	0.88
NULL	Br_J_Pharmacol_2012_Apr_165(8)_2611-2619.nxml.txt.nlp	21718301	SENT16	9	9	7	7	rimonabant	GPR55	PA152407999	9290	0.88
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_79-96.nxml.txt.nlp	19305789	SENT266	0	0	8	8	ethanol	TRPM8	PA448073	79054	0.88
NULL	Adv_Ther_2014_May_13_31(5)_473-493.nxml.txt.nlp	24821599	SENT138	16	16	5	5	dabigatran	TTR		7276	0.88
NULL	Aging_(Albany_NY)_2009_May_22_1(6)_557-572.nxml.txt.nlp	20195383	SENT2	13	13	8	8	creatine	gamma	PA164778930	9913	0.88
NULL	Breast_Cancer_Res_Treat_2013_Oct_4_141(3)_385-395.nxml.txt.nlp	24091769	SENT30	3	3	19	19	trastuzumab	PTEN	PA451743	5728	0.88
NULL	Indian_J_Pharmacol_2008_Oct_40(Suppl_2)_S112-S142.nxml.txt.nlp	21593965	SENT237	0	0	14	14	ezetimibe	STZ	PA10816	6484	0.88
NULL	Pharmaceutics_2011_Oct_12_3(4)_680-705.nxml.txt.nlp	24309303	SENT80	23	23	13	13	repaglinide	SLCO1B1	PA451234	10599	0.88
NULL	Neuropsychopharmacology_2009_Jul_11_34(8)_1946-1957.nxml.txt.nlp	19279569	SENT94	6	6	13	13	cocaine	DOR	PA449072	58476	0.88
NULL	Cardiol_Res_Pract_2013_Feb_21_2013_127270.nxml.txt.nlp	23509665	SENT175	29	29	21	21	clopidogrel	ADP	PA449053	23038	0.88
NULL	Mol_Neurodegener_2010_Nov_10_5_49.nxml.txt.nlp	21067594	SENT88	12	12	5	5	staurosporine	PTEN	PA165109623	5728	0.88
NULL	Breast_Cancer_Res_Treat_2015_Nov_27_149_31-39.nxml.txt.nlp	25428789	SENT200	8	8	14	14	olaparib	BRCA2		675	0.88
NULL	Eur_J_Immunol_2014_Jun_10_44(6)_1759-1769.nxml.txt.nlp	24595810	SENT91	7	7	22	22	fludrocortisone	CD4	PA164743961	920	0.88
NULL	Clin_Epigenetics_2011_Nov_1_3(1)_5.nxml.txt.nlp	22414227	SENT148	3	3	34	34	imipramine	HDAC5	PA449969	10014	0.88
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT111	5	5	2	2	doxorubicin	B7-H1	PA449412	29126	0.88
NULL	Cancer_Cell_Int_2011_Aug_19_11_29.nxml.txt.nlp	21854619	SENT275	3	3	6	6	platinum	HDAC	PA150595617	9734	0.88
NULL	Nat_Methods_2013_Aug_9_10(8)_795-803.nxml.txt.nlp	23749299	SENT188	27	27	18	18	estradiol	IFN	PA449503	3439	0.88
NULL	BMB_Rep_2014_Mar_47(3)_130-134.nxml.txt.nlp	24499668	SENT22	3	3	36	36	trastuzumab	HER2	PA451743	2064	0.88
NULL	Cancer_Metab_2014_May_28_2(Suppl_1)_P84.nxml.txt.nlp	NULL	SENT20	22	22	11	11	metformin	SMAD2	PA450395	4087	0.88
NULL	Acta_Pharmacol_Sin_2011_Oct_15_32(10)_1233-1238.nxml.txt.nlp	21841815	SENT142	13	13	5	5	naloxone	CTX	PA450586	1593	0.88
NULL	Cancer_Metab_2014_Jan_3_2_1.nxml.txt.nlp	24383451	SENT114	20	20	3	3	l-cysteine	TIGAR	PA449173	57103	0.88
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT22	20	20	3	3	gefitinib	KRAS	PA131301952	3845	0.88
NULL	Breast_Cancer_Res_2007_Aug_8_9(4)_R50.nxml.txt.nlp	17686159	SENT195	5	5	8	8	trastuzumab	HRG	PA451743	3084;3273	0.88
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT26	6	6	13	13	perifosine	TRAIL	PA165291471	8743	0.88
NULL	Acta_Pharmacol_Sin_2009_Jul_22_30(7)_956-964.nxml.txt.nlp	19543298	SENT5	7	7	18	18	atorvastatin	ABCG2	PA448500	9429	0.88
NULL	Front_Behav_Neurosci_2014_Sep_24_8_317.nxml.txt.nlp	25309368	SENT146	12	12	3	3	choline	EGR1	PA448976	1958	0.88
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S279-S284.nxml.txt.nlp	21525469	SENT97	13	13	7	7	exenatide	GLP-1	PA164749238	100125288	0.88
NULL	Cardiovasc_Diabetol_2013_Jul_17_12_105.nxml.txt.nlp	23866022	SENT123	6	6	12	12	atorvastatin	A-FABP	PA448500	2167	0.88
NULL	Neural_Dev_2011_Feb_1_6_4.nxml.txt.nlp	21284844	SENT208	29	29	23	23	bumetanide	NKCC1	PA448682	6558	0.88
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jan_21_68(Pt_2)_m185-m186.nxml.txt.nlp	22346857	SENT59	30	30	39	39	doxorubicin	MDR1	PA449412	5243	0.88
NULL	Mol_Cells_2014_Sep_30_37(9)_664-671.nxml.txt.nlp	25234467	SENT14	18	18	12	12	cisplatin	KRAS	PA449014	3845	0.88
NULL	Ann_Hematol_2014_Sep_10_93(1)_1-11.nxml.txt.nlp	24018623	SENT135	6	6	20	20	lenalidomide	CDC25C	PA162363968	995	0.88
NULL	JAKSTAT_2013_Jan_1_2(1)_e23576.nxml.txt.nlp	24058797	SENT35	2	2	13	13	staurosporine	IFN	PA165109623	3439	0.88
NULL	Br_J_Cancer_2010_Oct_26_103(9)_1380-1390.nxml.txt.nlp	20877355	SENT182	40	40	27	27	vincristine	FasL	PA451879	356	0.88
NULL	Ann_Indian_Acad_Neurol_2010_Oct-Dec_13(4)_241-246.nxml.txt.nlp	21264130	SENT172	16	16	31	31	phenytoin	KLS	PA450947	6199	0.88
NULL	J_Immunother_2014_Feb_21_37(2)_105-114.nxml.txt.nlp	24509173	SENT147	22	22	17	17	gemcitabine	WT1	PA449748	7490	0.88
NULL	Front_Microbiol_2015_Jan_15_5_798.nxml.txt.nlp	25642226	SENT50	15	15	6	6	oxygen	HIF1	PA450744	3091	0.88
NULL	Apoptosis_2012_Sep_30_17(9)_989-997.nxml.txt.nlp	22460505	SENT118	28	28	16	16	thioridazine	p27	PA451666	5715;10534	0.88
NULL	Arthritis_Res_Ther_2009_Nov_17_11(6)_R173.nxml.txt.nlp	19919704	SENT255	11	11	23	23	hyaluronan	CD44	PA165958431	960	0.88
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT215	0	0	19	19	chloroquine	BMP9	PA448948	2658	0.88
NULL	Environ_Health_Perspect_2010_May_22_118(5)_627-634.nxml.txt.nlp	20439172	SENT37	10	10	3	3	resveratrol	AMPK		5563	0.88
NULL	Arthritis_Res_Ther_2008_Aug_22_10(4)_R97.nxml.txt.nlp	18718031	SENT181	19	19	2	2	rituximab	BAFF	PA451261	10673	0.88
NULL	Breast_Cancer_Res_2003_Feb_5_5(2)_113-116.nxml.txt.nlp	12631392	SENT103	13	13	23	23	trastuzumab	HER-2	PA451743	2064	0.88
NULL	Mol_Cancer_2008_Jun_5_7_50.nxml.txt.nlp	18534018	SENT72	4	4	0	0	bortezomib	Mcl-1	PA10252	4170	0.88
NULL	Breast_Cancer_Res_2011_Mar_1_13(2)_R21.nxml.txt.nlp	21362200	SENT310	14	14	32	32	fulvestrant	PIK3CA	PA164747170	5290	0.88
NULL	Front_Physiol_2013_Dec_24_4_386.nxml.txt.nlp	24399968	SENT195	11	11	23	23	glimepiride	SUR2	PA449761	10060	0.88
NULL	Front_Immunol_2012_May_7_3_101.nxml.txt.nlp	22783250	SENT244	3	3	10	10	papain	IL-4	PA450778	3565	0.88
NULL	Virol_J_2009_Jul_24_6_114.nxml.txt.nlp	19630958	SENT57	27	27	0	0	l-glutamine	ACH2	PA10090	641371	0.88
NULL	Ann_Rheum_Dis_2008_Sep_11_68(7)_1146-1152.nxml.txt.nlp	18794178	SENT159	31	31	23	23	sulfasalazine	ACR	PA451547	49	0.88
NULL	Nat_Neurosci_2012_Sep_5_15(9)_1245-1254.nxml.txt.nlp	22864611	SENT457	34	34	10	10	fluoxetine	mGlu2	PA449673	2912	0.88
NULL	Br_J_Cancer_2013_Jul_23_109(2)_502-511.nxml.txt.nlp	23799850	SENT167	8	8	5	5	gemcitabine	SMARCC1	PA449748	6599	0.88
NULL	Biosci_Rep_2014_Aug_6_34(4)_e00131.nxml.txt.nlp	24975826	SENT10	13	13	0	0	pp2	TRPA1		8989	0.88
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Apr_25_65(Pt_5)_o1118.nxml.txt.nlp	21583930	SENT68	17	17	8	8	ethanol	mol	PA448073	90527	0.88
NULL	Clin_Interv_Aging_2012_Dec_30_7_1-13.nxml.txt.nlp	22291468	SENT136	42	42	35	35	dronedarone	CYP3A4	PA153619853	1576	0.88
NULL	Eur_J_Med_Res_2010_Feb_26_15(2)_47-53.nxml.txt.nlp	20452883	SENT15	13	13	1	1	fentanyl	ESG	PA449599	7089;7088;7090;7091	0.88
NULL	Mol_Biol_Cell_2014_Jul_1_25(13)_2116-2127.nxml.txt.nlp	24807908	SENT70	23	23	29	29	hemin	p66	PA449849	6464	0.88
NULL	Core_Evid_2009_Jun_15_4_181-189.nxml.txt.nlp	20694074	SENT6	6	6	3	3	tocilizumab	IL-6	PA165292659	3569	0.88
NULL	J_Biol_Chem_2008_Jun_13_283(24)_16293-16298.nxml.txt.nlp	18397880	SENT10	18	18	21	21	curcumin	p300	PA151958596	2033	0.88
NULL	Target_Oncol_2013_Jun_27_8(2)_127-136.nxml.txt.nlp	23625191	SENT79	10	10	17	17	panitumumab	KRAS	PA162373091	3845	0.88
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT120	18	18	29	29	metformin	HIF-1	PA450395	29072	0.88
NULL	Mol_Biol_Int_2011_Jun_8_2011_571242.nxml.txt.nlp	22091408	SENT380	4	4	11	11	lovastatin	MRP1	PA450272	4437	0.88
NULL	Leukemia_2013_Apr_14_27(4)_803-812.nxml.txt.nlp	23238589	SENT153	42	42	38	38	dasatinib	IFN	PA162372878	3439	0.88
NULL	Pharmaceuticals_(Basel)_2013_May_23_6(6)_689-699.nxml.txt.nlp	24276256	SENT108	13	13	6	6	nifedipine	PTB	PA450631	58155	0.88
NULL	J_Occup_Med_Toxicol_2008_Feb_27_3(Suppl_1)_S6.nxml.txt.nlp	18315837	SENT95	10	10	20	20	montelukast	IL-13	PA450546	3596	0.88
NULL	Oncogene_2009_Aug_27_28(34)_3022-3032.nxml.txt.nlp	19543317	SENT209	23	23	6	6	etoposide	p53	PA449552	7157	0.88
NULL	J_Lipid_Res_2014_Oct_55(10)_2103-2112.nxml.txt.nlp	25139399	SENT111	4	4	10	10	atorvastatin	LDLR	PA448500	3949	0.88
NULL	Br_J_Pharmacol_2008_Nov_11_155(6)_896-905.nxml.txt.nlp	18695641	SENT115	5	5	15	15	genistein	OPG	PA165109660	690	0.88
NULL	Curr_Neuropharmacol_2013_Dec_11(6)_652-663.nxml.txt.nlp	24396340	SENT78	12	12	14	14	oxaliplatin	TRPA1	PA131285527	8989	0.88
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_P122.nxml.txt.nlp	NULL	SENT3	0	0	12	12	abacavir	HLA-B	PA448004	3106	0.88
NULL	Glia_2013_Aug_6_61(8)_1331-1346.nxml.txt.nlp	23832647	SENT101	21	21	33	33	clodronate	DKK2	PA10239	27123	0.88
NULL	Mar_Drugs_2011_Apr_28_9(5)_719-738.nxml.txt.nlp	21673885	SENT376	4	4	2	2	ethanol	CO2	PA448073	4513	0.88
NULL	Blood_Cancer_J_2013_Oct_4_3(10)_e150.nxml.txt.nlp	24096714	SENT157	35	35	18	18	bortezomib	TNFSF2	PA10252	7124	0.88
NULL	Ann_Indian_Acad_Neurol_2009_Oct-Dec_12(4)_273-282.nxml.txt.nlp	20182575	SENT39	27	27	5	5	mitoxantrone	IFN	PA450526	3439	0.88
NULL	Oncol_Lett_2014_May_11_7(5)_1401-1408.nxml.txt.nlp	24765145	SENT135	7	7	16	16	paclitaxel	HIF-1	PA450761	29072	0.88
NULL	Clin_Ophthalmol_2012_Dec_13_6_1-4.nxml.txt.nlp	22259229	SENT70	16	16	33	33	travoprost	BAK	PA164781371	578	0.88
NULL	J_Immunother_Cancer_2014_Nov_6_2(Suppl_3)_P210.nxml.txt.nlp	NULL	SENT14	26	26	10	10	curcumin	PD-L1	PA151958596	29126	0.88
NULL	Mol_Cancer_2008_Jun_30_7_60.nxml.txt.nlp	18590557	SENT168	9	9	22	22	vincristine	TRAIL	PA451879	8743	0.88
NULL	Mol_Biol_Cell_2013_Dec_1_24(23)_3620-3633.nxml.txt.nlp	24109599	SENT90	30	30	6	6	galactose	S20	PA449725	6224	0.88
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1495-1502.nxml.txt.nlp	21989186	SENT148	16	16	28	28	cetuximab	KRAS	PA10040	3845	0.88
NULL	Br_J_Cancer_2013_Mar_19_108(5)_1079-1091.nxml.txt.nlp	23449353	SENT27	20	20	29	29	docetaxel	CD133	PA449383	8842	0.88
NULL	Oncoscience_2014_Mar_24_1(3)_196-204.nxml.txt.nlp	25594012	SENT71	23	23	18	18	erlotinib	EGFR	PA134687924	1956	0.88
NULL	Oncotarget_2014_Jun_7_5(13)_5017-5028.nxml.txt.nlp	24970809	SENT147	4	4	0	0	carboplatin	GCIP	PA448803	23582	0.88
NULL	Mol_Cancer_2011_Sep_30_10_125.nxml.txt.nlp	21962244	SENT29	3	3	0	0	dasatinib	EPHA2	PA162372878	1969	0.88
NULL	Braz_J_Med_Biol_Res_2012_Mar_9_45(4)_357-365.nxml.txt.nlp	22392189	SENT139	10	10	19	19	capsaicin	EPM	PA448776	2054	0.88
NULL	Cancers_(Basel)_2014_Apr_16_6(2)_926-957.nxml.txt.nlp	24743778	SENT2098	2	2	10	10	niclosamide	STAT3	PA165958408	6774	0.88
NULL	Breast_Cancer_Res_2009_Jul_15_11(4)_207.nxml.txt.nlp	19664181	SENT46	11	11	7	7	trastuzumab	MUC4	PA451743	4585	0.88
NULL	Breast_Cancer_Res_2005_Apr_6_7(3)_119-130.nxml.txt.nlp	15987442	SENT38	17	17	31	31	tamoxifen	N-CoR	PA451581	9611	0.88
NULL	Br_J_Haematol_2008_Mar_3_144(5)_677-685.nxml.txt.nlp	19055662	SENT87	19	19	13	13	vincristine	CHOP	PA451879	1649	0.88
NULL	Neuropsychopharmacology_2009_Oct_24_34(11)_2442-2449.nxml.txt.nlp	19553914	SENT26	20	20	18	18	ly686017	NK1R		6869	0.88
NULL	Oxid_Med_Cell_Longev_2013_Jun_5_2013_485201.nxml.txt.nlp	23840918	SENT55	27	27	18	18	collagenase	F12	PA449107	2161	0.88
NULL	Acta_Pharmacol_Sin_2009_Jan_8_30(1)_1-24.nxml.txt.nlp	19060915	SENT382	4	4	16	16	sildenafil	APE	PA451346	55704;328	0.88
NULL	J_Hematol_Oncol_2009_Apr_22_2_18.nxml.txt.nlp	19386128	SENT112	32	32	11	11	irinotecan	KRAS	PA450085	3845	0.88
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT161	17	17	2	2	trastuzumab	MUC1	PA451743	4582	0.88
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1150.nxml.txt.nlp	24675468	SENT93	40	40	5	5	ethanol	AMPK	PA448073	5563	0.88
NULL	Indian_J_Orthop_2014_Mar-Apr_48(2)_158-162.nxml.txt.nlp	24741137	SENT70	6	6	16	16	mannitol	B12	PA450320	7126;4709	0.88
NULL	Acta_Pharmacol_Sin_2014_Jun_4_35(6)_752-757.nxml.txt.nlp	24902786	SENT94	14	14	8	8	letrozole	STZ	PA450196	6484	0.88
NULL	Front_Behav_Neurosci_2011_Sep_28_5_64.nxml.txt.nlp	21991251	SENT78	45	45	18	18	estradiol	CB1	PA449503	1268	0.88
NULL	Clin_Cosmet_Investig_Dermatol_2011_Jul_1_4_93-99.nxml.txt.nlp	21760744	SENT99	13	13	5	5	acitretin	IL-22	PA448039	50616;53342	0.88
NULL	Adipocyte_2014_Jul_1_3(3)_180-189.nxml.txt.nlp	25068084	SENT246	2	2	23	23	pioglitazone	gamma	PA450970	9913	0.88
NULL	Int_J_Lab_Hematol_2009_Aug_31(4)_468-470.nxml.txt.nlp	18294236	SENT13	15	15	28	28	rituximab	CHOP	PA451261	1649	0.88
NULL	J_Thorac_Oncol_2014_Feb_23_9(2)_231-238.nxml.txt.nlp	24419421	SENT192	19	19	45	45	cisplatin	EGFR	PA449014	1956	0.88
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_6_2014_270930.nxml.txt.nlp	25431606	SENT28	10	10	6	6	losartan	AT1	PA450268	9197;185	0.88
NULL	J_Biomed_Sci_2012_Nov_21_19(1)_99.nxml.txt.nlp	23170833	SENT165	12	12	17	17	atorvastatin	CXCR4	PA448500	7852	0.88
NULL	Diabetes_Metab_Syndr_Obes_2014_Jun_24_7_229-239.nxml.txt.nlp	25018644	SENT55	19	19	6	6	liraglutide	GLP-1	PA165958364	100125288	0.88
NULL	Br_J_Cancer_2010_Sep_7_103(6)_889-898.nxml.txt.nlp	20664599	SENT204	19	19	9	9	paclitaxel	HER-2	PA450761	2064	0.88
NULL	J_Ophthalmic_Inflamm_Infect_2013_Feb_11_3_31.nxml.txt.nlp	23514571	SENT21	20	20	2	2	mitomycin	PRK	PA450524	1263	0.88
NULL	Oxid_Med_Cell_Longev_2012_Jan_19_2012_390678.nxml.txt.nlp	22315655	SENT69	5	5	7	7	gliclazide	NAC	PA10892	22861	0.88
NULL	Oncotarget_2013_Dec_18_5(2)_375-385.nxml.txt.nlp	24495868	SENT116	24	24	7	7	fludarabine	BCL2	PA449655	596	0.88
NULL	AIDS_Res_Ther_2009_Apr_9_6_3.nxml.txt.nlp	19358725	SENT57	27	27	34	34	fosamprenavir	BID	PA10084	637	0.88
NULL	Chin_J_Cancer_2011_Oct_30(10)_731-738.nxml.txt.nlp	21959050	SENT76	33	33	29	29	vincristine	CHOP	PA451879	1649	0.88
NULL	Iran_J_Pharm_Res_2013_Winter_12(Suppl)_37-46.nxml.txt.nlp	24250670	SENT130	19	19	6	6	etoposide	P-gp	PA449552	5243	0.88
NULL	Oxid_Med_Cell_Longev_2013_Jul_9_2013_574029.nxml.txt.nlp	23936610	SENT205	22	22	4	4	resveratrol	RAGE		177	0.88
NULL	Iran_J_Pharm_Res_2013_Winter_12(Suppl)_37-46.nxml.txt.nlp	24250670	SENT6	34	34	27	27	etoposide	P-gp	PA449552	5243	0.88
NULL	Acta_Pharmacol_Sin_2012_May_16_33(5)_682-690.nxml.txt.nlp	22504904	SENT42	33	33	35	35	celecoxib	STAT3	PA448871	6774	0.88
NULL	Arch_Drug_Inf_2009_Mar_2(1)_1-7.nxml.txt.nlp	19381337	SENT23	0	0	12	12	efavirenz	CYP3A4	PA449441	1576	0.88
NULL	J_Biomed_Biotechnol_2010_Jun_7_2010_150960.nxml.txt.nlp	20617134	SENT241	46	46	16	16	bevacizumab	KRAS	PA130232992	3845	0.88
NULL	Diabetes_Metab_Syndr_Obes_2014_Sep_18_7_421-435.nxml.txt.nlp	25258547	SENT252	7	7	28	28	olmesartan	adiponectin	PA164742950	9370	0.88
NULL	Oncoscience_2014_Oct_22_1(10)_614-623.nxml.txt.nlp	25593991	SENT109	34	34	25	25	dacarbazine	BRAF	PA449197	673	0.88
NULL	JAKSTAT_2012_Apr_1_1(2)_55-64.nxml.txt.nlp	24058751	SENT117	17	17	22	22	sorafenib	STAT3	PA7000	6774	0.88
NULL	Mol_Cancer_2014_Aug_22_13(1)_195.nxml.txt.nlp	NULL	SENT92	1	1	23	23	cisplatin	TBL1XR1	PA449014	79718	0.88
NULL	N_Am_J_Med_Sci_2011_Oct_3(10)_441-450.nxml.txt.nlp	22363081	SENT105	15	15	36	36	gemcitabine	EGFR	PA449748	1956	0.88
NULL	Mol_Cancer_2009_Feb_28_8_11.nxml.txt.nlp	19250552	SENT49	24	24	8	8	hydroxyurea	RRM2	PA449942	6241	0.88
NULL	Tuberculosis_(Edinb)_2011_Nov_91(6-3)_549-555.nxml.txt.nlp	21764638	SENT75	14	14	47	47	amikacin	CO2	PA164744372	4513	0.88
NULL	Oncotarget_2014_Feb_25_5(5)_1304-1314.nxml.txt.nlp	24675421	SENT146	29	29	0	0	cisplatin	RIP1	PA449014	10928;7386	0.88
NULL	Arch_Med_Sci_2014_Feb_24_10(1)_1-9.nxml.txt.nlp	24701207	SENT125	13	13	10	10	cetuximab	PIK3CA	PA10040	5290	0.88
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1196-1204.nxml.txt.nlp	22315058	SENT146	18	18	31	31	lapatinib	HER2	PA152241907	2064	0.88
NULL	Br_J_Ophthalmol_2008_Sep_22_92(9)_1275-1282.nxml.txt.nlp	18723745	SENT151	37	37	12	12	tafluprost	BAK	PA165958432	578	0.88
NULL	Leukemia_2013_Jan_11_27(1)_32-40.nxml.txt.nlp	22781593	SENT207	8	8	17	17	ponatinib	FGFR1	PA165980594	2260	0.88
NULL	Biotechnol_Res_Int_2013_Dec_1_2013_253286.nxml.txt.nlp	24363937	SENT58	25	25	3	3	urea	ADP	PA451831	23038	0.88
NULL	Indian_J_Pharm_Sci_2008_Mar-Apr_70(2)_145-153.nxml.txt.nlp	20046703	SENT28	14	14	17	17	biricodar	P-gp		5243	0.88
NULL	Oncotarget_2014_Nov_11_5(22)_10963-10964.nxml.txt.nlp	25460503	SENT11	21	21	13	13	trastuzumab	ADAM10	PA451743	102	0.88
NULL	Arthritis_Res_Ther_2012_Jun_4_14(3)_R133.nxml.txt.nlp	22656185	SENT97	16	16	7	7	ethanol	TRAF6	PA448073	7189	0.88
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Mar_24_68(Pt_4)_o1180.nxml.txt.nlp	22606121	SENT63	36	36	27	27	ethanol	mol	PA448073	90527	0.88
NULL	Emerg_Infect_Dis_2012_Jul_18(7)_1072-1080.nxml.txt.nlp	22709685	SENT147	1	1	24	24	vancomycin	VISA	PA451850	57506	0.88
NULL	Oncol_Rep_2013_Apr_23_29(4)_1268-1274.nxml.txt.nlp	23354756	SENT117	38	38	6	6	trastuzumab	SLC25A43	PA451743	203427	0.88
NULL	Clin_Drug_Investig_2014_Nov_9_34(2)_107-115.nxml.txt.nlp	24214232	SENT208	24	24	13	13	paricalcitol	IMPACT	PA450798	55364	0.88
NULL	Front_Behav_Neurosci_2010_Apr_5_4_14.nxml.txt.nlp	20407577	SENT291	24	24	0	0	cocaine	HDAC	PA449072	9734	0.88
NULL	Mol_Cancer_2012_Sep_21_11_72.nxml.txt.nlp	22995644	SENT8	6	6	15	15	imatinib	PRL-3	PA10804	11156	0.88
NULL	Oncotarget_2013_Apr_13_4(4)_502-530.nxml.txt.nlp	23594434	SENT241	10	10	14	14	nelfinavir	sit	PA450606	55733	0.88
NULL	Mol_Cancer_2010_Dec_2_9_309.nxml.txt.nlp	21122157	SENT111	6	6	1	1	paclitaxel	IL-6	PA450761	3569	0.88
NULL	EMBO_Mol_Med_2012_Sep_7_4(9)_896-909.nxml.txt.nlp	22887866	SENT7	21	21	31	31	lovastatin	c-Myc	PA450272	4609	0.88
NULL	Oxid_Med_Cell_Longev_2013_Jun_2_2013_793525.nxml.txt.nlp	23819014	SENT167	37	37	27	27	resveratrol	ROS		6098	0.88
NULL	Br_J_Clin_Pharmacol_2013_Aug_23_76(2)_299-315.nxml.txt.nlp	23701319	SENT72	16	16	6	6	etanercept	IL-2	PA449515	3558	0.88
NULL	Nat_Commun_2014_5_3128.nxml.txt.nlp	24451681	SENT37	40	40	26	26	gemcitabine	TYMS	PA449748	7298	0.88
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT160	6	6	0	0	nutlin-3	PUMA		27113	0.88
NULL	Acta_Pharmacol_Sin_2012_Jul_18_33(7)_918-923.nxml.txt.nlp	22705728	SENT132	10	10	7	7	estradiol	aromatase	PA449503	1588	0.88
NULL	Cancer_Immunol_Immunother_2012_Jul_23_61(7)_1101-1111.nxml.txt.nlp	22193989	SENT92	22	22	15	15	oxaliplatin	TLR9	PA131285527	54106	0.88
NULL	J_Mol_Signal_2011_Aug_12_6_9.nxml.txt.nlp	21838893	SENT255	31	31	26	26	formoterol	SSTR5	PA134687907	6755	0.88
NULL	J_Oncol_2013_Aug_20_2013_732047.nxml.txt.nlp	24027583	SENT193	0	0	13	13	neratinib	HER2	PA165291472	2064	0.88
NULL	J_Biomed_Biotechnol_2010_Mar_15_2010_721485.nxml.txt.nlp	20300551	SENT22	16	16	0	0	thrombin	TSP1	PA451674	7057	0.88
NULL	Cancers_(Basel)_2010_Mar_26_2(2)_274-304.nxml.txt.nlp	24281071	SENT1707	5	5	12	12	resveratrol	AP-1		2353;3727;2354;3725	0.88
NULL	Cancer_Immunol_Immunother_2013_Aug_27_62(10)_1637-1648.nxml.txt.nlp	23982484	SENT182	9	9	6	6	lenalidomide	STAT3	PA162363968	6774	0.88
NULL	Exp_Ther_Med_2013_Jul_25_6(1)_109-114.nxml.txt.nlp	23935730	SENT142	33	33	43	43	doxorubicin	CHOP	PA449412	1649	0.88
NULL	Cancer_Cell_2007_Dec_11_12(6)_514-527.nxml.txt.nlp	18068629	SENT57	4	4	11	11	paclitaxel	TGFBI	PA450761	7045	0.88
NULL	Oncol_Lett_2014_Aug_19_8(2)_809-812.nxml.txt.nlp	25009658	SENT76	0	0	11	11	metformin	AMPK	PA450395	5563	0.88
NULL	Clin_Drug_Investig_2014_Nov_9_34(2)_107-115.nxml.txt.nlp	24214232	SENT24	24	24	13	13	paricalcitol	IMPACT	PA450798	55364	0.88
NULL	Ital_J_Pediatr_2014_Jun_7_40_55.nxml.txt.nlp	24906390	SENT258	18	18	4	4	teriparatide	CTX	PA451620	1593	0.88
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Oct_2_66(Pt_11)_o2698.nxml.txt.nlp	21588914	SENT63	16	16	7	7	ethanol	mol	PA448073	90527	0.88
NULL	Glycoconj_J_2012_Apr_14_29(2-3)_93-105.nxml.txt.nlp	22246380	SENT181	20	20	6	6	galactose	SNA	PA449725	6615	0.88
NULL	Infect_Dis_Obstet_Gynecol_2012_Feb_25_2012_157159.nxml.txt.nlp	22505797	SENT173	15	15	13	13	metronidazole	SPTB	PA450484	6710	0.88
NULL	Eur_J_Clin_Pharmacol_2013_Mar_11_69(3)_327-339.nxml.txt.nlp	22782539	SENT230	16	16	10	10	clopidogrel	ADP	PA449053	23038	0.88
NULL	J_Cell_Biol_2000_Feb_21_148(4)_791-800.nxml.txt.nlp	10684259	SENT176	27	27	8	8	estradiol	Raf-1	PA449503	5894	0.88
NULL	Arthritis_Res_2000_Jun_8_2(5)_348-355.nxml.txt.nlp	11094447	SENT73	29	29	0	0	collagenase	EMMPRIN	PA449107	682	0.88
NULL	Indian_J_Psychiatry_2009_Jul-Sep_51(3)_222-224.nxml.txt.nlp	19881055	SENT63	16	16	12	12	sertraline	CYP2D6	PA451333	1565	0.88
NULL	J_Lipid_Res_2015_Jan_56(1)_109-121.nxml.txt.nlp	25421061	SENT330	5	5	10	10	forskolin	CGI-58	PA146096022	51099	0.88
NULL	Diabetes_2011_Jun_21_60(6)_1705-1715.nxml.txt.nlp	21521872	SENT125	11	11	20	20	doxycycline	STZ	PA449415	6484	0.88
NULL	Biomed_Res_Int_2014_Feb_10_2014_760303.nxml.txt.nlp	24689055	SENT177	11	11	17	17	gemcitabine	CD24	PA449748	100133941	0.88
NULL	Mol_Cells_2014_Mar_31_37(3)_234-240.nxml.txt.nlp	24642709	SENT164	20	20	12	12	capsaicin	HO-1	PA448776	3162	0.88
NULL	Mol_Med_Rep_2014_Oct_21_10(4)_1734-1738.nxml.txt.nlp	25050485	SENT39	24	24	16	16	streptomycin	FBS	PA451512	64319;26269	0.88
NULL	Biosci_Rep_2014_Aug_6_34(4)_e00131.nxml.txt.nlp	24975826	SENT41	15	15	23	23	probenecid	TRPA1	PA451106	8989	0.88
NULL	Breast_Cancer_Res_2009_Oct_12_11(5)_R74.nxml.txt.nlp	19821999	SENT248	29	29	7	7	bortezomib	p27	PA10252	5715;10534	0.88
NULL	Core_Evid_2011_Mar_17_6_31-42.nxml.txt.nlp	21468241	SENT80	17	17	8	8	ticagrelor	P2Y12	PA165374673	64805	0.88
NULL	Aging_(Albany_NY)_2009_Feb_18_1(3)_335-349.nxml.txt.nlp	20195489	SENT67	21	21	6	6	etoposide	p65	PA449552	5970	0.88
NULL	Nature_2008_Dec_11_456(7223)_819-823.nxml.txt.nlp	18849970	SENT86	17	17	30	30	etoposide	CD69	PA449552	969	0.88
NULL	Adv_Pharmacol_Sci_2014_Feb_24_2014_809438.nxml.txt.nlp	24707284	SENT336	21	21	40	40	glibenclamide	ANOVA	PA449782	4858	0.88
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT212	10	10	20	20	metformin	HIF-1	PA450395	29072	0.88
NULL	Neuropsychopharmacology_2009_Oct_10_34(11)_2404-2419.nxml.txt.nlp	19516250	SENT316	9	9	15	15	rolipram	PDE4D	PA153906323	5144	0.88
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Dec_24_67(Pt_1)_o235.nxml.txt.nlp	21522735	SENT73	15	15	7	7	ethanol	mol	PA448073	90527	0.88
NULL	ScientificWorldJournal_2012_Mar_12_2012_746412.nxml.txt.nlp	22489201	SENT83	39	39	11	11	genistein	mol	PA165109660	90527	0.88
NULL	Mol_Cell_Biochem_2014_Oct_9_385(1-2)_265-275.nxml.txt.nlp	24104452	SENT176	29	29	15	15	bortezomib	U87	PA10252	677775;641648	0.88
NULL	Ann_Hematol_2010_Nov_25_89(11)_1115-1124.nxml.txt.nlp	20499237	SENT103	14	14	8	8	simvastatin	CD5	PA451363	921	0.88
NULL	Int_J_Cell_Biol_2014_Nov_17_2014_280638.nxml.txt.nlp	25477962	SENT271	5	5	21	21	paclitaxel	CDK1	PA450761	983	0.88
NULL	BMB_Rep_2014_Mar_47(3)_167-172.nxml.txt.nlp	24499665	SENT115	13	13	21	21	nutlin-3	p53		7157	0.88
NULL	Open_AIDS_J_2011_Jul_11_5_62-66.nxml.txt.nlp	21772932	SENT14	9	9	36	36	tenofovir	CD4	PA10204	920	0.88
NULL	Arthritis_Res_Ther_2011_Mar_16_13(2)_R44.nxml.txt.nlp	21410959	SENT297	5	5	0	0	glucosamine	Hua	PA164747613	1994	0.88
NULL	Cancer_Cell_Int_2013_Feb_12_13_14.nxml.txt.nlp	23402310	SENT163	19	19	8	8	celecoxib	p65	PA448871	5970	0.88
NULL	Infect_Dis_Obstet_Gynecol_2012_Nov_29_2012_543916.nxml.txt.nlp	23251074	SENT37	30	30	15	15	ritonavir	CD4	PA451260	920	0.88
NULL	Indian_Dermatol_Online_J_2013_Jul-Sep_4(3)_246-249.nxml.txt.nlp	23984250	SENT38	38	38	26	26	cetuximab	EGFR	PA10040	1956	0.88
NULL	Front_Endocrinol_(Lausanne)_2014_Aug_4_5_131.nxml.txt.nlp	25136332	SENT193	0	0	19	19	naltrexone	MC4R	PA450588	4160	0.88
NULL	Biosci_Rep_2014_Jan_31_34(1)_e00092.nxml.txt.nlp	24393046	SENT103	3	3	13	13	chloroquine	LAMP2	PA448948	3920	0.88
NULL	Target_Oncol_2013_Jun_27_8(2)_127-136.nxml.txt.nlp	23625191	SENT52	11	11	4	4	panitumumab	KRAS	PA162373091	3845	0.88
NULL	Arthritis_Res_Ther_2014_Jul_18_16(4)_R153.nxml.txt.nlp	25037855	SENT143	15	15	31	31	adalimumab	CD14	PA10004	929	0.88
NULL	Oncol_Lett_2014_Jun_4_7(6)_2175-2179.nxml.txt.nlp	24932311	SENT19	8	8	4	4	choline	PEMT	PA448976	10400	0.88
NULL	J_Cardiothorac_Surg_2014_Sep_17_9(1)_129.nxml.txt.nlp	NULL	SENT77	2	2	15	15	heparin	ACT	PA449855	12;11332;9457;641455	0.88
NULL	Neuroscience_2013_Oct_10_250(100)_493-506.nxml.txt.nlp	23892006	SENT259	4	4	14	14	ethanol	ZO-1	PA448073	7082	0.88
NULL	Allergy_Asthma_Immunol_Res_2014_Mar_15_6(2)_126-130.nxml.txt.nlp	24587948	SENT18	16	16	26	26	salbutamol	TTN	PA448068	7273	0.88
NULL	Mol_Vis_2012_Apr_11_18_901-908.nxml.txt.nlp	22539869	SENT143	5	5	17	17	curcumin	HO-1	PA151958596	3162	0.88
NULL	Chemother_Res_Pract_2011_Apr_5_2011_989520.nxml.txt.nlp	22312561	SENT51	13	13	8	8	linezolid	Kist	PA450233	127933	0.88
NULL	Breast_Cancer_Res_2010_Oct_22_12(Suppl_2)_S1.nxml.txt.nlp	21050422	SENT184	15	15	26	26	capecitabine	HER2	PA448771	2064	0.88
NULL	Oncotarget_2014_Aug_29_5(18)_8052-8082.nxml.txt.nlp	25211298	SENT151	4	4	18	18	artesunate	U87	PA165111697	677775;641648	0.88
NULL	Ecancermedicalscience_2009_Jun_9_3_148.nxml.txt.nlp	22276013	SENT43	26	26	4	4	tamoxifen	ATAC	PA451581	6375	0.88
NULL	Ther_Clin_Risk_Manag_2006_Jun_2(2)_129-158.nxml.txt.nlp	18360588	SENT176	1	1	3	3	voriconazole	CYP3A4	PA10233	1576	0.88
NULL	ScientificWorldJournal_2014_Jul_22_2014_750634.nxml.txt.nlp	25147862	SENT7	6	6	4	4	resveratrol	SIRT1		23411	0.88
NULL	Curr_Cardiol_Rev_2013_Feb_9(1)_82-96.nxml.txt.nlp	22920474	SENT294	22	22	28	28	halothane	HCN	PA449845	378938	0.88
NULL	Int_J_Mol_Sci_2014_Mar_5_15(3)_3970-3988.nxml.txt.nlp	24603537	SENT95	6	6	1	1	curcumin	MCH	PA151958596	5367	0.88
NULL	Indian_J_Nucl_Med_2015_Jan-Mar_30(1)_42-46.nxml.txt.nlp	25589805	SENT108	12	12	8	8	octreotide	SSTR5	PA450678	6755	0.88
NULL	Chem_Res_Toxicol_2013_Jun_17_26(6)_878-895.nxml.txt.nlp	23611293	SENT862	22	22	10	10	amisulpride	5-HT2A	PA162565877	3356	0.88
NULL	Mol_Cancer_2008_Jun_30_7_60.nxml.txt.nlp	18590557	SENT140	16	16	18	18	doxorubicin	TRAIL	PA449412	8743	0.88
NULL	Mol_Pain_2013_Mar_7_9_11.nxml.txt.nlp	23497285	SENT57	9	9	35	35	sevoflurane	ANOVA	PA451341	4858	0.88
NULL	Nat_Commun_2014_5_3361.nxml.txt.nlp	24553445	SENT126	15	15	18	18	vorinostat	Hsp90	PA164748224	3320	0.88
NULL	Int_J_Mol_Sci_2014_Sep_22_15(9)_16848-16884.nxml.txt.nlp	25247581	SENT479	7	7	5	5	resveratrol	SIRT1		23411	0.88
NULL	Anat_Cell_Biol_2011_Sep_29_44(3)_169-175.nxml.txt.nlp	22025968	SENT65	19	19	2	2	ethanol	CLU	PA448073	1191	0.88
NULL	Cell_Res_2009_Aug_19(8)_950-961.nxml.txt.nlp	19546888	SENT68	32	32	14	14	camptothecin	Cbl-b	PA153590860	868	0.88
NULL	Acta_Neuropathol_2008_Sep_29_116(3)_247-260.nxml.txt.nlp	18509662	SENT245	0	0	8	8	acetazolamide	AQP1	PA448018	358	0.88
NULL	Allergy_Asthma_Clin_Immunol_2011_Apr_20_7(1)_7.nxml.txt.nlp	21507228	SENT92	35	35	4	4	heparin	CD4	PA449855	920	0.88
NULL	Diabetes_Metab_J_2012_Jun_14_36(3)_207-210.nxml.txt.nlp	22737660	SENT58	7	7	5	5	metformin	HSD1	PA450395	26871	0.88
NULL	J_Korean_Assoc_Oral_Maxillofac_Surg_2014_Dec_26_40(6)_291-296.nxml.txt.nlp	25551094	SENT115	13	13	24	24	risedronate	M-CSF	PA451255	1435	0.88
NULL	Mol_Cancer_2013_Sep_11_12_104.nxml.txt.nlp	24025152	SENT227	24	24	11	11	gemcitabine	STAT3	PA449748	6774	0.88
NULL	EPMA_J_2012_Sep_27_3(1)_10.nxml.txt.nlp	23016735	SENT179	17	17	10	10	warfarin	PROC	PA451906	5624	0.88
NULL	Clin_Pharmacokinet_2014_Sep_3_53(1)_1-16.nxml.txt.nlp	23999929	SENT284	22	22	10	10	fluconazole	P-gp	PA449653	5243	0.88
NULL	Cancers_(Basel)_2014_Mar_26_6(2)_708-722.nxml.txt.nlp	24675568	SENT112	29	29	17	17	afatinib	IL-6	PA165981154	3569	0.88
NULL	Behav_Brain_Funct_2008_Sep_18_4_42.nxml.txt.nlp	18801187	SENT165	13	13	0	0	ethanol	ADH4	PA448073	127	0.88
NULL	N_Am_J_Med_Sci_2013_Jul_5(7)_432-437.nxml.txt.nlp	24020054	SENT63	12	12	20	20	dacarbazine	CHOP	PA449197	1649	0.88
NULL	J_Breast_Cancer_2011_Jun_18_14(2)_135-139.nxml.txt.nlp	21847409	SENT21	21	21	27	27	toremifene	aromatase	PA451731	1588	0.88
NULL	Breast_Cancer_Res_Treat_2014_Dec_19_143(2)_351-358.nxml.txt.nlp	24352574	SENT172	7	7	21	21	filgrastim	HER-2	PA449626	2064	0.88
NULL	Protein_J_2012_Aug_5_31(6)_511-518.nxml.txt.nlp	22763563	SENT144	3	3	11	11	atorvastatin	MSR1	PA448500	4481	0.88
NULL	JAKSTAT_2013_Jan_1_2(1)_e23576.nxml.txt.nlp	24058797	SENT61	7	7	22	22	staurosporine	STAT1	PA165109623	6772	0.88
NULL	Alcohol_Res_Health_2007_30(1)_38-47.nxml.txt.nlp	17718399	SENT194	5	5	24	24	ethanol	CYP2E1	PA448073	1571	0.88
NULL	Breast_Cancer_Res_Treat_2013_Jul_28_140(1)_195-205.nxml.txt.nlp	23813303	SENT26	14	14	0	0	hyaluronan	CD44	PA165958431	960	0.88
NULL	Breast_Cancer_Res_Treat_2013_Aug_20_141(1)_43-53.nxml.txt.nlp	23959396	SENT185	37	37	20	20	trastuzumab	PI3	PA451743	5266	0.88
NULL	J_Membr_Biol_2009_Oct_29_231(2-3)_117-124.nxml.txt.nlp	19865785	SENT109	16	16	2	2	choline	FXYD2	PA448976	486	0.88
NULL	Onco_Targets_Ther_2014_Sep_9_7_1571-1582.nxml.txt.nlp	25228815	SENT247	9	9	13	13	sorafenib	VEGFR1	PA7000	2321	0.88
NULL	J_Cancer_2013_Sep_10_4(8)_614-625.nxml.txt.nlp	24155773	SENT115	15	15	10	10	doxorubicin	CRM1	PA449412	7514	0.88
NULL	J_Korean_Med_Sci_2013_Apr_27_28(4)_527-533.nxml.txt.nlp	23580227	SENT155	4	4	9	9	genistein	TRAIL	PA165109660	8743	0.88
NULL	Mol_Cancer_2014_Jan_13_13_7.nxml.txt.nlp	24418169	SENT177	19	19	7	7	sorafenib	SHP-1	PA7000	5777	0.88
NULL	Clin_Ophthalmol_2011_Apr_18_5_495-502.nxml.txt.nlp	21573098	SENT117	12	12	18	18	gatifloxacin	BAK	PA449738	578	0.88
NULL	Clin_Ophthalmol_2008_Jun_2(2)_425-433.nxml.txt.nlp	19668733	SENT146	31	31	35	35	bevacizumab	VEGF-A	PA130232992	7422	0.88
NULL	Breast_Cancer_Res_2014_Sep_9_16(5)_433.nxml.txt.nlp	25212966	SENT321	12	12	4	4	aprotinin	ILEI	PA448472	10447	0.88
NULL	Core_Evid_2011_Feb_8_6_23-29.nxml.txt.nlp	21468240	SENT56	34	34	8	8	plerixafor	CD34	PA165958410	947	0.88
NULL	ISRN_Oxidative_Med_2013_2013_831596.nxml.txt.nlp	25506596	SENT151	13	13	17	17	hemin	HO-1	PA449849	3162	0.88
NULL	Oncogene_2010_Jan_7_29(1)_81-92.nxml.txt.nlp	19784067	SENT174	27	27	10	10	cisplatin	MITF	PA449014	4286	0.88
NULL	J_Exp_Med_1962_Feb_28_115(3)_641-653.nxml.txt.nlp	13862910	SENT4	8	8	31	31	papain	S20	PA450778	6224	0.88
NULL	eLife_2014_Apr_22_3_e02450.nxml.txt.nlp	24755292	SENT570	43	43	15	15	ethanol	mol	PA448073	90527	0.88
NULL	Ann_Oncol_2010_Feb_21(2)_217-222.nxml.txt.nlp	20110292	SENT114	21	21	40	40	erlotinib	RAPGEF5	PA134687924	9771	0.88
NULL	Oncol_Lett_2015_Jan_4_9(1)_91-95.nxml.txt.nlp	25435939	SENT28	21	21	3	3	cisplatin	NACT	PA449014	284111	0.88
NULL	Oncoimmunology_2012_Jul_1_1(4)_563-565.nxml.txt.nlp	22754788	SENT4	2	2	11	11	cyclophosphamide	GM-CSF	PA449165	1437	0.88
NULL	Appl_Microbiol_Biotechnol_2014_Feb_18_98(8)_3829-3840.nxml.txt.nlp	24535257	SENT139	29	29	36	36	ethanol	CAT-1	PA448073	6541	0.88
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Apr_7_9_12.nxml.txt.nlp	20374640	SENT48	20	20	41	41	ciprofloxacin	BSAC	PA449009	57591	0.88
NULL	BMJ_Open_2012_Nov_7_2(6)_e001637.nxml.txt.nlp	23144259	SENT246	18	18	13	13	methamphetamine	spatial	PA450403	219793	0.88
NULL	J_Cell_Biol_1982_Feb_1_92(2)_313-323.nxml.txt.nlp	6801061	SENT2	16	16	10	10	thrombin	ADP	PA451674	23038	0.88
NULL	Oncogene_2014_Jun_26_33(26)_3422-3431.nxml.txt.nlp	23912457	SENT10	23	23	11	11	trastuzumab	HER2	PA451743	2064	0.88
NULL	Oncotarget_2013_Jul_21_4(8)_1253-1265.nxml.txt.nlp	23896512	SENT200	33	33	25	25	lapatinib	EGFR	PA152241907	1956	0.88
NULL	Pharmaceuticals_(Basel)_2013_Aug_6_6(8)_929-959.nxml.txt.nlp	24276377	SENT178	3	3	11	11	curcumin	CXCL8	PA151958596	3576	0.88
NULL	Crit_Care_2012_Jun_7_16(Suppl_2)_A25.nxml.txt.nlp	NULL	SENT92	9	9	34	34	methylprednisolone	IL-6	PA450466	3569	0.88
NULL	Chemother_Res_Pract_2012_Aug_29_2012_817297.nxml.txt.nlp	22970367	SENT192	21	21	8	8	erlotinib	EGFR	PA134687924	1956	0.88
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1067.nxml.txt.nlp	24556682	SENT39	19	19	25	25	doxorubicin	BTZ	PA449412	22794	0.88
NULL	Target_Oncol_2013_Jun_27_8(2)_127-136.nxml.txt.nlp	23625191	SENT21	22	22	5	5	panitumumab	KRAS	PA162373091	3845	0.88
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1676-1682.nxml.txt.nlp	19844234	SENT109	9	9	18	18	lapatinib	HER2	PA152241907	2064	0.88
NULL	Exp_Neurobiol_2013_Mar_31_22(1)_45-50.nxml.txt.nlp	23585722	SENT165	11	11	3	3	fluoxetine	EPO	PA449673	7076;8288;2056	0.88
NULL	JAKSTAT_2012_Apr_1_1(2)_55-64.nxml.txt.nlp	24058751	SENT140	21	21	26	26	flavopiridol	STAT3	PA452627	6774	0.88
NULL	Oncoimmunology_2012_May_1_1(3)_380-382.nxml.txt.nlp	22737622	SENT43	10	10	17	17	imiquimod	IFN	PA449972	3439	0.88
NULL	Mol_Cancer_2010_Jun_25_9_166.nxml.txt.nlp	20579378	SENT244	23	23	41	41	gefitinib	EGR1	PA131301952	1958	0.88
NULL	Front_Chem_2014_Jul_15_2_48.nxml.txt.nlp	25077142	SENT228	9	9	16	16	doxorubicin	MDR1	PA449412	5243	0.88
NULL	J_Biol_Inorg_Chem_2014_Oct_17_19(1)_17-27.nxml.txt.nlp	24132751	SENT24	10	10	19	19	cisplatin	CTR1	PA449014	1317	0.88
NULL	Pain_2012_Apr_153(4)_775-783.nxml.txt.nlp	22325744	SENT438	0	0	15	15	naloxone	P28	PA450586	9446;7802;9527	0.88
NULL	Cancer_Imaging_2010_Jul_6_10(1)_144-152.nxml.txt.nlp	20605761	SENT78	18	18	14	14	pertuzumab	HER2		2064	0.88
NULL	Bioinformation_2012_Jan_6_8(1)_48-57.nxml.txt.nlp	22359435	SENT183	26	26	39	39	doxycycline	IL-6	PA449415	3569	0.88
NULL	Diabetes_Metab_Syndr_Obes_2014_Aug_28_7_391-400.nxml.txt.nlp	25210468	SENT51	7	7	13	13	metformin	B12	PA450395	7126;4709	0.88
NULL	Br_J_Haematol_2014_Jan_28_164(2)_233-244.nxml.txt.nlp	24206017	SENT274	23	23	11	11	lenalidomide	CRBN	PA162363968	51185	0.88
NULL	Br_J_Cancer_2004_Mar_22_90(6)_1285-1292.nxml.txt.nlp	15026814	SENT106	6	6	11	11	doxorubicin	p53	PA449412	7157	0.88
NULL	Indian_J_Anaesth_2014_Sep-Oct_58(5)_596-602.nxml.txt.nlp	25535422	SENT154	0	0	19	19	heparin	PF4	PA449855	5196	0.88
NULL	Eur_J_Endocrinol_2011_Jan_164(1)_69-74.nxml.txt.nlp	20961967	SENT79	16	16	13	13	pioglitazone	adiponectin	PA450970	9370	0.88
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT160	26	26	8	8	erlotinib	AKT	PA134687924	207	0.88
NULL	Front_Genet_2012_Nov_12_3_235.nxml.txt.nlp	23162568	SENT168	15	15	21	21	methamphetamine	CYP2D6	PA450403	1565	0.88
NULL	Cancer_Cell_Int_2011_Aug_19_11_29.nxml.txt.nlp	21854619	SENT219	25	25	8	8	cisplatin	BRCA1	PA449014	672	0.88
NULL	Arthritis_Res_Ther_2011_Sep_21_13(5)_239.nxml.txt.nlp	21955617	SENT102	27	27	24	24	celecoxib	COX	PA448871	1351	0.88
NULL	Exp_Diabetes_Res_2012_Apr_17_2012_635472.nxml.txt.nlp	22577369	SENT106	30	30	7	7	nitroprusside	GLP-1	PA451406	100125288	0.88
NULL	J_Gynecol_Oncol_2013_Jul_4_24(3)_273-279.nxml.txt.nlp	23875078	SENT154	17	17	3	3	paclitaxel	COX	PA450761	1351	0.88
NULL	Front_Behav_Neurosci_2012_Jun_13_6_24.nxml.txt.nlp	22707936	SENT327	8	8	15	15	scopolamine	spatial	PA451308	219793	0.88
NULL	Breast_Cancer_Res_2011_Mar_1_13(2)_R21.nxml.txt.nlp	21362200	SENT12	15	15	8	8	fulvestrant	PI3K	PA164747170	5290	0.88
NULL	Oncoimmunology_2013_Jan_1_2(1)_e23033.nxml.txt.nlp	23483678	SENT0	21	21	12	12	paclitaxel	CD40	PA450761	958	0.88
NULL	Oncol_Lett_2014_Jun_4_7(6)_2175-2179.nxml.txt.nlp	24932311	SENT99	10	10	6	6	choline	PEMT	PA448976	10400	0.88
NULL	Oxid_Med_Cell_Longev_2013_Jun_2_2013_793525.nxml.txt.nlp	23819014	SENT267	11	11	0	0	resveratrol	SGBS		2719	0.88
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_127043.nxml.txt.nlp	23227093	SENT132	7	7	39	39	lovastatin	CYP1A2	PA450272	1544	0.88
NULL	Cancers_(Basel)_2013_Nov_1_5(4)_1379-1412.nxml.txt.nlp	24202450	SENT178	0	0	6	6	celecoxib	CXCL10	PA448871	3627	0.88
NULL	Exp_Cell_Res_2011_Apr_15_317(7)_1028-1039.nxml.txt.nlp	21237154	SENT250	25	25	3	3	staurosporine	JIP1	PA165109623	9479	0.88
NULL	Br_J_Cancer_2011_Dec_6_105(12)_1920-1926.nxml.txt.nlp	22095222	SENT117	10	10	4	4	erlotinib	EGFR	PA134687924	1956	0.88
NULL	Braz_J_Med_Biol_Res_2012_Feb_17_45(3)_244-249.nxml.txt.nlp	22331137	SENT38	24	24	7	7	gentamicin	PAG	PA449753	55824	0.88
NULL	Cancer_Med_2012_Oct_1_1(2)_114-127.nxml.txt.nlp	23342262	SENT34	8	8	4	4	sirolimus	EGFR	PA451365	1956	0.88
NULL	Evid_Based_Complement_Alternat_Med_2011_Feb_13_2011_248481.nxml.txt.nlp	19861508	SENT161	9	9	31	31	hesperidin	5-HT4	PA449867	3360	0.88
NULL	Environ_Health_Perspect_1995_Oct_103(Suppl_7)_113-122.nxml.txt.nlp	8593856	SENT9	7	7	22	22	estradiol	pS2	PA449503	7031	0.88
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Dec_17_3(12)_e152.nxml.txt.nlp	25518025	SENT57	14	14	16	16	oxymorphone	CYP2D6	PA450748	1565	0.88
NULL	Biologics_2009_Oct_12_3_443-457.nxml.txt.nlp	19851470	SENT118	22	22	6	6	etanercept	ACR	PA449515	49	0.88
NULL	Cardiovasc_Res_2012_Mar_15_93(4)_674-681.nxml.txt.nlp	22166712	SENT129	27	27	13	13	ketoconazole	CYP3A	PA450146	1574	0.88
NULL	Evid_Based_Complement_Alternat_Med_2011_Jan_20_2011_713523.nxml.txt.nlp	21318104	SENT19	35	35	27	27	verapamil	P-gp	PA451868	5243	0.88
NULL	Exp_Diabetes_Res_2012_Oct_29_2012_894605.nxml.txt.nlp	22110482	SENT118	1	1	7	7	heparin	RAGE	PA449855	177	0.88
NULL	Br_J_Cancer_2010_Feb_2_102(3)_520-529.nxml.txt.nlp	20029417	SENT120	23	23	15	15	trastuzumab	IL-21	PA451743	59067;50616;27189	0.88
NULL	Mol_Biol_Int_2011_Jun_8_2011_571242.nxml.txt.nlp	22091408	SENT298	32	32	3	3	arsenite	ODC	PA452638	4953;89874	0.88
NULL	Neuro_Oncol_2010_Apr_27_12(4)_389-400.nxml.txt.nlp	20308316	SENT172	3	3	10	10	chloroquine	p53	PA448948	7157	0.88
NULL	Indian_J_Anaesth_2012_Jul-Aug_56(4)_430-431.nxml.txt.nlp	23087482	SENT35	5	5	20	20	heparin	ACT	PA449855	12;11332;9457;641455	0.88
NULL	Biologics_2011_Aug_9_5_87-94.nxml.txt.nlp	21847344	SENT75	38	38	11	11	docetaxel	San	PA449383	80218	0.88
NULL	Ann_Dermatol_2011_Oct_31_23(Suppl_2)_S169-S174.nxml.txt.nlp	22148042	SENT104	24	24	11	11	etoposide	CHOP	PA449552	1649	0.88
NULL	Drugs_2014_Jul_18_74(11)_1209-1231.nxml.txt.nlp	25034361	SENT59	11	11	1	1	verapamil	P-gp	PA451868	5243	0.88
NULL	Sensors_(Basel)_2012_May_8_12(5)_5951-5965.nxml.txt.nlp	22778624	SENT10	9	9	13	13	genistein	PI3K	PA165109660	5290	0.879
NULL	Chemother_Res_Pract_2011_Dec_1_2011_715469.nxml.txt.nlp	22312557	SENT155	9	9	4	4	cisplatin	p53	PA449014	7157	0.879
NULL	Korean_Circ_J_2013_May_31_43(5)_343-346.nxml.txt.nlp	23755082	SENT10	27	27	24	24	clopidogrel	DES	PA449053	1674	0.879
NULL	Patient_Prefer_Adherence_2014_Apr_8_8_463-471.nxml.txt.nlp	24748775	SENT107	4	4	15	15	denosumab	BMD	PA166048634	1756;7439	0.879
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1554-1562.nxml.txt.nlp	21970876	SENT3	20	20	10	10	gemcitabine	EGFR	PA449748	1956	0.879
NULL	Mol_Cancer_2010_Apr_23_9_87.nxml.txt.nlp	20416058	SENT245	20	20	11	11	etoposide	TRAIL	PA449552	8743	0.879
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT24	9	9	23	23	trastuzumab	STAT3	PA451743	6774	0.879
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_May_14_65(Pt_6)_o1303.nxml.txt.nlp	21583160	SENT66	25	25	6	6	ethanol	mol	PA448073	90527	0.879
NULL	Ann_Oncol_2011_Mar_8_22(3)_503-514.nxml.txt.nlp	20616198	SENT172	12	12	30	30	exemestane	aromatase	PA449563	1588	0.879
NULL	Lipids_Health_Dis_2011_Feb_28_10_38.nxml.txt.nlp	21352602	SENT129	20	20	31	31	fenofibrate	PCSK9	PA449594	255738	0.879
NULL	Cell_Death_Dis_2013_Jul_4_4(7)_e700.nxml.txt.nlp	23828563	SENT18	32	32	2	2	doxycycline	Math1	PA449415	474	0.879
NULL	Breast_Cancer_Res_2012_May_23_14(3)_R82.nxml.txt.nlp	22621306	SENT79	17	17	6	6	trastuzumab	HER2	PA451743	2064	0.879
NULL	Evid_Based_Complement_Alternat_Med_2012_Sep_11_2012_765316.nxml.txt.nlp	22997533	SENT219	5	5	13	13	mitomycin	CT1	PA450524	1489;6535	0.879
NULL	Breast_Cancer_Res_2011_Jun_29_13(3)_R70.nxml.txt.nlp	21707964	SENT26	39	39	8	8	tamoxifen	YWHAZ	PA451581	7534	0.879
NULL	ScientificWorldJournal_2013_Dec_24_2013_958724.nxml.txt.nlp	24453930	SENT92	29	29	41	41	bevacizumab	ERM	PA130232992	2119	0.879
NULL	Oncotarget_2013_Nov_24_4(12)_2430-2438.nxml.txt.nlp	24280348	SENT128	11	11	6	6	gefitinib	EGFR	PA131301952	1956	0.879
NULL	J_Cancer_2013_Jul_1_4(5)_433-446.nxml.txt.nlp	23833688	SENT234	11	11	4	4	raloxifene	STAR	PA451221	6770;2984	0.879
NULL	Eur_J_Clin_Pharmacol_2012_Jan_8_68(1)_29-37.nxml.txt.nlp	21739267	SENT3	14	14	21	21	aripiprazole	CYP2D6	PA10026	1565	0.879
NULL	Oncotarget_2012_May_18_3(5)_525-534.nxml.txt.nlp	22619113	SENT10	44	44	10	10	fludarabine	CFLAR	PA449655	8837	0.879
NULL	J_Hum_Genet_2009_Sep_24_54(9)_516-524.nxml.txt.nlp	19629138	SENT113	24	24	10	10	tetracycline	POLG	PA451640	5428	0.879
NULL	Evid_Based_Complement_Alternat_Med_2013_Aug_12_2013_982689.nxml.txt.nlp	23997806	SENT225	5	5	20	20	tolbutamide	APE	PA451718	55704;328	0.879
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_17_2013_549174.nxml.txt.nlp	23843879	SENT101	3	3	21	21	curcumin	AKT	PA151958596	207	0.879
NULL	Oncotarget_2014_Jun_26_5(14)_5559-5569.nxml.txt.nlp	24980819	SENT80	11	11	3	3	vemurafenib	BRAF	PA165946873	673	0.879
NULL	Clin_Drug_Investig_2013_Jan_27_33(1)_45-54.nxml.txt.nlp	23184666	SENT65	15	15	25	25	anagrelide	ANOVA	PA164742986	4858	0.879
NULL	Mol_Cancer_2013_Oct_24_12_128.nxml.txt.nlp	24156782	SENT332	18	18	1	1	paraformaldehyde	CD44	PA450790	960	0.879
NULL	J_Mol_Signal_2010_Jul_12_5_8.nxml.txt.nlp	20624308	SENT32	21	21	5	5	gefitinib	EGFR	PA131301952	1956	0.879
NULL	J_Korean_Med_Sci_2010_May_16_25(5)_716-722.nxml.txt.nlp	20436707	SENT103	10	10	25	25	simvastatin	DES	PA451363	1674	0.879
NULL	Surg_Neurol_Int_2013_May_2_4(Suppl_4)_S265-S288.nxml.txt.nlp	23717798	SENT505	8	8	39	39	erlotinib	EGFR	PA134687924	1956	0.879
NULL	Front_Oncol_2014_Mar_6_4_40.nxml.txt.nlp	24639951	SENT134	29	29	4	4	trastuzumab	EGFR	PA451743	1956	0.879
NULL	J_Mol_Signal_2011_Aug_12_6_9.nxml.txt.nlp	21838893	SENT337	22	22	17	17	isoproterenol	SSTR5	PA450121	6755	0.879
NULL	Am_J_Case_Rep_2014_Apr_14_15_152-154.nxml.txt.nlp	24753783	SENT62	32	32	21	21	metformin	GLP1	PA450395	100125288;2641	0.879
NULL	Case_Rep_Infect_Dis_2012_Aug_15_2012_463569.nxml.txt.nlp	22928129	SENT31	7	7	11	11	cyclosporine	IL-2	PA449167	3558	0.879
NULL	Diabetes_2013_Jun_17_62(6)_1913-1922.nxml.txt.nlp	23349495	SENT201	7	7	13	13	sildenafil	VASP	PA451346	7408	0.879
NULL	Br_J_Cancer_2009_Jul_7_101(1)_38-47.nxml.txt.nlp	19513066	SENT274	11	11	34	34	dasatinib	p27	PA162372878	5715;10534	0.879
NULL	Arthritis_Res_Ther_2005_May_18_7(Suppl_3)_S19-S25.nxml.txt.nlp	15960818	SENT165	31	31	10	10	rituximab	CHOP	PA451261	1649	0.879
NULL	Exp_Ther_Med_2013_Mar_21_5(3)_987-991.nxml.txt.nlp	23407636	SENT40	15	15	5	5	fluorescein	CXCR1	PA164746009	3577	0.879
NULL	Diabetes_2009_Feb_58(2)_352-359.nxml.txt.nlp	19011168	SENT140	8	8	10	10	exenatide	GLP-1	PA164749238	100125288	0.879
NULL	Clin_Med_Insights_Ear_Nose_Throat_2012_Apr_3_5_1-16.nxml.txt.nlp	24179404	SENT177	7	7	21	21	galactose	ABO	PA449725	28	0.879
NULL	Mol_Cancer_2012_May_14_11_33.nxml.txt.nlp	22583829	SENT33	22	22	13	13	cisplatin	TLR4	PA449014	7099	0.879
NULL	Br_J_Cancer_2010_Oct_12_103(8)_1284-1291.nxml.txt.nlp	20859285	SENT142	11	11	18	18	tamoxifen	EGFR	PA451581	1956	0.879
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_25_2013_421051.nxml.txt.nlp	23878598	SENT32	25	25	27	27	tamoxifen	aromatase	PA451581	1588	0.879
NULL	Oncologist_2011_Jan_6_16(1)_5-24.nxml.txt.nlp	21212434	SENT196	18	18	25	25	dacarbazine	IFN	PA449197	3439	0.879
NULL	Cells_2014_Nov_27_3(4)_1089-1101.nxml.txt.nlp	25437439	SENT68	30	30	3	3	quinine	TRPM7	PA451213	54822	0.879
NULL	Diabetes_Obes_Metab_2010_Aug_12(8)_700-708.nxml.txt.nlp	20590747	SENT135	14	14	0	0	voglibose	PPG	PA164752433	5552	0.879
NULL	Mol_Cancer_2014_Jul_5_13_165.nxml.txt.nlp	24996221	SENT129	27	27	17	17	docetaxel	HMGB1	PA449383	3146	0.879
NULL	Virchows_Arch_2011_Jan_13_458(1)_55-64.nxml.txt.nlp	20941507	SENT230	8	8	14	14	olaparib	BRCA2		675	0.879
NULL	Acta_Pharmacol_Sin_2012_Dec_17_33(12)_1441-1458.nxml.txt.nlp	22983389	SENT258	0	0	8	8	pioglitazone	gamma	PA450970	9913	0.879
NULL	BMJ_Open_2014_May_5_4(5)_e005268.nxml.txt.nlp	24801283	SENT81	5	5	2	2	ketoconazole	CYP3A4	PA450146	1576	0.879
NULL	J_Oncol_2012_Mar_26_2012_198412.nxml.txt.nlp	22536237	SENT82	41	41	16	16	lapatinib	HER2	PA152241907	2064	0.879
NULL	Clin_Med_Insights_Womens_Health_2013_Jan_22_6_1-11.nxml.txt.nlp	24665209	SENT215	2	2	7	7	tamoxifen	aromatase	PA451581	1588	0.879
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT44	2	2	9	9	pertuzumab	HER2		2064	0.879
NULL	ScientificWorldJournal_2014_Mar_12_2014_731462.nxml.txt.nlp	24715817	SENT181	22	22	29	29	diclofenac	IL-6	PA449293	3569	0.879
NULL	ScientificWorldJournal_2014_Feb_5_2014_786130.nxml.txt.nlp	24688431	SENT244	24	24	19	19	phenol	TPC	PA450913	8030;60386	0.879
NULL	Colorectal_Dis_2012_Feb_14(2)_e31-e47.nxml.txt.nlp	21848897	SENT117	37	37	28	28	cetuximab	KRAS	PA10040	3845	0.879
NULL	Curr_Neuropharmacol_2014_Jul_12(4)_365-379.nxml.txt.nlp	25342944	SENT463	0	0	3	3	fluoxetine	5-HT2B	PA449673	3357	0.879
NULL	Indian_J_Pharmacol_2014_Nov-Dec_46(6)_627-632.nxml.txt.nlp	25538335	SENT167	13	13	16	16	metformin	Q10	PA450395	27161	0.879
NULL	J_Hematol_Oncol_2014_Apr_16_7_34.nxml.txt.nlp	24739401	SENT42	19	19	7	7	rituximab	CD44	PA451261	960	0.879
NULL	Ther_Clin_Risk_Manag_2005_Mar_1(1)_3-13.nxml.txt.nlp	18360537	SENT61	19	19	12	12	isoniazid	CYP3A4	PA450112	1576	0.879
NULL	Eur_J_Epidemiol_2011_Aug_30_26(8)_657-686.nxml.txt.nlp	21877163	SENT942	19	19	14	14	acenocoumarol	CYP2C9	PA452632	1559	0.879
NULL	Exp_Diabetes_Res_2009_Jul_7_2009_910783.nxml.txt.nlp	19609456	SENT134	24	24	7	7	rosiglitazone	AMPK	PA451283	5563	0.879
NULL	Adv_Ther_2014_Feb_18_31(3)_247-263.nxml.txt.nlp	24535624	SENT99	17	17	10	10	exenatide	PPG	PA164749238	5552	0.879
NULL	Ann_Hematol_2014_Sep_10_93(1)_1-11.nxml.txt.nlp	24018623	SENT170	0	0	43	43	lenalidomide	CXCR4	PA162363968	7852	0.879
NULL	Apoptosis_2012_Sep_30_17(9)_989-997.nxml.txt.nlp	22460505	SENT133	11	11	15	15	thioridazine	p53	PA451666	7157	0.879
NULL	Indian_J_Endocrinol_Metab_2012_Dec_16(Suppl_2)_S509-S511.nxml.txt.nlp	23565482	SENT7	21	21	15	15	clonidine	IGF1	PA449051	3479	0.879
NULL	Front_Endocrinol_(Lausanne)_2013_Jul_8_4_80.nxml.txt.nlp	23847592	SENT36	6	6	42	42	diclofenac	UGT2B15	PA449293	7366	0.879
NULL	J_Gen_Physiol_2003_Mar_121(3)_181-197.nxml.txt.nlp	12601083	SENT260	12	12	29	29	forskolin	SUR1	PA146096022	6833	0.879
NULL	Front_Pharmacol_2014_Oct_20_5_230.nxml.txt.nlp	25368579	SENT76	5	5	11	11	berberine	IL-6	PA165860812	3569	0.879
NULL	Biol_Proced_Online_2004_Mar_19_6_16-22.nxml.txt.nlp	15103396	SENT87	16	16	30	30	trypsin	HAND1	PA451806	9421	0.879
NULL	Front_Neurosci_2010_Nov_19_4_192.nxml.txt.nlp	21151361	SENT774	5	5	0	0	haloperidol	5-HT6	PA449841	3362	0.879
NULL	Cell_Biol_Int_Rep_(2010)_2012_Jun_21_19(1)_e00017.nxml.txt.nlp	23124518	SENT73	14	14	3	3	etoposide	TRAIL-R2	PA449552	8795	0.879
NULL	Environ_Health_Perspect_2011_Aug_22_119(8)_1053-1061.nxml.txt.nlp	21697028	SENT320	6	6	8	8	diethylstilbestrol	DES	PA449307	1674	0.879
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2751-2762.nxml.txt.nlp	24169358	SENT188	0	0	20	20	fulvestrant	CDK6	PA164747170	1021	0.879
NULL	Curr_Cardiol_Rev_2008_Nov_4(4)_293-299.nxml.txt.nlp	20066137	SENT34	5	5	26	26	heparin	ACT	PA449855	12;11332;9457;641455	0.879
NULL	Acta_Pharmacol_Sin_2012_May_4_33(5)_710-716.nxml.txt.nlp	22555373	SENT118	11	11	23	23	phenylbutazone	DOM	PA450932	6663	0.879
NULL	Alzheimers_Res_Ther_2013_Apr_22_5(2)_15.nxml.txt.nlp	23607787	SENT130	14	14	4	4	phencyclidine	5-HT6	PA128406980	3362	0.879
NULL	Indian_Dermatol_Online_J_2013_Jan-Mar_4(1)_2-11.nxml.txt.nlp	23439959	SENT162	3	3	18	18	ustekinumab	IL-23	PA166048654	51561	0.879
NULL	Arthritis_Rheum_2013_Sep_26_65(9)_2290-2300.nxml.txt.nlp	23740547	SENT238	17	17	3	3	doxycycline	S100A9	PA449415	6280	0.879
NULL	Arthritis_Res_Ther_2012_Jul_27_14(4)_R176.nxml.txt.nlp	22838845	SENT244	5	5	25	25	acetazolamide	BSP	PA448018	3381	0.879
NULL	Oxid_Med_Cell_Longev_2013_Apr_30_2013_796891.nxml.txt.nlp	23738041	SENT246	5	5	19	19	resveratrol	SIRT1		23411	0.879
NULL	J_Carcinog_2011_Jul_19_10_17.nxml.txt.nlp	21799661	SENT241	17	17	7	7	metformin	AMPK	PA450395	5563	0.879
NULL	Acta_Histochem_Cytochem_2013_Dec_28_46(6)_187-197.nxml.txt.nlp	24610966	SENT171	20	20	9	9	pilocarpine	AQP5	PA450962	362	0.879
NULL	ScientificWorldJournal_2014_Mar_12_2014_731462.nxml.txt.nlp	24715817	SENT169	18	18	29	29	diclofenac	IL-6	PA449293	3569	0.879
NULL	F1000_Med_Rep_2010_May_24_2_39.nxml.txt.nlp	20948846	SENT44	13	13	7	7	capsaicin	TRPV1	PA448776	7442	0.879
NULL	Ann_Oncol_2012_Dec_2_23(12)_3007-3016.nxml.txt.nlp	22865781	SENT171	9	9	6	6	trastuzumab	IGF1R	PA451743	3480	0.879
NULL	Genome_Biol_2008_Oct_13_9(10)_R150.nxml.txt.nlp	18851746	SENT78	13	13	0	0	tetracycline	MYCN	PA451640	4613	0.879
NULL	Int_J_Biomed_Sci_2013_Sep_9(3)_112-122.nxml.txt.nlp	24170986	SENT111	0	0	17	17	benazepril	RAGE	PA448561	177	0.879
NULL	Clin_Exp_Gastroenterol_2012_May_14_5_49-59.nxml.txt.nlp	22649281	SENT89	5	5	20	20	omeprazole	CYP2C19	PA450704	1557	0.879
NULL	Acta_Pharmacol_Sin_2010_Mar_22_31(3)_329-340.nxml.txt.nlp	20173759	SENT152	14	14	6	6	ethanol	AMPK	PA448073	5563	0.879
NULL	Hum_Mol_Genet_2013_Nov_15_22(22)_4528-4544.nxml.txt.nlp	23804751	SENT329	34	34	2	2	l-glutamine	ATG5	PA10090	9474	0.879
NULL	Pharmaceuticals_(Basel)_2011_Jan_26_4(2)_285-342.nxml.txt.nlp	NULL	SENT2049	0	0	18	18	fluvoxamine	5-HT2A	PA449690	3356	0.879
NULL	EMBO_Mol_Med_2013_Dec_8_5(12)_1821-1834.nxml.txt.nlp	24293316	SENT52	26	26	14	14	doxorubicin	UNC5D	PA449412	137970	0.879
NULL	Diabetes_Care_2013_Jan_11_36(1)_124-129.nxml.txt.nlp	22923670	SENT155	14	14	4	4	metformin	LKB1	PA450395	6794	0.879
NULL	Mol_Cancer_2008_Jun_5_7_50.nxml.txt.nlp	18534018	SENT66	27	27	10	10	bortezomib	PUMA	PA10252	27113	0.879
NULL	Acta_Orthop_2009_Dec_4_80(6)_693-703.nxml.txt.nlp	19968600	SENT247	27	27	20	20	methotrexate	ACR	PA450428	49	0.879
NULL	Arthritis_Res_Ther_2006_Jul_21_8(4)_R130.nxml.txt.nlp	16859540	SENT121	18	18	23	23	atorvastatin	CD59	PA448500	966	0.879
NULL	Mol_Microbiol_2013_Aug_27_89(3)_420-432.nxml.txt.nlp	23750752	SENT42	8	8	22	22	lipase	MCOLN1	PA450239	57192	0.879
NULL	J_Hematol_Oncol_2012_May_17_5_24.nxml.txt.nlp	22594538	SENT183	16	16	10	10	vincristine	CHOP	PA451879	1649	0.879
NULL	Diabetes_Care_2013_Aug_17_36(Suppl_2)_S245-S252.nxml.txt.nlp	23882053	SENT28	28	28	22	22	sitagliptin	HIP	PA164748978	6767;6159;64399;5068	0.879
NULL	Carcinogenesis_2013_Oct_19_34(10)_2341-2349.nxml.txt.nlp	23784081	SENT222	15	15	13	13	pitrakinra	IL-4	PA165983754	3565	0.879
NULL	J_Cell_Mol_Med_2014_Oct_11_18(10)_2031-2043.nxml.txt.nlp	25109475	SENT269	28	28	26	26	valsartan	STZ	PA451848	6484	0.879
NULL	J_Invest_Dermatol_2013_Jun_14_133(6)_1541-1549.nxml.txt.nlp	23407395	SENT269	9	9	14	14	imiquimod	CXCL1	PA449972	2919	0.879
NULL	Protein_Cell_2014_Feb_29_5(2)_113-123.nxml.txt.nlp	24474196	SENT128	7	7	11	11	metformin	CYP2B6	PA450395	1555	0.879
NULL	Pharmaceuticals_(Basel)_2012_Jun_19_5(6)_665-673.nxml.txt.nlp	24281668	SENT68	31	31	18	18	ethanol	CTX	PA448073	1593	0.879
NULL	Biochem_Res_Int_2012_Mar_4_2012_685267.nxml.txt.nlp	22496978	SENT251	10	10	35	35	thrombin	MT1-MMP	PA451674	4323	0.879
NULL	Lab_Invest_2011_Oct_18_91(10)_1414-1426.nxml.txt.nlp	21769085	SENT146	3	3	18	18	gefitinib	EGFR	PA131301952	1956	0.879
NULL	Crit_Care_2010_Aug_11_14(4)_R153.nxml.txt.nlp	20701787	SENT155	9	9	30	30	exenatide	GLP-1	PA164749238	100125288	0.879
NULL	Br_J_Pharmacol_2011_Feb_162(4)_989-999.nxml.txt.nlp	21054342	SENT157	17	17	21	21	ketoconazole	CYP3A4	PA450146	1576	0.879
NULL	J_Korean_Med_Sci_2007_Jun_30_22(3)_557-559.nxml.txt.nlp	17596671	SENT60	18	18	11	11	warfarin	CYP2C9	PA451906	1559	0.879
NULL	Cancer_Med_2013_Oct_19_2(5)_646-653.nxml.txt.nlp	24403230	SENT246	25	25	18	18	cisplatin	c-Jun	PA449014	3725	0.879
NULL	Breast_Cancer_Res_2006_Nov_6_8(6)_215.nxml.txt.nlp	17096862	SENT69	13	13	10	10	trastuzumab	PI3K	PA451743	5290	0.879
NULL	Int_J_Mol_Sci_2014_Sep_15_15(9)_16284-16301.nxml.txt.nlp	25226537	SENT10	37	37	11	11	curcumin	p38	PA151958596	10598;1432;7965	0.879
NULL	Indian_J_Nephrol_2013_May-Jun_23(3)_222-225.nxml.txt.nlp	23814425	SENT22	29	29	15	15	tacrolimus	SPK	PA451578	55872;8189	0.879
NULL	Exp_Neurobiol_2014_Mar_27_23(1)_65-76.nxml.txt.nlp	24737941	SENT126	23	23	12	12	etoposide	TRAP1	PA449552	9392;10131	0.879
NULL	Arthritis_Res_Ther_2009_Mar_16_11(2)_R41.nxml.txt.nlp	19291317	SENT29	12	12	17	17	collagenase	IL-6	PA449107	3569	0.879
NULL	Indian_J_Pharmacol_2014_Nov-Dec_46(6)_627-632.nxml.txt.nlp	25538335	SENT132	9	9	12	12	metformin	Q10	PA450395	27161	0.879
NULL	Curr_Cardiol_Rev_2010_Nov_6(4)_363-372.nxml.txt.nlp	22043213	SENT239	6	6	17	17	oxygen	PAH	PA450744	5053	0.879
NULL	J_Obes_2011_Dec_12_2011_179674.nxml.txt.nlp	21197148	SENT294	6	6	9	9	exenatide	GLP-1	PA164749238	100125288	0.879
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT133	17	17	37	37	pp2	LYN		4067	0.879
NULL	J_Korean_Med_Sci_2014_Jul_11_29(7)_965-972.nxml.txt.nlp	25045229	SENT76	16	16	1	1	metformin	B12	PA450395	7126;4709	0.879
NULL	Br_J_Cancer_2011_Apr_12_104(8)_1256-1261.nxml.txt.nlp	21448165	SENT126	16	16	44	44	sorafenib	IL-2	PA7000	3558	0.879
NULL	Front_Genet_2011_May_4_2_20.nxml.txt.nlp	22303316	SENT12	16	16	2	2	hyaluronan	HPSE	PA165958431	10855	0.879
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT385	5	5	42	42	resveratrol	IL-6		3569	0.879
NULL	Drug_Healthc_Patient_Saf_2012_Nov_29_4_173-180.nxml.txt.nlp	23236256	SENT67	2	2	12	12	risperidone	FGA	PA451257	2243	0.879
NULL	J_Headache_Pain_2013_Aug_13_14(1)_71.nxml.txt.nlp	23941062	SENT34	12	12	2	2	probenecid	TRPV2	PA451106	51393	0.879
NULL	Indian_J_Endocrinol_Metab_2013_Sep-Oct_17(5)_899-905.nxml.txt.nlp	24083174	SENT130	33	33	16	16	glucose	p53	PA449773	7157	0.879
NULL	Toxins_(Basel)_2010_Oct_26_2(11)_2490-2518.nxml.txt.nlp	22069563	SENT151	4	4	12	12	cisplatin	p38	PA449014	10598;1432;7965	0.879
NULL	Hum_Mol_Genet_2013_Nov_15_22(22)_4616-4626.nxml.txt.nlp	23814041	SENT179	26	26	15	15	simvastatin	neuroserpin	PA451363	5274	0.879
NULL	J_Bras_Pneumol_2014_Jan-Feb_40(1)_77-81.nxml.txt.nlp	24626274	SENT46	32	32	18	18	methotrexate	IFN	PA450428	3439	0.879
NULL	Int_J_Gen_Med_2010_Nov_19_3_379-382.nxml.txt.nlp	21189835	SENT60	23	23	4	4	simvastatin	JBS	PA451363	3719	0.879
NULL	J_Lipid_Res_2012_May_53(5)_1000-1011.nxml.txt.nlp	22368281	SENT737	14	14	7	7	simvastatin	HMGCR	PA451363	3156	0.879
NULL	J_Cell_Biol_2001_Apr_2_153(1)_207-220.nxml.txt.nlp	11285286	SENT35	8	8	15	15	carbachol	DGK	PA448784	8526;1607	0.879
NULL	Nat_Med_2011_Dec_11_18(1)_74-82.nxml.txt.nlp	22157681	SENT235	18	18	13	13	gefitinib	BIM	PA131301952	10018	0.879
NULL	Cancer_Manag_Res_2013_Jun_27_5_133-146.nxml.txt.nlp	23869177	SENT124	31	31	36	36	cetuximab	EGFR	PA10040	1956	0.879
NULL	Br_J_Cancer_2011_Jun_7_104(12)_1828-1835.nxml.txt.nlp	21559012	SENT167	40	40	10	10	tamoxifen	EGFR	PA451581	1956	0.879
NULL	CNS_Spectr_2014_Apr_1_19(2)_121-133.nxml.txt.nlp	23903233	SENT439	24	24	13	13	diazepam	5-HT1A	PA449283	3350	0.879
NULL	Hum_Genomics_2014_Sep_30_8(1)_17.nxml.txt.nlp	25265995	SENT245	6	6	27	27	estradiol	aromatase	PA449503	1588	0.879
NULL	Nat_Biotechnol_2013_Jul_30_31(7)_630-637.nxml.txt.nlp	23811600	SENT191	16	16	9	9	crizotinib	NTRK3	PA165946122	4916	0.879
NULL	eLife_2014_May_19_3_e02784.nxml.txt.nlp	24842878	SENT396	12	12	2	2	paraformaldehyde	SLY1	PA450790	23256	0.879
NULL	Cancer_Imaging_2005_Nov_23_5(Spec_No_A)_S27-S32.nxml.txt.nlp	16361133	SENT164	17	17	7	7	paclitaxel	HER2	PA450761	2064	0.879
NULL	Acta_Pharmacol_Sin_2013_May_8_34(5)_612-624.nxml.txt.nlp	23564085	SENT116	3	3	26	26	bortezomib	JNK	PA10252	5599	0.879
NULL	Evid_Based_Complement_Alternat_Med_2013_May_16_2013_470975.nxml.txt.nlp	23762140	SENT184	25	25	16	16	curcumin	p65	PA151958596	5970	0.879
NULL	J_Med_Case_Rep_2014_Aug_25_8_286.nxml.txt.nlp	25155131	SENT42	14	14	24	24	warfarin	B12	PA451906	7126;4709	0.879
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2751-2762.nxml.txt.nlp	24169358	SENT13	0	0	36	36	fulvestrant	BCAR1	PA164747170	9564	0.879
NULL	Breast_Cancer_(Auckl)_2011_Oct_9_5_209-226.nxml.txt.nlp	22084574	SENT250	16	16	10	10	exemestane	aromatase	PA449563	1588	0.879
NULL	Front_Mol_Neurosci_2009_Nov_6_2_24.nxml.txt.nlp	19936315	SENT213	30	30	14	14	tamoxifen	E12	PA451581	64100	0.879
NULL	Mol_Cancer_2012_Dec_12_11_91.nxml.txt.nlp	23234355	SENT72	4	4	11	11	cetuximab	HER2	PA10040	2064	0.879
NULL	Arch_Drug_Inf_2008_Jul_1(1)_14-22.nxml.txt.nlp	20157364	SENT15	0	0	9	9	pravastatin	IL-6	PA451089	3569	0.879
NULL	Diabetologia_2014_Sep_29_57(1)_192-203.nxml.txt.nlp	24078137	SENT176	41	41	18	18	metformin	RDH12	PA450395	145226	0.879
NULL	FEBS_Open_Bio_2014_Oct_22_4_898-904.nxml.txt.nlp	25383313	SENT266	0	0	15	15	genistein	adiponectin	PA165109660	9370	0.879
NULL	Adv_Biomed_Res_2014_Feb_28_3_86.nxml.txt.nlp	24761394	SENT67	8	8	14	14	budesonide	IL-8	PA448681	3576	0.879
NULL	Subst_Abuse_Rehabil_2014_Aug_14_5_95-105.nxml.txt.nlp	25187752	SENT78	31	31	22	22	anastrozole	aromatase	PA448432	1588	0.879
NULL	N_Am_J_Med_Sci_2013_Mar_5(3)_202-206.nxml.txt.nlp	23626956	SENT80	23	23	4	4	cetuximab	EGFR	PA10040	1956	0.879
NULL	J_Ophthalmol_2011_Oct_20_2011_252549.nxml.txt.nlp	22046503	SENT114	8	8	27	27	ranibizumab	LRP5	PA164746012	4041	0.879
NULL	Clin_Ophthalmol_2014_Jun_26_8_1213-1219.nxml.txt.nlp	25061267	SENT27	0	0	44	44	proparacaine	PRK	PA164776849	1263	0.879
NULL	Chemother_Res_Pract_2011_Apr_18_2011_619321.nxml.txt.nlp	22312555	SENT62	40	40	9	9	daptomycin	VISA	PA164768820	57506	0.879
NULL	Exp_Mol_Med_2012_Dec_17_44(12)_749-755.nxml.txt.nlp	23178275	SENT10	5	5	0	0	phenylephrine	CAL	PA450935	54751;57120	0.879
NULL	EMBO_J_2013_Feb_20_32(4)_511-523.nxml.txt.nlp	23241948	SENT129	24	24	5	5	kanamycin	FRP	PA450137	11167;6422	0.879
NULL	Oncogene_2014_Jul_24_33(30)_3927-3938.nxml.txt.nlp	23995784	SENT40	14	14	24	24	doxycycline	FLI1	PA449415	2313	0.879
NULL	Biochemistry_2012_Sep_25_51(38)_7456-7464.nxml.txt.nlp	22947085	SENT54	11	11	41	41	thyroglobulin	B12	PA164754910	7126;4709	0.879
NULL	Front_Genet_2012_Nov_22_3_249.nxml.txt.nlp	23189085	SENT66	28	28	16	16	cyclophosphamide	MTHFR	PA449165	4524	0.879
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT15	23	23	15	15	sulindac	survivin	PA451565	332	0.879
NULL	Eur_J_Clin_Pharmacol_2014_Oct_8_70(1)_37-45.nxml.txt.nlp	24100471	SENT15	11	11	30	30	rosuvastatin	CYP2C8	PA134308647	1558	0.879
NULL	J_Adv_Pharm_Technol_Res_2011_Apr-Jun_2(2)_81-87.nxml.txt.nlp	22171298	SENT184	18	18	24	24	nifedipine	p53	PA450631	7157	0.879
NULL	Int_J_Nanomedicine_2012_May_7_7_2307-2314.nxml.txt.nlp	22661887	SENT12	6	6	11	11	gemcitabine	zeta	PA449748	9907	0.879
NULL	Biosci_Rep_2014_Apr_15_34(2)_e00105.nxml.txt.nlp	24617546	SENT125	30	30	12	12	metformin	AMPK	PA450395	5563	0.879
NULL	Ecancermedicalscience_2008_Feb_18_2_75.nxml.txt.nlp	22275966	SENT176	30	30	5	5	irinotecan	EREG	PA450085	2069	0.879
NULL	Front_Genet_2013_Aug_29_4_163.nxml.txt.nlp	24009622	SENT343	16	16	4	4	imatinib	SIRT1	PA10804	23411	0.879
NULL	Breast_Cancer_Res_2008_Mar_29_10(2)_R28.nxml.txt.nlp	18373870	SENT93	26	26	5	5	ethanol	HSPC111	PA448073	51491	0.879
NULL	Front_Neurol_2014_Sep_2_5_159.nxml.txt.nlp	25228896	SENT62	24	24	7	7	midazolam	GCS	PA450496	2729;7357	0.879
NULL	Anat_Cell_Biol_2011_Sep_29_44(3)_194-203.nxml.txt.nlp	22025971	SENT174	5	5	7	7	berberine	AMPK	PA165860812	5563	0.879
NULL	Case_Rep_Genet_2013_Jan_29_2013_573841.nxml.txt.nlp	23509644	SENT44	42	42	15	15	cabergoline	PRL	PA448708	5617	0.879
NULL	Anal_Chem_2014_Mar_18_86(6)_2867-2870.nxml.txt.nlp	24579851	SENT60	15	15	31	31	hemin	HBG2	PA449849	3048	0.879
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1522-1532.nxml.txt.nlp	21997136	SENT8	8	8	5	5	gefitinib	EGFR	PA131301952	1956	0.879
NULL	Mol_Biol_Cell_2012_Nov_1_23(21)_4212-4225.nxml.txt.nlp	22956765	SENT289	14	14	6	6	thrombin	RhoA	PA451674	387	0.879
NULL	Br_J_Cancer_2013_Mar_5_108(4)_973-982.nxml.txt.nlp	23299537	SENT126	18	18	7	7	doxorubicin	p53	PA449412	7157	0.879
NULL	Oncotarget_2014_Jun_3_5(13)_4920-4928.nxml.txt.nlp	24952482	SENT95	0	0	2	2	crizotinib	MET	PA165946122	4233	0.879
NULL	Cancer_Med_2013_Dec_31_2(6)_826-835.nxml.txt.nlp	24403256	SENT9	22	22	15	15	daunorubicin	HDM2	PA449212	4193	0.879
NULL	Biosci_Rep_2012_Aug_1_32(Pt_4)_361-374.nxml.txt.nlp	22762204	SENT1038	14	14	5	5	cisplatin	p27	PA449014	5715;10534	0.879
NULL	Mucosal_Immunol_2011_Nov_6_4(6)_648-657.nxml.txt.nlp	21734653	SENT283	6	6	17	17	azithromycin	HEC	PA448519	10403	0.879
NULL	Mol_Biol_Cell_2012_Nov_1_23(21)_4212-4225.nxml.txt.nlp	22956765	SENT140	15	15	4	4	thrombin	SHP2	PA451674	5781	0.879
NULL	Angew_Chem_Int_Ed_Engl_2013_Jan_2_52(1)_325-330.nxml.txt.nlp	23080482	SENT30	19	19	4	4	thrombin	ACPP	PA451674	55	0.879
NULL	Aging_(Albany_NY)_2013_Feb_21_5(2)_94-95.nxml.txt.nlp	23518473	SENT22	24	24	29	29	resveratrol	SIRT1		23411	0.879
NULL	Subst_Abuse_Rehabil_2014_Aug_14_5_95-105.nxml.txt.nlp	25187752	SENT78	19	19	22	22	raloxifene	aromatase	PA451221	1588	0.879
NULL	Br_J_Haematol_2011_Apr_153(1)_83-91.nxml.txt.nlp	21332705	SENT11	3	3	10	10	cangrelor	P2Y12	PA165945763	64805	0.879
NULL	Front_Neural_Circuits_2014_Aug_5_8_93.nxml.txt.nlp	25140130	SENT133	17	17	11	11	haloperidol	spatial	PA449841	219793	0.879
NULL	Br_J_Cancer_2009_Jul_21_101(2)_269-277.nxml.txt.nlp	19603033	SENT7	13	13	16	16	cisplatin	XIAP	PA449014	331	0.879
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT147	10	10	18	18	dasatinib	EGR1	PA162372878	1958	0.879
NULL	Cancers_(Basel)_2013_May_27_5(2)_617-638.nxml.txt.nlp	24216994	SENT208	12	12	5	5	curcumin	PC3	PA151958596	57332;7832;5122	0.879
NULL	Clin_Ophthalmol_2009_Jun_2_3_199-210.nxml.txt.nlp	19668566	SENT84	17	17	4	4	ketorolac	COX	PA450150	1351	0.879
NULL	Diabetes_Care_2010_Aug_33(8)_1908-1910.nxml.txt.nlp	20668159	SENT63	21	21	4	4	rosiglitazone	DREAM	PA451283	30818	0.879
NULL	Protein_Expr_Purif_2009_Aug_66(2)_181-184.nxml.txt.nlp	19269329	SENT8	22	22	15	15	thrombin	AMPK	PA451674	5563	0.879
NULL	Indian_J_Pharm_Sci_2009_Nov-Dec_71(6)_622-629.nxml.txt.nlp	20376214	SENT69	15	15	1	1	captopril	B10	PA448780	5169	0.879
NULL	Chin_J_Cancer_2011_May_30(5)_327-335.nxml.txt.nlp	21527065	SENT35	44	44	37	37	lapatinib	PIK3CA	PA152241907	5290	0.879
NULL	J_Gynecol_Oncol_2014_Apr_9_25(2)_130-135.nxml.txt.nlp	24761217	SENT112	21	21	29	29	paclitaxel	P-gp	PA450761	5243	0.879
NULL	Acta_Pharmacol_Sin_2009_Nov_12_30(11)_1566-1572.nxml.txt.nlp	19820718	SENT150	14	14	11	11	ketoconazole	P-gp	PA450146	5243	0.879
NULL	Cancer_Cell_Int_2014_Jan_27_14_8.nxml.txt.nlp	24467885	SENT103	15	15	11	11	fluorouracil	IFN	PA128406956	3439	0.879
NULL	Br_J_Cancer_2012_Nov_6_107(10)_1737-1744.nxml.txt.nlp	23037715	SENT259	42	42	10	10	chlorpromazine	PC-3	PA448964	692094	0.879
NULL	Thorax_2014_Jul_24_69(7)_638-647.nxml.txt.nlp	24567297	SENT86	15	15	33	33	doxycycline	TRAIL	PA449415	8743	0.879
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT177	7	7	13	13	tacrolimus	RANKL	PA451578	8600	0.879
NULL	Drugs_R_D_2013_Sep_19_13(3)_199-205.nxml.txt.nlp	24048773	SENT30	9	9	0	0	l-cysteine	NAC	PA449173	22861	0.879
NULL	Case_Rep_Infect_Dis_2013_Oct_8_2013_693480.nxml.txt.nlp	24223316	SENT117	26	26	4	4	caspofungin	gamma	PA164743013	9913	0.879
NULL	Cancer_Cell_Int_2014_Jun_16_14_53.nxml.txt.nlp	24966801	SENT239	3	3	9	9	metformin	Bcl-2	PA450395	596	0.879
NULL	J_Gen_Physiol_1938_Jan_20_21(3)_289-295.nxml.txt.nlp	19873051	SENT3	7	7	27	27	choline	mol	PA448976	90527	0.879
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT100	6	6	32	32	pertuzumab	PI3K		5290	0.879
NULL	Case_Rep_Ophthalmol_2010_Dec_8_1(2)_110-113.nxml.txt.nlp	21373383	SENT46	15	15	6	6	ranibizumab	PED	PA164746012	8682	0.879
NULL	Cell_Death_Dis_2014_Mar_13_5(3)_e1125.nxml.txt.nlp	24625984	SENT110	26	26	8	8	clodronate	TNF	PA10239	7124	0.879
NULL	Onco_Targets_Ther_2014_Dec_4_7_2249-2255.nxml.txt.nlp	25587220	SENT106	11	11	23	23	vinblastine	P-gp	PA451877	5243	0.879
NULL	Ann_Hematol_2010_Nov_25_89(11)_1115-1124.nxml.txt.nlp	20499237	SENT118	25	25	2	2	fludarabine	CD19	PA449655	930	0.879
NULL	Drug_Des_Devel_Ther_2014_Oct_31_8_2121-2128.nxml.txt.nlp	25382970	SENT9	21	21	29	29	curcumin	TTR	PA151958596	7276	0.879
NULL	Br_J_Cancer_2012_Nov_6_107(10)_1714-1721.nxml.txt.nlp	23073173	SENT152	14	14	7	7	bicalutamide	RUNX2	PA164746255	860	0.879
NULL	Cell_Cycle_2012_Dec_15_11(24)_4499-4506.nxml.txt.nlp	23114620	SENT73	14	14	19	19	choline	DAG	PA448976	1605	0.879
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1150.nxml.txt.nlp	24675468	SENT91	16	16	23	23	ethanol	adiponectin	PA448073	9370	0.879
NULL	Cancers_(Basel)_2014_Mar_26_6(2)_708-722.nxml.txt.nlp	24675568	SENT59	17	17	1	1	doxorubicin	STAT3	PA449412	6774	0.879
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT154	0	0	7	7	pp2	JNK		5599	0.879
NULL	Br_J_Cancer_2010_Jun_29_103(1)_61-72.nxml.txt.nlp	20588279	SENT272	8	8	11	11	trastuzumab	RhoB	PA451743	388	0.879
NULL	J_Hematol_Oncol_2011_Mar_9_4_9.nxml.txt.nlp	21388537	SENT55	13	13	5	5	phenytoin	UGT1A1	PA450947	54658	0.879
NULL	Diabetes_Care_2011_May_20_34(5)_1077-1080.nxml.txt.nlp	21421801	SENT140	16	16	10	10	nortriptyline	B12	PA450657	7126;4709	0.879
NULL	Cancer_Metastasis_Rev_2014_Apr_18_33(2-3)_695-720.nxml.txt.nlp	24744103	SENT310	33	33	46	46	gefitinib	PTEN	PA131301952	5728	0.879
NULL	Nat_Methods_2012_Jul_1_9(8)_805-807.nxml.txt.nlp	22751204	SENT157	2	2	14	14	methotrexate	DHFR	PA450428	1719	0.879
NULL	Allergy_Asthma_Clin_Immunol_2012_May_20_8(1)_6.nxml.txt.nlp	22607519	SENT101	11	11	18	18	infliximab	IL-6	PA452639	3569	0.879
NULL	J_Hematol_Oncol_2013_Jul_9_6_49.nxml.txt.nlp	23837843	SENT228	15	15	5	5	verapamil	P-gp	PA451868	5243	0.879
NULL	J_Adv_Pract_Oncol_2013_Jan_1_Jan-Feb_4(1)_59-64.nxml.txt.nlp	25031982	SENT54	19	19	21	21	diethylstilbestrol	DES	PA449307	1674	0.879
NULL	Pharmaceuticals_(Basel)_2013_Aug_21_6(8)_988-1038.nxml.txt.nlp	24276379	SENT370	15	15	28	28	cetuximab	EGFR	PA10040	1956	0.879
NULL	Mol_Cancer_2014_Jun_24_13_157.nxml.txt.nlp	24958351	SENT60	33	33	19	19	lapatinib	AKT	PA152241907	207	0.879
NULL	Chem_Cent_J_2012_Jan_22_6_7.nxml.txt.nlp	22264235	SENT193	16	16	25	25	chloramphenicol	PC2	PA448927	5126;5311;8535	0.879
NULL	Oncotarget_2011_Sep_9_2(9)_658-668.nxml.txt.nlp	21911919	SENT79	9	9	11	11	daunorubicin	HO-1	PA449212	3162	0.879
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1137-1144.nxml.txt.nlp	20234366	SENT61	15	15	6	6	cetuximab	MKP-1	PA10040	1843	0.879
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_29_2013_590393.nxml.txt.nlp	23737838	SENT308	8	8	2	2	resveratrol	p53		7157	0.879
NULL	Mucosal_Immunol_2013_Nov_10_6(6)_1179-1190.nxml.txt.nlp	23571504	SENT108	9	9	22	22	auranofin	IL-4	PA448510	3565	0.879
NULL	Front_Mol_Neurosci_2014_Oct_14_7_80.nxml.txt.nlp	25352776	SENT42	14	14	3	3	l-lysine	p75NTR	PA450280	4804	0.879
NULL	J_Korean_Neurosurg_Soc_2014_Jun_30_55(6)_313-320.nxml.txt.nlp	25237426	SENT67	40	40	8	8	urokinase	Penumbra	PA451836	340348	0.879
NULL	Diabetes_2008_Sep_57(9)_2288-2295.nxml.txt.nlp	18535187	SENT124	12	12	20	20	pioglitazone	mol	PA450970	90527	0.879
NULL	Oncotarget_2013_Dec_4_5(4)_944-958.nxml.txt.nlp	24659709	SENT153	32	32	10	10	cisplatin	JAG1	PA449014	182	0.879
NULL	J_Med_Case_Reports_2011_Jan_12_5_5.nxml.txt.nlp	21226894	SENT101	13	13	5	5	cyclophosphamide	CHOP	PA449165	1649	0.879
NULL	BMB_Rep_2014_Nov_47(11)_649-654.nxml.txt.nlp	25301019	SENT87	5	5	13	13	l-alanine	IL-10	PA448055	3586	0.879
NULL	Oncol_Lett_2013_Apr_28_5(4)_1149-1154.nxml.txt.nlp	23599754	SENT25	21	21	9	9	cisplatin	Dicer	PA449014	23405	0.879
NULL	Nat_Commun_2010_Dec_21_1_147.nxml.txt.nlp	21266997	SENT181	26	26	16	16	kanamycin	DLP12	PA450137	201625	0.879
NULL	Chemother_Res_Pract_2012_Aug_29_2012_817297.nxml.txt.nlp	22970367	SENT125	19	19	5	5	erlotinib	AXL	PA134687924	558	0.879
NULL	Leukemia_2014_Jan_12_28(1)_15-33.nxml.txt.nlp	23778311	SENT577	35	35	26	26	imatinib	p53	PA10804	7157	0.879
NULL	J_Clin_Biochem_Nutr_2011_May_13_48(3)_237-244.nxml.txt.nlp	21562645	SENT256	6	6	10	10	resveratrol	AMPK		5563	0.879
NULL	Int_J_Gen_Med_2013_Dec_27_7_43-47.nxml.txt.nlp	24403843	SENT66	8	8	11	11	roxithromycin	ACR	PA164750505	49	0.879
NULL	Oncol_Lett_2013_Mar_28_5(3)_983-991.nxml.txt.nlp	23426861	SENT27	17	17	6	6	gemcitabine	BRCA1	PA449748	672	0.879
NULL	Ther_Clin_Risk_Manag_2007_Mar_3(1)_133-148.nxml.txt.nlp	18360621	SENT15	36	36	30	30	adalimumab	p75	PA10004	7133;11168	0.879
NULL	Ther_Clin_Risk_Manag_2006_Sep_2(3)_235-249.nxml.txt.nlp	18360599	SENT300	7	7	10	10	alendronate	PTH	PA448082	5741	0.879
NULL	Oncotarget_2014_Aug_25_5(17)_7945-7959.nxml.txt.nlp	25277206	SENT27	3	3	6	6	sorafenib	Raf-1	PA7000	5894	0.879
NULL	Osteoarthritis_Cartilage_2013_Sep_21(9)_1336-1345.nxml.txt.nlp	23973148	SENT25	0	0	23	23	triamcinolone	MIA	PA451749	8190	0.879
NULL	Clin_Interv_Aging_2013_Jul_16_8_889-897.nxml.txt.nlp	23898224	SENT67	4	4	13	13	gemcitabine	SIRT1	PA449748	23411	0.879
NULL	J_Autom_Methods_Manag_Chem_2007_Jun_19_2007_86857.nxml.txt.nlp	17671612	SENT49	4	4	33	33	tinidazole	mol	PA10813	90527	0.879
NULL	Mar_Drugs_2010_Mar_15_8(3)_629-657.nxml.txt.nlp	20411119	SENT209	24	24	41	41	l-arginine	PP1	PA448478	5540;5464	0.879
NULL	Int_J_Endocrinol_2014_Jul_16_2014_690783.nxml.txt.nlp	25140176	SENT574	8	8	5	5	metformin	AMPK	PA450395	5563	0.879
NULL	Int_J_Endocrinol_2010_Jun_27_2010_206801.nxml.txt.nlp	20652073	SENT51	4	4	15	15	cinacalcet	PTH	PA164776671	5741	0.879
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Aug_17_67(Pt_9)_o2351.nxml.txt.nlp	22058967	SENT78	32	32	24	24	ethanol	mol	PA448073	90527	0.879
NULL	Cancers_(Basel)_2012_Oct_29_4(4)_1146-1160.nxml.txt.nlp	24213502	SENT54	13	13	4	4	raloxifene	STAR	PA451221	6770;2984	0.879
NULL	Protein_Cell_2014_Jun_19_5(6)_469-479.nxml.txt.nlp	24748116	SENT168	7	7	19	19	paclitaxel	EB1	PA450761	9167;22919;10982	0.879
NULL	J_Cell_Mol_Med_2014_Dec_7_18(12)_2536-2552.nxml.txt.nlp	25287328	SENT87	10	10	31	31	phenol	San	PA450913	80218	0.879
NULL	Core_Evid_2007_Nov_30_2(2)_121-129.nxml.txt.nlp	21221180	SENT234	34	34	36	36	rituximab	CHOP	PA451261	1649	0.879
NULL	Pharmaceuticals_(Basel)_2011_Jan_12_4(1)_187-201.nxml.txt.nlp	NULL	SENT117	7	7	31	31	l-arginine	ANOVA	PA448478	4858	0.879
NULL	Cell_Commun_Signal_2014_Sep_25_12(1)_61.nxml.txt.nlp	NULL	SENT427	27	27	5	5	doxycycline	PC-3	PA449415	692094	0.879
NULL	Int_J_Surg_Oncol_2012_Jun_12_2012_862879.nxml.txt.nlp	22778941	SENT240	28	28	12	12	cisplatin	c-Myc	PA449014	4609	0.879
NULL	Br_J_Cancer_2009_Jun_2_100(11)_1739-1745.nxml.txt.nlp	19436299	SENT98	14	14	9	9	everolimus	FDG	PA164746311	23583	0.879
NULL	Diabetes_2011_Jun_21_60(6)_1770-1778.nxml.txt.nlp	21562078	SENT296	24	24	11	11	metformin	AMPK	PA450395	5563	0.879
NULL	Exp_Ther_Med_2012_Sep_12_4(3)_475-480.nxml.txt.nlp	23181121	SENT170	22	22	16	16	vincristine	CHOP	PA451879	1649	0.879
NULL	Nat_Commun_2011_Feb_8_2_192.nxml.txt.nlp	21304521	SENT76	11	11	4	4	methotrexate	DHFR	PA450428	1719	0.879
NULL	Mol_Cancer_2012_Apr_5_11_20.nxml.txt.nlp	22480225	SENT105	5	5	1	1	temozolomide	SPARC	PA451609	6678	0.879
NULL	J_Asthma_Allergy_2008_Sep_19_1_19-29.nxml.txt.nlp	21436982	SENT110	30	30	21	21	fexofenadine	I-TAC	PA449621	6373	0.879
NULL	Diabetes_Care_2010_Jul_31_33(7)_1544-1548.nxml.txt.nlp	20357370	SENT25	16	16	0	0	metformin	STK11	PA450395	6794	0.879
NULL	Int_J_Biol_Sci_2014_Nov_26_10(10)_1193-1202.nxml.txt.nlp	25516717	SENT38	34	34	9	9	hydroxyurea	SIRT1	PA449942	23411	0.879
NULL	Front_Behav_Neurosci_2012_Jun_13_6_24.nxml.txt.nlp	22707936	SENT238	32	32	26	26	carbachol	CA1	PA448784	759	0.879
NULL	Tuberc_Respir_Dis_(Seoul)_2013_Nov_29_75(5)_181-187.nxml.txt.nlp	24348665	SENT22	9	9	18	18	crizotinib	ALK7	PA165946122	130399	0.879
NULL	Oncoimmunology_2012_Aug_1_1(5)_762-764.nxml.txt.nlp	22934275	SENT20	29	29	35	35	indomethacin	COX2	PA449982	4513;5743	0.879
NULL	Mol_Vis_2012_Apr_11_18_901-908.nxml.txt.nlp	22539869	SENT155	20	20	31	31	curcumin	p38	PA151958596	10598;1432;7965	0.879
NULL	Indian_J_Hum_Genet_2013_Oct-Dec_19(4)_472-474.nxml.txt.nlp	24497716	SENT65	31	31	8	8	tamoxifen	aromatase	PA451581	1588	0.879
NULL	Anesth_Pain_Med_2014_Apr_7_4(2)_e15460.nxml.txt.nlp	24790902	SENT97	23	23	19	19	esmolol	NTG	PA449500	4976	0.879
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT132	0	0	3	3	metformin	HIF-1	PA450395	29072	0.879
NULL	Mol_Cancer_2010_May_18_9_110.nxml.txt.nlp	20482802	SENT162	19	19	10	10	chymotrypsin	PSMB5	PA448994	5693	0.879
NULL	Mol_Cancer_2008_Jun_30_7_60.nxml.txt.nlp	18590557	SENT168	11	11	22	22	vinblastine	TRAIL	PA451877	8743	0.879
NULL	Br_J_Cancer_2010_Nov_9_103(11)_1692-1697.nxml.txt.nlp	21063402	SENT94	12	12	17	17	doxycycline	TRAIL	PA449415	8743	0.879
NULL	Front_Oncol_2013_Apr_29_3_92.nxml.txt.nlp	23641361	SENT106	10	10	17	17	bevacizumab	NF2	PA130232992	4771	0.879
NULL	Exp_Ther_Med_2014_Jun_28_7(6)_1767-1771.nxml.txt.nlp	24926382	SENT116	11	11	22	22	etoposide	JNK	PA449552	5599	0.879
NULL	Indian_J_Dermatol_2011_May-Jun_56(3)_306-308.nxml.txt.nlp	21772594	SENT69	25	25	21	21	doxorubicin	CHOP	PA449412	1649	0.879
NULL	Evid_Based_Complement_Alternat_Med_2011_Jan_20_2011_751671.nxml.txt.nlp	21318106	SENT145	20	20	9	9	tacrolimus	P-gp	PA451578	5243	0.879
NULL	Iran_J_Basic_Med_Sci_2012_Sep-Oct_15(5)_1102-1105.nxml.txt.nlp	23492757	SENT85	0	0	10	10	celecoxib	IL-10	PA448871	3586	0.879
NULL	Iran_J_Pharm_Res_2014_Autumn_13(4)_1183-1190.nxml.txt.nlp	25587306	SENT44	21	21	4	4	ethanol	mol	PA448073	90527	0.879
NULL	Indian_J_Pharmacol_2008_Oct_40(Suppl_2)_S171-S173.nxml.txt.nlp	21593970	SENT14	18	18	5	5	fluoxetine	STZ	PA449673	6484	0.879
NULL	Ann_Coloproctol_2014_Aug_26_30(4)_165-174.nxml.txt.nlp	25210685	SENT137	14	14	6	6	panitumumab	EGFR	PA162373091	1956	0.879
NULL	Mol_Biol_Cell_2012_Jun_1_23(11)_2226-2234.nxml.txt.nlp	22493319	SENT129	7	7	15	15	doxorubicin	FOXO3	PA449412	2309	0.879
NULL	J_Hematol_Oncol_2012_Apr_25_5(Suppl_1)_A1.nxml.txt.nlp	22738713	SENT7	0	0	28	28	trastuzumab	HER2	PA451743	2064	0.879
NULL	Breast_Cancer_Res_2012_Jun_7_14(3)_R89.nxml.txt.nlp	22676470	SENT337	19	19	3	3	geldanamycin	HER2	PA152031327	2064	0.879
NULL	Clin_Dev_Immunol_2013_Nov_21_2013_923107.nxml.txt.nlp	24348684	SENT109	8	8	16	16	imatinib	CD4	PA10804	920	0.879
NULL	Cancer_Metab_2013_Feb_4_1_7.nxml.txt.nlp	24280108	SENT199	21	21	6	6	doxycycline	GLS1	PA449415	2744	0.879
NULL	Exp_Ther_Med_2014_May_21_7(5)_1388-1392.nxml.txt.nlp	24940444	SENT85	6	6	19	19	oxygen	ROS	PA450744	6098	0.879
NULL	Br_J_Cancer_2013_Mar_19_108(5)_1079-1091.nxml.txt.nlp	23449353	SENT126	10	10	31	31	docetaxel	MIC-1	PA449383	29919;9518	0.879
NULL	Breast_Cancer_Res_2010_May_18_12(Suppl_1)_P45.nxml.txt.nlp	NULL	SENT10	23	23	1	1	estradiol	FKBPL	PA449503	63943	0.879
NULL	Biomed_Res_Int_2014_Jan_12_2014_276918.nxml.txt.nlp	24524073	SENT98	15	15	35	35	paroxetine	CYP2C19	PA450801	1557	0.879
NULL	J_Cancer_Res_Clin_Oncol_2015_Aug_3_141_61-68.nxml.txt.nlp	25086987	SENT21	2	2	15	15	gefitinib	EGFR	PA131301952	1956	0.879
NULL	Biomed_Res_Int_2013_May_22_2013_430791.nxml.txt.nlp	23762845	SENT4	15	15	32	32	fasudil	STZ	PA165946121	6484	0.879
NULL	Carcinogenesis_2014_May_13_35(5)_1055-1066.nxml.txt.nlp	24419232	SENT272	10	10	23	23	metformin	CD31	PA450395	5175	0.879
NULL	Br_J_Cancer_2014_Nov_25_111(11)_2091-2102.nxml.txt.nlp	25349971	SENT14	19	19	4	4	imatinib	PTPN18	PA10804	26469	0.879
NULL	Chin_J_Cancer_2011_May_30(5)_287-292.nxml.txt.nlp	21527061	SENT65	23	23	7	7	paclitaxel	EGFR	PA450761	1956	0.879
NULL	Cancer_Med_2013_Feb_3_2(1)_40-49.nxml.txt.nlp	24133626	SENT385	14	14	7	7	cilostazol	PDE3B	PA164746334	5140	0.879
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT196	27	27	14	14	cisplatin	p53	PA449014	7157	0.879
NULL	Br_J_Pharmacol_2008_Sep_9_155(1)_127-137.nxml.txt.nlp	18536750	SENT190	19	19	0	0	piroxicam	IL-6	PA450985	3569	0.879
NULL	Int_Semin_Surg_Oncol_2007_Feb_14_4_5.nxml.txt.nlp	17394628	SENT15	35	35	13	13	cyclophosphamide	MSH6	PA449165	2956	0.879
NULL	Oncotarget_2014_Mar_10_5(10)_3023-3028.nxml.txt.nlp	24632590	SENT59	40	40	36	36	gefitinib	EGFR	PA131301952	1956	0.879
NULL	Cell_Death_Dis_2013_Sep_5_4(9)_e792.nxml.txt.nlp	24008736	SENT6	25	25	10	10	methotrexate	WWOX	PA450428	51741	0.879
NULL	Cancers_(Basel)_2011_Apr_1_3(2)_1844-1860.nxml.txt.nlp	24212785	SENT453	21	21	2	2	irinotecan	BRAF	PA450085	673	0.879
NULL	Front_Genet_2012_Nov_22_3_249.nxml.txt.nlp	23189085	SENT115	17	17	21	21	etoposide	AGPAT2	PA449552	10555	0.879
NULL	Mol_Cells_2014_Mar_31_37(3)_234-240.nxml.txt.nlp	24642709	SENT126	8	8	10	10	capsaicin	HO-1	PA448776	3162	0.879
NULL	Oxid_Med_Cell_Longev_2013_Nov_28_2013_568093.nxml.txt.nlp	24379901	SENT52	8	8	15	15	resveratrol	AMPK		5563	0.879
NULL	Eur_J_Med_Res_2009_Nov_24_14(Suppl_3)_36-42.nxml.txt.nlp	19959415	SENT34	21	21	14	14	emtricitabine	gamma	PA10069	9913	0.879
NULL	Orphanet_J_Rare_Dis_2014_Oct_29_9(1)_162.nxml.txt.nlp	NULL	SENT256	7	7	2	2	diltiazem	CYP3A4	PA449334	1576	0.879
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_105-115.nxml.txt.nlp	17912640	SENT35	8	8	25	25	tamoxifen	AIB1	PA451581	8202	0.879
NULL	Onco_Targets_Ther_2014_Mar_20_7_447-456.nxml.txt.nlp	24672247	SENT149	30	30	20	20	sorafenib	CLU	PA7000	1191	0.879
NULL	Front_Oncol_2014_Sep_29_4_251.nxml.txt.nlp	25325012	SENT244	19	19	2	2	erlotinib	EGFR	PA134687924	1956	0.879
NULL	Diabetes_Care_2013_Jan_10_36(Suppl_1)_S11-S66.nxml.txt.nlp	23264422	SENT1932	22	22	7	7	rosiglitazone	DREAM	PA451283	30818	0.879
NULL	Arthritis_Res_Ther_2011_May_25_13(Suppl_1)_S2.nxml.txt.nlp	21624181	SENT268	9	9	1	1	infliximab	IMPACT	PA452639	55364	0.879
NULL	Osteoporos_Int_2010_Oct_18_21(10)_1657-1680.nxml.txt.nlp	20480148	SENT430	4	4	21	21	denosumab	RANKL	PA166048634	8600	0.879
NULL	Cell_Death_Dis_2014_Jan_30_5(1)_e1030.nxml.txt.nlp	24481444	SENT266	31	31	8	8	sorafenib	EGF	PA7000	1950	0.879
NULL	Contemp_Oncol_(Pozn)_2012_Nov_20_16(5)_401-406.nxml.txt.nlp	23788917	SENT152	11	11	22	22	afatinib	HER2	PA165981154	2064	0.879
NULL	Oncotarget_2013_Nov_24_4(12)_2430-2438.nxml.txt.nlp	24280348	SENT128	11	11	36	36	gefitinib	STAT3	PA131301952	6774	0.879
NULL	Cancers_(Basel)_2012_Oct_12_4(4)_989-1035.nxml.txt.nlp	24213498	SENT438	32	32	27	27	gemcitabine	CD133	PA449748	8842	0.879
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT72	5	5	9	9	erlotinib	AKT	PA134687924	207	0.879
NULL	Mol_Cancer_2012_Apr_26_11_26.nxml.txt.nlp	22537224	SENT180	28	28	15	15	cisplatin	BRCA2	PA449014	675	0.879
NULL	Curr_Med_Chem_2013_Aug_20(25)_3103-3115.nxml.txt.nlp	23514419	SENT54	6	6	1	1	sitagliptin	DPPIV	PA164748978	2191;1803	0.879
NULL	Iran_J_Pharm_Res_2013_Winter_12(1)_175-184.nxml.txt.nlp	24250586	SENT127	33	33	22	22	celecoxib	COX1	PA448871	4512;5742	0.879
NULL	Aging_(Albany_NY)_2012_Mar_12_4(3)_146-158.nxml.txt.nlp	22436213	SENT58	8	8	11	11	resveratrol	AMPK		5563	0.879
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT332	2	2	7	7	olanzapine	PRL	PA450688	5617	0.879
NULL	Int_J_Breast_Cancer_2011_Feb_24_2011_967419.nxml.txt.nlp	22332018	SENT236	7	7	12	12	methotrexate	MRP1	PA450428	4437	0.879
NULL	Ann_Rheum_Dis_2008_Nov_14_67(11)_1516-1523.nxml.txt.nlp	18625622	SENT212	10	10	7	7	tocilizumab	IL-6	PA165292659	3569	0.879
NULL	Cell_Death_Dis_2014_Jul_10_5(7)_e1318.nxml.txt.nlp	25010984	SENT39	4	4	23	23	nutlin-3	p53		7157	0.879
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT116	42	42	19	19	raltitrexed	UNG	PA131625240	7374	0.879
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Jul_9_3(7)_e124.nxml.txt.nlp	25006781	SENT53	37	37	26	26	rosuvastatin	OATP1B1	PA134308647	10599	0.879
NULL	Arthritis_Res_Ther_2006_Dec_28_8(1)_R18.nxml.txt.nlp	16507118	SENT97	30	30	12	12	infliximab	IL-15	PA452639	3600	0.879
NULL	Am_J_Cardiovasc_Drugs_2013_Jun_20_13(5)_331-342.nxml.txt.nlp	23784266	SENT195	11	11	14	14	dronedarone	P-gp	PA153619853	5243	0.879
NULL	Cancer_Cell_Int_2009_Sep_10_9_25.nxml.txt.nlp	19744341	SENT163	4	4	19	19	glucosamine	STAT3	PA164747613	6774	0.879
NULL	Comp_Hepatol_2004_Jan_14_3(Suppl_1)_S31.nxml.txt.nlp	14960183	SENT95	24	24	8	8	ethanol	p38	PA448073	10598;1432;7965	0.879
NULL	Acta_Histochem_Cytochem_2007_Jul_3_40(3)_93-99.nxml.txt.nlp	17653301	SENT64	6	6	28	28	glutaraldehyde	CO2	PA449777	4513	0.879
NULL	J_Hematol_Oncol_2011_Jan_21_4_5.nxml.txt.nlp	21255411	SENT28	16	16	28	28	paclitaxel	EGFR	PA450761	1956	0.878
NULL	Cancer_Manag_Res_2014_Jan_28_6_39-51.nxml.txt.nlp	24501545	SENT137	13	13	8	8	bicalutamide	CYP3A4	PA164746255	1576	0.878
NULL	Evid_Based_Complement_Alternat_Med_2014_Oct_19_2014_628712.nxml.txt.nlp	25389442	SENT8	42	42	30	30	erlotinib	PTEN	PA134687924	5728	0.878
NULL	Basic_Clin_Neurosci_2014_Summer_5(3)_182-190.nxml.txt.nlp	25337378	SENT54	27	27	24	24	bupropion	mol	PA448687	90527	0.878
NULL	Oncotarget_2011_Nov_5_2(11)_833-849.nxml.txt.nlp	22064833	SENT303	40	40	32	32	heparin	EGF	PA449855	1950	0.878
NULL	Aging_(Albany_NY)_2014_Oct_30_6(10)_788-819.nxml.txt.nlp	25411230	SENT245	15	15	0	0	levodopa	COMT	PA450213	1312	0.878
NULL	Diabetes_2011_May_23_60(5)_1361-1369.nxml.txt.nlp	21525507	SENT155	11	11	0	0	glucose	MRS	PA449773	8011	0.878
NULL	Chin_J_Cancer_2011_Sep_30(9)_645-654.nxml.txt.nlp	21880186	SENT131	25	25	1	1	bleomycin	NACT	PA448645	284111	0.878
NULL	Nat_Commun_2013_Sep_4_4_2338.nxml.txt.nlp	24005565	SENT125	15	15	23	23	cisplatin	XRCC3	PA449014	7517	0.878
NULL	Br_J_Pharmacol_2014_Feb_24_171(1)_1019-1032.nxml.txt.nlp	24251620	SENT271	28	28	5	5	nifedipine	TRPM3	PA450631	80036	0.878
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_4_2013_378657.nxml.txt.nlp	23662132	SENT495	23	23	3	3	sitagliptin	GLP-1	PA164748978	100125288	0.878
NULL	Oncol_Lett_2014_Aug_19_8(2)_809-812.nxml.txt.nlp	25009658	SENT91	6	6	18	18	metformin	ACC1	PA450395	31	0.878
NULL	Mediators_Inflamm_2010_Oct_5_2010_321061.nxml.txt.nlp	20953358	SENT214	23	23	4	4	methacholine	NOS1	PA165958382	340719;4842	0.878
NULL	J_Hematol_Oncol_2008_Oct_23_1_19.nxml.txt.nlp	18947412	SENT126	25	25	30	30	alemtuzumab	CD34	PA164783958	947	0.878
NULL	Int_J_Nanomedicine_2009_Apr_20_4_99-105.nxml.txt.nlp	19516888	SENT95	22	22	31	31	paclitaxel	castor	PA450761	54897	0.878
NULL	Environ_Health_Perspect_2006_Sep_23_114(9)_1401-1406.nxml.txt.nlp	16966095	SENT183	4	4	16	16	arsenite	p53	PA452638	7157	0.878
NULL	Eur_J_Clin_Pharmacol_2011_Dec_23_67(12)_1231-1241.nxml.txt.nlp	21698374	SENT182	20	20	6	6	tacrolimus	ABCB1	PA451578	5243	0.878
NULL	Support_Care_Cancer_2009_Sep_10_17(9)_1177-1185.nxml.txt.nlp	19205755	SENT0	24	24	17	17	ondansetron	NK-1	PA450705	27087	0.878
NULL	Front_Oncol_2014_Sep_24_4_260.nxml.txt.nlp	25309876	SENT125	7	7	1	1	collagenase	PEN	PA449107	9933	0.878
NULL	Cancers_(Basel)_2010_Jan_14_2(1)_1-19.nxml.txt.nlp	24281029	SENT1030	11	11	21	21	vinorelbine	San	PA451881	80218	0.878
NULL	Oncoimmunology_2014_Jan_17_3_e27574.nxml.txt.nlp	24800167	SENT27	29	29	9	9	vancomycin	TH1	PA451850	51497	0.878
NULL	BMB_Rep_2014_May_47(5)_268-273.nxml.txt.nlp	24286315	SENT17	10	10	22	22	trastuzumab	PTEN	PA451743	5728	0.878
NULL	Acta_Otolaryngol_2010_Nov_30_130(11)_1278-1286.nxml.txt.nlp	20586674	SENT9	24	24	17	17	methimazole	TRPV1	PA450422	7442	0.878
NULL	Cancers_(Basel)_2010_Dec_30_3(1)_106-125.nxml.txt.nlp	24212609	SENT8	17	17	14	14	gemcitabine	MRP5	PA449748	10057	0.878
NULL	Eur_Arch_Psychiatry_Clin_Neurosci_2010_Mar_12_260(2)_101-111.nxml.txt.nlp	19856012	SENT168	32	32	18	18	haloperidol	NR2D	PA449841	2906	0.878
NULL	Br_J_Cancer_2011_Jul_26_105(3)_353-359.nxml.txt.nlp	21750549	SENT159	3	3	20	20	sorafenib	BRAF	PA7000	673	0.878
NULL	Front_Physiol_2012_Oct_22_3_408.nxml.txt.nlp	23097643	SENT754	2	2	15	15	methacholine	FEV	PA165958382	54738	0.878
NULL	Neuro_Oncol_2011_Jan_25_13(1)_70-83.nxml.txt.nlp	20978004	SENT259	26	26	13	13	etoposide	ABCC1	PA449552	4363	0.878
NULL	Acta_Neuropathol_2012_Jul_7_124(1)_99-110.nxml.txt.nlp	22311740	SENT35	28	28	19	19	thalidomide	CD105	PA451644	2022	0.878
NULL	J_Korean_Med_Sci_2014_Jan_26_29(1)_53-60.nxml.txt.nlp	24431906	SENT117	18	18	11	11	rituximab	CHOP	PA451261	1649	0.878
NULL	Arthritis_Res_Ther_2010_Sep_20_12(5)_R176.nxml.txt.nlp	20854662	SENT163	32	32	1	1	etanercept	IL-6	PA449515	3569	0.878
NULL	Case_Rep_Oncol_2010_Dec_17_3(3)_480-488.nxml.txt.nlp	21611102	SENT88	8	8	2	2	cisplatin	CTX	PA449014	1593	0.878
NULL	Hum_Reprod_2008_Oct_16_23(10)_2273-2281.nxml.txt.nlp	18635530	SENT73	11	11	8	8	etoposide	p53	PA449552	7157	0.878
NULL	Cancer_Manag_Res_2013_Nov_21_5_387-400.nxml.txt.nlp	24294007	SENT192	12	12	22	22	capecitabine	DPD	PA448771	1806	0.878
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT158	31	31	21	21	metformin	HIF-1	PA450395	29072	0.878
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1224-1233.nxml.txt.nlp	22353810	SENT198	26	26	17	17	vincristine	MRP-1	PA451879	928	0.878
NULL	Int_J_Biol_Sci_2011_May_24_7(5)_673-684.nxml.txt.nlp	21647250	SENT267	26	26	6	6	berberine	AMPK	PA165860812	5563	0.878
NULL	Cell_Commun_Signal_2013_Nov_11_11_86.nxml.txt.nlp	24215724	SENT256	39	39	18	18	thrombin	PAR1	PA451674	79581;2149	0.878
NULL	FEBS_Open_Bio_2013_Jul_4_3_279-284.nxml.txt.nlp	23905010	SENT359	8	8	17	17	olmesartan	MMP13	PA164742950	4322	0.878
NULL	Int_J_Nanomedicine_2008_Mar_3(1)_1-19.nxml.txt.nlp	18488412	SENT336	9	9	13	13	rolipram	Stella	PA153906323	359787	0.878
NULL	Diabetes_2013_Jun_17_62(6)_1843-1854.nxml.txt.nlp	23349486	SENT235	22	22	37	37	hyaluronan	MCP-1	PA165958431	6347	0.878
NULL	Environ_Health_Perspect_2009_Feb_8_117(2)_175-180.nxml.txt.nlp	19270784	SENT188	15	15	1	1	doxorubicin	survivin	PA449412	332	0.878
NULL	Appl_Plant_Sci_2015_Jan_5_3(1)_apps_1400086.nxml.txt.nlp	25606353	SENT98	7	7	2	2	vancomycin	ANOVA	PA451850	4858	0.878
NULL	Eur_J_Neurosci_2008_Apr_1_27(7)_1722-1730.nxml.txt.nlp	18380669	SENT12	27	27	25	25	sr144528	CB2		1269	0.878
NULL	Indian_J_Anaesth_2009_Oct_53(5)_582-591.nxml.txt.nlp	20640109	SENT84	21	21	11	11	clopidogrel	ADP	PA449053	23038	0.878
NULL	Environ_Health_Perspect_2010_Dec_12_118(12)_1707-1713.nxml.txt.nlp	20705543	SENT208	3	3	13	13	bleomycin	XRCC1	PA448645	7515	0.878
NULL	Drugs_R_D_2013_Mar_21_13(1)_29-36.nxml.txt.nlp	23322527	SENT205	9	9	2	2	risperidone	CYP2D6	PA451257	1565	0.878
NULL	Arch_Med_Sci_2012_Nov_9_8(5)_907-917.nxml.txt.nlp	23185203	SENT157	0	0	23	23	metformin	GADD153	PA450395	1649	0.878
NULL	Br_J_Cancer_2011_Sep_6_105(6)_807-813.nxml.txt.nlp	21847121	SENT86	29	29	9	9	pha-665752	HER2		2064	0.878
NULL	Drug_Saf_2014_Feb_19_37(4)_201-211.nxml.txt.nlp	24550106	SENT118	29	29	3	3	citalopram	CYP2C19	PA449015	1557	0.878
NULL	Diabetes_Care_2011_Aug_16_34(8)_1854-1859.nxml.txt.nlp	21715518	SENT181	20	20	0	0	estradiol	Men	PA449503	8178	0.878
NULL	Open_AIDS_J_2013_Oct_18_7_47-50.nxml.txt.nlp	24222813	SENT21	21	21	13	13	galactose	ABO	PA449725	28	0.878
NULL	Front_Synaptic_Neurosci_2013_Oct_17_5_8.nxml.txt.nlp	24146648	SENT401	23	23	33	33	forskolin	RIM1	PA146096022	22999	0.878
NULL	Breast_Cancer_Res_2002_Aug_19_4(6)_224-230.nxml.txt.nlp	12473168	SENT219	13	13	6	6	chymotrypsin	CD44	PA448994	960	0.878
NULL	Diagn_Pathol_2013_Jun_17_8_95.nxml.txt.nlp	23773402	SENT26	26	26	0	0	s-adenosylmethionine	MTHFR	PA164754994	4524	0.878
NULL	Crit_Care_2013_Mar_19_17(Suppl_2)_P228.nxml.txt.nlp	NULL	SENT10	7	7	13	13	levosimendan	ANOVA	PA164749138	4858	0.878
NULL	Curr_Neuropharmacol_2013_Dec_11(6)_652-663.nxml.txt.nlp	24396340	SENT193	10	10	18	18	desflurane	TRPV1	PA164749136	7442	0.878
NULL	J_Gen_Physiol_2013_Aug_142(2)_137-155.nxml.txt.nlp	23858003	SENT447	14	14	19	19	forskolin	TREK-1	PA146096022	3776	0.878
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT47	4	4	22	22	curcumin	PC-3	PA151958596	692094	0.878
NULL	Clin_Dev_Immunol_2013_Nov_26_2013_325481.nxml.txt.nlp	24371447	SENT142	9	9	19	19	propofol	p47phox	PA451141	653361	0.878
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT112	3	3	24	24	capsaicin	p53	PA448776	7157	0.878
NULL	Cancers_(Basel)_2014_Sep_5_6(3)_1769-1792.nxml.txt.nlp	25198391	SENT85	39	39	14	14	trastuzumab	PTEN	PA451743	5728	0.878
NULL	Br_J_Cancer_2012_May_8_106(10)_1587-1590.nxml.txt.nlp	22568998	SENT83	7	7	26	26	sunitinib	IFN	PA162372840	3439	0.878
NULL	Int_J_Mol_Sci_2014_Jun_25_15(7)_11220-11233.nxml.txt.nlp	24968265	SENT93	17	17	29	29	temsirolimus	REST	PA164746890	5978	0.878
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jul_9_67(Pt_8)_o2006.nxml.txt.nlp	22091040	SENT59	12	12	4	4	ethanol	mol	PA448073	90527	0.878
NULL	Evid_Based_Complement_Alternat_Med_2012_Dec_29_2012_138954.nxml.txt.nlp	23346188	SENT301	4	4	11	11	indomethacin	IL-6	PA449982	3569	0.878
NULL	Core_Evid_2012_Sep_27_7_105-114.nxml.txt.nlp	23055948	SENT187	10	10	29	29	icatibant	C1-INH	PA164749185	710	0.878
NULL	Evid_Based_Complement_Alternat_Med_2014_Jul_24_2014_107501.nxml.txt.nlp	25152756	SENT39	8	8	5	5	l-arginine	TMP	PA448478	2012	0.878
NULL	Environ_Health_Perspect_2006_Sep_23_114(9)_1401-1406.nxml.txt.nlp	16966095	SENT59	11	11	23	23	tetracycline	p53	PA451640	7157	0.878
NULL	Oncoimmunology_2013_Jun_1_2(6)_e24677.nxml.txt.nlp	23894722	SENT113	3	3	19	19	cetuximab	CD83	PA10040	9308	0.878
NULL	Cells_2013_Jan_10_2(1)_43-56.nxml.txt.nlp	24709643	SENT18	5	5	11	11	doxycycline	MYC	PA449415	4609	0.878
NULL	Cancer_Cell_Int_2008_Mar_18_8_3.nxml.txt.nlp	18348720	SENT69	32	32	28	28	lapatinib	EGFR	PA152241907	1956	0.878
NULL	Acta_Pharmacol_Sin_2009_Jun_5_30(6)_859-867.nxml.txt.nlp	19498425	SENT42	5	5	18	18	carbachol	CA1	PA448784	759	0.878
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Apr_30_65(Pt_5)_m595.nxml.txt.nlp	21583817	SENT56	21	21	7	7	ethanol	mol	PA448073	90527	0.878
NULL	Cancers_(Basel)_2014_Jul_8_6(3)_1487-1499.nxml.txt.nlp	25006835	SENT545	4	4	14	14	cisplatin	Bcl-2	PA449014	596	0.878
NULL	Clin_Exp_Gastroenterol_2012_May_14_5_49-59.nxml.txt.nlp	22649281	SENT89	7	7	20	20	lansoprazole	CYP2C19	PA450180	1557	0.878
NULL	J_Anim_Sci_Biotechnol_2013_Jul_30_4(1)_27.nxml.txt.nlp	23899038	SENT197	3	3	20	20	l-cysteine	MCP-1	PA449173	6347	0.878
NULL	Hum_Psychopharmacol_2008_Jan_23(1)_13-20.nxml.txt.nlp	17907263	SENT111	5	5	17	17	zolpidem	CRT	PA451976	811	0.878
NULL	F1000Prime_Rep_2014_Dec_1_6_117.nxml.txt.nlp	25580271	SENT66	35	35	22	22	gemcitabine	EGFR	PA449748	1956	0.878
NULL	Cell_Death_Dis_2014_Jan_16_5(1)_e1005.nxml.txt.nlp	24434513	SENT5	20	20	15	15	dasatinib	NK4	PA162372878	9235	0.878
NULL	Cancer_Cell_Int_2012_Jun_18_12_30.nxml.txt.nlp	22709569	SENT57	18	18	33	33	cisplatin	CALM1	PA449014	801	0.878
NULL	Int_J_Biol_Sci_2006_Mar_1_2(1)_1-9.nxml.txt.nlp	16585947	SENT53	6	6	14	14	pp2	PP1		5540;5464	0.878
NULL	Indian_J_Psychol_Med_2012_Apr-Jun_34(2)_140-143.nxml.txt.nlp	23162189	SENT82	5	5	18	18	dextromethorphan	CRT	PA449273	811	0.878
NULL	Diabetes_2009_Dec_31_58(12)_2851-2862.nxml.txt.nlp	19720788	SENT7	23	23	19	19	forskolin	GLP-1	PA146096022	100125288	0.878
NULL	Int_J_Breast_Cancer_2012_May_9_2012_415170.nxml.txt.nlp	22649737	SENT202	29	29	19	19	lapatinib	VEGFR	PA152241907	3791	0.878
NULL	Int_J_Mol_Sci_2014_Mar_6_15(3)_4088-4103.nxml.txt.nlp	24663083	SENT17	18	18	41	41	l-arginine	DDAH2	PA448478	23564	0.878
NULL	Oncotarget_2014_Oct_22_5(20)_9532-9533.nxml.txt.nlp	25393981	SENT3	17	17	24	24	imatinib	KIT	PA10804	3815	0.878
NULL	Int_J_Mol_Sci_2013_Apr_29_14(5)_9338-9364.nxml.txt.nlp	23629668	SENT1150	18	18	32	32	bevacizumab	ACT	PA130232992	12;11332;9457;641455	0.878
NULL	Br_J_Cancer_2011_May_10_104(10)_1558-1563.nxml.txt.nlp	21522148	SENT136	18	18	24	24	tamoxifen	ATAC	PA451581	6375	0.878
NULL	Clin_Med_Insights_Oncol_2012_May_16_6_205-217.nxml.txt.nlp	22654526	SENT248	10	10	32	32	pravastatin	VEGFR	PA451089	3791	0.878
NULL	Target_Oncol_2013_Jun_27_8(2)_127-136.nxml.txt.nlp	23625191	SENT75	18	18	26	26	panitumumab	KRAS	PA162373091	3845	0.878
NULL	Breast_Cancer_Res_2011_Aug_31_13(4)_R84.nxml.txt.nlp	21884573	SENT149	11	11	0	0	lapatinib	HER2	PA152241907	2064	0.878
NULL	Curr_Neuropharmacol_2010_Sep_8(3)_254-267.nxml.txt.nlp	21358975	SENT191	10	10	32	32	lamotrigine	CYP3A4	PA450164	1576	0.878
NULL	Front_Physiol_2011_Jun_30_2_33.nxml.txt.nlp	21747769	SENT20	0	0	12	12	berberine	KCNQ1	PA165860812	3784	0.878
NULL	Eur_J_Haematol_2014_Feb_25_92(2)_127-136.nxml.txt.nlp	24118452	SENT192	38	38	29	29	anagrelide	CRT	PA164742986	811	0.878
NULL	Clin_Transl_Allergy_2013_Sep_2_3_29.nxml.txt.nlp	24004581	SENT164	4	4	22	22	omalizumab	IL-4	PA164752253	3565	0.878
NULL	Ann_Lab_Med_2013_May_17_33(3)_229-232.nxml.txt.nlp	23667855	SENT47	38	38	33	33	imatinib	MPN	PA10804	83886	0.878
NULL	Indian_J_Med_Res_2012_Sep_136(3)_391-403.nxml.txt.nlp	23041732	SENT194	20	20	7	7	sorafenib	HCC	PA7000	84668	0.878
NULL	Colorectal_Dis_2012_Feb_14(2)_e31-e47.nxml.txt.nlp	21848897	SENT117	39	39	28	28	irinotecan	KRAS	PA450085	3845	0.878
NULL	Clin_Exp_Metastasis_2012_Oct_13_29(7)_657-662.nxml.txt.nlp	22692562	SENT21	0	0	13	13	bevacizumab	VEGF-A	PA130232992	7422	0.878
NULL	Cough_2006_Dec_15_2_10.nxml.txt.nlp	17173683	SENT171	1	1	7	7	capsaicin	TRPV1	PA448776	7442	0.878
NULL	Mol_Cancer_2009_Nov_10_8_99.nxml.txt.nlp	19903356	SENT88	6	6	23	23	imatinib	IGFBP3	PA10804	3486	0.878
NULL	EMBO_J_2010_Nov_17_29(22)_3869-3878.nxml.txt.nlp	21037554	SENT185	18	18	5	5	paraformaldehyde	HCN4	PA450790	10021	0.878
NULL	Int_J_Genomics_2014_Jan_29_2014_894296.nxml.txt.nlp	24616891	SENT186	37	37	5	5	ethanol	PC1	PA448073	5122	0.878
NULL	Cancer_Cell_Int_2013_Jun_26_13_63.nxml.txt.nlp	23800022	SENT213	12	12	29	29	genistein	PUMA	PA165109660	27113	0.878
NULL	Indian_J_Ophthalmol_2014_Jul_62(7)_761-767.nxml.txt.nlp	25116765	SENT96	5	5	36	36	bevacizumab	CRT	PA130232992	811	0.878
NULL	Biomed_Res_Int_2014_Jan_20_2014_948427.nxml.txt.nlp	24563867	SENT81	3	3	28	28	buspirone	STZ	PA448689	6484	0.878
NULL	J_Hematol_Oncol_2013_Jun_3_6_38.nxml.txt.nlp	23731980	SENT100	22	22	10	10	docetaxel	HER2	PA449383	2064	0.878
NULL	Chemother_Res_Pract_2012_Aug_29_2012_817297.nxml.txt.nlp	22970367	SENT135	9	9	3	3	cetuximab	EGFR	PA10040	1956	0.878
NULL	J_Oncol_2010_Dec_24_2010_497429.nxml.txt.nlp	20066162	SENT74	22	22	12	12	gemcitabine	AGO	PA449748	55294	0.878
NULL	J_Adv_Pract_Oncol_2013_Jul_1_Jul-Aug_4(4)_238-250.nxml.txt.nlp	25032004	SENT28	22	22	7	7	imatinib	PDGFRA	PA10804	5156	0.878
NULL	Cell_Biochem_Biophys_2013_May_28_67(1)_25-43.nxml.txt.nlp	23712866	SENT134	21	21	25	25	cisplatin	USP2	PA449014	9099	0.878
NULL	Nucleic_Acids_Res_2011_Aug_29_39(15)_6620-6632.nxml.txt.nlp	21531700	SENT214	16	16	5	5	doxycycline	TOP1MT	PA449415	116447	0.878
NULL	Cell_J_2012_Dec_22_Winter_13(4)_281-289.nxml.txt.nlp	23507624	SENT171	25	25	9	9	propranolol	IFN	PA451145	3439	0.878
NULL	Pharmaceutics_2011_Oct_12_3(4)_680-705.nxml.txt.nlp	24309303	SENT634	0	0	3	3	trimethoprim	CYP2C8	PA451788	1558	0.878
NULL	Breast_Cancer_Res_2011_May_25_13(3)_107.nxml.txt.nlp	21635706	SENT35	9	9	6	6	denosumab	RANKL	PA166048634	8600	0.878
NULL	Indian_J_Radiol_Imaging_2010_Aug_20(3)_188-191.nxml.txt.nlp	21042441	SENT70	32	32	3	3	iron	PANK2	PA450087	80025	0.878
NULL	Int_J_Endocrinol_2013_Nov_13_2013_686315.nxml.txt.nlp	24324494	SENT161	27	27	15	15	metformin	SLC22A1	PA450395	6580	0.878
NULL	Br_J_Cancer_2003_Mar_10_88(5)_754-759.nxml.txt.nlp	12618886	SENT61	10	10	3	3	amifostine	p53	PA448365	7157	0.878
NULL	Acta_Pharmacol_Sin_2013_Sep_5_34(9)_1192-1200.nxml.txt.nlp	23685957	SENT182	5	5	12	12	curcumin	AP-2	PA151958596	7020	0.878
NULL	Diabetes_2008_Sep_57(9)_2272-2279.nxml.txt.nlp	18519799	SENT150	14	14	11	11	rosiglitazone	PDK4	PA451283	5166	0.878
NULL	Am_J_Transplant_2012_Oct_12(10)_2825-2831.nxml.txt.nlp	22759200	SENT60	23	23	40	40	tacrolimus	ANOVA	PA451578	4858	0.878
NULL	J_Immune_Based_Ther_Vaccines_2008_Jun_9_6_3.nxml.txt.nlp	18541039	SENT184	6	6	12	12	ribavirin	IL-10	PA451241	3586	0.878
NULL	Behav_Brain_Funct_2009_Jan_15_5_3.nxml.txt.nlp	19146665	SENT178	24	24	1	1	ethanol	ANOVA	PA448073	4858	0.878
NULL	Case_Rep_Oncol_Med_2013_Dec_5_2013_838941.nxml.txt.nlp	24381773	SENT63	10	10	3	3	vincristine	CHOP	PA451879	1649	0.878
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Dec_17_3(12)_e152.nxml.txt.nlp	25518025	SENT41	6	6	13	13	ketoconazole	CYP2D6	PA450146	1565	0.878
NULL	Br_J_Cancer_2012_Dec_4_107(12)_1950-1955.nxml.txt.nlp	23169295	SENT18	26	26	3	3	oxaliplatin	DPD	PA131285527	1806	0.878
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT226	14	14	31	31	bevacizumab	VEGFR1	PA130232992	2321	0.878
NULL	Gastric_Cancer_2014_Apr_7_17(1)_1-12.nxml.txt.nlp	23563986	SENT164	4	4	19	19	trastuzumab	DM1	PA451743	338023;1760;28509	0.878
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_13_2013_468537.nxml.txt.nlp	23956772	SENT141	0	0	14	14	doxorubicin	p53	PA449412	7157	0.878
NULL	Neuropsychologia_2012_Nov_50(13)_3156-3168.nxml.txt.nlp	22884957	SENT425	29	29	21	21	ondansetron	spatial	PA450705	219793	0.878
NULL	Cell_Death_Dis_2010_Nov_18_1(11)_e102.nxml.txt.nlp	21368867	SENT17	25	25	13	13	gentamicin	CLIMP-63	PA449753	10970	0.878
NULL	Front_Immunol_2012_May_7_3_101.nxml.txt.nlp	22783250	SENT241	4	4	23	23	papain	IL-13	PA450778	3596	0.878
NULL	Case_Rep_Oncol_2014_Mar_26_7(1)_204-209.nxml.txt.nlp	24803896	SENT8	17	17	13	13	trabectedin	MRCL	PA165958349	348174	0.878
NULL	Cell_Commun_Signal_2014_Sep_25_12(1)_61.nxml.txt.nlp	NULL	SENT238	5	5	19	19	urokinase	PC-3	PA451836	692094	0.878
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_29_2013_590393.nxml.txt.nlp	23737838	SENT312	8	8	2	2	resveratrol	p53		7157	0.878
NULL	Mol_Biol_Cell_2014_Feb_15_25(4)_470-480.nxml.txt.nlp	24356448	SENT222	20	20	2	2	vasopressin	AQP2	PA451858	359	0.878
NULL	BMJ_Open_2013_Feb_12_3(2)_e002242.nxml.txt.nlp	23408078	SENT210	13	13	1	1	clonazepam	Gen	PA449050	348654	0.878
NULL	Acta_Pharmacol_Sin_2013_Jan_3_34(1)_119-128.nxml.txt.nlp	23202804	SENT168	1	1	27	27	rimonabant	NG2	PA152407999	1464;6048	0.878
NULL	Adv_Hematol_2011_Apr_10_2011_960137.nxml.txt.nlp	21547266	SENT88	15	15	22	22	cyclophosphamide	NHL	PA449165	51750	0.878
NULL	Breast_Cancer_Res_Treat_2013_May_12_139(1)_107-113.nxml.txt.nlp	23580070	SENT25	26	26	28	28	trastuzumab	HER2	PA451743	2064	0.878
NULL	Cancer_Cell_Int_2009_Jan_8_9_3.nxml.txt.nlp	19128511	SENT31	20	20	9	9	oxaliplatin	PI3K	PA131285527	5290	0.878
NULL	Nat_Med_2013_Mar_10_19(3)_313-321.nxml.txt.nlp	23396211	SENT368	38	38	13	13	amlexanox	TBK1	PA164745310	29110	0.878
NULL	Clin_Dev_Immunol_2011_Dec_27_2011_814943.nxml.txt.nlp	21234341	SENT143	29	29	15	15	nitrogen	TNF	PA450643	7124	0.878
NULL	Oncol_Rep_2013_Apr_5_29(4)_1671-1677.nxml.txt.nlp	23404329	SENT6	11	11	34	34	aspirin	MIA	PA448497	8190	0.878
NULL	Mol_Cell_Biochem_2013_Jun_3_378(1-2)_137-144.nxml.txt.nlp	23456481	SENT30	14	14	5	5	creatine	RANTES	PA164778930	6352	0.878
NULL	Osteoporos_Int_2012_May_19_23(5)_1613-1622.nxml.txt.nlp	21769661	SENT163	14	14	10	10	teriparatide	VCF	PA451620	7413	0.878
NULL	ScientificWorldJournal_2014_Mar_12_2014_731462.nxml.txt.nlp	24715817	SENT136	9	9	20	20	diclofenac	IL-6	PA449293	3569	0.878
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT369	14	14	42	42	resveratrol	IL-6		3569	0.878
NULL	Nat_Methods_2013_Aug_30_10(8)_768-773.nxml.txt.nlp	23817070	SENT280	47	47	10	10	l-lysine	DDC	PA450280	1644	0.878
NULL	J_Cancer_2013_Aug_28_4(7)_585-596.nxml.txt.nlp	24069069	SENT111	19	19	11	11	verteporfin	DPC4	PA451871	4089	0.878
NULL	Open_Biol_2014_Nov_4(11)_140180.nxml.txt.nlp	25392452	SENT361	25	25	13	13	imatinib	LEF1	PA10804	51176	0.878
NULL	Clinics_(Sao_Paulo)_2010_Sep_65(9)_885-894.nxml.txt.nlp	21049217	SENT243	14	14	25	25	haloperidol	spatial	PA449841	219793	0.878
NULL	Pharmaceutics_2011_Oct_12_3(4)_680-705.nxml.txt.nlp	24309303	SENT1025	30	30	18	18	repaglinide	BSP	PA451234	3381	0.878
NULL	Oncol_Rep_2013_Mar_3_29(3)_855-860.nxml.txt.nlp	23291663	SENT142	0	0	8	8	metformin	AMPK	PA450395	5563	0.878
NULL	Iran_J_Basic_Med_Sci_2011_Nov-Dec_14(6)_485-498.nxml.txt.nlp	23493821	SENT121	14	14	8	8	cyclosporine	CYP3A	PA449167	1574	0.878
NULL	Front_Oncol_2013_Aug_5_3_195.nxml.txt.nlp	23936763	SENT108	18	18	25	25	gefitinib	EGFR	PA131301952	1956	0.878
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Jul_21_9_20.nxml.txt.nlp	20663145	SENT92	7	7	5	5	gentamicin	LBH	PA449753	81606;221491	0.878
NULL	Mol_Cancer_2012_Dec_12_11_91.nxml.txt.nlp	23234355	SENT184	11	11	37	37	erlotinib	ULBP1	PA134687924	80329	0.878
NULL	Biomed_Imaging_Interv_J_2008_Jul_1_4(3)_e38.nxml.txt.nlp	21611004	SENT147	27	27	21	21	letrozole	aromatase	PA450196	1588	0.878
NULL	Cancers_(Basel)_2010_Jan_14_2(1)_1-19.nxml.txt.nlp	24281029	SENT1075	15	15	23	23	capecitabine	San	PA448771	80218	0.878
NULL	Aging_(Albany_NY)_2012_Feb_21_4(2)_133-143.nxml.txt.nlp	22361433	SENT163	22	22	6	6	glucose	MEF2C	PA449773	4208	0.878
NULL	Br_J_Cancer_2013_Feb_19_108(3)_668-675.nxml.txt.nlp	23348520	SENT26	20	20	8	8	cetuximab	HER2	PA10040	2064	0.878
NULL	Int_J_Mol_Sci_2014_Sep_2_15(9)_15512-15529.nxml.txt.nlp	25184950	SENT197	8	8	24	24	resveratrol	IL-10		3586	0.878
NULL	J_Biol_Chem_2008_Apr_4_283(14)_8837-8845.nxml.txt.nlp	18250166	SENT192	10	10	21	21	trypsin	VDAC1	PA451806	7416	0.878
NULL	Am_J_Pathol_2011_Mar_178(3)_1245-1256.nxml.txt.nlp	21356375	SENT34	3	3	14	14	indomethacin	IL-8	PA449982	3576	0.878
NULL	Pain_Res_Treat_2014_Apr_9_2014_654578.nxml.txt.nlp	24818020	SENT76	36	36	14	14	naloxone	ANOVA	PA450586	4858	0.878
NULL	Indian_J_Pharmacol_2008_Oct_40(Suppl_2)_S66-S91.nxml.txt.nlp	21593982	SENT1005	10	10	16	16	ethanol	FRE	PA448073	2487	0.878
NULL	Clinics_(Sao_Paulo)_2014_Jan_69(Suppl_1)_8-16.nxml.txt.nlp	24860853	SENT19	3	3	36	36	alemtuzumab	CD4	PA164783958	920	0.878
NULL	Expert_Rev_Mol_Med_2009_May_11_e16.nxml.txt.nlp	19467172	SENT431	22	22	1	1	levamisole	CD36	PA450205	948	0.878
NULL	Drugs_Context_2012_Nov_19_2012_212242.nxml.txt.nlp	24432031	SENT128	4	4	17	17	cisplatin	IL-2	PA449014	3558	0.878
NULL	Nano_Rev_2010_Feb_22_1_10_3402_nano_v1i0_4883.nxml.txt.nlp	22110854	SENT216	23	23	17	17	iron	CD34	PA450087	947	0.878
NULL	Cent_European_J_Urol_2013_Dec_19_66(4)_394-404.nxml.txt.nlp	24757527	SENT261	26	26	12	12	sunitinib	IFN	PA162372840	3439	0.878
NULL	Cancers_(Basel)_2012_Sep_25_4(4)_969-988.nxml.txt.nlp	24213497	SENT160	20	20	14	14	fulvestrant	EGFR	PA164747170	1956	0.878
NULL	Clin_Microbiol_Infect_2014_Jun_21_20(6)_536-541.nxml.txt.nlp	24107197	SENT107	29	29	2	2	isoniazid	DST	PA450112	667	0.878
NULL	JRSM_Cardiovasc_Dis_2012_Nov_30_1(8)_cvd_2012_012026.nxml.txt.nlp	24175078	SENT182	21	21	11	11	atorvastatin	MDR1	PA448500	5243	0.878
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Oct_20_66(Pt_11)_o2822.nxml.txt.nlp	21589010	SENT65	26	26	6	6	ethanol	mol	PA448073	90527	0.878
NULL	Diabetes_Metab_Syndr_Obes_2014_Jul_17_7_313-319.nxml.txt.nlp	25092992	SENT107	27	27	24	24	glimepiride	adiponectin	PA449761	9370	0.878
NULL	Pharmaceuticals_(Basel)_2012_Aug_17_5(8)_837-852.nxml.txt.nlp	24280677	SENT72	23	23	4	4	capsaicin	TRPV1	PA448776	7442	0.878
NULL	Clin_Sci_(Lond)_2013_Feb_1_124(Pt_3)_153-164.nxml.txt.nlp	23075334	SENT183	21	21	15	15	cisplatin	SIRT1	PA449014	23411	0.878
NULL	Case_Rep_Obstet_Gynecol_2014_Jul_21_2014_314587.nxml.txt.nlp	25143845	SENT78	16	16	12	12	raloxifene	aromatase	PA451221	1588	0.878
NULL	Oncotarget_2014_Oct_18_5(21)_10206-10221.nxml.txt.nlp	25344914	SENT218	18	18	5	5	vemurafenib	BRAF	PA165946873	673	0.878
NULL	J_Mol_Signal_2010_May_10_5_4.nxml.txt.nlp	20459745	SENT147	28	28	4	4	cisplatin	p53	PA449014	7157	0.878
NULL	Clin_Pharmacokinet_2014_Aug_21_53(10)_931-941.nxml.txt.nlp	25141974	SENT3	24	24	1	1	midazolam	CYP3A	PA450496	1574	0.878
NULL	J_Cell_Mol_Med_2013_Oct_23_17(10)_1207-1217.nxml.txt.nlp	24106980	SENT75	9	9	28	28	paclitaxel	MAD2	PA450761	4085;4601	0.878
NULL	Curr_Gerontol_Geriatr_Res_2010_Jun_20_2010_348174.nxml.txt.nlp	20672050	SENT57	23	23	5	5	gefitinib	EGFR	PA131301952	1956	0.878
NULL	J_Oncol_2010_Jun_13_2010_915046.nxml.txt.nlp	20628484	SENT163	14	14	30	30	cyclosporine	ABCC1	PA449167	4363	0.878
NULL	Cancer_Cell_Int_2013_Apr_16_13_36.nxml.txt.nlp	23590596	SENT97	13	13	5	5	doxorubicin	HIF-1	PA449412	29072	0.878
NULL	Cancer_Cell_Int_2011_Aug_19_11_29.nxml.txt.nlp	21854619	SENT163	27	27	2	2	cisplatin	HDAC	PA449014	9734	0.878
NULL	Cardiovasc_J_Afr_2013_Apr_24(3)_58-65.nxml.txt.nlp	23736127	SENT82	24	24	16	16	irbesartan	AT1	PA450084	9197;185	0.878
NULL	Kidney_Int_Suppl_(2011)_2013_Dec_27_3(5)_462-468.nxml.txt.nlp	25019031	SENT60	4	4	13	13	cinacalcet	PTH	PA164776671	5741	0.878
NULL	Diagn_Pathol_2013_Feb_4_8_17.nxml.txt.nlp	23379971	SENT25	24	24	12	12	trastuzumab	HER2	PA451743	2064	0.878
NULL	Biomed_Res_Int_2013_May_16_2013_389672.nxml.txt.nlp	23762842	SENT119	6	6	1	1	imatinib	FDG	PA10804	23583	0.878
NULL	Cell_Death_Dis_2014_Jul_3_5(7)_e1311.nxml.txt.nlp	24991763	SENT340	8	8	15	15	ketamine	GluN1	PA450144	2902	0.878
NULL	Br_J_Cancer_2010_Jan_5_102(1)_162-164.nxml.txt.nlp	19953097	SENT56	23	23	8	8	cetuximab	EGFR	PA10040	1956	0.878
NULL	Lab_Anim_Res_2014_Dec_24_30(4)_143-150.nxml.txt.nlp	25628724	SENT77	4	4	31	31	genistein	PIN	PA165109660	8655	0.878
NULL	Oncogene_2009_Aug_27_28(34)_3022-3032.nxml.txt.nlp	19543317	SENT209	23	23	19	19	etoposide	BMI1	PA449552	648	0.878
NULL	Patient_Prefer_Adherence_2009_Nov_3_3_205-211.nxml.txt.nlp	19936163	SENT38	15	15	10	10	levonorgestrel	ENG	PA450218	2022	0.878
NULL	Int_J_Med_Sci_2012_Dec_28_10(2)_110-118.nxml.txt.nlp	23329881	SENT54	26	26	28	28	epirubicin	NACT	PA449476	284111	0.878
NULL	Diabetes_Metab_J_2013_Oct_17_37(5)_315-325.nxml.txt.nlp	24199159	SENT194	10	10	17	17	resveratrol	AMPK		5563	0.878
NULL	Mol_Cancer_2010_Jun_25_9_166.nxml.txt.nlp	20579378	SENT224	32	32	10	10	gefitinib	EGR1	PA131301952	1958	0.878
NULL	Drug_Target_Insights_2011_Jun_7_5_11-32.nxml.txt.nlp	22087060	SENT235	8	8	5	5	geldanamycin	Hsp90	PA152031327	3320	0.878
NULL	Int_J_Endocrinol_2014_Mar_12_2014_847827.nxml.txt.nlp	24744784	SENT142	6	6	33	33	geldanamycin	MCP-1	PA152031327	6347	0.878
NULL	Int_J_Biol_Sci_2012_Oct_25_8(9)_1281-1290.nxml.txt.nlp	23136556	SENT85	40	40	27	27	methacholine	IL-5	PA165958382	3567	0.878
NULL	Br_J_Cancer_2010_Feb_2_102(3)_541-552.nxml.txt.nlp	20087344	SENT185	25	25	9	9	cisplatin	NRP1	PA449014	8829	0.878
NULL	Br_J_Cancer_2004_Mar_22_90(6)_1285-1292.nxml.txt.nlp	15026814	SENT202	7	7	12	12	doxorubicin	p53	PA449412	7157	0.878
NULL	Mol_Cancer_2014_Jun_30_13_160.nxml.txt.nlp	24976026	SENT160	17	17	24	24	bortezomib	AGR2	PA10252	10551	0.878
NULL	Ann_Oncol_2011_Mar_8_22(3)_503-514.nxml.txt.nlp	20616198	SENT220	12	12	38	38	anastrozole	aromatase	PA448432	1588	0.878
NULL	Clin_Drug_Investig_2015_Dec_4_35_45-51.nxml.txt.nlp	25471740	SENT146	32	32	26	26	omeprazole	CYP2C19	PA450704	1557	0.878
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT72	0	0	22	22	metformin	ADP	PA450395	23038	0.878
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_2_2014_789142.nxml.txt.nlp	25530790	SENT60	4	4	9	9	tacrine	CES1	PA451576	1066	0.878
NULL	Br_J_Cancer_2010_Jan_19_102(2)_383-391.nxml.txt.nlp	20010943	SENT66	12	12	0	0	cisplatin	P31	PA449014	529	0.878
NULL	Br_J_Cancer_2012_Jul_24_107(3)_435-441.nxml.txt.nlp	22767144	SENT146	17	17	13	13	oxaliplatin	TEF	PA131285527	7008	0.878
NULL	Hum_Genomics_2009_Dec_1_4(2)_91-106.nxml.txt.nlp	20038497	SENT145	13	13	4	4	donepezil	APOE	PA449394	348	0.878
NULL	Biomed_Res_Int_2014_Aug_7_2014_191967.nxml.txt.nlp	25165691	SENT237	20	20	34	34	rosiglitazone	IL-8	PA451283	3576	0.878
NULL	Ther_Clin_Risk_Manag_2006_Jun_2(2)_129-158.nxml.txt.nlp	18360588	SENT136	1	1	3	3	voriconazole	CYP3A4	PA10233	1576	0.878
NULL	J_Exp_Med_1996_May_1_183(5)_1987-1994.nxml.txt.nlp	8642309	SENT6	22	22	17	17	fluorescein	CD44	PA164746009	960	0.878
NULL	Nat_Commun_2011_Oct_18_2_503.nxml.txt.nlp	22009035	SENT65	10	10	33	33	chloroquine	CRIK	PA448948	11113	0.878
NULL	J_Immunother_Cancer_2013_Nov_7_1(Suppl_1)_P71.nxml.txt.nlp	NULL	SENT5	5	5	30	30	decitabine	DAC	PA164749631	13	0.878
NULL	Int_J_Surg_Oncol_2012_Apr_2_2012_984346.nxml.txt.nlp	22577534	SENT79	28	28	10	10	estradiol	aromatase	PA449503	1588	0.878
NULL	Subst_Abuse_Treat_Prev_Policy_2007_Oct_31_2_32.nxml.txt.nlp	17974020	SENT209	34	34	9	9	methamphetamine	NMU	PA450403	10874	0.878
NULL	J_Cancer_2013_Nov_23_4(9)_736-754.nxml.txt.nlp	24312144	SENT146	13	13	9	9	crizotinib	Met	PA165946122	79811	0.878
NULL	Ther_Clin_Risk_Manag_2006_Mar_2(1)_59-75.nxml.txt.nlp	18360582	SENT235	5	5	10	10	itraconazole	CYP3A4	PA450132	1576	0.878
NULL	Curr_Neuropharmacol_2008_Jun_6(2)_151-163.nxml.txt.nlp	19305794	SENT44	3	3	25	25	capsaicin	TRPV1	PA448776	7442	0.878
NULL	Endocrinol_Metab_(Seoul)_2013_Dec_12_28(4)_262-274.nxml.txt.nlp	24396690	SENT107	3	3	9	9	exenatide	GLP-1	PA164749238	100125288	0.878
NULL	AIDS_Res_Ther_2013_May_1_10_10.nxml.txt.nlp	23634877	SENT148	3	3	31	31	lovastatin	ANOVA	PA450272	4858	0.878
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT85	13	13	6	6	atorvastatin	IL-6	PA448500	3569	0.878
NULL	Anal_Bioanal_Chem_2010_Oct_22_398(4)_1771-1780.nxml.txt.nlp	20730527	SENT127	0	0	18	18	carbamazepine	p38	PA448785	10598;1432;7965	0.878
NULL	Front_Microbiol_2014_Mar_14_5_99.nxml.txt.nlp	24672516	SENT86	12	12	20	20	caspofungin	TLR2	PA164743013	7097	0.878
NULL	J_Young_Pharm_2012_Oct-Dec_4(4)_287-289.nxml.txt.nlp	23493253	SENT54	10	10	18	18	amlodipine	MDR1	PA448388	5243	0.878
NULL	Acta_Histochem_Cytochem_2012_Apr_26_45(2)_139-146.nxml.txt.nlp	22685356	SENT35	14	14	2	2	forskolin	AQP2	PA146096022	359	0.878
NULL	Acta_Diabetol_2012_Aug_11_49(4)_277-289.nxml.txt.nlp	21833779	SENT203	31	31	28	28	carbachol	ANOVA	PA448784	4858	0.878
NULL	Ann_Oncol_2009_Aug_17_20(8)_1319-1329.nxml.txt.nlp	19535820	SENT349	27	27	43	43	docetaxel	San	PA449383	80218	0.878
NULL	Diabetes_Care_2009_Jan_32(Suppl_1)_S13-S61.nxml.txt.nlp	19118286	SENT2163	12	12	23	23	ramipril	STOP	PA451223	4135	0.878
NULL	Ann_Hematol_2010_Oct_22_89(10)_971-978.nxml.txt.nlp	20567823	SENT132	13	13	2	2	filgrastim	CD34	PA449626	947	0.878
NULL	Behav_Neurosci_2014_Aug_16_128(4)_504-522.nxml.txt.nlp	24933661	SENT800	13	13	7	7	scopolamine	CA3	PA451308	761	0.878
NULL	Br_J_Clin_Pharmacol_2011_Oct_72(4)_647-657.nxml.txt.nlp	21518389	SENT92	2	2	26	26	clopidogrel	ADP	PA449053	23038	0.878
NULL	Lancet_2008_Jul_12_372(9633)_127-138.nxml.txt.nlp	18620950	SENT45	10	10	5	5	sulfadoxine	IPT	PA451540	54802	0.878
NULL	BMB_Rep_2014_Oct_47(10)_575-580.nxml.txt.nlp	24499675	SENT99	25	25	14	14	arsenite	p16	PA452638	1029	0.878
NULL	Genetics_2014_Jan_11_196(1)_321-347.nxml.txt.nlp	24240528	SENT437	1	1	18	18	haloperidol	CAST	PA449841	10849;26059;831	0.878
NULL	Arthritis_Res_Ther_2012_Jul_27_14(4)_R176.nxml.txt.nlp	22838845	SENT244	5	5	27	27	acetazolamide	OCN	PA448018	632	0.878
NULL	Oncoimmunology_2013_Oct_1_2(10)_e27025.nxml.txt.nlp	24353914	SENT179	10	10	28	28	cisplatin	CD25	PA449014	3669;3559	0.878
NULL	Oncol_Lett_2013_Aug_17_6(2)_605-611.nxml.txt.nlp	24137379	SENT138	12	12	22	22	imatinib	KIT	PA10804	3815	0.878
NULL	Arthritis_Res_Ther_2014_Jan_20_16(1)_R16.nxml.txt.nlp	24438745	SENT8	7	7	15	15	indomethacin	NAMPT	PA449982	10135	0.878
NULL	Mol_Immunol_2009_Mar_46(6)_1149-1162.nxml.txt.nlp	19100624	SENT184	40	40	19	19	nystatin	C5L2	PA450666	27202	0.878
NULL	Psychiatry_Investig_2009_Sep_3_6(3)_222-225.nxml.txt.nlp	20046399	SENT86	16	16	6	6	risperidone	DRD2	PA451257	1813	0.878
NULL	Cancer_Cell_Int_2009_Sep_10_9_25.nxml.txt.nlp	19744341	SENT176	11	11	20	20	glucosamine	STAT3	PA164747613	6774	0.878
NULL	Cardiol_Res_Pract_2013_Feb_21_2013_127270.nxml.txt.nlp	23509665	SENT125	11	11	28	28	ticagrelor	NNT	PA165374673	23530	0.878
NULL	J_Exp_Clin_Cancer_Res_2008_Sep_24_27(1)_44.nxml.txt.nlp	18811981	SENT56	23	23	11	11	trypsin	CO2	PA451806	4513	0.878
NULL	Cardiovasc_Res_2009_Apr_1_82(1)_67-76.nxml.txt.nlp	19201758	SENT215	24	24	12	12	salbutamol	PP1	PA448068	5540;5464	0.878
NULL	Br_J_Haematol_2008_Jun_141(5)_659-671.nxml.txt.nlp	18410446	SENT132	0	0	11	11	cerulenin	IL-6	PA164764551	3569	0.878
NULL	EMBO_Mol_Med_2012_Jul_11_4(7)_577-593.nxml.txt.nlp	22496117	SENT99	11	11	7	7	clofazimine	PAP-1	PA164748759	6100	0.878
NULL	Clinics_(Sao_Paulo)_2014_Oct_69(10)_655-659.nxml.txt.nlp	25518015	SENT42	20	20	27	27	sevoflurane	NGAL	PA451341	3934	0.878
NULL	Biomed_Res_Int_2014_Feb_23_2014_168949.nxml.txt.nlp	24707474	SENT5	6	6	9	9	lapatinib	EGFR	PA152241907	1956	0.878
NULL	Br_J_Cancer_2013_Jul_9_109(1)_1-7.nxml.txt.nlp	23736035	SENT102	4	4	1	1	exemestane	aromatase	PA449563	1588	0.878
NULL	Int_J_Mol_Sci_2014_Sep_19_15(9)_16698-16718.nxml.txt.nlp	25244018	SENT95	25	25	40	40	geldanamycin	LKB1	PA152031327	6794	0.878
NULL	Chem_Rev_2011_Oct_12_111(10)_5899-5921.nxml.txt.nlp	21923193	SENT542	14	14	25	25	ibuprofen	COX	PA449957	1351	0.878
NULL	Oncol_Lett_2013_Mar_8_5(3)_1058-1062.nxml.txt.nlp	23426782	SENT116	6	6	12	12	bevacizumab	VEGF-A	PA130232992	7422	0.878
NULL	Med_Sci_Monit_2012_Mar_1_18(3)_PI11-PI15.nxml.txt.nlp	22367138	SENT23	33	33	12	12	omalizumab	TRAIL	PA164752253	8743	0.878
NULL	Indian_J_Med_Res_2012_Dec_136(6)_926-941.nxml.txt.nlp	23391788	SENT110	0	0	12	12	clopidogrel	P2Y12	PA449053	64805	0.878
NULL	Mol_Biol_Rep_2013_Sep_28_40(10)_5573-5585.nxml.txt.nlp	24078156	SENT27	0	0	27	27	iron	FPN1	PA450087	30061	0.878
NULL	Int_Semin_Surg_Oncol_2006_Sep_18_3_31.nxml.txt.nlp	16981992	SENT13	9	9	1	1	exemestane	aromatase	PA449563	1588	0.878
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT280	0	0	11	11	nutlin-3	DR5		8795	0.878
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jul_23_67(Pt_8)_m1132.nxml.txt.nlp	22090894	SENT62	11	11	6	6	ethanol	mol	PA448073	90527	0.878
NULL	J_Hematol_Oncol_2010_Mar_23_3_11.nxml.txt.nlp	20331897	SENT146	43	43	15	15	cisplatin	ACT	PA449014	12;11332;9457;641455	0.878
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT128	2	2	7	7	dasatinib	LYN	PA162372878	4067	0.878
NULL	Int_J_Biol_Sci_2014_Sep_21_10(10)_1108-1115.nxml.txt.nlp	25332685	SENT191	7	7	13	13	dexmedetomidine	c-Jun	PA449256	3725	0.878
NULL	Oncotarget_2010_Nov_22_1(7)_606-619.nxml.txt.nlp	21317456	SENT149	29	29	0	0	doxorubicin	BRCA2	PA449412	675	0.878
NULL	Int_J_Biol_Sci_2014_Jan_20_10(2)_171-180.nxml.txt.nlp	24520215	SENT165	0	0	28	28	cerulenin	L-FABP	PA164764551	2168	0.878
NULL	J_Breast_Cancer_2013_Sep_30_16(3)_274-284.nxml.txt.nlp	24155756	SENT49	18	18	24	24	tamoxifen	aromatase	PA451581	1588	0.878
NULL	Oncogene_2014_Sep_11_33(37)_4579-4588.nxml.txt.nlp	24662835	SENT84	11	11	6	6	tamoxifen	MAGEA2	PA451581	4101;266740	0.878
NULL	Int_J_Mol_Sci_2012_Apr_24_13(4)_5254-5277.nxml.txt.nlp	22606042	SENT161	14	14	25	25	cetuximab	EGFR	PA10040	1956	0.878
NULL	Evid_Based_Complement_Alternat_Med_2011_Jan_20_2011_713523.nxml.txt.nlp	21318104	SENT117	28	28	0	0	naproxen	SRM	PA450595	6723;6725	0.878
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT305	6	6	12	12	gefitinib	EGFR	PA131301952	1956	0.878
NULL	Int_J_Mol_Sci_2014_Nov_10_15(11)_20607-20637.nxml.txt.nlp	25391045	SENT342	0	0	26	26	simvastatin	GDNF	PA451363	2668	0.878
NULL	Front_Physiol_2013_Feb_4_4_10.nxml.txt.nlp	23382716	SENT759	2	2	11	11	hyaluronan	spatial	PA165958431	219793	0.878
NULL	BMB_Rep_2013_Feb_46(2)_92-96.nxml.txt.nlp	23433111	SENT112	0	0	6	6	etoposide	San	PA449552	80218	0.878
NULL	Int_J_Mol_Sci_2012_Sep_26_13(10)_12268-12286.nxml.txt.nlp	23202898	SENT106	7	7	10	10	erlotinib	EGFR	PA134687924	1956	0.878
NULL	JAKSTAT_2013_Jan_1_2(1)_e23820.nxml.txt.nlp	24058799	SENT92	25	25	8	8	imiquimod	STAT1	PA449972	6772	0.878
NULL	Br_J_Cancer_2012_Jul_24_107(3)_455-461.nxml.txt.nlp	22767146	SENT24	4	4	7	7	sorafenib	BRAF	PA7000	673	0.878
NULL	Clin_Med_Insights_Oncol_2012_Feb_28_6_125-135.nxml.txt.nlp	22408376	SENT90	10	10	36	36	panitumumab	KRAS	PA162373091	3845	0.878
NULL	J_Headache_Pain_2012_Nov_16_13(8)_677-684.nxml.txt.nlp	23070400	SENT132	28	28	4	4	nabilone	DAI	PA164746998	81030	0.878
NULL	Aging_(Albany_NY)_2009_Oct_13_1(10)_842-844.nxml.txt.nlp	20157556	SENT24	17	17	5	5	nutlin-3	p53		7157	0.878
NULL	Front_Oncol_2014_Apr_22_4_86.nxml.txt.nlp	24795863	SENT107	11	11	18	18	resveratrol	NBS1		55655	0.878
NULL	Oncotarget_2011_Mar_23_2(3)_165-177.nxml.txt.nlp	21444946	SENT181	4	4	10	10	cetuximab	KRAS	PA10040	3845	0.878
NULL	Cell_Death_Dis_2011_Apr_28_2(4)_e152.nxml.txt.nlp	21525939	SENT136	29	29	41	41	gentamicin	CO2	PA449753	4513	0.878
NULL	J_Adv_Pract_Oncol_2013_Jul_1_Jul-Aug_4(4)_263-268.nxml.txt.nlp	25032007	SENT45	3	3	11	11	tacrolimus	CYP2C19	PA451578	1557	0.878
NULL	J_Neuroinflammation_2011_Feb_4_8_10.nxml.txt.nlp	21294877	SENT157	15	15	7	7	capsaicin	TAC1	PA448776	6863	0.878
NULL	Oncotarget_2011_Aug_30_2(8)_610-626.nxml.txt.nlp	21881167	SENT134	12	12	42	42	doxorubicin	Raf-1	PA449412	5894	0.878
NULL	Cell_Death_Dis_2012_Mar_1_3(3)_e275.nxml.txt.nlp	22378068	SENT50	18	18	6	6	metformin	AMPK	PA450395	5563	0.878
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT4	5	5	13	13	methotrexate	MSH2	PA450428	4436	0.878
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT77	18	18	2	2	gefitinib	AKT	PA131301952	207	0.878
NULL	FASEB_J_2013_Jul_27(7)_2880-2892.nxml.txt.nlp	23543682	SENT155	14	14	30	30	choline	ABCA1	PA448976	19	0.878
NULL	Eur_J_Epidemiol_2009_Sep_2_24(9)_553-572.nxml.txt.nlp	19728115	SENT1537	20	20	9	9	phenprocoumon	CYP2C9	PA450921	1559	0.878
NULL	Biochem_Res_Int_2010_Aug_4_2010_549572.nxml.txt.nlp	21188077	SENT140	14	14	30	30	l-phenylalanine	TAT	PA450931	6898	0.878
NULL	ScientificWorldJournal_2012_Apr_1_2012_381434.nxml.txt.nlp	22545017	SENT327	36	36	25	25	aprepitant	NK-1	PA164747039	27087	0.878
NULL	J_Lipid_Res_2013_May_54(5)_1410-1420.nxml.txt.nlp	23419260	SENT165	13	13	2	2	tetracycline	IDOL	PA451640	29116	0.878
NULL	J_Cell_Mol_Med_2014_Oct_11_18(10)_2031-2043.nxml.txt.nlp	25109475	SENT285	2	2	8	8	valsartan	TLR-4	PA451848	7099	0.878
NULL	Tuberc_Respir_Dis_(Seoul)_2013_Nov_29_75(5)_188-198.nxml.txt.nlp	24348666	SENT175	22	22	34	34	crizotinib	EGFR	PA165946122	1956	0.878
NULL	Acta_Pharmacol_Sin_2014_Jun_4_35(6)_792-805.nxml.txt.nlp	24902787	SENT194	20	20	30	30	paroxetine	INS-1	PA450801	2305	0.878
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT220	11	11	0	0	panitumumab	KRAS	PA162373091	3845	0.878
NULL	Cancers_(Basel)_2010_Dec_23_3(1)_17-42.nxml.txt.nlp	24212604	SENT904	9	9	29	29	estradiol	PPX	PA449503	5531	0.878
NULL	Breast_Cancer_Res_2010_Aug_9_12(4)_R62.nxml.txt.nlp	20696059	SENT241	17	17	23	23	trastuzumab	AKT	PA451743	207	0.878
NULL	J_Gen_Physiol_2010_Apr_135(4)_333-353.nxml.txt.nlp	20231374	SENT441	8	8	16	16	amitriptyline	P2X4	PA448385	5025	0.878
NULL	Mol_Cancer_2010_Oct_12_9_269.nxml.txt.nlp	20939893	SENT143	19	19	27	27	isoproterenol	AP-1	PA450121	2353;3727;2354;3725	0.878
NULL	Hum_Genomics_2009_Jan_1_3(2)_128-142.nxml.txt.nlp	19164090	SENT267	11	11	9	9	carboplatin	CD44	PA448803	960	0.878
NULL	Thorax_2011_Dec_23_66(12)_1029-1035.nxml.txt.nlp	21606476	SENT82	25	25	40	40	papaverine	EP2	PA164745550	5732;10407	0.878
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Sep_4_66(Pt_10)_o2479.nxml.txt.nlp	21587480	SENT70	27	27	11	11	ethanol	mol	PA448073	90527	0.878
NULL	Acta_Pharmacol_Sin_2014_Jun_5_35(6)_716-726.nxml.txt.nlp	24793311	SENT54	4	4	21	21	atorvastatin	p38	PA448500	10598;1432;7965	0.878
NULL	Curr_Neuropharmacol_2013_Dec_11(6)_606-620.nxml.txt.nlp	24396337	SENT384	16	16	21	21	capsaicin	TRPV1	PA448776	7442	0.878
NULL	Oncogene_2014_Oct_23_33(43)_5109-5120.nxml.txt.nlp	24858043	SENT79	3	3	31	31	pp2	MCT-1		28985	0.878
NULL	Br_J_Cancer_2010_Jan_5_102(1)_1-7.nxml.txt.nlp	19935796	SENT132	21	21	5	5	orlistat	PI3K	PA164776864	5290	0.878
NULL	Korean_J_Anesthesiol_2013_Jan_21_64(1)_47-53.nxml.txt.nlp	23372886	SENT96	8	8	25	25	bupivacaine	IGK	PA135057240	50802	0.878
NULL	J_Physiol_2014_Nov_15_592(22)_5093-5107.nxml.txt.nlp	25239460	SENT241	24	24	27	27	sc-560	PAG		55824	0.878
NULL	Evid_Based_Complement_Alternat_Med_2013_May_16_2013_470975.nxml.txt.nlp	23762140	SENT183	2	2	10	10	curcumin	p65	PA151958596	5970	0.878
NULL	Front_Oncol_2013_Apr_23_3_86.nxml.txt.nlp	23630663	SENT149	20	20	7	7	afatinib	ERBB2	PA165981154	2064	0.878
NULL	Biomed_Res_Int_2014_Jan_23_2014_312647.nxml.txt.nlp	24587984	SENT133	3	3	16	16	infliximab	ABCA1	PA452639	19	0.878
NULL	Biosci_Rep_2012_Aug_1_32(Pt_4)_361-374.nxml.txt.nlp	22762204	SENT150	30	30	6	6	trastuzumab	PI3K	PA451743	5290	0.878
NULL	Pharmaceuticals_(Basel)_2014_Jan_23_7(2)_113-135.nxml.txt.nlp	24463342	SENT108	14	14	35	35	memantine	spatial	PA10364	219793	0.878
NULL	Biosci_Rep_2012_Aug_1_32(Pt_4)_361-374.nxml.txt.nlp	22762204	SENT150	11	11	6	6	trastuzumab	PI3K	PA451743	5290	0.878
NULL	Breast_Cancer_(Auckl)_2011_Oct_9_5_209-226.nxml.txt.nlp	22084574	SENT206	10	10	8	8	exemestane	aromatase	PA449563	1588	0.878
NULL	Cell_Logist_2012_Apr_1_2(2)_69-77.nxml.txt.nlp	23162739	SENT114	18	18	11	11	staurosporine	PAK1	PA165109623	5585;5058	0.878
NULL	Acta_Pharmacol_Sin_2009_Oct_5_30(10)_1399-1414.nxml.txt.nlp	19801996	SENT66	19	19	2	2	glibenclamide	BIM	PA449782	10018	0.878
NULL	Front_Mol_Neurosci_2012_May_7_5_60.nxml.txt.nlp	22586367	SENT228	28	28	0	0	ivermectin	VCF	PA450133	7413	0.878
NULL	Acta_Pharmacol_Sin_2013_Jul_5_34(7)_870-879.nxml.txt.nlp	23624759	SENT140	26	26	22	22	tamoxifen	Bcl-2	PA451581	596	0.878
NULL	Front_Neurosci_2014_May_27_8_129.nxml.txt.nlp	24904269	SENT153	24	24	15	15	ethanol	AC8	PA448073	114	0.878
NULL	Adv_Hematol_2012_Nov_20_2012_861060.nxml.txt.nlp	23251161	SENT13	20	20	16	16	vincristine	CHOP	PA451879	1649	0.878
NULL	Arthritis_Res_Ther_2009_Jan_26_11(1)_R12.nxml.txt.nlp	19171052	SENT319	17	17	7	7	dipyridamole	ACTH	PA449367	5443	0.878
NULL	Mol_Biol_Cell_2013_Sep_1_24(17)_2678-2688.nxml.txt.nlp	23864716	SENT149	14	14	28	28	thrombin	GEF	PA451674	56731	0.878
NULL	Clin_Interv_Aging_2015_Jan_6_10_157-174.nxml.txt.nlp	25609933	SENT251	21	21	8	8	tamoxifen	BCS	PA451581	617	0.878
NULL	Mol_Pain_2013_Jun_10_9_27.nxml.txt.nlp	23758830	SENT13	17	17	11	11	tetracaine	ASIC2a	PA451638	40	0.878
NULL	Br_J_Cancer_2012_Aug_7_107(4)_639-645.nxml.txt.nlp	22805326	SENT166	41	41	18	18	pazopanib	VEGFR2	PA165291492	3791	0.878
NULL	Oncotarget_2013_Nov_24_4(12)_2186-2207.nxml.txt.nlp	24327604	SENT237	12	12	0	0	lenalidomide	CD44	PA162363968	960	0.878
NULL	Bioinformation_2012_Apr_30_8(8)_369-380.nxml.txt.nlp	22570518	SENT68	17	17	0	0	artemisinin	C10	PA165111696	113246	0.878
NULL	Int_J_Mol_Sci_2014_Mar_20_15(3)_4965-4976.nxml.txt.nlp	24658440	SENT5	20	20	7	7	tacrolimus	P-gp	PA451578	5243	0.878
NULL	Hum_Mol_Genet_2013_Nov_15_22(22)_4616-4626.nxml.txt.nlp	23814041	SENT186	0	0	9	9	simvastatin	neuroserpin	PA451363	5274	0.878
NULL	Acta_Pharmacol_Sin_2009_Oct_5_30(10)_1399-1414.nxml.txt.nlp	19801996	SENT74	10	10	0	0	glibenclamide	BIM	PA449782	10018	0.878
NULL	Acta_Pharmacol_Sin_2010_Apr_8_31(4)_461-469.nxml.txt.nlp	20208553	SENT203	3	3	16	16	ethanol	adiponectin	PA448073	9370	0.878
NULL	Adv_Hematol_2009_Jul_7_2009_495863.nxml.txt.nlp	19960059	SENT185	11	11	2	2	exemestane	aromatase	PA449563	1588	0.878
NULL	Exp_Ther_Med_2013_Jul_23_6(1)_199-203.nxml.txt.nlp	23935746	SENT188	6	6	19	19	capecitabine	CXCR4	PA448771	7852	0.878
NULL	Cell_Death_Dis_2010_Nov_18_1(11)_e102.nxml.txt.nlp	21368867	SENT307	17	17	11	11	gentamicin	CLIMP-63	PA449753	10970	0.878
NULL	Int_J_Med_Sci_2013_Jun_15_10(8)_1015-1021.nxml.txt.nlp	23801888	SENT96	21	21	5	5	ribavirin	IL28B	PA451241	282617	0.878
NULL	FEBS_Open_Bio_2014_Oct_22_4_905-914.nxml.txt.nlp	25383314	SENT97	2	2	11	11	physostigmine	L-FABP	PA450957	2168	0.878
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT301	2	2	20	20	atorvastatin	PIK3CA	PA448500	5290	0.878
NULL	Cancer_Immunol_Immunother_2011_Jun_25_60(6)_793-808.nxml.txt.nlp	21350947	SENT192	24	24	11	11	sorafenib	IFNAR2	PA7000	3455	0.878
NULL	J_Cell_Biol_1998_Jan_26_140(2)_335-345.nxml.txt.nlp	9442109	SENT191	2	2	22	22	chloroquine	NHE	PA448948	285335	0.878
NULL	Cancer_Metastasis_Rev_2014_Dec_28_33(1)_161-171.nxml.txt.nlp	24375389	SENT21	26	26	17	17	gefitinib	EGFR	PA131301952	1956	0.877
NULL	Exp_Ther_Med_2013_Nov_13_6(5)_1317-1321.nxml.txt.nlp	24223665	SENT170	11	11	13	13	curcumin	CD133	PA151958596	8842	0.877
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Jun_4_70(Pt_7)_o747-o748.nxml.txt.nlp	25161543	SENT86	11	11	23	23	ethanol	mol	PA448073	90527	0.877
NULL	Open_Med_2007_Dec_18_1(3)_e184-e190.nxml.txt.nlp	21673951	SENT67	7	7	36	36	raloxifene	aromatase	PA451221	1588	0.877
NULL	Case_Rep_Oncol_2014_Jun_18_7(2)_393-400.nxml.txt.nlp	25076890	SENT87	14	14	7	7	erlotinib	RAI	PA134687924	10848;6050	0.877
NULL	Clin_Dev_Immunol_2013_Oct_8_2013_859761.nxml.txt.nlp	24222777	SENT117	14	14	35	35	rituximab	CAMR	PA451261	3028	0.877
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jul_14_66(Pt_8)_o1996.nxml.txt.nlp	21588310	SENT73	43	43	34	34	ethanol	mol	PA448073	90527	0.877
NULL	Br_J_Cancer_1996_Sep_74(5)_704-710.nxml.txt.nlp	8795571	SENT17	3	3	28	28	paclitaxel	PA1	PA450761	79447	0.877
NULL	Curr_Neuropharmacol_2014_Jul_12(4)_365-379.nxml.txt.nlp	25342944	SENT116	45	45	19	19	fluoxetine	EGF	PA449673	1950	0.877
NULL	Oncotarget_2014_Nov_2_5(21)_10222-10236.nxml.txt.nlp	25400118	SENT208	23	23	2	2	erlotinib	HER3	PA134687924	2065	0.877
NULL	Pharmaceuticals_(Basel)_2013_Aug_21_6(8)_988-1038.nxml.txt.nlp	24276379	SENT2577	17	17	2	2	cetuximab	KRAS	PA10040	3845	0.877
NULL	Int_J_Ion_Mobil_Spectrom_2009_Aug_1_12(3)_91-102.nxml.txt.nlp	20835390	SENT126	20	20	24	24	loratadine	mol	PA450266	90527	0.877
NULL	Ital_J_Pediatr_2013_Jul_6_39_42.nxml.txt.nlp	23830064	SENT107	12	12	7	7	rituximab	CD25	PA451261	3669;3559	0.877
NULL	Eur_J_Neurosci_2007_Apr_1_25(8)_2445-2456.nxml.txt.nlp	17445240	SENT374	9	9	6	6	rimonabant	CB1	PA152407999	1268	0.877
NULL	Brain_Res_2013_Jul_12_1521(100)_1-15.nxml.txt.nlp	22789905	SENT275	0	0	16	16	colchicine	P-gp	PA449092	5243	0.877
NULL	BMB_Rep_2013_Aug_46(8)_410-415.nxml.txt.nlp	23977989	SENT31	12	12	4	4	curcumin	HO-1	PA151958596	3162	0.877
NULL	Biomed_Res_Int_2014_Jan_12_2014_276918.nxml.txt.nlp	24524073	SENT98	13	13	35	35	sertraline	CYP2C19	PA451333	1557	0.877
NULL	Breast_Cancer_Res_2008_May_13_10(Suppl_2)_P95.nxml.txt.nlp	NULL	SENT7	21	21	13	13	carboplatin	PARP-1	PA448803	25976	0.877
NULL	Oxid_Med_Cell_Longev_2013_Nov_28_2013_568093.nxml.txt.nlp	24379901	SENT72	6	6	19	19	resveratrol	SIRT1		23411	0.877
NULL	Oncotarget_2011_Mar_7_2(3)_122-134.nxml.txt.nlp	21399234	SENT67	11	11	30	30	sunitinib	Raf-1	PA162372840	5894	0.877
NULL	Chem_Rev_2014_Jun_11_114(11)_5753-5774.nxml.txt.nlp	24758331	SENT210	6	6	31	31	verapamil	P-gp	PA451868	5243	0.877
NULL	Br_J_Cancer_2011_Jul_12_105(2)_221-230.nxml.txt.nlp	21750559	SENT191	22	22	35	35	fludarabine	Mcl-1	PA449655	4170	0.877
NULL	Mol_Cancer_2007_Jan_2_6_1.nxml.txt.nlp	17199893	SENT76	31	31	13	13	cisplatin	MAD2B	PA449014	10459	0.877
NULL	Curr_Genomics_2013_Nov_14(7)_441-452.nxml.txt.nlp	24396276	SENT103	26	26	15	15	cisplatin	ATOX1	PA449014	475	0.877
NULL	Alcohol_Clin_Exp_Res_2014_Mar_11_38(3)_657-671.nxml.txt.nlp	24117525	SENT141	1	1	20	20	ethanol	IL-6	PA448073	3569	0.877
NULL	Pharmaceuticals_(Basel)_2014_Jan_9_7(1)_46-57.nxml.txt.nlp	24451403	SENT73	10	10	8	8	ritonavir	Bcl-2	PA451260	596	0.877
NULL	Arthritis_Res_Ther_2005_Feb_17_7(Suppl_1)_P74.nxml.txt.nlp	NULL	SENT3	28	28	25	25	losartan	AT1	PA450268	9197;185	0.877
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT85	27	27	13	13	heparin	FGF1	PA449855	2246	0.877
NULL	AMB_Express_2011_Nov_21_1_42.nxml.txt.nlp	22104600	SENT209	0	0	20	20	rosiglitazone	AMPK	PA451283	5563	0.877
NULL	Front_Physiol_2012_Sep_12_3_362.nxml.txt.nlp	22988443	SENT372	15	15	1	1	nadh	IDH2	PA164755085	3418	0.877
NULL	Ther_Clin_Risk_Manag_2006_Dec_2(4)_435-445.nxml.txt.nlp	18360654	SENT33	18	18	8	8	erlotinib	EGFR	PA134687924	1956	0.877
NULL	Diabetes_2013_Jun_17_62(6)_1843-1854.nxml.txt.nlp	23349486	SENT203	19	19	7	7	pioglitazone	CD68	PA450970	968	0.877
NULL	Int_J_Mol_Sci_2014_Sep_5_15(9)_15754-15765.nxml.txt.nlp	25198898	SENT97	9	9	15	15	curcumin	JNK	PA151958596	5599	0.877
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT85	17	17	4	4	phenprocoumon	ANOVA	PA450921	4858	0.877
NULL	Ann_Rheum_Dis_2008_Jun_2_68(5)_654-657.nxml.txt.nlp	18519424	SENT115	15	15	22	22	tocilizumab	IL6	PA165292659	3569	0.877
NULL	J_Breast_Cancer_2012_Jun_28_15(2)_239-243.nxml.txt.nlp	22807943	SENT78	16	16	24	24	tamoxifen	aromatase	PA451581	1588	0.877
NULL	Br_J_Cancer_2012_Sep_4_107(6)_947-955.nxml.txt.nlp	22892392	SENT116	22	22	5	5	lapatinib	EGFR	PA152241907	1956	0.877
NULL	J_Hematol_Oncol_2011_Aug_1_4_31.nxml.txt.nlp	21806788	SENT84	10	10	22	22	rituximab	CHOP	PA451261	1649	0.877
NULL	Mol_Cancer_2010_Dec_20_9_317.nxml.txt.nlp	21172025	SENT141	23	23	7	7	tamoxifen	HER2	PA451581	2064	0.877
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_O3.nxml.txt.nlp	NULL	SENT20	4	4	12	12	amoxicillin	DRB1	PA448406	129831	0.877
NULL	J_Hematol_Oncol_2013_Apr_29_6_32.nxml.txt.nlp	23627920	SENT152	10	10	24	24	azacitidine	6-16	PA451996	2537	0.877
NULL	J_Mol_Signal_2011_Aug_10_6_8.nxml.txt.nlp	21831305	SENT93	11	11	5	5	isoproterenol	AKAP12	PA450121	9590	0.877
NULL	J_Korean_Med_Sci_2006_Dec_31_21(6)_1037-1040.nxml.txt.nlp	17179683	SENT51	26	26	12	12	amoxicillin	BAM	PA448406	9126	0.877
NULL	Diabetes_2009_Mar_58(3)_641-651.nxml.txt.nlp	19073764	SENT227	29	29	18	18	sitagliptin	CHS	PA164748978	1130	0.877
NULL	Eur_J_Pediatr_2012_Sep_29_171(9)_1339-1348.nxml.txt.nlp	22543566	SENT219	7	7	1	1	icatibant	C1-INH	PA164749185	710	0.877
NULL	Br_J_Cancer_2011_Dec_6_105(12)_1920-1926.nxml.txt.nlp	22095222	SENT7	27	27	10	10	gefitinib	EGFR	PA131301952	1956	0.877
NULL	Biologics_2014_Nov_14_8_269-280.nxml.txt.nlp	25484574	SENT124	40	40	26	26	cisplatin	BRCA1	PA449014	672	0.877
NULL	Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_1029-1037.nxml.txt.nlp	25049660	SENT127	27	27	7	7	l-cysteine	MC1R	PA449173	4157	0.877
NULL	Mediators_Inflamm_2010_May_5_2010_495416.nxml.txt.nlp	20454534	SENT86	9	9	15	15	hyaluronan	IL-6	PA165958431	3569	0.877
NULL	Diabetes_Metab_J_2014_Aug_20_38(4)_274-277.nxml.txt.nlp	25215273	SENT14	23	23	2	2	glucose	ABCA1	PA449773	19	0.877
NULL	Oncotarget_2011_Dec_31_2(12)_935-947.nxml.txt.nlp	22249213	SENT228	9	9	4	4	paclitaxel	MCAK	PA450761	11004	0.877
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Mar_26_3(3)_e107.nxml.txt.nlp	24670388	SENT90	11	11	16	16	midazolam	CYP3A	PA450496	1574	0.877
NULL	Oncogenesis_2012_Apr_2_1(4)_e5.nxml.txt.nlp	23552603	SENT241	21	21	33	33	celecoxib	MCL1	PA448871	4170	0.877
NULL	Oncogenesis_2012_Apr_2_1(4)_e5.nxml.txt.nlp	23552603	SENT241	21	21	35	35	celecoxib	BAX	PA448871	581	0.877
NULL	Pharmaceuticals_(Basel)_2013_Nov_11_6(11)_1429-1450.nxml.txt.nlp	24287465	SENT283	20	20	31	31	vemurafenib	SMO	PA165946873	6608;54498	0.877
NULL	Oncotarget_2014_Aug_29_5(18)_8052-8082.nxml.txt.nlp	25211298	SENT389	3	3	20	20	ritonavir	MRP1	PA451260	4437	0.877
NULL	Mol_Cancer_2009_Jun_8_8_34.nxml.txt.nlp	19500427	SENT76	7	7	14	14	gemcitabine	p53	PA449748	7157	0.877
NULL	Br_J_Cancer_2012_May_8_106(10)_1591-1597.nxml.txt.nlp	22516947	SENT39	24	24	21	21	irinotecan	UGT1A1	PA450085	54658	0.877
NULL	Nat_Commun_2014_Jun_25_5_4182.nxml.txt.nlp	24964370	SENT100	10	10	3	3	oxaliplatin	CT26	PA131285527	168400	0.877
NULL	Toxins_(Basel)_2010_Oct_26_2(11)_2490-2518.nxml.txt.nlp	22069563	SENT305	11	11	7	7	metformin	OCT2	PA450395	6582;5452	0.877
NULL	Diabetes_Care_2013_Dec_13_36(12)_e214.nxml.txt.nlp	24265383	SENT37	19	19	22	22	liraglutide	GLP-1	PA165958364	100125288	0.877
NULL	J_Gen_Physiol_1989_Jun_1_93(6)_1109-1127.nxml.txt.nlp	2549176	SENT0	17	17	1	1	amlodipine	Gen	PA448388	348654	0.877
NULL	Cell_Biol_Int_Rep_(2010)_2012_Jun_21_19(1)_e00017.nxml.txt.nlp	23124518	SENT78	33	33	8	8	etoposide	TRAIL-R2	PA449552	8795	0.877
NULL	Oncol_Lett_2013_Mar_28_5(3)_935-942.nxml.txt.nlp	23426424	SENT13	29	29	22	22	cisplatin	ERCC1	PA449014	2067	0.877
NULL	Cell_Cycle_2012_Oct_1_11(19)_3536-3542.nxml.txt.nlp	22895112	SENT143	4	4	35	35	vincristine	Bcl-2	PA451879	596	0.877
NULL	Diabetes_Care_2011_Jul_17_34(7)_1678-1680.nxml.txt.nlp	21709302	SENT72	22	22	7	7	rosiglitazone	DREAM	PA451283	30818	0.877
NULL	Cell_Death_Dis_2012_Jun_21_3(6)_e330.nxml.txt.nlp	22717585	SENT66	0	0	21	21	simvastatin	NOXA	PA451363	5366	0.877
NULL	Mediators_Inflamm_2011_Jun_7_2011_432080.nxml.txt.nlp	21772662	SENT176	6	6	12	12	rivaroxaban	MCP-1	PA165958360	6347	0.877
NULL	Drugs_Aging_2014_May_6_31(6)_413-424.nxml.txt.nlp	24797286	SENT37	0	0	13	13	denosumab	RANKL	PA166048634	8600	0.877
NULL	Cardiovasc_Ther_2009_27(4)_259-274.nxml.txt.nlp	19604248	SENT127	7	7	0	0	ticagrelor	IPA	PA165374673	3160	0.877
NULL	Cancers_(Basel)_2013_Jul_24_5(3)_901-918.nxml.txt.nlp	24202326	SENT51	35	35	8	8	thalidomide	CD138	PA451644	6382	0.877
NULL	Mol_Vis_2011_Aug_25_17_2297-2310.nxml.txt.nlp	21921981	SENT216	9	9	16	16	estradiol	HSD17B2	PA449503	3294	0.877
NULL	Ann_Med_Health_Sci_Res_2013_Apr-Jun_3(2)_282-284.nxml.txt.nlp	23919207	SENT70	24	24	4	4	linezolid	RGM	PA450233	56963	0.877
NULL	Mol_Cancer_2014_Jul_5_13_165.nxml.txt.nlp	24996221	SENT42	11	11	32	32	docetaxel	p62	PA449383	8878;10657;23636	0.877
NULL	J_Immunol_Res_2014_Jul_16_2014_696812.nxml.txt.nlp	25133198	SENT159	19	19	9	9	rifaximin	TLR4	PA164752443	7099	0.877
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R91.nxml.txt.nlp	22541814	SENT131	30	30	14	14	thrombin	PAR1	PA451674	79581;2149	0.877
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Jul_9_3(7)_e124.nxml.txt.nlp	25006781	SENT100	2	2	25	25	rosuvastatin	OATP1B1	PA134308647	10599	0.877
NULL	Carcinogenesis_2014_May_13_35(5)_1055-1066.nxml.txt.nlp	24419232	SENT606	6	6	9	9	metformin	CD133	PA450395	8842	0.877
NULL	J_Korean_Med_Sci_2007_Apr_30_22(2)_283-289.nxml.txt.nlp	17449938	SENT99	2	2	7	7	minoxidil	Bcl-2	PA450521	596	0.877
NULL	EPMA_J_2013_Jan_28_4(1)_3.nxml.txt.nlp	23356214	SENT286	38	38	33	33	cetuximab	BRAF	PA10040	673	0.877
NULL	Diabetes_Care_2013_Jul_12_36(7)_1933-1940.nxml.txt.nlp	23462665	SENT258	27	27	21	21	liraglutide	GLP-1	PA165958364	100125288	0.877
NULL	Br_J_Pharmacol_2014_Jun_15_171(11)_2705-2725.nxml.txt.nlp	24467436	SENT8	14	14	4	4	hydralazine	NAT1	PA449894	9;1982	0.877
NULL	Clin_Exp_Vaccine_Res_2014_Jul_20_3(2)_113-116.nxml.txt.nlp	25003083	SENT41	5	5	17	17	imiquimod	TLR7	PA449972	51284	0.877
NULL	Front_Oncol_2014_Apr_22_4_86.nxml.txt.nlp	24795863	SENT673	9	9	15	15	olaparib	BRCA2		675	0.877
NULL	Oncol_Lett_2013_Jun_3_5(6)_1760-1764.nxml.txt.nlp	23833637	SENT8	11	11	40	40	gemcitabine	XIAP	PA449748	331	0.877
NULL	Cancer_Cell_Int_2009_Sep_10_9_25.nxml.txt.nlp	19744341	SENT97	0	0	2	2	glucosamine	STAT3	PA164747613	6774	0.877
NULL	Oncogene_2014_Mar_20_33(12)_1590-1600.nxml.txt.nlp	23542178	SENT13	8	8	28	28	vemurafenib	BRAF	PA165946873	673	0.877
NULL	Biologics_2009_Sep_15_3_419-428.nxml.txt.nlp	19774209	SENT170	11	11	33	33	everolimus	EGFR	PA164746311	1956	0.877
NULL	Br_J_Cancer_2010_Dec_7_103(12)_1765-1772.nxml.txt.nlp	21139621	SENT75	32	32	16	16	cetuximab	PTEN	PA10040	5728	0.877
NULL	Lipids_Health_Dis_2011_Dec_30_10_246.nxml.txt.nlp	22208561	SENT127	19	19	11	11	ethanol	adiponectin	PA448073	9370	0.877
NULL	J_Hematol_Oncol_2013_Sep_5_6_66.nxml.txt.nlp	24010946	SENT84	31	31	0	0	leucovorin	CRT	PA450198	811	0.877
NULL	Cancer_Cell_Int_2010_Sep_9_10_32.nxml.txt.nlp	20828393	SENT8	14	14	11	11	cisplatin	ATF3	PA449014	467	0.877
NULL	Soc_Neurosci_2014_Aug_7_9(4)_326-331.nxml.txt.nlp	24802255	SENT25	15	15	1	1	vasopressin	SGC	PA451858	6443	0.877
NULL	Arthritis_Res_Ther_2003_Sep_3_5(6)_R317-R328.nxml.txt.nlp	14680506	SENT174	20	20	13	13	rolipram	IL-10	PA153906323	3586	0.877
NULL	Crit_Care_2010_Apr_19_14(2)_R70.nxml.txt.nlp	20403177	SENT259	16	16	10	10	thrombin	cPLA2	PA451674	10524	0.877
NULL	Cell_Res_2013_Jul_21_23(7)_915-930.nxml.txt.nlp	23689279	SENT158	16	16	8	8	ethanol	ALDH2	PA448073	217	0.877
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Sep_12_69(Pt_10)_o1525.nxml.txt.nlp	24098214	SENT78	10	10	5	5	ethanol	mol	PA448073	90527	0.877
NULL	Eur_J_Clin_Pharmacol_2012_May_21_68(5)_553-560.nxml.txt.nlp	22189672	SENT44	8	8	13	13	diazepam	CYP2C19	PA449283	1557	0.877
NULL	Breast_Cancer_Res_2012_Jul_12_14(4)_R104.nxml.txt.nlp	22788954	SENT194	13	13	11	11	gefitinib	EGFR	PA131301952	1956	0.877
NULL	Oncoscience_2014_Mar_12_1(2)_158-166.nxml.txt.nlp	25594008	SENT9	29	29	19	19	dasatinib	ANXA1	PA162372878	301	0.877
NULL	Pharmaceuticals_(Basel)_2011_Sep_1_4(9)_1196-1215.nxml.txt.nlp	NULL	SENT170	35	35	31	31	timolol	ADRB2	PA451690	154	0.877
NULL	Breast_Cancer_Res_Treat_2013_Aug_20_141(1)_43-53.nxml.txt.nlp	23959396	SENT30	18	18	27	27	trastuzumab	HER2	PA451743	2064	0.877
NULL	J_Nat_Sci_Biol_Med_2011_Jan-Jun_2(1)_13-25.nxml.txt.nlp	22470230	SENT247	38	38	36	36	capsaicin	TRPV1	PA448776	7442	0.877
NULL	Arthritis_Res_Ther_2010_Jun_2_12(3)_R107.nxml.txt.nlp	20525198	SENT210	5	5	27	27	rolipram	IFN	PA153906323	3439	0.877
NULL	Nat_Med_2011_Oct_9_17(11)_1448-1455.nxml.txt.nlp	21983856	SENT104	3	3	12	12	fluoxetine	NRM	PA449673	11270	0.877
NULL	Cancer_Immunol_Immunother_2012_Jul_23_61(7)_1101-1111.nxml.txt.nlp	22193989	SENT137	14	14	9	9	oxaliplatin	TLR3	PA131285527	7098	0.877
NULL	Blood_Cancer_J_2012_Oct_19_2(10)_e95.nxml.txt.nlp	23085780	SENT116	37	37	13	13	dasatinib	PAH	PA162372878	5053	0.877
NULL	Int_J_Surg_Oncol_2010_Oct_28_2010_251621.nxml.txt.nlp	22312487	SENT84	19	19	21	21	tamoxifen	aromatase	PA451581	1588	0.877
NULL	J_Cell_Biol_1998_Aug_24_142(4)_923-936.nxml.txt.nlp	9722606	SENT253	23	23	15	15	fluorescein	TGN	PA164746009	7038	0.877
NULL	EMBO_Mol_Med_2012_Jun_13_4(6)_515-527.nxml.txt.nlp	22416035	SENT227	19	19	38	38	olaparib	p53		7157	0.877
NULL	Evid_Based_Complement_Alternat_Med_2011_Mar_13_2011_913898.nxml.txt.nlp	21785639	SENT220	7	7	14	14	curcumin	CYP3A	PA151958596	1574	0.877
NULL	Ecancermedicalscience_2009_Aug_5_3_144.nxml.txt.nlp	22276009	SENT22	23	23	15	15	rituximab	CHOP	PA451261	1649	0.877
NULL	Front_Immunol_2012_Mar_21_3_57.nxml.txt.nlp	22566938	SENT56	17	17	39	39	vasopressin	IRAP	PA451858	3557	0.877
NULL	J_Gastroenterol_2013_Feb_22_48(2)_222-237.nxml.txt.nlp	22722906	SENT8	39	39	29	29	ethanol	p38	PA448073	10598;1432;7965	0.877
NULL	J_Mol_Signal_2011_Oct_5_6_13.nxml.txt.nlp	21975218	SENT139	24	24	42	42	ethanol	E4BP4	PA448073	4783	0.877
NULL	J_Exp_Med_2003_Aug_4_198(3)_443-453.nxml.txt.nlp	12900520	SENT39	14	14	5	5	ethanol	p24	PA448073	11261;140767	0.877
NULL	Lancet_2011_Jun_9_377(9784)_2181-2192.nxml.txt.nlp	21663949	SENT105	12	12	1	1	simvastatin	SHARP	PA451363	23013	0.877
NULL	Calcif_Tissue_Int_2014_Aug_21_94(2)_170-175.nxml.txt.nlp	23963633	SENT125	12	12	3	3	teriparatide	PTH	PA451620	5741	0.877
NULL	Mol_Cancer_2012_May_1_11_28.nxml.txt.nlp	22548705	SENT213	47	47	3	3	etoposide	p53	PA449552	7157	0.877
NULL	Indian_J_Pharmacol_2013_Mar-Apr_45(2)_121-125.nxml.txt.nlp	23716885	SENT2	0	0	11	11	aripiprazole	CYP3A4	PA10026	1576	0.877
NULL	Arthritis_Res_Ther_2003_Sep_12_5(Suppl_3)_120.nxml.txt.nlp	NULL	SENT7	14	14	8	8	glutaraldehyde	CD28	PA449777	1493;940	0.877
NULL	Gut_2009_Jun_10_58(6)_846-858.nxml.txt.nlp	19074178	SENT270	22	22	8	8	ribavirin	CXCL10	PA451241	3627	0.877
NULL	J_Headache_Pain_2010_Feb_10_11(1)_5-12.nxml.txt.nlp	20012125	SENT170	6	6	22	22	sumatriptan	c-fos	PA451566	2353	0.877
NULL	Mol_Cancer_2012_Apr_26_11_24.nxml.txt.nlp	22537161	SENT222	21	21	45	45	pp2	MUC4		4585	0.877
NULL	Cardiovasc_Res_2010_Jul_1_87(1)_60-72.nxml.txt.nlp	20110334	SENT156	13	13	25	25	orciprenaline	SCN5A	PA450390	6331	0.877
NULL	Autoimmune_Dis_2013_Jul_10_2013_728529.nxml.txt.nlp	23936634	SENT167	9	9	18	18	rituximab	IL-10	PA451261	3586	0.877
NULL	Ann_Oncol_2009_Aug_17_20(8)_1319-1329.nxml.txt.nlp	19535820	SENT49	4	4	18	18	tamoxifen	PAX2	PA451581	5076	0.877
NULL	Cancers_(Basel)_2011_Apr_13_3(2)_1957-1974.nxml.txt.nlp	24212791	SENT150	22	22	35	35	cetuximab	KRAS	PA10040	3845	0.877
NULL	J_Mol_Signal_2010_Jul_12_5_8.nxml.txt.nlp	20624308	SENT56	11	11	19	19	gefitinib	Met	PA131301952	79811	0.877
NULL	J_Hematol_Oncol_2013_Jun_3_6_38.nxml.txt.nlp	23731980	SENT55	27	27	7	7	lapatinib	San	PA152241907	80218	0.877
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT7	11	11	0	0	metformin	HIP	PA450395	6767;6159;64399;5068	0.877
NULL	Oxid_Med_Cell_Longev_2013_Jul_9_2013_574029.nxml.txt.nlp	23936610	SENT268	13	13	7	7	resveratrol	RAGE		177	0.877
NULL	Breast_Cancer_Res_2011_Jun_21_13(3)_R66.nxml.txt.nlp	21693010	SENT228	7	7	29	29	sunitinib	VEGF-D	PA162372840	2277	0.877
NULL	Br_J_Cancer_2012_Aug_21_107(5)_800-807.nxml.txt.nlp	22850554	SENT147	17	17	14	14	trastuzumab	HER2	PA451743	2064	0.877
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_13_2013_468537.nxml.txt.nlp	23956772	SENT141	7	7	27	27	cisplatin	PUMA	PA449014	27113	0.877
NULL	Clin_Exp_Otorhinolaryngol_2011_Dec_15_4(4)_177-183.nxml.txt.nlp	22232712	SENT11	29	29	7	7	doxycycline	MUC5B	PA449415	727897	0.877
NULL	Behav_Genet_2012_Jul_17_42(4)_509-527.nxml.txt.nlp	22426781	SENT355	21	21	12	12	paraformaldehyde	CO2	PA450790	4513	0.877
NULL	Breast_Cancer_Res_2006_Nov_6_8(6)_215.nxml.txt.nlp	17096862	SENT104	13	13	4	4	lapatinib	HER2	PA152241907	2064	0.877
NULL	Oxid_Med_Cell_Longev_2013_Jun_2_2013_793525.nxml.txt.nlp	23819014	SENT163	12	12	15	15	resveratrol	SGBS		2719	0.877
NULL	J_Exp_Clin_Cancer_Res_2009_Sep_7_28(1)_124.nxml.txt.nlp	19735546	SENT8	19	19	23	23	genistein	cadherin	PA165109660	1015	0.877
NULL	Exp_Neurobiol_2013_Mar_31_22(1)_45-50.nxml.txt.nlp	23585722	SENT164	8	8	3	3	fluoxetine	EPO	PA449673	7076;8288;2056	0.877
NULL	Case_Rep_Transplant_2012_Sep_27_2012_493758.nxml.txt.nlp	23259133	SENT73	37	37	30	30	voriconazole	IFN	PA10233	3439	0.877
NULL	Hum_Mol_Genet_2008_Aug_1_17(15)_2293-2309.nxml.txt.nlp	18424448	SENT201	43	43	29	29	estradiol	ESR1	PA449503	2099	0.877
NULL	EPMA_J_2010_Sep_25_1(3)_495-502.nxml.txt.nlp	23199091	SENT113	14	14	35	35	cyclophosphamide	DPD	PA449165	1806	0.877
NULL	Breast_Cancer_Res_2008_Dec_18_10(Suppl_4)_S18.nxml.txt.nlp	19128431	SENT26	14	14	39	39	tamoxifen	LBA	PA451581	987	0.877
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT180	3	3	8	8	atorvastatin	TNF	PA448500	7124	0.877
NULL	J_Cell_Mol_Med_2014_Dec_9_18(12)_2425-2436.nxml.txt.nlp	25297942	SENT175	10	10	3	3	cisplatin	HOTAIR	PA449014	100124700	0.877
NULL	Int_J_Biol_Sci_2011_Nov_5_8(1)_1-14.nxml.txt.nlp	22211100	SENT136	2	2	10	10	evodiamine	PI3K	PA165860788	5290	0.877
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Aug_21_66(Pt_9)_o2379-o2380.nxml.txt.nlp	21588717	SENT73	31	31	9	9	ethanol	mol	PA448073	90527	0.877
NULL	Indian_J_Pharmacol_2014_Nov-Dec_46(6)_627-632.nxml.txt.nlp	25538335	SENT170	32	32	35	35	metformin	Q10	PA450395	27161	0.877
NULL	Bone_Marrow_Res_2011_Mar_2_2011_924058.nxml.txt.nlp	22046572	SENT168	0	0	25	25	denosumab	RANKL	PA166048634	8600	0.877
NULL	Mol_Cancer_2008_Sep_12_7_70.nxml.txt.nlp	18789133	SENT71	7	7	0	0	belinostat	HDAC1		3065	0.877
NULL	Oxid_Med_Cell_Longev_2012_Jan_19_2012_390678.nxml.txt.nlp	22315655	SENT8	2	2	27	27	gliclazide	NAC	PA10892	22861	0.877
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Nov_25_65(Pt_12)_o3189.nxml.txt.nlp	21578901	SENT73	25	25	13	13	ethanol	mol	PA448073	90527	0.877
NULL	Mol_Biol_Cell_2013_Aug_15_24(16)_2582-2592.nxml.txt.nlp	23783032	SENT101	23	23	31	31	bortezomib	FANCL	PA10252	55120	0.877
NULL	Cancer_Cell_Int_2007_Sep_10_7_14.nxml.txt.nlp	17845729	SENT166	17	17	2	2	decitabine	PAWR	PA164749631	5074	0.877
NULL	Acta_Vet_Scand_2008_Jul_4_50(1)_27.nxml.txt.nlp	18601734	SENT146	32	32	11	11	doxorubicin	MTSS1	PA449412	9788	0.877
NULL	Indian_J_Pharmacol_2009_Dec_41(6)_289a.nxml.txt.nlp	20407565	SENT18	10	10	17	17	pioglitazone	CYP3A4	PA450970	1576	0.877
NULL	Oncoimmunology_2013_May_1_2(5)_e23850.nxml.txt.nlp	23762785	SENT40	48	48	30	30	denosumab	RANKL	PA166048634	8600	0.877
NULL	Clin_Pharmacol_2011_Jun_22_3_13-25.nxml.txt.nlp	22287853	SENT190	9	9	5	5	ketoconazole	CYP3A4	PA450146	1576	0.877
NULL	Mol_Cancer_2014_Jun_24_13_157.nxml.txt.nlp	24958351	SENT60	33	33	24	24	lapatinib	ERK	PA152241907	5594	0.877
NULL	Front_Oncol_2014_Apr_22_4_86.nxml.txt.nlp	24795863	SENT674	21	21	27	27	olaparib	BRCA2		675	0.877
NULL	Br_J_Cancer_2010_Mar_16_102(6)_1003-1009.nxml.txt.nlp	20179710	SENT130	8	8	29	29	thiotepa	CYP2B6	PA451668	1555	0.877
NULL	Mol_Cancer_2014_Feb_20_13_32.nxml.txt.nlp	24555657	SENT197	28	28	3	3	cisplatin	SET	PA449014	6418	0.877
NULL	Front_Neurol_2014_Feb_18_5_17.nxml.txt.nlp	24600432	SENT20	4	4	13	13	levetiracetam	C17	PA450206	54360	0.877
NULL	Thorax_2014_Jul_24_69(7)_638-647.nxml.txt.nlp	24567297	SENT82	13	13	3	3	doxycycline	TRAIL	PA449415	8743	0.877
NULL	J_Korean_Neurosurg_Soc_2013_Mar_31_53(3)_139-144.nxml.txt.nlp	23634262	SENT111	20	20	9	9	isoflurane	CA3	PA450106	761	0.877
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT268	5	5	8	8	metformin	HIF-1	PA450395	29072	0.877
NULL	Sci_Rep_2014_Nov_28_4_7237.nxml.txt.nlp	25429875	SENT569	9	9	2	2	hesperidin	p38	PA449867	10598;1432;7965	0.877
NULL	Bone_Joint_Res_2014_Mar_1_3(3)_51-59.nxml.txt.nlp	24615710	SENT183	18	18	12	12	resveratrol	RUNX2		860	0.877
NULL	Mol_Biol_Cell_2013_Jul_15_24(14)_2186-2200.nxml.txt.nlp	23699397	SENT83	1	1	37	37	staurosporine	TRAIL	PA165109623	8743	0.877
NULL	Arthritis_Res_Ther_2010_May_28_12(3)_R105.nxml.txt.nlp	20509880	SENT171	11	11	7	7	celecoxib	p38	PA448871	10598;1432;7965	0.877
NULL	Bioinformation_2013_Nov_11_9(18)_929-936.nxml.txt.nlp	24307772	SENT121	0	0	12	12	trypsin	MTHFR	PA451806	4524	0.877
NULL	Br_J_Cancer_2010_Nov_2_103(11)_1671-1679.nxml.txt.nlp	21045835	SENT37	21	21	4	4	gemcitabine	CXCL12	PA449748	6387	0.877
NULL	Oncotarget_2013_Nov_4_5(1)_161-172.nxml.txt.nlp	24389287	SENT173	6	6	22	22	propranolol	p53	PA451145	7157	0.877
NULL	Mol_Biol_Cell_2012_Jul_15_23(14)_2658-2670.nxml.txt.nlp	22621899	SENT188	22	22	32	32	doxycycline	AURKA	PA449415	6790	0.877
NULL	Oncotarget_2014_Oct_18_5(22)_11604-11619.nxml.txt.nlp	25344099	SENT230	28	28	15	15	cisplatin	RYBP	PA449014	23429	0.877
NULL	Breast_Cancer_Res_2011_Mar_1_13(2)_R21.nxml.txt.nlp	21362200	SENT224	11	11	7	7	fulvestrant	PI3K	PA164747170	5290	0.877
NULL	Patient_Prefer_Adherence_2010_Mar_24_4_61-68.nxml.txt.nlp	20361006	SENT17	0	0	11	11	liraglutide	GLP-1	PA165958364	100125288	0.877
NULL	Int_J_Breast_Cancer_2012_Oct_15_2012_809291.nxml.txt.nlp	22295251	SENT197	37	37	16	16	carboplatin	EGFR	PA448803	1956	0.877
NULL	Environ_Health_Perspect_2006_Jun_2_114(6)_898-904.nxml.txt.nlp	16759992	SENT58	22	22	1	1	ethanol	PCB	PA448073	5091	0.877
NULL	Arch_Drug_Inf_2009_Mar_2(1)_8-16.nxml.txt.nlp	19381336	SENT138	37	37	11	11	ritonavir	CYP3A4	PA451260	1576	0.877
NULL	Acta_Pharmacol_Sin_2009_Oct_5_30(10)_1399-1414.nxml.txt.nlp	19801996	SENT70	13	13	0	0	glibenclamide	BIM	PA449782	10018	0.877
NULL	Nucleic_Acids_Res_2013_Nov_27_41(21)_9786-9799.nxml.txt.nlp	23982513	SENT197	4	4	13	13	arsenite	ADAR1	PA452638	103	0.877
NULL	J_Biomed_Sci_2013_May_20_20(1)_30.nxml.txt.nlp	23687991	SENT96	14	14	8	8	ethanol	PGD2	PA448073	27306	0.877
NULL	Int_J_Mol_Sci_2010_Sep_13_11(9)_3195-3208.nxml.txt.nlp	20957088	SENT219	14	14	5	5	lipase	AT2	PA450239	186	0.877
NULL	Front_Neurosci_2013_Dec_20_7_256.nxml.txt.nlp	24391536	SENT99	19	19	5	5	rimonabant	CB1	PA152407999	1268	0.877
NULL	Biomed_Res_Int_2013_Aug_29_2013_392010.nxml.txt.nlp	24073402	SENT103	12	12	24	24	clarithromycin	MDR1	PA449028	5243	0.877
NULL	Acta_Pharmacol_Sin_2011_Jul_9_32(7)_879-887.nxml.txt.nlp	21552292	SENT224	4	4	13	13	metformin	AMPK	PA450395	5563	0.877
NULL	Clin_Exp_Gastroenterol_2014_Feb_5_7_39-46.nxml.txt.nlp	24523594	SENT37	3	3	28	28	budesonide	CYP3A4	PA448681	1576	0.877
NULL	Indian_J_Med_Res_2010_Dec_132(6)_676-682.nxml.txt.nlp	21245614	SENT100	23	23	12	12	zinc	p53	PA451956	7157	0.877
NULL	Clin_Med_Oncol_2008_Jun_11_2_469-470.nxml.txt.nlp	21892319	SENT22	31	31	23	23	doxorubicin	HER2	PA449412	2064	0.877
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT134	5	5	0	0	tenofovir	ABCB1	PA10204	5243	0.877
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_24_2012_673132.nxml.txt.nlp	23133498	SENT22	4	4	17	17	ciprofloxacin	P-gp	PA449009	5243	0.877
NULL	J_Biol_Chem_2013_Dec_6_288(49)_35387-35395.nxml.txt.nlp	24142790	SENT153	0	0	20	20	meclizine	PCYT2	PA450338	5833	0.877
NULL	Mol_Cancer_2007_Oct_22_6_66.nxml.txt.nlp	17953743	SENT192	20	20	22	22	cisplatin	TRAIL	PA449014	8743	0.877
NULL	Cancer_Sci_2012_Nov_17_103(11)_1907-1912.nxml.txt.nlp	22809142	SENT136	20	20	22	22	decitabine	RASD1	PA164749631	51655	0.877
NULL	Onco_Targets_Ther_2014_Jun_11_7_969-983.nxml.txt.nlp	24959084	SENT115	17	17	4	4	ritonavir	CYP3A4	PA451260	1576	0.877
NULL	Nat_Biotechnol_2013_Jul_30_31(7)_630-637.nxml.txt.nlp	23811600	SENT214	2	2	26	26	crizotinib	STAT3	PA165946122	6774	0.877
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT132	41	41	20	20	cisplatin	p53	PA449014	7157	0.877
NULL	Clin_Interv_Aging_2009_May_14_4_197-205.nxml.txt.nlp	19503782	SENT195	12	12	27	27	fludarabine	CD33	PA449655	945	0.877
NULL	Oncol_Lett_2013_Apr_22_5(4)_1093-1100.nxml.txt.nlp	23599746	SENT232	0	0	5	5	ketoconazole	CYP3A4	PA450146	1576	0.877
NULL	Front_Behav_Neurosci_2011_Sep_6_5_53.nxml.txt.nlp	21922005	SENT332	12	12	4	4	ethanol	CB1	PA448073	1268	0.877
NULL	Arthritis_Res_Ther_2013_Jul_9_15(4)_R73.nxml.txt.nlp	23837669	SENT304	10	10	17	17	colchicine	MSU	PA449092	593	0.877
NULL	Ann_Thorac_Med_2014_Jul-Sep_9(Suppl_1)_S79-S91.nxml.txt.nlp	25077002	SENT307	16	16	7	7	sildenafil	CYP3A4	PA451346	1576	0.877
NULL	Int_J_Cell_Biol_2013_Sep_12_2013_153634.nxml.txt.nlp	24159334	SENT140	9	9	14	14	doxorubicin	MDM2	PA449412	4193	0.877
NULL	Pharmaceuticals_(Basel)_2013_Aug_21_6(8)_988-1038.nxml.txt.nlp	24276379	SENT2640	23	23	1	1	panitumumab	KRAS	PA162373091	3845	0.877
NULL	Breast_Cancer_Res_2007_Aug_10_9(4)_R52.nxml.txt.nlp	17692126	SENT5	17	17	13	13	letrozole	aromatase	PA450196	1588	0.877
NULL	Front_Behav_Neurosci_2011_Sep_8_5_56.nxml.txt.nlp	21927600	SENT1665	12	12	5	5	fluoxetine	DARPP-32	PA449673	84152	0.877
NULL	AAPS_J_2013_Aug_20_15(4)_1119-1127.nxml.txt.nlp	23959685	SENT45	18	18	5	5	lidocaine	CPE	PA450226	1363	0.877
NULL	Diabetes_Obes_Metab_2011_Nov_13(11)_982-989.nxml.txt.nlp	21615670	SENT23	9	9	5	5	sitagliptin	GLP-1	PA164748978	100125288	0.877
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT244	4	4	23	23	perifosine	JNK	PA165291471	5599	0.877
NULL	Cell_Commun_Signal_2003_Nov_24_1_5.nxml.txt.nlp	14636425	SENT35	25	25	19	19	heparin	CCN5	PA449855	8839	0.877
NULL	Cancer_Cell_2007_Dec_11_12(6)_514-527.nxml.txt.nlp	18068629	SENT170	14	14	5	5	paclitaxel	TGFBI	PA450761	7045	0.877
NULL	Mol_Cancer_2007_Oct_11_6_63.nxml.txt.nlp	17931419	SENT113	16	16	22	22	gefitinib	HIF-1	PA131301952	29072	0.877
NULL	Ann_Clin_Microbiol_Antimicrob_2005_Sep_13_4_13.nxml.txt.nlp	16159399	SENT202	30	30	20	20	ribavirin	IFN	PA451241	3439	0.877
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT209	5	5	2	2	perifosine	DR5	PA165291471	8795	0.877
NULL	J_Hematol_Oncol_2009_Feb_23_2_10.nxml.txt.nlp	19236716	SENT107	22	22	25	25	simvastatin	CYP3A4	PA451363	1576	0.877
NULL	Front_Oncol_2014_Apr_9_4_75.nxml.txt.nlp	24782986	SENT126	3	3	20	20	paclitaxel	Oct4	PA450761	5460	0.877
NULL	Int_J_Endocrinol_Metab_2013_Dec_21_Winter_11(1)_52-56.nxml.txt.nlp	23853621	SENT150	24	24	19	19	imatinib	NF1	PA10804	4763	0.877
NULL	Oncotarget_2014_Jun_3_5(13)_4920-4928.nxml.txt.nlp	24952482	SENT132	7	7	20	20	crizotinib	ALK	PA165946122	238	0.877
NULL	Front_Oncol_2011_Aug_22_1_22.nxml.txt.nlp	22666659	SENT88	7	7	1	1	talotrexin	DHFR	PA165109542	1719	0.877
NULL	Acta_Pharmacol_Sin_2010_Dec_3_31(12)_1635-1642.nxml.txt.nlp	21127497	SENT155	7	7	18	18	fluconazole	UGT	PA449653	7361;7355	0.877
NULL	Cell_Oncol_(Dordr)_2011_Apr_19_34(2)_71-88.nxml.txt.nlp	21336636	SENT74	23	23	7	7	cisplatin	BRCA2	PA449014	675	0.877
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT124	23	23	13	13	sulindac	AKT	PA451565	207	0.877
NULL	Breast_Cancer_Res_2004_Nov_25_6(1)_E8.nxml.txt.nlp	14680493	SENT44	0	0	9	9	tamoxifen	BRCA1	PA451581	672	0.877
NULL	Mol_Pain_2012_Sep_21_8_70.nxml.txt.nlp	22998799	SENT6	9	9	32	32	capsaicin	TRPV1	PA448776	7442	0.877
NULL	J_Lipid_Res_2014_Apr_55(4)_645-658.nxml.txt.nlp	24493834	SENT358	33	33	20	20	lipase	PLIN5	PA450239	440503	0.877
NULL	Arch_Med_Sci_2014_Aug_29_10(4)_717-724.nxml.txt.nlp	25276156	SENT147	0	0	6	6	bevacizumab	VEGFR	PA130232992	3791	0.877
NULL	Br_J_Cancer_2013_May_14_108(9)_1862-1869.nxml.txt.nlp	23579219	SENT153	9	9	21	21	bevacizumab	ANXA11	PA130232992	311	0.877
NULL	Mol_Pain_2012_Sep_12_8_67.nxml.txt.nlp	22971334	SENT203	13	13	7	7	halothane	PAG	PA449845	55824	0.877
NULL	Acta_Pharmacol_Sin_2013_Jun_8_34(6)_830-836.nxml.txt.nlp	23564080	SENT180	36	36	27	27	simvastatin	HMGB1	PA451363	3146	0.877
NULL	J_Biomed_Sci_2013_Jan_25_20(1)_4.nxml.txt.nlp	23350663	SENT161	24	24	36	36	thrombin	ADP	PA451674	23038	0.877
NULL	Clin_Ophthalmol_2009_Jun_2_3_291-295.nxml.txt.nlp	19668581	SENT60	27	27	23	23	travoprost	BAK	PA164781371	578	0.877
NULL	Mol_Cancer_2014_Feb_24_13_36.nxml.txt.nlp	24568192	SENT285	7	7	35	35	fluorescein	SP2	PA164746009	6668	0.877
NULL	Ann_Surg_Oncol_2010_Apr_20_17(4)_1168-1176.nxml.txt.nlp	19936839	SENT172	7	7	3	3	panitumumab	KRAS	PA162373091	3845	0.877
NULL	Drug_Target_Insights_2012_Aug_6_6_19-39.nxml.txt.nlp	22915839	SENT261	36	36	19	19	doxorubicin	MDR1	PA449412	5243	0.877
NULL	Alcohol_Res_2013_35(1)_6-16.nxml.txt.nlp	24313160	SENT125	5	5	0	0	ethanol	CYP2E1	PA448073	1571	0.877
NULL	Int_J_Endocrinol_2010_Feb_10_2010_625852.nxml.txt.nlp	20169119	SENT159	19	19	37	37	cinacalcet	PTH	PA164776671	5741	0.877
NULL	J_Nutr_Metab_2011_Jun_1_2011_708183.nxml.txt.nlp	21773024	SENT142	13	13	26	26	rosiglitazone	gamma	PA451283	9913	0.877
NULL	Acta_Pharmacol_Sin_2012_May_16_33(5)_682-690.nxml.txt.nlp	22504904	SENT163	11	11	14	14	celecoxib	STAT3	PA448871	6774	0.877
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT170	21	21	35	35	cisplatin	MDM2	PA449014	4193	0.877
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT280	22	22	1	1	cisplatin	ABCC6	PA449014	368	0.877
NULL	Iran_J_Pharm_Res_2014_Summer_13(3)_919-926.nxml.txt.nlp	25276192	SENT12	20	20	9	9	doxorubicin	Bcl-2	PA449412	596	0.877
NULL	Arthritis_Res_Ther_2012_Sep_24_14(5)_R200.nxml.txt.nlp	23006144	SENT155	0	0	26	26	alefacept	CD68	PA164748040	968	0.877
NULL	J_Cancer_2013_Sep_10_4(8)_614-625.nxml.txt.nlp	24155773	SENT199	6	6	15	15	bortezomib	CRM1	PA10252	7514	0.877
NULL	Ther_Clin_Risk_Manag_2006_Jun_2(2)_187-192.nxml.txt.nlp	18360592	SENT43	2	2	6	6	olanzapine	5-HT2C	PA450688	3358	0.877
NULL	Case_Rep_Oncol_Med_2012_Sep_11_2012_726424.nxml.txt.nlp	22997596	SENT11	19	19	29	29	cyclophosphamide	CHOP	PA449165	1649	0.877
NULL	Breast_Cancer_Res_2011_Dec_8_13(6)_R126.nxml.txt.nlp	22151962	SENT240	13	13	8	8	doxorubicin	CT26	PA449412	168400	0.877
NULL	Basic_Clin_Pharmacol_Toxicol_2013_Feb_5_112(2)_132-137.nxml.txt.nlp	22900583	SENT12	30	30	25	25	flurbiprofen	CYP3A4	PA449683	1576	0.877
NULL	Chonnam_Med_J_2013_Dec_23_49(3)_125-128.nxml.txt.nlp	24400215	SENT11	25	25	11	11	lipase	PTH	PA450239	5741	0.877
NULL	Adv_Hematol_2012_Jul_8_2012_478164.nxml.txt.nlp	22829834	SENT26	4	4	9	9	tamoxifen	MYC	PA451581	4609	0.877
NULL	Brain_Sci_2013_Jun_19_3(2)_964-991.nxml.txt.nlp	24961433	SENT69	6	6	36	36	ethanol	ngn1	PA448073	4762	0.877
NULL	Crit_Care_2011_Mar_11_15(Suppl_1)_P347.nxml.txt.nlp	NULL	SENT2	16	16	9	9	tramadol	CYP2D6	PA451735	1565	0.877
NULL	Br_J_Pharmacol_2014_Oct_26_171(20)_4785-4796.nxml.txt.nlp	25074741	SENT180	0	0	21	21	guanfacine	EPM	PA449825	2054	0.877
NULL	Breast_Cancer_Res_2011_Sep_13_13(5)_R87.nxml.txt.nlp	21914172	SENT168	16	16	8	8	neratinib	EGFR	PA165291472	1956	0.877
NULL	Acta_Histochem_Cytochem_2012_Apr_26_45(2)_139-146.nxml.txt.nlp	22685356	SENT35	42	42	2	2	forskolin	AQP2	PA146096022	359	0.877
NULL	Emerg_Infect_Dis_2012_Aug_18(8)_1290-1297.nxml.txt.nlp	22840274	SENT315	7	7	16	16	ciprofloxacin	GISP	PA449009	83998	0.877
NULL	Curr_Gerontol_Geriatr_Res_2012_Mar_4_2012_361218.nxml.txt.nlp	22474448	SENT130	14	14	6	6	estradiol	HSD1	PA449503	26871	0.877
NULL	Nat_Med_2011_Dec_4_18(1)_111-119.nxml.txt.nlp	22138751	SENT61	22	22	10	10	doxycycline	TERT	PA449415	7015	0.877
NULL	Biologics_2009_Jul_13_3_289-301.nxml.txt.nlp	19707416	SENT213	31	31	24	24	trastuzumab	HER2	PA451743	2064	0.877
NULL	Biomed_Res_Int_2014_Jan_20_2014_948427.nxml.txt.nlp	24563867	SENT83	2	2	30	30	buspirone	STZ	PA448689	6484	0.877
NULL	Environ_Health_Perspect_2009_Nov_26_117(11)_1737-1744.nxml.txt.nlp	20049126	SENT181	36	36	25	25	arsenite	KU70	PA452638	2547	0.877
NULL	Arthritis_Res_Ther_2009_Jun_23_11(3)_R95.nxml.txt.nlp	19549290	SENT216	22	22	11	11	rituximab	ACR	PA451261	49	0.877
NULL	Biomed_Res_Int_2013_Aug_6_2013_909613.nxml.txt.nlp	24027765	SENT8	24	24	3	3	metronidazole	IL-10	PA450484	3586	0.877
NULL	Mol_Cancer_2009_Nov_10_8_99.nxml.txt.nlp	19903356	SENT8	6	6	10	10	imatinib	IGFBP3	PA10804	3486	0.877
NULL	Front_Neurosci_2014_Jan_31_8_6.nxml.txt.nlp	24550768	SENT214	12	12	21	21	capsaicin	TRPV3	PA448776	162514	0.877
NULL	Nat_Commun_2013_Aug_15_4_2130.nxml.txt.nlp	23945651	SENT130	25	25	22	22	etoposide	ATG5	PA449552	9474	0.877
NULL	Crit_Care_2011_Mar_22_15(2)_211.nxml.txt.nlp	21457505	SENT211	0	0	13	13	bivalirudin	ACT	PA10032	12;11332;9457;641455	0.877
NULL	Crit_Care_2010_Mar_15_14(2)_R30.nxml.txt.nlp	20226064	SENT198	8	8	18	18	propofol	IL-10	PA451141	3586	0.877
NULL	Front_Psychiatry_2014_Jul_31_5_92.nxml.txt.nlp	25132823	SENT554	15	15	12	12	rimonabant	CB1	PA152407999	1268	0.877
NULL	Arthritis_Res_Ther_2006_Jul_21_8(4)_R130.nxml.txt.nlp	16859540	SENT99	2	2	9	9	atorvastatin	CD59	PA448500	966	0.877
NULL	Ann_Lab_Med_2012_Jul_20_32(4)_264-269.nxml.txt.nlp	22779067	SENT43	11	11	7	7	rifampin	DST	PA451250	667	0.877
NULL	Cardiovasc_Diabetol_2013_Mar_23_12_48.nxml.txt.nlp	23522121	SENT190	9	9	3	3	exenatide	NNT	PA164749238	23530	0.877
NULL	Mol_Cells_2014_Nov_30_37(11)_804-811.nxml.txt.nlp	25410909	SENT111	33	33	6	6	thrombin	PAR-1	PA451674	2011;2149	0.877
NULL	Nat_Commun_2014_Dec_8_5_5736.nxml.txt.nlp	25484020	SENT122	25	25	9	9	exemestane	TRPA1	PA449563	8989	0.877
NULL	Acta_Pharmacol_Sin_2010_Apr_22_31(4)_450-454.nxml.txt.nlp	20305679	SENT84	26	26	21	21	repaglinide	NOS1AP	PA451234	9722	0.877
NULL	Kidney_Int_Suppl_(2011)_2013_Dec_27_3(4)_392-409.nxml.txt.nlp	NULL	SENT653	5	5	25	25	resveratrol	OAT		4942	0.877
NULL	Curr_Mol_Med_2012_Jan_12(1)_96-110.nxml.txt.nlp	22082486	SENT228	6	6	1	1	olaparib	PARP1		142	0.877
NULL	Nat_Commun_2013_Sep_4_4_2338.nxml.txt.nlp	24005565	SENT552	26	26	3	3	etoposide	HELQ	PA449552	113510	0.877
NULL	J_Neuroinflammation_2010_Sep_7_7_51.nxml.txt.nlp	20822529	SENT13	2	2	14	14	hemin	HO-1	PA449849	3162	0.877
NULL	Curr_Chem_Genomics_2010_Mar_1_4_1-8.nxml.txt.nlp	20448812	SENT28	23	23	14	14	fluorescein	OATP1B3	PA164746009	28234	0.877
NULL	Breast_Cancer_Res_2011_Oct_25_13(5)_222.nxml.txt.nlp	22078011	SENT119	13	13	23	23	trastuzumab	CK19	PA451743	3880	0.877
NULL	Oxid_Med_Cell_Longev_2013_Nov_28_2013_568093.nxml.txt.nlp	24379901	SENT65	8	8	27	27	resveratrol	adiponectin		9370	0.877
NULL	Sci_Rep_2014_Dec_1_4_7270.nxml.txt.nlp	25434829	SENT51	25	25	15	15	naltrexone	5-HT1A	PA450588	3350	0.877
NULL	Oxid_Med_Cell_Longev_2013_Apr_21_2013_412576.nxml.txt.nlp	23710286	SENT103	8	8	14	14	curcumin	NRF2	PA151958596	2551;4780	0.877
NULL	Clin_Mol_Hepatol_2013_Dec_28_19(4)_417-420.nxml.txt.nlp	24459647	SENT75	12	12	22	22	terlipressin	HRS	PA164781020	6430	0.877
NULL	JAKSTAT_2014_Jun_12_3_e29554.nxml.txt.nlp	25105067	SENT104	19	19	5	5	propofol	p65	PA451141	5970	0.877
NULL	Gut_Liver_2011_Jun_24_5(2)_160-164.nxml.txt.nlp	21814595	SENT6	11	11	23	23	midazolam	ESD	PA450496	2098	0.877
NULL	J_Cancer_Prev_2013_Sep_18(3)_227-234.nxml.txt.nlp	25337550	SENT72	16	16	6	6	cisplatin	STAT1	PA449014	6772	0.877
NULL	Ann_Med_2011_Nov_5_43(7)_531-544.nxml.txt.nlp	21815879	SENT117	34	34	4	4	prasugrel	ADP	PA154410481	23038	0.877
NULL	Pharmaceuticals_(Basel)_2012_Feb_24_5(3)_279-296.nxml.txt.nlp	24281379	SENT20	12	12	18	18	clopidogrel	ADP	PA449053	23038	0.877
NULL	J_Cell_Biol_1998_May_4_141(3)_715-726.nxml.txt.nlp	9566971	SENT132	24	24	0	0	creatine	HER2	PA164778930	2064	0.877
NULL	J_Cell_Biol_1997_Mar_24_136(6)_1213-1226.nxml.txt.nlp	9087438	SENT148	16	16	10	10	chymotrypsin	p34	PA448994	902;79719	0.877
NULL	Int_J_Mol_Sci_2012_Sep_26_13(10)_12268-12286.nxml.txt.nlp	23202898	SENT183	1	1	12	12	lapatinib	AMPK	PA152241907	5563	0.877
NULL	Braz_J_Med_Biol_Res_2013_Dec_12_47(1)_24-34.nxml.txt.nlp	24345874	SENT24	8	8	3	3	doxorubicin	FANCF	PA449412	2188	0.877
NULL	Braz_J_Med_Biol_Res_2013_Jun_25_46(6)_507-512.nxml.txt.nlp	23802227	SENT133	8	8	34	34	propofol	TNF-alpha	PA451141	7124	0.877
NULL	Open_Access_J_Urol_2010_Aug_12_2_143-154.nxml.txt.nlp	24198622	SENT286	31	31	27	27	cisplatin	CS3	PA449014	91977	0.877
NULL	Front_Physiol_2010_Oct_14_1_135.nxml.txt.nlp	21423376	SENT1435	3	3	10	10	lidocaine	CD44	PA450226	960	0.877
NULL	Biomed_Res_Int_2014_Jan_20_2014_948427.nxml.txt.nlp	24563867	SENT209	23	23	5	5	buspirone	COB	PA448689	4519	0.877
NULL	Clin_Pharmacol_2011_Jun_22_3_13-25.nxml.txt.nlp	22287853	SENT206	17	17	22	22	ketoconazole	CYP3A4	PA450146	1576	0.877
NULL	Pharmaceuticals_(Basel)_2011_Jan_12_4(1)_187-201.nxml.txt.nlp	NULL	SENT165	29	29	22	22	l-arginine	NOS2	PA448478	339345;4843	0.877
NULL	Indian_J_Pharmacol_2012_Sep-Oct_44(5)_624-628.nxml.txt.nlp	23112426	SENT135	25	25	28	28	pravastatin	CYP3A4	PA451089	1576	0.877
NULL	Ann_Saudi_Med_2010_Mar-Apr_30(2)_162-164.nxml.txt.nlp	20220270	SENT4	30	30	15	15	glibenclamide	KCNJ11	PA449782	3767	0.877
NULL	Exp_Diabetes_Res_2012_Oct_15_2012_465282.nxml.txt.nlp	23118742	SENT4	17	17	10	10	metformin	FGF21	PA450395	26291	0.877
NULL	Onco_Targets_Ther_2014_Jun_11_7_969-983.nxml.txt.nlp	24959084	SENT115	9	9	20	20	itraconazole	CYP3A4	PA450132	1576	0.877
NULL	Indian_Dermatol_Online_J_2013_Jul-Sep_4(3)_246-249.nxml.txt.nlp	23984250	SENT38	40	40	26	26	panitumumab	EGFR	PA162373091	1956	0.877
NULL	Nat_Commun_2013_Oct_1_4_2516.nxml.txt.nlp	24084631	SENT50	14	14	18	18	losartan	CCN2	PA450268	1490	0.877
NULL	EMBO_Mol_Med_2013_Aug_4_5(8)_1180-1195.nxml.txt.nlp	23828858	SENT166	11	11	19	19	rituximab	MYC	PA451261	4609	0.877
NULL	Arch_Drug_Inf_2011_Mar_4(1)_1-9.nxml.txt.nlp	21572514	SENT41	12	12	7	7	colchicine	MDR1	PA449092	5243	0.877
NULL	Cancers_(Basel)_2010_May_26_2(2)_955-969.nxml.txt.nlp	24281101	SENT59	21	21	7	7	vincristine	BHD	PA451879	201163	0.877
NULL	Oncotarget_2013_Aug_24_4(10)_1618-1631.nxml.txt.nlp	24113128	SENT64	6	6	33	33	sorafenib	CD31	PA7000	5175	0.877
NULL	Onco_Targets_Ther_2014_Sep_9_7_1571-1582.nxml.txt.nlp	25228815	SENT128	13	13	20	20	sorafenib	VEGFR1	PA7000	2321	0.877
NULL	Br_J_Dermatol_2014_Feb_18_170(1)_342-351.nxml.txt.nlp	24547721	SENT132	19	19	4	4	esomeprazole	CLE	PA10075	51637	0.877
NULL	Onco_Targets_Ther_2014_Jun_20_7_1123-1127.nxml.txt.nlp	25018638	SENT5	17	17	11	11	vincristine	CHOP	PA451879	1649	0.877
NULL	Ann_Rheum_Dis_2009_Jan_18_68(1)_25-32.nxml.txt.nlp	18203761	SENT204	7	7	33	33	adalimumab	STAR	PA10004	6770;2984	0.877
NULL	Cell_Biochem_Biophys_2013_May_24_66(1)_53-63.nxml.txt.nlp	22918821	SENT22	2	2	35	35	lubiprostone	ClC-2	PA164777012	1181	0.877
NULL	N_Am_J_Med_Sci_2013_Sep_5(9)_499-504.nxml.txt.nlp	24251266	SENT111	6	6	18	18	vemurafenib	BRAF	PA165946873	673	0.877
NULL	Breast_Cancer_Res_2002_Jan_14_4(2)_65-69.nxml.txt.nlp	11879566	SENT2	6	6	18	18	estradiol	IL-6	PA449503	3569	0.877
NULL	J_Med_Case_Reports_2011_Jan_12_5_5.nxml.txt.nlp	21226894	SENT101	15	15	5	5	methotrexate	CHOP	PA450428	1649	0.877
NULL	Blood_Cancer_J_2012_Mar_23_2(3)_e63.nxml.txt.nlp	22829258	SENT24	41	41	6	6	hydroxyurea	BCS	PA449942	617	0.877
NULL	Ann_Rheum_Dis_2014_Mar_11_73(3)_536-543.nxml.txt.nlp	23316080	SENT195	7	7	33	33	adalimumab	STAR	PA10004	6770;2984	0.877
NULL	ASN_Neuro_2012_Dec_6_4(7)_e00102.nxml.txt.nlp	23240583	SENT127	14	14	18	18	geldanamycin	Hsp90	PA152031327	3320	0.877
NULL	Cancer_Immunol_Immunother_2013_Aug_27_62(10)_1637-1648.nxml.txt.nlp	23982484	SENT128	18	18	29	29	lenalidomide	IFN	PA162363968	3439	0.877
NULL	Br_J_Cancer_2011_Sep_6_105(6)_787-795.nxml.txt.nlp	21847125	SENT117	7	7	12	12	dextran	LAK	PA449261	10123	0.877
NULL	Mol_Cancer_2007_Oct_11_6_63.nxml.txt.nlp	17931419	SENT33	21	21	17	17	gefitinib	EGFR	PA131301952	1956	0.877
NULL	J_Carcinog_2014_Feb_7_13_1.nxml.txt.nlp	24737949	SENT88	23	23	35	35	paclitaxel	BRAF	PA450761	673	0.877
NULL	Cancers_(Basel)_2014_Nov_14_6(4)_2275-2295.nxml.txt.nlp	25405526	SENT231	30	30	14	14	vinblastine	CHOP	PA451877	1649	0.877
NULL	Breast_Cancer_Res_2007_Aug_8_9(4)_R50.nxml.txt.nlp	17686159	SENT13	9	9	14	14	gefitinib	HRG	PA131301952	3084;3273	0.877
NULL	J_Hematol_Oncol_2009_Dec_23_2_50.nxml.txt.nlp	20030851	SENT301	21	21	11	11	vincristine	CHOP	PA451879	1649	0.877
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT350	16	16	37	37	sertindole	PRL	PA164784002	5617	0.877
NULL	Nucleic_Acids_Res_2011_Sep_7_39(17)_7465-7476.nxml.txt.nlp	21653549	SENT29	18	18	2	2	doxorubicin	DEK	PA449412	7913	0.877
NULL	Mol_Cancer_2006_Oct_17_5_45.nxml.txt.nlp	17044934	SENT100	42	42	35	35	resveratrol	COX		1351	0.877
NULL	Cancer_Immunol_Immunother_2008_Jul_7_57(7)_931-950.nxml.txt.nlp	18256831	SENT423	13	13	18	18	dacarbazine	IL-2	PA449197	3558	0.877
NULL	Cell_Res_2013_Jun_21_23(6)_746-758.nxml.txt.nlp	23689277	SENT74	12	12	4	4	resveratrol	SIRT1		23411	0.877
NULL	Cell_Cycle_2013_May_15_12(10)_1492-1500.nxml.txt.nlp	23598717	SENT78	18	18	9	9	doxorubicin	ROCK2	PA449412	9475	0.877
NULL	Arthritis_Res_Ther_2010_Sep_8_12(5)_R167.nxml.txt.nlp	20825639	SENT240	39	39	20	20	resveratrol	AP-1		2353;3727;2354;3725	0.877
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT331	8	8	19	19	acetaminophen	ROS	PA448015	6098	0.877
NULL	Mol_Cancer_2010_Dec_20_9_317.nxml.txt.nlp	21172025	SENT97	33	33	23	23	tamoxifen	HER2	PA451581	2064	0.877
NULL	Exp_Ther_Med_2013_Apr_5_5(4)_1259-1263.nxml.txt.nlp	23596498	SENT105	23	23	26	26	propofol	TRPV1	PA451141	7442	0.877
NULL	J_Asthma_Allergy_2011_Sep_26_4_93-102.nxml.txt.nlp	22034573	SENT253	11	11	19	19	fluorescein	CD11c	PA164746009	3687	0.877
NULL	Drugs_2014_Nov_12_74(18)_2129-2139.nxml.txt.nlp	25389048	SENT77	25	25	2	2	tocilizumab	DREAM	PA165292659	30818	0.877
NULL	Indian_J_Pharm_Sci_2013_Jan-Feb_75(1)_94-98.nxml.txt.nlp	23901167	SENT30	8	8	30	30	tolbutamide	CYP1A2	PA451718	1544	0.877
NULL	Angiogenesis_2010_Dec_7_13(4)_305-315.nxml.txt.nlp	20927579	SENT3	7	7	20	20	resveratrol	TSP1		7057	0.877
NULL	Cancer_Imaging_2012_May_7_12(1)_163-172.nxml.txt.nlp	22571819	SENT94	26	26	8	8	sunitinib	EGFR	PA162372840	1956	0.877
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R91.nxml.txt.nlp	22541814	SENT142	32	32	4	4	thrombin	PAR1	PA451674	79581;2149	0.877
NULL	Int_J_Mol_Imaging_2011_Oct_26_2011_874585.nxml.txt.nlp	21490735	SENT79	15	15	7	7	tamoxifen	FDG	PA451581	23583	0.877
NULL	Indian_J_Pharm_Sci_2014_Jan-Feb_76(1)_72-77.nxml.txt.nlp	24799741	SENT117	13	13	8	8	diclofenac	CYP2C9	PA449293	1559	0.877
NULL	Oncotarget_2012_Jan_28_3(1)_78-83.nxml.txt.nlp	22289679	SENT85	6	6	1	1	gefitinib	EGFR	PA131301952	1956	0.877
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_650809.nxml.txt.nlp	23258995	SENT151	8	8	11	11	forskolin	AQP2	PA146096022	359	0.877
NULL	Front_Mol_Neurosci_2014_Oct_29_7_82.nxml.txt.nlp	25400545	SENT14	27	27	3	3	doxycycline	spatial	PA449415	219793	0.877
NULL	Cancer_Inform_2008_Jun_10_6_315-355.nxml.txt.nlp	19259415	SENT340	14	14	10	10	cisplatin	IL-8	PA449014	3576	0.877
NULL	Cell_Cycle_2013_Dec_15_12(24)_3791-3803.nxml.txt.nlp	24107631	SENT276	24	24	12	12	cisplatin	YB-1	PA449014	4904	0.877
NULL	J_Mol_Med_2008_Sep_4_86(9)_1045-1056.nxml.txt.nlp	18600309	SENT189	0	0	23	23	salmeterol	p65	PA451300	5970	0.877
NULL	Neural_Dev_2010_May_6_5_13.nxml.txt.nlp	20459606	SENT146	40	40	38	38	heparin	FGF2	PA449855	2247;2258	0.876
NULL	Biomed_Res_Int_2014_Jan_20_2014_948427.nxml.txt.nlp	24563867	SENT134	2	2	14	14	buspirone	5-HT1A	PA448689	3350	0.876
NULL	Basic_Clin_Pharmacol_Toxicol_2013_Sep_20_113(3)_179-186.nxml.txt.nlp	23639045	SENT35	14	14	26	26	lenalidomide	E14	PA162363968	4863	0.876
NULL	Front_Cell_Neurosci_2015_Jan_14_8_460.nxml.txt.nlp	25642167	SENT53	28	28	41	41	l-glutamine	CO2	PA10090	4513	0.876
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_29_2013_590393.nxml.txt.nlp	23737838	SENT193	25	25	9	9	resveratrol	p53		7157	0.876
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2675-2684.nxml.txt.nlp	24129246	SENT315	22	22	9	9	etoposide	KSR1	PA449552	8844	0.876
NULL	Front_Oncol_2014_May_7_4_95.nxml.txt.nlp	24847444	SENT343	24	24	6	6	cytarabine	CD19	PA449177	930	0.876
NULL	Comput_Struct_Biotechnol_J_2013_Feb_22_3_e201210020.nxml.txt.nlp	24688680	SENT97	0	0	26	26	naringenin	CHS	PA151958361	1130	0.876
NULL	Oncotarget_2011_Dec_20_2(12)_1075-1093.nxml.txt.nlp	22185818	SENT121	24	24	5	5	etoposide	ANXA2	PA449552	302	0.876
NULL	Allergy_Asthma_Clin_Immunol_2005_Jun_15_1(2)_65-80.nxml.txt.nlp	20529227	SENT66	13	13	7	7	trypsin	PAR2	PA451806	2150;55065;8856	0.876
NULL	Clin_Med_Insights_Womens_Health_2013_Jan_22_6_1-11.nxml.txt.nlp	24665209	SENT50	18	18	30	30	tamoxifen	aromatase	PA451581	1588	0.876
NULL	Environ_Health_Perspect_2010_Jul_3_118(7)_936-942.nxml.txt.nlp	20199942	SENT47	24	24	5	5	arsenite	p53	PA452638	7157	0.876
NULL	Scientifica_(Cairo)_2012_Nov_25_2012_473829.nxml.txt.nlp	24278698	SENT343	1	1	14	14	cisplatin	OCT1	PA449014	5451;6580	0.876
NULL	Korean_Circ_J_2013_Aug_31_43(8)_541-549.nxml.txt.nlp	24044013	SENT29	8	8	41	41	clopidogrel	CYP2C19	PA449053	1557	0.876
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_16_2012_395912.nxml.txt.nlp	23118789	SENT148	25	25	0	0	naproxen	UGT1A3	PA450595	54659	0.876
NULL	Environ_Health_Perspect_2006_Sep_23_114(9)_1401-1406.nxml.txt.nlp	16966095	SENT22	5	5	12	12	arsenite	p53	PA452638	7157	0.876
NULL	Acta_Pharmacol_Sin_2013_Mar_11_34(3)_403-413.nxml.txt.nlp	23396374	SENT231	0	0	6	6	curcumin	AP-1	PA151958596	2353;3727;2354;3725	0.876
NULL	Arthritis_Res_Ther_2010_Apr_29_12(2)_R73.nxml.txt.nlp	20429888	SENT172	0	0	19	19	bortezomib	COL1A2	PA10252	1278	0.876
NULL	Front_Cell_Neurosci_2014_Jul_8_8_188.nxml.txt.nlp	25071448	SENT230	9	9	1	1	estradiol	ANOVA	PA449503	4858	0.876
NULL	EMBO_Mol_Med_2013_Aug_5_5(8)_1213-1226.nxml.txt.nlp	23918228	SENT361	6	6	1	1	cetuximab	EGFR	PA10040	1956	0.876
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT27	3	3	7	7	heparin	FGF1	PA449855	2246	0.876
NULL	Clin_Pharmacokinet_2014_Oct_15_53(2)_155-164.nxml.txt.nlp	24127209	SENT29	6	6	26	26	clopidogrel	CYP3A4	PA449053	1576	0.876
NULL	Breast_Cancer_Res_2006_Nov_6_8(6)_215.nxml.txt.nlp	17096862	SENT95	2	2	12	12	pertuzumab	HER2		2064	0.876
NULL	Diabetes_Obes_Metab_2010_Aug_12(8)_700-708.nxml.txt.nlp	20590747	SENT190	29	29	24	24	voglibose	PPG	PA164752433	5552	0.876
NULL	J_Org_Chem_2011_Aug_19_76(16)_6703-6714.nxml.txt.nlp	21739961	SENT168	24	24	6	6	vanillin	mol	PA451852	90527	0.876
NULL	Arch_Plast_Surg_2012_Sep_12_39(5)_540-545.nxml.txt.nlp	23094252	SENT70	4	4	1	1	propofol	TCI	PA451141	6947	0.876
NULL	Oncotarget_2013_Apr_13_4(4)_502-530.nxml.txt.nlp	23594434	SENT511	20	20	25	25	nelfinavir	IL-18	PA450606	3606	0.876
NULL	Int_J_Gen_Med_2010_Nov_19_3_379-382.nxml.txt.nlp	21189835	SENT60	31	31	4	4	pravastatin	JBS	PA451089	3719	0.876
NULL	Clinics_(Sao_Paulo)_2012_Sep_67(9)_1029-1034.nxml.txt.nlp	23018299	SENT63	33	33	8	8	desflurane	CO2	PA164749136	4513	0.876
NULL	Oncol_Lett_2013_Oct_26_6(4)_1063-1067.nxml.txt.nlp	24137465	SENT9	22	22	7	7	afatinib	HER2	PA165981154	2064	0.876
NULL	Nat_Commun_2014_Aug_6_5_4602.nxml.txt.nlp	25098764	SENT644	22	22	11	11	chloroquine	TRAF2	PA448948	7186	0.876
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT169	5	5	13	13	glucose	EGFR	PA449773	1956	0.876
NULL	Gene_Regul_Syst_Bio_2014_Mar_4_8_63-73.nxml.txt.nlp	24634581	SENT135	10	10	15	15	minocycline	BNIP3	PA450519	664	0.876
NULL	J_Cancer_2012_Aug_24_3_354-361.nxml.txt.nlp	22962562	SENT169	6	6	13	13	fludarabine	p53	PA449655	7157	0.876
NULL	Mol_Cancer_2012_Sep_14_11_69.nxml.txt.nlp	22978347	SENT176	10	10	5	5	letrozole	TRAP1	PA450196	9392;10131	0.876
NULL	Br_J_Cancer_2006_Feb_13_94(3)_363-371.nxml.txt.nlp	16465172	SENT209	27	27	5	5	oxaliplatin	CRT	PA131285527	811	0.876
NULL	J_Korean_Med_Sci_2010_Sep_14_25(9)_1277-1283.nxml.txt.nlp	20808669	SENT166	2	2	13	13	pamidronate	IL-6	PA450767	3569	0.876
NULL	Oncotarget_2013_Nov_24_4(12)_2430-2438.nxml.txt.nlp	24280348	SENT100	7	7	20	20	gefitinib	STAT3	PA131301952	6774	0.876
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT108	14	14	29	29	trastuzumab	MUC4	PA451743	4585	0.876
NULL	Br_J_Pharmacol_2012_Apr_165(8)_2611-2619.nxml.txt.nlp	21718301	SENT16	9	9	15	15	rimonabant	GPR55	PA152407999	9290	0.876
NULL	Front_Oncol_2011_Jun_17_1_10.nxml.txt.nlp	22655230	SENT243	7	7	13	13	olaparib	BRCA2		675	0.876
NULL	Clin_Interv_Aging_2014_Nov_18_9_1963-1980.nxml.txt.nlp	25429208	SENT140	0	0	4	4	metformin	DPP4	PA450395	1803	0.876
NULL	Tuberc_Respir_Dis_(Seoul)_2014_Feb_27_76(2)_66-74.nxml.txt.nlp	24624215	SENT36	27	27	19	19	linezolid	HCAP	PA450233	117159;9126	0.876
NULL	Breast_Cancer_Res_Treat_2013_Jan_13_137(2)_471-482.nxml.txt.nlp	23239151	SENT2	8	8	17	17	pazopanib	HER2	PA165291492	2064	0.876
NULL	J_Oncol_2011_Dec_5_2011_465343.nxml.txt.nlp	21188169	SENT186	12	12	17	17	gemcitabine	CXCR4	PA449748	7852	0.876
NULL	F1000_Med_Rep_2012_Feb_1_4_4.nxml.txt.nlp	22312414	SENT114	0	0	12	12	vancomycin	VISA	PA451850	57506	0.876
NULL	Cancer_Res_Treat_2015_Jan_21_47(1)_55-63.nxml.txt.nlp	25187267	SENT123	19	19	9	9	goserelin	VIII	PA164747674	1351	0.876
NULL	Breast_Cancer_Res_2004_Jul_29_6(5)_204-210.nxml.txt.nlp	15318926	SENT102	22	22	7	7	tamoxifen	EGFR	PA451581	1956	0.876
NULL	J_Cancer_2013_Aug_28_4(7)_585-596.nxml.txt.nlp	24069069	SENT153	6	6	19	19	verteporfin	LC3	PA451871	84557	0.876
NULL	Cancer_Immunol_Immunother_2015_Oct_7_64_61-73.nxml.txt.nlp	25287778	SENT258	21	21	5	5	lenalidomide	IFN	PA162363968	3439	0.876
NULL	Oncoimmunology_2013_Dec_1_2(12)_e27058.nxml.txt.nlp	24498564	SENT59	18	18	29	29	cyclophosphamide	THBS1	PA449165	7057	0.876
NULL	Am_J_Case_Rep_2014_Jan_10_15_7-12.nxml.txt.nlp	24454975	SENT130	0	0	15	15	imatinib	CD117	PA10804	3815	0.876
NULL	Org_Med_Chem_Lett_2014_Feb_28_4_1.nxml.txt.nlp	24576663	SENT65	29	29	6	6	ethanol	mol	PA448073	90527	0.876
NULL	Comp_Hepatol_2004_Jan_14_3(Suppl_1)_S21.nxml.txt.nlp	14960173	SENT53	24	24	6	6	simvastatin	RhoA	PA451363	387	0.876
NULL	Breast_Cancer_Res_2011_Oct_12_13(5)_220.nxml.txt.nlp	22018398	SENT34	2	2	7	7	trastuzumab	JAK2	PA451743	3717	0.876
NULL	Exp_Brain_Res_2014_Jun_27_232(8)_2637-2644.nxml.txt.nlp	24969614	SENT27	18	18	13	13	palonosetron	NK1	PA10352	11126	0.876
NULL	Onco_Targets_Ther_2014_Sep_9_7_1571-1582.nxml.txt.nlp	25228815	SENT155	32	32	27	27	sunitinib	VEGFA	PA162372840	7422	0.876
NULL	Diabetes_Care_2013_Aug_17_36(Suppl_2)_S180-S189.nxml.txt.nlp	23882044	SENT202	7	7	31	31	metformin	GLP-1	PA450395	100125288	0.876
NULL	Acta_Pharmacol_Sin_2011_Jul_13_32(7)_967-972.nxml.txt.nlp	21666702	SENT131	17	17	6	6	losartan	P-gp	PA450268	5243	0.876
NULL	Br_J_Cancer_2010_Feb_2_102(3)_513-519.nxml.txt.nlp	20051960	SENT16	14	14	27	27	trastuzumab	HER2	PA451743	2064	0.876
NULL	Ann_Dermatol_2011_Oct_31_23(Suppl_2)_S169-S174.nxml.txt.nlp	22148042	SENT104	17	17	11	11	doxorubicin	CHOP	PA449412	1649	0.876
NULL	Biomed_Res_Int_2014_May_29_2014_768758.nxml.txt.nlp	24971349	SENT73	6	6	3	3	plerixafor	CXCR4	PA165958410	7852	0.876
NULL	Curr_HIV_Res_2014_May_12(3)_174-188.nxml.txt.nlp	24862327	SENT147	14	14	31	31	hemin	HO-1	PA449849	3162	0.876
NULL	Ann_Hematol_2010_Nov_25_89(11)_1115-1124.nxml.txt.nlp	20499237	SENT149	17	17	20	20	simvastatin	ZAP-70	PA451363	7535	0.876
NULL	Diabetes_Metab_J_2014_Apr_18_38(2)_100-106.nxml.txt.nlp	24851203	SENT91	12	12	0	0	glucose	MET	PA449773	4233	0.876
NULL	Nature_2008_Jan_17_451(7176)_335-339.nxml.txt.nlp	18202658	SENT25	11	11	3	3	lenalidomide	RPS14	PA162363968	6208	0.876
NULL	Front_Mol_Neurosci_2009_Oct_23_2_16.nxml.txt.nlp	19893765	SENT114	18	18	2	2	forskolin	Rog	PA146096022	27033	0.876
NULL	Jpn_Clin_Med_2014_Sep_17_5_33-41.nxml.txt.nlp	25288908	SENT3	11	11	5	5	sitagliptin	GLP-1	PA164748978	100125288	0.876
NULL	EMBO_Mol_Med_2013_Jul_16_5(7)_1019-1034.nxml.txt.nlp	23681745	SENT112	0	0	35	35	lapatinib	ERBB4	PA152241907	2066	0.876
NULL	Biomed_Res_Int_2014_Jan_20_2014_948427.nxml.txt.nlp	24563867	SENT200	23	23	5	5	buspirone	COB	PA448689	4519	0.876
NULL	Pharmaceuticals_(Basel)_2011_Nov_10_4(11)_1488-1502.nxml.txt.nlp	NULL	SENT109	12	12	24	24	geldanamycin	HER2	PA152031327	2064	0.876
NULL	Springerplus_2013_Jan_11_2_5.nxml.txt.nlp	23520572	SENT129	19	19	12	12	tamoxifen	aromatase	PA451581	1588	0.876
NULL	EJC_Suppl_2013_Sep_5_11(2)_45-59.nxml.txt.nlp	NULL	SENT553	21	21	14	14	capecitabine	CRT	PA448771	811	0.876
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_105-115.nxml.txt.nlp	17912640	SENT146	15	15	26	26	tamoxifen	aromatase	PA451581	1588	0.876
NULL	Oncotarget_2014_Aug_19_5(18)_8737-8749.nxml.txt.nlp	25228590	SENT79	29	29	24	24	doxycycline	MYCN	PA449415	4613	0.876
NULL	Mol_Cancer_2013_Sep_11_12_104.nxml.txt.nlp	24025152	SENT222	13	13	4	4	gemcitabine	STAT3	PA449748	6774	0.876
NULL	J_Cancer_2013_Nov_23_4(9)_736-754.nxml.txt.nlp	24312144	SENT118	13	13	40	40	erlotinib	Met	PA134687924	79811	0.876
NULL	Int_J_Endocrinol_2010_Mar_2_2010_621687.nxml.txt.nlp	20204178	SENT168	2	2	7	7	paricalcitol	PTH	PA450798	5741	0.876
NULL	Cancer_Immunol_Immunother_2013_Aug_27_62(10)_1637-1648.nxml.txt.nlp	23982484	SENT219	20	20	32	32	lenalidomide	IL-6	PA162363968	3569	0.876
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1522-1532.nxml.txt.nlp	21997136	SENT256	8	8	3	3	gefitinib	EGFR	PA131301952	1956	0.876
NULL	J_Health_Popul_Nutr_2007_Jun_25(2)_179-188.nxml.txt.nlp	17985819	SENT69	16	16	5	5	trimethoprim	Spn	PA451788	84687	0.876
NULL	J_Oncol_2012_Mar_26_2012_198412.nxml.txt.nlp	22536237	SENT82	32	32	16	16	trastuzumab	HER2	PA451743	2064	0.876
NULL	J_Korean_Med_Sci_2013_Apr_27_28(4)_527-533.nxml.txt.nlp	23580227	SENT149	6	6	11	11	genistein	TRAIL	PA165109660	8743	0.876
NULL	J_Mol_Signal_2008_Dec_1_3_18.nxml.txt.nlp	19046439	SENT45	15	15	6	6	metformin	AMPK	PA450395	5563	0.876
NULL	Ann_Clin_Transl_Neurol_2014_Jan_20_1(1)_15-26.nxml.txt.nlp	25356379	SENT116	9	9	19	19	isoflurane	gamma	PA450106	9913	0.876
NULL	Mar_Drugs_2014_Oct_17_12(10)_5240-5257.nxml.txt.nlp	25329706	SENT236	14	14	32	32	calcein	TES	PA132595336	26136	0.876
NULL	Cancer_Cell_Int_2005_Aug_23_5_27.nxml.txt.nlp	16117829	SENT139	16	16	10	10	doxycycline	p53	PA449415	7157	0.876
NULL	Chin_J_Cancer_2012_Jun_31(6)_306-314.nxml.txt.nlp	22640627	SENT148	7	7	18	18	rituximab	Bcl-2	PA451261	596	0.876
NULL	Int_J_Endocrinol_Metab_2014_Apr_1_12(2)_e14098.nxml.txt.nlp	24803942	SENT121	11	11	23	23	vasopressin	AVP	PA451858	114548;551	0.876
NULL	Mol_Biol_Cell_2014_Jun_1_25(11)_1782-1792.nxml.txt.nlp	24719457	SENT29	5	5	13	13	nicotine	ASCL1	PA450626	429	0.876
NULL	Carcinogenesis_2010_Dec_15_31(12)_2031-2038.nxml.txt.nlp	20952512	SENT62	37	37	13	13	camptothecin	XRCC3	PA153590860	7517	0.876
NULL	Cancer_Med_2013_Feb_3_2(1)_11-20.nxml.txt.nlp	24133623	SENT163	13	13	5	5	panitumumab	KRAS	PA162373091	3845	0.876
NULL	J_Cell_Mol_Med_2013_Oct_2_17(10)_1218-1235.nxml.txt.nlp	23998913	SENT316	27	27	3	3	hydroxyurea	PDGFRA	PA449942	5156	0.876
NULL	Int_J_Biomed_Sci_2014_Sep_10(3)_146-157.nxml.txt.nlp	25324695	SENT204	39	39	42	42	lovastatin	LFA-1	PA450272	3683;3689	0.876
NULL	Anticancer_Agents_Med_Chem_2013_Jun_13(5)_681-688.nxml.txt.nlp	23092289	SENT223	13	13	35	35	rituximab	HER2	PA451261	2064	0.876
NULL	Int_J_Biol_Sci_2013_Nov_16_9(10)_1070-1078.nxml.txt.nlp	24250252	SENT156	24	24	29	29	lipase	adiponectin	PA450239	9370	0.876
NULL	J_Cereb_Blood_Flow_Metab_2014_Oct_23_34(10)_1688-1694.nxml.txt.nlp	25052553	SENT103	2	2	19	19	losartan	SMAD1	PA450268	2617;4086	0.876
NULL	Braz_J_Med_Biol_Res_2013_May_10_46(5)_433-439.nxml.txt.nlp	23681290	SENT182	7	7	20	20	bezafibrate	IL-10	PA162364313	3586	0.876
NULL	Cardiovasc_Diabetol_2013_Mar_23_12_48.nxml.txt.nlp	23522121	SENT173	11	11	1	1	exenatide	NNT	PA164749238	23530	0.876
NULL	Cancer_2014_Jun_15_120(12)_1871-1880.nxml.txt.nlp	24634003	SENT124	20	20	23	23	sunitinib	IFN	PA162372840	3439	0.876
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT141	0	0	2	2	metformin	ADP	PA450395	23038	0.876
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT226	14	14	33	33	bevacizumab	VEGFR2	PA130232992	3791	0.876
NULL	Psychiatry_Investig_2009_Mar_31_6(1)_39-43.nxml.txt.nlp	20046372	SENT31	4	4	8	8	sibutramine	GNB3	PA451344	2784	0.876
NULL	Cancer_Cell_Int_2013_Mar_4_13_21.nxml.txt.nlp	23497288	SENT59	22	22	3	3	doxorubicin	EWS	PA449412	2130	0.876
NULL	Ann_Clin_Microbiol_Antimicrob_2007_Nov_11_6_14.nxml.txt.nlp	17996119	SENT145	6	6	3	3	ethanol	MUC7	PA448073	4589	0.876
NULL	Biomed_Res_Int_2014_Jun_3_2014_459823.nxml.txt.nlp	25025052	SENT145	25	25	18	18	lipase	LIPA	PA450239	3988;10648	0.876
NULL	J_Clin_Biochem_Nutr_2009_Jul_30_45(1)_37-43.nxml.txt.nlp	19590705	SENT245	0	0	16	16	taurine	p47	PA451590	3621;55968	0.876
NULL	Cancer_Metastasis_Rev_2014_Apr_18_33(2-3)_695-720.nxml.txt.nlp	24744103	SENT310	33	33	40	40	gefitinib	EGFR	PA131301952	1956	0.876
NULL	Front_Cell_Neurosci_2014_Feb_6_8_27.nxml.txt.nlp	24567703	SENT1546	0	0	3	3	bumetanide	NKCC1	PA448682	6558	0.876
NULL	Nucleic_Acids_Res_2013_Dec_4_41(22)_10124-10134.nxml.txt.nlp	24005039	SENT86	29	29	16	16	ethanol	CYC1	PA448073	1537	0.876
NULL	ISRN_Otolaryngol_2012_Oct_16_2012_706896.nxml.txt.nlp	23762616	SENT24	16	16	23	23	vasopressin	AQP5	PA451858	362	0.876
NULL	Cell_Res_2014_Jul_9_24(7)_820-841.nxml.txt.nlp	24810299	SENT129	31	31	16	16	doxycycline	Hes1	PA449415	3280	0.876
NULL	eLife_2014_May_20_3_e01763.nxml.txt.nlp	24844244	SENT339	12	12	3	3	doxycycline	MELK	PA449415	9833	0.876
NULL	Nat_Med_2013_Oct_8_19(10)_1313-1317.nxml.txt.nlp	24013700	SENT18	22	22	13	13	ribavirin	IFN	PA451241	3439	0.876
NULL	Biomed_Res_Int_2013_Dec_16_2013_741403.nxml.txt.nlp	24455721	SENT60	25	25	9	9	clarithromycin	CYP3A4	PA449028	1576	0.876
NULL	Acta_Pharmacol_Sin_2013_Sep_5_34(9)_1192-1200.nxml.txt.nlp	23685957	SENT18	0	0	13	13	curcumin	AP-2	PA151958596	7020	0.876
NULL	Indian_J_Pharm_Sci_2008_Jan-Feb_70(1)_102-105.nxml.txt.nlp	20390092	SENT75	2	2	0	0	lansoprazole	LAN	PA450180	9993	0.876
NULL	Clin_Sci_(Lond)_2013_Feb_1_124(Pt_3)_153-164.nxml.txt.nlp	23075334	SENT117	5	5	12	12	resveratrol	SIRT1		23411	0.876
NULL	Ann_Oncol_2013_Aug_12_24(8)_1994-1999.nxml.txt.nlp	23670096	SENT1	17	17	12	12	tamoxifen	AIB1	PA451581	8202	0.876
NULL	Cancer_Cell_Int_2013_Jan_15_13_3.nxml.txt.nlp	23320839	SENT132	7	7	19	19	dasatinib	ABCG2	PA162372878	9429	0.876
NULL	Clin_Dev_Immunol_2011_Mar_28_2011_370872.nxml.txt.nlp	21461372	SENT103	20	20	4	4	tetracycline	IL-6	PA451640	3569	0.876
NULL	Cancers_(Basel)_2011_Apr_1_3(2)_1844-1860.nxml.txt.nlp	24212785	SENT71	36	36	23	23	cetuximab	KRAS	PA10040	3845	0.876
NULL	Arthritis_Res_Ther_2014_Sep_26_16(5)_429.nxml.txt.nlp	25606593	SENT106	0	0	14	14	tocilizumab	ADAMTS4	PA165292659	9507	0.876
NULL	AIDS_Res_Ther_2013_May_16_10_13.nxml.txt.nlp	23680529	SENT30	17	17	26	26	ritonavir	ATV	PA451260	4683	0.876
NULL	Ther_Clin_Risk_Manag_2006_Jun_2(2)_129-158.nxml.txt.nlp	18360588	SENT213	9	9	11	11	voriconazole	CYP3A4	PA10233	1576	0.876
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Dec_10_3(12)_e151.nxml.txt.nlp	25494035	SENT252	8	8	23	23	fluvastatin	OATP2B1	PA449688	11309	0.876
NULL	Cancers_(Basel)_2014_Feb_26_6(1)_436-458.nxml.txt.nlp	24577242	SENT986	37	37	26	26	cisplatin	Mcl-1	PA449014	4170	0.876
NULL	Br_J_Cancer_2012_Feb_14_106(4)_685-692.nxml.txt.nlp	22294184	SENT130	20	20	10	10	lovastatin	JNK	PA450272	5599	0.876
NULL	Cancer_Growth_Metastasis_2014_Jun_19_7_27-32.nxml.txt.nlp	25002816	SENT47	21	21	40	40	ethanol	LLC1	PA448073	128602	0.876
NULL	Genome_Biol_2008_Nov_25_9(11)_R166.nxml.txt.nlp	19032775	SENT42	4	4	15	15	suramin	EGFR	PA10292	1956	0.876
NULL	Cancer_Cell_Int_2014_Jul_2_14_59.nxml.txt.nlp	25120382	SENT196	20	20	22	22	metformin	Met	PA450395	79811	0.876
NULL	eLife_2014_May_6_3_e02482.nxml.txt.nlp	24843002	SENT603	6	6	12	12	etoposide	53BP1	PA449552	7158	0.876
NULL	Ann_Dermatol_2014_Dec_26_26(6)_706-712.nxml.txt.nlp	25473222	SENT120	33	33	22	22	isotretinoin	EPO	PA450128	7076;8288;2056	0.876
NULL	An_Bras_Dermatol_2014_Jan-Feb_89(1)_118-125.nxml.txt.nlp	24626656	SENT81	0	0	8	8	thalidomide	LEP	PA451644	3952	0.876
NULL	Int_J_Biol_Sci_2015_Jan_1_11(1)_48-58.nxml.txt.nlp	25552929	SENT180	6	6	14	14	paclitaxel	TSP-1	PA450761	7057	0.876
NULL	Oncol_Rep_2012_Aug_22_28(2)_439-445.nxml.txt.nlp	22641525	SENT35	13	13	24	24	cyclophosphamide	San	PA449165	80218	0.876
NULL	Cancers_(Basel)_2011_Oct_19_3(4)_3909-3920.nxml.txt.nlp	24213117	SENT212	8	8	0	0	cisplatin	ZNF143	PA449014	7702	0.876
NULL	Diabetes_Care_2013_Aug_17_36(Suppl_2)_S245-S252.nxml.txt.nlp	23882053	SENT87	25	25	21	21	exenatide	GLP-1	PA164749238	100125288	0.876
NULL	Biochem_Res_Int_2012_Mar_4_2012_685267.nxml.txt.nlp	22496978	SENT211	13	13	16	16	thrombin	PI3K	PA451674	5290	0.876
NULL	Eur_J_Haematol_2008_Feb_80(2)_93-106.nxml.txt.nlp	18081719	SENT158	18	18	8	8	iron	MRI	PA450087	78996	0.876
NULL	Oxid_Med_Cell_Longev_2013_Mar_7_2013_148725.nxml.txt.nlp	23533683	SENT164	28	28	7	7	ethanol	IFNAR1	PA448073	3454	0.876
NULL	J_Oncol_2010_Dec_15_2010_821717.nxml.txt.nlp	20049172	SENT163	16	16	23	23	paclitaxel	TUBB3	PA450761	10381	0.876
NULL	Ther_Clin_Risk_Manag_2006_Jun_2(2)_129-158.nxml.txt.nlp	18360588	SENT161	6	6	8	8	voriconazole	CYP3A4	PA10233	1576	0.876
NULL	Mol_Biol_Cell_2012_Sep_1_23(17)_3370-3379.nxml.txt.nlp	22809625	SENT91	21	21	33	33	paraformaldehyde	CD2AP	PA450790	23607	0.876
NULL	Gastroenterol_Hepatol_Bed_Bench_2011_Spring_4(2)_43-52.nxml.txt.nlp	24834156	SENT102	0	0	23	23	trypsin	TATI	PA451806	6690	0.876
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S279-S284.nxml.txt.nlp	21525469	SENT180	13	13	18	18	liraglutide	GLP-1	PA165958364	100125288	0.876
NULL	EJC_Suppl_2013_Sep_5_11(2)_307-309.nxml.txt.nlp	NULL	SENT50	8	8	30	30	afatinib	EGFR	PA165981154	1956	0.876
NULL	Nucleic_Acids_Res_2011_Dec_2_39(22)_9549-9558.nxml.txt.nlp	21890893	SENT49	14	14	22	22	resveratrol	SIRT1		23411	0.876
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jan_12_67(Pt_2)_o365.nxml.txt.nlp	21523043	SENT56	21	21	16	16	ethanol	mol	PA448073	90527	0.876
NULL	ScientificWorldJournal_2012_Apr_26_2012_215231.nxml.txt.nlp	22629121	SENT29	18	18	7	7	doxorubicin	CHOP	PA449412	1649	0.876
NULL	Mol_Immunol_2009_Apr_46(7)_1561-1567.nxml.txt.nlp	19200600	SENT166	24	24	17	17	dextran	CD59	PA449261	966	0.876
NULL	COPD_2009_Jun_27_6(3)_211-225.nxml.txt.nlp	19811377	SENT139	6	6	25	25	tiotropium	TDI	PA164769056	100038246	0.876
NULL	Breast_Cancer_Res_2010_Jun_28_12(3)_R43.nxml.txt.nlp	20579400	SENT253	27	27	11	11	paclitaxel	MAPT	PA450761	4137	0.876
NULL	Biomed_Res_Int_2014_Jan_29_2014_831845.nxml.txt.nlp	24605337	SENT112	12	12	5	5	bupivacaine	S6K1	PA135057240	6198	0.876
NULL	Front_Mol_Neurosci_2012_Nov_12_5_99.nxml.txt.nlp	23162427	SENT726	19	19	22	22	cocaine	CRF1	PA449072	1394	0.876
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_33-43.nxml.txt.nlp	17912634	SENT90	12	12	2	2	letrozole	aromatase	PA450196	1588	0.876
NULL	Exp_Mol_Med_2012_Aug_31_44(8)_473-482.nxml.txt.nlp	22627808	SENT13	9	9	23	23	lapatinib	HER2	PA152241907	2064	0.876
NULL	Oncotarget_2014_Oct_21_5(22)_11252-11268.nxml.txt.nlp	25361004	SENT183	4	4	0	0	metformin	CLIC1	PA450395	1192	0.876
NULL	Emerg_Infect_Dis_2013_Jul_19(7)_1151-1152.nxml.txt.nlp	23763791	SENT19	24	24	19	19	rifampin	DST	PA451250	667	0.876
NULL	Libyan_J_Med_2006_Jul_28_1(1)_42-59.nxml.txt.nlp	21526020	SENT203	14	14	23	23	irinotecan	IFL	PA450085	3439	0.876
NULL	J_Cell_Biol_2000_Jan_10_148(1)_173-188.nxml.txt.nlp	10629227	SENT5	7	7	37	37	estradiol	p120ctn	PA449503	1500	0.876
NULL	J_Exp_Bot_2012_Jan_7_63(2)_941-961.nxml.txt.nlp	22068145	SENT102	5	5	15	15	ethanol	CO2	PA448073	4513	0.876
NULL	Environ_Health_Perspect_2005_Sep_7_113(9)_1125-1133.nxml.txt.nlp	16140616	SENT207	28	28	17	17	genistein	DES	PA165109660	1674	0.876
NULL	Indian_J_Endocrinol_Metab_2013_May-Jun_17(3)_402-412.nxml.txt.nlp	23869295	SENT167	23	23	41	41	clopidogrel	PON1	PA449053	5444	0.876
NULL	Neural_Regen_Res_2014_May_15_9(10)_1055-1062.nxml.txt.nlp	25206759	SENT218	33	33	23	23	bumetanide	KCC2	PA448682	57468	0.876
NULL	Anesth_Essays_Res_2013_Sep-Dec_7(3)_302-306.nxml.txt.nlp	NULL	SENT108	0	0	13	13	neostigmine	NMB	PA450611	10457;4828	0.876
NULL	J_Gen_Physiol_2008_May_131(5)_421-429.nxml.txt.nlp	18411332	SENT136	0	0	16	16	capsaicin	TRPV1	PA448776	7442	0.876
NULL	J_Cachexia_Sarcopenia_Muscle_2010_Sep_26_1(1)_43-128.nxml.txt.nlp	22477519	SENT1022	2	2	27	27	theophylline	TNF-alpha	PA451647	7124	0.876
NULL	Aging_(Albany_NY)_2009_Mar_31_1(4)_412-424.nxml.txt.nlp	20195491	SENT206	2	2	8	8	resveratrol	TXNIP		10628	0.876
NULL	BioData_Min_2008_Jul_17_1_2.nxml.txt.nlp	18822146	SENT190	12	12	25	25	ethanol	MTHFR	PA448073	4524	0.876
NULL	Front_Genet_2012_Sep_11_3_177.nxml.txt.nlp	22973301	SENT133	42	42	3	3	resveratrol	AMPK		5563	0.876
NULL	Acta_Pharmacol_Sin_2012_Mar_27_33(3)_342-350.nxml.txt.nlp	22367283	SENT193	27	27	21	21	thrombin	PAR3	PA451674	56288;2151	0.876
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT154	2	2	5	5	dasatinib	LYN	PA162372878	4067	0.876
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT235	10	10	4	4	cisplatin	IBP	PA449014	706;50619	0.876
NULL	Core_Evid_2010_Oct_21_5_61-76.nxml.txt.nlp	21042543	SENT253	23	23	11	11	cetuximab	PTEN	PA10040	5728	0.876
NULL	Front_Oncol_2013_Oct_1_3_237.nxml.txt.nlp	24098868	SENT329	24	24	30	30	olaparib	BRCA2		675	0.876
NULL	J_Cell_Biol_2005_Jun_20_169(6)_871-884.nxml.txt.nlp	15967811	SENT97	13	13	40	40	arsenite	TIAR	PA452638	7073	0.876
NULL	Mol_Cancer_2013_Mar_5_12_17.nxml.txt.nlp	23497256	SENT185	13	13	27	27	sunitinib	HDM2	PA162372840	4193	0.876
NULL	Oncogenesis_2012_Apr_2_1(4)_e5.nxml.txt.nlp	23552603	SENT241	23	23	33	33	ns-398	MCL1		4170	0.876
NULL	Arthritis_Res_Ther_2006_Jul_17_8(4)_R107.nxml.txt.nlp	16846531	SENT168	0	0	27	27	thrombin	CXCL8	PA451674	3576	0.876
NULL	J_Biol_Chem_2012_Apr_6_287(15)_12433-12444.nxml.txt.nlp	22351758	SENT474	13	13	16	16	hyaluronan	TSG-6	PA165958431	7130	0.876
NULL	Cancer_Manag_Res_2012_Nov_9_4_383-395.nxml.txt.nlp	23204869	SENT236	12	12	3	3	carmustine	PC-3	PA448810	692094	0.876
NULL	Oncotarget_2012_May_4_3(4)_395-398.nxml.txt.nlp	22565037	SENT20	37	37	15	15	metformin	CD44	PA450395	960	0.876
NULL	Neural_Dev_2010_May_6_5_13.nxml.txt.nlp	20459606	SENT82	41	41	39	39	heparin	FGF2	PA449855	2247;2258	0.876
NULL	Oncol_Rep_2013_Sep_1_30(3)_1045-1052.nxml.txt.nlp	23817662	SENT137	37	37	6	6	gefitinib	EGFR	PA131301952	1956	0.876
NULL	Clin_Transl_Allergy_2013_Sep_2_3_29.nxml.txt.nlp	24004581	SENT180	0	0	17	17	omalizumab	IL-4	PA164752253	3565	0.876
NULL	Iran_Red_Crescent_Med_J_2014_Sep_5_16(9)_e20153.nxml.txt.nlp	25593732	SENT74	15	15	2	2	halothane	CYP2E1	PA449845	1571	0.876
NULL	Clinics_(Sao_Paulo)_2013_Feb_68(2)_253-262.nxml.txt.nlp	23525324	SENT161	17	17	21	21	genistein	Gen	PA165109660	348654	0.876
NULL	J_Biomed_Biotechnol_2010_May_27_2010_932527.nxml.txt.nlp	20589070	SENT340	34	34	5	5	mannitol	SPS2	PA450320	22928	0.876
NULL	BMB_Rep_2014_Apr_47(4)_221-226.nxml.txt.nlp	24286312	SENT23	26	26	12	12	cisplatin	p53	PA449014	7157	0.876
NULL	J_Cell_Biol_1998_May_18_141(4)_849-862.nxml.txt.nlp	9585405	SENT80	26	26	11	11	paraformaldehyde	CLIP-170	PA450790	6249	0.876
NULL	Patient_Prefer_Adherence_2011_Dec_23_6_1-9.nxml.txt.nlp	22272064	SENT3	34	34	26	26	ramipril	ACE	PA451223	1636	0.876
NULL	Biomed_Res_Int_2014_Jan_20_2014_948427.nxml.txt.nlp	24563867	SENT95	3	3	26	26	buspirone	STZ	PA448689	6484	0.876
NULL	J_Thromb_Haemost_2011_Oct_9(10)_2103-2105.nxml.txt.nlp	21812912	SENT15	9	9	18	18	ticagrelor	ADP	PA165374673	23038	0.876
NULL	Breast_Cancer_Res_2005_May_24_7(5)_R589-R597.nxml.txt.nlp	16168102	SENT136	20	20	30	30	doxorubicin	HER2	PA449412	2064	0.876
NULL	Br_J_Cancer_2004_May_4_90(9)_1710-1714.nxml.txt.nlp	15150625	SENT10	20	20	17	17	oxaliplatin	GEM	PA131285527	2669	0.876
NULL	Evid_Based_Complement_Alternat_Med_2011_Jan_20_2011_713523.nxml.txt.nlp	21318104	SENT117	5	5	0	0	naproxen	SRM	PA450595	6723;6725	0.876
NULL	Mol_Cancer_2007_Jan_14_6_5.nxml.txt.nlp	17222355	SENT205	8	8	29	29	doxorubicin	HMGA2	PA449412	8091	0.876
NULL	Clin_Med_Insights_Oncol_2012_Mar_19_6_165-178.nxml.txt.nlp	22474408	SENT220	7	7	12	12	cyclophosphamide	GM-CSF	PA449165	1437	0.876
NULL	Cell_Death_Dis_2010_May_13_1(5)_e41.nxml.txt.nlp	21364648	SENT147	18	18	12	12	etoposide	p53	PA449552	7157	0.876
NULL	Reprod_Biol_Endocrinol_2004_Aug_24_2_61.nxml.txt.nlp	15327693	SENT62	30	30	19	19	glutaraldehyde	HE2	PA449777	653423;10407	0.876
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Sep_26_65(Pt_10)_o2518.nxml.txt.nlp	21577965	SENT66	24	24	6	6	ethanol	mol	PA448073	90527	0.876
NULL	Nat_Genet_2011_Feb_26_43(2)_117-120.nxml.txt.nlp	21186350	SENT24	22	22	18	18	metformin	AMPK	PA450395	5563	0.876
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jan_12_67(Pt_2)_o336.nxml.txt.nlp	21523019	SENT73	33	33	22	22	ethanol	mol	PA448073	90527	0.876
NULL	J_Cell_Biol_1998_Jul_13_142(1)_85-100.nxml.txt.nlp	9660865	SENT40	15	15	30	30	doxycycline	RhoA	PA449415	387	0.876
NULL	Int_J_Mol_Sci_2014_Jun_5_15(6)_10083-10100.nxml.txt.nlp	24905407	SENT220	34	34	18	18	tetracycline	STP	PA451640	9322	0.876
NULL	J_Neural_Transm_2014_Mar_27_121(10)_1221-1232.nxml.txt.nlp	24671607	SENT242	6	6	0	0	ethanol	PSD-95	PA448073	1742	0.876
NULL	Nat_Med_2013_Dec_3_19(12)_10_1038_nm_3384.nxml.txt.nlp	24185693	SENT398	6	6	12	12	furosemide	UMOD	PA449719	7369	0.876
NULL	Biologics_2012_Jun_20_6_137-146.nxml.txt.nlp	22807624	SENT49	8	8	2	2	cisplatin	VEGFR	PA449014	3791	0.876
NULL	Angiogenesis_2013_Apr_10_16(2)_373-386.nxml.txt.nlp	23143659	SENT258	28	28	5	5	etoposide	LDM	PA449552	1595	0.876
NULL	Oncoimmunology_2013_Jun_1_2(6)_e24462.nxml.txt.nlp	23894707	SENT55	2	2	37	37	vemurafenib	PI3K	PA165946873	5290	0.876
NULL	Nat_Med_2010_Jun_23_16(6)_671-677.nxml.txt.nlp	20495567	SENT111	25	25	33	33	sorafenib	ATF5	PA7000	22809	0.876
NULL	Br_J_Cancer_2011_May_10_104(10)_1587-1593.nxml.txt.nlp	21487405	SENT8	27	27	14	14	docetaxel	PTEN	PA449383	5728	0.876
NULL	Breast_Cancer_Res_2009_Jun_18_11(3)_R37.nxml.txt.nlp	19538720	SENT20	12	12	3	3	lapatinib	HER-2	PA152241907	2064	0.876
NULL	J_Neurochem_2010_Jun_113(5)_1177-1187.nxml.txt.nlp	20374431	SENT197	0	0	16	16	forskolin	P2X1	PA146096022	5023	0.876
NULL	Mol_Neurobiol_2010_Jun_2_41(2-3)_392-409.nxml.txt.nlp	20437209	SENT299	26	26	28	28	curcumin	5-LOX	PA151958596	240	0.876
NULL	Springerplus_2014_Sep_17_3_535.nxml.txt.nlp	25279326	SENT153	20	20	5	5	everolimus	aromatase	PA164746311	1588	0.876
NULL	J_Cell_Mol_Med_2013_Dec_6_17(12)_1588-1597.nxml.txt.nlp	24199964	SENT65	34	34	28	28	dobutamine	APT	PA449381	653639	0.876
NULL	Nat_Commun_2013_Sep_20_4_2444.nxml.txt.nlp	24051492	SENT113	15	15	7	7	nutlin-3	p53		7157	0.876
NULL	Sex_Transm_Infect_2011_Dec_87(Suppl_2)_ii39-ii43.nxml.txt.nlp	22110154	SENT105	9	9	38	38	azithromycin	San	PA448519	80218	0.876
NULL	Ann_Hematol_2014_Nov_28_93(3)_361-374.nxml.txt.nlp	24288111	SENT146	21	21	33	33	fludarabine	CD49d	PA449655	3676	0.876
NULL	Acta_Neuropathol_Commun_2014_May_30_2_57.nxml.txt.nlp	24887326	SENT185	31	31	21	21	etoposide	MED1	PA449552	5469;8930	0.876
NULL	Int_J_Chron_Obstruct_Pulmon_Dis_2007_Dec_2(4)_409-428.nxml.txt.nlp	18268916	SENT140	17	17	11	11	trypsin	SLPI	PA451806	6590	0.876
NULL	Breast_Cancer_Res_Treat_2012_Jul_24_134(1)_13-20.nxml.txt.nlp	22198412	SENT182	27	27	31	31	pertuzumab	HER2		2064	0.876
NULL	Oncol_Rep_2014_Jul_15_32(1)_45-49.nxml.txt.nlp	24841138	SENT40	30	30	15	15	pp2	EGFR		1956	0.876
NULL	Cancer_Metastasis_Rev_2014_Dec_28_33(1)_161-171.nxml.txt.nlp	24375389	SENT21	24	24	17	17	erlotinib	EGFR	PA134687924	1956	0.876
NULL	Kidney_Int_Suppl_(2011)_2013_Dec_27_3(4)_392-409.nxml.txt.nlp	NULL	SENT770	22	22	10	10	everolimus	MCP-1	PA164746311	6347	0.876
NULL	Cell_Death_Dis_2013_Jul_25_4(7)_e740.nxml.txt.nlp	23887631	SENT75	4	4	20	20	vorinostat	ABCG2	PA164748224	9429	0.876
NULL	J_Cell_Biol_2000_Aug_7_150(3)_613-626.nxml.txt.nlp	10931872	SENT124	24	24	12	12	trypsin	PI-PLC	PA451806	2923	0.876
NULL	Indian_J_Anaesth_2013_Jan-Feb_57(1)_56-61.nxml.txt.nlp	23716768	SENT44	0	0	8	8	heparin	ACT	PA449855	12;11332;9457;641455	0.876
NULL	Breast_Cancer_Res_2010_Jun_4_12(3)_R32.nxml.txt.nlp	20525379	SENT18	7	7	13	13	tamoxifen	AGR2	PA451581	10551	0.876
NULL	Hum_Genomics_2008_Sep_1_3(1)_7-16.nxml.txt.nlp	19129086	SENT10	34	34	3	3	rosiglitazone	CYP2C8	PA451283	1558	0.876
NULL	EMBO_Mol_Med_2013_Jul_30_5(7)_932-948.nxml.txt.nlp	23723167	SENT248	5	5	20	20	pilocarpine	MMP13	PA450962	4322	0.876
NULL	Evid_Based_Complement_Alternat_Med_2012_Aug_27_2012_361516.nxml.txt.nlp	22969825	SENT148	30	30	33	33	ketoconazole	P-gp	PA450146	5243	0.876
NULL	J_Oncol_2012_Mar_26_2012_986725.nxml.txt.nlp	22545054	SENT176	26	26	29	29	cetuximab	PI3K	PA10040	5290	0.876
NULL	Breast_Cancer_(Auckl)_2009_Sep_2_3_61-75.nxml.txt.nlp	19809577	SENT245	3	3	24	24	curcumin	BRCA1	PA151958596	672	0.876
NULL	Clin_Pharmacokinet_2014_Oct_15_53(2)_155-164.nxml.txt.nlp	24127209	SENT149	22	22	16	16	omeprazole	CYP2C19	PA450704	1557	0.876
NULL	Ther_Clin_Risk_Manag_2007_Dec_3(6)_1009-1020.nxml.txt.nlp	18516316	SENT134	40	40	6	6	ondansetron	HEC	PA450705	10403	0.876
NULL	Open_Biol_2013_Nov_3(11)_130130.nxml.txt.nlp	24258275	SENT306	22	22	10	10	imatinib	SIRT1	PA10804	23411	0.876
NULL	Oncotarget_2011_Dec_31_2(12)_1322-1328.nxml.txt.nlp	22249159	SENT48	4	4	20	20	resveratrol	AMPK		5563	0.876
NULL	Br_J_Cancer_2011_Aug_23_105(5)_618-627.nxml.txt.nlp	21829197	SENT47	8	8	3	3	cisplatin	CRT	PA449014	811	0.876
NULL	Br_J_Cancer_2013_Mar_19_108(5)_1079-1091.nxml.txt.nlp	23449353	SENT27	20	20	11	11	docetaxel	MIC-1	PA449383	29919;9518	0.876
NULL	Apoptosis_2012_Sep_30_17(9)_989-997.nxml.txt.nlp	22460505	SENT137	7	7	17	17	thioridazine	p53	PA451666	7157	0.876
NULL	Breast_Cancer_Res_2013_Nov_29_15(6)_R114.nxml.txt.nlp	24289103	SENT337	22	22	6	6	tamoxifen	EGFR	PA451581	1956	0.876
NULL	Eur_J_Clin_Pharmacol_2014_Oct_8_70(1)_37-45.nxml.txt.nlp	24100471	SENT15	8	8	28	28	omeprazole	CYP3A4	PA450704	1576	0.876
NULL	Mol_Cancer_2010_Apr_12_9_75.nxml.txt.nlp	20385023	SENT210	5	5	10	10	imatinib	P-gp	PA10804	5243	0.876
NULL	Curr_Oncol_2010_Feb_17(1)_81-86.nxml.txt.nlp	20179808	SENT35	4	4	1	1	tamoxifen	aromatase	PA451581	1588	0.876
NULL	Biomed_Res_Int_2013_Jun_6_2013_928271.nxml.txt.nlp	23841099	SENT19	6	6	2	2	prasugrel	P2Y12	PA154410481	64805	0.876
NULL	Biomed_Res_Int_2013_Jul_18_2013_485246.nxml.txt.nlp	23971038	SENT118	20	20	6	6	ethanol	ANOVA	PA448073	4858	0.876
NULL	Acta_Pharmacol_Sin_2012_Dec_5_33(12)_1502-1510.nxml.txt.nlp	23123644	SENT244	8	8	15	15	losartan	LARG	PA450268	23365	0.876
NULL	Cancer_Cell_Int_2009_Sep_10_9_25.nxml.txt.nlp	19744341	SENT130	35	35	28	28	glucosamine	survivin	PA164747613	332	0.876
NULL	J_Clin_Biochem_Nutr_2009_Nov_28_45(3)_285-291.nxml.txt.nlp	19902018	SENT159	16	16	5	5	hesperetin	XOR	PA164742902	7498	0.876
NULL	Mol_Biol_Int_2014_Sep_7_2014_852748.nxml.txt.nlp	25276427	SENT44	8	8	15	15	trastuzumab	HER2	PA451743	2064	0.876
NULL	J_Breast_Cancer_2013_Jun_28_16(2)_164-170.nxml.txt.nlp	23843848	SENT110	2	2	10	10	doxorubicin	p53	PA449412	7157	0.876
NULL	J_Lipid_Res_2015_Jan_56(1)_109-121.nxml.txt.nlp	25421061	SENT312	28	28	18	18	forskolin	CGI-58	PA146096022	51099	0.876
NULL	Mol_Cancer_2012_Dec_12_11_91.nxml.txt.nlp	23234355	SENT199	11	11	23	23	cetuximab	EGFR	PA10040	1956	0.876
NULL	Lab_Invest_2011_Apr_14_91(4)_598-608.nxml.txt.nlp	21321535	SENT133	6	6	26	26	sorafenib	CD4	PA7000	920	0.876
NULL	Cell_Death_Dis_2013_Oct_3_4(10)_e828.nxml.txt.nlp	24091671	SENT271	23	23	9	9	cetuximab	CD44	PA10040	960	0.876
NULL	Breast_Cancer_(Auckl)_2012_Mar_7_6_67-77.nxml.txt.nlp	22438669	SENT33	20	20	22	22	capecitabine	HER2	PA448771	2064	0.876
NULL	Biosci_Rep_2012_Dec_1_32(Pt_6)_511-519.nxml.txt.nlp	NULL	SENT106	15	15	6	6	lovastatin	ERK2	PA450272	5594	0.876
NULL	BioData_Min_2011_Jun_14_4_15.nxml.txt.nlp	21672238	SENT32	5	5	27	27	geldanamycin	Hsp90	PA152031327	3320	0.876
NULL	Osteoporos_Int_2011_Jun_12_22(6)_1935-1946.nxml.txt.nlp	20938767	SENT263	5	5	3	3	alendronate	PTH	PA448082	5741	0.876
NULL	Acta_Pharmacol_Sin_2009_Jul_3_30(7)_1025-1032.nxml.txt.nlp	19575006	SENT164	17	17	3	3	bortezomib	JNK	PA10252	5599	0.876
NULL	J_Inflamm_(Lond)_2005_Oct_31_2_14.nxml.txt.nlp	16259633	SENT251	29	29	19	19	staurosporine	CCR2	PA165109623	729230	0.876
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT91	9	9	21	21	resveratrol	TRAIL		8743	0.876
NULL	Cell_Commun_Signal_2013_Oct_1_11_73.nxml.txt.nlp	24083678	SENT168	15	15	36	36	sulindac	IL-8	PA451565	3576	0.876
NULL	Cell_Death_Dis_2010_Oct_21_1(10)_e86.nxml.txt.nlp	21368859	SENT182	22	22	13	13	doxorubicin	TRAIL	PA449412	8743	0.876
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Dec_17_3(12)_e152.nxml.txt.nlp	25518025	SENT175	8	8	4	4	oxycodone	CYP2D6	PA450741	1565	0.876
NULL	Biomed_Res_Int_2014_Aug_7_2014_621437.nxml.txt.nlp	25170513	SENT167	4	4	10	10	rosiglitazone	adiponectin	PA451283	9370	0.876
NULL	Cancer_Cell_Int_2011_Nov_17_11_40.nxml.txt.nlp	22088142	SENT151	23	23	9	9	gemcitabine	EGFR	PA449748	1956	0.876
NULL	Exp_Ther_Med_2015_Feb_8_9(2)_303-310.nxml.txt.nlp	25574190	SENT24	5	5	30	30	calcipotriol	p53	PA448714	7157	0.876
NULL	Oncotarget_2012_May_4_3(4)_395-398.nxml.txt.nlp	22565037	SENT20	37	37	7	7	metformin	CD44	PA450395	960	0.876
NULL	J_Exp_Clin_Cancer_Res_2009_Oct_7_28(1)_134.nxml.txt.nlp	19811659	SENT10	22	22	2	2	nilotinib	CD117	PA165958345	3815	0.876
NULL	J_Immunother_Cancer_2014_Jan_27_2_2.nxml.txt.nlp	24829759	SENT106	30	30	21	21	sorafenib	IL-21	PA7000	59067;50616;27189	0.876
NULL	Clin_Exp_Otorhinolaryngol_2013_Dec_29_6(4)_237-242.nxml.txt.nlp	24353864	SENT116	0	0	3	3	doxycycline	MUC5B	PA449415	727897	0.876
NULL	Br_J_Cancer_2010_Jan_5_102(1)_80-86.nxml.txt.nlp	19920817	SENT73	45	45	29	29	sunitinib	IFN	PA162372840	3439	0.876
NULL	J_Immunol_Res_2014_May_12_2014_897249.nxml.txt.nlp	24901013	SENT259	27	27	8	8	natalizumab	BIM	PA164747191	10018	0.876
NULL	Breast_Cancer_Res_2007_Jul_5_9(4)_R41.nxml.txt.nlp	17612393	SENT129	0	0	26	26	celecoxib	PARP	PA448871	142	0.876
NULL	J_Neuroinflammation_2010_Sep_7_7_51.nxml.txt.nlp	20822529	SENT154	15	15	20	20	hemin	p38	PA449849	10598;1432;7965	0.876
NULL	Oncotarget_2014_Mar_26_5(21)_10342-10355.nxml.txt.nlp	25431950	SENT125	23	23	4	4	doxycycline	EZH2	PA449415	2146	0.876
NULL	Mol_Cancer_2012_Aug_8_11_53.nxml.txt.nlp	22871047	SENT296	10	10	6	6	paclitaxel	ES2	PA450761	8220	0.876
NULL	Ann_Rheum_Dis_2014_Sep_2_73(9)_1626-1634.nxml.txt.nlp	24297381	SENT273	24	24	28	28	tocilizumab	IL-6	PA165292659	3569	0.876
NULL	Cancer_Cell_Int_2013_Feb_14_13_16.nxml.txt.nlp	23409704	SENT103	32	32	16	16	pp2	LOX		4015	0.876
NULL	Breast_Cancer_Res_2012_Mar_8_14(2)_R40.nxml.txt.nlp	22405092	SENT54	14	14	16	16	tamoxifen	aromatase	PA451581	1588	0.876
NULL	Cancers_(Basel)_2014_Jul_8_6(3)_1487-1499.nxml.txt.nlp	25006835	SENT44	31	31	42	42	cisplatin	p38	PA449014	10598;1432;7965	0.876
NULL	Acta_Pharmacol_Sin_2012_May_4_33(5)_710-716.nxml.txt.nlp	22555373	SENT118	11	11	19	19	phenylbutazone	DOM	PA450932	6663	0.876
NULL	Cent_European_J_Urol_2011_Dec_9_64(4)_256-257.nxml.txt.nlp	24578906	SENT51	15	15	4	4	doxazosin	CD133	PA449407	8842	0.876
NULL	Br_J_Cancer_2003_Mar_10_88(5)_754-759.nxml.txt.nlp	12618886	SENT153	0	0	24	24	amifostine	p53	PA448365	7157	0.876
NULL	Indian_J_Endocrinol_Metab_2013_Jul-Aug_17(4)_636-646.nxml.txt.nlp	23961479	SENT155	14	14	17	17	fluvastatin	CYP2C9	PA449688	1559	0.876
NULL	Cancer_Med_2014_Aug_18_3(4)_1025-1034.nxml.txt.nlp	24944108	SENT173	27	27	5	5	metformin	HER2	PA450395	2064	0.876
NULL	J_Occup_Med_Toxicol_2008_Feb_27_3(Suppl_1)_S6.nxml.txt.nlp	18315837	SENT67	2	2	10	10	salmeterol	IL-5	PA451300	3567	0.876
NULL	Aging_(Albany_NY)_2011_Apr_6_3(4)_444-449.nxml.txt.nlp	21483037	SENT64	4	4	2	2	resveratrol	AMPK		5563	0.876
NULL	Front_Neurol_2014_Sep_3_5_169.nxml.txt.nlp	25232349	SENT208	0	0	22	22	estradiol	aromatase	PA449503	1588	0.876
NULL	Oncotarget_2014_Jun_3_5(13)_4920-4928.nxml.txt.nlp	24952482	SENT98	19	19	29	29	crizotinib	HGF	PA165946122	3569;6654;3082	0.876
NULL	J_Inflamm_(Lond)_2008_May_29_5_7.nxml.txt.nlp	18507870	SENT43	8	8	46	46	l-glutamine	CO2	PA10090	4513	0.876
NULL	Mol_Cancer_2012_Mar_21_11_13.nxml.txt.nlp	22436134	SENT60	8	8	12	12	doxorubicin	HuR	PA449412	1994	0.876
NULL	Acta_Physiol_(Oxf)_2008_Oct_194(2)_123-140.nxml.txt.nlp	18419777	SENT17	15	15	13	13	isoproterenol	PES	PA450121	23481	0.876
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_13_2012_636848.nxml.txt.nlp	23258994	SENT230	17	17	7	7	carrageenan	TRPV4	PA448814	59341	0.876
NULL	Front_Endocrinol_(Lausanne)_2013_Jul_3_4_79.nxml.txt.nlp	23840193	SENT211	21	21	14	14	estradiol	Pref-1	PA449503	8788	0.876
NULL	Indian_J_Pharm_Sci_2008_May-Jun_70(3)_386-390.nxml.txt.nlp	20046755	SENT15	0	0	4	4	ondansetron	USP1	PA450705	7398	0.876
NULL	J_Signal_Transduct_2011_Jun_27_2011_541851.nxml.txt.nlp	21776386	SENT59	31	31	0	0	l-glutamine	PC-3	PA10090	692094	0.876
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_23_2013_185158.nxml.txt.nlp	23864881	SENT234	15	15	5	5	vorinostat	MMP2	PA164748224	4313	0.876
NULL	J_Cell_Biol_1998_Jan_26_140(2)_335-345.nxml.txt.nlp	9442109	SENT4	16	16	3	3	chloroquine	NHE	PA448948	285335	0.876
NULL	Nat_Commun_2013_4_10_1038_ncomms3472.nxml.txt.nlp	24045463	SENT127	21	21	12	12	propranolol	UCP1	PA451145	7350	0.876
NULL	J_Oncol_2009_May_6_2009_567486.nxml.txt.nlp	19424511	SENT138	7	7	19	19	sorafenib	SHARP	PA7000	23013	0.876
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT99	8	8	18	18	atorvastatin	IL-6	PA448500	3569	0.876
NULL	Blood_Cancer_J_2012_Mar_9_2(3)_e60.nxml.txt.nlp	22829255	SENT10	18	18	5	5	cytarabine	FLT3	PA449177	2322	0.876
NULL	Case_Rep_Oncol_2010_Apr_22_3(2)_98-105.nxml.txt.nlp	20740181	SENT13	2	2	9	9	gefitinib	EGFR	PA131301952	1956	0.876
NULL	Oncotarget_2012_Dec_17_4(1)_48-63.nxml.txt.nlp	23295955	SENT186	13	13	4	4	methotrexate	MTHFD2	PA450428	10797	0.876
NULL	Breast_Cancer_Res_2006_Nov_27_8(6)_R66.nxml.txt.nlp	17129383	SENT31	9	9	6	6	paclitaxel	HER2	PA450761	2064	0.876
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT116	7	7	22	22	atorvastatin	RANKL	PA448500	8600	0.876
NULL	Adolesc_Health_Med_Ther_2010_Dec_23_2_1-8.nxml.txt.nlp	24600270	SENT33	4	4	15	15	adalimumab	TNF-alpha	PA10004	7124	0.876
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_7-17.nxml.txt.nlp	17912633	SENT368	6	6	29	29	letrozole	AMH	PA450196	268	0.876
NULL	Exp_Ther_Med_2012_Sep_12_4(3)_475-480.nxml.txt.nlp	23181121	SENT163	10	10	22	22	doxorubicin	CHOP	PA449412	1649	0.876
NULL	Cancer_Res_Treat_2013_Sep_30_45(3)_178-185.nxml.txt.nlp	24155676	SENT103	2	2	6	6	gefitinib	EGFR	PA131301952	1956	0.876
NULL	Indian_J_Pharmacol_2013_Mar-Apr_45(2)_155-158.nxml.txt.nlp	23716892	SENT119	15	15	25	25	voriconazole	CYP3A4	PA10233	1576	0.876
NULL	Cancer_Manag_Res_2013_May_8_5_57-66.nxml.txt.nlp	23696715	SENT98	28	28	8	8	sorafenib	CEA	PA7000	5670;1087	0.876
NULL	Breast_Cancer_Res_2006_Nov_6_8(6)_215.nxml.txt.nlp	17096862	SENT85	9	9	31	31	trastuzumab	HER2	PA451743	2064	0.876
NULL	Front_Neurol_2014_Feb_18_5_17.nxml.txt.nlp	24600432	SENT135	8	8	17	17	levetiracetam	C17	PA450206	54360	0.876
NULL	Eur_J_Med_Res_2009_Dec_7_14(Suppl_4)_108-111.nxml.txt.nlp	20156738	SENT75	30	30	4	4	theophylline	FKBP51	PA451647	2289	0.876
NULL	Infect_Agent_Cancer_2012_Apr_19_7(Suppl_1)_P32.nxml.txt.nlp	NULL	SENT7	6	6	20	20	bortezomib	ATF4	PA10252	468	0.876
NULL	Trials_2012_Dec_13_13_239.nxml.txt.nlp	23237631	SENT33	4	4	18	18	acenocoumarol	CYP2C9	PA452632	1559	0.876
NULL	Endocrinol_Metab_(Seoul)_2013_Dec_12_28(4)_262-274.nxml.txt.nlp	24396690	SENT77	19	19	37	37	liraglutide	GLP-1	PA165958364	100125288	0.876
NULL	Curr_Neuropharmacol_2013_Dec_11(6)_652-663.nxml.txt.nlp	24396340	SENT81	0	0	20	20	paclitaxel	TRPV1	PA450761	7442	0.876
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT199	13	13	17	17	perifosine	TRAIL	PA165291471	8743	0.876
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jan_23_65(Pt_2)_o360.nxml.txt.nlp	21581958	SENT54	25	25	22	22	sc-560	COX		1351	0.876
NULL	Breast_Cancer_Res_2013_Nov_27_15(6)_R113.nxml.txt.nlp	24283570	SENT337	21	21	9	9	estradiol	MYB	PA449503	4602	0.876
NULL	Arthritis_Res_Ther_2005_Jul_13_7(5)_R1072-R1081.nxml.txt.nlp	16207324	SENT16	12	12	22	22	methimazole	TRF	PA450422	7013;3567	0.876
NULL	Front_Oncol_2014_Apr_9_4_75.nxml.txt.nlp	24782986	SENT50	8	8	19	19	paclitaxel	Oct4	PA450761	5460	0.876
NULL	Neuropsychopharmacology_2011_Apr_2_36(5)_1033-1046.nxml.txt.nlp	21289603	SENT256	10	10	18	18	ethanol	MSN	PA448073	4478	0.876
NULL	Target_Oncol_2013_Jun_27_8(2)_127-136.nxml.txt.nlp	23625191	SENT51	10	10	4	4	panitumumab	KRAS	PA162373091	3845	0.876
NULL	Hum_Genomics_2010_Oct_1_5(1)_61-72.nxml.txt.nlp	21106490	SENT152	35	35	25	25	lovastatin	CYP3A	PA450272	1574	0.876
NULL	Arthritis_Res_Ther_2005_Mar_16_7(Suppl_2)_S15-S20.nxml.txt.nlp	15833144	SENT73	14	14	26	26	abatacept	CTLA4	PA164747080	1493	0.876
NULL	J_Cell_Mol_Med_2014_Dec_9_18(12)_2425-2436.nxml.txt.nlp	25297942	SENT196	18	18	1	1	cisplatin	HOTAIR	PA449014	100124700	0.876
NULL	Evid_Based_Complement_Alternat_Med_2011_Jan_20_2011_751671.nxml.txt.nlp	21318106	SENT170	8	8	19	19	tacrolimus	P-gp	PA451578	5243	0.876
NULL	J_Exp_Clin_Cancer_Res_2009_Sep_1_28(1)_123.nxml.txt.nlp	19723324	SENT122	9	9	18	18	gefitinib	PTEN	PA131301952	5728	0.876
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Sep_4_66(Pt_10)_o2472.nxml.txt.nlp	21587473	SENT59	22	22	9	9	ethanol	mol	PA448073	90527	0.876
NULL	Eur_J_Epidemiol_2009_Sep_2_24(9)_553-572.nxml.txt.nlp	19728115	SENT1546	20	20	11	11	acenocoumarol	CYP2C9	PA452632	1559	0.876
NULL	Korean_Circ_J_2013_Sep_30_43(9)_600-606.nxml.txt.nlp	24174960	SENT74	21	21	13	13	abciximab	CD42b	PA448006	2811	0.876
NULL	Mol_Cancer_2008_Jan_25_7_14.nxml.txt.nlp	18221502	SENT16	11	11	25	25	l-serine	PSAT1	PA451330	29968	0.876
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Mar_19_65(Pt_4)_o799.nxml.txt.nlp	21582523	SENT3	13	13	2	2	benzaldehyde	mol	PA448571	90527	0.876
NULL	Diabetes_2009_Feb_58(2)_344-351.nxml.txt.nlp	19008341	SENT315	19	19	10	10	resveratrol	IFN		3439	0.876
NULL	J_Hematol_Oncol_2008_Oct_1_1_16.nxml.txt.nlp	18828924	SENT105	16	16	39	39	trastuzumab	HER2	PA451743	2064	0.876
NULL	Braz_J_Med_Biol_Res_2014_Sep_5_47(11)_929-939.nxml.txt.nlp	25296354	SENT79	2	2	28	28	erlotinib	EGFR	PA134687924	1956	0.876
NULL	Acta_Pharmacol_Sin_2013_Mar_11_34(3)_403-413.nxml.txt.nlp	23396374	SENT314	10	10	36	36	curcumin	IL-6	PA151958596	3569	0.876
NULL	Osteoporos_Int_2008_Apr_12_19(4)_399-428.nxml.txt.nlp	18266020	SENT248	8	8	13	13	teriparatide	PTH	PA451620	5741	0.876
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT14	15	15	10	10	chloroquine	BMPR-II	PA448948	659	0.876
NULL	Front_Pharmacol_2014_May_9_5_103.nxml.txt.nlp	24847272	SENT223	17	17	5	5	midazolam	POR	PA450496	5447	0.876
NULL	Pharmaceuticals_(Basel)_2013_Nov_11_6(11)_1429-1450.nxml.txt.nlp	24287465	SENT283	20	20	29	29	vemurafenib	GLI2	PA165946873	2736	0.876
NULL	Ann_Surg_Treat_Res_2014_Feb_22_86(2)_68-75.nxml.txt.nlp	24761411	SENT138	8	8	3	3	resveratrol	survivin		332	0.876
NULL	Clin_Pharmacol_2011_Jun_22_3_13-25.nxml.txt.nlp	22287853	SENT21	27	27	7	7	saxagliptin	GLP-1	PA165958362	100125288	0.876
NULL	Indian_J_Endocrinol_Metab_2011_Jul_15(Suppl1)_S17-S24.nxml.txt.nlp	21847449	SENT188	13	13	8	8	bromocriptine	CYP3A4	PA448671	1576	0.876
NULL	J_Cancer_2013_Nov_23_4(9)_736-754.nxml.txt.nlp	24312144	SENT222	33	33	12	12	erlotinib	VEGFR	PA134687924	3791	0.876
NULL	Nat_Methods_2013_Aug_30_10(8)_768-773.nxml.txt.nlp	23817070	SENT139	1	1	9	9	l-lysine	DDC	PA450280	1644	0.875
NULL	J_Cell_Mol_Med_2013_Oct_23_17(10)_1207-1217.nxml.txt.nlp	24106980	SENT149	13	13	32	32	paclitaxel	MDR1	PA450761	5243	0.875
NULL	J_Lipid_Res_2011_May_52(5)_873-884.nxml.txt.nlp	21324916	SENT265	7	7	27	27	bezafibrate	adiponectin	PA162364313	9370	0.875
NULL	Mol_Cancer_2012_Jun_18_11_41.nxml.txt.nlp	22709873	SENT257	34	34	6	6	lapatinib	RB1CC1	PA152241907	9821	0.875
NULL	J_Nutr_Metab_2010_Nov_23_2010_415075.nxml.txt.nlp	20721351	SENT131	26	26	1	1	lipase	PLB	PA450239	151056	0.875
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Dec_4_66(Pt_1)_o24.nxml.txt.nlp	21580121	SENT72	27	27	13	13	ethanol	mol	PA448073	90527	0.875
NULL	Nat_Commun_2012_Jan_17_3_626.nxml.txt.nlp	22252550	SENT109	30	30	12	12	imatinib	E16	PA10804	8140	0.875
NULL	Drug_Target_Insights_2013_Aug_19_7_27-34.nxml.txt.nlp	24023511	SENT27	11	11	24	24	verapamil	P-gp	PA451868	5243	0.875
NULL	Drug_Target_Insights_2012_Aug_6_6_19-39.nxml.txt.nlp	22915839	SENT96	0	0	34	34	doxorubicin	Hsp90	PA449412	3320	0.875
NULL	Nat_Neurosci_2012_Sep_5_15(9)_1245-1254.nxml.txt.nlp	22864611	SENT457	14	14	10	10	clozapine	mGlu2	PA449061	2912	0.875
NULL	Int_J_Med_Sci_2015_Jan_5_12(2)_135-140.nxml.txt.nlp	25589889	SENT15	13	13	5	5	aripiprazole	NMS	PA10026	129521	0.875
NULL	Crit_Care_2011_Jun_24_15(3)_R153.nxml.txt.nlp	21702944	SENT207	11	11	14	14	dexmedetomidine	TLR-4	PA449256	7099	0.875
NULL	J_Cell_Mol_Med_2013_Sep_24_17(9)_1065-1087.nxml.txt.nlp	24151975	SENT348	0	0	15	15	palifermin	CCL2	PA164744014	6347	0.875
NULL	Biomed_Res_Int_2014_Jan_20_2014_948427.nxml.txt.nlp	24563867	SENT223	23	23	5	5	buspirone	COB	PA448689	4519	0.875
NULL	Indian_J_Pharmacol_2008_Oct_40(Suppl_2)_S97-S112.nxml.txt.nlp	21593984	SENT453	5	5	3	3	telmisartan	STZ	PA451605	6484	0.875
NULL	AIDS_Res_Ther_2006_Sep_14_3_21.nxml.txt.nlp	16970827	SENT32	5	5	26	26	lamivudine	CD4	PA450163	920	0.875
NULL	Nat_Med_2013_Nov_27_19(11)_10_1038_nm_3352.nxml.txt.nlp	24162815	SENT136	14	14	2	2	thyroglobulin	TTF-1	PA164754910	7080	0.875
NULL	Clinics_(Sao_Paulo)_2013_Oct_68(10)_1305-1311.nxml.txt.nlp	24212836	SENT61	45	45	7	7	desflurane	CO2	PA164749136	4513	0.875
NULL	Nat_Med_2010_Feb_24_16(2)_214-218.nxml.txt.nlp	20098429	SENT61	23	23	4	4	epirubicin	YWHAZ	PA449476	7534	0.875
NULL	Int_J_Mol_Sci_2012_Dec_5_13(12)_16624-16635.nxml.txt.nlp	23443122	SENT7	14	14	23	23	paclitaxel	MDR1	PA450761	5243	0.875
NULL	Biomed_Res_Int_2013_Dec_30_2013_470217.nxml.txt.nlp	23509726	SENT145	2	2	35	35	ethanol	IL-13	PA448073	3596	0.875
NULL	Br_J_Cancer_2012_May_22_106(11)_1742-1752.nxml.txt.nlp	22538973	SENT180	16	16	21	21	imatinib	IFN	PA10804	3439	0.875
NULL	Diabetes_2009_Jan_58(1)_61-70.nxml.txt.nlp	18931039	SENT294	20	20	45	45	forskolin	adiponectin	PA146096022	9370	0.875
NULL	Diabetes_Care_2010_Jun_23_33(6)_1294-1296.nxml.txt.nlp	20332358	SENT72	6	6	0	0	exenatide	GLP-1	PA164749238	100125288	0.875
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Dec_9_6_191-203.nxml.txt.nlp	25525387	SENT158	29	29	37	37	trastuzumab	aromatase	PA451743	1588	0.875
NULL	Breast_Cancer_Res_2002_Jun_21_4(5)_R9.nxml.txt.nlp	12223126	SENT127	20	20	8	8	tamoxifen	FasL	PA451581	356	0.875
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Jun_25_3(6)_e120.nxml.txt.nlp	24964282	SENT269	13	13	7	7	ketoconazole	CYP3A	PA450146	1574	0.875
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT288	15	15	5	5	warfarin	VKORC1	PA451906	79001	0.875
NULL	Oxid_Med_Cell_Longev_2011_Aug_4_2011_471590.nxml.txt.nlp	21904644	SENT8	4	4	21	21	probucol	CA1	PA451107	759	0.875
NULL	EPMA_J_2012_Sep_27_3(1)_10.nxml.txt.nlp	23016735	SENT242	21	21	9	9	warfarin	VKORC1	PA451906	79001	0.875
NULL	ScientificWorldJournal_2013_Dec_24_2013_196541.nxml.txt.nlp	24453810	SENT108	7	7	31	31	trastuzumab	HER2	PA451743	2064	0.875
NULL	J_Anim_Sci_Biotechnol_2013_Jul_30_4(1)_27.nxml.txt.nlp	23899038	SENT197	3	3	29	29	l-cysteine	IL-6	PA449173	3569	0.875
NULL	Cancer_Metab_2014_May_28_2(Suppl_1)_P24.nxml.txt.nlp	NULL	SENT22	3	3	17	17	etoposide	p53	PA449552	7157	0.875
NULL	J_Immunother_Cancer_2013_Jul_15_1_10.nxml.txt.nlp	24829747	SENT42	7	7	24	24	sildenafil	ARG1	PA451346	383;64129	0.875
NULL	Cardiovasc_Diabetol_2006_Sep_26_5_20.nxml.txt.nlp	17002798	SENT138	0	0	7	7	torcetrapib	CETP	PA145007158	1071	0.875
NULL	Oncol_Lett_2014_Jan_11_7(1)_156-158.nxml.txt.nlp	24348840	SENT4	5	5	18	18	cyclophosphamide	CHOP	PA449165	1649	0.875
NULL	Am_J_Case_Rep_2012_May_23_13_79-85.nxml.txt.nlp	23569495	SENT57	14	14	8	8	vincristine	CHOP	PA451879	1649	0.875
NULL	Case_Rep_Med_2009_Aug_4_2009_148795.nxml.txt.nlp	19721708	SENT69	29	29	7	7	amoxicillin	CCS	PA448406	9973	0.875
NULL	Cell_Death_Differ_2010_Oct_30_17(10)_1624-1635.nxml.txt.nlp	20431602	SENT111	0	0	7	7	paclitaxel	Bcl-2	PA450761	596	0.875
NULL	Fibrogenesis_Tissue_Repair_2010_Jan_5_3_2.nxml.txt.nlp	20051102	SENT166	33	33	8	8	bleomycin	BMP7	PA448645	655	0.875
NULL	CNS_Drugs_2013_May_27_27(5)_335-343.nxml.txt.nlp	23533009	SENT124	18	18	33	33	quetiapine	FGA	PA451201	2243	0.875
NULL	Asian_J_Androl_2014_Apr_25_Sep-Oct_16(5)_761-766.nxml.txt.nlp	24799635	SENT126	13	13	20	20	fructose	DM2	PA449716	28508	0.875
NULL	Mol_Cancer_2014_Aug_15_13(1)_192.nxml.txt.nlp	NULL	SENT316	10	10	5	5	trastuzumab	DARPP-32	PA451743	84152	0.875
NULL	Breast_Cancer_Res_2011_Jan_28_13(1)_302.nxml.txt.nlp	21345281	SENT4	19	19	3	3	denosumab	RANKL	PA166048634	8600	0.875
NULL	J_Exp_Bot_2012_Aug_14_63(13)_4861-4873.nxml.txt.nlp	22888122	SENT81	30	30	16	16	l-arginine	DAG	PA448478	1605	0.875
NULL	Pain_Res_Treat_2012_Apr_23_2012_295926.nxml.txt.nlp	22577544	SENT60	17	17	45	45	dicyclomine	ARC	PA164744928	8996;23237	0.875
NULL	Oxid_Med_Cell_Longev_2012_Jan_19_2012_390678.nxml.txt.nlp	22315655	SENT61	7	7	2	2	ethanol	NAC	PA448073	22861	0.875
NULL	Cardiovasc_Diabetol_2013_Oct_17_12_150.nxml.txt.nlp	24134550	SENT104	17	17	7	7	pioglitazone	activin	PA450970	83729	0.875
NULL	BMB_Rep_2014_Mar_47(3)_167-172.nxml.txt.nlp	24499665	SENT108	5	5	16	16	nutlin-3	MDM2		4193	0.875
NULL	Biomed_Res_Int_2014_Jan_20_2014_948427.nxml.txt.nlp	24563867	SENT19	8	8	2	2	clozapine	5-HT1A	PA449061	3350	0.875
NULL	Front_Oncol_2011_Aug_10_1_20.nxml.txt.nlp	22649757	SENT39	24	24	18	18	temozolomide	MSH2	PA451609	4436	0.875
NULL	Ann_Hematol_2011_May_12_90(5)_557-568.nxml.txt.nlp	20938660	SENT36	6	6	4	4	plerixafor	CXCR4	PA165958410	7852	0.875
NULL	Fibrogenesis_Tissue_Repair_2012_Jul_23_5_11.nxml.txt.nlp	22824096	SENT407	4	4	2	2	thrombin	PAR-1	PA451674	2011;2149	0.875
NULL	Breast_Cancer_Res_2001_Jul_11_3(5)_294-298.nxml.txt.nlp	11597317	SENT118	26	26	9	9	cisplatin	BRCA1	PA449014	672	0.875
NULL	Curr_Neuropharmacol_2012_Jun_10(2)_97-123.nxml.txt.nlp	23204981	SENT190	10	10	26	26	venlafaxine	IL-10	PA451866	3586	0.875
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2013_Dec_8_6_75-79.nxml.txt.nlp	24348081	SENT20	42	42	33	33	colesevelam	TGR5	PA449095	151306	0.875
NULL	EMBO_Mol_Med_2012_Jun_13_4(6)_515-527.nxml.txt.nlp	22416035	SENT40	26	26	8	8	doxorubicin	p53	PA449412	7157	0.875
NULL	Breast_Cancer_Res_2014_Sep_11_16(5)_430.nxml.txt.nlp	25212826	SENT318	8	8	11	11	everolimus	aromatase	PA164746311	1588	0.875
NULL	EMBO_Mol_Med_2013_Dec_8_5(12)_1821-1834.nxml.txt.nlp	24293316	SENT51	25	25	20	20	doxorubicin	UNC5D	PA449412	137970	0.875
NULL	Cell_Res_2011_Mar_11_21(3)_530-545.nxml.txt.nlp	21221130	SENT413	15	15	5	5	thrombin	PAC-1	PA451674	1844	0.875
NULL	Acta_Pharmacol_Sin_2009_Sep_24_30(9)_1262-1275.nxml.txt.nlp	19701231	SENT144	41	41	33	33	lovastatin	LRH-1	PA450272	2494	0.875
NULL	Oncogene_2014_Apr_3_33(14)_1828-1839.nxml.txt.nlp	23624914	SENT88	0	0	3	3	doxycycline	survivin	PA449415	332	0.875
NULL	Br_J_Cancer_2013_Jul_23_109(2)_502-511.nxml.txt.nlp	23799850	SENT200	16	16	22	22	gemcitabine	SMARCC1	PA449748	6599	0.875
NULL	Nucleic_Acids_Res_2012_Apr_16_40(8)_3511-3523.nxml.txt.nlp	22180533	SENT199	13	13	3	3	hydroxyurea	RAD51	PA449942	5888	0.875
NULL	J_Headache_Pain_2014_May_1_15(1)_24.nxml.txt.nlp	24885962	SENT150	17	17	26	26	sumatriptan	c-fos	PA451566	2353	0.875
NULL	Oncogene_2010_Sep_23_29(38)_5299-5310.nxml.txt.nlp	20622903	SENT64	26	26	5	5	paclitaxel	p53	PA450761	7157	0.875
NULL	Acta_Pharmacol_Sin_2010_Feb_5_31(2)_137-144.nxml.txt.nlp	20139896	SENT5	21	21	6	6	oxygen	5-LOX	PA450744	240	0.875
NULL	Case_Rep_Endocrinol_2013_Dec_22_2013_675298.nxml.txt.nlp	24455332	SENT185	18	18	1	1	etoposide	ACTH	PA449552	5443	0.875
NULL	J_Headache_Pain_2010_Oct_22_11(5)_431-435.nxml.txt.nlp	20652353	SENT14	8	8	13	13	almotriptan	CYP3A4	PA10246	1576	0.875
NULL	J_Biomed_Biotechnol_2011_Jan_19_2011_720603.nxml.txt.nlp	21331360	SENT173	11	11	25	25	diazepam	gamma	PA449283	9913	0.875
NULL	ScientificWorldJournal_2012_Dec_27_2012_740308.nxml.txt.nlp	23346021	SENT142	11	11	24	24	ethanol	GM-CSF	PA448073	1437	0.875
NULL	Arthritis_Res_Ther_2009_Mar_16_11(2)_R41.nxml.txt.nlp	19291317	SENT45	17	17	8	8	pentobarbital	ACL	PA450859	47	0.875
NULL	Front_Oncol_2014_Apr_9_4_75.nxml.txt.nlp	24782986	SENT238	16	16	41	41	paclitaxel	CD117	PA450761	3815	0.875
NULL	Breast_Cancer_Res_2012_Jul_12_14(4)_R105.nxml.txt.nlp	22788972	SENT195	4	4	19	19	hyaluronan	Rho	PA165958431	29984	0.875
NULL	Neural_Dev_2013_Sep_17_8_18.nxml.txt.nlp	24044555	SENT177	13	13	41	41	l-glutamine	CO2	PA10090	4513	0.875
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Apr_15_6_37-41.nxml.txt.nlp	24833915	SENT4	9	9	36	36	trastuzumab	HER2	PA451743	2064	0.875
NULL	Acta_Pharmacol_Sin_2009_Sep_17_30(9)_1316-1322.nxml.txt.nlp	19684609	SENT173	6	6	8	8	rosiglitazone	PTEN	PA451283	5728	0.875
NULL	Biomed_Res_Int_2014_Jan_29_2014_458592.nxml.txt.nlp	24592391	SENT25	5	5	16	16	curcumin	HO-1	PA151958596	3162	0.875
NULL	Clin_Mol_Hepatol_2012_Jun_26_18(2)_109-162.nxml.txt.nlp	22893865	SENT688	17	17	25	25	lamivudine	IFN	PA450163	3439	0.875
NULL	N_Am_J_Med_Sci_2012_Aug_4(8)_331-335.nxml.txt.nlp	22912940	SENT28	24	24	29	29	creatine	ACR	PA164778930	49	0.875
NULL	Oncotarget_2013_Jul_14_4(8)_1185-1198.nxml.txt.nlp	23852390	SENT222	2	2	20	20	bortezomib	AKT	PA10252	207	0.875
NULL	Mol_Cancer_2010_Jun_25_9_166.nxml.txt.nlp	20579378	SENT213	20	20	26	26	gefitinib	EGFR	PA131301952	1956	0.875
NULL	Breast_Cancer_Res_2010_Oct_14_12(5)_R84.nxml.txt.nlp	20946630	SENT300	5	5	27	27	choline	Hsp90	PA448976	3320	0.875
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jan_31_68(Pt_2)_o541.nxml.txt.nlp	22347135	SENT66	12	12	23	23	ethanol	mol	PA448073	90527	0.875
NULL	Nat_Commun_2014_Nov_19_5_5479.nxml.txt.nlp	25407222	SENT38	20	20	37	37	dextran	YTS	PA449261	8565	0.875
NULL	Oncotarget_2014_Jun_26_5(12)_3996-4010.nxml.txt.nlp	24994118	SENT62	5	5	19	19	dasatinib	AKT	PA162372878	207	0.875
NULL	J_Gen_Physiol_2013_Aug_142(2)_137-155.nxml.txt.nlp	23858003	SENT10	2	2	16	16	mibefradil	TREK-1	PA450492	3776	0.875
NULL	Osteoporos_Int_2011_Oct_27_22(10)_2709-2719.nxml.txt.nlp	21113576	SENT220	2	2	15	15	teriparatide	PDF	PA451620	64146;9518	0.875
NULL	J_Biomed_Biotechnol_2004_Jun_30_2004(2)_113-120.nxml.txt.nlp	15240922	SENT172	26	26	19	19	thyroglobulin	SAGE	PA164754910	55511	0.875
NULL	Br_J_Cancer_2009_Jul_7_101(1)_166-173.nxml.txt.nlp	19513072	SENT150	21	21	43	43	trastuzumab	UBE2C	PA451743	11065	0.875
NULL	Aging_(Albany_NY)_2013_Jan_26_4(12)_894-898.nxml.txt.nlp	23525940	SENT46	9	9	28	28	metformin	AMPK	PA450395	5563	0.875
NULL	J_Carcinog_2011_Nov_30_10_28.nxml.txt.nlp	22190870	SENT225	13	13	23	23	trastuzumab	PTPN11	PA451743	5781	0.875
NULL	Biomed_Res_Int_2013_Dec_17_2013_865197.nxml.txt.nlp	24455734	SENT47	9	9	21	21	isoniazid	EMB	PA450112	133418	0.875
NULL	Cancer_Med_2014_Aug_7_3(4)_796-811.nxml.txt.nlp	24802970	SENT302	3	3	17	17	amiloride	CD49f	PA448368	3655	0.875
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT207	42	42	21	21	metformin	HIP	PA450395	6767;6159;64399;5068	0.875
NULL	Leukemia_2013_Jan_11_27(1)_32-40.nxml.txt.nlp	22781593	SENT208	11	11	45	45	ponatinib	FGFR1	PA165980594	2260	0.875
NULL	Clin_Drug_Investig_2013_Aug_23_33(10)_727-736.nxml.txt.nlp	23975654	SENT80	3	3	21	21	fluconazole	P-gp	PA449653	5243	0.875
NULL	Int_J_Biomed_Sci_2008_Dec_4(4)_260-265.nxml.txt.nlp	19568323	SENT83	20	20	6	6	forskolin	BRCA1	PA146096022	672	0.875
NULL	Acta_Pharmacol_Sin_2011_Jun_3_32(6)_805-816.nxml.txt.nlp	21642949	SENT201	7	7	3	3	ekb-569	EGFR		1956	0.875
NULL	Acta_Pharmacol_Sin_2013_Feb_31_34(2)_231-238.nxml.txt.nlp	23274414	SENT174	5	5	13	13	amiloride	Bcl-2	PA448368	596	0.875
NULL	Acta_Pharmacol_Sin_2011_Jul_9_32(7)_879-887.nxml.txt.nlp	21552292	SENT100	0	0	25	25	metformin	AMPK	PA450395	5563	0.875
NULL	Case_Rep_Med_2014_Feb_10_2014_747280.nxml.txt.nlp	24660002	SENT99	17	17	14	14	rituximab	CHOP	PA451261	1649	0.875
NULL	Biosci_Rep_2014_Jun_25_34(3)_e00112.nxml.txt.nlp	24837198	SENT423	10	10	2	2	sorafenib	Bcl-2	PA7000	596	0.875
NULL	Infect_Dis_Ther_2014_Dec_24_3(2)_83-102.nxml.txt.nlp	25134686	SENT21	3	3	15	15	enfuvirtide	CRA	PA164744517	51747;10903	0.875
NULL	Diabetes_Care_2009_Sep_28_32(9)_1649-1655.nxml.txt.nlp	19478198	SENT152	15	15	6	6	saxagliptin	PPG	PA165958362	5552	0.875
NULL	Cancer_Manag_Res_2014_May_23_6_225-252.nxml.txt.nlp	24904222	SENT120	4	4	8	8	pertuzumab	HER2		2064	0.875
NULL	Eur_J_Clin_Pharmacol_2012_Jan_7_68(1)_55-64.nxml.txt.nlp	21735164	SENT25	17	17	15	15	oxymorphone	CYP2D6	PA450748	1565	0.875
NULL	Acta_Pharmacol_Sin_2014_Jul_9_35(7)_889-898.nxml.txt.nlp	24909515	SENT181	8	8	13	13	methamphetamine	SULT	PA450403	6816	0.875
NULL	Int_J_Endocrinol_2010_Aug_29_2010_481326.nxml.txt.nlp	20871656	SENT24	39	39	32	32	glucose	MPG	PA449773	4350	0.875
NULL	Scientifica_(Cairo)_2012_Oct_9_2012_821549.nxml.txt.nlp	24278743	SENT189	12	12	20	20	citalopram	5-HT1A	PA449015	3350	0.875
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1563-1573.nxml.txt.nlp	22015557	SENT10	22	22	3	3	sunitinib	c-Myc	PA162372840	4609	0.875
NULL	Oncotarget_2013_Nov_26_4(12)_2502-2511.nxml.txt.nlp	24318446	SENT101	18	18	0	0	doxycycline	PHGDH	PA449415	26227	0.875
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT202	5	5	7	7	tacrolimus	SOCS3	PA451578	9021	0.875
NULL	Mol_Cancer_2008_Sep_12_7_70.nxml.txt.nlp	18789133	SENT97	12	12	22	22	belinostat	CDKN1A		1026	0.875
NULL	Neuropsychopharmacology_2012_Feb_2_37(3)_641-650.nxml.txt.nlp	22048466	SENT98	4	4	26	26	bupropion	CYP2B6	PA448687	1555	0.875
NULL	Ann_Indian_Acad_Neurol_2010_Jul-Sep_13(3)_207-210.nxml.txt.nlp	21085534	SENT96	8	8	0	0	etanercept	TNF	PA449515	7124	0.875
NULL	Antimicrob_Agents_Chemother_2014_Aug_58(8)_4971-4973.nxml.txt.nlp	24913169	SENT78	16	16	28	28	primaquine	G6PD	PA451103	2539	0.875
NULL	Breast_Cancer_Res_2012_Jul_19_14(4)_R108.nxml.txt.nlp	22812534	SENT197	3	3	10	10	pargyline	aromatase	PA450797	1588	0.875
NULL	Acta_Pharmacol_Sin_2012_Feb_3_33(2)_145-147.nxml.txt.nlp	22301854	SENT31	16	16	6	6	liraglutide	GLP-1	PA165958364	100125288	0.875
NULL	Cardiovasc_Ther_2009_27(4)_259-274.nxml.txt.nlp	19604248	SENT57	43	43	18	18	ticagrelor	ADP	PA165374673	23038	0.875
NULL	Environ_Health_Perspect_2005_Jun_10_113(6)_659-664.nxml.txt.nlp	15929885	SENT41	6	6	16	16	arsenite	c-Jun	PA452638	3725	0.875
NULL	Toxins_(Basel)_2010_Oct_26_2(11)_2490-2518.nxml.txt.nlp	22069563	SENT221	12	12	5	5	cisplatin	TLR4	PA449014	7099	0.875
NULL	Mol_Clin_Oncol_2013_Sep_24_1(5)_918-924.nxml.txt.nlp	24649271	SENT92	7	7	18	18	gemcitabine	EGFR	PA449748	1956	0.875
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Aug_1_68(Pt_9)_o2615-o2616.nxml.txt.nlp	22969518	SENT69	23	23	13	13	ethanol	mol	PA448073	90527	0.875
NULL	Eur_J_Clin_Pharmacol_2011_Dec_23_67(12)_1231-1241.nxml.txt.nlp	21698374	SENT268	17	17	6	6	cyclosporine	CYP3A5	PA449167	1577	0.875
NULL	Cancers_(Basel)_2014_Aug_12_6(3)_1631-1669.nxml.txt.nlp	25119536	SENT438	9	9	18	18	cisplatin	NK4	PA449014	9235	0.875
NULL	Cell_Death_Dis_2010_Jul_1_1(7)_e51.nxml.txt.nlp	21364656	SENT221	14	14	8	8	gentamicin	survivin	PA449753	332	0.875
NULL	Indian_J_Pharmacol_2013_Mar-Apr_45(2)_195-196.nxml.txt.nlp	23716902	SENT5	13	13	5	5	aripiprazole	EOS	PA10026	260429	0.875
NULL	J_Cardiothorac_Surg_2010_Apr_5_5_20.nxml.txt.nlp	20367880	SENT44	15	15	20	20	heparin	ACT	PA449855	12;11332;9457;641455	0.875
NULL	Biochem_Res_Int_2012_Feb_12_2012_346972.nxml.txt.nlp	22400115	SENT57	31	31	23	23	hyaluronan	LYVE-1	PA165958431	10894	0.875
NULL	Oncol_Lett_2013_Mar_28_5(3)_935-942.nxml.txt.nlp	23426424	SENT142	40	40	30	30	oxaliplatin	ERCC1	PA131285527	2067	0.875
NULL	Diabetes_2008_Sep_57(9)_2470-2479.nxml.txt.nlp	18511847	SENT141	21	21	6	6	pioglitazone	adiponectin	PA450970	9370	0.875
NULL	Oncotarget_2012_Sep_28_3(10)_1169-1181.nxml.txt.nlp	23045411	SENT185	30	30	33	33	doxorubicin	JIP1	PA449412	9479	0.875
NULL	Br_J_Cancer_2010_May_25_102(11)_1600-1607.nxml.txt.nlp	20461087	SENT171	3	3	14	14	cisplatin	ERCC1	PA449014	2067	0.875
NULL	Curr_Med_Chem_2014_May_21(14)_1595-1606.nxml.txt.nlp	23992330	SENT66	24	24	17	17	trastuzumab	HER2	PA451743	2064	0.875
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Dec_17_65(Pt_1)_m82-m83.nxml.txt.nlp	21581547	SENT73	37	37	15	15	ethanol	mol	PA448073	90527	0.875
NULL	Anesth_Pain_Med_2013_Dec_27_4(1)_e11906.nxml.txt.nlp	24660144	SENT39	37	37	26	26	rituximab	VIII	PA451261	1351	0.875
NULL	Br_J_Haematol_2014_Mar_13_164(1)_811-821.nxml.txt.nlp	24328678	SENT133	6	6	13	13	lenalidomide	Aiolos	PA162363968	22806	0.875
NULL	Adv_Hematol_2012_Aug_2_2012_842945.nxml.txt.nlp	22919394	SENT94	9	9	26	26	lenalidomide	cIAP2	PA162363968	330	0.875
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S251-S257.nxml.txt.nlp	21525464	SENT173	16	16	28	28	metformin	GLP-1	PA450395	100125288	0.875
NULL	J_Mol_Med_2011_Jul_23_89(7)_667-676.nxml.txt.nlp	21431325	SENT59	27	27	6	6	curcumin	AMPK	PA151958596	5563	0.875
NULL	Indian_J_Anaesth_2012_Jul-Aug_56(4)_430-431.nxml.txt.nlp	23087482	SENT44	5	5	14	14	heparin	ACT	PA449855	12;11332;9457;641455	0.875
NULL	Int_J_Biol_Sci_2013_Aug_27_9(8)_842-852.nxml.txt.nlp	23983617	SENT214	40	40	43	43	heparin	PPX	PA449855	5531	0.875
NULL	J_Breast_Cancer_2011_Jun_18_14(2)_135-139.nxml.txt.nlp	21847409	SENT21	19	19	27	27	tamoxifen	aromatase	PA451581	1588	0.875
NULL	Br_J_Cancer_2011_Mar_15_104(6)_941-947.nxml.txt.nlp	21407223	SENT158	8	8	22	22	sorafenib	Bcl-2	PA7000	596	0.875
NULL	Neuro_Oncol_2010_Mar_6_12(3)_233-242.nxml.txt.nlp	20167811	SENT179	8	8	3	3	bevacizumab	U87	PA130232992	677775;641648	0.875
NULL	Neural_Regen_Res_2014_Mar_15_9(6)_622-629.nxml.txt.nlp	25206865	SENT13	42	42	23	23	vasopressin	c-Jun	PA451858	3725	0.875
NULL	Acta_Neuropathol_2012_Mar_16_123(3)_369-380.nxml.txt.nlp	22083253	SENT140	12	12	5	5	imatinib	NF1	PA10804	4763	0.875
NULL	Cancer_Med_2014_Dec_13_3(6)_1579-1594.nxml.txt.nlp	25124282	SENT233	14	14	5	5	cisplatin	DNA-PKcs	PA449014	5591	0.875
NULL	Br_J_Pharmacol_2013_Jun_27_169(4)_736-747.nxml.txt.nlp	23489111	SENT168	3	3	12	12	mefloquine	5-HT3A	PA450348	3359	0.875
NULL	Oncogene_2010_Sep_16_29(37)_5193-5203.nxml.txt.nlp	20581867	SENT122	27	27	7	7	lapatinib	HRG	PA152241907	3084;3273	0.875
NULL	Mol_Pain_2013_May_20_9_25.nxml.txt.nlp	23688027	SENT197	20	20	30	30	carrageenan	TRPV1	PA448814	7442	0.875
NULL	Carcinogenesis_2013_Mar_7_34(3)_703-712.nxml.txt.nlp	23222814	SENT148	14	14	5	5	curcumin	AKT	PA151958596	207	0.875
NULL	J_Gen_Physiol_2000_Jun_1_115(6)_685-696.nxml.txt.nlp	10828243	SENT116	13	13	3	3	genistein	OLF	PA165109660	83857	0.875
NULL	Cell_Microbiol_2011_Jul_26_13(7)_955-966.nxml.txt.nlp	21518218	SENT245	9	9	20	20	dantrolene	PI-PLC	PA449208	2923	0.875
NULL	Br_J_Cancer_2013_Feb_19_108(3)_668-675.nxml.txt.nlp	23348520	SENT114	19	19	3	3	panitumumab	HER2	PA162373091	2064	0.875
NULL	Mol_Cancer_2012_May_14_11_33.nxml.txt.nlp	22583829	SENT151	30	30	10	10	cisplatin	IL-6	PA449014	3569	0.875
NULL	Exp_Diabetes_Res_2010_Feb_17_2010_686734.nxml.txt.nlp	21403818	SENT167	20	20	17	17	pimozide	5-HT7	PA450965	3363	0.875
NULL	J_Asthma_Allergy_2008_Sep_19_1_19-29.nxml.txt.nlp	21436982	SENT110	30	30	19	19	fexofenadine	RANTES	PA449621	6352	0.875
NULL	Pharmaceuticals_(Basel)_2013_Aug_21_6(8)_988-1038.nxml.txt.nlp	24276379	SENT2132	27	27	4	4	leucovorin	UGT1A1	PA450198	54658	0.875
NULL	Oncol_Rep_2013_Apr_23_29(4)_1268-1274.nxml.txt.nlp	23354756	SENT192	8	8	39	39	trastuzumab	SLC25A43	PA451743	203427	0.875
NULL	J_Infect_Dis_2011_May_1_203(9)_1204-1214.nxml.txt.nlp	21459813	SENT57	20	20	3	3	raltegravir	INI		84844	0.875
NULL	Arthritis_Res_Ther_2011_Feb_10_13(1)_R26.nxml.txt.nlp	21329504	SENT175	21	21	23	23	sulfasalazine	TNF	PA451547	7124	0.875
NULL	Br_J_Cancer_2012_Apr_10_106(8)_1367-1373.nxml.txt.nlp	22454081	SENT167	31	31	7	7	trastuzumab	EGFR	PA451743	1956	0.875
NULL	Comp_Hepatol_2005_Feb_8_4_2.nxml.txt.nlp	15701172	SENT153	6	6	13	13	ketoconazole	CYP3A	PA450146	1574	0.875
NULL	Pharmaceuticals_(Basel)_2014_Feb_11_7(2)_192-206.nxml.txt.nlp	24521925	SENT21	44	44	0	0	nadh	GPD2	PA164755085	2820	0.875
NULL	J_Hematol_Oncol_2012_Apr_25_5(Suppl_1)_A1.nxml.txt.nlp	22738713	SENT3	0	0	7	7	cetuximab	EGFR	PA10040	1956	0.875
NULL	Biol_Open_2013_Aug_6_2(10)_1022-1031.nxml.txt.nlp	24167712	SENT287	6	6	28	28	doxycycline	PLK1	PA449415	5347	0.875
NULL	Int_J_Nanomedicine_2010_Feb_2_5_13-23.nxml.txt.nlp	20161984	SENT23	9	9	12	12	simvastatin	BCS	PA451363	617	0.875
NULL	Am_J_Cardiovasc_Drugs_2013_Jun_20_13(5)_331-342.nxml.txt.nlp	23784266	SENT195	4	4	14	14	verapamil	P-gp	PA451868	5243	0.875
NULL	J_Nutr_Metab_2012_Apr_10_2012_431574.nxml.txt.nlp	22570769	SENT157	11	11	18	18	sertraline	TPH1	PA451333	7166	0.875
NULL	Breast_Cancer_2014_Feb_13_21(6)_703-714.nxml.txt.nlp	23404211	SENT53	37	37	23	23	anastrozole	HER2	PA448432	2064	0.875
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_23_2013_941093.nxml.txt.nlp	23864901	SENT247	0	0	2	2	omeprazole	CYP2C19	PA450704	1557	0.875
NULL	Ann_Oncol_2012_Dec_2_23(12)_3007-3016.nxml.txt.nlp	22865781	SENT70	16	16	25	25	trastuzumab	HER2	PA451743	2064	0.875
NULL	Cancers_(Basel)_2014_Mar_6_6(1)_494-525.nxml.txt.nlp	24662938	SENT99	13	13	30	30	dasatinib	STAT3	PA162372878	6774	0.875
NULL	ScientificWorldJournal_2014_Mar_24_2014_694326.nxml.txt.nlp	24782665	SENT64	14	14	40	40	metformin	ANOVA	PA450395	4858	0.875
NULL	Aging_Cell_2012_Aug_11(4)_579-587.nxml.txt.nlp	22435726	SENT89	18	18	9	9	etoposide	CD28	PA449552	1493;940	0.875
NULL	Br_J_Cancer_2013_Feb_19_108(3)_668-675.nxml.txt.nlp	23348520	SENT27	19	19	7	7	gefitinib	HER2	PA131301952	2064	0.875
NULL	Oncotarget_2012_Oct_20_3(10)_1236-1245.nxml.txt.nlp	23100449	SENT105	20	20	13	13	doxorubicin	NGAL	PA449412	3934	0.875
NULL	Iran_J_Reprod_Med_2012_Jan_10(1)_33-40.nxml.txt.nlp	25242972	SENT135	11	11	9	9	letrozole	aromatase	PA450196	1588	0.875
NULL	Acta_Histochem_Cytochem_2008_Dec_27_41(6)_149-155.nxml.txt.nlp	19180199	SENT70	33	33	23	23	colchicine	TGN38	PA449092	10618	0.875
NULL	Eur_Respir_J_2014_Jul_23_44(1)_23-63.nxml.txt.nlp	24659544	SENT281	10	10	3	3	ethambutol	LPA	PA164784021	4018	0.875
NULL	Br_J_Pharmacol_2013_Jun_27_169(4)_736-747.nxml.txt.nlp	23489111	SENT169	4	4	22	22	mefloquine	5-HT3A	PA450348	3359	0.875
NULL	Int_J_Mol_Sci_2012_Sep_25_13(10)_12153-12168.nxml.txt.nlp	23202889	SENT104	9	9	19	19	cetuximab	KRAS	PA10040	3845	0.875
NULL	Crit_Care_2009_Mar_16_13(2)_R37.nxml.txt.nlp	19291300	SENT66	31	31	3	3	urea	SWA	PA451831	50618	0.875
NULL	Front_Genet_2012_Nov_22_3_249.nxml.txt.nlp	23189085	SENT63	14	14	10	10	cyclophosphamide	GSTP1	PA449165	2950	0.875
NULL	Mol_Biol_Cell_2014_Mar_15_25(6)_739-752.nxml.txt.nlp	24430869	SENT288	5	5	14	14	pp2	EGF		1950	0.875
NULL	Evid_Based_Complement_Alternat_Med_2013_May_22_2013_921012.nxml.txt.nlp	23762167	SENT34	12	12	20	20	glucose	AMPK	PA449773	5563	0.875
NULL	Int_J_Mol_Sci_2014_Mar_18_15(3)_4747-4779.nxml.txt.nlp	24646914	SENT372	8	8	11	11	maraviroc	CXCR4	PA164768835	7852	0.875
NULL	Nat_Commun_2013_Aug_15_4_2130.nxml.txt.nlp	23945651	SENT721	7	7	11	11	etoposide	ATG5	PA449552	9474	0.875
NULL	Curr_Neuropharmacol_2013_Dec_11(6)_652-663.nxml.txt.nlp	24396340	SENT193	4	4	28	28	isoflurane	TRPA1	PA450106	8989	0.875
NULL	J_Gen_Physiol_1997_Dec_1_110(6)_643-654.nxml.txt.nlp	9382893	SENT151	6	6	18	18	diazoxide	SUR1	PA449285	6833	0.875
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT192	12	12	7	7	cisplatin	AKT	PA449014	207	0.875
NULL	Lab_Invest_2013_Dec_14_93(12)_1265-1275.nxml.txt.nlp	24126890	SENT301	19	19	3	3	celecoxib	JAM-A	PA448871	50848	0.875
NULL	Contemp_Oncol_(Pozn)_2013_Apr_29_17(2)_128-133.nxml.txt.nlp	23788978	SENT44	19	19	33	33	oxymorphone	CYP2D6	PA450748	1565	0.875
NULL	Oncol_Lett_2013_Dec_18_6(6)_1539-1542.nxml.txt.nlp	24260043	SENT83	12	12	5	5	doxorubicin	NDRG1	PA449412	10397	0.875
NULL	Oncol_Rep_2014_Mar_14_31(3)_1035-1042.nxml.txt.nlp	24424445	SENT146	0	0	19	19	metformin	AMPK	PA450395	5563	0.875
NULL	Oncol_Lett_2013_Feb_27_5(2)_435-439.nxml.txt.nlp	23420613	SENT87	14	14	8	8	erlotinib	EGFR	PA134687924	1956	0.875
NULL	Ann_Rehabil_Med_2012_Aug_27_36(4)_466-473.nxml.txt.nlp	22977771	SENT22	6	6	0	0	hyaluronidase	ILEI	PA164745713	10447	0.875
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Apr_7_9_12.nxml.txt.nlp	20374640	SENT48	18	18	41	41	chloramphenicol	BSAC	PA448927	57591	0.875
NULL	Int_J_Mol_Sci_2014_Oct_14_15(10)_18557-18573.nxml.txt.nlp	25318057	SENT100	13	13	21	21	doxorubicin	TRAIL-R2	PA449412	8795	0.875
NULL	Arthritis_Res_Ther_2013_Apr_17_15(2)_R51.nxml.txt.nlp	23594962	SENT277	8	8	22	22	muraglitazar	IL-6	PA162356187	3569	0.875
NULL	Oncotarget_2014_Nov_28_5(22)_11737-11751.nxml.txt.nlp	25473889	SENT233	31	31	9	9	ethanol	p53	PA448073	7157	0.875
NULL	Clin_Pediatr_Endocrinol_2009_May_1_18(2)_65-72.nxml.txt.nlp	24790382	SENT114	8	8	21	21	cabergoline	PRL	PA448708	5617	0.875
NULL	Cancer_Cell_Int_2013_Feb_8_13_11.nxml.txt.nlp	23394616	SENT107	7	7	20	20	geldanamycin	Hsp90	PA152031327	3320	0.875
NULL	Exp_Neurobiol_2014_Mar_27_23(1)_65-76.nxml.txt.nlp	24737941	SENT126	21	21	12	12	staurosporine	TRAP1	PA165109623	9392;10131	0.875
NULL	J_Cell_Biol_2004_Feb_16_164(4)_527-534.nxml.txt.nlp	14769862	SENT49	25	25	13	13	forskolin	CO2	PA146096022	4513	0.875
NULL	Oncotarget_2011_Mar_27_2(3)_209-221.nxml.txt.nlp	21444945	SENT161	13	13	27	27	bortezomib	p53	PA10252	7157	0.875
NULL	Front_Immunol_2013_May_15_4_116.nxml.txt.nlp	23720663	SENT294	12	12	17	17	rituximab	CD25	PA451261	3669;3559	0.875
NULL	Oncoscience_2014_Oct_24_1(10)_665-673.nxml.txt.nlp	25593995	SENT77	19	19	13	13	doxorubicin	MDR1	PA449412	5243	0.875
NULL	Front_Pharmacol_2014_May_30_5_132.nxml.txt.nlp	24910615	SENT134	8	8	18	18	estradiol	PDE7B	PA449503	27115	0.875
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jun_25_67(Pt_7)_o1809.nxml.txt.nlp	21837180	SENT64	12	12	7	7	ethanol	mol	PA448073	90527	0.875
NULL	Exp_Brain_Res_2014_Nov_30_232(3)_765-773.nxml.txt.nlp	24292518	SENT159	12	12	1	1	haloperidol	ERG	PA449841	2078	0.875
NULL	Environ_Health_Perspect_2009_Apr_12_117(4)_624-631.nxml.txt.nlp	19440503	SENT33	27	27	10	10	estradiol	aromatase	PA449503	1588	0.875
NULL	ScientificWorldJournal_2014_Mar_23_2014_183147.nxml.txt.nlp	24790551	SENT25	8	8	13	13	aprepitant	NK1	PA164747039	11126	0.875
NULL	Front_Neurosci_2014_Dec_11_8_389.nxml.txt.nlp	25561905	SENT279	0	0	12	12	fentanyl	NeuroD	PA449599	4760	0.875
NULL	Nat_Prod_Bioprospect_2014_Jun_21_4(3)_181-188.nxml.txt.nlp	24955300	SENT49	32	32	0	0	phenol	B12	PA450913	7126;4709	0.875
NULL	Eur_J_Neurosci_2008_Jun_27(11)_2783-2802.nxml.txt.nlp	18588525	SENT230	8	8	14	14	l-arginine	NOS	PA448478	4843	0.875
NULL	Br_J_Cancer_2013_Apr_16_108(7)_1408-1414.nxml.txt.nlp	23511562	SENT36	9	9	16	16	tamoxifen	aromatase	PA451581	1588	0.875
NULL	Int_J_Womens_Health_2012_Oct_10_4_543-549.nxml.txt.nlp	23091400	SENT7	18	18	3	3	drospirenone	aromatase	PA164749409	1588	0.875
NULL	Exp_Diabetes_Res_2012_Oct_15_2012_465282.nxml.txt.nlp	23118742	SENT129	6	6	9	9	metformin	FGF21	PA450395	26291	0.875
NULL	AIDS_Res_Treat_2012_Jul_5_2012_874083.nxml.txt.nlp	22829999	SENT133	13	13	15	15	ethambutol	EMB	PA164784021	133418	0.875
NULL	Breast_Cancer_Res_2005_Jul_20_7(5)_205-211.nxml.txt.nlp	16168139	SENT123	11	11	26	26	gefitinib	AIB1	PA131301952	8202	0.875
NULL	Br_J_Cancer_2004_Mar_22_90(6)_1285-1292.nxml.txt.nlp	15026814	SENT15	10	10	15	15	doxorubicin	P-gp	PA449412	5243	0.875
NULL	Cell_Logist_2012_Apr_1_2(2)_117-125.nxml.txt.nlp	23162743	SENT70	0	0	4	4	curcumin	PAK1	PA151958596	5585;5058	0.875
NULL	Oncol_Lett_2014_Sep_19_8(3)_1320-1322.nxml.txt.nlp	25120716	SENT35	5	5	24	24	gemcitabine	DDP	PA449748	1678	0.875
NULL	Oncotarget_2013_Nov_24_4(12)_2430-2438.nxml.txt.nlp	24280348	SENT28	3	3	14	14	gefitinib	SOCS3	PA131301952	9021	0.875
NULL	Arthritis_Res_Ther_2009_Nov_4_11(6)_R165.nxml.txt.nlp	19889203	SENT354	36	36	28	28	curcumin	p65	PA151958596	5970	0.875
NULL	Indian_J_Med_Res_2011_Nov_134(5)_704-708.nxml.txt.nlp	22199111	SENT22	35	35	7	7	vancomycin	VISA	PA451850	57506	0.875
NULL	Cancer_Cell_Int_2010_May_11_10_16.nxml.txt.nlp	20459793	SENT86	18	18	40	40	cisplatin	CDKN1A	PA449014	1026	0.875
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT435	17	17	24	24	haloperidol	PRL	PA449841	5617	0.875
NULL	Br_J_Cancer_2012_Jul_10_107(2)_230-233.nxml.txt.nlp	22735900	SENT4	25	25	11	11	tamoxifen	CYP2D6	PA451581	1565	0.875
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT46	2	2	14	14	dasatinib	LYN	PA162372878	4067	0.875
NULL	Cancers_(Basel)_2014_Nov_25_6(4)_2313-2329.nxml.txt.nlp	25534569	SENT82	12	12	36	36	crizotinib	HGF	PA165946122	3569;6654;3082	0.875
NULL	Cancer_Immunol_Immunother_2012_Jul_23_61(7)_1101-1111.nxml.txt.nlp	22193989	SENT37	7	7	30	30	oxaliplatin	STAT6	PA131285527	6778	0.875
NULL	J_Biomed_Biotechnol_2010_Mar_3_2010_289360.nxml.txt.nlp	20204129	SENT161	9	9	20	20	triamcinolone	MMP8	PA451749	4317	0.875
NULL	Breast_Cancer_Res_2009_Jul_15_11(4)_207.nxml.txt.nlp	19664181	SENT153	6	6	21	21	pertuzumab	HER2		2064	0.875
NULL	Diabetes_2009_Dec_31_58(12)_2851-2862.nxml.txt.nlp	19720788	SENT290	5	5	19	19	forskolin	BiP	PA146096022	3309	0.875
NULL	Cases_J_2008_Jun_5_1_15.nxml.txt.nlp	18577260	SENT78	14	14	20	20	vincristine	CHOP	PA451879	1649	0.875
NULL	Clin_Ophthalmol_2012_Oct_30_6_1749-1753.nxml.txt.nlp	23152652	SENT11	6	6	32	32	travoprost	ANOVA	PA164781371	4858	0.875
NULL	Arthritis_Res_Ther_2009_Aug_28_11(4)_R131.nxml.txt.nlp	19715572	SENT120	7	7	22	22	rituximab	CD25	PA451261	3669;3559	0.875
NULL	Diabetes_2009_Feb_58(2)_329-336.nxml.txt.nlp	19171749	SENT128	37	37	19	19	imatinib	JNK	PA10804	5599	0.875
NULL	Evid_Based_Complement_Alternat_Med_2012_Dec_31_2012_364604.nxml.txt.nlp	23365596	SENT356	3	3	40	40	curcumin	RANKL	PA151958596	8600	0.875
NULL	Case_Rep_Oncol_2010_Apr_29_3(2)_137-141.nxml.txt.nlp	20740186	SENT17	16	16	25	25	tamoxifen	GCDFP-15	PA451581	5304	0.875
NULL	Neuro_Oncol_2010_Apr_27_12(4)_389-400.nxml.txt.nlp	20308316	SENT117	13	13	32	32	chloroquine	p53	PA448948	7157	0.875
NULL	Oncotarget_2013_Oct_19_4(11)_2045-2056.nxml.txt.nlp	24185104	SENT144	31	31	20	20	cisplatin	14-3-3	PA449014	10971	0.875
NULL	Patient_Prefer_Adherence_2010_Sep_7_4_313-324.nxml.txt.nlp	20859458	SENT50	11	11	2	2	exenatide	AMIGO	PA164749238	57463	0.875
NULL	Nat_Commun_2014_Aug_22_5_4684.nxml.txt.nlp	25147954	SENT324	3	3	12	12	adalimumab	IL-17	PA10004	3605	0.875
NULL	Front_Oncol_2013_Sep_11_3_228.nxml.txt.nlp	24062981	SENT275	24	24	28	28	olaparib	BRCA1		672	0.875
NULL	J_Gen_Physiol_2013_Dec_142(6)_561-573.nxml.txt.nlp	24277600	SENT250	12	12	23	23	creatine	ADP	PA164778930	23038	0.875
NULL	Mol_Cancer_2010_Jun_7_9_139.nxml.txt.nlp	20529262	SENT196	0	0	3	3	cetuximab	EGFR	PA10040	1956	0.875
NULL	Clinics_(Sao_Paulo)_2012_Apr_67(Suppl_1)_125-129.nxml.txt.nlp	22584717	SENT61	2	2	28	28	sunitinib	VEGFR	PA162372840	3791	0.875
NULL	Crit_Care_2010_Mar_15_14(2)_R30.nxml.txt.nlp	20226064	SENT207	4	4	16	16	clonidine	IL-6	PA449051	3569	0.875
NULL	Leukemia_2013_Apr_14_27(4)_803-812.nxml.txt.nlp	23238589	SENT37	15	15	4	4	imatinib	IFN	PA10804	3439	0.875
NULL	Cell_Commun_Signal_2011_May_20_9_14.nxml.txt.nlp	21599982	SENT73	22	22	16	16	pp2	p38		10598;1432;7965	0.875
NULL	J_Lipid_Res_2011_May_52(5)_873-884.nxml.txt.nlp	21324916	SENT265	7	7	22	22	bezafibrate	aP2	PA162364313	2167	0.875
NULL	Fibrogenesis_Tissue_Repair_2010_Aug_25_3_15.nxml.txt.nlp	20738867	SENT261	13	13	10	10	imatinib	IFN	PA10804	3439	0.875
NULL	J_Thromb_Haemost_2008_Apr_1_6(4)_583-588.nxml.txt.nlp	18194418	SENT141	20	20	28	28	desmopressin	VWF	PA449237	7450	0.875
NULL	Mol_Biol_Cell_2012_Nov_1_23(21)_4212-4225.nxml.txt.nlp	22956765	SENT189	8	8	31	31	thrombin	SHP2	PA451674	5781	0.875
NULL	Mol_Cancer_2014_Jun_24_13_157.nxml.txt.nlp	24958351	SENT131	14	14	26	26	lapatinib	AKT	PA152241907	207	0.875
NULL	Oncoscience_2014_Mar_12_1(2)_167-179.nxml.txt.nlp	25126591	SENT224	7	7	3	3	trastuzumab	PTEN	PA451743	5728	0.875
NULL	Core_Evid_2007_Nov_30_2(2)_121-129.nxml.txt.nlp	21221180	SENT234	34	34	31	31	rituximab	CHOP	PA451261	1649	0.875
NULL	Breast_Cancer_Res_2007_Oct_26_9(5)_112.nxml.txt.nlp	17980056	SENT37	7	7	10	10	gefitinib	aromatase	PA131301952	1588	0.875
NULL	Infect_Drug_Resist_2010_Apr_22_3_5-14.nxml.txt.nlp	21694889	SENT105	8	8	28	28	linezolid	VISA	PA450233	57506	0.875
NULL	Acta_Pharmacol_Sin_2014_Jun_4_35(6)_792-805.nxml.txt.nlp	24902787	SENT79	15	15	10	10	paroxetine	INS-1	PA450801	2305	0.875
NULL	Tuberc_Respir_Dis_(Seoul)_2014_Dec_31_77(6)_271-273.nxml.txt.nlp	25580145	SENT22	6	6	15	15	gefitinib	EGFR	PA131301952	1956	0.875
NULL	J_Breast_Cancer_2013_Mar_31_16(1)_23-31.nxml.txt.nlp	23593078	SENT150	18	18	11	11	curcumin	DNMT1	PA151958596	1786	0.875
NULL	J_Geriatr_Cardiol_2012_Jun_9(2)_180-184.nxml.txt.nlp	22916066	SENT4	28	28	13	13	rosuvastatin	Rho	PA134308647	29984	0.875
NULL	Cardiol_Res_Pract_2014_Mar_11_2014_943162.nxml.txt.nlp	24711954	SENT103	6	6	0	0	lipase	IL-6	PA450239	3569	0.875
NULL	Arthritis_Res_Ther_2009_Aug_3_11(4)_238.nxml.txt.nlp	19678909	SENT74	3	3	14	14	hydroquinone	CD4	PA449924	920	0.875
NULL	Biologics_2014_Apr_23_8_183-192.nxml.txt.nlp	24790411	SENT3	29	29	21	21	gefitinib	EGFR	PA131301952	1956	0.875
NULL	Br_J_Cancer_2006_Feb_13_94(3)_407-426.nxml.txt.nlp	16434996	SENT230	30	30	3	3	genistein	BRCA1	PA165109660	672	0.875
NULL	Exp_Hematol_Oncol_2014_Mar_11_3_7.nxml.txt.nlp	24618035	SENT30	21	21	0	0	imatinib	ABL1	PA10804	25	0.875
NULL	Evid_Based_Complement_Alternat_Med_2014_May_8_2014_364819.nxml.txt.nlp	24899907	SENT4	12	12	1	1	tacrolimus	FKBP52	PA451578	2288	0.875
NULL	Oncotarget_2014_Oct_21_5(22)_11252-11268.nxml.txt.nlp	25361004	SENT35	8	8	2	2	metformin	CLIC1	PA450395	1192	0.875
NULL	Diabetes_Metab_Syndr_Obes_2010_May_10_3_125-143.nxml.txt.nlp	21437083	SENT117	34	34	8	8	lipase	flower	PA450239	11094	0.875
NULL	Oncotarget_2014_Nov_3_5(20)_10127-10139.nxml.txt.nlp	25333256	SENT146	4	4	19	19	vemurafenib	TRIM16	PA165946873	10626	0.875
NULL	Indian_J_Pharm_Sci_2014_Mar-Apr_76(2)_166-169.nxml.txt.nlp	24843191	SENT29	0	0	9	9	nebivolol	HEC	PA151958426	10403	0.875
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT78	0	0	8	8	methotrexate	MSH2	PA450428	4436	0.875
NULL	Oncoimmunology_2014_Jan_10_3_e27659.nxml.txt.nlp	24778928	SENT13	13	13	35	35	dextran	CD4	PA449261	920	0.875
NULL	Braz_J_Med_Biol_Res_2013_Aug_13_46(8)_650-658.nxml.txt.nlp	23969971	SENT186	2	2	14	14	cisplatin	STAT3	PA449014	6774	0.875
NULL	J_Thromb_Haemost_2007_May_1_5(5)_910-917.nxml.txt.nlp	17362227	SENT150	12	12	23	23	thrombin	P2X1	PA451674	5023	0.875
NULL	Oncol_Lett_2013_Mar_28_5(3)_935-942.nxml.txt.nlp	23426424	SENT118	35	35	2	2	oxaliplatin	ERCC1	PA131285527	2067	0.875
NULL	J_Immunol_Res_2014_Feb_5_2014_632307.nxml.txt.nlp	24741610	SENT82	18	18	33	33	ranibizumab	San	PA164746012	80218	0.875
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jul_7_68(Pt_8)_o2392-o2393.nxml.txt.nlp	22904850	SENT72	22	22	7	7	ethanol	mol	PA448073	90527	0.875
NULL	Arthritis_Res_Ther_2008_Aug_22_10(4)_R97.nxml.txt.nlp	18718031	SENT182	4	4	12	12	rituximab	BAFF	PA451261	10673	0.875
NULL	J_Breast_Cancer_2014_Jun_27_17(2)_113-120.nxml.txt.nlp	25013431	SENT35	0	0	2	2	tamoxifen	aromatase	PA451581	1588	0.875
NULL	Oncol_Rep_2013_Mar_8_29(3)_917-924.nxml.txt.nlp	23314174	SENT9	5	5	9	9	sorafenib	CD44	PA7000	960	0.875
NULL	Br_J_Cancer_2009_Nov_3_101(9)_1620-1629.nxml.txt.nlp	19809428	SENT5	0	0	8	8	geldanamycin	CXCR2	PA152031327	3579	0.875
NULL	Case_Rep_Dermatol_2011_Oct_11_3(3)_223-227.nxml.txt.nlp	22135629	SENT54	0	0	7	7	trastuzumab	HER2	PA451743	2064	0.875
NULL	J_Gynecol_Oncol_2014_Jan_8_25(1)_22-29.nxml.txt.nlp	24459577	SENT148	30	30	28	28	bleomycin	NACT	PA448645	284111	0.875
NULL	Clin_Ophthalmol_2011_Jun_9_5_771-781.nxml.txt.nlp	21750610	SENT3	18	18	25	25	ranibizumab	San	PA164746012	80218	0.875
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S31-S40.nxml.txt.nlp	20680106	SENT28	9	9	24	24	panitumumab	KRAS	PA162373091	3845	0.875
NULL	Cardiol_Res_Pract_2013_Jan_31_2013_128795.nxml.txt.nlp	23431496	SENT129	9	9	6	6	prasugrel	P2Y12	PA154410481	64805	0.875
NULL	J_Oncol_2013_Feb_17_2013_872957.nxml.txt.nlp	23476648	SENT36	20	20	35	35	cisplatin	SFN	PA449014	25996;2810	0.875
NULL	J_Obes_2011_Dec_15_2011_928165.nxml.txt.nlp	21197151	SENT55	46	46	18	18	orlistat	GIT	PA164776864	5034	0.875
NULL	Oncotarget_2013_Aug_9_4(9)_1332-1333.nxml.txt.nlp	23934763	SENT9	16	16	11	11	imatinib	ABL1	PA10804	25	0.875
NULL	Cancer_Cell_Int_2012_Jul_4_12_19.nxml.txt.nlp	22631225	SENT194	5	5	2	2	heparin	PPIA	PA449855	5478	0.875
NULL	J_Korean_Med_Sci_2010_Jun_24_25(6)_829-834.nxml.txt.nlp	20514301	SENT140	16	16	4	4	papain	IL-25	PA450778	64806;56005	0.875
NULL	J_Radiat_Res_2014_Mar_26_55(2)_205-209.nxml.txt.nlp	23979075	SENT92	7	7	16	16	fludarabine	CD25	PA449655	3669;3559	0.875
NULL	Mol_Cancer_2014_Jun_20_13_155.nxml.txt.nlp	24950741	SENT16	6	6	16	16	bortezomib	p53	PA10252	7157	0.875
NULL	Oncogene_2010_Nov_18_29(46)_6115-6124.nxml.txt.nlp	20729912	SENT99	24	24	12	12	doxorubicin	ABCB5	PA449412	340273	0.875
NULL	Breast_Cancer_Res_2012_Nov_14_14(6)_R146.nxml.txt.nlp	23151593	SENT3	8	8	10	10	tamoxifen	aromatase	PA451581	1588	0.875
NULL	J_Adv_Pharm_Technol_Res_2012_Oct-Dec_3(4)_202-209.nxml.txt.nlp	23378940	SENT164	24	24	5	5	astemizole	CYP3A4	PA448498	1576	0.875
NULL	Front_Neurosci_2014_Dec_5_8_398.nxml.txt.nlp	25538552	SENT98	16	16	36	36	oxygen	CA3	PA450744	761	0.875
NULL	Springerplus_2013_Feb_15_2_52.nxml.txt.nlp	23476897	SENT87	14	14	28	28	tamoxifen	CYP2D6	PA451581	1565	0.875
NULL	Med_Sci_Monit_2013_Sep_9_19_751-756.nxml.txt.nlp	24019010	SENT140	28	28	18	18	entecavir	LAM	PA164784025	7249;7248	0.875
NULL	Open_AIDS_J_2010_May_14_4_116-122.nxml.txt.nlp	20657827	SENT1	31	31	0	0	methamphetamine	Men	PA450403	8178	0.875
NULL	Br_J_Cancer_2010_Jan_19_102(2)_383-391.nxml.txt.nlp	20010943	SENT48	4	4	30	30	fluorescein	P31	PA164746009	529	0.875
NULL	Bioinform_Biol_Insights_2009_Oct_5_3_109-127.nxml.txt.nlp	20140064	SENT523	11	11	27	27	tenofovir	P200	PA10204	5035	0.875
NULL	Emerg_Infect_Dis_2013_Jan_19(1)_129-132.nxml.txt.nlp	23260390	SENT18	31	31	17	17	linezolid	L22	PA450233	6146	0.875
NULL	Case_Rep_Transplant_2014_Jan_2_2014_548243.nxml.txt.nlp	24575309	SENT12	35	35	7	7	sirolimus	CYP3A	PA451365	1574	0.875
NULL	Cancer_Cell_Int_2013_Jan_15_13_3.nxml.txt.nlp	23320839	SENT135	13	13	35	35	sorafenib	ABCC3	PA7000	8714	0.875
NULL	Core_Evid_2012_Sep_14_7_93-103.nxml.txt.nlp	23055947	SENT100	13	13	4	4	temozolomide	GM-CSF	PA451609	1437	0.875
NULL	EMBO_Mol_Med_2012_Sep_7_4(9)_896-909.nxml.txt.nlp	22887866	SENT149	9	9	2	2	lovastatin	c-Myc	PA450272	4609	0.875
NULL	J_Phys_Ther_Sci_2014_Nov_13_26(11)_1723-1727.nxml.txt.nlp	25435686	SENT74	0	0	11	11	glucose	DTD	PA449773	1728	0.875
NULL	Oncotarget_2010_Oct_22_1(7)_530-543.nxml.txt.nlp	21317449	SENT98	8	8	6	6	gefitinib	EGFR	PA131301952	1956	0.875
NULL	BMB_Rep_2014_Mar_47(3)_167-172.nxml.txt.nlp	24499665	SENT96	6	6	10	10	nutlin-3	MDM2		4193	0.875
NULL	Mol_Cell_Endocrinol_2012_Apr_28_353(1-2)_114-127.nxml.txt.nlp	22100614	SENT219	37	37	21	21	carbachol	INS-1	PA448784	2305	0.875
NULL	Arthritis_Res_Ther_2013_Aug_30_15(4)_R100.nxml.txt.nlp	24000795	SENT140	29	29	9	9	methotrexate	TREM1	PA450428	54210	0.875
NULL	Ann_Pediatr_Endocrinol_Metab_2014_Jun_30_19(2)_57-68.nxml.txt.nlp	25077087	SENT11	12	12	14	14	carbamazepine	GLP1	PA448785	100125288;2641	0.875
NULL	Nat_Commun_2014_Jun_24_2_4172.nxml.txt.nlp	24960204	SENT740	13	13	3	3	ns-398	53BP1		7158	0.875
NULL	Front_Genet_2012_Nov_26_3_241.nxml.txt.nlp	23233859	SENT36	26	26	7	7	fentanyl	NeuroD	PA449599	4760	0.875
NULL	BMB_Rep_2013_Feb_46(2)_92-96.nxml.txt.nlp	23433111	SENT10	13	13	6	6	etoposide	BRCA1	PA449552	672	0.875
NULL	Cancer_Manag_Res_2014_Oct_6_6_389-395.nxml.txt.nlp	25336989	SENT44	35	35	19	19	everolimus	HER2	PA164746311	2064	0.875
NULL	Front_Genet_2014_Jul_25_5_242.nxml.txt.nlp	25120559	SENT170	19	19	8	8	dextran	IRE1	PA449261	2081	0.875
NULL	J_Oncol_2011_Oct_12_2011_941876.nxml.txt.nlp	20981352	SENT14	4	4	36	36	bevacizumab	EGFR	PA130232992	1956	0.875
NULL	Cell_Death_Dis_2010_Oct_21_1(10)_e86.nxml.txt.nlp	21368859	SENT221	7	7	9	9	doxorubicin	TRAIL	PA449412	8743	0.875
NULL	Nat_Med_2013_Sep_11_19(9)_1153-1156.nxml.txt.nlp	23933983	SENT91	9	9	27	27	estradiol	FGF21	PA449503	26291	0.875
NULL	J_Cancer_2013_Sep_27_4(8)_662-670.nxml.txt.nlp	24155778	SENT243	14	14	5	5	cisplatin	UCHL1	PA449014	7345	0.875
NULL	Biologics_2013_Dec_9_8_1-12.nxml.txt.nlp	24353404	SENT80	12	12	41	41	abatacept	CD28	PA164747080	1493;940	0.875
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_29_2013_590393.nxml.txt.nlp	23737838	SENT314	8	8	2	2	resveratrol	p53		7157	0.875
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT38	15	15	11	11	exenatide	GLP-1	PA164749238	100125288	0.875
NULL	Breast_Cancer_Res_2014_Oct_31_16(5)_447.nxml.txt.nlp	25358600	SENT253	29	29	9	9	fulvestrant	CXCR7	PA164747170	57007	0.875
NULL	Br_J_Cancer_2011_Dec_6_105(12)_1920-1926.nxml.txt.nlp	22095222	SENT7	27	27	6	6	gefitinib	PTEN	PA131301952	5728	0.875
NULL	Diabetes_2009_Aug_28_58(8)_1826-1834.nxml.txt.nlp	19401415	SENT196	14	14	19	19	lipase	adiponutrin	PA450239	80339	0.875
NULL	J_Nutr_Metab_2011_Jul_28_2011_235389.nxml.txt.nlp	21811679	SENT79	24	24	11	11	olanzapine	CORT	PA450688	1325	0.875
NULL	Acta_Pharmacol_Sin_2010_Jan_5_31(1)_93-101.nxml.txt.nlp	20048748	SENT155	24	24	32	32	cisplatin	DAPK	PA449014	1612	0.875
NULL	Nat_Commun_2014_Dec_8_5_5736.nxml.txt.nlp	25484020	SENT53	35	35	32	32	capsaicin	TRPV1	PA448776	7442	0.875
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_13_2012_636848.nxml.txt.nlp	23258994	SENT273	15	15	0	0	carrageenan	TRPV1	PA448814	7442	0.875
NULL	Pharmaceuticals_(Basel)_2011_Jun_15_4(6)_822-847.nxml.txt.nlp	NULL	SENT896	15	15	8	8	methamphetamine	spatial	PA450403	219793	0.875
NULL	Cancer_Cell_Int_2005_Jul_7_5_20.nxml.txt.nlp	16001980	SENT98	11	11	20	20	methotrexate	P-gp	PA450428	5243	0.875
NULL	Arthritis_Res_Ther_2010_Jan_8_12(1)_R4.nxml.txt.nlp	20064200	SENT277	1	1	15	15	infliximab	COX2	PA452639	4513;5743	0.875
NULL	F1000Res_2014_Sep_2_3_207.nxml.txt.nlp	25383187	SENT73	10	10	14	14	methylphenidate	p53	PA450464	7157	0.875
NULL	Nat_Commun_2011_May_24_2_326.nxml.txt.nlp	21610729	SENT62	8	8	3	3	l-tyrosine	TYR	PA451822	7299	0.875
NULL	Case_Rep_Gastroenterol_2013_Apr_19_7(1)_195-201.nxml.txt.nlp	23687488	SENT70	14	14	8	8	rituximab	CHOP	PA451261	1649	0.875
NULL	Arthritis_2012_Nov_8_2012_601763.nxml.txt.nlp	23243507	SENT162	10	10	28	28	tetracycline	ACTH	PA451640	5443	0.875
NULL	Mol_Pain_2013_Jun_17_9_29.nxml.txt.nlp	23773289	SENT212	5	5	1	1	minocycline	LPA	PA450519	4018	0.875
NULL	J_Korean_Med_Sci_2009_Jun_15_24(3)_511-512.nxml.txt.nlp	19543518	SENT9	0	0	36	36	clarithromycin	DST	PA449028	667	0.875
NULL	Indian_J_Pharmacol_2014_Nov-Dec_46(6)_627-632.nxml.txt.nlp	25538335	SENT163	18	18	21	21	metformin	Q10	PA450395	27161	0.875
NULL	Biomed_Res_Int_2013_Jul_31_2013_692071.nxml.txt.nlp	23984399	SENT20	10	10	2	2	sorafenib	OCT1	PA7000	5451;6580	0.875
NULL	Diabetes_Metab_Syndr_Obes_2010_Jul_20_3_263-273.nxml.txt.nlp	21437094	SENT6	8	8	0	0	liraglutide	GLP-1	PA165958364	100125288	0.875
NULL	Parasit_Vectors_2013_Oct_1_6_287.nxml.txt.nlp	24289745	SENT11	23	23	26	26	mebendazole	gamma	PA164776669	9913	0.875
NULL	Acta_Pharmacol_Sin_2014_Jan_9_35(1)_1-10.nxml.txt.nlp	24317012	SENT49	1	1	7	7	imatinib	OCT1	PA10804	5451;6580	0.875
NULL	Cancers_(Basel)_2013_May_27_5(2)_617-638.nxml.txt.nlp	24216994	SENT223	15	15	4	4	curcumin	MMP9	PA151958596	4318	0.875
NULL	Indian_J_Anaesth_2014_Jul-Aug_58(4)_423-429.nxml.txt.nlp	25197110	SENT114	7	7	5	5	ondansetron	ODF	PA450705	8600	0.875
NULL	Eur_J_Epidemiol_2011_Aug_30_26(8)_657-686.nxml.txt.nlp	21877163	SENT941	19	19	14	14	acenocoumarol	CYP2C9	PA452632	1559	0.874
NULL	Ann_Gastroenterol_2013_26(3)_204-211.nxml.txt.nlp	24714281	SENT127	0	0	4	4	cisapride	5-HT4	PA449011	3360	0.874
NULL	EMBO_Mol_Med_2012_Jan_4(1)_15-26.nxml.txt.nlp	22095752	SENT251	30	30	10	10	paraformaldehyde	CO2	PA450790	4513	0.874
NULL	Clin_Pharmacol_2010_Jun_22_2_105-110.nxml.txt.nlp	22291493	SENT56	6	6	19	19	sibutramine	ADIPOQ	PA451344	9370	0.874
NULL	Breast_Cancer_Res_2007_Jan_23_9(1)_R7.nxml.txt.nlp	17244352	SENT132	6	6	14	14	tamoxifen	SULT1A1	PA451581	6817	0.874
NULL	Br_J_Cancer_2013_Jul_23_109(2)_342-350.nxml.txt.nlp	23807172	SENT22	6	6	22	22	sorafenib	Bcl-2	PA7000	596	0.874
NULL	Oxid_Med_Cell_Longev_2012_Jan_19_2012_390678.nxml.txt.nlp	22315655	SENT156	5	5	7	7	gliclazide	NAC	PA10892	22861	0.874
NULL	Cancer_Metab_2013_Aug_14_1_18.nxml.txt.nlp	24280377	SENT290	0	0	21	21	metformin	LKB1	PA450395	6794	0.874
NULL	Mol_Neurodegener_2011_Mar_9_6_22.nxml.txt.nlp	21388539	SENT152	19	19	4	4	paraformaldehyde	CO2	PA450790	4513	0.874
NULL	Br_J_Cancer_2013_Nov_26_109(11)_2778-2782.nxml.txt.nlp	24169350	SENT45	23	23	45	45	cisplatin	NACT	PA449014	284111	0.874
NULL	Br_J_Ophthalmol_2012_Jul_26_96(7)_1023-1028.nxml.txt.nlp	22539748	SENT109	13	13	3	3	bevacizumab	TER	PA130232992	9524	0.874
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Sep_19_65(Pt_10)_o2502.nxml.txt.nlp	21577951	SENT63	25	25	6	6	ethanol	mol	PA448073	90527	0.874
NULL	Int_J_Biol_Sci_2012_Mar_7_8(4)_470-485.nxml.txt.nlp	22419892	SENT262	14	14	22	22	tamoxifen	SRC-3	PA451581	8202	0.874
NULL	Iran_J_Pharm_Res_2014_Autumn_13(4)_1393-1401.nxml.txt.nlp	25587329	SENT6	31	31	20	20	celecoxib	ABCG2	PA448871	9429	0.874
NULL	Oncotarget_2013_Nov_24_4(12)_2430-2438.nxml.txt.nlp	24280348	SENT26	14	14	21	21	gefitinib	STAT3	PA131301952	6774	0.874
NULL	ScientificWorldJournal_2014_Dec_9_2014_808320.nxml.txt.nlp	25548793	SENT94	16	16	2	2	heparin	ACT	PA449855	12;11332;9457;641455	0.874
NULL	Behav_Brain_Funct_2012_Dec_19_8_61.nxml.txt.nlp	23253178	SENT124	34	34	4	4	allopregnanolone	AKR1C4	PA142320763	1109	0.874
NULL	Hum_Genomics_2008_Sep_1_3(1)_7-16.nxml.txt.nlp	19129086	SENT35	25	25	10	10	repaglinide	SLCO1B1	PA451234	10599	0.874
NULL	Biologics_2009_Jul_13_3_289-301.nxml.txt.nlp	19707416	SENT213	11	11	24	24	trastuzumab	HER2	PA451743	2064	0.874
NULL	Oncotarget_2014_Aug_19_5(18)_8737-8749.nxml.txt.nlp	25228590	SENT77	27	27	16	16	doxycycline	MYCN	PA449415	4613	0.874
NULL	J_Biol_Chem_2013_May_3_288(18)_13057-13067.nxml.txt.nlp	23508950	SENT85	20	20	1	1	galactose	GAAP	PA449725	51643	0.874
NULL	J_Oncol_2013_Apr_29_2013_854121.nxml.txt.nlp	23737784	SENT120	22	22	39	39	lapatinib	PTEN	PA152241907	5728	0.874
NULL	Oncotarget_2011_Jan_28_3(1)_31-43.nxml.txt.nlp	22289787	SENT145	7	7	10	10	gefitinib	BIM	PA131301952	10018	0.874
NULL	Cancers_(Basel)_2010_Feb_23_2(1)_88-113.nxml.txt.nlp	24281034	SENT1267	3	3	13	13	cisplatin	p53	PA449014	7157	0.874
NULL	Avicenna_J_Phytomed_2013_Summer_3(3)_201-204.nxml.txt.nlp	25050275	SENT48	17	17	9	9	erythromycin	CYP3A4	PA449493	1576	0.874
NULL	Indian_J_Pharm_Sci_2013_Jan-Feb_75(1)_94-98.nxml.txt.nlp	23901167	SENT87	32	32	21	21	phenacetin	CYP2B6	PA450897	1555	0.874
NULL	Clin_Drug_Investig_2013_Jun_20_33(6)_419-427.nxml.txt.nlp	23605507	SENT140	24	24	16	16	ciprofloxacin	DPI	PA449009	1832	0.874
NULL	Genome_Med_2010_Jun_29_2(6)_41.nxml.txt.nlp	20587003	SENT168	35	35	13	13	imatinib	STAT3	PA10804	6774	0.874
NULL	Iran_J_Psychiatry_2010_Winter_5(1)_11-17.nxml.txt.nlp	22952484	SENT142	5	5	15	15	pyrilamine	OAT	PA165817939	4942	0.874
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT89	10	10	4	4	cisplatin	XPA	PA449014	7507	0.874
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT248	24	24	27	27	metformin	HIF-1	PA450395	29072	0.874
NULL	J_Exp_Clin_Cancer_Res_2010_Aug_11_29(1)_110.nxml.txt.nlp	20701792	SENT47	20	20	2	2	paclitaxel	CSE1L	PA450761	1434	0.874
NULL	Oncol_Rep_2014_Feb_13_31(2)_581-588.nxml.txt.nlp	24337105	SENT37	11	11	7	7	capsaicin	TRPV1	PA448776	7442	0.874
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT227	20	20	8	8	atorvastatin	RANKL	PA448500	8600	0.874
NULL	Oncoscience_2014_Oct_5_1(10)_624-633.nxml.txt.nlp	25593992	SENT52	25	25	14	14	doxycycline	PCTAIRE1	PA449415	5127	0.874
NULL	Stroke_Res_Treat_2009_Dec_20_2010_386389.nxml.txt.nlp	20700422	SENT289	26	26	30	30	resveratrol	NAC		22861	0.874
NULL	Diabetes_2009_Aug_15_58(8)_1893-1901.nxml.txt.nlp	19528375	SENT239	28	28	21	21	metformin	adiponectin	PA450395	9370	0.874
NULL	Ann_Dermatol_2013_Aug_13_25(3)_310-314.nxml.txt.nlp	24003273	SENT79	0	0	21	21	lipase	LIP1	PA450239	114790;55835	0.874
NULL	Arch_Osteoporos_2013_Oct_11_8(1-2)_136.nxml.txt.nlp	24113837	SENT3087	19	19	8	8	teriparatide	PTH	PA451620	5741	0.874
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_May_15_69(Pt_6)_o883.nxml.txt.nlp	23795059	SENT63	32	32	1	1	phenol	C11	PA450913	1109	0.874
NULL	AIDS_Res_Ther_2008_Mar_28_5_5.nxml.txt.nlp	18373851	SENT16	1	1	3	3	ritonavir	CYP3A4	PA451260	1576	0.874
NULL	Cancer_Immunol_Immunother_2011_Jun_25_60(6)_793-808.nxml.txt.nlp	21350947	SENT60	6	6	3	3	sorafenib	IFN	PA7000	3439	0.874
NULL	Mol_Cancer_2012_Dec_12_11_91.nxml.txt.nlp	23234355	SENT188	4	4	11	11	erlotinib	HER2	PA134687924	2064	0.874
NULL	Curr_Pain_Headache_Rep_2011_Aug_12_15(4)_271-279.nxml.txt.nlp	21479998	SENT162	0	0	24	24	sertraline	CYP2D6	PA451333	1565	0.874
NULL	Arthritis_Res_Ther_2009_Jan_30_11(1)_210.nxml.txt.nlp	19232069	SENT70	15	15	38	38	tocilizumab	IL-6	PA165292659	3569	0.874
NULL	Int_J_Breast_Cancer_2011_Sep_6_2011_352182.nxml.txt.nlp	22295219	SENT134	7	7	12	12	trastuzumab	PTEN	PA451743	5728	0.874
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Oct_25_64(Pt_11)_o2199.nxml.txt.nlp	21581057	SENT62	23	23	15	15	ethanol	mol	PA448073	90527	0.874
NULL	Oncogene_2013_Sep_12_32(37)_4355-4365.nxml.txt.nlp	23108409	SENT37	34	34	27	27	hyaluronan	HAS2	PA165958431	3037	0.874
NULL	Reprod_Biol_Endocrinol_2004_Jul_5_2_49.nxml.txt.nlp	15236653	SENT251	6	6	29	29	estradiol	PGF	PA449503	5228	0.874
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT55	15	15	26	26	curcumin	TRAIL	PA151958596	8743	0.874
NULL	Br_J_Cancer_2009_Mar_10_100(5)_758-763.nxml.txt.nlp	19259094	SENT140	19	19	3	3	decitabine	MLH1	PA164749631	4292	0.874
NULL	Front_Genet_2012_Nov_12_3_235.nxml.txt.nlp	23162568	SENT131	20	20	17	17	paroxetine	CYP2D6	PA450801	1565	0.874
NULL	Cancer_Metab_2014_May_28_2(Suppl_1)_P61.nxml.txt.nlp	NULL	SENT14	0	0	20	20	troglitazone	ASCT2	PA451799	6510	0.874
NULL	Clin_Cosmet_Investig_Dermatol_2014_Sep_2_7_243-249.nxml.txt.nlp	25214798	SENT88	5	5	8	8	methotrexate	ACR	PA450428	49	0.874
NULL	Mol_Cancer_2014_Jun_24_13_157.nxml.txt.nlp	24958351	SENT60	33	33	14	14	lapatinib	EGFR	PA152241907	1956	0.874
NULL	Acta_Pharmacol_Sin_2009_Feb_5_30(2)_202-208.nxml.txt.nlp	19122671	SENT80	6	6	30	30	nadh	G6PD	PA164755085	2539	0.874
NULL	Biologics_2012_Feb_1_6_31-35.nxml.txt.nlp	22355257	SENT85	11	11	43	43	rituximab	IL-10	PA451261	3586	0.874
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT86	5	5	18	18	pp2	CD11b		3684	0.874
NULL	Oncotarget_2013_Mar_9_4(3)_376-377.nxml.txt.nlp	23530115	SENT14	22	22	5	5	hyaluronan	LOX	PA165958431	4015	0.874
NULL	Cell_Death_Dis_2012_Jun_21_3(6)_e330.nxml.txt.nlp	22717585	SENT66	0	0	19	19	simvastatin	PUMA	PA451363	27113	0.874
NULL	Oncogene_2010_Sep_16_29(37)_5193-5203.nxml.txt.nlp	20581867	SENT169	11	11	30	30	lapatinib	HRG	PA152241907	3084;3273	0.874
NULL	Br_J_Cancer_2009_Mar_10_100(5)_758-763.nxml.txt.nlp	19259094	SENT139	33	33	3	3	belinostat	MLH1		4292	0.874
NULL	Allergy_Asthma_Clin_Immunol_2013_Aug_15_9(1)_30.nxml.txt.nlp	23947590	SENT388	7	7	1	1	teriparatide	ACR	PA451620	49	0.874
NULL	Arthritis_2012_Oct_11_2012_713618.nxml.txt.nlp	23133751	SENT84	0	0	22	22	abatacept	CD4	PA164747080	920	0.874
NULL	Arthritis_Res_Ther_2011_Apr_27_13(2)_404.nxml.txt.nlp	21542887	SENT5	11	11	40	40	infliximab	adiponectin	PA452639	9370	0.874
NULL	Acta_Pharmacol_Sin_2011_Feb_4_32(2)_223-229.nxml.txt.nlp	21293474	SENT3	31	31	42	42	l-arginine	FKBP12	PA448478	2280	0.874
NULL	Cancer_Cell_Int_2013_Feb_8_13_11.nxml.txt.nlp	23394616	SENT117	9	9	0	0	geldanamycin	Hsp90	PA152031327	3320	0.874
NULL	J_Int_Soc_Sports_Nutr_2015_Jan_21_12(1)_5.nxml.txt.nlp	NULL	SENT150	17	17	7	7	curcumin	IL-6	PA151958596	3569	0.874
NULL	Br_J_Cancer_2013_Mar_5_108(4)_983-992.nxml.txt.nlp	23361057	SENT121	10	10	15	15	cytarabine	MLH1	PA449177	4292	0.874
NULL	Biochem_Res_Int_2012_May_9_2012_290971.nxml.txt.nlp	22649731	SENT179	22	22	28	28	staurosporine	FFR	PA165109623	738	0.874
NULL	Evid_Based_Complement_Alternat_Med_2011_Mar_1_2011_207034.nxml.txt.nlp	21423686	SENT123	14	14	22	22	clopidogrel	CYP2C19	PA449053	1557	0.874
NULL	Curr_Genomics_2014_Feb_15(1)_18-27.nxml.txt.nlp	24653660	SENT147	40	40	30	30	levodopa	DYT3	PA450213	1863	0.874
NULL	J_Mol_Signal_2011_Jul_20_6_7.nxml.txt.nlp	21774804	SENT257	13	13	29	29	dasatinib	CD44	PA162372878	960	0.874
NULL	J_Hematol_Oncol_2008_Oct_23_1_19.nxml.txt.nlp	18947412	SENT111	14	14	8	8	alemtuzumab	CD34	PA164783958	947	0.874
NULL	J_Oncol_2010_May_24_2010_729725.nxml.txt.nlp	20508816	SENT91	13	13	3	3	thalidomide	MVD	PA451644	4597	0.874
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jan_31_65(Pt_2)_o439.nxml.txt.nlp	21582024	SENT69	25	25	3	3	ethanol	mol	PA448073	90527	0.874
NULL	Br_J_Pharmacol_2014_Jan_23_171(2)_523-535.nxml.txt.nlp	24372553	SENT138	29	29	16	16	metformin	SIRT1	PA450395	23411	0.874
NULL	Br_J_Cancer_2010_Oct_12_103(8)_1297-1304.nxml.txt.nlp	20842126	SENT106	28	28	14	14	taurine	SMO	PA451590	6608;54498	0.874
NULL	Respir_Med_Case_Rep_2013_Apr_24_9_8-10.nxml.txt.nlp	NULL	SENT75	1	1	7	7	gefitinib	EGFR	PA131301952	1956	0.874
NULL	Mol_Cancer_2008_Nov_24_7_87.nxml.txt.nlp	19025616	SENT29	24	24	8	8	cyclophosphamide	ALDH1A1	PA449165	216	0.874
NULL	J_Mol_Signal_2008_Mar_31_3_8.nxml.txt.nlp	18377662	SENT69	9	9	39	39	pp2	KDR		3791	0.874
NULL	J_Mol_Signal_2012_Aug_16_7_12.nxml.txt.nlp	22898329	SENT269	0	0	23	23	vorinostat	BIM	PA164748224	10018	0.874
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jan_16_66(Pt_2)_o391.nxml.txt.nlp	21579812	SENT59	12	12	7	7	ethanol	mol	PA448073	90527	0.874
NULL	Oncotarget_2013_Dec_18_5(2)_375-385.nxml.txt.nlp	24495868	SENT128	28	28	7	7	fludarabine	MCL1	PA449655	4170	0.874
NULL	J_Carcinog_2012_Sep_13_11_15.nxml.txt.nlp	23230392	SENT139	22	22	7	7	gemcitabine	TP53INP1	PA449748	94241	0.874
NULL	Acta_Neuropathol_Commun_2014_May_30_2_57.nxml.txt.nlp	24887326	SENT34	20	20	34	34	vincristine	ABCB1	PA451879	5243	0.874
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT119	14	14	33	33	dasatinib	ABCB1	PA162372878	5243	0.874
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT7	9	9	36	36	pemetrexed	UNG	PA10810	7374	0.874
NULL	Case_Rep_Rheumatol_2013_Dec_17_2013_923497.nxml.txt.nlp	24455384	SENT54	28	28	20	20	tocilizumab	IL6	PA165292659	3569	0.874
NULL	Mol_Vis_2011_Dec_27_17_3415-3422.nxml.txt.nlp	22219637	SENT180	7	7	26	26	estradiol	JNK	PA449503	5599	0.874
NULL	Infect_Dis_Ther_2014_Dec_5_3(2)_69-81.nxml.txt.nlp	25475412	SENT80	29	29	13	13	colistin	TEC	PA164760862	7006	0.874
NULL	AAPS_J_2012_Jan_4_14(1)_87-96.nxml.txt.nlp	22215264	SENT76	35	35	21	21	quinidine	P-gp	PA451209	5243	0.874
NULL	Oncoscience_2014_Oct_22_1(10)_614-623.nxml.txt.nlp	25593991	SENT97	19	19	5	5	afatinib	EGFR	PA165981154	1956	0.874
NULL	Biomed_Res_Int_2014_Aug_6_2014_967826.nxml.txt.nlp	25165721	SENT88	26	26	9	9	cisplatin	p53	PA449014	7157	0.874
NULL	J_Invest_Dermatol_2013_Aug_133(8)_1928-1929.nxml.txt.nlp	23856932	SENT23	26	26	14	14	vemurafenib	STAT3	PA165946873	6774	0.874
NULL	Int_J_Mol_Sci_2014_Oct_15_15(10)_18574-18592.nxml.txt.nlp	25322151	SENT166	20	20	22	22	sirolimus	RAPA	PA451365	55809	0.874
NULL	Case_Rep_Oncol_2012_Dec_6_5(3)_651-656.nxml.txt.nlp	23275781	SENT83	25	25	7	7	bevacizumab	VEGFR	PA130232992	3791	0.874
NULL	Calcif_Tissue_Int_2014_Aug_21_94(2)_170-175.nxml.txt.nlp	23963633	SENT121	3	3	6	6	teriparatide	PTH	PA451620	5741	0.874
NULL	Mol_Cancer_2009_Dec_10_8_118.nxml.txt.nlp	20003259	SENT49	8	8	24	24	sorafenib	ERM	PA7000	2119	0.874
NULL	Cancer_Med_2014_Jun_25_3(3)_674-680.nxml.txt.nlp	24668895	SENT153	25	25	11	11	trastuzumab	HER2	PA451743	2064	0.874
NULL	Cancer_Cell_Int_2013_Jan_15_13_3.nxml.txt.nlp	23320839	SENT16	17	17	11	11	doxorubicin	MRP1	PA449412	4437	0.874
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT254	5	5	17	17	bevacizumab	PlGF-2	PA130232992	5228	0.874
NULL	Front_Neurosci_2010_Jun_17_4_35.nxml.txt.nlp	20661455	SENT585	18	18	2	2	tamoxifen	5-HT1A	PA451581	3350	0.874
NULL	Indian_J_Urol_2009_Apr-Jun_25(2)_186-189.nxml.txt.nlp	19672343	SENT49	33	33	8	8	vinblastine	GTS	PA451877	2973	0.874
NULL	Mol_Imaging_Biol_2011_Dec_16_13(6)_1234-1240.nxml.txt.nlp	21161686	SENT221	3	3	11	11	imatinib	KIT	PA10804	3815	0.874
NULL	Breast_Cancer_Res_2010_Jan_15_12(1)_R8.nxml.txt.nlp	20078855	SENT261	21	21	10	10	paclitaxel	JNK	PA450761	5599	0.874
NULL	Br_J_Pharmacol_2010_Sep_161(2)_241-270.nxml.txt.nlp	20735414	SENT275	24	24	17	17	cisplatin	LPA	PA449014	4018	0.874
NULL	Ann_Gen_Psychiatry_2008_Aug_18_7_11.nxml.txt.nlp	18706108	SENT108	36	36	1	1	bupropion	CD50	PA448687	3385	0.874
NULL	J_Allergy_(Cairo)_2011_Dec_11_2011_742710.nxml.txt.nlp	22220184	SENT177	21	21	12	12	isoproterenol	ASM	PA450121	6609;283120	0.874
NULL	Onco_Targets_Ther_2014_Mar_24_7_491-500.nxml.txt.nlp	24711706	SENT9	0	0	11	11	lapatinib	HER2	PA152241907	2064	0.874
NULL	Br_J_Cancer_2011_May_24_104(11)_1716-1723.nxml.txt.nlp	21559015	SENT220	10	10	3	3	trastuzumab	Erb	PA451743	2100	0.874
NULL	Iran_Red_Crescent_Med_J_2012_Jul_30_14(7)_442-446.nxml.txt.nlp	22997561	SENT7	37	37	9	9	sugar	HBM	PA451529	3042;4041	0.874
NULL	Mol_Cancer_2013_May_24_12_46.nxml.txt.nlp	23705826	SENT272	37	37	14	14	imatinib	KIT	PA10804	3815	0.874
NULL	Eur_J_Clin_Pharmacol_2011_May_8_67(5)_493-506.nxml.txt.nlp	21140139	SENT41	20	20	27	27	oxymorphone	CYP2D6	PA450748	1565	0.874
NULL	Oncol_Lett_2013_Feb_7_5(2)_440-446.nxml.txt.nlp	23420122	SENT5	11	11	20	20	sorafenib	EGFR	PA7000	1956	0.874
NULL	Neuroscience_2013_Oct_10_250(100)_493-506.nxml.txt.nlp	23892006	SENT246	14	14	9	9	ethanol	ZO-1	PA448073	7082	0.874
NULL	Cancer_Manag_Res_2014_May_23_6_225-252.nxml.txt.nlp	24904222	SENT120	2	2	8	8	trastuzumab	HER2	PA451743	2064	0.874
NULL	Sci_Rep_2014_Dec_17_4_7461.nxml.txt.nlp	25514838	SENT9	7	7	9	9	cisplatin	DDP	PA449014	1678	0.874
NULL	EMBO_Mol_Med_2013_Jul_14_5(7)_999-1018.nxml.txt.nlp	23776131	SENT188	2	2	23	23	doxycycline	MYC	PA449415	4609	0.874
NULL	Acta_Pharmacol_Sin_2014_Aug_21_35(8)_1082-1092.nxml.txt.nlp	25047514	SENT139	20	20	10	10	estradiol	aromatase	PA449503	1588	0.874
NULL	Cancer_Cell_Int_2013_Feb_12_13_14.nxml.txt.nlp	23402310	SENT13	13	13	2	2	celecoxib	p65	PA448871	5970	0.874
NULL	Nat_Med_2013_Dec_10_19(12)_10_1038_nm_3385.nxml.txt.nlp	24216752	SENT143	28	28	13	13	thrombin	PAR4	PA451674	9002;5074	0.874
NULL	Int_J_Endocrinol_2013_Oct_1_2013_405127.nxml.txt.nlp	24194757	SENT85	26	26	11	11	paraformaldehyde	CO2	PA450790	4513	0.874
NULL	Exp_Ther_Med_2012_Sep_12_4(3)_475-480.nxml.txt.nlp	23181121	SENT159	6	6	0	0	vincristine	CHOP	PA451879	1649	0.874
NULL	Breast_Cancer_Res_2005_Jun_17_7(Suppl_2)_S_32.nxml.txt.nlp	NULL	SENT4	22	22	12	12	mitomycin	TP53	PA450524	7157	0.874
NULL	Diabetes_Care_2010_Jul_31_33(7)_1607-1609.nxml.txt.nlp	20357375	SENT53	6	6	22	22	sitagliptin	CXCR4	PA164748978	7852	0.874
NULL	Anal_Chem_Insights_2007_Nov_11_2_111-118.nxml.txt.nlp	19662185	SENT47	9	9	38	38	naphthol	mol	PA154081779	90527	0.874
NULL	Case_Rep_Obstet_Gynecol_2014_Mar_24_2014_549619.nxml.txt.nlp	24782935	SENT86	20	20	16	16	rituximab	CHOP	PA451261	1649	0.874
NULL	Arthritis_Res_Ther_2014_Jul_18_16(4)_R153.nxml.txt.nlp	25037855	SENT107	28	28	11	11	methotrexate	CD14	PA450428	929	0.874
NULL	Br_J_Cancer_2013_Feb_5_108(2)_259-264.nxml.txt.nlp	23322191	SENT107	4	4	11	11	lidocaine	p38	PA450226	10598;1432;7965	0.874
NULL	Ann_Hematol_2010_Nov_25_89(11)_1115-1124.nxml.txt.nlp	20499237	SENT8	8	8	21	21	simvastatin	ZAP-70	PA451363	7535	0.874
NULL	J_Am_Heart_Assoc_2013_Dec_19_2(6)_e000355.nxml.txt.nlp	24190878	SENT177	6	6	19	19	isoproterenol	HK2	PA450121	3796;3099;29911;3741	0.874
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1148.nxml.txt.nlp	24675466	SENT112	6	6	1	1	vasopressin	AVP	PA451858	114548;551	0.874
NULL	J_Med_Chem_2014_Feb_13_57(3)_677-685.nxml.txt.nlp	24428777	SENT322	15	15	4	4	resveratrol	FOXC2		2303	0.874
NULL	Ther_Clin_Risk_Manag_2007_Jun_3(3)_449-459.nxml.txt.nlp	18488069	SENT289	25	25	20	20	rofecoxib	RIZ	PA451268	7799	0.874
NULL	EMBO_Mol_Med_2012_Jun_13_4(6)_515-527.nxml.txt.nlp	22416035	SENT5	25	25	17	17	olaparib	p53		7157	0.874
NULL	Oncotarget_2012_Dec_18_3(12)_1615-1628.nxml.txt.nlp	23271044	SENT210	34	34	42	42	temsirolimus	STAT3	PA164746890	6774	0.874
NULL	Cancers_(Basel)_2014_Mar_13_6(1)_595-624.nxml.txt.nlp	24633084	SENT222	14	14	11	11	pertuzumab	EGFR		1956	0.874
NULL	Aging_Cell_2012_Aug_11(4)_579-587.nxml.txt.nlp	22435726	SENT125	15	15	6	6	etoposide	CD28	PA449552	1493;940	0.874
NULL	J_Geriatr_Cardiol_2012_Jun_9(2)_180-184.nxml.txt.nlp	22916066	SENT22	17	17	24	24	rosuvastatin	Rho	PA134308647	29984	0.874
NULL	Ann_Rheum_Dis_2011_Oct_12_71(4)_541-548.nxml.txt.nlp	21994233	SENT157	9	9	1	1	methotrexate	IMPACT	PA450428	55364	0.874
NULL	Bioinformation_2011_Nov_20_7(6)_296-298.nxml.txt.nlp	22355224	SENT14	0	0	15	15	imatinib	TK1	PA10804	7083	0.874
NULL	Patient_Prefer_Adherence_2010_Mar_24_4_61-68.nxml.txt.nlp	20361006	SENT167	15	15	22	22	liraglutide	GLP-1	PA165958364	100125288	0.874
NULL	Mol_Vis_2014_May_2_20_616-628.nxml.txt.nlp	24826069	SENT154	7	7	13	13	fluorescein	CD11b	PA164746009	3684	0.874
NULL	Mol_Cells_2014_Mar_31_37(3)_234-240.nxml.txt.nlp	24642709	SENT115	4	4	6	6	capsaicin	HO-1	PA448776	3162	0.874
NULL	Int_J_Fertil_Steril_2013_Mar_3_Jan-Mar_6(4)_304-309.nxml.txt.nlp	24520455	SENT115	21	21	3	3	estradiol	ARC	PA449503	8996;23237	0.874
NULL	Arch_Med_Sci_2012_Nov_9_8(5)_899-906.nxml.txt.nlp	23185202	SENT116	24	24	14	14	acarbose	adiponectin	PA448010	9370	0.874
NULL	J_Clin_Biochem_Nutr_2008_May_29_42(3)_197-203.nxml.txt.nlp	18545641	SENT88	15	15	32	32	curcumin	JNK	PA151958596	5599	0.874
NULL	Oncotarget_2012_Aug_9_3(8)_774-782.nxml.txt.nlp	22885298	SENT69	3	3	13	13	tetracycline	IDH1	PA451640	3417	0.874
NULL	Int_J_Environ_Res_Public_Health_2012_Jun_31_9(6)_2075-2091.nxml.txt.nlp	22829791	SENT349	15	15	11	11	mitoxantrone	RUNX1	PA450526	861	0.874
NULL	Gut_Liver_2012_Apr_17_6(2)_210-217.nxml.txt.nlp	22570750	SENT112	11	11	0	0	indomethacin	cPLA2	PA449982	10524	0.874
NULL	Environ_Health_Perspect_2010_Jul_3_118(7)_936-942.nxml.txt.nlp	20199942	SENT206	22	22	7	7	arsenite	mot-2	PA452638	3313	0.874
NULL	J_Adv_Pharm_Technol_Res_2014_Jan-Mar_5(1)_21-27.nxml.txt.nlp	24696814	SENT46	24	24	16	16	ethanol	mol	PA448073	90527	0.874
NULL	Acta_Pharmacol_Sin_2014_Jun_5_35(6)_727-737.nxml.txt.nlp	24793312	SENT199	7	7	18	18	telmisartan	B27	PA451605	56246	0.874
NULL	Biomed_Res_Int_2013_Jun_13_2013_851428.nxml.txt.nlp	23841096	SENT50	1	1	5	5	l-serine	SHMT	PA451330	6470	0.874
NULL	Environ_Health_Perspect_2013_Mar_1_121(3)_a97.nxml.txt.nlp	23454847	SENT25	11	11	14	14	estradiol	JNK	PA449503	5599	0.874
NULL	Mol_Neurodegener_2011_Aug_16_6_58.nxml.txt.nlp	21846363	SENT76	0	0	9	9	candesartan	AT2	PA448765	186	0.874
NULL	Front_Pharmacol_2014_May_30_5_132.nxml.txt.nlp	24910615	SENT106	3	3	15	15	estradiol	PDE7B	PA449503	27115	0.874
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT196	6	6	22	22	cisplatin	SAPK	PA449014	5601	0.874
NULL	Int_J_Vasc_Med_2014_Jun_3_2014_294065.nxml.txt.nlp	24987529	SENT89	3	3	16	16	verapamil	MPG	PA451868	4350	0.874
NULL	Orphanet_J_Rare_Dis_2014_Jan_9_9_4.nxml.txt.nlp	24405637	SENT106	23	23	16	16	celecoxib	p38	PA448871	10598;1432;7965	0.874
NULL	Oncol_Lett_2014_Oct_22_8(4)_1603-1607.nxml.txt.nlp	25202376	SENT85	21	21	40	40	cisplatin	XRCC1	PA449014	7515	0.874
NULL	Oncotarget_2013_Jun_3_4(6)_875-883.nxml.txt.nlp	23900261	SENT127	3	3	7	7	estradiol	RB1	PA449503	5925	0.874
NULL	Breast_Cancer_Res_Treat_2012_Jul_31_134(1)_199-205.nxml.txt.nlp	22290080	SENT26	5	5	7	7	tamoxifen	aromatase	PA451581	1588	0.874
NULL	Drugs_R_D_2014_Sep_31_14(3)_177-184.nxml.txt.nlp	25079671	SENT105	8	8	21	21	voglibose	MCP-1	PA164752433	6347	0.874
NULL	J_Hematol_Oncol_2009_Feb_27_2_11.nxml.txt.nlp	19250532	SENT59	4	4	0	0	doxorubicin	CHOP	PA449412	1649	0.874
NULL	Med_Sci_Monit_2012_May_1_18(5)_CR290-CR295.nxml.txt.nlp	22534708	SENT151	21	21	7	7	metformin	apelin	PA450395	8862	0.874
NULL	Arch_Med_Sci_2011_Dec_31_7(6)_977-983.nxml.txt.nlp	22328880	SENT127	14	14	46	46	heparin	PAPP-A	PA449855	5069	0.874
NULL	Oncogene_2009_Dec_3_28(48)_4237-4248.nxml.txt.nlp	19734937	SENT134	1	1	20	20	collagenase	PAR-1	PA449107	2011;2149	0.874
NULL	Oncol_Lett_2014_Nov_12_8(5)_2203-2208.nxml.txt.nlp	25295109	SENT176	27	27	3	3	celecoxib	PTCH1	PA448871	5727	0.874
NULL	Clin_Sci_(Lond)_2009_Nov_16_118(Pt_4)_269-279.nxml.txt.nlp	19698082	SENT165	3	3	26	26	ramipril	ACE2	PA451223	59272	0.874
NULL	Breast_Cancer_Res_2012_Jul_23_14(4)_R112.nxml.txt.nlp	22824341	SENT231	13	13	5	5	doxorubicin	RANKL	PA449412	8600	0.874
NULL	Br_J_Cancer_2012_Aug_7_107(4)_626-631.nxml.txt.nlp	22805329	SENT20	14	14	26	26	panitumumab	KRAS	PA162373091	3845	0.874
NULL	Acta_Pharmacol_Sin_2009_Sep_24_30(9)_1262-1275.nxml.txt.nlp	19701231	SENT225	11	11	6	6	lovastatin	SSR3	PA450272	6747	0.874
NULL	Chin_J_Cancer_2012_Jun_31(6)_306-314.nxml.txt.nlp	22640627	SENT160	13	13	2	2	rituximab	Bcl-2	PA451261	596	0.874
NULL	J_Immunother_Cancer_2014_Mar_12_2(Suppl_2)_I2.nxml.txt.nlp	NULL	SENT9	44	44	0	0	bevacizumab	IMPACT	PA130232992	55364	0.874
NULL	Ann_Gen_Psychiatry_2010_Apr_22_9(Suppl_1)_S83.nxml.txt.nlp	NULL	SENT5	17	17	6	6	carbamazepine	AC5	PA448785	111	0.874
NULL	Nucleic_Acids_Res_2013_Mar_26_41(5)_e60.nxml.txt.nlp	23275569	SENT29	21	21	8	8	gentamicin	MRF	PA449753	745	0.874
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT172	28	28	16	16	heparin	FGF1	PA449855	2246	0.874
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT266	12	12	23	23	panitumumab	EGFR	PA162373091	1956	0.874
NULL	Indian_J_Dermatol_2013_May-Jun_58(3)_247d.nxml.txt.nlp	23723525	SENT14	22	22	26	26	imiquimod	IFN	PA449972	3439	0.874
NULL	Biomed_Res_Int_2013_Jun_6_2013_626910.nxml.txt.nlp	23841079	SENT194	31	31	26	26	doxorubicin	CHOP	PA449412	1649	0.874
NULL	Int_J_Endocrinol_2010_Aug_29_2010_481326.nxml.txt.nlp	20871656	SENT95	16	16	35	35	glucose	MPG1	PA449773	219972	0.874
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Dec_17_3(12)_e152.nxml.txt.nlp	25518025	SENT67	29	29	21	21	oxymorphone	CYP2C19	PA450748	1557	0.874
NULL	Bone_Marrow_Transplant_2011_Mar_24_46(3)_430-435.nxml.txt.nlp	20498647	SENT25	26	26	10	10	infliximab	IL-2	PA452639	3558	0.874
NULL	Mol_Biol_Cell_2012_Oct_1_23(19)_3851-3862.nxml.txt.nlp	22875990	SENT74	10	10	2	2	l-leucine	GDH	PA450197	51084;2746	0.874
NULL	Oncol_Lett_2013_Mar_8_5(3)_805-812.nxml.txt.nlp	23426281	SENT146	10	10	22	22	gemcitabine	survivin	PA449748	332	0.874
NULL	Mol_Pain_2012_Sep_22_8_71.nxml.txt.nlp	22998838	SENT132	41	41	18	18	cisplatin	CB2	PA449014	1269	0.874
NULL	Comput_Struct_Biotechnol_J_2013_May_27_4_e201301012.nxml.txt.nlp	24688693	SENT34	28	28	12	12	nadh	MS2	PA164755085	101	0.874
NULL	Br_J_Cancer_2012_Jan_17_106(2)_254-261.nxml.txt.nlp	22166799	SENT111	8	8	18	18	camptothecin	TOP1	PA153590860	7150	0.874
NULL	Diabetes_Metab_Syndr_Obes_2010_Aug_24_3_297-299.nxml.txt.nlp	21437098	SENT56	6	6	1	1	liraglutide	GLP-1	PA165958364	100125288	0.874
NULL	Ther_Clin_Risk_Manag_2007_Mar_3(1)_71-97.nxml.txt.nlp	18360617	SENT270	24	24	11	11	micafungin	CYP3A	PA164781026	1574	0.874
NULL	Viruses_2014_Aug_19_6(8)_3181-3227.nxml.txt.nlp	25196285	SENT2534	16	16	2	2	imatinib	p53	PA10804	7157	0.874
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT439	24	24	40	40	quetiapine	PRL	PA451201	5617	0.874
NULL	Cell_Death_Dis_2013_Jun_13_4(6)_e663.nxml.txt.nlp	23764844	SENT96	13	13	1	1	oxygen	HIF1	PA450744	3091	0.874
NULL	Oncogene_2010_Jul_22_29(29)_4170-4182.nxml.txt.nlp	20498638	SENT126	5	5	9	9	cetuximab	EGFR	PA10040	1956	0.874
NULL	Bioinformation_2011_Sep_6_7(2)_59-63.nxml.txt.nlp	21938206	SENT36	5	5	26	26	cefazolin	PON1	PA448839	5444	0.874
NULL	Oxid_Med_Cell_Longev_2013_Jun_2_2013_793525.nxml.txt.nlp	23819014	SENT167	37	37	23	23	resveratrol	AMPK		5563	0.874
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_17_2013_514719.nxml.txt.nlp	23843876	SENT219	19	19	6	6	cisplatin	LC3	PA449014	84557	0.874
NULL	Cancers_(Basel)_2014_Apr_9_6(2)_829-859.nxml.txt.nlp	24722453	SENT251	3	3	21	21	sorafenib	JAK2	PA7000	3717	0.874
NULL	Indian_J_Endocrinol_Metab_2015_Jan-Feb_19(1)_30-38.nxml.txt.nlp	25593823	SENT102	14	14	24	24	sitagliptin	adiponectin	PA164748978	9370	0.874
NULL	Br_J_Cancer_2009_Jun_2_100(11)_1697-1703.nxml.txt.nlp	19384299	SENT88	25	25	32	32	fludarabine	CD25	PA449655	3669;3559	0.874
NULL	J_Invest_Dermatol_2011_Aug_28_131(8)_1754-1760.nxml.txt.nlp	21525885	SENT93	3	3	25	25	curcumin	HO-1	PA151958596	3162	0.874
NULL	Acta_Pharmacol_Sin_2014_Jun_4_35(6)_752-757.nxml.txt.nlp	24902786	SENT92	17	17	9	9	tamoxifen	STZ	PA451581	6484	0.874
NULL	Cancer_Med_2013_Feb_3_2(1)_11-20.nxml.txt.nlp	24133623	SENT277	11	11	0	0	cetuximab	KRAS	PA10040	3845	0.874
NULL	Clin_Med_Insights_Womens_Health_2013_Jan_22_6_1-11.nxml.txt.nlp	24665209	SENT213	32	32	29	29	tamoxifen	aromatase	PA451581	1588	0.874
NULL	Trials_2012_Aug_31_13_156.nxml.txt.nlp	22937736	SENT180	28	28	36	36	azithromycin	IL-10	PA448519	3586	0.874
NULL	Indian_J_Pharmacol_2014_Jan-Feb_46(1)_3-12.nxml.txt.nlp	24550577	SENT226	24	24	16	16	estradiol	CYP2C8	PA449503	1558	0.874
NULL	Front_Immunol_2013_Nov_18_4_382.nxml.txt.nlp	24302925	SENT176	9	9	12	12	imatinib	CD4	PA10804	920	0.874
NULL	Oncotarget_2014_Oct_15_5(21)_10763-10777.nxml.txt.nlp	25333257	SENT72	5	5	15	15	tariquidar	P-gp		5243	0.874
NULL	J_Cancer_Prev_2013_Sep_18(3)_227-234.nxml.txt.nlp	25337550	SENT95	35	35	26	26	decitabine	MLH1	PA164749631	4292	0.874
NULL	Biomed_Res_Int_2014_Feb_23_2014_168949.nxml.txt.nlp	24707474	SENT119	10	10	21	21	chloroquine	EGFR	PA448948	1956	0.874
NULL	Breast_Cancer_Res_2014_May_5_16(3)_R45.nxml.txt.nlp	24887236	SENT287	11	11	13	13	lapatinib	EGFR	PA152241907	1956	0.874
NULL	Oncotarget_2013_Dec_18_5(2)_375-385.nxml.txt.nlp	24495868	SENT125	23	23	11	11	fludarabine	CD40L	PA449655	959	0.874
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1137-1144.nxml.txt.nlp	20234366	SENT113	16	16	7	7	cetuximab	KRAS	PA10040	3845	0.874
NULL	Aging_(Albany_NY)_2012_Jan_29_4(1)_28-39.nxml.txt.nlp	22289634	SENT213	17	17	4	4	ethanol	PC3	PA448073	57332;7832;5122	0.874
NULL	Curr_Hematol_Malig_Rep_2012_Jun_31_7(2)_125-132.nxml.txt.nlp	22467334	SENT69	6	6	26	26	imatinib	CXCR4	PA10804	7852	0.874
NULL	Exp_Ther_Med_2013_Mar_24_5(3)_902-906.nxml.txt.nlp	23408108	SENT10	17	17	9	9	anastrozole	aromatase	PA448432	1588	0.874
NULL	Mol_Cancer_2010_Aug_20_9_220.nxml.txt.nlp	20727180	SENT167	10	10	23	23	nicotine	p53	PA450626	7157	0.874
NULL	Curr_Cardiol_Rev_2012_Aug_8(3)_239-249.nxml.txt.nlp	22935021	SENT257	19	19	15	15	prasugrel	P2Y12	PA154410481	64805	0.874
NULL	Arthritis_Res_Ther_2006_Dec_19_8(6)_R187.nxml.txt.nlp	17177994	SENT239	36	36	13	13	etanercept	p75	PA449515	7133;11168	0.874
NULL	Biomed_Res_Int_2013_Mar_17_2013_315980.nxml.txt.nlp	23586031	SENT22	10	10	2	2	coumarin	CYP2C9	PA134521193	1559	0.874
NULL	Curr_Immunol_Rev_2013_Feb_9(1)_13-22.nxml.txt.nlp	23853604	SENT172	24	24	7	7	vincristine	CHOP	PA451879	1649	0.874
NULL	J_Invest_Dermatol_2012_Mar_10_132(3_Pt_1)_583-592.nxml.txt.nlp	22071477	SENT136	8	8	28	28	adalimumab	ST7	PA10004	7982;29967	0.874
NULL	Br_J_Cancer_2011_Jun_28_105(1)_118-123.nxml.txt.nlp	21654685	SENT90	5	5	19	19	dasatinib	S100beta	PA162372878	6285	0.874
NULL	Curr_Med_Chem_2014_May_21(14)_1595-1606.nxml.txt.nlp	23992330	SENT345	28	28	13	13	cetuximab	KRAS	PA10040	3845	0.874
NULL	Arthritis_Res_Ther_2003_Sep_3_5(6)_R317-R328.nxml.txt.nlp	14680506	SENT173	24	24	16	16	rolipram	IL-10	PA153906323	3586	0.874
NULL	Ann_Rheum_Dis_2008_May_21_68(2)_175-182.nxml.txt.nlp	18495735	SENT139	7	7	31	31	infliximab	CTX	PA452639	1593	0.874
NULL	Breast_Cancer_Res_2006_Nov_6_8(6)_215.nxml.txt.nlp	17096862	SENT47	35	35	27	27	trastuzumab	MUC4	PA451743	4585	0.874
NULL	Diabetes_Metab_Syndr_Obes_2014_Jun_24_7_229-239.nxml.txt.nlp	25018644	SENT104	20	20	16	16	sitagliptin	GLP-1	PA164748978	100125288	0.874
NULL	Clinics_2008_Oct_63(5)_651b-660.nxml.txt.nlp	18925326	SENT173	10	10	8	8	chlorpromazine	adiponectin	PA448964	9370	0.874
NULL	Exp_Brain_Res_2014_Jun_27_232(8)_2637-2644.nxml.txt.nlp	24969614	SENT133	5	5	36	36	palonosetron	NK1	PA10352	11126	0.874
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Apr_13_67(Pt_5)_o1090.nxml.txt.nlp	21754410	SENT69	27	27	6	6	ethanol	mol	PA448073	90527	0.874
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT370	14	14	0	0	resveratrol	TNF		7124	0.874
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_May_14_65(Pt_6)_o1266.nxml.txt.nlp	21583130	SENT51	35	35	10	10	benzaldehyde	mol	PA448571	90527	0.874
NULL	Curr_Oncol_2009_Jul_16(Suppl_2)_S1-S13.nxml.txt.nlp	19672416	SENT101	12	12	5	5	anastrozole	ATAC	PA448432	6375	0.874
NULL	FEBS_Open_Bio_2013_Dec_30_4_96-104.nxml.txt.nlp	24490130	SENT139	15	15	5	5	cisplatin	BRCA1	PA449014	672	0.874
NULL	Nucleic_Acids_Res_2013_Dec_17_41(22)_10241-10253.nxml.txt.nlp	24049075	SENT32	27	27	3	3	l-glutamine	MED23	PA10090	9439	0.874
NULL	Adv_Hematol_2012_Nov_20_2012_861060.nxml.txt.nlp	23251161	SENT13	22	22	16	16	doxorubicin	CHOP	PA449412	1649	0.874
NULL	Oncol_Lett_2014_Mar_2_7(3)_791-796.nxml.txt.nlp	24527087	SENT99	9	9	17	17	imatinib	CD34	PA10804	947	0.874
NULL	Korean_Circ_J_2013_Aug_31_43(8)_541-549.nxml.txt.nlp	24044013	SENT104	39	39	17	17	ticagrelor	CYP2C19	PA165374673	1557	0.874
NULL	Front_Neurosci_2011_Mar_3_5_23.nxml.txt.nlp	21519398	SENT246	30	30	25	25	exenatide	GLP-1	PA164749238	100125288	0.874
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT238	18	18	11	11	nutlin-3	FasL		356	0.874
NULL	Exp_Lung_Res_2013_Oct_1_39(8)_336-348.nxml.txt.nlp	23919450	SENT244	4	4	8	8	thrombin	PAR-1	PA451674	2011;2149	0.874
NULL	Croat_Med_J_2013_Apr_54(2)_171-179.nxml.txt.nlp	23630144	SENT105	12	12	19	19	taurine	STZ	PA451590	6484	0.874
NULL	Arthritis_Res_Ther_2008_Mar_17_10(2)_R33.nxml.txt.nlp	18346273	SENT187	23	23	9	9	infliximab	HMGB1	PA452639	3146	0.874
NULL	Crit_Care_2001_Mar_2_5(Suppl_1)_P208.nxml.txt.nlp	NULL	SENT7	9	9	1	1	propofol	PTH	PA451141	5741	0.874
NULL	Int_J_Biol_Sci_2013_Mar_7_9(3)_279-288.nxml.txt.nlp	23493630	SENT161	3	3	25	25	tocilizumab	IL-6	PA165292659	3569	0.874
NULL	Br_J_Pharmacol_2008_Oct_18_155(4)_596-605.nxml.txt.nlp	18852694	SENT146	7	7	13	13	fenofibrate	SREBP2	PA449594	6721	0.874
NULL	Arq_Bras_Cardiol_2013_Nov_101(5)_379-387.nxml.txt.nlp	24100691	SENT33	24	24	22	22	sirolimus	DES	PA451365	1674	0.874
NULL	Oncotarget_2011_Dec_24_2(12)_896-917.nxml.txt.nlp	22203527	SENT160	10	10	36	36	paclitaxel	LKB1	PA450761	6794	0.874
NULL	Endocrinol_Metab_(Seoul)_2014_Mar_14_29(1)_96-100.nxml.txt.nlp	24741461	SENT55	11	11	4	4	ketoconazole	ACTH	PA450146	5443	0.874
NULL	ScientificWorldJournal_2012_Apr_26_2012_358102.nxml.txt.nlp	22645419	SENT142	32	32	29	29	losartan	AT1	PA450268	9197;185	0.874
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT207	42	42	17	17	metformin	HIP	PA450395	6767;6159;64399;5068	0.874
NULL	Ther_Clin_Risk_Manag_2006_Jun_2(2)_129-158.nxml.txt.nlp	18360588	SENT203	1	1	3	3	voriconazole	CYP3A4	PA10233	1576	0.874
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT373	24	24	22	22	pp2	PP1		5540;5464	0.874
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT112	19	19	8	8	glucose	EGFR	PA449773	1956	0.874
NULL	J_Invest_Dermatol_2013_Dec_30_133(12)_10_1038_jid_2013_237.nxml.txt.nlp	23732752	SENT114	2	2	30	30	etanercept	IL-8	PA449515	3576	0.874
NULL	Exp_Ther_Med_2013_May_12_5(5)_1367-1370.nxml.txt.nlp	23737881	SENT98	3	3	36	36	heparin	CO2	PA449855	4513	0.874
NULL	Mol_Med_Rep_2015_Jan_22_11(1)_83-90.nxml.txt.nlp	25338529	SENT117	0	0	5	5	octreotide	HO-1	PA450678	3162	0.874
NULL	Int_J_Nanomedicine_2007_Jun_2(2)_241-252.nxml.txt.nlp	17722552	SENT66	8	8	32	32	dextran	HEMA	PA449261	2157	0.874
NULL	Exp_Ther_Med_2012_Sep_12_4(3)_475-480.nxml.txt.nlp	23181121	SENT8	11	11	19	19	cyclophosphamide	CHOP	PA449165	1649	0.874
NULL	Biomed_Imaging_Interv_J_2011_Oct_1_7(4)_e25.nxml.txt.nlp	22279502	SENT23	19	19	34	34	oxaliplatin	LARC	PA131285527	6364	0.874
NULL	Clin_Drug_Investig_2013_Aug_23_33(10)_727-736.nxml.txt.nlp	23975654	SENT72	9	9	26	26	bupropion	CYP2D6	PA448687	1565	0.874
NULL	Nat_Genet_2011_Jun_5_43(7)_621-629.nxml.txt.nlp	21642992	SENT105	11	11	22	22	doxorubicin	CDKN1A	PA449412	1026	0.874
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT38	38	38	10	10	mitomycin	MVP	PA450524	9961	0.874
NULL	Open_Virol_J_2009_Apr_1_3_21-25.nxml.txt.nlp	19572053	SENT23	25	25	0	0	l-glutamine	CD4	PA10090	920	0.874
NULL	Cancer_Cell_Int_2011_Aug_19_11_29.nxml.txt.nlp	21854619	SENT269	9	9	12	12	cisplatin	HDAC	PA449014	9734	0.874
NULL	Oncotarget_2014_Nov_3_5(20)_10127-10139.nxml.txt.nlp	25333256	SENT148	10	10	5	5	vemurafenib	TRIM16	PA165946873	10626	0.874
NULL	Clin_Sarcoma_Res_2014_Jan_31_4_2.nxml.txt.nlp	24484617	SENT46	24	24	1	1	paclitaxel	SPARC	PA450761	6678	0.874
NULL	Tumour_Biol_2012_Jun_21_33(3)_607-615.nxml.txt.nlp	22270450	SENT131	10	10	22	22	gefitinib	EGFR	PA131301952	1956	0.874
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT99	10	10	26	26	nutlin-3	p53		7157	0.874
NULL	Diabetes_2011_Mar_21_60(3)_757-765.nxml.txt.nlp	21282370	SENT11	21	21	2	2	isoproterenol	PTRF	PA450121	284119	0.874
NULL	Exp_Brain_Res_2014_Jun_27_232(8)_2637-2644.nxml.txt.nlp	24969614	SENT10	22	22	24	24	palonosetron	NK1	PA10352	11126	0.874
NULL	Bone_Marrow_Transplant_2012_Feb_28_47(2)_203-211.nxml.txt.nlp	21441963	SENT37	16	16	0	0	fludarabine	NMA	PA449655	25805	0.874
NULL	Hum_Genomics_2010_Feb_1_4(3)_194-201.nxml.txt.nlp	20368140	SENT51	2	2	12	12	collagenase	MMP2	PA449107	4313	0.874
NULL	Cell_Cycle_2013_May_15_12(10)_1492-1500.nxml.txt.nlp	23598717	SENT105	10	10	1	1	doxorubicin	ROCK1	PA449412	6093	0.874
NULL	Oncol_Lett_2013_Feb_10_5(2)_527-532.nxml.txt.nlp	23420605	SENT147	2	2	11	11	dasatinib	EGFR	PA162372878	1956	0.874
NULL	J_Cell_Mol_Med_2013_Oct_16_17(10)_1261-1270.nxml.txt.nlp	23855452	SENT41	16	16	26	26	cisplatin	p53	PA449014	7157	0.874
NULL	Curr_Oncol_2007_Aug_14(4)_154-161.nxml.txt.nlp	17710208	SENT143	0	0	10	10	sunitinib	CYP3A4	PA162372840	1576	0.874
NULL	Chin_J_Cancer_2012_Feb_31(2)_110-118.nxml.txt.nlp	22098951	SENT167	11	11	6	6	imatinib	P-gp	PA10804	5243	0.874
NULL	J_Gen_Intern_Med_2009_May_21_24(5)_656-664.nxml.txt.nlp	19306050	SENT333	7	7	3	3	warfarin	GGCX	PA451906	2677	0.874
NULL	Nat_Commun_2013_4_10_1038_ncomms2884.nxml.txt.nlp	23673639	SENT131	9	9	15	15	nadh	RNF	PA164755085	11074	0.874
NULL	J_Hematol_Oncol_2009_Feb_23_2_10.nxml.txt.nlp	19236716	SENT112	10	10	5	5	dasatinib	CYP3A4	PA162372878	1576	0.874
NULL	Front_Neurol_2014_Feb_18_5_17.nxml.txt.nlp	24600432	SENT20	4	4	8	8	levetiracetam	CD95	PA450206	355	0.874
NULL	Clinicoecon_Outcomes_Res_2014_Oct_17_6_451-461.nxml.txt.nlp	25378939	SENT78	21	21	11	11	vancomycin	HAP	PA451850	5915;10313	0.874
NULL	Nucl_Recept_Signal_2010_Nov_19_8_e005.nxml.txt.nlp	21383957	SENT31	26	26	32	32	taurine	BAAT	PA451590	570	0.874
NULL	Mol_Cancer_2010_Nov_2_9_289.nxml.txt.nlp	21044322	SENT60	34	34	14	14	cisplatin	FBS	PA449014	64319;26269	0.874
NULL	JAKSTAT_2014_Jun_12_3_e29554.nxml.txt.nlp	25105067	SENT10	12	12	4	4	propofol	STAT3	PA451141	6774	0.874
NULL	Oncotarget_2014_Mar_14_5(10)_3029-3038.nxml.txt.nlp	24912489	SENT1	23	23	14	14	everolimus	aromatase	PA164746311	1588	0.874
NULL	Open_Biochem_J_2011_Sep_23_5_45-51.nxml.txt.nlp	21966325	SENT191	14	14	4	4	diclofenac	JNK	PA449293	5599	0.874
NULL	Chemother_Res_Pract_2012_Aug_29_2012_817297.nxml.txt.nlp	22970367	SENT65	15	15	24	24	erlotinib	EGFR	PA134687924	1956	0.874
NULL	Adv_Appl_Bioinforma_Chem_2008_Oct_30_1_85-98.nxml.txt.nlp	21918608	SENT6	11	11	1	1	bortezomib	SPARC	PA10252	6678	0.874
NULL	Mol_Vis_2012_Nov_29_18_2839-2846.nxml.txt.nlp	23233786	SENT119	0	0	30	30	geldanamycin	Hsp90	PA152031327	3320	0.874
NULL	Braz_J_Med_Biol_Res_2012_Mar_2_45(3)_250-255.nxml.txt.nlp	22370705	SENT94	1	1	12	12	mecamylamine	ADM	PA450334	133	0.874
NULL	Mol_Vis_2010_Sep_2_16_1781-1790.nxml.txt.nlp	20824160	SENT165	9	9	14	14	rolipram	p38	PA153906323	10598;1432;7965	0.874
NULL	Diabetes_Care_2010_Jul_31_33(7)_1607-1609.nxml.txt.nlp	20357375	SENT53	6	6	13	13	sitagliptin	KDR	PA164748978	3791	0.874
NULL	J_Cardiothorac_Surg_2010_Jan_18_5_3.nxml.txt.nlp	20082695	SENT187	14	14	25	25	carvedilol	PARP-1	PA448817	25976	0.874
NULL	Breast_Cancer_Res_2009_Jun_29_11(3)_R41.nxml.txt.nlp	19563669	SENT278	29	29	23	23	gefitinib	TRAIL	PA131301952	8743	0.874
NULL	J_Korean_Med_Sci_2011_Jul_20_26(7)_893-899.nxml.txt.nlp	21738342	SENT104	8	8	26	26	resveratrol	COMT		1312	0.874
NULL	Oxid_Med_Cell_Longev_2013_Nov_28_2013_568093.nxml.txt.nlp	24379901	SENT74	3	3	5	5	resveratrol	AMPK		5563	0.874
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Jan_10_6_1-13.nxml.txt.nlp	24648765	SENT74	3	3	8	8	tamoxifen	P-gp	PA451581	5243	0.874
NULL	Mol_Cancer_2012_Jun_18_11_41.nxml.txt.nlp	22709873	SENT318	9	9	5	5	lapatinib	NR3C1	PA152241907	2908	0.874
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT376	6	6	14	14	lapatinib	HER2	PA152241907	2064	0.874
NULL	BMJ_2011_Aug_4_343_d4588.nxml.txt.nlp	21816733	SENT364	13	13	4	4	ticagrelor	ABCB1	PA165374673	5243	0.874
NULL	F1000Prime_Rep_2014_Dec_1_6_117.nxml.txt.nlp	25580271	SENT143	12	12	17	17	erlotinib	EGFR	PA134687924	1956	0.874
NULL	Front_Neurol_2014_Apr_9_5_44.nxml.txt.nlp	24782818	SENT106	8	8	15	15	methylprednisolone	IL-6	PA450466	3569	0.874
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT243	16	16	3	3	cisplatin	IBP	PA449014	706;50619	0.874
NULL	J_Headache_Pain_2014_Sep_18_15(Suppl_1)_F28.nxml.txt.nlp	NULL	SENT19	18	18	37	37	verapamil	P-gp	PA451868	5243	0.874
NULL	EMBO_Mol_Med_2011_May_3(5)_266-278.nxml.txt.nlp	21438154	SENT100	9	9	31	31	oxaliplatin	TRPM8	PA131285527	79054	0.874
NULL	Br_J_Cancer_2009_Jul_21_101(2)_238-243.nxml.txt.nlp	19568242	SENT99	2	2	9	9	sunitinib	IFN	PA162372840	3439	0.874
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT157	23	23	20	20	atorvastatin	TNF	PA448500	7124	0.874
NULL	Front_Oncol_2014_Apr_9_4_75.nxml.txt.nlp	24782986	SENT296	24	24	5	5	paclitaxel	Oct4	PA450761	5460	0.874
NULL	Int_J_Mol_Sci_2014_Oct_8_15(10)_17974-17999.nxml.txt.nlp	25299695	SENT102	11	11	23	23	curcumin	HO-2	PA151958596	3163	0.874
NULL	Ayu_2012_Jan-Mar_33(1)_38-43.nxml.txt.nlp	23049182	SENT60	34	34	16	16	ethambutol	AKT	PA164784021	207	0.874
NULL	Onco_Targets_Ther_2014_Mar_20_7_447-456.nxml.txt.nlp	24672247	SENT149	30	30	2	2	sorafenib	CLU	PA7000	1191	0.874
NULL	J_Biol_Chem_2012_Apr_27_287(18)_14644-14658.nxml.txt.nlp	22375002	SENT333	24	24	4	4	forskolin	CC2D1A	PA146096022	54862	0.874
NULL	Biomed_Res_Int_2013_Jul_15_2013_458571.nxml.txt.nlp	23956983	SENT178	28	28	11	11	l-serine	SHMT	PA451330	6470	0.874
NULL	Int_J_Cell_Biol_2012_May_16_2012_643929.nxml.txt.nlp	22666257	SENT163	14	14	2	2	neomycin	Bcl-2	PA450608	596	0.874
NULL	Acta_Pharmacol_Sin_2014_Jun_5_35(6)_716-726.nxml.txt.nlp	24793311	SENT167	8	8	19	19	atorvastatin	PSD-95	PA448500	1742	0.874
NULL	Pharm_Pract_(Granada)_2011_Mar_15_Jan-Mar_9(1)_1-10.nxml.txt.nlp	25132883	SENT35	8	8	28	28	rivaroxaban	SPAF	PA165958360	166378	0.874
NULL	Br_J_Cancer_2010_Jun_29_103(1)_61-72.nxml.txt.nlp	20588279	SENT259	13	13	18	18	trastuzumab	PTEN	PA451743	5728	0.874
NULL	Clin_Med_Insights_Oncol_2012_Mar_12_6_153-164.nxml.txt.nlp	22550404	SENT28	13	13	9	9	doxorubicin	CHOP	PA449412	1649	0.874
NULL	Biosci_Rep_2013_Oct_31_33(5)_e00078.nxml.txt.nlp	24073800	SENT164	22	22	20	20	capsaicin	TRPV1	PA448776	7442	0.874
NULL	Indian_J_Pharmacol_2009_Apr_41(2)_72-74.nxml.txt.nlp	20336221	SENT48	4	4	15	15	galactose	ANOVA	PA449725	4858	0.874
NULL	Pharmaceutics_2010_Jun_2_2(2)_258-274.nxml.txt.nlp	NULL	SENT23	15	15	29	29	paliperidone	P-gp	PA163518919	5243	0.874
NULL	Mol_Neurodegener_2011_May_19_6_34.nxml.txt.nlp	21595948	SENT98	19	19	3	3	trypsin	parkin	PA451806	5071	0.874
NULL	Pan_Afr_Med_J_2014_May_12_18_42.nxml.txt.nlp	25368731	SENT101	0	0	6	6	clopidogrel	P2Y12	PA449053	64805	0.874
NULL	J_Oncol_2009_Jul_14_2009_804108.nxml.txt.nlp	19636422	SENT143	0	0	6	6	lapatinib	EGFR	PA152241907	1956	0.874
NULL	BMB_Rep_2014_Apr_47(4)_221-226.nxml.txt.nlp	24286312	SENT98	15	15	8	8	nutlin-3	p53		7157	0.874
NULL	Pharmaceutics_2011_Nov_18_3(4)_865-913.nxml.txt.nlp	24309312	SENT79	3	3	16	16	amprenavir	CYP3A4	PA448422	1576	0.874
NULL	Cancers_(Basel)_2010_May_26_2(2)_955-969.nxml.txt.nlp	24281101	SENT59	19	19	7	7	bleomycin	BHD	PA448645	201163	0.874
NULL	Diabetol_Metab_Syndr_2014_Sep_23_6(1)_102.nxml.txt.nlp	NULL	SENT7	12	12	23	23	atorvastatin	RAGE	PA448500	177	0.874
NULL	Arthritis_Res_Ther_2006_Jul_20_8(4)_R129.nxml.txt.nlp	16859536	SENT210	29	29	11	11	rituximab	CD22	PA451261	933	0.874
NULL	Ann_Rheum_Dis_2008_Aug_5_68(5)_702-709.nxml.txt.nlp	18684743	SENT107	33	33	9	9	adalimumab	ACR	PA10004	49	0.874
NULL	J_Invest_Dermatol_2013_Aug_133(8)_1928-1929.nxml.txt.nlp	23856932	SENT23	26	26	17	17	vemurafenib	PAX3	PA165946873	5077	0.874
NULL	Oncol_Lett_2015_Jan_4_9(1)_91-95.nxml.txt.nlp	25435939	SENT73	14	14	33	33	vincristine	IB2	PA451879	23542	0.874
NULL	Indian_J_Nephrol_2012_Sep-Oct_22(5)_374-376.nxml.txt.nlp	23326050	SENT24	22	22	10	10	meropenem	ISPD	PA164764445	729920	0.874
NULL	Br_J_Cancer_2013_Dec_10_109(12)_3067-3072.nxml.txt.nlp	24263065	SENT6	27	27	6	6	irinotecan	KRAS	PA450085	3845	0.874
NULL	Nat_Commun_2014_Mar_24_5_3516.nxml.txt.nlp	24662724	SENT521	16	16	33	33	dextran	ADAM10	PA449261	102	0.874
NULL	Part_Fibre_Toxicol_2012_Nov_9_9_41.nxml.txt.nlp	23140310	SENT218	30	30	0	0	l-glutamine	TLR4	PA10090	7099	0.874
NULL	Blood_Cancer_J_2013_Dec_6_3(12)_e167.nxml.txt.nlp	24317089	SENT129	2	2	18	18	lovastatin	ATF6	PA450272	22926	0.874
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_13_2013_468537.nxml.txt.nlp	23956772	SENT141	0	0	32	32	doxorubicin	BAX	PA449412	581	0.874
NULL	Diabetologia_2010_Jun_27_53(6)_1142-1150.nxml.txt.nlp	20349036	SENT177	15	15	4	4	spermine	AMPK	PA164781199	5563	0.874
NULL	Cancer_Cell_Int_2010_Sep_9_10_32.nxml.txt.nlp	20828393	SENT196	0	0	14	14	cisplatin	ATF3	PA449014	467	0.874
NULL	Mol_Pain_2014_Feb_6_10_10.nxml.txt.nlp	24499354	SENT60	7	7	9	9	cyclophosphamide	CTX	PA449165	1593	0.874
NULL	Acta_Pharmacol_Sin_2010_Jun_4_31(6)_709-717.nxml.txt.nlp	20523342	SENT141	18	18	12	12	repaglinide	IGF2BP2	PA451234	10644	0.874
NULL	J_Korean_Med_Sci_2005_Dec_31_20(6)_1062-1065.nxml.txt.nlp	16361823	SENT89	8	8	6	6	cyclophosphamide	CHOP	PA449165	1649	0.874
NULL	Cell_Death_Differ_2009_Aug_20_16(8)_1135-1145.nxml.txt.nlp	19300452	SENT334	12	12	16	16	doxycycline	PUMA	PA449415	27113	0.874
NULL	Acta_Pharmacol_Sin_2012_May_16_33(5)_682-690.nxml.txt.nlp	22504904	SENT114	0	0	2	2	celecoxib	STAT3	PA448871	6774	0.874
NULL	J_Cancer_Res_Clin_Oncol_2013_Feb_10_139(2)_269-280.nxml.txt.nlp	23052698	SENT44	23	23	10	10	exemestane	aromatase	PA449563	1588	0.874
NULL	Neuropsychopharmacology_2009_Apr_2_34(5)_1135-1148.nxml.txt.nlp	18596687	SENT263	10	10	18	18	betaxolol	CRF	PA448611	1392;10882	0.874
NULL	Iran_J_Neurol_2014_13(1)_33-39.nxml.txt.nlp	24800045	SENT141	14	14	2	2	gentamicin	CDP	PA449753	1523	0.874
NULL	Int_J_Chron_Obstruct_Pulmon_Dis_2006_Dec_1(4)_373-379.nxml.txt.nlp	18044094	SENT57	11	11	15	15	cilomilast	PDE4B	PA165948031	5142	0.874
NULL	Cardiovasc_Res_2010_Jul_1_87(1)_60-72.nxml.txt.nlp	20110334	SENT240	21	21	26	26	atropine	LQT3	PA448505	6331	0.874
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT197	3	3	12	12	tacrolimus	IL-6	PA451578	3569	0.874
NULL	Jpn_Clin_Med_2013_Mar_6_4_7-13.nxml.txt.nlp	23966811	SENT8	30	30	25	25	omeprazole	ESD	PA450704	2098	0.874
NULL	Ann_Dermatol_2014_Jun_12_26(3)_363-373.nxml.txt.nlp	24966637	SENT14	20	20	6	6	imiquimod	MT1-MMP	PA449972	4323	0.874
NULL	Cell_Cycle_2012_Nov_1_11(21)_3983-3996.nxml.txt.nlp	22987153	SENT126	16	16	10	10	hydroxyurea	RAD51	PA449942	5888	0.874
NULL	Oncol_Lett_2014_Nov_14_8(5)_2086-2092.nxml.txt.nlp	25295095	SENT115	33	33	28	28	gemcitabine	LKB1	PA449748	6794	0.874
NULL	Arthritis_Res_Ther_2006_May_9_8(4)_R86.nxml.txt.nlp	16684367	SENT67	5	5	10	10	ethanol	MUT	PA448073	4594	0.874
NULL	Clin_Sci_(Lond)_2013_May_1_124(Pt_9)_567-578.nxml.txt.nlp	23113760	SENT301	20	20	11	11	oxygen	RRM2	PA450744	6241	0.874
NULL	Mol_Cancer_2014_Jul_5_13_165.nxml.txt.nlp	24996221	SENT222	11	11	5	5	docetaxel	HMGB1	PA449383	3146	0.874
NULL	Oncotarget_2014_Sep_10_5(19)_8924-8936.nxml.txt.nlp	25238040	SENT113	7	7	34	34	decitabine	p53	PA164749631	7157	0.874
NULL	Mol_Biol_Cell_2012_Jun_1_23(11)_2066-2075.nxml.txt.nlp	22496421	SENT206	7	7	0	0	staurosporine	HCA2	PA165109623	139081;55811;338442	0.874
NULL	J_Exp_Med_1994_Jul_1_180(1)_383-387.nxml.txt.nlp	7516415	SENT1	9	9	1	1	hyaluronan	CD44	PA165958431	960	0.874
NULL	Mol_Cancer_2009_Apr_22_8_26.nxml.txt.nlp	19386116	SENT125	3	3	5	5	ritonavir	AKT	PA451260	207	0.874
NULL	Exp_Lung_Res_2013_Oct_1_39(8)_336-348.nxml.txt.nlp	23919450	SENT139	5	5	0	0	argatroban	PAR-1	PA164745516	2011;2149	0.874
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2011_Jun_7_4_29-37.nxml.txt.nlp	22879792	SENT37	20	20	2	2	repaglinide	CYP2C8	PA451234	1558	0.874
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_91-103.nxml.txt.nlp	17912639	SENT72	17	17	33	33	trastuzumab	HER2	PA451743	2064	0.874
NULL	Clin_Pharmacol_2011_Jun_22_3_13-25.nxml.txt.nlp	22287853	SENT205	24	24	3	3	simvastatin	CYP3A4	PA451363	1576	0.874
NULL	ScientificWorldJournal_2013_Dec_30_2013_303950.nxml.txt.nlp	24489497	SENT73	25	25	20	20	thrombin	ADP	PA451674	23038	0.874
NULL	Nature_2009_Apr_2_458(7238)_591-596.nxml.txt.nlp	19234442	SENT76	23	23	34	34	etoposide	Fe65	PA449552	322	0.874
NULL	Oncogene_2013_Sep_26_32(39)_10_1038_onc_2012_491.nxml.txt.nlp	23108394	SENT123	13	13	32	32	epirubicin	FOXM1	PA449476	2305	0.874
NULL	Mol_Cancer_2009_Dec_23_8_129.nxml.txt.nlp	20030852	SENT247	18	18	23	23	curcumin	ABCA1	PA151958596	19	0.874
NULL	eLife_2013_Oct_29_2_e01222.nxml.txt.nlp	24171103	SENT481	29	29	11	11	doxycycline	LBH	PA449415	81606;221491	0.874
NULL	Indian_J_Crit_Care_Med_2010_Jan-Mar_14(1)_14-21.nxml.txt.nlp	20606904	SENT120	13	13	29	29	thrombin	PAR-1	PA451674	2011;2149	0.874
NULL	J_Mol_Signal_2010_Apr_22_5_3.nxml.txt.nlp	20412577	SENT152	8	8	14	14	isoproterenol	AKAP12	PA450121	9590	0.874
NULL	Acta_Pharmacol_Sin_2009_Sep_24_30(9)_1262-1275.nxml.txt.nlp	19701231	SENT226	39	39	25	25	lovastatin	PIGB	PA450272	9488	0.874
NULL	J_Hematol_Oncol_2012_Oct_11_5_64.nxml.txt.nlp	23057966	SENT61	13	13	16	16	ofatumumab	CHOP	PA165291493	1649	0.874
NULL	Oncotarget_2014_Mar_13_5(4)_1101-1110.nxml.txt.nlp	24658355	SENT33	17	17	21	21	tamoxifen	MKP-1	PA451581	1843	0.874
NULL	Drug_Target_Insights_2013_Aug_19_7_27-34.nxml.txt.nlp	24023511	SENT84	9	9	4	4	azithromycin	P-gp	PA448519	5243	0.874
NULL	Nat_Commun_2014_Dec_8_5_5736.nxml.txt.nlp	25484020	SENT52	7	7	15	15	letrozole	TRPA1	PA450196	8989	0.874
NULL	Evid_Based_Complement_Alternat_Med_2014_May_22_2014_601064.nxml.txt.nlp	25136372	SENT21	0	0	16	16	methotrexate	DHFR	PA450428	1719	0.873
NULL	Alcohol_Res_Health_2007_30(1)_38-47.nxml.txt.nlp	17718399	SENT76	33	33	6	6	ethanol	ADH1C	PA448073	126	0.873
NULL	Nat_Commun_2012_Feb_14_3_672.nxml.txt.nlp	22334075	SENT385	10	10	1	1	lovastatin	PTEN	PA450272	5728	0.873
NULL	Cancer_Cell_Int_2013_Feb_12_13_14.nxml.txt.nlp	23402310	SENT5	15	15	20	20	celecoxib	p65	PA448871	5970	0.873
NULL	J_Biol_Chem_2013_Nov_15_288(46)_33049-33059.nxml.txt.nlp	24089524	SENT279	11	11	19	19	nicotine	GATA4	PA450626	2626	0.873
NULL	Cardiovasc_Diabetol_2013_Nov_12_12_169.nxml.txt.nlp	24215514	SENT127	9	9	1	1	valsartan	AT2	PA451848	186	0.873
NULL	Behav_Brain_Funct_2011_Sep_7_7_39.nxml.txt.nlp	21899751	SENT79	22	22	11	11	phenytoin	KCNH2	PA450947	3757	0.873
NULL	Ann_Rheum_Dis_2008_Aug_12_68(6)_922-929.nxml.txt.nlp	18701556	SENT235	7	7	33	33	adalimumab	STAR	PA10004	6770;2984	0.873
NULL	Oncotarget_2013_Aug_24_4(10)_1618-1631.nxml.txt.nlp	24113128	SENT132	5	5	16	16	sorafenib	p53	PA7000	7157	0.873
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT275	19	19	14	14	acenocoumarol	CYP2C9	PA452632	1559	0.873
NULL	Indian_J_Pharm_Sci_2013_Jan-Feb_75(1)_94-98.nxml.txt.nlp	23901167	SENT87	32	32	19	19	phenacetin	CYP2C19	PA450897	1557	0.873
NULL	Ann_Hematol_2010_Sep_13_89(9)_861-871.nxml.txt.nlp	20387067	SENT104	0	0	10	10	dasatinib	CD34	PA162372878	947	0.873
NULL	Pharmaceutics_2011_Jul_13_3(3)_425-439.nxml.txt.nlp	24310588	SENT84	35	35	1	1	vicodin	SERS		6301;54938	0.873
NULL	BMJ_2013_Jan_16_346_f55.nxml.txt.nlp	23325883	SENT182	2	2	12	12	carvedilol	CARMEN	PA448817	8915	0.873
NULL	Mol_Cancer_2010_Oct_12_9_269.nxml.txt.nlp	20939893	SENT215	34	34	12	12	isoproterenol	AP-1	PA450121	2353;3727;2354;3725	0.873
NULL	J_Cell_Biol_2001_Apr_16_153(2)_413-428.nxml.txt.nlp	11309420	SENT322	27	27	2	2	doxorubicin	CARP	PA449412	27063;80013;767	0.873
NULL	Int_J_Mol_Sci_2014_Sep_11_15(9)_15994-16011.nxml.txt.nlp	25216334	SENT38	18	18	23	23	pegaptanib	VEGFR	PA164771236	3791	0.873
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT79	42	42	45	45	curcumin	TRAIL	PA151958596	8743	0.873
NULL	Int_J_Mol_Sci_2012_Feb_1_13(2)_1512-1523.nxml.txt.nlp	22408405	SENT30	4	4	30	30	olmesartan	LOX-1	PA164742950	4973	0.873
NULL	Indian_J_Med_Paediatr_Oncol_2013_Oct-Dec_34(4)_299-304.nxml.txt.nlp	24604961	SENT85	31	31	12	12	rituximab	CHOP	PA451261	1649	0.873
NULL	Oncol_Lett_2013_Mar_10_5(3)_1068-1074.nxml.txt.nlp	23426189	SENT238	0	0	10	10	4-methylumbelliferone	BAX	PA154081778	581	0.873
NULL	Arthritis_Res_Ther_2009_Apr_23_11(2)_R57.nxml.txt.nlp	19389237	SENT147	21	21	3	3	adalimumab	CD68	PA10004	968	0.873
NULL	Pharm_Pract_(Granada)_2011_Mar_15_Jan-Mar_9(1)_1-10.nxml.txt.nlp	25132883	SENT155	13	13	7	7	warfarin	SPAF	PA451906	166378	0.873
NULL	Cardiovasc_Diabetol_2013_Oct_17_12_150.nxml.txt.nlp	24134550	SENT104	31	31	7	7	metformin	activin	PA450395	83729	0.873
NULL	Clin_Interv_Aging_2014_Oct_21_9_1783-1791.nxml.txt.nlp	25364236	SENT144	13	13	44	44	donepezil	APOE	PA449394	348	0.873
NULL	Front_Immunol_2012_May_18_3_126.nxml.txt.nlp	22629256	SENT120	5	5	19	19	basiliximab	CD4	PA164747126	920	0.873
NULL	Cardiovasc_Diabetol_2013_Oct_17_12_150.nxml.txt.nlp	24134550	SENT111	16	16	2	2	pioglitazone	activin	PA450970	83729	0.873
NULL	J_Carcinog_2013_Dec_31_12_22.nxml.txt.nlp	24574860	SENT419	22	22	3	3	crizotinib	EGFR	PA165946122	1956	0.873
NULL	Clinics_(Sao_Paulo)_2014_Jan_69(1)_68-74.nxml.txt.nlp	24473562	SENT99	38	38	19	19	nutlin-3	SOCS-1		8651	0.873
NULL	Infect_Dis_Obstet_Gynecol_2012_Nov_29_2012_543916.nxml.txt.nlp	23251074	SENT37	33	33	15	15	lopinavir	CD4	PA450264	920	0.873
NULL	Br_J_Cancer_1998_Oct_78(8)_1024-1029.nxml.txt.nlp	9792145	SENT17	6	6	13	13	amifostine	CD34	PA448365	947	0.873
NULL	J_Biol_Chem_2012_Apr_27_287(18)_14644-14658.nxml.txt.nlp	22375002	SENT20	7	7	24	24	forskolin	CC2D1A	PA146096022	54862	0.873
NULL	Cancers_(Basel)_2011_Apr_13_3(2)_1957-1974.nxml.txt.nlp	24212791	SENT157	9	9	18	18	oxaliplatin	BMP4	PA131285527	652	0.873
NULL	J_Hematol_Oncol_2010_Mar_13_3_10.nxml.txt.nlp	20226083	SENT31	7	7	26	26	docetaxel	RRM2	PA449383	6241	0.873
NULL	Breast_Cancer_(Auckl)_2009_Apr_7_3_23-34.nxml.txt.nlp	21556247	SENT16	19	19	16	16	tamoxifen	aromatase	PA451581	1588	0.873
NULL	Breast_Cancer_Res_2010_Oct_14_12(5)_R84.nxml.txt.nlp	20946630	SENT238	12	12	34	34	choline	SLC44A1	PA448976	23446	0.873
NULL	Br_J_Cancer_2012_Dec_4_107(12)_1950-1955.nxml.txt.nlp	23169295	SENT14	3	3	7	7	oxaliplatin	ERCC1	PA131285527	2067	0.873
NULL	Infect_Dis_Obstet_Gynecol_2012_Nov_29_2012_543916.nxml.txt.nlp	23251074	SENT37	10	10	15	15	nevirapine	CD4	PA450616	920	0.873
NULL	BMB_Rep_2013_Nov_46(11)_544-549.nxml.txt.nlp	24152910	SENT51	19	19	24	24	thrombin	PAR-1	PA451674	2011;2149	0.873
NULL	Oncotarget_2011_Mar_23_2(3)_165-177.nxml.txt.nlp	21444946	SENT93	10	10	16	16	gefitinib	EGFR	PA131301952	1956	0.873
NULL	Int_J_Environ_Res_Public_Health_2012_Aug_3_9(8)_2788-2800.nxml.txt.nlp	23066397	SENT122	12	12	8	8	isoniazid	CYP2E1	PA450112	1571	0.873
NULL	Oncotarget_2012_May_9_3(4)_363-364.nxml.txt.nlp	22622047	SENT15	34	34	22	22	imatinib	SIRT1	PA10804	23411	0.873
NULL	Sci_Rep_2014_Dec_3_4_7294.nxml.txt.nlp	25465236	SENT532	41	41	3	3	erlotinib	EGFR	PA134687924	1956	0.873
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1651-1657.nxml.txt.nlp	19904273	SENT119	14	14	3	3	docetaxel	BRCA1	PA449383	672	0.873
NULL	Mol_Biol_Cell_2012_Jun_15_23(12)_2302-2318.nxml.txt.nlp	22553350	SENT345	9	9	2	2	doxycycline	MARK2	PA449415	2011	0.873
NULL	Front_Neurol_2014_Apr_9_5_44.nxml.txt.nlp	24782818	SENT110	6	6	14	14	methylprednisolone	Bcl-2	PA450466	596	0.873
NULL	Mol_Cancer_2014_Jul_28_13_179.nxml.txt.nlp	25070035	SENT304	12	12	0	0	fluorescein	NY-ESO-1	PA164746009	1485	0.873
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2751-2762.nxml.txt.nlp	24169358	SENT13	0	0	12	12	fulvestrant	CDK6	PA164747170	1021	0.873
NULL	Diabetes_Care_2013_Jul_12_36(7)_1913-1918.nxml.txt.nlp	23359361	SENT31	32	32	40	40	sitagliptin	GLP-1	PA164748978	100125288	0.873
NULL	Arthritis_Res_Ther_2009_Jun_29_11(3)_R100.nxml.txt.nlp	19563672	SENT224	15	15	30	30	adalimumab	IFN	PA10004	3439	0.873
NULL	Pharmaceuticals_(Basel)_2013_Apr_8_6(4)_500-509.nxml.txt.nlp	24276120	SENT88	30	30	39	39	benserazide	GPR35		2859	0.873
NULL	Acta_Pharmacol_Sin_2012_May_16_33(5)_682-690.nxml.txt.nlp	22504904	SENT226	0	0	2	2	celecoxib	STAT3	PA448871	6774	0.873
NULL	Anesth_Pain_Med_2014_Feb_15_4(1)_e15444.nxml.txt.nlp	24660158	SENT112	14	14	9	9	lidocaine	PSPS	PA450226	5967	0.873
NULL	Sci_Rep_2014_Nov_28_4_7237.nxml.txt.nlp	25429875	SENT114	21	21	7	7	hesperidin	p38	PA449867	10598;1432;7965	0.873
NULL	Oncologist_2010_Mar_9_15(3)_236-245.nxml.txt.nlp	20215359	SENT10	14	14	9	9	sunitinib	VEGFR	PA162372840	3791	0.873
NULL	Biomed_Res_Int_2013_May_16_2013_389672.nxml.txt.nlp	23762842	SENT166	6	6	1	1	imatinib	FDG	PA10804	23583	0.873
NULL	Front_Physiol_2013_Dec_20_4_380.nxml.txt.nlp	24391597	SENT703	0	0	8	8	trypsin	CFTR	PA451806	1080	0.873
NULL	J_Invest_Dermatol_2012_Jan_1_132(1)_105-113.nxml.txt.nlp	21881590	SENT76	24	24	16	16	etanercept	IL-23A	PA449515	51561	0.873
NULL	J_Thyroid_Res_2011_Apr_10_2011_895923.nxml.txt.nlp	21603172	SENT183	15	15	8	8	thyroglobulin	IFN	PA164754910	3439	0.873
NULL	Curr_Pharm_Biotechnol_2012_May_13(6)_969-986.nxml.txt.nlp	22039792	SENT75	14	14	30	30	loperamide	MDR1	PA450262	5243	0.873
NULL	Case_Rep_Gastroenterol_2010_Nov_23_4(3)_502-509.nxml.txt.nlp	21151634	SENT99	26	26	9	9	rituximab	CD4	PA451261	920	0.873
NULL	J_Mol_Signal_2011_Jul_20_6_7.nxml.txt.nlp	21774804	SENT257	13	13	31	31	dasatinib	CD133	PA162372878	8842	0.873
NULL	Diabetes_2011_Nov_17_60(11)_2691-2700.nxml.txt.nlp	21896928	SENT251	9	9	22	22	resveratrol	SIRT1		23411	0.873
NULL	Med_Sci_Monit_2014_Aug_1_20_1345-1352.nxml.txt.nlp	25080850	SENT109	20	20	8	8	rosiglitazone	AQP7	PA451283	364	0.873
NULL	Cancer_Metab_2014_May_28_2(Suppl_1)_P65.nxml.txt.nlp	NULL	SENT19	22	22	5	5	resveratrol	p53		7157	0.873
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT220	34	34	27	27	doxorubicin	ABCC10	PA449412	89845	0.873
NULL	Oncotarget_2013_Aug_30_4(10)_1698-1711.nxml.txt.nlp	24091605	SENT131	27	27	19	19	gefitinib	PDCL	PA131301952	5082	0.873
NULL	J_Headache_Pain_2014_Dec_8_15(1)_85.nxml.txt.nlp	25488888	SENT102	0	0	12	12	sumatriptan	5-HT1D	PA451566	3352	0.873
NULL	Nat_Biotechnol_2010_Aug_2_28(8)_839-847.nxml.txt.nlp	20601939	SENT196	34	34	24	24	heparin	CD34	PA449855	947	0.873
NULL	J_Lipid_Res_2015_Jan_56(1)_109-121.nxml.txt.nlp	25421061	SENT236	13	13	2	2	trypsin	CGI-58	PA451806	51099	0.873
NULL	Bioinformation_2012_Jan_6_8(1)_13-19.nxml.txt.nlp	22359429	SENT126	5	5	9	9	curcumin	MDR1	PA151958596	5243	0.873
NULL	ScientificWorldJournal_2012_Apr_19_2012_978913.nxml.txt.nlp	22593717	SENT135	0	0	10	10	naringin	CYP3A4	PA151958360	1576	0.873
NULL	Adv_Biomed_Res_2014_Sep_8_3_189.nxml.txt.nlp	25298958	SENT6	25	25	37	37	clarithromycin	NAC	PA449028	22861	0.873
NULL	Open_Biochem_J_2011_Sep_23_5_45-51.nxml.txt.nlp	21966325	SENT30	3	3	15	15	indomethacin	ATF6	PA449982	22926	0.873
NULL	J_Cardiothorac_Surg_2014_May_9_9_81.nxml.txt.nlp	24885948	SENT83	22	22	5	5	sorafenib	ANOVA	PA7000	4858	0.873
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1137-1144.nxml.txt.nlp	20234366	SENT166	11	11	8	8	cetuximab	MKP-1	PA10040	1843	0.873
NULL	Cancer_Manag_Res_2013_Oct_8_5_337-347.nxml.txt.nlp	24204170	SENT66	0	0	15	15	cabozantinib	VEGFR2	PA165906891	3791	0.873
NULL	Mol_Cancer_2009_Jun_8_8_34.nxml.txt.nlp	19500427	SENT121	3	3	9	9	gemcitabine	CLSPN	PA449748	63967	0.873
NULL	J_Adv_Pharm_Technol_Res_2012_Oct-Dec_3(4)_202-209.nxml.txt.nlp	23378940	SENT168	11	11	5	5	irinotecan	CYP3A4	PA450085	1576	0.873
NULL	J_Carcinog_2012_Jul_28_11_10.nxml.txt.nlp	22919283	SENT49	5	5	11	11	resveratrol	SIRT1		23411	0.873
NULL	Int_J_Endocrinol_2014_Jun_25_2014_534904.nxml.txt.nlp	25053942	SENT21	11	11	2	2	amiodarone	AIT	PA448383	160728	0.873
NULL	Breast_Cancer_Res_Treat_2014_Dec_19_143(2)_351-358.nxml.txt.nlp	24352574	SENT172	3	3	21	21	docetaxel	HER-2	PA449383	2064	0.873
NULL	Hum_Genomics_2011_May_1_5(4)_265-282.nxml.txt.nlp	21712189	SENT149	24	24	1	1	nevirapine	CYP2B6	PA450616	1555	0.873
NULL	Hum_Mol_Genet_2013_Nov_15_22(22)_4616-4626.nxml.txt.nlp	23814041	SENT186	0	0	21	21	simvastatin	neuroserpin	PA451363	5274	0.873
NULL	J_Cell_Mol_Med_2013_Dec_6_17(12)_1588-1597.nxml.txt.nlp	24199964	SENT171	4	4	10	10	doxycycline	APT	PA449415	653639	0.873
NULL	Sci_Rep_2015_Jan_6_5_7636.nxml.txt.nlp	25560045	SENT42	26	26	40	40	ethanol	NO3	PA448073	4681	0.873
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT111	9	9	35	35	trastuzumab	HER3	PA451743	2065	0.873
NULL	Nucleic_Acids_Res_2010_Oct_21_38(18)_6148-6158.nxml.txt.nlp	20494979	SENT266	22	22	28	28	paclitaxel	HLJ1	PA450761	11080	0.873
NULL	Hematol_Rep_2011_Oct_10_3(2)_e16.nxml.txt.nlp	22184537	SENT23	19	19	11	11	acenocoumarol	CYP2C9	PA452632	1559	0.873
NULL	Nucleic_Acids_Res_2005_Jun_8_33(10)_3283-3291.nxml.txt.nlp	15944449	SENT444	7	7	26	26	melphalan	XPB	PA450354	2071	0.873
NULL	Vet_Res_2013_Oct_2_44(1)_89.nxml.txt.nlp	24088531	SENT176	1	1	22	22	hemin	HO-1	PA449849	3162	0.873
NULL	Cell_Death_Dis_2014_Jul_17_5(7)_e1333.nxml.txt.nlp	25032856	SENT70	0	0	5	5	candesartan	TLR4	PA448765	7099	0.873
NULL	Nucleic_Acids_Res_2005_Apr_11_33(7)_2061-2077.nxml.txt.nlp	15824059	SENT86	21	21	1	1	thrombin	p53	PA451674	7157	0.873
NULL	Front_Oncol_2014_Jun_27_4_157.nxml.txt.nlp	25019058	SENT75	14	14	26	26	cetuximab	EGFR	PA10040	1956	0.873
NULL	Biologics_2014_Dec_4_8_281-291.nxml.txt.nlp	25506209	SENT69	15	15	6	6	sorafenib	BRAF	PA7000	673	0.873
NULL	Cancer_Cell_Int_2013_Dec_23_13_123.nxml.txt.nlp	24365069	SENT27	37	37	2	2	simvastatin	CD34	PA451363	947	0.873
NULL	Ann_Oncol_2009_Aug_20(Suppl_6)_vi35-vi40.nxml.txt.nlp	19617296	SENT73	0	0	23	23	tanespimycin	Hsp90	PA165291490	3320	0.873
NULL	J_Cell_Biol_2005_Jul_4_170(1)_49-59.nxml.txt.nlp	15983061	SENT156	19	19	3	3	fluorescein	MITF	PA164746009	4286	0.873
NULL	Int_J_Hypertens_2012_Jun_26_2012_124758.nxml.txt.nlp	22792446	SENT169	15	15	12	12	losartan	AT1	PA450268	9197;185	0.873
NULL	J_Clin_Biochem_Nutr_2009_Jul_30_45(1)_9-13.nxml.txt.nlp	19590701	SENT41	24	24	33	33	lansoprazole	HO-1	PA450180	3162	0.873
NULL	J_Exp_Clin_Cancer_Res_2009_Feb_15_28(1)_19.nxml.txt.nlp	19216799	SENT137	7	7	3	3	cisplatin	AEG-1	PA449014	92140	0.873
NULL	Braz_J_Med_Biol_Res_2013_Aug_13_46(8)_650-658.nxml.txt.nlp	23969971	SENT173	27	27	9	9	cisplatin	STAT3	PA449014	6774	0.873
NULL	Cell_Death_Dis_2010_Oct_21_1(10)_e86.nxml.txt.nlp	21368859	SENT219	7	7	9	9	doxorubicin	TRAIL	PA449412	8743	0.873
NULL	Nat_Neurosci_2013_Aug_14_16(8)_1049-1059.nxml.txt.nlp	23852115	SENT161	15	15	12	12	heparin	CA3	PA449855	761	0.873
NULL	Antimicrob_Resist_Infect_Control_2012_May_30_1_21.nxml.txt.nlp	22958440	SENT192	11	11	0	0	gentamicin	TC1	PA449753	6947	0.873
NULL	Open_Dent_J_2013_Jul_26_7_88-93.nxml.txt.nlp	24009648	SENT89	13	13	2	2	anakinra	IL-1B	PA10799	3553	0.873
NULL	Eur_Respir_J_2012_Nov_26_40(5)_1106-1114.nxml.txt.nlp	23060624	SENT171	28	28	26	26	tiotropium	NNT	PA164769056	23530	0.873
NULL	Acta_Pharmacol_Sin_2014_Jun_5_35(6)_727-737.nxml.txt.nlp	24793312	SENT13	8	8	14	14	candesartan	B27	PA448765	56246	0.873
NULL	J_Am_Heart_Assoc_2013_Apr_24_2(2)_e000128.nxml.txt.nlp	23584809	SENT46	7	7	31	31	nitroprusside	EPO	PA451406	7076;8288;2056	0.873
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2014_Jan_29_70(Pt_2)_279-289.nxml.txt.nlp	24531462	SENT68	10	10	36	36	thyroglobulin	B12	PA164754910	7126;4709	0.873
NULL	Ther_Clin_Risk_Manag_2006_Mar_2(1)_59-75.nxml.txt.nlp	18360582	SENT235	3	3	10	10	ketoconazole	CYP3A4	PA450146	1576	0.873
NULL	Chemother_Res_Pract_2012_Dec_20_2012_743193.nxml.txt.nlp	23320171	SENT125	0	0	16	16	trastuzumab	HER2	PA451743	2064	0.873
NULL	Exp_Ther_Med_2014_Sep_14_8(3)_836-840.nxml.txt.nlp	25120610	SENT12	3	3	32	32	fasudil	ROCK1	PA165946121	6093	0.873
NULL	Br_J_Cancer_2004_Mar_5_90(Suppl_1)_S2-S6.nxml.txt.nlp	15094757	SENT65	18	18	4	4	tamoxifen	AF1	PA451581	1946	0.873
NULL	Front_Behav_Neurosci_2009_Jun_29_3_10.nxml.txt.nlp	19587848	SENT45	4	4	0	0	genistein	DES	PA165109660	1674	0.873
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S31-S40.nxml.txt.nlp	20680106	SENT191	14	14	2	2	irinotecan	BRAF	PA450085	673	0.873
NULL	Ann_Oncol_2011_Mar_8_22(3)_503-514.nxml.txt.nlp	20616198	SENT22	4	4	9	9	aminoglutethimide	aromatase	PA448375	1588	0.873
NULL	Mol_Cancer_2012_Mar_25_11_16.nxml.txt.nlp	22443473	SENT304	10	10	15	15	fasudil	CD34	PA165946121	947	0.873
NULL	Br_J_Cancer_1998_77(2)_201-209.nxml.txt.nlp	9460989	SENT11	22	22	8	8	chlorambucil	MRP1	PA448926	4437	0.873
NULL	Acta_Pharmacol_Sin_2011_Jun_23_32(6)_711-715.nxml.txt.nlp	21602841	SENT25	7	7	14	14	capsaicin	AQP1	PA448776	358	0.873
NULL	BMJ_2011_Jul_26_343_d4366.nxml.txt.nlp	21791491	SENT159	0	0	30	30	potassium	ACE	PA451047	1636	0.873
NULL	Exp_Ther_Med_2013_Jul_25_6(1)_109-114.nxml.txt.nlp	23935730	SENT150	17	17	27	27	doxorubicin	CHOP	PA449412	1649	0.873
NULL	Core_Evid_2010_Oct_21_5_61-76.nxml.txt.nlp	21042543	SENT346	17	17	4	4	irinotecan	KRAS	PA450085	3845	0.873
NULL	Br_J_Cancer_2013_Feb_19_108(3)_570-578.nxml.txt.nlp	23299527	SENT150	13	13	11	11	acetohexamide	ALOX12	PA164777011	239	0.873
NULL	J_Skin_Cancer_2013_Feb_10_2013_327150.nxml.txt.nlp	23476782	SENT119	0	0	9	9	imiquimod	TLR7	PA449972	51284	0.873
NULL	Blood_Cancer_J_2014_Mar_7_4(3)_e190.nxml.txt.nlp	24608734	SENT98	18	18	14	14	doxorubicin	CHOP	PA449412	1649	0.873
NULL	Br_J_Cancer_2011_Jun_28_105(1)_118-123.nxml.txt.nlp	21654685	SENT14	16	16	7	7	dasatinib	S100beta	PA162372878	6285	0.873
NULL	Biomed_Res_Int_2014_Jan_29_2014_831845.nxml.txt.nlp	24605337	SENT188	26	26	31	31	bupivacaine	S6K1	PA135057240	6198	0.873
NULL	Inflamm_Res_2009_Dec_21_58(12)_873-880.nxml.txt.nlp	19544046	SENT323	7	7	15	15	pindolol	5-HT1A	PA450966	3350	0.873
NULL	J_Cell_Biol_2003_Aug_18_162(4)_661-671.nxml.txt.nlp	12925710	SENT291	18	18	29	29	suramin	PP2	PA10292	4888	0.873
NULL	Br_J_Cancer_2012_Feb_28_106(5)_858-866.nxml.txt.nlp	22343622	SENT155	11	11	17	17	paclitaxel	p38	PA450761	10598;1432;7965	0.873
NULL	Nature_2009_Apr_16_458(7240)_899-903.nxml.txt.nlp	19219027	SENT30	22	22	0	0	mitoxantrone	CLEC9A	PA450526	283420	0.873
NULL	Front_Neurol_2014_Dec_11_5_264.nxml.txt.nlp	25566171	SENT114	9	9	23	23	amantadine	IL-6	PA448360	3569	0.873
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_79-96.nxml.txt.nlp	19305789	SENT219	0	0	26	26	vanillin	TRPV3	PA451852	162514	0.873
NULL	Int_Semin_Surg_Oncol_2008_Apr_28_5_9.nxml.txt.nlp	18442393	SENT89	14	14	28	28	tamoxifen	HER2	PA451581	2064	0.873
NULL	Mol_Cancer_2009_Nov_10_8_99.nxml.txt.nlp	19903356	SENT27	28	28	22	22	imatinib	IGFBP3	PA10804	3486	0.873
NULL	Oxid_Med_Cell_Longev_2009_Sep-Oct_2(4)_214-221.nxml.txt.nlp	20716907	SENT220	3	3	33	33	pilocarpine	P400	PA450962	57634	0.873
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT60	21	21	28	28	bevacizumab	VEGFR1	PA130232992	2321	0.873
NULL	Protein_J_2012_Aug_5_31(6)_511-518.nxml.txt.nlp	22763563	SENT169	16	16	22	22	atorvastatin	CD36	PA448500	948	0.873
NULL	J_Cardiovasc_Magn_Reson_2011_Feb_2_13(Suppl_1)_P85.nxml.txt.nlp	NULL	SENT5	7	7	0	0	dobutamine	FFR	PA449381	738	0.873
NULL	Mar_Drugs_2009_Jul_17_7(3)_331-340.nxml.txt.nlp	19841717	SENT103	6	6	1	1	trabectedin	FDG	PA165958349	23583	0.873
NULL	Oncotarget_2010_Oct_25_1(7)_497-514.nxml.txt.nlp	21165163	SENT122	33	33	36	36	erlotinib	EGFR	PA134687924	1956	0.873
NULL	Anc_Sci_Life_2012_Oct-Dec_32(2)_93-98.nxml.txt.nlp	24167334	SENT120	7	7	14	14	cyclophosphamide	AR7	PA449165	7067	0.873
NULL	Front_Physiol_2013_Jun_28_4_152.nxml.txt.nlp	23825461	SENT99	28	28	14	14	diazoxide	ANG	PA449285	283	0.873
NULL	Breast_Cancer_Res_2007_Jun_7_9(3)_R37.nxml.txt.nlp	17555561	SENT212	32	32	24	24	raloxifene	PDGFRA	PA451221	5156	0.873
NULL	Br_J_Cancer_2013_Mar_5_108(4)_887-900.nxml.txt.nlp	23462807	SENT19	0	0	20	20	sunitinib	KIT	PA162372840	3815	0.873
NULL	Breast_Cancer_Res_2011_Nov_1_13(6)_R109.nxml.txt.nlp	22044691	SENT377	16	16	7	7	docetaxel	HER2	PA449383	2064	0.873
NULL	Int_Semin_Surg_Oncol_2008_Apr_28_5_9.nxml.txt.nlp	18442393	SENT121	29	29	15	15	tamoxifen	HER-2	PA451581	2064	0.873
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT37	13	13	3	3	afatinib	HER2	PA165981154	2064	0.873
NULL	Osteoporos_Int_2013_Oct_19_24(1)_23-57.nxml.txt.nlp	23079689	SENT510	10	10	15	15	teriparatide	PTH	PA451620	5741	0.873
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT113	9	9	2	2	sulindac	NAC	PA451565	22861	0.873
NULL	Mol_Cancer_2009_Nov_10_8_99.nxml.txt.nlp	19903356	SENT8	26	26	14	14	imatinib	IGFBP3	PA10804	3486	0.873
NULL	Mol_Cancer_2014_Jan_28_13_17.nxml.txt.nlp	24472312	SENT178	4	4	13	13	ponatinib	c-Myc	PA165980594	4609	0.873
NULL	Front_Psychol_2014_Apr_4_5_282.nxml.txt.nlp	24772099	SENT1212	4	4	6	6	resveratrol	KLF2		10365	0.873
NULL	J_Appl_Oral_Sci_2010_Nov-Dec_18(6)_630-634.nxml.txt.nlp	21308296	SENT61	34	34	36	36	ketorolac	KET	PA450150	8626	0.873
NULL	Br_J_Cancer_2013_Feb_5_108(2)_334-341.nxml.txt.nlp	23257893	SENT157	23	23	13	13	sorafenib	NOXA	PA7000	5366	0.873
NULL	J_Anim_Sci_Biotechnol_2013_Jul_30_4(1)_27.nxml.txt.nlp	23899038	SENT197	3	3	18	18	l-cysteine	IL-8	PA449173	3576	0.873
NULL	Acta_Neuropathol_Commun_2014_May_30_2_57.nxml.txt.nlp	24887326	SENT15	13	13	11	11	vardenafil	ABCB1	PA10229	5243	0.873
NULL	Drugs_Context_2012_Nov_19_2012_212242.nxml.txt.nlp	24432031	SENT128	8	8	15	15	tamoxifen	IL-2	PA451581	3558	0.873
NULL	Emerg_Infect_Dis_2013_Mar_19(3)_449-455.nxml.txt.nlp	23622714	SENT52	13	13	9	9	isoniazid	DST	PA450112	667	0.873
NULL	Open_Biochem_J_2011_Sep_23_5_45-51.nxml.txt.nlp	21966325	SENT89	4	4	7	7	indomethacin	PERK	PA449982	9451	0.873
NULL	Int_J_Biol_Sci_2013_Dec_17_10(1)_64-72.nxml.txt.nlp	24391452	SENT120	35	35	33	33	ketanserin	5-HT2A	PA131053734	3356	0.873
NULL	Fibrogenesis_Tissue_Repair_2008_Oct_13_1_5.nxml.txt.nlp	19014652	SENT585	22	22	5	5	thrombin	MCP-1	PA451674	6347	0.873
NULL	Br_J_Pharmacol_2012_Jan_165(2)_390-400.nxml.txt.nlp	21671897	SENT209	20	20	25	25	suramin	P2X2	PA10292	22953	0.873
NULL	J_Med_Chem_2014_Jan_23_57(2)_449-461.nxml.txt.nlp	24387105	SENT33	15	15	5	5	cyclophosphamide	ALDH3A1	PA449165	218	0.873
NULL	Cancer_Res_Treat_2014_Jan_15_46(1)_48-54.nxml.txt.nlp	24520223	SENT15	21	21	32	32	oxaliplatin	KRAS	PA131285527	3845	0.873
NULL	Oncotarget_2014_Oct_18_5(21)_10206-10221.nxml.txt.nlp	25344914	SENT41	0	0	11	11	vemurafenib	BRAF	PA165946873	673	0.873
NULL	Breast_Cancer_Res_2007_Aug_16_9(4)_305.nxml.txt.nlp	17705882	SENT7	44	44	8	8	fulvestrant	aromatase	PA164747170	1588	0.873
NULL	Indian_J_Dermatol_2013_May-Jun_58(3)_247d.nxml.txt.nlp	23723525	SENT14	22	22	15	15	imiquimod	IFN	PA449972	3439	0.873
NULL	Croat_Med_J_2012_Jun_53(3)_214-223.nxml.txt.nlp	22661134	SENT63	27	27	34	34	diazepam	ACTH	PA449283	5443	0.873
NULL	Diabetes_Care_2012_Feb_16_35(2)_327-333.nxml.txt.nlp	22179958	SENT14	0	0	10	10	metformin	B12	PA450395	7126;4709	0.873
NULL	Ann_Dermatol_2012_Aug_25_24(3)_295-305.nxml.txt.nlp	22879713	SENT192	36	36	30	30	estradiol	aromatase	PA449503	1588	0.873
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1059-1066.nxml.txt.nlp	21364577	SENT4	21	21	7	7	anastrozole	aromatase	PA448432	1588	0.873
NULL	J_Biol_Chem_2013_May_31_288(22)_15510-15519.nxml.txt.nlp	23599432	SENT91	7	7	0	0	heparin	LRPPRC	PA449855	10128	0.873
NULL	Oncotarget_2013_Jun_4_4(5)_772-784.nxml.txt.nlp	23800712	SENT125	45	45	27	27	erlotinib	PIK3CA	PA134687924	5290	0.873
NULL	Anticancer_Drugs_2015_Jan_28_26(1)_46-55.nxml.txt.nlp	25099621	SENT199	12	12	24	24	doxorubicin	p38	PA449412	10598;1432;7965	0.873
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_127043.nxml.txt.nlp	23227093	SENT17	18	18	2	2	lovastatin	RYR	PA450272	6261	0.873
NULL	Acta_Pharmacol_Sin_2012_May_26_33(5)_675-681.nxml.txt.nlp	22447226	SENT139	26	26	11	11	gefitinib	survivin	PA131301952	332	0.873
NULL	Cell_Death_Dis_2012_Mar_1_3(3)_e275.nxml.txt.nlp	22378068	SENT84	7	7	14	14	metformin	AMPK	PA450395	5563	0.873
NULL	Hum_Mol_Genet_2013_Jun_1_22(11)_2247-2262.nxml.txt.nlp	23424202	SENT308	22	22	8	8	haloperidol	AMPH	PA449841	273	0.873
NULL	Diabetes_Care_2013_Mar_13_36(3)_498-504.nxml.txt.nlp	23139373	SENT22	8	8	4	4	liraglutide	GLP-1	PA165958364	100125288	0.873
NULL	Orphanet_J_Rare_Dis_2014_Apr_29_9_66.nxml.txt.nlp	24775865	SENT86	40	40	3	3	paraformaldehyde	ALPL	PA450790	249	0.873
NULL	Nucleic_Acids_Res_2005_Jun_22_33(11)_3591-3597.nxml.txt.nlp	15972855	SENT283	14	14	9	9	cisplatin	p53	PA449014	7157	0.873
NULL	Tech_Coloproctol_2014_Sep_13_18(4)_373-380.nxml.txt.nlp	24030782	SENT256	2	2	33	33	lidocaine	AAP	PA450226	5345	0.873
NULL	Contemp_Oncol_(Pozn)_2012_Nov_20_16(5)_363-370.nxml.txt.nlp	23788912	SENT144	6	6	12	12	imatinib	KIT	PA10804	3815	0.873
NULL	Scientifica_(Cairo)_2013_Apr_17_2013_217513.nxml.txt.nlp	24278769	SENT205	12	12	0	0	estradiol	FKBP2	PA449503	2286	0.873
NULL	Acta_Pharmacol_Sin_2012_May_26_33(5)_675-681.nxml.txt.nlp	22447226	SENT132	17	17	7	7	gefitinib	survivin	PA131301952	332	0.873
NULL	Biomed_Res_Int_2014_Jan_12_2014_276918.nxml.txt.nlp	24524073	SENT98	15	15	33	33	paroxetine	CYP2D6	PA450801	1565	0.873
NULL	J_Cancer_2012_Oct_13_3_432-448.nxml.txt.nlp	23074383	SENT141	12	12	6	6	staurosporine	PC-3	PA165109623	692094	0.873
NULL	Curr_Neuropharmacol_2008_Jun_6(2)_151-163.nxml.txt.nlp	19305794	SENT127	17	17	0	0	dextran	TRPV1	PA449261	7442	0.873
NULL	Ann_Clin_Transl_Neurol_2014_Dec_21_1(12)_996-1005.nxml.txt.nlp	25574474	SENT123	28	28	4	4	riluzole	P-gp	PA451251	5243	0.873
NULL	Arthritis_Res_Ther_2012_Jun_12_14(3)_R142.nxml.txt.nlp	22691272	SENT139	11	11	31	31	mianserin	IL-17	PA134687937	3605	0.873
NULL	Cancer_Res_Treat_2012_Mar_31_44(1)_1-10.nxml.txt.nlp	22500155	SENT45	8	8	12	12	cetuximab	EGFR	PA10040	1956	0.873
NULL	Autoimmune_Dis_2013_Aug_28_2013_613086.nxml.txt.nlp	24069534	SENT22	36	36	22	22	adalimumab	p40	PA10004	3921;339541;10314	0.873
NULL	Int_Semin_Surg_Oncol_2008_Apr_28_5_9.nxml.txt.nlp	18442393	SENT81	23	23	9	9	tamoxifen	HER-2	PA451581	2064	0.873
NULL	Int_J_Environ_Res_Public_Health_2012_Sep_19_9(9)_3354-3364.nxml.txt.nlp	23202692	SENT104	16	16	8	8	hydroquinone	CYP2E1	PA449924	1571	0.873
NULL	Cardiovasc_Diabetol_2013_Jun_14_12_87.nxml.txt.nlp	23767412	SENT138	13	13	22	22	clopidogrel	CYP2C19	PA449053	1557	0.873
NULL	Ann_Clin_Transl_Neurol_2014_Sep_30_1(9)_721-732.nxml.txt.nlp	25493285	SENT12	19	19	21	21	liraglutide	GLP-1	PA165958364	100125288	0.873
NULL	Neural_Plast_2013_Nov_28_2013_740581.nxml.txt.nlp	24379976	SENT115	5	5	30	30	taurine	CA1	PA451590	759	0.873
NULL	Adv_Ther_2013_Nov_28_30(12)_1067-1085.nxml.txt.nlp	24287690	SENT58	29	29	18	18	metformin	GLP-1	PA450395	100125288	0.873
NULL	Evid_Based_Complement_Alternat_Med_2013_Mar_14_2013_247145.nxml.txt.nlp	23573120	SENT129	15	15	18	18	omeprazole	MPO	PA450704	4353	0.873
NULL	Exp_Ther_Med_2012_Sep_29_4(3)_375-380.nxml.txt.nlp	23181102	SENT141	5	5	21	21	lovastatin	P27	PA450272	3429	0.873
NULL	Acta_Pharmacol_Sin_2012_Apr_12_33(4)_542-550.nxml.txt.nlp	22407228	SENT146	7	7	10	10	perifosine	ATG5	PA165291471	9474	0.873
NULL	Exp_Diabetes_Res_2012_Mar_15_2012_146194.nxml.txt.nlp	22474415	SENT123	0	0	29	29	valsartan	GLP-1	PA451848	100125288	0.873
NULL	Br_J_Cancer_2012_Sep_4_107(6)_967-976.nxml.txt.nlp	22892391	SENT16	21	21	29	29	cisplatin	BCL2	PA449014	596	0.873
NULL	J_Hematol_Oncol_2011_Jan_21_4_5.nxml.txt.nlp	21255411	SENT253	11	11	27	27	paclitaxel	EGFR	PA450761	1956	0.873
NULL	Cancers_(Basel)_2014_Oct_24_6(4)_2187-2223.nxml.txt.nlp	25347122	SENT1182	10	10	4	4	carboplatin	EGFR	PA448803	1956	0.873
NULL	Clin_Ophthalmol_2014_Jun_3_8_1057-1064.nxml.txt.nlp	24940042	SENT35	0	0	7	7	bevacizumab	CST	PA130232992	9514	0.873
NULL	Nucleic_Acids_Res_2012_Apr_16_40(8)_3511-3523.nxml.txt.nlp	22180533	SENT250	24	24	14	14	doxycycline	E2F7	PA449415	144455	0.873
NULL	Chem_Rev_2011_Oct_12_111(10)_5899-5921.nxml.txt.nlp	21923193	SENT536	29	29	11	11	sulindac	FAAH	PA451565	79152;2166	0.873
NULL	Mol_Cancer_2014_Jun_24_13_157.nxml.txt.nlp	24958351	SENT206	7	7	28	28	lapatinib	HER2	PA152241907	2064	0.873
NULL	Braz_J_Med_Biol_Res_2012_Feb_17_45(3)_244-249.nxml.txt.nlp	22331137	SENT134	19	19	4	4	gentamicin	PAG	PA449753	55824	0.873
NULL	Ann_Oncol_2009_Nov_23_20(11)_1803-1812.nxml.txt.nlp	19549706	SENT254	23	23	17	17	sunitinib	IFN	PA162372840	3439	0.873
NULL	Ann_Surg_Treat_Res_2014_Feb_22_86(2)_68-75.nxml.txt.nlp	24761411	SENT171	6	6	19	19	resveratrol	survivin		332	0.873
NULL	J_Korean_Med_Sci_2007_Dec_20_22(6)_1055-1059.nxml.txt.nlp	18162722	SENT32	2	2	19	19	pantoprazole	ESD	PA450774	2098	0.873
NULL	Chemother_Res_Pract_2012_Aug_29_2012_817297.nxml.txt.nlp	22970367	SENT125	19	19	7	7	erlotinib	EGFR	PA134687924	1956	0.873
NULL	Virchows_Arch_2012_Feb_16_460(2)_141-149.nxml.txt.nlp	22173329	SENT220	6	6	2	2	panitumumab	KRAS	PA162373091	3845	0.873
NULL	Subst_Abuse_Rehabil_2014_Aug_14_5_95-105.nxml.txt.nlp	25187752	SENT78	28	28	22	22	letrozole	aromatase	PA450196	1588	0.873
NULL	J_Biol_Chem_2012_Dec_14_287(51)_43094-43107.nxml.txt.nlp	23118219	SENT13	4	4	22	22	hyaluronan	CD44	PA165958431	960	0.873
NULL	Breast_Cancer_Res_2009_Jun_23_11(Suppl_1)_P28.nxml.txt.nlp	NULL	SENT12	27	27	22	22	paclitaxel	VEGFR	PA450761	3791	0.873
NULL	Cancer_Cell_Int_2013_Feb_8_13_11.nxml.txt.nlp	23394616	SENT166	21	21	33	33	geldanamycin	Hsp90	PA152031327	3320	0.873
NULL	Anesthesiol_Res_Pract_2013_Sep_23_2013_297141.nxml.txt.nlp	24174934	SENT181	26	26	13	13	ropivacaine	mol	PA451271	90527	0.873
NULL	Oncotarget_2014_Jun_7_5(14)_5257-5271.nxml.txt.nlp	24913448	SENT100	20	20	18	18	nilotinib	LASP1	PA165958345	3927	0.873
NULL	Front_Physiol_2011_Jun_30_2_33.nxml.txt.nlp	21747769	SENT269	17	17	8	8	berberine	p38	PA165860812	10598;1432;7965	0.873
NULL	Br_J_Cancer_2012_Jul_10_107(2)_315-324.nxml.txt.nlp	22713656	SENT254	23	23	1	1	paraformaldehyde	MLL4	PA450790	;8085	0.873
NULL	J_Cardiothorac_Surg_2010_Aug_21_5_66.nxml.txt.nlp	20727201	SENT41	11	11	19	19	collagenase	MMP2	PA449107	4313	0.873
NULL	Med_Sci_Monit_2013_Nov_29_19_1080-1088.nxml.txt.nlp	24287619	SENT49	14	14	2	2	estradiol	ACL	PA449503	47	0.873
NULL	Clin_Drug_Investig_2013_Sep_3_33(10)_761-771.nxml.txt.nlp	23999912	SENT39	17	17	29	29	ketoconazole	CYP3A4	PA450146	1576	0.873
NULL	Cancers_(Basel)_2010_May_28_2(2)_1040-1065.nxml.txt.nlp	24281106	SENT97	41	41	23	23	bevacizumab	EGFR	PA130232992	1956	0.873
NULL	Chin_J_Cancer_2011_May_30(5)_287-292.nxml.txt.nlp	21527061	SENT65	21	21	7	7	carboplatin	EGFR	PA448803	1956	0.873
NULL	Int_J_Nephrol_2011_Apr_26_2011_245823.nxml.txt.nlp	21603155	SENT111	13	13	9	9	ribavirin	IFN	PA451241	3439	0.873
NULL	Br_J_Cancer_2010_Oct_12_103(8)_1297-1304.nxml.txt.nlp	20842126	SENT135	30	30	9	9	creatine	SMO	PA164778930	6608;54498	0.873
NULL	Exp_Diabetes_Res_2012_Apr_17_2012_635472.nxml.txt.nlp	22577369	SENT69	22	22	18	18	exenatide	GLP-1	PA164749238	100125288	0.873
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_297-299.nxml.txt.nlp	20049732	SENT54	27	27	8	8	methotrexate	MLH1	PA450428	4292	0.873
NULL	Cost_Eff_Resour_Alloc_2006_May_31_4_9.nxml.txt.nlp	16737538	SENT127	41	41	29	29	rofecoxib	OTC	PA451268	5009	0.873
NULL	Diabetes_Care_2013_Aug_17_36(Suppl_2)_S245-S252.nxml.txt.nlp	23882053	SENT87	27	27	21	21	liraglutide	GLP-1	PA165958364	100125288	0.873
NULL	Diabetes_Metab_Syndr_Obes_2010_Dec_6_3_421-429.nxml.txt.nlp	21437112	SENT43	42	42	36	36	curcumin	STZ	PA151958596	6484	0.873
NULL	J_Asthma_Allergy_2012_Nov_8_5_65-70.nxml.txt.nlp	23204847	SENT134	15	15	0	0	omalizumab	ACT	PA164752253	12;11332;9457;641455	0.873
NULL	Eur_J_Clin_Pharmacol_2012_Sep_15_68(9)_1267-1274.nxml.txt.nlp	22418828	SENT181	24	24	3	3	esomeprazole	CYP2C19	PA10075	1557	0.873
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT84	15	15	5	5	resveratrol	TNF		7124	0.873
NULL	Clinics_(Sao_Paulo)_2013_Feb_68(2)_253-262.nxml.txt.nlp	23525324	SENT244	30	30	9	9	genistein	Gen	PA165109660	348654	0.873
NULL	J_Biol_2009_Apr_15_8(3)_30.nxml.txt.nlp	19435483	SENT64	29	29	4	4	imatinib	NQO2	PA10804	4835	0.873
NULL	Eur_J_Dent_2014_Oct-Dec_8(4)_521-527.nxml.txt.nlp	25512735	SENT43	19	19	24	24	minocycline	San	PA450519	80218	0.873
NULL	Oncogenesis_2012_Apr_2_1(4)_e5.nxml.txt.nlp	23552603	SENT288	2	2	7	7	ns-398	p65		5970	0.873
NULL	Br_J_Cancer_2010_Jan_5_102(1)_134-143.nxml.txt.nlp	19920829	SENT182	2	2	17	17	pertuzumab	IL-2		3558	0.873
NULL	Diabetes_Metab_Syndr_Obes_2014_Aug_28_7_391-400.nxml.txt.nlp	25210468	SENT51	25	25	13	13	metformin	B12	PA450395	7126;4709	0.873
NULL	Eur_J_Clin_Pharmacol_2008_Feb_26_64(2)_133-157.nxml.txt.nlp	18224312	SENT572	8	8	2	2	celecoxib	CYP2C9	PA448871	1559	0.873
NULL	Scientifica_(Cairo)_2012_Oct_9_2012_821549.nxml.txt.nlp	24278743	SENT338	9	9	22	22	risperidone	5-HT2A	PA451257	3356	0.873
NULL	EMBO_Mol_Med_2013_Jan_26_5(1)_52-63.nxml.txt.nlp	23184605	SENT226	18	18	9	9	floxuridine	CO2	PA449652	4513	0.873
NULL	Exp_Diabetes_Res_2012_Oct_15_2012_465282.nxml.txt.nlp	23118742	SENT28	5	5	10	10	metformin	FGF21	PA450395	26291	0.873
NULL	Biologics_2011_Feb_15_5_45-60.nxml.txt.nlp	21383915	SENT114	9	9	32	32	fluorescein	mol	PA164746009	90527	0.873
NULL	J_Gastroenterol_2013_Jan_27_48(1)_22-30.nxml.txt.nlp	23104468	SENT38	7	7	15	15	ribavirin	SOC	PA451241	91544	0.873
NULL	F1000_Biol_Rep_2012_Mar_1_4_5.nxml.txt.nlp	22403588	SENT93	11	11	8	8	ribavirin	IFN	PA451241	3439	0.873
NULL	Oxid_Med_Cell_Longev_2013_Jul_9_2013_574029.nxml.txt.nlp	23936610	SENT157	4	4	9	9	resveratrol	CD83		9308	0.873
NULL	ScientificWorldJournal_2013_Sep_21_2013_208309.nxml.txt.nlp	24170980	SENT94	15	15	20	20	lenalidomide	MRP8	PA162363968	6833;6279;85320	0.873
NULL	Mol_Pain_2013_Jun_10_9_27.nxml.txt.nlp	23758830	SENT48	0	0	2	2	tetracaine	ASIC3	PA451638	9311	0.873
NULL	Environ_Health_Perspect_2011_Apr_16_119(4)_534-541.nxml.txt.nlp	21081300	SENT197	12	12	20	20	genistein	COX	PA165109660	1351	0.873
NULL	Mol_Cancer_2014_Apr_29_13_96.nxml.txt.nlp	24779681	SENT206	9	9	12	12	carboplatin	PC-3	PA448803	692094	0.873
NULL	J_Cancer_2013_Sep_27_4(8)_662-670.nxml.txt.nlp	24155778	SENT187	14	14	10	10	cisplatin	UCHL1	PA449014	7345	0.873
NULL	Eur_J_Clin_Pharmacol_2012_Jan_8_68(1)_29-37.nxml.txt.nlp	21739267	SENT187	14	14	4	4	fluvoxamine	CYP1A2	PA449690	1544	0.873
NULL	Drug_Target_Insights_2006_Oct_23_1_5-10.nxml.txt.nlp	21901053	SENT41	18	18	8	8	thrombin	CRT	PA451674	811	0.873
NULL	Evid_Based_Complement_Alternat_Med_2012_Dec_20_2012_908601.nxml.txt.nlp	23326293	SENT69	1	1	23	23	trypsin	CD90	PA451806	7070	0.873
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT94	24	24	13	13	curcumin	p27	PA151958596	5715;10534	0.873
NULL	Biol_Open_2012_May_21_1(7)_629-639.nxml.txt.nlp	23125914	SENT60	13	13	6	6	doxycycline	PITX1	PA449415	5307	0.873
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_May_22_66(Pt_6)_o1406.nxml.txt.nlp	21579485	SENT3	29	29	4	4	benzaldehyde	mol	PA448571	90527	0.873
NULL	Drugs_R_D_2010_Sep_27_10(3)_179-202.nxml.txt.nlp	20945948	SENT348	10	10	42	42	telaprevir	PR22	PA165958354	3925	0.873
NULL	Bioinformation_2012_Jan_6_8(1)_13-19.nxml.txt.nlp	22359429	SENT140	40	40	44	44	curcumin	MRP1	PA151958596	4437	0.873
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT247	20	20	9	9	cetuximab	BRAF	PA10040	673	0.873
NULL	Br_J_Cancer_2013_Apr_16_108(7)_1408-1414.nxml.txt.nlp	23511562	SENT8	13	13	16	16	tamoxifen	aromatase	PA451581	1588	0.873
NULL	Oncotarget_2014_Feb_13_5(3)_577-586.nxml.txt.nlp	24583697	SENT195	9	9	5	5	methotrexate	HMGB1	PA450428	3146	0.873
NULL	Eur_J_Med_Res_2011_May_12_16(5)_197-205.nxml.txt.nlp	21719392	SENT18	8	8	1	1	foscarnet	IL-2	PA449706	3558	0.873
NULL	Chonnam_Med_J_2013_Dec_23_49(3)_125-128.nxml.txt.nlp	24400215	SENT44	25	25	11	11	lipase	PTH	PA450239	5741	0.873
NULL	Environ_Health_Perspect_2010_Jul_3_118(7)_936-942.nxml.txt.nlp	20199942	SENT222	14	14	8	8	arsenite	p53	PA452638	7157	0.873
NULL	Acta_Pharmacol_Sin_2012_Mar_27_33(3)_342-350.nxml.txt.nlp	22367283	SENT193	27	27	16	16	thrombin	PAR3	PA451674	56288;2151	0.873
NULL	Cell_Biol_Int_Rep_(2010)_2012_Jun_21_19(1)_e00017.nxml.txt.nlp	23124518	SENT83	6	6	34	34	etoposide	TRAIL	PA449552	8743	0.873
NULL	J_Biomed_Biotechnol_2010_Jun_7_2010_150960.nxml.txt.nlp	20617134	SENT227	24	24	37	37	fluorouracil	KRAS	PA128406956	3845	0.873
NULL	Diabetes_Metab_J_2013_Oct_17_37(5)_315-325.nxml.txt.nlp	24199159	SENT162	25	25	21	21	resveratrol	SIRT1		23411	0.873
NULL	Eur_J_Epidemiol_2007_Nov_23_22(11)_819-829.nxml.txt.nlp	17955331	SENT706	21	21	10	10	phenprocoumon	CYP2C9	PA450921	1559	0.873
NULL	Oncologist_2010_Mar_9_15(3)_236-245.nxml.txt.nlp	20215359	SENT33	14	14	9	9	sorafenib	VEGFR	PA7000	3791	0.873
NULL	Ann_Hematol_2014_Sep_10_93(1)_1-11.nxml.txt.nlp	24018623	SENT147	4	4	7	7	lenalidomide	SPARC	PA162363968	6678	0.873
NULL	Clin_Interv_Aging_2014_Oct_21_9_1783-1791.nxml.txt.nlp	25364236	SENT150	19	19	34	34	donepezil	FOXO1	PA449394	2308	0.873
NULL	Front_Behav_Neurosci_2014_Oct_30_8_366.nxml.txt.nlp	25400560	SENT100	33	33	2	2	ethanol	GLAST	PA448073	6507	0.873
NULL	Mol_Cancer_2009_Dec_23_8_129.nxml.txt.nlp	20030852	SENT190	11	11	5	5	curcumin	ABCA1	PA151958596	19	0.873
NULL	Breast_Cancer_Res_2012_Mar_15_14(2)_R47.nxml.txt.nlp	22420423	SENT133	7	7	20	20	doxorubicin	CHEK2	PA449412	11200	0.873
NULL	Br_J_Cancer_2010_Nov_2_103(11)_1671-1679.nxml.txt.nlp	21045835	SENT141	24	24	18	18	gemcitabine	CXCL12	PA449748	6387	0.873
NULL	Cancer_Res_Treat_2014_Jan_15_46(1)_48-54.nxml.txt.nlp	24520223	SENT118	27	27	32	32	bevacizumab	KRAS	PA130232992	3845	0.873
NULL	Bioinform_Biol_Insights_2013_Sep_18_7_289-306.nxml.txt.nlp	24092970	SENT209	19	19	30	30	vincristine	PRAME	PA451879	23532	0.873
NULL	Breast_Cancer_(Auckl)_2009_Sep_2_3_61-75.nxml.txt.nlp	19809577	SENT88	27	27	13	13	curcumin	BRCA1	PA151958596	672	0.873
NULL	Cancer_Med_2013_Jun_25_2(3)_277-285.nxml.txt.nlp	23930204	SENT195	25	25	3	3	bevacizumab	KRAS	PA130232992	3845	0.873
NULL	Biomed_Eng_Online_2011_Dec_2_10_104.nxml.txt.nlp	22136408	SENT38	21	21	3	3	cisplatin	CFD	PA449014	1675	0.873
NULL	Br_J_Cancer_2000_Jun_82(11)_1851-1859.nxml.txt.nlp	10839301	SENT9	22	22	27	27	bleomycin	CD95	PA448645	355	0.873
NULL	J_Cell_Sci_2013_Sep_1_126(17)_3873-3883.nxml.txt.nlp	23843614	SENT229	21	21	7	7	forskolin	N-WASP	PA146096022	8976	0.873
NULL	Clin_Dev_Immunol_2013_Sep_24_2013_814973.nxml.txt.nlp	24174972	SENT176	19	19	13	13	rituximab	CHOP	PA451261	1649	0.873
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT107	34	34	24	24	celecoxib	IL-6	PA448871	3569	0.873
NULL	Mol_Cancer_2009_Dec_23_8_129.nxml.txt.nlp	20030852	SENT8	11	11	5	5	curcumin	CXCL1	PA151958596	2919	0.873
NULL	Arthritis_Res_Ther_2006_Dec_14_8(1)_102.nxml.txt.nlp	16542465	SENT26	41	41	19	19	infliximab	ACR	PA452639	49	0.873
NULL	Clin_Interv_Aging_2014_Dec_30_10_105-115.nxml.txt.nlp	25565793	SENT121	2	2	15	15	denosumab	CTX	PA166048634	1593	0.873
NULL	J_Neurochem_2008_Nov_107(4)_1136-1146.nxml.txt.nlp	18823367	SENT399	4	4	19	19	suramin	P-gp	PA10292	5243	0.873
NULL	J_Obes_2011_Sep_30_2011_431985.nxml.txt.nlp	20953366	SENT247	12	12	21	21	sitagliptin	GLP-1	PA164748978	100125288	0.873
NULL	Mol_Cancer_2009_Aug_25_8_66.nxml.txt.nlp	19706164	SENT5	14	14	3	3	celecoxib	p53	PA448871	7157	0.873
NULL	Biochim_Biophys_Acta_2014_Jul_1842(7)_959-970.nxml.txt.nlp	24594481	SENT812	38	38	18	18	lipase	HSL	PA450239	3991	0.873
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT233	24	24	36	36	doxorubicin	B7-H1	PA449412	29126	0.873
NULL	Biomed_Res_Int_2014_Jan_6_2014_152659.nxml.txt.nlp	24511528	SENT11	6	6	8	8	chlorpromazine	CPZ	PA448964	8532	0.873
NULL	Acta_Pharmacol_Sin_2013_Mar_11_34(3)_403-413.nxml.txt.nlp	23396374	SENT47	19	19	29	29	triciribine	GAPDH	PA165958661	2597	0.873
NULL	F1000Prime_Rep_2013_Jul_1_5_24.nxml.txt.nlp	23864931	SENT101	1	1	14	14	boceprevir	CYP3A4	PA165948902	1576	0.873
NULL	Am_J_Trop_Med_Hyg_2013_Feb_6_88(2)_390-396.nxml.txt.nlp	23185075	SENT27	5	5	1	1	trypsin	AAT	PA451806	5265	0.873
NULL	Br_J_Cancer_2011_May_10_104(10)_1587-1593.nxml.txt.nlp	21487405	SENT104	3	3	21	21	docetaxel	PC3	PA449383	57332;7832;5122	0.873
NULL	Mol_Cancer_2009_Nov_10_8_99.nxml.txt.nlp	19903356	SENT105	9	9	2	2	imatinib	IGFBP3	PA10804	3486	0.873
NULL	Nucleic_Acids_Res_2011_Mar_17_39(6)_2144-2152.nxml.txt.nlp	21087997	SENT103	33	33	2	2	etoposide	HSF1	PA449552	3297	0.873
NULL	Mol_Immunol_2009_Mar_46(6)_1149-1162.nxml.txt.nlp	19100624	SENT184	0	0	19	19	chlorpromazine	C5L2	PA448964	27202	0.873
NULL	Cancer_Immunol_Immunother_2013_Aug_27_62(10)_1637-1648.nxml.txt.nlp	23982484	SENT181	0	0	3	3	lenalidomide	IL-6	PA162363968	3569	0.873
NULL	Mol_Cancer_2010_Oct_12_9_269.nxml.txt.nlp	20939893	SENT7	10	10	5	5	isoproterenol	AP-1	PA450121	2353;3727;2354;3725	0.873
NULL	Carcinogenesis_2014_May_13_35(5)_1055-1066.nxml.txt.nlp	24419232	SENT174	5	5	22	22	metformin	CYP1B1	PA450395	1545	0.873
NULL	Oncol_Lett_2014_Aug_19_8(2)_809-812.nxml.txt.nlp	25009658	SENT13	4	4	15	15	metformin	AMPK	PA450395	5563	0.873
NULL	Front_Neurosci_2011_Jan_14_4_207.nxml.txt.nlp	21258618	SENT164	6	6	4	4	ethanol	AC7	PA448073	113	0.873
NULL	Cell_Mol_Life_Sci_2011_Nov_2_68(21)_3573-3587.nxml.txt.nlp	21365278	SENT167	32	32	11	11	iloprost	EP2	PA164746843	5732;10407	0.873
NULL	Drugs_Context_2012_Nov_19_2012_212242.nxml.txt.nlp	24432031	SENT128	6	6	17	17	dacarbazine	IL-2	PA449197	3558	0.873
NULL	Asia_Pac_Allergy_2013_Oct_31_3(4)_231-240.nxml.txt.nlp	24260728	SENT146	10	10	3	3	theophylline	CYP2E1	PA451647	1571	0.873
NULL	Clin_Med_Insights_Oncol_2012_Dec_6_6_407-421.nxml.txt.nlp	23239933	SENT62	12	12	18	18	gefitinib	EGFR	PA131301952	1956	0.873
NULL	J_Oncol_2011_Jun_12_2011_542358.nxml.txt.nlp	21772843	SENT368	17	17	0	0	irinotecan	EGFR	PA450085	1956	0.873
NULL	J_Mol_Signal_2009_Sep_2_4_6.nxml.txt.nlp	19725972	SENT158	5	5	15	15	staurosporine	p38	PA165109623	10598;1432;7965	0.873
NULL	Clin_Pharmacol_2010_Jun_22_2_105-110.nxml.txt.nlp	22291493	SENT96	5	5	8	8	sibutramine	ADIPOQ	PA451344	9370	0.873
NULL	EJC_Suppl_2013_Sep_5_11(2)_296-298.nxml.txt.nlp	NULL	SENT33	0	0	38	38	cetuximab	EGFR	PA10040	1956	0.873
NULL	Indian_J_Urol_2009_Apr-Jun_25(2)_186-189.nxml.txt.nlp	19672343	SENT49	31	31	8	8	etoposide	GTS	PA449552	2973	0.873
NULL	South_Asian_J_Cancer_2014_Jul-Sep_3(3)_154-158.nxml.txt.nlp	25136521	SENT144	14	14	9	9	ethanol	CYP2C9	PA448073	1559	0.873
NULL	Biochem_Biophys_Res_Commun_2008_Sep_5_373(4)_584-588.nxml.txt.nlp	18586007	SENT123	2	2	4	4	curcumin	HO-1	PA151958596	3162	0.873
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R91.nxml.txt.nlp	22541814	SENT131	30	30	36	36	thrombin	HO-1	PA451674	3162	0.873
NULL	EMBO_Mol_Med_2011_May_3(5)_266-278.nxml.txt.nlp	21438154	SENT213	27	27	35	35	oxaliplatin	TRPM8	PA131285527	79054	0.873
NULL	J_Cell_Sci_2014_Feb_1_127(3)_497-508.nxml.txt.nlp	24284071	SENT381	25	25	1	1	aprotinin	p120	PA448472	4839;1500;55695;10902	0.873
NULL	J_Gen_Physiol_2008_Nov_132(5)_521-535.nxml.txt.nlp	18852303	SENT127	12	12	4	4	aprotinin	CAP2	PA448472	5271;10486	0.873
NULL	Arthritis_Res_Ther_2008_Mar_17_10(2)_R33.nxml.txt.nlp	18346273	SENT134	3	3	12	12	infliximab	HMGB1	PA452639	3146	0.873
NULL	Onco_Targets_Ther_2014_Jun_20_7_1123-1127.nxml.txt.nlp	25018638	SENT5	13	13	11	11	cyclophosphamide	CHOP	PA449165	1649	0.873
NULL	Aging_(Albany_NY)_2012_Oct_28_4(10)_662-663.nxml.txt.nlp	23104867	SENT7	18	18	15	15	isoproterenol	BAR	PA450121	154;51283	0.873
NULL	Braz_J_Med_Biol_Res_2014_May_9_47(6)_478-482.nxml.txt.nlp	24770568	SENT92	9	9	30	30	cisplatin	CD133	PA449014	8842	0.873
NULL	Braz_J_Med_Biol_Res_2013_Aug_13_46(8)_650-658.nxml.txt.nlp	23969971	SENT163	3	3	0	0	cisplatin	STAT3	PA449014	6774	0.873
NULL	Br_J_Cancer_2011_Mar_15_104(6)_957-967.nxml.txt.nlp	21364585	SENT109	41	41	15	15	doxorubicin	TRAIL	PA449412	8743	0.873
NULL	J_Cell_Mol_Med_2014_Mar_22_18(3)_480-491.nxml.txt.nlp	24450440	SENT61	0	0	6	6	bevacizumab	San	PA130232992	80218	0.873
NULL	Mol_Cancer_2010_Nov_2_9_289.nxml.txt.nlp	21044322	SENT165	26	26	6	6	vincristine	RGS10	PA451879	6001	0.873
NULL	J_Antimicrob_Chemother_2014_Dec_20_69(12)_3329-3334.nxml.txt.nlp	25147095	SENT138	30	30	5	5	nevirapine	HLA-C	PA450616	3107	0.873
NULL	EMBO_Mol_Med_2012_Jun_13_4(6)_515-527.nxml.txt.nlp	22416035	SENT88	15	15	4	4	olaparib	p53		7157	0.873
NULL	J_Cell_Biol_1998_Aug_10_142(3)_827-835.nxml.txt.nlp	9700169	SENT78	7	7	17	17	forskolin	GAL	PA146096022	51083	0.873
NULL	Oncol_Lett_2014_May_4_7(5)_1352-1362.nxml.txt.nlp	24765137	SENT142	15	15	11	11	cisplatin	p53	PA449014	7157	0.873
NULL	Theranostics_2013_Jan_15_3(1)_47-75.nxml.txt.nlp	23382786	SENT97	13	13	10	10	plerixafor	CXCR4	PA165958410	7852	0.873
NULL	Nucleic_Acids_Res_2010_Oct_21_38(18)_6148-6158.nxml.txt.nlp	20494979	SENT266	24	24	28	28	staurosporine	HLJ1	PA165109623	11080	0.873
NULL	N_Am_J_Med_Sci_2012_Dec_4(12)_648-650.nxml.txt.nlp	23272308	SENT20	15	15	2	2	cefoperazone	CRA	PA448849	51747;10903	0.873
NULL	Int_J_Breast_Cancer_2013_Jun_24_2013_137414.nxml.txt.nlp	23864953	SENT88	14	14	36	36	trastuzumab	aromatase	PA451743	1588	0.873
NULL	Oncoimmunology_2012_May_1_1(3)_372-374.nxml.txt.nlp	22737619	SENT19	28	28	39	39	lenalidomide	IL-2	PA162363968	3558	0.873
NULL	Bioinorg_Chem_Appl_2014_Feb_23_2014_276598.nxml.txt.nlp	24707242	SENT89	19	19	14	14	ethanol	mol	PA448073	90527	0.873
NULL	J_Hematol_Oncol_2012_Sep_18_5_57.nxml.txt.nlp	22989009	SENT269	9	9	34	34	nutlin-3	HDM2		4193	0.873
NULL	Biochem_Res_Int_2012_Jul_1_2012_832059.nxml.txt.nlp	22811914	SENT229	2	2	13	13	docetaxel	PC3	PA449383	57332;7832;5122	0.873
NULL	ScientificWorldJournal_2013_Sep_26_2013_608415.nxml.txt.nlp	24191141	SENT136	14	14	7	7	ritonavir	APOE	PA451260	348	0.873
NULL	Biomed_Res_Int_2014_Jun_25_2014_203693.nxml.txt.nlp	25089265	SENT286	6	6	39	39	cabozantinib	TRKB	PA165906891	4915	0.873
NULL	Cancers_(Basel)_2013_Aug_22_5(3)_1103-1119.nxml.txt.nlp	24202336	SENT643	18	18	7	7	temozolomide	CD133	PA451609	8842	0.873
NULL	Oncogene_2009_Aug_27_28(34)_3022-3032.nxml.txt.nlp	19543317	SENT98	10	10	13	13	etoposide	p53	PA449552	7157	0.873
NULL	J_Invest_Dermatol_2012_May_16_132(5)_1435-1442.nxml.txt.nlp	22336948	SENT228	18	18	15	15	doxycycline	TLSP	PA449415	11012	0.873
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT273	10	10	23	23	cetuximab	KRAS	PA10040	3845	0.873
NULL	Indian_J_Endocrinol_Metab_2012_May-Jun_16(3)_349-357.nxml.txt.nlp	22629498	SENT155	6	6	15	15	raloxifene	CTX	PA451221	1593	0.872
NULL	J_Gastrointest_Cancer_2013_Aug_7_44(4)_385-392.nxml.txt.nlp	23921604	SENT174	4	4	10	10	imatinib	KIT	PA10804	3815	0.872
NULL	Bioinformation_2012_Jan_6_8(1)_13-19.nxml.txt.nlp	22359429	SENT165	2	2	32	32	curcumin	MRP1	PA151958596	4437	0.872
NULL	Oncotarget_2014_Sep_8_5(20)_9619-9625.nxml.txt.nlp	25294813	SENT10	28	28	8	8	trastuzumab	TAZ	PA451743	25937;6901	0.872
NULL	Protein_Expr_Purif_2009_Aug_66(2)_181-184.nxml.txt.nlp	19269329	SENT167	9	9	5	5	thrombin	AMPK	PA451674	5563	0.872
NULL	Mol_Cancer_2009_Oct_24_8_91.nxml.txt.nlp	19852844	SENT40	20	20	9	9	cisplatin	TUSC2	PA449014	11334	0.872
NULL	Oncotarget_2014_Aug_8_5(17)_7902-7916.nxml.txt.nlp	25277203	SENT144	26	26	12	12	gefitinib	ZEB1	PA131301952	6935	0.872
NULL	Mar_Drugs_2014_Mar_18_12(3)_1580-1622.nxml.txt.nlp	24646945	SENT69	33	33	25	25	l-lysine	C10	PA450280	113246	0.872
NULL	J_Physiol_2008_Sep_1_586(Pt_17)_4061-4067.nxml.txt.nlp	18599538	SENT107	27	27	9	9	valganciclovir	SLC6A14	PA10227	11254	0.872
NULL	Mol_Cancer_2012_Jul_12_11_45.nxml.txt.nlp	22788833	SENT154	8	8	12	12	cisplatin	HER2	PA449014	2064	0.872
NULL	Anesthesiol_Res_Pract_2013_Sep_23_2013_297141.nxml.txt.nlp	24174934	SENT349	12	12	27	27	capsaicin	TRPV1	PA448776	7442	0.872
NULL	Br_J_Cancer_1996_Jul_74(2)_187-193.nxml.txt.nlp	8688320	SENT15	21	21	6	6	doxorubicin	P-gp	PA449412	5243	0.872
NULL	Cancer_Cell_Int_2010_Sep_9_10_32.nxml.txt.nlp	20828393	SENT187	11	11	3	3	cisplatin	ATF3	PA449014	467	0.872
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_55-66.nxml.txt.nlp	17912636	SENT75	25	25	6	6	letrozole	HER2	PA450196	2064	0.872
NULL	Crit_Care_2007_Feb_19_11(1)_407.nxml.txt.nlp	17328792	SENT19	17	17	13	13	thrombin	PAR-1	PA451674	2011;2149	0.872
NULL	J_Hematol_Oncol_2013_Jul_9_6_49.nxml.txt.nlp	23837843	SENT281	30	30	24	24	verapamil	P-gp	PA451868	5243	0.872
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1137-1144.nxml.txt.nlp	20234366	SENT171	21	21	14	14	irinotecan	BRAF	PA450085	673	0.872
NULL	Pediatr_Nephrol_2009_Jul_20_24(7)_1355-1361.nxml.txt.nlp	19301038	SENT132	13	13	20	20	sevelamer	PTH	PA164781197	5741	0.872
NULL	Indian_J_Dermatol_2014_May-Jun_59(3)_271-274.nxml.txt.nlp	24891659	SENT3	16	16	5	5	cetuximab	EGFR	PA10040	1956	0.872
NULL	J_Gen_Physiol_2008_May_131(5)_421-429.nxml.txt.nlp	18411332	SENT136	31	31	16	16	capsaicin	TRPV1	PA448776	7442	0.872
NULL	Oncogenesis_2014_Dec_15_3(12)_e133.nxml.txt.nlp	25500906	SENT105	7	7	2	2	trastuzumab	HER3	PA451743	2065	0.872
NULL	Glob_Health_Action_2014_May_22_7_10_3402_gha_v7_24303.nxml.txt.nlp	24857613	SENT212	35	35	25	25	amoxicillin	PTB	PA448406	58155	0.872
NULL	Arch_Med_Sci_2013_Aug_30_9(4)_739-744.nxml.txt.nlp	24049538	SENT107	37	37	21	21	candesartan	PC-3	PA448765	692094	0.872
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT186	8	8	13	13	probenecid	SLC22A6	PA451106	9356	0.872
NULL	Oncotarget_2012_Sep_28_3(10)_1169-1181.nxml.txt.nlp	23045411	SENT95	17	17	7	7	doxorubicin	JIP1	PA449412	9479	0.872
NULL	Oncotarget_2012_Sep_3_3(9)_921-939.nxml.txt.nlp	22948112	SENT332	34	34	14	14	bevacizumab	VEGFR2	PA130232992	3791	0.872
NULL	Cancers_(Basel)_2014_Jul_7_6(3)_1441-1463.nxml.txt.nlp	25003395	SENT298	4	4	16	16	pha-665752	PI3K		5290	0.872
NULL	Endocr_Rev_2013_Jun_10_34(3)_339-376.nxml.txt.nlp	23575763	SENT560	4	4	32	32	imatinib	KIT	PA10804	3815	0.872
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Jul_23_3(7)_e126.nxml.txt.nlp	25054314	SENT19	17	17	2	2	docetaxel	MRP2	PA449383	100130958;57626;1244	0.872
NULL	Ann_Oncol_2009_Nov_23_20(11)_1803-1812.nxml.txt.nlp	19549706	SENT14	21	21	36	36	sunitinib	IFN	PA162372840	3439	0.872
NULL	Eur_J_Clin_Pharmacol_2008_Feb_26_64(2)_133-157.nxml.txt.nlp	18224312	SENT561	39	39	7	7	warfarin	CYP2C9	PA451906	1559	0.872
NULL	Diabetes_2009_Dec_31_58(12)_2851-2862.nxml.txt.nlp	19720788	SENT126	5	5	10	10	forskolin	PERK	PA146096022	9451	0.872
NULL	Biologics_2012_Feb_1_6_31-35.nxml.txt.nlp	22355257	SENT63	26	26	11	11	rituximab	IL-6	PA451261	3569	0.872
NULL	Indian_J_Med_Paediatr_Oncol_2013_Apr-Jun_34(2)_101-103.nxml.txt.nlp	24049297	SENT23	12	12	35	35	rituximab	FDG	PA451261	23583	0.872
NULL	An_Bras_Dermatol_2014_Mar-Apr_89(2)_365-367.nxml.txt.nlp	24770527	SENT20	31	31	13	13	infliximab	IL-23	PA452639	51561	0.872
NULL	BMB_Rep_2013_Aug_46(8)_410-415.nxml.txt.nlp	23977989	SENT63	13	13	3	3	curcumin	HO-1	PA151958596	3162	0.872
NULL	Iran_J_Pharm_Res_2014_Summer_13(3)_919-926.nxml.txt.nlp	25276192	SENT114	24	24	13	13	doxorubicin	Bcl-2	PA449412	596	0.872
NULL	Cardiovasc_Diabetol_2013_Jan_9_12_8.nxml.txt.nlp	23298374	SENT146	10	10	18	18	sitagliptin	adiponectin	PA164748978	9370	0.872
NULL	EMBO_Mol_Med_2013_Aug_8_5(8)_1227-1246.nxml.txt.nlp	23836498	SENT234	11	11	0	0	doxycycline	HIF-1	PA449415	29072	0.872
NULL	Lab_Invest_2013_Dec_14_93(12)_1265-1275.nxml.txt.nlp	24126890	SENT303	19	19	3	3	celecoxib	ZO-1	PA448871	7082	0.872
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2751-2762.nxml.txt.nlp	24169358	SENT188	0	0	28	28	fulvestrant	BAF155	PA164747170	6599	0.872
NULL	Arch_Drug_Inf_2008_Sep_1(2)_56-62.nxml.txt.nlp	19915709	SENT51	27	27	21	21	naltrexone	CYP3A4	PA450588	1576	0.872
NULL	Iran_J_Public_Health_2010_Dec_31_39(4)_1-14.nxml.txt.nlp	23113033	SENT47	33	33	41	41	galactose	LPH	PA449725	5443	0.872
NULL	Carcinogenesis_2014_May_13_35(5)_1055-1066.nxml.txt.nlp	24419232	SENT263	5	5	17	17	metformin	CD34	PA450395	947	0.872
NULL	Arch_Med_Sci_2012_Jul_4_8(3)_533-541.nxml.txt.nlp	22852012	SENT214	7	7	2	2	cytarabine	IFN	PA449177	3439	0.872
NULL	Breast_Cancer_Res_Treat_2013_Oct_8_141(3)_437-446.nxml.txt.nlp	24101324	SENT27	14	14	9	9	trastuzumab	PI3K	PA451743	5290	0.872
NULL	Indian_J_Nephrol_2010_Jul_20(3)_146-151.nxml.txt.nlp	21072155	SENT104	28	28	14	14	cyclosporine	CYP3A5	PA449167	1577	0.872
NULL	Arthritis_Res_Ther_2005_Feb_17_7(Suppl_1)_P81.nxml.txt.nlp	NULL	SENT13	3	3	8	8	infliximab	OPG	PA452639	690	0.872
NULL	Acta_Histochem_Cytochem_2014_Jun_28_47(3)_103-112.nxml.txt.nlp	25320407	SENT151	21	21	14	14	estradiol	SF-1	PA449503	2516	0.872
NULL	Br_J_Cancer_2012_Feb_28_106(5)_883-888.nxml.txt.nlp	22315050	SENT98	11	11	25	25	cetuximab	EGFR	PA10040	1956	0.872
NULL	Mol_Pain_2012_Sep_22_8_71.nxml.txt.nlp	22998838	SENT218	9	9	30	30	paclitaxel	CXCR4	PA450761	7852	0.872
NULL	Eur_J_Clin_Pharmacol_2010_Nov_29_66(11)_1131-1136.nxml.txt.nlp	20669013	SENT133	8	8	1	1	voriconazole	CYP2C19	PA10233	1557	0.872
NULL	Case_Rep_Oncol_2011_Jan_18_4(1)_19-24.nxml.txt.nlp	21526002	SENT52	22	22	4	4	trastuzumab	HER-2	PA451743	2064	0.872
NULL	AIDS_Res_Ther_2012_Aug_1_9_23.nxml.txt.nlp	22853692	SENT92	7	7	17	17	vorinostat	CD4	PA164748224	920	0.872
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_105-115.nxml.txt.nlp	17912640	SENT44	2	2	23	23	trastuzumab	EGFR	PA451743	1956	0.872
NULL	Front_Neurosci_2015_Jan_9_8_441.nxml.txt.nlp	25620908	SENT229	5	5	0	0	nadh	MDH1	PA164755085	4190	0.872
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT116	9	9	26	26	ethanol	TNF	PA448073	7124	0.872
NULL	Open_Access_J_Urol_2010_Aug_12_2_143-154.nxml.txt.nlp	24198622	SENT82	14	14	8	8	carboplatin	CS1	PA448803	57823	0.872
NULL	Trials_2014_May_15_15_171.nxml.txt.nlp	24885324	SENT57	23	23	38	38	estradiol	CA125	PA449503	4077;94025	0.872
NULL	Environ_Health_Perspect_2006_Sep_23_114(9)_1401-1406.nxml.txt.nlp	16966095	SENT125	23	23	27	27	tetracycline	p53	PA451640	7157	0.872
NULL	Br_J_Clin_Pharmacol_2011_Oct_72(4)_647-657.nxml.txt.nlp	21518389	SENT144	7	7	33	33	cangrelor	P2Y12	PA165945763	64805	0.872
NULL	Mol_Cancer_2012_Apr_16_11_21.nxml.txt.nlp	22507190	SENT96	3	3	17	17	doxycycline	IRF5	PA449415	3663	0.872
NULL	Cancer_Cell_2013_Nov_11_24(5)_617-630.nxml.txt.nlp	24229709	SENT531	27	27	7	7	tamoxifen	AKT	PA451581	207	0.872
NULL	Cancer_Cell_2015_Jan_12_27(1)_138-148.nxml.txt.nlp	25500122	SENT305	17	17	7	7	gemcitabine	CD40	PA449748	958	0.872
NULL	Cell_Death_Dis_2010_Feb_4_1(2)_e23.nxml.txt.nlp	21364631	SENT100	28	28	35	35	desipramine	JNK	PA449233	5599	0.872
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1059-1066.nxml.txt.nlp	21364577	SENT0	20	20	16	16	letrozole	aromatase	PA450196	1588	0.872
NULL	J_Adv_Pharm_Technol_Res_2010_Jan-Mar_1(1)_88-96.nxml.txt.nlp	22247836	SENT128	13	13	5	5	metronidazole	MCC	PA450484	4163	0.872
NULL	Int_Clin_Psychopharmacol_2014_Mar_31_29(2)_86-92.nxml.txt.nlp	24247740	SENT169	19	19	0	0	vilazodone	Gen	PA165958365	348654	0.872
NULL	Br_J_Pharmacol_2013_Jun_27_169(4)_922-932.nxml.txt.nlp	23488457	SENT175	5	5	35	35	phenylephrine	PAG	PA450935	55824	0.872
NULL	J_Gen_Intern_Med_2009_May_21_24(5)_656-664.nxml.txt.nlp	19306050	SENT504	32	32	22	22	warfarin	VKORC1	PA451906	79001	0.872
NULL	Breast_Cancer_Res_2001_Apr_2_3(4)_253-263.nxml.txt.nlp	11434876	SENT275	15	15	6	6	reserpine	P-gp	PA451236	5243	0.872
NULL	Reprod_Biol_Endocrinol_2003_Feb_11_1_19.nxml.txt.nlp	12646058	SENT62	39	39	13	13	gentamicin	CO2	PA449753	4513	0.872
NULL	Pharmaceuticals_(Basel)_2014_Jan_9_7(1)_46-57.nxml.txt.nlp	24451403	SENT140	12	12	40	40	ritonavir	AKT	PA451260	207	0.872
NULL	Nucleic_Acids_Res_2005_Jun_8_33(10)_3283-3291.nxml.txt.nlp	15944449	SENT139	28	28	17	17	melphalan	XRCC3	PA450354	7517	0.872
NULL	Br_J_Cancer_2013_Feb_19_108(3)_668-675.nxml.txt.nlp	23348520	SENT28	22	22	10	10	panitumumab	HER2	PA162373091	2064	0.872
NULL	Cell_Death_Dis_2014_Jan_30_5(1)_e1038.nxml.txt.nlp	24481452	SENT79	11	11	26	26	raloxifene	ARNT	PA451221	405	0.872
NULL	Mol_Cancer_2012_Sep_11_11_66.nxml.txt.nlp	22966907	SENT346	0	0	39	39	hyaluronan	RANKL	PA165958431	8600	0.872
NULL	Gastric_Cancer_2014_Feb_28_17(1)_76-86.nxml.txt.nlp	23455716	SENT33	15	15	25	25	trastuzumab	HER2	PA451743	2064	0.872
NULL	Open_Biochem_J_2011_Sep_23_5_45-51.nxml.txt.nlp	21966325	SENT71	15	15	11	11	diclofenac	XBP1	PA449293	7494	0.872
NULL	AIDS_Care_2013_Jun_23_25(6)_657-666.nxml.txt.nlp	23088551	SENT82	5	5	3	3	maraviroc	CCR5	PA164768835	1234	0.872
NULL	Pharmaceuticals_(Basel)_2012_Nov_20_5(11)_1236-1264.nxml.txt.nlp	24281308	SENT1460	17	17	14	14	temsirolimus	MTOR	PA164746890	2475	0.872
NULL	Brain_Sci_2013_Jun_14_3(2)_941-963.nxml.txt.nlp	24961432	SENT187	26	26	3	3	ethanol	RhoA	PA448073	387	0.872
NULL	Int_J_Biol_Sci_2006_Mar_1_2(1)_1-9.nxml.txt.nlp	16585947	SENT53	6	6	19	19	pp2	PP2		4888	0.872
NULL	Adv_Hematol_2012_Mar_8_2012_856341.nxml.txt.nlp	22496694	SENT181	25	25	20	20	quinidine	P-gp	PA451209	5243	0.872
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_127043.nxml.txt.nlp	23227093	SENT202	18	18	2	2	lovastatin	RYR	PA450272	6261	0.872
NULL	Oncol_Lett_2013_May_22_5(5)_1653-1655.nxml.txt.nlp	23760305	SENT56	20	20	15	15	thyroglobulin	CEA	PA164754910	5670;1087	0.872
NULL	J_Biol_Chem_2013_Nov_15_288(46)_33049-33059.nxml.txt.nlp	24089524	SENT24	4	4	9	9	nicotine	GATA4	PA450626	2626	0.872
NULL	Cardiovasc_Drugs_Ther_2013_Feb_29_27(1)_61-68.nxml.txt.nlp	23274937	SENT159	2	2	15	15	ranolazine	HERG	PA164746007	3757	0.872
NULL	Exp_Lung_Res_2013_Oct_1_39(8)_336-348.nxml.txt.nlp	23919450	SENT99	0	0	16	16	thrombin	PAR-1	PA451674	2011;2149	0.872
NULL	Blood_Cancer_J_2013_Jun_7_3(6)_e120.nxml.txt.nlp	23749045	SENT89	7	7	26	26	imatinib	JAG2	PA10804	3714	0.872
NULL	Exp_Ther_Med_2014_Sep_4_8(3)_851-855.nxml.txt.nlp	25120613	SENT70	17	17	3	3	darunavir	IRS1	PA163522472	3667	0.872
NULL	J_Clin_Biochem_Nutr_2011_Nov_29_49(3)_216-221.nxml.txt.nlp	22128222	SENT129	30	30	10	10	clopidogrel	CYP2C19	PA449053	1557	0.872
NULL	Environ_Health_Perspect_1993_Oct_101(Suppl_3)_303-308.nxml.txt.nlp	8143636	SENT13	10	10	20	20	mitomycin	gamma	PA450524	9913	0.872
NULL	Oncol_Lett_2014_Oct_28_8(4)_1563-1566.nxml.txt.nlp	25202368	SENT6	0	0	6	6	gefitinib	EGFR	PA131301952	1956	0.872
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT304	3	3	17	17	resveratrol	SIRT1		23411	0.872
NULL	Clin_Exp_Gastroenterol_2012_May_14_5_49-59.nxml.txt.nlp	22649281	SENT38	14	14	5	5	lansoprazole	CYP2C19	PA450180	1557	0.872
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT88	4	4	10	10	celecoxib	IL-6	PA448871	3569	0.872
NULL	Br_J_Cancer_2010_Feb_16_102(4)_774-782.nxml.txt.nlp	20087350	SENT222	15	15	35	35	tetracycline	CLCN4	PA451640	1183	0.872
NULL	Breast_Cancer_(Auckl)_2009_Sep_2_3_61-75.nxml.txt.nlp	19809577	SENT86	28	28	16	16	curcumin	BRCA1	PA151958596	672	0.872
NULL	Biomed_Res_Int_2013_Dec_19_2013_817279.nxml.txt.nlp	24455727	SENT126	12	12	29	29	panitumumab	EGFR	PA162373091	1956	0.872
NULL	Ann_Saudi_Med_2011_May-Jun_31(3)_279-283.nxml.txt.nlp	21623058	SENT61	21	21	3	3	azathioprine	IL-2	PA448515	3558	0.872
NULL	Int_J_Cell_Biol_2013_Nov_17_2013_769536.nxml.txt.nlp	24348564	SENT79	8	8	5	5	estradiol	HSD1	PA449503	26871	0.872
NULL	Indian_J_Psychiatry_2012_Apr-Jun_54(2)_196-197.nxml.txt.nlp	22988332	SENT56	23	23	1	1	risperidone	Gen	PA451257	348654	0.872
NULL	Anal_Bioanal_Chem_2012_Feb_16_402(4)_1611-1623.nxml.txt.nlp	22173207	SENT205	15	15	0	0	zanamivir	SRM	PA164740891	6723;6725	0.872
NULL	Thorax_2010_Jul_13_65(7)_654-658.nxml.txt.nlp	20627927	SENT45	6	6	10	10	tobramycin	NAG	PA451704	51594;4669	0.872
NULL	Semin_Immunol_2011_Feb_23(1)_28-41.nxml.txt.nlp	21295490	SENT804	15	15	2	2	efalizumab	TNF-alpha	PA164748817	7124	0.872
NULL	Neural_Dev_2010_May_6_5_13.nxml.txt.nlp	20459606	SENT108	17	17	15	15	heparin	FGF2	PA449855	2247;2258	0.872
NULL	Evid_Based_Complement_Alternat_Med_2011_Mar_10_2011_624375.nxml.txt.nlp	20008903	SENT157	9	9	17	17	pioglitazone	adiponectin	PA450970	9370	0.872
NULL	Acta_Pharmacol_Sin_2012_Apr_12_33(4)_542-550.nxml.txt.nlp	22407228	SENT115	21	21	29	29	perifosine	ATG7	PA165291471	10533	0.872
NULL	Cancer_Med_2013_Jun_25_2(3)_277-285.nxml.txt.nlp	23930204	SENT114	6	6	28	28	bevacizumab	PTEN	PA130232992	5728	0.872
NULL	Oncotarget_2011_Dec_31_2(12)_1314-1321.nxml.txt.nlp	22248929	SENT140	13	13	28	28	lapatinib	HER3	PA152241907	2065	0.872
NULL	Biomed_Opt_Express_2012_Aug_1_3(9)_1978-1992.nxml.txt.nlp	23024894	SENT224	17	17	6	6	isoflurane	PCL	PA450106	9033;2324	0.872
NULL	Clin_Epigenetics_2010_Sep_18_1(3-4)_101-116.nxml.txt.nlp	21258631	SENT215	0	0	2	2	genistein	DNMT1	PA165109660	1786	0.872
NULL	Behav_Ecol_Sociobiol_2011_Oct_17_65(10)_2007-2019.nxml.txt.nlp	21957328	SENT226	15	15	38	38	estradiol	aromatase	PA449503	1588	0.872
NULL	Br_J_Cancer_2011_Aug_23_105(5)_618-627.nxml.txt.nlp	21829197	SENT175	4	4	14	14	lapatinib	EGFR	PA152241907	1956	0.872
NULL	J_Oncol_2012_Apr_10_2012_931071.nxml.txt.nlp	22570654	SENT47	14	14	6	6	plerixafor	CD34	PA165958410	947	0.872
NULL	Front_Neuroenergetics_2013_Mar_27_5_2.nxml.txt.nlp	23543638	SENT178	24	24	22	22	exenatide	GLP-1	PA164749238	100125288	0.872
NULL	Ann_Dermatol_2014_Dec_26_26(6)_706-712.nxml.txt.nlp	25473222	SENT15	18	18	7	7	isotretinoin	EPO	PA450128	7076;8288;2056	0.872
NULL	Cardiol_Res_Pract_2013_Jan_31_2013_128795.nxml.txt.nlp	23431496	SENT123	35	35	30	30	clopidogrel	CYP2C19	PA449053	1557	0.872
NULL	Indian_J_Pharmacol_2014_Mar-Apr_46(2)_211-215.nxml.txt.nlp	24741196	SENT98	2	2	26	26	carbamazepine	NAC	PA448785	22861	0.872
NULL	J_Cell_Mol_Med_2014_Mar_10_18(3)_514-529.nxml.txt.nlp	24410795	SENT219	27	27	29	29	resveratrol	SIRT1		23411	0.872
NULL	Clin_Exp_Otorhinolaryngol_2014_Jun_21_7(2)_79-86.nxml.txt.nlp	24917902	SENT54	33	33	18	18	piperacillin	TOB	PA450975	10140	0.872
NULL	Ann_Rheum_Dis_2015_Jan_20_74(1)_285-293.nxml.txt.nlp	24257023	SENT306	8	8	12	12	hyaluronan	ADAMTS4	PA165958431	9507	0.872
NULL	Curr_Pain_Headache_Rep_2011_Aug_12_15(4)_271-279.nxml.txt.nlp	21479998	SENT162	19	19	24	24	fluoxetine	CYP2D6	PA449673	1565	0.872
NULL	Cardiol_Ther_2013_Jun_7_2(1)_57-68.nxml.txt.nlp	25135289	SENT41	5	5	0	0	prasugrel	P2Y12	PA154410481	64805	0.872
NULL	Cancer_Manag_Res_2012_Mar_29_4_105-111.nxml.txt.nlp	22570564	SENT117	26	26	4	4	letrozole	aromatase	PA450196	1588	0.872
NULL	Arthritis_Res_Ther_2005_Jan_21_7(2)_55-61.nxml.txt.nlp	15743490	SENT106	6	6	43	43	simvastatin	CCR7	PA451363	1236	0.872
NULL	Open_Cardiovasc_Med_J_2007_Jun_11_1_1-7.nxml.txt.nlp	18949084	SENT93	0	0	8	8	losartan	AT1	PA450268	9197;185	0.872
NULL	Oncogenesis_2012_Apr_2_1(4)_e5.nxml.txt.nlp	23552603	SENT234	22	22	34	34	ns-398	BAX		581	0.872
NULL	Front_Genet_2013_Aug_30_4_166.nxml.txt.nlp	24009623	SENT655	9	9	0	0	sirolimus	CYP3A5	PA451365	1577	0.872
NULL	Mol_Vis_2011_Feb_1_17_332-340.nxml.txt.nlp	21297899	SENT230	28	28	35	35	benazepril	DPI	PA448561	1832	0.872
NULL	Oncol_Lett_2014_Sep_19_8(3)_1320-1322.nxml.txt.nlp	25120716	SENT3	18	18	5	5	erlotinib	EGFR	PA134687924	1956	0.872
NULL	Biochem_Res_Int_2012_May_7_2012_395974.nxml.txt.nlp	22611495	SENT247	21	21	8	8	tacrolimus	GLP-1	PA451578	100125288	0.872
NULL	Virol_J_2010_Oct_27_7_285.nxml.txt.nlp	20979618	SENT7	11	11	7	7	isoproterenol	c-fos	PA450121	2353	0.872
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT5	16	16	5	5	nilotinib	CML	PA165958345	613	0.872
NULL	Carcinogenesis_2010_Dec_27_31(12)_2049-2057.nxml.txt.nlp	20876285	SENT336	21	21	31	31	tamoxifen	c-Myc	PA451581	4609	0.872
NULL	Gynecol_Oncol_Case_Rep_2013_Sep_21_6_42-44.nxml.txt.nlp	24371718	SENT107	4	4	19	19	anastrozole	ATAC	PA448432	6375	0.872
NULL	Eur_J_Clin_Pharmacol_2014_Oct_8_70(12)_1433-1441.nxml.txt.nlp	25291992	SENT111	10	10	3	3	olanzapine	FES	PA450688	2242	0.872
NULL	Iran_J_Pharm_Res_2014_Autumn_13(4)_1393-1401.nxml.txt.nlp	25587329	SENT130	4	4	6	6	sulindac	MRP1	PA451565	4437	0.872
NULL	Ann_Coloproctol_2014_Aug_26_30(4)_165-174.nxml.txt.nlp	25210685	SENT137	12	12	6	6	cetuximab	EGFR	PA10040	1956	0.872
NULL	Int_J_Gen_Med_2013_May_29_6_413-417.nxml.txt.nlp	23761981	SENT34	0	0	6	6	pregabalin	gamma	PA164754814	9913	0.872
NULL	J_Cell_Mol_Med_2013_Nov_9_17(11)_1484-1493.nxml.txt.nlp	24015932	SENT166	7	7	23	23	berberine	c-Myc	PA165860812	4609	0.872
NULL	ScientificWorldJournal_2013_Oct_1_2013_654829.nxml.txt.nlp	24198725	SENT279	6	6	17	17	naproxen	NF2	PA450595	4771	0.872
NULL	Open_Biochem_J_2011_Sep_23_5_45-51.nxml.txt.nlp	21966325	SENT183	8	8	4	4	diclofenac	XBP1	PA449293	7494	0.872
NULL	Cell_Death_Dis_2010_May_13_1(5)_e41.nxml.txt.nlp	21364648	SENT141	6	6	16	16	etoposide	DR5	PA449552	8795	0.872
NULL	Oncol_Rep_2012_Apr_16_27(4)_971-978.nxml.txt.nlp	22266706	SENT12	10	10	20	20	cisplatin	Mcl-1	PA449014	4170	0.872
NULL	Crit_Care_2009_Jun_23_13(3)_R98.nxml.txt.nlp	19549333	SENT152	38	38	6	6	vasopressin	AVP	PA451858	114548;551	0.872
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1495-1502.nxml.txt.nlp	21989186	SENT79	35	35	23	23	panitumumab	HSI	PA162373091	57016	0.872
NULL	Biochimie_2010_Nov_92(11)_1546-1567.nxml.txt.nlp	20615447	SENT122	7	7	33	33	trypsin	KLK4	PA451806	9622	0.872
NULL	Front_Genet_2012_Nov_2_3_229.nxml.txt.nlp	23130019	SENT502	11	11	15	15	nifedipine	CYP3A4	PA450631	1576	0.872
NULL	J_Korean_Med_Sci_2009_Jan_29_24(Suppl_1)_S170-S175.nxml.txt.nlp	19194548	SENT81	41	41	9	9	cisplatin	EPO	PA449014	7076;8288;2056	0.872
NULL	J_Neurosci_Rural_Pract_2014_Nov_5(Suppl_1)_S110-S111.nxml.txt.nlp	25540529	SENT13	17	17	7	7	methylprednisolone	ACTH	PA450466	5443	0.872
NULL	J_Biol_Chem_2009_Apr_3_284(14)_9558-9565.nxml.txt.nlp	19202191	SENT70	20	20	25	25	camptothecin	CtIP	PA153590860	5932	0.872
NULL	Exp_Diabetes_Res_2011_Jun_20_2011_601047.nxml.txt.nlp	21747830	SENT88	32	32	24	24	liraglutide	GLP-1	PA165958364	100125288	0.872
NULL	Mol_Vis_2012_Oct_5_18_2454-2467.nxml.txt.nlp	23077404	SENT76	8	8	2	2	bevacizumab	VEGF-A	PA130232992	7422	0.872
NULL	Arthritis_Res_Ther_2006_Jul_19_8(4)_R118.nxml.txt.nlp	16859514	SENT214	7	7	17	17	fluorescein	CD4	PA164746009	920	0.872
NULL	Oncogenesis_2012_Apr_2_1(4)_e5.nxml.txt.nlp	23552603	SENT325	9	9	6	6	celecoxib	DR5	PA448871	8795	0.872
NULL	Daru_2011_19(2)_138-144.nxml.txt.nlp	22615650	SENT79	2	2	10	10	heparin	FGF20	PA449855	26281	0.872
NULL	Exp_Diabetes_Res_2012_May_14_2012_470851.nxml.txt.nlp	22666230	SENT203	32	32	6	6	liraglutide	GLP-1	PA165958364	100125288	0.872
NULL	Cancers_(Basel)_2011_Aug_5_3(3)_3114-3142.nxml.txt.nlp	24212948	SENT688	3	3	28	28	cyclophosphamide	TLR3	PA449165	7098	0.872
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jan_31_65(Pt_2)_o439.nxml.txt.nlp	21582024	SENT69	25	25	9	9	ethanol	mol	PA448073	90527	0.872
NULL	Ann_Lab_Med_2012_Jul_20_32(4)_270-275.nxml.txt.nlp	22779068	SENT105	17	17	33	33	cefotaxime	FOX-1	PA448852	54715	0.872
NULL	Ann_Dermatol_2013_Nov_30_25(4)_500-502.nxml.txt.nlp	24371403	SENT23	9	9	7	7	imatinib	LDE	PA10804	7957	0.872
NULL	J_Biol_Chem_2009_Dec_25_284(52)_36137-36145.nxml.txt.nlp	19828449	SENT34	28	28	15	15	nadh	ADP	PA164755085	23038	0.872
NULL	Mol_Cancer_2010_Mar_25_9_68.nxml.txt.nlp	20338046	SENT10	12	12	5	5	doxorubicin	ABCB1	PA449412	5243	0.872
NULL	Drug_Des_Devel_Ther_2014_Sep_23_8_1527-1538.nxml.txt.nlp	25284985	SENT95	21	21	3	3	celecoxib	IFN	PA448871	3439	0.872
NULL	Int_J_Biol_Sci_2014_Jun_10_10(7)_654-663.nxml.txt.nlp	25013375	SENT117	6	6	8	8	nelfinavir	AKT	PA450606	207	0.872
NULL	Aliment_Pharmacol_Ther_2012_Apr_22_35(7)_745-767.nxml.txt.nlp	22356640	SENT224	18	18	11	11	tegaserod	5-HT4	PA130413154	3360	0.872
NULL	Nucleic_Acids_Res_2013_May_5_41(10)_5210-5222.nxml.txt.nlp	23563151	SENT85	8	8	28	28	arsenite	GADD45	PA452638	1647	0.872
NULL	Biomed_Res_Int_2014_Jan_29_2014_458592.nxml.txt.nlp	24592391	SENT38	11	11	17	17	curcumin	HO-1	PA151958596	3162	0.872
NULL	CNS_Drugs_2013_Jun_26_27(9)_743-751.nxml.txt.nlp	23801529	SENT125	17	17	33	33	lisdexamfetamine	NNT	PA164748975	23530	0.872
NULL	Pharmaceutics_2011_Mar_9_3(1)_73-87.nxml.txt.nlp	24310426	SENT30	13	13	9	9	hydrocodone	API	PA449900	5345	0.872
NULL	J_Hematol_Oncol_2011_Nov_4_4_44.nxml.txt.nlp	22053759	SENT103	2	2	7	7	thrombin	PAR3	PA451674	56288;2151	0.872
NULL	BMB_Rep_2014_May_47(5)_274-279.nxml.txt.nlp	24286313	SENT124	9	9	6	6	bortezomib	CD52	PA10252	1043	0.872
NULL	Contemp_Oncol_(Pozn)_2013_Apr_29_17(2)_137-143.nxml.txt.nlp	23788980	SENT179	15	15	24	24	bromocriptine	PRL	PA448671	5617	0.872
NULL	Mol_Cancer_2003_Jan_7_2_10.nxml.txt.nlp	12575899	SENT400	6	6	20	20	celecoxib	Bcl-2	PA448871	596	0.872
NULL	Diabetes_Metab_Syndr_Obes_2014_Aug_1_7_381-389.nxml.txt.nlp	25120374	SENT183	41	41	20	20	salsalate	adiponectin	PA164745462	9370	0.872
NULL	Front_Genet_2012_Nov_5_3_236.nxml.txt.nlp	23133441	SENT15	31	31	22	22	efavirenz	ABCB1	PA449441	5243	0.872
NULL	Emerg_Med_J_2011_Apr_26_28(4)_313-315.nxml.txt.nlp	20581384	SENT40	33	33	11	11	atropine	PON1	PA448505	5444	0.872
NULL	Adv_Urol_2010_Jul_20_2010_687043.nxml.txt.nlp	20721275	SENT91	2	2	28	28	pazopanib	BRAF	PA165291492	673	0.872
NULL	Cancer_Manag_Res_2013_Nov_21_5_387-400.nxml.txt.nlp	24294007	SENT80	24	24	8	8	panitumumab	KRAS	PA162373091	3845	0.872
NULL	Front_Physiol_2013_Jul_24_4_181.nxml.txt.nlp	23898301	SENT242	0	0	22	22	dihydroergotamine	PAG	PA164743028	55824	0.872
NULL	Brain_2008_Nov_22_131(11)_3072-3080.nxml.txt.nlp	18945724	SENT9	15	15	9	9	rituximab	CD19	PA451261	930	0.872
NULL	Breast_Cancer_Res_2011_Oct_14_13(5)_316.nxml.txt.nlp	22017807	SENT12	35	35	16	16	tamoxifen	c-Raf	PA451581	5894	0.872
NULL	Nat_Med_2010_Jun_23_16(6)_671-677.nxml.txt.nlp	20495567	SENT111	25	25	31	31	sorafenib	CREB3L2	PA7000	64764	0.872
NULL	J_Mol_Med_2009_Oct_8_87(10)_971-980.nxml.txt.nlp	19669106	SENT151	2	2	14	14	methimazole	TPO	PA450422	7066;7173	0.872
NULL	J_Biol_Chem_2011_Sep_16_286(37)_32834-32842.nxml.txt.nlp	21795713	SENT61	26	26	16	16	ampicillin	RILP	PA448419	83547	0.872
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT261	25	25	12	12	adalimumab	CD36	PA10004	948	0.872
NULL	Crit_Care_2009_Jul_2_13(4)_161.nxml.txt.nlp	19591659	SENT44	14	14	9	9	exenatide	GLP-1	PA164749238	100125288	0.872
NULL	Arch_Toxicol_2014_Nov_5_88(12)_2135-2190.nxml.txt.nlp	25370008	SENT1041	11	11	8	8	4-methylumbelliferone	UGT	PA154081778	7361;7355	0.872
NULL	Chemother_Res_Pract_2011_Apr_7_2011_393976.nxml.txt.nlp	22312553	SENT39	18	18	6	6	artemether	CYP3A4	PA165111698	1576	0.872
NULL	J_Korean_Med_Sci_2010_Aug_21_25(8)_1222-1227.nxml.txt.nlp	20676337	SENT70	0	0	8	8	propofol	LPA	PA451141	4018	0.872
NULL	Breast_Cancer_Res_Treat_2013_Apr_12_138(2)_427-435.nxml.txt.nlp	23479422	SENT28	7	7	21	21	trastuzumab	HER2	PA451743	2064	0.872
NULL	Virol_J_2012_Dec_6_9_303.nxml.txt.nlp	23216755	SENT53	0	0	16	16	geldanamycin	San	PA152031327	80218	0.872
NULL	Oncoimmunology_2012_Nov_1_1(8)_1376-1386.nxml.txt.nlp	23243601	SENT99	0	0	22	22	lenalidomide	SPIB	PA162363968	6689	0.872
NULL	Breast_Cancer_Res_2011_Nov_1_13(6)_224.nxml.txt.nlp	22114931	SENT126	31	31	42	42	trastuzumab	PI3K	PA451743	5290	0.872
NULL	Oncotarget_2010_Jul_9_1(3)_185-197.nxml.txt.nlp	21037799	SENT106	12	12	4	4	choline	Hsp90	PA448976	3320	0.872
NULL	Br_J_Cancer_2010_Nov_9_103(11)_1692-1697.nxml.txt.nlp	21063402	SENT94	24	24	17	17	doxycycline	TRAIL	PA449415	8743	0.872
NULL	ISRN_AIDS_2012_Jul_12_2012_485307.nxml.txt.nlp	24052874	SENT74	9	9	1	1	tenofovir	PTH	PA10204	5741	0.872
NULL	Biomed_Res_Int_2013_Aug_6_2013_602987.nxml.txt.nlp	24027759	SENT261	28	28	13	13	doxorubicin	SMF	PA449412	22993	0.872
NULL	Cancer_Microenviron_2009_Sep_26_2(Suppl_1)_19-204.nxml.txt.nlp	NULL	SENT6584	6	6	0	0	hyaluronan	CD44	PA165958431	960	0.872
NULL	Inflammation_2014_Apr_6_37(5)_1476-1485.nxml.txt.nlp	24706026	SENT27	5	5	28	28	curcumin	GATA3	PA151958596	2625	0.872
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT57	18	18	24	24	neratinib	HER2	PA165291472	2064	0.872
NULL	Mol_Pain_2013_Jan_2_9_1.nxml.txt.nlp	23279936	SENT27	23	23	9	9	capsaicin	TRPV1	PA448776	7442	0.872
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT30	8	8	14	14	gefitinib	KRAS	PA131301952	3845	0.872
NULL	Iran_J_Pharm_Res_2013_Winter_12(Suppl)_169-174.nxml.txt.nlp	24250685	SENT89	14	14	22	22	clopidogrel	ADP	PA449053	23038	0.872
NULL	Exp_Mol_Med_2012_Aug_31_44(8)_473-482.nxml.txt.nlp	22627808	SENT13	9	9	15	15	lapatinib	HER2	PA152241907	2064	0.872
NULL	Mol_Pain_2013_Nov_28_9_60.nxml.txt.nlp	24283218	SENT266	37	37	29	29	capsaicin	TRPV1	PA448776	7442	0.872
NULL	Eur_J_Nutr_2012_Aug_15_51(5)_513-528.nxml.txt.nlp	22584415	SENT138	7	7	16	16	adalimumab	adiponectin	PA10004	9370	0.872
NULL	Int_J_Cell_Biol_2013_Feb_12_2013_805975.nxml.txt.nlp	23476653	SENT199	15	15	9	9	etoposide	CD133	PA449552	8842	0.872
NULL	Braz_J_Med_Biol_Res_2012_Sep_21_45(12)_1240-1243.nxml.txt.nlp	22983178	SENT88	2	2	4	4	indomethacin	FAAH	PA449982	79152;2166	0.872
NULL	Cancers_(Basel)_2013_Dec_27_6(1)_67-78.nxml.txt.nlp	24378752	SENT56	7	7	17	17	etoposide	p53	PA449552	7157	0.872
NULL	Mol_Biol_Cell_2013_Dec_15_24(24)_3939-3944.nxml.txt.nlp	24152728	SENT111	7	7	24	24	tamoxifen	CCN2	PA451581	1490	0.872
NULL	Exp_Hematol_Oncol_2014_Jun_4_3_15.nxml.txt.nlp	24926417	SENT45	10	10	32	32	octreotide	FVIII	PA450678	2157	0.872
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT61	27	27	18	18	neratinib	HER2	PA165291472	2064	0.872
NULL	Nat_Med_2011_Oct_9_17(11)_1448-1455.nxml.txt.nlp	21983856	SENT104	3	3	32	32	fluoxetine	NRM	PA449673	11270	0.872
NULL	Front_Genet_2012_Oct_19_3_180.nxml.txt.nlp	23091478	SENT658	17	17	7	7	cetuximab	KRAS	PA10040	3845	0.872
NULL	Diabetes_Care_2010_Jun_3_33(6)_1186-1192.nxml.txt.nlp	20200299	SENT171	29	29	17	17	estradiol	aromatase	PA449503	1588	0.872
NULL	Case_Rep_Oncol_Med_2013_Sep_26_2013_234391.nxml.txt.nlp	24191208	SENT62	7	7	15	15	capecitabine	HER2	PA448771	2064	0.872
NULL	J_Immunother_Cancer_2013_Nov_7_1(Suppl_1)_P175.nxml.txt.nlp	NULL	SENT14	19	19	13	13	cetuximab	STAT1	PA10040	6772	0.872
NULL	Parasit_Vectors_2010_Aug_4_3_67.nxml.txt.nlp	20684757	SENT108	1	1	11	11	permethrin	ANOVA	PA164743137	4858	0.872
NULL	Antimicrob_Agents_Chemother_2014_Dec_58(12)_7340-7346.nxml.txt.nlp	25267661	SENT203	29	29	9	9	primaquine	CYP2D6	PA451103	1565	0.872
NULL	Clin_Psychopharmacol_Neurosci_2012_Aug_31_10(2)_78-87.nxml.txt.nlp	23430971	SENT34	23	23	18	18	olanzapine	FES	PA450688	2242	0.872
NULL	Br_J_Cancer_2013_Jun_25_108(12)_2464-2469.nxml.txt.nlp	23695016	SENT99	12	12	15	15	cisplatin	CRT	PA449014	811	0.872
NULL	Evid_Based_Complement_Alternat_Med_2013_Aug_28_2013_516017.nxml.txt.nlp	24066014	SENT141	8	8	1	1	doxorubicin	AT1	PA449412	9197;185	0.872
NULL	Ann_Clin_Transl_Neurol_2014_Dec_21_1(12)_996-1005.nxml.txt.nlp	25574474	SENT132	16	16	9	9	riluzole	P-gp	PA451251	5243	0.872
NULL	J_Biomed_Sci_2014_Apr_17_21(1)_30.nxml.txt.nlp	24742230	SENT164	7	7	35	35	lovastatin	RANKL	PA450272	8600	0.872
NULL	Cancer_Med_2013_Oct_19_2(5)_646-653.nxml.txt.nlp	24403230	SENT129	22	22	13	13	trastuzumab	GADD45	PA451743	1647	0.872
NULL	Acta_Neuropathol_Commun_2014_May_30_2_57.nxml.txt.nlp	24887326	SENT106	22	22	7	7	vardenafil	ABCB1	PA10229	5243	0.872
NULL	Adv_Ther_2014_May_13_31(5)_473-493.nxml.txt.nlp	24821599	SENT138	16	16	21	21	dabigatran	TTR		7276	0.872
NULL	Ann_Surg_Oncol_2012_Dec_6_19(13)_4287-4299.nxml.txt.nlp	22766981	SENT20	34	34	25	25	panitumumab	VEGF-A	PA162373091	7422	0.872
NULL	Exp_Ther_Med_2013_Apr_5_5(4)_1259-1263.nxml.txt.nlp	23596498	SENT107	10	10	13	13	propofol	TRPV1	PA451141	7442	0.872
NULL	Int_J_Circumpolar_Health_2013_Aug_5_72_10_3402_ijch_v72i0_20854.nxml.txt.nlp	23984273	SENT119	17	17	4	4	erythromycin	19A	PA449493	57823	0.872
NULL	Arch_Plast_Surg_2014_Nov_3_41(6)_759-767.nxml.txt.nlp	25396192	SENT157	14	14	19	19	clarithromycin	RGM	PA449028	56963	0.872
NULL	Front_Genet_2012_Sep_3_3_169.nxml.txt.nlp	22969794	SENT324	16	16	9	9	estradiol	pS2	PA449503	7031	0.872
NULL	Nat_Chem_Biol_2010_Apr_28_6(4)_291-299.nxml.txt.nlp	20190765	SENT149	4	4	36	36	dasatinib	EGFR	PA162372878	1956	0.872
NULL	Arthritis_Res_Ther_2009_Jul_23_11(4)_236.nxml.txt.nlp	19664185	SENT66	2	2	10	10	benzbromarone	URAT1	PA134852920	116085	0.872
NULL	Biomed_Res_Int_2013_Oct_28_2013_382184.nxml.txt.nlp	24286077	SENT208	1	1	19	19	galactose	spatial	PA449725	219793	0.872
NULL	Exp_Ther_Med_2013_Nov_13_6(5)_1317-1321.nxml.txt.nlp	24223665	SENT110	11	11	18	18	cisplatin	ABCG2	PA449014	9429	0.872
NULL	Oncotarget_2014_Feb_14_5(5)_1279-1289.nxml.txt.nlp	24658133	SENT52	15	15	35	35	doxycycline	p63	PA449415	8626	0.872
NULL	Eur_J_Clin_Pharmacol_2010_Nov_29_66(11)_1131-1136.nxml.txt.nlp	20669013	SENT14	21	21	4	4	voriconazole	CYP3A4	PA10233	1576	0.872
NULL	Oxid_Med_Cell_Longev_2013_Apr_30_2013_796891.nxml.txt.nlp	23738041	SENT114	5	5	18	18	rosuvastatin	AT1	PA134308647	9197;185	0.872
NULL	Br_J_Cancer_2012_Jan_31_106(3)_482-489.nxml.txt.nlp	22233925	SENT150	12	12	18	18	carboplatin	PEO1	PA448803	56652	0.872
NULL	Cardiovasc_Diabetol_2013_Nov_12_12_169.nxml.txt.nlp	24215514	SENT107	7	7	27	27	candesartan	ANG	PA448765	283	0.872
NULL	Indian_J_Pharm_Sci_2014_Jan-Feb_76(1)_72-77.nxml.txt.nlp	24799741	SENT10	20	20	3	3	glipizide	CYP2C9	PA449762	1559	0.872
NULL	Cell_Death_Dis_2014_Jan_2_5(1)_e980.nxml.txt.nlp	24384723	SENT58	2	2	11	11	lapatinib	EGFR	PA152241907	1956	0.872
NULL	Br_J_Cancer_2010_Mar_16_102(6)_1003-1009.nxml.txt.nlp	20179710	SENT130	32	32	18	18	thiotepa	CYP2B6	PA451668	1555	0.872
NULL	Case_Rep_Oncol_2012_May_15_5(2)_238-245.nxml.txt.nlp	22679430	SENT50	11	11	6	6	rituximab	CHOP	PA451261	1649	0.872
NULL	Diabetes_Care_2013_Jul_12_36(7)_1933-1940.nxml.txt.nlp	23462665	SENT238	6	6	33	33	exenatide	GLP-1	PA164749238	100125288	0.872
NULL	Nat_Chem_Biol_2010_Apr_28_6(4)_291-299.nxml.txt.nlp	20190765	SENT77	30	30	25	25	dasatinib	EGFR	PA162372878	1956	0.872
NULL	F1000_Biol_Rep_2012_Mar_1_4_5.nxml.txt.nlp	22403588	SENT115	2	2	9	9	telaprevir	IFN	PA165958354	3439	0.872
NULL	Evid_Based_Complement_Alternat_Med_2012_Sep_13_2012_940846.nxml.txt.nlp	23008744	SENT135	20	20	8	8	fluoxetine	ACTH	PA449673	5443	0.872
NULL	Br_J_Cancer_2010_Jun_8_102(12)_1707-1716.nxml.txt.nlp	20461078	SENT38	2	2	19	19	bortezomib	TRAIL	PA10252	8743	0.872
NULL	Acta_Oncol_2014_Oct_9_53(10)_1347-1355.nxml.txt.nlp	24909504	SENT125	21	21	4	4	doxorubicin	TP53	PA449412	7157	0.872
NULL	Indian_J_Pharmacol_2014_May-Jun_46(3)_292-297.nxml.txt.nlp	24987176	SENT158	4	4	15	15	udenafil	DES	PA164776753	1674	0.872
NULL	Anal_Chem_2014_Mar_18_86(6)_2867-2870.nxml.txt.nlp	24579851	SENT60	15	15	29	29	hemin	GAPDH	PA449849	2597	0.872
NULL	Front_Endocrinol_(Lausanne)_2014_Apr_1_5_39.nxml.txt.nlp	24744750	SENT68	3	3	26	26	estradiol	IL-10	PA449503	3586	0.872
NULL	Front_Genet_2015_Jan_14_5_469.nxml.txt.nlp	25642242	SENT163	15	15	8	8	paromomycin	SDHA	PA164784023	6389	0.872
NULL	Scientifica_(Cairo)_2013_Dec_12_2013_635203.nxml.txt.nlp	24416617	SENT405	9	9	30	30	sorafenib	VEGFR	PA7000	3791	0.872
NULL	Cancer_Cell_Int_2011_Aug_19_11_29.nxml.txt.nlp	21854619	SENT157	23	23	4	4	cisplatin	BRCA1	PA449014	672	0.872
NULL	Pharmaceuticals_(Basel)_2013_Oct_10_6(10)_1221-1286.nxml.txt.nlp	24275849	SENT542	10	10	5	5	propiomazine	LGA	PA164778685	27165	0.872
NULL	Cardiovasc_Diabetol_2008_Jun_22_7_20.nxml.txt.nlp	18570678	SENT114	30	30	15	15	metformin	CD11b	PA450395	3684	0.872
NULL	Int_J_Biol_Sci_2013_Dec_22_10(1)_90-102.nxml.txt.nlp	24391455	SENT197	28	28	2	2	doxorubicin	MKP-1	PA449412	1843	0.872
NULL	Cancers_(Basel)_2014_Oct_21_6(4)_2137-2154.nxml.txt.nlp	25337831	SENT23	11	11	19	19	erlotinib	EGFR	PA134687924	1956	0.872
NULL	Eur_J_Appl_Physiol_2012_Apr_28_112(4)_1315-1325.nxml.txt.nlp	21796411	SENT91	34	34	13	13	aprotinin	ADM	PA448472	133	0.872
NULL	Breast_Cancer_Res_2010_Jun_4_12(3)_R32.nxml.txt.nlp	20525379	SENT299	9	9	18	18	fulvestrant	AGR2	PA164747170	10551	0.872
NULL	Biochemistry_2009_Feb_3_48(4)_800-809.nxml.txt.nlp	19132922	SENT204	23	23	9	9	raloxifene	XOR	PA451221	7498	0.872
NULL	Clin_Pharmacokinet_2014_Sep_3_53(1)_1-16.nxml.txt.nlp	23999929	SENT287	19	19	10	10	erythromycin	P-gp	PA449493	5243	0.872
NULL	Br_J_Cancer_2009_Mar_10_100(5)_684-692.nxml.txt.nlp	19259090	SENT51	18	18	25	25	trastuzumab	HER2	PA451743	2064	0.872
NULL	Case_Rep_Otolaryngol_2013_Dec_15_2013_918132.nxml.txt.nlp	24396622	SENT77	26	26	24	24	cyclophosphamide	CHOP	PA449165	1649	0.872
NULL	Br_J_Cancer_2011_Apr_12_104(8)_1256-1261.nxml.txt.nlp	21448165	SENT126	30	30	44	44	sorafenib	IL-2	PA7000	3558	0.872
NULL	J_Invest_Dermatol_2013_Mar_25_133(3)_793-802.nxml.txt.nlp	23096711	SENT10	13	13	18	18	diethylstilbestrol	STIM1	PA449307	6786	0.872
NULL	Drugs_R_D_2010_Nov_25_10(4)_243-251.nxml.txt.nlp	21171670	SENT179	7	7	15	15	esomeprazole	CYP2C19	PA10075	1557	0.872
NULL	J_Gastroenterol_2013_Feb_22_48(2)_222-237.nxml.txt.nlp	22722906	SENT8	39	39	34	34	ethanol	p38	PA448073	10598;1432;7965	0.872
NULL	J_Asthma_Allergy_2008_Sep_19_1_19-29.nxml.txt.nlp	21436982	SENT46	5	5	13	13	fexofenadine	CYP3A	PA449621	1574	0.872
NULL	Acta_Pharmacol_Sin_2012_May_16_33(5)_682-690.nxml.txt.nlp	22504904	SENT227	26	26	29	29	celecoxib	STAT3	PA448871	6774	0.872
NULL	Int_J_Mol_Sci_2014_Sep_26_15(10)_17204-17220.nxml.txt.nlp	25264738	SENT120	3	3	19	19	sildenafil	HO-1	PA451346	3162	0.872
NULL	Oncol_Lett_2014_Nov_12_8(5)_2203-2208.nxml.txt.nlp	25295109	SENT133	23	23	1	1	celecoxib	GLI1	PA448871	2735	0.872
NULL	Mol_Vis_2012_Apr_21_18_1010-1020.nxml.txt.nlp	22550395	SENT153	9	9	7	7	fasudil	Rho	PA165946121	29984	0.872
NULL	Environ_Health_Perspect_2010_Jul_3_118(7)_936-942.nxml.txt.nlp	20199942	SENT220	9	9	21	21	arsenite	mot-2	PA452638	3313	0.872
NULL	Acta_Pharmacol_Sin_2011_Oct_12_32(10)_1259-1265.nxml.txt.nlp	21909126	SENT122	6	6	14	14	rosuvastatin	LOX-1	PA134308647	4973	0.872
NULL	Cancers_(Basel)_2011_May_25_3(2)_2501-2515.nxml.txt.nlp	24212821	SENT433	18	18	4	4	gemcitabine	EGFR	PA449748	1956	0.872
NULL	Cardiol_Ther_2013_Jun_4_2(1)_17-25.nxml.txt.nlp	25135286	SENT174	14	14	23	23	everolimus	OUT	PA164746311	150921	0.872
NULL	Oncol_Lett_2013_Dec_4_6(6)_1665-1672.nxml.txt.nlp	24273604	SENT96	13	13	36	36	chloroquine	TLR9	PA448948	54106	0.872
NULL	Int_J_Gen_Med_2009_Jul_30_2_129-140.nxml.txt.nlp	20360896	SENT9	11	11	4	4	exemestane	aromatase	PA449563	1588	0.872
NULL	Clinics_(Sao_Paulo)_2013_Feb_68(2)_253-262.nxml.txt.nlp	23525324	SENT213	29	29	8	8	genistein	Gen	PA165109660	348654	0.872
NULL	Evid_Based_Complement_Alternat_Med_2012_May_7_2012_242810.nxml.txt.nlp	22645625	SENT269	4	4	7	7	ketoconazole	CYP3A4	PA450146	1576	0.872
NULL	Eur_Heart_J_2013_May_21_34(20)_1498-1505.nxml.txt.nlp	23487517	SENT111	6	6	2	2	warfarin	TTR	PA451906	7276	0.872
NULL	Evid_Based_Complement_Alternat_Med_2011_Feb_14_2011_248231.nxml.txt.nlp	19233878	SENT92	5	5	3	3	rosiglitazone	DBT	PA451283	1629	0.872
NULL	Target_Oncol_2013_Jun_27_8(2)_127-136.nxml.txt.nlp	23625191	SENT50	8	8	2	2	panitumumab	KRAS	PA162373091	3845	0.872
NULL	Ann_Dermatol_2011_Sep_30_23(Suppl_1)_S100-S104.nxml.txt.nlp	22028551	SENT71	23	23	19	19	doxorubicin	CHOP	PA449412	1649	0.872
NULL	Case_Rep_Med_2010_Feb_28_2010_352417.nxml.txt.nlp	20204071	SENT55	24	24	6	6	colchicine	COPE	PA449092	11316	0.872
NULL	Clin_Med_Insights_Circ_Respir_Pulm_Med_2012_Jun_12_6_27-40.nxml.txt.nlp	22745565	SENT52	23	23	11	11	omalizumab	ACT	PA164752253	12;11332;9457;641455	0.872
NULL	Ann_Surg_Oncol_2009_Aug_10_16(8)_2086-2088.nxml.txt.nlp	19513600	SENT72	29	29	4	4	cetuximab	gamma	PA10040	9913	0.872
NULL	Mol_Cancer_2012_Jan_6_11_2.nxml.txt.nlp	22226043	SENT51	24	24	13	13	tamoxifen	MST1R	PA451581	4486	0.872
NULL	Pharmaceuticals_(Basel)_2014_Apr_14_7(4)_453-463.nxml.txt.nlp	24736104	SENT155	10	10	17	17	diclofenac	GIT	PA449293	5034	0.872
NULL	Breast_Cancer_Res_Treat_2013_Jan_10_137(1)_1-12.nxml.txt.nlp	23143215	SENT108	10	10	5	5	lapatinib	BCRP1	PA152241907	317687	0.872
NULL	J_Nutr_Metab_2011_Jun_1_2011_708183.nxml.txt.nlp	21773024	SENT184	6	6	3	3	liraglutide	GLP-1	PA165958364	100125288	0.872
NULL	Front_Genet_2012_Nov_5_3_236.nxml.txt.nlp	23133441	SENT119	17	17	8	8	efavirenz	ABCB1	PA449441	5243	0.872
NULL	Front_Pharmacol_2014_May_27_5_115.nxml.txt.nlp	24904418	SENT778	6	6	14	14	hemin	JNK	PA449849	5599	0.872
NULL	ASN_Neuro_2012_Feb_8_4(1)_e00074.nxml.txt.nlp	22220511	SENT275	17	17	7	7	ceftriaxone	xCT	PA448866	23657	0.872
NULL	BioDrugs_2014_Aug_18_28(1)_27-39.nxml.txt.nlp	23955284	SENT250	18	18	4	4	cisplatin	TRAIL	PA449014	8743	0.872
NULL	BMJ_2011_Jul_26_343_d4366.nxml.txt.nlp	21791491	SENT160	0	0	30	30	potassium	ACE	PA451047	1636	0.872
NULL	J_Biol_Chem_2008_Jun_20_283(25)_17194-17204.nxml.txt.nlp	18442977	SENT132	27	27	23	23	ketanserin	5-HT2A	PA131053734	3356	0.872
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2007_Dec_6_64(Pt_1)_o127.nxml.txt.nlp	21200691	SENT56	11	11	6	6	ethanol	mol	PA448073	90527	0.872
NULL	Clin_Transl_Allergy_2013_Sep_2_3_29.nxml.txt.nlp	24004581	SENT34	4	4	17	17	omalizumab	IL-4	PA164752253	3565	0.872
NULL	EMBO_Mol_Med_2013_Aug_4_5(8)_1165-1179.nxml.txt.nlp	23828861	SENT300	23	23	7	7	collagenase	CO2	PA449107	4513	0.872
NULL	Oxid_Med_Cell_Longev_2013_May_7_2013_984546.nxml.txt.nlp	23738048	SENT174	29	29	18	18	arsenite	HO-1	PA452638	3162	0.872
NULL	Int_J_Anal_Chem_2013_Jul_9_2013_934357.nxml.txt.nlp	23935625	SENT62	2	2	13	13	sumatriptan	MSN	PA451566	4478	0.872
NULL	J_Biol_Chem_2013_Dec_13_288(50)_35877-35885.nxml.txt.nlp	24155236	SENT195	32	32	9	9	heparin	DR5	PA449855	8795	0.872
NULL	Clin_Exp_Gastroenterol_2013_Aug_5_6_139-148.nxml.txt.nlp	23950655	SENT126	13	13	5	5	thrombin	PAR-1	PA451674	2011;2149	0.872
NULL	Oncoimmunology_2012_Oct_1_1(7)_1004-1016.nxml.txt.nlp	23170249	SENT115	29	29	18	18	paclitaxel	HER-2	PA450761	2064	0.872
NULL	Int_J_Environ_Res_Public_Health_2012_Sep_19_9(9)_3354-3364.nxml.txt.nlp	23202692	SENT405	9	9	2	2	resveratrol	CYP3A		1574	0.872
NULL	Pain_2011_Aug_152(8)_1899-1908.nxml.txt.nlp	21600693	SENT226	22	22	20	20	cangrelor	P2Y12	PA165945763	64805	0.872
NULL	Curr_Rheumatol_Rep_2010_Feb_8_12(1)_45-52.nxml.txt.nlp	20425533	SENT86	5	5	21	21	thrombin	EGF	PA451674	1950	0.872
NULL	Nat_Chem_Biol_2010_Apr_28_6(4)_291-299.nxml.txt.nlp	20190765	SENT149	4	4	17	17	dasatinib	AKT	PA162372878	207	0.872
NULL	Nucleic_Acids_Res_2012_Apr_18_40(8)_e59.nxml.txt.nlp	22259038	SENT218	7	7	27	27	erythromycin	L12	PA449493	26156;6136	0.872
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT49	42	42	13	13	chlorzoxazone	CYP2D6	PA448971	1565	0.872
NULL	Br_J_Cancer_2010_Nov_9_103(11)_1692-1697.nxml.txt.nlp	21063402	SENT140	24	24	29	29	doxycycline	TRAIL	PA449415	8743	0.872
NULL	Mol_Pain_2014_Aug_15_10_53.nxml.txt.nlp	25127716	SENT114	25	25	11	11	paclitaxel	SDH	PA450761	1757;10993	0.872
NULL	Exp_Brain_Res_2014_Jun_27_232(8)_2637-2644.nxml.txt.nlp	24969614	SENT20	13	13	39	39	palonosetron	NK1	PA10352	11126	0.872
NULL	Drug_Target_Insights_2013_Aug_19_7_27-34.nxml.txt.nlp	24023511	SENT104	8	8	24	24	doxorubicin	P-gp	PA449412	5243	0.872
NULL	Front_Immunol_2013_May_15_4_116.nxml.txt.nlp	23720663	SENT1815	14	14	3	3	cyclophosphamide	CD4	PA449165	920	0.872
NULL	Mol_Cancer_2009_Aug_25_8_66.nxml.txt.nlp	19706164	SENT91	5	5	15	15	celecoxib	p53	PA448871	7157	0.872
NULL	Fibrogenesis_Tissue_Repair_2012_Jan_3_5_1.nxml.txt.nlp	22214245	SENT182	47	47	19	19	ribavirin	IL28B	PA451241	282617	0.872
NULL	Acta_Neuropathol_2015_Oct_17_129_81-96.nxml.txt.nlp	25322817	SENT158	11	11	36	36	capsaicin	TRPV1	PA448776	7442	0.872
NULL	Cancer_Cell_Int_2009_Sep_10_9_25.nxml.txt.nlp	19744341	SENT162	12	12	32	32	glucosamine	STAT3	PA164747613	6774	0.872
NULL	Diabetes_2009_Jan_58(1)_215-226.nxml.txt.nlp	18840783	SENT117	10	10	36	36	fasudil	CO2	PA165946121	4513	0.872
NULL	J_Carcinog_2012_Sep_13_11_15.nxml.txt.nlp	23230392	SENT127	44	44	19	19	axitinib	EGFR	PA164924493	1956	0.872
NULL	Core_Evid_2011_Sep_8_6_67-79.nxml.txt.nlp	22022289	SENT185	1	1	28	28	liraglutide	GLP-1	PA165958364	100125288	0.872
NULL	Diabetes_Care_2013_Aug_17_36(Suppl_2)_S162-S174.nxml.txt.nlp	23882042	SENT297	27	27	17	17	troglitazone	PPARG	PA451799	5468	0.872
NULL	Eur_J_Med_Res_2009_Nov_24_14(Suppl_3)_17-21.nxml.txt.nlp	19959412	SENT69	26	26	5	5	atazanavir	UGT1A1	PA10251	54658	0.872
NULL	J_Biomed_Biotechnol_2011_Dec_5_2011_172965.nxml.txt.nlp	22187520	SENT159	17	17	25	25	dextran	IFN	PA449261	3439	0.871
NULL	Breast_Cancer_Res_2010_Jul_22_12(4)_R53.nxml.txt.nlp	20649975	SENT6	9	9	18	18	tamoxifen	HOXB13	PA451581	10481	0.871
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT299	24	24	6	6	nelfinavir	ABCC1	PA450606	4363	0.871
NULL	Breast_Cancer_Res_2012_Jan_6_14(1)_R2.nxml.txt.nlp	22225778	SENT219	20	20	29	29	docetaxel	TNFAIP3	PA449383	7128	0.871
NULL	Oncotarget_2014_Aug_19_5(18)_8703-8715.nxml.txt.nlp	25237928	SENT65	27	27	12	12	glucose	CD44	PA449773	960	0.871
NULL	Cell_Commun_Signal_2013_Aug_2_11_55.nxml.txt.nlp	23915343	SENT324	1	1	12	12	creatine	NAC	PA164778930	22861	0.871
NULL	Biomed_Res_Int_2014_Jun_26_2014_161346.nxml.txt.nlp	25054130	SENT225	41	41	21	21	curcumin	STZ	PA151958596	6484	0.871
NULL	Arthritis_Res_Ther_2010_Jun_2_12(3)_R107.nxml.txt.nlp	20525198	SENT121	15	15	4	4	rolipram	TNF	PA153906323	7124	0.871
NULL	Oxid_Med_Cell_Longev_2012_Aug_8_2012_920932.nxml.txt.nlp	22919442	SENT170	0	0	7	7	creatine	IFN	PA164778930	3439	0.871
NULL	Curr_Neuropharmacol_2013_Dec_11(6)_652-663.nxml.txt.nlp	24396340	SENT172	7	7	29	29	capsaicin	TRPV1	PA448776	7442	0.871
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Apr_8_65(Pt_5)_m489.nxml.txt.nlp	21583740	SENT54	27	27	22	22	ethanol	mol	PA448073	90527	0.871
NULL	J_Neurol_Surg_Rep_2013_Jun_9_74(1)_33-36.nxml.txt.nlp	23943718	SENT32	19	19	12	12	octreotide	ACTH	PA450678	5443	0.871
NULL	J_Biomed_Biotechnol_2007_Jun_10_2007_43785.nxml.txt.nlp	17641725	SENT79	7	7	0	0	hyaluronan	CD44	PA165958431	960	0.871
NULL	Breast_Cancer_Res_2012_Apr_4_14(2)_R57.nxml.txt.nlp	22475046	SENT22	20	20	10	10	anastrozole	ATAC	PA448432	6375	0.871
NULL	J_Immune_Based_Ther_Vaccines_2006_Nov_28_4_7.nxml.txt.nlp	17132168	SENT51	12	12	37	37	didanosine	GM-CSF	PA449301	1437	0.871
NULL	Biosci_Rep_2012_Aug_1_32(Pt_4)_361-374.nxml.txt.nlp	22762204	SENT182	23	23	8	8	paclitaxel	LATS1	PA450761	9113	0.871
NULL	Endocrinol_Diabetes_Metab_Case_Rep_2014_Mar_1_2014_140001.nxml.txt.nlp	24683487	SENT113	19	19	3	3	cabergoline	ACTH	PA448708	5443	0.871
NULL	Int_J_Mol_Sci_2014_Jun_26_15(7)_11416-11434.nxml.txt.nlp	24972137	SENT132	28	28	6	6	sitagliptin	AMPK	PA164748978	5563	0.871
NULL	Front_Physiol_2011_Nov_24_2_83.nxml.txt.nlp	22131977	SENT96	0	0	21	21	dobutamine	ANOVA	PA449381	4858	0.871
NULL	Br_J_Cancer_2010_Oct_12_103(8)_1297-1304.nxml.txt.nlp	20842126	SENT103	38	38	13	13	taurine	SMO	PA451590	6608;54498	0.871
NULL	Cancer_Metastasis_Rev_2014_Apr_18_33(2-3)_695-720.nxml.txt.nlp	24744103	SENT310	20	20	46	46	gefitinib	PTEN	PA131301952	5728	0.871
NULL	Oncotarget_2014_Oct_16_5(22)_11442-11451.nxml.txt.nlp	25347345	SENT102	12	12	21	21	oxaliplatin	CXCL1	PA131285527	2919	0.871
NULL	Adolesc_Health_Med_Ther_2013_Aug_27_4_79-87.nxml.txt.nlp	24600298	SENT24	0	0	30	30	raltegravir	CD4		920	0.871
NULL	Drug_Healthc_Patient_Saf_2012_Nov_29_4_173-180.nxml.txt.nlp	23236256	SENT66	12	12	22	22	ziprasidone	FGA	PA451974	2243	0.871
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT75	13	13	19	19	gefitinib	AKT	PA131301952	207	0.871
NULL	Breast_Cancer_Res_2005_Apr_12_7(4)_R570-R579.nxml.txt.nlp	15987464	SENT8	10	10	36	36	gefitinib	EGFR	PA131301952	1956	0.871
NULL	Arch_Sex_Behav_2011_Apr_28_40(2)_273-279.nxml.txt.nlp	19330436	SENT161	6	6	0	0	methamphetamine	Men	PA450403	8178	0.871
NULL	Clinics_(Sao_Paulo)_2010_Aug_65(8)_803b-807.nxml.txt.nlp	20835559	SENT15	25	25	13	13	l-arginine	spatial	PA448478	219793	0.871
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jul_31_65(Pt_8)_o2057.nxml.txt.nlp	21583719	SENT57	25	25	14	14	ethanol	mol	PA448073	90527	0.871
NULL	J_Geriatr_Cardiol_2012_Sep_9(3)_305-317.nxml.txt.nlp	23097661	SENT239	33	33	19	19	darapladib	CCL5	PA165884699	6352	0.871
NULL	Am_J_Cardiovasc_Drugs_2013_Jun_20_13(5)_331-342.nxml.txt.nlp	23784266	SENT183	17	17	21	21	amiodarone	P-gp	PA448383	5243	0.871
NULL	Nucleic_Acids_Res_2012_Sep_28_40(17)_8440-8448.nxml.txt.nlp	22753029	SENT190	27	27	21	21	hydroxyurea	CHK1	PA449942	1111	0.871
NULL	Mol_Cancer_2010_Apr_21_9_83.nxml.txt.nlp	20409325	SENT191	10	10	3	3	paclitaxel	AKT2	PA450761	208	0.871
NULL	Leukemia_2014_Jun_25_28(6)_1280-1288.nxml.txt.nlp	24270737	SENT209	19	19	9	9	decitabine	CTLA4	PA164749631	1493	0.871
NULL	Oncotarget_2014_Oct_18_5(22)_11604-11619.nxml.txt.nlp	25344099	SENT231	4	4	13	13	cisplatin	RYBP	PA449014	23429	0.871
NULL	J_Cell_Mol_Med_2014_Jan_4_18(1)_104-114.nxml.txt.nlp	24188055	SENT75	21	21	10	10	hydrocortisone	CD34	PA449905	947	0.871
NULL	Pharmaceutics_2011_Nov_18_3(4)_865-913.nxml.txt.nlp	24309312	SENT1879	1	1	7	7	clarithromycin	CYP3A	PA449028	1574	0.871
NULL	Ann_Indian_Acad_Neurol_2011_Jan-Mar_14(1)_50-52.nxml.txt.nlp	21655207	SENT85	10	10	25	25	methylphenidate	KLS	PA450464	6199	0.871
NULL	Arthritis_Res_2001_Aug_2_3(5)_311-318.nxml.txt.nlp	11549373	SENT5	27	27	8	8	chloramphenicol	COL1A2	PA448927	1278	0.871
NULL	Breast_Cancer_Res_2012_Mar_15_14(2)_R47.nxml.txt.nlp	22420423	SENT133	7	7	18	18	doxorubicin	TP53	PA449412	7157	0.871
NULL	Cancer_Immunol_Immunother_2012_Jul_23_61(7)_1101-1111.nxml.txt.nlp	22193989	SENT126	4	4	8	8	oxaliplatin	TLR3	PA131285527	7098	0.871
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1137-1144.nxml.txt.nlp	20234366	SENT168	34	34	37	37	cetuximab	KRAS	PA10040	3845	0.871
NULL	Oncoscience_2014_Nov_15_1(11)_674-705.nxml.txt.nlp	25593996	SENT294	34	34	8	8	cisplatin	MCL1	PA449014	4170	0.871
NULL	Breast_Cancer_Res_2011_Jan_17_13(1)_R5.nxml.txt.nlp	21241485	SENT197	22	22	14	14	estradiol	Brn-3b	PA449503	5458	0.871
NULL	BMB_Rep_2014_Jul_47(7)_376-381.nxml.txt.nlp	24286332	SENT5	15	15	2	2	thrombin	PPG	PA451674	5552	0.871
NULL	Cancer_Manag_Res_2013_Jul_31_5_187-195.nxml.txt.nlp	23986650	SENT61	26	26	10	10	trastuzumab	CD44	PA451743	960	0.871
NULL	Eur_J_Clin_Microbiol_Infect_Dis_2012_Apr_29_31(4)_571-574.nxml.txt.nlp	21796345	SENT23	15	15	10	10	lamivudine	IFN	PA450163	3439	0.871
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT166	14	14	43	43	pertuzumab	HER2		2064	0.871
NULL	J_Cell_Biol_2002_Jun_10_157(6)_975-984.nxml.txt.nlp	12045187	SENT169	26	26	14	14	doxycycline	p53	PA449415	7157	0.871
NULL	Breast_Cancer_Res_Treat_2014_Sep_25_148(1)_81-90.nxml.txt.nlp	25253174	SENT180	31	31	16	16	metformin	AMPK	PA450395	5563	0.871
NULL	Brain_Sci_2012_Aug_20_2(3)_298-318.nxml.txt.nlp	24961196	SENT264	22	22	4	4	scopolamine	spatial	PA451308	219793	0.871
NULL	Indian_J_Endocrinol_Metab_2013_May-Jun_17(3)_413-421.nxml.txt.nlp	23869296	SENT6	9	9	28	28	exenatide	GLP-1	PA164749238	100125288	0.871
NULL	Exp_Ther_Med_2014_Oct_24_8(4)_1092-1096.nxml.txt.nlp	25187802	SENT73	6	6	14	14	carvedilol	Bcl-2	PA448817	596	0.871
NULL	Int_J_Alzheimers_Dis_2012_Feb_1_2012_109324.nxml.txt.nlp	22506129	SENT190	36	36	20	20	simvastatin	ZO-1	PA451363	7082	0.871
NULL	Ann_Saudi_Med_2011_May-Jun_31(3)_279-283.nxml.txt.nlp	21623058	SENT23	13	13	20	20	alemtuzumab	IL-2	PA164783958	3558	0.871
NULL	F1000_Med_Rep_2009_Dec_9_1_93.nxml.txt.nlp	20948684	SENT82	22	22	17	17	doxycycline	LAM	PA449415	7249;7248	0.871
NULL	J_Oncol_2011_Sep_15_2011_528353.nxml.txt.nlp	21941546	SENT337	28	28	22	22	genistein	COX	PA165109660	1351	0.871
NULL	Br_J_Pharmacol_2014_Jun_15_171(11)_2705-2725.nxml.txt.nlp	24467436	SENT82	6	6	1	1	hydralazine	NAT2	PA449894	10;81539	0.871
NULL	J_Cell_Biol_2003_Sep_29_162(7)_1197-1209.nxml.txt.nlp	14517203	SENT225	16	16	34	34	mimosine	NBS1	PA164752445	55655	0.871
NULL	Oncoimmunology_2013_Jul_1_2(7)_e24882.nxml.txt.nlp	24073370	SENT7	22	22	6	6	gemcitabine	BTC	PA449748	685	0.871
NULL	Fibrogenesis_Tissue_Repair_2011_Aug_2_4_18.nxml.txt.nlp	21810214	SENT240	7	7	2	2	bleomycin	IFN	PA448645	3439	0.871
NULL	Oncogenesis_2014_Dec_15_3(12)_e133.nxml.txt.nlp	25500906	SENT113	6	6	12	12	trastuzumab	PI3K	PA451743	5290	0.871
NULL	Oncotarget_2014_Jun_26_5(14)_5559-5569.nxml.txt.nlp	24980819	SENT99	32	32	40	40	vemurafenib	p53	PA165946873	7157	0.871
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_408-414.nxml.txt.nlp	21372831	SENT138	8	8	1	1	vincristine	CHOP	PA451879	1649	0.871
NULL	Nat_Med_2010_Nov_17_16(11)_1328-1332.nxml.txt.nlp	20953200	SENT40	4	4	18	18	fluoxetine	CA1	PA449673	759	0.871
NULL	J_Thromb_Haemost_2011_Oct_9(10)_2103-2105.nxml.txt.nlp	21812912	SENT71	12	12	21	21	ticagrelor	mol	PA165374673	90527	0.871
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT274	43	43	37	37	glucose	EGFR	PA449773	1956	0.871
NULL	Clin_Psychopharmacol_Neurosci_2013_Dec_24_11(3)_144-151.nxml.txt.nlp	24465251	SENT13	2	2	6	6	quetiapine	IL-4	PA451201	3565	0.871
NULL	J_Biomed_Biotechnol_2003_Apr_21_2003(2)_110-137.nxml.txt.nlp	12721516	SENT465	42	42	20	20	tamoxifen	E2F1	PA451581	1869	0.871
NULL	Br_J_Pharmacol_2008_Oct_18_155(4)_596-605.nxml.txt.nlp	18852694	SENT44	9	9	32	32	fenofibrate	SREBP2	PA449594	6721	0.871
NULL	Diabetes_2013_Mar_14_62(3)_811-824.nxml.txt.nlp	23209186	SENT328	33	33	13	13	bortezomib	JNK	PA10252	5599	0.871
NULL	Bioinformatics_2013_Jul_1_29(13)_i126-i134.nxml.txt.nlp	23812976	SENT287	29	29	25	25	mesalazine	gamma	PA450384	9913	0.871
NULL	J_Biol_Chem_2013_Jan_25_288(4)_2721-2733.nxml.txt.nlp	23209292	SENT123	30	30	23	23	heparin	FGF1	PA449855	2246	0.871
NULL	Diagn_Pathol_2014_Jan_23_9_19.nxml.txt.nlp	24457059	SENT138	5	5	12	12	erlotinib	EGFR	PA134687924	1956	0.871
NULL	Oncoimmunology_2013_Apr_1_2(4)_e23973.nxml.txt.nlp	23734333	SENT50	7	7	3	3	imiquimod	IL-2	PA449972	3558	0.871
NULL	Nat_Med_2010_Jun_23_16(6)_671-677.nxml.txt.nlp	20495567	SENT192	39	39	2	2	sorafenib	ANOVA	PA7000	4858	0.871
NULL	N_Am_J_Med_Sci_2012_Dec_4(12)_638-640.nxml.txt.nlp	23272306	SENT13	3	3	1	1	liraglutide	GLP-1	PA165958364	100125288	0.871
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1033-1038.nxml.txt.nlp	22374460	SENT187	14	14	4	4	capecitabine	HER2	PA448771	2064	0.871
NULL	Nat_Med_2010_Feb_24_16(2)_214-218.nxml.txt.nlp	20098429	SENT53	6	6	0	0	doxorubicin	YWHAZ	PA449412	7534	0.871
NULL	Exp_Diabetes_Res_2012_Mar_29_2012_916560.nxml.txt.nlp	22536216	SENT49	7	7	20	20	anakinra	IL-6	PA10799	3569	0.871
NULL	Behav_Neurol_2014_Nov_16_2014_360978.nxml.txt.nlp	25477708	SENT520	6	6	1	1	nicotine	CAD	PA450626	1677;790	0.871
NULL	J_Neuroinflammation_2011_Aug_5_8_91.nxml.txt.nlp	21819568	SENT175	22	22	35	35	pioglitazone	ANOVA	PA450970	4858	0.871
NULL	J_Cell_Mol_Med_2013_Oct_23_17(10)_1207-1217.nxml.txt.nlp	24106980	SENT149	13	13	40	40	paclitaxel	HIF-1	PA450761	29072	0.871
NULL	Endocrine_2012_Dec_14_42(3)_622-636.nxml.txt.nlp	22695986	SENT271	13	13	19	19	forskolin	PTH	PA146096022	5741	0.871
NULL	Oncologist_2010_Apr_15(4)_372-381.nxml.txt.nlp	20413642	SENT147	2	2	11	11	erlotinib	EGFR	PA134687924	1956	0.871
NULL	Br_J_Cancer_2013_Jul_23_109(2)_351-359.nxml.txt.nlp	23799854	SENT164	19	19	6	6	paclitaxel	BLT2	PA450761	56413	0.871
NULL	Eur_J_Clin_Pharmacol_2012_Jan_7_68(1)_55-64.nxml.txt.nlp	21735164	SENT40	5	5	2	2	oxycodone	CYP2D6	PA450741	1565	0.871
NULL	Breast_Cancer_Res_2011_Apr_21_13(2)_R46.nxml.txt.nlp	21510863	SENT263	20	20	8	8	trastuzumab	HER2	PA451743	2064	0.871
NULL	Pharmaceuticals_(Basel)_2013_Aug_2_6(8)_915-928.nxml.txt.nlp	24276376	SENT127	41	41	24	24	aspirin	CAD	PA448497	1677;790	0.871
NULL	Cancer_Manag_Res_2011_Aug_10_3_273-285.nxml.txt.nlp	21931501	SENT53	0	0	10	10	pazopanib	VEGFR2	PA165291492	3791	0.871
NULL	EMBO_Mol_Med_2012_Jul_11_4(7)_577-593.nxml.txt.nlp	22496117	SENT246	19	19	0	0	clofazimine	PAP-1	PA164748759	6100	0.871
NULL	Oncoimmunology_2012_Nov_1_1(8)_1376-1386.nxml.txt.nlp	23243601	SENT99	0	0	27	27	lenalidomide	IFN	PA162363968	3439	0.871
NULL	Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.nxml.txt.nlp	24736980	SENT9	11	11	25	25	rosuvastatin	OATP1B1	PA134308647	10599	0.871
NULL	Chemother_Res_Pract_2011_Dec_1_2011_715469.nxml.txt.nlp	22312557	SENT10	11	11	6	6	cisplatin	p53	PA449014	7157	0.871
NULL	Br_J_Cancer_2013_Jul_23_109(2)_433-443.nxml.txt.nlp	23807168	SENT101	2	2	13	13	bortezomib	ATF4	PA10252	468	0.871
NULL	J_Exp_Med_2000_Nov_20_192(10)_1403-1414.nxml.txt.nlp	11085743	SENT112	6	6	19	19	staurosporine	IL-3	PA165109623	3562	0.871
NULL	Psychiatry_Investig_2012_Jun_30_9(2)_187-190.nxml.txt.nlp	22707971	SENT89	14	14	7	7	capsaicin	POMC	PA448776	5443	0.871
NULL	Mol_Cancer_2006_Oct_17_5_45.nxml.txt.nlp	17044934	SENT142	3	3	9	9	resveratrol	COX		1351	0.871
NULL	J_Cell_Mol_Med_2014_Apr_20_18(4)_709-720.nxml.txt.nlp	24444314	SENT36	24	24	30	30	losartan	AMPK	PA450268	5563	0.871
NULL	Cancers_(Basel)_2011_Apr_1_3(2)_1844-1860.nxml.txt.nlp	24212785	SENT98	29	29	17	17	irinotecan	PTEN	PA450085	5728	0.871
NULL	Drug_Des_Devel_Ther_2014_Oct_14_8_1911-1922.nxml.txt.nlp	25342884	SENT107	25	25	28	28	toremifene	aromatase	PA451731	1588	0.871
NULL	eLife_2014_May_19_3_e02784.nxml.txt.nlp	24842878	SENT396	16	16	2	2	glutaraldehyde	SLY1	PA449777	23256	0.871
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT258	28	28	11	11	pp2	PP2		4888	0.871
NULL	Mol_Cells_2014_Nov_30_37(11)_804-811.nxml.txt.nlp	25410909	SENT111	3	3	6	6	thrombin	PAR-1	PA451674	2011;2149	0.871
NULL	Leukemia_2012_Sep_19_26(9)_2114-2123.nxml.txt.nlp	22425892	SENT182	4	4	19	19	bortezomib	AP-1	PA10252	2353;3727;2354;3725	0.871
NULL	Br_J_Haematol_2014_Mar_13_164(1)_811-821.nxml.txt.nlp	24328678	SENT129	30	30	45	45	lenalidomide	Aiolos	PA162363968	22806	0.871
NULL	J_Cell_Biol_1997_Jun_30_137(7)_1639-1649.nxml.txt.nlp	9199177	SENT160	9	9	28	28	paraformaldehyde	ZAP-70	PA450790	7535	0.871
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1137-1144.nxml.txt.nlp	20234366	SENT35	21	21	3	3	cetuximab	KRAS	PA10040	3845	0.871
NULL	J_Radiat_Res_2014_May_28_55(3)_432-442.nxml.txt.nlp	24375278	SENT189	9	9	15	15	metformin	AMPK	PA450395	5563	0.871
NULL	Pharmaceuticals_(Basel)_2012_Nov_20_5(11)_1236-1264.nxml.txt.nlp	24281308	SENT142	24	24	22	22	gefitinib	EGFR	PA131301952	1956	0.871
NULL	Neural_Dev_2010_Feb_1_5_5.nxml.txt.nlp	20122141	SENT180	19	19	24	24	picrotoxin	AP-5	PA164777007	91056	0.871
NULL	Oncol_Lett_2013_Mar_19_5(3)_923-928.nxml.txt.nlp	23426648	SENT181	12	12	0	0	sc-560	MVD		4597	0.871
NULL	Ann_Indian_Acad_Neurol_2014_Mar_17(Suppl_1)_S3-S11.nxml.txt.nlp	24791085	SENT215	11	11	27	27	levetiracetam	LOR	PA450206	4014	0.871
NULL	Nucleic_Acids_Res_2013_Dec_21_41(22)_10283-10297.nxml.txt.nlp	24005041	SENT38	27	27	10	10	camptothecin	HELQ	PA153590860	113510	0.871
NULL	Mol_Biol_Evol_2013_Dec_11_30(12)_2568-2578.nxml.txt.nlp	23938868	SENT198	12	12	7	7	galactose	CIT1	PA449725	53844	0.871
NULL	Clinics_(Sao_Paulo)_2013_May_68(5)_694-701.nxml.txt.nlp	23778405	SENT174	5	5	30	30	curcumin	P-gp	PA151958596	5243	0.871
NULL	Ann_Hematol_2014_Apr_1_93(8)_1371-1380.nxml.txt.nlp	24687382	SENT187	15	15	35	35	lenalidomide	MYC	PA162363968	4609	0.871
NULL	Mol_Cancer_2009_Dec_14_8_121.nxml.txt.nlp	20003443	SENT50	19	19	9	9	estradiol	aromatase	PA449503	1588	0.871
NULL	Adv_Ther_2014_Jul_2_31(7)_762-775.nxml.txt.nlp	24985411	SENT260	5	5	17	17	amlodipine	Xin	PA448388	165904	0.871
NULL	Front_Immunol_2012_Jan_24_3_3.nxml.txt.nlp	22566889	SENT1607	16	16	9	9	rituximab	Bcl-2	PA451261	596	0.871
NULL	Br_J_Cancer_2010_Sep_7_103(6)_796-801.nxml.txt.nlp	20823888	SENT34	7	7	32	32	erlotinib	AST	PA134687924	26503	0.871
NULL	Br_J_Cancer_2003_Mar_24_88(6)_848-854.nxml.txt.nlp	12644821	SENT21	26	26	21	21	cisplatin	TP53	PA449014	7157	0.871
NULL	Front_Oncol_2014_Mar_3_4_34.nxml.txt.nlp	24624361	SENT331	21	21	27	27	olaparib	BRCA2		675	0.871
NULL	Acta_Histochem_Cytochem_2011_Apr_28_44(2)_51-60.nxml.txt.nlp	21614166	SENT170	7	7	16	16	thalidomide	EMT	PA451644	3702;6581	0.871
NULL	J_Invest_Dermatol_2012_Oct_24_132(10)_2440-2450.nxml.txt.nlp	22622430	SENT98	9	9	2	2	temozolomide	IL-8	PA451609	3576	0.871
NULL	J_Cell_Mol_Med_2014_Dec_7_18(12)_2536-2552.nxml.txt.nlp	25287328	SENT174	13	13	3	3	estradiol	PKD1	PA449503	5310	0.871
NULL	Indian_J_Pharm_Sci_2008_May-Jun_70(3)_381-383.nxml.txt.nlp	20046753	SENT28	23	23	15	15	ethanol	mol	PA448073	90527	0.871
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1059-1066.nxml.txt.nlp	21364577	SENT120	17	17	4	4	anastrozole	ATAC	PA448432	6375	0.871
NULL	Br_J_Haematol_2014_Jan_28_164(2)_233-244.nxml.txt.nlp	24206017	SENT225	40	40	15	15	lenalidomide	CRBN	PA162363968	51185	0.871
NULL	Front_Mol_Neurosci_2015_Jan_6_7_99.nxml.txt.nlp	25610367	SENT720	13	13	0	0	ethanol	TLR4	PA448073	7099	0.871
NULL	Ann_Rheum_Dis_2011_Nov_25_71(5)_687-693.nxml.txt.nlp	22121130	SENT9	10	10	6	6	tocilizumab	IL-6	PA165292659	3569	0.871
NULL	Cell_Cycle_2012_Nov_1_11(21)_3983-3996.nxml.txt.nlp	22987153	SENT179	7	7	13	13	cisplatin	DNA2	PA449014	1763	0.871
NULL	Front_Oncol_2013_Apr_23_3_86.nxml.txt.nlp	23630663	SENT128	18	18	8	8	trastuzumab	MUC4	PA451743	4585	0.871
NULL	Br_J_Pharmacol_2010_Aug_160(8)_1997-2007.nxml.txt.nlp	20649597	SENT122	9	9	17	17	pp2	NOD1		10392	0.871
NULL	J_Oral_Pathol_Med_2013_Jul_18_42(6)_499-506.nxml.txt.nlp	23331485	SENT72	25	25	7	7	celecoxib	COX	PA448871	1351	0.871
NULL	Cell_Commun_Signal_2013_Nov_5_11_83.nxml.txt.nlp	24192293	SENT83	8	8	12	12	doxycycline	IL-6	PA449415	3569	0.871
NULL	Nucleic_Acids_Res_2012_Jul_5_40(13)_5988-6000.nxml.txt.nlp	22492511	SENT207	2	2	10	10	fulvestrant	CDK9	PA164747170	1025	0.871
NULL	Oncotarget_2012_Oct_20_3(10)_1236-1245.nxml.txt.nlp	23100449	SENT105	20	20	22	22	doxorubicin	NGAL	PA449412	3934	0.871
NULL	Adipocyte_2012_Oct_1_1(4)_256-258.nxml.txt.nlp	23700542	SENT41	4	4	6	6	rolipram	AMPK	PA153906323	5563	0.871
NULL	Mucosal_Immunol_2013_May_19_6(3)_498-510.nxml.txt.nlp	22990622	SENT68	11	11	31	31	dextran	CD11b	PA449261	3684	0.871
NULL	Trials_2012_Aug_3_13_130.nxml.txt.nlp	22862827	SENT80	7	7	5	5	aprepitant	NK-1	PA164747039	27087	0.871
NULL	Orphanet_J_Rare_Dis_2010_Nov_26_5_31.nxml.txt.nlp	21110857	SENT103	21	21	8	8	pregabalin	gamma	PA164754814	9913	0.871
NULL	Oncotarget_2012_Aug_9_3(8)_774-782.nxml.txt.nlp	22885298	SENT74	31	31	15	15	tetracycline	IDH1	PA451640	3417	0.871
NULL	Oncotarget_2013_Aug_24_4(10)_1618-1631.nxml.txt.nlp	24113128	SENT203	19	19	6	6	sorafenib	p53	PA7000	7157	0.871
NULL	Cancers_(Basel)_2011_Apr_1_3(2)_1844-1860.nxml.txt.nlp	24212785	SENT453	21	21	0	0	irinotecan	KRAS	PA450085	3845	0.871
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1063.nxml.txt.nlp	24556678	SENT9	3	3	5	5	thioridazine	c-FLIP	PA451666	8837	0.871
NULL	Breast_Cancer_Res_Treat_2015_Nov_27_149_31-39.nxml.txt.nlp	25428789	SENT200	8	8	12	12	olaparib	BRCA1		672	0.871
NULL	Br_J_Cancer_2010_Nov_2_103(11)_1671-1679.nxml.txt.nlp	21045835	SENT116	8	8	19	19	gemcitabine	CXCL12	PA449748	6387	0.871
NULL	Mol_Cancer_2010_Dec_2_9_309.nxml.txt.nlp	21122157	SENT197	22	22	16	16	paclitaxel	IL-6	PA450761	3569	0.871
NULL	Br_J_Cancer_2003_Mar_24_88(6)_822-827.nxml.txt.nlp	12644816	SENT62	12	12	8	8	thalidomide	PSA	PA451644	29968;9520;354	0.871
NULL	Int_J_Gen_Med_2013_Dec_27_7_43-47.nxml.txt.nlp	24403843	SENT78	6	6	25	25	roxithromycin	ACR	PA164750505	49	0.871
NULL	Patient_Prefer_Adherence_2014_Apr_8_8_463-471.nxml.txt.nlp	24748775	SENT154	2	2	18	18	denosumab	RANKL	PA166048634	8600	0.871
NULL	J_Carcinog_2014_Feb_20_13_4.nxml.txt.nlp	24737952	SENT56	19	19	8	8	trastuzumab	HER2	PA451743	2064	0.871
NULL	Oxid_Med_Cell_Longev_2010_Sep-Oct_3(5)_308-316.nxml.txt.nlp	21150336	SENT56	5	5	8	8	probucol	p53	PA451107	7157	0.871
NULL	Cancer_Microenviron_2009_Sep_26_2(Suppl_1)_19-204.nxml.txt.nlp	NULL	SENT2557	4	4	21	21	estradiol	ENL	PA449503	4298	0.871
NULL	Mol_Biol_Cell_2013_Jun_15_24(12)_1996-2007.nxml.txt.nlp	23637462	SENT305	10	10	41	41	phenol	TGN	PA450913	7038	0.871
NULL	Cardiovasc_Drugs_Ther_2011_Jun_12_25(3)_223-232.nxml.txt.nlp	21562974	SENT50	5	5	22	22	milrinone	AKT	PA164749171	207	0.871
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Jan_4_69(Pt_2)_o167-o168.nxml.txt.nlp	23424455	SENT82	18	18	7	7	ethanol	mol	PA448073	90527	0.871
NULL	Diabetes_2011_Mar_21_60(3)_757-765.nxml.txt.nlp	21282370	SENT173	1	1	13	13	isoproterenol	HSL	PA450121	3991	0.871
NULL	Breast_Cancer_Res_2006_Nov_6_8(6)_215.nxml.txt.nlp	17096862	SENT86	17	17	12	12	trastuzumab	HER2	PA451743	2064	0.871
NULL	Biol_Proced_Online_2003_Feb_17_5_43-52.nxml.txt.nlp	12734557	SENT177	10	10	13	13	bupivacaine	IFNA6	PA135057240	3443	0.871
NULL	Cancer_Res_Treat_2013_Sep_30_45(3)_178-185.nxml.txt.nlp	24155676	SENT110	26	26	10	10	gefitinib	EGFR	PA131301952	1956	0.871
NULL	Arthritis_Res_Ther_2003_Sep_3_5(6)_R317-R328.nxml.txt.nlp	14680506	SENT173	21	21	16	16	rolipram	IL-10	PA153906323	3586	0.871
NULL	J_Invest_Dermatol_2013_Jan_16_133(1)_164-171.nxml.txt.nlp	22895364	SENT26	0	0	11	11	ustekinumab	IL-23	PA166048654	51561	0.871
NULL	J_Res_Med_Sci_2012_Oct_17(10)_928-933.nxml.txt.nlp	23825991	SENT62	30	30	14	14	tretinoin	CO2	PA451746	4513	0.871
NULL	Biochem_Res_Int_2012_Aug_15_2012_940405.nxml.txt.nlp	22928112	SENT116	15	15	7	7	erlotinib	EGFR	PA134687924	1956	0.871
NULL	Blood_Res_2013_Jun_25_48(2)_160-163.nxml.txt.nlp	23826591	SENT62	0	0	13	13	heparin	PF4	PA449855	5196	0.871
NULL	Breast_Cancer_Res_2003_Oct_3_5(6)_R242-R249.nxml.txt.nlp	14580260	SENT78	25	25	2	2	tamoxifen	HER-2	PA451581	2064	0.871
NULL	Mediators_Inflamm_2000_9(1)_39-43.nxml.txt.nlp	10877454	SENT2	3	3	14	14	roxithromycin	CD40	PA164750505	958	0.871
NULL	J_Headache_Pain_2011_Aug_29_12(4)_411-417.nxml.txt.nlp	21626018	SENT86	7	7	27	27	naratriptan	mol	PA450597	90527	0.871
NULL	Breast_Cancer_Res_2007_Jul_5_9(4)_R41.nxml.txt.nlp	17612393	SENT129	0	0	8	8	celecoxib	PARP	PA448871	142	0.871
NULL	Acta_Pharmacol_Sin_2009_Oct_21_30(10)_1392-1398.nxml.txt.nlp	19767766	SENT12	0	0	16	16	atorvastatin	ROS	PA448500	6098	0.871
NULL	ScientificWorldJournal_2013_Oct_1_2013_523480.nxml.txt.nlp	24198723	SENT111	12	12	19	19	sertraline	Bcl-2	PA451333	596	0.871
NULL	Int_J_Nanomedicine_2012_May_7_7_2307-2314.nxml.txt.nlp	22661887	SENT99	16	16	6	6	gemcitabine	F10	PA449748	2159	0.871
NULL	Indian_J_Pharmacol_2008_Oct_40(Suppl_2)_S91-S97.nxml.txt.nlp	21593983	SENT299	0	0	2	2	piperaquine	CYP3A4	PA166104279	1576	0.871
NULL	EMBO_Mol_Med_2012_Jun_13_4(6)_515-527.nxml.txt.nlp	22416035	SENT223	29	29	1	1	olaparib	p53		7157	0.871
NULL	Pharmaceutics_2011_Oct_12_3(4)_680-705.nxml.txt.nlp	24309303	SENT96	10	10	33	33	metformin	OCT3	PA450395	5460;6581	0.871
NULL	Arthritis_Res_Ther_2005_Feb_17_7(Suppl_1)_P74.nxml.txt.nlp	NULL	SENT24	8	8	27	27	losartan	AT1	PA450268	9197;185	0.871
NULL	Oncogenesis_2014_Dec_15_3(12)_e133.nxml.txt.nlp	25500906	SENT118	25	25	18	18	trastuzumab	PI3K	PA451743	5290	0.871
NULL	Mol_Cancer_2010_Mar_2_9_46.nxml.txt.nlp	20196838	SENT38	2	2	23	23	irinotecan	NR1I2	PA450085	8856	0.871
NULL	Diabetes_2008_Sep_57(9)_2272-2279.nxml.txt.nlp	18519799	SENT130	7	7	0	0	rosiglitazone	PDP1	PA451283	403313;54704	0.871
NULL	Contemp_Oncol_(Pozn)_2012_Nov_20_16(5)_416-419.nxml.txt.nlp	23788920	SENT17	15	15	7	7	enoxaparin	CRT	PA449463	811	0.871
NULL	Anemia_2012_May_23_2012_265790.nxml.txt.nlp	22675615	SENT203	27	27	16	16	ethanol	FANCD2	PA448073	2177	0.871
NULL	Autophagy_2013_Mar_1_9(3)_317-327.nxml.txt.nlp	23242206	SENT108	17	17	7	7	chloroquine	LC3	PA448948	84557	0.871
NULL	Curr_Cardiol_Rev_2009_Aug_5(3)_166-176.nxml.txt.nlp	20676275	SENT197	9	9	19	19	loratadine	HERG	PA450266	3757	0.871
NULL	Scientifica_(Cairo)_2013_Feb_3_2013_125705.nxml.txt.nlp	24278766	SENT270	6	6	23	23	ritonavir	RANKL	PA451260	8600	0.871
NULL	J_Korean_Med_Sci_2007_Apr_30_22(2)_283-289.nxml.txt.nlp	17449938	SENT174	3	3	10	10	minoxidil	Bcl-2	PA450521	596	0.871
NULL	FEBS_Open_Bio_2013_Aug_17_3_352-356.nxml.txt.nlp	24251095	SENT181	12	12	0	0	hyaluronan	KIAA1199	PA165958431	57214	0.871
NULL	Cancer_Manag_Res_2013_Jun_7_5_91-101.nxml.txt.nlp	23785245	SENT149	24	24	9	9	gefitinib	HER3	PA131301952	2065	0.871
NULL	Mol_Cancer_2008_Nov_24_7_87.nxml.txt.nlp	19025616	SENT29	24	24	10	10	cyclophosphamide	ALDH3A1	PA449165	218	0.871
NULL	Oncotarget_2011_Oct_17_2(10)_797-809.nxml.txt.nlp	22006582	SENT85	16	16	34	34	paclitaxel	U87	PA450761	677775;641648	0.871
NULL	Acta_Pharmacol_Sin_2013_Jun_8_34(6)_830-836.nxml.txt.nlp	23564080	SENT20	2	2	23	23	simvastatin	HMGB1	PA451363	3146	0.871
NULL	Pharmaceuticals_(Basel)_2013_May_23_6(6)_689-699.nxml.txt.nlp	24276256	SENT101	4	4	21	21	nifedipine	PTB	PA450631	58155	0.871
NULL	Med_Sci_Monit_2012_May_1_18(5)_CR290-CR295.nxml.txt.nlp	22534708	SENT151	23	23	7	7	rosiglitazone	apelin	PA451283	8862	0.871
NULL	Mol_Biol_Cell_2012_Nov_1_23(21)_4212-4225.nxml.txt.nlp	22956765	SENT79	3	3	11	11	thrombin	SHP2	PA451674	5781	0.871
NULL	J_Adv_Pharm_Technol_Res_2010_Jan-Mar_1(1)_88-96.nxml.txt.nlp	22247836	SENT30	21	21	8	8	metronidazole	K15	PA450484	3866	0.871
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT396	6	6	16	16	risperidone	PRL	PA451257	5617	0.871
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT101	7	7	21	21	irinotecan	EGFR	PA450085	1956	0.871
NULL	Aging_Cell_2009_Apr_8(2)_113-127.nxml.txt.nlp	19239417	SENT50	14	14	2	2	resveratrol	AMPK		5563	0.871
NULL	Cancer_Med_2013_Feb_3_2(1)_11-20.nxml.txt.nlp	24133623	SENT291	4	4	26	26	fluorouracil	BRAF	PA128406956	673	0.871
NULL	Oncotarget_2014_Feb_13_5(3)_577-586.nxml.txt.nlp	24583697	SENT196	8	8	19	19	methotrexate	HMGB1	PA450428	3146	0.871
NULL	Oncol_Lett_2014_Nov_14_8(5)_2086-2092.nxml.txt.nlp	25295095	SENT7	22	22	1	1	gemcitabine	LKB1	PA449748	6794	0.871
NULL	Orphanet_J_Rare_Dis_2014_Aug_5_9_122.nxml.txt.nlp	25091295	SENT231	14	14	3	3	metyrapone	ACTH	PA450486	5443	0.871
NULL	Acta_Pharmacol_Sin_2013_Sep_5_34(9)_1192-1200.nxml.txt.nlp	23685957	SENT127	0	0	6	6	curcumin	Bcl-2	PA151958596	596	0.871
NULL	Mol_Clin_Oncol_2013_Sep_23_1(5)_869-874.nxml.txt.nlp	24649263	SENT4	17	17	13	13	gemcitabine	HAI	PA449748	6692;6768	0.871
NULL	Case_Rep_Surg_2012_Aug_5_2012_713148.nxml.txt.nlp	22919533	SENT30	18	18	22	22	scopolamine	OTC	PA451308	5009	0.871
NULL	J_Oncol_2012_Apr_23_2012_901956.nxml.txt.nlp	22619676	SENT160	20	20	22	22	docetaxel	eIF3a	PA449383	8661	0.871
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1709-1716.nxml.txt.nlp	19844235	SENT140	31	31	6	6	gemcitabine	B7-H3	PA449748	80381	0.871
NULL	Nat_Med_2014_Jun_11_20(6)_599-606.nxml.txt.nlp	24813251	SENT53	2	2	13	13	imatinib	ABL1	PA10804	25	0.871
NULL	Oncol_Lett_2013_Feb_9_5(2)_552-558.nxml.txt.nlp	23420128	SENT35	14	14	6	6	imatinib	KIT	PA10804	3815	0.871
NULL	Oncogenesis_2014_May_12_3(5)_e102.nxml.txt.nlp	24819061	SENT98	45	45	4	4	nadh	p53	PA164755085	7157	0.871
NULL	Endosc_Ultrasound_2013_Oct-Dec_2(4)_181-189.nxml.txt.nlp	24949393	SENT57	9	9	18	18	gemcitabine	CD11c	PA449748	3687	0.871
NULL	Clin_Psychopharmacol_Neurosci_2011_Apr_30_9(1)_36-43.nxml.txt.nlp	23431025	SENT95	34	34	25	25	sulpiride	NAC	PA164745485	22861	0.871
NULL	Diabetes_2013_May_16_62(5)_1697-1708.nxml.txt.nlp	23364453	SENT27	13	13	7	7	vildagliptin	GLP-1	PA165958346	100125288	0.871
NULL	Biomed_Res_Int_2013_Jun_6_2013_928271.nxml.txt.nlp	23841099	SENT19	8	8	2	2	ticagrelor	P2Y12	PA165374673	64805	0.871
NULL	Ayu_2012_Jan-Mar_33(1)_38-43.nxml.txt.nlp	23049182	SENT60	19	19	16	16	isoniazid	AKT	PA450112	207	0.871
NULL	Cancers_(Basel)_2010_Dec_30_3(1)_106-125.nxml.txt.nlp	24212609	SENT21	3	3	29	29	gemcitabine	SLC28A1	PA449748	9154	0.871
NULL	Breast_Cancer_Res_2013_Nov_29_15(6)_R114.nxml.txt.nlp	24289103	SENT188	16	16	4	4	tamoxifen	EGFR	PA451581	1956	0.871
NULL	Front_Oncol_2013_Nov_15_3_281.nxml.txt.nlp	24298448	SENT181	33	33	14	14	irinotecan	BRAF	PA450085	673	0.871
NULL	Cardiovasc_Ther_2009_27(4)_259-274.nxml.txt.nlp	19604248	SENT57	43	43	7	7	ticagrelor	P2Y12	PA165374673	64805	0.871
NULL	Pharmaceuticals_(Basel)_2012_Aug_10_5(8)_802-836.nxml.txt.nlp	24280676	SENT40	29	29	11	11	ribavirin	CNT3	PA451241	64078	0.871
NULL	Braz_J_Med_Biol_Res_2014_Jan_10_47(1)_60-69.nxml.txt.nlp	24519092	SENT229	14	14	25	25	gefitinib	REDD1	PA131301952	54541	0.871
NULL	J_Cell_Mol_Med_2013_Jan_11_17(1)_134-146.nxml.txt.nlp	23305490	SENT306	3	3	8	8	lidocaine	TASK-2	PA450226	8645	0.871
NULL	Curr_Cardiol_Rev_2009_Nov_5(4)_279-288.nxml.txt.nlp	21037845	SENT81	28	28	30	30	acetazolamide	CO2	PA448018	4513	0.871
NULL	J_Cell_Mol_Med_2013_Jan_10_17(1)_30-54.nxml.txt.nlp	23301832	SENT223	17	17	12	12	doxorubicin	PC3	PA449412	57332;7832;5122	0.871
NULL	EMBO_Mol_Med_2012_Jul_18_4(7)_557-560.nxml.txt.nlp	22610822	SENT20	38	38	8	8	resveratrol	SIRT1		23411	0.871
NULL	Acta_Pharmacol_Sin_2012_Oct_3_33(10)_1311-1318.nxml.txt.nlp	22941289	SENT17	18	18	10	10	sorafenib	VEGFR2	PA7000	3791	0.871
NULL	ACS_Appl_Mater_Interfaces_2013_Sep_11_5(17)_8537-8545.nxml.txt.nlp	23961698	SENT219	3	3	19	19	ketoprofen	NIP	PA450149	90527;10755	0.871
NULL	J_Korean_Med_Sci_2011_Feb_24_26(2)_301-303.nxml.txt.nlp	21286026	SENT52	3	3	1	1	vancomycin	DPT	PA451850	1805	0.871
NULL	J_Biol_Chem_2013_Dec_6_288(49)_35387-35395.nxml.txt.nlp	24142790	SENT157	39	39	5	5	meclizine	PCYT2	PA450338	5833	0.871
NULL	Anal_Chem_Insights_2007_Sep_17_2_69-74.nxml.txt.nlp	19662179	SENT30	2	2	19	19	chymotrypsin	San	PA448994	80218	0.871
NULL	Interdiscip_Toxicol_2011_Sep_4(3)_132-143.nxml.txt.nlp	22058654	SENT185	22	22	37	37	alprazolam	IL-2	PA448333	3558	0.871
NULL	Ann_Oncol_2011_May_3_22(5)_1078-1087.nxml.txt.nlp	21048039	SENT22	43	43	34	34	trastuzumab	ERBB2	PA451743	2064	0.871
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Jun_27_5_15.nxml.txt.nlp	16803618	SENT13	8	8	26	26	flucloxacillin	LTA	PA164781042	4049	0.871
NULL	J_Lipid_Res_2012_May_53(5)_1000-1011.nxml.txt.nlp	22368281	SENT127	22	22	16	16	atorvastatin	LPA	PA448500	4018	0.871
NULL	Allergy_Asthma_Clin_Immunol_2010_Jul_28_6(1)_20.nxml.txt.nlp	20667123	SENT53	0	0	17	17	icatibant	C1-INH	PA164749185	710	0.871
NULL	Environ_Health_Perspect_2005_Oct_14_113(10)_1330-1335.nxml.txt.nlp	16203242	SENT115	11	11	21	21	phenylephrine	MLC	PA450935	23209	0.871
NULL	Arthritis_Res_Ther_2008_Jan_7_10(1)_R1.nxml.txt.nlp	18179697	SENT184	34	34	24	24	oxaliplatin	IFN	PA131285527	3439	0.871
NULL	Breast_Cancer_Res_Treat_2013_Oct_12_142(1)_69-80.nxml.txt.nlp	24122389	SENT145	34	34	7	7	docetaxel	STEPP	PA449383	222659	0.871
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S279-S284.nxml.txt.nlp	21525469	SENT136	29	29	17	17	liraglutide	GLP-1	PA165958364	100125288	0.871
NULL	Case_Rep_Dermatol_2012_Mar_17_4(1)_56-60.nxml.txt.nlp	22548037	SENT57	15	15	24	24	cyclophosphamide	CHOP	PA449165	1649	0.871
NULL	Comp_Hepatol_2004_Jan_14_3(Suppl_1)_S31.nxml.txt.nlp	14960183	SENT36	19	19	7	7	ethanol	TNF-alpha	PA448073	7124	0.871
NULL	J_Cancer_2013_Nov_23_4(9)_736-754.nxml.txt.nlp	24312144	SENT222	9	9	12	12	sunitinib	VEGFR	PA162372840	3791	0.871
NULL	Cell_Commun_Signal_2011_May_20_9_14.nxml.txt.nlp	21599982	SENT19	14	14	20	20	pp2	JAK2		3717	0.871
NULL	Arthritis_Res_Ther_2011_Jul_13_13(4)_229.nxml.txt.nlp	21787439	SENT169	35	35	8	8	imatinib	IL-4	PA10804	3565	0.871
NULL	Cell_Res_2010_Apr_26_20(4)_434-444.nxml.txt.nlp	20101261	SENT187	12	12	3	3	rosiglitazone	FABP4	PA451283	2167	0.871
NULL	Diabetes_2009_Dec_31_58(12)_2851-2862.nxml.txt.nlp	19720788	SENT268	28	28	11	11	forskolin	CHOP	PA146096022	1649	0.871
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R91.nxml.txt.nlp	22541814	SENT115	4	4	6	6	thrombin	HO-1	PA451674	3162	0.871
NULL	J_Infect_Dis_2013_Aug_15_208(4)_637-644.nxml.txt.nlp	23633403	SENT45	24	24	29	29	heparin	LAMP	PA449855	4045;27074	0.871
NULL	J_Breast_Cancer_2011_Sep_29_14(3)_185-190.nxml.txt.nlp	22031799	SENT105	26	26	5	5	fulvestrant	EGFR	PA164747170	1956	0.871
NULL	Braz_J_Med_Biol_Res_2013_Aug_16_46(8)_708-714.nxml.txt.nlp	23969974	SENT154	7	7	11	11	alendronate	ANOVA	PA448082	4858	0.871
NULL	Int_J_Mol_Sci_2014_Oct_24_15(11)_19342-19354.nxml.txt.nlp	25347273	SENT40	15	15	5	5	dextran	PAG	PA449261	55824	0.871
NULL	Cancer_Cell_Int_2003_Jul_23_3_12.nxml.txt.nlp	12914669	SENT145	18	18	38	38	doxycycline	PP1	PA449415	5540;5464	0.871
NULL	Mol_Biol_Cell_2012_Nov_1_23(21)_4256-4272.nxml.txt.nlp	22973053	SENT439	18	18	40	40	thyroglobulin	B12	PA164754910	7126;4709	0.871
NULL	ARYA_Atheroscler_2011_Spring_7(1)_24-30.nxml.txt.nlp	22577441	SENT53	0	0	34	34	clopidogrel	DES	PA449053	1674	0.871
NULL	BioData_Min_2008_Jul_17_1_2.nxml.txt.nlp	18822146	SENT239	19	19	7	7	ethanol	MTHFR	PA448073	4524	0.871
NULL	J_Geriatr_Cardiol_2013_Jun_10(2)_198-201.nxml.txt.nlp	23888180	SENT35	37	37	20	20	tirofiban	LCX	PA451698	80312	0.871
NULL	eLife_2014_May_27_3_e02200.nxml.txt.nlp	24867637	SENT947	30	30	36	36	doxorubicin	p53	PA449412	7157	0.871
NULL	Acta_Pharmacol_Sin_2014_Jun_4_35(6)_752-757.nxml.txt.nlp	24902786	SENT11	2	2	23	23	flutamide	STZ	PA449685	6484	0.871
NULL	Iran_J_Pharm_Res_2013_Summer_12(3)_411-421.nxml.txt.nlp	24250648	SENT132	33	33	13	13	vanillin	ANOVA	PA451852	4858	0.871
NULL	Environ_Health_Perspect_2008_Mar_11_116(3)_297-302.nxml.txt.nlp	18335094	SENT141	0	0	12	12	permethrin	OTC	PA164743137	5009	0.871
NULL	Nat_Chem_Biol_2009_Jan_23_5(1)_37-44.nxml.txt.nlp	19029917	SENT55	4	4	44	44	piperazine	FAAH	PA450977	79152;2166	0.871
NULL	Daru_2011_19(2)_138-144.nxml.txt.nlp	22615650	SENT5	33	33	27	27	heparin	FGF20	PA449855	26281	0.871
NULL	Front_Physiol_2011_Jun_30_2_33.nxml.txt.nlp	21747769	SENT243	10	10	21	21	berberine	KCNQ1	PA165860812	3784	0.871
NULL	Biologics_2012_Dec_17_6_429-464.nxml.txt.nlp	23269860	SENT246	17	17	30	30	infliximab	ACR	PA452639	49	0.871
NULL	Int_J_Mol_Sci_2014_Sep_15_15(9)_16284-16301.nxml.txt.nlp	25226537	SENT4	7	7	34	34	curcumin	IPA	PA151958596	3160	0.871
NULL	N_Am_J_Med_Sci_2014_Sep_6(9)_481-483.nxml.txt.nlp	25317395	SENT40	27	27	16	16	protamine	ACT	PA10366	12;11332;9457;641455	0.871
NULL	Ann_Rheum_Dis_2009_Oct_17_68(10)_1580-1584.nxml.txt.nlp	19019888	SENT155	36	36	12	12	tocilizumab	IL-6	PA165292659	3569	0.871
NULL	Front_Neuroenergetics_2014_Jan_9_5_13.nxml.txt.nlp	24409143	SENT229	22	22	29	29	isoflurane	FDG	PA450106	23583	0.871
NULL	Curr_Neuropharmacol_2008_Jun_6(2)_151-163.nxml.txt.nlp	19305794	SENT139	10	10	3	3	capsaicin	TRPV1	PA448776	7442	0.871
NULL	Nat_Chem_Biol_2010_Apr_28_6(4)_291-299.nxml.txt.nlp	20190765	SENT134	0	0	2	2	dasatinib	AKT	PA162372878	207	0.871
NULL	Br_J_Cancer_2010_Jul_13_103(2)_265-274.nxml.txt.nlp	20551953	SENT215	10	10	22	22	cisplatin	JNK	PA449014	5599	0.871
NULL	Oncotarget_2014_Oct_18_5(22)_11604-11619.nxml.txt.nlp	25344099	SENT176	18	18	9	9	cisplatin	RYBP	PA449014	23429	0.871
NULL	Br_J_Haematol_2009_Feb_144(3)_367-375.nxml.txt.nlp	19036078	SENT69	21	21	19	19	cyclophosphamide	CHOP	PA449165	1649	0.871
NULL	J_Gynecol_Oncol_2013_Jul_4_24(3)_273-279.nxml.txt.nlp	23875078	SENT118	9	9	17	17	paclitaxel	P-gp	PA450761	5243	0.871
NULL	Ther_Clin_Risk_Manag_2006_Jun_2(2)_187-192.nxml.txt.nlp	18360592	SENT49	26	26	30	30	haloperidol	5-HT2A	PA449841	3356	0.871
NULL	Leukemia_2014_Jun_25_28(6)_1280-1288.nxml.txt.nlp	24270737	SENT210	17	17	5	5	decitabine	PD-L1	PA164749631	29126	0.871
NULL	J_Exp_Clin_Cancer_Res_2009_Feb_15_28(1)_19.nxml.txt.nlp	19216799	SENT129	7	7	3	3	cisplatin	AEG-1	PA449014	92140	0.871
NULL	Breast_Cancer_Res_2011_Mar_1_13(2)_R21.nxml.txt.nlp	21362200	SENT216	2	2	8	8	fulvestrant	PI3K	PA164747170	5290	0.871
NULL	Clinics_(Sao_Paulo)_2011_Dec_66(12)_2121-2124.nxml.txt.nlp	22189739	SENT13	12	12	41	41	curcumin	p53	PA151958596	7157	0.871
NULL	Behav_Brain_Funct_2010_Aug_30_6_50.nxml.txt.nlp	20799992	SENT23	19	19	0	0	amphetamine	ADORA2A	PA448408	135	0.871
NULL	Br_J_Dermatol_2009_Feb_160(2)_438-441.nxml.txt.nlp	19016697	SENT107	24	24	8	8	methotrexate	FPGS	PA450428	2356	0.871
NULL	Int_J_Mol_Sci_2014_Sep_15_15(9)_16284-16301.nxml.txt.nlp	25226537	SENT308	13	13	20	20	cyclophosphamide	HER-2	PA449165	2064	0.871
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1066.nxml.txt.nlp	24556681	SENT215	27	27	7	7	ethanol	ATG5	PA448073	9474	0.871
NULL	Oncol_Rep_2013_Apr_5_29(4)_1671-1677.nxml.txt.nlp	23404329	SENT156	11	11	0	0	aspirin	MIA	PA448497	8190	0.871
NULL	Diabetes_Metab_Syndr_Obes_2014_May_23_7_169-183.nxml.txt.nlp	24920930	SENT112	0	0	11	11	prasugrel	P2Y12	PA154410481	64805	0.871
NULL	Osteoarthritis_Cartilage_2013_Sep_21(9)_1336-1345.nxml.txt.nlp	23973148	SENT185	13	13	5	5	diclofenac	MIA	PA449293	8190	0.871
NULL	Osteoporos_Int_2013_Jan_24_24(1)_219-226.nxml.txt.nlp	23093347	SENT52	0	0	21	21	teriparatide	PTH	PA451620	5741	0.871
NULL	EMBO_Mol_Med_2012_Jun_13_4(6)_515-527.nxml.txt.nlp	22416035	SENT44	19	19	14	14	olaparib	p53		7157	0.871
NULL	J_Hematol_Oncol_2011_Jan_21_4_5.nxml.txt.nlp	21255411	SENT235	12	12	20	20	gefitinib	EGFR	PA131301952	1956	0.871
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT265	13	13	15	15	lapatinib	HER3	PA152241907	2065	0.871
NULL	Arthritis_Res_Ther_2005_May_18_7(Suppl_3)_S19-S25.nxml.txt.nlp	15960818	SENT12	26	26	24	24	cyclophosphamide	CHOP	PA449165	1649	0.871
NULL	Environ_Health_Perspect_2007_Jul_5_115(7)_1094-1100.nxml.txt.nlp	17637928	SENT185	4	4	18	18	etoposide	Bcl-2	PA449552	596	0.871
NULL	Indian_J_Pharm_Sci_2008_Jan-Feb_70(1)_105-108.nxml.txt.nlp	20390093	SENT23	22	22	25	25	isoniazid	mol	PA450112	90527	0.871
NULL	Acta_Pharmacol_Sin_2012_Jan_28_33(1)_75-81.nxml.txt.nlp	22120969	SENT94	12	12	17	17	sitagliptin	GLP-1	PA164748978	100125288	0.871
NULL	Breast_Cancer_Res_Treat_2012_Apr_25_132(3)_1049-1062.nxml.txt.nlp	22198468	SENT98	17	17	3	3	trastuzumab	HER2	PA451743	2064	0.871
NULL	Cancer_Immunol_Immunother_2012_Jul_24_61(7)_1113-1124.nxml.txt.nlp	22198309	SENT211	10	10	4	4	imatinib	KIT	PA10804	3815	0.871
NULL	J_Cell_Sci_2013_Nov_15_126(22)_5259-5270.nxml.txt.nlp	24006262	SENT355	15	15	0	0	hyaluronan	LYVE-1	PA165958431	10894	0.871
NULL	Antimicrob_Agents_Chemother_2014_Aug_58(8)_4971-4973.nxml.txt.nlp	24913169	SENT91	13	13	19	19	artesunate	G6PD	PA165111697	2539	0.871
NULL	Br_J_Cancer_1996_Jul_74(1)_63-68.nxml.txt.nlp	8679460	SENT13	34	34	14	14	doxorubicin	p53	PA449412	7157	0.871
NULL	Breast_Cancer_Res_2011_Dec_8_13(6)_R126.nxml.txt.nlp	22151962	SENT240	13	13	34	34	doxorubicin	CT26	PA449412	168400	0.871
NULL	Cardiovasc_Diabetol_2007_Apr_3_6_12.nxml.txt.nlp	17407587	SENT34	9	9	16	16	telmisartan	gamma	PA451605	9913	0.871
NULL	Ther_Clin_Risk_Manag_2006_Jun_2(2)_129-158.nxml.txt.nlp	18360588	SENT216	3	3	5	5	voriconazole	CYP3A4	PA10233	1576	0.871
NULL	J_Cell_Sci_2011_Oct_1_124(19)_3344-3355.nxml.txt.nlp	21940797	SENT215	27	27	7	7	arsenite	PABP4	PA452638	728773	0.871
NULL	ScientificWorldJournal_2013_Nov_5_2013_383574.nxml.txt.nlp	24298214	SENT132	4	4	20	20	genistein	TIC	PA165109660	23550	0.871
NULL	Iran_J_Pharm_Res_2014_Summer_13(3)_919-926.nxml.txt.nlp	25276192	SENT12	20	20	7	7	doxorubicin	p53	PA449412	7157	0.871
NULL	Clin_Dev_Immunol_2011_Dec_27_2011_814943.nxml.txt.nlp	21234341	SENT142	30	30	2	2	oxygen	IFN	PA450744	3439	0.871
NULL	Oxid_Med_Cell_Longev_2012_Jun_3_2012_914273.nxml.txt.nlp	22701758	SENT235	7	7	21	21	resveratrol	IFN		3439	0.871
NULL	Oncotarget_2012_Nov_17_4(1)_18-28.nxml.txt.nlp	23248157	SENT144	10	10	33	33	pargyline	p53	PA450797	7157	0.871
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1137-1144.nxml.txt.nlp	20234366	SENT171	21	21	12	12	irinotecan	KRAS	PA450085	3845	0.871
NULL	Arthritis_Res_Ther_2009_Aug_28_11(4)_R131.nxml.txt.nlp	19715572	SENT98	6	6	11	11	rituximab	CD19	PA451261	930	0.871
NULL	Br_J_Cancer_2013_Dec_10_109(12)_3067-3072.nxml.txt.nlp	24263065	SENT38	25	25	10	10	cetuximab	KRAS	PA10040	3845	0.871
NULL	Crit_Care_2011_May_30_15(3)_R132.nxml.txt.nlp	21624138	SENT118	12	12	9	9	dobutamine	CTRL	PA449381	1506	0.871
NULL	Int_J_Mol_Sci_2012_Sep_26_13(10)_12268-12286.nxml.txt.nlp	23202898	SENT183	10	10	12	12	trastuzumab	AMPK	PA451743	5563	0.871
NULL	Front_Oncol_2014_Apr_8_4_71.nxml.txt.nlp	24782983	SENT208	28	28	19	19	carboplatin	HOXA10	PA448803	3206	0.871
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S202-S209.nxml.txt.nlp	21525456	SENT119	4	4	17	17	rosiglitazone	DREAM	PA451283	30818	0.871
NULL	Exp_Ther_Med_2013_Nov_13_6(5)_1317-1321.nxml.txt.nlp	24223665	SENT24	24	24	18	18	cisplatin	CD133	PA449014	8842	0.871
NULL	Case_Rep_Med_2014_May_4_2014_964082.nxml.txt.nlp	24876846	SENT111	10	10	12	12	bortezomib	BOR	PA10252	55143	0.871
NULL	Genome_Biol_2005_Jul_29_6(8)_228.nxml.txt.nlp	16086858	SENT45	23	23	5	5	daunorubicin	CBR1	PA449212	873	0.871
NULL	Drugs_R_D_2011_Jun_27_11(2)_113-126.nxml.txt.nlp	21679004	SENT39	35	35	48	48	temsirolimus	IFN	PA164746890	3439	0.871
NULL	Int_J_Biomed_Sci_2007_Sep_3(3)_176-184.nxml.txt.nlp	23675041	SENT115	0	0	3	3	cisplatin	Bcl-2	PA449014	596	0.871
NULL	Curr_Neuropharmacol_2013_May_11(3)_263-275.nxml.txt.nlp	24179463	SENT140	3	3	6	6	fluoxetine	CB1	PA449673	1268	0.871
NULL	Anesth_Essays_Res_2010_Jul-Dec_4(2)_96-101.nxml.txt.nlp	NULL	SENT58	15	15	18	18	heparin	ACT	PA449855	12;11332;9457;641455	0.871
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT1673	26	26	30	30	diazepam	CYP3A4	PA449283	1576	0.871
NULL	Gastric_Cancer_2014_Apr_7_17(1)_1-12.nxml.txt.nlp	23563986	SENT56	22	22	18	18	trastuzumab	HER2	PA451743	2064	0.871
NULL	Pak_J_Med_Sci_2013_Nov-Dec_29(6)_1459-1461.nxml.txt.nlp	24550976	SENT55	0	0	6	6	heparin	ACT	PA449855	12;11332;9457;641455	0.871
NULL	Viruses_2014_Feb_18_6(2)_875-892.nxml.txt.nlp	24553110	SENT127	6	6	12	12	erlotinib	CD81	PA134687924	975	0.871
NULL	Oncol_Lett_2015_Jan_4_9(1)_91-95.nxml.txt.nlp	25435939	SENT73	16	16	8	8	mitomycin	NACT	PA450524	284111	0.871
NULL	J_Biomed_Sci_2012_Nov_21_19(1)_99.nxml.txt.nlp	23170833	SENT164	16	16	9	9	atorvastatin	CXCR4	PA448500	7852	0.871
NULL	Cell_Commun_Signal_2009_Aug_13_7_19.nxml.txt.nlp	19678929	SENT90	10	10	3	3	cetuximab	EGFR	PA10040	1956	0.87
NULL	Onco_Targets_Ther_2014_Mar_20_7_457-467.nxml.txt.nlp	24672248	SENT99	15	15	8	8	everolimus	PIK3CA	PA164746311	5290	0.87
NULL	Mol_Cancer_2010_Aug_20_9_220.nxml.txt.nlp	20727180	SENT110	35	35	32	32	nicotine	AP-1	PA450626	2353;3727;2354;3725	0.87
NULL	Lab_Anim_Res_2013_Jun_24_29(2)_84-95.nxml.txt.nlp	23825481	SENT8	0	0	13	13	nifedipine	INS-1	PA450631	2305	0.87
NULL	Cell_Death_Dis_2010_Nov_18_1(11)_e102.nxml.txt.nlp	21368867	SENT156	8	8	5	5	gentamicin	14-3-3	PA449753	10971	0.87
NULL	J_Hematol_Oncol_2013_Jul_9_6_49.nxml.txt.nlp	23837843	SENT83	8	8	0	0	verapamil	P-gp	PA451868	5243	0.87
NULL	Hum_Genomics_2010_Apr_1_4(4)_238-249.nxml.txt.nlp	20511137	SENT114	10	10	17	17	irinotecan	UGT1A1	PA450085	54658	0.87
NULL	Oncotarget_2014_Oct_31_5(20)_9756-9769.nxml.txt.nlp	25230151	SENT147	2	2	23	23	glutaraldehyde	p53	PA449777	7157	0.87
NULL	Cancer_Cell_Int_2014_Jun_11_14_49.nxml.txt.nlp	24991192	SENT130	16	16	5	5	berberine	AMPK	PA165860812	5563	0.87
NULL	Biol_Open_2014_Jul_25_3(8)_741-758.nxml.txt.nlp	25063196	SENT278	4	4	11	11	ethanol	CD24	PA448073	100133941	0.87
NULL	Adv_Biol_Regul_2014_Jan_19_0_197-206.nxml.txt.nlp	24103483	SENT53	37	37	12	12	lipase	PLD2	PA450239	5338	0.87
NULL	Arthritis_Res_Ther_2008_Nov_25_10(6)_R137.nxml.txt.nlp	19032782	SENT57	10	10	14	14	isoflurane	CO2	PA450106	4513	0.87
NULL	EMBO_Mol_Med_2013_Dec_8_5(12)_1821-1834.nxml.txt.nlp	24293316	SENT119	9	9	29	29	doxorubicin	UNC5B	PA449412	219699	0.87
NULL	Br_J_Cancer_2012_Apr_10_106(8)_1406-1414.nxml.txt.nlp	22491422	SENT5	34	34	15	15	cetuximab	EGFR	PA10040	1956	0.87
NULL	Cancer_Cell_Int_2013_Jan_15_13_3.nxml.txt.nlp	23320839	SENT15	2	2	15	15	gemcitabine	MRP3	PA449748	8714	0.87
NULL	Open_Biochem_J_2011_Sep_23_5_45-51.nxml.txt.nlp	21966325	SENT6	3	3	15	15	indomethacin	ATF6	PA449982	22926	0.87
NULL	Oncol_Lett_2013_Dec_4_6(6)_1665-1672.nxml.txt.nlp	24273604	SENT94	2	2	21	21	chloroquine	TLR9	PA448948	54106	0.87
NULL	Exp_Ther_Med_2013_Mar_24_5(3)_902-906.nxml.txt.nlp	23408108	SENT104	22	22	6	6	anastrozole	aromatase	PA448432	1588	0.87
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT107	4	4	19	19	chloroquine	BMPR-II	PA448948	659	0.87
NULL	Int_J_Biol_Sci_2014_Jun_10_10(7)_654-663.nxml.txt.nlp	25013375	SENT111	31	31	28	28	nelfinavir	AKT	PA450606	207	0.87
NULL	J_Cereb_Blood_Flow_Metab_2012_Apr_4_32(4)_731-744.nxml.txt.nlp	22214903	SENT119	36	36	2	2	flumazenil	ANOVA	PA449659	4858	0.87
NULL	Toxins_(Basel)_2010_Oct_26_2(11)_2490-2518.nxml.txt.nlp	22069563	SENT118	30	30	13	13	cisplatin	p53	PA449014	7157	0.87
NULL	Acta_Pharmacol_Sin_2012_Dec_29_33(12)_1518-1524.nxml.txt.nlp	23103625	SENT108	15	15	3	3	telmisartan	ACE2	PA451605	59272	0.87
NULL	Cell_Cycle_2012_Dec_15_11(24)_4499-4506.nxml.txt.nlp	23114620	SENT96	4	4	41	41	choline	LPA	PA448976	4018	0.87
NULL	Acta_Pharmacol_Sin_2012_Jul_18_33(7)_861-872.nxml.txt.nlp	22705730	SENT206	4	4	11	11	atorvastatin	4E-BP1	PA448500	1978	0.87
NULL	Nucleic_Acids_Res_2012_Apr_18_40(8)_e59.nxml.txt.nlp	22259038	SENT218	7	7	14	14	erythromycin	L28	PA449493	6158	0.87
NULL	Cancers_(Basel)_2014_Nov_14_6(4)_2275-2295.nxml.txt.nlp	25405526	SENT204	22	22	16	16	etoposide	CHOP	PA449552	1649	0.87
NULL	Cancers_(Basel)_2011_May_18_3(2)_2444-2461.nxml.txt.nlp	24212818	SENT105	15	15	5	5	erlotinib	IGF1R	PA134687924	3480	0.87
NULL	Evid_Based_Complement_Alternat_Med_2014_Jul_20_2014_821569.nxml.txt.nlp	25140189	SENT243	25	25	34	34	metformin	AMPK	PA450395	5563	0.87
NULL	Cancers_(Basel)_2011_Apr_19_3(2)_2106-2130.nxml.txt.nlp	24212798	SENT166	43	43	35	35	mitoxantrone	ABCG2	PA450526	9429	0.87
NULL	Springerplus_2014_Sep_9_3_510.nxml.txt.nlp	25279302	SENT44	2	2	14	14	creatine	CKM	PA164778930	1158	0.87
NULL	Chin_J_Cancer_2011_Oct_30(10)_731-738.nxml.txt.nlp	21959050	SENT76	35	35	29	29	doxorubicin	CHOP	PA449412	1649	0.87
NULL	Breast_Cancer_Res_2012_Jun_14_14(3)_R95.nxml.txt.nlp	22697792	SENT167	30	30	2	2	doxorubicin	ADP	PA449412	23038	0.87
NULL	Int_J_Inflam_2010_Nov_25_2010_910283.nxml.txt.nlp	21151692	SENT135	17	17	0	0	chymotrypsin	HD-5	PA448994	1670	0.87
NULL	F1000_Med_Rep_2009_Dec_9_1_94.nxml.txt.nlp	20948683	SENT52	22	22	8	8	pazopanib	VEGFR	PA165291492	3791	0.87
NULL	J_Mol_Med_2008_Sep_4_86(9)_1045-1056.nxml.txt.nlp	18600309	SENT256	2	2	17	17	salmeterol	CXCR1	PA451300	3577	0.87
NULL	Indian_J_Pharm_Sci_2014_Jan-Feb_76(1)_72-77.nxml.txt.nlp	24799741	SENT117	23	23	8	8	cimetidine	CYP2C9	PA449001	1559	0.87
NULL	Br_J_Cancer_2014_Jan_21_110(2)_510-519.nxml.txt.nlp	24327015	SENT218	23	23	16	16	cisplatin	NDC80	PA449014	10403	0.87
NULL	Case_Rep_Oncol_2014_Feb_27_7(1)_132-138.nxml.txt.nlp	24707261	SENT70	29	29	40	40	trabectedin	FDG	PA165958349	23583	0.87
NULL	Drug_Target_Insights_2006_Oct_23_1_5-10.nxml.txt.nlp	21901053	SENT124	6	6	1	1	thrombin	INCA	PA451674	440068	0.87
NULL	Semin_Immunopathol_2010_Dec_30_32(4)_383-396.nxml.txt.nlp	20589500	SENT80	29	29	12	12	l-glutamine	SLC1A5	PA10090	6510	0.87
NULL	eLife_2014_Aug_1_3_e02725.nxml.txt.nlp	25085081	SENT750	30	30	9	9	irinotecan	KRAS	PA450085	3845	0.87
NULL	Brain_Sci_2014_May_6_4(2)_356-375.nxml.txt.nlp	24961766	SENT490	1	1	6	6	propofol	p75	PA451141	7133;11168	0.87
NULL	J_Hematol_Oncol_2013_Apr_27_6_31.nxml.txt.nlp	23622716	SENT96	21	21	3	3	bevacizumab	CD31	PA130232992	5175	0.87
NULL	Ann_Hematol_2010_Sep_13_89(9)_861-871.nxml.txt.nlp	20387067	SENT138	3	3	12	12	dasatinib	CD34	PA162372878	947	0.87
NULL	Exp_Transl_Stroke_Med_2011_Dec_16_3_16.nxml.txt.nlp	22177314	SENT41	0	0	2	2	minocycline	PARP-1	PA450519	25976	0.87
NULL	AAPS_J_2011_Jun_1_13(3)_405-416.nxml.txt.nlp	21630127	SENT252	43	43	20	20	tocilizumab	CYP2C19	PA165292659	1557	0.87
NULL	J_Thromb_Haemost_2010_Mar_8(3)_577-587.nxml.txt.nlp	20040043	SENT164	23	23	26	26	indomethacin	mol	PA449982	90527	0.87
NULL	F1000Prime_Rep_2014_Dec_1_6_117.nxml.txt.nlp	25580271	SENT66	19	19	22	22	pemetrexed	EGFR	PA10810	1956	0.87
NULL	Indian_J_Pharmacol_2012_Sep-Oct_44(5)_624-628.nxml.txt.nlp	23112426	SENT28	8	8	14	14	pravastatin	CYP3A	PA451089	1574	0.87
NULL	Can_J_Infect_Dis_Med_Microbiol_2014_Nov-Dec_25(6)_327-343.nxml.txt.nlp	25587296	SENT301	16	16	3	3	everolimus	CYP3A4	PA164746311	1576	0.87
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1554-1562.nxml.txt.nlp	21970876	SENT137	3	3	14	14	gemcitabine	EGFR	PA449748	1956	0.87
NULL	J_Oncol_2010_Jun_6_2010_921682.nxml.txt.nlp	20628483	SENT92	0	0	6	6	axitinib	VEGFR	PA164924493	3791	0.87
NULL	Mol_Vis_2007_Jul_12_13_1130-1137.nxml.txt.nlp	17653058	SENT168	7	7	41	41	isoflurane	IL-6	PA450106	3569	0.87
NULL	Semin_Immunopathol_2013_Jun_4_35(5)_601-612.nxml.txt.nlp	23732506	SENT52	12	12	16	16	ganciclovir	CD11b	PA449733	3684	0.87
NULL	EMBO_Mol_Med_2014_Oct_17_6(10)_1294-1311.nxml.txt.nlp	25231413	SENT146	17	17	23	23	calcein	CD4	PA132595336	920	0.87
NULL	Front_Pharmacol_2014_Nov_26_5_258.nxml.txt.nlp	25505415	SENT35	24	24	45	45	metoprolol	CYP2D6	PA450480	1565	0.87
NULL	Cancers_(Basel)_2014_Mar_25_6(2)_684-707.nxml.txt.nlp	24670368	SENT1031	4	4	10	10	lapatinib	HER2	PA152241907	2064	0.87
NULL	Saudi_J_Anaesth_2013_Jan-Mar_7(1)_68-74.nxml.txt.nlp	23717236	SENT148	3	3	27	27	granisetron	5-HT4	PA449809	3360	0.87
NULL	Mol_Cancer_2010_May_18_9_110.nxml.txt.nlp	20482802	SENT152	29	29	20	20	bortezomib	p53	PA10252	7157	0.87
NULL	BMB_Rep_2014_Apr_47(4)_221-226.nxml.txt.nlp	24286312	SENT5	0	0	3	3	nutlin-3	MDM2		4193	0.87
NULL	Br_J_Cancer_2012_Nov_20_107(11)_1815-1819.nxml.txt.nlp	23099804	SENT96	5	5	13	13	letrozole	aromatase	PA450196	1588	0.87
NULL	Evid_Based_Complement_Alternat_Med_2014_Jul_20_2014_821569.nxml.txt.nlp	25140189	SENT243	25	25	4	4	metformin	AMPK	PA450395	5563	0.87
NULL	Cancers_(Basel)_2010_Jan_14_2(1)_1-19.nxml.txt.nlp	24281029	SENT1030	4	4	26	26	neratinib	San	PA165291472	80218	0.87
NULL	Arthritis_Res_Ther_2007_Oct_10_9(5)_R105.nxml.txt.nlp	17927818	SENT50	43	43	17	17	pp2	PP2		4888	0.87
NULL	Curr_Neuropharmacol_2007_Dec_5(4)_232-243.nxml.txt.nlp	19305740	SENT182	24	24	4	4	minocycline	IL-6	PA450519	3569	0.87
NULL	Indian_J_Med_Res_2012_Aug_136(2)_249-259.nxml.txt.nlp	22960892	SENT35	15	15	8	8	irinotecan	UGT1A1	PA450085	54658	0.87
NULL	Cell_Death_Dis_2014_Mar_13_5(3)_e1113.nxml.txt.nlp	24625972	SENT337	18	18	26	26	bleomycin	BI-1	PA448645	7009	0.87
NULL	Exp_Hematol_Oncol_2012_Sep_6_1_26.nxml.txt.nlp	23210433	SENT101	26	26	16	16	eculizumab	BCS	PA164776637	617	0.87
NULL	Clin_Ophthalmol_2014_Mar_2_8_343-346.nxml.txt.nlp	24591809	SENT110	10	10	18	18	ranibizumab	PED	PA164746012	8682	0.87
NULL	Int_J_Biol_Sci_2011_May_24_7(5)_673-684.nxml.txt.nlp	21647250	SENT200	5	5	7	7	berberine	AMPK	PA165860812	5563	0.87
NULL	Front_Immunol_2013_Nov_8_4_363.nxml.txt.nlp	24265631	SENT255	13	13	23	23	temozolomide	CXCL9	PA451609	4283	0.87
NULL	F1000_Biol_Rep_2009_Mar_24_1_23.nxml.txt.nlp	20948663	SENT49	19	19	7	7	citalopram	ABCB1	PA449015	5243	0.87
NULL	Br_J_Cancer_2013_Oct_15_109(8)_2248-2258.nxml.txt.nlp	24045665	SENT92	29	29	13	13	paraformaldehyde	CO2	PA450790	4513	0.87
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT147	12	12	8	8	sitagliptin	HIP	PA164748978	6767;6159;64399;5068	0.87
NULL	Cancer_Inform_2014_Oct_14_13(Suppl_1)_103-111.nxml.txt.nlp	25392688	SENT225	23	23	29	29	domperidone	CYP3A4	PA134711056	1576	0.87
NULL	J_Parasitol_Res_2010_Dec_29_2010_716498.nxml.txt.nlp	21253549	SENT94	10	10	22	22	hydroquinone	Hsp90	PA449924	3320	0.87
NULL	Adv_Biomed_Res_2012_Jul_6_1_21.nxml.txt.nlp	23210080	SENT25	3	3	12	12	trastuzumab	HER-2	PA451743	2064	0.87
NULL	Oncotarget_2014_Feb_27_5(5)_1315-1325.nxml.txt.nlp	24675476	SENT162	25	25	13	13	choline	PEMT	PA448976	10400	0.87
NULL	Case_Rep_Pathol_2014_Jul_15_2014_313974.nxml.txt.nlp	25133003	SENT66	15	15	6	6	thyroglobulin	TTF-1	PA164754910	7080	0.87
NULL	J_Nutr_Metab_2011_Oct_1_2011_525094.nxml.txt.nlp	21977315	SENT5	3	3	21	21	resveratrol	SIRT4		23409	0.87
NULL	Cardiovasc_Diabetol_2013_May_4_12_73.nxml.txt.nlp	23642288	SENT125	5	5	19	19	acarbose	GLP-1	PA448010	100125288	0.87
NULL	J_Physiol_2014_Feb_15_592(4)_759-776.nxml.txt.nlp	24324003	SENT253	9	9	29	29	capsaicin	TRPV1	PA448776	7442	0.87
NULL	Croat_Med_J_2012_Dec_53(6)_558-567.nxml.txt.nlp	23275321	SENT136	10	10	19	19	perifosine	MT3	PA165291471	4504	0.87
NULL	Oncotarget_2012_Dec_18_3(12)_1615-1628.nxml.txt.nlp	23271044	SENT109	6	6	13	13	clofarabine	TOR	PA164754863	6097	0.87
NULL	Cell_Death_Dis_2010_Nov_18_1(11)_e101.nxml.txt.nlp	21368866	SENT89	35	35	11	11	cisplatin	Bcl-2	PA449014	596	0.87
NULL	Front_Neurosci_2012_May_30_6_77.nxml.txt.nlp	22661925	SENT156	25	25	34	34	ethanol	DCX	PA448073	1641	0.87
NULL	J_Inflamm_(Lond)_2005_Oct_31_2_14.nxml.txt.nlp	16259633	SENT275	4	4	21	21	staurosporine	M-CSF	PA165109623	1435	0.87
NULL	BMJ_2013_Aug_21_347_f4877.nxml.txt.nlp	23965506	SENT172	34	34	27	27	trazodone	5-HT2A	PA451744	3356	0.87
NULL	Cardiovasc_Diabetol_2005_Oct_5_4_16.nxml.txt.nlp	16207378	SENT104	5	5	10	10	glucosamine	perlecan	PA164747613	3339	0.87
NULL	Hum_Mol_Genet_2013_Jul_1_22(13)_2676-2688.nxml.txt.nlp	23474818	SENT159	16	16	20	20	arsenite	FUS	PA452638	2521	0.87
NULL	Curr_Cardiol_Rev_2009_Aug_5(3)_216-222.nxml.txt.nlp	20676280	SENT50	16	16	28	28	lipase	HSL	PA450239	3991	0.87
NULL	Oncogene_2014_Jun_5_33(23)_3033-3042.nxml.txt.nlp	23851504	SENT342	31	31	6	6	doxycycline	AIB1	PA449415	8202	0.87
NULL	Cancers_(Basel)_2013_Aug_14_5(3)_1020-1048.nxml.txt.nlp	24202332	SENT463	11	11	8	8	rifampin	P-gp	PA451250	5243	0.87
NULL	J_Cell_Mol_Med_2013_Oct_16_17(10)_1261-1270.nxml.txt.nlp	23855452	SENT266	13	13	15	15	gemcitabine	GEM	PA449748	2669	0.87
NULL	Breast_Cancer_Res_2007_May_30_9(3)_R34.nxml.txt.nlp	17537232	SENT173	16	16	8	8	tamoxifen	TP53	PA451581	7157	0.87
NULL	Breast_Cancer_Res_2010_Jun_28_12(3)_R43.nxml.txt.nlp	20579400	SENT180	3	3	10	10	estradiol	MAPT	PA449503	4137	0.87
NULL	Nat_Biotechnol_2013_Jan_16_31(1)_63-70.nxml.txt.nlp	23242163	SENT110	23	23	30	30	marimastat	G10	PA164748329	8896;221527	0.87
NULL	Pain_2012_Apr_153(4)_775-783.nxml.txt.nlp	22325744	SENT94	15	15	20	20	naloxone	P21	PA450586	1026;9338	0.87
NULL	Oncol_Rep_2012_Apr_16_27(4)_971-978.nxml.txt.nlp	22266706	SENT112	14	14	27	27	cisplatin	Bcl-2	PA449014	596	0.87
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT1416	5	5	0	0	cisplatin	MRP2	PA449014	100130958;57626;1244	0.87
NULL	J_Cell_Mol_Med_2013_Jan_10_17(1)_30-54.nxml.txt.nlp	23301832	SENT225	19	19	24	24	docetaxel	HIF-1	PA449383	29072	0.87
NULL	Arch_Med_Sci_2013_Jun_20_9(3)_418-426.nxml.txt.nlp	23847661	SENT100	3	3	1	1	atorvastatin	NNT	PA448500	23530	0.87
NULL	J_Biomed_Sci_2014_Jan_24_21(1)_7.nxml.txt.nlp	24456003	SENT28	14	14	9	9	oxygen	HIF-1	PA450744	29072	0.87
NULL	Mol_Vis_2012_Nov_29_18_2839-2846.nxml.txt.nlp	23233786	SENT181	0	0	24	24	geldanamycin	Hsp90	PA152031327	3320	0.87
NULL	Nucleic_Acids_Res_2005_Jun_8_33(10)_3283-3291.nxml.txt.nlp	15944449	SENT139	6	6	17	17	mechlorethamine	XRCC3	PA450336	7517	0.87
NULL	Br_J_Cancer_2010_Mar_16_102(6)_1003-1009.nxml.txt.nlp	20179710	SENT130	32	32	29	29	thiotepa	CYP2B6	PA451668	1555	0.87
NULL	J_Hematol_Oncol_2013_Jun_3_6_38.nxml.txt.nlp	23731980	SENT199	19	19	11	11	pertuzumab	HER2		2064	0.87
NULL	J_Immunol_Res_2014_Apr_10_2014_268479.nxml.txt.nlp	24818166	SENT159	45	45	41	41	gemcitabine	CD22	PA449748	933	0.87
NULL	Int_J_Mol_Sci_2014_Oct_14_15(10)_18557-18573.nxml.txt.nlp	25318057	SENT178	4	4	9	9	bortezomib	TRAIL-R2	PA10252	8795	0.87
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT147	6	6	19	19	atorvastatin	KRAS	PA448500	3845	0.87
NULL	Environ_Health_Perspect_2007_Mar_115(3)_A126-A127.nxml.txt.nlp	17431460	SENT38	23	23	13	13	cholestyramine	PEAS	PA448974	116138	0.87
NULL	Curr_Chem_Genomics_Transl_Med_2013_Sep_3_7_30-38.nxml.txt.nlp	24396733	SENT32	7	7	12	12	staurosporine	AMPK	PA165109623	5563	0.87
NULL	Pan_Afr_Med_J_2014_May_12_18_42.nxml.txt.nlp	25368731	SENT101	0	0	7	7	clopidogrel	ADP	PA449053	23038	0.87
NULL	J_Immunol_Res_2014_Apr_28_2014_286170.nxml.txt.nlp	24868562	SENT112	20	20	8	8	docetaxel	CD4	PA449383	920	0.87
NULL	Breast_Cancer_Res_2008_Dec_18_10(Suppl_4)_S25.nxml.txt.nlp	19128439	SENT12	33	33	17	17	anastrozole	ATAC	PA448432	6375	0.87
NULL	Bioinformation_2012_Dec_19_8(25)_1249-1254.nxml.txt.nlp	23275729	SENT9	17	17	23	23	finasteride	VEGFR	PA449627	3791	0.87
NULL	Lab_Invest_2011_Apr_14_91(4)_598-608.nxml.txt.nlp	21321535	SENT129	6	6	16	16	sorafenib	CD11b	PA7000	3684	0.87
NULL	Pharmaceutics_2011_Nov_18_3(4)_865-913.nxml.txt.nlp	24309312	SENT121	16	16	36	36	pravastatin	MRP2	PA451089	100130958;57626;1244	0.87
NULL	Cancer_Cell_2013_Aug_12_24(2)_229-241.nxml.txt.nlp	23871637	SENT560	13	13	17	17	bevacizumab	CAGE	PA130232992	168400	0.87
NULL	Cancer_Med_2012_Oct_16_1(2)_207-217.nxml.txt.nlp	23342270	SENT204	16	16	8	8	saracatinib	IGFBP2		3485	0.87
NULL	Neuropsychologia_2011_Jul_49(9)_2755-2765.nxml.txt.nlp	21689671	SENT55	31	31	28	28	donepezil	LPA	PA449394	4018	0.87
NULL	Diabetes_Care_2008_Jul_31(7)_1427-1432.nxml.txt.nlp	18390799	SENT161	11	11	0	0	rosiglitazone	RBP4	PA451283	5433;5950	0.87
NULL	Indian_J_Pharmacol_2008_Oct_40(Suppl_2)_S150-S160.nxml.txt.nlp	21593968	SENT221	0	0	23	23	carrageenan	LOX	PA448814	4015	0.87
NULL	Nat_Commun_2011_Jul_19_2_402.nxml.txt.nlp	21772273	SENT118	10	10	3	3	etoposide	CHK2	PA449552	11200	0.87
NULL	Cancer_Cell_Int_2013_Jun_26_13_63.nxml.txt.nlp	23800022	SENT115	24	24	7	7	genistein	MCL1	PA165109660	4170	0.87
NULL	Nat_Commun_2013_Aug_15_4_2130.nxml.txt.nlp	23945651	SENT53	10	10	12	12	cisplatin	ATG5	PA449014	9474	0.87
NULL	Clin_Ophthalmol_2011_Jun_30_5_897-900.nxml.txt.nlp	21760719	SENT46	28	28	3	3	fluorescein	F10	PA164746009	2159	0.87
NULL	J_Vet_Med_Sci_2013_Nov_5_75(11)_1443-1448.nxml.txt.nlp	23832627	SENT41	4	4	33	33	sevoflurane	MOK	PA451341	5891	0.87
NULL	AIDS_Res_Treat_2014_Feb_25_2014_636584.nxml.txt.nlp	24715982	SENT52	19	19	5	5	etravirine	DUET	PA166014703	8997	0.87
NULL	Cancer_Med_2013_Jun_24_2(3)_360-366.nxml.txt.nlp	23930213	SENT121	30	30	5	5	thalidomide	FGFR1	PA451644	2260	0.87
NULL	Br_J_Cancer_2013_Jul_9_109(1)_76-82.nxml.txt.nlp	23807161	SENT60	38	38	11	11	fluorescein	San	PA164746009	80218	0.87
NULL	BMB_Rep_2014_Apr_47(4)_221-226.nxml.txt.nlp	24286312	SENT74	16	16	21	21	nutlin-3	p53		7157	0.87
NULL	Inflammation_2014_Apr_6_37(5)_1476-1485.nxml.txt.nlp	24706026	SENT170	5	5	13	13	curcumin	GATA3	PA151958596	2625	0.87
NULL	Braz_J_Med_Biol_Res_2014_Oct_14_47(12)_1068-1074.nxml.txt.nlp	25387674	SENT99	7	7	27	27	phentolamine	HCS	PA450926	3141;54205	0.87
NULL	Int_J_Biol_Sci_2013_Mar_7_9(3)_279-288.nxml.txt.nlp	23493630	SENT15	17	17	25	25	tocilizumab	CD4	PA165292659	920	0.87
NULL	J_Immunother_Cancer_2014_Jan_27_2_2.nxml.txt.nlp	24829759	SENT138	18	18	3	3	sorafenib	IL-21	PA7000	59067;50616;27189	0.87
NULL	Acta_Pharmacol_Sin_2013_Dec_21_34(12)_1554-1559.nxml.txt.nlp	24141568	SENT130	7	7	0	0	heparin	CXCL12	PA449855	6387	0.87
NULL	Open_Biochem_J_2009_Dec_11_3_78-84.nxml.txt.nlp	20111725	SENT92	11	11	8	8	morphine	GPI	PA450550	10007;2821	0.87
NULL	J_Infect_Dis_2012_Jul_15_206(2)_229-237.nxml.txt.nlp	22291195	SENT144	20	20	16	16	pentamidine	B28	PA450850	54069	0.87
NULL	Chemother_Res_Pract_2012_Dec_20_2012_743193.nxml.txt.nlp	23320171	SENT9	24	24	33	33	trastuzumab	HER2	PA451743	2064	0.87
NULL	JAKSTAT_2014_Jun_12_3_e29554.nxml.txt.nlp	25105067	SENT99	32	32	34	34	propofol	EGF	PA451141	1950	0.87
NULL	Nat_Med_2013_Mar_10_19(3)_313-321.nxml.txt.nlp	23396211	SENT368	38	38	30	30	amlexanox	TBK1	PA164745310	29110	0.87
NULL	Breast_Cancer_(Auckl)_2009_Sep_2_3_61-75.nxml.txt.nlp	19809577	SENT6	16	16	2	2	curcumin	BRCA1	PA151958596	672	0.87
NULL	Clin_Ophthalmol_2012_Oct_30_6_1749-1753.nxml.txt.nlp	23152652	SENT11	1	1	32	32	bimatoprost	ANOVA	PA164748867	4858	0.87
NULL	Oxid_Med_Cell_Longev_2013_Jun_2_2013_793525.nxml.txt.nlp	23819014	SENT204	8	8	16	16	resveratrol	PI3K		5290	0.87
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_11_2014_274786.nxml.txt.nlp	25505920	SENT240	27	27	23	23	oxaliplatin	ERCC1	PA131285527	2067	0.87
NULL	Drugs_R_D_2010_Nov_25_10(4)_271-284.nxml.txt.nlp	21171673	SENT300	8	8	14	14	fluconazole	JAK3	PA449653	3718	0.87
NULL	Int_J_Surg_Oncol_2012_Jun_12_2012_862879.nxml.txt.nlp	22778941	SENT15	36	36	28	28	cisplatin	BIN1	PA449014	274	0.87
NULL	Br_J_Cancer_2009_Mar_24_100(6)_923-931.nxml.txt.nlp	19259085	SENT139	4	4	17	17	imatinib	mol	PA10804	90527	0.87
NULL	Breast_Cancer_Res_2013_Nov_29_15(6)_R114.nxml.txt.nlp	24289103	SENT342	16	16	24	24	tamoxifen	EGFR	PA451581	1956	0.87
NULL	Breast_Cancer_Res_2004_Jun_29_6(5)_R488-R498.nxml.txt.nlp	15318931	SENT10	29	29	12	12	estradiol	UGT2B15	PA449503	7366	0.87
NULL	Evid_Based_Complement_Alternat_Med_2011_Aug_11_2011_237941.nxml.txt.nlp	19887507	SENT173	36	36	11	11	metformin	STZ	PA450395	6484	0.87
NULL	Anc_Sci_Life_2012_Oct-Dec_32(2)_112-115.nxml.txt.nlp	24167338	SENT71	3	3	12	12	indomethacin	CO2	PA449982	4513	0.87
NULL	Clin_Ophthalmol_2008_Jun_2(2)_355-368.nxml.txt.nlp	19668727	SENT209	13	13	7	7	nepafenac	PRK	PA165958407	1263	0.87
NULL	Arthritis_Res_Ther_2011_May_25_13(Suppl_1)_S2.nxml.txt.nlp	21624181	SENT352	31	31	23	23	infliximab	ACR	PA452639	49	0.87
NULL	Cell_Commun_Signal_2014_Dec_5_12(1)_75.nxml.txt.nlp	NULL	SENT58	20	20	10	10	memantine	CD40	PA10364	958	0.87
NULL	Mol_Cells_2014_Mar_31_37(3)_234-240.nxml.txt.nlp	24642709	SENT163	16	16	5	5	capsaicin	HO-1	PA448776	3162	0.87
NULL	Breast_Cancer_Res_2014_May_30_16(3)_R55.nxml.txt.nlp	24886669	SENT298	19	19	15	15	paclitaxel	survivin	PA450761	332	0.87
NULL	Cardiovasc_Diabetol_2013_Mar_23_12_48.nxml.txt.nlp	23522121	SENT211	8	8	11	11	liraglutide	NNT	PA165958364	23530	0.87
NULL	Hum_Genomics_2009_Jan_1_3(2)_128-142.nxml.txt.nlp	19164090	SENT234	34	34	37	37	carboplatin	CD44	PA448803	960	0.87
NULL	Ann_Indian_Acad_Neurol_2010_Jan-Mar_13(1)_6-13.nxml.txt.nlp	20436740	SENT263	20	20	14	14	cangrelor	ADP	PA165945763	23038	0.87
NULL	Mol_Cancer_2009_Jun_23_8_39.nxml.txt.nlp	19549337	SENT234	8	8	23	23	resveratrol	AKT		207	0.87
NULL	Mol_Biol_Cell_2012_Oct_15_23(20)_4109-4117.nxml.txt.nlp	22918949	SENT197	26	26	2	2	paraformaldehyde	PTEN	PA450790	5728	0.87
NULL	Clin_Ophthalmol_2012_Mar_8_6_377-383.nxml.txt.nlp	22457587	SENT103	16	16	8	8	chloroquine	ERG	PA448948	2078	0.87
NULL	Neuroscience_2009_Jun_30_161(2-3)_572-577.nxml.txt.nlp	19327387	SENT89	29	29	13	13	capsaicin	NAPE-PLD	PA448776	222236	0.87
NULL	Int_J_Med_Sci_2013_Feb_11_10(3)_320-330.nxml.txt.nlp	23423768	SENT77	24	24	16	16	cetuximab	EGFR	PA10040	1956	0.87
NULL	Braz_J_Med_Biol_Res_2014_Feb_17_47(2)_101-109.nxml.txt.nlp	24519125	SENT131	6	6	16	16	isoproterenol	IL-6	PA450121	3569	0.87
NULL	Oncotarget_2014_Aug_4_5(17)_7776-7787.nxml.txt.nlp	25277200	SENT132	30	30	0	0	cisplatin	ANXA4	PA449014	307	0.87
NULL	Pak_J_Med_Sci_2013_May-Jun_29(3)_768-772.nxml.txt.nlp	24353625	SENT7	22	22	5	5	ceftazidime	API	PA448861	5345	0.87
NULL	Nat_Commun_2011_Dec_20_2_593.nxml.txt.nlp	22186889	SENT431	23	23	6	6	cisplatin	BRCA1	PA449014	672	0.87
NULL	Breast_Cancer_Res_2008_Dec_18_10(Suppl_4)_S26.nxml.txt.nlp	19128440	SENT14	19	19	2	2	tamoxifen	IMPACT	PA451581	55364	0.87
NULL	Braz_J_Med_Biol_Res_2013_Aug_13_46(8)_650-658.nxml.txt.nlp	23969971	SENT172	7	7	12	12	oxaliplatin	STAT3	PA131285527	6774	0.87
NULL	Cancer_Metab_2013_Mar_18_1_11.nxml.txt.nlp	24280190	SENT27	26	26	5	5	nadh	HIF-1	PA164755085	29072	0.87
NULL	Int_J_Nanomedicine_2010_Aug_9_5_437-444.nxml.txt.nlp	20957165	SENT28	13	13	2	2	daunorubicin	ADM	PA449212	133	0.87
NULL	J_Cell_Biol_2001_Oct_15_155(2)_207-216.nxml.txt.nlp	11591730	SENT104	25	25	15	15	camptothecin	p53	PA153590860	7157	0.87
NULL	Oxid_Med_Cell_Longev_2013_Nov_28_2013_568093.nxml.txt.nlp	24379901	SENT74	3	3	10	10	resveratrol	4E-BP1		1978	0.87
NULL	Front_Oncol_2014_Sep_29_4_251.nxml.txt.nlp	25325012	SENT244	17	17	2	2	gefitinib	EGFR	PA131301952	1956	0.87
NULL	Oncogene_2013_Sep_26_32(39)_10_1038_onc_2012_491.nxml.txt.nlp	23108394	SENT89	16	16	9	9	epirubicin	FOXM1	PA449476	2305	0.87
NULL	J_Inherit_Metab_Dis_2010_Oct_3_33(5)_625-632.nxml.txt.nlp	20814828	SENT146	17	17	32	32	simvastatin	RhoA	PA451363	387	0.87
NULL	J_Gen_Physiol_1997_Dec_1_110(6)_693-715.nxml.txt.nlp	9382897	SENT470	32	32	28	28	choline	EAOH	PA448976	54840	0.87
NULL	Asia_Pac_Allergy_2014_Jan_31_4(1)_54-67.nxml.txt.nlp	24527412	SENT244	0	0	18	18	enfuvirtide	CD4	PA164744517	920	0.87
NULL	Clin_Ophthalmol_2008_Jun_2(2)_355-368.nxml.txt.nlp	19668727	SENT81	9	9	26	26	nepafenac	COX1	PA165958407	4512;5742	0.87
NULL	Cancer_Cell_Int_2013_Dec_23_13_123.nxml.txt.nlp	24365069	SENT27	20	20	24	24	imatinib	CD34	PA10804	947	0.87
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2751-2762.nxml.txt.nlp	24169358	SENT13	0	0	24	24	fulvestrant	GREB1	PA164747170	9687	0.87
NULL	J_Clin_Biochem_Nutr_2010_Jan_29_46(1)_36-42.nxml.txt.nlp	20104263	SENT121	27	27	44	44	ribavirin	IFN	PA451241	3439	0.87
NULL	J_Lipid_Res_2014_Oct_55(10)_2103-2112.nxml.txt.nlp	25139399	SENT114	2	2	10	10	atorvastatin	LDLR	PA448500	3949	0.87
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT6	10	10	3	3	atorvastatin	IL-6	PA448500	3569	0.87
NULL	Nat_Commun_2013_Apr_9_4_1684.nxml.txt.nlp	23575688	SENT79	4	4	27	27	rolipram	p65	PA153906323	5970	0.87
NULL	EMBO_Mol_Med_2012_Sep_7_4(9)_896-909.nxml.txt.nlp	22887866	SENT166	6	6	3	3	lovastatin	c-Myc	PA450272	4609	0.87
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_May_14_3(5)_e114.nxml.txt.nlp	24827872	SENT122	20	20	30	30	sorafenib	PSMD2	PA7000	5708	0.87
NULL	Neuro_Oncol_2013_Sep_30_15(9)_1200-1211.nxml.txt.nlp	23723255	SENT65	6	6	18	18	bupivacaine	hole	PA135057240	80757	0.87
NULL	Clin_Sci_(Lond)_2010_Mar_9_118(Pt_11)_681-689.nxml.txt.nlp	20088827	SENT332	0	0	3	3	losartan	AT1	PA450268	9197;185	0.87
NULL	BMB_Rep_2014_Apr_47(4)_221-226.nxml.txt.nlp	24286312	SENT131	6	6	32	32	nutlin-3	p53		7157	0.87
NULL	Br_J_Cancer_2013_Mar_5_108(4)_983-992.nxml.txt.nlp	23361057	SENT11	2	2	14	14	cytarabine	MLH1	PA449177	4292	0.87
NULL	J_Gen_Physiol_1993_Aug_1_102(2)_257-275.nxml.txt.nlp	8228911	SENT4	13	13	3	3	forskolin	CTX	PA146096022	1593	0.87
NULL	Ann_Surg_Treat_Res_2014_Feb_22_86(2)_68-75.nxml.txt.nlp	24761411	SENT145	11	11	17	17	oxaliplatin	survivin	PA131285527	332	0.87
NULL	Biomed_Eng_Online_2010_Mar_9_9_15.nxml.txt.nlp	20214774	SENT290	16	16	29	29	paclitaxel	mol	PA450761	90527	0.87
NULL	Mar_Drugs_2009_Mar_31_7(2)_71-84.nxml.txt.nlp	19597572	SENT93	5	5	13	13	carrageenan	CAM	PA448814	889	0.87
NULL	Acta_Pharmacol_Sin_2011_Jun_23_32(6)_834-839.nxml.txt.nlp	21602836	SENT36	12	12	7	7	l-glutamine	F12	PA10090	2161	0.87
NULL	Diabetes_2013_Jun_17_62(6)_1913-1922.nxml.txt.nlp	23349495	SENT181	7	7	16	16	sildenafil	AMPK	PA451346	5563	0.87
NULL	Arthritis_Res_Ther_2010_Sep_8_12(5)_R167.nxml.txt.nlp	20825639	SENT171	11	11	35	35	resveratrol	JNK		5599	0.87
NULL	Mol_Cancer_2009_Aug_25_8_66.nxml.txt.nlp	19706164	SENT180	17	17	6	6	celecoxib	p53	PA448871	7157	0.87
NULL	Apoptosis_2012_Sep_30_17(9)_989-997.nxml.txt.nlp	22460505	SENT144	3	3	17	17	thioridazine	4E-BP1	PA451666	1978	0.87
NULL	Behav_Brain_Funct_2009_Jan_15_5_3.nxml.txt.nlp	19146665	SENT205	22	22	2	2	ethanol	ANOVA	PA448073	4858	0.87
NULL	Nat_Commun_2013_4_1963.nxml.txt.nlp	23739639	SENT352	30	30	2	2	heparin	MARCO	PA449855	8685	0.87
NULL	Evid_Based_Complement_Alternat_Med_2012_Dec_20_2012_908601.nxml.txt.nlp	23326293	SENT24	14	14	5	5	daunorubicin	CD34	PA449212	947	0.87
NULL	Breast_Cancer_(Auckl)_2014_Oct_12_8_135-144.nxml.txt.nlp	25368520	SENT5	31	31	17	17	cisplatin	RAD51B	PA449014	5890	0.87
NULL	Iran_J_Basic_Med_Sci_2012_Mar-Apr_15(2)_768-776.nxml.txt.nlp	23493923	SENT149	8	8	3	3	buspirone	5-HT1A	PA448689	3350	0.87
NULL	J_Oncol_2012_Feb_6_2012_737981.nxml.txt.nlp	22481932	SENT132	35	35	21	21	cisplatin	AKT	PA449014	207	0.87
NULL	Clin_Med_Insights_Oncol_2011_Nov_7_5_349-364.nxml.txt.nlp	22174596	SENT191	9	9	6	6	pazopanib	VEGFR	PA165291492	3791	0.87
NULL	Breast_Cancer_Res_2011_Nov_30_13(6)_R123.nxml.txt.nlp	22129105	SENT22	38	38	0	0	trastuzumab	HER2	PA451743	2064	0.87
NULL	Nat_Commun_2014_Dec_9_5_5691.nxml.txt.nlp	25487737	SENT52	3	3	36	36	doxorubicin	SUV39H2	PA449412	79723	0.87
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Sep_3_67(Pt_10)_o2550.nxml.txt.nlp	22064894	SENT61	6	6	18	18	ethanol	mol	PA448073	90527	0.87
NULL	Cancers_(Basel)_2013_Mar_11_5(1)_255-280.nxml.txt.nlp	24216707	SENT633	1	1	8	8	genistein	CYP27B1	PA165109660	1594	0.87
NULL	Int_J_Mol_Sci_2014_Mar_24_15(3)_5140-5162.nxml.txt.nlp	24663085	SENT745	10	10	19	19	cyclophosphamide	IFN	PA449165	3439	0.87
NULL	Oncotarget_2013_Jul_7_4(7)_1065-1074.nxml.txt.nlp	23867252	SENT4	13	13	7	7	geldanamycin	Hsp90	PA152031327	3320	0.87
NULL	J_Biomed_Biotechnol_2010_Jun_7_2010_150960.nxml.txt.nlp	20617134	SENT207	15	15	19	19	imatinib	KRAS	PA10804	3845	0.87
NULL	Breast_Cancer_Res_2010_Jul_26_12(4)_R55.nxml.txt.nlp	20659323	SENT130	5	5	15	15	doxycycline	MYB	PA449415	4602	0.87
NULL	Cancer_Cell_Int_2013_Jun_26_13_63.nxml.txt.nlp	23800022	SENT213	12	12	3	3	genistein	MDM2	PA165109660	4193	0.87
NULL	J_Immunother_Cancer_2013_Nov_7_1(Suppl_1)_P86.nxml.txt.nlp	NULL	SENT4	7	7	9	9	gemcitabine	GEM	PA449748	2669	0.87
NULL	ACS_Med_Chem_Lett_2013_Mar_25_4(5)_486-490.nxml.txt.nlp	23687559	SENT4	8	8	14	14	indomethacin	COX	PA449982	1351	0.87
NULL	Oncoimmunology_2013_May_1_2(5)_e23850.nxml.txt.nlp	23762785	SENT40	48	48	13	13	denosumab	RANKL	PA166048634	8600	0.87
NULL	Br_J_Cancer_2009_Oct_20_101(8)_1253-1260.nxml.txt.nlp	19755984	SENT131	19	19	14	14	tamoxifen	HER-2	PA451581	2064	0.87
NULL	Int_J_Biol_Sci_2013_Sep_20_9(9)_917-933.nxml.txt.nlp	24155666	SENT201	9	9	21	21	cisplatin	SOD1	PA449014	6647	0.87
NULL	J_Antimicrob_Chemother_2009_May_5_63(5)_1034-1042.nxml.txt.nlp	19264792	SENT36	9	9	44	44	daptomycin	CLCR	PA164768820	11330	0.87
NULL	J_Thromb_Thrombolysis_2013_Jul_17_36(1)_31-41.nxml.txt.nlp	23073747	SENT207	10	10	27	27	abciximab	AIDA	PA448006	64853	0.87
NULL	Br_J_Cancer_2009_Sep_15_101(6)_875-878.nxml.txt.nlp	19672259	SENT34	19	19	8	8	anastrozole	ATAC	PA448432	6375	0.87
NULL	Drug_Des_Devel_Ther_2014_Oct_31_8_2121-2128.nxml.txt.nlp	25382970	SENT87	24	24	5	5	curcumin	TTR	PA151958596	7276	0.87
NULL	Curr_Oncol_2009_Jul_16(Suppl_2)_S14-S23.nxml.txt.nlp	19672417	SENT204	4	4	6	6	tamoxifen	aromatase	PA451581	1588	0.87
NULL	F1000Prime_Rep_2014_Aug_1_6_65.nxml.txt.nlp	25165564	SENT39	3	3	1	1	alemtuzumab	CD52	PA164783958	1043	0.87
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT58	23	23	9	9	trastuzumab	HER-2	PA451743	2064	0.87
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R91.nxml.txt.nlp	22541814	SENT229	9	9	27	27	thrombin	HO-1	PA451674	3162	0.87
NULL	Curr_HIV_Res_2014_May_12(3)_174-188.nxml.txt.nlp	24862327	SENT147	25	25	11	11	hemin	HO-1	PA449849	3162	0.87
NULL	J_Thorac_Oncol_2014_Jun_30_9(6)_775-783.nxml.txt.nlp	24828661	SENT12	8	8	4	4	erlotinib	Met	PA134687924	79811	0.87
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT35	36	36	28	28	phenprocoumon	CYP3A4	PA450921	1576	0.87
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT138	30	30	25	25	pertuzumab	HER2		2064	0.87
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1033-1038.nxml.txt.nlp	22374460	SENT35	17	17	29	29	capecitabine	HER2	PA448771	2064	0.87
NULL	N_Am_J_Med_Sci_2014_Sep_6(9)_478-480.nxml.txt.nlp	25317394	SENT7	20	20	11	11	phenytoin	CYP2C9	PA450947	1559	0.87
NULL	Oncotarget_2013_Jun_30_4(7)_1037-1049.nxml.txt.nlp	23900414	SENT183	32	32	2	2	pp2	PP2		4888	0.87
NULL	Front_Oncol_2014_May_7_4_95.nxml.txt.nlp	24847444	SENT307	10	10	5	5	vincristine	CD19	PA451879	930	0.87
NULL	Breast_Cancer_Res_2011_Mar_14_13(2)_205.nxml.txt.nlp	21457526	SENT21	5	5	8	8	letrozole	aromatase	PA450196	1588	0.87
NULL	Oncotarget_2014_Mar_26_5(21)_10342-10355.nxml.txt.nlp	25431950	SENT123	15	15	4	4	doxycycline	EZH2	PA449415	2146	0.87
NULL	Mol_Cancer_2009_Jul_31_8_57.nxml.txt.nlp	19646263	SENT208	39	39	27	27	docetaxel	IL-8	PA449383	3576	0.87
NULL	Cancer_Med_2013_Aug_10_2(4)_488-495.nxml.txt.nlp	24156021	SENT123	5	5	16	16	sn-38	TYMS		7298	0.87
NULL	Oncogene_2010_Jun_10_29(23)_3335-3348.nxml.txt.nlp	20383197	SENT130	21	21	15	15	cetuximab	HER2	PA10040	2064	0.87
NULL	Ann_Oncol_2012_Dec_2_23(12)_3007-3016.nxml.txt.nlp	22865781	SENT171	23	23	6	6	trastuzumab	IGF1R	PA451743	3480	0.87
NULL	Br_J_Cancer_2009_Mar_10_100(5)_758-763.nxml.txt.nlp	19259094	SENT6	29	29	17	17	decitabine	MLH1	PA164749631	4292	0.87
NULL	Oncotarget_2013_Dec_18_5(2)_375-385.nxml.txt.nlp	24495868	SENT143	44	44	29	29	flavopiridol	CD34	PA452627	947	0.87
NULL	J_Cell_Biol_2008_Jul_28_182(2)_327-340.nxml.txt.nlp	18644889	SENT104	6	6	19	19	estradiol	CRM1	PA449503	7514	0.87
NULL	J_Interv_Cardiol_2014_Apr_12_27(2)_119-126.nxml.txt.nlp	24617336	SENT133	31	31	28	28	everolimus	DES	PA164746311	1674	0.87
NULL	Oncotarget_2013_Mar_26_4(3)_397-412.nxml.txt.nlp	23651630	SENT308	24	24	18	18	vincristine	CHOP	PA451879	1649	0.87
NULL	Basic_Clin_Neurosci_2014_Winter_5(1)_31-41.nxml.txt.nlp	25436082	SENT18	9	9	6	6	bupropion	ANOVA	PA448687	4858	0.87
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT38	0	0	9	9	neratinib	HER2	PA165291472	2064	0.87
NULL	Nat_Methods_2011_Jun_24_8(6)_487-493.nxml.txt.nlp	21516115	SENT158	20	20	17	17	gefitinib	ERK	PA131301952	5594	0.87
NULL	Oncotarget_2011_Nov_30_2(11)_874-885.nxml.txt.nlp	22141136	SENT48	11	11	17	17	staurosporine	AXL	PA165109623	558	0.87
NULL	J_Lipid_Res_2012_Nov_53(11)_2355-2363.nxml.txt.nlp	22956783	SENT46	18	18	33	33	isoflurane	CO2	PA450106	4513	0.87
NULL	Clin_Med_Insights_Oncol_2012_Nov_20_6_381-393.nxml.txt.nlp	23226079	SENT136	3	3	7	7	sunitinib	CYP3A4	PA162372840	1576	0.87
NULL	Mol_Cancer_2010_Aug_23_9_222.nxml.txt.nlp	20731837	SENT197	1	1	23	23	gefitinib	KRAS	PA131301952	3845	0.87
NULL	Arthritis_Res_Ther_2008_Jan_7_10(1)_R1.nxml.txt.nlp	18179697	SENT184	34	34	14	14	oxaliplatin	IFN	PA131285527	3439	0.87
NULL	Oncotarget_2014_Oct_24_5(22)_11452-11463.nxml.txt.nlp	25360516	SENT157	0	0	20	20	doxorubicin	BAX	PA449412	581	0.87
NULL	Cell_Commun_Signal_2014_May_15_12_34.nxml.txt.nlp	24885272	SENT186	10	10	6	6	heparin	FGF2	PA449855	2247;2258	0.87
NULL	Chin_J_Cancer_2012_Jun_31(6)_266-280.nxml.txt.nlp	22313597	SENT305	13	13	19	19	letrozole	IGFBP5	PA450196	3488	0.87
NULL	Hum_Genomics_2010_Oct_1_5(1)_61-72.nxml.txt.nlp	21106490	SENT90	15	15	3	3	midazolam	CYP3A	PA450496	1574	0.87
NULL	Breast_Cancer_Res_2005_Nov_19_7(1)_18-20.nxml.txt.nlp	15642177	SENT55	10	10	13	13	raloxifene	aromatase	PA451221	1588	0.87
NULL	Biomed_Res_Int_2014_Apr_28_2014_153867.nxml.txt.nlp	24877058	SENT60	1	1	18	18	ethanol	CYP2E1	PA448073	1571	0.87
NULL	Breast_Cancer_Res_Treat_2013_Oct_4_141(3)_385-395.nxml.txt.nlp	24091769	SENT143	14	14	5	5	lapatinib	MVD	PA152241907	4597	0.87
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT201	4	4	32	32	curcumin	TRAIL	PA151958596	8743	0.87
NULL	Cardiovasc_Ther_2009_27(4)_259-274.nxml.txt.nlp	19604248	SENT23	34	34	29	29	clopidogrel	ADP	PA449053	23038	0.87
NULL	J_Carcinog_2013_Dec_31_12_22.nxml.txt.nlp	24574860	SENT419	18	18	3	3	erlotinib	EGFR	PA134687924	1956	0.87
NULL	J_Exp_Med_1998_Jun_1_187(11)_1885-1892.nxml.txt.nlp	9607928	SENT223	2	2	10	10	thalidomide	CD4	PA451644	920	0.87
NULL	J_Cell_Sci_2013_Sep_1_126(17)_3873-3883.nxml.txt.nlp	23843614	SENT283	14	14	7	7	forskolin	N-WASP	PA146096022	8976	0.87
NULL	Acta_Inform_Med_2012_Mar_20(1)_18-21.nxml.txt.nlp	23322949	SENT93	11	11	34	34	diclofenac	NNT-1	PA449293	23529	0.87
NULL	Breast_Cancer_Res_2011_Nov_1_13(6)_224.nxml.txt.nlp	22114931	SENT128	11	11	5	5	lapatinib	PTEN	PA152241907	5728	0.87
NULL	Child_Adolesc_Psychiatry_Ment_Health_2013_Aug_15_7_31.nxml.txt.nlp	23947389	SENT70	13	13	6	6	molindone	IMPACT	PA164746756	55364	0.87
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT224	5	5	18	18	atorvastatin	JNK	PA448500	5599	0.87
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT46	2	2	16	16	dasatinib	JNK	PA162372878	5599	0.87
NULL	J_Oncol_2012_Mar_26_2012_986725.nxml.txt.nlp	22545054	SENT164	22	22	6	6	gefitinib	EGFR	PA131301952	1956	0.87
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2675-2684.nxml.txt.nlp	24129246	SENT198	37	37	25	25	etoposide	p53	PA449552	7157	0.87
NULL	JAKSTAT_2012_Apr_1_1(2)_55-64.nxml.txt.nlp	24058751	SENT134	3	3	25	25	cisplatin	STAT1	PA449014	6772	0.87
NULL	J_Headache_Pain_2014_Dec_8_15(1)_85.nxml.txt.nlp	25488888	SENT84	13	13	33	33	zolmitriptan	5-HT1D	PA451975	3352	0.87
NULL	Biomed_Res_Int_2014_Aug_6_2014_967826.nxml.txt.nlp	25165721	SENT287	42	42	12	12	cisplatin	CD4	PA449014	920	0.87
NULL	Mol_Cancer_2014_Aug_22_13(1)_195.nxml.txt.nlp	NULL	SENT18	8	8	2	2	cisplatin	TBL1XR1	PA449014	79718	0.87
NULL	Breast_Cancer_Res_2012_May_2_14(3)_R70.nxml.txt.nlp	22551440	SENT6	38	38	16	16	doxorubicin	TP53	PA449412	7157	0.87
NULL	Mol_Biol_Rep_2013_May_11_40(8)_5013-5026.nxml.txt.nlp	23666059	SENT266	5	5	10	10	resveratrol	p53		7157	0.87
NULL	Adv_Hematol_2012_Jan_11_2012_130680.nxml.txt.nlp	22287968	SENT138	31	31	37	37	methotrexate	COP1	PA450428	64326;114769	0.87
NULL	Iran_J_Pharm_Res_2013_Winter_12(Suppl)_37-46.nxml.txt.nlp	24250670	SENT61	28	28	33	33	etoposide	P-gp	PA449552	5243	0.87
NULL	Oxid_Med_Cell_Longev_2013_Mar_5_2013_264935.nxml.txt.nlp	23533686	SENT5	9	9	5	5	hemin	HO-1	PA449849	3162	0.87
NULL	Environ_Health_Perspect_2010_Jul_3_118(7)_936-942.nxml.txt.nlp	20199942	SENT197	18	18	3	3	arsenite	NKRF	PA452638	55922	0.87
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT116	42	42	31	31	raltitrexed	UNG	PA131625240	7374	0.87
NULL	Int_J_Mol_Sci_2013_Apr_26_14(5)_9111-9125.nxml.txt.nlp	23624604	SENT187	19	19	36	36	iron	MRI	PA450087	78996	0.87
NULL	Biomed_Res_Int_2013_Aug_28_2013_590359.nxml.txt.nlp	24066293	SENT14	31	31	0	0	vanillin	FAE	PA451852	2178	0.87
NULL	Breast_Cancer_Res_2010_Jun_24_12(3)_R41.nxml.txt.nlp	20576088	SENT153	14	14	3	3	paclitaxel	PPM1D	PA450761	8493	0.87
NULL	Breast_Cancer_Res_2007_Jul_22_9(4)_R45.nxml.txt.nlp	17659092	SENT124	29	29	1	1	tamoxifen	FDG	PA451581	23583	0.87
NULL	Curr_Gerontol_Geriatr_Res_2010_Jun_20_2010_348174.nxml.txt.nlp	20672050	SENT28	6	6	19	19	lapatinib	EGFR	PA152241907	1956	0.87
NULL	J_Cancer_Prev_2014_Mar_19(1)_39-46.nxml.txt.nlp	25337571	SENT109	20	20	8	8	ethanol	p38	PA448073	10598;1432;7965	0.87
NULL	Ther_Clin_Risk_Manag_2006_Jun_2(2)_129-158.nxml.txt.nlp	18360588	SENT206	8	8	10	10	voriconazole	CYP3A4	PA10233	1576	0.87
NULL	J_Korean_Med_Sci_2009_Jun_12_24(3)_448-452.nxml.txt.nlp	19543508	SENT12	14	14	20	20	gefitinib	EGFR	PA131301952	1956	0.87
NULL	J_Hematol_Oncol_2010_Mar_23_3_11.nxml.txt.nlp	20331897	SENT158	16	16	32	32	capecitabine	LARC	PA448771	6364	0.87
NULL	Bioinformation_2012_Apr_30_8(8)_369-380.nxml.txt.nlp	22570518	SENT98	19	19	23	23	artemisinin	mol	PA165111696	90527	0.87
NULL	J_Korean_Med_Sci_2010_Feb_19_25(2)_240-244.nxml.txt.nlp	20119577	SENT16	22	22	4	4	cisplatin	NAC	PA449014	22861	0.87
NULL	Int_J_Biomed_Sci_2014_Sep_10(3)_146-157.nxml.txt.nlp	25324695	SENT25	11	11	19	19	hyaluronan	TLR2	PA165958431	7097	0.87
NULL	Drugs_Context_2012_Nov_19_2012_212242.nxml.txt.nlp	24432031	SENT128	6	6	15	15	dacarbazine	IL-2	PA449197	3558	0.87
NULL	Breast_Cancer_Res_2004_Oct_6_6(6)_262-268.nxml.txt.nlp	15535857	SENT110	30	30	32	32	tamoxifen	aromatase	PA451581	1588	0.87
NULL	Pharmaceuticals_(Basel)_2012_Oct_15_5(10)_1092-1103.nxml.txt.nlp	24281259	SENT49	9	9	3	3	camptothecin	zeta	PA153590860	9907	0.87
NULL	Breast_Cancer_Res_2010_Jun_28_12(3)_R43.nxml.txt.nlp	20579400	SENT166	10	10	26	26	estradiol	MAPT	PA449503	4137	0.87
NULL	Mol_Vis_2012_Oct_5_18_2454-2467.nxml.txt.nlp	23077404	SENT138	11	11	0	0	bevacizumab	VEGF-A	PA130232992	7422	0.87
NULL	Int_J_Biol_Sci_2005_Dec_1_1(4)_146-151.nxml.txt.nlp	18167569	SENT138	14	14	10	10	zinc	IMAC	PA451956	10344	0.87
NULL	Eur_J_Clin_Pharmacol_2009_Sep_3_65(9)_957.nxml.txt.nlp	19415250	SENT18	17	17	11	11	entacapone	PRX	PA164748726	9588;57716	0.87
NULL	Cancers_(Basel)_2014_Mar_6_6(1)_494-525.nxml.txt.nlp	24662938	SENT146	5	5	19	19	gefitinib	EGFR	PA131301952	1956	0.87
NULL	Eur_J_Nucl_Med_Mol_Imaging_2008_May_22_35(5)_1008-1018.nxml.txt.nlp	18157531	SENT43	25	25	35	35	trastuzumab	HER2	PA451743	2064	0.87
NULL	Gastric_Cancer_2013_Jul_12_16(3)_345-354.nxml.txt.nlp	22968820	SENT204	20	20	23	23	oxaliplatin	FANCJ	PA131285527	83990	0.87
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT276	12	12	6	6	resveratrol	NAC		22861	0.87
NULL	Pain_2012_Apr_153(4)_775-783.nxml.txt.nlp	22325744	SENT435	5	5	21	21	naloxone	P28	PA450586	9446;7802;9527	0.87
NULL	Breast_Cancer_Res_2008_Jul_24_10(4)_211.nxml.txt.nlp	18671839	SENT220	17	17	11	11	trastuzumab	HER2	PA451743	2064	0.869
NULL	Brain_Res_2013_Jul_12_1521(100)_1-15.nxml.txt.nlp	22789905	SENT278	11	11	13	13	verapamil	P-gp	PA451868	5243	0.869
NULL	Int_J_Cell_Biol_2013_Nov_17_2013_769536.nxml.txt.nlp	24348564	SENT90	30	30	27	27	estradiol	HSD1	PA449503	26871	0.869
NULL	Cell_Commun_Signal_2013_Oct_1_11_73.nxml.txt.nlp	24083678	SENT228	11	11	20	20	sulindac	A20	PA451565	7128;28935	0.869
NULL	Mol_Cancer_2012_Jul_12_11_45.nxml.txt.nlp	22788833	SENT136	30	30	35	35	cisplatin	EGFR	PA449014	1956	0.869
NULL	J_Oncol_2013_Feb_28_2013_897025.nxml.txt.nlp	23533410	SENT268	5	5	27	27	temsirolimus	CD34	PA164746890	947	0.869
NULL	Oncotarget_2011_Sep_9_2(9)_658-668.nxml.txt.nlp	21911919	SENT115	5	5	20	20	cytarabine	HO-1	PA449177	3162	0.869
NULL	J_Cell_Mol_Med_2014_Mar_10_18(3)_514-529.nxml.txt.nlp	24410795	SENT234	36	36	38	38	resveratrol	SIRT1		23411	0.869
NULL	Curr_Neuropharmacol_2009_Sep_7(3)_160-179.nxml.txt.nlp	20190959	SENT258	43	43	15	15	suramin	CO2	PA10292	4513	0.869
NULL	Br_J_Cancer_2011_Aug_23_105(5)_649-657.nxml.txt.nlp	21811251	SENT151	7	7	37	37	gefitinib	IGF1R	PA131301952	3480	0.869
NULL	Front_Oncol_2014_Apr_28_4_90.nxml.txt.nlp	24809021	SENT86	0	0	15	15	resveratrol	U87		677775;641648	0.869
NULL	Toxins_(Basel)_2010_Oct_28_2(11)_2584-2592.nxml.txt.nlp	22069565	SENT69	1	1	45	45	warfarin	CYP2C9	PA451906	1559	0.869
NULL	N_Am_J_Med_Sci_2013_Nov_5(11)_637-640.nxml.txt.nlp	24404541	SENT15	6	6	19	19	cefoxitin	MSRA	PA448856	4482	0.869
NULL	J_Clin_Biochem_Nutr_2011_May_13_48(3)_237-244.nxml.txt.nlp	21562645	SENT131	12	12	3	3	resveratrol	AMPK		5563	0.869
NULL	Evid_Based_Complement_Alternat_Med_2012_May_8_2012_132829.nxml.txt.nlp	22645624	SENT254	20	20	32	32	terbutaline	ANOVA	PA451616	4858	0.869
NULL	Endocrinol_Metab_(Seoul)_2014_Sep_25_29(3)_211-216.nxml.txt.nlp	25309777	SENT83	15	15	10	10	pazopanib	RET	PA165291492	5979	0.869
NULL	Cancers_(Basel)_2011_Apr_1_3(2)_1844-1860.nxml.txt.nlp	24212785	SENT602	16	16	3	3	cetuximab	KRAS	PA10040	3845	0.869
NULL	Exp_Hematol_Oncol_2013_Oct_4_2_26.nxml.txt.nlp	24219920	SENT238	7	7	18	18	reserpine	ABCA1	PA451236	19	0.869
NULL	Cancers_(Basel)_2013_Jul_26_5(3)_943-958.nxml.txt.nlp	24202328	SENT853	10	10	16	16	olaparib	BRCA2		675	0.869
NULL	Osteoporos_Int_2014_Oct_10_25(3)_1173-1180.nxml.txt.nlp	24108429	SENT58	1	1	29	29	teriparatide	San	PA451620	80218	0.869
NULL	Diabetes_Care_2009_Aug_32(8)_1398-1403.nxml.txt.nlp	19549737	SENT106	20	20	2	2	telmisartan	ANOVA	PA451605	4858	0.869
NULL	Int_J_Mol_Sci_2014_Nov_7_15(11)_20500-20517.nxml.txt.nlp	25387078	SENT132	5	5	33	33	sorafenib	c-FLIP	PA7000	8837	0.869
NULL	J_Hematol_Oncol_2011_Nov_4_4_44.nxml.txt.nlp	22053759	SENT97	5	5	17	17	ticagrelor	ACS	PA165374673	55902;84680	0.869
NULL	Br_J_Cancer_2010_Sep_28_103(7)_1019-1024.nxml.txt.nlp	20842128	SENT116	29	29	8	8	cetuximab	EGFR	PA10040	1956	0.869
NULL	J_Vet_Med_Sci_2013_Nov_22_75(11)_1485-1490.nxml.txt.nlp	23877792	SENT114	17	17	4	4	estradiol	aromatase	PA449503	1588	0.869
NULL	J_Oncol_2013_Feb_17_2013_872957.nxml.txt.nlp	23476648	SENT10	10	10	18	18	cisplatin	p27	PA449014	5715;10534	0.869
NULL	Adv_Ther_2013_Nov_28_30(12)_1067-1085.nxml.txt.nlp	24287690	SENT59	11	11	5	5	metformin	GLP-1	PA450395	100125288	0.869
NULL	Cancers_(Basel)_2010_Jan_14_2(1)_1-19.nxml.txt.nlp	24281029	SENT759	21	21	14	14	trastuzumab	HER2	PA451743	2064	0.869
NULL	Oxid_Med_Cell_Longev_2012_Jun_3_2012_914273.nxml.txt.nlp	22701758	SENT151	3	3	24	24	resveratrol	p40		3921;339541;10314	0.869
NULL	Curr_Neuropharmacol_2013_May_11(3)_276-297.nxml.txt.nlp	24179464	SENT777	9	9	32	32	isradipine	CA1	PA450131	759	0.869
NULL	Breast_Cancer_Res_2004_Jun_29_6(5)_R488-R498.nxml.txt.nlp	15318931	SENT7	3	3	16	16	estradiol	SULT	PA449503	6816	0.869
NULL	Biochemistry_2008_Jul_15_47(28)_7485-7495.nxml.txt.nlp	18570382	SENT236	10	10	29	29	levosimendan	C35	PA164749138	84299	0.869
NULL	Nat_Commun_2014_Nov_25_5_5548.nxml.txt.nlp	25420520	SENT112	18	18	30	30	docetaxel	TMPRSS2	PA449383	7113	0.869
NULL	J_Thromb_Thrombolysis_2011_Nov_26_32(4)_459-466.nxml.txt.nlp	21706290	SENT224	13	13	4	4	ticagrelor	ABCB1	PA165374673	5243	0.869
NULL	Front_Mol_Neurosci_2008_Mar_28_1_4.nxml.txt.nlp	18946537	SENT889	19	19	7	7	potassium	PSD-95	PA451047	1742	0.869
NULL	J_Med_Case_Rep_2013_May_31_7_144.nxml.txt.nlp	23724918	SENT37	28	28	3	3	lactulose	NAC	PA164748762	22861	0.869
NULL	Case_Rep_Endocrinol_2014_Oct_20_2014_851942.nxml.txt.nlp	25386368	SENT109	39	39	8	8	hydrocortisone	ACTH	PA449905	5443	0.869
NULL	Arthritis_Res_Ther_2009_Jun_29_11(3)_R100.nxml.txt.nlp	19563672	SENT148	28	28	42	42	infliximab	IFN	PA452639	3439	0.869
NULL	Paediatr_Drugs_2013_Apr_20_15(2)_119-131.nxml.txt.nlp	23512128	SENT288	10	10	4	4	tacrolimus	CYP2C19	PA451578	1557	0.869
NULL	Cancers_(Basel)_2011_Aug_15_3(3)_3331-3352.nxml.txt.nlp	24212957	SENT233	8	8	4	4	bevacizumab	CD133	PA130232992	8842	0.869
NULL	Cell_Death_Dis_2014_Feb_13_5(2)_e1055.nxml.txt.nlp	24525731	SENT312	11	11	5	5	cisplatin	XRCC1	PA449014	7515	0.869
NULL	Breast_Cancer_Res_2008_Jul_24_10(4)_211.nxml.txt.nlp	18671839	SENT79	37	37	31	31	tamoxifen	AP-1	PA451581	2353;3727;2354;3725	0.869
NULL	Acta_Naturae_2012_Jan-Mar_4(1)_82-85.nxml.txt.nlp	22708067	SENT35	30	30	13	13	gefitinib	EGFR	PA131301952	1956	0.869
NULL	Br_J_Clin_Pharmacol_2013_Apr_10_75(4)_979-989.nxml.txt.nlp	22882281	SENT31	32	32	12	12	exenatide	GLP-1	PA164749238	100125288	0.869
NULL	Clin_Interv_Aging_2008_Mar_3(1)_45-50.nxml.txt.nlp	18488877	SENT39	17	17	13	13	alendronate	BMD	PA448082	1756;7439	0.869
NULL	J_Gynecol_Oncol_2013_Jul_4_24(3)_273-279.nxml.txt.nlp	23875078	SENT133	4	4	6	6	paclitaxel	COX	PA450761	1351	0.869
NULL	Oncotarget_2013_Feb_26_4(2)_298-309.nxml.txt.nlp	23593653	SENT168	23	23	5	5	quinacrine	DNMT1	PA164745551	1786	0.869
NULL	Cells_2014_May_23_3(2)_500-516.nxml.txt.nlp	24861976	SENT308	15	15	4	4	gemcitabine	TRPM7	PA449748	54822	0.869
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT301	2	2	22	22	atorvastatin	PTEN	PA448500	5728	0.869
NULL	J_Hematol_Oncol_2011_Jan_21_4_5.nxml.txt.nlp	21255411	SENT240	26	26	38	38	cisplatin	GC-E	PA449014	390226	0.869
NULL	Oncoimmunology_2013_Dec_1_2(12)_e27215.nxml.txt.nlp	24501692	SENT32	31	31	11	11	panitumumab	STAT3	PA162373091	6774	0.869
NULL	Nat_Commun_2014_Dec_10_5_5715.nxml.txt.nlp	25493654	SENT639	0	0	13	13	lapatinib	HER2	PA152241907	2064	0.869
NULL	Curr_Pharm_Biotechnol_2012_May_13(6)_969-986.nxml.txt.nlp	22039792	SENT76	5	5	22	22	loperamide	P-gp	PA450262	5243	0.869
NULL	Breast_Cancer_Res_2002_Sep_10_4(6)_218-221.nxml.txt.nlp	12473166	SENT61	7	7	1	1	raloxifene	STAR	PA451221	6770;2984	0.869
NULL	Aging_(Albany_NY)_2013_Jan_29_5(1)_3-17.nxml.txt.nlp	23363843	SENT51	1	1	46	46	etoposide	p53	PA449552	7157	0.869
NULL	J_Biomed_Biotechnol_2011_Dec_6_2011_856985.nxml.txt.nlp	21188173	SENT206	8	8	21	21	tamoxifen	HDAC3	PA451581	8841	0.869
NULL	Biomed_Res_Int_2013_Sep_8_2013_808713.nxml.txt.nlp	24083242	SENT197	25	25	9	9	isoflurane	STR	PA450106	6779	0.869
NULL	J_Exp_Med_1998_Jun_15_187(12)_2023-2030.nxml.txt.nlp	9625761	SENT8	9	9	0	0	chloramphenicol	IFN	PA448927	3439	0.869
NULL	Clin_Pharmacol_2009_Sep_7_1_1-6.nxml.txt.nlp	22291481	SENT82	6	6	18	18	fluoxetine	PDE8B	PA449673	8622	0.869
NULL	J_Mol_Signal_2010_Jun_11_5_6.nxml.txt.nlp	20540776	SENT4	22	22	0	0	hydroxyurea	SSBP2	PA449942	23635	0.869
NULL	Front_Immunol_2012_May_7_3_101.nxml.txt.nlp	22783250	SENT253	30	30	8	8	papain	IL-9	PA450778	3578	0.869
NULL	J_Mol_Signal_2009_Sep_2_4_6.nxml.txt.nlp	19725972	SENT10	16	16	19	19	staurosporine	p38	PA165109623	10598;1432;7965	0.869
NULL	Aging_(Albany_NY)_2009_Dec_31_1(12)_988-1007.nxml.txt.nlp	20157582	SENT211	25	25	16	16	trastuzumab	CTX	PA451743	1593	0.869
NULL	Int_J_Endocrinol_2011_Aug_21_2011_742719.nxml.txt.nlp	21869886	SENT261	16	16	10	10	cilostazol	P2Y12	PA164746334	64805	0.869
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_16_2012_395912.nxml.txt.nlp	23118789	SENT149	7	7	0	0	imipramine	UGT1A4	PA449969	54657	0.869
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1013.nxml.txt.nlp	24457957	SENT126	5	5	11	11	bortezomib	NOXA	PA10252	5366	0.869
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_79-96.nxml.txt.nlp	19305789	SENT67	16	16	43	43	capsaicin	TRPV1	PA448776	7442	0.869
NULL	J_Cereb_Blood_Flow_Metab_2014_Oct_23_34(10)_1688-1694.nxml.txt.nlp	25052553	SENT179	30	30	6	6	losartan	SMAD4	PA450268	4089	0.869
NULL	Acta_Pharmacol_Sin_2011_May_18_32(5)_591-600.nxml.txt.nlp	21499286	SENT188	12	12	21	21	bezafibrate	AMPK	PA162364313	5563	0.869
NULL	Int_J_Womens_Health_2010_Aug_9_1_11-20.nxml.txt.nlp	21072271	SENT33	4	4	42	42	raloxifene	IL-6	PA451221	3569	0.869
NULL	J_Biol_Chem_2012_Apr_27_287(18)_14644-14658.nxml.txt.nlp	22375002	SENT92	26	26	14	14	l-glutamine	B27	PA10090	56246	0.869
NULL	Front_Immunol_2012_Mar_19_3_47.nxml.txt.nlp	22566929	SENT58	3	3	30	30	abatacept	B7-H2	PA164747080	23308	0.869
NULL	Br_J_Cancer_2010_Jul_13_103(2)_186-195.nxml.txt.nlp	20588277	SENT96	27	27	19	19	nutlin-3	p53		7157	0.869
NULL	Drugs_R_D_2011_Dec_27_11(4)_317-326.nxml.txt.nlp	22133387	SENT121	3	3	21	21	cetuximab	EGFR	PA10040	1956	0.869
NULL	J_Cell_Mol_Med_2014_Jul_10_18(7)_1290-1299.nxml.txt.nlp	24720832	SENT8	17	17	5	5	dextran	UNC5B	PA449261	219699	0.869
NULL	Emerg_Med_J_2011_Apr_26_28(4)_313-315.nxml.txt.nlp	20581384	SENT10	28	28	11	11	atropine	PON1	PA448505	5444	0.869
NULL	Cancers_(Basel)_2013_Jul_24_5(3)_901-918.nxml.txt.nlp	24202326	SENT7	22	22	36	36	melphalan	CDK9	PA450354	1025	0.869
NULL	Front_Immunol_2012_Jan_11_2_96.nxml.txt.nlp	22566885	SENT321	7	7	0	0	galactose	CD22	PA449725	933	0.869
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT94	6	6	30	30	curcumin	Bcl-2	PA151958596	596	0.869
NULL	Eur_J_Clin_Pharmacol_2012_Jan_8_68(1)_29-37.nxml.txt.nlp	21739267	SENT187	10	10	8	8	citalopram	CYP2D6	PA449015	1565	0.869
NULL	Acta_Pharmacol_Sin_2013_Apr_11_34(4)_473-479.nxml.txt.nlp	23474709	SENT165	5	5	8	8	arsenite	MRP2	PA452638	100130958;57626;1244	0.869
NULL	Oncotarget_2014_May_27_5(19)_9049-9064.nxml.txt.nlp	24979294	SENT201	4	4	16	16	dasatinib	AKT	PA162372878	207	0.869
NULL	J_Headache_Pain_2014_Dec_8_15(1)_85.nxml.txt.nlp	25488888	SENT102	21	21	10	10	rizatriptan	5-HT1B	PA451264	3351	0.869
NULL	Reprod_Biol_Endocrinol_2003_Feb_14_1_24.nxml.txt.nlp	12646052	SENT109	3	3	0	0	estradiol	ANOVA	PA449503	4858	0.869
NULL	Exp_Lung_Res_2013_Oct_1_39(8)_336-348.nxml.txt.nlp	23919450	SENT104	6	6	19	19	thrombin	PAR-1	PA451674	2011;2149	0.869
NULL	Pharmacogn_Mag_2014_Jan-Mar_10(37)_61-65.nxml.txt.nlp	24696547	SENT92	29	29	6	6	curcumin	CA1	PA151958596	759	0.869
NULL	J_Vis_Exp_2014_Jun_13_(88)_50668.nxml.txt.nlp	24962356	SENT25	26	26	41	41	trastuzumab	HER2	PA451743	2064	0.869
NULL	Cost_Eff_Resour_Alloc_2006_May_31_4_9.nxml.txt.nlp	16737538	SENT127	39	39	19	19	celecoxib	OTC	PA448871	5009	0.869
NULL	Oncotarget_2014_Sep_3_5(19)_9362-9381.nxml.txt.nlp	25313139	SENT121	6	6	25	25	orlistat	PTGS1	PA164776864	5742	0.869
NULL	J_Hematol_Oncol_2013_Dec_17_6_93.nxml.txt.nlp	24341609	SENT115	12	12	22	22	gefitinib	EGF	PA131301952	1950	0.869
NULL	Biologics_2012_Jan_5_6_13-20.nxml.txt.nlp	22291463	SENT61	16	16	3	3	cetuximab	EGFR	PA10040	1956	0.869
NULL	Acta_Pharmacol_Sin_2013_Feb_12_34(2)_255-261.nxml.txt.nlp	23147557	SENT156	26	26	19	19	pioglitazone	PTPRD	PA450970	5789	0.869
NULL	Biomed_Res_Int_2013_Dec_31_2013_273498.nxml.txt.nlp	23484100	SENT153	0	0	5	5	genistein	ABCG2	PA165109660	9429	0.869
NULL	Int_J_Gen_Med_2013_Dec_27_7_43-47.nxml.txt.nlp	24403843	SENT36	31	31	23	23	minocycline	RAIN	PA450519	54922	0.869
NULL	Front_Physiol_2013_Nov_14_4_323.nxml.txt.nlp	24294204	SENT94	32	32	6	6	bisoprolol	CYP2C9	PA448641	1559	0.869
NULL	Mol_Cancer_2007_Aug_21_6_53.nxml.txt.nlp	17711579	SENT154	34	34	13	13	cisplatin	BIRC7	PA449014	79444	0.869
NULL	J_Lipid_Res_2014_Oct_55(10)_2103-2112.nxml.txt.nlp	25139399	SENT48	29	29	0	0	niacin	CETP	PA450617	1071	0.869
NULL	J_Cell_Biol_1999_Jul_12_146(1)_233-242.nxml.txt.nlp	10402473	SENT104	19	19	10	10	paraformaldehyde	CO2	PA450790	4513	0.869
NULL	Ther_Clin_Risk_Manag_2007_Aug_3(4)_675-684.nxml.txt.nlp	18472990	SENT77	9	9	0	0	vancomycin	VISA	PA451850	57506	0.869
NULL	Endocr_Relat_Cancer_2014_Jun_21(3)_R209-R225.nxml.txt.nlp	24500760	SENT88	8	8	11	11	resveratrol	COX2		4513;5743	0.869
NULL	Br_J_Cancer_1997_76(8)_1029-1034.nxml.txt.nlp	9376262	SENT20	10	10	20	20	daunorubicin	P-gp	PA449212	5243	0.869
NULL	Cancer_Immunol_Immunother_2012_Jul_23_61(7)_1101-1111.nxml.txt.nlp	22193989	SENT156	12	12	6	6	oxaliplatin	IL-4	PA131285527	3565	0.869
NULL	Arthritis_Res_Ther_2013_Dec_3_15(6)_R205.nxml.txt.nlp	24295447	SENT139	38	38	14	14	methotrexate	RANKL	PA450428	8600	0.869
NULL	Comp_Hepatol_2005_Feb_8_4_2.nxml.txt.nlp	15701172	SENT185	12	12	9	9	ketoconazole	CYP3A	PA450146	1574	0.869
NULL	Libyan_J_Med_2006_Jul_28_1(1)_42-59.nxml.txt.nlp	21526020	SENT196	11	11	5	5	irinotecan	EGFR	PA450085	1956	0.869
NULL	Biomed_Res_Int_2013_Jul_18_2013_358945.nxml.txt.nlp	23971029	SENT159	18	18	8	8	genistein	NQO1	PA165109660	1728	0.869
NULL	Ther_Clin_Risk_Manag_2006_Sep_2(3)_235-249.nxml.txt.nlp	18360599	SENT332	30	30	19	19	alendronate	PTH	PA448082	5741	0.869
NULL	Diabetes_Metab_J_2012_Oct_18_36(5)_328-335.nxml.txt.nlp	23130316	SENT136	8	8	10	10	rosiglitazone	PDK4	PA451283	5166	0.869
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT208	4	4	25	25	adalimumab	DPI	PA10004	1832	0.869
NULL	Cancer_Cell_Int_2010_Apr_29_10_12.nxml.txt.nlp	20429927	SENT169	19	19	7	7	bortezomib	HRI	PA10252	27102	0.869
NULL	Nat_Med_2010_Jun_23_16(6)_671-677.nxml.txt.nlp	20495567	SENT128	7	7	29	29	sorafenib	ATF5	PA7000	22809	0.869
NULL	Oncotarget_2014_Aug_29_5(18)_8052-8082.nxml.txt.nlp	25211298	SENT129	19	19	5	5	aprepitant	NK-1	PA164747039	27087	0.869
NULL	Indian_J_Med_Res_2014_Jan_139(1)_27-65.nxml.txt.nlp	24604039	SENT215	12	12	21	21	sn-38	UGT1A1		54658	0.869
NULL	Breast_Cancer_Res_2012_Feb_14_14(1)_R30.nxml.txt.nlp	22333315	SENT228	27	27	23	23	celecoxib	COX	PA448871	1351	0.869
NULL	Genetics_2012_Jul_191(3)_765-780.nxml.txt.nlp	22505622	SENT280	19	19	8	8	staurosporine	Eaf3	PA165109623	10933	0.869
NULL	Kidney_Int_Suppl_(2011)_2013_Dec_27_3(5)_451-456.nxml.txt.nlp	25019029	SENT81	1	1	8	8	cinacalcet	PTH	PA164776671	5741	0.869
NULL	Fibrogenesis_Tissue_Repair_2011_Aug_2_4_18.nxml.txt.nlp	21810214	SENT120	7	7	0	0	bleomycin	TLR9	PA448645	54106	0.869
NULL	Acta_Pharmacol_Sin_2014_Aug_7_35(8)_1023-1030.nxml.txt.nlp	24998255	SENT192	25	25	10	10	octreotide	STAT3	PA450678	6774	0.869
NULL	Blood_Res_2014_Mar_24_49(1)_36-41.nxml.txt.nlp	24724065	SENT107	37	37	46	46	doxorubicin	CHOP	PA449412	1649	0.869
NULL	J_Oncol_2009_Jun_14_2009_814140.nxml.txt.nlp	19547715	SENT126	12	12	8	8	cisplatin	MRP1	PA449014	4437	0.869
NULL	Oncoimmunology_2012_Oct_1_1(7)_1191-1193.nxml.txt.nlp	23170276	SENT36	14	14	7	7	cyclophosphamide	CD4	PA449165	920	0.869
NULL	Pharmaceutics_2012_Jul_11_4(3)_343-353.nxml.txt.nlp	24300295	SENT173	37	37	16	16	hydrocortisone	ERM	PA449905	2119	0.869
NULL	Clin_Ophthalmol_2009_Oct_19_3_567-579.nxml.txt.nlp	19898629	SENT248	0	0	23	23	etanercept	p75	PA449515	7133;11168	0.869
NULL	Mol_Neurobiol_2010_Jun_2_41(2-3)_392-409.nxml.txt.nlp	20437209	SENT318	7	7	15	15	curcumin	LOX	PA151958596	4015	0.869
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT604	10	10	7	7	sulpiride	PRL	PA164745485	5617	0.869
NULL	Cell_Death_Dis_2011_Aug_11_2(8)_e191.nxml.txt.nlp	21833029	SENT72	47	47	30	30	oxaliplatin	CT26	PA131285527	168400	0.869
NULL	Oxid_Med_Cell_Longev_2013_Feb_24_2013_438321.nxml.txt.nlp	23533691	SENT65	10	10	13	13	trypsin	AAT	PA451806	5265	0.869
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT142	9	9	15	15	lopinavir	ABCB1	PA450264	5243	0.869
NULL	J_Cardiothorac_Surg_2012_Sep_27_7_97.nxml.txt.nlp	23013706	SENT29	13	13	10	10	warfarin	CYP4F2	PA451906	8529	0.869
NULL	Bone_Marrow_Transplant_2011_Mar_24_46(3)_430-435.nxml.txt.nlp	20498647	SENT25	0	0	20	20	daclizumab	IL2	PA164764446	3558	0.869
NULL	Cell_Commun_Signal_2013_Nov_11_11_86.nxml.txt.nlp	24215724	SENT23	10	10	5	5	thrombin	PAR1	PA451674	79581;2149	0.869
NULL	J_Biomed_Biotechnol_2003_Apr_21_2003(2)_102-109.nxml.txt.nlp	12721515	SENT43	14	14	26	26	ganciclovir	MUC1	PA449733	4582	0.869
NULL	Int_J_Emerg_Med_2010_May_26_3(2)_81-84.nxml.txt.nlp	20606815	SENT90	19	19	16	16	ritonavir	CYP3A4	PA451260	1576	0.869
NULL	Colomb_Med_(Cali)_44(1)_42-45.nxml.txt.nlp	24892321	SENT13	4	4	1	1	cyanocobalamin	B12	PA451892	7126;4709	0.869
NULL	Aging_(Albany_NY)_2010_Sep_18_2(9)_535-537.nxml.txt.nlp	20876940	SENT10	36	36	33	33	doxorubicin	HDM2	PA449412	4193	0.869
NULL	F1000Res_2013_Mar_5_2_74.nxml.txt.nlp	24358880	SENT386	31	31	7	7	capsaicin	TRPV1	PA448776	7442	0.869
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT245	17	17	39	39	pertuzumab	HER3		2065	0.869
NULL	Mol_Cancer_2007_Aug_21_6_53.nxml.txt.nlp	17711579	SENT179	16	16	0	0	cisplatin	BCL2L10	PA449014	10017	0.869
NULL	Emerg_Med_Int_2013_Oct_31_2013_258517.nxml.txt.nlp	24307946	SENT21	26	26	8	8	ceftriaxone	TMP	PA448866	2012	0.869
NULL	Eur_J_Endocrinol_2010_May_162(5)_987-992.nxml.txt.nlp	20164212	SENT106	22	22	16	16	diazoxide	HNF4A	PA449285	3172	0.869
NULL	Int_J_Mol_Sci_2014_Sep_9_15(9)_15791-15805.nxml.txt.nlp	25207595	SENT313	5	5	7	7	diethylstilbestrol	DES	PA449307	1674	0.869
NULL	Child_Adolesc_Psychiatry_Ment_Health_2009_Mar_12_3_9.nxml.txt.nlp	19284622	SENT42	8	8	22	22	ziprasidone	PES	PA451974	23481	0.869
NULL	Target_Oncol_2013_Jun_27_8(2)_127-136.nxml.txt.nlp	23625191	SENT48	11	11	4	4	panitumumab	KRAS	PA162373091	3845	0.869
NULL	Bone_Joint_Res_2014_Mar_1_3(3)_51-59.nxml.txt.nlp	24615710	SENT120	25	25	8	8	resveratrol	SIRT1		23411	0.869
NULL	J_Carcinog_2011_Nov_30_10_28.nxml.txt.nlp	22190870	SENT225	13	13	30	30	trastuzumab	STK10	PA451743	6793	0.869
NULL	AIDS_2013_Nov_28_27(18)_F21-F28.nxml.txt.nlp	24051706	SENT227	5	5	13	13	maraviroc	CD4	PA164768835	920	0.869
NULL	Nat_Med_2013_Mar_10_19(3)_313-321.nxml.txt.nlp	23396211	SENT137	11	11	0	0	amlexanox	UCP1	PA164745310	7350	0.869
NULL	Indian_J_Dermatol_2013_May-Jun_58(3)_247c.nxml.txt.nlp	23723524	SENT25	10	10	4	4	vincristine	CHOP	PA451879	1649	0.869
NULL	J_Carcinog_2013_Dec_31_12_22.nxml.txt.nlp	24574860	SENT84	47	47	19	19	afatinib	HER2	PA165981154	2064	0.869
NULL	Eur_J_Med_Res_2009_Nov_24_14(Suppl_3)_17-21.nxml.txt.nlp	19959412	SENT55	6	6	14	14	raltegravir	UGT		7361;7355	0.869
NULL	Int_J_Endocrinol_2010_Mar_2_2010_621687.nxml.txt.nlp	20204178	SENT177	2	2	10	10	paricalcitol	PTH	PA450798	5741	0.869
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT111	15	15	25	25	l-leucine	S6K1	PA450197	6198	0.869
NULL	J_Adv_Pract_Oncol_2013_Jul_1_Jul-Aug_4(4)_238-250.nxml.txt.nlp	25032004	SENT59	10	10	16	16	imatinib	KIT	PA10804	3815	0.869
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT222	13	13	16	16	perifosine	DR4	PA165291471	8797	0.869
NULL	Mol_Syst_Biol_2011_Apr_26_7_486.nxml.txt.nlp	21525872	SENT501	7	7	21	21	simvastatin	FGFR3	PA451363	2261	0.869
NULL	Int_J_Breast_Cancer_2011_Sep_6_2011_352182.nxml.txt.nlp	22295219	SENT131	12	12	17	17	trastuzumab	PTEN	PA451743	5728	0.869
NULL	Chin_J_Cancer_2012_Nov_31(11)_507-518.nxml.txt.nlp	22640626	SENT173	11	11	17	17	nilotinib	ARG	PA165958345	473;27	0.869
NULL	Ecancermedicalscience_2009_Oct_29_3_157.nxml.txt.nlp	22276018	SENT71	6	6	25	25	tamoxifen	EGFR	PA451581	1956	0.869
NULL	Acta_Pharmacol_Sin_2010_Sep_2_31(9)_1172-1180.nxml.txt.nlp	20676117	SENT181	7	7	16	16	bsi-201	PARP1		142	0.869
NULL	Thorax_2014_Jul_24_69(7)_638-647.nxml.txt.nlp	24567297	SENT86	42	42	21	21	doxycycline	TRAIL	PA449415	8743	0.869
NULL	J_Invest_Dermatol_2012_Nov_21_132(11)_2642-2651.nxml.txt.nlp	22718118	SENT224	4	4	20	20	collagenase	CD33	PA449107	945	0.869
NULL	Clin_Psychopharmacol_Neurosci_2012_Apr_30_10(1)_25-33.nxml.txt.nlp	23429852	SENT17	3	3	6	6	olanzapine	alpha-synuclein	PA450688	6622	0.869
NULL	Nucleic_Acids_Res_2012_Apr_16_40(8)_3641-3652.nxml.txt.nlp	22180534	SENT108	13	13	30	30	tobramycin	MS2	PA451704	101	0.869
NULL	Breast_Cancer_Res_2006_Nov_6_8(6)_215.nxml.txt.nlp	17096862	SENT41	12	12	8	8	trastuzumab	HER2	PA451743	2064	0.869
NULL	J_Bras_Pneumol_2014_May-Jun_40(3)_238-243.nxml.txt.nlp	25029646	SENT106	12	12	15	15	methylprednisolone	LPO	PA450466	4025	0.869
NULL	Nat_Commun_2013_Sep_4_4_2338.nxml.txt.nlp	24005565	SENT552	30	30	3	3	temozolomide	HELQ	PA451609	113510	0.869
NULL	FEBS_Open_Bio_2012_Aug_22_2_279-283.nxml.txt.nlp	23650611	SENT56	3	3	0	0	tamoxifen	IFN	PA451581	3439	0.869
NULL	Exp_Lung_Res_2013_Oct_1_39(8)_336-348.nxml.txt.nlp	23919450	SENT191	30	30	0	0	thrombin	PAR-1	PA451674	2011;2149	0.869
NULL	Allergy_Asthma_Immunol_Res_2009_Oct_25_1(1)_30-35.nxml.txt.nlp	20224667	SENT95	18	18	10	10	aspirin	PPARG	PA448497	5468	0.869
NULL	Front_Oncol_2014_Apr_1_4_58.nxml.txt.nlp	24744988	SENT172	20	20	33	33	cabozantinib	VEGFR2	PA165906891	3791	0.869
NULL	Neuro_Oncol_2010_Apr_27_12(4)_389-400.nxml.txt.nlp	20308316	SENT116	4	4	11	11	chloroquine	p53	PA448948	7157	0.869
NULL	J_Hematop_2009_Mar_5_2(1)_50-61.nxml.txt.nlp	19669224	SENT52	6	6	11	11	bortezomib	SKP2	PA10252	6502	0.869
NULL	Br_J_Cancer_2009_May_19_100(10)_1517-1522.nxml.txt.nlp	19367275	SENT68	25	25	45	45	trastuzumab	AKT	PA451743	207	0.869
NULL	Mol_Clin_Oncol_2013_Jul_15_1(4)_661-667.nxml.txt.nlp	24649225	SENT29	21	21	5	5	methotrexate	RFC1	PA450428	5981	0.869
NULL	Acta_Vet_Scand_2008_Jul_4_50(1)_27.nxml.txt.nlp	18601734	SENT146	32	32	17	17	doxorubicin	MTSS1	PA449412	9788	0.869
NULL	J_Immunother_2014_Feb_21_37(2)_105-114.nxml.txt.nlp	24509173	SENT169	26	26	14	14	gemcitabine	WT1	PA449748	7490	0.869
NULL	Tumour_Biol_2014_Jan_13_35(1)_257-264.nxml.txt.nlp	24222327	SENT127	34	34	28	28	artemisinin	mol	PA165111696	90527	0.869
NULL	Nano_Rev_2012_Jul_23_3_10_3402_nano_v3i0_17240.nxml.txt.nlp	22833780	SENT462	11	11	30	30	trastuzumab	HER2	PA451743	2064	0.869
NULL	Curr_Cardiol_Rev_2009_Aug_5(3)_166-176.nxml.txt.nlp	20676275	SENT76	15	15	7	7	clarithromycin	MiRP1	PA449028	9992	0.869
NULL	Biomed_Res_Int_2014_Jun_26_2014_161346.nxml.txt.nlp	25054130	SENT216	41	41	21	21	curcumin	STZ	PA151958596	6484	0.869
NULL	Biol_Proced_Online_2004_Mar_19_6_16-22.nxml.txt.nlp	15103396	SENT86	14	14	2	2	trypsin	HAND1	PA451806	9421	0.869
NULL	Orphanet_J_Rare_Dis_2014_Oct_29_9(1)_162.nxml.txt.nlp	NULL	SENT256	16	16	2	2	clarithromycin	CYP3A4	PA449028	1576	0.869
NULL	Clin_Psychopharmacol_Neurosci_2011_Aug_31_9(2)_45-53.nxml.txt.nlp	23429653	SENT37	15	15	4	4	olanzapine	TMAP	PA450688	26586	0.869
NULL	Oncotarget_2014_Aug_29_5(18)_8052-8082.nxml.txt.nlp	25211298	SENT389	5	5	20	20	ketoconazole	MRP1	PA450146	4437	0.869
NULL	BMB_Rep_2014_Nov_47(11)_649-654.nxml.txt.nlp	25301019	SENT130	18	18	11	11	l-serine	T1R1	PA451330	80835	0.869
NULL	Acta_Pharmacol_Sin_2011_Oct_15_32(10)_1303-1308.nxml.txt.nlp	21841812	SENT131	2	2	9	9	losartan	CYP2C9	PA450268	1559	0.869
NULL	Biomed_Res_Int_2014_Feb_19_2014_162314.nxml.txt.nlp	24701564	SENT74	5	5	12	12	lansoprazole	NHE	PA450180	285335	0.869
NULL	Br_J_Haematol_2014_Mar_13_164(1)_811-821.nxml.txt.nlp	24328678	SENT201	12	12	1	1	lenalidomide	Aiolos	PA162363968	22806	0.869
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT201	5	5	34	34	resveratrol	p53		7157	0.869
NULL	Ther_Clin_Risk_Manag_2006_Sep_2(3)_297-301.nxml.txt.nlp	18360604	SENT47	3	3	14	14	paricalcitol	PTH	PA450798	5741	0.869
NULL	Cardiovasc_Diabetol_2010_Sep_23_9_57.nxml.txt.nlp	20863381	SENT188	16	16	2	2	pioglitazone	DM2	PA450970	28508	0.869
NULL	Cell_Cycle_2013_Feb_15_12(4)_547-552.nxml.txt.nlp	23370393	SENT111	22	22	13	13	paraformaldehyde	53BP1	PA450790	7158	0.869
NULL	Breast_Cancer_Res_2009_Jun_29_11(3)_R41.nxml.txt.nlp	19563669	SENT19	29	29	5	5	gefitinib	XIAP	PA131301952	331	0.869
NULL	Oncogenesis_2014_Dec_15_3(12)_e133.nxml.txt.nlp	25500906	SENT8	40	40	12	12	trastuzumab	HER2	PA451743	2064	0.869
NULL	J_Gynecol_Oncol_2014_Jul_3_25(3)_236-248.nxml.txt.nlp	25045437	SENT260	15	15	9	9	trastuzumab	HER2	PA451743	2064	0.869
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT170	3	3	7	7	tacrolimus	OPG	PA451578	690	0.869
NULL	Contemp_Oncol_(Pozn)_2012_Feb_29_16(1)_86-89.nxml.txt.nlp	23788860	SENT45	21	21	9	9	etoposide	DDP	PA449552	1678	0.869
NULL	Leukemia_2013_Jan_11_27(1)_32-40.nxml.txt.nlp	22781593	SENT8	5	5	22	22	ponatinib	FGFR1	PA165980594	2260	0.869
NULL	J_Biomed_Biotechnol_2010_Mar_3_2010_289360.nxml.txt.nlp	20204129	SENT161	9	9	18	18	triamcinolone	MMP2	PA451749	4313	0.869
NULL	Chin_J_Cancer_2012_Mar_31(3)_126-133.nxml.txt.nlp	22237041	SENT34	0	0	21	21	lapatinib	HER2	PA152241907	2064	0.869
NULL	Cardiovasc_Diabetol_2013_May_4_12_73.nxml.txt.nlp	23642288	SENT27	28	28	13	13	acarbose	GLP-1	PA448010	100125288	0.869
NULL	Ind_Psychiatry_J_2011_Jan-Jun_20(1)_25-31.nxml.txt.nlp	22969177	SENT200	13	13	0	0	paliperidone	BARS	PA163518919	1487	0.869
NULL	Biomed_Res_Int_2013_Aug_7_2013_546318.nxml.txt.nlp	23986907	SENT70	14	14	0	0	hyaluronan	LYVE-1	PA165958431	10894	0.869
NULL	Osteoporos_Int_2012_May_19_23(5)_1613-1622.nxml.txt.nlp	21769661	SENT144	26	26	21	21	teriparatide	VCF	PA451620	7413	0.869
NULL	Curr_Genomics_2014_Jun_15(3)_217-230.nxml.txt.nlp	24955029	SENT180	20	20	27	27	oxygen	ROS	PA450744	6098	0.869
NULL	Biomed_Res_Int_2013_Dec_20_2013_162724.nxml.txt.nlp	23509685	SENT52	20	20	10	10	glibenclamide	STZ	PA449782	6484	0.869
NULL	Clin_Sci_(Lond)_2011_Nov_1_121(Pt_10)_449-458.nxml.txt.nlp	21671887	SENT114	25	25	0	0	simvastatin	ANOVA	PA451363	4858	0.869
NULL	Pharmaceuticals_(Basel)_2012_Jun_28_5(7)_674-689.nxml.txt.nlp	24281706	SENT559	11	11	0	0	trastuzumab	Hsp90	PA451743	3320	0.869
NULL	Breast_Cancer_Res_2011_Dec_16_13(6)_R131.nxml.txt.nlp	22177475	SENT275	35	35	23	23	gefitinib	AKT	PA131301952	207	0.869
NULL	Cancer_Cell_2007_Dec_11_12(6)_514-527.nxml.txt.nlp	18068629	SENT54	7	7	3	3	paclitaxel	TGFBI	PA450761	7045	0.869
NULL	Oncoimmunology_2013_May_1_2(5)_e24436.nxml.txt.nlp	23762809	SENT45	44	44	27	27	bevacizumab	RPC1	PA130232992	11128	0.869
NULL	Case_Rep_Gastroenterol_2011_May_3_5(2)_262-266.nxml.txt.nlp	21887126	SENT46	24	24	0	0	rituximab	CHOP	PA451261	1649	0.869
NULL	Front_Neurol_2011_Dec_16_2_72.nxml.txt.nlp	22203815	SENT49	12	12	6	6	protamine	VSOP	PA10366	84329	0.869
NULL	Oncotarget_2013_Aug_21_4(9)_1484-1495.nxml.txt.nlp	23986086	SENT161	35	35	5	5	metformin	PIK3CA	PA450395	5290	0.869
NULL	Pharmaceuticals_(Basel)_2013_Aug_21_6(8)_988-1038.nxml.txt.nlp	24276379	SENT2132	27	27	6	6	leucovorin	UGT1A7	PA450198	54577	0.869
NULL	Br_J_Cancer_2000_Jun_82(11)_1851-1859.nxml.txt.nlp	10839301	SENT9	22	22	6	6	bleomycin	CD95	PA448645	355	0.869
NULL	Nat_Biotechnol_2009_Jul_5_27(7)_659-666.nxml.txt.nlp	19581876	SENT106	12	12	27	27	nortriptyline	ADRB2	PA450657	154	0.869
NULL	BMB_Rep_2014_Feb_47(2)_60-68.nxml.txt.nlp	24411465	SENT685	16	16	3	3	efalizumab	TNF-alpha	PA164748817	7124	0.869
NULL	Anal_Chem_Insights_2014_Mar_2_9_1-7.nxml.txt.nlp	24634579	SENT23	9	9	16	16	fluoxetine	TRB	PA449673	6957	0.869
NULL	Braz_J_Med_Biol_Res_2013_Aug_13_46(8)_650-658.nxml.txt.nlp	23969971	SENT10	37	37	22	22	oxaliplatin	STAT3	PA131285527	6774	0.869
NULL	Arthritis_Res_Ther_2010_Oct_12_12(5)_R188.nxml.txt.nlp	20939892	SENT109	24	24	19	19	hyaluronidase	VIII	PA164745713	1351	0.869
NULL	Breast_Cancer_Res_2009_Jun_29_11(3)_R41.nxml.txt.nlp	19563669	SENT19	36	36	5	5	gefitinib	XIAP	PA131301952	331	0.869
NULL	Oncotarget_2013_Dec_18_5(2)_375-385.nxml.txt.nlp	24495868	SENT128	28	28	18	18	fludarabine	MCL1	PA449655	4170	0.869
NULL	Arthritis_Res_Ther_2013_Dec_19_15(6)_R218.nxml.txt.nlp	24351550	SENT47	2	2	6	6	methotrexate	AMPK	PA450428	5563	0.869
NULL	Clin_Psychopharmacol_Neurosci_2013_Dec_24_11(3)_144-151.nxml.txt.nlp	24465251	SENT82	17	17	37	37	quetiapine	IL-4	PA451201	3565	0.869
NULL	Oncotarget_2013_Apr_10_4(4)_622-635.nxml.txt.nlp	23599172	SENT80	3	3	5	5	gefitinib	EGF	PA131301952	1950	0.869
NULL	Pharmaceuticals_(Basel)_2012_Aug_30_5(9)_890-898.nxml.txt.nlp	24280696	SENT299	29	29	2	2	fludarabine	Hsp90	PA449655	3320	0.869
NULL	Exp_Diabetes_Res_2012_Jun_14_2012_859395.nxml.txt.nlp	22778716	SENT9	12	12	30	30	glucose	adiponectin	PA449773	9370	0.869
NULL	Breast_Cancer_Res_2012_May_4_14(3)_R72.nxml.txt.nlp	22559056	SENT209	8	8	13	13	tamoxifen	CENP-A	PA451581	1058	0.869
NULL	Br_J_Cancer_2014_Dec_9_111(12)_2205-2213.nxml.txt.nlp	25268373	SENT26	18	18	11	11	tamoxifen	aromatase	PA451581	1588	0.869
NULL	Viruses_2014_Oct_23_6(10)_4024-4046.nxml.txt.nlp	25341665	SENT565	16	16	12	12	heparin	KCP	PA449855	375616	0.869
NULL	Environ_Health_2011_Mar_18_10_20.nxml.txt.nlp	21418576	SENT27	22	22	1	1	estradiol	PCB	PA449503	5091	0.869
NULL	Cancer_Manag_Res_2011_Sep_9_3_301-309.nxml.txt.nlp	21931504	SENT126	4	4	8	8	dextran	CXCR4	PA449261	7852	0.869
NULL	Eur_J_Endocrinol_2011_Jan_164(1)_69-74.nxml.txt.nlp	20961967	SENT75	7	7	1	1	pioglitazone	adiponectin	PA450970	9370	0.869
NULL	Indian_J_Dermatol_2011_May-Jun_56(3)_306-308.nxml.txt.nlp	21772594	SENT69	27	27	21	21	vincristine	CHOP	PA451879	1649	0.869
NULL	Core_Evid_2010_Oct_21_5_61-76.nxml.txt.nlp	21042543	SENT199	23	23	19	19	panitumumab	EGFR	PA162373091	1956	0.869
NULL	Front_Oncol_2013_Nov_15_3_281.nxml.txt.nlp	24298448	SENT118	13	13	17	17	nutlin-3	p53		7157	0.869
NULL	Cell_Death_Differ_2011_Nov_13_18(11)_1791-1804.nxml.txt.nlp	21566658	SENT189	18	18	8	8	paraformaldehyde	P14	PA450790	11102;;6280;56259	0.869
NULL	J_Clin_Immunol_2007_May_14_27(3)_275-283.nxml.txt.nlp	17510806	SENT148	8	8	24	24	rosiglitazone	ZO-1	PA451283	7082	0.869
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT535	31	31	3	3	pp2	STAT3		6774	0.869
NULL	Breast_Cancer_Res_2007_Jun_7_9(3)_R37.nxml.txt.nlp	17555561	SENT23	13	13	5	5	letrozole	aromatase	PA450196	1588	0.869
NULL	Mol_Cancer_2010_Apr_16_9_79.nxml.txt.nlp	20398364	SENT189	25	25	19	19	geldanamycin	NAC	PA152031327	22861	0.869
NULL	Acta_Pharmacol_Sin_2010_Jun_4_31(6)_709-717.nxml.txt.nlp	20523342	SENT107	16	16	9	9	repaglinide	IGF2BP2	PA451234	10644	0.869
NULL	J_Immunother_Cancer_2014_Aug_19_2_27.nxml.txt.nlp	25324973	SENT38	8	8	15	15	vemurafenib	BRAF	PA165946873	673	0.869
NULL	Cancers_(Basel)_2010_May_11_2(2)_842-858.nxml.txt.nlp	24281097	SENT163	9	9	25	25	thrombin	PAR-1	PA451674	2011;2149	0.869
NULL	Cell_Cycle_2012_Nov_1_11(21)_3983-3996.nxml.txt.nlp	22987153	SENT88	18	18	11	11	cisplatin	DNA2	PA449014	1763	0.869
NULL	Breast_Cancer_Res_2007_Aug_8_9(4)_R50.nxml.txt.nlp	17686159	SENT258	21	21	14	14	gefitinib	AKT	PA131301952	207	0.869
NULL	Environ_Health_Perspect_2013_May_22_121(5)_551-557.nxml.txt.nlp	23434795	SENT167	15	15	6	6	hyaluronan	MCP-1	PA165958431	6347	0.869
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_P42.nxml.txt.nlp	NULL	SENT15	0	0	21	21	amoxicillin	CD4	PA448406	920	0.869
NULL	Pharmaceuticals_(Basel)_2011_Jan_12_4(1)_187-201.nxml.txt.nlp	NULL	SENT165	33	33	22	22	l-arginine	NOS2	PA448478	339345;4843	0.869
NULL	Cancer_Med_2014_Apr_27_3(2)_245-251.nxml.txt.nlp	24464861	SENT114	0	0	8	8	metformin	HIF1	PA450395	3091	0.869
NULL	Oncotarget_2013_Feb_27_4(2)_329-345.nxml.txt.nlp	23593654	SENT82	18	18	9	9	staurosporine	RSK1	PA165109623	6195	0.869
NULL	Front_Cell_Neurosci_2014_Jan_29_8_11.nxml.txt.nlp	24523671	SENT173	10	10	1	1	ethanol	GluN1	PA448073	2902	0.869
NULL	Cell_Commun_Signal_2009_Aug_13_7_19.nxml.txt.nlp	19678929	SENT47	5	5	29	29	cetuximab	KRAS	PA10040	3845	0.869
NULL	Exp_Ther_Med_2012_Sep_12_4(3)_475-480.nxml.txt.nlp	23181121	SENT159	4	4	0	0	doxorubicin	CHOP	PA449412	1649	0.869
NULL	Oncogene_2009_Feb_5_28(5)_674-685.nxml.txt.nlp	19015634	SENT102	20	20	12	12	hydroxyurea	FANCD2	PA449942	2177	0.869
NULL	Clin_Psychopharmacol_Neurosci_2013_Dec_24_11(3)_144-151.nxml.txt.nlp	24465251	SENT13	19	19	6	6	clozapine	IL-4	PA449061	3565	0.869
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1709-1716.nxml.txt.nlp	19844235	SENT227	22	22	8	8	gemcitabine	B7-H3	PA449748	80381	0.869
NULL	Int_J_Cell_Biol_2010_Jan_17_2010_930509.nxml.txt.nlp	20145727	SENT373	13	13	23	23	bortezomib	ATF4	PA10252	468	0.869
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT280	10	10	13	13	trastuzumab	HER2	PA451743	2064	0.869
NULL	Crit_Care_2001_Mar_2_5(Suppl_1)_P103.nxml.txt.nlp	NULL	SENT7	21	21	2	2	rolipram	ATIII	PA153906323	462	0.869
NULL	Adv_Ther_2013_Oct_25_30(10)_870-884.nxml.txt.nlp	24158787	SENT23	9	9	4	4	anastrozole	aromatase	PA448432	1588	0.869
NULL	Int_J_Biol_Sci_2011_Oct_25_7(9)_1298-1310.nxml.txt.nlp	22110382	SENT270	5	5	37	37	phenol	TNF-alpha	PA450913	7124	0.869
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT42	11	11	26	26	pemetrexed	UNG	PA10810	7374	0.869
NULL	Cancer_2014_Apr_8_120(8)_1145-1154.nxml.txt.nlp	24501009	SENT79	24	24	5	5	neratinib	EGFR	PA165291472	1956	0.869
NULL	Environ_Health_Perspect_2013_Oct_1_121(10)_A298-A303.nxml.txt.nlp	24218659	SENT41	13	13	15	15	diethylstilbestrol	DES	PA449307	1674	0.869
NULL	J_Biomed_Sci_2014_Feb_3_21(1)_10.nxml.txt.nlp	24490900	SENT120	11	11	18	18	alendronate	RANKL	PA448082	8600	0.869
NULL	Crit_Care_2008_Nov_12_12(6)_235.nxml.txt.nlp	19040780	SENT177	23	23	13	13	midazolam	CYP3A4	PA450496	1576	0.869
NULL	Clin_Med_Insights_Blood_Disord_2013_Nov_14_6_23-27.nxml.txt.nlp	25512717	SENT112	32	32	28	28	cyclophosphamide	CHOP	PA449165	1649	0.869
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT15	25	25	10	10	imatinib	ABCB1	PA10804	5243	0.869
NULL	Iran_J_Basic_Med_Sci_2012_Nov-Dec_15(6)_1202-1209.nxml.txt.nlp	23653852	SENT138	0	0	2	2	metformin	VEGF-A	PA450395	7422	0.869
NULL	Scientifica_(Cairo)_2013_Feb_7_2013_249101.nxml.txt.nlp	24278770	SENT187	10	10	18	18	alemtuzumab	IFN	PA164783958	3439	0.869
NULL	Nat_Chem_Biol_2010_Apr_28_6(4)_291-299.nxml.txt.nlp	20190765	SENT129	16	16	18	18	dasatinib	EGFR	PA162372878	1956	0.869
NULL	Open_Biol_2014_May_4(5)_140065.nxml.txt.nlp	24850914	SENT147	22	22	7	7	bortezomib	ALK3	PA10252	657	0.869
NULL	Nat_Commun_2010_Nov_30_1_130.nxml.txt.nlp	21119643	SENT49	6	6	15	15	fenofibrate	PS1	PA449594	5663	0.869
NULL	J_Cell_Biol_1999_Jan_25_144(2)_373-384.nxml.txt.nlp	9922462	SENT39	0	0	18	18	trypsin	TIMP2	PA451806	7077	0.869
NULL	J_Nutr_Metab_2011_Jul_28_2011_235389.nxml.txt.nlp	21811679	SENT28	14	14	0	0	olanzapine	CORT	PA450688	1325	0.869
NULL	Bioinformation_2012_Oct_1_8(19)_931-937.nxml.txt.nlp	23144553	SENT41	4	4	10	10	zinc	BANK	PA451956	55024	0.869
NULL	Breast_Cancer_Res_2004_Mar_26_6(3)_R252-R263.nxml.txt.nlp	15084249	SENT163	29	29	4	4	tamoxifen	CYP2A6	PA451581	1548	0.869
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT100	9	9	38	38	pp2	RAR		10966;5914	0.869
NULL	Oncol_Lett_2014_Nov_12_8(5)_2203-2208.nxml.txt.nlp	25295109	SENT79	8	8	13	13	celecoxib	GLI1	PA448871	2735	0.869
NULL	Indian_J_Pharm_Sci_2009_Nov-Dec_71(6)_622-629.nxml.txt.nlp	20376214	SENT72	9	9	1	1	captopril	B13	PA448780	4698	0.869
NULL	Curr_Oncol_2009_Jul_16(Suppl_2)_S1-S13.nxml.txt.nlp	19672416	SENT258	9	9	1	1	anastrozole	ATAC	PA448432	6375	0.869
NULL	Virol_J_2012_Feb_15_9_37.nxml.txt.nlp	22336004	SENT7	17	17	38	38	ethanol	PV-1	PA448073	83483	0.869
NULL	Protein_Cell_2014_Jun_19_5(6)_469-479.nxml.txt.nlp	24748116	SENT157	15	15	3	3	paclitaxel	EB1	PA450761	9167;22919;10982	0.869
NULL	Indian_J_Nucl_Med_2010_Jul-Sep_25(3)_78-87.nxml.txt.nlp	NULL	SENT212	12	12	18	18	piperazine	5-HT1A	PA450977	3350	0.869
NULL	Cancers_(Basel)_2014_Jul_17_6(3)_1500-1521.nxml.txt.nlp	25037020	SENT261	8	8	18	18	montelukast	5-LOX	PA450546	240	0.869
NULL	Breast_Cancer_Res_2009_Jun_23_11(Suppl_1)_P10.nxml.txt.nlp	NULL	SENT6	41	41	21	21	tamoxifen	p27	PA451581	5715;10534	0.869
NULL	Exp_Cell_Res_2011_Apr_15_317(7)_1028-1039.nxml.txt.nlp	21237154	SENT112	16	16	11	11	staurosporine	TRAIL	PA165109623	8743	0.869
NULL	Acta_Pharmacol_Sin_2014_Aug_7_35(8)_1023-1030.nxml.txt.nlp	24998255	SENT12	5	5	24	24	octreotide	SSTR2	PA450678	6752	0.869
NULL	Exp_Diabetes_Res_2012_Jul_19_2012_242984.nxml.txt.nlp	21785581	SENT57	0	0	18	18	rosiglitazone	adiponectin	PA451283	9370	0.869
NULL	Eur_J_Neurosci_2007_Sep_26(6)_1657-1669.nxml.txt.nlp	17880399	SENT362	7	7	13	13	haloperidol	DAO	PA449841	26;1610	0.869
NULL	Breast_Cancer_Res_2011_Oct_12_13(5)_220.nxml.txt.nlp	22018398	SENT197	26	26	32	32	vinorelbine	STAT3	PA451881	6774	0.869
NULL	Clin_Exp_Vaccine_Res_2013_Jul_3_2(2)_128-134.nxml.txt.nlp	23858404	SENT57	7	7	0	0	cisplatin	TC-1	PA449014	56892	0.869
NULL	Libyan_J_Med_2007_Dec_1_2(4)_169-175.nxml.txt.nlp	21503240	SENT239	27	27	33	33	yohimbine	CA1	PA451946	759	0.869
NULL	Braz_J_Med_Biol_Res_2014_Sep_5_47(11)_929-939.nxml.txt.nlp	25296354	SENT84	5	5	0	0	erlotinib	EGFR	PA134687924	1956	0.869
NULL	Diabetes_2009_Apr_23_58(4)_917-925.nxml.txt.nlp	19168598	SENT7	18	18	0	0	trypsin	FOXO1	PA451806	2308	0.869
NULL	Int_J_Mol_Sci_2014_Sep_15_15(9)_16284-16301.nxml.txt.nlp	25226537	SENT308	16	16	20	20	docetaxel	HER-2	PA449383	2064	0.869
NULL	Iran_J_Pharm_Res_2015_Winter_14(1)_321-328.nxml.txt.nlp	25561938	SENT78	7	7	28	28	forskolin	VASP	PA146096022	7408	0.869
NULL	Blood_Res_2014_Mar_24_49(1)_15-21.nxml.txt.nlp	24724062	SENT165	35	35	22	22	vincristine	CHOP	PA451879	1649	0.869
NULL	Ann_Oncol_2011_Mar_8_22(3)_503-514.nxml.txt.nlp	20616198	SENT25	11	11	27	27	letrozole	aromatase	PA450196	1588	0.869
NULL	Curr_Neuropharmacol_2008_Jun_6(2)_151-163.nxml.txt.nlp	19305794	SENT28	25	25	13	13	capsaicin	TRPV1	PA448776	7442	0.869
NULL	Mol_Vis_2012_Nov_29_18_2839-2846.nxml.txt.nlp	23233786	SENT120	7	7	15	15	geldanamycin	CB2	PA152031327	1269	0.869
NULL	Environ_Health_Perspect_2009_Feb_8_117(2)_175-180.nxml.txt.nlp	19270784	SENT18	18	18	9	9	doxorubicin	BPA	PA449412	667	0.869
NULL	Subst_Abuse_Treat_Prev_Policy_2007_Oct_31_2_32.nxml.txt.nlp	17974020	SENT209	11	11	39	39	methamphetamine	NMU	PA450403	10874	0.869
NULL	J_Lipid_Res_2015_Jan_56(1)_109-121.nxml.txt.nlp	25421061	SENT283	3	3	25	25	forskolin	CGI-58	PA146096022	51099	0.869
NULL	Case_Rep_Rheumatol_2011_Dec_15_2011_185657.nxml.txt.nlp	22937439	SENT93	15	15	3	3	etanercept	TNF-alpha	PA449515	7124	0.869
NULL	Clin_Interv_Aging_2009_May_14_4_197-205.nxml.txt.nlp	19503782	SENT319	7	7	14	14	cytarabine	CD33	PA449177	945	0.869
NULL	Exp_Ther_Med_2013_Nov_13_6(5)_1225-1228.nxml.txt.nlp	24223648	SENT154	6	6	19	19	capecitabine	CXCR4	PA448771	7852	0.869
NULL	Diabetes_2008_Sep_57(9)_2470-2479.nxml.txt.nlp	18511847	SENT141	1	1	14	14	pioglitazone	adiponectin	PA450970	9370	0.869
NULL	J_Biol_Chem_2010_Apr_23_285(17)_12979-12989.nxml.txt.nlp	20189985	SENT102	5	5	17	17	forskolin	PTH	PA146096022	5741	0.869
NULL	Leukemia_2013_Jan_11_27(1)_32-40.nxml.txt.nlp	22781593	SENT24	36	36	29	29	dasatinib	gamma	PA162372878	9913	0.869
NULL	Ann_Oncol_2011_May_3_22(5)_1078-1087.nxml.txt.nlp	21048039	SENT97	22	22	9	9	cetuximab	EGFR	PA10040	1956	0.869
NULL	Mol_Cancer_2010_Apr_21_9_83.nxml.txt.nlp	20409325	SENT215	19	19	13	13	doxycycline	MYCN	PA449415	4613	0.869
NULL	Ther_Clin_Risk_Manag_2006_Jun_2(2)_187-192.nxml.txt.nlp	18360592	SENT49	23	23	30	30	risperidone	5-HT2A	PA451257	3356	0.869
NULL	Cancer_Cell_Int_2013_Jun_26_13_63.nxml.txt.nlp	23800022	SENT13	3	3	5	5	genistein	MDM2	PA165109660	4193	0.869
NULL	Breast_Cancer_Res_2008_Dec_18_10(Suppl_4)_S25.nxml.txt.nlp	19128439	SENT10	9	9	11	11	tamoxifen	IMPACT	PA451581	55364	0.869
NULL	Br_J_Cancer_2013_Feb_19_108(3)_557-563.nxml.txt.nlp	23361053	SENT106	25	25	6	6	tamoxifen	PAK1	PA451581	5585;5058	0.868
NULL	Asia_Pac_Allergy_2013_Oct_31_3(4)_231-240.nxml.txt.nlp	24260728	SENT146	19	19	3	3	theophylline	CYP2E1	PA451647	1571	0.868
NULL	eLife_2014_May_7_3_e02669.nxml.txt.nlp	24843006	SENT158	6	6	30	30	tamoxifen	CD24	PA451581	100133941	0.868
NULL	Br_J_Cancer_2013_Feb_19_108(3)_557-563.nxml.txt.nlp	23361053	SENT166	19	19	3	3	tamoxifen	PAK1	PA451581	5585;5058	0.868
NULL	Mol_Cell_2014_Jun_5_54(5)_858-869.nxml.txt.nlp	24905007	SENT57	24	24	4	4	mitomycin	FANCD2	PA450524	2177	0.868
NULL	J_Biol_Chem_2013_Feb_22_288(8)_5530-5538.nxml.txt.nlp	23235146	SENT534	7	7	4	4	hyaluronan	TSG-6	PA165958431	7130	0.868
NULL	Sci_Rep_2014_Dec_1_4_7270.nxml.txt.nlp	25434829	SENT281	11	11	14	14	naltrexone	5-HT1A	PA450588	3350	0.868
NULL	Oncoimmunology_2012_Aug_1_1(5)_618-629.nxml.txt.nlp	22934254	SENT199	16	16	21	21	imatinib	IFN	PA10804	3439	0.868
NULL	J_Korean_Med_Sci_2008_Apr_20_23(2)_320-323.nxml.txt.nlp	18437019	SENT68	5	5	11	11	deferoxamine	IL-2	PA164746490	3558	0.868
NULL	J_Immune_Based_Ther_Vaccines_2008_Jun_9_6_3.nxml.txt.nlp	18541039	SENT24	0	0	11	11	ribavirin	IL-10	PA451241	3586	0.868
NULL	Nat_Med_2013_Oct_22_19(10)_1281-1287.nxml.txt.nlp	24056772	SENT75	6	6	25	25	chloroquine	VWF	PA448948	7450	0.868
NULL	J_Ophthalmol_2011_Oct_20_2011_252549.nxml.txt.nlp	22046503	SENT114	8	8	25	25	ranibizumab	KDR	PA164746012	3791	0.868
NULL	Alcohol_Res_2013_35(1)_77-85.nxml.txt.nlp	24313167	SENT98	6	6	38	38	ethanol	SOX2	PA448073	6657	0.868
NULL	Clin_Mol_Hepatol_2014_Mar_26_20(1)_38-46.nxml.txt.nlp	24757657	SENT23	8	8	2	2	ribavirin	IFN	PA451241	3439	0.868
NULL	Cardiovasc_Diabetol_2008_Aug_11_7_24.nxml.txt.nlp	18694484	SENT208	5	5	0	0	exenatide	Ray	PA164749238	26751	0.868
NULL	Epilepsia_2012_Jun_21_53(Suppl_1)_18-25.nxml.txt.nlp	22612805	SENT162	7	7	5	5	furosemide	NKCC1	PA449719	6558	0.868
NULL	Cancer_Imaging_2005_Nov_23_5(Spec_No_A)_S27-S32.nxml.txt.nlp	16361133	SENT130	7	7	14	14	choline	FDG	PA448976	23583	0.868
NULL	J_Gen_Physiol_1993_Mar_1_101(3)_337-353.nxml.txt.nlp	8386216	SENT4	35	35	24	24	propranolol	gamma	PA451145	9913	0.868
NULL	Oncol_Lett_2014_Jan_29_7(1)_121-124.nxml.txt.nlp	24348832	SENT12	5	5	11	11	cisplatin	p53	PA449014	7157	0.868
NULL	Target_Oncol_2013_Jun_27_8(2)_127-136.nxml.txt.nlp	23625191	SENT51	19	19	4	4	panitumumab	KRAS	PA162373091	3845	0.868
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_16_2012_395912.nxml.txt.nlp	23118789	SENT149	17	17	0	0	loxapine	UGT1A4	PA450273	54657	0.868
NULL	Indian_J_Ophthalmol_2011_Jan-Feb_59(1)_73-74.nxml.txt.nlp	21157086	SENT36	5	5	14	14	bevacizumab	ERG	PA130232992	2078	0.868
NULL	Mol_Cancer_2009_Nov_24_8_109.nxml.txt.nlp	19930708	SENT183	26	26	47	47	exemestane	aromatase	PA449563	1588	0.868
NULL	Br_J_Cancer_2009_Mar_10_100(5)_758-763.nxml.txt.nlp	19259094	SENT71	27	27	21	21	decitabine	MLH1	PA164749631	4292	0.868
NULL	Front_Genet_2012_Oct_10_3_206.nxml.txt.nlp	23087703	SENT240	1	1	7	7	omeprazole	CYP2C19	PA450704	1557	0.868
NULL	BMJ_Open_2014_Sep_17_4(9)_e005651.nxml.txt.nlp	25231491	SENT343	19	19	8	8	ketamine	HCN1	PA450144	348980	0.868
NULL	Osteoporos_Int_2011_Jan_1_22(1)_27-35.nxml.txt.nlp	20358360	SENT74	33	33	29	29	anastrozole	aromatase	PA448432	1588	0.868
NULL	Eur_Heart_J_2012_May_23_33(9)_1067-1075.nxml.txt.nlp	22362515	SENT113	14	14	24	24	phenylephrine	CTR	PA450935	799	0.868
NULL	Int_J_Mol_Sci_2013_Apr_16_14(4)_8291-8305.nxml.txt.nlp	23591843	SENT96	2	2	15	15	bevacizumab	VEGF-A	PA130232992	7422	0.868
NULL	Oncologist_2010_Mar_9_15(3)_236-245.nxml.txt.nlp	20215359	SENT88	7	7	17	17	bevacizumab	IFN	PA130232992	3439	0.868
NULL	Oncotarget_2011_Dec_21_2(12)_1134-1144.nxml.txt.nlp	22193779	SENT9	24	24	16	16	gefitinib	PC3	PA131301952	57332;7832;5122	0.868
NULL	Autoimmune_Dis_2011_Nov_1_2011_404101.nxml.txt.nlp	22110902	SENT142	5	5	15	15	azathioprine	OMG	PA448515	4974	0.868
NULL	J_Obes_2011_Apr_26_2011_250496.nxml.txt.nlp	21603262	SENT130	18	18	5	5	metformin	AMPK	PA450395	5563	0.868
NULL	Eur_J_Epidemiol_2007_Nov_23_22(11)_819-829.nxml.txt.nlp	17955331	SENT696	18	18	9	9	acenocoumarol	CYP2C9	PA452632	1559	0.868
NULL	FEBS_Open_Bio_2011_Dec_27_2_1-5.nxml.txt.nlp	23650573	SENT27	0	0	8	8	sunitinib	VEGFR	PA162372840	3791	0.868
NULL	Mol_Biol_Rep_2013_May_11_40(8)_5013-5026.nxml.txt.nlp	23666059	SENT34	8	8	26	26	resveratrol	p53		7157	0.868
NULL	Br_J_Cancer_2009_Mar_10_100(5)_758-763.nxml.txt.nlp	19259094	SENT136	41	41	0	0	belinostat	MLH1		4292	0.868
NULL	Breast_Cancer_(Dove_Med_Press)_2014_May_2_6_59-71.nxml.txt.nlp	24833917	SENT131	20	20	1	1	letrozole	aromatase	PA450196	1588	0.868
NULL	Oncoimmunology_2012_Aug_1_1(5)_618-629.nxml.txt.nlp	22934254	SENT212	2	2	15	15	triciribine	p38	PA165958661	10598;1432;7965	0.868
NULL	EMBO_Mol_Med_2013_Aug_1_5(8)_1196-1212.nxml.txt.nlp	23818228	SENT8	14	14	2	2	temozolomide	ZEB1	PA451609	6935	0.868
NULL	Front_Oncol_2014_May_16_4_107.nxml.txt.nlp	24904823	SENT212	12	12	34	34	metformin	c-Myc	PA450395	4609	0.868
NULL	Oncotarget_2011_Apr_20_2(4)_274-276.nxml.txt.nlp	21512204	SENT29	32	32	25	25	nutlin-3	p53		7157	0.868
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT226	16	16	9	9	cisplatin	p53	PA449014	7157	0.868
NULL	Chin_J_Cancer_2011_May_30(5)_293-302.nxml.txt.nlp	21527062	SENT67	21	21	30	30	trastuzumab	HER2	PA451743	2064	0.868
NULL	Breast_Cancer_Res_2010_Jun_28_12(3)_R43.nxml.txt.nlp	20579400	SENT239	20	20	27	27	tamoxifen	MAPT	PA451581	4137	0.868
NULL	Braz_J_Med_Biol_Res_2013_Apr_19_46(5)_440-446.nxml.txt.nlp	23598647	SENT91	5	5	38	38	chlorpheniramine	OAT	PA448960	4942	0.868
NULL	Clin_Psychopharmacol_Neurosci_2011_Apr_30_9(1)_36-43.nxml.txt.nlp	23431025	SENT15	3	3	14	14	haloperidol	FLI	PA449841	2314	0.868
NULL	Oncogene_2010_Sep_16_29(37)_5135-5145.nxml.txt.nlp	20622897	SENT137	12	12	30	30	cetuximab	HIF-1	PA10040	29072	0.868
NULL	J_Oncol_2010_Feb_22_2010_891059.nxml.txt.nlp	20182637	SENT148	25	25	12	12	cisplatin	BRCA1	PA449014	672	0.868
NULL	Clin_Psychopharmacol_Neurosci_2011_Apr_30_9(1)_36-43.nxml.txt.nlp	23431025	SENT14	15	15	3	3	aripiprazole	FLI	PA10026	2314	0.868
NULL	Leukemia_2013_Feb_3_27(2)_315-324.nxml.txt.nlp	22751450	SENT12	25	25	6	6	sorafenib	Mcl-1	PA7000	4170	0.868
NULL	Mol_Cancer_2009_Aug_25_8_66.nxml.txt.nlp	19706164	SENT36	18	18	4	4	celecoxib	COX	PA448871	1351	0.868
NULL	Ann_Rheum_Dis_2008_Dec_9_68(6)_789-796.nxml.txt.nlp	19066176	SENT203	7	7	35	35	adalimumab	STAR	PA10004	6770;2984	0.868
NULL	Pediatr_Cardiol_2010_Jan_14_31(1)_90-95.nxml.txt.nlp	19915892	SENT116	24	24	17	17	palivizumab	AAP	PA164748781	5345	0.868
NULL	Case_Rep_Gastroenterol_2009_Apr_10_3(1)_49-55.nxml.txt.nlp	20651965	SENT44	12	12	21	21	mitomycin	CEA	PA450524	5670;1087	0.868
NULL	Front_Surg_2015_Jan_5_1_50.nxml.txt.nlp	25593974	SENT194	36	36	21	21	cetuximab	KRAS	PA10040	3845	0.868
NULL	J_Exp_Clin_Cancer_Res_2009_Feb_15_28(1)_19.nxml.txt.nlp	19216799	SENT177	12	12	2	2	doxorubicin	AEG-1	PA449412	92140	0.868
NULL	Semin_Immunol_2011_Aug_23(4)_293-303.nxml.txt.nlp	21616680	SENT461	11	11	6	6	sirolimus	CD80	PA451365	941	0.868
NULL	Cell_Death_Dis_2013_Sep_5_4(9)_e791.nxml.txt.nlp	24008735	SENT74	12	12	23	23	gemcitabine	PUMA	PA449748	27113	0.868
NULL	J_Signal_Transduct_2011_Jun_7_2011_982879.nxml.txt.nlp	21776391	SENT63	31	31	8	8	cetuximab	EGFR	PA10040	1956	0.868
NULL	Mol_Cancer_2013_Mar_5_12_17.nxml.txt.nlp	23497256	SENT11	30	30	16	16	sunitinib	CD11b	PA162372840	3684	0.868
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT120	13	13	24	24	nutlin-3	p53		7157	0.868
NULL	Cell_Biosci_2011_Nov_7_1_36.nxml.txt.nlp	22060137	SENT52	15	15	5	5	paclitaxel	AEG-1	PA450761	92140	0.868
NULL	Lab_Invest_2010_Oct_28_90(10)_1415-1424.nxml.txt.nlp	20585313	SENT214	18	18	8	8	celecoxib	HRG	PA448871	3084;3273	0.868
NULL	Mar_Drugs_2011_Jun_23_9(6)_1142-1156.nxml.txt.nlp	21747752	SENT198	13	13	20	20	aprotinin	B12	PA448472	7126;4709	0.868
NULL	Brain_Res_2011_Mar_25_1382(C)_29-36.nxml.txt.nlp	21276431	SENT49	6	6	45	45	ketanserin	ANOVA	PA131053734	4858	0.868
NULL	Oncol_Lett_2013_Sep_28_6(3)_795-800.nxml.txt.nlp	24137413	SENT97	4	4	0	0	paclitaxel	HIF-1	PA450761	29072	0.868
NULL	Oncotarget_2014_Jun_8_5(13)_5040-5053.nxml.txt.nlp	24970815	SENT124	27	27	19	19	cisplatin	BBC3	PA449014	27113	0.868
NULL	Indian_J_Med_Paediatr_Oncol_2013_Jan-Mar_34(1)_24-27.nxml.txt.nlp	23878483	SENT7	9	9	3	3	paclitaxel	EGFR	PA450761	1956	0.868
NULL	Indian_J_Pharm_Sci_2008_Mar-Apr_70(2)_251-255.nxml.txt.nlp	20046726	SENT21	0	0	11	11	olanzapine	TRD	PA450688	6964	0.868
NULL	Front_Neurosci_2011_Mar_3_5_23.nxml.txt.nlp	21519398	SENT246	30	30	14	14	exenatide	GLP-1	PA164749238	100125288	0.868
NULL	Arch_Orthop_Trauma_Surg_2009_Oct_2_129(10)_1427-1432.nxml.txt.nlp	18677494	SENT111	28	28	16	16	ketorolac	COX	PA450150	1351	0.868
NULL	Emerg_Infect_Dis_2012_Apr_18(4)_689-691.nxml.txt.nlp	22469015	SENT33	5	5	20	20	ribavirin	CD4	PA451241	920	0.868
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_79-85.nxml.txt.nlp	23864840	SENT106	14	14	17	17	cetuximab	EGFR	PA10040	1956	0.868
NULL	J_Biol_Chem_2011_Oct_7_286(40)_34998-35006.nxml.txt.nlp	21757733	SENT32	7	7	29	29	lipase	HSL	PA450239	3991	0.868
NULL	J_Cell_Biol_2000_Jan_10_148(1)_59-72.nxml.txt.nlp	10629218	SENT177	11	11	5	5	staurosporine	Bcl-2	PA165109623	596	0.868
NULL	Nucleic_Acids_Res_2010_Oct_4_38(19)_6375-6388.nxml.txt.nlp	20525792	SENT271	36	36	30	30	doxycycline	YY1	PA449415	7528	0.868
NULL	Hum_Mol_Genet_2011_Mar_15_20(6)_1154-1163.nxml.txt.nlp	21199860	SENT182	16	16	3	3	doxycycline	BCL2	PA449415	596	0.868
NULL	Int_J_Environ_Res_Public_Health_2006_Mar_31_3(1)_23-30.nxml.txt.nlp	16823073	SENT181	16	16	22	22	salbutamol	CXCL8	PA448068	3576	0.868
NULL	Front_Immunol_2012_Nov_16_3_343.nxml.txt.nlp	23162557	SENT169	15	15	0	0	hyaluronan	LYVE-1	PA165958431	10894	0.868
NULL	Nat_Commun_2014_Nov_25_5_5548.nxml.txt.nlp	25420520	SENT97	23	23	3	3	paclitaxel	ERG	PA450761	2078	0.868
NULL	Acta_Pharmacol_Sin_2011_Jul_9_32(7)_879-887.nxml.txt.nlp	21552292	SENT165	6	6	18	18	metformin	AKT	PA450395	207	0.868
NULL	Aging_(Albany_NY)_2014_May_5_6(4)_320-334.nxml.txt.nlp	24827396	SENT93	1	1	19	19	oxygen	ADP	PA450744	23038	0.868
NULL	Oncogene_2009_Apr_23_28(16)_1821-1832.nxml.txt.nlp	19305428	SENT75	11	11	8	8	erlotinib	EGFR	PA134687924	1956	0.868
NULL	Cancer_Cell_Int_2012_Jun_6_12_22.nxml.txt.nlp	22672528	SENT44	6	6	21	21	perifosine	DR4	PA165291471	8797	0.868
NULL	Eur_J_Clin_Pharmacol_2011_May_2_67(Suppl_1)_87-107.nxml.txt.nlp	21287160	SENT112	0	0	6	6	aprepitant	NK1	PA164747039	11126	0.868
NULL	J_Oral_Pathol_Med_2013_Jul_18_42(6)_499-506.nxml.txt.nlp	23331485	SENT183	12	12	7	7	celecoxib	COX	PA448871	1351	0.868
NULL	Blood_Res_2014_Dec_23_49(4)_253-258.nxml.txt.nlp	25548759	SENT75	7	7	26	26	vincristine	CHOP	PA451879	1649	0.868
NULL	J_Headache_Pain_2014_Sep_18_15(Suppl_1)_F28.nxml.txt.nlp	NULL	SENT19	29	29	26	26	telmisartan	P-gp	PA451605	5243	0.868
NULL	Curr_Gerontol_Geriatr_Res_2010_May_4_2010_420139.nxml.txt.nlp	20454643	SENT88	5	5	11	11	estradiol	AMPK	PA449503	5563	0.868
NULL	J_Cell_Biol_1986_Jul_1_103(1)_87-94.nxml.txt.nlp	3013901	SENT9	9	9	3	3	glutaraldehyde	EGF	PA449777	1950	0.868
NULL	Br_J_Cancer_2013_Feb_19_108(3)_557-563.nxml.txt.nlp	23361053	SENT153	17	17	29	29	tamoxifen	IPA	PA451581	3160	0.868
NULL	J_Hematol_Oncol_2012_Oct_10_5_62.nxml.txt.nlp	23050865	SENT100	6	6	3	3	erlotinib	EGFR	PA134687924	1956	0.868
NULL	Curr_Pain_Headache_Rep_2013_May_13_17(5)_334.nxml.txt.nlp	23584563	SENT372	13	13	17	17	sumatriptan	MELAS	PA451566	4219	0.868
NULL	Br_J_Cancer_2012_Jul_10_107(2)_360-369.nxml.txt.nlp	22713663	SENT92	20	20	9	9	bevacizumab	DDP	PA130232992	1678	0.868
NULL	Acta_Pharmacol_Sin_2014_Oct_25_35(10)_1293-1301.nxml.txt.nlp	25152022	SENT127	7	7	16	16	enalapril	NLRP3	PA449456	114548	0.868
NULL	Arthritis_Rheumatol_2014_Jun_27_66(6)_1574-1582.nxml.txt.nlp	24577881	SENT113	4	4	19	19	hydralazine	CD28	PA449894	1493;940	0.868
NULL	Eur_J_Med_Res_2009_Nov_24_14(Suppl_3)_17-21.nxml.txt.nlp	19959412	SENT12	19	19	17	17	raltegravir	UGT		7361;7355	0.868
NULL	Diabetes_2008_Sep_57(9)_2332-2340.nxml.txt.nlp	18567824	SENT128	20	20	14	14	atropine	ghrelin	PA448505	51738	0.868
NULL	Core_Evid_2009_Jun_15_4_131-147.nxml.txt.nlp	20694070	SENT191	2	2	11	11	raltegravir	CD4		920	0.868
NULL	J_Korean_Neurosurg_Soc_2014_Sep_30_56(3)_175-187.nxml.txt.nlp	25368758	SENT163	36	36	17	17	oxygen	CPP	PA450744	340451	0.868
NULL	Indian_J_Urol_2007_Jan-Mar_23(1)_61-66.nxml.txt.nlp	19675766	SENT66	26	26	1	1	docetaxel	Bcl-2	PA449383	596	0.868
NULL	Case_Rep_Med_2009_Aug_9_2009_378287.nxml.txt.nlp	19721707	SENT44	9	9	27	27	tadalafil	CYP3A	PA10333	1574	0.868
NULL	Front_Oncol_2014_Apr_9_4_75.nxml.txt.nlp	24782986	SENT178	15	15	35	35	paclitaxel	Oct4	PA450761	5460	0.868
NULL	J_Exp_Med_2000_May_15_191(10)_1745-1754.nxml.txt.nlp	10811867	SENT45	34	34	0	0	l-glutamine	BTK	PA10090	695	0.868
NULL	Breast_Cancer_Res_2014_Sep_9_16(5)_437.nxml.txt.nlp	25200860	SENT274	13	13	6	6	pha-665752	Met		79811	0.868
NULL	Comput_Struct_Biotechnol_J_2013_Apr_5_5_e201302012.nxml.txt.nlp	24688705	SENT93	13	13	21	21	glucosamine	MD-2	PA164747613	23643	0.868
NULL	Front_Pharmacol_2014_Nov_26_5_258.nxml.txt.nlp	25505415	SENT60	13	13	25	25	metoprolol	CYP2D6	PA450480	1565	0.868
NULL	Part_Fibre_Toxicol_2011_Jan_25_8_5.nxml.txt.nlp	21266073	SENT93	8	8	1	1	glutaraldehyde	BAL	PA449777	83666	0.868
NULL	Br_J_Cancer_2013_Jul_9_109(1)_68-75.nxml.txt.nlp	23807173	SENT180	11	11	8	8	cisplatin	XPA	PA449014	7507	0.868
NULL	Biomed_Res_Int_2014_Feb_17_2014_614506.nxml.txt.nlp	24696859	SENT116	14	14	18	18	indomethacin	COX	PA449982	1351	0.868
NULL	Oncotarget_2013_Oct_19_4(11)_2045-2056.nxml.txt.nlp	24185104	SENT101	20	20	14	14	cisplatin	p38	PA449014	10598;1432;7965	0.868
NULL	Clin_Epidemiol_2014_Apr_1_6_111-118.nxml.txt.nlp	24729727	SENT69	28	28	35	35	ethionamide	DST	PA164768738	667	0.868
NULL	Int_J_Nanomedicine_2012_Sep_13_7_4917-4926.nxml.txt.nlp	23028220	SENT119	7	7	26	26	calcein	mol	PA132595336	90527	0.868
NULL	Cancers_(Basel)_2010_Dec_30_3(1)_106-125.nxml.txt.nlp	24212609	SENT86	14	14	2	2	gemcitabine	S100A4	PA449748	6275	0.868
NULL	Acta_Histochem_Cytochem_2014_Jun_28_47(3)_103-112.nxml.txt.nlp	25320407	SENT239	8	8	21	21	estradiol	SF-1	PA449503	2516	0.868
NULL	Arthritis_Res_Ther_2003_Aug_5_5(6)_R310-R316.nxml.txt.nlp	12932295	SENT37	7	7	11	11	thrombin	San	PA451674	80218	0.868
NULL	Indian_Dermatol_Online_J_2014_Dec_5(Suppl_2)_S140-S141.nxml.txt.nlp	25593810	SENT31	6	6	13	13	calcipotriol	CO2	PA448714	4513	0.868
NULL	Cancer_Med_2013_Feb_3_2(1)_76-85.nxml.txt.nlp	24133630	SENT183	4	4	7	7	vemurafenib	PI3K	PA165946873	5290	0.868
NULL	Case_Rep_Infect_Dis_2011_Jun_30_2011_530568.nxml.txt.nlp	22570799	SENT47	31	31	39	39	infliximab	TNF-alpha	PA452639	7124	0.868
NULL	Oncotarget_2014_Sep_16_5(20)_10034-10047.nxml.txt.nlp	25296981	SENT179	43	43	26	26	doxorubicin	CHK2	PA449412	11200	0.868
NULL	Br_J_Pharmacol_2014_May_11_171(9)_2385-2398.nxml.txt.nlp	24467222	SENT172	0	0	2	2	rolipram	Rho	PA153906323	29984	0.868
NULL	Acta_Pharmacol_Sin_2010_Feb_5_31(2)_137-144.nxml.txt.nlp	20139896	SENT139	20	20	23	23	zileuton	5-LOX	PA451955	240	0.868
NULL	Antimicrob_Agents_Chemother_2014_Oct_58(10)_5900-5908.nxml.txt.nlp	25070091	SENT275	4	4	26	26	metoprolol	CYP2D6	PA450480	1565	0.868
NULL	Cell_Biol_Int_Rep_(2010)_2012_Jun_21_19(1)_e00017.nxml.txt.nlp	23124518	SENT137	1	1	29	29	etoposide	TRAIL	PA449552	8743	0.868
NULL	J_Invest_Dermatol_2012_Nov_21_132(11)_2642-2651.nxml.txt.nlp	22718118	SENT56	11	11	15	15	collagenase	CD11b	PA449107	3684	0.868
NULL	Case_Rep_Pathol_2014_Jul_15_2014_313974.nxml.txt.nlp	25133003	SENT66	15	15	30	30	thyroglobulin	CEA	PA164754910	5670;1087	0.868
NULL	Exp_Diabetes_Res_2011_Jun_4_2011_489708.nxml.txt.nlp	21747829	SENT112	20	20	31	31	aliskiren	GLP-1	PA143487910	100125288	0.868
NULL	J_Cell_Biol_2001_Mar_5_152(5)_877-894.nxml.txt.nlp	11238446	SENT100	14	14	2	2	heparin	FTCD	PA449855	10841	0.868
NULL	Int_J_Mol_Sci_2014_May_12_15(5)_8372-8392.nxml.txt.nlp	24823882	SENT81	2	2	22	22	oxygen	AP-1	PA450744	2353;3727;2354;3725	0.868
NULL	Mol_Cell_Proteomics_2012_Feb_6_11(2)_M111_015222.nxml.txt.nlp	22147731	SENT165	6	6	20	20	gefitinib	EGF	PA131301952	1950	0.868
NULL	Neuro_Oncol_2010_Mar_6_12(3)_233-242.nxml.txt.nlp	20167811	SENT10	33	33	22	22	bevacizumab	U87	PA130232992	677775;641648	0.868
NULL	Clin_Med_Insights_Cardiol_2013_Aug_11_7_127-140.nxml.txt.nlp	23997577	SENT84	0	0	16	16	dronedarone	CYP3A4	PA153619853	1576	0.868
NULL	Exp_Diabetes_Res_2012_Feb_19_2012_749812.nxml.txt.nlp	22454628	SENT133	16	16	18	18	resveratrol	AMPK		5563	0.868
NULL	Curr_Cardiol_Rev_2008_Nov_4(4)_259-268.nxml.txt.nlp	20066133	SENT136	4	4	23	23	resveratrol	STZ		6484	0.868
NULL	Cancer_Cell_Int_2007_Sep_10_7_14.nxml.txt.nlp	17845729	SENT164	14	14	25	25	decitabine	NFKBIA	PA164749631	4792	0.868
NULL	J_Signal_Transduct_2011_Feb_24_2011_804236.nxml.txt.nlp	21637380	SENT22	0	0	11	11	trastuzumab	HER2	PA451743	2064	0.868
NULL	J_Cell_Mol_Med_2013_Jan_10_17(1)_30-54.nxml.txt.nlp	23301832	SENT222	18	18	11	11	daunorubicin	PC3	PA449212	57332;7832;5122	0.868
NULL	Antiviral_Res_2009_May_82(2)_A99-A109.nxml.txt.nlp	19176219	SENT866	10	10	20	20	indinavir	CD4	PA449977	920	0.868
NULL	Cell_Commun_Signal_2011_May_15_9_13.nxml.txt.nlp	21569639	SENT320	12	12	23	23	quinacrine	p53	PA164745551	7157	0.868
NULL	Endocrinol_Metab_(Seoul)_2014_Sep_25_29(3)_379-387.nxml.txt.nlp	25309798	SENT113	6	6	17	17	resveratrol	CLOCK		9575	0.868
NULL	J_Inherit_Metab_Dis_2010_Oct_3_33(5)_625-632.nxml.txt.nlp	20814828	SENT133	13	13	26	26	simvastatin	RhoA	PA451363	387	0.868
NULL	Diabetes_Care_2013_Jun_15_36(6)_1629-1634.nxml.txt.nlp	23321217	SENT152	10	10	13	13	atorvastatin	CD34	PA448500	947	0.868
NULL	Target_Oncol_2013_Jun_27_8(2)_127-136.nxml.txt.nlp	23625191	SENT50	17	17	2	2	panitumumab	KRAS	PA162373091	3845	0.868
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jul_23_67(Pt_8)_m1132.nxml.txt.nlp	22090894	SENT58	12	12	7	7	ethanol	mol	PA448073	90527	0.868
NULL	Mol_Cancer_2009_Jul_3_8_43.nxml.txt.nlp	19575780	SENT295	23	23	1	1	oxaliplatin	survivin	PA131285527	332	0.868
NULL	Cancers_(Basel)_2010_Jan_14_2(1)_1-19.nxml.txt.nlp	24281029	SENT1001	11	11	21	21	paclitaxel	San	PA450761	80218	0.868
NULL	Mol_Cancer_2010_May_18_9_110.nxml.txt.nlp	20482802	SENT152	29	29	9	9	bortezomib	p53	PA10252	7157	0.868
NULL	J_Mol_Recognit_2013_Dec_11_26(12)_679-688.nxml.txt.nlp	24277613	SENT57	0	0	23	23	kanamycin	ACC2	PA450137	32	0.868
NULL	Cancers_(Basel)_2014_Nov_26_6(4)_2330-2342.nxml.txt.nlp	25534570	SENT506	12	12	3	3	cisplatin	VEGFR2	PA449014	3791	0.868
NULL	Oncotarget_2014_May_27_5(19)_9049-9064.nxml.txt.nlp	24979294	SENT236	13	13	9	9	fulvestrant	EGFR	PA164747170	1956	0.868
NULL	Arthritis_Res_Ther_2011_Feb_4_13(1)_R14.nxml.txt.nlp	21294864	SENT91	4	4	17	17	indomethacin	IL-17	PA449982	3605	0.868
NULL	Clin_Ophthalmol_2007_Sep_1(3)_225-232.nxml.txt.nlp	19668476	SENT41	6	6	25	25	latanoprost	C-1	PA164774763	5203	0.868
NULL	Oncotarget_2014_Oct_21_5(22)_11709-11722.nxml.txt.nlp	25365944	SENT119	4	4	13	13	metformin	JNK	PA450395	5599	0.868
NULL	Br_J_Haematol_2014_Jul_25_166(1)_77-83.nxml.txt.nlp	24661044	SENT21	8	8	6	6	cyclophosphamide	CHOP	PA449165	1649	0.868
NULL	J_Exp_Clin_Cancer_Res_2009_Feb_15_28(1)_19.nxml.txt.nlp	19216799	SENT135	22	22	14	14	doxorubicin	AEG-1	PA449412	92140	0.868
NULL	Ann_Oncol_2011_Dec_17_22(12)_2610-2615.nxml.txt.nlp	21415234	SENT189	8	8	20	20	lapatinib	HER2	PA152241907	2064	0.868
NULL	Clin_Exp_Otorhinolaryngol_2008_Mar_20_1(1)_41-45.nxml.txt.nlp	19434261	SENT13	3	3	20	20	thyroglobulin	RAI	PA164754910	10848;6050	0.868
NULL	Nat_Commun_2013_Oct_1_4_2516.nxml.txt.nlp	24084631	SENT392	0	0	3	3	losartan	AT1	PA450268	9197;185	0.868
NULL	Br_J_Cancer_2010_Jan_5_102(1)_104-114.nxml.txt.nlp	20051961	SENT210	7	7	20	20	tamoxifen	PDK1	PA451581	5170;5163	0.868
NULL	Front_Immunol_2013_May_15_4_116.nxml.txt.nlp	23720663	SENT1815	14	14	5	5	cyclophosphamide	CD25	PA449165	3669;3559	0.868
NULL	Br_J_Cancer_2009_Jul_21_101(2)_238-243.nxml.txt.nlp	19568242	SENT123	30	30	11	11	bevacizumab	IFN	PA130232992	3439	0.868
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT122	5	5	9	9	vemurafenib	ABCB1	PA165946873	5243	0.868
NULL	Breast_Cancer_(Auckl)_2009_Aug_17_3_47-60.nxml.txt.nlp	21556249	SENT48	45	45	41	41	tamoxifen	AF-1	PA451581	3460;5710	0.868
NULL	Breast_Cancer_Res_Treat_2013_Jan_13_137(2)_471-482.nxml.txt.nlp	23239151	SENT33	18	18	25	25	pazopanib	HER2	PA165291492	2064	0.868
NULL	Diabetes_2011_Jan_4_60(1)_119-126.nxml.txt.nlp	20921208	SENT238	6	6	18	18	glucose	TRPM2	PA449773	7226	0.868
NULL	Cancers_(Basel)_2014_Apr_9_6(2)_829-859.nxml.txt.nlp	24722453	SENT262	6	6	16	16	curcumin	JAK2	PA151958596	3717	0.868
NULL	Front_Oncol_2013_Oct_31_3_273.nxml.txt.nlp	24199173	SENT293	16	16	19	19	docetaxel	p38	PA449383	10598;1432;7965	0.868
NULL	J_Biol_Chem_2014_Dec_26_289(52)_36018-36030.nxml.txt.nlp	25336647	SENT485	18	18	26	26	s-adenosylmethionine	CBS	PA164754994	875	0.868
NULL	Arch_Microbiol_2012_Apr_24_194(4)_255-268.nxml.txt.nlp	21947170	SENT273	12	12	27	27	ceftriaxone	MN1	PA448866	4330	0.868
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT117	10	10	20	20	atorvastatin	IL-6	PA448500	3569	0.868
NULL	Ther_Clin_Risk_Manag_2006_Sep_2(3)_229-234.nxml.txt.nlp	18360598	SENT56	3	3	25	25	oxycodone	CYP2D6	PA450741	1565	0.868
NULL	Mol_Neurodegener_2010_Nov_10_5_50.nxml.txt.nlp	21067605	SENT187	8	8	0	0	calcein	LIP	PA132595336	23049	0.868
NULL	Case_Rep_Med_2012_Dec_3_2012_163173.nxml.txt.nlp	23326270	SENT8	5	5	10	10	fenofibrate	CPT2	PA449594	1376	0.868
NULL	Biomed_Res_Int_2014_Jan_20_2014_948427.nxml.txt.nlp	24563867	SENT126	22	22	4	4	glucose	5-HT1A	PA449773	3350	0.868
NULL	Mol_Cancer_2014_Jun_5_13_143.nxml.txt.nlp	24898067	SENT278	26	26	14	14	erlotinib	EGFR	PA134687924	1956	0.868
NULL	Cell_Death_Dis_2013_Jun_27_4(6)_e694.nxml.txt.nlp	23807223	SENT62	3	3	9	9	chloroquine	p62	PA448948	8878;10657;23636	0.868
NULL	Environ_Health_Perspect_2006_Sep_23_114(9)_1401-1406.nxml.txt.nlp	16966095	SENT148	0	0	18	18	arsenite	p53	PA452638	7157	0.868
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1059-1066.nxml.txt.nlp	21364577	SENT59	7	7	18	18	aminoglutethimide	aromatase	PA448375	1588	0.868
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Oct_28_65(Pt_11)_o2898.nxml.txt.nlp	21578480	SENT59	16	16	29	29	ethanol	mol	PA448073	90527	0.868
NULL	Eur_J_Endocrinol_2011_Jan_164(1)_69-74.nxml.txt.nlp	20961967	SENT14	20	20	12	12	pioglitazone	OPG	PA450970	690	0.868
NULL	Exp_Diabetes_Res_2012_Nov_1_2012_892706.nxml.txt.nlp	23197976	SENT186	34	34	21	21	vildagliptin	HIF-1	PA165958346	29072	0.868
NULL	Mol_Med_Rep_2015_Feb_29_11(2)_821-828.nxml.txt.nlp	25354708	SENT8	33	33	29	29	estradiol	OATP1	PA449503	4945;53919	0.868
NULL	Breast_Cancer_Res_2008_Dec_5_10(6)_R104.nxml.txt.nlp	19061505	SENT231	12	12	35	35	ethanol	JNK	PA448073	5599	0.868
NULL	Drugs_R_D_2011_Mar_27_11(1)_37-51.nxml.txt.nlp	21410294	SENT2	30	30	15	15	itraconazole	CYP3A4	PA450132	1576	0.868
NULL	Oncotarget_2012_Dec_30_3(12)_1505-1521.nxml.txt.nlp	23455493	SENT95	29	29	20	20	doxorubicin	Raf-1	PA449412	5894	0.868
NULL	Croat_Med_J_2012_Aug_53(4)_314-320.nxml.txt.nlp	22911523	SENT113	43	43	29	29	pertuzumab	HER2		2064	0.868
NULL	Acta_Pharmacol_Sin_2012_Jan_28_33(1)_75-81.nxml.txt.nlp	22120969	SENT147	30	30	7	7	exenatide	GLP-1	PA164749238	100125288	0.868
NULL	J_Mol_Med_(Berl)_2014_May_10_92(7)_709-722.nxml.txt.nlp	24811491	SENT125	29	29	21	21	cetuximab	HER2	PA10040	2064	0.868
NULL	Cell_Commun_Signal_2011_May_20_9_14.nxml.txt.nlp	21599982	SENT19	14	14	17	17	pp2	ERK		5594	0.868
NULL	Int_J_Hypertens_2013_Dec_9_2013_547809.nxml.txt.nlp	24386559	SENT141	24	24	16	16	valsartan	AT1	PA451848	9197;185	0.868
NULL	Adv_Hematol_2012_Nov_20_2012_861060.nxml.txt.nlp	23251161	SENT70	0	0	6	6	lenalidomide	FOXP3	PA162363968	50943	0.868
NULL	Exp_Ther_Med_2015_Jan_5_9(1)_84-88.nxml.txt.nlp	25452780	SENT111	2	2	35	35	vildagliptin	GLP-1	PA165958346	100125288	0.868
NULL	Mol_Cancer_2010_May_17_9_108.nxml.txt.nlp	20478051	SENT70	13	13	0	0	deferoxamine	PC-3	PA164746490	692094	0.868
NULL	Cancer_Cell_Int_2013_Feb_12_13_14.nxml.txt.nlp	23402310	SENT115	25	25	5	5	celecoxib	p65	PA448871	5970	0.868
NULL	J_Invest_Dermatol_2012_Nov_21_132(11)_2642-2651.nxml.txt.nlp	22718118	SENT56	11	11	19	19	collagenase	CD33	PA449107	945	0.868
NULL	J_Biol_Chem_2008_Apr_4_283(14)_8837-8845.nxml.txt.nlp	18250166	SENT192	10	10	19	19	trypsin	StAR	PA451806	6770	0.868
NULL	Indian_J_Med_Res_2012_Dec_136(6)_926-941.nxml.txt.nlp	23391788	SENT177	38	38	18	18	clopidogrel	CYP2C19	PA449053	1557	0.868
NULL	Mol_Clin_Oncol_2013_Sep_26_1(5)_799-804.nxml.txt.nlp	24649249	SENT103	28	28	20	20	erlotinib	EGFR	PA134687924	1956	0.868
NULL	J_Cell_Mol_Med_2013_Dec_6_17(12)_1588-1597.nxml.txt.nlp	24199964	SENT242	6	6	24	24	doxycycline	APT	PA449415	653639	0.868
NULL	J_Neuroinflammation_2011_Feb_4_8_10.nxml.txt.nlp	21294877	SENT112	15	15	26	26	capsaicin	NK1	PA448776	11126	0.868
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Dec_17_3(12)_e152.nxml.txt.nlp	25518025	SENT48	13	13	6	6	paroxetine	CYP2D6	PA450801	1565	0.868
NULL	Breast_Cancer_Res_2008_Mar_27_10(2)_R27.nxml.txt.nlp	18371219	SENT143	36	36	7	7	camptothecin	HER2	PA153590860	2064	0.868
NULL	eLife_2014_May_27_3_e02200.nxml.txt.nlp	24867637	SENT56	26	26	35	35	nutlin-3	p53		7157	0.868
NULL	Oncogene_2010_Mar_11_29(10)_1509-1518.nxml.txt.nlp	19946334	SENT98	1	1	21	21	bortezomib	pS2	PA10252	7031	0.868
NULL	Mol_Cancer_2009_Nov_10_8_99.nxml.txt.nlp	19903356	SENT101	21	21	9	9	imatinib	ANOVA	PA10804	4858	0.868
NULL	Aging_(Albany_NY)_2009_Feb_12_1(2)_245-253.nxml.txt.nlp	19946467	SENT195	7	7	0	0	vasopressin	AVP	PA451858	114548;551	0.868
NULL	Ital_J_Pediatr_2014_Feb_13_40_17.nxml.txt.nlp	24524345	SENT99	17	17	35	35	methylprednisolone	CHP	PA450466	11261	0.868
NULL	Cell_Death_Differ_2009_Aug_20_16(8)_1135-1145.nxml.txt.nlp	19300452	SENT254	13	13	7	7	doxycycline	PUMA	PA449415	27113	0.868
NULL	BMB_Rep_2013_Aug_46(8)_410-415.nxml.txt.nlp	23977989	SENT60	30	30	23	23	curcumin	HO-1	PA151958596	3162	0.868
NULL	Diabetes_2009_Jun_27_58(6)_1356-1364.nxml.txt.nlp	19252136	SENT153	22	22	31	31	mannitol	F12	PA450320	2161	0.868
NULL	Acta_Neuropathol_Commun_2014_Mar_7_2_27.nxml.txt.nlp	24606807	SENT197	10	10	15	15	natalizumab	CD4	PA164747191	920	0.868
NULL	Exp_Brain_Res_2014_Jun_27_232(8)_2637-2644.nxml.txt.nlp	24969614	SENT138	17	17	26	26	palonosetron	NK1	PA10352	11126	0.868
NULL	Br_J_Cancer_1999_Mar_79(7-8)_1104-1110.nxml.txt.nlp	10098743	SENT7	4	4	6	6	cisplatin	JNK	PA449014	5599	0.868
NULL	BMJ_Open_2014_Oct_21_4(10)_e006359.nxml.txt.nlp	25335963	SENT374	4	4	13	13	citalopram	STAR	PA449015	6770;2984	0.868
NULL	Clin_Pediatr_Endocrinol_2009_May_1_18(2)_65-72.nxml.txt.nlp	24790382	SENT72	18	18	10	10	cabergoline	PRL	PA448708	5617	0.868
NULL	Epigenetics_Chromatin_2013_Mar_18_6(Suppl_1)_P33.nxml.txt.nlp	NULL	SENT23	9	9	27	27	diethylstilbestrol	A10	PA449307	28870	0.868
NULL	Onco_Targets_Ther_2014_Sep_9_7_1571-1582.nxml.txt.nlp	25228815	SENT128	13	13	22	22	sorafenib	VEGFR2	PA7000	3791	0.868
NULL	Int_J_Mol_Sci_2012_Feb_2_13(2)_1598-1611.nxml.txt.nlp	22408410	SENT179	5	5	14	14	carrageenan	CO2	PA448814	4513	0.868
NULL	Evid_Based_Complement_Alternat_Med_2013_May_23_2013_632121.nxml.txt.nlp	23762150	SENT7	18	18	14	14	resveratrol	MITF		4286	0.868
NULL	J_Hematol_Oncol_2013_Jun_3_6_38.nxml.txt.nlp	23731980	SENT125	9	9	2	2	trastuzumab	DM1	PA451743	338023;1760;28509	0.868
NULL	Oncotarget_2014_Jun_8_5(13)_5040-5053.nxml.txt.nlp	24970815	SENT151	9	9	17	17	cisplatin	AKT	PA449014	207	0.868
NULL	Acta_Pharmacol_Sin_2011_Jun_23_32(6)_765-780.nxml.txt.nlp	21602835	SENT263	7	7	13	13	gliclazide	SUR1	PA10892	6833	0.868
NULL	Support_Care_Cancer_2011_Aug_1_19(8)_1079-1095.nxml.txt.nlp	21630130	SENT177	2	2	5	5	aprepitant	NK-1	PA164747039	27087	0.868
NULL	Iran_J_Basic_Med_Sci_2012_Nov-Dec_15(6)_1202-1209.nxml.txt.nlp	23653852	SENT160	28	28	7	7	metformin	AMPK	PA450395	5563	0.868
NULL	Mar_Drugs_2014_Jun_27_12(7)_3818-3837.nxml.txt.nlp	24979269	SENT148	14	14	10	10	calcein	MRP1	PA132595336	4437	0.868
NULL	Front_Behav_Neurosci_2011_Sep_13_5_57.nxml.txt.nlp	21949506	SENT243	32	32	30	30	rimonabant	CB1	PA152407999	1268	0.868
NULL	Leukemia_2013_Apr_14_27(4)_803-812.nxml.txt.nlp	23238589	SENT159	30	30	26	26	nilotinib	IFN	PA165958345	3439	0.868
NULL	Amino_Acids_2012_Oct_10_43(4)_1751-1759.nxml.txt.nlp	22407485	SENT70	20	20	8	8	carrageenan	DAG	PA448814	1605	0.868
NULL	Diabetol_Metab_Syndr_2014_Mar_31_6_47.nxml.txt.nlp	24684779	SENT166	23	23	7	7	pioglitazone	adiponectin	PA450970	9370	0.868
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT122	1	1	26	26	maraviroc	CYP3A4	PA164768835	1576	0.868
NULL	Mol_Cancer_2014_Jul_5_13_165.nxml.txt.nlp	24996221	SENT133	26	26	19	19	docetaxel	HMGB1	PA449383	3146	0.868
NULL	J_Oncol_2010_Jan_5_2010_257058.nxml.txt.nlp	20069126	SENT223	3	3	21	21	metformin	AMPK	PA450395	5563	0.868
NULL	Environ_Health_Perspect_2001_Mar_109(3)_257-264.nxml.txt.nlp	11333187	SENT6	12	12	17	17	estradiol	aromatase	PA449503	1588	0.868
NULL	Cardiovasc_Res_2010_Mar_1_85(4)_825-835.nxml.txt.nlp	19840952	SENT92	15	15	2	2	staurosporine	CX3CL1	PA165109623	6376	0.868
NULL	Cancers_(Basel)_2012_Oct_12_4(4)_989-1035.nxml.txt.nlp	24213498	SENT438	2	2	27	27	gemcitabine	CD133	PA449748	8842	0.868
NULL	J_Exp_Med_1994_Oct_1_180(4)_1457-1469.nxml.txt.nlp	7931078	SENT12	33	33	17	17	ethanol	IL-4	PA448073	3565	0.868
NULL	Braz_J_Med_Biol_Res_2012_Mar_2_45(3)_250-255.nxml.txt.nlp	22370705	SENT13	19	19	32	32	atropine	ADM	PA448505	133	0.868
NULL	J_Cell_Physiol_2012_May_21_227(5)_2106-2116.nxml.txt.nlp	21780113	SENT74	31	31	2	2	aprotinin	Rho	PA448472	29984	0.868
NULL	Diabetes_Metab_J_2013_Dec_12_37(6)_423-428.nxml.txt.nlp	24404513	SENT53	11	11	13	13	thrombin	ADP	PA451674	23038	0.868
NULL	EJNMMI_Res_2011_Aug_17_1_15.nxml.txt.nlp	22214307	SENT15	8	8	26	26	trastuzumab	HER2	PA451743	2064	0.868
NULL	J_Med_Chem_2014_Jan_23_57(2)_449-461.nxml.txt.nlp	24387105	SENT7	3	3	24	24	cyclophosphamide	ALDH1A1	PA449165	216	0.868
NULL	Semin_Immunol_2011_Feb_23(1)_28-41.nxml.txt.nlp	21295490	SENT253	0	0	13	13	efalizumab	LFA-1	PA164748817	3683;3689	0.868
NULL	Biomed_Res_Int_2014_Jan_2_2014_126586.nxml.txt.nlp	24527434	SENT123	5	5	25	25	metformin	CD44	PA450395	960	0.868
NULL	Comput_Struct_Biotechnol_J_2012_Nov_15_3_e201210012.nxml.txt.nlp	24688672	SENT105	35	35	0	0	ethanol	IRA1	PA448073	79718	0.868
NULL	J_Gynecol_Oncol_2013_Jul_4_24(3)_273-279.nxml.txt.nlp	23875078	SENT38	2	2	5	5	sc-560	COX		1351	0.868
NULL	Mol_Biol_Cell_2013_Jul_15_24(14)_2186-2200.nxml.txt.nlp	23699397	SENT86	39	39	13	13	staurosporine	TRAIL	PA165109623	8743	0.868
NULL	Biochemistry_2008_Aug_26_47(34)_8961-8969.nxml.txt.nlp	18652489	SENT73	19	19	0	0	thrombin	NEDD8	PA451674	4738	0.868
NULL	Exp_Ther_Med_2015_Feb_3_9(2)_377-383.nxml.txt.nlp	25574201	SENT118	20	20	9	9	curcumin	TSP-1	PA151958596	7057	0.868
NULL	FEBS_Open_Bio_2014_Oct_22_4_905-914.nxml.txt.nlp	25383314	SENT98	4	4	16	16	physostigmine	L-FABP	PA450957	2168	0.868
NULL	J_Korean_Med_Sci_2013_Apr_27_28(4)_527-533.nxml.txt.nlp	23580227	SENT160	4	4	9	9	genistein	TRAIL	PA165109660	8743	0.868
NULL	Daru_2012_Oct_4_20(1)_45.nxml.txt.nlp	23351300	SENT36	30	30	39	39	flurbiprofen	API	PA449683	5345	0.868
NULL	Cancer_Res_Treat_2012_Sep_30_44(3)_195-201.nxml.txt.nlp	23091446	SENT162	36	36	14	14	irinotecan	MKP-1	PA450085	1843	0.868
NULL	BMB_Rep_2013_Aug_46(8)_410-415.nxml.txt.nlp	23977989	SENT34	6	6	33	33	curcumin	HO-1	PA151958596	3162	0.868
NULL	Curr_Opin_Infect_Dis_2013_Dec_6_26(6)_538-544.nxml.txt.nlp	24126716	SENT111	4	4	26	26	tobramycin	San	PA451704	80218	0.868
NULL	Carcinogenesis_2010_Dec_27_31(12)_2049-2057.nxml.txt.nlp	20876285	SENT336	19	19	9	9	letrozole	Bcl-2	PA450196	596	0.868
NULL	Front_Oncol_2013_Sep_9_3_235.nxml.txt.nlp	24058902	SENT91	3	3	25	25	erlotinib	EGFR	PA134687924	1956	0.868
NULL	Biosci_Rep_2012_Aug_1_32(Pt_4)_361-374.nxml.txt.nlp	22762204	SENT1259	3	3	18	18	docetaxel	BRCA1	PA449383	672	0.868
NULL	J_Biomed_Biotechnol_2010_Mar_9_2010_525180.nxml.txt.nlp	20300455	SENT42	13	13	21	21	calcein	P-gp	PA132595336	5243	0.868
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_17_2013_523484.nxml.txt.nlp	23843878	SENT8	1	1	9	9	curcumin	CYP2E1	PA151958596	1571	0.868
NULL	Int_J_Inflam_2011_Sep_29_2011_170352.nxml.txt.nlp	21977329	SENT45	19	19	5	5	imiquimod	TLR8	PA449972	51311	0.868
NULL	Exp_Mol_Med_2012_Sep_30_44(9)_536-544.nxml.txt.nlp	22771771	SENT32	28	28	33	33	celecoxib	COX	PA448871	1351	0.868
NULL	J_Adv_Pract_Oncol_2014_Mar_1_Mar-Apr_5(2)_134-139.nxml.txt.nlp	25032047	SENT47	2	2	12	12	trastuzumab	HER2	PA451743	2064	0.868
NULL	Cancer_Cell_Int_2011_Nov_2_11_39.nxml.txt.nlp	22047021	SENT232	15	15	7	7	cyclophosphamide	REV1	PA449165	51455	0.868
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT107	7	7	20	20	vinorelbine	HER2	PA451881	2064	0.868
NULL	Adv_Hematol_2012_Mar_8_2012_856341.nxml.txt.nlp	22496694	SENT139	31	31	26	26	ritonavir	CYP3A4	PA451260	1576	0.868
NULL	Oncotarget_2014_Aug_29_5(19)_8947-8958.nxml.txt.nlp	25333254	SENT34	13	13	7	7	plerixafor	CXCR4	PA165958410	7852	0.868
NULL	Am_J_Clin_Dermatol_2013_Jun_24_14(3)_163-178.nxml.txt.nlp	23703374	SENT533	9	9	16	16	pimecrolimus	ASM	PA164783790	6609;283120	0.868
NULL	Curr_Neuropharmacol_2009_Mar_7(1)_37-49.nxml.txt.nlp	19721816	SENT171	13	13	3	3	naloxone	ghrelin	PA450586	51738	0.868
NULL	Cell_Commun_Signal_2014_Sep_25_12(1)_61.nxml.txt.nlp	NULL	SENT411	20	20	11	11	doxycycline	INPP4B	PA449415	8821	0.868
NULL	FASEB_J_2014_Sep_28(9)_3906-3918.nxml.txt.nlp	24858279	SENT110	18	18	0	0	paraformaldehyde	CTR	PA450790	799	0.868
NULL	Br_J_Cancer_2002_Jan_21_86(2)_218-221.nxml.txt.nlp	11870509	SENT84	21	21	28	28	tamoxifen	BRCA2	PA451581	675	0.868
NULL	Neuroscience_2009_Jun_30_161(2-3)_572-577.nxml.txt.nlp	19327387	SENT86	15	15	17	17	capsaicin	TRPV1	PA448776	7442	0.868
NULL	Diabetes_Obes_Metab_2010_Aug_12(8)_700-708.nxml.txt.nlp	20590747	SENT139	21	21	15	15	vildagliptin	PPG	PA165958346	5552	0.868
NULL	Acta_Pharmacol_Sin_2010_Jul_28_31(7)_867-873.nxml.txt.nlp	20581857	SENT39	22	22	14	14	docetaxel	PC3	PA449383	57332;7832;5122	0.868
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Apr_13_67(Pt_5)_o1081.nxml.txt.nlp	21754403	SENT52	8	8	3	3	ethanol	mol	PA448073	90527	0.868
NULL	Eur_J_Clin_Pharmacol_2011_May_2_67(Suppl_1)_87-107.nxml.txt.nlp	21287160	SENT82	17	17	6	6	sn-38	UGT1A		7361;54658	0.868
NULL	Orphanet_J_Rare_Dis_2014_Oct_29_9(1)_162.nxml.txt.nlp	NULL	SENT256	9	9	2	2	verapamil	CYP3A4	PA451868	1576	0.868
NULL	Mol_Vis_2007_Jan_24_13_57-65.nxml.txt.nlp	17277739	SENT54	22	22	0	0	heparin	FGF2	PA449855	2247;2258	0.868
NULL	Indian_J_Crit_Care_Med_2011_Jul-Sep_15(3)_179-181.nxml.txt.nlp	22013312	SENT24	8	8	3	3	meropenem	NRP	PA164764445	8829;4673;10133	0.868
NULL	Breast_Cancer_Res_2011_Jun_29_13(3)_R70.nxml.txt.nlp	21707964	SENT148	9	9	4	4	tamoxifen	14-3-3	PA451581	10971	0.868
NULL	Biomed_Res_Int_2014_Jan_29_2014_831845.nxml.txt.nlp	24605337	SENT158	33	33	14	14	bupivacaine	S6K1	PA135057240	6198	0.868
NULL	BMB_Rep_2013_Aug_46(8)_410-415.nxml.txt.nlp	23977989	SENT30	26	26	2	2	curcumin	HO-1	PA151958596	3162	0.868
NULL	Mol_Cancer_2013_Mar_5_12_18.nxml.txt.nlp	23497290	SENT141	5	5	17	17	dasatinib	GRK6	PA162372878	2870	0.868
NULL	Genome_Med_2010_Jun_14_2(6)_37.nxml.txt.nlp	20546595	SENT231	11	11	6	6	doxorubicin	p53	PA449412	7157	0.868
NULL	Curr_Pain_Headache_Rep_2011_Aug_12_15(4)_271-279.nxml.txt.nlp	21479998	SENT150	9	9	6	6	oxymorphone	CYP2D6	PA450748	1565	0.868
NULL	Indian_J_Psychiatry_2014_Jan_56(Suppl_1)_S63-S96.nxml.txt.nlp	NULL	SENT814	16	16	23	23	tetrabenazine	OGC	PA140222719	8402	0.868
NULL	Osteoporos_Int_2013_Jan_24_24(1)_219-226.nxml.txt.nlp	23093347	SENT22	0	0	10	10	teriparatide	PTH	PA451620	5741	0.868
NULL	J_Thorac_Oncol_2014_Jun_30_9(6)_775-783.nxml.txt.nlp	24828661	SENT296	12	12	4	4	erlotinib	EGFR	PA134687924	1956	0.868
NULL	Front_Pharmacol_2014_Nov_25_5_256.nxml.txt.nlp	25505414	SENT305	1	1	13	13	allopregnanolone	PSEN1	PA142320763	5663	0.868
NULL	BMB_Rep_2014_Apr_47(4)_221-226.nxml.txt.nlp	24286312	SENT121	29	29	34	34	nutlin-3	p53		7157	0.868
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_13_2013_468537.nxml.txt.nlp	23956772	SENT141	7	7	29	29	cisplatin	PIG3	PA449014	64975;9540	0.868
NULL	BMB_Rep_2014_May_47(5)_274-279.nxml.txt.nlp	24286313	SENT62	12	12	4	4	bortezomib	p65	PA10252	5970	0.868
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT126	15	15	23	23	tenofovir	ABCC4	PA10204	10257	0.868
NULL	Oncotarget_2012_Jan_30_3(1)_98-106.nxml.txt.nlp	22298889	SENT36	6	6	13	13	bevacizumab	VEGF-A	PA130232992	7422	0.868
NULL	Cell_Cycle_2012_Nov_1_11(21)_3983-3996.nxml.txt.nlp	22987153	SENT86	30	30	22	22	cisplatin	DNA2	PA449014	1763	0.868
NULL	Cardiovasc_Diabetol_2013_Oct_17_12_150.nxml.txt.nlp	24134550	SENT100	2	2	6	6	pioglitazone	activin	PA450970	83729	0.868
NULL	Breast_Cancer_Res_2002_Apr_4_4(3)_85-89.nxml.txt.nlp	12052249	SENT40	24	24	4	4	tamoxifen	SULT1A1	PA451581	6817	0.868
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT117	10	10	3	3	cisplatin	IBP	PA449014	706;50619	0.868
NULL	Int_J_Gen_Med_2012_May_4_5_403-411.nxml.txt.nlp	22615536	SENT83	16	16	22	22	rosiglitazone	RBP4	PA451283	5433;5950	0.868
NULL	Onco_Targets_Ther_2014_May_16_7_761-770.nxml.txt.nlp	24876785	SENT165	14	14	20	20	pemetrexed	EGFR	PA10810	1956	0.868
NULL	Neural_Dev_2010_May_6_5_13.nxml.txt.nlp	20459606	SENT127	19	19	17	17	heparin	FGF2	PA449855	2247;2258	0.868
NULL	J_Hematol_Oncol_2013_Aug_2_6_55.nxml.txt.nlp	23915913	SENT189	8	8	25	25	lenalidomide	FLG3	PA162363968	388697	0.868
NULL	Neural_Regen_Res_2013_Mar_25_8(9)_825-832.nxml.txt.nlp	25206730	SENT106	34	34	40	40	isoflurane	P2X7	PA450106	5027	0.868
NULL	Mol_Cancer_2007_Jan_19_6_9.nxml.txt.nlp	17233922	SENT169	5	5	25	25	flavopiridol	CDK9	PA452627	1025	0.868
NULL	Clin_Cosmet_Investig_Dermatol_2014_Apr_17_7_119-132.nxml.txt.nlp	24790463	SENT92	14	14	2	2	lipase	IL-6	PA450239	3569	0.868
NULL	ScientificWorldJournal_2013_Dec_31_2013_837573.nxml.txt.nlp	24501586	SENT184	10	10	3	3	alendronate	PTH	PA448082	5741	0.868
NULL	Br_J_Cancer_2014_Jan_21_110(2)_421-429.nxml.txt.nlp	24300973	SENT173	24	24	0	0	oxaliplatin	DAP3	PA131285527	58512;7818	0.868
NULL	Oncogene_2010_Sep_16_29(37)_5193-5203.nxml.txt.nlp	20581867	SENT21	6	6	10	10	trastuzumab	HER3	PA451743	2065	0.868
NULL	Oncotarget_2014_Aug_4_5(17)_7776-7787.nxml.txt.nlp	25277200	SENT152	18	18	27	27	cisplatin	ANXA4	PA449014	307	0.868
NULL	Support_Care_Cancer_2014_Dec_14_22(3)_837-846.nxml.txt.nlp	24337717	SENT19	12	12	16	16	phenytoin	CYP3A4	PA450947	1576	0.868
NULL	Oxid_Med_Cell_Longev_2013_Jun_2_2013_793525.nxml.txt.nlp	23819014	SENT84	7	7	0	0	resveratrol	SGBS		2719	0.868
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Mar_26_3(3)_e107.nxml.txt.nlp	24670388	SENT402	10	10	6	6	alfentanil	CYP3A4	PA448084	1576	0.868
NULL	Case_Rep_Gastrointest_Med_2013_Mar_27_2013_386263.nxml.txt.nlp	23607002	SENT62	9	9	20	20	sunitinib	BRAF	PA162372840	673	0.868
NULL	Aging_(Albany_NY)_2014_Jan_14_6(1)_70-81.nxml.txt.nlp	24429382	SENT64	12	12	2	2	trypsin	WRN	PA451806	7486	0.868
NULL	Cardiovasc_Res_2010_Mar_1_85(4)_825-835.nxml.txt.nlp	19840952	SENT100	18	18	15	15	staurosporine	CX3CL1	PA165109623	6376	0.868
NULL	Front_Endocrinol_(Lausanne)_2013_Jan_4_3_175.nxml.txt.nlp	23316183	SENT41	20	20	29	29	vasopressin	ADRB2	PA451858	154	0.868
NULL	Diabetol_Metab_Syndr_2014_May_18_6_56.nxml.txt.nlp	24860622	SENT167	38	38	21	21	amlodipine	adiponectin	PA448388	9370	0.868
NULL	Indian_J_Pharmacol_2013_Sep-Oct_45(5)_458-463.nxml.txt.nlp	24130379	SENT157	3	3	9	9	carvedilol	TLR4	PA448817	7099	0.868
NULL	Gene_Ther_2010_Apr_25_17(4)_550-559.nxml.txt.nlp	20182517	SENT6	23	23	20	20	oxaliplatin	TNFSF10	PA131285527	8743	0.868
NULL	Front_Immunol_2013_Nov_7_4_360.nxml.txt.nlp	24223576	SENT348	3	3	1	1	imiquimod	TLR7	PA449972	51284	0.867
NULL	Breast_Cancer_Res_2012_May_18_14(3)_R78.nxml.txt.nlp	22608253	SENT257	26	26	29	29	nilotinib	AKT	PA165958345	207	0.867
NULL	Reprod_Biol_Endocrinol_2013_Feb_26_11_15.nxml.txt.nlp	23442442	SENT141	2	2	8	8	l-arginine	BAX	PA448478	581	0.867
NULL	Ital_J_Pediatr_2014_Feb_13_40_17.nxml.txt.nlp	24524345	SENT85	24	24	6	6	cyclosporine	CHP	PA449167	11261	0.867
NULL	J_Vis_Exp_2010_Nov_6_(45)_2032.nxml.txt.nlp	21085105	SENT94	13	13	2	2	trypsin	RPE	PA451806	6120	0.867
NULL	CNS_Drugs_2013_Jun_26_27(9)_743-751.nxml.txt.nlp	23801529	SENT122	17	17	33	33	lisdexamfetamine	NNT	PA164748975	23530	0.867
NULL	J_Cell_Sci_2014_May_15_127(10)_2313-2325.nxml.txt.nlp	24634514	SENT244	1	1	15	15	galactose	AFG3L2	PA449725	10939	0.867
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1676-1682.nxml.txt.nlp	19844234	SENT146	36	36	30	30	lapatinib	HER2	PA152241907	2064	0.867
NULL	Ann_Gastroenterol_2014_27(3)_250-257.nxml.txt.nlp	24974978	SENT179	14	14	6	6	naltrexone	gamma	PA450588	9913	0.867
NULL	Diabetes_2009_Jul_23_58(7)_1544-1549.nxml.txt.nlp	19389827	SENT57	25	25	5	5	ethanol	DPI	PA448073	1832	0.867
NULL	Breast_Cancer_Res_2009_Jun_23_11(Suppl_1)_P10.nxml.txt.nlp	NULL	SENT15	11	11	4	4	tamoxifen	p27	PA451581	5715;10534	0.867
NULL	Mol_Brain_2013_Jun_19_6_29.nxml.txt.nlp	23782671	SENT310	17	17	5	5	paraformaldehyde	PSD-95	PA450790	1742	0.867
NULL	Oncotarget_2014_Oct_21_5(22)_11252-11268.nxml.txt.nlp	25361004	SENT122	5	5	23	23	metformin	CLIC1	PA450395	1192	0.867
NULL	J_Korean_Med_Sci_2006_Oct_31_21(5)_891-896.nxml.txt.nlp	17043425	SENT21	15	15	0	0	estradiol	RERG	PA449503	85004	0.867
NULL	Comput_Struct_Biotechnol_J_2013_Mar_12_4_e201301008.nxml.txt.nlp	24688689	SENT168	7	7	2	2	ethanol	NAT	PA448073	6046	0.867
NULL	Aging_(Albany_NY)_2013_Jun_23_5(7)_515-530.nxml.txt.nlp	24018842	SENT197	6	6	4	4	metformin	AMPK	PA450395	5563	0.867
NULL	Psychiatry_Investig_2010_Dec_30_7(4)_236-242.nxml.txt.nlp	21253406	SENT78	27	27	17	17	desipramine	CA1	PA449233	759	0.867
NULL	Mol_Neurodegener_2011_Aug_8_6_57.nxml.txt.nlp	21819629	SENT379	5	5	25	25	arsenite	TDP-43	PA452638	23435	0.867
NULL	Open_Microbiol_J_2008_May_23_2_66-73.nxml.txt.nlp	19088913	SENT246	5	5	15	15	ketoconazole	HSCO	PA450146	23474	0.867
NULL	Exp_Anim_2014_Apr_26_63(2)_257-267.nxml.txt.nlp	24770651	SENT105	2	2	7	7	olmesartan	APJ	PA164742950	187	0.867
NULL	Front_Neuroanat_2011_Aug_26_5_50.nxml.txt.nlp	21904525	SENT1060	8	8	3	3	trastuzumab	DARPP-32	PA451743	84152	0.867
NULL	Cancer_Cell_Int_2013_Sep_23_13_94.nxml.txt.nlp	24059699	SENT154	22	22	32	32	bevacizumab	NRP1	PA130232992	8829	0.867
NULL	Nucleic_Acids_Res_2005_Jun_8_33(10)_3283-3291.nxml.txt.nlp	15944449	SENT186	8	8	24	24	sjg-136	XRCC3		7517	0.867
NULL	Sci_Rep_2014_Nov_28_4_7237.nxml.txt.nlp	25429875	SENT108	3	3	30	30	hesperidin	p38	PA449867	10598;1432;7965	0.867
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT111	9	9	29	29	trastuzumab	EGFR	PA451743	1956	0.867
NULL	Exp_Brain_Res_2014_Jun_27_232(8)_2637-2644.nxml.txt.nlp	24969614	SENT19	19	19	7	7	palonosetron	NK1	PA10352	11126	0.867
NULL	Neuropsychopharmacology_2009_Sep_3_34(10)_2227-2236.nxml.txt.nlp	19494805	SENT46	24	24	1	1	bupropion	STAR	PA448687	6770;2984	0.867
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT223	30	30	24	24	panitumumab	KRAS	PA162373091	3845	0.867
NULL	Curr_Opin_Pharmacol_2013_Aug_13(4)_497-503.nxml.txt.nlp	23664091	SENT62	17	17	20	20	panitumumab	KRAS	PA162373091	3845	0.867
NULL	Breast_Cancer_Res_2008_Jun_9_10(3)_R52.nxml.txt.nlp	18541018	SENT140	23	23	11	11	fluorescein	CD44	PA164746009	960	0.867
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1066.nxml.txt.nlp	24556681	SENT215	27	27	11	11	ethanol	LC3	PA448073	84557	0.867
NULL	Biomed_Res_Int_2013_Jan_22_2013_346480.nxml.txt.nlp	23484111	SENT117	0	0	5	5	geldanamycin	Hsp90	PA152031327	3320	0.867
NULL	Breast_Cancer_Res_Treat_2012_Jul_24_134(1)_13-20.nxml.txt.nlp	22198412	SENT242	25	25	16	16	trastuzumab	HER2	PA451743	2064	0.867
NULL	Ann_Rheum_Dis_2011_Jun_27_70(9)_1631-1640.nxml.txt.nlp	21708910	SENT192	9	9	35	35	adalimumab	STAR	PA10004	6770;2984	0.867
NULL	Cancer_Cell_Int_2011_Oct_28_11_35.nxml.txt.nlp	22035360	SENT179	13	13	16	16	doxorubicin	TRAIL	PA449412	8743	0.867
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1137-1144.nxml.txt.nlp	20234366	SENT140	19	19	33	33	cetuximab	MKP-1	PA10040	1843	0.867
NULL	Oncogene_2013_Sep_12_32(37)_4355-4365.nxml.txt.nlp	23108409	SENT80	4	4	24	24	hyaluronan	HAS2	PA165958431	3037	0.867
NULL	Pain_2012_Apr_153(4)_775-783.nxml.txt.nlp	22325744	SENT164	6	6	11	11	naloxone	P28	PA450586	9446;7802;9527	0.867
NULL	Breast_Cancer_(Auckl)_2010_Feb_16_4_1-3.nxml.txt.nlp	20697527	SENT7	26	26	43	43	curcumin	14-3-3	PA151958596	10971	0.867
NULL	Neural_Regen_Res_2014_Oct_15_9(20)_1839-1843.nxml.txt.nlp	25422647	SENT66	14	14	16	16	apomorphine	APO	PA164781163	84909	0.867
NULL	Cancer_Metab_2013_Aug_14_1_18.nxml.txt.nlp	24280377	SENT288	22	22	10	10	metformin	LKB1	PA450395	6794	0.867
NULL	Cancer_Manag_Res_2011_Aug_10_3_273-285.nxml.txt.nlp	21931501	SENT62	3	3	6	6	pazopanib	VEGFR2	PA165291492	3791	0.867
NULL	Ann_Oncol_2012_Dec_2_23(12)_3007-3016.nxml.txt.nlp	22865781	SENT103	14	14	19	19	lapatinib	PTEN	PA152241907	5728	0.867
NULL	Ecancermedicalscience_2009_Sep_24_3_153.nxml.txt.nlp	22276017	SENT56	8	8	24	24	oxaliplatin	ERCC1	PA131285527	2067	0.867
NULL	Front_Immunol_2013_Mar_27_4_76.nxml.txt.nlp	23543707	SENT784	8	8	1	1	cetuximab	gamma	PA10040	9913	0.867
NULL	Breast_Cancer_Res_2010_Mar_5_12(2)_R16.nxml.txt.nlp	20205716	SENT341	2	2	23	23	lovastatin	DJ-1	PA450272	11315	0.867
NULL	Arthritis_Res_Ther_2006_Dec_28_8(1)_R18.nxml.txt.nlp	16507118	SENT128	28	28	9	9	adalimumab	IL-15	PA10004	3600	0.867
NULL	Breast_Cancer_Res_Treat_2014_Dec_19_143(2)_351-358.nxml.txt.nlp	24352574	SENT215	2	2	8	8	vinorelbine	HER-2	PA451881	2064	0.867
NULL	J_Gynecol_Oncol_2013_Jul_4_24(3)_273-279.nxml.txt.nlp	23875078	SENT136	11	11	8	8	paclitaxel	COX	PA450761	1351	0.867
NULL	Cancer_Biol_Med_2012_Mar_9(1)_1-8.nxml.txt.nlp	23691447	SENT170	14	14	4	4	lipase	OTP	PA450239	23440	0.867
NULL	Front_Neurol_2014_Sep_11_5_173.nxml.txt.nlp	25309501	SENT167	35	35	17	17	hyaluronan	CD44	PA165958431	960	0.867
NULL	Nat_Commun_2014_Dec_8_5_5736.nxml.txt.nlp	25484020	SENT140	3	3	14	14	anastrozole	TRPA1	PA448432	8989	0.867
NULL	J_Immunother_Cancer_2013_Jul_15_1_10.nxml.txt.nlp	24829747	SENT192	0	0	23	23	gemcitabine	CD4	PA449748	920	0.867
NULL	J_Infect_Dis_2012_Apr_15_205(8)_1278-1286.nxml.txt.nlp	22396598	SENT177	2	2	23	23	proguanil	DHODH	PA451124	1723	0.867
NULL	Acta_Pharmacol_Sin_2014_Jun_5_35(6)_716-726.nxml.txt.nlp	24793311	SENT253	8	8	22	22	atorvastatin	PSD-95	PA448500	1742	0.867
NULL	Pharmaceuticals_(Basel)_2012_Feb_6_5(2)_169-188.nxml.txt.nlp	24288087	SENT27	5	5	9	9	papaverine	PDE10A	PA164745550	10846	0.867
NULL	BMB_Rep_2014_Sep_47(9)_494-499.nxml.txt.nlp	24393524	SENT2	0	0	27	27	nadh	NQO1	PA164755085	1728	0.867
NULL	Front_Neurol_2011_Dec_26_2_83.nxml.txt.nlp	22363312	SENT123	14	14	6	6	clopidogrel	CYP2C19	PA449053	1557	0.867
NULL	J_Hematol_Oncol_2011_Aug_15_4_34.nxml.txt.nlp	21843362	SENT19	7	7	5	5	cyclophosphamide	CHOP	PA449165	1649	0.867
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT312	21	21	25	25	metformin	HIF-1	PA450395	29072	0.867
NULL	Breast_Cancer_Res_2004_Oct_6_6(6)_262-268.nxml.txt.nlp	15535857	SENT148	41	41	43	43	tamoxifen	aromatase	PA451581	1588	0.867
NULL	J_Oncol_2009_Mar_24_2009_491985.nxml.txt.nlp	19325924	SENT87	11	11	4	4	genistein	CXCL12	PA165109660	6387	0.867
NULL	Mol_Pain_2013_Jun_10_9_27.nxml.txt.nlp	23758830	SENT183	16	16	1	1	tetracaine	ASIC2a	PA451638	40	0.867
NULL	Exp_Ther_Med_2013_May_8_5(5)_1491-1495.nxml.txt.nlp	23737905	SENT101	4	4	9	9	hemin	HO-1	PA449849	3162	0.867
NULL	Tuberc_Res_Treat_2013_Mar_27_2013_285094.nxml.txt.nlp	23634300	SENT31	21	21	4	4	pyrazinamide	PTB	PA451182	58155	0.867
NULL	Oncotarget_2011_Jan_25_2(1-2)_8-17.nxml.txt.nlp	21378407	SENT34	9	9	13	13	thrombin	PAR-1	PA451674	2011;2149	0.867
NULL	Clin_Med_Insights_Oncol_2013_Jun_3_7_103-122.nxml.txt.nlp	23843721	SENT137	5	5	0	0	trastuzumab	PI3K	PA451743	5290	0.867
NULL	Cancer_Manag_Res_2011_May_9_3_117-141.nxml.txt.nlp	21625397	SENT57	0	0	8	8	resveratrol	SIRT1		23411	0.867
NULL	Br_J_Cancer_2000_Jun_82(11)_1851-1859.nxml.txt.nlp	10839301	SENT9	20	20	6	6	topotecan	CD95	PA451729	355	0.867
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT207	7	7	23	23	tacrolimus	SOCS3	PA451578	9021	0.867
NULL	Ecancermedicalscience_2009_Jun_9_3_148.nxml.txt.nlp	22276013	SENT13	19	19	8	8	exemestane	aromatase	PA449563	1588	0.867
NULL	EMBO_Mol_Med_2013_May_22_5(5)_776-794.nxml.txt.nlp	23606583	SENT352	17	17	0	0	maraviroc	CCL5	PA164768835	6352	0.867
NULL	J_Exp_Med_1980_Dec_1_152(6)_1699-1708.nxml.txt.nlp	7452150	SENT9	11	11	5	5	trypsin	gp160	PA451806	2028	0.867
NULL	Acta_Pharmacol_Sin_2014_Jan_16_35(1)_41-47.nxml.txt.nlp	24335844	SENT152	32	32	5	5	capsaicin	AQP4	PA448776	361	0.867
NULL	Cases_J_2009_Oct_29_2_175.nxml.txt.nlp	19946486	SENT48	24	24	37	37	zidovudine	ART	PA451954	181	0.867
NULL	Blood_Res_2013_Sep_25_48(3)_171-177.nxml.txt.nlp	24086936	SENT92	5	5	9	9	bortezomib	CHOP	PA10252	1649	0.867
NULL	Onco_Targets_Ther_2014_Sep_23_7_1647-1652.nxml.txt.nlp	25285014	SENT93	0	0	8	8	trastuzumab	HER2	PA451743	2064	0.867
NULL	Int_J_Biol_Sci_2011_Nov_16_8(1)_39-48.nxml.txt.nlp	22211103	SENT126	12	12	2	2	heparin	CHI3L1	PA449855	1116	0.867
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jul_6_67(Pt_8)_o1934.nxml.txt.nlp	22090978	SENT75	21	21	6	6	ethanol	mol	PA448073	90527	0.867
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_11_2014_274786.nxml.txt.nlp	25505920	SENT246	21	21	15	15	cisplatin	ERCC1	PA449014	2067	0.867
NULL	Mol_Biol_Evol_2014_Apr_20_31(4)_765-778.nxml.txt.nlp	24361996	SENT153	24	24	20	20	vasopressin	OXTR	PA451858	5021	0.867
NULL	Sensors_(Basel)_2013_Dec_27_14(1)_458-467.nxml.txt.nlp	24379050	SENT87	14	14	37	37	glucose	SPR	PA449773	6697;6869	0.867
NULL	Cells_2012_Aug_21_1(3)_535-557.nxml.txt.nlp	24710489	SENT233	0	0	12	12	cetuximab	KRAS	PA10040	3845	0.867
NULL	J_Immunother_Cancer_2014_Jan_27_2_2.nxml.txt.nlp	24829759	SENT100	15	15	24	24	sorafenib	IL-21	PA7000	59067;50616;27189	0.867
NULL	Orphanet_J_Rare_Dis_2011_May_21_6_28.nxml.txt.nlp	21600006	SENT118	34	34	24	24	imatinib	KIT	PA10804	3815	0.867
NULL	Clin_Med_Insights_Arthritis_Musculoskelet_Disord_2012_Mar_5_5_27-42.nxml.txt.nlp	22438671	SENT13	40	40	27	27	tocilizumab	IL-6	PA165292659	3569	0.867
NULL	BMB_Rep_2013_Aug_46(8)_410-415.nxml.txt.nlp	23977989	SENT30	26	26	12	12	curcumin	HO-1	PA151958596	3162	0.867
NULL	F1000Res_2013_Mar_5_2_74.nxml.txt.nlp	24358880	SENT386	33	33	7	7	benzaldehyde	TRPV1	PA448571	7442	0.867
NULL	Mol_Vis_2011_Dec_24_17_3384-3391.nxml.txt.nlp	22219634	SENT151	27	27	14	14	mannitol	TLR4	PA450320	7099	0.867
NULL	Cell_Commun_Signal_2013_Apr_22_11_30.nxml.txt.nlp	23607741	SENT16	35	35	21	21	imatinib	PIP1	PA10804	55003	0.867
NULL	Acta_Pharmacol_Sin_2013_Jun_11_34(6)_784-792.nxml.txt.nlp	23474707	SENT168	9	9	1	1	hyaluronan	TSG-6	PA165958431	7130	0.867
NULL	Colomb_Med_(Cali)_43(4)_305-311.nxml.txt.nlp	24893304	SENT152	45	45	25	25	valganciclovir	CD4	PA10227	920	0.867
NULL	Blood_Cancer_J_2014_Oct_10_4(10)_eXX.nxml.txt.nlp	25303370	SENT58	9	9	35	35	fluorescein	CD4	PA164746009	920	0.867
NULL	Indian_J_Pharm_Sci_2013_Jan-Feb_75(1)_94-98.nxml.txt.nlp	23901167	SENT87	34	34	21	21	omeprazole	CYP2B6	PA450704	1555	0.867
NULL	Cell_Commun_Signal_2014_Sep_25_12(1)_61.nxml.txt.nlp	NULL	SENT431	15	15	3	3	doxycycline	PC-3	PA449415	692094	0.867
NULL	Eur_J_Epidemiol_2009_Sep_2_24(9)_553-572.nxml.txt.nlp	19728115	SENT1546	20	20	15	15	acenocoumarol	CYP2C9	PA452632	1559	0.867
NULL	Br_J_Cancer_2004_Mar_22_90(6)_1285-1292.nxml.txt.nlp	15026814	SENT117	4	4	11	11	cisplatin	p53	PA449014	7157	0.867
NULL	Front_Pharmacol_2014_May_9_5_103.nxml.txt.nlp	24847272	SENT229	12	12	6	6	tacrolimus	POR	PA451578	5447	0.867
NULL	Gene_Regul_Syst_Bio_2014_Mar_4_8_63-73.nxml.txt.nlp	24634581	SENT136	11	11	17	17	minocycline	MT1-MMP	PA450519	4323	0.867
NULL	Ann_Saudi_Med_2011_Jul-Aug_31(4)_417-420.nxml.txt.nlp	21293067	SENT17	11	11	14	14	nelfinavir	CD4	PA450606	920	0.867
NULL	Cell_Death_Dis_2012_Jun_21_3(6)_e330.nxml.txt.nlp	22717585	SENT66	0	0	29	29	simvastatin	Bcl-2	PA451363	596	0.867
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT293	24	24	16	16	cisplatin	JNK	PA449014	5599	0.867
NULL	Acta_Pharmacol_Sin_2012_Jun_6_33(6)_798-808.nxml.txt.nlp	22669117	SENT194	8	8	21	21	heparin	14-3-3	PA449855	10971	0.867
NULL	Arthritis_Res_Ther_2008_Mar_17_10(2)_R33.nxml.txt.nlp	18346273	SENT164	43	43	12	12	infliximab	IFN	PA452639	3439	0.867
NULL	Cancer_Imaging_2013_Jul_22_13(3)_306-313.nxml.txt.nlp	23876444	SENT39	7	7	26	26	vemurafenib	FDG	PA165946873	23583	0.867
NULL	Braz_J_Med_Biol_Res_2014_May_9_47(6)_478-482.nxml.txt.nlp	24770568	SENT81	30	30	11	11	cisplatin	CD133	PA449014	8842	0.867
NULL	Amino_Acids_2012_Oct_10_43(4)_1751-1759.nxml.txt.nlp	22407485	SENT106	29	29	16	16	carrageenan	ghrelin	PA448814	51738	0.867
NULL	Arthritis_Res_Ther_2008_Mar_17_10(2)_R33.nxml.txt.nlp	18346273	SENT131	12	12	6	6	infliximab	HMGB1	PA452639	3146	0.867
NULL	Cancers_(Basel)_2012_Jun_18_4(2)_581-600.nxml.txt.nlp	24213326	SENT48	22	22	7	7	paclitaxel	CD4	PA450761	920	0.867
NULL	J_Cell_Mol_Med_2014_Jul_13_18(7)_1300-1312.nxml.txt.nlp	24725889	SENT8	13	13	28	28	minocycline	TLR9	PA450519	54106	0.867
NULL	Diabetes_Care_2010_Apr_12_33(4)_861-868.nxml.txt.nlp	20067962	SENT216	35	35	30	30	hyaluronan	HMGB1	PA165958431	3146	0.867
NULL	Acta_Pharmacol_Sin_2009_Feb_26_30(2)_175-183.nxml.txt.nlp	19169269	SENT139	7	7	18	18	iptakalim	NUP54	PA165949694	53371	0.867
NULL	Daru_2011_19(2)_138-144.nxml.txt.nlp	22615650	SENT93	37	37	16	16	heparin	FGF20	PA449855	26281	0.867
NULL	Cancer_Inform_2009_Nov_13_7_253-269.nxml.txt.nlp	20011461	SENT169	11	11	27	27	acetanilide	C11	PA448016	1109	0.867
NULL	Cough_2006_Mar_30_2_2.nxml.txt.nlp	16623933	SENT156	8	8	5	5	capsaicin	TRPV1	PA448776	7442	0.867
NULL	Cardiovasc_Ultrasound_2005_Sep_2_3_26.nxml.txt.nlp	16138923	SENT54	35	35	14	14	sildenafil	IFN	PA451346	3439	0.867
NULL	Cancers_(Basel)_2011_Sep_28_3(4)_3762-3772.nxml.txt.nlp	24213110	SENT352	2	2	5	5	celecoxib	PC-3	PA448871	692094	0.867
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R91.nxml.txt.nlp	22541814	SENT15	3	3	11	11	thrombin	HO-1	PA451674	3162	0.867
NULL	Curr_Hematol_Malig_Rep_2013_Mar_8_8(1)_28-36.nxml.txt.nlp	23296408	SENT299	26	26	13	13	imatinib	CD34	PA10804	947	0.867
NULL	Am_J_Clin_Dermatol_2013_Jun_24_14(3)_163-178.nxml.txt.nlp	23703374	SENT548	13	13	3	3	tacrolimus	ASM	PA451578	6609;283120	0.867
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT333	7	7	28	28	risperidone	PRL	PA451257	5617	0.867
NULL	Eur_J_Haematol_2009_Apr_82(4)_277-287.nxml.txt.nlp	19187270	SENT62	32	32	40	40	gentamicin	IL-6	PA449753	3569	0.867
NULL	Oncotarget_2011_Dec_22_2(12)_1176-1190.nxml.txt.nlp	22202492	SENT128	11	11	17	17	pravastatin	PLA2G7	PA451089	7941	0.867
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_O3.nxml.txt.nlp	NULL	SENT15	13	13	8	8	amoxicillin	IFN	PA448406	3439	0.867
NULL	Int_J_Endocrinol_2011_Aug_21_2011_742719.nxml.txt.nlp	21869886	SENT262	20	20	31	31	cilostazol	DES	PA164746334	1674	0.867
NULL	Hum_Genomics_2009_Dec_1_4(2)_91-106.nxml.txt.nlp	20038497	SENT171	20	20	7	7	rivastigmine	BCHE	PA451262	590	0.867
NULL	Nat_Commun_2011_Oct_25_2_513.nxml.txt.nlp	22027593	SENT72	20	20	11	11	doxorubicin	RBM38	PA449412	55544	0.867
NULL	Clin_Med_Insights_Womens_Health_2013_Jan_22_6_1-11.nxml.txt.nlp	24665209	SENT207	11	11	7	7	tamoxifen	aromatase	PA451581	1588	0.867
NULL	J_Inherit_Metab_Dis_2012_Jan_10_35(1)_141-149.nxml.txt.nlp	21556832	SENT5	32	32	12	12	l-arginine	CRTR	PA448478	6535	0.867
NULL	Ann_Rheum_Dis_2008_Oct_16_68(8)_1277-1284.nxml.txt.nlp	18930987	SENT15	13	13	15	15	infliximab	ANOVA	PA452639	4858	0.867
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_39-54.nxml.txt.nlp	19305787	SENT150	21	21	37	37	ethanol	NR1	PA448073	27158	0.867
NULL	Int_J_Mol_Sci_2014_Oct_20_15(10)_18840-18855.nxml.txt.nlp	25334060	SENT156	8	8	29	29	heparin	OPG	PA449855	690	0.867
NULL	Leukemia_2014_Apr_14_28(4)_961-964.nxml.txt.nlp	24418991	SENT29	38	38	43	43	nilotinib	P-gp	PA165958345	5243	0.867
NULL	Cell_Biol_Int_Rep_(2010)_2012_Jun_21_19(1)_e00017.nxml.txt.nlp	23124518	SENT27	0	0	3	3	etoposide	TRAIL-R2	PA449552	8795	0.867
NULL	Arthritis_Res_Ther_2012_Feb_9_14(Suppl_1)_P48.nxml.txt.nlp	NULL	SENT4	0	0	17	17	abatacept	CD80	PA164747080	941	0.867
NULL	Case_Rep_Med_2012_Dec_3_2012_163173.nxml.txt.nlp	23326270	SENT97	8	8	28	28	fenofibrate	CPT2	PA449594	1376	0.867
NULL	Cardiovasc_Res_2014_Oct_1_104(1)_206-215.nxml.txt.nlp	25205295	SENT168	6	6	23	23	propranolol	ANOVA	PA451145	4858	0.867
NULL	Acta_Pharmacol_Sin_2012_Mar_27_33(3)_342-350.nxml.txt.nlp	22367283	SENT193	27	27	23	23	thrombin	PAR4	PA451674	9002;5074	0.867
NULL	Biochemistry_2010_Jan_26_49(3)_623-634.nxml.txt.nlp	19921809	SENT75	9	9	0	0	fluorescein	PSK	PA164746009	9344	0.867
NULL	Ann_Clin_Transl_Neurol_2014_Dec_3_1(12)_1024-1035.nxml.txt.nlp	25574476	SENT189	10	10	3	3	staurosporine	PTRH2	PA165109623	51651	0.867
NULL	Oncotarget_2012_Oct_27_3(10)_1052-1053.nxml.txt.nlp	23165648	SENT25	26	26	5	5	nutlin-3	p53		7157	0.867
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_May_7_67(Pt_6)_o1308-o1309.nxml.txt.nlp	21754710	SENT67	23	23	15	15	ethanol	mol	PA448073	90527	0.867
NULL	J_Vet_Med_Sci_2014_Oct_19_76(10)_1339-1345.nxml.txt.nlp	24942113	SENT14	0	0	3	3	losartan	AT1	PA450268	9197;185	0.867
NULL	Oncotarget_2012_Oct_20_3(10)_1236-1245.nxml.txt.nlp	23100449	SENT109	24	24	5	5	doxorubicin	NGAL	PA449412	3934	0.867
NULL	Oncotarget_2011_Dec_22_2(12)_1176-1190.nxml.txt.nlp	22202492	SENT128	9	9	17	17	lovastatin	PLA2G7	PA450272	7941	0.867
NULL	Cell_Death_Dis_2014_Apr_17_5(4)_e1185.nxml.txt.nlp	24743740	SENT49	1	1	11	11	pha-665752	Met		79811	0.867
NULL	J_Oncol_2012_Dec_7_2012_192464.nxml.txt.nlp	22187555	SENT326	34	34	16	16	docetaxel	IGFR	PA449383	3480	0.867
NULL	Oncoimmunology_2014_Jun_3_3_e29030.nxml.txt.nlp	25083328	SENT57	48	48	22	22	temozolomide	IFN	PA451609	3439	0.867
NULL	Protein_Cell_2014_Feb_29_5(2)_141-150.nxml.txt.nlp	24474202	SENT67	7	7	27	27	trypsin	ORF26	PA451806	57728	0.867
NULL	Eur_J_Clin_Pharmacol_2008_Feb_26_64(2)_133-157.nxml.txt.nlp	18224312	SENT314	39	39	24	24	tamoxifen	HER2	PA451581	2064	0.867
NULL	Biochem_Res_Int_2012_Apr_3_2012_738274.nxml.txt.nlp	22548175	SENT31	39	39	26	26	paclitaxel	CHFR	PA450761	55743	0.867
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Dec_4_67(Pt_1)_o37.nxml.txt.nlp	21522747	SENT66	33	33	14	14	ethanol	mol	PA448073	90527	0.867
NULL	Theranostics_2013_Jun_24_3(7)_448-466.nxml.txt.nlp	23843893	SENT130	7	7	11	11	celecoxib	COX	PA448871	1351	0.867
NULL	Surg_Neurol_Int_2013_Sep_6_4_114.nxml.txt.nlp	24083050	SENT215	7	7	27	27	clopidogrel	PED	PA449053	8682	0.867
NULL	Oncogene_2014_Jan_23_33(4)_421-428.nxml.txt.nlp	23318437	SENT323	19	19	3	3	etoposide	MDM2	PA449552	4193	0.867
NULL	Curr_Neuropharmacol_2013_May_11(3)_263-275.nxml.txt.nlp	24179463	SENT93	17	17	15	15	sr144528	CB2		1269	0.867
NULL	J_Nutr_Metab_2011_Jun_1_2011_708183.nxml.txt.nlp	21773024	SENT142	15	15	26	26	pioglitazone	gamma	PA450970	9913	0.867
NULL	J_Cell_Mol_Med_2014_Aug_17_18(8)_1491-1508.nxml.txt.nlp	24237862	SENT289	0	0	23	23	pegaptanib	VEGF-A	PA164771236	7422	0.867
NULL	Oncologist_2011_Feb_1_16(2)_136-145.nxml.txt.nlp	21285392	SENT100	5	5	12	12	denosumab	OPG	PA166048634	690	0.867
NULL	AIDS_Res_Ther_2009_Apr_9_6_3.nxml.txt.nlp	19358725	SENT56	9	9	22	22	abacavir	BID	PA448004	637	0.867
NULL	Arthritis_Res_Ther_2012_Jul_12_14(4)_R163.nxml.txt.nlp	22784880	SENT167	18	18	21	21	leflunomide	CYP2C19	PA450192	1557	0.867
NULL	Breast_Cancer_Res_2005_Apr_12_7(4)_R570-R579.nxml.txt.nlp	15987464	SENT4	0	0	21	21	gefitinib	EGFR	PA131301952	1956	0.867
NULL	Nucleic_Acids_Res_2013_May_5_41(10)_5210-5222.nxml.txt.nlp	23563151	SENT210	16	16	6	6	arsenite	MDM2	PA452638	4193	0.867
NULL	BMB_Rep_2013_Aug_46(8)_410-415.nxml.txt.nlp	23977989	SENT56	14	14	31	31	curcumin	HO-1	PA151958596	3162	0.867
NULL	Neuroscience_2011_Nov_10_195(4)_191-200.nxml.txt.nlp	21875651	SENT66	26	26	2	2	paraformaldehyde	P21	PA450790	1026;9338	0.867
NULL	Cancer_Med_2014_Aug_7_3(4)_796-811.nxml.txt.nlp	24802970	SENT364	28	28	5	5	etoposide	CD44	PA449552	960	0.867
NULL	EMBO_Mol_Med_2012_Jun_13_4(6)_515-527.nxml.txt.nlp	22416035	SENT154	26	26	6	6	olaparib	p53		7157	0.867
NULL	Biomed_Res_Int_2014_Jan_16_2014_821513.nxml.txt.nlp	24527458	SENT118	17	17	11	11	ketamine	NAC	PA450144	22861	0.867
NULL	Diabetes_Metab_J_2012_Jun_14_36(3)_207-210.nxml.txt.nlp	22737660	SENT58	9	9	5	5	rosiglitazone	HSD1	PA451283	26871	0.867
NULL	Breast_Cancer_Res_2005_Apr_4_7(4)_R422-R435.nxml.txt.nlp	15987447	SENT160	39	39	26	26	celecoxib	Bcl-2	PA448871	596	0.867
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT209	10	10	13	13	bevacizumab	VEGFR2	PA130232992	3791	0.867
NULL	J_Hematol_Oncol_2014_Apr_4_7_30.nxml.txt.nlp	24708874	SENT8	14	14	10	10	sulfasalazine	xCT	PA451547	23657	0.867
NULL	Pharmaceuticals_(Basel)_2011_Jan_28_4(2)_366-381.nxml.txt.nlp	NULL	SENT170	26	26	15	15	naltrexone	ACTH	PA450588	5443	0.867
NULL	Evid_Based_Complement_Alternat_Med_2013_May_22_2013_921012.nxml.txt.nlp	23762167	SENT121	18	18	1	1	glucose	AMPK	PA449773	5563	0.867
NULL	J_Exp_Med_2000_May_15_191(10)_1661-1674.nxml.txt.nlp	10811860	SENT77	12	12	30	30	collagenase	CD11c	PA449107	3687	0.867
NULL	Front_Oncol_2011_Jun_17_1_10.nxml.txt.nlp	22655230	SENT1104	7	7	13	13	olaparib	BRCA2		675	0.867
NULL	Clin_Med_Insights_Oncol_2012_Apr_3_6_179-187.nxml.txt.nlp	22518088	SENT87	21	21	13	13	pertuzumab	HER2		2064	0.867
NULL	Chemother_Res_Pract_2012_Aug_29_2012_817297.nxml.txt.nlp	22970367	SENT190	12	12	32	32	afatinib	EGFR	PA165981154	1956	0.867
NULL	Orphanet_J_Rare_Dis_2010_Dec_16_5_39.nxml.txt.nlp	21162721	SENT70	35	35	29	29	carbamazepine	HLA-B	PA448785	3106	0.867
NULL	Cancer_Cell_Int_2013_Feb_8_13_11.nxml.txt.nlp	23394616	SENT59	15	15	5	5	geldanamycin	E2F1	PA152031327	1869	0.867
NULL	Oncotarget_2013_Jun_4_4(5)_772-784.nxml.txt.nlp	23800712	SENT125	47	47	27	27	dasatinib	PIK3CA	PA162372878	5290	0.867
NULL	Breast_Cancer_Res_2008_Mar_27_10(2)_R27.nxml.txt.nlp	18371219	SENT143	29	29	7	7	doxorubicin	HER2	PA449412	2064	0.867
NULL	Pharmaceutics_2011_Nov_18_3(4)_865-913.nxml.txt.nlp	24309312	SENT2034	2	2	11	11	clarithromycin	CYP2C19	PA449028	1557	0.867
NULL	JRSM_Short_Rep_2011_Dec_15_2(12)_97.nxml.txt.nlp	22279607	SENT79	17	17	4	4	dalteparin	TED	PA165958404	27112	0.867
NULL	JAKSTAT_2014_Jun_12_3_e29554.nxml.txt.nlp	25105067	SENT4	4	4	22	22	propofol	AKT	PA451141	207	0.867
NULL	Nat_Neurosci_2012_Jun_15(6)_845-852.nxml.txt.nlp	22522402	SENT239	17	17	25	25	paraformaldehyde	EEA1	PA450790	8411	0.867
NULL	Braz_J_Microbiol_2012_Jun_1_Oct-Dec_43(4)_1490-1498.nxml.txt.nlp	24031980	SENT90	3	3	15	15	lipase	mol	PA450239	90527	0.867
NULL	J_Cell_Biol_2006_Sep_25_174(7)_1047-1058.nxml.txt.nlp	17000881	SENT37	18	18	11	11	heparin	FGF2	PA449855	2247;2258	0.867
NULL	Breast_Cancer_Res_2004_Mar_26_6(3)_R252-R263.nxml.txt.nlp	15084249	SENT166	36	36	16	16	tamoxifen	NAT1	PA451581	9;1982	0.867
NULL	Ann_Rheum_Dis_2009_Jan_15_69(1)_301-304.nxml.txt.nlp	19147618	SENT76	24	24	29	29	infliximab	TWEAK	PA452639	8742	0.867
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1699-1708.nxml.txt.nlp	19861960	SENT159	21	21	34	34	dasatinib	STAT3	PA162372878	6774	0.867
NULL	Patient_Prefer_Adherence_2013_May_7_7_391-400.nxml.txt.nlp	23687442	SENT2	12	12	41	41	aprepitant	HEC	PA164747039	10403	0.867
NULL	Acta_Pharmacol_Sin_2011_Jul_13_32(7)_967-972.nxml.txt.nlp	21666702	SENT16	15	15	3	3	ticlopidine	P-gp	PA451686	5243	0.867
NULL	Oncotarget_2011_May_16_2(5)_378-392.nxml.txt.nlp	21623005	SENT178	37	37	28	28	oxaliplatin	MDM2	PA131285527	4193	0.867
NULL	NMR_Biomed_2014_Jul_5_27(7)_760-773.nxml.txt.nlp	24798066	SENT105	23	23	1	1	carboplatin	NACT	PA448803	284111	0.867
NULL	Cytotechnology_2014_Dec_8_66(6)_979-986.nxml.txt.nlp	24101443	SENT19	15	15	7	7	collagenase	IVD	PA449107	3712	0.867
NULL	Nat_Methods_2011_Jun_24_8(6)_487-493.nxml.txt.nlp	21516115	SENT67	30	30	27	27	erlotinib	EGFR	PA134687924	1956	0.867
NULL	Cancers_(Basel)_2014_Jul_7_6(3)_1441-1463.nxml.txt.nlp	25003395	SENT184	3	3	19	19	etoposide	PI3K	PA449552	5290	0.867
NULL	Front_Neurosci_2014_Jan_10_7_270.nxml.txt.nlp	24454277	SENT160	23	23	6	6	resveratrol	SIRT1		23411	0.867
NULL	Breast_Cancer_Res_2014_May_5_16(3)_R45.nxml.txt.nlp	24887236	SENT188	11	11	17	17	saracatinib	HER2		2064	0.867
NULL	Daru_2011_19(2)_138-144.nxml.txt.nlp	22615650	SENT116	8	8	22	22	heparin	FGF20	PA449855	26281	0.867
NULL	Mol_Cancer_2010_Nov_18_9_295.nxml.txt.nlp	21087507	SENT21	17	17	25	25	tamoxifen	aromatase	PA451581	1588	0.867
NULL	eLife_2013_Nov_5_2_e00969.nxml.txt.nlp	24192036	SENT212	0	0	9	9	vemurafenib	MKK4	PA165946873	6416	0.867
NULL	Br_J_Cancer_2011_Jan_4_104(1)_91-100.nxml.txt.nlp	21139584	SENT5	16	16	7	7	coumarin	p53	PA134521193	7157	0.867
NULL	Clin_Med_Insights_Womens_Health_2013_Jan_22_6_1-11.nxml.txt.nlp	24665209	SENT205	33	33	17	17	tamoxifen	aromatase	PA451581	1588	0.867
NULL	Acta_Pharmacol_Sin_2010_Sep_16_31(9)_1075-1084.nxml.txt.nlp	20711221	SENT73	36	36	9	9	glucose	AMPK	PA449773	5563	0.867
NULL	Crit_Care_2000_Mar_21_4(Suppl_1)_P90.nxml.txt.nlp	NULL	SENT3	17	17	42	42	vancomycin	VAN	PA451850	10318	0.867
NULL	Diabetes_2011_Mar_21_60(3)_757-765.nxml.txt.nlp	21282370	SENT118	0	0	31	31	isoproterenol	PTRF	PA450121	284119	0.867
NULL	Cardiol_Res_Pract_2013_Jan_31_2013_128795.nxml.txt.nlp	23431496	SENT29	17	17	11	11	clopidogrel	CYP2C19	PA449053	1557	0.867
NULL	Cancers_(Basel)_2014_Mar_26_6(2)_708-722.nxml.txt.nlp	24675568	SENT120	9	9	11	11	erlotinib	STAT3	PA134687924	6774	0.867
NULL	Croat_Med_J_2012_Aug_53(4)_314-320.nxml.txt.nlp	22911523	SENT209	23	23	17	17	cetuximab	PIK3CA	PA10040	5290	0.867
NULL	Onco_Targets_Ther_2014_May_28_7_841-852.nxml.txt.nlp	24920926	SENT73	22	22	15	15	gefitinib	EGFR	PA131301952	1956	0.867
NULL	Ann_Neurol_2011_Feb_69(2)_312-319.nxml.txt.nlp	21387376	SENT63	24	24	15	15	vasopressin	TDP-43	PA451858	23435	0.867
NULL	J_Carcinog_2014_Feb_20_13_4.nxml.txt.nlp	24737952	SENT204	23	23	10	10	gefitinib	p53	PA131301952	7157	0.867
NULL	Int_J_Mol_Sci_2013_Aug_14_14(8)_16719-16731.nxml.txt.nlp	23949634	SENT112	4	4	22	22	thrombin	RhoA	PA451674	387	0.867
NULL	J_Cell_Biol_1998_May_4_141(3)_637-646.nxml.txt.nlp	9566965	SENT155	27	27	10	10	trypsin	CST	PA451806	9514	0.867
NULL	J_Midlife_Health_2013_Jul-Sep_4(3)_147-152.nxml.txt.nlp	24672186	SENT96	25	25	5	5	teriparatide	PTH	PA451620	5741	0.867
NULL	J_Biol_Chem_2008_Nov_14_283(46)_31679-31689.nxml.txt.nlp	18755684	SENT233	27	27	3	3	iron	FTH1	PA450087	2495	0.867
NULL	Biologics_2012_Feb_1_6_31-35.nxml.txt.nlp	22355257	SENT63	26	26	16	16	rituximab	IL-10	PA451261	3586	0.867
NULL	Diabetes_2008_Oct_57(10)_2784-2793.nxml.txt.nlp	18599521	SENT175	3	3	23	23	simvastatin	Rho	PA451363	29984	0.867
NULL	Indian_J_Med_Res_2012_Dec_136(6)_926-941.nxml.txt.nlp	23391788	SENT221	38	38	3	3	clopidogrel	P2Y12	PA449053	64805	0.867
NULL	Ann_Saudi_Med_2011_May-Jun_31(3)_279-283.nxml.txt.nlp	21623058	SENT54	21	21	3	3	azathioprine	IL-2	PA448515	3558	0.867
NULL	Arch_Med_Sci_2013_Aug_30_9(4)_724-730.nxml.txt.nlp	24049536	SENT95	10	10	1	1	genistein	PTH	PA165109660	5741	0.867
NULL	Behav_Brain_Funct_2014_Jun_16_10_21.nxml.txt.nlp	24934302	SENT246	36	36	7	7	methamphetamine	gamma	PA450403	9913	0.867
NULL	Breast_Cancer_Res_2011_Nov_28_13(6)_R121.nxml.txt.nlp	22123186	SENT62	0	0	9	9	trastuzumab	San	PA451743	80218	0.867
NULL	J_Exp_Med_2003_Aug_4_198(3)_505-512.nxml.txt.nlp	12900524	SENT110	9	9	0	0	dextran	CD11c	PA449261	3687	0.867
NULL	Mol_Biol_Rep_2013_May_11_40(8)_5013-5026.nxml.txt.nlp	23666059	SENT117	5	5	15	15	resveratrol	p53		7157	0.867
NULL	J_Invest_Dermatol_2012_Sep_10_132(9)_2255-2262.nxml.txt.nlp	22572817	SENT60	12	12	9	9	forskolin	ASIP	PA146096022	434;56288	0.867
NULL	Curr_Neuropharmacol_2012_Mar_10(1)_72-79.nxml.txt.nlp	22942880	SENT85	8	8	30	30	cisplatin	GSTP1	PA449014	2950	0.867
NULL	Nanoscale_Res_Lett_2012_Jul_17_7(1)_398.nxml.txt.nlp	22805742	SENT30	19	19	11	11	ethanol	mol	PA448073	90527	0.867
NULL	Clin_Med_Insights_Oncol_2012_Mar_12_6_153-164.nxml.txt.nlp	22550404	SENT28	15	15	9	9	vincristine	CHOP	PA451879	1649	0.867
NULL	Int_J_Endocrinol_Metab_2013_Dec_21_Winter_11(1)_57-61.nxml.txt.nlp	23853622	SENT111	18	18	10	10	bromocriptine	PRL	PA448671	5617	0.867
NULL	Front_Oncol_2013_Aug_20_3_202.nxml.txt.nlp	23971004	SENT150	10	10	22	22	vanillin	p65	PA451852	5970	0.867
NULL	J_Korean_Med_Sci_2005_Oct_31_20(5)_721-726.nxml.txt.nlp	16224142	SENT123	12	12	22	22	betaine	Met	PA448603	79811	0.867
NULL	Oncotarget_2011_Sep_9_2(9)_658-668.nxml.txt.nlp	21911919	SENT125	27	27	8	8	daunorubicin	HO-1	PA449212	3162	0.867
NULL	Exp_Mol_Med_2012_Feb_29_44(2)_159-166.nxml.txt.nlp	22127053	SENT45	20	20	6	6	simvastatin	RhoA	PA451363	387	0.867
NULL	Acta_Pharmacol_Sin_2011_Jun_3_32(6)_817-823.nxml.txt.nlp	21642950	SENT142	0	0	23	23	propofol	HCN1	PA451141	348980	0.867
NULL	Int_J_Hypertens_2012_Feb_8_2012_189512.nxml.txt.nlp	22518281	SENT131	7	7	17	17	hemin	HO-2	PA449849	3163	0.867
NULL	Front_Genet_2011_Jul_18_2_49.nxml.txt.nlp	22303345	SENT143	22	22	13	13	estradiol	ESR1	PA449503	2099	0.867
NULL	Ann_Surg_Oncol_2010_Apr_20_17(4)_1168-1176.nxml.txt.nlp	19936839	SENT113	13	13	5	5	bevacizumab	KRAS	PA130232992	3845	0.867
NULL	Front_Public_Health_2013_Nov_14_1_50.nxml.txt.nlp	24350219	SENT12	20	20	27	27	hydrocortisone	TREM-1	PA449905	54210	0.867
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT77	23	23	17	17	erlotinib	CYP3A	PA134687924	1574	0.867
NULL	Iran_J_Pharm_Res_2014_Spring_13(2)_583-590.nxml.txt.nlp	25237354	SENT114	30	30	3	3	enoxaparin	IL-6	PA449463	3569	0.867
NULL	J_Cell_Biol_2005_Jul_4_170(1)_73-79.nxml.txt.nlp	15998800	SENT30	21	21	4	4	thrombin	NAC	PA451674	22861	0.867
NULL	Int_J_Med_Sci_2012_Dec_28_10(2)_110-118.nxml.txt.nlp	23329881	SENT55	9	9	3	3	docetaxel	NACT	PA449383	284111	0.867
NULL	Front_Physiol_2011_Jun_30_2_33.nxml.txt.nlp	21747769	SENT15	9	9	28	28	berberine	KCNQ1	PA165860812	3784	0.867
NULL	J_Biol_Chem_2009_Sep_4_284(36)_24553-24567.nxml.txt.nlp	19570982	SENT439	0	0	16	16	heparin	PF1	PA449855	57649	0.867
NULL	Eur_J_Med_Res_2011_May_12_16(5)_197-205.nxml.txt.nlp	21719392	SENT203	6	6	0	0	foscarnet	IL-2	PA449706	3558	0.867
NULL	Curr_Neuropharmacol_2009_Sep_7(3)_180-194.nxml.txt.nlp	20190960	SENT121	10	10	6	6	ethanol	CB1	PA448073	1268	0.867
NULL	Int_J_Gen_Med_2013_Dec_4_6_877-895.nxml.txt.nlp	24403842	SENT55	28	28	14	14	exenatide	GLP-1	PA164749238	100125288	0.867
NULL	Diabetes_2009_Jan_58(1)_104-115.nxml.txt.nlp	18835938	SENT165	2	2	16	16	rosiglitazone	MRP-1	PA451283	928	0.867
NULL	Front_Genet_2012_Sep_12_3_171.nxml.txt.nlp	22988450	SENT511	12	12	2	2	etoposide	RAD21	PA449552	5885	0.867
NULL	Clin_Ophthalmol_2011_Feb_10_5_171-176.nxml.txt.nlp	21383945	SENT30	1	1	20	20	heparin	ACT	PA449855	12;11332;9457;641455	0.867
NULL	J_Korean_Med_Sci_2009_Jun_16_24(3)_525-528.nxml.txt.nlp	19543522	SENT14	22	22	6	6	vincristine	CHOP	PA451879	1649	0.867
NULL	Oncotarget_2013_Nov_22_5(4)_933-943.nxml.txt.nlp	24659749	SENT93	2	2	8	8	nutlin-3	p53		7157	0.867
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Apr_7_9_12.nxml.txt.nlp	20374640	SENT10	17	17	5	5	ampicillin	TEM	PA448419	64102	0.867
NULL	Cell_Death_Dis_2014_Feb_13_5(2)_e1055.nxml.txt.nlp	24525731	SENT8	44	44	29	29	cisplatin	XRCC1	PA449014	7515	0.867
NULL	Breast_Cancer_Res_2011_Nov_1_13(6)_224.nxml.txt.nlp	22114931	SENT91	37	37	11	11	tamoxifen	PTEN	PA451581	5728	0.867
NULL	Evid_Based_Complement_Alternat_Med_2013_May_13_2013_506324.nxml.txt.nlp	23818927	SENT260	26	26	8	8	doxorubicin	STAT3	PA449412	6774	0.867
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Apr_16_67(Pt_5)_o1144.nxml.txt.nlp	21754452	SENT56	7	7	4	4	hydroquinone	mol	PA449924	90527	0.867
NULL	Br_J_Cancer_2009_Sep_15_101(6)_875-878.nxml.txt.nlp	19672259	SENT53	31	31	22	22	anastrozole	aromatase	PA448432	1588	0.867
NULL	J_Thyroid_Res_2011_Apr_10_2011_895923.nxml.txt.nlp	21603172	SENT107	6	6	19	19	thyroglobulin	CO2	PA164754910	4513	0.867
NULL	Arthritis_Res_Ther_2010_Apr_29_12(2)_R73.nxml.txt.nlp	20429888	SENT282	6	6	15	15	bortezomib	COL1A2	PA10252	1278	0.867
NULL	Biomed_Res_Int_2014_Feb_10_2014_760303.nxml.txt.nlp	24689055	SENT177	11	11	19	19	gemcitabine	Oct4	PA449748	5460	0.867
NULL	Sci_Rep_2014_Dec_16_4_7500.nxml.txt.nlp	25511254	SENT161	9	9	30	30	hyperforin	TRPC6	PA165985514	7225	0.867
NULL	Pharmaceutics_2011_Oct_12_3(4)_680-705.nxml.txt.nlp	24309303	SENT1028	23	23	2	2	repaglinide	OATP1B1	PA451234	10599	0.867
NULL	Diabetes_2011_Nov_17_60(11)_2691-2700.nxml.txt.nlp	21896928	SENT242	16	16	21	21	resveratrol	SIRT1		23411	0.867
NULL	Cell_Commun_Signal_2013_Oct_1_11_73.nxml.txt.nlp	24083678	SENT43	13	13	18	18	sulindac	IL-8	PA451565	3576	0.867
NULL	Indian_J_Endocrinol_Metab_2013_Mar-Apr_17(2)_281-284.nxml.txt.nlp	23776903	SENT32	20	20	17	17	thyroglobulin	TPO	PA164754910	7066;7173	0.867
NULL	Br_J_Cancer_2013_Sep_3_109(5)_1214-1222.nxml.txt.nlp	23922104	SENT123	6	6	16	16	dasatinib	AKT	PA162372878	207	0.867
NULL	Chemother_Res_Pract_2011_Sep_25_2011_730360.nxml.txt.nlp	22295205	SENT192	8	8	11	11	trastuzumab	survivin	PA451743	332	0.867
NULL	Oncotarget_2012_Feb_2_3(1)_58-66.nxml.txt.nlp	22308267	SENT58	27	27	24	24	doxycycline	MYC	PA449415	4609	0.867
NULL	J_Indian_Soc_Periodontol_2014_May-Jun_18(3)_282-288.nxml.txt.nlp	25024538	SENT87	26	26	22	22	denosumab	RANKL	PA166048634	8600	0.867
NULL	Oncol_Lett_2014_Mar_16_7(3)_827-833.nxml.txt.nlp	24527090	SENT76	31	31	24	24	cisplatin	IFN	PA449014	3439	0.867
NULL	Oncol_Lett_2013_Dec_4_6(6)_1665-1672.nxml.txt.nlp	24273604	SENT144	3	3	9	9	chloroquine	TLR9	PA448948	54106	0.867
NULL	Cell_Death_Dis_2014_Jan_30_5(1)_e1033.nxml.txt.nlp	24481447	SENT129	5	5	14	14	rosiglitazone	CDK5	PA451283	1020	0.867
NULL	Iran_Red_Crescent_Med_J_2014_Aug_5_16(8)_e6915.nxml.txt.nlp	25389496	SENT32	17	17	7	7	simvastatin	adiponectin	PA451363	9370	0.867
NULL	J_Oncol_2013_Feb_17_2013_872957.nxml.txt.nlp	23476648	SENT96	13	13	2	2	cisplatin	SFN	PA449014	25996;2810	0.867
NULL	Int_J_Biol_Sci_2011_Nov_5_8(1)_1-14.nxml.txt.nlp	22211100	SENT237	7	7	27	27	evodiamine	PI3K	PA165860788	5290	0.867
NULL	Antimicrob_Agents_Chemother_2014_Dec_58(12)_7340-7346.nxml.txt.nlp	25267661	SENT202	0	0	9	9	piperaquine	CYP2C19	PA166104279	1557	0.867
NULL	Oncotarget_2012_Jan_28_3(1)_78-83.nxml.txt.nlp	22289679	SENT77	15	15	0	0	geldanamycin	Raf-1	PA152031327	5894	0.867
NULL	BMB_Rep_2013_Jan_46(1)_59-64.nxml.txt.nlp	23351386	SENT102	3	3	25	25	auranofin	STAT3	PA448510	6774	0.867
NULL	Acta_Pharmacol_Sin_2012_Apr_5_33(4)_551-557.nxml.txt.nlp	22388075	SENT114	5	5	16	16	imatinib	Wip1	PA10804	8493	0.867
NULL	Atten_Defic_Hyperact_Disord_2009_Dec_23_1(2)_201-210.nxml.txt.nlp	20234828	SENT25	4	4	30	30	atomoxetine	CYP2D6	PA134688071	1565	0.867
NULL	Mol_Cancer_2009_Dec_10_8_118.nxml.txt.nlp	20003259	SENT125	0	0	2	2	sorafenib	MMP2	PA7000	4313	0.867
NULL	J_Bras_Pneumol_2013_Jan-Feb_39(1)_5-15.nxml.txt.nlp	23503480	SENT227	14	14	12	12	doxycycline	LAM	PA449415	7249;7248	0.867
NULL	Aging_Cell_2012_Aug_11(4)_579-587.nxml.txt.nlp	22435726	SENT194	6	6	14	14	etoposide	IL-15	PA449552	3600	0.867
NULL	Oncol_Lett_2013_Apr_22_5(4)_1093-1100.nxml.txt.nlp	23599746	SENT190	6	6	16	16	etoposide	MDR1	PA449552	5243	0.867
NULL	J_Cereb_Blood_Flow_Metab_2012_Dec_5_32(12)_2171-2180.nxml.txt.nlp	22948298	SENT171	14	14	5	5	paraformaldehyde	NOTCH3	PA450790	4854	0.867
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT40	7	7	31	31	pemetrexed	UNG	PA10810	7374	0.867
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT212	6	6	28	28	resveratrol	FADD		8772	0.867
NULL	Clin_Dev_Immunol_2011_Dec_6_2011_349575.nxml.txt.nlp	22190970	SENT216	16	16	8	8	ribavirin	IFN	PA451241	3439	0.867
NULL	Blood_Cancer_J_2013_Mar_1_3(3)_e103.nxml.txt.nlp	23454896	SENT141	40	40	10	10	nelfinavir	p27	PA450606	5715;10534	0.867
NULL	Clin_Dev_Immunol_2011_Mar_22_2011_790460.nxml.txt.nlp	21603161	SENT185	13	13	6	6	tacrolimus	CD34	PA451578	947	0.867
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT868	14	14	5	5	ritonavir	MRP2	PA451260	100130958;57626;1244	0.867
NULL	J_Bras_Pneumol_2013_Jan-Feb_39(1)_5-15.nxml.txt.nlp	23503480	SENT20	5	5	3	3	doxycycline	LAM	PA449415	7249;7248	0.867
NULL	J_Exp_Med_2000_Mar_20_191(6)_1005-1016.nxml.txt.nlp	10727462	SENT186	16	16	37	37	flavopiridol	MITF	PA452627	4286	0.867
NULL	eLife_2014_Aug_1_3_e02725.nxml.txt.nlp	25085081	SENT750	30	30	11	11	irinotecan	BRAF	PA450085	673	0.867
NULL	Front_Chem_2014_May_1_2_20.nxml.txt.nlp	24822174	SENT259	0	0	13	13	trastuzumab	HER2	PA451743	2064	0.867
NULL	Nucleic_Acids_Res_2012_Jul_19_40(13)_5910-5925.nxml.txt.nlp	22434882	SENT303	24	24	12	12	curcumin	HBZ	PA151958596	3050	0.867
NULL	Front_Immunol_2013_Nov_7_4_360.nxml.txt.nlp	24223576	SENT248	30	30	14	14	etoposide	p53	PA449552	7157	0.867
NULL	Case_Rep_Nephrol_2013_Nov_20_2013_801575.nxml.txt.nlp	24558627	SENT33	20	20	31	31	vasopressin	AVP	PA451858	114548;551	0.867
NULL	Brain_2014_Oct_17_137(10)_2731-2742.nxml.txt.nlp	25034897	SENT149	31	31	2	2	levodopa	ANOVA	PA450213	4858	0.867
NULL	Ther_Clin_Risk_Manag_2006_Mar_2(1)_19-24.nxml.txt.nlp	18360578	SENT35	2	2	6	6	oxybutynin	CYP3A4	PA164746030	1576	0.867
NULL	Int_J_Mol_Sci_2014_Mar_7_15(3)_4104-4125.nxml.txt.nlp	24608924	SENT183	20	20	32	32	cisplatin	IFN	PA449014	3439	0.867
NULL	Pharm_Methods_2011_Jul-Sep_2(3)_178-183.nxml.txt.nlp	23781452	SENT19	10	10	0	0	piroxicam	LOR	PA450985	4014	0.867
NULL	Mol_Biol_Cell_2012_Jun_1_23(11)_2066-2075.nxml.txt.nlp	22496421	SENT202	7	7	0	0	staurosporine	HCA2	PA165109623	139081;55811;338442	0.867
NULL	Onco_Targets_Ther_2014_Jun_11_7_969-983.nxml.txt.nlp	24959084	SENT115	13	13	20	20	clarithromycin	CYP3A4	PA449028	1576	0.867
NULL	BMB_Rep_2013_Jan_46(1)_59-64.nxml.txt.nlp	23351386	SENT62	4	4	29	29	auranofin	NAC	PA448510	22861	0.867
NULL	Int_J_Med_Sci_2014_Mar_29_11(5)_528-537.nxml.txt.nlp	24693223	SENT49	5	5	21	21	resveratrol	SIRT1		23411	0.867
NULL	Sci_Rep_2014_Nov_28_4_7237.nxml.txt.nlp	25429875	SENT569	9	9	0	0	hesperidin	JNK	PA449867	5599	0.867
NULL	Evid_Based_Complement_Alternat_Med_2012_Sep_4_2012_485042.nxml.txt.nlp	22988474	SENT126	15	15	26	26	docetaxel	P-gp	PA449383	5243	0.867
NULL	Biologics_2010_Sep_13_4_237-243.nxml.txt.nlp	20859451	SENT115	5	5	8	8	everolimus	EGFR	PA164746311	1956	0.867
NULL	Endocr_Relat_Cancer_2014_Jun_21(3)_R209-R225.nxml.txt.nlp	24500760	SENT32	12	12	27	27	resveratrol	COX		1351	0.867
NULL	Arch_Virol_2014_Dec_24_159(6)_1365-1371.nxml.txt.nlp	24366548	SENT6	28	28	17	17	ribavirin	IFI27	PA451241	3429	0.867
NULL	Clin_Interv_Aging_2008_Sep_3(3)_421-430.nxml.txt.nlp	18982913	SENT232	4	4	8	8	fluvoxamine	CYP3A4	PA449690	1576	0.867
NULL	Clin_Pharmacokinet_2014_Sep_3_53(1)_1-16.nxml.txt.nlp	23999929	SENT338	20	20	9	9	rivaroxaban	CLCR	PA165958360	11330	0.867
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT213	9	9	2	2	sulindac	survivin	PA451565	332	0.867
NULL	Hum_Genomics_2008_Sep_1_3(1)_7-16.nxml.txt.nlp	19129086	SENT173	19	19	16	16	rosiglitazone	SLCO1B1	PA451283	10599	0.867
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Dec_8_69(Pt_1)_o49.nxml.txt.nlp	23476432	SENT65	15	15	10	10	ethanol	mol	PA448073	90527	0.867
NULL	J_Biol_Eng_2009_Oct_16_3_18.nxml.txt.nlp	19835592	SENT56	22	22	12	12	erythromycin	CPZ	PA449493	8532	0.867
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Sep_8_68(Pt_10)_o2897-o2898.nxml.txt.nlp	23125693	SENT88	24	24	36	36	isoniazid	mol	PA450112	90527	0.866
NULL	Clin_Cosmet_Investig_Dermatol_2014_Sep_2_7_243-249.nxml.txt.nlp	25214798	SENT54	13	13	1	1	ustekinumab	ACR	PA166048654	49	0.866
NULL	Oncol_Rep_2012_Apr_16_27(4)_971-978.nxml.txt.nlp	22266706	SENT112	14	14	31	31	cisplatin	Mcl-1	PA449014	4170	0.866
NULL	Onco_Targets_Ther_2014_Nov_28_7_2183-2195.nxml.txt.nlp	25506223	SENT6	24	24	10	10	doxorubicin	MICA	PA449412	100507436	0.866
NULL	Cancer_Cell_Int_2010_Oct_25_10_40.nxml.txt.nlp	20974006	SENT161	19	19	3	3	paraformaldehyde	DR5	PA450790	8795	0.866
NULL	Braz_J_Med_Biol_Res_2014_Sep_5_47(11)_929-939.nxml.txt.nlp	25296354	SENT114	33	33	21	21	afatinib	EGFR	PA165981154	1956	0.866
NULL	Mol_Cancer_2010_Aug_20_9_220.nxml.txt.nlp	20727180	SENT9	8	8	25	25	nicotine	p53	PA450626	7157	0.866
NULL	Nat_Med_2014_Apr_16_20(4)_385-397.nxml.txt.nlp	24633305	SENT56	8	8	22	22	triciribine	FOXO1	PA165958661	2308	0.866
NULL	Arch_Drug_Inf_2008_Dec_1(3)_97-106.nxml.txt.nlp	19639031	SENT25	4	4	28	28	irinotecan	UGT	PA450085	7361;7355	0.866
NULL	Indian_J_Med_Paediatr_Oncol_2014_Apr-Jun_35(2)_140-142.nxml.txt.nlp	25197175	SENT7	33	33	11	11	bevacizumab	EGFR	PA130232992	1956	0.866
NULL	Breast_Cancer_Res_2012_Jun_15_14(3)_R96.nxml.txt.nlp	22703841	SENT26	7	7	10	10	estradiol	HER2	PA449503	2064	0.866
NULL	Oncoscience_2013_Dec_11_1(1)_30-38.nxml.txt.nlp	25593982	SENT23	8	8	2	2	glucose	Met	PA449773	79811	0.866
NULL	Mol_Cancer_2013_Mar_5_12_17.nxml.txt.nlp	23497256	SENT161	12	12	4	4	sunitinib	p53	PA162372840	7157	0.866
NULL	Adv_Hematol_2010_Dec_5_2010_595934.nxml.txt.nlp	21151515	SENT117	12	12	17	17	ticagrelor	ADP	PA165374673	23038	0.866
NULL	Cell_Mol_Life_Sci_2011_Nov_2_68(21)_3573-3587.nxml.txt.nlp	21365278	SENT172	15	15	18	18	iloprost	EP2	PA164746843	5732;10407	0.866
NULL	Curr_Gerontol_Geriatr_Res_2010_May_4_2010_420139.nxml.txt.nlp	20454643	SENT89	18	18	4	4	estradiol	AMPK	PA449503	5563	0.866
NULL	Braz_J_Med_Biol_Res_2013_Aug_13_46(8)_659-669.nxml.txt.nlp	24036938	SENT35	0	0	5	5	resveratrol	SIRT1		23411	0.866
NULL	Mol_Med_Rep_2015_Jan_16_11(1)_189-195.nxml.txt.nlp	25323748	SENT94	9	9	16	16	cisplatin	CHOP	PA449014	1649	0.866
NULL	Pharmaceutics_2010_Jun_2_2(2)_258-274.nxml.txt.nlp	NULL	SENT184	20	20	27	27	risperidone	P-gp	PA451257	5243	0.866
NULL	Ann_Hematol_2011_Feb_17_90(2)_173-183.nxml.txt.nlp	20714724	SENT149	21	21	13	13	resveratrol	CD5		921	0.866
NULL	Br_J_Cancer_2011_Jul_26_105(3)_407-412.nxml.txt.nlp	21730976	SENT100	17	17	13	13	pha-665752	STAT3		6774	0.866
NULL	Clin_Med_Insights_Arthritis_Musculoskelet_Disord_2012_Jan_5_5_1-14.nxml.txt.nlp	22267947	SENT122	7	7	19	19	risedronate	NNT	PA451255	23530	0.866
NULL	Onco_Targets_Ther_2014_Jul_1_7_1185-1193.nxml.txt.nlp	25061320	SENT153	6	6	20	20	gemcitabine	EGFR	PA449748	1956	0.866
NULL	J_Korean_Med_Sci_2009_Jan_29_24(Suppl_1)_S183-S188.nxml.txt.nlp	19194550	SENT83	2	2	11	11	celecoxib	CD2AP	PA448871	23607	0.866
NULL	Eur_J_Med_Res_2013_Jul_3_18(1)_22.nxml.txt.nlp	23822543	SENT43	4	4	22	22	everolimus	gamma	PA164746311	9913	0.866
NULL	Arthritis_Res_Ther_2008_Jan_18_10(1)_R8.nxml.txt.nlp	18205921	SENT34	1	1	16	16	hyaluronan	MRP5	PA165958431	10057	0.866
NULL	Cardiovasc_Diabetol_2013_Mar_23_12_48.nxml.txt.nlp	23522121	SENT40	20	20	10	10	liraglutide	GLP-1	PA165958364	100125288	0.866
NULL	Lab_Invest_2009_Nov_7_89(11)_1275-1290.nxml.txt.nlp	19736547	SENT335	4	4	34	34	curcumin	c-Myc	PA151958596	4609	0.866
NULL	J_Oncol_2010_Nov_19_2010_568938.nxml.txt.nlp	20037743	SENT208	15	15	20	20	gefitinib	HER3	PA131301952	2065	0.866
NULL	J_Inherit_Metab_Dis_2010_Oct_3_33(5)_625-632.nxml.txt.nlp	20814828	SENT113	2	2	9	9	simvastatin	RhoA	PA451363	387	0.866
NULL	Diabetes_Obes_Metab_2011_Nov_13(11)_982-989.nxml.txt.nlp	21615670	SENT165	21	21	16	16	exenatide	GLP-1	PA164749238	100125288	0.866
NULL	Mol_Cancer_2009_Apr_16_8_24.nxml.txt.nlp	19371427	SENT221	8	8	5	5	cisplatin	CHK1	PA449014	1111	0.866
NULL	Exp_Diabetes_Res_2012_Mar_15_2012_146194.nxml.txt.nlp	22474415	SENT207	0	0	39	39	valsartan	MCP-1	PA451848	6347	0.866
NULL	Arch_Med_Sci_2013_Oct_31_9(5)_936-943.nxml.txt.nlp	24273582	SENT103	27	27	13	13	nateglinide	GLP-1	PA450600	100125288	0.866
NULL	J_Thromb_Haemost_2011_Oct_9(10)_2103-2105.nxml.txt.nlp	21812912	SENT16	1	1	11	11	ticagrelor	ADP	PA165374673	23038	0.866
NULL	Hum_Mol_Genet_2008_Jul_15_17(14)_2101-2107.nxml.txt.nlp	18413323	SENT112	16	16	3	3	ezetimibe	NPC1L1	PA10816	29881	0.866
NULL	Acta_Pharmacol_Sin_2009_Jan_8_30(1)_25-30.nxml.txt.nlp	19060918	SENT43	6	6	3	3	ribavirin	IFN	PA451241	3439	0.866
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT88	19	19	36	36	perifosine	TRAIL	PA165291471	8743	0.866
NULL	Oncol_Lett_2013_Feb_27_5(2)_435-439.nxml.txt.nlp	23420613	SENT96	10	10	15	15	paclitaxel	EGFR	PA450761	1956	0.866
NULL	Comput_Struct_Biotechnol_J_2012_Oct_31_3_e201210005.nxml.txt.nlp	24688665	SENT144	10	10	3	3	nadh	PDH	PA164755085	54704	0.866
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT158	2	2	17	17	l-methionine	SIRT3	PA450423	23410	0.866
NULL	Cancers_(Basel)_2012_Jun_18_4(2)_581-600.nxml.txt.nlp	24213326	SENT29	28	28	23	23	paclitaxel	CD25	PA450761	3669;3559	0.866
NULL	Blood_Cancer_J_2013_Oct_4_3(10)_e150.nxml.txt.nlp	24096714	SENT115	20	20	13	13	bortezomib	IL2	PA10252	3558	0.866
NULL	Mol_Pain_2013_Feb_15_9_3.nxml.txt.nlp	23413875	SENT37	12	12	23	23	resveratrol	TRPV1		7442	0.866
NULL	Nat_Neurosci_2012_Jun_15(6)_845-852.nxml.txt.nlp	22522402	SENT239	17	17	1	1	paraformaldehyde	EEA1	PA450790	8411	0.866
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1145.nxml.txt.nlp	24675463	SENT113	3	3	9	9	cetuximab	EGFR	PA10040	1956	0.866
NULL	Mol_Cell_Proteomics_2012_Feb_6_11(2)_M111_015222.nxml.txt.nlp	22147731	SENT335	4	4	9	9	cetuximab	JAG1	PA10040	182	0.866
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2011_Sep_13_4_47-62.nxml.txt.nlp	22879794	SENT48	25	25	6	6	liraglutide	PPG	PA165958364	5552	0.866
NULL	BMB_Rep_2013_Feb_46(2)_92-96.nxml.txt.nlp	23433111	SENT42	2	2	7	7	etoposide	BRCA1	PA449552	672	0.866
NULL	Nature_2008_Oct_23_455(7216)_1129-1133.nxml.txt.nlp	18948956	SENT184	11	11	5	5	triciribine	AKT	PA165958661	207	0.866
NULL	Indian_J_Pharmacol_2013_Jul-Aug_45(4)_365-370.nxml.txt.nlp	24014912	SENT49	2	2	18	18	prazosin	AT1	PA451093	9197;185	0.866
NULL	Br_J_Cancer_2011_Sep_27_105(7)_1012-1022.nxml.txt.nlp	21863032	SENT133	1	1	11	11	nutlin-3	DR5		8795	0.866
NULL	J_Immunother_Cancer_2013_Nov_7_1(Suppl_1)_P71.nxml.txt.nlp	NULL	SENT5	5	5	26	26	decitabine	DAC	PA164749631	13	0.866
NULL	Oncotarget_2012_May_4_3(4)_395-398.nxml.txt.nlp	22565037	SENT29	39	39	34	34	metformin	CD24	PA450395	100133941	0.866
NULL	Exp_Ther_Med_2012_Sep_12_4(3)_475-480.nxml.txt.nlp	23181121	SENT156	4	4	0	0	doxorubicin	CHOP	PA449412	1649	0.866
NULL	Breast_Cancer_Res_2010_Jul_22_12(4)_R53.nxml.txt.nlp	20649975	SENT21	20	20	4	4	tamoxifen	HOXB13	PA451581	10481	0.866
NULL	Int_J_Endocrinol_2013_Jul_22_2013_638727.nxml.txt.nlp	23970897	SENT286	22	22	0	0	pamidronate	Men	PA450767	8178	0.866
NULL	Biomed_Res_Int_2014_Jan_20_2014_948427.nxml.txt.nlp	24563867	SENT41	18	18	20	20	buspirone	COB	PA448689	4519	0.866
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Mar_14_68(Pt_4)_o1044.nxml.txt.nlp	22589914	SENT62	16	16	8	8	ethanol	mol	PA448073	90527	0.866
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1063.nxml.txt.nlp	24556678	SENT83	4	4	6	6	thioridazine	c-FLIP	PA451666	8837	0.866
NULL	Evid_Based_Complement_Alternat_Med_2013_May_27_2013_582493.nxml.txt.nlp	23781264	SENT43	12	12	4	4	ethanol	CO2	PA448073	4513	0.866
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT131	15	15	22	22	simvastatin	AKT	PA451363	207	0.866
NULL	Pain_2014_Nov_155(11)_2306-2322.nxml.txt.nlp	25168672	SENT630	0	0	2	2	lamotrigine	TRESK	PA450164	338567	0.866
NULL	Mol_Cancer_2010_Aug_23_9_222.nxml.txt.nlp	20731837	SENT197	1	1	21	21	gefitinib	EGFR	PA131301952	1956	0.866
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT191	8	8	19	19	bevacizumab	PlGF-2	PA130232992	5228	0.866
NULL	Korean_J_Anesthesiol_2013_Dec_26_65(6)_501-507.nxml.txt.nlp	24427455	SENT11	10	10	16	16	glycopyrrolate	NMB	PA164754882	10457;4828	0.866
NULL	Clin_Exp_Otorhinolaryngol_2011_Mar_17_4(1)_18-23.nxml.txt.nlp	21461058	SENT96	7	7	20	20	furosemide	NKCC1	PA449719	6558	0.866
NULL	Oncotarget_2011_Mar_10_2(3)_186-196.nxml.txt.nlp	21406729	SENT120	21	21	25	25	orlistat	SREBP1	PA164776864	6720	0.866
NULL	Cancer_Cell_Int_2009_Feb_17_9_4.nxml.txt.nlp	19222856	SENT225	39	39	33	33	cisplatin	p53	PA449014	7157	0.866
NULL	Br_J_Cancer_2010_Jun_8_102(12)_1717-1723.nxml.txt.nlp	20485285	SENT138	17	17	9	9	doxorubicin	SMAC	PA449412	56616	0.866
NULL	BMB_Rep_2013_Aug_46(8)_410-415.nxml.txt.nlp	23977989	SENT56	14	14	7	7	curcumin	HO-1	PA151958596	3162	0.866
NULL	Exp_Diabetes_Res_2012_Oct_15_2012_465282.nxml.txt.nlp	23118742	SENT150	17	17	3	3	metformin	FGF21	PA450395	26291	0.866
NULL	J_Adv_Pract_Oncol_2014_May_1_May-Jun_5(3)_193-202.nxml.txt.nlp	25089218	SENT103	13	13	15	15	denosumab	RANKL	PA166048634	8600	0.866
NULL	Support_Care_Cancer_2009_Sep_10_17(9)_1187-1193.nxml.txt.nlp	19205754	SENT139	41	41	18	18	palonosetron	CYP2D6	PA10352	1565	0.866
NULL	J_Cancer_Epidemiol_2012_Oct_24_2012_294730.nxml.txt.nlp	23150730	SENT243	30	30	3	3	cetuximab	KRAS	PA10040	3845	0.866
NULL	Biochimie_2014_Jun_101(100)_67-74.nxml.txt.nlp	24394625	SENT67	19	19	34	34	l-methionine	CO2	PA450423	4513	0.866
NULL	Arthritis_Res_Ther_2009_Aug_17_11(4)_R123.nxml.txt.nlp	19686595	SENT250	42	42	25	25	rituximab	CD27	PA451261	939	0.866
NULL	Oncotarget_2014_Sep_8_5(20)_9609-9618.nxml.txt.nlp	25228592	SENT101	25	25	27	27	vemurafenib	BRAF	PA165946873	673	0.866
NULL	Ann_Gen_Psychiatry_2013_Jan_24_12_1.nxml.txt.nlp	23347694	SENT384	25	25	20	20	clarithromycin	CYP3A4	PA449028	1576	0.866
NULL	Cardiovasc_Diabetol_2010_Nov_16_9_76.nxml.txt.nlp	21080957	SENT28	7	7	5	5	exenatide	GLP-1	PA164749238	100125288	0.866
NULL	Breast_Cancer_Res_2008_Jul_24_10(4)_211.nxml.txt.nlp	18671839	SENT223	6	6	15	15	pertuzumab	HER2		2064	0.866
NULL	J_Exp_Clin_Cancer_Res_2009_Jul_22_28(1)_105.nxml.txt.nlp	19624845	SENT57	23	23	44	44	risedronate	CO2	PA451255	4513	0.866
NULL	F1000Prime_Rep_2014_Dec_1_6_117.nxml.txt.nlp	25580271	SENT21	19	19	8	8	afatinib	EGFR	PA165981154	1956	0.866
NULL	Cell_Biol_Int_Rep_(2010)_2012_Jun_21_19(1)_e00017.nxml.txt.nlp	23124518	SENT90	43	43	17	17	etoposide	TRAIL	PA449552	8743	0.866
NULL	Mol_Cells_2014_Mar_31_37(3)_234-240.nxml.txt.nlp	24642709	SENT401	20	20	10	10	capsaicin	HO-1	PA448776	3162	0.866
NULL	J_Inflamm_(Lond)_2005_Nov_29_2_16.nxml.txt.nlp	16316467	SENT157	35	35	5	5	collagenase	TLR3	PA449107	7098	0.866
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_39-54.nxml.txt.nlp	19305787	SENT237	35	35	27	27	ethanol	DARPP-32	PA448073	84152	0.866
NULL	Breast_Cancer_Res_2007_Dec_17_9(6)_115.nxml.txt.nlp	18190722	SENT51	21	21	26	26	tamoxifen	aromatase	PA451581	1588	0.866
NULL	Diabetes_Care_2010_Mar_33(3)_683-689.nxml.txt.nlp	20190297	SENT79	11	11	14	14	miglitol	GLP-1	PA164776726	100125288	0.866
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT174	14	14	31	31	metformin	AMPK	PA450395	5563	0.866
NULL	Mol_Brain_2013_Apr_9_6_16.nxml.txt.nlp	23570271	SENT237	0	0	21	21	sulindac	cPLA2	PA451565	10524	0.866
NULL	Breast_Cancer_Res_2008_Dec_18_10(Suppl_4)_S18.nxml.txt.nlp	19128431	SENT44	25	25	21	21	tamoxifen	CYP2D6	PA451581	1565	0.866
NULL	Cancer_Cell_Int_2011_Aug_19_11_29.nxml.txt.nlp	21854619	SENT206	22	22	8	8	platinum	BRCA1	PA150595617	672	0.866
NULL	Oncoscience_2014_Oct_24_1(10)_665-673.nxml.txt.nlp	25593995	SENT77	19	19	15	15	doxorubicin	NANOG	PA449412	79923	0.866
NULL	J_Cancer_2012_Aug_24_3_354-361.nxml.txt.nlp	22962562	SENT88	11	11	28	28	fludarabine	p53	PA449655	7157	0.866
NULL	Breast_Cancer_Res_2004_Jan_29_6(2)_84-87.nxml.txt.nlp	14979912	SENT35	24	24	26	26	tamoxifen	IMPACT	PA451581	55364	0.866
NULL	Breast_Cancer_Res_2011_Dec_16_13(6)_R131.nxml.txt.nlp	22177475	SENT199	2	2	13	13	trastuzumab	AKT	PA451743	207	0.866
NULL	Dement_Geriatr_Cogn_Dis_Extra_2013_Feb_28_3(1)_39-47.nxml.txt.nlp	23569457	SENT113	10	10	35	35	forskolin	GCN2	PA146096022	440275	0.866
NULL	Ann_Surg_Oncol_2010_Apr_20_17(4)_1168-1176.nxml.txt.nlp	19936839	SENT84	14	14	5	5	cetuximab	KRAS	PA10040	3845	0.866
NULL	Int_J_Endocrinol_2010_Mar_2_2010_621687.nxml.txt.nlp	20204178	SENT168	2	2	9	9	paricalcitol	PTH	PA450798	5741	0.866
NULL	Oncotarget_2011_Dec_24_2(12)_896-917.nxml.txt.nlp	22203527	SENT114	27	27	5	5	metformin	LKB1	PA450395	6794	0.866
NULL	Oncotarget_2014_Aug_4_5(17)_7776-7787.nxml.txt.nlp	25277200	SENT181	45	45	12	12	paclitaxel	ANXA4	PA450761	307	0.866
NULL	Indian_J_Endocrinol_Metab_2012_May-Jun_16(3)_349-357.nxml.txt.nlp	22629498	SENT155	39	39	15	15	raloxifene	CTX	PA451221	1593	0.866
NULL	Int_J_Biol_Sci_2014_Jun_21_10(7)_702-714.nxml.txt.nlp	25013379	SENT19	41	41	34	34	gefitinib	EGFR	PA131301952	1956	0.866
NULL	J_Thromb_Thrombolysis_2011_Nov_26_32(4)_459-466.nxml.txt.nlp	21706290	SENT88	35	35	7	7	prasugrel	CYP2C19	PA154410481	1557	0.866
NULL	Mol_Biol_Cell_2012_Jun_1_23(11)_2092-2108.nxml.txt.nlp	22513089	SENT222	10	10	32	32	trypsin	p120	PA451806	4839;1500;55695;10902	0.866
NULL	J_Biol_Chem_2009_Sep_18_284(38)_26096-26105.nxml.txt.nlp	19628870	SENT118	3	3	24	24	pp2	PP2		4888	0.866
NULL	Acta_Pharmacol_Sin_2014_Jun_5_35(6)_727-737.nxml.txt.nlp	24793312	SENT132	3	3	7	7	telmisartan	B27	PA451605	56246	0.866
NULL	Acta_Pharmacol_Sin_2013_Jun_5_34(6)_805-810.nxml.txt.nlp	23736005	SENT13	22	22	41	41	piperazine	p53	PA450977	7157	0.866
NULL	J_Cell_Mol_Med_2013_Oct_23_17(10)_1207-1217.nxml.txt.nlp	24106980	SENT146	15	15	2	2	colchicine	P-gp	PA449092	5243	0.866
NULL	Pharmaceutics_2011_Oct_12_3(4)_680-705.nxml.txt.nlp	24309303	SENT115	18	18	8	8	metformin	P-gp	PA450395	5243	0.866
NULL	Drugs_Context_2012_Nov_26_2012_212243.nxml.txt.nlp	24432032	SENT406	2	2	12	12	cilomilast	GM-CSF	PA165948031	1437	0.866
NULL	Breast_Cancer_Res_2001_Aug_10_3(5)_E004.nxml.txt.nlp	NULL	SENT26	26	26	5	5	letrozole	HER2	PA450196	2064	0.866
NULL	Diabetol_Metab_Syndr_2014_Mar_31_6_47.nxml.txt.nlp	24684779	SENT160	30	30	15	15	pioglitazone	IL-6	PA450970	3569	0.866
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT71	4	4	9	9	neratinib	EGFR	PA165291472	1956	0.866
NULL	Arthritis_Res_Ther_2008_Sep_24_10(5)_R115.nxml.txt.nlp	18816401	SENT16	2	2	17	17	etanercept	BMP2	PA449515	650	0.866
NULL	J_Cell_Biol_2002_Nov_25_159(4)_613-624.nxml.txt.nlp	12438411	SENT212	11	11	36	36	nadh	Bcl-2	PA164755085	596	0.866
NULL	Int_J_Nanomedicine_2007_Sep_2(3)_277-288.nxml.txt.nlp	18019828	SENT46	27	27	13	13	bleomycin	CHOP	PA448645	1649	0.866
NULL	Front_Physiol_2013_May_15_4_103.nxml.txt.nlp	23720630	SENT97	4	4	11	11	simvastatin	ADP	PA451363	23038	0.866
NULL	Cancer_Cell_Int_2008_Mar_18_8_3.nxml.txt.nlp	18348720	SENT104	5	5	22	22	gefitinib	EGF	PA131301952	1950	0.866
NULL	Brain_Sci_2014_Apr_16_4(2)_295-310.nxml.txt.nlp	24961762	SENT977	1	1	6	6	propofol	p75	PA451141	7133;11168	0.866
NULL	Breast_Cancer_Res_Treat_2013_Aug_20_141(1)_43-53.nxml.txt.nlp	23959396	SENT189	10	10	19	19	trastuzumab	HER3	PA451743	2065	0.866
NULL	Eur_J_Haematol_2008_Feb_80(2)_93-106.nxml.txt.nlp	18081719	SENT50	33	33	3	3	iron	MRI	PA450087	78996	0.866
NULL	Front_Oncol_2014_Apr_9_4_75.nxml.txt.nlp	24782986	SENT265	31	31	18	18	paclitaxel	STAT3	PA450761	6774	0.866
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT199	21	21	4	4	metformin	p53	PA450395	7157	0.866
NULL	Leukemia_2014_Aug_4_28(8)_1573-1585.nxml.txt.nlp	24496300	SENT71	10	10	19	19	moxifloxacin	CYP1A2	PA450555	1544	0.866
NULL	Breast_Cancer_Res_2007_Jan_23_9(1)_R7.nxml.txt.nlp	17244352	SENT165	14	14	10	10	tamoxifen	CYP3A5	PA451581	1577	0.866
NULL	J_Hematol_Oncol_2008_Oct_1_1_16.nxml.txt.nlp	18828924	SENT239	13	13	22	22	trastuzumab	HER2	PA451743	2064	0.866
NULL	Mol_Biol_Int_2014_Nov_20_2014_686984.nxml.txt.nlp	25505994	SENT158	16	16	23	23	etoposide	4E-BP1	PA449552	1978	0.866
NULL	J_Cell_Biol_1984_Feb_1_98(2)_748-760.nxml.txt.nlp	6229546	SENT1	28	28	13	13	thrombin	PF4	PA451674	5196	0.866
NULL	Int_J_Med_Sci_2012_Dec_10_10(1)_43-49.nxml.txt.nlp	23289004	SENT30	4	4	15	15	ribavirin	SOC	PA451241	91544	0.866
NULL	Acta_Histochem_Cytochem_2013_Dec_28_46(6)_187-197.nxml.txt.nlp	24610966	SENT143	4	4	13	13	pilocarpine	AQP5	PA450962	362	0.866
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Apr_26_64(Pt_5)_m718-m719.nxml.txt.nlp	21202245	SENT68	22	22	17	17	ethanol	mol	PA448073	90527	0.866
NULL	Curr_Neuropharmacol_2014_Jul_12(4)_365-379.nxml.txt.nlp	25342944	SENT192	23	23	18	18	fluoxetine	GluA2	PA449673	2891	0.866
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R91.nxml.txt.nlp	22541814	SENT247	17	17	10	10	thrombin	HO-1	PA451674	3162	0.866
NULL	Cancer_Cell_Int_2003_Jul_15_3_11.nxml.txt.nlp	12904267	SENT148	17	17	37	37	vinblastine	p53	PA451877	7157	0.866
NULL	Drug_Target_Insights_2014_Mar_5_8_11-21.nxml.txt.nlp	24634580	SENT190	9	9	25	25	agomelatine	5-HT2C	PA165958363	3358	0.866
NULL	Acta_Pharmacol_Sin_2013_Feb_31_34(2)_231-238.nxml.txt.nlp	23274414	SENT141	0	0	6	6	amiloride	Bcl-2	PA448368	596	0.866
NULL	Comp_Hepatol_2004_Jan_14_3(Suppl_1)_S31.nxml.txt.nlp	14960183	SENT67	8	8	14	14	ethanol	TNF-alpha	PA448073	7124	0.866
NULL	Front_Oncol_2014_May_14_4_106.nxml.txt.nlp	24860786	SENT159	19	19	33	33	doxorubicin	p53	PA449412	7157	0.866
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT129	7	7	13	13	dasatinib	CML	PA162372878	613	0.866
NULL	Breast_Cancer_Res_2012_Feb_14_14(1)_R30.nxml.txt.nlp	22333315	SENT17	12	12	20	20	celecoxib	CXCL10	PA448871	3627	0.866
NULL	Clin_Ophthalmol_2010_Apr_26_4_369-374.nxml.txt.nlp	20463807	SENT60	14	14	31	31	pegaptanib	PED	PA164771236	8682	0.866
NULL	Br_J_Cancer_2013_May_14_108(9)_1862-1869.nxml.txt.nlp	23579219	SENT115	5	5	13	13	cetuximab	EGFR	PA10040	1956	0.866
NULL	Exp_Hematol_Oncol_2013_Oct_4_2_26.nxml.txt.nlp	24219920	SENT144	32	32	4	4	probucol	ABCA1	PA451107	19	0.866
NULL	Oncol_Lett_2014_Nov_13_8(5)_2043-2048.nxml.txt.nlp	25289090	SENT76	9	9	17	17	doxorubicin	p53	PA449412	7157	0.866
NULL	Adv_Hematol_2010_Dec_5_2010_595934.nxml.txt.nlp	21151515	SENT117	7	7	17	17	clopidogrel	ADP	PA449053	23038	0.866
NULL	Core_Evid_2010_Oct_22_5_91-105.nxml.txt.nlp	21468365	SENT113	31	31	13	13	pitavastatin	CYP3A4	PA142650384	1576	0.866
NULL	Pharmaceuticals_(Basel)_2014_Jan_9_7(1)_46-57.nxml.txt.nlp	24451403	SENT320	18	18	11	11	docetaxel	CYP3A4	PA449383	1576	0.866
NULL	J_Antimicrob_Chemother_2014_Apr_27_69(4)_907-910.nxml.txt.nlp	24284779	SENT73	34	34	11	11	cefoxitin	BSAC	PA448856	57591	0.866
NULL	Diabetes_Metab_Syndr_Obes_2010_May_17_3_155-163.nxml.txt.nlp	21437085	SENT60	24	24	19	19	exenatide	GLP-1	PA164749238	100125288	0.866
NULL	Aging_(Albany_NY)_2009_Jun_3_1(6)_515-528.nxml.txt.nlp	20157535	SENT18	27	27	16	16	resveratrol	SIRT1		23411	0.866
NULL	Br_J_Cancer_2012_Nov_6_107(10)_1714-1721.nxml.txt.nlp	23073173	SENT101	20	20	26	26	bicalutamide	RUNX2	PA164746255	860	0.866
NULL	EPMA_J_2013_Jan_28_4(1)_3.nxml.txt.nlp	23356214	SENT240	10	10	21	21	cetuximab	KRAS	PA10040	3845	0.866
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jul_18_68(Pt_8)_o2484.nxml.txt.nlp	22904926	SENT3	39	39	1	1	phenol	mol	PA450913	90527	0.866
NULL	Daru_2011_19(6)_446-454.nxml.txt.nlp	23008691	SENT67	3	3	17	17	ethanol	PF6	PA448073	200162	0.866
NULL	Diabetes_2013_Jun_17_62(6)_1843-1854.nxml.txt.nlp	23349486	SENT235	5	5	28	28	pioglitazone	CD44	PA450970	960	0.866
NULL	Curr_Pain_Headache_Rep_2011_Aug_12_15(4)_271-279.nxml.txt.nlp	21479998	SENT39	15	15	3	3	cimetidine	CYP2D6	PA449001	1565	0.866
NULL	Blood_Res_2014_Mar_24_49(1)_15-21.nxml.txt.nlp	24724062	SENT165	26	26	22	22	doxorubicin	CHOP	PA449412	1649	0.866
NULL	Int_J_Biol_Sci_2012_Jan_6_8(2)_249-257.nxml.txt.nlp	22253568	SENT97	7	7	17	17	lipase	IL-22	PA450239	50616;53342	0.866
NULL	JAKSTAT_2014_Jun_12_3_e29554.nxml.txt.nlp	25105067	SENT11	14	14	3	3	propofol	STAT3	PA451141	6774	0.866
NULL	Cancer_Cell_Int_2013_Sep_23_13_94.nxml.txt.nlp	24059699	SENT113	23	23	30	30	bevacizumab	VEGFR2	PA130232992	3791	0.866
NULL	Braz_J_Med_Biol_Res_2014_Oct_24_48(1)_65-76.nxml.txt.nlp	25493385	SENT165	28	28	12	12	aliskiren	AT2	PA143487910	186	0.866
NULL	Exp_Ther_Med_2013_Nov_13_6(5)_1317-1321.nxml.txt.nlp	24223665	SENT111	11	11	17	17	curcumin	CD133	PA151958596	8842	0.866
NULL	Int_J_Endocrinol_Metab_2013_Jul_1_Summer_11(3)_184-190.nxml.txt.nlp	24348591	SENT14	11	11	5	5	liraglutide	INS-1	PA165958364	2305	0.866
NULL	Clin_Pharmacol_2012_Feb_20_4_13-20.nxml.txt.nlp	22427735	SENT4	32	32	18	18	clopidogrel	PON1	PA449053	5444	0.866
NULL	Oncoimmunology_2013_Jan_1_2(1)_e22890.nxml.txt.nlp	23483066	SENT128	4	4	7	7	vemurafenib	IFN	PA165946873	3439	0.866
NULL	Int_Semin_Surg_Oncol_2008_Apr_28_5_9.nxml.txt.nlp	18442393	SENT69	14	14	11	11	tamoxifen	HER2	PA451581	2064	0.866
NULL	Cancer_Manag_Res_2013_Jan_17_5_15-20.nxml.txt.nlp	23378782	SENT65	17	17	26	26	erlotinib	Met	PA134687924	79811	0.866
NULL	Pharmaceuticals_(Basel)_2013_Jan_7_6(1)_54-69.nxml.txt.nlp	24275787	SENT420	4	4	19	19	staurosporine	Bcl-2	PA165109623	596	0.866
NULL	Cell_Death_Dis_2010_Oct_21_1(10)_e86.nxml.txt.nlp	21368859	SENT49	11	11	24	24	doxorubicin	TRAIL	PA449412	8743	0.866
NULL	J_Cell_Biol_2005_Nov_21_171(4)_651-661.nxml.txt.nlp	16301331	SENT7	1	1	12	12	flutamide	Bcl-2	PA449685	596	0.866
NULL	Curr_Neuropharmacol_2014_Jul_12(4)_365-379.nxml.txt.nlp	25342944	SENT34	0	0	5	5	fluoxetine	5-HT1A	PA449673	3350	0.866
NULL	Hum_Genomics_2009_Dec_1_4(2)_91-106.nxml.txt.nlp	20038497	SENT66	0	0	13	13	donepezil	CYP2D6	PA449394	1565	0.866
NULL	Adv_Hematol_2014_Apr_3_2014_864058.nxml.txt.nlp	24803933	SENT207	10	10	5	5	curcumin	STAT3	PA151958596	6774	0.866
NULL	Arch_Med_Sci_2012_Jul_4_8(3)_549-554.nxml.txt.nlp	22852014	SENT92	20	20	25	25	clopidogrel	CYP3A4	PA449053	1576	0.866
NULL	Addict_Sci_Clin_Pract_2014_Sep_13_9(1)_20.nxml.txt.nlp	25217046	SENT40	38	38	6	6	naltrexone	OPRM1	PA450588	4988	0.866
NULL	Channels_(Austin)_2010_Jan_1_4(1)_22-41.nxml.txt.nlp	19934650	SENT13	25	25	1	1	quinidine	Slo3	PA451209	157855	0.866
NULL	J_Clin_Biochem_Nutr_2010_Mar_27_46(2)_177-185.nxml.txt.nlp	20216951	SENT105	15	15	28	28	l-arginine	CEA	PA448478	5670;1087	0.866
NULL	Biomed_Res_Int_2013_Dec_5_2013_984523.nxml.txt.nlp	23509827	SENT215	36	36	6	6	oxygen	HIF-1	PA450744	29072	0.866
NULL	Breast_Cancer_Res_2011_Nov_23_13(6)_R116.nxml.txt.nlp	22113133	SENT69	13	13	33	33	phenol	FBS	PA450913	64319;26269	0.866
NULL	Mar_Drugs_2014_Nov_24_12(11)_5677-5697.nxml.txt.nlp	25421323	SENT183	9	9	19	19	berberine	IFN	PA165860812	3439	0.866
NULL	J_Korean_Med_Sci_2010_Sep_12_25(9)_1364-1367.nxml.txt.nlp	20808682	SENT18	0	0	14	14	tocilizumab	IL-6	PA165292659	3569	0.866
NULL	Genome_Med_2010_Aug_11_2(8)_53.nxml.txt.nlp	20701793	SENT81	6	6	21	21	everolimus	FKBP12	PA164746311	2280	0.866
NULL	J_Cell_Biol_2002_Jun_24_157(7)_1151-1160.nxml.txt.nlp	12082077	SENT147	18	18	2	2	trypsin	COX	PA451806	1351	0.866
NULL	Bone_Marrow_Transplant_2011_Dec_24_46(12)_1503-1509.nxml.txt.nlp	21258420	SENT125	12	12	5	5	tositumomab	gamma	PA164748364	9913	0.866
NULL	Oncotarget_2012_Oct_27_3(10)_1052-1053.nxml.txt.nlp	23165648	SENT25	26	26	15	15	nutlin-3	p38		10598;1432;7965	0.866
NULL	J_Clin_Biochem_Nutr_2009_Sep_28_45(2)_125-130.nxml.txt.nlp	19794918	SENT8	17	17	6	6	lansoprazole	HO-1	PA450180	3162	0.866
NULL	Breast_Cancer_Res_2008_Dec_5_10(6)_R104.nxml.txt.nlp	19061505	SENT231	12	12	40	40	ethanol	c-Jun	PA448073	3725	0.866
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT148	19	19	13	13	capecitabine	HER2	PA448771	2064	0.866
NULL	Breast_Cancer_Res_2010_Jul_1_12(4)_R45.nxml.txt.nlp	20594311	SENT135	34	34	37	37	nelfinavir	AKT	PA450606	207	0.866
NULL	Oncotarget_2014_Aug_19_5(18)_8737-8749.nxml.txt.nlp	25228590	SENT76	14	14	6	6	crizotinib	MYCN	PA165946122	4613	0.866
NULL	Genome_Biol_2003_Oct_15_4(11)_233.nxml.txt.nlp	14611650	SENT112	37	37	39	39	galactose	GAL	PA449725	51083	0.866
NULL	Anal_Bioanal_Chem_2012_Mar_29_402(7)_2267-2274.nxml.txt.nlp	22038587	SENT157	39	39	32	32	pilocarpine	CA3	PA450962	761	0.866
NULL	Front_Oncol_2014_Oct_9_4_277.nxml.txt.nlp	25346912	SENT122	8	8	12	12	trastuzumab	HER2	PA451743	2064	0.866
NULL	Diabetes_Care_2011_Mar_17_34(3)_782-784.nxml.txt.nlp	21357366	SENT36	6	6	3	3	aspirin	ADA	PA448497	100	0.866
NULL	JAKSTAT_2012_Apr_1_1(2)_55-64.nxml.txt.nlp	24058751	SENT134	3	3	27	27	cisplatin	STAT3	PA449014	6774	0.866
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT7	0	0	35	35	curcumin	TRAIL-R2	PA151958596	8795	0.866
NULL	Br_J_Cancer_2012_Sep_25_107(7)_1009-1016.nxml.txt.nlp	22948724	SENT46	13	13	18	18	sunitinib	CAIX	PA162372840	768	0.866
NULL	Behav_Brain_Funct_2011_Sep_7_7_39.nxml.txt.nlp	21899751	SENT79	22	22	8	8	phenytoin	KCNC1	PA450947	3746	0.866
NULL	Exp_Ther_Med_2013_Mar_21_5(3)_987-991.nxml.txt.nlp	23407636	SENT99	17	17	10	10	losartan	CXCR1	PA450268	3577	0.866
NULL	Ann_Dermatol_2013_Nov_30_25(4)_500-502.nxml.txt.nlp	24371403	SENT27	8	8	13	13	imatinib	LDE	PA10804	7957	0.866
NULL	Acta_Pharmacol_Sin_2012_Mar_27_33(3)_342-350.nxml.txt.nlp	22367283	SENT193	27	27	12	12	thrombin	PAR1	PA451674	79581;2149	0.866
NULL	Clin_Pharmacokinet_2014_Sep_3_53(1)_1-16.nxml.txt.nlp	23999929	SENT120	26	26	29	29	rivaroxaban	CLCR	PA165958360	11330	0.866
NULL	Oncotarget_2012_May_19_3(5)_535-545.nxml.txt.nlp	22619121	SENT108	6	6	16	16	camptothecin	MYCN	PA153590860	4613	0.866
NULL	Ann_Oncol_2013_Sep_4_24(9)_2206-2223.nxml.txt.nlp	23917950	SENT318	11	11	0	0	anastrozole	SP3	PA448432	6670	0.866
NULL	J_Cell_Mol_Med_2014_Oct_11_18(10)_2031-2043.nxml.txt.nlp	25109475	SENT213	1	1	15	15	valsartan	IL-6	PA451848	3569	0.866
NULL	Chem_Cent_J_2013_Jul_18_7_124.nxml.txt.nlp	23866043	SENT171	36	36	5	5	metformin	HPS3	PA450395	84343	0.866
NULL	Mol_Cancer_2012_Sep_14_11_69.nxml.txt.nlp	22978347	SENT43	33	33	36	36	letrozole	TRAP1	PA450196	9392;10131	0.866
NULL	Mol_Cancer_2013_Mar_5_12_17.nxml.txt.nlp	23497256	SENT185	13	13	25	25	sunitinib	NOXA	PA162372840	5366	0.866
NULL	Diagn_Pathol_2013_Nov_25_8_192.nxml.txt.nlp	24274261	SENT89	10	10	14	14	cisplatin	IFN	PA449014	3439	0.866
NULL	Breast_Cancer_Res_2002_Jul_24_4(6)_R12.nxml.txt.nlp	12473173	SENT10	9	9	38	38	estradiol	BRCA1	PA449503	672	0.866
NULL	J_Cell_Biol_2006_Sep_25_174(7)_1047-1058.nxml.txt.nlp	17000881	SENT37	18	18	13	13	heparin	EGF	PA449855	1950	0.866
NULL	Eur_J_Med_Res_2009_Nov_24_14(Suppl_3)_17-21.nxml.txt.nlp	19959412	SENT79	35	35	31	31	lamotrigine	UGT	PA450164	7361;7355	0.866
NULL	Clin_Cosmet_Investig_Dermatol_2014_Apr_17_7_119-132.nxml.txt.nlp	24790463	SENT92	14	14	5	5	lipase	TNF-alpha	PA450239	7124	0.866
NULL	Gynecol_Endocrinol_2014_Jun_27_30(6)_444-450.nxml.txt.nlp	24576226	SENT73	24	24	45	45	estradiol	AMH	PA449503	268	0.866
NULL	Front_Cell_Neurosci_2014_Jul_30_8_203.nxml.txt.nlp	25126056	SENT622	1	1	13	13	allopregnanolone	PSEN1	PA142320763	5663	0.866
NULL	Environ_Health_Perspect_2007_Apr_115(4)_A192-A194.nxml.txt.nlp	17450203	SENT8	8	8	10	10	diethylstilbestrol	DES	PA449307	1674	0.866
NULL	Indian_J_Med_Res_2014_Jan_139(1)_117-124.nxml.txt.nlp	24604047	SENT154	4	4	11	11	fluvastatin	RhoA	PA449688	387	0.866
NULL	J_Mol_Signal_2010_May_10_5_4.nxml.txt.nlp	20459745	SENT8	14	14	10	10	cisplatin	p53	PA449014	7157	0.866
NULL	Mol_Biol_Cell_2012_May_15_23(10)_1812-1825.nxml.txt.nlp	22438585	SENT400	1	1	35	35	dextran	VIII	PA449261	1351	0.866
NULL	Breast_Cancer_Res_2008_Jul_16_10(4)_R60.nxml.txt.nlp	18631394	SENT138	18	18	8	8	trastuzumab	San	PA451743	80218	0.866
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Aug_22_65(Pt_9)_o2213.nxml.txt.nlp	21577614	SENT72	33	33	14	14	ethanol	mol	PA448073	90527	0.866
NULL	Int_J_Endocrinol_2013_Jun_16_2013_290734.nxml.txt.nlp	23843787	SENT114	29	29	14	14	rosiglitazone	CTX	PA451283	1593	0.866
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT94	29	29	17	17	trastuzumab	HER3	PA451743	2065	0.866
NULL	J_Oncol_2010_Mar_9_2010_835680.nxml.txt.nlp	20224655	SENT119	19	19	13	13	sunitinib	IL-6	PA162372840	3569	0.866
NULL	Adv_Prev_Med_2012_Dec_5_2012_316871.nxml.txt.nlp	23304535	SENT68	23	23	21	21	buprenorphine	OST	PA448685	1650;23263	0.866
NULL	Case_Rep_Transplant_2014_Jan_2_2014_548243.nxml.txt.nlp	24575309	SENT80	18	18	27	27	clarithromycin	CYP3A	PA449028	1574	0.866
NULL	Front_Neurosci_2011_Sep_28_5_113.nxml.txt.nlp	21994486	SENT120	15	15	7	7	ketamine	p38	PA450144	10598;1432;7965	0.866
NULL	Behav_Brain_Res_2011_Sep_12_222(1)_274-278.nxml.txt.nlp	21440571	SENT42	19	19	21	21	glucosamine	GSN	PA164747613	2934	0.866
NULL	Breast_Cancer_Res_2012_Feb_13_14(1)_R28.nxml.txt.nlp	22330809	SENT144	29	29	16	16	trastuzumab	ERBB2	PA451743	2064	0.866
NULL	Chin_J_Cancer_2012_Feb_31(2)_73-99.nxml.txt.nlp	22098950	SENT261	12	12	36	36	axitinib	AKT	PA164924493	207	0.866
NULL	Exp_Hematol_Oncol_2013_Aug_8_2_21.nxml.txt.nlp	23927414	SENT94	30	30	16	16	enoxaparin	HARE	PA449463	55576	0.866
NULL	Oncotarget_2011_Dec_15_2(12)_984-996.nxml.txt.nlp	22184287	SENT207	10	10	29	29	olaparib	NF1		4763	0.866
NULL	Biomed_Res_Int_2014_Jun_3_2014_534969.nxml.txt.nlp	25136593	SENT77	22	22	13	13	trastuzumab	IL-6	PA451743	3569	0.866
NULL	Br_J_Clin_Pharmacol_2013_Aug_23_76(2)_299-315.nxml.txt.nlp	23701319	SENT94	14	14	21	21	trastuzumab	IFN	PA451743	3439	0.866
NULL	Mol_Cancer_2014_Jan_13_13_7.nxml.txt.nlp	24418169	SENT242	16	16	13	13	sorafenib	STAT3	PA7000	6774	0.866
NULL	Br_J_Cancer_2004_Mar_22_90(6)_1285-1292.nxml.txt.nlp	15026814	SENT87	39	39	1	1	doxorubicin	p53	PA449412	7157	0.866
NULL	Mol_Cancer_2014_Jan_7_13_4.nxml.txt.nlp	24393163	SENT208	24	24	30	30	imatinib	JNK	PA10804	5599	0.866
NULL	Exp_Ther_Med_2013_May_15_5(5)_1327-1331.nxml.txt.nlp	23737873	SENT28	41	41	7	7	imidapril	AQP2	PA452640	359	0.866
NULL	Arthritis_Res_Ther_2006_Dec_28_8(1)_R18.nxml.txt.nlp	16507118	SENT128	26	26	9	9	etanercept	IL-15	PA449515	3600	0.866
NULL	Front_Oncol_2014_Apr_9_4_73.nxml.txt.nlp	24782984	SENT40	35	35	23	23	octreotide	PRL	PA450678	5617	0.866
NULL	Int_J_Mol_Sci_2014_Nov_7_15(11)_20500-20517.nxml.txt.nlp	25387078	SENT147	9	9	5	5	sorafenib	Mcl-1	PA7000	4170	0.866
NULL	J_Breast_Cancer_2013_Jun_28_16(2)_178-183.nxml.txt.nlp	23843850	SENT98	4	4	28	28	trastuzumab	Bcl-2	PA451743	596	0.866
NULL	Mol_Biol_Rep_2013_Sep_28_40(10)_5573-5585.nxml.txt.nlp	24078156	SENT35	6	6	15	15	iron	FPN1	PA450087	30061	0.866
NULL	Pharmaceuticals_(Basel)_2014_May_14_7(5)_621-633.nxml.txt.nlp	24830987	SENT216	39	39	32	32	ethanol	FDG	PA448073	23583	0.866
NULL	Clin_Med_Insights_Oncol_2011_Oct_31_5_333-342.nxml.txt.nlp	22084622	SENT127	36	36	3	3	pazopanib	IL-8	PA165291492	3576	0.866
NULL	Front_Neurol_2014_Sep_2_5_159.nxml.txt.nlp	25228896	SENT62	27	27	7	7	propofol	GCS	PA451141	2729;7357	0.866
NULL	J_Biol_2009_Apr_15_8(3)_30.nxml.txt.nlp	19435483	SENT48	5	5	34	34	imatinib	NQO2	PA10804	4835	0.866
NULL	Cancer_Cell_Int_2011_Aug_19_11_29.nxml.txt.nlp	21854619	SENT40	12	12	21	21	platinum	BRCA1	PA150595617	672	0.866
NULL	Front_Oncol_2014_Sep_29_4_251.nxml.txt.nlp	25325012	SENT249	1	1	18	18	afatinib	HER2	PA165981154	2064	0.866
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jul_7_66(Pt_8)_o1952.nxml.txt.nlp	21588276	SENT76	41	41	22	22	ethanol	mol	PA448073	90527	0.866
NULL	Brain_2014_Apr_27_137(4)_1145-1155.nxml.txt.nlp	24578545	SENT220	15	15	9	9	citalopram	5-HT2A	PA449015	3356	0.866
NULL	Curr_Neuropharmacol_2014_Jul_12(4)_365-379.nxml.txt.nlp	25342944	SENT116	45	45	6	6	fluoxetine	5-HT2B	PA449673	3357	0.866
NULL	Iran_J_Reprod_Med_2012_Jan_10(1)_29-32.nxml.txt.nlp	25242971	SENT91	36	36	9	9	letrozole	aromatase	PA450196	1588	0.866
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT104	27	27	10	10	erlotinib	AKT	PA134687924	207	0.866
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1044.nxml.txt.nlp	24503536	SENT133	15	15	22	22	cisplatin	XIAP	PA449014	331	0.866
NULL	Asian_J_Androl_2014_Mar_7_Jul-Aug_16(4)_647-649.nxml.txt.nlp	24625882	SENT57	13	13	1	1	tacrolimus	WT1	PA451578	7490	0.866
NULL	Pharmaceutics_2011_Feb_7_3(1)_53-72.nxml.txt.nlp	24310425	SENT236	11	11	26	26	procainamide	NAT	PA451108	6046	0.866
NULL	J_Mol_Med_(Berl)_2014_May_10_92(7)_709-722.nxml.txt.nlp	24811491	SENT229	6	6	28	28	fluorouracil	BRAF	PA128406956	673	0.866
NULL	Anat_Cell_Biol_2013_Jun_30_46(2)_113-121.nxml.txt.nlp	23869258	SENT126	20	20	25	25	hyaluronan	CD44	PA165958431	960	0.866
NULL	Cancer_Cell_Int_2007_Apr_3_7_4.nxml.txt.nlp	17407577	SENT141	7	7	22	22	methotrexate	p53	PA450428	7157	0.866
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT93	29	29	18	18	sitagliptin	HIP	PA164748978	6767;6159;64399;5068	0.866
NULL	Blood_Res_2014_Sep_25_49(3)_162-169.nxml.txt.nlp	25325035	SENT124	3	3	11	11	rituximab	CHOP	PA451261	1649	0.866
NULL	Behav_Brain_Funct_2009_Jun_4_5_23.nxml.txt.nlp	19497110	SENT124	23	23	26	26	ethanol	P90	PA448073	821	0.866
NULL	J_Biomed_Biotechnol_2011_Dec_9_2011_690848.nxml.txt.nlp	21197454	SENT159	18	18	0	0	quinidine	HDAC1	PA451209	3065	0.866
NULL	J_Hematol_Oncol_2010_Sep_9_3_31.nxml.txt.nlp	20828403	SENT49	45	45	9	9	trastuzumab	HER2	PA451743	2064	0.866
NULL	Int_J_Mol_Cell_Med_2012_Winter_1(1)_30-38.nxml.txt.nlp	24551756	SENT153	25	25	20	20	copper	14-3-3	PA449114	10971	0.866
NULL	Clinics_(Sao_Paulo)_2013_Jun_68(6)_766-771.nxml.txt.nlp	23778483	SENT24	6	6	12	12	hydroxychloroquine	IL-22	PA164777036	50616;53342	0.866
NULL	Indian_J_Hum_Genet_2007_Sep-Dec_13(3)_114-118.nxml.txt.nlp	21957359	SENT41	15	15	22	22	methotrexate	GM-CSF	PA450428	1437	0.866
NULL	Lab_Anim_Res_2013_Dec_20_29(4)_212-220.nxml.txt.nlp	24396386	SENT17	32	32	12	12	nifedipine	INS-1	PA450631	2305	0.866
NULL	Acta_Pharmacol_Sin_2013_Jan_17_34(1)_157-166.nxml.txt.nlp	23247593	SENT142	10	10	2	2	berberine	Set9	PA165860812	80854	0.866
NULL	Emerg_Infect_Dis_2012_Nov_18(11)_e2.nxml.txt.nlp	23092736	SENT64	23	23	18	18	cycloserine	DST	PA164764600	667	0.866
NULL	Breast_Cancer_Res_2010_Jun_24_12(3)_R41.nxml.txt.nlp	20576088	SENT317	10	10	5	5	paclitaxel	BRCA1	PA450761	672	0.866
NULL	Cancer_Metastasis_Rev_2014_Dec_28_33(1)_161-171.nxml.txt.nlp	24375389	SENT167	26	26	10	10	paclitaxel	CHFR	PA450761	55743	0.866
NULL	Arthritis_Res_Ther_2009_Aug_28_11(4)_R131.nxml.txt.nlp	19715572	SENT14	0	0	16	16	rituximab	CD25	PA451261	3669;3559	0.866
NULL	Protein_Cell_2014_Apr_4_5(4)_307-316.nxml.txt.nlp	24585413	SENT157	10	10	27	27	fluorescein	CD40	PA164746009	958	0.866
NULL	Protein_Cell_2014_Jun_19_5(6)_469-479.nxml.txt.nlp	24748116	SENT81	14	14	7	7	paclitaxel	EB1	PA450761	9167;22919;10982	0.866
NULL	J_Antimicrob_Chemother_2013_Jul_6_68(7)_1594-1600.nxml.txt.nlp	23467176	SENT59	29	29	20	20	meropenem	BSAC	PA164764445	57591	0.866
NULL	J_Immunother_Cancer_2013_Sep_23_1_16.nxml.txt.nlp	24829752	SENT19	23	23	29	29	methylcholanthrene	IFN	PA165816878	3439	0.866
NULL	Gene_Regul_Syst_Bio_2014_Mar_4_8_63-73.nxml.txt.nlp	24634581	SENT139	3	3	28	28	minocycline	MT1-MMP	PA450519	4323	0.866
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jan_23_65(Pt_2)_o360.nxml.txt.nlp	21581958	SENT54	6	6	22	22	celecoxib	COX	PA448871	1351	0.866
NULL	Diabetes_Care_2011_Jun_20_34(6)_e61-e99.nxml.txt.nlp	21617108	SENT702	7	7	24	24	nitroprusside	HBA	PA451406	85340	0.866
NULL	Acta_Pharmacol_Sin_2013_Apr_18_34(4)_555-560.nxml.txt.nlp	23503472	SENT6	21	21	15	15	cyclosporine	NFKB1	PA449167	4790	0.866
NULL	Cell_Commun_Signal_2013_Jul_4_11_47.nxml.txt.nlp	23826796	SENT9	4	4	1	1	rolipram	PDE4D	PA153906323	5144	0.866
NULL	Arch_Drug_Inf_2009_Mar_2(1)_8-16.nxml.txt.nlp	19381336	SENT115	11	11	18	18	saquinavir	CYP3A4	PA451305	1576	0.866
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_P42.nxml.txt.nlp	NULL	SENT15	0	0	6	6	amoxicillin	CD4	PA448406	920	0.866
NULL	Int_J_Biol_Sci_2013_Apr_22_9(4)_350-360.nxml.txt.nlp	23630447	SENT131	23	23	10	10	doxorubicin	EPHX1	PA449412	2052	0.866
NULL	Front_Neuroendocrinol_2012_Jan_33(1)_45-66.nxml.txt.nlp	21802439	SENT419	20	20	31	31	naloxone	ACTH	PA450586	5443	0.866
NULL	Semin_Immunopathol_2013_Jan_26_35(1)_39-52.nxml.txt.nlp	22829332	SENT197	35	35	30	30	fludarabine	CHOP	PA449655	1649	0.866
NULL	Oncol_Lett_2014_Jul_12_8(1)_223-229.nxml.txt.nlp	24959250	SENT93	0	0	17	17	captopril	IL-18	PA448780	3606	0.866
NULL	Front_Behav_Neurosci_2012_Nov_22_6_78.nxml.txt.nlp	23189046	SENT79	13	13	20	20	ethanol	OX1R	PA448073	3061	0.866
NULL	J_Korean_Med_Sci_2009_Jan_29_24(Suppl_1)_S183-S188.nxml.txt.nlp	19194550	SENT111	7	7	24	24	celecoxib	LOX	PA448871	4015	0.866
NULL	Cancers_(Basel)_2011_Aug_5_3(3)_3114-3142.nxml.txt.nlp	24212948	SENT814	14	14	3	3	cyclophosphamide	CD4	PA449165	920	0.866
NULL	Exp_Hematol_Oncol_2013_Oct_4_2_26.nxml.txt.nlp	24219920	SENT238	5	5	18	18	verapamil	ABCA1	PA451868	19	0.866
NULL	Oncol_Lett_2013_Sep_28_6(3)_795-800.nxml.txt.nlp	24137413	SENT152	4	4	0	0	paclitaxel	HIF-1	PA450761	29072	0.866
NULL	Arthritis_Res_Ther_2012_Apr_16_14(2)_R76.nxml.txt.nlp	22507741	SENT175	21	21	6	6	estradiol	IL-10	PA449503	3586	0.866
NULL	Cell_Death_Differ_2010_May_13_17(5)_774-786.nxml.txt.nlp	19911006	SENT343	6	6	15	15	doxycycline	AATF	PA449415	26574	0.866
NULL	J_Biomed_Biotechnol_2011_Jun_13_2011_861920.nxml.txt.nlp	21716670	SENT80	2	2	11	11	methylprednisolone	NKp30	PA450466	259197	0.866
NULL	Diabetes_2009_Dec_31_58(12)_2920-2929.nxml.txt.nlp	19720797	SENT202	14	14	3	3	fosinopril	S28	PA449710	6234	0.866
NULL	Case_Rep_Oncol_Med_2013_Apr_11_2013_485025.nxml.txt.nlp	23878753	SENT96	9	9	16	16	thyroglobulin	CD10	PA164754910	4311	0.866
NULL	Exp_Ther_Med_2014_Apr_5_7(4)_785-790.nxml.txt.nlp	24660028	SENT26	10	10	5	5	paclitaxel	L1CAM	PA450761	3897	0.866
NULL	Cell_J_2014_May_25_Summer_16(2)_163-170.nxml.txt.nlp	24567946	SENT115	22	22	19	19	naloxone	CA1	PA450586	759	0.866
NULL	Arch_Toxicol_2011_Feb_12_85(2)_79-117.nxml.txt.nlp	21225242	SENT187	32	32	41	41	mitomycin	P19	PA450524	51561	0.866
NULL	Breast_Cancer_Res_2010_Oct_22_12(Suppl_2)_S2.nxml.txt.nlp	21050423	SENT99	20	20	11	11	epirubicin	MLH1	PA449476	4292	0.866
NULL	Case_Rep_Dermatol_2012_Sep_16_4(3)_256-260.nxml.txt.nlp	23275770	SENT64	1	1	32	32	pyridostigmine	OMG	PA451185	4974	0.866
NULL	Clin_Pharmacol_2010_Sep_17_2_185-198.nxml.txt.nlp	22291504	SENT18	23	23	18	18	creatine	Q10	PA164778930	27161	0.866
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jul_10_68(Pt_8)_o2421.nxml.txt.nlp	22904872	SENT65	44	44	4	4	ethanol	mol	PA448073	90527	0.866
NULL	Eur_J_Clin_Pharmacol_2011_Dec_23_67(12)_1231-1241.nxml.txt.nlp	21698374	SENT298	15	15	5	5	tacrolimus	MDR1	PA451578	5243	0.866
NULL	Arthritis_Res_Ther_2006_Dec_28_8(1)_R18.nxml.txt.nlp	16507118	SENT107	24	24	29	29	infliximab	ACR	PA452639	49	0.866
NULL	J_Cell_Biol_2002_Nov_25_159(4)_637-648.nxml.txt.nlp	12438416	SENT140	18	18	3	3	etoposide	p115	PA449552	8615;393	0.866
NULL	Acta_Histochem_Cytochem_2013_Dec_28_46(6)_187-197.nxml.txt.nlp	24610966	SENT135	24	24	10	10	pilocarpine	AQP5	PA450962	362	0.866
NULL	Pharmaceutics_2011_Nov_18_3(4)_865-913.nxml.txt.nlp	24309312	SENT163	3	3	33	33	raltegravir	UGT		7361;7355	0.866
NULL	J_Cardiothorac_Surg_2010_Aug_21_5_66.nxml.txt.nlp	20727201	SENT55	11	11	19	19	collagenase	MMP2	PA449107	4313	0.866
NULL	Br_J_Cancer_2011_Jul_26_105(3)_403-406.nxml.txt.nlp	21730978	SENT86	25	25	18	18	cetuximab	KRAS	PA10040	3845	0.866
NULL	Case_Rep_Ophthalmol_2010_Dec_8_1(2)_110-113.nxml.txt.nlp	21373383	SENT46	39	39	6	6	ranibizumab	PED	PA164746012	8682	0.866
NULL	Clin_Epigenetics_2011_Dec_5_3(1)_8.nxml.txt.nlp	22414275	SENT38	3	3	9	9	ribavirin	ESR1	PA451241	2099	0.866
NULL	Br_J_Pharmacol_2014_Oct_26_171(20)_4785-4796.nxml.txt.nlp	25074741	SENT59	25	25	15	15	guanfacine	EPM	PA449825	2054	0.866
NULL	J_Signal_Transduct_2011_Dec_19_2011_636951.nxml.txt.nlp	21258655	SENT118	16	16	7	7	pp2	EGFR		1956	0.866
NULL	Biochem_Res_Int_2012_May_17_2012_973723.nxml.txt.nlp	22666593	SENT101	26	26	3	3	isoproterenol	MYOCD	PA450121	93649	0.866
NULL	Oncotarget_2012_Nov_17_4(1)_18-28.nxml.txt.nlp	23248157	SENT108	15	15	34	34	pargyline	CD133	PA450797	8842	0.866
NULL	Cancer_Res_Treat_2013_Sep_30_45(3)_178-185.nxml.txt.nlp	24155676	SENT110	26	26	21	21	gefitinib	EGFR	PA131301952	1956	0.866
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Jul_21_9_20.nxml.txt.nlp	20663145	SENT112	32	32	5	5	clindamycin	LBH	PA449035	81606;221491	0.865
NULL	JAKSTAT_2014_Jun_12_3_e29554.nxml.txt.nlp	25105067	SENT12	9	9	12	12	propofol	STAT3	PA451141	6774	0.865
NULL	EMBO_Mol_Med_2013_May_22_5(5)_776-794.nxml.txt.nlp	23606583	SENT174	42	42	7	7	maraviroc	CCR5	PA164768835	1234	0.865
NULL	Br_J_Cancer_1997_75(11)_1559-1566.nxml.txt.nlp	9184169	SENT7	5	5	18	18	genistein	p53	PA165109660	7157	0.865
NULL	J_Hematol_Oncol_2013_Jan_4_6_1.nxml.txt.nlp	23286345	SENT143	12	12	18	18	cetuximab	KRAS	PA10040	3845	0.865
NULL	Clin_Med_Oncol_2008_Feb_9_2_103-108.nxml.txt.nlp	21892271	SENT102	10	10	26	26	trastuzumab	Era	PA451743	2099	0.865
NULL	J_Cell_Biol_2001_May_28_153(5)_1127-1132.nxml.txt.nlp	11381096	SENT73	13	13	0	0	ethanol	MAGI-1	PA448073	9223	0.865
NULL	FASEB_J_2008_Sep_22(9)_3120-3128.nxml.txt.nlp	18495755	SENT75	18	18	2	2	collagenase	U87	PA449107	677775;641648	0.865
NULL	Diabetes_Care_2011_Jul_17_34(7)_e115-e120.nxml.txt.nlp	21709286	SENT88	17	17	0	0	resveratrol	AMPK		5563	0.865
NULL	J_Thromb_Haemost_2007_May_5(5)_1010-1018.nxml.txt.nlp	17355572	SENT166	3	3	12	12	thrombin	VWF	PA451674	7450	0.865
NULL	Biomed_Res_Int_2014_Aug_6_2014_967826.nxml.txt.nlp	25165721	SENT228	4	4	14	14	cisplatin	CXCL1	PA449014	2919	0.865
NULL	Oncol_Lett_2013_Apr_28_5(4)_1149-1154.nxml.txt.nlp	23599754	SENT156	6	6	2	2	cisplatin	Dicer	PA449014	23405	0.865
NULL	Acta_Neuropathol_2012_Jun_27_123(6)_807-823.nxml.txt.nlp	22539017	SENT39	38	38	6	6	tetracycline	TDP-43	PA451640	23435	0.865
NULL	Genet_Mol_Biol_2009_Mar_1_Jan-Mar_32(1)_144-150.nxml.txt.nlp	21637660	SENT125	19	19	28	28	etoposide	AF9	PA449552	4300	0.865
NULL	J_Immunol_Res_2014_Jul_16_2014_696812.nxml.txt.nlp	25133198	SENT249	14	14	3	3	rifaximin	TLR2	PA164752443	7097	0.865
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1013.nxml.txt.nlp	24457957	SENT119	18	18	8	8	bortezomib	NOXA	PA10252	5366	0.865
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT11	19	19	12	12	heparin	FGF1	PA449855	2246	0.865
NULL	Nucl_Recept_Signal_2009_Jan_16_7_e001.nxml.txt.nlp	19240808	SENT425	18	18	29	29	phenytoin	CYP3A	PA450947	1574	0.865
NULL	Crit_Care_2004_May_14_8(4)_R163-R171.nxml.txt.nlp	15312214	SENT140	10	10	7	7	candesartan	AT1	PA448765	9197;185	0.865
NULL	Cancer_Res_Treat_2014_Jul_15_46(3)_209-222.nxml.txt.nlp	25038756	SENT169	20	20	4	4	imatinib	EZH2	PA10804	2146	0.865
NULL	Exp_Hematol_Oncol_2014_Jun_4_3_15.nxml.txt.nlp	24926417	SENT45	10	10	37	37	octreotide	VWF	PA450678	7450	0.865
NULL	Mol_Cancer_2012_Jul_25_11_47.nxml.txt.nlp	22830443	SENT117	3	3	6	6	panitumumab	EGFR	PA162373091	1956	0.865
NULL	J_Viral_Hepat_2009_May_16(5)_315-324.nxml.txt.nlp	19243499	SENT107	3	3	11	11	imiquimod	IFN	PA449972	3439	0.865
NULL	J_Thromb_Thrombolysis_2012_Feb_20_33(2)_143-153.nxml.txt.nlp	22183178	SENT250	14	14	5	5	ticagrelor	ABCB1	PA165374673	5243	0.865
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT188	0	0	37	37	curcumin	Bcl-2	PA151958596	596	0.865
NULL	Front_Oncol_2013_Sep_23_3_250.nxml.txt.nlp	24069582	SENT142	14	14	2	2	lapatinib	HER2	PA152241907	2064	0.865
NULL	Infect_Dis_Obstet_Gynecol_2012_Aug_14_2012_890160.nxml.txt.nlp	22927715	SENT279	28	28	11	11	efavirenz	ENG	PA449441	2022	0.865
NULL	Arthritis_Res_Ther_2008_Oct_10_10(5)_224.nxml.txt.nlp	18947376	SENT95	9	9	6	6	alefacept	LFA-1	PA164748040	3683;3689	0.865
NULL	Oncotarget_2013_Nov_24_4(12)_2430-2438.nxml.txt.nlp	24280348	SENT56	0	0	2	2	gefitinib	EGFR	PA131301952	1956	0.865
NULL	J_Hematol_Oncol_2011_Jan_21_4_5.nxml.txt.nlp	21255411	SENT37	24	24	12	12	gefitinib	EGFR	PA131301952	1956	0.865
NULL	Addict_Sci_Clin_Pract_2014_Sep_13_9(1)_20.nxml.txt.nlp	25217046	SENT121	10	10	27	27	naltrexone	OPRM1	PA450588	4988	0.865
NULL	Mol_Cancer_2008_Mar_6_7_24.nxml.txt.nlp	18325101	SENT155	23	23	15	15	cisplatin	FANCD2	PA449014	2177	0.865
NULL	Bioinformation_2012_Jan_6_8(1)_13-19.nxml.txt.nlp	22359429	SENT96	4	4	10	10	curcumin	MRP1	PA151958596	4437	0.865
NULL	Cancer_Res_Treat_2011_Jun_30_43(2)_89-95.nxml.txt.nlp	21811424	SENT50	15	15	12	12	letrozole	aromatase	PA450196	1588	0.865
NULL	Diabetes_2009_Mar_58(3)_579-589.nxml.txt.nlp	19074989	SENT97	38	38	11	11	rosiglitazone	ANGPTL4	PA451283	51129	0.865
NULL	Indian_J_Med_Res_2011_Sep_134(3)_295-301.nxml.txt.nlp	21985811	SENT122	29	29	18	18	phenytoin	MDR1	PA450947	5243	0.865
NULL	Case_Rep_Ophthalmol_Med_2012_Nov_6_2012_968180.nxml.txt.nlp	23198204	SENT56	20	20	3	3	tocilizumab	IL-6	PA165292659	3569	0.865
NULL	Mol_Cancer_2009_Nov_10_8_99.nxml.txt.nlp	19903356	SENT112	9	9	26	26	imatinib	IGFBP3	PA10804	3486	0.865
NULL	Breast_Cancer_Res_Treat_2012_Jun_18_133(3)_937-947.nxml.txt.nlp	22094936	SENT163	13	13	4	4	tamoxifen	EZH2	PA451581	2146	0.865
NULL	Anesthesiol_Res_Pract_2013_Sep_23_2013_297141.nxml.txt.nlp	24174934	SENT181	28	28	13	13	lidocaine	mol	PA450226	90527	0.865
NULL	Biomed_Res_Int_2014_Aug_6_2014_621827.nxml.txt.nlp	25165710	SENT254	6	6	11	11	dexmedetomidine	CD68	PA449256	968	0.865
NULL	JRSM_Cardiovasc_Dis_2012_Sep_24_1(6)_cvd_2012_012015.nxml.txt.nlp	24175073	SENT30	7	7	16	16	clopidogrel	CYP2C19	PA449053	1557	0.865
NULL	Oncoimmunology_2013_Jan_1_2(1)_e22890.nxml.txt.nlp	23483066	SENT76	0	0	36	36	sorafenib	ANOVA	PA7000	4858	0.865
NULL	Biomed_Res_Int_2014_Jun_26_2014_161346.nxml.txt.nlp	25054130	SENT232	7	7	21	21	curcumin	STZ	PA151958596	6484	0.865
NULL	Mar_Drugs_2009_Jul_17_7(3)_331-340.nxml.txt.nlp	19841717	SENT116	6	6	40	40	imatinib	FDG	PA10804	23583	0.865
NULL	Breast_Cancer_Res_2010_Jun_24_12(3)_R41.nxml.txt.nlp	20576088	SENT137	16	16	12	12	paclitaxel	EGFR	PA450761	1956	0.865
NULL	Cancer_Causes_Control_2012_Oct_21_23(10)_1739-1744.nxml.txt.nlp	22907422	SENT20	38	38	17	17	sulindac	CRA	PA451565	51747;10903	0.865
NULL	Indian_Dermatol_Online_J_2014_Dec_5(Suppl_2)_S140-S141.nxml.txt.nlp	25593810	SENT31	2	2	13	13	metformin	CO2	PA450395	4513	0.865
NULL	An_Bras_Dermatol_2014_Mar-Apr_89(2)_301-310.nxml.txt.nlp	24770508	SENT110	15	15	31	31	vinblastine	IL-2	PA451877	3558	0.865
NULL	Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.nxml.txt.nlp	24736980	SENT222	27	27	9	9	rosuvastatin	OATP1B1	PA134308647	10599	0.865
NULL	Ann_Rheum_Dis_2011_Sep_12_70(11)_2003-2007.nxml.txt.nlp	21914628	SENT41	25	25	7	7	infliximab	ACR	PA452639	49	0.865
NULL	EPMA_J_2012_Sep_27_3(1)_10.nxml.txt.nlp	23016735	SENT109	15	15	5	5	warfarin	CYP2C9	PA451906	1559	0.865
NULL	Braz_J_Med_Biol_Res_2014_Sep_5_47(11)_929-939.nxml.txt.nlp	25296354	SENT117	8	8	15	15	erlotinib	EGFR	PA134687924	1956	0.865
NULL	J_Inflamm_(Lond)_2005_Oct_31_2_14.nxml.txt.nlp	16259633	SENT221	36	36	7	7	staurosporine	CCR2	PA165109623	729230	0.865
NULL	J_Med_Radiat_Sci_2014_Sep_22_61(3)_202-209.nxml.txt.nlp	NULL	SENT48	4	4	0	0	basiliximab	IL-2	PA164747126	3558	0.865
NULL	Exp_Ther_Med_2014_Sep_4_8(3)_851-855.nxml.txt.nlp	25120613	SENT68	0	0	2	2	lopinavir	IRS1	PA450264	3667	0.865
NULL	Int_J_Gen_Med_2012_Apr_13_5_317-322.nxml.txt.nlp	22536087	SENT36	0	0	20	20	liraglutide	GLP-1	PA165958364	100125288	0.865
NULL	J_Vis_Exp_2014_Jun_28_(88)_51278.nxml.txt.nlp	24998179	SENT183	21	21	8	8	cyclosporine	P-gp	PA449167	5243	0.865
NULL	Int_J_Surg_Oncol_2012_May_17_2012_347385.nxml.txt.nlp	22675624	SENT246	8	8	22	22	tamoxifen	BCS	PA451581	617	0.865
NULL	Cell_Death_Dis_2012_Nov_15_3(11)_e422.nxml.txt.nlp	23152058	SENT32	29	29	15	15	cisplatin	ZNF143	PA449014	7702	0.865
NULL	JRSM_Cardiovasc_Dis_2012_Sep_24_1(6)_cvd_2012_012015.nxml.txt.nlp	24175073	SENT143	18	18	0	0	clopidogrel	JAMA	PA449053	50848	0.865
NULL	Bone_Joint_Res_2012_May_1_1(5)_78-85.nxml.txt.nlp	23610675	SENT209	31	31	19	19	gemcitabine	EGFR	PA449748	1956	0.865
NULL	Evid_Based_Complement_Alternat_Med_2013_Mar_28_2013_845172.nxml.txt.nlp	23606892	SENT132	7	7	14	14	glibenclamide	BGL	PA449782	987	0.865
NULL	Front_Neurol_2011_Dec_26_2_83.nxml.txt.nlp	22363312	SENT610	17	17	5	5	prasugrel	P2Y12	PA154410481	64805	0.865
NULL	Clin_Dev_Immunol_2011_Nov_3_2011_320571.nxml.txt.nlp	22110523	SENT201	28	28	15	15	etoposide	LGR5	PA449552	8549	0.865
NULL	Cancer_Cell_Int_2013_Feb_5_13_9.nxml.txt.nlp	23383739	SENT189	10	10	18	18	etoposide	VDBP	PA449552	2638	0.865
NULL	Cancer_Metastasis_Rev_2010_Dec_10_29(4)_581-594.nxml.txt.nlp	20830503	SENT278	35	35	11	11	tamoxifen	ARNO	PA451581	9266	0.865
NULL	Cancer_Immunol_Immunother_2011_Jun_25_60(6)_793-808.nxml.txt.nlp	21350947	SENT59	22	22	6	6	sorafenib	IFN	PA7000	3439	0.865
NULL	Oncotarget_2014_Mar_13_5(4)_1101-1110.nxml.txt.nlp	24658355	SENT33	17	17	13	13	tamoxifen	MKP-2	PA451581	1846	0.865
NULL	Acta_Pharmacol_Sin_2010_Oct_27_31(10)_1389-1394.nxml.txt.nlp	20871620	SENT35	18	18	33	33	carbachol	cadherin	PA448784	1015	0.865
NULL	Int_J_Mol_Sci_2012_Aug_13_13(8)_10091-10112.nxml.txt.nlp	22949849	SENT112	45	45	26	26	ethanol	PPL	PA448073	5493	0.865
NULL	Clin_Interv_Aging_2008_Mar_3(1)_45-50.nxml.txt.nlp	18488877	SENT52	12	12	15	15	raloxifene	STAR	PA451221	6770;2984	0.865
NULL	Br_J_Cancer_2011_Jul_26_105(3)_353-359.nxml.txt.nlp	21750549	SENT160	24	24	28	28	sorafenib	CRAF	PA7000	5894	0.865
NULL	Exp_Ther_Med_2013_Nov_6_6(5)_1089-1095.nxml.txt.nlp	24223627	SENT32	42	42	2	2	cyclophosphamide	NAC	PA449165	22861	0.865
NULL	Br_J_Cancer_2012_Jul_24_107(3)_516-526.nxml.txt.nlp	22782351	SENT335	4	4	12	12	tamoxifen	TIGAR	PA451581	57103	0.865
NULL	Front_Neurosci_2014_Feb_14_8_23.nxml.txt.nlp	24592205	SENT48	6	6	4	4	capsaicin	TRPV1	PA448776	7442	0.865
NULL	Biomed_Res_Int_2014_Feb_10_2014_305610.nxml.txt.nlp	24683545	SENT72	26	26	38	38	naringenin	ANOVA	PA151958361	4858	0.865
NULL	Cardiovasc_Res_2010_Oct_1_88(1)_51-57.nxml.txt.nlp	20558439	SENT101	37	37	18	18	doxorubicin	ALDH2	PA449412	217	0.865
NULL	J_Oncol_2012_Feb_6_2012_737981.nxml.txt.nlp	22481932	SENT132	16	16	21	21	cisplatin	AKT	PA449014	207	0.865
NULL	J_Cancer_Epidemiol_2012_Oct_24_2012_294730.nxml.txt.nlp	23150730	SENT243	30	30	6	6	cetuximab	KRAS	PA10040	3845	0.865
NULL	Avicenna_J_Phytomed_2013_Spring_3(2)_178-185.nxml.txt.nlp	25050272	SENT127	29	29	16	16	curcumin	CD4	PA151958596	920	0.865
NULL	Int_J_Impot_Res_2010_Mar_26_22(2)_120-126.nxml.txt.nlp	19940852	SENT82	4	4	21	21	nitroprusside	mol	PA451406	90527	0.865
NULL	Biologics_2012_Feb_1_6_31-35.nxml.txt.nlp	22355257	SENT85	11	11	38	38	rituximab	IL-6	PA451261	3569	0.865
NULL	Breast_Cancer_Res_2007_Aug_10_9(4)_R52.nxml.txt.nlp	17692126	SENT274	23	23	9	9	anastrozole	aromatase	PA448432	1588	0.865
NULL	Cancer_Cell_Int_2014_Jul_2_14_59.nxml.txt.nlp	25120382	SENT95	20	20	22	22	metformin	Met	PA450395	79811	0.865
NULL	Indian_J_Pharmacol_2014_Nov-Dec_46(6)_627-632.nxml.txt.nlp	25538335	SENT150	21	21	26	26	metformin	Q10	PA450395	27161	0.865
NULL	J_Oncol_2012_Nov_20_2012_236530.nxml.txt.nlp	23213333	SENT126	21	21	40	40	resveratrol	PTEN		5728	0.865
NULL	Cancer_Cell_Int_2014_Jul_2_14_59.nxml.txt.nlp	25120382	SENT197	20	20	22	22	metformin	Met	PA450395	79811	0.865
NULL	F1000_Biol_Rep_2012_Mar_1_4_5.nxml.txt.nlp	22403588	SENT73	5	5	2	2	ribavirin	IFN	PA451241	3439	0.865
NULL	Breast_Cancer_(Auckl)_2009_Apr_7_3_23-34.nxml.txt.nlp	21556247	SENT103	17	17	10	10	celecoxib	AKT	PA448871	207	0.865
NULL	Cancer_Cell_Int_2013_Nov_1_13_108.nxml.txt.nlp	24176221	SENT163	11	11	20	20	cisplatin	Bcl-2	PA449014	596	0.865
NULL	Front_Genet_2012_Nov_5_3_236.nxml.txt.nlp	23133441	SENT61	12	12	1	1	efavirenz	ABCB1	PA449441	5243	0.865
NULL	BMJ_Open_2013_Nov_4_3(11)_e003556.nxml.txt.nlp	24189081	SENT298	17	17	21	21	cyclophosphamide	TOP2A	PA449165	7153	0.865
NULL	Oncol_Lett_2013_Feb_7_5(2)_440-446.nxml.txt.nlp	23420122	SENT99	17	17	8	8	gemcitabine	EGFR	PA449748	1956	0.865
NULL	Int_J_Mol_Sci_2014_Oct_17_15(10)_18789-18803.nxml.txt.nlp	25329619	SENT477	3	3	19	19	hyaluronan	ADAMTS-4	PA165958431	9508	0.865
NULL	Br_J_Cancer_2010_Jul_13_103(2)_186-195.nxml.txt.nlp	20588277	SENT136	25	25	21	21	nutlin-3	p53		7157	0.865
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R91.nxml.txt.nlp	22541814	SENT162	36	36	29	29	pp2	HO-1		3162	0.865
NULL	Arthritis_Res_2002_Nov_14_4(2)_139-144.nxml.txt.nlp	11879550	SENT116	20	20	2	2	aprotinin	F10	PA448472	2159	0.865
NULL	Hum_Genomics_2008_Sep_1_3(1)_7-16.nxml.txt.nlp	19129086	SENT170	26	26	31	31	gemfibrozil	OATP1B1	PA449750	10599	0.865
NULL	Clinics_(Sao_Paulo)_2014_Jan_69(1)_68-74.nxml.txt.nlp	24473562	SENT90	7	7	20	20	nutlin-3	p53		7157	0.865
NULL	Arch_Public_Health_2014_Jun_6_72(Suppl_1)_O5.nxml.txt.nlp	NULL	SENT19	11	11	8	8	indomethacin	COX	PA449982	1351	0.865
NULL	Adv_Virol_2012_Jul_19_2012_267483.nxml.txt.nlp	22851970	SENT91	5	5	11	11	ribavirin	IFN	PA451241	3439	0.865
NULL	Acta_Pharmacol_Sin_2010_Jan_5_31(1)_93-101.nxml.txt.nlp	20048748	SENT36	19	19	8	8	cisplatin	DAPK	PA449014	1612	0.865
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jun_18_67(Pt_7)_o1733.nxml.txt.nlp	21837122	SENT68	17	17	9	9	ethanol	mol	PA448073	90527	0.865
NULL	J_Gen_Intern_Med_2009_May_21_24(5)_656-664.nxml.txt.nlp	19306050	SENT393	9	9	7	7	warfarin	CYP2C9	PA451906	1559	0.865
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT155	3	3	9	9	nutlin-3	p53		7157	0.865
NULL	ScientificWorldJournal_2012_Apr_24_2012_184362.nxml.txt.nlp	22619618	SENT114	21	21	5	5	lenalidomide	p53	PA162363968	7157	0.865
NULL	Int_J_Womens_Health_2013_Dec_4_5_811-818.nxml.txt.nlp	24348074	SENT86	15	15	2	2	levonorgestrel	LARC	PA450218	6364	0.865
NULL	Support_Care_Cancer_2009_Sep_10_17(9)_1177-1185.nxml.txt.nlp	19205755	SENT31	0	0	17	17	ondansetron	CYP1A2	PA450705	1544	0.865
NULL	Br_J_Cancer_2011_Nov_22_105(11)_1759-1767.nxml.txt.nlp	22045189	SENT32	13	13	35	35	cetuximab	XRCC1	PA10040	7515	0.865
NULL	Oncotarget_2011_Sep_5_2(8)_646-653.nxml.txt.nlp	21896960	SENT108	31	31	27	27	temozolomide	TRAIL	PA451609	8743	0.865
NULL	Breast_Cancer_Res_2012_Jun_7_14(3)_R89.nxml.txt.nlp	22676470	SENT162	14	14	9	9	trastuzumab	HER2	PA451743	2064	0.865
NULL	Biomed_Res_Int_2013_Sep_5_2013_929531.nxml.txt.nlp	24083250	SENT110	9	9	19	19	hyaluronan	HAS2	PA165958431	3037	0.865
NULL	Cell_Death_Dis_2012_Jun_21_3(6)_e330.nxml.txt.nlp	22717585	SENT32	35	35	43	43	simvastatin	RhoC	PA451363	389	0.865
NULL	J_Infect_Dis_2011_May_1_203(9)_1204-1214.nxml.txt.nlp	21459813	SENT13	17	17	21	21	maraviroc	CCR5	PA164768835	1234	0.865
NULL	Br_J_Ophthalmol_2013_Sep_13_97(9)_1161-1167.nxml.txt.nlp	23850682	SENT204	25	25	18	18	ranibizumab	WAVE	PA164746012	8936	0.865
NULL	J_Hematol_Oncol_2011_Apr_23_4_19.nxml.txt.nlp	21513557	SENT51	2	2	22	22	fluorescein	CD4	PA164746009	920	0.865
NULL	Oncogene_2010_Jul_8_29(27)_3896-3907.nxml.txt.nlp	20453888	SENT139	16	16	4	4	trastuzumab	HER2	PA451743	2064	0.865
NULL	Pharmaceutics_2011_Feb_7_3(1)_53-72.nxml.txt.nlp	24310425	SENT236	4	4	26	26	hydralazine	NAT	PA449894	6046	0.865
NULL	Oncologist_2011_Jan_6_16(1)_5-24.nxml.txt.nlp	21212434	SENT194	26	26	11	11	temozolomide	IFN	PA451609	3439	0.865
NULL	Brain_2008_Nov_22_131(11)_3072-3080.nxml.txt.nlp	18945724	SENT160	12	12	18	18	rituximab	CD19	PA451261	930	0.865
NULL	Acta_Pharmacol_Sin_2009_Sep_24_30(9)_1262-1275.nxml.txt.nlp	19701231	SENT146	40	40	23	23	lovastatin	SCARB1	PA450272	949	0.865
NULL	J_Lipid_Res_2014_Mar_55(3)_385-397.nxml.txt.nlp	24347527	SENT14	14	14	35	35	lipase	HSL	PA450239	3991	0.865
NULL	Adv_Hematol_2009_Jul_7_2009_495863.nxml.txt.nlp	19960059	SENT185	27	27	2	2	tamoxifen	aromatase	PA451581	1588	0.865
NULL	J_Immunother_2014_Feb_21_37(2)_105-114.nxml.txt.nlp	24509173	SENT172	15	15	4	4	gemcitabine	WT1	PA449748	7490	0.865
NULL	Mol_Cancer_2010_Jun_9_9_140.nxml.txt.nlp	20529378	SENT20	12	12	19	19	dacarbazine	IFN	PA449197	3439	0.865
NULL	Case_Rep_Rheumatol_2014_Nov_11_2014_536856.nxml.txt.nlp	25436167	SENT88	18	18	15	15	infliximab	CPDD	PA452639	882	0.865
NULL	Arch_Med_Sci_2013_Jun_20_9(3)_569-575.nxml.txt.nlp	23847684	SENT144	0	0	22	22	cisplatin	BCL2L1	PA449014	598	0.865
NULL	Diabetes_2009_Jul_58(7)_1471-1478.nxml.txt.nlp	19564458	SENT66	13	13	23	23	hydralazine	VEGF-A	PA449894	7422	0.865
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Jun_25_3(6)_e120.nxml.txt.nlp	24964282	SENT181	12	12	5	5	itraconazole	CYP3A4	PA450132	1576	0.865
NULL	Breast_Cancer_Res_Treat_2015_Dec_30_149_171-179.nxml.txt.nlp	25547219	SENT10	22	22	8	8	docetaxel	survivin	PA449383	332	0.865
NULL	J_Clin_Biochem_Nutr_2009_Jan_27_44(1)_79-84.nxml.txt.nlp	19177192	SENT4	43	43	36	36	curcumin	HO-1	PA151958596	3162	0.865
NULL	Brain_2014_Aug_18_137(8)_2312-2328.nxml.txt.nlp	24941947	SENT125	1	1	12	12	dextran	CTR	PA449261	799	0.865
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jul_18_65(Pt_8)_o1910-o1911.nxml.txt.nlp	21583598	SENT70	26	26	7	7	ethanol	mol	PA448073	90527	0.865
NULL	Cell_Death_Dis_2013_Jul_11_4(7)_e719.nxml.txt.nlp	23846221	SENT73	5	5	3	3	cisplatin	TRAIL	PA449014	8743	0.865
NULL	J_Immunother_Cancer_2013_Nov_7_1(Suppl_1)_P255.nxml.txt.nlp	NULL	SENT6	11	11	5	5	cyclophosphamide	OX40	PA449165	7293	0.865
NULL	Ann_Dermatol_2012_Aug_25_24(3)_253-260.nxml.txt.nlp	22879707	SENT160	5	5	12	12	etanercept	IL-5	PA449515	3567	0.865
NULL	Eur_J_Clin_Pharmacol_2010_Nov_29_66(11)_1131-1136.nxml.txt.nlp	20669013	SENT111	7	7	11	11	erythromycin	CYP2C19	PA449493	1557	0.865
NULL	Front_Pharmacol_2014_Nov_26_5_258.nxml.txt.nlp	25505415	SENT29	8	8	18	18	rosuvastatin	OATP1B1	PA134308647	10599	0.865
NULL	Open_Biochem_J_2014_May_16_8_44-51.nxml.txt.nlp	24894970	SENT73	15	15	0	0	phenol	PON1	PA450913	5444	0.865
NULL	Cancer_Metab_2013_Jan_23_1_3.nxml.txt.nlp	24280005	SENT213	7	7	22	22	cerulenin	PERK	PA164764551	9451	0.865
NULL	Braz_J_Med_Biol_Res_2014_Jan_10_47(1)_60-69.nxml.txt.nlp	24519092	SENT214	21	21	9	9	doxorubicin	YWHAZ	PA449412	7534	0.865
NULL	Anal_Bioanal_Chem_2012_Feb_16_402(4)_1611-1623.nxml.txt.nlp	22173207	SENT205	17	17	0	0	ribavirin	SRM	PA451241	6723;6725	0.865
NULL	Case_Rep_Dermatol_2013_Nov_7_5(3)_326-331.nxml.txt.nlp	24348382	SENT44	36	36	8	8	imiquimod	IFN	PA449972	3439	0.865
NULL	Pain_2012_Apr_153(4)_775-783.nxml.txt.nlp	22325744	SENT94	15	15	22	22	naloxone	P28	PA450586	9446;7802;9527	0.865
NULL	Nat_Med_2013_Dec_24_19(12)_1632-1637.nxml.txt.nlp	24270545	SENT116	0	0	3	3	abatacept	CD28	PA164747080	1493;940	0.865
NULL	Mol_Cancer_2012_Nov_1_11_82.nxml.txt.nlp	23116066	SENT139	21	21	13	13	paraformaldehyde	DDX11	PA450790	1663	0.865
NULL	Mol_Cancer_2014_Aug_16_13(1)_193.nxml.txt.nlp	NULL	SENT29	8	8	31	31	cisplatin	RUNX3	PA449014	864	0.865
NULL	Clin_Med_Case_Rep_2008_Aug_29_1_119-122.nxml.txt.nlp	24179360	SENT66	2	2	19	19	teriparatide	RANKL	PA451620	8600	0.865
NULL	Biochim_Biophys_Acta_2014_Jul_1842(7)_959-970.nxml.txt.nlp	24594481	SENT14	8	8	21	21	lipase	FGF21	PA450239	26291	0.865
NULL	Front_Oncol_2011_Aug_10_1_20.nxml.txt.nlp	22649757	SENT39	24	24	16	16	temozolomide	MLH1	PA451609	4292	0.865
NULL	J_Biol_Chem_2008_Nov_7_283(45)_31005-31011.nxml.txt.nlp	18765663	SENT209	30	30	16	16	baclofen	CA1	PA448533	759	0.865
NULL	Breast_Cancer_Res_Treat_2013_Oct_16_142(1)_89-99.nxml.txt.nlp	24129974	SENT185	10	10	23	23	trastuzumab	aromatase	PA451743	1588	0.865
NULL	Mol_Cancer_2007_Oct_11_6_63.nxml.txt.nlp	17931419	SENT112	10	10	26	26	gefitinib	HIF-1	PA131301952	29072	0.865
NULL	Eur_J_Clin_Pharmacol_2011_May_9_67(5)_477-482.nxml.txt.nlp	21305273	SENT116	20	20	7	7	atropine	ADRB1	PA448505	153	0.865
NULL	Ann_Lab_Med_2013_Sep_8_33(5)_349-352.nxml.txt.nlp	24003425	SENT83	21	21	29	29	ethambutol	EMB	PA164784021	133418	0.865
NULL	Int_J_Biol_Sci_2014_Jun_10_10(7)_654-663.nxml.txt.nlp	25013375	SENT226	4	4	18	18	nitroxoline	p53	PA164754993	7157	0.865
NULL	Acta_Pharmacol_Sin_2013_Sep_5_34(9)_1192-1200.nxml.txt.nlp	23685957	SENT134	9	9	3	3	curcumin	AP-2	PA151958596	7020	0.865
NULL	Br_J_Cancer_2004_Mar_22_90(6)_1285-1292.nxml.txt.nlp	15026814	SENT124	6	6	11	11	cisplatin	p53	PA449014	7157	0.865
NULL	Int_J_Med_Sci_2012_Dec_28_10(2)_110-118.nxml.txt.nlp	23329881	SENT54	24	24	28	28	docetaxel	NACT	PA449383	284111	0.865
NULL	Ann_Rheum_Dis_2010_Jan_17_69(1)_88-96.nxml.txt.nlp	19297346	SENT170	14	14	22	22	tocilizumab	IL6R	PA165292659	3570	0.865
NULL	Mol_Biol_Cell_2013_Feb_15_24(4)_495-509.nxml.txt.nlp	23408788	SENT159	3	3	29	29	pp2	PP2		4888	0.865
NULL	Exp_Diabetes_Res_2012_Oct_15_2012_465282.nxml.txt.nlp	23118742	SENT27	6	6	12	12	metformin	FGF21	PA450395	26291	0.865
NULL	Mol_Biol_Rep_2013_May_11_40(8)_5013-5026.nxml.txt.nlp	23666059	SENT218	3	3	6	6	resveratrol	p53		7157	0.865
NULL	FEBS_Open_Bio_2014_Jan_6_4_77-89.nxml.txt.nlp	24490132	SENT202	26	26	17	17	ebselen	GDH	PA161660841	51084;2746	0.865
NULL	Br_J_Cancer_2012_Jun_5_106(12)_1997-2003.nxml.txt.nlp	22596232	SENT6	21	21	7	7	sorafenib	JNK	PA7000	5599	0.865
NULL	Evid_Based_Complement_Alternat_Med_2014_May_18_2014_156276.nxml.txt.nlp	24963318	SENT106	5	5	22	22	hesperidin	SOD1	PA449867	6647	0.865
NULL	Ann_Clin_Transl_Neurol_2014_Sep_30_1(9)_721-732.nxml.txt.nlp	25493285	SENT31	8	8	5	5	liraglutide	GLP-1	PA165958364	100125288	0.865
NULL	Cancer_Cell_2015_Jan_12_27(1)_57-71.nxml.txt.nlp	25584894	SENT199	37	37	4	4	hydrocortisone	HER2	PA449905	2064	0.865
NULL	Cancers_(Basel)_2010_Jul_27_2(3)_1528-1554.nxml.txt.nlp	24281171	SENT301	29	29	2	2	temozolomide	CD133	PA451609	8842	0.865
NULL	Br_J_Cancer_2010_Sep_7_103(6)_889-898.nxml.txt.nlp	20664599	SENT151	12	12	8	8	paclitaxel	AKT	PA450761	207	0.865
NULL	Clin_Pharmacol_2013_Apr_19_5_67-83.nxml.txt.nlp	23650452	SENT28	30	30	15	15	ticagrelor	CYP3A4	PA165374673	1576	0.865
NULL	BMB_Rep_2013_Aug_46(8)_410-415.nxml.txt.nlp	23977989	SENT214	1	1	24	24	curcumin	JNK	PA151958596	5599	0.865
NULL	Br_J_Cancer_1997_75(8)_1111-1118.nxml.txt.nlp	9099957	SENT12	4	4	24	24	flurbiprofen	PC-3	PA449683	692094	0.865
NULL	Breast_Cancer_(Auckl)_2014_Mar_23_8_51-56.nxml.txt.nlp	24678242	SENT7	24	24	15	15	carboplatin	GAL4	PA448803	3960	0.865
NULL	J_Hematol_Oncol_2012_May_15_5_23.nxml.txt.nlp	22587422	SENT19	26	26	13	13	dasatinib	ALL	PA162372878	613	0.865
NULL	Diabetes_2009_Feb_58(2)_352-359.nxml.txt.nlp	19011168	SENT5	6	6	16	16	exenatide	GLP-1	PA164749238	100125288	0.865
NULL	Mol_Clin_Oncol_2013_Sep_24_1(5)_918-924.nxml.txt.nlp	24649271	SENT92	16	16	22	22	gemcitabine	EGFR	PA449748	1956	0.865
NULL	Oncol_Lett_2013_Sep_3_6(3)_807-810.nxml.txt.nlp	24137415	SENT29	35	35	0	0	l-glutamine	p53	PA10090	7157	0.865
NULL	Cancer_Cell_Int_2010_Sep_9_10_32.nxml.txt.nlp	20828393	SENT196	0	0	21	21	cisplatin	ATF3	PA449014	467	0.865
NULL	Cancer_Cell_Int_2004_Aug_17_4_5.nxml.txt.nlp	15315711	SENT116	24	24	22	22	genistein	PC3	PA165109660	57332;7832;5122	0.865
NULL	Diabetes_Obes_Metab_2012_Dec_19_14(12)_1097-1103.nxml.txt.nlp	22734440	SENT29	6	6	37	37	exenatide	GLP-1	PA164749238	100125288	0.865
NULL	Orphanet_J_Rare_Dis_2014_Dec_5_9(1)_194.nxml.txt.nlp	NULL	SENT795	8	8	27	27	desogestrel	CO2	PA449238	4513	0.865
NULL	Clinics_(Sao_Paulo)_2014_Jul_69(7)_491-496.nxml.txt.nlp	25029582	SENT110	13	13	20	20	methacholine	IFN	PA165958382	3439	0.865
NULL	Scientifica_(Cairo)_2012_Nov_25_2012_473829.nxml.txt.nlp	24278698	SENT225	35	35	24	24	carboplatin	ATP7B	PA448803	540	0.865
NULL	Arthritis_Res_Ther_2011_May_25_13(Suppl_1)_S2.nxml.txt.nlp	21624181	SENT65	44	44	28	28	infliximab	ACR	PA452639	49	0.865
NULL	Cancers_(Basel)_2013_Jun_24_5(3)_762-785.nxml.txt.nlp	24202320	SENT49	10	10	25	25	heparin	VEGF-D	PA449855	2277	0.865
NULL	J_Radiat_Res_2014_Mar_1_55(2)_359-363.nxml.txt.nlp	24187329	SENT43	38	38	0	0	cyclophosphamide	CHOP	PA449165	1649	0.865
NULL	Breast_Cancer_Res_Treat_2013_Aug_20_141(1)_43-53.nxml.txt.nlp	23959396	SENT191	38	38	32	32	trastuzumab	HER3	PA451743	2065	0.865
NULL	Ital_J_Pediatr_2013_Jul_6_39_42.nxml.txt.nlp	23830064	SENT107	12	12	22	22	rituximab	CD25	PA451261	3669;3559	0.865
NULL	J_Korean_Med_Sci_2013_Oct_25_28(10)_1555-1558.nxml.txt.nlp	24133367	SENT19	16	16	8	8	gefitinib	EGFR	PA131301952	1956	0.865
NULL	J_Cell_Mol_Med_2014_Nov_11_18(11)_2275-2286.nxml.txt.nlp	25208472	SENT228	26	26	10	10	cisplatin	p53	PA449014	7157	0.865
NULL	Int_J_Surg_Oncol_2012_Jun_12_2012_862879.nxml.txt.nlp	22778941	SENT146	24	24	14	14	cisplatin	BIN1	PA449014	274	0.865
NULL	Br_J_Pharmacol_2012_Apr_165(8)_2611-2619.nxml.txt.nlp	21718301	SENT201	12	12	19	19	rimonabant	GPR55	PA152407999	9290	0.865
NULL	J_Hematol_Oncol_2011_Dec_1_4_49.nxml.txt.nlp	22128838	SENT131	9	9	22	22	bortezomib	Mcl-1	PA10252	4170	0.865
NULL	Biologics_2009_Oct_12_3_443-457.nxml.txt.nlp	19851470	SENT117	19	19	9	9	infliximab	ACR	PA452639	49	0.865
NULL	Mol_Vis_2012_Oct_5_18_2454-2467.nxml.txt.nlp	23077404	SENT176	7	7	16	16	bevacizumab	VEGF-A	PA130232992	7422	0.865
NULL	Adv_Hematol_2010_May_16_2010_672137.nxml.txt.nlp	20490274	SENT14	43	43	18	18	mitoxantrone	AIDA	PA450526	64853	0.865
NULL	Nat_Chem_Biol_2010_Apr_28_6(4)_291-299.nxml.txt.nlp	20190765	SENT127	16	16	10	10	dasatinib	EGFR	PA162372878	1956	0.865
NULL	Cancer_Med_2012_Oct_1_1(2)_114-127.nxml.txt.nlp	23342262	SENT118	5	5	9	9	sirolimus	EGFR	PA451365	1956	0.865
NULL	Aging_(Albany_NY)_2009_Sep_25_1(10)_845-854.nxml.txt.nlp	20157557	SENT157	33	33	11	11	doxorubicin	p53	PA449412	7157	0.865
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT8	23	23	19	19	sulindac	survivin	PA451565	332	0.865
NULL	Ann_Hematol_2010_Sep_13_89(9)_861-871.nxml.txt.nlp	20387067	SENT236	10	10	13	13	dasatinib	TPO	PA162372878	7066;7173	0.865
NULL	J_Inherit_Metab_Dis_2010_Oct_3_33(5)_625-632.nxml.txt.nlp	20814828	SENT126	10	10	23	23	simvastatin	RhoA	PA451363	387	0.865
NULL	Mol_Cancer_2010_Nov_2_9_289.nxml.txt.nlp	21044322	SENT60	36	36	14	14	vincristine	FBS	PA451879	64319;26269	0.865
NULL	Arthritis_Res_Ther_2009_Nov_24_11(6)_134.nxml.txt.nlp	20017888	SENT4	30	30	11	11	rituximab	CD19	PA451261	930	0.865
NULL	EMBO_Mol_Med_2013_Aug_5_5(8)_1213-1226.nxml.txt.nlp	23918228	SENT137	11	11	0	0	cetuximab	EGFR	PA10040	1956	0.865
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1013.nxml.txt.nlp	24457957	SENT118	17	17	3	3	bortezomib	NOXA	PA10252	5366	0.865
NULL	Hum_Mol_Genet_2013_Nov_15_22(22)_4616-4626.nxml.txt.nlp	23814041	SENT181	0	0	6	6	simvastatin	neuroserpin	PA451363	5274	0.865
NULL	Virol_J_2010_Nov_17_7_323.nxml.txt.nlp	21083916	SENT38	6	6	9	9	telbivudine	gamma	PA164760861	9913	0.865
NULL	Cancers_(Basel)_2010_Jun_8_2(2)_1221-1235.nxml.txt.nlp	24281114	SENT216	8	8	12	12	trastuzumab	HER2	PA451743	2064	0.865
NULL	Crit_Care_2001_Mar_2_5(Suppl_1)_P197.nxml.txt.nlp	NULL	SENT20	0	0	8	8	propofol	PTH	PA451141	5741	0.865
NULL	Support_Care_Cancer_2012_Jul_27_20(7)_1353-1360.nxml.txt.nlp	22539050	SENT213	7	7	5	5	denosumab	NNT	PA166048634	23530	0.865
NULL	Cancers_(Basel)_2010_Jan_14_2(1)_1-19.nxml.txt.nlp	24281029	SENT1014	4	4	30	30	neratinib	San	PA165291472	80218	0.865
NULL	Clin_Ophthalmol_2014_Jun_26_8_1213-1219.nxml.txt.nlp	25061267	SENT151	6	6	16	16	proparacaine	PRK	PA164776849	1263	0.865
NULL	Br_J_Cancer_2010_Sep_28_103(7)_1008-1018.nxml.txt.nlp	20736947	SENT7	16	16	6	6	docetaxel	CD147	PA449383	682	0.865
NULL	Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.nxml.txt.nlp	24736980	SENT181	38	38	5	5	rosuvastatin	OATP1B1	PA134308647	10599	0.865
NULL	Nucleic_Acids_Res_2013_Apr_17_41(7)_4129-4143.nxml.txt.nlp	23420868	SENT42	14	14	44	44	hemin	GATA-1	PA449849	2623	0.865
NULL	Behav_Neurol_2014_Nov_16_2014_360978.nxml.txt.nlp	25477708	SENT145	5	5	19	19	nicotine	spatial	PA450626	219793	0.865
NULL	Aging_(Albany_NY)_2012_Jul_22_4(7)_480-498.nxml.txt.nlp	22837425	SENT91	5	5	24	24	metformin	LKB1	PA450395	6794	0.865
NULL	Ann_Coloproctol_2013_Apr_30_29(2)_66-71.nxml.txt.nlp	23700573	SENT45	21	21	4	4	leucovorin	CRT	PA450198	811	0.865
NULL	Br_J_Haematol_2014_Feb_16_164(4)_469-480.nxml.txt.nlp	24372186	SENT8	36	36	16	16	primaquine	G6PD	PA451103	2539	0.865
NULL	Exp_Ther_Med_2014_Apr_5_7(4)_785-790.nxml.txt.nlp	24660028	SENT26	8	8	5	5	gemcitabine	L1CAM	PA449748	3897	0.865
NULL	J_Cell_Mol_Med_2014_Oct_11_18(10)_2031-2043.nxml.txt.nlp	25109475	SENT278	27	27	14	14	valsartan	STZ	PA451848	6484	0.865
NULL	Curr_Control_Trials_Cardiovasc_Med_2001_Oct_16_2(6)_271-277.nxml.txt.nlp	11806813	SENT58	4	4	24	24	amlodipine	IL-6	PA448388	3569	0.865
NULL	Oncologist_2010_Sep_26_15(9)_944-953.nxml.txt.nlp	20798196	SENT30	31	31	21	21	exemestane	aromatase	PA449563	1588	0.865
NULL	Exp_Ther_Med_2012_Sep_12_4(3)_475-480.nxml.txt.nlp	23181121	SENT156	6	6	0	0	vincristine	CHOP	PA451879	1649	0.865
NULL	Exp_Ther_Med_2013_May_15_5(5)_1327-1331.nxml.txt.nlp	23737873	SENT4	4	4	24	24	imidapril	AQP2	PA452640	359	0.865
NULL	J_Cell_Biol_1999_Jul_12_146(1)_243-254.nxml.txt.nlp	10402474	SENT216	5	5	13	13	forskolin	IP-10	PA146096022	3627	0.865
NULL	Diabetes_Care_2013_Jul_12_36(7)_1913-1918.nxml.txt.nlp	23359361	SENT143	33	33	14	14	sitagliptin	GLP-1	PA164748978	100125288	0.865
NULL	AAPS_J_2014_Jun_11_16(5)_1029-1037.nxml.txt.nlp	24917180	SENT128	7	7	19	19	quinidine	P-gp	PA451209	5243	0.865
NULL	J_Immunol_Res_2014_May_12_2014_897249.nxml.txt.nlp	24901013	SENT5	20	20	7	7	natalizumab	CD4	PA164747191	920	0.865
NULL	Indian_J_Pharmacol_2013_Sep-Oct_45(5)_458-463.nxml.txt.nlp	24130379	SENT157	3	3	22	22	carvedilol	TLR4	PA448817	7099	0.865
NULL	Cell_Death_Dis_2014_Apr_24_5(4)_e1197.nxml.txt.nlp	24763054	SENT106	30	30	5	5	cisplatin	RUNX3	PA449014	864	0.865
NULL	Case_Rep_Oncol_2010_May_7_3(2)_154-159.nxml.txt.nlp	20740189	SENT25	17	17	14	14	cetuximab	EGFR	PA10040	1956	0.865
NULL	Mol_Biol_Cell_2013_Aug_1_24(15)_2328-2339.nxml.txt.nlp	23783029	SENT343	10	10	24	24	glucose	GAP	PA449773	5921	0.865
NULL	Breast_Cancer_Res_2010_Oct_20_12(5)_315.nxml.txt.nlp	21062517	SENT15	9	9	1	1	tamoxifen	PI3K	PA451581	5290	0.865
NULL	Diabetes_Care_2012_Feb_16_35(2)_327-333.nxml.txt.nlp	22179958	SENT100	0	0	6	6	metformin	B12	PA450395	7126;4709	0.865
NULL	Front_Oncol_2014_Jun_18_4_159.nxml.txt.nlp	24995161	SENT126	7	7	16	16	indomethacin	AKR1C3	PA449982	8644	0.865
NULL	Int_J_Mol_Sci_2014_Oct_20_15(10)_18919-18940.nxml.txt.nlp	25334063	SENT366	1	1	18	18	curcumin	AP-1	PA151958596	2353;3727;2354;3725	0.865
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Aug_1_68(Pt_9)_o2617.nxml.txt.nlp	22969519	SENT5	24	24	5	5	nitrile	mol	PA450636	90527	0.865
NULL	Mol_Cancer_2009_Jul_30_8_53.nxml.txt.nlp	19642975	SENT149	10	10	39	39	mitomycin	14-3-3	PA450524	10971	0.865
NULL	Biomed_Res_Int_2013_Aug_29_2013_392010.nxml.txt.nlp	24073402	SENT103	14	14	24	24	telithromycin	MDR1	PA10202	5243	0.865
NULL	Oncogene_2014_Aug_28_33(35)_4396-4406.nxml.txt.nlp	24531714	SENT58	29	29	32	32	nutlin-3	p53		7157	0.865
NULL	Am_J_Cardiovasc_Drugs_2013_Jun_20_13(5)_331-342.nxml.txt.nlp	23784266	SENT183	14	14	6	6	dronedarone	P-gp	PA153619853	5243	0.865
NULL	J_Korean_Med_Sci_2010_Aug_21_25(8)_1222-1227.nxml.txt.nlp	20676337	SENT153	29	29	21	21	propofol	LPA	PA451141	4018	0.865
NULL	Oncoimmunology_2012_Aug_1_1(5)_618-629.nxml.txt.nlp	22934254	SENT212	2	2	9	9	triciribine	JNK	PA165958661	5599	0.865
NULL	J_Cell_Mol_Med_2014_Apr_20_18(4)_709-720.nxml.txt.nlp	24444314	SENT12	13	13	18	18	metformin	AMPK	PA450395	5563	0.865
NULL	Biomed_Res_Int_2013_Sep_4_2013_185362.nxml.txt.nlp	24093091	SENT115	16	16	35	35	rituximab	CHOP	PA451261	1649	0.865
NULL	Allergy_2014_Jul_29_69(7)_817-827.nxml.txt.nlp	24773466	SENT175	7	7	22	22	pitrakinra	IL-13R	PA165983754	3598	0.865
NULL	Breast_Cancer_Res_2012_Jan_6_14(1)_R2.nxml.txt.nlp	22225778	SENT179	35	35	19	19	docetaxel	p65	PA449383	5970	0.865
NULL	Cell_Commun_Signal_2013_Oct_1_11_73.nxml.txt.nlp	24083678	SENT149	17	17	36	36	sulindac	JNK	PA451565	5599	0.865
NULL	Front_Neural_Circuits_2013_Sep_20_7_148.nxml.txt.nlp	24065892	SENT194	7	7	14	14	scopolamine	MOB	PA451308	259230	0.865
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT429	17	17	4	4	irinotecan	KRAS	PA450085	3845	0.865
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT287	24	24	13	13	ranibizumab	VEGFR2	PA164746012	3791	0.865
NULL	Oncotarget_2013_Dec_4_5(4)_944-958.nxml.txt.nlp	24659709	SENT160	34	34	12	12	cisplatin	JAG1	PA449014	182	0.865
NULL	Breast_Cancer_Res_2012_Mar_9_14(2)_R41.nxml.txt.nlp	22405131	SENT11	0	0	11	11	estradiol	TCL1A	PA449503	8115	0.865
NULL	Cardiovasc_Drugs_Ther_2011_Jun_12_25(3)_223-232.nxml.txt.nlp	21562974	SENT105	11	11	24	24	milrinone	AKT	PA164749171	207	0.865
NULL	J_Hematol_Oncol_2013_Jun_3_6_38.nxml.txt.nlp	23731980	SENT111	23	23	18	18	pertuzumab	aromatase		1588	0.865
NULL	Evid_Based_Complement_Alternat_Med_2011_Mar_1_2011_207034.nxml.txt.nlp	21423686	SENT52	10	10	30	30	clopidogrel	CYP2C19	PA449053	1557	0.865
NULL	J_Hematol_Oncol_2010_Mar_23_3_11.nxml.txt.nlp	20331897	SENT146	43	43	30	30	cisplatin	CRT	PA449014	811	0.865
NULL	Cell_Commun_Signal_2014_May_15_12_34.nxml.txt.nlp	24885272	SENT188	12	12	8	8	heparin	FGF2	PA449855	2247;2258	0.865
NULL	J_Mol_Med_2008_Sep_4_86(9)_1045-1056.nxml.txt.nlp	18600309	SENT9	8	8	20	20	salmeterol	IL-8	PA451300	3576	0.865
NULL	Cell_Death_Dis_2013_Sep_5_4(9)_e792.nxml.txt.nlp	24008736	SENT118	16	16	27	27	tamoxifen	WWOX	PA451581	51741	0.865
NULL	Anesthesiol_Res_Pract_2012_Nov_24_2012_921405.nxml.txt.nlp	22162685	SENT156	4	4	13	13	lidocaine	NPY	PA450226	4852	0.865
NULL	Br_J_Cancer_2011_Oct_11_105(8)_1123-1130.nxml.txt.nlp	21934690	SENT120	3	3	14	14	gemcitabine	TTP1	PA449748	55352	0.865
NULL	Case_Rep_Oncol_2013_Mar_29_6(1)_189-196.nxml.txt.nlp	23626560	SENT14	18	18	10	10	gefitinib	EGFR	PA131301952	1956	0.865
NULL	Oncotarget_2014_Sep_5_5(22)_11333-11344.nxml.txt.nlp	25226614	SENT217	25	25	12	12	celecoxib	HBD-2	PA448871	1673	0.865
NULL	Br_J_Cancer_2012_Oct_9_107(8)_1433-1441.nxml.txt.nlp	22929880	SENT19	19	19	5	5	sunitinib	PDGFRA	PA162372840	5156	0.865
NULL	Exp_Ther_Med_2012_Oct_3_4(4)_594-604.nxml.txt.nlp	23170111	SENT99	27	27	10	10	propranolol	p42	PA451145	5706;23552	0.865
NULL	Nat_Med_2013_Nov_27_19(11)_10_1038_nm_3364.nxml.txt.nlp	24162813	SENT193	23	23	19	19	imatinib	PTH	PA10804	5741	0.865
NULL	Diabetes_Care_2010_Jul_31_33(7)_1607-1609.nxml.txt.nlp	20357375	SENT68	9	9	6	6	sitagliptin	MCP-1	PA164748978	6347	0.865
NULL	Mol_Biol_Cell_2013_Sep_15_24(18)_2795-2806.nxml.txt.nlp	23904266	SENT97	23	23	35	35	hydroxyurea	EGF	PA449942	1950	0.865
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT57	14	14	3	3	mitomycin	ASC	PA450524	29108	0.865
NULL	Pharm_Pract_(Granada)_2011_Mar_15_Jan-Mar_9(1)_1-10.nxml.txt.nlp	25132883	SENT151	2	2	15	15	warfarin	SPAF	PA451906	166378	0.865
NULL	ISRN_Obstet_Gynecol_2011_Dec_1_2011_350813.nxml.txt.nlp	22191044	SENT67	28	28	31	31	tamoxifen	aromatase	PA451581	1588	0.865
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jul_18_65(Pt_8)_o1900.nxml.txt.nlp	21583590	SENT63	11	11	6	6	ethanol	mol	PA448073	90527	0.865
NULL	Libyan_J_Med_2007_Jun_1_2(2)_66-72.nxml.txt.nlp	21503256	SENT172	2	2	15	15	amantadine	DIP	PA448360	23151;1831	0.865
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT38	15	15	38	38	exenatide	GLP-1	PA164749238	100125288	0.865
NULL	Case_Rep_Oncol_2012_Jul_3_5(2)_339-346.nxml.txt.nlp	22807902	SENT53	12	12	22	22	cyclophosphamide	CHOP	PA449165	1649	0.865
NULL	Ther_Clin_Risk_Manag_2006_Jun_2(2)_129-158.nxml.txt.nlp	18360588	SENT147	1	1	3	3	voriconazole	CYP3A4	PA10233	1576	0.865
NULL	Toxins_(Basel)_2010_Jun_9_2(6)_1381-1398.nxml.txt.nlp	22069643	SENT106	26	26	4	4	tetracycline	OAT2	PA451640	10864	0.865
NULL	J_Mol_Signal_2008_Mar_31_3_8.nxml.txt.nlp	18377662	SENT122	20	20	15	15	pp2	KDR		3791	0.865
NULL	J_Hematol_Oncol_2013_Jul_18_6_53.nxml.txt.nlp	23866964	SENT57	9	9	15	15	temsirolimus	BECN1	PA164746890	8678	0.865
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Sep_12_65(Pt_10)_o2435.nxml.txt.nlp	21577891	SENT70	18	18	10	10	ethanol	mol	PA448073	90527	0.865
NULL	Ther_Clin_Risk_Manag_2006_Jun_2(2)_129-158.nxml.txt.nlp	18360588	SENT126	10	10	12	12	voriconazole	CYP3A4	PA10233	1576	0.865
NULL	Indian_J_Med_Paediatr_Oncol_2013_Oct-Dec_34(4)_330-332.nxml.txt.nlp	24604969	SENT44	6	6	26	26	cisplatin	ROS	PA449014	6098	0.865
NULL	Cell_Death_Dis_2012_Jun_21_3(6)_e330.nxml.txt.nlp	22717585	SENT253	6	6	15	15	simvastatin	RhoA	PA451363	387	0.865
NULL	Crit_Care_2007_Aug_14_11(4)_R87.nxml.txt.nlp	17697359	SENT176	3	3	12	12	aprotinin	IL-10	PA448472	3586	0.865
NULL	Mol_Cancer_2014_Apr_17_13_85.nxml.txt.nlp	24741998	SENT286	25	25	9	9	rituximab	CD40L	PA451261	959	0.865
NULL	Arthritis_Res_Ther_2008_Mar_17_10(2)_R33.nxml.txt.nlp	18346273	SENT133	12	12	8	8	infliximab	HMGB1	PA452639	3146	0.865
NULL	Protein_Cell_2014_Jun_19_5(6)_469-479.nxml.txt.nlp	24748116	SENT157	15	15	9	9	paclitaxel	EB1	PA450761	9167;22919;10982	0.865
NULL	Biomed_Res_Int_2013_Jun_13_2013_851428.nxml.txt.nlp	23841096	SENT228	16	16	23	23	l-serine	SHMT	PA451330	6470	0.865
NULL	J_Carcinog_2013_Mar_18_12_7.nxml.txt.nlp	23599689	SENT179	11	11	3	3	vemurafenib	BRAF	PA165946873	673	0.865
NULL	Oncol_Lett_2014_Nov_14_8(5)_2086-2092.nxml.txt.nlp	25295095	SENT130	28	28	5	5	gemcitabine	LKB1	PA449748	6794	0.865
NULL	Acta_Pharmacol_Sin_2014_Jun_4_35(6)_792-805.nxml.txt.nlp	24902787	SENT34	14	14	6	6	paroxetine	CYP2D6	PA450801	1565	0.865
NULL	Nat_Commun_2013_Aug_15_4_2130.nxml.txt.nlp	23945651	SENT681	7	7	18	18	etoposide	ATG5	PA449552	9474	0.865
NULL	Mol_Biol_Cell_2012_Mar_15_23(6)_996-1009.nxml.txt.nlp	22278744	SENT89	12	12	3	3	forskolin	14-3-3	PA146096022	10971	0.865
NULL	Oncoscience_2014_Jun_1_1(5)_383-391.nxml.txt.nlp	25594033	SENT85	28	28	13	13	cisplatin	BRCA1	PA449014	672	0.865
NULL	Chemother_Res_Pract_2011_Dec_1_2011_715469.nxml.txt.nlp	22312557	SENT122	10	10	6	6	cisplatin	p53	PA449014	7157	0.865
NULL	Evid_Based_Complement_Alternat_Med_2011_Aug_7_2011_271419.nxml.txt.nlp	21845199	SENT73	5	5	18	18	lipase	mol	PA450239	90527	0.865
NULL	Int_J_Mol_Sci_2014_Sep_22_15(9)_16848-16884.nxml.txt.nlp	25247581	SENT299	4	4	1	1	resveratrol	SIRT1		23411	0.865
NULL	Oncotarget_2011_Sep_9_2(9)_658-668.nxml.txt.nlp	21911919	SENT54	2	2	4	4	daunorubicin	HO-1	PA449212	3162	0.865
NULL	Oncogene_2010_Nov_11_29(45)_6051-6063.nxml.txt.nlp	20729921	SENT57	10	10	17	17	paclitaxel	CAR	PA450761	1525;6687;9970	0.865
NULL	Infection_2013_Sep_14_41(Suppl_2)_91-115.nxml.txt.nlp	24037688	SENT142	15	15	28	28	dapsone	G6PD	PA449211	2539	0.865
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT352	23	23	12	12	pp2	TFF3		7033	0.865
NULL	Adolesc_Health_Med_Ther_2014_Sep_26_5_171-182.nxml.txt.nlp	25298741	SENT209	12	12	1	1	aripiprazole	IMPACT	PA10026	55364	0.865
NULL	Case_Rep_Med_2012_Oct_17_2012_310104.nxml.txt.nlp	23193411	SENT35	20	20	16	16	cefotaxime	19A	PA448852	57823	0.865
NULL	Front_Immunol_2012_May_7_3_101.nxml.txt.nlp	22783250	SENT253	30	30	15	15	papain	IL-9	PA450778	3578	0.865
NULL	Protein_J_2012_Aug_5_31(6)_511-518.nxml.txt.nlp	22763563	SENT83	21	21	14	14	atorvastatin	MSR1	PA448500	4481	0.865
NULL	Chem_Cent_J_2012_Sep_20_6_105.nxml.txt.nlp	22995678	SENT94	4	4	17	17	moxifloxacin	C10	PA450555	113246	0.865
NULL	Cancer_Cell_Int_2009_Sep_10_9_25.nxml.txt.nlp	19744341	SENT118	33	33	4	4	glucosamine	STAT3	PA164747613	6774	0.865
NULL	Mol_Cancer_2009_Nov_10_8_99.nxml.txt.nlp	19903356	SENT74	7	7	0	0	imatinib	IGFBP3	PA10804	3486	0.865
NULL	Oncoimmunology_2013_Jan_1_2(1)_e23033.nxml.txt.nlp	23483678	SENT14	18	18	1	1	carboplatin	CD40	PA448803	958	0.865
NULL	Cardiol_Res_Pract_2011_Apr_3_2011_320983.nxml.txt.nlp	21559260	SENT17	9	9	11	11	paclitaxel	PES	PA450761	23481	0.865
NULL	Mol_Cancer_2009_Aug_25_8_66.nxml.txt.nlp	19706164	SENT36	18	18	2	2	celecoxib	COX	PA448871	1351	0.865
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT272	1	1	14	14	tacrolimus	SOCS3	PA451578	9021	0.865
NULL	Nat_Neurosci_2014_Jul_25_17(7)_943-952.nxml.txt.nlp	24859199	SENT282	16	16	36	36	doxycycline	P56	PA449415	8999	0.865
NULL	Nat_Med_2010_Jun_23_16(6)_671-677.nxml.txt.nlp	20495567	SENT227	26	26	8	8	sorafenib	ATF5	PA7000	22809	0.865
NULL	Gynecol_Oncol_Case_Rep_2013_Sep_21_6_42-44.nxml.txt.nlp	24371718	SENT100	9	9	28	28	tamoxifen	ATAC	PA451581	6375	0.865
NULL	Cancer_Cell_Int_2014_Jul_2_14_59.nxml.txt.nlp	25120382	SENT91	18	18	20	20	metformin	Met	PA450395	79811	0.865
NULL	Endocrinology_2014_Apr_17_155(4)_1453-1465.nxml.txt.nlp	24437488	SENT212	3	3	11	11	estradiol	IL-6	PA449503	3569	0.865
NULL	Asia_Pac_Allergy_2013_Oct_31_3(4)_266-280.nxml.txt.nlp	24260732	SENT104	22	22	14	14	amoxicillin	CD63	PA448406	967	0.865
NULL	Adv_Hematol_2012_Jun_19_2012_851674.nxml.txt.nlp	22778745	SENT157	15	15	9	9	sulindac	COX	PA451565	1351	0.865
NULL	Aging_(Albany_NY)_2011_Jan_18_3(1)_33-43.nxml.txt.nlp	21248371	SENT117	24	24	19	19	zinc	HIF-1	PA451956	29072	0.865
NULL	Oncol_Rep_2013_Apr_23_29(4)_1268-1274.nxml.txt.nlp	23354756	SENT92	16	16	8	8	epirubicin	SLC25A43	PA449476	203427	0.865
NULL	Environ_Health_2006_Aug_7_5_23.nxml.txt.nlp	16893447	SENT28	7	7	0	0	ethanol	CO2	PA448073	4513	0.865
NULL	BMB_Rep_2014_Apr_47(4)_221-226.nxml.txt.nlp	24286312	SENT131	6	6	28	28	nutlin-3	MDM2		4193	0.865
NULL	Case_Rep_Oncol_2010_Dec_17_3(3)_480-488.nxml.txt.nlp	21611102	SENT23	7	7	2	2	cisplatin	CTX	PA449014	1593	0.865
NULL	Toxins_(Basel)_2010_Nov_10_2(11)_2699-2737.nxml.txt.nlp	22069572	SENT1577	15	15	9	9	urokinase	IL-13	PA451836	3596	0.865
NULL	Indian_J_Anaesth_2009_Aug_53(4)_399-400.nxml.txt.nlp	20640200	SENT3	21	21	10	10	sevoflurane	NMB	PA451341	10457;4828	0.865
NULL	J_Headache_Pain_2003_Apr_4(1)_18-23.nxml.txt.nlp	NULL	SENT3	5	5	3	3	ketanserin	5-HT2A	PA131053734	3356	0.865
NULL	Clin_Pharmacokinet_2014_Sep_3_53(1)_1-16.nxml.txt.nlp	23999929	SENT269	38	38	7	7	rivaroxaban	CYP3A4	PA165958360	1576	0.865
NULL	J_Neuroinflammation_2011_Apr_8_8_28.nxml.txt.nlp	21473788	SENT33	5	5	13	13	thrombin	PAR-1	PA451674	2011;2149	0.865
NULL	J_Korean_Med_Sci_2011_Dec_29_26(12)_1556-1562.nxml.txt.nlp	22147991	SENT95	25	25	17	17	rituximab	CHOP	PA451261	1649	0.865
NULL	Mol_Biol_Cell_2012_Jul_1_23(13)_2583-2592.nxml.txt.nlp	22593214	SENT114	18	18	20	20	paclitaxel	GEF-H1	PA450761	9181	0.865
NULL	Chin_J_Cancer_2011_Sep_30(9)_638-644.nxml.txt.nlp	21880185	SENT22	11	11	4	4	valspodar	P-gp		5243	0.865
NULL	Arthritis_Res_Ther_2014_Apr_3_16(2)_R86.nxml.txt.nlp	24708674	SENT276	2	2	15	15	bosentan	Fli1	PA10034	2314	0.865
NULL	Breast_Cancer_Res_2014_Sep_9_16(5)_433.nxml.txt.nlp	25212966	SENT302	18	18	9	9	aprotinin	ILEI	PA448472	10447	0.865
NULL	Mol_Med_Rep_2014_Nov_5_10(5)_2334-2340.nxml.txt.nlp	25189202	SENT6	0	0	14	14	ceftazidime	CFP	PA448861	5199	0.865
NULL	EMBO_J_2013_Oct_16_32(20)_2751-2763.nxml.txt.nlp	24065129	SENT110	10	10	4	4	doxorubicin	IRF9	PA449412	10379	0.865
NULL	Cancers_(Basel)_2010_Jan_14_2(1)_1-19.nxml.txt.nlp	24281029	SENT1001	4	4	26	26	neratinib	San	PA165291472	80218	0.865
NULL	Breast_Cancer_Res_2012_Feb_14_14(1)_R30.nxml.txt.nlp	22333315	SENT38	31	31	6	6	indomethacin	IFN	PA449982	3439	0.865
NULL	J_Cardiothorac_Surg_2010_Apr_19_5_26.nxml.txt.nlp	20403156	SENT168	5	5	13	13	etomidate	RAI	PA164743987	10848;6050	0.865
NULL	Oncotarget_2014_Jun_26_5(14)_5510-5522.nxml.txt.nlp	24980816	SENT93	11	11	18	18	doxycycline	BSP	PA449415	3381	0.865
NULL	Evid_Based_Complement_Alternat_Med_2014_Oct_19_2014_628712.nxml.txt.nlp	25389442	SENT172	7	7	14	14	erlotinib	PTEN	PA134687924	5728	0.865
NULL	Diabetes_Care_2009_Oct_8_32(10)_1873-1879.nxml.txt.nlp	19587362	SENT107	35	35	16	16	irbesartan	ANG	PA450084	283	0.865
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1420-1426.nxml.txt.nlp	24056704	SENT37	5	5	11	11	ketoconazole	CYP3A	PA450146	1574	0.865
NULL	Arch_Drug_Inf_2008_Sep_1(2)_56-62.nxml.txt.nlp	19915709	SENT63	1	1	23	23	fentanyl	API	PA449599	5345	0.865
NULL	Mol_Vis_2012_Apr_11_18_901-908.nxml.txt.nlp	22539869	SENT161	6	6	32	32	curcumin	HO-1	PA151958596	3162	0.865
NULL	Leukemia_2014_Mar_13_28(3)_600-608.nxml.txt.nlp	24240203	SENT195	32	32	22	22	nutlin-3	MDM2		4193	0.865
NULL	Indian_J_Pharmacol_2008_Aug_40(4)_137-143.nxml.txt.nlp	20040945	SENT114	7	7	11	11	trastuzumab	HER2	PA451743	2064	0.865
NULL	Korean_J_Anesthesiol_2013_Jan_21_64(1)_47-53.nxml.txt.nlp	23372886	SENT10	12	12	22	22	bupivacaine	PTG	PA135057240	5507	0.864
NULL	J_Nanopart_Res_2013_Oct_9_15(11)_2026.nxml.txt.nlp	24307859	SENT133	22	22	31	31	benzaldehyde	mol	PA448571	90527	0.864
NULL	EMBO_J_2014_Jul_17_33(14)_1514-1526.nxml.txt.nlp	24872509	SENT351	14	14	26	26	zinc	CYC1	PA451956	1537	0.864
NULL	Adv_Hematol_2011_Apr_10_2011_960137.nxml.txt.nlp	21547266	SENT67	10	10	14	14	rituximab	CAD	PA451261	1677;790	0.864
NULL	Blood_Cancer_J_2012_Oct_19_2(10)_e95.nxml.txt.nlp	23085780	SENT194	30	30	23	23	imatinib	CML	PA10804	613	0.864
NULL	Amyloid_2014_Sep_11_21(3)_175-184.nxml.txt.nlp	24918964	SENT135	24	24	15	15	anakinra	p65	PA10799	5970	0.864
NULL	Oncotarget_2011_Dec_24_2(12)_896-917.nxml.txt.nlp	22203527	SENT140	19	19	27	27	metformin	AMPK	PA450395	5563	0.864
NULL	Int_J_Biol_Sci_2013_Mar_7_9(3)_279-288.nxml.txt.nlp	23493630	SENT125	23	23	16	16	tocilizumab	CD4	PA165292659	920	0.864
NULL	Neural_Dev_2009_Dec_2_4_42.nxml.txt.nlp	19954518	SENT107	24	24	1	1	paraformaldehyde	P18	PA450790	7975;10168	0.864
NULL	Ann_Med_Health_Sci_Res_2012_Jul-Dec_2(2)_191-198.nxml.txt.nlp	23439914	SENT166	9	9	1	1	biricodar	P-gp		5243	0.864
NULL	Clin_Med_Insights_Circ_Respir_Pulm_Med_2011_Oct_18_5_57-70.nxml.txt.nlp	22084617	SENT88	4	4	11	11	roflumilast	PDE4B	PA165948052	5142	0.864
NULL	Cancer_Immunol_Immunother_2013_Aug_27_62(10)_1637-1648.nxml.txt.nlp	23982484	SENT38	36	36	28	28	lenalidomide	IL-15	PA162363968	3600	0.864
NULL	Environ_Health_Perspect_2010_Jul_3_118(7)_936-942.nxml.txt.nlp	20199942	SENT133	24	24	19	19	arsenite	p53	PA452638	7157	0.864
NULL	Acta_Pharmacol_Sin_2012_May_16_33(5)_682-690.nxml.txt.nlp	22504904	SENT115	3	3	6	6	celecoxib	STAT3	PA448871	6774	0.864
NULL	Adv_Prev_Med_2012_Dec_5_2012_316871.nxml.txt.nlp	23304535	SENT38	5	5	3	3	buprenorphine	OST	PA448685	1650;23263	0.864
NULL	J_Headache_Pain_2013_Feb_21_14(Suppl_1)_P123.nxml.txt.nlp	NULL	SENT6	0	0	12	12	capsaicin	TRPV1	PA448776	7442	0.864
NULL	Crit_Care_2007_Feb_23_11(1)_116.nxml.txt.nlp	17331268	SENT30	23	23	10	10	nadh	CO2	PA164755085	4513	0.864
NULL	Open_Access_J_Urol_2011_May_10_3_69-82.nxml.txt.nlp	24198638	SENT67	16	16	33	33	phenprocoumon	UGT1A9	PA450921	54600	0.864
NULL	Exp_Ther_Med_2013_Jan_10_5(1)_287-291.nxml.txt.nlp	23251285	SENT20	2	2	14	14	aspirin	APS	PA448497	10603	0.864
NULL	CNS_Drugs_2013_Jun_26_27(9)_743-751.nxml.txt.nlp	23801529	SENT122	17	17	23	23	lisdexamfetamine	NNT	PA164748975	23530	0.864
NULL	Acta_Vet_Scand_2009_Dec_10_51(1)_51.nxml.txt.nlp	20003293	SENT133	15	15	11	11	genistein	aromatase	PA165109660	1588	0.864
NULL	Clin_Exp_Gastroenterol_2012_May_14_5_49-59.nxml.txt.nlp	22649281	SENT89	5	5	22	22	omeprazole	CYP3A4	PA450704	1576	0.864
NULL	Ecancermedicalscience_2010_Apr_30_4_ed6.nxml.txt.nlp	24966881	SENT8	33	33	26	26	trastuzumab	PTEN	PA451743	5728	0.864
NULL	Reprod_Biol_Endocrinol_2013_Feb_26_11_15.nxml.txt.nlp	23442442	SENT141	20	20	8	8	l-arginine	BAX	PA448478	581	0.864
NULL	Mol_Cancer_2012_Apr_26_11_26.nxml.txt.nlp	22537224	SENT115	19	19	4	4	geldanamycin	FANCF	PA152031327	2188	0.864
NULL	Kidney_Int_Suppl_(2011)_2013_Dec_27_3(4)_392-409.nxml.txt.nlp	NULL	SENT653	5	5	40	40	resveratrol	STZ		6484	0.864
NULL	Int_J_Cell_Biol_2014_Jan_22_2014_709828.nxml.txt.nlp	24578708	SENT92	1	1	19	19	choline	DAG	PA448976	1605	0.864
NULL	Int_J_Breast_Cancer_2011_Jan_20_2011_807380.nxml.txt.nlp	22332017	SENT6	10	10	15	15	clotrimazole	ABCC11	PA449057	85320	0.864
NULL	Pediatr_Nephrol_2007_Dec_7_22(12)_1983-1990.nxml.txt.nlp	17554565	SENT62	4	4	2	2	irbesartan	AT1	PA450084	9197;185	0.864
NULL	J_Cancer_2013_Nov_23_4(9)_736-754.nxml.txt.nlp	24312144	SENT106	6	6	30	30	cetuximab	EGFR	PA10040	1956	0.864
NULL	Mol_Brain_2014_Nov_19_7(1)_80.nxml.txt.nlp	NULL	SENT26	33	33	3	3	halothane	TWIK-1	PA449845	3775	0.864
NULL	Int_J_Mol_Sci_2012_Aug_10_13(8)_9971-9979.nxml.txt.nlp	22949842	SENT214	33	33	23	23	lipase	mol	PA450239	90527	0.864
NULL	Trials_2014_Dec_3_15(1)_474.nxml.txt.nlp	NULL	SENT150	31	31	25	25	sorafenib	SHARP	PA7000	23013	0.864
NULL	J_Cell_Mol_Med_2013_Sep_11_17(9)_1160-1172.nxml.txt.nlp	23844832	SENT156	10	10	3	3	erlotinib	EGFR	PA134687924	1956	0.864
NULL	J_Physiol_2009_Feb_15_587(Pt_4)_731-744.nxml.txt.nlp	19074966	SENT11	6	6	0	0	taurine	PAT1	PA451590	10513;206358	0.864
NULL	Neuro_Oncol_2010_Apr_27_12(4)_389-400.nxml.txt.nlp	20308316	SENT117	29	29	32	32	chloroquine	p53	PA448948	7157	0.864
NULL	Clinics_(Sao_Paulo)_2014_Jan_69(1)_68-74.nxml.txt.nlp	24473562	SENT97	27	27	15	15	nutlin-3	p38		10598;1432;7965	0.864
NULL	Cell_Death_Dis_2014_Mar_13_5(3)_e1118.nxml.txt.nlp	24625977	SENT290	13	13	27	27	etoposide	UBXN2A	PA449552	165324	0.864
NULL	Case_Rep_Oncol_Med_2014_Sep_14_2014_532924.nxml.txt.nlp	25298899	SENT23	4	4	17	17	trastuzumab	HER2	PA451743	2064	0.864
NULL	Open_Biol_2014_May_4(5)_140065.nxml.txt.nlp	24850914	SENT208	12	12	23	23	bortezomib	USP15	PA10252	9958	0.864
NULL	Diabetes_2011_Nov_17_60(11)_2691-2700.nxml.txt.nlp	21896928	SENT151	15	15	6	6	resveratrol	SIRT1		23411	0.864
NULL	Cancer_Biol_Med_2013_Mar_10(1)_16-21.nxml.txt.nlp	23691440	SENT8	22	22	6	6	methotrexate	Bcl-2	PA450428	596	0.864
NULL	Oncol_Lett_2014_Apr_22_7(4)_1191-1196.nxml.txt.nlp	24944691	SENT115	20	20	17	17	paclitaxel	PC-3	PA450761	692094	0.864
NULL	Diabetes_2013_Oct_17_62(10)_3500-3513.nxml.txt.nlp	23884882	SENT204	2	2	20	20	resveratrol	NKX6-1		4825	0.864
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Jun_25_3(6)_e120.nxml.txt.nlp	24964282	SENT44	19	19	16	16	ketoconazole	CYP3A4	PA450146	1576	0.864
NULL	Acta_Pharmacol_Sin_2010_May_26_31(5)_554-559.nxml.txt.nlp	20418892	SENT5	12	12	14	14	bleomycin	BLM	PA448645	641	0.864
NULL	Onco_Targets_Ther_2014_Mar_6_7_387-393.nxml.txt.nlp	24623981	SENT99	23	23	6	6	gefitinib	EGFR	PA131301952	1956	0.864
NULL	Cancer_Immunol_Immunother_2011_Jan_21_60(1)_75-85.nxml.txt.nlp	20857100	SENT164	10	10	5	5	fludarabine	IL-10	PA449655	3586	0.864
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_39-54.nxml.txt.nlp	19305787	SENT230	22	22	6	6	ethanol	DARPP-32	PA448073	84152	0.864
NULL	Nucleic_Acids_Res_2010_Sep_25_38(16)_5315-5326.nxml.txt.nlp	20421203	SENT290	39	39	27	27	doxycycline	RRN3	PA449415	54700	0.864
NULL	Br_J_Cancer_2010_Jul_13_103(2)_186-195.nxml.txt.nlp	20588277	SENT124	15	15	23	23	nutlin-3	p53		7157	0.864
NULL	Infect_Dis_Ther_2014_Jun_20_3(1)_1-17.nxml.txt.nlp	25134808	SENT163	18	18	20	20	atazanavir	ATV	PA10251	4683	0.864
NULL	Drug_Des_Devel_Ther_2014_Oct_31_8_2121-2128.nxml.txt.nlp	25382970	SENT80	5	5	12	12	curcumin	LC3	PA151958596	84557	0.864
NULL	Glycoconj_J_2012_Apr_14_29(2-3)_93-105.nxml.txt.nlp	22246380	SENT90	29	29	5	5	galactose	SNA	PA449725	6615	0.864
NULL	Eur_J_Endocrinol_2013_Apr_168(4)_557-564.nxml.txt.nlp	23345197	SENT165	11	11	16	16	diazoxide	ABCC8	PA449285	6833	0.864
NULL	Ecancermedicalscience_2009_Sep_24_3_153.nxml.txt.nlp	22276017	SENT53	26	26	19	19	oxaliplatin	ERCC1	PA131285527	2067	0.864
NULL	Chem_Res_Toxicol_2011_Aug_15_24(8)_1275-1282.nxml.txt.nlp	21749116	SENT291	14	14	10	10	geldanamycin	Hsp90	PA152031327	3320	0.864
NULL	BMJ_2013_Apr_15_346_f2109.nxml.txt.nlp	23587564	SENT106	24	24	5	5	dutasteride	NNT	PA164749300	23530	0.864
NULL	J_Invest_Dermatol_2014_Jan_134(1)_10_1038_jid_2013_372.nxml.txt.nlp	24352079	SENT42	9	9	30	30	verteporfin	BRAF	PA451871	673	0.864
NULL	Int_J_Surg_Oncol_2012_Jun_12_2012_862879.nxml.txt.nlp	22778941	SENT110	21	21	10	10	cisplatin	BIN1	PA449014	274	0.864
NULL	Front_Neurol_2014_Feb_18_5_17.nxml.txt.nlp	24600432	SENT107	10	10	5	5	levetiracetam	C17	PA450206	54360	0.864
NULL	Cell_Commun_Signal_2014_Sep_25_12(1)_61.nxml.txt.nlp	NULL	SENT411	32	32	3	3	doxycycline	PC-3	PA449415	692094	0.864
NULL	Lab_Invest_2009_Nov_7_89(11)_1275-1290.nxml.txt.nlp	19736547	SENT183	17	17	22	22	curcumin	LOX-1	PA151958596	4973	0.864
NULL	Front_Immunol_2012_Jan_12_2_98.nxml.txt.nlp	22566887	SENT199	10	10	7	7	tocilizumab	IL-6	PA165292659	3569	0.864
NULL	Environ_Health_Perspect_2010_Jul_3_118(7)_936-942.nxml.txt.nlp	20199942	SENT124	6	6	19	19	arsenite	NKRF	PA452638	55922	0.864
NULL	Cell_Commun_Signal_2013_Oct_1_11_73.nxml.txt.nlp	24083678	SENT149	17	17	28	28	sulindac	c-Jun	PA451565	3725	0.864
NULL	Mol_Cells_2014_Dec_31_37(12)_899a-906.nxml.txt.nlp	25431425	SENT38	7	7	18	18	curcumin	cPLA2	PA151958596	10524	0.864
NULL	Blood_Cancer_J_2013_Mar_1_3(3)_e103.nxml.txt.nlp	23454896	SENT94	21	21	13	13	nelfinavir	ATF6	PA450606	22926	0.864
NULL	ScientificWorldJournal_2013_Jun_24_2013_534807.nxml.txt.nlp	23864826	SENT84	25	25	5	5	diazepam	ANOVA	PA449283	4858	0.864
NULL	J_Ayurveda_Integr_Med_2010_Oct-Dec_1(4)_287-291.nxml.txt.nlp	21731376	SENT58	16	16	43	43	loperamide	castor	PA450262	54897	0.864
NULL	Oncotarget_2014_Aug_29_5(19)_8947-8958.nxml.txt.nlp	25333254	SENT33	5	5	32	32	plerixafor	CXCR4	PA165958410	7852	0.864
NULL	Clin_Med_Insights_Oncol_2011_Mar_16_5_35-43.nxml.txt.nlp	21499557	SENT46	9	9	15	15	trabectedin	p53	PA165958349	7157	0.864
NULL	J_Oncol_2009_Mar_10_2009_831626.nxml.txt.nlp	20300583	SENT68	21	21	14	14	cetuximab	KRAS	PA10040	3845	0.864
NULL	Breast_Cancer_Res_2012_May_23_14(3)_R84.nxml.txt.nlp	22621373	SENT4	0	0	8	8	hyaluronan	CD44	PA165958431	960	0.864
NULL	Indian_J_Med_Res_2013_May_137(5)_977-980.nxml.txt.nlp	23760386	SENT65	13	13	4	4	galantamine	ADP	PA449726	23038	0.864
NULL	Diabetes_2008_Sep_57(9)_2453-2460.nxml.txt.nlp	18567822	SENT285	34	34	8	8	fluoxetine	NEFA	PA449673	4925	0.864
NULL	Cent_European_J_Urol_2012_Dec_11_65(4)_227-229.nxml.txt.nlp	24578969	SENT31	13	13	34	34	gemcitabine	IFN	PA449748	3439	0.864
NULL	Cancer_Cell_Int_2011_Aug_19_11_29.nxml.txt.nlp	21854619	SENT249	31	31	15	15	etoposide	HDAC	PA449552	9734	0.864
NULL	Hum_Reprod_2014_Oct_10_29(10)_2302-2316.nxml.txt.nlp	25139174	SENT337	2	2	27	27	metformin	AMPK	PA450395	5563	0.864
NULL	Cell_Death_Dis_2013_Jun_13_4(6)_e669.nxml.txt.nlp	23764850	SENT116	3	3	20	20	choline	NNMT	PA448976	4837	0.864
NULL	Anesthesiol_Res_Pract_2011_Oct_27_2011_317410.nxml.txt.nlp	22110498	SENT94	9	9	25	25	isoflurane	IL-8	PA450106	3576	0.864
NULL	Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.nxml.txt.nlp	24736980	SENT181	26	26	10	10	rosuvastatin	OATP1B1	PA134308647	10599	0.864
NULL	Breast_Cancer_Res_Treat_2012_Jul_8_134(2)_617-624.nxml.txt.nlp	22678156	SENT133	4	4	22	22	trastuzumab	HER2	PA451743	2064	0.864
NULL	Clin_Ophthalmol_2012_Dec_13_6_1-4.nxml.txt.nlp	22259229	SENT70	25	25	30	30	travoprost	BAK	PA164781371	578	0.864
NULL	Biomed_Res_Int_2014_Feb_10_2014_708593.nxml.txt.nlp	24689050	SENT187	3	3	16	16	etoposide	TEM	PA449552	64102	0.864
NULL	Clin_Dev_Immunol_2013_Sep_12_2013_569751.nxml.txt.nlp	24151518	SENT24	15	15	23	23	ustekinumab	IL-23	PA166048654	51561	0.864
NULL	J_Gen_Physiol_2010_Apr_135(4)_333-353.nxml.txt.nlp	20231374	SENT1009	16	16	5	5	ivermectin	P2X4	PA450133	5025	0.864
NULL	Ann_Gen_Psychiatry_2013_Jan_24_12_1.nxml.txt.nlp	23347694	SENT60	8	8	2	2	buspirone	5-HT1A	PA448689	3350	0.864
NULL	Br_J_Cancer_2011_Jul_12_105(2)_255-262.nxml.txt.nlp	21694725	SENT167	6	6	16	16	panitumumab	EGFR	PA162373091	1956	0.864
NULL	Blood_Cancer_J_2014_May_30_4(5)_e215.nxml.txt.nlp	24879116	SENT110	23	23	18	18	doxycycline	BANK1	PA449415	55024	0.864
NULL	Mol_Cancer_2010_Aug_20_9_220.nxml.txt.nlp	20727180	SENT38	8	8	21	21	curcumin	p53	PA151958596	7157	0.864
NULL	Biochimie_2010_Nov_92(11)_1546-1567.nxml.txt.nlp	20615447	SENT212	14	14	9	9	heparin	KLK2	PA449855	3817	0.864
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT295	2	2	23	23	atorvastatin	PTEN	PA448500	5728	0.864
NULL	J_Cereb_Blood_Flow_Metab_2011_Oct_20_31(10)_2030-2040.nxml.txt.nlp	21505475	SENT205	18	18	23	23	cilostazol	Bcl-2	PA164746334	596	0.864
NULL	Cancer_Cell_Int_2011_Nov_2_11_39.nxml.txt.nlp	22047021	SENT417	27	27	19	19	cisplatin	REV1	PA449014	51455	0.864
NULL	Br_J_Cancer_2012_Jan_17_106(2)_348-357.nxml.txt.nlp	22146521	SENT47	6	6	3	3	doxycycline	TP53	PA449415	7157	0.864
NULL	Diabetes_Care_2010_Nov_33(11)_2484-2485.nxml.txt.nlp	20980428	SENT36	25	25	19	19	bevacizumab	VEGF-A	PA130232992	7422	0.864
NULL	Pain_2011_Aug_152(8)_1899-1908.nxml.txt.nlp	21600693	SENT538	37	37	20	20	cangrelor	ADP	PA165945763	23038	0.864
NULL	Oncoimmunology_2013_May_1_2(5)_e24436.nxml.txt.nlp	23762809	SENT45	44	44	32	32	bevacizumab	RPC2	PA130232992	55703	0.864
NULL	Crit_Care_2005_Nov_4_9(6)_561-565.nxml.txt.nlp	16356239	SENT115	2	2	20	20	propranolol	IL-2	PA451145	3558	0.864
NULL	Br_J_Pharmacol_2008_Sep_9_155(1)_127-137.nxml.txt.nlp	18536750	SENT81	15	15	6	6	piroxicam	IL-10	PA450985	3586	0.864
NULL	Indian_J_Anaesth_2013_Jan-Feb_57(1)_66-68.nxml.txt.nlp	23716770	SENT37	20	20	9	9	ephedrine	NIBP	PA449466	83696	0.864
NULL	Biomed_Res_Int_2014_May_13_2014_697935.nxml.txt.nlp	24949465	SENT65	43	43	26	26	risperidone	EGF	PA451257	1950	0.864
NULL	Cancer_Cell_Int_2010_Oct_25_10_40.nxml.txt.nlp	20974006	SENT161	19	19	7	7	paraformaldehyde	FADD	PA450790	8772	0.864
NULL	Scientifica_(Cairo)_2012_Aug_8_2012_424802.nxml.txt.nlp	24278691	SENT54	0	0	3	3	exenatide	GLP1	PA164749238	100125288;2641	0.864
NULL	Ann_Rheum_Dis_2008_Sep_11_68(7)_1146-1152.nxml.txt.nlp	18794178	SENT159	33	33	23	23	adalimumab	ACR	PA10004	49	0.864
NULL	Oxid_Med_Cell_Longev_2013_Nov_4_2013_564902.nxml.txt.nlp	24303086	SENT75	11	11	1	1	glucose	STZ	PA449773	6484	0.864
NULL	J_Int_Soc_Sports_Nutr_2012_Nov_15_9_49.nxml.txt.nlp	23153110	SENT264	28	28	34	34	l-tyrosine	SHOT	PA451822	6474	0.864
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_75-89.nxml.txt.nlp	17912638	SENT372	16	16	7	7	anastrozole	ATAC	PA448432	6375	0.864
NULL	Oncogene_2009_Apr_23_28(16)_1821-1832.nxml.txt.nlp	19305428	SENT70	3	3	16	16	erlotinib	EGFR	PA134687924	1956	0.864
NULL	J_Korean_Med_Sci_2009_Jan_29_24(Suppl_1)_S170-S175.nxml.txt.nlp	19194548	SENT79	28	28	7	7	cisplatin	EPO	PA449014	7076;8288;2056	0.864
NULL	Diabetes_Care_2010_Nov_3_33(11)_2349-2354.nxml.txt.nlp	20682680	SENT21	19	19	22	22	liraglutide	GLP-1	PA165958364	100125288	0.864
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT117	3	3	13	13	bevacizumab	VEGFR2	PA130232992	3791	0.864
NULL	Breast_Cancer_Res_2004_Nov_7_6(1)_39-52.nxml.txt.nlp	14680484	SENT90	27	27	9	9	fulvestrant	DES	PA164747170	1674	0.864
NULL	Clin_Pharmacol_2011_Jun_22_3_13-25.nxml.txt.nlp	22287853	SENT205	0	0	14	14	saxagliptin	CYP3A4	PA165958362	1576	0.864
NULL	Front_Oncol_2014_Jun_18_4_153.nxml.txt.nlp	24995158	SENT175	2	2	19	19	etoposide	p53	PA449552	7157	0.864
NULL	Iran_J_Pharm_Res_2013_Summer_12(3)_457-469.nxml.txt.nlp	24250652	SENT211	20	20	13	13	indomethacin	spatial	PA449982	219793	0.864
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT124	14	14	6	6	paclitaxel	SLK	PA450761	9748;2534	0.864
NULL	Oncogenesis_2012_Apr_2_1(4)_e5.nxml.txt.nlp	23552603	SENT117	0	0	14	14	celecoxib	p65	PA448871	5970	0.864
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Jul_23_6_103-113.nxml.txt.nlp	25114588	SENT180	17	17	25	25	capecitabine	PIK3CA	PA448771	5290	0.864
NULL	Arthritis_Res_Ther_2006_Mar_6_8(2)_R53.nxml.txt.nlp	16519795	SENT64	5	5	22	22	methotrexate	IL-10	PA450428	3586	0.864
NULL	Int_J_Mol_Sci_2012_Dec_5_13(12)_16658-16667.nxml.txt.nlp	23443124	SENT62	27	27	8	8	cisplatin	XRCC3	PA449014	7517	0.864
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT26	6	6	8	8	perifosine	DR5	PA165291471	8795	0.864
NULL	Oncotarget_2011_Mar_11_2(3)_135-164.nxml.txt.nlp	21411864	SENT238	0	0	4	4	sorafenib	VEGFR	PA7000	3791	0.864
NULL	Int_J_Biol_Sci_2013_Dec_17_10(1)_64-72.nxml.txt.nlp	24391452	SENT120	30	30	41	41	verapamil	5-HT2B	PA451868	3357	0.864
NULL	JAKSTAT_2013_Jan_1_2(1)_e23820.nxml.txt.nlp	24058799	SENT92	25	25	19	19	imiquimod	CXCL10	PA449972	3627	0.864
NULL	Ann_Indian_Acad_Neurol_2009_Oct-Dec_12(4)_273-282.nxml.txt.nlp	20182575	SENT184	20	20	8	8	natalizumab	IFN	PA164747191	3439	0.864
NULL	Ther_Clin_Risk_Manag_2006_Mar_2(1)_59-75.nxml.txt.nlp	18360582	SENT243	7	7	5	5	cisapride	CYP3A4	PA449011	1576	0.864
NULL	Vet_Res_2013_Dec_5_44(1)_119.nxml.txt.nlp	24308795	SENT84	42	42	11	11	nitrogen	CD11b	PA450643	3684	0.864
NULL	Oncogenesis_2012_Apr_2_1(4)_e5.nxml.txt.nlp	23552603	SENT234	22	22	28	28	ns-398	Bcl-2		596	0.864
NULL	Avicenna_J_Phytomed_2014_Jul-Aug_4(4)_260-266.nxml.txt.nlp	25068140	SENT101	8	8	15	15	hesperetin	flower	PA164742902	11094	0.864
NULL	Ther_Clin_Risk_Manag_2006_Sep_2(3)_235-249.nxml.txt.nlp	18360599	SENT299	25	25	37	37	alendronate	PTH	PA448082	5741	0.864
NULL	Pharmaceutics_2010_Jun_2_2(2)_258-274.nxml.txt.nlp	NULL	SENT24	11	11	7	7	risperidone	P-gp	PA451257	5243	0.864
NULL	Pharmaceutics_2011_Nov_18_3(4)_865-913.nxml.txt.nlp	24309312	SENT163	10	10	40	40	raltegravir	UGT1A1		54658	0.864
NULL	J_Cell_Biol_2002_Sep_16_158(6)_1051-1066.nxml.txt.nlp	12235123	SENT173	15	15	31	31	etoposide	DEDD	PA449552	9191	0.864
NULL	Oncotarget_2014_Oct_16_5(20)_9546-9563.nxml.txt.nlp	25337673	SENT115	13	13	3	3	erlotinib	AXL	PA134687924	558	0.864
NULL	Breast_Cancer_Res_2007_Aug_8_9(4)_R50.nxml.txt.nlp	17686159	SENT253	27	27	10	10	gefitinib	HRG	PA131301952	3084;3273	0.864
NULL	J_Cell_Mol_Med_2013_Oct_23_17(10)_1207-1217.nxml.txt.nlp	24106980	SENT138	16	16	25	25	docetaxel	KRAS	PA449383	3845	0.864
NULL	Case_Rep_Oncol_2013_Dec_12_6(3)_602-608.nxml.txt.nlp	24474924	SENT8	27	27	9	9	gemcitabine	EGFR	PA449748	1956	0.864
NULL	Eur_J_Med_Res_2014_Jun_24_19(1)_34.nxml.txt.nlp	24961604	SENT90	21	21	18	18	vincristine	BCL11A	PA451879	53335	0.864
NULL	Environ_Health_Perspect_2010_Jan_10_118(1)_108-115.nxml.txt.nlp	20056578	SENT21	22	22	32	32	arsenite	PTEN	PA452638	5728	0.864
NULL	Oncol_Lett_2013_Mar_8_5(3)_805-812.nxml.txt.nlp	23426281	SENT188	12	12	3	3	gemcitabine	survivin	PA449748	332	0.864
NULL	Int_J_Mol_Imaging_2011_Oct_26_2011_874585.nxml.txt.nlp	21490735	SENT98	28	28	7	7	docetaxel	FDG	PA449383	23583	0.864
NULL	Oncotarget_2014_Jun_5_5(21)_10382-10392.nxml.txt.nlp	25071015	SENT112	15	15	7	7	trastuzumab	p53	PA451743	7157	0.864
NULL	Mediators_Inflamm_2000_9(3-4)_155-160.nxml.txt.nlp	11132772	SENT10	14	14	9	9	collagenase	TNF-alpha	PA449107	7124	0.864
NULL	Mol_Vis_2012_Apr_11_18_901-908.nxml.txt.nlp	22539869	SENT85	11	11	0	0	curcumin	HO-1	PA151958596	3162	0.864
NULL	Cancers_(Basel)_2013_Apr_11_5(2)_418-429.nxml.txt.nlp	24216984	SENT114	27	27	30	30	irinotecan	HIF-1	PA450085	29072	0.864
NULL	Neural_Regen_Res_2012_Oct_25_7(30)_2377-2383.nxml.txt.nlp	25538763	SENT93	0	0	8	8	urokinase	PLAU	PA451836	5328	0.864
NULL	Exp_Lung_Res_2013_Oct_1_39(8)_336-348.nxml.txt.nlp	23919450	SENT104	23	23	19	19	argatroban	PAR-1	PA164745516	2011;2149	0.864
NULL	Eur_J_Neurosci_2007_Mar_1_25(6)_1619-1630.nxml.txt.nlp	17408433	SENT212	16	16	7	7	dextran	CB1	PA449261	1268	0.864
NULL	Breast_Cancer_Res_Treat_2013_Aug_20_141(1)_43-53.nxml.txt.nlp	23959396	SENT31	46	46	23	23	trastuzumab	HER3	PA451743	2065	0.864
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT94	40	40	37	37	imatinib	ABCG2	PA10804	9429	0.864
NULL	J_Mol_Signal_2010_May_10_5_4.nxml.txt.nlp	20459745	SENT121	7	7	3	3	cisplatin	p53	PA449014	7157	0.864
NULL	Neuroscience_2006_137(1-5)_83-92.nxml.txt.nlp	16289354	SENT47	10	10	6	6	isoflurane	ADX	PA450106	2230	0.864
NULL	Biochemistry_2012_Sep_25_51(38)_7456-7464.nxml.txt.nlp	22947085	SENT104	5	5	35	35	thyroglobulin	B12	PA164754910	7126;4709	0.864
NULL	Cell_Death_Dis_2014_Jul_10_5(7)_e1318.nxml.txt.nlp	25010984	SENT136	31	31	3	3	nutlin-3	RITA		55422;84934	0.864
NULL	Adv_Hematol_2012_Mar_8_2012_856341.nxml.txt.nlp	22496694	SENT139	29	29	26	26	ketoconazole	CYP3A4	PA450146	1576	0.864
NULL	Aging_(Albany_NY)_2009_Dec_31_1(12)_988-1007.nxml.txt.nlp	20157582	SENT211	23	23	16	16	paclitaxel	CTX	PA450761	1593	0.864
NULL	Breast_Cancer_Res_2011_Apr_1_13(2)_R35.nxml.txt.nlp	21457545	SENT175	16	16	6	6	erlotinib	EGFR	PA134687924	1956	0.864
NULL	J_Cereb_Blood_Flow_Metab_2012_Sep_20_32(9)_1699-1717.nxml.txt.nlp	22714048	SENT202	5	5	20	20	glibenclamide	spatial	PA449782	219793	0.864
NULL	Front_Neurosci_2011_Jul_26_5_92.nxml.txt.nlp	21845173	SENT59	21	21	28	28	naloxone	NRM	PA450586	11270	0.864
NULL	Exp_Ther_Med_2014_Nov_17_8(5)_1484-1488.nxml.txt.nlp	25289046	SENT53	10	10	2	2	cisplatin	ECRG2	PA449014	84651	0.864
NULL	Arthritis_Res_Ther_2013_Jul_9_15(4)_R73.nxml.txt.nlp	23837669	SENT262	3	3	18	18	colchicine	MSU	PA449092	593	0.864
NULL	Breast_Cancer_Res_2005_Jul_18_7(5)_187-189.nxml.txt.nlp	16168136	SENT25	11	11	4	4	tamoxifen	p38	PA451581	10598;1432;7965	0.864
NULL	Clin_Exp_Otorhinolaryngol_2011_Dec_15_4(4)_177-183.nxml.txt.nlp	22232712	SENT106	2	2	5	5	doxycycline	MUC5B	PA449415	727897	0.864
NULL	Asia_Pac_Allergy_2012_Oct_31_2(4)_280-282.nxml.txt.nlp	23130335	SENT8	30	30	14	14	gemifloxacin	ACE	PA10088	1636	0.864
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT71	19	19	5	5	capsaicin	p53	PA448776	7157	0.864
NULL	J_Mol_Signal_2010_May_10_5_4.nxml.txt.nlp	20459745	SENT197	17	17	12	12	cisplatin	p53	PA449014	7157	0.864
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jul_1_65(Pt_8)_o1724.nxml.txt.nlp	21583441	SENT82	39	39	11	11	ethanol	mol	PA448073	90527	0.864
NULL	J_Hematol_Oncol_2013_Jan_17_6_8.nxml.txt.nlp	23327547	SENT93	6	6	12	12	sulindac	PTEN	PA451565	5728	0.864
NULL	Cell_Death_Dis_2013_Jul_4_4(7)_e700.nxml.txt.nlp	23828563	SENT18	32	32	20	20	doxycycline	Math1	PA449415	474	0.864
NULL	Front_Chem_2014_Mar_14_2_12.nxml.txt.nlp	24790981	SENT175	17	17	28	28	curcumin	p300	PA151958596	2033	0.864
NULL	J_Korean_Med_Sci_2007_Jun_30_22(3)_557-559.nxml.txt.nlp	17596671	SENT20	9	9	30	30	warfarin	CYP2C9	PA451906	1559	0.864
NULL	Mol_Cancer_2014_Jun_30_13_160.nxml.txt.nlp	24976026	SENT152	2	2	9	9	bortezomib	AGR2	PA10252	10551	0.864
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT98	11	11	20	20	bevacizumab	VEGFR1	PA130232992	2321	0.864
NULL	Cancer_Metastasis_Rev_2014_Dec_28_33(1)_161-171.nxml.txt.nlp	24375389	SENT170	23	23	4	4	paclitaxel	CHFR	PA450761	55743	0.864
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_May_14_3(5)_e114.nxml.txt.nlp	24827872	SENT122	40	40	4	4	bortezomib	MYC	PA10252	4609	0.864
NULL	Blood_Cancer_J_2013_Jun_7_3(6)_e120.nxml.txt.nlp	23749045	SENT215	4	4	10	10	imatinib	JAG2	PA10804	3714	0.864
NULL	Blood_Cancer_J_2014_Mar_7_4(3)_e190.nxml.txt.nlp	24608734	SENT98	20	20	14	14	vincristine	CHOP	PA451879	1649	0.864
NULL	EMBO_Mol_Med_2011_Jul_3(7)_410-427.nxml.txt.nlp	21567994	SENT236	2	2	37	37	probucol	HMOX1	PA451107	3162	0.864
NULL	J_Gen_Physiol_2009_Sep_134(3)_243-258.nxml.txt.nlp	19720962	SENT307	21	21	11	11	capsaicin	TRPV1	PA448776	7442	0.864
NULL	BMB_Rep_2013_Aug_46(8)_410-415.nxml.txt.nlp	23977989	SENT103	21	21	9	9	curcumin	HO-1	PA151958596	3162	0.864
NULL	Mol_Biol_Rep_2013_Jul_11_40(7)_4211-4217.nxml.txt.nlp	23666051	SENT94	19	19	32	32	montelukast	OATP2B1	PA450546	11309	0.864
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Mar_31_68(Pt_4)_o1263.nxml.txt.nlp	22606192	SENT60	23	23	14	14	exemestane	aromatase	PA449563	1588	0.864
NULL	EMBO_Mol_Med_2013_Jul_30_5(7)_932-948.nxml.txt.nlp	23723167	SENT77	23	23	12	12	pilocarpine	MMP13	PA450962	4322	0.864
NULL	Aging_(Albany_NY)_2011_Jan_18_3(1)_33-43.nxml.txt.nlp	21248371	SENT129	11	11	36	36	zinc	HIPK2	PA451956	28996	0.864
NULL	Biomed_Res_Int_2013_Jun_9_2013_654354.nxml.txt.nlp	23841084	SENT31	30	30	25	25	gefitinib	EGFR	PA131301952	1956	0.864
NULL	Front_Microbiol_2014_Mar_14_5_99.nxml.txt.nlp	24672516	SENT91	5	5	10	10	voriconazole	TLR2	PA10233	7097	0.864
NULL	Int_J_Hypertens_2012_Mar_7_2012_842632.nxml.txt.nlp	22506100	SENT77	34	34	4	4	doxorubicin	HO-1	PA449412	3162	0.864
NULL	Diabetes_Care_2011_Jul_17_34(7)_1601-1604.nxml.txt.nlp	21709296	SENT87	13	13	6	6	ramipril	DREAM	PA451223	30818	0.864
NULL	Diabetes_2013_Sep_15_62(9)_3224-3231.nxml.txt.nlp	23545707	SENT159	18	18	27	27	losartan	ACR	PA450268	49	0.864
NULL	EMBO_Mol_Med_2012_Oct_30_4(10)_1087-1096.nxml.txt.nlp	22933245	SENT105	16	16	11	11	olaparib	BRCA2		675	0.864
NULL	Front_Oncol_2014_Jun_18_4_153.nxml.txt.nlp	24995158	SENT546	34	34	18	18	vinblastine	JNK	PA451877	5599	0.864
NULL	Nat_Cell_Biol_2014_May_6_16(5)_401-414.nxml.txt.nlp	24705551	SENT170	0	0	9	9	tamoxifen	EMB	PA451581	133418	0.864
NULL	Nucleic_Acids_Res_2011_Dec_2_39(22)_9549-9558.nxml.txt.nlp	21890893	SENT90	12	12	7	7	resveratrol	SIRT1		23411	0.864
NULL	Drugs_R_D_2014_Sep_31_14(3)_177-184.nxml.txt.nlp	25079671	SENT172	13	13	25	25	miglitol	MCP-1	PA164776726	6347	0.864
NULL	Mol_Cancer_2009_Apr_16_8_24.nxml.txt.nlp	19371427	SENT233	11	11	8	8	cisplatin	CHK1	PA449014	1111	0.864
NULL	Br_J_Cancer_2009_Jul_21_101(2)_269-277.nxml.txt.nlp	19603033	SENT156	13	13	23	23	cisplatin	p53	PA449014	7157	0.864
NULL	Int_J_Mol_Sci_2014_Mar_18_15(3)_4747-4779.nxml.txt.nlp	24646914	SENT372	13	13	6	6	plerixafor	CCR5	PA165958410	1234	0.864
NULL	Arthritis_Res_Ther_2011_Sep_21_13(5)_239.nxml.txt.nlp	21955617	SENT70	11	11	3	3	celecoxib	EP4	PA448871	5734	0.864
NULL	Breast_Cancer_Res_2004_Jul_29_6(5)_204-210.nxml.txt.nlp	15318926	SENT48	4	4	22	22	gefitinib	San	PA131301952	80218	0.864
NULL	Int_J_Biol_Sci_2013_Dec_17_10(1)_64-72.nxml.txt.nlp	24391452	SENT213	19	19	30	30	verapamil	5-HT2B	PA451868	3357	0.864
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT200	9	9	14	14	metformin	AKT	PA450395	207	0.864
NULL	Exp_Hematol_Oncol_2013_Oct_4_2_26.nxml.txt.nlp	24219920	SENT238	7	7	16	16	reserpine	ABCG2	PA451236	9429	0.864
NULL	Environ_Health_Perspect_1993_Aug_101(3)_208-213.nxml.txt.nlp	8404755	SENT3	18	18	20	20	diethylstilbestrol	DES	PA449307	1674	0.864
NULL	Breast_Cancer_Res_Treat_2013_Jun_5_139(3)_649-655.nxml.txt.nlp	23736997	SENT11	18	18	3	3	tamoxifen	CYP2C19	PA451581	1557	0.864
NULL	Oncogenesis_2012_Apr_2_1(4)_e5.nxml.txt.nlp	23552603	SENT234	20	20	32	32	celecoxib	MCL1	PA448871	4170	0.864
NULL	F1000_Biol_Rep_2011_Nov_1_3_23.nxml.txt.nlp	22065982	SENT140	6	6	20	20	probenecid	GLUT9	PA451106	11182	0.864
NULL	Nat_Commun_2013_4_2373.nxml.txt.nlp	23974433	SENT249	16	16	4	4	paraformaldehyde	CO2	PA450790	4513	0.864
NULL	Front_Neurosci_2015_Jan_6_8_437.nxml.txt.nlp	25610366	SENT15	11	11	17	17	pramipexole	spatial	PA164742949	219793	0.864
NULL	Adv_Hematol_2012_Nov_14_2012_735392.nxml.txt.nlp	22190945	SENT206	14	14	19	19	rituximab	CD4	PA451261	920	0.864
NULL	Oxid_Med_Cell_Longev_2013_Nov_10_2013_680414.nxml.txt.nlp	24319532	SENT194	29	29	20	20	minocycline	PARP-1	PA450519	25976	0.864
NULL	Curr_Neuropharmacol_2008_Jun_6(2)_151-163.nxml.txt.nlp	19305794	SENT123	12	12	35	35	indomethacin	EP1	PA449982	5731	0.864
NULL	Braz_J_Med_Biol_Res_2014_Oct_24_48(1)_65-76.nxml.txt.nlp	25493385	SENT160	18	18	25	25	l-arginine	AT1	PA448478	9197;185	0.864
NULL	Indian_Dermatol_Online_J_2013_Oct-Dec_4(4)_365-368.nxml.txt.nlp	24350028	SENT76	30	30	21	21	azithromycin	P-gp	PA448519	5243	0.864
NULL	Croat_Med_J_2012_Aug_53(4)_314-320.nxml.txt.nlp	22911523	SENT64	39	39	21	21	warfarin	CYP2C9	PA451906	1559	0.864
NULL	J_Vet_Med_Sci_2014_Jun_15_76(6)_813-817.nxml.txt.nlp	24531829	SENT94	7	7	11	11	doxycycline	DPT	PA449415	1805	0.864
NULL	Front_Syst_Neurosci_2014_Mar_10_8_27.nxml.txt.nlp	24653682	SENT134	40	40	46	46	baclofen	ANOVA	PA448533	4858	0.864
NULL	J_Int_Soc_Sports_Nutr_2008_Mar_4_5_8.nxml.txt.nlp	18318910	SENT141	7	7	18	18	lidocaine	hole	PA450226	80757	0.864
NULL	Case_Rep_Med_2012_Dec_3_2012_163173.nxml.txt.nlp	23326270	SENT103	24	24	12	12	bezafibrate	CPT2	PA162364313	1376	0.864
NULL	Nat_Commun_2014_Mar_24_5_3516.nxml.txt.nlp	24662724	SENT517	14	14	24	24	dextran	ADAM10	PA449261	102	0.864
NULL	Oncotarget_2014_Aug_29_5(18)_8052-8082.nxml.txt.nlp	25211298	SENT389	10	10	20	20	itraconazole	MRP1	PA450132	4437	0.864
NULL	Breast_Cancer_Res_2007_Dec_20_9(Suppl_2)_S13.nxml.txt.nlp	NULL	SENT55	13	13	10	10	tamoxifen	aromatase	PA451581	1588	0.864
NULL	J_Mol_Signal_2007_Feb_26_2_2.nxml.txt.nlp	17319972	SENT79	7	7	3	3	thrombin	LPA	PA451674	4018	0.864
NULL	Int_J_Anal_Chem_2012_Feb_8_2012_341260.nxml.txt.nlp	22505915	SENT48	30	30	21	21	ethanol	hole	PA448073	80757	0.864
NULL	Core_Evid_2011_Mar_17_6_31-42.nxml.txt.nlp	21468241	SENT95	20	20	17	17	ticagrelor	IPA	PA165374673	3160	0.864
NULL	Br_J_Cancer_2003_Mar_10_88(5)_788-795.nxml.txt.nlp	12618891	SENT128	10	10	5	5	bosentan	FasL	PA10034	356	0.864
NULL	Acta_Pharmacol_Sin_2010_Mar_22_31(3)_329-340.nxml.txt.nlp	20173759	SENT172	5	5	2	2	ethanol	AMPK	PA448073	5563	0.864
NULL	J_Adv_Pharm_Technol_Res_2012_Oct-Dec_3(4)_202-209.nxml.txt.nlp	23378940	SENT171	8	8	24	24	aprepitant	CYP3A4	PA164747039	1576	0.864
NULL	Mol_Cancer_2008_Jun_5_7_50.nxml.txt.nlp	18534018	SENT145	16	16	37	37	bortezomib	Mcl-1	PA10252	4170	0.864
NULL	Br_J_Cancer_2012_Apr_10_106(8)_1406-1414.nxml.txt.nlp	22491422	SENT5	34	34	7	7	cetuximab	KRAS	PA10040	3845	0.864
NULL	Patient_Prefer_Adherence_2010_Feb_4_4_11-16.nxml.txt.nlp	20165594	SENT71	7	7	22	22	duloxetine	BPI	PA10066	671	0.864
NULL	Br_J_Cancer_2010_Oct_12_103(8)_1297-1304.nxml.txt.nlp	20842126	SENT135	21	21	9	9	taurine	SMO	PA451590	6608;54498	0.864
NULL	J_Pain_Res_2014_Jun_23_7_353-357.nxml.txt.nlp	25018649	SENT32	12	12	27	27	lidocaine	LNP	PA450226	80856;51203	0.864
NULL	Open_Access_J_Urol_2010_Aug_4_2_125-141.nxml.txt.nlp	24198621	SENT117	6	6	24	24	sunitinib	CXCR3	PA162372840	2833	0.864
NULL	J_Headache_Pain_2008_Oct_8_9(5)_317-323.nxml.txt.nlp	18688693	SENT187	6	6	21	21	sumatriptan	c-fos	PA451566	2353	0.864
NULL	Diabetes_Care_2009_Nov_32(Suppl_2)_S223-S231.nxml.txt.nlp	19875556	SENT79	27	27	11	11	sitagliptin	GLP-1	PA164748978	100125288	0.864
NULL	Int_Semin_Surg_Oncol_2007_Feb_14_4_5.nxml.txt.nlp	17394628	SENT15	35	35	9	9	cyclophosphamide	MLH1	PA449165	4292	0.864
NULL	Cancer_Med_2013_Feb_3_2(1)_76-85.nxml.txt.nlp	24133630	SENT353	13	13	29	29	vemurafenib	ABCG2	PA165946873	9429	0.864
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_75-89.nxml.txt.nlp	17912638	SENT370	16	16	7	7	anastrozole	ATAC	PA448432	6375	0.864
NULL	Clin_Infect_Dis_2014_Apr_1_58(7)_928-936.nxml.txt.nlp	24399087	SENT98	18	18	27	27	ribavirin	API	PA451241	5345	0.864
NULL	Protein_Expr_Purif_2009_Aug_66(2)_181-184.nxml.txt.nlp	19269329	SENT53	24	24	34	34	thrombin	AMPK	PA451674	5563	0.864
NULL	Inflammation_2012_Apr_24_35(2)_566-573.nxml.txt.nlp	21607702	SENT20	22	22	7	7	dextran	VASP	PA449261	7408	0.864
NULL	J_Res_Med_Sci_2011_Jun_16(6)_814-820.nxml.txt.nlp	22091312	SENT66	2	2	19	19	cyclophosphamide	CHOP	PA449165	1649	0.864
NULL	Cancer_Cell_Int_2011_Nov_17_11_40.nxml.txt.nlp	22088142	SENT153	23	23	9	9	gefitinib	MRP2	PA131301952	100130958;57626;1244	0.864
NULL	Comp_Hepatol_2004_Jan_14_3(Suppl_1)_S37.nxml.txt.nlp	14960189	SENT104	8	8	25	25	thalidomide	TNF-alpha	PA451644	7124	0.864
NULL	Cancer_Cell_Int_2010_Oct_25_10_40.nxml.txt.nlp	20974006	SENT186	5	5	26	26	desipramine	DR5	PA449233	8795	0.864
NULL	Curr_Neuropharmacol_2012_Jun_10(2)_139-158.nxml.txt.nlp	23204984	SENT676	17	17	7	7	citalopram	STAR	PA449015	6770;2984	0.864
NULL	Anticancer_Agents_Med_Chem_2014_Oct_14(8)_1121-1127.nxml.txt.nlp	24893730	SENT141	6	6	29	29	exemestane	aromatase	PA449563	1588	0.864
NULL	J_Cell_Mol_Med_2014_Aug_1_18(8)_1599-1611.nxml.txt.nlp	24889822	SENT234	4	4	0	0	resveratrol	SIRT1		23411	0.864
NULL	Nat_Med_2013_Mar_3_19(3)_368-371.nxml.txt.nlp	23377281	SENT59	10	10	17	17	nelarabine	NT5C2	PA164752425	22978	0.864
NULL	Onco_Targets_Ther_2014_Sep_23_7_1653-1661.nxml.txt.nlp	25285015	SENT108	33	33	3	3	irinotecan	UGT1A1	PA450085	54658	0.864
NULL	J_Mol_Signal_2008_Dec_1_3_18.nxml.txt.nlp	19046439	SENT109	14	14	29	29	metformin	AMPK	PA450395	5563	0.864
NULL	Ann_Rehabil_Med_2012_Dec_28_36(6)_857-860.nxml.txt.nlp	23342320	SENT64	11	11	3	3	warfarin	CYP2C9	PA451906	1559	0.864
NULL	Protein_Cell_2014_Jun_19_5(6)_469-479.nxml.txt.nlp	24748116	SENT168	25	25	19	19	paclitaxel	EB1	PA450761	9167;22919;10982	0.864
NULL	Br_J_Cancer_2011_Mar_15_104(6)_899-902.nxml.txt.nlp	21343938	SENT63	27	27	17	17	tamoxifen	aromatase	PA451581	1588	0.864
NULL	Alcohol_Res_Health_2008_31(4)_310-339.nxml.txt.nlp	20729980	SENT133	10	10	6	6	rimonabant	CB1	PA152407999	1268	0.864
NULL	Acta_Naturae_2012_Jan-Mar_4(1)_82-85.nxml.txt.nlp	22708067	SENT43	0	0	11	11	gefitinib	p27	PA131301952	5715;10534	0.864
NULL	Onco_Targets_Ther_2014_Nov_28_7_2183-2195.nxml.txt.nlp	25506223	SENT45	14	14	28	28	doxorubicin	mol	PA449412	90527	0.864
NULL	Int_J_Biol_Sci_2014_Jan_11_10(2)_142-148.nxml.txt.nlp	24520212	SENT102	11	11	5	5	tamoxifen	WWOX	PA451581	51741	0.864
NULL	Oncoimmunology_2013_Oct_1_2(10)_e27025.nxml.txt.nlp	24353914	SENT179	19	19	28	28	docetaxel	CD25	PA449383	3669;3559	0.864
NULL	Cardiovasc_Diabetol_2013_Oct_17_12_150.nxml.txt.nlp	24134550	SENT117	18	18	8	8	metformin	activin	PA450395	83729	0.864
NULL	Front_Neurosci_2010_Jun_17_4_35.nxml.txt.nlp	20661455	SENT102	18	18	5	5	milnacipran	5-HT1A	PA164752812	3350	0.864
NULL	J_Mol_Med_2008_Sep_4_86(9)_1045-1056.nxml.txt.nlp	18600309	SENT249	8	8	15	15	salmeterol	IL-8	PA451300	3576	0.864
NULL	Cell_Death_Dis_2010_Oct_21_1(10)_e86.nxml.txt.nlp	21368859	SENT230	8	8	10	10	doxorubicin	TRAIL	PA449412	8743	0.864
NULL	Biologics_2012_Apr_12_6_89-99.nxml.txt.nlp	22532777	SENT3	14	14	25	25	denosumab	RANKL	PA166048634	8600	0.864
NULL	J_Breast_Cancer_2012_Mar_28_15(1)_71-78.nxml.txt.nlp	22493631	SENT105	21	21	12	12	trastuzumab	HER2	PA451743	2064	0.864
NULL	Br_J_Cancer_2012_May_22_106(11)_1779-1789.nxml.txt.nlp	22549178	SENT134	8	8	34	34	pertuzumab	HER3		2065	0.864
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT176	29	29	8	8	phenprocoumon	VKORC1	PA450921	79001	0.864
NULL	Br_J_Cancer_2010_Jan_19_102(2)_383-391.nxml.txt.nlp	20010943	SENT8	16	16	0	0	cisplatin	P31	PA449014	529	0.864
NULL	Front_Immunol_2013_May_15_4_116.nxml.txt.nlp	23720663	SENT15	9	9	37	37	cyclophosphamide	GITR	PA449165	8784	0.864
NULL	Cancer_Med_2014_Apr_27_3(2)_245-251.nxml.txt.nlp	24464861	SENT66	20	20	17	17	metformin	HIF1	PA450395	3091	0.864
NULL	Cancers_(Basel)_2014_Nov_25_6(4)_2313-2329.nxml.txt.nlp	25534569	SENT76	2	2	5	5	cabozantinib	PI3K	PA165906891	5290	0.864
NULL	Acta_Oncol_2014_Oct_9_53(10)_1347-1355.nxml.txt.nlp	24909504	SENT172	15	15	3	3	doxorubicin	TP53	PA449412	7157	0.864
NULL	Breast_Cancer_Res_2009_Oct_28_11(5)_211.nxml.txt.nlp	19889200	SENT150	20	20	7	7	exemestane	PTH	PA449563	5741	0.864
NULL	eLife_2014_Apr_24_3_e02419.nxml.txt.nlp	24843028	SENT196	9	9	2	2	tetracycline	IFT27	PA451640	11020	0.864
NULL	Brain_Sci_2013_Jun_19_3(2)_964-991.nxml.txt.nlp	24961433	SENT87	16	16	18	18	ethanol	ngn1	PA448073	4762	0.864
NULL	Evid_Based_Complement_Alternat_Med_2012_May_22_2012_601018.nxml.txt.nlp	22675385	SENT5	28	28	15	15	choline	TMT	PA448976	25823	0.864
NULL	Oncologist_2010_Jul_24_15(7)_665-672.nxml.txt.nlp	20576644	SENT119	33	33	21	21	trastuzumab	HER-2	PA451743	2064	0.864
NULL	Int_J_Chron_Obstruct_Pulmon_Dis_2006_Dec_1(4)_345-354.nxml.txt.nlp	18044091	SENT108	40	40	14	14	salmeterol	NNT	PA451300	23530	0.864
NULL	Int_J_Mol_Sci_2013_Apr_10_14(4)_7742-7756.nxml.txt.nlp	23574936	SENT167	29	29	20	20	carboplatin	ATX	PA448803	5168;23049	0.864
NULL	Clin_Dev_Immunol_2011_Sep_14_2011_267539.nxml.txt.nlp	21922022	SENT110	25	25	31	31	gemcitabine	survivin	PA449748	332	0.864
NULL	Breast_Cancer_Res_2005_Nov_11_7(6)_255-257.nxml.txt.nlp	16457700	SENT44	23	23	15	15	tamoxifen	aromatase	PA451581	1588	0.864
NULL	Comp_Hepatol_2005_Feb_8_4_2.nxml.txt.nlp	15701172	SENT217	1	1	16	16	ketoconazole	CYP3A	PA450146	1574	0.864
NULL	J_Hematol_Oncol_2008_Oct_23_1_19.nxml.txt.nlp	18947412	SENT112	39	39	12	12	alemtuzumab	CD34	PA164783958	947	0.864
NULL	Cell_Death_Dis_2014_Apr_17_5(4)_e1182.nxml.txt.nlp	24743737	SENT44	7	7	5	5	capsaicin	TRPV1	PA448776	7442	0.864
NULL	Cardiovasc_Diabetol_2010_Nov_5_9_72.nxml.txt.nlp	21054861	SENT110	0	0	14	14	isoproterenol	ANOVA	PA450121	4858	0.864
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jan_11_68(Pt_2)_o324-o325.nxml.txt.nlp	22346958	SENT70	18	18	6	6	ethanol	mol	PA448073	90527	0.864
NULL	Reprod_Biol_Endocrinol_2003_Jun_12_1_47.nxml.txt.nlp	12816542	SENT169	14	14	20	20	estradiol	MCM7	PA449503	4176	0.864
NULL	Br_J_Cancer_2011_Jun_28_105(1)_118-123.nxml.txt.nlp	21654685	SENT151	5	5	7	7	dasatinib	S100beta	PA162372878	6285	0.864
NULL	Clin_J_Gastroenterol_2012_Oct_22_5(6)_407-412.nxml.txt.nlp	24672586	SENT130	12	12	5	5	sorafenib	DLST	PA7000	1743	0.864
NULL	Biologics_2009_Sep_15_3_429-441.nxml.txt.nlp	19774210	SENT24	4	4	21	21	bevacizumab	IFL	PA130232992	3439	0.864
NULL	Antibiotics_(Basel)_2014_Jul_1_3(3)_285-316.nxml.txt.nlp	25364574	SENT181	19	19	2	2	ceftazidime	IMP-1	PA448861	10642	0.864
NULL	Cancer_Res_Treat_2014_Jul_15_46(3)_234-242.nxml.txt.nlp	25038758	SENT28	20	20	5	5	paclitaxel	P-gp	PA450761	5243	0.864
NULL	Cancer_Cell_Int_2014_Aug_16_14_74.nxml.txt.nlp	25187756	SENT120	21	21	32	32	cytarabine	CCN1	PA449177	3491	0.864
NULL	Crit_Care_2008_Jul_2_12(4)_163.nxml.txt.nlp	18620550	SENT14	24	24	29	29	hydrocortisone	RAI	PA449905	10848;6050	0.864
NULL	Cell_Death_Dis_2010_Oct_21_1(10)_e86.nxml.txt.nlp	21368859	SENT68	7	7	9	9	doxorubicin	TRAIL	PA449412	8743	0.864
NULL	Cancer_Cell_Int_2013_Jan_15_13_3.nxml.txt.nlp	23320839	SENT142	14	14	19	19	gemcitabine	MRP3	PA449748	8714	0.864
NULL	Clin_Interv_Aging_2013_Jan_18_8_47-59.nxml.txt.nlp	23355775	SENT86	4	4	29	29	lovastatin	CYP3A4	PA450272	1576	0.864
NULL	Breast_Cancer_Res_2005_Dec_7_7(1)_R156-R163.nxml.txt.nlp	15642164	SENT102	0	0	3	3	letrozole	aromatase	PA450196	1588	0.864
NULL	J_Carcinog_2012_Sep_13_11_15.nxml.txt.nlp	23230392	SENT127	32	32	19	19	bevacizumab	EGFR	PA130232992	1956	0.864
NULL	Int_J_Med_Sci_2014_Sep_6_11(11)_1185-1200.nxml.txt.nlp	25249787	SENT147	9	9	4	4	exenatide	GLP-1	PA164749238	100125288	0.864
NULL	Int_J_Mol_Sci_2014_Oct_27_15(11)_19458-19471.nxml.txt.nlp	25350111	SENT163	7	7	0	0	formaldehyde	CAT	PA449703	847	0.864
NULL	Diabetes_2013_Oct_17_62(10)_3500-3513.nxml.txt.nlp	23884882	SENT204	2	2	33	33	resveratrol	SIRT1		23411	0.864
NULL	FEBS_Open_Bio_2014_May_22_4_485-495.nxml.txt.nlp	24944883	SENT101	26	26	6	6	ethanol	CD44	PA448073	960	0.864
NULL	Br_J_Cancer_2012_May_8_106(10)_1587-1590.nxml.txt.nlp	22568998	SENT11	26	26	13	13	sunitinib	IFN	PA162372840	3439	0.864
NULL	Biosci_Rep_2014_Jan_31_34(1)_e00092.nxml.txt.nlp	24393046	SENT150	22	22	8	8	chloroquine	LAMP2	PA448948	3920	0.864
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT273	0	0	11	11	atorvastatin	AKT	PA448500	207	0.864
NULL	Biol_Open_2012_May_21_1(7)_629-639.nxml.txt.nlp	23125914	SENT7	44	44	33	33	doxycycline	PITX1	PA449415	5307	0.864
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT521	0	0	8	8	paliperidone	PRL	PA163518919	5617	0.864
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT245	12	12	36	36	heparin	FGF1	PA449855	2246	0.864
NULL	Oncotarget_2012_Nov_17_3(12)_1600-1614.nxml.txt.nlp	23307622	SENT6	23	23	9	9	gefitinib	ATG12	PA131301952	9140	0.864
NULL	Saudi_J_Anaesth_2013_Apr-Jun_7(2)_151-154.nxml.txt.nlp	23956714	SENT58	23	23	25	25	theophylline	NAC	PA451647	22861	0.864
NULL	J_Oncol_2009_Mar_24_2009_491985.nxml.txt.nlp	19325924	SENT105	3	3	19	19	genistein	CXCL12	PA165109660	6387	0.864
NULL	J_Korean_Med_Sci_2013_Feb_29_28(2)_308-314.nxml.txt.nlp	23399960	SENT137	24	24	10	10	gabapentin	IL-10	PA449720	3586	0.864
NULL	Biol_Open_2013_Aug_14_2(10)_1013-1021.nxml.txt.nlp	24167711	SENT176	9	9	22	22	ethanol	EVL	PA448073	51466	0.864
NULL	Arch_Med_Sci_2013_Feb_21_9(1)_146-150.nxml.txt.nlp	23516061	SENT128	12	12	20	20	berberine	spatial	PA165860812	219793	0.864
NULL	Breast_Cancer_Res_2010_Sep_29_12(5)_209.nxml.txt.nlp	21067536	SENT260	5	5	16	16	bevacizumab	HER2	PA130232992	2064	0.864
NULL	Virulence_2013_Oct_1_4(7)_646-653.nxml.txt.nlp	24045422	SENT111	4	4	16	16	l-lysine	CD4	PA450280	920	0.864
NULL	Br_J_Clin_Pharmacol_2013_Aug_23_76(2)_299-315.nxml.txt.nlp	23701319	SENT94	4	4	21	21	infliximab	IFN	PA452639	3439	0.864
NULL	Nat_Genet_2011_Feb_16_43(2)_147-152.nxml.txt.nlp	21240276	SENT73	25	25	3	3	camptothecin	SLX4	PA153590860	84464	0.864
NULL	Mol_Cancer_2010_Apr_21_9_83.nxml.txt.nlp	20409325	SENT214	23	23	4	4	doxycycline	MYCN	PA449415	4613	0.864
NULL	Br_J_Cancer_2009_Jan_27_100(2)_366-369.nxml.txt.nlp	19165200	SENT61	9	9	21	21	bortezomib	Apo2	PA10252	8797	0.864
NULL	Dement_Geriatr_Cogn_Dis_Extra_2014_Nov_15_4(3)_450-456.nxml.txt.nlp	25538729	SENT72	5	5	12	12	donepezil	APOE	PA449394	348	0.864
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R91.nxml.txt.nlp	22541814	SENT112	1	1	14	14	thrombin	HO-1	PA451674	3162	0.864
NULL	Cancer_Cell_Int_2013_Jun_26_13_63.nxml.txt.nlp	23800022	SENT140	34	34	38	38	genistein	MDM2	PA165109660	4193	0.864
NULL	J_Brachial_Plex_Peripher_Nerve_Inj_2008_Mar_19_3_8.nxml.txt.nlp	18353188	SENT9	22	22	30	30	capsaicin	SSeCKS	PA448776	9590	0.864
NULL	Curr_Cardiol_Rev_2009_May_5(2)_125-132.nxml.txt.nlp	20436853	SENT95	32	32	17	17	clopidogrel	ADP	PA449053	23038	0.863
NULL	Diabetes_2011_Nov_17_60(11)_2691-2700.nxml.txt.nlp	21896928	SENT239	10	10	1	1	resveratrol	SIRT1		23411	0.863
NULL	Nat_Med_2010_Jun_23_16(6)_671-677.nxml.txt.nlp	20495567	SENT219	0	0	10	10	sorafenib	ATF5	PA7000	22809	0.863
NULL	Onco_Targets_Ther_2014_May_23_7_799-805.nxml.txt.nlp	24920920	SENT160	12	12	6	6	pemetrexed	EGFR	PA10810	1956	0.863
NULL	Cancer_Cell_Int_2014_Jul_2_14_59.nxml.txt.nlp	25120382	SENT134	15	15	17	17	metformin	Met	PA450395	79811	0.863
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S18-S30.nxml.txt.nlp	20680104	SENT198	16	16	8	8	panitumumab	IFL	PA162373091	3439	0.863
NULL	Open_Access_J_Urol_2011_May_10_3_69-82.nxml.txt.nlp	24198638	SENT67	39	39	33	33	sorafenib	UGT1A9	PA7000	54600	0.863
NULL	Nucl_Recept_Signal_2006_Jul_7_4_e016.nxml.txt.nlp	16862222	SENT24	13	13	27	27	estradiol	CYP1A1	PA449503	1543	0.863
NULL	Behav_Brain_Funct_2010_Jul_9_6_41.nxml.txt.nlp	20615259	SENT31	0	0	16	16	methamphetamine	DTNBP1	PA450403	84062	0.863
NULL	Cell_Res_2014_Jul_9_24(7)_820-841.nxml.txt.nlp	24810299	SENT474	6	6	24	24	doxycycline	CD14	PA449415	929	0.863
NULL	Br_J_Pharmacol_2010_Sep_161(2)_288-307.nxml.txt.nlp	20735416	SENT245	23	23	28	28	halothane	TASK	PA449845	3777	0.863
NULL	Biomed_Eng_Online_2012_Sep_10_11_67.nxml.txt.nlp	22963645	SENT207	2	2	24	24	dextran	CO2	PA449261	4513	0.863
NULL	Nat_Commun_2013_Apr_9_4_1685.nxml.txt.nlp	23575689	SENT219	14	14	37	37	fluorescein	IL-4	PA164746009	3565	0.863
NULL	Front_Psychol_2013_Jan_7_3_601.nxml.txt.nlp	23308072	SENT180	7	7	20	20	estradiol	DYX1C1	PA449503	161582	0.863
NULL	Nucleic_Acids_Res_2012_Sep_8_40(16)_8059-8071.nxml.txt.nlp	22684629	SENT129	9	9	15	15	forskolin	U2AF65	PA146096022	11338	0.863
NULL	Open_Biochem_J_2011_Sep_23_5_45-51.nxml.txt.nlp	21966325	SENT30	3	3	7	7	indomethacin	PERK	PA449982	9451	0.863
NULL	Drugs_Context_2012_Nov_19_2012_212242.nxml.txt.nlp	24432031	SENT128	4	4	20	20	cisplatin	IFN	PA449014	3439	0.863
NULL	Oncotarget_2011_Sep_8_2(9)_728-736.nxml.txt.nlp	21908901	SENT78	13	13	29	29	pertuzumab	EGFR		1956	0.863
NULL	Neural_Plast_2012_Jul_8_2012_710943.nxml.txt.nlp	22830052	SENT234	22	22	31	31	betaine	UBE3A	PA448603	7337	0.863
NULL	Br_J_Cancer_2004_Mar_8_90(5)_1003-1010.nxml.txt.nlp	14997197	SENT4	14	14	28	28	leucovorin	IMPACT	PA450198	55364	0.863
NULL	Evid_Based_Complement_Alternat_Med_2011_Feb_14_2011_650263.nxml.txt.nlp	21799686	SENT13	9	9	5	5	atropine	IRS1	PA448505	3667	0.863
NULL	Mol_Cancer_2009_Apr_16_8_24.nxml.txt.nlp	19371427	SENT295	6	6	3	3	cisplatin	CHK1	PA449014	1111	0.863
NULL	ScientificWorldJournal_2012_May_2_2012_823493.nxml.txt.nlp	22629209	SENT131	26	26	2	2	yohimbine	5-HT2B	PA451946	3357	0.863
NULL	Mol_Cancer_2008_Jun_5_7_50.nxml.txt.nlp	18534018	SENT132	33	33	5	5	bortezomib	Mcl-1	PA10252	4170	0.863
NULL	Indian_J_Med_Res_2012_Sep_136(3)_391-403.nxml.txt.nlp	23041732	SENT193	27	27	33	33	sorafenib	HCC	PA7000	84668	0.863
NULL	Acta_Pharmacol_Sin_2010_Sep_16_31(9)_1075-1084.nxml.txt.nlp	20711221	SENT110	11	11	25	25	metformin	PI3K	PA450395	5290	0.863
NULL	J_Thromb_Haemost_2011_Oct_9(10)_2103-2105.nxml.txt.nlp	21812912	SENT28	35	35	43	43	ticagrelor	P2Y12	PA165374673	64805	0.863
NULL	Oncologist_2010_Nov_4_15(11)_1135-1146.nxml.txt.nlp	21051659	SENT157	3	3	31	31	sunitinib	IFN	PA162372840	3439	0.863
NULL	ACS_Appl_Mater_Interfaces_2013_Sep_11_5(17)_8537-8545.nxml.txt.nlp	23961698	SENT221	0	0	17	17	ketoprofen	NIP	PA450149	90527;10755	0.863
NULL	Clin_Neuroradiol_2012_Sep_18_22(3)_227-233.nxml.txt.nlp	22252289	SENT136	16	16	8	8	everolimus	DES	PA164746311	1674	0.863
NULL	Front_Neurosci_2014_Jan_31_8_6.nxml.txt.nlp	24550768	SENT77	4	4	1	1	capsaicin	TRPV1	PA448776	7442	0.863
NULL	J_Hematol_Oncol_2009_Jan_21_2_2.nxml.txt.nlp	19159467	SENT116	11	11	18	18	cetuximab	EGFR	PA10040	1956	0.863
NULL	Int_J_Biomed_Sci_2006_Dec_2(4)_333-336.nxml.txt.nlp	23675001	SENT64	17	17	29	29	telmisartan	NEFA	PA451605	4925	0.863
NULL	Breast_Cancer_Res_2004_Aug_5_6(5)_R601-R607.nxml.txt.nlp	15318941	SENT131	20	20	10	10	teniposide	p27	PA451611	5715;10534	0.863
NULL	Arthritis_Res_Ther_2013_Feb_27_15(1)_R35.nxml.txt.nlp	23446139	SENT6	34	34	18	18	cyclophosphamide	CD4	PA449165	920	0.863
NULL	Open_Biol_2014_May_4(5)_140065.nxml.txt.nlp	24850914	SENT185	24	24	12	12	bortezomib	ALK3	PA10252	657	0.863
NULL	Oncogenesis_2012_Apr_2_1(4)_e5.nxml.txt.nlp	23552603	SENT568	40	40	19	19	celecoxib	BIM	PA448871	10018	0.863
NULL	Oncotarget_2014_Sep_3_5(19)_9362-9381.nxml.txt.nlp	25313139	SENT152	20	20	18	18	metformin	AMPK	PA450395	5563	0.863
NULL	Oncotarget_2012_Nov_17_3(12)_1600-1614.nxml.txt.nlp	23307622	SENT74	16	16	6	6	trastuzumab	ATG12	PA451743	9140	0.863
NULL	Eur_Radiol_2011_Jun_3_21(6)_1188-1199.nxml.txt.nlp	21127880	SENT58	11	11	4	4	cyclophosphamide	NAC	PA449165	22861	0.863
NULL	J_Gastroenterol_2013_Jan_27_48(1)_22-30.nxml.txt.nlp	23104468	SENT118	20	20	11	11	ribavirin	IL28B	PA451241	282617	0.863
NULL	Leukemia_2014_Aug_4_28(8)_1573-1585.nxml.txt.nlp	24496300	SENT71	12	12	19	19	gemifloxacin	CYP1A2	PA10088	1544	0.863
NULL	Apoptosis_2012_Sep_30_17(9)_989-997.nxml.txt.nlp	22460505	SENT127	4	4	8	8	thioridazine	p53	PA451666	7157	0.863
NULL	Cancer_Cell_Int_2013_Apr_16_13_36.nxml.txt.nlp	23590596	SENT103	16	16	13	13	doxorubicin	TRAIL	PA449412	8743	0.863
NULL	Br_J_Cancer_2009_Jul_21_101(2)_269-277.nxml.txt.nlp	19603033	SENT124	7	7	4	4	cisplatin	XIAP	PA449014	331	0.863
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT246	0	0	16	16	warfarin	CYP2C9	PA451906	1559	0.863
NULL	J_Thromb_Haemost_2011_Oct_9(10)_2103-2105.nxml.txt.nlp	21812912	SENT38	9	9	12	12	ticagrelor	mol	PA165374673	90527	0.863
NULL	Cancer_Metab_2014_Aug_18_2_13.nxml.txt.nlp	25225614	SENT309	5	5	22	22	taurine	CDO1	PA451590	1036	0.863
NULL	Braz_J_Med_Biol_Res_2013_Aug_13_46(8)_650-658.nxml.txt.nlp	23969971	SENT137	15	15	2	2	cisplatin	survivin	PA449014	332	0.863
NULL	J_Oncol_2010_Apr_8_2010_785934.nxml.txt.nlp	20396391	SENT154	29	29	5	5	pemetrexed	MTHFR	PA10810	4524	0.863
NULL	J_Vet_Med_Sci_2013_Oct_30_75(10)_1303-1308.nxml.txt.nlp	23719750	SENT59	12	12	35	35	tropicamide	ERG	PA164749389	2078	0.863
NULL	Front_Oncol_2014_May_30_4_128.nxml.txt.nlp	24910845	SENT381	36	36	17	17	doxorubicin	TRAIL	PA449412	8743	0.863
NULL	Chem_Rev_2011_Oct_12_111(10)_5899-5921.nxml.txt.nlp	21923193	SENT536	17	17	11	11	suprofen	FAAH	PA451569	79152;2166	0.863
NULL	Arch_Plast_Surg_2014_Nov_3_41(6)_620-629.nxml.txt.nlp	25396172	SENT103	8	8	0	0	collagenase	IFN	PA449107	3439	0.863
NULL	Iran_J_Public_Health_2012_Jan_31_41(1)_37-44.nxml.txt.nlp	23113120	SENT161	11	11	2	2	imatinib	survivin	PA10804	332	0.863
NULL	Comp_Hepatol_2005_Feb_8_4_2.nxml.txt.nlp	15701172	SENT74	5	5	15	15	ketoconazole	CYP3A	PA450146	1574	0.863
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT140	24	24	16	16	atazanavir	ABCB1	PA10251	5243	0.863
NULL	EMBO_Mol_Med_2012_Jun_13_4(6)_515-527.nxml.txt.nlp	22416035	SENT45	39	39	15	15	olaparib	p53		7157	0.863
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT120	22	22	31	31	pertuzumab	AKT		207	0.863
NULL	BMJ_2010_Feb_8_340_c693.nxml.txt.nlp	20142325	SENT261	24	24	17	17	sertraline	CYP2D6	PA451333	1565	0.863
NULL	Oncotarget_2013_Nov_24_4(12)_2430-2438.nxml.txt.nlp	24280348	SENT145	31	31	21	21	gefitinib	STAT3	PA131301952	6774	0.863
NULL	J_Signal_Transduct_2011_Jun_7_2011_982879.nxml.txt.nlp	21776391	SENT168	17	17	25	25	gefitinib	Met	PA131301952	79811	0.863
NULL	J_Biol_Chem_2012_Apr_27_287(18)_14950-14959.nxml.txt.nlp	22393063	SENT120	21	21	1	1	heparin	mol	PA449855	90527	0.863
NULL	J_Invest_Dermatol_2012_May_16_132(5)_1435-1442.nxml.txt.nlp	22336948	SENT96	13	13	21	21	doxycycline	TLSP	PA449415	11012	0.863
NULL	BMJ_Open_2013_Dec_4_3(12)_e004157.nxml.txt.nlp	24309172	SENT133	10	10	29	29	fosfomycin	TMP	PA164748039	2012	0.863
NULL	Braz_J_Med_Biol_Res_2012_Mar_2_45(3)_250-255.nxml.txt.nlp	22370705	SENT94	3	3	12	12	atropine	ADM	PA448505	133	0.863
NULL	Oncol_Lett_2013_Aug_17_6(2)_295-305.nxml.txt.nlp	24137320	SENT306	10	10	29	29	tamoxifen	ATAC	PA451581	6375	0.863
NULL	Neuropsychopharmacology_2012_Feb_2_37(3)_641-650.nxml.txt.nlp	22048466	SENT165	4	4	6	6	varenicline	CHRNG	PA164781343	1146	0.863
NULL	Br_J_Cancer_2012_Nov_20_107(11)_1901-1907.nxml.txt.nlp	23079577	SENT170	6	6	12	12	tamoxifen	aromatase	PA451581	1588	0.863
NULL	Br_J_Cancer_2010_Oct_12_103(8)_1284-1291.nxml.txt.nlp	20859285	SENT13	14	14	5	5	tamoxifen	ERBB3	PA451581	2065	0.863
NULL	Mol_Cancer_2012_Sep_14_11_69.nxml.txt.nlp	22978347	SENT184	5	5	12	12	cisplatin	TRAP1	PA449014	9392;10131	0.863
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT258	13	13	23	23	trastuzumab	HRG	PA451743	3084;3273	0.863
NULL	Allergy_Asthma_Proc_2013_Sep-Oct_34(5)_446-452.nxml.txt.nlp	23998242	SENT94	15	15	25	25	omalizumab	ATPO	PA164752253	539	0.863
NULL	Gene_Regul_Syst_Bio_2014_Mar_4_8_63-73.nxml.txt.nlp	24634581	SENT231	0	0	3	3	minocycline	NANOS1	PA450519	340719	0.863
NULL	Antiviral_Res_2009_May_82(2)_A99-A109.nxml.txt.nlp	19176219	SENT180	5	5	11	11	lamivudine	OCT1	PA450163	5451;6580	0.863
NULL	Indian_J_Endocrinol_Metab_2013_Jan-Feb_17(1)_69-75.nxml.txt.nlp	23776855	SENT149	16	16	21	21	thyroglobulin	TPO	PA164754910	7066;7173	0.863
NULL	Oncoscience_2014_Mar_12_1(2)_158-166.nxml.txt.nlp	25594008	SENT130	19	19	12	12	dasatinib	ANXA1	PA162372878	301	0.863
NULL	Drug_Saf_2014_Feb_19_37(4)_201-211.nxml.txt.nlp	24550106	SENT163	3	3	15	15	fluvoxamine	CYP2C19	PA449690	1557	0.863
NULL	Extremophiles_2009_Sep_5_13(5)_769-783.nxml.txt.nlp	19579003	SENT102	7	7	20	20	lipase	mol	PA450239	90527	0.863
NULL	Front_Oncol_2013_Sep_25_3_256.nxml.txt.nlp	24093089	SENT312	39	39	24	24	paclitaxel	GM-CSF	PA450761	1437	0.863
NULL	FEBS_J_2009_Oct_276(19)_5571-5578.nxml.txt.nlp	19702827	SENT33	23	23	20	20	gefitinib	EGFR	PA131301952	1956	0.863
NULL	Acta_Orthop_2010_Apr_6_81(2)_263-267.nxml.txt.nlp	20148646	SENT166	16	16	28	28	taurine	CHOP	PA451590	1649	0.863
NULL	EMBO_Mol_Med_2013_Feb_9_5(2)_309-325.nxml.txt.nlp	23300147	SENT186	13	13	6	6	geldanamycin	HER2	PA152031327	2064	0.863
NULL	Breast_Cancer_Res_2010_Dec_1_12(6)_R103.nxml.txt.nlp	21122099	SENT168	21	21	9	9	tamoxifen	ESR1	PA451581	2099	0.863
NULL	Clin_Exp_Gastroenterol_2014_Feb_5_7_39-46.nxml.txt.nlp	24523594	SENT37	3	3	30	30	budesonide	CYP3A5	PA448681	1577	0.863
NULL	Mol_Cell_Biochem_2013_Jul_20_383(1-2)_95-102.nxml.txt.nlp	23873331	SENT46	5	5	2	2	resveratrol	CYP1		1594	0.863
NULL	J_Young_Pharm_2011_Apr-Jun_3(2)_90-96.nxml.txt.nlp	21731352	SENT226	7	7	32	32	ramipril	NMT	PA451223	4836	0.863
NULL	Br_J_Haematol_2009_Nov_2_147(3)_396-410.nxml.txt.nlp	19758122	SENT42	2	2	14	14	dasatinib	p53	PA162372878	7157	0.863
NULL	Brain_Behav_2011_Sep_1(1)_44-54.nxml.txt.nlp	22398980	SENT221	20	20	3	3	methysergide	LSD	PA164743265	1776	0.863
NULL	Cell_Mol_Life_Sci_2013_Aug_18_70(15)_2697-2712.nxml.txt.nlp	23076254	SENT253	15	15	28	28	metformin	AMPK	PA450395	5563	0.863
NULL	Cancer_Manag_Res_2012_Nov_9_4_383-395.nxml.txt.nlp	23204869	SENT231	10	10	3	3	carmustine	PC-3	PA448810	692094	0.863
NULL	Acta_Pharmacol_Sin_2013_Oct_7_34(10)_1317-1324.nxml.txt.nlp	23933652	SENT144	22	22	13	13	rosiglitazone	p65	PA451283	5970	0.863
NULL	Arthritis_Res_Ther_2014_Apr_15_16(2)_R95.nxml.txt.nlp	24735586	SENT202	34	34	8	8	methotrexate	CD19	PA450428	930	0.863
NULL	Int_J_Mol_Sci_2012_Aug_13_13(8)_10091-10112.nxml.txt.nlp	22949849	SENT169	38	38	22	22	lipase	PPL	PA450239	5493	0.863
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_P43.nxml.txt.nlp	NULL	SENT11	12	12	22	22	abacavir	HLA-B	PA448004	3106	0.863
NULL	Cancer_Microenviron_2013_Jan_22_6(3)_231-240.nxml.txt.nlp	23335094	SENT8	7	7	2	2	simvastatin	PC-3	PA451363	692094	0.863
NULL	Front_Neurosci_2014_Jan_31_8_6.nxml.txt.nlp	24550768	SENT214	12	12	23	23	capsaicin	TRPM3	PA448776	80036	0.863
NULL	Cancers_(Basel)_2014_Mar_26_6(2)_708-722.nxml.txt.nlp	24675568	SENT106	29	29	16	16	afatinib	STAT3	PA165981154	6774	0.863
NULL	Curr_Pharm_Des_2011_Feb_17(6)_578-590.nxml.txt.nlp	21391908	SENT177	2	2	14	14	nutlin-3	p53		7157	0.863
NULL	J_Adv_Pract_Oncol_2013_Jul_1_Jul-Aug_4(4)_238-250.nxml.txt.nlp	25032004	SENT162	0	0	12	12	imatinib	CYP3A4	PA10804	1576	0.863
NULL	Neural_Plast_2008_Nov_17_2008_401645.nxml.txt.nlp	19043593	SENT143	16	16	23	23	carbachol	gamma	PA448784	9913	0.863
NULL	Biochem_Res_Int_2011_Sep_15_2011_238601.nxml.txt.nlp	21152185	SENT52	18	18	25	25	hemin	HSF2	PA449849	3298	0.863
NULL	Sensors_(Basel)_2012_Nov_22_12(12)_16037-16045.nxml.txt.nlp	23443365	SENT90	6	6	18	18	rituximab	FGFR3	PA451261	2261	0.863
NULL	Clin_Dev_Immunol_2013_Oct_1_2013_764395.nxml.txt.nlp	24194774	SENT260	25	25	41	41	terbutaline	IFN	PA451616	3439	0.863
NULL	Br_J_Cancer_2010_Jun_8_102(12)_1707-1716.nxml.txt.nlp	20461078	SENT213	19	19	6	6	bortezomib	PARP	PA10252	142	0.863
NULL	Cell_Res_2013_Jul_21_23(7)_915-930.nxml.txt.nlp	23689279	SENT106	16	16	2	2	ethanol	ALDH2	PA448073	217	0.863
NULL	FASEB_J_2008_Sep_22(9)_3120-3128.nxml.txt.nlp	18495755	SENT55	11	11	40	40	ketamine	hole	PA450144	80757	0.863
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_91-103.nxml.txt.nlp	17912639	SENT102	14	14	5	5	letrozole	HER2	PA450196	2064	0.863
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_105-115.nxml.txt.nlp	17912640	SENT46	3	3	10	10	tamoxifen	HER2	PA451581	2064	0.863
NULL	J_Biomed_Opt_2013_Oct_19_18(10)_101315.nxml.txt.nlp	23958947	SENT42	31	31	20	20	dextran	NIR	PA449261	26155	0.863
NULL	Oncotarget_2014_Jun_8_5(13)_5040-5053.nxml.txt.nlp	24970815	SENT107	15	15	10	10	cisplatin	PUMA	PA449014	27113	0.863
NULL	Exp_Ther_Med_2013_Apr_18_5(4)_1219-1225.nxml.txt.nlp	23596493	SENT97	10	10	26	26	cyclophosphamide	DNMT1	PA449165	1786	0.863
NULL	Acta_Pharmacol_Sin_2012_Mar_27_33(3)_342-350.nxml.txt.nlp	22367283	SENT193	27	27	18	18	thrombin	PAR4	PA451674	9002;5074	0.863
NULL	Breast_Cancer_Res_2007_Sep_17_9(5)_R61.nxml.txt.nlp	17875215	SENT267	14	14	6	6	erlotinib	EGFR	PA134687924	1956	0.863
NULL	Br_J_Cancer_2002_Jan_21_86(2)_179-184.nxml.txt.nlp	11870502	SENT23	21	21	37	37	carmustine	IL-2	PA448810	3558	0.863
NULL	Springerplus_2014_Sep_11_3_516.nxml.txt.nlp	25279308	SENT7	0	0	11	11	ethanol	SHF	PA448073	90525	0.863
NULL	Biomed_Res_Int_2014_Jun_26_2014_161346.nxml.txt.nlp	25054130	SENT232	41	41	21	21	curcumin	STZ	PA151958596	6484	0.863
NULL	Acta_Pharmacol_Sin_2011_Jul_13_32(7)_967-972.nxml.txt.nlp	21666702	SENT23	29	29	18	18	losartan	P-gp	PA450268	5243	0.863
NULL	J_Res_Pharm_Pract_2013_Jan-Mar_2(1)_34-39.nxml.txt.nlp	24991602	SENT100	6	6	16	16	glucosamine	COX	PA164747613	1351	0.863
NULL	Case_Rep_Oncol_2011_Mar_12_4(1)_136-142.nxml.txt.nlp	21691572	SENT79	31	31	10	10	rituximab	CD4	PA451261	920	0.863
NULL	Indian_J_Pharmacol_2013_Mar-Apr_45(2)_121-125.nxml.txt.nlp	23716885	SENT38	0	0	6	6	fluvoxamine	CYP3A4	PA449690	1576	0.863
NULL	Br_J_Cancer_2010_Feb_16_102(4)_658-664.nxml.txt.nlp	20104222	SENT75	10	10	17	17	sunitinib	IFN	PA162372840	3439	0.863
NULL	Arthritis_Res_Ther_2012_Jul_12_14(4)_R163.nxml.txt.nlp	22784880	SENT127	13	13	20	20	leflunomide	CYP2C19	PA450192	1557	0.863
NULL	Oncol_Lett_2014_Mar_2_7(3)_791-796.nxml.txt.nlp	24527087	SENT8	0	0	21	21	imatinib	CD34	PA10804	947	0.863
NULL	Evid_Based_Complement_Alternat_Med_2012_Aug_25_2012_946867.nxml.txt.nlp	21876716	SENT121	2	2	17	17	oseltamivir	TRAIL	PA450721	8743	0.863
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Dec_16_66(Pt_1)_o157.nxml.txt.nlp	21580046	SENT72	16	16	13	13	benzaldehyde	mol	PA448571	90527	0.863
NULL	Pharmaceuticals_(Basel)_2013_Aug_2_6(8)_915-928.nxml.txt.nlp	24276376	SENT67	25	25	0	0	thrombin	PAR-1	PA451674	2011;2149	0.863
NULL	Cell_Death_Dis_2010_Oct_28_1(10)_e89.nxml.txt.nlp	21368862	SENT140	13	13	6	6	ethanol	SP6	PA448073	80320	0.863
NULL	Evid_Based_Complement_Alternat_Med_2014_Jul_20_2014_821569.nxml.txt.nlp	25140189	SENT273	3	3	1	1	metformin	AMPK	PA450395	5563	0.863
NULL	Oncoimmunology_2013_Oct_1_2(10)_e25771.nxml.txt.nlp	24286020	SENT37	33	33	19	19	cyclophosphamide	CD4	PA449165	920	0.863
NULL	Oncoimmunology_2012_Jul_1_1(4)_493-506.nxml.txt.nlp	22754768	SENT50	3	3	9	9	maraviroc	CCR5	PA164768835	1234	0.863
NULL	Diabetes_2013_Jun_17_62(6)_1843-1854.nxml.txt.nlp	23349486	SENT185	19	19	34	34	pioglitazone	CD14	PA450970	929	0.863
NULL	Ann_Nucl_Med_2013_May_12_27(4)_400-405.nxml.txt.nlp	23400394	SENT26	11	11	26	26	glucose	FDG	PA449773	23583	0.863
NULL	Br_J_Cancer_2013_Mar_19_108(5)_1079-1091.nxml.txt.nlp	23449353	SENT10	19	19	3	3	docetaxel	MIC-1	PA449383	29919;9518	0.863
NULL	Genet_Vaccines_Ther_2008_Feb_15_6_7.nxml.txt.nlp	18279512	SENT14	10	10	31	31	imiquimod	IL-5	PA449972	3567	0.863
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_16_2014_926087.nxml.txt.nlp	25478000	SENT101	5	5	13	13	atorvastatin	PCSK9	PA448500	255738	0.863
NULL	Br_J_Cancer_2006_Feb_13_94(3)_407-426.nxml.txt.nlp	16434996	SENT189	20	20	5	5	genistein	BRCA1	PA165109660	672	0.863
NULL	Arch_Drug_Inf_2009_Mar_2(1)_8-16.nxml.txt.nlp	19381336	SENT115	13	13	18	18	ritonavir	CYP3A4	PA451260	1576	0.863
NULL	Aging_(Albany_NY)_2012_Jul_22_4(7)_480-498.nxml.txt.nlp	22837425	SENT21	9	9	12	12	metformin	AMPK	PA450395	5563	0.863
NULL	Cancers_(Basel)_2010_Jan_14_2(1)_1-19.nxml.txt.nlp	24281029	SENT177	0	0	4	4	pertuzumab	HER2		2064	0.863
NULL	Clin_Med_Oncol_2008_Feb_9_2_47-61.nxml.txt.nlp	21892266	SENT257	15	15	11	11	chloroquine	EGF	PA448948	1950	0.863
NULL	Biomed_Res_Int_2014_Jan_2_2014_126586.nxml.txt.nlp	24527434	SENT123	9	9	25	25	trastuzumab	CD44	PA451743	960	0.863
NULL	J_Hematol_Oncol_2012_Apr_25_5(Suppl_1)_A1.nxml.txt.nlp	22738713	SENT7	0	0	6	6	trastuzumab	HER2	PA451743	2064	0.863
NULL	Arthritis_Res_Ther_2013_Sep_16_15(5)_R120.nxml.txt.nlp	24286160	SENT157	2	2	9	9	propylthiouracil	RHO	PA451156	6010	0.863
NULL	Br_J_Cancer_2009_Jan_27_100(2)_298-304.nxml.txt.nlp	19127259	SENT152	5	5	15	15	cetuximab	EGFR	PA10040	1956	0.863
NULL	Clin_Dev_Immunol_2007_Jan_20_2007_76396.nxml.txt.nlp	18317531	SENT6	35	35	13	13	sertraline	IL-4	PA451333	3565	0.863
NULL	Breast_Cancer_Res_2010_Jun_28_12(3)_R43.nxml.txt.nlp	20579400	SENT178	8	8	10	10	tamoxifen	MAPT	PA451581	4137	0.863
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT12	8	8	18	18	atorvastatin	RANK	PA448500	8792	0.863
NULL	Mol_Pain_2013_Jun_10_9_27.nxml.txt.nlp	23758830	SENT176	13	13	7	7	tetracaine	ASIC2a	PA451638	40	0.863
NULL	Cancer_Metastasis_Rev_2014_Dec_28_33(1)_161-171.nxml.txt.nlp	24375389	SENT169	12	12	4	4	paclitaxel	CHFR	PA450761	55743	0.863
NULL	Endocrinol_Metab_(Seoul)_2013_Dec_12_28(4)_262-274.nxml.txt.nlp	24396690	SENT58	24	24	1	1	liraglutide	GLP-1	PA165958364	100125288	0.863
NULL	Curr_Neuropharmacol_2013_Jul_11(4)_338-378.nxml.txt.nlp	24381528	SENT402	0	0	8	8	curcumin	PS1	PA151958596	5663	0.863
NULL	J_Mol_Med_(Berl)_2014_May_10_92(7)_709-722.nxml.txt.nlp	24811491	SENT273	13	13	6	6	cetuximab	IGF1R	PA10040	3480	0.863
NULL	Mycobiology_2008_Mar_31_36(1)_70-73.nxml.txt.nlp	23997612	SENT72	18	18	4	4	kanamycin	PDH	PA450137	54704	0.863
NULL	Mol_Cancer_2008_May_21_7_42.nxml.txt.nlp	18492291	SENT8	37	37	27	27	gefitinib	EGFR	PA131301952	1956	0.863
NULL	Surg_Today_2012_Jan_6_42(1)_8-28.nxml.txt.nlp	22139128	SENT239	6	6	11	11	cyclophosphamide	PSK	PA449165	9344	0.863
NULL	Curr_Med_Chem_2011_Jun_18(18)_2686-2714.nxml.txt.nlp	21649578	SENT214	31	31	22	22	gefitinib	KRAS	PA131301952	3845	0.863
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Mar_9_67(Pt_4)_o813.nxml.txt.nlp	21754099	SENT62	22	22	6	6	ethanol	mol	PA448073	90527	0.863
NULL	Cancer_Res_Treat_2011_Jun_30_43(2)_131-133.nxml.txt.nlp	21811430	SENT14	7	7	4	4	letrozole	aromatase	PA450196	1588	0.863
NULL	Diabetes_2013_Oct_17_62(10)_3547-3552.nxml.txt.nlp	23863812	SENT89	7	7	14	14	valsartan	ANOVA	PA451848	4858	0.863
NULL	EMBO_Mol_Med_2013_Mar_4_5(3)_366-383.nxml.txt.nlp	23381944	SENT225	0	0	16	16	paromomycin	ALKBH8	PA164784023	91801	0.863
NULL	J_Cell_Mol_Med_2013_Oct_23_17(10)_1207-1217.nxml.txt.nlp	24106980	SENT87	36	36	25	25	docetaxel	E2F3	PA449383	1871	0.863
NULL	Multidiscip_Respir_Med_2013_Jun_21_8(1)_40.nxml.txt.nlp	23800154	SENT5	12	12	15	15	creatine	Q10	PA164778930	27161	0.863
NULL	Eur_J_Nutr_2012_Aug_15_51(5)_513-528.nxml.txt.nlp	22584415	SENT287	19	19	28	28	etanercept	IL-6	PA449515	3569	0.863
NULL	Patient_Prefer_Adherence_2009_Nov_3_3_205-211.nxml.txt.nlp	19936163	SENT26	7	7	4	4	estradiol	ENG	PA449503	2022	0.863
NULL	Biomed_Res_Int_2014_Jan_29_2014_831845.nxml.txt.nlp	24605337	SENT110	39	39	23	23	bupivacaine	S6K1	PA135057240	6198	0.863
NULL	Front_Oncol_2014_Sep_11_4_245.nxml.txt.nlp	25309871	SENT43	20	20	24	24	thrombin	LPA	PA451674	4018	0.863
NULL	Mol_Med_Rep_2014_Oct_23_10(4)_1717-1724.nxml.txt.nlp	25069516	SENT166	3	3	9	9	resveratrol	PC-3		692094	0.863
NULL	Br_J_Cancer_1996_Jul_74(2)_187-193.nxml.txt.nlp	8688320	SENT13	24	24	7	7	daunorubicin	P-gp	PA449212	5243	0.863
NULL	Oncotarget_2013_Aug_21_4(9)_1484-1495.nxml.txt.nlp	23986086	SENT14	42	42	5	5	metformin	PIK3CA	PA450395	5290	0.863
NULL	J_Korean_Med_Sci_2014_Jan_26_29(1)_53-60.nxml.txt.nlp	24431906	SENT169	27	27	21	21	vincristine	CHOP	PA451879	1649	0.863
NULL	Mol_Cancer_2010_Apr_23_9_87.nxml.txt.nlp	20416058	SENT6	3	3	16	16	doxorubicin	TRAIL	PA449412	8743	0.863
NULL	Iran_J_Basic_Med_Sci_2011_Sep-Oct_14(5)_414-421.nxml.txt.nlp	23493814	SENT17	3	3	20	20	doxepin	CB1	PA449409	1268	0.863
NULL	Chin_J_Cancer_2011_Oct_30(10)_701-711.nxml.txt.nlp	21959047	SENT128	24	24	3	3	cetuximab	EGFR	PA10040	1956	0.863
NULL	Cardiol_Ther_2013_Jun_1_2(1)_111-124.nxml.txt.nlp	25135294	SENT121	10	10	14	14	dabigatran	P-gp		5243	0.863
NULL	Cancer_Cell_Int_2011_Aug_19_11_29.nxml.txt.nlp	21854619	SENT139	4	4	10	10	cisplatin	BRCA1	PA449014	672	0.863
NULL	EMBO_J_2008_Mar_19_27(6)_852-864.nxml.txt.nlp	18309296	SENT66	6	6	35	35	nutlin-3	p53		7157	0.863
NULL	Br_J_Cancer_2012_Feb_28_106(5)_876-882.nxml.txt.nlp	22333597	SENT101	0	0	6	6	everolimus	4E-BP1	PA164746311	1978	0.863
NULL	BMB_Rep_2014_May_47(5)_268-273.nxml.txt.nlp	24286315	SENT5	7	7	17	17	trastuzumab	PTEN	PA451743	5728	0.863
NULL	Blood_Res_2014_Dec_23_49(4)_253-258.nxml.txt.nlp	25548759	SENT78	20	20	12	12	melphalan	CHOP	PA450354	1649	0.863
NULL	Mol_Cancer_2010_May_19_9_112.nxml.txt.nlp	20482842	SENT12	6	6	21	21	imatinib	p65	PA10804	5970	0.863
NULL	Front_Neurosci_2014_Dec_9_8_407.nxml.txt.nlp	25538557	SENT62	41	41	2	2	nadh	RGM	PA164755085	56963	0.863
NULL	Nat_Genet_2011_Oct_23_43(12)_1232-1236.nxml.txt.nlp	22019782	SENT83	28	28	13	13	heparin	CFH	PA449855	3075	0.863
NULL	Clin_Dev_Immunol_2013_Oct_1_2013_764395.nxml.txt.nlp	24194774	SENT260	25	25	29	29	terbutaline	IFN	PA451616	3439	0.863
NULL	Int_J_Environ_Res_Public_Health_2010_May_28_7(5)_2033-2044.nxml.txt.nlp	20623009	SENT168	11	11	3	3	hydroxyurea	AP-1	PA449942	2353;3727;2354;3725	0.863
NULL	J_Biomed_Biotechnol_2010_Jun_8_2010_757301.nxml.txt.nlp	20625414	SENT113	23	23	39	39	ethanol	SP5	PA448073	389058	0.863
NULL	Mol_Cell_Proteomics_2012_Sep_10_11(9)_596-604.nxml.txt.nlp	22580590	SENT59	24	24	16	16	kanamycin	San	PA450137	80218	0.863
NULL	Breast_Cancer_(Auckl)_2012_Nov_19_6_191-207.nxml.txt.nlp	23226023	SENT236	3	3	5	5	trastuzumab	HER2	PA451743	2064	0.863
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT367	7	7	11	11	pp2	CDH1		51343;999	0.863
NULL	Front_Pharmacol_2014_Oct_31_5_231.nxml.txt.nlp	25400580	SENT4408	12	12	20	20	gemcitabine	BTC	PA449748	685	0.863
NULL	J_Exp_Clin_Cancer_Res_2009_May_27_28(1)_68.nxml.txt.nlp	19470182	SENT195	17	17	6	6	cisplatin	p53	PA449014	7157	0.863
NULL	Adv_Biol_Regul_2014_Jan_19_0_197-206.nxml.txt.nlp	24103483	SENT77	26	26	42	42	lipase	PLD1	PA450239	5337	0.863
NULL	J_Psychopharmacol_2010_Jan_24(1)_27-38.nxml.txt.nlp	19204064	SENT18	11	11	3	3	cocaine	NK1R	PA449072	6869	0.863
NULL	Oncotarget_2012_Mar_31_3(3)_236-260.nxml.txt.nlp	22470194	SENT247	2	2	5	5	celecoxib	IL-6	PA448871	3569	0.863
NULL	Eur_J_Clin_Pharmacol_2010_Nov_29_66(11)_1131-1136.nxml.txt.nlp	20669013	SENT118	17	17	9	9	voriconazole	CYP2C19	PA10233	1557	0.863
NULL	Arthritis_Res_Ther_2010_Apr_29_12(2)_R73.nxml.txt.nlp	20429888	SENT282	6	6	22	22	bortezomib	SP1	PA10252	6667	0.863
NULL	Br_J_Cancer_2013_Nov_26_109(11)_2864-2874.nxml.txt.nlp	24201754	SENT40	10	10	31	31	gefitinib	OED	PA131301952	4961	0.863
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1013.nxml.txt.nlp	24457957	SENT118	17	17	20	20	bortezomib	NOXA	PA10252	5366	0.863
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT156	16	16	21	21	pertuzumab	HER3		2065	0.863
NULL	ScientificWorldJournal_2013_Feb_3_2013_593267.nxml.txt.nlp	23431256	SENT132	0	0	8	8	chloramphenicol	MEF2C	PA448927	4208	0.863
NULL	Contemp_Oncol_(Pozn)_2012_Jan_4_16(6)_461-466.nxml.txt.nlp	23788931	SENT76	35	35	22	22	doxorubicin	CTX	PA449412	1593	0.863
NULL	Ann_Oncol_2011_Mar_8_22(3)_503-514.nxml.txt.nlp	20616198	SENT67	31	31	15	15	exemestane	aromatase	PA449563	1588	0.863
NULL	Indian_J_Pharm_Sci_2014_Mar-Apr_76(2)_163-166.nxml.txt.nlp	24843190	SENT28	37	37	32	32	ethanol	mol	PA448073	90527	0.863
NULL	Lab_Invest_2014_May_10_94(5)_503-516.nxml.txt.nlp	24614199	SENT247	1	1	11	11	curcumin	NAC	PA151958596	22861	0.863
NULL	Front_Pharmacol_2014_Nov_21_5_257.nxml.txt.nlp	25484865	SENT247	10	10	8	8	imatinib	ABCG2	PA10804	9429	0.863
NULL	Breast_Cancer_Res_2010_Mar_5_12(2)_R16.nxml.txt.nlp	20205716	SENT234	28	28	7	7	lovastatin	E2F1	PA450272	1869	0.863
NULL	J_Vis_Exp_2014_Jun_13_(88)_50668.nxml.txt.nlp	24962356	SENT303	27	27	17	17	doxorubicin	EGFR	PA449412	1956	0.863
NULL	Front_Neurol_2011_Dec_16_2_72.nxml.txt.nlp	22203815	SENT190	5	5	27	27	protamine	CD4	PA10366	920	0.863
NULL	Oncotarget_2014_Aug_6_5(17)_7870-7885.nxml.txt.nlp	25149540	SENT96	10	10	17	17	cisplatin	LLC1	PA449014	128602	0.863
NULL	Arthritis_Res_Ther_2005_Mar_16_7(Suppl_2)_S21-S25.nxml.txt.nlp	15833145	SENT93	27	27	17	17	abatacept	ACR	PA164747080	49	0.863
NULL	Br_J_Cancer_2012_Sep_4_107(6)_956-960.nxml.txt.nlp	22892393	SENT26	0	0	4	4	trastuzumab	HER2	PA451743	2064	0.863
NULL	Leukemia_2013_Jan_11_27(1)_32-40.nxml.txt.nlp	22781593	SENT231	5	5	12	12	ponatinib	FGFR1	PA165980594	2260	0.863
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT138	6	6	9	9	metformin	HIF-1	PA450395	29072	0.863
NULL	J_Asthma_Allergy_2008_Sep_19_1_19-29.nxml.txt.nlp	21436982	SENT110	43	43	10	10	fexofenadine	IL-8	PA449621	3576	0.863
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT47	29	29	21	21	cisplatin	TRAIL	PA449014	8743	0.863
NULL	Breast_Cancer_Res_2012_Feb_14_14(1)_R30.nxml.txt.nlp	22333315	SENT21	11	11	7	7	indomethacin	COX	PA449982	1351	0.863
NULL	J_Cancer_2012_Aug_24_3_354-361.nxml.txt.nlp	22962562	SENT88	13	13	28	28	chlorambucil	p53	PA448926	7157	0.863
NULL	Case_Rep_Gastroenterol_2012_May_23_6(2)_285-292.nxml.txt.nlp	22754488	SENT18	18	18	6	6	fluorescein	CLE	PA164746009	51637	0.863
NULL	J_Hematol_Oncol_2008_Oct_23_1_19.nxml.txt.nlp	18947412	SENT112	39	39	18	18	alemtuzumab	CD34	PA164783958	947	0.863
NULL	Curr_Neuropharmacol_2008_Sep_6(3)_215-234.nxml.txt.nlp	19506722	SENT238	3	3	27	27	fluoxetine	5-HTT	PA449673	6532	0.863
NULL	Int_J_Endocrinol_2011_Mar_6_2011_415719.nxml.txt.nlp	21461394	SENT92	4	4	16	16	cinacalcet	PTH	PA164776671	5741	0.863
NULL	Breast_Cancer_Res_2010_Mar_5_12(2)_R16.nxml.txt.nlp	20205716	SENT185	24	24	7	7	lovastatin	G3BP1	PA450272	10146	0.863
NULL	J_Immunol_Res_2014_May_8_2014_565320.nxml.txt.nlp	24901010	SENT66	21	21	30	30	lamotrigine	HLA-B	PA450164	3106	0.863
NULL	Cancers_(Basel)_2012_Feb_22_4(1)_193-217.nxml.txt.nlp	24213236	SENT184	15	15	4	4	trastuzumab	HER-2	PA451743	2064	0.863
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT247	44	44	38	38	doxorubicin	B7-H1	PA449412	29126	0.863
NULL	Front_Neurosci_2014_Aug_28_8_271.nxml.txt.nlp	25221469	SENT947	4	4	1	1	fasudil	Rho	PA165946121	29984	0.863
NULL	Proteome_Sci_2009_May_28_7_20.nxml.txt.nlp	19476632	SENT188	1	1	17	17	galactose	IDH3A	PA449725	3419	0.863
NULL	Curr_Neuropharmacol_2011_Dec_9(4)_530-552.nxml.txt.nlp	22654714	SENT647	3	3	35	35	lithium	BDNF	PA450243	627	0.863
NULL	Clin_Med_Insights_Oncol_2012_May_16_6_205-217.nxml.txt.nlp	22654526	SENT248	12	12	32	32	lovastatin	VEGFR	PA450272	3791	0.863
NULL	Oncol_Lett_2014_Mar_16_7(3)_827-833.nxml.txt.nlp	24527090	SENT86	27	27	10	10	cisplatin	IFN	PA449014	3439	0.863
NULL	Biomed_Res_Int_2014_Feb_17_2014_172913.nxml.txt.nlp	24696843	SENT64	10	10	41	41	l-glutamine	CO2	PA10090	4513	0.863
NULL	Int_J_Endocrinol_Metab_2013_Jul_1_Summer_11(3)_184-190.nxml.txt.nlp	24348591	SENT124	23	23	30	30	liraglutide	MDC	PA165958364	6367	0.863
NULL	Breast_Cancer_Res_2012_Apr_4_14(2)_R57.nxml.txt.nlp	22475046	SENT41	37	37	45	45	tamoxifen	CCND1	PA451581	595	0.863
NULL	Cardiovasc_Res_2012_Dec_1_96(3)_552-560.nxml.txt.nlp	22918977	SENT268	15	15	20	20	losartan	JAM-A	PA450268	50848	0.863
NULL	Cancers_(Basel)_2014_Oct_24_6(4)_2187-2223.nxml.txt.nlp	25347122	SENT288	33	33	25	25	dasatinib	YAP1	PA162372878	10413	0.863
NULL	J_Korean_Med_Sci_2012_Sep_22_27(9)_1037-1043.nxml.txt.nlp	22969249	SENT132	4	4	6	6	paricalcitol	CDK2	PA450798	1017	0.863
NULL	J_Am_Heart_Assoc_2013_Dec_19_2(6)_e000439.nxml.txt.nlp	24334905	SENT323	7	7	12	12	doxorubicin	p53	PA449412	7157	0.863
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT257	0	0	12	12	atorvastatin	AKT	PA448500	207	0.863
NULL	Cancer_Cell_Int_2011_Nov_2_11_39.nxml.txt.nlp	22047021	SENT232	13	13	7	7	cisplatin	REV1	PA449014	51455	0.863
NULL	Anemia_2012_Nov_8_2012_607436.nxml.txt.nlp	23198140	SENT162	12	12	16	16	capsaicin	TRPV1	PA448776	7442	0.863
NULL	Contemp_Oncol_(Pozn)_2012_Jan_4_16(6)_582-585.nxml.txt.nlp	23788948	SENT27	10	10	20	20	trastuzumab	HER2	PA451743	2064	0.863
NULL	J_Cell_Mol_Med_2014_Aug_1_18(8)_1599-1611.nxml.txt.nlp	24889822	SENT12	5	5	12	12	resveratrol	SIRT1		23411	0.863
NULL	Br_J_Cancer_2013_Sep_3_109(5)_1214-1222.nxml.txt.nlp	23922104	SENT173	3	3	7	7	dasatinib	p53	PA162372878	7157	0.863
NULL	Core_Evid_2007_Nov_30_2(2)_81-88.nxml.txt.nlp	21221177	SENT231	31	31	1	1	panitumumab	EGF	PA162373091	1950	0.863
NULL	Clin_Ophthalmol_2014_Aug_26_8_1611-1621.nxml.txt.nlp	25210429	SENT22	18	18	10	10	bevacizumab	San	PA130232992	80218	0.863
NULL	J_Hum_Genet_2013_Jun_23_58(6)_339-345.nxml.txt.nlp	23697979	SENT35	26	26	6	6	mephenytoin	CYP2C19	PA450373	1557	0.863
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Dec_19_66(Pt_1)_o186.nxml.txt.nlp	21580070	SENT55	19	19	14	14	ethanol	mol	PA448073	90527	0.863
NULL	Mol_Brain_2014_Oct_9_7(1)_74.nxml.txt.nlp	NULL	SENT264	11	11	6	6	methamphetamine	DTNBP1	PA450403	84062	0.863
NULL	Genome_Med_2010_Jan_26_2(1)_5.nxml.txt.nlp	20193050	SENT254	22	22	7	7	procainamide	CD4	PA451108	920	0.863
NULL	Case_Rep_Hematol_2014_Apr_14_2014_359158.nxml.txt.nlp	24822133	SENT49	9	9	5	5	methotrexate	POMP	PA450428	51371;51251	0.863
NULL	J_Neural_Transm_2014_Feb_19_121(7)_707-715.nxml.txt.nlp	24549572	SENT206	42	42	29	29	clobazam	CB2	PA10888	1269	0.863
NULL	Eur_J_Clin_Pharmacol_2012_Sep_15_68(9)_1267-1274.nxml.txt.nlp	22418828	SENT171	24	24	16	16	pantoprazole	CYP2C19	PA450774	1557	0.863
NULL	Endocrinol_Diabetes_Metab_Case_Rep_2014_Mar_1_2014_140001.nxml.txt.nlp	24683487	SENT125	23	23	12	12	bromocriptine	ACTH	PA448671	5443	0.863
NULL	Oncotarget_2011_Dec_31_2(12)_1329-1338.nxml.txt.nlp	22246171	SENT62	31	31	7	7	ganciclovir	Bcl-2	PA449733	596	0.863
NULL	Evid_Based_Complement_Alternat_Med_2012_Feb_12_2012_472897.nxml.txt.nlp	22454667	SENT184	14	14	6	6	roflumilast	PDE4D	PA165948052	5144	0.863
NULL	Oxid_Med_Cell_Longev_2012_Jan_19_2012_390678.nxml.txt.nlp	22315655	SENT119	24	24	19	19	gliclazide	NAC	PA10892	22861	0.863
NULL	J_Invest_Dermatol_2012_Sep_10_132(9)_2255-2262.nxml.txt.nlp	22572817	SENT60	12	12	7	7	forskolin	HBD3	PA146096022	414325	0.863
NULL	Open_Neurol_J_2013_May_31_7_23-31.nxml.txt.nlp	23894259	SENT33	25	25	15	15	olanzapine	FGA	PA450688	2243	0.863
NULL	Drug_Des_Devel_Ther_2014_Oct_31_8_2121-2128.nxml.txt.nlp	25382970	SENT98	16	16	20	20	curcumin	TTR	PA151958596	7276	0.863
NULL	Br_J_Haematol_2014_Mar_13_164(1)_811-821.nxml.txt.nlp	24328678	SENT105	4	4	13	13	lenalidomide	Aiolos	PA162363968	22806	0.863
NULL	Oncol_Lett_2014_Mar_19_7(3)_674-678.nxml.txt.nlp	24527071	SENT8	23	23	7	7	cisplatin	AKR1C2	PA449014	1646	0.863
NULL	J_Biol_Chem_2013_Dec_6_288(49)_35387-35395.nxml.txt.nlp	24142790	SENT153	0	0	2	2	meclizine	PCYT2	PA450338	5833	0.863
NULL	Oncotarget_2012_Nov_17_4(1)_18-28.nxml.txt.nlp	23248157	SENT142	3	3	13	13	pargyline	p53	PA450797	7157	0.863
NULL	Diagn_Pathol_2014_Jan_23_9_19.nxml.txt.nlp	24457059	SENT138	2	2	12	12	gefitinib	EGFR	PA131301952	1956	0.863
NULL	EMBO_Mol_Med_2012_Jul_11_4(7)_577-593.nxml.txt.nlp	22496117	SENT83	23	23	17	17	staurosporine	PAP-1	PA165109623	6100	0.863
NULL	J_Korean_Med_Sci_2011_Aug_27_26(8)_1007-1013.nxml.txt.nlp	21860550	SENT20	31	31	25	25	tamoxifen	CYP2D6	PA451581	1565	0.863
NULL	Mol_Cancer_2010_Dec_7_9_311.nxml.txt.nlp	21138557	SENT200	10	10	4	4	etoposide	MCT-1	PA449552	28985	0.863
NULL	Cancer_Med_2014_Feb_10_3(1)_134-142.nxml.txt.nlp	24407937	SENT246	3	3	18	18	anastrozole	ATAC	PA448432	6375	0.863
NULL	Front_Neuroendocrinol_2012_Jan_33(1)_45-66.nxml.txt.nlp	21802439	SENT1638	23	23	8	8	vasopressin	AT2	PA451858	186	0.863
NULL	ScientificWorldJournal_2014_Jul_23_2014_854093.nxml.txt.nlp	25147870	SENT168	5	5	14	14	chlorophyll	gamma	PA448942	9913	0.863
NULL	Clin_Dev_Immunol_2011_Dec_5_2011_894704.nxml.txt.nlp	22190975	SENT230	12	12	7	7	doxorubicin	CHOP	PA449412	1649	0.863
NULL	J_Oncol_2012_Apr_10_2012_931071.nxml.txt.nlp	22570654	SENT53	15	15	4	4	plerixafor	CD34	PA165958410	947	0.863
NULL	Int_J_Nanomedicine_2010_Apr_7_5_249-259.nxml.txt.nlp	20463941	SENT76	44	44	6	6	cisplatin	mol	PA449014	90527	0.863
NULL	J_Viral_Hepat_2012_Feb_19(2)_e134-e142.nxml.txt.nlp	22239511	SENT31	9	9	17	17	telaprevir	SOC	PA165958354	91544	0.863
NULL	Oncol_Rep_2012_Sep_6_28(3)_785-790.nxml.txt.nlp	22825751	SENT28	20	20	31	31	gefitinib	EGFR	PA131301952	1956	0.863
NULL	J_Exp_Med_2003_Aug_4_198(3)_513-520.nxml.txt.nlp	12900525	SENT349	14	14	11	11	imiquimod	TLR7	PA449972	51284	0.863
NULL	Breast_Cancer_Res_Treat_2014_Apr_9_145(1)_73-82.nxml.txt.nlp	24715380	SENT128	11	11	24	24	tamoxifen	CXCR3	PA451581	2833	0.863
NULL	Nat_Neurosci_2012_Jun_15(6)_845-852.nxml.txt.nlp	22522402	SENT106	13	13	9	9	primaquine	GluK2	PA451103	2898	0.863
NULL	Cell_Commun_Signal_2013_Nov_5_11_83.nxml.txt.nlp	24192293	SENT147	14	14	18	18	doxycycline	IL-6	PA449415	3569	0.863
NULL	Aging_(Albany_NY)_2009_Jun_3_1(6)_515-528.nxml.txt.nlp	20157535	SENT112	16	16	2	2	resveratrol	S6K1		6198	0.863
NULL	Exp_Ther_Med_2014_Sep_4_8(3)_851-855.nxml.txt.nlp	25120613	SENT71	19	19	7	7	lopinavir	IRS1	PA450264	3667	0.863
NULL	Child_Adolesc_Psychiatry_Ment_Health_2009_Mar_12_3_9.nxml.txt.nlp	19284622	SENT110	13	13	37	37	ziprasidone	PES	PA451974	23481	0.863
NULL	Cardiovasc_Diabetol_2005_May_15_4_6.nxml.txt.nlp	15892894	SENT60	4	4	29	29	losartan	ANOVA	PA450268	4858	0.863
NULL	Clin_Interv_Aging_2008_Mar_3(1)_45-50.nxml.txt.nlp	18488877	SENT39	27	27	13	13	teriparatide	BMD	PA451620	1756;7439	0.863
NULL	Arch_Med_Sci_2013_Aug_30_9(4)_739-744.nxml.txt.nlp	24049538	SENT107	37	37	33	33	candesartan	PC-3	PA448765	692094	0.863
NULL	Acta_Pharmacol_Sin_2013_Oct_7_34(10)_1317-1324.nxml.txt.nlp	23933652	SENT144	22	22	30	30	rosiglitazone	p65	PA451283	5970	0.863
NULL	Tob_Control_2009_Feb_13_18(1)_34-42.nxml.txt.nlp	18845621	SENT274	39	39	44	44	phenytoin	CYP2B6	PA450947	1555	0.863
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT417	14	14	2	2	irinotecan	BRAF	PA450085	673	0.863
NULL	J_Oncol_2010_Dec_24_2010_497429.nxml.txt.nlp	20066162	SENT74	28	28	12	12	carboplatin	AGO	PA448803	55294	0.863
NULL	Oncotarget_2013_Mar_21_4(3)_446-462.nxml.txt.nlp	23530113	SENT311	39	39	11	11	hydrocortisone	F12	PA449905	2161	0.863
NULL	Exp_Neurobiol_2013_Jun_27_22(2)_96-106.nxml.txt.nlp	23833558	SENT160	11	11	16	16	sertraline	spatial	PA451333	219793	0.863
NULL	Biomed_Imaging_Interv_J_2008_Jul_1_4(3)_e40.nxml.txt.nlp	21611006	SENT142	1	1	7	7	trastuzumab	HER2	PA451743	2064	0.863
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT89	19	19	14	14	cisplatin	MDM2	PA449014	4193	0.863
NULL	Curr_Neuropharmacol_2009_Sep_7(3)_246-256.nxml.txt.nlp	20190966	SENT186	14	14	28	28	ebselen	p53	PA161660841	7157	0.863
NULL	Oncotarget_2013_Nov_24_4(12)_2430-2438.nxml.txt.nlp	24280348	SENT8	12	12	6	6	gefitinib	STAT3	PA131301952	6774	0.863
NULL	Cell_Cycle_2013_Dec_15_12(24)_3791-3803.nxml.txt.nlp	24107631	SENT188	7	7	11	11	etoposide	YB-1	PA449552	4904	0.863
NULL	Int_J_Mol_Sci_2007_Mar_13_8(3)_229-240.nxml.txt.nlp	NULL	SENT146	9	9	38	38	acetazolamide	AQP1	PA448018	358	0.863
NULL	Oncoimmunology_2014_May_29_3_e28925.nxml.txt.nlp	25083322	SENT103	20	20	14	14	dasatinib	CCR7	PA162372878	1236	0.862
NULL	F1000Res_2014_Jul_1_3_149.nxml.txt.nlp	25352980	SENT109	13	13	7	7	galactose	GAL4	PA449725	3960	0.862
NULL	Front_Immunol_2012_Jul_20_3_212.nxml.txt.nlp	22833744	SENT141	18	18	20	20	cyclophosphamide	CTX	PA449165	1593	0.862
NULL	Clinics_(Sao_Paulo)_2014_Jan_69(1)_68-74.nxml.txt.nlp	24473562	SENT102	27	27	11	11	nutlin-3	SOCS-1		8651	0.862
NULL	Clin_Med_Insights_Case_Rep_2014_Oct_1_7_117-121.nxml.txt.nlp	25336995	SENT33	24	24	37	37	cytarabine	CD34	PA449177	947	0.862
NULL	BMB_Rep_2013_Jan_46(1)_59-64.nxml.txt.nlp	23351386	SENT97	4	4	17	17	auranofin	STAT3	PA448510	6774	0.862
NULL	Case_Rep_Pathol_2012_Aug_23_2012_678746.nxml.txt.nlp	22957288	SENT74	8	8	25	25	cyclophosphamide	ABRA	PA449165	137735	0.862
NULL	Ann_Hematol_2010_Sep_13_89(9)_861-871.nxml.txt.nlp	20387067	SENT136	3	3	13	13	dasatinib	CD34	PA162372878	947	0.862
NULL	Int_J_Mol_Sci_2013_Apr_15_14(4)_8271-8290.nxml.txt.nlp	23591842	SENT223	34	34	26	26	gefitinib	EGFR	PA131301952	1956	0.862
NULL	Diabetes_2013_Oct_17_62(10)_3500-3513.nxml.txt.nlp	23884882	SENT269	17	17	4	4	resveratrol	FOXO1		2308	0.862
NULL	Indian_J_Pharm_Sci_2014_Jan-Feb_76(1)_72-77.nxml.txt.nlp	24799741	SENT10	22	22	3	3	glimepiride	CYP2C9	PA449761	1559	0.862
NULL	Diabetes_Care_2011_Jul_17_34(7)_e115-e120.nxml.txt.nlp	21709286	SENT108	15	15	26	26	metformin	IGF1	PA450395	3479	0.862
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT374	9	9	18	18	resveratrol	IL-6		3569	0.862
NULL	Diabetes_Care_2011_Mar_17_34(3)_730-733.nxml.txt.nlp	21289232	SENT9	0	0	17	17	pioglitazone	IL-10	PA450970	3586	0.862
NULL	Cancer_Cell_Int_2002_Jul_5_2_7.nxml.txt.nlp	12234376	SENT131	30	30	41	41	tamoxifen	ERCC1	PA451581	2067	0.862
NULL	Oncotarget_2014_Mar_15_5(10)_3055-3065.nxml.txt.nlp	24931391	SENT207	23	23	6	6	hydrocortisone	F12	PA449905	2161	0.862
NULL	Nat_Med_2012_Jul_18(7)_1118-1122.nxml.txt.nlp	22683780	SENT57	41	41	12	12	crizotinib	FGFR1	PA165946122	2260	0.862
NULL	Biochem_Biophys_Res_Commun_2008_Sep_5_373(4)_584-588.nxml.txt.nlp	18586007	SENT94	26	26	8	8	curcumin	HO-1	PA151958596	3162	0.862
NULL	Breast_Cancer_Res_2011_May_25_13(3)_107.nxml.txt.nlp	21635706	SENT28	20	20	9	9	medroxyprogesterone	RANKL	PA450344	8600	0.862
NULL	Oncol_Lett_2014_May_27_7(5)_1327-1332.nxml.txt.nlp	24765133	SENT69	12	12	21	21	celecoxib	c-FLIP	PA448871	8837	0.862
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jun_27_68(Pt_7)_o2237.nxml.txt.nlp	22798893	SENT75	19	19	10	10	ethanol	mol	PA448073	90527	0.862
NULL	Nat_Med_2013_Dec_10_19(12)_10_1038_nm_3385.nxml.txt.nlp	24216752	SENT114	19	19	24	24	thrombin	PAR4	PA451674	9002;5074	0.862
NULL	Gut_Microbes_2012_Nov_1_3(6)_501-509.nxml.txt.nlp	22895085	SENT170	28	28	10	10	gentamicin	CO2	PA449753	4513	0.862
NULL	Curr_Rev_Musculoskelet_Med_2009_Mar_10_2(1)_56-64.nxml.txt.nlp	19468919	SENT86	13	13	0	0	heparin	OPG	PA449855	690	0.862
NULL	Onco_Targets_Ther_2014_Dec_4_7_2249-2255.nxml.txt.nlp	25587220	SENT106	11	11	25	25	vinblastine	ABCG2	PA451877	9429	0.862
NULL	Exp_Mol_Med_2012_Aug_31_44(8)_473-482.nxml.txt.nlp	22627808	SENT84	12	12	19	19	lapatinib	HER3	PA152241907	2065	0.862
NULL	AIDS_Res_Treat_2014_Feb_25_2014_636584.nxml.txt.nlp	24715982	SENT48	11	11	4	4	etravirine	DUET	PA166014703	8997	0.862
NULL	Mol_Cancer_2009_Dec_31_8_133.nxml.txt.nlp	20043851	SENT229	30	30	33	33	curcumin	FANCD2	PA151958596	2177	0.862
NULL	Indian_J_Pharmacol_2008_Jan-Feb_40(1)_10-14.nxml.txt.nlp	21264154	SENT159	0	0	10	10	vildagliptin	GLP-1	PA165958346	100125288	0.862
NULL	Clin_Genet_2014_Jan_1_86(1)_21-28.nxml.txt.nlp	24684508	SENT58	17	17	23	23	warfarin	4F2	PA451906	6520	0.862
NULL	Breast_Cancer_Res_2005_Jan_28_7(3)_R284-R290.nxml.txt.nlp	15987423	SENT86	15	15	8	8	tamoxifen	SULT1A1	PA451581	6817	0.862
NULL	Exp_Neurobiol_2013_Jun_27_22(2)_96-106.nxml.txt.nlp	23833558	SENT160	9	9	16	16	curcumin	spatial	PA151958596	219793	0.862
NULL	Cardiovasc_Res_2010_Mar_1_85(4)_825-835.nxml.txt.nlp	19840952	SENT160	28	28	25	25	staurosporine	CX3CL1	PA165109623	6376	0.862
NULL	Breast_Cancer_Res_Treat_2012_Jun_18_133(3)_937-947.nxml.txt.nlp	22094936	SENT24	24	24	6	6	tamoxifen	CCNE1	PA451581	898	0.862
NULL	Mol_Neurodegener_2011_Jun_7_6_40.nxml.txt.nlp	21649894	SENT22	19	19	4	4	levodopa	PTN	PA450213	5764	0.862
NULL	Clin_Endosc_2013_Jan_31_46(1)_30-37.nxml.txt.nlp	23423151	SENT80	13	13	8	8	porfimer	HGD	PA164752658	3081	0.862
NULL	Cancer_Cell_Int_2012_Jun_18_12_30.nxml.txt.nlp	22709569	SENT66	17	17	2	2	doxorubicin	PLCG2	PA449412	5336	0.862
NULL	Case_Rep_Obstet_Gynecol_2011_Sep_22_2011_896964.nxml.txt.nlp	22567519	SENT22	35	35	2	2	nevirapine	CD4	PA450616	920	0.862
NULL	Gastric_Cancer_2014_Dec_8_17(4)_630-637.nxml.txt.nlp	24318670	SENT192	5	5	27	27	fluorouracil	BRAF	PA128406956	673	0.862
NULL	J_Oncol_2010_May_4_2010_373491.nxml.txt.nlp	20454582	SENT46	5	5	0	0	carmustine	TRG	PA448810	6965	0.862
NULL	Korean_J_Anesthesiol_2013_Jan_21_64(1)_47-53.nxml.txt.nlp	23372886	SENT10	12	12	18	18	bupivacaine	IGK	PA135057240	50802	0.862
NULL	Clin_Ophthalmol_2008_Dec_2(4)_821-828.nxml.txt.nlp	19668436	SENT93	12	12	25	25	nilvadipine	Rho	PA165958385	29984	0.862
NULL	Diabetes_Care_2013_Aug_17_36(Suppl_2)_S245-S252.nxml.txt.nlp	23882053	SENT87	27	27	10	10	liraglutide	GLP-1	PA165958364	100125288	0.862
NULL	Oncotarget_2011_Jun_5_2(6)_448-460.nxml.txt.nlp	21646687	SENT59	21	21	6	6	tetracycline	PIM3	PA451640	415116	0.862
NULL	Breast_Cancer_Res_2009_Sep_16_11(5)_R69.nxml.txt.nlp	19758440	SENT182	4	4	8	8	trastuzumab	HER2	PA451743	2064	0.862
NULL	Mediators_Inflamm_2010_Mar_30_2010_280464.nxml.txt.nlp	20369000	SENT6	23	23	6	6	pp2	ghrelin		51738	0.862
NULL	Int_J_Mol_Sci_2014_Nov_25_15(12)_21703-21722.nxml.txt.nlp	25429431	SENT61	6	6	17	17	curcumin	mol	PA151958596	90527	0.862
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT8	12	12	6	6	trastuzumab	STAT3	PA451743	6774	0.862
NULL	Eur_J_Clin_Pharmacol_2010_Nov_29_66(11)_1131-1136.nxml.txt.nlp	20669013	SENT160	13	13	2	2	voriconazole	CYP3A4	PA10233	1576	0.862
NULL	Front_Cell_Neurosci_2014_Jul_28_8_209.nxml.txt.nlp	25120433	SENT11	2	2	13	13	potassium	KCNT2	PA451047	343450	0.862
NULL	Int_J_Mol_Sci_2014_May_12_15(5)_8335-8351.nxml.txt.nlp	24823879	SENT142	19	19	1	1	doxorubicin	XIAP	PA449412	331	0.862
NULL	Cell_Death_Dis_2014_Jan_30_5(1)_e1038.nxml.txt.nlp	24481452	SENT230	12	12	8	8	raloxifene	CYP1A1	PA451221	1543	0.862
NULL	Diabetes_2011_May_23_60(5)_1361-1369.nxml.txt.nlp	21525507	SENT177	9	9	37	37	glucose	MRS	PA449773	8011	0.862
NULL	Acta_Pharmacol_Sin_2010_Jun_4_31(6)_753-758.nxml.txt.nlp	20523346	SENT117	40	40	18	18	quinidine	MDR1	PA451209	5243	0.862
NULL	Arthritis_Rheumatol_2014_Aug_28_66(8)_2297-2307.nxml.txt.nlp	24756912	SENT119	16	16	12	12	doxorubicin	CHOP	PA449412	1649	0.862
NULL	Int_J_Environ_Res_Public_Health_2005_May_30_2(1)_156-163.nxml.txt.nlp	16705813	SENT47	45	45	11	11	l-glutamine	CO2	PA10090	4513	0.862
NULL	Cancers_(Basel)_2011_May_25_3(2)_2501-2515.nxml.txt.nlp	24212821	SENT433	18	18	6	6	gemcitabine	VEGFR	PA449748	3791	0.862
NULL	Breast_Cancer_Res_2004_Aug_5_6(5)_R601-R607.nxml.txt.nlp	15318941	SENT104	10	10	3	3	docetaxel	p27	PA449383	5715;10534	0.862
NULL	BMB_Rep_2014_Mar_47(3)_167-172.nxml.txt.nlp	24499665	SENT103	7	7	20	20	nutlin-3	MDM2		4193	0.862
NULL	Biomed_Res_Int_2014_Jan_20_2014_948427.nxml.txt.nlp	24563867	SENT230	23	23	5	5	buspirone	COB	PA448689	4519	0.862
NULL	J_Infect_Dis_2015_Jan_1_211(1)_10-18.nxml.txt.nlp	25030058	SENT133	9	9	0	0	darunavir	ATV	PA163522472	4683	0.862
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT134	26	26	22	22	sitagliptin	HIP	PA164748978	6767;6159;64399;5068	0.862
NULL	Oncogene_2010_Sep_9_29(36)_5032-5047.nxml.txt.nlp	20603614	SENT192	13	13	32	32	mitomycin	P200	PA450524	5035	0.862
NULL	Target_Oncol_2010_Jun_14_5(2)_95-112.nxml.txt.nlp	20625845	SENT232	19	19	12	12	sunitinib	FDG	PA162372840	23583	0.862
NULL	J_Bras_Pneumol_2014_Sep-Oct_40(5)_495-503.nxml.txt.nlp	25410837	SENT144	12	12	26	26	salmeterol	IL-6	PA451300	3569	0.862
NULL	Lab_Invest_2011_Apr_14_91(4)_598-608.nxml.txt.nlp	21321535	SENT239	0	0	7	7	sorafenib	CD4	PA7000	920	0.862
NULL	J_Gen_Physiol_2003_Jul_122(1)_45-61.nxml.txt.nlp	12835470	SENT18	5	5	18	18	capsaicin	VR1	PA448776	56664	0.862
NULL	Breast_Cancer_Res_2007_Oct_19_9(5)_111.nxml.txt.nlp	17983482	SENT80	19	19	9	9	gefitinib	HER2	PA131301952	2064	0.862
NULL	Mol_Pain_2014_Apr_9_10_24.nxml.txt.nlp	24716552	SENT245	6	6	34	34	capsaicin	NK1R	PA448776	6869	0.862
NULL	Br_J_Cancer_2009_Mar_10_100(5)_758-763.nxml.txt.nlp	19259094	SENT109	22	22	32	32	decitabine	MLH1	PA164749631	4292	0.862
NULL	Oncotarget_2012_Nov_17_3(12)_1600-1614.nxml.txt.nlp	23307622	SENT93	10	10	0	0	trastuzumab	ATG12	PA451743	9140	0.862
NULL	J_Radiat_Res_2014_Mar_1_55(2)_359-363.nxml.txt.nlp	24187329	SENT43	4	4	0	0	doxorubicin	CHOP	PA449412	1649	0.862
NULL	Mol_Cancer_2012_Dec_12_11_91.nxml.txt.nlp	23234355	SENT172	17	17	8	8	trastuzumab	EGFR	PA451743	1956	0.862
NULL	Br_J_Cancer_2010_Jun_29_103(1)_61-72.nxml.txt.nlp	20588279	SENT270	26	26	18	18	trastuzumab	PTEN	PA451743	5728	0.862
NULL	J_Adv_Pharm_Technol_Res_2013_Jan-Mar_4(1)_65-68.nxml.txt.nlp	23662284	SENT27	3	3	0	0	dexibuprofen	AMH	PA166049174	268	0.862
NULL	J_Signal_Transduct_2011_Feb_24_2011_804236.nxml.txt.nlp	21637380	SENT79	18	18	24	24	trastuzumab	PI3K	PA451743	5290	0.862
NULL	Open_Access_J_Urol_2010_Dec_30_3_7-17.nxml.txt.nlp	24198630	SENT99	15	15	9	9	darifenacin	CYP3A4	PA164774901	1576	0.862
NULL	Crit_Care_2010_Apr_1_14(2)_R51.nxml.txt.nlp	20359352	SENT45	3	3	26	26	cefepime	TMC	PA164754876	3703	0.862
NULL	Biomed_Res_Int_2014_Jan_29_2014_831845.nxml.txt.nlp	24605337	SENT138	24	24	12	12	bupivacaine	S6K1	PA135057240	6198	0.862
NULL	Br_J_Cancer_2012_Apr_10_106(8)_1406-1414.nxml.txt.nlp	22491422	SENT5	34	34	41	41	cetuximab	EGFR	PA10040	1956	0.862
NULL	Mol_Cancer_2008_Jul_24_7_64.nxml.txt.nlp	18652674	SENT134	18	18	2	2	doxorubicin	cIAP2	PA449412	330	0.862
NULL	J_Oncol_2010_May_24_2010_729725.nxml.txt.nlp	20508816	SENT37	11	11	6	6	sorafenib	VEGFR	PA7000	3791	0.862
NULL	Mol_Pain_2013_Nov_27_9_59.nxml.txt.nlp	24279796	SENT254	34	34	3	3	isoflurane	STZ	PA450106	6484	0.862
NULL	Cancer_Med_2012_Oct_1_1(2)_114-127.nxml.txt.nlp	23342262	SENT125	5	5	9	9	sirolimus	EGFR	PA451365	1956	0.862
NULL	Case_Rep_Oncol_Med_2012_Sep_11_2012_726424.nxml.txt.nlp	22997596	SENT23	31	31	9	9	rituximab	PRL	PA451261	5617	0.862
NULL	Mol_Cancer_2007_Oct_22_6_66.nxml.txt.nlp	17953743	SENT94	18	18	2	2	cisplatin	TRAIL	PA449014	8743	0.862
NULL	Indian_J_Pharmacol_2012_Sep-Oct_44(5)_624-628.nxml.txt.nlp	23112426	SENT37	35	35	17	17	pravastatin	P-gp	PA451089	5243	0.862
NULL	Theranostics_2014_Aug_15_4(11)_1072-1084.nxml.txt.nlp	25250092	SENT172	17	17	28	28	bevacizumab	HER2	PA130232992	2064	0.862
NULL	Surg_Res_Pract_2014_Feb_6_2014_801643.nxml.txt.nlp	25379560	SENT13	15	15	7	7	cyclosporine	CD25	PA449167	3669;3559	0.862
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1137-1144.nxml.txt.nlp	20234366	SENT139	15	15	8	8	cetuximab	KRAS	PA10040	3845	0.862
NULL	Br_J_Cancer_2011_Sep_6_105(6)_796-806.nxml.txt.nlp	21847123	SENT125	0	0	5	5	trastuzumab	HEY1	PA451743	23462	0.862
NULL	Oxid_Med_Cell_Longev_2013_Apr_21_2013_412576.nxml.txt.nlp	23710286	SENT144	5	5	7	7	curcumin	NRF2	PA151958596	2551;4780	0.862
NULL	Indian_J_Pharm_Sci_2013_Jan-Feb_75(1)_102-106.nxml.txt.nlp	23901169	SENT34	17	17	34	34	gentamicin	CO2	PA449753	4513	0.862
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT90	29	29	11	11	erlotinib	AKT	PA134687924	207	0.862
NULL	Mol_Cancer_2010_Nov_25_9_305.nxml.txt.nlp	21108789	SENT121	4	4	14	14	decitabine	TRAIL	PA164749631	8743	0.862
NULL	Diabetes_Metab_Syndr_Obes_2010_May_10_3_117-124.nxml.txt.nlp	21437082	SENT81	20	20	2	2	saxagliptin	GLP-1	PA165958362	100125288	0.862
NULL	Biomed_Res_Int_2013_Sep_5_2013_929531.nxml.txt.nlp	24083250	SENT203	10	10	2	2	hyaluronan	CD44	PA165958431	960	0.862
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT102	11	11	26	26	ethanol	TNF	PA448073	7124	0.862
NULL	Breast_Cancer_Res_Treat_2013_Jan_13_137(2)_471-482.nxml.txt.nlp	23239151	SENT195	15	15	28	28	bevacizumab	HER2	PA130232992	2064	0.862
NULL	J_Cardiovasc_Dis_Res_2012_Jan-Mar_3(1)_5-11.nxml.txt.nlp	22346138	SENT132	10	10	17	17	repaglinide	IL-6	PA451234	3569	0.862
NULL	eLife_2013_Nov_19_2_e01157.nxml.txt.nlp	24252875	SENT229	26	26	20	20	zolpidem	spatial	PA451976	219793	0.862
NULL	Mol_Cancer_2007_Jan_14_6_5.nxml.txt.nlp	17222355	SENT7	16	16	1	1	doxorubicin	HMGA2	PA449412	8091	0.862
NULL	Cancer_Cell_Int_2011_Nov_2_11_39.nxml.txt.nlp	22047021	SENT392	39	39	28	28	cisplatin	REV1	PA449014	51455	0.862
NULL	Blood_Cancer_J_2013_Mar_1_3(3)_e103.nxml.txt.nlp	23454896	SENT94	3	3	13	13	bortezomib	ATF6	PA10252	22926	0.862
NULL	Cancers_(Basel)_2012_Sep_25_4(4)_969-988.nxml.txt.nlp	24213497	SENT129	25	25	30	30	estradiol	aromatase	PA449503	1588	0.862
NULL	Biomed_Res_Int_2013_Jun_18_2013_104315.nxml.txt.nlp	23853765	SENT108	5	5	31	31	pitrakinra	IL-4	PA165983754	3565	0.862
NULL	Blood_Cancer_J_2012_Jul_20_2(7)_e79.nxml.txt.nlp	22852048	SENT110	4	4	9	9	tubercidin	XBP1	PA152530738	7494	0.862
NULL	Mol_Syst_Biol_2009_Jul_28_5_288.nxml.txt.nlp	19638969	SENT176	2	2	13	13	resveratrol	CSF2		1437	0.862
NULL	Oncotarget_2014_Oct_18_5(22)_11604-11619.nxml.txt.nlp	25344099	SENT236	10	10	12	12	doxorubicin	RYBP	PA449412	23429	0.862
NULL	Cancer_Cell_Int_2002_Apr_4_2_2.nxml.txt.nlp	11983028	SENT262	7	7	14	14	cisplatin	p53	PA449014	7157	0.862
NULL	Br_J_Cancer_2012_Oct_9_107(8)_1433-1441.nxml.txt.nlp	22929880	SENT19	17	17	3	3	imatinib	KIT	PA10804	3815	0.862
NULL	Onco_Targets_Ther_2014_Sep_9_7_1571-1582.nxml.txt.nlp	25228815	SENT131	8	8	4	4	sunitinib	VEGFR2	PA162372840	3791	0.862
NULL	Onco_Targets_Ther_2014_Mar_24_7_491-500.nxml.txt.nlp	24711706	SENT187	13	13	20	20	trastuzumab	HER-2	PA451743	2064	0.862
NULL	J_Mol_Med_2009_Oct_8_87(10)_971-980.nxml.txt.nlp	19669106	SENT171	10	10	0	0	fluorescein	TPO	PA164746009	7066;7173	0.862
NULL	BMB_Rep_2014_Apr_47(4)_221-226.nxml.txt.nlp	24286312	SENT30	0	0	3	3	nutlin-3	MDM2		4193	0.862
NULL	Oncotarget_2013_Nov_23_5(1)_196-210.nxml.txt.nlp	24344116	SENT132	23	23	5	5	doxorubicin	p53	PA449412	7157	0.862
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT200	27	27	31	31	ketoconazole	CYP3A4	PA450146	1576	0.862
NULL	Adolesc_Health_Med_Ther_2010_Oct_11_1_137-143.nxml.txt.nlp	24600269	SENT36	0	0	18	18	ziprasidone	5-HT1D	PA451974	3352	0.862
NULL	Indian_J_Pharm_Sci_2013_Jan-Feb_75(1)_31-35.nxml.txt.nlp	23901158	SENT75	14	14	8	8	dicloxacillin	DCX	PA164749649	1641	0.862
NULL	Front_Neurol_2014_Nov_17_5_234.nxml.txt.nlp	25452743	SENT226	13	13	18	18	propofol	p75	PA451141	7133;11168	0.862
NULL	Mol_Cancer_2007_Jun_6_6_38.nxml.txt.nlp	17553164	SENT76	13	13	34	34	tetracycline	DDC	PA451640	1644	0.862
NULL	J_Breast_Cancer_2012_Sep_28_15(3)_273-282.nxml.txt.nlp	23091539	SENT130	30	30	26	26	doxycycline	TRAIL	PA449415	8743	0.862
NULL	J_Thromb_Haemost_2014_May_22_12(5)_748-760.nxml.txt.nlp	24612393	SENT116	4	4	6	6	thrombin	TSC2	PA451674	7249	0.862
NULL	Int_J_Gen_Med_2009_Dec_29_2_209-217.nxml.txt.nlp	20360906	SENT139	20	20	9	9	cabergoline	PRL	PA448708	5617	0.862
NULL	Adv_Hematol_2012_Aug_2_2012_842945.nxml.txt.nlp	22919394	SENT159	19	19	4	4	lenalidomide	CRBN	PA162363968	51185	0.862
NULL	J_Biol_Chem_2013_Apr_5_288(14)_9767-9778.nxml.txt.nlp	23439651	SENT218	7	7	5	5	nutlin-3	p53		7157	0.862
NULL	Cell_Death_Dis_2014_Mar_13_5(3)_e1118.nxml.txt.nlp	24625977	SENT80	40	40	12	12	etoposide	mot-2	PA449552	3313	0.862
NULL	Int_J_Fertil_Steril_2013_Mar_3_Jan-Mar_6(4)_266-271.nxml.txt.nlp	24520450	SENT26	17	17	6	6	estradiol	aromatase	PA449503	1588	0.862
NULL	Cell_J_2014_May_25_Summer_16(2)_163-170.nxml.txt.nlp	24567946	SENT149	5	5	2	2	naloxone	CA1	PA450586	759	0.862
NULL	Cell_Death_Dis_2014_Jan_16_5(1)_e1000.nxml.txt.nlp	24434508	SENT94	24	24	5	5	etoposide	p53	PA449552	7157	0.862
NULL	Am_J_Trop_Med_Hyg_2012_Sep_5_87(3)_437-446.nxml.txt.nlp	22848096	SENT13	24	24	8	8	chloroquine	ACT	PA448948	12;11332;9457;641455	0.862
NULL	Ann_Rheum_Dis_2008_Sep_11_68(7)_1146-1152.nxml.txt.nlp	18794178	SENT207	12	12	38	38	adalimumab	STAR	PA10004	6770;2984	0.862
NULL	Int_J_Mol_Sci_2012_Feb_17_13(2)_2219-2238.nxml.txt.nlp	22408449	SENT554	0	0	6	6	nicotine	IL-6	PA450626	3569	0.862
NULL	Case_Rep_Hematol_2014_Dec_24_2014_460574.nxml.txt.nlp	25610674	SENT9	22	22	12	12	rituximab	PHL	PA451261	613	0.862
NULL	Front_Zool_2011_Jun_14_8_15.nxml.txt.nlp	21672209	SENT1007	6	6	15	15	ethanol	CO2	PA448073	4513	0.862
NULL	Biosci_Rep_2012_Dec_1_32(Pt_6)_619-629.nxml.txt.nlp	NULL	SENT114	4	4	19	19	troglitazone	aP2	PA451799	2167	0.862
NULL	Hum_Mol_Genet_2012_Oct_15_21(R1)_R97-R110.nxml.txt.nlp	22914737	SENT1045	0	0	3	3	losartan	AT1	PA450268	9197;185	0.862
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT253	1	1	27	27	perifosine	TRAIL	PA165291471	8743	0.862
NULL	J_Oncol_2013_Apr_29_2013_854121.nxml.txt.nlp	23737784	SENT174	14	14	25	25	pertuzumab	HER2		2064	0.862
NULL	Cancers_(Basel)_2014_Mar_26_6(2)_708-722.nxml.txt.nlp	24675568	SENT117	24	24	15	15	erlotinib	STAT3	PA134687924	6774	0.862
NULL	BMJ_2011_Aug_4_343_d4588.nxml.txt.nlp	21816733	SENT220	28	28	9	9	clopidogrel	CYP2C19	PA449053	1557	0.862
NULL	J_Oncol_2010_Apr_26_2010_132641.nxml.txt.nlp	20445741	SENT531	9	9	15	15	dacarbazine	IFN	PA449197	3439	0.862
NULL	Ann_Rheum_Dis_2008_Nov_14_67(11)_1516-1523.nxml.txt.nlp	18625622	SENT182	20	20	15	15	tocilizumab	TNF	PA165292659	7124	0.862
NULL	J_Hum_Genet_2013_Jun_23_58(6)_339-345.nxml.txt.nlp	23697979	SENT86	16	16	33	33	clopidogrel	P2RY12	PA449053	64805	0.862
NULL	Acta_Pharmacol_Sin_2010_Jul_28_31(7)_867-873.nxml.txt.nlp	20581857	SENT123	11	11	19	19	docetaxel	PDCD4	PA449383	27250	0.862
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jul_15_65(Pt_8)_o1860-o1861.nxml.txt.nlp	21583558	SENT52	23	23	18	18	ethanol	mol	PA448073	90527	0.862
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT102	15	15	34	34	l-leucine	4E-BP1	PA450197	1978	0.862
NULL	Clin_Pharmacol_2012_Feb_20_4_13-20.nxml.txt.nlp	22427735	SENT98	37	37	14	14	clopidogrel	LTA	PA449053	4049	0.862
NULL	Arch_Drug_Inf_2011_Mar_4(1)_1-9.nxml.txt.nlp	21572514	SENT35	13	13	29	29	vinblastine	P-gp	PA451877	5243	0.862
NULL	BioData_Min_2011_Jun_14_4_15.nxml.txt.nlp	21672238	SENT32	5	5	18	18	geldanamycin	Hsp90	PA152031327	3320	0.862
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2013_Jul_31_6_15-24.nxml.txt.nlp	23966808	SENT28	6	6	1	1	exenatide	GLP-1	PA164749238	100125288	0.862
NULL	Diabetes_2009_Jan_58(1)_243-249.nxml.txt.nlp	18840785	SENT20	27	27	7	7	glucose	GLP-1	PA449773	100125288	0.862
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jan_22_67(Pt_2)_m236-m237.nxml.txt.nlp	21522892	SENT4	8	8	1	1	zinc	mol	PA451956	90527	0.862
NULL	Ann_Oncol_2013_Aug_12_24(8)_1994-1999.nxml.txt.nlp	23670096	SENT137	4	4	19	19	tamoxifen	BCS	PA451581	617	0.862
NULL	Indian_J_Ophthalmol_2014_May_62(5)_642-644.nxml.txt.nlp	23571268	SENT61	34	34	1	1	hydroxychloroquine	APS	PA164777036	10603	0.862
NULL	Cell_Death_Differ_2010_May_13_17(5)_774-786.nxml.txt.nlp	19911006	SENT372	6	6	13	13	doxycycline	AATF	PA449415	26574	0.862
NULL	Cell_Death_Dis_2012_Jun_21_3(6)_e330.nxml.txt.nlp	22717585	SENT66	0	0	23	23	simvastatin	BNIP3	PA451363	664	0.862
NULL	Br_J_Cancer_2010_Jan_5_102(1)_134-143.nxml.txt.nlp	19920829	SENT182	32	32	27	27	rituximab	IL-2	PA451261	3558	0.862
NULL	Evid_Based_Complement_Alternat_Med_2006_Sep_20_3(3)_365-372.nxml.txt.nlp	16951721	SENT9	3	3	17	17	ginseng	Bcl-2	PA164781150	596	0.862
NULL	Nucleic_Acids_Res_2011_Mar_17_39(6)_2057-2072.nxml.txt.nlp	21087998	SENT453	10	10	6	6	gemcitabine	HMGA1	PA449748	3159	0.862
NULL	Breast_Cancer_Res_Treat_2014_Nov_24_143(1)_125-133.nxml.txt.nlp	24272078	SENT183	5	5	15	15	anastrozole	aromatase	PA448432	1588	0.862
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT11	0	0	14	14	atorvastatin	AKT	PA448500	207	0.862
NULL	Acta_Pharmacol_Sin_2009_May_5_30(5)_646-652.nxml.txt.nlp	19417737	SENT120	30	30	17	17	midazolam	CYP3A	PA450496	1574	0.862
NULL	J_Biol_Chem_2013_Feb_1_288(5)_3312-3321.nxml.txt.nlp	23255604	SENT210	3	3	11	11	mitomycin	IP6K1	PA450524	9807	0.862
NULL	Breast_Cancer_Res_2012_Jun_15_14(3)_R96.nxml.txt.nlp	22703841	SENT25	13	13	30	30	tamoxifen	HER2	PA451581	2064	0.862
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Oct_15_64(Pt_11)_o2118-o2119.nxml.txt.nlp	21580981	SENT66	23	23	18	18	ethanol	mol	PA448073	90527	0.862
NULL	Oncotarget_2014_Oct_18_5(22)_11588-11603.nxml.txt.nlp	25473890	SENT121	24	24	3	3	imatinib	AMACR	PA10804	23600	0.862
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT224	15	15	5	5	panitumumab	KRAS	PA162373091	3845	0.862
NULL	Anesth_Pain_Med_2013_Jan_1_Winter_2(3)_104-106.nxml.txt.nlp	24244917	SENT32	22	22	10	10	tramadol	CYP2D6	PA451735	1565	0.862
NULL	Genome_Biol_2008_Aug_13_9(8)_318.nxml.txt.nlp	18710599	SENT47	31	31	19	19	trastuzumab	PTEN	PA451743	5728	0.862
NULL	Acta_Pharmacol_Sin_2009_Feb_5_30(2)_228-234.nxml.txt.nlp	19122672	SENT26	6	6	8	8	isoflurane	HO-1	PA450106	3162	0.862
NULL	Breast_Cancer_Res_2009_Jun_16_11(3)_R35.nxml.txt.nlp	19531217	SENT25	23	23	5	5	exemestane	aromatase	PA449563	1588	0.862
NULL	Ann_Hematol_2011_May_12_90(5)_557-568.nxml.txt.nlp	20938660	SENT206	12	12	24	24	plerixafor	CD34	PA165958410	947	0.862
NULL	Arthritis_Res_Ther_2003_Oct_2_5(Suppl_4)_S17-S21.nxml.txt.nlp	15180893	SENT54	11	11	37	37	methotrexate	ACR	PA450428	49	0.862
NULL	Lab_Invest_2011_Apr_14_91(4)_598-608.nxml.txt.nlp	21321535	SENT133	6	6	31	31	sorafenib	CD11b	PA7000	3684	0.862
NULL	G3_(Bethesda)_2014_Nov_6_5(1)_21-33.nxml.txt.nlp	25380729	SENT72	13	13	10	10	galactose	GAL7	PA449725	3963;653499	0.862
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT319	34	34	29	29	nutlin-3	DR5		8795	0.862
NULL	Infect_Drug_Resist_2010_Mar_11_3_45-51.nxml.txt.nlp	21694893	SENT115	29	29	16	16	quinidine	CYP3A4	PA451209	1576	0.862
NULL	Biologics_2012_Jul_26_6_233-244.nxml.txt.nlp	22904615	SENT47	5	5	15	15	bevacizumab	EGFR	PA130232992	1956	0.862
NULL	Curr_Neuropharmacol_2007_Sep_5(3)_180-186.nxml.txt.nlp	19305800	SENT146	36	36	14	14	cinacalcet	PTH	PA164776671	5741	0.862
NULL	Mol_Cancer_2007_Aug_21_6_53.nxml.txt.nlp	17711579	SENT154	34	34	15	15	cisplatin	MXD4	PA449014	10608	0.862
NULL	Oncoimmunology_2012_Aug_1_1(5)_618-629.nxml.txt.nlp	22934254	SENT160	19	19	13	13	nilotinib	p38	PA165958345	10598;1432;7965	0.862
NULL	Aging_(Albany_NY)_2009_Jul_30_1(7)_669-673.nxml.txt.nlp	20157548	SENT50	28	28	3	3	forskolin	SIRT1	PA146096022	23411	0.862
NULL	Indian_J_Psychol_Med_2014_Jan-Mar_36(1)_66-70.nxml.txt.nlp	24701014	SENT98	14	14	41	41	risperidone	CARS	PA451257	833	0.862
NULL	Cancers_(Basel)_2011_Apr_1_3(2)_1844-1860.nxml.txt.nlp	24212785	SENT602	16	16	5	5	cetuximab	BRAF	PA10040	673	0.862
NULL	J_Cancer_2013_Sep_27_4(8)_662-670.nxml.txt.nlp	24155778	SENT244	4	4	0	0	cisplatin	UCHL1	PA449014	7345	0.862
NULL	Breast_Cancer_Res_2011_Apr_21_13(2)_R46.nxml.txt.nlp	21510863	SENT144	13	13	4	4	trastuzumab	DM1	PA451743	338023;1760;28509	0.862
NULL	Eur_Heart_J_2013_Dec_1_34(45)_3515-3524.nxml.txt.nlp	23594590	SENT84	3	3	11	11	eplerenone	p47phox	PA164749044	653361	0.862
NULL	Case_Rep_Oncol_2012_Apr_13_5(1)_173-180.nxml.txt.nlp	22666209	SENT34	22	22	18	18	paclitaxel	OSC	PA450761	4047	0.862
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1063.nxml.txt.nlp	24556678	SENT89	6	6	22	22	thioridazine	c-FLIP	PA451666	8837	0.862
NULL	Lab_Anim_Res_2011_Jun_22_27(2)_171-176.nxml.txt.nlp	21826178	SENT45	8	8	20	20	ketamine	STZ	PA450144	6484	0.862
NULL	Breast_Cancer_Res_2007_Aug_8_9(4)_R50.nxml.txt.nlp	17686159	SENT246	19	19	37	37	gefitinib	HRG	PA131301952	3084;3273	0.862
NULL	Br_J_Cancer_2013_May_28_108(10)_1957-1963.nxml.txt.nlp	23640393	SENT25	5	5	3	3	vincristine	NACT	PA451879	284111	0.862
NULL	Front_Oncol_2013_Nov_15_3_281.nxml.txt.nlp	24298448	SENT181	33	33	12	12	irinotecan	KRAS	PA450085	3845	0.862
NULL	Front_Immunol_2012_May_7_3_101.nxml.txt.nlp	22783250	SENT251	25	25	32	32	papain	IL-9	PA450778	3578	0.862
NULL	Br_J_Cancer_2013_Mar_19_108(5)_1052-1060.nxml.txt.nlp	23422754	SENT35	29	29	4	4	bevacizumab	VEGF-A	PA130232992	7422	0.862
NULL	Diabetes_Obes_Metab_2010_Aug_12(8)_700-708.nxml.txt.nlp	20590747	SENT214	4	4	21	21	vildagliptin	PPG	PA165958346	5552	0.862
NULL	Exp_Ther_Med_2014_Sep_14_8(3)_836-840.nxml.txt.nlp	25120610	SENT12	3	3	34	34	fasudil	ROCK2	PA165946121	9475	0.862
NULL	Acta_Pharmacol_Sin_2010_Oct_13_31(10)_1350-1358.nxml.txt.nlp	20835264	SENT194	2	2	36	36	simvastatin	gamma	PA451363	9913	0.862
NULL	Br_J_Cancer_2010_Feb_2_102(3)_541-552.nxml.txt.nlp	20087344	SENT154	30	30	3	3	paclitaxel	NRP1	PA450761	8829	0.862
NULL	Oncotarget_2014_Aug_29_5(17)_7217-7259.nxml.txt.nlp	25277175	SENT99	4	4	1	1	olaparib	PARP-1		25976	0.862
NULL	Trials_2012_Aug_3_13_130.nxml.txt.nlp	22862827	SENT81	2	2	6	6	aprepitant	NK-1	PA164747039	27087	0.862
NULL	Ann_Oncol_2014_Oct_18_25(10)_1871-1888.nxml.txt.nlp	25234545	SENT325	26	26	29	29	tamoxifen	aromatase	PA451581	1588	0.862
NULL	Nanoscale_Res_Lett_2013_Nov_5_8(1)_462.nxml.txt.nlp	24191909	SENT28	20	20	11	11	ethanol	FTO	PA448073	79068	0.862
NULL	Mol_Biol_Cell_2012_Sep_1_23(17)_3461-3472.nxml.txt.nlp	22767580	SENT142	17	17	11	11	staurosporine	ADAM12	PA165109623	8038	0.862
NULL	Anesth_Pain_Med_2013_Mar_26_Spring_2(4)_149-153.nxml.txt.nlp	24223351	SENT50	4	4	17	17	propofol	JMS	PA451141	3721	0.862
NULL	Pharmaceutics_2011_Aug_31_3(3)_582-600.nxml.txt.nlp	24310598	SENT564	8	8	25	25	theophylline	TC1	PA451647	6947	0.862
NULL	Cell_J_2012_Dec_22_Winter_13(4)_281-289.nxml.txt.nlp	23507624	SENT171	20	20	9	9	isoproterenol	IFN	PA450121	3439	0.862
NULL	Acta_Pharmacol_Sin_2009_Aug_13_30(8)_1099-1106.nxml.txt.nlp	19597524	SENT159	31	31	12	12	isoproterenol	p47phox	PA450121	653361	0.862
NULL	Korean_J_Anesthesiol_2013_Jan_21_64(1)_47-53.nxml.txt.nlp	23372886	SENT102	22	22	8	8	bupivacaine	IGK	PA135057240	50802	0.862
NULL	J_Exp_Bot_2011_Oct_4_62(14)_4787-4803.nxml.txt.nlp	21821598	SENT302	15	15	18	18	mannitol	M6PR	PA450320	4074	0.862
NULL	Breast_Cancer_Res_Treat_2014_Jul_20_146(3)_627-636.nxml.txt.nlp	25038878	SENT236	3	3	18	18	anastrozole	ATAC	PA448432	6375	0.862
NULL	Int_J_Mol_Imaging_2011_Oct_26_2011_874585.nxml.txt.nlp	21490735	SENT14	19	19	3	3	tamoxifen	FDG	PA451581	23583	0.862
NULL	Clin_Pediatr_Endocrinol_2007_Nov_17_16(4)_81-84.nxml.txt.nlp	24790350	SENT8	7	7	0	0	levodopa	PRL	PA450213	5617	0.862
NULL	Alcohol_Res_2012_34(3)_274-281.nxml.txt.nlp	23134043	SENT138	16	16	7	7	ethanol	ADH1B	PA448073	125	0.862
NULL	J_Thorac_Oncol_2014_Oct_23_9(10)_1532-1539.nxml.txt.nlp	25170639	SENT190	12	12	17	17	erlotinib	EGFR	PA134687924	1956	0.862
NULL	Br_J_Cancer_1998_Jun_77(Suppl_4)_12-14.nxml.txt.nlp	9647614	SENT6	27	27	17	17	cisplatin	p53	PA449014	7157	0.862
NULL	Biomed_Res_Int_2013_Dec_5_2013_642848.nxml.txt.nlp	24381940	SENT138	31	31	16	16	telmisartan	IL-6	PA451605	3569	0.862
NULL	Virulence_2013_Nov_15_4(8)_833-846.nxml.txt.nlp	24225421	SENT85	29	29	33	33	galactose	CLC	PA449725	23529;1178	0.862
NULL	Cancer_Med_2013_Jun_25_2(3)_277-285.nxml.txt.nlp	23930204	SENT117	6	6	28	28	bevacizumab	PTEN	PA130232992	5728	0.862
NULL	Cell_Death_Dis_2012_Jun_21_3(6)_e327.nxml.txt.nlp	22717582	SENT23	14	14	8	8	doxorubicin	NOXA	PA449412	5366	0.862
NULL	Br_J_Cancer_2006_Feb_13_94(3)_407-426.nxml.txt.nlp	16434996	SENT321	21	21	5	5	genistein	BRCA1	PA165109660	672	0.862
NULL	Drug_Des_Devel_Ther_2014_Oct_31_8_2121-2128.nxml.txt.nlp	25382970	SENT79	16	16	10	10	curcumin	LC3	PA151958596	84557	0.862
NULL	J_Carcinog_2014_Mar_5_13_5.nxml.txt.nlp	24799832	SENT46	6	6	24	24	flutamide	DES	PA449685	1674	0.862
NULL	Indian_J_Pharm_Sci_2014_Jan-Feb_76(1)_72-77.nxml.txt.nlp	24799741	SENT10	22	22	27	27	glimepiride	CYP2C9	PA449761	1559	0.862
NULL	Biologics_2010_Sep_28_4_273-287.nxml.txt.nlp	21116326	SENT73	7	7	12	12	bortezomib	NOXA	PA10252	5366	0.862
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Jun_18_70(Pt_7)_o788.nxml.txt.nlp	25161573	SENT70	11	11	4	4	ethanol	mol	PA448073	90527	0.862
NULL	Breast_Cancer_Res_2007_Jan_23_9(1)_R7.nxml.txt.nlp	17244352	SENT205	19	19	3	3	tamoxifen	UGT2B15	PA451581	7366	0.862
NULL	Gastric_Cancer_2014_Apr_7_17(1)_1-12.nxml.txt.nlp	23563986	SENT194	12	12	9	9	trastuzumab	HER2	PA451743	2064	0.862
NULL	Exp_Ther_Med_2013_Feb_13_5(2)_581-585.nxml.txt.nlp	23403473	SENT83	12	12	15	15	etanercept	HMGB1	PA449515	3146	0.862
NULL	Arthritis_Res_Ther_2005_Feb_18_7(3)_R476-R484.nxml.txt.nlp	15899034	SENT100	16	16	36	36	thrombin	GEF	PA451674	56731	0.862
NULL	Biosci_Microbiota_Food_Health_2014_Jun_25_33(4)_147-155.nxml.txt.nlp	25379362	SENT182	8	8	14	14	hesperidin	IL-5	PA449867	3567	0.862
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT236	20	20	10	10	heparin	FGF1	PA449855	2246	0.862
NULL	Ann_Dermatol_2011_Aug_6_23(3)_329-337.nxml.txt.nlp	21909203	SENT81	11	11	27	27	doxorubicin	CHOP	PA449412	1649	0.862
NULL	Oncotarget_2014_Sep_2_5(19)_9295-9307.nxml.txt.nlp	25238228	SENT151	12	12	31	31	crizotinib	AKT	PA165946122	207	0.862
NULL	ScientificWorldJournal_2014_Mar_16_2014_179698.nxml.txt.nlp	24757411	SENT119	11	11	3	3	mitomycin	FHIT	PA450524	2272	0.862
NULL	Acta_Diabetol_2012_Aug_11_49(4)_277-289.nxml.txt.nlp	21833779	SENT177	24	24	21	21	carbachol	ANOVA	PA448784	4858	0.862
NULL	Exp_Hematol_Oncol_2013_Aug_2_2_19.nxml.txt.nlp	23915571	SENT148	5	5	14	14	cyclophosphamide	CHOP	PA449165	1649	0.862
NULL	Mol_Biol_Cell_2013_Sep_1_24(17)_2678-2688.nxml.txt.nlp	23864716	SENT49	2	2	9	9	thrombin	Rho	PA451674	29984	0.862
NULL	Epilepsia_2012_Jun_21_53(Suppl_1)_18-25.nxml.txt.nlp	22612805	SENT116	7	7	18	18	furosemide	CA3	PA449719	761	0.862
NULL	Neuroimage_Clin_2013_Sep_6_3_290-300.nxml.txt.nlp	24273714	SENT160	8	8	3	3	pioglitazone	spatial	PA450970	219793	0.862
NULL	J_Oncol_2014_Mar_26_2014_625060.nxml.txt.nlp	24795759	SENT45	28	28	30	30	risedronate	aromatase	PA451255	1588	0.862
NULL	Front_Behav_Neurosci_2012_Nov_22_6_78.nxml.txt.nlp	23189046	SENT81	18	18	10	10	ethanol	OX1R	PA448073	3061	0.862
NULL	Mol_Cell_Proteomics_2012_Feb_6_11(2)_M111_015222.nxml.txt.nlp	22147731	SENT226	9	9	19	19	gefitinib	EGF	PA131301952	1950	0.862
NULL	Cancers_(Basel)_2010_Apr_20_2(2)_611-623.nxml.txt.nlp	24281084	SENT150	14	14	8	8	aprepitant	NK-1	PA164747039	27087	0.862
NULL	Curr_Hepat_Rep_2010_Nov_26_9(4)_231-238.nxml.txt.nlp	20949114	SENT15	15	15	2	2	lamivudine	IFN	PA450163	3439	0.862
NULL	J_Biomed_Biotechnol_2010_Mar_24_2010_107859.nxml.txt.nlp	20368775	SENT170	26	26	12	12	thrombin	RANTES	PA451674	6352	0.862
NULL	Cell_Death_Dis_2014_Apr_17_5(4)_e1182.nxml.txt.nlp	24743737	SENT81	8	8	6	6	capsaicin	TRPV1	PA448776	7442	0.862
NULL	Arthritis_Res_Ther_2007_Jun_29_9(Suppl_1)_S2.nxml.txt.nlp	17634141	SENT7	0	0	7	7	denosumab	RANKL	PA166048634	8600	0.862
NULL	Carcinogenesis_2010_Dec_15_31(12)_2031-2038.nxml.txt.nlp	20952512	SENT181	14	14	3	3	hydroxyurea	BRCA1	PA449942	672	0.862
NULL	Drugs_R_D_2014_Sep_28_14(3)_159-164.nxml.txt.nlp	24973042	SENT140	15	15	19	19	omeprazole	CYP2C19	PA450704	1557	0.862
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_79-85.nxml.txt.nlp	23864840	SENT106	27	27	10	10	trastuzumab	EGFR	PA451743	1956	0.862
NULL	Br_J_Haematol_2014_Mar_13_164(1)_811-821.nxml.txt.nlp	24328678	SENT109	21	21	34	34	thalidomide	Aiolos	PA451644	22806	0.862
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT220	18	18	25	25	paclitaxel	ABCG2	PA450761	9429	0.862
NULL	Front_Oncol_2014_Jun_13_4_141.nxml.txt.nlp	24982846	SENT259	6	6	15	15	bsi-201	PARP1		142	0.862
NULL	Br_J_Cancer_2012_Dec_4_107(12)_1950-1955.nxml.txt.nlp	23169295	SENT149	25	25	9	9	oxaliplatin	ERCC1	PA131285527	2067	0.862
NULL	Biomed_Res_Int_2014_Aug_6_2014_967826.nxml.txt.nlp	25165721	SENT287	42	42	14	14	cisplatin	CD25	PA449014	3669;3559	0.862
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Feb_15_5_3.nxml.txt.nlp	16480505	SENT101	12	12	5	5	rifapentine	CYP3A4	PA164783809	1576	0.862
NULL	BMB_Rep_2013_Nov_46(11)_544-549.nxml.txt.nlp	24152910	SENT4	35	35	33	33	thrombin	PAR-1	PA451674	2011;2149	0.862
NULL	Ther_Clin_Risk_Manag_2006_Dec_2(4)_335-480.nxml.txt.nlp	18360645	SENT66	3	3	9	9	infliximab	IMPACT	PA452639	55364	0.862
NULL	BMB_Rep_2014_May_47(5)_274-279.nxml.txt.nlp	24286313	SENT114	13	13	9	9	bortezomib	CD138	PA10252	6382	0.862
NULL	Int_J_Biol_Sci_2014_May_14_10(5)_566-575.nxml.txt.nlp	24910535	SENT141	35	35	24	24	nadh	BRCA1	PA164755085	672	0.862
NULL	Support_Care_Cancer_2012_May_1_20(5)_941-949.nxml.txt.nlp	21533811	SENT19	0	0	16	16	palonosetron	NK-1	PA10352	27087	0.862
NULL	Thorax_2012_Sep_11_67(9)_796-803.nxml.txt.nlp	22496351	SENT111	14	14	16	16	bleomycin	TRAIL	PA448645	8743	0.862
NULL	Behav_Neurol_2014_Nov_16_2014_360978.nxml.txt.nlp	25477708	SENT99	25	25	17	17	nicotine	P28	PA450626	9446;7802;9527	0.862
NULL	Cell_Death_Dis_2010_Oct_21_1(10)_e86.nxml.txt.nlp	21368859	SENT82	11	11	23	23	doxorubicin	Mcl-1	PA449412	4170	0.862
NULL	Breast_Cancer_Res_2004_Jun_29_6(5)_R488-R498.nxml.txt.nlp	15318931	SENT10	29	29	14	14	estradiol	SULT1A1	PA449503	6817	0.862
NULL	Exp_Hematol_Oncol_2012_Sep_6_1_26.nxml.txt.nlp	23210433	SENT129	15	15	23	23	eculizumab	BCS	PA164776637	617	0.862
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2011_Jun_7_4_29-37.nxml.txt.nlp	22879792	SENT75	2	2	22	22	metformin	B12	PA450395	7126;4709	0.862
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Oct_31_66(Pt_11)_o2999.nxml.txt.nlp	21589160	SENT65	18	18	6	6	ethanol	mol	PA448073	90527	0.862
NULL	Infect_Dis_Ther_2014_Jun_18_3(1)_35-43.nxml.txt.nlp	25134810	SENT27	17	17	19	19	vancomycin	VAN	PA451850	10318	0.862
NULL	Cardiovasc_Diabetol_2005_Oct_5_4_16.nxml.txt.nlp	16207378	SENT163	34	34	6	6	glucosamine	perlecan	PA164747613	3339	0.862
NULL	Cancer_Immunol_Immunother_2013_Aug_27_62(10)_1637-1648.nxml.txt.nlp	23982484	SENT160	10	10	43	43	lenalidomide	STAT3	PA162363968	6774	0.862
NULL	J_Cell_Mol_Med_2014_Dec_7_18(12)_2536-2552.nxml.txt.nlp	25287328	SENT326	35	35	29	29	tamoxifen	PKD1	PA451581	5310	0.862
NULL	Exp_Ther_Med_2013_Jan_1_5(1)_338-342.nxml.txt.nlp	23251295	SENT153	11	11	5	5	everolimus	HK2	PA164746311	3796;3099;29911;3741	0.862
NULL	J_Cell_Mol_Med_2013_Feb_10_17(2)_233-241.nxml.txt.nlp	23301673	SENT162	18	18	5	5	cisplatin	REN	PA449014	5972;147040	0.862
NULL	Br_J_Cancer_2012_Oct_9_107(8)_1277-1285.nxml.txt.nlp	22990652	SENT164	21	21	5	5	axitinib	CYP2C8	PA164924493	1558	0.862
NULL	Front_Oncol_2013_Nov_15_3_281.nxml.txt.nlp	24298448	SENT193	18	18	40	40	fluorouracil	BRAF	PA128406956	673	0.862
NULL	J_Acquir_Immune_Defic_Syndr_2014_Jan_1_65(1)_78-81.nxml.txt.nlp	24419064	SENT32	26	26	16	16	tipranavir	CYP3A4	PA163522473	1576	0.862
NULL	Arthritis_Res_Ther_2005_Oct_26_7(6)_253-269.nxml.txt.nlp	16277701	SENT313	21	21	7	7	infliximab	DPPIV	PA452639	2191;1803	0.862
NULL	Cell_Death_Dis_2014_Jan_30_5(1)_e1030.nxml.txt.nlp	24481444	SENT111	28	28	22	22	sorafenib	Mcl-1	PA7000	4170	0.862
NULL	Acta_Pharmacol_Sin_2014_Sep_25_35(9)_1199-1206.nxml.txt.nlp	25152024	SENT92	5	5	9	9	cisplatin	mig-2	PA449014	10979	0.862
NULL	Nature_2012_Aug_16_488(7411)_337-342.nxml.txt.nlp	22895339	SENT40	19	19	6	6	doxycycline	ENO2	PA449415	2026	0.862
NULL	Springerplus_2014_Sep_17_3_535.nxml.txt.nlp	25279326	SENT30	13	13	8	8	fulvestrant	aromatase	PA164747170	1588	0.862
NULL	Cells_2014_Apr_4_3(2)_199-235.nxml.txt.nlp	24709958	SENT326	6	6	19	19	erlotinib	EGFR	PA134687924	1956	0.862
NULL	Clin_Exp_Gastroenterol_2012_May_14_5_49-59.nxml.txt.nlp	22649281	SENT76	16	16	19	19	esomeprazole	CYP2C19	PA10075	1557	0.862
NULL	Eur_J_Neurosci_2009_Jan_29(2)_307-318.nxml.txt.nlp	19200236	SENT22	10	10	1	1	fentanyl	GRK3	PA449599	157	0.862
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1137-1144.nxml.txt.nlp	20234366	SENT144	14	14	3	3	cetuximab	MKP-1	PA10040	1843	0.862
NULL	Mol_Biol_Cell_2012_Nov_1_23(21)_4212-4225.nxml.txt.nlp	22956765	SENT93	11	11	18	18	thrombin	SHP2	PA451674	5781	0.862
NULL	Oncotarget_2013_Aug_24_4(10)_1618-1631.nxml.txt.nlp	24113128	SENT217	5	5	12	12	sorafenib	CD31	PA7000	5175	0.862
NULL	Oncogene_2010_Sep_23_29(38)_5299-5310.nxml.txt.nlp	20622903	SENT290	4	4	8	8	melphalan	HMGB1	PA450354	3146	0.862
NULL	Oncol_Lett_2013_Jun_4_5(6)_1872-1876.nxml.txt.nlp	23833659	SENT86	12	12	4	4	flavopiridol	Bcl-2	PA452627	596	0.862
NULL	Cell_Commun_Signal_2005_Aug_9_3_10.nxml.txt.nlp	16091148	SENT72	2	2	17	17	isoproterenol	IL-8	PA450121	3576	0.862
NULL	Ann_Neurosci_2011_Apr_18(2)_48-55.nxml.txt.nlp	25205921	SENT118	7	7	14	14	forskolin	SOD1	PA146096022	6647	0.862
NULL	J_Carcinog_2011_Dec_31_10_40.nxml.txt.nlp	22368515	SENT95	16	16	20	20	ethanol	San	PA448073	80218	0.862
NULL	Indian_J_Med_Res_2013_Jan_137(1)_203-209.nxml.txt.nlp	23481074	SENT3	26	26	12	12	acenocoumarol	VKORC1	PA452632	79001	0.862
NULL	Acta_Neuropathol_Commun_2013_Aug_9_1_49.nxml.txt.nlp	24252504	SENT40	0	0	11	11	arsenite	HRI	PA452638	27102	0.862
NULL	Nat_Commun_2013_Aug_15_4_2130.nxml.txt.nlp	23945651	SENT647	43	43	35	35	etoposide	ATG5	PA449552	9474	0.862
NULL	Sci_Rep_2015_Jan_6_5_7642.nxml.txt.nlp	25560837	SENT137	10	10	6	6	sr144528	CB2		1269	0.862
NULL	Cardiovasc_Diabetol_2013_Oct_17_12_150.nxml.txt.nlp	24134550	SENT34	41	41	5	5	pioglitazone	activin	PA450970	83729	0.862
NULL	Br_J_Cancer_2013_Jul_9_109(1)_1-7.nxml.txt.nlp	23736035	SENT98	6	6	31	31	tamoxifen	STAR	PA451581	6770;2984	0.862
NULL	Cells_2012_Jul_6_1(3)_284-312.nxml.txt.nlp	24710477	SENT298	19	19	22	22	lapatinib	Bcl-2	PA152241907	596	0.862
NULL	Infect_Drug_Resist_2010_Apr_26_3_15-23.nxml.txt.nlp	21694890	SENT130	30	30	24	24	raltegravir	TRIO		7204	0.862
NULL	Nat_Med_2010_Feb_24_16(2)_214-218.nxml.txt.nlp	20098429	SENT53	6	6	14	14	doxorubicin	YWHAZ	PA449412	7534	0.862
NULL	Environ_Health_Perspect_2006_Sep_23_114(9)_1401-1406.nxml.txt.nlp	16966095	SENT167	7	7	15	15	arsenite	p53	PA452638	7157	0.862
NULL	Acta_Orthop_2010_Apr_6_81(2)_263-267.nxml.txt.nlp	20148646	SENT161	6	6	18	18	taurine	CHOP	PA451590	1649	0.862
NULL	Oncotarget_2014_Aug_29_5(19)_8947-8958.nxml.txt.nlp	25333254	SENT105	9	9	7	7	cytarabine	CXCR4	PA449177	7852	0.862
NULL	Int_J_Appl_Basic_Med_Res_2013_Jan-Jun_3(1)_19-21.nxml.txt.nlp	23776835	SENT24	3	3	9	9	ticagrelor	ADP	PA165374673	23038	0.862
NULL	Cell_Commun_Signal_2014_Jan_14_12_6.nxml.txt.nlp	24423080	SENT165	5	5	24	24	curcumin	JNK	PA151958596	5599	0.862
NULL	Front_Neural_Circuits_2015_Jan_12_8_150.nxml.txt.nlp	25628540	SENT270	5	5	9	9	midazolam	CA1	PA450496	759	0.862
NULL	J_Biol_Chem_2008_Oct_31_283(44)_29841-29846.nxml.txt.nlp	18765669	SENT19	26	26	30	30	suramin	P2X1	PA10292	5023	0.862
NULL	Case_Rep_Neurol_2011_Oct_14_3(3)_258-262.nxml.txt.nlp	22114583	SENT64	6	6	9	9	cidofovir	5-HT2A	PA448997	3356	0.862
NULL	Adv_Biomed_Res_2014_Jan_27_3_72.nxml.txt.nlp	24627880	SENT46	16	16	3	3	creatine	DMD	PA164778930	1756	0.862
NULL	Cancer_Cell_Int_2009_Jan_8_9_3.nxml.txt.nlp	19128511	SENT95	9	9	2	2	oxaliplatin	PI3K	PA131285527	5290	0.862
NULL	J_Exp_Med_1998_Mar_16_187(6)_855-864.nxml.txt.nlp	9500788	SENT121	0	0	13	13	trypsin	CD4	PA451806	920	0.862
NULL	Cell_Death_Dis_2012_Mar_15_3(3)_e283.nxml.txt.nlp	22419112	SENT23	15	15	27	27	cisplatin	CSIG	PA449014	26156	0.862
NULL	Front_Zool_2013_Aug_14_10_50.nxml.txt.nlp	23945354	SENT347	25	25	34	34	atropine	Gen	PA448505	348654	0.862
NULL	Adv_Hematol_2014_Dec_8_2014_735751.nxml.txt.nlp	25548568	SENT188	11	11	25	25	ethanol	ALDH2	PA448073	217	0.861
NULL	Environ_Health_Perspect_2007_Oct_19_115(10)_1454-1459.nxml.txt.nlp	17938735	SENT207	12	12	4	4	procainamide	p16	PA451108	1029	0.861
NULL	J_Oncol_2010_Feb_22_2010_891059.nxml.txt.nlp	20182637	SENT132	16	16	33	33	cisplatin	ERCC1	PA449014	2067	0.861
NULL	Indian_J_Pharm_Sci_2013_Jan-Feb_75(1)_94-98.nxml.txt.nlp	23901167	SENT69	12	12	37	37	phenacetin	CYP2C19	PA450897	1557	0.861
NULL	J_Cancer_Epidemiol_2012_Apr_12_2012_529357.nxml.txt.nlp	22570656	SENT84	30	30	14	14	aprepitant	CYP3A4	PA164747039	1576	0.861
NULL	Brain_Tumor_Res_Treat_2013_Apr_30_1(1)_32-35.nxml.txt.nlp	24904887	SENT43	26	26	20	20	vincristine	CHOP	PA451879	1649	0.861
NULL	Cancer_Cell_Int_2013_Jun_26_13_63.nxml.txt.nlp	23800022	SENT223	7	7	22	22	genistein	XIAP	PA165109660	331	0.861
NULL	J_Breast_Cancer_2013_Mar_31_16(1)_23-31.nxml.txt.nlp	23593078	SENT111	6	6	20	20	curcumin	DNMT1	PA151958596	1786	0.861
NULL	Cancers_(Basel)_2013_May_24_5(2)_569-590.nxml.txt.nlp	24216992	SENT243	13	13	6	6	cyclophosphamide	CD4	PA449165	920	0.861
NULL	Mol_Cancer_2014_Jul_5_13_165.nxml.txt.nlp	24996221	SENT111	8	8	0	0	docetaxel	HMGB1	PA449383	3146	0.861
NULL	Clinics_(Sao_Paulo)_2014_Jul_69(7)_491-496.nxml.txt.nlp	25029582	SENT104	13	13	18	18	methacholine	IL-4	PA165958382	3565	0.861
NULL	Eur_J_Nucl_Med_Mol_Imaging_2005_Feb_4_32(2)_153-162.nxml.txt.nlp	15690223	SENT227	26	26	12	12	imatinib	FDG	PA10804	23583	0.861
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Apr_25_68(Pt_5)_m664.nxml.txt.nlp	22590148	SENT74	20	20	15	15	ethanol	mol	PA448073	90527	0.861
NULL	Ann_Dermatol_2011_Nov_3_23(4)_526-528.nxml.txt.nlp	22148027	SENT48	14	14	21	21	erlotinib	EGF	PA134687924	1950	0.861
NULL	Mol_Cancer_2007_Aug_21_6_53.nxml.txt.nlp	17711579	SENT248	30	30	13	13	cisplatin	CAPN2	PA449014	824	0.861
NULL	Endocr_Connect_2012_Jun_8_1(1)_1-12.nxml.txt.nlp	23781298	SENT35	8	8	12	12	fenofibrate	adiponectin	PA449594	9370	0.861
NULL	Br_J_Cancer_2010_Jan_19_102(2)_325-331.nxml.txt.nlp	20051959	SENT107	27	27	21	21	neomycin	MRGBP	PA450608	55257	0.861
NULL	Nucleic_Acids_Res_2011_Oct_9_39(19)_8472-8487.nxml.txt.nlp	21745814	SENT301	38	38	11	11	spermine	ODC	PA164781199	4953;89874	0.861
NULL	Br_J_Pharmacol_2008_Dec_25_155(7)_1056-1065.nxml.txt.nlp	18724386	SENT257	39	39	20	20	diazoxide	GLP-1	PA449285	100125288	0.861
NULL	Ann_Clin_Microbiol_Antimicrob_2008_Jan_28_7_3.nxml.txt.nlp	18226256	SENT81	21	21	6	6	indinavir	SXR	PA449977	8856	0.861
NULL	Eur_J_Clin_Pharmacol_2011_Dec_23_67(12)_1231-1241.nxml.txt.nlp	21698374	SENT269	7	7	4	4	tacrolimus	CYP3A5	PA451578	1577	0.861
NULL	Mol_Biol_Cell_2012_Mar_15_23(6)_996-1009.nxml.txt.nlp	22278744	SENT90	13	13	7	7	forskolin	14-3-3	PA146096022	10971	0.861
NULL	Mol_Cancer_2008_Jun_30_7_60.nxml.txt.nlp	18590557	SENT72	24	24	39	39	doxorubicin	TRAIL	PA449412	8743	0.861
NULL	Nat_Med_2011_May_1_17(5)_604-609.nxml.txt.nlp	21532597	SENT52	9	9	31	31	daclizumab	IL-2	PA164764446	3558	0.861
NULL	Breast_Cancer_Res_Treat_2013_Oct_8_141(3)_437-446.nxml.txt.nlp	24101324	SENT173	19	19	9	9	everolimus	HER2	PA164746311	2064	0.861
NULL	Open_Med_Chem_J_2010_May_27_4_20-36.nxml.txt.nlp	21160908	SENT111	43	43	18	18	clozapine	c-fos	PA449061	2353	0.861
NULL	Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.nxml.txt.nlp	24736980	SENT110	37	37	27	27	rosuvastatin	BSP	PA134308647	3381	0.861
NULL	Case_Rep_Oncol_2014_Mar_26_7(1)_204-209.nxml.txt.nlp	24803896	SENT57	14	14	11	11	trabectedin	MRCL	PA165958349	348174	0.861
NULL	J_Exp_Clin_Cancer_Res_2009_Jun_2_28(1)_72.nxml.txt.nlp	19490637	SENT9	27	27	13	13	verapamil	DDP	PA451868	1678	0.861
NULL	J_Antimicrob_Chemother_2014_Dec_20_69(12)_3329-3334.nxml.txt.nlp	25147095	SENT92	5	5	19	19	nevirapine	NIR	PA450616	26155	0.861
NULL	Oncotarget_2010_Oct_25_1(7)_497-514.nxml.txt.nlp	21165163	SENT75	11	11	8	8	cetuximab	EGFR	PA10040	1956	0.861
NULL	Exp_Brain_Res_2014_Jun_27_232(8)_2637-2644.nxml.txt.nlp	24969614	SENT6	18	18	31	31	palonosetron	NK1	PA10352	11126	0.861
NULL	Indian_J_Nephrol_2014_Mar-Apr_24(2)_117-119.nxml.txt.nlp	24701046	SENT67	12	12	5	5	ifosfamide	KIN	PA449964	22944	0.861
NULL	Antonie_Van_Leeuwenhoek_2014_Aug_5_106_693-706.nxml.txt.nlp	25090957	SENT155	10	10	29	29	glucosamine	LTA	PA164747613	4049	0.861
NULL	Breast_Cancer_(Auckl)_2009_Apr_7_3_23-34.nxml.txt.nlp	21556247	SENT20	38	38	43	43	trastuzumab	HER-2	PA451743	2064	0.861
NULL	Oxid_Med_Cell_Longev_2012_Jan_19_2012_390678.nxml.txt.nlp	22315655	SENT3	5	5	17	17	gliclazide	NAC	PA10892	22861	0.861
NULL	Mol_Cancer_2008_Mar_26_7_27.nxml.txt.nlp	18366759	SENT145	26	26	7	7	etoposide	p53	PA449552	7157	0.861
NULL	FEBS_Open_Bio_2013_Aug_19_3_379-386.nxml.txt.nlp	24251099	SENT178	17	17	23	23	nadh	ADP	PA164755085	23038	0.861
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT13	0	0	5	5	phenprocoumon	VKORC1	PA450921	79001	0.861
NULL	Braz_J_Med_Biol_Res_2013_May_10_46(5)_433-439.nxml.txt.nlp	23681290	SENT141	8	8	0	0	bezafibrate	BAFF	PA162364313	10673	0.861
NULL	Int_J_Endocrinol_2014_Jul_14_2014_535401.nxml.txt.nlp	25132853	SENT139	21	21	0	0	chloramphenicol	FBP1	PA448927	2203	0.861
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1047.nxml.txt.nlp	24503539	SENT152	6	6	13	13	resveratrol	SIRT3		23410	0.861
NULL	Indian_J_Pharm_Sci_2014_Mar-Apr_76(2)_166-169.nxml.txt.nlp	24843191	SENT67	6	6	22	22	nebivolol	HEC	PA151958426	10403	0.861
NULL	Arthritis_Res_Ther_2012_Dec_7_14(6)_R265.nxml.txt.nlp	23217273	SENT23	0	0	11	11	lenalidomide	CLE	PA162363968	51637	0.861
NULL	Int_J_Breast_Cancer_2011_Sep_6_2011_352182.nxml.txt.nlp	22295219	SENT133	22	22	27	27	trastuzumab	PTEN	PA451743	5728	0.861
NULL	Int_J_Biomed_Sci_2006_Jun_2(2)_114-120.nxml.txt.nlp	23674973	SENT111	12	12	30	30	hydrocortisone	IL-10	PA449905	3586	0.861
NULL	Acta_Neuropathol_2015_Oct_17_129_81-96.nxml.txt.nlp	25322817	SENT145	6	6	18	18	capsaicin	TRPV1	PA448776	7442	0.861
NULL	Br_J_Cancer_2010_Jul_27_103(3)_340-346.nxml.txt.nlp	20606684	SENT25	10	10	8	8	cetuximab	EGFR	PA10040	1956	0.861
NULL	Oncogene_2014_Aug_28_33(35)_4396-4406.nxml.txt.nlp	24531714	SENT58	29	29	2	2	nutlin-3	MDM2		4193	0.861
NULL	Breast_J_2013_Sep_19_19(5)_470-477.nxml.txt.nlp	23865786	SENT64	14	14	27	27	tamoxifen	aromatase	PA451581	1588	0.861
NULL	Br_J_Cancer_2009_Sep_15_101(6)_957-966.nxml.txt.nlp	19738618	SENT148	39	39	34	34	dexrazoxane	THBS-1	PA449259	7057	0.861
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT232	8	8	17	17	clozapine	PRL	PA449061	5617	0.861
NULL	Curr_Pharm_Des_2012_Apr_18(11)_1519-1530.nxml.txt.nlp	22364136	SENT115	5	5	17	17	atorvastatin	CD40	PA448500	958	0.861
NULL	Indian_J_Endocrinol_Metab_2013_May-Jun_17(3)_402-412.nxml.txt.nlp	23869295	SENT51	0	0	6	6	orlistat	PON1	PA164776864	5444	0.861
NULL	Clin_Ophthalmol_2008_Dec_2(4)_897-905.nxml.txt.nlp	19668444	SENT130	3	3	9	9	latanoprost	BAK	PA164774763	578	0.861
NULL	Acta_Physiol_(Oxf)_2007_Sep_191(1)_43-57.nxml.txt.nlp	17524066	SENT144	17	17	2	2	nifedipine	PES	PA450631	23481	0.861
NULL	Ann_Oncol_2014_Oct_18_25(10)_1871-1888.nxml.txt.nlp	25234545	SENT325	22	22	29	29	tamoxifen	aromatase	PA451581	1588	0.861
NULL	J_Inherit_Metab_Dis_2010_Oct_3_33(5)_625-632.nxml.txt.nlp	20814828	SENT90	2	2	15	15	simvastatin	RhoA	PA451363	387	0.861
NULL	Am_J_Trop_Med_Hyg_2011_Jan_5_84(1)_5-14.nxml.txt.nlp	21212194	SENT44	23	23	14	14	albendazole	STH	PA164746058	246744	0.861
NULL	Semin_Immunopathol_2013_Jan_26_35(1)_39-52.nxml.txt.nlp	22829332	SENT197	14	14	18	18	cytarabine	CHOP	PA449177	1649	0.861
NULL	J_Invest_Dermatol_2013_Jun_14_133(6)_1541-1549.nxml.txt.nlp	23407395	SENT73	15	15	21	21	imiquimod	CXCL2	PA449972	2920	0.861
NULL	J_Clin_Biochem_Nutr_2011_Mar_26_48(2)_154-160.nxml.txt.nlp	21373269	SENT11	21	21	9	9	dextran	IFN	PA449261	3439	0.861
NULL	Infect_Dis_Ther_2014_Dec_5_3(2)_69-81.nxml.txt.nlp	25475412	SENT80	29	29	8	8	colistin	VAN	PA164760862	10318	0.861
NULL	Bioinformation_2012_Jul_6_8(13)_634-638.nxml.txt.nlp	22829745	SENT77	31	31	44	44	nadh	CO2	PA164755085	4513	0.861
NULL	Evid_Based_Complement_Alternat_Med_2013_May_15_2013_413808.nxml.txt.nlp	23762130	SENT198	8	8	36	36	ethanol	BACE1	PA448073	23621	0.861
NULL	Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.nxml.txt.nlp	24736980	SENT225	12	12	1	1	rosuvastatin	OATP1B1	PA134308647	10599	0.861
NULL	G3_(Bethesda)_2014_Nov_5_4(12)_2493-2503.nxml.txt.nlp	25378474	SENT126	25	25	37	37	gentamicin	CO2	PA449753	4513	0.861
NULL	Br_J_Cancer_2002_Jan_21_86(2)_218-221.nxml.txt.nlp	11870509	SENT71	8	8	16	16	tamoxifen	BRCA1	PA451581	672	0.861
NULL	Biochemistry_2011_May_3_50(17)_3408-3410.nxml.txt.nlp	21425834	SENT7	14	14	24	24	nadh	VDAC2	PA164755085	7417	0.861
NULL	J_Bras_Pneumol_2013_May-Jun_39(3)_257-258.nxml.txt.nlp	23857696	SENT23	17	17	30	30	esomeprazole	GOR	PA10075	254958	0.861
NULL	Pharmaceutics_2011_Nov_18_3(4)_865-913.nxml.txt.nlp	24309312	SENT500	30	30	16	16	ximelagatran	P-gp	PA161748474	5243	0.861
NULL	Allergy_Asthma_Immunol_Res_2010_Jul_19_2(3)_177-182.nxml.txt.nlp	20592916	SENT91	42	42	9	9	montelukast	MRP1	PA450546	4437	0.861
NULL	Mol_Cells_2014_Mar_31_37(3)_234-240.nxml.txt.nlp	24642709	SENT102	12	12	3	3	capsaicin	TLR4	PA448776	7099	0.861
NULL	Mol_Vis_2012_Apr_11_18_901-908.nxml.txt.nlp	22539869	SENT157	9	9	2	2	curcumin	p38	PA151958596	10598;1432;7965	0.861
NULL	Oncotarget_2011_Dec_20_2(12)_1094-1108.nxml.txt.nlp	22190353	SENT144	10	10	27	27	gemcitabine	p53	PA449748	7157	0.861
NULL	Cell_Biol_Int_Rep_(2010)_2012_Jun_21_19(1)_e00017.nxml.txt.nlp	23124518	SENT133	23	23	11	11	etoposide	p65	PA449552	5970	0.861
NULL	J_Young_Pharm_2010_Jul-Sep_2(3)_326-331.nxml.txt.nlp	21042495	SENT127	24	24	22	22	fluvastatin	CYP3A4	PA449688	1576	0.861
NULL	Case_Rep_Pediatr_2013_Feb_20_2013_727824.nxml.txt.nlp	23509655	SENT86	17	17	1	1	vancomycin	BSAC	PA451850	57591	0.861
NULL	FEBS_Open_Bio_2012_Aug_22_2_279-283.nxml.txt.nlp	23650611	SENT100	4	4	20	20	raloxifene	IFN	PA451221	3439	0.861
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Apr_8_65(Pt_5)_o1004.nxml.txt.nlp	21583829	SENT72	15	15	37	37	piperazine	mol	PA450977	90527	0.861
NULL	Pain_Ther_2014_Dec_29_3(2)_73-84.nxml.txt.nlp	25069571	SENT38	29	29	37	37	capsaicin	TRPV1	PA448776	7442	0.861
NULL	J_Oncol_2010_Aug_24_2010_654348.nxml.txt.nlp	20871846	SENT179	4	4	20	20	anastrozole	ATAC	PA448432	6375	0.861
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jun_25_67(Pt_7)_o1809.nxml.txt.nlp	21837180	SENT68	11	11	6	6	ethanol	mol	PA448073	90527	0.861
NULL	Br_J_Cancer_2011_Aug_23_105(5)_649-657.nxml.txt.nlp	21811251	SENT147	8	8	14	14	gefitinib	AKT	PA131301952	207	0.861
NULL	Biomed_Res_Int_2013_Sep_4_2013_185362.nxml.txt.nlp	24093091	SENT115	42	42	35	35	vincristine	CHOP	PA451879	1649	0.861
NULL	Breast_Cancer_Res_2007_Jan_23_9(1)_R7.nxml.txt.nlp	17244352	SENT18	15	15	10	10	tamoxifen	CYP3A5	PA451581	1577	0.861
NULL	J_RNAi_Gene_Silencing_2009_Mar_9_5(1)_321-330.nxml.txt.nlp	19771229	SENT229	20	20	2	2	hydroxyurea	RRM1	PA449942	6240	0.861
NULL	Nat_Chem_Biol_2008_Nov_12_4(11)_691-699.nxml.txt.nlp	18849971	SENT127	25	25	20	20	imatinib	PP1	PA10804	5540;5464	0.861
NULL	Mol_Cancer_2010_Jun_25_9_166.nxml.txt.nlp	20579378	SENT245	18	18	12	12	gefitinib	EGF	PA131301952	1950	0.861
NULL	Diabetes_Metab_Syndr_Obes_2013_Sep_2_6_317-325.nxml.txt.nlp	24039439	SENT58	9	9	19	19	voglibose	GLP-1	PA164752433	100125288	0.861
NULL	Br_J_Cancer_2014_Nov_25_111(11)_2091-2102.nxml.txt.nlp	25349971	SENT314	32	32	12	12	imatinib	PTPN18	PA10804	26469	0.861
NULL	Exp_Diabetes_Res_2012_Dec_26_2012_230624.nxml.txt.nlp	23365557	SENT185	1	1	36	36	liraglutide	LIR1	PA165958364	10859	0.861
NULL	Can_J_Infect_Dis_Med_Microbiol_2014_May-Jun_25(3)_155-158.nxml.txt.nlp	25285112	SENT80	23	23	29	29	clarithromycin	TMP	PA449028	2012	0.861
NULL	Cardiovasc_Diabetol_2011_Dec_22_10_115.nxml.txt.nlp	22189184	SENT115	10	10	15	15	miglitol	GLP-1	PA164776726	100125288	0.861
NULL	Indian_J_Orthop_2010_Jul-Sep_44(3)_246-251.nxml.txt.nlp	20697475	SENT14	7	7	18	18	vancomycin	DBM	PA451850	1621	0.861
NULL	Cancer_Cell_Int_2003_Jul_23_3_12.nxml.txt.nlp	12914669	SENT13	43	43	11	11	tetracycline	PP1	PA451640	5540;5464	0.861
NULL	J_Infect_Dis_2011_Oct_1_204(7)_1104-1114.nxml.txt.nlp	21881126	SENT162	6	6	0	0	chloroquine	MxA	PA448948	4599	0.861
NULL	Eur_Respir_J_2013_Dec_30_42(6)_1484-1494.nxml.txt.nlp	23722616	SENT166	7	7	11	11	tiotropium	TDI	PA164769056	100038246	0.861
NULL	Arthritis_Res_Ther_2006_May_11_8(3)_209.nxml.txt.nlp	16712713	SENT446	32	32	28	28	anakinra	TNF	PA10799	7124	0.861
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Jan_15_70(Pt_2)_o138.nxml.txt.nlp	24764864	SENT81	14	14	9	9	ethanol	mol	PA448073	90527	0.861
NULL	Br_J_Cancer_2011_Jul_26_105(3)_372-381.nxml.txt.nlp	21730979	SENT240	18	18	25	25	cisplatin	PARP	PA449014	142	0.861
NULL	ScientificWorldJournal_2014_May_19_2014_567148.nxml.txt.nlp	24971383	SENT168	9	9	17	17	epirubicin	TLR4	PA449476	7099	0.861
NULL	Oncotarget_2012_Dec_17_4(1)_48-63.nxml.txt.nlp	23295955	SENT188	22	22	34	34	methotrexate	MTHFD2	PA450428	10797	0.861
NULL	JRSM_Cardiovasc_Dis_2012_Sep_24_1(6)_cvd_2012_012015.nxml.txt.nlp	24175073	SENT144	43	43	17	17	aspirin	CYP2C19	PA448497	1557	0.861
NULL	Br_J_Cancer_2011_Jul_26_105(3)_372-381.nxml.txt.nlp	21730979	SENT205	6	6	12	12	hydroxyurea	ATR	PA449942	390502;84168;545	0.861
NULL	Nucleic_Acids_Res_2012_Jul_30_40(13)_6319-6337.nxml.txt.nlp	22467215	SENT266	15	15	3	3	cisplatin	Bcl-2	PA449014	596	0.861
NULL	Exp_Mol_Med_2012_Feb_29_44(2)_159-166.nxml.txt.nlp	22127053	SENT43	0	0	3	3	simvastatin	RhoA	PA451363	387	0.861
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT207	31	31	17	17	metformin	HIP	PA450395	6767;6159;64399;5068	0.861
NULL	Arch_Med_Sci_2014_Aug_29_10(4)_684-691.nxml.txt.nlp	25276151	SENT21	13	13	31	31	dobutamine	CRT	PA449381	811	0.861
NULL	Mol_Cancer_2010_Jun_25_9_165.nxml.txt.nlp	20576164	SENT218	24	24	19	19	curcumin	STAT3	PA151958596	6774	0.861
NULL	Acta_Histochem_Cytochem_2013_Dec_28_46(6)_187-197.nxml.txt.nlp	24610966	SENT4	20	20	36	36	isoproterenol	AQP5	PA450121	362	0.861
NULL	Anemia_2012_May_23_2012_265790.nxml.txt.nlp	22675615	SENT357	15	15	38	38	etanercept	HOXB4	PA449515	3214	0.861
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Mar_5_67(Pt_4)_o795.nxml.txt.nlp	21754085	SENT62	24	24	6	6	ethanol	mol	PA448073	90527	0.861
NULL	Emerg_Infect_Dis_2012_Mar_18(3)_537-539.nxml.txt.nlp	22377132	SENT22	16	16	7	7	amikacin	EMB	PA164744372	133418	0.861
NULL	Cell_Logist_2014_Jan_9_4_e27732.nxml.txt.nlp	24843827	SENT58	33	33	7	7	perifosine	PI3K	PA165291471	5290	0.861
NULL	Dev_Immunol_1995_4(3)_189-197.nxml.txt.nlp	8770558	SENT4	18	18	44	44	mitomycin	IL-2	PA450524	3558	0.861
NULL	Aging_Cell_2012_Aug_11(4)_579-587.nxml.txt.nlp	22435726	SENT157	38	38	26	26	etoposide	p53	PA449552	7157	0.861
NULL	Nat_Commun_2012_Apr_17_3_782.nxml.txt.nlp	22510687	SENT193	16	16	1	1	thrombin	MHF1	PA451674	378708	0.861
NULL	Cancer_Cell_Int_2011_Nov_2_11_39.nxml.txt.nlp	22047021	SENT392	39	39	23	23	cisplatin	RAD18	PA449014	56852	0.861
NULL	Breast_Cancer_Res_2004_Mar_26_6(3)_R252-R263.nxml.txt.nlp	15084249	SENT163	29	29	10	10	tamoxifen	NAT1	PA451581	9;1982	0.861
NULL	Cell_Death_Dis_2013_Oct_3_4(10)_e827.nxml.txt.nlp	24091670	SENT14	12	12	2	2	nilotinib	PI3K	PA165958345	5290	0.861
NULL	Arthritis_Res_Ther_2005_Feb_17_7(Suppl_1)_P74.nxml.txt.nlp	NULL	SENT18	27	27	30	30	losartan	mol	PA450268	90527	0.861
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2675-2684.nxml.txt.nlp	24129246	SENT308	19	19	12	12	etoposide	KSR1	PA449552	8844	0.861
NULL	Oncotarget_2012_Oct_27_3(10)_1052-1053.nxml.txt.nlp	23165648	SENT25	26	26	12	12	nutlin-3	IFN		3439	0.861
NULL	Adv_Biomed_Res_2014_Sep_8_3_189.nxml.txt.nlp	25298958	SENT75	26	26	30	30	clarithromycin	NAC	PA449028	22861	0.861
NULL	Drug_Target_Insights_2013_Aug_19_7_27-34.nxml.txt.nlp	24023511	SENT83	11	11	9	9	verapamil	P-gp	PA451868	5243	0.861
NULL	Infect_Drug_Resist_2014_May_20_7_129-135.nxml.txt.nlp	24876786	SENT7	28	28	33	33	vancomycin	HAP	PA451850	5915;10313	0.861
NULL	BMB_Rep_2013_Feb_46(2)_92-96.nxml.txt.nlp	23433111	SENT33	26	26	16	16	etoposide	BRCA1	PA449552	672	0.861
NULL	Br_J_Cancer_2004_Mar_22_90(6)_1285-1292.nxml.txt.nlp	15026814	SENT97	6	6	11	11	doxorubicin	p53	PA449412	7157	0.861
NULL	AAPS_J_2011_May_11_13(3)_365-377.nxml.txt.nlp	21560017	SENT180	19	19	6	6	ethanol	AKR1C3	PA448073	8644	0.861
NULL	J_Antimicrob_Chemother_2009_Oct_13_64(4)_829-836.nxml.txt.nlp	19679597	SENT18	22	22	6	6	tobramycin	SMF	PA451704	22993	0.861
NULL	Exp_Ther_Med_2013_Jan_10_5(1)_11-16.nxml.txt.nlp	23251234	SENT7	5	5	26	26	cetuximab	EGFR	PA10040	1956	0.861
NULL	J_Neurosci_Rural_Pract_2014_Nov_5(Suppl_1)_S7-S12.nxml.txt.nlp	25540548	SENT68	8	8	10	10	clobazam	CLB	PA10888	171425	0.861
NULL	J_Breast_Cancer_2013_Jun_28_16(2)_164-170.nxml.txt.nlp	23843848	SENT150	15	15	23	23	doxorubicin	p53	PA449412	7157	0.861
NULL	Exp_Hematol_2009_Oct_37(10)_1238-1249_e5.nxml.txt.nlp	19619605	SENT403	20	20	15	15	indomethacin	TPO	PA449982	7066;7173	0.861
NULL	Oncol_Lett_2014_Jul_16_8(1)_211-217.nxml.txt.nlp	24959248	SENT96	7	7	11	11	cisplatin	ANGPTL4	PA449014	51129	0.861
NULL	Oncotarget_2012_May_19_3(5)_535-545.nxml.txt.nlp	22619121	SENT77	9	9	16	16	camptothecin	TPT	PA153590860	23590;6469	0.861
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1821-1889.nxml.txt.nlp	25268160	SENT447	8	8	2	2	sorafenib	SHARP	PA7000	23013	0.861
NULL	Br_J_Clin_Pharmacol_2013_Aug_23_76(2)_299-315.nxml.txt.nlp	23701319	SENT240	8	8	16	16	daclizumab	CD25	PA164764446	3669;3559	0.861
NULL	Int_J_Biol_Sci_2013_Mar_7_9(3)_279-288.nxml.txt.nlp	23493630	SENT165	18	18	12	12	tocilizumab	CD4	PA165292659	920	0.861
NULL	Diabetes_2013_Sep_15_62(9)_3224-3231.nxml.txt.nlp	23545707	SENT26	43	43	23	23	losartan	ACR	PA450268	49	0.861
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_45-53.nxml.txt.nlp	17912635	SENT2	21	21	1	1	tamoxifen	aromatase	PA451581	1588	0.861
NULL	Nucleic_Acids_Res_2012_Jul_5_40(13)_5988-6000.nxml.txt.nlp	22492511	SENT130	4	4	0	0	flavopiridol	CDK9	PA452627	1025	0.861
NULL	Oncotarget_2012_Sep_11_3(9)_1026-1035.nxml.txt.nlp	22976441	SENT103	26	26	19	19	etoposide	CKI	PA449552	1119	0.861
NULL	Acta_Pharmacol_Sin_2012_Mar_27_33(3)_342-350.nxml.txt.nlp	22367283	SENT193	27	27	19	19	thrombin	PAR1	PA451674	79581;2149	0.861
NULL	Aging_(Albany_NY)_2010_Nov_9_2(12)_981-989.nxml.txt.nlp	21098885	SENT141	13	13	1	1	paraformaldehyde	CD36	PA450790	948	0.861
NULL	Nucleic_Acids_Res_2013_May_5_41(10)_5210-5222.nxml.txt.nlp	23563151	SENT239	1	1	6	6	arsenite	p53	PA452638	7157	0.861
NULL	J_Cancer_Res_Clin_Oncol_2013_Feb_10_139(2)_269-280.nxml.txt.nlp	23052698	SENT44	4	4	10	10	tamoxifen	aromatase	PA451581	1588	0.861
NULL	Mol_Cancer_2010_Aug_20_9_220.nxml.txt.nlp	20727180	SENT110	35	35	13	13	nicotine	AP-1	PA450626	2353;3727;2354;3725	0.861
NULL	Endocrinol_Metab_(Seoul)_2014_Sep_25_29(3)_379-387.nxml.txt.nlp	25309798	SENT118	4	4	8	8	resveratrol	SIRT1		23411	0.861
NULL	Cells_2014_May_23_3(2)_517-545.nxml.txt.nlp	24861977	SENT1550	8	8	4	4	capsaicin	TRPV1	PA448776	7442	0.861
NULL	Arthritis_Res_Ther_2004_Oct_17_6(1)_R7-R14.nxml.txt.nlp	14979933	SENT134	6	6	20	20	naloxone	VIII	PA450586	1351	0.861
NULL	Diabetes_Care_2009_Sep_5_32(9)_1589-1590.nxml.txt.nlp	19502536	SENT70	11	11	16	16	metformin	B12	PA450395	7126;4709	0.861
NULL	Eur_J_Med_Res_2009_Nov_24_14(Suppl_3)_17-21.nxml.txt.nlp	19959412	SENT56	19	19	12	12	raltegravir	UGT		7361;7355	0.861
NULL	Exp_Diabetes_Res_2012_Mar_15_2012_146194.nxml.txt.nlp	22474415	SENT213	14	14	8	8	valsartan	GLP-1	PA451848	100125288	0.861
NULL	Indian_J_Endocrinol_Metab_2013_Nov-Dec_17(6)_996-1004.nxml.txt.nlp	24381874	SENT70	16	16	10	10	vasopressin	AVP	PA451858	114548;551	0.861
NULL	Oncol_Rep_2013_Oct_24_30(4)_1587-1592.nxml.txt.nlp	23900512	SENT129	15	15	8	8	pargyline	NOXA	PA450797	5366	0.861
NULL	Br_J_Cancer_2014_Jan_7_110(1)_55-62.nxml.txt.nlp	24263064	SENT139	19	19	22	22	gefitinib	EGFR	PA131301952	1956	0.861
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT275	19	19	10	10	acenocoumarol	CYP2C9	PA452632	1559	0.861
NULL	Breast_Cancer_Res_2008_Dec_5_10(6)_R104.nxml.txt.nlp	19061505	SENT233	20	20	5	5	estradiol	JNK	PA449503	5599	0.861
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S291-S296.nxml.txt.nlp	21525471	SENT174	10	10	12	12	valsartan	STAR	PA451848	6770;2984	0.861
NULL	Tumour_Biol_2013_Jun_5_34(3)_1371-1380.nxml.txt.nlp	23558965	SENT124	4	4	9	9	genistein	TERT	PA165109660	7015	0.861
NULL	Exp_Ther_Med_2013_Mar_24_5(3)_902-906.nxml.txt.nlp	23408108	SENT112	18	18	16	16	anastrozole	aromatase	PA448432	1588	0.861
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT44	8	8	15	15	nutlin-3	p53		7157	0.861
NULL	Biologics_2014_Apr_23_8_183-192.nxml.txt.nlp	24790411	SENT93	36	36	40	40	afatinib	EGFR	PA165981154	1956	0.861
NULL	Int_J_Breast_Cancer_2012_May_9_2012_415170.nxml.txt.nlp	22649737	SENT161	10	10	26	26	lapatinib	EGFR	PA152241907	1956	0.861
NULL	Acta_Pharmacol_Sin_2011_Jul_9_32(7)_879-887.nxml.txt.nlp	21552292	SENT93	10	10	17	17	metformin	AMPK	PA450395	5563	0.861
NULL	Br_J_Cancer_2011_Jun_7_104(12)_1822-1827.nxml.txt.nlp	21587257	SENT187	11	11	4	4	cisplatin	VWF	PA449014	7450	0.861
NULL	Int_J_Vasc_Med_2014_Nov_17_2014_254270.nxml.txt.nlp	25485154	SENT453	1	1	11	11	probenecid	HMGB1	PA451106	3146	0.861
NULL	Biomed_Res_Int_2013_Jul_16_2013_687658.nxml.txt.nlp	23956997	SENT13	12	12	5	5	l-alanine	AGXT	PA448055	189	0.861
NULL	J_Young_Pharm_2010_Jul-Sep_2(3)_311-314.nxml.txt.nlp	21042492	SENT79	7	7	12	12	heparin	GIT	PA449855	5034	0.861
NULL	Indian_J_Pharm_Sci_2013_Jul-Aug_75(4)_406-412.nxml.txt.nlp	24302794	SENT17	0	0	32	32	etodolac	COX	PA449550	1351	0.861
NULL	ScientificWorldJournal_2014_Feb_9_2014_964380.nxml.txt.nlp	24764772	SENT113	0	0	12	12	paliperidone	VIII	PA163518919	1351	0.861
NULL	Cancers_(Basel)_2011_Mar_3_3(1)_1042-1080.nxml.txt.nlp	24212653	SENT374	9	9	1	1	genistein	GPR78	PA165109660	27201	0.861
NULL	Exp_Diabetes_Res_2012_Jun_28_2012_518426.nxml.txt.nlp	21754923	SENT70	12	12	1	1	paraformaldehyde	P18	PA450790	7975;10168	0.861
NULL	Oxid_Med_Cell_Longev_2013_Sep_24_2013_102741.nxml.txt.nlp	24205431	SENT238	2	2	7	7	hesperidin	Bcl-2	PA449867	596	0.861
NULL	J_Headache_Pain_2012_Jun_20_13(4)_271-275.nxml.txt.nlp	22430431	SENT29	1	1	4	4	sumatriptan	5-HT1B	PA451566	3351	0.861
NULL	Iran_J_Pediatr_2011_Dec_21(4)_497-501.nxml.txt.nlp	23056838	SENT44	15	15	17	17	diethylstilbestrol	DES	PA449307	1674	0.861
NULL	J_Gen_Intern_Med_2009_May_21_24(5)_656-664.nxml.txt.nlp	19306050	SENT418	18	18	10	10	warfarin	CYP2C9	PA451906	1559	0.861
NULL	Acta_Pharmacol_Sin_2009_Oct_21_30(10)_1392-1398.nxml.txt.nlp	19767766	SENT86	0	0	9	9	atorvastatin	ROS	PA448500	6098	0.861
NULL	F1000Res_2013_Feb_28_2_65.nxml.txt.nlp	24358861	SENT358	20	20	18	18	naloxone	TLR4	PA450586	7099	0.861
NULL	Neural_Dev_2013_Mar_7_8_4.nxml.txt.nlp	23497494	SENT172	9	9	22	22	chlorpheniramine	FOXP2	PA448960	93986	0.861
NULL	Ann_Dermatol_2012_Feb_2_24(1)_39-44.nxml.txt.nlp	22363154	SENT115	13	13	20	20	genistein	AMPK	PA165109660	5563	0.861
NULL	Biomed_Res_Int_2013_Jan_21_2013_581631.nxml.txt.nlp	23484133	SENT81	10	10	0	0	infliximab	GM-CSF	PA452639	1437	0.861
NULL	Biochem_Res_Int_2012_Mar_20_2012_951539.nxml.txt.nlp	22482055	SENT213	8	8	4	4	doxorubicin	p300	PA449412	2033	0.861
NULL	Indian_J_Med_Res_2013_May_137(5)_977-980.nxml.txt.nlp	23760386	SENT87	7	7	20	20	galantamine	ADP	PA449726	23038	0.861
NULL	J_Korean_Med_Sci_2007_Dec_20_22(6)_1055-1059.nxml.txt.nlp	18162722	SENT117	9	9	19	19	pantoprazole	ESD	PA450774	2098	0.861
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT126	2	2	8	8	phenprocoumon	VKORC1	PA450921	79001	0.861
NULL	J_Cell_Biol_1997_May_5_137(3)_595-608.nxml.txt.nlp	9151667	SENT2	30	30	6	6	papain	INS-1	PA450778	2305	0.861
NULL	J_Cell_Biol_1999_Feb_8_144(3)_575-586.nxml.txt.nlp	9971750	SENT91	20	20	32	32	paraformaldehyde	FAST	PA450790	10922	0.861
NULL	Indian_J_Pharmacol_2008_Oct_40(Suppl_2)_S150-S160.nxml.txt.nlp	21593968	SENT221	0	0	21	21	carrageenan	COX	PA448814	1351	0.861
NULL	Bioinformation_2012_Jan_6_8(1)_13-19.nxml.txt.nlp	22359429	SENT165	19	19	4	4	curcumin	MRP1	PA151958596	4437	0.861
NULL	Mol_Vis_2012_Apr_11_18_901-908.nxml.txt.nlp	22539869	SENT12	0	0	12	12	curcumin	HO-1	PA151958596	3162	0.861
NULL	Mol_Cancer_2009_Nov_10_8_99.nxml.txt.nlp	19903356	SENT76	12	12	16	16	imatinib	IGFBP3	PA10804	3486	0.861
NULL	Mol_Cells_2014_Sep_30_37(9)_664-671.nxml.txt.nlp	25234467	SENT160	12	12	2	2	cisplatin	miR-217	PA449014	406999	0.861
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_21-38.nxml.txt.nlp	19305786	SENT255	5	5	30	30	ifosfamide	TRPA1	PA449964	8989	0.861
NULL	Breast_Cancer_Res_2011_Nov_30_13(6)_R123.nxml.txt.nlp	22129105	SENT245	10	10	1	1	trastuzumab	CD32A	PA451743	2212	0.861
NULL	J_Oncol_2009_Mar_24_2009_491985.nxml.txt.nlp	19325924	SENT87	11	11	2	2	genistein	CXCR4	PA165109660	7852	0.861
NULL	Diabetes_Care_2009_Aug_32(8)_1398-1403.nxml.txt.nlp	19549737	SENT106	22	22	2	2	hydrochlorothiazide	ANOVA	PA449899	4858	0.861
NULL	Kidney_Int_Suppl_(2011)_2013_Dec_27_3(5)_451-456.nxml.txt.nlp	25019029	SENT81	29	29	19	19	cinacalcet	PTH	PA164776671	5741	0.861
NULL	Ann_Oncol_2011_Aug_27_22(8)_1736-1747.nxml.txt.nlp	21709140	SENT205	20	20	9	9	tamoxifen	slim	PA451581	23008	0.861
NULL	Biologics_2012_Feb_1_6_31-35.nxml.txt.nlp	22355257	SENT66	33	33	18	18	rituximab	IL-6	PA451261	3569	0.861
NULL	Cell_Death_Differ_2009_May_27_16(5)_758-769.nxml.txt.nlp	19247369	SENT65	2	2	9	9	nutlin-3	p53		7157	0.861
NULL	Ann_Rheum_Dis_2012_Sep_71(9)_1510-1516.nxml.txt.nlp	22440821	SENT241	24	24	16	16	adalimumab	adiponectin	PA10004	9370	0.861
NULL	Mol_Cancer_2013_Nov_13_12_137.nxml.txt.nlp	24225025	SENT198	2	2	23	23	doxorubicin	MRP1	PA449412	4437	0.861
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Dec_17_3(12)_e152.nxml.txt.nlp	25518025	SENT48	9	9	6	6	paroxetine	CYP2D6	PA450801	1565	0.861
NULL	J_Cardiovasc_Electrophysiol_2010_Oct_21(10)_1153-1159.nxml.txt.nlp	20384647	SENT100	18	18	12	12	quinidine	PES	PA451209	23481	0.861
NULL	Arthritis_Res_Ther_2012_Sep_24_14(5)_R200.nxml.txt.nlp	23006144	SENT6	3	3	6	6	alefacept	IL-20	PA164748040	27190;50604	0.861
NULL	Int_J_Mol_Sci_2012_Aug_23_13(8)_10608-10629.nxml.txt.nlp	22949883	SENT963	20	20	15	15	creatine	Q10	PA164778930	27161	0.861
NULL	J_Hum_Genet_2013_Jun_2_58(6)_306-312.nxml.txt.nlp	23635953	SENT149	29	29	35	35	estradiol	CYP19A1	PA449503	1588	0.861
NULL	AIDS_Res_Ther_2008_Oct_28_5_24.nxml.txt.nlp	18957095	SENT118	8	8	13	13	zidovudine	CD4	PA451954	920	0.861
NULL	Br_J_Cancer_2012_May_22_106(11)_1779-1789.nxml.txt.nlp	22549178	SENT28	0	0	14	14	trastuzumab	HER2	PA451743	2064	0.861
NULL	Archaea_2011_Oct_10_2011_693253.nxml.txt.nlp	22007151	SENT108	24	24	6	6	glucosamine	MT4	PA164747613	84560	0.861
NULL	J_Cell_Biol_2003_Sep_29_162(7)_1197-1209.nxml.txt.nlp	14517203	SENT225	16	16	32	32	mimosine	BRCA1	PA164752445	672	0.861
NULL	Indian_J_Hum_Genet_2013_Oct-Dec_19(4)_472-474.nxml.txt.nlp	24497716	SENT65	31	31	28	28	tamoxifen	aromatase	PA451581	1588	0.861
NULL	Mol_Cancer_2007_Apr_16_6_30.nxml.txt.nlp	17437646	SENT15	10	10	8	8	gefitinib	EGFR	PA131301952	1956	0.861
NULL	EPMA_J_2012_Sep_27_3(1)_10.nxml.txt.nlp	23016735	SENT162	7	7	21	21	warfarin	GGCX	PA451906	2677	0.861
NULL	Exp_Ther_Med_2015_Jan_5_9(1)_84-88.nxml.txt.nlp	25452780	SENT111	4	4	35	35	voglibose	GLP-1	PA164752433	100125288	0.861
NULL	Ann_Hematol_2014_Apr_1_93(8)_1371-1380.nxml.txt.nlp	24687382	SENT32	7	7	10	10	lenalidomide	IKZF1	PA162363968	10320	0.861
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT154	0	0	5	5	pp2	LYN		4067	0.861
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jul_18_65(Pt_8)_o1918-o1919.nxml.txt.nlp	21583604	SENT74	26	26	7	7	ethanol	mol	PA448073	90527	0.861
NULL	Crit_Care_2011_Jul_8_15(4)_R163.nxml.txt.nlp	21740551	SENT60	13	13	7	7	fluorescein	CD63	PA164746009	967	0.861
NULL	Hum_Genomics_2009_Dec_1_4(2)_91-106.nxml.txt.nlp	20038497	SENT145	15	15	4	4	rivastigmine	APOE	PA451262	348	0.861
NULL	Arthritis_Res_Ther_2009_Aug_17_11(4)_R123.nxml.txt.nlp	19686595	SENT157	29	29	14	14	rituximab	CD27	PA451261	939	0.861
NULL	Cancer_Med_2012_Oct_16_1(2)_207-217.nxml.txt.nlp	23342270	SENT204	16	16	6	6	saracatinib	LRRC19		64922	0.861
NULL	Biologics_2012_Jun_20_6_137-146.nxml.txt.nlp	22807624	SENT49	12	12	2	2	capecitabine	VEGFR	PA448771	3791	0.861
NULL	Environ_Health_Perspect_2006_Jun_114(6)_A368b-A369.nxml.txt.nlp	NULL	SENT14	16	16	18	18	diethylstilbestrol	DES	PA449307	1674	0.861
NULL	EMBO_J_2008_Nov_5_27(21)_2809-2816.nxml.txt.nlp	18923420	SENT86	9	9	0	0	capsaicin	TRPV1	PA448776	7442	0.861
NULL	Br_J_Cancer_2012_Dec_4_107(12)_1950-1955.nxml.txt.nlp	23169295	SENT167	4	4	11	11	oxaliplatin	ERCC1	PA131285527	2067	0.861
NULL	Adv_Hematol_2012_Jul_24_2012_513702.nxml.txt.nlp	22888354	SENT49	2	2	6	6	lenalidomide	IL-2	PA162363968	3558	0.861
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT164	26	26	11	11	erlotinib	PI3K	PA134687924	5290	0.861
NULL	Crit_Care_2007_Mar_22_11(Suppl_2)_P423.nxml.txt.nlp	NULL	SENT3	6	6	18	18	dexmedetomidine	SOC	PA449256	91544	0.861
NULL	Oxid_Med_Cell_Longev_2011_Oct_9_2011_756938.nxml.txt.nlp	22007271	SENT154	12	12	23	23	forskolin	PNMT	PA146096022	5409	0.861
NULL	Eur_J_Haematol_2009_Apr_82(4)_277-287.nxml.txt.nlp	19187270	SENT156	12	12	21	21	pha-665752	IL-6		3569	0.861
NULL	Diagn_Pathol_2013_May_15_8_80.nxml.txt.nlp	23675755	SENT43	8	8	0	0	thyroglobulin	TTF-1	PA164754910	7080	0.861
NULL	Infect_Drug_Resist_2010_Mar_11_3_45-51.nxml.txt.nlp	21694893	SENT115	9	9	16	16	sirolimus	CYP3A4	PA451365	1576	0.861
NULL	Cancer_Med_2012_Oct_16_1(2)_207-217.nxml.txt.nlp	23342270	SENT151	19	19	9	9	saracatinib	LRRC19		64922	0.861
NULL	Breast_Cancer_Res_2006_Nov_6_8(6)_215.nxml.txt.nlp	17096862	SENT95	27	27	42	42	pertuzumab	HER2		2064	0.861
NULL	Cancers_(Basel)_2014_Jul_8_6(3)_1487-1499.nxml.txt.nlp	25006835	SENT99	6	6	1	1	platinum	STAT3	PA150595617	6774	0.861
NULL	Oncol_Lett_2014_Jan_1_7(1)_3-9.nxml.txt.nlp	24348811	SENT114	18	18	7	7	cisplatin	ABCC2	PA449014	1244	0.861
NULL	Mar_Drugs_2014_Jun_27_12(7)_3818-3837.nxml.txt.nlp	24979269	SENT314	4	4	8	8	dasatinib	ABCB1	PA162372878	5243	0.861
NULL	Gene_Ther_2011_Jul_17_18(7)_637-645.nxml.txt.nlp	21412286	SENT130	11	11	44	44	ketamine	ERG	PA450144	2078	0.861
NULL	Allergy_Asthma_Immunol_Res_2014_Nov_19_6(6)_548-557.nxml.txt.nlp	25374755	SENT147	2	2	33	33	lovastatin	Rho	PA450272	29984	0.861
NULL	Curr_Neuropharmacol_2013_Jan_11(1)_114-127.nxml.txt.nlp	23814544	SENT256	0	0	3	3	resveratrol	TLR3		7098	0.861
NULL	Cancers_(Basel)_2014_Nov_25_6(4)_2313-2329.nxml.txt.nlp	25534569	SENT76	0	0	5	5	crizotinib	PI3K	PA165946122	5290	0.861
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_8_2013_964070.nxml.txt.nlp	23690868	SENT35	2	2	6	6	resveratrol	AMPK		5563	0.861
NULL	ChemistryOpen_2014_Jun_18_3(3)_115-123.nxml.txt.nlp	25050230	SENT266	46	46	21	21	heparin	mol	PA449855	90527	0.861
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT138	9	9	16	16	neratinib	HER2	PA165291472	2064	0.861
NULL	Oncotarget_2011_Dec_31_2(12)_1322-1328.nxml.txt.nlp	22249159	SENT50	12	12	14	14	metformin	AMPK	PA450395	5563	0.861
NULL	Chin_J_Cancer_2012_Feb_31(2)_73-99.nxml.txt.nlp	22098950	SENT403	22	22	28	28	trastuzumab	HER3	PA451743	2065	0.861
NULL	Cell_Cycle_2013_May_1_12(9)_1331-1332.nxml.txt.nlp	23588071	SENT12	11	11	30	30	doxorubicin	p53	PA449412	7157	0.861
NULL	Eur_J_Clin_Pharmacol_2010_Nov_29_66(11)_1131-1136.nxml.txt.nlp	20669013	SENT92	3	3	10	10	voriconazole	CYP2C19	PA10233	1557	0.861
NULL	Diabetes_Care_2009_Sep_29_32(9)_1620-1625.nxml.txt.nlp	19564453	SENT155	0	0	2	2	metformin	AMPK	PA450395	5563	0.861
NULL	Biochem_Res_Int_2012_Jun_25_2012_518437.nxml.txt.nlp	22792465	SENT200	25	25	6	6	doxycycline	RGS5	PA449415	8490	0.861
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Dec_17_3(12)_e152.nxml.txt.nlp	25518025	SENT74	11	11	9	9	ketoconazole	CYP3A4	PA450146	1576	0.861
NULL	Aging_(Albany_NY)_2010_Oct_31_2(10)_669-677.nxml.txt.nlp	21076179	SENT96	16	16	36	36	vorinostat	GCN2	PA164748224	440275	0.861
NULL	Breast_Cancer_Res_2011_Aug_16_13(4)_R81.nxml.txt.nlp	21846333	SENT320	14	14	7	7	zoledronate	gamma	PA10235	9913	0.861
NULL	Cancer_Imaging_2012_May_25_12(1)_225-235.nxml.txt.nlp	22743083	SENT23	28	28	7	7	carboplatin	VEGF-A	PA448803	7422	0.861
NULL	Oncoscience_2014_Mar_12_1(2)_158-166.nxml.txt.nlp	25594008	SENT125	19	19	6	6	dasatinib	ANXA1	PA162372878	301	0.861
NULL	Allergy_Asthma_Immunol_Res_2014_Nov_24_6(6)_558-566.nxml.txt.nlp	25374756	SENT69	13	13	21	21	fluorescein	CD4	PA164746009	920	0.861
NULL	Mol_Cancer_2012_May_14_11_33.nxml.txt.nlp	22583829	SENT172	20	20	24	24	cisplatin	p38	PA449014	10598;1432;7965	0.861
NULL	Basic_Clin_Pharmacol_Toxicol_2013_Feb_5_112(2)_132-137.nxml.txt.nlp	22900583	SENT154	3	3	5	5	ritonavir	CYP3A	PA451260	1574	0.861
NULL	Diabetes_Metab_Syndr_Obes_2014_Jun_24_7_229-239.nxml.txt.nlp	25018644	SENT55	26	26	6	6	exenatide	GLP-1	PA164749238	100125288	0.861
NULL	Ann_Rheum_Dis_2010_Dec_20_70(5)_747-754.nxml.txt.nlp	21173013	SENT17	45	45	35	35	anakinra	IFN	PA10799	3439	0.861
NULL	Int_J_Gen_Med_2010_Oct_5_3_313-320.nxml.txt.nlp	21042570	SENT117	6	6	19	19	natalizumab	CD25	PA164747191	3669;3559	0.861
NULL	Acta_Pharmacol_Sin_2012_Jan_28_33(1)_75-81.nxml.txt.nlp	22120969	SENT184	19	19	12	12	exenatide	GLP-1	PA164749238	100125288	0.861
NULL	Front_Genet_2014_Oct_14_5_314.nxml.txt.nlp	25352860	SENT117	20	20	14	14	napqi	CYP2A6		1548	0.861
NULL	Breast_Cancer_Res_2010_Jun_24_12(3)_R41.nxml.txt.nlp	20576088	SENT153	14	14	5	5	paclitaxel	CENPF	PA450761	1063	0.861
NULL	Mar_Drugs_2008_May_28_6(2)_180-219.nxml.txt.nlp	18728725	SENT334	20	20	7	7	terfenadine	DOM	PA451619	6663	0.861
NULL	Cell_Death_Dis_2014_Apr_17_5(4)_e1182.nxml.txt.nlp	24743737	SENT34	0	0	29	29	capsaicin	TRPV1	PA448776	7442	0.861
NULL	Br_J_Cancer_2011_Mar_15_104(6)_941-947.nxml.txt.nlp	21407223	SENT119	17	17	12	12	sorafenib	p27	PA7000	5715;10534	0.861
NULL	Ann_Oncol_2011_Aug_27_22(8)_1736-1747.nxml.txt.nlp	21709140	SENT316	26	26	44	44	lapatinib	San	PA152241907	80218	0.861
NULL	Ecancermedicalscience_2009_Sep_24_3_153.nxml.txt.nlp	22276017	SENT64	26	26	10	10	platinum	NER	PA150595617	7376	0.861
NULL	Cancer_Cell_Int_2010_Aug_13_10_26.nxml.txt.nlp	20707917	SENT89	33	33	14	14	doxorubicin	RhoA	PA449412	387	0.861
NULL	J_Lipid_Res_2013_Nov_54(11)_3085-3097.nxml.txt.nlp	23883581	SENT143	9	9	21	21	thrombin	PGD2	PA451674	27306	0.861
NULL	Exp_Anim_2014_Apr_26_63(2)_257-267.nxml.txt.nlp	24770651	SENT94	2	2	20	20	perindopril	apelin	PA450877	8862	0.861
NULL	Oncogenesis_2012_Apr_2_1(4)_e5.nxml.txt.nlp	23552603	SENT234	22	22	32	32	ns-398	MCL1		4170	0.861
NULL	Sci_Rep_2014_Dec_17_4_7035.nxml.txt.nlp	25516351	SENT273	6	6	21	21	docetaxel	SPARC	PA449383	6678	0.861
NULL	Front_Oncol_2013_Sep_23_3_250.nxml.txt.nlp	24069582	SENT424	25	25	15	15	metformin	LKB1	PA450395	6794	0.861
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT226	37	37	17	17	metformin	ADP	PA450395	23038	0.861
NULL	Mol_Cancer_2010_Jun_25_9_166.nxml.txt.nlp	20579378	SENT54	9	9	11	11	gefitinib	EGF	PA131301952	1950	0.861
NULL	Acta_Pharmacol_Sin_2012_May_16_33(5)_682-690.nxml.txt.nlp	22504904	SENT233	0	0	6	6	celecoxib	IL-6	PA448871	3569	0.861
NULL	Oncotarget_2011_May_16_2(5)_378-392.nxml.txt.nlp	21623005	SENT26	26	26	11	11	gemcitabine	MDM2	PA449748	4193	0.861
NULL	J_Hematol_Oncol_2013_Apr_25_6_30.nxml.txt.nlp	23617957	SENT212	8	8	22	22	vemurafenib	AKT	PA165946873	207	0.861
NULL	Eur_J_Clin_Pharmacol_2011_May_8_67(5)_493-506.nxml.txt.nlp	21140139	SENT288	22	22	3	3	oxycodone	CYP3A4	PA450741	1576	0.861
NULL	Cell_Death_Dis_2014_Apr_17_5(4)_e1182.nxml.txt.nlp	24743737	SENT47	8	8	6	6	capsaicin	TRPV1	PA448776	7442	0.861
NULL	Drug_Des_Devel_Ther_2014_Oct_31_8_2121-2128.nxml.txt.nlp	25382970	SENT78	4	4	23	23	curcumin	TTR	PA151958596	7276	0.861
NULL	Acta_Orthop_2013_Dec_2_84(6)_585-592.nxml.txt.nlp	24237425	SENT198	38	38	23	23	hyaluronan	S100A8	PA165958431	6279	0.861
NULL	Br_J_Cancer_2004_Mar_22_90(6)_1285-1292.nxml.txt.nlp	15026814	SENT144	9	9	21	21	doxorubicin	p53	PA449412	7157	0.861
NULL	J_Hematol_Oncol_2011_Feb_7_4_6.nxml.txt.nlp	21299849	SENT130	2	2	10	10	imatinib	RPS6	PA10804	6194	0.861
NULL	Ecancermedicalscience_2008_Feb_18_2_75.nxml.txt.nlp	22275966	SENT139	23	23	19	19	gefitinib	EGFR	PA131301952	1956	0.861
NULL	Int_J_Nanomedicine_2012_Oct_25_7_5565-5575.nxml.txt.nlp	23118538	SENT191	6	6	16	16	fenofibrate	CO2	PA449594	4513	0.861
NULL	Eur_J_Neurosci_2008_Jun_27(12)_3151-3160.nxml.txt.nlp	18598259	SENT99	21	21	7	7	paraformaldehyde	TRPA1	PA450790	8989	0.861
NULL	Arthritis_Res_Ther_2012_Jun_12_14(3)_R142.nxml.txt.nlp	22691272	SENT187	13	13	21	21	mianserin	IL-6	PA134687937	3569	0.861
NULL	Toxins_(Basel)_2010_Oct_28_2(11)_2584-2592.nxml.txt.nlp	22069565	SENT264	19	19	14	14	acenocoumarol	CYP2C9	PA452632	1559	0.861
NULL	Cardiol_Res_Pract_2012_Apr_22_2012_181394.nxml.txt.nlp	22577589	SENT216	10	10	16	16	simvastatin	IL-6	PA451363	3569	0.861
NULL	Clin_Transl_Allergy_2014_Feb_28_4(Suppl_1)_P35.nxml.txt.nlp	25045492	SENT14	0	0	30	30	atorvastatin	CD86	PA448500	942	0.861
NULL	Biomed_Res_Int_2014_Jun_25_2014_764981.nxml.txt.nlp	25057499	SENT185	12	12	37	37	sorafenib	SHP-1	PA7000	5777	0.861
NULL	J_Gen_Physiol_2013_Aug_142(2)_137-155.nxml.txt.nlp	23858003	SENT443	3	3	10	10	forskolin	ACTH	PA146096022	5443	0.861
NULL	Braz_J_Med_Biol_Res_2012_Sep_21_45(12)_1240-1243.nxml.txt.nlp	22983178	SENT33	9	9	24	24	indomethacin	COX	PA449982	1351	0.861
NULL	Br_J_Cancer_2006_Dec_4_95(11)_1483-1489.nxml.txt.nlp	17106442	SENT145	16	16	8	8	gefitinib	TTP	PA131301952	7538;11093	0.861
NULL	Hematol_Rep_2011_Oct_28_3(3_Suppl)_e5.nxml.txt.nlp	22586513	SENT34	5	5	12	12	doxorubicin	CHOP	PA449412	1649	0.861
NULL	Oncol_Lett_2013_May_27_5(5)_1599-1600.nxml.txt.nlp	23761825	SENT10	0	0	8	8	gefitinib	EGFR	PA131301952	1956	0.861
NULL	Int_J_Endocrinol_Metab_2013_Jul_1_Summer_11(3)_184-190.nxml.txt.nlp	24348591	SENT98	8	8	14	14	liraglutide	INS-1	PA165958364	2305	0.861
NULL	Front_Neurol_2011_Mar_18_2_14.nxml.txt.nlp	21516258	SENT206	7	7	17	17	modafinil	MCHR1	PA450530	2847	0.861
NULL	Nat_Med_2010_Nov_24_16(11)_1299-1304.nxml.txt.nlp	20972434	SENT189	11	11	4	4	chloroquine	ASM	PA448948	6609;283120	0.861
NULL	J_Vet_Med_Sci_2014_Nov_5_76(11)_1527-1529.nxml.txt.nlp	25099737	SENT24	10	10	19	19	clarithromycin	CYP3A	PA449028	1574	0.861
NULL	Cancer_Manag_Res_2012_Nov_9_4_383-395.nxml.txt.nlp	23204869	SENT252	12	12	3	3	carmustine	PC-3	PA448810	692094	0.861
NULL	Multidiscip_Respir_Med_2013_Feb_6_8(1)_11.nxml.txt.nlp	23388501	SENT61	28	28	3	3	indomethacin	ASM	PA449982	6609;283120	0.861
NULL	Genome_Biol_2011_Jun_16_12(6)_R53.nxml.txt.nlp	21679406	SENT462	21	21	6	6	cisplatin	Dicer	PA449014	23405	0.861
NULL	Indian_J_Pharmacol_2012_Sep-Oct_44(5)_624-628.nxml.txt.nlp	23112426	SENT95	0	0	2	2	pravastatin	CYP3A4	PA451089	1576	0.861
NULL	Ther_Clin_Risk_Manag_2007_Jun_3(3)_411-420.nxml.txt.nlp	18488075	SENT152	5	5	8	8	alefacept	CD4	PA164748040	920	0.861
NULL	Int_J_Womens_Health_2012_Oct_10_4_543-549.nxml.txt.nlp	23091400	SENT55	15	15	19	19	resveratrol	aromatase		1588	0.861
NULL	Front_Neurosci_2011_Sep_28_5_113.nxml.txt.nlp	21994486	SENT128	17	17	9	9	ketamine	p68	PA450144	1655	0.861
NULL	Br_J_Cancer_2010_Sep_7_103(6)_889-898.nxml.txt.nlp	20664599	SENT199	10	10	13	13	paclitaxel	AKT	PA450761	207	0.861
NULL	Ann_Clin_Microbiol_Antimicrob_2009_Jan_15_8_2.nxml.txt.nlp	19146672	SENT12	22	22	11	11	isoniazid	EMB	PA450112	133418	0.861
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT164	27	27	8	8	atorvastatin	CD14	PA448500	929	0.861
NULL	Ann_Oncol_2013_Apr_31_24(4)_1067-1073.nxml.txt.nlp	23117073	SENT172	23	23	6	6	etoposide	CYP3A4	PA449552	1576	0.861
NULL	Nat_Commun_2013_Sep_20_4_2444.nxml.txt.nlp	24051492	SENT370	40	40	21	21	nutlin-3	p53		7157	0.861
NULL	Am_J_Transplant_2010_Jan_10(1)_69-80.nxml.txt.nlp	19889125	SENT116	9	9	16	16	fludarabine	CD4	PA449655	920	0.861
NULL	Nucleic_Acids_Res_2005_Jun_8_33(10)_3283-3291.nxml.txt.nlp	15944449	SENT14	4	4	19	19	sjg-136	XRCC2		7516	0.861
NULL	Arch_Med_Sci_2011_Aug_2_7(4)_713-719.nxml.txt.nlp	22291810	SENT124	7	7	9	9	calcipotriol	IL-19	PA448714	29949	0.861
NULL	J_Immunol_Methods_2009_Jan_1_340(1)_11-24.nxml.txt.nlp	18929568	SENT61	0	0	23	23	staurosporine	PP2	PA165109623	4888	0.861
NULL	Cancer_Cell_Int_2011_Jun_1_11_15.nxml.txt.nlp	21631944	SENT191	26	26	14	14	etoposide	MICA	PA449552	100507436	0.861
NULL	Mol_Cancer_2010_Dec_2_9_309.nxml.txt.nlp	21122157	SENT106	6	6	1	1	paclitaxel	IL-6	PA450761	3569	0.861
NULL	J_Invest_Dermatol_2012_Sep_10_132(9)_2255-2262.nxml.txt.nlp	22572817	SENT157	31	31	21	21	forskolin	ASIP	PA146096022	434;56288	0.861
NULL	Neural_Regen_Res_2013_Mar_25_8(9)_825-832.nxml.txt.nlp	25206730	SENT123	3	3	11	11	isoflurane	P2X7	PA450106	5027	0.861
NULL	Exp_Mol_Med_2012_Sep_30_44(9)_545-553.nxml.txt.nlp	22809901	SENT96	0	0	3	3	quetiapine	PRDM16	PA451201	63976	0.861
NULL	Biologics_2010_Aug_9_4_173-185.nxml.txt.nlp	20714355	SENT266	5	5	16	16	cetuximab	gamma	PA10040	9913	0.861
NULL	Cancer_Cell_Int_2013_Feb_12_13_14.nxml.txt.nlp	23402310	SENT5	15	15	9	9	celecoxib	p65	PA448871	5970	0.861
NULL	Int_J_Endocrinol_2014_Jun_25_2014_534904.nxml.txt.nlp	25053942	SENT152	6	6	11	11	amiodarone	AIT	PA448383	160728	0.861
NULL	Mol_Biol_Cell_2012_Jul_1_23(13)_2583-2592.nxml.txt.nlp	22593214	SENT114	18	18	6	6	paclitaxel	GEF-H1	PA450761	9181	0.861
NULL	Acta_Pharmacol_Sin_2014_Aug_21_35(8)_994-1004.nxml.txt.nlp	25042549	SENT283	5	5	10	10	pravastatin	PCSK9	PA451089	255738	0.861
NULL	Eur_J_Clin_Pharmacol_2012_Jan_8_68(1)_29-37.nxml.txt.nlp	21739267	SENT187	14	14	6	6	fluvoxamine	CYP2C19	PA449690	1557	0.861
NULL	Neural_Regen_Res_2014_May_15_9(10)_1055-1062.nxml.txt.nlp	25206759	SENT53	8	8	45	45	bumetanide	NKCC1	PA448682	6558	0.861
NULL	J_Neural_Transm_2014_Mar_27_121(10)_1221-1232.nxml.txt.nlp	24671607	SENT178	31	31	6	6	sertraline	PSD-95	PA451333	1742	0.861
NULL	Front_Neurol_2011_Nov_21_2_68.nxml.txt.nlp	22125548	SENT246	0	0	11	11	minocycline	p38	PA450519	10598;1432;7965	0.86
NULL	FEBS_Open_Bio_2014_Jan_6_4_77-89.nxml.txt.nlp	24490132	SENT114	8	8	2	2	ebselen	GDH	PA161660841	51084;2746	0.86
NULL	Indian_J_Ophthalmol_2007_Nov-Dec_55(6)_445-450.nxml.txt.nlp	17951902	SENT46	27	27	41	41	ranibizumab	VEGF-A	PA164746012	7422	0.86
NULL	Orphanet_J_Rare_Dis_2014_Dec_5_9(1)_194.nxml.txt.nlp	NULL	SENT381	16	16	6	6	desogestrel	CO2	PA449238	4513	0.86
NULL	Br_J_Cancer_2010_Jul_13_103(2)_186-195.nxml.txt.nlp	20588277	SENT96	27	27	21	21	nutlin-3	MDM2		4193	0.86
NULL	Cancer_Cell_Int_2007_Mar_2_7_1.nxml.txt.nlp	17331262	SENT153	13	13	22	22	bromocriptine	p53	PA448671	7157	0.86
NULL	Front_Neuroenergetics_2014_Jan_9_5_13.nxml.txt.nlp	24409143	SENT229	10	10	29	29	ketamine	FDG	PA450144	23583	0.86
NULL	Mol_Cytogenet_2014_Feb_27_7_15.nxml.txt.nlp	24576355	SENT30	10	10	28	28	phenol	CYP2E1	PA450913	1571	0.86
NULL	Front_Immunol_2012_Jan_24_3_3.nxml.txt.nlp	22566889	SENT1735	17	17	9	9	rituximab	CD22	PA451261	933	0.86
NULL	Crit_Care_2008_Mar_13_12(Suppl_2)_P438.nxml.txt.nlp	NULL	SENT4	8	8	16	16	vasopressin	AVP	PA451858	114548;551	0.86
NULL	Case_Rep_Dent_2013_Jul_10_2013_812323.nxml.txt.nlp	23936686	SENT96	34	34	10	10	hyaluronan	CD34	PA165958431	947	0.86
NULL	Arch_Toxicol_2014_Nov_5_88(12)_2135-2190.nxml.txt.nlp	25370008	SENT241	3	3	0	0	minoxidil	SULT	PA450521	6816	0.86
NULL	Int_J_Cell_Biol_2013_Mar_19_2013_834684.nxml.txt.nlp	23573093	SENT150	3	3	17	17	ketoconazole	CYP11A1	PA450146	1583	0.86
NULL	Front_Oncol_2013_Aug_28_3_219.nxml.txt.nlp	24010120	SENT301	16	16	30	30	gefitinib	KRAS	PA131301952	3845	0.86
NULL	Mar_Drugs_2014_Sep_12_12(9)_4756-4782.nxml.txt.nlp	25222666	SENT151	5	5	21	21	methyltestosterone	aromatase	PA165958383	1588	0.86
NULL	Acta_Orthop_2010_Apr_6_81(2)_263-267.nxml.txt.nlp	20148646	SENT11	1	1	45	45	taurine	CHOP	PA451590	1649	0.86
NULL	Br_J_Pharmacol_2014_Feb_24_171(1)_1019-1032.nxml.txt.nlp	24251620	SENT48	24	24	29	29	nicardipine	TRPM3	PA450620	80036	0.86
NULL	Biochem_Res_Int_2012_May_7_2012_395974.nxml.txt.nlp	22611495	SENT247	2	2	8	8	exenatide	GLP-1	PA164749238	100125288	0.86
NULL	Acta_Pharmacol_Sin_2011_Aug_18_32(8)_1031-1037.nxml.txt.nlp	21765446	SENT19	3	3	12	12	raloxifene	MCP-1	PA451221	6347	0.86
NULL	Lab_Invest_2011_Apr_14_91(4)_598-608.nxml.txt.nlp	21321535	SENT239	0	0	9	9	sorafenib	CD25	PA7000	3669;3559	0.86
NULL	Ann_Gen_Psychiatry_2008_Aug_28_7_16.nxml.txt.nlp	18755025	SENT242	25	25	3	3	haloperidol	Gen	PA449841	348654	0.86
NULL	Int_J_Med_Sci_2012_Jul_25_9(6)_435-440.nxml.txt.nlp	22859903	SENT23	10	10	3	3	sevoflurane	CO2	PA451341	4513	0.86
NULL	J_Carcinog_2012_Oct_27_11_16.nxml.txt.nlp	23230393	SENT54	20	20	12	12	trastuzumab	HER-2	PA451743	2064	0.86
NULL	Cancers_(Basel)_2011_Aug_9_3(3)_3189-3205.nxml.txt.nlp	24212952	SENT63	6	6	17	17	hyaluronan	TLR4	PA165958431	7099	0.86
NULL	Br_J_Cancer_2010_Jul_13_103(2)_186-195.nxml.txt.nlp	20588277	SENT143	7	7	18	18	nutlin-3	p53		7157	0.86
NULL	Cancer_Manag_Res_2014_Oct_4_6_397-404.nxml.txt.nlp	25328417	SENT116	7	7	21	21	erlotinib	KRAS	PA134687924	3845	0.86
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT7	2	2	7	7	heparin	FGF1	PA449855	2246	0.86
NULL	Exp_Ther_Med_2013_Nov_6_6(5)_1089-1095.nxml.txt.nlp	24223627	SENT32	22	22	2	2	fluorouracil	NAC	PA128406956	22861	0.86
NULL	J_Biol_Chem_2009_Apr_3_284(14)_9558-9565.nxml.txt.nlp	19202191	SENT123	29	29	12	12	camptothecin	CtIP	PA153590860	5932	0.86
NULL	Arthritis_Res_Ther_2014_Apr_3_16(2)_R86.nxml.txt.nlp	24708674	SENT264	4	4	7	7	bosentan	Fli1	PA10034	2314	0.86
NULL	Pharmaceutics_2010_Apr_1_2(2)_105-118.nxml.txt.nlp	NULL	SENT257	13	13	8	8	methotrexate	SRM	PA450428	6723;6725	0.86
NULL	Nat_Genet_2013_Mar_3_45(3)_290-294.nxml.txt.nlp	23377183	SENT69	13	13	8	8	cytarabine	NT5C2	PA449177	22978	0.86
NULL	Biomed_Res_Int_2014_Jun_26_2014_161346.nxml.txt.nlp	25054130	SENT228	41	41	21	21	curcumin	STZ	PA151958596	6484	0.86
NULL	Breast_Cancer_Res_Treat_2012_Jul_31_134(1)_199-205.nxml.txt.nlp	22290080	SENT162	27	27	14	14	estradiol	c-fos	PA449503	2353	0.86
NULL	Drugs_R_D_2011_Jun_27_11(2)_101-111.nxml.txt.nlp	21679003	SENT114	34	34	27	27	bevacizumab	IFL	PA130232992	3439	0.86
NULL	Adipocyte_2012_Oct_1_1(4)_256-258.nxml.txt.nlp	23700542	SENT33	1	1	6	6	resveratrol	AMPK		5563	0.86
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT30	5	5	20	20	atorvastatin	PTEN	PA448500	5728	0.86
NULL	Jpn_Clin_Med_2014_Sep_17_5_33-41.nxml.txt.nlp	25288908	SENT56	14	14	25	25	gliclazide	GLP-1	PA10892	100125288	0.86
NULL	Mol_Cancer_2008_Jun_5_7_50.nxml.txt.nlp	18534018	SENT145	16	16	30	30	bortezomib	HSP27	PA10252	3315	0.86
NULL	Front_Pharmacol_2014_Dec_15_5_277.nxml.txt.nlp	25566074	SENT270	4	4	17	17	scopolamine	PSD-95	PA451308	1742	0.86
NULL	J_Breast_Cancer_2011_Jun_18_14(2)_135-139.nxml.txt.nlp	21847409	SENT105	18	18	21	21	tamoxifen	aromatase	PA451581	1588	0.86
NULL	Arthritis_Res_Ther_2009_Nov_4_11(6)_R165.nxml.txt.nlp	19889203	SENT351	7	7	35	35	resveratrol	p65		5970	0.86
NULL	Nucleic_Acids_Res_2007_Jan_7_35(2)_e9.nxml.txt.nlp	17158148	SENT535	17	17	2	2	camptothecin	XRCC1	PA153590860	7515	0.86
NULL	Mol_Biol_Cell_2012_May_15_23(10)_1812-1825.nxml.txt.nlp	22438585	SENT400	1	1	37	37	dextran	EGF	PA449261	1950	0.86
NULL	Exp_Ther_Med_2013_Oct_20_6(4)_899-903.nxml.txt.nlp	24137286	SENT95	13	13	22	22	rosuvastatin	p38	PA134308647	10598;1432;7965	0.86
NULL	Diabetes_2013_Jun_17_62(6)_1800-1807.nxml.txt.nlp	23704521	SENT138	4	4	13	13	metformin	SIRT1	PA450395	23411	0.86
NULL	Mol_Cancer_2003_Jan_7_2_8.nxml.txt.nlp	12556241	SENT41	13	13	0	0	heparin	VEGF-A	PA449855	7422	0.86
NULL	Front_Physiol_2011_Jun_30_2_33.nxml.txt.nlp	21747769	SENT202	4	4	8	8	berberine	p38	PA165860812	10598;1432;7965	0.86
NULL	Clin_Sci_(Lond)_2011_Nov_1_121(Pt_10)_449-458.nxml.txt.nlp	21671887	SENT117	14	14	16	16	simvastatin	ANOVA	PA451363	4858	0.86
NULL	Mol_Cancer_2009_Aug_25_8_66.nxml.txt.nlp	19706164	SENT227	8	8	19	19	celecoxib	p53	PA448871	7157	0.86
NULL	Arthritis_Res_Ther_2008_Jan_7_10(1)_R1.nxml.txt.nlp	18179697	SENT177	2	2	13	13	oxaliplatin	HMGB1	PA131285527	3146	0.86
NULL	Arthritis_Res_Ther_2012_Sep_24_14(5)_R200.nxml.txt.nlp	23006144	SENT45	22	22	25	25	alefacept	IL-20	PA164748040	27190;50604	0.86
NULL	EPMA_J_2012_Sep_27_3(1)_10.nxml.txt.nlp	23016735	SENT109	2	2	5	5	warfarin	CYP2C9	PA451906	1559	0.86
NULL	Diabetes_Care_2010_Jan_33(Suppl_1)_S11-S61.nxml.txt.nlp	20042772	SENT1972	26	26	8	8	rosiglitazone	DREAM	PA451283	30818	0.86
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT168	18	18	7	7	simvastatin	AKT	PA451363	207	0.86
NULL	Nat_Commun_2014_Apr_9_5_3600.nxml.txt.nlp	24714562	SENT223	7	7	39	39	cyclosporine	CO2	PA449167	4513	0.86
NULL	Oxid_Med_Cell_Longev_2013_Nov_28_2013_568093.nxml.txt.nlp	24379901	SENT79	0	0	29	29	resveratrol	SIRT1		23411	0.86
NULL	Front_Immunol_2012_Mar_19_3_47.nxml.txt.nlp	22566929	SENT166	31	31	23	23	cyclosporine	CD28	PA449167	1493;940	0.86
NULL	Diabetes_Obes_Metab_2010_Aug_12(8)_700-708.nxml.txt.nlp	20590747	SENT13	13	13	31	31	voglibose	PPG	PA164752433	5552	0.86
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_16_2013_146142.nxml.txt.nlp	23843863	SENT13	15	15	35	35	ns-398	IL6		3569	0.86
NULL	Arthritis_Res_Ther_2003_Dec_2_5(Suppl_4)_S12-S16.nxml.txt.nlp	15180892	SENT75	20	20	18	18	cyclophosphamide	CHOP	PA449165	1649	0.86
NULL	Diabetes_2009_Jan_58(1)_104-115.nxml.txt.nlp	18835938	SENT165	2	2	12	12	rosiglitazone	MCP-3	PA451283	6354	0.86
NULL	Oncotarget_2012_Dec_23_3(12)_1489-1490.nxml.txt.nlp	23455231	SENT32	17	17	20	20	promazine	MALT1	PA451126	10892	0.86
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT9	0	0	19	19	perifosine	DR5	PA165291471	8795	0.86
NULL	Cancer_Cell_Int_2009_Aug_18_9_23.nxml.txt.nlp	19689790	SENT247	11	11	20	20	hyperforin	TRPC6	PA165985514	7225	0.86
NULL	Emerg_Infect_Dis_2007_Jul_13(7)_1024-1030.nxml.txt.nlp	18214174	SENT152	25	25	34	34	linezolid	LSE	PA450233	54414	0.86
NULL	Front_Neurosci_2014_Jan_10_7_270.nxml.txt.nlp	24454277	SENT436	6	6	2	2	resveratrol	SIRT1		23411	0.86
NULL	Mol_Cancer_2014_Jan_15_13_8.nxml.txt.nlp	24423412	SENT114	8	8	30	30	cisplatin	CD44	PA449014	960	0.86
NULL	FEBS_Open_Bio_2012_Aug_22_2_279-283.nxml.txt.nlp	23650611	SENT111	11	11	4	4	raloxifene	IFN	PA451221	3439	0.86
NULL	Int_J_Mol_Sci_2013_Apr_29_14(5)_9338-9364.nxml.txt.nlp	23629668	SENT66	12	12	22	22	bevacizumab	BRAF	PA130232992	673	0.86
NULL	Acta_Pharmacol_Sin_2011_Apr_28_32(4)_441-448.nxml.txt.nlp	21441944	SENT65	22	22	12	12	sildenafil	CASQ2	PA451346	845	0.86
NULL	Tuberc_Respir_Dis_(Seoul)_2014_Feb_27_76(2)_66-74.nxml.txt.nlp	24624215	SENT36	29	29	19	19	vancomycin	HCAP	PA451850	117159;9126	0.86
NULL	Ann_Dermatol_2011_Oct_31_23(Suppl_2)_S169-S174.nxml.txt.nlp	22148042	SENT104	13	13	11	11	cyclophosphamide	CHOP	PA449165	1649	0.86
NULL	Oncoimmunology_2013_Jan_1_2(1)_e22890.nxml.txt.nlp	23483066	SENT140	21	21	30	30	vemurafenib	IFN	PA165946873	3439	0.86
NULL	Eur_J_Histochem_2011_Mar_24_55(1)_e6.nxml.txt.nlp	21556121	SENT134	21	21	7	7	heparin	HRG	PA449855	3084;3273	0.86
NULL	Int_J_Mol_Sci_2014_Oct_20_15(10)_18840-18855.nxml.txt.nlp	25334060	SENT156	8	8	20	20	heparin	RANKL	PA449855	8600	0.86
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_55-78.nxml.txt.nlp	19305788	SENT500	2	2	21	21	memantine	VGLUT1	PA10364	57030	0.86
NULL	Front_Physiol_2012_Nov_30_3_450.nxml.txt.nlp	23226132	SENT355	31	31	16	16	levodopa	gamma	PA450213	9913	0.86
NULL	Oncotarget_2014_Mar_13_5(4)_1101-1110.nxml.txt.nlp	24658355	SENT90	16	16	5	5	tamoxifen	MKP-1	PA451581	1843	0.86
NULL	Nat_Commun_2013_Aug_15_4_2130.nxml.txt.nlp	23945651	SENT674	3	3	0	0	etoposide	ATG5	PA449552	9474	0.86
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Feb_17_68(Pt_3)_o715-o716.nxml.txt.nlp	22412599	SENT6	21	21	1	1	piperazine	mol	PA450977	90527	0.86
NULL	Exp_Diabetes_Res_2011_Jun_4_2011_489708.nxml.txt.nlp	21747829	SENT158	20	20	31	31	aliskiren	GLP-1	PA143487910	100125288	0.86
NULL	Int_J_Mol_Sci_2012_Dec_5_13(12)_16554-16579.nxml.txt.nlp	23443118	SENT235	8	8	13	13	azacitidine	DAC	PA451996	13	0.86
NULL	Lab_Invest_2011_Apr_14_91(4)_598-608.nxml.txt.nlp	21321535	SENT127	6	6	14	14	sorafenib	CD4	PA7000	920	0.86
NULL	Front_Genet_2012_Nov_5_3_236.nxml.txt.nlp	23133441	SENT408	19	19	2	2	irinotecan	SLCO1B1	PA450085	10599	0.86
NULL	Nat_Med_2010_Jun_23_16(6)_671-677.nxml.txt.nlp	20495567	SENT192	23	23	2	2	sorafenib	ANOVA	PA7000	4858	0.86
NULL	Mol_Cancer_2013_Mar_7_12_19.nxml.txt.nlp	23497317	SENT275	19	19	13	13	neomycin	KIT	PA450608	3815	0.86
NULL	Contemp_Oncol_(Pozn)_2012_Nov_20_16(5)_401-406.nxml.txt.nlp	23788917	SENT149	14	14	6	6	afatinib	HER2	PA165981154	2064	0.86
NULL	Toxins_(Basel)_2010_Oct_26_2(11)_2490-2518.nxml.txt.nlp	22069563	SENT230	8	8	17	17	cisplatin	TLR9	PA449014	54106	0.86
NULL	J_Immunol_Res_2014_Apr_10_2014_845763.nxml.txt.nlp	24818169	SENT129	14	14	34	34	cisplatin	4E-BP1	PA449014	1978	0.86
NULL	Curr_Neuropharmacol_2009_Dec_7(4)_276-285.nxml.txt.nlp	20514207	SENT60	3	3	11	11	guanidine	Rho	PA164781028	29984	0.86
NULL	Cells_2014_Jun_11_3(2)_616-626.nxml.txt.nlp	24921186	SENT62	40	40	9	9	capsaicin	TRPA1	PA448776	8989	0.86
NULL	Clin_Ophthalmol_2008_Jun_2(2)_347-354.nxml.txt.nlp	19668726	SENT49	5	5	23	23	pegaptanib	VEGF-A	PA164771236	7422	0.86
NULL	J_Carcinog_2012_Sep_13_11_15.nxml.txt.nlp	23230392	SENT137	18	18	42	42	gemcitabine	TP53INP1	PA449748	94241	0.86
NULL	Clin_Med_Insights_Oncol_2011_Sep_21_5_265-314.nxml.txt.nlp	22084619	SENT119	18	18	5	5	glucose	HIF-1	PA449773	29072	0.86
NULL	Exp_Diabetes_Res_2012_Sep_12_2012_183535.nxml.txt.nlp	23008698	SENT200	28	28	0	0	glibenclamide	MMP2	PA449782	4313	0.86
NULL	Int_J_Chron_Obstruct_Pulmon_Dis_2006_Dec_1(4)_373-379.nxml.txt.nlp	18044094	SENT43	15	15	11	11	cilomilast	PDE4D	PA165948031	5144	0.86
NULL	Oncotarget_2013_Oct_19_4(11)_2045-2056.nxml.txt.nlp	24185104	SENT87	14	14	8	8	cisplatin	p38	PA449014	10598;1432;7965	0.86
NULL	Br_J_Cancer_2010_Oct_26_103(9)_1331-1334.nxml.txt.nlp	20877352	SENT5	9	9	7	7	trastuzumab	GM-CSF	PA451743	1437	0.86
NULL	Exp_Lung_Res_2013_Oct_1_39(8)_336-348.nxml.txt.nlp	23919450	SENT196	5	5	14	14	thrombin	PAR-1	PA451674	2011;2149	0.86
NULL	Subst_Abuse_Rehabil_2011_Mar_16_2_11-20.nxml.txt.nlp	24474851	SENT39	6	6	15	15	ketamine	CYP2C9	PA450144	1559	0.86
NULL	Iran_J_Pharm_Res_2013_Summer_12(3)_457-469.nxml.txt.nlp	24250652	SENT206	5	5	9	9	indomethacin	COX	PA449982	1351	0.86
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Jun_27_5_15.nxml.txt.nlp	16803618	SENT136	5	5	13	13	erythromycin	IL-8	PA449493	3576	0.86
NULL	Breast_Cancer_Res_2001_Nov_8_3(1)_66-75.nxml.txt.nlp	11250748	SENT306	16	16	7	7	tamoxifen	NMU	PA451581	10874	0.86
NULL	Cancers_(Basel)_2013_Jul_4_5(3)_838-856.nxml.txt.nlp	24202322	SENT191	15	15	30	30	doxorubicin	p53	PA449412	7157	0.86
NULL	Indian_J_Urol_2009_Apr-Jun_25(2)_186-189.nxml.txt.nlp	19672343	SENT49	35	35	8	8	cyclophosphamide	GTS	PA449165	2973	0.86
NULL	Int_J_Endocrinol_2010_Aug_19_2010_320721.nxml.txt.nlp	20016682	SENT33	22	22	26	26	zoledronate	PTH	PA10235	5741	0.86
NULL	Breast_Cancer_Res_2011_Feb_23_13(1)_203.nxml.txt.nlp	21392408	SENT101	12	12	15	15	tamoxifen	aromatase	PA451581	1588	0.86
NULL	Aging_(Albany_NY)_2009_Mar_31_1(4)_412-424.nxml.txt.nlp	20195491	SENT69	6	6	12	12	resveratrol	TXNIP		10628	0.86
NULL	Nucleic_Acids_Res_2012_Apr_16_40(8)_3511-3523.nxml.txt.nlp	22180533	SENT250	24	24	3	3	doxycycline	RAD51	PA449415	5888	0.86
NULL	Clin_Ophthalmol_2012_Sep_7_6_1471-1476.nxml.txt.nlp	23055666	SENT10	20	20	10	10	betaxolol	NAC	PA448611	22861	0.86
NULL	Acta_Pharmacol_Sin_2010_Jan_5_31(1)_93-101.nxml.txt.nlp	20048748	SENT106	5	5	10	10	cisplatin	DAPK	PA449014	1612	0.86
NULL	Mol_Cell_Biochem_2014_Oct_9_385(1-2)_265-275.nxml.txt.nlp	24104452	SENT229	36	36	23	23	bortezomib	U87	PA10252	677775;641648	0.86
NULL	Drugs_R_D_2013_Mar_21_13(1)_29-36.nxml.txt.nlp	23322527	SENT189	8	8	20	20	risperidone	CYP2D6	PA451257	1565	0.86
NULL	AAPS_J_2011_Jun_1_13(3)_405-416.nxml.txt.nlp	21630127	SENT334	16	16	8	8	trastuzumab	HER2	PA451743	2064	0.86
NULL	J_Adv_Pharm_Technol_Res_2012_Oct-Dec_3(4)_202-209.nxml.txt.nlp	23378940	SENT153	5	5	11	11	aprepitant	CYP3A4	PA164747039	1576	0.86
NULL	J_Allergy_(Cairo)_2011_Apr_26_2011_736319.nxml.txt.nlp	21747870	SENT144	3	3	5	5	doxycycline	IL-13	PA449415	3596	0.86
NULL	Diabetes_Care_2010_Oct_13_33(10)_2250-2253.nxml.txt.nlp	20628086	SENT69	6	6	20	20	rosiglitazone	DREAM	PA451283	30818	0.86
NULL	Breast_Cancer_Res_2000_Dec_17_2(1)_10-12.nxml.txt.nlp	11250686	SENT53	5	5	21	21	raloxifene	STAR	PA451221	6770;2984	0.86
NULL	Clin_Med_Insights_Cardiol_2011_Jun_28_5_55-66.nxml.txt.nlp	21792345	SENT109	5	5	1	1	bucindolol	BEST	PA165945764	7439	0.86
NULL	J_Immunol_Res_2014_Jul_16_2014_696812.nxml.txt.nlp	25133198	SENT32	23	23	33	33	rifaximin	CD103	PA164752443	3682	0.86
NULL	Nat_Med_2011_Aug_28_17(9)_1094-1100.nxml.txt.nlp	21873989	SENT25	1	1	19	19	imatinib	CD4	PA10804	920	0.86
NULL	Br_J_Cancer_2010_Mar_2_102(5)_815-826.nxml.txt.nlp	20145614	SENT194	18	18	33	33	letrozole	HER2	PA450196	2064	0.86
NULL	Pharmaceuticals_(Basel)_2013_Aug_2_6(8)_915-928.nxml.txt.nlp	24276376	SENT209	18	18	7	7	aspirin	PAR-1	PA448497	2011;2149	0.86
NULL	Case_Rep_Dermatol_2014_Feb_12_6(1)_37-42.nxml.txt.nlp	24707248	SENT25	13	13	5	5	doxorubicin	CHOP	PA449412	1649	0.86
NULL	Int_J_Endocrinol_2014_Aug_11_2014_312452.nxml.txt.nlp	25183970	SENT14	10	10	16	16	liraglutide	PI3K	PA165958364	5290	0.86
NULL	Environ_Health_Perspect_2010_Jul_3_118(7)_936-942.nxml.txt.nlp	20199942	SENT197	18	18	5	5	arsenite	mot-2	PA452638	3313	0.86
NULL	Int_J_Mol_Sci_2014_Mar_3_15(3)_3768-3783.nxml.txt.nlp	24595239	SENT90	12	12	6	6	hyaluronan	CD44	PA165958431	960	0.86
NULL	Cell_Commun_Signal_2011_May_15_9_13.nxml.txt.nlp	21569639	SENT290	8	8	16	16	quinacrine	p53	PA164745551	7157	0.86
NULL	Curr_Pharm_Des_2012_Apr_18(11)_1519-1530.nxml.txt.nlp	22364136	SENT106	8	8	30	30	lovastatin	AP-1	PA450272	2353;3727;2354;3725	0.86
NULL	EMBO_Mol_Med_2009_Apr_1(1)_66-78.nxml.txt.nlp	20049704	SENT215	15	15	10	10	sorafenib	VEGFR2	PA7000	3791	0.86
NULL	Cancers_(Basel)_2010_Sep_27_2(3)_1731-1770.nxml.txt.nlp	24281185	SENT1693	6	6	12	12	cyclophosphamide	F10	PA449165	2159	0.86
NULL	Mol_Vis_2012_Nov_29_18_2839-2846.nxml.txt.nlp	23233786	SENT181	0	0	20	20	geldanamycin	Hsp90	PA152031327	3320	0.86
NULL	J_Biol_Chem_2009_Jan_9_284(2)_784-791.nxml.txt.nlp	19008230	SENT202	30	30	15	15	isoproterenol	CO2	PA450121	4513	0.86
NULL	Mol_Cancer_2008_Mar_6_7_24.nxml.txt.nlp	18325101	SENT153	8	8	13	13	cisplatin	BRCA1	PA449014	672	0.86
NULL	Pharmaceuticals_(Basel)_2011_Mar_25_4(4)_567-589.nxml.txt.nlp	NULL	SENT380	5	5	9	9	doxazosin	NF-kappaB	PA449407	4790	0.86
NULL	Cancers_(Basel)_2014_Aug_12_6(3)_1631-1669.nxml.txt.nlp	25119536	SENT361	6	6	2	2	pha-665752	Met		79811	0.86
NULL	Diagn_Pathol_2014_Aug_9_9(1)_153.nxml.txt.nlp	NULL	SENT27	4	4	38	38	imatinib	PIK3CA	PA10804	5290	0.86
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Sep_9_65(Pt_10)_o2389.nxml.txt.nlp	21577853	SENT65	23	23	11	11	ethanol	mol	PA448073	90527	0.86
NULL	Int_J_Surg_Oncol_2012_Jun_12_2012_862879.nxml.txt.nlp	22778941	SENT240	28	28	2	2	cisplatin	BIN1	PA449014	274	0.86
NULL	Acta_Pharmacol_Sin_2013_Jul_5_34(7)_870-879.nxml.txt.nlp	23624759	SENT118	24	24	12	12	gemcitabine	SIDT1	PA449748	54847	0.86
NULL	Arthritis_Res_Ther_2006_Mar_6_8(2)_R53.nxml.txt.nlp	16519795	SENT64	5	5	7	7	methotrexate	IL-10	PA450428	3586	0.86
NULL	Oncotarget_2011_May_16_2(5)_418-421.nxml.txt.nlp	21789791	SENT27	21	21	8	8	bortezomib	TRAIL	PA10252	8743	0.86
NULL	Int_Semin_Surg_Oncol_2007_Feb_14_4_5.nxml.txt.nlp	17394628	SENT175	2	2	7	7	cisplatin	PMS2	PA449014	5395	0.86
NULL	Arthritis_Res_Ther_2008_Jan_7_10(1)_R1.nxml.txt.nlp	18179697	SENT177	2	2	9	9	oxaliplatin	HMGB1	PA131285527	3146	0.86
NULL	Pharmaceuticals_(Basel)_2012_Aug_10_5(8)_802-836.nxml.txt.nlp	24280676	SENT25	12	12	8	8	ribavirin	CNT2	PA451241	9153	0.86
NULL	Open_Biochem_J_2012_Mar_19_6_11-15.nxml.txt.nlp	22481982	SENT27	10	10	2	2	nadh	Mal	PA164755085	114609	0.86
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT173	18	18	26	26	sitagliptin	HIP	PA164748978	6767;6159;64399;5068	0.86
NULL	Diabetes_Care_2012_Jun_11_35(6)_1225-1231.nxml.txt.nlp	22432104	SENT202	7	7	15	15	exenatide	GLP-1	PA164749238	100125288	0.86
NULL	Int_J_Mol_Sci_2012_Dec_5_13(12)_16624-16635.nxml.txt.nlp	23443122	SENT10	8	8	14	14	carboplatin	MDR1	PA448803	5243	0.86
NULL	Protein_Cell_2014_Apr_4_5(4)_307-316.nxml.txt.nlp	24585413	SENT157	10	10	25	25	fluorescein	CD83	PA164746009	9308	0.86
NULL	Nat_Commun_2011_Oct_25_2_513.nxml.txt.nlp	22027593	SENT569	24	24	34	34	doxorubicin	RBM38	PA449412	55544	0.86
NULL	Ann_Rheum_Dis_2009_Dec_4_68(12)_1870-1877.nxml.txt.nlp	19124524	SENT160	43	43	16	16	methotrexate	ACR	PA450428	49	0.86
NULL	J_Cell_Mol_Med_2013_Dec_6_17(12)_1588-1597.nxml.txt.nlp	24199964	SENT241	34	34	36	36	dobutamine	APT	PA449381	653639	0.86
NULL	Cancers_(Basel)_2013_Jul_25_5(3)_919-942.nxml.txt.nlp	24202327	SENT164	17	17	9	9	ketoconazole	CYP3A4	PA450146	1576	0.86
NULL	Aging_(Albany_NY)_2013_Feb_21_5(2)_94-95.nxml.txt.nlp	23518473	SENT28	9	9	27	27	resveratrol	HGPS		4000;10269;64221	0.86
NULL	Acta_Pharmacol_Sin_2009_Sep_24_30(9)_1262-1275.nxml.txt.nlp	19701231	SENT146	40	40	31	31	lovastatin	NPC1L1	PA450272	29881	0.86
NULL	Aging_(Albany_NY)_2014_Jan_14_6(1)_70-81.nxml.txt.nlp	24429382	SENT176	13	13	0	0	etoposide	WRN	PA449552	7486	0.86
NULL	J_Obes_2011_Dec_15_2011_928165.nxml.txt.nlp	21197151	SENT142	2	2	43	43	octreotide	ghrelin	PA450678	51738	0.86
NULL	Leukemia_2014_Jan_12_28(1)_15-33.nxml.txt.nlp	23778311	SENT252	27	27	12	12	imatinib	SIRT1	PA10804	23411	0.86
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT102	20	20	13	13	heparin	FGF1	PA449855	2246	0.86
NULL	Nanoscale_Res_Lett_2010_Aug_18_6(1)_1.nxml.txt.nlp	21711573	SENT3	38	38	6	6	ethanol	NO3	PA448073	4681	0.86
NULL	Springerplus_2014_Sep_17_3_535.nxml.txt.nlp	25279326	SENT153	20	20	13	13	everolimus	aromatase	PA164746311	1588	0.86
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Apr_30_65(Pt_5)_m595.nxml.txt.nlp	21583817	SENT56	40	40	7	7	ethanol	mol	PA448073	90527	0.86
NULL	Arthritis_Res_Ther_2006_Apr_12_8(Suppl_1)_S3.nxml.txt.nlp	16820042	SENT125	36	36	29	29	indomethacin	ACTH	PA449982	5443	0.86
NULL	Cancer_Manag_Res_2012_Nov_9_4_383-395.nxml.txt.nlp	23204869	SENT217	9	9	0	0	carmustine	PC-3	PA448810	692094	0.86
NULL	Breast_Cancer_Res_2007_Jun_7_9(3)_R37.nxml.txt.nlp	17555561	SENT112	8	8	14	14	anastrozole	GIDE	PA448432	79594	0.86
NULL	Oncotarget_2014_Nov_8_5(21)_10280-10292.nxml.txt.nlp	25373733	SENT31	1	1	23	23	bortezomib	HIF-1	PA10252	29072	0.86
NULL	J_Anaesthesiol_Clin_Pharmacol_2011_Jul-Sep_27(3)_315-322.nxml.txt.nlp	21897499	SENT48	13	13	7	7	clonidine	CNB	PA449051	5534	0.86
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT347	27	27	3	3	pp2	CDH1		51343;999	0.86
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jan_11_68(Pt_2)_o352.nxml.txt.nlp	22346980	SENT63	19	19	6	6	ethanol	mol	PA448073	90527	0.86
NULL	Cell_Death_Dis_2012_Jul_26_3(7)_e359.nxml.txt.nlp	22833098	SENT209	15	15	9	9	trypsin	SDS	PA451806	51119;10993	0.86
NULL	Biomed_Res_Int_2014_Jun_26_2014_161346.nxml.txt.nlp	25054130	SENT236	7	7	21	21	curcumin	STZ	PA151958596	6484	0.86
NULL	Diabetes_2009_Aug_28_58(8)_1826-1834.nxml.txt.nlp	19401415	SENT196	42	42	19	19	lipase	adiponutrin	PA450239	80339	0.86
NULL	Br_J_Cancer_2009_Mar_24_100(6)_870-873.nxml.txt.nlp	19293806	SENT38	13	13	27	27	gemcitabine	CDA	PA449748	978	0.86
NULL	Oncotarget_2010_Oct_25_1(7)_497-514.nxml.txt.nlp	21165163	SENT236	43	43	26	26	gefitinib	EGFR	PA131301952	1956	0.86
NULL	Neuro_Oncol_2010_Apr_27_12(4)_389-400.nxml.txt.nlp	20308316	SENT117	29	29	38	38	chloroquine	p53	PA448948	7157	0.86
NULL	Clin_Med_Insights_Cardiol_2015_Jan_5_8(Suppl_1)_39-44.nxml.txt.nlp	25628512	SENT88	10	10	8	8	resveratrol	TTR		7276	0.86
NULL	Front_Endocrinol_(Lausanne)_2014_Oct_27_5_163.nxml.txt.nlp	25386163	SENT216	18	18	21	21	ethanol	ghrelin	PA448073	51738	0.86
NULL	Nat_Commun_2014_Dec_8_5_5736.nxml.txt.nlp	25484020	SENT164	9	9	2	2	exemestane	PAR2	PA449563	2150;55065;8856	0.86
NULL	Curr_Pharm_Des_2011_Feb_17(6)_578-590.nxml.txt.nlp	21391908	SENT177	2	2	19	19	nutlin-3	p53		7157	0.86
NULL	Cancer_Inform_2014_Oct_14_13(Suppl_1)_103-111.nxml.txt.nlp	25392688	SENT92	5	5	9	9	simvastatin	CYR61	PA451363	3491	0.86
NULL	Acta_Orthop_2009_Feb_26_80(1)_46-50.nxml.txt.nlp	19234885	SENT105	3	3	21	21	celecoxib	TKR	PA448871	8277	0.86
NULL	Int_J_Mol_Sci_2012_Sep_25_13(10)_12153-12168.nxml.txt.nlp	23202889	SENT534	15	15	9	9	cetuximab	PIK3CA	PA10040	5290	0.86
NULL	Biomed_Res_Int_2014_May_29_2014_463767.nxml.txt.nlp	24987683	SENT125	12	12	2	2	warfarin	VKORC1	PA451906	79001	0.86
NULL	Mol_Cancer_2007_Oct_22_6_66.nxml.txt.nlp	17953743	SENT188	23	23	17	17	cisplatin	TRAIL	PA449014	8743	0.86
NULL	Endocrinol_Metab_(Seoul)_2014_Sep_25_29(3)_379-387.nxml.txt.nlp	25309798	SENT132	0	0	9	9	resveratrol	SIRT1		23411	0.86
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT152	7	7	13	13	perifosine	DR4	PA165291471	8797	0.86
NULL	Eur_J_Clin_Pharmacol_2010_Feb_17_66(2)_165-170.nxml.txt.nlp	19838691	SENT100	15	15	23	23	midazolam	CYP3A	PA450496	1574	0.86
NULL	Oncotarget_2012_Dec_17_4(1)_48-63.nxml.txt.nlp	23295955	SENT182	20	20	9	9	paclitaxel	MTHFD2	PA450761	10797	0.86
NULL	Nat_Methods_2012_Feb_19_9(4)_396-402.nxml.txt.nlp	22343342	SENT337	24	24	17	17	capsaicin	TRPV1	PA448776	7442	0.86
NULL	Diabetes_Metab_Syndr_Obes_2014_Aug_28_7_391-400.nxml.txt.nlp	25210468	SENT100	21	21	9	9	liraglutide	GLP-1	PA165958364	100125288	0.86
NULL	Int_J_Vasc_Med_2012_Oct_22_2012_641917.nxml.txt.nlp	23133757	SENT117	10	10	5	5	thrombin	VWF	PA451674	7450	0.86
NULL	J_Thromb_Haemost_2014_May_22_12(5)_748-760.nxml.txt.nlp	24612393	SENT24	4	4	14	14	thrombin	ADP	PA451674	23038	0.86
NULL	Biomed_Res_Int_2013_Jun_13_2013_851428.nxml.txt.nlp	23841096	SENT228	16	16	32	32	l-serine	SHMT	PA451330	6470	0.86
NULL	Acta_Naturae_2011_Jul-Sep_3(3)_12-28.nxml.txt.nlp	22649690	SENT212	21	21	24	24	efavirenz	CD4	PA449441	920	0.86
NULL	Curr_Oncol_Rep_2011_Apr_12_13(2)_103-111.nxml.txt.nlp	21318618	SENT4	22	22	11	11	axitinib	VEGFR	PA164924493	3791	0.86
NULL	Exp_Ther_Med_2013_Apr_5_5(4)_1259-1263.nxml.txt.nlp	23596498	SENT5	5	5	17	17	propofol	TRPV1	PA451141	7442	0.86
NULL	J_Cell_Mol_Med_2014_Oct_11_18(10)_2031-2043.nxml.txt.nlp	25109475	SENT244	27	27	19	19	valsartan	AMPK	PA451848	5563	0.86
NULL	Core_Evid_2011_Jan_6_6_13-21.nxml.txt.nlp	21468239	SENT73	27	27	15	15	ketoconazole	CYP4F	PA450146	4051	0.86
NULL	Nature_2008_Oct_23_455(7216)_1076-1081.nxml.txt.nlp	18948948	SENT10	18	18	27	27	staurosporine	BIM	PA165109623	10018	0.86
NULL	Arthritis_Res_Ther_2014_Apr_7_16(2)_R88.nxml.txt.nlp	24708712	SENT96	23	23	8	8	heparin	CO2	PA449855	4513	0.86
NULL	Biotechnol_Res_Int_2013_Dec_1_2013_253286.nxml.txt.nlp	24363937	SENT100	10	10	3	3	nitrogen	DAP	PA450643	23549;3375;1611	0.86
NULL	Mol_Cancer_2010_Apr_23_9_87.nxml.txt.nlp	20416058	SENT183	5	5	9	9	doxorubicin	TRAIL	PA449412	8743	0.86
NULL	Br_J_Cancer_2013_Jul_9_109(1)_164-171.nxml.txt.nlp	23799852	SENT15	23	23	9	9	chloroquine	ATG7	PA448948	10533	0.86
NULL	Crit_Care_2008_Nov_12_12(6)_235.nxml.txt.nlp	19040780	SENT177	19	19	13	13	cyclosporine	CYP3A4	PA449167	1576	0.86
NULL	J_Headache_Pain_2008_Apr_7_9(2)_103-107.nxml.txt.nlp	18256782	SENT82	21	21	0	0	cabergoline	PRL	PA448708	5617	0.86
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT56	9	9	1	1	doxorubicin	SLK	PA449412	9748;2534	0.86
NULL	J_Korean_Med_Sci_2011_Aug_27_26(8)_1007-1013.nxml.txt.nlp	21860550	SENT20	0	0	25	25	tamoxifen	CYP2D6	PA451581	1565	0.86
NULL	Endocrinol_Metab_(Seoul)_2014_Sep_25_29(3)_379-387.nxml.txt.nlp	25309798	SENT109	3	3	25	25	resveratrol	BMAL1		406	0.86
NULL	Cancer_Res_Treat_2014_Jul_15_46(3)_209-222.nxml.txt.nlp	25038756	SENT169	24	24	4	4	paclitaxel	EZH2	PA450761	2146	0.86
NULL	J_Adv_Pract_Oncol_2013_Jul_1_Jul-Aug_4(4)_263-268.nxml.txt.nlp	25032007	SENT45	28	28	11	11	tacrolimus	CYP2C19	PA451578	1557	0.86
NULL	Diabetes_2013_Jun_17_62(6)_1843-1854.nxml.txt.nlp	23349486	SENT235	5	5	20	20	pioglitazone	MCP-1	PA450970	6347	0.86
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R91.nxml.txt.nlp	22541814	SENT156	21	21	27	27	thrombin	HO-1	PA451674	3162	0.86
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT378	34	34	14	14	resveratrol	NMNAT1		64802	0.86
NULL	J_Cancer_Epidemiol_2012_Oct_24_2012_294730.nxml.txt.nlp	23150730	SENT150	38	38	28	28	cetuximab	KRAS	PA10040	3845	0.86
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jan_8_67(Pt_2)_o313-o314.nxml.txt.nlp	21523001	SENT73	27	27	6	6	ethanol	mol	PA448073	90527	0.86
NULL	Cell_Death_Dis_2013_Jul_11_4(7)_e719.nxml.txt.nlp	23846221	SENT64	11	11	9	9	cisplatin	TRAIL	PA449014	8743	0.86
NULL	Br_J_Cancer_2010_Aug_24_103(5)_663-667.nxml.txt.nlp	20700126	SENT76	27	27	31	31	trastuzumab	HER2	PA451743	2064	0.86
NULL	Exp_Lung_Res_2013_Oct_1_39(8)_336-348.nxml.txt.nlp	23919450	SENT92	6	6	0	0	argatroban	PAR-1	PA164745516	2011;2149	0.86
NULL	Oncotarget_2014_Aug_29_5(17)_7217-7259.nxml.txt.nlp	25277175	SENT336	10	10	12	12	bicalutamide	AKT	PA164746255	207	0.86
NULL	Mol_Cancer_2008_Sep_30_7_73.nxml.txt.nlp	18826597	SENT84	8	8	18	18	doxycycline	c-Myc	PA449415	4609	0.86
NULL	Diabetes_Care_2009_Nov_32(Suppl_2)_S362-S367.nxml.txt.nlp	19875582	SENT87	28	28	16	16	deferoxamine	RBP4	PA164746490	5433;5950	0.86
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Feb_24_68(Pt_3)_o825-o826.nxml.txt.nlp	22412689	SENT5	11	11	1	1	phenol	mol	PA450913	90527	0.86
NULL	J_Immunother_2014_Feb_21_37(2)_105-114.nxml.txt.nlp	24509173	SENT8	28	28	10	10	gemcitabine	WT1	PA449748	7490	0.86
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Dec_16_66(Pt_1)_o157.nxml.txt.nlp	21580046	SENT72	25	25	13	13	ethanol	mol	PA448073	90527	0.86
NULL	Mucosal_Immunol_2013_May_7_6(3)_626-638.nxml.txt.nlp	23131784	SENT212	11	11	4	4	paraformaldehyde	CD14	PA450790	929	0.86
NULL	Oncotarget_2011_Mar_27_2(3)_209-221.nxml.txt.nlp	21444945	SENT159	15	15	6	6	bortezomib	p53	PA10252	7157	0.86
NULL	Br_J_Cancer_2012_May_22_106(11)_1779-1789.nxml.txt.nlp	22549178	SENT134	8	8	25	25	pertuzumab	HER2		2064	0.86
NULL	Case_Rep_Dermatol_2012_Sep_16_4(3)_256-260.nxml.txt.nlp	23275770	SENT75	10	10	21	21	pyridostigmine	OMG	PA451185	4974	0.86
NULL	Mol_Vis_2012_Feb_11_18_431-438.nxml.txt.nlp	22355254	SENT12	3	3	10	10	timolol	CXCL8	PA451690	3576	0.86
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT29	26	26	18	18	atorvastatin	survivin	PA448500	332	0.86
NULL	Br_J_Cancer_1999_Aug_80(12)_1912-1919.nxml.txt.nlp	10471039	SENT9	31	31	8	8	cisplatin	p53	PA449014	7157	0.86
NULL	Arch_Drug_Inf_2011_Mar_4(1)_1-9.nxml.txt.nlp	21572514	SENT22	0	0	6	6	vinblastine	P-gp	PA451877	5243	0.86
NULL	Br_J_Cancer_2009_Jun_2_100(11)_1739-1745.nxml.txt.nlp	19436299	SENT182	14	14	18	18	everolimus	FDG	PA164746311	23583	0.86
NULL	Oncol_Rep_2013_Apr_5_29(4)_1671-1677.nxml.txt.nlp	23404329	SENT165	14	14	16	16	aspirin	ASP	PA448497	259266;443;9474;29974;434;83853	0.86
NULL	Core_Evid_2009_Jun_15_4_215-245.nxml.txt.nlp	20694078	SENT226	6	6	24	24	lenalidomide	CD34	PA162363968	947	0.86
NULL	Arthritis_Res_Ther_2005_Feb_18_7(3)_R476-R484.nxml.txt.nlp	15899034	SENT143	6	6	18	18	thrombin	Rho	PA451674	29984	0.86
NULL	Oncotarget_2013_Nov_24_4(12)_2186-2207.nxml.txt.nlp	24327604	SENT130	32	32	17	17	doxorubicin	p53	PA449412	7157	0.86
NULL	Biotechnol_Res_Int_2013_Dec_1_2013_253286.nxml.txt.nlp	24363937	SENT100	18	18	3	3	ethanol	DAP	PA448073	23549;3375;1611	0.86
NULL	Exp_Ther_Med_2012_Sep_12_4(3)_475-480.nxml.txt.nlp	23181121	SENT159	4	4	16	16	doxorubicin	CHOP	PA449412	1649	0.86
NULL	Breast_Cancer_Res_2014_May_5_16(3)_R45.nxml.txt.nlp	24887236	SENT233	29	29	22	22	lapatinib	EGFR	PA152241907	1956	0.86
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT119	44	44	7	7	perifosine	DR5	PA165291471	8795	0.86
NULL	Curr_Neuropharmacol_2008_Dec_6(4)_293-310.nxml.txt.nlp	19587851	SENT248	13	13	17	17	methysergide	5-HT7	PA164743265	3363	0.86
NULL	Genome_Biol_Evol_2011_Mar_7_3_272-283.nxml.txt.nlp	21383383	SENT77	3	3	27	27	fluorescein	CD19	PA164746009	930	0.86
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jun_25_67(Pt_7)_m978.nxml.txt.nlp	21836952	SENT61	11	11	6	6	ethanol	mol	PA448073	90527	0.86
NULL	Br_J_Cancer_1994_Mar_69(3)_497-501.nxml.txt.nlp	8123480	SENT0	19	19	9	9	vincristine	ACTH	PA451879	5443	0.86
NULL	Eur_J_Clin_Pharmacol_2013_Jan_11_69(6)_1275-1283.nxml.txt.nlp	23307232	SENT238	20	20	12	12	warfarin	VKORC1	PA451906	79001	0.86
NULL	J_Inherit_Metab_Dis_2010_Oct_3_33(5)_625-632.nxml.txt.nlp	20814828	SENT133	13	13	8	8	simvastatin	RhoA	PA451363	387	0.86
NULL	eLife_2014_May_20_3_e02324.nxml.txt.nlp	24844706	SENT269	1	1	20	20	tetracycline	EP1	PA451640	5731	0.86
NULL	Jpn_Clin_Med_2013_Mar_6_4_7-13.nxml.txt.nlp	23966811	SENT32	24	24	17	17	omeprazole	ESD	PA450704	2098	0.86
NULL	BMJ_2011_Aug_4_343_d4588.nxml.txt.nlp	21816733	SENT392	31	31	23	23	escitalopram	CYP2C19	PA10074	1557	0.86
NULL	Oxid_Med_Cell_Longev_2013_Apr_21_2013_412576.nxml.txt.nlp	23710286	SENT10	10	10	14	14	curcumin	NRF2	PA151958596	2551;4780	0.86
NULL	Sci_Rep_2014_Nov_28_4_7237.nxml.txt.nlp	25429875	SENT110	0	0	21	21	hesperidin	p38	PA449867	10598;1432;7965	0.86
NULL	Indian_J_Med_Res_2012_Jul_136(1)_54-59.nxml.txt.nlp	22885264	SENT145	7	7	19	19	cisplatin	IFN	PA449014	3439	0.86
NULL	Trials_2012_Sep_8_13_160.nxml.txt.nlp	22958580	SENT44	26	26	12	12	succinylcholine	LSR	PA451522	51599	0.86
NULL	Exp_Diabetes_Res_2012_May_14_2012_470851.nxml.txt.nlp	22666230	SENT203	30	30	25	25	exenatide	GLP-1	PA164749238	100125288	0.86
NULL	Diabetes_Care_2011_Aug_16_34(8)_1854-1859.nxml.txt.nlp	21715518	SENT19	12	12	6	6	estradiol	aromatase	PA449503	1588	0.86
NULL	Core_Evid_2008_Jun_3(1)_13-30.nxml.txt.nlp	20694081	SENT164	3	3	1	1	exenatide	GLP-1	PA164749238	100125288	0.86
NULL	Curr_Neuropharmacol_2008_Jun_6(2)_125-150.nxml.txt.nlp	19305793	SENT759	6	6	17	17	buprenorphine	ORL1	PA448685	4987	0.86
NULL	J_Thromb_Haemost_2014_May_22_12(5)_748-760.nxml.txt.nlp	24612393	SENT113	6	6	12	12	thrombin	TSC2	PA451674	7249	0.86
NULL	Acta_Pharmacol_Sin_2012_Mar_27_33(3)_342-350.nxml.txt.nlp	22367283	SENT193	27	27	14	14	thrombin	PAR2	PA451674	2150;55065;8856	0.86
NULL	Biomed_Res_Int_2014_Jan_20_2014_948427.nxml.txt.nlp	24563867	SENT89	3	3	24	24	buspirone	STZ	PA448689	6484	0.86
NULL	Oncogenesis_2012_Apr_2_1(4)_e5.nxml.txt.nlp	23552603	SENT234	20	20	28	28	celecoxib	Bcl-2	PA448871	596	0.86
NULL	Breast_Cancer_Res_2007_Jul_5_9(4)_R41.nxml.txt.nlp	17612393	SENT183	24	24	30	30	celecoxib	Bcl-2	PA448871	596	0.86
NULL	Curr_Neuropharmacol_2013_Jul_11(4)_338-378.nxml.txt.nlp	24381528	SENT395	0	0	13	13	curcumin	Bcl-2	PA151958596	596	0.86
NULL	Cancer_Med_2014_Oct_2_3(5)_1385-1395.nxml.txt.nlp	24890702	SENT153	5	5	27	27	fluorouracil	BRAF	PA128406956	673	0.86
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jul_7_68(Pt_8)_o2392-o2393.nxml.txt.nlp	22904850	SENT72	22	22	19	19	ethanol	mol	PA448073	90527	0.86
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT279	2	2	10	10	chloroquine	BMPR-II	PA448948	659	0.86
NULL	Clin_Pract_2013_Jan_25_3(1)_e2.nxml.txt.nlp	24765495	SENT58	25	25	11	11	l-arginine	ASS1	PA448478	445	0.86
NULL	Mol_Cancer_2010_Nov_2_9_289.nxml.txt.nlp	21044322	SENT173	22	22	9	9	vincristine	RGS17	PA451879	26575	0.86
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT32	9	9	5	5	erlotinib	CYP3A	PA134687924	1574	0.86
NULL	Hum_Genomics_2009_Dec_1_4(2)_91-106.nxml.txt.nlp	20038497	SENT198	14	14	8	8	tacrine	GSTM1	PA451576	2944	0.86
NULL	Ther_Clin_Risk_Manag_2005_Dec_1(4)_299-306.nxml.txt.nlp	18360572	SENT74	4	4	2	2	itraconazole	CYP3A4	PA450132	1576	0.86
NULL	Arthritis_Res_Ther_2014_Apr_3_16(2)_R86.nxml.txt.nlp	24708674	SENT227	24	24	17	17	bleomycin	Fli1	PA448645	2314	0.86
NULL	J_Cell_Biol_2005_May_23_169(4)_681-691.nxml.txt.nlp	15911882	SENT377	7	7	17	17	paraformaldehyde	CD31	PA450790	5175	0.86
NULL	Aging_(Albany_NY)_2011_May_8_3(5)_515-532.nxml.txt.nlp	21666281	SENT202	15	15	6	6	mitomycin	BRCA1	PA450524	672	0.86
NULL	Breast_Cancer_Res_Treat_2014_Dec_21_143(3)_459-467.nxml.txt.nlp	24362951	SENT215	10	10	34	34	everolimus	aromatase	PA164746311	1588	0.86
NULL	J_Hematol_Oncol_2013_Nov_16_6_86.nxml.txt.nlp	24238138	SENT149	15	15	4	4	doxorubicin	CHOP	PA449412	1649	0.86
NULL	Arthritis_Res_Ther_2005_Feb_17_7(Suppl_1)_P74.nxml.txt.nlp	NULL	SENT18	27	27	33	33	losartan	mol	PA450268	90527	0.86
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT46	16	16	10	10	nutlin-3	TRAIL		8743	0.86
NULL	Cell_Commun_Signal_2003_Nov_24_1_5.nxml.txt.nlp	14636425	SENT199	18	18	6	6	heparin	CCN5	PA449855	8839	0.86
NULL	Cardiol_Ther_2013_Jun_1_2(1)_111-124.nxml.txt.nlp	25135294	SENT121	19	19	2	2	ketoconazole	P-gp	PA450146	5243	0.86
NULL	Core_Evid_2008_Jun_3(1)_45-54.nxml.txt.nlp	20694083	SENT97	14	14	5	5	cisapride	5-HT4	PA449011	3360	0.86
NULL	J_Cell_Mol_Med_2013_Dec_6_17(12)_1588-1597.nxml.txt.nlp	24199964	SENT21	16	16	18	18	dobutamine	APT	PA449381	653639	0.86
NULL	J_Invest_Dermatol_2013_Sep_31_133(9)_2247-2254.nxml.txt.nlp	23370537	SENT72	17	17	23	23	chloroquine	PUMA	PA448948	27113	0.86
NULL	Br_J_Cancer_2010_Nov_9_103(10)_1588-1596.nxml.txt.nlp	20978505	SENT38	5	5	18	18	temozolomide	PARP-1	PA451609	25976	0.86
NULL	EMBO_Mol_Med_2012_Oct_30_4(10)_1087-1096.nxml.txt.nlp	22933245	SENT109	34	34	4	4	olaparib	NAMPT		10135	0.86
NULL	Br_J_Cancer_2011_Jun_7_104(12)_1816-1821.nxml.txt.nlp	21610711	SENT123	26	26	28	28	cisplatin	IL-2	PA449014	3558	0.86
NULL	Int_J_Endocrinol_2010_Mar_2_2010_621687.nxml.txt.nlp	20204178	SENT6	9	9	17	17	paricalcitol	PTH	PA450798	5741	0.86
NULL	Chem_Rev_2011_Oct_12_111(10)_5899-5921.nxml.txt.nlp	21923193	SENT551	38	38	19	19	indomethacin	CB1	PA449982	1268	0.86
NULL	Br_J_Cancer_2009_Mar_24_100(6)_870-873.nxml.txt.nlp	19293806	SENT3	26	26	5	5	gemcitabine	CDA	PA449748	978	0.86
NULL	Autoimmune_Dis_2013_Jul_10_2013_728529.nxml.txt.nlp	23936634	SENT167	9	9	11	11	rituximab	p38	PA451261	10598;1432;7965	0.86
NULL	Cancer_Med_2013_Dec_31_2(6)_826-835.nxml.txt.nlp	24403256	SENT68	9	9	23	23	daunorubicin	p53	PA449212	7157	0.86
NULL	Nucleic_Acids_Res_2011_May_10_39(9)_3607-3620.nxml.txt.nlp	21227924	SENT387	21	21	6	6	camptothecin	XRCC1	PA153590860	7515	0.86
NULL	Br_J_Cancer_2011_Jul_26_105(3)_372-381.nxml.txt.nlp	21730979	SENT6	11	11	22	22	cisplatin	ATR	PA449014	390502;84168;545	0.86
NULL	Protein_Expr_Purif_2009_Aug_66(2)_181-184.nxml.txt.nlp	19269329	SENT22	15	15	8	8	thrombin	AMPK	PA451674	5563	0.86
NULL	Cardiovasc_Ther_2009_27(4)_259-274.nxml.txt.nlp	19604248	SENT162	32	32	4	4	clopidogrel	IPA	PA449053	3160	0.86
NULL	Case_Rep_Med_2013_Dec_12_2013_834164.nxml.txt.nlp	24416042	SENT31	5	5	10	10	metoprolol	B12	PA450480	7126;4709	0.859
NULL	Drugs_R_D_2010_Sep_27_10(3)_165-178.nxml.txt.nlp	20945947	SENT219	9	9	27	27	ridaforolimus	PTEN	PA165291475	5728	0.859
NULL	EMBO_Mol_Med_2012_Jul_18_4(7)_557-560.nxml.txt.nlp	22610822	SENT37	9	9	12	12	resveratrol	SIRT1		23411	0.859
NULL	Acta_Pharmacol_Sin_2014_Aug_21_35(8)_1082-1092.nxml.txt.nlp	25047514	SENT80	17	17	14	14	letrozole	aromatase	PA450196	1588	0.859
NULL	J_Cardiothorac_Surg_2010_Nov_3_5_101.nxml.txt.nlp	21047408	SENT168	0	0	10	10	heparin	ACT	PA449855	12;11332;9457;641455	0.859
NULL	Aging_Cell_2012_Aug_11(4)_579-587.nxml.txt.nlp	22435726	SENT115	1	1	32	32	etoposide	CO2	PA449552	4513	0.859
NULL	Br_J_Pharmacol_2008_Oct_18_155(4)_596-605.nxml.txt.nlp	18852694	SENT149	16	16	8	8	fenofibrate	SREBP2	PA449594	6721	0.859
NULL	Mol_Cancer_2009_Nov_10_8_99.nxml.txt.nlp	19903356	SENT76	12	12	3	3	imatinib	IGFBP3	PA10804	3486	0.859
NULL	Blood_Res_2014_Mar_24_49(1)_36-41.nxml.txt.nlp	24724065	SENT107	39	39	33	33	vincristine	CHOP	PA451879	1649	0.859
NULL	Breast_Cancer_Res_2003_Mar_27_5(3)_154-159.nxml.txt.nlp	12793897	SENT15	6	6	11	11	tamoxifen	aromatase	PA451581	1588	0.859
NULL	Br_J_Cancer_2013_May_14_108(9)_1862-1869.nxml.txt.nlp	23579219	SENT109	24	24	5	5	bevacizumab	KRAS	PA130232992	3845	0.859
NULL	Diabetes_2013_Jun_17_62(6)_1843-1854.nxml.txt.nlp	23349486	SENT190	4	4	10	10	pioglitazone	IL-6	PA450970	3569	0.859
NULL	Eur_J_Pediatr_2011_Jun_8_170(6)_709-718.nxml.txt.nlp	20931226	SENT28	31	31	20	20	budesonide	BDP	PA448681	10620;152926	0.859
NULL	Core_Evid_2011_Sep_8_6_67-79.nxml.txt.nlp	22022289	SENT182	18	18	8	8	liraglutide	GLP-1	PA165958364	100125288	0.859
NULL	ScientificWorldJournal_2014_Feb_11_2014_898361.nxml.txt.nlp	24678280	SENT15	8	8	21	21	curcumin	IL-4	PA151958596	3565	0.859
NULL	Leukemia_2013_Feb_3_27(2)_315-324.nxml.txt.nlp	22751450	SENT152	7	7	16	16	sorafenib	Mcl-1	PA7000	4170	0.859
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_28_2012_937605.nxml.txt.nlp	23304227	SENT134	4	4	20	20	resveratrol	GDNF		2668	0.859
NULL	EMBO_J_2008_Jan_9_27(1)_201-211.nxml.txt.nlp	18046456	SENT286	35	35	28	28	geldanamycin	Hsp90	PA152031327	3320	0.859
NULL	Thorax_2012_Sep_11_67(9)_796-803.nxml.txt.nlp	22496351	SENT129	5	5	11	11	bleomycin	TRAIL	PA448645	8743	0.859
NULL	Br_J_Cancer_2013_Feb_19_108(3)_493-502.nxml.txt.nlp	23299530	SENT157	21	21	27	27	bevacizumab	VEGF-A	PA130232992	7422	0.859
NULL	Int_J_Breast_Cancer_2012_May_9_2012_415170.nxml.txt.nlp	22649737	SENT44	26	26	36	36	trastuzumab	PI3K	PA451743	5290	0.859
NULL	BioData_Min_2008_Jul_17_1_2.nxml.txt.nlp	18822146	SENT194	24	24	37	37	ethanol	MTHFR	PA448073	4524	0.859
NULL	Br_J_Cancer_2014_Aug_12_111(4)_696-707.nxml.txt.nlp	24937672	SENT45	24	24	10	10	docetaxel	ABCC10	PA449383	89845	0.859
NULL	Oncotarget_2011_Sep_9_2(9)_658-668.nxml.txt.nlp	21911919	SENT65	0	0	4	4	cytarabine	HO-1	PA449177	3162	0.859
NULL	Cancers_(Basel)_2010_Feb_23_2(1)_88-113.nxml.txt.nlp	24281034	SENT248	17	17	27	27	cisplatin	survivin	PA449014	332	0.859
NULL	Arthritis_Res_Ther_2012_Jul_12_14(4)_R163.nxml.txt.nlp	22784880	SENT131	12	12	31	31	leflunomide	CYP1A2	PA450192	1544	0.859
NULL	Acta_Pharmacol_Sin_2014_Sep_25_35(9)_1199-1206.nxml.txt.nlp	25152024	SENT104	5	5	25	25	cisplatin	p38	PA449014	10598;1432;7965	0.859
NULL	Bone_Marrow_Transplant_2012_Feb_28_47(2)_203-211.nxml.txt.nlp	21441963	SENT37	23	23	0	0	fludarabine	NMA	PA449655	25805	0.859
NULL	J_Breast_Cancer_2011_Mar_31_14(1)_20-27.nxml.txt.nlp	21847390	SENT120	6	6	10	10	estradiol	CLDN6	PA449503	9074	0.859
NULL	Br_J_Cancer_2010_May_11_102(10)_1503-1510.nxml.txt.nlp	20461093	SENT179	9	9	34	34	tamoxifen	HER2	PA451581	2064	0.859
NULL	Oncotarget_2013_Nov_24_4(12)_2430-2438.nxml.txt.nlp	24280348	SENT116	16	16	7	7	gefitinib	STAT3	PA131301952	6774	0.859
NULL	Chem_Rev_2011_Oct_12_111(10)_5899-5921.nxml.txt.nlp	21923193	SENT555	16	16	10	10	flurbiprofen	FAAH	PA449683	79152;2166	0.859
NULL	Endocrinol_Metab_(Seoul)_2014_Sep_25_29(3)_379-387.nxml.txt.nlp	25309798	SENT17	8	8	14	14	resveratrol	SIRT1		23411	0.859
NULL	Curr_Biol_2012_Mar_6_22(5)_397-402.nxml.txt.nlp	22305751	SENT22	25	25	12	12	physostigmine	spatial	PA450957	219793	0.859
NULL	Diabetes_Metab_Syndr_Obes_2014_Jan_18_7_15-24.nxml.txt.nlp	24465132	SENT56	14	14	0	0	metformin	GLP-1	PA450395	100125288	0.859
NULL	Cancers_(Basel)_2011_Oct_26_3(4)_4024-4045.nxml.txt.nlp	24213123	SENT209	28	28	19	19	paclitaxel	TRAIL	PA450761	8743	0.859
NULL	Oncotarget_2013_Oct_19_4(11)_2045-2056.nxml.txt.nlp	24185104	SENT60	7	7	3	3	cisplatin	14-3-3	PA449014	10971	0.859
NULL	Indian_J_Endocrinol_Metab_2015_Jan-Feb_19(1)_30-38.nxml.txt.nlp	25593823	SENT103	19	19	34	34	sitagliptin	adiponectin	PA164748978	9370	0.859
NULL	Cancers_(Basel)_2010_Jun_11_2(2)_1251-1287.nxml.txt.nlp	22180839	SENT325	4	4	13	13	trastuzumab	HER2	PA451743	2064	0.859
NULL	FEBS_Open_Bio_2013_Sep_17_3_394-397.nxml.txt.nlp	24251101	SENT57	31	31	7	7	geldanamycin	UBR1	PA152031327	197131	0.859
NULL	Infection_2013_Sep_14_41(Suppl_2)_91-115.nxml.txt.nlp	24037688	SENT578	16	16	5	5	raltegravir	UGT1A1		54658	0.859
NULL	Ann_Rheum_Dis_2009_Nov_23_69(3)_510-516.nxml.txt.nlp	19933744	SENT189	25	25	17	17	abatacept	ACR	PA164747080	49	0.859
NULL	Mol_Cancer_2008_May_21_7_42.nxml.txt.nlp	18492291	SENT8	8	8	27	27	gefitinib	EGFR	PA131301952	1956	0.859
NULL	Apoptosis_2012_Sep_30_17(9)_989-997.nxml.txt.nlp	22460505	SENT117	6	6	15	15	thioridazine	CDK4	PA451666	1019	0.859
NULL	Cancer_2014_Aug_1_120(15)_2343-2351.nxml.txt.nlp	24752945	SENT155	27	27	16	16	gemcitabine	RRM1	PA449748	6240	0.859
NULL	Oncoimmunology_2013_Jun_1_2(6)_e24677.nxml.txt.nlp	23894722	SENT113	3	3	17	17	cetuximab	CD80	PA10040	941	0.859
NULL	Endocrinol_Metab_(Seoul)_2014_Sep_25_29(3)_379-387.nxml.txt.nlp	25309798	SENT186	10	10	34	34	resveratrol	BMAL1		406	0.859
NULL	J_Cell_Mol_Med_2013_Feb_10_17(2)_265-276.nxml.txt.nlp	23301855	SENT133	4	4	15	15	doxycycline	STAT3	PA449415	6774	0.859
NULL	AIDS_Res_Ther_2013_May_1_10_10.nxml.txt.nlp	23634877	SENT187	34	34	5	5	atorvastatin	CXCR4	PA448500	7852	0.859
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT151	0	0	3	3	metformin	HIF-1	PA450395	29072	0.859
NULL	Int_J_Breast_Cancer_2011_Jul_12_2011_232435.nxml.txt.nlp	22295213	SENT32	26	26	17	17	fulvestrant	aromatase	PA164747170	1588	0.859
NULL	Nat_Biotechnol_2010_May_28(5)_478-485.nxml.txt.nlp	20458318	SENT44	7	7	32	32	vancomycin	NAG	PA451850	51594;4669	0.859
NULL	Breast_Cancer_(Auckl)_2014_Oct_8_8_125-133.nxml.txt.nlp	25336961	SENT174	29	29	19	19	trastuzumab	HER2	PA451743	2064	0.859
NULL	Psychiatry_Investig_2010_Dec_30_7(4)_236-242.nxml.txt.nlp	21253406	SENT100	17	17	10	10	lithium	BDNF	PA450243	627	0.859
NULL	Cell_Death_Dis_2012_Oct_11_3(10)_e403.nxml.txt.nlp	23059822	SENT116	9	9	0	0	allopurinol	MSU	PA448320	593	0.859
NULL	Int_J_Mol_Sci_2014_May_8_15(5)_8106-8121.nxml.txt.nlp	24815071	SENT81	3	3	9	9	atorvastatin	LC3	PA448500	84557	0.859
NULL	Br_J_Pharmacol_2008_Dec_25_155(7)_1056-1065.nxml.txt.nlp	18724386	SENT257	29	29	20	20	nitrendipine	GLP-1	PA146096020	100125288	0.859
NULL	Front_Immunol_2013_Oct_31_4_351.nxml.txt.nlp	24198817	SENT394	37	37	42	42	etanercept	PAPA	PA449515	2737;5069	0.859
NULL	Gut_2015_Jan_19_64(1)_111-120.nxml.txt.nlp	24647007	SENT19	10	10	39	39	capecitabine	ENOSF1	PA448771	55556	0.859
NULL	Anesth_Essays_Res_2011_Jul-Dec_5(2)_182-186.nxml.txt.nlp	NULL	SENT24	18	18	28	28	ondansetron	CYP3A4	PA450705	1576	0.859
NULL	Int_J_Mol_Sci_2014_Sep_5_15(9)_15754-15765.nxml.txt.nlp	25198898	SENT5	5	5	7	7	curcumin	ASK1	PA151958596	4217	0.859
NULL	Case_Rep_Oncol_2014_Mar_26_7(1)_204-209.nxml.txt.nlp	24803896	SENT14	17	17	14	14	trabectedin	MRCL	PA165958349	348174	0.859
NULL	J_Cell_Biol_1983_Oct_1_97(4)_1107-1112.nxml.txt.nlp	6137486	SENT6	8	8	3	3	trypsin	CST	PA451806	9514	0.859
NULL	Br_J_Cancer_2010_Jun_29_103(1)_61-72.nxml.txt.nlp	20588279	SENT186	4	4	16	16	trastuzumab	AKT	PA451743	207	0.859
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2011_Sep_13_4_47-62.nxml.txt.nlp	22879794	SENT78	9	9	2	2	liraglutide	PPG	PA165958364	5552	0.859
NULL	Oncoimmunology_2014_Jun_25_3_e29351.nxml.txt.nlp	25083341	SENT44	15	15	6	6	cyclophosphamide	CD25	PA449165	3669;3559	0.859
NULL	Eur_J_Clin_Microbiol_Infect_Dis_2014_Nov_10_33(2)_201-209.nxml.txt.nlp	24213847	SENT154	34	34	36	36	vancomycin	NAP1	PA451850	4673;64343;9476;3576;51531	0.859
NULL	Nanoscale_Res_Lett_2011_Jul_22_6(1)_464.nxml.txt.nlp	21777482	SENT55	25	25	18	18	phenol	RANKL	PA450913	8600	0.859
NULL	Int_J_Biomed_Sci_2006_Dec_2(4)_395-401.nxml.txt.nlp	23675007	SENT72	18	18	12	12	fluorescein	CD14	PA164746009	929	0.859
NULL	Cardiovasc_Diabetol_2011_Dec_1_10_109.nxml.txt.nlp	22132774	SENT4	5	5	11	11	liraglutide	GLP-1	PA165958364	100125288	0.859
NULL	BMB_Rep_2014_Nov_47(11)_649-654.nxml.txt.nlp	25301019	SENT129	9	9	15	15	l-alanine	TLR4	PA448055	7099	0.859
NULL	Protein_Cell_2014_Jul_2_5(7)_544-551.nxml.txt.nlp	24691905	SENT72	17	17	8	8	nutlin-3	p53		7157	0.859
NULL	Gastric_Cancer_2013_Jul_12_16(3)_345-354.nxml.txt.nlp	22968820	SENT18	41	41	26	26	oxaliplatin	FANCJ	PA131285527	83990	0.859
NULL	Br_J_Cancer_2009_Jan_27_100(2)_334-343.nxml.txt.nlp	19142186	SENT186	40	40	37	37	gefitinib	EGFR	PA131301952	1956	0.859
NULL	Emerg_Infect_Dis_2011_Mar_17(3)_495-497.nxml.txt.nlp	21392442	SENT17	26	26	1	1	ciprofloxacin	DST	PA449009	667	0.859
NULL	Psychol_Res_Behav_Manag_2011_Sep_12_4_119-128.nxml.txt.nlp	22114542	SENT76	24	24	20	20	rimonabant	CB1	PA152407999	1268	0.859
NULL	J_Cell_Biol_2003_Sep_29_162(7)_1281-1292.nxml.txt.nlp	14517207	SENT216	17	17	7	7	tetracycline	RhoA	PA451640	387	0.859
NULL	J_Physiol_2009_Feb_15_587(Pt_4)_731-744.nxml.txt.nlp	19074966	SENT23	10	10	28	28	taurine	SLC6A6	PA451590	6533	0.859
NULL	Iran_J_Pharm_Res_2013_Winter_12(1)_141-146.nxml.txt.nlp	24250582	SENT11	29	29	11	11	rifampin	NAC	PA451250	22861	0.859
NULL	Contemp_Clin_Dent_2013_Jan-Mar_4(1)_48-53.nxml.txt.nlp	23853452	SENT136	44	44	21	21	minocycline	CAL	PA450519	54751;57120	0.859
NULL	EMBO_Mol_Med_2012_Jun_13_4(6)_515-527.nxml.txt.nlp	22416035	SENT83	33	33	28	28	olaparib	p53		7157	0.859
NULL	Ecancermedicalscience_2009_Oct_12_3_161.nxml.txt.nlp	22276022	SENT140	9	9	5	5	trastuzumab	HER-2	PA451743	2064	0.859
NULL	Hum_Genomics_Proteomics_2010_Sep_13_2010_754919.nxml.txt.nlp	20981234	SENT48	20	20	17	17	warfarin	VKORC1	PA451906	79001	0.859
NULL	Acta_Pharmacol_Sin_2010_Mar_22_31(3)_329-340.nxml.txt.nlp	20173759	SENT138	37	37	28	28	ethanol	MEF2A	PA448073	4205	0.859
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Sep_12_69(Pt_10)_o1525.nxml.txt.nlp	24098214	SENT78	10	10	32	32	ethanol	mol	PA448073	90527	0.859
NULL	Exp_Anim_2014_Apr_26_63(2)_257-267.nxml.txt.nlp	24770651	SENT94	2	2	25	25	perindopril	APJ	PA450877	187	0.859
NULL	Br_J_Ophthalmol_2012_Jul_26_96(7)_1023-1028.nxml.txt.nlp	22539748	SENT109	15	15	3	3	ranibizumab	TER	PA164746012	9524	0.859
NULL	Mol_Cancer_2013_Mar_2_12_16.nxml.txt.nlp	23452820	SENT133	13	13	20	20	chloroquine	Mcl-1	PA448948	4170	0.859
NULL	Acta_Pharmacol_Sin_2009_Sep_24_30(9)_1262-1275.nxml.txt.nlp	19701231	SENT226	39	39	23	23	lovastatin	MOSPD1	PA450272	56180	0.859
NULL	Oncotarget_2014_May_27_5(19)_9049-9064.nxml.txt.nlp	24979294	SENT203	7	7	13	13	dasatinib	c-Myc	PA162372878	4609	0.859
NULL	J_Hematol_Oncol_2012_Oct_10_5_62.nxml.txt.nlp	23050865	SENT97	28	28	10	10	docetaxel	EGFR	PA449383	1956	0.859
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Aug_1_68(Pt_9)_o2617.nxml.txt.nlp	22969519	SENT5	19	19	5	5	phenol	mol	PA450913	90527	0.859
NULL	J_Clin_Biochem_Nutr_2011_May_13_48(3)_237-244.nxml.txt.nlp	21562645	SENT185	5	5	15	15	resveratrol	AMPK		5563	0.859
NULL	Br_J_Cancer_2011_Jul_26_105(3)_372-381.nxml.txt.nlp	21730979	SENT35	7	7	19	19	cisplatin	ATR	PA449014	390502;84168;545	0.859
NULL	Avicenna_J_Phytomed_2012_Spring_2(2)_72-78.nxml.txt.nlp	25050233	SENT72	15	15	1	1	haloperidol	HIC	PA449841	29969	0.859
NULL	Br_J_Cancer_1995_Feb_71(2)_282-289.nxml.txt.nlp	7841041	SENT8	42	42	25	25	cisplatin	U87	PA449014	677775;641648	0.859
NULL	J_Cell_Biol_2008_Jul_14_182(1)_197-213.nxml.txt.nlp	18625847	SENT192	7	7	18	18	nutlin-3	p53		7157	0.859
NULL	Exp_Cell_Res_2011_Apr_15_317(7)_1028-1039.nxml.txt.nlp	21237154	SENT216	31	31	3	3	staurosporine	JNK	PA165109623	5599	0.859
NULL	Calcif_Tissue_Int_2014_Aug_21_94(2)_170-175.nxml.txt.nlp	23963633	SENT122	12	12	26	26	teriparatide	PTH	PA451620	5741	0.859
NULL	EMBO_Mol_Med_2012_Jun_4_4(6)_486-499.nxml.txt.nlp	22488882	SENT6	36	36	17	17	tamoxifen	PI3	PA451581	5266	0.859
NULL	Eur_J_Clin_Pharmacol_2012_Apr_8_68(4)_363-370.nxml.txt.nlp	21984116	SENT118	27	27	2	2	paroxetine	CYP2D6	PA450801	1565	0.859
NULL	J_Burns_Wounds_2007_Apr_11_6_e6.nxml.txt.nlp	17492051	SENT54	11	11	3	3	sulfadiazine	VIII	PA451539	1351	0.859
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Apr_24_66(Pt_5)_o1139.nxml.txt.nlp	21579187	SENT73	30	30	11	11	ethanol	mol	PA448073	90527	0.859
NULL	Oncogene_2009_Apr_9_28(14)_1694-1705.nxml.txt.nlp	19252526	SENT178	26	26	34	34	ethanol	E14	PA448073	4863	0.859
NULL	Front_Behav_Neurosci_2014_Dec_16_8_437.nxml.txt.nlp	25566005	SENT149	20	20	1	1	nicotine	ANOVA	PA450626	4858	0.859
NULL	Clin_Ophthalmol_2008_Mar_2(1)_1-14.nxml.txt.nlp	19668384	SENT176	14	14	1	1	verteporfin	VEGF-A	PA451871	7422	0.859
NULL	AIDS_Res_Ther_2013_May_1_10_10.nxml.txt.nlp	23634877	SENT152	10	10	5	5	atorvastatin	CCR5	PA448500	1234	0.859
NULL	Oncotarget_2013_Feb_26_4(2)_298-309.nxml.txt.nlp	23593653	SENT61	9	9	23	23	quinacrine	TFPI2	PA164745551	7980	0.859
NULL	J_Antimicrob_Chemother_2012_May_8_67(5)_1217-1223.nxml.txt.nlp	22316571	SENT31	25	25	8	8	lumefantrine	CYP3A4	PA165111722	1576	0.859
NULL	Protein_Cell_2014_Feb_29_5(2)_113-123.nxml.txt.nlp	24474196	SENT125	11	11	21	21	metformin	CYP2B	PA450395	1554;1556	0.859
NULL	Drug_Healthc_Patient_Saf_2013_Mar_28_5_79-99.nxml.txt.nlp	23569399	SENT35	21	21	6	6	isoniazid	IFN	PA450112	3439	0.859
NULL	Nanoscale_Res_Lett_2009_Aug_2_4(11)_1319-1323.nxml.txt.nlp	20628461	SENT32	20	20	13	13	ethanol	OTS	PA448073	5012	0.859
NULL	Cancer_Med_2014_Apr_7_3(2)_349-361.nxml.txt.nlp	24515895	SENT190	20	20	13	13	doxycycline	HSC3	PA449415	150353	0.859
NULL	J_Korean_Med_Sci_2007_Dec_20_22(6)_1055-1059.nxml.txt.nlp	18162722	SENT32	5	5	19	19	pantoprazole	ESD	PA450774	2098	0.859
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT45	15	15	1	1	trastuzumab	HER-2	PA451743	2064	0.859
NULL	Open_Access_J_Urol_2011_Jun_15_3_95-104.nxml.txt.nlp	24198641	SENT73	9	9	18	18	lovastatin	gamma	PA450272	9913	0.859
NULL	J_Gynecol_Oncol_2013_Jul_4_24(3)_273-279.nxml.txt.nlp	23875078	SENT38	0	0	5	5	ns-398	COX		1351	0.859
NULL	Pharmaceuticals_(Basel)_2012_Oct_23_5(10)_1128-1146.nxml.txt.nlp	24281261	SENT619	8	8	0	0	doxorubicin	TRAIL	PA449412	8743	0.859
NULL	J_Gen_Physiol_2013_Dec_142(6)_561-573.nxml.txt.nlp	24277600	SENT256	6	6	20	20	amrinone	ADP	PA164746803	23038	0.859
NULL	Oxid_Med_Cell_Longev_2013_Jun_2_2013_793525.nxml.txt.nlp	23819014	SENT204	42	42	36	36	resveratrol	ROS		6098	0.859
NULL	J_Org_Chem_2011_Aug_19_76(16)_6703-6714.nxml.txt.nlp	21739961	SENT168	24	24	16	16	vanillin	mol	PA451852	90527	0.859
NULL	Patient_Prefer_Adherence_2013_Mar_27_7_245-258.nxml.txt.nlp	23569364	SENT156	7	7	3	3	exemestane	aromatase	PA449563	1588	0.859
NULL	Mol_Cancer_2010_Aug_23_9_222.nxml.txt.nlp	20731837	SENT121	22	22	46	46	gefitinib	ATM	PA131301952	472	0.859
NULL	J_Int_Soc_Sports_Nutr_2009_Feb_19_6_6.nxml.txt.nlp	19228401	SENT239	11	11	21	21	creatine	CEE	PA164778930	51608	0.859
NULL	Br_J_Cancer_2010_Jan_19_102(2)_268-275.nxml.txt.nlp	20010948	SENT187	22	22	10	10	erlotinib	CD133	PA134687924	8842	0.859
NULL	Curr_Clin_Pharmacol_2008_Sep_3(3)_198-203.nxml.txt.nlp	18781906	SENT5	10	10	0	0	phenytoin	CYP3A4	PA450947	1576	0.859
NULL	J_Adv_Pharm_Technol_Res_2012_Oct-Dec_3(4)_202-209.nxml.txt.nlp	23378940	SENT106	7	7	3	3	nabilone	CB1	PA164746998	1268	0.859
NULL	Ann_Dermatol_2014_Dec_26_26(6)_706-712.nxml.txt.nlp	25473222	SENT16	31	31	20	20	isotretinoin	EPO	PA450128	7076;8288;2056	0.859
NULL	Breast_Cancer_Res_2007_Jan_23_9(1)_R7.nxml.txt.nlp	17244352	SENT133	26	26	33	33	tamoxifen	CYP2D6	PA451581	1565	0.859
NULL	Environ_Health_Perspect_2005_Aug_15_113(8)_1009-1014.nxml.txt.nlp	16079071	SENT116	19	19	15	15	losartan	p38	PA450268	10598;1432;7965	0.859
NULL	Breast_Cancer_(Auckl)_2014_Mar_23_8_51-56.nxml.txt.nlp	24678242	SENT64	5	5	27	27	carboplatin	BRCA1	PA448803	672	0.859
NULL	Clin_Dev_Immunol_2013_Nov_26_2013_325481.nxml.txt.nlp	24371447	SENT85	2	2	8	8	propofol	IL-6	PA451141	3569	0.859
NULL	Ann_Surg_Treat_Res_2014_Feb_22_86(2)_68-75.nxml.txt.nlp	24761411	SENT172	4	4	14	14	oxaliplatin	survivin	PA131285527	332	0.859
NULL	ScientificWorldJournal_2014_Mar_24_2014_694326.nxml.txt.nlp	24782665	SENT61	29	29	32	32	metformin	FDG	PA450395	23583	0.859
NULL	Cardiol_Res_Pract_2013_Feb_19_2013_195456.nxml.txt.nlp	23533940	SENT127	5	5	23	23	clopidogrel	CYP2C9	PA449053	1559	0.859
NULL	BMB_Rep_2014_Mar_47(3)_122-129.nxml.txt.nlp	24499671	SENT123	21	21	23	23	cyclophosphamide	CTX	PA449165	1593	0.859
NULL	Nucleic_Acids_Res_2012_Sep_28_40(17)_8425-8439.nxml.txt.nlp	22753026	SENT382	25	25	17	17	mitomycin	FANCD2	PA450524	2177	0.859
NULL	Mol_Cancer_2010_Aug_23_9_222.nxml.txt.nlp	20731837	SENT124	23	23	20	20	gefitinib	ATM	PA131301952	472	0.859
NULL	Clinics_(Sao_Paulo)_2014_Jan_69(Suppl_1)_55-72.nxml.txt.nlp	24860861	SENT288	21	21	30	30	rituximab	B7-1	PA451261	941	0.859
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT16	5	5	2	2	dasatinib	PP2	PA162372878	4888	0.859
NULL	Cell_Microbiol_2013_Aug_14_15(8)_1385-1400.nxml.txt.nlp	23421931	SENT295	1	1	29	29	gentamicin	CO2	PA449753	4513	0.859
NULL	J_Immunol_Res_2014_Apr_10_2014_845763.nxml.txt.nlp	24818169	SENT18	19	19	39	39	temsirolimus	FKBP12	PA164746890	2280	0.859
NULL	Breast_Cancer_Res_2011_Sep_29_13(5)_219.nxml.txt.nlp	22017761	SENT79	24	24	11	11	estradiol	aromatase	PA449503	1588	0.859
NULL	Cardiovasc_J_Afr_2013_Apr_24(3)_78-81.nxml.txt.nlp	23736131	SENT20	25	25	4	4	hemin	HO-1	PA449849	3162	0.859
NULL	Mol_Cell_Biochem_2012_Apr_3_363(1-2)_135-145.nxml.txt.nlp	22139302	SENT178	7	7	15	15	curcumin	survivin	PA151958596	332	0.859
NULL	Indian_J_Dermatol_2014_Mar-Apr_59(2)_198a.nxml.txt.nlp	24700946	SENT14	31	31	35	35	maraviroc	CD4	PA164768835	920	0.859
NULL	Hum_Genomics_2011_May_1_5(4)_265-282.nxml.txt.nlp	21712189	SENT139	37	37	13	13	lopinavir	CYP3A5	PA450264	1577	0.859
NULL	J_Immunother_2014_Apr_12_37(3)_180-186.nxml.txt.nlp	24598448	SENT154	7	7	20	20	sorafenib	IL-2	PA7000	3558	0.859
NULL	Front_Neurosci_2012_May_30_6_77.nxml.txt.nlp	22661925	SENT158	5	5	26	26	ethanol	DCX	PA448073	1641	0.859
NULL	Indian_J_Pharm_Sci_2014_Jan-Feb_76(1)_72-77.nxml.txt.nlp	24799741	SENT10	20	20	27	27	glipizide	CYP2C9	PA449762	1559	0.859
NULL	Cancer_Cell_Int_2013_Aug_19_13_82.nxml.txt.nlp	23958424	SENT155	30	30	26	26	lenalidomide	Hsp90	PA162363968	3320	0.859
NULL	Environ_Health_Perspect_2006_Apr_27_114(4)_500-506.nxml.txt.nlp	16581536	SENT47	13	13	5	5	estradiol	aromatase	PA449503	1588	0.859
NULL	Int_J_Mol_Sci_2010_Sep_13_11(9)_3195-3208.nxml.txt.nlp	20957088	SENT150	3	3	12	12	lipase	mol	PA450239	90527	0.859
NULL	Acta_Pharmacol_Sin_2009_Nov_12_30(11)_1566-1572.nxml.txt.nlp	19820718	SENT13	20	20	33	33	ketoconazole	P-gp	PA450146	5243	0.859
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT49	9	9	11	11	curcumin	TRAIL	PA151958596	8743	0.859
NULL	Cell_Biol_Toxicol_2012_Apr_19_28(2)_69-87.nxml.txt.nlp	22258563	SENT265	13	13	0	0	bupropion	CYP1A2	PA448687	1544	0.859
NULL	Springerplus_2014_Sep_17_3_535.nxml.txt.nlp	25279326	SENT186	15	15	5	5	carboplatin	San	PA448803	80218	0.859
NULL	Cardiovasc_Psychiatry_Neurol_2010_Jun_10_2010_480707.nxml.txt.nlp	20631894	SENT151	12	12	32	32	haloperidol	S100B	PA449841	6285	0.859
NULL	Br_J_Clin_Pharmacol_2010_Dec_70(6)_807-814.nxml.txt.nlp	21175436	SENT44	5	5	17	17	liraglutide	GLP-1	PA165958364	100125288	0.859
NULL	Indian_J_Pharmacol_2012_Sep-Oct_44(5)_624-628.nxml.txt.nlp	23112426	SENT135	25	25	6	6	pravastatin	P-gp	PA451089	5243	0.859
NULL	AIDS_Res_Ther_2013_May_1_10_10.nxml.txt.nlp	23634877	SENT126	36	36	28	28	lovastatin	CD4	PA450272	920	0.859
NULL	Comp_Hepatol_2004_Jan_14_3(Suppl_1)_S31.nxml.txt.nlp	14960183	SENT78	9	9	3	3	ethanol	TNF-alpha	PA448073	7124	0.859
NULL	Breast_Cancer_Res_2012_Jun_19_14(3)_209.nxml.txt.nlp	22713170	SENT145	15	15	22	22	bevacizumab	VEGF-A	PA130232992	7422	0.859
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1066.nxml.txt.nlp	24556681	SENT52	6	6	28	28	ethanol	ATG12	PA448073	9140	0.859
NULL	J_Oncol_2010_Dec_23_2010_372547.nxml.txt.nlp	20072701	SENT120	7	7	10	10	paclitaxel	VEGFR2	PA450761	3791	0.859
NULL	Nat_Commun_2013_Aug_15_4_2130.nxml.txt.nlp	23945651	SENT53	8	8	12	12	etoposide	ATG5	PA449552	9474	0.859
NULL	Curr_Neuropharmacol_2012_Jun_10(2)_139-158.nxml.txt.nlp	23204984	SENT251	12	12	2	2	citalopram	STAR	PA449015	6770;2984	0.859
NULL	Front_Behav_Neurosci_2014_Nov_5_8_388.nxml.txt.nlp	25414651	SENT144	27	27	7	7	ketamine	NAC	PA450144	22861	0.859
NULL	Mar_Drugs_2012_Aug_22_10(8)_1852-1872.nxml.txt.nlp	23015777	SENT18	7	7	19	19	melphalan	TNF	PA450354	7124	0.859
NULL	J_Health_Popul_Nutr_2011_Oct_29(5)_446-453.nxml.txt.nlp	22106750	SENT135	11	11	13	13	vancomycin	VISA	PA451850	57506	0.859
NULL	Arthritis_Res_Ther_2011_Feb_8_13(1)_R17.nxml.txt.nlp	21303509	SENT213	26	26	1	1	leflunomide	FSTL1	PA450192	11167	0.859
NULL	Evid_Based_Complement_Alternat_Med_2013_Mar_21_2013_701956.nxml.txt.nlp	23573147	SENT63	13	13	28	28	lidocaine	hole	PA450226	80757	0.859
NULL	J_Gen_Physiol_2000_Jun_1_115(6)_685-696.nxml.txt.nlp	10828243	SENT170	32	32	4	4	genistein	OLF	PA165109660	83857	0.859
NULL	Oncol_Rep_2013_Apr_6_29(4)_1285-1292.nxml.txt.nlp	23404427	SENT136	18	18	7	7	gemcitabine	GEM	PA449748	2669	0.859
NULL	Oncotarget_2014_Oct_16_5(22)_11442-11451.nxml.txt.nlp	25347345	SENT102	12	12	23	23	oxaliplatin	IL-8	PA131285527	3576	0.859
NULL	Hum_Genomics_2010_Apr_1_4(4)_238-249.nxml.txt.nlp	20511137	SENT6	35	35	17	17	irinotecan	UGT1A1	PA450085	54658	0.859
NULL	Acta_Vet_Scand_2014_May_20_56(1)_33.nxml.txt.nlp	24884817	SENT145	14	14	9	9	heparin	IL-17A	PA449855	3605	0.859
NULL	Mol_Cancer_2010_Apr_21_9_83.nxml.txt.nlp	20409325	SENT215	19	19	21	21	doxycycline	MYCN	PA449415	4613	0.859
NULL	Protein_Cell_2014_Jun_19_5(6)_469-479.nxml.txt.nlp	24748116	SENT5	10	10	5	5	paclitaxel	EB1	PA450761	9167;22919;10982	0.859
NULL	J_Hematol_Oncol_2013_Nov_5_6_83.nxml.txt.nlp	24283248	SENT52	19	19	6	6	nutlin-3	TP53		7157	0.859
NULL	CNS_Drugs_2014_Jun_24_28(10)_875-886.nxml.txt.nlp	24958205	SENT101	16	16	5	5	sucralfate	ghrelin	PA451524	51738	0.859
NULL	Mol_Cancer_2010_Apr_15_9_77.nxml.txt.nlp	20398291	SENT85	2	2	14	14	geldanamycin	survivin	PA152031327	332	0.859
NULL	J_Exp_Clin_Cancer_Res_2010_Aug_11_29(1)_110.nxml.txt.nlp	20701792	SENT39	7	7	1	1	doxorubicin	CSE1L	PA449412	1434	0.859
NULL	Pharm_Pract_(Granada)_2011_Mar_15_Jan-Mar_9(1)_1-10.nxml.txt.nlp	25132883	SENT58	15	15	12	12	warfarin	SPAF	PA451906	166378	0.859
NULL	Oncotarget_2014_Jun_19_5(15)_6540-6551.nxml.txt.nlp	25153728	SENT142	20	20	29	29	paclitaxel	PI3K	PA450761	5290	0.859
NULL	Mol_Biol_Cell_2013_Jul_15_24(14)_2186-2200.nxml.txt.nlp	23699397	SENT263	47	47	28	28	doxorubicin	TRAIL	PA449412	8743	0.859
NULL	Iran_J_Pharm_Res_2014_Autumn_13(4)_1313-1318.nxml.txt.nlp	25587320	SENT165	24	24	5	5	berberine	AMPK	PA165860812	5563	0.859
NULL	Nat_Med_2013_Feb_6_19(2)_217-226.nxml.txt.nlp	23291629	SENT92	24	24	12	12	forskolin	TRIP-Br2	PA146096022	9792	0.859
NULL	J_Exp_Bot_2011_Oct_4_62(14)_4787-4803.nxml.txt.nlp	21821598	SENT21	9	9	16	16	mannitol	M6PR	PA450320	4074	0.859
NULL	Clin_Med_Insights_Ear_Nose_Throat_2012_Apr_3_5_1-16.nxml.txt.nlp	24179404	SENT177	11	11	21	21	galactose	ABO	PA449725	28	0.859
NULL	Ann_Med_Health_Sci_Res_2012_Jul-Dec_2(2)_191-198.nxml.txt.nlp	23439914	SENT165	22	22	1	1	erythromycin	P-gp	PA449493	5243	0.859
NULL	Diabetes_2013_Jun_17_62(6)_1843-1854.nxml.txt.nlp	23349486	SENT206	7	7	16	16	pioglitazone	DEC-205	PA450970	4065	0.859
NULL	Front_Behav_Neurosci_2014_Oct_30_8_366.nxml.txt.nlp	25400560	SENT100	27	27	15	15	ethanol	GAPDH	PA448073	2597	0.859
NULL	Cancer_Biol_Med_2013_Mar_10(1)_16-21.nxml.txt.nlp	23691440	SENT17	30	30	20	20	methotrexate	Bcl-2	PA450428	596	0.859
NULL	Arch_Med_Sci_2013_Aug_30_9(4)_739-744.nxml.txt.nlp	24049538	SENT122	37	37	8	8	candesartan	PC-3	PA448765	692094	0.859
NULL	Indian_J_Anaesth_2011_May-Jun_55(3)_318-320.nxml.txt.nlp	21808420	SENT41	25	25	9	9	tramadol	CO2	PA451735	4513	0.859
NULL	Mol_Cancer_2010_Jun_25_9_165.nxml.txt.nlp	20576164	SENT3	20	20	10	10	curcumin	STAT3	PA151958596	6774	0.859
NULL	Chemother_Res_Pract_2011_Apr_7_2011_393976.nxml.txt.nlp	22312553	SENT44	9	9	17	17	lumefantrine	CYP3A4	PA165111722	1576	0.859
NULL	Mol_Cancer_2013_Oct_24_12_128.nxml.txt.nlp	24156782	SENT332	18	18	3	3	paraformaldehyde	SOX2	PA450790	6657	0.859
NULL	Biomed_Res_Int_2014_Jun_3_2014_516734.nxml.txt.nlp	24991556	SENT158	39	39	0	0	bupropion	Yes	PA448687	7525	0.859
NULL	J_Gen_Physiol_2010_Jun_135(6)_619-628.nxml.txt.nlp	20479110	SENT110	2	2	38	38	nifedipine	DHPR	PA450631	5860	0.859
NULL	Int_J_Hypertens_2013_Jun_17_2013_627938.nxml.txt.nlp	23844279	SENT126	20	20	7	7	amlodipine	A10	PA448388	28870	0.859
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT146	6	6	17	17	resveratrol	cIAP2		330	0.859
NULL	Breast_Cancer_Res_2012_Mar_15_14(2)_R47.nxml.txt.nlp	22420423	SENT219	21	21	41	41	mitomycin	TP53	PA450524	7157	0.859
NULL	Asian_J_Transfus_Sci_2007_Jan-Jun_1(1)_24-32.nxml.txt.nlp	21938229	SENT267	3	3	0	0	hyaluronan	CD44	PA165958431	960	0.859
NULL	Biomed_Res_Int_2014_Jan_20_2014_948427.nxml.txt.nlp	24563867	SENT97	3	3	27	27	buspirone	STZ	PA448689	6484	0.859
NULL	F1000Res_2014_Apr_3_3_83.nxml.txt.nlp	24860645	SENT42	26	26	34	34	baclofen	CMT1A	PA448533	1248	0.859
NULL	J_Biol_Chem_2009_Sep_18_284(38)_25714-25722.nxml.txt.nlp	19596853	SENT31	23	23	4	4	heparin	IL-3	PA449855	3562	0.859
NULL	Nat_Neurosci_2014_Jun_4_17(6)_813-821.nxml.txt.nlp	24793032	SENT430	7	7	17	17	topotecan	E14	PA451729	4863	0.859
NULL	Curr_Gerontol_Geriatr_Res_2012_Mar_20_2012_463909.nxml.txt.nlp	22545043	SENT66	16	16	22	22	memantine	spatial	PA10364	219793	0.859
NULL	Ann_Thorac_Med_2014_Apr-Jun_9(2)_124-126.nxml.txt.nlp	24791177	SENT75	14	14	30	30	sirolimus	LAM	PA451365	7249;7248	0.859
NULL	Nat_Commun_2012_3_1147.nxml.txt.nlp	23093184	SENT222	24	24	9	9	tetracycline	ND5	PA451640	4540	0.859
NULL	Nat_Commun_2013_Sep_20_4_2444.nxml.txt.nlp	24051492	SENT50	13	13	21	21	nutlin-3	PER2		8864	0.859
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT207	13	13	4	4	nifedipine	CYP3A	PA450631	1574	0.859
NULL	Biomed_Res_Int_2013_Oct_27_2013_798261.nxml.txt.nlp	24282821	SENT216	0	0	12	12	ethanol	AQP4	PA448073	361	0.859
NULL	Oncotarget_2014_Jun_3_5(13)_4920-4928.nxml.txt.nlp	24952482	SENT22	32	32	20	20	geldanamycin	Hsp90	PA152031327	3320	0.859
NULL	J_Korean_Med_Sci_2014_Jul_11_29(7)_965-972.nxml.txt.nlp	25045229	SENT135	25	25	19	19	metformin	B12	PA450395	7126;4709	0.859
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_8_2013_964070.nxml.txt.nlp	23690868	SENT37	27	27	3	3	resveratrol	AMPK		5563	0.859
NULL	J_Adv_Pract_Oncol_2014_Mar_1_Mar-Apr_5(2)_100-106.nxml.txt.nlp	25032044	SENT70	13	13	0	0	l-arginine	IMPACT	PA448478	55364	0.859
NULL	J_Exp_Med_1998_Jun_1_187(11)_1885-1892.nxml.txt.nlp	9607928	SENT204	7	7	15	15	thalidomide	CD4	PA451644	920	0.859
NULL	Arch_Drug_Inf_2008_Sep_1(2)_50-55.nxml.txt.nlp	19915714	SENT42	27	27	21	21	naltrexone	CYP3A4	PA450588	1576	0.859
NULL	Oncotarget_2011_May_16_2(5)_418-421.nxml.txt.nlp	21789791	SENT37	23	23	14	14	bortezomib	TRAIL	PA10252	8743	0.859
NULL	Oncol_Lett_2015_Jan_4_9(1)_91-95.nxml.txt.nlp	25435939	SENT28	31	31	3	3	etoposide	NACT	PA449552	284111	0.859
NULL	Hum_Mol_Genet_2014_Apr_15_23(8)_2055-2077.nxml.txt.nlp	24282027	SENT251	33	33	9	9	ethanol	LRRK2	PA448073	120892	0.859
NULL	Br_J_Haematol_2008_Jun_141(5)_659-671.nxml.txt.nlp	18410446	SENT268	7	7	9	9	cerulenin	JNK	PA164764551	5599	0.859
NULL	Cancers_(Basel)_2010_Feb_23_2(1)_88-113.nxml.txt.nlp	24281034	SENT1438	8	8	2	2	cetuximab	BRAF	PA10040	673	0.859
NULL	Nucleic_Acids_Res_2006_Jul_5_34(11)_e82.nxml.txt.nlp	16822855	SENT389	8	8	10	10	decitabine	DAC	PA164749631	13	0.859
NULL	Cell_Death_Dis_2010_May_27_1(5)_e46.nxml.txt.nlp	21364652	SENT7	8	8	6	6	choline	CDP	PA448976	1523	0.859
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT71	4	4	11	11	neratinib	HER2	PA165291472	2064	0.859
NULL	Cerebrospinal_Fluid_Res_2008_May_14_5_10.nxml.txt.nlp	18479516	SENT250	10	10	2	2	furosemide	NKCC1	PA449719	6558	0.859
NULL	Infect_Drug_Resist_2010_Mar_11_3_45-51.nxml.txt.nlp	21694893	SENT115	22	22	16	16	cisapride	CYP3A4	PA449011	1576	0.859
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1063.nxml.txt.nlp	24556678	SENT71	5	5	18	18	thioridazine	c-FLIP	PA451666	8837	0.859
NULL	Acta_Pharmacol_Sin_2010_Jan_5_31(1)_93-101.nxml.txt.nlp	20048748	SENT225	9	9	13	13	cisplatin	DAPK	PA449014	1612	0.859
NULL	Acta_Diabetol_2011_Dec_2_48(4)_257-273.nxml.txt.nlp	21964884	SENT285	5	5	0	0	lipase	FIAF	PA450239	51129	0.859
NULL	J_Hematol_Oncol_2013_Jun_11_6_39.nxml.txt.nlp	23759001	SENT38	6	6	3	3	sorafenib	FLT3	PA7000	2322	0.859
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_29_2012_164689.nxml.txt.nlp	22203865	SENT222	13	13	10	10	camptothecin	MAX	PA153590860	4149	0.859
NULL	Acta_Pharmacol_Sin_2013_Jun_8_34(6)_830-836.nxml.txt.nlp	23564080	SENT104	26	26	5	5	simvastatin	HMGB1	PA451363	3146	0.859
NULL	Acta_Pharmacol_Sin_2010_Nov_18_31(11)_1447-1453.nxml.txt.nlp	20953204	SENT13	18	18	23	23	rimonabant	IL-6	PA152407999	3569	0.859
NULL	Oncotarget_2014_Jun_1_5(13)_4868-4880.nxml.txt.nlp	24947902	SENT36	24	24	29	29	afatinib	HER2	PA165981154	2064	0.859
NULL	Nat_Commun_2014_Dec_9_5_5691.nxml.txt.nlp	25487737	SENT50	22	22	12	12	cisplatin	SUV39H2	PA449014	79723	0.859
NULL	J_Hematol_Oncol_2009_Apr_22_2_18.nxml.txt.nlp	19386128	SENT170	23	23	35	35	oxaliplatin	KRAS	PA131285527	3845	0.859
NULL	FEBS_Open_Bio_2012_Aug_22_2_279-283.nxml.txt.nlp	23650611	SENT105	10	10	14	14	raloxifene	IFN	PA451221	3439	0.859
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT345	21	21	11	11	metformin	LKB1	PA450395	6794	0.859
NULL	J_Med_Case_Reports_2011_Mar_28_5_117.nxml.txt.nlp	21443773	SENT20	19	19	3	3	saxagliptin	GLP-1	PA165958362	100125288	0.859
NULL	Front_Oncol_2011_Aug_10_1_20.nxml.txt.nlp	22649757	SENT431	15	15	5	5	temozolomide	MSH6	PA451609	2956	0.859
NULL	J_Invest_Dermatol_2012_May_16_132(5)_1435-1442.nxml.txt.nlp	22336948	SENT79	5	5	28	28	doxycycline	KLK5	PA449415	25818	0.859
NULL	Ann_Oncol_2012_Nov_22_23(11)_2782-2790.nxml.txt.nlp	22730099	SENT123	5	5	22	22	estradiol	OPG	PA449503	690	0.859
NULL	Br_J_Cancer_2013_Jun_25_108(12)_2464-2469.nxml.txt.nlp	23695016	SENT7	3	3	21	21	carboplatin	CRT	PA448803	811	0.859
NULL	J_Breast_Cancer_2013_Sep_30_16(3)_274-284.nxml.txt.nlp	24155756	SENT46	21	21	14	14	paclitaxel	ACT	PA450761	12;11332;9457;641455	0.859
NULL	Curr_Neuropharmacol_2013_May_11(3)_263-275.nxml.txt.nlp	24179463	SENT93	17	17	5	5	sr144528	CB2		1269	0.859
NULL	J_Biol_Chem_2013_Dec_6_288(49)_35387-35395.nxml.txt.nlp	24142790	SENT152	3	3	6	6	meclizine	PCYT2	PA450338	5833	0.859
NULL	Virol_J_2010_Oct_27_7_285.nxml.txt.nlp	20979618	SENT7	11	11	19	19	isoproterenol	c-fos	PA450121	2353	0.859
NULL	Oncoimmunology_2012_Oct_1_1(7)_1004-1016.nxml.txt.nlp	23170249	SENT52	13	13	3	3	trastuzumab	HER-2	PA451743	2064	0.859
NULL	Acta_Pharmacol_Sin_2009_Nov_12_30(11)_1566-1572.nxml.txt.nlp	19820718	SENT150	33	33	11	11	omeprazole	P-gp	PA450704	5243	0.859
NULL	Diabetes_2011_Nov_17_60(11)_2872-2882.nxml.txt.nlp	21926270	SENT253	5	5	2	2	tamoxifen	STZ	PA451581	6484	0.859
NULL	Braz_J_Microbiol_2009_Jun_1_Apr-Jun_40(2)_358-366.nxml.txt.nlp	24031373	SENT53	3	3	15	15	lipase	mol	PA450239	90527	0.859
NULL	Cancer_Cell_Int_2013_Sep_23_13_94.nxml.txt.nlp	24059699	SENT104	29	29	8	8	bevacizumab	VEGFR2	PA130232992	3791	0.859
NULL	Cell_Death_Dis_2014_Jan_30_5(1)_e1043.nxml.txt.nlp	24481457	SENT10	12	12	26	26	urokinase	TRAIL	PA451836	8743	0.859
NULL	Int_J_Surg_Oncol_2012_May_17_2012_406830.nxml.txt.nlp	22675625	SENT213	29	29	16	16	perifosine	JNK	PA165291471	5599	0.859
NULL	Clin_Drug_Investig_2012_Dec_13_32(8)_e1-e15.nxml.txt.nlp	22712629	SENT145	34	34	10	10	memantine	ANOVA	PA10364	4858	0.859
NULL	Adv_Ther_2013_Nov_30_30(12)_1128-1140.nxml.txt.nlp	24293131	SENT25	5	5	1	1	liraglutide	GLP-1	PA165958364	100125288	0.859
NULL	Biosci_Microbiota_Food_Health_2014_Jun_25_33(4)_147-155.nxml.txt.nlp	25379362	SENT183	12	12	23	23	hesperidin	IL-5	PA449867	3567	0.859
NULL	Acta_Histochem_Cytochem_2011_Dec_28_44(6)_247-258.nxml.txt.nlp	22282585	SENT30	23	23	4	4	estradiol	PHB2	PA449503	11331	0.859
NULL	Eur_J_Med_Res_2013_Dec_13_18(1)_56.nxml.txt.nlp	24330823	SENT44	31	31	12	12	trypsin	CO2	PA451806	4513	0.859
NULL	Mol_Cancer_2012_Dec_12_11_91.nxml.txt.nlp	23234355	SENT44	3	3	7	7	erlotinib	HER2	PA134687924	2064	0.859
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Mar_6_65(Pt_4)_o703.nxml.txt.nlp	21582441	SENT53	12	12	3	3	ethanol	mol	PA448073	90527	0.859
NULL	Clin_Pharmacokinet_2014_Jul_24_53(1)_73-87.nxml.txt.nlp	23881596	SENT369	13	13	5	5	pravastatin	ABCB1	PA451089	5243	0.859
NULL	Drug_Des_Devel_Ther_2014_Sep_26_8_1595-1611.nxml.txt.nlp	25302015	SENT186	19	19	24	24	afatinib	EGFR	PA165981154	1956	0.859
NULL	Arthritis_Res_Ther_2012_Apr_26_14(2)_R90.nxml.txt.nlp	22537858	SENT20	10	10	1	1	atorvastatin	IFN	PA448500	3439	0.859
NULL	Eur_J_Clin_Pharmacol_2010_Feb_17_66(2)_165-170.nxml.txt.nlp	19838691	SENT37	9	9	18	18	dobutamine	CYP3A	PA449381	1574	0.859
NULL	BMB_Rep_2014_Oct_47(10)_575-580.nxml.txt.nlp	24499675	SENT27	7	7	24	24	arsenite	p53	PA452638	7157	0.859
NULL	Braz_J_Med_Biol_Res_2013_Feb_1_46(2)_171-177.nxml.txt.nlp	23369979	SENT121	0	0	5	5	enalapril	IL-10	PA449456	3586	0.859
NULL	Nucleic_Acids_Res_2011_Sep_7_39(17)_7465-7476.nxml.txt.nlp	21653549	SENT219	18	18	38	38	etoposide	DEK	PA449552	7913	0.859
NULL	Mol_Vis_2012_Apr_11_18_901-908.nxml.txt.nlp	22539869	SENT81	23	23	16	16	curcumin	HO-1	PA151958596	3162	0.859
NULL	Cancers_(Basel)_2013_Nov_7_5(4)_1456-1468.nxml.txt.nlp	24213559	SENT553	15	15	40	40	bevacizumab	SNO	PA130232992	6498	0.859
NULL	Core_Evid_2010_Jul_27_5_1-10.nxml.txt.nlp	20694135	SENT200	12	12	21	21	levodopa	CLE	PA450213	51637	0.859
NULL	Oncol_Lett_2014_May_27_7(5)_1327-1332.nxml.txt.nlp	24765133	SENT69	10	10	30	30	camptothecin	TRAIL	PA153590860	8743	0.859
NULL	Oncotarget_2012_Dec_30_3(12)_1505-1521.nxml.txt.nlp	23455493	SENT260	15	15	9	9	berberine	NGAL	PA165860812	3934	0.859
NULL	CNS_Drugs_2014_Apr_11_28(6)_535-558.nxml.txt.nlp	24723124	SENT199	5	5	8	8	alemtuzumab	IFN	PA164783958	3439	0.859
NULL	Exp_Lung_Res_2013_Oct_1_39(8)_336-348.nxml.txt.nlp	23919450	SENT242	7	7	21	21	thrombin	PAR-1	PA451674	2011;2149	0.859
NULL	Oncotarget_2014_Aug_29_5(17)_7217-7259.nxml.txt.nlp	25277175	SENT288	16	16	12	12	dutasteride	EGFR	PA164749300	1956	0.859
NULL	Front_Microbiol_2012_Nov_30_3_406.nxml.txt.nlp	23226145	SENT477	0	0	18	18	capsaicin	p65	PA448776	5970	0.859
NULL	Hum_Genomics_2011_May_1_5(4)_265-282.nxml.txt.nlp	21712189	SENT136	19	19	12	12	lopinavir	CYP3A	PA450264	1574	0.859
NULL	Acta_Pharmacol_Sin_2014_Sep_25_35(9)_1199-1206.nxml.txt.nlp	25152024	SENT104	5	5	16	16	cisplatin	JNK	PA449014	5599	0.859
NULL	Cent_European_J_Urol_2013_Dec_19_66(4)_394-404.nxml.txt.nlp	24757527	SENT265	8	8	4	4	sunitinib	IFN	PA162372840	3439	0.859
NULL	Nat_Commun_2011_Aug_9_2_424.nxml.txt.nlp	21829186	SENT98	36	36	34	34	decitabine	DAC	PA164749631	13	0.859
NULL	Cell_Death_Dis_2014_Feb_27_5(2)_e1088.nxml.txt.nlp	24577086	SENT102	23	23	15	15	metformin	Bcl-2	PA450395	596	0.859
NULL	Indian_J_Med_Res_2012_Aug_136(2)_249-259.nxml.txt.nlp	22960892	SENT35	15	15	21	21	irinotecan	UGT1A1	PA450085	54658	0.859
NULL	Front_Aging_Neurosci_2010_Feb_3_2_2.nxml.txt.nlp	20552042	SENT130	24	24	30	30	isoproterenol	CA1	PA450121	759	0.859
NULL	Breast_Cancer_Res_2003_Feb_5_5(2)_113-116.nxml.txt.nlp	12631392	SENT76	13	13	7	7	paclitaxel	TPC	PA450761	8030;60386	0.859
NULL	Cancer_Cell_Int_2012_Feb_21_12_5.nxml.txt.nlp	22353776	SENT119	13	13	9	9	pravastatin	MAT1A	PA451089	4143	0.859
NULL	Breast_Cancer_Res_2007_Aug_8_9(4)_R50.nxml.txt.nlp	17686159	SENT280	13	13	4	4	gefitinib	HRG	PA131301952	3084;3273	0.859
NULL	Int_J_Mol_Sci_2014_Jun_26_15(7)_11416-11434.nxml.txt.nlp	24972137	SENT612	4	4	19	19	sitagliptin	GLP-1	PA164748978	100125288	0.859
NULL	Breast_Cancer_Res_2011_Feb_23_13(1)_203.nxml.txt.nlp	21392408	SENT13	23	23	13	13	letrozole	aromatase	PA450196	1588	0.859
NULL	J_Hematol_Oncol_2011_Apr_20_4_17.nxml.txt.nlp	21507255	SENT53	41	41	13	13	cisplatin	XPC	PA449014	7508	0.859
NULL	Clin_Med_Insights_Oncol_2012_May_16_6_205-217.nxml.txt.nlp	22654526	SENT248	34	34	32	32	pazopanib	VEGFR	PA165291492	3791	0.859
NULL	Int_J_Gen_Med_2011_Jul_13_4_529-533.nxml.txt.nlp	21845061	SENT119	18	18	8	8	ribavirin	HFE	PA451241	3077	0.858
NULL	Breast_Cancer_Res_2014_May_5_16(3)_R45.nxml.txt.nlp	24887236	SENT236	22	22	43	43	lapatinib	EGFR	PA152241907	1956	0.858
NULL	Biomed_Res_Int_2013_Dec_5_2013_642848.nxml.txt.nlp	24381940	SENT25	0	0	3	3	telmisartan	IL-6	PA451605	3569	0.858
NULL	J_Korean_Med_Sci_2010_Feb_19_25(2)_304-308.nxml.txt.nlp	20119588	SENT35	39	39	46	46	clarithromycin	EMB	PA449028	133418	0.858
NULL	Acta_Pharmacol_Sin_2010_Dec_3_31(12)_1635-1642.nxml.txt.nlp	21127497	SENT155	27	27	18	18	phenylbutazone	UGT	PA450932	7361;7355	0.858
NULL	Oncotarget_2011_May_13_2(5)_401-406.nxml.txt.nlp	21576761	SENT75	23	23	11	11	lapatinib	YB-1	PA152241907	4904	0.858
NULL	Pharmaceuticals_(Basel)_2012_Jun_28_5(7)_674-689.nxml.txt.nlp	24281706	SENT145	4	4	14	14	pertuzumab	EEA1		8411	0.858
NULL	Front_Oncol_2012_Oct_31_2_157.nxml.txt.nlp	23120745	SENT18	41	41	18	18	temozolomide	p53	PA451609	7157	0.858
NULL	Hum_Genomics_2013_Sep_23_7(1)_20.nxml.txt.nlp	24060470	SENT95	15	15	17	17	nutlin-3	p53		7157	0.858
NULL	Cell_Commun_Signal_2014_Mar_11_12_16.nxml.txt.nlp	24618498	SENT433	27	27	22	22	erlotinib	STAT3	PA134687924	6774	0.858
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1066.nxml.txt.nlp	24556681	SENT204	35	35	16	16	ethanol	PSME1	PA448073	5720	0.858
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1059-1066.nxml.txt.nlp	21364577	SENT120	19	19	4	4	letrozole	ATAC	PA450196	6375	0.858
NULL	Diabetes_2011_Jun_21_60(6)_1770-1778.nxml.txt.nlp	21562078	SENT267	16	16	28	28	metformin	AMPK	PA450395	5563	0.858
NULL	Adv_Hematol_2012_Jan_11_2012_130680.nxml.txt.nlp	22287968	SENT138	20	20	37	37	vincristine	COP1	PA451879	64326;114769	0.858
NULL	Ann_Oncol_2010_Mar_28_21(3)_498-505.nxml.txt.nlp	19717534	SENT219	16	16	31	31	anastrozole	ATAC	PA448432	6375	0.858
NULL	Emerg_Infect_Dis_2012_Apr_18(4)_689-691.nxml.txt.nlp	22469015	SENT32	28	28	21	21	ribavirin	IFN	PA451241	3439	0.858
NULL	Diabetes_Care_2010_Nov_3_33(11)_2349-2354.nxml.txt.nlp	20682680	SENT19	3	3	7	7	exenatide	GLP-1	PA164749238	100125288	0.858
NULL	Nat_Biotechnol_2010_May_28(5)_478-485.nxml.txt.nlp	20458318	SENT68	1	1	6	6	gentamicin	NAG	PA449753	51594;4669	0.858
NULL	Mol_Cancer_2011_Sep_7_10_109.nxml.txt.nlp	21899742	SENT214	28	28	11	11	etoposide	TRAIL-R2	PA449552	8795	0.858
NULL	Front_Cell_Neurosci_2014_Jul_1_8_183.nxml.txt.nlp	25071444	SENT114	23	23	11	11	paraformaldehyde	CO2	PA450790	4513	0.858
NULL	Cardiovasc_Diabetol_2006_Sep_26_5_20.nxml.txt.nlp	17002798	SENT57	0	0	25	25	bezafibrate	gamma	PA162364313	9913	0.858
NULL	Int_J_Surg_Oncol_2012_May_16_2012_863034.nxml.txt.nlp	22666572	SENT41	22	22	16	16	vincristine	MOF	PA451879	84148	0.858
NULL	Breast_Cancer_Res_2004_May_7_6(4)_R352-R365.nxml.txt.nlp	15217502	SENT231	8	8	3	3	estradiol	CYP1A2	PA449503	1544	0.858
NULL	Cancer_Med_2013_Jun_25_2(3)_277-285.nxml.txt.nlp	23930204	SENT39	26	26	8	8	bevacizumab	PTEN	PA130232992	5728	0.858
NULL	Breast_Cancer_Res_2008_Feb_28_10(1)_R20.nxml.txt.nlp	18307763	SENT106	35	35	19	19	trastuzumab	HER2	PA451743	2064	0.858
NULL	Ther_Clin_Risk_Manag_2006_Mar_2(1)_59-75.nxml.txt.nlp	18360582	SENT243	2	2	5	5	telithromycin	CYP3A4	PA10202	1576	0.858
NULL	Cancer_Microenviron_2009_Sep_26_2(Suppl_1)_19-204.nxml.txt.nlp	NULL	SENT2005	6	6	9	9	curcumin	p16	PA151958596	1029	0.858
NULL	Arthritis_Res_Ther_2010_Jun_10_12(3)_R114.nxml.txt.nlp	20537160	SENT133	2	2	30	30	etanercept	ANOVA	PA449515	4858	0.858
NULL	Acta_Pharmacol_Sin_2014_Oct_15_35(10)_1227-1246.nxml.txt.nlp	25220640	SENT231	15	15	5	5	mechlorethamine	MKP-1	PA450336	1843	0.858
NULL	Nucleic_Acids_Res_2012_Sep_4_40(16)_8119-8128.nxml.txt.nlp	22669903	SENT27	11	11	18	18	thrombin	TGT	PA451674	9097;81890	0.858
NULL	Clin_Ophthalmol_2010_Apr_26_4_369-374.nxml.txt.nlp	20463807	SENT64	6	6	19	19	pegaptanib	PED	PA164771236	8682	0.858
NULL	Biochemistry_2009_Feb_3_48(4)_800-809.nxml.txt.nlp	19132922	SENT204	13	13	9	9	allopurinol	XOR	PA448320	7498	0.858
NULL	Mol_Neurodegener_2011_Aug_8_6_57.nxml.txt.nlp	21819629	SENT242	10	10	31	31	arsenite	TDP-43	PA452638	23435	0.858
NULL	Cancer_Med_2014_Aug_14_3(4)_1010-1024.nxml.txt.nlp	24931821	SENT251	25	25	18	18	rituximab	IVL	PA451261	3713	0.858
NULL	Clin_Interv_Aging_2014_Oct_21_9_1783-1791.nxml.txt.nlp	25364236	SENT144	18	18	44	44	galantamine	APOE	PA449726	348	0.858
NULL	J_Immunother_2014_Feb_21_37(2)_105-114.nxml.txt.nlp	24509173	SENT24	16	16	10	10	gemcitabine	WT1	PA449748	7490	0.858
NULL	Biomed_Res_Int_2014_Jan_2_2014_682010.nxml.txt.nlp	24524084	SENT87	11	11	41	41	imatinib	CD28	PA10804	1493;940	0.858
NULL	Case_Rep_Oncol_2012_Oct_10_5(3)_546-553.nxml.txt.nlp	23139670	SENT42	32	32	12	12	gefitinib	CEA	PA131301952	5670;1087	0.858
NULL	J_Cell_Mol_Med_2013_Dec_6_17(12)_1588-1597.nxml.txt.nlp	24199964	SENT8	18	18	20	20	dobutamine	APT	PA449381	653639	0.858
NULL	Bioinform_Biol_Insights_2009_Oct_5_3_109-127.nxml.txt.nlp	20140064	SENT431	8	8	23	23	didanosine	P62	PA449301	2965	0.858
NULL	Cell_Commun_Signal_2013_Nov_11_11_86.nxml.txt.nlp	24215724	SENT524	15	15	1	1	ketamine	PAR1	PA450144	79581;2149	0.858
NULL	Front_Pharmacol_2014_Oct_20_5_230.nxml.txt.nlp	25368579	SENT13	11	11	26	26	berberine	IL-6	PA165860812	3569	0.858
NULL	EMBO_Mol_Med_2012_Apr_4(4)_298-312.nxml.txt.nlp	22331558	SENT263	11	11	4	4	mi-63	MDM2		4193	0.858
NULL	Chonnam_Med_J_2011_Aug_31_47(2)_130-133.nxml.txt.nlp	22111075	SENT31	8	8	20	20	thyroglobulin	CD10	PA164754910	4311	0.858
NULL	Curr_Control_Trials_Cardiovasc_Med_2001_Jul_26_2(4)_171-179.nxml.txt.nlp	11806792	SENT56	4	4	22	22	eptifibatide	IMPACT	PA449483	55364	0.858
NULL	Support_Care_Cancer_2009_Sep_10_17(9)_1187-1193.nxml.txt.nlp	19205754	SENT140	14	14	10	10	aprepitant	NK-1	PA164747039	27087	0.858
NULL	Breast_Cancer_Res_2007_Feb_6_9(1)_R17.nxml.txt.nlp	17280616	SENT4	21	21	18	18	trastuzumab	aromatase	PA451743	1588	0.858
NULL	Oncotarget_2014_Jun_3_5(13)_4920-4928.nxml.txt.nlp	24952482	SENT131	18	18	11	11	crizotinib	KIT	PA165946122	3815	0.858
NULL	Biomed_Res_Int_2014_Jan_20_2014_948427.nxml.txt.nlp	24563867	SENT87	3	3	26	26	buspirone	STZ	PA448689	6484	0.858
NULL	Leukemia_2014_Jun_25_28(6)_1280-1288.nxml.txt.nlp	24270737	SENT121	7	7	18	18	decitabine	CTLA4	PA164749631	1493	0.858
NULL	Cancer_Cell_Int_2004_Aug_17_4_5.nxml.txt.nlp	15315711	SENT119	31	31	29	29	genistein	PC3	PA165109660	57332;7832;5122	0.858
NULL	ScientificWorldJournal_2013_Sep_25_2013_807284.nxml.txt.nlp	24187524	SENT17	28	28	22	22	panitumumab	HER2	PA162373091	2064	0.858
NULL	Exp_Ther_Med_2014_Nov_26_8(5)_1611-1615.nxml.txt.nlp	25289068	SENT112	20	20	3	3	epirubicin	P-gp	PA449476	5243	0.858
NULL	J_Hematol_Oncol_2010_Nov_24_3_46.nxml.txt.nlp	21106054	SENT8	27	27	29	29	gemcitabine	GEM	PA449748	2669	0.858
NULL	Cell_Commun_Signal_2013_Jan_11_11_2.nxml.txt.nlp	23305203	SENT160	10	10	4	4	forskolin	RACK1	PA146096022	10399	0.858
NULL	Leukemia_2013_Apr_14_27(4)_803-812.nxml.txt.nlp	23238589	SENT124	3	3	1	1	imatinib	IFN	PA10804	3439	0.858
NULL	Mol_Cancer_2007_Apr_2_6_26.nxml.txt.nlp	17407576	SENT147	16	16	11	11	cisplatin	p53	PA449014	7157	0.858
NULL	Breast_Cancer_Res_2007_Jul_5_9(4)_R41.nxml.txt.nlp	17612393	SENT186	12	12	7	7	celecoxib	Bcl-2	PA448871	596	0.858
NULL	Breast_Cancer_Res_2011_Mar_1_13(2)_R21.nxml.txt.nlp	21362200	SENT297	29	29	31	31	fulvestrant	PI3K	PA164747170	5290	0.858
NULL	Br_J_Cancer_2014_Jan_21_110(2)_384-391.nxml.txt.nlp	24346286	SENT130	31	31	16	16	trastuzumab	HER3	PA451743	2065	0.858
NULL	Cardiovasc_Ther_2009_27(4)_259-274.nxml.txt.nlp	19604248	SENT139	39	39	15	15	clopidogrel	IPA	PA449053	3160	0.858
NULL	Oncotarget_2014_Mar_10_5(10)_3023-3028.nxml.txt.nlp	24632590	SENT65	9	9	25	25	olaparib	STAT3		6774	0.858
NULL	Toxins_(Basel)_2010_Oct_26_2(11)_2490-2518.nxml.txt.nlp	22069563	SENT151	4	4	14	14	cisplatin	JNK	PA449014	5599	0.858
NULL	J_Korean_Med_Sci_2010_Sep_14_25(9)_1305-1312.nxml.txt.nlp	20808673	SENT5	4	4	18	18	hydrochlorothiazide	TRPV5	PA449899	56302	0.858
NULL	Diabetes_Care_2010_Apr_19_33(4)_914-919.nxml.txt.nlp	20086255	SENT181	22	22	6	6	rosiglitazone	DREAM	PA451283	30818	0.858
NULL	Int_J_Endocrinol_2013_Nov_14_2013_453898.nxml.txt.nlp	24348555	SENT114	6	6	9	9	estradiol	MVD	PA449503	4597	0.858
NULL	Mol_Cancer_2013_May_24_12_46.nxml.txt.nlp	23705826	SENT357	23	23	17	17	neomycin	FLT3	PA450608	2322	0.858
NULL	Prostate_Int_2014_Sep_21_2(3)_105-113.nxml.txt.nlp	25325021	SENT156	8	8	21	21	dutasteride	SRD5A3	PA164749300	79644	0.858
NULL	Nucleic_Acids_Res_2012_Sep_31_40(16)_8033-8047.nxml.txt.nlp	22661577	SENT115	42	42	28	28	ethanol	NAP5	PA448073	344148	0.858
NULL	Br_J_Haematol_2014_Mar_6_164(6)_759-766.nxml.txt.nlp	24387053	SENT107	31	31	23	23	rituximab	PEX	PA451261	5251	0.858
NULL	JRSM_Cardiovasc_Dis_2012_Apr_5_1(1)_cvd_2012_012001.nxml.txt.nlp	24175062	SENT242	27	27	24	24	warfarin	VKORC1	PA451906	79001	0.858
NULL	Nat_Commun_2014_Nov_25_5_5548.nxml.txt.nlp	25420520	SENT43	31	31	3	3	doxycycline	ERG	PA449415	2078	0.858
NULL	Cancer_Med_2014_Dec_13_3(6)_1579-1594.nxml.txt.nlp	25124282	SENT285	18	18	2	2	olaparib	PARP1		142	0.858
NULL	Mar_Drugs_2014_Jun_27_12(7)_3818-3837.nxml.txt.nlp	24979269	SENT61	6	6	38	38	calcein	P-gp	PA132595336	5243	0.858
NULL	Arthritis_Res_Ther_2011_Feb_11_13(1)_R21.nxml.txt.nlp	21314928	SENT155	6	6	3	3	tocilizumab	IL-6	PA165292659	3569	0.858
NULL	Chin_J_Cancer_2011_Oct_30(10)_701-711.nxml.txt.nlp	21959047	SENT170	8	8	4	4	gefitinib	EGFR	PA131301952	1956	0.858
NULL	J_Thromb_Haemost_2014_May_22_12(5)_748-760.nxml.txt.nlp	24612393	SENT141	3	3	6	6	thrombin	TSC2	PA451674	7249	0.858
NULL	J_Cell_Biol_2003_Aug_4_162(3)_443-455.nxml.txt.nlp	12885763	SENT337	28	28	20	20	glutaraldehyde	PAG	PA449777	55824	0.858
NULL	Br_J_Ophthalmol_2013_Sep_13_97(9)_1161-1167.nxml.txt.nlp	23850682	SENT149	17	17	11	11	ranibizumab	WAVE	PA164746012	8936	0.858
NULL	Br_J_Cancer_2012_May_22_106(11)_1722-1727.nxml.txt.nlp	22568966	SENT137	35	35	4	4	bevacizumab	VEGF-A	PA130232992	7422	0.858
NULL	J_Invest_Surg_2013_Jun_20_26(3)_141-148.nxml.txt.nlp	23514063	SENT95	7	7	32	32	thrombin	CO2	PA451674	4513	0.858
NULL	Oncotarget_2013_Aug_30_4(10)_1698-1711.nxml.txt.nlp	24091605	SENT124	22	22	13	13	gefitinib	PDCL	PA131301952	5082	0.858
NULL	Mol_Cancer_2007_Oct_11_6_63.nxml.txt.nlp	17931419	SENT57	17	17	12	12	gefitinib	EGFR	PA131301952	1956	0.858
NULL	Scientifica_(Cairo)_2012_Dec_23_2012_606104.nxml.txt.nlp	24278719	SENT84	9	9	30	30	arsenite	NRF2	PA452638	2551;4780	0.858
NULL	Mol_Vis_2012_Feb_16_18_471-478.nxml.txt.nlp	22393273	SENT190	10	10	12	12	atropine	FGF2	PA448505	2247;2258	0.858
NULL	Oncoimmunology_2013_Jan_1_2(1)_e22890.nxml.txt.nlp	23483066	SENT59	15	15	27	27	vemurafenib	IFN	PA165946873	3439	0.858
NULL	Kidney_Int_Suppl_(2011)_2013_Dec_27_3(4)_392-409.nxml.txt.nlp	NULL	SENT644	11	11	4	4	cisplatin	OCT2	PA449014	6582;5452	0.858
NULL	Curr_Neuropharmacol_2008_Sep_6(3)_193-202.nxml.txt.nlp	19506720	SENT177	39	39	43	43	mirtazapine	ghrelin	PA450522	51738	0.858
NULL	J_Cell_Biol_2001_Oct_29_155(3)_427-438.nxml.txt.nlp	11673478	SENT179	0	0	13	13	pp2	PP1		5540;5464	0.858
NULL	Mol_Cells_2014_Sep_30_37(9)_664-671.nxml.txt.nlp	25234467	SENT13	15	15	5	5	cisplatin	miR-217	PA449014	406999	0.858
NULL	Mol_Cancer_2007_Aug_21_6_53.nxml.txt.nlp	17711579	SENT154	34	34	25	25	cisplatin	BCL2L11	PA449014	10018	0.858
NULL	Front_Genet_2012_Nov_22_3_249.nxml.txt.nlp	23189085	SENT115	17	17	23	23	etoposide	IL1B	PA449552	3553	0.858
NULL	J_Cell_Biol_2003_Dec_22_163(6)_1385-1395.nxml.txt.nlp	14676308	SENT10	6	6	2	2	thrombin	RhoA	PA451674	387	0.858
NULL	Cancer_Med_2013_Oct_19_2(5)_646-653.nxml.txt.nlp	24403230	SENT77	31	31	16	16	trastuzumab	PCBP4	PA451743	57060	0.858
NULL	Acta_Orthop_2013_Dec_2_84(6)_585-592.nxml.txt.nlp	24237425	SENT198	38	38	25	25	hyaluronan	S100A9	PA165958431	6280	0.858
NULL	Tumour_Biol_2014_Mar_12_35(3)_2053-2062.nxml.txt.nlp	24122205	SENT74	47	47	5	5	ethanol	CD44	PA448073	960	0.858
NULL	CNS_Drugs_2013_Aug_20_27(12)_1081-1092.nxml.txt.nlp	23959815	SENT30	30	30	11	11	clonidine	ATX	PA449051	5168;23049	0.858
NULL	Oncoimmunology_2013_Jan_1_2(1)_e23033.nxml.txt.nlp	23483678	SENT66	26	26	40	40	cisplatin	IFN	PA449014	3439	0.858
NULL	Br_J_Cancer_2012_Sep_4_107(6)_947-955.nxml.txt.nlp	22892392	SENT253	5	5	10	10	lapatinib	ERBB3	PA152241907	2065	0.858
NULL	Oncotarget_2014_Jun_6_5(13)_4945-4958.nxml.txt.nlp	24970814	SENT114	15	15	6	6	cisplatin	PTB	PA449014	58155	0.858
NULL	Ecancermedicalscience_2011_Dec_1_5_237.nxml.txt.nlp	22276069	SENT29	3	3	11	11	exemestane	CEA	PA449563	5670;1087	0.858
NULL	BioData_Min_2011_Jun_14_4_15.nxml.txt.nlp	21672238	SENT32	5	5	25	25	geldanamycin	p23	PA152031327	10728	0.858
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S101-S106.nxml.txt.nlp	21525438	SENT169	12	12	0	0	metformin	JAMA	PA450395	50848	0.858
NULL	Case_Rep_Infect_Dis_2013_May_12_2013_761793.nxml.txt.nlp	23762676	SENT50	4	4	31	31	vancomycin	TMX	PA451850	81542	0.858
NULL	Int_J_Biol_Sci_2011_Nov_5_8(1)_1-14.nxml.txt.nlp	22211100	SENT35	37	37	12	12	gemcitabine	PTEN	PA449748	5728	0.858
NULL	Oncotarget_2012_May_18_3(5)_525-534.nxml.txt.nlp	22619113	SENT93	4	4	12	12	fludarabine	MCL1	PA449655	4170	0.858
NULL	Cancer_Med_2013_Feb_3_2(1)_108-115.nxml.txt.nlp	24279005	SENT379	9	9	13	13	gemcitabine	NF-kappaB	PA449748	4790	0.858
NULL	Nucleic_Acids_Res_2014_Jan_25_42(2)_952-967.nxml.txt.nlp	24163258	SENT87	12	12	7	7	paraformaldehyde	mtSSB	PA450790	6742	0.858
NULL	Arthritis_Res_Ther_2012_Feb_15_14(1)_R34.nxml.txt.nlp	22336440	SENT13	33	33	25	25	methotrexate	CXCL13	PA450428	10563	0.858
NULL	J_Cell_Mol_Med_2013_Dec_6_17(12)_1588-1597.nxml.txt.nlp	24199964	SENT171	4	4	16	16	doxycycline	APT	PA449415	653639	0.858
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1137-1144.nxml.txt.nlp	20234366	SENT147	20	20	17	17	cetuximab	MKP-1	PA10040	1843	0.858
NULL	Acta_Pharmacol_Sin_2012_Dec_29_33(12)_1518-1524.nxml.txt.nlp	23103625	SENT12	2	2	9	9	telmisartan	ACE2	PA451605	59272	0.858
NULL	Mol_Cancer_2010_Mar_25_9_68.nxml.txt.nlp	20338046	SENT178	33	33	4	4	tamoxifen	GSTP1	PA451581	2950	0.858
NULL	Breast_Cancer_Res_2004_May_7_6(4)_R338-R351.nxml.txt.nlp	15217501	SENT214	17	17	7	7	estradiol	CYP1A2	PA449503	1544	0.858
NULL	Clinics_(Sao_Paulo)_2014_Jan_69(1)_68-74.nxml.txt.nlp	24473562	SENT26	15	15	18	18	nutlin-3	SOCS-1		8651	0.858
NULL	J_Cardiovasc_Dis_Res_2012_Jan-Mar_3(1)_5-11.nxml.txt.nlp	22346138	SENT111	32	32	18	18	glimepiride	IL-6	PA449761	3569	0.858
NULL	Anal_Bioanal_Chem_2010_Aug_14_397(7)_2977-2986.nxml.txt.nlp	20549493	SENT117	29	29	5	5	estradiol	TRIM	PA449503	50852	0.858
NULL	Clin_Epigenetics_2011_Dec_5_3(1)_8.nxml.txt.nlp	22414275	SENT40	10	10	18	18	ribavirin	ESR1	PA451241	2099	0.858
NULL	Br_J_Cancer_2013_Jul_23_109(2)_502-511.nxml.txt.nlp	23799850	SENT149	15	15	6	6	gemcitabine	SMARCC1	PA449748	6599	0.858
NULL	Int_J_Gen_Med_2011_Jul_20_4_539-545.nxml.txt.nlp	21845063	SENT98	24	24	21	21	miglitol	adiponectin	PA164776726	9370	0.858
NULL	Arthritis_Res_Ther_2008_Jan_7_10(1)_R1.nxml.txt.nlp	18179697	SENT53	11	11	27	27	oxaliplatin	HMGB1	PA131285527	3146	0.858
NULL	Acta_Pharmacol_Sin_2009_Feb_26_30(2)_219-227.nxml.txt.nlp	19169271	SENT43	12	12	4	4	naloxone	CTX	PA450586	1593	0.858
NULL	Oncotarget_2011_Dec_31_2(12)_1314-1321.nxml.txt.nlp	22248929	SENT68	15	15	7	7	lapatinib	HER2	PA152241907	2064	0.858
NULL	Carcinogenesis_2010_Dec_27_31(12)_2049-2057.nxml.txt.nlp	20876285	SENT205	11	11	4	4	tamoxifen	HER2	PA451581	2064	0.858
NULL	Parasit_Vectors_2013_Oct_1_6_287.nxml.txt.nlp	24289745	SENT4	20	20	23	23	albendazole	gamma	PA164746058	9913	0.858
NULL	Mol_Cancer_2006_Oct_17_5_45.nxml.txt.nlp	17044934	SENT90	33	33	39	39	resveratrol	COX		1351	0.858
NULL	Anesth_Essays_Res_2010_Jan-Jun_4(1)_41-43.nxml.txt.nlp	NULL	SENT19	20	20	39	39	fentanyl	NIBP	PA449599	83696	0.858
NULL	Acta_Pharmacol_Sin_2013_Jun_8_34(6)_830-836.nxml.txt.nlp	23564080	SENT139	20	20	28	28	simvastatin	RAGE	PA451363	177	0.858
NULL	Cancer_Cell_Int_2005_Aug_24_5_28.nxml.txt.nlp	16120219	SENT157	12	12	29	29	etoposide	MDM2	PA449552	4193	0.858
NULL	J_Clin_Biochem_Nutr_2009_Sep_28_45(2)_125-130.nxml.txt.nlp	19794918	SENT8	22	22	6	6	omeprazole	HO-1	PA450704	3162	0.858
NULL	Breast_Cancer_Res_Treat_2013_Jan_6_137(1)_167-174.nxml.txt.nlp	23129173	SENT187	3	3	14	14	letrozole	CYP19A1	PA450196	1588	0.858
NULL	Biosensors_(Basel)_2012_Jan_13_2(1)_1-14.nxml.txt.nlp	25585628	SENT121	16	16	3	3	thrombin	GPD	PA451674	2532	0.858
NULL	Biotechnol_Res_Int_2013_Dec_1_2013_253286.nxml.txt.nlp	24363937	SENT128	6	6	18	18	ethanol	DAP	PA448073	23549;3375;1611	0.858
NULL	J_Cell_Biol_1998_May_4_141(3)_839-847.nxml.txt.nlp	9566981	SENT267	18	18	3	3	guanidine	osteoadherin	PA164781028	4958	0.858
NULL	Acta_Neuropathol_2007_Nov_6_114(5)_443-458.nxml.txt.nlp	17805551	SENT263	19	19	13	13	erlotinib	EGFR	PA134687924	1956	0.858
NULL	Endocrinol_Metab_(Seoul)_2014_Sep_25_29(3)_379-387.nxml.txt.nlp	25309798	SENT109	3	3	23	23	resveratrol	CLOCK		9575	0.858
NULL	Acta_Pharmacol_Sin_2012_Jan_3_33(1)_49-56.nxml.txt.nlp	22212430	SENT142	4	4	0	0	thrombin	PAR-1	PA451674	2011;2149	0.858
NULL	J_Neurol_2013_Mar_17_260(12)_2959-2963.nxml.txt.nlp	23504049	SENT106	14	14	26	26	natalizumab	IFN	PA164747191	3439	0.858
NULL	J_Mol_Med_2011_Jul_23_89(7)_667-676.nxml.txt.nlp	21431325	SENT59	25	25	6	6	resveratrol	AMPK		5563	0.858
NULL	Oncol_Lett_2014_Jul_25_8(1)_313-316.nxml.txt.nlp	24959268	SENT8	4	4	7	7	sulindac	c-Jun	PA451565	3725	0.858
NULL	Springerplus_2014_Sep_9_3_510.nxml.txt.nlp	25279302	SENT35	31	31	8	8	creatine	CT1	PA164778930	1489;6535	0.858
NULL	Oncotarget_2014_Dec_4_5(22)_11365-11380.nxml.txt.nlp	25426548	SENT130	15	15	3	3	nutlin-3	p53		7157	0.858
NULL	Aging_(Albany_NY)_2013_Feb_21_5(2)_94-95.nxml.txt.nlp	23518473	SENT22	24	24	38	38	resveratrol	p53		7157	0.858
NULL	Breast_Cancer_Res_Treat_2014_Nov_11_148(3)_563-570.nxml.txt.nlp	25385180	SENT58	13	13	10	10	trastuzumab	PTH	PA451743	5741	0.858
NULL	Eur_J_Med_Res_2011_Apr_28_16(4)_139-144.nxml.txt.nlp	21486727	SENT74	17	17	3	3	voriconazole	CYP2C19	PA10233	1557	0.858
NULL	Biomed_Res_Int_2014_Feb_6_2014_323594.nxml.txt.nlp	24689036	SENT248	2	2	9	9	raloxifene	PC3	PA451221	57332;7832;5122	0.858
NULL	Int_J_Breast_Cancer_2011_Sep_6_2011_352182.nxml.txt.nlp	22295219	SENT144	31	31	27	27	trastuzumab	AKT	PA451743	207	0.858
NULL	Aging_(Albany_NY)_2012_Jul_22_4(7)_480-498.nxml.txt.nlp	22837425	SENT30	23	23	11	11	metformin	B12	PA450395	7126;4709	0.858
NULL	Cancer_Cell_Int_2013_Jan_15_13_3.nxml.txt.nlp	23320839	SENT139	14	14	11	11	gemcitabine	MRP3	PA449748	8714	0.858
NULL	Infect_Agent_Cancer_2014_Feb_26_9_8.nxml.txt.nlp	24572088	SENT136	5	5	17	17	ganciclovir	TERT	PA449733	7015	0.858
NULL	Ann_Lab_Med_2014_Nov_28_34(6)_439-445.nxml.txt.nlp	25368819	SENT55	18	18	11	11	moxifloxacin	VAN	PA450555	10318	0.858
NULL	CNS_Drugs_2014_Apr_11_28(6)_535-558.nxml.txt.nlp	24723124	SENT355	8	8	15	15	alemtuzumab	IFN	PA164783958	3439	0.858
NULL	Oncoimmunology_2012_Nov_1_1(8)_1435-1437.nxml.txt.nlp	23243620	SENT9	0	0	5	5	vemurafenib	BRAF	PA165946873	673	0.858
NULL	Infect_Dis_Ther_2014_Dec_12_3(2)_103-122.nxml.txt.nlp	25388760	SENT240	9	9	4	4	loperamide	P-gp	PA450262	5243	0.858
NULL	J_Cardiothorac_Surg_2010_Aug_21_5_66.nxml.txt.nlp	20727201	SENT55	11	11	21	21	collagenase	MMP9	PA449107	4318	0.858
NULL	Oncol_Lett_2013_Apr_22_5(4)_1093-1100.nxml.txt.nlp	23599746	SENT221	37	37	26	26	vinblastine	MDR1	PA451877	5243	0.858
NULL	Asian-Australas_J_Anim_Sci_2014_Dec_27(12)_1783-1793.nxml.txt.nlp	25358373	SENT193	13	13	6	6	capsaicin	CASP3	PA448776	836	0.858
NULL	Int_J_Surg_Oncol_2012_Jun_12_2012_862879.nxml.txt.nlp	22778941	SENT110	21	21	7	7	cisplatin	BIN1	PA449014	274	0.858
NULL	Exp_Ther_Med_2013_Nov_6_6(5)_1089-1095.nxml.txt.nlp	24223627	SENT32	15	15	2	2	docetaxel	NAC	PA449383	22861	0.858
NULL	Mol_Microbiol_2014_May_28_92(3)_453-470.nxml.txt.nlp	24533860	SENT317	1	1	13	13	tetracycline	HMI	PA451640	3160	0.858
NULL	Nat_Commun_2013_Aug_15_4_2130.nxml.txt.nlp	23945651	SENT713	1	1	5	5	etoposide	ATG5	PA449552	9474	0.858
NULL	Exp_Mol_Med_2012_Aug_31_44(8)_473-482.nxml.txt.nlp	22627808	SENT118	6	6	23	23	lapatinib	HER3	PA152241907	2065	0.858
NULL	J_Int_AIDS_Soc_2012_Oct_22_15(Suppl_3)_18439.nxml.txt.nlp	NULL	SENT1323	8	8	30	30	etravirine	DUET	PA166014703	8997	0.858
NULL	Braz_J_Med_Biol_Res_2011_Dec_9_45(1)_13-19.nxml.txt.nlp	22147192	SENT56	25	25	3	3	isoflurane	P21	PA450106	1026;9338	0.858
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Jul_5_64(Pt_8)_o1398.nxml.txt.nlp	21203118	SENT60	20	20	12	12	ethanol	mol	PA448073	90527	0.858
NULL	Am_J_Trop_Med_Hyg_2014_Mar_5_90(3)_530-534.nxml.txt.nlp	24420779	SENT83	22	22	5	5	lumefantrine	CYP3A4	PA165111722	1576	0.858
NULL	Case_Rep_Med_2013_Oct_24_2013_270419.nxml.txt.nlp	24250338	SENT42	0	0	8	8	heparin	PTA	PA449855	171558	0.858
NULL	Arch_Med_Sci_2011_Oct_8_7(5)_889-895.nxml.txt.nlp	22291837	SENT154	30	30	20	20	collagenase	I-1	PA449107	11188	0.858
NULL	Acta_Orthop_2011_Apr_5_82(2)_211-216.nxml.txt.nlp	21434784	SENT22	18	18	3	3	cisplatin	VIII	PA449014	1351	0.858
NULL	Clin_Med_Insights_Womens_Health_2013_Jan_22_6_1-11.nxml.txt.nlp	24665209	SENT50	18	18	10	10	tamoxifen	aromatase	PA451581	1588	0.858
NULL	Blood_Cancer_J_2013_Mar_1_3(3)_e103.nxml.txt.nlp	23454896	SENT89	3	3	9	9	lopinavir	AKT	PA450264	207	0.858
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Oct_30_66(Pt_11)_o2981.nxml.txt.nlp	21589147	SENT60	18	18	6	6	ethanol	mol	PA448073	90527	0.858
NULL	ACS_Med_Chem_Lett_2011_May_16_2(7)_549-554.nxml.txt.nlp	21765967	SENT53	41	41	35	35	maraviroc	CCR5	PA164768835	1234	0.858
NULL	Breast_Cancer_(Auckl)_2009_Sep_2_3_61-75.nxml.txt.nlp	19809577	SENT268	25	25	38	38	curcumin	PARP	PA151958596	142	0.858
NULL	Arthritis_Res_Ther_2009_Oct_14_11(5)_251.nxml.txt.nlp	19849819	SENT298	16	16	27	27	alendronate	PTH	PA448082	5741	0.858
NULL	Endocr_Relat_Cancer_2014_Apr_21(2)_355-369.nxml.txt.nlp	24481325	SENT255	2	2	6	6	genistein	GPER	PA165109660	2852	0.858
NULL	J_Cell_Biol_2001_Apr_30_153(3)_613-620.nxml.txt.nlp	11331310	SENT65	2	2	13	13	cisplatin	53BP1	PA449014	7158	0.858
NULL	Cell_Death_Dis_2010_Nov_18_1(11)_e102.nxml.txt.nlp	21368867	SENT71	27	27	30	30	gentamicin	CLIMP-63	PA449753	10970	0.858
NULL	Breast_Cancer_Res_2008_Dec_18_10(Suppl_4)_S20.nxml.txt.nlp	19128434	SENT30	39	39	25	25	lapatinib	HER2	PA152241907	2064	0.858
NULL	Am_J_Transplant_2010_Jan_10(1)_69-80.nxml.txt.nlp	19889125	SENT116	9	9	6	6	fludarabine	STAT1	PA449655	6772	0.858
NULL	Autophagy_2012_May_1_8(5)_853-855.nxml.txt.nlp	22617440	SENT53	20	20	7	7	imatinib	BECN1	PA10804	8678	0.858
NULL	Case_Rep_Ophthalmol_Med_2014_Nov_23_2014_682583.nxml.txt.nlp	25506450	SENT123	1	1	6	6	ranibizumab	VEGF-A	PA164746012	7422	0.858
NULL	Exp_Ther_Med_2014_Mar_24_7(3)_663-668.nxml.txt.nlp	24520264	SENT140	33	33	24	24	curcumin	IL-6	PA151958596	3569	0.858
NULL	Leukemia_2014_Mar_13_28(3)_600-608.nxml.txt.nlp	24240203	SENT195	32	32	24	24	nutlin-3	PUMA		27113	0.858
NULL	Mol_Cancer_2009_Oct_1_8_81.nxml.txt.nlp	19796390	SENT18	10	10	25	25	celecoxib	Bcl-2	PA448871	596	0.858
NULL	Exp_Ther_Med_2013_Dec_15_6(6)_1565-1569.nxml.txt.nlp	24255692	SENT98	12	12	19	19	atorvastatin	adiponectin	PA448500	9370	0.858
NULL	Cancer_Immunol_Immunother_2012_Jul_23_61(7)_1101-1111.nxml.txt.nlp	22193989	SENT10	2	2	24	24	oxaliplatin	IFN	PA131285527	3439	0.858
NULL	Clin_Ophthalmol_2009_Jun_2_3_175-182.nxml.txt.nlp	19668562	SENT129	3	3	8	8	ranibizumab	VEGF-A	PA164746012	7422	0.858
NULL	Nucl_Recept_Signal_2012_Feb_27_10_e001.nxml.txt.nlp	22438791	SENT132	35	35	28	28	tamoxifen	HER2	PA451581	2064	0.858
NULL	Oncogene_2014_Apr_3_33(14)_1828-1839.nxml.txt.nlp	23624914	SENT66	29	29	2	2	doxycycline	survivin	PA449415	332	0.858
NULL	Crit_Care_2008_Mar_13_12(Suppl_2)_P438.nxml.txt.nlp	NULL	SENT4	8	8	24	24	vasopressin	AVP	PA451858	114548;551	0.858
NULL	J_Invest_Dermatol_2012_Jan_18_132(1)_163-169.nxml.txt.nlp	21850019	SENT60	20	20	3	3	imiquimod	CD4	PA449972	920	0.858
NULL	Oncol_Rep_2013_Jun_2_29(6)_2095-2100.nxml.txt.nlp	23563900	SENT118	8	8	2	2	cetuximab	EGFR	PA10040	1956	0.858
NULL	Evid_Based_Complement_Alternat_Med_2013_Mar_14_2013_429706.nxml.txt.nlp	23573127	SENT155	16	16	0	0	indomethacin	IDS	PA449982	3423	0.858
NULL	Mol_Biol_Int_2014_Sep_7_2014_852748.nxml.txt.nlp	25276427	SENT133	12	12	25	25	cyclophosphamide	HER2	PA449165	2064	0.858
NULL	Acta_Neuropathol_2009_Sep_14_118(3)_329-347.nxml.txt.nlp	19597829	SENT417	14	14	5	5	mi-63	HDM2		4193	0.858
NULL	Cancers_(Basel)_2014_Nov_14_6(4)_2275-2295.nxml.txt.nlp	25405526	SENT83	27	27	13	13	cyclophosphamide	CHOP	PA449165	1649	0.858
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT173	8	8	14	14	metformin	HIP	PA450395	6767;6159;64399;5068	0.858
NULL	Acta_Pharmacol_Sin_2013_Jun_8_34(6)_830-836.nxml.txt.nlp	23564080	SENT143	16	16	30	30	simvastatin	RAGE	PA451363	177	0.858
NULL	Mol_Vis_2012_Apr_11_18_901-908.nxml.txt.nlp	22539869	SENT14	0	0	14	14	curcumin	HO-1	PA151958596	3162	0.858
NULL	Endocr_Relat_Cancer_2014_Jun_21(3)_R209-R225.nxml.txt.nlp	24500760	SENT62	10	10	19	19	resveratrol	IGFBP3		3486	0.858
NULL	Gene_Regul_Syst_Bio_2014_Mar_4_8_63-73.nxml.txt.nlp	24634581	SENT231	0	0	8	8	minocycline	STAT3	PA450519	6774	0.858
NULL	Ann_Gen_Psychiatry_2010_Apr_22_9(Suppl_1)_S142.nxml.txt.nlp	NULL	SENT4	16	16	7	7	donepezil	CYP2D6	PA449394	1565	0.858
NULL	Int_J_Environ_Res_Public_Health_2012_Aug_27_9(8)_2636-2657.nxml.txt.nlp	23066388	SENT599	14	14	9	9	cisplatin	p53	PA449014	7157	0.858
NULL	Exp_Ther_Med_2014_Sep_14_8(3)_836-840.nxml.txt.nlp	25120610	SENT12	3	3	18	18	fasudil	ROCK2	PA165946121	9475	0.858
NULL	J_Cell_Biol_2004_Apr_26_165(2)_175-180.nxml.txt.nlp	15096524	SENT79	7	7	19	19	forskolin	VASP	PA146096022	7408	0.858
NULL	Acta_Pharmacol_Sin_2014_Jun_4_35(6)_752-757.nxml.txt.nlp	24902786	SENT88	7	7	25	25	tamoxifen	castor	PA451581	54897	0.858
NULL	Chin_J_Cancer_2012_Nov_31(11)_507-518.nxml.txt.nlp	22640626	SENT173	11	11	29	29	nilotinib	DDR1	PA165958345	780	0.858
NULL	Arthritis_Res_2000_Nov_15_1(Suppl_1)_S47.nxml.txt.nlp	NULL	SENT12	3	3	16	16	etanercept	ACR	PA449515	49	0.858
NULL	Neural_Dev_2009_Mar_16_4_11.nxml.txt.nlp	19291307	SENT89	38	38	28	28	doxycycline	E12	PA449415	64100	0.858
NULL	Breast_Cancer_Res_2012_Jun_7_14(3)_R89.nxml.txt.nlp	22676470	SENT161	7	7	3	3	lapatinib	EGFR	PA152241907	1956	0.858
NULL	ScientificWorldJournal_2013_Sep_19_2013_809891.nxml.txt.nlp	24170983	SENT116	18	18	4	4	dexketoprofen	ANOVA	PA166049175	4858	0.858
NULL	Cell_Commun_Signal_2013_Dec_20_11_97.nxml.txt.nlp	24359404	SENT174	26	26	23	23	nilotinib	NF2	PA165958345	4771	0.858
NULL	Cells_2012_Oct_10_1(4)_711-737.nxml.txt.nlp	24710527	SENT241	10	10	20	20	etoposide	cIAP1	PA449552	329	0.858
NULL	Hum_Mol_Genet_2013_Nov_15_22(22)_4616-4626.nxml.txt.nlp	23814041	SENT123	8	8	21	21	doxycycline	neuroserpin	PA449415	5274	0.858
NULL	Br_J_Ophthalmol_2012_Jul_26_96(7)_1023-1028.nxml.txt.nlp	22539748	SENT139	11	11	5	5	bevacizumab	REC	PA130232992	84515	0.858
NULL	Cell_Death_Dis_2013_Oct_3_4(10)_e828.nxml.txt.nlp	24091671	SENT91	29	29	5	5	cetuximab	CD44	PA10040	960	0.858
NULL	Breast_Cancer_Res_2012_Aug_8_14(4)_R116.nxml.txt.nlp	22873525	SENT172	3	3	15	15	trastuzumab	gamma	PA451743	9913	0.858
NULL	Breast_Cancer_Res_2007_Mar_2_9(2)_205.nxml.txt.nlp	NULL	SENT49	4	4	29	29	canertinib	p27	PA134687925	5715;10534	0.858
NULL	Oncologist_2011_Jan_6_16(1)_5-24.nxml.txt.nlp	21212434	SENT196	13	13	29	29	vincristine	IFN	PA451879	3439	0.858
NULL	Environ_Health_Perspect_2006_Sep_23_114(9)_1401-1406.nxml.txt.nlp	16966095	SENT44	13	13	9	9	arsenite	p53	PA452638	7157	0.858
NULL	Colomb_Med_(Cali)_43(4)_305-311.nxml.txt.nlp	24893304	SENT85	22	22	13	13	ganciclovir	CD4	PA449733	920	0.858
NULL	J_Lipid_Res_2015_Jan_56(1)_109-121.nxml.txt.nlp	25421061	SENT310	8	8	27	27	forskolin	CGI-58	PA146096022	51099	0.858
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT191	8	8	25	25	bevacizumab	PlGF-2	PA130232992	5228	0.858
NULL	Indian_J_Hum_Genet_2014_Apr-Jun_20(2)_175-184.nxml.txt.nlp	25400347	SENT9	46	46	33	33	clopidogrel	CYP2C9	PA449053	1559	0.858
NULL	Br_J_Cancer_2012_Oct_9_107(8)_1233-1238.nxml.txt.nlp	22955852	SENT109	8	8	3	3	docetaxel	RPN2	PA449383	6185	0.858
NULL	Biomed_Res_Int_2013_Feb_21_2013_856754.nxml.txt.nlp	23555099	SENT127	1	1	6	6	thrombin	FIX	PA451674	2158	0.858
NULL	Breast_Cancer_Res_Treat_2013_Jun_5_139(3)_649-655.nxml.txt.nlp	23736997	SENT196	9	9	4	4	tamoxifen	CYP2C19	PA451581	1557	0.858
NULL	Front_Immunol_2013_May_24_4_126.nxml.txt.nlp	23745124	SENT175	22	22	16	16	indomethacin	COX	PA449982	1351	0.858
NULL	Cancers_(Basel)_2014_Oct_24_6(4)_2187-2223.nxml.txt.nlp	25347122	SENT185	16	16	4	4	cisplatin	EGFR	PA449014	1956	0.858
NULL	Front_Immunol_2013_Oct_31_4_351.nxml.txt.nlp	24198817	SENT442	30	30	20	20	anakinra	P2X7	PA10799	5027	0.858
NULL	Diabetes_2008_Oct_57(10)_2818-2823.nxml.txt.nlp	18633114	SENT94	26	26	12	12	ethanol	CO2	PA448073	4513	0.858
NULL	Gut_Liver_2011_Sep_18_5(3)_293-297.nxml.txt.nlp	21927656	SENT34	6	6	19	19	omeprazole	ESD	PA450704	2098	0.858
NULL	Br_J_Cancer_2013_Jul_23_109(2)_342-350.nxml.txt.nlp	23807172	SENT181	24	24	7	7	sorafenib	p38	PA7000	10598;1432;7965	0.858
NULL	Braz_J_Med_Biol_Res_2014_Sep_5_47(11)_929-939.nxml.txt.nlp	25296354	SENT163	40	40	29	29	erlotinib	EGFR	PA134687924	1956	0.858
NULL	Breast_Cancer_Res_2012_May_2_14(3)_R70.nxml.txt.nlp	22551440	SENT6	45	45	16	16	docetaxel	TP53	PA449383	7157	0.858
NULL	J_Biol_Chem_2009_Oct_16_284(42)_28885-28895.nxml.txt.nlp	19687008	SENT286	24	24	30	30	simvastatin	PCSK9	PA451363	255738	0.858
NULL	Int_J_Appl_Basic_Med_Res_2013_Jan-Jun_3(1)_19-21.nxml.txt.nlp	23776835	SENT23	3	3	11	11	ticagrelor	ADP	PA165374673	23038	0.858
NULL	Front_Oncol_2014_Apr_9_4_75.nxml.txt.nlp	24782986	SENT179	11	11	19	19	paclitaxel	CD117	PA450761	3815	0.858
NULL	Cancer_Immunol_Immunother_2013_Aug_27_62(10)_1637-1648.nxml.txt.nlp	23982484	SENT239	25	25	9	9	simvastatin	STAT3	PA451363	6774	0.858
NULL	J_Med_Case_Reports_2011_Jan_12_5_5.nxml.txt.nlp	21226894	SENT101	17	17	5	5	bleomycin	CHOP	PA448645	1649	0.858
NULL	Clin_Interv_Aging_2009_May_14_4_179-186.nxml.txt.nlp	19503779	SENT54	17	17	13	13	levodopa	COMT	PA450213	1312	0.858
NULL	Semin_Immunol_2011_Feb_23(1)_28-41.nxml.txt.nlp	21295490	SENT234	21	21	13	13	etanercept	CD86	PA449515	942	0.858
NULL	Contemp_Oncol_(Pozn)_2012_Feb_29_16(1)_86-89.nxml.txt.nlp	23788860	SENT53	8	8	5	5	oxaliplatin	DDP	PA131285527	1678	0.858
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT328	24	24	7	7	resveratrol	AMPK		5563	0.858
NULL	Croat_Med_J_2012_Jun_53(3)_224-233.nxml.txt.nlp	22661135	SENT67	2	2	10	10	sulpiride	PRL	PA164745485	5617	0.858
NULL	Oncol_Lett_2014_Nov_14_8(5)_2086-2092.nxml.txt.nlp	25295095	SENT131	14	14	5	5	gemcitabine	LKB1	PA449748	6794	0.858
NULL	Arthritis_Res_Ther_2013_Nov_1_15(6)_R176.nxml.txt.nlp	24456929	SENT385	24	24	20	20	colchicine	MSU	PA449092	593	0.858
NULL	J_Hematol_Oncol_2008_Oct_23_1_19.nxml.txt.nlp	18947412	SENT12	7	7	19	19	alemtuzumab	CD34	PA164783958	947	0.858
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1150.nxml.txt.nlp	24675468	SENT105	31	31	12	12	ethanol	PARP-1	PA448073	25976	0.858
NULL	Angiogenesis_2010_Dec_7_13(4)_305-315.nxml.txt.nlp	20927579	SENT143	4	4	24	24	resveratrol	p53		7157	0.858
NULL	FEBS_Open_Bio_2014_Oct_22_4_905-914.nxml.txt.nlp	25383314	SENT143	4	4	7	7	physostigmine	L-FABP	PA450957	2168	0.858
NULL	Biochem_Res_Int_2012_Jun_25_2012_518437.nxml.txt.nlp	22792465	SENT108	31	31	19	19	doxycycline	RGS5	PA449415	8490	0.858
NULL	Adv_Appl_Bioinforma_Chem_2008_Oct_30_1_85-98.nxml.txt.nlp	21918608	SENT80	21	21	6	6	bortezomib	SPARC	PA10252	6678	0.858
NULL	J_Cardiothorac_Surg_2014_Sep_17_9(1)_129.nxml.txt.nlp	NULL	SENT168	21	21	10	10	heparin	ACT	PA449855	12;11332;9457;641455	0.858
NULL	J_Thorac_Oncol_2014_Feb_23_9(2)_231-238.nxml.txt.nlp	24419421	SENT192	21	21	45	45	docetaxel	EGFR	PA449383	1956	0.858
NULL	Environ_Health_2013_Apr_16_12_33.nxml.txt.nlp	23590724	SENT29	12	12	25	25	genistein	B12	PA165109660	7126;4709	0.858
NULL	Arch_Drug_Inf_2008_Sep_1(2)_56-62.nxml.txt.nlp	19915709	SENT63	1	1	26	26	fentanyl	API	PA449599	5345	0.858
NULL	Crit_Care_2008_Jan_24_12(1)_R27.nxml.txt.nlp	18304335	SENT209	5	5	19	19	thrombin	Rho	PA451674	29984	0.858
NULL	Breast_Cancer_Res_2012_Jul_27_14(4)_R113.nxml.txt.nlp	22839103	SENT258	36	36	24	24	tamoxifen	p53	PA451581	7157	0.858
NULL	Int_J_Mol_Sci_2014_Jun_26_15(7)_11416-11434.nxml.txt.nlp	24972137	SENT90	0	0	22	22	sitagliptin	AMPK	PA164748978	5563	0.858
NULL	Br_J_Cancer_2013_Jul_9_109(1)_68-75.nxml.txt.nlp	23807173	SENT180	11	11	4	4	cisplatin	ERCC1	PA449014	2067	0.858
NULL	J_Exp_Med_1969_May_1_129(5)_1109-1130.nxml.txt.nlp	5778786	SENT7	32	32	0	0	trypsin	C3a	PA451806	718	0.858
NULL	Iran_J_Pharm_Res_2013_Winter_12(Suppl)_169-174.nxml.txt.nlp	24250685	SENT29	4	4	11	11	clopidogrel	ADP	PA449053	23038	0.858
NULL	J_Mol_Signal_2012_Aug_16_7_12.nxml.txt.nlp	22898329	SENT254	13	13	19	19	gefitinib	BIM	PA131301952	10018	0.858
NULL	Thorax_2012_Oct_12_67(10)_891-900.nxml.txt.nlp	22693178	SENT113	2	2	13	13	capsaicin	CAPZ	PA448776	830	0.858
NULL	Front_Neurosci_2012_May_30_6_77.nxml.txt.nlp	22661925	SENT43	14	14	8	8	ethanol	HEC	PA448073	10403	0.858
NULL	J_Cell_Biol_2001_Dec_24_155(7)_1333-1344.nxml.txt.nlp	11748248	SENT547	3	3	28	28	collagenase	c-Jun	PA449107	3725	0.858
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT95	13	13	25	25	atorvastatin	AKT	PA448500	207	0.858
NULL	Acta_Pharmacol_Sin_2013_Sep_5_34(9)_1192-1200.nxml.txt.nlp	23685957	SENT174	5	5	14	14	curcumin	AP-2	PA151958596	7020	0.858
NULL	Oncotarget_2011_Jun_15_2(6)_518-524.nxml.txt.nlp	21680956	SENT138	3	3	14	14	pimozide	p53	PA450965	7157	0.858
NULL	Biomed_Res_Int_2014_Jan_29_2014_831845.nxml.txt.nlp	24605337	SENT110	17	17	6	6	bupivacaine	S6K1	PA135057240	6198	0.858
NULL	Mol_Immunol_2009_Apr_46(7)_1561-1567.nxml.txt.nlp	19200600	SENT166	24	24	8	8	dextran	CD59	PA449261	966	0.858
NULL	Biomed_Res_Int_2013_Jul_18_2013_603782.nxml.txt.nlp	23971041	SENT138	8	8	13	13	tafluprost	BAK	PA165958432	578	0.858
NULL	J_Thyroid_Res_2011_Apr_10_2011_895923.nxml.txt.nlp	21603172	SENT29	27	27	16	16	thyroglobulin	CD4	PA164754910	920	0.858
NULL	Acta_Pharmacol_Sin_2012_Jan_28_33(1)_75-81.nxml.txt.nlp	22120969	SENT142	6	6	16	16	exenatide	GLP-1	PA164749238	100125288	0.858
NULL	Reprod_Biol_Endocrinol_2003_Oct_7_1_71.nxml.txt.nlp	14577832	SENT117	5	5	39	39	cisplatin	p38	PA449014	10598;1432;7965	0.858
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT142	20	20	10	10	simvastatin	survivin	PA451363	332	0.858
NULL	Eur_J_Clin_Pharmacol_2012_Jan_7_68(1)_55-64.nxml.txt.nlp	21735164	SENT8	14	14	8	8	oxycodone	CYP2D6	PA450741	1565	0.858
NULL	Mol_Cancer_2012_Oct_22_11_80.nxml.txt.nlp	23088607	SENT102	5	5	1	1	estradiol	PI3K	PA449503	5290	0.858
NULL	Mol_Neurodegener_2011_May_19_6_34.nxml.txt.nlp	21595948	SENT343	23	23	8	8	trypsin	parkin	PA451806	5071	0.858
NULL	Acta_Pharmacol_Sin_2010_Jun_4_31(6)_753-758.nxml.txt.nlp	20523346	SENT117	37	37	18	18	amiodarone	MDR1	PA448383	5243	0.858
NULL	Leukemia_2013_Feb_3_27(2)_315-324.nxml.txt.nlp	22751450	SENT153	4	4	15	15	sorafenib	Mcl-1	PA7000	4170	0.858
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT148	17	17	13	13	lapatinib	HER2	PA152241907	2064	0.858
NULL	EMBO_Mol_Med_2010_Jul_2(7)_247-257.nxml.txt.nlp	20597104	SENT122	26	26	32	32	lisinopril	MCP-1	PA450242	6347	0.858
NULL	Acta_Pharmacol_Sin_2012_May_26_33(5)_675-681.nxml.txt.nlp	22447226	SENT146	5	5	9	9	gefitinib	survivin	PA131301952	332	0.858
NULL	J_Oncol_2009_Mar_24_2009_491985.nxml.txt.nlp	19325924	SENT105	3	3	24	24	genistein	IL-6	PA165109660	3569	0.858
NULL	FEBS_Open_Bio_2014_Oct_30_4_966-975.nxml.txt.nlp	25426416	SENT224	0	0	11	11	tamoxifen	TRPM7	PA451581	54822	0.858
NULL	EMBO_Mol_Med_2012_Jul_11_4(7)_577-593.nxml.txt.nlp	22496117	SENT90	14	14	10	10	clofazimine	PAP-1	PA164748759	6100	0.858
NULL	Patient_Prefer_Adherence_2009_Nov_3_3_9-20.nxml.txt.nlp	19936140	SENT235	3	3	13	13	escitalopram	Gen	PA10074	348654	0.858
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2011_Jun_7_4_29-37.nxml.txt.nlp	22879792	SENT37	10	10	4	4	ketoconazole	CYP3A4	PA450146	1576	0.858
NULL	Acta_Orthop_2010_Apr_6_81(2)_263-267.nxml.txt.nlp	20148646	SENT162	7	7	13	13	taurine	CHOP	PA451590	1649	0.858
NULL	Br_J_Pharmacol_2014_Oct_26_171(20)_4785-4796.nxml.txt.nlp	25074741	SENT15	3	3	20	20	guanfacine	NK1R	PA449825	6869	0.858
NULL	J_Int_AIDS_Soc_2010_Nov_8_13(Suppl_4)_P75.nxml.txt.nlp	NULL	SENT14	5	5	11	11	stavudine	adiponectin	PA451494	9370	0.858
NULL	Arthritis_Res_Ther_2014_Aug_22_16(4)_423.nxml.txt.nlp	25606590	SENT59	12	12	2	2	infliximab	FDG	PA452639	23583	0.858
NULL	Cancers_(Basel)_2011_May_3_3(2)_2243-2254.nxml.txt.nlp	24212807	SENT74	6	6	4	4	bevacizumab	EGFR	PA130232992	1956	0.858
NULL	Gut_Liver_2013_Sep_14_7(5)_585-593.nxml.txt.nlp	24073317	SENT121	27	27	22	22	ribavirin	IFN	PA451241	3439	0.858
NULL	Oncoimmunology_2012_Dec_1_1(9)_1476-1483.nxml.txt.nlp	23264894	SENT203	21	21	2	2	irinotecan	BRAF	PA450085	673	0.858
NULL	Arthritis_Res_Ther_2009_Oct_14_11(5)_251.nxml.txt.nlp	19849819	SENT298	16	16	4	4	alendronate	PTH	PA448082	5741	0.858
NULL	Cancer_Causes_Control_2013_Aug_18_24(8)_1605-1614.nxml.txt.nlp	23775025	SENT243	31	31	23	23	cyclophosphamide	ALDH1A1	PA449165	216	0.858
NULL	Open_Virol_J_2010_Jun_23_4_157-162.nxml.txt.nlp	20835359	SENT32	25	25	0	0	l-glutamine	CD4	PA10090	920	0.858
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT57	18	18	3	3	vinblastine	ASC	PA451877	29108	0.858
NULL	Int_J_Mol_Imaging_2011_Oct_26_2011_874585.nxml.txt.nlp	21490735	SENT79	28	28	7	7	docetaxel	FDG	PA449383	23583	0.858
NULL	Allergy_Asthma_Immunol_Res_2013_Mar_20_5(2)_106-109.nxml.txt.nlp	23449963	SENT60	29	29	7	7	methacholine	IL-5	PA165958382	3567	0.858
NULL	Oncol_Rep_2013_Jun_2_29(6)_2095-2100.nxml.txt.nlp	23563900	SENT32	44	44	40	40	sorafenib	Mcl-1	PA7000	4170	0.858
NULL	Cell_Biol_Int_Rep_(2010)_2012_Jun_21_19(1)_e00017.nxml.txt.nlp	23124518	SENT133	23	23	25	25	etoposide	TRAIL-R2	PA449552	8795	0.858
NULL	Oncotarget_2014_Sep_10_5(20)_9877-9888.nxml.txt.nlp	25245676	SENT97	3	3	0	0	cetuximab	EGFR	PA10040	1956	0.858
NULL	Ann_Oncol_2014_Jul_5_25(7)_1328-1333.nxml.txt.nlp	24603643	SENT7	18	18	15	15	palonosetron	NK1	PA10352	11126	0.858
NULL	Mol_Biol_Cell_2014_Jun_1_25(11)_1782-1792.nxml.txt.nlp	24719457	SENT107	17	17	26	26	nicotine	p53	PA450626	7157	0.858
NULL	Carcinogenesis_2011_Nov_1_32(11)_1724-1733.nxml.txt.nlp	21890461	SENT412	19	19	31	31	paclitaxel	AKT	PA450761	207	0.858
NULL	Nat_Commun_2014_Dec_8_5_5736.nxml.txt.nlp	25484020	SENT140	1	1	14	14	letrozole	TRPA1	PA450196	8989	0.858
NULL	J_Cell_Biol_1983_Mar_1_96(3)_633-638.nxml.txt.nlp	6833374	SENT5	12	12	5	5	chymotrypsin	MP26	PA448994	4284	0.858
NULL	Clin_Med_Insights_Oncol_2012_Dec_6_6_407-421.nxml.txt.nlp	23239933	SENT120	37	37	13	13	gefitinib	EGFR	PA131301952	1956	0.857
NULL	Biofactors_2014_May_6_40(3)_277-283.nxml.txt.nlp	24353111	SENT78	24	24	27	27	choline	BHMT	PA448976	635	0.857
NULL	Clin_Interv_Aging_2013_Oct_2_8_1329-1337.nxml.txt.nlp	24124355	SENT68	19	19	2	2	zileuton	CysLT1	PA451955	10800	0.857
NULL	Cancer_Med_2013_Aug_2_2(4)_571-582.nxml.txt.nlp	24156030	SENT274	17	17	21	21	cisplatin	HER2	PA449014	2064	0.857
NULL	Front_Mol_Neurosci_2008_Mar_28_1_4.nxml.txt.nlp	18946537	SENT889	19	19	5	5	potassium	PSD-95	PA451047	1742	0.857
NULL	Ann_Biomed_Eng_2011_Apr_1_39(4)_1174-1185.nxml.txt.nlp	21120695	SENT174	27	27	16	16	calcein	DM1	PA132595336	338023;1760;28509	0.857
NULL	Front_Neuroanat_2014_Sep_26_8_104.nxml.txt.nlp	25309345	SENT101	10	10	0	0	thyroglobulin	NPY	PA164754910	4852	0.857
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT222	8	8	14	14	erlotinib	AKT	PA134687924	207	0.857
NULL	Br_J_Cancer_2012_Jun_5_106(12)_1997-2003.nxml.txt.nlp	22596232	SENT111	4	4	8	8	sorafenib	CD133	PA7000	8842	0.857
NULL	Mediators_Inflamm_2010_May_25_2010_367838.nxml.txt.nlp	20508825	SENT53	9	9	36	36	capsaicin	adiponectin	PA448776	9370	0.857
NULL	Br_J_Cancer_1998_Aug_78(3)_375-381.nxml.txt.nlp	9703286	SENT9	31	31	25	25	paclitaxel	TP53	PA450761	7157	0.857
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT231	3	3	21	21	cisplatin	DR5	PA449014	8795	0.857
NULL	Biosci_Rep_2012_Aug_1_32(Pt_4)_361-374.nxml.txt.nlp	22762204	SENT60	32	32	14	14	paclitaxel	p53	PA450761	7157	0.857
NULL	EMBO_Mol_Med_2012_Jun_13_4(6)_515-527.nxml.txt.nlp	22416035	SENT141	26	26	21	21	olaparib	p53		7157	0.857
NULL	Chem_Cent_J_2012_Sep_20_6_105.nxml.txt.nlp	22995678	SENT109	6	6	19	19	moxifloxacin	C10	PA450555	113246	0.857
NULL	Ann_Lab_Med_2014_Jul_19_34(4)_321-324.nxml.txt.nlp	24982839	SENT50	6	6	3	3	amikacin	DST	PA164744372	667	0.857
NULL	Carbohydr_Res_2014_Mar_31_387(100)_54-58.nxml.txt.nlp	24589444	SENT239	4	4	15	15	trypsin	CD55	PA451806	1604	0.857
NULL	Blood_Cancer_J_2013_Dec_6_3(12)_e167.nxml.txt.nlp	24317089	SENT104	8	8	5	5	lovastatin	IBP	PA450272	706;50619	0.857
NULL	BMB_Rep_2014_Apr_47(4)_221-226.nxml.txt.nlp	24286312	SENT131	24	24	28	28	nutlin-3	MDM2		4193	0.857
NULL	Atherosclerosis_2011_Nov_219(1)_109-115.nxml.txt.nlp	21820657	SENT298	0	0	9	9	probucol	CETP	PA451107	1071	0.857
NULL	Arch_Med_Sci_2013_Aug_30_9(4)_739-744.nxml.txt.nlp	24049538	SENT122	37	37	3	3	candesartan	PC-3	PA448765	692094	0.857
NULL	Pain_Res_Treat_2010_Mar_4_2010_705874.nxml.txt.nlp	22110916	SENT189	16	16	3	3	gabapentin	EPM	PA449720	2054	0.857
NULL	Clin_Med_Oncol_2008_Apr_28_2_375-383.nxml.txt.nlp	21892302	SENT122	6	6	19	19	tegafur	DPD	PA452620	1806	0.857
NULL	Curr_Oncol_2009_Jul_16(Suppl_2)_S1-S13.nxml.txt.nlp	19672416	SENT251	32	32	21	21	anastrozole	ARNO	PA448432	9266	0.857
NULL	J_Gen_Physiol_2009_Apr_133(4)_421-438.nxml.txt.nlp	19289574	SENT313	13	13	22	22	forskolin	SLC26A9	PA146096022	115019	0.857
NULL	Crit_Care_2009_Mar_13_13(Suppl_1)_P406.nxml.txt.nlp	NULL	SENT19	19	19	28	28	clonidine	UROD	PA449051	7389	0.857
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT199	13	13	38	38	metformin	p53	PA450395	7157	0.857
NULL	Diabetes_2013_May_16_62(5)_1537-1546.nxml.txt.nlp	23321073	SENT92	37	37	19	19	fluorescein	CD25	PA164746009	3669;3559	0.857
NULL	Cell_Death_Dis_2012_Nov_29_3(11)_e436.nxml.txt.nlp	23190608	SENT110	16	16	5	5	bortezomib	CD138	PA10252	6382	0.857
NULL	Case_Rep_Oncol_2013_Jan_29_6(1)_72-77.nxml.txt.nlp	23466899	SENT52	22	22	3	3	docetaxel	GTX	PA449383	84504	0.857
NULL	Exp_Neurobiol_2013_Mar_31_22(1)_1-10.nxml.txt.nlp	23585716	SENT38	38	38	19	19	rasagiline	GDNF	PA164764584	2668	0.857
NULL	J_Oncol_2013_Feb_17_2013_872957.nxml.txt.nlp	23476648	SENT37	28	28	10	10	cisplatin	SFN	PA449014	25996;2810	0.857
NULL	Indian_J_Endocrinol_Metab_2013_Sep-Oct_17(5)_910-912.nxml.txt.nlp	24083176	SENT42	13	13	19	19	propofol	PTH	PA451141	5741	0.857
NULL	Mol_Biol_Cell_2014_Jan_1_25(1)_76-86.nxml.txt.nlp	24173717	SENT43	15	15	12	12	paclitaxel	TUBB6	PA450761	84617	0.857
NULL	Int_J_Mol_Sci_2012_Apr_24_13(4)_5254-5277.nxml.txt.nlp	22606042	SENT174	17	17	10	10	bevacizumab	VEGFR2	PA130232992	3791	0.857
NULL	Core_Evid_2010_Oct_21_5_61-76.nxml.txt.nlp	21042543	SENT267	30	30	26	26	panitumumab	EGFR	PA162373091	1956	0.857
NULL	Case_Rep_Oncol_2010_May_7_3(2)_154-159.nxml.txt.nlp	20740189	SENT11	23	23	13	13	panitumumab	KRAS	PA162373091	3845	0.857
NULL	J_Geriatr_Cardiol_2012_Jun_9(2)_180-184.nxml.txt.nlp	22916066	SENT110	29	29	14	14	rosuvastatin	Rho	PA134308647	29984	0.857
NULL	J_Vet_Emerg_Crit_Care_(San_Antonio)_2013_Mar_8_23(2)_134-162.nxml.txt.nlp	23566108	SENT62	29	29	17	17	calcidiol	CYP2R1	PA164745614	120227	0.857
NULL	Cancers_(Basel)_2011_May_18_3(2)_2444-2461.nxml.txt.nlp	24212818	SENT105	15	15	3	3	erlotinib	EGFR	PA134687924	1956	0.857
NULL	F1000_Biol_Rep_2011_Nov_1_3_23.nxml.txt.nlp	22065982	SENT140	8	8	20	20	benzbromarone	GLUT9	PA134852920	11182	0.857
NULL	BMJ_2011_Jul_26_343_d4366.nxml.txt.nlp	21791491	SENT159	0	0	17	17	potassium	ACE	PA451047	1636	0.857
NULL	J_Inherit_Metab_Dis_2012_Jan_10_35(1)_141-149.nxml.txt.nlp	21556832	SENT133	28	28	11	11	l-arginine	CRTR	PA448478	6535	0.857
NULL	Case_Rep_Dermatol_2010_Dec_29_2(3)_207-213.nxml.txt.nlp	21537372	SENT29	16	16	21	21	bleomycin	CO2	PA448645	4513	0.857
NULL	Nat_Med_2010_Nov_24_16(11)_1299-1304.nxml.txt.nlp	20972434	SENT187	25	25	5	5	isoproterenol	ASM	PA450121	6609;283120	0.857
NULL	Lipids_Health_Dis_2011_Dec_30_10_246.nxml.txt.nlp	22208561	SENT78	35	35	7	7	ethanol	adiponectin	PA448073	9370	0.857
NULL	Breast_Cancer_(Auckl)_2009_Sep_2_3_61-75.nxml.txt.nlp	19809577	SENT268	20	20	38	38	curcumin	PARP	PA151958596	142	0.857
NULL	Ann_Clin_Microbiol_Antimicrob_2007_Nov_12_6_15.nxml.txt.nlp	17997852	SENT114	17	17	5	5	griseofulvin	ANOVA	PA449814	4858	0.857
NULL	Cell_Death_Dis_2014_Feb_13_5(2)_e1055.nxml.txt.nlp	24525731	SENT53	12	12	41	41	cisplatin	FANCD2	PA449014	2177	0.857
NULL	Nat_Commun_2014_Nov_25_5_5548.nxml.txt.nlp	25420520	SENT62	12	12	39	39	cabazitaxel	DTE	PA165958401	199699	0.857
NULL	Brain_Sci_2013_Jun_3_3(2)_877-907.nxml.txt.nlp	24961429	SENT288	0	0	19	19	taurine	CHOP	PA451590	1649	0.857
NULL	Arthritis_Res_Ther_2009_Aug_17_11(4)_R123.nxml.txt.nlp	19686595	SENT250	42	42	17	17	rituximab	CD27	PA451261	939	0.857
NULL	Nat_Commun_2014_Dec_17_5_5777.nxml.txt.nlp	25517116	SENT765	19	19	13	13	metoprolol	Bcl-2	PA450480	596	0.857
NULL	J_Oncol_2009_Jul_27_2009_305420.nxml.txt.nlp	19644558	SENT92	27	27	24	24	tamoxifen	HER2	PA451581	2064	0.857
NULL	J_Obes_2010_Jan_14_2010_970865.nxml.txt.nlp	20798864	SENT157	2	2	5	5	metformin	AMPK	PA450395	5563	0.857
NULL	Nucleic_Acids_Res_2005_Jun_8_33(10)_3283-3291.nxml.txt.nlp	15944449	SENT14	4	4	21	21	sjg-136	XRCC3		7517	0.857
NULL	Mol_Neurodegener_2011_Aug_8_6_57.nxml.txt.nlp	21819629	SENT226	24	24	41	41	arsenite	JNK	PA452638	5599	0.857
NULL	Breast_Cancer_Res_2009_Sep_9_11(5)_R67.nxml.txt.nlp	19740422	SENT73	33	33	20	20	tamoxifen	LBA	PA451581	987	0.857
NULL	Nat_Commun_2014_Dec_18_5_5815.nxml.txt.nlp	25519973	SENT81	29	29	25	25	tranylcypromine	ATN1	PA451741	1822	0.857
NULL	Cell_Biosci_2011_Nov_7_1_36.nxml.txt.nlp	22060137	SENT52	17	17	5	5	doxorubicin	AEG-1	PA449412	92140	0.857
NULL	Breast_Cancer_Res_2011_Dec_16_13(6)_R131.nxml.txt.nlp	22177475	SENT275	33	33	23	23	erlotinib	AKT	PA134687924	207	0.857
NULL	J_Korean_Med_Sci_2011_Aug_27_26(8)_1007-1013.nxml.txt.nlp	21860550	SENT139	21	21	6	6	tamoxifen	CYP2D6	PA451581	1565	0.857
NULL	Biomed_Res_Int_2014_Jun_26_2014_161346.nxml.txt.nlp	25054130	SENT216	7	7	21	21	curcumin	STZ	PA151958596	6484	0.857
NULL	J_Gastroenterol_2013_Jan_27_48(1)_22-30.nxml.txt.nlp	23104468	SENT126	25	25	15	15	ribavirin	RVR	PA451241	9975	0.857
NULL	J_Int_AIDS_Soc_2011_Oct_11_14_48.nxml.txt.nlp	21988905	SENT159	16	16	10	10	fluconazole	ART	PA449653	181	0.857
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jul_15_65(Pt_8)_o1857.nxml.txt.nlp	21583555	SENT49	15	15	21	21	benzaldehyde	mol	PA448571	90527	0.857
NULL	Mol_Cancer_2014_Jul_5_13_165.nxml.txt.nlp	24996221	SENT124	23	23	2	2	docetaxel	HMGB1	PA449383	3146	0.857
NULL	Mol_Cancer_2004_Jul_8_3_18.nxml.txt.nlp	15242522	SENT173	20	20	9	9	bleomycin	p53	PA448645	7157	0.857
NULL	Mol_Pain_2012_Sep_22_8_71.nxml.txt.nlp	22998838	SENT217	36	36	29	29	cisplatin	CXCR4	PA449014	7852	0.857
NULL	Respir_Med_Case_Rep_2013_Oct_26_10_53-55.nxml.txt.nlp	NULL	SENT71	7	7	9	9	abatacept	IL-17	PA164747080	3605	0.857
NULL	Mol_Biol_Cell_2013_Sep_1_24(17)_2678-2688.nxml.txt.nlp	23864716	SENT247	14	14	33	33	thrombin	PAK1	PA451674	5585;5058	0.857
NULL	J_Inherit_Metab_Dis_2010_Oct_3_33(5)_625-632.nxml.txt.nlp	20814828	SENT110	2	2	10	10	simvastatin	RhoA	PA451363	387	0.857
NULL	Daru_2012_Oct_4_20(1)_45.nxml.txt.nlp	23351300	SENT36	11	11	39	39	theophylline	API	PA451647	5345	0.857
NULL	Iran_J_Pharm_Res_2014_Spring_13(2)_683-693.nxml.txt.nlp	25237365	SENT14	26	26	21	21	tamoxifen	CXCL12	PA451581	6387	0.857
NULL	Appl_Microbiol_Biotechnol_2013_Aug_28_97(22)_9647-9655.nxml.txt.nlp	23982327	SENT68	3	3	22	22	lipase	mol	PA450239	90527	0.857
NULL	J_Cancer_Prev_2013_Sep_18(3)_227-234.nxml.txt.nlp	25337550	SENT95	9	9	26	26	decitabine	MLH1	PA164749631	4292	0.857
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT149	8	8	4	4	dasatinib	PP2	PA162372878	4888	0.857
NULL	Angew_Chem_Int_Ed_Engl_2013_Jan_2_52(1)_325-330.nxml.txt.nlp	23080482	SENT30	1	1	12	12	thrombin	PAR1	PA451674	79581;2149	0.857
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT68	30	30	7	7	methotrexate	MSH2	PA450428	4436	0.857
NULL	Cancer_Immunol_Immunother_2011_Jun_24_60(6)_771-780.nxml.txt.nlp	21347809	SENT217	33	33	27	27	rituximab	CD22	PA451261	933	0.857
NULL	Br_J_Cancer_2013_Mar_19_108(5)_1052-1060.nxml.txt.nlp	23422754	SENT151	34	34	40	40	bevacizumab	VEGF-A	PA130232992	7422	0.857
NULL	Case_Rep_Oncol_2014_Jul_16_7(2)_478-483.nxml.txt.nlp	25202262	SENT20	15	15	23	23	afatinib	EGFR	PA165981154	1956	0.857
NULL	Angiogenesis_2013_Apr_10_16(2)_373-386.nxml.txt.nlp	23143659	SENT258	26	26	5	5	vinblastine	LDM	PA451877	1595	0.857
NULL	J_Immune_Based_Ther_Vaccines_2005_Sep_2_3_6.nxml.txt.nlp	16138929	SENT222	0	0	18	18	daclizumab	IL-2	PA164764446	3558	0.857
NULL	Mol_Cancer_2007_Aug_21_6_53.nxml.txt.nlp	17711579	SENT154	34	34	19	19	cisplatin	ING2	PA449014	3622	0.857
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT130	43	43	22	22	doxorubicin	B7-H1	PA449412	29126	0.857
NULL	Breast_Cancer_Res_2009_Oct_12_11(5)_R74.nxml.txt.nlp	19821999	SENT248	29	29	9	9	bortezomib	p53	PA10252	7157	0.857
NULL	J_Bras_Pneumol_2013_May-Jun_39(3)_339-348.nxml.txt.nlp	23857697	SENT151	27	27	8	8	ciprofloxacin	HAP	PA449009	5915;10313	0.857
NULL	Neuropsychopharmacology_2009_Oct_24_34(11)_2420-2429.nxml.txt.nlp	19553918	SENT227	25	25	13	13	ethanol	EPM	PA448073	2054	0.857
NULL	Oncol_Lett_2014_Mar_14_7(3)_663-668.nxml.txt.nlp	24527070	SENT103	7	7	4	4	trastuzumab	aromatase	PA451743	1588	0.857
NULL	Autophagy_2013_May_1_9(5)_789-790.nxml.txt.nlp	23388383	SENT25	20	20	13	13	docetaxel	VEGFC	PA449383	7424	0.857
NULL	Eur_J_Epidemiol_2009_Sep_2_24(9)_553-572.nxml.txt.nlp	19728115	SENT1547	19	19	14	14	acenocoumarol	CYP2C9	PA452632	1559	0.857
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R91.nxml.txt.nlp	22541814	SENT210	29	29	7	7	thrombin	PP2	PA451674	4888	0.857
NULL	Br_J_Cancer_2006_Feb_13_94(3)_407-426.nxml.txt.nlp	16434996	SENT264	20	20	9	9	genistein	BRCA2	PA165109660	675	0.857
NULL	Aging_(Albany_NY)_2012_Apr_30_4(5)_320-329.nxml.txt.nlp	22589237	SENT33	25	25	16	16	metformin	NEGR1	PA450395	257194	0.857
NULL	Breast_Cancer_Res_2005_Nov_11_7(6)_255-257.nxml.txt.nlp	16457700	SENT10	33	33	30	30	letrozole	aromatase	PA450196	1588	0.857
NULL	Front_Behav_Neurosci_2011_Sep_8_5_56.nxml.txt.nlp	21927600	SENT1857	8	8	2	2	cocaine	DARPP-32	PA449072	84152	0.857
NULL	J_Headache_Pain_2014_Sep_18_15(Suppl_1)_F28.nxml.txt.nlp	NULL	SENT14	10	10	24	24	telmisartan	MDR1	PA451605	5243	0.857
NULL	J_Oncol_2011_Nov_8_2011_762780.nxml.txt.nlp	21076545	SENT145	12	12	4	4	cisplatin	CD44	PA449014	960	0.857
NULL	Cell_Biochem_Biophys_2013_May_24_66(1)_53-63.nxml.txt.nlp	22918821	SENT35	27	27	37	37	lubiprostone	ClC-2	PA164777012	1181	0.857
NULL	Acta_Pharmacol_Sin_2012_Oct_3_33(10)_1311-1318.nxml.txt.nlp	22941289	SENT3	20	20	10	10	sorafenib	VEGFR2	PA7000	3791	0.857
NULL	Mol_Pain_2012_Sep_22_8_71.nxml.txt.nlp	22998838	SENT218	9	9	34	34	paclitaxel	CB2	PA450761	1269	0.857
NULL	Br_J_Cancer_2012_Aug_21_107(5)_793-799.nxml.txt.nlp	22850551	SENT107	21	21	38	38	trastuzumab	p27	PA451743	5715;10534	0.857
NULL	Br_J_Pharmacol_2010_Mar_8_159(5)_1092-1105.nxml.txt.nlp	20148890	SENT55	0	0	2	2	montelukast	CysLT1	PA450546	10800	0.857
NULL	Support_Care_Cancer_2009_Sep_10_17(9)_1177-1185.nxml.txt.nlp	19205755	SENT31	0	0	22	22	ondansetron	CYP3A	PA450705	1574	0.857
NULL	Oncoimmunology_2013_Oct_1_2(10)_e27025.nxml.txt.nlp	24353914	SENT181	8	8	15	15	docetaxel	CD25	PA449383	3669;3559	0.857
NULL	Clin_Exp_Otorhinolaryngol_2011_Dec_15_4(4)_177-183.nxml.txt.nlp	22232712	SENT15	0	0	3	3	doxycycline	MUC5B	PA449415	727897	0.857
NULL	Core_Evid_2011_Sep_8_6_67-79.nxml.txt.nlp	22022289	SENT182	16	16	8	8	exenatide	GLP-1	PA164749238	100125288	0.857
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT267	20	20	11	11	warfarin	EPHX1	PA451906	2052	0.857
NULL	Mol_Cancer_2008_Oct_23_7_82.nxml.txt.nlp	18947424	SENT279	25	25	18	18	doxazosin	EGF	PA449407	1950	0.857
NULL	Oncotarget_2011_Dec_24_2(12)_896-917.nxml.txt.nlp	22203527	SENT160	8	8	36	36	metformin	LKB1	PA450395	6794	0.857
NULL	Hum_Genomics_2009_Jan_1_3(2)_128-142.nxml.txt.nlp	19164090	SENT238	7	7	17	17	carboplatin	CD44	PA448803	960	0.857
NULL	Nat_Methods_2012_Jul_1_9(8)_805-807.nxml.txt.nlp	22751204	SENT157	1	1	14	14	fluorescein	DHFR	PA164746009	1719	0.857
NULL	Dev_Genes_Evol_2008_Aug_1_218(8)_439-444.nxml.txt.nlp	18592265	SENT62	15	15	22	22	phenol	BCS	PA450913	617	0.857
NULL	Cancer_Cell_Int_2011_Aug_19_11_29.nxml.txt.nlp	21854619	SENT224	19	19	33	33	cisplatin	BRCA1	PA449014	672	0.857
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT166	27	27	32	32	cisplatin	p53	PA449014	7157	0.857
NULL	J_Med_Case_Reports_2011_Aug_25_5_413.nxml.txt.nlp	21867542	SENT126	22	22	10	10	choline	B12	PA448976	7126;4709	0.857
NULL	Acta_Pharmacol_Sin_2009_May_6_30(5)_605-616.nxml.txt.nlp	19349962	SENT43	2	2	11	11	vincristine	HIF-1	PA451879	29072	0.857
NULL	Cell_Death_Dis_2011_Aug_11_2(8)_e191.nxml.txt.nlp	21833029	SENT71	16	16	3	3	oxaliplatin	CT26	PA131285527	168400	0.857
NULL	Breast_Cancer_Res_Treat_2013_Jan_10_137(1)_1-12.nxml.txt.nlp	23143215	SENT136	0	0	9	9	neratinib	HER2	PA165291472	2064	0.857
NULL	Br_J_Cancer_2009_Sep_15_101(6)_957-966.nxml.txt.nlp	19738618	SENT244	11	11	4	4	dexrazoxane	THBS-1	PA449259	7057	0.857
NULL	Oncogene_2009_Apr_2_28(13)_1616-1625.nxml.txt.nlp	19219073	SENT101	17	17	8	8	nutlin-3	p53		7157	0.857
NULL	EMBO_Mol_Med_2013_Mar_18_5(3)_344-352.nxml.txt.nlp	23417962	SENT127	12	12	10	10	resveratrol	SIRT1		23411	0.857
NULL	Evid_Based_Complement_Alternat_Med_2011_Feb_14_2011_429843.nxml.txt.nlp	21869897	SENT105	31	31	14	14	ethanol	PC6	PA448073	5125	0.857
NULL	Mol_Med_Rep_2015_Feb_5_11(2)_805-814.nxml.txt.nlp	25373883	SENT134	0	0	15	15	colchicine	APE	PA449092	55704;328	0.857
NULL	J_Korean_Med_Sci_2013_Jul_3_28(7)_1111-1113.nxml.txt.nlp	23853500	SENT70	25	25	11	11	naloxone	DM1	PA450586	338023;1760;28509	0.857
NULL	Breast_Cancer_Res_2010_Jun_24_12(3)_R41.nxml.txt.nlp	20576088	SENT303	7	7	2	2	paclitaxel	PPM1D	PA450761	8493	0.857
NULL	Comput_Struct_Biotechnol_J_2012_Oct_30_3_e201210004.nxml.txt.nlp	24688664	SENT233	8	8	23	23	l-valine	AHAS	PA451843	10994	0.857
NULL	Clin_Sarcoma_Res_2013_Nov_26_3_13.nxml.txt.nlp	24279994	SENT106	1	1	24	24	imatinib	VEGFR	PA10804	3791	0.857
NULL	J_Oncol_2009_Mar_24_2009_491985.nxml.txt.nlp	19325924	SENT166	13	13	3	3	genistein	CXCR4	PA165109660	7852	0.857
NULL	J_Cell_Biol_2001_Aug_6_154(3)_599-610.nxml.txt.nlp	11481345	SENT172	29	29	40	40	doxycycline	ARNO	PA449415	9266	0.857
NULL	Libyan_J_Med_2008_Jun_1_3(2)_84-90.nxml.txt.nlp	21499464	SENT154	17	17	40	40	simvastatin	ACTH	PA451363	5443	0.857
NULL	F1000Prime_Rep_2014_Dec_1_6_117.nxml.txt.nlp	25580271	SENT21	19	19	3	3	afatinib	EGFR	PA165981154	1956	0.857
NULL	Cancers_(Basel)_2012_Apr_5_4(2)_354-378.nxml.txt.nlp	24213315	SENT163	4	4	17	17	sorafenib	STAT3	PA7000	6774	0.857
NULL	Mol_Syst_Biol_2009_Jul_28_5_289.nxml.txt.nlp	19638970	SENT37	5	5	15	15	resveratrol	HuR		1994	0.857
NULL	Emerg_Infect_Dis_2014_May_20(5)_812-821.nxml.txt.nlp	24751166	SENT70	24	24	0	0	linezolid	DST	PA450233	667	0.857
NULL	EMBO_Mol_Med_2012_Oct_2_4(10)_1043-1056.nxml.txt.nlp	23027611	SENT125	15	15	0	0	phencyclidine	5-HT6	PA128406980	3362	0.857
NULL	Oncotarget_2012_Dec_31_3(12)_1653-1668.nxml.txt.nlp	23391506	SENT55	9	9	0	0	temozolomide	U87	PA451609	677775;641648	0.857
NULL	Mol_Cancer_2009_Dec_3_8_115.nxml.txt.nlp	19958544	SENT141	26	26	15	15	nutlin-3	MDM2		4193	0.857
NULL	Front_Neurosci_2011_Jul_26_5_92.nxml.txt.nlp	21845173	SENT101	5	5	11	11	naloxone	NRM	PA450586	11270	0.857
NULL	J_Cereb_Blood_Flow_Metab_2012_Dec_5_32(12)_2171-2180.nxml.txt.nlp	22948298	SENT59	7	7	13	13	paraformaldehyde	NOTCH3	PA450790	4854	0.857
NULL	Eur_J_Clin_Pharmacol_2012_Sep_15_68(9)_1267-1274.nxml.txt.nlp	22418828	SENT181	29	29	3	3	rabeprazole	CYP2C19	PA451216	1557	0.857
NULL	Arthritis_Res_Ther_2011_Sep_21_13(5)_239.nxml.txt.nlp	21955617	SENT246	1	1	7	7	celecoxib	RANKL	PA448871	8600	0.857
NULL	Clin_Psychopharmacol_Neurosci_2011_Aug_31_9(2)_45-53.nxml.txt.nlp	23429653	SENT37	13	13	4	4	clozapine	TMAP	PA449061	26586	0.857
NULL	Sci_Rep_2014_Dec_10_4_7395.nxml.txt.nlp	25491663	SENT214	11	11	28	28	phenol	IFN	PA450913	3439	0.857
NULL	J_Appl_Physiol_(1985)_2013_Nov_15_115(10)_1562-1571.nxml.txt.nlp	23970537	SENT80	10	10	29	29	ethanol	CO2	PA448073	4513	0.857
NULL	Cardiovasc_Diabetol_2013_May_4_12_73.nxml.txt.nlp	23642288	SENT26	13	13	22	22	acarbose	GLP-1	PA448010	100125288	0.857
NULL	Mol_Syst_Biol_2009_Jul_28_5_288.nxml.txt.nlp	19638969	SENT171	4	4	19	19	resveratrol	HuR		1994	0.857
NULL	Scientifica_(Cairo)_2012_Nov_25_2012_473829.nxml.txt.nlp	24278698	SENT225	35	35	22	22	carboplatin	ATP7A	PA448803	538	0.857
NULL	Mol_Neurodegener_2011_Feb_10_6_15.nxml.txt.nlp	21310068	SENT95	5	5	12	12	fenofibrate	PS1	PA449594	5663	0.857
NULL	Cancer_Manag_Res_2012_Nov_9_4_383-395.nxml.txt.nlp	23204869	SENT209	17	17	3	3	carmustine	PC-3	PA448810	692094	0.857
NULL	Gene_Regul_Syst_Bio_2014_Mar_4_8_63-73.nxml.txt.nlp	24634581	SENT88	25	25	22	22	minocycline	MT1-MMP	PA450519	4323	0.857
NULL	Toxins_(Basel)_2010_Jun_9_2(6)_1381-1398.nxml.txt.nlp	22069643	SENT231	1	1	13	13	probenecid	OAT1	PA451106	9356	0.857
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT520	33	33	43	43	quetiapine	PRL	PA451201	5617	0.857
NULL	Int_J_Biol_Sci_2013_Apr_22_9(4)_350-360.nxml.txt.nlp	23630447	SENT173	23	23	9	9	doxorubicin	HSF1	PA449412	3297	0.857
NULL	Biologics_2010_Feb_4_4_19-31.nxml.txt.nlp	20161982	SENT143	0	0	34	34	sunitinib	FLT3	PA162372840	2322	0.857
NULL	Cancer_Cell_Int_2005_Jul_24_5_22.nxml.txt.nlp	16042792	SENT134	11	11	5	5	vincristine	NAC	PA451879	22861	0.857
NULL	Exp_Ther_Med_2012_Sep_12_4(3)_475-480.nxml.txt.nlp	23181121	SENT156	4	4	16	16	doxorubicin	CHOP	PA449412	1649	0.857
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT130	43	43	10	10	doxorubicin	B7-H1	PA449412	29126	0.857
NULL	Clin_Interv_Aging_2008_Sep_3(3)_421-430.nxml.txt.nlp	18982913	SENT232	17	17	8	8	buprenorphine	CYP3A4	PA448685	1576	0.857
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT541	4	4	31	31	amisulpride	PRL	PA162565877	5617	0.857
NULL	J_Carcinog_Mutagen_2013_May_27_Suppl_14_S14-004.nxml.txt.nlp	25328816	SENT139	3	3	27	27	cisplatin	XIAP	PA449014	331	0.857
NULL	Osteoporos_Int_2013_Jan_10_24(1)_227-235.nxml.txt.nlp	22776860	SENT145	13	13	5	5	denosumab	RANK	PA166048634	8792	0.857
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT172	0	0	16	16	heparin	FGF1	PA449855	2246	0.857
NULL	Int_J_Mol_Sci_2014_Mar_18_15(3)_4747-4779.nxml.txt.nlp	24646914	SENT357	7	7	5	5	maraviroc	CCR5	PA164768835	1234	0.857
NULL	J_Breast_Cancer_2012_Jun_28_15(2)_203-210.nxml.txt.nlp	22807938	SENT131	8	8	13	13	trastuzumab	NACT	PA451743	284111	0.857
NULL	Clin_Dev_Immunol_2013_Sep_17_2013_791262.nxml.txt.nlp	24151519	SENT120	26	26	38	38	heparin	CCR2	PA449855	729230	0.857
NULL	Biol_Open_2014_Nov_21_3(12)_1207-1216.nxml.txt.nlp	25416063	SENT234	16	16	6	6	fluorescein	NANOS3	PA164746009	342977	0.857
NULL	Int_J_Chron_Obstruct_Pulmon_Dis_2007_Jun_2(2)_141-150.nxml.txt.nlp	18044686	SENT197	17	17	36	36	ipratropium	Mal	PA450082	114609	0.857
NULL	Case_Rep_Dermatol_2014_Sep_25_6(3)_227-231.nxml.txt.nlp	25408651	SENT47	25	25	18	18	rituximab	EGFR	PA451261	1956	0.857
NULL	Br_J_Cancer_2013_Oct_15_109(8)_2131-2141.nxml.txt.nlp	24052043	SENT50	13	13	4	4	l-glutamine	F12	PA10090	2161	0.857
NULL	Oncoimmunology_2014_Jan_3_3_e27499.nxml.txt.nlp	24800164	SENT34	12	12	4	4	doxorubicin	TLR4	PA449412	7099	0.857
NULL	J_Exp_Clin_Cancer_Res_2009_Feb_15_28(1)_19.nxml.txt.nlp	19216799	SENT142	24	24	6	6	doxorubicin	AEG-1	PA449412	92140	0.857
NULL	J_Aquat_Anim_Health_2012_Sep_16_24(3)_185-194.nxml.txt.nlp	22897202	SENT116	12	12	22	22	lipase	HSL	PA450239	3991	0.857
NULL	Arch_Drug_Inf_2011_Mar_4(1)_1-9.nxml.txt.nlp	21572514	SENT30	2	2	13	13	ciprofloxacin	P-gp	PA449009	5243	0.857
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Dec_10_68(Pt_1)_o60.nxml.txt.nlp	22259561	SENT61	19	19	4	4	ethanol	mol	PA448073	90527	0.857
NULL	Oncol_Lett_2013_Mar_14_5(3)_756-760.nxml.txt.nlp	23426872	SENT8	6	6	0	0	cisplatin	AKT	PA449014	207	0.857
NULL	Aging_(Albany_NY)_2012_Mar_12_4(3)_146-158.nxml.txt.nlp	22436213	SENT61	33	33	23	23	resveratrol	AMPK		5563	0.857
NULL	Br_J_Cancer_2013_Jul_23_109(2)_502-511.nxml.txt.nlp	23799850	SENT220	13	13	30	30	gemcitabine	PSN1	PA449748	51251	0.857
NULL	Exp_Diabetes_Res_2012_Dec_26_2012_230624.nxml.txt.nlp	23365557	SENT185	1	1	40	40	liraglutide	LIR1	PA165958364	10859	0.857
NULL	Biomed_Microdevices_2014_Jun_7_16(5)_727-736.nxml.txt.nlp	24907052	SENT149	22	22	17	17	rifampin	CYP3A4	PA451250	1576	0.857
NULL	Arthritis_Res_Ther_2010_Apr_9_12(2)_R65.nxml.txt.nlp	20380722	SENT207	1	1	5	5	imatinib	PI3K	PA10804	5290	0.857
NULL	Int_J_Inflam_2011_Sep_29_2011_170352.nxml.txt.nlp	21977329	SENT45	19	19	0	0	imiquimod	TLR7	PA449972	51284	0.857
NULL	J_Hematol_Oncol_2008_Oct_23_1_19.nxml.txt.nlp	18947412	SENT59	2	2	8	8	alemtuzumab	CD34	PA164783958	947	0.857
NULL	Oncotarget_2013_Nov_19_5(2)_309-325.nxml.txt.nlp	24525395	SENT102	2	2	16	16	sorafenib	Mcl-1	PA7000	4170	0.857
NULL	Biochem_Res_Int_2012_Feb_9_2012_592806.nxml.txt.nlp	22400117	SENT32	3	3	17	17	nadh	Q10	PA164755085	27161	0.857
NULL	Environ_Health_Perspect_2007_Dec_8_115(Suppl_1)_77-83.nxml.txt.nlp	18174954	SENT82	3	3	33	33	genistein	TPO	PA165109660	7066;7173	0.857
NULL	Acta_Pharmacol_Sin_2009_Jan_8_30(1)_1-24.nxml.txt.nlp	19060915	SENT110	0	0	25	25	milrinone	NCX	PA164749171	3196	0.857
NULL	J_Mol_Signal_2010_May_10_5_4.nxml.txt.nlp	20459745	SENT110	9	9	3	3	cisplatin	p53	PA449014	7157	0.857
NULL	Crit_Care_2005_Aug_25_9(Suppl_4)_S38-S45.nxml.txt.nlp	16168074	SENT135	26	26	30	30	thrombin	PAR-1	PA451674	2011;2149	0.857
NULL	Clin_Exp_Gastroenterol_2012_May_14_5_49-59.nxml.txt.nlp	22649281	SENT89	3	3	20	20	esomeprazole	CYP2C19	PA10075	1557	0.857
NULL	Clin_Ophthalmol_2008_Jun_2(2)_355-368.nxml.txt.nlp	19668727	SENT81	22	22	34	34	ketorolac	COX2	PA450150	4513;5743	0.857
NULL	J_Carcinog_2013_Mar_16_12_6.nxml.txt.nlp	23599688	SENT94	29	29	13	13	cisplatin	CD133	PA449014	8842	0.857
NULL	Infect_Dis_Rep_2010_Feb_2_2(1)_e1.nxml.txt.nlp	24470884	SENT16	0	0	9	9	tigecycline	HAP	PA164746412	5915;10313	0.857
NULL	Cancer_Immunol_Immunother_2012_Jul_23_61(7)_1101-1111.nxml.txt.nlp	22193989	SENT229	22	22	15	15	oxaliplatin	CD86	PA131285527	942	0.857
NULL	Protein_Cell_2014_Jun_7_5(6)_457-468.nxml.txt.nlp	24801752	SENT150	12	12	17	17	geldanamycin	PI4KII	PA152031327	55361	0.857
NULL	Br_J_Cancer_2011_Jan_4_104(1)_91-100.nxml.txt.nlp	21139584	SENT200	5	5	11	11	bortezomib	c-Raf	PA10252	5894	0.857
NULL	Free_Radic_Res_2012_Aug_14_46(8)_1011-1018.nxml.txt.nlp	22329629	SENT64	41	41	3	3	paraformaldehyde	parkin	PA450790	5071	0.857
NULL	Clin_Dev_Immunol_2013_Sep_22_2013_317682.nxml.txt.nlp	24171032	SENT23	12	12	8	8	hyaluronan	IFN	PA165958431	3439	0.857
NULL	Br_J_Cancer_2014_Apr_15_110(8)_2144-2158.nxml.txt.nlp	24667650	SENT284	20	20	9	9	tamoxifen	BCAS2	PA451581	10286	0.857
NULL	Br_J_Cancer_1994_Sep_70(3)_449-452.nxml.txt.nlp	8080729	SENT7	5	5	7	7	cisplatin	DDP	PA449014	1678	0.857
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT254	3	3	17	17	ranibizumab	PlGF-2	PA164746012	5228	0.857
NULL	J_Infect_Dis_2011_Feb_15_203(4)_464-472.nxml.txt.nlp	21216867	SENT6	8	8	4	4	sulfadoxine	CTX	PA451540	1593	0.857
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT61	10	10	18	18	neratinib	HER2	PA165291472	2064	0.857
NULL	Mol_Cancer_2007_Nov_17_6_73.nxml.txt.nlp	18021420	SENT55	25	25	31	31	bortezomib	Mcl-1	PA10252	4170	0.857
NULL	Hum_Reprod_Update_2011_Jul_16_Jan-Feb_17(1)_17-33.nxml.txt.nlp	20639519	SENT47	29	29	23	23	estradiol	aromatase	PA449503	1588	0.857
NULL	Nat_Commun_2014_Dec_8_5_5736.nxml.txt.nlp	25484020	SENT652	0	0	18	18	exemestane	TRPA1	PA449563	8989	0.857
NULL	Ann_Indian_Acad_Neurol_2009_Apr-Jun_12(2)_89-98.nxml.txt.nlp	20142853	SENT202	19	19	28	28	tiagabine	MRP5	PA451682	10057	0.857
NULL	Mol_Imaging_Radionucl_Ther_2011_Apr_1_20(1)_1-6.nxml.txt.nlp	23486728	SENT53	29	29	2	2	l-carnitine	DBL	PA450154	4168	0.857
NULL	Allergy_2014_Feb_14_69(2)_137-149.nxml.txt.nlp	24117861	SENT193	25	25	18	18	trastuzumab	HER-2	PA451743	2064	0.857
NULL	Clin_Med_Insights_Oncol_2013_Aug_21_7_235-245.nxml.txt.nlp	24179414	SENT52	29	29	32	32	itraconazole	CYP3A4	PA450132	1576	0.857
NULL	J_Anaesthesiol_Clin_Pharmacol_2012_Jan-Mar_28(1)_92-100.nxml.txt.nlp	22345954	SENT120	3	3	17	17	desflurane	CO2	PA164749136	4513	0.857
NULL	Pharmaceutics_2011_Aug_31_3(3)_582-600.nxml.txt.nlp	24310598	SENT564	8	8	31	31	theophylline	TC4	PA451647	5901	0.857
NULL	Mol_Vis_2012_Oct_5_18_2454-2467.nxml.txt.nlp	23077404	SENT240	27	27	12	12	bevacizumab	HIF-1	PA130232992	29072	0.857
NULL	Core_Evid_2011_Feb_8_6_23-29.nxml.txt.nlp	21468240	SENT84	32	32	35	35	plerixafor	CD34	PA165958410	947	0.857
NULL	J_Cancer_Prev_2013_Jun_18(2)_123-134.nxml.txt.nlp	25337538	SENT144	29	29	3	3	ns-398	EP1		5731	0.857
NULL	Front_Chem_2014_Dec_23_2_113.nxml.txt.nlp	25566531	SENT158	3	3	13	13	curcumin	GSTT1	PA151958596	2952	0.857
NULL	Mol_Cancer_2012_Jul_25_11_47.nxml.txt.nlp	22830443	SENT149	2	2	8	8	panitumumab	EGFR	PA162373091	1956	0.857
NULL	Acta_Pharmacol_Sin_2010_Mar_8_31(3)_382-386.nxml.txt.nlp	20140004	SENT3	30	30	3	3	pitavastatin	SLCO1B1	PA142650384	10599	0.857
NULL	Oncogene_2014_Sep_4_33(36)_4521-4530.nxml.txt.nlp	24662833	SENT57	33	33	17	17	bicalutamide	ARSI	PA164746255	340075	0.857
NULL	Reprod_Biol_Endocrinol_2013_Mar_5_11_19.nxml.txt.nlp	23510640	SENT113	24	24	13	13	tamoxifen	aromatase	PA451581	1588	0.857
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT203	26	26	11	11	perifosine	TRAIL	PA165291471	8743	0.857
NULL	Neural_Regen_Res_2014_Nov_1_9(21)_1897-1901.nxml.txt.nlp	25558239	SENT75	0	0	17	17	diazepam	CA1	PA449283	759	0.857
NULL	Cancer_Cell_Int_2011_Nov_17_11_40.nxml.txt.nlp	22088142	SENT154	3	3	8	8	gemcitabine	MRP1	PA449748	4437	0.857
NULL	Mol_Cancer_2014_Jun_5_13_143.nxml.txt.nlp	24898067	SENT63	11	11	27	27	trastuzumab	HER-2	PA451743	2064	0.857
NULL	Br_J_Cancer_2010_Jan_5_102(1)_80-86.nxml.txt.nlp	19920817	SENT38	28	28	22	22	sunitinib	IFN	PA162372840	3439	0.857
NULL	Front_Oncol_2013_Aug_12_3_206.nxml.txt.nlp	23964347	SENT23	31	31	4	4	paclitaxel	BRCA1	PA450761	672	0.857
NULL	Diabetes_2008_Sep_57(9)_2503-2510.nxml.txt.nlp	18544707	SENT134	2	2	16	16	metformin	HHEX	PA450395	3087	0.857
NULL	Indian_J_Pharm_Sci_2013_Nov-Dec_75(6)_700-706.nxml.txt.nlp	24591745	SENT27	40	40	4	4	meloxicam	K100	PA450353	389941	0.857
NULL	Br_J_Cancer_1990_May_61(5)_749-754.nxml.txt.nlp	1692472	SENT21	9	9	19	19	melphalan	GM-CSF	PA450354	1437	0.857
NULL	EJNMMI_Res_2011_Aug_24_1_18.nxml.txt.nlp	22214432	SENT37	21	21	31	31	trastuzumab	HER2	PA451743	2064	0.857
NULL	Cancer_Med_2013_Feb_3_2(1)_11-20.nxml.txt.nlp	24133623	SENT163	11	11	5	5	cetuximab	KRAS	PA10040	3845	0.857
NULL	Anesth_Essays_Res_2011_Jan-Jun_5(1)_33-38.nxml.txt.nlp	NULL	SENT129	14	14	2	2	fentanyl	NNT	PA449599	23530	0.857
NULL	Cell_Death_Dis_2014_Feb_27_5(2)_e1093.nxml.txt.nlp	24577091	SENT293	7	7	3	3	curcumin	AP-1	PA151958596	2353;3727;2354;3725	0.857
NULL	Mol_Cancer_2012_Apr_26_11_24.nxml.txt.nlp	22537161	SENT139	36	36	9	9	pp2	IFN		3439	0.857
NULL	Curr_Neuropharmacol_2008_Sep_6(3)_215-234.nxml.txt.nlp	19506722	SENT401	24	24	19	19	paroxetine	5-HT1B	PA450801	3351	0.857
NULL	Nucleic_Acids_Res_2010_Oct_4_38(19)_e182.nxml.txt.nlp	20685815	SENT64	17	17	0	0	ethanol	TMP	PA448073	2012	0.857
NULL	Eur_J_Clin_Pharmacol_2008_Feb_26_64(2)_133-157.nxml.txt.nlp	18224312	SENT561	39	39	37	37	warfarin	CYP2C9	PA451906	1559	0.857
NULL	Virulence_2014_Jan_1_5(1)_36-44.nxml.txt.nlp	23774844	SENT142	5	5	9	9	thrombin	PAR1	PA451674	79581;2149	0.857
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT79	12	12	26	26	curcumin	DR5	PA151958596	8795	0.857
NULL	Cell_Death_Dis_2013_Jul_11_4(7)_e719.nxml.txt.nlp	23846221	SENT56	38	38	4	4	cisplatin	TRAIL	PA449014	8743	0.857
NULL	Ann_Oncol_2013_Aug_12_24(8)_1994-1999.nxml.txt.nlp	23670096	SENT145	10	10	19	19	tamoxifen	AIB1	PA451581	8202	0.857
NULL	Breast_Cancer_Res_2003_Jan_13_5(2)_R30-R36.nxml.txt.nlp	12631396	SENT80	18	18	35	35	tamoxifen	HER-2	PA451581	2064	0.857
NULL	Blood_Coagul_Fibrinolysis_2014_Sep_4_25(6)_561-570.nxml.txt.nlp	24717423	SENT55	4	4	9	9	protamine	ACT	PA10366	12;11332;9457;641455	0.857
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jun_16_66(Pt_7)_o1638.nxml.txt.nlp	21587867	SENT74	34	34	15	15	ethanol	mol	PA448073	90527	0.857
NULL	Chin_J_Cancer_2013_Aug_32(8)_419-426.nxml.txt.nlp	23668930	SENT47	11	11	27	27	sorafenib	SOCS1	PA7000	8651	0.857
NULL	Cancers_(Basel)_2011_Apr_1_3(2)_1844-1860.nxml.txt.nlp	24212785	SENT55	11	11	32	32	cetuximab	EGFR	PA10040	1956	0.857
NULL	Clin_Sci_(Lond)_2009_Nov_23_118(Pt_5)_315-332.nxml.txt.nlp	19922415	SENT222	6	6	10	10	metformin	AMPK	PA450395	5563	0.857
NULL	J_Thorac_Oncol_2014_Jun_30_9(6)_775-783.nxml.txt.nlp	24828661	SENT16	27	27	7	7	erlotinib	EGFR	PA134687924	1956	0.857
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1046.nxml.txt.nlp	24503538	SENT56	9	9	25	25	oxaliplatin	FGFR4	PA131285527	2264	0.857
NULL	Case_Rep_Oncol_2014_Jan_24_7(1)_58-64.nxml.txt.nlp	24575018	SENT64	21	21	15	15	ethanol	castor	PA448073	54897	0.857
NULL	Int_J_Inflam_2011_Aug_15_2011_580295.nxml.txt.nlp	21876832	SENT77	12	12	38	38	adalimumab	IL-6	PA10004	3569	0.857
NULL	Clin_Pharmacokinet_2014_Oct_15_53(2)_155-164.nxml.txt.nlp	24127209	SENT149	24	24	16	16	pantoprazole	CYP2C19	PA450774	1557	0.857
NULL	Curr_Neuropharmacol_2013_Dec_11(6)_652-663.nxml.txt.nlp	24396340	SENT81	0	0	24	24	paclitaxel	TRPA1	PA450761	8989	0.857
NULL	Arthritis_Res_Ther_2012_Sep_24_14(5)_R200.nxml.txt.nlp	23006144	SENT120	0	0	5	5	alefacept	IL-20	PA164748040	27190;50604	0.857
NULL	Pharmaceutics_2010_Oct_14_2(4)_321-338.nxml.txt.nlp	NULL	SENT117	8	8	21	21	creatine	ADP	PA164778930	23038	0.857
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_29_2013_590393.nxml.txt.nlp	23737838	SENT304	20	20	26	26	resveratrol	p53		7157	0.857
NULL	Front_Oncol_2013_Apr_23_3_86.nxml.txt.nlp	23630663	SENT149	23	23	7	7	lapatinib	ERBB2	PA152241907	2064	0.857
NULL	Biomed_Res_Int_2014_Jan_2_2014_126586.nxml.txt.nlp	24527434	SENT183	27	27	19	19	gemcitabine	Bcl-2	PA449748	596	0.857
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT276	16	16	10	10	resveratrol	ROS		6098	0.857
NULL	Front_Cell_Neurosci_2013_Dec_18_7_250.nxml.txt.nlp	24391538	SENT1788	2	2	6	6	ivermectin	P2X4	PA450133	5025	0.857
NULL	Diabetes_2009_Dec_31_58(12)_2851-2862.nxml.txt.nlp	19720788	SENT272	7	7	13	13	forskolin	IRE1	PA146096022	2081	0.857
NULL	Int_J_Biol_Sci_2012_Mar_7_8(4)_470-485.nxml.txt.nlp	22419892	SENT272	20	20	1	1	tamoxifen	HER2	PA451581	2064	0.857
NULL	J_Ayurveda_Integr_Med_2010_Oct-Dec_1(4)_287-291.nxml.txt.nlp	21731376	SENT72	3	3	31	31	loperamide	castor	PA450262	54897	0.857
NULL	Breast_Cancer_Res_2009_Jul_15_11(4)_207.nxml.txt.nlp	19664181	SENT39	17	17	10	10	trastuzumab	PTEN	PA451743	5728	0.857
NULL	Breast_Cancer_Res_2010_Aug_9_12(4)_R62.nxml.txt.nlp	20696059	SENT241	0	0	7	7	trastuzumab	AKT	PA451743	207	0.857
NULL	Indian_J_Urol_2015_Jan-Mar_31(1)_73-74.nxml.txt.nlp	25624582	SENT60	1	1	9	9	vasopressin	VIII	PA451858	1351	0.857
NULL	Virol_J_2008_Sep_26_5_109.nxml.txt.nlp	18822145	SENT10	12	12	28	28	amantadine	IMP	PA448360	8315	0.857
NULL	J_Antimicrob_Chemother_2015_Jan_3_70(1)_182-189.nxml.txt.nlp	25190720	SENT73	9	9	16	16	metronidazole	VAN	PA450484	10318	0.857
NULL	Diabetes_2013_Mar_14_62(3)_811-824.nxml.txt.nlp	23209186	SENT349	9	9	16	16	bortezomib	JNK	PA10252	5599	0.857
NULL	Infect_Drug_Resist_2008_Sep_9_1_27-44.nxml.txt.nlp	21694878	SENT243	22	22	11	11	sulfamethoxazole	TMP	PA451544	2012	0.857
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT106	26	26	41	41	l-methionine	S6K1	PA450423	6198	0.857
NULL	Anal_Biochem_2014_Jun_1_454(100)_17-22.nxml.txt.nlp	24637157	SENT20	28	28	26	26	camptothecin	TOP1	PA153590860	7150	0.857
NULL	Mol_Cancer_2010_Apr_23_9_87.nxml.txt.nlp	20416058	SENT262	25	25	23	23	doxorubicin	TRAIL	PA449412	8743	0.857
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S31-S40.nxml.txt.nlp	20680106	SENT39	21	21	11	11	panitumumab	KRAS	PA162373091	3845	0.857
NULL	Mol_Cancer_2010_Jun_9_9_140.nxml.txt.nlp	20529378	SENT20	12	12	24	24	dacarbazine	IL-2	PA449197	3558	0.857
NULL	Evid_Based_Complement_Alternat_Med_2014_Dec_25_2014_871720.nxml.txt.nlp	25610485	SENT50	4	4	14	14	berberine	G6PD	PA165860812	2539	0.857
NULL	F1000Res_2013_Mar_5_2_74.nxml.txt.nlp	24358880	SENT46	14	14	3	3	capsaicin	TRPV1	PA448776	7442	0.857
NULL	Front_Genet_2012_Nov_5_3_236.nxml.txt.nlp	23133441	SENT408	19	19	0	0	irinotecan	ABCB1	PA450085	5243	0.857
NULL	Clin_Exp_Gastroenterol_2011_Feb_25_4_33-41.nxml.txt.nlp	21694870	SENT68	0	0	11	11	sildenafil	GMP	PA451346	22978	0.857
NULL	Oncotarget_2014_Aug_29_5(19)_8947-8958.nxml.txt.nlp	25333254	SENT6	4	4	16	16	plerixafor	CXCR7	PA165958410	57007	0.857
NULL	Kidney_Int_Suppl_(2011)_2013_Dec_27_3(4)_392-409.nxml.txt.nlp	NULL	SENT771	6	6	20	20	everolimus	NGAL	PA164746311	3934	0.857
NULL	Br_J_Cancer_2014_Jan_7_110(1)_55-62.nxml.txt.nlp	24263064	SENT24	15	15	2	2	erlotinib	EGFR	PA134687924	1956	0.857
NULL	Clin_Med_Insights_Oncol_2012_Feb_28_6_125-135.nxml.txt.nlp	22408376	SENT277	2	2	10	10	cetuximab	KRAS	PA10040	3845	0.857
NULL	Case_Rep_Med_2012_Jun_19_2012_680431.nxml.txt.nlp	22778751	SENT92	20	20	18	18	cyclophosphamide	CHOP	PA449165	1649	0.857
NULL	Oncotarget_2014_Jun_6_5(13)_4935-4944.nxml.txt.nlp	24952732	SENT90	17	17	21	21	doxazosin	PI3K	PA449407	5290	0.857
NULL	Int_J_Gen_Med_2011_May_3_4_345-357.nxml.txt.nlp	21674027	SENT198	23	23	8	8	pioglitazone	adiponectin	PA450970	9370	0.857
NULL	Front_Genet_2012_Nov_2_3_229.nxml.txt.nlp	23130019	SENT45	19	19	7	7	ifosfamide	CYP3A	PA449964	1574	0.857
NULL	Curr_Oncol_2009_Jan_16(1)_16-26.nxml.txt.nlp	19229368	SENT60	33	33	5	5	panitumumab	KRAS	PA162373091	3845	0.857
NULL	Case_Rep_Endocrinol_2012_Dec_12_2012_165056.nxml.txt.nlp	23304571	SENT16	9	9	1	1	metformin	B12	PA450395	7126;4709	0.857
NULL	Nat_Med_2013_Apr_24_19(4)_473-480.nxml.txt.nlp	23524343	SENT14	15	15	0	0	methamphetamine	SNX27	PA450403	81609	0.857
NULL	Aging_(Albany_NY)_2010_Dec_20_2(12)_959-968.nxml.txt.nlp	21191146	SENT74	5	5	23	23	cisplatin	UCH37	PA449014	51377	0.857
NULL	Arthritis_Res_Ther_2012_Jan_23_14(1)_R17.nxml.txt.nlp	22269139	SENT8	11	11	28	28	diethylstilbestrol	IVD	PA449307	3712	0.857
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT278	31	31	3	3	neratinib	HRG	PA165291472	3084;3273	0.857
NULL	Biologics_2012_Dec_17_6_429-464.nxml.txt.nlp	23269860	SENT199	0	0	9	9	etanercept	ACR	PA449515	49	0.857
NULL	J_Oncol_2009_May_6_2009_567486.nxml.txt.nlp	19424511	SENT135	22	22	7	7	sorafenib	SHARP	PA7000	23013	0.857
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT94	5	5	13	13	curcumin	p27	PA151958596	5715;10534	0.857
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jan_31_65(Pt_2)_o439.nxml.txt.nlp	21582024	SENT69	25	25	16	16	ethanol	mol	PA448073	90527	0.857
NULL	Int_J_Mol_Sci_2014_Sep_29_15(10)_17411-17441.nxml.txt.nlp	25268615	SENT217	25	25	3	3	paclitaxel	CD147	PA450761	682	0.857
NULL	Natl_J_Maxillofac_Surg_2011_Jul-Dec_2(2)_210-213.nxml.txt.nlp	22639517	SENT63	21	21	8	8	vincristine	CHOP	PA451879	1649	0.857
NULL	Cancer_Med_2013_Oct_19_2(5)_646-653.nxml.txt.nlp	24403230	SENT77	31	31	10	10	trastuzumab	GADD45	PA451743	1647	0.857
NULL	J_Inherit_Metab_Dis_2012_Jan_10_35(1)_141-149.nxml.txt.nlp	21556832	SENT185	3	3	41	41	creatine	CRTR	PA164778930	6535	0.857
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S279-S284.nxml.txt.nlp	21525469	SENT7	11	11	4	4	liraglutide	GLP-1	PA165958364	100125288	0.857
NULL	J_Cell_Mol_Med_2014_Mar_10_18(3)_514-529.nxml.txt.nlp	24410795	SENT276	19	19	21	21	resveratrol	SIRT1		23411	0.857
NULL	Arthritis_Res_Ther_2014_Sep_26_16(5)_429.nxml.txt.nlp	25606593	SENT104	14	14	16	16	tocilizumab	IL-6	PA165292659	3569	0.857
NULL	Sensors_(Basel)_2012_Dec_3_12(12)_16614-16627.nxml.txt.nlp	23208557	SENT155	21	21	17	17	panitumumab	EGFR	PA162373091	1956	0.857
NULL	Addict_Sci_Clin_Pract_2012_Sep_24_7(1)_19.nxml.txt.nlp	23186390	SENT72	12	12	4	4	levamisole	AKA	PA450205	4762	0.857
NULL	Br_J_Cancer_2011_Apr_12_104(8)_1278-1287.nxml.txt.nlp	21487429	SENT107	17	17	2	2	cisplatin	TRAIL	PA449014	8743	0.857
NULL	Arthritis_Res_Ther_2006_Jul_21_8(4)_R130.nxml.txt.nlp	16859540	SENT9	4	4	11	11	ng-monomethyl-l-arginine	CD59		966	0.857
NULL	Mol_Cancer_2013_Mar_2_12_16.nxml.txt.nlp	23452820	SENT93	11	11	17	17	chloroquine	BECN1	PA448948	8678	0.857
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT116	27	27	3	3	tenofovir	SLC22A7	PA10204	10864	0.857
NULL	Open_Biochem_J_2010_May_18_4_59-67.nxml.txt.nlp	20648216	SENT117	36	36	14	14	thrombin	NOX5	PA451674	79400	0.857
NULL	Oncogenesis_2012_Apr_16_1(4)_e7.nxml.txt.nlp	23552604	SENT74	40	40	27	27	etoposide	CEACAM1	PA449552	634	0.857
NULL	Cancer_Med_2013_Oct_19_2(5)_646-653.nxml.txt.nlp	24403230	SENT77	31	31	12	12	trastuzumab	GADD45	PA451743	1647	0.857
NULL	Exp_Diabetes_Res_2012_Sep_20_2012_936518.nxml.txt.nlp	23049542	SENT131	19	19	8	8	glucose	TRPV4	PA449773	59341	0.857
NULL	Diabetes_Care_2012_Apr_13_35(4)_868-872.nxml.txt.nlp	22357182	SENT117	22	22	7	7	rosiglitazone	DREAM	PA451283	30818	0.857
NULL	Braz_J_Med_Biol_Res_2013_Jun_25_46(6)_528-532.nxml.txt.nlp	23802228	SENT116	3	3	12	12	rosiglitazone	PON1	PA451283	5444	0.857
NULL	J_Gen_Physiol_2009_Jun_133(6)_623-625.nxml.txt.nlp	19468076	SENT24	0	0	7	7	caffeine	TRPA1	PA448710	8989	0.857
NULL	Oncotarget_2014_Oct_21_5(22)_11709-11722.nxml.txt.nlp	25365944	SENT215	4	4	14	14	metformin	JNK	PA450395	5599	0.857
NULL	Orphanet_J_Rare_Dis_2011_Apr_12_6_14.nxml.txt.nlp	21486454	SENT70	30	30	7	7	dapsone	AAT	PA449211	5265	0.857
NULL	Nat_Med_2010_Nov_24_16(11)_1299-1304.nxml.txt.nlp	20972434	SENT199	8	8	27	27	chloroquine	ASM	PA448948	6609;283120	0.857
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT10	0	0	21	21	atorvastatin	KRAS	PA448500	3845	0.857
NULL	Int_J_Endocrinol_Metab_2013_Dec_21_Winter_11(1)_52-56.nxml.txt.nlp	23853621	SENT17	37	37	23	23	imatinib	ACTH	PA10804	5443	0.857
NULL	Arthritis_Res_Ther_2010_Feb_24_12(1)_R32.nxml.txt.nlp	20181277	SENT134	40	40	19	19	imatinib	M-CSF	PA10804	1435	0.857
NULL	J_Invest_Dermatol_2012_May_16_132(5)_1435-1442.nxml.txt.nlp	22336948	SENT121	10	10	15	15	doxycycline	TLSP	PA449415	11012	0.857
NULL	Oxid_Med_Cell_Longev_2013_Jun_2_2013_793525.nxml.txt.nlp	23819014	SENT10	39	39	3	3	resveratrol	PI3K		5290	0.857
NULL	Breast_Cancer_Res_Treat_2015_Dec_30_149_171-179.nxml.txt.nlp	25547219	SENT2	22	22	16	16	docetaxel	survivin	PA449383	332	0.857
NULL	Cardiol_Res_Pract_2012_Jul_30_2012_731970.nxml.txt.nlp	22900227	SENT130	6	6	17	17	estradiol	ETB	PA449503	1910	0.857
NULL	Br_J_Cancer_2012_Feb_28_106(5)_916-922.nxml.txt.nlp	22333602	SENT13	19	19	23	23	doxorubicin	HER2	PA449412	2064	0.857
NULL	Cancer_Med_2013_Feb_3_2(1)_40-49.nxml.txt.nlp	24133626	SENT139	8	8	15	15	cilostazol	PDE3B	PA164746334	5140	0.857
NULL	Psychiatr_Genet_2013_Aug_28_23(4)_153-162.nxml.txt.nlp	23811784	SENT192	19	19	38	38	clozapine	5-HT2A	PA449061	3356	0.857
NULL	Cancers_(Basel)_2014_Apr_9_6(2)_829-859.nxml.txt.nlp	24722453	SENT219	3	3	6	6	paclitaxel	STAT3	PA450761	6774	0.857
NULL	Front_Endocrinol_(Lausanne)_2014_Jan_16_5_1.nxml.txt.nlp	24474947	SENT59	42	42	14	14	estradiol	ESR2	PA449503	2100	0.857
NULL	Cancer_Manag_Res_2014_Jun_20_6_279-289.nxml.txt.nlp	25018651	SENT82	14	14	26	26	tamoxifen	IFN	PA451581	3439	0.857
NULL	Mol_Cancer_2010_Apr_21_9_83.nxml.txt.nlp	20409325	SENT212	22	22	11	11	doxycycline	MYCN	PA449415	4613	0.857
NULL	Arch_Dis_Child_2008_Jul_1_93(7)_620-625.nxml.txt.nlp	18381346	SENT182	5	5	12	12	warfarin	CYP2C9	PA451906	1559	0.857
NULL	Sci_Rep_2014_Dec_3_4_7294.nxml.txt.nlp	25465236	SENT93	17	17	1	1	gefitinib	EGFR	PA131301952	1956	0.857
NULL	Indian_J_Ophthalmol_2007_Nov-Dec_55(6)_445-450.nxml.txt.nlp	17951902	SENT46	18	18	41	41	ranibizumab	VEGF-A	PA164746012	7422	0.857
NULL	Biochem_Res_Int_2012_Feb_9_2012_592806.nxml.txt.nlp	22400117	SENT32	11	11	17	17	nadh	Q10	PA164755085	27161	0.857
NULL	Cancer_Cell_Int_2011_Dec_29_11_44.nxml.txt.nlp	22206574	SENT151	8	8	6	6	sorafenib	Mcl-1	PA7000	4170	0.857
NULL	Indian_J_Med_Res_2014_Aug_140(2)_209-215.nxml.txt.nlp	25297352	SENT103	18	18	5	5	oxcarbazepine	CLB	PA450732	171425	0.857
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT334	20	20	24	24	cisplatin	PTEN	PA449014	5728	0.856
NULL	Oncotarget_2012_Sep_28_3(10)_1169-1181.nxml.txt.nlp	23045411	SENT171	24	24	13	13	doxorubicin	JIP1	PA449412	9479	0.856
NULL	J_Oncol_2012_Sep_27_2012_461562.nxml.txt.nlp	23056046	SENT127	6	6	19	19	cisplatin	4E-BP1	PA449014	1978	0.856
NULL	Breast_Cancer_(Auckl)_2014_Oct_12_8_135-144.nxml.txt.nlp	25368520	SENT5	33	33	17	17	hydroxyurea	RAD51B	PA449942	5890	0.856
NULL	Oncotarget_2014_Nov_2_5(21)_10222-10236.nxml.txt.nlp	25400118	SENT208	25	25	2	2	paclitaxel	HER3	PA450761	2065	0.856
NULL	Cell_Death_Dis_2012_Mar_1_3(3)_e275.nxml.txt.nlp	22378068	SENT52	19	19	24	24	metformin	AKT	PA450395	207	0.856
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT187	19	19	14	14	cisplatin	IBP	PA449014	706;50619	0.856
NULL	Cell_Commun_Signal_2003_Nov_24_1_5.nxml.txt.nlp	14636425	SENT35	25	25	10	10	heparin	CCN5	PA449855	8839	0.856
NULL	Mol_Cancer_2009_Aug_25_8_66.nxml.txt.nlp	19706164	SENT71	4	4	12	12	celecoxib	p53	PA448871	7157	0.856
NULL	Biochimie_2014_Jun_101(100)_67-74.nxml.txt.nlp	24394625	SENT67	21	21	34	34	l-cysteine	CO2	PA449173	4513	0.856
NULL	Breast_Cancer_Res_2009_Nov_17_11(6)_R84.nxml.txt.nlp	19919679	SENT120	24	24	44	44	capecitabine	HER2	PA448771	2064	0.856
NULL	J_Cell_Mol_Med_2014_Oct_11_18(10)_2031-2043.nxml.txt.nlp	25109475	SENT278	18	18	16	16	valsartan	STZ	PA451848	6484	0.856
NULL	ScientificWorldJournal_2013_Dec_24_2013_958724.nxml.txt.nlp	24453930	SENT92	29	29	36	36	bevacizumab	ERM	PA130232992	2119	0.856
NULL	J_Invest_Dermatol_2013_Sep_31_133(9)_2247-2254.nxml.txt.nlp	23370537	SENT156	12	12	6	6	chloroquine	PUMA	PA448948	27113	0.856
NULL	Cancers_(Basel)_2014_Nov_6_6(4)_2243-2258.nxml.txt.nlp	25383481	SENT32	9	9	18	18	auranofin	TRPA1	PA448510	8989	0.856
NULL	J_Headache_Pain_2013_Aug_13_14(1)_71.nxml.txt.nlp	23941062	SENT68	13	13	19	19	oxaliplatin	TRPA1	PA131285527	8989	0.856
NULL	J_Cancer_2011_Mar_8_2_142-152.nxml.txt.nlp	21475719	SENT42	9	9	33	33	lipase	CEA	PA450239	5670;1087	0.856
NULL	J_Hematol_Oncol_2012_Oct_10_5_62.nxml.txt.nlp	23050865	SENT101	16	16	7	7	carboplatin	EGFR	PA448803	1956	0.856
NULL	Indian_J_Pharmacol_2014_Jan-Feb_46(1)_82-87.nxml.txt.nlp	24550590	SENT64	15	15	38	38	loperamide	castor	PA450262	54897	0.856
NULL	Curr_Genomics_2013_Nov_14(7)_441-452.nxml.txt.nlp	24396276	SENT103	26	26	19	19	cisplatin	ATP7B	PA449014	540	0.856
NULL	Biochemistry_2009_Jun_23_48(24)_5541-5552.nxml.txt.nlp	19419198	SENT531	23	23	25	25	trifluoperazine	TFP	PA451771	7034	0.856
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT109	5	5	17	17	atorvastatin	IL-6	PA448500	3569	0.856
NULL	ScientificWorldJournal_2013_Sep_19_2013_809891.nxml.txt.nlp	24170983	SENT134	12	12	18	18	ketorolac	CD86	PA450150	942	0.856
NULL	Diabetes_Metab_J_2013_Oct_17_37(5)_301-314.nxml.txt.nlp	24199158	SENT118	4	4	11	11	simvastatin	PDK4	PA451363	5166	0.856
NULL	Case_Rep_Dermatol_2014_Feb_12_6(1)_37-42.nxml.txt.nlp	24707248	SENT25	11	11	5	5	cyclophosphamide	CHOP	PA449165	1649	0.856
NULL	Breast_Cancer_Res_2004_Mar_26_6(3)_R252-R263.nxml.txt.nlp	15084249	SENT163	29	29	21	21	tamoxifen	NAT1	PA451581	9;1982	0.856
NULL	Endocrinol_Metab_(Seoul)_2014_Sep_25_29(3)_379-387.nxml.txt.nlp	25309798	SENT186	41	41	7	7	resveratrol	SIRT1		23411	0.856
NULL	Cancer_Med_2014_Apr_27_3(2)_245-251.nxml.txt.nlp	24464861	SENT103	19	19	15	15	metformin	HIF1	PA450395	3091	0.856
NULL	Oncotarget_2014_Oct_21_5(22)_11709-11722.nxml.txt.nlp	25365944	SENT119	4	4	25	25	metformin	JNK	PA450395	5599	0.856
NULL	Oncotarget_2014_Aug_29_5(19)_8947-8958.nxml.txt.nlp	25333254	SENT131	2	2	9	9	plerixafor	CD49d	PA165958410	3676	0.856
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT221	6	6	8	8	perifosine	JNK	PA165291471	5599	0.856
NULL	EMBO_Mol_Med_2013_Aug_5_5(8)_1213-1226.nxml.txt.nlp	23918228	SENT319	5	5	3	3	cetuximab	EGFR	PA10040	1956	0.856
NULL	Int_J_Nanomedicine_2007_Jun_2(2)_241-252.nxml.txt.nlp	17722552	SENT66	25	25	32	32	dextran	HEMA	PA449261	2157	0.856
NULL	F1000_Med_Rep_2012_Feb_1_4_4.nxml.txt.nlp	22312414	SENT171	12	12	22	22	daptomycin	VISA	PA164768820	57506	0.856
NULL	J_Korean_Med_Sci_2014_Jan_26_29(1)_53-60.nxml.txt.nlp	24431906	SENT16	14	14	17	17	rituximab	CHOP	PA451261	1649	0.856
NULL	Mol_Pain_2012_Sep_22_8_71.nxml.txt.nlp	22998838	SENT106	17	17	5	5	cisplatin	CXCR4	PA449014	7852	0.856
NULL	Hum_Reprod_2014_Oct_10_29(10)_2302-2316.nxml.txt.nlp	25139174	SENT375	5	5	17	17	metformin	StAR	PA450395	6770	0.856
NULL	Evid_Based_Complement_Alternat_Med_2011_Aug_11_2011_657056.nxml.txt.nlp	21876711	SENT8	3	3	10	10	ethanol	ERK	PA448073	5594	0.856
NULL	Cancer_Immunol_Immunother_2012_May_28_61(5)_655-665.nxml.txt.nlp	22033581	SENT241	26	26	8	8	bevacizumab	ML-IAP	PA130232992	79444	0.856
NULL	Mol_Cancer_2009_Dec_3_8_115.nxml.txt.nlp	19958544	SENT74	14	14	22	22	nutlin-3	MDM2		4193	0.856
NULL	Ann_Rheum_Dis_2008_Nov_14_67(11)_1516-1523.nxml.txt.nlp	18625622	SENT182	22	22	15	15	methotrexate	TNF	PA450428	7124	0.856
NULL	Cancer_Res_Treat_2014_Jul_15_46(3)_234-242.nxml.txt.nlp	25038758	SENT26	11	11	8	8	paclitaxel	P-gp	PA450761	5243	0.856
NULL	Acta_Pharmacol_Sin_2010_Sep_16_31(9)_1075-1084.nxml.txt.nlp	20711221	SENT113	6	6	9	9	metformin	AMPK	PA450395	5563	0.856
NULL	Infect_Drug_Resist_2010_Aug_9_3_87-94.nxml.txt.nlp	21694897	SENT115	12	12	4	4	chloroquine	ACT	PA448948	12;11332;9457;641455	0.856
NULL	BMB_Rep_2013_Jan_46(1)_59-64.nxml.txt.nlp	23351386	SENT83	5	5	18	18	auranofin	NAC	PA448510	22861	0.856
NULL	Clin_Cosmet_Investig_Dermatol_2014_Sep_2_7_243-249.nxml.txt.nlp	25214798	SENT81	21	21	1	1	ustekinumab	ACR	PA166048654	49	0.856
NULL	Oncoimmunology_2013_Dec_1_2(12)_e26689.nxml.txt.nlp	24527364	SENT16	15	15	6	6	doxorubicin	CD4	PA449412	920	0.856
NULL	Cardiol_Res_Pract_2013_Jan_31_2013_128795.nxml.txt.nlp	23431496	SENT158	11	11	33	33	clopidogrel	CYP2C19	PA449053	1557	0.856
NULL	Nat_Neurosci_2012_Sep_5_15(9)_1245-1254.nxml.txt.nlp	22864611	SENT56	8	8	22	22	clozapine	mGlu2	PA449061	2912	0.856
NULL	EMBO_J_2013_Apr_3_32(7)_1008-1022.nxml.txt.nlp	23463102	SENT272	18	18	3	3	ethanol	IL-7	PA448073	3574	0.856
NULL	Arthritis_Res_Ther_2014_Jul_18_16(4)_R153.nxml.txt.nlp	25037855	SENT196	19	19	8	8	adalimumab	CD14	PA10004	929	0.856
NULL	Acta_Neuropathol_Commun_2014_Feb_7_2_16.nxml.txt.nlp	24507707	SENT35	23	23	11	11	ethanol	BAX	PA448073	581	0.856
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT71	14	14	22	22	curcumin	FADD	PA151958596	8772	0.856
NULL	Oncol_Lett_2014_Sep_19_8(3)_1320-1322.nxml.txt.nlp	25120716	SENT17	18	18	5	5	erlotinib	EGFR	PA134687924	1956	0.856
NULL	Mol_Cancer_2008_Mar_26_7_27.nxml.txt.nlp	18366759	SENT145	24	24	7	7	etoposide	p53	PA449552	7157	0.856
NULL	Front_Oncol_2014_Apr_9_4_75.nxml.txt.nlp	24782986	SENT179	11	11	24	24	paclitaxel	CA125	PA450761	4077;94025	0.856
NULL	Gut_Liver_2013_Sep_14_7(5)_505-512.nxml.txt.nlp	24073306	SENT39	14	14	37	37	aprotinin	ghrelin	PA448472	51738	0.856
NULL	Br_J_Cancer_2013_Mar_19_108(5)_1079-1091.nxml.txt.nlp	23449353	SENT126	10	10	25	25	docetaxel	MIC-1	PA449383	29919;9518	0.856
NULL	Curr_Neuropharmacol_2007_Dec_5(4)_224-231.nxml.txt.nlp	19305739	SENT192	8	8	3	3	tegaserod	5-HT4	PA130413154	3360	0.856
NULL	Mol_Clin_Oncol_2013_Sep_26_1(5)_799-804.nxml.txt.nlp	24649249	SENT112	0	0	9	9	trastuzumab	HER2	PA451743	2064	0.856
NULL	Int_J_Cell_Biol_2012_Mar_27_2012_189794.nxml.txt.nlp	22536246	SENT98	33	33	17	17	etoposide	PI3K	PA449552	5290	0.856
NULL	J_RNAi_Gene_Silencing_2009_Mar_9_5(1)_321-330.nxml.txt.nlp	19771229	SENT226	33	33	15	15	gemcitabine	RRM1	PA449748	6240	0.856
NULL	Breast_Cancer_Res_2009_Jul_15_11(4)_207.nxml.txt.nlp	19664181	SENT132	14	14	34	34	trastuzumab	EGFR	PA451743	1956	0.856
NULL	Ann_Hematol_2011_Feb_17_90(2)_173-183.nxml.txt.nlp	20714724	SENT166	4	4	9	9	resveratrol	CD19		930	0.856
NULL	Oncoimmunology_2012_Oct_1_1(7)_1048-1060.nxml.txt.nlp	23170253	SENT57	11	11	7	7	pertuzumab	HER-2		2064	0.856
NULL	Anemia_2012_Nov_8_2012_607436.nxml.txt.nlp	23198140	SENT165	6	6	2	2	capsaicin	TRPV1	PA448776	7442	0.856
NULL	Lipids_Health_Dis_2011_Feb_12_10_31.nxml.txt.nlp	21314960	SENT136	3	3	17	17	hemin	SOCS1	PA449849	8651	0.856
NULL	Front_Endocrinol_(Lausanne)_2014_Jan_16_5_1.nxml.txt.nlp	24474947	SENT134	12	12	25	25	estradiol	GPER	PA449503	2852	0.856
NULL	Autophagy_2012_May_1_8(5)_853-855.nxml.txt.nlp	22617440	SENT35	23	23	4	4	imatinib	MIR30A	PA10804	407029	0.856
NULL	Endocrinol_Diabetes_Metab_Case_Rep_2014_Mar_1_2014_140001.nxml.txt.nlp	24683487	SENT10	24	24	6	6	etomidate	ACTH	PA164743987	5443	0.856
NULL	Indian_J_Urol_2007_Apr-Jun_23(2)_91-96.nxml.txt.nlp	19675781	SENT179	6	6	4	4	finasteride	NNT	PA449627	23530	0.856
NULL	EMBO_J_2009_May_20_28(10)_1479-1491.nxml.txt.nlp	19322198	SENT32	3	3	30	30	capsaicin	TRPM8	PA448776	79054	0.856
NULL	J_Carcinog_2014_Feb_7_13_1.nxml.txt.nlp	24737949	SENT88	21	21	35	35	dacarbazine	BRAF	PA449197	673	0.856
NULL	Cancer_Cell_Int_2011_Jun_1_11_15.nxml.txt.nlp	21631944	SENT155	9	9	26	26	etoposide	GAPDH	PA449552	2597	0.856
NULL	J_Immunother_Cancer_2014_Nov_6_2(Suppl_3)_P210.nxml.txt.nlp	NULL	SENT14	16	16	10	10	curcumin	PD-L1	PA151958596	29126	0.856
NULL	Curr_Control_Trials_Cardiovasc_Med_2000_Dec_4_1(3)_166-171.nxml.txt.nlp	11714434	SENT192	30	30	8	8	cyclosporine	EDA	PA449167	1896	0.856
NULL	Acta_Pharmacol_Sin_2010_Nov_18_31(11)_1447-1453.nxml.txt.nlp	20953204	SENT101	7	7	13	13	rimonabant	IL-6	PA152407999	3569	0.856
NULL	Int_J_Breast_Cancer_2012_May_9_2012_415170.nxml.txt.nlp	22649737	SENT69	7	7	24	24	trastuzumab	HER3	PA451743	2065	0.856
NULL	Br_J_Cancer_2006_Feb_13_94(3)_407-426.nxml.txt.nlp	16434996	SENT265	16	16	26	26	genistein	BRCA2	PA165109660	675	0.856
NULL	Clin_Ophthalmol_2014_Jun_28_8_1241-1252.nxml.txt.nlp	25061271	SENT36	6	6	20	20	latanoprost	BAK	PA164774763	578	0.856
NULL	Cell_Death_Dis_2010_Feb_4_1(2)_e23.nxml.txt.nlp	21364631	SENT272	37	37	13	13	imipramine	c-Jun	PA449969	3725	0.856
NULL	J_Oncol_2013_Feb_17_2013_872957.nxml.txt.nlp	23476648	SENT136	19	19	6	6	cisplatin	SFN	PA449014	25996;2810	0.856
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT141	21	21	10	10	sulindac	survivin	PA451565	332	0.856
NULL	Oncogene_2013_Oct_17_32(42)_5101-5110.nxml.txt.nlp	23208508	SENT33	45	45	11	11	metformin	AMPK	PA450395	5563	0.856
NULL	Int_J_Breast_Cancer_2011_Feb_24_2011_967419.nxml.txt.nlp	22332018	SENT142	36	36	19	19	carboplatin	p53	PA448803	7157	0.856
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT383	24	24	22	22	pp2	PP1		5540;5464	0.856
NULL	Breast_Cancer_Res_2005_Nov_11_7(6)_255-257.nxml.txt.nlp	16457700	SENT44	23	23	32	32	tamoxifen	aromatase	PA451581	1588	0.856
NULL	Biomed_Res_Int_2013_Sep_5_2013_929531.nxml.txt.nlp	24083250	SENT182	3	3	0	0	hyaluronan	CD44	PA165958431	960	0.856
NULL	Mol_Pain_2012_Sep_22_8_71.nxml.txt.nlp	22998838	SENT55	21	21	33	33	paclitaxel	ANOVA	PA450761	4858	0.856
NULL	J_Cell_Mol_Med_2014_May_14_18(5)_811-823.nxml.txt.nlp	24628949	SENT10	25	25	19	19	docetaxel	FOXM1	PA449383	2305	0.856
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT112	37	37	13	13	carboplatin	MVP	PA448803	9961	0.856
NULL	Pharmacogn_Mag_2014_Jan-Mar_10(37)_61-65.nxml.txt.nlp	24696547	SENT92	29	29	8	8	curcumin	CA3	PA151958596	761	0.856
NULL	Exp_Mol_Med_2012_Sep_30_44(9)_536-544.nxml.txt.nlp	22771771	SENT88	25	25	12	12	ns-398	p53		7157	0.856
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT225	6	6	1	1	nutlin-3	p53		7157	0.856
NULL	Emerg_Infect_Dis_2012_Nov_18(11)_e2.nxml.txt.nlp	23092736	SENT64	10	10	3	3	ethionamide	DST	PA164768738	667	0.856
NULL	Oxid_Med_Cell_Longev_2013_Apr_21_2013_412576.nxml.txt.nlp	23710286	SENT164	9	9	13	13	curcumin	NRF2	PA151958596	2551;4780	0.856
NULL	Aging_(Albany_NY)_2011_Apr_6_3(4)_444-449.nxml.txt.nlp	21483037	SENT99	4	4	14	14	resveratrol	SIRT1		23411	0.856
NULL	Oncotarget_2013_Nov_23_5(1)_196-210.nxml.txt.nlp	24344116	SENT12	19	19	4	4	doxorubicin	p53	PA449412	7157	0.856
NULL	Theranostics_2013_Jan_15_3(1)_47-75.nxml.txt.nlp	23382786	SENT377	7	7	4	4	plerixafor	CXCR4	PA165958410	7852	0.856
NULL	Curr_Cardiol_Rev_2012_May_8(2)_158-165.nxml.txt.nlp	22708914	SENT193	19	19	31	31	enoxaparin	TKR	PA449463	8277	0.856
NULL	Cancers_(Basel)_2013_Jul_4_5(3)_838-856.nxml.txt.nlp	24202322	SENT150	4	4	26	26	nutlin-3	p53		7157	0.856
NULL	Breast_Cancer_Res_Treat_2013_Aug_20_141(1)_43-53.nxml.txt.nlp	23959396	SENT20	9	9	3	3	trastuzumab	HER2	PA451743	2064	0.856
NULL	Eur_Heart_J_2012_May_16_33(9)_1150-1158.nxml.txt.nlp	21411816	SENT70	10	10	7	7	neomycin	HO-1	PA450608	3162	0.856
NULL	Exp_Ther_Med_2013_Dec_23_6(6)_1494-1498.nxml.txt.nlp	24255680	SENT101	10	10	17	17	losartan	ILK	PA450268	3611	0.856
NULL	J_Immunother_Cancer_2013_Nov_7_1(Suppl_1)_P191.nxml.txt.nlp	NULL	SENT15	15	15	32	32	propranolol	p38	PA451145	10598;1432;7965	0.856
NULL	Curr_Neuropharmacol_2008_Jun_6(2)_151-163.nxml.txt.nlp	19305794	SENT168	19	19	1	1	capsaicin	TRPV1	PA448776	7442	0.856
NULL	Chin_J_Cancer_2011_Sep_30(9)_645-654.nxml.txt.nlp	21880186	SENT131	23	23	1	1	cisplatin	NACT	PA449014	284111	0.856
NULL	Mol_Cancer_2010_Dec_20_9_316.nxml.txt.nlp	21172016	SENT351	0	0	10	10	heparin	CCL21	PA449855	6366	0.856
NULL	Emerg_Infect_Dis_2013_Mar_19(3)_449-455.nxml.txt.nlp	23622714	SENT52	15	15	9	9	rifampin	DST	PA451250	667	0.856
NULL	Front_Aging_Neurosci_2010_May_18_2_16.nxml.txt.nlp	20559464	SENT222	16	16	25	25	pioglitazone	BACE1	PA450970	23621	0.856
NULL	Mol_Cancer_2010_Dec_20_9_317.nxml.txt.nlp	21172025	SENT214	10	10	21	21	tamoxifen	EVL	PA451581	51466	0.856
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT34	39	39	32	32	doxorubicin	TRAIL	PA449412	8743	0.856
NULL	Br_J_Cancer_2013_Mar_19_108(5)_1079-1091.nxml.txt.nlp	23449353	SENT172	28	28	10	10	docetaxel	PC3	PA449383	57332;7832;5122	0.856
NULL	Br_J_Cancer_2011_Apr_12_104(8)_1278-1287.nxml.txt.nlp	21487429	SENT7	20	20	14	14	cisplatin	TRAIL	PA449014	8743	0.856
NULL	Drugs_Context_2013_May_22_2013_212255.nxml.txt.nlp	24432042	SENT250	14	14	8	8	acarbose	GLP-1	PA448010	100125288	0.856
NULL	Diabetes_Obes_Metab_2011_Nov_13(11)_982-989.nxml.txt.nlp	21615670	SENT23	0	0	12	12	exenatide	GLP-1	PA164749238	100125288	0.856
NULL	J_Immunother_Cancer_2013_Jul_15_1_10.nxml.txt.nlp	24829747	SENT49	42	42	31	31	sildenafil	CD28	PA451346	1493;940	0.856
NULL	Drug_Target_Insights_2013_Aug_19_7_27-34.nxml.txt.nlp	24023511	SENT84	13	13	4	4	telithromycin	P-gp	PA10202	5243	0.856
NULL	Part_Fibre_Toxicol_2011_Aug_2_8_23.nxml.txt.nlp	21810225	SENT193	12	12	21	21	zinc	ROS	PA451956	6098	0.856
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_23_2013_185158.nxml.txt.nlp	23864881	SENT109	23	23	32	32	vorinostat	CO2	PA164748224	4513	0.856
NULL	Oncotarget_2014_Oct_21_5(22)_11252-11268.nxml.txt.nlp	25361004	SENT66	5	5	2	2	metformin	CLIC1	PA450395	1192	0.856
NULL	Biomed_Res_Int_2014_Jan_20_2014_948427.nxml.txt.nlp	24563867	SENT75	3	3	32	32	buspirone	STZ	PA448689	6484	0.856
NULL	Oncogene_2014_Feb_6_33(6)_713-723.nxml.txt.nlp	23435429	SENT53	14	14	7	7	etoposide	BRCA1	PA449552	672	0.856
NULL	J_Biol_2009_Apr_15_8(3)_30.nxml.txt.nlp	19435483	SENT26	18	18	15	15	imatinib	NQO2	PA10804	4835	0.856
NULL	Curr_Neuropharmacol_2008_Sep_6(3)_193-202.nxml.txt.nlp	19506720	SENT177	39	39	12	12	mirtazapine	ghrelin	PA450522	51738	0.856
NULL	J_Carcinog_2011_Nov_30_10_27.nxml.txt.nlp	22190869	SENT75	6	6	12	12	curcumin	TRAMP	PA151958596	8718;23471;9189	0.856
NULL	Cell_Cycle_2012_Dec_15_11(24)_4499-4506.nxml.txt.nlp	23114620	SENT73	14	14	21	21	choline	DAG	PA448976	1605	0.856
NULL	Br_J_Cancer_2011_Dec_6_105(12)_1920-1926.nxml.txt.nlp	22095222	SENT9	25	25	8	8	gefitinib	PIK3CA	PA131301952	5290	0.856
NULL	Eur_J_Clin_Pharmacol_2014_Oct_8_70(12)_1433-1441.nxml.txt.nlp	25291992	SENT67	10	10	3	3	olanzapine	FES	PA450688	2242	0.856
NULL	Biomed_Res_Int_2013_Aug_29_2013_560141.nxml.txt.nlp	24073410	SENT27	14	14	0	0	trypsin	SLPI	PA451806	6590	0.856
NULL	Mol_Cancer_2012_Oct_22_11_80.nxml.txt.nlp	23088607	SENT72	13	13	22	22	estradiol	YC1	PA449503	5937	0.856
NULL	Cell_Commun_Signal_2014_Sep_25_12(1)_61.nxml.txt.nlp	NULL	SENT411	32	32	11	11	doxycycline	INPP4B	PA449415	8821	0.856
NULL	Clin_Ophthalmol_2009_Jun_2_3_199-210.nxml.txt.nlp	19668566	SENT84	33	33	4	4	bromfenac	COX	PA448670	1351	0.856
NULL	Biomed_Res_Int_2013_Jan_22_2013_758341.nxml.txt.nlp	23484154	SENT69	17	17	8	8	fluorescein	CLS	PA164746009	1210	0.856
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT184	2	2	8	8	tacrolimus	RANKL	PA451578	8600	0.856
NULL	J_Invest_Dermatol_2013_Jun_14_133(6)_1541-1549.nxml.txt.nlp	23407395	SENT130	27	27	21	21	imiquimod	CXCL1	PA449972	2919	0.856
NULL	Cancers_(Basel)_2011_May_18_3(2)_2444-2461.nxml.txt.nlp	24212818	SENT73	22	22	16	16	gefitinib	EGFR	PA131301952	1956	0.856
NULL	Clin_Exp_Gastroenterol_2012_May_14_5_49-59.nxml.txt.nlp	22649281	SENT89	3	3	22	22	esomeprazole	CYP3A4	PA10075	1576	0.856
NULL	Gut_2012_Jan_3_61(1)_6-32.nxml.txt.nlp	22052063	SENT364	1	1	15	15	octreotide	SSTR5	PA450678	6755	0.856
NULL	Ann_Oncol_2012_Dec_2_23(12)_3007-3016.nxml.txt.nlp	22865781	SENT107	6	6	16	16	trastuzumab	HER2	PA451743	2064	0.856
NULL	Mol_Cancer_2013_Mar_5_12_17.nxml.txt.nlp	23497256	SENT197	8	8	24	24	sunitinib	HDM2	PA162372840	4193	0.856
NULL	JMIR_Res_Protoc_2014_Dec_10_3(4)_e73.nxml.txt.nlp	25500152	SENT176	12	12	3	3	carbamazepine	CYP3A4	PA448785	1576	0.856
NULL	Clin_Ophthalmol_2011_Dec_30_5_23-25.nxml.txt.nlp	21311653	SENT39	19	19	7	7	tocilizumab	IL-6	PA165292659	3569	0.856
NULL	Aging_(Albany_NY)_2010_Oct_31_2(10)_669-677.nxml.txt.nlp	21076179	SENT96	16	16	32	32	vorinostat	PERK	PA164748224	9451	0.856
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Apr_30_65(Pt_5)_m594.nxml.txt.nlp	21583816	SENT52	40	40	7	7	ethanol	mol	PA448073	90527	0.856
NULL	Diabetes_2013_Jun_17_62(6)_2141-2150.nxml.txt.nlp	23378610	SENT178	31	31	17	17	betaine	SLC6A12	PA448603	6539	0.856
NULL	Neural_Plast_2014_Mar_17_2014_123026.nxml.txt.nlp	24757568	SENT114	1	1	14	14	fluoxetine	ANOVA	PA449673	4858	0.856
NULL	Oncotarget_2011_Jun_15_2(6)_518-524.nxml.txt.nlp	21680956	SENT94	11	11	14	14	pimozide	STAT3	PA450965	6774	0.856
NULL	Clin_Interv_Aging_2013_Mar_26_8_347-352.nxml.txt.nlp	23569367	SENT91	9	9	23	23	levodopa	GRK6	PA450213	2870	0.856
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT229	13	13	0	0	panitumumab	STEPP	PA162373091	222659	0.856
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT148	16	16	26	26	l-leucine	ATP5A	PA450197	498	0.856
NULL	Br_J_Cancer_2011_Aug_9_105(4)_523-533.nxml.txt.nlp	21792199	SENT175	17	17	20	20	erlotinib	AKT	PA134687924	207	0.856
NULL	Target_Oncol_2013_Jun_27_8(2)_127-136.nxml.txt.nlp	23625191	SENT84	18	18	26	26	panitumumab	KRAS	PA162373091	3845	0.856
NULL	Cholesterol_2011_Feb_22_2011_503028.nxml.txt.nlp	21490773	SENT109	29	29	10	10	methotrexate	ABCA1	PA450428	19	0.856
NULL	Atherosclerosis_2012_Oct_224(2)_348-354.nxml.txt.nlp	22901457	SENT214	1	1	9	9	lipase	IL-8	PA450239	3576	0.856
NULL	Biomed_Res_Int_2014_Jan_15_2014_859871.nxml.txt.nlp	24527460	SENT126	0	0	10	10	metformin	CD24	PA450395	100133941	0.856
NULL	Int_J_Mol_Sci_2014_Jun_25_15(7)_11220-11233.nxml.txt.nlp	24968265	SENT29	20	20	1	1	tanespimycin	REST	PA165291490	5978	0.856
NULL	Case_Rep_Surg_2012_Nov_28_2012_179407.nxml.txt.nlp	23243548	SENT63	13	13	15	15	thyroglobulin	TTF-1	PA164754910	7080	0.856
NULL	Patient_Prefer_Adherence_2014_Apr_8_8_463-471.nxml.txt.nlp	24748775	SENT154	2	2	14	14	denosumab	RANKL	PA166048634	8600	0.856
NULL	Diabetes_2011_Jul_20_60(7)_1917-1925.nxml.txt.nlp	21593202	SENT117	17	17	25	25	troglitazone	adiponectin	PA451799	9370	0.856
NULL	Front_Neurosci_2013_Jan_31_7_3.nxml.txt.nlp	23386808	SENT176	26	26	24	24	capsaicin	TRPV1	PA448776	7442	0.856
NULL	Indian_J_Anaesth_2014_Sep-Oct_58(5)_565-572.nxml.txt.nlp	25535418	SENT183	36	36	16	16	abciximab	P2Y12	PA448006	64805	0.856
NULL	Allergy_2015_Jan_28_70(1)_80-89.nxml.txt.nlp	25331546	SENT69	20	20	26	26	clodronate	IL-13	PA10239	3596	0.856
NULL	J_Ophthalmol_2011_Oct_30_2011_589813.nxml.txt.nlp	22132311	SENT201	14	14	11	11	sirolimus	TORC1	PA451365	23373	0.856
NULL	Acta_Diabetol_2012_Aug_11_49(4)_277-289.nxml.txt.nlp	21833779	SENT196	31	31	28	28	carbachol	ANOVA	PA448784	4858	0.856
NULL	Indian_J_Pharmacol_2012_Sep-Oct_44(5)_619-623.nxml.txt.nlp	23112425	SENT79	16	16	13	13	forskolin	CFTR	PA146096022	1080	0.856
NULL	Br_J_Cancer_2010_Feb_2_102(3)_513-519.nxml.txt.nlp	20051960	SENT23	28	28	16	16	trastuzumab	MUC4	PA451743	4585	0.856
NULL	Core_Evid_2012_Dec_11_7_131-143.nxml.txt.nlp	23271985	SENT112	14	14	39	39	rifampin	hole	PA451250	80757	0.856
NULL	Nat_Commun_2013_Apr_23_4_1758.nxml.txt.nlp	23612299	SENT78	4	4	18	18	isoproterenol	SOD1	PA450121	6647	0.856
NULL	Mol_Cancer_2007_Jan_14_6_5.nxml.txt.nlp	17222355	SENT36	16	16	1	1	doxorubicin	HMGA2	PA449412	8091	0.856
NULL	Viruses_2013_Jun_27_5(7)_1607-1632.nxml.txt.nlp	23807710	SENT1104	0	0	13	13	resveratrol	SIRT1		23411	0.856
NULL	Mol_Biol_Int_2012_May_24_2012_705948.nxml.txt.nlp	22693671	SENT201	30	30	7	7	cisplatin	RASSF2	PA449014	9770	0.856
NULL	J_Vet_Med_Sci_2014_Nov_21_76(11)_1539-1543.nxml.txt.nlp	25141879	SENT62	28	28	5	5	paraformaldehyde	CD11b	PA450790	3684	0.856
NULL	J_Korean_Assoc_Oral_Maxillofac_Surg_2014_Dec_26_40(6)_291-296.nxml.txt.nlp	25551094	SENT112	17	17	20	20	ibandronate	RANKL	PA10270	8600	0.856
NULL	Support_Care_Cancer_2012_Sep_17_20(9)_1991-1997.nxml.txt.nlp	22089428	SENT19	6	6	18	18	paclitaxel	castor	PA450761	54897	0.856
NULL	J_Biol_Chem_2010_Aug_20_285(34)_25913-25927.nxml.txt.nlp	20452970	SENT158	31	31	26	26	iloprost	cPLA2	PA164746843	10524	0.856
NULL	J_Exp_Med_1998_May_18_187(10)_1583-1598.nxml.txt.nlp	9584137	SENT47	9	9	33	33	phenol	CO2	PA450913	4513	0.856
NULL	Asian-Australas_J_Anim_Sci_2013_Jun_26(6)_879-885.nxml.txt.nlp	25049863	SENT16	13	13	23	23	halothane	RYR1	PA449845	6261	0.856
NULL	Can_J_Infect_Dis_Med_Microbiol_2014_Nov-Dec_25(6)_327-343.nxml.txt.nlp	25587296	SENT177	1	1	4	4	itraconazole	CYP3A4	PA450132	1576	0.856
NULL	Cancer_Cell_Int_2010_Apr_29_10_12.nxml.txt.nlp	20429927	SENT98	14	14	29	29	bortezomib	GCN2	PA10252	440275	0.856
NULL	Br_J_Cancer_2011_Jan_4_104(1)_91-100.nxml.txt.nlp	21139584	SENT65	18	18	7	7	geldanamycin	Hsp90	PA152031327	3320	0.856
NULL	Mar_Drugs_2014_Jun_27_12(7)_3818-3837.nxml.txt.nlp	24979269	SENT64	34	34	41	41	doxorubicin	P-gp	PA449412	5243	0.856
NULL	Oncogene_2010_Sep_16_29(37)_5135-5145.nxml.txt.nlp	20622897	SENT137	12	12	5	5	cetuximab	HIF-1	PA10040	29072	0.856
NULL	Cancers_(Basel)_2010_May_28_2(2)_1040-1065.nxml.txt.nlp	24281106	SENT1249	10	10	4	4	carboplatin	EGFR	PA448803	1956	0.856
NULL	Mol_Cancer_2012_Dec_12_11_91.nxml.txt.nlp	23234355	SENT19	22	22	17	17	erlotinib	EGFR	PA134687924	1956	0.856
NULL	Leukemia_2014_Aug_7_28(8)_1636-1646.nxml.txt.nlp	24418989	SENT106	17	17	5	5	bortezomib	SQSTM1	PA10252	8878	0.856
NULL	Cancer_Cell_Int_2013_Feb_12_13_14.nxml.txt.nlp	23402310	SENT189	17	17	34	34	celecoxib	p65	PA448871	5970	0.856
NULL	Pharmaceuticals_(Basel)_2013_Aug_21_6(8)_988-1038.nxml.txt.nlp	24276379	SENT2679	15	15	9	9	cetuximab	PIK3CA	PA10040	5290	0.856
NULL	Br_J_Haematol_2014_Mar_6_164(6)_759-766.nxml.txt.nlp	24387053	SENT190	11	11	22	22	eculizumab	CD46	PA164776637	4179	0.856
NULL	Br_J_Cancer_2011_Jul_26_105(3)_353-359.nxml.txt.nlp	21750549	SENT160	8	8	13	13	sorafenib	BRAF	PA7000	673	0.856
NULL	Br_J_Cancer_2003_Mar_24_88(6)_848-854.nxml.txt.nlp	12644821	SENT21	26	26	13	13	cisplatin	TP53	PA449014	7157	0.856
NULL	Neural_Dev_2012_Jul_4_7_11.nxml.txt.nlp	22458943	SENT79	2	2	29	29	probenecid	ANOVA	PA451106	4858	0.856
NULL	Crit_Care_2004_Sep_2_8(5)_R353-R357.nxml.txt.nlp	15469580	SENT42	3	3	18	18	fentanyl	CO2	PA449599	4513	0.856
NULL	Int_J_Mol_Sci_2012_Dec_5_13(12)_16624-16635.nxml.txt.nlp	23443122	SENT11	6	6	13	13	paclitaxel	MDR1	PA450761	5243	0.856
NULL	J_Cancer_2013_Jan_11_4(2)_117-132.nxml.txt.nlp	23386910	SENT227	24	24	34	34	trastuzumab	PI3K	PA451743	5290	0.856
NULL	J_Hematol_Oncol_2013_Mar_27_6_23.nxml.txt.nlp	23531342	SENT85	6	6	12	12	fludarabine	p53	PA449655	7157	0.856
NULL	J_Antimicrob_Chemother_2014_Apr_27_69(4)_907-910.nxml.txt.nlp	24284779	SENT73	7	7	11	11	cefoxitin	BSAC	PA448856	57591	0.856
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT42	20	20	12	12	trastuzumab	HER2	PA451743	2064	0.856
NULL	Mol_Cancer_2010_Nov_2_9_289.nxml.txt.nlp	21044322	SENT290	25	25	16	16	cisplatin	AKT	PA449014	207	0.856
NULL	Open_Access_J_Urol_2011_May_10_3_69-82.nxml.txt.nlp	24198638	SENT59	27	27	14	14	sorafenib	CYP3A4	PA7000	1576	0.856
NULL	Int_J_Endocrinol_Metab_2013_Dec_21_Winter_11(1)_57-61.nxml.txt.nlp	23853622	SENT133	1	1	8	8	bromocriptine	PRL	PA448671	5617	0.856
NULL	Br_J_Cancer_2012_May_22_106(11)_1722-1727.nxml.txt.nlp	22568966	SENT137	0	0	4	4	bevacizumab	VEGF-A	PA130232992	7422	0.856
NULL	Diabetol_Metab_Syndr_2014_Sep_23_6(1)_102.nxml.txt.nlp	NULL	SENT38	9	9	12	12	atorvastatin	RAGE	PA448500	177	0.856
NULL	Chemother_Res_Pract_2012_Aug_29_2012_817297.nxml.txt.nlp	22970367	SENT190	19	19	5	5	cetuximab	EGFR	PA10040	1956	0.856
NULL	Br_J_Anaesth_2014_Jul_22_113(1)_157-167.nxml.txt.nlp	24154701	SENT267	7	7	4	4	sevoflurane	TREK-1	PA451341	3776	0.856
NULL	J_Res_Med_Sci_2012_May_17(5)_487-490.nxml.txt.nlp	23626617	SENT83	11	11	20	20	cyclophosphamide	CHOP	PA449165	1649	0.856
NULL	J_Gen_Physiol_2008_Nov_132(5)_521-535.nxml.txt.nlp	18852303	SENT86	33	33	24	24	trypsin	CAP2	PA451806	5271;10486	0.856
NULL	Cancers_(Basel)_2010_Jul_27_2(3)_1528-1554.nxml.txt.nlp	24281171	SENT320	29	29	37	37	doxorubicin	CD133	PA449412	8842	0.856
NULL	Diabetes_Care_2009_Aug_9_32(8)_1485-1490.nxml.txt.nlp	19509012	SENT114	38	38	18	18	valsartan	REN	PA451848	5972;147040	0.856
NULL	Diabetes_Metab_J_2013_Feb_15_37(1)_72-80.nxml.txt.nlp	23439802	SENT102	0	0	17	17	vildagliptin	GLP-1	PA165958346	100125288	0.856
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT90	14	14	22	22	cisplatin	XPC	PA449014	7508	0.856
NULL	Front_Endocrinol_(Lausanne)_2014_Oct_27_5_163.nxml.txt.nlp	25386163	SENT289	14	14	26	26	olanzapine	ghrelin	PA450688	51738	0.856
NULL	J_Cell_Biol_2001_May_14_153(4)_785-794.nxml.txt.nlp	11352939	SENT36	31	31	15	15	tetracycline	LIP	PA451640	23049	0.856
NULL	Infect_Drug_Resist_2011_Mar_2_4_77-86.nxml.txt.nlp	21694911	SENT75	18	18	3	3	tigecycline	HAP	PA164746412	5915;10313	0.856
NULL	Anticancer_Agents_Med_Chem_2012_Feb_12(2)_163-171.nxml.txt.nlp	22043994	SENT149	14	14	6	6	cetuximab	KRAS	PA10040	3845	0.856
NULL	J_Headache_Pain_2008_Feb_24_9(1)_13-18.nxml.txt.nlp	18217199	SENT129	4	4	8	8	nortriptyline	CYP2C19	PA450657	1557	0.856
NULL	J_Cardiovasc_Electrophysiol_2010_Oct_21(10)_1153-1159.nxml.txt.nlp	20384647	SENT100	16	16	12	12	flecainide	PES	PA449646	23481	0.856
NULL	Cell_Commun_Signal_2014_Sep_25_12(1)_61.nxml.txt.nlp	NULL	SENT411	20	20	3	3	doxycycline	PC-3	PA449415	692094	0.856
NULL	Eur_J_Clin_Pharmacol_2008_Feb_26_64(2)_133-157.nxml.txt.nlp	18224312	SENT572	39	39	2	2	celecoxib	CYP2C9	PA448871	1559	0.856
NULL	Cancer_Immunol_Immunother_2013_Jul_20_62(9)_1533-1545.nxml.txt.nlp	23873089	SENT102	29	29	15	15	ixabepilone	CD69		969	0.856
NULL	Arthritis_Res_Ther_2012_Sep_24_14(5)_R200.nxml.txt.nlp	23006144	SENT114	4	4	15	15	alefacept	CD4	PA164748040	920	0.856
NULL	Clinics_(Sao_Paulo)_2014_Jul_69(7)_491-496.nxml.txt.nlp	25029582	SENT110	13	13	18	18	methacholine	IL-4	PA165958382	3565	0.856
NULL	Breast_Cancer_Res_Treat_2013_Jun_5_139(3)_649-655.nxml.txt.nlp	23736997	SENT138	13	13	45	45	tamoxifen	CYP2C19	PA451581	1557	0.856
NULL	Br_J_Cancer_2013_Apr_16_108(7)_1408-1414.nxml.txt.nlp	23511562	SENT8	11	11	16	16	tamoxifen	aromatase	PA451581	1588	0.856
NULL	Breast_Cancer_Res_2011_Apr_6_13(2)_207.nxml.txt.nlp	21586099	SENT60	22	22	5	5	denosumab	RANKL	PA166048634	8600	0.856
NULL	Case_Rep_Hematol_2013_Oct_9_2013_458303.nxml.txt.nlp	24224106	SENT37	15	15	13	13	cyclophosphamide	CHOP	PA449165	1649	0.856
NULL	Nucleic_Acids_Res_2011_Dec_10_39(22)_9498-9507.nxml.txt.nlp	21835778	SENT178	8	8	25	25	camptothecin	p53	PA153590860	7157	0.856
NULL	Korean_J_Anesthesiol_2013_Jan_21_64(1)_47-53.nxml.txt.nlp	23372886	SENT33	8	8	28	28	bupivacaine	IGK	PA135057240	50802	0.856
NULL	Evid_Based_Complement_Alternat_Med_2013_Aug_12_2013_301549.nxml.txt.nlp	23997792	SENT177	13	13	4	4	tamoxifen	CAM	PA451581	889	0.856
NULL	Acta_Pharmacol_Sin_2011_Oct_15_32(10)_1233-1238.nxml.txt.nlp	21841815	SENT107	26	26	9	9	naloxone	CTX	PA450586	1593	0.856
NULL	J_Adv_Pharm_Technol_Res_2011_Apr-Jun_2(2)_81-87.nxml.txt.nlp	22171298	SENT184	16	16	24	24	indomethacin	p53	PA449982	7157	0.856
NULL	Arthritis_Res_Ther_2009_May_19_11(3)_225.nxml.txt.nlp	19490600	SENT188	0	0	13	13	abatacept	CD28	PA164747080	1493;940	0.856
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Feb_15_5_3.nxml.txt.nlp	16480505	SENT101	14	14	5	5	rifabutin	CYP3A4	PA451249	1576	0.856
NULL	Cell_Commun_Signal_2004_Jun_25_2_5.nxml.txt.nlp	15219238	SENT156	9	9	17	17	estradiol	JNK	PA449503	5599	0.856
NULL	Biomed_Res_Int_2013_Oct_20_2013_584549.nxml.txt.nlp	24228255	SENT176	10	10	2	2	raloxifene	zeta	PA451221	9907	0.856
NULL	Arch_Med_Sci_2013_Oct_31_9(5)_936-943.nxml.txt.nlp	24273582	SENT103	27	27	21	21	nateglinide	GLP-1	PA450600	100125288	0.856
NULL	Blood_Cancer_J_2012_Oct_12_2(10)_e93.nxml.txt.nlp	23064741	SENT134	19	19	8	8	alemtuzumab	CHOP	PA164783958	1649	0.856
NULL	Biologics_2013_May_6_7_115-122.nxml.txt.nlp	23674887	SENT96	16	16	5	5	ketoconazole	CYP3A4	PA450146	1576	0.856
NULL	Int_J_Biomed_Sci_2014_Sep_10(3)_217-220.nxml.txt.nlp	25324704	SENT96	6	6	2	2	amiodarone	APT	PA448383	653639	0.856
NULL	J_Mol_Med_(Berl)_2014_May_10_92(7)_709-722.nxml.txt.nlp	24811491	SENT219	19	19	8	8	cetuximab	BRAF	PA10040	673	0.856
NULL	Cell_Res_2013_Jul_21_23(7)_915-930.nxml.txt.nlp	23689279	SENT100	17	17	29	29	ethanol	ALDH2	PA448073	217	0.856
NULL	Breast_Cancer_Res_2005_Jan_17_7(2)_R248-R255.nxml.txt.nlp	15743505	SENT193	14	14	16	16	fluorescein	ZO-1	PA164746009	7082	0.856
NULL	Br_J_Cancer_2012_Nov_20_107(11)_1844-1852.nxml.txt.nlp	23169337	SENT293	17	17	33	33	bortezomib	AKT	PA10252	207	0.856
NULL	J_Gastrointest_Surg_2012_Apr_13_16(4)_842-848.nxml.txt.nlp	22246855	SENT94	20	20	16	16	cetuximab	HER2	PA10040	2064	0.856
NULL	Gene_Ther_2010_Apr_25_17(4)_550-559.nxml.txt.nlp	20182517	SENT6	23	23	18	18	oxaliplatin	TRAIL	PA131285527	8743	0.856
NULL	Cancer_Cell_Int_2010_Apr_29_10_12.nxml.txt.nlp	20429927	SENT117	15	15	7	7	arsenite	HRI	PA452638	27102	0.856
NULL	eLife_2013_Nov_5_2_e00969.nxml.txt.nlp	24192036	SENT212	0	0	25	25	vemurafenib	JNK	PA165946873	5599	0.856
NULL	Arthritis_Res_Ther_2011_Feb_4_13(1)_R14.nxml.txt.nlp	21294864	SENT94	28	28	21	21	indomethacin	IL-17	PA449982	3605	0.856
NULL	Arthritis_Res_Ther_2006_Jul_21_8(4)_R130.nxml.txt.nlp	16859540	SENT169	32	32	35	35	atorvastatin	CD59	PA448500	966	0.856
NULL	Br_J_Cancer_2010_Oct_26_103(9)_1331-1334.nxml.txt.nlp	20877352	SENT7	10	10	2	2	trastuzumab	HER2	PA451743	2064	0.856
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2011_Jun_7_4_29-37.nxml.txt.nlp	22879792	SENT37	8	8	2	2	gemfibrozil	CYP2C8	PA449750	1558	0.856
NULL	Br_J_Clin_Pharmacol_2014_Nov_20_78(5)_981-995.nxml.txt.nlp	24802902	SENT403	35	35	3	3	gabapentin	gamma	PA449720	9913	0.856
NULL	Genet_Sel_Evol_2004_Mar_15_36(2)_243-257.nxml.txt.nlp	15040901	SENT6	36	36	20	20	taurine	CSN1S1	PA451590	1446	0.856
NULL	J_Korean_Med_Sci_2008_Aug_25_23(4)_598-603.nxml.txt.nlp	18756044	SENT111	34	34	28	28	docetaxel	CRT	PA449383	811	0.856
NULL	Environ_Health_Perspect_2008_Jan_5_116(1)_1-6.nxml.txt.nlp	18197291	SENT143	27	27	16	16	arsenite	p85	PA452638	5296;5295;54776;23368	0.856
NULL	Cell_Death_Dis_2010_May_13_1(5)_e41.nxml.txt.nlp	21364648	SENT80	16	16	4	4	etoposide	p53	PA449552	7157	0.856
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jun_13_68(Pt_7)_o2086.nxml.txt.nlp	22798767	SENT66	12	12	6	6	ethanol	mol	PA448073	90527	0.856
NULL	Indian_J_Med_Res_2013_Jan_137(1)_125-129.nxml.txt.nlp	23481061	SENT13	19	19	13	13	cisplatin	GSTM1	PA449014	2944	0.856
NULL	Protein_Cell_2014_Dec_21_5(12)_899-911.nxml.txt.nlp	25411122	SENT184	6	6	4	4	imiquimod	TLR7	PA449972	51284	0.856
NULL	Ther_Clin_Risk_Manag_2006_Jun_2(2)_129-158.nxml.txt.nlp	18360588	SENT197	0	0	2	2	voriconazole	CYP3A4	PA10233	1576	0.856
NULL	Biomed_Res_Int_2013_Jul_31_2013_692071.nxml.txt.nlp	23984399	SENT154	8	8	16	16	lamivudine	OCT1	PA450163	5451;6580	0.856
NULL	Nat_Commun_2013_Sep_17_4_2464.nxml.txt.nlp	24043118	SENT121	33	33	9	9	estradiol	MYC	PA449503	4609	0.856
NULL	Blood_Cancer_J_2012_Oct_19_2(10)_e95.nxml.txt.nlp	23085780	SENT153	16	16	45	45	dasatinib	CML	PA162372878	613	0.856
NULL	Eur_J_Med_Res_2014_Sep_16_19(1)_50.nxml.txt.nlp	25223338	SENT49	16	16	43	43	docetaxel	TYMS	PA449383	7298	0.856
NULL	Onco_Targets_Ther_2014_Sep_5_7_1551-1562.nxml.txt.nlp	25228814	SENT178	7	7	0	0	bevacizumab	MMP9	PA130232992	4318	0.856
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2014_Jun_29_70(Pt_7)_1922-1933.nxml.txt.nlp	25004969	SENT186	24	24	10	10	cycloserine	PLP	PA164764600	25824;5744	0.856
NULL	J_Biol_Eng_2009_Oct_16_3_18.nxml.txt.nlp	19835592	SENT140	1	1	28	28	tetracycline	CPZ	PA451640	8532	0.856
NULL	Cancer_Manag_Res_2012_Nov_9_4_383-395.nxml.txt.nlp	23204869	SENT244	9	9	0	0	carmustine	PC-3	PA448810	692094	0.856
NULL	Indian_J_Pharmacol_2014_May-Jun_46(3)_266-269.nxml.txt.nlp	24987171	SENT73	9	9	19	19	dextromethorphan	CYP2D6	PA449273	1565	0.856
NULL	Environ_Health_Perspect_2008_Nov_30_116(11)_1439-1442.nxml.txt.nlp	19057693	SENT65	8	8	10	10	diethylstilbestrol	DES	PA449307	1674	0.856
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_11_2014_274786.nxml.txt.nlp	25505920	SENT246	7	7	15	15	cisplatin	ERCC1	PA449014	2067	0.856
NULL	Adv_Urol_2012_Oct_26_2012_812398.nxml.txt.nlp	22110495	SENT116	12	12	32	32	cisplatin	ERCC1	PA449014	2067	0.856
NULL	J_Geriatr_Cardiol_2012_Jun_9(2)_180-184.nxml.txt.nlp	22916066	SENT125	29	29	20	20	rosuvastatin	Rho	PA134308647	29984	0.856
NULL	Clin_Endosc_2013_Nov_19_46(6)_620-626.nxml.txt.nlp	24340254	SENT90	0	0	11	11	cetuximab	EGFR	PA10040	1956	0.856
NULL	Acta_Pharmacol_Sin_2010_Jun_4_31(6)_709-717.nxml.txt.nlp	20523342	SENT142	15	15	27	27	repaglinide	CYP2C8	PA451234	1558	0.856
NULL	J_Korean_Med_Sci_2001_Apr_16(2)_135-139.nxml.txt.nlp	11306736	SENT13	10	10	12	12	etoposide	MDM2	PA449552	4193	0.856
NULL	Oxid_Med_Cell_Longev_2013_Jul_9_2013_574029.nxml.txt.nlp	23936610	SENT157	4	4	32	32	resveratrol	CD80		941	0.856
NULL	Diabetes_2013_Sep_15_62(9)_3232-3240.nxml.txt.nlp	23835329	SENT7	3	3	24	24	olanzapine	GLP-1	PA450688	100125288	0.856
NULL	Eur_J_Endocrinol_2011_Jan_164(1)_69-74.nxml.txt.nlp	20961967	SENT101	2	2	15	15	pioglitazone	OPG	PA450970	690	0.856
NULL	Mol_Cancer_2014_Apr_30_13_98.nxml.txt.nlp	24779770	SENT196	12	12	6	6	oxygen	Bcl-2	PA450744	596	0.856
NULL	Open_Biochem_J_2014_Nov_1_8_74-82.nxml.txt.nlp	25400709	SENT168	16	16	24	24	curcumin	PTEN	PA151958596	5728	0.856
NULL	Endocr_Connect_2012_Jun_8_1(1)_1-12.nxml.txt.nlp	23781298	SENT42	9	9	13	13	fenofibrate	ATROGIN1	PA449594	114907	0.856
NULL	Exp_Brain_Res_2014_Jun_27_232(8)_2637-2644.nxml.txt.nlp	24969614	SENT166	13	13	16	16	palonosetron	NK1	PA10352	11126	0.856
NULL	Braz_J_Med_Biol_Res_2012_Mar_2_45(3)_250-255.nxml.txt.nlp	22370705	SENT147	11	11	3	3	vasopressin	SON	PA451858	6651	0.856
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_11_2014_274786.nxml.txt.nlp	25505920	SENT164	23	23	9	9	oxaliplatin	ERCC1	PA131285527	2067	0.856
NULL	Adv_Hematol_2010_Dec_30_2010_624040.nxml.txt.nlp	21234357	SENT112	11	11	20	20	vincristine	CHOP	PA451879	1649	0.856
NULL	Cancer_Manag_Res_2012_Nov_9_4_383-395.nxml.txt.nlp	23204869	SENT257	10	10	3	3	carmustine	PC-3	PA448810	692094	0.856
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Dec_17_3(12)_e152.nxml.txt.nlp	25518025	SENT41	8	8	3	3	itraconazole	CYP3A	PA450132	1574	0.856
NULL	Mol_Cancer_2008_Oct_23_7_82.nxml.txt.nlp	18947424	SENT278	2	2	17	17	doxazosin	AP-1	PA449407	2353;3727;2354;3725	0.856
NULL	CNS_Spectr_2014_Apr_1_19(2)_121-133.nxml.txt.nlp	23903233	SENT442	9	9	6	6	phencyclidine	5-HT1A	PA128406980	3350	0.856
NULL	Mol_Cancer_2010_May_28_9_127.nxml.txt.nlp	20509860	SENT47	12	12	35	35	mitomycin	FANCD2	PA450524	2177	0.856
NULL	J_Cancer_2014_Jul_29_5(7)_609-624.nxml.txt.nlp	25161699	SENT266	5	5	25	25	curcumin	p38	PA151958596	10598;1432;7965	0.856
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT153	38	38	14	14	capsaicin	TP53	PA448776	7157	0.856
NULL	Cell_Res_2013_Jul_21_23(7)_915-930.nxml.txt.nlp	23689279	SENT4	12	12	4	4	ethanol	ALDH2	PA448073	217	0.856
NULL	Acta_Pharmacol_Sin_2013_Apr_11_34(4)_473-479.nxml.txt.nlp	23474709	SENT165	5	5	0	0	arsenite	MRP1	PA452638	4437	0.856
NULL	Br_J_Cancer_2010_Jul_27_103(3)_315-323.nxml.txt.nlp	20661248	SENT270	38	38	6	6	irinotecan	UGT1A1	PA450085	54658	0.856
NULL	Eur_J_Pharmacol_2008_Feb_12_580(3-3)_291-297.nxml.txt.nlp	18082160	SENT103	3	3	17	17	granisetron	5-HT3A	PA449809	3359	0.856
NULL	Arthritis_Rheumatol_2014_Jun_27_66(6)_1574-1582.nxml.txt.nlp	24577881	SENT131	37	37	11	11	hydralazine	CD4	PA449894	920	0.856
NULL	Cell_Biol_Int_Rep_(2010)_2012_Jun_21_19(1)_e00017.nxml.txt.nlp	23124518	SENT135	17	17	19	19	etoposide	TRAIL	PA449552	8743	0.856
NULL	Breast_Cancer_Res_2007_Jan_23_9(1)_R7.nxml.txt.nlp	17244352	SENT43	5	5	12	12	tamoxifen	CYP2D6	PA451581	1565	0.856
NULL	J_Cell_Biol_2001_Feb_19_152(4)_717-728.nxml.txt.nlp	11266463	SENT133	24	24	0	0	lipase	PI3K	PA450239	5290	0.856
NULL	Br_J_Cancer_2010_Oct_12_103(8)_1309-1310.nxml.txt.nlp	NULL	SENT16	19	19	14	14	sunitinib	IFN	PA162372840	3439	0.856
NULL	J_Cell_Mol_Med_2013_Dec_6_17(12)_1588-1597.nxml.txt.nlp	24199964	SENT65	4	4	28	28	dobutamine	APT	PA449381	653639	0.856
NULL	Cell_Death_Dis_2014_Jan_30_5(1)_e1030.nxml.txt.nlp	24481444	SENT111	28	28	18	18	sorafenib	Bcl-2	PA7000	596	0.856
NULL	Diabetes_Care_2009_Nov_32(Suppl_2)_S362-S367.nxml.txt.nlp	19875582	SENT87	28	28	22	22	deferoxamine	RBP4	PA164746490	5433;5950	0.856
NULL	Diabetes_Care_2013_May_13_36(5)_1074-1082.nxml.txt.nlp	23275352	SENT12	14	14	8	8	liraglutide	ZAG	PA165958364	563	0.856
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT102	15	15	26	26	l-leucine	4E-BP1	PA450197	1978	0.856
NULL	Cancer_Med_2014_Dec_1_3(6)_1493-1501.nxml.txt.nlp	25081631	SENT203	24	24	21	21	cetuximab	EGFR	PA10040	1956	0.856
NULL	Braz_J_Med_Biol_Res_2014_Feb_17_47(2)_90-100.nxml.txt.nlp	24519124	SENT161	32	32	20	20	losartan	AT2	PA450268	186	0.856
NULL	Biology_(Basel)_2012_Dec_31_2(1)_40-63.nxml.txt.nlp	24832651	SENT557	23	23	6	6	cisplatin	BRCA1	PA449014	672	0.856
NULL	Oncotarget_2014_Sep_9_5(20)_9811-9822.nxml.txt.nlp	25238146	SENT155	0	0	7	7	bevacizumab	VEGF-A	PA130232992	7422	0.856
NULL	Nucleic_Acids_Res_2013_Dec_12_41(22)_10312-10322.nxml.txt.nlp	24038355	SENT83	31	31	5	5	paraformaldehyde	REV1	PA450790	51455	0.856
NULL	Cancer_Cell_Int_2011_Nov_17_11_40.nxml.txt.nlp	22088142	SENT153	23	23	11	11	gefitinib	MRP3	PA131301952	8714	0.856
NULL	Diabetes_Metab_Syndr_Obes_2010_Sep_22_3_325-335.nxml.txt.nlp	21437102	SENT27	27	27	39	39	saxagliptin	GLP-1	PA165958362	100125288	0.856
NULL	J_Biol_Chem_2013_Aug_23_288(34)_24799-24808.nxml.txt.nlp	23836892	SENT72	18	18	13	13	chymotrypsin	PSST	PA448994	374291	0.856
NULL	Clin_Epigenetics_2011_May_7_2(2)_249-256.nxml.txt.nlp	22704340	SENT139	7	7	29	29	l-methionine	RELN	PA450423	5649	0.856
NULL	Clin_Dev_Immunol_2007_Jan_20_2007_76396.nxml.txt.nlp	18317531	SENT88	5	5	27	27	sertraline	IL-4	PA451333	3565	0.856
NULL	J_Invest_Dermatol_2012_Sep_10_132(9)_2255-2262.nxml.txt.nlp	22572817	SENT157	31	31	23	23	forskolin	HBD3	PA146096022	414325	0.856
NULL	Gut_2013_Apr_14_62(4)_540-549.nxml.txt.nlp	22798500	SENT257	23	23	17	17	cetuximab	PIK3CA	PA10040	5290	0.856
NULL	Case_Rep_Oncol_2013_Mar_29_6(1)_189-196.nxml.txt.nlp	23626560	SENT4	14	14	6	6	gefitinib	EGFR	PA131301952	1956	0.856
NULL	Indian_J_Anaesth_2014_Mar-Apr_58(2)_238-239.nxml.txt.nlp	24963210	SENT48	16	16	8	8	sevoflurane	LGS	PA451341	51557	0.856
NULL	J_Invest_Dermatol_2012_Sep_19_132(9)_2198-2205.nxml.txt.nlp	22513780	SENT189	31	31	9	9	isotretinoin	TLR2	PA450128	7097	0.856
NULL	Cancer_Manag_Res_2014_Jan_28_6_39-51.nxml.txt.nlp	24501545	SENT138	6	6	12	12	rifampin	CYP3A4	PA451250	1576	0.856
NULL	Angiogenesis_2012_Sep_27_15(3)_361-376.nxml.txt.nlp	22451299	SENT62	9	9	21	21	resveratrol	HHS		2591	0.856
NULL	Cancers_(Basel)_2013_Mar_11_5(1)_255-280.nxml.txt.nlp	24216707	SENT112	26	26	18	18	rifampin	CYP3A4	PA451250	1576	0.856
NULL	Oncotarget_2013_Nov_7_4(12)_2550-2566.nxml.txt.nlp	24334291	SENT207	5	5	17	17	dasatinib	p53	PA162372878	7157	0.855
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT293	7	7	16	16	cisplatin	JNK	PA449014	5599	0.855
NULL	Mol_Cancer_2009_Dec_21_8_125.nxml.txt.nlp	20021699	SENT7	22	22	24	24	gemcitabine	Gem	PA449748	51053	0.855
NULL	Oncotarget_2013_Dec_18_5(2)_375-385.nxml.txt.nlp	24495868	SENT157	32	32	10	10	fludarabine	MCL1	PA449655	4170	0.855
NULL	Acta_Pharmacol_Sin_2010_Sep_23_31(9)_1213-1222.nxml.txt.nlp	20729877	SENT40	8	8	18	18	suramin	LPA	PA10292	4018	0.855
NULL	Br_J_Pharmacol_2011_Apr_162(8)_1832-1842.nxml.txt.nlp	21232033	SENT253	9	9	18	18	resveratrol	SIRT1		23411	0.855
NULL	Breast_Cancer_Res_2005_Jun_7_7(5)_R645-R654.nxml.txt.nlp	16168109	SENT29	6	6	23	23	propofol	Rho	PA451141	29984	0.855
NULL	Acta_Pharmacol_Sin_2014_Jun_5_35(6)_727-737.nxml.txt.nlp	24793312	SENT119	0	0	14	14	telmisartan	B27	PA451605	56246	0.855
NULL	Front_Endocrinol_(Lausanne)_2013_Oct_29_4_161.nxml.txt.nlp	24194732	SENT144	0	0	12	12	estradiol	AT1	PA449503	9197;185	0.855
NULL	Chem_Cent_J_2013_Apr_15_7_68.nxml.txt.nlp	23587363	SENT240	28	28	19	19	ethanol	mol	PA448073	90527	0.855
NULL	J_Korean_Med_Sci_2011_Jul_20_26(7)_893-899.nxml.txt.nlp	21738342	SENT10	4	4	27	27	genistein	CD97	PA165109660	976	0.855
NULL	Lipids_Health_Dis_2011_Jul_5_10_112.nxml.txt.nlp	21729290	SENT18	18	18	0	0	simvastatin	ApoM	PA451363	55937	0.855
NULL	Case_Rep_Transplant_2013_Aug_1_2013_765230.nxml.txt.nlp	23984169	SENT37	4	4	13	13	cyclophosphamide	CHOP	PA449165	1649	0.855
NULL	Nat_Commun_2014_Nov_25_5_5582.nxml.txt.nlp	25420773	SENT111	13	13	28	28	erlotinib	PHD3	PA134687924	112399	0.855
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_28_2012_259523.nxml.txt.nlp	23243436	SENT61	17	17	25	25	cisplatin	Bcl-2	PA449014	596	0.855
NULL	Oncol_Lett_2014_Mar_19_7(3)_674-678.nxml.txt.nlp	24527071	SENT86	4	4	12	12	cisplatin	AKR1C2	PA449014	1646	0.855
NULL	J_Cell_Biol_2003_Sep_1_162(5)_773-780.nxml.txt.nlp	12952931	SENT63	14	14	5	5	tetracycline	AAK1	PA451640	22848	0.855
NULL	Oncol_Lett_2014_Jul_12_8(1)_223-229.nxml.txt.nlp	24959250	SENT93	0	0	24	24	captopril	MCP-1	PA448780	6347	0.855
NULL	BMB_Rep_2014_Nov_47(11)_649-654.nxml.txt.nlp	25301019	SENT128	5	5	12	12	l-alanine	STAT3	PA448055	6774	0.855
NULL	Cardiol_Res_Pract_2013_Jan_31_2013_128795.nxml.txt.nlp	23431496	SENT59	26	26	23	23	clopidogrel	P2Y12	PA449053	64805	0.855
NULL	Biologics_2012_Oct_25_6_371-378.nxml.txt.nlp	23118526	SENT229	3	3	9	9	tocilizumab	TNF-alpha	PA165292659	7124	0.855
NULL	J_Biol_Chem_2008_Jun_20_283(25)_17194-17204.nxml.txt.nlp	18442977	SENT90	26	26	28	28	ketanserin	5-HT2A	PA131053734	3356	0.855
NULL	AAPS_J_2012_Jan_4_14(1)_87-96.nxml.txt.nlp	22215264	SENT245	27	27	10	10	quinidine	P-gp	PA451209	5243	0.855
NULL	Front_Genet_2012_Nov_12_3_235.nxml.txt.nlp	23162568	SENT40	17	17	0	0	methamphetamine	CYP2D6	PA450403	1565	0.855
NULL	Nat_Commun_2014_Nov_25_5_5548.nxml.txt.nlp	25420520	SENT105	47	47	31	31	docetaxel	ERG	PA449383	2078	0.855
NULL	Biologics_2011_Aug_9_5_87-94.nxml.txt.nlp	21847344	SENT176	6	6	29	29	trastuzumab	San	PA451743	80218	0.855
NULL	Breast_Cancer_Res_2012_May_4_14(3)_R72.nxml.txt.nlp	22559056	SENT48	10	10	5	5	tamoxifen	CENP-A	PA451581	1058	0.855
NULL	Arch_Pharm_Res_2014_Sep_20_37(12)_1507-1514.nxml.txt.nlp	25239110	SENT137	2	2	5	5	metformin	AMPK	PA450395	5563	0.855
NULL	Cell_Biol_Int_Rep_(2010)_2012_Jun_21_19(1)_e00017.nxml.txt.nlp	23124518	SENT137	36	36	29	29	etoposide	TRAIL	PA449552	8743	0.855
NULL	Curr_Cardiol_Rev_2012_Aug_8(3)_177-180.nxml.txt.nlp	22920485	SENT58	22	22	28	28	heparin	P2Y12	PA449855	64805	0.855
NULL	Biomed_Res_Int_2013_Dec_5_2013_642848.nxml.txt.nlp	24381940	SENT167	12	12	5	5	cisplatin	IL-6	PA449014	3569	0.855
NULL	J_Oral_Pathol_Med_2013_Jul_18_42(6)_499-506.nxml.txt.nlp	23331485	SENT72	16	16	7	7	indomethacin	COX	PA449982	1351	0.855
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Mar_31_68(Pt_4)_o1263.nxml.txt.nlp	22606192	SENT60	23	23	29	29	exemestane	aromatase	PA449563	1588	0.855
NULL	Mol_Pain_2013_Feb_15_9_3.nxml.txt.nlp	23413875	SENT201	21	21	7	7	resveratrol	TRPA1		8989	0.855
NULL	Mol_Biol_Cell_2013_Jul_15_24(14)_2186-2200.nxml.txt.nlp	23699397	SENT95	5	5	22	22	staurosporine	TRAIL	PA165109623	8743	0.855
NULL	Breast_Cancer_Res_2007_Aug_31_9(4)_R56.nxml.txt.nlp	17764562	SENT229	29	29	19	19	doxorubicin	gamma	PA449412	9913	0.855
NULL	Neuropsychopharmacology_2009_Jul_11_34(8)_1946-1957.nxml.txt.nlp	19279569	SENT94	6	6	18	18	cocaine	DOR	PA449072	58476	0.855
NULL	Breast_Cancer_Res_2011_May_19_13(3)_R52.nxml.txt.nlp	21595894	SENT320	27	27	16	16	tamoxifen	HER2	PA451581	2064	0.855
NULL	Nat_Biotechnol_2010_Mar_14_28(3)_249-255.nxml.txt.nlp	20160716	SENT178	22	22	29	29	meclizine	ADP	PA450338	23038	0.855
NULL	Breast_Cancer_Res_2011_Mar_1_13(2)_R21.nxml.txt.nlp	21362200	SENT154	5	5	17	17	estradiol	p110	PA449503	9733	0.855
NULL	J_Carcinog_2013_Dec_31_12_22.nxml.txt.nlp	24574860	SENT48	6	6	21	21	cetuximab	EGFR	PA10040	1956	0.855
NULL	Eur_J_Neurosci_2008_Jun_27(12)_3151-3160.nxml.txt.nlp	18598259	SENT253	8	8	27	27	capsaicin	TRPV1	PA448776	7442	0.855
NULL	Breast_Cancer_Res_2010_Mar_5_12(2)_R16.nxml.txt.nlp	20205716	SENT283	8	8	33	33	lovastatin	AKT	PA450272	207	0.855
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT94	31	31	10	10	pertuzumab	HER3		2065	0.855
NULL	Oncotarget_2011_Dec_15_2(12)_984-996.nxml.txt.nlp	22184287	SENT8	5	5	26	26	olaparib	PARP1		142	0.855
NULL	Clin_Dev_Immunol_2013_Nov_26_2013_325481.nxml.txt.nlp	24371447	SENT157	2	2	8	8	propofol	IL-6	PA451141	3569	0.855
NULL	Br_J_Cancer_2014_Dec_9_111(12)_2380.nxml.txt.nlp	24619079	SENT28	22	22	9	9	irinotecan	EGFR	PA450085	1956	0.855
NULL	Arch_Sex_Behav_2009_Jun_11_38(3)_411-416.nxml.txt.nlp	18784994	SENT16	8	8	10	10	diethylstilbestrol	DES	PA449307	1674	0.855
NULL	Indian_J_Med_Res_2013_Jan_137(1)_125-129.nxml.txt.nlp	23481061	SENT85	17	17	11	11	cisplatin	GSTM1	PA449014	2944	0.855
NULL	Biol_Proced_Online_2003_Oct_24_5_204-210.nxml.txt.nlp	14615817	SENT67	16	16	24	24	imatinib	IL-3	PA10804	3562	0.855
NULL	Curr_Neuropharmacol_2013_May_11(3)_263-275.nxml.txt.nlp	24179463	SENT127	3	3	16	16	imipramine	CB1	PA449969	1268	0.855
NULL	Croat_Med_J_2013_Apr_54(2)_171-179.nxml.txt.nlp	23630144	SENT113	15	15	25	25	taurine	STZ	PA451590	6484	0.855
NULL	Breast_Cancer_Res_2006_Nov_6_8(6)_215.nxml.txt.nlp	17096862	SENT47	18	18	11	11	trastuzumab	MUC4	PA451743	4585	0.855
NULL	J_Lipid_Res_2015_Jan_56(1)_109-121.nxml.txt.nlp	25421061	SENT35	35	35	15	15	lipase	CGI-58	PA450239	51099	0.855
NULL	Breast_Cancer_Res_2007_Jul_5_9(4)_R41.nxml.txt.nlp	17612393	SENT159	37	37	9	9	celecoxib	Bcl-2	PA448871	596	0.855
NULL	Br_J_Cancer_2012_Jan_31_106(3)_475-481.nxml.txt.nlp	22187040	SENT157	23	23	17	17	sorafenib	FLT3	PA7000	2322	0.855
NULL	J_Cardiothorac_Surg_2014_Sep_17_9(1)_129.nxml.txt.nlp	NULL	SENT173	17	17	9	9	heparin	ACT	PA449855	12;11332;9457;641455	0.855
NULL	Breast_Cancer_Res_2008_Mar_29_10(2)_R28.nxml.txt.nlp	18373870	SENT168	34	34	42	42	estradiol	MYC	PA449503	4609	0.855
NULL	Br_J_Pharmacol_2010_Aug_160(8)_1997-2007.nxml.txt.nlp	20649597	SENT122	9	9	11	11	pp2	NOS2		339345;4843	0.855
NULL	Clin_Ophthalmol_2009_Jun_2_3_199-210.nxml.txt.nlp	19668566	SENT84	25	25	4	4	ketorolac	COX	PA450150	1351	0.855
NULL	Breast_Cancer_Res_2014_Dec_19_16(6)_499.nxml.txt.nlp	25522654	SENT43	27	27	19	19	estradiol	CYP19A1	PA449503	1588	0.855
NULL	J_Hematol_Oncol_2011_Apr_20_4_17.nxml.txt.nlp	21507255	SENT53	41	41	9	9	cisplatin	HDAC4	PA449014	9759	0.855
NULL	J_Cell_Biol_1998_Jan_26_140(2)_335-345.nxml.txt.nlp	9442109	SENT242	5	5	10	10	chloroquine	NHE	PA448948	285335	0.855
NULL	Indian_J_Ophthalmol_2013_Sep_61(9)_475-478.nxml.txt.nlp	24104704	SENT10	0	0	19	19	pegaptanib	VEGF-A	PA164771236	7422	0.855
NULL	Evid_Based_Complement_Alternat_Med_2013_Aug_12_2013_982689.nxml.txt.nlp	23997806	SENT248	23	23	9	9	tolbutamide	APE	PA451718	55704;328	0.855
NULL	Arthritis_Res_Ther_2011_Aug_11_13(4)_R130.nxml.txt.nlp	21835001	SENT279	19	19	9	9	collagenase	FGFR1	PA449107	2260	0.855
NULL	Diabetes_Obes_Metab_2010_Aug_12(8)_700-708.nxml.txt.nlp	20590747	SENT28	3	3	20	20	vildagliptin	PPG	PA165958346	5552	0.855
NULL	J_Ophthalmol_2011_Oct_20_2011_252549.nxml.txt.nlp	22046503	SENT114	8	8	21	21	ranibizumab	ARMS2	PA164746012	387715	0.855
NULL	Oncol_Lett_2013_Jul_8_6(1)_75-80.nxml.txt.nlp	23946780	SENT173	7	7	20	20	diclofenac	AP-1	PA449293	2353;3727;2354;3725	0.855
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT290	12	12	18	18	tacrolimus	RANKL	PA451578	8600	0.855
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT166	12	12	18	18	cisplatin	p53	PA449014	7157	0.855
NULL	Cardiovasc_Diabetol_2011_Feb_10_10_17.nxml.txt.nlp	21306649	SENT179	7	7	3	3	cinacalcet	PTH	PA164776671	5741	0.855
NULL	Nanoscale_Res_Lett_2010_Aug_18_6(1)_1.nxml.txt.nlp	21711573	SENT116	35	35	6	6	ethanol	NO3	PA448073	4681	0.855
NULL	Biologics_2010_Aug_9_4_173-185.nxml.txt.nlp	20714355	SENT130	5	5	8	8	cisplatin	PD2	PA449014	54623	0.855
NULL	Mol_Cell_Biochem_2013_Jun_3_378(1-2)_137-144.nxml.txt.nlp	23456481	SENT30	14	14	3	3	creatine	CCR5	PA164778930	1234	0.855
NULL	Biomed_Res_Int_2014_Feb_27_2014_214587.nxml.txt.nlp	24716192	SENT141	13	13	27	27	valsartan	LPA	PA451848	4018	0.855
NULL	Blood_Cancer_J_2014_Feb_28_4(2)_e187.nxml.txt.nlp	24583533	SENT30	30	30	11	11	azacitidine	CD25	PA451996	3669;3559	0.855
NULL	J_Carcinog_2011_Jun_17_10_15.nxml.txt.nlp	NULL	SENT1076	39	39	15	15	cyclophosphamide	CYP2C9	PA449165	1559	0.855
NULL	Biologics_2011_Aug_9_5_87-94.nxml.txt.nlp	21847344	SENT18	37	37	12	12	cyclophosphamide	B18	PA449165	59271;4713	0.855
NULL	Biomed_Res_Int_2014_Jan_29_2014_458592.nxml.txt.nlp	24592391	SENT82	8	8	4	4	curcumin	HO-1	PA151958596	3162	0.855
NULL	Oncoimmunology_2013_Apr_1_2(4)_e24117.nxml.txt.nlp	23734336	SENT93	29	29	26	26	docetaxel	STAT3	PA449383	6774	0.855
NULL	J_Hematop_2009_Sep_26_2(4)_205-210.nxml.txt.nlp	20309429	SENT62	15	15	8	8	imatinib	KIT	PA10804	3815	0.855
NULL	Clin_Exp_Otorhinolaryngol_2013_Mar_1_6(1)_48-51.nxml.txt.nlp	23526700	SENT56	24	24	30	30	thyroglobulin	CK20	PA164754910	54474	0.855
NULL	Breast_Cancer_Res_2012_Nov_13_14(6)_115.nxml.txt.nlp	23146216	SENT5	22	22	42	42	cisplatin	BRCA1	PA449014	672	0.855
NULL	Nucleic_Acids_Res_2011_Sep_19_39(16)_6932-6943.nxml.txt.nlp	21596782	SENT113	16	16	26	26	estradiol	pS2	PA449503	7031	0.855
NULL	Br_J_Pharmacol_2014_May_171(10)_2659-2670.nxml.txt.nlp	24116661	SENT17	13	13	2	2	naringenin	TRPP2	PA151958361	5311	0.855
NULL	J_Gen_Physiol_1990_Oct_1_96(4)_735-755.nxml.txt.nlp	2124257	SENT11	3	3	24	24	indomethacin	gamma	PA449982	9913	0.855
NULL	J_Immunother_2014_Apr_12_37(3)_180-186.nxml.txt.nlp	24598448	SENT30	34	34	23	23	sorafenib	IL-2	PA7000	3558	0.855
NULL	Acta_Pharmacol_Sin_2010_May_12_31(5)_578-584.nxml.txt.nlp	20383171	SENT137	3	3	18	18	berberine	JNK	PA165860812	5599	0.855
NULL	Cell_Death_Dis_2014_Apr_17_5(4)_e1182.nxml.txt.nlp	24743737	SENT48	4	4	8	8	capsaicin	AMPK	PA448776	5563	0.855
NULL	Mol_Pain_2014_Apr_18_10_27.nxml.txt.nlp	24742127	SENT39	15	15	4	4	vincristine	CB2	PA451879	1269	0.855
NULL	Cancers_(Basel)_2014_Jun_27_6(3)_1363-1381.nxml.txt.nlp	24978438	SENT220	9	9	15	15	bortezomib	CD138	PA10252	6382	0.855
NULL	Mar_Drugs_2011_Nov_2_9(11)_2188-2200.nxml.txt.nlp	22163181	SENT5	29	29	18	18	glibenclamide	PAG	PA449782	55824	0.855
NULL	Cancer_Metab_2014_May_28_2(Suppl_1)_O25.nxml.txt.nlp	NULL	SENT14	8	8	0	0	s-adenosylmethionine	NNMT	PA164754994	4837	0.855
NULL	Int_Clin_Psychopharmacol_2014_Mar_31_29(2)_86-92.nxml.txt.nlp	24247740	SENT24	9	9	12	12	vilazodone	5-HT1A	PA165958365	3350	0.855
NULL	Arch_Toxicol_2014_Nov_5_88(12)_2135-2190.nxml.txt.nlp	25370008	SENT1020	1	1	20	20	4-methylumbelliferone	UGT	PA154081778	7361;7355	0.855
NULL	Diagn_Pathol_2007_Dec_19_2_49.nxml.txt.nlp	18093326	SENT76	12	12	10	10	cyclophosphamide	CHOP	PA449165	1649	0.855
NULL	Commun_Integr_Biol_2013_Sep_1_6(5)_e25145.nxml.txt.nlp	24255740	SENT61	4	4	8	8	neomycin	DAG	PA450608	1605	0.855
NULL	Cardiovasc_J_Afr_2009_Apr_20(2)_127-134.nxml.txt.nlp	19421649	SENT168	24	24	33	33	ramipril	DREAM	PA451223	30818	0.855
NULL	Pharm_Pract_(Granada)_2011_Mar_15_Jan-Mar_9(1)_1-10.nxml.txt.nlp	25132883	SENT177	17	17	33	33	rivaroxaban	SPAF	PA165958360	166378	0.855
NULL	Theranostics_2013_Jan_15_3(1)_47-75.nxml.txt.nlp	23382786	SENT75	3	3	0	0	plerixafor	CXCR4	PA165958410	7852	0.855
NULL	Br_J_Cancer_2011_Jun_7_104(12)_1848-1853.nxml.txt.nlp	21610704	SENT90	16	16	4	4	panitumumab	REL	PA162373091	5966	0.855
NULL	J_Int_AIDS_Soc_2013_Apr_30_16(1)_18059.nxml.txt.nlp	23639243	SENT0	28	28	37	37	tenofovir	CD4	PA10204	920	0.855
NULL	J_Cardiothorac_Surg_2013_May_17_8_131.nxml.txt.nlp	23684153	SENT41	24	24	10	10	thyroglobulin	CK19	PA164754910	3880	0.855
NULL	Oncol_Lett_2014_May_11_7(5)_1401-1408.nxml.txt.nlp	24765145	SENT109	24	24	11	11	paclitaxel	HIF-1	PA450761	29072	0.855
NULL	Cell_Death_Dis_2013_Oct_3_4(10)_e828.nxml.txt.nlp	24091671	SENT271	23	23	11	11	cetuximab	CD54	PA10040	3383	0.855
NULL	BMJ_Open_2013_Nov_4_3(11)_e003995.nxml.txt.nlp	24189085	SENT358	26	26	3	3	liraglutide	PNN	PA165958364	5411	0.855
NULL	Oncogenesis_2012_Apr_2_1(4)_e5.nxml.txt.nlp	23552603	SENT241	23	23	35	35	ns-398	BAX		581	0.855
NULL	Front_Chem_2014_Mar_14_2_12.nxml.txt.nlp	24790981	SENT173	0	0	2	2	curcumin	p300	PA151958596	2033	0.855
NULL	Ann_Thorac_Med_2008_Oct-Dec_3(4)_149-151.nxml.txt.nlp	19561898	SENT3	15	15	17	17	ethambutol	EMB	PA164784021	133418	0.855
NULL	Cancer_Biol_Med_2013_Dec_10(4)_192-205.nxml.txt.nlp	24349829	SENT94	8	8	19	19	erlotinib	EGFR	PA134687924	1956	0.855
NULL	Biochem_Biophys_Res_Commun_2009_Apr_17_381(4)_523-527.nxml.txt.nlp	19239903	SENT81	18	18	16	16	betaine	GNMT	PA448603	27232	0.855
NULL	Arthritis_Res_Ther_2007_Sep_7_9(5)_R87.nxml.txt.nlp	17825098	SENT171	24	24	32	32	methotrexate	CD4	PA450428	920	0.855
NULL	ScientificWorldJournal_2012_Jun_18_2012_373709.nxml.txt.nlp	22761550	SENT106	26	26	17	17	isoflurane	NALCN	PA450106	259232	0.855
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Oct_22_67(Pt_11)_o3000.nxml.txt.nlp	22220018	SENT8	10	10	4	4	nitrile	mol	PA450636	90527	0.855
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_127043.nxml.txt.nlp	23227093	SENT141	11	11	4	4	lovastatin	RYR	PA450272	6261	0.855
NULL	Acta_Pharmacol_Sin_2013_Apr_25_34(4)_455-463.nxml.txt.nlp	23524568	SENT5	5	5	20	20	pioglitazone	STZ	PA450970	6484	0.855
NULL	Nat_Commun_2011_Jul_5_2_376.nxml.txt.nlp	21730957	SENT1459	16	16	9	9	picrotoxin	GAD65	PA164777007	2572	0.855
NULL	Crit_Care_2011_Aug_11_15(4)_226.nxml.txt.nlp	21892977	SENT379	41	41	33	33	vasopressin	AVPR2	PA451858	554	0.855
NULL	Case_Rep_Med_2013_Apr_10_2013_461409.nxml.txt.nlp	23662106	SENT41	3	3	13	13	mitotane	ACTH	PA164746157	5443	0.855
NULL	Nucleic_Acids_Res_2005_Jun_8_33(10)_3283-3291.nxml.txt.nlp	15944449	SENT434	32	32	22	22	sjg-136	XRCC3		7517	0.855
NULL	Mol_Cancer_2009_Jul_14_8_48.nxml.txt.nlp	19602291	SENT299	9	9	4	4	paclitaxel	BRCA1	PA450761	672	0.855
NULL	Infect_Dis_Ther_2014_Dec_24_3(2)_83-102.nxml.txt.nlp	25134686	SENT98	8	8	11	11	midazolam	CYP3A4	PA450496	1576	0.855
NULL	EMBO_Mol_Med_2012_Sep_7_4(9)_896-909.nxml.txt.nlp	22887866	SENT179	18	18	25	25	lovastatin	c-Myc	PA450272	4609	0.855
NULL	Eur_J_Clin_Pharmacol_2011_May_2_67(Suppl_1)_87-107.nxml.txt.nlp	21287160	SENT181	15	15	9	9	vincristine	CYP3A5	PA451879	1577	0.855
NULL	Cancer_Res_Treat_2012_Sep_30_44(3)_195-201.nxml.txt.nlp	23091446	SENT96	21	21	3	3	epirubicin	MKP-1	PA449476	1843	0.855
NULL	Biomed_Res_Int_2014_Jun_26_2014_483501.nxml.txt.nlp	25057490	SENT138	26	26	36	36	resveratrol	Bcl-2		596	0.855
NULL	Nat_Commun_2014_Nov_25_5_5548.nxml.txt.nlp	25420520	SENT620	12	12	38	38	cabazitaxel	ERG	PA165958401	2078	0.855
NULL	Int_J_Gen_Med_2012_Nov_9_5_935-942.nxml.txt.nlp	23204857	SENT8	43	43	4	4	pentobarbital	AIDA	PA450859	64853	0.855
NULL	Case_Rep_Pathol_2013_Nov_28_2013_736048.nxml.txt.nlp	24369519	SENT30	17	17	14	14	thyroglobulin	TTF-1	PA164754910	7080	0.855
NULL	J_Thromb_Haemost_2014_May_22_12(5)_748-760.nxml.txt.nlp	24612393	SENT24	4	4	20	20	thrombin	P2Y12	PA451674	64805	0.855
NULL	Allergy_Asthma_Immunol_Res_2010_Jul_19_2(3)_177-182.nxml.txt.nlp	20592916	SENT113	3	3	8	8	tiotropium	ADRB2	PA164769056	154	0.855
NULL	AAPS_J_2011_Jun_1_13(3)_405-416.nxml.txt.nlp	21630127	SENT252	25	25	22	22	simvastatin	CYP3A4	PA451363	1576	0.855
NULL	Eur_J_Clin_Pharmacol_2014_Oct_8_70(12)_1433-1441.nxml.txt.nlp	25291992	SENT140	30	30	8	8	risperidone	OCM	PA451257	654231	0.855
NULL	Oncotarget_2013_Dec_28_5(6)_1475-1490.nxml.txt.nlp	24721996	SENT75	9	9	13	13	celecoxib	CD44	PA448871	960	0.855
NULL	JAKSTAT_2012_Apr_1_1(2)_55-64.nxml.txt.nlp	24058751	SENT117	19	19	22	22	sunitinib	STAT3	PA162372840	6774	0.855
NULL	Emerg_Infect_Dis_2013_Jul_19(7)_1151-1152.nxml.txt.nlp	23763791	SENT40	3	3	0	0	ethambutol	DST	PA164784021	667	0.855
NULL	Arthritis_Res_Ther_2014_Jan_28_16(1)_R29.nxml.txt.nlp	24472528	SENT116	21	21	6	6	paraformaldehyde	CO2	PA450790	4513	0.855
NULL	Diagn_Pathol_2014_Jul_10_9_143.nxml.txt.nlp	25012722	SENT17	19	19	22	22	cisplatin	PDCD4	PA449014	27250	0.855
NULL	Br_J_Cancer_2011_Jul_26_105(3)_372-381.nxml.txt.nlp	21730979	SENT162	9	9	16	16	temozolomide	ATR	PA451609	390502;84168;545	0.855
NULL	J_Vet_Med_Sci_2014_Oct_16_76(10)_1383-1387.nxml.txt.nlp	24931645	SENT70	39	39	20	20	sitagliptin	GLP-1	PA164748978	100125288	0.855
NULL	Br_J_Cancer_2011_Dec_6_105(12)_1920-1926.nxml.txt.nlp	22095222	SENT25	35	35	21	21	gefitinib	PI3K	PA131301952	5290	0.855
NULL	Oncotarget_2014_Oct_15_5(19)_8853-8868.nxml.txt.nlp	25326682	SENT336	46	46	4	4	saracatinib	RCC4		84925	0.855
NULL	Br_J_Cancer_2009_Jul_21_101(2)_238-243.nxml.txt.nlp	19568242	SENT123	9	9	32	32	bevacizumab	IFN	PA130232992	3439	0.855
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT57	17	17	6	6	nutlin-3	p53		7157	0.855
NULL	J_Headache_Pain_2013_Apr_10_14(1)_33.nxml.txt.nlp	23574808	SENT182	30	30	36	36	capsaicin	CO2	PA448776	4513	0.855
NULL	Basic_Clin_Pharmacol_Toxicol_2013_Feb_5_112(2)_132-137.nxml.txt.nlp	22900583	SENT153	17	17	9	9	ketoconazole	CYP3A	PA450146	1574	0.855
NULL	Cancer_Res_Treat_2014_Jan_15_46(1)_48-54.nxml.txt.nlp	24520223	SENT121	12	12	16	16	bevacizumab	KRAS	PA130232992	3845	0.855
NULL	Interdiscip_Perspect_Infect_Dis_2014_May_7_2014_849432.nxml.txt.nlp	24895495	SENT126	27	27	17	17	ritonavir	CYP3A4	PA451260	1576	0.855
NULL	Indian_J_Pharmacol_2014_Jan-Feb_46(1)_3-12.nxml.txt.nlp	24550577	SENT222	30	30	16	16	erythromycin	P-gp	PA449493	5243	0.855
NULL	J_Lipids_2011_Jan_13_2011_565316.nxml.txt.nlp	21490804	SENT118	5	5	21	21	vorinostat	CD95	PA164748224	355	0.855
NULL	Biosci_Rep_2012_Aug_1_32(Pt_4)_361-374.nxml.txt.nlp	22762204	SENT185	33	33	10	10	paclitaxel	TAZ	PA450761	25937;6901	0.855
NULL	Cell_Death_Dis_2012_Jun_28_3(6)_e336.nxml.txt.nlp	22739988	SENT253	13	13	6	6	estradiol	BRCA1	PA449503	672	0.855
NULL	Cell_Res_2012_Aug_22_22(8)_1227-1245.nxml.txt.nlp	22613949	SENT106	12	12	15	15	bortezomib	KRAS	PA10252	3845	0.855
NULL	J_Korean_Assoc_Oral_Maxillofac_Surg_2014_Aug_26_40(4)_195-198.nxml.txt.nlp	25247150	SENT82	9	9	3	3	nafcillin	CST	PA450576	9514	0.855
NULL	Arthritis_Res_Ther_2013_Aug_30_15(4)_R100.nxml.txt.nlp	24000795	SENT140	21	21	4	4	etanercept	CD22	PA449515	933	0.855
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT176	22	22	14	14	pp2	PP1		5540;5464	0.855
NULL	Br_J_Cancer_2004_Mar_22_90(6)_1285-1292.nxml.txt.nlp	15026814	SENT15	10	10	1	1	doxorubicin	p53	PA449412	7157	0.855
NULL	Bioinform_Biol_Insights_2009_Oct_5_3_109-127.nxml.txt.nlp	20140064	SENT463	11	11	17	17	tenofovir	P200	PA10204	5035	0.855
NULL	J_Adv_Pharm_Technol_Res_2011_Apr-Jun_2(2)_81-87.nxml.txt.nlp	22171298	SENT184	12	12	24	24	ketotifen	p53	PA450152	7157	0.855
NULL	Breast_Cancer_Res_2011_May_25_13(3)_107.nxml.txt.nlp	21635706	SENT28	20	20	0	0	medroxyprogesterone	RANK	PA450344	8792	0.855
NULL	Neural_Regen_Res_2013_Jul_15_8(20)_1853-1862.nxml.txt.nlp	25206494	SENT179	3	3	15	15	ethanol	p53	PA448073	7157	0.855
NULL	J_Mammary_Gland_Biol_Neoplasia_2012_Jun_1_17(2)_167-188.nxml.txt.nlp	22752723	SENT753	9	9	1	1	genistein	adiponectin	PA165109660	9370	0.855
NULL	Iran_J_Pharm_Res_2013_Winter_12(Suppl)_37-46.nxml.txt.nlp	24250670	SENT130	9	9	6	6	verapamil	P-gp	PA451868	5243	0.855
NULL	Case_Rep_Med_2010_Jun_13_2010_974149.nxml.txt.nlp	20592997	SENT68	23	23	15	15	clopidogrel	ADP	PA449053	23038	0.855
NULL	Front_Neurosci_2010_Jun_17_4_35.nxml.txt.nlp	20661455	SENT572	16	16	4	4	fluoxetine	5-HT1A	PA449673	3350	0.855
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT149	31	31	38	38	perifosine	p38	PA165291471	10598;1432;7965	0.855
NULL	Am_J_Trop_Med_Hyg_2012_Mar_1_86(3)_403-408.nxml.txt.nlp	22403308	SENT102	9	9	39	39	artesunate	ACT	PA165111697	12;11332;9457;641455	0.855
NULL	Breast_Cancer_Res_2012_Mar_19_14(2)_R50.nxml.txt.nlp	22429397	SENT240	23	23	30	30	cisplatin	p63	PA449014	8626	0.855
NULL	Curr_Cardiol_Rev_2010_Nov_6(4)_298-308.nxml.txt.nlp	22043206	SENT156	7	7	19	19	isoproterenol	p47phox	PA450121	653361	0.855
NULL	Front_Oncol_2014_Sep_29_4_262.nxml.txt.nlp	25325014	SENT558	35	35	37	37	trastuzumab	HER2	PA451743	2064	0.855
NULL	Aging_Cell_2012_Aug_11(4)_579-587.nxml.txt.nlp	22435726	SENT114	23	23	7	7	etoposide	CD28	PA449552	1493;940	0.855
NULL	Cancers_(Basel)_2010_Dec_29_3(1)_79-90.nxml.txt.nlp	24212607	SENT108	18	18	26	26	gemcitabine	CSNK2A1	PA449748	1457;1459	0.855
NULL	J_Exp_Clin_Cancer_Res_2009_Aug_19_28(1)_116.nxml.txt.nlp	19689822	SENT0	28	28	25	25	rituximab	CHOP	PA451261	1649	0.855
NULL	J_Cancer_2013_Sep_10_4(8)_614-625.nxml.txt.nlp	24155773	SENT18	16	16	3	3	bortezomib	CRM1	PA10252	7514	0.855
NULL	Acta_Pharmacol_Sin_2013_Jan_3_34(1)_119-128.nxml.txt.nlp	23202804	SENT106	23	23	9	9	rimonabant	NG2	PA152407999	1464;6048	0.855
NULL	Clin_Drug_Investig_2013_Jun_20_33(6)_419-427.nxml.txt.nlp	23605507	SENT91	16	16	24	24	ciprofloxacin	DPI	PA449009	1832	0.855
NULL	J_Biol_Chem_2009_Oct_16_284(42)_28885-28895.nxml.txt.nlp	19687008	SENT7	6	6	15	15	berberine	PCSK9	PA165860812	255738	0.855
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_33-43.nxml.txt.nlp	17912634	SENT168	10	10	1	1	tamoxifen	aromatase	PA451581	1588	0.855
NULL	ScientificWorldJournal_2013_Sep_22_2013_752184.nxml.txt.nlp	24174916	SENT107	2	2	20	20	gentamicin	DBT	PA449753	1629	0.855
NULL	Cancers_(Basel)_2013_May_10_5(2)_529-549.nxml.txt.nlp	24216990	SENT226	11	11	3	3	sorafenib	TKR	PA7000	8277	0.855
NULL	Br_J_Cancer_2013_Jun_11_108(11)_2304-2311.nxml.txt.nlp	23695020	SENT144	5	5	11	11	resveratrol	EEF1A2		1917	0.855
NULL	BMJ_Open_2014_Feb_27_4(2)_e004071.nxml.txt.nlp	24578536	SENT14	0	0	17	17	warfarin	TTR	PA451906	7276	0.855
NULL	Oncotarget_2014_Aug_19_5(18)_8737-8749.nxml.txt.nlp	25228590	SENT64	2	2	11	11	doxycycline	MYCN	PA449415	4613	0.855
NULL	Gut_2013_Apr_14_62(4)_540-549.nxml.txt.nlp	22798500	SENT44	25	25	4	4	cetuximab	PTEN	PA10040	5728	0.855
NULL	Biologics_2011_Feb_14_5_21-31.nxml.txt.nlp	21383913	SENT180	14	14	29	29	tacrolimus	CLE	PA451578	51637	0.855
NULL	Front_Neurosci_2014_Jun_3_8_128.nxml.txt.nlp	24917782	SENT164	33	33	10	10	ethanol	MC4R	PA448073	4160	0.855
NULL	Open_Med_Chem_J_2010_May_27_4_10-19.nxml.txt.nlp	21253021	SENT210	19	19	11	11	clozapine	ALX	PA449061	84941	0.855
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT39	25	25	4	4	lapatinib	HRG	PA152241907	3084;3273	0.855
NULL	Orphanet_J_Rare_Dis_2007_Oct_4_2_40.nxml.txt.nlp	17916236	SENT173	0	0	7	7	teriparatide	PTH	PA451620	5741	0.855
NULL	Curr_Neuropharmacol_2010_Dec_8(4)_382-393.nxml.txt.nlp	21629445	SENT135	16	16	31	31	haloperidol	NEDD4	PA449841	4734	0.855
NULL	Clin_Exp_Metastasis_2014_Sep_17_31(1)_135-147.nxml.txt.nlp	24043563	SENT183	25	25	8	8	tamoxifen	KLK10	PA451581	5655	0.855
NULL	Br_J_Cancer_2006_Feb_13_94(3)_407-426.nxml.txt.nlp	16434996	SENT151	20	20	23	23	genistein	BRCA1	PA165109660	672	0.855
NULL	Cancers_(Basel)_2013_May_10_5(2)_529-549.nxml.txt.nlp	24216990	SENT226	9	9	3	3	pazopanib	TKR	PA165291492	8277	0.855
NULL	EMBO_Mol_Med_2014_Oct_17_6(10)_1294-1311.nxml.txt.nlp	25231413	SENT144	27	27	17	17	calcein	PC3	PA132595336	57332;7832;5122	0.855
NULL	Br_J_Cancer_2012_Jan_3_106(1)_25-31.nxml.txt.nlp	22127284	SENT127	0	0	9	9	lapatinib	HER2	PA152241907	2064	0.855
NULL	Biochem_Res_Int_2012_Aug_15_2012_940405.nxml.txt.nlp	22928112	SENT272	29	29	21	21	crizotinib	ROS1	PA165946122	6098	0.855
NULL	Mol_Cancer_2008_Jun_5_7_50.nxml.txt.nlp	18534018	SENT128	20	20	9	9	bortezomib	survivin	PA10252	332	0.855
NULL	Arthritis_Res_Ther_2010_Jun_2_12(3)_R107.nxml.txt.nlp	20525198	SENT20	10	10	2	2	etanercept	TNF	PA449515	7124	0.855
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Apr_21_68(Pt_5)_o1492.nxml.txt.nlp	22590364	SENT71	3	3	9	9	isoniazid	mol	PA450112	90527	0.855
NULL	Biochem_Res_Int_2012_Feb_12_2012_346972.nxml.txt.nlp	22400115	SENT193	4	4	15	15	hyaluronan	EMMPRIN	PA165958431	682	0.855
NULL	Oncotarget_2012_May_19_3(5)_535-545.nxml.txt.nlp	22619121	SENT96	2	2	9	9	camptothecin	TPT	PA153590860	23590;6469	0.855
NULL	Subst_Abuse_Treat_Prev_Policy_2007_Oct_31_2_32.nxml.txt.nlp	17974020	SENT283	7	7	38	38	methamphetamine	NMU	PA450403	10874	0.855
NULL	Br_J_Cancer_2013_Feb_19_108(3)_557-563.nxml.txt.nlp	23361053	SENT125	43	43	8	8	tamoxifen	PAK1	PA451581	5585;5058	0.855
NULL	Proteome_Sci_2009_May_28_7_20.nxml.txt.nlp	19476632	SENT168	27	27	20	20	galactose	VDAC1	PA449725	7416	0.855
NULL	BMB_Rep_2014_Jan_47(1)_33-38.nxml.txt.nlp	24209634	SENT6	29	29	5	5	cisplatin	CXCR4	PA449014	7852	0.855
NULL	Allergy_Asthma_Immunol_Res_2014_Nov_19_6(6)_548-557.nxml.txt.nlp	25374755	SENT147	2	2	5	5	lovastatin	Rho	PA450272	29984	0.855
NULL	Int_J_Biol_Sci_2006_Mar_1_2(1)_1-9.nxml.txt.nlp	16585947	SENT221	14	14	3	3	trypsin	MLC2	PA451806	10398	0.855
NULL	J_Cancer_2014_Jan_5_5(1)_69-78.nxml.txt.nlp	24396499	SENT223	15	15	6	6	trastuzumab	HER2	PA451743	2064	0.855
NULL	Exp_Ther_Med_2013_Oct_7_6(4)_989-994.nxml.txt.nlp	24137303	SENT111	4	4	21	21	rosiglitazone	AMY	PA451283	10439	0.855
NULL	Environ_Health_Perspect_2008_Jul_26_116(7)_854-862.nxml.txt.nlp	18629305	SENT209	8	8	0	0	ebselen	NAC	PA161660841	22861	0.855
NULL	EPMA_J_2013_Jan_28_4(1)_3.nxml.txt.nlp	23356214	SENT240	12	12	21	21	panitumumab	KRAS	PA162373091	3845	0.855
NULL	Mol_Cancer_2012_Mar_21_11_13.nxml.txt.nlp	22436134	SENT213	12	12	1	1	doxorubicin	HuR	PA449412	1994	0.855
NULL	J_Breast_Cancer_2013_Jun_28_16(2)_220-228.nxml.txt.nlp	23843857	SENT168	5	5	21	21	tamoxifen	ATAC	PA451581	6375	0.855
NULL	Cardiol_Res_Pract_2014_Nov_20_2014_784018.nxml.txt.nlp	25506463	SENT156	12	12	19	19	heparin	ACT	PA449855	12;11332;9457;641455	0.855
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT174	22	22	2	2	perifosine	NAC	PA165291471	22861	0.855
NULL	Br_J_Cancer_2010_Feb_2_102(3)_489-494.nxml.txt.nlp	20051955	SENT56	7	7	18	18	betaine	mol	PA448603	90527	0.855
NULL	J_Hum_Genet_2013_Jun_2_58(6)_306-312.nxml.txt.nlp	23635953	SENT149	29	29	18	18	estradiol	aromatase	PA449503	1588	0.855
NULL	Int_J_Breast_Cancer_2012_May_9_2012_415170.nxml.txt.nlp	22649737	SENT150	42	42	15	15	lapatinib	HER2	PA152241907	2064	0.855
NULL	Cancer_Immunol_Immunother_2012_Jul_23_61(7)_1101-1111.nxml.txt.nlp	22193989	SENT133	6	6	1	1	oxaliplatin	PD-L1	PA131285527	29126	0.855
NULL	Cancer_Immunol_Immunother_2013_Aug_27_62(10)_1637-1648.nxml.txt.nlp	23982484	SENT172	30	30	14	14	lenalidomide	IL-2	PA162363968	3558	0.855
NULL	Nat_Commun_2012_Apr_10_3_771.nxml.txt.nlp	22491319	SENT61	38	38	15	15	bleomycin	CYLD	PA448645	1540	0.855
NULL	Oncol_Lett_2014_Jul_25_8(1)_62-66.nxml.txt.nlp	24959219	SENT20	11	11	22	22	vincristine	CHOP	PA451879	1649	0.855
NULL	J_Cell_Biol_2001_Dec_10_155(6)_893-898.nxml.txt.nlp	11733546	SENT151	6	6	14	14	paraformaldehyde	MAP1B	PA450790	4131	0.855
NULL	Clin_Dev_Immunol_2013_May_8_2013_608951.nxml.txt.nlp	23737813	SENT90	8	8	17	17	lenalidomide	IFN	PA162363968	3439	0.855
NULL	Breast_Cancer_Res_2004_Oct_6_6(6)_269-274.nxml.txt.nlp	15535858	SENT61	7	7	0	0	tamoxifen	AF1	PA451581	1946	0.855
NULL	Clin_Exp_Gastroenterol_2014_Aug_11_7_261-272.nxml.txt.nlp	25143751	SENT202	9	9	5	5	tocilizumab	IL-6	PA165292659	3569	0.855
NULL	Diagn_Pathol_2013_Jul_17_8_120.nxml.txt.nlp	23866960	SENT100	28	28	15	15	nitrofurazone	SNK	PA164754877	10769	0.855
NULL	Breast_Cancer_Res_2007_Jun_7_9(3)_R37.nxml.txt.nlp	17555561	SENT112	6	6	14	14	letrozole	GIDE	PA450196	79594	0.855
NULL	Allergy_Asthma_Clin_Immunol_2008_Sep_15_4(3)_95-105.nxml.txt.nlp	20525130	SENT219	4	4	20	20	fluorescein	CD11c	PA164746009	3687	0.855
NULL	J_Bras_Pneumol_2013_Jan-Feb_39(1)_5-15.nxml.txt.nlp	23503480	SENT230	30	30	37	37	doxycycline	LAM	PA449415	7249;7248	0.855
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT42	3	3	40	40	gefitinib	KRAS	PA131301952	3845	0.855
NULL	Breast_Cancer_Res_2005_Jan_12_7(2)_45-47.nxml.txt.nlp	15743509	SENT15	28	28	21	21	estradiol	aromatase	PA449503	1588	0.855
NULL	Mol_Cancer_2012_Mar_21_11_13.nxml.txt.nlp	22436134	SENT17	42	42	5	5	doxorubicin	HuR	PA449412	1994	0.855
NULL	Nat_Commun_2013_Apr_23_4_1738.nxml.txt.nlp	23612279	SENT80	12	12	5	5	papain	IL-4	PA450778	3565	0.855
NULL	Oncoimmunology_2012_Sep_1_1(6)_810-821.nxml.txt.nlp	23162748	SENT4	9	9	12	12	trastuzumab	HER2	PA451743	2064	0.855
NULL	Mol_Syst_Biol_2009_Jul_28_5_288.nxml.txt.nlp	19638969	SENT176	2	2	16	16	resveratrol	ANP32A		8125	0.855
NULL	ScientificWorldJournal_2012_Apr_26_2012_215231.nxml.txt.nlp	22629121	SENT29	20	20	7	7	vincristine	CHOP	PA451879	1649	0.855
NULL	Biologics_2014_Dec_4_8_281-291.nxml.txt.nlp	25506209	SENT112	26	26	19	19	vemurafenib	BRAF	PA165946873	673	0.855
NULL	Breast_Cancer_Res_Treat_2014_Sep_25_148(1)_81-90.nxml.txt.nlp	25253174	SENT33	15	15	43	43	metformin	adiponectin	PA450395	9370	0.855
NULL	Acta_Pharmacol_Sin_2013_Sep_5_34(9)_1192-1200.nxml.txt.nlp	23685957	SENT156	3	3	19	19	curcumin	AP-2	PA151958596	7020	0.855
NULL	J_Oncol_2009_Jan_17_2009_581939.nxml.txt.nlp	20145720	SENT58	19	19	7	7	cisplatin	p53	PA449014	7157	0.855
NULL	Biomed_Res_Int_2014_Aug_6_2014_967826.nxml.txt.nlp	25165721	SENT36	7	7	3	3	cisplatin	OCT2	PA449014	6582;5452	0.855
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_6_2014_270930.nxml.txt.nlp	25431606	SENT182	2	2	5	5	curcumin	MCP-1	PA151958596	6347	0.855
NULL	J_Oncol_2012_Sep_5_2012_141236.nxml.txt.nlp	21904550	SENT157	24	24	14	14	sorafenib	VEGF-A	PA7000	7422	0.855
NULL	Exp_Diabetes_Res_2012_Oct_15_2012_465282.nxml.txt.nlp	23118742	SENT120	4	4	8	8	metformin	FGF21	PA450395	26291	0.855
NULL	Br_J_Cancer_2010_Feb_2_102(3)_457-461.nxml.txt.nlp	20010942	SENT120	15	15	21	21	trastuzumab	MARK	PA451743	4139	0.855
NULL	Breast_Cancer_Res_2011_Jan_10_13(1)_R2.nxml.txt.nlp	21219636	SENT55	25	25	3	3	fluorescein	spatial	PA164746009	219793	0.855
NULL	Drugs_R_D_2014_Sep_28_14(3)_159-164.nxml.txt.nlp	24973042	SENT167	3	3	9	9	omeprazole	CYP2C19	PA450704	1557	0.855
NULL	Environ_Health_Perspect_2013_May_22_121(5)_551-557.nxml.txt.nlp	23434795	SENT176	23	23	2	2	hyaluronan	BAL	PA165958431	83666	0.855
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT164	10	10	19	19	neratinib	HER2	PA165291472	2064	0.855
NULL	Cell_Res_2013_Jul_21_23(7)_915-930.nxml.txt.nlp	23689279	SENT103	6	6	0	0	ethanol	ALDH2	PA448073	217	0.855
NULL	Int_J_Biol_Sci_2012_Oct_24_8(9)_1227-1236.nxml.txt.nlp	23136551	SENT56	2	2	10	10	tocilizumab	IL-6	PA165292659	3569	0.855
NULL	Int_J_Environ_Res_Public_Health_2011_Mar_1_8(3)_683-697.nxml.txt.nlp	21556173	SENT81	36	36	23	23	bevacizumab	HER-2	PA130232992	2064	0.855
NULL	Oncotarget_2010_May_15_1(1)_22-33.nxml.txt.nlp	20930946	SENT50	8	8	10	10	bortezomib	Vel	PA10252	388588	0.855
NULL	J_Carcinog_2014_Feb_20_13_4.nxml.txt.nlp	24737952	SENT55	11	11	21	21	capecitabine	HER2	PA448771	2064	0.855
NULL	Mol_Cell_Biochem_2012_Apr_3_363(1-2)_135-145.nxml.txt.nlp	22139302	SENT156	5	5	13	13	curcumin	survivin	PA151958596	332	0.855
NULL	Clin_Endosc_2011_Sep_30_44(1)_22-26.nxml.txt.nlp	22741108	SENT6	24	24	32	32	midazolam	ESD	PA450496	2098	0.855
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT140	15	15	38	38	perifosine	DR4	PA165291471	8797	0.855
NULL	J_Invest_Dermatol_2015_Feb_9_135(2)_389-399.nxml.txt.nlp	25184961	SENT232	12	12	2	2	clodronate	IL-6	PA10239	3569	0.855
NULL	Cancers_(Basel)_2011_Sep_28_3(4)_3740-3761.nxml.txt.nlp	24213109	SENT97	0	0	21	21	hyaluronan	CD44	PA165958431	960	0.855
NULL	Cell_Death_Dis_2010_Nov_18_1(11)_e102.nxml.txt.nlp	21368867	SENT335	3	3	21	21	gentamicin	14-3-3	PA449753	10971	0.855
NULL	JAKSTAT_2014_Jun_12_3_e29554.nxml.txt.nlp	25105067	SENT108	7	7	15	15	propofol	p65	PA451141	5970	0.855
NULL	Mol_Cancer_2008_May_16_7_38.nxml.txt.nlp	18485224	SENT7	11	11	3	3	celecoxib	DMC	PA448871	284340;54808	0.855
NULL	Mol_Imaging_Biol_2009_Sep_27_11(5)_364-368.nxml.txt.nlp	19326174	SENT15	13	13	2	2	diazepam	NUC	PA449283	4924	0.855
NULL	Front_Neurol_2014_Feb_18_5_17.nxml.txt.nlp	24600432	SENT135	8	8	12	12	levetiracetam	CD95	PA450206	355	0.855
NULL	Clin_Exp_Gastroenterol_2012_May_14_5_49-59.nxml.txt.nlp	22649281	SENT89	7	7	22	22	lansoprazole	CYP3A4	PA450180	1576	0.855
NULL	Acta_Pharmacol_Sin_2014_Jun_4_35(6)_792-805.nxml.txt.nlp	24902787	SENT248	27	27	16	16	paroxetine	INS-1	PA450801	2305	0.855
NULL	Arthritis_Res_Ther_2003_Sep_12_5(Suppl_3)_55.nxml.txt.nlp	NULL	SENT5	6	6	33	33	rosiglitazone	ARC	PA451283	8996;23237	0.855
NULL	Eur_J_Clin_Pharmacol_2010_Nov_29_66(11)_1131-1136.nxml.txt.nlp	20669013	SENT14	16	16	1	1	erythromycin	CYP2C19	PA449493	1557	0.855
NULL	eLife_2014_May_6_3_e02482.nxml.txt.nlp	24843002	SENT607	8	8	4	4	etoposide	p53	PA449552	7157	0.855
NULL	Eur_J_Endocrinol_2010_May_162(5)_987-992.nxml.txt.nlp	20164212	SENT25	0	0	4	4	diazoxide	SUR1	PA449285	6833	0.855
NULL	Hum_Genomics_2008_Sep_1_3(1)_53-70.nxml.txt.nlp	19129090	SENT148	6	6	44	44	perifosine	EXOC4	PA165291471	60412	0.855
NULL	Ann_Gastroenterol_2012_25(3)_232-240.nxml.txt.nlp	24714071	SENT57	13	13	17	17	telaprevir	IFN	PA165958354	3439	0.855
NULL	Diabetologia_2009_Oct_14_52(10)_2046-2055.nxml.txt.nlp	19688338	SENT166	23	23	12	12	liraglutide	PPG	PA165958364	5552	0.855
NULL	Iran_J_Pharm_Res_2014_Spring_13(2)_683-693.nxml.txt.nlp	25237365	SENT97	2	2	7	7	tamoxifen	CXCL12	PA451581	6387	0.855
NULL	Arthritis_Res_Ther_2007_Oct_9_9(5)_R104.nxml.txt.nlp	17925024	SENT144	2	2	9	9	glucosamine	JNK	PA164747613	5599	0.855
NULL	Clin_Pharmacokinet_2014_Sep_3_53(1)_1-16.nxml.txt.nlp	23999929	SENT287	12	12	28	28	erythromycin	CYP3A4	PA449493	1576	0.855
NULL	Aging_(Albany_NY)_2011_Dec_12_3(11)_1063-1077.nxml.txt.nlp	22170748	SENT121	4	4	2	2	metformin	AMPK	PA450395	5563	0.855
NULL	Cell_Death_Dis_2014_Apr_17_5(4)_e1182.nxml.txt.nlp	24743737	SENT43	4	4	2	2	capsaicin	TRPV1	PA448776	7442	0.855
NULL	BMJ_Open_2013_Nov_4_3(11)_e003556.nxml.txt.nlp	24189081	SENT298	13	13	21	21	docetaxel	TOP2A	PA449383	7153	0.855
NULL	J_Biol_Chem_2009_Sep_18_284(38)_26096-26105.nxml.txt.nlp	19628870	SENT247	9	9	2	2	pp2	G10		8896;221527	0.855
NULL	Endocrinol_Diabetes_Metab_Case_Rep_2014_Sep_1_2014_140072.nxml.txt.nlp	25332771	SENT66	7	7	20	20	sitagliptin	CD25	PA164748978	3669;3559	0.855
NULL	Br_J_Cancer_2006_Feb_13_94(3)_407-426.nxml.txt.nlp	16434996	SENT261	19	19	24	24	genistein	BRCA1	PA165109660	672	0.855
NULL	Crit_Care_2004_May_14_8(4)_R163-R171.nxml.txt.nlp	15312214	SENT140	10	10	21	21	candesartan	AT2	PA448765	186	0.855
NULL	Curr_Gerontol_Geriatr_Res_2012_Mar_4_2012_361218.nxml.txt.nlp	22474448	SENT6	19	19	0	0	estradiol	HSD17B1	PA449503	3292	0.855
NULL	Drugs_2009_Mar_17_69(5)_549-565.nxml.txt.nlp	19368417	SENT42	3	3	7	7	formoterol	DPI	PA134687907	1832	0.855
NULL	Oncoscience_2014_Mar_12_1(2)_158-166.nxml.txt.nlp	25594008	SENT60	13	13	5	5	dasatinib	ANXA1	PA162372878	301	0.855
NULL	Cell_Commun_Signal_2011_May_14_9_12.nxml.txt.nlp	21569606	SENT94	7	7	1	1	pioglitazone	FGF2	PA450970	2247;2258	0.855
NULL	J_Immunol_Res_2014_Jul_16_2014_696812.nxml.txt.nlp	25133198	SENT191	4	4	9	9	rifaximin	TLR2	PA164752443	7097	0.855
NULL	J_Physiol_2009_Feb_15_587(Pt_4)_731-744.nxml.txt.nlp	19074966	SENT87	5	5	22	22	taurine	PAT1	PA451590	10513;206358	0.855
NULL	Breast_Cancer_Res_2004_Nov_7_6(1)_39-52.nxml.txt.nlp	14680484	SENT195	38	38	23	23	tamoxifen	AIB1	PA451581	8202	0.855
NULL	Exp_Ther_Med_2014_Sep_14_8(3)_836-840.nxml.txt.nlp	25120610	SENT12	3	3	16	16	fasudil	ROCK1	PA165946121	6093	0.855
NULL	Br_J_Cancer_2010_Dec_7_103(12)_1794-1800.nxml.txt.nlp	21063406	SENT156	31	31	16	16	cyclophosphamide	TP53	PA449165	7157	0.855
NULL	Hum_Genomics_2009_Jan_1_3(2)_169-190.nxml.txt.nlp	19164093	SENT28	17	17	4	4	phenytoin	CYP2C9	PA450947	1559	0.855
NULL	Int_J_Crit_Illn_Inj_Sci_2012_May-Aug_2(2)_82-97.nxml.txt.nlp	22837896	SENT306	33	33	36	36	natalizumab	CD4	PA164747191	920	0.855
NULL	Clin_Mol_Hepatol_2014_Sep_25_20(3)_283-290.nxml.txt.nlp	25320732	SENT21	7	7	0	0	propranolol	EVL	PA451145	51466	0.855
NULL	Evid_Based_Complement_Alternat_Med_2012_May_7_2012_242810.nxml.txt.nlp	22645625	SENT153	24	24	20	20	rifampin	CYP3A4	PA451250	1576	0.855
NULL	J_Lipid_Res_2015_Jan_56(1)_109-121.nxml.txt.nlp	25421061	SENT348	8	8	28	28	forskolin	CGI-58	PA146096022	51099	0.855
NULL	Br_J_Cancer_2011_Jul_12_105(2)_212-220.nxml.txt.nlp	21694723	SENT39	4	4	19	19	curcumin	CD133	PA151958596	8842	0.855
NULL	BMB_Rep_2013_Feb_46(2)_97-102.nxml.txt.nlp	23433112	SENT103	0	0	16	16	decitabine	p53	PA164749631	7157	0.855
NULL	Breast_Cancer_Res_2004_Oct_6_6(6)_269-274.nxml.txt.nlp	15535858	SENT60	23	23	28	28	tamoxifen	AF1	PA451581	1946	0.855
NULL	Cardiovasc_Diabetol_2013_Mar_18_12_46.nxml.txt.nlp	23497197	SENT214	8	8	18	18	metformin	adiponectin	PA450395	9370	0.855
NULL	Cancer_Manag_Res_2012_Jul_31_4_207-214.nxml.txt.nlp	22904642	SENT90	17	17	25	25	octreotide	SSTR3	PA450678	6753	0.855
NULL	J_Hematol_Oncol_2013_Mar_27_6_23.nxml.txt.nlp	23531342	SENT102	30	30	40	40	doxorubicin	RITA	PA449412	55422;84934	0.855
NULL	Clin_Dev_Immunol_2007_Jan_20_2007_76396.nxml.txt.nlp	18317531	SENT9	5	5	28	28	sertraline	IL-4	PA451333	3565	0.855
NULL	Front_Physiol_2011_Jun_30_2_33.nxml.txt.nlp	21747769	SENT252	13	13	15	15	berberine	KCNQ1	PA165860812	3784	0.855
NULL	J_Gynecol_Oncol_2012_Jul_2_23(3)_139-140.nxml.txt.nlp	NULL	SENT26	28	28	7	7	cisplatin	EZH2	PA449014	2146	0.855
NULL	Cancer_Immunol_Immunother_2015_Oct_7_64_61-73.nxml.txt.nlp	25287778	SENT170	10	10	24	24	lenalidomide	CD16	PA162363968	2215;2214	0.855
NULL	Endocrinol_Metab_(Seoul)_2014_Jun_26_29(2)_208-209.nxml.txt.nlp	25031896	SENT10	4	4	23	23	thyroglobulin	WBS	PA164754910	2006	0.855
NULL	Biologics_2014_Apr_7_8_141-153.nxml.txt.nlp	24741293	SENT199	25	25	22	22	tocilizumab	IL-6	PA165292659	3569	0.854
NULL	Int_Semin_Surg_Oncol_2008_Apr_28_5_9.nxml.txt.nlp	18442393	SENT81	14	14	9	9	tamoxifen	HER-2	PA451581	2064	0.854
NULL	Patient_Prefer_Adherence_2011_Dec_23_6_1-9.nxml.txt.nlp	22272064	SENT108	37	37	21	21	telmisartan	ACE	PA451605	1636	0.854
NULL	Mol_Cell_Biochem_2014_Oct_9_385(1-2)_265-275.nxml.txt.nlp	24104452	SENT223	5	5	10	10	bortezomib	U87	PA10252	677775;641648	0.854
NULL	Allergy_Asthma_Immunol_Res_2012_Mar_25_4(2)_68-79.nxml.txt.nlp	22379601	SENT36	14	14	0	0	zinc	GATA-1	PA451956	2623	0.854
NULL	Colorectal_Dis_2012_Feb_14(2)_e31-e47.nxml.txt.nlp	21848897	SENT41	27	27	31	31	irinotecan	KRAS	PA450085	3845	0.854
NULL	Clin_Ophthalmol_2010_Sep_7_4_993-1001.nxml.txt.nlp	20856595	SENT47	23	23	1	1	azelastine	BAK	PA448517	578	0.854
NULL	Oncotarget_2013_Nov_24_4(12)_2430-2438.nxml.txt.nlp	24280348	SENT62	36	36	32	32	gefitinib	EGFR	PA131301952	1956	0.854
NULL	Cancer_Immunol_Immunother_2012_Jul_23_61(7)_1101-1111.nxml.txt.nlp	22193989	SENT203	3	3	15	15	oxaliplatin	IL-4	PA131285527	3565	0.854
NULL	Cancer_Cell_Int_2010_Sep_9_10_32.nxml.txt.nlp	20828393	SENT8	5	5	11	11	cisplatin	ATF3	PA449014	467	0.854
NULL	Curr_Oncol_2009_Jan_16(1)_16-26.nxml.txt.nlp	19229368	SENT44	20	20	12	12	panitumumab	KRAS	PA162373091	3845	0.854
NULL	J_Biol_Eng_2009_Jan_2_3_1.nxml.txt.nlp	19118500	SENT200	10	10	1	1	ethanol	LEU2	PA448073	8847	0.854
NULL	Pharmaceuticals_(Basel)_2013_Nov_4_6(11)_1347-1360.nxml.txt.nlp	24287461	SENT77	12	12	24	24	benzbromarone	URAT1	PA134852920	116085	0.854
NULL	Oncotarget_2013_Mar_23_4(3)_463-473.nxml.txt.nlp	23531874	SENT186	31	31	28	28	erlotinib	EGFR	PA134687924	1956	0.854
NULL	J_Adv_Pharm_Technol_Res_2010_Jan-Mar_1(1)_88-96.nxml.txt.nlp	22247836	SENT31	5	5	11	11	metronidazole	MCC	PA450484	4163	0.854
NULL	Ther_Clin_Risk_Manag_2007_Aug_3(4)_533-542.nxml.txt.nlp	18472974	SENT181	6	6	35	35	posaconazole	CYP2D6	PA151958574	1565	0.854
NULL	Br_J_Cancer_2013_Feb_19_108(3)_668-675.nxml.txt.nlp	23348520	SENT9	24	24	3	3	panitumumab	HER2	PA162373091	2064	0.854
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT107	10	10	17	17	capsaicin	p53	PA448776	7157	0.854
NULL	Arch_Med_Sci_2013_Dec_30_9(6)_1090-1096.nxml.txt.nlp	24482655	SENT149	6	6	40	40	tacrolimus	IL-10	PA451578	3586	0.854
NULL	Ann_Rheum_Dis_2010_Sep_1_69(9)_1629-1635.nxml.txt.nlp	20488885	SENT53	3	3	23	23	rituximab	ANOVA	PA451261	4858	0.854
NULL	Oncol_Rep_2013_Apr_23_29(4)_1268-1274.nxml.txt.nlp	23354756	SENT117	16	16	6	6	trastuzumab	SLC25A43	PA451743	203427	0.854
NULL	Clin_Pharmacokinet_2014_Oct_15_53(2)_155-164.nxml.txt.nlp	24127209	SENT174	30	30	15	15	clopidogrel	CYP2C19	PA449053	1557	0.854
NULL	Biologics_2009_Sep_15_3_419-428.nxml.txt.nlp	19774209	SENT170	4	4	33	33	gefitinib	EGFR	PA131301952	1956	0.854
NULL	Cells_2014_Jul_30_3(3)_751-777.nxml.txt.nlp	25079291	SENT1157	15	15	4	4	gemcitabine	TRPM7	PA449748	54822	0.854
NULL	Oncol_Lett_2013_Aug_20_6(2)_329-335.nxml.txt.nlp	24137325	SENT35	2	2	7	7	estradiol	PP2	PA449503	4888	0.854
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Dec_17_3(12)_e152.nxml.txt.nlp	25518025	SENT175	8	8	6	6	oxycodone	CYP3A	PA450741	1574	0.854
NULL	J_Korean_Med_Sci_2009_Jun_15_24(3)_511-512.nxml.txt.nlp	19543518	SENT42	17	17	26	26	clarithromycin	DST	PA449028	667	0.854
NULL	Breast_Cancer_Res_2007_Oct_26_9(5)_112.nxml.txt.nlp	17980056	SENT82	31	31	15	15	trastuzumab	HER2	PA451743	2064	0.854
NULL	Springerplus_2013_Jan_23_2_22.nxml.txt.nlp	23420789	SENT102	13	13	9	9	gefitinib	EGFR	PA131301952	1956	0.854
NULL	Mol_Vis_2012_Oct_5_18_2454-2467.nxml.txt.nlp	23077404	SENT17	10	10	14	14	bevacizumab	VEGF-A	PA130232992	7422	0.854
NULL	J_Neuroinflammation_2010_Oct_12_7_64.nxml.txt.nlp	20937161	SENT70	13	13	23	23	paraformaldehyde	DC11	PA450790	57001	0.854
NULL	Nucleic_Acids_Res_2012_Sep_8_40(16)_8059-8071.nxml.txt.nlp	22684629	SENT222	25	25	20	20	forskolin	U2AF65	PA146096022	11338	0.854
NULL	Nat_Med_2011_Dec_11_18(1)_74-82.nxml.txt.nlp	22157681	SENT235	18	18	15	15	gefitinib	APAF-1	PA131301952	317	0.854
NULL	Clinics_(Sao_Paulo)_2010_Jan_65(1)_29-34.nxml.txt.nlp	20126343	SENT106	1	1	17	17	midazolam	LPSB	PA450496	8991	0.854
NULL	Cancers_(Basel)_2010_Dec_30_3(1)_106-125.nxml.txt.nlp	24212609	SENT21	3	3	44	44	gemcitabine	SLC29A2	PA449748	3177	0.854
NULL	BMB_Rep_2014_Nov_47(11)_649-654.nxml.txt.nlp	25301019	SENT85	7	7	21	21	l-serine	CCL2	PA451330	6347	0.854
NULL	Cancer_Immunol_Immunother_2012_Jul_23_61(7)_1101-1111.nxml.txt.nlp	22193989	SENT229	22	22	10	10	oxaliplatin	PD-L1	PA131285527	29126	0.854
NULL	Mol_Cell_Biochem_2013_Jul_20_383(1-2)_95-102.nxml.txt.nlp	23873331	SENT47	26	26	16	16	resveratrol	CYP1B1		1545	0.854
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT106	11	11	13	13	pertuzumab	HER2		2064	0.854
NULL	Case_Rep_Hematol_2013_Sep_5_2013_708489.nxml.txt.nlp	24083040	SENT145	13	13	10	10	iron	B12	PA450087	7126;4709	0.854
NULL	Neural_Regen_Res_2014_May_15_9(10)_1055-1062.nxml.txt.nlp	25206759	SENT53	8	8	47	47	bumetanide	KCC2	PA448682	57468	0.854
NULL	Iran_J_Neurol_2011_10(1-2)_19-21.nxml.txt.nlp	24250838	SENT60	33	33	37	37	selegiline	COMT	PA451316	1312	0.854
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_23_2013_185158.nxml.txt.nlp	23864881	SENT202	7	7	0	0	vorinostat	p53	PA164748224	7157	0.854
NULL	Acta_Neuropathol_Commun_2013_Jul_17_1_39.nxml.txt.nlp	24252174	SENT152	6	6	3	3	erlotinib	Erb	PA134687924	2100	0.854
NULL	Virchows_Arch_2012_Feb_16_460(2)_141-149.nxml.txt.nlp	22173329	SENT218	6	6	28	28	fluorouracil	BRAF	PA128406956	673	0.854
NULL	Acta_Oncol_2013_May_13_52(4)_776-782.nxml.txt.nlp	23480638	SENT24	11	11	19	19	imatinib	PDGFRA	PA10804	5156	0.854
NULL	Curr_Neuropharmacol_2008_Jun_6(2)_151-163.nxml.txt.nlp	19305794	SENT258	21	21	29	29	capsaicin	TRPV1	PA448776	7442	0.854
NULL	Evid_Based_Complement_Alternat_Med_2011_Mar_13_2011_913898.nxml.txt.nlp	21785639	SENT219	0	0	6	6	curcumin	CYP3A4	PA151958596	1576	0.854
NULL	Oncotarget_2014_Dec_4_5(22)_11365-11380.nxml.txt.nlp	25426548	SENT31	9	9	0	0	nutlin-3	TP53		7157	0.854
NULL	Open_Cardiovasc_Med_J_2012_Jun_12_6_72-75.nxml.txt.nlp	22723807	SENT48	2	2	31	31	warfarin	ANOVA	PA451906	4858	0.854
NULL	Int_J_Cell_Biol_2012_May_15_2012_219625.nxml.txt.nlp	22666256	SENT121	21	21	16	16	chloroquine	PI3K	PA448948	5290	0.854
NULL	Diabetes_Care_2012_Feb_16_35(2)_327-333.nxml.txt.nlp	22179958	SENT3	15	15	36	36	metformin	B12	PA450395	7126;4709	0.854
NULL	Int_J_Gen_Med_2009_Jul_30_2_129-140.nxml.txt.nlp	20360896	SENT163	29	29	19	19	tamoxifen	ATAC	PA451581	6375	0.854
NULL	J_Cell_Mol_Med_2014_Jan_4_18(1)_38-48.nxml.txt.nlp	24188742	SENT152	30	30	5	5	vincristine	PAX3	PA451879	5077	0.854
NULL	Oncogenesis_2012_Apr_2_1(4)_e5.nxml.txt.nlp	23552603	SENT291	4	4	14	14	celecoxib	p65	PA448871	5970	0.854
NULL	Br_J_Pharmacol_2008_Dec_25_155(7)_1056-1065.nxml.txt.nlp	18724386	SENT257	29	29	37	37	nitrendipine	GLP-1	PA146096020	100125288	0.854
NULL	Daru_2012_Oct_4_20(1)_45.nxml.txt.nlp	23351300	SENT36	15	15	39	39	carbamazepine	API	PA448785	5345	0.854
NULL	Front_Neurosci_2013_Jan_31_7_3.nxml.txt.nlp	23386808	SENT274	16	16	9	9	capsaicin	TRPV1	PA448776	7442	0.854
NULL	Breast_Cancer_Res_2014_Sep_12_16(5)_436.nxml.txt.nlp	25213081	SENT161	4	4	12	12	tamoxifen	ERK2	PA451581	5594	0.854
NULL	Physiology_(Bethesda)_2014_Mar_29(2)_99-107.nxml.txt.nlp	24583766	SENT78	33	33	12	12	metformin	TAK1	PA450395	7182	0.854
NULL	Br_J_Cancer_1998_May_77(10)_1562-1567.nxml.txt.nlp	9635829	SENT11	18	18	6	6	cisplatin	p53	PA449014	7157	0.854
NULL	AIDS_Res_Ther_2013_May_1_10_10.nxml.txt.nlp	23634877	SENT156	14	14	9	9	atorvastatin	CXCL12	PA448500	6387	0.854
NULL	J_Bras_Pneumol_2013_Jan-Feb_39(1)_5-15.nxml.txt.nlp	23503480	SENT60	28	28	24	24	doxycycline	LAM	PA449415	7249;7248	0.854
NULL	Front_Immunol_2014_Aug_11_5_379.nxml.txt.nlp	25157251	SENT293	5	5	7	7	metformin	AMPK	PA450395	5563	0.854
NULL	J_Cell_Mol_Med_2014_Aug_6_18(8)_1519-1539.nxml.txt.nlp	25100284	SENT51	9	9	30	30	gefitinib	EGFR	PA131301952	1956	0.854
NULL	Biochemistry_2008_Aug_19_47(33)_8689-8696.nxml.txt.nlp	18642884	SENT93	16	16	8	8	nadh	XMP	PA164755085	2013	0.854
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT153	1	1	14	14	glucose	EGFR	PA449773	1956	0.854
NULL	Arthritis_Res_Ther_2013_Dec_3_15(6)_R205.nxml.txt.nlp	24295447	SENT139	38	38	27	27	methotrexate	OPG	PA450428	690	0.854
NULL	Cell_Microbiol_2014_Apr_6_16(4)_519-534.nxml.txt.nlp	24152255	SENT264	23	23	8	8	glucosamine	DC-SIGN	PA164747613	30835	0.854
NULL	Lab_Invest_2011_Apr_14_91(4)_598-608.nxml.txt.nlp	21321535	SENT191	2	2	29	29	sunitinib	gamma	PA162372840	9913	0.854
NULL	Diabetes_Care_2010_Apr_19_33(4)_914-919.nxml.txt.nlp	20086255	SENT109	2	2	7	7	valsartan	RBP4	PA451848	5433;5950	0.854
NULL	J_Mol_Signal_2010_May_10_5_4.nxml.txt.nlp	20459745	SENT57	0	0	26	26	cisplatin	p53	PA449014	7157	0.854
NULL	Eur_J_Clin_Pharmacol_2010_Nov_29_66(11)_1131-1136.nxml.txt.nlp	20669013	SENT137	21	21	16	16	voriconazole	CYP3A4	PA10233	1576	0.854
NULL	Biomed_Res_Int_2013_Mar_18_2013_720975.nxml.txt.nlp	23586055	SENT101	4	4	28	28	ceftazidime	CXCL8	PA448861	3576	0.854
NULL	Onco_Targets_Ther_2014_May_28_7_841-852.nxml.txt.nlp	24920926	SENT102	20	20	3	3	erlotinib	KRAS	PA134687924	3845	0.854
NULL	Biomed_Res_Int_2014_Jan_20_2014_948427.nxml.txt.nlp	24563867	SENT123	2	2	14	14	buspirone	5-HT1A	PA448689	3350	0.854
NULL	Clin_Ophthalmol_2012_Aug_10_6_1287-1291.nxml.txt.nlp	22927741	SENT73	3	3	11	11	ranibizumab	PED	PA164746012	8682	0.854
NULL	Eur_J_Clin_Pharmacol_2012_Jan_8_68(1)_29-37.nxml.txt.nlp	21739267	SENT9	14	14	39	39	aripiprazole	CYP2D6	PA10026	1565	0.854
NULL	Open_Access_J_Urol_2011_May_10_3_69-82.nxml.txt.nlp	24198638	SENT60	18	18	27	27	dextromethorphan	CYP2C19	PA449273	1557	0.854
NULL	Core_Evid_2011_Feb_8_6_23-29.nxml.txt.nlp	21468240	SENT99	23	23	6	6	lenalidomide	CD34	PA162363968	947	0.854
NULL	Br_J_Cancer_2013_Feb_5_108(2)_334-341.nxml.txt.nlp	23257893	SENT156	17	17	10	10	sorafenib	NOXA	PA7000	5366	0.854
NULL	Cases_J_2009_Jan_6_2_15.nxml.txt.nlp	19126225	SENT8	33	33	7	7	cetuximab	EGFR	PA10040	1956	0.854
NULL	Br_J_Cancer_2012_Oct_9_107(8)_1207-1212.nxml.txt.nlp	23047591	SENT96	23	23	5	5	metformin	AMPK	PA450395	5563	0.854
NULL	J_Hematol_Oncol_2009_Apr_22_2_18.nxml.txt.nlp	19386128	SENT231	14	14	10	10	panitumumab	KRAS	PA162373091	3845	0.854
NULL	Front_Genet_2012_Sep_6_3_173.nxml.txt.nlp	22973297	SENT132	13	13	5	5	gemcitabine	FKBP5	PA449748	2289	0.854
NULL	J_Invest_Dermatol_2013_Jun_14_133(6)_1541-1549.nxml.txt.nlp	23407395	SENT128	31	31	4	4	imiquimod	CXCL1	PA449972	2919	0.854
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Oct_2_66(Pt_11)_o2698.nxml.txt.nlp	21588914	SENT64	14	14	6	6	ethanol	mol	PA448073	90527	0.854
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Jul_23_6_103-113.nxml.txt.nlp	25114588	SENT180	19	19	12	12	lapatinib	PIK3CA	PA152241907	5290	0.854
NULL	Crit_Care_2011_Jun_24_15(3)_R153.nxml.txt.nlp	21702944	SENT216	12	12	17	17	dexmedetomidine	TLR-4	PA449256	7099	0.854
NULL	Arthritis_Res_Ther_2009_Aug_3_11(4)_238.nxml.txt.nlp	19678909	SENT73	0	0	6	6	hydroquinone	IFN	PA449924	3439	0.854
NULL	Br_J_Cancer_2009_Sep_15_101(6)_957-966.nxml.txt.nlp	19738618	SENT217	9	9	2	2	dexrazoxane	ANOVA	PA449259	4858	0.854
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2735-2743.nxml.txt.nlp	24129244	SENT178	3	3	6	6	crizotinib	MET	PA165946122	4233	0.854
NULL	J_Cell_Biol_1999_Feb_8_144(3)_563-574.nxml.txt.nlp	9971749	SENT40	12	12	27	27	aprotinin	IL-2	PA448472	3558	0.854
NULL	J_Immunother_Cancer_2013_Jul_15_1_10.nxml.txt.nlp	24829747	SENT52	6	6	18	18	tadalafil	CD4	PA10333	920	0.854
NULL	Biochem_Res_Int_2012_Dec_18_2012_893947.nxml.txt.nlp	22216413	SENT135	24	24	13	13	hyaluronidase	HYAL1	PA164745713	3373	0.854
NULL	Case_Rep_Oncol_2014_Mar_26_7(1)_204-209.nxml.txt.nlp	24803896	SENT23	18	18	27	27	trabectedin	MRCL	PA165958349	348174	0.854
NULL	Curr_Pharm_Biotechnol_2012_May_13(6)_969-986.nxml.txt.nlp	22039792	SENT437	9	9	5	5	ivermectin	MDR1	PA450133	5243	0.854
NULL	Oncogene_2014_Mar_6_33(10)_1316-1324.nxml.txt.nlp	23474758	SENT90	7	7	13	13	etoposide	AXL	PA449552	558	0.854
NULL	Arch_Gynecol_Obstet_2012_May_30_285(5)_1447-1453.nxml.txt.nlp	22127553	SENT202	19	19	5	5	paclitaxel	p53	PA450761	7157	0.854
NULL	Clin_Med_Insights_Cardiol_2013_Aug_11_7_127-140.nxml.txt.nlp	23997577	SENT56	3	3	7	7	dronedarone	NCX	PA153619853	3196	0.854
NULL	Cancer_Metab_2014_Jan_3_2_1.nxml.txt.nlp	24383451	SENT114	20	20	27	27	l-cysteine	TIGAR	PA449173	57103	0.854
NULL	Aging_(Albany_NY)_2012_Jun_16_4(6)_393-401.nxml.txt.nlp	22713507	SENT45	14	14	12	12	metformin	AMPK	PA450395	5563	0.854
NULL	J_Geriatr_Cardiol_2014_Jun_11(2)_151-157.nxml.txt.nlp	25009566	SENT123	11	11	13	13	cilostazol	CDP	PA164746334	1523	0.854
NULL	Exp_Hematol_Oncol_2013_Apr_10_2_11.nxml.txt.nlp	23574711	SENT200	28	28	8	8	l-arginine	OTC	PA448478	5009	0.854
NULL	Leukemia_2013_Feb_3_27(2)_315-324.nxml.txt.nlp	22751450	SENT193	21	21	12	12	sorafenib	Mcl-1	PA7000	4170	0.854
NULL	Paediatr_Drugs_2014_Feb_27_16(3)_199-211.nxml.txt.nlp	24574047	SENT123	26	26	30	30	doxylamine	PLP	PA449419	25824;5744	0.854
NULL	J_Hematol_Oncol_2011_Apr_20_4_16.nxml.txt.nlp	21504625	SENT212	9	9	17	17	bsi-201	PARP-1		25976	0.854
NULL	Int_J_Biol_Sci_2013_Dec_17_10(1)_64-72.nxml.txt.nlp	24391452	SENT213	24	24	22	22	ketanserin	5-HT2A	PA131053734	3356	0.854
NULL	Environ_Health_Perspect_2013_Mar_1_121(3)_a97.nxml.txt.nlp	23454847	SENT26	12	12	7	7	estradiol	JNK	PA449503	5599	0.854
NULL	Comp_Hepatol_2004_Jan_14_3(Suppl_1)_S37.nxml.txt.nlp	14960189	SENT63	2	2	13	13	ethanol	TNF-alpha	PA448073	7124	0.854
NULL	Nat_Commun_2013_Aug_15_4_2130.nxml.txt.nlp	23945651	SENT185	10	10	2	2	cisplatin	ATG5	PA449014	9474	0.854
NULL	Eplasty_2012_Aug_31_12_e41.nxml.txt.nlp	22977676	SENT78	16	16	7	7	fluorescein	NIR	PA164746009	26155	0.854
NULL	Br_J_Cancer_2012_Jan_3_106(1)_126-132.nxml.txt.nlp	22095227	SENT132	14	14	34	34	cisplatin	SMURF2	PA449014	64750	0.854
NULL	Cancers_(Basel)_2011_Aug_5_3(3)_3114-3142.nxml.txt.nlp	24212948	SENT814	14	14	5	5	cyclophosphamide	CD25	PA449165	3669;3559	0.854
NULL	Breast_Cancer_Res_2011_Aug_31_13(4)_R84.nxml.txt.nlp	21884573	SENT149	19	19	0	0	trastuzumab	HER2	PA451743	2064	0.854
NULL	Breast_Cancer_Res_2011_Apr_20_13(2)_307.nxml.txt.nlp	21575280	SENT25	15	15	10	10	tamoxifen	FOXA1	PA451581	3169	0.854
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_105-115.nxml.txt.nlp	17912640	SENT55	11	11	4	4	gefitinib	HER2	PA131301952	2064	0.854
NULL	J_Gen_Physiol_1955_Nov_20_39(2)_185-195.nxml.txt.nlp	13271719	SENT0	20	20	1	1	hyaluronidase	Gen	PA164745713	348654	0.854
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_39-54.nxml.txt.nlp	19305787	SENT148	4	4	29	29	ethanol	NR1	PA448073	27158	0.854
NULL	Osteoporos_Int_2012_Feb_4_23(Suppl_1)_S1-S23.nxml.txt.nlp	22311111	SENT363	9	9	18	18	tamoxifen	STAR	PA451581	6770;2984	0.854
NULL	Oncologist_2010_Feb_15_15(2)_122-129.nxml.txt.nlp	20156908	SENT87	15	15	7	7	letrozole	HER-2	PA450196	2064	0.854
NULL	Eur_J_Med_Res_2011_Jul_25_16(7)_303-314.nxml.txt.nlp	21813371	SENT62	15	15	36	36	telaprevir	SOC	PA165958354	91544	0.854
NULL	Arch_Virol_2014_Dec_24_159(6)_1365-1371.nxml.txt.nlp	24366548	SENT6	28	28	15	15	ribavirin	SOCS3	PA451241	9021	0.854
NULL	Oncologist_2010_Mar_9_15(3)_236-245.nxml.txt.nlp	20215359	SENT160	0	0	40	40	everolimus	VEGFR	PA164746311	3791	0.854
NULL	Chin_J_Cancer_2011_Oct_30(10)_712-720.nxml.txt.nlp	21959048	SENT57	4	4	30	30	trypsin	EGF	PA451806	1950	0.854
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT87	25	25	20	20	resveratrol	TNF		7124	0.854
NULL	Br_J_Cancer_2010_Oct_26_103(9)_1335-1342.nxml.txt.nlp	20978512	SENT22	17	17	38	38	trastuzumab	HER-2	PA451743	2064	0.854
NULL	Cough_2006_Dec_15_2_10.nxml.txt.nlp	17173683	SENT28	22	22	17	17	capsaicin	TRPV1	PA448776	7442	0.854
NULL	Ann_Dermatol_2014_Dec_26_26(6)_706-712.nxml.txt.nlp	25473222	SENT29	23	23	11	11	isotretinoin	EPO	PA450128	7076;8288;2056	0.854
NULL	J_Exp_Med_1996_Dec_1_184(6)_2341-2352.nxml.txt.nlp	8976188	SENT278	17	17	9	9	metrizamide	PLN	PA164742936	5350	0.854
NULL	Br_J_Cancer_2010_Nov_2_103(11)_1671-1679.nxml.txt.nlp	21045835	SENT88	13	13	20	20	gemcitabine	CXCL12	PA449748	6387	0.854
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT231	22	22	5	5	perifosine	JNK	PA165291471	5599	0.854
NULL	J_Clin_Biochem_Nutr_2009_Jul_30_45(1)_9-13.nxml.txt.nlp	19590701	SENT56	9	9	19	19	lansoprazole	HO-1	PA450180	3162	0.854
NULL	Int_J_Womens_Health_2012_Oct_10_4_543-549.nxml.txt.nlp	23091400	SENT9	4	4	20	20	resveratrol	aromatase		1588	0.854
NULL	Oxid_Med_Cell_Longev_2013_Mar_5_2013_264935.nxml.txt.nlp	23533686	SENT222	8	8	11	11	hemin	HO-1	PA449849	3162	0.854
NULL	Acta_Pharmacol_Sin_2010_Nov_18_31(11)_1447-1453.nxml.txt.nlp	20953204	SENT125	9	9	15	15	rimonabant	IL-6	PA152407999	3569	0.854
NULL	Ecancermedicalscience_2008_Jun_9_2_81.nxml.txt.nlp	22275970	SENT28	16	16	31	31	pentoxifylline	CO2	PA450864	4513	0.854
NULL	Hum_Genomics_2009_Jan_1_3(2)_121-127.nxml.txt.nlp	19164089	SENT45	17	17	2	2	ethanol	ALDH2	PA448073	217	0.854
NULL	Oncoscience_2014_Mar_12_1(2)_158-166.nxml.txt.nlp	25594008	SENT62	14	14	8	8	dasatinib	IGFBP2	PA162372878	3485	0.854
NULL	Acta_Neuropathol_Commun_2013_Aug_9_1_49.nxml.txt.nlp	24252504	SENT155	27	27	20	20	arsenite	TDP-43	PA452638	23435	0.854
NULL	EMBO_Mol_Med_2012_Jun_13_4(6)_515-527.nxml.txt.nlp	22416035	SENT154	26	26	22	22	olaparib	p53		7157	0.854
NULL	Exp_Ther_Med_2012_Sep_29_4(3)_524-532.nxml.txt.nlp	23181130	SENT131	21	21	40	40	mk-571	MRP4		10257	0.854
NULL	Arthritis_Res_Ther_2012_Jun_12_14(3)_R142.nxml.txt.nlp	22691272	SENT103	0	0	9	9	mianserin	TLR7	PA134687937	51284	0.854
NULL	Hum_Genomics_2010_Apr_1_4(4)_238-249.nxml.txt.nlp	20511137	SENT106	45	45	41	41	ritonavir	UGT1A1	PA451260	54658	0.854
NULL	Oncotarget_2012_Nov_17_3(12)_1600-1614.nxml.txt.nlp	23307622	SENT18	8	8	3	3	trastuzumab	HER2	PA451743	2064	0.854
NULL	Oncotarget_2013_Nov_24_4(12)_2430-2438.nxml.txt.nlp	24280348	SENT64	42	42	40	40	gefitinib	EGFR	PA131301952	1956	0.854
NULL	Br_J_Cancer_2013_Jun_25_108(12)_2505-2515.nxml.txt.nlp	23736036	SENT222	22	22	14	14	capecitabine	MTHFR	PA448771	4524	0.854
NULL	Cancer_Immunol_Immunother_2014_Feb_11_63(5)_419-435.nxml.txt.nlp	24514955	SENT429	8	8	23	23	trastuzumab	gamma	PA451743	9913	0.854
NULL	Cell_Death_Dis_2013_Jan_31_4(1)_e480.nxml.txt.nlp	23370280	SENT124	9	9	5	5	cisplatin	WWOX	PA449014	51741	0.854
NULL	Support_Care_Cancer_2010_May_27_18(5)_529-541.nxml.txt.nlp	20191292	SENT62	3	3	0	0	doxorubicin	CHOP	PA449412	1649	0.854
NULL	Cancers_(Basel)_2012_Sep_6_4(3)_873-903.nxml.txt.nlp	24213471	SENT584	3	3	12	12	hyaluronan	spatial	PA165958431	219793	0.854
NULL	Breast_Cancer_Res_2007_Jan_23_9(1)_R7.nxml.txt.nlp	17244352	SENT118	9	9	16	16	tamoxifen	CYP3A5	PA451581	1577	0.854
NULL	Acta_Pharmacol_Sin_2012_Jan_12_33(1)_27-33.nxml.txt.nlp	22158109	SENT186	17	17	29	29	isoflurane	AMPK	PA450106	5563	0.854
NULL	Cardiovasc_Diabetol_2013_May_4_12_73.nxml.txt.nlp	23642288	SENT47	15	15	8	8	heparin	GLP-1	PA449855	100125288	0.854
NULL	J_Cardiothorac_Surg_2012_Sep_27_7_97.nxml.txt.nlp	23013706	SENT134	19	19	10	10	warfarin	CYP2C9	PA451906	1559	0.854
NULL	Br_J_Cancer_2010_Sep_7_103(6)_889-898.nxml.txt.nlp	20664599	SENT231	3	3	7	7	paclitaxel	HER-2	PA450761	2064	0.854
NULL	Eur_J_Clin_Pharmacol_2010_Nov_29_66(11)_1131-1136.nxml.txt.nlp	20669013	SENT14	16	16	4	4	erythromycin	CYP3A4	PA449493	1576	0.854
NULL	Biochemistry_2009_Feb_3_48(4)_800-809.nxml.txt.nlp	19132922	SENT147	16	16	7	7	raloxifene	XOR	PA451221	7498	0.854
NULL	Int_J_Biol_Sci_2013_Mar_7_9(3)_279-288.nxml.txt.nlp	23493630	SENT166	19	19	10	10	tocilizumab	IL-17	PA165292659	3605	0.854
NULL	Cancer_Cell_Int_2012_Jul_18_12_34.nxml.txt.nlp	22809533	SENT104	31	31	3	3	cisplatin	HK1	PA449014	3098;51361;3739	0.854
NULL	J_Thromb_Haemost_2014_May_22_12(5)_748-760.nxml.txt.nlp	24612393	SENT141	3	3	12	12	thrombin	PI3	PA451674	5266	0.854
NULL	Cancer_Manag_Res_2014_Feb_19_6_77-92.nxml.txt.nlp	24600246	SENT270	14	14	2	2	paclitaxel	GAJ	PA450761	84057	0.854
NULL	J_Oncol_2010_Nov_19_2010_568938.nxml.txt.nlp	20037743	SENT141	21	21	10	10	bevacizumab	EGFR	PA130232992	1956	0.854
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Sep_30_67(Pt_10)_o2776.nxml.txt.nlp	22065516	SENT73	23	23	18	18	ethanol	mol	PA448073	90527	0.854
NULL	Cancer_Cell_Int_2013_Nov_8_13_111.nxml.txt.nlp	24209962	SENT4	3	3	24	24	fluvastatin	Bcl-2	PA449688	596	0.854
NULL	Nat_Med_2011_Nov_13_17(12)_1641-1645.nxml.txt.nlp	22081024	SENT122	24	24	28	28	paclitaxel	CRAF	PA450761	5894	0.854
NULL	J_Korean_Med_Sci_2011_Dec_29_26(12)_1634-1637.nxml.txt.nlp	22148003	SENT82	18	18	27	27	candesartan	CYP2C9	PA448765	1559	0.854
NULL	Arthritis_Res_Ther_2010_Apr_1_12(2)_R60.nxml.txt.nlp	20359365	SENT152	13	13	23	23	bleomycin	SPARC	PA448645	6678	0.854
NULL	Br_J_Cancer_2010_Feb_2_102(3)_520-529.nxml.txt.nlp	20029417	SENT135	23	23	27	27	trastuzumab	IL-21	PA451743	59067;50616;27189	0.854
NULL	Ann_Lab_Med_2012_Jul_20_32(4)_270-275.nxml.txt.nlp	22779068	SENT105	24	24	33	33	imipenem	FOX-1	PA449968	54715	0.854
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_11_2014_274786.nxml.txt.nlp	25505920	SENT237	9	9	0	0	oxaliplatin	ERCC1	PA131285527	2067	0.854
NULL	BMJ_Qual_Saf_2011_Oct_30_20(10)_875-884.nxml.txt.nlp	21719560	SENT220	4	4	26	26	propoxyphene	OTC	PA451142	5009	0.854
NULL	J_Biol_Chem_2013_Dec_6_288(49)_35387-35395.nxml.txt.nlp	24142790	SENT152	30	30	19	19	meclizine	PCYT2	PA450338	5833	0.854
NULL	Arthritis_Res_Ther_2012_Sep_24_14(5)_R200.nxml.txt.nlp	23006144	SENT144	10	10	13	13	alefacept	IL-20	PA164748040	27190;50604	0.854
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2008_Jun_1_64(Pt_6)_611-619.nxml.txt.nlp	18560148	SENT179	14	14	26	26	heparin	IP-10	PA449855	3627	0.854
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT128	10	10	35	35	erlotinib	CYP3A	PA134687924	1574	0.854
NULL	J_Breast_Cancer_2011_Dec_27_14(4)_276-282.nxml.txt.nlp	22323913	SENT20	9	9	27	27	trastuzumab	HER2	PA451743	2064	0.854
NULL	Br_J_Cancer_2002_Jan_21_86(2)_179-184.nxml.txt.nlp	11870502	SENT23	21	21	40	40	carmustine	IFN	PA448810	3439	0.854
NULL	F1000_Biol_Rep_2010_Oct_21_2_76.nxml.txt.nlp	21173839	SENT41	3	3	16	16	metformin	AMPK	PA450395	5563	0.854
NULL	Int_J_Mol_Sci_2014_Oct_23_15(10)_19265-19280.nxml.txt.nlp	25342321	SENT65	16	16	0	0	cisplatin	MVD	PA449014	4597	0.854
NULL	Clin_Interv_Aging_2008_Mar_3(1)_i-ii.nxml.txt.nlp	18488872	SENT32	16	16	4	4	sermorelin	ghrelin	PA164749110	51738	0.854
NULL	Biosci_Rep_2014_Apr_15_34(2)_e00105.nxml.txt.nlp	24617546	SENT125	21	21	35	35	metformin	AMPK	PA450395	5563	0.854
NULL	Cancer_Metab_2013_Aug_14_1_18.nxml.txt.nlp	24280377	SENT330	26	26	5	5	creatine	LKB1	PA164778930	6794	0.854
NULL	Diabetes_2008_Sep_57(9)_2272-2279.nxml.txt.nlp	18519799	SENT145	5	5	14	14	rosiglitazone	PDK4	PA451283	5166	0.854
NULL	Cell_Div_2012_Dec_26_7_26.nxml.txt.nlp	23268747	SENT114	0	0	31	31	bortezomib	CDK4	PA10252	1019	0.854
NULL	Med_Sci_Monit_2012_Mar_1_18(3)_PI11-PI15.nxml.txt.nlp	22367138	SENT113	17	17	4	4	omalizumab	TRAIL	PA164752253	8743	0.854
NULL	Mol_Cancer_2010_Apr_23_9_87.nxml.txt.nlp	20416058	SENT262	25	25	9	9	doxorubicin	TRAIL	PA449412	8743	0.854
NULL	Arthritis_Res_Ther_2013_Jul_9_15(4)_R73.nxml.txt.nlp	23837669	SENT300	3	3	14	14	colchicine	MSU	PA449092	593	0.854
NULL	Neural_Regen_Res_2014_Feb_15_9(4)_420-429.nxml.txt.nlp	25206830	SENT57	8	8	43	43	pentobarbital	gamma	PA450859	9913	0.854
NULL	Breast_Cancer_Res_2008_Dec_4_10(6)_R103.nxml.txt.nlp	19055788	SENT85	17	17	9	9	tamoxifen	CDH1	PA451581	51343;999	0.854
NULL	Int_J_Nanomedicine_2012_Oct_25_7_5565-5575.nxml.txt.nlp	23118538	SENT34	5	5	17	17	fenofibrate	CO2	PA449594	4513	0.854
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jun_26_66(Pt_7)_o1792.nxml.txt.nlp	21588002	SENT4	17	17	1	1	resveratrol	mol		90527	0.854
NULL	Int_J_Mol_Sci_2014_Sep_22_15(9)_16848-16884.nxml.txt.nlp	25247581	SENT248	31	31	19	19	nadh	SIRT1	PA164755085	23411	0.854
NULL	J_Cell_Mol_Med_2014_Mar_10_18(3)_514-529.nxml.txt.nlp	24410795	SENT259	37	37	39	39	resveratrol	SIRT1		23411	0.854
NULL	Core_Evid_2013_May_16_8_37-45.nxml.txt.nlp	23717217	SENT223	14	14	6	6	rituximab	BTK	PA451261	695	0.854
NULL	Arch_Drug_Inf_2008_Jul_1(1)_14-22.nxml.txt.nlp	20157364	SENT83	15	15	0	0	pravastatin	IL-6	PA451089	3569	0.854
NULL	Comp_Hepatol_2004_Jan_14_3(Suppl_1)_S37.nxml.txt.nlp	14960189	SENT85	0	0	8	8	thalidomide	TNF-alpha	PA451644	7124	0.854
NULL	Prz_Gastroenterol_2014_Sep_16_9(4)_179-193.nxml.txt.nlp	25276248	SENT269	26	26	20	20	iron	B12	PA450087	7126;4709	0.854
NULL	Lab_Invest_2013_Dec_14_93(12)_1265-1275.nxml.txt.nlp	24126890	SENT300	23	23	3	3	celecoxib	JAM-A	PA448871	50848	0.854
NULL	J_Biomed_Biotechnol_2010_May_13_2010_270985.nxml.txt.nlp	20490265	SENT39	31	31	5	5	neomycin	CEA	PA450608	5670;1087	0.854
NULL	Hum_Genomics_2009_Jan_1_3(2)_128-142.nxml.txt.nlp	19164090	SENT264	9	9	19	19	carboplatin	CD44	PA448803	960	0.854
NULL	Oncol_Rep_2013_Apr_23_29(4)_1268-1274.nxml.txt.nlp	23354756	SENT138	8	8	24	24	epirubicin	SLC25A43	PA449476	203427	0.854
NULL	Calcif_Tissue_Int_2011_Apr_21_88(4)_294-303.nxml.txt.nlp	21253714	SENT302	4	4	15	15	risedronate	PTH	PA451255	5741	0.854
NULL	Oncol_Lett_2013_Feb_7_5(2)_440-446.nxml.txt.nlp	23420122	SENT212	9	9	20	20	sorafenib	BRAF	PA7000	673	0.854
NULL	J_Cell_Biol_2001_Apr_30_153(3)_613-620.nxml.txt.nlp	11331310	SENT65	33	33	44	44	paclitaxel	53BP1	PA450761	7158	0.854
NULL	Mol_Cancer_2010_Dec_20_9_317.nxml.txt.nlp	21172025	SENT229	19	19	13	13	paclitaxel	TXNIP	PA450761	10628	0.854
NULL	Diabetes_Care_2009_Aug_9_32(8)_1485-1490.nxml.txt.nlp	19509012	SENT15	9	9	24	24	valsartan	REN	PA451848	5972;147040	0.854
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT261	3	3	21	21	trastuzumab	HER2	PA451743	2064	0.854
NULL	Lab_Invest_2014_May_10_94(5)_503-516.nxml.txt.nlp	24614199	SENT271	4	4	26	26	curcumin	RAGE	PA151958596	177	0.854
NULL	Br_J_Pharmacol_2014_Oct_26_171(20)_4785-4796.nxml.txt.nlp	25074741	SENT180	0	0	16	16	guanfacine	NK1R	PA449825	6869	0.854
NULL	Br_J_Cancer_2003_Jun_16_88(12)_1956-1962.nxml.txt.nlp	12799643	SENT188	36	36	30	30	doxorubicin	p53	PA449412	7157	0.854
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2007_Dec_6_64(Pt_1)_o117-o118.nxml.txt.nlp	21200681	SENT68	14	14	6	6	ethanol	mol	PA448073	90527	0.854
NULL	J_Biomed_Biotechnol_2008_Jul_8_2008_597913.nxml.txt.nlp	18629230	SENT569	4	4	20	20	ethanol	PFK-1	PA448073	5213	0.854
NULL	Hum_Genomics_2009_Dec_1_4(2)_91-106.nxml.txt.nlp	20038497	SENT92	23	23	11	11	galantamine	ACHE	PA449726	43	0.854
NULL	Mol_Cancer_2007_Sep_18_6_56.nxml.txt.nlp	17877814	SENT33	47	47	44	44	erlotinib	EGFR	PA134687924	1956	0.854
NULL	Oncotarget_2014_Oct_18_5(22)_11588-11603.nxml.txt.nlp	25473890	SENT158	5	5	36	36	imatinib	PDGFRA	PA10804	5156	0.854
NULL	Exp_Mol_Med_2012_May_31_44(5)_311-318.nxml.txt.nlp	22282402	SENT49	8	8	15	15	cilostazol	MCP-1	PA164746334	6347	0.854
NULL	Anal_Chem_Insights_2014_Mar_2_9_1-7.nxml.txt.nlp	24634579	SENT23	9	9	14	14	fluoxetine	SLB	PA449673	26160	0.854
NULL	J_Carcinog_2011_Aug_23_10_20.nxml.txt.nlp	21886458	SENT194	10	10	24	24	lapatinib	HER2	PA152241907	2064	0.854
NULL	Lab_Invest_2014_May_10_94(5)_503-516.nxml.txt.nlp	24614199	SENT297	10	10	21	21	curcumin	NAC	PA151958596	22861	0.854
NULL	Daru_2012_Oct_15_20(1)_55.nxml.txt.nlp	23352178	SENT48	31	31	34	34	clozapine	CYP1A2	PA449061	1544	0.854
NULL	Br_J_Pharmacol_2011_Oct_164(3)_866-883.nxml.txt.nlp	21323893	SENT320	17	17	32	32	thrombin	NOX4	PA451674	50507	0.854
NULL	Pharmaceutics_2011_Nov_18_3(4)_865-913.nxml.txt.nlp	24309312	SENT2064	2	2	9	9	clarithromycin	CYP2C19	PA449028	1557	0.854
NULL	Indian_J_Endocrinol_Metab_2013_May-Jun_17(3)_402-412.nxml.txt.nlp	23869295	SENT162	14	14	19	19	fenofibrate	PON1	PA449594	5444	0.854
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1522-1532.nxml.txt.nlp	21997136	SENT102	28	28	23	23	gefitinib	GEM	PA131301952	2669	0.854
NULL	Int_J_Mol_Sci_2014_Jun_25_15(7)_11234-11244.nxml.txt.nlp	24968266	SENT66	11	11	24	24	docetaxel	PC-3	PA449383	692094	0.854
NULL	J_Cell_Mol_Med_2014_Dec_6_18(12)_2331-2339.nxml.txt.nlp	25284457	SENT153	22	22	3	3	bleomycin	RAGE	PA448645	177	0.854
NULL	Acta_Pharmacol_Sin_2009_Feb_5_30(2)_228-234.nxml.txt.nlp	19122672	SENT120	3	3	10	10	isoflurane	HO-1	PA450106	3162	0.854
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_17_2013_514719.nxml.txt.nlp	23843876	SENT129	19	19	12	12	docetaxel	LC3	PA449383	84557	0.854
NULL	J_Biomed_Biotechnol_2010_Sep_26_2010_607084.nxml.txt.nlp	20936125	SENT202	14	14	29	29	fluvastatin	RhoA	PA449688	387	0.854
NULL	Bioinorg_Chem_Appl_2014_Sep_14_2014_764085.nxml.txt.nlp	25298760	SENT58	20	20	1	1	ethanol	BEF	PA448073	10189	0.854
NULL	Reprod_Biol_Endocrinol_2003_Oct_7_1_66.nxml.txt.nlp	14609433	SENT24	48	48	19	19	cisplatin	p53	PA449014	7157	0.854
NULL	Front_Chem_2014_Dec_23_2_113.nxml.txt.nlp	25566531	SENT607	7	7	19	19	curcumin	CXCL1	PA151958596	2919	0.854
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2654-2664.nxml.txt.nlp	24136149	SENT183	23	23	10	10	doxorubicin	JNK	PA449412	5599	0.854
NULL	Cell_Microbiol_2014_Apr_6_16(4)_519-534.nxml.txt.nlp	24152255	SENT74	17	17	12	12	glucosamine	DC-SIGN	PA164747613	30835	0.854
NULL	Neural_Plast_2007_Jun_19_2007_52908.nxml.txt.nlp	17641734	SENT51	17	17	6	6	lipase	FAAH	PA450239	79152;2166	0.854
NULL	Acta_Pharmacol_Sin_2009_Jan_8_30(1)_25-30.nxml.txt.nlp	19060918	SENT52	8	8	5	5	lamivudine	IFN	PA450163	3439	0.854
NULL	J_Immunother_Cancer_2013_Nov_7_1(Suppl_1)_P191.nxml.txt.nlp	NULL	SENT15	21	21	32	32	celecoxib	p38	PA448871	10598;1432;7965	0.854
NULL	Environ_Health_Perspect_2005_Oct_14_113(10)_1330-1335.nxml.txt.nlp	16203242	SENT115	13	13	21	21	arsenite	MLC	PA452638	23209	0.854
NULL	Allergy_Asthma_Clin_Immunol_2011_Aug_25_7(1)_13.nxml.txt.nlp	21867553	SENT221	23	23	28	28	voriconazole	CYP3A4	PA10233	1576	0.854
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Dec_4_67(Pt_1)_o37.nxml.txt.nlp	21522747	SENT66	33	33	20	20	ethanol	mol	PA448073	90527	0.854
NULL	Acta_Pharmacol_Sin_2010_Jan_5_31(1)_93-101.nxml.txt.nlp	20048748	SENT144	14	14	5	5	cisplatin	DAPK	PA449014	1612	0.854
NULL	J_Cancer_Prev_2014_Jun_19(2)_97-102.nxml.txt.nlp	25337577	SENT113	14	14	27	27	genistein	p38	PA165109660	10598;1432;7965	0.854
NULL	Oncotarget_2014_Oct_18_5(22)_11604-11619.nxml.txt.nlp	25344099	SENT135	10	10	3	3	cisplatin	RYBP	PA449014	23429	0.854
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_15_2012_726025.nxml.txt.nlp	23118796	SENT50	43	43	33	33	streptomycin	FBS	PA451512	64319;26269	0.854
NULL	Br_J_Cancer_2013_May_28_108(10)_2039-2044.nxml.txt.nlp	23652306	SENT77	40	40	31	31	carboplatin	SRC3	PA448803	8202	0.854
NULL	J_Cell_Mol_Med_2014_Jan_4_18(1)_38-48.nxml.txt.nlp	24188742	SENT137	14	14	0	0	vincristine	PAX3	PA451879	5077	0.854
NULL	Oxid_Med_Cell_Longev_2013_Apr_18_2013_186795.nxml.txt.nlp	23710283	SENT55	23	23	3	3	paraformaldehyde	spatial	PA450790	219793	0.854
NULL	Br_J_Pharmacol_2014_Aug_17_171(15)_3651-3665.nxml.txt.nlp	24712679	SENT293	15	15	39	39	liraglutide	GLP-1	PA165958364	100125288	0.854
NULL	Nat_Commun_2014_Jun_19_5_4196.nxml.txt.nlp	24943270	SENT193	6	6	2	2	thrombin	PAR1	PA451674	79581;2149	0.854
NULL	Int_J_Biol_Sci_2015_Jan_1_11(2)_144-155.nxml.txt.nlp	25561897	SENT210	20	20	13	13	epirubicin	POLB	PA449476	5423	0.854
NULL	Front_Oncol_2014_Apr_9_4_75.nxml.txt.nlp	24782986	SENT265	29	29	9	9	cisplatin	IL-6	PA449014	3569	0.854
NULL	Biologics_2009_Sep_15_3_419-428.nxml.txt.nlp	19774209	SENT150	27	27	36	36	erlotinib	IGF1R	PA134687924	3480	0.854
NULL	Br_J_Pharmacol_2012_Jan_165(2)_390-400.nxml.txt.nlp	21671897	SENT206	11	11	3	3	suramin	P2X2	PA10292	22953	0.854
NULL	Br_J_Cancer_2009_Mar_10_100(5)_758-763.nxml.txt.nlp	19259094	SENT80	3	3	19	19	decitabine	MLH1	PA164749631	4292	0.854
NULL	Oncotarget_2013_Jul_5_4(7)_984-994.nxml.txt.nlp	23846322	SENT74	10	10	7	7	resveratrol	SIRT1		23411	0.854
NULL	Saudi_J_Anaesth_2013_Apr-Jun_7(2)_151-154.nxml.txt.nlp	23956714	SENT97	28	28	30	30	theophylline	NAC	PA451647	22861	0.854
NULL	Neural_Regen_Res_2013_May_5_8(13)_1180-1189.nxml.txt.nlp	25206412	SENT38	8	8	27	27	fasudil	CA1	PA165946121	759	0.854
NULL	Breast_Cancer_Res_2007_Jun_4_9(3)_207.nxml.txt.nlp	17561991	SENT181	12	12	27	27	capecitabine	HER-2	PA448771	2064	0.854
NULL	Clin_Pediatr_Endocrinol_2009_May_1_18(2)_65-72.nxml.txt.nlp	24790382	SENT149	9	9	22	22	cabergoline	PRL	PA448708	5617	0.854
NULL	Blood_Res_2013_Jun_25_48(2)_72-73.nxml.txt.nlp	23826573	SENT22	22	22	7	7	plerixafor	CD34	PA165958410	947	0.854
NULL	Arthritis_Res_Ther_2006_Dec_28_8(1)_R18.nxml.txt.nlp	16507118	SENT159	8	8	2	2	infliximab	IL-15	PA452639	3600	0.854
NULL	Clin_Exp_Otorhinolaryngol_2012_Sep_27_5(3)_132-138.nxml.txt.nlp	22977709	SENT9	16	16	12	12	fluorescein	P21	PA164746009	1026;9338	0.854
NULL	Mol_Vis_2012_Oct_5_18_2454-2467.nxml.txt.nlp	23077404	SENT153	11	11	5	5	bevacizumab	VEGF-A	PA130232992	7422	0.854
NULL	Breast_Cancer_Res_2008_Dec_18_10(Suppl_4)_S20.nxml.txt.nlp	19128434	SENT27	20	20	7	7	fulvestrant	FACT	PA164747170	11198	0.854
NULL	Cancers_(Basel)_2014_Jul_8_6(3)_1487-1499.nxml.txt.nlp	25006835	SENT428	8	8	5	5	platinum	STAT3	PA150595617	6774	0.854
NULL	Cell_Cycle_2012_Aug_15_11(16)_3097-3108.nxml.txt.nlp	22871741	SENT127	5	5	18	18	hyaluronan	HAS2	PA165958431	3037	0.854
NULL	ScientificWorldJournal_2012_May_1_2012_490968.nxml.txt.nlp	22645425	SENT113	11	11	22	22	theophylline	IL-6	PA451647	3569	0.854
NULL	F1000Res_2014_Aug_19_3_198.nxml.txt.nlp	25400908	SENT524	39	39	41	41	tamoxifen	IMPACT	PA451581	55364	0.854
NULL	Cancer_Med_2012_Aug_8_1(1)_5-16.nxml.txt.nlp	23342249	SENT267	23	23	4	4	paclitaxel	AKT2	PA450761	208	0.854
NULL	Clin_Pharmacol_2011_Jun_22_3_13-25.nxml.txt.nlp	22287853	SENT181	16	16	40	40	saxagliptin	CYP3A4	PA165958362	1576	0.854
NULL	J_Radiat_Res_2014_Mar_1_55(2)_359-363.nxml.txt.nlp	24187329	SENT43	14	14	0	0	cyclophosphamide	CHOP	PA449165	1649	0.854
NULL	Breast_Cancer_Res_2011_Jun_29_13(3)_R70.nxml.txt.nlp	21707964	SENT124	24	24	5	5	tamoxifen	14-3-3	PA451581	10971	0.854
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S320-S324.nxml.txt.nlp	21525476	SENT68	9	9	3	3	ramipril	DREAM	PA451223	30818	0.854
NULL	Case_Rep_Pediatr_2013_Jul_9_2013_254089.nxml.txt.nlp	23936711	SENT30	31	31	10	10	gentamicin	IL6	PA449753	3569	0.854
NULL	Breast_Cancer_Res_2014_May_5_16(3)_R45.nxml.txt.nlp	24887236	SENT288	4	4	9	9	lapatinib	HER2	PA152241907	2064	0.854
NULL	Clin_Ophthalmol_2014_Jun_28_8_1241-1252.nxml.txt.nlp	25061271	SENT151	20	20	28	28	timolol	BAK	PA451690	578	0.854
NULL	Eur_J_Dent_2009_Jan_3(1)_3-9.nxml.txt.nlp	19262725	SENT101	40	40	33	33	glutaraldehyde	HEMA	PA449777	2157	0.854
NULL	Arch_Med_Sci_2013_Aug_30_9(4)_739-744.nxml.txt.nlp	24049538	SENT122	37	37	33	33	candesartan	PC-3	PA448765	692094	0.854
NULL	Ann_Dermatol_2014_Aug_31_26(4)_517-520.nxml.txt.nlp	25143685	SENT20	11	11	7	7	fluorescein	TIG3	PA164746009	5920	0.854
NULL	EMBO_J_2013_Feb_20_32(4)_511-523.nxml.txt.nlp	23241948	SENT131	23	23	29	29	lincomycin	FRP	PA164749212	11167;6422	0.854
NULL	Ann_R_Coll_Surg_Engl_2012_Nov_94(8)_579-584.nxml.txt.nlp	23131229	SENT131	10	10	12	12	ciprofloxacin	CD4	PA449009	920	0.854
NULL	Acta_Pharmacol_Sin_2009_Sep_24_30(9)_1323-1329.nxml.txt.nlp	19701237	SENT44	19	19	23	23	clarithromycin	CYP3A	PA449028	1574	0.854
NULL	Exp_Neurobiol_2014_Jun_13_23(2)_124-129.nxml.txt.nlp	24963276	SENT51	8	8	13	13	naringin	GDNF	PA151958360	2668	0.854
NULL	Nat_Commun_2013_Apr_23_4_1738.nxml.txt.nlp	23612279	SENT19	28	28	5	5	papain	CD49b	PA450778	3673	0.854
NULL	BMB_Rep_2013_Aug_46(8)_410-415.nxml.txt.nlp	23977989	SENT102	33	33	26	26	curcumin	HO-1	PA151958596	3162	0.854
NULL	Structure_2012_May_9_20-540(5-7)_841-849.nxml.txt.nlp	22579251	SENT86	31	31	40	40	carvedilol	EL2	PA448817	6708	0.854
NULL	Mol_Syst_Biol_2009_Jul_28_5_288.nxml.txt.nlp	19638969	SENT178	2	2	16	16	resveratrol	HuR		1994	0.854
NULL	Aging_(Albany_NY)_2013_Feb_21_5(2)_94-95.nxml.txt.nlp	23518473	SENT24	5	5	9	9	resveratrol	SIRT1		23411	0.854
NULL	J_Radiat_Res_2014_May_5_55(3)_443-450.nxml.txt.nlp	24309719	SENT168	15	15	4	4	nitroprusside	SRC-3	PA451406	8202	0.854
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT293	24	24	5	5	cisplatin	JNK	PA449014	5599	0.854
NULL	J_Clin_Biochem_Nutr_2010_Sep_6_47(2)_121-129.nxml.txt.nlp	20838567	SENT396	1	1	3	3	ethanol	ATX	PA448073	5168;23049	0.854
NULL	Int_J_Breast_Cancer_2011_Feb_24_2011_967419.nxml.txt.nlp	22332018	SENT142	30	30	19	19	cisplatin	p53	PA449014	7157	0.854
NULL	Breast_Cancer_Res_2011_Jun_29_13(3)_R70.nxml.txt.nlp	21707964	SENT26	39	39	3	3	tamoxifen	14-3-3	PA451581	10971	0.854
NULL	Case_Rep_Orthop_2014_Dec_2_2014_197061.nxml.txt.nlp	25544922	SENT28	17	17	12	12	ethambutol	hole	PA164784021	80757	0.854
NULL	Med_Sci_Monit_2012_Jan_1_18(1)_RA1-RA11.nxml.txt.nlp	22207127	SENT215	5	5	12	12	raloxifene	RANKL	PA451221	8600	0.854
NULL	Evid_Based_Complement_Alternat_Med_2013_Nov_25_2013_429393.nxml.txt.nlp	24371460	SENT84	29	29	8	8	paraformaldehyde	CO2	PA450790	4513	0.854
NULL	Eur_J_Haematol_2014_Nov_28_93(5)_369-376.nxml.txt.nlp	24797664	SENT22	8	8	22	22	thrombin	FVIII	PA451674	2157	0.854
NULL	Cell_Death_Dis_2014_Feb_27_5(2)_e1088.nxml.txt.nlp	24577086	SENT121	37	37	11	11	metformin	Bcl-2	PA450395	596	0.854
NULL	Neuro_Oncol_2010_Apr_27_12(4)_389-400.nxml.txt.nlp	20308316	SENT117	13	13	38	38	chloroquine	p53	PA448948	7157	0.854
NULL	Br_J_Pharmacol_2008_Dec_25_155(7)_1056-1065.nxml.txt.nlp	18724386	SENT288	7	7	9	9	forskolin	GLP-1	PA146096022	100125288	0.854
NULL	Br_J_Cancer_2009_Nov_3_101(9)_1585-1595.nxml.txt.nlp	19809435	SENT306	19	19	39	39	curcumin	MDC	PA151958596	6367	0.854
NULL	Oncotarget_2014_Sep_2_5(19)_9308-9321.nxml.txt.nlp	25301721	SENT207	31	31	36	36	forskolin	CD38	PA146096022	952	0.854
NULL	Acta_Pharmacol_Sin_2011_Jul_6_32(7)_921-929.nxml.txt.nlp	21643005	SENT57	16	16	23	23	indomethacin	COX	PA449982	1351	0.853
NULL	Breast_Cancer_Res_2009_Jul_15_11(4)_207.nxml.txt.nlp	19664181	SENT112	26	26	19	19	paclitaxel	HER2	PA450761	2064	0.853
NULL	Braz_J_Microbiol_2014_Jan_10_44(3)_915-921.nxml.txt.nlp	24516460	SENT66	3	3	14	14	lipase	mol	PA450239	90527	0.853
NULL	Nat_Chem_Biol_2010_Apr_28_6(4)_291-299.nxml.txt.nlp	20190765	SENT114	15	15	29	29	dasatinib	LYN	PA162372878	4067	0.853
NULL	Biochem_Res_Int_2012_Dec_18_2012_893947.nxml.txt.nlp	22216413	SENT135	24	24	2	2	hyaluronidase	HYAL1	PA164745713	3373	0.853
NULL	Mol_Cancer_2014_Jun_24_13_157.nxml.txt.nlp	24958351	SENT44	18	18	12	12	gefitinib	EGFR	PA131301952	1956	0.853
NULL	Cell_Death_Dis_2013_Jul_11_4(7)_e719.nxml.txt.nlp	23846221	SENT78	13	13	11	11	cisplatin	TRAIL	PA449014	8743	0.853
NULL	Cancer_Med_2013_Feb_3_2(1)_11-20.nxml.txt.nlp	24133623	SENT445	15	15	9	9	cetuximab	PIK3CA	PA10040	5290	0.853
NULL	J_Invest_Dermatol_2012_May_16_132(5)_1435-1442.nxml.txt.nlp	22336948	SENT69	7	7	16	16	doxycycline	TLSP	PA449415	11012	0.853
NULL	Ann_Oncol_2012_Dec_2_23(12)_3007-3016.nxml.txt.nlp	22865781	SENT68	3	3	19	19	lapatinib	HER2	PA152241907	2064	0.853
NULL	Indian_Dermatol_Online_J_2014_Dec_5(Suppl_2)_S140-S141.nxml.txt.nlp	25593810	SENT31	4	4	13	13	tretinoin	CO2	PA451746	4513	0.853
NULL	Int_J_Mol_Sci_2013_Apr_24_14(5)_8801-8817.nxml.txt.nlp	23615471	SENT147	19	19	11	11	trypsin	CO2	PA451806	4513	0.853
NULL	Oncogenesis_2012_Apr_2_1(4)_e5.nxml.txt.nlp	23552603	SENT288	2	2	11	11	ns-398	p65		5970	0.853
NULL	Tob_Control_2009_Feb_13_18(1)_34-42.nxml.txt.nlp	18845621	SENT275	11	11	6	6	cyclophosphamide	CYP2B6	PA449165	1555	0.853
NULL	Arthritis_Res_Ther_2008_Jan_7_10(1)_R1.nxml.txt.nlp	18179697	SENT220	24	24	9	9	oxaliplatin	HMGB1	PA131285527	3146	0.853
NULL	Cell_Cycle_2012_Nov_1_11(21)_4069-4078.nxml.txt.nlp	23095523	SENT70	13	13	19	19	imatinib	PERK	PA10804	9451	0.853
NULL	Oncologist_2010_Apr_15(4)_360-371.nxml.txt.nlp	20413641	SENT206	25	25	0	0	oxygen	KGF	PA450744	2252	0.853
NULL	J_Biomed_Biotechnol_2010_Jun_7_2010_150960.nxml.txt.nlp	20617134	SENT226	18	18	26	26	paclitaxel	KRAS	PA450761	3845	0.853
NULL	J_Gastroenterol_2013_Feb_22_48(2)_222-237.nxml.txt.nlp	22722906	SENT8	39	39	25	25	ethanol	JNK	PA448073	5599	0.853
NULL	Ther_Clin_Risk_Manag_2006_Jun_2(2)_129-158.nxml.txt.nlp	18360588	SENT151	1	1	3	3	voriconazole	CYP3A4	PA10233	1576	0.853
NULL	eLife_2014_May_20_3_e01763.nxml.txt.nlp	24844244	SENT427	12	12	17	17	doxycycline	MELK	PA449415	9833	0.853
NULL	Breast_Cancer_Res_2007_Jul_5_9(4)_R41.nxml.txt.nlp	17612393	SENT129	0	0	39	39	celecoxib	PARP	PA448871	142	0.853
NULL	Br_J_Cancer_2012_Jan_3_106(1)_18-24.nxml.txt.nlp	22108516	SENT140	19	19	13	13	cetuximab	BRAF	PA10040	673	0.853
NULL	Evid_Based_Complement_Alternat_Med_2012_Feb_12_2012_472897.nxml.txt.nlp	22454667	SENT184	14	14	9	9	roflumilast	PDE4A	PA165948052	5141	0.853
NULL	Curr_Biol_2009_Oct_13_19(19)_1648-1653.nxml.txt.nlp	19765991	SENT113	26	26	6	6	paraformaldehyde	STIM1	PA450790	6786	0.853
NULL	Blood_Res_2013_Jun_25_48(2)_72-73.nxml.txt.nlp	23826573	SENT12	22	22	32	32	plerixafor	CD34	PA165958410	947	0.853
NULL	Arthritis_Res_Ther_2012_May_1_14(3)_R99.nxml.txt.nlp	22546542	SENT234	7	7	26	26	infliximab	CD4	PA452639	920	0.853
NULL	Oncol_Lett_2014_Jun_8_7(6)_1903-1910.nxml.txt.nlp	24932256	SENT144	21	21	0	0	cisplatin	MDC	PA449014	6367	0.853
NULL	Brain_Behav_2014_Jan_27_4(1)_51-59.nxml.txt.nlp	24653954	SENT17	30	30	11	11	estradiol	EPM	PA449503	2054	0.853
NULL	Mediators_Inflamm_2010_Oct_5_2010_321061.nxml.txt.nlp	20953358	SENT168	6	6	11	11	methacholine	NOS3	PA165958382	4846;342977	0.853
NULL	Ann_Dermatol_2011_Nov_3_23(4)_468-473.nxml.txt.nlp	22148014	SENT111	2	2	11	11	tacrolimus	IL-2	PA451578	3558	0.853
NULL	Front_Neurosci_2014_Apr_8_8_63.nxml.txt.nlp	24782698	SENT644	3	3	9	9	fluoxetine	5-HT1A	PA449673	3350	0.853
NULL	Clinics_(Sao_Paulo)_2013_May_68(5)_694-701.nxml.txt.nlp	23778405	SENT140	11	11	22	22	curcumin	P-gp	PA151958596	5243	0.853
NULL	Anesthesiol_Res_Pract_2013_Sep_23_2013_297141.nxml.txt.nlp	24174934	SENT181	25	25	13	13	bupivacaine	mol	PA135057240	90527	0.853
NULL	Anal_Chem_2014_Feb_18_86(4)_1988-1996.nxml.txt.nlp	24446580	SENT97	39	39	15	15	trypsin	PPG	PA451806	5552	0.853
NULL	Front_Endocrinol_(Lausanne)_2014_Oct_27_5_163.nxml.txt.nlp	25386163	SENT283	12	12	25	25	amisulpride	ghrelin	PA162565877	51738	0.853
NULL	Br_J_Pharmacol_2014_May_11_171(9)_2385-2398.nxml.txt.nlp	24467222	SENT174	7	7	22	22	rolipram	Rho	PA153906323	29984	0.853
NULL	BMJ_Open_2013_Nov_4_3(11)_e003556.nxml.txt.nlp	24189081	SENT265	15	15	36	36	paclitaxel	AGO	PA450761	55294	0.853
NULL	Clin_Cosmet_Investig_Dermatol_2014_Sep_2_7_243-249.nxml.txt.nlp	25214798	SENT54	44	44	1	1	ustekinumab	ACR	PA166048654	49	0.853
NULL	BMB_Rep_2013_Aug_46(8)_410-415.nxml.txt.nlp	23977989	SENT51	6	6	0	0	curcumin	HO-1	PA151958596	3162	0.853
NULL	Archaea_2014_May_29_2014_349379.nxml.txt.nlp	24982594	SENT23	32	32	11	11	ethanol	ES1	PA448073	8209	0.853
NULL	Br_J_Cancer_2004_Mar_22_90(6)_1285-1292.nxml.txt.nlp	15026814	SENT189	30	30	24	24	cisplatin	p53	PA449014	7157	0.853
NULL	Int_J_Med_Sci_2013_Mar_1_10(4)_427-433.nxml.txt.nlp	23471472	SENT51	13	13	11	11	telbivudine	LAM	PA164760861	7249;7248	0.853
NULL	Cancer_Cell_Int_2007_Sep_10_7_14.nxml.txt.nlp	17845729	SENT195	14	14	2	2	decitabine	PAWR	PA164749631	5074	0.853
NULL	J_Am_Heart_Assoc_2013_Dec_19_2(6)_e000441.nxml.txt.nlp	24252844	SENT315	19	19	22	22	fenofibrate	PPARgamma	PA449594	5468	0.853
NULL	Oncoimmunology_2012_Oct_1_1(7)_1048-1060.nxml.txt.nlp	23170253	SENT49	18	18	26	26	pertuzumab	HER-2		2064	0.853
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT83	8	8	17	17	curcumin	DR5	PA151958596	8795	0.853
NULL	Insights_Imaging_2011_Mar_25_2(3)_235-246.nxml.txt.nlp	22347950	SENT100	31	31	5	5	choline	MRI	PA448976	78996	0.853
NULL	Biomed_Res_Int_2013_Nov_7_2013_946958.nxml.txt.nlp	24312914	SENT26	3	3	7	7	hyaluronan	CD44	PA165958431	960	0.853
NULL	Cancer_Manag_Res_2011_Sep_9_3_301-309.nxml.txt.nlp	21931504	SENT138	9	9	6	6	spermine	CXCR4	PA164781199	7852	0.853
NULL	Allergy_Asthma_Clin_Immunol_2010_May_12_6(1)_8.nxml.txt.nlp	20462426	SENT197	18	18	10	10	metformin	DDP	PA450395	1678	0.853
NULL	Clinics_(Sao_Paulo)_2011_Aug_66(8)_1313-1319.nxml.txt.nlp	21915477	SENT61	3	3	0	0	docetaxel	NACT	PA449383	284111	0.853
NULL	Cell_Death_Differ_2010_Mar_16_17(3)_499-512.nxml.txt.nlp	19834490	SENT121	6	6	33	33	bevacizumab	VEGFR2	PA130232992	3791	0.853
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jun_23_66(Pt_7)_o1766.nxml.txt.nlp	21587980	SENT58	4	4	25	25	isopropamide	mol	PA164781398	90527	0.853
NULL	Indian_J_Pharmacol_2013_May-Jun_45(3)_298-300.nxml.txt.nlp	23833379	SENT13	10	10	23	23	lamivudine	CD4	PA450163	920	0.853
NULL	Ann_Dermatol_2014_Dec_26_26(6)_706-712.nxml.txt.nlp	25473222	SENT91	9	9	1	1	isotretinoin	EPO	PA450128	7076;8288;2056	0.853
NULL	Front_Oncol_2014_Jun_18_4_159.nxml.txt.nlp	24995161	SENT151	17	17	9	9	estradiol	AKR1C3	PA449503	8644	0.853
NULL	J_Cancer_2013_Nov_23_4(9)_736-754.nxml.txt.nlp	24312144	SENT82	22	22	11	11	paclitaxel	EGFR	PA450761	1956	0.853
NULL	Acta_Neuropathol_Commun_2014_May_30_2_57.nxml.txt.nlp	24887326	SENT267	3	3	11	11	etoposide	ABCB1	PA449552	5243	0.853
NULL	Environ_Health_Perspect_2007_Dec_8_115(Suppl_1)_77-83.nxml.txt.nlp	18174954	SENT201	4	4	11	11	genistein	TPO	PA165109660	7066;7173	0.853
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Oct_23_65(Pt_11)_o2827.nxml.txt.nlp	21578418	SENT78	30	30	18	18	ethanol	mol	PA448073	90527	0.853
NULL	J_Hematol_Oncol_2008_Oct_1_1_16.nxml.txt.nlp	18828924	SENT56	11	11	36	36	lapatinib	HER2	PA152241907	2064	0.853
NULL	Breast_Cancer_Res_2011_Jan_26_13(1)_R10.nxml.txt.nlp	21269472	SENT274	18	18	8	8	estradiol	PPARGC1B	PA449503	133522	0.853
NULL	Cancers_(Basel)_2012_Jun_27_4(3)_618-657.nxml.txt.nlp	22946011	SENT684	16	16	1	1	hyaluronan	LYVE-1	PA165958431	10894	0.853
NULL	Antiviral_Res_2009_May_82(2)_A99-A109.nxml.txt.nlp	19176219	SENT76	22	22	16	16	zidovudine	P-gp	PA451954	5243	0.853
NULL	Tumour_Biol_2012_Dec_14_33(6)_2209-2216.nxml.txt.nlp	22890830	SENT13	47	47	39	39	erlotinib	EGFR	PA134687924	1956	0.853
NULL	Breast_Cancer_Res_Treat_2014_Jul_8_146(3)_557-566.nxml.txt.nlp	25001612	SENT343	2	2	11	11	bsi-201	PARP1		142	0.853
NULL	J_Korean_Med_Sci_2010_Apr_19_25(4)_557-563.nxml.txt.nlp	20357998	SENT120	14	14	4	4	rosiglitazone	IFN	PA451283	3439	0.853
NULL	BMB_Rep_2013_Aug_46(8)_410-415.nxml.txt.nlp	23977989	SENT20	0	0	10	10	curcumin	IL-6	PA151958596	3569	0.853
NULL	Arthritis_Res_Ther_2014_Jul_18_16(4)_R153.nxml.txt.nlp	25037855	SENT209	3	3	17	17	infliximab	CD14	PA452639	929	0.853
NULL	Cell_Death_Dis_2014_Jan_30_5(1)_e1030.nxml.txt.nlp	24481444	SENT65	1	1	17	17	sorafenib	Bcl-2	PA7000	596	0.853
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT205	19	19	12	12	sulindac	AKT	PA451565	207	0.853
NULL	Ann_Surg_Treat_Res_2014_Feb_22_86(2)_68-75.nxml.txt.nlp	24761411	SENT191	2	2	14	14	resveratrol	survivin		332	0.853
NULL	Gut_Liver_2012_Oct_18_6(4)_464-470.nxml.txt.nlp	23170151	SENT29	38	38	21	21	midazolam	ESD	PA450496	2098	0.853
NULL	Aging_(Albany_NY)_2013_Jul_20_5(7)_495-506.nxml.txt.nlp	24073437	SENT121	32	32	17	17	resveratrol	IL-8		3576	0.853
NULL	Mol_Biol_Rep_2013_May_11_40(8)_5013-5026.nxml.txt.nlp	23666059	SENT257	10	10	23	23	resveratrol	PLK1		5347	0.853
NULL	Clin_Pediatr_Endocrinol_2009_May_1_18(2)_65-72.nxml.txt.nlp	24790382	SENT127	14	14	23	23	cabergoline	PRL	PA448708	5617	0.853
NULL	Indian_J_Nucl_Med_2015_Jan-Mar_30(1)_42-46.nxml.txt.nlp	25589805	SENT108	12	12	5	5	octreotide	SSTR3	PA450678	6753	0.853
NULL	Ann_Gen_Psychiatry_2013_Jan_24_12_1.nxml.txt.nlp	23347694	SENT384	37	37	20	20	carbamazepine	CYP3A4	PA448785	1576	0.853
NULL	Oncotarget_2011_Dec_24_2(12)_896-917.nxml.txt.nlp	22203527	SENT115	28	28	6	6	metformin	LKB1	PA450395	6794	0.853
NULL	J_Korean_Med_Sci_2010_Aug_21_25(8)_1222-1227.nxml.txt.nlp	20676337	SENT157	29	29	21	21	propofol	LPA	PA451141	4018	0.853
NULL	Cancer_Cell_Int_2013_Oct_11_13_97.nxml.txt.nlp	24119761	SENT52	9	9	13	13	trastuzumab	EGF	PA451743	1950	0.853
NULL	Cancer_Immunol_Immunother_2012_Jul_23_61(7)_1101-1111.nxml.txt.nlp	22193989	SENT176	2	2	13	13	oxaliplatin	SHP-1	PA131285527	5777	0.853
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT170	21	21	32	32	cisplatin	AKT	PA449014	207	0.853
NULL	J_Cardiovasc_Magn_Reson_2009_Jul_27_11(1)_24.nxml.txt.nlp	19635160	SENT168	9	9	0	0	rosiglitazone	ATV	PA451283	4683	0.853
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Dec_6_65(Pt_1)_o39.nxml.txt.nlp	21581681	SENT61	27	27	16	16	ethanol	mol	PA448073	90527	0.853
NULL	J_Cancer_2012_Oct_13_3_432-448.nxml.txt.nlp	23074383	SENT163	16	16	21	21	trastuzumab	PTEN	PA451743	5728	0.853
NULL	J_Signal_Transduct_2011_Feb_24_2011_804236.nxml.txt.nlp	21637380	SENT56	4	4	2	2	trastuzumab	HER2	PA451743	2064	0.853
NULL	J_Biol_Chem_2009_Jan_2_284(1)_77-84.nxml.txt.nlp	18854318	SENT36	12	12	19	19	phenformin	LKB1	PA1000	6794	0.853
NULL	Curr_Pharm_Des_2011_Feb_17(6)_578-590.nxml.txt.nlp	21391908	SENT177	31	31	19	19	nutlin-3	p53		7157	0.853
NULL	Breast_Cancer_Res_2011_Dec_16_13(6)_R131.nxml.txt.nlp	22177475	SENT12	13	13	36	36	erlotinib	HER2	PA134687924	2064	0.853
NULL	Breast_Cancer_Res_2009_Oct_28_11(5)_211.nxml.txt.nlp	19889200	SENT46	5	5	18	18	tamoxifen	San	PA451581	80218	0.853
NULL	Indian_J_Pharmacol_2014_Jan-Feb_46(1)_3-12.nxml.txt.nlp	24550577	SENT221	21	21	7	7	carbamazepine	CYP3A4	PA448785	1576	0.853
NULL	Arthritis_Res_Ther_2008_Jun_30_10(3)_209.nxml.txt.nlp	18598385	SENT243	3	3	18	18	oxaliplatin	HMGB1	PA131285527	3146	0.853
NULL	Int_J_Mol_Sci_2014_Oct_14_15(10)_18557-18573.nxml.txt.nlp	25318057	SENT100	13	13	25	25	doxorubicin	c-FLIP	PA449412	8837	0.853
NULL	Oncotarget_2014_Oct_21_5(22)_11252-11268.nxml.txt.nlp	25361004	SENT181	24	24	26	26	metformin	CLIC1	PA450395	1192	0.853
NULL	Arthritis_Res_Ther_2012_Apr_30_14(2)_R96.nxml.txt.nlp	22546471	SENT167	5	5	17	17	methotrexate	SLC19A1	PA450428	6573	0.853
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT156	3	3	7	7	tacrolimus	RANKL	PA451578	8600	0.853
NULL	J_Biol_Chem_2008_Nov_14_283(46)_31679-31689.nxml.txt.nlp	18755684	SENT29	14	14	1	1	iron	FTH1	PA450087	2495	0.853
NULL	Braz_J_Med_Biol_Res_2013_Mar_15_46(3)_299-305.nxml.txt.nlp	23532269	SENT156	0	0	9	9	propofol	CD14	PA451141	929	0.853
NULL	ScientificWorldJournal_2012_Apr_1_2012_381434.nxml.txt.nlp	22545017	SENT382	12	12	9	9	aprepitant	NK-1	PA164747039	27087	0.853
NULL	J_Cell_Mol_Med_2014_Oct_11_18(10)_2031-2043.nxml.txt.nlp	25109475	SENT353	9	9	18	18	valsartan	TLR-4	PA451848	7099	0.853
NULL	Front_Endocrinol_(Lausanne)_2013_Jul_16_4_87.nxml.txt.nlp	23882260	SENT41	12	12	5	5	l-cysteine	PLP	PA449173	25824;5744	0.853
NULL	Neural_Dev_2014_Oct_29_9_23.nxml.txt.nlp	25352248	SENT230	23	23	12	12	heparin	EGF	PA449855	1950	0.853
NULL	J_Exp_Clin_Cancer_Res_2009_Jul_3_28(1)_97.nxml.txt.nlp	19575783	SENT21	14	14	4	4	cisplatin	HER2	PA449014	2064	0.853
NULL	Clin_Pharmacol_2012_Feb_20_4_13-20.nxml.txt.nlp	22427735	SENT94	14	14	9	9	clopidogrel	CYP2C19	PA449053	1557	0.853
NULL	Mol_Biol_Cell_2013_Dec_1_24(23)_3588-3602.nxml.txt.nlp	24109600	SENT67	19	19	13	13	galactose	STI1	PA449725	10963	0.853
NULL	Oncol_Lett_2014_Jul_16_8(1)_211-217.nxml.txt.nlp	24959248	SENT94	29	29	8	8	cisplatin	ALDOA	PA449014	226	0.853
NULL	Front_Oncol_2014_Sep_15_4_248.nxml.txt.nlp	25309873	SENT140	15	15	6	6	afatinib	EGFR	PA165981154	1956	0.853
NULL	Clinicoecon_Outcomes_Res_2014_Oct_17_6_451-461.nxml.txt.nlp	25378939	SENT31	30	30	34	34	linezolid	HAP	PA450233	5915;10313	0.853
NULL	Mol_Cancer_2010_Jun_7_9_139.nxml.txt.nlp	20529262	SENT179	9	9	29	29	cetuximab	C3b	PA10040	718	0.853
NULL	Nucleic_Acids_Res_2011_Dec_31_39(22)_9536-9548.nxml.txt.nlp	21880590	SENT224	16	16	5	5	etoposide	BRCA1	PA449552	672	0.853
NULL	Diabetes_2011_Nov_17_60(11)_2975-2984.nxml.txt.nlp	21885871	SENT327	6	6	15	15	curcumin	p300	PA151958596	2033	0.853
NULL	Mol_Cancer_2008_Jun_5_7_50.nxml.txt.nlp	18534018	SENT127	8	8	15	15	bortezomib	NOXA	PA10252	5366	0.853
NULL	Nanoscale_Res_Lett_2009_Apr_25_4(8)_789-793.nxml.txt.nlp	20596333	SENT61	4	4	12	12	copper	TEM	PA449114	64102	0.853
NULL	Mol_Biol_Cell_2012_Nov_1_23(21)_4212-4225.nxml.txt.nlp	22956765	SENT98	22	22	16	16	thrombin	PP2	PA451674	4888	0.853
NULL	Oxid_Med_Cell_Longev_2013_Mar_5_2013_264935.nxml.txt.nlp	23533686	SENT45	15	15	21	21	hemin	HO-1	PA449849	3162	0.853
NULL	Cell_Death_Dis_2013_Jul_11_4(7)_e719.nxml.txt.nlp	23846221	SENT56	38	38	16	16	cisplatin	TRAIL	PA449014	8743	0.853
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT133	0	0	9	9	metformin	CCL16	PA450395	6360	0.853
NULL	Evid_Based_Complement_Alternat_Med_2011_Aug_21_2011_131042.nxml.txt.nlp	19789212	SENT74	7	7	35	35	paraformaldehyde	MAP2	PA450790	4133;10988	0.853
NULL	Hum_Genomics_2013_Sep_23_7(1)_20.nxml.txt.nlp	24060470	SENT18	0	0	3	3	imatinib	KIT	PA10804	3815	0.853
NULL	Eur_J_Haematol_2014_Feb_25_92(2)_127-136.nxml.txt.nlp	24118452	SENT26	17	17	21	21	anagrelide	IFN	PA164742986	3439	0.853
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT151	38	38	33	33	glucose	p38	PA449773	10598;1432;7965	0.853
NULL	Ann_Oncol_2011_Mar_8_22(3)_503-514.nxml.txt.nlp	20616198	SENT220	20	20	38	38	exemestane	aromatase	PA449563	1588	0.853
NULL	J_Infect_Chemother_2012_Oct_28_18(5)_753-755.nxml.txt.nlp	22203121	SENT26	7	7	15	15	cyclophosphamide	ADM	PA449165	133	0.853
NULL	J_Biol_Chem_2013_Oct_11_288(41)_29642-29653.nxml.txt.nlp	24005673	SENT694	13	13	16	16	hyaluronan	TSG-6	PA165958431	7130	0.853
NULL	Alzheimers_Res_Ther_2011_Jul_20_3(4)_23.nxml.txt.nlp	21774798	SENT244	22	22	13	13	donepezil	APOE	PA449394	348	0.853
NULL	Br_J_Cancer_2011_Jul_12_105(2)_212-220.nxml.txt.nlp	21694723	SENT43	19	19	4	4	curcumin	STAT3	PA151958596	6774	0.853
NULL	Br_J_Haematol_2014_Mar_13_164(1)_811-821.nxml.txt.nlp	24328678	SENT209	3	3	14	14	lenalidomide	Aiolos	PA162363968	22806	0.853
NULL	Cancer_Immunol_Immunother_2013_Aug_27_62(10)_1637-1648.nxml.txt.nlp	23982484	SENT128	18	18	11	11	lenalidomide	IL-6	PA162363968	3569	0.853
NULL	J_Pain_Res_2014_Jun_23_7_353-357.nxml.txt.nlp	25018649	SENT21	7	7	19	19	lidocaine	LNP	PA450226	80856;51203	0.853
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jun_16_68(Pt_7)_o2122.nxml.txt.nlp	22798798	SENT74	22	22	15	15	ethanol	mol	PA448073	90527	0.853
NULL	Int_J_Environ_Res_Public_Health_2012_Aug_27_9(8)_2636-2657.nxml.txt.nlp	23066388	SENT1047	22	22	9	9	sjg-136	ERCC1		2067	0.853
NULL	Osteoporos_Int_2014_Oct_10_25(3)_1173-1180.nxml.txt.nlp	24108429	SENT133	36	36	22	22	teriparatide	PTH	PA451620	5741	0.853
NULL	J_Headache_Pain_2009_Dec_3_10(6)_407-417.nxml.txt.nlp	19802522	SENT155	7	7	1	1	topiramate	MIDAS	PA451728	64083	0.853
NULL	Cardiovasc_Diabetol_2010_Feb_1_9_8.nxml.txt.nlp	20122173	SENT128	4	4	11	11	vasopressin	STZ	PA451858	6484	0.853
NULL	Curr_Neuropharmacol_2013_Dec_11(6)_652-663.nxml.txt.nlp	24396340	SENT193	13	13	28	28	propofol	TRPA1	PA451141	8989	0.853
NULL	Exp_Mol_Med_2012_Sep_30_44(9)_545-553.nxml.txt.nlp	22809901	SENT61	4	4	21	21	clozapine	PRDM16	PA449061	63976	0.853
NULL	Breast_Cancer_(Auckl)_2014_Jul_29_8_109-118.nxml.txt.nlp	25125981	SENT97	10	10	25	25	afatinib	HER2	PA165981154	2064	0.853
NULL	Breast_Cancer_Res_2011_Jan_11_13(1)_R3.nxml.txt.nlp	21223569	SENT138	3	3	6	6	etoposide	p53	PA449552	7157	0.853
NULL	Gastroenterol_Hepatol_Bed_Bench_2011_Spring_4(2)_43-52.nxml.txt.nlp	24834156	SENT104	11	11	23	23	trypsin	TATI	PA451806	6690	0.853
NULL	Oncogenesis_2014_Dec_15_3(12)_e133.nxml.txt.nlp	25500906	SENT8	16	16	32	32	trastuzumab	PI3K	PA451743	5290	0.853
NULL	Crit_Care_2011_Aug_2_15(4)_177.nxml.txt.nlp	21861863	SENT4	3	3	10	10	fenoldopam	NGAL	PA164784034	3934	0.853
NULL	Drug_Des_Devel_Ther_2014_Oct_31_8_2121-2128.nxml.txt.nlp	25382970	SENT87	24	24	9	9	curcumin	TTR	PA151958596	7276	0.853
NULL	Nat_Neurosci_2012_Sep_5_15(9)_1245-1254.nxml.txt.nlp	22864611	SENT171	29	29	14	14	clozapine	mGlu3	PA449061	2913	0.853
NULL	Acta_Pharmacol_Sin_2012_Apr_5_33(4)_551-557.nxml.txt.nlp	22388075	SENT111	0	0	11	11	imatinib	Wip1	PA10804	8493	0.853
NULL	Pain_2012_Apr_153(4)_775-783.nxml.txt.nlp	22325744	SENT164	6	6	9	9	naloxone	P21	PA450586	1026;9338	0.853
NULL	Exp_Diabetes_Res_2012_May_28_2012_924168.nxml.txt.nlp	22693487	SENT37	8	8	0	0	exenatide	GLP-1	PA164749238	100125288	0.853
NULL	Aging_(Albany_NY)_2012_Dec_6_4(11)_823-842.nxml.txt.nlp	23235539	SENT180	44	44	2	2	bleomycin	SRM	PA448645	6723;6725	0.853
NULL	Am_J_Physiol_Cell_Physiol_2010_Mar_16_298(3)_C430-C441.nxml.txt.nlp	20018950	SENT403	10	10	12	12	thrombin	ADP	PA451674	23038	0.853
NULL	FASEB_J_2014_Jul_28(7)_3050-3063.nxml.txt.nlp	24732131	SENT46	11	11	45	45	l-glutamine	CO2	PA10090	4513	0.853
NULL	Biologics_2009_Jul_13_3_289-301.nxml.txt.nlp	19707416	SENT81	37	37	14	14	trastuzumab	HER2	PA451743	2064	0.853
NULL	J_Cell_Biol_2005_Jun_20_169(6)_871-884.nxml.txt.nlp	15967811	SENT97	13	13	32	32	arsenite	eIF3b	PA452638	8662	0.853
NULL	Hum_Mol_Genet_2011_May_15_20(10)_2037-2047.nxml.txt.nlp	21372148	SENT32	16	16	6	6	oxygen	CLN3	PA450744	1201	0.853
NULL	Biomed_Res_Int_2014_Jun_25_2014_764981.nxml.txt.nlp	25057499	SENT185	12	12	30	30	sorafenib	survivin	PA7000	332	0.853
NULL	Environ_Health_Perspect_2010_Sep_19_118(9)_1243-1250.nxml.txt.nlp	20488778	SENT225	8	8	10	10	diethylstilbestrol	DES	PA449307	1674	0.853
NULL	Cancer_Cell_Int_2013_Jan_15_13_3.nxml.txt.nlp	23320839	SENT15	4	4	15	15	doxorubicin	MRP3	PA449412	8714	0.853
NULL	Oncotarget_2013_Dec_18_5(2)_375-385.nxml.txt.nlp	24495868	SENT116	24	24	5	5	fludarabine	MCL1	PA449655	4170	0.853
NULL	J_Hematol_Oncol_2012_Oct_22_5_67.nxml.txt.nlp	23088650	SENT94	22	22	19	19	rituximab	TFI	PA451261	7035	0.853
NULL	Oncogenesis_2012_Apr_2_1(4)_e5.nxml.txt.nlp	23552603	SENT573	7	7	12	12	ns-398	DR4		8797	0.853
NULL	Nat_Med_2013_Oct_8_19(10)_1313-1317.nxml.txt.nlp	24013700	SENT148	8	8	4	4	ribavirin	IFN	PA451241	3439	0.853
NULL	Int_J_Mol_Sci_2014_Nov_10_15(11)_20607-20637.nxml.txt.nlp	25391045	SENT40	18	18	24	24	lovastatin	CYP3A4	PA450272	1576	0.853
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT178	36	36	32	32	adalimumab	CD36	PA10004	948	0.853
NULL	Diabetes_2013_Jun_17_62(6)_1800-1807.nxml.txt.nlp	23704521	SENT254	13	13	15	15	curcumin	p300	PA151958596	2033	0.853
NULL	J_Headache_Pain_2012_Nov_16_13(8)_677-684.nxml.txt.nlp	23070400	SENT165	7	7	4	4	nabilone	DAI	PA164746998	81030	0.853
NULL	Brain_Res_2011_Mar_25_1382(C)_29-36.nxml.txt.nlp	21276431	SENT109	29	29	27	27	ketanserin	5-HT2A	PA131053734	3356	0.853
NULL	Br_J_Cancer_2010_Oct_12_103(8)_1263-1268.nxml.txt.nlp	20842121	SENT116	7	7	14	14	ns-398	CD59		966	0.853
NULL	J_Korean_Med_Sci_2013_Feb_29_28(2)_308-314.nxml.txt.nlp	23399960	SENT145	21	21	7	7	gabapentin	IL-10	PA449720	3586	0.853
NULL	Braz_J_Med_Biol_Res_2013_Mar_19_46(3)_257-262.nxml.txt.nlp	23558860	SENT60	12	12	46	46	tropicamide	ERG	PA164749389	2078	0.853
NULL	Oncotarget_2014_Aug_24_5(16)_6556-6557.nxml.txt.nlp	25179303	SENT31	16	16	6	6	curcumin	COX	PA151958596	1351	0.853
NULL	Pharmaceuticals_(Basel)_2014_Jan_9_7(1)_46-57.nxml.txt.nlp	24451403	SENT140	12	12	47	47	ritonavir	PI3K	PA451260	5290	0.853
NULL	J_Korean_Med_Sci_2007_Apr_30_22(2)_283-289.nxml.txt.nlp	17449938	SENT184	3	3	12	12	minoxidil	P21	PA450521	1026;9338	0.853
NULL	Br_J_Cancer_2004_Mar_22_90(6)_1285-1292.nxml.txt.nlp	15026814	SENT132	32	32	4	4	doxorubicin	p53	PA449412	7157	0.853
NULL	Clin_Exp_Gastroenterol_2012_Jul_19_5_139-150.nxml.txt.nlp	22888267	SENT154	13	13	7	7	indomethacin	I-FABP	PA449982	2169	0.853
NULL	Diabetes_Care_2013_Jul_12_36(7)_1913-1918.nxml.txt.nlp	23359361	SENT138	26	26	7	7	sitagliptin	GLP-1	PA164748978	100125288	0.853
NULL	J_Gastroenterol_2013_Jun_6_48(6)_681-688.nxml.txt.nlp	23463401	SENT111	30	30	2	2	sorafenib	SHARP	PA7000	23013	0.853
NULL	Evid_Based_Complement_Alternat_Med_2012_Dec_20_2012_908601.nxml.txt.nlp	23326293	SENT69	1	1	29	29	trypsin	EPCAM	PA451806	4072	0.853
NULL	Clin_Pharmacol_2010_Sep_6_2_155-162.nxml.txt.nlp	22291500	SENT43	34	34	16	16	clopidogrel	P2Y12	PA449053	64805	0.853
NULL	Breast_Cancer_Res_2011_Mar_10_13(2)_R28.nxml.txt.nlp	21392397	SENT203	6	6	22	22	erlotinib	YB-1	PA134687924	4904	0.853
NULL	J_Radiat_Res_2014_Mar_1_55(2)_359-363.nxml.txt.nlp	24187329	SENT43	16	16	0	0	doxorubicin	CHOP	PA449412	1649	0.853
NULL	Int_J_Biomed_Sci_2013_Sep_9(3)_112-122.nxml.txt.nlp	24170986	SENT110	3	3	22	22	perindopril	RAGE	PA450877	177	0.853
NULL	Indian_J_Pharmacol_2014_Nov-Dec_46(6)_627-632.nxml.txt.nlp	25538335	SENT106	6	6	4	4	metformin	Q10	PA450395	27161	0.853
NULL	J_Clin_Biochem_Nutr_2007_Sep_29_41(2)_84-91.nxml.txt.nlp	18193101	SENT117	25	25	9	9	lansoprazole	RANTES	PA450180	6352	0.853
NULL	Arch_Drug_Inf_2011_Mar_4(1)_1-9.nxml.txt.nlp	21572514	SENT171	16	16	14	14	probenecid	OAT3	PA451106	9376	0.853
NULL	Curr_Oncol_Rep_2011_Apr_12_13(2)_103-111.nxml.txt.nlp	21318618	SENT4	22	22	18	18	axitinib	VEGFR	PA164924493	3791	0.853
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jul_7_66(Pt_8)_o1952.nxml.txt.nlp	21588276	SENT76	41	41	32	32	ethanol	mol	PA448073	90527	0.853
NULL	Cases_J_2009_Aug_24_2_7024.nxml.txt.nlp	19918503	SENT21	9	9	18	18	warfarin	CYP2C9	PA451906	1559	0.853
NULL	Case_Rep_Med_2012_Dec_3_2012_163173.nxml.txt.nlp	23326270	SENT89	8	8	19	19	rosuvastatin	CPT2	PA134308647	1376	0.853
NULL	J_Oncol_2013_Apr_29_2013_854121.nxml.txt.nlp	23737784	SENT120	22	22	32	32	lapatinib	PI3K	PA152241907	5290	0.853
NULL	Br_J_Pharmacol_2014_Oct_1_171(20)_4524-4538.nxml.txt.nlp	24467454	SENT201	27	27	22	22	rimonabant	CB1	PA152407999	1268	0.853
NULL	J_Korean_Med_Sci_2011_Aug_27_26(8)_1007-1013.nxml.txt.nlp	21860550	SENT123	33	33	23	23	tamoxifen	CYP2D6	PA451581	1565	0.853
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT12	13	13	16	16	pp2	LYN		4067	0.853
NULL	Acta_Pharmacol_Sin_2011_Oct_12_32(10)_1259-1265.nxml.txt.nlp	21909126	SENT129	7	7	15	15	fluvastatin	MCP-1	PA449688	6347	0.853
NULL	Arthritis_Res_Ther_2011_Feb_4_13(1)_R14.nxml.txt.nlp	21294864	SENT108	22	22	15	15	indomethacin	IL-17	PA449982	3605	0.853
NULL	Acta_Diabetol_2012_Aug_11_49(4)_277-289.nxml.txt.nlp	21833779	SENT194	31	31	28	28	carbachol	ANOVA	PA448784	4858	0.853
NULL	Mol_Cancer_2012_Jul_12_11_45.nxml.txt.nlp	22788833	SENT134	16	16	31	31	cisplatin	EGFR	PA449014	1956	0.853
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jun_18_67(Pt_7)_o1665.nxml.txt.nlp	21837064	SENT58	40	40	26	26	ethanol	mol	PA448073	90527	0.853
NULL	Nature_2008_Oct_23_455(7216)_1129-1133.nxml.txt.nlp	18948956	SENT184	11	11	15	15	triciribine	c-Myc	PA165958661	4609	0.853
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1137-1144.nxml.txt.nlp	20234366	SENT139	15	15	25	25	cetuximab	KRAS	PA10040	3845	0.853
NULL	J_Oral_Pathol_Med_2013_Jul_18_42(6)_499-506.nxml.txt.nlp	23331485	SENT66	15	15	7	7	indomethacin	COX	PA449982	1351	0.853
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2008_Jun_1_64(Pt_6)_611-619.nxml.txt.nlp	18560148	SENT191	10	10	7	7	heparin	IP-10	PA449855	3627	0.853
NULL	Arthritis_Res_Ther_2009_Jan_26_11(1)_R12.nxml.txt.nlp	19171052	SENT122	39	39	1	1	dipyridamole	ACTH	PA449367	5443	0.853
NULL	Exp_Ther_Med_2014_Jun_28_7(6)_1767-1771.nxml.txt.nlp	24926382	SENT116	11	11	24	24	etoposide	p38	PA449552	10598;1432;7965	0.853
NULL	Front_Immunol_2013_Nov_12_4_372.nxml.txt.nlp	24282405	SENT485	20	20	4	4	imiquimod	TRAIL	PA449972	8743	0.853
NULL	Nat_Biotechnol_2013_Jul_30_31(7)_630-637.nxml.txt.nlp	23811600	SENT199	5	5	13	13	ponatinib	NTRK3	PA165980594	4916	0.853
NULL	Asian-Australas_J_Anim_Sci_2014_Dec_27(12)_1783-1793.nxml.txt.nlp	25358373	SENT193	13	13	4	4	capsaicin	BAX	PA448776	581	0.853
NULL	Oncotarget_2014_Aug_29_5(19)_8947-8958.nxml.txt.nlp	25333254	SENT221	11	11	9	9	plerixafor	CXCR4	PA165958410	7852	0.853
NULL	eLife_2013_Nov_5_2_e00969.nxml.txt.nlp	24192036	SENT109	6	6	20	20	vemurafenib	BRAF	PA165946873	673	0.853
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT29	26	26	16	16	atorvastatin	IL-6	PA448500	3569	0.853
NULL	Mol_Cancer_2010_Oct_12_9_269.nxml.txt.nlp	20939893	SENT130	10	10	2	2	isoproterenol	STAT3	PA450121	6774	0.853
NULL	J_Biomed_Biotechnol_2008_Jul_8_2008_597913.nxml.txt.nlp	18629230	SENT56	11	11	22	22	ethanol	CO2	PA448073	4513	0.853
NULL	Breast_Cancer_Res_2007_Jan_23_9(1)_R7.nxml.txt.nlp	17244352	SENT193	19	19	3	3	tamoxifen	SULT1A1	PA451581	6817	0.853
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT219	5	5	12	12	resveratrol	TRAIL		8743	0.853
NULL	Cardiovasc_Diabetol_2013_Oct_17_12_150.nxml.txt.nlp	24134550	SENT109	19	19	7	7	pioglitazone	activin	PA450970	83729	0.853
NULL	ISRN_Oxidative_Med_2013_2013_831596.nxml.txt.nlp	25506596	SENT39	7	7	14	14	hemin	TLR4	PA449849	7099	0.853
NULL	Diabetol_Metab_Syndr_2014_Mar_31_6_47.nxml.txt.nlp	24684779	SENT105	3	3	27	27	simvastatin	IL-6	PA451363	3569	0.853
NULL	Cardiovasc_Diabetol_2013_May_4_12_73.nxml.txt.nlp	23642288	SENT129	12	12	26	26	acarbose	GLP-1	PA448010	100125288	0.853
NULL	Indian_J_Med_Res_2014_Feb_139(2)_279-284.nxml.txt.nlp	24718404	SENT121	17	17	35	35	trypsin	PTH	PA451806	5741	0.853
NULL	Breast_Cancer_Res_2012_Aug_8_14(4)_R116.nxml.txt.nlp	22873525	SENT172	25	25	15	15	trastuzumab	gamma	PA451743	9913	0.853
NULL	Breast_Cancer_Res_2008_Jul_24_10(4)_211.nxml.txt.nlp	18671839	SENT232	0	0	28	28	paclitaxel	EGFR	PA450761	1956	0.853
NULL	Breast_Cancer_(Auckl)_2009_Sep_2_3_61-75.nxml.txt.nlp	19809577	SENT270	12	12	7	7	curcumin	PARP	PA151958596	142	0.853
NULL	F1000Res_2014_Aug_19_3_198.nxml.txt.nlp	25400908	SENT195	25	25	11	11	lapatinib	EGFR	PA152241907	1956	0.853
NULL	Oncologist_2010_Feb_15_15(2)_122-129.nxml.txt.nlp	20156908	SENT139	6	6	17	17	letrozole	HER-2	PA450196	2064	0.853
NULL	Oncotarget_2014_Mar_26_5(21)_10342-10355.nxml.txt.nlp	25431950	SENT126	21	21	3	3	doxycycline	PC3	PA449415	57332;7832;5122	0.853
NULL	Biomed_Res_Int_2014_Jan_20_2014_948427.nxml.txt.nlp	24563867	SENT19	10	10	2	2	olanzapine	5-HT1A	PA450688	3350	0.853
NULL	Eur_J_Clin_Pharmacol_2011_Dec_23_67(12)_1231-1241.nxml.txt.nlp	21698374	SENT297	12	12	6	6	cyclosporine	MDR1	PA449167	5243	0.853
NULL	BMJ_2011_Aug_4_343_d4588.nxml.txt.nlp	21816733	SENT29	19	19	28	28	clopidogrel	CYP2C19	PA449053	1557	0.853
NULL	Mol_Neurodegener_2010_Nov_10_5_49.nxml.txt.nlp	21067594	SENT32	13	13	0	0	oxygen	PTEN	PA450744	5728	0.853
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_29_2013_590393.nxml.txt.nlp	23737838	SENT10	6	6	9	9	resveratrol	p53		7157	0.853
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT221	18	18	26	26	cisplatin	DR4	PA449014	8797	0.853
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT217	14	14	19	19	resveratrol	TRAIL		8743	0.853
NULL	Mol_Brain_2014_Apr_21_7_28.nxml.txt.nlp	24751148	SENT10	3	3	7	7	minocycline	TLR4	PA450519	7099	0.853
NULL	Br_J_Cancer_2011_Apr_26_104(9)_1384-1392.nxml.txt.nlp	21487411	SENT102	0	0	10	10	tamoxifen	BRCA2	PA451581	675	0.853
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT133	19	19	7	7	metformin	HIF-1	PA450395	29072	0.853
NULL	Nat_Med_2010_Jun_23_16(6)_671-677.nxml.txt.nlp	20495567	SENT219	0	0	22	22	sorafenib	ATF5	PA7000	22809	0.853
NULL	Exp_Hematol_Oncol_2013_Aug_8_2_21.nxml.txt.nlp	23927414	SENT94	12	12	7	7	enoxaparin	HARE	PA449463	55576	0.853
NULL	Korean_J_Radiol_2010_Feb_22_Mar-Apr_11(2)_234-238.nxml.txt.nlp	20191072	SENT62	20	20	13	13	doxorubicin	CHOP	PA449412	1649	0.853
NULL	Endocrinol_Diabetes_Metab_Case_Rep_2014_Sep_1_2014_140072.nxml.txt.nlp	25332771	SENT66	7	7	18	18	sitagliptin	CD4	PA164748978	920	0.853
NULL	Nat_Commun_2014_Nov_25_5_5548.nxml.txt.nlp	25420520	SENT41	11	11	27	27	cabazitaxel	ERG	PA165958401	2078	0.853
NULL	Int_J_Breast_Cancer_2012_Oct_15_2012_809291.nxml.txt.nlp	22295251	SENT197	28	28	16	16	carboplatin	EGFR	PA448803	1956	0.853
NULL	Nucl_Recept_Signal_2006_Jul_7_4_e016.nxml.txt.nlp	16862222	SENT24	13	13	29	29	estradiol	CYP1B1	PA449503	1545	0.853
NULL	Arthritis_Res_Ther_2012_Sep_24_14(5)_R200.nxml.txt.nlp	23006144	SENT52	6	6	16	16	alefacept	San	PA164748040	80218	0.853
NULL	Anesthesiol_Res_Pract_2012_Feb_13_2012_690362.nxml.txt.nlp	22400022	SENT163	0	0	2	2	etomidate	ACTH	PA164743987	5443	0.853
NULL	Exp_Ther_Med_2013_Aug_20_6(2)_355-360.nxml.txt.nlp	24137188	SENT10	18	18	30	30	paclitaxel	EGFR	PA450761	1956	0.853
NULL	EMBO_Mol_Med_2013_Mar_4_5(3)_397-412.nxml.txt.nlp	23381957	SENT314	46	46	4	4	trypsin	TFEB	PA451806	7942	0.853
NULL	J_Headache_Pain_2008_Oct_31_9(5)_267-276.nxml.txt.nlp	18668197	SENT136	0	0	9	9	fenfluramine	5-HT2C	PA449592	3358	0.853
NULL	Oncoscience_2014_Dec_15_1(12)_844-853.nxml.txt.nlp	25621299	SENT88	19	19	6	6	sunitinib	MVD	PA162372840	4597	0.853
NULL	Clin_Ophthalmol_2010_Oct_21_4_1229-1236.nxml.txt.nlp	21060677	SENT92	12	12	25	25	tafluprost	BAK	PA165958432	578	0.853
NULL	Gastric_Cancer_2012_Jul_17_15(3)_313-322.nxml.txt.nlp	22179434	SENT5	1	1	25	25	trastuzumab	HER2	PA451743	2064	0.853
NULL	Clin_Dev_Immunol_2013_Nov_26_2013_875343.nxml.txt.nlp	24371449	SENT62	23	23	8	8	rituximab	B10	PA451261	5169	0.853
NULL	Diabetes_Care_2010_Feb_33(2)_e20-e25.nxml.txt.nlp	20103551	SENT79	0	0	27	27	pioglitazone	adiponectin	PA450970	9370	0.853
NULL	Ann_Oncol_2014_Oct_23_25(10)_1941-1948.nxml.txt.nlp	25057173	SENT14	23	23	10	10	docetaxel	EGFR	PA449383	1956	0.853
NULL	Biomed_Res_Int_2013_Jun_13_2013_851428.nxml.txt.nlp	23841096	SENT228	16	16	41	41	l-serine	SHMT	PA451330	6470	0.853
NULL	J_Gen_Physiol_2009_Apr_133(4)_421-438.nxml.txt.nlp	19289574	SENT243	17	17	11	11	forskolin	SLC26A9	PA146096022	115019	0.853
NULL	Mol_Biol_Cell_2012_Sep_1_23(17)_3357-3369.nxml.txt.nlp	22809628	SENT67	11	11	22	22	triciribine	AKT	PA165958661	207	0.853
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT90	4	4	12	12	docetaxel	B7-H1	PA449383	29126	0.853
NULL	Diabetol_Metab_Syndr_2014_Mar_31_6_47.nxml.txt.nlp	24684779	SENT166	21	21	7	7	simvastatin	adiponectin	PA451363	9370	0.853
NULL	Mol_Cancer_2009_Nov_24_8_109.nxml.txt.nlp	19930708	SENT194	23	23	8	8	erlotinib	aromatase	PA134687924	1588	0.853
NULL	Br_J_Pharmacol_2014_May_171(10)_2659-2670.nxml.txt.nlp	24116661	SENT227	19	19	23	23	naringenin	TRPP2	PA151958361	5311	0.853
NULL	Acta_Vet_Scand_2011_May_31_53(1)_34.nxml.txt.nlp	21627797	SENT281	30	30	6	6	meloxicam	COX	PA450353	1351	0.853
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_3_2014_473213.nxml.txt.nlp	25538791	SENT122	4	4	23	23	ethanol	MDR1	PA448073	5243	0.853
NULL	Curr_Hematol_Malig_Rep_2012_Sep_27_7(3)_235-240.nxml.txt.nlp	22538464	SENT40	30	30	19	19	daclizumab	IL-2	PA164764446	3558	0.853
NULL	Cent_European_J_Urol_2013_Aug_13_66(2)_144-149.nxml.txt.nlp	24579014	SENT60	32	32	23	23	resveratrol	PTEN		5728	0.853
NULL	Diabetes_2013_Mar_14_62(3)_953-964.nxml.txt.nlp	23223176	SENT146	19	19	2	2	paroxetine	ROS	PA450801	6098	0.853
NULL	ScientificWorldJournal_2014_Feb_9_2014_964380.nxml.txt.nlp	24764772	SENT15	0	0	12	12	paliperidone	VIII	PA163518919	1351	0.853
NULL	Oncol_Lett_2013_Mar_8_5(3)_805-812.nxml.txt.nlp	23426281	SENT202	10	10	0	0	gemcitabine	B7-H3	PA449748	80381	0.853
NULL	Pharmaceutics_2011_Nov_18_3(4)_865-913.nxml.txt.nlp	24309312	SENT90	2	2	22	22	fluconazole	CYP3A	PA449653	1574	0.853
NULL	Int_J_Mol_Sci_2012_Aug_10_13(8)_9971-9979.nxml.txt.nlp	22949842	SENT214	33	33	30	30	lipase	mol	PA450239	90527	0.853
NULL	Clin_Ophthalmol_2014_Jan_31_8_335-341.nxml.txt.nlp	24520190	SENT36	2	2	11	11	fluorescein	FAF	PA164746009	8239;2188	0.853
NULL	Diabetol_Metab_Syndr_2014_Mar_31_6_47.nxml.txt.nlp	24684779	SENT160	33	33	15	15	simvastatin	IL-6	PA451363	3569	0.853
NULL	Breast_Cancer_Res_2007_Jan_23_9(1)_R7.nxml.txt.nlp	17244352	SENT132	6	6	16	16	tamoxifen	UGT2B15	PA451581	7366	0.853
NULL	Protein_Cell_2014_Jun_19_5(6)_469-479.nxml.txt.nlp	24748116	SENT59	17	17	4	4	vinblastine	EB1	PA451877	9167;22919;10982	0.853
NULL	Multidiscip_Respir_Med_2014_Nov_4_9(1)_54.nxml.txt.nlp	25419460	SENT111	20	20	3	3	choline	ANOVA	PA448976	4858	0.853
NULL	Front_Physiol_2013_Jun_20_4_147.nxml.txt.nlp	23801966	SENT495	0	0	11	11	doxorubicin	ABCB1	PA449412	5243	0.853
NULL	Oncotarget_2012_May_18_3(5)_525-534.nxml.txt.nlp	22619113	SENT93	4	4	14	14	fludarabine	BIRC5	PA449655	332	0.853
NULL	Acta_Pharmacol_Sin_2011_Feb_4_32(2)_223-229.nxml.txt.nlp	21293474	SENT3	6	6	14	14	isoproterenol	FKBP12	PA450121	2280	0.853
NULL	Indian_J_Med_Res_2013_Jan_137(1)_203-209.nxml.txt.nlp	23481074	SENT23	34	34	6	6	acenocoumarol	CYP2C9	PA452632	1559	0.853
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT218	30	30	41	41	panitumumab	KRAS	PA162373091	3845	0.853
NULL	Arthritis_Res_Ther_2012_Apr_16_14(2)_R76.nxml.txt.nlp	22507741	SENT132	0	0	12	12	estradiol	IL-10	PA449503	3586	0.853
NULL	Cancer_Immunol_Immunother_2011_Jun_25_60(6)_793-808.nxml.txt.nlp	21350947	SENT194	24	24	11	11	sorafenib	IFNAR2	PA7000	3455	0.853
NULL	Basic_Clin_Neurosci_2014_Winter_5(1)_74-79.nxml.txt.nlp	25436087	SENT84	5	5	34	34	fluoxetine	EPAC	PA449673	10411	0.853
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Mar_14_68(Pt_4)_o1060.nxml.txt.nlp	22589927	SENT70	36	36	18	18	ethanol	mol	PA448073	90527	0.853
NULL	J_Skin_Cancer_2011_Nov_17_2011_423239.nxml.txt.nlp	22175026	SENT141	21	21	30	30	dacarbazine	BRAF	PA449197	673	0.853
NULL	Emerg_Infect_Dis_2011_Mar_17(3)_495-497.nxml.txt.nlp	21392442	SENT17	33	33	1	1	capreomycin	DST	PA164746226	667	0.853
NULL	Oncotarget_2012_Nov_17_4(1)_18-28.nxml.txt.nlp	23248157	SENT167	11	11	21	21	pargyline	p53	PA450797	7157	0.853
NULL	FEBS_Open_Bio_2012_Sep_29_2_305-312.nxml.txt.nlp	23772363	SENT206	31	31	6	6	nadh	CO2	PA164755085	4513	0.853
NULL	Oncologist_2010_Mar_9_15(3)_236-245.nxml.txt.nlp	20215359	SENT62	6	6	9	9	sunitinib	IFN	PA162372840	3439	0.853
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT191	2	2	12	12	tacrolimus	SOCS3	PA451578	9021	0.853
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_P27.nxml.txt.nlp	NULL	SENT16	17	17	21	21	sulfamethoxazole	LTA	PA451544	4049	0.853
NULL	Exp_Diabetes_Res_2012_Sep_20_2012_936518.nxml.txt.nlp	23049542	SENT200	11	11	0	0	glucose	HCD	PA449773	1732	0.853
NULL	Mol_Cancer_2007_Aug_21_6_53.nxml.txt.nlp	17711579	SENT242	10	10	1	1	cisplatin	p53	PA449014	7157	0.853
NULL	Pharmaceuticals_(Basel)_2013_Aug_21_6(8)_988-1038.nxml.txt.nlp	24276379	SENT2621	8	8	3	3	cetuximab	KRAS	PA10040	3845	0.853
NULL	Biol_Open_2014_Nov_13_3(12)_1164-1172.nxml.txt.nlp	25395667	SENT225	11	11	7	7	capsaicin	TRPV1	PA448776	7442	0.853
NULL	Br_J_Haematol_2008_Mar_3_144(5)_677-685.nxml.txt.nlp	19055662	SENT96	4	4	0	0	doxorubicin	CHOP	PA449412	1649	0.853
NULL	Clin_Psychopharmacol_Neurosci_2011_Apr_30_9(1)_36-43.nxml.txt.nlp	23431025	SENT123	10	10	14	14	aripiprazole	FLI	PA10026	2314	0.853
NULL	Br_J_Cancer_2010_Oct_26_103(9)_1331-1334.nxml.txt.nlp	20877352	SENT49	15	15	11	11	trastuzumab	GM-CSF	PA451743	1437	0.853
NULL	J_Cell_Biol_2004_Apr_26_165(2)_263-273.nxml.txt.nlp	15117969	SENT128	13	13	29	29	trypsin	cadherin	PA451806	1015	0.853
NULL	N_Am_J_Med_Sci_2011_Jan_3(1)_1-12.nxml.txt.nlp	22540056	SENT64	12	12	23	23	gemcitabine	HuR	PA449748	1994	0.853
NULL	J_Oncol_2009_Jul_14_2009_804108.nxml.txt.nlp	19636422	SENT129	0	0	9	9	gefitinib	EGFR	PA131301952	1956	0.853
NULL	Ann_Oncol_2014_Jul_7_25(7)_1340-1346.nxml.txt.nlp	24608196	SENT31	19	19	16	16	palonosetron	NK1	PA10352	11126	0.853
NULL	J_Biol_Eng_2014_Nov_19_8(1)_26.nxml.txt.nlp	NULL	SENT47	35	35	21	21	tetracycline	p14	PA451640	10923;10263;1029;28956	0.853
NULL	J_Cell_Mol_Med_2014_Apr_20_18(4)_709-720.nxml.txt.nlp	24444314	SENT125	13	13	3	3	metformin	AMPK	PA450395	5563	0.853
NULL	Biochemistry_2011_May_10_50(18)_3609-3620.nxml.txt.nlp	21410224	SENT17	22	22	2	2	trimethoprim	DHFR	PA451788	1719	0.853
NULL	Indian_J_Med_Res_2013_Jan_137(1)_125-129.nxml.txt.nlp	23481061	SENT79	5	5	0	0	platinum	GSTP1	PA150595617	2950	0.853
NULL	Indian_J_Anaesth_2009_Dec_53(6)_696-699.nxml.txt.nlp	20640100	SENT62	21	21	4	4	ketamine	CEA	PA450144	5670;1087	0.853
NULL	Adv_Urol_2012_Feb_13_2012_364919.nxml.txt.nlp	22400017	SENT163	11	11	26	26	paclitaxel	RRM1	PA450761	6240	0.853
NULL	Mol_Cancer_2010_Nov_2_9_289.nxml.txt.nlp	21044322	SENT39	11	11	27	27	paclitaxel	FBS	PA450761	64319;26269	0.853
NULL	Ann_Hematol_2011_Feb_17_90(2)_173-183.nxml.txt.nlp	20714724	SENT149	21	21	16	16	resveratrol	CD19		930	0.853
NULL	Br_J_Cancer_2012_Jan_3_106(1)_18-24.nxml.txt.nlp	22108516	SENT75	17	17	6	6	camptothecin	TDP1	PA153590860	55775	0.853
NULL	Drugs_R_D_2011_Jun_27_11(2)_101-111.nxml.txt.nlp	21679003	SENT104	26	26	35	35	bevacizumab	p53	PA130232992	7157	0.853
NULL	J_Gen_Intern_Med_2009_May_21_24(5)_656-664.nxml.txt.nlp	19306050	SENT392	9	9	7	7	warfarin	CYP2C9	PA451906	1559	0.853
NULL	Oncotarget_2011_Sep_9_2(9)_658-668.nxml.txt.nlp	21911919	SENT97	13	13	7	7	cytarabine	NAC	PA449177	22861	0.853
NULL	Mol_Biol_Rep_2012_May_20_39(5)_5253-5267.nxml.txt.nlp	22183301	SENT29	16	16	5	5	glibenclamide	SUR1	PA449782	6833	0.853
NULL	Tumour_Biol_2014_Aug_12_35(8)_7807-7819.nxml.txt.nlp	24817012	SENT3	8	8	4	4	mitomycin	ERCC1	PA450524	2067	0.853
NULL	J_Gen_Physiol_1995_Mar_1_105(3)_363-383.nxml.txt.nlp	7769380	SENT3	16	16	12	12	nifedipine	DHPR	PA450631	5860	0.853
NULL	Pharmaceuticals_(Basel)_2013_Feb_7_6(2)_269-286.nxml.txt.nlp	24275951	SENT914	35	35	21	21	cisplatin	survivin	PA449014	332	0.853
NULL	Pharmaceuticals_(Basel)_2011_May_17_4(5)_741-757.nxml.txt.nlp	NULL	SENT183	10	10	13	13	ethanol	RhoA	PA448073	387	0.853
NULL	Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.nxml.txt.nlp	24736980	SENT187	22	22	25	25	rosuvastatin	OATP1B1	PA134308647	10599	0.853
NULL	Ann_Indian_Acad_Neurol_2010_Apr-Jun_13(2)_136-138.nxml.txt.nlp	20814499	SENT71	22	22	28	28	voriconazole	CD4	PA10233	920	0.853
NULL	Clin_Med_Insights_Oncol_2011_Sep_21_5_315-323.nxml.txt.nlp	22084620	SENT75	5	5	11	11	gemcitabine	IFN	PA449748	3439	0.853
NULL	Indian_J_Endocrinol_Metab_2013_Nov-Dec_17(6)_1108-1113.nxml.txt.nlp	24381894	SENT181	8	8	20	20	tocilizumab	IL-6	PA165292659	3569	0.853
NULL	Neural_Plast_2012_May_22_2012_584071.nxml.txt.nlp	22685678	SENT330	8	8	5	5	fluoxetine	5-HT1A	PA449673	3350	0.853
NULL	J_Orthop_Sci_2007_Jul_2_12(4)_405-412.nxml.txt.nlp	17657564	SENT120	0	0	7	7	estradiol	RANKL	PA449503	8600	0.853
NULL	J_Korean_Med_Sci_2011_Feb_24_26(2)_304-307.nxml.txt.nlp	21286027	SENT45	16	16	10	10	vincristine	CHOP	PA451879	1649	0.853
NULL	Carcinogenesis_2010_Dec_27_31(12)_2049-2057.nxml.txt.nlp	20876285	SENT200	23	23	19	19	tamoxifen	HER2	PA451581	2064	0.852
NULL	Clin_Transl_Allergy_2013_Sep_2_3_29.nxml.txt.nlp	24004581	SENT100	29	29	13	13	omalizumab	IL-4	PA164752253	3565	0.852
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT349	0	0	6	6	sertindole	PRL	PA164784002	5617	0.852
NULL	Infect_Dis_Obstet_Gynecol_2014_Sep_25_2014_961375.nxml.txt.nlp	25328370	SENT195	17	17	0	0	atazanavir	ATV	PA10251	4683	0.852
NULL	Pharmacogn_Rev_2011_Jul-Dec_5(10)_159-163.nxml.txt.nlp	22279373	SENT125	16	16	7	7	tolbutamide	CEE	PA451718	51608	0.852
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT364	20	20	4	4	pp2	STAT3		6774	0.852
NULL	J_Exp_Clin_Cancer_Res_2009_May_26_28(1)_67.nxml.txt.nlp	19470173	SENT41	5	5	21	21	paraformaldehyde	ELF1	PA450790	84337;1997	0.852
NULL	Arthritis_Res_Ther_2005_Apr_1_7(3)_R694-R703.nxml.txt.nlp	15899055	SENT22	0	0	3	3	leflunomide	DHODH	PA450192	1723	0.852
NULL	Protein_J_2012_Aug_5_31(6)_511-518.nxml.txt.nlp	22763563	SENT134	29	29	17	17	atorvastatin	MSR1	PA448500	4481	0.852
NULL	Br_J_Cancer_2013_May_28_108(10)_2039-2044.nxml.txt.nlp	23652306	SENT77	15	15	2	2	carboplatin	SRC3	PA448803	8202	0.852
NULL	Angiogenesis_2013_Apr_10_16(2)_373-386.nxml.txt.nlp	23143659	SENT114	13	13	35	35	paclitaxel	LDM	PA450761	1595	0.852
NULL	Oncotarget_2012_Sep_11_3(9)_1026-1035.nxml.txt.nlp	22976441	SENT89	4	4	13	13	etoposide	CKI	PA449552	1119	0.852
NULL	Int_J_Environ_Res_Public_Health_2012_Aug_3_9(8)_2788-2800.nxml.txt.nlp	23066397	SENT201	14	14	3	3	hydroquinone	CYP2E1	PA449924	1571	0.852
NULL	Cell_Mol_Life_Sci_2011_Nov_2_68(21)_3573-3587.nxml.txt.nlp	21365278	SENT203	17	17	20	20	iloprost	EP2	PA164746843	5732;10407	0.852
NULL	Clin_Dev_Immunol_2013_Nov_26_2013_325481.nxml.txt.nlp	24371447	SENT111	2	2	8	8	propofol	p47phox	PA451141	653361	0.852
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jun_16_66(Pt_7)_o1638.nxml.txt.nlp	21587867	SENT74	34	34	25	25	ethanol	mol	PA448073	90527	0.852
NULL	Breast_Cancer_Res_2008_Mar_27_10(2)_R27.nxml.txt.nlp	18371219	SENT143	33	33	7	7	etoposide	HER2	PA449552	2064	0.852
NULL	EJC_Suppl_2013_Sep_5_11(2)_3-22.nxml.txt.nlp	NULL	SENT1021	28	28	24	24	tamoxifen	ATAC	PA451581	6375	0.852
NULL	Pharmaceuticals_(Basel)_2013_Oct_11_6(10)_1287-1303.nxml.txt.nlp	24275850	SENT94	3	3	12	12	glibenclamide	spatial	PA449782	219793	0.852
NULL	Am_J_Trop_Med_Hyg_2014_Jul_2_91(1)_1-2.nxml.txt.nlp	24752684	SENT33	12	12	6	6	primaquine	G6PD	PA451103	2539	0.852
NULL	Mol_Cancer_2014_Aug_22_13(1)_195.nxml.txt.nlp	NULL	SENT123	8	8	0	0	cisplatin	TBL1XR1	PA449014	79718	0.852
NULL	Oncotarget_2014_May_27_5(19)_9049-9064.nxml.txt.nlp	24979294	SENT23	9	9	21	21	fulvestrant	IGF1R	PA164747170	3480	0.852
NULL	Front_Behav_Neurosci_2014_Oct_1_8_306.nxml.txt.nlp	25324743	SENT143	16	16	27	27	lisuride	5-HT7	PA164749019	3363	0.852
NULL	Aging_(Albany_NY)_2009_Jun_3_1(6)_515-528.nxml.txt.nlp	20157535	SENT112	16	16	22	22	resveratrol	S6K1		6198	0.852
NULL	Chem_Cent_J_2012_May_11_6_41.nxml.txt.nlp	22578215	SENT14	2	2	14	14	lipase	castor	PA450239	54897	0.852
NULL	J_Oncol_2010_Nov_19_2010_568938.nxml.txt.nlp	20037743	SENT162	25	25	3	3	ekb-569	EGFR		1956	0.852
NULL	Oncologist_2010_Jan_19_15(1)_3-5.nxml.txt.nlp	20086166	SENT28	21	21	9	9	vinorelbine	EGFR	PA451881	1956	0.852
NULL	Iran_J_Pediatr_2012_Mar_22(1)_23-27.nxml.txt.nlp	23056855	SENT53	7	7	3	3	dapsone	G6PD	PA449211	2539	0.852
NULL	Cells_2014_Apr_29_3(2)_331-362.nxml.txt.nlp	24785347	SENT156	4	4	6	6	capsaicin	TRPV1	PA448776	7442	0.852
NULL	Emerg_Infect_Dis_2003_Jul_9(7)_864-867.nxml.txt.nlp	12890330	SENT62	21	21	40	40	dapsone	DHPS	PA449211	1725	0.852
NULL	Int_J_Biol_Sci_2014_Jun_10_10(7)_654-663.nxml.txt.nlp	25013375	SENT114	20	20	33	33	nelfinavir	HER2	PA450606	2064	0.852
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Apr_28_66(Pt_5)_o1189-o1190.nxml.txt.nlp	21579227	SENT80	14	14	6	6	ethanol	mol	PA448073	90527	0.852
NULL	JAKSTAT_2014_Jun_12_3_e29554.nxml.txt.nlp	25105067	SENT115	4	4	28	28	propofol	Bcl-2	PA451141	596	0.852
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Nov_21_65(Pt_12)_o3168.nxml.txt.nlp	21578884	SENT64	18	18	3	3	ethanol	mol	PA448073	90527	0.852
NULL	Mol_Cell_Biochem_2015_Oct_8_398(1-2)_165-173.nxml.txt.nlp	25292312	SENT108	12	12	40	40	bortezomib	HIF-1	PA10252	29072	0.852
NULL	Case_Rep_Otolaryngol_2014_Aug_25_2014_902071.nxml.txt.nlp	25243089	SENT72	5	5	19	19	desmopressin	VWF	PA449237	7450	0.852
NULL	Br_J_Cancer_2012_May_22_106(11)_1779-1789.nxml.txt.nlp	22549178	SENT27	4	4	9	9	pertuzumab	HER2		2064	0.852
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT94	6	6	16	16	curcumin	PUMA	PA151958596	27113	0.852
NULL	Ann_Oncol_2011_Mar_8_22(3)_503-514.nxml.txt.nlp	20616198	SENT9	6	6	21	21	tamoxifen	aromatase	PA451581	1588	0.852
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT153	1	1	9	9	glucose	p38	PA449773	10598;1432;7965	0.852
NULL	Oncotarget_2014_Aug_19_5(18)_8703-8715.nxml.txt.nlp	25237928	SENT52	38	38	5	5	glucose	CD44	PA449773	960	0.852
NULL	Cell_Cycle_2012_Dec_15_11(24)_4499-4506.nxml.txt.nlp	23114620	SENT96	4	4	32	32	choline	DAG	PA448976	1605	0.852
NULL	Cancers_(Basel)_2014_Mar_13_6(1)_595-624.nxml.txt.nlp	24633084	SENT222	25	25	30	30	trastuzumab	HER2	PA451743	2064	0.852
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT418	18	18	6	6	cetuximab	BRAF	PA10040	673	0.852
NULL	Oncoimmunology_2012_Oct_1_1(7)_1004-1016.nxml.txt.nlp	23170249	SENT159	20	20	8	8	paclitaxel	HER-2	PA450761	2064	0.852
NULL	Mol_Vis_2012_Jul_20_18_2033-2042.nxml.txt.nlp	22876131	SENT212	22	22	8	8	genistein	Bcl-2	PA165109660	596	0.852
NULL	Clinics_(Sao_Paulo)_2011_Aug_66(8)_1361-1365.nxml.txt.nlp	21915484	SENT88	37	37	31	31	fludrocortisone	CYP21A2	PA164743961	1589	0.852
NULL	Ann_Oncol_2014_Apr_26_25(4)_801-807.nxml.txt.nlp	24577117	SENT79	3	3	15	15	cetuximab	p16	PA10040	1029	0.852
NULL	Front_Psychol_2014_Sep_17_5_919.nxml.txt.nlp	25278909	SENT93	31	31	13	13	haloperidol	A10	PA449841	28870	0.852
NULL	Diabetes_Obes_Metab_2010_May_12(5)_437-441.nxml.txt.nlp	20415692	SENT33	24	24	19	19	metformin	GLA	PA450395	9027;2717	0.852
NULL	Mol_Cell_Biochem_2013_Jun_3_378(1-2)_137-144.nxml.txt.nlp	23456481	SENT30	14	14	0	0	creatine	CCR5	PA164778930	1234	0.852
NULL	Front_Genet_2012_Nov_5_3_236.nxml.txt.nlp	23133441	SENT318	11	11	5	5	cyclosporine	MDR1	PA449167	5243	0.852
NULL	Breast_Cancer_Res_2008_Jul_24_10(4)_211.nxml.txt.nlp	18671839	SENT81	17	17	24	24	tamoxifen	AP-1	PA451581	2353;3727;2354;3725	0.852
NULL	J_Thromb_Haemost_2011_Oct_9(10)_2103-2105.nxml.txt.nlp	21812912	SENT41	13	13	3	3	ticagrelor	mol	PA165374673	90527	0.852
NULL	Oncol_Rep_2013_Oct_22_30(4)_1535-1541.nxml.txt.nlp	23877481	SENT149	13	13	24	24	bevacizumab	EGFR	PA130232992	1956	0.852
NULL	Cardiovasc_Diabetol_2010_Nov_25_9_78.nxml.txt.nlp	21106105	SENT150	9	9	15	15	nitroprusside	STZ	PA451406	6484	0.852
NULL	Mol_Biol_Int_2012_May_24_2012_705948.nxml.txt.nlp	22693671	SENT121	26	26	9	9	cisplatin	RASSF2	PA449014	9770	0.852
NULL	Comp_Funct_Genomics_2012_May_14_2012_178525.nxml.txt.nlp	22666083	SENT158	23	23	41	41	urokinase	HuR	PA451836	1994	0.852
NULL	J_Gen_Physiol_2003_Jul_122(1)_1a-46a.nxml.txt.nlp	NULL	SENT299	19	19	12	12	diazepam	GABRG2	PA449283	2566	0.852
NULL	Oncotarget_2012_May_19_3(5)_535-545.nxml.txt.nlp	22619121	SENT9	19	19	8	8	topotecan	MYCN	PA451729	4613	0.852
NULL	Indian_J_Endocrinol_Metab_2013_May-Jun_17(3)_413-421.nxml.txt.nlp	23869296	SENT6	11	11	28	28	exenatide	GLP-1	PA164749238	100125288	0.852
NULL	J_Biol_Chem_2012_Aug_24_287(35)_30000-30013.nxml.txt.nlp	22773837	SENT333	35	35	8	8	thrombin	GPVI	PA451674	51206	0.852
NULL	Arthritis_Res_Ther_2009_Jul_23_11(4)_236.nxml.txt.nlp	19664185	SENT45	18	18	9	9	colchicine	COX2	PA449092	4513;5743	0.852
NULL	Adv_Urol_2010_Jul_20_2010_687043.nxml.txt.nlp	20721275	SENT106	16	16	35	35	bevacizumab	IFN	PA130232992	3439	0.852
NULL	Evid_Based_Complement_Alternat_Med_2014_Oct_14_2014_734867.nxml.txt.nlp	25371696	SENT37	2	2	12	12	buspirone	CYP3A	PA448689	1574	0.852
NULL	Environ_Health_Perspect_2010_Jul_3_118(7)_936-942.nxml.txt.nlp	20199942	SENT124	6	6	25	25	arsenite	mot-2	PA452638	3313	0.852
NULL	Front_Genet_2012_Nov_2_3_229.nxml.txt.nlp	23130019	SENT502	11	11	26	26	nifedipine	CYP3A5	PA450631	1577	0.852
NULL	Dermatol_Pract_Concept_2012_Apr_30_2(2)_0202a03.nxml.txt.nlp	23785591	SENT54	7	7	15	15	cyclophosphamide	CHOP	PA449165	1649	0.852
NULL	Emerg_Infect_Dis_2011_Mar_17(3)_510-513.nxml.txt.nlp	21392446	SENT78	10	10	2	2	pyrazinamide	DST	PA451182	667	0.852
NULL	Clin_Ophthalmol_2008_Mar_2(1)_1-14.nxml.txt.nlp	19668384	SENT4	0	0	14	14	ranibizumab	VEGF-A	PA164746012	7422	0.852
NULL	Oncoscience_2014_Jun_19_1(7)_478-479.nxml.txt.nlp	25594047	SENT17	19	19	4	4	paclitaxel	P-gp	PA450761	5243	0.852
NULL	Front_Neurosci_2014_Jan_10_7_270.nxml.txt.nlp	24454277	SENT196	8	8	41	41	resveratrol	SUR1		6833	0.852
NULL	Eur_J_Nutr_2012_Aug_15_51(5)_513-528.nxml.txt.nlp	22584415	SENT137	11	11	20	20	etanercept	IL-6	PA449515	3569	0.852
NULL	Chemother_Res_Pract_2012_Apr_11_2012_283181.nxml.txt.nlp	22567280	SENT79	20	20	12	12	tamoxifen	AKT	PA451581	207	0.852
NULL	J_Cell_Mol_Med_2014_Aug_6_18(8)_1519-1539.nxml.txt.nlp	25100284	SENT51	13	13	30	30	afatinib	EGFR	PA165981154	1956	0.852
NULL	J_Gen_Physiol_2009_Jun_133(6)_603-622.nxml.txt.nlp	19468075	SENT419	4	4	13	13	acetazolamide	CO2	PA448018	4513	0.852
NULL	Oxid_Med_Cell_Longev_2013_Jun_2_2013_793525.nxml.txt.nlp	23819014	SENT167	37	37	25	25	resveratrol	PI3K		5290	0.852
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT686	9	9	14	14	resveratrol	EMMPRIN		682	0.852
NULL	Acta_Pharmacol_Sin_2013_Jun_8_34(6)_830-836.nxml.txt.nlp	23564080	SENT20	2	2	30	30	simvastatin	MCP-1	PA451363	6347	0.852
NULL	Breast_Cancer_Res_2010_Sep_29_12(5)_209.nxml.txt.nlp	21067536	SENT53	30	30	20	20	paclitaxel	HER2	PA450761	2064	0.852
NULL	Acta_Pharmacol_Sin_2014_Jun_4_35(6)_792-805.nxml.txt.nlp	24902787	SENT194	13	13	30	30	paroxetine	INS-1	PA450801	2305	0.852
NULL	J_Cancer_2013_Nov_14_4(9)_697-702.nxml.txt.nlp	24312139	SENT39	23	23	9	9	paclitaxel	CDK1	PA450761	983	0.852
NULL	Acta_Pharmacol_Sin_2011_Feb_4_32(2)_230-238.nxml.txt.nlp	21293475	SENT118	2	2	10	10	troglitazone	aP2	PA451799	2167	0.852
NULL	Mol_Cancer_2014_Jul_5_13_165.nxml.txt.nlp	24996221	SENT208	25	25	33	33	docetaxel	HMGB1	PA449383	3146	0.852
NULL	Ther_Clin_Risk_Manag_2005_Mar_1(1)_3-13.nxml.txt.nlp	18360537	SENT126	19	19	7	7	phenytoin	CYP3A4	PA450947	1576	0.852
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT239	4	4	43	43	perifosine	DR5	PA165291471	8795	0.852
NULL	Diabetes_2008_Sep_57(9)_2272-2279.nxml.txt.nlp	18519799	SENT130	7	7	2	2	rosiglitazone	PDP2	PA451283	57546	0.852
NULL	Braz_J_Med_Biol_Res_2012_Feb_17_45(3)_244-249.nxml.txt.nlp	22331137	SENT134	39	39	41	41	gentamicin	PAG	PA449753	55824	0.852
NULL	J_Clin_Exp_Pathol_2012_May_17_Suppl_4_7327.nxml.txt.nlp	25379357	SENT30	21	21	19	19	resveratrol	AMPK		5563	0.852
NULL	Daru_2011_19(2)_138-144.nxml.txt.nlp	22615650	SENT99	2	2	10	10	heparin	FGF20	PA449855	26281	0.852
NULL	Breast_Cancer_Res_2008_Jul_7_10(Suppl_3)_P9.nxml.txt.nlp	NULL	SENT2	18	18	5	5	choline	MRS	PA448976	8011	0.852
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT132	13	13	0	0	sulindac	AKT	PA451565	207	0.852
NULL	Br_J_Clin_Pharmacol_2010_Dec_70(6)_807-814.nxml.txt.nlp	21175436	SENT198	7	7	11	11	liraglutide	GLP-1	PA165958364	100125288	0.852
NULL	J_Inherit_Metab_Dis_2012_May_2_35(3)_399-405.nxml.txt.nlp	22134542	SENT73	3	3	15	15	ethanol	CYP2E1	PA448073	1571	0.852
NULL	J_Korean_Med_Sci_2007_Apr_30_22(2)_283-289.nxml.txt.nlp	17449938	SENT97	19	19	5	5	minoxidil	Bcl-2	PA450521	596	0.852
NULL	J_Cardiothorac_Surg_2012_Sep_27_7_95.nxml.txt.nlp	23013647	SENT133	25	25	36	36	aprotinin	BART	PA448472	7809;23568	0.852
NULL	Nat_Commun_2010_Jun_1_1(3)_1-9.nxml.txt.nlp	20975695	SENT386	4	4	22	22	tamoxifen	E12	PA451581	64100	0.852
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT12	3	3	19	19	curcumin	TRAIL	PA151958596	8743	0.852
NULL	Int_J_Chron_Obstruct_Pulmon_Dis_2006_Dec_1(4)_373-379.nxml.txt.nlp	18044094	SENT57	4	4	15	15	roflumilast	PDE4B	PA165948052	5142	0.852
NULL	J_Biomed_Sci_2014_Feb_3_21(1)_10.nxml.txt.nlp	24490900	SENT254	9	9	25	25	alendronate	RANKL	PA448082	8600	0.852
NULL	Emerg_Infect_Dis_2012_Jan_18(1)_29-37.nxml.txt.nlp	22260950	SENT55	10	10	0	0	isoniazid	DST	PA450112	667	0.852
NULL	J_Korean_Med_Sci_2005_Oct_31_20(5)_883-885.nxml.txt.nlp	16224167	SENT23	19	19	24	24	azathioprine	gamma	PA448515	9913	0.852
NULL	J_Biomed_Biotechnol_2011_Feb_15_2011_523481.nxml.txt.nlp	21403879	SENT33	0	0	10	10	suramin	SIRT2	PA10292	22933	0.852
NULL	Cancer_Growth_Metastasis_2013_Aug_8_6_35-52.nxml.txt.nlp	24665206	SENT81	11	11	0	0	curcumin	TRPV1	PA151958596	7442	0.852
NULL	Indian_J_Endocrinol_Metab_2012_Dec_16(Suppl_2)_S242-S244.nxml.txt.nlp	23565389	SENT63	16	16	13	13	sitagliptin	DPPIV	PA164748978	2191;1803	0.852
NULL	Cancer_Med_2013_Feb_3_2(1)_86-98.nxml.txt.nlp	24133631	SENT73	15	15	27	27	cisplatin	HAI	PA449014	6692;6768	0.852
NULL	Crit_Care_2007_Mar_22_11(Suppl_2)_P31.nxml.txt.nlp	NULL	SENT14	19	19	2	2	dobutamine	p38	PA449381	10598;1432;7965	0.852
NULL	Drugs_Context_2012_Nov_19_2012_212242.nxml.txt.nlp	24432031	SENT202	30	30	37	37	dacarbazine	BRAF	PA449197	673	0.852
NULL	Biochim_Biophys_Acta_2007_Aug_1767(8)_1007-1031.nxml.txt.nlp	17631856	SENT446	28	28	14	14	diazoxide	ADP	PA449285	23038	0.852
NULL	J_Gen_Physiol_2000_Jun_1_115(6)_685-696.nxml.txt.nlp	10828243	SENT438	10	10	2	2	genistein	OLF	PA165109660	83857	0.852
NULL	Biomed_Res_Int_2013_Oct_29_2013_792940.nxml.txt.nlp	24288687	SENT62	21	21	6	6	ether	ghrelin	PA449525	51738	0.852
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT107	8	8	2	2	glucose	EGFR	PA449773	1956	0.852
NULL	J_Biomed_Biotechnol_2002_2(1)_7-13.nxml.txt.nlp	12488594	SENT104	11	11	41	41	cisplatin	ANOVA	PA449014	4858	0.852
NULL	Oncoimmunology_2012_Oct_1_1(7)_1191-1193.nxml.txt.nlp	23170276	SENT36	14	14	9	9	cyclophosphamide	FOXP3	PA449165	50943	0.852
NULL	Breast_Cancer_Res_2009_Sep_9_11(5)_R67.nxml.txt.nlp	19740422	SENT72	29	29	20	20	tamoxifen	LBA	PA451581	987	0.852
NULL	EMBO_Mol_Med_2011_May_3(5)_266-278.nxml.txt.nlp	21438154	SENT212	18	18	16	16	oxaliplatin	TRPM8	PA131285527	79054	0.852
NULL	Indian_J_Pharmacol_2012_Sep-Oct_44(5)_624-628.nxml.txt.nlp	23112426	SENT37	23	23	17	17	nimodipine	P-gp	PA450633	5243	0.852
NULL	Evid_Based_Complement_Alternat_Med_2015_Jan_6_2015_736431.nxml.txt.nlp	25632290	SENT62	7	7	33	33	ritonavir	P-gp	PA451260	5243	0.852
NULL	Front_Immunol_2012_May_7_3_101.nxml.txt.nlp	22783250	SENT241	4	4	15	15	papain	IL-7	PA450778	3574	0.852
NULL	Front_Mol_Neurosci_2012_Jun_20_5_76.nxml.txt.nlp	22723769	SENT51	20	20	8	8	paraformaldehyde	E16	PA450790	8140	0.852
NULL	Nat_Med_2014_Apr_16_20(4)_385-397.nxml.txt.nlp	24633305	SENT92	27	27	9	9	glibenclamide	MST1	PA449782	6789;4485	0.852
NULL	Indian_J_Nucl_Med_2015_Jan-Mar_30(1)_21-25.nxml.txt.nlp	25589801	SENT28	10	10	3	3	gefitinib	EGFR	PA131301952	1956	0.852
NULL	J_Thromb_Haemost_2007_May_5(5)_1010-1018.nxml.txt.nlp	17355572	SENT224	26	26	16	16	thrombin	VWF	PA451674	7450	0.852
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT163	13	13	10	10	perifosine	DR5	PA165291471	8795	0.852
NULL	Bone_Marrow_Res_2012_Oct_18_2012_180391.nxml.txt.nlp	23119165	SENT238	34	34	6	6	alemtuzumab	NOD2	PA164783958	64127	0.852
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT241	19	19	27	27	perifosine	DR5	PA165291471	8795	0.852
NULL	Front_Behav_Neurosci_2010_Apr_5_4_14.nxml.txt.nlp	20407577	SENT311	13	13	34	34	doxycycline	NAC1	PA449415	112939;6323	0.852
NULL	Orphanet_J_Rare_Dis_2014_May_21_9_78.nxml.txt.nlp	24885036	SENT0	19	19	29	29	resveratrol	ALS		3483	0.852
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT308	37	37	22	22	cisplatin	ASK1	PA449014	4217	0.852
NULL	J_Gynecol_Oncol_2013_Jan_8_24(1)_66-82.nxml.txt.nlp	23346316	SENT71	24	24	38	38	olaparib	BRCA1		672	0.852
NULL	J_Antimicrob_Chemother_2012_May_8_67(5)_1217-1223.nxml.txt.nlp	22316571	SENT32	18	18	6	6	lumefantrine	CYP3A4	PA165111722	1576	0.852
NULL	Nanoscale_Res_Lett_2010_Jul_21_5(10)_1596-1602.nxml.txt.nlp	21076670	SENT28	7	7	1	1	acetone	BSG	PA448025	682	0.852
NULL	Acta_Pharmacol_Sin_2012_Jan_3_33(1)_49-56.nxml.txt.nlp	22212430	SENT92	15	15	11	11	thrombin	A10	PA451674	28870	0.852
NULL	Nat_Commun_2011_Apr_5_2_269.nxml.txt.nlp	21468021	SENT116	31	31	8	8	tamoxifen	CD4	PA451581	920	0.852
NULL	Breast_Cancer_Res_2004_Mar_11_6(3)_109-118.nxml.txt.nlp	15084231	SENT91	25	25	14	14	trastuzumab	HER-2	PA451743	2064	0.852
NULL	Br_J_Cancer_2010_Jul_27_103(3)_297-302.nxml.txt.nlp	20606681	SENT117	5	5	2	2	paclitaxel	HER2	PA450761	2064	0.852
NULL	J_Breast_Cancer_2013_Dec_31_16(4)_386-394.nxml.txt.nlp	24454460	SENT34	33	33	30	30	tamoxifen	p53	PA451581	7157	0.852
NULL	Br_J_Cancer_2011_Jul_12_105(2)_212-220.nxml.txt.nlp	21694723	SENT40	2	2	16	16	curcumin	STAT3	PA151958596	6774	0.852
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Nov_19_67(Pt_12)_o3364.nxml.txt.nlp	22199858	SENT64	3	3	16	16	benzaldehyde	mol	PA448571	90527	0.852
NULL	Arthritis_Res_Ther_2009_Jun_25_11(3)_R97.nxml.txt.nlp	19555469	SENT31	11	11	13	13	estradiol	aromatase	PA449503	1588	0.852
NULL	J_Korean_Med_Sci_2010_Feb_19_25(2)_203-210.nxml.txt.nlp	20119571	SENT108	14	14	22	22	glucose	ANOVA	PA449773	4858	0.852
NULL	Mol_Cancer_2012_Apr_26_11_26.nxml.txt.nlp	22537224	SENT176	20	20	7	7	cisplatin	p53	PA449014	7157	0.852
NULL	Nucleic_Acids_Res_2011_Nov_16_39(21)_9181-9193.nxml.txt.nlp	21846776	SENT37	21	21	45	45	l-glutamine	CO2	PA10090	4513	0.852
NULL	Cancers_(Basel)_2014_Nov_25_6(4)_2313-2329.nxml.txt.nlp	25534569	SENT132	7	7	2	2	crizotinib	MET	PA165946122	4233	0.852
NULL	Oncoimmunology_2012_Oct_1_1(7)_1004-1016.nxml.txt.nlp	23170249	SENT174	27	27	19	19	trastuzumab	HER-2	PA451743	2064	0.852
NULL	J_Hematol_Oncol_2012_Jul_16_5_39.nxml.txt.nlp	22800464	SENT28	2	2	11	11	sorafenib	VEGFR	PA7000	3791	0.852
NULL	J_Mol_Signal_2010_May_10_5_4.nxml.txt.nlp	20459745	SENT147	6	6	4	4	cisplatin	p53	PA449014	7157	0.852
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT12	14	14	18	18	atorvastatin	RANK	PA448500	8792	0.852
NULL	Case_Rep_Dermatol_2011_Oct_11_3(3)_223-227.nxml.txt.nlp	22135629	SENT66	5	5	27	27	paclitaxel	HER2	PA450761	2064	0.852
NULL	Clinics_(Sao_Paulo)_2010_Jan_65(1)_29-34.nxml.txt.nlp	20126343	SENT119	11	11	24	24	ephedrine	LPSB	PA449466	8991	0.852
NULL	Am_J_Case_Rep_2012_Jun_5_13_96-98.nxml.txt.nlp	23569499	SENT96	20	20	23	23	rituximab	CHOP	PA451261	1649	0.852
NULL	Trials_2013_Aug_19_14_261.nxml.txt.nlp	23958221	SENT146	18	18	0	0	trastuzumab	HER2	PA451743	2064	0.852
NULL	Breast_Cancer_Res_2009_Nov_18_11(6)_R85.nxml.txt.nlp	19922614	SENT177	31	31	6	6	tamoxifen	BCS	PA451581	617	0.852
NULL	J_Lipid_Res_2011_May_52(5)_873-884.nxml.txt.nlp	21324916	SENT265	7	7	41	41	bezafibrate	UCP3	PA162364313	7352	0.852
NULL	Oncologist_2010_Nov_4_15(11)_1135-1146.nxml.txt.nlp	21051659	SENT150	21	21	28	28	sunitinib	IFN	PA162372840	3439	0.852
NULL	J_Cancer_Prev_2014_Mar_19(1)_39-46.nxml.txt.nlp	25337571	SENT94	16	16	21	21	ethanol	JNK	PA448073	5599	0.852
NULL	Cancer_Metab_2013_Jan_23_1_3.nxml.txt.nlp	24280005	SENT261	35	35	6	6	ethanol	SREBP1	PA448073	6720	0.852
NULL	Nat_Neurosci_2012_Sep_5_15(9)_1245-1254.nxml.txt.nlp	22864611	SENT43	27	27	17	17	haloperidol	mGlu2	PA449841	2912	0.852
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT116	2	2	15	15	doxorubicin	B7-H1	PA449412	29126	0.852
NULL	Eur_J_Haematol_2008_Feb_80(2)_93-106.nxml.txt.nlp	18081719	SENT325	21	21	2	2	iron	MRI	PA450087	78996	0.852
NULL	Glycoconj_J_2012_Apr_14_29(2-3)_93-105.nxml.txt.nlp	22246380	SENT90	29	29	3	3	galactose	MAA	PA449725	4080	0.852
NULL	Nat_Commun_2012_Feb_14_3_678.nxml.txt.nlp	22334081	SENT224	14	14	2	2	paraformaldehyde	IFN	PA450790	3439	0.852
NULL	Cell_Commun_Signal_2013_Oct_1_11_73.nxml.txt.nlp	24083678	SENT48	4	4	24	24	sulindac	IL-8	PA451565	3576	0.852
NULL	ScientificWorldJournal_2012_Apr_1_2012_381434.nxml.txt.nlp	22545017	SENT382	12	12	30	30	aprepitant	NK-1	PA164747039	27087	0.852
NULL	Clin_Ophthalmol_2008_Jun_2(2)_347-354.nxml.txt.nlp	19668726	SENT49	8	8	23	23	ranibizumab	VEGF-A	PA164746012	7422	0.852
NULL	Arthritis_Res_Ther_2012_Apr_30_14(2)_R96.nxml.txt.nlp	22546471	SENT1	13	13	17	17	methotrexate	SLC19A1	PA450428	6573	0.852
NULL	Angiogenesis_2013_Apr_10_16(2)_373-386.nxml.txt.nlp	23143659	SENT114	4	4	35	35	vinblastine	LDM	PA451877	1595	0.852
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT150	36	36	44	44	l-methionine	SIRT3	PA450423	23410	0.852
NULL	Blood_Cancer_J_2012_Oct_12_2(10)_e93.nxml.txt.nlp	23064741	SENT134	5	5	8	8	etoposide	CHOP	PA449552	1649	0.852
NULL	Neuropsychopharmacology_2009_Apr_2_34(5)_1135-1148.nxml.txt.nlp	18596687	SENT176	0	0	11	11	betaxolol	CRF	PA448611	1392;10882	0.852
NULL	Mol_Vis_2007_Jul_12_13_1130-1137.nxml.txt.nlp	17653058	SENT168	3	3	21	21	fentanyl	IFN	PA449599	3439	0.852
NULL	Oncotarget_2011_Sep_8_2(9)_728-736.nxml.txt.nlp	21908901	SENT78	13	13	35	35	pertuzumab	HER2		2064	0.852
NULL	Chemother_Res_Pract_2011_Jun_21_2011_696208.nxml.txt.nlp	22312556	SENT65	28	28	4	4	paclitaxel	HER2	PA450761	2064	0.852
NULL	J_Hum_Genet_2013_Jun_16_58(6)_353-361.nxml.txt.nlp	23677058	SENT168	35	35	25	25	cytarabine	RRM1	PA449177	6240	0.852
NULL	J_Gastrointest_Surg_2012_Apr_13_16(4)_842-848.nxml.txt.nlp	22246855	SENT94	22	22	12	12	lapatinib	EGFR	PA152241907	1956	0.852
NULL	J_Invest_Dermatol_2012_Jan_18_132(1)_163-169.nxml.txt.nlp	21850019	SENT5	7	7	28	28	imiquimod	CD4	PA449972	920	0.852
NULL	Front_Endocrinol_(Lausanne)_2014_Oct_9_5_161.nxml.txt.nlp	25346723	SENT417	8	8	25	25	exenatide	GLP-1	PA164749238	100125288	0.852
NULL	Cancers_(Basel)_2010_Jun_14_2(2)_1328-1353.nxml.txt.nlp	24281118	SENT921	16	16	18	18	gefitinib	EGFR	PA131301952	1956	0.852
NULL	Environ_Health_Perspect_2013_Sep_14_121(9)_1002-1010.nxml.txt.nlp	23771518	SENT95	15	15	41	41	propiconazole	aromatase	PA165107991	1588	0.852
NULL	Nucleic_Acids_Res_2012_Jul_5_40(13)_5819-5831.nxml.txt.nlp	22492510	SENT103	5	5	15	15	hemin	GATA-1	PA449849	2623	0.852
NULL	Breast_Cancer_Res_2007_Jul_5_9(4)_R41.nxml.txt.nlp	17612393	SENT194	0	0	20	20	ns-398	PC-3		692094	0.852
NULL	Eur_J_Haematol_2013_Feb_22_90(2)_89-98.nxml.txt.nlp	23181448	SENT142	0	0	10	10	dasatinib	KIT	PA162372878	3815	0.852
NULL	Oncotarget_2011_Sep_9_2(9)_658-668.nxml.txt.nlp	21911919	SENT115	7	7	20	20	daunorubicin	HO-1	PA449212	3162	0.852
NULL	FEBS_Open_Bio_2014_Jan_6_4_77-89.nxml.txt.nlp	24490132	SENT197	11	11	15	15	ebselen	GDH	PA161660841	51084;2746	0.852
NULL	Acta_Neuropathol_Commun_2014_Oct_21_2(1)_149.nxml.txt.nlp	NULL	SENT280	9	9	21	21	riluzole	gamma	PA451251	9913	0.852
NULL	Breast_Cancer_Res_2007_Apr_13_9(2)_103.nxml.txt.nlp	17433116	SENT22	6	6	14	14	tamoxifen	CYP2D6	PA451581	1565	0.852
NULL	Case_Rep_Oncol_2014_Sep_25_7(3)_669-672.nxml.txt.nlp	25408661	SENT63	2	2	11	11	aprepitant	CYP3A4	PA164747039	1576	0.852
NULL	Arthritis_Res_Ther_2006_Feb_3_8(2)_R43.nxml.txt.nlp	16507142	SENT118	9	9	24	24	heparin	CXCL12	PA449855	6387	0.852
NULL	Ann_Rheum_Dis_2008_Jul_26_67(7)_917-925.nxml.txt.nlp	17965121	SENT43	20	20	0	0	rituximab	CD19	PA451261	930	0.852
NULL	Comp_Hepatol_2004_Jan_14_3(Suppl_1)_S37.nxml.txt.nlp	14960189	SENT70	17	17	6	6	thalidomide	CD14	PA451644	929	0.852
NULL	Drug_Saf_2014_Feb_19_37(4)_201-211.nxml.txt.nlp	24550106	SENT116	14	14	39	39	diazepam	CYP2C19	PA449283	1557	0.852
NULL	Mol_Vis_2011_Feb_1_17_332-340.nxml.txt.nlp	21297899	SENT214	2	2	9	9	telmisartan	DPI	PA451605	1832	0.852
NULL	Indian_J_Psychiatry_2009_Jul-Sep_51(3)_222-224.nxml.txt.nlp	19881055	SENT63	19	19	12	12	venlafaxine	CYP2D6	PA451866	1565	0.852
NULL	Clin_Drug_Investig_2013_Aug_23_33(10)_727-736.nxml.txt.nlp	23975654	SENT181	25	25	21	21	bupropion	CYP2D6	PA448687	1565	0.852
NULL	J_Asthma_Allergy_2010_Jul_16_3_57-63.nxml.txt.nlp	21437040	SENT155	15	15	0	0	simvastatin	CD4	PA451363	920	0.852
NULL	Clin_Mol_Hepatol_2014_Dec_24_20(4)_338-344.nxml.txt.nlp	25548738	SENT50	27	27	29	29	boceprevir	BOC	PA165948902	91653	0.852
NULL	J_Int_Soc_Sports_Nutr_2009_Feb_19_6_6.nxml.txt.nlp	19228401	SENT9	2	2	29	29	creatine	CRT	PA164778930	811	0.852
NULL	J_Hematol_Oncol_2012_Aug_13_5_49.nxml.txt.nlp	22889180	SENT25	12	12	10	10	cyclophosphamide	CHOP	PA449165	1649	0.852
NULL	J_Oncol_2013_Apr_29_2013_854121.nxml.txt.nlp	23737784	SENT120	24	24	27	27	capecitabine	HER2	PA448771	2064	0.852
NULL	Anal_Bioanal_Chem_2012_Feb_16_402(4)_1611-1623.nxml.txt.nlp	22173207	SENT207	12	12	0	0	zanamivir	SRM	PA164740891	6723;6725	0.852
NULL	Evid_Based_Complement_Alternat_Med_2012_Dec_17_2012_857123.nxml.txt.nlp	23365602	SENT119	20	20	7	7	capsaicin	TRPV1	PA448776	7442	0.852
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT214	13	13	18	18	adalimumab	CD36	PA10004	948	0.852
NULL	J_Cardiothorac_Surg_2009_Nov_13_4_65.nxml.txt.nlp	19912629	SENT17	3	3	13	13	pergolide	5-HT2B	PA450873	3357	0.852
NULL	Int_J_Endocrinol_2010_Jul_18_2010_205357.nxml.txt.nlp	20706540	SENT123	21	21	0	0	galactose	GLUT7	PA449725	155184	0.852
NULL	J_Immunol_Res_2014_Jul_21_2014_297073.nxml.txt.nlp	25143957	SENT193	15	15	9	9	cyclosporine	HLA-G	PA449167	3135	0.852
NULL	Cancers_(Basel)_2011_Oct_14_3(4)_3894-3908.nxml.txt.nlp	24213116	SENT138	13	13	18	18	panitumumab	EGFR	PA162373091	1956	0.852
NULL	Arch_Med_Sci_2014_Aug_29_10(4)_717-724.nxml.txt.nlp	25276156	SENT148	0	0	5	5	gefitinib	EGFR	PA131301952	1956	0.852
NULL	Chemother_Res_Pract_2011_Dec_1_2011_715469.nxml.txt.nlp	22312557	SENT120	11	11	17	17	cisplatin	p53	PA449014	7157	0.852
NULL	Clinics_(Sao_Paulo)_2014_Jul_69(7)_491-496.nxml.txt.nlp	25029582	SENT104	13	13	20	20	methacholine	IFN	PA165958382	3439	0.852
NULL	Acta_Neuropathol_2012_Feb_19_123(2)_247-258.nxml.txt.nlp	22009304	SENT50	10	10	19	19	tamoxifen	flower	PA451581	11094	0.852
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S31-S40.nxml.txt.nlp	20680106	SENT69	12	12	30	30	irinotecan	KRAS	PA450085	3845	0.852
NULL	Clin_Ophthalmol_2014_Jun_3_8_1057-1064.nxml.txt.nlp	24940042	SENT44	5	5	17	17	bevacizumab	CST	PA130232992	9514	0.852
NULL	Diabetes_2013_May_16_62(5)_1689-1696.nxml.txt.nlp	23274908	SENT215	27	27	3	3	diazoxide	ABCC8	PA449285	6833	0.852
NULL	Neuro_Oncol_2010_Apr_27_12(4)_389-400.nxml.txt.nlp	20308316	SENT185	21	21	12	12	chloroquine	p53	PA448948	7157	0.852
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2675-2684.nxml.txt.nlp	24129246	SENT308	19	19	10	10	etoposide	DBC1	PA449552	57805;1620	0.852
NULL	Cancer_Res_Treat_2011_Dec_27_43(4)_255-259.nxml.txt.nlp	22247712	SENT8	25	25	8	8	cyclosporine	CHOP	PA449167	1649	0.852
NULL	Exp_Ther_Med_2013_Apr_5_5(4)_1259-1263.nxml.txt.nlp	23596498	SENT26	3	3	15	15	propofol	TRPV1	PA451141	7442	0.852
NULL	Breast_Cancer_Res_2014_Jul_29_16(4)_412.nxml.txt.nlp	25410383	SENT159	11	11	22	22	vorinostat	aromatase	PA164748224	1588	0.852
NULL	Int_J_Nephrol_2011_Apr_26_2011_245823.nxml.txt.nlp	21603155	SENT116	17	17	13	13	ribavirin	IFN	PA451241	3439	0.852
NULL	Appl_Microbiol_Biotechnol_2014_Feb_18_98(8)_3829-3840.nxml.txt.nlp	24535257	SENT139	4	4	36	36	ethanol	CAT-1	PA448073	6541	0.852
NULL	Cardiovasc_Diabetol_2013_Mar_18_12_46.nxml.txt.nlp	23497197	SENT231	16	16	29	29	metformin	adiponectin	PA450395	9370	0.852
NULL	Eur_J_Clin_Pharmacol_2012_Sep_15_68(9)_1267-1274.nxml.txt.nlp	22418828	SENT200	10	10	18	18	esomeprazole	CYP2C19	PA10075	1557	0.852
NULL	Biomed_Res_Int_2014_Jun_4_2014_253243.nxml.txt.nlp	24995279	SENT45	25	25	7	7	cyclophosphamide	CHOP	PA449165	1649	0.852
NULL	J_Carcinog_2011_Nov_30_10_28.nxml.txt.nlp	22190870	SENT166	41	41	22	22	trastuzumab	PI3K	PA451743	5290	0.852
NULL	Basic_Res_Cardiol_2014_Oct_31_109(6)_451.nxml.txt.nlp	25358972	SENT10	24	24	7	7	phenylephrine	FHL2	PA450935	2274	0.852
NULL	Gut_Liver_2011_Dec_21_5(4)_454-459.nxml.txt.nlp	22195243	SENT63	5	5	2	2	pantoprazole	ESD	PA450774	2098	0.852
NULL	Diabetes_2009_Feb_58(2)_329-336.nxml.txt.nlp	19171749	SENT128	37	37	42	42	imatinib	JNK	PA10804	5599	0.852
NULL	Breast_Cancer_Res_Treat_2014_Nov_8_148(3)_553-561.nxml.txt.nlp	NULL	SENT28	16	16	27	27	capecitabine	HER2	PA448771	2064	0.852
NULL	EMBO_Mol_Med_2011_Jul_3(7)_367-369.nxml.txt.nlp	21591260	SENT40	13	13	10	10	thrombin	PAR1	PA451674	79581;2149	0.852
NULL	Hum_Genomics_2009_Dec_1_4(2)_91-106.nxml.txt.nlp	20038497	SENT70	5	5	2	2	galantamine	CYP2D6	PA449726	1565	0.852
NULL	Acta_Orthop_2014_Apr_20_85(2)_141-146.nxml.txt.nlp	24650022	SENT22	8	8	20	20	ropivacaine	PAO	PA451271	196743;54498	0.852
NULL	Mol_Cancer_2007_Sep_18_6_56.nxml.txt.nlp	17877814	SENT33	47	47	9	9	erlotinib	EGFR	PA134687924	1956	0.852
NULL	EPMA_J_2012_Jun_18_3(1)_6.nxml.txt.nlp	22738201	SENT97	14	14	10	10	gefitinib	BIM	PA131301952	10018	0.852
NULL	Dis_Markers_2010_Jun_29_28(5)_307-313.nxml.txt.nlp	20592455	SENT3	22	22	4	4	atorvastatin	ABCG8	PA448500	64241	0.852
NULL	Arch_Drug_Inf_2009_Mar_2(1)_8-16.nxml.txt.nlp	19381336	SENT138	20	20	11	11	rifampin	CYP3A4	PA451250	1576	0.852
NULL	Eur_J_Nutr_2009_Jun_24_48(4)_229-234.nxml.txt.nlp	19238310	SENT155	16	16	25	25	capsaicin	GLP-1	PA448776	100125288	0.852
NULL	Front_Chem_2013_Dec_16_1_36.nxml.txt.nlp	24790964	SENT16	11	11	17	17	phenol	COD	PA450913	6628	0.852
NULL	Hum_Reprod_Update_2008_Sep_23_Nov-Dec_14(6)_571-582.nxml.txt.nlp	18812422	SENT187	9	9	30	30	letrozole	Casper	PA450196	8837	0.852
NULL	Clin_Dev_Immunol_2011_Nov_24_2011_174149.nxml.txt.nlp	22162710	SENT144	5	5	40	40	oxaliplatin	TLR4	PA131285527	7099	0.852
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT195	29	29	23	23	cetuximab	KRAS	PA10040	3845	0.852
NULL	Target_Oncol_2013_Jun_27_8(2)_127-136.nxml.txt.nlp	23625191	SENT75	18	18	12	12	panitumumab	KRAS	PA162373091	3845	0.852
NULL	Eur_J_Clin_Pharmacol_2010_Nov_29_66(11)_1131-1136.nxml.txt.nlp	20669013	SENT111	7	7	35	35	erythromycin	CYP2C19	PA449493	1557	0.852
NULL	Open_Microbiol_J_2008_May_23_2_66-73.nxml.txt.nlp	19088913	SENT247	1	1	18	18	ketoconazole	Yes	PA450146	7525	0.852
NULL	J_Exp_Clin_Cancer_Res_2008_Sep_15_27(1)_38.nxml.txt.nlp	18793406	SENT112	14	14	8	8	cisplatin	XRCC1	PA449014	7515	0.852
NULL	Core_Evid_2008_Jun_3(1)_45-54.nxml.txt.nlp	20694083	SENT97	0	0	5	5	tegaserod	5-HT4	PA130413154	3360	0.852
NULL	Ann_Gen_Psychiatry_2009_Jul_27_8_16.nxml.txt.nlp	19635147	SENT63	8	8	23	23	aripiprazole	c-fos	PA10026	2353	0.852
NULL	Bioinformation_2012_Dec_19_8(25)_1249-1254.nxml.txt.nlp	23275729	SENT8	29	29	19	19	pazopanib	VEGFR	PA165291492	3791	0.852
NULL	Mol_Cancer_2009_Dec_10_8_118.nxml.txt.nlp	20003259	SENT37	8	8	35	35	sorafenib	Bcl-2	PA7000	596	0.852
NULL	Sci_Rep_2014_Dec_12_4_7456.nxml.txt.nlp	25503852	SENT106	7	7	11	11	resveratrol	SIRT1		23411	0.852
NULL	Hum_Genomics_2010_Apr_1_4(4)_238-249.nxml.txt.nlp	20511137	SENT37	25	25	6	6	simvastatin	UGT1A1	PA451363	54658	0.852
NULL	Ann_Med_2011_Nov_5_43(7)_531-544.nxml.txt.nlp	21815879	SENT48	0	0	3	3	thrombin	PAR-1	PA451674	2011;2149	0.852
NULL	Oncotarget_2013_Nov_23_5(1)_196-210.nxml.txt.nlp	24344116	SENT149	24	24	10	10	doxorubicin	p53	PA449412	7157	0.852
NULL	Pharmaceutics_2011_Nov_18_3(4)_865-913.nxml.txt.nlp	24309312	SENT80	0	0	6	6	indinavir	CYP3A4	PA449977	1576	0.852
NULL	Mol_Cell_Proteomics_2012_Feb_6_11(2)_M111_015222.nxml.txt.nlp	22147731	SENT335	4	4	7	7	cetuximab	CLDN4	PA10040	1364	0.852
NULL	J_Mol_Med_2008_Sep_4_86(9)_1045-1056.nxml.txt.nlp	18600309	SENT176	5	5	12	12	salmeterol	p38	PA451300	10598;1432;7965	0.852
NULL	Breast_Cancer_Res_2010_Mar_5_12(2)_R16.nxml.txt.nlp	20205716	SENT234	34	34	7	7	lovastatin	E2F1	PA450272	1869	0.852
NULL	Crit_Care_2006_Dec_7_10(6)_239.nxml.txt.nlp	17169139	SENT57	4	4	11	11	thrombin	PAR1	PA451674	79581;2149	0.852
NULL	Environ_Health_Perspect_2008_Mar_26_116(3)_322-328.nxml.txt.nlp	18335098	SENT134	43	43	32	32	estradiol	PMI	PA449503	8834;5373	0.852
NULL	Arch_Med_Sci_2010_Dec_29_6(6)_964-970.nxml.txt.nlp	22427774	SENT123	7	7	9	9	calcipotriol	IL-19	PA448714	29949	0.852
NULL	Biomed_Res_Int_2014_Jun_26_2014_161346.nxml.txt.nlp	25054130	SENT240	7	7	21	21	curcumin	STZ	PA151958596	6484	0.852
NULL	Neural_Plast_2007_Jan_1_2007_30585.nxml.txt.nlp	25148070	SENT3530	38	38	14	14	gabapentin	gamma	PA449720	9913	0.852
NULL	J_Gastroenterol_Hepatol_2014_Dec_18_29(12)_1996-2005.nxml.txt.nlp	24910341	SENT21	18	18	0	0	ribavirin	IL28B	PA451241	282617	0.852
NULL	Cell_Tissue_Res_2013_May_18_352(2)_191-198.nxml.txt.nlp	23329124	SENT43	0	0	11	11	methotrexate	IL-6	PA450428	3569	0.852
NULL	Eur_J_Clin_Pharmacol_2008_Feb_26_64(2)_133-157.nxml.txt.nlp	18224312	SENT205	21	21	17	17	warfarin	VKORC1	PA451906	79001	0.852
NULL	Breast_Cancer_Res_2006_Nov_1_8(Suppl_2)_P31.nxml.txt.nlp	NULL	SENT15	40	40	34	34	tamoxifen	aromatase	PA451581	1588	0.852
NULL	Adv_Hematol_2010_Dec_30_2010_624040.nxml.txt.nlp	21234357	SENT112	9	9	20	20	cyclophosphamide	CHOP	PA449165	1649	0.852
NULL	Cell_Commun_Signal_2014_Sep_25_12(1)_61.nxml.txt.nlp	NULL	SENT246	14	14	0	0	bicalutamide	IL-8	PA164746255	3576	0.852
NULL	Mol_Cancer_2013_May_24_12_46.nxml.txt.nlp	23705826	SENT357	23	23	13	13	neomycin	KIT	PA450608	3815	0.852
NULL	Biologics_2010_May_25_4_91-101.nxml.txt.nlp	20531964	SENT99	8	8	14	14	everolimus	VEGFR	PA164746311	3791	0.852
NULL	Mult_Scler_Int_2013_Nov_7_2013_151427.nxml.txt.nlp	24312732	SENT158	38	38	11	11	cyclophosphamide	PLP	PA449165	25824;5744	0.852
NULL	Cancers_(Basel)_2012_Sep_25_4(4)_969-988.nxml.txt.nlp	24213497	SENT153	12	12	22	22	fulvestrant	EGFR	PA164747170	1956	0.852
NULL	J_Breast_Cancer_2013_Jun_28_16(2)_133-137.nxml.txt.nlp	23843843	SENT64	4	4	18	18	curcumin	p38	PA151958596	10598;1432;7965	0.852
NULL	Front_Oncol_2013_Nov_15_3_281.nxml.txt.nlp	24298448	SENT188	29	29	23	23	cetuximab	PIK3CA	PA10040	5290	0.852
NULL	Front_Neurosci_2010_Jun_17_4_35.nxml.txt.nlp	20661455	SENT93	29	29	22	22	pindolol	5-HT1A	PA450966	3350	0.852
NULL	Mol_Cells_2014_Sep_30_37(9)_664-671.nxml.txt.nlp	25234467	SENT185	12	12	9	9	cisplatin	miR-217	PA449014	406999	0.852
NULL	Nat_Commun_2012_Feb_21_3_682.nxml.txt.nlp	22353713	SENT325	16	16	3	3	galactose	GAL4	PA449725	3960	0.852
NULL	Int_J_Mol_Sci_2014_Jun_18_15(6)_11013-11029.nxml.txt.nlp	24945311	SENT138	5	5	9	9	celecoxib	STAT3	PA448871	6774	0.852
NULL	EMBO_Mol_Med_2012_Jun_13_4(6)_515-527.nxml.txt.nlp	22416035	SENT79	13	13	3	3	olaparib	p53		7157	0.852
NULL	Angiogenesis_2010_Dec_7_13(4)_305-315.nxml.txt.nlp	20927579	SENT242	30	30	14	14	resveratrol	TSP1		7057	0.852
NULL	Breast_Cancer_Res_Treat_2013_Oct_8_141(3)_437-446.nxml.txt.nlp	24101324	SENT173	19	19	7	7	everolimus	PTEN	PA164746311	5728	0.852
NULL	J_Gen_Physiol_1997_Dec_1_110(6)_655-664.nxml.txt.nlp	9382894	SENT59	37	37	2	2	spermine	SUR1	PA164781199	6833	0.852
NULL	J_Cardiothorac_Surg_2011_Feb_8_6_14.nxml.txt.nlp	21303502	SENT131	19	19	3	3	helium	CO2	PA449848	4513	0.852
NULL	Carcinogenesis_2014_May_13_35(5)_1055-1066.nxml.txt.nlp	24419232	SENT262	0	0	12	12	metformin	CD34	PA450395	947	0.852
NULL	Patient_Prefer_Adherence_2011_Dec_23_6_1-9.nxml.txt.nlp	22272064	SENT56	21	21	23	23	telmisartan	ACE	PA451605	1636	0.852
NULL	Diabetes_2013_Nov_18_62(11)_3751-3759.nxml.txt.nlp	23897951	SENT112	20	20	8	8	rosiglitazone	FRS2	PA451283	10818	0.852
NULL	Mol_Vis_2011_Apr_27_17_1044-1055.nxml.txt.nlp	21552499	SENT32	21	21	35	35	bevacizumab	apelin	PA130232992	8862	0.852
NULL	Oncotarget_2011_Mar_7_2(3)_122-134.nxml.txt.nlp	21399234	SENT100	15	15	27	27	cetuximab	EGFR	PA10040	1956	0.852
NULL	Br_J_Cancer_1998_Sep_78(6)_745-751.nxml.txt.nlp	9743293	SENT6	32	32	15	15	sn-38	p53		7157	0.852
NULL	Support_Care_Cancer_2011_Oct_12_19(10)_1609-1617.nxml.txt.nlp	20835873	SENT181	21	21	16	16	aprepitant	NK-1	PA164747039	27087	0.852
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT16	13	13	25	25	l-leucine	p27	PA450197	5715;10534	0.852
NULL	Oncotarget_2014_Jun_30_5(12)_4011-4025.nxml.txt.nlp	24994117	SENT104	23	23	35	35	estradiol	IRF7	PA449503	3665	0.852
NULL	Oncol_Lett_2014_Jun_4_7(6)_2175-2179.nxml.txt.nlp	24932311	SENT101	19	19	5	5	choline	PEMT	PA448976	10400	0.852
NULL	Nat_Methods_2012_Sep_12_9(9)_923-928.nxml.txt.nlp	22886092	SENT73	35	35	13	13	erlotinib	EGFR	PA134687924	1956	0.852
NULL	Lab_Invest_2009_Nov_7_89(11)_1275-1290.nxml.txt.nlp	19736547	SENT336	4	4	21	21	curcumin	p300	PA151958596	2033	0.852
NULL	Int_J_Breast_Cancer_2011_Sep_6_2011_352182.nxml.txt.nlp	22295219	SENT268	0	0	11	11	pertuzumab	HER2		2064	0.852
NULL	Diabetes_2009_Feb_58(2)_344-351.nxml.txt.nlp	19008341	SENT156	12	12	1	1	resveratrol	SIRT1		23411	0.852
NULL	Sci_Rep_2014_Dec_23_4_7593.nxml.txt.nlp	25534349	SENT57	4	4	12	12	atorvastatin	HMGCR	PA448500	3156	0.852
NULL	Acta_Physiol_(Oxf)_2008_Apr_192(4)_505-517.nxml.txt.nlp	17973950	SENT110	6	6	11	11	propranolol	PES	PA451145	23481	0.852
NULL	Br_J_Pharmacol_2014_May_171(10)_2659-2670.nxml.txt.nlp	24116661	SENT163	5	5	27	27	naringenin	TRPP2	PA151958361	5311	0.852
NULL	Breast_Cancer_Res_2012_Apr_17_14(2)_R61.nxml.txt.nlp	22510481	SENT35	0	0	13	13	trastuzumab	HER2	PA451743	2064	0.852
NULL	Adv_Appl_Bioinforma_Chem_2008_Oct_30_1_85-98.nxml.txt.nlp	21918608	SENT161	11	11	6	6	bortezomib	SPARC	PA10252	6678	0.852
NULL	Clin_Interv_Aging_2009_Jun_9_4_241-250.nxml.txt.nlp	19554095	SENT167	6	6	9	9	alendronate	RANKL	PA448082	8600	0.852
NULL	Oncotarget_2013_Dec_28_5(6)_1475-1490.nxml.txt.nlp	24721996	SENT189	5	5	10	10	celecoxib	PTEN	PA448871	5728	0.852
NULL	Oncotarget_2013_Aug_21_4(9)_1484-1495.nxml.txt.nlp	23986086	SENT172	44	44	5	5	metformin	PIK3CA	PA450395	5290	0.852
NULL	Oncotarget_2014_Sep_16_5(20)_9930-9938.nxml.txt.nlp	25294819	SENT98	10	10	6	6	plerixafor	CXCR4	PA165958410	7852	0.852
NULL	Br_J_Cancer_2009_Oct_6_101(7)_1155-1161.nxml.txt.nlp	19738614	SENT96	33	33	15	15	gemcitabine	MUC4	PA449748	4585	0.852
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Apr_29_67(Pt_5)_o1251.nxml.txt.nlp	21754542	SENT67	28	28	20	20	ethanol	mol	PA448073	90527	0.852
NULL	J_Gen_Physiol_2010_Apr_135(4)_333-353.nxml.txt.nlp	20231374	SENT440	12	12	27	27	amitriptyline	P2X4	PA448385	5025	0.852
NULL	Indian_J_Pharmacol_2014_Nov-Dec_46(6)_627-632.nxml.txt.nlp	25538335	SENT170	32	32	30	30	metformin	Q10	PA450395	27161	0.852
NULL	Cell_Death_Dis_2014_Apr_24_5(4)_e1197.nxml.txt.nlp	24763054	SENT341	15	15	7	7	cisplatin	RUNX3	PA449014	864	0.852
NULL	Br_J_Cancer_2013_Dec_10_109(12)_3067-3072.nxml.txt.nlp	24263065	SENT113	15	15	1	1	irinotecan	KRAS	PA450085	3845	0.852
NULL	Oxid_Med_Cell_Longev_2009_Sep-Oct_2(4)_214-221.nxml.txt.nlp	20716907	SENT255	3	3	33	33	pilocarpine	P400	PA450962	57634	0.852
NULL	Breast_Cancer_Res_2004_May_7_6(4)_R338-R351.nxml.txt.nlp	15217501	SENT213	20	20	4	4	estradiol	CYP1A2	PA449503	1544	0.852
NULL	Cancer_Immunol_Immunother_2011_Jun_25_60(6)_793-808.nxml.txt.nlp	21350947	SENT154	20	20	8	8	sorafenib	IFN	PA7000	3439	0.852
NULL	Int_J_Biomed_Sci_2013_Sep_9(3)_112-122.nxml.txt.nlp	24170986	SENT112	2	2	4	4	benazepril	RAGE	PA448561	177	0.852
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Dec_16_66(Pt_1)_o158.nxml.txt.nlp	21580047	SENT64	24	24	12	12	ethanol	mol	PA448073	90527	0.852
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT109	16	16	31	31	trastuzumab	MUC4	PA451743	4585	0.852
NULL	Endocrinol_Metab_(Seoul)_2014_Mar_14_29(1)_54-61.nxml.txt.nlp	24741455	SENT19	2	2	5	5	curcumin	p65	PA151958596	5970	0.852
NULL	J_Gen_Intern_Med_2009_May_21_24(5)_656-664.nxml.txt.nlp	19306050	SENT311	8	8	2	2	warfarin	VKORC1	PA451906	79001	0.852
NULL	Arthritis_Res_Ther_2005_Feb_18_7(3)_R476-R484.nxml.txt.nlp	15899034	SENT143	6	6	10	10	thrombin	IL-6	PA451674	3569	0.852
NULL	Int_J_Gen_Med_2011_Jul_20_4_539-545.nxml.txt.nlp	21845063	SENT72	22	22	10	10	miglitol	adiponectin	PA164776726	9370	0.852
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Oct_8_70(Pt_11)_o1151.nxml.txt.nlp	25484795	SENT82	15	15	4	4	ethanol	mol	PA448073	90527	0.852
NULL	Clin_Interv_Aging_2008_Sep_3(3)_431-444.nxml.txt.nlp	18982914	SENT60	10	10	5	5	mitomycin	WRN	PA450524	7486	0.852
NULL	Nat_Commun_2012_Feb_21_3_682.nxml.txt.nlp	22353713	SENT190	0	0	6	6	galactose	GAL	PA449725	51083	0.852
NULL	Nucleic_Acids_Res_2013_May_5_41(10)_5210-5222.nxml.txt.nlp	23563151	SENT245	4	4	27	27	arsenite	GADD45	PA452638	1647	0.852
NULL	J_Anaesthesiol_Clin_Pharmacol_2011_Jul-Sep_27(3)_315-322.nxml.txt.nlp	21897499	SENT48	15	15	7	7	fentanyl	CNB	PA449599	5534	0.852
NULL	Oncotarget_2014_Jun_3_5(13)_4920-4928.nxml.txt.nlp	24952482	SENT96	9	9	16	16	crizotinib	EGFR	PA165946122	1956	0.852
NULL	Crit_Care_1998_Mar_1_2(Suppl_1)_P028.nxml.txt.nlp	NULL	SENT8	9	9	7	7	thrombin	ADP	PA451674	23038	0.852
NULL	Eur_J_Med_Res_2009_Nov_24_14(Suppl_3)_17-21.nxml.txt.nlp	19959412	SENT99	12	12	20	20	raltegravir	UGT		7361;7355	0.852
NULL	Biologics_2010_Aug_9_4_173-185.nxml.txt.nlp	20714355	SENT193	33	33	19	19	cetuximab	EGFR	PA10040	1956	0.852
NULL	Cancer_Cell_Int_2003_Mar_25_3_4.nxml.txt.nlp	12787470	SENT192	17	17	11	11	ethanol	STAT1	PA448073	6772	0.852
NULL	Med_Sci_Monit_2012_Jul_1_18(7)_CS57-CS62.nxml.txt.nlp	22739739	SENT103	35	35	12	12	sulfapyridine	CYP2E1	PA164779050	1571	0.852
NULL	AIDS_Res_Treat_2011_Feb_9_2011_463704.nxml.txt.nlp	21490779	SENT24	45	45	41	41	abacavir	CCR5	PA448004	1234	0.852
NULL	Allergy_Asthma_Clin_Immunol_2014_Oct_24_10(1)_50.nxml.txt.nlp	25352908	SENT189	18	18	6	6	icatibant	C1-INH	PA164749185	710	0.852
NULL	Breast_Cancer_Res_2004_Mar_18_6(3)_119-127.nxml.txt.nlp	15084232	SENT144	12	12	24	24	genistein	p53	PA165109660	7157	0.852
NULL	Reprod_Biol_Endocrinol_2004_Jul_5_2_51.nxml.txt.nlp	15236651	SENT158	7	7	4	4	heparin	PRL	PA449855	5617	0.852
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT231	3	3	19	19	cisplatin	MDM2	PA449014	4193	0.852
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT132	4	4	9	9	chloroquine	BMPR-II	PA448948	659	0.852
NULL	EMBO_Mol_Med_2012_Sep_7_4(9)_896-909.nxml.txt.nlp	22887866	SENT281	0	0	17	17	lovastatin	c-Myc	PA450272	4609	0.852
NULL	Curr_Hypertens_Rep_2011_Oct_13_13(5)_356-361.nxml.txt.nlp	21562941	SENT62	21	21	26	26	benazepril	AT1	PA448561	9197;185	0.851
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1522-1532.nxml.txt.nlp	21997136	SENT152	13	13	25	25	gefitinib	UGT1A1	PA131301952	54658	0.851
NULL	ISRN_Neurosci_2013_Sep_5_2013_759640.nxml.txt.nlp	24959565	SENT106	23	23	38	38	thiopental	ANOVA	PA451664	4858	0.851
NULL	Mucosal_Immunol_2013_Nov_6_6(6)_1091-1100.nxml.txt.nlp	23385428	SENT235	12	12	1	1	methacholine	gamma	PA165958382	9913	0.851
NULL	Int_J_Mol_Sci_2007_Feb_28_8(2)_166-179.nxml.txt.nlp	NULL	SENT75	26	26	21	21	coumarin	CYP2A6	PA134521193	1548	0.851
NULL	Br_J_Pharmacol_2008_Oct_18_155(4)_596-605.nxml.txt.nlp	18852694	SENT190	7	7	23	23	fenofibrate	SREBP2	PA449594	6721	0.851
NULL	J_Hematol_Oncol_2013_Oct_12_6_78.nxml.txt.nlp	24283803	SENT172	27	27	0	0	doxorubicin	STAT3	PA449412	6774	0.851
NULL	Int_J_Mol_Sci_2014_May_12_15(5)_8335-8351.nxml.txt.nlp	24823879	SENT166	3	3	20	20	perifosine	CD34	PA165291471	947	0.851
NULL	Cancer_Cell_Int_2005_Aug_24_5_28.nxml.txt.nlp	16120219	SENT155	5	5	25	25	etoposide	MDM2	PA449552	4193	0.851
NULL	Oncotarget_2014_Oct_18_5(22)_11604-11619.nxml.txt.nlp	25344099	SENT11	7	7	11	11	cisplatin	RYBP	PA449014	23429	0.851
NULL	Chemother_Res_Pract_2011_Sep_25_2011_730360.nxml.txt.nlp	22295205	SENT192	4	4	11	11	lapatinib	survivin	PA152241907	332	0.851
NULL	Mol_Cell_Proteomics_2012_Feb_6_11(2)_M111_015222.nxml.txt.nlp	22147731	SENT386	30	30	3	3	gefitinib	GFPT2	PA131301952	9945	0.851
NULL	Braz_J_Med_Biol_Res_2012_Mar_2_45(3)_250-255.nxml.txt.nlp	22370705	SENT93	24	24	42	42	atropine	ADM	PA448505	133	0.851
NULL	Neural_Regen_Res_2013_Jul_15_8(20)_1853-1862.nxml.txt.nlp	25206494	SENT68	16	16	19	19	ethanol	JNK	PA448073	5599	0.851
NULL	J_Adv_Pharm_Technol_Res_2012_Oct-Dec_3(4)_202-209.nxml.txt.nlp	23378940	SENT165	20	20	16	16	tacrolimus	CYP3A4	PA451578	1576	0.851
NULL	Osteoporos_Int_2013_Jan_10_24(1)_227-235.nxml.txt.nlp	22776860	SENT116	9	9	14	14	denosumab	CTX	PA166048634	1593	0.851
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT177	4	4	8	8	phenprocoumon	VKORC1	PA450921	79001	0.851
NULL	Indian_J_Pharmacol_2013_Jan-Feb_45(1)_98-99.nxml.txt.nlp	23543750	SENT34	21	21	44	44	lorazepam	BPAD	PA450267	4095	0.851
NULL	J_Med_Chem_2014_Jan_23_57(2)_449-461.nxml.txt.nlp	24387105	SENT7	3	3	26	26	cyclophosphamide	ALDH3A1	PA449165	218	0.851
NULL	Mol_Clin_Oncol_2013_Sep_23_1(5)_887-893.nxml.txt.nlp	24649266	SENT119	15	15	4	4	vinblastine	TUBB3	PA451877	10381	0.851
NULL	Cancer_Res_Treat_2013_Dec_31_45(4)_251-262.nxml.txt.nlp	24453997	SENT88	38	38	23	23	chloroquine	PI3K	PA448948	5290	0.851
NULL	Ann_Hematol_2013_Aug_24_92(11)_1521-1528.nxml.txt.nlp	23978945	SENT31	3	3	6	6	alemtuzumab	CD52	PA164783958	1043	0.851
NULL	Arthritis_Res_Ther_2003_Aug_5_5(5)_214-222.nxml.txt.nlp	12932280	SENT76	24	24	32	32	alendronate	PTH	PA448082	5741	0.851
NULL	AIDS_2014_Jun_1_28(9)_1333-1339.nxml.txt.nlp	24583670	SENT151	10	10	19	19	tenofovir	CD4	PA10204	920	0.851
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Nov_5_67(Pt_12)_o3168.nxml.txt.nlp	22199692	SENT70	3	3	9	9	vanillin	mol	PA451852	90527	0.851
NULL	Korean_J_Radiol_2011_Apr_25_May-Jun_12(3)_319-326.nxml.txt.nlp	21603291	SENT81	13	13	4	4	propranolol	DBP	PA451145	3295;1628;2638	0.851
NULL	Oncoimmunology_2012_Oct_1_1(7)_1004-1016.nxml.txt.nlp	23170249	SENT189	7	7	11	11	paclitaxel	HER-2	PA450761	2064	0.851
NULL	Oncol_Lett_2013_Mar_8_5(3)_805-812.nxml.txt.nlp	23426281	SENT148	8	8	2	2	gemcitabine	B7-H3	PA449748	80381	0.851
NULL	Oncoscience_2014_Mar_24_1(3)_196-204.nxml.txt.nlp	25594012	SENT117	11	11	4	4	lapatinib	PIK3CA	PA152241907	5290	0.851
NULL	Oncogene_2010_Sep_9_29(36)_5048-5060.nxml.txt.nlp	20639907	SENT107	7	7	5	5	cisplatin	TRAIL	PA449014	8743	0.851
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT125	16	16	2	2	nutlin-3	DR5		8795	0.851
NULL	Aging_(Albany_NY)_2011_Jan_18_3(1)_33-43.nxml.txt.nlp	21248371	SENT3	15	15	3	3	oxygen	HIF-1	PA450744	29072	0.851
NULL	Exp_Ther_Med_2013_Nov_13_6(5)_1317-1321.nxml.txt.nlp	24223665	SENT24	3	3	18	18	curcumin	CD133	PA151958596	8842	0.851
NULL	Indian_J_Pharmacol_2014_Jan-Feb_46(1)_3-12.nxml.txt.nlp	24550577	SENT221	13	13	5	5	erythromycin	CYP2C9	PA449493	1559	0.851
NULL	Diabetes_Care_2010_Feb_33(2)_453-455.nxml.txt.nlp	20103562	SENT60	13	13	6	6	sitagliptin	HIP	PA164748978	6767;6159;64399;5068	0.851
NULL	J_Exp_Med_1996_Dec_1_184(6)_2445-2450.nxml.txt.nlp	8976202	SENT96	31	31	37	37	etoposide	IL-2	PA449552	3558	0.851
NULL	Mol_Cancer_2009_Aug_25_8_66.nxml.txt.nlp	19706164	SENT46	9	9	21	21	celecoxib	p53	PA448871	7157	0.851
NULL	Breast_Cancer_Res_2005_Apr_6_7(3)_119-130.nxml.txt.nlp	15987442	SENT36	5	5	3	3	tamoxifen	AP-1	PA451581	2353;3727;2354;3725	0.851
NULL	Int_J_Biol_Sci_2012_Jan_6_8(2)_236-248.nxml.txt.nlp	22253567	SENT223	7	7	9	9	simvastatin	PC3	PA451363	57332;7832;5122	0.851
NULL	Biochem_Biophys_Res_Commun_2013_Aug_23_438(2)_249-256.nxml.txt.nlp	23850620	SENT159	32	32	38	38	indomethacin	IFN	PA449982	3439	0.851
NULL	Cardiovasc_Drugs_Ther_2011_Jun_12_25(3)_223-232.nxml.txt.nlp	21562974	SENT105	9	9	24	24	esmolol	AKT	PA449500	207	0.851
NULL	Oncogene_2010_Jun_10_29(23)_3398-3410.nxml.txt.nlp	20348947	SENT254	4	4	7	7	rofecoxib	BimEL	PA451268	10018	0.851
NULL	Arthritis_Res_Ther_2009_Oct_14_11(5)_245.nxml.txt.nlp	19849817	SENT195	3	3	11	11	abatacept	CD40	PA164747080	958	0.851
NULL	EMBO_Mol_Med_2012_Sep_7_4(9)_896-909.nxml.txt.nlp	22887866	SENT150	6	6	3	3	lovastatin	c-Myc	PA450272	4609	0.851
NULL	Eur_J_Clin_Pharmacol_2013_Mar_11_69(3)_327-339.nxml.txt.nlp	22782539	SENT33	0	0	6	6	clopidogrel	P2Y12	PA449053	64805	0.851
NULL	Support_Care_Cancer_2010_May_27_18(5)_529-541.nxml.txt.nlp	20191292	SENT62	3	3	10	10	doxorubicin	gamma	PA449412	9913	0.851
NULL	Colorectal_Dis_2012_Feb_14(2)_e31-e47.nxml.txt.nlp	21848897	SENT148	6	6	25	25	panitumumab	KRAS	PA162373091	3845	0.851
NULL	J_Biol_Chem_2013_Dec_6_288(49)_35387-35395.nxml.txt.nlp	24142790	SENT155	0	0	4	4	meclizine	PCYT2	PA450338	5833	0.851
NULL	Brain_Res_2013_Jul_12_1521(100)_1-15.nxml.txt.nlp	22789905	SENT69	5	5	8	8	colchicine	P-gp	PA449092	5243	0.851
NULL	Core_Evid_2011_Mar_17_6_31-42.nxml.txt.nlp	21468241	SENT148	22	22	8	8	clopidogrel	ADP	PA449053	23038	0.851
NULL	Diabetes_Care_2010_Mar_15_33(3)_608-613.nxml.txt.nlp	20009095	SENT172	22	22	4	4	rosiglitazone	DREAM	PA451283	30818	0.851
NULL	Arthritis_Res_Ther_2005_Feb_18_7(3)_R476-R484.nxml.txt.nlp	15899034	SENT104	29	29	13	13	thrombin	Rho	PA451674	29984	0.851
NULL	Br_J_Cancer_2012_Dec_4_107(12)_1950-1955.nxml.txt.nlp	23169295	SENT96	9	9	5	5	oxaliplatin	ERCC1	PA131285527	2067	0.851
NULL	J_Cell_Mol_Med_2014_Aug_6_18(8)_1519-1539.nxml.txt.nlp	25100284	SENT26	0	0	24	24	afatinib	EGFR	PA165981154	1956	0.851
NULL	Cell_Death_Dis_2013_Sep_19_4(9)_e810.nxml.txt.nlp	24052078	SENT64	8	8	3	3	erlotinib	EGFR	PA134687924	1956	0.851
NULL	Breast_Cancer_Res_2010_Oct_22_12(Suppl_2)_S2.nxml.txt.nlp	21050423	SENT99	22	22	11	11	doxorubicin	MLH1	PA449412	4292	0.851
NULL	Adv_Ther_2014_May_13_31(5)_473-493.nxml.txt.nlp	24821599	SENT238	29	29	24	24	warfarin	TTR	PA451906	7276	0.851
NULL	Crit_Care_2011_Jun_28_15(3)_R159.nxml.txt.nlp	21711554	SENT106	5	5	14	14	fluconazole	CYP3A4	PA449653	1576	0.851
NULL	Cancer_Manag_Res_2013_Jan_17_5_15-20.nxml.txt.nlp	23378782	SENT40	7	7	22	22	erlotinib	Met	PA134687924	79811	0.851
NULL	Oncotarget_2011_Sep_10_2(9)_695-704.nxml.txt.nlp	21911917	SENT132	21	21	25	25	imatinib	KIT	PA10804	3815	0.851
NULL	Br_J_Cancer_2009_Mar_24_100(6)_894-900.nxml.txt.nlp	19240719	SENT2	18	18	9	9	trastuzumab	HER2	PA451743	2064	0.851
NULL	Environ_Health_Perspect_1995_Jul-Aug_103(7-8)_708-713.nxml.txt.nlp	7588483	SENT3	13	13	15	15	diethylstilbestrol	DES	PA449307	1674	0.851
NULL	Biomed_Res_Int_2014_Jan_2_2014_126586.nxml.txt.nlp	24527434	SENT112	8	8	18	18	metformin	p27	PA450395	5715;10534	0.851
NULL	Cells_2014_May_23_3(2)_517-545.nxml.txt.nlp	24861977	SENT35	33	33	21	21	capsaicin	TRPV1	PA448776	7442	0.851
NULL	Nat_Commun_2013_Aug_15_4_2130.nxml.txt.nlp	23945651	SENT84	8	8	12	12	etoposide	ATG5	PA449552	9474	0.851
NULL	Cardiovasc_Diabetol_2007_Apr_3_6_12.nxml.txt.nlp	17407587	SENT151	16	16	32	32	irbesartan	adiponectin	PA450084	9370	0.851
NULL	Mol_Cancer_2012_Dec_12_11_91.nxml.txt.nlp	23234355	SENT106	12	12	7	7	erlotinib	EGFR	PA134687924	1956	0.851
NULL	Fibrogenesis_Tissue_Repair_2012_Apr_13_5_5.nxml.txt.nlp	22502865	SENT72	28	28	9	9	troglitazone	CCN2	PA451799	1490	0.851
NULL	Int_J_Biol_Sci_2011_Nov_2_7(9)_1427-1442.nxml.txt.nlp	22110393	SENT202	14	14	21	21	thrombin	RANTES	PA451674	6352	0.851
NULL	Core_Evid_2011_Feb_8_6_23-29.nxml.txt.nlp	21468240	SENT24	7	7	17	17	plerixafor	CD34	PA165958410	947	0.851
NULL	Support_Care_Cancer_2012_Apr_25_20(4)_705-714.nxml.txt.nlp	21437780	SENT145	30	30	27	27	tamoxifen	aromatase	PA451581	1588	0.851
NULL	Biomed_Res_Int_2014_Jun_3_2014_590848.nxml.txt.nlp	24995312	SENT46	0	0	13	13	ciprofloxacin	RAK	PA449009	2444	0.851
NULL	Arthritis_Res_Ther_2011_Feb_8_13(1)_R17.nxml.txt.nlp	21303509	SENT213	35	35	1	1	methotrexate	FSTL1	PA450428	11167	0.851
NULL	AIDS_Res_Ther_2013_May_1_10_10.nxml.txt.nlp	23634877	SENT126	36	36	25	25	lovastatin	CXCR4	PA450272	7852	0.851
NULL	J_Exp_Med_1998_Jun_1_187(11)_1885-1892.nxml.txt.nlp	9607928	SENT160	10	10	21	21	thalidomide	IL-2	PA451644	3558	0.851
NULL	Case_Rep_Endocrinol_2014_Feb_10_2014_479641.nxml.txt.nlp	24660072	SENT86	12	12	2	2	cinacalcet	PTH	PA164776671	5741	0.851
NULL	Lab_Invest_2010_Oct_28_90(10)_1415-1424.nxml.txt.nlp	20585313	SENT50	14	14	19	19	celecoxib	Ray	PA448871	26751	0.851
NULL	Lipids_Health_Dis_2011_Jan_18_10_8.nxml.txt.nlp	21241519	SENT33	7	7	19	19	simvastatin	ABCG1	PA451363	9619	0.851
NULL	Acta_Pharmacol_Sin_2009_Feb_26_30(2)_175-183.nxml.txt.nlp	19169269	SENT161	4	4	15	15	iptakalim	NUP54	PA165949694	53371	0.851
NULL	J_Invest_Dermatol_2015_Feb_9_135(2)_389-399.nxml.txt.nlp	25184961	SENT259	0	0	11	11	rosiglitazone	IL-6	PA451283	3569	0.851
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT74	22	22	18	18	trastuzumab	HER2	PA451743	2064	0.851
NULL	Case_Rep_Transplant_2011_Jan_5_2011_210178.nxml.txt.nlp	23213600	SENT79	14	14	19	19	tacrolimus	CYP2C19	PA451578	1557	0.851
NULL	Front_Neurosci_2011_Jul_26_5_92.nxml.txt.nlp	21845173	SENT106	5	5	11	11	naloxone	NRM	PA450586	11270	0.851
NULL	Diabetes_Care_2010_Feb_33(2)_e20-e25.nxml.txt.nlp	20103551	SENT65	27	27	8	8	exenatide	GLP-1	PA164749238	100125288	0.851
NULL	Acta_Oncol_2014_Oct_9_53(10)_1347-1355.nxml.txt.nlp	24909504	SENT125	21	21	7	7	doxorubicin	TP53	PA449412	7157	0.851
NULL	Environ_Health_Perspect_2003_Sep_111(12)_1568-1570.nxml.txt.nlp	12948899	SENT9	28	28	30	30	diethylstilbestrol	DES	PA449307	1674	0.851
NULL	Archaea_2012_Aug_15_2012_315153.nxml.txt.nlp	22927778	SENT130	19	19	6	6	nadh	mol	PA164755085	90527	0.851
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT40	15	15	36	36	metformin	EGFR	PA450395	1956	0.851
NULL	Br_J_Cancer_2010_Sep_7_103(6)_889-898.nxml.txt.nlp	20664599	SENT199	10	10	5	5	paclitaxel	HER-2	PA450761	2064	0.851
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT49	9	9	16	16	curcumin	TRAIL	PA151958596	8743	0.851
NULL	Mol_Cancer_2013_May_4_12_37.nxml.txt.nlp	23642048	SENT230	16	16	8	8	curcumin	PI3K	PA151958596	5290	0.851
NULL	Diabetes_Metab_J_2013_Aug_14_37(4)_240-248.nxml.txt.nlp	23991401	SENT116	5	5	3	3	ezetimibe	NPC1L1	PA10816	29881	0.851
NULL	Front_Aging_Neurosci_2010_Feb_3_2_2.nxml.txt.nlp	20552042	SENT130	2	2	12	12	isoproterenol	CA1	PA450121	759	0.851
NULL	Case_Rep_Dent_2013_Jul_10_2013_812323.nxml.txt.nlp	23936686	SENT96	34	34	24	24	hyaluronan	CD34	PA165958431	947	0.851
NULL	Ann_Oncol_2010_Apr_4_21(4)_815-819.nxml.txt.nlp	19889613	SENT149	0	0	8	8	lapatinib	HER2	PA152241907	2064	0.851
NULL	J_Korean_Med_Sci_2006_Aug_22_21(4)_596-601.nxml.txt.nlp	16891799	SENT29	2	2	15	15	infliximab	p75	PA452639	7133;11168	0.851
NULL	Breast_Cancer_Res_2007_Jul_5_9(4)_R41.nxml.txt.nlp	17612393	SENT194	0	0	8	8	ns-398	PGD2		27306	0.851
NULL	Cancer_Growth_Metastasis_2014_Aug_10_7_33-42.nxml.txt.nlp	25187738	SENT187	32	32	23	23	bortezomib	BMP2	PA10252	650	0.851
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT133	20	20	26	26	adalimumab	CD36	PA10004	948	0.851
NULL	Am_J_Trop_Med_Hyg_2012_Mar_1_86(3)_403-408.nxml.txt.nlp	22403308	SENT102	1	1	39	39	artesunate	ACT	PA165111697	12;11332;9457;641455	0.851
NULL	Oncotarget_2012_May_19_3(5)_535-545.nxml.txt.nlp	22619121	SENT92	2	2	9	9	camptothecin	TPT	PA153590860	23590;6469	0.851
NULL	Reprod_Biol_Endocrinol_2003_Oct_3_1_62.nxml.txt.nlp	14567758	SENT177	0	0	27	27	lindane	ANOVA	PA164754914	4858	0.851
NULL	Biosci_Rep_2012_Dec_20_33(1)_e00011.nxml.txt.nlp	23137297	SENT267	13	13	4	4	heparin	RPSA	PA449855	3921	0.851
NULL	Contemp_Oncol_(Pozn)_2013_Apr_29_17(2)_137-143.nxml.txt.nlp	23788980	SENT182	15	15	7	7	cabergoline	PRL	PA448708	5617	0.851
NULL	Ann_Clin_Transl_Neurol_2014_Dec_21_1(12)_996-1005.nxml.txt.nlp	25574474	SENT181	16	16	7	7	riluzole	P-gp	PA451251	5243	0.851
NULL	Clin_Med_Insights_Cardiol_2010_Oct_11_4_89-93.nxml.txt.nlp	20981132	SENT89	9	9	40	40	fosinopril	TNF	PA449710	7124	0.851
NULL	Acta_Neuropathol_Commun_2014_May_30_2_57.nxml.txt.nlp	24887326	SENT34	22	22	15	15	methotrexate	ABCB1	PA450428	5243	0.851
NULL	Gut_Liver_2012_Jul_2_6(3)_316-320.nxml.txt.nlp	22844558	SENT127	34	34	41	41	clopidogrel	ESD	PA449053	2098	0.851
NULL	Nucleic_Acids_Res_2011_Nov_19_39(20)_9009-9022.nxml.txt.nlp	21771857	SENT71	10	10	43	43	thyroglobulin	B12	PA164754910	7126;4709	0.851
NULL	Breast_Cancer_Res_Treat_2012_Jul_28_134(1)_267-276.nxml.txt.nlp	22453754	SENT27	33	33	15	15	tamoxifen	aromatase	PA451581	1588	0.851
NULL	Anticancer_Drugs_2015_Jan_28_26(1)_46-55.nxml.txt.nlp	25099621	SENT106	0	0	18	18	doxorubicin	p38	PA449412	10598;1432;7965	0.851
NULL	Indian_J_Pharmacol_2008_Mar-Apr_40(2)_84-86.nxml.txt.nlp	21279172	SENT27	14	14	11	11	erythromycin	CYP3A4	PA449493	1576	0.851
NULL	Cancer_Immunol_Immunother_2011_Jun_25_60(6)_793-808.nxml.txt.nlp	21350947	SENT224	32	32	21	21	sorafenib	IFN	PA7000	3439	0.851
NULL	Mol_Cancer_2014_Jun_3_13_139.nxml.txt.nlp	24894297	SENT124	15	15	9	9	cisplatin	HES1	PA449014	3280;8209	0.851
NULL	Nat_Commun_2013_Apr_3_4_1652.nxml.txt.nlp	23552067	SENT22	21	21	1	1	ketamine	gamma	PA450144	9913	0.851
NULL	ScientificWorldJournal_2012_Aug_1_2012_387923.nxml.txt.nlp	22919313	SENT47	9	9	28	28	fluorescein	San	PA164746009	80218	0.851
NULL	J_Int_Soc_Sports_Nutr_2012_Nov_15_9_49.nxml.txt.nlp	23153110	SENT264	28	28	8	8	l-tyrosine	SHOT	PA451822	6474	0.851
NULL	Mol_Cancer_2009_Aug_25_8_66.nxml.txt.nlp	19706164	SENT201	8	8	35	35	celecoxib	p53	PA448871	7157	0.851
NULL	Oncol_Lett_2013_Oct_26_6(4)_1063-1067.nxml.txt.nlp	24137465	SENT100	2	2	11	11	trastuzumab	HER2	PA451743	2064	0.851
NULL	Front_Mol_Neurosci_2012_Nov_12_5_99.nxml.txt.nlp	23162427	SENT297	19	19	14	14	cocaine	CPP	PA449072	340451	0.851
NULL	Breast_Cancer_(Auckl)_2013_Feb_13_7_7-22.nxml.txt.nlp	23492649	SENT159	5	5	9	9	everolimus	HER2	PA164746311	2064	0.851
NULL	Arthritis_Res_Ther_2011_Apr_4_13(2)_R56.nxml.txt.nlp	21463515	SENT19	13	13	26	26	etanercept	IL-6	PA449515	3569	0.851
NULL	Exp_Diabetes_Res_2012_Mar_4_2012_653678.nxml.txt.nlp	22474428	SENT31	28	28	23	23	pioglitazone	gamma	PA450970	9913	0.851
NULL	J_Oncol_2012_Feb_6_2012_737981.nxml.txt.nlp	22481932	SENT132	23	23	21	21	triciribine	AKT	PA165958661	207	0.851
NULL	Ann_Oncol_2011_Mar_8_22(3)_503-514.nxml.txt.nlp	20616198	SENT302	26	26	28	28	tamoxifen	IMPACT	PA451581	55364	0.851
NULL	Cancer_Res_Treat_2013_Mar_31_45(1)_63-69.nxml.txt.nlp	23613672	SENT124	20	20	7	7	oxaliplatin	ERCC1	PA131285527	2067	0.851
NULL	Hum_Genomics_Proteomics_2010_Sep_13_2010_754919.nxml.txt.nlp	20981234	SENT102	24	24	10	10	phenprocoumon	VKORC1	PA450921	79001	0.851
NULL	Cancer_Med_2014_Feb_10_3(1)_134-142.nxml.txt.nlp	24407937	SENT228	27	27	29	29	tamoxifen	IMPACT	PA451581	55364	0.851
NULL	Biosci_Rep_2012_Aug_1_32(Pt_4)_361-374.nxml.txt.nlp	22762204	SENT164	25	25	3	3	doxorubicin	BRCA1	PA449412	672	0.851
NULL	Cancer_Microenviron_2009_Sep_26_2(Suppl_1)_19-204.nxml.txt.nlp	NULL	SENT6591	0	0	6	6	docetaxel	CD44	PA449383	960	0.851
NULL	CNS_Neurosci_Ther_2009_Spring_15(1)_32-51.nxml.txt.nlp	19228178	SENT73	2	2	9	9	prazosin	MT3	PA451093	4504	0.851
NULL	Cell_Death_Dis_2013_Oct_3_4(10)_e827.nxml.txt.nlp	24091670	SENT88	17	17	22	22	nilotinib	CD38	PA165958345	952	0.851
NULL	Br_J_Cancer_2003_Mar_10_88(5)_754-759.nxml.txt.nlp	12618886	SENT104	12	12	31	31	amifostine	p53	PA448365	7157	0.851
NULL	Crit_Care_2004_Oct_27_8(6)_R474-R482.nxml.txt.nlp	15566594	SENT36	9	9	12	12	tenoxicam	PGD2	PA131890625	27306	0.851
NULL	Diabetes_2013_Jun_17_62(6)_1913-1922.nxml.txt.nlp	23349495	SENT216	15	15	27	27	sildenafil	AMPK	PA451346	5563	0.851
NULL	Biomed_Res_Int_2014_Jan_2_2014_126586.nxml.txt.nlp	24527434	SENT107	6	6	16	16	metformin	AMPK	PA450395	5563	0.851
NULL	Indian_J_Pharmacol_2012_Sep-Oct_44(5)_624-628.nxml.txt.nlp	23112426	SENT21	4	4	26	26	nimodipine	P-gp	PA450633	5243	0.851
NULL	Exp_Ther_Med_2013_Apr_24_5(4)_1105-1112.nxml.txt.nlp	23596478	SENT20	4	4	0	0	cytarabine	IFN	PA449177	3439	0.851
NULL	Clin_Exp_Reprod_Med_2012_Dec_31_39(4)_153-160.nxml.txt.nlp	23346525	SENT55	6	6	38	38	hyaluronidase	MTF	PA164745713	4500	0.851
NULL	J_Adv_Pharm_Technol_Res_2014_Oct-Dec_5(4)_171-178.nxml.txt.nlp	25364695	SENT9	0	0	7	7	curcumin	ARG	PA151958596	473;27	0.851
NULL	Clin_Pharmacol_2013_Jul_4_5_117-129.nxml.txt.nlp	23861604	SENT83	12	12	23	23	denosumab	RANKL	PA166048634	8600	0.851
NULL	Arthritis_Res_Ther_2011_May_13_13(3)_R75.nxml.txt.nlp	21569519	SENT123	29	29	7	7	rituximab	ANOVA	PA451261	4858	0.851
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_75-89.nxml.txt.nlp	17912638	SENT226	13	13	7	7	anastrozole	ATAC	PA448432	6375	0.851
NULL	Mol_Cancer_2009_Dec_3_8_115.nxml.txt.nlp	19958544	SENT74	14	14	7	7	nutlin-3	p53		7157	0.851
NULL	Neuroscience_2010_Jun_16_168(1-6)_263-272.nxml.txt.nlp	20363297	SENT275	17	17	5	5	apomorphine	A10	PA164781163	28870	0.851
NULL	Br_J_Cancer_2013_Jul_23_109(2)_342-350.nxml.txt.nlp	23807172	SENT113	21	21	26	26	sorafenib	Mcl-1	PA7000	4170	0.851
NULL	Evid_Based_Complement_Alternat_Med_2013_Dec_12_2013_324618.nxml.txt.nlp	24416065	SENT112	14	14	8	8	nevirapine	P-gp	PA450616	5243	0.851
NULL	Br_J_Haematol_2009_Feb_144(3)_367-375.nxml.txt.nlp	19036078	SENT69	23	23	19	19	doxorubicin	CHOP	PA449412	1649	0.851
NULL	Clin_Interv_Aging_2009_Jun_9_4_251-258.nxml.txt.nlp	19554096	SENT141	14	14	11	11	fluoxetine	CYP2D6	PA449673	1565	0.851
NULL	Front_Microbiol_2014_May_20_5_233.nxml.txt.nlp	24904547	SENT1570	0	0	8	8	fenofibrate	adiponectin	PA449594	9370	0.851
NULL	J_Invest_Dermatol_2012_Nov_21_132(11)_2642-2651.nxml.txt.nlp	22718118	SENT224	4	4	17	17	collagenase	CD11b	PA449107	3684	0.851
NULL	Breast_Cancer_Res_2009_Sep_29_11(5)_209.nxml.txt.nlp	19818165	SENT119	19	19	22	22	gefitinib	EGFR	PA131301952	1956	0.851
NULL	Clin_Exp_Gastroenterol_2011_Jul_15_4_163-172.nxml.txt.nlp	21904462	SENT89	43	43	27	27	infliximab	OLC	PA452639	26679	0.851
NULL	Iran_J_Basic_Med_Sci_2013_Apr_16(4)_610-614.nxml.txt.nlp	24250937	SENT30	0	0	7	7	coumarin	CYP2A6	PA134521193	1548	0.851
NULL	Eur_J_Clin_Pharmacol_2012_Jan_8_68(1)_29-37.nxml.txt.nlp	21739267	SENT3	9	9	21	21	fluvoxamine	CYP2D6	PA449690	1565	0.851
NULL	J_Cell_Biol_2000_Dec_11_151(6)_1235-1246.nxml.txt.nlp	11121438	SENT194	13	13	24	24	heparin	p29	PA449855	25949;9588	0.851
NULL	Eur_J_Epidemiol_2009_Sep_2_24(9)_553-572.nxml.txt.nlp	19728115	SENT1547	21	21	10	10	phenprocoumon	CYP2C9	PA450921	1559	0.851
NULL	F1000Prime_Rep_2013_Dec_3_5_56.nxml.txt.nlp	24381731	SENT73	10	10	1	1	abciximab	AIDA	PA448006	64853	0.851
NULL	Diabetes_2013_Jun_17_62(6)_1816-1817.nxml.txt.nlp	23704523	SENT7	27	27	25	25	hyaluronan	ECM	PA165958431	22915	0.851
NULL	J_Breast_Cancer_2013_Sep_30_16(3)_274-284.nxml.txt.nlp	24155756	SENT49	31	31	24	24	tamoxifen	aromatase	PA451581	1588	0.851
NULL	Leukemia_2013_Feb_3_27(2)_315-324.nxml.txt.nlp	22751450	SENT189	0	0	12	12	sorafenib	Mcl-1	PA7000	4170	0.851
NULL	Cancer_Metastasis_Rev_2010_Dec_10_29(4)_581-594.nxml.txt.nlp	20830503	SENT313	15	15	30	30	anastrozole	ATAC	PA448432	6375	0.851
NULL	Crit_Care_2008_Nov_12_12(6)_235.nxml.txt.nlp	19040780	SENT108	34	34	18	18	methotrexate	OAT3	PA450428	9376	0.851
NULL	Arthritis_Res_Ther_2011_Dec_12_13(6)_R204.nxml.txt.nlp	22151924	SENT12	13	13	4	4	abatacept	CFB	PA164747080	629	0.851
NULL	Anal_Bioanal_Chem_2013_Jul_23_405(23)_7337-7345.nxml.txt.nlp	23877175	SENT142	9	9	21	21	creatine	CA3	PA164778930	761	0.851
NULL	Anesth_Essays_Res_2012_Jul-Dec_6(2)_140-146.nxml.txt.nlp	NULL	SENT19	15	15	5	5	lidocaine	IL8	PA450226	3576	0.851
NULL	Eur_J_Haematol_2009_Apr_82(4)_277-287.nxml.txt.nlp	19187270	SENT183	22	22	12	12	pha-665752	IL-6		3569	0.851
NULL	Oncogene_2013_Sep_12_32(37)_4355-4365.nxml.txt.nlp	23108409	SENT74	30	30	20	20	hyaluronan	HAS2	PA165958431	3037	0.851
NULL	Evid_Based_Complement_Alternat_Med_2012_Feb_12_2012_743075.nxml.txt.nlp	22454682	SENT186	4	4	11	11	forskolin	TARC	PA146096022	6361	0.851
NULL	Br_J_Haematol_2014_Mar_13_164(1)_811-821.nxml.txt.nlp	24328678	SENT122	3	3	29	29	lenalidomide	Aiolos	PA162363968	22806	0.851
NULL	Drugs_R_D_2014_Sep_31_14(3)_177-184.nxml.txt.nlp	25079671	SENT28	13	13	38	38	miglitol	MCP-1	PA164776726	6347	0.851
NULL	Clin_Ophthalmol_2008_Mar_2(1)_1-14.nxml.txt.nlp	19668384	SENT176	3	3	1	1	ranibizumab	VEGF-A	PA164746012	7422	0.851
NULL	Alzheimers_Res_Ther_2013_Jan_21_5(1)_6.nxml.txt.nlp	23336974	SENT88	31	31	7	7	memantine	APT	PA10364	653639	0.851
NULL	Curr_Pain_Headache_Rep_2011_Aug_12_15(4)_271-279.nxml.txt.nlp	21479998	SENT162	19	19	3	3	fluoxetine	CYP2D6	PA449673	1565	0.851
NULL	Br_J_Cancer_2010_Jul_13_103(2)_186-195.nxml.txt.nlp	20588277	SENT145	27	27	23	23	nutlin-3	p53		7157	0.851
NULL	Oncotarget_2013_Nov_15_5(6)_1458-1474.nxml.txt.nlp	24681547	SENT149	1	1	29	29	celecoxib	CDH11	PA448871	1009	0.851
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_11_2014_274786.nxml.txt.nlp	25505920	SENT186	20	20	7	7	irinotecan	CYP3A	PA450085	1574	0.851
NULL	Front_Mol_Neurosci_2012_Nov_12_5_99.nxml.txt.nlp	23162427	SENT768	2	2	10	10	cocaine	c-fos	PA449072	2353	0.851
NULL	Oncogene_2010_Jun_10_29(23)_3398-3410.nxml.txt.nlp	20348947	SENT134	8	8	15	15	rofecoxib	BimEL	PA451268	10018	0.851
NULL	Bioinform_Biol_Insights_2009_Oct_5_3_109-127.nxml.txt.nlp	20140064	SENT389	10	10	16	16	tenofovir	P65	PA10204	64689;6857	0.851
NULL	N_Am_J_Med_Sci_2009_Jun_1(1)_16-24.nxml.txt.nlp	22666666	SENT82	33	33	4	4	l-glutamine	19A	PA10090	57823	0.851
NULL	Br_J_Cancer_2010_Dec_7_103(12)_1794-1800.nxml.txt.nlp	21063406	SENT156	29	29	16	16	epirubicin	TP53	PA449476	7157	0.851
NULL	Breast_Cancer_Res_2012_Jul_19_14(4)_R109.nxml.txt.nlp	22812567	SENT291	24	24	27	27	gemcitabine	CHK1	PA449748	1111	0.851
NULL	Breast_Cancer_Res_2007_Dec_20_9(Suppl_2)_S19.nxml.txt.nlp	NULL	SENT9	37	37	40	40	tamoxifen	aromatase	PA451581	1588	0.851
NULL	Front_Neurosci_2014_May_27_8_129.nxml.txt.nlp	24904269	SENT153	24	24	12	12	ethanol	AC1	PA448073	107	0.851
NULL	Arthritis_Res_Ther_2009_Aug_17_11(4)_R123.nxml.txt.nlp	19686595	SENT112	5	5	8	8	rituximab	CD19	PA451261	930	0.851
NULL	Int_J_Hypertens_2011_Nov_13_2011_902129.nxml.txt.nlp	22164326	SENT82	17	17	2	2	l-arginine	NOS	PA448478	4843	0.851
NULL	Pharmaceuticals_(Basel)_2011_Oct_27_4(11)_1450-1474.nxml.txt.nlp	NULL	SENT119	16	16	11	11	naproxen	COX	PA450595	1351	0.851
NULL	Front_Genet_2012_Nov_22_3_249.nxml.txt.nlp	23189085	SENT662	20	20	0	0	cyclophosphamide	ABCG2	PA449165	9429	0.851
NULL	Oncotarget_2013_Nov_4_5(1)_161-172.nxml.txt.nlp	24389287	SENT121	10	10	15	15	propranolol	p53	PA451145	7157	0.851
NULL	Evid_Based_Complement_Alternat_Med_2013_May_28_2013_629750.nxml.txt.nlp	23781265	SENT149	13	13	3	3	capsaicin	GADD153	PA448776	1649	0.851
NULL	Int_Neurourol_J_2014_Sep_24_18(3)_115-125.nxml.txt.nlp	25279238	SENT119	2	2	11	11	berberine	CA1	PA165860812	759	0.851
NULL	J_Ginseng_Res_2011_Sep_35(3)_308-314.nxml.txt.nlp	23717074	SENT136	15	15	5	5	metformin	LKB1	PA450395	6794	0.851
NULL	Clin_Exp_Gastroenterol_2013_Aug_5_6_139-148.nxml.txt.nlp	23950655	SENT150	19	19	21	21	thrombin	ADP	PA451674	23038	0.851
NULL	Cell_Commun_Signal_2013_Jan_11_11_2.nxml.txt.nlp	23305203	SENT264	9	9	18	18	forskolin	RACK1	PA146096022	10399	0.851
NULL	Nat_Med_2012_Jun_18(6)_956-960.nxml.txt.nlp	22610278	SENT51	24	24	11	11	auranofin	AIRAP	PA448510	90637	0.851
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT42	11	11	37	37	pemetrexed	UNG	PA10810	7374	0.851
NULL	J_Cell_Biol_2001_Nov_26_155(5)_845-858.nxml.txt.nlp	11724824	SENT332	32	32	2	2	paraformaldehyde	E16	PA450790	8140	0.851
NULL	Biosci_Rep_2014_Dec_12_34(6)_e00162.nxml.txt.nlp	25385088	SENT167	10	10	18	18	chymotrypsin	XPA	PA448994	7507	0.851
NULL	Clin_Med_Insights_Cardiol_2010_Oct_11_4_89-93.nxml.txt.nlp	20981132	SENT89	9	9	38	38	fosinopril	TLR4	PA449710	7099	0.851
NULL	Cancer_Imaging_2010_Jul_6_10(1)_144-152.nxml.txt.nlp	20605761	SENT81	0	0	7	7	pertuzumab	HER2		2064	0.851
NULL	Mol_Cancer_2012_Jun_26_11_43.nxml.txt.nlp	22731636	SENT124	7	7	18	18	pp2	PP2		4888	0.851
NULL	J_Cancer_2014_Jul_29_5(7)_609-624.nxml.txt.nlp	25161699	SENT266	5	5	13	13	curcumin	p38	PA151958596	10598;1432;7965	0.851
NULL	J_Headache_Pain_2009_Apr_27_10(2)_105-110.nxml.txt.nlp	19172228	SENT99	31	31	10	10	capsaicin	c-fos	PA448776	2353	0.851
NULL	Arthritis_Res_Ther_2008_Oct_15_10(Suppl_1)_S5.nxml.txt.nlp	19007425	SENT113	28	28	17	17	infliximab	ACR	PA452639	49	0.851
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT187	14	14	28	28	ranibizumab	VEGFR1	PA164746012	2321	0.851
NULL	Biomed_Res_Int_2013_Nov_28_2013_791406.nxml.txt.nlp	24369536	SENT41	30	30	10	10	sunitinib	MDC	PA162372840	6367	0.851
NULL	Evid_Based_Complement_Alternat_Med_2013_May_29_2013_385219.nxml.txt.nlp	23818925	SENT52	0	0	21	21	chloroquine	San	PA448948	80218	0.851
NULL	Mol_Cancer_2010_Aug_20_9_220.nxml.txt.nlp	20727180	SENT234	23	23	15	15	curcumin	p53	PA151958596	7157	0.851
NULL	J_Hum_Reprod_Sci_2009_Jul-Dec_2(2)_87-89.nxml.txt.nlp	19881156	SENT52	11	11	13	13	diethylstilbestrol	DES	PA449307	1674	0.851
NULL	Front_Endocrinol_(Lausanne)_2013_Nov_11_4_171.nxml.txt.nlp	24273532	SENT175	21	21	6	6	forskolin	RXFP1	PA146096022	59350	0.851
NULL	Diabetes_2009_Aug_15_58(8)_1893-1901.nxml.txt.nlp	19528375	SENT210	0	0	20	20	metformin	AMPK	PA450395	5563	0.851
NULL	J_Hypertens_2014_Mar_16_32(3)_555-564.nxml.txt.nlp	24309493	SENT160	0	0	11	11	losartan	AT1	PA450268	9197;185	0.851
NULL	Eur_J_Clin_Pharmacol_2014_Oct_8_70(12)_1433-1441.nxml.txt.nlp	25291992	SENT12	17	17	9	9	risperidone	B12	PA451257	7126;4709	0.851
NULL	Mol_Cancer_2010_May_20_9_115.nxml.txt.nlp	20487546	SENT242	35	35	17	17	fludarabine	ITGB3BP	PA449655	23421	0.851
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT2406	38	38	23	23	amiodarone	CYP3A4	PA448383	1576	0.851
NULL	J_Clin_Biochem_Nutr_2011_Mar_26_48(2)_126-133.nxml.txt.nlp	21373265	SENT135	2	2	19	19	dextran	HO-1	PA449261	3162	0.851
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT71	4	4	13	13	neratinib	HER3	PA165291472	2065	0.851
NULL	Biosci_Rep_2012_Aug_1_32(Pt_4)_361-374.nxml.txt.nlp	22762204	SENT154	17	17	4	4	trastuzumab	EGFR	PA451743	1956	0.851
NULL	J_Hematol_Oncol_2011_Jan_21_4_5.nxml.txt.nlp	21255411	SENT37	22	22	12	12	paclitaxel	EGFR	PA450761	1956	0.851
NULL	Indian_J_Psychiatry_2010_Jan_52(Suppl1)_S317-S340.nxml.txt.nlp	21836703	SENT290	26	26	5	5	chlorpromazine	CPZ	PA448964	8532	0.851
NULL	Clinics_(Sao_Paulo)_2014_Feb_69(2)_145-149.nxml.txt.nlp	24519206	SENT16	16	16	9	9	candesartan	AT-1	PA448765	9197	0.851
NULL	J_Cell_Physiol_2012_Apr_15_227(4)_1553-1560.nxml.txt.nlp	21678418	SENT48	10	10	7	7	hydrocortisone	EGF	PA449905	1950	0.851
NULL	Curr_Gerontol_Geriatr_Res_2010_May_4_2010_420139.nxml.txt.nlp	20454643	SENT89	18	18	21	21	estradiol	AMPK	PA449503	5563	0.851
NULL	Asia_Pac_Allergy_2013_Oct_31_3(4)_231-240.nxml.txt.nlp	24260728	SENT108	9	9	13	13	theophylline	CYP1A2	PA451647	1544	0.851
NULL	Open_Biol_2014_May_4(5)_140065.nxml.txt.nlp	24850914	SENT147	22	22	32	32	bortezomib	ALK3	PA10252	657	0.851
NULL	Case_Rep_Gastrointest_Med_2012_Dec_17_2012_124275.nxml.txt.nlp	23346427	SENT74	14	14	11	11	omalizumab	IL5	PA164752253	3567	0.851
NULL	Acta_Orthop_2011_Apr_5_82(2)_211-216.nxml.txt.nlp	21434784	SENT22	13	13	3	3	methotrexate	VIII	PA450428	1351	0.851
NULL	Cancer_Res_Treat_2012_Mar_31_44(1)_1-10.nxml.txt.nlp	22500155	SENT160	15	15	6	6	vemurafenib	BRAF	PA165946873	673	0.851
NULL	Lab_Invest_2009_Nov_7_89(11)_1275-1290.nxml.txt.nlp	19736547	SENT301	11	11	17	17	curcumin	CD36	PA151958596	948	0.851
NULL	Biomed_Res_Int_2014_Feb_23_2014_168949.nxml.txt.nlp	24707474	SENT145	6	6	8	8	lapatinib	HDAC3	PA152241907	8841	0.851
NULL	Br_J_Cancer_2014_Aug_12_111(4)_646-650.nxml.txt.nlp	24755886	SENT77	5	5	13	13	trabectedin	IL-6	PA165958349	3569	0.851
NULL	Mediators_Inflamm_2011_Jun_7_2011_432080.nxml.txt.nlp	21772662	SENT81	17	17	25	25	rivaroxaban	ANOVA	PA165958360	4858	0.851
NULL	Nat_Chem_Biol_2010_Apr_28_6(4)_291-299.nxml.txt.nlp	20190765	SENT134	0	0	22	22	dasatinib	AKT	PA162372878	207	0.851
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT156	2	2	12	12	atorvastatin	RANK	PA448500	8792	0.851
NULL	J_Radiat_Res_2014_Mar_1_55(2)_359-363.nxml.txt.nlp	24187329	SENT43	36	36	0	0	doxorubicin	CHOP	PA449412	1649	0.851
NULL	Pharmaceuticals_(Basel)_2011_Oct_27_4(11)_1450-1474.nxml.txt.nlp	NULL	SENT25	15	15	41	41	thalidomide	IFN	PA451644	3439	0.851
NULL	Braz_J_Med_Biol_Res_2012_Mar_9_45(4)_357-365.nxml.txt.nlp	22392189	SENT168	9	9	12	12	capsaicin	TRPV1	PA448776	7442	0.851
NULL	Hum_Genomics_2013_Apr_5_7(1)_10.nxml.txt.nlp	23561625	SENT179	27	27	23	23	flavopiridol	CDK7	PA452627	1022	0.851
NULL	Mol_Vis_2012_Jun_1_18_1402-1410.nxml.txt.nlp	22690118	SENT66	16	16	0	0	paraformaldehyde	NHC	PA450790	10473	0.851
NULL	Cell_Cycle_2013_Mar_15_12(6)_889-898.nxml.txt.nlp	23422002	SENT206	24	24	10	10	l-glutamine	CO2	PA10090	4513	0.851
NULL	J_Adv_Pharm_Technol_Res_2012_Oct-Dec_3(4)_202-209.nxml.txt.nlp	23378940	SENT157	18	18	33	33	ondansetron	NK-1	PA450705	27087	0.851
NULL	Curr_Pharm_Des_2008_Dec_14(34)_3637-3655.nxml.txt.nlp	19075740	SENT493	30	30	15	15	chloroquine	MPG	PA448948	4350	0.851
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2010_Aug_3_3_43-51.nxml.txt.nlp	22879786	SENT84	34	34	22	22	pioglitazone	CYP2C8	PA450970	1558	0.851
NULL	Br_J_Cancer_2013_May_28_108(10)_2070-2078.nxml.txt.nlp	23591200	SENT167	5	5	19	19	genistein	NF-kappaB	PA165109660	4790	0.851
NULL	Cancers_(Basel)_2013_Nov_26_5(4)_1601-1618.nxml.txt.nlp	24287743	SENT71	11	11	15	15	thrombin	Met	PA451674	79811	0.851
NULL	Arthritis_Res_Ther_2004_Jun_21_6(4)_169-173.nxml.txt.nlp	15225361	SENT77	12	12	2	2	collagenase	RUNX2	PA449107	860	0.851
NULL	Nucleic_Acids_Res_2011_Oct_6_39(19)_8651-8664.nxml.txt.nlp	21737428	SENT272	3	3	10	10	theophylline	CEB	PA451647	9341	0.851
NULL	Arch_Virol_2014_Dec_24_159(6)_1365-1371.nxml.txt.nlp	24366548	SENT29	30	30	5	5	ribavirin	IFN	PA451241	3439	0.851
NULL	Front_Neurosci_2010_Jun_28_4_41.nxml.txt.nlp	20661453	SENT54	13	13	10	10	ethanol	NRSF	PA448073	5978	0.851
NULL	Ann_Oncol_2009_Aug_17_20(8)_1319-1329.nxml.txt.nlp	19535820	SENT80	30	30	11	11	tamoxifen	CYP2D6	PA451581	1565	0.851
NULL	Acta_Pharmacol_Sin_2010_Nov_18_31(11)_1447-1453.nxml.txt.nlp	20953204	SENT141	31	31	3	3	rimonabant	CB1	PA152407999	1268	0.851
NULL	Clin_Med_Insights_Cardiol_2010_Oct_11_4_89-93.nxml.txt.nlp	20981132	SENT19	0	0	11	11	benazepril	TNF	PA448561	7124	0.851
NULL	Int_J_Biol_Sci_2015_Jan_1_11(1)_48-58.nxml.txt.nlp	25552929	SENT196	8	8	24	24	paclitaxel	TSP-1	PA450761	7057	0.851
NULL	Clin_Endosc_2011_Sep_30_44(1)_22-26.nxml.txt.nlp	22741108	SENT19	21	21	1	1	midazolam	ESD	PA450496	2098	0.851
NULL	Blood_Res_2014_Sep_25_49(3)_170-176.nxml.txt.nlp	25325036	SENT72	30	30	18	18	rituximab	CHOP	PA451261	1649	0.851
NULL	Ann_Surg_Oncol_2010_Apr_20_17(4)_1168-1176.nxml.txt.nlp	19936839	SENT94	14	14	10	10	panitumumab	KRAS	PA162373091	3845	0.851
NULL	Comp_Hepatol_2004_Jan_14_3(Suppl_1)_S31.nxml.txt.nlp	14960183	SENT71	38	38	11	11	ethanol	TNF-alpha	PA448073	7124	0.851
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT222	8	8	16	16	erlotinib	EGFR	PA134687924	1956	0.851
NULL	Int_J_Biol_Sci_2014_Jun_5_10(6)_614-619.nxml.txt.nlp	24948874	SENT119	0	0	16	16	paclitaxel	FOXO1	PA450761	2308	0.851
NULL	J_Physiol_2009_Jul_15_587(Pt_14)_3493-3503.nxml.txt.nlp	19505980	SENT116	10	10	19	19	suramin	P2Y1	PA10292	5028	0.851
NULL	Front_Behav_Neurosci_2012_Nov_22_6_78.nxml.txt.nlp	23189046	SENT134	10	10	0	0	ethanol	OX1R	PA448073	3061	0.851
NULL	Biomed_Res_Int_2013_Sep_5_2013_929531.nxml.txt.nlp	24083250	SENT56	8	8	29	29	hyaluronan	HAS1	PA165958431	3036	0.851
NULL	Mol_Cancer_2010_Mar_4_9_49.nxml.txt.nlp	20202195	SENT129	13	13	19	19	vorinostat	HDAC7	PA164748224	51564	0.851
NULL	Diabetes_2009_Dec_31_58(12)_2851-2862.nxml.txt.nlp	19720788	SENT149	22	22	5	5	forskolin	CHOP	PA146096022	1649	0.851
NULL	Oxid_Med_Cell_Longev_2013_Apr_21_2013_412576.nxml.txt.nlp	23710286	SENT110	14	14	4	4	curcumin	NRF2	PA151958596	2551;4780	0.851
NULL	Am_J_Rhinol_Allergy_2012_Jan-Feb_26(1)_e20-e22.nxml.txt.nlp	22391072	SENT20	5	5	30	30	aspirin	CRS	PA448497	1403	0.851
NULL	Osteoporos_Int_2013_Jan_10_24(1)_227-235.nxml.txt.nlp	22776860	SENT34	12	12	5	5	denosumab	RANK	PA166048634	8792	0.851
NULL	Oncotarget_2012_Nov_17_3(12)_1600-1614.nxml.txt.nlp	23307622	SENT36	16	16	4	4	trastuzumab	ATG12	PA451743	9140	0.851
NULL	Breast_Cancer_Res_2004_Aug_5_6(5)_R601-R607.nxml.txt.nlp	15318941	SENT147	42	42	10	10	docetaxel	CDKN1B	PA449383	1027	0.851
NULL	Mol_Vis_2011_Aug_18_17_2228-2240.nxml.txt.nlp	21897745	SENT43	8	8	13	13	isoflurane	STZ	PA450106	6484	0.851
NULL	EMBO_Mol_Med_2013_Aug_4_5(8)_1247-1262.nxml.txt.nlp	23737459	SENT157	2	2	17	17	nilotinib	parkin	PA165958345	5071	0.851
NULL	Brief_Bioinform_2013_Jul_9_14(4)_491-505.nxml.txt.nlp	22877768	SENT51	9	9	18	18	doxorubicin	CHOP	PA449412	1649	0.851
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Sep_30_67(Pt_10)_o2811.nxml.txt.nlp	22065696	SENT63	22	22	16	16	piperazine	mol	PA450977	90527	0.851
NULL	Inflamm_Res_2009_Dec_21_58(12)_873-880.nxml.txt.nlp	19544046	SENT112	29	29	27	27	ketanserin	5-HT2A	PA131053734	3356	0.851
NULL	Cancers_(Basel)_2009_Dec_15_1(1)_23-28.nxml.txt.nlp	20535236	SENT126	37	37	8	8	cisplatin	SOD1	PA449014	6647	0.851
NULL	Endocrinol_Diabetes_Metab_Case_Rep_2013_Oct_21_2013_130068.nxml.txt.nlp	24616780	SENT25	29	29	8	8	desmopressin	AVP	PA449237	114548;551	0.851
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT223	5	5	10	10	cisplatin	p53	PA449014	7157	0.851
NULL	Am_J_Transplant_2010_Jan_10(1)_69-80.nxml.txt.nlp	19889125	SENT116	9	9	18	18	fludarabine	CD25	PA449655	3669;3559	0.851
NULL	Child_Adolesc_Psychiatry_Ment_Health_2009_Mar_12_3_9.nxml.txt.nlp	19284622	SENT91	9	9	1	1	ziprasidone	BARS	PA451974	1487	0.851
NULL	Aging_(Albany_NY)_2013_Apr_14_5(4)_288-303.nxml.txt.nlp	23596277	SENT192	24	24	35	35	l-glutamine	CO2	PA10090	4513	0.851
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT73	3	3	14	14	trastuzumab	EGFR	PA451743	1956	0.851
NULL	Chin_J_Cancer_2012_Feb_31(2)_73-99.nxml.txt.nlp	22098950	SENT99	28	28	9	9	mitoxantrone	CD34	PA450526	947	0.851
NULL	Comp_Hepatol_2005_Feb_8_4_2.nxml.txt.nlp	15701172	SENT167	9	9	15	15	ketoconazole	CYP3A	PA450146	1574	0.851
NULL	Br_J_Cancer_2009_Mar_10_100(5)_758-763.nxml.txt.nlp	19259094	SENT136	39	39	0	0	decitabine	MLH1	PA164749631	4292	0.851
NULL	Indian_J_Pharm_Sci_2009_Nov-Dec_71(6)_622-629.nxml.txt.nlp	20376214	SENT80	11	11	1	1	captopril	B13	PA448780	4698	0.851
NULL	Cardiovasc_J_Afr_2010_Feb_21(1)_37-41.nxml.txt.nlp	20224844	SENT161	6	6	22	22	thrombin	p22	PA451674	11331;11261;1778	0.851
NULL	Arthritis_Res_Ther_2009_Jan_13_11(1)_R5.nxml.txt.nlp	19134200	SENT191	14	14	22	22	chloroquine	TLR9	PA448948	54106	0.851
NULL	Oncotarget_2012_May_18_3(5)_525-534.nxml.txt.nlp	22619113	SENT28	22	22	5	5	fludarabine	Hsp90	PA449655	3320	0.851
NULL	Environ_Health_Perspect_2007_Dec_8_115(Suppl_1)_129-136.nxml.txt.nlp	18174961	SENT120	13	13	23	23	lindane	Bcl-2	PA164754914	596	0.851
NULL	Core_Evid_2012_Dec_11_7_131-143.nxml.txt.nlp	23271985	SENT225	19	19	14	14	linezolid	HAP	PA450233	5915;10313	0.851
NULL	Int_J_Mol_Sci_2012_Sep_25_13(10)_12153-12168.nxml.txt.nlp	23202889	SENT497	4	4	26	26	fluorouracil	BRAF	PA128406956	673	0.851
NULL	J_Cell_Mol_Med_2013_Sep_24_17(9)_1065-1087.nxml.txt.nlp	24151975	SENT246	32	32	38	38	palifermin	IL7	PA164744014	3574	0.851
NULL	Gut_2008_Jan_1_58(1)_41-48.nxml.txt.nlp	18829978	SENT165	4	4	14	14	mannitol	IL10	PA450320	3586	0.851
NULL	Cancer_Cell_Int_2009_Sep_10_9_25.nxml.txt.nlp	19744341	SENT129	0	0	2	2	glucosamine	survivin	PA164747613	332	0.851
NULL	Mol_Cancer_2013_Mar_5_12_17.nxml.txt.nlp	23497256	SENT194	21	21	31	31	sunitinib	p53	PA162372840	7157	0.851
NULL	Oncotarget_2011_Sep_9_2(9)_658-668.nxml.txt.nlp	21911919	SENT54	0	0	4	4	cytarabine	HO-1	PA449177	3162	0.851
NULL	Exp_Ther_Med_2013_Nov_13_6(5)_1317-1321.nxml.txt.nlp	24223665	SENT24	9	9	18	18	cisplatin	CD133	PA449014	8842	0.851
NULL	Mol_Cancer_2014_Jun_24_13_157.nxml.txt.nlp	24958351	SENT29	0	0	16	16	lapatinib	HER2	PA152241907	2064	0.851
NULL	Evid_Based_Complement_Alternat_Med_2013_Dec_17_2013_589169.nxml.txt.nlp	24454499	SENT12	6	6	17	17	resveratrol	AT1		9197;185	0.851
NULL	Genet_Vaccines_Ther_2005_Jun_30_3_5.nxml.txt.nlp	15987532	SENT250	13	13	7	7	cisplatin	EGFR	PA449014	1956	0.851
NULL	Sensors_(Basel)_2013_Feb_12_13(2)_2419-2429.nxml.txt.nlp	23403643	SENT44	7	7	34	34	ethanol	mol	PA448073	90527	0.851
NULL	Mol_Cells_2014_Dec_31_37(12)_899a-906.nxml.txt.nlp	25431425	SENT181	0	0	5	5	curcumin	p50	PA151958596	958;4790	0.851
NULL	J_Psychopharmacol_2014_Oct_28(10)_973-977.nxml.txt.nlp	25122042	SENT168	28	28	20	20	clozapine	ALX	PA449061	84941	0.851
NULL	Breast_Cancer_Res_Treat_2013_Jan_13_137(2)_471-482.nxml.txt.nlp	23239151	SENT242	19	19	7	7	trastuzumab	HER2	PA451743	2064	0.851
NULL	Diabetes_Metab_J_2014_Jun_17_38(3)_181-186.nxml.txt.nlp	25003070	SENT39	0	0	3	3	metformin	PDK4	PA450395	5166	0.851
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_4_2013_378657.nxml.txt.nlp	23662132	SENT495	25	25	34	34	vildagliptin	GLP-1	PA165958346	100125288	0.851
NULL	Diabetes_2009_Jan_58(1)_243-249.nxml.txt.nlp	18840785	SENT20	30	30	7	7	glucose	GLP-1	PA449773	100125288	0.851
NULL	J_Oncol_2012_Oct_22_2012_391629.nxml.txt.nlp	23133451	SENT262	15	15	41	41	pazopanib	VEGFR	PA165291492	3791	0.851
NULL	J_Cell_Mol_Med_2014_Oct_11_18(10)_2031-2043.nxml.txt.nlp	25109475	SENT345	4	4	15	15	valsartan	TLR-4	PA451848	7099	0.851
NULL	Carcinogenesis_2014_May_13_35(5)_1055-1066.nxml.txt.nlp	24419232	SENT13	20	20	8	8	metformin	CYP1B1	PA450395	1545	0.851
NULL	Cell_Death_Dis_2012_Jul_19_3(7)_e351.nxml.txt.nlp	22825469	SENT84	0	0	10	10	sorafenib	MCL1	PA7000	4170	0.851
NULL	Breast_Cancer_Res_2012_Nov_5_14(6)_324.nxml.txt.nlp	23127286	SENT28	19	19	2	2	docetaxel	DUSP4	PA449383	1846	0.851
NULL	Mol_Cancer_2014_Aug_22_13(1)_195.nxml.txt.nlp	NULL	SENT161	19	19	12	12	cisplatin	TBL1XR1	PA449014	79718	0.851
NULL	Cancer_Cell_Int_2013_Jun_7_13_57.nxml.txt.nlp	23758695	SENT18	0	0	15	15	rituximab	CHOP	PA451261	1649	0.851
NULL	Lab_Invest_2013_Dec_14_93(12)_1265-1275.nxml.txt.nlp	24126890	SENT302	20	20	3	3	celecoxib	ZO-1	PA448871	7082	0.851
NULL	Diabetes_Care_2009_Nov_32(Suppl_2)_S403-S409.nxml.txt.nlp	19875589	SENT226	28	28	11	11	rimonabant	CB1	PA152407999	1268	0.851
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1067-1070.nxml.txt.nlp	21386841	SENT81	22	22	24	24	capecitabine	STZ	PA448771	6484	0.851
NULL	ScientificWorldJournal_2013_Oct_1_2013_265234.nxml.txt.nlp	24235880	SENT44	22	22	14	14	doxazosin	c-FLIP	PA449407	8837	0.851
NULL	Cell_Death_Dis_2013_Jul_11_4(7)_e719.nxml.txt.nlp	23846221	SENT11	27	27	25	25	cisplatin	TRAIL	PA449014	8743	0.851
NULL	J_Cell_Biol_1997_Jul_28_138(2)_435-448.nxml.txt.nlp	9230084	SENT325	35	35	3	3	paraformaldehyde	IFN	PA450790	3439	0.851
NULL	Europace_2014_Oct_12_16(10)_1443-1449.nxml.txt.nlp	25115168	SENT13	10	10	16	16	heparin	ACT	PA449855	12;11332;9457;641455	0.851
NULL	Parasit_Vectors_2009_Sep_25_2(Suppl_2)_S5.nxml.txt.nlp	19778466	SENT184	8	8	4	4	ivermectin	MDR1	PA450133	5243	0.851
NULL	Curr_Neuropharmacol_2009_Sep_7(3)_195-206.nxml.txt.nlp	20190961	SENT417	13	13	10	10	clozapine	c-fos	PA449061	2353	0.851
NULL	Anal_Bioanal_Chem_2009_Oct_30_395(4)_893-905.nxml.txt.nlp	19484227	SENT29	7	7	9	9	trimethoprim	TMP	PA451788	2012	0.851
NULL	J_Exp_Clin_Cancer_Res_2009_Nov_24_28(1)_144.nxml.txt.nlp	19930704	SENT121	38	38	3	3	epirubicin	P-gp	PA449476	5243	0.851
NULL	Diabetes_2011_Mar_21_60(3)_735-745.nxml.txt.nlp	21266325	SENT300	19	19	9	9	metformin	LKB1	PA450395	6794	0.851
NULL	Diabetes_Care_2010_Feb_23_33(2)_246-251.nxml.txt.nlp	19933994	SENT24	4	4	20	20	metformin	B12	PA450395	7126;4709	0.851
NULL	Comp_Funct_Genomics_2012_Feb_6_2012_876893.nxml.txt.nlp	22400011	SENT137	14	14	1	1	zinc	CPSF4	PA451956	10898	0.851
NULL	J_Pain_Res_2014_Jun_23_7_353-357.nxml.txt.nlp	25018649	SENT32	12	12	25	25	lidocaine	LNP	PA450226	80856;51203	0.851
NULL	Oncotarget_2014_Aug_19_5(18)_8737-8749.nxml.txt.nlp	25228590	SENT185	5	5	14	14	crizotinib	MYCN	PA165946122	4613	0.851
NULL	Environ_Health_Perspect_2011_Apr_16_119(4)_534-541.nxml.txt.nlp	21081300	SENT188	2	2	10	10	phenol	COX	PA450913	1351	0.851
NULL	Biomed_Res_Int_2014_Jun_2_2014_946492.nxml.txt.nlp	24991574	SENT72	7	7	20	20	olmesartan	adiponectin	PA164742950	9370	0.851
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT88	15	15	31	31	methotrexate	MSH2	PA450428	4436	0.851
NULL	Clin_Pharmacol_2011_Jun_22_3_13-25.nxml.txt.nlp	22287853	SENT119	11	11	28	28	saxagliptin	ANOVA	PA165958362	4858	0.851
NULL	Ther_Clin_Risk_Manag_2007_Jun_3(3)_363-379.nxml.txt.nlp	18488081	SENT57	2	2	15	15	rabeprazole	CYP2C19	PA451216	1557	0.851
NULL	J_Oncol_2009_Mar_24_2009_491985.nxml.txt.nlp	19325924	SENT186	24	24	14	14	genistein	CXCL12	PA165109660	6387	0.851
NULL	Mol_Biol_Cell_2014_Sep_15_25(18)_2866-2881.nxml.txt.nlp	25057015	SENT259	11	11	3	3	protamine	p60	PA10366	8878	0.851
NULL	Cardiol_Ther_2013_Jun_1_2(1)_111-124.nxml.txt.nlp	25135294	SENT121	6	6	14	14	rifampin	P-gp	PA451250	5243	0.851
NULL	J_Clin_Biochem_Nutr_2010_Jan_29_46(1)_43-51.nxml.txt.nlp	20104264	SENT120	17	17	10	10	napqi	CYP2E1		1571	0.851
NULL	J_Young_Pharm_2010_Oct-Dec_2(4)_428-429.nxml.txt.nlp	21264109	SENT5	16	16	42	42	metformin	B12	PA450395	7126;4709	0.851
NULL	Front_Neurol_2013_Jun_25_4_78.nxml.txt.nlp	23805124	SENT246	13	13	8	8	pilocarpine	NKCC1	PA450962	6558	0.851
NULL	Clinicoecon_Outcomes_Res_2014_Oct_17_6_451-461.nxml.txt.nlp	25378939	SENT126	32	32	23	23	linezolid	HAP	PA450233	5915;10313	0.851
NULL	Biomed_Res_Int_2013_Jul_31_2013_692071.nxml.txt.nlp	23984399	SENT207	25	25	16	16	sorafenib	OCT1	PA7000	5451;6580	0.851
NULL	Calcif_Tissue_Int_2011_Aug_3_89(2)_91-104.nxml.txt.nlp	21637997	SENT251	18	18	12	12	teriparatide	PTH	PA451620	5741	0.851
NULL	Front_Physiol_2013_Nov_14_4_323.nxml.txt.nlp	24294204	SENT55	8	8	16	16	bisoprolol	GRK2	PA448641	156	0.851
NULL	Cancer_Imaging_2013_May_2_13(2)_197-211.nxml.txt.nlp	23649384	SENT13	0	0	9	9	sunitinib	VEGFR	PA162372840	3791	0.851
NULL	An_Bras_Dermatol_2014_Sep-Oct_89(5)_792-795.nxml.txt.nlp	25184919	SENT27	6	6	15	15	tenofovir	CD4	PA10204	920	0.851
NULL	Crit_Care_2005_May_23_9(4)_409-413.nxml.txt.nlp	16137392	SENT100	6	6	18	18	ceftazidime	IL-6	PA448861	3569	0.851
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT64	4	4	13	13	neratinib	HER2	PA165291472	2064	0.851
NULL	Int_J_Nanomedicine_2012_Sep_21_7_5091-5106.nxml.txt.nlp	23049256	SENT135	11	11	1	1	heparin	SOD1	PA449855	6647	0.851
NULL	Int_J_Biol_Sci_2014_Feb_20_10(3)_268-277.nxml.txt.nlp	24644425	SENT247	8	8	10	10	metformin	Met	PA450395	79811	0.851
NULL	Br_J_Cancer_2013_Oct_15_109(8)_2051-2057.nxml.txt.nlp	24064969	SENT85	12	12	27	27	bevacizumab	SOC	PA130232992	91544	0.851
NULL	Cancer_Immunol_Immunother_2012_Jul_23_61(7)_1101-1111.nxml.txt.nlp	22193989	SENT145	16	16	4	4	oxaliplatin	PD-L1	PA131285527	29126	0.851
NULL	J_Hematol_Oncol_2008_Oct_1_1_16.nxml.txt.nlp	18828924	SENT56	23	23	36	36	paclitaxel	HER2	PA450761	2064	0.851
NULL	Ann_Dermatol_2013_Nov_30_25(4)_500-502.nxml.txt.nlp	24371403	SENT5	26	26	4	4	imatinib	LDE	PA10804	7957	0.851
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT281	10	10	22	22	ranibizumab	VEGFR1	PA164746012	2321	0.851
NULL	Pain_Res_Manag_2014_Nov-Dec_19(6)_328-335.nxml.txt.nlp	25479151	SENT129	0	0	19	19	duloxetine	NNT	PA10066	23530	0.851
NULL	Oncoimmunology_2012_Oct_1_1(7)_1048-1060.nxml.txt.nlp	23170253	SENT57	1	1	7	7	trastuzumab	HER-2	PA451743	2064	0.851
NULL	Chin_J_Cancer_2011_Sep_30(9)_645-654.nxml.txt.nlp	21880186	SENT168	9	9	4	4	cisplatin	NACT	PA449014	284111	0.851
NULL	Oncoimmunology_2012_Dec_1_1(9)_1661-1663.nxml.txt.nlp	23264929	SENT26	20	20	9	9	imiquimod	IFNAR1	PA449972	3454	0.851
NULL	Int_J_Mol_Sci_2014_Sep_22_15(9)_16848-16884.nxml.txt.nlp	25247581	SENT252	7	7	0	0	resveratrol	AMPK		5563	0.851
NULL	J_Hematol_Oncol_2011_Feb_7_4_6.nxml.txt.nlp	21299849	SENT126	5	5	14	14	imatinib	RPS6	PA10804	6194	0.85
NULL	Clin_Interv_Aging_2008_Sep_3(3)_445-451.nxml.txt.nlp	18982915	SENT104	15	15	6	6	alendronate	CTX	PA448082	1593	0.85
NULL	Acta_Pharmacol_Sin_2012_Jul_18_33(7)_918-923.nxml.txt.nlp	22705728	SENT175	15	15	6	6	genistein	aromatase	PA165109660	1588	0.85
NULL	Curr_Neuropharmacol_2013_Dec_11(6)_641-651.nxml.txt.nlp	24396339	SENT207	12	12	2	2	capsaicin	TRPV1	PA448776	7442	0.85
NULL	Front_Synaptic_Neurosci_2014_Sep_5_6_18.nxml.txt.nlp	25249974	SENT230	10	10	6	6	atropine	DSI	PA448505	5034	0.85
NULL	Br_J_Cancer_2010_Jan_5_102(1)_80-86.nxml.txt.nlp	19920817	SENT66	10	10	15	15	sunitinib	IFN	PA162372840	3439	0.85
NULL	Breast_Cancer_(Auckl)_2010_Feb_16_4_1-3.nxml.txt.nlp	20697527	SENT3	9	9	21	21	curcumin	BRCA1	PA151958596	672	0.85
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT8	6	6	14	14	methotrexate	DHFR	PA450428	1719	0.85
NULL	J_Mol_Med_(Berl)_2014_May_10_92(7)_709-722.nxml.txt.nlp	24811491	SENT218	19	19	13	13	cetuximab	PIK3CA	PA10040	5290	0.85
NULL	Br_J_Haematol_2008_Mar_3_144(5)_677-685.nxml.txt.nlp	19055662	SENT87	8	8	13	13	bleomycin	CHOP	PA448645	1649	0.85
NULL	Neural_Regen_Res_2013_Jul_15_8(20)_1853-1862.nxml.txt.nlp	25206494	SENT127	7	7	2	2	ethanol	JNK	PA448073	5599	0.85
NULL	Nat_Commun_2011_Feb_8_2_190.nxml.txt.nlp	21304519	SENT508	12	12	21	21	indomethacin	PTGER4	PA449982	5734	0.85
NULL	Acta_Pharmacol_Sin_2012_Jun_6_33(6)_798-808.nxml.txt.nlp	22669117	SENT202	3	3	8	8	heparin	14-3-3	PA449855	10971	0.85
NULL	Evid_Based_Complement_Alternat_Med_2004_Dec_21_1(3)_269-276.nxml.txt.nlp	15841260	SENT51	12	12	3	3	pentobarbital	STZ	PA450859	6484	0.85
NULL	Indian_J_Pharmacol_2013_Sep-Oct_45(5)_458-463.nxml.txt.nlp	24130379	SENT14	8	8	25	25	carvedilol	TLR4	PA448817	7099	0.85
NULL	Mol_Cancer_2012_Jun_26_11_43.nxml.txt.nlp	22731636	SENT316	33	33	19	19	dasatinib	IL-4	PA162372878	3565	0.85
NULL	Oncotarget_2011_Mar_19_2(3)_239-244.nxml.txt.nlp	21608150	SENT61	11	11	8	8	sorafenib	Mcl-1	PA7000	4170	0.85
NULL	Oncotarget_2013_Nov_24_4(12)_2430-2438.nxml.txt.nlp	24280348	SENT140	15	15	9	9	gefitinib	STAT3	PA131301952	6774	0.85
NULL	Cancer_Cell_2007_Dec_11_12(6)_514-527.nxml.txt.nlp	18068629	SENT123	24	24	12	12	paclitaxel	ANOVA	PA450761	4858	0.85
NULL	Osteoporos_Int_2012_Jun_20_23(6)_1737-1745.nxml.txt.nlp	21932114	SENT156	12	12	6	6	alendronate	PTH	PA448082	5741	0.85
NULL	Hum_Reprod_2014_Oct_10_29(10)_2302-2316.nxml.txt.nlp	25139174	SENT353	14	14	17	17	metformin	AKT	PA450395	207	0.85
NULL	ScientificWorldJournal_2012_Mar_12_2012_285274.nxml.txt.nlp	22536131	SENT159	14	14	10	10	diphenhydramine	IFN	PA449349	3439	0.85
NULL	Biomed_Res_Int_2013_Sep_5_2013_929531.nxml.txt.nlp	24083250	SENT59	13	13	24	24	hyaluronan	HYAL1	PA165958431	3373	0.85
NULL	Toxins_(Basel)_2010_Oct_28_2(11)_2584-2592.nxml.txt.nlp	22069565	SENT70	10	10	17	17	warfarin	CYP2C9	PA451906	1559	0.85
NULL	Cancers_(Basel)_2010_Jan_14_2(1)_1-19.nxml.txt.nlp	24281029	SENT848	24	24	15	15	trastuzumab	HER2	PA451743	2064	0.85
NULL	Crit_Care_2006_Dec_7_10(6)_239.nxml.txt.nlp	17169139	SENT72	12	12	16	16	thrombin	PAR1	PA451674	79581;2149	0.85
NULL	Mol_Vis_2007_Jul_9_13_1083-1093.nxml.txt.nlp	17653053	SENT153	2	2	21	21	minocycline	RANTES	PA450519	6352	0.85
NULL	Br_J_Cancer_2010_Jul_13_103(2)_186-195.nxml.txt.nlp	20588277	SENT234	12	12	15	15	nutlin-3	TP53		7157	0.85
NULL	Diabetes_Metab_Syndr_Obes_2014_Aug_1_7_381-389.nxml.txt.nlp	25120374	SENT146	7	7	16	16	salsalate	adiponectin	PA164745462	9370	0.85
NULL	Oncol_Lett_2014_Nov_14_8(5)_2086-2092.nxml.txt.nlp	25295095	SENT115	8	8	28	28	gemcitabine	LKB1	PA449748	6794	0.85
NULL	Br_J_Cancer_2011_Apr_12_104(8)_1256-1261.nxml.txt.nlp	21448165	SENT84	36	36	29	29	sorafenib	IL-2	PA7000	3558	0.85
NULL	Br_J_Cancer_2010_Jun_29_103(1)_18-28.nxml.txt.nlp	20551952	SENT221	22	22	17	17	vatalanib	VEGFR	PA7001	3791	0.85
NULL	J_Hematol_Oncol_2011_Nov_4_4_44.nxml.txt.nlp	22053759	SENT103	16	16	7	7	thrombin	PAR3	PA451674	56288;2151	0.85
NULL	Front_Synaptic_Neurosci_2014_May_30_6_12.nxml.txt.nlp	24910611	SENT162	18	18	7	7	l-cysteine	asc-1	PA449173	56301	0.85
NULL	JRSM_Cardiovasc_Dis_2012_Apr_5_1(1)_cvd_2012_012001.nxml.txt.nlp	24175062	SENT240	22	22	20	20	warfarin	CYP2C9	PA451906	1559	0.85
NULL	Nucleic_Acids_Res_2012_Jul_19_40(13)_5910-5925.nxml.txt.nlp	22434882	SENT346	3	3	10	10	etoposide	p65	PA449552	5970	0.85
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1137-1144.nxml.txt.nlp	20234366	SENT161	36	36	28	28	cetuximab	BRAF	PA10040	673	0.85
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT94	21	21	2	2	trastuzumab	PTEN	PA451743	5728	0.85
NULL	Cent_European_J_Urol_2011_Dec_9_64(4)_256-257.nxml.txt.nlp	24578906	SENT15	15	15	25	25	doxazosin	CD133	PA449407	8842	0.85
NULL	Environ_Health_Perspect_2007_Oct_19_115(10)_1454-1459.nxml.txt.nlp	17938735	SENT119	2	2	10	10	procainamide	p16	PA451108	1029	0.85
NULL	Oncoimmunology_2014_Apr_25_3_e28518.nxml.txt.nlp	25071979	SENT152	10	10	16	16	oxaliplatin	HMGB1	PA131285527	3146	0.85
NULL	Breast_Cancer_Res_2011_Aug_16_13(4)_218.nxml.txt.nlp	21884642	SENT62	13	13	17	17	olaparib	BRCA2		675	0.85
NULL	J_Geriatr_Cardiol_2014_Mar_11(1)_26-31.nxml.txt.nlp	24748878	SENT88	0	0	8	8	sirolimus	DES	PA451365	1674	0.85
NULL	Nat_Commun_2014_5_3206.nxml.txt.nlp	24487777	SENT220	11	11	0	0	paraformaldehyde	HL1	PA450790	1767	0.85
NULL	Mol_Cancer_2008_Sep_12_7_70.nxml.txt.nlp	18789133	SENT97	12	12	35	35	belinostat	KPNB1		3837	0.85
NULL	Blood_Cancer_J_2014_Jan_17_4(1)_e175.nxml.txt.nlp	24442204	SENT86	12	12	7	7	bortezomib	c-MAF	PA10252	4094	0.85
NULL	Breast_Cancer_Res_2014_Sep_9_16(5)_433.nxml.txt.nlp	25212966	SENT8	24	24	30	30	aprotinin	ILEI	PA448472	10447	0.85
NULL	Mol_Vis_2013_Apr_17_19_894-903.nxml.txt.nlp	23687426	SENT21	0	0	9	9	adalimumab	CRALBP	PA10004	6017	0.85
NULL	Indian_J_Endocrinol_Metab_2013_Jul-Aug_17(4)_636-646.nxml.txt.nlp	23961479	SENT159	14	14	24	24	fluvastatin	CYP2C9	PA449688	1559	0.85
NULL	Diabetes_Metab_Syndr_Obes_2014_Jun_24_7_229-239.nxml.txt.nlp	25018644	SENT219	3	3	17	17	exenatide	GLP1	PA164749238	100125288;2641	0.85
NULL	Int_J_Endocrinol_Metab_2013_Dec_21_Winter_11(1)_57-61.nxml.txt.nlp	23853622	SENT39	13	13	22	22	quetiapine	FGA	PA451201	2243	0.85
NULL	Anal_Chem_Insights_2008_Aug_27_3_103-109.nxml.txt.nlp	19609394	SENT120	3	3	6	6	griseofulvin	H17	PA449814	55572	0.85
NULL	Nat_Commun_2013_Aug_15_4_2130.nxml.txt.nlp	23945651	SENT673	5	5	13	13	etoposide	ATG5	PA449552	9474	0.85
NULL	Biosci_Rep_2012_Dec_6_33(1)_e00006.nxml.txt.nlp	23050906	SENT202	39	39	12	12	lovastatin	DHCR24	PA450272	1718	0.85
NULL	Front_Chem_2014_Dec_23_2_113.nxml.txt.nlp	25566531	SENT158	3	3	18	18	curcumin	AREG	PA151958596	374	0.85
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT53	10	10	13	13	tenofovir	ABCG2	PA10204	9429	0.85
NULL	J_Biol_Chem_2012_Apr_27_287(18)_14644-14658.nxml.txt.nlp	22375002	SENT420	5	5	10	10	forskolin	CC2D1A	PA146096022	54862	0.85
NULL	J_Breast_Cancer_2013_Jun_28_16(2)_220-228.nxml.txt.nlp	23843857	SENT197	12	12	21	21	tamoxifen	aromatase	PA451581	1588	0.85
NULL	Oxid_Med_Cell_Longev_2012_Jul_4_2012_761710.nxml.txt.nlp	22829962	SENT164	39	39	32	32	indomethacin	COX	PA449982	1351	0.85
NULL	Pharmaceuticals_(Basel)_2014_Sep_17_7(9)_943-953.nxml.txt.nlp	25232798	SENT21	19	19	11	11	trastuzumab	HER2	PA451743	2064	0.85
NULL	Cell_Death_Dis_2010_May_13_1(5)_e41.nxml.txt.nlp	21364648	SENT97	16	16	32	32	etoposide	p65	PA449552	5970	0.85
NULL	Behav_Neurol_2014_Nov_16_2014_360978.nxml.txt.nlp	25477708	SENT99	25	25	34	34	nicotine	P56	PA450626	8999	0.85
NULL	J_Biol_Chem_2013_Feb_15_288(7)_5127-5135.nxml.txt.nlp	23264619	SENT65	16	16	27	27	indomethacin	ADP	PA449982	23038	0.85
NULL	Biomed_Res_Int_2013_Jul_18_2013_635143.nxml.txt.nlp	23971042	SENT97	21	21	11	11	indomethacin	ANOVA	PA449982	4858	0.85
NULL	Arthritis_Res_Ther_2014_Jul_18_16(4)_R153.nxml.txt.nlp	25037855	SENT9	31	31	21	21	adalimumab	CD14	PA10004	929	0.85
NULL	J_Oncol_2012_Aug_24_2012_281261.nxml.txt.nlp	21876693	SENT270	6	6	18	18	thalidomide	EGFR	PA451644	1956	0.85
NULL	Carcinogenesis_2008_Sep_9_29(9)_1751-1757.nxml.txt.nlp	18544568	SENT25	9	9	2	2	estradiol	CYP1B1	PA449503	1545	0.85
NULL	Case_Rep_Oncol_2014_Apr_25_7(1)_277-284.nxml.txt.nlp	24926257	SENT11	34	34	40	40	lenalidomide	B12	PA162363968	7126;4709	0.85
NULL	Biochemistry_2012_Oct_9_51(40)_8027-8038.nxml.txt.nlp	22989207	SENT292	20	20	30	30	l-serine	PGDH	PA451330	26227	0.85
NULL	Int_J_Biol_Sci_2013_Dec_17_10(1)_64-72.nxml.txt.nlp	24391452	SENT213	24	24	30	30	ketanserin	5-HT2B	PA131053734	3357	0.85
NULL	Evid_Based_Complement_Alternat_Med_2012_May_7_2012_242810.nxml.txt.nlp	22645625	SENT218	6	6	14	14	paclitaxel	CYP3A4	PA450761	1576	0.85
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_2_2012_692625.nxml.txt.nlp	23082083	SENT83	30	30	1	1	ethanol	TEM	PA448073	64102	0.85
NULL	Cardiovasc_Diabetol_2013_May_2_12_71.nxml.txt.nlp	23635096	SENT30	4	4	11	11	candesartan	ADN	PA448765	1675	0.85
NULL	Indian_J_Endocrinol_Metab_2012_Dec_16(Suppl_2)_S474-S476.nxml.txt.nlp	23565471	SENT76	9	9	0	0	metformin	PPG	PA450395	5552	0.85
NULL	Atherosclerosis_2011_Jun_216(2)_342-347.nxml.txt.nlp	21420681	SENT206	14	14	1	1	urokinase	LRP1B	PA451836	53353	0.85
NULL	Mol_Cancer_2010_Aug_16_9_217.nxml.txt.nlp	20712901	SENT157	9	9	21	21	curcumin	STAT3	PA151958596	6774	0.85
NULL	J_Ginseng_Res_2012_Jan_36(1)_68-77.nxml.txt.nlp	23717106	SENT237	9	9	18	18	estradiol	Bcl-2	PA449503	596	0.85
NULL	J_Cell_Biol_2001_Aug_6_154(3)_499-510.nxml.txt.nlp	11489914	SENT369	23	23	11	11	paraformaldehyde	CSK	PA450790	1445	0.85
NULL	J_Korean_Med_Sci_2010_Apr_19_25(4)_557-563.nxml.txt.nlp	20357998	SENT123	29	29	16	16	cisplatin	IFN	PA449014	3439	0.85
NULL	Mol_Biol_Int_2014_Feb_19_2014_375325.nxml.txt.nlp	24693428	SENT103	17	17	26	26	paclitaxel	ABCG2	PA450761	9429	0.85
NULL	J_Breast_Cancer_2012_Sep_28_15(3)_273-282.nxml.txt.nlp	23091539	SENT63	27	27	4	4	doxycycline	TRAIL	PA449415	8743	0.85
NULL	Mol_Cancer_2010_May_20_9_115.nxml.txt.nlp	20487546	SENT121	9	9	19	19	fludarabine	TP53	PA449655	7157	0.85
NULL	Case_Rep_Oncol_2014_Mar_26_7(1)_204-209.nxml.txt.nlp	24803896	SENT67	5	5	10	10	trabectedin	MRCL	PA165958349	348174	0.85
NULL	Indian_J_Psychiatry_2010_Jan_52(Suppl1)_S317-S340.nxml.txt.nlp	21836703	SENT119	24	24	33	33	thioproperazine	CPZ	PA164754875	8532	0.85
NULL	Lab_Invest_2011_Apr_14_91(4)_598-608.nxml.txt.nlp	21321535	SENT129	6	6	12	12	sorafenib	FOXP3	PA7000	50943	0.85
NULL	FEBS_Open_Bio_2014_Aug_30_4_763-776.nxml.txt.nlp	25349781	SENT219	4	4	34	34	curcumin	TFEB	PA151958596	7942	0.85
NULL	Mol_Cancer_2012_Jun_18_11_41.nxml.txt.nlp	22709873	SENT293	13	13	17	17	lapatinib	NR3C1	PA152241907	2908	0.85
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT170	4	4	12	12	chloroquine	BMP9	PA448948	2658	0.85
NULL	Bone_Joint_Res_2012_May_1_1(5)_78-85.nxml.txt.nlp	23610675	SENT209	31	31	21	21	gemcitabine	VEGFR	PA449748	3791	0.85
NULL	Mol_Neurodegener_2011_Jun_22_6_43.nxml.txt.nlp	21696630	SENT147	9	9	3	3	desmopressin	PKD1	PA449237	5310	0.85
NULL	Br_J_Cancer_2013_Jun_25_108(12)_2485-2494.nxml.txt.nlp	23695022	SENT161	12	12	17	17	vincristine	P-gp	PA451879	5243	0.85
NULL	Adv_Hematol_2012_Nov_20_2012_861060.nxml.txt.nlp	23251161	SENT70	0	0	10	10	lenalidomide	CD4	PA162363968	920	0.85
NULL	Oncoimmunology_2012_Nov_1_1(8)_1323-1343.nxml.txt.nlp	23243596	SENT284	31	31	5	5	imatinib	NKp30	PA10804	259197	0.85
NULL	F1000Res_2014_Aug_19_3_198.nxml.txt.nlp	25400908	SENT259	6	6	2	2	anastrozole	IMPACT	PA448432	55364	0.85
NULL	Allergy_Asthma_Immunol_Res_2013_Jan_29_5(1)_55-58.nxml.txt.nlp	23277879	SENT26	29	29	9	9	aspirin	IPA	PA448497	3160	0.85
NULL	Drug_Healthc_Patient_Saf_2014_Jun_24_6_77-88.nxml.txt.nlp	25018652	SENT82	15	15	4	4	vemurafenib	BRAF	PA165946873	673	0.85
NULL	Indian_J_Pharmacol_2014_Nov-Dec_46(6)_627-632.nxml.txt.nlp	25538335	SENT39	21	21	14	14	metformin	Q10	PA450395	27161	0.85
NULL	Br_J_Clin_Pharmacol_2013_Apr_10_75(4)_979-989.nxml.txt.nlp	22882281	SENT71	3	3	8	8	exenatide	San	PA164749238	80218	0.85
NULL	Oncogene_2010_Nov_18_29(46)_6160-6171.nxml.txt.nlp	20729916	SENT127	47	47	3	3	cisplatin	YAP	PA449014	55249	0.85
NULL	Cardiovasc_Res_2012_Dec_1_96(3)_552-560.nxml.txt.nlp	22918977	SENT227	10	10	3	3	losartan	JAM-A	PA450268	50848	0.85
NULL	Cancer_2014_Jun_15_120(12)_1871-1880.nxml.txt.nlp	24634003	SENT113	28	28	31	31	sunitinib	IFN	PA162372840	3439	0.85
NULL	J_Cardiothorac_Surg_2014_Nov_23_9(1)_175.nxml.txt.nlp	NULL	SENT15	16	16	10	10	oxycodone	EDA	PA450741	1896	0.85
NULL	Neural_Regen_Res_2014_May_15_9(10)_1055-1062.nxml.txt.nlp	25206759	SENT218	25	25	30	30	furosemide	NKCC1	PA449719	6558	0.85
NULL	Clin_Med_Cardiol_2009_Sep_3_3_77-91.nxml.txt.nlp	20508768	SENT119	15	15	6	6	clopidogrel	ADP	PA449053	23038	0.85
NULL	Int_J_Breast_Cancer_2012_May_9_2012_415170.nxml.txt.nlp	22649737	SENT65	21	21	3	3	trastuzumab	PTEN	PA451743	5728	0.85
NULL	Arthritis_Res_Ther_2011_Mar_30_13(2)_105.nxml.txt.nlp	21542897	SENT24	19	19	25	25	mianserin	TLR8	PA134687937	51311	0.85
NULL	J_Occup_Med_Toxicol_2008_Feb_27_3(Suppl_1)_S6.nxml.txt.nlp	18315837	SENT92	11	11	13	13	pranlukast	IL-5	PA134698661	3567	0.85
NULL	Glia_2013_Aug_6_61(8)_1331-1346.nxml.txt.nlp	23832647	SENT304	25	25	27	27	clodronate	DKK2	PA10239	27123	0.85
NULL	J_Biol_Chem_2012_Dec_14_287(51)_43094-43107.nxml.txt.nlp	23118219	SENT255	11	11	45	45	hyaluronidase	CD44	PA164745713	960	0.85
NULL	Cell_Biochem_Biophys_2014_Jun_28_70(2)_1459-1467.nxml.txt.nlp	24972691	SENT56	23	23	8	8	trypsin	CO2	PA451806	4513	0.85
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jan_27_66(Pt_2)_o445.nxml.txt.nlp	21579860	SENT57	16	16	6	6	benzaldehyde	mol	PA448571	90527	0.85
NULL	Allergy_Asthma_Immunol_Res_2011_Apr_14_3(2)_123-127.nxml.txt.nlp	21461252	SENT91	8	8	29	29	aspirin	TLR3	PA448497	7098	0.85
NULL	Eur_Arch_Psychiatry_Clin_Neurosci_2011_Mar_1_261(2)_133-138.nxml.txt.nlp	20593192	SENT5	24	24	0	0	ethanol	S100B	PA448073	6285	0.85
NULL	Arthritis_Res_Ther_2013_Apr_17_15(2)_R51.nxml.txt.nlp	23594962	SENT281	5	5	33	33	muraglitazar	IL-6	PA162356187	3569	0.85
NULL	Trials_2012_Aug_31_13_156.nxml.txt.nlp	22937736	SENT180	28	28	38	38	azithromycin	IP-10	PA448519	3627	0.85
NULL	Mol_Cancer_2012_Apr_5_11_20.nxml.txt.nlp	22480225	SENT105	5	5	14	14	temozolomide	HSP27	PA451609	3315	0.85
NULL	Cancer_Cell_Int_2013_May_15_13_42.nxml.txt.nlp	23672670	SENT199	24	24	15	15	paclitaxel	RAIDD	PA450761	8738	0.85
NULL	Braz_J_Microbiol_2014_May_19_45(1)_294-302.nxml.txt.nlp	24948948	SENT67	3	3	15	15	lipase	mol	PA450239	90527	0.85
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT122	7	7	17	17	dasatinib	LYN	PA162372878	4067	0.85
NULL	Cell_Death_Dis_2014_Mar_13_5(3)_e1111.nxml.txt.nlp	24625970	SENT22	27	27	10	10	cisplatin	p53	PA449014	7157	0.85
NULL	Clin_Proteomics_2014_Jun_5_11(1)_25.nxml.txt.nlp	24994967	SENT92	7	7	0	0	heparin	HRG	PA449855	3084;3273	0.85
NULL	Front_Behav_Neurosci_2010_Apr_5_4_14.nxml.txt.nlp	20407577	SENT558	7	7	1	1	cocaine	BDNF	PA449072	627	0.85
NULL	Pharmaceutics_2011_Nov_18_3(4)_865-913.nxml.txt.nlp	24309312	SENT163	3	3	44	44	raltegravir	CYP3A4		1576	0.85
NULL	Diabetes_2013_Jun_17_62(6)_1843-1854.nxml.txt.nlp	23349486	SENT160	25	25	2	2	pioglitazone	CCR2	PA450970	729230	0.85
NULL	EMBO_Mol_Med_2013_Dec_8_5(12)_1821-1834.nxml.txt.nlp	24293316	SENT169	18	18	29	29	doxorubicin	p53	PA449412	7157	0.85
NULL	Oncologist_2011_Jan_6_16(1)_5-24.nxml.txt.nlp	21212434	SENT189	6	6	12	12	vinblastine	IFN	PA451877	3439	0.85
NULL	Indian_J_Nephrol_2011_Oct-Dec_21(4)_286-288.nxml.txt.nlp	22022093	SENT67	29	29	26	26	basiliximab	IL-2	PA164747126	3558	0.85
NULL	Clin_Sarcoma_Res_2013_Mar_7_3_3.nxml.txt.nlp	23497641	SENT33	18	18	12	12	imatinib	EGFR	PA10804	1956	0.85
NULL	Breast_Cancer_Res_2007_Aug_8_9(4)_R50.nxml.txt.nlp	17686159	SENT178	0	0	5	5	gefitinib	HRG	PA131301952	3084;3273	0.85
NULL	AIDS_Res_Treat_2013_Sep_3_2013_585143.nxml.txt.nlp	24078868	SENT309	2	2	34	34	methamphetamine	San	PA450403	80218	0.85
NULL	Br_J_Cancer_2010_Nov_2_103(11)_1671-1679.nxml.txt.nlp	21045835	SENT91	12	12	14	14	gemcitabine	CXCL12	PA449748	6387	0.85
NULL	Physiol_Rep_2014_Sep_11_2(9)_e12133.nxml.txt.nlp	25214520	SENT481	9	9	3	3	bleomycin	activin	PA448645	83729	0.85
NULL	Oncotarget_2013_Nov_24_4(12)_2430-2438.nxml.txt.nlp	24280348	SENT140	15	15	38	38	gefitinib	STAT3	PA131301952	6774	0.85
NULL	Biomed_Res_Int_2013_Oct_27_2013_725410.nxml.txt.nlp	24282820	SENT87	11	11	17	17	sunitinib	VEGFR	PA162372840	3791	0.85
NULL	Arthritis_Res_Ther_2009_Aug_17_11(4)_R123.nxml.txt.nlp	19686595	SENT252	7	7	26	26	rituximab	CD38	PA451261	952	0.85
NULL	Bone_Marrow_Res_2011_Jul_7_2011_362938.nxml.txt.nlp	22046561	SENT178	13	13	21	21	paraformaldehyde	CD44	PA450790	960	0.85
NULL	Acta_Pharmacol_Sin_2010_Jul_28_31(7)_867-873.nxml.txt.nlp	20581857	SENT194	15	15	6	6	docetaxel	PC3	PA449383	57332;7832;5122	0.85
NULL	Acta_Pharmacol_Sin_2013_Feb_31_34(2)_231-238.nxml.txt.nlp	23274414	SENT176	9	9	15	15	amiloride	Bcl-2	PA448368	596	0.85
NULL	Biomed_Res_Int_2013_Apr_18_2013_351031.nxml.txt.nlp	23691498	SENT151	14	14	2	2	paclitaxel	Xin	PA450761	165904	0.85
NULL	Br_J_Cancer_2011_Jul_12_105(2)_221-230.nxml.txt.nlp	21750559	SENT44	7	7	14	14	cyclophosphamide	Mcl-1	PA449165	4170	0.85
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1699-1708.nxml.txt.nlp	19861960	SENT159	21	21	29	29	dasatinib	HER2	PA162372878	2064	0.85
NULL	An_Bras_Dermatol_2013_Nov-Dec_88(6_Suppl_1)_120-123.nxml.txt.nlp	24346897	SENT25	9	9	16	16	imiquimod	CO2	PA449972	4513	0.85
NULL	Int_J_Biol_Sci_2011_May_19_7(5)_645-650.nxml.txt.nlp	21647332	SENT166	28	28	46	46	metformin	CO2	PA450395	4513	0.85
NULL	Oncotarget_2012_May_4_3(4)_395-398.nxml.txt.nlp	22565037	SENT20	37	37	17	17	metformin	CD24	PA450395	100133941	0.85
NULL	Pharmaceuticals_(Basel)_2013_Nov_4_6(11)_1347-1360.nxml.txt.nlp	24287461	SENT77	12	12	7	7	benzbromarone	URAT1	PA134852920	116085	0.85
NULL	Acta_Pharmacol_Sin_2012_Jan_12_33(1)_27-33.nxml.txt.nlp	22158109	SENT186	13	13	29	29	propofol	AMPK	PA451141	5563	0.85
NULL	Arthritis_Res_Ther_2012_Jul_12_14(4)_R163.nxml.txt.nlp	22784880	SENT30	6	6	9	9	leflunomide	CYP1A2	PA450192	1544	0.85
NULL	Oncotarget_2014_Oct_21_5(22)_11252-11268.nxml.txt.nlp	25361004	SENT178	2	2	20	20	metformin	CLIC1	PA450395	1192	0.85
NULL	J_Oncol_2012_Mar_11_2012_382159.nxml.txt.nlp	22481926	SENT90	19	19	16	16	pertuzumab	HER2		2064	0.85
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT29	12	12	26	26	lapatinib	HER-2	PA152241907	2064	0.85
NULL	Mol_Cancer_2010_Apr_29_9_95.nxml.txt.nlp	20429933	SENT25	10	10	13	13	camptothecin	p53	PA153590860	7157	0.85
NULL	Mol_Cancer_2010_Aug_23_9_222.nxml.txt.nlp	20731837	SENT104	5	5	8	8	gefitinib	ATM	PA131301952	472	0.85
NULL	Diabetes_2009_Mar_58(3)_579-589.nxml.txt.nlp	19074989	SENT99	22	22	3	3	troglitazone	ANGPTL4	PA451799	51129	0.85
NULL	Exp_Ther_Med_2012_Oct_3_4(4)_594-604.nxml.txt.nlp	23170111	SENT99	27	27	8	8	propranolol	p44	PA451145	10561;2966	0.85
NULL	Biochim_Biophys_Acta_2014_Apr_1841(4)_588-594.nxml.txt.nlp	24440819	SENT33	23	23	0	0	lipase	ATGL	PA450239	57104	0.85
NULL	Cancer_Cell_Int_2013_Jan_15_13_3.nxml.txt.nlp	23320839	SENT139	14	14	9	9	gemcitabine	MRP1	PA449748	4437	0.85
NULL	Mucosal_Immunol_2014_Mar_24_7(2)_335-347.nxml.txt.nlp	23881354	SENT320	3	3	5	5	galantamine	GAL	PA449726	51083	0.85
NULL	Front_Cell_Neurosci_2013_Dec_5_7_243.nxml.txt.nlp	24367290	SENT589	3	3	8	8	resveratrol	SIRT1		23411	0.85
NULL	Psychiatry_Investig_2010_Sep_9_7(3)_189-195.nxml.txt.nlp	20927307	SENT112	21	21	2	2	aripiprazole	ANOVA	PA10026	4858	0.85
NULL	Epigenetics_Chromatin_2014_Jun_26_7_12.nxml.txt.nlp	25028596	SENT120	19	19	9	9	doxycycline	ATF7IP	PA449415	55729	0.85
NULL	Biomed_Res_Int_2014_Apr_29_2014_186864.nxml.txt.nlp	24877064	SENT134	3	3	14	14	curcumin	p300	PA151958596	2033	0.85
NULL	Br_J_Cancer_2011_Jan_4_104(1)_91-100.nxml.txt.nlp	21139584	SENT101	5	5	18	18	geldanamycin	Hsp90	PA152031327	3320	0.85
NULL	Mol_Biol_Evol_2013_Sep_12_30(9)_2099-2112.nxml.txt.nlp	23765379	SENT262	19	19	3	3	trypsin	ASM	PA451806	6609;283120	0.85
NULL	Nucleic_Acids_Res_2010_Oct_28_38(19)_6418-6432.nxml.txt.nlp	20511593	SENT181	2	2	13	13	collagenase	c-Jun	PA449107	3725	0.85
NULL	Arthritis_Res_Ther_2011_Feb_28_13(1)_205.nxml.txt.nlp	21371351	SENT155	17	17	6	6	rituximab	CD27	PA451261	939	0.85
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT780	31	31	0	0	enalapril	OATP1B3	PA449456	28234	0.85
NULL	Curr_Cardiol_Rev_2013_Feb_9(1)_82-96.nxml.txt.nlp	22920474	SENT294	20	20	28	28	propofol	HCN	PA451141	378938	0.85
NULL	Acta_Neuropathol_2010_Aug_8_120(2)_223-236.nxml.txt.nlp	20532539	SENT39	32	32	24	24	paraformaldehyde	CO2	PA450790	4513	0.85
NULL	Oncotarget_2014_Jun_3_5(13)_4920-4928.nxml.txt.nlp	24952482	SENT98	5	5	29	29	crizotinib	HGF	PA165946122	3569;6654;3082	0.85
NULL	Biomed_Res_Int_2014_Apr_14_2014_507234.nxml.txt.nlp	24826378	SENT84	18	18	31	31	forskolin	CYP26	PA146096022	1592	0.85
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT378	34	34	26	26	resveratrol	SMRT		9612	0.85
NULL	Oxid_Med_Cell_Longev_2009_Sep-Oct_2(4)_214-221.nxml.txt.nlp	20716907	SENT243	3	3	33	33	pilocarpine	P400	PA450962	57634	0.85
NULL	Indian_J_Dermatol_2014_Sep-Oct_59(5)_425-441.nxml.txt.nlp	25284845	SENT181	8	8	0	0	adalimumab	TNF-alpha	PA10004	7124	0.85
NULL	Biologics_2009_Sep_15_3_429-441.nxml.txt.nlp	19774210	SENT24	14	14	45	45	irinotecan	IFL	PA450085	3439	0.85
NULL	J_Nutr_Metab_2011_Jul_28_2011_235389.nxml.txt.nlp	21811679	SENT6	35	35	20	20	rosiglitazone	CORT	PA451283	1325	0.85
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT102	30	30	24	24	metformin	HIP	PA450395	6767;6159;64399;5068	0.85
NULL	Cell_Death_Dis_2014_Feb_13_5(2)_e1057.nxml.txt.nlp	24525733	SENT212	2	2	26	26	thyroglobulin	SMAC	PA164754910	56616	0.85
NULL	Diabetes_Care_2010_May_15_33(5)_1134-1139.nxml.txt.nlp	20185740	SENT12	4	4	43	43	ezetimibe	adiponectin	PA10816	9370	0.85
NULL	J_Gastroenterol_2013_Mar_9_48(3)_382-390.nxml.txt.nlp	22875473	SENT141	19	19	8	8	ribavirin	IL28B	PA451241	282617	0.85
NULL	Diabetes_Care_2011_Jun_20_34(6)_1265-1269.nxml.txt.nlp	21515846	SENT148	15	15	7	7	rosiglitazone	DREAM	PA451283	30818	0.85
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jun_26_66(Pt_7)_o1807.nxml.txt.nlp	21588016	SENT60	26	26	23	23	ethanol	mol	PA448073	90527	0.85
NULL	Hum_Genomics_2009_Jan_1_3(2)_121-127.nxml.txt.nlp	19164089	SENT7	40	40	31	31	ethanol	ALDH2	PA448073	217	0.85
NULL	Eur_J_Med_Res_2009_Nov_24_14(Suppl_3)_17-21.nxml.txt.nlp	19959412	SENT56	19	19	10	10	raltegravir	CYP3A		1574	0.85
NULL	Acta_Pharmacol_Sin_2009_Sep_24_30(9)_1262-1275.nxml.txt.nlp	19701231	SENT226	39	39	30	30	lovastatin	TMCO3	PA450272	55002	0.85
NULL	Libyan_J_Med_2009_Jun_1_4(2)_83-85.nxml.txt.nlp	21483516	SENT68	14	14	25	25	imatinib	KIT	PA10804	3815	0.85
NULL	J_Cell_Mol_Med_2014_May_7_18(5)_766-779.nxml.txt.nlp	24606538	SENT285	3	3	10	10	methylprednisolone	IL-8	PA450466	3576	0.85
NULL	Arthritis_Res_Ther_2006_Jul_21_8(4)_R130.nxml.txt.nlp	16859540	SENT98	2	2	24	24	atorvastatin	CD59	PA448500	966	0.85
NULL	Front_Oncol_2014_Jun_18_4_153.nxml.txt.nlp	24995158	SENT546	39	39	18	18	etoposide	JNK	PA449552	5599	0.85
NULL	Oncotarget_2014_Jun_19_5(15)_6540-6551.nxml.txt.nlp	25153728	SENT104	3	3	13	13	paclitaxel	CDK1	PA450761	983	0.85
NULL	J_Lipid_Res_2014_Oct_55(10)_2103-2112.nxml.txt.nlp	25139399	SENT679	8	8	0	0	atorvastatin	CETP	PA448500	1071	0.85
NULL	Int_J_Biol_Sci_2014_Jun_10_10(7)_654-663.nxml.txt.nlp	25013375	SENT217	7	7	27	27	nelfinavir	AKT	PA450606	207	0.85
NULL	Cell_Death_Dis_2014_Jan_30_5(1)_e1038.nxml.txt.nlp	24481452	SENT38	6	6	16	16	raloxifene	NQO1	PA451221	1728	0.85
NULL	Pharmaceutics_2010_Apr_27_2(2)_136-158.nxml.txt.nlp	NULL	SENT172	2	2	16	16	diclofenac	HSM	PA449293	94030	0.85
NULL	Front_Endocrinol_(Lausanne)_2014_Aug_27_5_140.nxml.txt.nlp	25221543	SENT108	17	17	3	3	liraglutide	GLP-1	PA165958364	100125288	0.85
NULL	Clin_Dev_Immunol_2008_Feb_25_2008_794050.nxml.txt.nlp	18354729	SENT10	22	22	9	9	cyclosporine	DPPIV	PA449167	2191;1803	0.85
NULL	Acta_Pharmacol_Sin_2012_Jan_3_33(1)_49-56.nxml.txt.nlp	22212430	SENT90	12	12	5	5	thrombin	A10	PA451674	28870	0.85
NULL	Cancers_(Basel)_2014_Jan_27_6(1)_226-239.nxml.txt.nlp	24473088	SENT353	17	17	7	7	temozolomide	MSH6	PA451609	2956	0.85
NULL	Br_J_Cancer_2010_Dec_7_103(12)_1822-1830.nxml.txt.nlp	21063405	SENT271	16	16	8	8	cisplatin	CD31	PA449014	5175	0.85
NULL	Asian-Australas_J_Anim_Sci_2014_Dec_27(12)_1783-1793.nxml.txt.nlp	25358373	SENT204	3	3	8	8	capsaicin	CASP3	PA448776	836	0.85
NULL	Cell_Death_Dis_2014_Jan_9_5(1)_e991.nxml.txt.nlp	24407244	SENT61	16	16	28	28	cisplatin	c-Jun	PA449014	3725	0.85
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Apr_17_6_43-57.nxml.txt.nlp	24833916	SENT146	9	9	15	15	capecitabine	aromatase	PA448771	1588	0.85
NULL	Aging_(Albany_NY)_2013_Aug_21_5(8)_623-636.nxml.txt.nlp	23974852	SENT175	30	30	21	21	metformin	AMPK	PA450395	5563	0.85
NULL	Gene_Regul_Syst_Bio_2014_Mar_4_8_63-73.nxml.txt.nlp	24634581	SENT86	27	27	18	18	minocycline	BNIP3	PA450519	664	0.85
NULL	Acta_Pharmacol_Sin_2014_Oct_25_35(10)_1293-1301.nxml.txt.nlp	25152022	SENT131	7	7	35	35	enalapril	NLRP3	PA449456	114548	0.85
NULL	Biochem_Res_Int_2011_Sep_22_2011_285618.nxml.txt.nlp	21949907	SENT120	34	34	17	17	resveratrol	adiponectin		9370	0.85
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT188	0	0	14	14	neratinib	EGFR	PA165291472	1956	0.85
NULL	Aging_(Albany_NY)_2014_Jul_19_6(9)_755-769.nxml.txt.nlp	25324471	SENT274	16	16	2	2	ethanol	MADA	PA448073	270	0.85
NULL	Nat_Med_2012_Apr_15_18(5)_774-782.nxml.txt.nlp	22504483	SENT298	15	15	24	24	forskolin	ACT	PA146096022	12;11332;9457;641455	0.85
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT397	4	4	35	35	resveratrol	SRC		6714	0.85
NULL	Nat_Neurosci_2013_Apr_17_16(4)_464-472.nxml.txt.nlp	23502536	SENT457	7	7	13	13	imipramine	GluA1	PA449969	2890	0.85
NULL	Acta_Diabetol_2011_Mar_21_48(1)_71-77.nxml.txt.nlp	20963449	SENT129	9	9	27	27	miglitol	PPG	PA164776726	5552	0.85
NULL	Mol_Vis_2012_Oct_3_18_2420-2437.nxml.txt.nlp	23077401	SENT72	29	29	3	3	guanidine	HMGA2	PA164781028	8091	0.85
NULL	Eur_J_Clin_Pharmacol_2012_Sep_15_68(9)_1267-1274.nxml.txt.nlp	22418828	SENT216	3	3	9	9	omeprazole	CYP2C19	PA450704	1557	0.85
NULL	Nucleic_Acids_Res_2012_Jun_22_40(11)_4861-4878.nxml.txt.nlp	22362753	SENT247	21	21	27	27	trypsin	NPM2	PA451806	10361	0.85
NULL	Oncotarget_2014_Oct_21_5(22)_11252-11268.nxml.txt.nlp	25361004	SENT238	19	19	21	21	metformin	Met	PA450395	79811	0.85
NULL	Behav_Brain_Funct_2014_Jun_16_10_21.nxml.txt.nlp	24934302	SENT8	22	22	36	36	rosiglitazone	gamma	PA451283	9913	0.85
NULL	Int_J_Mol_Sci_2012_Dec_5_13(12)_16624-16635.nxml.txt.nlp	23443122	SENT10	6	6	14	14	paclitaxel	MDR1	PA450761	5243	0.85
NULL	Diabetes_2009_Dec_9_58(12)_2828-2834.nxml.txt.nlp	19741164	SENT30	0	0	5	5	resveratrol	SIRT1		23411	0.85
NULL	J_Exp_Med_1998_May_4_187(9)_1417-1426.nxml.txt.nlp	9565634	SENT44	18	18	40	40	neomycin	SHP-2	PA450608	5781	0.85
NULL	Mol_Cancer_2014_Jul_5_13_165.nxml.txt.nlp	24996221	SENT208	25	25	11	11	docetaxel	HMGB1	PA449383	3146	0.85
NULL	Oncotarget_2010_Oct_9_1(6)_387-395.nxml.txt.nlp	21311095	SENT99	12	12	21	21	oxaliplatin	CD44	PA131285527	960	0.85
NULL	Viruses_2013_May_22_5(5)_1272-1291.nxml.txt.nlp	23698399	SENT213	39	39	34	34	tranylcypromine	LSD1	PA451741	23028	0.85
NULL	Stroke_Res_Treat_2011_Nov_10_2011_212485.nxml.txt.nlp	22135769	SENT120	5	5	28	28	warfarin	CYP2C9	PA451906	1559	0.85
NULL	Br_J_Cancer_2011_Jul_26_105(3)_366-371.nxml.txt.nlp	21750556	SENT125	11	11	5	5	trastuzumab	T-bet	PA451743	30009	0.85
NULL	Arthritis_Res_Ther_2014_Jul_18_16(4)_R153.nxml.txt.nlp	25037855	SENT107	24	24	11	11	adalimumab	CD14	PA10004	929	0.85
NULL	Breast_Cancer_Res_2000_Mar_12_2(Suppl_1)_P4_03.nxml.txt.nlp	NULL	SENT3	33	33	6	6	neomycin	BRCA1	PA450608	672	0.85
NULL	Avicenna_J_Med_2012_Jul-Sep_2(3)_71-73.nxml.txt.nlp	23826550	SENT52	7	7	14	14	lapatinib	EGFR	PA152241907	1956	0.85
NULL	Mol_Cancer_2010_Aug_23_9_222.nxml.txt.nlp	20731837	SENT139	3	3	18	18	gefitinib	ATM	PA131301952	472	0.85
NULL	Exp_Hematol_Oncol_2013_Aug_28_2_23.nxml.txt.nlp	24499526	SENT266	21	21	12	12	ethanol	OPTC	PA448073	26254	0.85
NULL	Cancers_(Basel)_2014_Mar_26_6(2)_708-722.nxml.txt.nlp	24675568	SENT106	29	29	35	35	afatinib	EGFR	PA165981154	1956	0.85
NULL	Neural_Plast_2007_Oct_10_2007_23250.nxml.txt.nlp	NULL	SENT273	24	24	4	4	methamphetamine	CB1	PA450403	1268	0.85
NULL	Mol_Cell_Biochem_2013_Sep_4_384(1-2)_155-162.nxml.txt.nlp	24002703	SENT143	23	23	31	31	doxycycline	PI3K	PA449415	5290	0.85
NULL	Pediatr_Blood_Cancer_2015_Jan_30_62(1)_5-11.nxml.txt.nlp	25175627	SENT152	31	31	16	16	topotecan	ADP	PA451729	23038	0.85
NULL	Br_J_Cancer_2004_May_4_90(9)_1740-1746.nxml.txt.nlp	15150624	SENT59	27	27	9	9	paclitaxel	ASAT	PA450761	22	0.85
NULL	Brain_Sci_2013_Jun_14_3(2)_941-963.nxml.txt.nlp	24961432	SENT186	13	13	19	19	ethanol	ROCK1	PA448073	6093	0.85
NULL	J_Cell_Mol_Med_2014_May_14_18(5)_811-823.nxml.txt.nlp	24628949	SENT135	4	4	0	0	docetaxel	FOXM1	PA449383	2305	0.85
NULL	Brain_Sci_2013_Jun_14_3(2)_941-963.nxml.txt.nlp	24961432	SENT189	5	5	12	12	ethanol	RhoE	PA448073	390	0.85
NULL	Oncol_Rep_2012_Apr_30_27(4)_923-928.nxml.txt.nlp	22209766	SENT123	0	0	3	3	erlotinib	EGFR	PA134687924	1956	0.85
NULL	Cell_Death_Dis_2010_Nov_18_1(11)_e102.nxml.txt.nlp	21368867	SENT71	18	18	30	30	gentamicin	CLIMP-63	PA449753	10970	0.85
NULL	Biomed_Eng_Online_2010_Mar_9_9_15.nxml.txt.nlp	20214774	SENT290	16	16	37	37	paclitaxel	mol	PA450761	90527	0.85
NULL	Int_J_Mol_Sci_2014_Jun_23_15(6)_11190-11203.nxml.txt.nlp	24960362	SENT315	3	3	7	7	ethanol	AMPK	PA448073	5563	0.85
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT179	27	27	32	32	adalimumab	CD36	PA10004	948	0.85
NULL	J_Hematol_Oncol_2013_Jul_9_6_49.nxml.txt.nlp	23837843	SENT225	37	37	3	3	verapamil	Rho	PA451868	29984	0.85
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT113	25	25	32	32	neratinib	HER2	PA165291472	2064	0.85
NULL	Br_J_Cancer_2003_Mar_10_88(5)_754-759.nxml.txt.nlp	12618886	SENT163	15	15	4	4	amifostine	p53	PA448365	7157	0.85
NULL	Emerg_Infect_Dis_2003_Jul_9(7)_833-837.nxml.txt.nlp	12890324	SENT43	26	26	7	7	ciprofloxacin	BSP	PA449009	3381	0.85
NULL	Cardiovasc_J_Afr_2009_Apr_20(2)_127-134.nxml.txt.nlp	19421649	SENT167	2	2	11	11	ramipril	DREAM	PA451223	30818	0.85
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1137-1144.nxml.txt.nlp	20234366	SENT35	23	23	3	3	panitumumab	KRAS	PA162373091	3845	0.85
NULL	Clin_Med_Insights_Case_Rep_2014_Oct_1_7_117-121.nxml.txt.nlp	25336995	SENT33	18	18	37	37	rituximab	CD34	PA451261	947	0.85
NULL	Arthritis_Res_Ther_2005_Feb_17_7(Suppl_1)_P81.nxml.txt.nlp	NULL	SENT13	5	5	8	8	etanercept	OPG	PA449515	690	0.85
NULL	Oncoimmunology_2013_Jul_1_2(7)_e24679.nxml.txt.nlp	24073364	SENT46	8	8	32	32	sunitinib	TH1	PA162372840	51497	0.85
NULL	Cell_Commun_Signal_2013_Aug_27_11_63.nxml.txt.nlp	24103640	SENT210	14	14	6	6	doxorubicin	YB-1	PA449412	4904	0.85
NULL	Br_J_Cancer_2010_Oct_12_103(8)_1284-1291.nxml.txt.nlp	20859285	SENT155	17	17	5	5	tamoxifen	BCAR4	PA451581	400500	0.85
NULL	Oncol_Lett_2014_May_18_7(5)_1499-1502.nxml.txt.nlp	24765164	SENT67	11	11	8	8	oxaliplatin	GSTP1	PA131285527	2950	0.85
NULL	Breast_Cancer_Res_2005_Jan_28_7(3)_R284-R290.nxml.txt.nlp	15987423	SENT89	20	20	9	9	tamoxifen	CYP2D6	PA451581	1565	0.85
NULL	Mol_Biol_Cell_2013_Aug_1_24(15)_2328-2339.nxml.txt.nlp	23783029	SENT282	23	23	38	38	glucose	GEF	PA449773	56731	0.85
NULL	Breast_Cancer_(Auckl)_2009_Sep_2_3_61-75.nxml.txt.nlp	19809577	SENT245	3	3	18	18	curcumin	BRCA1	PA151958596	672	0.85
NULL	Mol_Cell_Biochem_2014_Jul_26_396(1-2)_221-228.nxml.txt.nlp	25063218	SENT147	9	9	31	31	resveratrol	EGFR		1956	0.85
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT138	30	30	13	13	pertuzumab	HER3		2065	0.85
NULL	Arthritis_Res_Ther_2013_Aug_30_15(4)_R100.nxml.txt.nlp	24000795	SENT140	21	21	9	9	etanercept	TREM1	PA449515	54210	0.85
NULL	Br_J_Cancer_2009_Jul_21_101(2)_238-243.nxml.txt.nlp	19568242	SENT103	6	6	10	10	sunitinib	IFN	PA162372840	3439	0.85
NULL	Amino_Acids_2012_Oct_10_43(4)_1751-1759.nxml.txt.nlp	22407485	SENT175	17	17	11	11	carrageenan	ghrelin	PA448814	51738	0.85
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2654-2664.nxml.txt.nlp	24136149	SENT147	4	4	0	0	doxorubicin	DNA-PKcs	PA449412	5591	0.85
NULL	Mol_Imaging_Radionucl_Ther_2012_Apr_1_21(1)_38-41.nxml.txt.nlp	23487501	SENT30	27	27	42	42	thyroglobulin	WBS	PA164754910	2006	0.85
NULL	Front_Genet_2012_Oct_26_3_213.nxml.txt.nlp	23112805	SENT250	0	0	7	7	furafylline	CYP1A2	PA452614	1544	0.85
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT148	18	18	26	26	l-methionine	ATP5A	PA450423	498	0.85
NULL	Front_Psychol_2014_Apr_4_5_282.nxml.txt.nlp	24772099	SENT1212	4	4	2	2	resveratrol	SIRT1		23411	0.85
NULL	J_Orthop_Sci_2014_Apr_12_19(3)_377-378.nxml.txt.nlp	24728494	SENT10	18	18	34	34	imatinib	EGFR	PA10804	1956	0.85
NULL	Front_Microbiol_2013_Aug_19_4_241.nxml.txt.nlp	23966991	SENT2017	14	14	2	2	rifampin	NF-kappaB	PA451250	4790	0.85
NULL	Cancer_Med_2013_Jun_25_2(3)_277-285.nxml.txt.nlp	23930204	SENT170	16	16	3	3	bevacizumab	PTEN	PA130232992	5728	0.85
NULL	Clin_Pharmacol_2010_Jun_22_2_105-110.nxml.txt.nlp	22291493	SENT103	3	3	6	6	sibutramine	ADIPOQ	PA451344	9370	0.85
NULL	Front_Neurosci_2010_Jun_17_4_35.nxml.txt.nlp	20661455	SENT309	1	1	13	13	fluoxetine	5-HT1A	PA449673	3350	0.85
NULL	Avicenna_J_Phytomed_2012_Spring_2(2)_72-78.nxml.txt.nlp	25050233	SENT4	10	10	46	46	imipramine	PST	PA449969	7903	0.85
NULL	Chemother_Res_Pract_2011_Sep_25_2011_730360.nxml.txt.nlp	22295205	SENT212	5	5	13	13	trastuzumab	HER2	PA451743	2064	0.85
NULL	Contemp_Oncol_(Pozn)_2012_Sep_29_16(4)_316-321.nxml.txt.nlp	23788901	SENT158	13	13	22	22	etoposide	STAT3	PA449552	6774	0.85
NULL	J_Bras_Pneumol_2013_Jan-Feb_39(1)_5-15.nxml.txt.nlp	23503480	SENT129	34	34	14	14	doxycycline	LAM	PA449415	7249;7248	0.85
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1224-1233.nxml.txt.nlp	22353810	SENT165	31	31	29	29	doxorubicin	MRP-1	PA449412	928	0.85
NULL	Infect_Ecol_Epidemiol_2011_Aug_31_1_10_3402_iee_v1i0_7030.nxml.txt.nlp	22957123	SENT33	12	12	22	22	cefpodoxime	MAST	PA164746385	51324	0.85
NULL	Clin_Med_Case_Rep_2009_Jul_31_2_43-49.nxml.txt.nlp	24179373	SENT94	39	39	9	9	methotrexate	CD33	PA450428	945	0.85
NULL	Cancers_(Basel)_2014_Aug_12_6(3)_1631-1669.nxml.txt.nlp	25119536	SENT328	0	0	18	18	imatinib	p38	PA10804	10598;1432;7965	0.85
NULL	Eur_J_Epidemiol_2007_Nov_23_22(11)_819-829.nxml.txt.nlp	17955331	SENT696	20	20	9	9	phenprocoumon	CYP2C9	PA450921	1559	0.85
NULL	Front_Oncol_2014_Apr_9_4_75.nxml.txt.nlp	24782986	SENT235	29	29	12	12	paclitaxel	Oct4	PA450761	5460	0.85
NULL	South_Asian_J_Cancer_2014_Jul-Sep_3(3)_175-178.nxml.txt.nlp	25136526	SENT106	8	8	16	16	panitumumab	EGFR	PA162373091	1956	0.85
NULL	Clin_Pharmacol_2011_Jun_22_3_13-25.nxml.txt.nlp	22287853	SENT182	23	23	42	42	saxagliptin	CYP3A4	PA165958362	1576	0.85
NULL	Ann_Rheum_Dis_2009_Jan_5_68(6)_1051-1058.nxml.txt.nlp	18662930	SENT211	9	9	25	25	hyaluronan	ADAMTS-4	PA165958431	9508	0.85
NULL	Clin_Transl_Allergy_2013_Sep_2_3_29.nxml.txt.nlp	24004581	SENT197	20	20	26	26	omalizumab	IL-4	PA164752253	3565	0.85
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_21_2012_234987.nxml.txt.nlp	23133491	SENT230	25	25	10	10	ethanol	TLR4	PA448073	7099	0.85
NULL	Front_Genet_2012_Nov_26_3_273.nxml.txt.nlp	23233861	SENT145	11	11	8	8	warfarin	VKORC1	PA451906	79001	0.85
NULL	Neural_Regen_Res_2014_May_15_9(10)_1055-1062.nxml.txt.nlp	25206759	SENT218	33	33	21	21	bumetanide	NKCC1	PA448682	6558	0.85
NULL	Croat_Med_J_2013_Apr_54(2)_171-179.nxml.txt.nlp	23630144	SENT144	12	12	14	14	taurine	STZ	PA451590	6484	0.85
NULL	Biomed_Imaging_Interv_J_2008_Jul_1_4(3)_e38.nxml.txt.nlp	21611004	SENT147	18	18	21	21	tamoxifen	aromatase	PA451581	1588	0.85
NULL	Acta_Pharmacol_Sin_2012_Jan_3_33(1)_82-90.nxml.txt.nlp	22212431	SENT112	8	8	14	14	fenofibrate	adiponectin	PA449594	9370	0.85
NULL	Cell_Biol_Int_Rep_(2010)_2012_Jun_21_19(1)_e00017.nxml.txt.nlp	23124518	SENT135	17	17	5	5	etoposide	TRAIL	PA449552	8743	0.85
NULL	Breast_Cancer_Res_2002_Mar_26_4(3)_91-94.nxml.txt.nlp	12052250	SENT22	0	0	27	27	perphenazine	p53	PA450882	7157	0.85
NULL	Bioinform_Biol_Insights_2013_Sep_18_7_289-306.nxml.txt.nlp	24092970	SENT209	21	21	30	30	etoposide	PRAME	PA449552	23532	0.85
NULL	J_Korean_Med_Sci_2009_Jun_12_24(3)_448-452.nxml.txt.nlp	19543508	SENT6	29	29	24	24	gefitinib	EGFR	PA131301952	1956	0.85
NULL	Pharmaceuticals_(Basel)_2011_Jan_12_4(1)_187-201.nxml.txt.nlp	NULL	SENT163	38	38	27	27	l-arginine	NOS2	PA448478	339345;4843	0.85
NULL	Arthritis_Res_Ther_2014_Jan_23_16(1)_R21.nxml.txt.nlp	24457003	SENT66	22	22	0	0	paraformaldehyde	IVD	PA450790	3712	0.85
NULL	Arthritis_Res_2002_Mar_27_4(Suppl_2)_S22-S28.nxml.txt.nlp	12110154	SENT61	14	14	4	4	infliximab	IL-6	PA452639	3569	0.85
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT296	26	26	20	20	atorvastatin	PTEN	PA448500	5728	0.85
NULL	J_Radiat_Res_2014_Nov_16_55(6)_1171-1177.nxml.txt.nlp	25129557	SENT46	10	10	6	6	bevacizumab	CRT	PA130232992	811	0.85
NULL	Acta_Naturae_2012_Jan-Mar_4(1)_82-85.nxml.txt.nlp	22708067	SENT37	21	21	6	6	gefitinib	EGFR	PA131301952	1956	0.85
NULL	Nat_Neurosci_2011_May_17_14(5)_612-619.nxml.txt.nlp	21499254	SENT71	27	27	6	6	ethanol	spatial	PA448073	219793	0.85
NULL	Exp_Ther_Med_2015_Jan_19_9(1)_154-158.nxml.txt.nlp	25452793	SENT133	18	18	15	15	tacrolimus	hole	PA451578	80757	0.85
NULL	Cardiol_Res_Pract_2010_Dec_13_2010_295297.nxml.txt.nlp	21197071	SENT53	16	16	4	4	heparin	ACT	PA449855	12;11332;9457;641455	0.849
NULL	Breast_Cancer_(Auckl)_2010_Feb_16_4_1-3.nxml.txt.nlp	20697527	SENT19	5	5	32	32	curcumin	CTX	PA151958596	1593	0.849
NULL	Exp_Ther_Med_2013_Jan_10_5(1)_11-16.nxml.txt.nlp	23251234	SENT19	0	0	8	8	cetuximab	EGFR	PA10040	1956	0.849
NULL	J_Carcinog_2013_Dec_31_12_22.nxml.txt.nlp	24574860	SENT84	47	47	33	33	afatinib	BMX	PA165981154	660	0.849
NULL	Exp_Ther_Med_2015_Jan_11_9(1)_17-24.nxml.txt.nlp	25452770	SENT142	7	7	3	3	pertuzumab	HER-2		2064	0.849
NULL	Bioinform_Biol_Insights_2009_Oct_5_3_109-127.nxml.txt.nlp	20140064	SENT523	9	9	27	27	stavudine	P200	PA451494	5035	0.849
NULL	Int_J_Biol_Sci_2011_Nov_1_7(9)_1345-1356.nxml.txt.nlp	22110386	SENT55	10	10	31	31	l-glutamine	CO2	PA10090	4513	0.849
NULL	Adv_Hematol_2009_Jun_22_2009_251915.nxml.txt.nlp	19946423	SENT122	27	27	6	6	hemin	HRI	PA449849	27102	0.849
NULL	Aging_(Albany_NY)_2009_Jun_3_1(6)_515-528.nxml.txt.nlp	20157535	SENT74	26	26	8	8	resveratrol	NLK		51701;2821	0.849
NULL	Allergy_Asthma_Immunol_Res_2014_Nov_28_6(6)_567-572.nxml.txt.nlp	25374757	SENT88	0	0	28	28	fexofenadine	IL-6	PA449621	3569	0.849
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT85	6	6	15	15	atorvastatin	PI3K	PA448500	5290	0.849
NULL	Cancers_(Basel)_2014_Jul_8_6(3)_1487-1499.nxml.txt.nlp	25006835	SENT44	31	31	45	45	cisplatin	AMPK	PA449014	5563	0.849
NULL	J_Biol_Chem_2012_Apr_27_287(18)_14644-14658.nxml.txt.nlp	22375002	SENT354	5	5	10	10	forskolin	CC2D1A	PA146096022	54862	0.849
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1224-1233.nxml.txt.nlp	22353810	SENT191	11	11	4	4	doxorubicin	MRP-1	PA449412	928	0.849
NULL	Int_J_Appl_Basic_Med_Res_2014_Sep_4(Suppl_1)_S1.nxml.txt.nlp	25298933	SENT16	22	22	15	15	metformin	OCT1	PA450395	5451;6580	0.849
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT93	29	29	38	38	sitagliptin	HIP	PA164748978	6767;6159;64399;5068	0.849
NULL	Crit_Care_2011_Oct_26_15(5)_R257.nxml.txt.nlp	22030215	SENT257	17	17	34	34	dexmedetomidine	SAPS	PA449256	8935	0.849
NULL	Protein_Cell_2014_Apr_4_5(4)_307-316.nxml.txt.nlp	24585413	SENT157	10	10	29	29	fluorescein	CD80	PA164746009	941	0.849
NULL	Acta_Pharmacol_Sin_2013_Feb_17_34(2)_309-313.nxml.txt.nlp	22983388	SENT115	6	6	16	16	cisplatin	Bcl-2	PA449014	596	0.849
NULL	J_Biol_Chem_2009_Oct_16_284(42)_28885-28895.nxml.txt.nlp	19687008	SENT37	22	22	16	16	pravastatin	PCSK9	PA451089	255738	0.849
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT51	0	0	12	12	doxorubicin	SLK	PA449412	9748;2534	0.849
NULL	J_Viral_Hepat_2010_Feb_17(2)_139-147.nxml.txt.nlp	19674282	SENT142	12	12	34	34	ribavirin	RVR	PA451241	9975	0.849
NULL	J_Oncol_2012_Jun_19_2012_521215.nxml.txt.nlp	22778735	SENT102	5	5	12	12	cetuximab	EGFR	PA10040	1956	0.849
NULL	Mol_Cancer_2014_Jun_24_13_157.nxml.txt.nlp	24958351	SENT44	18	18	10	10	gefitinib	HER2	PA131301952	2064	0.849
NULL	Exp_Cell_Res_2011_Apr_15_317(7)_1028-1039.nxml.txt.nlp	21237154	SENT11	6	6	8	8	staurosporine	JNK	PA165109623	5599	0.849
NULL	J_Antimicrob_Chemother_2012_Sep_11_67(9)_2213-2221.nxml.txt.nlp	22687893	SENT200	0	0	17	17	nevirapine	CYP3A4	PA450616	1576	0.849
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT85	3	3	21	21	curcumin	Bcl-2	PA151958596	596	0.849
NULL	Clinics_(Sao_Paulo)_2013_May_68(5)_694-701.nxml.txt.nlp	23778405	SENT152	5	5	25	25	curcumin	MDR1	PA151958596	5243	0.849
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT10	13	13	35	35	atorvastatin	IL-6	PA448500	3569	0.849
NULL	Biol_Open_2014_May_2_3(6)_418-430.nxml.txt.nlp	24795145	SENT127	6	6	35	35	etoposide	RanBPM	PA449552	10048	0.849
NULL	Exp_Ther_Med_2014_Sep_20_8(3)_968-972.nxml.txt.nlp	25120631	SENT76	2	2	9	9	naringin	ADP	PA151958360	23038	0.849
NULL	Arthritis_Res_Ther_2014_Sep_18_16(Suppl_1)_A50.nxml.txt.nlp	NULL	SENT9	0	0	20	20	eculizumab	C5b	PA164776637	727	0.849
NULL	Drug_Des_Devel_Ther_2014_Oct_16_8_1941-1953.nxml.txt.nlp	25342887	SENT143	23	23	30	30	genistein	TLR4	PA165109660	7099	0.849
NULL	J_Cancer_2013_Sep_14_4(8)_635-643.nxml.txt.nlp	24155775	SENT162	11	11	23	23	sorafenib	SHARP	PA7000	23013	0.849
NULL	J_Biomed_Sci_2014_Feb_12_21(1)_14.nxml.txt.nlp	24521134	SENT204	18	18	27	27	amantadine	MAVS	PA448360	57506	0.849
NULL	Breast_Cancer_Res_2005_Jul_20_7(5)_205-211.nxml.txt.nlp	16168139	SENT110	8	8	2	2	fulvestrant	aromatase	PA164747170	1588	0.849
NULL	Aging_(Albany_NY)_2012_Apr_30_4(5)_320-329.nxml.txt.nlp	22589237	SENT33	42	42	16	16	metformin	NEGR1	PA450395	257194	0.849
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1692-1698.nxml.txt.nlp	19861963	SENT150	4	4	31	31	phenol	XBP1	PA450913	7494	0.849
NULL	J_Invest_Dermatol_2012_May_16_132(5)_1435-1442.nxml.txt.nlp	22336948	SENT5	44	44	20	20	doxycycline	TLSP	PA449415	11012	0.849
NULL	Cancer_Cell_Int_2009_Sep_10_9_25.nxml.txt.nlp	19744341	SENT293	0	0	5	5	glucosamine	STAT3	PA164747613	6774	0.849
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT535	31	31	20	20	pp2	TFF3		7033	0.849
NULL	Int_J_Cell_Biol_2013_Sep_12_2013_153634.nxml.txt.nlp	24159334	SENT140	9	9	22	22	doxorubicin	EWS	PA449412	2130	0.849
NULL	Br_J_Cancer_1997_75(11)_1559-1566.nxml.txt.nlp	9184169	SENT0	22	22	29	29	genistein	p53	PA165109660	7157	0.849
NULL	Adv_Hematol_2012_Jul_24_2012_513702.nxml.txt.nlp	22888354	SENT94	28	28	11	11	lenalidomide	CD4	PA162363968	920	0.849
NULL	Int_J_Biol_Sci_2013_Apr_22_9(4)_350-360.nxml.txt.nlp	23630447	SENT28	32	32	13	13	doxorubicin	ABCB1	PA449412	5243	0.849
NULL	Br_J_Cancer_2012_Dec_4_107(12)_1950-1955.nxml.txt.nlp	23169295	SENT15	20	20	9	9	oxaliplatin	TOP1	PA131285527	7150	0.849
NULL	J_Asthma_Allergy_2012_Nov_8_5_65-70.nxml.txt.nlp	23204847	SENT132	17	17	0	0	omalizumab	ACT	PA164752253	12;11332;9457;641455	0.849
NULL	Oncogenesis_2014_Dec_15_3(12)_e133.nxml.txt.nlp	25500906	SENT110	29	29	8	8	trastuzumab	HER3	PA451743	2065	0.849
NULL	Mol_Biol_Cell_2012_Jun_1_23(11)_2017-2027.nxml.txt.nlp	22496424	SENT99	3	3	22	22	warfarin	BiP	PA451906	3309	0.849
NULL	Mol_Cancer_2006_Oct_17_5_45.nxml.txt.nlp	17044934	SENT90	2	2	39	39	ns-398	COX		1351	0.849
NULL	Oncoscience_2014_Jul_3_1(6)_407-422.nxml.txt.nlp	25594039	SENT199	19	19	16	16	olaparib	PARP1		142	0.849
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_39-54.nxml.txt.nlp	19305787	SENT239	7	7	35	35	ethanol	DARPP-32	PA448073	84152	0.849
NULL	Diabetes_2013_Oct_17_62(10)_3373-3383.nxml.txt.nlp	23835335	SENT229	27	27	11	11	glucose	POMC	PA449773	5443	0.849
NULL	Br_J_Clin_Pharmacol_2011_Oct_72(4)_647-657.nxml.txt.nlp	21518389	SENT60	34	34	23	23	clopidogrel	CYP2C9	PA449053	1559	0.849
NULL	Ther_Clin_Risk_Manag_2007_Jun_3(3)_411-420.nxml.txt.nlp	18488075	SENT198	16	16	7	7	alefacept	CD4	PA164748040	920	0.849
NULL	Oncogene_2014_Feb_6_33(6)_713-723.nxml.txt.nlp	23435429	SENT7	15	15	9	9	camptothecin	BRCA1	PA153590860	672	0.849
NULL	Oncogene_2013_Oct_17_32(42)_5089-5100.nxml.txt.nlp	23178492	SENT294	33	33	8	8	vorinostat	LOX	PA164748224	4015	0.849
NULL	Aging_(Albany_NY)_2009_Jun_3_1(6)_515-528.nxml.txt.nlp	20157535	SENT124	27	27	10	10	resveratrol	S6K1		6198	0.849
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_7-17.nxml.txt.nlp	17912633	SENT376	2	2	31	31	exemestane	AMH	PA449563	268	0.849
NULL	Case_Rep_Med_2009_Jan_3_2009_371698.nxml.txt.nlp	20066171	SENT73	17	17	20	20	quetiapine	5-HT2A	PA451201	3356	0.849
NULL	EMBO_Mol_Med_2013_Aug_5_5(8)_1213-1226.nxml.txt.nlp	23918228	SENT31	10	10	8	8	cetuximab	EGFR	PA10040	1956	0.849
NULL	Int_J_Mol_Sci_2014_Sep_29_15(10)_17411-17441.nxml.txt.nlp	25268615	SENT247	0	0	12	12	cyclosporine	MCT1	PA449167	6566	0.849
NULL	Open_AIDS_J_2009_Jul_8_3_24-30.nxml.txt.nlp	19639037	SENT22	15	15	9	9	nevirapine	CD4	PA450616	920	0.849
NULL	Eur_J_Clin_Pharmacol_2011_Dec_23_67(12)_1231-1241.nxml.txt.nlp	21698374	SENT297	14	14	4	4	tacrolimus	CYP3A5	PA451578	1577	0.849
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT7	9	9	31	31	pemetrexed	UNG	PA10810	7374	0.849
NULL	Br_J_Pharmacol_2010_Sep_161(2)_288-307.nxml.txt.nlp	20735416	SENT125	28	28	30	30	pentobarbital	c-fos	PA450859	2353	0.849
NULL	Breast_Cancer_Res_2012_Jul_27_14(4)_R113.nxml.txt.nlp	22839103	SENT258	36	36	7	7	tamoxifen	p53	PA451581	7157	0.849
NULL	J_Invest_Dermatol_2012_Jan_1_132(1)_105-113.nxml.txt.nlp	21881590	SENT76	24	24	14	14	etanercept	CCL20	PA449515	6364	0.849
NULL	Br_J_Cancer_2012_Apr_24_106(9)_1543-1550.nxml.txt.nlp	22531721	SENT127	25	25	6	6	trastuzumab	CD55	PA451743	1604	0.849
NULL	Cancers_(Basel)_2011_Apr_18_3(2)_2014-2031.nxml.txt.nlp	24212794	SENT182	13	13	4	4	cetuximab	KRAS	PA10040	3845	0.849
NULL	J_RNAi_Gene_Silencing_2009_Mar_9_5(1)_321-330.nxml.txt.nlp	19771229	SENT163	3	3	11	11	hydroxyurea	RRM2	PA449942	6241	0.849
NULL	Br_J_Cancer_2006_Dec_4_95(11)_1504-1513.nxml.txt.nlp	17088902	SENT198	47	47	16	16	gefitinib	HER2	PA131301952	2064	0.849
NULL	Eur_J_Clin_Pharmacol_2010_Nov_29_66(11)_1131-1136.nxml.txt.nlp	20669013	SENT2	5	5	15	15	erythromycin	CYP2C19	PA449493	1557	0.849
NULL	J_Med_Case_Reports_2011_Oct_5_5_504.nxml.txt.nlp	21975443	SENT18	0	0	26	26	imatinib	KIT	PA10804	3815	0.849
NULL	Cancer_Cell_Int_2010_Oct_25_10_40.nxml.txt.nlp	20974006	SENT186	5	5	30	30	desipramine	FADD	PA449233	8772	0.849
NULL	J_Gynecol_Oncol_2013_Jul_4_24(3)_273-279.nxml.txt.nlp	23875078	SENT104	9	9	5	5	paclitaxel	COX	PA450761	1351	0.849
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Oct_23_69(Pt_11)_o1697.nxml.txt.nlp	24454123	SENT68	9	9	24	24	paraformaldehyde	mol	PA450790	90527	0.849
NULL	Exp_Anim_2014_Aug_22_63(3)_277-287.nxml.txt.nlp	25077757	SENT4	14	14	21	21	resveratrol	STZ		6484	0.849
NULL	J_Int_Soc_Sports_Nutr_2010_Jan_22_7_3.nxml.txt.nlp	20205750	SENT54	2	2	7	7	betaine	mol	PA448603	90527	0.849
NULL	Cancers_(Basel)_2013_May_27_5(2)_617-638.nxml.txt.nlp	24216994	SENT340	12	12	8	8	curcumin	PC3	PA151958596	57332;7832;5122	0.849
NULL	Arthritis_Rheumatol_2014_Aug_28_66(8)_2297-2307.nxml.txt.nlp	24756912	SENT119	18	18	12	12	vincristine	CHOP	PA451879	1649	0.849
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Dec_10_3(12)_e151.nxml.txt.nlp	25494035	SENT69	29	29	8	8	fluvastatin	OATP1B1	PA449688	10599	0.849
NULL	J_Cancer_Res_Clin_Oncol_2011_Feb_11_137(2)_183-192.nxml.txt.nlp	21069385	SENT218	12	12	10	10	cetuximab	EGFR	PA10040	1956	0.849
NULL	Oxid_Med_Cell_Longev_2011_Oct_15_2011_703676.nxml.txt.nlp	22013498	SENT329	18	18	6	6	resveratrol	IL-6		3569	0.849
NULL	Clin_Med_Insights_Oncol_2011_Nov_9_5_365-379.nxml.txt.nlp	22174597	SENT109	6	6	17	17	imatinib	KIT	PA10804	3815	0.849
NULL	Genome_Biol_2011_Jun_22_12(6)_R57.nxml.txt.nlp	21696594	SENT205	14	14	8	8	aripiprazole	PRL	PA10026	5617	0.849
NULL	Exp_Ther_Med_2013_Jan_10_5(1)_11-16.nxml.txt.nlp	23251234	SENT152	18	18	8	8	cetuximab	UST	PA10040	10090	0.849
NULL	Clin_Interv_Aging_2009_May_14_4_109-113.nxml.txt.nlp	19503773	SENT56	48	48	26	26	levodopa	COMT	PA450213	1312	0.849
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Mar_23_69(Pt_4)_o558-o559.nxml.txt.nlp	23634097	SENT83	16	16	22	22	vanillin	mol	PA451852	90527	0.849
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT211	8	8	20	20	chloroquine	BMP9	PA448948	2658	0.849
NULL	Oncologist_2010_Mar_3_15(3)_216-235.nxml.txt.nlp	20200040	SENT122	21	21	33	33	trastuzumab	HER-2	PA451743	2064	0.849
NULL	Clin_Dev_Immunol_2013_Nov_25_2013_271246.nxml.txt.nlp	24371445	SENT36	20	20	16	16	imiquimod	TLR3	PA449972	7098	0.849
NULL	Front_Chem_2014_Mar_14_2_12.nxml.txt.nlp	24790981	SENT152	15	15	12	12	curcumin	GATA4	PA151958596	2626	0.849
NULL	Indian_J_Nucl_Med_2012_Jul-Sep_27(3)_145-150.nxml.txt.nlp	23919066	SENT46	37	37	26	26	furosemide	FDG	PA449719	23583	0.849
NULL	Front_Immunol_2012_Jun_4_3_134.nxml.txt.nlp	22675325	SENT120	6	6	19	19	enprofylline	IL-8	PA164749350	3576	0.849
NULL	Mol_Pain_2012_Sep_24_8_74.nxml.txt.nlp	23006894	SENT68	30	30	25	25	pregabalin	TNP1	PA164754814	7141	0.849
NULL	Pharmaceutics_2011_Nov_18_3(4)_865-913.nxml.txt.nlp	24309312	SENT208	21	21	32	32	buspirone	CYP3A4	PA448689	1576	0.849
NULL	Cancer_Cell_Int_2008_Sep_17_8_13.nxml.txt.nlp	18798999	SENT32	30	30	0	0	l-glutamine	PC3	PA10090	57332;7832;5122	0.849
NULL	Clin_Interv_Aging_2010_Dec_3_5_403-416.nxml.txt.nlp	21152242	SENT76	36	36	27	27	hydralazine	ACE	PA449894	1636	0.849
NULL	Arthritis_Res_Ther_2007_May_14_9(3)_210.nxml.txt.nlp	17509159	SENT154	9	9	35	35	hydralazine	DNMT1	PA449894	1786	0.849
NULL	Glycobiology_2011_Jun_21_21(6)_806-812.nxml.txt.nlp	21257728	SENT138	24	24	3	3	ampicillin	LSECtin	PA448419	339390	0.849
NULL	Breast_Cancer_Res_2010_May_18_12(Suppl_1)_P2.nxml.txt.nlp	NULL	SENT13	30	30	5	5	tamoxifen	FOXM1	PA451581	2305	0.849
NULL	J_Korean_Med_Sci_2006_Jun_21_21(3)_418-424.nxml.txt.nlp	16778382	SENT157	19	19	6	6	hemin	HO-1	PA449849	3162	0.849
NULL	Infect_Drug_Resist_2010_Nov_23_3_133-145.nxml.txt.nlp	21694902	SENT100	16	16	10	10	boceprevir	San	PA165948902	80218	0.849
NULL	Curr_Med_Chem_2011_Jun_18(18)_2686-2714.nxml.txt.nlp	21649578	SENT214	33	33	22	22	erlotinib	KRAS	PA134687924	3845	0.849
NULL	Diabetes_Metab_Syndr_Obes_2014_Aug_1_7_381-389.nxml.txt.nlp	25120374	SENT12	4	4	9	9	salsalate	adiponectin	PA164745462	9370	0.849
NULL	J_Carcinog_2011_Nov_30_10_28.nxml.txt.nlp	22190870	SENT96	26	26	33	33	trastuzumab	PIK3CA	PA451743	5290	0.849
NULL	Behav_Brain_Funct_2009_Jun_4_5_23.nxml.txt.nlp	19497110	SENT135	4	4	28	28	ethanol	P90	PA448073	821	0.849
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Dec_17_3(12)_e152.nxml.txt.nlp	25518025	SENT227	6	6	4	4	ketoconazole	CYP3A4	PA450146	1576	0.849
NULL	Diabetes_Care_2013_May_13_36(5)_1074-1082.nxml.txt.nlp	23275352	SENT172	9	9	2	2	liraglutide	ZAG	PA165958364	563	0.849
NULL	Int_J_Surg_Oncol_2012_Jun_12_2012_862879.nxml.txt.nlp	22778941	SENT141	15	15	5	5	cisplatin	BIN1	PA449014	274	0.849
NULL	Oncoscience_2014_Mar_24_1(3)_196-204.nxml.txt.nlp	25594012	SENT71	23	23	9	9	erlotinib	HER3	PA134687924	2065	0.849
NULL	Br_J_Cancer_2011_Jul_26_105(3)_403-406.nxml.txt.nlp	21730978	SENT86	25	25	12	12	cetuximab	KRAS	PA10040	3845	0.849
NULL	BMJ_Open_2013_Oct_14_3(10)_e003912.nxml.txt.nlp	24127058	SENT52	7	7	12	12	vancomycin	HAP	PA451850	5915;10313	0.849
NULL	Int_J_Biol_Sci_2013_Dec_17_10(1)_64-72.nxml.txt.nlp	24391452	SENT120	35	35	41	41	ketanserin	5-HT2B	PA131053734	3357	0.849
NULL	Biomed_Res_Int_2014_May_12_2014_261745.nxml.txt.nlp	24900960	SENT374	20	20	30	30	loperamide	castor	PA450262	54897	0.849
NULL	J_Antimicrob_Chemother_2014_Jul_14_69(7)_1945-1953.nxml.txt.nlp	24633206	SENT47	13	13	17	17	tigecycline	RGM	PA164746412	56963	0.849
NULL	Part_Fibre_Toxicol_2011_Aug_2_8_23.nxml.txt.nlp	21810225	SENT16	34	34	8	8	deferoxamine	ROS	PA164746490	6098	0.849
NULL	J_Adv_Pharm_Technol_Res_2010_Oct-Dec_1(4)_396-400.nxml.txt.nlp	22247879	SENT45	15	15	1	1	benzaldehyde	mol	PA448571	90527	0.849
NULL	Front_Oncol_2014_Sep_23_4_264.nxml.txt.nlp	25295231	SENT108	10	10	3	3	lenalidomide	MDM2	PA162363968	4193	0.849
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT222	4	4	6	6	capsaicin	p53	PA448776	7157	0.849
NULL	Arthritis_Res_Ther_2014_Jan_15_16(1)_R10.nxml.txt.nlp	24423138	SENT293	11	11	20	20	collagenase	TRPV1	PA449107	7442	0.849
NULL	Cancer_Inform_2008_Jun_10_6_315-355.nxml.txt.nlp	19259415	SENT65	19	19	38	38	cisplatin	CO2	PA449014	4513	0.849
NULL	Alcohol_Res_Health_2007_30(1)_5-13.nxml.txt.nlp	17718394	SENT49	9	9	0	0	ethanol	ADH4	PA448073	127	0.849
NULL	Biomed_Res_Int_2014_Jun_26_2014_161346.nxml.txt.nlp	25054130	SENT240	41	41	21	21	curcumin	STZ	PA151958596	6484	0.849
NULL	Mol_Biol_Cell_2012_Jun_1_23(11)_2226-2234.nxml.txt.nlp	22493319	SENT162	6	6	12	12	etoposide	FOXO3	PA449552	2309	0.849
NULL	Breast_Cancer_Res_Treat_2014_Sep_13_147(3)_631-638.nxml.txt.nlp	25216762	SENT155	34	34	26	26	capecitabine	HER-2	PA448771	2064	0.849
NULL	Breast_Cancer_Res_2011_Apr_15_13(2)_R44.nxml.txt.nlp	21496232	SENT246	30	30	10	10	erlotinib	HER2	PA134687924	2064	0.849
NULL	Front_Aging_Neurosci_2015_Jan_6_6_342.nxml.txt.nlp	25610395	SENT167	12	12	31	31	imatinib	GSAP	PA10804	54103	0.849
NULL	J_Biol_Chem_2012_Apr_27_287(18)_14644-14658.nxml.txt.nlp	22375002	SENT254	17	17	5	5	forskolin	CC2D1A	PA146096022	54862	0.849
NULL	Int_J_Endocrinol_2010_Mar_2_2010_621687.nxml.txt.nlp	20204178	SENT6	9	9	24	24	paricalcitol	PTH	PA450798	5741	0.849
NULL	J_Res_Pharm_Pract_2013_Oct-Dec_2(4)_156-161.nxml.txt.nlp	24991625	SENT126	29	29	36	36	imatinib	IFN	PA10804	3439	0.849
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1066.nxml.txt.nlp	24556681	SENT214	36	36	12	12	ethanol	ATG5	PA448073	9474	0.849
NULL	Front_Behav_Neurosci_2014_Nov_7_8_391.nxml.txt.nlp	25426041	SENT56	12	12	45	45	trypsin	CO2	PA451806	4513	0.849
NULL	Open_Biol_2014_Nov_4(11)_140180.nxml.txt.nlp	25392452	SENT225	9	9	11	11	imatinib	LEF1	PA10804	51176	0.849
NULL	Ann_Surg_Oncol_2010_Apr_20_17(4)_1168-1176.nxml.txt.nlp	19936839	SENT64	8	8	22	22	panitumumab	KRAS	PA162373091	3845	0.849
NULL	Oncotarget_2014_Mar_16_5(12)_4087-4102.nxml.txt.nlp	24961479	SENT89	32	32	21	21	hemin	PC3	PA449849	57332;7832;5122	0.849
NULL	Biosci_Rep_2013_Jun_5_33(3)_e00041.nxml.txt.nlp	23577625	SENT293	13	13	5	5	arsenite	p38	PA452638	10598;1432;7965	0.849
NULL	Indian_J_Anaesth_2009_Jun_53(3)_268-269.nxml.txt.nlp	20640133	SENT4	0	0	17	17	desmopressin	VIII	PA449237	1351	0.849
NULL	Biomed_Res_Int_2013_Dec_10_2013_159786.nxml.txt.nlp	24386633	SENT30	18	18	4	4	doxorubicin	GMF	PA449412	2764	0.849
NULL	Exp_Mol_Med_2012_Sep_30_44(9)_536-544.nxml.txt.nlp	22771771	SENT57	31	31	12	12	celecoxib	p53	PA448871	7157	0.849
NULL	Aging_(Albany_NY)_2012_Jul_22_4(7)_480-498.nxml.txt.nlp	22837425	SENT70	27	27	6	6	methotrexate	TMP	PA450428	2012	0.849
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_11_2014_274786.nxml.txt.nlp	25505920	SENT164	23	23	26	26	oxaliplatin	ERCC1	PA131285527	2067	0.849
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT209	13	13	8	8	adalimumab	DPI	PA10004	1832	0.849
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT141	7	7	4	4	pp2	LYN		4067	0.849
NULL	Behav_Brain_Funct_2008_Aug_15_4_37.nxml.txt.nlp	18702828	SENT11	15	15	9	9	methamphetamine	FZD3	PA450403	7976;8326	0.849
NULL	Psychiatry_Investig_2009_Sep_3_6(3)_222-225.nxml.txt.nlp	20046399	SENT15	20	20	8	8	risperidone	DRD2	PA451257	1813	0.849
NULL	Mol_Cancer_2009_Nov_24_8_109.nxml.txt.nlp	19930708	SENT11	8	8	15	15	exemestane	EGFR	PA449563	1956	0.849
NULL	Clin_Interv_Aging_2014_Oct_21_9_1783-1791.nxml.txt.nlp	25364236	SENT150	19	19	12	12	donepezil	APOE	PA449394	348	0.849
NULL	Mol_Cancer_2010_Apr_15_9_77.nxml.txt.nlp	20398291	SENT135	17	17	5	5	geldanamycin	Hsp90	PA152031327	3320	0.849
NULL	Ann_Surg_Oncol_2011_Jun_14_18(6)_1657-1664.nxml.txt.nlp	21153885	SENT215	2	2	17	17	anastrozole	ATAC	PA448432	6375	0.849
NULL	Biol_Open_2012_Oct_4_1(12)_1215-1225.nxml.txt.nlp	23259056	SENT190	30	30	14	14	l-glutamine	S6K1	PA10090	6198	0.849
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Feb_24_68(Pt_3)_o792-o793.nxml.txt.nlp	22412664	SENT11	10	10	18	18	deferasirox	mol	PA164760843	90527	0.849
NULL	Br_J_Anaesth_2013_Jan_9_110(1)_87-95.nxml.txt.nlp	23048069	SENT71	9	9	6	6	ropivacaine	EDA	PA451271	1896	0.849
NULL	Cardiovasc_Res_2011_Mar_1_89(4)_794-804.nxml.txt.nlp	20621925	SENT169	29	29	7	7	isoproterenol	PES	PA450121	23481	0.849
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT206	34	34	30	30	adalimumab	CD36	PA10004	948	0.849
NULL	Breast_Cancer_Res_2012_Mar_20_14(2)_R53.nxml.txt.nlp	22433433	SENT110	20	20	28	28	cisplatin	CDK2	PA449014	1017	0.849
NULL	Breast_Cancer_Res_2010_Nov_16_12(6)_R96.nxml.txt.nlp	21080941	SENT235	31	31	7	7	trastuzumab	HER2	PA451743	2064	0.849
NULL	BMB_Rep_2014_May_47(5)_274-279.nxml.txt.nlp	24286313	SENT216	3	3	17	17	bortezomib	PSMB5	PA10252	5693	0.849
NULL	Can_J_Infect_Dis_Med_Microbiol_2014_Nov-Dec_25(6)_327-343.nxml.txt.nlp	25587296	SENT155	2	2	4	4	posaconazole	CYP3A4	PA151958574	1576	0.849
NULL	Oncogenesis_2014_Dec_15_3(12)_e133.nxml.txt.nlp	25500906	SENT108	13	13	3	3	trastuzumab	HER3	PA451743	2065	0.849
NULL	Cell_Death_Dis_2010_Nov_18_1(11)_e102.nxml.txt.nlp	21368867	SENT283	11	11	15	15	gentamicin	CLIMP-63	PA449753	10970	0.849
NULL	Open_Med_Chem_J_2011_Sep_9_5_82-92.nxml.txt.nlp	21966329	SENT70	3	3	12	12	exenatide	GLP-1	PA164749238	100125288	0.849
NULL	Nat_Commun_2013_Apr_23_4_1758.nxml.txt.nlp	23612299	SENT556	2	2	6	6	isoproterenol	SOD1	PA450121	6647	0.849
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT40	9	9	2	2	raltitrexed	UNG	PA131625240	7374	0.849
NULL	Ann_N_Y_Acad_Sci_2012_Oct_10_1271(1)_10-19.nxml.txt.nlp	23050959	SENT131	11	11	4	4	resveratrol	AMPK		5563	0.849
NULL	Biosci_Rep_2012_Aug_1_32(Pt_4)_361-374.nxml.txt.nlp	22762204	SENT191	19	19	8	8	temozolomide	CD44	PA451609	960	0.849
NULL	Cancers_(Basel)_2014_Oct_24_6(4)_2187-2223.nxml.txt.nlp	25347122	SENT977	23	23	6	6	cisplatin	BRCA1	PA449014	672	0.849
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Mar_21_68(Pt_4)_o1129.nxml.txt.nlp	22589984	SENT65	42	42	17	17	acetone	mol	PA448025	90527	0.849
NULL	Brain_2008_Nov_22_131(11)_3072-3080.nxml.txt.nlp	18945724	SENT80	41	41	20	20	cyclophosphamide	TPO	PA449165	7066;7173	0.849
NULL	Viruses_2014_Aug_19_6(8)_3181-3227.nxml.txt.nlp	25196285	SENT2534	16	16	4	4	imatinib	SIRT1	PA10804	23411	0.849
NULL	Breast_Cancer_Res_2012_Jun_19_14(3)_209.nxml.txt.nlp	22713170	SENT47	0	0	11	11	lapatinib	EGFR	PA152241907	1956	0.849
NULL	J_Hematol_Oncol_2011_Dec_1_4_49.nxml.txt.nlp	22128838	SENT33	4	4	19	19	bortezomib	Bcl-2	PA10252	596	0.849
NULL	Arthritis_Res_Ther_2005_Feb_17_7(Suppl_1)_P30.nxml.txt.nlp	NULL	SENT4	4	4	33	33	infliximab	TP2	PA452639	7015;7142	0.849
NULL	Crit_Care_2009_Mar_13_13(Suppl_1)_P168.nxml.txt.nlp	NULL	SENT25	7	7	11	11	levosimendan	LCO	PA164749138	3935	0.849
NULL	Mutat_Res_2010_Aug_7_690(1-2)_24-39.nxml.txt.nlp	19769993	SENT1669	12	12	1	1	methacholine	gamma	PA165958382	9913	0.849
NULL	Exp_Ther_Med_2013_Mar_21_5(3)_987-991.nxml.txt.nlp	23407636	SENT40	15	15	7	7	fluorescein	CXCR2	PA164746009	3579	0.849
NULL	Facts_Views_Vis_Obgyn_2011_3(2)_109-120.nxml.txt.nlp	24753856	SENT144	18	18	12	12	medroxyprogesterone	CEE	PA450344	51608	0.849
NULL	Mol_Cancer_2007_Apr_2_6_26.nxml.txt.nlp	17407576	SENT96	16	16	30	30	temozolomide	p53	PA451609	7157	0.849
NULL	Oncogene_2010_Mar_11_29(10)_1509-1518.nxml.txt.nlp	19946334	SENT150	9	9	4	4	bortezomib	pS2	PA10252	7031	0.849
NULL	Cancer_Med_2014_Aug_7_3(4)_796-811.nxml.txt.nlp	24802970	SENT240	24	24	8	8	amiloride	CD49f	PA448368	3655	0.849
NULL	Nat_Med_2014_Jul_8_20(7)_764-768.nxml.txt.nlp	24908571	SENT77	30	30	13	13	imipramine	GRM4	PA449969	2914	0.849
NULL	Diabetol_Metab_Syndr_2014_Mar_4_6_31.nxml.txt.nlp	24594121	SENT74	24	24	18	18	metformin	DM2	PA450395	28508	0.849
NULL	Acta_Pharmacol_Sin_2013_Apr_18_34(4)_555-560.nxml.txt.nlp	23503472	SENT6	21	21	11	11	cyclosporine	CYP3A5	PA449167	1577	0.849
NULL	Arthritis_Res_Ther_2011_Mar_16_13(2)_R44.nxml.txt.nlp	21410959	SENT312	1	1	8	8	glucosamine	RANKL	PA164747613	8600	0.849
NULL	Eur_J_Clin_Pharmacol_2012_Jan_7_68(1)_55-64.nxml.txt.nlp	21735164	SENT215	11	11	5	5	oxycodone	CYP2D6	PA450741	1565	0.849
NULL	J_Biol_Eng_2009_Oct_16_3_18.nxml.txt.nlp	19835592	SENT50	11	11	17	17	ciprofloxacin	CPZ	PA449009	8532	0.849
NULL	Clin_Sci_(Lond)_2013_Feb_1_124(Pt_3)_153-164.nxml.txt.nlp	23075334	SENT115	7	7	10	10	resveratrol	SIRT1		23411	0.849
NULL	Arthritis_Res_Ther_2008_Mar_6_10(2)_R29.nxml.txt.nlp	18321389	SENT115	27	27	6	6	hydroxychloroquine	IFN	PA164777036	3439	0.849
NULL	Front_Neurosci_2014_Jun_3_8_128.nxml.txt.nlp	24917782	SENT131	25	25	41	41	ethanol	MC4R	PA448073	4160	0.849
NULL	J_Gastroenterol_2014_Dec_24_49(12)_1536-1547.nxml.txt.nlp	24366288	SENT161	30	30	8	8	rabeprazole	CYP2C19	PA451216	1557	0.849
NULL	Aging_(Albany_NY)_2009_Jun_29_1(6)_511-514.nxml.txt.nlp	20157534	SENT66	2	2	20	20	resveratrol	AMPK		5563	0.849
NULL	Chin_J_Cancer_2011_Nov_30(11)_739-748.nxml.txt.nlp	22035854	SENT41	19	19	25	25	fludarabine	p53	PA449655	7157	0.849
NULL	Oncoscience_2014_Jul_27_1(7)_540-555.nxml.txt.nlp	25580447	SENT32	9	9	36	36	mitomycin	FANCD2	PA450524	2177	0.849
NULL	Aging_(Albany_NY)_2011_Apr_6_3(4)_444-449.nxml.txt.nlp	21483037	SENT71	19	19	11	11	resveratrol	SIRT1		23411	0.849
NULL	Eur_J_Haematol_2014_Feb_25_92(2)_127-136.nxml.txt.nlp	24118452	SENT212	11	11	7	7	anagrelide	CRT	PA164742986	811	0.849
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT151	38	38	31	31	glucose	ERK	PA449773	5594	0.849
NULL	J_Korean_Med_Sci_2005_Oct_31_20(5)_883-885.nxml.txt.nlp	16224167	SENT74	21	21	26	26	azathioprine	gamma	PA448515	9913	0.849
NULL	Eur_J_Med_Res_2010_Apr_8_15(4)_145-151.nxml.txt.nlp	20554495	SENT63	35	35	13	13	abacavir	HLA-B	PA448004	3106	0.849
NULL	Daru_2011_19(6)_455-461.nxml.txt.nlp	23008692	SENT149	6	6	13	13	daunorubicin	survivin	PA449212	332	0.849
NULL	Breast_Cancer_Res_2011_Dec_16_13(6)_R131.nxml.txt.nlp	22177475	SENT12	11	11	46	46	lapatinib	AKT	PA152241907	207	0.849
NULL	F1000Prime_Rep_2014_Apr_1_6_21.nxml.txt.nlp	24765526	SENT72	6	6	11	11	anakinra	IL-6	PA10799	3569	0.849
NULL	Oncotarget_2014_Jun_8_5(13)_5040-5053.nxml.txt.nlp	24970815	SENT112	3	3	0	0	cisplatin	PUMA	PA449014	27113	0.849
NULL	Cancer_Cell_Int_2011_Aug_19_11_29.nxml.txt.nlp	21854619	SENT140	29	29	0	0	cisplatin	BRCA1	PA449014	672	0.849
NULL	Mol_Cancer_2003_Jan_7_2_10.nxml.txt.nlp	12575899	SENT150	18	18	6	6	indomethacin	BOP	PA449982	611;150572	0.849
NULL	Contemp_Oncol_(Pozn)_2012_Nov_20_16(5)_401-406.nxml.txt.nlp	23788917	SENT95	18	18	25	25	erlotinib	EGFR	PA134687924	1956	0.849
NULL	Breast_Cancer_Res_2014_May_5_16(3)_R45.nxml.txt.nlp	24887236	SENT188	11	11	19	19	saracatinib	EGFR		1956	0.849
NULL	Arch_Gynecol_Obstet_2012_May_30_285(5)_1447-1453.nxml.txt.nlp	22127553	SENT40	17	17	1	1	carboplatin	TEC	PA448803	7006	0.849
NULL	Mol_Cancer_2010_Aug_20_9_220.nxml.txt.nlp	20727180	SENT140	0	0	10	10	curcumin	p53	PA151958596	7157	0.849
NULL	Int_J_Nanomedicine_2012_Nov_2_7_5625-5639.nxml.txt.nlp	23144562	SENT108	24	24	7	7	paraformaldehyde	CO2	PA450790	4513	0.849
NULL	BMB_Rep_2013_Nov_46(11)_544-549.nxml.txt.nlp	24152910	SENT26	15	15	13	13	thrombin	PAR-1	PA451674	2011;2149	0.849
NULL	Sci_Rep_2014_Dec_4_4_7310.nxml.txt.nlp	25472472	SENT129	5	5	12	12	decitabine	CD34	PA164749631	947	0.849
NULL	J_Cell_Biol_2004_Apr_26_165(2)_175-180.nxml.txt.nlp	15096524	SENT101	6	6	12	12	forskolin	ZO-1	PA146096022	7082	0.849
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Mar_6_65(Pt_4)_o703.nxml.txt.nlp	21582441	SENT53	12	12	9	9	ethanol	mol	PA448073	90527	0.849
NULL	Mol_Cell_Biochem_2014_Oct_9_385(1-2)_265-275.nxml.txt.nlp	24104452	SENT141	19	19	15	15	bortezomib	U87	PA10252	677775;641648	0.849
NULL	Mol_Biol_Cell_2013_Dec_15_24(24)_3776-3786.nxml.txt.nlp	24131995	SENT128	18	18	0	0	geldanamycin	SGK1	PA152031327	6446	0.849
NULL	Antonie_Van_Leeuwenhoek_2014_Aug_5_106_693-706.nxml.txt.nlp	25090957	SENT155	10	10	2	2	glucosamine	LTA	PA164747613	4049	0.849
NULL	Oncoimmunology_2013_Jun_1_2(6)_e24452.nxml.txt.nlp	23894705	SENT12	39	39	26	26	imatinib	KIT	PA10804	3815	0.849
NULL	Environ_Health_Perspect_2006_Sep_23_114(9)_1401-1406.nxml.txt.nlp	16966095	SENT119	13	13	5	5	tetracycline	p53	PA451640	7157	0.849
NULL	Hum_Genomics_Proteomics_2010_Aug_3_2010_159761.nxml.txt.nlp	20981231	SENT127	8	8	31	31	lithium	c-Jun	PA450243	3725	0.849
NULL	Front_Oncol_2014_Apr_9_4_75.nxml.txt.nlp	24782986	SENT17	5	5	16	16	paclitaxel	Oct4	PA450761	5460	0.849
NULL	Mol_Brain_2014_Apr_24_7_32.nxml.txt.nlp	24758222	SENT187	4	4	1	1	metyrapone	CORT	PA450486	1325	0.849
NULL	Breast_Cancer_Res_Treat_2014_Mar_2_144(2)_371-378.nxml.txt.nlp	24584875	SENT235	2	2	17	17	anastrozole	ATAC	PA448432	6375	0.849
NULL	Br_J_Cancer_2009_Mar_24_100(6)_941-949.nxml.txt.nlp	19240716	SENT142	21	21	6	6	gefitinib	Met	PA131301952	79811	0.849
NULL	Biomed_Res_Int_2013_Aug_6_2013_602987.nxml.txt.nlp	24027759	SENT263	25	25	20	20	cisplatin	SMF	PA449014	22993	0.849
NULL	Clin_Pharmacol_2011_Jun_22_3_13-25.nxml.txt.nlp	22287853	SENT127	11	11	27	27	saxagliptin	ANOVA	PA165958362	4858	0.849
NULL	Jpn_Clin_Med_2013_Apr_9_4_21-24.nxml.txt.nlp	23966813	SENT32	9	9	11	11	diethylstilbestrol	DES	PA449307	1674	0.849
NULL	Oxid_Med_Cell_Longev_2009_Sep-Oct_2(4)_214-221.nxml.txt.nlp	20716907	SENT232	3	3	33	33	pilocarpine	P400	PA450962	57634	0.849
NULL	Calcif_Tissue_Int_2010_Nov_20_87(5)_375-384.nxml.txt.nlp	20725827	SENT227	7	7	19	19	teriparatide	DANCE	PA451620	10516	0.849
NULL	Exp_Hematol_Oncol_2014_Feb_17_3_6.nxml.txt.nlp	24528501	SENT7	1	1	16	16	dasatinib	CD34	PA162372878	947	0.849
NULL	Hematol_Rep_2013_Jan_25_5(1)_5-7.nxml.txt.nlp	23888238	SENT79	3	3	11	11	rituximab	VWF	PA451261	7450	0.849
NULL	Breast_Cancer_(Auckl)_2009_Sep_2_3_61-75.nxml.txt.nlp	19809577	SENT269	17	17	7	7	curcumin	PARP	PA151958596	142	0.849
NULL	Acta_Pharmacol_Sin_2014_Jun_4_35(6)_752-757.nxml.txt.nlp	24902786	SENT11	4	4	23	23	letrozole	STZ	PA450196	6484	0.849
NULL	Evid_Based_Complement_Alternat_Med_2013_Mar_19_2013_184358.nxml.txt.nlp	23573117	SENT249	0	0	24	24	resveratrol	AMPK		5563	0.849
NULL	Clin_Med_Insights_Oncol_2011_Mar_16_5_35-43.nxml.txt.nlp	21499557	SENT46	25	25	15	15	doxorubicin	p53	PA449412	7157	0.849
NULL	CNS_Drugs_2013_Jun_26_27(9)_743-751.nxml.txt.nlp	23801529	SENT125	17	17	23	23	lisdexamfetamine	NNT	PA164748975	23530	0.849
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT533	27	27	3	3	pp2	CDH1		51343;999	0.849
NULL	Saudi_J_Anaesth_2013_Apr-Jun_7(2)_151-154.nxml.txt.nlp	23956714	SENT86	19	19	21	21	theophylline	NAC	PA451647	22861	0.849
NULL	Br_J_Cancer_2010_Jul_27_103(3)_347-353.nxml.txt.nlp	20628392	SENT43	17	17	7	7	l-glutamine	EGFR	PA10090	1956	0.849
NULL	Crit_Rev_Toxicol_2013_Mar_13_43(3)_200-219.nxml.txt.nlp	23405971	SENT157	23	23	3	3	estradiol	BBP	PA449503	83941	0.849
NULL	Breast_Cancer_Res_2008_Jul_24_10(4)_211.nxml.txt.nlp	18671839	SENT139	5	5	2	2	flavopiridol	survivin	PA452627	332	0.849
NULL	Croat_Med_J_2013_Apr_54(2)_171-179.nxml.txt.nlp	23630144	SENT172	0	0	10	10	taurine	STZ	PA451590	6484	0.849
NULL	Ann_Dermatol_2014_Dec_26_26(6)_706-712.nxml.txt.nlp	25473222	SENT6	20	20	8	8	isotretinoin	EPO	PA450128	7076;8288;2056	0.849
NULL	Springerplus_2013_Dec_18_2_679.nxml.txt.nlp	24386625	SENT58	8	8	5	5	vemurafenib	BRAF	PA165946873	673	0.849
NULL	Biologics_2010_Nov_9_4_289-298.nxml.txt.nlp	21116327	SENT29	35	35	24	24	cetuximab	EGFR	PA10040	1956	0.849
NULL	Br_J_Pharmacol_2008_Nov_11_155(6)_896-905.nxml.txt.nlp	18695641	SENT152	8	8	12	12	genistein	OPG	PA165109660	690	0.849
NULL	Toxins_(Basel)_2010_Mar_31_2(4)_517-551.nxml.txt.nlp	22069598	SENT127	5	5	13	13	curcumin	STAT3	PA151958596	6774	0.849
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT29	4	4	14	14	gefitinib	PI3K	PA131301952	5290	0.849
NULL	Pharmaceuticals_(Basel)_2011_Oct_25_4(11)_1400-1422.nxml.txt.nlp	NULL	SENT220	16	16	0	0	irinotecan	TRAP1	PA450085	9392;10131	0.849
NULL	Front_Oncol_2013_Nov_15_3_281.nxml.txt.nlp	24298448	SENT78	24	24	22	22	panitumumab	EGFR	PA162373091	1956	0.849
NULL	Antimicrob_Agents_Chemother_2013_Oct_57(10)_4872-4876.nxml.txt.nlp	23877700	SENT38	5	5	21	21	vancomycin	San	PA451850	80218	0.849
NULL	J_Mol_Med_(Berl)_2013_Aug_17_91(11)_1257-1271.nxml.txt.nlp	23955016	SENT186	38	38	6	6	thrombin	p38	PA451674	10598;1432;7965	0.849
NULL	Mol_Cancer_2010_Nov_2_9_289.nxml.txt.nlp	21044322	SENT173	22	22	7	7	vincristine	RGS10	PA451879	6001	0.849
NULL	Subst_Abuse_Rehabil_2013_Nov_6_4_75-82.nxml.txt.nlp	24648790	SENT71	8	8	5	5	quinidine	CYP2D6	PA451209	1565	0.849
NULL	Target_Oncol_2013_Jun_27_8(2)_127-136.nxml.txt.nlp	23625191	SENT4	19	19	27	27	panitumumab	KRAS	PA162373091	3845	0.849
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT360	14	14	4	4	pp2	STAT3		6774	0.849
NULL	Exp_Ther_Med_2015_Feb_15_9(2)_384-388.nxml.txt.nlp	25574202	SENT102	14	14	27	27	iohexol	ROS	PA450061	6098	0.849
NULL	Vet_Res_Forum_2013_Winter_4(1)_19-24.nxml.txt.nlp	25593681	SENT84	31	31	26	26	diclofenac	B12	PA449293	7126;4709	0.849
NULL	Cancer_Immunol_Immunother_2012_Jul_23_61(7)_1101-1111.nxml.txt.nlp	22193989	SENT211	5	5	7	7	oxaliplatin	PD-L1	PA131285527	29126	0.849
NULL	Cell_Death_Dis_2010_May_13_1(5)_e41.nxml.txt.nlp	21364648	SENT130	12	12	9	9	etoposide	FasL	PA449552	356	0.849
NULL	Mol_Cancer_2012_Jul_12_11_45.nxml.txt.nlp	22788833	SENT136	30	30	12	12	cisplatin	EGFR	PA449014	1956	0.849
NULL	Apoptosis_2014_Aug_26_19(11)_1603-1615.nxml.txt.nlp	25156145	SENT273	2	2	20	20	mitomycin	JNK	PA450524	5599	0.849
NULL	J_Lipid_Res_2014_Aug_55(8)_1657-1667.nxml.txt.nlp	24879802	SENT237	4	4	17	17	bortezomib	ACSL4	PA10252	2182	0.849
NULL	J_Cell_Biol_2001_Mar_19_152(6)_1169-1182.nxml.txt.nlp	11257118	SENT682	10	10	19	19	trypsin	CD47	PA451806	961	0.849
NULL	Cancers_(Basel)_2012_Apr_25_4(2)_475-489.nxml.txt.nlp	22582143	SENT293	8	8	3	3	tamoxifen	Rho	PA451581	29984	0.849
NULL	Adv_Hematol_2012_Mar_8_2012_856341.nxml.txt.nlp	22496694	SENT181	23	23	20	20	verapamil	P-gp	PA451868	5243	0.849
NULL	Front_Oncol_2014_May_14_4_106.nxml.txt.nlp	24860786	SENT269	42	42	32	32	tamoxifen	TIMELESS	PA451581	8914	0.849
NULL	Int_J_Mol_Sci_2014_Oct_27_15(11)_19417-19443.nxml.txt.nlp	25350109	SENT192	7	7	13	13	nadh	p47phox	PA164755085	653361	0.849
NULL	J_Hepatol_2013_Aug_59(2)_318-326.nxml.txt.nlp	23624001	SENT213	32	32	15	15	oxaliplatin	VEGF-D	PA131285527	2277	0.849
NULL	Environ_Health_Perspect_2009_Feb_117(2)_A75.nxml.txt.nlp	NULL	SENT23	8	8	12	12	doxorubicin	Bcl-2	PA449412	596	0.849
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT2406	38	38	6	6	amiodarone	ROS	PA448383	6098	0.849
NULL	Exp_Hematol_Oncol_2013_Nov_8_2_30.nxml.txt.nlp	24499550	SENT101	5	5	11	11	vinblastine	IL-2	PA451877	3558	0.849
NULL	J_Korean_Med_Sci_2002_Apr_17(2)_208-212.nxml.txt.nlp	11961304	SENT11	3	3	28	28	losartan	IL-6	PA450268	3569	0.849
NULL	Chemother_Res_Pract_2011_Dec_1_2011_715469.nxml.txt.nlp	22312557	SENT101	6	6	20	20	cisplatin	P21	PA449014	1026;9338	0.849
NULL	J_Asthma_Allergy_2008_Sep_19_1_19-29.nxml.txt.nlp	21436982	SENT110	30	30	26	26	fexofenadine	TARC	PA449621	6361	0.849
NULL	Indian_J_Sex_Transm_Dis_2013_Jul-Dec_34(2)_148-149.nxml.txt.nlp	24339470	SENT18	10	10	28	28	efavirenz	AKT	PA449441	207	0.849
NULL	Thorax_2010_Jul_13_65(7)_654-658.nxml.txt.nlp	20627927	SENT214	6	6	12	12	minocycline	p38	PA450519	10598;1432;7965	0.849
NULL	Eur_Heart_J_2014_Jun_14_35(23)_1510-1514.nxml.txt.nlp	24748565	SENT24	32	32	6	6	prasugrel	P2Y12	PA154410481	64805	0.849
NULL	Oncol_Rep_2014_Sep_20_32(3)_875-886.nxml.txt.nlp	24969320	SENT153	16	16	14	14	imiquimod	TLR7	PA449972	51284	0.849
NULL	Diabetes_Obes_Metab_2010_Aug_12(8)_700-708.nxml.txt.nlp	20590747	SENT191	18	18	32	32	voglibose	PPG	PA164752433	5552	0.849
NULL	J_Cardiovasc_Dis_Res_2010_Jan-Mar_1(1)_19-22.nxml.txt.nlp	21188085	SENT150	25	25	42	42	valsartan	AT1	PA451848	9197;185	0.849
NULL	Int_J_Biomed_Sci_2006_Dec_2(4)_375-394.nxml.txt.nlp	23675006	SENT55	14	14	30	30	estradiol	ACTH	PA449503	5443	0.849
NULL	Br_J_Cancer_2014_Mar_4_110(5)_1221-1227.nxml.txt.nlp	24496456	SENT26	24	24	15	15	panitumumab	EGFR	PA162373091	1956	0.849
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT33	25	25	21	21	gefitinib	KRAS	PA131301952	3845	0.849
NULL	Int_J_Endocrinol_2012_Dec_22_2012_789653.nxml.txt.nlp	22235202	SENT152	29	29	14	14	estradiol	aromatase	PA449503	1588	0.849
NULL	Curr_Med_Chem_2014_May_21(14)_1595-1606.nxml.txt.nlp	23992330	SENT67	7	7	22	22	trastuzumab	MUC4	PA451743	4585	0.849
NULL	Oncol_Rep_2013_Mar_8_29(3)_917-924.nxml.txt.nlp	23314174	SENT9	5	5	11	11	sorafenib	CD24	PA7000	100133941	0.849
NULL	Evid_Based_Complement_Alternat_Med_2014_May_21_2014_707908.nxml.txt.nlp	25628748	SENT5	7	7	11	11	ethanol	flower	PA448073	11094	0.849
NULL	Front_Neurosci_2014_Feb_7_8_14.nxml.txt.nlp	24570653	SENT51	21	21	11	11	capsaicin	TRPM8	PA448776	79054	0.849
NULL	Cancer_Cell_Int_2012_Jul_4_12_19.nxml.txt.nlp	22631225	SENT233	16	16	3	3	heparin	PPIA	PA449855	5478	0.849
NULL	J_Cancer_Prev_2014_Mar_19(1)_7-13.nxml.txt.nlp	25337567	SENT100	5	5	26	26	evodiamine	Bcl-2	PA165860788	596	0.849
NULL	Br_J_Cancer_2013_Feb_19_108(3)_570-578.nxml.txt.nlp	23299527	SENT143	30	30	38	38	acetohexamide	MLC2	PA164777011	10398	0.849
NULL	Cancers_(Basel)_2013_Jun_5_5(2)_676-713.nxml.txt.nlp	24216997	SENT122	7	7	19	19	s-adenosylmethionine	DNMT1	PA164754994	1786	0.849
NULL	Drugs_2012_Sep_6_72(9)_e1-e25.nxml.txt.nlp	22686620	SENT484	4	4	15	15	zidovudine	CD4	PA451954	920	0.849
NULL	Crit_Care_2007_Aug_14_11(4)_220.nxml.txt.nlp	17705883	SENT287	7	7	25	25	dapsone	San	PA449211	80218	0.849
NULL	Onco_Targets_Ther_2014_Sep_9_7_1571-1582.nxml.txt.nlp	25228815	SENT139	4	4	15	15	sunitinib	CD31	PA162372840	5175	0.849
NULL	Case_Rep_Hematol_2012_Nov_7_2012_589718.nxml.txt.nlp	23198191	SENT64	7	7	9	9	chlorambucil	CHOP	PA448926	1649	0.849
NULL	Clinics_(Sao_Paulo)_2013_May_68(5)_579-585.nxml.txt.nlp	23778418	SENT56	5	5	13	13	desmopressin	ACTH	PA449237	5443	0.849
NULL	Patient_Prefer_Adherence_2013_Jan_9_7_35-45.nxml.txt.nlp	23341736	SENT260	10	10	6	6	liraglutide	GLP-1	PA165958364	100125288	0.849
NULL	Mol_Cancer_2014_Jun_24_13_157.nxml.txt.nlp	24958351	SENT44	16	16	10	10	trastuzumab	HER2	PA451743	2064	0.849
NULL	Stroke_Res_Treat_2012_Nov_30_2012_382361.nxml.txt.nlp	22195291	SENT85	6	6	13	13	dipyridamole	CEA	PA449367	5670;1087	0.849
NULL	Indian_J_Pharm_Sci_2014_Mar-Apr_76(2)_125-131.nxml.txt.nlp	24843185	SENT9	5	5	14	14	resveratrol	CA1		759	0.849
NULL	Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.nxml.txt.nlp	24736980	SENT6	22	22	25	25	rosuvastatin	OATP1B1	PA134308647	10599	0.849
NULL	Acta_Pharmacol_Sin_2012_Jan_28_33(1)_75-81.nxml.txt.nlp	22120969	SENT92	0	0	12	12	exenatide	GLP-1	PA164749238	100125288	0.849
NULL	Hum_Genet_2014_Nov_19_133(4)_463-469.nxml.txt.nlp	24241281	SENT123	32	32	24	24	cetuximab	KRAS	PA10040	3845	0.849
NULL	Int_Clin_Psychopharmacol_2014_Jul_26_29(4)_185-196.nxml.txt.nlp	24424469	SENT10	14	14	11	11	sertraline	CYP2D6	PA451333	1565	0.849
NULL	Int_J_Surg_Oncol_2012_Jun_12_2012_862879.nxml.txt.nlp	22778941	SENT124	40	40	4	4	cisplatin	PARP1	PA449014	142	0.849
NULL	Ann_Gen_Psychiatry_2008_Oct_15_7_19.nxml.txt.nlp	18922171	SENT93	30	30	17	17	bupropion	CD50	PA448687	3385	0.849
NULL	Cancers_(Basel)_2010_May_26_2(2)_955-969.nxml.txt.nlp	24281101	SENT59	14	14	7	7	dacarbazine	BHD	PA449197	201163	0.849
NULL	Case_Rep_Endocrinol_2013_Dec_22_2013_675298.nxml.txt.nlp	24455332	SENT154	10	10	15	15	vincristine	ACTH	PA451879	5443	0.849
NULL	Cancer_Cell_Int_2013_Sep_23_13_94.nxml.txt.nlp	24059699	SENT104	29	29	6	6	bevacizumab	VEGFR1	PA130232992	2321	0.849
NULL	Mol_Cancer_2013_Nov_13_12_137.nxml.txt.nlp	24225025	SENT335	0	0	8	8	simvastatin	San	PA451363	80218	0.849
NULL	Arthritis_Res_Ther_2009_Nov_4_11(6)_R165.nxml.txt.nlp	19889203	SENT356	0	0	17	17	resveratrol	MMP3		4314	0.849
NULL	Int_J_Cell_Biol_2010_Apr_29_2010_928169.nxml.txt.nlp	20454702	SENT217	20	20	13	13	nystatin	AP-2	PA450666	7020	0.848
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT219	7	7	24	24	atorvastatin	RANK	PA448500	8792	0.848
NULL	Physiol_Rep_2014_Aug_28_2(8)_e12108.nxml.txt.nlp	25168868	SENT297	7	7	5	5	olmesartan	AT1	PA164742950	9197;185	0.848
NULL	J_Gynecol_Oncol_2013_Jan_8_24(1)_66-82.nxml.txt.nlp	23346316	SENT249	0	0	31	31	pertuzumab	HER2		2064	0.848
NULL	Br_J_Cancer_2010_Sep_7_103(6)_845-851.nxml.txt.nlp	20700125	SENT36	21	21	12	12	capecitabine	DPD	PA448771	1806	0.848
NULL	Biol_Open_2014_May_2_3(6)_418-430.nxml.txt.nlp	24795145	SENT126	15	15	11	11	etoposide	HDAC6	PA449552	10013	0.848
NULL	Int_J_Mol_Sci_2014_Oct_20_15(10)_18856-18891.nxml.txt.nlp	25334061	SENT1532	1	1	9	9	metformin	AKT	PA450395	207	0.848
NULL	Br_J_Cancer_1995_Sep_72(3)_543-549.nxml.txt.nlp	7669559	SENT10	19	19	40	40	daunorubicin	P-gp	PA449212	5243	0.848
NULL	Mol_Cancer_2014_Jun_24_13_157.nxml.txt.nlp	24958351	SENT206	7	7	20	20	lapatinib	HER2	PA152241907	2064	0.848
NULL	Front_Physiol_2012_Oct_19_3_56.nxml.txt.nlp	23091461	SENT298	2	2	24	24	clodronate	IL-18	PA10239	3606	0.848
NULL	J_Innate_Immun_2011_Dec_12_4(1)_69-79.nxml.txt.nlp	21997473	SENT207	3	3	0	0	hyaluronan	CD44	PA165958431	960	0.848
NULL	Breast_Cancer_Res_2014_May_30_16(3)_R55.nxml.txt.nlp	24886669	SENT174	29	29	9	9	doxorubicin	p53	PA449412	7157	0.848
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_May_14_65(Pt_6)_o1257.nxml.txt.nlp	21583122	SENT58	9	9	21	21	ethanol	mol	PA448073	90527	0.848
NULL	Med_Sci_Monit_2013_Nov_17_19_1006-1012.nxml.txt.nlp	24241246	SENT155	18	18	8	8	fluvastatin	CD14	PA449688	929	0.848
NULL	Environ_Health_Perspect_1990_Aug_88_117-121.nxml.txt.nlp	2272305	SENT2	12	12	14	14	diethylstilbestrol	DES	PA449307	1674	0.848
NULL	J_Oncol_2013_Aug_20_2013_732047.nxml.txt.nlp	24027583	SENT109	13	13	4	4	epirubicin	HER2	PA449476	2064	0.848
NULL	Contemp_Oncol_(Pozn)_2012_Jul_6_16(3)_223-229.nxml.txt.nlp	23788884	SENT92	0	0	21	21	metformin	E2F1	PA450395	1869	0.848
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT82	23	23	7	7	vinorelbine	HER2	PA451881	2064	0.848
NULL	Acta_Neuropathol_Commun_2014_May_30_2_57.nxml.txt.nlp	24887326	SENT272	6	6	10	10	vardenafil	ABCB1	PA10229	5243	0.848
NULL	Oncotarget_2014_Jun_6_5(13)_4935-4944.nxml.txt.nlp	24952732	SENT5	0	0	15	15	doxazosin	PI3K	PA449407	5290	0.848
NULL	Oncotarget_2013_Nov_15_5(6)_1458-1474.nxml.txt.nlp	24681547	SENT126	6	6	4	4	celecoxib	CDH11	PA448871	1009	0.848
NULL	Br_J_Cancer_2010_Jul_13_103(2)_265-274.nxml.txt.nlp	20551953	SENT329	5	5	0	0	cisplatin	JNK	PA449014	5599	0.848
NULL	Indian_J_Psychol_Med_2013_Jul-Sep_35(3)_311-313.nxml.txt.nlp	24249938	SENT76	27	27	25	25	warfarin	CYP2C9	PA451906	1559	0.848
NULL	J_Cachexia_Sarcopenia_Muscle_2011_Dec_8_2(4)_209-261.nxml.txt.nlp	22476871	SENT89	12	12	39	39	resveratrol	SIRT1		23411	0.848
NULL	Mol_Cancer_2009_Apr_22_8_26.nxml.txt.nlp	19386116	SENT189	24	24	11	11	ritonavir	AKT	PA451260	207	0.848
NULL	J_Cell_Mol_Med_2014_Nov_11_18(11)_2275-2286.nxml.txt.nlp	25208472	SENT40	16	16	8	8	cisplatin	p53	PA449014	7157	0.848
NULL	Front_Neurosci_2011_Jan_14_4_207.nxml.txt.nlp	21258618	SENT12	6	6	36	36	ethanol	CRF1	PA448073	1394	0.848
NULL	Acta_Pharmacol_Sin_2013_Jan_17_34(1)_157-166.nxml.txt.nlp	23247593	SENT142	36	36	2	2	berberine	Set9	PA165860812	80854	0.848
NULL	Cancers_(Basel)_2014_May_16_6(2)_1180-1194.nxml.txt.nlp	24840048	SENT125	12	12	32	32	pazopanib	KIT	PA165291492	3815	0.848
NULL	Open_Biochem_J_2007_Jun_15_1_1-6.nxml.txt.nlp	18949066	SENT60	18	18	26	26	suramin	CPX	PA10292	1371;10682;1377	0.848
NULL	Case_Rep_Oncol_2014_Apr_25_7(1)_277-284.nxml.txt.nlp	24926257	SENT23	14	14	24	24	lenalidomide	p53	PA162363968	7157	0.848
NULL	J_Mol_Signal_2010_May_10_5_4.nxml.txt.nlp	20459745	SENT122	10	10	2	2	cisplatin	p53	PA449014	7157	0.848
NULL	Acta_Pharmacol_Sin_2011_Oct_15_32(10)_1253-1258.nxml.txt.nlp	21970837	SENT87	17	17	11	11	darapladib	IL-6	PA165884699	3569	0.848
NULL	Brain_Res_2011_Mar_25_1382(C)_29-36.nxml.txt.nlp	21276431	SENT39	0	0	9	9	ketanserin	5-HT2C	PA131053734	3358	0.848
NULL	Anesthesiol_Res_Pract_2013_Jul_29_2013_236089.nxml.txt.nlp	23983684	SENT78	14	14	0	0	dexmedetomidine	NNT	PA449256	23530	0.848
NULL	Mol_Cancer_2008_Sep_12_7_69.nxml.txt.nlp	18789131	SENT171	16	16	26	26	pp2	EGFR		1956	0.848
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT267	20	20	9	9	warfarin	CYP2C9	PA451906	1559	0.848
NULL	Cancer_Cell_Int_2013_Jun_17_13_61.nxml.txt.nlp	23773282	SENT465	16	16	31	31	etoposide	p53	PA449552	7157	0.848
NULL	Acta_Pharmacol_Sin_2010_Oct_30_31(10)_1359-1366.nxml.txt.nlp	20802507	SENT157	16	16	3	3	forskolin	ADM	PA146096022	133	0.848
NULL	Cell_Death_Dis_2014_Feb_27_5(2)_e1088.nxml.txt.nlp	24577086	SENT340	37	37	17	17	metformin	Bcl-2	PA450395	596	0.848
NULL	J_Brachial_Plex_Peripher_Nerve_Inj_2008_Mar_19_3_8.nxml.txt.nlp	18353188	SENT40	26	26	15	15	capsaicin	SSeCKS	PA448776	9590	0.848
NULL	Neural_Plast_2007_Oct_10_2007_23250.nxml.txt.nlp	NULL	SENT4481	21	21	9	9	anastrozole	CA3	PA448432	761	0.848
NULL	J_Gen_Physiol_2009_Oct_134(4)_323-337.nxml.txt.nlp	19786585	SENT329	1	1	33	33	dantrolene	ClC-1	PA449208	1180	0.848
NULL	Sci_Rep_2014_Nov_28_4_7237.nxml.txt.nlp	25429875	SENT108	3	3	16	16	hesperidin	p38	PA449867	10598;1432;7965	0.848
NULL	Br_J_Cancer_2012_Oct_9_107(8)_1233-1238.nxml.txt.nlp	22955852	SENT31	40	40	15	15	docetaxel	RPN2	PA449383	6185	0.848
NULL	J_Inherit_Metab_Dis_2012_Jan_10_35(1)_141-149.nxml.txt.nlp	21556832	SENT187	7	7	1	1	creatine	CRTR	PA164778930	6535	0.848
NULL	J_Hematol_Oncol_2012_Apr_25_5(Suppl_1)_A1.nxml.txt.nlp	22738713	SENT21	29	29	5	5	docetaxel	HER2	PA449383	2064	0.848
NULL	Oncotarget_2012_Oct_20_3(10)_1068-1111.nxml.txt.nlp	23085539	SENT535	22	22	17	17	gefitinib	PIK3CA	PA131301952	5290	0.848
NULL	Clin_Exp_Pharmacol_Physiol_2009_Oct_36(10)_969-980.nxml.txt.nlp	19298534	SENT250	21	21	46	46	nifedipine	spatial	PA450631	219793	0.848
NULL	Am_J_Trop_Med_Hyg_2012_Mar_1_86(3)_489-495.nxml.txt.nlp	22403324	SENT179	13	13	23	23	ritonavir	P-gp	PA451260	5243	0.848
NULL	Cancer_Immunol_Immunother_2014_Feb_11_63(5)_419-435.nxml.txt.nlp	24514955	SENT57	29	29	42	42	sunitinib	IL-12B	PA162372840	3593	0.848
NULL	Oncotarget_2011_Dec_24_2(12)_896-917.nxml.txt.nlp	22203527	SENT207	0	0	10	10	metformin	CD24	PA450395	100133941	0.848
NULL	Front_Oncol_2014_Mar_25_4_54.nxml.txt.nlp	24724051	SENT421	5	5	30	30	nilotinib	AXL	PA165958345	558	0.848
NULL	Clinics_(Sao_Paulo)_2014_Jan_69(1)_68-74.nxml.txt.nlp	24473562	SENT22	5	5	10	10	nutlin-3	p53		7157	0.848
NULL	Breast_Cancer_Res_2010_Jun_28_12(3)_R43.nxml.txt.nlp	20579400	SENT129	20	20	5	5	doxorubicin	MAPT	PA449412	4137	0.848
NULL	Breast_Cancer_Res_2010_May_18_12(Suppl_1)_P58.nxml.txt.nlp	NULL	SENT13	11	11	8	8	doxorubicin	TRAIL	PA449412	8743	0.848
NULL	Clin_Cosmet_Investig_Dermatol_2014_Sep_2_7_243-249.nxml.txt.nlp	25214798	SENT88	24	24	8	8	ustekinumab	ACR	PA166048654	49	0.848
NULL	J_Breast_Cancer_2013_Sep_30_16(3)_274-284.nxml.txt.nlp	24155756	SENT49	18	18	33	33	tamoxifen	aromatase	PA451581	1588	0.848
NULL	Dement_Geriatr_Cogn_Dis_Extra_2014_Nov_15_4(3)_450-456.nxml.txt.nlp	25538729	SENT24	12	12	1	1	donepezil	CYP2D6	PA449394	1565	0.848
NULL	Aging_(Albany_NY)_2012_Jul_22_4(7)_480-498.nxml.txt.nlp	22837425	SENT132	0	0	35	35	metformin	AMPK	PA450395	5563	0.848
NULL	Cell_Death_Dis_2010_May_13_1(5)_e41.nxml.txt.nlp	21364648	SENT306	23	23	14	14	etoposide	p53	PA449552	7157	0.848
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT98	11	11	22	22	bevacizumab	VEGFR2	PA130232992	3791	0.848
NULL	Br_J_Cancer_2012_Nov_6_107(10)_1745-1753.nxml.txt.nlp	23099808	SENT22	0	0	19	19	gefitinib	EGFR	PA131301952	1956	0.848
NULL	Diabetes_Metab_J_2013_Aug_14_37(4)_240-248.nxml.txt.nlp	23991401	SENT48	15	15	12	12	ezetimibe	NPC1L1	PA10816	29881	0.848
NULL	Arthritis_Res_Ther_2005_Feb_18_7(3)_R476-R484.nxml.txt.nlp	15899034	SENT138	5	5	8	8	thrombin	IL-6	PA451674	3569	0.848
NULL	Biomed_Res_Int_2013_Feb_19_2013_814390.nxml.txt.nlp	24575399	SENT71	3	3	5	5	lovastatin	ADAM10	PA450272	102	0.848
NULL	Cancers_(Basel)_2014_Jun_27_6(3)_1298-1327.nxml.txt.nlp	24978435	SENT914	1	1	9	9	finasteride	MMP2	PA449627	4313	0.848
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT187	16	16	28	28	bevacizumab	VEGFR1	PA130232992	2321	0.848
NULL	Mol_Cancer_2010_Nov_8_9_291.nxml.txt.nlp	21059223	SENT185	24	24	11	11	paclitaxel	ZNF217	PA450761	7764	0.848
NULL	J_Carcinog_2013_Dec_31_12_22.nxml.txt.nlp	24574860	SENT234	23	23	19	19	docetaxel	KRAS	PA449383	3845	0.848
NULL	Nat_Commun_2014_Jun_9_5_3986.nxml.txt.nlp	24909159	SENT18	26	26	15	15	imiquimod	IL-23	PA449972	51561	0.848
NULL	Br_J_Cancer_2011_Apr_12_104(8)_1278-1287.nxml.txt.nlp	21487429	SENT137	3	3	5	5	cisplatin	p53	PA449014	7157	0.848
NULL	Oncol_Rep_2013_May_21_29(5)_1721-1729.nxml.txt.nlp	23440494	SENT165	17	17	24	24	mitoxantrone	ADM	PA450526	133	0.848
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1013.nxml.txt.nlp	24457957	SENT316	3	3	10	10	bortezomib	NOXA	PA10252	5366	0.848
NULL	J_Korean_Med_Sci_2006_Dec_31_21(6)_1037-1040.nxml.txt.nlp	17179683	SENT90	16	16	22	22	clarithromycin	BAM	PA449028	9126	0.848
NULL	Breast_Cancer_Res_2010_May_10_12(3)_R26.nxml.txt.nlp	20459744	SENT115	27	27	22	22	cyclophosphamide	GSTT1	PA449165	2952	0.848
NULL	Mol_Cancer_2013_Nov_15_12_139.nxml.txt.nlp	24238140	SENT199	15	15	3	3	paraformaldehyde	ALDH1A1	PA450790	216	0.848
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT118	5	5	8	8	metformin	HIF-1	PA450395	29072	0.848
NULL	Cancer_Biol_Med_2012_Mar_9(1)_1-8.nxml.txt.nlp	23691447	SENT170	10	10	2	2	lipase	LPA	PA450239	4018	0.848
NULL	Chem_Rev_2011_Oct_12_111(10)_5899-5921.nxml.txt.nlp	21923193	SENT478	13	13	15	15	ether	IL-2	PA449525	3558	0.848
NULL	Arthritis_Res_Ther_2003_Oct_2_5(Suppl_4)_S17-S21.nxml.txt.nlp	15180893	SENT54	5	5	17	17	cyclophosphamide	ACR	PA449165	49	0.848
NULL	Clin_Pharmacol_2010_Jun_22_2_105-110.nxml.txt.nlp	22291493	SENT55	23	23	11	11	sibutramine	ADIPOQ	PA451344	9370	0.848
NULL	Br_J_Cancer_2013_Feb_19_108(3)_557-563.nxml.txt.nlp	23361053	SENT96	18	18	4	4	tamoxifen	PAK1	PA451581	5585;5058	0.848
NULL	Oncotarget_2013_Jan_14_4(1)_118-127.nxml.txt.nlp	23435217	SENT35	28	28	15	15	bevacizumab	EGFR	PA130232992	1956	0.848
NULL	Acta_Pharmacol_Sin_2014_Oct_25_35(10)_1293-1301.nxml.txt.nlp	25152022	SENT168	0	0	2	2	enalapril	NLRP3	PA449456	114548	0.848
NULL	Neural_Regen_Res_2014_Apr_15_9(8)_878-887.nxml.txt.nlp	25206906	SENT181	25	25	8	8	capsaicin	TRPV1	PA448776	7442	0.848
NULL	Clin_Med_Cardiol_2009_Sep_3_3_77-91.nxml.txt.nlp	20508768	SENT51	32	32	6	6	clopidogrel	P2Y12	PA449053	64805	0.848
NULL	Protein_Cell_2014_Jul_10_5(7)_532-543.nxml.txt.nlp	24715268	SENT126	6	6	12	12	pp2	FXYD6		53826	0.848
NULL	Mol_Cancer_2014_Jun_30_13_160.nxml.txt.nlp	24976026	SENT161	16	16	5	5	bortezomib	AGR2	PA10252	10551	0.848
NULL	Mol_Pain_2012_Sep_22_8_71.nxml.txt.nlp	22998838	SENT132	41	41	30	30	cisplatin	CB1	PA449014	1268	0.848
NULL	Front_Neuroenergetics_2014_Jan_9_5_13.nxml.txt.nlp	24409143	SENT229	17	17	29	29	pentobarbital	FDG	PA450859	23583	0.848
NULL	J_Res_Med_Sci_2012_Jul_17(7)_642-648.nxml.txt.nlp	23798924	SENT49	18	18	15	15	gliclazide	ACE	PA10892	1636	0.848
NULL	Korean_J_Thorac_Cardiovasc_Surg_2014_Aug_5_47(4)_350-357.nxml.txt.nlp	25207243	SENT68	1	1	15	15	protamine	ACT	PA10366	12;11332;9457;641455	0.848
NULL	Int_J_Hypertens_2013_Dec_9_2013_547809.nxml.txt.nlp	24386559	SENT143	37	37	31	31	enalapril	ACE1	PA449456	1636	0.848
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1137-1144.nxml.txt.nlp	20234366	SENT171	23	23	14	14	oxaliplatin	BRAF	PA131285527	673	0.848
NULL	Int_J_Mol_Sci_2012_Aug_24_13(9)_10697-10721.nxml.txt.nlp	23109817	SENT580	19	19	6	6	curcumin	NFkappaB	PA151958596	4790	0.848
NULL	Anesthesiol_Res_Pract_2011_Oct_27_2011_317410.nxml.txt.nlp	22110498	SENT85	23	23	5	5	isoflurane	IL-8	PA450106	3576	0.848
NULL	J_Inflamm_(Lond)_2005_Oct_31_2_13.nxml.txt.nlp	16259632	SENT51	22	22	5	5	dextran	IL-10	PA449261	3586	0.848
NULL	Int_J_Mol_Sci_2013_Apr_26_14(5)_9111-9125.nxml.txt.nlp	23624604	SENT88	25	25	9	9	iron	MRI	PA450087	78996	0.848
NULL	Int_J_Lab_Hematol_2009_Aug_31(4)_468-470.nxml.txt.nlp	18294236	SENT30	12	12	16	16	rituximab	CHOP	PA451261	1649	0.848
NULL	Breast_Cancer_Res_Treat_2012_Jun_18_133(3)_937-947.nxml.txt.nlp	22094936	SENT24	24	24	9	9	tamoxifen	CDC2	PA451581	5424	0.848
NULL	Cancer_Cell_Int_2014_Apr_17_14_34.nxml.txt.nlp	24739220	SENT205	12	12	16	16	resveratrol	miR-17-92		407975	0.848
NULL	J_Hematol_Oncol_2013_Jul_18_6_53.nxml.txt.nlp	23866964	SENT85	3	3	15	15	temsirolimus	HDAC1	PA164746890	3065	0.848
NULL	Tumour_Biol_2012_Jun_21_33(3)_607-615.nxml.txt.nlp	22270450	SENT89	37	37	12	12	bevacizumab	Hsp90	PA130232992	3320	0.848
NULL	Core_Evid_2011_Feb_8_6_23-29.nxml.txt.nlp	21468240	SENT99	16	16	6	6	cyclophosphamide	CD34	PA449165	947	0.848
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT1245	2	2	13	13	tenofovir	ABCG2	PA10204	9429	0.848
NULL	Cancers_(Basel)_2014_Feb_26_6(1)_436-458.nxml.txt.nlp	24577242	SENT986	37	37	23	23	cisplatin	survivin	PA449014	332	0.848
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT165	8	8	18	18	capsaicin	p53	PA448776	7157	0.848
NULL	Cancer_Cell_Int_2010_Sep_9_10_32.nxml.txt.nlp	20828393	SENT49	17	17	14	14	cisplatin	ATF3	PA449014	467	0.848
NULL	Iran_J_Psychiatry_2013_Jun_8(2)_86-91.nxml.txt.nlp	24130607	SENT100	3	3	14	14	citalopram	Men	PA449015	8178	0.848
NULL	BMJ_Open_2014_Oct_31_4(10)_e005781.nxml.txt.nlp	25361837	SENT106	36	36	30	30	prasugrel	ADP	PA154410481	23038	0.848
NULL	Acta_Pharmacol_Sin_2012_Oct_3_33(10)_1311-1318.nxml.txt.nlp	22941289	SENT131	25	25	34	34	sorafenib	VEGFR2	PA7000	3791	0.848
NULL	Int_J_Biol_Sci_2013_Aug_14_9(8)_766-777.nxml.txt.nlp	23983610	SENT162	11	11	39	39	curcumin	B19	PA151958596	59271	0.848
NULL	Front_Neurosci_2014_Jun_24_8_176.nxml.txt.nlp	25009459	SENT1048	2	2	6	6	ivermectin	P2X4	PA450133	5025	0.848
NULL	Mol_Biol_Cell_2012_Sep_1_23(17)_3473-3484.nxml.txt.nlp	22787275	SENT263	17	17	33	33	calcein	San	PA132595336	80218	0.848
NULL	J_Hematol_Oncol_2013_Mar_27_6_23.nxml.txt.nlp	23531342	SENT85	6	6	23	23	fludarabine	p53	PA449655	7157	0.848
NULL	Biologics_2013_May_29_7_131-138.nxml.txt.nlp	23807836	SENT57	14	14	6	6	ribavirin	IFN	PA451241	3439	0.848
NULL	J_Oncol_2011_Dec_5_2011_465343.nxml.txt.nlp	21188169	SENT174	18	18	4	4	gemcitabine	CD133	PA449748	8842	0.848
NULL	Lab_Anim_Res_2014_Dec_24_30(4)_143-150.nxml.txt.nlp	25628724	SENT48	17	17	25	25	genistein	BRCA1	PA165109660	672	0.848
NULL	JAKSTAT_2014_Jun_12_3_e29554.nxml.txt.nlp	25105067	SENT25	3	3	11	11	propofol	AKT	PA451141	207	0.848
NULL	Nucl_Recept_Signal_2012_Feb_27_10_e001.nxml.txt.nlp	22438791	SENT132	35	35	38	38	tamoxifen	aromatase	PA451581	1588	0.848
NULL	Front_Microbiol_2014_Mar_14_5_99.nxml.txt.nlp	24672516	SENT86	30	30	37	37	caspofungin	TLR4	PA164743013	7099	0.848
NULL	Cancers_(Basel)_2013_Nov_26_5(4)_1601-1618.nxml.txt.nlp	24287743	SENT22	2	2	11	11	cetuximab	EGFR	PA10040	1956	0.848
NULL	Br_J_Cancer_2010_Jun_29_103(1)_36-42.nxml.txt.nlp	20517311	SENT4	26	26	17	17	carboplatin	survivin	PA448803	332	0.848
NULL	Scientifica_(Cairo)_2013_Feb_7_2013_249101.nxml.txt.nlp	24278770	SENT189	5	5	16	16	alemtuzumab	IFN	PA164783958	3439	0.848
NULL	Indian_J_Crit_Care_Med_2014_Nov_18(11)_766-767.nxml.txt.nlp	25425852	SENT17	4	4	14	14	heparin	Gen	PA449855	348654	0.848
NULL	J_Ginseng_Res_2011_Jun_35(2)_176-190.nxml.txt.nlp	23717060	SENT340	29	29	8	8	nitroprusside	GMP	PA451406	22978	0.848
NULL	Cancer_Causes_Control_2013_Aug_18_24(8)_1605-1614.nxml.txt.nlp	23775025	SENT243	31	31	11	11	cyclophosphamide	CYP2C9	PA449165	1559	0.848
NULL	Mol_Vis_2007_Jan_19_13_47-56.nxml.txt.nlp	17277743	SENT220	6	6	33	33	heparin	VEGF-A	PA449855	7422	0.848
NULL	Curr_Neuropharmacol_2007_Dec_5(4)_232-243.nxml.txt.nlp	19305740	SENT100	12	12	17	17	flurbiprofen	COX	PA449683	1351	0.848
NULL	Br_J_Cancer_2009_May_5_100(9)_1379-1384.nxml.txt.nlp	19401697	SENT33	5	5	11	11	bortezomib	EGFR	PA10252	1956	0.848
NULL	Cancer_Med_2014_Oct_2_3(5)_1385-1395.nxml.txt.nlp	24890702	SENT166	27	27	19	19	cetuximab	KRAS	PA10040	3845	0.848
NULL	Nucleic_Acids_Res_2005_Jun_8_33(10)_3283-3291.nxml.txt.nlp	15944449	SENT434	32	32	9	9	sjg-136	XPB		2071	0.848
NULL	Cancer_Med_2012_Oct_16_1(2)_207-217.nxml.txt.nlp	23342270	SENT151	19	19	13	13	saracatinib	IGFBP2		3485	0.848
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_79-96.nxml.txt.nlp	19305789	SENT67	16	16	22	22	capsaicin	TRPV1	PA448776	7442	0.848
NULL	Breast_Cancer_Res_2010_Mar_5_12(2)_R16.nxml.txt.nlp	20205716	SENT14	0	0	19	19	lovastatin	NDRG1	PA450272	10397	0.848
NULL	Clin_Interv_Aging_2013_Mar_26_8_347-352.nxml.txt.nlp	23569367	SENT90	11	11	13	13	levodopa	GRK6	PA450213	2870	0.848
NULL	BMB_Rep_2014_Nov_47(11)_649-654.nxml.txt.nlp	25301019	SENT120	8	8	17	17	l-serine	CCL2	PA451330	6347	0.848
NULL	Behav_Brain_Funct_2008_Aug_12_4_36.nxml.txt.nlp	18700002	SENT39	18	18	6	6	neomycin	PTPH1	PA450608	5774	0.848
NULL	Br_J_Cancer_2013_Jul_23_109(2)_342-350.nxml.txt.nlp	23807172	SENT186	0	0	12	12	sorafenib	Bcl-2	PA7000	596	0.848
NULL	Mol_Cancer_2014_Jun_24_13_157.nxml.txt.nlp	24958351	SENT29	26	26	16	16	capecitabine	HER2	PA448771	2064	0.848
NULL	Cancer_Med_2013_Jun_25_2(3)_277-285.nxml.txt.nlp	23930204	SENT195	25	25	5	5	bevacizumab	BRAF	PA130232992	673	0.848
NULL	Nat_Chem_2014_Jul_25_6(7)_614-622.nxml.txt.nlp	24950332	SENT17	25	25	10	10	nilotinib	ABL1	PA165958345	25	0.848
NULL	Exp_Ther_Med_2013_Mar_20_5(3)_840-844.nxml.txt.nlp	23408173	SENT70	32	32	11	11	citalopram	SERS	PA449015	6301;54938	0.848
NULL	Mol_Pain_2013_Jun_10_9_27.nxml.txt.nlp	23758830	SENT8	0	0	4	4	tetracaine	ASIC3	PA451638	9311	0.848
NULL	Cancers_(Basel)_2014_Apr_4_6(2)_796-812.nxml.txt.nlp	24713998	SENT172	30	30	37	37	imatinib	NGAL	PA10804	3934	0.848
NULL	Eur_J_Clin_Pharmacol_2011_May_9_67(5)_477-482.nxml.txt.nlp	21305273	SENT101	5	5	30	30	atropine	ADRB1	PA448505	153	0.848
NULL	J_Exp_Clin_Cancer_Res_2009_Jul_10_28(1)_99.nxml.txt.nlp	19591692	SENT114	13	13	4	4	imatinib	ABCG2	PA10804	9429	0.848
NULL	Eur_J_Clin_Pharmacol_2012_Jan_8_68(1)_29-37.nxml.txt.nlp	21739267	SENT187	14	14	8	8	fluvoxamine	CYP2D6	PA449690	1565	0.848
NULL	Protein_Cell_2014_Jun_19_5(6)_469-479.nxml.txt.nlp	24748116	SENT6	23	23	12	12	paclitaxel	EB1	PA450761	9167;22919;10982	0.848
NULL	Br_J_Cancer_2004_Mar_22_90(6)_1285-1292.nxml.txt.nlp	15026814	SENT148	15	15	19	19	doxorubicin	p53	PA449412	7157	0.848
NULL	Osteoporos_Int_2010_Oct_18_21(10)_1657-1680.nxml.txt.nlp	20480148	SENT430	4	4	23	23	denosumab	OPG	PA166048634	690	0.848
NULL	J_Anim_Sci_Biotechnol_2013_Jul_30_4(1)_27.nxml.txt.nlp	23899038	SENT191	5	5	9	9	taurine	NF-kappaB	PA451590	4790	0.848
NULL	Indian_J_Med_Paediatr_Oncol_2013_Oct-Dec_34(4)_292-298.nxml.txt.nlp	24604960	SENT47	4	4	0	0	cyclophosphamide	CHOP	PA449165	1649	0.848
NULL	Arthritis_Res_Ther_2010_Apr_29_12(2)_R73.nxml.txt.nlp	20429888	SENT158	24	24	4	4	bortezomib	AP2	PA10252	2971	0.848
NULL	Front_Microbiol_2014_Mar_14_5_99.nxml.txt.nlp	24672516	SENT95	17	17	4	4	voriconazole	TLR2	PA10233	7097	0.848
NULL	Nucleic_Acids_Res_2013_Mar_29_41(5)_2981-2992.nxml.txt.nlp	23361461	SENT225	6	6	0	0	tetracycline	TDP1	PA451640	55775	0.848
NULL	Hum_Genomics_2008_Sep_1_3(1)_7-16.nxml.txt.nlp	19129086	SENT179	17	17	10	10	rosiglitazone	CYP2C8	PA451283	1558	0.848
NULL	Int_J_Mol_Sci_2012_Sep_25_13(10)_12153-12168.nxml.txt.nlp	23202889	SENT99	21	21	13	13	cetuximab	KRAS	PA10040	3845	0.848
NULL	Theranostics_2014_Jan_2_4(2)_119-133.nxml.txt.nlp	24465270	SENT133	0	0	30	30	estradiol	EGF	PA449503	1950	0.848
NULL	Mol_Cells_2014_Sep_30_37(9)_664-671.nxml.txt.nlp	25234467	SENT266	13	13	2	2	cisplatin	miR-217	PA449014	406999	0.848
NULL	J_Headache_Pain_2010_Dec_27_11(6)_477-483.nxml.txt.nlp	20978816	SENT19	14	14	10	10	indomethacin	COX	PA449982	1351	0.848
NULL	Iran_J_Pharm_Res_2014_Autumn_13(4)_1183-1190.nxml.txt.nlp	25587306	SENT44	21	21	13	13	ethanol	mol	PA448073	90527	0.848
NULL	J_Cell_Mol_Med_2014_Jul_30_18(7)_1392-1406.nxml.txt.nlp	24779927	SENT193	16	16	5	5	curcumin	HIF-1	PA151958596	29072	0.848
NULL	J_Gen_Physiol_2000_Jun_1_115(6)_685-696.nxml.txt.nlp	10828243	SENT6	16	16	37	37	genistein	OLF	PA165109660	83857	0.848
NULL	Oncoscience_2014_Mar_24_1(3)_196-204.nxml.txt.nlp	25594012	SENT71	23	23	20	20	erlotinib	HER2	PA134687924	2064	0.848
NULL	Int_Clin_Psychopharmacol_2014_Jul_26_29(4)_229-234.nxml.txt.nlp	24419004	SENT130	18	18	1	1	quetiapine	Gen	PA451201	348654	0.848
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1495-1502.nxml.txt.nlp	21989186	SENT191	16	16	28	28	leucovorin	HSI	PA450198	57016	0.848
NULL	Clin_Dev_Immunol_2011_Mar_22_2011_790460.nxml.txt.nlp	21603161	SENT416	9	9	26	26	imatinib	CD34	PA10804	947	0.848
NULL	Ther_Clin_Risk_Manag_2007_Aug_3(4)_675-684.nxml.txt.nlp	18472990	SENT73	13	13	20	20	vancomycin	VISA	PA451850	57506	0.848
NULL	Oncotarget_2010_Oct_30_1(7)_639-650.nxml.txt.nlp	21317459	SENT35	6	6	16	16	nutlin-3	p53		7157	0.848
NULL	Cancer_Immunol_Immunother_2011_Jun_25_60(6)_793-808.nxml.txt.nlp	21350947	SENT13	16	16	3	3	sorafenib	IFNAR2	PA7000	3455	0.848
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT232	7	7	2	2	lapatinib	ADAM17	PA152241907	6868	0.848
NULL	Oncogene_2010_Jan_7_29(1)_81-92.nxml.txt.nlp	19784067	SENT262	11	11	3	3	cisplatin	BRG1	PA449014	6597	0.848
NULL	Exp_Diabetes_Res_2012_Jan_29_2012_159874.nxml.txt.nlp	22319521	SENT138	27	27	24	24	telmisartan	Hes1	PA451605	3280	0.848
NULL	Acta_Pharmacol_Sin_2010_Feb_5_31(2)_184-190.nxml.txt.nlp	20139901	SENT124	33	33	9	9	metformin	SLC22A2	PA450395	6582	0.848
NULL	Environ_Health_Perspect_1999_May_107(5)_397-405.nxml.txt.nlp	10210696	SENT7	4	4	24	24	estradiol	DES	PA449503	1674	0.848
NULL	Case_Rep_Oncol_2011_Aug_18_4(2)_385-391.nxml.txt.nlp	21941487	SENT67	8	8	13	13	erlotinib	EGFR	PA134687924	1956	0.848
NULL	Oncoimmunology_2012_Dec_1_1(9)_1661-1663.nxml.txt.nlp	23264929	SENT30	8	8	18	18	imiquimod	DR5	PA449972	8795	0.848
NULL	Hum_Genomics_2009_Jan_1_3(2)_121-127.nxml.txt.nlp	19164089	SENT82	36	36	1	1	ethanol	ALDH1A1	PA448073	216	0.848
NULL	Front_Immunol_2012_May_7_3_101.nxml.txt.nlp	22783250	SENT241	4	4	21	21	papain	IL-5	PA450778	3567	0.848
NULL	Acta_Pharmacol_Sin_2011_Nov_10_32(11)_1402-1410.nxml.txt.nlp	21986579	SENT122	4	4	38	38	curcumin	CDK4	PA151958596	1019	0.848
NULL	Front_Immunol_2012_Jul_23_3_206.nxml.txt.nlp	22837759	SENT75	6	6	11	11	rituximab	IL-2	PA451261	3558	0.848
NULL	Front_Endocrinol_(Lausanne)_2013_May_16_4_51.nxml.txt.nlp	23720652	SENT51	5	5	19	19	diclofenac	UGT2B15	PA449293	7366	0.848
NULL	Oncotarget_2013_Aug_24_4(10)_1618-1631.nxml.txt.nlp	24113128	SENT134	6	6	9	9	sorafenib	p53	PA7000	7157	0.848
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT180	12	12	23	23	doxorubicin	ABCB1	PA449412	5243	0.848
NULL	Iran_Red_Crescent_Med_J_2014_Sep_5_16(9)_e11662.nxml.txt.nlp	25593707	SENT14	24	24	13	13	metformin	AMPK	PA450395	5563	0.848
NULL	Br_J_Cancer_2012_Sep_4_107(6)_947-955.nxml.txt.nlp	22892392	SENT111	0	0	2	2	lapatinib	ERBB2	PA152241907	2064	0.848
NULL	Vet_Res_Forum_2013_Winter_4(1)_19-24.nxml.txt.nlp	25593681	SENT89	32	32	27	27	diclofenac	B12	PA449293	7126;4709	0.848
NULL	Indian_J_Med_Res_2013_Oct_138(4)_461-491.nxml.txt.nlp	24434254	SENT449	22	22	30	30	fluvastatin	2A9	PA449688	6277	0.848
NULL	Arq_Bras_Cardiol_2014_Nov_103(5)_403-409.nxml.txt.nlp	25229355	SENT124	3	3	1	1	metoprolol	PZP	PA450480	5858	0.848
NULL	Acta_Pharmacol_Sin_2011_Jul_6_32(7)_921-929.nxml.txt.nlp	21643005	SENT57	16	16	5	5	indomethacin	5-LOX	PA449982	240	0.848
NULL	Breast_Cancer_Res_2004_Jul_29_6(5)_204-210.nxml.txt.nlp	15318926	SENT48	15	15	22	22	erlotinib	San	PA134687924	80218	0.848
NULL	Indian_J_Med_Res_2011_Sep_134(3)_295-301.nxml.txt.nlp	21985811	SENT109	14	14	0	0	phenytoin	CYP2C9	PA450947	1559	0.848
NULL	Mol_Cells_2014_Nov_30_37(11)_812-818.nxml.txt.nlp	25377255	SENT9	26	26	37	37	doxorubicin	PARP-1	PA449412	25976	0.848
NULL	Avicenna_J_Med_Biotechnol_2014_Apr-Jun_6(2)_113-118.nxml.txt.nlp	24834313	SENT36	7	7	28	28	trypsin	CO2	PA451806	4513	0.848
NULL	J_Adv_Pract_Oncol_2012_May_1_May-Jun_3(3)_184-190.nxml.txt.nlp	25031945	SENT10	21	21	15	15	vincristine	CHOP	PA451879	1649	0.848
NULL	Ann_Clin_Microbiol_Antimicrob_2009_Jan_15_8_2.nxml.txt.nlp	19146672	SENT12	22	22	14	14	isoniazid	EMB	PA450112	133418	0.848
NULL	Nat_Methods_2011_Nov_27_9(1)_78-80.nxml.txt.nlp	22120468	SENT84	17	17	8	8	streptomycin	FBS	PA451512	64319;26269	0.848
NULL	J_Biol_Eng_2010_Jan_29_4_2.nxml.txt.nlp	20205817	SENT47	6	6	15	15	hydralazine	zeta	PA449894	9907	0.848
NULL	J_Cell_Biol_2001_Apr_2_153(1)_207-220.nxml.txt.nlp	11285286	SENT119	19	19	11	11	carbachol	CD69	PA448784	969	0.848
NULL	Int_J_Mol_Sci_2014_Sep_29_15(10)_17411-17441.nxml.txt.nlp	25268615	SENT37	13	13	0	0	collagenase	CD147	PA449107	682	0.848
NULL	Iran_J_Pharm_Res_2014_Summer_13(3)_919-926.nxml.txt.nlp	25276192	SENT28	15	15	26	26	doxorubicin	Bcl-2	PA449412	596	0.848
NULL	Acta_Neuropathol_Commun_2014_Nov_7_2(1)_158.nxml.txt.nlp	NULL	SENT127	19	19	4	4	oxygen	IDH1	PA450744	3417	0.848
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_7-17.nxml.txt.nlp	17912633	SENT44	31	31	6	6	aminoglutethimide	aromatase	PA448375	1588	0.848
NULL	J_Cell_Biol_2000_Feb_21_148(4)_811-824.nxml.txt.nlp	10684261	SENT342	18	18	2	2	thrombin	syndecan	PA451674	6382	0.848
NULL	Diabetes_2011_Nov_17_60(11)_2691-2700.nxml.txt.nlp	21896928	SENT155	0	0	35	35	resveratrol	CTRL		1506	0.848
NULL	Cancers_(Basel)_2010_May_28_2(2)_1040-1065.nxml.txt.nlp	24281106	SENT97	18	18	23	23	cetuximab	EGFR	PA10040	1956	0.848
NULL	Front_Oncol_2013_Nov_14_3_279.nxml.txt.nlp	24294592	SENT135	22	22	15	15	temozolomide	PARP-1	PA451609	25976	0.848
NULL	EMBO_Mol_Med_2012_Jun_13_4(6)_515-527.nxml.txt.nlp	22416035	SENT222	15	15	35	35	olaparib	p53		7157	0.848
NULL	Onco_Targets_Ther_2014_Dec_4_7_2249-2255.nxml.txt.nlp	25587220	SENT106	8	8	23	23	paclitaxel	P-gp	PA450761	5243	0.848
NULL	Acta_Otolaryngol_2010_Nov_30_130(11)_1278-1286.nxml.txt.nlp	20586674	SENT9	24	24	19	19	methimazole	TRPV2	PA450422	51393	0.848
NULL	Br_J_Cancer_2011_Jul_12_105(2)_212-220.nxml.txt.nlp	21694723	SENT158	6	6	16	16	curcumin	CD133	PA151958596	8842	0.848
NULL	Breast_Cancer_Res_2006_May_31_8(3)_R25.nxml.txt.nlp	16737553	SENT162	27	27	15	15	tamoxifen	HER2	PA451581	2064	0.848
NULL	Acta_Pharmacol_Sin_2011_Mar_31_32(3)_295-302.nxml.txt.nlp	21278785	SENT136	4	4	19	19	evodiamine	IL-6	PA165860788	3569	0.848
NULL	Indian_J_Med_Res_2013_Apr_137(4)_734-741.nxml.txt.nlp	23703341	SENT127	12	12	3	3	warfarin	VKORC1	PA451906	79001	0.848
NULL	Protein_Cell_2014_May_26_5(5)_343-347.nxml.txt.nlp	24668462	SENT19	1	1	10	10	heparin	FGF18	PA449855	8817	0.848
NULL	Cancers_(Basel)_2010_May_28_2(2)_1027-1039.nxml.txt.nlp	24281105	SENT50	10	10	38	38	vatalanib	HIF1	PA7001	3091	0.848
NULL	Int_J_Med_Sci_2013_Feb_11_10(3)_320-330.nxml.txt.nlp	23423768	SENT243	18	18	8	8	gefitinib	EGFR	PA131301952	1956	0.848
NULL	Eur_Heart_J_2013_Aug_14_34(31)_2453-2463.nxml.txt.nlp	23713082	SENT170	27	27	8	8	eplerenone	ARTS	PA164749044	5414	0.848
NULL	Indian_J_Dermatol_2011_Mar-Apr_56(2)_137-144.nxml.txt.nlp	21716938	SENT103	9	9	12	12	abacavir	HLA-B	PA448004	3106	0.848
NULL	ARYA_Atheroscler_2014_Jul_10(4)_192-198.nxml.txt.nlp	25258634	SENT146	11	11	14	14	l-carnitine	Q10	PA450154	27161	0.848
NULL	Cancers_(Basel)_2011_May_9_3(2)_2286-2301.nxml.txt.nlp	24212810	SENT177	6	6	3	3	cetuximab	EGFR	PA10040	1956	0.848
NULL	Clin_Med_Insights_Oncol_2012_Dec_20_7_1-12.nxml.txt.nlp	23362372	SENT27	8	8	23	23	cabazitaxel	P-gp	PA165958401	5243	0.848
NULL	Exp_Ther_Med_2013_Nov_13_6(5)_1317-1321.nxml.txt.nlp	24223665	SENT100	9	9	14	14	cisplatin	CD133	PA449014	8842	0.848
NULL	Br_J_Cancer_2010_Aug_24_103(5)_656-662.nxml.txt.nlp	20700122	SENT121	1	1	19	19	topotecan	p53	PA451729	7157	0.848
NULL	Front_Oncol_2014_Sep_15_4_244.nxml.txt.nlp	25309870	SENT100	0	0	4	4	afatinib	EGFR	PA165981154	1956	0.848
NULL	Breast_Cancer_Res_2008_Jul_24_10(4)_211.nxml.txt.nlp	18671839	SENT232	0	0	30	30	paclitaxel	HER2	PA450761	2064	0.848
NULL	Indian_J_Pharmacol_2014_Sep-Oct_46(5)_549-550.nxml.txt.nlp	25298588	SENT64	9	9	3	3	warfarin	CYP2C9	PA451906	1559	0.848
NULL	Biochem_Res_Int_2012_Dec_18_2012_893947.nxml.txt.nlp	22216413	SENT223	35	35	0	0	heparin	HARE	PA449855	55576	0.848
NULL	Cancers_(Basel)_2014_Nov_25_6(4)_2313-2329.nxml.txt.nlp	25534569	SENT136	11	11	13	13	crizotinib	Met	PA165946122	79811	0.848
NULL	Clin_Pharmacol_2013_Dec_9_5_185-192.nxml.txt.nlp	24353446	SENT77	22	22	37	37	clopidogrel	CYP3A4	PA449053	1576	0.848
NULL	Hum_Genomics_2010_Apr_1_4(4)_238-249.nxml.txt.nlp	20511137	SENT37	9	9	6	6	irinotecan	UGT1A1	PA450085	54658	0.848
NULL	J_Breast_Cancer_2013_Mar_31_16(1)_23-31.nxml.txt.nlp	23593078	SENT115	6	6	19	19	curcumin	DNMT1	PA151958596	1786	0.848
NULL	Mediators_Inflamm_2010_Oct_5_2010_321061.nxml.txt.nlp	20953358	SENT166	28	28	10	10	methacholine	NOS2	PA165958382	339345;4843	0.848
NULL	Arthritis_Rheum_2013_Sep_26_65(9)_2290-2300.nxml.txt.nlp	23740547	SENT168	23	23	3	3	doxycycline	DIP	PA449415	23151;1831	0.848
NULL	Chem_Senses_2008_Sep_5_33(7)_665-680.nxml.txt.nlp	18603652	SENT430	30	30	17	17	amiloride	TRPV1	PA448368	7442	0.848
NULL	Nucleic_Acids_Res_2011_Oct_30_39(18)_7908-7919.nxml.txt.nlp	21724609	SENT285	0	0	11	11	flavopiridol	CDK9	PA452627	1025	0.848
NULL	Mol_Vis_2012_Oct_5_18_2454-2467.nxml.txt.nlp	23077404	SENT134	19	19	26	26	bevacizumab	VEGF-A	PA130232992	7422	0.848
NULL	Oncotarget_2012_Nov_19_3(11)_1272-1283.nxml.txt.nlp	23174755	SENT111	32	32	17	17	doxorubicin	NRF2	PA449412	2551;4780	0.848
NULL	Amino_Acids_2013_Jan_1_44(1)_63-72.nxml.txt.nlp	22130737	SENT61	29	29	10	10	doxorubicin	EGF	PA449412	1950	0.848
NULL	Mol_Cancer_2008_May_19_7_40.nxml.txt.nlp	18489772	SENT140	21	21	7	7	bortezomib	PIR	PA10252	8544	0.848
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Nov_26_3(11)_e149.nxml.txt.nlp	25426564	SENT81	18	18	24	24	atorvastatin	PCSK9	PA448500	255738	0.848
NULL	Arthritis_Res_Ther_2009_Aug_28_11(4)_R131.nxml.txt.nlp	19715572	SENT14	0	0	14	14	rituximab	CD4	PA451261	920	0.848
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_105-115.nxml.txt.nlp	17912640	SENT57	18	18	25	25	trastuzumab	EGFR	PA451743	1956	0.848
NULL	Clin_Med_Insights_Oncol_2011_Oct_31_5_333-342.nxml.txt.nlp	22084622	SENT240	38	38	11	11	sunitinib	VEGFR2	PA162372840	3791	0.848
NULL	J_Exp_Med_2003_Aug_4_198(3)_475-481.nxml.txt.nlp	12885872	SENT116	27	27	3	3	ns-398	COX		1351	0.848
NULL	Cancer_Cell_Int_2006_Mar_23_6_6.nxml.txt.nlp	16556298	SENT120	0	0	12	12	imatinib	FDG	PA10804	23583	0.848
NULL	Acta_Pharmacol_Sin_2014_Aug_7_35(8)_1023-1030.nxml.txt.nlp	24998255	SENT12	5	5	3	3	octreotide	SSTR2	PA450678	6752	0.848
NULL	Int_J_Surg_Oncol_2012_Jun_12_2012_862879.nxml.txt.nlp	22778941	SENT107	9	9	5	5	cisplatin	BIN1	PA449014	274	0.848
NULL	Cancer_Cell_Int_2011_Jun_1_11_15.nxml.txt.nlp	21631944	SENT190	6	6	10	10	etoposide	MICB	PA449552	4277	0.848
NULL	Braz_J_Med_Biol_Res_2013_Jun_25_46(6)_528-532.nxml.txt.nlp	23802228	SENT83	5	5	35	35	rosiglitazone	p53	PA451283	7157	0.848
NULL	Cancer_Imaging_2008_Nov_25_8(1)_206-215.nxml.txt.nlp	19028613	SENT148	9	9	22	22	trastuzumab	NIR	PA451743	26155	0.848
NULL	Mol_Syst_Biol_2010_Jul_27_6_392.nxml.txt.nlp	20664638	SENT252	18	18	38	38	l-glutamine	CO2	PA10090	4513	0.848
NULL	Int_J_Mol_Sci_2013_Apr_10_14(4)_7742-7756.nxml.txt.nlp	23574936	SENT70	11	11	5	5	urokinase	LPA	PA451836	4018	0.848
NULL	Evid_Based_Complement_Alternat_Med_2013_May_26_2013_349790.nxml.txt.nlp	23762123	SENT123	20	20	15	15	rosiglitazone	LSP1	PA451283	4046	0.848
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT270	21	21	7	7	hydrocortisone	F12	PA449905	2161	0.848
NULL	Cancer_Cell_Int_2007_Jun_8_7_11.nxml.txt.nlp	17559657	SENT30	31	31	20	20	estradiol	CD34	PA449503	947	0.848
NULL	Patient_Prefer_Adherence_2011_Dec_23_6_1-9.nxml.txt.nlp	22272064	SENT138	20	20	22	22	telmisartan	ACE	PA451605	1636	0.848
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R91.nxml.txt.nlp	22541814	SENT165	24	24	9	9	thrombin	HO-1	PA451674	3162	0.848
NULL	Aging_(Albany_NY)_2013_Feb_21_5(2)_94-95.nxml.txt.nlp	23518473	SENT22	14	14	29	29	resveratrol	SIRT1		23411	0.848
NULL	J_Biol_Chem_2013_Nov_22_288(47)_34217-34229.nxml.txt.nlp	24106270	SENT274	16	16	37	37	thrombin	RhoG	PA451674	391	0.848
NULL	J_Cell_Mol_Med_2014_Apr_20_18(4)_709-720.nxml.txt.nlp	24444314	SENT167	17	17	8	8	losartan	p53	PA450268	7157	0.848
NULL	J_Biol_Chem_2010_Apr_23_285(17)_12979-12989.nxml.txt.nlp	20189985	SENT251	7	7	15	15	forskolin	IP3R2	PA146096022	3709	0.848
NULL	J_Thromb_Haemost_2011_Oct_9(10)_2050-2056.nxml.txt.nlp	21794076	SENT40	8	8	27	27	prasugrel	2-21	PA154410481	54097	0.848
NULL	Clin_Med_Insights_Cardiol_2011_Oct_6_5_103-119.nxml.txt.nlp	22084608	SENT39	7	7	5	5	dronedarone	CYP3A4	PA153619853	1576	0.848
NULL	Pancreas_2014_Oct_12_43(7)_1060-1065.nxml.txt.nlp	25121413	SENT128	18	18	12	12	erlotinib	EGFR	PA134687924	1956	0.848
NULL	Aging_(Albany_NY)_2009_Jun_3_1(6)_515-528.nxml.txt.nlp	20157535	SENT219	17	17	3	3	resveratrol	MDC		6367	0.848
NULL	Basic_Clin_Neurosci_2014_Winter_5(1)_74-79.nxml.txt.nlp	25436087	SENT9	9	9	13	13	fluoxetine	AQP4	PA449673	361	0.848
NULL	Cancer_2014_Apr_8_120(8)_1145-1154.nxml.txt.nlp	24501009	SENT79	16	16	5	5	cetuximab	EGFR	PA10040	1956	0.848
NULL	Diabetes_2011_Nov_17_60(11)_2691-2700.nxml.txt.nlp	21896928	SENT179	7	7	23	23	resveratrol	SIRT1		23411	0.848
NULL	Front_Endocrinol_(Lausanne)_2013_Nov_11_4_165.nxml.txt.nlp	24273530	SENT616	20	20	12	12	ethanol	GAT1	PA448073	6529	0.848
NULL	Int_J_Vasc_Med_2013_Mar_31_2013_543141.nxml.txt.nlp	23606968	SENT161	4	4	19	19	etanercept	IL-13	PA449515	3596	0.848
NULL	Indian_J_Pharmacol_2013_Mar-Apr_45(2)_121-125.nxml.txt.nlp	23716885	SENT146	17	17	25	25	fluvoxamine	CYP3A4	PA449690	1576	0.848
NULL	Front_Neurol_2011_Nov_23_2_67.nxml.txt.nlp	22131983	SENT24	13	13	4	4	xanthophyll	CRX	PA164748318	1406	0.848
NULL	Case_Rep_Med_2011_Mar_2_2011_767610.nxml.txt.nlp	21423546	SENT47	11	11	32	32	thyroglobulin	CK7	PA164754910	3855	0.848
NULL	Cancer_Biol_Med_2012_Mar_9(1)_1-8.nxml.txt.nlp	23691447	SENT170	10	10	4	4	lipase	OTP	PA450239	23440	0.848
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT170	18	18	22	22	nutlin-3	p53		7157	0.848
NULL	Oncol_Rep_2013_Apr_23_29(4)_1268-1274.nxml.txt.nlp	23354756	SENT174	4	4	21	21	trastuzumab	SLC25A43	PA451743	203427	0.848
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT115	10	10	22	22	atorvastatin	survivin	PA448500	332	0.848
NULL	Genet_Vaccines_Ther_2004_Apr_27_2_3.nxml.txt.nlp	15109394	SENT66	6	6	0	0	iodixanol	RPE65	PA164783998	6121	0.848
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_16_2014_926087.nxml.txt.nlp	25478000	SENT107	20	20	34	34	atorvastatin	PCSK9	PA448500	255738	0.848
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT79	12	12	24	24	curcumin	DR4	PA151958596	8797	0.848
NULL	Oncotarget_2011_Sep_9_2(9)_658-668.nxml.txt.nlp	21911919	SENT5	35	35	27	27	cytarabine	HO-1	PA449177	3162	0.848
NULL	Acta_Pharmacol_Sin_2009_Apr_3_30(4)_478-484.nxml.txt.nlp	19343062	SENT100	31	31	4	4	amitriptyline	CYP3A4	PA448385	1576	0.848
NULL	Int_J_Alzheimers_Dis_2012_Feb_1_2012_109324.nxml.txt.nlp	22506129	SENT115	8	8	25	25	simvastatin	ZO-1	PA451363	7082	0.848
NULL	Front_Immunol_2012_Feb_2_3_9.nxml.txt.nlp	22566895	SENT66	3	3	12	12	neomycin	CD4	PA450608	920	0.848
NULL	Br_J_Cancer_2013_Sep_3_109(5)_1279-1286.nxml.txt.nlp	23949154	SENT253	16	16	28	28	flutamide	PC-3	PA449685	692094	0.848
NULL	Breast_Cancer_Res_2011_Nov_30_13(6)_R123.nxml.txt.nlp	22129105	SENT192	10	10	16	16	trastuzumab	IL-6	PA451743	3569	0.848
NULL	EPMA_J_2012_Sep_27_3(1)_10.nxml.txt.nlp	23016735	SENT195	3	3	13	13	warfarin	APOE	PA451906	348	0.848
NULL	Acta_Pharmacol_Sin_2014_Jun_4_35(6)_792-805.nxml.txt.nlp	24902787	SENT242	8	8	18	18	pravastatin	INS-1	PA451089	2305	0.848
NULL	Braz_J_Med_Biol_Res_2013_May_10_46(5)_433-439.nxml.txt.nlp	23681290	SENT157	3	3	22	22	bezafibrate	IL-10	PA162364313	3586	0.848
NULL	Oxid_Med_Cell_Longev_2012_Jun_3_2012_914273.nxml.txt.nlp	22701758	SENT201	8	8	6	6	resveratrol	SIRT1		23411	0.848
NULL	J_Biomed_Biotechnol_2010_Mar_2_2010_793843.nxml.txt.nlp	20204133	SENT127	0	0	7	7	valsartan	CYP11B2	PA451848	1585	0.848
NULL	Clin_Med_Insights_Blood_Disord_2013_Nov_14_6_23-27.nxml.txt.nlp	25512717	SENT112	30	30	28	28	doxorubicin	CHOP	PA449412	1649	0.848
NULL	Eur_J_Haematol_2009_Apr_82(4)_277-287.nxml.txt.nlp	19187270	SENT198	27	27	10	10	pha-665752	IL-6		3569	0.848
NULL	Pharmaceuticals_(Basel)_2014_Sep_4_7(9)_913-942.nxml.txt.nlp	25192192	SENT109	21	21	6	6	resveratrol	UCP1		7350	0.848
NULL	J_Exp_Clin_Cancer_Res_2009_Jul_10_28(1)_99.nxml.txt.nlp	19591692	SENT114	6	6	2	2	tariquidar	ABCB1		5243	0.848
NULL	Springerplus_2013_Jul_3_2_297.nxml.txt.nlp	23888269	SENT140	19	19	6	6	trastuzumab	HER2	PA451743	2064	0.848
NULL	Basic_Res_Cardiol_2009_Jan_16_104(1)_5-21.nxml.txt.nlp	19101749	SENT279	8	8	6	6	fasudil	Rho	PA165946121	29984	0.848
NULL	Mol_Cancer_2009_Jun_23_8_39.nxml.txt.nlp	19549337	SENT146	25	25	11	11	etoposide	TRAIL	PA449552	8743	0.848
NULL	Acta_Pharmacol_Sin_2009_Oct_21_30(10)_1392-1398.nxml.txt.nlp	19767766	SENT157	0	0	8	8	atorvastatin	ROS	PA448500	6098	0.848
NULL	Biologics_2013_Apr_15_7_77-90.nxml.txt.nlp	23723688	SENT111	18	18	11	11	cetuximab	CRT	PA10040	811	0.848
NULL	Clin_Pharmacol_2009_Sep_7_1_1-6.nxml.txt.nlp	22291481	SENT86	14	14	6	6	fluoxetine	PDE4B	PA449673	5142	0.848
NULL	Cases_J_2009_Mar_10_2_6464.nxml.txt.nlp	20181162	SENT38	9	9	5	5	ribavirin	IFN	PA451241	3439	0.848
NULL	Genome_Med_2009_Sep_29_1(9)_88.nxml.txt.nlp	19754960	SENT156	26	26	17	17	warfarin	CYP2C9	PA451906	1559	0.848
NULL	Front_Neurol_2014_Jun_23_5_98.nxml.txt.nlp	25002857	SENT68	30	30	34	34	fluorescein	LAS	PA164746009	11019	0.848
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT113	9	9	7	7	sulindac	survivin	PA451565	332	0.848
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT263	11	11	23	23	adalimumab	CD36	PA10004	948	0.847
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_15_2012_591654.nxml.txt.nlp	23118793	SENT182	28	28	17	17	berberine	PPG	PA165860812	5552	0.847
NULL	Oncol_Discov_2013_1(4)_10_7243_2052-6199-1-4.nxml.txt.nlp	25383193	SENT190	3	3	9	9	oltipraz	SHP2		5781	0.847
NULL	Am_J_Trop_Med_Hyg_2012_Nov_7_87(5)_783-784.nxml.txt.nlp	23136171	SENT24	1	1	20	20	mefloquine	ACT	PA450348	12;11332;9457;641455	0.847
NULL	Eur_J_Med_Res_2010_Feb_26_15(2)_47-53.nxml.txt.nlp	20452883	SENT122	6	6	14	14	fentanyl	ESG	PA449599	7089;7088;7090;7091	0.847
NULL	Acta_Pharmacol_Sin_2013_Apr_5_34(4)_581.nxml.txt.nlp	NULL	SENT6	0	0	6	6	celecoxib	IL-6	PA448871	3569	0.847
NULL	Oncoimmunology_2013_Aug_1_2(8)_e25123.nxml.txt.nlp	24083076	SENT17	28	28	33	33	everolimus	EGFR	PA164746311	1956	0.847
NULL	Acta_Pharmacol_Sin_2013_Apr_25_34(4)_455-463.nxml.txt.nlp	23524568	SENT141	0	0	2	2	pioglitazone	RAGE	PA450970	177	0.847
NULL	Oncogenesis_2012_Apr_16_1(4)_e7.nxml.txt.nlp	23552604	SENT49	7	7	32	32	nutlin-3	p53		7157	0.847
NULL	AIDS_Res_Ther_2013_Dec_13_10_33.nxml.txt.nlp	24330617	SENT45	28	28	21	21	lopinavir	CCR5	PA450264	1234	0.847
NULL	J_Am_Heart_Assoc_2013_Dec_19_2(6)_e000433.nxml.txt.nlp	24275630	SENT106	33	33	19	19	lipase	DAG	PA450239	1605	0.847
NULL	Oncol_Rep_2013_Sep_5_30(3)_1053-1058.nxml.txt.nlp	23836376	SENT125	1	1	9	9	camptothecin	TOP1	PA153590860	7150	0.847
NULL	Biomed_Res_Int_2013_Jul_17_2013_549359.nxml.txt.nlp	23956990	SENT15	22	22	31	31	bevacizumab	EGFR	PA130232992	1956	0.847
NULL	J_Cell_Biol_2004_Jul_5_166(1)_37-47.nxml.txt.nlp	15240568	SENT283	10	10	0	0	doxycycline	SOX9	PA449415	6662	0.847
NULL	Addict_Sci_Clin_Pract_2014_Sep_13_9(1)_20.nxml.txt.nlp	25217046	SENT27	15	15	8	8	naltrexone	OPRM1	PA450588	4988	0.847
NULL	Front_Microbiol_2014_Mar_14_5_99.nxml.txt.nlp	24672516	SENT89	13	13	21	21	voriconazole	TLR9	PA10233	54106	0.847
NULL	Exp_Ther_Med_2012_Sep_12_4(3)_475-480.nxml.txt.nlp	23181121	SENT170	20	20	32	32	doxorubicin	CHOP	PA449412	1649	0.847
NULL	Oncotarget_2014_Jun_6_5(13)_4935-4944.nxml.txt.nlp	24952732	SENT177	7	7	11	11	doxazosin	HIF-1	PA449407	29072	0.847
NULL	Cancer_Cell_Int_2010_Sep_9_10_32.nxml.txt.nlp	20828393	SENT53	30	30	10	10	cisplatin	ATF3	PA449014	467	0.847
NULL	Front_Genet_2012_Nov_9_3_223.nxml.txt.nlp	23162566	SENT105	9	9	25	25	fentanyl	NeuroD	PA449599	4760	0.847
NULL	Iran_J_Pharm_Res_2014_Spring_13(2)_683-693.nxml.txt.nlp	25237365	SENT95	8	8	21	21	tamoxifen	CXCL12	PA451581	6387	0.847
NULL	Acta_Pharmacol_Sin_2011_May_18_32(5)_591-600.nxml.txt.nlp	21499286	SENT134	2	2	5	5	bezafibrate	AMPK	PA162364313	5563	0.847
NULL	Curr_Gerontol_Geriatr_Res_2010_May_4_2010_420139.nxml.txt.nlp	20454643	SENT88	5	5	14	14	estradiol	AMPK	PA449503	5563	0.847
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Apr_24_66(Pt_5)_o1139.nxml.txt.nlp	21579187	SENT73	19	19	25	25	benzaldehyde	mol	PA448571	90527	0.847
NULL	Breast_Cancer_Res_2011_Dec_8_13(6)_R126.nxml.txt.nlp	22151962	SENT246	10	10	17	17	doxorubicin	HMGB1	PA449412	3146	0.847
NULL	Int_J_Biol_Sci_2011_Sep_8_7(8)_1077-1092.nxml.txt.nlp	21927577	SENT162	8	8	2	2	captopril	ANG	PA448780	283	0.847
NULL	Br_J_Cancer_2010_Jul_13_103(2)_265-274.nxml.txt.nlp	20551953	SENT204	16	16	8	8	cisplatin	JNK	PA449014	5599	0.847
NULL	Clin_Ophthalmol_2012_May_14_6_747-754.nxml.txt.nlp	22654502	SENT119	20	20	34	34	rituximab	San	PA451261	80218	0.847
NULL	Iran_J_Pharm_Res_2014_Autumn_13(4)_1393-1401.nxml.txt.nlp	25587329	SENT132	3	3	5	5	celecoxib	MRP1	PA448871	4437	0.847
NULL	Nucleic_Acids_Res_2005_Jun_8_33(10)_3283-3291.nxml.txt.nlp	15944449	SENT114	22	22	17	17	melphalan	XRCC3	PA450354	7517	0.847
NULL	Nucleic_Acids_Res_2012_Jun_22_40(11)_4861-4878.nxml.txt.nlp	22362753	SENT391	16	16	5	5	guanidine	NPM1	PA164781028	4869	0.847
NULL	Br_J_Clin_Pharmacol_2011_Oct_72(4)_647-657.nxml.txt.nlp	21518389	SENT144	23	23	33	33	clopidogrel	P2Y12	PA449053	64805	0.847
NULL	Diabetes_2014_Jan_13_63(1)_42-44.nxml.txt.nlp	24357693	SENT11	6	6	0	0	lipase	PNPLA3	PA450239	80339	0.847
NULL	Cells_2012_Oct_15_1(4)_754-773.nxml.txt.nlp	24710529	SENT172	20	20	16	16	glucose	ULK1	PA449773	8408	0.847
NULL	J_Thromb_Haemost_2007_May_1_5(5)_910-917.nxml.txt.nlp	17362227	SENT112	30	30	5	5	thrombin	P2X1	PA451674	5023	0.847
NULL	Clin_Med_Oncol_2008_Feb_9_2_47-61.nxml.txt.nlp	21892266	SENT257	15	15	4	4	chloroquine	EGFR	PA448948	1956	0.847
NULL	Mediators_Inflamm_2010_May_17_2010_841343.nxml.txt.nlp	20490358	SENT142	20	20	6	6	candesartan	MCP-1	PA448765	6347	0.847
NULL	Pharmaceutics_2011_Aug_31_3(3)_582-600.nxml.txt.nlp	24310598	SENT564	8	8	27	27	theophylline	TC2	PA451647	6948	0.847
NULL	Front_Comput_Neurosci_2012_Aug_17_6_59.nxml.txt.nlp	22912614	SENT225	5	5	14	14	taurine	CA3	PA451590	761	0.847
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT203	9	9	30	30	erlotinib	PI3K	PA134687924	5290	0.847
NULL	Physiol_Rep_2014_Aug_5_2(8)_e12090.nxml.txt.nlp	25096552	SENT221	27	27	6	6	dextran	CD137	PA449261	3604	0.847
NULL	Biomed_Res_Int_2013_Jul_31_2013_692071.nxml.txt.nlp	23984399	SENT161	4	4	8	8	tramadol	OCT1	PA451735	5451;6580	0.847
NULL	Cancer_Immunol_Immunother_2011_Jul_24_60(7)_943-951.nxml.txt.nlp	21431918	SENT155	9	9	20	20	doxorubicin	CD34	PA449412	947	0.847
NULL	Eur_J_Clin_Pharmacol_2007_Apr_21_63(4)_335-343.nxml.txt.nlp	17318526	SENT234	37	37	9	9	sulfamethoxazole	CYP2C9	PA451544	1559	0.847
NULL	Br_J_Pharmacol_2011_Nov_164(5)_1522-1533.nxml.txt.nlp	21557728	SENT155	23	23	27	27	cangrelor	P2Y1	PA165945763	5028	0.847
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1013.nxml.txt.nlp	24457957	SENT17	3	3	14	14	bortezomib	NOXA	PA10252	5366	0.847
NULL	Extremophiles_2013_Jul_15_17(4)_601-610.nxml.txt.nlp	23674353	SENT38	9	9	25	25	nadh	CO2	PA164755085	4513	0.847
NULL	J_Invest_Dermatol_2012_Jan_1_132(1)_105-113.nxml.txt.nlp	21881590	SENT250	0	0	2	2	etanercept	CCL20	PA449515	6364	0.847
NULL	Curr_Neuropharmacol_2010_Sep_8(3)_287-304.nxml.txt.nlp	21358978	SENT99	20	20	8	8	agomelatine	5-HT2C	PA165958363	3358	0.847
NULL	Environ_Health_Perspect_2006_Sep_23_114(9)_1401-1406.nxml.txt.nlp	16966095	SENT183	4	4	20	20	arsenite	p53	PA452638	7157	0.847
NULL	Cancer_Res_Treat_2013_Mar_31_45(1)_55-62.nxml.txt.nlp	23613671	SENT111	14	14	7	7	irinotecan	KRAS	PA450085	3845	0.847
NULL	Breast_Cancer_(Auckl)_2010_May_7_4_23-33.nxml.txt.nlp	20697530	SENT166	2	2	11	11	bsi-201	PARP1		142	0.847
NULL	Chem_Rev_2011_Oct_12_111(10)_5899-5921.nxml.txt.nlp	21923193	SENT536	21	21	11	11	fenoprofen	FAAH	PA449597	79152;2166	0.847
NULL	Mol_Cell_Biochem_2014_Oct_9_385(1-2)_265-275.nxml.txt.nlp	24104452	SENT228	20	20	4	4	bortezomib	LC3	PA10252	84557	0.847
NULL	Core_Evid_2010_Oct_21_5_77-90.nxml.txt.nlp	21042544	SENT64	5	5	12	12	aprepitant	NK1	PA164747039	11126	0.847
NULL	Mol_Cancer_2014_Aug_16_13(1)_193.nxml.txt.nlp	NULL	SENT151	30	30	39	39	cisplatin	RKIP	PA449014	5037	0.847
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Apr_13_67(Pt_5)_o1087.nxml.txt.nlp	21754408	SENT57	33	33	19	19	ethanol	mol	PA448073	90527	0.847
NULL	Exp_Ther_Med_2015_Jan_10_9(1)_267-271.nxml.txt.nlp	25452814	SENT29	8	8	10	10	clopidogrel	ABCB1	PA449053	5243	0.847
NULL	Biosci_Rep_2012_Dec_20_33(1)_e00011.nxml.txt.nlp	23137297	SENT256	3	3	13	13	heparin	RPSA	PA449855	3921	0.847
NULL	Breast_Cancer_Res_Treat_2014_Jul_20_146(3)_627-636.nxml.txt.nlp	25038878	SENT127	19	19	24	24	tamoxifen	aromatase	PA451581	1588	0.847
NULL	Breast_Cancer_Res_2009_Oct_28_11(5)_211.nxml.txt.nlp	19889200	SENT150	23	23	18	18	anastrozole	PTH	PA448432	5741	0.847
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT227	20	20	27	27	heparin	FGF1	PA449855	2246	0.847
NULL	Anesth_Pain_Med_2012_Apr_1_Spring_1(4)_262-264.nxml.txt.nlp	24904812	SENT14	10	10	5	5	oxycodone	CYP3A4	PA450741	1576	0.847
NULL	Oncol_Lett_2014_Mar_2_7(3)_791-796.nxml.txt.nlp	24527087	SENT90	2	2	7	7	imatinib	CD34	PA10804	947	0.847
NULL	Breast_Cancer_Res_2014_Oct_31_16(5)_447.nxml.txt.nlp	25358600	SENT271	19	19	24	24	tamoxifen	CXCR7	PA451581	57007	0.847
NULL	Diabetes_Care_2010_Oct_13_33(10)_2250-2253.nxml.txt.nlp	20628086	SENT112	23	23	6	6	rosiglitazone	DREAM	PA451283	30818	0.847
NULL	Biotechnol_Res_Int_2012_Jul_20_2012_817549.nxml.txt.nlp	22919503	SENT104	20	20	10	10	ampicillin	SOC	PA448419	91544	0.847
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT146	7	7	22	22	heparin	FGF1	PA449855	2246	0.847
NULL	Arthritis_Res_Ther_2006_Apr_12_8(Suppl_1)_S3.nxml.txt.nlp	16820042	SENT148	34	34	16	16	colchicine	NALP3	PA449092	114548	0.847
NULL	Mucosal_Immunol_2013_Nov_10_6(6)_1179-1190.nxml.txt.nlp	23571504	SENT426	26	26	9	9	auranofin	TRX	PA448510	7295	0.847
NULL	J_Inherit_Metab_Dis_2010_Oct_3_33(5)_625-632.nxml.txt.nlp	20814828	SENT133	13	13	32	32	simvastatin	RhoA	PA451363	387	0.847
NULL	Iran_J_Psychiatry_2010_Fall_5(4)_119-127.nxml.txt.nlp	22952505	SENT176	2	2	10	10	minocycline	Rho	PA450519	29984	0.847
NULL	Acta_Neuropathol_Commun_2014_May_30_2_57.nxml.txt.nlp	24887326	SENT184	10	10	2	2	etoposide	ABCB1	PA449552	5243	0.847
NULL	Ann_Oncol_2009_Aug_17_20(8)_1319-1329.nxml.txt.nlp	19535820	SENT349	18	18	43	43	doxorubicin	San	PA449412	80218	0.847
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Apr_25_68(Pt_5)_m664.nxml.txt.nlp	22590148	SENT74	20	20	38	38	ethanol	mol	PA448073	90527	0.847
NULL	Oncotarget_2014_Oct_15_5(22)_11541-11551.nxml.txt.nlp	25426552	SENT70	9	9	25	25	doxycycline	GAPDH	PA449415	2597	0.847
NULL	Trials_2014_Oct_27_15(1)_412.nxml.txt.nlp	NULL	SENT65	10	10	21	21	chloroquine	IL-18	PA448948	3606	0.847
NULL	J_Ophthalmol_2011_Mar_30_2011_584238.nxml.txt.nlp	21584260	SENT55	5	5	12	12	ranibizumab	San	PA164746012	80218	0.847
NULL	Endocrinol_Diabetes_Metab_Case_Rep_2014_Mar_1_2014_140001.nxml.txt.nlp	24683487	SENT18	24	24	6	6	etomidate	ACTH	PA164743987	5443	0.847
NULL	Exp_Ther_Med_2014_Sep_14_8(3)_836-840.nxml.txt.nlp	25120610	SENT12	3	3	14	14	fasudil	RhoA	PA165946121	387	0.847
NULL	J_Exp_Med_2000_Mar_6_191(5)_859-870.nxml.txt.nlp	10704466	SENT729	17	17	8	8	arsenite	p38	PA452638	10598;1432;7965	0.847
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT110	1	1	20	20	pp2	EGFR		1956	0.847
NULL	Oncotarget_2013_Dec_28_5(6)_1475-1490.nxml.txt.nlp	24721996	SENT136	39	39	12	12	celecoxib	PTEN	PA448871	5728	0.847
NULL	Br_J_Cancer_2002_Jan_21_86(2)_218-221.nxml.txt.nlp	11870509	SENT5	44	44	28	28	tamoxifen	BRCA2	PA451581	675	0.847
NULL	Oncotarget_2013_Feb_27_4(2)_329-345.nxml.txt.nlp	23593654	SENT48	14	14	3	3	paclitaxel	YB-1	PA450761	4904	0.847
NULL	Arthritis_Res_Ther_2005_Aug_31_7(5)_208-214.nxml.txt.nlp	16207350	SENT111	2	2	5	5	cyclosporine	FasL	PA449167	356	0.847
NULL	J_Cell_Biol_2004_Jul_5_166(1)_133-143.nxml.txt.nlp	15226308	SENT116	39	39	8	8	hydrocortisone	BRCA1	PA449905	672	0.847
NULL	Breast_Cancer_Res_2007_Aug_8_9(4)_R50.nxml.txt.nlp	17686159	SENT83	18	18	5	5	trastuzumab	HRG	PA451743	3084;3273	0.847
NULL	Biologics_2009_Jul_13_3_289-301.nxml.txt.nlp	19707416	SENT89	11	11	7	7	lapatinib	HER2	PA152241907	2064	0.847
NULL	Ann_Hematol_2014_Mar_18_93(8)_1335-1344.nxml.txt.nlp	24638841	SENT92	24	24	19	19	vincristine	CHOP	PA451879	1649	0.847
NULL	J_Mol_Signal_2008_Dec_1_3_18.nxml.txt.nlp	19046439	SENT199	1	1	16	16	metformin	CDK2	PA450395	1017	0.847
NULL	Br_J_Cancer_2004_Mar_22_90(6)_1285-1292.nxml.txt.nlp	15026814	SENT133	21	21	15	15	doxorubicin	p53	PA449412	7157	0.847
NULL	Clin_Psychopharmacol_Neurosci_2014_Apr_24_12(1)_54-64.nxml.txt.nlp	24851122	SENT161	21	21	32	32	methamphetamine	MAPK4	PA450403	5596	0.847
NULL	J_Biol_Chem_2009_Oct_16_284(42)_28885-28895.nxml.txt.nlp	19687008	SENT283	22	22	11	11	simvastatin	SREBP2	PA451363	6721	0.847
NULL	Evid_Based_Complement_Alternat_Med_2012_May_29_2012_548430.nxml.txt.nlp	22690247	SENT177	6	6	0	0	l-carnitine	OCTN2	PA450154	6584	0.847
NULL	Clin_Med_Insights_Cardiol_2011_Jun_28_5_55-66.nxml.txt.nlp	21792345	SENT4	17	17	7	7	bucindolol	BEST	PA165945764	7439	0.847
NULL	ScientificWorldJournal_2013_Sep_22_2013_752184.nxml.txt.nlp	24174916	SENT107	4	4	20	20	vancomycin	DBT	PA451850	1629	0.847
NULL	Ann_Oncol_2011_Mar_8_22(3)_503-514.nxml.txt.nlp	20616198	SENT222	7	7	13	13	fulvestrant	aromatase	PA164747170	1588	0.847
NULL	Br_J_Cancer_2010_Jan_5_102(1)_80-86.nxml.txt.nlp	19920817	SENT140	14	14	16	16	bevacizumab	IFN	PA130232992	3439	0.847
NULL	Oncologist_2010_Feb_15_15(2)_122-129.nxml.txt.nlp	20156908	SENT87	24	24	7	7	letrozole	HER-2	PA450196	2064	0.847
NULL	Breast_Cancer_Res_Treat_2013_Sep_1_141(2)_243-248.nxml.txt.nlp	23996142	SENT157	8	8	5	5	tamoxifen	CYP3A	PA451581	1574	0.847
NULL	Hum_Mol_Genet_2013_Nov_15_22(22)_4528-4544.nxml.txt.nlp	23804751	SENT329	34	34	7	7	l-glutamine	ATG5	PA10090	9474	0.847
NULL	Ther_Clin_Risk_Manag_2006_Jun_2(2)_129-158.nxml.txt.nlp	18360588	SENT166	1	1	3	3	voriconazole	CYP3A4	PA10233	1576	0.847
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT57	17	17	2	2	nutlin-3	p53		7157	0.847
NULL	Oncotarget_2014_Oct_29_5(22)_11168-11179.nxml.txt.nlp	25426553	SENT82	6	6	1	1	paclitaxel	PI3K	PA450761	5290	0.847
NULL	Arthritis_Res_Ther_2003_Dec_2_5(Suppl_4)_S12-S16.nxml.txt.nlp	15180892	SENT99	4	4	0	0	doxorubicin	CHOP	PA449412	1649	0.847
NULL	Nat_Commun_2014_Dec_8_5_5736.nxml.txt.nlp	25484020	SENT662	0	0	18	18	exemestane	TRPA1	PA449563	8989	0.847
NULL	Diabetes_Care_2011_Jul_17_34(7)_e115-e120.nxml.txt.nlp	21709286	SENT108	15	15	18	18	metformin	AMPK	PA450395	5563	0.847
NULL	Cancers_(Basel)_2014_Aug_12_6(3)_1631-1669.nxml.txt.nlp	25119536	SENT414	3	3	9	9	bortezomib	Hsp90	PA10252	3320	0.847
NULL	Diabetes_2011_Mar_21_60(3)_757-765.nxml.txt.nlp	21282370	SENT177	8	8	3	3	isoproterenol	PTRF	PA450121	284119	0.847
NULL	Acta_Pharmacol_Sin_2012_Jan_3_33(1)_49-56.nxml.txt.nlp	22212430	SENT83	38	38	3	3	thrombin	A10	PA451674	28870	0.847
NULL	Br_J_Clin_Pharmacol_2013_Aug_23_76(2)_299-315.nxml.txt.nlp	23701319	SENT72	14	14	6	6	adalimumab	IL-2	PA10004	3558	0.847
NULL	Orphanet_J_Rare_Dis_2010_Dec_16_5_39.nxml.txt.nlp	21162721	SENT78	33	33	4	4	lamotrigine	HLA-B	PA450164	3106	0.847
NULL	Cancer_Cell_Int_2009_Sep_10_9_25.nxml.txt.nlp	19744341	SENT203	25	25	30	30	glucosamine	STAT3	PA164747613	6774	0.847
NULL	J_Carcinog_2011_Nov_30_10_28.nxml.txt.nlp	22190870	SENT193	14	14	4	4	maytansine	DM1	PA165291473	338023;1760;28509	0.847
NULL	Surg_Neurol_Int_2013_May_2_4(Suppl_4)_S265-S288.nxml.txt.nlp	23717798	SENT506	27	27	35	35	gefitinib	EGFR	PA131301952	1956	0.847
NULL	Cell_Death_Dis_2010_Nov_18_1(11)_e102.nxml.txt.nlp	21368867	SENT139	46	46	23	23	gentamicin	CLIMP-63	PA449753	10970	0.847
NULL	ScientificWorldJournal_2014_Mar_12_2014_731462.nxml.txt.nlp	24715817	SENT138	9	9	21	21	diclofenac	IL-6	PA449293	3569	0.847
NULL	J_Cell_Mol_Med_2014_Oct_11_18(10)_2031-2043.nxml.txt.nlp	25109475	SENT239	0	0	2	2	valsartan	TLR-4	PA451848	7099	0.847
NULL	Acta_Vet_Scand_2003_Sep_30_44(3)_121-129.nxml.txt.nlp	15074625	SENT118	16	16	20	20	oxytetracycline	TMP	PA450757	2012	0.847
NULL	Cancer_Cell_Int_2013_Nov_8_13_111.nxml.txt.nlp	24209962	SENT95	5	5	23	23	fluvastatin	A20	PA449688	7128;28935	0.847
NULL	Basic_Clin_Neurosci_2014_Summer_5(3)_182-190.nxml.txt.nlp	25337378	SENT199	8	8	5	5	bupropion	mol	PA448687	90527	0.847
NULL	J_Mol_Signal_2010_May_10_5_4.nxml.txt.nlp	20459745	SENT124	20	20	10	10	cisplatin	p53	PA449014	7157	0.847
NULL	Protein_Cell_2014_Jun_19_5(6)_469-479.nxml.txt.nlp	24748116	SENT87	25	25	19	19	paclitaxel	EB1	PA450761	9167;22919;10982	0.847
NULL	Cardiovasc_Diabetol_2013_Jun_19_12_92.nxml.txt.nlp	23777506	SENT237	9	9	12	12	miglitol	GLP-1	PA164776726	100125288	0.847
NULL	Nat_Commun_2014_Nov_21_5_5383.nxml.txt.nlp	25415230	SENT773	19	19	10	10	bicalutamide	TRPM8	PA164746255	79054	0.847
NULL	Biologics_2012_Feb_1_6_31-35.nxml.txt.nlp	22355257	SENT66	33	33	16	16	rituximab	IL-2	PA451261	3558	0.847
NULL	Diabetes_Obes_Metab_2012_Dec_19_14(12)_1097-1103.nxml.txt.nlp	22734440	SENT29	13	13	37	37	exenatide	GLP-1	PA164749238	100125288	0.847
NULL	Acta_Pharmacol_Sin_2013_Dec_18_34(12)_1568-1574.nxml.txt.nlp	24241343	SENT95	22	22	2	2	doxazosin	ANOVA	PA449407	4858	0.847
NULL	J_Oncol_2012_Feb_15_2012_168303.nxml.txt.nlp	22481917	SENT79	17	17	13	13	carboplatin	CAM	PA448803	889	0.847
NULL	Int_Neurourol_J_2014_Sep_24_18(3)_115-125.nxml.txt.nlp	25279238	SENT112	2	2	6	6	berberine	CD11b	PA165860812	3684	0.847
NULL	Oncogene_2010_Sep_16_29(37)_5193-5203.nxml.txt.nlp	20581867	SENT22	38	38	18	18	trastuzumab	HER2	PA451743	2064	0.847
NULL	Acta_Histochem_Cytochem_2006_Mar_2_39(1)_1-7.nxml.txt.nlp	17460766	SENT11	5	5	20	20	choline	FGF1	PA448976	2246	0.847
NULL	Biologics_2012_Feb_1_6_31-35.nxml.txt.nlp	22355257	SENT63	26	26	9	9	rituximab	IL-2	PA451261	3558	0.847
NULL	Int_J_Biol_Sci_2013_Nov_21_9(10)_1089-1098.nxml.txt.nlp	24339730	SENT123	10	10	13	13	genistein	mol	PA165109660	90527	0.847
NULL	Indian_J_Endocrinol_Metab_2013_Dec_17(Suppl_3)_S674-S679.nxml.txt.nlp	24910836	SENT164	4	4	15	15	acarbose	PPG	PA448010	5552	0.847
NULL	Nat_Commun_2011_Jul_19_2_402.nxml.txt.nlp	21772273	SENT38	28	28	2	2	doxorubicin	CHK2	PA449412	11200	0.847
NULL	Cancer_Cell_Int_2011_Aug_19_11_29.nxml.txt.nlp	21854619	SENT150	4	4	10	10	cisplatin	BRCA1	PA449014	672	0.847
NULL	Breast_Cancer_Res_2001_Mar_26_3(3)_180-182.nxml.txt.nlp	11305952	SENT33	11	11	2	2	raloxifene	STAR	PA451221	6770;2984	0.847
NULL	J_Korean_Med_Sci_2013_Nov_31_28(11)_1595-1602.nxml.txt.nlp	24265521	SENT82	0	0	15	15	pemetrexed	EGFR	PA10810	1956	0.847
NULL	Ital_J_Pediatr_2014_Nov_25_40(1)_88.nxml.txt.nlp	NULL	SENT42	23	23	4	4	methimazole	VIII	PA450422	1351	0.847
NULL	Diabetes_Care_2012_Dec_14_35(12)_2432-2437.nxml.txt.nlp	23173132	SENT270	11	11	9	9	rimonabant	CB1	PA152407999	1268	0.847
NULL	Oncotarget_2013_Nov_23_5(1)_196-210.nxml.txt.nlp	24344116	SENT77	13	13	6	6	doxorubicin	IL8	PA449412	3576	0.847
NULL	J_Headache_Pain_2010_Oct_22_11(5)_431-435.nxml.txt.nlp	20652353	SENT14	8	8	22	22	almotriptan	CYP3A4	PA10246	1576	0.847
NULL	Oxid_Med_Cell_Longev_2013_Jun_2_2013_793525.nxml.txt.nlp	23819014	SENT10	39	39	9	9	resveratrol	ROS		6098	0.847
NULL	J_Korean_Med_Sci_2013_Feb_29_28(2)_308-314.nxml.txt.nlp	23399960	SENT149	14	14	26	26	gabapentin	IL-10	PA449720	3586	0.847
NULL	Cancer_Cell_Int_2007_Sep_10_7_14.nxml.txt.nlp	17845729	SENT166	17	17	5	5	decitabine	PDCD5	PA164749631	9141	0.847
NULL	Curr_Genomics_2013_Nov_14(7)_477-484.nxml.txt.nlp	24396279	SENT424	5	5	15	15	cyclosporine	NPHS2	PA449167	7827	0.847
NULL	Biomed_Res_Int_2013_Aug_6_2013_602987.nxml.txt.nlp	24027759	SENT269	29	29	36	36	paclitaxel	SMF	PA450761	22993	0.847
NULL	Environ_Health_Perspect_1985_Sep_61_111-121.nxml.txt.nlp	3905370	SENT7	15	15	4	4	estradiol	gamma	PA449503	9913	0.847
NULL	Oncol_Lett_2014_Jul_25_8(1)_313-316.nxml.txt.nlp	24959268	SENT19	5	5	31	31	sulindac	JNK1	PA451565	5599	0.847
NULL	J_Oncol_2012_Jun_19_2012_521215.nxml.txt.nlp	22778735	SENT24	24	24	36	36	erlotinib	San	PA134687924	80218	0.847
NULL	Br_J_Clin_Pharmacol_2013_Aug_23_76(2)_299-315.nxml.txt.nlp	23701319	SENT239	8	8	5	5	alemtuzumab	IL-8	PA164783958	3576	0.847
NULL	Acta_Neuropathol_Commun_2014_Sep_4_2(1)_93.nxml.txt.nlp	NULL	SENT340	27	27	19	19	ethanol	IKZF1	PA448073	10320	0.847
NULL	J_Hum_Genet_2013_Jun_23_58(6)_339-345.nxml.txt.nlp	23697979	SENT54	12	12	9	9	clopidogrel	CYP2C19	PA449053	1557	0.847
NULL	Biosci_Rep_2012_Aug_1_32(Pt_4)_361-374.nxml.txt.nlp	22762204	SENT1100	8	8	1	1	trastuzumab	PTEN	PA451743	5728	0.847
NULL	J_Korean_Med_Sci_2009_Jun_16_24(3)_525-528.nxml.txt.nlp	19543522	SENT14	20	20	6	6	cyclophosphamide	CHOP	PA449165	1649	0.847
NULL	J_Cardiothorac_Surg_2013_May_13_8_127.nxml.txt.nlp	23668669	SENT23	37	37	17	17	oxycodone	CPP	PA450741	340451	0.847
NULL	Cancer_Med_2014_Aug_7_3(4)_796-811.nxml.txt.nlp	24802970	SENT68	16	16	26	26	trypsin	CD49f	PA451806	3655	0.847
NULL	Mol_Cancer_2008_Mar_6_7_24.nxml.txt.nlp	18325101	SENT160	25	25	7	7	curcumin	FANCD2	PA151958596	2177	0.847
NULL	Acta_Pharmacol_Sin_2010_May_5_31(5)_523-530.nxml.txt.nlp	20364156	SENT182	17	17	5	5	dexmedetomidine	GAPDH	PA449256	2597	0.847
NULL	Cancer_Cell_Int_2011_Dec_29_11_44.nxml.txt.nlp	22206574	SENT66	18	18	26	26	sorafenib	VEGFR2	PA7000	3791	0.847
NULL	J_Cell_Biol_1998_Jan_26_140(2)_335-345.nxml.txt.nlp	9442109	SENT82	13	13	10	10	chloroquine	NHE	PA448948	285335	0.847
NULL	Drugs_R_D_2011_Jun_27_11(2)_113-126.nxml.txt.nlp	21679004	SENT39	20	20	48	48	sorafenib	IFN	PA7000	3439	0.847
NULL	Breast_Cancer_Res_Treat_2014_Jan_9_143(3)_493-505.nxml.txt.nlp	24402830	SENT122	10	10	2	2	vinorelbine	TTR	PA451881	7276	0.847
NULL	Antimicrob_Agents_Chemother_2013_Oct_57(10)_5096-5103.nxml.txt.nlp	23917320	SENT193	12	12	5	5	lumefantrine	CYP3A4	PA165111722	1576	0.847
NULL	J_Asthma_Allergy_2008_Sep_19_1_19-29.nxml.txt.nlp	21436982	SENT110	43	43	23	23	fexofenadine	MDC	PA449621	6367	0.847
NULL	Mol_Cell_Biochem_2014_Oct_9_385(1-2)_265-275.nxml.txt.nlp	24104452	SENT61	6	6	8	8	bortezomib	U87	PA10252	677775;641648	0.847
NULL	Evid_Based_Complement_Alternat_Med_2011_Mar_1_2011_207034.nxml.txt.nlp	21423686	SENT157	27	27	4	4	clopidogrel	CYP2C19	PA449053	1557	0.847
NULL	Mol_Cancer_2014_Apr_29_13_96.nxml.txt.nlp	24779681	SENT217	1	1	41	41	tamoxifen	HER-2	PA451581	2064	0.847
NULL	Oncotarget_2014_Oct_21_5(22)_11709-11722.nxml.txt.nlp	25365944	SENT224	4	4	19	19	metformin	Rho	PA450395	29984	0.847
NULL	Cancers_(Basel)_2013_Mar_21_5(1)_296-319.nxml.txt.nlp	24216709	SENT984	16	16	4	4	bortezomib	ATF4	PA10252	468	0.847
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1420-1426.nxml.txt.nlp	24056704	SENT125	26	26	20	20	nifedipine	CYP3A	PA450631	1574	0.847
NULL	F1000Prime_Rep_2014_Apr_1_6_23.nxml.txt.nlp	24765528	SENT221	12	12	4	4	mitomycin	FANCD2	PA450524	2177	0.847
NULL	Oncoimmunology_2012_Oct_1_1(7)_1004-1016.nxml.txt.nlp	23170249	SENT106	17	17	8	8	paclitaxel	HER-2	PA450761	2064	0.847
NULL	Oncotarget_2014_Feb_16_5(4)_1062-1070.nxml.txt.nlp	24658085	SENT119	19	19	48	48	pemetrexed	4E-BP1	PA10810	1978	0.847
NULL	Diabetes_Care_2010_Nov_33(11)_2484-2485.nxml.txt.nlp	20980428	SENT36	13	13	19	19	pegaptanib	VEGF-A	PA164771236	7422	0.847
NULL	Br_J_Cancer_2014_Jan_21_110(2)_330-340.nxml.txt.nlp	24281000	SENT25	0	0	23	23	choline	PI3K	PA448976	5290	0.847
NULL	J_Korean_Med_Sci_2010_Aug_21_25(8)_1222-1227.nxml.txt.nlp	20676337	SENT163	24	24	18	18	propofol	LPA	PA451141	4018	0.847
NULL	Cell_Commun_Signal_2013_Nov_4_11_82.nxml.txt.nlp	24188565	SENT154	25	25	12	12	gentamicin	N-WASP	PA449753	8976	0.847
NULL	Biomed_Res_Int_2014_Jan_29_2014_831845.nxml.txt.nlp	24605337	SENT7	11	11	16	16	bupivacaine	S6K1	PA135057240	6198	0.847
NULL	J_Carcinog_2014_Feb_7_13_1.nxml.txt.nlp	24737949	SENT59	14	14	9	9	vemurafenib	BRAF	PA165946873	673	0.847
NULL	N_Am_J_Med_Sci_2011_Apr_3(4)_167-175.nxml.txt.nlp	22540086	SENT148	0	0	7	7	brivanib	VEGFR	PA164924492	3791	0.847
NULL	Acta_Pharmacol_Sin_2012_Jul_18_33(7)_861-872.nxml.txt.nlp	22705730	SENT14	0	0	11	11	atorvastatin	PDK1	PA448500	5170;5163	0.847
NULL	Mol_Cell_Proteomics_2014_May_20_13(5)_1184-1197.nxml.txt.nlp	24556848	SENT307	42	42	40	40	pp2	PP1		5540;5464	0.847
NULL	Int_J_Mol_Imaging_2012_Oct_2_2012_379807.nxml.txt.nlp	23091717	SENT230	22	22	9	9	cilengitide	VEGF-A	PA164924491	7422	0.847
NULL	J_Headache_Pain_2001_Jun_2(1)_3-11.nxml.txt.nlp	NULL	SENT1	0	0	27	27	sumatriptan	5-HT1D	PA451566	3352	0.847
NULL	Breast_Cancer_Res_2011_Nov_4_13(6)_R111.nxml.txt.nlp	22053985	SENT56	0	0	7	7	doxorubicin	IFN	PA449412	3439	0.847
NULL	Acta_Pharmacol_Sin_2014_Sep_25_35(9)_1199-1206.nxml.txt.nlp	25152024	SENT104	5	5	33	33	cisplatin	mig-2	PA449014	10979	0.847
NULL	Clin_Ophthalmol_2009_Jun_2_3_291-295.nxml.txt.nlp	19668581	SENT69	21	21	19	19	travoprost	BAK	PA164781371	578	0.847
NULL	BMB_Rep_2014_Jul_47(7)_376-381.nxml.txt.nlp	24286332	SENT112	23	23	9	9	thrombin	PPG	PA451674	5552	0.847
NULL	Front_Oncol_2014_Sep_23_4_264.nxml.txt.nlp	25295231	SENT265	32	32	25	25	cyclophosphamide	p53	PA449165	7157	0.847
NULL	Int_J_Mol_Sci_2014_Mar_5_15(3)_3970-3988.nxml.txt.nlp	24603537	SENT36	25	25	6	6	curcumin	MCH	PA151958596	5367	0.847
NULL	Open_Biol_2014_May_4(5)_140065.nxml.txt.nlp	24850914	SENT187	4	4	10	10	bortezomib	ALK3	PA10252	657	0.847
NULL	Mol_Brain_2013_May_4_6_22.nxml.txt.nlp	23641686	SENT195	19	19	2	2	pentobarbital	NR2D	PA450859	2906	0.847
NULL	Mol_Vis_2007_Jul_9_13_1073-1082.nxml.txt.nlp	17653052	SENT44	0	0	27	27	minocycline	P14	PA450519	11102;;6280;56259	0.847
NULL	Avicenna_J_Phytomed_2013_Autumn_3(4)_302-312.nxml.txt.nlp	25050287	SENT68	23	23	1	1	ethanol	hole	PA448073	80757	0.847
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT74	12	12	34	34	metformin	p53	PA450395	7157	0.847
NULL	Breast_Cancer_Res_2008_Jul_28_10(4)_R65.nxml.txt.nlp	18662380	SENT193	28	28	34	34	trastuzumab	ERBB2	PA451743	2064	0.847
NULL	Brain_Res_2011_Mar_25_1382(C)_29-36.nxml.txt.nlp	21276431	SENT266	0	0	18	18	fluvoxamine	5-HT2A	PA449690	3356	0.847
NULL	Breast_Cancer_Res_2008_Jul_8_10(4)_R56.nxml.txt.nlp	18611244	SENT245	22	22	29	29	tamoxifen	EGFR	PA451581	1956	0.847
NULL	Arthritis_Res_Ther_2004_Feb_24_6(Suppl_1)_61.nxml.txt.nlp	NULL	SENT11	15	15	22	22	genistein	PP1	PA165109660	5540;5464	0.847
NULL	Indian_J_Crit_Care_Med_2010_Oct-Dec_14(4)_188-195.nxml.txt.nlp	21572750	SENT68	32	32	22	22	thrombin	ADP	PA451674	23038	0.847
NULL	Endocrinol_Metab_(Seoul)_2014_Sep_25_29(3)_379-387.nxml.txt.nlp	25309798	SENT109	3	3	20	20	resveratrol	SIRT1		23411	0.847
NULL	Europace_2012_Aug_27_14(8)_1206-1214.nxml.txt.nlp	22454409	SENT93	39	39	9	9	olmesartan	FN1	PA164742950	2335	0.847
NULL	Diabetes_Care_2012_Jul_12_35(7)_1473-1478.nxml.txt.nlp	22446170	SENT59	10	10	23	23	pioglitazone	PPG	PA450970	5552	0.847
NULL	Br_J_Cancer_2011_Jul_26_105(3)_382-392.nxml.txt.nlp	21750552	SENT134	21	21	19	19	erlotinib	EGFR	PA134687924	1956	0.847
NULL	Support_Care_Cancer_2012_Mar_20_20(3)_647-652.nxml.txt.nlp	22101611	SENT21	16	16	10	10	vincristine	CHOP	PA451879	1649	0.847
NULL	Acta_Naturae_2013_Oct-Dec_5(4)_71-77.nxml.txt.nlp	24455185	SENT14	3	3	11	11	iron	TNF	PA450087	7124	0.847
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2014_Sep_27_70(Pt_10)_2740-2753.nxml.txt.nlp	25286857	SENT588	14	14	25	25	bsi-201	TNKS2		80351	0.847
NULL	Cardiovasc_Res_2011_Apr_1_90(1)_140-147.nxml.txt.nlp	21071431	SENT85	0	0	6	6	resveratrol	DPI		1832	0.847
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT313	6	6	10	10	curcumin	p53	PA151958596	7157	0.847
NULL	J_Breast_Cancer_2011_Mar_31_14(1)_20-27.nxml.txt.nlp	21847390	SENT198	18	18	6	6	estradiol	CLDN6	PA449503	9074	0.847
NULL	Nat_Commun_2012_Dec_27_3_1316.nxml.txt.nlp	23271650	SENT531	34	34	2	2	tamoxifen	P60	PA451581	7984	0.847
NULL	J_Gen_Intern_Med_2009_May_21_24(5)_656-664.nxml.txt.nlp	19306050	SENT254	19	19	11	11	warfarin	gamma	PA451906	9913	0.847
NULL	Front_Oncol_2013_Sep_25_3_256.nxml.txt.nlp	24093089	SENT312	39	39	20	20	paclitaxel	IL-8	PA450761	3576	0.847
NULL	Hematol_Rep_2011_Aug_1_3(2)_e9.nxml.txt.nlp	22184541	SENT46	14	14	10	10	methotrexate	SMILE	PA450428	160418	0.847
NULL	Pharmaceutics_2010_Jun_2_2(2)_258-274.nxml.txt.nlp	NULL	SENT177	36	36	34	34	risperidone	P-gp	PA451257	5243	0.847
NULL	Cancers_(Basel)_2014_Jul_7_6(3)_1441-1463.nxml.txt.nlp	25003395	SENT184	5	5	19	19	doxorubicin	PI3K	PA449412	5290	0.847
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT53	38	38	27	27	pertuzumab	HRG		3084;3273	0.847
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Dec_18_67(Pt_1)_o184-o185.nxml.txt.nlp	21522689	SENT67	30	30	17	17	ethanol	mol	PA448073	90527	0.847
NULL	Mol_Clin_Oncol_2013_Jul_27_1(4)_768-772.nxml.txt.nlp	24649244	SENT193	9	9	6	6	gemcitabine	NAC	PA449748	22861	0.847
NULL	Mol_Biol_Cell_2014_Jun_1_25(11)_1782-1792.nxml.txt.nlp	24719457	SENT96	5	5	18	18	nicotine	NeuN	PA450626	146713	0.847
NULL	J_Young_Pharm_2010_Oct-Dec_2(4)_428-429.nxml.txt.nlp	21264109	SENT3	14	14	6	6	metformin	B12	PA450395	7126;4709	0.847
NULL	Int_J_Hypertens_2012_Feb_22_2012_127910.nxml.txt.nlp	22518279	SENT121	13	13	28	28	ns-398	HO-1		3162	0.847
NULL	Chem_Cent_J_2013_Jan_31_7_20.nxml.txt.nlp	23363878	SENT125	27	27	5	5	nitrile	EWG	PA450636	4899	0.847
NULL	Curr_Hypertens_Rep_2014_Jan_11_16(2)_416.nxml.txt.nlp	24414230	SENT149	9	9	15	15	olmesartan	C21	PA164742950	79718	0.847
NULL	J_Cell_Biol_1998_Jan_26_140(2)_335-345.nxml.txt.nlp	9442109	SENT337	0	0	13	13	chloroquine	NHE	PA448948	285335	0.847
NULL	Breast_Cancer_Res_2004_Nov_7_6(1)_39-52.nxml.txt.nlp	14680484	SENT156	4	4	21	21	tamoxifen	AF-1	PA451581	3460;5710	0.847
NULL	Front_Microbiol_2014_Mar_14_5_99.nxml.txt.nlp	24672516	SENT86	12	12	37	37	caspofungin	TLR4	PA164743013	7099	0.847
NULL	Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.nxml.txt.nlp	24736980	SENT6	22	22	31	31	rosuvastatin	OATP1B1	PA134308647	10599	0.847
NULL	Clin_Med_Insights_Oncol_2012_Mar_12_6_137-147.nxml.txt.nlp	22550402	SENT78	32	32	29	29	gefitinib	EGFR	PA131301952	1956	0.847
NULL	Iran_J_Basic_Med_Sci_2011_Jul-Aug_14(4)_327-339.nxml.txt.nlp	23492840	SENT52	15	15	35	35	collagenase	CO2	PA449107	4513	0.847
NULL	Br_J_Clin_Pharmacol_2012_Apr_7_73(4)_518-535.nxml.txt.nlp	22053916	SENT62	24	24	9	9	gemfibrozil	CYP3A4	PA449750	1576	0.847
NULL	J_Am_Heart_Assoc_2013_Aug_23_2(4)_e000170.nxml.txt.nlp	23832325	SENT94	40	40	15	15	warfarin	TTR	PA451906	7276	0.847
NULL	Curr_Neuropharmacol_2012_Sep_10(3)_212-218.nxml.txt.nlp	23449551	SENT239	8	8	5	5	rimonabant	CB1	PA152407999	1268	0.847
NULL	Int_J_Mol_Sci_2014_Nov_10_15(11)_20572-20584.nxml.txt.nlp	25391043	SENT86	22	22	30	30	bupivacaine	S12	PA135057240	3351;6206;5713;6268	0.847
NULL	Exp_Ther_Med_2014_Aug_4_8(2)_657-661.nxml.txt.nlp	25009636	SENT91	25	25	15	15	propofol	CCL2	PA451141	6347	0.847
NULL	Breast_Cancer_Res_Treat_2012_Apr_3_132(3)_895-915.nxml.txt.nlp	22048814	SENT354	27	27	29	29	tamoxifen	IMPACT	PA451581	55364	0.847
NULL	Neural_Plast_2007_Jun_19_2007_52908.nxml.txt.nlp	17641734	SENT196	27	27	33	33	rimonabant	CB1	PA152407999	1268	0.847
NULL	Cancers_(Basel)_2012_Oct_29_4(4)_1146-1160.nxml.txt.nlp	24213502	SENT53	7	7	16	16	raloxifene	STAR	PA451221	6770;2984	0.847
NULL	Neuropsychopharmacology_2009_Apr_2_34(5)_1135-1148.nxml.txt.nlp	18596687	SENT15	34	34	5	5	cocaine	CRF	PA449072	1392;10882	0.847
NULL	Biosci_Rep_2012_Aug_1_32(Pt_4)_361-374.nxml.txt.nlp	22762204	SENT66	19	19	3	3	paclitaxel	p53	PA450761	7157	0.847
NULL	J_Hematol_Oncol_2012_Dec_6_5_72.nxml.txt.nlp	23216927	SENT53	15	15	10	10	sorafenib	FLT3	PA7000	2322	0.847
NULL	Apoptosis_2013_Apr_31_18(4)_509-520.nxml.txt.nlp	23371322	SENT281	2	2	12	12	cisplatin	p53	PA449014	7157	0.847
NULL	J_Immunother_2014_Apr_12_37(3)_180-186.nxml.txt.nlp	24598448	SENT193	3	3	15	15	sorafenib	IL-2	PA7000	3558	0.847
NULL	Bioinorg_Chem_Appl_2013_Dec_11_2013_524701.nxml.txt.nlp	24391528	SENT239	21	21	10	10	cisplatin	TSC1	PA449014	7248	0.847
NULL	Clin_Dev_Immunol_2013_Nov_26_2013_325481.nxml.txt.nlp	24371447	SENT9	3	3	9	9	propofol	IL-6	PA451141	3569	0.847
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2012_Nov_7_1(11)_e13.nxml.txt.nlp	23835795	SENT284	9	9	1	1	pravastatin	SLCO1B1	PA451089	10599	0.847
NULL	Case_Rep_Hematol_2013_Feb_3_2013_837906.nxml.txt.nlp	23431487	SENT10	2	2	14	14	desmopressin	VWF	PA449237	7450	0.847
NULL	Lipids_Health_Dis_2011_Feb_12_10_31.nxml.txt.nlp	21314960	SENT136	3	3	15	15	hemin	IL-6	PA449849	3569	0.847
NULL	Br_J_Pharmacol_2014_May_171(10)_2659-2670.nxml.txt.nlp	24116661	SENT198	24	24	17	17	naringenin	TRPP2	PA151958361	5311	0.847
NULL	Breast_Cancer_Res_2011_Jun_9_13(3)_R57.nxml.txt.nlp	21658222	SENT23	5	5	14	14	epirubicin	UGT	PA449476	7361;7355	0.847
NULL	Mol_Neurodegener_2011_Aug_8_6_57.nxml.txt.nlp	21819629	SENT242	10	10	25	25	arsenite	HuR	PA452638	1994	0.847
NULL	Br_J_Cancer_2012_Sep_4_107(6)_947-955.nxml.txt.nlp	22892392	SENT252	40	40	17	17	lapatinib	EGF	PA152241907	1950	0.847
NULL	Diabetes_2009_Jun_31_58(6)_1434-1439.nxml.txt.nlp	19336679	SENT116	25	25	13	13	metformin	SLC22A1	PA450395	6580	0.847
NULL	Exp_Ther_Med_2013_Mar_20_5(3)_689-694.nxml.txt.nlp	23403765	SENT4	35	35	29	29	l-cysteine	PAG	PA449173	55824	0.847
NULL	Br_J_Cancer_2009_May_19_100(10)_1589-1602.nxml.txt.nlp	19436306	SENT8	15	15	19	19	amiloride	TLR-4	PA448368	7099	0.847
NULL	Clin_Sci_(Lond)_2011_Mar_1_120(Pt_5)_195-206.nxml.txt.nlp	20840078	SENT178	4	4	8	8	indomethacin	COX	PA449982	1351	0.847
NULL	Br_J_Cancer_2000_Jun_82(11)_1851-1859.nxml.txt.nlp	10839301	SENT7	40	40	32	32	bleomycin	CD95	PA448645	355	0.847
NULL	Nucleic_Acids_Res_2012_Jul_19_40(13)_5910-5925.nxml.txt.nlp	22434882	SENT302	19	19	15	15	curcumin	HBZ	PA151958596	3050	0.847
NULL	Pharmaceuticals_(Basel)_2013_Aug_2_6(8)_915-928.nxml.txt.nlp	24276376	SENT11	30	30	20	20	thrombin	ADP	PA451674	23038	0.847
NULL	J_Ophthalmol_2011_Oct_20_2011_252549.nxml.txt.nlp	22046503	SENT114	8	8	17	17	ranibizumab	CFB	PA164746012	629	0.847
NULL	J_Cell_Biol_1998_Mar_9_140(5)_991-1002.nxml.txt.nlp	9490714	SENT70	16	16	3	3	paraformaldehyde	INCENP	PA450790	3619	0.847
NULL	Int_J_Mol_Sci_2014_Nov_10_15(11)_20607-20637.nxml.txt.nlp	25391045	SENT40	18	18	31	31	lovastatin	CYP2C9	PA450272	1559	0.847
NULL	Open_Access_J_Urol_2010_Mar_12_2_35-40.nxml.txt.nlp	24198612	SENT59	0	0	4	4	pazopanib	VEGFR	PA165291492	3791	0.847
NULL	Indian_J_Med_Res_2011_Sep_134(3)_295-301.nxml.txt.nlp	21985811	SENT122	27	27	18	18	carbamazepine	MDR1	PA448785	5243	0.847
NULL	Oncol_Lett_2013_Feb_30_5(2)_588-592.nxml.txt.nlp	23420263	SENT81	18	18	15	15	lenalidomide	NKX2-1	PA162363968	7080	0.847
NULL	Int_J_Emerg_Med_2012_Nov_6_5_39.nxml.txt.nlp	23131076	SENT150	32	32	18	18	alteplase	COX	PA164776730	1351	0.847
NULL	Clin_Exp_Reprod_Med_2012_Sep_30_39(3)_95-106.nxml.txt.nlp	23106040	SENT204	11	11	21	21	hyaluronan	gremlin	PA165958431	26585	0.847
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT133	19	19	22	22	metformin	HIF-1	PA450395	29072	0.847
NULL	Anemia_2012_Aug_12_2012_297641.nxml.txt.nlp	22924125	SENT143	3	3	43	43	deferasirox	EOS	PA164760843	260429	0.847
NULL	Int_Semin_Surg_Oncol_2007_Feb_14_4_5.nxml.txt.nlp	17394628	SENT15	35	35	15	15	cyclophosphamide	PMS2	PA449165	5395	0.847
NULL	Clinics_(Sao_Paulo)_2014_Jan_69(1)_68-74.nxml.txt.nlp	24473562	SENT84	11	11	22	22	nutlin-3	SOCS-1		8651	0.847
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT115	3	3	10	10	resveratrol	PARP		142	0.847
NULL	Br_J_Cancer_2014_Jan_21_110(2)_384-391.nxml.txt.nlp	24346286	SENT131	25	25	13	13	trastuzumab	HER3	PA451743	2065	0.847
NULL	Acta_Pharmacol_Sin_2012_May_4_33(5)_644-651.nxml.txt.nlp	22555371	SENT168	21	21	11	11	sulodexide	eNOS	PA164746343	4846	0.847
NULL	Drug_Des_Devel_Ther_2014_Sep_26_8_1595-1611.nxml.txt.nlp	25302015	SENT133	27	27	9	9	afatinib	EGFR	PA165981154	1956	0.847
NULL	Mol_Vis_2011_Dec_16_17_3300-3308.nxml.txt.nlp	22194656	SENT55	24	24	48	48	l-glutamine	B27	PA10090	56246	0.847
NULL	Ann_Gastroenterol_2014_27(4)_380-386.nxml.txt.nlp	25331321	SENT27	31	31	14	14	telbivudine	IFN	PA164760861	3439	0.846
NULL	J_Hematol_Oncol_2008_Aug_11_1_11.nxml.txt.nlp	18694493	SENT141	17	17	11	11	temsirolimus	IL-2	PA164746890	3558	0.846
NULL	Br_J_Cancer_2013_Jun_25_108(12)_2464-2469.nxml.txt.nlp	23695016	SENT141	15	15	13	13	carboplatin	NACT	PA448803	284111	0.846
NULL	Lancet_2011_Jun_9_377(9784)_2181-2192.nxml.txt.nlp	21663949	SENT129	5	5	1	1	simvastatin	SHARP	PA451363	23013	0.846
NULL	eLife_2014_Aug_1_3_e02725.nxml.txt.nlp	25085081	SENT764	18	18	8	8	oxaliplatin	MSH3	PA131285527	4437	0.846
NULL	Arch_Med_Sci_2012_Jul_4_8(3)_533-541.nxml.txt.nlp	22852012	SENT214	9	9	2	2	fludarabine	IFN	PA449655	3439	0.846
NULL	Br_J_Cancer_2011_Mar_15_104(6)_957-967.nxml.txt.nlp	21364585	SENT94	6	6	12	12	doxorubicin	CD138	PA449412	6382	0.846
NULL	Mol_Cancer_2009_Nov_10_8_99.nxml.txt.nlp	19903356	SENT35	13	13	2	2	imatinib	IGFBP3	PA10804	3486	0.846
NULL	Cancer_Immunol_Immunother_2011_Jun_25_60(6)_793-808.nxml.txt.nlp	21350947	SENT216	8	8	5	5	sorafenib	IFN	PA7000	3439	0.846
NULL	Oncotarget_2012_Aug_7_3(8)_783-797.nxml.txt.nlp	22878175	SENT231	32	32	1	1	fluorescein	S100A4	PA164746009	6275	0.846
NULL	Clin_Ophthalmol_2011_Jul_26_5_1043-1049.nxml.txt.nlp	21845032	SENT11	14	14	22	22	bevacizumab	San	PA130232992	80218	0.846
NULL	Mol_Cancer_2009_Dec_3_8_115.nxml.txt.nlp	19958544	SENT74	14	14	20	20	nutlin-3	p53		7157	0.846
NULL	Eur_J_Clin_Pharmacol_2008_Feb_26_64(2)_133-157.nxml.txt.nlp	18224312	SENT59	18	18	10	10	tamoxifen	CYP2D6	PA451581	1565	0.846
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT94	31	31	48	48	pertuzumab	HER2		2064	0.846
NULL	J_Anaesthesiol_Clin_Pharmacol_2011_Jan-Mar_27(1)_91-96.nxml.txt.nlp	21804715	SENT152	20	20	5	5	fentanyl	DBP	PA449599	3295;1628;2638	0.846
NULL	Biomed_Res_Int_2014_May_4_2014_428619.nxml.txt.nlp	24883312	SENT71	15	15	23	23	glutaraldehyde	CO2	PA449777	4513	0.846
NULL	Int_J_Nephrol_2010_Jun_21_2010_957645.nxml.txt.nlp	21188242	SENT30	4	4	26	26	heparin	IL-6	PA449855	3569	0.846
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT233	24	24	6	6	doxorubicin	B7-H1	PA449412	29126	0.846
NULL	J_Virol_2014_Apr_88(7)_3664-3677.nxml.txt.nlp	24429366	SENT570	9	9	12	12	temozolomide	HIF-1alpha	PA451609	3091	0.846
NULL	Front_Chem_2014_Mar_14_2_12.nxml.txt.nlp	24790981	SENT119	18	18	30	30	curcumin	GATA4	PA151958596	2626	0.846
NULL	Iran_J_Pharm_Res_2014_Spring_13(2)_683-693.nxml.txt.nlp	25237365	SENT9	8	8	20	20	tranilast	CXCL12	PA131890628	6387	0.846
NULL	Onco_Targets_Ther_2014_May_28_7_841-852.nxml.txt.nlp	24920926	SENT94	0	0	4	4	afatinib	EGFR	PA165981154	1956	0.846
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT147	8	8	19	19	gefitinib	KRAS	PA131301952	3845	0.846
NULL	Cancer_Manag_Res_2013_Jun_11_5_103-115.nxml.txt.nlp	23807861	SENT63	19	19	27	27	bevacizumab	VEGF-A	PA130232992	7422	0.846
NULL	J_Midlife_Health_2014_Jan-Mar_5(1)_38-40.nxml.txt.nlp	24672205	SENT26	21	21	18	18	medroxyprogesterone	CEE	PA450344	51608	0.846
NULL	J_Biol_Chem_2012_Apr_20_287(17)_14122-14135.nxml.txt.nlp	22351750	SENT870	13	13	16	16	hyaluronan	TSG-6	PA165958431	7130	0.846
NULL	Iran_J_Pharm_Res_2014_Autumn_13(4)_1227-1233.nxml.txt.nlp	25587311	SENT144	17	17	4	4	bupropion	CYP2C9	PA448687	1559	0.846
NULL	Breast_Cancer_Res_2008_Jul_24_10(4)_211.nxml.txt.nlp	18671839	SENT206	16	16	14	14	erlotinib	EGFR	PA134687924	1956	0.846
NULL	Acta_Pharmacol_Sin_2013_Jun_8_34(6)_811-818.nxml.txt.nlp	23564082	SENT152	29	29	3	3	naloxone	RhoA	PA450586	387	0.846
NULL	Cell_Commun_Signal_2011_May_15_9_13.nxml.txt.nlp	21569639	SENT292	9	9	11	11	quinacrine	p53	PA164745551	7157	0.846
NULL	N_Am_J_Med_Sci_2010_Nov_2(11)_540-543.nxml.txt.nlp	22558563	SENT37	13	13	3	3	fluorescein	DIF	PA164746009	7124	0.846
NULL	Iran_J_Pharm_Res_2014_Spring_13(2)_459-469.nxml.txt.nlp	25237341	SENT51	27	27	9	9	ethanol	mol	PA448073	90527	0.846
NULL	Int_J_Mol_Sci_2012_Aug_24_13(9)_10697-10721.nxml.txt.nlp	23109817	SENT1105	16	16	8	8	vasopressin	AT2	PA451858	186	0.846
NULL	J_Korean_Neurosurg_Soc_2014_Jan_31_55(1)_5-11.nxml.txt.nlp	24570811	SENT163	46	46	30	30	bevacizumab	CRT	PA130232992	811	0.846
NULL	Exp_Ther_Med_2013_Mar_8_5(3)_707-710.nxml.txt.nlp	23404433	SENT81	13	13	30	30	cisplatin	Bcl-2	PA449014	596	0.846
NULL	Anesthesiol_Res_Pract_2011_Oct_27_2011_317410.nxml.txt.nlp	22110498	SENT94	14	14	25	25	propofol	IL-8	PA451141	3576	0.846
NULL	Br_J_Haematol_2014_Mar_13_164(1)_811-821.nxml.txt.nlp	24328678	SENT20	8	8	24	24	lenalidomide	IL2	PA162363968	3558	0.846
NULL	Cancer_Metastasis_Rev_2014_Dec_28_33(1)_161-171.nxml.txt.nlp	24375389	SENT163	15	15	34	34	paclitaxel	CHFR	PA450761	55743	0.846
NULL	Acta_Pharmacol_Sin_2013_Apr_25_34(4)_455-463.nxml.txt.nlp	23524568	SENT143	5	5	21	21	pioglitazone	RAGE	PA450970	177	0.846
NULL	Arthritis_Res_Ther_2012_Apr_16_14(2)_R76.nxml.txt.nlp	22507741	SENT171	4	4	6	6	estradiol	IL-10	PA449503	3586	0.846
NULL	Clin_Exp_Gastroenterol_2014_Apr_11_7_83-92.nxml.txt.nlp	24748811	SENT94	6	6	22	22	adalimumab	CDAI	PA10004	146059	0.846
NULL	Vet_Res_2013_Jul_22_44(1)_61.nxml.txt.nlp	23876161	SENT188	5	5	16	16	etoposide	TRAIL	PA449552	8743	0.846
NULL	Breast_Cancer_(Auckl)_2012_Nov_19_6_191-207.nxml.txt.nlp	23226023	SENT84	10	10	12	12	capecitabine	HER2	PA448771	2064	0.846
NULL	J_Hum_Genet_2013_Jun_23_58(6)_339-345.nxml.txt.nlp	23697979	SENT114	30	30	23	23	prasugrel	CYP2C19	PA154410481	1557	0.846
NULL	Breast_Cancer_Res_Treat_2014_Sep_19_147(3)_599-607.nxml.txt.nlp	25234842	SENT18	12	12	22	22	trastuzumab	HER2	PA451743	2064	0.846
NULL	Biosci_Rep_2014_Aug_6_34(4)_e00131.nxml.txt.nlp	24975826	SENT147	13	13	19	19	pp2	PP2		4888	0.846
NULL	Angew_Chem_Int_Ed_Engl_2012_Nov_19_51(47)_11853-11857.nxml.txt.nlp	23081716	SENT15	11	11	42	42	doxorubicin	NIR	PA449412	26155	0.846
NULL	Oncol_Lett_2014_Jan_20_7(1)_260-266.nxml.txt.nlp	24348860	SENT141	21	21	18	18	fluorouracil	CRT	PA128406956	811	0.846
NULL	EMBO_Mol_Med_2013_Apr_25_5(4)_531-547.nxml.txt.nlp	23526793	SENT10	29	29	26	26	rosiglitazone	EZH2	PA451283	2146	0.846
NULL	Basic_Clin_Pharmacol_Toxicol_2013_Feb_5_112(2)_132-137.nxml.txt.nlp	22900583	SENT149	23	23	16	16	prasugrel	CYP3A	PA154410481	1574	0.846
NULL	Arthritis_Res_Ther_2012_Jun_12_14(3)_R142.nxml.txt.nlp	22691272	SENT105	4	4	11	11	mianserin	RANTES	PA134687937	6352	0.846
NULL	Cell_Commun_Signal_2013_Nov_11_11_86.nxml.txt.nlp	24215724	SENT496	6	6	4	4	thrombin	PAR1	PA451674	79581;2149	0.846
NULL	Exp_Ther_Med_2014_Apr_21_7(4)_855-859.nxml.txt.nlp	24669240	SENT16	0	0	8	8	gefitinib	EGFR	PA131301952	1956	0.846
NULL	Genome_Biol_2008_Nov_25_9(11)_R166.nxml.txt.nlp	19032775	SENT283	0	0	12	12	suramin	San	PA10292	80218	0.846
NULL	Biomed_Res_Int_2014_Jan_20_2014_948427.nxml.txt.nlp	24563867	SENT19	13	13	2	2	risperidone	5-HT1A	PA451257	3350	0.846
NULL	Mol_Cancer_2009_Dec_10_8_119.nxml.txt.nlp	20003272	SENT82	31	31	20	20	doxorubicin	p53	PA449412	7157	0.846
NULL	Acta_Pharmacol_Sin_2012_Aug_23_33(8)_1095-1100.nxml.txt.nlp	22820908	SENT114	30	30	27	27	ilaprazole	CYP3A	PA165947499	1574	0.846
NULL	Sensors_(Basel)_2012_Dec_28_13(1)_500-515.nxml.txt.nlp	23275085	SENT319	3	3	14	14	isoflurane	ARC	PA450106	8996;23237	0.846
NULL	Arthritis_Res_Ther_2012_Apr_16_14(2)_R76.nxml.txt.nlp	22507741	SENT175	21	21	31	31	estradiol	IL-10	PA449503	3586	0.846
NULL	J_Inflamm_(Lond)_2005_Oct_31_2_14.nxml.txt.nlp	16259633	SENT296	5	5	18	18	staurosporine	CCR2	PA165109623	729230	0.846
NULL	Diabetes_Care_2009_Jan_32(1)_84-90.nxml.txt.nlp	18931095	SENT45	12	12	8	8	metformin	GLP-1	PA450395	100125288	0.846
NULL	Exp_Ther_Med_2013_Mar_24_5(3)_902-906.nxml.txt.nlp	23408108	SENT116	13	13	4	4	letrozole	CYP19A1	PA450196	1588	0.846
NULL	Leukemia_2015_Jan_26_29(1)_237-241.nxml.txt.nlp	25257991	SENT7	6	6	4	4	cyclophosphamide	CHOP	PA449165	1649	0.846
NULL	Ann_Dermatol_2013_Nov_30_25(4)_500-502.nxml.txt.nlp	24371403	SENT5	15	15	4	4	imatinib	LDE	PA10804	7957	0.846
NULL	Nucl_Recept_Signal_2009_Dec_31_7_e012.nxml.txt.nlp	20087433	SENT194	7	7	20	20	ns-398	cGKII		5593	0.846
NULL	Bioinform_Biol_Insights_2009_Oct_5_3_109-127.nxml.txt.nlp	20140064	SENT389	8	8	16	16	stavudine	P65	PA451494	64689;6857	0.846
NULL	Eur_J_Clin_Pharmacol_2012_May_21_68(5)_553-560.nxml.txt.nlp	22189672	SENT42	21	21	15	15	dextromethorphan	CYP3A	PA449273	1574	0.846
NULL	Acta_Pharmacol_Sin_2012_Jan_3_33(1)_49-56.nxml.txt.nlp	22212430	SENT37	5	5	17	17	thrombin	PAR-1	PA451674	2011;2149	0.846
NULL	Gastric_Cancer_2013_Jul_12_16(3)_345-354.nxml.txt.nlp	22968820	SENT178	21	21	7	7	oxaliplatin	FANCC	PA131285527	2176	0.846
NULL	Cardiovasc_Diabetol_2011_Dec_1_10_109.nxml.txt.nlp	22132774	SENT162	30	30	5	5	liraglutide	GLP-1	PA165958364	100125288	0.846
NULL	Breast_Cancer_Res_2003_Jul_28_5(5)_276-279.nxml.txt.nlp	12927039	SENT94	3	3	18	18	carboplatin	HER-2	PA448803	2064	0.846
NULL	Oncoimmunology_2013_Aug_1_2(8)_e25594.nxml.txt.nlp	24179707	SENT19	16	16	26	26	vemurafenib	IFN	PA165946873	3439	0.846
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT31	7	7	22	22	tamoxifen	p27	PA451581	5715;10534	0.846
NULL	Cell_Cycle_2013_May_15_12(10)_1492-1500.nxml.txt.nlp	23598717	SENT78	18	18	7	7	doxorubicin	ROCK1	PA449412	6093	0.846
NULL	Europace_2014_Feb_12_16(2)_195-201.nxml.txt.nlp	24036378	SENT143	11	11	2	2	warfarin	SPAF	PA451906	166378	0.846
NULL	Clin_Sci_(Lond)_2011_Apr_1_120(Pt_8)_335-345.nxml.txt.nlp	21091432	SENT155	7	7	16	16	ramipril	ACE2	PA451223	59272	0.846
NULL	Front_Immunol_2013_May_27_4_118.nxml.txt.nlp	23750159	SENT790	18	18	4	4	abacavir	HLA-B	PA448004	3106	0.846
NULL	Int_Semin_Surg_Oncol_2007_Feb_14_4_5.nxml.txt.nlp	17394628	SENT15	35	35	11	11	cyclophosphamide	MSH2	PA449165	4436	0.846
NULL	Acta_Pharmacol_Sin_2010_Jun_4_31(6)_709-717.nxml.txt.nlp	20523342	SENT212	26	26	19	19	repaglinide	IGF2BP2	PA451234	10644	0.846
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT108	0	0	11	11	neratinib	HER3	PA165291472	2065	0.846
NULL	J_Headache_Pain_2010_Apr_6_11(2)_151-156.nxml.txt.nlp	20213484	SENT16	16	16	24	24	zolmitriptan	CYP3A4	PA451975	1576	0.846
NULL	eLife_2014_May_6_3_e02482.nxml.txt.nlp	24843002	SENT215	33	33	23	23	etoposide	p53	PA449552	7157	0.846
NULL	Cardiovasc_Psychiatry_Neurol_2009_Oct_13_2009_475108.nxml.txt.nlp	20029624	SENT76	17	17	3	3	ketanserin	5-HT2A	PA131053734	3356	0.846
NULL	J_Carcinog_2011_Jul_19_10_17.nxml.txt.nlp	21799661	SENT196	33	33	2	2	metformin	OCT3	PA450395	5460;6581	0.846
NULL	Oncogene_2013_Oct_17_32(42)_5101-5110.nxml.txt.nlp	23208508	SENT33	45	45	41	41	metformin	AMPK	PA450395	5563	0.846
NULL	Br_J_Cancer_2009_May_19_100(10)_1608-1616.nxml.txt.nlp	19401687	SENT50	31	31	25	25	bicalutamide	CO2	PA164746255	4513	0.846
NULL	Expert_Opin_Drug_Deliv_2014_Dec_18_11(12)_1939-1954.nxml.txt.nlp	25035968	SENT167	42	42	33	33	l-lysine	HER2	PA450280	2064	0.846
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jul_18_68(Pt_8)_o2473.nxml.txt.nlp	22904915	SENT4	1	1	24	24	phenol	mol	PA450913	90527	0.846
NULL	Mucosal_Immunol_2014_Mar_24_7(2)_335-347.nxml.txt.nlp	23881354	SENT111	2	2	26	26	atropine	GAL	PA448505	51083	0.846
NULL	BMB_Rep_2013_Jan_46(1)_59-64.nxml.txt.nlp	23351386	SENT30	5	5	15	15	auranofin	STAT3	PA448510	6774	0.846
NULL	Oncotarget_2014_Aug_25_5(17)_7945-7959.nxml.txt.nlp	25277206	SENT373	3	3	13	13	cabozantinib	VEGFR	PA165906891	3791	0.846
NULL	Open_Access_J_Urol_2011_May_10_3_69-82.nxml.txt.nlp	24198638	SENT66	20	20	27	27	paclitaxel	CYP2C9	PA450761	1559	0.846
NULL	Br_J_Clin_Pharmacol_2014_Nov_20_78(5)_1050-1057.nxml.txt.nlp	24962564	SENT143	10	10	7	7	ketoconazole	CYP3A4	PA450146	1576	0.846
NULL	Ann_Surg_Treat_Res_2014_Feb_22_86(2)_68-75.nxml.txt.nlp	24761411	SENT191	9	9	5	5	oxaliplatin	survivin	PA131285527	332	0.846
NULL	Mol_Cancer_2010_Aug_20_9_220.nxml.txt.nlp	20727180	SENT217	9	9	2	2	nicotine	p53	PA450626	7157	0.846
NULL	Arthritis_Res_Ther_2006_Dec_28_8(1)_R18.nxml.txt.nlp	16507118	SENT160	29	29	5	5	infliximab	IL-15	PA452639	3600	0.846
NULL	EMBO_Mol_Med_2013_Dec_15_5(12)_1871-1886.nxml.txt.nlp	24127423	SENT241	29	29	33	33	alendronate	10C	PA448082	64333	0.846
NULL	Breast_Cancer_Res_2011_Apr_20_13(2)_307.nxml.txt.nlp	21575280	SENT26	36	36	19	19	tamoxifen	FOXA1	PA451581	3169	0.846
NULL	Curr_Neuropharmacol_2013_Jul_11(4)_338-378.nxml.txt.nlp	24381528	SENT698	6	6	29	29	curcumin	p53	PA151958596	7157	0.846
NULL	Clin_Exp_Gastroenterol_2012_May_14_5_49-59.nxml.txt.nlp	22649281	SENT38	26	26	5	5	esomeprazole	CYP2C19	PA10075	1557	0.846
NULL	Nat_Commun_2013_Aug_15_4_2130.nxml.txt.nlp	23945651	SENT43	22	22	17	17	cisplatin	ATG5	PA449014	9474	0.846
NULL	J_Radiat_Res_2014_Nov_16_55(6)_1171-1177.nxml.txt.nlp	25129557	SENT199	9	9	16	16	bevacizumab	LARC	PA130232992	6364	0.846
NULL	Clin_Med_Oncol_2008_Feb_9_2_47-61.nxml.txt.nlp	21892266	SENT64	5	5	15	15	lapatinib	EGFR	PA152241907	1956	0.846
NULL	Diabetes_Care_2009_Sep_32(9)_e104-e111.nxml.txt.nlp	19717816	SENT134	23	23	13	13	glimepiride	GLP-1	PA449761	100125288	0.846
NULL	Diabetologia_2014_Sep_29_57(1)_192-203.nxml.txt.nlp	24078137	SENT195	2	2	24	24	metformin	RDH12	PA450395	145226	0.846
NULL	Emerg_Infect_Dis_2014_Apr_20(4)_612-619.nxml.txt.nlp	24655615	SENT36	0	0	6	6	ciprofloxacin	GISP	PA449009	83998	0.846
NULL	Chonnam_Med_J_2014_Apr_22_50(1)_27-30.nxml.txt.nlp	24855605	SENT48	4	4	6	6	rituximab	CHOP	PA451261	1649	0.846
NULL	Cancers_(Basel)_2012_Sep_3_4(3)_846-872.nxml.txt.nlp	24213470	SENT1036	9	9	15	15	temozolomide	p53	PA451609	7157	0.846
NULL	Front_Oncol_2013_Apr_23_3_86.nxml.txt.nlp	23630663	SENT138	3	3	15	15	afatinib	ERBB2	PA165981154	2064	0.846
NULL	Blood_Res_2014_Sep_25_49(3)_200-203.nxml.txt.nlp	25325043	SENT27	5	5	14	14	cyclophosphamide	CHOP	PA449165	1649	0.846
NULL	Patient_Prefer_Adherence_2008_Feb_2_2_387-392.nxml.txt.nlp	19920986	SENT8	2	2	11	11	methotrexate	gamma	PA450428	9913	0.846
NULL	Br_J_Cancer_2012_Sep_4_107(6)_947-955.nxml.txt.nlp	22892392	SENT241	5	5	0	0	lapatinib	BCAR4	PA152241907	400500	0.846
NULL	Genetics_2013_Jan_193(1)_1-50.nxml.txt.nlp	23275493	SENT410	20	20	10	10	lipase	DAG	PA450239	1605	0.846
NULL	J_Hematol_Oncol_2011_Nov_4_4_44.nxml.txt.nlp	22053759	SENT103	2	2	5	5	thrombin	PAR1	PA451674	79581;2149	0.846
NULL	Cancers_(Basel)_2012_May_8_4(2)_523-530.nxml.txt.nlp	24213322	SENT19	22	22	33	33	erlotinib	EGFR	PA134687924	1956	0.846
NULL	Allergy_Asthma_Clin_Immunol_2010_Jul_28_6(1)_19.nxml.txt.nlp	20667122	SENT157	17	17	10	10	icatibant	C1-INH	PA164749185	710	0.846
NULL	J_Cell_Biol_2004_Apr_26_165(2)_175-180.nxml.txt.nlp	15096524	SENT79	7	7	15	15	forskolin	PKG	PA146096022	5592	0.846
NULL	Ann_Indian_Acad_Neurol_2013_Apr-Jun_16(2)_249-251.nxml.txt.nlp	23956575	SENT39	13	13	6	6	lipase	B12	PA450239	7126;4709	0.846
NULL	J_Cancer_2013_Nov_23_4(9)_736-754.nxml.txt.nlp	24312144	SENT169	3	3	21	21	gefitinib	EGFR	PA131301952	1956	0.846
NULL	Acta_Pharmacol_Sin_2013_Sep_5_34(9)_1192-1200.nxml.txt.nlp	23685957	SENT139	6	6	22	22	curcumin	AP-2	PA151958596	7020	0.846
NULL	Diabetes_Obes_Metab_2011_Nov_13(11)_982-989.nxml.txt.nlp	21615670	SENT107	13	13	7	7	sitagliptin	GLP-1	PA164748978	100125288	0.846
NULL	Cell_Death_Dis_2014_Mar_13_5(3)_e1119.nxml.txt.nlp	24625978	SENT135	7	7	0	0	hyaluronan	HAPLN1	PA165958431	1404	0.846
NULL	JAKSTAT_2012_Jul_1_1(3)_197-199.nxml.txt.nlp	24058771	SENT59	7	7	19	19	fulvestrant	BCL2	PA164747170	596	0.846
NULL	Mol_Immunol_2008_Jan_45(2)_395-405.nxml.txt.nlp	17651804	SENT63	29	29	0	0	barbital	CFD	PA448538	1675	0.846
NULL	Exp_Ther_Med_2012_Oct_6_4(4)_655-660.nxml.txt.nlp	23170121	SENT67	14	14	23	23	fluorescein	CD80	PA164746009	941	0.846
NULL	J_Gastroenterol_2014_Dec_24_49(12)_1536-1547.nxml.txt.nlp	24366288	SENT110	22	22	29	29	rabeprazole	CYP2C19	PA451216	1557	0.846
NULL	Oncotarget_2014_Oct_21_5(22)_11709-11722.nxml.txt.nlp	25365944	SENT193	0	0	8	8	metformin	RhoA	PA450395	387	0.846
NULL	Neural_Regen_Res_2013_Jul_15_8(20)_1853-1862.nxml.txt.nlp	25206494	SENT24	5	5	17	17	ethanol	c-Jun	PA448073	3725	0.846
NULL	Cancer_Med_2013_Jun_25_2(3)_277-285.nxml.txt.nlp	23930204	SENT107	4	4	26	26	bevacizumab	PTEN	PA130232992	5728	0.846
NULL	Mediators_Inflamm_2001_Aug_10(4)_199-208.nxml.txt.nlp	11577996	SENT6	1	1	24	24	methotrexate	TNF-alpha	PA450428	7124	0.846
NULL	Breast_Cancer_Res_Treat_2013_Jan_15_137(2)_397-406.nxml.txt.nlp	23242584	SENT229	7	7	31	31	everolimus	aromatase	PA164746311	1588	0.846
NULL	J_Oncol_2010_Dec_15_2010_821717.nxml.txt.nlp	20049172	SENT264	8	8	2	2	paclitaxel	TUBB3	PA450761	10381	0.846
NULL	Cell_Commun_Signal_2010_Jun_12_8_11.nxml.txt.nlp	20540792	SENT335	2	2	20	20	thalidomide	CRBN	PA451644	51185	0.846
NULL	Int_J_Mol_Sci_2013_Apr_12_14(4)_8062-8072.nxml.txt.nlp	23584024	SENT4	22	22	26	26	hydralazine	HYD	PA449894	51366	0.846
NULL	Arch_Med_Sci_2013_Aug_30_9(4)_713-718.nxml.txt.nlp	24049534	SENT55	21	21	15	15	sevoflurane	CO2	PA451341	4513	0.846
NULL	Brain_2014_Aug_18_137(8)_2312-2328.nxml.txt.nlp	24941947	SENT102	8	8	20	20	pentobarbital	CO2	PA450859	4513	0.846
NULL	Ann_Surg_Treat_Res_2014_Feb_22_86(2)_68-75.nxml.txt.nlp	24761411	SENT122	4	4	13	13	oxaliplatin	survivin	PA131285527	332	0.846
NULL	Oncotarget_2013_Aug_21_4(9)_1484-1495.nxml.txt.nlp	23986086	SENT166	33	33	41	41	metformin	PIK3CA	PA450395	5290	0.846
NULL	Oncotarget_2014_Sep_3_5(19)_8879-8892.nxml.txt.nlp	25294809	SENT316	27	27	19	19	etoposide	p53	PA449552	7157	0.846
NULL	Spermatogenesis_2013_Apr_1_3(2)_e24194.nxml.txt.nlp	23885303	SENT55	12	12	19	19	oxygen	ROS	PA450744	6098	0.846
NULL	Curr_Neuropharmacol_2013_Jul_11(4)_338-378.nxml.txt.nlp	24381528	SENT573	4	4	28	28	curcumin	Bcl-2	PA151958596	596	0.846
NULL	Mol_Cancer_2014_Jul_5_13_165.nxml.txt.nlp	24996221	SENT187	10	10	2	2	docetaxel	HMGB1	PA449383	3146	0.846
NULL	Core_Evid_2013_Sep_30_8_69-78.nxml.txt.nlp	24115917	SENT71	22	22	17	17	lapatinib	HER-2	PA152241907	2064	0.846
NULL	Am_J_Case_Rep_2014_Feb_24_15_85-89.nxml.txt.nlp	24587856	SENT95	2	2	5	5	exemestane	aromatase	PA449563	1588	0.846
NULL	Indian_J_Dermatol_2009_Jul-Sep_54(3)_211-220.nxml.txt.nlp	20161849	SENT162	2	2	9	9	efalizumab	LFA-1	PA164748817	3683;3689	0.846
NULL	Cell_Death_Differ_2010_Apr_23_17(4)_699-709.nxml.txt.nlp	19851330	SENT299	3	3	25	25	tetracycline	PUMA	PA451640	27113	0.846
NULL	Br_J_Clin_Pharmacol_2011_Oct_72(4)_647-657.nxml.txt.nlp	21518389	SENT214	39	39	21	21	cangrelor	ADP	PA165945763	23038	0.846
NULL	Front_Neural_Circuits_2013_Sep_17_7_144.nxml.txt.nlp	24062647	SENT259	41	41	18	18	finasteride	CA3	PA449627	761	0.846
NULL	Clin_Ophthalmol_2008_Jun_2(2)_339-346.nxml.txt.nlp	19668725	SENT119	2	2	9	9	ranibizumab	VEGF-A	PA164746012	7422	0.846
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Dec_8_67(Pt_1)_o50.nxml.txt.nlp	21522760	SENT48	3	3	12	12	benzaldehyde	mol	PA448571	90527	0.846
NULL	Clin_Dev_Immunol_2013_May_22_2013_701305.nxml.txt.nlp	23762095	SENT149	13	13	16	16	vinblastine	MCL1	PA451877	4170	0.846
NULL	Sci_Rep_2015_Jan_22_5_7947.nxml.txt.nlp	25609312	SENT149	29	29	40	40	l-glutamine	CO2	PA10090	4513	0.846
NULL	Ann_Saudi_Med_2011_Mar-Apr_31(2)_140-144.nxml.txt.nlp	21403409	SENT14	3	3	29	29	glucose	ABO	PA449773	28	0.846
NULL	Arthritis_Res_Ther_2010_May_28_12(3)_R105.nxml.txt.nlp	20509880	SENT247	15	15	7	7	celecoxib	p38	PA448871	10598;1432;7965	0.846
NULL	Cancer_Cell_Int_2011_Nov_17_11_40.nxml.txt.nlp	22088142	SENT86	29	29	5	5	doxorubicin	MRP2	PA449412	100130958;57626;1244	0.846
NULL	Oncoimmunology_2014_Jan_1_3_e27414.nxml.txt.nlp	24701376	SENT30	16	16	8	8	vorinostat	IFN	PA164748224	3439	0.846
NULL	Cancer_Manag_Res_2011_Aug_10_3_273-285.nxml.txt.nlp	21931501	SENT53	0	0	13	13	pazopanib	VEGFR3	PA165291492	2324	0.846
NULL	Mol_Cancer_2010_Dec_20_9_317.nxml.txt.nlp	21172025	SENT156	14	14	10	10	tamoxifen	HER2	PA451581	2064	0.846
NULL	Acta_Pharmacol_Sin_2011_Oct_12_32(10)_1259-1265.nxml.txt.nlp	21909126	SENT95	7	7	12	12	losartan	MCP-1	PA450268	6347	0.846
NULL	Br_J_Pharmacol_2014_May_171(10)_2659-2670.nxml.txt.nlp	24116661	SENT208	3	3	7	7	naringenin	TRPP2	PA151958361	5311	0.846
NULL	Front_Endocrinol_(Lausanne)_2013_Jun_12_4_71.nxml.txt.nlp	23781214	SENT1236	3	3	14	14	etanercept	adiponectin	PA449515	9370	0.846
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT119	44	44	25	25	perifosine	DR5	PA165291471	8795	0.846
NULL	Endocrinol_Metab_(Seoul)_2014_Dec_29_29(4)_553-560.nxml.txt.nlp	25325265	SENT39	13	13	2	2	lipase	AMPK	PA450239	5563	0.846
NULL	Front_Oncol_2014_May_16_4_108.nxml.txt.nlp	24904824	SENT66	0	0	15	15	sirolimus	CRLF2	PA451365	64109	0.846
NULL	Arthritis_Res_Ther_2014_Apr_11_16(2)_R93.nxml.txt.nlp	24725461	SENT136	18	18	37	37	fluorescein	aromatase	PA164746009	1588	0.846
NULL	Oxid_Med_Cell_Longev_2012_Oct_15_2012_781516.nxml.txt.nlp	23119122	SENT45	27	27	42	42	l-glutamine	CO2	PA10090	4513	0.846
NULL	Blood_Cancer_J_2014_Feb_28_4(2)_e187.nxml.txt.nlp	24583533	SENT27	12	12	6	6	azacitidine	CD25	PA451996	3669;3559	0.846
NULL	Angiogenesis_2013_Apr_10_16(2)_373-386.nxml.txt.nlp	23143659	SENT44	5	5	28	28	vinblastine	LDM	PA451877	1595	0.846
NULL	Protein_Cell_2014_Jun_19_5(6)_469-479.nxml.txt.nlp	24748116	SENT159	25	25	19	19	paclitaxel	EB1	PA450761	9167;22919;10982	0.846
NULL	Evid_Based_Complement_Alternat_Med_2012_Aug_26_2012_973712.nxml.txt.nlp	22966246	SENT112	21	21	9	9	metformin	AMH	PA450395	268	0.846
NULL	Int_J_Alzheimers_Dis_2011_Oct_19_2011_864753.nxml.txt.nlp	22028985	SENT107	15	15	29	29	picrotoxin	CA3	PA164777007	761	0.846
NULL	Curr_Opin_Allergy_Clin_Immunol_2014_Oct_28_14(5)_397-403.nxml.txt.nlp	25115682	SENT233	15	15	22	22	indomethacin	CRTH2	PA449982	11251	0.846
NULL	J_Ophthalmic_Inflamm_Infect_2013_Feb_11_3_34.nxml.txt.nlp	23514634	SENT71	0	0	25	25	fluorescein	hole	PA164746009	80757	0.846
NULL	Pain_Res_Treat_2012_Oct_31_2012_104782.nxml.txt.nlp	22135737	SENT87	10	10	13	13	cyanocobalamin	B12	PA451892	7126;4709	0.846
NULL	J_Exp_Clin_Cancer_Res_2009_Feb_15_28(1)_19.nxml.txt.nlp	19216799	SENT81	11	11	19	19	cisplatin	CO2	PA449014	4513	0.846
NULL	Biomed_Res_Int_2014_Jan_12_2014_276918.nxml.txt.nlp	24524073	SENT98	17	17	35	35	fluoxetine	CYP2C19	PA449673	1557	0.846
NULL	J_Cell_Biol_2001_May_28_153(5)_1085-1096.nxml.txt.nlp	11381092	SENT43	14	14	7	7	kanamycin	OXA1	PA450137	5018	0.846
NULL	Cancer_Med_2013_Feb_3_2(1)_76-85.nxml.txt.nlp	24133630	SENT197	38	38	28	28	vemurafenib	P-gp	PA165946873	5243	0.846
NULL	Cancer_Cell_Int_2011_Jun_1_11_15.nxml.txt.nlp	21631944	SENT149	19	19	13	13	etoposide	MICB	PA449552	4277	0.846
NULL	Saudi_J_Anaesth_2013_Apr-Jun_7(2)_151-154.nxml.txt.nlp	23956714	SENT16	21	21	23	23	theophylline	NAC	PA451647	22861	0.846
NULL	Oncotarget_2011_Nov_30_2(11)_874-885.nxml.txt.nlp	22141136	SENT30	19	19	8	8	imatinib	MEK1	PA10804	5604	0.846
NULL	Diabetes_Care_2011_Apr_21_34(4)_e36-e42.nxml.txt.nlp	21447655	SENT203	15	15	7	7	rosiglitazone	DREAM	PA451283	30818	0.846
NULL	Acta_Oncol_2014_Oct_9_53(10)_1347-1355.nxml.txt.nlp	24909504	SENT118	36	36	12	12	doxorubicin	TP53	PA449412	7157	0.846
NULL	Rare_Dis_2013_Oct_7_1_e26690.nxml.txt.nlp	25003011	SENT121	4	4	9	9	laronidase	MPS-1	PA164776670	6232	0.846
NULL	J_Invest_Dermatol_2012_Nov_14_132(11)_2601-2609.nxml.txt.nlp	22696056	SENT60	22	22	4	4	phenol	PERK	PA450913	9451	0.846
NULL	Diabetes_2009_Feb_58(2)_344-351.nxml.txt.nlp	19008341	SENT156	12	12	15	15	resveratrol	SIRT1		23411	0.846
NULL	Oncotarget_2012_Nov_17_3(12)_1600-1614.nxml.txt.nlp	23307622	SENT128	0	0	31	31	lapatinib	AMPK	PA152241907	5563	0.846
NULL	Mediators_Inflamm_2010_Jun_21_2010_194896.nxml.txt.nlp	20652055	SENT186	24	24	29	29	berberine	mol	PA165860812	90527	0.846
NULL	Cancers_(Basel)_2009_Dec_15_1(1)_23-28.nxml.txt.nlp	20535236	SENT98	7	7	11	11	cisplatin	TRX	PA449014	7295	0.846
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT160	3	3	7	7	doxorubicin	AKT	PA449412	207	0.846
NULL	Br_J_Cancer_2010_Nov_9_103(11)_1692-1697.nxml.txt.nlp	21063402	SENT47	20	20	7	7	doxycycline	TRAIL	PA449415	8743	0.846
NULL	Clin_Pharmacol_2013_Dec_9_5_185-192.nxml.txt.nlp	24353446	SENT9	17	17	13	13	clopidogrel	LTA	PA449053	4049	0.846
NULL	J_Breast_Cancer_2011_Sep_29_14(3)_167-174.nxml.txt.nlp	22031796	SENT56	10	10	26	26	doxorubicin	HSP27	PA449412	3315	0.846
NULL	Breast_Cancer_Res_2008_Dec_5_10(6)_R104.nxml.txt.nlp	19061505	SENT226	4	4	10	10	estradiol	JNK	PA449503	5599	0.846
NULL	Cancers_(Basel)_2010_Oct_25_2(4)_1794-1812.nxml.txt.nlp	24281201	SENT152	11	11	20	20	forskolin	MUC5AC	PA146096022	4586	0.846
NULL	Front_Pharmacol_2014_Oct_20_5_230.nxml.txt.nlp	25368579	SENT70	0	0	8	8	berberine	IL-6	PA165860812	3569	0.846
NULL	J_Cell_Mol_Med_2014_Dec_9_18(12)_2499-2511.nxml.txt.nlp	24912879	SENT244	14	14	3	3	docetaxel	DACH1	PA449383	1602	0.846
NULL	Case_Rep_Oncol_Med_2013_Jan_16_2013_320797.nxml.txt.nlp	23401820	SENT39	24	24	15	15	trabectedin	IL-6	PA165958349	3569	0.846
NULL	Cell_Death_Dis_2014_Feb_27_5(2)_e1088.nxml.txt.nlp	24577086	SENT83	4	4	19	19	metformin	Bcl-2	PA450395	596	0.846
NULL	Mol_Clin_Oncol_2013_Jul_27_1(4)_768-772.nxml.txt.nlp	24649244	SENT3	35	35	32	32	gemcitabine	NAC	PA449748	22861	0.846
NULL	Br_J_Cancer_2013_Feb_19_108(3)_512-518.nxml.txt.nlp	23340449	SENT157	29	29	3	3	sulindac	ODC1	PA451565	4953;89874	0.846
NULL	Eur_J_Immunol_2014_Jan_21_44(1)_69-79.nxml.txt.nlp	24114780	SENT277	17	17	8	8	cyclophosphamide	CD4	PA449165	920	0.846
NULL	Diabetes_Metab_Syndr_Obes_2010_May_10_3_117-124.nxml.txt.nlp	21437082	SENT72	18	18	5	5	saxagliptin	GLP-1	PA165958362	100125288	0.846
NULL	Diabetes_Care_2011_Dec_14_34(12)_2576-2580.nxml.txt.nlp	21994427	SENT161	11	11	21	21	atorvastatin	APOE	PA448500	348	0.846
NULL	Cough_2010_Aug_9_6_7.nxml.txt.nlp	20696045	SENT102	9	9	6	6	indomethacin	COX	PA449982	1351	0.846
NULL	Arch_Med_Sci_2013_Oct_31_9(5)_936-943.nxml.txt.nlp	24273582	SENT37	25	25	39	39	glimepiride	SUR2	PA449761	10060	0.846
NULL	Blood_Cancer_J_2013_Mar_1_3(3)_e103.nxml.txt.nlp	23454896	SENT93	13	13	38	38	nelfinavir	ATF6	PA450606	22926	0.846
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT98	42	42	29	29	trastuzumab	HER2	PA451743	2064	0.846
NULL	Diabetes_2011_Nov_17_60(11)_2691-2700.nxml.txt.nlp	21896928	SENT127	5	5	1	1	resveratrol	SIRT1		23411	0.846
NULL	Child_Adolesc_Psychiatry_Ment_Health_2011_Nov_4_5_35.nxml.txt.nlp	22054243	SENT213	36	36	33	33	dextroamphetamine	Gen	PA449269	348654	0.846
NULL	Exp_Ther_Med_2012_Oct_3_4(4)_594-604.nxml.txt.nlp	23170111	SENT99	27	27	6	6	propranolol	p38	PA451145	10598;1432;7965	0.846
NULL	Oncotarget_2013_Jul_5_4(7)_984-994.nxml.txt.nlp	23846322	SENT176	21	21	3	3	resveratrol	SIRT1		23411	0.846
NULL	Nucleic_Acids_Res_2005_Jun_8_33(10)_3283-3291.nxml.txt.nlp	15944449	SENT434	32	32	14	14	sjg-136	ERCC1		2067	0.846
NULL	J_Hematol_Oncol_2008_Oct_1_1_16.nxml.txt.nlp	18828924	SENT22	5	5	14	14	trastuzumab	EGFR	PA451743	1956	0.846
NULL	Allergy_Asthma_Clin_Immunol_2007_Sep_15_3(3)_84-103.nxml.txt.nlp	20525114	SENT4	5	5	11	11	methacholine	ASM	PA165958382	6609;283120	0.846
NULL	Ann_Oncol_2014_Jul_7_25(7)_1340-1346.nxml.txt.nlp	24608196	SENT10	27	27	19	19	palonosetron	NK1	PA10352	11126	0.846
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT211	8	8	16	16	chloroquine	BMP9	PA448948	2658	0.846
NULL	Mol_Cancer_2010_Apr_23_9_87.nxml.txt.nlp	20416058	SENT259	16	16	30	30	doxorubicin	TRAIL	PA449412	8743	0.846
NULL	Br_J_Cancer_2013_Jun_25_108(12)_2464-2469.nxml.txt.nlp	23695016	SENT16	11	11	9	9	carboplatin	NACT	PA448803	284111	0.846
NULL	Oncotarget_2014_Oct_18_5(22)_11641-11652.nxml.txt.nlp	25361002	SENT73	11	11	16	16	cisplatin	NAC	PA449014	22861	0.846
NULL	J_Oncol_2012_Jun_4_2012_928127.nxml.txt.nlp	22701483	SENT107	8	8	10	10	metformin	AMPK	PA450395	5563	0.846
NULL	Eur_J_Clin_Pharmacol_2007_Apr_21_63(4)_335-343.nxml.txt.nlp	17318526	SENT179	19	19	11	11	coumarin	VKORC1	PA134521193	79001	0.846
NULL	Calcif_Tissue_Int_2014_Aug_21_94(2)_170-175.nxml.txt.nlp	23963633	SENT124	17	17	23	23	teriparatide	PTH	PA451620	5741	0.846
NULL	Acta_Pharmacol_Sin_2009_Apr_3_30(4)_478-484.nxml.txt.nlp	19343062	SENT118	21	21	7	7	cyclosporine	CYP3A4	PA449167	1576	0.846
NULL	Arthritis_Res_Ther_2009_Jun_25_11(3)_R97.nxml.txt.nlp	19555469	SENT49	22	22	1	1	estradiol	aromatase	PA449503	1588	0.846
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Oct_31_66(Pt_11)_o3000.nxml.txt.nlp	21589161	SENT52	26	26	5	5	ethanol	mol	PA448073	90527	0.846
NULL	Mol_Immunol_2009_Mar_46(6)_1229-1239.nxml.txt.nlp	19135256	SENT106	4	4	11	11	trypsin	DC2	PA451806	58505	0.846
NULL	Onco_Targets_Ther_2014_Dec_3_7_2227-2236.nxml.txt.nlp	25506226	SENT103	0	0	14	14	trastuzumab	HER2	PA451743	2064	0.846
NULL	EMBO_Mol_Med_2013_Jan_29_5(1)_137-148.nxml.txt.nlp	23197407	SENT110	3	3	27	27	propranolol	TR3	PA451145	8718;3164;10587	0.846
NULL	Nucleic_Acids_Res_2005_Apr_22_33(7)_2310-2317.nxml.txt.nlp	15849317	SENT136	6	6	9	9	geldanamycin	Hsp90	PA152031327	3320	0.846
NULL	Arthritis_Res_Ther_2009_Feb_3_11(1)_R15.nxml.txt.nlp	19192274	SENT223	16	16	30	30	piroxicam	IL-6	PA450985	3569	0.846
NULL	Int_J_Mol_Sci_2012_Sep_26_13(10)_12336-12348.nxml.txt.nlp	23202901	SENT61	17	17	29	29	phenol	P90	PA450913	821	0.846
NULL	Indian_J_Pharm_Sci_2008_May-Jun_70(3)_386-390.nxml.txt.nlp	20046755	SENT18	0	0	4	4	omeprazole	USP1	PA450704	7398	0.846
NULL	Eur_J_Med_Res_2009_Nov_24_14(Suppl_3)_43-46.nxml.txt.nlp	19959416	SENT76	8	8	15	15	nevirapine	CD4	PA450616	920	0.846
NULL	Ann_Oncol_2011_Mar_8_22(3)_503-514.nxml.txt.nlp	20616198	SENT291	11	11	15	15	estradiol	aromatase	PA449503	1588	0.846
NULL	Pharmaceuticals_(Basel)_2012_Aug_10_5(8)_802-836.nxml.txt.nlp	24280676	SENT25	12	12	6	6	ribavirin	CNT1	PA451241	9154	0.846
NULL	Korean_J_Anesthesiol_2013_Mar_19_64(3)_212-217.nxml.txt.nlp	23560185	SENT94	0	0	12	12	aprepitant	NK1	PA164747039	11126	0.846
NULL	Nucleic_Acids_Res_2012_Jan_9_40(1)_181-195.nxml.txt.nlp	21908405	SENT264	12	12	5	5	bleomycin	p65	PA448645	5970	0.846
NULL	Eur_J_Endocrinol_2011_Jan_164(1)_69-74.nxml.txt.nlp	20961967	SENT79	16	16	8	8	pioglitazone	OPG	PA450970	690	0.846
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT755	20	20	13	13	resveratrol	AMPK		5563	0.846
NULL	Crit_Care_2011_Mar_11_15(Suppl_1)_P366.nxml.txt.nlp	NULL	SENT8	13	13	7	7	atropine	NAC	PA448505	22861	0.846
NULL	Indian_J_Endocrinol_Metab_2014_Jul-Aug_18(4)_546-551.nxml.txt.nlp	25143915	SENT130	5	5	14	14	denosumab	RANKL	PA166048634	8600	0.846
NULL	Exp_Ther_Med_2013_Dec_23_6(6)_1494-1498.nxml.txt.nlp	24255680	SENT7	2	2	8	8	losartan	ILK	PA450268	3611	0.846
NULL	Case_Rep_Rheumatol_2013_Jul_24_2013_249471.nxml.txt.nlp	23984159	SENT60	12	12	28	28	colchicine	MEFV	PA449092	4210	0.846
NULL	Allergy_Asthma_Clin_Immunol_2013_Jul_3_9(1)_23.nxml.txt.nlp	23822853	SENT67	7	7	16	16	paraformaldehyde	ADP	PA450790	23038	0.846
NULL	N_Am_J_Med_Sci_2009_Nov_1(6)_309-313.nxml.txt.nlp	22666713	SENT47	32	32	3	3	fluorescein	DIF	PA164746009	7124	0.846
NULL	J_Cell_Biol_1997_Jul_28_138(2)_323-330.nxml.txt.nlp	9230074	SENT160	17	17	19	19	thrombin	ADP	PA451674	23038	0.846
NULL	Cell_Commun_Signal_2005_Aug_9_3_10.nxml.txt.nlp	16091148	SENT72	2	2	14	14	isoproterenol	IL-10	PA450121	3586	0.846
NULL	J_Inflamm_(Lond)_2008_Jul_29_5_11.nxml.txt.nlp	18664275	SENT81	14	14	0	0	ciprofloxacin	IL-8	PA449009	3576	0.846
NULL	Indian_J_Pharm_Sci_2014_Jan-Feb_76(1)_62-71.nxml.txt.nlp	24799740	SENT85	1	1	14	14	nevirapine	Q10	PA450616	27161	0.846
NULL	Front_Microbiol_2014_May_1_5_200.nxml.txt.nlp	24822053	SENT38	28	28	2	2	ganciclovir	SBP-1	PA449733	3146	0.846
NULL	Mol_Cancer_2014_Apr_29_13_96.nxml.txt.nlp	24779681	SENT215	34	34	10	10	tamoxifen	EGF	PA451581	1950	0.846
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_3_2012_908562.nxml.txt.nlp	23082087	SENT181	23	23	13	13	hesperidin	IL-2	PA449867	3558	0.846
NULL	Diabetes_Obes_Metab_2010_Aug_12(8)_700-708.nxml.txt.nlp	20590747	SENT214	34	34	21	21	voglibose	PPG	PA164752433	5552	0.846
NULL	Nature_2012_Aug_16_488(7411)_394-398.nxml.txt.nlp	22810587	SENT90	18	18	21	21	forskolin	apelin	PA146096022	8862	0.846
NULL	Cancer_2014_Dec_15_120(24)_3862-3865.nxml.txt.nlp	25155780	SENT48	35	35	30	30	cetuximab	KRAS	PA10040	3845	0.846
NULL	Breast_Cancer_Res_2012_Mar_19_14(2)_R50.nxml.txt.nlp	22429397	SENT240	23	23	3	3	cisplatin	MFG-E8	PA449014	4240	0.846
NULL	Cancer_Med_2013_Feb_3_2(1)_40-49.nxml.txt.nlp	24133626	SENT140	8	8	5	5	cilostazol	PDE3B	PA164746334	5140	0.846
NULL	J_Cancer_2013_Mar_15_4(3)_241-250.nxml.txt.nlp	23459666	SENT94	20	20	13	13	vemurafenib	BRAF	PA165946873	673	0.846
NULL	J_Cardiovasc_Dis_Res_2012_Jul-Sep_3(3)_231-235.nxml.txt.nlp	22923943	SENT51	1	1	12	12	dobutamine	LCX	PA449381	80312	0.846
NULL	Int_J_Mol_Sci_2014_Sep_30_15(10)_17686-17704.nxml.txt.nlp	25272226	SENT103	15	15	12	12	cetuximab	EGFR	PA10040	1956	0.846
NULL	AAPS_J_2014_Jun_11_16(5)_1029-1037.nxml.txt.nlp	24917180	SENT202	8	8	6	6	tariquidar	P-gp		5243	0.846
NULL	Angiogenesis_2012_Dec_28_15(4)_623-641.nxml.txt.nlp	22843200	SENT275	1	1	8	8	sunitinib	MVD	PA162372840	4597	0.846
NULL	Mol_Cancer_2013_Oct_8_12_119.nxml.txt.nlp	24103454	SENT189	25	25	8	8	nutlin-3	p53		7157	0.846
NULL	Environ_Health_Perspect_2007_Apr_14_115(4)_513-518.nxml.txt.nlp	17450217	SENT161	11	11	32	32	arsenite	GAPDH	PA452638	2597	0.846
NULL	Bioinform_Biol_Insights_2009_Oct_5_3_109-127.nxml.txt.nlp	20140064	SENT463	9	9	17	17	stavudine	P200	PA451494	5035	0.846
NULL	Breast_Cancer_Res_2008_Jul_8_10(4)_R56.nxml.txt.nlp	18611244	SENT301	4	4	20	20	letrozole	HER2	PA450196	2064	0.846
NULL	Oncogene_2014_Aug_28_33(35)_4396-4406.nxml.txt.nlp	24531714	SENT58	0	0	32	32	nutlin-3	p53		7157	0.846
NULL	Br_J_Pharmacol_2008_Oct_18_155(4)_596-605.nxml.txt.nlp	18852694	SENT158	33	33	8	8	fenofibrate	PI3K	PA449594	5290	0.846
NULL	Cancer_Med_2013_Jun_25_2(3)_277-285.nxml.txt.nlp	23930204	SENT40	18	18	9	9	bevacizumab	KRAS	PA130232992	3845	0.846
NULL	Clin_Interv_Aging_2013_Jul_16_8_889-897.nxml.txt.nlp	23898224	SENT10	32	32	5	5	gemcitabine	SIRT1	PA449748	23411	0.846
NULL	Oxid_Med_Cell_Longev_2013_Nov_28_2013_568093.nxml.txt.nlp	24379901	SENT94	11	11	8	8	resveratrol	SIRT1		23411	0.846
NULL	Clin_Med_Insights_Cardiol_2012_Feb_1_6_17-33.nxml.txt.nlp	22442638	SENT185	20	20	31	31	rosuvastatin	CYP3A4	PA134308647	1576	0.846
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT319	10	10	18	18	risperidone	PRL	PA451257	5617	0.846
NULL	Indian_Dermatol_Online_J_2010_Jul-Dec_1(1)_14-17.nxml.txt.nlp	23130185	SENT64	29	29	40	40	capecitabine	EGFR	PA448771	1956	0.846
NULL	Diabetes_Metab_Syndr_Obes_2010_Dec_6_3_421-429.nxml.txt.nlp	21437112	SENT128	21	21	35	35	curcumin	p65	PA151958596	5970	0.846
NULL	Mol_Vis_2010_Sep_2_16_1781-1790.nxml.txt.nlp	20824160	SENT209	28	28	5	5	rolipram	ZO-1	PA153906323	7082	0.846
NULL	Neural_Dev_2013_Mar_7_8_4.nxml.txt.nlp	23497494	SENT123	21	21	0	0	cimetidine	FGFR1	PA449001	2260	0.846
NULL	Breast_Cancer_Res_2011_Dec_16_13(6)_R131.nxml.txt.nlp	22177475	SENT275	33	33	21	21	erlotinib	HER2	PA134687924	2064	0.846
NULL	Clin_Neuroradiol_2012_Sep_18_22(3)_227-233.nxml.txt.nlp	22252289	SENT136	16	16	25	25	everolimus	ICAD	PA164746311	1676	0.846
NULL	Braz_J_Microbiol_2012_Jun_1_Jan-Mar_43(1)_30-42.nxml.txt.nlp	24031801	SENT3	2	2	14	14	lipase	LBN	PA450239	132884	0.846
NULL	J_Ophthalmol_2012_Nov_3_2012_852183.nxml.txt.nlp	22132316	SENT167	27	27	8	8	bevacizumab	CD34	PA130232992	947	0.846
NULL	Cancer_Cell_Int_2014_Jun_19_14_54.nxml.txt.nlp	24966802	SENT314	6	6	12	12	phenol	LTA	PA450913	4049	0.846
NULL	Evid_Based_Complement_Alternat_Med_2013_Aug_13_2013_976342.nxml.txt.nlp	23997804	SENT190	19	19	41	41	telithromycin	IL-10	PA10202	3586	0.846
NULL	BioDrugs_2013_May_9_27(5)_469-478.nxml.txt.nlp	23658121	SENT90	14	14	2	2	capecitabine	TPC	PA448771	8030;60386	0.846
NULL	Carcinogenesis_2010_Dec_27_31(12)_2049-2057.nxml.txt.nlp	20876285	SENT263	17	17	6	6	tamoxifen	HER2	PA451581	2064	0.846
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT217	11	11	1	1	doxorubicin	ABCB1	PA449412	5243	0.846
NULL	Front_Cell_Neurosci_2014_Feb_5_8_6.nxml.txt.nlp	24550775	SENT1182	4	4	8	8	ivermectin	P2X4	PA450133	5025	0.846
NULL	Biomed_Res_Int_2014_Apr_23_2014_893106.nxml.txt.nlp	24868552	SENT179	15	15	9	9	creatine	CXCL10	PA164778930	3627	0.846
NULL	Indian_J_Pharmacol_2008_Mar-Apr_40(2)_84-86.nxml.txt.nlp	21279172	SENT89	7	7	4	4	fluvoxamine	CYP1A2	PA449690	1544	0.846
NULL	Hum_Mol_Genet_2013_Jul_1_22(13)_2676-2688.nxml.txt.nlp	23474818	SENT105	2	2	36	36	arsenite	ANOVA	PA452638	4858	0.846
NULL	Mol_Cancer_2009_Aug_25_8_66.nxml.txt.nlp	19706164	SENT50	8	8	12	12	celecoxib	p53	PA448871	7157	0.846
NULL	BMB_Rep_2013_Jan_46(1)_59-64.nxml.txt.nlp	23351386	SENT50	23	23	8	8	auranofin	NAC	PA448510	22861	0.846
NULL	J_Biol_Chem_2010_Apr_16_285(16)_11892-11902.nxml.txt.nlp	20177059	SENT213	21	21	10	10	olmesartan	CMBL	PA164742950	134147	0.846
NULL	Cancer_Cell_Int_2014_Apr_17_14_34.nxml.txt.nlp	24739220	SENT220	2	2	9	9	curcumin	ERBB2	PA151958596	2064	0.846
NULL	J_Oncol_2009_Jan_17_2009_581939.nxml.txt.nlp	20145720	SENT58	15	15	7	7	doxorubicin	p53	PA449412	7157	0.846
NULL	Daru_2013_Jan_5_21(1)_4.nxml.txt.nlp	23351476	SENT84	27	27	8	8	imipramine	ANOVA	PA449969	4858	0.846
NULL	J_Gastroenterol_2014_Dec_24_49(12)_1536-1547.nxml.txt.nlp	24366288	SENT153	25	25	8	8	rabeprazole	CYP2C19	PA451216	1557	0.846
NULL	J_Cell_Mol_Med_2014_Apr_20_18(4)_709-720.nxml.txt.nlp	24444314	SENT112	3	3	5	5	metformin	Met	PA450395	79811	0.846
NULL	Brain_Behav_2012_Jan_2(1)_22-31.nxml.txt.nlp	22574271	SENT89	5	5	13	13	ethanol	ANOVA	PA448073	4858	0.846
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT167	27	27	7	7	tenofovir	ABCC4	PA10204	10257	0.846
NULL	AIDS_Behav_2012_Feb_30_16(2)_396-403.nxml.txt.nlp	21190073	SENT179	4	4	16	16	methamphetamine	San	PA450403	80218	0.846
NULL	Nat_Biotechnol_2010_Aug_2_28(8)_839-847.nxml.txt.nlp	20601939	SENT187	17	17	34	34	hydrocortisone	IL-6	PA449905	3569	0.846
NULL	Front_Physiol_2013_Dec_24_4_386.nxml.txt.nlp	24399968	SENT191	9	9	21	21	glibenclamide	SUR1	PA449782	6833	0.846
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1495-1502.nxml.txt.nlp	21989186	SENT195	11	11	23	23	leucovorin	HSI	PA450198	57016	0.846
NULL	Nat_Commun_2013_Oct_1_4_2516.nxml.txt.nlp	24084631	SENT693	0	0	24	24	losartan	AK4	PA450268	205	0.845
NULL	Ann_Surg_Oncol_2011_Sep_23_18(9)_2442-2452.nxml.txt.nlp	21347782	SENT244	6	6	11	11	capecitabine	TYMS	PA448771	7298	0.845
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1709-1716.nxml.txt.nlp	19844235	SENT140	31	31	34	34	gemcitabine	B7-H3	PA449748	80381	0.845
NULL	Br_J_Ophthalmol_2012_Jul_26_96(7)_1023-1028.nxml.txt.nlp	22539748	SENT70	22	22	14	14	bevacizumab	TER	PA130232992	9524	0.845
NULL	Mol_Biol_Cell_2013_Jan_15_24(2)_115-128.nxml.txt.nlp	23171550	SENT228	29	29	11	11	galactose	MSI1	PA449725	4440	0.845
NULL	Int_J_Mol_Sci_2014_Mar_24_15(3)_5140-5162.nxml.txt.nlp	24663085	SENT743	11	11	3	3	cyclophosphamide	LP1	PA449165	6176	0.845
NULL	Leukemia_2014_Apr_8_28(4)_894-903.nxml.txt.nlp	23925045	SENT296	11	11	7	7	tamoxifen	TMP	PA451581	2012	0.845
NULL	Cell_Commun_Signal_2013_Oct_1_11_73.nxml.txt.nlp	24083678	SENT149	17	17	4	4	sulindac	c-Jun	PA451565	3725	0.845
NULL	Int_J_Environ_Res_Public_Health_2011_Oct_29_8(10)_3889-3921.nxml.txt.nlp	22073019	SENT378	23	23	29	29	temozolomide	p65	PA451609	5970	0.845
NULL	Front_Endocrinol_(Lausanne)_2013_Oct_29_4_161.nxml.txt.nlp	24194732	SENT146	6	6	19	19	estradiol	AT1	PA449503	9197;185	0.845
NULL	Indian_J_Pharm_Sci_2013_Jan-Feb_75(1)_94-98.nxml.txt.nlp	23901167	SENT87	30	30	21	21	tolbutamide	CYP2B6	PA451718	1555	0.845
NULL	Int_J_Nanomedicine_2009_Dec_29_4_321-333.nxml.txt.nlp	20054435	SENT117	13	13	3	3	ethanol	ANOVA	PA448073	4858	0.845
NULL	Open_Ophthalmol_J_2014_Oct_3_8_67-72.nxml.txt.nlp	25317218	SENT102	9	9	0	0	travoprost	SPK	PA164781371	55872;8189	0.845
NULL	Br_J_Pharmacol_2012_Jan_165(2)_390-400.nxml.txt.nlp	21671897	SENT8	19	19	23	23	suramin	P2X1	PA10292	5023	0.845
NULL	ASN_Neuro_2009_Oct_21_1(4)_e00018.nxml.txt.nlp	19807694	SENT175	37	37	42	42	ganciclovir	E14	PA449733	4863	0.845
NULL	Arthritis_Res_2002_Nov_23_4(3)_157-164.nxml.txt.nlp	12010565	SENT198	5	5	30	30	collagenase	c-Jun	PA449107	3725	0.845
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1063.nxml.txt.nlp	24556678	SENT104	7	7	30	30	thioridazine	c-FLIP	PA451666	8837	0.845
NULL	Front_Oncol_2013_Apr_23_3_86.nxml.txt.nlp	23630663	SENT104	0	0	6	6	trastuzumab	DM1	PA451743	338023;1760;28509	0.845
NULL	Support_Care_Cancer_2014_Dec_14_22(3)_837-846.nxml.txt.nlp	24337717	SENT20	15	15	10	10	sn-38	UGT1A9		54600	0.845
NULL	J_Cell_Biol_1998_Mar_23_140(6)_1453-1461.nxml.txt.nlp	9508777	SENT39	27	27	0	0	mitomycin	E14	PA450524	4863	0.845
NULL	Biol_Proced_Online_2003_Oct_24_5_211-221.nxml.txt.nlp	14615818	SENT189	29	29	14	14	hydralazine	CD4	PA449894	920	0.845
NULL	Bioinformation_2012_Apr_30_8(8)_369-380.nxml.txt.nlp	22570518	SENT117	17	17	7	7	artemisinin	C10	PA165111696	113246	0.845
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Dec_10_3(12)_e151.nxml.txt.nlp	25494035	SENT5	3	3	19	19	rosuvastatin	OATP1B1	PA134308647	10599	0.845
NULL	Chemother_Res_Pract_2012_Aug_29_2012_817297.nxml.txt.nlp	22970367	SENT157	17	17	39	39	bortezomib	EGFR	PA10252	1956	0.845
NULL	Int_J_Mol_Sci_2014_Oct_20_15(10)_18840-18855.nxml.txt.nlp	25334060	SENT156	31	31	20	20	heparin	RANKL	PA449855	8600	0.845
NULL	Aging_(Albany_NY)_2009_Jun_3_1(6)_515-528.nxml.txt.nlp	20157535	SENT74	26	26	14	14	resveratrol	S6K1		6198	0.845
NULL	EMBO_Mol_Med_2012_Mar_4(3)_218-233.nxml.txt.nlp	22294553	SENT44	13	13	22	22	tamoxifen	P28	PA451581	9446;7802;9527	0.845
NULL	J_Gen_Physiol_2010_Jun_135(6)_619-628.nxml.txt.nlp	20479110	SENT188	21	21	12	12	nifedipine	DHPR	PA450631	5860	0.845
NULL	Dermatoendocrinol_2013_Apr_1_5(2)_252-263.nxml.txt.nlp	24194965	SENT84	34	34	15	15	metformin	MATE1	PA450395	55244	0.845
NULL	Ann_Indian_Acad_Neurol_2013_Apr-Jun_16(2)_135-136.nxml.txt.nlp	23956549	SENT30	23	23	11	11	carbamazepine	HLA-B	PA448785	3106	0.845
NULL	Am_J_Case_Rep_2014_Apr_14_15_152-154.nxml.txt.nlp	24753783	SENT64	10	10	2	2	liraglutide	GLP1	PA165958364	100125288;2641	0.845
NULL	J_Immunother_Cancer_2014_Aug_19_2_27.nxml.txt.nlp	25324973	SENT38	45	45	15	15	vemurafenib	BRAF	PA165946873	673	0.845
NULL	Cancer_Immunol_Immunother_2012_Jul_23_61(7)_1101-1111.nxml.txt.nlp	22193989	SENT206	7	7	11	11	oxaliplatin	STAT3	PA131285527	6774	0.845
NULL	Clin_Sci_(Lond)_2009_Nov_16_118(Pt_4)_269-279.nxml.txt.nlp	19698082	SENT142	32	32	4	4	ramipril	ACE2	PA451223	59272	0.845
NULL	J_Cell_Mol_Med_2014_Dec_9_18(12)_2499-2511.nxml.txt.nlp	24912879	SENT242	12	12	7	7	docetaxel	DACH1	PA449383	1602	0.845
NULL	Indian_J_Med_Res_2011_Sep_134(3)_295-301.nxml.txt.nlp	21985811	SENT112	11	11	8	8	phenytoin	CYP2C9	PA450947	1559	0.845
NULL	Amino_Acids_2012_May_25_42(5)_1529-1539.nxml.txt.nlp	21437784	SENT144	21	21	8	8	taurine	Bcl-2	PA451590	596	0.845
NULL	Gut_2013_Apr_14_62(4)_540-549.nxml.txt.nlp	22798500	SENT251	20	20	11	11	cetuximab	KRAS	PA10040	3845	0.845
NULL	Orphanet_J_Rare_Dis_2006_Aug_9_1_30.nxml.txt.nlp	16899117	SENT155	22	22	6	6	levodopa	FTDP-17	PA450213	4137	0.845
NULL	Evid_Based_Complement_Alternat_Med_2013_May_26_2013_349790.nxml.txt.nlp	23762123	SENT108	7	7	0	0	rosiglitazone	TLSP	PA451283	11012	0.845
NULL	J_Community_Hosp_Intern_Med_Perspect_2012_Apr_30_2(1)_10_3402_jchimp_v2i1_11453.nxml.txt.nlp	23882359	SENT128	19	19	3	3	thyroglobulin	TPO	PA164754910	7066;7173	0.845
NULL	Acta_Pharmacol_Sin_2014_Aug_21_35(8)_1082-1092.nxml.txt.nlp	25047514	SENT240	13	13	10	10	letrozole	aromatase	PA450196	1588	0.845
NULL	J_Immunother_2014_Apr_12_37(3)_180-186.nxml.txt.nlp	24598448	SENT30	34	34	16	16	sorafenib	IL-2	PA7000	3558	0.845
NULL	Lipids_Health_Dis_2011_Feb_12_10_31.nxml.txt.nlp	21314960	SENT170	12	12	10	10	hemin	HO-1	PA449849	3162	0.845
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT97	24	24	35	35	l-leucine	4E-BP1	PA450197	1978	0.845
NULL	Carcinogenesis_2010_Dec_15_31(12)_2031-2038.nxml.txt.nlp	20952512	SENT62	37	37	11	11	camptothecin	XRCC2	PA153590860	7516	0.845
NULL	J_Adv_Pract_Oncol_2014_Jan_1_Jan-Feb_5(1)_57-60.nxml.txt.nlp	25032035	SENT101	8	8	23	23	anastrozole	ATAC	PA448432	6375	0.845
NULL	Mol_Cancer_2014_Jan_28_13_17.nxml.txt.nlp	24472312	SENT126	7	7	24	24	ponatinib	Mcl-1	PA165980594	4170	0.845
NULL	Mol_Vis_2011_May_4_17_1172-1181.nxml.txt.nlp	21617754	SENT20	13	13	4	4	staurosporine	FKBP51	PA165109623	2289	0.845
NULL	Cancers_(Basel)_2012_Oct_12_4(4)_989-1035.nxml.txt.nlp	24213498	SENT435	42	42	15	15	gemcitabine	CD44	PA449748	960	0.845
NULL	Adv_Pharmacol_Sci_2014_Apr_17_2014_354264.nxml.txt.nlp	24822061	SENT394	10	10	16	16	rosiglitazone	STZ	PA451283	6484	0.845
NULL	Genome_Biol_2008_Oct_13_9(10)_R150.nxml.txt.nlp	18851746	SENT70	6	6	12	12	tetracycline	MYCN	PA451640	4613	0.845
NULL	Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.nxml.txt.nlp	24736980	SENT229	19	19	8	8	rosuvastatin	OATP1B1	PA134308647	10599	0.845
NULL	Int_J_Gen_Med_2009_Jul_30_2_129-140.nxml.txt.nlp	20360896	SENT19	14	14	11	11	letrozole	aromatase	PA450196	1588	0.845
NULL	Indian_J_Endocrinol_Metab_2013_Dec_17(Suppl_3)_S696-S699.nxml.txt.nlp	24910842	SENT52	0	0	10	10	metoclopramide	PRL	PA450475	5617	0.845
NULL	J_Cell_Biol_1998_Jan_26_140(2)_335-345.nxml.txt.nlp	9442109	SENT5	6	6	16	16	chloroquine	NHE	PA448948	285335	0.845
NULL	Br_J_Cancer_2013_Jul_9_109(1)_1-7.nxml.txt.nlp	23736035	SENT100	29	29	4	4	tamoxifen	STAR	PA451581	6770;2984	0.845
NULL	J_Skin_Cancer_2012_Dec_13_2012_147863.nxml.txt.nlp	23316365	SENT182	25	25	8	8	curcumin	IL-6	PA151958596	3569	0.845
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT15	24	24	22	22	lapatinib	EGFR	PA152241907	1956	0.845
NULL	Mol_Biol_Cell_2014_Jan_1_25(1)_145-159.nxml.txt.nlp	24196833	SENT240	20	20	3	3	valinomycin	Fis1	PA151917011	51024	0.845
NULL	Front_Oncol_2014_Apr_9_4_75.nxml.txt.nlp	24782986	SENT126	3	3	13	13	paclitaxel	CD117	PA450761	3815	0.845
NULL	Breast_Cancer_Res_2012_Feb_9_14(1)_R27.nxml.txt.nlp	22321971	SENT331	5	5	21	21	bicalutamide	EGF	PA164746255	1950	0.845
NULL	Arthritis_Res_Ther_2009_Aug_17_11(4)_R123.nxml.txt.nlp	19686595	SENT180	27	27	20	20	rituximab	CD27	PA451261	939	0.845
NULL	Front_Neurol_2014_Feb_18_5_17.nxml.txt.nlp	24600432	SENT20	4	4	10	10	levetiracetam	CD178	PA450206	356	0.845
NULL	Gastric_Cancer_2013_Jul_12_16(3)_345-354.nxml.txt.nlp	22968820	SENT38	31	31	12	12	oxaliplatin	FANCJ	PA131285527	83990	0.845
NULL	J_Cancer_Res_Clin_Oncol_2015_Aug_3_141_61-68.nxml.txt.nlp	25086987	SENT21	11	11	15	15	afatinib	EGFR	PA165981154	1956	0.845
NULL	Acta_Neuropathol_Commun_2013_Dec_24_1_85.nxml.txt.nlp	24367907	SENT52	17	17	9	9	paraformaldehyde	CO2	PA450790	4513	0.845
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT166	34	34	21	21	trastuzumab	STAT3	PA451743	6774	0.845
NULL	Adv_Pharmacol_Sci_2013_Apr_11_2013_692613.nxml.txt.nlp	23662099	SENT75	22	22	7	7	clotrimazole	KAL	PA449057	5267	0.845
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_112-117.nxml.txt.nlp	23864844	SENT25	5	5	14	14	cyclophosphamide	CHOP	PA449165	1649	0.845
NULL	Arthritis_Res_Ther_2006_Nov_9_8(1)_R2.nxml.txt.nlp	16356188	SENT5	17	17	34	34	indomethacin	COX	PA449982	1351	0.845
NULL	Int_J_Environ_Res_Public_Health_2013_Feb_31_10(2)_541-555.nxml.txt.nlp	23435586	SENT50	15	15	8	8	ethanol	hole	PA448073	80757	0.845
NULL	Adv_Appl_Bioinforma_Chem_2008_Oct_30_1_85-98.nxml.txt.nlp	21918608	SENT5	19	19	11	11	bortezomib	SPARC	PA10252	6678	0.845
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT156	12	12	21	21	lapatinib	HER3	PA152241907	2065	0.845
NULL	Int_J_Breast_Cancer_2011_Feb_24_2011_967419.nxml.txt.nlp	22332018	SENT120	21	21	8	8	mitoxantrone	MRP1	PA450526	4437	0.845
NULL	ACS_Med_Chem_Lett_2013_Mar_25_4(5)_486-490.nxml.txt.nlp	23687559	SENT65	5	5	2	2	indomethacin	COX	PA449982	1351	0.845
NULL	Cancer_Med_2014_Apr_7_3(2)_349-361.nxml.txt.nlp	24515895	SENT196	23	23	0	0	doxycycline	HSC3	PA449415	150353	0.845
NULL	Oncotarget_2014_Jul_25_5(21)_10460-10472.nxml.txt.nlp	25361005	SENT126	16	16	4	4	everolimus	AKT	PA164746311	207	0.845
NULL	J_Clin_Biochem_Nutr_2011_Jul_30_49(1)_20-24.nxml.txt.nlp	21765602	SENT156	19	19	9	9	ethanol	IL-6	PA448073	3569	0.845
NULL	Int_J_Surg_Oncol_2012_Aug_27_2012_180574.nxml.txt.nlp	22970358	SENT107	11	11	1	1	tamoxifen	IMPACT	PA451581	55364	0.845
NULL	J_Biomed_Biotechnol_2011_Jul_6_2011_783528.nxml.txt.nlp	21785566	SENT150	7	7	9	9	ritonavir	P-gp	PA451260	5243	0.845
NULL	Addict_Sci_Clin_Pract_2010_Dec_5(2)_17-29.nxml.txt.nlp	22002450	SENT135	5	5	21	21	bupropion	CYP2B6	PA448687	1555	0.845
NULL	Mol_Vis_2012_Oct_5_18_2454-2467.nxml.txt.nlp	23077404	SENT138	6	6	0	0	bevacizumab	VEGF-A	PA130232992	7422	0.845
NULL	Mol_Cell_2012_Feb_10_45(3)_371-383.nxml.txt.nlp	22325354	SENT722	17	17	9	9	olaparib	S14		5714;6208;7069	0.845
NULL	Oncotarget_2011_Mar_23_2(3)_165-177.nxml.txt.nlp	21444946	SENT77	10	10	0	0	erlotinib	EGFR	PA134687924	1956	0.845
NULL	J_Headache_Pain_2013_Jul_12_14(1)_61.nxml.txt.nlp	23848401	SENT83	7	7	23	23	tacrolimus	TRESK	PA451578	338567	0.845
NULL	Oncoimmunology_2013_Jun_1_2(6)_e24677.nxml.txt.nlp	23894722	SENT98	5	5	11	11	cetuximab	CD107a	PA10040	3916	0.845
NULL	Case_Rep_Pediatr_2012_Aug_9_2012_323681.nxml.txt.nlp	22924145	SENT92	1	1	16	16	tocilizumab	IL-6	PA165292659	3569	0.845
NULL	J_Korean_Med_Sci_2007_Dec_20_22(6)_1055-1059.nxml.txt.nlp	18162722	SENT35	2	2	21	21	famotidine	ESD	PA449586	2098	0.845
NULL	Oncotarget_2014_May_27_5(19)_9049-9064.nxml.txt.nlp	24979294	SENT183	13	13	34	34	fulvestrant	FBS	PA164747170	64319;26269	0.845
NULL	Biomed_Res_Int_2014_Jan_12_2014_276918.nxml.txt.nlp	24524073	SENT98	17	17	33	33	fluoxetine	CYP2D6	PA449673	1565	0.845
NULL	Cancer_Cell_Int_2009_Sep_10_9_25.nxml.txt.nlp	19744341	SENT189	9	9	6	6	glucosamine	STAT3	PA164747613	6774	0.845
NULL	Int_J_Vasc_Med_2013_Mar_31_2013_543141.nxml.txt.nlp	23606968	SENT161	4	4	22	22	etanercept	IL-17	PA449515	3605	0.845
NULL	Trials_2014_Nov_6_15(1)_430.nxml.txt.nlp	NULL	SENT74	27	27	20	20	tacrolimus	RTR	PA451578	2649	0.845
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT79	12	12	32	32	curcumin	Bcl-2	PA151958596	596	0.845
NULL	Breast_Cancer_Res_2012_Feb_14_14(1)_R30.nxml.txt.nlp	22333315	SENT228	27	27	10	10	celecoxib	CXCR3	PA448871	2833	0.845
NULL	Genome_Med_2010_Aug_25_2(8)_56.nxml.txt.nlp	20804565	SENT41	5	5	11	11	paclitaxel	TLR4	PA450761	7099	0.845
NULL	Cancer_Cell_Int_2010_Sep_9_10_32.nxml.txt.nlp	20828393	SENT14	25	25	7	7	cisplatin	ATF3	PA449014	467	0.845
NULL	Mol_Cancer_2010_Nov_25_9_305.nxml.txt.nlp	21108789	SENT94	11	11	7	7	cisplatin	MLH1	PA449014	4292	0.845
NULL	Diabetes_Metab_Syndr_Obes_2010_May_17_3_165-172.nxml.txt.nlp	21437086	SENT135	18	18	12	12	metformin	GLP-1	PA450395	100125288	0.845
NULL	Front_Chem_2014_Mar_14_2_12.nxml.txt.nlp	24790981	SENT261	0	0	4	4	curcumin	p300	PA151958596	2033	0.845
NULL	Mol_Cancer_2012_Jun_18_11_41.nxml.txt.nlp	22709873	SENT328	20	20	10	10	lapatinib	CDKN1B	PA152241907	1027	0.845
NULL	Oncotarget_2014_Dec_4_5(22)_11365-11380.nxml.txt.nlp	25426548	SENT141	22	22	8	8	nutlin-3	p53		7157	0.845
NULL	Natl_J_Maxillofac_Surg_2012_Jan-Jun_3(1)_91-95.nxml.txt.nlp	23251069	SENT55	0	0	14	14	pregabalin	CACNA2D1	PA164754814	781	0.845
NULL	Evol_Med_Public_Health_2013_May_15_2013(1)_118-134.nxml.txt.nlp	24481193	SENT228	7	7	16	16	amodiaquine	CYP1A2	PA448404	1544	0.845
NULL	Breast_Cancer_Res_2008_Dec_18_10(Suppl_4)_S20.nxml.txt.nlp	19128434	SENT27	18	18	7	7	anastrozole	FACT	PA448432	11198	0.845
NULL	Bioinformation_2011_Sep_28_7(3)_130-133.nxml.txt.nlp	22125383	SENT53	26	26	14	14	ketoconazole	PLP1	PA450146	5354	0.845
NULL	Chemother_Res_Pract_2012_Dec_20_2012_743193.nxml.txt.nlp	23320171	SENT122	22	22	7	7	pertuzumab	HER2		2064	0.845
NULL	Int_J_Environ_Res_Public_Health_2010_May_28_7(5)_1996-2007.nxml.txt.nlp	20632473	SENT103	13	13	20	20	arsenite	LEC	PA452638	6360	0.845
NULL	Osteoporos_Int_2014_Dec_4_25(3)_1141-1150.nxml.txt.nlp	24301537	SENT297	7	7	10	10	alendronate	RANKL	PA448082	8600	0.845
NULL	J_Gen_Physiol_1997_Dec_1_110(6)_643-654.nxml.txt.nlp	9382893	SENT183	23	23	19	19	diazoxide	SUR1	PA449285	6833	0.845
NULL	Oncol_Lett_2013_Mar_11_5(3)_1010-1016.nxml.txt.nlp	23426784	SENT106	13	13	29	29	midazolam	TRPM7	PA450496	54822	0.845
NULL	Case_Rep_Hematol_2014_Dec_24_2014_460574.nxml.txt.nlp	25610674	SENT9	24	24	12	12	cyclophosphamide	PHL	PA449165	613	0.845
NULL	J_Gen_Physiol_2013_Aug_142(2)_137-155.nxml.txt.nlp	23858003	SENT387	0	0	10	10	mibefradil	ACTH	PA450492	5443	0.845
NULL	Oncotarget_2013_Nov_15_5(6)_1458-1474.nxml.txt.nlp	24681547	SENT243	11	11	7	7	celecoxib	CDH11	PA448871	1009	0.845
NULL	Int_J_Endocrinol_2010_Feb_10_2010_625852.nxml.txt.nlp	20169119	SENT123	28	28	35	35	cinacalcet	PTH	PA164776671	5741	0.845
NULL	Mutat_Res_2010_Aug_7_690(1-2)_24-39.nxml.txt.nlp	19769993	SENT1669	12	12	4	4	methacholine	gamma	PA165958382	9913	0.845
NULL	EMBO_Mol_Med_2013_Aug_4_5(8)_1247-1262.nxml.txt.nlp	23737459	SENT153	35	35	20	20	nilotinib	parkin	PA165958345	5071	0.845
NULL	Breast_Cancer_Res_2000_May_25_2(4)_283-290.nxml.txt.nlp	11250722	SENT114	4	4	10	10	tamoxifen	BRCA1	PA451581	672	0.845
NULL	J_Mol_Signal_2008_Mar_31_3_8.nxml.txt.nlp	18377662	SENT63	3	3	15	15	pp2	SHP-1		5777	0.845
NULL	Anal_Chem_Insights_2007_Sep_17_2_69-74.nxml.txt.nlp	19662179	SENT30	0	0	19	19	trypsin	San	PA451806	80218	0.845
NULL	J_Thorac_Oncol_2015_Jan_29_10(1)_156-163.nxml.txt.nlp	25247337	SENT263	41	41	28	28	gefitinib	BSC	PA131301952	6558	0.845
NULL	Mediators_Inflamm_2011_Jun_7_2011_432080.nxml.txt.nlp	21772662	SENT176	6	6	17	17	rivaroxaban	IL-6	PA165958360	3569	0.845
NULL	Acta_Pharmacol_Sin_2014_Aug_30_35(8)_1045-1054.nxml.txt.nlp	24976155	SENT93	0	0	11	11	resveratrol	STAT3		6774	0.845
NULL	AIDS_Res_Ther_2014_Oct_7_11(1)_33.nxml.txt.nlp	NULL	SENT171	15	15	21	21	maraviroc	CD4	PA164768835	920	0.845
NULL	Croat_Med_J_2014_Jun_55(3)_206-217.nxml.txt.nlp	24891279	SENT82	11	11	42	42	doxorubicin	p53	PA449412	7157	0.845
NULL	Cells_2014_Sep_12_3(3)_914-938.nxml.txt.nlp	25222270	SENT78	26	26	24	24	capsaicin	TRPV1	PA448776	7442	0.845
NULL	Mol_Cell_Biochem_2014_Oct_9_385(1-2)_265-275.nxml.txt.nlp	24104452	SENT113	18	18	2	2	bortezomib	U87	PA10252	677775;641648	0.845
NULL	Oncotarget_2013_Nov_7_4(12)_2550-2566.nxml.txt.nlp	24334291	SENT215	4	4	16	16	dasatinib	AMPK	PA162372878	5563	0.845
NULL	JAKSTAT_2013_Jul_1_2(3)_e25025.nxml.txt.nlp	24069563	SENT180	8	8	11	11	hydroxyurea	IFN	PA449942	3439	0.845
NULL	Braz_J_Med_Biol_Res_2013_Aug_13_46(8)_650-658.nxml.txt.nlp	23969971	SENT195	20	20	9	9	cisplatin	survivin	PA449014	332	0.845
NULL	Indian_J_Endocrinol_Metab_2011_Jan-Mar_15(1)_9-17.nxml.txt.nlp	21584160	SENT172	33	33	24	24	liraglutide	PPG	PA165958364	5552	0.845
NULL	Diabetes_2009_Jul_14_58(7)_1539-1543.nxml.txt.nlp	19366865	SENT68	1	1	20	20	glucose	mol	PA449773	90527	0.845
NULL	J_Korean_Med_Sci_2007_Dec_20_22(6)_1055-1059.nxml.txt.nlp	18162722	SENT35	5	5	21	21	famotidine	ESD	PA449586	2098	0.845
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Dec_4_66(Pt_1)_o24.nxml.txt.nlp	21580121	SENT72	27	27	24	24	ethanol	mol	PA448073	90527	0.845
NULL	Crit_Care_2008_Mar_13_12(Suppl_2)_P254.nxml.txt.nlp	NULL	SENT2	5	5	11	11	cisplatin	HIC	PA449014	29969	0.845
NULL	Indian_J_Med_Res_2012_Aug_136(2)_242-248.nxml.txt.nlp	22960891	SENT118	2	2	23	23	carbimazole	ghrelin	PA164742970	51738	0.845
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT331	23	23	35	35	risperidone	PRL	PA451257	5617	0.845
NULL	Cell_Death_Dis_2012_Jul_5_3(7)_e343.nxml.txt.nlp	22764102	SENT60	38	38	29	29	clopidogrel	P2Y12	PA449053	64805	0.845
NULL	BMB_Rep_2013_Jan_46(1)_59-64.nxml.txt.nlp	23351386	SENT8	4	4	20	20	auranofin	STAT3	PA448510	6774	0.845
NULL	Arthritis_Res_Ther_2006_Jul_21_8(4)_R130.nxml.txt.nlp	16859540	SENT169	9	9	20	20	atorvastatin	CD59	PA448500	966	0.845
NULL	Int_J_Impot_Res_2010_Mar_26_22(2)_120-126.nxml.txt.nlp	19940852	SENT50	29	29	20	20	nitroprusside	mol	PA451406	90527	0.845
NULL	Mol_Cancer_2013_Sep_11_12_104.nxml.txt.nlp	24025152	SENT105	17	17	12	12	gemcitabine	EGFR	PA449748	1956	0.845
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_91-103.nxml.txt.nlp	17912639	SENT70	27	27	41	41	anastrozole	HER2	PA448432	2064	0.845
NULL	Front_Oncol_2014_Jun_12_4_144.nxml.txt.nlp	24971229	SENT180	9	9	4	4	cisplatin	EZH2	PA449014	2146	0.845
NULL	Br_J_Cancer_2011_Nov_22_105(11)_1654-1662.nxml.txt.nlp	22045187	SENT132	37	37	9	9	irinotecan	UGT1A1	PA450085	54658	0.845
NULL	Acta_Pharmacol_Sin_2009_Oct_21_30(10)_1392-1398.nxml.txt.nlp	19767766	SENT14	2	2	7	7	atorvastatin	p38	PA448500	10598;1432;7965	0.845
NULL	Oncogene_2014_Aug_28_33(35)_4407-4417.nxml.txt.nlp	24469038	SENT102	13	13	7	7	cisplatin	p53	PA449014	7157	0.845
NULL	Case_Rep_Dermatol_2011_May_20_3(2)_113-117.nxml.txt.nlp	21677889	SENT41	30	30	17	17	hydrocortisone	COL1A1	PA449905	1277	0.845
NULL	Ann_Oncol_2012_Dec_2_23(12)_3007-3016.nxml.txt.nlp	22865781	SENT81	12	12	18	18	pertuzumab	HER2		2064	0.845
NULL	Br_J_Cancer_2011_Mar_15_104(6)_941-947.nxml.txt.nlp	21407223	SENT164	15	15	17	17	sorafenib	survivin	PA7000	332	0.845
NULL	Breast_Cancer_Res_2010_Jul_22_12(4)_R53.nxml.txt.nlp	20649975	SENT128	21	21	35	35	tamoxifen	BCS	PA451581	617	0.845
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Jul_16_64(Pt_8)_o1506.nxml.txt.nlp	21203215	SENT57	20	20	15	15	ethanol	mol	PA448073	90527	0.845
NULL	Mol_Cancer_2013_Apr_22_12_29.nxml.txt.nlp	23601052	SENT62	34	34	0	0	hydroxyurea	ORC2	PA449942	4999	0.845
NULL	Acta_Pharmacol_Sin_2009_Jul_22_30(7)_956-964.nxml.txt.nlp	19543298	SENT172	4	4	8	8	simvastatin	ABCB1	PA451363	5243	0.845
NULL	Clin_Epigenetics_2011_May_7_2(2)_249-256.nxml.txt.nlp	22704340	SENT155	15	15	29	29	doxorubicin	RELN	PA449412	5649	0.845
NULL	Environ_Health_Perspect_2013_May_22_121(5)_551-557.nxml.txt.nlp	23434795	SENT175	6	6	36	36	hyaluronan	AHR	PA165958431	196	0.845
NULL	Cell_Cycle_2013_Dec_15_12(24)_3759-3769.nxml.txt.nlp	24107633	SENT119	5	5	34	34	metformin	EGFR	PA450395	1956	0.845
NULL	Oncoscience_2014_Oct_22_1(10)_614-623.nxml.txt.nlp	25593991	SENT97	16	16	5	5	gefitinib	EGFR	PA131301952	1956	0.845
NULL	Breast_Cancer_Res_2012_Jan_17_14(1)_R13.nxml.txt.nlp	22251615	SENT52	2	2	4	4	tamoxifen	aromatase	PA451581	1588	0.845
NULL	Ann_Hematol_2010_Nov_25_89(11)_1115-1124.nxml.txt.nlp	20499237	SENT258	10	10	22	22	simvastatin	Bcl-2	PA451363	596	0.845
NULL	Hum_Genomics_Proteomics_2010_Sep_13_2010_754919.nxml.txt.nlp	20981234	SENT101	1	1	6	6	phenprocoumon	CYP2C9	PA450921	1559	0.845
NULL	Acta_Pharmacol_Sin_2013_Jan_3_34(1)_119-128.nxml.txt.nlp	23202804	SENT143	0	0	44	44	rimonabant	CB2	PA152407999	1269	0.845
NULL	Mol_Vis_2012_Mar_16_18_645-656.nxml.txt.nlp	22509096	SENT109	12	12	3	3	paraformaldehyde	E14	PA450790	4863	0.845
NULL	Acta_Pharmacol_Sin_2010_Mar_22_31(3)_329-340.nxml.txt.nlp	20173759	SENT154	41	41	6	6	ethanol	AMPK	PA448073	5563	0.845
NULL	Drugs_Context_2012_Nov_19_2012_212242.nxml.txt.nlp	24432031	SENT128	8	8	17	17	tamoxifen	IL-2	PA451581	3558	0.845
NULL	Evid_Based_Complement_Alternat_Med_2011_Mar_6_2011_851396.nxml.txt.nlp	21527979	SENT248	0	0	8	8	trypsin	SP1	PA451806	6667	0.845
NULL	Int_J_Biol_Sci_2013_Apr_22_9(4)_350-360.nxml.txt.nlp	23630447	SENT43	10	10	27	27	trastuzumab	EGF	PA451743	1950	0.845
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Nov_24_66(Pt_12)_o3273-o3274.nxml.txt.nlp	21589556	SENT3	22	22	1	1	piperazine	mol	PA450977	90527	0.845
NULL	Chem_Rev_2013_Oct_9_113(10)_7769-7792.nxml.txt.nlp	23808632	SENT48	9	9	21	21	s-adenosylmethionine	AS3MT	PA164754994	57412	0.845
NULL	Br_J_Cancer_2006_Feb_13_94(3)_407-426.nxml.txt.nlp	16434996	SENT121	19	19	7	7	genistein	BRCA1	PA165109660	672	0.845
NULL	Evid_Based_Complement_Alternat_Med_2014_Sep_3_2014_809083.nxml.txt.nlp	25276218	SENT7	11	11	29	29	berberine	IRAK1	PA165860812	3654	0.845
NULL	Gut_Liver_2013_Nov_14_7(6)_696-703.nxml.txt.nlp	24312711	SENT132	13	13	16	16	sorafenib	SHARP	PA7000	23013	0.845
NULL	Oncotarget_2011_Sep_9_2(9)_658-668.nxml.txt.nlp	21911919	SENT104	38	38	26	26	cytarabine	NAC	PA449177	22861	0.845
NULL	Oncotarget_2014_Jun_1_5(13)_4868-4880.nxml.txt.nlp	24947902	SENT105	8	8	29	29	afatinib	HER2	PA165981154	2064	0.845
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Sep_18_66(Pt_10)_o2587-o2588.nxml.txt.nlp	21587568	SENT6	5	5	26	26	coumarin	mol	PA134521193	90527	0.845
NULL	Biochim_Biophys_Acta_2014_Apr_1841(4)_588-594.nxml.txt.nlp	24440819	SENT184	8	8	23	23	lipase	ACBP	PA450239	1622	0.845
NULL	Mol_Biol_Rep_2013_May_11_40(8)_5013-5026.nxml.txt.nlp	23666059	SENT257	10	10	30	30	resveratrol	p53		7157	0.845
NULL	Mol_Vis_2011_Dec_27_17_3415-3422.nxml.txt.nlp	22219637	SENT180	7	7	17	17	estradiol	p38	PA449503	10598;1432;7965	0.845
NULL	Case_Rep_Surg_2012_Sep_4_2012_815941.nxml.txt.nlp	22988538	SENT86	16	16	7	7	imatinib	PDGFRA	PA10804	5156	0.845
NULL	Int_J_Endocrinol_Metab_2013_Dec_21_Winter_11(1)_52-56.nxml.txt.nlp	23853621	SENT17	37	37	10	10	imatinib	NF1	PA10804	4763	0.845
NULL	Int_J_Hypertens_2012_Jan_19_2012_594361.nxml.txt.nlp	22315665	SENT139	38	38	46	46	fasudil	ACE2	PA165946121	59272	0.845
NULL	Apoptosis_2007_Jan_31_12(1)_3-18.nxml.txt.nlp	17080328	SENT131	13	13	42	42	staurosporine	GAPDH	PA165109623	2597	0.845
NULL	Open_Virol_J_2009_Apr_1_3_21-25.nxml.txt.nlp	19572053	SENT58	10	10	21	21	pp2	CD4		920	0.845
NULL	Breast_Cancer_(Auckl)_2008_May_23_2_11-16.nxml.txt.nlp	19430575	SENT84	27	27	14	14	doxorubicin	PTEN	PA449412	5728	0.845
NULL	Mol_Cells_2014_Mar_31_37(3)_234-240.nxml.txt.nlp	24642709	SENT403	17	17	7	7	capsaicin	HO-1	PA448776	3162	0.845
NULL	Eur_J_Clin_Pharmacol_2007_Apr_21_63(4)_335-343.nxml.txt.nlp	17318526	SENT179	19	19	4	4	coumarin	CYP2C9	PA134521193	1559	0.845
NULL	Cell_Death_Dis_2010_Feb_4_1(2)_e21.nxml.txt.nlp	21364629	SENT176	28	28	10	10	glutaraldehyde	PRELI	PA449777	27166	0.845
NULL	Interdiscip_Toxicol_2011_Dec_4(4)_173-183.nxml.txt.nlp	22319251	SENT119	7	7	9	9	diethylstilbestrol	DES	PA449307	1674	0.845
NULL	Int_J_Mol_Sci_2014_Sep_5_15(9)_15754-15765.nxml.txt.nlp	25198898	SENT126	12	12	16	16	curcumin	NAC	PA151958596	22861	0.845
NULL	Cancers_(Basel)_2012_Jun_18_4(2)_581-600.nxml.txt.nlp	24213326	SENT29	28	28	21	21	paclitaxel	CD4	PA450761	920	0.845
NULL	Antimicrob_Resist_Infect_Control_2012_May_30_1_21.nxml.txt.nlp	22958440	SENT192	4	4	0	0	vancomycin	TC1	PA451850	6947	0.845
NULL	FEBS_Open_Bio_2013_Aug_17_3_352-356.nxml.txt.nlp	24251095	SENT181	17	17	0	0	hyaluronan	KIAA1199	PA165958431	57214	0.845
NULL	Indian_J_Pharm_Sci_2014_Jul-Aug_76(4)_299-307.nxml.txt.nlp	25284927	SENT146	37	37	16	16	carrageenan	2-19	PA448814	60343	0.845
NULL	Arthritis_Res_Ther_2008_Jan_18_10(1)_R8.nxml.txt.nlp	18205921	SENT185	19	19	44	44	vardenafil	MRP5	PA10229	10057	0.845
NULL	Croat_Med_J_2013_Apr_54(2)_171-179.nxml.txt.nlp	23630144	SENT91	10	10	20	20	taurine	STZ	PA451590	6484	0.845
NULL	Mol_Vis_2011_Aug_18_17_2221-2227.nxml.txt.nlp	21897744	SENT122	16	16	8	8	l-arginine	NAC	PA448478	22861	0.845
NULL	Nucleic_Acids_Res_2011_May_10_39(9)_3607-3620.nxml.txt.nlp	21227924	SENT366	11	11	22	22	camptothecin	SCAN1	PA153590860	55775	0.845
NULL	Mol_Vis_2007_Jul_12_13_1130-1137.nxml.txt.nlp	17653058	SENT168	7	7	21	21	isoflurane	IFN	PA450106	3439	0.845
NULL	Nat_Genet_2011_Feb_26_43(2)_117-120.nxml.txt.nlp	21186350	SENT77	32	32	30	30	metformin	AMPK	PA450395	5563	0.845
NULL	Mol_Cell_Biochem_2014_Oct_9_385(1-2)_265-275.nxml.txt.nlp	24104452	SENT229	36	36	33	33	bortezomib	U87	PA10252	677775;641648	0.845
NULL	Pharmaceuticals_(Basel)_2012_Sep_10_5(9)_944-962.nxml.txt.nlp	24280699	SENT48	12	12	9	9	novobiocin	Hsp90	PA164768819	3320	0.845
NULL	Breast_Cancer_Res_2001_Oct_11_3(6)_380-384.nxml.txt.nlp	11737889	SENT142	10	10	21	21	paclitaxel	HER2	PA450761	2064	0.845
NULL	Asia_Pac_Allergy_2012_Apr_30_2(2)_109-114.nxml.txt.nlp	22701860	SENT67	12	12	39	39	tiotropium	ADRB2	PA164769056	154	0.845
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Apr_17_66(Pt_5)_o1108.nxml.txt.nlp	21579160	SENT57	24	24	19	19	ethanol	mol	PA448073	90527	0.845
NULL	J_Immunol_Res_2014_Nov_30_2014_342693.nxml.txt.nlp	25762441	SENT181	25	25	20	20	valsartan	AT1	PA451848	9197;185	0.845
NULL	Ann_Rheum_Dis_2013_Apr_21_72(4)_482-492.nxml.txt.nlp	23172750	SENT374	12	12	28	28	tocilizumab	ACR	PA165292659	49	0.845
NULL	J_Hematol_Oncol_2011_Jan_21_4_5.nxml.txt.nlp	21255411	SENT272	33	33	46	46	docetaxel	CLC	PA449383	23529;1178	0.845
NULL	Case_Rep_Transplant_2011_Jan_5_2011_210178.nxml.txt.nlp	23213600	SENT110	20	20	8	8	tacrolimus	CYP2C19	PA451578	1557	0.845
NULL	Front_Oncol_2014_Mar_3_4_34.nxml.txt.nlp	24624361	SENT191	4	4	13	13	olaparib	PARP1		142	0.845
NULL	Oncol_Lett_2014_Nov_14_8(5)_2086-2092.nxml.txt.nlp	25295095	SENT148	16	16	7	7	gemcitabine	LKB1	PA449748	6794	0.845
NULL	BMB_Rep_2013_Nov_46(11)_544-549.nxml.txt.nlp	24152910	SENT7	8	8	21	21	thrombin	PAR-1	PA451674	2011;2149	0.845
NULL	Cancers_(Basel)_2010_May_26_2(2)_970-988.nxml.txt.nlp	24281102	SENT142	32	32	28	28	bevacizumab	VEGFR2	PA130232992	3791	0.845
NULL	Diabetes_Care_2008_Oct_31(10)_2062-2069.nxml.txt.nlp	18820229	SENT129	18	18	2	2	rosiglitazone	STOP	PA451283	4135	0.845
NULL	Eur_J_Appl_Physiol_2011_Feb_24_111(2)_275-283.nxml.txt.nlp	20865425	SENT53	18	18	3	3	glucose	MRS	PA449773	8011	0.845
NULL	Arthritis_Res_Ther_2009_Aug_3_11(4)_238.nxml.txt.nlp	19678909	SENT74	3	3	22	22	hydroquinone	CD4	PA449924	920	0.845
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Apr_16_67(Pt_5)_o1159.nxml.txt.nlp	21754467	SENT72	37	37	4	4	ethanol	mol	PA448073	90527	0.845
NULL	Oncoimmunology_2012_Aug_1_1(5)_618-629.nxml.txt.nlp	22934254	SENT13	28	28	2	2	nilotinib	p38	PA165958345	10598;1432;7965	0.845
NULL	Brain_Res_2012_Feb_3_1436(C)_111-121.nxml.txt.nlp	22200378	SENT586	8	8	1	1	haloperidol	P-gp	PA449841	5243	0.845
NULL	Tumour_Biol_2014_Mar_20_35(3)_2191-2197.nxml.txt.nlp	24142546	SENT177	23	23	16	16	imatinib	MDR1	PA10804	5243	0.845
NULL	Cell_Commun_Signal_2013_Jan_11_11_2.nxml.txt.nlp	23305203	SENT136	36	36	43	43	forskolin	TIMAP	PA146096022	26051	0.845
NULL	eLife_2013_Nov_5_2_e00969.nxml.txt.nlp	24192036	SENT212	0	0	20	20	vemurafenib	MKK4	PA165946873	6416	0.845
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Nov_21_65(Pt_12)_o3168.nxml.txt.nlp	21578884	SENT64	18	18	11	11	ethanol	mol	PA448073	90527	0.845
NULL	J_Biol_Chem_2013_Nov_15_288(46)_33049-33059.nxml.txt.nlp	24089524	SENT312	8	8	23	23	nicotine	GATA6	PA450626	2627	0.845
NULL	Crit_Care_2011_Oct_26_15(5)_R257.nxml.txt.nlp	22030215	SENT223	2	2	35	35	dexmedetomidine	SAPS	PA449256	8935	0.845
NULL	EMBO_Mol_Med_2012_Sep_7_4(9)_896-909.nxml.txt.nlp	22887866	SENT153	1	1	35	35	lovastatin	MYC	PA450272	4609	0.845
NULL	Ann_Oncol_2014_Oct_18_25(10)_1871-1888.nxml.txt.nlp	25234545	SENT319	25	25	29	29	fulvestrant	aromatase	PA164747170	1588	0.845
NULL	Indian_J_Med_Res_2011_Nov_134(5)_732-734.nxml.txt.nlp	22199115	SENT2	34	34	4	4	buprenorphine	OST	PA448685	1650;23263	0.845
NULL	Clin_Ophthalmol_2008_Jun_2(2)_355-368.nxml.txt.nlp	19668727	SENT213	35	35	19	19	nepafenac	PRK	PA165958407	1263	0.845
NULL	Theranostics_2013_Jan_13_3(1)_34-39.nxml.txt.nlp	23382784	SENT112	19	19	2	2	sorafenib	CXCR4	PA7000	7852	0.845
NULL	Gut_Liver_2012_Oct_18_6(4)_464-470.nxml.txt.nlp	23170151	SENT117	23	23	11	11	propofol	ESD	PA451141	2098	0.845
NULL	Arthritis_Res_Ther_2010_Jul_6_12(4)_R129.nxml.txt.nlp	20604932	SENT213	31	31	4	4	collagenase	CCL2	PA449107	6347	0.845
NULL	Cancer_Med_2014_Oct_2_3(5)_1256-1265.nxml.txt.nlp	24890382	SENT182	27	27	22	22	trastuzumab	HER2	PA451743	2064	0.845
NULL	Breast_Cancer_Res_2008_Dec_5_10(6)_R104.nxml.txt.nlp	19061505	SENT231	12	12	43	43	ethanol	c-Jun	PA448073	3725	0.845
NULL	Cancer_Med_2013_Dec_31_2(6)_950-963.nxml.txt.nlp	24403269	SENT264	16	16	8	8	cisplatin	RAB25	PA449014	57111	0.845
NULL	Adv_Biomed_Res_2014_Mar_25_3_98.nxml.txt.nlp	24800187	SENT42	0	0	22	22	clarithromycin	CO2	PA449028	4513	0.845
NULL	Patient_Prefer_Adherence_2014_Apr_8_8_463-471.nxml.txt.nlp	24748775	SENT133	25	25	15	15	teriparatide	BMD	PA451620	1756;7439	0.845
NULL	Int_J_Gen_Med_2009_Jul_30_2_19-32.nxml.txt.nlp	20360883	SENT92	22	22	30	30	vasopressin	ACTH	PA451858	5443	0.845
NULL	Virol_J_2011_May_24_8_255.nxml.txt.nlp	21609431	SENT41	28	28	16	16	l-glutamine	F12	PA10090	2161	0.845
NULL	Mol_Cell_2014_Sep_4_55(5)_723-732.nxml.txt.nlp	25066234	SENT403	3	3	20	20	doxycycline	MS2	PA449415	101	0.845
NULL	Crit_Care_2009_Feb_6_13(1)_R11.nxml.txt.nlp	19196475	SENT161	22	22	5	5	clonidine	IL-6	PA449051	3569	0.845
NULL	J_Gen_Physiol_2010_Apr_135(4)_333-353.nxml.txt.nlp	20231374	SENT872	4	4	8	8	ivermectin	P2X4	PA450133	5025	0.845
NULL	Biochemistry_2009_Jun_9_48(22)_4871-4880.nxml.txt.nlp	19364131	SENT480	9	9	14	14	cisplatin	ATP7B	PA449014	540	0.845
NULL	Indian_J_Dermatol_2011_May-Jun_56(3)_306-308.nxml.txt.nlp	21772594	SENT69	23	23	11	11	cyclophosphamide	CHP	PA449165	11261	0.845
NULL	Mol_Cancer_2007_Aug_21_6_53.nxml.txt.nlp	17711579	SENT154	34	34	21	21	cisplatin	PAWR	PA449014	5074	0.845
NULL	Case_Rep_Hematol_2013_Feb_3_2013_837906.nxml.txt.nlp	23431487	SENT5	2	2	14	14	desmopressin	VWF	PA449237	7450	0.845
NULL	J_Cell_Biol_2005_Jul_4_170(1)_37-47.nxml.txt.nlp	15998798	SENT241	8	8	13	13	doxycycline	CRT	PA449415	811	0.845
NULL	Mol_Cancer_2007_Oct_11_6_63.nxml.txt.nlp	17931419	SENT84	25	25	22	22	cetuximab	EGFR	PA10040	1956	0.845
NULL	Breast_Cancer_(Auckl)_2012_Mar_7_6_67-77.nxml.txt.nlp	22438669	SENT123	11	11	7	7	lapatinib	HER2	PA152241907	2064	0.845
NULL	Cancers_(Basel)_2014_Aug_5_6(3)_1597-1614.nxml.txt.nlp	25099886	SENT200	16	16	8	8	methotrexate	MSH2	PA450428	4436	0.845
NULL	Oncol_Lett_2013_Mar_19_5(3)_923-928.nxml.txt.nlp	23426648	SENT108	29	29	0	0	sc-560	MVD		4597	0.845
NULL	Curr_Pharm_Des_2008_Oct_14(28)_2983-2998.nxml.txt.nlp	18991714	SENT115	0	0	24	24	cetuximab	EGFR	PA10040	1956	0.845
NULL	Exp_Neurobiol_2014_Mar_27_23(1)_65-76.nxml.txt.nlp	24737941	SENT9	10	10	18	18	staurosporine	TRAP1	PA165109623	9392;10131	0.845
NULL	Int_J_Endocrinol_Metab_2013_Jul_1_Summer_11(3)_184-190.nxml.txt.nlp	24348591	SENT98	12	12	0	0	liraglutide	INS-1	PA165958364	2305	0.845
NULL	Acta_Pharmacol_Sin_2012_Jun_14_33(6)_832-838.nxml.txt.nlp	22580740	SENT13	25	25	13	13	methotrexate	GEM	PA450428	2669	0.845
NULL	Psychiatry_Investig_2009_Sep_23_6(3)_185-193.nxml.txt.nlp	20046394	SENT176	7	7	20	20	phenytoin	TGB	PA450947	5473	0.845
NULL	Reprod_Biol_Endocrinol_2003_Apr_1_1_31.nxml.txt.nlp	12740033	SENT57	37	37	9	9	gentamicin	F10	PA449753	2159	0.845
NULL	J_Neurochem_2014_Feb_24_128(3)_391-402.nxml.txt.nlp	24117850	SENT254	40	40	13	13	trifluoperazine	CAMSAP1	PA451771	157922	0.845
NULL	J_Mol_Signal_2008_Dec_1_3_18.nxml.txt.nlp	19046439	SENT68	11	11	34	34	metformin	CDK4	PA450395	1019	0.845
NULL	Oncotarget_2013_Jun_4_4(5)_772-784.nxml.txt.nlp	23800712	SENT6	21	21	12	12	erlotinib	EGFR	PA134687924	1956	0.845
NULL	J_Emerg_Trauma_Shock_2012_Oct-Dec_5(4)_279-284.nxml.txt.nlp	23248494	SENT65	18	18	12	12	ketamine	OST	PA450144	1650;23263	0.845
NULL	Oncotarget_2011_Sep_9_2(9)_658-668.nxml.txt.nlp	21911919	SENT104	14	14	26	26	daunorubicin	NAC	PA449212	22861	0.845
NULL	Cancer_Med_2013_Oct_19_2(5)_646-653.nxml.txt.nlp	24403230	SENT77	31	31	14	14	trastuzumab	IP6K3	PA451743	117283	0.845
NULL	F1000Res_2013_Jul_9_2_150.nxml.txt.nlp	24627787	SENT43	2	2	18	18	ziprasidone	DIP	PA451974	23151;1831	0.845
NULL	Clin_Ophthalmol_2011_Jun_7_5_759-765.nxml.txt.nlp	21691584	SENT124	6	6	40	40	bimatoprost	CA13	PA164748867	377677	0.845
NULL	Cell_Death_Dis_2010_Feb_4_1(2)_e21.nxml.txt.nlp	21364629	SENT121	37	37	9	9	nadh	PRELI	PA164755085	27166	0.845
NULL	Br_J_Cancer_2009_Mar_10_100(5)_758-763.nxml.txt.nlp	19259094	SENT69	12	12	19	19	decitabine	MLH1	PA164749631	4292	0.845
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT153	38	38	34	34	capsaicin	p53	PA448776	7157	0.845
NULL	Biomed_Res_Int_2014_Jan_20_2014_948427.nxml.txt.nlp	24563867	SENT156	11	11	21	21	buspirone	5-HT1A	PA448689	3350	0.845
NULL	Acta_Pharmacol_Sin_2014_Oct_15_35(10)_1227-1246.nxml.txt.nlp	25220640	SENT231	13	13	5	5	doxorubicin	MKP-1	PA449412	1843	0.845
NULL	Am_J_Cardiovasc_Drugs_2013_Jun_20_13(5)_331-342.nxml.txt.nlp	23784266	SENT195	6	6	33	33	quinidine	P-gp	PA451209	5243	0.845
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_P39.nxml.txt.nlp	NULL	SENT8	5	5	9	9	piperacillin	CD4	PA450975	920	0.845
NULL	Int_J_Nanomedicine_2012_Sep_17_7_5039-5049.nxml.txt.nlp	23055722	SENT177	20	20	16	16	docetaxel	PTEN	PA449383	5728	0.845
NULL	Clin_Epigenetics_2010_Aug_20_1(3-4)_71-83.nxml.txt.nlp	22704201	SENT50	6	6	15	15	resveratrol	SIRT1		23411	0.845
NULL	J_Cancer_Prev_2013_Jun_18(2)_186-191.nxml.txt.nlp	25337545	SENT15	8	8	12	12	curcumin	STAT3	PA151958596	6774	0.845
NULL	Diabetes_Care_2009_Oct_8_32(10)_1873-1879.nxml.txt.nlp	19587362	SENT107	35	35	20	20	irbesartan	ANG	PA450084	283	0.845
NULL	Oncotarget_2014_Feb_7_5(3)_775-787.nxml.txt.nlp	24519956	SENT106	7	7	17	17	dasatinib	PC3	PA162372878	57332;7832;5122	0.845
NULL	Clin_Dev_Immunol_2011_Dec_5_2011_894704.nxml.txt.nlp	22190975	SENT110	19	19	16	16	cetuximab	EGFR	PA10040	1956	0.845
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Apr_21_68(Pt_5)_o1479.nxml.txt.nlp	22590351	SENT60	17	17	9	9	ethanol	mol	PA448073	90527	0.845
NULL	Front_Behav_Neurosci_2010_Apr_5_4_14.nxml.txt.nlp	20407577	SENT180	11	11	0	0	cocaine	HDAC	PA449072	9734	0.845
NULL	Adv_Ther_2013_Oct_25_30(10)_870-884.nxml.txt.nlp	24158787	SENT221	5	5	29	29	everolimus	aromatase	PA164746311	1588	0.845
NULL	Cancers_(Basel)_2013_Jul_4_5(3)_838-856.nxml.txt.nlp	24202322	SENT191	17	17	30	30	etoposide	p53	PA449552	7157	0.845
NULL	J_Immunol_Res_2014_Apr_28_2014_286170.nxml.txt.nlp	24868562	SENT112	20	20	10	10	docetaxel	CD25	PA449383	3669;3559	0.845
NULL	Cancers_(Basel)_2014_Mar_6_6(1)_494-525.nxml.txt.nlp	24662938	SENT146	8	8	19	19	afatinib	EGFR	PA165981154	1956	0.845
NULL	Br_J_Haematol_2014_Jan_28_164(2)_233-244.nxml.txt.nlp	24206017	SENT225	40	40	28	28	lenalidomide	CRBN	PA162363968	51185	0.845
NULL	Iran_J_Public_Health_2012_Nov_1_41(11)_1-9.nxml.txt.nlp	23304670	SENT204	16	16	11	11	anastrozole	aromatase	PA448432	1588	0.845
NULL	Br_J_Pharmacol_2010_Sep_161(2)_241-270.nxml.txt.nlp	20735414	SENT142	0	0	8	8	lipase	PA-PLA1	PA450239	80821	0.845
NULL	Braz_J_Med_Biol_Res_2013_Mar_19_46(3)_257-262.nxml.txt.nlp	23558860	SENT60	23	23	46	46	phenylephrine	ERG	PA450935	2078	0.845
NULL	Environ_Health_Perspect_2007_Dec_8_115(Suppl_1)_129-136.nxml.txt.nlp	18174961	SENT117	10	10	34	34	lindane	Bcl-2	PA164754914	596	0.845
NULL	J_Am_Heart_Assoc_2013_Dec_19_2(6)_e000376.nxml.txt.nlp	24308935	SENT314	27	27	39	39	crizotinib	Met	PA165946122	79811	0.845
NULL	Anat_Cell_Biol_2010_Dec_31_43(4)_325-331.nxml.txt.nlp	21267407	SENT99	0	0	14	14	tetracycline	p38	PA451640	10598;1432;7965	0.845
NULL	Drug_Des_Devel_Ther_2014_Sep_23_8_1527-1538.nxml.txt.nlp	25284985	SENT95	5	5	19	19	celecoxib	IFN	PA448871	3439	0.845
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_23_2013_941093.nxml.txt.nlp	23864901	SENT241	0	0	2	2	quinidine	CYP2D6	PA451209	1565	0.845
NULL	Acta_Naturae_2011_Jul-Sep_3(3)_12-28.nxml.txt.nlp	22649690	SENT349	32	32	19	19	raltegravir	N155		9631	0.845
NULL	Cell_Death_Dis_2013_Jun_27_4(6)_e696.nxml.txt.nlp	23807225	SENT295	23	23	8	8	doxycycline	ACL	PA449415	47	0.845
NULL	Mar_Drugs_2014_Jun_27_12(7)_3818-3837.nxml.txt.nlp	24979269	SENT64	34	34	0	0	doxorubicin	P-gp	PA449412	5243	0.845
NULL	Oncotarget_2014_Oct_18_5(22)_11604-11619.nxml.txt.nlp	25344099	SENT177	18	18	22	22	cisplatin	RYBP	PA449014	23429	0.845
NULL	Cells_2014_Apr_4_3(2)_199-235.nxml.txt.nlp	24709958	SENT1152	1	1	11	11	celecoxib	EGFR	PA448871	1956	0.845
NULL	Target_Oncol_2013_Jun_27_8(2)_127-136.nxml.txt.nlp	23625191	SENT36	23	23	14	14	panitumumab	KRAS	PA162373091	3845	0.845
NULL	Arch_Med_Sci_2013_Oct_31_9(5)_936-943.nxml.txt.nlp	24273582	SENT103	3	3	13	13	nateglinide	GLP-1	PA450600	100125288	0.845
NULL	Int_J_Mol_Sci_2013_Apr_17_14(4)_8422-8436.nxml.txt.nlp	23594994	SENT68	14	14	5	5	flutamide	HIF-1	PA449685	29072	0.845
NULL	Ann_Oncol_2011_Mar_8_22(3)_503-514.nxml.txt.nlp	20616198	SENT69	4	4	12	12	aminoglutethimide	aromatase	PA448375	1588	0.845
NULL	Front_Behav_Neurosci_2010_Apr_5_4_14.nxml.txt.nlp	20407577	SENT261	0	0	32	32	doxycycline	NAC-1	PA449415	112939	0.845
NULL	Cell_Death_Dis_2014_Jan_16_5(1)_e1000.nxml.txt.nlp	24434508	SENT87	19	19	8	8	etoposide	p53	PA449552	7157	0.845
NULL	Acta_Pharmacol_Sin_2010_May_26_31(5)_554-559.nxml.txt.nlp	20418892	SENT151	2	2	4	4	bleomycin	BLM	PA448645	641	0.845
NULL	Diabetes_Care_2010_Jul_31_33(7)_1544-1548.nxml.txt.nlp	20357370	SENT132	20	20	10	10	metformin	LKB1	PA450395	6794	0.845
NULL	Acta_Neuropathol_2010_Nov_17_120(5)_567-584.nxml.txt.nlp	20714900	SENT267	13	13	7	7	temozolomide	MSH6	PA451609	2956	0.845
NULL	Mol_Biol_Cell_2012_Mar_1_23(5)_758-770.nxml.txt.nlp	22219383	SENT91	12	12	27	27	doxycycline	IRE1	PA449415	2081	0.845
NULL	Cancer_Med_2012_Aug_15_1(1)_28-38.nxml.txt.nlp	23342251	SENT216	17	17	22	22	pertuzumab	HER2		2064	0.845
NULL	Arch_Gynecol_Obstet_2012_May_30_285(5)_1447-1453.nxml.txt.nlp	22127553	SENT29	36	36	9	9	epirubicin	TEC	PA449476	7006	0.845
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT296	28	28	20	20	gefitinib	PTEN	PA131301952	5728	0.845
NULL	J_Cell_Mol_Med_2014_May_14_18(5)_811-823.nxml.txt.nlp	24628949	SENT15	12	12	5	5	docetaxel	FOXM1	PA449383	2305	0.845
NULL	Dermatoendocrinol_2013_Apr_1_5(2)_252-263.nxml.txt.nlp	24194965	SENT148	0	0	4	4	metformin	gamma	PA450395	9913	0.845
NULL	Adv_Hematol_2012_Aug_2_2012_842945.nxml.txt.nlp	22919394	SENT74	0	0	23	23	lenalidomide	IL-10	PA162363968	3586	0.845
NULL	J_Korean_Med_Sci_2013_Apr_27_28(4)_527-533.nxml.txt.nlp	23580227	SENT142	8	8	23	23	genistein	DR4	PA165109660	8797	0.845
NULL	Cell_Death_Dis_2014_Feb_13_5(2)_e1055.nxml.txt.nlp	24525731	SENT7	13	13	8	8	cisplatin	XRCC1	PA449014	7515	0.845
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1046.nxml.txt.nlp	24503538	SENT85	30	30	4	4	oxaliplatin	FGFR4	PA131285527	2264	0.845
NULL	Case_Rep_Dent_2013_Jul_10_2013_812323.nxml.txt.nlp	23936686	SENT96	34	34	22	22	hyaluronan	CD31	PA165958431	5175	0.845
NULL	Cell_Death_Dis_2013_Jul_11_4(7)_e719.nxml.txt.nlp	23846221	SENT61	11	11	9	9	cisplatin	TRAIL	PA449014	8743	0.845
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT291	23	23	18	18	cisplatin	JNK	PA449014	5599	0.845
NULL	Mol_Cell_2014_Jan_9_53(1)_140-147.nxml.txt.nlp	24374310	SENT148	23	23	10	10	l-glutamine	CO2	PA10090	4513	0.845
NULL	Br_J_Cancer_2014_Jan_21_110(2)_510-519.nxml.txt.nlp	24327015	SENT218	23	23	14	14	cisplatin	CDK1	PA449014	983	0.844
NULL	Evid_Based_Complement_Alternat_Med_2013_May_28_2013_629750.nxml.txt.nlp	23781265	SENT166	11	11	34	34	capsaicin	ATF4	PA448776	468	0.844
NULL	Open_Biochem_J_2011_Sep_23_5_45-51.nxml.txt.nlp	21966325	SENT6	3	3	7	7	indomethacin	PERK	PA449982	9451	0.844
NULL	Int_J_Biol_Sci_2013_Nov_21_9(10)_1089-1098.nxml.txt.nlp	24339730	SENT177	32	32	9	9	genistein	BMP6	PA165109660	654	0.844
NULL	Case_Rep_Nephrol_Urol_2013_Mar_7_3(1)_22-27.nxml.txt.nlp	23569460	SENT51	5	5	20	20	cefazolin	ISPD	PA448839	729920	0.844
NULL	AIDS_Res_Ther_2011_Oct_6_8_36.nxml.txt.nlp	21978457	SENT122	35	35	18	18	zinc	TNF	PA451956	7124	0.844
NULL	J_Headache_Pain_2010_Oct_22_11(5)_431-435.nxml.txt.nlp	20652353	SENT14	16	16	22	22	zolmitriptan	CYP3A4	PA451975	1576	0.844
NULL	Int_J_Pediatr_2010_Dec_23_2010_376287.nxml.txt.nlp	21234103	SENT92	23	23	28	28	ciprofloxacin	gamma	PA449009	9913	0.844
NULL	Int_J_Mol_Sci_2014_Nov_18_15(11)_21366-21380.nxml.txt.nlp	25411800	SENT45	27	27	4	4	furosemide	OAT	PA449719	4942	0.844
NULL	Cancers_(Basel)_2014_Oct_24_6(4)_2187-2223.nxml.txt.nlp	25347122	SENT288	33	33	18	18	dasatinib	MSN	PA162372878	4478	0.844
NULL	Mol_Cancer_2012_May_28_11_36.nxml.txt.nlp	22640878	SENT11	27	27	4	4	paclitaxel	TGFBI	PA450761	7045	0.844
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT99	10	10	18	18	nutlin-3	MDM2		4193	0.844
NULL	Blood_Cancer_J_2013_Oct_18_3(10)_e153.nxml.txt.nlp	24141622	SENT5	11	11	21	21	fludarabine	Mcl-1	PA449655	4170	0.844
NULL	Acta_Histochem_Cytochem_2012_Apr_26_45(2)_139-146.nxml.txt.nlp	22685356	SENT84	3	3	8	8	forskolin	AQP2	PA146096022	359	0.844
NULL	J_Skin_Cancer_2013_Feb_21_2013_742925.nxml.txt.nlp	23533767	SENT140	7	7	40	40	hydroquinone	CD63	PA449924	967	0.844
NULL	Clin_Interv_Aging_2010_Feb_2_5_7-18.nxml.txt.nlp	20169038	SENT140	0	0	10	10	febuxostat	CYP2D6	PA165958521	1565	0.844
NULL	Front_Immunol_2012_Mar_19_3_47.nxml.txt.nlp	22566929	SENT231	20	20	15	15	cyclosporine	B7-H3	PA449167	80381	0.844
NULL	Leukemia_2013_Feb_3_27(2)_315-324.nxml.txt.nlp	22751450	SENT206	3	3	11	11	sorafenib	Mcl-1	PA7000	4170	0.844
NULL	J_Clin_Exp_Pathol_2012_May_17_Suppl_4_7327.nxml.txt.nlp	25379357	SENT36	16	16	19	19	resveratrol	AMPK		5563	0.844
NULL	Addict_Sci_Clin_Pract_2012_Jun_9_7(1)_10.nxml.txt.nlp	23186149	SENT21	9	9	17	17	buprenorphine	OAT	PA448685	4942	0.844
NULL	Aging_(Albany_NY)_2009_Jul_30_1(7)_669-673.nxml.txt.nlp	20157548	SENT25	5	5	3	3	resveratrol	SIRT1		23411	0.844
NULL	Nat_Methods_2011_Jun_24_8(6)_487-493.nxml.txt.nlp	21516115	SENT82	12	12	14	14	gefitinib	EGF	PA131301952	1950	0.844
NULL	Cancer_Causes_Control_2013_Aug_18_24(8)_1605-1614.nxml.txt.nlp	23775025	SENT221	15	15	5	5	cyclophosphamide	CYP2C19	PA449165	1557	0.844
NULL	Environ_Health_Perspect_1995_Oct_103(Suppl_7)_95-97.nxml.txt.nlp	8593884	SENT6	20	20	22	22	diethylstilbestrol	DES	PA449307	1674	0.844
NULL	Oncol_Rep_2013_Oct_22_30(4)_1535-1541.nxml.txt.nlp	23877481	SENT149	33	33	24	24	etoricoxib	EGFR	PA164776853	1956	0.844
NULL	Korean_J_Anesthesiol_2013_Dec_26_65(6)_501-507.nxml.txt.nlp	24427455	SENT11	6	6	16	16	neostigmine	NMB	PA450611	10457;4828	0.844
NULL	Clin_Mol_Allergy_2011_May_31_9_10.nxml.txt.nlp	21624140	SENT291	16	16	9	9	trimethoprim	gamma	PA451788	9913	0.844
NULL	Arthritis_Res_Ther_2013_Sep_4_15(5)_R106.nxml.txt.nlp	24008023	SENT149	34	34	3	3	glucosamine	OTC	PA164747613	5009	0.844
NULL	Acta_Pharmacol_Sin_2014_Jan_2_35(1)_98-112.nxml.txt.nlp	24292379	SENT64	19	19	11	11	methotrexate	CYP3A4	PA450428	1576	0.844
NULL	J_Gen_Physiol_2003_Jul_122(1)_45-61.nxml.txt.nlp	12835470	SENT645	13	13	11	11	capsaicin	VR1	PA448776	56664	0.844
NULL	Eur_J_Med_Res_2009_Nov_24_14(Suppl_3)_17-21.nxml.txt.nlp	19959412	SENT56	7	7	12	12	lamotrigine	UGT	PA450164	7361;7355	0.844
NULL	FEBS_Open_Bio_2012_Sep_8_2_273-277.nxml.txt.nlp	23650610	SENT53	13	13	32	32	collagenase	CO2	PA449107	4513	0.844
NULL	J_Immunother_Cancer_2014_Jan_27_2_2.nxml.txt.nlp	24829759	SENT61	14	14	4	4	sorafenib	IL-21	PA7000	59067;50616;27189	0.844
NULL	Open_Med_Chem_J_2011_Sep_9_5_82-92.nxml.txt.nlp	21966329	SENT142	3	3	11	11	vildagliptin	GLP-1	PA165958346	100125288	0.844
NULL	Protein_Eng_Des_Sel_2009_Jul_10_22(7)_421-430.nxml.txt.nlp	19515728	SENT98	6	6	2	2	urea	p53	PA451831	7157	0.844
NULL	Crit_Care_2010_Apr_19_14(2)_R70.nxml.txt.nlp	20403177	SENT303	7	7	15	15	thrombin	RhoA	PA451674	387	0.844
NULL	Front_Aging_Neurosci_2014_Sep_11_6_218.nxml.txt.nlp	25309423	SENT225	0	0	9	9	resveratrol	AMPK		5563	0.844
NULL	Ann_Surg_Oncol_2014_Feb_13_21(5)_1575-1582.nxml.txt.nlp	24522992	SENT174	27	27	29	29	tamoxifen	IMPACT	PA451581	55364	0.844
NULL	Exp_Ther_Med_2013_Jul_25_6(1)_109-114.nxml.txt.nlp	23935730	SENT150	19	19	27	27	vincristine	CHOP	PA451879	1649	0.844
NULL	Cardiovasc_Diabetol_2013_May_4_12_73.nxml.txt.nlp	23642288	SENT47	20	20	8	8	sitagliptin	GLP-1	PA164748978	100125288	0.844
NULL	Front_Oncol_2013_Apr_29_3_92.nxml.txt.nlp	23641361	SENT163	8	8	14	14	bevacizumab	CLS	PA130232992	1210	0.844
NULL	Eur_J_Endocrinol_2010_May_162(5)_987-992.nxml.txt.nlp	20164212	SENT6	21	21	9	9	diazoxide	GLUD1	PA449285	2746	0.844
NULL	Br_J_Cancer_2011_Apr_12_104(8)_1278-1287.nxml.txt.nlp	21487429	SENT14	27	27	7	7	cisplatin	p53	PA449014	7157	0.844
NULL	Nucleic_Acids_Res_2007_Jan_7_35(2)_e9.nxml.txt.nlp	17158148	SENT535	17	17	5	5	camptothecin	EM9	PA153590860	2068	0.844
NULL	J_Korean_Med_Sci_2006_Dec_31_21(6)_1037-1040.nxml.txt.nlp	17179683	SENT90	37	37	22	22	metronidazole	BAM	PA450484	9126	0.844
NULL	Theranostics_2014_Aug_15_4(11)_1072-1084.nxml.txt.nlp	25250092	SENT190	9	9	20	20	panitumumab	HER2	PA162373091	2064	0.844
NULL	Exp_Diabetes_Res_2012_Apr_17_2012_635472.nxml.txt.nlp	22577369	SENT69	11	11	18	18	saxagliptin	GLP-1	PA165958362	100125288	0.844
NULL	Oxid_Med_Cell_Longev_2013_Apr_21_2013_412576.nxml.txt.nlp	23710286	SENT127	8	8	25	25	curcumin	NRF2	PA151958596	2551;4780	0.844
NULL	J_Biomed_Sci_2012_Oct_30_19(1)_92.nxml.txt.nlp	23110561	SENT208	18	18	21	21	geldanamycin	Hsp90	PA152031327	3320	0.844
NULL	Clin_Ophthalmol_2008_Mar_2(1)_31-55.nxml.txt.nlp	19668387	SENT116	27	27	1	1	fluorescein	SPK	PA164746009	55872;8189	0.844
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jan_11_68(Pt_2)_o352.nxml.txt.nlp	22346980	SENT63	19	19	12	12	ethanol	mol	PA448073	90527	0.844
NULL	Behav_Brain_Funct_2013_Nov_26_9_43.nxml.txt.nlp	24279870	SENT232	30	30	20	20	ethanol	NR1	PA448073	27158	0.844
NULL	J_Gynecol_Oncol_2012_Jan_9_23(1)_35-42.nxml.txt.nlp	22355465	SENT105	13	13	20	20	cisplatin	CDK1	PA449014	983	0.844
NULL	Biomed_Res_Int_2014_Feb_13_2014_309151.nxml.txt.nlp	24683546	SENT6	19	19	16	16	rosiglitazone	STZ	PA451283	6484	0.844
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Jul_26_64(Pt_8)_o1586.nxml.txt.nlp	21203284	SENT64	33	33	13	13	ethanol	mol	PA448073	90527	0.844
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Oct_20_66(Pt_11)_o2870.nxml.txt.nlp	21589052	SENT67	6	6	23	23	coumarin	C21	PA134521193	79718	0.844
NULL	Br_J_Cancer_2013_Mar_19_108(5)_1079-1091.nxml.txt.nlp	23449353	SENT207	11	11	3	3	docetaxel	MIC-1	PA449383	29919;9518	0.844
NULL	Br_J_Cancer_2006_Feb_13_94(3)_363-371.nxml.txt.nlp	16465172	SENT46	18	18	47	47	oxaliplatin	CRT	PA131285527	811	0.844
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT128	7	7	16	16	docetaxel	B7-H1	PA449383	29126	0.844
NULL	Diabetes_2013_Sep_15_62(9)_3033-3043.nxml.txt.nlp	23649519	SENT417	20	20	10	10	metformin	LKB1	PA450395	6794	0.844
NULL	Oncol_Lett_2013_Mar_19_5(3)_923-928.nxml.txt.nlp	23426648	SENT191	6	6	3	3	sc-560	COX		1351	0.844
NULL	Acta_Pharmacol_Sin_2009_Jul_22_30(7)_956-964.nxml.txt.nlp	19543298	SENT174	2	2	9	9	atorvastatin	ABCB1	PA448500	5243	0.844
NULL	Breast_Cancer_Res_2004_Jul_29_6(5)_204-210.nxml.txt.nlp	15318926	SENT102	17	17	7	7	fulvestrant	EGFR	PA164747170	1956	0.844
NULL	J_Exp_Med_1973_Nov_30_138(6)_1564-1583.nxml.txt.nlp	4271629	SENT16	6	6	20	20	trypsin	mol	PA451806	90527	0.844
NULL	JMIR_Res_Protoc_2014_Jul_8_3(3)_e35.nxml.txt.nlp	25004932	SENT81	0	0	18	18	propofol	BRI	PA451141	9445	0.844
NULL	Dis_Markers_2010_Jun_29_28(5)_307-313.nxml.txt.nlp	20592455	SENT3	22	22	16	16	atorvastatin	CAD	PA448500	1677;790	0.844
NULL	Chin_J_Cancer_2012_May_31(5)_248-256.nxml.txt.nlp	22507221	SENT172	16	16	6	6	gefitinib	EGFR	PA131301952	1956	0.844
NULL	Adv_Hematol_2009_Jun_22_2009_251915.nxml.txt.nlp	19946423	SENT122	27	27	24	24	hemin	HRI	PA449849	27102	0.844
NULL	Front_Neurosci_2014_Feb_14_8_23.nxml.txt.nlp	24592205	SENT636	0	0	15	15	capsaicin	VR1	PA448776	56664	0.844
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1150.nxml.txt.nlp	24675468	SENT54	5	5	9	9	ethanol	Bcl-2	PA448073	596	0.844
NULL	Indian_J_Med_Res_2012_Sep_136(3)_391-403.nxml.txt.nlp	23041732	SENT190	14	14	35	35	doxorubicin	HCC	PA449412	84668	0.844
NULL	Front_Psychol_2014_Mar_26_5_183.nxml.txt.nlp	24723897	SENT256	22	22	24	24	atomoxetine	ATX	PA134688071	5168;23049	0.844
NULL	Indian_J_Med_Res_2011_Mar_133(3)_257-266.nxml.txt.nlp	21441678	SENT107	30	30	18	18	rifampin	TST	PA451250	7263	0.844
NULL	Arthritis_Res_Ther_2005_Feb_18_7(3)_R476-R484.nxml.txt.nlp	15899034	SENT104	6	6	31	31	thrombin	Rho	PA451674	29984	0.844
NULL	Oncotarget_2011_Sep_9_2(9)_658-668.nxml.txt.nlp	21911919	SENT61	35	35	29	29	cytarabine	HO-1	PA449177	3162	0.844
NULL	J_Hematol_Oncol_2012_Aug_16_5_51.nxml.txt.nlp	22897949	SENT38	0	0	14	14	rituximab	CHOP	PA451261	1649	0.844
NULL	Biomed_Res_Int_2013_Oct_27_2013_798261.nxml.txt.nlp	24282821	SENT9	39	39	10	10	ethanol	AQP4	PA448073	361	0.844
NULL	Cell_Biol_Int_Rep_(2010)_2012_Jun_21_19(1)_e00017.nxml.txt.nlp	23124518	SENT58	4	4	6	6	etoposide	TRAIL	PA449552	8743	0.844
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1046.nxml.txt.nlp	24503538	SENT51	21	21	4	4	oxaliplatin	FGFR4	PA131285527	2264	0.844
NULL	Mol_Cancer_2008_Oct_23_7_82.nxml.txt.nlp	18947424	SENT278	2	2	6	6	doxazosin	EGFR	PA449407	1956	0.844
NULL	Biomed_Res_Int_2014_Jan_6_2014_520763.nxml.txt.nlp	24527450	SENT206	4	4	17	17	resveratrol	JNK		5599	0.844
NULL	Eur_J_Haematol_2009_May_82(5)_339-349.nxml.txt.nlp	19187276	SENT88	38	38	45	45	rivaroxaban	TKR	PA165958360	8277	0.844
NULL	Front_Oncol_2014_Jun_18_4_159.nxml.txt.nlp	24995161	SENT10	33	33	0	0	estradiol	AKR1C3	PA449503	8644	0.844
NULL	Arthritis_Res_Ther_2010_Jun_2_12(3)_R107.nxml.txt.nlp	20525198	SENT112	23	23	19	19	rolipram	TNF	PA153906323	7124	0.844
NULL	Oncol_Rep_2014_Feb_13_31(2)_581-588.nxml.txt.nlp	24337105	SENT155	12	12	15	15	capsaicin	CHOP	PA448776	1649	0.844
NULL	Curr_Neuropharmacol_2014_Jul_12(4)_365-379.nxml.txt.nlp	25342944	SENT119	12	12	4	4	fluoxetine	cPLA2	PA449673	10524	0.844
NULL	Acta_Neuropathol_2015_Oct_17_129_115-131.nxml.txt.nlp	25322816	SENT274	21	21	18	18	bevacizumab	LDHA	PA130232992	3939	0.844
NULL	eLife_2014_May_27_3_e02439.nxml.txt.nlp	24867641	SENT242	17	17	4	4	doxycycline	OLIG2	PA449415	10215	0.844
NULL	Ecancermedicalscience_2008_Feb_18_2_75.nxml.txt.nlp	22275966	SENT148	17	17	32	32	erlotinib	NSCL	PA134687924	4807	0.844
NULL	Neuro_Oncol_2014_Jul_23_16(7)_933-945.nxml.txt.nlp	24463355	SENT219	15	15	5	5	triciribine	AKT	PA165958661	207	0.844
NULL	Mol_Cancer_2014_Jun_24_13_157.nxml.txt.nlp	24958351	SENT4	4	4	0	0	trastuzumab	HER2	PA451743	2064	0.844
NULL	Front_Cell_Neurosci_2013_Apr_23_7_39.nxml.txt.nlp	23630460	SENT903	19	19	11	11	clozapine	ALX	PA449061	84941	0.844
NULL	Braz_J_Med_Biol_Res_2014_Sep_5_47(11)_929-939.nxml.txt.nlp	25296354	SENT144	20	20	24	24	afatinib	EGFR	PA165981154	1956	0.844
NULL	Mol_Pain_2013_May_20_9_25.nxml.txt.nlp	23688027	SENT196	20	20	30	30	carrageenan	TRPV1	PA448814	7442	0.844
NULL	J_Hematol_Oncol_2013_Jan_4_6_1.nxml.txt.nlp	23286345	SENT89	4	4	16	16	trastuzumab	FCGR2A	PA451743	2212	0.844
NULL	Clin_Med_Insights_Oncol_2011_Oct_31_5_333-342.nxml.txt.nlp	22084622	SENT240	38	38	7	7	sunitinib	CD34	PA162372840	947	0.844
NULL	J_Hematol_Oncol_2013_Mar_27_6_23.nxml.txt.nlp	23531342	SENT104	14	14	2	2	mi-63	RITA		55422;84934	0.844
NULL	Cancer_Cell_Int_2013_Mar_4_13_21.nxml.txt.nlp	23497288	SENT220	14	14	10	10	vincristine	EWS	PA451879	2130	0.844
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT150	34	34	44	44	l-leucine	SIRT3	PA450197	23410	0.844
NULL	Neuropsychopharmacology_2009_Sep_3_34(10)_2237-2251.nxml.txt.nlp	19494808	SENT61	15	15	2	2	ethanol	PEN	PA448073	9933	0.844
NULL	Aging_(Albany_NY)_2009_Feb_18_1(3)_335-349.nxml.txt.nlp	20195489	SENT211	19	19	5	5	etoposide	p65	PA449552	5970	0.844
NULL	Mol_Cancer_2007_Aug_21_6_53.nxml.txt.nlp	17711579	SENT154	34	34	27	27	cisplatin	TNFAIP8	PA449014	25816	0.844
NULL	Endocrine_2012_Dec_14_42(3)_622-636.nxml.txt.nlp	22695986	SENT125	29	29	6	6	forskolin	PTH	PA146096022	5741	0.844
NULL	Oncotarget_2013_Jul_14_4(8)_1185-1198.nxml.txt.nlp	23852390	SENT222	2	2	24	24	bortezomib	XIAP	PA10252	331	0.844
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_31_2012_656150.nxml.txt.nlp	23304209	SENT93	33	33	3	3	paraformaldehyde	STZ	PA450790	6484	0.844
NULL	J_Korean_Med_Sci_2011_Aug_27_26(8)_1007-1013.nxml.txt.nlp	21860550	SENT24	10	10	0	0	tamoxifen	CYP2D6	PA451581	1565	0.844
NULL	Cell_Mol_Life_Sci_2011_Nov_2_68(21)_3573-3587.nxml.txt.nlp	21365278	SENT295	20	20	23	23	iloprost	EP2	PA164746843	5732;10407	0.844
NULL	Int_J_Med_Sci_2015_Jan_1_12(1)_63-71.nxml.txt.nlp	25552920	SENT175	35	35	6	6	berberine	PC-3	PA165860812	692094	0.844
NULL	Arthritis_Res_2001_Sep_18_3(6)_381-388.nxml.txt.nlp	11714393	SENT153	15	15	4	4	collagenase	AP-1	PA449107	2353;3727;2354;3725	0.844
NULL	Clin_Pharmacol_2012_Feb_20_4_13-20.nxml.txt.nlp	22427735	SENT69	12	12	4	4	clopidogrel	ADP	PA449053	23038	0.844
NULL	eLife_2013_Nov_5_2_e01319.nxml.txt.nlp	24192038	SENT172	33	33	15	15	rolipram	AKAP18	PA153906323	9465	0.844
NULL	Int_J_Breast_Cancer_2012_Oct_25_2012_829315.nxml.txt.nlp	22295252	SENT84	31	31	15	15	olaparib	BRCA1		672	0.844
NULL	Br_J_Cancer_2011_Sep_27_105(7)_1012-1022.nxml.txt.nlp	21863032	SENT188	14	14	10	10	nutlin-3	p53		7157	0.844
NULL	Oncotarget_2011_Mar_23_2(3)_165-177.nxml.txt.nlp	21444946	SENT179	10	10	4	4	cetuximab	KRAS	PA10040	3845	0.844
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT349	27	27	16	16	pp2	TFF3		7033	0.844
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Oct_29_67(Pt_11)_o3069-o3070.nxml.txt.nlp	22220078	SENT65	32	32	7	7	ethanol	mol	PA448073	90527	0.844
NULL	Acta_Neuropathol_Commun_2013_Dec_5_1(1)_79.nxml.txt.nlp	24314025	SENT426	27	27	15	15	mannitol	alpha-synuclein	PA450320	6622	0.844
NULL	Core_Evid_2010_Oct_21_5_77-90.nxml.txt.nlp	21042544	SENT21	0	0	17	17	fosaprepitant	NK1	PA165958390	11126	0.844
NULL	Cancer_Immunol_Immunother_2015_Oct_7_64_61-73.nxml.txt.nlp	25287778	SENT259	4	4	11	11	lenalidomide	CD4	PA162363968	920	0.844
NULL	Nat_Commun_2014_Nov_25_5_5548.nxml.txt.nlp	25420520	SENT12	15	15	0	0	cabazitaxel	ERG	PA165958401	2078	0.844
NULL	Cardiovasc_Drugs_Ther_2010_Dec_13_24(5-6)_391-399.nxml.txt.nlp	20640495	SENT167	0	0	13	13	aminophylline	DIP	PA164781029	23151;1831	0.844
NULL	F1000Res_2014_Aug_19_3_198.nxml.txt.nlp	25400908	SENT289	20	20	9	9	trastuzumab	ACT	PA451743	12;11332;9457;641455	0.844
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT188	0	0	16	16	neratinib	HER2	PA165291472	2064	0.844
NULL	Diabetes_Care_2009_Nov_32(Suppl_2)_S223-S231.nxml.txt.nlp	19875556	SENT106	6	6	3	3	liraglutide	GLP-1	PA165958364	100125288	0.844
NULL	Chin_J_Cancer_2012_Feb_31(2)_100-109.nxml.txt.nlp	22237039	SENT80	11	11	16	16	doxorubicin	P-gp	PA449412	5243	0.844
NULL	Biol_Open_2014_Nov_21_3(12)_1207-1216.nxml.txt.nlp	25416063	SENT41	13	13	5	5	fluorescein	NANOS2	PA164746009	339345	0.844
NULL	Exp_Ther_Med_2013_Dec_26_6(6)_1359-1364.nxml.txt.nlp	24255662	SENT14	15	15	8	8	dexmedetomidine	TLR4	PA449256	7099	0.844
NULL	Blood_Cancer_J_2013_Sep_13_3(9)_e146.nxml.txt.nlp	24036945	SENT51	33	33	4	4	ribavirin	AKT	PA451241	207	0.844
NULL	Orphanet_J_Rare_Dis_2014_Jun_5_9_79.nxml.txt.nlp	24898617	SENT117	2	2	9	9	resveratrol	CPT2		1376	0.844
NULL	Anat_Cell_Biol_2011_Sep_29_44(3)_194-203.nxml.txt.nlp	22025971	SENT228	2	2	10	10	resveratrol	COX		1351	0.844
NULL	J_Mol_Signal_2010_May_10_5_4.nxml.txt.nlp	20459745	SENT13	15	15	10	10	cisplatin	p53	PA449014	7157	0.844
NULL	AIDS_Res_Treat_2011_Aug_15_2011_562790.nxml.txt.nlp	21860787	SENT86	9	9	2	2	tenofovir	MRP4	PA10204	10257	0.844
NULL	Nucleic_Acids_Res_2012_Jul_30_40(13)_6319-6337.nxml.txt.nlp	22467215	SENT22	0	0	21	21	trastuzumab	HER2	PA451743	2064	0.844
NULL	Front_Mol_Neurosci_2012_Nov_12_5_99.nxml.txt.nlp	23162427	SENT761	7	7	1	1	cocaine	BDNF	PA449072	627	0.844
NULL	Front_Oncol_2014_Oct_13_4_229.nxml.txt.nlp	25353005	SENT72	12	12	7	7	panitumumab	EGFR	PA162373091	1956	0.844
NULL	Diabetol_Metab_Syndr_2014_Mar_31_6_47.nxml.txt.nlp	24684779	SENT160	35	35	15	15	pioglitazone	IL-6	PA450970	3569	0.844
NULL	Br_J_Cancer_2010_Feb_16_102(4)_658-664.nxml.txt.nlp	20104222	SENT84	19	19	12	12	sunitinib	IFN	PA162372840	3439	0.844
NULL	J_Bras_Pneumol_2013_Jan-Feb_39(1)_5-15.nxml.txt.nlp	23503480	SENT129	34	34	26	26	doxycycline	VEGF-D	PA449415	2277	0.844
NULL	Mol_Cancer_2012_Sep_28_11_74.nxml.txt.nlp	23021083	SENT175	18	18	8	8	gemcitabine	CEACAM6	PA449748	4680	0.844
NULL	Pharmaceuticals_(Basel)_2011_May_16_4(5)_726-740.nxml.txt.nlp	NULL	SENT108	10	10	0	0	estradiol	CEE	PA449503	51608	0.844
NULL	Front_Physiol_2013_Nov_14_4_323.nxml.txt.nlp	24294204	SENT256	19	19	7	7	metoprolol	UGT1A1	PA450480	54658	0.844
NULL	Nucleic_Acids_Res_2012_Jul_30_40(13)_6319-6337.nxml.txt.nlp	22467215	SENT334	19	19	29	29	cisplatin	HER2	PA449014	2064	0.844
NULL	Neural_Plast_2012_May_20_2012_569149.nxml.txt.nlp	22685677	SENT37	35	35	14	14	lipase	iPLA2	PA450239	8398	0.844
NULL	J_Exp_Med_1994_Oct_1_180(4)_1457-1469.nxml.txt.nlp	7931078	SENT13	0	0	29	29	propranolol	IL-4	PA451145	3565	0.844
NULL	Breast_Cancer_Res_2011_Sep_20_13(5)_R91.nxml.txt.nlp	21933397	SENT43	24	24	42	42	gentamicin	CO2	PA449753	4513	0.844
NULL	Mol_Pain_2014_Feb_6_10_10.nxml.txt.nlp	24499354	SENT50	2	2	4	4	cyclophosphamide	CTX	PA449165	1593	0.844
NULL	Oncotarget_2011_Nov_30_2(11)_874-885.nxml.txt.nlp	22141136	SENT48	11	11	3	3	staurosporine	AXL	PA165109623	558	0.844
NULL	Mol_Vis_2012_Nov_29_18_2839-2846.nxml.txt.nlp	23233786	SENT122	4	4	10	10	geldanamycin	Hsp90	PA152031327	3320	0.844
NULL	Biochem_Biophys_Res_Commun_2011_Sep_9_412(4)_747-751.nxml.txt.nlp	21871446	SENT95	14	14	3	3	l-arginine	PI3	PA448478	5266	0.844
NULL	Crit_Care_2011_Feb_22_15(1)_123.nxml.txt.nlp	21345242	SENT44	8	8	3	3	enoxaparin	APC	PA449463	324	0.844
NULL	Saudi_J_Anaesth_2013_Jan-Mar_7(1)_68-74.nxml.txt.nlp	23717236	SENT148	14	14	27	27	tropisetron	5-HT4	PA161925594	3360	0.844
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT315	15	15	10	10	doxorubicin	ABCG2	PA449412	9429	0.844
NULL	Prostate_Int_2014_Sep_21_2(3)_105-113.nxml.txt.nlp	25325021	SENT136	0	0	14	14	coumarin	HSD3	PA134521193	55812	0.844
NULL	Cells_2014_Jul_30_3(3)_751-777.nxml.txt.nlp	25079291	SENT355	12	12	15	15	midazolam	TRPM7	PA450496	54822	0.844
NULL	Pharmaceuticals_(Basel)_2013_Aug_21_6(8)_988-1038.nxml.txt.nlp	24276379	SENT369	13	13	2	2	cetuximab	EGFR	PA10040	1956	0.844
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT15	23	23	11	11	sulindac	AKT	PA451565	207	0.844
NULL	J_Skin_Cancer_2013_Apr_22_2013_632028.nxml.txt.nlp	23710361	SENT61	20	20	13	13	neomycin	p63	PA450608	8626	0.844
NULL	Breast_Cancer_Res_2007_Jul_5_9(4)_R41.nxml.txt.nlp	17612393	SENT175	4	4	16	16	celecoxib	Bcl-2	PA448871	596	0.844
NULL	Front_Endocrinol_(Lausanne)_2014_Oct_9_5_161.nxml.txt.nlp	25346723	SENT407	11	11	17	17	metformin	gamma	PA450395	9913	0.844
NULL	Breast_Cancer_Res_2014_Sep_11_16(5)_430.nxml.txt.nlp	25212826	SENT34	8	8	22	22	fulvestrant	PI3K	PA164747170	5290	0.844
NULL	Int_J_Endocrinol_2011_Jun_2_2011_251410.nxml.txt.nlp	21747852	SENT142	3	3	23	23	cinacalcet	PTH	PA164776671	5741	0.844
NULL	Oncogene_2009_Feb_5_28(5)_625-637.nxml.txt.nlp	19015636	SENT36	3	3	15	15	doxycycline	GLI1	PA449415	2735	0.844
NULL	Front_Pharmacol_2014_May_16_5_80.nxml.txt.nlp	24904415	SENT54	34	34	1	1	doxycycline	CD25	PA449415	3669;3559	0.844
NULL	Acta_Pharmacol_Sin_2012_Aug_23_33(8)_1095-1100.nxml.txt.nlp	22820908	SENT114	20	20	27	27	ilaprazole	CYP3A	PA165947499	1574	0.844
NULL	Int_J_Nephrol_2011_Apr_26_2011_245823.nxml.txt.nlp	21603155	SENT116	17	17	20	20	ribavirin	IFN	PA451241	3439	0.844
NULL	Mol_Cells_2014_Mar_31_37(3)_234-240.nxml.txt.nlp	24642709	SENT158	14	14	5	5	capsaicin	HO-1	PA448776	3162	0.844
NULL	J_Mol_Med_(Berl)_2014_May_10_92(7)_709-722.nxml.txt.nlp	24811491	SENT36	8	8	1	1	panitumumab	EGFR	PA162373091	1956	0.844
NULL	Cell_Death_Dis_2010_Nov_18_1(11)_e102.nxml.txt.nlp	21368867	SENT69	14	14	5	5	gentamicin	CLIMP-63	PA449753	10970	0.844
NULL	J_Hematol_Oncol_2012_May_15_5_23.nxml.txt.nlp	22587422	SENT8	9	9	19	19	dasatinib	ALL	PA162372878	613	0.844
NULL	Mol_Cancer_2010_Oct_12_9_269.nxml.txt.nlp	20939893	SENT79	4	4	25	25	isoproterenol	c-Jun	PA450121	3725	0.844
NULL	CNS_Spectr_2014_Apr_1_19(2)_121-133.nxml.txt.nlp	23903233	SENT118	22	22	8	8	imipramine	5-HT1B	PA449969	3351	0.844
NULL	J_Clin_Biochem_Nutr_2007_Sep_29_41(2)_106-114.nxml.txt.nlp	18193104	SENT61	24	24	21	21	misoprostol	VIII	PA450523	1351	0.844
NULL	Biomed_Res_Int_2014_Jan_29_2014_458592.nxml.txt.nlp	24592391	SENT172	8	8	13	13	curcumin	HO-1	PA151958596	3162	0.844
NULL	Expert_Rev_Mol_Med_2010_Apr_12_e12.nxml.txt.nlp	20398440	SENT348	0	0	7	7	geldanamycin	Hsp90	PA152031327	3320	0.844
NULL	Cancers_(Basel)_2013_Jun_24_5(3)_739-761.nxml.txt.nlp	24202319	SENT104	21	21	24	24	olaparib	PARP1		142	0.844
NULL	Leukemia_2014_Jun_25_28(6)_1280-1288.nxml.txt.nlp	24270737	SENT202	22	22	11	11	vorinostat	CTLA4	PA164748224	1493	0.844
NULL	Mol_Biol_Cell_2014_May_15_25(10)_1586-1593.nxml.txt.nlp	24623725	SENT109	18	18	12	12	doxycycline	MEK1	PA449415	5604	0.844
NULL	J_Cell_Biol_2003_Dec_22_163(6)_1385-1395.nxml.txt.nlp	14676308	SENT164	3	3	5	5	thrombin	p38	PA451674	10598;1432;7965	0.844
NULL	Oncotarget_2014_Nov_3_5(20)_10127-10139.nxml.txt.nlp	25333256	SENT201	7	7	2	2	vemurafenib	TRIM16	PA165946873	10626	0.844
NULL	FEBS_Open_Bio_2014_Jan_6_4_77-89.nxml.txt.nlp	24490132	SENT750	22	22	15	15	ebselen	NAC	PA161660841	22861	0.844
NULL	Cell_Commun_Signal_2014_Sep_25_12(1)_61.nxml.txt.nlp	NULL	SENT310	29	29	0	0	doxycycline	PC-3	PA449415	692094	0.844
NULL	Mol_Med_Rep_2015_Feb_29_11(2)_821-828.nxml.txt.nlp	25354708	SENT8	33	33	43	43	estradiol	OATP1B3	PA449503	28234	0.844
NULL	Oncoscience_2014_Mar_12_1(2)_158-166.nxml.txt.nlp	25594008	SENT31	19	19	12	12	dasatinib	ANXA1	PA162372878	301	0.844
NULL	J_Adv_Pract_Oncol_2014_Mar_1_Mar-Apr_5(2)_144-150.nxml.txt.nlp	25032048	SENT89	31	31	28	28	granisetron	GTS	PA449809	2973	0.844
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT396	0	0	9	9	trastuzumab	HER2	PA451743	2064	0.844
NULL	J_Thromb_Haemost_2014_May_22_12(5)_748-760.nxml.txt.nlp	24612393	SENT127	6	6	8	8	thrombin	TSC2	PA451674	7249	0.844
NULL	Chem_Res_Toxicol_2012_Aug_20_25(8)_1708-1719.nxml.txt.nlp	22793666	SENT511	22	22	8	8	abacavir	HLA-B	PA448004	3106	0.844
NULL	Int_J_Biol_Sci_2013_Dec_17_10(1)_64-72.nxml.txt.nlp	24391452	SENT120	30	30	33	33	verapamil	5-HT2A	PA451868	3356	0.844
NULL	J_Mol_Signal_2010_Jul_12_5_8.nxml.txt.nlp	20624308	SENT32	21	21	26	26	gefitinib	EGFR	PA131301952	1956	0.844
NULL	Mediators_Inflamm_2001_Oct_10(5)_253-258.nxml.txt.nlp	11759109	SENT9	8	8	6	6	ribavirin	IFN	PA451241	3439	0.844
NULL	Iran_J_Reprod_Med_2013_Oct_11(10)_791-800.nxml.txt.nlp	24639699	SENT99	4	4	16	16	cyclophosphamide	TDI	PA449165	100038246	0.844
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT440	10	10	1	1	quetiapine	PRL	PA451201	5617	0.844
NULL	Exp_Brain_Res_2014_Jun_27_232(8)_2637-2644.nxml.txt.nlp	24969614	SENT26	10	10	13	13	palonosetron	NK1	PA10352	11126	0.844
NULL	Int_J_Mol_Sci_2014_Mar_6_15(3)_4049-4059.nxml.txt.nlp	24663080	SENT28	4	4	7	7	dexmedetomidine	IL-6	PA449256	3569	0.844
NULL	ScientificWorldJournal_2012_Apr_1_2012_840421.nxml.txt.nlp	22566780	SENT126	2	2	12	12	ethanol	LPO	PA448073	4025	0.844
NULL	Breast_Cancer_Res_2007_Aug_8_9(4)_R50.nxml.txt.nlp	17686159	SENT13	5	5	23	23	trastuzumab	HRG	PA451743	3084;3273	0.844
NULL	Exp_Ther_Med_2013_Jan_10_5(1)_287-291.nxml.txt.nlp	23251285	SENT128	14	14	28	28	aspirin	APS	PA448497	10603	0.844
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT170	25	25	8	8	lapatinib	HER2	PA152241907	2064	0.844
NULL	EURASIP_J_Bioinform_Syst_Biol_2012_Oct_26_2012(1)_17.nxml.txt.nlp	23102048	SENT144	29	29	24	24	vasopressin	ACTH	PA451858	5443	0.844
NULL	Oncotarget_2014_Oct_18_5(22)_11641-11652.nxml.txt.nlp	25361002	SENT76	13	13	18	18	cisplatin	NAC	PA449014	22861	0.844
NULL	Nat_Commun_2013_Apr_30_4_1792.nxml.txt.nlp	23653204	SENT297	6	6	3	3	hydrocortisone	CYP3A4	PA449905	1576	0.844
NULL	Mol_Cancer_2006_Oct_17_5_45.nxml.txt.nlp	17044934	SENT87	43	43	22	22	resveratrol	COX		1351	0.844
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S279-S284.nxml.txt.nlp	21525469	SENT7	9	9	4	4	exenatide	GLP-1	PA164749238	100125288	0.844
NULL	Open_AIDS_J_2014_Dec_29_8_66-78.nxml.txt.nlp	25624956	SENT413	5	5	14	14	chloroquine	DC-SIGN	PA448948	30835	0.844
NULL	Trials_2012_May_30_13_74.nxml.txt.nlp	22647439	SENT120	4	4	17	17	fentanyl	ANOVA	PA449599	4858	0.844
NULL	Eur_J_Clin_Pharmacol_2011_Dec_23_67(12)_1231-1241.nxml.txt.nlp	21698374	SENT177	16	16	13	13	tacrolimus	CYP3A5	PA451578	1577	0.844
NULL	Cancer_Cell_Int_2013_Feb_14_13_16.nxml.txt.nlp	23409704	SENT91	0	0	25	25	pp2	LOX		4015	0.844
NULL	Nat_Med_2013_Mar_10_19(3)_313-321.nxml.txt.nlp	23396211	SENT143	22	22	7	7	amlexanox	TBK1	PA164745310	29110	0.844
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT183	13	13	19	19	metformin	HIF-1	PA450395	29072	0.844
NULL	Mol_Vis_2007_Jul_9_13_1073-1082.nxml.txt.nlp	17653052	SENT44	0	0	34	34	minocycline	P28	PA450519	9446;7802;9527	0.844
NULL	Breast_Cancer_Res_2011_Jun_21_13(3)_R66.nxml.txt.nlp	21693010	SENT44	0	0	10	10	sunitinib	VEGFR	PA162372840	3791	0.844
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT170	16	16	7	7	phenprocoumon	VKORC1	PA450921	79001	0.844
NULL	Clin_Psychopharmacol_Neurosci_2011_Apr_30_9(1)_36-43.nxml.txt.nlp	23431025	SENT125	12	12	31	31	haloperidol	CA3	PA449841	761	0.844
NULL	Evid_Based_Complement_Alternat_Med_2013_Aug_22_2013_423164.nxml.txt.nlp	24027594	SENT242	0	0	22	22	berberine	AP-1	PA165860812	2353;3727;2354;3725	0.844
NULL	Leukemia_2013_Jan_11_27(1)_32-40.nxml.txt.nlp	22781593	SENT192	5	5	7	7	ponatinib	FGFR1	PA165980594	2260	0.844
NULL	Br_J_Cancer_2010_Sep_7_103(6)_765-771.nxml.txt.nlp	20700120	SENT126	25	25	22	22	tamoxifen	CYP2D6	PA451581	1565	0.844
NULL	Ann_Hematol_2010_Nov_25_89(11)_1115-1124.nxml.txt.nlp	20499237	SENT103	14	14	2	2	simvastatin	BAX	PA451363	581	0.844
NULL	Braz_J_Med_Biol_Res_2014_Jan_10_47(1)_60-69.nxml.txt.nlp	24519092	SENT159	7	7	0	0	doxorubicin	YWHAZ	PA449412	7534	0.844
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_19_2012_967573.nxml.txt.nlp	23304232	SENT117	25	25	15	15	indomethacin	MSU	PA449982	593	0.844
NULL	J_Korean_Med_Sci_2007_Jun_30_22(3)_577-579.nxml.txt.nlp	17596676	SENT47	0	0	14	14	clopidogrel	ADP	PA449053	23038	0.844
NULL	Biol_Open_2014_May_2_3(6)_418-430.nxml.txt.nlp	24795145	SENT127	6	6	33	33	etoposide	HDAC6	PA449552	10013	0.844
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_P104.nxml.txt.nlp	NULL	SENT18	10	10	1	1	ritonavir	DPT	PA451260	1805	0.844
NULL	Int_J_Environ_Res_Public_Health_2010_Apr_30_7(4)_1448-1466.nxml.txt.nlp	20617039	SENT359	14	14	4	4	ethanol	NR1	PA448073	27158	0.844
NULL	Br_J_Cancer_2012_Sep_4_107(6)_947-955.nxml.txt.nlp	22892392	SENT118	6	6	9	9	lapatinib	ERBB2	PA152241907	2064	0.844
NULL	Front_Synaptic_Neurosci_2010_Jul_1_2_15.nxml.txt.nlp	21423501	SENT76	25	25	22	22	cyclothiazide	HMBS	PA449168	3145	0.844
NULL	Breast_Cancer_Res_2011_Jan_17_13(1)_R5.nxml.txt.nlp	21241485	SENT201	9	9	0	0	estradiol	Brn-3b	PA449503	5458	0.844
NULL	J_Biol_Chem_2009_Jul_31_284(31)_20556-20561.nxml.txt.nlp	19473966	SENT155	24	24	3	3	hemin	HO-2	PA449849	3163	0.844
NULL	Mol_Biol_Rep_2013_Sep_28_40(10)_5573-5585.nxml.txt.nlp	24078156	SENT48	22	22	9	9	iron	DMT1	PA450087	4891;1761	0.844
NULL	Breast_Cancer_Res_2007_Jan_23_9(1)_R7.nxml.txt.nlp	17244352	SENT201	19	19	3	3	tamoxifen	CYP2D6	PA451581	1565	0.844
NULL	Trials_2013_May_4_14_125.nxml.txt.nlp	23782591	SENT208	13	13	17	17	donepezil	CYP2D6	PA449394	1565	0.844
NULL	Arthritis_Res_Ther_2007_Oct_31_9(5)_221.nxml.txt.nlp	18001502	SENT215	0	0	7	7	clodronate	MT1-MMP	PA10239	4323	0.844
NULL	Brain_Behav_2011_Sep_1(1)_44-54.nxml.txt.nlp	22398980	SENT221	28	28	3	3	verapamil	LSD	PA451868	1776	0.844
NULL	Biologics_2010_Aug_9_4_173-185.nxml.txt.nlp	20714355	SENT218	24	24	16	16	cetuximab	EGFR	PA10040	1956	0.844
NULL	Int_J_Mol_Sci_2014_Jun_18_15(6)_11013-11029.nxml.txt.nlp	24945311	SENT138	17	17	9	9	celecoxib	STAT3	PA448871	6774	0.844
NULL	Br_J_Cancer_2013_Dec_10_109(12)_3034-3041.nxml.txt.nlp	24178758	SENT142	29	29	7	7	tamoxifen	CHOP	PA451581	1649	0.844
NULL	Crit_Rev_Toxicol_2013_Mar_13_43(3)_200-219.nxml.txt.nlp	23405971	SENT165	11	11	3	3	estradiol	BBP	PA449503	83941	0.844
NULL	J_Gen_Physiol_2000_Dec_1_116(6)_769-780.nxml.txt.nlp	11099346	SENT136	17	17	3	3	tetracaine	DAG	PA451638	1605	0.844
NULL	Biomed_Res_Int_2014_Jun_3_2014_656370.nxml.txt.nlp	24995318	SENT87	13	13	29	29	risperidone	FGA	PA451257	2243	0.844
NULL	Acta_Pharmacol_Sin_2010_Jan_5_31(1)_81-92.nxml.txt.nlp	20048747	SENT268	21	21	0	0	resveratrol	NAC		22861	0.844
NULL	Gastric_Cancer_2013_Jul_12_16(3)_345-354.nxml.txt.nlp	22968820	SENT205	26	26	8	8	oxaliplatin	FANCJ	PA131285527	83990	0.844
NULL	Br_J_Cancer_2009_Sep_15_101(6)_957-966.nxml.txt.nlp	19738618	SENT210	9	9	2	2	dexrazoxane	ANOVA	PA449259	4858	0.844
NULL	Br_J_Cancer_2012_Jan_3_106(1)_107-115.nxml.txt.nlp	22116303	SENT108	19	19	14	14	vorinostat	AKT	PA164748224	207	0.844
NULL	Indian_J_Urol_2009_Oct-Dec_25(4)_427-436.nxml.txt.nlp	19955664	SENT106	29	29	18	18	erlotinib	VEGFR	PA134687924	3791	0.844
NULL	Cardiovasc_Diabetol_2013_Oct_17_12_150.nxml.txt.nlp	24134550	SENT116	6	6	11	11	pioglitazone	activin	PA450970	83729	0.844
NULL	FEBS_Open_Bio_2014_Aug_30_4_763-776.nxml.txt.nlp	25349781	SENT211	23	23	15	15	curcumin	NAC	PA151958596	22861	0.844
NULL	Case_Rep_Pulmonol_2012_Aug_23_2012_257827.nxml.txt.nlp	22957291	SENT30	14	14	9	9	gefitinib	EGFR	PA131301952	1956	0.844
NULL	Oncotarget_2012_Jul_13_3(6)_601-607.nxml.txt.nlp	22802145	SENT33	3	3	18	18	doxorubicin	p53	PA449412	7157	0.844
NULL	Exp_Ther_Med_2014_Sep_23_8(3)_893-898.nxml.txt.nlp	25120620	SENT28	5	5	2	2	geldanamycin	Hsp90	PA152031327	3320	0.844
NULL	EMBO_Mol_Med_2012_Jun_13_4(6)_515-527.nxml.txt.nlp	22416035	SENT209	11	11	17	17	doxorubicin	p53	PA449412	7157	0.844
NULL	Cancers_(Basel)_2010_Jan_14_2(1)_1-19.nxml.txt.nlp	24281029	SENT1001	11	11	26	26	paclitaxel	San	PA450761	80218	0.844
NULL	Breast_Cancer_Res_Treat_2014_Sep_13_147(3)_631-638.nxml.txt.nlp	25216762	SENT2	0	0	9	9	lapatinib	HER-2	PA152241907	2064	0.844
NULL	Drugs_R_D_2014_Jun_2_14(2)_63-71.nxml.txt.nlp	24691742	SENT24	10	10	3	3	moxifloxacin	E14	PA450555	4863	0.844
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Feb_17_66(Pt_3)_o641-o642.nxml.txt.nlp	21580396	SENT79	42	42	19	19	ethanol	mol	PA448073	90527	0.844
NULL	J_Gynecol_Oncol_2012_Jan_9_23(1)_35-42.nxml.txt.nlp	22355465	SENT107	4	4	11	11	cisplatin	CDK1	PA449014	983	0.844
NULL	Diabetes_2009_Apr_9_58(4)_965-974.nxml.txt.nlp	19136651	SENT121	10	10	24	24	nadh	NQO1	PA164755085	1728	0.844
NULL	Cancer_Microenviron_2009_Sep_26_2(Suppl_1)_19-204.nxml.txt.nlp	NULL	SENT6591	0	0	8	8	docetaxel	CD147	PA449383	682	0.844
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT930	9	9	33	33	doxorubicin	MDR1	PA449412	5243	0.844
NULL	Cancer_Cell_2007_Dec_11_12(6)_514-527.nxml.txt.nlp	18068629	SENT180	13	13	7	7	paclitaxel	TGFBI	PA450761	7045	0.844
NULL	Diabetes_Care_2013_May_13_36(5)_1074-1082.nxml.txt.nlp	23275352	SENT183	4	4	8	8	liraglutide	ZAG	PA165958364	563	0.844
NULL	Oncotarget_2013_Nov_23_5(1)_196-210.nxml.txt.nlp	24344116	SENT181	22	22	14	14	doxorubicin	p53	PA449412	7157	0.844
NULL	J_Cell_Biol_2001_Apr_2_153(1)_207-220.nxml.txt.nlp	11285286	SENT172	10	10	7	7	carbachol	CD69	PA448784	969	0.844
NULL	Breast_Cancer_Res_2007_Jul_5_9(4)_R41.nxml.txt.nlp	17612393	SENT160	18	18	0	0	celecoxib	Bcl-2	PA448871	596	0.844
NULL	Core_Evid_2011_Feb_8_6_23-29.nxml.txt.nlp	21468240	SENT107	4	4	20	20	plerixafor	CD34	PA165958410	947	0.844
NULL	Neural_Plast_2007_Oct_10_2007_23250.nxml.txt.nlp	NULL	SENT163	27	27	13	13	citalopram	TPH1	PA449015	7166	0.844
NULL	Indian_J_Pharmacol_2013_Mar-Apr_45(2)_195-196.nxml.txt.nlp	23716902	SENT13	10	10	5	5	aripiprazole	EOS	PA10026	260429	0.844
NULL	Oncotarget_2010_May_27_1(2)_89-103.nxml.txt.nlp	20671809	SENT214	27	27	15	15	perifosine	PDK1	PA165291471	5170;5163	0.844
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1717-1723.nxml.txt.nlp	19844230	SENT130	10	10	19	19	pazopanib	GM-CSF	PA165291492	1437	0.844
NULL	Chin_J_Cancer_2012_Oct_31(10)_476-483.nxml.txt.nlp	22692073	SENT140	17	17	7	7	cisplatin	RRM1	PA449014	6240	0.844
NULL	Cancer_Biol_Med_2013_Dec_10(4)_192-205.nxml.txt.nlp	24349829	SENT309	21	21	15	15	cetuximab	PIK3CA	PA10040	5290	0.844
NULL	J_Inflamm_(Lond)_2008_Jul_29_5_11.nxml.txt.nlp	18664275	SENT37	15	15	18	18	ciprofloxacin	IL-8	PA449009	3576	0.844
NULL	Int_J_Med_Sci_2012_Nov_7_9(10)_881-893.nxml.txt.nlp	23155362	SENT28	10	10	13	13	fulvestrant	aromatase	PA164747170	1588	0.844
NULL	Nat_Commun_2014_Dec_19_5_5812.nxml.txt.nlp	25524025	SENT99	19	19	9	9	doxorubicin	p53	PA449412	7157	0.844
NULL	Br_J_Clin_Pharmacol_2013_Feb_3_75(2)_524-537.nxml.txt.nlp	22759078	SENT36	2	2	15	15	artemisinin	ACT	PA165111696	12;11332;9457;641455	0.844
NULL	Case_Rep_Endocrinol_2014_Feb_10_2014_479641.nxml.txt.nlp	24660072	SENT114	36	36	3	3	cinacalcet	PTH	PA164776671	5741	0.844
NULL	Nucleic_Acids_Res_2013_Apr_17_41(7)_4129-4143.nxml.txt.nlp	23420868	SENT281	17	17	6	6	hemin	SHP2	PA449849	5781	0.844
NULL	Int_J_Mol_Cell_Med_2012_Winter_1(1)_30-38.nxml.txt.nlp	24551756	SENT145	15	15	7	7	iron	14-3-3	PA450087	10971	0.844
NULL	Drug_Healthc_Patient_Saf_2012_Nov_29_4_173-180.nxml.txt.nlp	23236256	SENT66	43	43	22	22	risperidone	FGA	PA451257	2243	0.844
NULL	Oncotarget_2013_May_1_4(5)_705-714.nxml.txt.nlp	23670029	SENT155	18	18	20	20	bevacizumab	p53	PA130232992	7157	0.844
NULL	Adv_Pharmacol_Sci_2013_Nov_26_2013_423750.nxml.txt.nlp	24371437	SENT153	18	18	5	5	lipase	flower	PA450239	11094	0.844
NULL	Evid_Based_Complement_Alternat_Med_2013_Aug_12_2013_982689.nxml.txt.nlp	23997806	SENT223	32	32	23	23	tolbutamide	APE	PA451718	55704;328	0.844
NULL	Clin_Ophthalmol_2012_Jul_12_6_1063-1071.nxml.txt.nlp	22888204	SENT139	29	29	16	16	thyroglobulin	GPC	PA164754910	2995	0.844
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Apr_7_9_12.nxml.txt.nlp	20374640	SENT48	22	22	41	41	tetracycline	BSAC	PA451640	57591	0.844
NULL	Am_J_Case_Rep_2012_Jun_5_13_96-98.nxml.txt.nlp	23569499	SENT41	9	9	4	4	daunorubicin	CHOP	PA449212	1649	0.844
NULL	J_Biomed_Biotechnol_2011_Feb_23_2011_631268.nxml.txt.nlp	21528007	SENT32	38	38	31	31	fluorescein	TP53	PA164746009	7157	0.844
NULL	Virol_J_2011_Nov_28_8_523.nxml.txt.nlp	22122911	SENT6	25	25	36	36	heparin	DARC	PA449855	2532	0.844
NULL	Breast_Cancer_Res_2011_Apr_14_13(2)_R43.nxml.txt.nlp	21492444	SENT35	28	28	20	20	tamoxifen	HER3	PA451581	2065	0.844
NULL	Eur_J_Endocrinol_2013_Feb_168(2)_K19-K26.nxml.txt.nlp	23132696	SENT164	37	37	21	21	hydrocortisone	HSD1	PA449905	26871	0.844
NULL	Diabetes_Care_2013_Aug_17_36(Suppl_2)_S180-S189.nxml.txt.nlp	23882044	SENT141	32	32	15	15	metformin	GLP-1	PA450395	100125288	0.844
NULL	Int_J_Mol_Sci_2014_May_8_15(5)_8106-8121.nxml.txt.nlp	24815071	SENT58	10	10	16	16	atorvastatin	LC3	PA448500	84557	0.844
NULL	J_Cell_Mol_Med_2014_Oct_11_18(10)_2031-2043.nxml.txt.nlp	25109475	SENT149	3	3	7	7	valsartan	LKB1	PA451848	6794	0.844
NULL	J_Carcinog_2013_Dec_31_12_22.nxml.txt.nlp	24574860	SENT6	18	18	21	21	afatinib	EGFR	PA165981154	1956	0.844
NULL	Neural_Plast_2012_May_20_2012_124548.nxml.txt.nlp	22685676	SENT59	2	2	12	12	minocycline	FMR1	PA450519	2332	0.844
NULL	Br_J_Cancer_2010_Jan_5_102(1)_80-86.nxml.txt.nlp	19920817	SENT7	14	14	16	16	bevacizumab	IFN	PA130232992	3439	0.844
NULL	Oncol_Lett_2014_Nov_11_8(5)_2103-2109.nxml.txt.nlp	25295098	SENT113	24	24	10	10	docetaxel	P-gp	PA449383	5243	0.844
NULL	J_Cell_Mol_Med_2014_Oct_11_18(10)_2031-2043.nxml.txt.nlp	25109475	SENT232	3	3	16	16	valsartan	TLR-4	PA451848	7099	0.844
NULL	Oncogene_2013_Sep_26_32(39)_10_1038_onc_2012_491.nxml.txt.nlp	23108394	SENT47	10	10	2	2	epirubicin	FOXM1	PA449476	2305	0.844
NULL	Acta_Pharmacol_Sin_2010_Nov_18_31(11)_1447-1453.nxml.txt.nlp	20953204	SENT85	9	9	15	15	rimonabant	IL-6	PA152407999	3569	0.844
NULL	Indian_J_Pharmacol_2014_Jan-Feb_46(1)_3-12.nxml.txt.nlp	24550577	SENT173	3	3	11	11	vismodegib	SMO		6608;54498	0.844
NULL	Ann_Neurosci_2011_Apr_18(2)_48-55.nxml.txt.nlp	25205921	SENT138	20	20	1	1	forskolin	SOD1	PA146096022	6647	0.844
NULL	Antiinflamm_Antiallergy_Agents_Med_Chem_2011_Oct_10(5)_327-338.nxml.txt.nlp	NULL	SENT202	6	6	24	24	hydrocortisone	IFN	PA449905	3439	0.844
NULL	J_Immunother_Cancer_2014_Jul_15_2_24.nxml.txt.nlp	25089198	SENT79	7	7	4	4	vemurafenib	BRAF	PA165946873	673	0.844
NULL	Jpn_Clin_Med_2014_Sep_17_5_33-41.nxml.txt.nlp	25288908	SENT23	8	8	14	14	liraglutide	GLP-1	PA165958364	100125288	0.844
NULL	Biologics_2012_Jan_5_6_13-20.nxml.txt.nlp	22291463	SENT126	11	11	18	18	pertuzumab	HER2		2064	0.844
NULL	Cancers_(Basel)_2012_Oct_12_4(4)_989-1035.nxml.txt.nlp	24213498	SENT435	3	3	15	15	gemcitabine	CD44	PA449748	960	0.844
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Nov_18_65(Pt_12)_o3103.nxml.txt.nlp	21578830	SENT66	43	43	6	6	ethanol	mol	PA448073	90527	0.844
NULL	ChemistryOpen_2014_Jun_18_3(3)_115-123.nxml.txt.nlp	25050230	SENT266	32	32	21	21	heparin	mol	PA449855	90527	0.844
NULL	Protein_J_2012_Aug_5_31(6)_511-518.nxml.txt.nlp	22763563	SENT32	13	13	25	25	atorvastatin	MSR1	PA448500	4481	0.844
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1013.nxml.txt.nlp	24457957	SENT119	18	18	13	13	bortezomib	NOXA	PA10252	5366	0.844
NULL	Front_Endocrinol_(Lausanne)_2014_Aug_27_5_140.nxml.txt.nlp	25221543	SENT36	0	0	16	16	liraglutide	GLP-1	PA165958364	100125288	0.844
NULL	Biomed_Res_Int_2014_Jan_29_2014_831845.nxml.txt.nlp	24605337	SENT137	5	5	24	24	bupivacaine	S6K1	PA135057240	6198	0.843
NULL	Mol_Cancer_2010_Aug_23_9_222.nxml.txt.nlp	20731837	SENT207	9	9	12	12	gefitinib	ATM	PA131301952	472	0.843
NULL	Theranostics_2014_Aug_15_4(11)_1072-1084.nxml.txt.nlp	25250092	SENT190	9	9	12	12	panitumumab	EGFR	PA162373091	1956	0.843
NULL	Springerplus_2013_Dec_6_2_658.nxml.txt.nlp	24349960	SENT88	8	8	19	19	heparin	OPG	PA449855	690	0.843
NULL	Mol_Cancer_2012_Sep_28_11_74.nxml.txt.nlp	23021083	SENT213	23	23	25	25	gemcitabine	PI3K	PA449748	5290	0.843
NULL	Clinics_(Sao_Paulo)_2013_May_68(5)_694-701.nxml.txt.nlp	23778405	SENT137	5	5	25	25	curcumin	MDR1	PA151958596	5243	0.843
NULL	Oncotarget_2013_Mar_26_4(3)_397-412.nxml.txt.nlp	23651630	SENT201	19	19	25	25	capecitabine	HER2	PA448771	2064	0.843
NULL	Acta_Pharmacol_Sin_2009_Jul_22_30(7)_956-964.nxml.txt.nlp	19543298	SENT5	7	7	20	20	atorvastatin	ABCC2	PA448500	1244	0.843
NULL	Cancer_Med_2014_Aug_16_3(4)_775-786.nxml.txt.nlp	24737784	SENT120	11	11	14	14	warfarin	mol	PA451906	90527	0.843
NULL	Exp_Mol_Med_2012_Nov_30_44(11)_665-673.nxml.txt.nlp	23114424	SENT73	20	20	6	6	taurine	adiponectin	PA451590	9370	0.843
NULL	Evid_Based_Complement_Alternat_Med_2011_Jan_9_2011_619650.nxml.txt.nlp	21799685	SENT142	3	3	32	32	ketanserin	5-HT2A	PA131053734	3356	0.843
NULL	Case_Rep_Rheumatol_2013_Jan_22_2013_175261.nxml.txt.nlp	23401835	SENT42	38	38	14	14	lipase	B12	PA450239	7126;4709	0.843
NULL	Cancer_Cell_Int_2012_Jul_4_12_19.nxml.txt.nlp	22631225	SENT304	5	5	7	7	heparin	PPIA	PA449855	5478	0.843
NULL	Stroke_Res_Treat_2011_Nov_10_2011_212485.nxml.txt.nlp	22135769	SENT120	5	5	33	33	warfarin	GGCX	PA451906	2677	0.843
NULL	Aging_(Albany_NY)_2012_Jul_22_4(7)_480-498.nxml.txt.nlp	22837425	SENT118	5	5	30	30	metformin	ADP	PA450395	23038	0.843
NULL	Eur_J_Neurosci_2008_Apr_1_27(7)_1722-1730.nxml.txt.nlp	18380669	SENT165	20	20	5	5	sr144528	CB2		1269	0.843
NULL	Cancer_Growth_Metastasis_2013_Nov_27_6_61-80.nxml.txt.nlp	24665208	SENT283	0	0	11	11	sunitinib	VEGFR	PA162372840	3791	0.843
NULL	Anesth_Pain_Med_2014_Jun_17_4(3)_e16316.nxml.txt.nlp	25237633	SENT143	11	11	16	16	aprotinin	CD11b	PA448472	3684	0.843
NULL	Diabetes_Care_2010_Jul_31_33(7)_1544-1548.nxml.txt.nlp	20357370	SENT103	11	11	0	0	metformin	AMPK	PA450395	5563	0.843
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1224-1233.nxml.txt.nlp	22353810	SENT165	33	33	29	29	etoposide	MRP-1	PA449552	928	0.843
NULL	Nature_2008_Oct_23_455(7216)_1076-1081.nxml.txt.nlp	18948948	SENT229	8	8	4	4	staurosporine	BAX	PA165109623	581	0.843
NULL	Med_Sci_Monit_2013_Feb_7_19_95-101.nxml.txt.nlp	23396358	SENT118	7	7	23	23	glucose	FDG	PA449773	23583	0.843
NULL	Front_Oncol_2013_Sep_23_3_250.nxml.txt.nlp	24069582	SENT114	8	8	22	22	exemestane	aromatase	PA449563	1588	0.843
NULL	Cancers_(Basel)_2014_Nov_6_6(4)_2243-2258.nxml.txt.nlp	25383481	SENT384	12	12	3	3	auranofin	TRPA1	PA448510	8989	0.843
NULL	Biomed_Res_Int_2014_Jan_27_2014_696107.nxml.txt.nlp	24587987	SENT43	39	39	2	2	ebselen	NAC	PA161660841	22861	0.843
NULL	Breast_Cancer_Res_2006_Nov_6_8(6)_215.nxml.txt.nlp	17096862	SENT67	18	18	7	7	trastuzumab	PTEN	PA451743	5728	0.843
NULL	Chemother_Res_Pract_2011_Dec_1_2011_715469.nxml.txt.nlp	22312557	SENT98	4	4	8	8	cisplatin	p53	PA449014	7157	0.843
NULL	Iran_J_Pharm_Res_2014_Spring_13(2)_683-693.nxml.txt.nlp	25237365	SENT9	8	8	18	18	tranilast	CXCR4	PA131890628	7852	0.843
NULL	Arch_Med_Sci_2012_Sep_8_8(4)_589-597.nxml.txt.nlp	23056066	SENT124	0	0	10	10	pitrakinra	IL-13	PA165983754	3596	0.843
NULL	Breast_Cancer_Res_2006_Nov_6_8(6)_215.nxml.txt.nlp	17096862	SENT95	15	15	12	12	trastuzumab	HER2	PA451743	2064	0.843
NULL	J_Oncol_2012_Feb_6_2012_737981.nxml.txt.nlp	22481932	SENT101	16	16	5	5	cisplatin	IL-6	PA449014	3569	0.843
NULL	Br_J_Pharmacol_2010_Mar_8_159(5)_1092-1105.nxml.txt.nlp	20148890	SENT323	6	6	3	3	montelukast	CysLT1	PA450546	10800	0.843
NULL	J_Cell_Biol_2008_Jul_14_182(1)_197-213.nxml.txt.nlp	18625847	SENT365	8	8	13	13	nutlin-3	p53		7157	0.843
NULL	Mar_Drugs_2011_Nov_2_9(11)_2188-2200.nxml.txt.nlp	22163181	SENT465	30	30	18	18	glibenclamide	PAG	PA449782	55824	0.843
NULL	Clin_Dev_Immunol_2011_Dec_26_2011_890758.nxml.txt.nlp	22235224	SENT146	22	22	3	3	trastuzumab	HER2	PA451743	2064	0.843
NULL	Exp_Hematol_Oncol_2013_Jan_10_2_2.nxml.txt.nlp	23305345	SENT139	7	7	20	20	rituximab	BTZ	PA451261	22794	0.843
NULL	J_Skin_Cancer_2011_Nov_17_2011_423239.nxml.txt.nlp	22175026	SENT141	23	23	30	30	paclitaxel	BRAF	PA450761	673	0.843
NULL	Ann_Med_2011_Nov_5_43(7)_531-544.nxml.txt.nlp	21815879	SENT39	15	15	5	5	thrombin	PAR-1	PA451674	2011;2149	0.843
NULL	Case_Rep_Hematol_2013_Aug_31_2013_687260.nxml.txt.nlp	24073345	SENT32	8	8	17	17	cyclophosphamide	CHOP	PA449165	1649	0.843
NULL	Br_J_Cancer_2010_Feb_2_102(3)_520-529.nxml.txt.nlp	20029417	SENT146	20	20	24	24	trastuzumab	IL-21	PA451743	59067;50616;27189	0.843
NULL	Mar_Drugs_2010_Nov_29_8(12)_2871-2892.nxml.txt.nlp	21339954	SENT131	29	29	7	7	dextran	CD4	PA449261	920	0.843
NULL	Breast_Cancer_Res_2013_Oct_18_15(5)_R97.nxml.txt.nlp	24135425	SENT92	6	6	16	16	letrozole	PIK3CA	PA450196	5290	0.843
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT94	29	29	8	8	trastuzumab	HER2	PA451743	2064	0.843
NULL	Oncotarget_2014_Oct_23_5(22)_11154-11167.nxml.txt.nlp	25525888	SENT180	32	32	14	14	bevacizumab	VEGFR	PA130232992	3791	0.843
NULL	Oncotarget_2013_Apr_10_4(4)_622-635.nxml.txt.nlp	23599172	SENT9	17	17	27	27	lapatinib	EGF	PA152241907	1950	0.843
NULL	Pharmaceutics_2011_Jul_13_3(3)_425-439.nxml.txt.nlp	24310588	SENT15	17	17	32	32	hydrocodone	OTC	PA449900	5009	0.843
NULL	Endocrine_2012_Dec_14_42(3)_622-636.nxml.txt.nlp	22695986	SENT220	34	34	28	28	forskolin	ADRP	PA146096022	123	0.843
NULL	J_Inherit_Metab_Dis_2011_Apr_29_34(2)_315-325.nxml.txt.nlp	20668944	SENT213	15	15	19	19	resveratrol	SIRT1		23411	0.843
NULL	Anesth_Pain_Med_2014_Feb_13_4(1)_e16222.nxml.txt.nlp	24701420	SENT337	9	9	3	3	drotaverine	Tech	PA165958398	57449	0.843
NULL	Mol_Cancer_2014_Jun_4_13_141.nxml.txt.nlp	24894453	SENT22	30	30	1	1	panitumumab	EGFR	PA162373091	1956	0.843
NULL	Nat_Biotechnol_2013_Jul_30_31(7)_630-637.nxml.txt.nlp	23811600	SENT213	19	19	11	11	crizotinib	MIB1	PA165946122	57534	0.843
NULL	Oncol_Lett_2013_Dec_4_6(6)_1665-1672.nxml.txt.nlp	24273604	SENT11	9	9	44	44	chloroquine	TLR9	PA448948	54106	0.843
NULL	Onco_Targets_Ther_2014_May_28_7_841-852.nxml.txt.nlp	24920926	SENT141	3	3	8	8	gefitinib	EGFR	PA131301952	1956	0.843
NULL	Cancer_Cell_2013_Aug_12_24(2)_229-241.nxml.txt.nlp	23871637	SENT583	6	6	0	0	bevacizumab	U87	PA130232992	677775;641648	0.843
NULL	Front_Neurosci_2012_May_30_6_77.nxml.txt.nlp	22661925	SENT305	13	13	8	8	ethanol	HEC	PA448073	10403	0.843
NULL	F1000Res_2013_Mar_5_2_74.nxml.txt.nlp	24358880	SENT271	4	4	19	19	benzaldehyde	TRPV1	PA448571	7442	0.843
NULL	Patient_Prefer_Adherence_2008_Feb_2_2_387-392.nxml.txt.nlp	19920986	SENT113	11	11	14	14	azathioprine	TPMT	PA448515	7172	0.843
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT103	4	4	19	19	neratinib	HER2	PA165291472	2064	0.843
NULL	Biomed_Res_Int_2013_Jul_15_2013_458571.nxml.txt.nlp	23956983	SENT131	19	19	32	32	l-serine	PLP	PA451330	25824;5744	0.843
NULL	Clin_Med_Insights_Oncol_2011_May_10_5_131-144.nxml.txt.nlp	21695100	SENT160	20	20	6	6	gefitinib	EGFR	PA131301952	1956	0.843
NULL	Int_J_Alzheimers_Dis_2010_Dec_27_2011_231595.nxml.txt.nlp	21234401	SENT106	4	4	26	26	iron	APP	PA450087	351	0.843
NULL	J_Cardiothorac_Surg_2010_Apr_19_5_26.nxml.txt.nlp	20403156	SENT153	14	14	6	6	etomidate	RAI	PA164743987	10848;6050	0.843
NULL	Mol_Cancer_2010_Aug_25_9_225.nxml.txt.nlp	20738848	SENT263	32	32	15	15	staurosporine	IL3	PA165109623	3562	0.843
NULL	Cancers_(Basel)_2010_Nov_29_2(4)_2026-2043.nxml.txt.nlp	24281216	SENT808	1	1	3	3	bortezomib	PKR	PA10252	5610	0.843
NULL	Toxins_(Basel)_2010_Oct_26_2(11)_2490-2518.nxml.txt.nlp	22069563	SENT195	8	8	2	2	cisplatin	IFN	PA449014	3439	0.843
NULL	Endocrinol_Metab_(Seoul)_2014_Mar_14_29(1)_33-39.nxml.txt.nlp	24741452	SENT13	4	4	23	23	thyroglobulin	WBS	PA164754910	2006	0.843
NULL	Oncoimmunology_2013_Dec_1_2(12)_e27215.nxml.txt.nlp	24501692	SENT32	31	31	34	34	panitumumab	EGFR	PA162373091	1956	0.843
NULL	J_Radiat_Res_2014_Nov_16_55(6)_1171-1177.nxml.txt.nlp	25129557	SENT48	23	23	30	30	capecitabine	LARC	PA448771	6364	0.843
NULL	J_Immunother_Cancer_2014_Jan_27_2_2.nxml.txt.nlp	24829759	SENT139	12	12	4	4	sorafenib	IL-21	PA7000	59067;50616;27189	0.843
NULL	Biomed_Res_Int_2013_Jan_21_2013_581631.nxml.txt.nlp	23484133	SENT73	6	6	14	14	infliximab	IFN	PA452639	3439	0.843
NULL	Lab_Invest_2011_Apr_14_91(4)_598-608.nxml.txt.nlp	21321535	SENT131	0	0	8	8	sorafenib	CD11b	PA7000	3684	0.843
NULL	Indian_J_Nephrol_2011_Jan-Mar_21(1)_56-58.nxml.txt.nlp	21655173	SENT58	29	29	27	27	cyclophosphamide	CHOP	PA449165	1649	0.843
NULL	Ther_Clin_Risk_Manag_2007_Jun_3(2)_259-268.nxml.txt.nlp	18360634	SENT73	10	10	16	16	natalizumab	DMT	PA164747191	2039	0.843
NULL	Acta_Pharmacol_Sin_2012_Jul_18_33(7)_861-872.nxml.txt.nlp	22705730	SENT15	2	2	11	11	atorvastatin	4E-BP1	PA448500	1978	0.843
NULL	Arthritis_Res_Ther_2013_Sep_16_15(5)_R120.nxml.txt.nlp	24286160	SENT162	2	2	9	9	propylthiouracil	RHO	PA451156	6010	0.843
NULL	Evid_Based_Complement_Alternat_Med_2013_Aug_22_2013_423164.nxml.txt.nlp	24027594	SENT238	16	16	21	21	berberine	AP-1	PA165860812	2353;3727;2354;3725	0.843
NULL	Arch_Drug_Inf_2008_Sep_1(2)_56-62.nxml.txt.nlp	19915709	SENT63	1	1	29	29	fentanyl	API	PA449599	5345	0.843
NULL	Oncotarget_2014_Jun_3_5(13)_4920-4928.nxml.txt.nlp	24952482	SENT11	0	0	16	16	crizotinib	ROS1	PA165946122	6098	0.843
NULL	Exp_Diabetes_Res_2011_Jun_4_2011_489708.nxml.txt.nlp	21747829	SENT9	5	5	15	15	aliskiren	GLP-1	PA143487910	100125288	0.843
NULL	Front_Oncol_2013_Sep_17_3_221.nxml.txt.nlp	24062980	SENT62	32	32	24	24	gemcitabine	EGFR	PA449748	1956	0.843
NULL	Ann_Oncol_2013_Aug_12_24(8)_1994-1999.nxml.txt.nlp	23670096	SENT155	24	24	20	20	tamoxifen	HER2	PA451581	2064	0.843
NULL	Oncotarget_2014_Jun_30_5(12)_4011-4025.nxml.txt.nlp	24994117	SENT105	10	10	2	2	estradiol	AREG	PA449503	374	0.843
NULL	Adv_Hematol_2012_Sep_14_2012_524308.nxml.txt.nlp	21941553	SENT247	18	18	10	10	fludarabine	BCL2	PA449655	596	0.843
NULL	Front_Immunol_2012_May_8_3_104.nxml.txt.nlp	22586429	SENT82	23	23	1	1	fluorescein	spatial	PA164746009	219793	0.843
NULL	Biol_Proced_Online_2002_Apr_8_3_70-78.nxml.txt.nlp	12734577	SENT136	5	5	8	8	atropine	mol	PA448505	90527	0.843
NULL	Mol_Pain_2013_Jun_10_9_27.nxml.txt.nlp	23758830	SENT86	31	31	22	22	tetracaine	ASIC3	PA451638	9311	0.843
NULL	Oncol_Lett_2013_Feb_26_5(2)_637-640.nxml.txt.nlp	23420587	SENT25	5	5	17	17	cetuximab	EGFR	PA10040	1956	0.843
NULL	Braz_J_Med_Biol_Res_2014_Jan_10_47(1)_60-69.nxml.txt.nlp	24519092	SENT28	10	10	34	34	doxorubicin	YWHAZ	PA449412	7534	0.843
NULL	Biomed_Res_Int_2013_Dec_4_2013_685308.nxml.txt.nlp	23509762	SENT134	28	28	31	31	bevacizumab	HIF-1	PA130232992	29072	0.843
NULL	Chem_Rev_2014_Jun_11_114(11)_5753-5774.nxml.txt.nlp	24758331	SENT121	22	22	36	36	geldanamycin	P-gp	PA152031327	5243	0.843
NULL	AIDS_Res_Ther_2013_May_1_10_10.nxml.txt.nlp	23634877	SENT12	12	12	21	21	lovastatin	CCL3	PA450272	6348	0.843
NULL	Mol_Cancer_2013_Mar_5_12_17.nxml.txt.nlp	23497256	SENT168	14	14	5	5	sunitinib	p53	PA162372840	7157	0.843
NULL	J_Cell_Mol_Med_2014_Dec_9_18(12)_2425-2436.nxml.txt.nlp	25297942	SENT176	16	16	7	7	cisplatin	HOTAIR	PA449014	100124700	0.843
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Sep_30_66(Pt_10)_o2686.nxml.txt.nlp	21587654	SENT54	9	9	6	6	benzaldehyde	mol	PA448571	90527	0.843
NULL	Biomed_Res_Int_2014_Jan_20_2014_948427.nxml.txt.nlp	24563867	SENT6	22	22	0	0	buspirone	STZ	PA448689	6484	0.843
NULL	Glycobiology_2012_Jan_26_22(1)_134-145.nxml.txt.nlp	21873605	SENT35	10	10	8	8	heparin	IL-8	PA449855	3576	0.843
NULL	Breast_Cancer_Res_2011_Aug_11_13(3)_R80.nxml.txt.nlp	21834972	SENT190	37	37	42	42	tamoxifen	CDK2	PA451581	1017	0.843
NULL	Oncogene_2010_Mar_11_29(10)_1509-1518.nxml.txt.nlp	19946334	SENT108	12	12	6	6	bortezomib	pS2	PA10252	7031	0.843
NULL	Front_Oncol_2013_Sep_24_3_251.nxml.txt.nlp	24069583	SENT166	7	7	30	30	carboplatin	GCG	PA448803	2641	0.843
NULL	Acta_Histochem_Cytochem_2010_May_1_43(2)_61-68.nxml.txt.nlp	20514293	SENT61	21	21	17	17	hyaluronan	LYVE-1	PA165958431	10894	0.843
NULL	Int_J_Biol_Sci_2012_Oct_25_8(9)_1281-1290.nxml.txt.nlp	23136556	SENT85	40	40	29	29	methacholine	IL-13	PA165958382	3596	0.843
NULL	Eur_J_Clin_Microbiol_Infect_Dis_2010_Jan_10_29(1)_89-95.nxml.txt.nlp	19902279	SENT41	14	14	36	36	mannitol	CO2	PA450320	4513	0.843
NULL	Arthritis_Res_Ther_2003_Sep_12_5(Suppl_3)_145.nxml.txt.nlp	NULL	SENT4	28	28	30	30	staurosporine	IL-16	PA165109623	3603	0.843
NULL	Arthritis_Res_Ther_2014_Jul_24_16(4)_R157.nxml.txt.nlp	25059342	SENT227	7	7	12	12	bleomycin	IL-6	PA448645	3569	0.843
NULL	Int_J_Cosmet_Sci_2014_Jun_27_36(3)_253-261.nxml.txt.nlp	24697191	SENT334	2	2	9	9	isotretinoin	B12	PA450128	7126;4709	0.843
NULL	Clin_Med_Insights_Oncol_2012_Feb_28_6_125-135.nxml.txt.nlp	22408376	SENT90	28	28	36	36	panitumumab	KRAS	PA162373091	3845	0.843
NULL	Blood_Cancer_J_2013_Sep_13_3(9)_e146.nxml.txt.nlp	24036945	SENT41	0	0	17	17	ribavirin	BCL2	PA451241	596	0.843
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT170	11	11	26	26	trastuzumab	HER3	PA451743	2065	0.843
NULL	EMBO_J_2010_Nov_17_29(22)_3773-3786.nxml.txt.nlp	20924358	SENT88	5	5	24	24	novobiocin	Hsp90	PA164768819	3320	0.843
NULL	J_Cell_Biol_2001_Oct_29_155(3)_447-458.nxml.txt.nlp	11684709	SENT79	15	15	46	46	pp2	EGF		1950	0.843
NULL	Biomed_Res_Int_2013_Jul_21_2013_723129.nxml.txt.nlp	23971044	SENT91	2	2	4	4	itraconazole	BAL	PA450132	83666	0.843
NULL	Clin_Med_Insights_Cardiol_2011_Oct_6_5_103-119.nxml.txt.nlp	22084608	SENT40	11	11	22	22	dronedarone	CYP3A4	PA153619853	1576	0.843
NULL	Oncotarget_2014_Mar_13_5(4)_1101-1110.nxml.txt.nlp	24658355	SENT60	8	8	0	0	tamoxifen	MKP-2	PA451581	1846	0.843
NULL	Br_J_Cancer_2000_Jul_24_83(4)_544-549.nxml.txt.nlp	10945505	SENT8	18	18	7	7	docetaxel	MAP2	PA449383	4133;10988	0.843
NULL	Front_Oncol_2014_Aug_11_4_204.nxml.txt.nlp	25157335	SENT70	9	9	18	18	afatinib	EGFR	PA165981154	1956	0.843
NULL	Eur_J_Immunol_2013_Apr_11_43(5)_1153-1161.nxml.txt.nlp	23400868	SENT158	22	22	8	8	chloroquine	MARCH8	PA448948	220972	0.843
NULL	Br_J_Cancer_2012_May_8_106(10)_1587-1590.nxml.txt.nlp	22568998	SENT102	6	6	15	15	sunitinib	IFN	PA162372840	3439	0.843
NULL	Nat_Genet_2014_Feb_12_46(2)_166-170.nxml.txt.nlp	24413734	SENT185	13	13	25	25	dasatinib	FYN	PA162372878	2534	0.843
NULL	Breast_Cancer_Res_2007_Aug_8_9(4)_R50.nxml.txt.nlp	17686159	SENT265	7	7	12	12	trastuzumab	HRG	PA451743	3084;3273	0.843
NULL	Ann_Hematol_2011_Feb_17_90(2)_173-183.nxml.txt.nlp	20714724	SENT210	4	4	18	18	resveratrol	p53		7157	0.843
NULL	Front_Genet_2012_Nov_5_3_236.nxml.txt.nlp	23133441	SENT18	10	10	0	0	efavirenz	ABCB1	PA449441	5243	0.843
NULL	J_Biol_Chem_2013_Feb_1_288(5)_3312-3321.nxml.txt.nlp	23255604	SENT210	3	3	6	6	mitomycin	IP6K1	PA450524	9807	0.843
NULL	Indian_J_Pharmacol_2012_Sep-Oct_44(5)_624-628.nxml.txt.nlp	23112426	SENT37	13	13	17	17	pravastatin	P-gp	PA451089	5243	0.843
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT185	8	8	20	20	ranibizumab	VEGFR1	PA164746012	2321	0.843
NULL	Front_Pharmacol_2014_Nov_25_5_256.nxml.txt.nlp	25505414	SENT111	7	7	33	33	midazolam	KCC2	PA450496	57468	0.843
NULL	Front_Microbiol_2012_Mar_29_3_116.nxml.txt.nlp	22479260	SENT208	32	32	35	35	geldanamycin	Hsp90	PA152031327	3320	0.843
NULL	Front_Immunol_2013_Nov_20_4_385.nxml.txt.nlp	24312095	SENT211	31	31	41	41	heparin	CXCR4	PA449855	7852	0.843
NULL	Front_Neurol_2014_Jul_31_5_141.nxml.txt.nlp	25132831	SENT113	24	24	1	1	nadh	Q10	PA164755085	27161	0.843
NULL	Cells_2014_Jan_27_3(1)_53-78.nxml.txt.nlp	24709902	SENT261	22	22	4	4	trastuzumab	PTEN	PA451743	5728	0.843
NULL	Cancer_Metab_2015_Jan_25_3(1)_1.nxml.txt.nlp	NULL	SENT150	0	0	10	10	doxorubicin	DHODH	PA449412	1723	0.843
NULL	Biomed_Res_Int_2014_Jan_29_2014_458592.nxml.txt.nlp	24592391	SENT171	8	8	11	11	curcumin	HO-1	PA151958596	3162	0.843
NULL	Mol_Syst_Biol_2009_Jul_28_5_290.nxml.txt.nlp	19638971	SENT373	5	5	13	13	thrombin	EGFR	PA451674	1956	0.843
NULL	J_Cell_Biol_1983_Jul_1_97(1)_166-172.nxml.txt.nlp	6863389	SENT4	7	7	23	23	choline	CDP	PA448976	1523	0.843
NULL	Int_J_Mol_Sci_2014_Sep_5_15(9)_15754-15765.nxml.txt.nlp	25198898	SENT62	4	4	13	13	curcumin	NAC	PA151958596	22861	0.843
NULL	Mol_Cancer_2009_Aug_25_8_66.nxml.txt.nlp	19706164	SENT105	22	22	15	15	celecoxib	p53	PA448871	7157	0.843
NULL	Int_J_Mol_Sci_2012_Sep_20_13(9)_12000-12016.nxml.txt.nlp	23109896	SENT573	17	17	5	5	cetuximab	EGFR	PA10040	1956	0.843
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT167	3	3	17	17	trastuzumab	HER2	PA451743	2064	0.843
NULL	Diabetes_Care_2012_Dec_14_35(12)_e84.nxml.txt.nlp	23173145	SENT34	12	12	15	15	cyanocobalamin	B12	PA451892	7126;4709	0.843
NULL	Ann_Gastroenterol_2014_27(4)_380-386.nxml.txt.nlp	25331321	SENT27	27	27	14	14	tenofovir	IFN	PA10204	3439	0.843
NULL	An_Bras_Dermatol_2014_Mar-Apr_89(2)_301-310.nxml.txt.nlp	24770508	SENT110	13	13	31	31	cisplatin	IL-2	PA449014	3558	0.843
NULL	Cancer_Manag_Res_2014_Oct_17_6_423-430.nxml.txt.nlp	25378950	SENT66	5	5	19	19	letrozole	aromatase	PA450196	1588	0.843
NULL	Crit_Care_2006_Feb_3_10(1)_R24.nxml.txt.nlp	16469128	SENT195	12	12	27	27	heparin	MARS	PA449855	4141	0.843
NULL	Oncoscience_2014_Mar_12_1(2)_167-179.nxml.txt.nlp	25126591	SENT228	33	33	11	11	temsirolimus	PI3K	PA164746890	5290	0.843
NULL	Br_J_Cancer_1997_75(11)_1559-1566.nxml.txt.nlp	9184169	SENT9	24	24	20	20	genistein	p53	PA165109660	7157	0.843
NULL	J_Cell_Mol_Med_2013_Dec_6_17(12)_1588-1597.nxml.txt.nlp	24199964	SENT37	26	26	29	29	dobutamine	APT	PA449381	653639	0.843
NULL	Clin_Endosc_2011_Sep_30_44(1)_22-26.nxml.txt.nlp	22741108	SENT27	20	20	25	25	propofol	ESD	PA451141	2098	0.843
NULL	Eur_J_Haematol_2009_May_82(5)_339-349.nxml.txt.nlp	19187276	SENT137	18	18	32	32	enoxaparin	TKR	PA449463	8277	0.843
NULL	Diabetes_2011_Nov_17_60(11)_2691-2700.nxml.txt.nlp	21896928	SENT168	9	9	5	5	resveratrol	SIRT1		23411	0.843
NULL	J_Gynecol_Oncol_2014_Jul_3_25(3)_249-259.nxml.txt.nlp	25045438	SENT191	9	9	13	13	cisplatin	PARP1	PA449014	142	0.843
NULL	Br_J_Cancer_2002_Dec_2_87(12)_1462-1469.nxml.txt.nlp	12454778	SENT145	6	6	18	18	nifedipine	mol	PA450631	90527	0.843
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1066.nxml.txt.nlp	24556681	SENT214	36	36	16	16	ethanol	LC3	PA448073	84557	0.843
NULL	J_Gastrointest_Surg_2012_Apr_13_16(4)_842-848.nxml.txt.nlp	22246855	SENT94	27	27	6	6	bevacizumab	EGFR	PA130232992	1956	0.843
NULL	Avicenna_J_Phytomed_2013_Summer_3(3)_201-204.nxml.txt.nlp	25050275	SENT48	13	13	9	9	nifedipine	CYP3A4	PA450631	1576	0.843
NULL	Biomed_Res_Int_2013_Jan_16_2013_937936.nxml.txt.nlp	23509814	SENT139	12	12	25	25	sirolimus	IL-6	PA451365	3569	0.843
NULL	Nucl_Recept_Signal_2010_Apr_16_8_e004.nxml.txt.nlp	20419060	SENT155	28	28	4	4	lipase	CD36	PA450239	948	0.843
NULL	Breast_Cancer_Res_2012_Feb_14_14(1)_R31.nxml.txt.nlp	22333393	SENT243	25	25	6	6	tamoxifen	HOXB7	PA451581	3217	0.843
NULL	Oncotarget_2014_Oct_21_5(22)_11180-11192.nxml.txt.nlp	25361003	SENT66	14	14	12	12	forskolin	NRG1	PA146096022	3084	0.843
NULL	J_Cancer_2013_Nov_21_4(9)_727-735.nxml.txt.nlp	24312143	SENT159	34	34	38	38	cisplatin	HIF-1	PA449014	29072	0.843
NULL	Eur_Respir_J_2012_Nov_26_40(5)_1106-1114.nxml.txt.nlp	23060624	SENT126	5	5	29	29	tiotropium	NNT	PA164769056	23530	0.843
NULL	Rare_Tumors_2010_Dec_31_2(4)_e63.nxml.txt.nlp	21234255	SENT33	31	31	6	6	methotrexate	CHOP	PA450428	1649	0.843
NULL	Oncogene_2011_Apr_21_30(16)_1901-1911.nxml.txt.nlp	21151179	SENT296	15	15	9	9	doxycycline	KLF8	PA449415	11279	0.843
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT55	27	27	8	8	cisplatin	CTR2	PA449014	1318	0.843
NULL	Pharmaceuticals_(Basel)_2013_Jan_7_6(1)_54-69.nxml.txt.nlp	24275787	SENT420	4	4	21	21	staurosporine	p53	PA165109623	7157	0.843
NULL	Exp_Mol_Med_2012_Sep_30_44(9)_536-544.nxml.txt.nlp	22771771	SENT57	25	25	12	12	ns-398	p53		7157	0.843
NULL	Curr_Med_Chem_2014_May_21(14)_1595-1606.nxml.txt.nlp	23992330	SENT75	21	21	19	19	gefitinib	EGFR	PA131301952	1956	0.843
NULL	Front_Plant_Sci_2011_Jun_6_2_18.nxml.txt.nlp	22645527	SENT121	24	24	9	9	trypsin	MP17	PA451806	3982	0.843
NULL	Thorax_2010_Jul_13_65(7)_654-658.nxml.txt.nlp	20627927	SENT47	5	5	27	27	tobramycin	NAG	PA451704	51594;4669	0.843
NULL	Autism_Res_Treat_2012_Nov_28_2012_870391.nxml.txt.nlp	23243505	SENT238	9	9	30	30	haloperidol	CARS	PA449841	833	0.843
NULL	Front_Oncol_2013_Sep_25_3_256.nxml.txt.nlp	24093089	SENT312	39	39	18	18	paclitaxel	IL-6	PA450761	3569	0.843
NULL	Indian_J_Orthop_2015_Jan-Feb_49(1)_83-100.nxml.txt.nlp	25593359	SENT150	0	0	8	8	denosumab	RANKL	PA166048634	8600	0.843
NULL	J_Mol_Signal_2011_May_9_6_3.nxml.txt.nlp	21554706	SENT79	35	35	41	41	isoproterenol	AKAP12	PA450121	9590	0.843
NULL	Nano_Rev_2010_Feb_22_1_10_3402_nano_v1i0_4883.nxml.txt.nlp	22110854	SENT220	39	39	27	27	protamine	CD34	PA10366	947	0.843
NULL	J_Biol_Chem_2009_Sep_11_284(37)_24965-24971.nxml.txt.nlp	19592485	SENT21	16	16	23	23	vasopressin	NKCC2	PA451858	6557	0.843
NULL	Int_J_Endocrinol_2011_Mar_6_2011_415719.nxml.txt.nlp	21461394	SENT95	8	8	19	19	cinacalcet	PTH	PA164776671	5741	0.843
NULL	ACS_Med_Chem_Lett_2011_Jun_18_2(8)_638-643.nxml.txt.nlp	21841964	SENT191	4	4	17	17	cisapride	CYP3A	PA449011	1574	0.843
NULL	Front_Physiol_2013_Nov_14_4_323.nxml.txt.nlp	24294204	SENT94	32	32	10	10	bisoprolol	CYP3A4	PA448641	1576	0.843
NULL	J_Biol_Chem_2009_Mar_6_284(10)_6260-6269.nxml.txt.nlp	19131328	SENT259	17	17	27	27	heparin	TBCA	PA449855	6902	0.843
NULL	J_Cell_Biol_1998_Jan_26_140(2)_335-345.nxml.txt.nlp	9442109	SENT3	8	8	12	12	chloroquine	NHE	PA448948	285335	0.843
NULL	Fibrogenesis_Tissue_Repair_2012_Apr_13_5_5.nxml.txt.nlp	22502865	SENT95	13	13	19	19	troglitazone	CCN2	PA451799	1490	0.843
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT283	7	7	15	15	neratinib	HER2	PA165291472	2064	0.843
NULL	Ther_Clin_Risk_Manag_2006_Sep_2(3)_235-249.nxml.txt.nlp	18360599	SENT340	13	13	10	10	alendronate	PTH	PA448082	5741	0.843
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT517	10	10	4	4	iloperidone	PRL	PA161199368	5617	0.843
NULL	Front_Oncol_2014_Jun_18_4_159.nxml.txt.nlp	24995161	SENT25	18	18	4	4	estradiol	AKR1C3	PA449503	8644	0.843
NULL	Cell_J_2012_Dec_22_Winter_13(4)_265-274.nxml.txt.nlp	23507995	SENT248	14	14	21	21	ethanol	spatial	PA448073	219793	0.843
NULL	Cancer_Med_2013_Oct_19_2(5)_646-653.nxml.txt.nlp	24403230	SENT77	31	31	8	8	trastuzumab	CIDEA	PA451743	1149	0.843
NULL	Arthritis_Res_Ther_2010_Apr_15_12(2)_R68.nxml.txt.nlp	20398308	SENT12	5	5	10	10	adalimumab	CD86	PA10004	942	0.843
NULL	J_Immunol_Res_2014_Jun_9_2014_326545.nxml.txt.nlp	25009822	SENT229	26	26	2	2	vemurafenib	BRAF	PA165946873	673	0.843
NULL	J_Neuroinflammation_2010_Sep_7_7_51.nxml.txt.nlp	20822529	SENT182	20	20	24	24	hemin	HO-1	PA449849	3162	0.843
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT170	25	25	4	4	lapatinib	HER2	PA152241907	2064	0.843
NULL	Braz_J_Med_Biol_Res_2014_Oct_14_47(12)_1068-1074.nxml.txt.nlp	25387674	SENT98	19	19	2	2	propranolol	HCS	PA451145	3141;54205	0.843
NULL	Case_Rep_Med_2009_Dec_23_2009_469343.nxml.txt.nlp	20069057	SENT14	17	17	34	34	methotrexate	6-16	PA450428	2537	0.843
NULL	Clin_Cosmet_Investig_Dermatol_2013_Mar_14_6_75-80.nxml.txt.nlp	23515267	SENT84	2	2	7	7	adalimumab	TNF-alpha	PA10004	7124	0.843
NULL	J_Oncol_2013_Feb_17_2013_872957.nxml.txt.nlp	23476648	SENT36	20	20	6	6	cisplatin	SFN	PA449014	25996;2810	0.843
NULL	Diabetes_2009_Apr_16_58(4)_975-983.nxml.txt.nlp	19151200	SENT210	8	8	42	42	liraglutide	HO-1	PA165958364	3162	0.843
NULL	Orphanet_J_Rare_Dis_2013_Sep_13_8_142.nxml.txt.nlp	24034279	SENT171	4	4	7	7	vasopressin	AVPR1A	PA451858	552	0.843
NULL	Acta_Histochem_Cytochem_2006_Dec_28_39(6)_163-172.nxml.txt.nlp	17327903	SENT350	4	4	14	14	staurosporine	ERK	PA165109623	5594	0.843
NULL	J_Cell_Sci_2011_Mar_15_124(6)_921-932.nxml.txt.nlp	21378310	SENT191	31	31	15	15	chloroquine	RNF41	PA448948	10193	0.843
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT133	25	25	31	31	perifosine	DR5	PA165291471	8795	0.843
NULL	Cardiol_Res_Pract_2010_Dec_13_2010_295297.nxml.txt.nlp	21197071	SENT53	16	16	20	20	heparin	ACT	PA449855	12;11332;9457;641455	0.843
NULL	Diabetes_2009_Apr_9_58(4)_965-974.nxml.txt.nlp	19136651	SENT258	3	3	35	35	nadh	AMPK	PA164755085	5563	0.843
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT285	0	0	24	24	resveratrol	Bcl-2		596	0.843
NULL	J_Hematol_Oncol_2011_Dec_21_4_53.nxml.txt.nlp	22189016	SENT70	16	16	22	22	ketoconazole	P-gp	PA450146	5243	0.843
NULL	J_Hematol_Oncol_2010_Mar_23_3_11.nxml.txt.nlp	20331897	SENT161	13	13	38	38	capecitabine	LARC	PA448771	6364	0.843
NULL	Cancers_(Basel)_2014_Jan_27_6(1)_226-239.nxml.txt.nlp	24473088	SENT364	10	10	1	1	temozolomide	MSH6	PA451609	2956	0.843
NULL	J_Cell_Mol_Med_2013_Dec_6_17(12)_1588-1597.nxml.txt.nlp	24199964	SENT249	0	0	28	28	doxycycline	APT	PA449415	653639	0.843
NULL	J_Cancer_2013_Aug_16_4(7)_566-572.nxml.txt.nlp	23983821	SENT138	5	5	10	10	tetracycline	CD44	PA451640	960	0.843
NULL	J_Mol_Med_(Berl)_2014_May_10_92(7)_709-722.nxml.txt.nlp	24811491	SENT224	14	14	5	5	cetuximab	KRAS	PA10040	3845	0.843
NULL	J_Headache_Pain_2014_Dec_8_15(1)_85.nxml.txt.nlp	25488888	SENT102	21	21	12	12	rizatriptan	5-HT1D	PA451264	3352	0.843
NULL	Br_J_Cancer_2009_Mar_10_100(5)_758-763.nxml.txt.nlp	19259094	SENT80	30	30	19	19	decitabine	MLH1	PA164749631	4292	0.843
NULL	Mol_Cell_Biochem_2012_Apr_3_363(1-2)_135-145.nxml.txt.nlp	22139302	SENT252	14	14	22	22	curcumin	survivin	PA151958596	332	0.843
NULL	Cancers_(Basel)_2013_May_27_5(2)_617-638.nxml.txt.nlp	24216994	SENT134	15	15	20	20	curcumin	MMP9	PA151958596	4318	0.843
NULL	Biologics_2014_Apr_23_8_183-192.nxml.txt.nlp	24790411	SENT108	14	14	33	33	erlotinib	EGFR	PA134687924	1956	0.843
NULL	BMJ_Open_2014_May_5_4(5)_e005268.nxml.txt.nlp	24801283	SENT89	12	12	24	24	ticagrelor	SAS	PA165374673	54187	0.843
NULL	BMB_Rep_2013_Nov_46(11)_544-549.nxml.txt.nlp	24152910	SENT41	6	6	41	41	thrombin	HMGB1	PA451674	3146	0.843
NULL	Oncol_Rep_2013_Oct_22_30(4)_1535-1541.nxml.txt.nlp	23877481	SENT149	13	13	6	6	bevacizumab	VEGFR	PA130232992	3791	0.843
NULL	Psychiatr_Genet_2013_Aug_28_23(4)_153-162.nxml.txt.nlp	23811784	SENT213	27	27	9	9	clozapine	AP2A2	PA449061	161	0.843
NULL	EMBO_Mol_Med_2011_May_3(5)_266-278.nxml.txt.nlp	21438154	SENT266	34	34	23	23	oxaliplatin	HCN1	PA131285527	348980	0.843
NULL	Acta_Pharmacol_Sin_2010_Nov_18_31(11)_1447-1453.nxml.txt.nlp	20953204	SENT195	9	9	16	16	rimonabant	IL-6	PA152407999	3569	0.843
NULL	Breast_Cancer_(Auckl)_2011_Oct_9_5_209-226.nxml.txt.nlp	22084574	SENT250	14	14	10	10	anastrozole	aromatase	PA448432	1588	0.843
NULL	Int_J_Biol_Sci_2011_Sep_8_7(8)_1077-1092.nxml.txt.nlp	21927577	SENT46	8	8	34	34	olmesartan	ANG	PA164742950	283	0.843
NULL	Exp_Diabetes_Res_2012_Dec_26_2012_230624.nxml.txt.nlp	23365557	SENT166	0	0	6	6	exenatide	GLP-1	PA164749238	100125288	0.843
NULL	Onco_Targets_Ther_2014_Nov_26_7_2155-2160.nxml.txt.nlp	25473297	SENT119	2	2	0	0	cisplatin	NACT	PA449014	284111	0.843
NULL	Mol_Vis_2011_May_4_17_1172-1181.nxml.txt.nlp	21617754	SENT206	12	12	0	0	staurosporine	FKBP51	PA165109623	2289	0.843
NULL	Oncoimmunology_2012_May_1_1(3)_263-270.nxml.txt.nlp	22737601	SENT5	2	2	33	33	dextran	MUC1	PA449261	4582	0.843
NULL	Breast_Cancer_(Auckl)_2009_Sep_2_3_61-75.nxml.txt.nlp	19809577	SENT161	7	7	13	13	curcumin	BRCA1	PA151958596	672	0.843
NULL	Nat_Chem_Biol_2010_Jun_2_6(6)_411-417.nxml.txt.nlp	20436487	SENT244	11	11	16	16	curcumin	COX	PA151958596	1351	0.843
NULL	J_Hematol_Oncol_2013_Jul_18_6_53.nxml.txt.nlp	23866964	SENT141	3	3	13	13	temsirolimus	HDAC3	PA164746890	8841	0.843
NULL	Indian_J_Pharmacol_2014_Jan-Feb_46(1)_3-12.nxml.txt.nlp	24550577	SENT221	21	21	5	5	carbamazepine	CYP2C9	PA448785	1559	0.843
NULL	Oncoimmunology_2014_May_29_3_e28925.nxml.txt.nlp	25083322	SENT68	2	2	19	19	dasatinib	IFN	PA162372878	3439	0.843
NULL	Int_J_Endocrinol_2010_Aug_19_2010_320721.nxml.txt.nlp	20016682	SENT33	20	20	26	26	risedronate	PTH	PA451255	5741	0.843
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT365	3	3	8	8	methotrexate	MSH2	PA450428	4436	0.843
NULL	Breast_Cancer_Res_2010_Apr_30_12(2)_203.nxml.txt.nlp	20459590	SENT69	26	26	19	19	curcumin	FANCD2	PA151958596	2177	0.843
NULL	Br_J_Cancer_2013_Jul_9_109(1)_68-75.nxml.txt.nlp	23807173	SENT184	16	16	12	12	cisplatin	ERCC1	PA449014	2067	0.843
NULL	Breast_Cancer_Res_2008_Mar_29_10(2)_R28.nxml.txt.nlp	18373870	SENT168	34	34	44	44	estradiol	HSPC111	PA449503	51491	0.843
NULL	Front_Behav_Neurosci_2009_Aug_20_3_18.nxml.txt.nlp	19738931	SENT562	3	3	8	8	citalopram	5-HT2A	PA449015	3356	0.843
NULL	J_Mol_Signal_2010_May_10_5_4.nxml.txt.nlp	20459745	SENT64	10	10	32	32	cisplatin	p53	PA449014	7157	0.843
NULL	Ann_Surg_Oncol_2013_Jul_3_20(7)_2311-2316.nxml.txt.nlp	23377563	SENT107	22	22	14	14	cisplatin	CRS	PA449014	1403	0.843
NULL	Open_Cardiovasc_Med_J_2010_Nov_26_4_221-230.nxml.txt.nlp	21270944	SENT123	11	11	8	8	valsartan	AT1	PA451848	9197;185	0.843
NULL	Oncotarget_2012_Jan_28_3(1)_84-97.nxml.txt.nlp	22289741	SENT227	19	19	22	22	coumarin	CAIX	PA134521193	768	0.843
NULL	Case_Rep_Ophthalmol_2013_Sep_21_4(3)_122-128.nxml.txt.nlp	24163679	SENT61	10	10	0	0	bevacizumab	Ray	PA130232992	26751	0.843
NULL	Diabetes_2009_Dec_31_58(12)_2851-2862.nxml.txt.nlp	19720788	SENT132	9	9	3	3	forskolin	CHOP	PA146096022	1649	0.843
NULL	Eur_Respir_J_2012_Apr_39(4)_807-819.nxml.txt.nlp	22467723	SENT208	14	14	25	25	isoniazid	DST	PA450112	667	0.843
NULL	Hum_Reprod_2012_Jun_3_27(6)_1829-1839.nxml.txt.nlp	22473395	SENT31	24	24	9	9	estradiol	AMH	PA449503	268	0.843
NULL	Mol_Brain_2014_Apr_3_7_25.nxml.txt.nlp	24708812	SENT8	30	30	36	36	chloroquine	ERK	PA448948	5594	0.843
NULL	Front_Oncol_2013_Sep_25_3_256.nxml.txt.nlp	24093089	SENT312	39	39	22	22	paclitaxel	MCP-1	PA450761	6347	0.843
NULL	J_Cell_Biol_1998_Nov_30_143(5)_1317-1328.nxml.txt.nlp	9832559	SENT124	17	17	25	25	trypsin	EGF	PA451806	1950	0.843
NULL	Mol_Cancer_2009_Aug_25_8_66.nxml.txt.nlp	19706164	SENT36	16	16	2	2	rofecoxib	COX	PA451268	1351	0.843
NULL	J_Korean_Med_Sci_2013_Oct_25_28(10)_1454-1460.nxml.txt.nlp	24133349	SENT157	28	28	10	10	mexiletine	SCN5A	PA450488	6331	0.843
NULL	Int_J_Mol_Sci_2014_Oct_20_15(10)_18919-18940.nxml.txt.nlp	25334063	SENT366	1	1	20	20	curcumin	p38	PA151958596	10598;1432;7965	0.843
NULL	J_Geriatr_Cardiol_2013_Jun_10(2)_151-158.nxml.txt.nlp	23888175	SENT185	1	1	4	4	rosuvastatin	ACE2	PA134308647	59272	0.843
NULL	Crit_Care_2008_Jun_25_12(3)_R84.nxml.txt.nlp	18578859	SENT97	8	8	26	26	heparin	PF4	PA449855	5196	0.843
NULL	J_Clin_Biochem_Nutr_2007_Sep_29_41(2)_84-91.nxml.txt.nlp	18193101	SENT120	10	10	14	14	lansoprazole	IL-8	PA450180	3576	0.843
NULL	Arthritis_Res_Ther_2008_Jan_7_10(1)_R1.nxml.txt.nlp	18179697	SENT190	0	0	2	2	oxaliplatin	HMGB1	PA131285527	3146	0.843
NULL	Oncologist_2010_Nov_4_15(11)_1135-1146.nxml.txt.nlp	21051659	SENT122	11	11	17	17	bevacizumab	IFN	PA130232992	3439	0.843
NULL	J_Obes_2012_Sep_10_2012_956137.nxml.txt.nlp	22997570	SENT215	2	2	11	11	hyperforin	CRF1	PA165985514	1394	0.843
NULL	J_Clin_Biochem_Nutr_2009_Jan_27_44(1)_79-84.nxml.txt.nlp	19177192	SENT5	2	2	9	9	curcumin	HO-1	PA151958596	3162	0.843
NULL	Int_J_Gen_Med_2009_Dec_29_2_209-217.nxml.txt.nlp	20360906	SENT142	27	27	11	11	cabergoline	ACTH	PA448708	5443	0.843
NULL	Oncotarget_2011_Dec_24_2(12)_896-917.nxml.txt.nlp	22203527	SENT144	2	2	13	13	metformin	IGF1	PA450395	3479	0.843
NULL	Mol_Cancer_2010_Mar_10_9_56.nxml.txt.nlp	20219102	SENT157	10	10	4	4	bortezomib	CXCL2	PA10252	2920	0.843
NULL	Diabetes_Care_2010_Nov_33(11)_2484-2485.nxml.txt.nlp	20980428	SENT36	23	23	19	19	ranibizumab	VEGF-A	PA164746012	7422	0.843
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT114	21	21	5	5	trastuzumab	MUC1	PA451743	4582	0.843
NULL	Bone_Marrow_Transplant_2012_Apr_9_47(4)_581-588.nxml.txt.nlp	21552302	SENT164	4	4	11	11	sirolimus	CD4	PA451365	920	0.843
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT281	10	10	13	13	ranibizumab	VEGF-A	PA164746012	7422	0.843
NULL	EPMA_J_2012_Sep_27_3(1)_10.nxml.txt.nlp	23016735	SENT234	30	30	16	16	warfarin	CYP2C9	PA451906	1559	0.843
NULL	Reprod_Biol_Endocrinol_2003_Oct_7_1_71.nxml.txt.nlp	14577832	SENT114	22	22	7	7	cisplatin	JNK1	PA449014	5599	0.843
NULL	Eur_J_Immunol_2014_Jun_10_44(6)_1759-1769.nxml.txt.nlp	24595810	SENT102	3	3	7	7	fludrocortisone	CCR7	PA164743961	1236	0.843
NULL	Arch_Med_Sci_2010_Dec_29_6(6)_964-970.nxml.txt.nlp	22427774	SENT123	7	7	11	11	calcipotriol	IL-20	PA448714	27190;50604	0.843
NULL	Mol_Cells_2014_Mar_31_37(3)_234-240.nxml.txt.nlp	24642709	SENT165	6	6	21	21	capsaicin	HO-1	PA448776	3162	0.843
NULL	Cancer_Cell_Int_2013_Jul_8_13_68.nxml.txt.nlp	23834902	SENT169	34	34	38	38	cisplatin	PTEN	PA449014	5728	0.843
NULL	Breast_Cancer_Res_2014_Oct_31_16(5)_447.nxml.txt.nlp	25358600	SENT253	12	12	9	9	fulvestrant	CXCR7	PA164747170	57007	0.843
NULL	Cancers_(Basel)_2009_Dec_15_1(1)_23-28.nxml.txt.nlp	20535236	SENT132	4	4	20	20	cisplatin	TRX	PA449014	7295	0.843
NULL	Cancers_(Basel)_2014_Apr_4_6(2)_796-812.nxml.txt.nlp	24713998	SENT155	6	6	32	32	doxorubicin	EGF	PA449412	1950	0.843
NULL	Environ_Health_Perspect_2009_Nov_26_117(11)_1737-1744.nxml.txt.nlp	20049126	SENT199	11	11	18	18	arsenite	XRCC3	PA452638	7517	0.843
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT7	7	7	17	17	nutlin-3	p53		7157	0.843
NULL	Onco_Targets_Ther_2014_Sep_29_7_1793-1800.nxml.txt.nlp	25302026	SENT35	10	10	22	22	lenalidomide	MIR33B	PA162363968	693120	0.843
NULL	Br_J_Cancer_2012_Nov_20_107(11)_1833-1839.nxml.txt.nlp	23169336	SENT41	16	16	0	0	vinblastine	Men	PA451877	8178	0.843
NULL	Environ_Health_Perspect_2006_Apr_13_114(4)_494-499.nxml.txt.nlp	16581535	SENT211	5	5	9	9	ethanol	CYP2E1	PA448073	1571	0.843
NULL	Br_J_Cancer_2009_Oct_6_101(7)_1155-1161.nxml.txt.nlp	19738614	SENT82	14	14	7	7	gemcitabine	MUC4	PA449748	4585	0.843
NULL	Int_J_Surg_Oncol_2012_Jun_12_2012_862879.nxml.txt.nlp	22778941	SENT15	36	36	14	14	cisplatin	BIN1	PA449014	274	0.843
NULL	Core_Evid_2007_Nov_30_2(2)_121-129.nxml.txt.nlp	21221180	SENT171	11	11	19	19	rituximab	CHOP	PA451261	1649	0.843
NULL	Cell_Commun_Signal_2013_Nov_11_11_86.nxml.txt.nlp	24215724	SENT205	10	10	8	8	thrombin	PAR1	PA451674	79581;2149	0.843
NULL	Oncol_Rep_2014_Feb_16_31(2)_573-580.nxml.txt.nlp	24337632	SENT42	16	16	12	12	doxorubicin	AKT	PA449412	207	0.843
NULL	Emerg_Infect_Dis_2014_Apr_20(4)_701-704.nxml.txt.nlp	24655438	SENT69	8	8	20	20	chloramphenicol	CT28	PA448927	51213	0.843
NULL	Int_J_Endocrinol_2014_Feb_23_2014_397307.nxml.txt.nlp	24707287	SENT184	5	5	23	23	resveratrol	STZ		6484	0.843
NULL	Mol_Cancer_2007_Aug_21_6_53.nxml.txt.nlp	17711579	SENT154	34	34	17	17	cisplatin	APITD1	PA449014	378708	0.843
NULL	Emerg_Infect_Dis_2012_Jul_18(7)_1072-1080.nxml.txt.nlp	22709685	SENT147	6	6	24	24	daptomycin	VISA	PA164768820	57506	0.843
NULL	Aging_(Albany_NY)_2009_Jun_3_1(6)_515-528.nxml.txt.nlp	20157535	SENT227	0	0	8	8	resveratrol	SIRT1		23411	0.843
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT29	8	8	25	25	chloroquine	BMPR-II	PA448948	659	0.843
NULL	Nat_Prod_Bioprospect_2014_Jun_21_4(3)_181-188.nxml.txt.nlp	24955300	SENT49	32	32	26	26	phenol	B12	PA450913	7126;4709	0.843
NULL	Front_Endocrinol_(Lausanne)_2011_Jan_14_1_12.nxml.txt.nlp	22654789	SENT74	11	11	42	42	phenol	CO2	PA450913	4513	0.843
NULL	Clin_Interv_Aging_2008_Mar_3(1)_45-50.nxml.txt.nlp	18488877	SENT52	23	23	15	15	tamoxifen	STAR	PA451581	6770;2984	0.843
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_May_14_65(Pt_6)_o1303.nxml.txt.nlp	21583160	SENT66	25	25	17	17	ethanol	mol	PA448073	90527	0.843
NULL	Br_J_Cancer_2009_Oct_6_101(7)_1155-1161.nxml.txt.nlp	19738614	SENT125	17	17	11	11	gemcitabine	MUC4	PA449748	4585	0.843
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1063.nxml.txt.nlp	24556678	SENT29	0	0	35	35	thioridazine	TRAIL	PA451666	8743	0.843
NULL	Acta_Neuropathol_Commun_2013_Aug_9_1_49.nxml.txt.nlp	24252504	SENT111	20	20	3	3	arsenite	TDP-43	PA452638	23435	0.843
NULL	Hum_Genomics_2009_Jan_1_3(2)_128-142.nxml.txt.nlp	19164090	SENT174	24	24	35	35	carboplatin	CD44	PA448803	960	0.843
NULL	Int_J_Breast_Cancer_2011_Sep_6_2011_352182.nxml.txt.nlp	22295219	SENT52	19	19	33	33	trastuzumab	CDK2	PA451743	1017	0.843
NULL	Mol_Cancer_2010_Jun_25_9_166.nxml.txt.nlp	20579378	SENT188	10	10	4	4	gefitinib	EGF	PA131301952	1950	0.843
NULL	J_Cardiothorac_Surg_2014_Sep_17_9(1)_129.nxml.txt.nlp	NULL	SENT104	7	7	0	0	protamine	ACT	PA10366	12;11332;9457;641455	0.843
NULL	Mucosal_Immunol_2011_May_10_4(3)_304-313.nxml.txt.nlp	21068720	SENT208	6	6	4	4	pioglitazone	gamma	PA450970	9913	0.843
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT195	12	12	19	19	phenytoin	CYP3A4	PA450947	1576	0.843
NULL	J_Nat_Sci_Biol_Med_2011_Jul-Dec_2(2)_180-184.nxml.txt.nlp	22346232	SENT144	24	24	8	8	ethanol	SGB	PA448073	2719	0.843
NULL	Tumour_Biol_2013_Aug_12_34(4)_2367-2378.nxml.txt.nlp	23580181	SENT208	3	3	25	25	temozolomide	MRF	PA451609	745	0.843
NULL	Breast_Cancer_Res_2002_Feb_12_4(2)_70-76.nxml.txt.nlp	11879567	SENT216	16	16	4	4	doxorubicin	TP53	PA449412	7157	0.843
NULL	Diabetes_Care_2013_Aug_17_36(Suppl_2)_S245-S252.nxml.txt.nlp	23882053	SENT9	34	34	10	10	saxagliptin	GLP-1	PA165958362	100125288	0.843
NULL	Br_J_Cancer_2010_Jan_5_102(1)_134-143.nxml.txt.nlp	19920829	SENT228	29	29	24	24	pertuzumab	HER-2		2064	0.843
NULL	Eur_J_Drug_Metab_Pharmacokinet_2011_Jan_30_35(3-4)_79-82.nxml.txt.nlp	21302032	SENT20	9	9	15	15	estradiol	UGT	PA449503	7361;7355	0.843
NULL	ScientificWorldJournal_2014_Dec_24_2014_126051.nxml.txt.nlp	25610892	SENT163	2	2	23	23	phenol	ANOVA	PA450913	4858	0.843
NULL	Breast_Cancer_Res_2012_Mar_20_14(2)_R53.nxml.txt.nlp	22433433	SENT110	22	22	30	30	paclitaxel	CDK9	PA450761	1025	0.843
NULL	Int_J_Endocrinol_Metab_2013_Dec_21_Winter_11(1)_57-61.nxml.txt.nlp	23853622	SENT31	6	6	2	2	chlorpromazine	FGA	PA448964	2243	0.843
NULL	Int_J_Biol_Sci_2015_Jan_1_11(1)_48-58.nxml.txt.nlp	25552929	SENT299	1	1	7	7	paclitaxel	THBS1	PA450761	7057	0.843
NULL	Basic_Clin_Neurosci_2014_Summer_5(3)_182-190.nxml.txt.nlp	25337378	SENT124	15	15	12	12	bupropion	mol	PA448687	90527	0.843
NULL	J_Biomed_Sci_2013_Jan_25_20(1)_4.nxml.txt.nlp	23350663	SENT114	19	19	13	13	thrombin	ADP	PA451674	23038	0.843
NULL	J_Mol_Signal_2010_Jun_11_5_6.nxml.txt.nlp	20540776	SENT4	22	22	24	24	hydroxyurea	gamma	PA449942	9913	0.843
NULL	Breast_Cancer_Res_Treat_2012_Jun_18_133(3)_937-947.nxml.txt.nlp	22094936	SENT24	24	24	4	4	tamoxifen	EZH2	PA451581	2146	0.843
NULL	Open_Cardiovasc_Med_J_2011_Feb_15_5_15-21.nxml.txt.nlp	21660251	SENT23	12	12	8	8	sr144528	CB2		1269	0.843
NULL	Antimicrob_Agents_Chemother_2014_Feb_58(2)_706-712.nxml.txt.nlp	24217698	SENT330	10	10	7	7	nevirapine	ABCC10	PA450616	89845	0.843
NULL	Front_Genet_2013_Aug_29_4_163.nxml.txt.nlp	24009622	SENT118	9	9	13	13	ethanol	ABCG2	PA448073	9429	0.843
NULL	Cell_Res_2011_Mar_11_21(3)_530-545.nxml.txt.nlp	21221130	SENT101	39	39	35	35	thrombin	PAC-1	PA451674	1844	0.843
NULL	Acta_Histochem_Cytochem_2012_Oct_31_45(5)_251-259.nxml.txt.nlp	23209334	SENT32	12	12	0	0	vasopressin	AQP2	PA451858	359	0.842
NULL	Endocrinol_Diabetes_Metab_Case_Rep_2014_Sep_1_2014_140072.nxml.txt.nlp	25332771	SENT66	7	7	34	34	sitagliptin	GLP1	PA164748978	100125288;2641	0.842
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Aug_25_66(Pt_9)_o2400.nxml.txt.nlp	21588732	SENT69	22	22	6	6	ethanol	mol	PA448073	90527	0.842
NULL	Int_J_Environ_Res_Public_Health_2010_Apr_30_7(4)_1448-1466.nxml.txt.nlp	20617039	SENT25	13	13	5	5	ethanol	DRD2	PA448073	1813	0.842
NULL	Clinicoecon_Outcomes_Res_2014_Oct_17_6_451-461.nxml.txt.nlp	25378939	SENT126	32	32	17	17	linezolid	HAP	PA450233	5915;10313	0.842
NULL	Stroke_Res_Treat_2011_Nov_10_2011_212485.nxml.txt.nlp	22135769	SENT153	20	20	24	24	clopidogrel	ADP	PA449053	23038	0.842
NULL	Oncoimmunology_2013_Jun_1_2(6)_e24841.nxml.txt.nlp	23894724	SENT94	34	34	23	23	papain	NY-ESO-1	PA450778	1485	0.842
NULL	BMB_Rep_2013_Aug_46(8)_410-415.nxml.txt.nlp	23977989	SENT19	0	0	11	11	curcumin	IL-6	PA151958596	3569	0.842
NULL	Cardiol_Ther_2013_Jun_1_2(1)_111-124.nxml.txt.nlp	25135294	SENT121	21	21	2	2	dronedarone	P-gp	PA153619853	5243	0.842
NULL	Curr_Pharm_Des_2008_Dec_14(34)_3637-3655.nxml.txt.nlp	19075740	SENT490	31	31	17	17	chloroquine	MPG	PA448948	4350	0.842
NULL	Diabetes_2008_Sep_57(9)_2470-2479.nxml.txt.nlp	18511847	SENT150	3	3	6	6	rosiglitazone	p38	PA451283	10598;1432;7965	0.842
NULL	Breast_Cancer_Res_Treat_2012_Jul_24_134(1)_13-20.nxml.txt.nlp	22198412	SENT236	13	13	23	23	bevacizumab	HER-2	PA130232992	2064	0.842
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT207	31	31	21	21	metformin	HIP	PA450395	6767;6159;64399;5068	0.842
NULL	Blood_Res_2014_Jun_25_49(2)_95-99.nxml.txt.nlp	25025010	SENT37	44	44	18	18	hydroxyurea	LIR	PA449942	10871	0.842
NULL	Curr_Neuropharmacol_2010_Dec_8(4)_394-408.nxml.txt.nlp	21629446	SENT329	5	5	7	7	bupivacaine	AP-5	PA135057240	91056	0.842
NULL	Cancers_(Basel)_2013_Jul_24_5(3)_901-918.nxml.txt.nlp	24202326	SENT328	7	7	20	20	flavopiridol	Mcl-1	PA452627	4170	0.842
NULL	Breast_Cancer_Res_2007_Jan_23_9(1)_R7.nxml.txt.nlp	17244352	SENT205	19	19	14	14	tamoxifen	UGT2B15	PA451581	7366	0.842
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT170	8	8	22	22	cisplatin	p53	PA449014	7157	0.842
NULL	Breast_Cancer_Res_2009_Nov_9_11(6)_213.nxml.txt.nlp	19909494	SENT204	22	22	15	15	lapatinib	ERBB2	PA152241907	2064	0.842
NULL	J_Breast_Cancer_2013_Jun_28_16(2)_164-170.nxml.txt.nlp	23843848	SENT117	22	22	15	15	doxorubicin	PTEN	PA449412	5728	0.842
NULL	Diabetes_2008_Sep_57(9)_2470-2479.nxml.txt.nlp	18511847	SENT103	0	0	33	33	pioglitazone	ANOVA	PA450970	4858	0.842
NULL	FEBS_Open_Bio_2014_Jan_6_4_77-89.nxml.txt.nlp	24490132	SENT289	7	7	19	19	ebselen	GDH	PA161660841	51084;2746	0.842
NULL	J_Thorac_Oncol_2014_Jun_30_9(6)_805-811.nxml.txt.nlp	24787964	SENT152	12	12	34	34	afatinib	EGFR	PA165981154	1956	0.842
NULL	Br_J_Ophthalmol_2008_Sep_22_92(9)_1275-1282.nxml.txt.nlp	18723745	SENT82	2	2	9	9	latanoprost	BAK	PA164774763	578	0.842
NULL	J_Cell_Biol_1997_Mar_24_136(6)_1213-1226.nxml.txt.nlp	9087438	SENT61	0	0	13	13	hemin	San	PA449849	80218	0.842
NULL	Support_Care_Cancer_2012_May_1_20(5)_941-949.nxml.txt.nlp	21533811	SENT12	26	26	9	9	palonosetron	HEC	PA10352	10403	0.842
NULL	Biologics_2009_Sep_15_3_429-441.nxml.txt.nlp	19774210	SENT24	14	14	40	40	irinotecan	IFL	PA450085	3439	0.842
NULL	Curr_Neuropharmacol_2013_Dec_11(6)_652-663.nxml.txt.nlp	24396340	SENT193	4	4	18	18	isoflurane	TRPV1	PA450106	7442	0.842
NULL	J_Vet_Med_Sci_2014_Oct_16_76(10)_1383-1387.nxml.txt.nlp	24931645	SENT471	19	19	4	4	liraglutide	GLP-1	PA165958364	100125288	0.842
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT207	26	26	17	17	sitagliptin	HIP	PA164748978	6767;6159;64399;5068	0.842
NULL	Infect_Dis_Obstet_Gynecol_2011_Apr_11_2011_867674.nxml.txt.nlp	21603231	SENT19	36	36	30	30	tenofovir	CD4	PA10204	920	0.842
NULL	ASN_Neuro_2009_Apr_14_1(1)_e00004.nxml.txt.nlp	19570023	SENT56	25	25	5	5	heparin	P14	PA449855	11102;;6280;56259	0.842
NULL	Eur_J_Med_Res_2009_Dec_7_14(Suppl_4)_108-111.nxml.txt.nlp	20156738	SENT91	7	7	24	24	theophylline	FKBP51	PA451647	2289	0.842
NULL	Br_J_Ophthalmol_2008_Sep_22_92(9)_1275-1282.nxml.txt.nlp	18723745	SENT52	3	3	9	9	latanoprost	BAK	PA164774763	578	0.842
NULL	Arch_Med_Sci_2013_Aug_30_9(4)_739-744.nxml.txt.nlp	24049538	SENT107	37	37	8	8	candesartan	PC-3	PA448765	692094	0.842
NULL	Aging_(Albany_NY)_2010_Sep_18_2(9)_535-537.nxml.txt.nlp	20876940	SENT13	8	8	14	14	doxorubicin	TP53	PA449412	7157	0.842
NULL	Arch_Drug_Inf_2008_Sep_1(2)_56-62.nxml.txt.nlp	19915709	SENT63	1	1	33	33	fentanyl	API	PA449599	5345	0.842
NULL	Br_J_Cancer_1996_Jun_73(11)_1356-1361.nxml.txt.nlp	8645579	SENT17	16	16	21	21	hydrocortisone	IL-8	PA449905	3576	0.842
NULL	J_Cell_Mol_Med_2013_Dec_6_17(12)_1588-1597.nxml.txt.nlp	24199964	SENT277	16	16	18	18	dobutamine	APT	PA449381	653639	0.842
NULL	Oncotarget_2014_Jun_6_5(13)_4945-4958.nxml.txt.nlp	24970814	SENT112	21	21	32	32	cisplatin	PTB	PA449014	58155	0.842
NULL	Cancer_Cell_Int_2010_May_11_10_16.nxml.txt.nlp	20459793	SENT179	34	34	16	16	cisplatin	GAPDH	PA449014	2597	0.842
NULL	J_Gen_Physiol_2009_Apr_133(4)_421-438.nxml.txt.nlp	19289574	SENT239	16	16	9	9	forskolin	SLC26A9	PA146096022	115019	0.842
NULL	Channels_(Austin)_2010_Jan_1_4(1)_22-41.nxml.txt.nlp	19934650	SENT15	1	1	21	21	quinidine	Slo3	PA451209	157855	0.842
NULL	Clin_Infect_Dis_2011_Jan_1_52(1)_31-40.nxml.txt.nlp	21148517	SENT40	16	16	21	21	vancomycin	HAP	PA451850	5915;10313	0.842
NULL	Acta_Pharmacol_Sin_2011_Aug_11_32(8)_999-1008.nxml.txt.nlp	21743486	SENT190	0	0	22	22	fasudil	c-Jun	PA165946121	3725	0.842
NULL	Ann_Dermatol_2014_Dec_26_26(6)_743-746.nxml.txt.nlp	25473228	SENT39	16	16	10	10	anastrozole	aromatase	PA448432	1588	0.842
NULL	Biosci_Rep_2014_Aug_6_34(4)_e00131.nxml.txt.nlp	24975826	SENT157	22	22	16	16	pp2	TRPM8		79054	0.842
NULL	Oncol_Lett_2014_Jan_29_7(1)_183-188.nxml.txt.nlp	24348845	SENT173	10	10	3	3	cisplatin	PDCD4	PA449014	27250	0.842
NULL	Case_Rep_Rheumatol_2014_Nov_11_2014_536856.nxml.txt.nlp	25436167	SENT24	18	18	23	23	infliximab	CPDD	PA452639	882	0.842
NULL	Int_J_Gen_Med_2011_Jul_20_4_539-545.nxml.txt.nlp	21845063	SENT12	1	1	5	5	miglitol	adiponectin	PA164776726	9370	0.842
NULL	Comp_Funct_Genomics_2012_Feb_6_2012_876893.nxml.txt.nlp	22400011	SENT137	9	9	1	1	zinc	CPSF4	PA451956	10898	0.842
NULL	Cancer_Cell_Int_2013_Jun_26_13_63.nxml.txt.nlp	23800022	SENT12	23	23	11	11	genistein	MDM2	PA165109660	4193	0.842
NULL	Gut_Liver_2013_Sep_14_7(5)_552-559.nxml.txt.nlp	24073313	SENT74	13	13	24	24	celecoxib	EGFR	PA448871	1956	0.842
NULL	Breast_Cancer_Res_2011_Jun_29_13(3)_R70.nxml.txt.nlp	21707964	SENT219	19	19	17	17	tamoxifen	14-3-3	PA451581	10971	0.842
NULL	J_Ayurveda_Integr_Med_2014_Apr-Jun_5(2)_89-96.nxml.txt.nlp	24948859	SENT208	6	6	9	9	diazepam	EPM	PA449283	2054	0.842
NULL	J_Clin_Biochem_Nutr_2011_Jul_17_49(1)_50-56.nxml.txt.nlp	21765607	SENT170	27	27	24	24	arsenite	HO-1	PA452638	3162	0.842
NULL	Oncotarget_2013_Aug_30_4(10)_1698-1711.nxml.txt.nlp	24091605	SENT128	26	26	19	19	ethanol	PDCL	PA448073	5082	0.842
NULL	AIDS_Res_Ther_2013_Jan_28_10_5.nxml.txt.nlp	23351618	SENT44	8	8	2	2	capsaicin	TRPV1	PA448776	7442	0.842
NULL	J_Clin_Biochem_Nutr_2010_Jan_29_46(1)_87-92.nxml.txt.nlp	20104270	SENT75	8	8	2	2	hesperidin	STZ	PA449867	6484	0.842
NULL	J_RNAi_Gene_Silencing_2010_May_29_6(1)_386-400.nxml.txt.nlp	20628499	SENT113	34	34	8	8	flavopiridol	ACH2	PA452627	641371	0.842
NULL	Acta_Pharmacol_Sin_2010_Sep_9_31(9)_1181-1188.nxml.txt.nlp	20694025	SENT147	22	22	34	34	cetuximab	gene59	PA10040	1762	0.842
NULL	Exp_Ther_Med_2015_Jan_18_9(1)_105-111.nxml.txt.nlp	25452783	SENT127	33	33	7	7	celecoxib	ABCG2	PA448871	9429	0.842
NULL	Br_J_Cancer_2013_Dec_10_109(12)_2954-2958.nxml.txt.nlp	24231949	SENT74	12	12	25	25	nutlin-3	p53		7157	0.842
NULL	J_Hum_Reprod_Sci_2010_Jan-Apr_3(1)_44-48.nxml.txt.nlp	20607010	SENT24	20	20	22	22	hyaluronidase	SAGE	PA164745713	55511	0.842
NULL	F1000Res_2013_Mar_5_2_74.nxml.txt.nlp	24358880	SENT271	4	4	2	2	benzaldehyde	TRPA1	PA448571	8989	0.842
NULL	Cancer_Cell_Int_2005_Jul_24_5_22.nxml.txt.nlp	16042792	SENT32	10	10	14	14	vincristine	MRP1	PA451879	4437	0.842
NULL	Arthritis_Res_Ther_2005_Mar_1_7(3)_R545-R551.nxml.txt.nlp	15899041	SENT58	18	18	37	37	etanercept	ACR	PA449515	49	0.842
NULL	J_Cardiothorac_Surg_2014_Sep_17_9(1)_129.nxml.txt.nlp	NULL	SENT20	18	18	9	9	protamine	ACT	PA10366	12;11332;9457;641455	0.842
NULL	Int_J_Biol_Sci_2014_Mar_22_10(4)_426-437.nxml.txt.nlp	24719560	SENT69	26	26	13	13	fluorescein	HNPP	PA164746009	5376	0.842
NULL	Cell_Death_Dis_2014_Jul_3_5(7)_e1316.nxml.txt.nlp	24991768	SENT54	6	6	12	12	pemetrexed	ATF3	PA10810	467	0.842
NULL	Arthritis_Res_Ther_2014_Sep_18_16(5)_427.nxml.txt.nlp	25230745	SENT147	15	15	4	4	bevacizumab	IL1B	PA130232992	3553	0.842
NULL	Nucl_Recept_Signal_2008_Nov_26_6_e010.nxml.txt.nlp	19079612	SENT482	19	19	11	11	estradiol	aromatase	PA449503	1588	0.842
NULL	Adv_Hematol_2012_Jul_24_2012_513702.nxml.txt.nlp	22888354	SENT28	22	22	15	15	lenalidomide	IL-2	PA162363968	3558	0.842
NULL	Front_Hum_Neurosci_2013_Aug_23_7_486.nxml.txt.nlp	23986679	SENT849	13	13	3	3	clomipramine	5-HTT	PA449048	6532	0.842
NULL	AIDS_Res_Ther_2014_Oct_2_11(1)_32.nxml.txt.nlp	NULL	SENT38	31	31	4	4	abacavir	CD4	PA448004	920	0.842
NULL	Int_J_Mol_Sci_2012_Feb_1_13(2)_1512-1523.nxml.txt.nlp	22408405	SENT240	22	22	10	10	rosuvastatin	LOX-1	PA134308647	4973	0.842
NULL	J_Cancer_2014_Jan_29_5(3)_182-191.nxml.txt.nlp	24563673	SENT163	27	27	0	0	heparin	HSPG2	PA449855	3339	0.842
NULL	Br_J_Cancer_2009_Jul_7_101(1)_149-159.nxml.txt.nlp	19513073	SENT216	38	38	2	2	cisplatin	MUT	PA449014	4594	0.842
NULL	Diabetes_Obes_Metab_2012_Apr_14(4)_304-314.nxml.txt.nlp	22051096	SENT73	8	8	31	31	liraglutide	PPG	PA165958364	5552	0.842
NULL	Mol_Cancer_2009_Aug_3_8_59.nxml.txt.nlp	19650915	SENT60	10	10	23	23	estradiol	SERCA3	PA449503	489	0.842
NULL	Diabetes_Metab_J_2014_Jun_17_38(3)_211-219.nxml.txt.nlp	25003075	SENT76	15	15	3	3	vildagliptin	PPG	PA165958346	5552	0.842
NULL	Cancers_(Basel)_2010_May_28_2(2)_1040-1065.nxml.txt.nlp	24281106	SENT497	6	6	20	20	paclitaxel	San	PA450761	80218	0.842
NULL	Oncoimmunology_2012_Oct_1_1(7)_1004-1016.nxml.txt.nlp	23170249	SENT63	6	6	25	25	paclitaxel	HER-2	PA450761	2064	0.842
NULL	Diabetes_Care_2013_Dec_13_36(12)_3930-3937.nxml.txt.nlp	23990523	SENT14	21	21	2	2	glucose	adiponectin	PA449773	9370	0.842
NULL	Oncotarget_2013_Apr_10_4(4)_622-635.nxml.txt.nlp	23599172	SENT80	3	3	13	13	gefitinib	PI3	PA131301952	5266	0.842
NULL	Cases_J_2009_Mar_10_2_6464.nxml.txt.nlp	20181162	SENT39	5	5	1	1	ribavirin	IFN	PA451241	3439	0.842
NULL	Arch_Trauma_Res_2013_Dec_1_2(3)_124-128.nxml.txt.nlp	24693522	SENT148	10	10	15	15	propofol	Bcl-2	PA451141	596	0.842
NULL	Niger_J_Surg_2014_Jan-Jun_20(1)_9-15.nxml.txt.nlp	24665195	SENT224	0	0	4	4	denosumab	RANKL	PA166048634	8600	0.842
NULL	Acta_Pharmacol_Sin_2009_Jul_22_30(7)_956-964.nxml.txt.nlp	19543298	SENT125	0	0	6	6	atorvastatin	ABCG2	PA448500	9429	0.842
NULL	Ann_Surg_Treat_Res_2014_Feb_22_86(2)_68-75.nxml.txt.nlp	24761411	SENT123	8	8	16	16	oxaliplatin	survivin	PA131285527	332	0.842
NULL	Front_Oncol_2014_May_19_4_113.nxml.txt.nlp	24904827	SENT132	23	23	35	35	cisplatin	DGCR8	PA449014	54487	0.842
NULL	Front_Endocrinol_(Lausanne)_2013_Sep_17_4_123.nxml.txt.nlp	24062726	SENT14	32	32	30	30	hexachlorophene	GDH	PA449871	51084;2746	0.842
NULL	Br_J_Cancer_2009_Nov_3_101(9)_1574-1579.nxml.txt.nlp	19773761	SENT68	35	35	9	9	ethanol	CO2	PA448073	4513	0.842
NULL	Cancer_Med_2012_Oct_1_1(2)_114-127.nxml.txt.nlp	23342262	SENT376	15	15	18	18	cetuximab	EGF	PA10040	1950	0.842
NULL	Breast_Cancer_Res_2004_Aug_5_6(5)_R601-R607.nxml.txt.nlp	15318941	SENT147	42	42	8	8	docetaxel	CCNE1	PA449383	898	0.842
NULL	Int_J_Mol_Sci_2014_Mar_20_15(3)_4965-4976.nxml.txt.nlp	24658440	SENT35	19	19	6	6	cyclosporine	P-gp	PA449167	5243	0.842
NULL	Clin_Ophthalmol_2009_Jun_2_3_199-210.nxml.txt.nlp	19668566	SENT84	19	19	9	9	bromfenac	COX	PA448670	1351	0.842
NULL	Cell_Commun_Signal_2013_Nov_11_11_86.nxml.txt.nlp	24215724	SENT548	3	3	28	28	thrombin	PAR1	PA451674	79581;2149	0.842
NULL	Cell_Death_Dis_2010_Oct_7_1(10)_e79.nxml.txt.nlp	21368852	SENT124	21	21	3	3	lorazepam	Bcl-2	PA450267	596	0.842
NULL	Br_J_Cancer_2006_Dec_4_95(11)_1483-1489.nxml.txt.nlp	17106442	SENT145	38	38	1	1	platinum	EGFR	PA150595617	1956	0.842
NULL	Br_J_Cancer_2010_Oct_12_103(8)_1309-1310.nxml.txt.nlp	NULL	SENT15	17	17	27	27	sunitinib	IFN	PA162372840	3439	0.842
NULL	Cells_2014_Sep_12_3(3)_914-938.nxml.txt.nlp	25222270	SENT198	17	17	14	14	capsaicin	TRPV1	PA448776	7442	0.842
NULL	Biol_Proced_Online_2003_Oct_24_5_211-221.nxml.txt.nlp	14615818	SENT189	27	27	14	14	procainamide	CD4	PA451108	920	0.842
NULL	Orphanet_J_Rare_Dis_2014_Dec_10_9(1)_200.nxml.txt.nlp	NULL	SENT95	19	19	13	13	teriparatide	HCS	PA451620	3141;54205	0.842
NULL	Acta_Pharmacol_Sin_2011_Oct_15_32(10)_1233-1238.nxml.txt.nlp	21841815	SENT87	4	4	12	12	mecamylamine	CTX	PA450334	1593	0.842
NULL	J_Korean_Med_Sci_2006_Dec_31_21(6)_1037-1040.nxml.txt.nlp	17179683	SENT90	10	10	22	22	amoxicillin	BAM	PA448406	9126	0.842
NULL	Ann_Oncol_2014_Oct_18_25(10)_1871-1888.nxml.txt.nlp	25234545	SENT203	31	31	33	33	everolimus	aromatase	PA164746311	1588	0.842
NULL	Blood_Cancer_J_2014_Apr_25_4(4)_e206.nxml.txt.nlp	24769647	SENT140	22	22	0	0	doxorubicin	Xin	PA449412	165904	0.842
NULL	Biologics_2014_Apr_7_8_141-153.nxml.txt.nlp	24741293	SENT199	37	37	22	22	rituximab	IL-6	PA451261	3569	0.842
NULL	Onco_Targets_Ther_2014_Sep_9_7_1571-1582.nxml.txt.nlp	25228815	SENT134	16	16	4	4	sunitinib	VEGFR2	PA162372840	3791	0.842
NULL	J_Hematol_Oncol_2010_Apr_9_3_14.nxml.txt.nlp	20377918	SENT49	9	9	4	4	hydroxyurea	IFN	PA449942	3439	0.842
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Mar_26_3(3)_e107.nxml.txt.nlp	24670388	SENT143	20	20	4	4	midazolam	CTRC	PA450496	11330	0.842
NULL	Br_J_Pharmacol_2011_Oct_164(3)_866-883.nxml.txt.nlp	21323893	SENT116	17	17	11	11	nitrogen	ROS	PA450643	6098	0.842
NULL	AIDS_Res_Ther_2009_Dec_23_6_30.nxml.txt.nlp	20030841	SENT93	23	23	16	16	efavirenz	CD4	PA449441	920	0.842
NULL	J_Headache_Pain_2014_Dec_8_15(1)_85.nxml.txt.nlp	25488888	SENT102	0	0	10	10	sumatriptan	5-HT1B	PA451566	3351	0.842
NULL	Acta_Pharmacol_Sin_2009_Feb_26_30(2)_175-183.nxml.txt.nlp	19169269	SENT9	3	3	24	24	iptakalim	NUP54	PA165949694	53371	0.842
NULL	Cancer_Cell_Int_2013_Mar_4_13_21.nxml.txt.nlp	23497288	SENT27	14	14	7	7	doxorubicin	P-gp	PA449412	5243	0.842
NULL	ScientificWorldJournal_2012_Jan_2_11_2620-2634.nxml.txt.nlp	22262950	SENT214	20	20	22	22	cyclophosphamide	CTX	PA449165	1593	0.842
NULL	Diabetes_Metab_Syndr_Obes_2010_Mar_29_3_31-41.nxml.txt.nlp	21437074	SENT157	20	20	6	6	liraglutide	GLP-1	PA165958364	100125288	0.842
NULL	Oncotarget_2014_Aug_29_5(19)_8947-8958.nxml.txt.nlp	25333254	SENT104	9	9	29	29	cytarabine	CXCR4	PA449177	7852	0.842
NULL	Int_J_Biol_Sci_2013_Dec_17_10(1)_64-72.nxml.txt.nlp	24391452	SENT213	19	19	22	22	verapamil	5-HT2A	PA451868	3356	0.842
NULL	Oncol_Rep_2014_Apr_28_31(4)_1605-1612.nxml.txt.nlp	24481648	SENT10	31	31	23	23	vincristine	MRP7	PA451879	89845;1080	0.842
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Dec_17_3(12)_e152.nxml.txt.nlp	25518025	SENT59	6	6	9	9	oxycodone	CYP2D6	PA450741	1565	0.842
NULL	Biochem_Res_Int_2010_Aug_4_2010_549572.nxml.txt.nlp	21188077	SENT140	12	12	30	30	l-tyrosine	TAT	PA451822	6898	0.842
NULL	EPMA_J_2011_Dec_23_2(4)_351-356.nxml.txt.nlp	23199173	SENT41	21	21	11	11	estradiol	aromatase	PA449503	1588	0.842
NULL	J_Skin_Cancer_2013_Feb_24_2013_735282.nxml.txt.nlp	23533766	SENT34	28	28	34	34	cisplatin	IL-2	PA449014	3558	0.842
NULL	Hum_Genomics_2009_Jan_1_3(2)_169-190.nxml.txt.nlp	19164093	SENT133	27	27	17	17	warfarin	CYP2C9	PA451906	1559	0.842
NULL	Oncotarget_2014_Oct_21_5(22)_11709-11722.nxml.txt.nlp	25365944	SENT10	4	4	13	13	metformin	JNK	PA450395	5599	0.842
NULL	Oncotarget_2014_Mar_16_5(7)_1837-1845.nxml.txt.nlp	24742823	SENT112	15	15	10	10	trastuzumab	HER-2	PA451743	2064	0.842
NULL	Oxid_Med_Cell_Longev_2013_Jul_10_2013_286524.nxml.txt.nlp	23936606	SENT183	23	23	17	17	curcumin	NRF2	PA151958596	2551;4780	0.842
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT119	44	44	23	23	perifosine	DR4	PA165291471	8797	0.842
NULL	J_Ophthalmol_2011_Oct_20_2011_252549.nxml.txt.nlp	22046503	SENT122	11	11	25	25	bevacizumab	APOE	PA130232992	348	0.842
NULL	Ecancermedicalscience_2008_Feb_18_2_75.nxml.txt.nlp	22275966	SENT146	26	26	16	16	gefitinib	EGFR	PA131301952	1956	0.842
NULL	Toxins_(Basel)_2010_Oct_26_2(11)_2490-2518.nxml.txt.nlp	22069563	SENT220	24	24	12	12	cisplatin	TLR4	PA449014	7099	0.842
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Dec_10_3(12)_e151.nxml.txt.nlp	25494035	SENT213	9	9	1	1	pravastatin	SLCO1B1	PA451089	10599	0.842
NULL	Mol_Cancer_2013_Mar_5_12_17.nxml.txt.nlp	23497256	SENT66	23	23	17	17	sunitinib	HDMX	PA162372840	4194;4193	0.842
NULL	Iran_J_Pharm_Res_2014_Spring_13(2)_583-590.nxml.txt.nlp	25237354	SENT115	1	1	8	8	enoxaparin	IL-6	PA449463	3569	0.842
NULL	J_Biol_Chem_2013_Dec_6_288(49)_35387-35395.nxml.txt.nlp	24142790	SENT13	2	2	5	5	meclizine	PCYT2	PA450338	5833	0.842
NULL	Cases_J_2009_Mar_10_2_6464.nxml.txt.nlp	20181162	SENT6	26	26	35	35	ribavirin	IFN	PA451241	3439	0.842
NULL	Curr_Neuropharmacol_2010_Sep_8(3)_287-304.nxml.txt.nlp	21358978	SENT33	24	24	7	7	lamotrigine	CRF1	PA450164	1394	0.842
NULL	Croat_Med_J_2012_Jun_53(3)_214-223.nxml.txt.nlp	22661134	SENT85	6	6	24	24	reserpine	ACTH	PA451236	5443	0.842
NULL	Acta_Oncol_2013_May_13_52(4)_776-782.nxml.txt.nlp	23480638	SENT30	28	28	33	33	imatinib	KIT	PA10804	3815	0.842
NULL	Lipids_Health_Dis_2011_Feb_12_10_31.nxml.txt.nlp	21314960	SENT11	4	4	2	2	hemin	HO-1	PA449849	3162	0.842
NULL	Bone_Joint_Res_2014_Mar_1_3(3)_51-59.nxml.txt.nlp	24615710	SENT197	16	16	4	4	resveratrol	SIRT1		23411	0.842
NULL	Eur_J_Endocrinol_2011_Jan_164(1)_69-74.nxml.txt.nlp	20961967	SENT4	13	13	18	18	pioglitazone	PPARG	PA450970	5468	0.842
NULL	Curr_Neuropharmacol_2013_Mar_11(2)_160-170.nxml.txt.nlp	23997751	SENT123	25	25	11	11	haloperidol	5-HT2A	PA449841	3356	0.842
NULL	Diabetes_2011_Jul_20_60(7)_1990-1999.nxml.txt.nlp	21617181	SENT297	9	9	27	27	pioglitazone	adiponectin	PA450970	9370	0.842
NULL	Oncotarget_2011_Nov_9_2(11)_850-861.nxml.txt.nlp	22081665	SENT0	13	13	7	7	idarubicin	DNMT3A	PA449961	1788	0.842
NULL	Orphanet_J_Rare_Dis_2010_Jan_29_5_2.nxml.txt.nlp	20113479	SENT375	16	16	29	29	camptothecin	RECQL4	PA153590860	9401	0.842
NULL	Oxid_Med_Cell_Longev_2013_Jul_9_2013_574029.nxml.txt.nlp	23936610	SENT181	4	4	10	10	resveratrol	p50		958;4790	0.842
NULL	J_RNAi_Gene_Silencing_2009_Mar_9_5(1)_321-330.nxml.txt.nlp	19771229	SENT8	24	24	20	20	hydroxyurea	RRM2	PA449942	6241	0.842
NULL	Mol_Cancer_2010_May_18_9_110.nxml.txt.nlp	20482802	SENT33	10	10	6	6	bortezomib	PSMB5	PA10252	5693	0.842
NULL	Br_J_Cancer_2011_Sep_6_105(6)_807-813.nxml.txt.nlp	21847121	SENT86	31	31	7	7	gefitinib	EGFR	PA131301952	1956	0.842
NULL	Clin_Interv_Aging_2015_Jan_6_10_157-174.nxml.txt.nlp	25609933	SENT251	35	35	8	8	tamoxifen	BCS	PA451581	617	0.842
NULL	Indian_J_Pharmacol_2014_Nov-Dec_46(6)_627-632.nxml.txt.nlp	25538335	SENT150	21	21	17	17	metformin	Q10	PA450395	27161	0.842
NULL	Mol_Biol_Rep_2013_May_11_40(8)_5013-5026.nxml.txt.nlp	23666059	SENT252	28	28	19	19	resveratrol	CDC2		5424	0.842
NULL	Cancer_Immunol_Immunother_2013_Aug_27_62(10)_1637-1648.nxml.txt.nlp	23982484	SENT160	10	10	24	24	lenalidomide	IL-6	PA162363968	3569	0.842
NULL	Ecancermedicalscience_2009_Sep_24_3_153.nxml.txt.nlp	22276017	SENT41	36	36	3	3	platinum	XPA	PA150595617	7507	0.842
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT91	17	17	24	24	l-methionine	p27	PA450423	5715;10534	0.842
NULL	Oncotarget_2014_Sep_5_5(17)_7216.nxml.txt.nlp	25277174	SENT9	35	35	9	9	doxorubicin	STAT6	PA449412	6778	0.842
NULL	Exp_Ther_Med_2014_Mar_10_7(3)_640-648.nxml.txt.nlp	24520260	SENT49	13	13	18	18	resveratrol	p38		10598;1432;7965	0.842
NULL	Exp_Ther_Med_2013_Feb_13_5(2)_581-585.nxml.txt.nlp	23403473	SENT83	40	40	15	15	etanercept	HMGB1	PA449515	3146	0.842
NULL	Breast_Cancer_Res_2011_Apr_15_13(2)_R44.nxml.txt.nlp	21496232	SENT445	19	19	16	16	trastuzumab	PI3K	PA451743	5290	0.842
NULL	Cancer_Cell_Int_2005_Jul_24_5_22.nxml.txt.nlp	16042792	SENT40	10	10	15	15	vincristine	NAC	PA451879	22861	0.842
NULL	J_Mol_Signal_2012_Aug_16_7_12.nxml.txt.nlp	22898329	SENT199	0	0	12	12	dasatinib	LYN	PA162372878	4067	0.842
NULL	Eur_J_Med_Res_2011_Oct_10_16(10)_427-436.nxml.txt.nlp	22024421	SENT166	14	14	3	3	tenofovir	CD4	PA10204	920	0.842
NULL	Subst_Abuse_Treat_Prev_Policy_2009_Apr_17_4_6.nxml.txt.nlp	19374740	SENT49	27	27	7	7	buprenorphine	OST	PA448685	1650;23263	0.842
NULL	Breast_Cancer_Res_2013_Sep_25_15(5)_R88.nxml.txt.nlp	24063698	SENT30	22	22	12	12	olaparib	BRCA2		675	0.842
NULL	J_Mol_Med_2008_Sep_4_86(9)_1045-1056.nxml.txt.nlp	18600309	SENT119	8	8	30	30	salmeterol	IL-8	PA451300	3576	0.842
NULL	Mutat_Res_2011_Jul_728(1-2)_23-34.nxml.txt.nlp	21605699	SENT261	8	8	2	2	bevacizumab	VEGF-A	PA130232992	7422	0.842
NULL	J_Int_Soc_Sports_Nutr_2015_Jan_21_12(1)_5.nxml.txt.nlp	NULL	SENT41	9	9	13	13	curcumin	AP-1	PA151958596	2353;3727;2354;3725	0.842
NULL	Acta_Pharmacol_Sin_2010_Dec_3_31(12)_1635-1642.nxml.txt.nlp	21127497	SENT137	2	2	6	6	phenylbutazone	UGT	PA450932	7361;7355	0.842
NULL	Apoptosis_2012_Sep_30_17(9)_989-997.nxml.txt.nlp	22460505	SENT139	3	3	8	8	thioridazine	PI3K	PA451666	5290	0.842
NULL	Med_Sci_Monit_2013_Oct_31_19_916-926.nxml.txt.nlp	24172537	SENT178	0	0	9	9	erlotinib	KRAS	PA134687924	3845	0.842
NULL	J_Hematol_Oncol_2011_Dec_21_4_53.nxml.txt.nlp	22189016	SENT70	10	10	22	22	verapamil	P-gp	PA451868	5243	0.842
NULL	Arthritis_Res_Ther_2007_Oct_9_9(5)_R104.nxml.txt.nlp	17925024	SENT186	5	5	27	27	glucosamine	p38	PA164747613	10598;1432;7965	0.842
NULL	Br_J_Clin_Pharmacol_2011_Oct_72(4)_647-657.nxml.txt.nlp	21518389	SENT92	5	5	15	15	prasugrel	P2Y12	PA154410481	64805	0.842
NULL	Open_Access_J_Urol_2011_May_10_3_69-82.nxml.txt.nlp	24198638	SENT60	25	25	27	27	omeprazole	CYP2C19	PA450704	1557	0.842
NULL	Exp_Cell_Res_2009_Nov_15_315(19)_3433-3441.nxml.txt.nlp	19716819	SENT444	12	12	9	9	hyaluronan	CD44	PA165958431	960	0.842
NULL	Clin_Med_Insights_Circ_Respir_Pulm_Med_2011_Oct_18_5_57-70.nxml.txt.nlp	22084617	SENT141	7	7	1	1	roflumilast	EOS	PA165948052	260429	0.842
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT286	4	4	12	12	pertuzumab	HER2		2064	0.842
NULL	Br_J_Pharmacol_2008_Sep_9_155(1)_127-137.nxml.txt.nlp	18536750	SENT179	5	5	1	1	piroxicam	IL-10	PA450985	3586	0.842
NULL	Eur_J_Pharmacol_2012_Jul_5_686(1-3)_22-31.nxml.txt.nlp	22564863	SENT152	23	23	10	10	memantine	GluN3B	PA10364	116444	0.842
NULL	Breast_Cancer_Res_2012_May_14_14(3)_R77.nxml.txt.nlp	22583478	SENT425	41	41	18	18	tamoxifen	HER2	PA451581	2064	0.842
NULL	Cancer_Inform_2007_May_1_3_125-139.nxml.txt.nlp	19455240	SENT135	13	13	18	18	indomethacin	Bcl-2	PA449982	596	0.842
NULL	Front_Immunol_2012_Jul_4_3_185.nxml.txt.nlp	22783258	SENT211	4	4	11	11	curcumin	IL-13	PA151958596	3596	0.842
NULL	Breast_Cancer_Res_2004_Aug_5_6(5)_R601-R607.nxml.txt.nlp	15318941	SENT108	7	7	1	1	docetaxel	p27	PA449383	5715;10534	0.842
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT188	10	10	7	7	cisplatin	p53	PA449014	7157	0.842
NULL	Oncol_Lett_2014_May_11_7(5)_1401-1408.nxml.txt.nlp	24765145	SENT155	6	6	14	14	paclitaxel	PI3K	PA450761	5290	0.842
NULL	J_Cell_Biol_2008_Jul_14_182(1)_171-184.nxml.txt.nlp	18606850	SENT58	13	13	7	7	doxycycline	FN14	PA449415	51330	0.842
NULL	F1000Res_2014_Aug_19_3_198.nxml.txt.nlp	25400908	SENT289	20	20	15	15	trastuzumab	HER2	PA451743	2064	0.842
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT233	12	12	10	10	lapatinib	ADAM17	PA152241907	6868	0.842
NULL	Diabetes_Care_2010_Nov_3_33(11)_2349-2354.nxml.txt.nlp	20682680	SENT19	12	12	7	7	sitagliptin	GLP-1	PA164748978	100125288	0.842
NULL	Int_J_Hypertens_2012_Nov_21_2012_474870.nxml.txt.nlp	23227311	SENT183	13	13	10	10	vasopressin	AT1	PA451858	9197;185	0.842
NULL	Indian_J_Pharmacol_2013_May-Jun_45(3)_286-288.nxml.txt.nlp	23833375	SENT28	2	2	24	24	montelukast	NMU	PA450546	10874	0.842
NULL	Case_Rep_Med_2012_May_28_2012_757696.nxml.txt.nlp	22685471	SENT8	6	6	19	19	lorazepam	CHS	PA450267	1130	0.842
NULL	J_Int_AIDS_Soc_2012_Nov_11_15(6Suppl_4)_18154.nxml.txt.nlp	NULL	SENT22	18	18	24	24	ritonavir	RANTES	PA451260	6352	0.842
NULL	Indian_J_Med_Res_2014_Jan_139(1)_76-82.nxml.txt.nlp	24604041	SENT30	26	26	2	2	albendazole	STH	PA164746058	246744	0.842
NULL	Breast_Cancer_Res_2010_Jun_4_12(3)_R32.nxml.txt.nlp	20525379	SENT10	10	10	3	3	fulvestrant	AGR2	PA164747170	10551	0.842
NULL	Mol_Cancer_2010_May_27_9_124.nxml.txt.nlp	20504375	SENT141	27	27	2	2	doxycycline	HOXB13	PA449415	10481	0.842
NULL	Brain_Sci_2014_May_6_4(2)_356-375.nxml.txt.nlp	24961766	SENT223	3	3	23	23	propofol	P28	PA451141	9446;7802;9527	0.842
NULL	Mol_Cancer_2010_Dec_20_9_317.nxml.txt.nlp	21172025	SENT214	38	38	21	21	tamoxifen	EVL	PA451581	51466	0.842
NULL	Cancers_(Basel)_2009_Dec_15_1(1)_23-28.nxml.txt.nlp	20535236	SENT18	6	6	4	4	cisplatin	TRX	PA449014	7295	0.842
NULL	Br_J_Pharmacol_2014_Jan_23_171(2)_523-535.nxml.txt.nlp	24372553	SENT195	3	3	26	26	metformin	SIRT1	PA450395	23411	0.842
NULL	Turk_J_Haematol_2013_Dec_5_30(4)_424-425.nxml.txt.nlp	24385839	SENT9	26	26	2	2	carbamazepine	IL-6	PA448785	3569	0.842
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT93	0	0	11	11	mitoxantrone	B7-H1	PA450526	29126	0.842
NULL	Genetics_2014_Jun_20_197(2)_611-623.nxml.txt.nlp	24653001	SENT42	27	27	45	45	camptothecin	TEL1	PA153590860	472	0.842
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Feb_10_66(Pt_3)_o568.nxml.txt.nlp	21580336	SENT56	23	23	9	9	ethanol	mol	PA448073	90527	0.842
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT170	4	4	22	22	chloroquine	BMP9	PA448948	2658	0.842
NULL	Hum_Genomics_2004_Nov_1_1(6)_444-455.nxml.txt.nlp	15606999	SENT136	17	17	12	12	paroxetine	CYP2D6	PA450801	1565	0.842
NULL	Front_Oncol_2014_Oct_8_4_267.nxml.txt.nlp	25340037	SENT78	12	12	32	32	cetuximab	KRAS	PA10040	3845	0.842
NULL	Target_Oncol_2013_Jun_27_8(2)_127-136.nxml.txt.nlp	23625191	SENT154	24	24	18	18	cetuximab	PIK3CA	PA10040	5290	0.842
NULL	Aging_Cell_2013_Jun_27_12(3)_435-445.nxml.txt.nlp	23448364	SENT256	13	13	0	0	doxorubicin	p53	PA449412	7157	0.842
NULL	Ann_Oncol_2012_Nov_22_23(11)_2782-2790.nxml.txt.nlp	22730099	SENT122	15	15	24	24	estradiol	OPG	PA449503	690	0.842
NULL	Viruses_2013_Nov_22_5(11)_2898-2919.nxml.txt.nlp	24284880	SENT156	7	7	34	34	plerixafor	HSPC	PA165958410	5688	0.842
NULL	Int_J_Biol_Sci_2013_Mar_7_9(3)_279-288.nxml.txt.nlp	23493630	SENT15	17	17	6	6	tocilizumab	CD4	PA165292659	920	0.842
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_P108.nxml.txt.nlp	NULL	SENT14	4	4	15	15	piperacillin	IFN	PA450975	3439	0.842
NULL	Osteoarthritis_Cartilage_2010_Apr_18(4)_555-562.nxml.txt.nlp	20060953	SENT141	30	30	7	7	clenbuterol	MNX	PA164745640	3892	0.842
NULL	Cell_Regen_(Lond)_2012_Jun_28_1(1)_4.nxml.txt.nlp	25408867	SENT62	24	24	33	33	trypsin	SNX17	PA451806	9784	0.842
NULL	Nat_Commun_2014_Nov_25_5_5548.nxml.txt.nlp	25420520	SENT671	21	21	3	3	paclitaxel	ERG	PA450761	2078	0.842
NULL	Eur_J_Clin_Pharmacol_2013_Mar_11_69(3)_327-339.nxml.txt.nlp	22782539	SENT271	20	20	4	4	dabigatran	P-gp		5243	0.842
NULL	Cancer_Manag_Res_2013_Aug_23_5_251-269.nxml.txt.nlp	24049458	SENT177	7	7	10	10	perifosine	AKT	PA165291471	207	0.842
NULL	Onco_Targets_Ther_2014_Oct_29_7_1997-2006.nxml.txt.nlp	25378934	SENT132	12	12	24	24	docetaxel	San	PA449383	80218	0.842
NULL	Nat_Med_2013_Mar_10_19(3)_313-321.nxml.txt.nlp	23396211	SENT152	15	15	7	7	amlexanox	TBK1	PA164745310	29110	0.842
NULL	An_Bras_Dermatol_2014_Mar-Apr_89(2)_301-310.nxml.txt.nlp	24770508	SENT144	10	10	4	4	vemurafenib	BRAF	PA165946873	673	0.842
NULL	Cells_2014_Oct_14_3(4)_963-980.nxml.txt.nlp	25317928	SENT218	17	17	10	10	estradiol	RANK	PA449503	8792	0.842
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT94	4	4	9	9	chloroquine	BMPR-II	PA448948	659	0.842
NULL	Mol_Cancer_2009_Nov_24_8_109.nxml.txt.nlp	19930708	SENT183	26	26	15	15	exemestane	aromatase	PA449563	1588	0.842
NULL	Mol_Cell_2014_May_8_54(3)_445-459.nxml.txt.nlp	24746700	SENT39	13	13	32	32	etoposide	BRCA1	PA449552	672	0.842
NULL	Biochim_Biophys_Acta_2013_Jul_1832(7)_905-910.nxml.txt.nlp	23032152	SENT141	25	25	18	18	ketanserin	5-HT2B	PA131053734	3357	0.842
NULL	J_Hematol_Oncol_2013_Jul_18_6_53.nxml.txt.nlp	23866964	SENT53	33	33	16	16	temsirolimus	CD10	PA164746890	4311	0.842
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT49	42	42	3	3	chlorzoxazone	CYP3A	PA448971	1574	0.842
NULL	J_Thorac_Oncol_2014_May_22_9(5)_710-716.nxml.txt.nlp	24722157	SENT161	4	4	23	23	cetuximab	EGFR	PA10040	1956	0.842
NULL	Ann_N_Y_Acad_Sci_2013_Apr_6_1281(1)_36-50.nxml.txt.nlp	23387439	SENT204	2	2	34	34	metformin	Yes	PA450395	7525	0.842
NULL	Ann_Clin_Transl_Neurol_2014_Dec_21_1(12)_996-1005.nxml.txt.nlp	25574474	SENT119	11	11	20	20	riluzole	P-gp	PA451251	5243	0.842
NULL	Oncol_Rep_2012_Apr_20_27(4)_1128-1134.nxml.txt.nlp	22200845	SENT145	5	5	25	25	berberine	HCC	PA165860812	84668	0.842
NULL	Oncotarget_2011_Sep_9_2(9)_658-668.nxml.txt.nlp	21911919	SENT97	15	15	7	7	daunorubicin	NAC	PA449212	22861	0.842
NULL	Mar_Drugs_2014_Jun_27_12(7)_3818-3837.nxml.txt.nlp	24979269	SENT209	30	30	33	33	calcein	MRP1	PA132595336	4437	0.842
NULL	Eur_J_Immunol_2014_Jun_10_44(6)_1759-1769.nxml.txt.nlp	24595810	SENT137	20	20	7	7	fludrocortisone	CXCR4	PA164743961	7852	0.842
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT120	5	5	10	10	simvastatin	RANKL	PA451363	8600	0.842
NULL	Cancers_(Basel)_2010_May_28_2(2)_1040-1065.nxml.txt.nlp	24281106	SENT97	35	35	23	23	imatinib	EGFR	PA10804	1956	0.842
NULL	Breast_Cancer_(Auckl)_2011_Oct_9_5_209-226.nxml.txt.nlp	22084574	SENT195	2	2	17	17	anastrozole	ATAC	PA448432	6375	0.842
NULL	Indian_J_Anaesth_2009_Oct_53(5)_582-591.nxml.txt.nlp	20640109	SENT84	21	21	27	27	clopidogrel	ADP	PA449053	23038	0.842
NULL	BMB_Rep_2014_Apr_47(4)_221-226.nxml.txt.nlp	24286312	SENT121	7	7	34	34	nutlin-3	p53		7157	0.842
NULL	Scientifica_(Cairo)_2012_Dec_17_2012_502378.nxml.txt.nlp	24278706	SENT103	34	34	10	10	quinidine	P-gp	PA451209	5243	0.842
NULL	Genome_Biol_2008_Mar_11_9(3)_R53.nxml.txt.nlp	18334025	SENT420	9	9	3	3	cisplatin	TP53	PA449014	7157	0.842
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT718	17	17	3	3	pertuzumab	HER3		2065	0.842
NULL	Breast_Cancer_Res_2007_Mar_2_9(2)_205.nxml.txt.nlp	NULL	SENT55	12	12	38	38	imatinib	HER-2	PA10804	2064	0.842
NULL	Breast_Cancer_Res_2007_Dec_20_9(Suppl_2)_S11.nxml.txt.nlp	NULL	SENT19	21	21	24	24	tamoxifen	ATAC	PA451581	6375	0.842
NULL	Br_J_Cancer_2012_Nov_20_107(11)_1840-1843.nxml.txt.nlp	23099805	SENT77	20	20	10	10	s-adenosylmethionine	B12	PA164754994	7126;4709	0.842
NULL	Clin_Med_Insights_Oncol_2012_May_16_6_205-217.nxml.txt.nlp	22654526	SENT248	19	19	32	32	erlotinib	VEGFR	PA134687924	3791	0.842
NULL	Breast_Cancer_Res_2012_Jan_7_14(1)_R8.nxml.txt.nlp	22226054	SENT204	21	21	3	3	estradiol	c-Myc	PA449503	4609	0.842
NULL	Evid_Based_Complement_Alternat_Med_2011_Mar_10_2011_561396.nxml.txt.nlp	21792360	SENT122	9	9	7	7	simvastatin	CD40L	PA451363	959	0.842
NULL	Br_J_Cancer_2010_Feb_2_102(3)_520-529.nxml.txt.nlp	20029417	SENT120	25	25	15	15	cetuximab	IL-21	PA10040	59067;50616;27189	0.842
NULL	Int_J_Endocrinol_2011_Aug_21_2011_742719.nxml.txt.nlp	21869886	SENT103	23	23	13	13	thrombin	ADP	PA451674	23038	0.842
NULL	Mol_Biol_Cell_2014_Aug_15_25(16)_2416-2427.nxml.txt.nlp	24943843	SENT406	27	27	11	11	paraformaldehyde	NPY	PA450790	4852	0.842
NULL	Br_J_Cancer_2014_Jan_21_110(2)_510-519.nxml.txt.nlp	24327015	SENT14	28	28	23	23	cisplatin	CDK1	PA449014	983	0.842
NULL	Breast_Cancer_Res_2011_Nov_23_13(6)_R116.nxml.txt.nlp	22113133	SENT19	2	2	27	27	diethylstilbestrol	JAG1	PA449307	182	0.842
NULL	Ann_Rheum_Dis_2008_Oct_16_68(8)_1277-1284.nxml.txt.nlp	18930987	SENT27	7	7	31	31	infliximab	adiponectin	PA452639	9370	0.842
NULL	Int_J_Mol_Sci_2014_Jun_5_15(6)_10034-10051.nxml.txt.nlp	24905404	SENT33	37	37	21	21	doxorubicin	Bcl-2	PA449412	596	0.842
NULL	Addict_Biol_2011_Jan_16(1)_82-91.nxml.txt.nlp	20579004	SENT178	34	34	7	7	naltrexone	ghrelin	PA450588	51738	0.842
NULL	Br_J_Cancer_2010_Jul_13_103(2)_265-274.nxml.txt.nlp	20551953	SENT214	17	17	32	32	cisplatin	JNK	PA449014	5599	0.842
NULL	J_Thromb_Haemost_2007_May_1_5(5)_910-917.nxml.txt.nlp	17362227	SENT168	26	26	15	15	thrombin	P2X1	PA451674	5023	0.842
NULL	F1000Res_2014_Aug_19_3_198.nxml.txt.nlp	25400908	SENT297	19	19	27	27	docetaxel	HER2	PA449383	2064	0.842
NULL	Oxid_Med_Cell_Longev_2013_Nov_28_2013_568093.nxml.txt.nlp	24379901	SENT72	6	6	17	17	resveratrol	AMPK		5563	0.842
NULL	J_Korean_Med_Sci_2007_Aug_31_22(4)_611-615.nxml.txt.nlp	17728497	SENT29	6	6	22	22	lisinopril	MCP-1	PA450242	6347	0.842
NULL	Front_Neurol_2011_Jul_4_2_36.nxml.txt.nlp	21772826	SENT90	25	25	12	12	clopidogrel	NNT	PA449053	23530	0.842
NULL	Pharmaceutics_2011_Nov_18_3(4)_865-913.nxml.txt.nlp	24309312	SENT320	10	10	34	34	glibenclamide	P-gp	PA449782	5243	0.842
NULL	J_Thromb_Haemost_2007_May_5(5)_1010-1018.nxml.txt.nlp	17355572	SENT272	3	3	17	17	thrombin	VWF	PA451674	7450	0.842
NULL	Acta_Pharmacol_Sin_2011_Feb_4_32(2)_259-269.nxml.txt.nlp	21293479	SENT177	13	13	4	4	sn-38	UGT1A10		54575	0.842
NULL	Cardiovasc_Diabetol_2006_May_2_5_10.nxml.txt.nlp	16669997	SENT0	14	14	10	10	glucose	adiponectin	PA449773	9370	0.842
NULL	Cells_2014_Jan_27_3(1)_53-78.nxml.txt.nlp	24709902	SENT1462	8	8	1	1	trastuzumab	PTEN	PA451743	5728	0.842
NULL	Mol_Cancer_2008_Mar_26_7_27.nxml.txt.nlp	18366759	SENT228	12	12	0	0	etoposide	HIF-1	PA449552	29072	0.842
NULL	Environ_Health_Perspect_2005_Oct_14_113(10)_1330-1335.nxml.txt.nlp	16203242	SENT116	4	4	9	9	arsenite	MLC	PA452638	23209	0.842
NULL	J_Korean_Med_Sci_2002_Apr_17(2)_208-212.nxml.txt.nlp	11961304	SENT11	12	12	28	28	captopril	IL-6	PA448780	3569	0.842
NULL	J_Carcinog_2013_Dec_31_12_22.nxml.txt.nlp	24574860	SENT235	30	30	44	44	docetaxel	AKT	PA449383	207	0.842
NULL	Cancer_Med_2013_Feb_3_2(1)_40-49.nxml.txt.nlp	24133626	SENT130	8	8	5	5	cilostazol	PDE3B	PA164746334	5140	0.842
NULL	Clin_Pharmacokinet_2014_Sep_3_53(1)_1-16.nxml.txt.nlp	23999929	SENT342	3	3	7	7	dabigatran	P-gp		5243	0.842
NULL	Channels_(Austin)_2010_Jan_1_4(1)_22-41.nxml.txt.nlp	19934650	SENT39	11	11	19	19	quinidine	Slo3	PA451209	157855	0.842
NULL	Exp_Ther_Med_2014_Oct_29_8(4)_1313-1317.nxml.txt.nlp	25187846	SENT111	25	25	13	13	salmeterol	SP-D	PA451300	6441	0.842
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT284	4	4	13	13	neratinib	HER2	PA165291472	2064	0.842
NULL	Cell_Commun_Signal_2010_Sep_22_8_27.nxml.txt.nlp	20860841	SENT217	12	12	21	21	doxorubicin	CHK2	PA449412	11200	0.842
NULL	Croat_Med_J_2012_Jun_53(3)_214-223.nxml.txt.nlp	22661134	SENT63	18	18	34	34	diazepam	ACTH	PA449283	5443	0.842
NULL	Indian_J_Pharmacol_2013_Mar-Apr_45(2)_121-125.nxml.txt.nlp	23716885	SENT147	17	17	6	6	aripiprazole	CYP3A4	PA10026	1576	0.842
NULL	Front_Neural_Circuits_2010_Mar_22_4_8.nxml.txt.nlp	20407636	SENT86	29	29	22	22	carbachol	gamma	PA448784	9913	0.842
NULL	Chemother_Res_Pract_2011_Jun_15_2011_163736.nxml.txt.nlp	22295202	SENT87	14	14	1	1	cisplatin	ACT	PA449014	12;11332;9457;641455	0.842
NULL	Clin_Transl_Allergy_2013_Sep_2_3_29.nxml.txt.nlp	24004581	SENT141	29	29	19	19	omalizumab	IL-4	PA164752253	3565	0.842
NULL	Diabetes_2009_Aug_15_58(8)_1893-1901.nxml.txt.nlp	19528375	SENT86	4	4	2	2	metformin	AMPK	PA450395	5563	0.842
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R91.nxml.txt.nlp	22541814	SENT41	5	5	7	7	thrombin	HO-1	PA451674	3162	0.842
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT357	30	30	16	16	heparin	FGF1	PA449855	2246	0.842
NULL	Nat_Med_2012_Jul_18(7)_1118-1122.nxml.txt.nlp	22683780	SENT76	36	36	33	33	crizotinib	MET	PA165946122	4233	0.842
NULL	Front_Genet_2015_Jan_14_5_469.nxml.txt.nlp	25642242	SENT257	36	36	30	30	paromomycin	MRPS12	PA164784023	6183	0.842
NULL	Core_Evid_2010_Oct_22_5_91-105.nxml.txt.nlp	21468365	SENT113	1	1	13	13	pitavastatin	CYP3A4	PA142650384	1576	0.842
NULL	Oncotarget_2014_Nov_11_5(22)_11490-11500.nxml.txt.nlp	25359780	SENT90	7	7	0	0	docetaxel	LIMK1	PA449383	3984	0.842
NULL	Oncoimmunology_2013_Jun_1_2(6)_e24677.nxml.txt.nlp	23894722	SENT113	3	3	21	21	cetuximab	CD86	PA10040	942	0.842
NULL	Mol_Biol_Cell_2013_Aug_1_24(15)_2328-2339.nxml.txt.nlp	23783029	SENT301	6	6	18	18	glucose	GEF	PA449773	56731	0.842
NULL	Indian_J_Ophthalmol_2012_May-Jun_60(3)_207-209.nxml.txt.nlp	22569382	SENT50	43	43	11	11	fluorescein	CYP4V2	PA164746009	285440	0.842
NULL	J_Gen_Intern_Med_2009_May_21_24(5)_656-664.nxml.txt.nlp	19306050	SENT360	2	2	15	15	warfarin	CYP2C9	PA451906	1559	0.842
NULL	Curr_Cardiol_Rev_2008_Nov_4(4)_275-286.nxml.txt.nlp	20066135	SENT272	23	23	19	19	valsartan	AT1	PA451848	9197;185	0.842
NULL	Oncotarget_2013_Nov_15_5(6)_1458-1474.nxml.txt.nlp	24681547	SENT388	12	12	4	4	celecoxib	survivin	PA448871	332	0.842
NULL	Breast_Cancer_Res_2005_Apr_4_7(4)_R422-R435.nxml.txt.nlp	15987447	SENT161	2	2	29	29	celecoxib	Bcl-2	PA448871	596	0.842
NULL	Biomed_Res_Int_2014_Feb_19_2014_240642.nxml.txt.nlp	24701565	SENT114	3	3	36	36	sunitinib	CSF1R	PA162372840	1436	0.842
NULL	Mol_Biol_Cell_2013_Aug_1_24(15)_2389-2397.nxml.txt.nlp	23741049	SENT146	26	26	3	3	iodixanol	LDM	PA164783998	1595	0.842
NULL	Cell_Biosci_2011_May_24_1_20.nxml.txt.nlp	21711933	SENT177	0	0	26	26	curcumin	CD103	PA151958596	3682	0.842
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT186	9	9	16	16	curcumin	PC-3	PA151958596	692094	0.842
NULL	Oncoimmunology_2013_Sep_1_2(9)_e25773.nxml.txt.nlp	24319639	SENT28	22	22	30	30	rituximab	EGFR	PA451261	1956	0.842
NULL	Aging_(Albany_NY)_2009_Mar_28_1(3)_275-277.nxml.txt.nlp	20157515	SENT6	10	10	3	3	etoposide	p65	PA449552	5970	0.842
NULL	Breast_Cancer_Res_Treat_2007_Oct_27_105(Suppl_1)_19-29.nxml.txt.nlp	17333340	SENT27	1	1	4	4	tamoxifen	aromatase	PA451581	1588	0.841
NULL	Int_J_Hypertens_2012_Feb_8_2012_189512.nxml.txt.nlp	22518281	SENT7	0	0	5	5	hemin	HO-1	PA449849	3162	0.841
NULL	Indian_J_Med_Paediatr_Oncol_2014_Oct-Dec_35(4)_271-275.nxml.txt.nlp	25538404	SENT120	3	3	0	0	vemurafenib	BRAF	PA165946873	673	0.841
NULL	Mol_Pain_2012_Sep_27_8_75.nxml.txt.nlp	23013719	SENT289	9	9	7	7	capsaicin	TRPV1	PA448776	7442	0.841
NULL	J_Biomed_Biotechnol_2011_Jan_12_2011_342637.nxml.txt.nlp	21274454	SENT437	21	21	0	0	heparin	CHI3L1	PA449855	1116	0.841
NULL	J_Cell_Biol_2002_Jun_24_157(7)_1151-1160.nxml.txt.nlp	12082077	SENT100	15	15	6	6	trypsin	COX	PA451806	1351	0.841
NULL	Acta_Neuropathol_Commun_2013_Aug_9_1_49.nxml.txt.nlp	24252504	SENT105	4	4	8	8	arsenite	TDP-43	PA452638	23435	0.841
NULL	Int_J_Biol_Sci_2014_Sep_10_10(9)_1024-1038.nxml.txt.nlp	25285035	SENT338	6	6	26	26	haloperidol	Yes	PA449841	7525	0.841
NULL	Cell_Commun_Signal_2014_Oct_5_12(1)_54.nxml.txt.nlp	NULL	SENT110	31	31	18	18	doxycycline	ROCK1	PA449415	6093	0.841
NULL	Pharmaceuticals_(Basel)_2013_May_23_6(6)_689-699.nxml.txt.nlp	24276256	SENT89	6	6	19	19	nifedipine	PTB	PA450631	58155	0.841
NULL	J_Med_Chem_2014_Jul_24_57(14)_5995-6007.nxml.txt.nlp	24960438	SENT349	19	19	2	2	estradiol	HSD2	PA449503	6060	0.841
NULL	Mol_Pain_2012_Sep_22_8_71.nxml.txt.nlp	22998838	SENT9	29	29	5	5	paclitaxel	CXCR4	PA450761	7852	0.841
NULL	J_Headache_Pain_2014_Dec_8_15(1)_85.nxml.txt.nlp	25488888	SENT84	25	25	35	35	rizatriptan	5-HT1B	PA451264	3351	0.841
NULL	Cardiovasc_J_Afr_2009_Apr_20(2)_127-134.nxml.txt.nlp	19421649	SENT167	2	2	17	17	ramipril	AIRE	PA451223	326	0.841
NULL	Daru_2013_Dec_20_21(1)_78.nxml.txt.nlp	24359941	SENT9	41	41	17	17	gentamicin	EPO	PA449753	7076;8288;2056	0.841
NULL	Br_J_Ophthalmol_2008_Sep_22_92(9)_1275-1282.nxml.txt.nlp	18723745	SENT22	20	20	31	31	latanoprost	BAK	PA164774763	578	0.841
NULL	Cancer_Cell_Int_2014_Apr_17_14_34.nxml.txt.nlp	24739220	SENT205	12	12	26	26	resveratrol	PTEN		5728	0.841
NULL	Oncotarget_2011_Aug_23_2(8)_599-609.nxml.txt.nlp	21865609	SENT72	9	9	7	7	cetuximab	EGFR	PA10040	1956	0.841
NULL	Oncogenesis_2012_Apr_2_1(4)_e5.nxml.txt.nlp	23552603	SENT291	6	6	14	14	ns-398	p65		5970	0.841
NULL	Oncotarget_2013_Jan_14_4(1)_118-127.nxml.txt.nlp	23435217	SENT22	0	0	6	6	cetuximab	EGFR	PA10040	1956	0.841
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Mar_26_3(3)_e107.nxml.txt.nlp	24670388	SENT88	17	17	8	8	fluvastatin	CYP2C9	PA449688	1559	0.841
NULL	Br_J_Ophthalmol_2008_Sep_22_92(9)_1275-1282.nxml.txt.nlp	18723745	SENT79	2	2	9	9	latanoprost	BAK	PA164774763	578	0.841
NULL	Indian_J_Endocrinol_Metab_2012_Dec_16(Suppl_3)_S529-S531.nxml.txt.nlp	23565485	SENT32	4	4	26	26	metformin	NPY	PA450395	4852	0.841
NULL	J_Neurophysiol_2014_Feb_15_111(4)_755-767.nxml.txt.nlp	24225541	SENT356	24	24	12	12	apomorphine	A10	PA164781163	28870	0.841
NULL	Mol_Cancer_2010_Aug_20_9_220.nxml.txt.nlp	20727180	SENT229	13	13	23	23	nicotine	p53	PA450626	7157	0.841
NULL	Front_Genet_2012_Nov_12_3_235.nxml.txt.nlp	23162568	SENT499	9	9	1	1	methamphetamine	CYP2D6	PA450403	1565	0.841
NULL	Ann_Hematol_2012_Sep_28_91(9)_1499-1500.nxml.txt.nlp	22281990	SENT12	5	5	14	14	cyclophosphamide	CHOP	PA449165	1649	0.841
NULL	Br_J_Cancer_1996_Jan_73(2)_183-188.nxml.txt.nlp	8546904	SENT8	2	2	12	12	phenytoin	P-gp	PA450947	5243	0.841
NULL	J_Gastroenterol_2013_Jan_28_48(1)_1-12.nxml.txt.nlp	23188091	SENT148	0	0	11	11	telaprevir	IL28B	PA165958354	282617	0.841
NULL	Br_J_Cancer_2012_Sep_4_107(6)_947-955.nxml.txt.nlp	22892392	SENT70	25	25	10	10	tamoxifen	ERBB2	PA451581	2064	0.841
NULL	Mol_Vis_2012_May_1_18_1115-1122.nxml.txt.nlp	22605923	SENT159	7	7	26	26	estradiol	p38	PA449503	10598;1432;7965	0.841
NULL	Diabetes_Care_2012_Jul_12_35(7)_1446-1454.nxml.txt.nlp	22584132	SENT134	25	25	1	1	metformin	GLP	PA450395	342096	0.841
NULL	Clin_Interv_Aging_2012_Jul_12_7_235-247.nxml.txt.nlp	22866001	SENT133	11	11	20	20	alendronate	PTH	PA448082	5741	0.841
NULL	Cancer_Med_2013_Aug_28_2(4)_468-477.nxml.txt.nlp	24156019	SENT39	37	37	28	28	docetaxel	CLU	PA449383	1191	0.841
NULL	Cardiol_Ther_2013_Jun_26_2(1)_69-84.nxml.txt.nlp	25135290	SENT104	3	3	13	13	sirolimus	DES	PA451365	1674	0.841
NULL	J_Mol_Signal_2006_Dec_6_1_8.nxml.txt.nlp	17224083	SENT9	17	17	15	15	thrombin	Rho	PA451674	29984	0.841
NULL	Nucleic_Acids_Res_2013_May_5_41(10)_5210-5222.nxml.txt.nlp	23563151	SENT34	14	14	22	22	arsenite	GADD45	PA452638	1647	0.841
NULL	Breast_Cancer_(Auckl)_2014_Mar_23_8_51-56.nxml.txt.nlp	24678242	SENT5	34	34	28	28	carboplatin	BRCA1	PA448803	672	0.841
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_3_2014_473213.nxml.txt.nlp	25538791	SENT113	20	20	9	9	fexofenadine	MDR1	PA449621	5243	0.841
NULL	Clin_Ophthalmol_2010_Apr_26_4_369-374.nxml.txt.nlp	20463807	SENT65	43	43	29	29	bevacizumab	PED	PA130232992	8682	0.841
NULL	J_Vet_Med_Sci_2014_Nov_25_76(11)_1505-1512.nxml.txt.nlp	25452259	SENT661	18	18	10	10	docetaxel	survivin	PA449383	332	0.841
NULL	J_Adv_Pharm_Technol_Res_2014_Jan-Mar_5(1)_13-16.nxml.txt.nlp	24696812	SENT61	26	26	36	36	glutaraldehyde	UOX	PA449777	391051	0.841
NULL	Croat_Med_J_2012_Jun_53(3)_214-223.nxml.txt.nlp	22661134	SENT57	6	6	20	20	diazepam	ACTH	PA449283	5443	0.841
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1449-1456.nxml.txt.nlp	24077631	SENT115	21	21	3	3	warfarin	CYP2C9	PA451906	1559	0.841
NULL	Drugs_R_D_2014_Jun_6_14(2)_113-123.nxml.txt.nlp	24797400	SENT29	20	20	9	9	dabigatran	CES1		1066	0.841
NULL	Environ_Health_Perspect_2005_Apr_14_113(4)_431-439.nxml.txt.nlp	15811834	SENT245	10	10	3	3	nifedipine	PRL	PA450631	5617	0.841
NULL	Front_Behav_Neurosci_2011_Sep_8_5_56.nxml.txt.nlp	21927600	SENT1894	7	7	0	0	nicotine	DARPP-32	PA450626	84152	0.841
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT152	13	13	28	28	trastuzumab	STAT3	PA451743	6774	0.841
NULL	Nat_Med_2013_Feb_6_19(2)_217-226.nxml.txt.nlp	23291629	SENT92	22	22	9	9	isoproterenol	HSL	PA450121	3991	0.841
NULL	Mol_Cancer_2008_Jan_25_7_14.nxml.txt.nlp	18221502	SENT183	9	9	36	36	oxaliplatin	PSAT1	PA131285527	29968	0.841
NULL	Oncol_Rep_2014_Feb_13_31(2)_581-588.nxml.txt.nlp	24337105	SENT191	20	20	11	11	capsaicin	CHOP	PA448776	1649	0.841
NULL	Front_Neurol_2014_Feb_18_5_17.nxml.txt.nlp	24600432	SENT178	30	30	21	21	levetiracetam	SV2A	PA450206	9900	0.841
NULL	Mol_Cancer_2008_Aug_7_7_65.nxml.txt.nlp	18687124	SENT255	20	20	3	3	thrombin	parafibromin	PA451674	79577	0.841
NULL	Chin_J_Cancer_2012_Nov_31(11)_507-518.nxml.txt.nlp	22640626	SENT173	43	43	4	4	nilotinib	c-ABL	PA165958345	25	0.841
NULL	Ann_Oncol_2011_Mar_8_22(3)_503-514.nxml.txt.nlp	20616198	SENT69	4	4	7	7	aminoglutethimide	aromatase	PA448375	1588	0.841
NULL	Ann_Indian_Acad_Neurol_2010_Jan-Mar_13(1)_23-27.nxml.txt.nlp	20436742	SENT67	25	25	12	12	bromocriptine	spatial	PA448671	219793	0.841
NULL	JAKSTAT_2013_Jan_1_2(1)_e23576.nxml.txt.nlp	24058797	SENT62	29	29	22	22	staurosporine	U3A	PA165109623	692232	0.841
NULL	Oncotarget_2011_Dec_31_2(12)_1314-1321.nxml.txt.nlp	22248929	SENT62	13	13	21	21	lapatinib	HER3	PA152241907	2065	0.841
NULL	Indian_J_Pharmacol_2013_Jul-Aug_45(4)_365-370.nxml.txt.nlp	24014912	SENT49	0	0	18	18	capsaicin	AT1	PA448776	9197;185	0.841
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_55-66.nxml.txt.nlp	17912636	SENT75	25	25	32	32	letrozole	HER2	PA450196	2064	0.841
NULL	Croat_Med_J_2013_Apr_54(2)_171-179.nxml.txt.nlp	23630144	SENT105	12	12	14	14	taurine	STZ	PA451590	6484	0.841
NULL	Mediators_Inflamm_1998_7(3)_195-199.nxml.txt.nlp	9705607	SENT8	5	5	11	11	indomethacin	GM-CSF	PA449982	1437	0.841
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT113	3	3	13	13	pemetrexed	UNG	PA10810	7374	0.841
NULL	FEBS_Open_Bio_2014_Aug_30_4_763-776.nxml.txt.nlp	25349781	SENT183	23	23	14	14	curcumin	NAC	PA151958596	22861	0.841
NULL	Acta_Pharmacol_Sin_2011_Aug_18_32(8)_1078-1084.nxml.txt.nlp	21765448	SENT143	22	22	8	8	iptakalim	KCNJ11	PA165949694	3767	0.841
NULL	Arthritis_Res_Ther_2010_Apr_1_12(2)_R60.nxml.txt.nlp	20359365	SENT217	21	21	11	11	bleomycin	SPARC	PA448645	6678	0.841
NULL	Ann_Oncol_2011_Aug_27_22(8)_1736-1747.nxml.txt.nlp	21709140	SENT318	1	1	29	29	pertuzumab	San		80218	0.841
NULL	Breast_Cancer_Res_2007_Jan_22_9(1)_202.nxml.txt.nlp	17274834	SENT12	15	15	21	21	trastuzumab	San	PA451743	80218	0.841
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT204	36	36	17	17	cetuximab	KRAS	PA10040	3845	0.841
NULL	Mol_Cancer_2010_Aug_16_9_217.nxml.txt.nlp	20712901	SENT32	3	3	11	11	curcumin	STAT3	PA151958596	6774	0.841
NULL	eLife_2013_Nov_5_2_e00969.nxml.txt.nlp	24192036	SENT104	6	6	2	2	vemurafenib	MCL1	PA165946873	4170	0.841
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jun_11_67(Pt_7)_o1611.nxml.txt.nlp	21837019	SENT63	9	9	23	23	ethanol	mol	PA448073	90527	0.841
NULL	Oncotarget_2010_Nov_19_1(7)_596-605.nxml.txt.nlp	21317455	SENT59	11	11	17	17	oxaliplatin	IGF1	PA131285527	3479	0.841
NULL	Arthritis_Res_Ther_2014_May_16_16(3)_R113.nxml.txt.nlp	24886859	SENT333	6	6	13	13	pargyline	LSD1	PA450797	23028	0.841
NULL	Breast_Cancer_Res_2012_May_10_14(3)_309.nxml.txt.nlp	22574877	SENT11	24	24	13	13	fulvestrant	aromatase	PA164747170	1588	0.841
NULL	CNS_Drugs_2012_Dec_13_26(12)_1033-1049.nxml.txt.nlp	23192413	SENT49	8	8	15	15	trazodone	5-HT2A	PA451744	3356	0.841
NULL	Cancer_Metastasis_Rev_2011_Jun_23_30(2)_185-197.nxml.txt.nlp	21340664	SENT144	19	19	4	4	gemcitabine	CHK1	PA449748	1111	0.841
NULL	Biologics_2012_Jul_26_6_233-244.nxml.txt.nlp	22904615	SENT95	7	7	3	3	imatinib	EGFR	PA10804	1956	0.841
NULL	Neural_Dev_2011_Apr_30_6_18.nxml.txt.nlp	21529369	SENT124	30	30	5	5	ethanol	E12	PA448073	64100	0.841
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Oct_31_65(Pt_11)_o2963.nxml.txt.nlp	21578534	SENT47	3	3	14	14	benzaldehyde	mol	PA448571	90527	0.841
NULL	J_Vet_Med_Sci_2014_Nov_22_76(11)_1443-1450.nxml.txt.nlp	25452258	SENT55	6	6	20	20	fluorescein	San	PA164746009	80218	0.841
NULL	Curr_Neuropharmacol_2014_Jul_12(4)_365-379.nxml.txt.nlp	25342944	SENT189	0	0	21	21	fluoxetine	GluA2	PA449673	2891	0.841
NULL	Oncotarget_2012_Oct_20_3(10)_1068-1111.nxml.txt.nlp	23085539	SENT727	22	22	42	42	imatinib	CD34	PA10804	947	0.841
NULL	Front_Oncol_2014_Oct_13_4_229.nxml.txt.nlp	25353005	SENT72	14	14	7	7	erlotinib	EGFR	PA134687924	1956	0.841
NULL	Biomed_Res_Int_2013_Jun_17_2013_312656.nxml.txt.nlp	23844360	SENT177	13	13	20	20	natalizumab	CD34	PA164747191	947	0.841
NULL	Cell_Death_Dis_2014_Feb_13_5(2)_e1055.nxml.txt.nlp	24525731	SENT141	0	0	15	15	irinotecan	XRCC1	PA450085	7515	0.841
NULL	Iran_J_Public_Health_2012_Jan_31_41(1)_59-65.nxml.txt.nlp	23113123	SENT129	1	1	16	16	lipase	LIPC	PA450239	3990	0.841
NULL	Basic_Clin_Neurosci_2013_Autumn_4(4)_329-333.nxml.txt.nlp	25337365	SENT120	2	2	25	25	methamphetamine	Bcl-2	PA450403	596	0.841
NULL	Int_J_Mol_Cell_Med_2013_Summer_2(3)_99-109.nxml.txt.nlp	24551799	SENT158	16	16	37	37	l-carnitine	ROS	PA450154	6098	0.841
NULL	J_Nucl_Cardiol_2010_Jun_18_17(3)_479-485.nxml.txt.nlp	20238193	SENT79	12	12	19	19	dipyridamole	FDG	PA449367	23583	0.841
NULL	Cancer_Med_2014_Jun_27_3(3)_462-471.nxml.txt.nlp	24573979	SENT227	3	3	12	12	bevacizumab	HIF-1	PA130232992	29072	0.841
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT266	18	18	9	9	lapatinib	HER3	PA152241907	2065	0.841
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_11_2014_274786.nxml.txt.nlp	25505920	SENT186	23	23	7	7	oxaliplatin	CYP3A	PA131285527	1574	0.841
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT45	13	13	27	27	erlotinib	AMPK	PA134687924	5563	0.841
NULL	Pharmaceuticals_(Basel)_2014_Apr_10_7(4)_433-452.nxml.txt.nlp	24727459	SENT1	4	4	20	20	lopinavir	P-gp	PA450264	5243	0.841
NULL	Indian_J_Dermatol_2010_Oct-Dec_55(4)_316-324.nxml.txt.nlp	21430881	SENT165	6	6	9	9	thalidomide	ENL	PA451644	4298	0.841
NULL	J_Breast_Cancer_2013_Jun_28_16(2)_133-137.nxml.txt.nlp	23843843	SENT49	0	0	30	30	curcumin	EGFR	PA151958596	1956	0.841
NULL	Cell_Biol_Int_Rep_(2010)_2012_Jun_21_19(1)_e00017.nxml.txt.nlp	23124518	SENT5	30	30	8	8	etoposide	TRAIL	PA449552	8743	0.841
NULL	Oncoimmunology_2014_Jan_3_3_e27357.nxml.txt.nlp	24790790	SENT206	21	21	9	9	temozolomide	IL-7	PA451609	3574	0.841
NULL	Int_J_Endocrinol_2014_Aug_11_2014_312452.nxml.txt.nlp	25183970	SENT148	6	6	18	18	liraglutide	PI3K	PA165958364	5290	0.841
NULL	Front_Genet_2012_Nov_22_3_249.nxml.txt.nlp	23189085	SENT662	18	18	0	0	rituximab	ABCG2	PA451261	9429	0.841
NULL	Cell_Mol_Life_Sci_2012_Oct_6_69(20)_3481-3492.nxml.txt.nlp	22669259	SENT331	10	10	2	2	thrombin	P2Y12	PA451674	64805	0.841
NULL	J_Cancer_2013_Sep_27_4(8)_662-670.nxml.txt.nlp	24155778	SENT199	12	12	2	2	cisplatin	XIAP	PA449014	331	0.841
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jun_17_65(Pt_7)_o1596.nxml.txt.nlp	21582870	SENT68	41	41	15	15	ethanol	mol	PA448073	90527	0.841
NULL	Acta_Pharmacol_Sin_2011_May_18_32(5)_591-600.nxml.txt.nlp	21499286	SENT15	0	0	8	8	bezafibrate	AMPK	PA162364313	5563	0.841
NULL	Adv_Biomed_Res_2014_Sep_8_3_189.nxml.txt.nlp	25298958	SENT75	10	10	30	30	clarithromycin	NAC	PA449028	22861	0.841
NULL	Acta_Pharmacol_Sin_2014_Jun_4_35(6)_752-757.nxml.txt.nlp	24902786	SENT93	14	14	3	3	tamoxifen	STL2	PA451581	1301	0.841
NULL	Curr_Pain_Headache_Rep_2011_Aug_12_15(4)_271-279.nxml.txt.nlp	21479998	SENT162	0	0	3	3	sertraline	CYP2D6	PA451333	1565	0.841
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Jun_27_5_15.nxml.txt.nlp	16803618	SENT136	2	2	13	13	gentamicin	IL-8	PA449753	3576	0.841
NULL	Clin_Dev_Immunol_2011_Nov_3_2011_320571.nxml.txt.nlp	22110523	SENT201	28	28	11	11	etoposide	SOX2	PA449552	6657	0.841
NULL	Algorithms_Mol_Biol_2010_Jul_15_5_29.nxml.txt.nlp	20633297	SENT243	18	18	27	27	sildenafil	PDE5A	PA451346	8654	0.841
NULL	BMJ_2011_Jul_26_343_d4366.nxml.txt.nlp	21791491	SENT160	0	0	17	17	potassium	ACE	PA451047	1636	0.841
NULL	Europace_2012_Aug_27_14(8)_1206-1214.nxml.txt.nlp	22454409	SENT173	6	6	13	13	olmesartan	FN1	PA164742950	2335	0.841
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT299	1	1	10	10	metformin	HIF-1	PA450395	29072	0.841
NULL	Cancer_Cell_Int_2009_Feb_17_9_4.nxml.txt.nlp	19222856	SENT195	44	44	31	31	cisplatin	p53	PA449014	7157	0.841
NULL	Environ_Health_Perspect_2005_Jun_24_113(6)_680-687.nxml.txt.nlp	15929889	SENT183	10	10	4	4	estradiol	SULT1E1	PA449503	6783	0.841
NULL	Exp_Ther_Med_2013_Nov_2_6(5)_1251-1258.nxml.txt.nlp	24223654	SENT49	3	3	5	5	methacholine	MCH	PA165958382	5367	0.841
NULL	Braz_J_Med_Biol_Res_2013_Nov_29_47(1)_35-41.nxml.txt.nlp	24519090	SENT166	14	14	5	5	cetuximab	KRAS	PA10040	3845	0.841
NULL	Arch_Med_Sci_2012_Sep_8_8(4)_659-671.nxml.txt.nlp	23056078	SENT198	28	28	20	20	vincristine	P-gp	PA451879	5243	0.841
NULL	Diabetes_2009_Jul_28_58(7)_1518-1525.nxml.txt.nlp	19401427	SENT196	12	12	3	3	lisinopril	HMGCR	PA450242	3156	0.841
NULL	Cell_Cycle_2014_Jan_15_13(2)_303-314.nxml.txt.nlp	24247149	SENT129	16	16	23	23	gemcitabine	p53	PA449748	7157	0.841
NULL	Acta_Otorhinolaryngol_Ital_2011_Dec_14_31(6)_399-401.nxml.txt.nlp	22323852	SENT41	31	31	44	44	enoxaparin	CO2	PA449463	4513	0.841
NULL	Nucleic_Acids_Res_2005_Jun_8_33(10)_3283-3291.nxml.txt.nlp	15944449	SENT187	7	7	12	12	sjg-136	XRCC3		7517	0.841
NULL	Biomed_Res_Int_2013_Dec_4_2013_685308.nxml.txt.nlp	23509762	SENT134	8	8	11	11	bevacizumab	HIF-1	PA130232992	29072	0.841
NULL	J_Hematol_Oncol_2013_Feb_17_6_17.nxml.txt.nlp	23414938	SENT149	12	12	6	6	prasugrel	VASP	PA154410481	7408	0.841
NULL	Breast_Cancer_Res_2012_Aug_13_14(4)_109.nxml.txt.nlp	22889086	SENT18	6	6	9	9	tamoxifen	aromatase	PA451581	1588	0.841
NULL	Oncotarget_2013_Nov_23_5(1)_196-210.nxml.txt.nlp	24344116	SENT149	24	24	21	21	doxorubicin	p53	PA449412	7157	0.841
NULL	Cell_Commun_Signal_2014_Sep_25_12(1)_61.nxml.txt.nlp	NULL	SENT130	13	13	0	0	doxycycline	PC-3	PA449415	692094	0.841
NULL	Cancer_Causes_Control_2013_Aug_18_24(8)_1605-1614.nxml.txt.nlp	23775025	SENT243	31	31	17	17	cyclophosphamide	CYP3A5	PA449165	1577	0.841
NULL	Case_Rep_Ophthalmol_2012_Oct_23_3(3)_364-369.nxml.txt.nlp	23185178	SENT53	14	14	22	22	bevacizumab	San	PA130232992	80218	0.841
NULL	Nat_Med_2013_Mar_10_19(3)_313-321.nxml.txt.nlp	23396211	SENT149	5	5	14	14	amlexanox	TBK1	PA164745310	29110	0.841
NULL	Arthritis_Res_Ther_2010_May_18_12(3)_R90.nxml.txt.nlp	20478071	SENT181	7	7	22	22	methylprednisolone	MX1	PA450466	4599	0.841
NULL	Crit_Care_2010_Mar_15_14(2)_R30.nxml.txt.nlp	20226064	SENT279	0	0	2	2	propofol	IL-2	PA451141	3558	0.841
NULL	Exp_Cell_Res_2009_Nov_15_315(19)_3433-3441.nxml.txt.nlp	19716819	SENT188	23	23	2	2	hyaluronidase	CD44	PA164745713	960	0.841
NULL	Mol_Cancer_2010_May_18_9_110.nxml.txt.nlp	20482802	SENT142	12	12	4	4	bortezomib	Bcl-2	PA10252	596	0.841
NULL	Biochim_Biophys_Acta_2014_Jul_1842(7)_959-970.nxml.txt.nlp	24594481	SENT53	11	11	0	0	lipase	ATGL	PA450239	57104	0.841
NULL	AIDS_Res_Treat_2011_Aug_15_2011_562790.nxml.txt.nlp	21860787	SENT216	9	9	2	2	tenofovir	MRP4	PA10204	10257	0.841
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jan_11_68(Pt_2)_o340-o341.nxml.txt.nlp	22346970	SENT72	18	18	6	6	ethanol	mol	PA448073	90527	0.841
NULL	Diabetes_2013_Mar_14_62(3)_953-964.nxml.txt.nlp	23223176	SENT131	20	20	30	30	paroxetine	ROS	PA450801	6098	0.841
NULL	Clin_Med_Insights_Circ_Respir_Pulm_Med_2013_Apr_9_7_7-15.nxml.txt.nlp	23641160	SENT73	0	0	13	13	roflumilast	CYP2C19	PA165948052	1557	0.841
NULL	Onco_Targets_Ther_2014_Nov_18_7_2133-2136.nxml.txt.nlp	25429230	SENT55	5	5	22	22	verapamil	CYP3A4	PA451868	1576	0.841
NULL	Genet_Mol_Biol_2009_Mar_1_Jan-Mar_32(1)_144-150.nxml.txt.nlp	21637660	SENT241	14	14	18	18	etoposide	CD34	PA449552	947	0.841
NULL	Target_Oncol_2013_Jun_27_8(2)_127-136.nxml.txt.nlp	23625191	SENT61	29	29	31	31	panitumumab	KRAS	PA162373091	3845	0.841
NULL	Cell_Death_Dis_2010_Oct_21_1(10)_e86.nxml.txt.nlp	21368859	SENT60	4	4	8	8	doxorubicin	JNK	PA449412	5599	0.841
NULL	Nat_Commun_2013_Apr_9_4_1684.nxml.txt.nlp	23575688	SENT67	4	4	20	20	rolipram	CYLD	PA153906323	1540	0.841
NULL	Biomed_Res_Int_2014_May_27_2014_782625.nxml.txt.nlp	24971350	SENT71	13	13	5	5	mannitol	SUMO1	PA450320	7341	0.841
NULL	Front_Genet_2012_Nov_22_3_249.nxml.txt.nlp	23189085	SENT1004	11	11	3	3	mercaptopurine	TPMT	PA450379	7172	0.841
NULL	Clin_Interv_Aging_2014_Nov_18_9_1963-1980.nxml.txt.nlp	25429208	SENT145	2	2	4	4	acarbose	DPP4	PA448010	1803	0.841
NULL	ChemistryOpen_2014_Jun_18_3(3)_115-123.nxml.txt.nlp	25050230	SENT266	32	32	16	16	heparin	mol	PA449855	90527	0.841
NULL	AIDS_Res_Ther_2014_Aug_4_11_25.nxml.txt.nlp	25120580	SENT29	4	4	14	14	omeprazole	CYP2C19	PA450704	1557	0.841
NULL	Mol_Cancer_2014_Jan_15_13_8.nxml.txt.nlp	24423412	SENT13	14	14	19	19	cisplatin	CD44	PA449014	960	0.841
NULL	Front_Behav_Neurosci_2012_Mar_14_6_9.nxml.txt.nlp	22457644	SENT23	29	29	12	12	lipase	FAAH	PA450239	79152;2166	0.841
NULL	Int_J_Mol_Sci_2013_Apr_10_14(4)_7742-7756.nxml.txt.nlp	23574936	SENT830	9	9	3	3	paclitaxel	CERT	PA450761	10087	0.841
NULL	Diabetes_2008_Oct_57(10)_2784-2793.nxml.txt.nlp	18599521	SENT300	3	3	6	6	simvastatin	Rho	PA451363	29984	0.841
NULL	Chem_Cent_J_2013_Sep_4_7_147.nxml.txt.nlp	24006941	SENT94	31	31	13	13	lipase	LOX	PA450239	4015	0.841
NULL	Mol_Biol_Cell_2014_Jan_1_25(1)_76-86.nxml.txt.nlp	24173717	SENT309	12	12	9	9	paclitaxel	TUBB6	PA450761	84617	0.841
NULL	Breast_Cancer_Res_2006_Jul_25_8(4)_R48.nxml.txt.nlp	16869955	SENT33	18	18	6	6	methotrexate	p53	PA450428	7157	0.841
NULL	Mucosal_Immunol_2013_Nov_6_6(6)_1091-1100.nxml.txt.nlp	23385428	SENT235	12	12	4	4	methacholine	gamma	PA165958382	9913	0.841
NULL	Biologics_2009_Jul_13_3_289-301.nxml.txt.nlp	19707416	SENT33	11	11	22	22	trastuzumab	HER2	PA451743	2064	0.841
NULL	Indian_J_Ophthalmol_2014_Jul_62(7)_761-767.nxml.txt.nlp	25116765	SENT121	16	16	35	35	bevacizumab	CRT	PA130232992	811	0.841
NULL	J_Cancer_Prev_2014_Mar_19(1)_39-46.nxml.txt.nlp	25337571	SENT112	4	4	12	12	ethanol	JNK	PA448073	5599	0.841
NULL	Ann_Oncol_2011_Mar_8_22(3)_503-514.nxml.txt.nlp	20616198	SENT77	27	27	18	18	letrozole	aromatase	PA450196	1588	0.841
NULL	Front_Endocrinol_(Lausanne)_2014_Oct_9_5_161.nxml.txt.nlp	25346723	SENT417	10	10	25	25	liraglutide	GLP-1	PA165958364	100125288	0.841
NULL	EMBO_Mol_Med_2011_Nov_3(11)_623-636.nxml.txt.nlp	21953712	SENT184	20	20	7	7	trastuzumab	HER2	PA451743	2064	0.841
NULL	Autophagy_2012_May_1_8(5)_853-855.nxml.txt.nlp	22617440	SENT58	16	16	45	45	imatinib	CASP9	PA10804	842	0.841
NULL	Cardiovasc_Diabetol_2005_Oct_5_4_16.nxml.txt.nlp	16207378	SENT152	10	10	4	4	glucosamine	perlecan	PA164747613	3339	0.841
NULL	J_Cell_Mol_Med_2013_Jan_11_17(1)_134-146.nxml.txt.nlp	23305490	SENT337	28	28	7	7	curcumin	TREK-1	PA151958596	3776	0.841
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT377	16	16	23	23	neratinib	HRG	PA165291472	3084;3273	0.841
NULL	J_Res_Med_Sci_2012_Jan_17(1)_22-31.nxml.txt.nlp	23248653	SENT67	14	14	26	26	vecuronium	ANOVA	PA164748865	4858	0.841
NULL	Iran_J_Pharm_Res_2014_Spring_13(2)_635-639.nxml.txt.nlp	25237359	SENT18	37	37	25	25	chlorzoxazone	CYP2C19	PA448971	1557	0.841
NULL	Reprod_Biol_Endocrinol_2003_Oct_7_1_71.nxml.txt.nlp	14577832	SENT117	5	5	8	8	cisplatin	JNK	PA449014	5599	0.841
NULL	Oncogene_2010_Sep_16_29(37)_5193-5203.nxml.txt.nlp	20581867	SENT78	11	11	9	9	lapatinib	HER2	PA152241907	2064	0.841
NULL	Chem_Cent_J_2014_Jan_17_8_4.nxml.txt.nlp	24438453	SENT103	28	28	16	16	galactose	MP2	PA449725	5375	0.841
NULL	Mol_Vis_2007_Jul_9_13_1073-1082.nxml.txt.nlp	17653052	SENT44	0	0	31	31	minocycline	P21	PA450519	1026;9338	0.841
NULL	Anemia_2012_May_23_2012_265790.nxml.txt.nlp	22675615	SENT203	27	27	22	22	ethanol	ALDH2	PA448073	217	0.841
NULL	Front_Mol_Neurosci_2012_Feb_20_5_14.nxml.txt.nlp	22363263	SENT389	8	8	0	0	pilocarpine	IMPA1	PA450962	3612	0.841
NULL	Gut_Liver_2013_Sep_14_7(5)_552-559.nxml.txt.nlp	24073313	SENT138	7	7	16	16	celecoxib	EGFR	PA448871	1956	0.841
NULL	BMB_Rep_2013_Feb_46(2)_92-96.nxml.txt.nlp	23433111	SENT100	14	14	34	34	etoposide	BRCA1	PA449552	672	0.841
NULL	Biomed_Res_Int_2014_Jan_29_2014_458592.nxml.txt.nlp	24592391	SENT37	20	20	25	25	curcumin	HO-1	PA151958596	3162	0.841
NULL	Neural_Plast_2012_May_31_2012_456478.nxml.txt.nlp	22701806	SENT162	5	5	25	25	salbutamol	SMN2	PA448068	6607	0.841
NULL	J_Ayurveda_Integr_Med_2010_Oct-Dec_1(4)_257-265.nxml.txt.nlp	21731372	SENT169	2	2	24	24	curcumin	LOX	PA151958596	4015	0.841
NULL	Ann_Oncol_2011_Mar_8_22(3)_503-514.nxml.txt.nlp	20616198	SENT210	8	8	4	4	letrozole	aromatase	PA450196	1588	0.841
NULL	Iran_J_Pharm_Res_2014_Autumn_13(4)_1393-1401.nxml.txt.nlp	25587329	SENT11	5	5	17	17	celecoxib	ABCG2	PA448871	9429	0.841
NULL	Breast_Cancer_Res_2004_Mar_18_6(3)_128-132.nxml.txt.nlp	15084233	SENT30	0	0	21	21	bevacizumab	VEGF-A	PA130232992	7422	0.841
NULL	Cardiovasc_Res_2012_Dec_1_96(3)_552-560.nxml.txt.nlp	22918977	SENT253	5	5	8	8	losartan	JAM-A	PA450268	50848	0.841
NULL	Mol_Cancer_2013_Sep_11_12_104.nxml.txt.nlp	24025152	SENT214	6	6	11	11	gemcitabine	STAT3	PA449748	6774	0.841
NULL	Acta_Pharmacol_Sin_2011_Oct_12_32(10)_1259-1265.nxml.txt.nlp	21909126	SENT106	5	5	10	10	fluvastatin	p38	PA449688	10598;1432;7965	0.841
NULL	Cancer_Microenviron_2009_Aug_15_2(Suppl_1)_205-214.nxml.txt.nlp	19685283	SENT193	4	4	19	19	imiquimod	TLR7	PA449972	51284	0.841
NULL	Adolesc_Health_Med_Ther_2014_Sep_26_5_171-182.nxml.txt.nlp	25298741	SENT209	14	14	1	1	perphenazine	IMPACT	PA450882	55364	0.841
NULL	Bone_Marrow_Transplant_2011_Mar_24_46(3)_430-435.nxml.txt.nlp	20498647	SENT25	2	2	10	10	infliximab	IL-2	PA452639	3558	0.841
NULL	Acta_Pharmacol_Sin_2009_Dec_4_30(12)_1607-1615.nxml.txt.nlp	19960007	SENT239	8	8	17	17	metformin	AMPK	PA450395	5563	0.841
NULL	Psychiatry_Investig_2008_Sep_30_5(3)_125-141.nxml.txt.nlp	20046356	SENT433	8	8	19	19	fluoxetine	Gen	PA449673	348654	0.841
NULL	Front_Physiol_2011_Jun_30_2_33.nxml.txt.nlp	21747769	SENT254	5	5	13	13	berberine	KCNQ1	PA165860812	3784	0.841
NULL	Br_J_Cancer_2003_Mar_10_88(5)_788-795.nxml.txt.nlp	12618891	SENT156	5	5	28	28	bosentan	FasL	PA10034	356	0.841
NULL	Br_J_Pharmacol_2010_Nov_161(5)_961-971.nxml.txt.nlp	20977449	SENT217	0	0	10	10	suramin	P2X2	PA10292	22953	0.841
NULL	Pan_Afr_Med_J_2014_Jul_6_18_205.nxml.txt.nlp	25419332	SENT46	12	12	6	6	vincristine	CHOP	PA451879	1649	0.841
NULL	Asian-Australas_J_Anim_Sci_2013_Nov_26(11)_1545-1552.nxml.txt.nlp	25049740	SENT26	25	25	11	11	trypsin	TSG6	PA451806	7130	0.841
NULL	Mol_Cancer_2012_Apr_26_11_26.nxml.txt.nlp	22537224	SENT180	28	28	13	13	cisplatin	FANCA	PA449014	2175	0.841
NULL	Front_Genet_2012_Oct_10_3_206.nxml.txt.nlp	23087703	SENT651	12	12	2	2	clopidogrel	CYP2C19	PA449053	1557	0.841
NULL	Ann_Dermatol_2014_Aug_31_26(4)_517-520.nxml.txt.nlp	25143685	SENT31	9	9	11	11	tazarotene	TIG3	PA164746821	5920	0.841
NULL	J_Gen_Physiol_2009_Mar_133(3)_251-256.nxml.txt.nlp	19237590	SENT22	8	8	22	22	capsaicin	TRPV1	PA448776	7442	0.841
NULL	Hum_Mol_Genet_2013_Nov_15_22(22)_4616-4626.nxml.txt.nlp	23814041	SENT167	24	24	35	35	ketoconazole	neuroserpin	PA450146	5274	0.841
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT74	14	14	8	8	cetuximab	EGFR	PA10040	1956	0.841
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT142	18	18	23	23	sulindac	survivin	PA451565	332	0.841
NULL	J_Hematol_Oncol_2011_Jan_21_4_5.nxml.txt.nlp	21255411	SENT232	21	21	9	9	gefitinib	EGFR	PA131301952	1956	0.841
NULL	Br_J_Cancer_2010_Oct_12_103(8)_1284-1291.nxml.txt.nlp	20859285	SENT55	7	7	5	5	tamoxifen	BCAR4	PA451581	400500	0.841
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1066.nxml.txt.nlp	24556681	SENT215	27	27	9	9	ethanol	ATG12	PA448073	9140	0.841
NULL	Leukemia_2014_Jan_12_28(1)_15-33.nxml.txt.nlp	23778311	SENT397	4	4	25	25	imatinib	ATF5	PA10804	22809	0.841
NULL	Arch_Drug_Inf_2008_Sep_1(2)_50-55.nxml.txt.nlp	19915714	SENT57	0	0	28	28	fentanyl	API	PA449599	5345	0.841
NULL	Biologics_2011_Aug_9_5_87-94.nxml.txt.nlp	21847344	SENT75	46	46	11	11	pertuzumab	San		80218	0.841
NULL	Exp_Ther_Med_2013_Dec_14_6(6)_1499-1503.nxml.txt.nlp	24255681	SENT93	3	3	10	10	fluorouracil	S100A3	PA128406956	6274	0.841
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT136	13	13	6	6	capsaicin	p53	PA448776	7157	0.841
NULL	Gastroenterol_Hepatol_Bed_Bench_2011_Spring_4(2)_43-52.nxml.txt.nlp	24834156	SENT102	20	20	23	23	trypsin	TATI	PA451806	6690	0.841
NULL	Cancers_(Basel)_2013_Jun_24_5(3)_762-785.nxml.txt.nlp	24202320	SENT330	25	25	0	0	ibandronate	PF4	PA10270	5196	0.841
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT10	15	15	37	37	celecoxib	survivin	PA448871	332	0.841
NULL	Breast_Cancer_Res_2004_Nov_25_6(1)_E8.nxml.txt.nlp	14680493	SENT45	29	29	23	23	raloxifene	STAR	PA451221	6770;2984	0.841
NULL	Eur_J_Endocrinol_2014_Mar_170(3)_451-459.nxml.txt.nlp	24362411	SENT192	10	10	2	2	liraglutide	SFRP5	PA165958364	6425	0.841
NULL	Br_J_Cancer_2009_Jul_21_101(2)_238-243.nxml.txt.nlp	19568242	SENT10	5	5	11	11	sunitinib	IFN	PA162372840	3439	0.841
NULL	Arthritis_Res_Ther_2007_Oct_10_9(5)_R105.nxml.txt.nlp	17927818	SENT172	4	4	7	7	pp2	RhoA		387	0.841
NULL	Curr_Oncol_2006_Oct_13(5)_147-159.nxml.txt.nlp	22792012	SENT13	19	19	25	25	trastuzumab	San	PA451743	80218	0.841
NULL	Exp_Mol_Med_2012_Feb_29_44(2)_159-166.nxml.txt.nlp	22127053	SENT56	0	0	9	9	simvastatin	Rho	PA451363	29984	0.841
NULL	Lab_Invest_2011_Apr_14_91(4)_598-608.nxml.txt.nlp	21321535	SENT243	0	0	4	4	sorafenib	CD4	PA7000	920	0.841
NULL	J_Mol_Signal_2010_Jul_12_5_8.nxml.txt.nlp	20624308	SENT32	21	21	29	29	gefitinib	Met	PA131301952	79811	0.841
NULL	Oncol_Lett_2013_Feb_9_5(2)_552-558.nxml.txt.nlp	23420128	SENT139	9	9	14	14	imatinib	KIT	PA10804	3815	0.841
NULL	Front_Immunol_2014_Aug_11_5_379.nxml.txt.nlp	25157251	SENT391	12	12	23	23	etanercept	adiponectin	PA449515	9370	0.841
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT217	13	13	1	1	paclitaxel	ABCB1	PA450761	5243	0.841
NULL	FASEB_J_2010_Jan_24(1)_286-295.nxml.txt.nlp	19720623	SENT234	11	11	0	0	sulfanilamide	SNO	PA451545	6498	0.841
NULL	J_Clin_Biochem_Nutr_2010_Jan_29_46(1)_87-92.nxml.txt.nlp	20104270	SENT94	11	11	5	5	hesperidin	STZ	PA449867	6484	0.841
NULL	Clin_Sarcoma_Res_2014_Jun_28_4_6.nxml.txt.nlp	25009738	SENT28	17	17	3	3	doxorubicin	CHOP	PA449412	1649	0.841
NULL	Diabetes_2013_Mar_14_62(3)_789-800.nxml.txt.nlp	22966074	SENT229	15	15	7	7	liraglutide	GLP-1	PA165958364	100125288	0.841
NULL	Int_J_Mol_Imaging_2011_Oct_26_2011_874585.nxml.txt.nlp	21490735	SENT17	17	17	5	5	doxorubicin	FDG	PA449412	23583	0.841
NULL	Cell_Death_Dis_2012_Mar_1_3(3)_e275.nxml.txt.nlp	22378068	SENT48	12	12	24	24	metformin	AMPK	PA450395	5563	0.841
NULL	Cancer_Res_Treat_2011_Jun_30_43(2)_131-133.nxml.txt.nlp	21811430	SENT52	7	7	4	4	letrozole	aromatase	PA450196	1588	0.841
NULL	Br_J_Cancer_2011_Sep_27_105(7)_1012-1022.nxml.txt.nlp	21863032	SENT133	1	1	9	9	nutlin-3	TRAIL		8743	0.841
NULL	EMBO_J_2010_Jun_16_29(12)_2026-2036.nxml.txt.nlp	20453830	SENT378	36	36	13	13	galactose	GAL	PA449725	51083	0.841
NULL	ScientificWorldJournal_2012_Apr_30_2012_327071.nxml.txt.nlp	22654592	SENT120	6	6	0	0	ethanol	TEPP	PA448073	374739	0.841
NULL	Mol_Cancer_2009_Nov_10_8_99.nxml.txt.nlp	19903356	SENT22	7	7	11	11	imatinib	KIT	PA10804	3815	0.841
NULL	Acta_Pharmacol_Sin_2012_Jan_3_33(1)_49-56.nxml.txt.nlp	22212430	SENT17	0	0	7	7	thrombin	JNK	PA451674	5599	0.841
NULL	Front_Endocrinol_(Lausanne)_2013_Sep_18_4_129.nxml.txt.nlp	24065956	SENT100	29	29	5	5	methacholine	MARCKS	PA165958382	4082	0.841
NULL	J_Oncol_2013_Feb_17_2013_872957.nxml.txt.nlp	23476648	SENT114	28	28	25	25	cisplatin	SFN	PA449014	25996;2810	0.841
NULL	Endocr_Connect_2012_Jun_8_1(1)_1-12.nxml.txt.nlp	23781298	SENT43	4	4	7	7	fenofibrate	adiponectin	PA449594	9370	0.841
NULL	Cancer_Inform_2009_Feb_9_8_1-17.nxml.txt.nlp	19458790	SENT14	21	21	8	8	irinotecan	UGT1A1	PA450085	54658	0.841
NULL	Clin_Psychopharmacol_Neurosci_2011_Apr_30_9(1)_36-43.nxml.txt.nlp	23431025	SENT95	37	37	25	25	aripiprazole	NAC	PA10026	22861	0.841
NULL	Chin_J_Cancer_2012_Jun_31(6)_266-280.nxml.txt.nlp	22313597	SENT305	13	13	21	21	letrozole	IGFBP3	PA450196	3486	0.841
NULL	Oncotarget_2014_Mar_16_5(9)_2513-2528.nxml.txt.nlp	24810336	SENT80	9	9	28	28	vemurafenib	TPC1	PA165946873	53373	0.841
NULL	Lab_Anim_Res_2013_Mar_25_29(1)_19-26.nxml.txt.nlp	23573104	SENT49	25	25	44	44	dextran	CO2	PA449261	4513	0.841
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1063.nxml.txt.nlp	24556678	SENT51	19	19	2	2	thioridazine	c-FLIP	PA451666	8837	0.841
NULL	Breast_Cancer_Res_2012_Jul_12_14(4)_R104.nxml.txt.nlp	22788954	SENT286	8	8	47	47	gefitinib	CLC	PA131301952	23529;1178	0.841
NULL	Oncotarget_2012_Sep_11_3(9)_1026-1035.nxml.txt.nlp	22976441	SENT89	4	4	31	31	etoposide	ATM	PA449552	472	0.841
NULL	Cardiovasc_Diabetol_2011_Dec_22_10_115.nxml.txt.nlp	22189184	SENT33	5	5	9	9	sitagliptin	GLP-1	PA164748978	100125288	0.841
NULL	Indian_J_Pharmacol_2008_Oct_40(Suppl_2)_S91-S97.nxml.txt.nlp	21593983	SENT177	15	15	6	6	pioglitazone	CYP3A	PA450970	1574	0.841
NULL	Cases_J_2008_Oct_29_1_283.nxml.txt.nlp	18959805	SENT32	14	14	27	27	lamivudine	CD4	PA450163	920	0.841
NULL	EMBO_Mol_Med_2013_Feb_9_5(2)_309-325.nxml.txt.nlp	23300147	SENT227	0	0	4	4	trastuzumab	HER2	PA451743	2064	0.841
NULL	Indian_J_Anaesth_2013_Jan-Feb_57(1)_91-92.nxml.txt.nlp	23716783	SENT10	8	8	15	15	rocuronium	PORC	PA164754992	64840;5448	0.841
NULL	Orphanet_J_Rare_Dis_2013_Apr_4_8_51.nxml.txt.nlp	23557332	SENT60	21	21	3	3	galsulfase	ARSB	PA164746235	411	0.841
NULL	J_Gen_Physiol_2010_Apr_135(4)_333-353.nxml.txt.nlp	20231374	SENT427	11	11	14	14	paroxetine	P2X4	PA450801	5025	0.841
NULL	Br_J_Cancer_2012_Jan_3_106(1)_18-24.nxml.txt.nlp	22108516	SENT55	37	37	24	24	camptothecin	TDP1	PA153590860	55775	0.841
NULL	J_Biol_2009_Apr_15_8(3)_30.nxml.txt.nlp	19435483	SENT2	13	13	18	18	imatinib	NQO2	PA10804	4835	0.841
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2011_Mar_14_4_13-24.nxml.txt.nlp	22879790	SENT138	7	7	28	28	exenatide	PPG	PA164749238	5552	0.841
NULL	Arch_Med_Sci_2014_Aug_29_10(4)_684-691.nxml.txt.nlp	25276151	SENT126	8	8	36	36	dobutamine	CRT	PA449381	811	0.841
NULL	J_Exp_Clin_Cancer_Res_2009_Feb_15_28(1)_19.nxml.txt.nlp	19216799	SENT142	16	16	6	6	cisplatin	AEG-1	PA449014	92140	0.841
NULL	Oncogene_2009_Dec_3_28(48)_4237-4248.nxml.txt.nlp	19734937	SENT53	6	6	26	26	thrombin	PAR1	PA451674	79581;2149	0.841
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Dec_4_67(Pt_1)_o10.nxml.txt.nlp	21522613	SENT3	11	11	14	14	l-arginine	mol	PA448478	90527	0.841
NULL	Alcohol_Res_Health_2010_33(1-2)_76-86.nxml.txt.nlp	23579938	SENT79	7	7	2	2	resveratrol	SIRT1		23411	0.841
NULL	Br_J_Cancer_2014_Jan_21_110(2)_384-391.nxml.txt.nlp	24346286	SENT127	28	28	6	6	trastuzumab	PTEN	PA451743	5728	0.841
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_21-38.nxml.txt.nlp	19305786	SENT126	5	5	20	20	capsaicin	TRPV1	PA448776	7442	0.841
NULL	Clin_Transl_Allergy_2013_Sep_2_3_29.nxml.txt.nlp	24004581	SENT109	17	17	6	6	omalizumab	IL-4	PA164752253	3565	0.841
NULL	Atherosclerosis_2011_Nov_219(1)_109-115.nxml.txt.nlp	21820657	SENT183	5	5	29	29	probucol	CETP	PA451107	1071	0.841
NULL	Biologics_2012_Dec_17_6_429-464.nxml.txt.nlp	23269860	SENT246	6	6	27	27	tocilizumab	ACR	PA165292659	49	0.841
NULL	Exp_Anim_2014_Feb_7_63(1)_45-53.nxml.txt.nlp	24521862	SENT19	19	19	2	2	trypsin	SPINK1	PA451806	6690	0.841
NULL	Protein_Cell_2014_Jun_19_5(6)_469-479.nxml.txt.nlp	24748116	SENT160	19	19	6	6	paclitaxel	EB1	PA450761	9167;22919;10982	0.841
NULL	Acta_Pharmacol_Sin_2013_Jun_8_34(6)_830-836.nxml.txt.nlp	23564080	SENT20	2	2	25	25	simvastatin	RAGE	PA451363	177	0.841
NULL	Tumour_Biol_2011_Oct_16_32(5)_965-976.nxml.txt.nlp	21678067	SENT215	20	20	25	25	methotrexate	p38	PA450428	10598;1432;7965	0.841
NULL	Clin_Exp_Vaccine_Res_2014_Jul_20_3(2)_113-116.nxml.txt.nlp	25003083	SENT41	5	5	15	15	imiquimod	TLR3	PA449972	7098	0.841
NULL	Breast_Cancer_Res_2010_Oct_28_12(5)_212.nxml.txt.nlp	21067532	SENT134	34	34	27	27	estradiol	aromatase	PA449503	1588	0.841
NULL	Clin_Interv_Aging_2009_May_14_4_179-186.nxml.txt.nlp	19503779	SENT54	5	5	13	13	levodopa	COMT	PA450213	1312	0.841
NULL	Breast_Cancer_Res_2010_Jun_28_12(3)_R43.nxml.txt.nlp	20579400	SENT279	15	15	1	1	fulvestrant	MTS	PA164747170	1678	0.841
NULL	J_Aging_Res_2011_Sep_28_2011_251517.nxml.txt.nlp	21969914	SENT171	34	34	40	40	estradiol	aromatase	PA449503	1588	0.841
NULL	Oncol_Rep_2012_Sep_15_28(3)_763-767.nxml.txt.nlp	22710607	SENT28	21	21	38	38	erlotinib	PS2	PA134687924	5664	0.841
NULL	Eur_J_Clin_Pharmacol_2009_Dec_16_65(12)_1211-1228.nxml.txt.nlp	19756557	SENT246	12	12	3	3	infliximab	ACT	PA452639	12;11332;9457;641455	0.841
NULL	Mol_Cancer_2012_Apr_26_11_24.nxml.txt.nlp	22537161	SENT139	36	36	15	15	pp2	PP2		4888	0.841
NULL	Indian_J_Endocrinol_Metab_2015_Jan-Feb_19(1)_30-38.nxml.txt.nlp	25593823	SENT103	24	24	34	34	pioglitazone	adiponectin	PA450970	9370	0.841
NULL	Arch_Med_Sci_2012_Nov_9_8(5)_934-938.nxml.txt.nlp	23185207	SENT74	0	0	17	17	rituximab	ADAMTS13	PA451261	11093	0.841
NULL	Hum_Genomics_2009_Dec_1_4(2)_91-106.nxml.txt.nlp	20038497	SENT120	46	46	33	33	donepezil	CYP2D6	PA449394	1565	0.841
NULL	Diabetologia_2010_Jan_6_53(1)_1-6.nxml.txt.nlp	19894028	SENT122	35	35	28	28	metformin	GLP-1	PA450395	100125288	0.841
NULL	Cardiol_Res_Pract_2013_Feb_19_2013_195456.nxml.txt.nlp	23533940	SENT127	5	5	13	13	clopidogrel	CYP3A4	PA449053	1576	0.841
NULL	Blood_Cancer_J_2012_Mar_2_2(3)_e58.nxml.txt.nlp	22829253	SENT49	12	12	0	0	cyclophosphamide	CYP3A4	PA449165	1576	0.841
NULL	Brain_Sci_2014_May_6_4(2)_356-375.nxml.txt.nlp	24961766	SENT34	10	10	20	20	propofol	G18	PA451141	1154;63940	0.841
NULL	Eur_J_Clin_Pharmacol_2014_May_21_70(8)_915-920.nxml.txt.nlp	24839948	SENT97	29	29	6	6	ketoconazole	CYP3A4	PA450146	1576	0.841
NULL	Nucleic_Acids_Res_2013_Dec_30_41(22)_10268-10282.nxml.txt.nlp	23997120	SENT29	32	32	19	19	camptothecin	TRF1	PA153590860	7013	0.841
NULL	Breast_Cancer_Res_2001_Oct_1_3(6)_361-364.nxml.txt.nlp	11737886	SENT63	4	4	7	7	epirubicin	p53	PA449476	7157	0.841
NULL	Nat_Commun_2014_Dec_18_5_5815.nxml.txt.nlp	25519973	SENT10	2	2	16	16	tranylcypromine	ATN1	PA451741	1822	0.841
NULL	Oncotarget_2013_Dec_4_5(2)_351-362.nxml.txt.nlp	24504051	SENT202	25	25	11	11	nilotinib	ERG	PA165958345	2078	0.841
NULL	Clin_Med_Insights_Oncol_2012_Apr_3_6_179-187.nxml.txt.nlp	22518088	SENT87	19	19	13	13	lapatinib	HER2	PA152241907	2064	0.841
NULL	Br_J_Cancer_2010_Oct_26_103(9)_1380-1390.nxml.txt.nlp	20877355	SENT211	6	6	15	15	vincristine	ASK1	PA451879	4217	0.841
NULL	Br_J_Cancer_2011_Sep_27_105(7)_1030-1038.nxml.txt.nlp	21863025	SENT228	7	7	15	15	saracatinib	COPA		1314	0.841
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Nov_8_64(Pt_12)_o2270.nxml.txt.nlp	21581251	SENT62	16	16	27	27	ethanol	mol	PA448073	90527	0.841
NULL	Breast_Cancer_Res_2012_Jul_19_14(4)_R108.nxml.txt.nlp	22812534	SENT279	19	19	10	10	pargyline	SETDB1	PA450797	9869	0.841
NULL	Arthritis_Res_Ther_2012_Sep_24_14(5)_R200.nxml.txt.nlp	23006144	SENT128	8	8	1	1	alefacept	IL-20	PA164748040	27190;50604	0.841
NULL	J_Carcinog_2012_Oct_27_11_16.nxml.txt.nlp	23230393	SENT56	17	17	15	15	letrozole	HER-2	PA450196	2064	0.841
NULL	Glycobiology_2012_May_12_22(5)_696-703.nxml.txt.nlp	22241825	SENT108	11	11	31	31	tetracycline	CO2	PA451640	4513	0.841
NULL	Oncotarget_2014_Jun_6_5(13)_4935-4944.nxml.txt.nlp	24952732	SENT188	5	5	11	11	doxazosin	PDK1	PA449407	5170;5163	0.841
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_127043.nxml.txt.nlp	23227093	SENT170	11	11	9	9	lovastatin	P-gp	PA450272	5243	0.841
NULL	Clin_Interv_Aging_2010_Feb_2_5_7-18.nxml.txt.nlp	20169038	SENT203	24	24	10	10	febuxostat	FACT	PA165958521	11198	0.841
NULL	Indian_J_Pharm_Sci_2013_Jan-Feb_75(1)_94-98.nxml.txt.nlp	23901167	SENT87	34	34	19	19	omeprazole	CYP2C19	PA450704	1557	0.841
NULL	Ann_Indian_Acad_Neurol_2010_Jul-Sep_13(3)_207-210.nxml.txt.nlp	21085534	SENT96	5	5	0	0	adalimumab	TNF	PA10004	7124	0.841
NULL	Front_Pharmacol_2014_Dec_10_5_271.nxml.txt.nlp	25540621	SENT879	5	5	14	14	bleomycin	ghrelin	PA448645	51738	0.841
NULL	Aging_(Albany_NY)_2009_May_22_1(6)_557-572.nxml.txt.nlp	20195383	SENT16	12	12	20	20	creatine	ADP	PA164778930	23038	0.841
NULL	Structure_2013_Jun_4_21(6)_986-996.nxml.txt.nlp	23665168	SENT176	33	33	2	2	kanamycin	DYRK1A	PA450137	1859	0.841
NULL	Diabetes_Metab_J_2013_Oct_17_37(5)_315-325.nxml.txt.nlp	24199159	SENT196	8	8	23	23	resveratrol	AMPK		5563	0.841
NULL	Front_Mol_Neurosci_2012_Jun_20_5_76.nxml.txt.nlp	22723769	SENT51	20	20	5	5	paraformaldehyde	E14	PA450790	4863	0.841
NULL	Allergy_Asthma_Immunol_Res_2010_Jan_30_2(1)_48-54.nxml.txt.nlp	20224678	SENT24	37	37	22	22	zafirlukast	CYSLTR1	PA451949	10800	0.841
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S18-S30.nxml.txt.nlp	20680104	SENT197	15	15	20	20	irinotecan	IFL	PA450085	3439	0.841
NULL	Cancer_Cell_Int_2014_Jan_27_14_8.nxml.txt.nlp	24467885	SENT102	14	14	10	10	fluorouracil	IFN	PA128406956	3439	0.841
NULL	Arthritis_Res_Ther_2009_Aug_24_11(4)_R127.nxml.txt.nlp	19703304	SENT157	6	6	24	24	adalimumab	OASIS	PA10004	90993	0.841
NULL	Br_J_Cancer_2010_Jul_13_103(2)_186-195.nxml.txt.nlp	20588277	SENT119	8	8	12	12	nutlin-3	p53		7157	0.841
NULL	Nat_Commun_2014_Aug_22_5_4684.nxml.txt.nlp	25147954	SENT324	5	5	12	12	methotrexate	IL-17	PA450428	3605	0.841
NULL	Int_J_Endocrinol_2013_Nov_27_2013_592576.nxml.txt.nlp	24369464	SENT206	2	2	15	15	atorvastatin	SCAP	PA448500	22937	0.841
NULL	Breast_Cancer_Res_2000_Mar_12_2(Suppl_1)_P2_03.nxml.txt.nlp	NULL	SENT3	31	31	11	11	estradiol	HES-1	PA449503	3280	0.841
NULL	Breast_Cancer_Res_2004_Mar_26_6(3)_R252-R263.nxml.txt.nlp	15084249	SENT26	3	3	32	32	tamoxifen	CYP3A4	PA451581	1576	0.841
NULL	Oncogene_2009_Feb_5_28(5)_674-685.nxml.txt.nlp	19015634	SENT102	38	38	12	12	melphalan	FANCD2	PA450354	2177	0.841
NULL	Mol_Cells_2014_Mar_31_37(3)_234-240.nxml.txt.nlp	24642709	SENT120	24	24	5	5	capsaicin	HO-1	PA448776	3162	0.841
NULL	Clin_Pharmacol_2010_Jun_22_2_105-110.nxml.txt.nlp	22291493	SENT44	12	12	6	6	sibutramine	ADIPOQ	PA451344	9370	0.841
NULL	Asia_Pac_Allergy_2014_Jan_31_4(1)_54-67.nxml.txt.nlp	24527412	SENT214	31	31	19	19	efavirenz	CD4	PA449441	920	0.841
NULL	Oncotarget_2013_Jun_3_4(6)_875-883.nxml.txt.nlp	23900261	SENT108	22	22	27	27	estradiol	ESR1	PA449503	2099	0.841
NULL	EMBO_J_2013_Feb_20_32(4)_511-523.nxml.txt.nlp	23241948	SENT131	0	0	29	29	erythromycin	FRP	PA449493	11167;6422	0.841
NULL	Hum_Mol_Genet_2012_Apr_1_21(7)_1496-1503.nxml.txt.nlp	22171071	SENT209	19	19	13	13	l-methionine	TMP	PA450423	2012	0.841
NULL	Chin_J_Cancer_2011_Nov_30(11)_749-756.nxml.txt.nlp	22035855	SENT110	7	7	15	15	tamoxifen	EGFR	PA451581	1956	0.841
NULL	Clin_Dev_Immunol_2011_Nov_3_2011_320571.nxml.txt.nlp	22110523	SENT201	26	26	15	15	irinotecan	LGR5	PA450085	8549	0.841
NULL	Cancer_Cell_Int_2013_May_15_13_42.nxml.txt.nlp	23672670	SENT217	20	20	7	7	paclitaxel	RAIDD	PA450761	8738	0.84
NULL	Clin_Interv_Aging_2012_Dec_30_7_1-13.nxml.txt.nlp	22291468	SENT268	8	8	11	11	dronedarone	CYP3A4	PA153619853	1576	0.84
NULL	Oxid_Med_Cell_Longev_2012_Jan_19_2012_390678.nxml.txt.nlp	22315655	SENT174	23	23	25	25	gliclazide	NAC	PA10892	22861	0.84
NULL	Evid_Based_Complement_Alternat_Med_2014_Oct_14_2014_734867.nxml.txt.nlp	25371696	SENT38	12	12	5	5	piperazine	CYP3A	PA450977	1574	0.84
NULL	J_Cancer_2013_Nov_23_4(9)_736-754.nxml.txt.nlp	24312144	SENT177	10	10	13	13	erlotinib	EGFR	PA134687924	1956	0.84
NULL	Front_Cell_Neurosci_2015_Jan_15_8_459.nxml.txt.nlp	25642166	SENT71	3	3	17	17	hemin	HO-1	PA449849	3162	0.84
NULL	Allergy_Asthma_Immunol_Res_2014_Nov_28_6(6)_567-572.nxml.txt.nlp	25374757	SENT85	5	5	37	37	fexofenadine	JNK	PA449621	5599	0.84
NULL	Leukemia_2014_Apr_14_28(4)_961-964.nxml.txt.nlp	24418991	SENT14	18	18	10	10	nilotinib	P-gp	PA165958345	5243	0.84
NULL	Mol_Cancer_2009_May_15_8_28.nxml.txt.nlp	19445670	SENT86	34	34	1	1	doxorubicin	Bcl-2	PA449412	596	0.84
NULL	Clin_Med_Oncol_2008_Jul_8_2_471-475.nxml.txt.nlp	21892320	SENT89	31	31	24	24	thalidomide	GM-CSF	PA451644	1437	0.84
NULL	Acta_Pharmacol_Sin_2009_Nov_12_30(11)_1566-1572.nxml.txt.nlp	19820718	SENT13	22	22	31	31	verapamil	CYP3A4	PA451868	1576	0.84
NULL	Cardiovasc_Diabetol_2010_Mar_23_9_11.nxml.txt.nlp	20331890	SENT125	2	2	11	11	candesartan	IL-18	PA448765	3606	0.84
NULL	Biomed_Res_Int_2013_May_28_2013_197398.nxml.txt.nlp	23781498	SENT58	9	9	4	4	ethanol	LOR	PA448073	4014	0.84
NULL	J_Int_Soc_Sports_Nutr_2009_Feb_19_6_6.nxml.txt.nlp	19228401	SENT237	15	15	33	33	creatine	CEE	PA164778930	51608	0.84
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT213	5	5	10	10	perifosine	DR4	PA165291471	8797	0.84
NULL	Clin_Ophthalmol_2010_May_25_4_477-480.nxml.txt.nlp	20535224	SENT49	13	13	1	1	glutaraldehyde	TEM	PA449777	64102	0.84
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT331	23	23	15	15	risperidone	PRL	PA451257	5617	0.84
NULL	Cell_Death_Dis_2012_Jun_21_3(6)_e327.nxml.txt.nlp	22717582	SENT8	9	9	15	15	vincristine	p53	PA451879	7157	0.84
NULL	Cell_Death_Dis_2010_Nov_18_1(11)_e102.nxml.txt.nlp	21368867	SENT84	6	6	9	9	gentamicin	CLIMP-63	PA449753	10970	0.84
NULL	Br_J_Cancer_2009_Oct_20_101(8)_1253-1260.nxml.txt.nlp	19755984	SENT128	6	6	12	12	letrozole	HER-2	PA450196	2064	0.84
NULL	Br_J_Pharmacol_2014_Oct_26_171(20)_4785-4796.nxml.txt.nlp	25074741	SENT10	8	8	19	19	guanfacine	NK1R	PA449825	6869	0.84
NULL	Front_Oncol_2014_May_1_4_80.nxml.txt.nlp	24822169	SENT310	7	7	9	9	curcumin	DNMT1	PA151958596	1786	0.84
NULL	Cell_Cycle_2013_May_15_12(10)_1492-1500.nxml.txt.nlp	23598717	SENT19	21	21	16	16	doxorubicin	cadherin	PA449412	1015	0.84
NULL	Breast_Cancer_Res_Treat_2014_Nov_24_143(1)_125-133.nxml.txt.nlp	24272078	SENT8	12	12	31	31	fulvestrant	aromatase	PA164747170	1588	0.84
NULL	Clin_Mol_Hepatol_2013_Sep_30_19(3)_300-304.nxml.txt.nlp	24133668	SENT55	12	12	2	2	lamivudine	NUC	PA450163	4924	0.84
NULL	FEBS_Open_Bio_2014_Aug_30_4_763-776.nxml.txt.nlp	25349781	SENT141	15	15	26	26	curcumin	AMPK	PA151958596	5563	0.84
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT222	5	5	20	20	curcumin	Bcl-2	PA151958596	596	0.84
NULL	Biochem_Biophys_Res_Commun_2008_Mar_7_367(2)_271-276.nxml.txt.nlp	18164684	SENT297	23	23	34	34	doxycycline	p53	PA449415	7157	0.84
NULL	J_Biomed_Sci_2013_May_1_20(1)_26.nxml.txt.nlp	23634990	SENT130	14	14	2	2	bleomycin	P2X7	PA448645	5027	0.84
NULL	Int_J_Biol_Sci_2011_Nov_7_8(1)_15-29.nxml.txt.nlp	22211101	SENT27	12	12	18	18	cisplatin	BTC	PA449014	685	0.84
NULL	Br_J_Pharmacol_2010_Sep_161(2)_288-307.nxml.txt.nlp	20735416	SENT125	26	26	30	30	propofol	c-fos	PA451141	2353	0.84
NULL	Surg_Endosc_2013_Jun_18_27(6)_2094-2101.nxml.txt.nlp	23247745	SENT155	17	17	2	2	atorvastatin	CYP3A	PA448500	1574	0.84
NULL	Exp_Neurobiol_2013_Mar_31_22(1)_1-10.nxml.txt.nlp	23585716	SENT38	13	13	19	19	rasagiline	GDNF	PA164764584	2668	0.84
NULL	J_Gastrointest_Cancer_2013_Aug_7_44(4)_385-392.nxml.txt.nlp	23921604	SENT14	0	0	27	27	imatinib	BSC	PA10804	6558	0.84
NULL	Cell_Commun_Signal_2010_Sep_22_8_27.nxml.txt.nlp	20860841	SENT217	12	12	28	28	doxorubicin	CHK2	PA449412	11200	0.84
NULL	F1000Res_2014_Aug_19_3_198.nxml.txt.nlp	25400908	SENT297	13	13	27	27	pertuzumab	HER2		2064	0.84
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT176	29	29	11	11	phenprocoumon	CYP2C9	PA450921	1559	0.84
NULL	Oxid_Med_Cell_Longev_2012_May_30_2012_452902.nxml.txt.nlp	22701146	SENT279	2	2	26	26	cyclophosphamide	OCTN2	PA449165	6584	0.84
NULL	Arthritis_Res_Ther_2008_Sep_24_10(5)_R115.nxml.txt.nlp	18816401	SENT16	2	2	15	15	etanercept	GDF5	PA449515	8200	0.84
NULL	J_Oncol_2012_Jun_4_2012_928127.nxml.txt.nlp	22701483	SENT107	8	8	18	18	metformin	p27	PA450395	5715;10534	0.84
NULL	Biomed_Res_Int_2013_Apr_21_2013_759057.nxml.txt.nlp	23710458	SENT31	17	17	3	3	gefitinib	EGFR	PA131301952	1956	0.84
NULL	ScientificWorldJournal_2012_Sep_17_2012_637953.nxml.txt.nlp	23028251	SENT528	28	28	20	20	paclitaxel	CLB	PA450761	171425	0.84
NULL	Clin_Pediatr_Endocrinol_2014_Apr_20_23(2)_53-58.nxml.txt.nlp	24790387	SENT126	10	10	13	13	bicalutamide	aromatase	PA164746255	1588	0.84
NULL	Ann_Surg_Oncol_2014_Feb_13_21(5)_1575-1582.nxml.txt.nlp	24522992	SENT170	3	3	18	18	anastrozole	ATAC	PA448432	6375	0.84
NULL	Mol_Cancer_2014_Jan_13_13_7.nxml.txt.nlp	24418169	SENT287	2	2	9	9	sorafenib	STAT3	PA7000	6774	0.84
NULL	Brief_Bioinform_2013_Jul_9_14(4)_491-505.nxml.txt.nlp	22877768	SENT51	11	11	18	18	vincristine	CHOP	PA451879	1649	0.84
NULL	Eur_Heart_J_2013_Dec_1_34(45)_3515-3524.nxml.txt.nlp	23594590	SENT19	12	12	9	9	indomethacin	COX	PA449982	1351	0.84
NULL	Hum_Genomics_2013_Apr_5_7(1)_10.nxml.txt.nlp	23561625	SENT62	9	9	6	6	flavopiridol	CDK7	PA452627	1022	0.84
NULL	Breast_Cancer_Res_2008_Dec_18_10(Suppl_4)_S18.nxml.txt.nlp	19128431	SENT62	15	15	26	26	tamoxifen	aromatase	PA451581	1588	0.84
NULL	Breast_Cancer_Res_2009_Sep_29_11(5)_209.nxml.txt.nlp	19818165	SENT225	39	39	37	37	tamoxifen	JNK	PA451581	5599	0.84
NULL	Biomed_Res_Int_2013_May_8_2013_703130.nxml.txt.nlp	23738330	SENT146	27	27	16	16	lipase	SP75	PA450239	6674	0.84
NULL	Case_Rep_Endocrinol_2014_Feb_10_2014_479641.nxml.txt.nlp	24660072	SENT63	32	32	47	47	cinacalcet	PTH	PA164776671	5741	0.84
NULL	Front_Oncol_2014_Apr_22_4_86.nxml.txt.nlp	24795863	SENT558	15	15	25	25	resveratrol	CD95		355	0.84
NULL	EMBO_Mol_Med_2012_Aug_6_4(8)_705-718.nxml.txt.nlp	22674894	SENT193	0	0	38	38	tamoxifen	p53	PA451581	7157	0.84
NULL	Diabetes_2008_Sep_57(9)_2272-2279.nxml.txt.nlp	18519799	SENT197	22	22	36	36	rosiglitazone	PDK4	PA451283	5166	0.84
NULL	J_Gen_Physiol_2008_Nov_132(5)_521-535.nxml.txt.nlp	18852303	SENT218	13	13	0	0	trypsin	CAP2	PA451806	5271;10486	0.84
NULL	Angiogenesis_2012_Dec_28_15(4)_623-641.nxml.txt.nlp	22843200	SENT168	24	24	33	33	sunitinib	NG2	PA162372840	1464;6048	0.84
NULL	Pharmaceuticals_(Basel)_2012_Aug_10_5(8)_802-836.nxml.txt.nlp	24280676	SENT90	27	27	10	10	gemcitabine	CNT2	PA449748	9153	0.84
NULL	Arthritis_Res_Ther_2011_Feb_23_13(1)_R33.nxml.txt.nlp	21345222	SENT149	0	0	10	10	adalimumab	IL-8	PA10004	3576	0.84
NULL	Br_J_Cancer_2012_Jan_17_106(2)_284-289.nxml.txt.nlp	22215065	SENT182	18	18	8	8	sunitinib	IFN	PA162372840	3439	0.84
NULL	Arthritis_Res_Ther_2006_Apr_12_8(Suppl_1)_S3.nxml.txt.nlp	16820042	SENT134	3	3	12	12	triamcinolone	ACTH	PA451749	5443	0.84
NULL	Int_J_Mol_Sci_2013_Aug_14_14(8)_16719-16731.nxml.txt.nlp	23949634	SENT6	15	15	8	8	thrombin	CA1	PA451674	759	0.84
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Dec_6_65(Pt_1)_o39.nxml.txt.nlp	21581681	SENT61	27	27	7	7	ethanol	mol	PA448073	90527	0.84
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT98	6	6	10	10	trastuzumab	STAT3	PA451743	6774	0.84
NULL	Cancers_(Basel)_2014_Apr_30_6(2)_1031-1046.nxml.txt.nlp	24785146	SENT173	32	32	3	3	geldanamycin	Hsp90	PA152031327	3320	0.84
NULL	Ann_Surg_Oncol_2011_Mar_26_18(3)_659-669.nxml.txt.nlp	20976564	SENT143	19	19	4	4	irinotecan	HCN	PA450085	378938	0.84
NULL	Acta_Pharmacol_Sin_2013_Jun_8_34(6)_830-836.nxml.txt.nlp	23564080	SENT113	21	21	13	13	simvastatin	HMGB1	PA451363	3146	0.84
NULL	Cardiovasc_Diabetol_2010_Jul_27_9_31.nxml.txt.nlp	20663195	SENT14	30	30	9	9	irbesartan	CD31	PA450084	5175	0.84
NULL	Mol_Cancer_2012_Sep_14_11_69.nxml.txt.nlp	22978347	SENT43	33	33	20	20	letrozole	CA125	PA450196	4077;94025	0.84
NULL	Int_J_Environ_Res_Public_Health_2010_Feb_27_7(2)_364-379.nxml.txt.nlp	20616979	SENT107	13	13	5	5	ethanol	ADH1C	PA448073	126	0.84
NULL	Cancer_Microenviron_2009_Sep_26_2(Suppl_1)_19-204.nxml.txt.nlp	NULL	SENT1619	7	7	27	27	sildenafil	CD4	PA451346	920	0.84
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2751-2762.nxml.txt.nlp	24169358	SENT188	0	0	5	5	fulvestrant	CDK6	PA164747170	1021	0.84
NULL	Breast_Cancer_Res_2014_May_5_16(3)_R45.nxml.txt.nlp	24887236	SENT221	2	2	7	7	cetuximab	EGFR	PA10040	1956	0.84
NULL	Br_J_Cancer_2012_May_8_106(10)_1587-1590.nxml.txt.nlp	22568998	SENT11	10	10	13	13	sunitinib	IFN	PA162372840	3439	0.84
NULL	Int_J_Mol_Sci_2014_Sep_19_15(9)_16698-16718.nxml.txt.nlp	25244018	SENT68	8	8	20	20	estradiol	LKB1	PA449503	6794	0.84
NULL	Curr_Opin_HIV_AIDS_2014_May_10_9(3)_242-249.nxml.txt.nlp	24670321	SENT63	8	8	27	27	imiquimod	GM-CSF	PA449972	1437	0.84
NULL	Cell_Commun_Signal_2013_Oct_1_11_73.nxml.txt.nlp	24083678	SENT148	2	2	22	22	sulindac	p65	PA451565	5970	0.84
NULL	Front_Pharmacol_2014_May_8_5_108.nxml.txt.nlp	24847273	SENT517	0	0	6	6	propofol	NR1	PA451141	27158	0.84
NULL	Br_J_Cancer_2014_Nov_25_111(11)_2091-2102.nxml.txt.nlp	25349971	SENT159	18	18	25	25	imatinib	KIT	PA10804	3815	0.84
NULL	Cancers_(Basel)_2011_Sep_2_3(3)_3461-3495.nxml.txt.nlp	24212964	SENT447	18	18	27	27	gemcitabine	IFN	PA449748	3439	0.84
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT219	15	15	3	3	chloroquine	BMPR-II	PA448948	659	0.84
NULL	Oncotarget_2013_Aug_24_4(10)_1618-1631.nxml.txt.nlp	24113128	SENT210	8	8	21	21	sorafenib	p53	PA7000	7157	0.84
NULL	Biol_Open_2014_Sep_26_3(10)_995-1004.nxml.txt.nlp	25260916	SENT662	10	10	4	4	heparin	RANTES	PA449855	6352	0.84
NULL	Arthritis_Res_Ther_2006_Feb_28_8(2)_R49.nxml.txt.nlp	16507174	SENT39	18	18	12	12	fluorescein	CD86	PA164746009	942	0.84
NULL	Clin_Pract_2012_Nov_13_2(4)_e82.nxml.txt.nlp	24765481	SENT46	5	5	18	18	hydrocortisone	ACTH	PA449905	5443	0.84
NULL	Aging_(Albany_NY)_2010_Apr_30_2(4)_183-184.nxml.txt.nlp	20436227	SENT15	27	27	9	9	resveratrol	SIRT1		23411	0.84
NULL	J_Neurol_2012_Mar_13_259(3)_448-456.nxml.txt.nlp	21842303	SENT201	2	2	10	10	lipase	IL-8	PA450239	3576	0.84
NULL	Osteoporos_Int_2013_May_4_24(10)_2659-2670.nxml.txt.nlp	23644877	SENT231	2	2	5	5	metformin	AMPK	PA450395	5563	0.84
NULL	Nat_Commun_2013_Sep_20_4_2444.nxml.txt.nlp	24051492	SENT189	3	3	5	5	nutlin-3	p53		7157	0.84
NULL	Eur_J_Clin_Pharmacol_2010_Nov_29_66(11)_1131-1136.nxml.txt.nlp	20669013	SENT108	11	11	14	14	voriconazole	CYP2C19	PA10233	1557	0.84
NULL	Mol_Vis_2007_Jul_9_13_1083-1093.nxml.txt.nlp	17653053	SENT153	2	2	19	19	minocycline	eotaxin	PA450519	6356	0.84
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT187	19	19	1	1	cisplatin	IBP	PA449014	706;50619	0.84
NULL	Breast_Cancer_Res_2002_Apr_4_4(3)_85-89.nxml.txt.nlp	12052249	SENT40	24	24	6	6	tamoxifen	CYP3A4	PA451581	1576	0.84
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2011_Sep_13_4_47-62.nxml.txt.nlp	22879794	SENT93	12	12	5	5	liraglutide	PPG	PA165958364	5552	0.84
NULL	J_Cancer_2013_Nov_21_4(9)_727-735.nxml.txt.nlp	24312143	SENT129	14	14	2	2	temozolomide	SRPK1	PA451609	6732	0.84
NULL	Interdiscip_Toxicol_2011_Sep_4(3)_132-143.nxml.txt.nlp	22058654	SENT185	10	10	37	37	alprazolam	IL-2	PA448333	3558	0.84
NULL	Braz_J_Med_Biol_Res_2013_Jun_25_46(6)_528-532.nxml.txt.nlp	23802228	SENT101	9	9	11	11	rosiglitazone	PON1	PA451283	5444	0.84
NULL	Biomed_Res_Int_2013_Jul_1_2013_964743.nxml.txt.nlp	23936861	SENT81	11	11	7	7	erlotinib	EGFR	PA134687924	1956	0.84
NULL	J_Biol_Chem_2012_Apr_13_287(16)_12952-12965.nxml.txt.nlp	22371491	SENT333	6	6	16	16	terazosin	CXCR2	PA451612	3579	0.84
NULL	Environ_Health_Perspect_2005_Oct_14_113(10)_1330-1335.nxml.txt.nlp	16203242	SENT113	0	0	10	10	arsenite	MLC	PA452638	23209	0.84
NULL	J_Biol_Chem_2013_Mar_8_288(10)_7024-7036.nxml.txt.nlp	23303190	SENT377	25	25	19	19	lincomycin	DAC	PA164749212	13	0.84
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1046.nxml.txt.nlp	24503538	SENT77	1	1	12	12	oxaliplatin	FGFR4	PA131285527	2264	0.84
NULL	Carcinogenesis_2013_Mar_7_34(3)_703-712.nxml.txt.nlp	23222814	SENT36	11	11	27	27	curcumin	p53	PA151958596	7157	0.84
NULL	J_Cereb_Blood_Flow_Metab_2012_Dec_5_32(12)_2171-2180.nxml.txt.nlp	22948298	SENT59	7	7	21	21	paraformaldehyde	NOTCH3	PA450790	4854	0.84
NULL	Diabetes_Care_2011_Jul_17_34(7)_1678-1680.nxml.txt.nlp	21709302	SENT72	15	15	7	7	rosiglitazone	DREAM	PA451283	30818	0.84
NULL	Bone_Marrow_Transplant_2011_Oct_13_46(10)_1382-1388.nxml.txt.nlp	21151184	SENT56	5	5	20	20	paraformaldehyde	San	PA450790	80218	0.84
NULL	Arthritis_Res_Ther_2012_Sep_24_14(5)_R200.nxml.txt.nlp	23006144	SENT113	0	0	5	5	alefacept	IL-20	PA164748040	27190;50604	0.84
NULL	J_Inflamm_(Lond)_2008_Aug_8_5_14.nxml.txt.nlp	18691416	SENT150	9	9	47	47	troglitazone	GAL4	PA451799	3960	0.84
NULL	Angiogenesis_2010_Dec_7_13(4)_305-315.nxml.txt.nlp	20927579	SENT301	2	2	12	12	resveratrol	CD95		355	0.84
NULL	Breast_Cancer_Res_2007_Mar_2_9(2)_205.nxml.txt.nlp	NULL	SENT26	27	27	22	22	lapatinib	HER-2	PA152241907	2064	0.84
NULL	Cell_Death_Differ_2010_Dec_28_17(12)_1867-1881.nxml.txt.nlp	20508647	SENT149	9	9	2	2	bortezomib	NAC	PA10252	22861	0.84
NULL	Oncotarget_2013_Nov_7_4(12)_2550-2566.nxml.txt.nlp	24334291	SENT220	36	36	23	23	alemtuzumab	CHOP	PA164783958	1649	0.84
NULL	J_Obes_2010_Oct_31_2010_892081.nxml.txt.nlp	21052532	SENT26	10	10	1	1	glucose	adiponectin	PA449773	9370	0.84
NULL	J_Korean_Med_Sci_2005_Oct_31_20(5)_883-885.nxml.txt.nlp	16224167	SENT8	19	19	24	24	azathioprine	gamma	PA448515	9913	0.84
NULL	Mol_Cancer_2013_May_16_12_42.nxml.txt.nlp	23680104	SENT125	43	43	29	29	cisplatin	Mcl-1	PA449014	4170	0.84
NULL	Diabetologia_2010_Feb_4_53(2)_254-262.nxml.txt.nlp	19908023	SENT309	31	31	23	23	lisinopril	TES	PA450242	26136	0.84
NULL	Blood_Cancer_J_2014_Jan_17_4(1)_e175.nxml.txt.nlp	24442204	SENT84	7	7	21	21	bortezomib	MAFB	PA10252	9935	0.84
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Jul_21_9_20.nxml.txt.nlp	20663145	SENT112	34	34	5	5	clarithromycin	LBH	PA449028	81606;221491	0.84
NULL	Cancer_Microenviron_2009_Sep_26_2(Suppl_1)_19-204.nxml.txt.nlp	NULL	SENT3762	14	14	7	7	gemcitabine	MUC4	PA449748	4585	0.84
NULL	Br_J_Cancer_2012_Feb_14_106(4)_685-692.nxml.txt.nlp	22294184	SENT197	24	24	11	11	lovastatin	p38	PA450272	10598;1432;7965	0.84
NULL	BMJ_2010_Feb_8_340_c693.nxml.txt.nlp	20142325	SENT112	22	22	19	19	paroxetine	CYP2D6	PA450801	1565	0.84
NULL	An_Bras_Dermatol_2013_Mar-Apr_88(2)_264-267.nxml.txt.nlp	23739711	SENT59	9	9	7	7	cyclophosphamide	CHOP	PA449165	1649	0.84
NULL	Oxid_Med_Cell_Longev_2009_Jul-Aug_2(3)_130-137.nxml.txt.nlp	20592767	SENT124	12	12	0	0	pilocarpine	CAT	PA450962	847	0.84
NULL	Acta_Pharmacol_Sin_2009_Jul_3_30(7)_965-972.nxml.txt.nlp	19575000	SENT163	7	7	3	3	ketanserin	5-HT2A	PA131053734	3356	0.84
NULL	Int_J_Biol_Sci_2013_Apr_22_9(4)_350-360.nxml.txt.nlp	23630447	SENT166	27	27	13	13	doxorubicin	AKT	PA449412	207	0.84
NULL	Diabetes_2011_Jun_21_60(6)_1770-1778.nxml.txt.nlp	21562078	SENT148	0	0	2	2	metformin	AMPK	PA450395	5563	0.84
NULL	Adv_Hematol_2012_Mar_25_2012_302570.nxml.txt.nlp	22536253	SENT36	2	2	5	5	rituximab	CHOP	PA451261	1649	0.84
NULL	J_Cell_Biol_2002_Jun_10_157(6)_975-984.nxml.txt.nlp	12045187	SENT145	14	14	6	6	doxycycline	p53	PA449415	7157	0.84
NULL	J_Clin_Biochem_Nutr_2007_Jul_27_41(1)_32-42.nxml.txt.nlp	18392098	SENT147	6	6	4	4	arsenite	ROS	PA452638	6098	0.84
NULL	Indian_J_Endocrinol_Metab_2013_Jan-Feb_17(1)_91-94.nxml.txt.nlp	23776858	SENT31	8	8	16	16	vildagliptin	GLP-1	PA165958346	100125288	0.84
NULL	J_Signal_Transduct_2011_Jun_7_2011_982879.nxml.txt.nlp	21776391	SENT168	17	17	11	11	gefitinib	EGFR	PA131301952	1956	0.84
NULL	Diabetes_2013_Oct_17_62(10)_3500-3513.nxml.txt.nlp	23884882	SENT10	32	32	22	22	resveratrol	NKX2-2		4821	0.84
NULL	Virchows_Arch_2012_Feb_16_460(2)_141-149.nxml.txt.nlp	22173329	SENT228	20	20	14	14	cetuximab	PIK3CA	PA10040	5290	0.84
NULL	Orphanet_J_Rare_Dis_2010_Dec_16_5_39.nxml.txt.nlp	21162721	SENT7	35	35	27	27	carbamazepine	HLA-B	PA448785	3106	0.84
NULL	Biosensors_(Basel)_2013_Nov_13_3(4)_374-384.nxml.txt.nlp	25586413	SENT82	29	29	13	13	capsaicin	NHS	PA448776	4810	0.84
NULL	J_Infect_Dis_2011_May_1_203(9)_1204-1214.nxml.txt.nlp	21459813	SENT144	17	17	4	4	lamivudine	INI	PA450163	84844	0.84
NULL	Cancer_Cell_Int_2013_Jan_15_13_3.nxml.txt.nlp	23320839	SENT135	7	7	15	15	gefitinib	VEGFR	PA131301952	3791	0.84
NULL	Mol_Biol_Rep_2013_Jul_11_40(7)_4211-4217.nxml.txt.nlp	23666051	SENT118	20	20	5	5	midazolam	SLCO2B1	PA450496	11309	0.84
NULL	Case_Rep_Endocrinol_2014_Feb_10_2014_479641.nxml.txt.nlp	24660072	SENT114	28	28	3	3	cinacalcet	PTH	PA164776671	5741	0.84
NULL	Protein_Cell_2014_Apr_4_5(4)_307-316.nxml.txt.nlp	24585413	SENT157	10	10	31	31	fluorescein	CD86	PA164746009	942	0.84
NULL	Case_Rep_Endocrinol_2014_Feb_10_2014_479641.nxml.txt.nlp	24660072	SENT5	0	0	10	10	cinacalcet	PTH	PA164776671	5741	0.84
NULL	Oncoimmunology_2013_Mar_1_2(3)_e23402.nxml.txt.nlp	23802080	SENT167	0	0	7	7	sargramostim	IL-2	PA164748631	3558	0.84
NULL	Exp_Ther_Med_2013_Jan_19_5(1)_23-27.nxml.txt.nlp	23251236	SENT10	18	18	14	14	curcumin	EGF	PA151958596	1950	0.84
NULL	J_Cardiothorac_Surg_2012_Jun_20_7_57.nxml.txt.nlp	22716287	SENT176	7	7	33	33	rosiglitazone	p38	PA451283	10598;1432;7965	0.84
NULL	Curr_Neuropharmacol_2013_Dec_11(6)_652-663.nxml.txt.nlp	24396340	SENT78	12	12	18	18	oxaliplatin	TRPA1	PA131285527	8989	0.84
NULL	Oncoscience_2014_Jan_30_1(1)_57-68.nxml.txt.nlp	25593988	SENT302	24	24	26	26	nilotinib	AMN	PA165958345	215;81693	0.84
NULL	Int_J_Mol_Sci_2014_Jun_26_15(7)_11403-11415.nxml.txt.nlp	24972136	SENT123	28	28	38	38	stavudine	APOC3	PA451494	345	0.84
NULL	Indian_J_Endocrinol_Metab_2012_Dec_16(Suppl_3)_S529-S531.nxml.txt.nlp	23565485	SENT31	3	3	5	5	metformin	AMPK	PA450395	5563	0.84
NULL	Mol_Biol_Cell_2013_Jul_1_24(13)_2134-2145.nxml.txt.nlp	23657817	SENT182	23	23	20	20	pp2	ILK		3611	0.84
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2007_Dec_6_64(Pt_1)_o161.nxml.txt.nlp	21200727	SENT62	20	20	3	3	ethanol	mol	PA448073	90527	0.84
NULL	Nat_Commun_2013_Aug_15_4_2130.nxml.txt.nlp	23945651	SENT129	11	11	25	25	etoposide	ATG5	PA449552	9474	0.84
NULL	Drugs_2014_Apr_17_74(6)_659-674.nxml.txt.nlp	24740824	SENT363	21	21	25	25	azathioprine	CD4	PA448515	920	0.84
NULL	Oncogenesis_2012_Apr_2_1(4)_e5.nxml.txt.nlp	23552603	SENT240	2	2	8	8	ns-398	IEX-1		8870	0.84
NULL	Diabetes_Care_2012_Feb_16_35(2)_327-333.nxml.txt.nlp	22179958	SENT75	13	13	4	4	metformin	B12	PA450395	7126;4709	0.84
NULL	Crit_Care_2007_Feb_15_11(1)_R18.nxml.txt.nlp	17302971	SENT90	2	2	17	17	heparin	ACT	PA449855	12;11332;9457;641455	0.84
NULL	Oncol_Lett_2013_Mar_20_5(3)_865-869.nxml.txt.nlp	23425722	SENT101	6	6	4	4	bupivacaine	TREK-1	PA135057240	3776	0.84
NULL	Br_J_Cancer_2010_Jul_13_103(2)_186-195.nxml.txt.nlp	20588277	SENT167	15	15	37	37	nutlin-3	p53		7157	0.84
NULL	Diabetes_2009_Apr_9_58(4)_965-974.nxml.txt.nlp	19136651	SENT32	24	24	6	6	nadh	NQO1	PA164755085	1728	0.84
NULL	J_Korean_Med_Sci_2007_Dec_20_22(6)_1055-1059.nxml.txt.nlp	18162722	SENT131	19	19	35	35	famotidine	ESD	PA449586	2098	0.84
NULL	Neuropsychopharmacology_2009_Apr_2_34(5)_1135-1148.nxml.txt.nlp	18596687	SENT3	42	42	21	21	cocaine	CRF	PA449072	1392;10882	0.84
NULL	Genome_Med_2010_Apr_28_2(4)_27.nxml.txt.nlp	20423530	SENT239	10	10	21	21	ethanol	H19	PA448073	283120	0.84
NULL	Clinics_(Sao_Paulo)_2014_Jan_69(1)_68-74.nxml.txt.nlp	24473562	SENT90	7	7	11	11	nutlin-3	SOCS-1		8651	0.84
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1224-1233.nxml.txt.nlp	22353810	SENT161	20	20	17	17	etoposide	MRP-1	PA449552	928	0.84
NULL	Front_Oncol_2013_Sep_23_3_250.nxml.txt.nlp	24069582	SENT141	17	17	2	2	trastuzumab	HER2	PA451743	2064	0.84
NULL	J_Oncol_2013_Apr_29_2013_854121.nxml.txt.nlp	23737784	SENT174	14	14	6	6	pertuzumab	HER2		2064	0.84
NULL	Indian_J_Psychol_Med_2012_Apr-Jun_34(2)_140-143.nxml.txt.nlp	23162189	SENT70	26	26	3	3	dextromethorphan	CRT	PA449273	811	0.84
NULL	Pharmaceutics_2011_Nov_18_3(4)_865-913.nxml.txt.nlp	24309312	SENT163	25	25	33	33	raltegravir	UGT		7361;7355	0.84
NULL	Gut_2013_Sep_7_62(9)_1340-1346.nxml.txt.nlp	23135762	SENT84	18	18	34	34	ribavirin	IL28B	PA451241	282617	0.84
NULL	J_Korean_Neurosurg_Soc_2013_Oct_31_54(4)_329-335.nxml.txt.nlp	24294457	SENT184	22	22	15	15	trastuzumab	HER-2	PA451743	2064	0.84
NULL	J_Clin_Biochem_Nutr_2011_Mar_26_48(2)_154-160.nxml.txt.nlp	21373269	SENT11	21	21	7	7	dextran	IRF7	PA449261	3665	0.84
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT204	16	16	32	32	lapatinib	EGFR	PA152241907	1956	0.84
NULL	Breast_Cancer_Res_2014_Sep_12_16(5)_436.nxml.txt.nlp	25213081	SENT161	4	4	10	10	tamoxifen	FOXM1	PA451581	2305	0.84
NULL	Cell_Mol_Life_Sci_2011_Oct_11_68(19)_3201-3207.nxml.txt.nlp	21833583	SENT155	9	9	15	15	bleomycin	periostin	PA448645	10631	0.84
NULL	Oncotarget_2013_Nov_24_4(12)_2186-2207.nxml.txt.nlp	24327604	SENT130	34	34	22	22	etoposide	MDM2	PA449552	4193	0.84
NULL	Mol_Biol_Rep_2013_May_11_40(8)_5013-5026.nxml.txt.nlp	23666059	SENT257	10	10	25	25	resveratrol	CDC2		5424	0.84
NULL	J_Cardiothorac_Surg_2014_Sep_17_9(1)_129.nxml.txt.nlp	NULL	SENT93	12	12	5	5	protamine	ACT	PA10366	12;11332;9457;641455	0.84
NULL	Clin_Med_Insights_Oncol_2012_Apr_3_6_179-187.nxml.txt.nlp	22518088	SENT58	15	15	6	6	trastuzumab	DM1	PA451743	338023;1760;28509	0.84
NULL	Biol_Open_2013_Apr_9_2(6)_535-545.nxml.txt.nlp	23789104	SENT118	19	19	31	31	arsenite	p38	PA452638	10598;1432;7965	0.84
NULL	Front_Oncol_2013_Nov_15_3_281.nxml.txt.nlp	24298448	SENT229	11	11	14	14	nutlin-3	survivin		332	0.84
NULL	Diabetes_2013_May_16_62(5)_1738-1745.nxml.txt.nlp	23274905	SENT80	37	37	48	48	gentamicin	CO2	PA449753	4513	0.84
NULL	EMBO_J_2010_Jan_6_29(1)_68-79.nxml.txt.nlp	19927124	SENT46	7	7	16	16	tetracycline	NO66	PA451640	79697	0.84
NULL	Chemother_Res_Pract_2011_Sep_25_2011_730360.nxml.txt.nlp	22295205	SENT176	14	14	21	21	anastrozole	HER2	PA448432	2064	0.84
NULL	J_Hematol_Oncol_2013_Jun_3_6_38.nxml.txt.nlp	23731980	SENT131	39	39	13	13	docetaxel	HER2	PA449383	2064	0.84
NULL	Cancer_Med_2012_Aug_15_1(1)_28-38.nxml.txt.nlp	23342251	SENT219	9	9	14	14	pertuzumab	HER2		2064	0.84
NULL	Cell_Death_Dis_2014_Mar_13_5(3)_e1118.nxml.txt.nlp	24625977	SENT80	40	40	35	35	etoposide	mot-2	PA449552	3313	0.84
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1709-1716.nxml.txt.nlp	19844235	SENT226	2	2	4	4	gemcitabine	GEM	PA449748	2669	0.84
NULL	Psychiatr_Genet_2013_Aug_28_23(4)_153-162.nxml.txt.nlp	23811784	SENT213	27	27	20	20	clozapine	AP180	PA449061	9892	0.84
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT1051	0	0	10	10	tenofovir	MRP4	PA10204	10257	0.84
NULL	Nat_Cell_Biol_2014_May_6_16(5)_401-414.nxml.txt.nlp	24705551	SENT318	21	21	7	7	chloroquine	LC3	PA448948	84557	0.84
NULL	Biochim_Biophys_Acta_2014_Jun_1841(6)_827-835.nxml.txt.nlp	24603323	SENT36	34	34	23	23	lipase	ABCA1	PA450239	19	0.84
NULL	Breast_Cancer_Res_2005_Jan_28_7(3)_R284-R290.nxml.txt.nlp	15987423	SENT108	8	8	14	14	tamoxifen	CYP2D6	PA451581	1565	0.84
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S264-S271.nxml.txt.nlp	21525466	SENT172	12	12	29	29	vildagliptin	GLP-1	PA165958346	100125288	0.84
NULL	Ther_Clin_Risk_Manag_2005_Dec_1(4)_299-306.nxml.txt.nlp	18360572	SENT137	17	17	7	7	terbinafine	CYP2D6	PA451614	1565	0.84
NULL	Indian_J_Pharmacol_2014_Nov-Dec_46(6)_627-632.nxml.txt.nlp	25538335	SENT132	9	9	7	7	metformin	Q10	PA450395	27161	0.84
NULL	Breast_Cancer_Res_2010_Jul_6_12(4)_R46.nxml.txt.nlp	20604919	SENT181	18	18	14	14	trastuzumab	HER2	PA451743	2064	0.84
NULL	J_Cell_Sci_2014_Jul_1_127(13)_2898-2909.nxml.txt.nlp	24806960	SENT84	10	10	7	7	bortezomib	BAG6	PA10252	7917	0.84
NULL	Breast_Cancer_Res_2011_Mar_1_13(2)_R21.nxml.txt.nlp	21362200	SENT232	3	3	9	9	estradiol	PI3K	PA449503	5290	0.84
NULL	Case_Rep_Nephrol_2013_Nov_20_2013_801575.nxml.txt.nlp	24558627	SENT6	9	9	19	19	vasopressin	AVP	PA451858	114548;551	0.84
NULL	Brain_Sci_2013_Jul_19_3(3)_1076-1094.nxml.txt.nlp	24961522	SENT386	11	11	4	4	ethanol	spatial	PA448073	219793	0.84
NULL	J_Biol_Chem_2012_Dec_21_287(52)_43482-43491.nxml.txt.nlp	23135270	SENT167	14	14	30	30	trypsin	PCSK9	PA451806	255738	0.84
NULL	J_Thorac_Oncol_2014_Sep_22_9(9)_1345-1353.nxml.txt.nlp	25122430	SENT5	12	12	29	29	gefitinib	EGFR	PA131301952	1956	0.84
NULL	Int_J_Gen_Med_2012_Jun_18_5_535-540.nxml.txt.nlp	22807641	SENT81	35	35	39	39	pitavastatin	adiponectin	PA142650384	9370	0.84
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_7-17.nxml.txt.nlp	17912633	SENT75	7	7	16	16	exemestane	aromatase	PA449563	1588	0.84
NULL	J_Korean_Med_Sci_2006_Dec_31_21(6)_1037-1040.nxml.txt.nlp	17179683	SENT5	14	14	10	10	omeprazole	BAM	PA450704	9126	0.84
NULL	Breast_Cancer_Res_2002_Sep_12_4(6)_240-243.nxml.txt.nlp	12473170	SENT86	7	7	13	13	medroxyprogesterone	EGF	PA450344	1950	0.84
NULL	Mol_Cancer_2010_Nov_2_9_289.nxml.txt.nlp	21044322	SENT221	26	26	6	6	cisplatin	RGS10	PA449014	6001	0.84
NULL	Mol_Cancer_2004_May_18_3_16.nxml.txt.nlp	15149548	SENT14	32	32	9	9	cisplatin	HIC1	PA449014	3090	0.84
NULL	Br_J_Cancer_2009_Jul_7_101(1)_38-47.nxml.txt.nlp	19513066	SENT29	13	13	31	31	dasatinib	HER2	PA162372878	2064	0.84
NULL	Oncotarget_2014_Aug_4_5(17)_7776-7787.nxml.txt.nlp	25277200	SENT50	2	2	13	13	cisplatin	ANXA4	PA449014	307	0.84
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT155	17	17	12	12	neratinib	HER3	PA165291472	2065	0.84
NULL	J_Gen_Physiol_2013_Aug_142(2)_137-155.nxml.txt.nlp	23858003	SENT7	31	31	38	38	forskolin	TREK-1	PA146096022	3776	0.84
NULL	Cancer_Cell_Int_2011_Sep_23_11_33.nxml.txt.nlp	21943203	SENT249	4	4	16	16	trastuzumab	IL17A	PA451743	3605	0.84
NULL	Mol_Cancer_2012_Jun_18_11_41.nxml.txt.nlp	22709873	SENT308	17	17	13	13	lapatinib	CDKN1B	PA152241907	1027	0.84
NULL	Arthritis_Res_Ther_2008_Mar_14_10(2)_204.nxml.txt.nlp	18373887	SENT25	0	0	11	11	abatacept	CD28	PA164747080	1493;940	0.84
NULL	Pain_Res_Treat_2012_Apr_23_2012_295926.nxml.txt.nlp	22577544	SENT53	4	4	22	22	dexketoprofen	ARC	PA166049175	8996;23237	0.84
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Jul_6_69(Pt_8)_o1202.nxml.txt.nlp	24109300	SENT66	20	20	6	6	ethanol	mol	PA448073	90527	0.84
NULL	Mol_Biol_Int_2014_Sep_7_2014_852748.nxml.txt.nlp	25276427	SENT132	3	3	11	11	trastuzumab	HER2	PA451743	2064	0.84
NULL	Br_J_Cancer_2010_Sep_7_103(6)_889-898.nxml.txt.nlp	20664599	SENT162	16	16	22	22	paclitaxel	HER-2	PA450761	2064	0.84
NULL	J_Cell_Mol_Med_2014_Apr_20_18(4)_709-720.nxml.txt.nlp	24444314	SENT191	2	2	9	9	losartan	Met	PA450268	79811	0.84
NULL	Exp_Ther_Med_2013_Feb_13_5(2)_581-585.nxml.txt.nlp	23403473	SENT79	1	1	15	15	etanercept	HMGB1	PA449515	3146	0.84
NULL	Lancet_2008_Jul_12_372(9633)_127-138.nxml.txt.nlp	18620950	SENT45	12	12	5	5	pyrimethamine	IPT	PA451193	54802	0.84
NULL	Oncogenesis_2012_Apr_2_1(4)_e5.nxml.txt.nlp	23552603	SENT291	6	6	10	10	ns-398	p65		5970	0.84
NULL	Semin_Nephrol_2013_Nov_33(6)_508-530.nxml.txt.nlp	24161037	SENT46	15	15	17	17	heparin	C3b	PA449855	718	0.84
NULL	Eur_J_Clin_Pharmacol_2011_Nov_1_67(11)_1109-1117.nxml.txt.nlp	21630032	SENT50	14	14	28	28	bezafibrate	IFN	PA162364313	3439	0.84
NULL	J_Carcinog_2014_Nov_27_13_13.nxml.txt.nlp	25525412	SENT59	28	28	8	8	oxaliplatin	EGFR	PA131285527	1956	0.84
NULL	Biologics_2009_Jul_13_3_225-232.nxml.txt.nlp	19707411	SENT115	37	37	39	39	rituximab	CTX	PA451261	1593	0.84
NULL	Biomed_Res_Int_2013_Aug_13_2013_659254.nxml.txt.nlp	24000324	SENT253	13	13	40	40	ethanol	DAC	PA448073	13	0.84
NULL	Int_J_Alzheimers_Dis_2012_Feb_1_2012_109324.nxml.txt.nlp	22506129	SENT42	0	0	9	9	simvastatin	Hua	PA451363	1994	0.84
NULL	Cancer_Cell_Int_2012_Nov_13_12_45.nxml.txt.nlp	23148684	SENT27	23	23	8	8	cisplatin	WEE1	PA449014	7465	0.84
NULL	Orphanet_J_Rare_Dis_2010_Dec_16_5_39.nxml.txt.nlp	21162721	SENT73	16	16	12	12	carbamazepine	HLA-B	PA448785	3106	0.84
NULL	Biologics_2009_Jul_13_3_289-301.nxml.txt.nlp	19707416	SENT218	5	5	20	20	trastuzumab	HER2	PA451743	2064	0.84
NULL	Nat_Commun_2014_Dec_11_5_5744.nxml.txt.nlp	25501849	SENT92	20	20	4	4	hydroxyurea	Spartan	PA449942	83932	0.84
NULL	J_Clin_Biochem_Nutr_2009_Jan_27_44(1)_28-40.nxml.txt.nlp	19177185	SENT108	5	5	11	11	esmolol	HO-1	PA449500	3162	0.84
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Jan_22_70(Pt_2)_o176.nxml.txt.nlp	24764891	SENT65	1	1	28	28	coumarin	C15	PA134521193	51316	0.84
NULL	Cancer_Med_2014_Dec_1_3(6)_1493-1501.nxml.txt.nlp	25081631	SENT203	24	24	11	11	cetuximab	EGFR	PA10040	1956	0.84
NULL	ScientificWorldJournal_2014_Mar_12_2014_731462.nxml.txt.nlp	24715817	SENT12	24	24	30	30	diclofenac	COX	PA449293	1351	0.84
NULL	Mol_Cell_2014_Jun_5_54(5)_858-869.nxml.txt.nlp	24905007	SENT588	6	6	1	1	camptothecin	FANCD2	PA153590860	2177	0.84
NULL	Mediators_Inflamm_2010_Jun_21_2010_194896.nxml.txt.nlp	20652055	SENT116	2	2	9	9	berberine	mol	PA165860812	90527	0.84
NULL	Int_J_Biol_Sci_2012_Oct_25_8(9)_1281-1290.nxml.txt.nlp	23136556	SENT217	3	3	28	28	tocilizumab	IL-6	PA165292659	3569	0.84
NULL	Curr_Pharm_Biotechnol_2012_May_13(6)_969-986.nxml.txt.nlp	22039792	SENT182	32	32	19	19	ivermectin	P-gp	PA450133	5243	0.84
NULL	J_Lipid_Res_2013_May_54(5)_1410-1420.nxml.txt.nlp	23419260	SENT147	20	20	32	32	tetracycline	IDOL	PA451640	29116	0.84
NULL	Braz_J_Med_Biol_Res_2013_Jun_25_46(6)_528-532.nxml.txt.nlp	23802228	SENT66	0	0	14	14	rosiglitazone	PON1	PA451283	5444	0.84
NULL	Ann_Occup_Hyg_2010_Aug_21_54(6)_697-709.nxml.txt.nlp	20660144	SENT181	22	22	34	34	fluorescein	GK2	PA164746009	2712;2585	0.84
NULL	Mediators_Inflamm_2010_Mar_7_2010_364957.nxml.txt.nlp	20224654	SENT130	10	10	21	21	metformin	IL-6	PA450395	3569	0.84
NULL	Arthritis_Res_Ther_2003_Sep_12_5(Suppl_3)_55.nxml.txt.nlp	NULL	SENT4	5	5	21	21	rosiglitazone	ARC	PA451283	8996;23237	0.84
NULL	Angiogenesis_2010_Dec_7_13(4)_305-315.nxml.txt.nlp	20927579	SENT157	0	0	36	36	resveratrol	HIF-1		29072	0.84
NULL	J_Int_AIDS_Soc_2011_Dec_28_14_61.nxml.txt.nlp	22204313	SENT51	9	9	25	25	nevirapine	CD4	PA450616	920	0.84
NULL	Front_Physiol_2013_Dec_24_4_386.nxml.txt.nlp	24399968	SENT202	11	11	6	6	glibenclamide	SUR1	PA449782	6833	0.84
NULL	Indian_J_Ophthalmol_2011_Jul-Aug_59(4)_273-277.nxml.txt.nlp	21666310	SENT53	6	6	15	15	cyclophosphamide	CHOP	PA449165	1649	0.84
NULL	Anticancer_Agents_Med_Chem_2012_Feb_12(2)_163-171.nxml.txt.nlp	22043994	SENT146	22	22	7	7	cetuximab	KRAS	PA10040	3845	0.84
NULL	Cancer_Cell_Int_2013_Mar_4_13_21.nxml.txt.nlp	23497288	SENT15	19	19	8	8	doxorubicin	EWS	PA449412	2130	0.84
NULL	J_Cell_Mol_Med_2014_Oct_11_18(10)_2031-2043.nxml.txt.nlp	25109475	SENT178	0	0	5	5	valsartan	AMPK	PA451848	5563	0.84
NULL	J_Carcinog_2011_Nov_30_10_28.nxml.txt.nlp	22190870	SENT225	13	13	17	17	trastuzumab	p27	PA451743	5715;10534	0.84
NULL	Orphanet_J_Rare_Dis_2011_May_28_6_32.nxml.txt.nlp	21619687	SENT244	22	22	24	24	diethylstilbestrol	DES	PA449307	1674	0.84
NULL	Br_J_Cancer_2009_Mar_24_100(6)_941-949.nxml.txt.nlp	19240716	SENT264	5	5	12	12	gefitinib	Met	PA131301952	79811	0.84
NULL	Acta_Crystallogr_B_Struct_Sci_Cryst_Eng_Mater_2014_Sep_18_70(Pt_5)_820-827.nxml.txt.nlp	25274515	SENT126	18	18	21	21	pentamidine	ski	PA450850	55733	0.84
NULL	Drugs_Context_2013_May_22_2013_212255.nxml.txt.nlp	24432042	SENT137	31	31	26	26	pioglitazone	GLP-1	PA450970	100125288	0.84
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_P85.nxml.txt.nlp	NULL	SENT4	0	0	22	22	ranibizumab	VEGF-A	PA164746012	7422	0.84
NULL	Clin_Med_Insights_Oncol_2012_Jul_30_6_275-286.nxml.txt.nlp	22904648	SENT12	15	15	19	19	aldesleukin	IL-2	PA448081	3558	0.84
NULL	Eur_J_Endocrinol_2010_May_162(5)_987-992.nxml.txt.nlp	20164212	SENT31	3	3	10	10	diazoxide	GCK	PA449285	5871;2645	0.84
NULL	Drug_Target_Insights_2007_Mar_6_2_71-81.nxml.txt.nlp	21901064	SENT163	29	29	16	16	saquinavir	P-gp	PA451305	5243	0.84
NULL	J_Cardiothorac_Surg_2010_Nov_3_5_101.nxml.txt.nlp	21047408	SENT183	10	10	23	23	heparin	ACT	PA449855	12;11332;9457;641455	0.84
NULL	Cancer_Cell_2013_Nov_11_24(5)_617-630.nxml.txt.nlp	24229709	SENT117	0	0	7	7	tamoxifen	p110	PA451581	9733	0.84
NULL	Breast_Cancer_Res_2003_Mar_6_5(3)_R71-R76.nxml.txt.nlp	12793903	SENT33	12	12	3	3	urokinase	Met	PA451836	79811	0.84
NULL	Acta_Pharmacol_Sin_2009_Sep_24_30(9)_1330-1336.nxml.txt.nlp	19701234	SENT21	22	22	9	9	ilaprazole	CYP3A5	PA165947499	1577	0.84
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT15	16	16	27	27	capsaicin	p53	PA448776	7157	0.84
NULL	Hum_Genomics_Proteomics_2010_Sep_13_2010_754919.nxml.txt.nlp	20981234	SENT96	30	30	14	14	acenocoumarol	VKORC1	PA452632	79001	0.84
NULL	Infect_Dis_Ther_2014_Dec_24_3(2)_83-102.nxml.txt.nlp	25134686	SENT214	37	37	17	17	cimetidine	OCT2	PA449001	6582;5452	0.84
NULL	Mol_Cancer_2012_Oct_22_11_80.nxml.txt.nlp	23088607	SENT108	20	20	24	24	fulvestrant	YC1	PA164747170	5937	0.84
NULL	Arthritis_Res_Ther_2010_Oct_12_12(5)_R188.nxml.txt.nlp	20939892	SENT109	16	16	19	19	collagenase	VIII	PA449107	1351	0.84
NULL	Biologics_2011_Aug_9_5_87-94.nxml.txt.nlp	21847344	SENT75	44	44	11	11	trastuzumab	San	PA451743	80218	0.84
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Nov_26_3(11)_e149.nxml.txt.nlp	25426564	SENT31	19	19	5	5	atorvastatin	PCSK9	PA448500	255738	0.84
NULL	Breast_Cancer_Res_2004_Jun_29_6(5)_R488-R498.nxml.txt.nlp	15318931	SENT10	6	6	20	20	estradiol	UGT2B15	PA449503	7366	0.84
NULL	Oncotarget_2014_Sep_25_5(21)_10607-10620.nxml.txt.nlp	25431954	SENT33	23	23	17	17	doxorubicin	p53	PA449412	7157	0.84
NULL	J_Biol_Chem_2009_May_1_284(18)_11953-11962.nxml.txt.nlp	19254952	SENT273	12	12	23	23	pp2	ANG		283	0.84
NULL	Exp_Hematol_Oncol_2013_Jan_10_2_2.nxml.txt.nlp	23305345	SENT18	20	20	22	22	bortezomib	BTZ	PA10252	22794	0.84
NULL	Clin_Genet_2014_Jan_1_86(1)_21-28.nxml.txt.nlp	24684508	SENT81	15	15	19	19	carbamazepine	HLA-B	PA448785	3106	0.84
NULL	Clin_Pharmacokinet_2012_Jun_13_51(6)_e1-e18.nxml.txt.nlp	22550964	SENT36	0	0	3	3	canakinumab	IL-6	PA165958358	3569	0.84
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT152	8	8	20	20	metformin	AMPK	PA450395	5563	0.84
NULL	Osteoporos_Int_2012_Feb_11_23(2)_695-703.nxml.txt.nlp	21394496	SENT131	32	32	19	19	zoledronate	HIP	PA10235	6767;6159;64399;5068	0.84
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_7-17.nxml.txt.nlp	17912633	SENT44	31	31	27	27	aminoglutethimide	aromatase	PA448375	1588	0.84
NULL	Exp_Lung_Res_2013_Oct_1_39(8)_336-348.nxml.txt.nlp	23919450	SENT122	5	5	0	0	argatroban	PAR-1	PA164745516	2011;2149	0.84
NULL	Acta_Physiol_(Oxf)_2007_Sep_191(1)_43-57.nxml.txt.nlp	17524066	SENT303	5	5	25	25	nifedipine	PES	PA450631	23481	0.84
NULL	Breast_Cancer_Res_2012_Jun_19_14(3)_311.nxml.txt.nlp	22713135	SENT34	36	36	16	16	letrozole	PIK3CA	PA450196	5290	0.84
NULL	Arthritis_Res_Ther_2006_Jul_21_8(4)_R130.nxml.txt.nlp	16859540	SENT93	5	5	8	8	atorvastatin	CD59	PA448500	966	0.84
NULL	J_Clin_Exp_Pathol_2012_May_17_Suppl_4_7327.nxml.txt.nlp	25379357	SENT40	5	5	19	19	resveratrol	AMPK		5563	0.84
NULL	Pharmaceuticals_(Basel)_2011_Mar_17_4(3)_551-566.nxml.txt.nlp	NULL	SENT153	5	5	14	14	doxorubicin	MCP-1	PA449412	6347	0.84
NULL	Oncol_Rep_2013_Jun_22_29(6)_2479-2485.nxml.txt.nlp	23525656	SENT36	6	6	9	9	nilotinib	P-gp	PA165958345	5243	0.84
NULL	Acta_Pharmacol_Sin_2013_Apr_11_34(4)_473-479.nxml.txt.nlp	23474709	SENT160	4	4	2	2	probenecid	MRP1	PA451106	4437	0.84
NULL	Indian_J_Med_Res_2012_Dec_136(6)_926-941.nxml.txt.nlp	23391788	SENT119	1	1	16	16	clopidogrel	DES	PA449053	1674	0.84
NULL	Channels_(Austin)_2010_Jan_1_4(1)_22-41.nxml.txt.nlp	19934650	SENT14	15	15	6	6	quinidine	Slo3	PA451209	157855	0.84
NULL	Lab_Invest_2010_Dec_9_90(12)_1794-1804.nxml.txt.nlp	20697377	SENT47	19	19	5	5	choline	MCD	PA448976	23417;4169;4582	0.84
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT14	3	3	10	10	trastuzumab	San	PA451743	80218	0.84
NULL	Adv_Hematol_2010_Dec_30_2010_627401.nxml.txt.nlp	21234094	SENT114	29	29	21	21	ifosfamide	SMILE	PA449964	160418	0.84
NULL	Lipids_Health_Dis_2011_Feb_12_10_31.nxml.txt.nlp	21314960	SENT193	6	6	4	4	hemin	HO-1	PA449849	3162	0.839
NULL	Cell_Death_Dis_2014_Apr_24_5(4)_e1197.nxml.txt.nlp	24763054	SENT72	12	12	21	21	cisplatin	ARC	PA449014	8996;23237	0.839
NULL	Cancer_Med_2014_Jun_8_3(3)_681-692.nxml.txt.nlp	24711160	SENT151	29	29	1	1	carboplatin	San	PA448803	80218	0.839
NULL	Br_J_Cancer_2013_Aug_6_109(3)_686-693.nxml.txt.nlp	23839492	SENT194	24	24	7	7	sunitinib	IL-8	PA162372840	3576	0.839
NULL	Br_J_Cancer_2012_Oct_23_107(9)_1488-1497.nxml.txt.nlp	23033007	SENT175	0	0	23	23	disulfiram	p38	PA449376	10598;1432;7965	0.839
NULL	Exp_Ther_Med_2013_May_15_5(5)_1327-1331.nxml.txt.nlp	23737873	SENT26	17	17	22	22	enalapril	AQP2	PA449456	359	0.839
NULL	Arthritis_Res_Ther_2014_Apr_3_16(2)_R86.nxml.txt.nlp	24708674	SENT193	18	18	4	4	imatinib	Fli1	PA10804	2314	0.839
NULL	Pharmacogn_Rev_2013_Jul-Dec_7(14)_157-169.nxml.txt.nlp	24347924	SENT235	12	12	2	2	ethanol	flower	PA448073	11094	0.839
NULL	Br_J_Cancer_2002_Jan_21_86(2)_218-221.nxml.txt.nlp	11870509	SENT84	21	21	26	26	tamoxifen	BRCA1	PA451581	672	0.839
NULL	Allergy_Asthma_Clin_Immunol_2010_May_12_6(Suppl_1)_P14.nxml.txt.nlp	NULL	SENT6	5	5	9	9	resveratrol	CD34		947	0.839
NULL	Diabetes_Metab_Syndr_Obes_2014_Jul_17_7_313-319.nxml.txt.nlp	25092992	SENT91	8	8	1	1	pioglitazone	adiponectin	PA450970	9370	0.839
NULL	Chin_J_Cancer_2012_Mar_31(3)_150-158.nxml.txt.nlp	22360854	SENT24	13	13	22	22	methotrexate	ABCG2	PA450428	9429	0.839
NULL	Curr_Opin_Infect_Dis_2013_Dec_6_26(6)_538-544.nxml.txt.nlp	24126716	SENT214	13	13	17	17	fosfomycin	PARI	PA164748039	55010	0.839
NULL	Biosci_Rep_2012_Dec_1_32(Pt_6)_641-652.nxml.txt.nlp	NULL	SENT229	37	37	2	2	auranofin	adiponectin	PA448510	9370	0.839
NULL	Evid_Based_Complement_Alternat_Med_2013_May_26_2013_161628.nxml.txt.nlp	23781255	SENT253	2	2	15	15	sorafenib	ERK1	PA7000	5595	0.839
NULL	Ann_Rehabil_Med_2012_Aug_27_36(4)_466-473.nxml.txt.nlp	22977771	SENT22	4	4	0	0	triamcinolone	ILEI	PA451749	10447	0.839
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT154	15	15	6	6	erlotinib	PTEN	PA134687924	5728	0.839
NULL	Int_J_Med_Sci_2015_Jan_5_12(2)_135-140.nxml.txt.nlp	25589889	SENT35	9	9	1	1	aripiprazole	FGA	PA10026	2243	0.839
NULL	Cell_Death_Dis_2010_Nov_18_1(11)_e101.nxml.txt.nlp	21368866	SENT271	14	14	1	1	cisplatin	PC3	PA449014	57332;7832;5122	0.839
NULL	Br_J_Cancer_2012_Jan_3_106(1)_148-156.nxml.txt.nlp	22045191	SENT148	5	5	10	10	erlotinib	EGFR	PA134687924	1956	0.839
NULL	Syst_Synth_Biol_2010_Mar_24_4(1)_25-33.nxml.txt.nlp	19856130	SENT177	25	25	22	22	geldanamycin	Hsp90	PA152031327	3320	0.839
NULL	Acta_Pharmacol_Sin_2012_Jan_3_33(1)_49-56.nxml.txt.nlp	22212430	SENT117	13	13	20	20	thrombin	JNK	PA451674	5599	0.839
NULL	Clin_Sarcoma_Res_2014_Aug_10_4_10.nxml.txt.nlp	25132955	SENT156	3	3	15	15	imatinib	KIT	PA10804	3815	0.839
NULL	Cell_Commun_Signal_2013_Oct_1_11_73.nxml.txt.nlp	24083678	SENT148	2	2	17	17	sulindac	p65	PA451565	5970	0.839
NULL	Mol_Cancer_2010_Apr_12_9_75.nxml.txt.nlp	20385023	SENT307	40	40	31	31	cetuximab	KRAS	PA10040	3845	0.839
NULL	Br_J_Cancer_2012_Sep_25_107(7)_1044-1050.nxml.txt.nlp	22910317	SENT147	16	16	39	39	bevacizumab	CD34	PA130232992	947	0.839
NULL	Arthritis_Res_2002_Sep_16_4(6)_R12.nxml.txt.nlp	12453315	SENT100	0	0	37	37	chloroquine	CRP	PA448948	1401;140913	0.839
NULL	Gut_Liver_2013_Sep_14_7(5)_552-559.nxml.txt.nlp	24073313	SENT16	0	0	17	17	celecoxib	EGFR	PA448871	1956	0.839
NULL	Diabetes_Care_2013_May_13_36(5)_1074-1082.nxml.txt.nlp	23275352	SENT215	4	4	8	8	liraglutide	ZAG	PA165958364	563	0.839
NULL	Indian_J_Endocrinol_Metab_2012_Jan-Feb_16(1)_33-43.nxml.txt.nlp	22276251	SENT140	31	31	9	9	pioglitazone	ACT	PA450970	12;11332;9457;641455	0.839
NULL	Hum_Reprod_Update_2009_Mar_11_Sep-Oct_15(5)_517-535.nxml.txt.nlp	19279047	SENT273	8	8	33	33	estradiol	CD25	PA449503	3669;3559	0.839
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Apr_16_67(Pt_5)_o1159.nxml.txt.nlp	21754467	SENT72	37	37	13	13	ethanol	mol	PA448073	90527	0.839
NULL	Mucosal_Immunol_2013_Jan_27_6(1)_10_1038_mi_2012_49.nxml.txt.nlp	22739232	SENT252	39	39	15	15	trypsin	DPI	PA451806	1832	0.839
NULL	Cancers_(Basel)_2010_Dec_9_2(4)_2058-2083.nxml.txt.nlp	24281218	SENT326	0	0	12	12	gemcitabine	LOXL2	PA449748	4017	0.839
NULL	Biomed_Res_Int_2014_Mar_4_2014_836769.nxml.txt.nlp	24724101	SENT83	3	3	11	11	fulvestrant	EGFR	PA164747170	1956	0.839
NULL	J_Cell_Biol_1998_Apr_6_141(1)_135-142.nxml.txt.nlp	9531553	SENT205	19	19	14	14	carbachol	SMG	PA448784	23034	0.839
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT116	7	7	12	12	atorvastatin	TNF	PA448500	7124	0.839
NULL	Indian_J_Pharmacol_2013_Nov-Dec_45(6)_547-555.nxml.txt.nlp	24347760	SENT260	8	8	38	38	zonisamide	MANF	PA451978	7873	0.839
NULL	Acta_Pharmacol_Sin_2013_Jan_17_34(1)_157-166.nxml.txt.nlp	23247593	SENT142	10	10	41	41	berberine	Set9	PA165860812	80854	0.839
NULL	Oncotarget_2012_May_4_3(4)_371-394.nxml.txt.nlp	22564882	SENT297	5	5	21	21	nutlin-3	p53		7157	0.839
NULL	Curr_Med_Chem_2014_May_21(14)_1595-1606.nxml.txt.nlp	23992330	SENT67	29	29	22	22	trastuzumab	MUC4	PA451743	4585	0.839
NULL	Breast_Cancer_Res_2004_Jun_29_6(5)_R488-R498.nxml.txt.nlp	15318931	SENT7	3	3	14	14	estradiol	UGT	PA449503	7361;7355	0.839
NULL	Ann_Med_Health_Sci_Res_2012_Jul-Dec_2(2)_191-198.nxml.txt.nlp	23439914	SENT165	15	15	1	1	cyclosporine	P-gp	PA449167	5243	0.839
NULL	Cell_Cycle_2013_Dec_1_12(23)_3673-3680.nxml.txt.nlp	24091726	SENT92	18	18	2	2	cisplatin	PER2	PA449014	8864	0.839
NULL	Front_Physiol_2013_May_15_4_103.nxml.txt.nlp	23720630	SENT142	7	7	3	3	simvastatin	Q10	PA451363	27161	0.839
NULL	Br_J_Cancer_2011_Nov_22_105(11)_1708-1718.nxml.txt.nlp	22045188	SENT308	13	13	23	23	fluorescein	CD19	PA164746009	930	0.839
NULL	Biomed_Res_Int_2014_Jun_2_2014_946492.nxml.txt.nlp	24991574	SENT106	10	10	18	18	olmesartan	ATRAP	PA164742950	57085	0.839
NULL	AAPS_J_2012_Jan_4_14(1)_87-96.nxml.txt.nlp	22215264	SENT32	31	31	21	21	verapamil	P-gp	PA451868	5243	0.839
NULL	Cell_Death_Dis_2010_Nov_18_1(11)_e102.nxml.txt.nlp	21368867	SENT92	19	19	0	0	gentamicin	CLIMP-63	PA449753	10970	0.839
NULL	J_Gastroenterol_2013_Feb_23_48(12)_1373-1383.nxml.txt.nlp	23435670	SENT73	6	6	20	20	lamivudine	LAM	PA450163	7249;7248	0.839
NULL	Oncotarget_2011_Dec_21_2(12)_1134-1144.nxml.txt.nlp	22193779	SENT167	7	7	28	28	gefitinib	EGF	PA131301952	1950	0.839
NULL	Mol_Cells_2014_Sep_30_37(9)_664-671.nxml.txt.nlp	25234467	SENT267	10	10	27	27	cisplatin	miR-217	PA449014	406999	0.839
NULL	Breast_Cancer_Res_2004_Mar_26_6(3)_R252-R263.nxml.txt.nlp	15084249	SENT26	3	3	28	28	tamoxifen	CYP2D6	PA451581	1565	0.839
NULL	Indian_J_Med_Res_2011_Jun_133(6)_633-640.nxml.txt.nlp	21727662	SENT145	5	5	15	15	estradiol	aromatase	PA449503	1588	0.839
NULL	Clin_Mol_Allergy_2004_Mar_16_2_4.nxml.txt.nlp	15023231	SENT29	0	0	2	2	clarithromycin	IL-8	PA449028	3576	0.839
NULL	Emerg_Infect_Dis_2014_May_20(5)_812-821.nxml.txt.nlp	24751166	SENT70	32	32	0	0	clofazimine	DST	PA164748759	667	0.839
NULL	Cancer_Metab_2014_Nov_3_2(1)_20.nxml.txt.nlp	NULL	SENT213	11	11	7	7	erlotinib	PDK4	PA134687924	5166	0.839
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT1261	28	28	10	10	sunitinib	ABCB1	PA162372840	5243	0.839
NULL	Case_Rep_Pulmonol_2012_Sep_29_2012_913574.nxml.txt.nlp	23056987	SENT75	41	41	24	24	fluconazole	CYP3A4	PA449653	1576	0.839
NULL	Leukemia_2014_Apr_14_28(4)_961-964.nxml.txt.nlp	24418991	SENT33	15	15	24	24	nilotinib	P-gp	PA165958345	5243	0.839
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT7	12	12	24	24	methotrexate	MSH2	PA450428	4436	0.839
NULL	Front_Pharmacol_2014_Dec_10_5_271.nxml.txt.nlp	25540621	SENT124	14	14	33	33	hesperidin	ghrelin	PA449867	51738	0.839
NULL	Cancers_(Basel)_2010_Apr_9_2(2)_397-419.nxml.txt.nlp	24281076	SENT208	8	8	22	22	genistein	Bcl-2	PA165109660	596	0.839
NULL	Pharm_Pract_(Granada)_2011_Mar_15_Jan-Mar_9(1)_1-10.nxml.txt.nlp	25132883	SENT153	7	7	18	18	enoxaparin	SPAF	PA449463	166378	0.839
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT7	34	34	12	12	bevacizumab	VEGFR1	PA130232992	2321	0.839
NULL	Exp_Ther_Med_2013_Dec_26_6(6)_1359-1364.nxml.txt.nlp	24255662	SENT167	5	5	11	11	dexmedetomidine	IL-6	PA449256	3569	0.839
NULL	Emerg_Infect_Dis_2011_Feb_17(2)_317-319.nxml.txt.nlp	21291621	SENT21	14	14	23	23	moxifloxacin	CD196	PA450555	1235	0.839
NULL	J_Clin_Biochem_Nutr_2008_Mar_1_42(2)_78-88.nxml.txt.nlp	18385824	SENT134	3	3	9	9	hemin	HO-1	PA449849	3162	0.839
NULL	Clinics_(Sao_Paulo)_2012_May_67(5)_469-474.nxml.txt.nlp	22666791	SENT94	33	33	23	23	octreotide	IGF1	PA450678	3479	0.839
NULL	Infect_Agent_Cancer_2012_Apr_19_7(Suppl_1)_O15.nxml.txt.nlp	NULL	SENT17	21	21	27	27	efavirenz	CYP3A4	PA449441	1576	0.839
NULL	J_Oncol_2014_Mar_26_2014_625060.nxml.txt.nlp	24795759	SENT22	21	21	31	31	tamoxifen	aromatase	PA451581	1588	0.839
NULL	Oncotarget_2014_Aug_24_5(16)_6556-6557.nxml.txt.nlp	25179303	SENT31	21	21	6	6	naringenin	COX	PA151958361	1351	0.839
NULL	Ann_Rheum_Dis_2008_Aug_20_67(8)_1121-1126.nxml.txt.nlp	18029384	SENT104	10	10	33	33	bosentan	ETB	PA10034	1910	0.839
NULL	Support_Care_Cancer_2014_Dec_14_22(3)_837-846.nxml.txt.nlp	24337717	SENT19	21	21	16	16	clarithromycin	CYP3A4	PA449028	1576	0.839
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT204	16	16	7	7	lapatinib	HRG	PA152241907	3084;3273	0.839
NULL	Breast_Cancer_Res_Treat_2014_Apr_10_145(2)_371-379.nxml.txt.nlp	24718774	SENT222	3	3	13	13	estradiol	aromatase	PA449503	1588	0.839
NULL	Open_Biol_2014_Jan_4(1)_130138.nxml.txt.nlp	24403013	SENT46	5	5	10	10	etoposide	PP1	PA449552	5540;5464	0.839
NULL	Front_Microbiol_2014_Mar_14_5_99.nxml.txt.nlp	24672516	SENT89	13	13	18	18	voriconazole	TLR4	PA10233	7099	0.839
NULL	Oncol_Rep_2014_Jan_13_31(1)_376-383.nxml.txt.nlp	24220856	SENT148	14	14	0	0	paclitaxel	PA1	PA450761	79447	0.839
NULL	Biochemistry_2011_May_3_50(17)_3408-3410.nxml.txt.nlp	21425834	SENT7	14	14	11	11	nadh	VDAC2	PA164755085	7417	0.839
NULL	Case_Rep_Med_2014_Jan_16_2014_389425.nxml.txt.nlp	24550989	SENT40	19	19	30	30	trypsin	CDX2	PA451806	1045	0.839
NULL	Nucleic_Acids_Res_2013_Nov_27_41(21)_9786-9799.nxml.txt.nlp	23982513	SENT185	6	6	8	8	arsenite	TIAR	PA452638	7073	0.839
NULL	Evid_Based_Complement_Alternat_Med_2014_Jul_20_2014_821569.nxml.txt.nlp	25140189	SENT259	0	0	2	2	metformin	AMPK	PA450395	5563	0.839
NULL	Br_J_Clin_Pharmacol_2014_Nov_20_78(5)_1050-1057.nxml.txt.nlp	24962564	SENT191	0	0	7	7	ketoconazole	CYP3A4	PA450146	1576	0.839
NULL	Cell_Death_Differ_2010_May_13_17(5)_774-786.nxml.txt.nlp	19911006	SENT321	14	14	11	11	doxycycline	AATF	PA449415	26574	0.839
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_127043.nxml.txt.nlp	23227093	SENT10	38	38	7	7	lovastatin	RYR	PA450272	6261	0.839
NULL	Int_J_Breast_Cancer_2013_Jan_28_2013_101705.nxml.txt.nlp	23431460	SENT35	6	6	23	23	troglitazone	San	PA451799	80218	0.839
NULL	J_Cell_Biol_1998_Jan_26_140(2)_335-345.nxml.txt.nlp	9442109	SENT206	12	12	16	16	chloroquine	NHE	PA448948	285335	0.839
NULL	Pharmaceutics_2011_Nov_18_3(4)_865-913.nxml.txt.nlp	24309312	SENT307	0	0	8	8	rabeprazole	CYP2C19	PA451216	1557	0.839
NULL	Oncol_Lett_2013_Feb_22_5(2)_641-644.nxml.txt.nlp	23419988	SENT120	2	2	15	15	paclitaxel	CT10	PA450761	51438	0.839
NULL	J_Hematol_Oncol_2011_Apr_20_4_16.nxml.txt.nlp	21504625	SENT212	9	9	5	5	bsi-201	PARP-1		25976	0.839
NULL	Arthritis_Res_Ther_2009_Jan_26_11(1)_R12.nxml.txt.nlp	19171052	SENT247	3	3	16	16	dipyridamole	POMC	PA449367	5443	0.839
NULL	Acta_Naturae_2013_Oct-Dec_5(4)_83-93.nxml.txt.nlp	24455187	SENT65	28	28	6	6	ethanol	7SL	PA448073	6029	0.839
NULL	Arthritis_Res_Ther_2013_Dec_3_15(6)_R205.nxml.txt.nlp	24295447	SENT123	28	28	10	10	methotrexate	RANKL	PA450428	8600	0.839
NULL	Mol_Vis_2007_Jul_9_13_1083-1093.nxml.txt.nlp	17653053	SENT144	4	4	25	25	minocycline	IL-10	PA450519	3586	0.839
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT58	23	23	7	7	trastuzumab	EGFR	PA451743	1956	0.839
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Dec_8_67(Pt_1)_o50.nxml.txt.nlp	21522760	SENT48	3	3	6	6	benzaldehyde	mol	PA448571	90527	0.839
NULL	Iran_J_Public_Health_2012_Nov_1_41(11)_1-9.nxml.txt.nlp	23304670	SENT204	22	22	11	11	tamoxifen	aromatase	PA451581	1588	0.839
NULL	Allergy_Asthma_Clin_Immunol_2011_Nov_14_7(Suppl_2)_A37.nxml.txt.nlp	NULL	SENT12	33	33	4	4	ceftazidime	CD4	PA448861	920	0.839
NULL	Clin_Ophthalmol_2014_Apr_28_8_807-812.nxml.txt.nlp	24812486	SENT19	15	15	9	9	bevacizumab	CRT	PA130232992	811	0.839
NULL	Front_Oncol_2014_Mar_3_4_34.nxml.txt.nlp	24624361	SENT224	22	22	11	11	cisplatin	BRCA1	PA449014	672	0.839
NULL	Acta_Pharmacol_Sin_2012_Jun_14_33(6)_832-838.nxml.txt.nlp	22580740	SENT13	25	25	8	8	methotrexate	ADM	PA450428	133	0.839
NULL	Acta_Pharmacol_Sin_2010_Aug_19_31(8)_999-1004.nxml.txt.nlp	20644548	SENT92	9	9	17	17	imatinib	CYP2D6	PA10804	1565	0.839
NULL	AIDS_Res_Ther_2014_Oct_2_11(1)_32.nxml.txt.nlp	NULL	SENT38	24	24	4	4	tenofovir	CD4	PA10204	920	0.839
NULL	Anesthesiol_Res_Pract_2013_Sep_23_2013_297141.nxml.txt.nlp	24174934	SENT344	0	0	3	3	capsaicin	TRPV1	PA448776	7442	0.839
NULL	Indian_J_Urol_2009_Oct-Dec_25(4)_427-436.nxml.txt.nlp	19955664	SENT106	20	20	27	27	bevacizumab	EGFR	PA130232992	1956	0.839
NULL	Arthritis_Res_Ther_2012_Jul_12_14(4)_R163.nxml.txt.nlp	22784880	SENT145	32	32	22	22	leflunomide	CYP1A2	PA450192	1544	0.839
NULL	J_Korean_Med_Sci_2010_Jun_24_25(6)_829-834.nxml.txt.nlp	20514301	SENT139	13	13	6	6	papain	IL-25	PA450778	64806;56005	0.839
NULL	J_Int_AIDS_Soc_2010_Nov_8_13(Suppl_4)_P75.nxml.txt.nlp	NULL	SENT16	11	11	5	5	stavudine	adiponectin	PA451494	9370	0.839
NULL	Br_J_Cancer_2010_Oct_12_103(8)_1263-1268.nxml.txt.nlp	20842121	SENT182	5	5	15	15	ns-398	CD59		966	0.839
NULL	Endocrinol_Diabetes_Metab_Case_Rep_2014_Dec_1_2014_140083.nxml.txt.nlp	25535576	SENT141	7	7	13	13	metyrapone	ACTH	PA450486	5443	0.839
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jan_7_68(Pt_2)_o289.nxml.txt.nlp	22346928	SENT50	15	15	4	4	ethanol	mol	PA448073	90527	0.839
NULL	Oncol_Rep_2013_Apr_23_29(4)_1268-1274.nxml.txt.nlp	23354756	SENT118	14	14	23	23	paclitaxel	SLC25A43	PA450761	203427	0.839
NULL	J_Nucl_Cardiol_2012_Dec_17_19(6)_1211-1225.nxml.txt.nlp	23073913	SENT110	12	12	1	1	simvastatin	FDG	PA451363	23583	0.839
NULL	Curr_Neuropharmacol_2009_Jun_7(2)_83-95.nxml.txt.nlp	19949566	SENT404	8	8	14	14	oxcarbazepine	HLA-B	PA450732	3106	0.839
NULL	Biosci_Rep_2012_Aug_1_32(Pt_4)_361-374.nxml.txt.nlp	22762204	SENT164	37	37	10	10	etoposide	BRCA1	PA449552	672	0.839
NULL	Breast_Cancer_Res_2014_Sep_12_16(5)_436.nxml.txt.nlp	25213081	SENT161	21	21	10	10	tamoxifen	FOXM1	PA451581	2305	0.839
NULL	Eur_J_Endocrinol_2010_May_162(5)_987-992.nxml.txt.nlp	20164212	SENT6	21	21	7	7	diazoxide	GCK	PA449285	5871;2645	0.839
NULL	Arthritis_Res_Ther_2006_Apr_12_8(Suppl_1)_S4.nxml.txt.nlp	16820043	SENT62	5	5	18	18	probenecid	URAT1	PA451106	116085	0.839
NULL	Leukemia_2013_Apr_14_27(4)_803-812.nxml.txt.nlp	23238589	SENT139	25	25	11	11	imatinib	IFN	PA10804	3439	0.839
NULL	Breast_Cancer_Res_2006_Nov_27_8(6)_R66.nxml.txt.nlp	17129383	SENT185	10	10	12	12	paclitaxel	HER2	PA450761	2064	0.839
NULL	J_Biol_Chem_2013_Nov_15_288(46)_33049-33059.nxml.txt.nlp	24089524	SENT268	6	6	13	13	nicotine	GATA4	PA450626	2626	0.839
NULL	Lab_Invest_2014_May_10_94(5)_503-516.nxml.txt.nlp	24614199	SENT297	10	10	32	32	curcumin	RAGE	PA151958596	177	0.839
NULL	Oncogene_2014_Sep_4_33(36)_4521-4530.nxml.txt.nlp	24662833	SENT57	21	21	17	17	bicalutamide	ARSI	PA164746255	340075	0.839
NULL	Blood_Cancer_J_2013_Aug_9_3(8)_e131.nxml.txt.nlp	23933705	SENT207	0	0	23	23	trastuzumab	San	PA451743	80218	0.839
NULL	Sensors_(Basel)_2012_May_30_12(6)_7207-7258.nxml.txt.nlp	22969344	SENT512	21	21	6	6	ethanol	NO3	PA448073	4681	0.839
NULL	Ann_Oncol_2013_Aug_12_24(8)_1994-1999.nxml.txt.nlp	23670096	SENT147	18	18	27	27	tamoxifen	HER2	PA451581	2064	0.839
NULL	Cell_Death_Dis_2013_Jul_4_4(7)_e702.nxml.txt.nlp	23828565	SENT260	11	11	25	25	staurosporine	DR5	PA165109623	8795	0.839
NULL	Biochemistry_2009_Feb_3_48(4)_800-809.nxml.txt.nlp	19132922	SENT210	16	16	7	7	raloxifene	XOR	PA451221	7498	0.839
NULL	Oncotarget_2013_Jun_26_4(7)_1008-1018.nxml.txt.nlp	23900284	SENT156	33	33	14	14	bortezomib	SLAMF7	PA10252	57823	0.839
NULL	J_Korean_Med_Sci_2007_Dec_20_22(6)_1055-1059.nxml.txt.nlp	18162722	SENT31	10	10	7	7	pantoprazole	ESD	PA450774	2098	0.839
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Apr_16_67(Pt_5)_o1144.nxml.txt.nlp	21754452	SENT56	7	7	10	10	hydroquinone	mol	PA449924	90527	0.839
NULL	Onco_Targets_Ther_2014_Dec_3_7_2227-2236.nxml.txt.nlp	25506226	SENT105	19	19	43	43	trastuzumab	ADC	PA451743	113451	0.839
NULL	Eur_J_Clin_Pharmacol_2011_May_9_67(5)_477-482.nxml.txt.nlp	21305273	SENT130	30	30	4	4	dobutamine	ADRB1	PA449381	153	0.839
NULL	Crit_Care_2008_Apr_10_12(2)_132.nxml.txt.nlp	18423065	SENT31	18	18	28	28	vasopressin	AVP	PA451858	114548;551	0.839
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT417	12	12	5	5	cetuximab	EGFR	PA10040	1956	0.839
NULL	Clin_Med_Insights_Cardiol_2010_Oct_11_4_89-93.nxml.txt.nlp	20981132	SENT93	0	0	11	11	benazepril	TNF	PA448561	7124	0.839
NULL	Exp_Diabetes_Res_2011_Apr_26_2011_215764.nxml.txt.nlp	21584276	SENT23	7	7	1	1	liraglutide	GLP-1	PA165958364	100125288	0.839
NULL	Pharmaceuticals_(Basel)_2011_Nov_10_4(11)_1488-1502.nxml.txt.nlp	NULL	SENT198	8	8	1	1	trastuzumab	PTEN	PA451743	5728	0.839
NULL	Br_J_Cancer_2010_Jul_13_103(2)_186-195.nxml.txt.nlp	20588277	SENT186	0	0	3	3	nutlin-3	p53		7157	0.839
NULL	Curr_Neuropharmacol_2010_Sep_8(3)_287-304.nxml.txt.nlp	21358978	SENT53	9	9	19	19	agomelatine	5-HT2C	PA165958363	3358	0.839
NULL	Br_J_Cancer_2013_Jun_25_108(12)_2426-2432.nxml.txt.nlp	23756869	SENT103	38	38	14	14	trastuzumab	IL-6	PA451743	3569	0.839
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT169	12	12	31	31	metformin	HIF-1	PA450395	29072	0.839
NULL	Nat_Biotechnol_2013_Jul_30_31(7)_630-637.nxml.txt.nlp	23811600	SENT142	2	2	11	11	staurosporine	FLT4	PA165109623	2324	0.839
NULL	Crit_Care_2010_Jul_9_14(4)_R131.nxml.txt.nlp	20615266	SENT26	4	4	22	22	vasopressin	ACTH	PA451858	5443	0.839
NULL	Front_Neurosci_2014_Jan_31_8_6.nxml.txt.nlp	24550768	SENT55	14	14	9	9	isoflurane	TRPV1	PA450106	7442	0.839
NULL	Br_J_Cancer_2004_Mar_8_90(5)_1053-1058.nxml.txt.nlp	14997207	SENT114	7	7	2	2	heparin	ADAM9	PA449855	8754	0.839
NULL	Mol_Cancer_2007_Aug_21_6_53.nxml.txt.nlp	17711579	SENT179	16	16	4	4	cisplatin	GAS1	PA449014	2619	0.839
NULL	Sci_Rep_2015_Jan_6_5_7641.nxml.txt.nlp	25560734	SENT28	4	4	6	6	tamoxifen	14-3-3	PA451581	10971	0.839
NULL	Br_J_Cancer_2012_May_8_106(10)_1591-1597.nxml.txt.nlp	22516947	SENT142	7	7	2	2	irinotecan	UGT1A1	PA450085	54658	0.839
NULL	Br_J_Cancer_2013_Apr_16_108(7)_1408-1414.nxml.txt.nlp	23511562	SENT39	22	22	29	29	tamoxifen	aromatase	PA451581	1588	0.839
NULL	Ann_Oncol_2014_Oct_18_25(10)_1871-1888.nxml.txt.nlp	25234545	SENT325	24	24	29	29	everolimus	aromatase	PA164746311	1588	0.839
NULL	Br_J_Cancer_2009_Mar_24_100(6)_941-949.nxml.txt.nlp	19240716	SENT126	37	37	9	9	gefitinib	Met	PA131301952	79811	0.839
NULL	J_Young_Pharm_2010_Oct-Dec_2(4)_428-429.nxml.txt.nlp	21264109	SENT5	16	16	19	19	metformin	B12	PA450395	7126;4709	0.839
NULL	Ann_Surg_Oncol_2014_Feb_22_21(Suppl_4)_546-554.nxml.txt.nlp	24562936	SENT274	12	12	3	3	letrozole	FOXP3	PA450196	50943	0.839
NULL	Oncol_Lett_2014_Mar_2_7(3)_791-796.nxml.txt.nlp	24527087	SENT107	10	10	30	30	imatinib	CD34	PA10804	947	0.839
NULL	Arthritis_Res_Ther_2013_Nov_4_15(6)_R177.nxml.txt.nlp	24286387	SENT33	33	33	0	0	lipase	LRP2	PA450239	4036	0.839
NULL	Oncotarget_2013_Dec_17_5(1)_67-77.nxml.txt.nlp	24393766	SENT150	9	9	5	5	bevacizumab	NF2	PA130232992	4771	0.839
NULL	Indian_J_Med_Res_2011_Sep_134(3)_253-255.nxml.txt.nlp	21985806	SENT26	29	29	10	10	carbamazepine	P-gp	PA448785	5243	0.839
NULL	Oncoscience_2013_Dec_11_1(1)_30-38.nxml.txt.nlp	25593982	SENT23	6	6	2	2	oxygen	Met	PA450744	79811	0.839
NULL	Biosci_Rep_2013_Jun_11_33(3)_e00042.nxml.txt.nlp	23634903	SENT84	9	9	18	18	tetracycline	NDRG1	PA451640	10397	0.839
NULL	Toxins_(Basel)_2010_Mar_31_2(4)_517-551.nxml.txt.nlp	22069598	SENT127	5	5	7	7	curcumin	IL-6	PA151958596	3569	0.839
NULL	Mol_Biol_Rep_2013_May_11_40(8)_5013-5026.nxml.txt.nlp	23666059	SENT218	3	3	22	22	resveratrol	p53		7157	0.839
NULL	Clin_Ophthalmol_2009_Jun_2_3_291-295.nxml.txt.nlp	19668581	SENT63	21	21	19	19	travoprost	BAK	PA164781371	578	0.839
NULL	Nat_Commun_2012_Dec_4_3_1238.nxml.txt.nlp	23212367	SENT167	2	2	12	12	isoproterenol	TRPC6	PA450121	7225	0.839
NULL	J_Gynecol_Oncol_2011_Mar_31_22(1)_9-17.nxml.txt.nlp	21607090	SENT92	24	24	12	12	cyclophosphamide	PCFT	PA449165	113235	0.839
NULL	Breast_Cancer_Res_2011_Jan_17_13(1)_R5.nxml.txt.nlp	21241485	SENT12	15	15	7	7	estradiol	Brn-3b	PA449503	5458	0.839
NULL	Int_J_Mol_Sci_2014_May_12_15(5)_8335-8351.nxml.txt.nlp	24823879	SENT142	16	16	1	1	etoposide	XIAP	PA449552	331	0.839
NULL	Adv_Hematol_2012_Jul_24_2012_513702.nxml.txt.nlp	22888354	SENT105	7	7	12	12	lenalidomide	PD-L1	PA162363968	29126	0.839
NULL	Curr_Med_Chem_2013_Apr_20(10)_1241-1285.nxml.txt.nlp	23409712	SENT1147	10	10	26	26	carbamazepine	CA1	PA448785	759	0.839
NULL	Br_J_Dermatol_2014_Feb_18_170(1)_342-351.nxml.txt.nlp	24547721	SENT132	9	9	4	4	lansoprazole	CLE	PA450180	51637	0.839
NULL	Breast_Cancer_Res_2004_Oct_6_6(6)_262-268.nxml.txt.nlp	15535857	SENT148	24	24	43	43	tamoxifen	aromatase	PA451581	1588	0.839
NULL	Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.nxml.txt.nlp	24736980	SENT181	38	38	10	10	rosuvastatin	OATP1B1	PA134308647	10599	0.839
NULL	Acta_Pharmacol_Sin_2014_Aug_21_35(8)_1082-1092.nxml.txt.nlp	25047514	SENT198	3	3	7	7	letrozole	aromatase	PA450196	1588	0.839
NULL	Daru_2012_Oct_30_20(1)_69.nxml.txt.nlp	23351548	SENT154	12	12	28	28	coumarin	p53	PA134521193	7157	0.839
NULL	Breast_Cancer_Res_2012_Apr_4_14(2)_R57.nxml.txt.nlp	22475046	SENT129	14	14	1	1	tamoxifen	CCND1	PA451581	595	0.839
NULL	Protein_Cell_2014_Jul_2_5(7)_544-551.nxml.txt.nlp	24691905	SENT72	17	17	6	6	nutlin-3	p53		7157	0.839
NULL	J_Anaesthesiol_Clin_Pharmacol_2012_Oct-Dec_28(4)_423-425.nxml.txt.nlp	23225917	SENT55	18	18	29	29	desflurane	CO2	PA164749136	4513	0.839
NULL	Ann_Neurosci_2012_Jan_19(1)_31-39.nxml.txt.nlp	25205961	SENT166	13	13	28	28	chlorpromazine	TRAAK	PA448964	50801	0.839
NULL	ScientificWorldJournal_2014_Dec_31_2014_508178.nxml.txt.nlp	25614889	SENT20	18	18	32	32	ustekinumab	IL-17	PA166048654	3605	0.839
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT201	5	5	12	12	resveratrol	p53		7157	0.839
NULL	Oncotarget_2013_Nov_23_5(1)_196-210.nxml.txt.nlp	24344116	SENT308	18	18	41	41	doxorubicin	CO2	PA449412	4513	0.839
NULL	BMB_Rep_2013_Feb_46(2)_92-96.nxml.txt.nlp	23433111	SENT27	6	6	11	11	etoposide	BRCA1	PA449552	672	0.839
NULL	Arch_Med_Sci_2013_Aug_30_9(4)_724-730.nxml.txt.nlp	24049536	SENT88	24	24	6	6	genistein	PTH	PA165109660	5741	0.839
NULL	Blood_Res_2014_Mar_24_49(1)_15-21.nxml.txt.nlp	24724062	SENT165	44	44	22	22	carboplatin	CHOP	PA448803	1649	0.839
NULL	Environ_Health_Perspect_2013_May_22_121(5)_551-557.nxml.txt.nlp	23434795	SENT167	15	15	11	11	hyaluronan	TNF	PA165958431	7124	0.839
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT541	10	10	6	6	metformin	HIF-1	PA450395	29072	0.839
NULL	Clinics_(Sao_Paulo)_2013_May_68(5)_694-701.nxml.txt.nlp	23778405	SENT139	5	5	16	16	curcumin	P-gp	PA151958596	5243	0.839
NULL	Front_Neurosci_2014_Jul_1_8_168.nxml.txt.nlp	25018691	SENT592	10	10	3	3	phencyclidine	gamma	PA128406980	9913	0.839
NULL	Curr_Mol_Med_2013_Mar_13(3)_446-458.nxml.txt.nlp	23331017	SENT67	34	34	23	23	oprelvekin	IL-11	PA164747991	3589	0.839
NULL	Oncotarget_2011_Mar_27_2(3)_209-221.nxml.txt.nlp	21444945	SENT157	14	14	8	8	bortezomib	p53	PA10252	7157	0.839
NULL	Arthritis_Res_Ther_2009_Jul_23_11(4)_236.nxml.txt.nlp	19664185	SENT66	0	0	10	10	probenecid	URAT1	PA451106	116085	0.839
NULL	J_Cell_Biol_2000_Jul_10_150(1)_177-192.nxml.txt.nlp	10893266	SENT779	36	36	0	0	paraformaldehyde	SP1	PA450790	6667	0.839
NULL	Mol_Cancer_2010_Dec_20_9_316.nxml.txt.nlp	21172016	SENT163	31	31	42	42	heparin	CCL21	PA449855	6366	0.839
NULL	Diabetes_Care_2009_Sep_28_32(9)_1649-1655.nxml.txt.nlp	19478198	SENT180	3	3	16	16	metformin	PPG	PA450395	5552	0.839
NULL	Mol_Vis_2012_Oct_5_18_2454-2467.nxml.txt.nlp	23077404	SENT153	11	11	13	13	bevacizumab	HIF-1	PA130232992	29072	0.839
NULL	Oncotarget_2014_Oct_21_5(21)_10916-10933.nxml.txt.nlp	25373734	SENT351	25	25	29	29	heparin	CCL5	PA449855	6352	0.839
NULL	Infect_Drug_Resist_2010_Nov_23_3_133-145.nxml.txt.nlp	21694902	SENT100	4	4	10	10	telaprevir	San	PA165958354	80218	0.839
NULL	Hum_Reprod_2014_Oct_10_29(10)_2302-2316.nxml.txt.nlp	25139174	SENT375	5	5	19	19	metformin	aromatase	PA450395	1588	0.839
NULL	Ann_Surg_Treat_Res_2014_Apr_25_86(4)_220-225.nxml.txt.nlp	24783183	SENT71	15	15	12	12	bevacizumab	VEGFR	PA130232992	3791	0.839
NULL	Nat_Med_2011_Oct_2_17(10)_1304-1309.nxml.txt.nlp	21963515	SENT203	8	8	38	38	tacrolimus	TRPV5	PA451578	56302	0.839
NULL	Environ_Health_Perspect_2008_Sep_116(9)_A402a.nxml.txt.nlp	NULL	SENT15	34	34	1	1	iron	HFE	PA450087	3077	0.839
NULL	Int_J_Emerg_Med_2010_May_26_3(2)_81-84.nxml.txt.nlp	20606815	SENT93	26	26	3	3	quetiapine	CYP3A4	PA451201	1576	0.839
NULL	Am_J_Case_Rep_2012_May_23_13_79-85.nxml.txt.nlp	23569495	SENT57	10	10	8	8	cyclophosphamide	CHOP	PA449165	1649	0.839
NULL	Arthritis_Res_Ther_2006_Jul_3_8(4)_216.nxml.txt.nlp	16879719	SENT105	13	13	9	9	methotrexate	ACR	PA450428	49	0.839
NULL	J_Cell_Mol_Med_2014_Dec_9_18(12)_2499-2511.nxml.txt.nlp	24912879	SENT289	13	13	6	6	docetaxel	DACH1	PA449383	1602	0.839
NULL	Oncotarget_2014_Aug_12_5(20)_9710-9726.nxml.txt.nlp	25339152	SENT173	5	5	19	19	pp2	DGK		8526;1607	0.839
NULL	Braz_J_Med_Biol_Res_2011_Dec_9_45(1)_13-19.nxml.txt.nlp	22147192	SENT56	38	38	3	3	paraformaldehyde	P21	PA450790	1026;9338	0.839
NULL	Breast_Cancer_Res_2009_Nov_26_11(6)_111.nxml.txt.nlp	20017885	SENT18	6	6	17	17	olaparib	BRCA1		672	0.839
NULL	Adv_Hematol_2011_Apr_10_2011_960137.nxml.txt.nlp	21547266	SENT88	17	17	22	22	vincristine	NHL	PA451879	51750	0.839
NULL	Indian_J_Endocrinol_Metab_2014_Jan-Feb_18(1)_32-38.nxml.txt.nlp	24701427	SENT121	3	3	20	20	iron	TNF-alpha	PA450087	7124	0.839
NULL	Eur_J_Haematol_2014_Oct_13_93(4)_309-319.nxml.txt.nlp	24758317	SENT126	35	35	17	17	eculizumab	CD34	PA164776637	947	0.839
NULL	Mol_Pain_2013_Jun_10_9_27.nxml.txt.nlp	23758830	SENT208	0	0	3	3	tetracaine	ASIC3	PA451638	9311	0.839
NULL	Diabetes_Care_2013_Aug_11_36(8)_2408-2414.nxml.txt.nlp	23536583	SENT80	10	10	17	17	rosiglitazone	adiponectin	PA451283	9370	0.839
NULL	Alcohol_Res_Health_2007_30(1)_38-47.nxml.txt.nlp	17718399	SENT76	33	33	21	21	ethanol	ADH	PA448073	551	0.839
NULL	Evid_Based_Complement_Alternat_Med_2011_Mar_20_2011_571479.nxml.txt.nlp	21792361	SENT119	12	12	19	19	indomethacin	HIF-1	PA449982	29072	0.839
NULL	Cells_2012_Dec_5_1(4)_1156-1167.nxml.txt.nlp	24710548	SENT43	22	22	32	32	staurosporine	JNK	PA165109623	5599	0.839
NULL	Ann_Oncol_2011_Aug_27_22(8)_1736-1747.nxml.txt.nlp	21709140	SENT316	28	28	44	44	trastuzumab	San	PA451743	80218	0.839
NULL	Daru_2012_Oct_4_20(1)_45.nxml.txt.nlp	23351300	SENT36	17	17	39	39	fluoxetine	API	PA449673	5345	0.839
NULL	Case_Rep_Endocrinol_2013_Dec_22_2013_675298.nxml.txt.nlp	24455332	SENT154	8	8	15	15	cyclophosphamide	ACTH	PA449165	5443	0.839
NULL	J_Biomed_Biotechnol_2010_Jun_6_2010_571343.nxml.txt.nlp	20625496	SENT183	11	11	6	6	vincristine	ALG-2	PA451879	10016	0.839
NULL	Front_Oncol_2013_Nov_15_3_281.nxml.txt.nlp	24298448	SENT193	16	16	40	40	irinotecan	BRAF	PA450085	673	0.839
NULL	Br_J_Cancer_2010_May_11_102(10)_1456-1460.nxml.txt.nlp	20461090	SENT130	21	21	24	24	temsirolimus	IFN	PA164746890	3439	0.839
NULL	J_Oncol_2012_Jun_19_2012_521215.nxml.txt.nlp	22778735	SENT139	7	7	30	30	cisplatin	EGFR	PA449014	1956	0.839
NULL	Biol_Proced_Online_2003_Oct_24_5_204-210.nxml.txt.nlp	14615817	SENT72	47	47	20	20	imatinib	CO2	PA10804	4513	0.839
NULL	Ann_Occup_Hyg_2010_Aug_21_54(6)_697-709.nxml.txt.nlp	20660144	SENT240	16	16	7	7	fluorescein	GK2	PA164746009	2712;2585	0.839
NULL	Adv_Hematol_2012_Feb_26_2012_529572.nxml.txt.nlp	22474449	SENT10	10	10	7	7	crizotinib	ALK	PA165946122	238	0.839
NULL	Cancer_Cell_Int_2013_Jun_26_13_63.nxml.txt.nlp	23800022	SENT39	2	2	11	11	genistein	MDM2	PA165109660	4193	0.839
NULL	Breast_Cancer_Res_2007_Aug_8_9(4)_R50.nxml.txt.nlp	17686159	SENT258	21	21	39	39	gefitinib	HRG	PA131301952	3084;3273	0.839
NULL	Ann_Oncol_2012_Nov_22_23(11)_2782-2790.nxml.txt.nlp	22730099	SENT123	5	5	17	17	estradiol	RANKL	PA449503	8600	0.839
NULL	Oncotarget_2014_Aug_4_5(17)_7776-7787.nxml.txt.nlp	25277200	SENT105	13	13	8	8	cisplatin	ANXA4	PA449014	307	0.839
NULL	Exp_Ther_Med_2013_May_15_5(5)_1327-1331.nxml.txt.nlp	23737873	SENT149	4	4	13	13	imidapril	AQP2	PA452640	359	0.839
NULL	J_Cell_Sci_2014_Mar_15_127(6)_1263-1278.nxml.txt.nlp	24424030	SENT38	9	9	18	18	doxycycline	TDP-43	PA449415	23435	0.839
NULL	Front_Genet_2012_Nov_12_3_235.nxml.txt.nlp	23162568	SENT418	2	2	6	6	methamphetamine	CYP2D6	PA450403	1565	0.839
NULL	Open_Access_J_Urol_2010_Mar_12_2_35-40.nxml.txt.nlp	24198612	SENT1	0	0	13	13	pazopanib	VEGFR	PA165291492	3791	0.839
NULL	Arthritis_Res_Ther_2013_Apr_4_15(Suppl_1)_S4.nxml.txt.nlp	23566679	SENT153	7	7	13	13	rituximab	CD19	PA451261	930	0.839
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_127043.nxml.txt.nlp	23227093	SENT170	20	20	7	7	lovastatin	CYP3A4	PA450272	1576	0.839
NULL	Cancer_Immunol_Immunother_2013_Aug_27_62(10)_1637-1648.nxml.txt.nlp	23982484	SENT157	29	29	14	14	lenalidomide	IL-2	PA162363968	3558	0.839
NULL	Basic_Res_Cardiol_2012_Jul_24_107(4)_273.nxml.txt.nlp	22622703	SENT214	27	27	15	15	isoflurane	p53	PA450106	7157	0.839
NULL	Nat_Commun_2013_Sep_20_4_2444.nxml.txt.nlp	24051492	SENT109	10	10	6	6	nutlin-3	p53		7157	0.839
NULL	Tob_Induc_Dis_2004_Mar_15_2(1)_3-25.nxml.txt.nlp	19570267	SENT299	18	18	33	33	methacholine	SP-A	PA165958382	653509	0.839
NULL	J_Vet_Emerg_Crit_Care_(San_Antonio)_2013_Mar_8_23(2)_134-162.nxml.txt.nlp	23566108	SENT40	14	14	0	0	calcidiol	PTH	PA164745614	5741	0.839
NULL	Gut_2013_Mar_22_62(3)_358-367.nxml.txt.nlp	22442164	SENT123	6	6	8	8	genistein	PI3K	PA165109660	5290	0.839
NULL	Arch_Med_Sci_2011_Aug_2_7(4)_713-719.nxml.txt.nlp	22291810	SENT124	7	7	11	11	calcipotriol	IL-20	PA448714	27190;50604	0.839
NULL	Clin_Psychopharmacol_Neurosci_2012_Apr_30_10(1)_59-60.nxml.txt.nlp	23431323	SENT13	23	23	8	8	ketamine	Met	PA450144	79811	0.839
NULL	Indian_J_Ophthalmol_2014_Jan_62(1)_66-73.nxml.txt.nlp	24492504	SENT43	16	16	13	13	bevacizumab	VEGF-A	PA130232992	7422	0.839
NULL	Semin_Immunol_2011_Feb_23(1)_28-41.nxml.txt.nlp	21295490	SENT234	21	21	9	9	etanercept	CD83	PA449515	9308	0.839
NULL	Cell_Death_Dis_2010_May_13_1(5)_e41.nxml.txt.nlp	21364648	SENT32	7	7	2	2	etoposide	p65	PA449552	5970	0.839
NULL	Arthritis_Res_Ther_2014_Jul_18_16(4)_R153.nxml.txt.nlp	25037855	SENT100	3	3	9	9	adalimumab	CD14	PA10004	929	0.839
NULL	Br_J_Cancer_2010_Oct_26_103(9)_1331-1334.nxml.txt.nlp	20877352	SENT7	10	10	24	24	trastuzumab	GM-CSF	PA451743	1437	0.839
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT198	15	15	42	42	adalimumab	CD36	PA10004	948	0.839
NULL	Neuropsychopharmacology_2009_Jul_25_34(8)_1968-1978.nxml.txt.nlp	19322168	SENT258	10	10	2	2	clozapine	PI3K	PA449061	5290	0.839
NULL	Int_J_Alzheimers_Dis_2010_Dec_27_2011_231595.nxml.txt.nlp	21234401	SENT89	24	24	1	1	iron	MRI	PA450087	78996	0.839
NULL	J_Clin_Biochem_Nutr_2010_Jan_29_46(1)_87-92.nxml.txt.nlp	20104270	SENT102	5	5	12	12	naringenin	adiponectin	PA151958361	9370	0.839
NULL	ScientificWorldJournal_2013_Apr_24_2013_928197.nxml.txt.nlp	23737732	SENT59	4	4	16	16	enalapril	adiponectin	PA449456	9370	0.839
NULL	J_Mater_Sci_Mater_Med_2011_Apr_19_22(4)_1081-1086.nxml.txt.nlp	21424213	SENT35	21	21	15	15	thrombin	ADP	PA451674	23038	0.839
NULL	Cardiovasc_Diabetol_2006_Aug_30_5_17.nxml.txt.nlp	16939660	SENT25	23	23	13	13	metformin	AMPK	PA450395	5563	0.839
NULL	Cardiovasc_Diabetol_2013_Jun_18_12_90.nxml.txt.nlp	23777457	SENT159	14	14	40	40	liraglutide	TRAF2	PA165958364	7186	0.839
NULL	Curr_Oncol_2009_May_16(Suppl_1)_S52-S59.nxml.txt.nlp	19478903	SENT145	13	13	6	6	losartan	CYP3A4	PA450268	1576	0.839
NULL	AAPS_J_2011_Jun_1_13(3)_405-416.nxml.txt.nlp	21630127	SENT252	43	43	22	22	tocilizumab	CYP3A4	PA165292659	1576	0.839
NULL	Oncogene_2009_Dec_3_28(48)_4237-4248.nxml.txt.nlp	19734937	SENT86	32	32	17	17	collagenase	PAR-1	PA449107	2011;2149	0.839
NULL	Arthritis_Res_Ther_2010_Dec_21_12(6)_223.nxml.txt.nlp	21205285	SENT73	31	31	13	13	probenecid	URAT1	PA451106	116085	0.839
NULL	Front_Oncol_2013_Aug_20_3_202.nxml.txt.nlp	23971004	SENT150	10	10	16	16	vanillin	TRAIL	PA451852	8743	0.839
NULL	Mol_Vis_2007_Jul_9_13_1083-1093.nxml.txt.nlp	17653053	SENT172	8	8	19	19	minocycline	p65	PA450519	5970	0.839
NULL	Nat_Commun_2014_Apr_3_5_3608.nxml.txt.nlp	24699711	SENT118	31	31	13	13	metformin	PIK3CA	PA450395	5290	0.839
NULL	Front_Oncol_2014_Jun_12_4_144.nxml.txt.nlp	24971229	SENT162	11	11	2	2	cisplatin	HOTAIR	PA449014	100124700	0.839
NULL	Cell_Death_Dis_2014_Jul_24_5(7)_e1349.nxml.txt.nlp	25058423	SENT7	19	19	31	31	imatinib	REDD1	PA10804	54541	0.839
NULL	Acta_Pharmacol_Sin_2014_Aug_7_35(8)_1023-1030.nxml.txt.nlp	24998255	SENT86	3	3	14	14	octreotide	Oct4	PA450678	5460	0.839
NULL	Front_Endocrinol_(Lausanne)_2014_Feb_25_5_22.nxml.txt.nlp	24611062	SENT284	5	5	26	26	estradiol	RhoA	PA449503	387	0.839
NULL	Insights_Imaging_2013_Jan_29_4(2)_163-175.nxml.txt.nlp	23359240	SENT144	10	10	0	0	bevacizumab	HER2	PA130232992	2064	0.839
NULL	Cell_Death_Dis_2010_Nov_18_1(11)_e102.nxml.txt.nlp	21368867	SENT6	0	0	7	7	gentamicin	CLIMP-63	PA449753	10970	0.839
NULL	J_Antimicrob_Chemother_2012_Jul_30_67(7)_1683-1696.nxml.txt.nlp	22547662	SENT44	17	17	5	5	vancomycin	VISA	PA451850	57506	0.839
NULL	Indian_J_Endocrinol_Metab_2013_Jul-Aug_17(4)_636-646.nxml.txt.nlp	23961479	SENT157	4	4	24	24	simvastatin	CYP3A4	PA451363	1576	0.839
NULL	Int_J_Mol_Sci_2013_Apr_17_14(4)_8422-8436.nxml.txt.nlp	23594994	SENT68	14	14	7	7	flutamide	PC-3	PA449685	692094	0.839
NULL	Mol_Cancer_2013_Sep_11_12_104.nxml.txt.nlp	24025152	SENT116	11	11	17	17	gemcitabine	STAT3	PA449748	6774	0.839
NULL	Br_J_Cancer_2009_Jul_21_101(2)_269-277.nxml.txt.nlp	19603033	SENT136	22	22	37	37	carboplatin	MLH1	PA448803	4292	0.839
NULL	Adv_Hematol_2012_Nov_20_2012_861060.nxml.txt.nlp	23251161	SENT70	0	0	8	8	lenalidomide	CTLA4	PA162363968	1493	0.839
NULL	Cancer_Cell_Int_2010_Feb_19_10_3.nxml.txt.nlp	20170512	SENT157	7	7	21	21	tamoxifen	p27	PA451581	5715;10534	0.839
NULL	Cancer_Microenviron_2009_Sep_26_2(Suppl_1)_19-204.nxml.txt.nlp	NULL	SENT703	18	18	40	40	etoposide	survivin	PA449552	332	0.839
NULL	Nat_Med_2012_Feb_19_18(3)_446-451.nxml.txt.nlp	22344296	SENT36	19	19	3	3	efavirenz	ATV	PA449441	4683	0.839
NULL	Br_J_Cancer_1990_Dec_62(6)_891-896.nxml.txt.nlp	2124136	SENT17	10	10	23	23	mitomycin	HAI	PA450524	6692;6768	0.839
NULL	J_Young_Pharm_2010_Oct-Dec_2(4)_379-383.nxml.txt.nlp	21264098	SENT1	22	22	15	15	glibenclamide	P-gp	PA449782	5243	0.839
NULL	Niger_Med_J_2013_Mar-Apr_54(2)_100-106.nxml.txt.nlp	23798795	SENT120	3	3	0	0	indomethacin	PTEN	PA449982	5728	0.839
NULL	Brain_Behav_2014_Jan_27_4(1)_51-59.nxml.txt.nlp	24653954	SENT17	1	1	11	11	estradiol	EPM	PA449503	2054	0.839
NULL	Int_J_Endocrinol_Metab_2013_Dec_21_Winter_11(1)_57-61.nxml.txt.nlp	23853622	SENT126	0	0	6	6	bromocriptine	PRL	PA448671	5617	0.839
NULL	BMJ_Open_2014_Aug_30_4(8)_e005986.nxml.txt.nlp	25180056	SENT110	6	6	3	3	ciprofloxacin	CYP1A2	PA449009	1544	0.839
NULL	Cancer_Cell_Int_2005_Jul_29_5_24.nxml.txt.nlp	16053526	SENT135	4	4	0	0	estradiol	p53	PA449503	7157	0.839
NULL	Adv_Prev_Med_2012_Dec_6_2012_103728.nxml.txt.nlp	23304534	SENT55	7	7	0	0	ezetimibe	STAT2	PA10816	6773	0.839
NULL	Clin_Pharmacol_2011_Jun_22_3_13-25.nxml.txt.nlp	22287853	SENT25	6	6	11	11	saxagliptin	CYP1A2	PA165958362	1544	0.839
NULL	Br_J_Cancer_2009_Sep_15_101(6)_875-878.nxml.txt.nlp	19672259	SENT53	29	29	22	22	letrozole	aromatase	PA450196	1588	0.838
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1150.nxml.txt.nlp	24675468	SENT33	34	34	24	24	metformin	AMPK	PA450395	5563	0.838
NULL	Br_J_Ophthalmol_2012_Jul_26_96(7)_1023-1028.nxml.txt.nlp	22539748	SENT16	13	13	24	24	ranibizumab	TER	PA164746012	9524	0.838
NULL	Acta_Pharmacol_Sin_2014_Sep_25_35(9)_1199-1206.nxml.txt.nlp	25152024	SENT104	5	5	8	8	cisplatin	mig-2	PA449014	10979	0.838
NULL	Breast_Cancer_Res_2012_Mar_20_14(2)_R53.nxml.txt.nlp	22433433	SENT110	18	18	28	28	doxorubicin	CDK2	PA449412	1017	0.838
NULL	Cancer_Med_2013_Feb_3_2(1)_11-20.nxml.txt.nlp	24133623	SENT291	7	7	26	26	leucovorin	BRAF	PA450198	673	0.838
NULL	Breast_Cancer_Res_2011_Apr_15_13(2)_R44.nxml.txt.nlp	21496232	SENT37	36	36	12	12	trastuzumab	HER3	PA451743	2065	0.838
NULL	Exp_Ther_Med_2013_Jan_30_5(1)_308-314.nxml.txt.nlp	23251289	SENT149	15	15	0	0	methotrexate	ABCC3	PA450428	8714	0.838
NULL	Drugs_R_D_2014_Jun_6_14(2)_113-123.nxml.txt.nlp	24797400	SENT6	41	41	20	20	dabigatran	CES1		1066	0.838
NULL	Breast_Cancer_Res_2003_Feb_5_5(2)_113-116.nxml.txt.nlp	12631392	SENT76	11	11	7	7	trastuzumab	TPC	PA451743	8030;60386	0.838
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_P108.nxml.txt.nlp	NULL	SENT14	4	4	19	19	piperacillin	IL22	PA450975	50616	0.838
NULL	Cancer_Immunol_Immunother_2011_Jan_21_60(1)_75-85.nxml.txt.nlp	20857100	SENT206	25	25	14	14	fludarabine	CD4	PA449655	920	0.838
NULL	Ann_Clin_Transl_Neurol_2014_Dec_21_1(12)_996-1005.nxml.txt.nlp	25574474	SENT114	24	24	19	19	riluzole	P-gp	PA451251	5243	0.838
NULL	J_Headache_Pain_2013_Aug_13_14(1)_71.nxml.txt.nlp	23941062	SENT68	15	15	19	19	paclitaxel	TRPA1	PA450761	8989	0.838
NULL	Diabetes_Care_2010_Mar_15_33(3)_608-613.nxml.txt.nlp	20009095	SENT133	12	12	29	29	ramipril	DREAM	PA451223	30818	0.838
NULL	J_Gen_Physiol_2000_Jun_1_115(6)_685-696.nxml.txt.nlp	10828243	SENT163	6	6	1	1	genistein	OLF	PA165109660	83857	0.838
NULL	Curr_Neuropharmacol_2008_Sep_6(3)_215-234.nxml.txt.nlp	19506722	SENT117	8	8	16	16	fluoxetine	5-HT2C	PA449673	3358	0.838
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT141	5	5	10	10	sulindac	survivin	PA451565	332	0.838
NULL	Indian_J_Pharm_Sci_2014_Jan-Feb_76(1)_72-77.nxml.txt.nlp	24799741	SENT39	14	14	20	20	glimepiride	CYP2C9	PA449761	1559	0.838
NULL	J_Oncol_2012_Nov_20_2012_236530.nxml.txt.nlp	23213333	SENT126	19	19	27	27	curcumin	PTEN	PA151958596	5728	0.838
NULL	Oncotarget_2011_Dec_24_2(12)_896-917.nxml.txt.nlp	22203527	SENT144	2	2	16	16	metformin	AMPK	PA450395	5563	0.838
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Oct_12_67(Pt_11)_o2955.nxml.txt.nlp	22219981	SENT6	9	9	1	1	coumarin	mol	PA134521193	90527	0.838
NULL	J_Clin_Biochem_Nutr_2008_May_29_42(3)_197-203.nxml.txt.nlp	18545641	SENT88	18	18	22	22	curcumin	p38	PA151958596	10598;1432;7965	0.838
NULL	Support_Care_Cancer_2014_Oct_19_22(2)_469-477.nxml.txt.nlp	24141698	SENT155	18	18	25	25	epirubicin	NK1	PA449476	11126	0.838
NULL	Cancer_Cell_Int_2014_Jan_14_14_4.nxml.txt.nlp	24423208	SENT43	39	39	23	23	sorafenib	CAIX	PA7000	768	0.838
NULL	Br_J_Cancer_2013_Jul_23_109(2)_502-511.nxml.txt.nlp	23799850	SENT17	13	13	15	15	gemcitabine	SMARCC1	PA449748	6599	0.838
NULL	Br_J_Cancer_1990_Dec_62(6)_891-896.nxml.txt.nlp	2124136	SENT12	21	21	4	4	mitomycin	HAI	PA450524	6692;6768	0.838
NULL	Breast_Cancer_Res_2012_Jul_20_14(4)_R111.nxml.txt.nlp	22817771	SENT177	7	7	12	12	flutamide	DUSP6	PA449685	1848	0.838
NULL	J_Med_Case_Reports_2011_Mar_28_5_117.nxml.txt.nlp	21443773	SENT130	14	14	20	20	sitagliptin	GLP-1	PA164748978	100125288	0.838
NULL	Drug_Des_Devel_Ther_2014_Oct_16_8_1941-1953.nxml.txt.nlp	25342887	SENT143	7	7	30	30	genistein	TLR4	PA165109660	7099	0.838
NULL	EJC_Suppl_2013_Sep_5_11(2)_307-309.nxml.txt.nlp	NULL	SENT50	8	8	1	1	afatinib	EGFR	PA165981154	1956	0.838
NULL	Oncol_Lett_2013_Mar_11_5(3)_1010-1016.nxml.txt.nlp	23426784	SENT10	21	21	31	31	midazolam	TRPM7	PA450496	54822	0.838
NULL	Anticancer_Agents_Med_Chem_2012_Feb_12(2)_163-171.nxml.txt.nlp	22043994	SENT152	40	40	33	33	cetuximab	KRAS	PA10040	3845	0.838
NULL	Mol_Biol_Cell_2012_Mar_15_23(6)_996-1009.nxml.txt.nlp	22278744	SENT208	16	16	10	10	forskolin	14-3-3	PA146096022	10971	0.838
NULL	Arch_Drug_Inf_2011_Mar_4(1)_1-9.nxml.txt.nlp	21572514	SENT55	19	19	29	29	vinblastine	P-gp	PA451877	5243	0.838
NULL	Front_Oncol_2013_Nov_15_3_281.nxml.txt.nlp	24298448	SENT78	26	26	22	22	cetuximab	EGFR	PA10040	1956	0.838
NULL	Hum_Genomics_2010_Feb_1_4(3)_194-201.nxml.txt.nlp	20368140	SENT51	2	2	14	14	collagenase	MMP3	PA449107	4314	0.838
NULL	Scientifica_(Cairo)_2012_Nov_25_2012_473829.nxml.txt.nlp	24278698	SENT238	27	27	5	5	cisplatin	ATP7B	PA449014	540	0.838
NULL	Arthritis_Res_Ther_2005_Apr_4_7(4)_R756-R768.nxml.txt.nlp	15987477	SENT206	18	18	10	10	hyaluronidase	PH-20	PA164745713	6677	0.838
NULL	J_Cancer_2014_Jul_4_5(7)_559-571.nxml.txt.nlp	25057307	SENT229	15	15	18	18	tamoxifen	CD44	PA451581	960	0.838
NULL	Clin_Med_Insights_Cardiol_2012_Feb_1_6_17-33.nxml.txt.nlp	22442638	SENT70	11	11	8	8	itraconazole	CYP3A4	PA450132	1576	0.838
NULL	Diabetes_2013_Oct_17_62(10)_3500-3513.nxml.txt.nlp	23884882	SENT270	8	8	30	30	resveratrol	PDX1		8050;3651	0.838
NULL	Indian_J_Med_Res_2013_Jan_137(1)_203-209.nxml.txt.nlp	23481074	SENT3	26	26	6	6	acenocoumarol	CYP2C9	PA452632	1559	0.838
NULL	Breast_Cancer_Res_2011_Mar_14_13(2)_205.nxml.txt.nlp	21457526	SENT102	0	0	3	3	denosumab	RANKL	PA166048634	8600	0.838
NULL	Br_J_Cancer_2011_Mar_1_104(5)_781-789.nxml.txt.nlp	21304528	SENT69	13	13	0	0	paraformaldehyde	PC-3	PA450790	692094	0.838
NULL	Acta_Pharmacol_Sin_2009_Jul_22_30(7)_956-964.nxml.txt.nlp	19543298	SENT228	10	10	3	3	atorvastatin	SLCO2B1	PA448500	11309	0.838
NULL	Oncotarget_2014_Dec_4_5(22)_11365-11380.nxml.txt.nlp	25426548	SENT48	16	16	1	1	nutlin-3	HEC		10403	0.838
NULL	Bioeng_Bugs_2012_Jan_1_3(1)_13-31.nxml.txt.nlp	22126801	SENT300	21	21	5	5	imipenem	ACC-1	PA449968	597	0.838
NULL	Indian_J_Ophthalmol_2014_May_62(5)_554-560.nxml.txt.nlp	24881600	SENT21	19	19	13	13	bevacizumab	San	PA130232992	80218	0.838
NULL	Atherosclerosis_2011_Jun_216(2)_342-347.nxml.txt.nlp	21420681	SENT160	12	12	22	22	thrombin	LRP1	PA451674	10438;4035	0.838
NULL	J_Gynecol_Oncol_2014_Jan_8_25(1)_22-29.nxml.txt.nlp	24459577	SENT21	12	12	10	10	paclitaxel	NACT	PA450761	284111	0.838
NULL	Indian_J_Radiol_Imaging_2008_Aug_18(3)_256-263.nxml.txt.nlp	19774171	SENT22	11	11	17	17	heparin	ACT	PA449855	12;11332;9457;641455	0.838
NULL	Mol_Cancer_2014_Jun_5_13_143.nxml.txt.nlp	24898067	SENT7	2	2	19	19	trastuzumab	DM1	PA451743	338023;1760;28509	0.838
NULL	J_Immunol_Res_2014_Nov_11_2014_385352.nxml.txt.nlp	25436214	SENT147	21	21	28	28	adalimumab	IL-6	PA10004	3569	0.838
NULL	Acta_Pharmacol_Sin_2013_Sep_5_34(9)_1192-1200.nxml.txt.nlp	23685957	SENT137	17	17	10	10	curcumin	AP-2	PA151958596	7020	0.838
NULL	Arch_Gynecol_Obstet_2009_Oct_31_280(4)_529-538.nxml.txt.nlp	19644696	SENT117	37	37	29	29	estradiol	TIAR	PA449503	7073	0.838
NULL	Case_Rep_Oncol_Med_2013_Dec_5_2013_838941.nxml.txt.nlp	24381773	SENT63	6	6	3	3	cyclophosphamide	CHOP	PA449165	1649	0.838
NULL	JRSM_Cardiovasc_Dis_2012_Sep_24_1(6)_cvd_2012_012015.nxml.txt.nlp	24175073	SENT101	20	20	41	41	clopidogrel	HPR	PA449053	3250	0.838
NULL	Int_J_Surg_Oncol_2012_Aug_27_2012_180574.nxml.txt.nlp	22970358	SENT107	9	9	1	1	anastrozole	IMPACT	PA448432	55364	0.838
NULL	Pharmaceutics_2011_Oct_12_3(4)_680-705.nxml.txt.nlp	24309303	SENT93	10	10	20	20	metformin	OCT2	PA450395	6582;5452	0.838
NULL	Croat_Med_J_2012_Dec_53(6)_605-611.nxml.txt.nlp	23275326	SENT164	15	15	8	8	propafenone	CYP2D6	PA451131	1565	0.838
NULL	Front_Oncol_2014_Mar_3_4_35.nxml.txt.nlp	24624362	SENT124	18	18	12	12	cetuximab	PIK3CA	PA10040	5290	0.838
NULL	Diabetes_Care_2012_Dec_14_35(12)_2631-2639.nxml.txt.nlp	22912426	SENT292	15	15	23	23	rosiglitazone	CD4	PA451283	920	0.838
NULL	Mol_Cancer_2013_Nov_13_12_137.nxml.txt.nlp	24225025	SENT316	9	9	16	16	vincristine	MRP1	PA451879	4437	0.838
NULL	Case_Rep_Oncol_Med_2014_Aug_27_2014_165670.nxml.txt.nlp	25247100	SENT71	15	15	13	13	ribavirin	IFN	PA451241	3439	0.838
NULL	J_Lipid_Res_2015_Jan_56(1)_109-121.nxml.txt.nlp	25421061	SENT312	28	28	10	10	forskolin	CGI-58	PA146096022	51099	0.838
NULL	J_Korean_Med_Sci_2010_Aug_21_25(8)_1222-1227.nxml.txt.nlp	20676337	SENT72	8	8	19	19	propofol	LPA	PA451141	4018	0.838
NULL	Ann_Surg_Oncol_2013_Jul_3_20(7)_2311-2316.nxml.txt.nlp	23377563	SENT107	20	20	14	14	doxorubicin	CRS	PA449412	1403	0.838
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT381	6	6	10	10	resveratrol	IL-6		3569	0.838
NULL	Breast_Cancer_Res_2010_May_12_12(3)_R27.nxml.txt.nlp	20462431	SENT190	13	13	5	5	trastuzumab	HER2	PA451743	2064	0.838
NULL	Br_J_Cancer_2006_Dec_4_95(11)_1483-1489.nxml.txt.nlp	17106442	SENT155	11	11	24	24	gefitinib	EGFR	PA131301952	1956	0.838
NULL	Bone_Marrow_Res_2011_Mar_2_2011_924058.nxml.txt.nlp	22046572	SENT150	21	21	33	33	melphalan	SCT	PA450354	6343	0.838
NULL	Int_J_Mol_Sci_2014_Sep_30_15(10)_17686-17704.nxml.txt.nlp	25272226	SENT87	13	13	25	25	cetuximab	PIGF	PA10040	5281	0.838
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT110	16	16	6	6	perifosine	TRAIL	PA165291471	8743	0.838
NULL	Breast_Cancer_Res_2007_Aug_8_9(4)_R50.nxml.txt.nlp	17686159	SENT257	33	33	7	7	gefitinib	HRG	PA131301952	3084;3273	0.838
NULL	Hum_Genomics_2009_Dec_1_4(2)_91-106.nxml.txt.nlp	20038497	SENT120	46	46	35	35	donepezil	CYP3A4	PA449394	1576	0.838
NULL	Biochemistry_2008_Aug_19_47(33)_8689-8696.nxml.txt.nlp	18642884	SENT93	16	16	10	10	nadh	GMP	PA164755085	22978	0.838
NULL	Clin_Med_Insights_Circ_Respir_Pulm_Med_2013_Apr_9_7_7-15.nxml.txt.nlp	23641160	SENT73	0	0	6	6	roflumilast	CYP3A4	PA165948052	1576	0.838
NULL	Oncotarget_2014_Feb_7_5(3)_775-787.nxml.txt.nlp	24519956	SENT101	28	28	18	18	docetaxel	PC3	PA449383	57332;7832;5122	0.838
NULL	Front_Neurosci_2014_Feb_25_8_33.nxml.txt.nlp	24616657	SENT125	6	6	22	22	ethanol	ANOVA	PA448073	4858	0.838
NULL	Pharm_Methods_2011_Jul-Sep_2(3)_173-177.nxml.txt.nlp	23781451	SENT25	17	17	9	9	clopidogrel	ADP	PA449053	23038	0.838
NULL	Cell_Cycle_2012_Nov_1_11(21)_3983-3996.nxml.txt.nlp	22987153	SENT212	8	8	0	0	cisplatin	DNA2	PA449014	1763	0.838
NULL	Biomed_Res_Int_2013_Dec_30_2013_737264.nxml.txt.nlp	23509769	SENT106	13	13	3	3	curcumin	SNK	PA151958596	10769	0.838
NULL	Int_Clin_Psychopharmacol_2014_Jul_26_29(4)_206-211.nxml.txt.nlp	24374906	SENT74	11	11	13	13	venlafaxine	CYP3A4	PA451866	1576	0.838
NULL	Bioinformation_2012_Jan_6_8(1)_13-19.nxml.txt.nlp	22359429	SENT89	3	3	6	6	curcumin	MRP1	PA151958596	4437	0.838
NULL	Cancer_Immunol_Immunother_2015_Oct_7_64_61-73.nxml.txt.nlp	25287778	SENT221	16	16	0	0	lenalidomide	IL-2	PA162363968	3558	0.838
NULL	Mol_Cell_Biochem_2013_Jul_20_383(1-2)_95-102.nxml.txt.nlp	23873331	SENT8	22	22	11	11	resveratrol	CYP1B1		1545	0.838
NULL	Mol_Pain_2012_Sep_24_8_73.nxml.txt.nlp	23006841	SENT10	40	40	29	29	ketoconazole	TRPV1	PA450146	7442	0.838
NULL	J_Cell_Mol_Med_2014_Dec_9_18(12)_2499-2511.nxml.txt.nlp	24912879	SENT298	6	6	0	0	docetaxel	DACH1	PA449383	1602	0.838
NULL	Clin_Dev_Immunol_2013_May_23_2013_575936.nxml.txt.nlp	23762093	SENT110	4	4	13	13	denosumab	RANKL	PA166048634	8600	0.838
NULL	Mol_Biol_Evol_2013_Feb_27_30(2)_448-456.nxml.txt.nlp	23104081	SENT202	13	13	7	7	doxycycline	LCB2	PA449415	9517	0.838
NULL	Diabetes_2009_Jul_28_58(7)_1518-1525.nxml.txt.nlp	19401427	SENT290	23	23	12	12	rosuvastatin	LOX-1	PA134308647	4973	0.838
NULL	Cancer_Causes_Control_2013_Aug_18_24(8)_1605-1614.nxml.txt.nlp	23775025	SENT243	31	31	19	19	cyclophosphamide	GSTA1	PA449165	2938	0.838
NULL	Breast_Cancer_Res_2004_May_18_6(4)_148-152.nxml.txt.nlp	15217485	SENT69	38	38	21	21	tamoxifen	aromatase	PA451581	1588	0.838
NULL	Int_J_Nanomedicine_2012_Sep_21_7_5091-5106.nxml.txt.nlp	23049256	SENT98	10	10	4	4	phenol	SOD1	PA450913	6647	0.838
NULL	Oncol_Lett_2013_Mar_11_5(3)_1010-1016.nxml.txt.nlp	23426784	SENT106	25	25	29	29	midazolam	TRPM7	PA450496	54822	0.838
NULL	Evid_Based_Complement_Alternat_Med_2013_Aug_22_2013_423164.nxml.txt.nlp	24027594	SENT196	19	19	7	7	berberine	AP-1	PA165860812	2353;3727;2354;3725	0.838
NULL	Iran_J_Pharm_Res_2015_Winter_14(1)_77-87.nxml.txt.nlp	25561914	SENT225	8	8	2	2	carbamazepine	BIC	PA448785	114614	0.838
NULL	Breast_Cancer_Res_2007_Aug_8_9(4)_R50.nxml.txt.nlp	17686159	SENT262	20	20	11	11	gefitinib	HRG	PA131301952	3084;3273	0.838
NULL	Neural_Plast_2012_May_20_2012_124548.nxml.txt.nlp	22685676	SENT105	2	2	6	6	minocycline	FMR1	PA450519	2332	0.838
NULL	Diabetes_2008_Sep_57(9)_2272-2279.nxml.txt.nlp	18519799	SENT135	4	4	21	21	rosiglitazone	PDK2	PA451283	5164	0.838
NULL	Breast_Cancer_Res_Treat_2014_Apr_9_145(1)_73-82.nxml.txt.nlp	24715380	SENT2	18	18	6	6	tamoxifen	CXCL10	PA451581	3627	0.838
NULL	Bone_Joint_Res_2014_Mar_1_3(3)_51-59.nxml.txt.nlp	24615710	SENT111	23	23	10	10	resveratrol	SIRT1		23411	0.838
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT76	3	3	6	6	resveratrol	SRC3		8202	0.838
NULL	Acta_Pharmacol_Sin_2011_Feb_4_32(2)_259-269.nxml.txt.nlp	21293479	SENT124	1	1	14	14	irinotecan	IL-3	PA450085	3562	0.838
NULL	Acta_Pharmacol_Sin_2009_Sep_24_30(9)_1323-1329.nxml.txt.nlp	19701237	SENT184	12	12	2	2	clarithromycin	CYP3A	PA449028	1574	0.838
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT168	2	2	4	4	tacrolimus	RANKL	PA451578	8600	0.838
NULL	Int_J_Endocrinol_Metab_2013_Jul_1_Summer_11(3)_184-190.nxml.txt.nlp	24348591	SENT173	0	0	7	7	liraglutide	GLP-1	PA165958364	100125288	0.838
NULL	Front_Pharmacol_2014_May_27_5_123.nxml.txt.nlp	24904424	SENT101	19	19	13	13	thrombin	PAR1	PA451674	79581;2149	0.838
NULL	Mol_Cancer_2010_Nov_8_9_291.nxml.txt.nlp	21059223	SENT150	26	26	6	6	paclitaxel	Bcl-2	PA450761	596	0.838
NULL	Infect_Agent_Cancer_2012_Apr_19_7(Suppl_1)_P32.nxml.txt.nlp	NULL	SENT7	9	9	20	20	nelfinavir	ATF4	PA450606	468	0.838
NULL	Cancers_(Basel)_2014_Mar_26_6(2)_708-722.nxml.txt.nlp	24675568	SENT62	2	2	10	10	niclosamide	STAT3	PA165958408	6774	0.838
NULL	Curr_Cardiol_Rev_2009_May_5(2)_125-132.nxml.txt.nlp	20436853	SENT96	38	38	34	34	clopidogrel	ADP	PA449053	23038	0.838
NULL	Nucleic_Acids_Res_2012_Jul_19_40(13)_5910-5925.nxml.txt.nlp	22434882	SENT344	14	14	21	21	etoposide	p53	PA449552	7157	0.838
NULL	Br_J_Cancer_2012_Sep_4_107(6)_947-955.nxml.txt.nlp	22892392	SENT180	19	19	3	3	lapatinib	BCAR4	PA152241907	400500	0.838
NULL	Oncologist_2011_Mar_25_16(3)_296-309.nxml.txt.nlp	21355020	SENT179	10	10	8	8	thyroglobulin	TPO	PA164754910	7066;7173	0.838
NULL	Am_J_Cardiovasc_Drugs_2013_Jun_20_13(5)_331-342.nxml.txt.nlp	23784266	SENT223	27	27	16	16	clarithromycin	P-gp	PA449028	5243	0.838
NULL	Cell_Death_Dis_2014_Apr_17_5(4)_e1182.nxml.txt.nlp	24743737	SENT226	4	4	2	2	capsaicin	TRPV1	PA448776	7442	0.838
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2011_Mar_14_4_13-24.nxml.txt.nlp	22879790	SENT138	21	21	28	28	liraglutide	PPG	PA165958364	5552	0.838
NULL	Mol_Cancer_2010_May_18_9_110.nxml.txt.nlp	20482802	SENT29	20	20	10	10	bortezomib	HSP27	PA10252	3315	0.838
NULL	Eur_J_Clin_Pharmacol_2010_Jun_31_66(6)_579-590.nxml.txt.nlp	20354687	SENT291	14	14	4	4	tacrolimus	CYP3A5	PA451578	1577	0.838
NULL	J_Cell_Biol_2008_Jan_28_180(2)_341-355.nxml.txt.nlp	18209102	SENT471	6	6	19	19	flavopiridol	Mcl-1	PA452627	4170	0.838
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT413	13	13	4	4	cetuximab	KRAS	PA10040	3845	0.838
NULL	Drug_Des_Devel_Ther_2014_Oct_6_8_1723-1731.nxml.txt.nlp	25336916	SENT134	5	5	21	21	valsartan	CLCR	PA451848	11330	0.838
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1986-2011.nxml.txt.nlp	25268165	SENT569	1	1	16	16	resveratrol	STAT3		6774	0.838
NULL	Islets_2013_Jan_1_5(1)_22-28.nxml.txt.nlp	23514967	SENT143	21	21	40	40	collagenase	CO2	PA449107	4513	0.838
NULL	Indian_J_Med_Res_2013_Jan_137(1)_102-110.nxml.txt.nlp	23481058	SENT146	17	17	31	31	oxygen	HIF-1	PA450744	29072	0.838
NULL	Mol_Pain_2013_Jun_10_9_27.nxml.txt.nlp	23758830	SENT63	0	0	2	2	tetracaine	ASIC3	PA451638	9311	0.838
NULL	BMB_Rep_2014_Jan_47(1)_33-38.nxml.txt.nlp	24209634	SENT70	18	18	9	9	cisplatin	CXCR4	PA449014	7852	0.838
NULL	Aging_(Albany_NY)_2009_Mar_31_1(4)_412-424.nxml.txt.nlp	20195491	SENT128	13	13	11	11	resveratrol	TXNIP		10628	0.838
NULL	J_Adv_Pract_Oncol_2012_May_1_May-Jun_3(3)_138-150.nxml.txt.nlp	25031940	SENT317	2	2	14	14	tetracycline	EGFR	PA451640	1956	0.838
NULL	Nat_Neurosci_2012_Jun_15(6)_845-852.nxml.txt.nlp	22522402	SENT239	17	17	31	31	paraformaldehyde	PSD95	PA450790	1742	0.838
NULL	Br_J_Cancer_1998_May_77(10)_1562-1567.nxml.txt.nlp	9635829	SENT11	18	18	12	12	cisplatin	p53	PA449014	7157	0.838
NULL	Oncotarget_2014_Oct_21_5(22)_11709-11722.nxml.txt.nlp	25365944	SENT120	10	10	15	15	metformin	JNK	PA450395	5599	0.838
NULL	Anticancer_Agents_Med_Chem_2012_Feb_12(2)_163-171.nxml.txt.nlp	22043994	SENT174	37	37	31	31	cetuximab	BRAF	PA10040	673	0.838
NULL	Cell_J_2012_Dec_22_Winter_13(4)_281-289.nxml.txt.nlp	23507624	SENT171	20	20	4	4	isoproterenol	IFN	PA450121	3439	0.838
NULL	Arthritis_Res_Ther_2012_Nov_8_14(Suppl_5)_S1.nxml.txt.nlp	23281743	SENT220	11	11	19	19	rituximab	CD19	PA451261	930	0.838
NULL	Mol_Med_Rep_2015_Jan_22_11(1)_83-90.nxml.txt.nlp	25338529	SENT155	6	6	4	4	octreotide	HO-1	PA450678	3162	0.838
NULL	Chem_Rev_2011_Oct_12_111(10)_6387-6422.nxml.txt.nlp	21942574	SENT306	31	31	41	41	celecoxib	TRAIL	PA448871	8743	0.838
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT84	12	12	22	22	atorvastatin	IL-6	PA448500	3569	0.838
NULL	J_Hematol_Oncol_2009_Apr_22_2_18.nxml.txt.nlp	19386128	SENT112	32	32	16	16	irinotecan	EGFR	PA450085	1956	0.838
NULL	J_Biomed_Sci_2014_Apr_29_21(1)_35.nxml.txt.nlp	24780003	SENT48	34	34	24	24	bevacizumab	VEGF-A	PA130232992	7422	0.838
NULL	Oncoscience_2014_Jan_30_1(1)_57-68.nxml.txt.nlp	25593988	SENT215	15	15	1	1	imatinib	TNFSF10	PA10804	8743	0.838
NULL	Br_J_Cancer_2013_Sep_3_109(5)_1279-1286.nxml.txt.nlp	23949154	SENT253	16	16	35	35	flutamide	PC-3	PA449685	692094	0.838
NULL	J_Geriatr_Cardiol_2012_Jun_9(2)_180-184.nxml.txt.nlp	22916066	SENT4	40	40	13	13	rosuvastatin	Rho	PA134308647	29984	0.838
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT101	15	15	17	17	curcumin	TRAIL	PA151958596	8743	0.838
NULL	Physiol_Rep_2014_Sep_28_2(9)_e12160.nxml.txt.nlp	25263209	SENT10	0	0	3	3	capsaicin	TRPV1	PA448776	7442	0.838
NULL	Nucleic_Acids_Res_2011_Dec_31_39(22)_9536-9548.nxml.txt.nlp	21880590	SENT175	27	27	15	15	etoposide	PDE4DIP	PA449552	9659	0.838
NULL	J_Am_Heart_Assoc_2013_Dec_19_2(6)_e000441.nxml.txt.nlp	24252844	SENT300	18	18	12	12	methotrexate	gamma	PA450428	9913	0.838
NULL	J_Cardiothorac_Surg_2011_Oct_14_6_138.nxml.txt.nlp	21999189	SENT33	6	6	22	22	protamine	TA1	PA10366	134864	0.838
NULL	Biomed_Res_Int_2013_Jul_31_2013_692071.nxml.txt.nlp	23984399	SENT21	41	41	9	9	sorafenib	OCT1	PA7000	5451;6580	0.838
NULL	Clin_Psychopharmacol_Neurosci_2013_Dec_24_11(3)_144-151.nxml.txt.nlp	24465251	SENT44	9	9	23	23	quetiapine	IL-2	PA451201	3558	0.838
NULL	Cell_Microbiol_2014_Apr_6_16(4)_519-534.nxml.txt.nlp	24152255	SENT78	11	11	6	6	glucosamine	DC-SIGN	PA164747613	30835	0.838
NULL	Oncotarget_2014_Mar_11_5(4)_901-907.nxml.txt.nlp	24658650	SENT111	21	21	27	27	methotrexate	DHFR	PA450428	1719	0.838
NULL	Breast_Cancer_Res_Treat_2014_Nov_11_148(3)_563-570.nxml.txt.nlp	25385180	SENT24	7	7	11	11	trastuzumab	PTH	PA451743	5741	0.838
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1150.nxml.txt.nlp	24675468	SENT97	41	41	24	24	metformin	AMPK	PA450395	5563	0.838
NULL	Jpn_Clin_Med_2014_Sep_17_5_33-41.nxml.txt.nlp	25288908	SENT165	10	10	17	17	liraglutide	GLP-1	PA165958364	100125288	0.838
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT110	9	9	2	2	imatinib	ABCB1	PA10804	5243	0.838
NULL	Br_J_Pharmacol_2008_Sep_9_155(1)_127-137.nxml.txt.nlp	18536750	SENT185	8	8	3	3	piroxicam	IL-10	PA450985	3586	0.838
NULL	Open_Med_Chem_J_2012_May_17_6_1-14.nxml.txt.nlp	22876271	SENT43	25	25	22	22	sr144528	CB2		1269	0.838
NULL	J_Adv_Pract_Oncol_2012_Jan_1_Jan-Feb_3(1)_49-54.nxml.txt.nlp	25031928	SENT76	14	14	20	20	plerixafor	CD34	PA165958410	947	0.838
NULL	Int_J_Mol_Sci_2014_Nov_7_15(11)_20500-20517.nxml.txt.nlp	25387078	SENT127	3	3	9	9	vorinostat	Mcl-1	PA164748224	4170	0.838
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT91	15	15	24	24	l-leucine	p27	PA450197	5715;10534	0.838
NULL	Eur_J_Med_Res_2009_Nov_24_14(Suppl_3)_5-16.nxml.txt.nlp	19959411	SENT222	32	32	40	40	raltegravir	N155		9631	0.838
NULL	Br_J_Haematol_2008_Jun_141(5)_659-671.nxml.txt.nlp	18410446	SENT40	4	4	12	12	cerulenin	San	PA164764551	80218	0.838
NULL	Int_J_Mol_Sci_2014_Nov_21_15(11)_21505-21537.nxml.txt.nlp	25421245	SENT213	26	26	35	35	lipase	UCP3	PA450239	7352	0.838
NULL	Lancet_2011_Jun_9_377(9784)_2181-2192.nxml.txt.nlp	21663949	SENT124	38	38	16	16	ezetimibe	SHARP	PA10816	23013	0.838
NULL	Neural_Regen_Res_2013_Sep_25_8(27)_2573-2580.nxml.txt.nlp	25206568	SENT157	30	30	46	46	l-glutamine	CO2	PA10090	4513	0.838
NULL	Cancer_Cell_Int_2013_Jun_26_13_63.nxml.txt.nlp	23800022	SENT115	24	24	5	5	genistein	ATF3	PA165109660	467	0.838
NULL	Acta_Pharmacol_Sin_2010_Jan_5_31(1)_93-101.nxml.txt.nlp	20048748	SENT116	12	12	4	4	cisplatin	DAPK	PA449014	1612	0.838
NULL	Front_Endocrinol_(Lausanne)_2014_Dec_23_5_224.nxml.txt.nlp	25566194	SENT214	19	19	12	12	erlotinib	survivin	PA134687924	332	0.838
NULL	J_Biol_Chem_2008_May_23_283(21)_14845-14856.nxml.txt.nlp	18356157	SENT85	9	9	18	18	paraformaldehyde	SNAP45	PA450790	6618	0.838
NULL	Ann_Saudi_Med_2009_Jul-Aug_29(4)_288-293.nxml.txt.nlp	19584580	SENT121	15	15	1	1	trastuzumab	HER2	PA451743	2064	0.838
NULL	Ann_Lab_Med_2012_Jul_20_32(4)_270-275.nxml.txt.nlp	22779068	SENT105	17	17	35	35	cefotaxime	ACC-1	PA448852	597	0.838
NULL	Cell_Death_Dis_2010_Nov_18_1(11)_e101.nxml.txt.nlp	21368866	SENT278	14	14	1	1	cisplatin	PC3	PA449014	57332;7832;5122	0.838
NULL	Target_Oncol_2010_Jun_14_5(2)_95-112.nxml.txt.nlp	20625845	SENT237	4	4	14	14	sorafenib	FDG	PA7000	23583	0.838
NULL	Clin_Sci_(Lond)_2013_Feb_1_124(Pt_3)_153-164.nxml.txt.nlp	23075334	SENT669	12	12	5	5	resveratrol	AMPK		5563	0.838
NULL	Curr_Pain_Headache_Rep_2011_Aug_12_15(4)_271-279.nxml.txt.nlp	21479998	SENT130	2	2	7	7	fentanyl	CYP3A4	PA449599	1576	0.838
NULL	Clin_Ophthalmol_2011_Apr_18_5_495-502.nxml.txt.nlp	21573098	SENT117	12	12	26	26	gatifloxacin	BAK	PA449738	578	0.838
NULL	Oncol_Rep_2014_Apr_28_31(4)_1605-1612.nxml.txt.nlp	24481648	SENT174	6	6	19	19	ponatinib	MRP7	PA165980594	89845;1080	0.838
NULL	Acta_Pharmacol_Sin_2012_Jan_28_33(1)_66-74.nxml.txt.nlp	22120966	SENT239	2	2	15	15	genistein	RANKL	PA165109660	8600	0.838
NULL	Breast_Cancer_Res_2011_May_26_13(3)_209.nxml.txt.nlp	21635709	SENT157	26	26	6	6	tamoxifen	HER2	PA451581	2064	0.838
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT151	14	14	9	9	sulindac	survivin	PA451565	332	0.838
NULL	Br_J_Cancer_2011_Jul_12_105(2)_189-193.nxml.txt.nlp	21694726	SENT48	12	12	14	14	tamoxifen	ATAC	PA451581	6375	0.838
NULL	Biomed_Res_Int_2014_Aug_6_2014_967826.nxml.txt.nlp	25165721	SENT86	0	0	3	3	resveratrol	SIRT1		23411	0.838
NULL	Int_J_Biochem_Cell_Biol_2013_Feb_45(2)_283-291.nxml.txt.nlp	23085378	SENT12	3	3	19	19	finasteride	aromatase	PA449627	1588	0.838
NULL	Int_J_Mol_Sci_2014_Sep_30_15(10)_17686-17704.nxml.txt.nlp	25272226	SENT92	7	7	9	9	cetuximab	VEGF-A	PA10040	7422	0.838
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT175	5	5	10	10	curcumin	PC-3	PA151958596	692094	0.838
NULL	Cancers_(Basel)_2012_Oct_29_4(4)_1146-1160.nxml.txt.nlp	24213502	SENT183	26	26	28	28	raloxifene	aromatase	PA451221	1588	0.838
NULL	Breast_Cancer_Res_2008_Dec_5_10(6)_R104.nxml.txt.nlp	19061505	SENT231	12	12	37	37	ethanol	JNK	PA448073	5599	0.838
NULL	Exp_Neurobiol_2013_Mar_31_22(1)_1-10.nxml.txt.nlp	23585716	SENT108	16	16	11	11	scopolamine	spatial	PA451308	219793	0.838
NULL	Breast_Cancer_Res_2011_Nov_1_13(6)_224.nxml.txt.nlp	22114931	SENT91	37	37	19	19	tamoxifen	PTEN	PA451581	5728	0.838
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT213	8	8	2	2	cisplatin	p38	PA449014	10598;1432;7965	0.838
NULL	Int_J_Breast_Cancer_2011_Aug_23_2011_420981.nxml.txt.nlp	22295222	SENT134	4	4	22	22	chloroquine	CXCR4	PA448948	7852	0.838
NULL	Oncol_Lett_2014_May_11_7(5)_1401-1408.nxml.txt.nlp	24765145	SENT162	6	6	14	14	paclitaxel	PI3K	PA450761	5290	0.838
NULL	J_Int_AIDS_Soc_2010_Nov_8_13(Suppl_4)_P75.nxml.txt.nlp	NULL	SENT14	5	5	41	41	stavudine	adiponectin	PA451494	9370	0.838
NULL	Gynecol_Oncol_Case_Rep_2013_Dec_28_8_4-6.nxml.txt.nlp	24567884	SENT83	6	6	4	4	irinotecan	NAC	PA450085	22861	0.838
NULL	Sci_Rep_2015_Jan_6_5_7642.nxml.txt.nlp	25560837	SENT560	6	6	3	3	rimonabant	CB1	PA152407999	1268	0.838
NULL	Allergy_2014_Sep_16_69(9)_1189-1197.nxml.txt.nlp	24931417	SENT49	17	17	0	0	fluorescein	ASM	PA164746009	6609;283120	0.838
NULL	Pan_Afr_Med_J_2012_May_6_12_5.nxml.txt.nlp	22826730	SENT45	18	18	12	12	vincristine	CHOP	PA451879	1649	0.838
NULL	Oncoimmunology_2013_Dec_1_2(12)_e27090.nxml.txt.nlp	24501689	SENT143	12	12	25	25	curcumin	STAT3	PA151958596	6774	0.838
NULL	Bioimpacts_2014_Feb_27_4(1)_21-27.nxml.txt.nlp	24790895	SENT147	16	16	22	22	isoproterenol	ANOVA	PA450121	4858	0.838
NULL	Chin_J_Cancer_2011_Oct_30(10)_655-668.nxml.txt.nlp	21959043	SENT196	17	17	33	33	thalidomide	PTEN	PA451644	5728	0.838
NULL	Exp_Mol_Med_2012_Feb_29_44(2)_159-166.nxml.txt.nlp	22127053	SENT74	21	21	14	14	simvastatin	Rho	PA451363	29984	0.838
NULL	Case_Rep_Oncol_2013_Mar_29_6(1)_189-196.nxml.txt.nlp	23626560	SENT16	15	15	21	21	erlotinib	EGFR	PA134687924	1956	0.838
NULL	Amino_Acids_2011_May_22_40(5)_1369-1383.nxml.txt.nlp	21424716	SENT274	4	4	16	16	creatine	CEE	PA164778930	51608	0.838
NULL	Lab_Invest_2011_Apr_14_91(4)_598-608.nxml.txt.nlp	21321535	SENT129	6	6	10	10	sorafenib	CD25	PA7000	3669;3559	0.838
NULL	Oncotarget_2013_Nov_7_4(12)_2550-2566.nxml.txt.nlp	24334291	SENT220	3	3	23	23	chlorambucil	CHOP	PA448926	1649	0.838
NULL	Nat_Neurosci_2013_Dec_27_16(12)_1745-1753.nxml.txt.nlp	24162653	SENT228	11	11	1	1	trypsin	E16	PA451806	8140	0.838
NULL	Br_J_Cancer_2006_Feb_13_94(3)_407-426.nxml.txt.nlp	16434996	SENT124	27	27	9	9	genistein	BRCA1	PA165109660	672	0.838
NULL	Breast_Cancer_Res_Treat_2013_Apr_12_138(2)_427-435.nxml.txt.nlp	23479422	SENT151	8	8	14	14	trastuzumab	HER2	PA451743	2064	0.838
NULL	Mol_Vis_2007_Jan_24_13_57-65.nxml.txt.nlp	17277739	SENT54	22	22	28	28	heparin	FGF2	PA449855	2247;2258	0.838
NULL	Cancer_Res_Treat_2013_Mar_31_45(1)_63-69.nxml.txt.nlp	23613672	SENT126	5	5	21	21	cisplatin	ERCC1	PA449014	2067	0.838
NULL	Tuberc_Respir_Dis_(Seoul)_2013_Nov_29_75(5)_188-198.nxml.txt.nlp	24348666	SENT102	6	6	3	3	crizotinib	Met	PA165946122	79811	0.838
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1554-1562.nxml.txt.nlp	21970876	SENT137	3	3	27	27	gemcitabine	EGFR	PA449748	1956	0.838
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT43	15	15	26	26	trastuzumab	HER2	PA451743	2064	0.838
NULL	Biol_Proced_Online_2003_Feb_17_5_1-12.nxml.txt.nlp	12734561	SENT217	12	12	26	26	ethanol	CYP2E1	PA448073	1571	0.838
NULL	J_Korean_Med_Sci_2010_Feb_19_25(2)_240-244.nxml.txt.nlp	20119577	SENT16	17	17	4	4	vincristine	NAC	PA451879	22861	0.838
NULL	Aging_(Albany_NY)_2013_Feb_21_5(2)_94-95.nxml.txt.nlp	23518473	SENT24	5	5	17	17	resveratrol	SIRT1		23411	0.838
NULL	Oncoimmunology_2013_Oct_1_2(10)_e27025.nxml.txt.nlp	24353914	SENT179	12	12	26	26	vinorelbine	CD4	PA451881	920	0.838
NULL	Front_Neuroenergetics_2014_Jan_9_5_13.nxml.txt.nlp	24409143	SENT339	4	4	11	11	isoflurane	FDG	PA450106	23583	0.838
NULL	Br_J_Cancer_2011_Sep_27_105(7)_945-952.nxml.txt.nlp	21863030	SENT93	20	20	0	0	sorafenib	SHARP	PA7000	23013	0.838
NULL	Int_J_Biol_Sci_2011_May_24_7(5)_673-684.nxml.txt.nlp	21647250	SENT141	24	24	7	7	berberine	AMPK	PA165860812	5563	0.838
NULL	Blood_Cancer_J_2013_Dec_6_3(12)_e167.nxml.txt.nlp	24317089	SENT129	2	2	13	13	lovastatin	PERK	PA450272	9451	0.838
NULL	Mol_Vis_2011_Aug_11_17_2157-2170.nxml.txt.nlp	21850191	SENT228	21	21	17	17	tacrolimus	p50	PA451578	958;4790	0.838
NULL	EMBO_Mol_Med_2010_Feb_2(2)_39-41.nxml.txt.nlp	20112249	SENT29	19	19	0	0	furosemide	NKCC2	PA449719	6557	0.838
NULL	Acta_Pharmacol_Sin_2014_Jul_9_35(7)_889-898.nxml.txt.nlp	24909515	SENT223	15	15	20	20	bromocriptine	SULT1A1	PA448671	6817	0.838
NULL	Arthritis_Res_Ther_2014_Apr_11_16(2)_R93.nxml.txt.nlp	24725461	SENT161	22	22	10	10	letrozole	aromatase	PA450196	1588	0.838
NULL	Br_J_Cancer_2009_Jul_21_101(2)_269-277.nxml.txt.nlp	19603033	SENT99	2	2	5	5	cisplatin	XIAP	PA449014	331	0.838
NULL	Mol_Cancer_2012_Jul_12_11_45.nxml.txt.nlp	22788833	SENT24	4	4	7	7	cisplatin	EGFR	PA449014	1956	0.838
NULL	Lipids_Health_Dis_2011_Jan_18_10_8.nxml.txt.nlp	21241519	SENT33	7	7	30	30	simvastatin	ABCB4	PA451363	5244	0.838
NULL	Breast_Cancer_Res_2006_Jul_25_8(4)_R48.nxml.txt.nlp	16869955	SENT33	16	16	6	6	cyclophosphamide	p53	PA449165	7157	0.838
NULL	Oncoscience_2014_Oct_22_1(10)_614-623.nxml.txt.nlp	25593991	SENT109	28	28	13	13	vemurafenib	BRAF	PA165946873	673	0.838
NULL	Cell_Commun_Signal_2009_Oct_27_7_25.nxml.txt.nlp	19860902	SENT247	2	2	20	20	trifluoperazine	IL-2	PA451771	3558	0.838
NULL	J_Immunother_Cancer_2014_Dec_16_2(1)_46.nxml.txt.nlp	NULL	SENT218	20	20	31	31	l-glutamine	B27	PA10090	56246	0.838
NULL	Clin_Interv_Aging_2014_Apr_8_9_593-601.nxml.txt.nlp	24748777	SENT79	10	10	17	17	denosumab	RANKL	PA166048634	8600	0.838
NULL	Mol_Vis_2012_Oct_5_18_2454-2467.nxml.txt.nlp	23077404	SENT183	12	12	16	16	bevacizumab	VEGF-A	PA130232992	7422	0.838
NULL	ACS_Med_Chem_Lett_2011_May_16_2(7)_549-554.nxml.txt.nlp	21765967	SENT141	0	0	19	19	maraviroc	CCR5	PA164768835	1234	0.838
NULL	Behav_Neurol_2014_Nov_16_2014_360978.nxml.txt.nlp	25477708	SENT99	25	25	19	19	nicotine	P56	PA450626	8999	0.838
NULL	Hum_Genomics_2010_Apr_1_4(4)_238-249.nxml.txt.nlp	20511137	SENT49	24	24	30	30	atazanavir	UGT1A1	PA10251	54658	0.838
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Jul_23_3(7)_e126.nxml.txt.nlp	25054314	SENT154	10	10	15	15	telmisartan	SLCO1B3	PA451605	28234	0.838
NULL	J_Carcinog_2014_Jun_30_13_8.nxml.txt.nlp	25191136	SENT161	16	16	24	24	bevacizumab	HER2	PA130232992	2064	0.838
NULL	Diabetologia_2010_Jul_2_53(7)_1270-1287.nxml.txt.nlp	20361178	SENT273	0	0	28	28	pioglitazone	adiponectin	PA450970	9370	0.838
NULL	Bioimpacts_2014_May_28_4(2)_75-81.nxml.txt.nlp	25035850	SENT6	3	3	27	27	methacholine	IL-4	PA165958382	3565	0.838
NULL	J_Mol_Med_(Berl)_2014_May_10_92(7)_709-722.nxml.txt.nlp	24811491	SENT105	15	15	23	23	panitumumab	PIK3CA	PA162373091	5290	0.838
NULL	Lab_Invest_2011_Apr_14_91(4)_598-608.nxml.txt.nlp	21321535	SENT191	2	2	27	27	sunitinib	IFN	PA162372840	3439	0.838
NULL	Iran_J_Public_Health_2012_Mar_31_41(3)_127-132.nxml.txt.nlp	23113157	SENT86	6	6	20	20	nitrofurantoin	CTX	PA450640	1593	0.838
NULL	Aliment_Pharmacol_Ther_2012_Apr_22_35(7)_745-767.nxml.txt.nlp	22356640	SENT292	10	10	38	38	tegaserod	5-HT4	PA130413154	3360	0.838
NULL	Indian_J_Pharmacol_2013_Mar-Apr_45(2)_121-125.nxml.txt.nlp	23716885	SENT40	3	3	23	23	aripiprazole	CYP3A4	PA10026	1576	0.838
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT355	42	42	4	4	ziprasidone	PRL	PA451974	5617	0.838
NULL	Oncoimmunology_2014_May_29_3_e28925.nxml.txt.nlp	25083322	SENT42	27	27	13	13	imatinib	CD4	PA10804	920	0.838
NULL	Cancers_(Basel)_2010_Dec_22_2(4)_2153-2170.nxml.txt.nlp	21390244	SENT256	7	7	10	10	erlotinib	EGFR	PA134687924	1956	0.838
NULL	Cancer_Cell_Int_2013_Jun_17_13_61.nxml.txt.nlp	23773282	SENT230	8	8	16	16	nelfinavir	TRAIL	PA450606	8743	0.838
NULL	J_Lipids_2011_Jan_13_2011_565316.nxml.txt.nlp	21490804	SENT118	5	5	29	29	vorinostat	PERK	PA164748224	9451	0.838
NULL	Cancers_(Basel)_2014_Aug_12_6(3)_1631-1669.nxml.txt.nlp	25119536	SENT439	3	3	5	5	imatinib	Met	PA10804	79811	0.838
NULL	J_Biol_Chem_2013_Nov_15_288(46)_33049-33059.nxml.txt.nlp	24089524	SENT253	7	7	14	14	nicotine	GATA4	PA450626	2626	0.838
NULL	Indian_J_Endocrinol_Metab_2012_May-Jun_16(3)_343-348.nxml.txt.nlp	22629497	SENT28	33	33	5	5	teriparatide	PTH	PA451620	5741	0.838
NULL	Oncologist_2010_Mar_9_15(3)_236-245.nxml.txt.nlp	20215359	SENT10	16	16	9	9	sorafenib	VEGFR	PA7000	3791	0.838
NULL	Toxins_(Basel)_2010_Oct_26_2(11)_2490-2518.nxml.txt.nlp	22069563	SENT62	2	2	5	5	cimetidine	OCT2	PA449001	6582;5452	0.838
NULL	Int_J_Mol_Sci_2014_Nov_25_15(12)_21621-21630.nxml.txt.nlp	25429425	SENT327	4	4	15	15	sunitinib	CD133	PA162372840	8842	0.838
NULL	Nat_Chem_Biol_2010_Jun_9_6(6)_424-432.nxml.txt.nlp	20453863	SENT317	13	13	27	27	dantrolene	LAMP2	PA449208	3920	0.838
NULL	Med_Sci_Monit_2012_Jul_1_18(7)_CS57-CS62.nxml.txt.nlp	22739739	SENT103	35	35	10	10	sulfapyridine	CYP2C9	PA164779050	1559	0.838
NULL	Int_J_Med_Sci_2013_Mar_19_10(5)_599-606.nxml.txt.nlp	23569422	SENT80	7	7	25	25	propofol	HO-1	PA451141	3162	0.838
NULL	J_Inflamm_(Lond)_2008_Jul_29_5_11.nxml.txt.nlp	18664275	SENT101	16	16	6	6	ciprofloxacin	IL-8	PA449009	3576	0.838
NULL	Pharmaceutics_2011_Feb_7_3(1)_53-72.nxml.txt.nlp	24310425	SENT220	6	6	9	9	midazolam	CYP3A4	PA450496	1576	0.838
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT111	23	23	12	12	neratinib	HER2	PA165291472	2064	0.838
NULL	Adv_Hematol_2012_Sep_14_2012_524308.nxml.txt.nlp	21941553	SENT310	9	9	27	27	cyclophosphamide	BCL2	PA449165	596	0.838
NULL	J_Cell_Mol_Med_2013_Oct_23_17(10)_1207-1217.nxml.txt.nlp	24106980	SENT139	9	9	33	33	paclitaxel	p38	PA450761	10598;1432;7965	0.838
NULL	Biol_Open_2013_Apr_9_2(6)_535-545.nxml.txt.nlp	23789104	SENT130	19	19	12	12	arsenite	p38	PA452638	10598;1432;7965	0.838
NULL	Biomed_Res_Int_2014_Jan_20_2014_948427.nxml.txt.nlp	24563867	SENT80	14	14	19	19	urea	STZ	PA451831	6484	0.838
NULL	Mol_Cancer_2009_Dec_23_8_129.nxml.txt.nlp	20030852	SENT183	5	5	12	12	curcumin	survivin	PA151958596	332	0.838
NULL	Cell_Commun_Signal_2009_Feb_26_7(Suppl_1)_A63.nxml.txt.nlp	NULL	SENT19	28	28	33	33	pp2	GRHL3		57822	0.838
NULL	Case_Rep_Hematol_2014_Feb_6_2014_806541.nxml.txt.nlp	24649385	SENT72	16	16	3	3	azathioprine	AAT	PA448515	5265	0.838
NULL	J_Oncol_2013_Feb_17_2013_872957.nxml.txt.nlp	23476648	SENT36	20	20	17	17	cisplatin	SFN	PA449014	25996;2810	0.838
NULL	Front_Oncol_2014_Oct_21_4_285.nxml.txt.nlp	25374842	SENT703	9	9	18	18	nutlin-3	HDM2		4193	0.838
NULL	Br_J_Pharmacol_2014_Jun_15_171(11)_2705-2725.nxml.txt.nlp	24467436	SENT287	8	8	6	6	isoniazid	NAT2	PA450112	10;81539	0.838
NULL	Braz_J_Med_Biol_Res_2014_Oct_24_48(1)_65-76.nxml.txt.nlp	25493385	SENT163	26	26	18	18	l-arginine	AT1	PA448478	9197;185	0.838
NULL	Allergy_Asthma_Clin_Immunol_2011_Nov_14_7(Suppl_2)_A37.nxml.txt.nlp	NULL	SENT14	0	0	19	19	vancomycin	IFN	PA451850	3439	0.838
NULL	Front_Neurosci_2011_Jan_14_4_207.nxml.txt.nlp	21258618	SENT46	14	14	9	9	ethanol	AC7	PA448073	113	0.838
NULL	Ecancermedicalscience_2008_Feb_18_2_75.nxml.txt.nlp	22275966	SENT176	30	30	3	3	irinotecan	AREG	PA450085	374	0.838
NULL	NMR_Biomed_2014_Jul_5_27(7)_760-773.nxml.txt.nlp	24798066	SENT105	14	14	1	1	docetaxel	NACT	PA449383	284111	0.838
NULL	EPMA_J_2011_Sep_24_2(Suppl_1)_143-150.nxml.txt.nlp	NULL	SENT237	39	39	14	14	natalizumab	IFN	PA164747191	3439	0.838
NULL	F1000Res_2014_Aug_19_3_198.nxml.txt.nlp	25400908	SENT202	25	25	13	13	lapatinib	HER2	PA152241907	2064	0.838
NULL	Nucl_Recept_Signal_2014_Nov_4_12_e005.nxml.txt.nlp	25422595	SENT214	13	13	5	5	geldanamycin	p23	PA152031327	10728	0.838
NULL	J_Clin_Biochem_Nutr_2011_Mar_26_48(2)_154-160.nxml.txt.nlp	21373269	SENT11	21	21	5	5	dextran	IRF3	PA449261	3661	0.838
NULL	Drugs_2012_Sep_6_72(9)_e1-e25.nxml.txt.nlp	22686620	SENT1060	6	6	24	24	raltegravir	TRIO		7204	0.838
NULL	Br_J_Cancer_2010_Jun_8_102(12)_1687-1691.nxml.txt.nlp	20485287	SENT157	20	20	25	25	capecitabine	EGFR	PA448771	1956	0.838
NULL	Cell_Biol_Int_Rep_(2010)_2012_Jun_21_19(1)_e00017.nxml.txt.nlp	23124518	SENT135	2	2	19	19	etoposide	TRAIL	PA449552	8743	0.838
NULL	Nat_Commun_2014_Aug_4_5_4535.nxml.txt.nlp	25088745	SENT28	9	9	25	25	metformin	AMPK	PA450395	5563	0.838
NULL	Int_J_Biol_Sci_2012_Oct_25_8(9)_1281-1290.nxml.txt.nlp	23136556	SENT85	40	40	32	32	methacholine	eotaxin	PA165958382	6356	0.838
NULL	Eur_J_Clin_Pharmacol_2011_May_9_67(5)_477-482.nxml.txt.nlp	21305273	SENT29	28	28	11	11	dobutamine	ADRB1	PA449381	153	0.838
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT6	25	25	1	1	methotrexate	MSH2	PA450428	4436	0.838
NULL	Cancer_Imaging_2010_Jul_6_10(1)_144-152.nxml.txt.nlp	20605761	SENT79	22	22	8	8	lapatinib	HER2	PA152241907	2064	0.838
NULL	Breast_Cancer_Res_2008_Dec_18_10(Suppl_4)_S25.nxml.txt.nlp	19128439	SENT23	3	3	11	11	anastrozole	EGFR	PA448432	1956	0.838
NULL	Ann_Thorac_Med_2014_Apr-Jun_9(2)_124-126.nxml.txt.nlp	24791177	SENT77	1	1	35	35	sirolimus	LAM	PA451365	7249;7248	0.838
NULL	Lab_Invest_2010_Oct_28_90(10)_1415-1424.nxml.txt.nlp	20585313	SENT50	14	14	5	5	celecoxib	HRG	PA448871	3084;3273	0.838
NULL	Ann_Gastroenterol_2014_27(3)_250-257.nxml.txt.nlp	24974978	SENT179	16	16	6	6	baclofen	gamma	PA448533	9913	0.838
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT107	14	14	6	6	imatinib	ABCG2	PA10804	9429	0.838
NULL	Indian_J_Med_Res_2013_Jan_137(1)_125-129.nxml.txt.nlp	23481061	SENT22	1	1	17	17	cisplatin	GSTT1	PA449014	2952	0.838
NULL	J_Exp_Med_2003_Aug_4_198(3)_433-442.nxml.txt.nlp	12900519	SENT16	34	34	7	7	methylcholanthrene	IFN	PA165816878	3439	0.838
NULL	Crit_Care_2007_Dec_18_11(6)_178.nxml.txt.nlp	18177510	SENT15	19	19	17	17	terlipressin	AVP	PA164781020	114548;551	0.838
NULL	Clin_Ophthalmol_2012_Sep_7_6_1471-1476.nxml.txt.nlp	23055666	SENT10	18	18	10	10	propofol	NAC	PA451141	22861	0.838
NULL	Breast_Cancer_Res_2007_Jan_23_9(1)_R7.nxml.txt.nlp	17244352	SENT193	8	8	14	14	tamoxifen	SULT1A1	PA451581	6817	0.838
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT225	0	0	22	22	curcumin	MCP-1	PA151958596	6347	0.838
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT281	3	3	8	8	clozapine	PRL	PA449061	5617	0.838
NULL	Autophagy_2013_Mar_1_9(3)_287-302.nxml.txt.nlp	23221969	SENT436	8	8	11	11	fulvestrant	STAT1	PA164747170	6772	0.838
NULL	Interdiscip_Toxicol_2008_Sep_1(2)_160-168.nxml.txt.nlp	21218107	SENT142	9	9	7	7	indomethacin	COX	PA449982	1351	0.838
NULL	Leukemia_2014_Jun_25_28(6)_1280-1288.nxml.txt.nlp	24270737	SENT210	17	17	7	7	decitabine	PD-L2	PA164749631	80380	0.838
NULL	Braz_J_Med_Biol_Res_2012_Apr_27_45(6)_510-516.nxml.txt.nlp	22527124	SENT102	8	8	10	10	doxorubicin	ADM	PA449412	133	0.838
NULL	Biomed_Res_Int_2013_Dec_30_2013_482160.nxml.txt.nlp	23509727	SENT204	12	12	9	9	vincristine	HMGB1	PA451879	3146	0.838
NULL	Asian-Australas_J_Anim_Sci_2014_Dec_27(12)_1783-1793.nxml.txt.nlp	25358373	SENT204	3	3	22	22	capsaicin	PPARG	PA448776	5468	0.838
NULL	Evid_Based_Complement_Alternat_Med_2013_May_28_2013_629750.nxml.txt.nlp	23781265	SENT153	18	18	21	21	capsaicin	GADD153	PA448776	1649	0.838
NULL	Br_J_Cancer_2010_Jun_29_103(1)_61-72.nxml.txt.nlp	20588279	SENT14	7	7	0	0	trastuzumab	RhoB	PA451743	388	0.838
NULL	J_Carcinog_2011_Jul_19_10_17.nxml.txt.nlp	21799661	SENT196	14	14	2	2	metformin	OCT3	PA450395	5460;6581	0.838
NULL	Br_J_Cancer_2012_Apr_10_106(8)_1367-1373.nxml.txt.nlp	22454081	SENT139	13	13	2	2	trastuzumab	PIK3CA	PA451743	5290	0.838
NULL	Ann_N_Y_Acad_Sci_2012_Oct_10_1271(1)_10-19.nxml.txt.nlp	23050959	SENT141	4	4	13	13	resveratrol	SIRT1		23411	0.838
NULL	Infect_Dis_Rep_2013_Jun_6_5(Suppl_1)_e5.nxml.txt.nlp	24470969	SENT98	15	15	13	13	maraviroc	CCR5	PA164768835	1234	0.838
NULL	Breast_Cancer_Res_2012_May_18_14(3)_R78.nxml.txt.nlp	22608253	SENT264	8	8	22	22	nilotinib	AIB1	PA165958345	8202	0.837
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT191	6	6	19	19	ranibizumab	PlGF-2	PA164746012	5228	0.837
NULL	Breast_Cancer_Res_2010_May_18_12(Suppl_1)_P2.nxml.txt.nlp	NULL	SENT13	30	30	36	36	tamoxifen	FOXM1	PA451581	2305	0.837
NULL	Support_Care_Cancer_2014_Oct_19_22(2)_469-477.nxml.txt.nlp	24141698	SENT142	24	24	39	39	ondansetron	HEC	PA450705	10403	0.837
NULL	Cell_Commun_Signal_2011_May_15_9_13.nxml.txt.nlp	21569639	SENT295	6	6	3	3	quinacrine	p53	PA164745551	7157	0.837
NULL	Mol_Cancer_2007_Aug_21_6_53.nxml.txt.nlp	17711579	SENT179	16	16	2	2	cisplatin	HAP1	PA449014	328;9001	0.837
NULL	Crit_Care_2009_Jun_23_13(3)_R98.nxml.txt.nlp	19549333	SENT26	7	7	3	3	vasopressin	AVP	PA451858	114548;551	0.837
NULL	Mol_Vis_2012_Jun_22_18_1696-1700.nxml.txt.nlp	22773907	SENT96	10	10	14	14	colchicine	MTHFR	PA449092	4524	0.837
NULL	J_Korean_Med_Sci_2007_Dec_20_22(6)_1055-1059.nxml.txt.nlp	18162722	SENT117	25	25	19	19	pantoprazole	ESD	PA450774	2098	0.837
NULL	Clin_Pharmacol_2010_Sep_6_2_155-162.nxml.txt.nlp	22291500	SENT63	13	13	15	15	clopidogrel	CYP2C19	PA449053	1557	0.837
NULL	Arthritis_Res_Ther_2007_Oct_9_9(5)_R104.nxml.txt.nlp	17925024	SENT28	3	3	31	31	glucosamine	p38	PA164747613	10598;1432;7965	0.837
NULL	Acta_Neuropathol_Commun_2014_May_10_2(1)_54.nxml.txt.nlp	NULL	SENT316	26	26	9	9	curcumin	CLN6	PA151958596	54982	0.837
NULL	Oncotarget_2012_Jul_13_3(6)_601-607.nxml.txt.nlp	22802145	SENT28	3	3	23	23	doxorubicin	p53	PA449412	7157	0.837
NULL	Cancer_2014_Apr_8_120(8)_1145-1154.nxml.txt.nlp	24501009	SENT32	39	39	26	26	erlotinib	KRAS	PA134687924	3845	0.837
NULL	Biomed_Res_Int_2014_Feb_19_2014_371593.nxml.txt.nlp	24701574	SENT219	28	28	14	14	ethanol	IL-13	PA448073	3596	0.837
NULL	Br_J_Cancer_2013_Mar_19_108(5)_1079-1091.nxml.txt.nlp	23449353	SENT8	29	29	13	13	docetaxel	PC3	PA449383	57332;7832;5122	0.837
NULL	Oncotarget_2014_Jun_27_5(13)_4694-4708.nxml.txt.nlp	25051361	SENT135	5	5	25	25	fludarabine	p27	PA449655	5715;10534	0.837
NULL	Br_J_Cancer_2004_Mar_22_90(6)_1285-1292.nxml.txt.nlp	15026814	SENT189	12	12	24	24	doxorubicin	p53	PA449412	7157	0.837
NULL	Biomed_Res_Int_2014_Jan_2_2014_126586.nxml.txt.nlp	24527434	SENT148	17	17	8	8	metformin	CD133	PA450395	8842	0.837
NULL	Int_J_Mol_Sci_2014_May_9_15(5)_8216-8234.nxml.txt.nlp	24821542	SENT484	6	6	3	3	doxorubicin	MDR1	PA449412	5243	0.837
NULL	AIDS_Res_Ther_2013_May_1_10_10.nxml.txt.nlp	23634877	SENT149	25	25	27	27	atorvastatin	ANOVA	PA448500	4858	0.837
NULL	Oncotarget_2014_May_28_5(22)_11209-11224.nxml.txt.nlp	25526030	SENT94	29	29	2	2	doxorubicin	p53	PA449412	7157	0.837
NULL	J_Mov_Disord_2009_May_30_2(1)_33-36.nxml.txt.nlp	24868350	SENT18	0	0	13	13	s-adenosylmethionine	COMT	PA164754994	1312	0.837
NULL	Exp_Ther_Med_2013_Nov_13_6(5)_1317-1321.nxml.txt.nlp	24223665	SENT103	7	7	14	14	cisplatin	CD133	PA449014	8842	0.837
NULL	Case_Rep_Dermatol_2014_Feb_12_6(1)_37-42.nxml.txt.nlp	24707248	SENT11	11	11	6	6	cyclophosphamide	CHOP	PA449165	1649	0.837
NULL	Cancer_Immunol_Immunother_2012_Jul_23_61(7)_1101-1111.nxml.txt.nlp	22193989	SENT201	10	10	16	16	oxaliplatin	STAT1	PA131285527	6772	0.837
NULL	Breast_Cancer_Res_2007_Aug_8_9(4)_R50.nxml.txt.nlp	17686159	SENT246	26	26	32	32	gefitinib	EGFR	PA131301952	1956	0.837
NULL	Acta_Pharmacol_Sin_2012_Jan_3_33(1)_49-56.nxml.txt.nlp	22212430	SENT188	28	28	3	3	thrombin	A10	PA451674	28870	0.837
NULL	Biomed_Res_Int_2014_Jun_26_2014_161346.nxml.txt.nlp	25054130	SENT236	41	41	21	21	curcumin	STZ	PA151958596	6484	0.837
NULL	Oncotarget_2012_Nov_16_3(11)_1439-1454.nxml.txt.nlp	23183822	SENT174	34	34	6	6	temozolomide	CD133	PA451609	8842	0.837
NULL	Biomed_Res_Int_2014_Apr_10_2014_580852.nxml.txt.nlp	24812624	SENT57	6	6	0	0	resveratrol	PTEN		5728	0.837
NULL	Br_J_Cancer_2013_Jul_23_109(2)_351-359.nxml.txt.nlp	23799854	SENT164	19	19	28	28	paclitaxel	BLT2	PA450761	56413	0.837
NULL	Case_Rep_Endocrinol_2013_Oct_22_2013_815821.nxml.txt.nlp	24251048	SENT54	4	4	15	15	quetiapine	PRN	PA451201	64428	0.837
NULL	J_Hematol_Oncol_2013_Nov_5_6_83.nxml.txt.nlp	24283248	SENT122	21	21	17	17	nutlin-3	TP53		7157	0.837
NULL	Case_Rep_Transplant_2012_Sep_27_2012_493758.nxml.txt.nlp	23259133	SENT62	7	7	4	4	micafungin	IFN	PA164781026	3439	0.837
NULL	Cost_Eff_Resour_Alloc_2004_Apr_15_2_2.nxml.txt.nlp	15086954	SENT126	20	20	7	7	nateglinide	PPG	PA450600	5552	0.837
NULL	Aging_(Albany_NY)_2011_Apr_6_3(4)_444-449.nxml.txt.nlp	21483037	SENT81	9	9	7	7	resveratrol	SIRT1		23411	0.837
NULL	Int_J_Biol_Sci_2013_Apr_22_9(4)_350-360.nxml.txt.nlp	23630447	SENT138	9	9	0	0	doxorubicin	MDR1	PA449412	5243	0.837
NULL	Clin_Psychopharmacol_Neurosci_2011_Apr_30_9(1)_36-43.nxml.txt.nlp	23431025	SENT125	12	12	29	29	haloperidol	CA1	PA449841	759	0.837
NULL	Front_Neurosci_2011_Feb_22_5_20.nxml.txt.nlp	21373362	SENT966	10	10	2	2	cyclophosphamide	fractalkine	PA449165	6376	0.837
NULL	Diabetes_Metab_Syndr_Obes_2014_Aug_28_7_391-400.nxml.txt.nlp	25210468	SENT100	27	27	9	9	exenatide	GLP-1	PA164749238	100125288	0.837
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT172	28	28	18	18	metformin	AMPK	PA450395	5563	0.837
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Jan_26_69(Pt_2)_o292.nxml.txt.nlp	23424561	SENT56	9	9	37	37	guanidine	CO2	PA164781028	4513	0.837
NULL	J_Exp_Med_1998_Jun_1_187(11)_1885-1892.nxml.txt.nlp	9607928	SENT119	3	3	29	29	thalidomide	CD4	PA451644	920	0.837
NULL	Neural_Plast_2007_Dec_11_2007_73079.nxml.txt.nlp	NULL	SENT2648	13	13	33	33	vigabatrin	P14	PA10231	11102;;6280;56259	0.837
NULL	Cell_Cycle_2012_Nov_1_11(21)_3917-3918.nxml.txt.nlp	23032263	SENT8	36	36	8	8	hydroxyurea	p38	PA449942	10598;1432;7965	0.837
NULL	Hum_Genomics_2010_Apr_1_4(4)_238-249.nxml.txt.nlp	20511137	SENT49	24	24	11	11	atazanavir	UGT1A1	PA10251	54658	0.837
NULL	Biosci_Rep_2013_Aug_14_33(4)_e00057.nxml.txt.nlp	23837802	SENT120	13	13	31	31	cisplatin	STAT3	PA449014	6774	0.837
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT118	21	21	6	6	capsaicin	p53	PA448776	7157	0.837
NULL	Exp_Ther_Med_2013_Dec_14_6(6)_1499-1503.nxml.txt.nlp	24255681	SENT140	0	0	6	6	fluorouracil	S100A3	PA128406956	6274	0.837
NULL	Bioinformation_2010_Nov_27_5(6)_266-270.nxml.txt.nlp	21364830	SENT29	46	46	26	26	galactose	GAL	PA449725	51083	0.837
NULL	J_Korean_Med_Sci_2006_Dec_31_21(6)_1037-1040.nxml.txt.nlp	17179683	SENT90	31	31	22	22	amoxicillin	BAM	PA448406	9126	0.837
NULL	Cell_Res_2014_Feb_12_24(2)_143-160.nxml.txt.nlp	24217768	SENT67	7	7	46	46	heparin	FGF2	PA449855	2247;2258	0.837
NULL	Curr_Gerontol_Geriatr_Res_2010_Jun_20_2010_348174.nxml.txt.nlp	20672050	SENT58	12	12	5	5	vinorelbine	EGFR	PA451881	1956	0.837
NULL	Arch_Med_Sci_2013_Aug_30_9(4)_622-628.nxml.txt.nlp	24049520	SENT143	8	8	16	16	simvastatin	ADP	PA451363	23038	0.837
NULL	Subst_Abuse_Rehabil_2011_Oct_28_2_181-188.nxml.txt.nlp	24474855	SENT156	34	34	3	3	naltrexone	Gen	PA450588	348654	0.837
NULL	Cell_Res_2009_Aug_19(8)_950-961.nxml.txt.nlp	19546888	SENT68	32	32	7	7	camptothecin	Cbl-b	PA153590860	868	0.837
NULL	J_Gen_Physiol_2003_Jul_122(1)_45-61.nxml.txt.nlp	12835470	SENT545	0	0	15	15	capsaicin	VR1	PA448776	56664	0.837
NULL	Oncogene_2009_Apr_2_28(13)_1616-1625.nxml.txt.nlp	19219073	SENT101	17	17	5	5	nutlin-3	p53		7157	0.837
NULL	Pharmaceutics_2011_Nov_18_3(4)_865-913.nxml.txt.nlp	24309312	SENT345	13	13	3	3	midazolam	CYP3A	PA450496	1574	0.837
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2014_Sep_27_70(Pt_10)_2740-2753.nxml.txt.nlp	25286857	SENT246	1	1	19	19	piperazine	TNKS2	PA450977	80351	0.837
NULL	Arthritis_Res_Ther_2006_Dec_28_8(1)_R18.nxml.txt.nlp	16507118	SENT128	24	24	9	9	infliximab	IL-15	PA452639	3600	0.837
NULL	Clinics_(Sao_Paulo)_2013_May_68(5)_592-598.nxml.txt.nlp	23778413	SENT84	31	31	14	14	docetaxel	HIF1A	PA449383	3091	0.837
NULL	Eur_J_Immunol_2014_Jun_10_44(6)_1759-1769.nxml.txt.nlp	24595810	SENT80	29	29	5	5	fludrocortisone	CD4	PA164743961	920	0.837
NULL	J_Exp_Med_2000_May_15_191(10)_1789-1798.nxml.txt.nlp	10811871	SENT91	31	31	11	11	tetracycline	p53	PA451640	7157	0.837
NULL	Cancer_Cell_Int_2014_Jun_11_14_49.nxml.txt.nlp	24991192	SENT76	19	19	24	24	berberine	AMPK	PA165860812	5563	0.837
NULL	Acta_Pharmacol_Sin_2009_Jul_22_30(7)_956-964.nxml.txt.nlp	19543298	SENT129	3	3	17	17	simvastatin	ABCC2	PA451363	1244	0.837
NULL	Front_Comput_Neurosci_2014_Oct_17_8_133.nxml.txt.nlp	25368573	SENT180	42	42	2	2	ketamine	gamma	PA450144	9913	0.837
NULL	Ann_Clin_Microbiol_Antimicrob_2007_Nov_12_6_15.nxml.txt.nlp	17997852	SENT114	17	17	19	19	griseofulvin	ANOVA	PA449814	4858	0.837
NULL	Oncotarget_2014_Mar_13_5(4)_1101-1110.nxml.txt.nlp	24658355	SENT3	7	7	13	13	tamoxifen	MKP-1	PA451581	1843	0.837
NULL	Blood_Cancer_J_2013_Mar_1_3(3)_e103.nxml.txt.nlp	23454896	SENT67	13	13	33	33	nelfinavir	CD138	PA450606	6382	0.837
NULL	Cancer_Manag_Res_2014_May_23_6_225-252.nxml.txt.nlp	24904222	SENT121	13	13	9	9	lapatinib	HER2	PA152241907	2064	0.837
NULL	Exp_Ther_Med_2013_Mar_17_5(3)_797-802.nxml.txt.nlp	23403698	SENT112	9	9	3	3	triciribine	PI3K	PA165958661	5290	0.837
NULL	Acta_Neuropathol_Commun_2014_Oct_21_2(1)_149.nxml.txt.nlp	NULL	SENT241	1	1	21	21	riluzole	p38	PA451251	10598;1432;7965	0.837
NULL	Ann_Thorac_Med_2008_Oct-Dec_3(4)_149-151.nxml.txt.nlp	19561898	SENT10	22	22	24	24	ethambutol	EMB	PA164784021	133418	0.837
NULL	J_Cereb_Blood_Flow_Metab_2012_Dec_5_32(12)_2171-2180.nxml.txt.nlp	22948298	SENT85	4	4	17	17	paraformaldehyde	NOTCH3	PA450790	4854	0.837
NULL	Mol_Cancer_2009_Nov_19_8_108.nxml.txt.nlp	19925669	SENT36	17	17	12	12	doxorubicin	MRP3	PA449412	8714	0.837
NULL	J_Psychopharmacol_2010_Jan_24(1)_27-38.nxml.txt.nlp	19204064	SENT6	22	22	15	15	methylphenidate	NK1R	PA450464	6869	0.837
NULL	Indian_J_Pharm_Sci_2013_Jan-Feb_75(1)_94-98.nxml.txt.nlp	23901167	SENT30	12	12	34	34	omeprazole	CYP2B6	PA450704	1555	0.837
NULL	Case_Rep_Endocrinol_2014_Aug_18_2014_802473.nxml.txt.nlp	25202461	SENT3	0	0	4	4	teriparatide	PTH	PA451620	5741	0.837
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Apr_25_65(Pt_5)_o1118.nxml.txt.nlp	21583930	SENT68	17	17	14	14	ethanol	mol	PA448073	90527	0.837
NULL	Pharmaceutics_2011_Oct_12_3(4)_680-705.nxml.txt.nlp	24309303	SENT1025	25	25	18	18	rosiglitazone	BSP	PA451283	3381	0.837
NULL	Curr_Neuropharmacol_2014_Jul_12(4)_365-379.nxml.txt.nlp	25342944	SENT483	31	31	10	10	fluoxetine	5-HT2B	PA449673	3357	0.837
NULL	Mol_Cancer_2009_Nov_18_8_106.nxml.txt.nlp	19922650	SENT25	8	8	14	14	verapamil	CD5	PA451868	921	0.837
NULL	Mol_Cancer_2010_Aug_20_9_220.nxml.txt.nlp	20727180	SENT144	29	29	22	22	nicotine	p53	PA450626	7157	0.837
NULL	J_Biol_Chem_2009_Aug_14_284(33)_22364-22378.nxml.txt.nlp	19458089	SENT18	23	23	9	9	tetracycline	CD4	PA451640	920	0.837
NULL	Cancer_Manag_Res_2011_Aug_10_3_273-285.nxml.txt.nlp	21931501	SENT53	0	0	8	8	pazopanib	VEGFR1	PA165291492	2321	0.837
NULL	Front_Mol_Neurosci_2012_Mar_26_5_37.nxml.txt.nlp	22470318	SENT108	6	6	4	4	resveratrol	SIRT1		23411	0.837
NULL	Nat_Commun_2014_Nov_21_5_5456.nxml.txt.nlp	25413232	SENT459	27	27	25	25	pp2	PP1		5540;5464	0.837
NULL	BMB_Rep_2013_Aug_46(8)_410-415.nxml.txt.nlp	23977989	SENT214	1	1	20	20	curcumin	p38	PA151958596	10598;1432;7965	0.837
NULL	Adv_Hematol_2010_Dec_5_2010_595934.nxml.txt.nlp	21151515	SENT16	0	0	28	28	ticlopidine	ADP	PA451686	23038	0.837
NULL	Gynecol_Oncol_Case_Rep_2013_Sep_21_6_42-44.nxml.txt.nlp	24371718	SENT100	9	9	0	0	tamoxifen	ATAC	PA451581	6375	0.837
NULL	Br_J_Cancer_2011_Jun_28_105(1)_118-123.nxml.txt.nlp	21654685	SENT147	6	6	9	9	dasatinib	S100beta	PA162372878	6285	0.837
NULL	Mol_Cancer_2009_Oct_1_8_81.nxml.txt.nlp	19796390	SENT175	10	10	31	31	celecoxib	Bcl-2	PA448871	596	0.837
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT219	20	20	24	24	atorvastatin	RANK	PA448500	8792	0.837
NULL	EMBO_Mol_Med_2012_Dec_15_4(12)_1276-1293.nxml.txt.nlp	23065753	SENT179	7	7	0	0	cisplatin	HK-1	PA449014	255061	0.837
NULL	Case_Rep_Med_2012_Apr_4_2012_545492.nxml.txt.nlp	22548078	SENT84	0	0	3	3	erlotinib	EGFR	PA134687924	1956	0.837
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT114	9	9	5	5	trastuzumab	MUC1	PA451743	4582	0.837
NULL	Diabetol_Metab_Syndr_2014_Mar_31_6_47.nxml.txt.nlp	24684779	SENT152	0	0	12	12	simvastatin	IL-6	PA451363	3569	0.837
NULL	Springerplus_2014_Sep_9_3_510.nxml.txt.nlp	25279302	SENT43	5	5	7	7	creatine	GAMT	PA164778930	2593	0.837
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT166	34	34	1	1	trastuzumab	STAT3	PA451743	6774	0.837
NULL	Mol_Cancer_2009_Apr_22_8_26.nxml.txt.nlp	19386116	SENT146	10	10	13	13	ritonavir	AKT	PA451260	207	0.837
NULL	Exp_Ther_Med_2014_Jun_28_7(6)_1653-1658.nxml.txt.nlp	24926361	SENT95	6	6	9	9	curcumin	p65	PA151958596	5970	0.837
NULL	Cancer_Manag_Res_2011_May_9_3_117-141.nxml.txt.nlp	21625397	SENT57	0	0	11	11	resveratrol	HDAC11		79885	0.837
NULL	Clin_Pharmacol_2011_Jun_22_3_13-25.nxml.txt.nlp	22287853	SENT205	0	0	3	3	saxagliptin	CYP3A4	PA165958362	1576	0.837
NULL	Case_Rep_Crit_Care_2014_Nov_6_2014_214970.nxml.txt.nlp	25431684	SENT88	3	3	6	6	rituximab	CHOP	PA451261	1649	0.837
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT115	9	9	16	16	docetaxel	B7-H1	PA449383	29126	0.837
NULL	Brain_Res_2011_Mar_25_1382(C)_29-36.nxml.txt.nlp	21276431	SENT128	18	18	4	4	ketanserin	5-HT2A	PA131053734	3356	0.837
NULL	Cell_J_2012_Dec_12_Autumn_14(3)_177-184.nxml.txt.nlp	23508562	SENT188	3	3	26	26	methamphetamine	Bcl-2	PA450403	596	0.837
NULL	Breast_Cancer_Res_2014_Dec_6_16(6)_491.nxml.txt.nlp	25479686	SENT212	22	22	3	3	medroxyprogesterone	GATA3	PA450344	2625	0.837
NULL	Diabetes_Care_2009_Nov_32(Suppl_2)_S223-S231.nxml.txt.nlp	19875556	SENT153	17	17	26	26	metformin	GLP-1	PA450395	100125288	0.837
NULL	Br_J_Cancer_2013_Feb_19_108(3)_557-563.nxml.txt.nlp	23361053	SENT232	16	16	8	8	tamoxifen	PAK1	PA451581	5585;5058	0.837
NULL	J_Acquir_Immune_Defic_Syndr_2014_Jan_1_65(1)_72-77.nxml.txt.nlp	24025339	SENT183	17	17	7	7	efavirenz	CYP2B6	PA449441	1555	0.837
NULL	J_Hematol_Oncol_2013_Feb_17_6_17.nxml.txt.nlp	23414938	SENT32	0	0	5	5	prasugrel	P2Y12	PA154410481	64805	0.837
NULL	J_Clin_Exp_Pathol_2012_May_17_Suppl_4_7327.nxml.txt.nlp	25379357	SENT203	0	0	20	20	metformin	AMPK	PA450395	5563	0.837
NULL	Oncotarget_2014_Oct_21_5(22)_11252-11268.nxml.txt.nlp	25361004	SENT269	11	11	17	17	metformin	CLIC1	PA450395	1192	0.837
NULL	J_Cell_Mol_Med_2014_Apr_20_18(4)_709-720.nxml.txt.nlp	24444314	SENT205	2	2	9	9	losartan	Met	PA450268	79811	0.837
NULL	Aging_(Albany_NY)_2009_Apr_21_1(4)_402-411.nxml.txt.nlp	20148189	SENT123	31	31	12	12	bleomycin	IL-6	PA448645	3569	0.837
NULL	Ann_Oncol_2012_Dec_2_23(12)_3007-3016.nxml.txt.nlp	22865781	SENT111	9	9	16	16	trastuzumab	PTEN	PA451743	5728	0.837
NULL	Front_Neurosci_2013_Jan_31_7_3.nxml.txt.nlp	23386808	SENT280	7	7	25	25	capsaicin	TRPV1	PA448776	7442	0.837
NULL	Breast_Cancer_Res_2011_Jun_29_13(3)_R70.nxml.txt.nlp	21707964	SENT230	17	17	32	32	tamoxifen	14-3-3	PA451581	10971	0.837
NULL	J_Exp_Bot_2012_Mar_15_63(5)_1969-1983.nxml.txt.nlp	22174442	SENT220	24	24	12	12	l-alanine	NO3	PA448055	4681	0.837
NULL	J_Clin_Biochem_Nutr_2009_Sep_28_45(2)_241-247.nxml.txt.nlp	19794935	SENT2	10	10	25	25	lansoprazole	TLR4	PA450180	7099	0.837
NULL	Ann_Hematol_2011_Feb_17_90(2)_173-183.nxml.txt.nlp	20714724	SENT102	16	16	9	9	resveratrol	CD5		921	0.837
NULL	Int_J_Environ_Res_Public_Health_2010_May_28_7(5)_1996-2007.nxml.txt.nlp	20632473	SENT130	9	9	15	15	arsenite	p38	PA452638	10598;1432;7965	0.837
NULL	Breast_Cancer_Res_2010_Mar_12_12(2)_R20.nxml.txt.nlp	20226014	SENT144	28	28	11	11	trastuzumab	PI3K	PA451743	5290	0.837
NULL	J_Headache_Pain_2012_Jun_29_13(4)_327-330.nxml.txt.nlp	22374177	SENT81	7	7	13	13	indomethacin	COX	PA449982	1351	0.837
NULL	eLife_2014_May_6_3_e02482.nxml.txt.nlp	24843002	SENT70	30	30	16	16	etoposide	53BP1	PA449552	7158	0.837
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_15_2012_638197.nxml.txt.nlp	23118795	SENT128	13	13	4	4	ethanol	CYP2E1	PA448073	1571	0.837
NULL	Neuro_Oncol_2010_Apr_27_12(4)_389-400.nxml.txt.nlp	20308316	SENT20	5	5	20	20	chloroquine	p53	PA448948	7157	0.837
NULL	Eur_J_Clin_Pharmacol_2010_Nov_29_66(11)_1131-1136.nxml.txt.nlp	20669013	SENT141	30	30	21	21	erythromycin	CYP2C19	PA449493	1557	0.837
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT181	3	3	19	19	doxorubicin	ABCB1	PA449412	5243	0.837
NULL	Case_Rep_Transplant_2013_Jun_13_2013_375263.nxml.txt.nlp	23844312	SENT80	36	36	23	23	tacrolimus	CYP3A	PA451578	1574	0.837
NULL	Exp_Ther_Med_2013_Apr_5_5(4)_1259-1263.nxml.txt.nlp	23596498	SENT93	15	15	0	0	propofol	TRPA1	PA451141	8989	0.837
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Oct_24_70(Pt_11)_o1183-o1184.nxml.txt.nlp	25484819	SENT11	29	29	15	15	lamivudine	mol	PA450163	90527	0.837
NULL	Cancer_Cell_Int_2009_Jun_10_9_16.nxml.txt.nlp	19508737	SENT337	7	7	15	15	vinblastine	p53	PA451877	7157	0.837
NULL	Chonnam_Med_J_2011_Aug_31_47(2)_124-126.nxml.txt.nlp	22111073	SENT44	5	5	21	21	clopidogrel	DES	PA449053	1674	0.837
NULL	AAPS_J_2014_Jun_11_16(5)_1029-1037.nxml.txt.nlp	24917180	SENT202	8	8	21	21	tariquidar	P-gp		5243	0.837
NULL	Carcinogenesis_2014_May_13_35(5)_1055-1066.nxml.txt.nlp	24419232	SENT102	32	32	16	16	metformin	VEGF-A	PA450395	7422	0.837
NULL	Clin_Ophthalmol_2009_Jun_2_3_291-295.nxml.txt.nlp	19668581	SENT109	12	12	31	31	travoprost	BAK	PA164781371	578	0.837
NULL	Syst_Synth_Biol_2011_Jun_26_5(1-2)_21-31.nxml.txt.nlp	21949673	SENT82	20	20	6	6	galactose	FDG	PA449725	23583	0.837
NULL	J_Korean_Med_Sci_2005_Dec_31_20(6)_1062-1065.nxml.txt.nlp	16361823	SENT89	10	10	6	6	doxorubicin	CHOP	PA449412	1649	0.837
NULL	ScientificWorldJournal_2013_Sep_21_2013_208309.nxml.txt.nlp	24170980	SENT35	13	13	37	37	l-glutamine	CO2	PA10090	4513	0.837
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT265	7	7	4	4	aripiprazole	PRL	PA10026	5617	0.837
NULL	Eur_J_Dent_2013_Apr-Jun_7(2)_246-250.nxml.txt.nlp	24883036	SENT134	26	26	7	7	celecoxib	EGFR	PA448871	1956	0.837
NULL	Drugs_Aging_2014_May_6_31(6)_413-424.nxml.txt.nlp	24797286	SENT146	7	7	3	3	risedronate	CTX	PA451255	1593	0.837
NULL	Adv_Pharmacol_Sci_2013_Dec_5_2013_387071.nxml.txt.nlp	24381587	SENT118	3	3	24	24	methotrexate	TNF	PA450428	7124	0.837
NULL	J_Biol_Chem_2013_Nov_22_288(47)_34217-34229.nxml.txt.nlp	24106270	SENT173	23	23	27	27	abciximab	P2Y12	PA448006	64805	0.837
NULL	Cancers_(Basel)_2014_Feb_13_6(1)_396-415.nxml.txt.nlp	24531055	SENT419	4	4	13	13	thrombin	PAR-1	PA451674	2011;2149	0.837
NULL	Acta_Pharmacol_Sin_2009_Sep_24_30(9)_1220-1226.nxml.txt.nlp	19701239	SENT38	7	7	31	31	cyclosporine	KCNQ4	PA449167	9132	0.837
NULL	Mol_Cancer_2010_Apr_15_9_77.nxml.txt.nlp	20398291	SENT247	9	9	15	15	geldanamycin	survivin	PA152031327	332	0.837
NULL	Scientifica_(Cairo)_2012_Nov_25_2012_473829.nxml.txt.nlp	24278698	SENT390	16	16	5	5	cisplatin	MATE1	PA449014	55244	0.837
NULL	Mol_Vis_2007_Jun_11_13_833-839.nxml.txt.nlp	17615544	SENT19	0	0	18	18	timolol	B27	PA451690	56246	0.837
NULL	Angiogenesis_2010_Dec_7_13(4)_305-315.nxml.txt.nlp	20927579	SENT33	6	6	9	9	resveratrol	p53		7157	0.837
NULL	Turk_J_Haematol_2012_Mar_5_29(1)_1-9.nxml.txt.nlp	24744617	SENT52	31	31	2	2	cisplatin	NK-1	PA449014	27087	0.837
NULL	Oncologist_2010_Nov_4_15(11)_1135-1146.nxml.txt.nlp	21051659	SENT179	8	8	11	11	temsirolimus	IFN	PA164746890	3439	0.837
NULL	Br_J_Cancer_1998_Oct_78(8)_1024-1029.nxml.txt.nlp	9792145	SENT15	24	24	4	4	carboplatin	CD34	PA448803	947	0.837
NULL	Cell_Commun_Signal_2013_Jan_11_11_2.nxml.txt.nlp	23305203	SENT108	0	0	4	4	forskolin	RACK1	PA146096022	10399	0.837
NULL	Cancer_Metab_2014_May_28_2(Suppl_1)_P65.nxml.txt.nlp	NULL	SENT19	22	22	15	15	resveratrol	SIRT1		23411	0.837
NULL	Exp_Ther_Med_2013_Feb_30_5(2)_616-620.nxml.txt.nlp	23407814	SENT25	20	20	17	17	nitrogen	ROS	PA450643	6098	0.837
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT132	16	16	29	29	cisplatin	GSTP1	PA449014	2950	0.837
NULL	Protein_Cell_2014_Jun_19_5(6)_469-479.nxml.txt.nlp	24748116	SENT87	25	25	9	9	paclitaxel	EB1	PA450761	9167;22919;10982	0.837
NULL	Br_J_Cancer_2013_Feb_19_108(3)_493-502.nxml.txt.nlp	23299530	SENT24	21	21	14	14	leucovorin	VEGF-A	PA450198	7422	0.837
NULL	Asian-Australas_J_Anim_Sci_2014_Dec_27(12)_1783-1793.nxml.txt.nlp	25358373	SENT184	4	4	12	12	capsaicin	CASP3	PA448776	836	0.837
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R91.nxml.txt.nlp	22541814	SENT41	18	18	35	35	thrombin	HO-1	PA451674	3162	0.837
NULL	Cancer_Cell_Int_2008_Mar_18_8_3.nxml.txt.nlp	18348720	SENT104	7	7	22	22	lapatinib	EGF	PA152241907	1950	0.837
NULL	Breast_Cancer_Res_2002_Aug_27_4(6)_213-217.nxml.txt.nlp	12473165	SENT126	12	12	7	7	raloxifene	STAR	PA451221	6770;2984	0.837
NULL	Curr_HIV_Res_2014_May_12(3)_174-188.nxml.txt.nlp	24862327	SENT148	25	25	29	29	hemin	MCP-1	PA449849	6347	0.837
NULL	Arch_Med_Sci_2012_Jul_4_8(3)_578-581.nxml.txt.nlp	22852019	SENT58	5	5	7	7	diethylstilbestrol	DES	PA449307	1674	0.837
NULL	Front_Oncol_2014_Sep_23_4_264.nxml.txt.nlp	25295231	SENT104	0	0	16	16	lenalidomide	p53	PA162363968	7157	0.837
NULL	Biosci_Rep_2012_Dec_20_33(1)_e00011.nxml.txt.nlp	23137297	SENT148	3	3	11	11	heparin	RPSA	PA449855	3921	0.837
NULL	EMBO_Mol_Med_2012_Jun_13_4(6)_515-527.nxml.txt.nlp	22416035	SENT85	35	35	16	16	olaparib	p53		7157	0.837
NULL	Int_J_Mol_Imaging_2011_Oct_26_2011_874585.nxml.txt.nlp	21490735	SENT184	18	18	9	9	doxorubicin	FDG	PA449412	23583	0.837
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_55-78.nxml.txt.nlp	19305788	SENT330	4	4	16	16	memantine	CA2	PA10364	760	0.837
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1013.nxml.txt.nlp	24457957	SENT79	37	37	28	28	orlistat	NOXA	PA164776864	5366	0.837
NULL	Cancer_Metab_2013_Jan_23_1_3.nxml.txt.nlp	24280005	SENT533	32	32	6	6	ethanol	SREBP1	PA448073	6720	0.837
NULL	J_Clin_Biochem_Nutr_2011_May_13_48(3)_237-244.nxml.txt.nlp	21562645	SENT252	2	2	13	13	resveratrol	AMPK		5563	0.837
NULL	Crit_Care_2005_Oct_7_9(Suppl_5)_S15-S24.nxml.txt.nlp	16221315	SENT49	6	6	30	30	thrombin	FIX	PA451674	2158	0.837
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT283	28	28	41	41	atorvastatin	AKT	PA448500	207	0.837
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT279	0	0	31	31	clozapine	PRL	PA449061	5617	0.837
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1522-1532.nxml.txt.nlp	21997136	SENT205	16	16	10	10	gefitinib	p53	PA131301952	7157	0.837
NULL	J_Hematol_Oncol_2010_May_2_3_18.nxml.txt.nlp	20433767	SENT175	0	0	15	15	gefitinib	EGFR	PA131301952	1956	0.837
NULL	Antiviral_Res_2010_Aug_87(2)_125-148.nxml.txt.nlp	19945487	SENT2082	12	12	4	4	aprotinin	hole	PA448472	80757	0.837
NULL	Cell_Death_Dis_2014_Jan_30_5(1)_e1038.nxml.txt.nlp	24481452	SENT38	6	6	14	14	raloxifene	CYP1A1	PA451221	1543	0.837
NULL	Cancer_Med_2013_Apr_6_2(2)_234-242.nxml.txt.nlp	23634291	SENT176	13	13	2	2	bevacizumab	VEGF-A	PA130232992	7422	0.837
NULL	Oncotarget_2014_Oct_21_5(22)_11709-11722.nxml.txt.nlp	25365944	SENT93	5	5	18	18	metformin	AKT	PA450395	207	0.837
NULL	J_Biomed_Sci_2014_Jul_31_21(1)_69.nxml.txt.nlp	25077570	SENT94	19	19	14	14	mitomycin	TC-1	PA450524	56892	0.837
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT161	3	3	11	11	atorvastatin	CD14	PA448500	929	0.837
NULL	Clin_Ophthalmol_2007_Sep_1(3)_225-232.nxml.txt.nlp	19668476	SENT41	13	13	25	25	bimatoprost	C-1	PA164748867	5203	0.837
NULL	Eur_J_Clin_Pharmacol_2010_Nov_29_66(11)_1131-1136.nxml.txt.nlp	20669013	SENT139	26	26	12	12	erythromycin	CYP2C19	PA449493	1557	0.837
NULL	Cell_Death_Dis_2012_Mar_15_3(3)_e286.nxml.txt.nlp	22419115	SENT68	13	13	4	4	cisplatin	p53	PA449014	7157	0.837
NULL	N_Am_J_Med_Sci_2014_Sep_6(9)_478-480.nxml.txt.nlp	25317394	SENT30	24	24	15	15	phenytoin	CYP2C9	PA450947	1559	0.837
NULL	Mol_Cancer_2010_Aug_20_9_220.nxml.txt.nlp	20727180	SENT228	7	7	29	29	cisplatin	p53	PA449014	7157	0.837
NULL	Clin_Mol_Allergy_2004_Mar_16_2_4.nxml.txt.nlp	15023231	SENT31	0	0	2	2	erythromycin	RANTES	PA449493	6352	0.837
NULL	J_Exp_Clin_Cancer_Res_2009_Jul_10_28(1)_99.nxml.txt.nlp	19591692	SENT115	25	25	31	31	elacridar	ABCG2		9429	0.837
NULL	J_Midlife_Health_2014_Oct-Dec_5(4)_165-167.nxml.txt.nlp	25540565	SENT26	11	11	28	28	tamoxifen	aromatase	PA451581	1588	0.837
NULL	J_Cell_Biol_2002_Jun_24_157(7)_1267-1278.nxml.txt.nlp	12082084	SENT654	4	4	2	2	thrombin	RhoA	PA451674	387	0.837
NULL	Nat_Commun_2013_Sep_4_4_2338.nxml.txt.nlp	24005565	SENT552	32	32	3	3	hydroxyurea	HELQ	PA449942	113510	0.837
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT258	13	13	28	28	cisplatin	p53	PA449014	7157	0.837
NULL	Br_J_Clin_Pharmacol_2013_Apr_10_75(4)_979-989.nxml.txt.nlp	22882281	SENT215	13	13	9	9	liraglutide	GLP-1	PA165958364	100125288	0.837
NULL	Int_J_Surg_Oncol_2012_Jun_12_2012_862879.nxml.txt.nlp	22778941	SENT17	30	30	25	25	cisplatin	BIN1	PA449014	274	0.837
NULL	Front_Neurosci_2014_Apr_8_8_63.nxml.txt.nlp	24782698	SENT54	0	0	7	7	physostigmine	spatial	PA450957	219793	0.837
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Apr_16_64(Pt_5)_o862.nxml.txt.nlp	21202349	SENT59	20	20	3	3	ethanol	mol	PA448073	90527	0.837
NULL	JRSM_Cardiovasc_Dis_2012_Sep_24_1(6)_cvd_2012_012015.nxml.txt.nlp	24175073	SENT12	17	17	6	6	clopidogrel	P2Y12	PA449053	64805	0.837
NULL	Breast_Cancer_Res_2011_Nov_23_13(6)_R116.nxml.txt.nlp	22113133	SENT331	17	17	6	6	tamoxifen	JAG1	PA451581	182	0.837
NULL	Int_J_Mol_Sci_2013_Apr_29_14(5)_9338-9364.nxml.txt.nlp	23629668	SENT1172	25	25	3	3	bevacizumab	CD133	PA130232992	8842	0.837
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT97	24	24	42	42	l-leucine	4E-BP1	PA450197	1978	0.837
NULL	Bioinformation_2011_Sep_6_7(2)_59-63.nxml.txt.nlp	21938206	SENT38	34	34	30	30	cefazolin	PON1	PA448839	5444	0.837
NULL	Biol_Open_2013_Aug_14_2(10)_1013-1021.nxml.txt.nlp	24167711	SENT66	0	0	10	10	ethanol	EVL	PA448073	51466	0.837
NULL	Pharmaceuticals_(Basel)_2014_Jan_9_7(1)_46-57.nxml.txt.nlp	24451403	SENT132	38	38	10	10	ritonavir	AKT	PA451260	207	0.837
NULL	Cancer_Cell_Int_2013_Feb_14_13_16.nxml.txt.nlp	23409704	SENT101	28	28	10	10	pp2	LOX		4015	0.837
NULL	Mol_Cancer_2008_Jun_3_7_47.nxml.txt.nlp	18519000	SENT104	3	3	15	15	gefitinib	EGFR	PA131301952	1956	0.837
NULL	J_Cell_Biol_2005_May_23_169(4)_681-691.nxml.txt.nlp	15911882	SENT48	3	3	16	16	heparin	MMP9	PA449855	4318	0.837
NULL	Leukemia_2014_Mar_13_28(3)_600-608.nxml.txt.nlp	24240203	SENT195	32	32	26	26	nutlin-3	BAX		581	0.837
NULL	J_Exp_Med_2000_Mar_20_191(6)_995-1004.nxml.txt.nlp	10727461	SENT468	4	4	8	8	trypsin	STAT6	PA451806	6778	0.837
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Sep_16_65(Pt_10)_o2480.nxml.txt.nlp	21577931	SENT72	23	23	15	15	ethanol	mol	PA448073	90527	0.837
NULL	Cancer_Inform_2013_Nov_25_12_203-219.nxml.txt.nlp	24327800	SENT115	3	3	8	8	hyaluronan	CD44	PA165958431	960	0.837
NULL	Iran_J_Pharm_Res_2014_Spring_13(2)_635-639.nxml.txt.nlp	25237359	SENT18	10	10	25	25	midazolam	CYP2C19	PA450496	1557	0.837
NULL	J_Oncol_2012_Feb_6_2012_737981.nxml.txt.nlp	22481932	SENT83	26	26	6	6	doxorubicin	MUC16	PA449412	94025	0.837
NULL	Br_J_Cancer_2014_Dec_9_111(12)_2380.nxml.txt.nlp	24619079	SENT28	22	22	33	33	irinotecan	KRAS	PA450085	3845	0.837
NULL	Breast_Cancer_Res_2011_Mar_11_13(2)_R29.nxml.txt.nlp	21396094	SENT161	20	20	9	9	fulvestrant	HRG	PA164747170	3084;3273	0.837
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1149.nxml.txt.nlp	24675467	SENT89	14	14	32	32	trastuzumab	LC3	PA451743	84557	0.837
NULL	Indian_J_Med_Res_2014_Jan_139(1)_117-124.nxml.txt.nlp	24604047	SENT13	6	6	28	28	fluvastatin	RhoA	PA449688	387	0.837
NULL	Int_J_Biol_Sci_2012_Sep_6_8(8)_1109-1120.nxml.txt.nlp	22991499	SENT143	19	19	4	4	l-arginine	ARG2	PA448478	384	0.837
NULL	Biochemistry_2009_Jun_9_48(22)_4871-4880.nxml.txt.nlp	19364131	SENT128	22	22	37	37	papain	p44	PA450778	10561;2966	0.837
NULL	J_Biol_Chem_2008_Oct_31_283(44)_29841-29846.nxml.txt.nlp	18765669	SENT32	0	0	8	8	suramin	P2X1	PA10292	5023	0.837
NULL	Oncoimmunology_2013_Jun_1_2(6)_e24677.nxml.txt.nlp	23894722	SENT145	26	26	37	37	cetuximab	CD80	PA10040	941	0.837
NULL	Cancer_Cell_Int_2013_Oct_11_13_97.nxml.txt.nlp	24119761	SENT10	18	18	4	4	trastuzumab	EGF	PA451743	1950	0.837
NULL	Cancers_(Basel)_2011_Mar_7_3(1)_1158-1181.nxml.txt.nlp	24212658	SENT1268	3	3	17	17	bortezomib	PSMB5	PA10252	5693	0.837
NULL	Braz_J_Med_Biol_Res_2012_Jun_8_45(10)_988-994.nxml.txt.nlp	22666778	SENT167	4	4	0	0	lipase	HSL	PA450239	3991	0.837
NULL	Leukemia_2014_Jun_25_28(6)_1280-1288.nxml.txt.nlp	24270737	SENT202	26	26	5	5	azacitidine	PD-L1	PA451996	29126	0.837
NULL	Adv_Hematol_2012_Jan_18_2012_195484.nxml.txt.nlp	22312366	SENT22	5	5	14	14	cyclophosphamide	CHOP	PA449165	1649	0.837
NULL	Semin_Immunopathol_2012_Jan_4_34(1)_93-106.nxml.txt.nlp	21845431	SENT174	19	19	7	7	thrombin	PAR-1	PA451674	2011;2149	0.837
NULL	ScientificWorldJournal_2014_Dec_9_2014_808320.nxml.txt.nlp	25548793	SENT92	7	7	13	13	heparin	ACT	PA449855	12;11332;9457;641455	0.837
NULL	EMBO_Mol_Med_2012_Sep_7_4(9)_896-909.nxml.txt.nlp	22887866	SENT157	9	9	16	16	lovastatin	c-Myc	PA450272	4609	0.837
NULL	Front_Genet_2013_Aug_29_4_163.nxml.txt.nlp	24009622	SENT37	8	8	11	11	ethanol	ABCG2	PA448073	9429	0.837
NULL	Emerg_Infect_Dis_2012_Aug_18(8)_1290-1297.nxml.txt.nlp	22840274	SENT171	19	19	29	29	ciprofloxacin	GISP	PA449009	83998	0.837
NULL	Carcinogenesis_2010_Dec_27_31(12)_2049-2057.nxml.txt.nlp	20876285	SENT152	32	32	28	28	tamoxifen	HER2	PA451581	2064	0.837
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT53	14	14	19	19	letrozole	HER2	PA450196	2064	0.837
NULL	Breast_Cancer_Res_2009_Nov_18_11(6)_R85.nxml.txt.nlp	19922614	SENT103	25	25	14	14	tamoxifen	BCS	PA451581	617	0.837
NULL	Acta_Pharmacol_Sin_2010_May_12_31(5)_578-584.nxml.txt.nlp	20383171	SENT133	4	4	33	33	berberine	AKT	PA165860812	207	0.837
NULL	Nat_Commun_2014_Nov_25_5_5548.nxml.txt.nlp	25420520	SENT295	9	9	3	3	docetaxel	EB1	PA449383	9167;22919;10982	0.837
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1013.nxml.txt.nlp	24457957	SENT120	14	14	24	24	bortezomib	NOXA	PA10252	5366	0.837
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1676-1682.nxml.txt.nlp	19844234	SENT23	0	0	14	14	lapatinib	HER2	PA152241907	2064	0.837
NULL	J_Carcinog_2014_Feb_20_13_4.nxml.txt.nlp	24737952	SENT300	4	4	8	8	panitumumab	EGFR	PA162373091	1956	0.837
NULL	Inflammation_2014_Sep_5_37(1)_1-9.nxml.txt.nlp	24005897	SENT152	13	13	6	6	diclofenac	COX	PA449293	1351	0.837
NULL	J_Med_Case_Reports_2011_Jun_7_5_217.nxml.txt.nlp	21649896	SENT42	13	13	5	5	methylprednisolone	BCS	PA450466	617	0.837
NULL	Front_Cell_Neurosci_2013_Dec_18_7_250.nxml.txt.nlp	24391538	SENT1383	2	2	5	5	atropine	P2X1	PA448505	5023	0.837
NULL	Oncotarget_2013_Nov_19_5(2)_309-325.nxml.txt.nlp	24525395	SENT335	7	7	24	24	flavopiridol	Mcl-1	PA452627	4170	0.837
NULL	Mol_Biol_Int_2012_Aug_7_2012_863405.nxml.txt.nlp	22928108	SENT33	0	0	4	4	maraviroc	CCR5	PA164768835	1234	0.837
NULL	Cancer_Immunol_Immunother_2011_Jun_25_60(6)_793-808.nxml.txt.nlp	21350947	SENT171	9	9	7	7	sorafenib	IFN	PA7000	3439	0.837
NULL	Int_J_Biol_Sci_2011_May_19_7(5)_629-644.nxml.txt.nlp	21647331	SENT99	10	10	36	36	ethanol	CO2	PA448073	4513	0.837
NULL	Br_J_Cancer_2013_May_14_108(9)_1771-1777.nxml.txt.nlp	23612453	SENT132	3	3	9	9	everolimus	aromatase	PA164746311	1588	0.837
NULL	Evid_Based_Complement_Alternat_Med_2011_Mar_13_2011_913898.nxml.txt.nlp	21785639	SENT38	16	16	9	9	curcumin	CYP3A4	PA151958596	1576	0.837
NULL	Nat_Commun_2013_4_10_1038_ncomms3834.nxml.txt.nlp	24280772	SENT316	16	16	14	14	troglitazone	IL-4	PA451799	3565	0.837
NULL	Curr_Gerontol_Geriatr_Res_2010_Jun_20_2010_348174.nxml.txt.nlp	20672050	SENT144	8	8	5	5	erlotinib	EGFR	PA134687924	1956	0.837
NULL	Adv_Urol_2012_Sep_9_2012_181964.nxml.txt.nlp	22991510	SENT29	27	27	4	4	trastuzumab	HER2	PA451743	2064	0.837
NULL	Br_J_Cancer_2012_Jan_3_106(1)_148-156.nxml.txt.nlp	22045191	SENT153	8	8	0	0	erlotinib	ZEB1	PA134687924	6935	0.837
NULL	Cell_Mol_Life_Sci_2011_Mar_6_68(5)_903-917.nxml.txt.nlp	20820851	SENT97	35	35	9	9	galactose	CO2	PA449725	4513	0.837
NULL	Diabetes_Care_2013_Jan_10_36(Suppl_1)_S11-S66.nxml.txt.nlp	23264422	SENT1932	15	15	7	7	rosiglitazone	DREAM	PA451283	30818	0.837
NULL	Br_J_Cancer_2011_Apr_12_104(8)_1256-1261.nxml.txt.nlp	21448165	SENT74	18	18	20	20	sorafenib	IL-2	PA7000	3558	0.837
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT473	9	9	0	0	iloperidone	PRL	PA161199368	5617	0.837
NULL	Drugs_R_D_2011_Jun_27_11(2)_101-111.nxml.txt.nlp	21679003	SENT62	16	16	1	1	panitumumab	BRAF	PA162373091	673	0.837
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_11_2014_274786.nxml.txt.nlp	25505920	SENT246	9	9	15	15	curcumin	ERCC1	PA151958596	2067	0.837
NULL	Iran_J_Pharm_Res_2014_Spring_13(2)_683-693.nxml.txt.nlp	25237365	SENT86	2	2	8	8	tamoxifen	CXCR4	PA451581	7852	0.837
NULL	Mol_Pain_2012_Sep_22_8_71.nxml.txt.nlp	22998838	SENT148	0	0	9	9	paclitaxel	GLAST	PA450761	6507	0.837
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_105-115.nxml.txt.nlp	17912640	SENT57	18	18	30	30	trastuzumab	HER2	PA451743	2064	0.837
NULL	Arch_Med_Sci_2012_Feb_29_8(1)_138-153.nxml.txt.nlp	22457688	SENT422	8	8	14	14	atorvastatin	PON1	PA448500	5444	0.837
NULL	Int_J_Endocrinol_2014_Jun_25_2014_534904.nxml.txt.nlp	25053942	SENT94	15	15	9	9	amiodarone	AIT	PA448383	160728	0.837
NULL	Breast_Cancer_Res_2004_Jun_29_6(5)_R488-R498.nxml.txt.nlp	15318931	SENT152	27	27	3	3	estradiol	UGT2B15	PA449503	7366	0.837
NULL	J_Carcinog_2013_Dec_31_12_22.nxml.txt.nlp	24574860	SENT377	16	16	32	32	cabozantinib	AXL	PA165906891	558	0.837
NULL	Cancer_Cell_2015_Jan_12_27(1)_57-71.nxml.txt.nlp	25584894	SENT197	30	30	5	5	l-glutamine	PC3	PA10090	57332;7832;5122	0.837
NULL	J_Biol_Chem_2009_Nov_27_284(48)_33130-33138.nxml.txt.nlp	19801632	SENT293	26	26	8	8	coumarin	ADP	PA134521193	23038	0.837
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S18-S30.nxml.txt.nlp	20680104	SENT82	26	26	18	18	panitumumab	EGFR	PA162373091	1956	0.837
NULL	Int_J_Mol_Sci_2014_Sep_29_15(10)_17380-17395.nxml.txt.nlp	25268613	SENT302	5	5	1	1	cisplatin	CCN2	PA449014	1490	0.837
NULL	Diabetologia_2009_May_28_52(5)_891-900.nxml.txt.nlp	19252894	SENT336	21	21	8	8	pioglitazone	AS160	PA450970	9882	0.837
NULL	Nat_Chem_Biol_2010_Apr_28_6(4)_291-299.nxml.txt.nlp	20190765	SENT114	23	23	29	29	dasatinib	LYN	PA162372878	4067	0.837
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT164	30	30	33	33	metformin	HIF-1	PA450395	29072	0.837
NULL	Cancer_Immunol_Immunother_2013_Aug_27_62(10)_1637-1648.nxml.txt.nlp	23982484	SENT40	11	11	18	18	lenalidomide	IL-2	PA162363968	3558	0.837
NULL	Acta_Neuropathol_2015_Oct_17_129_81-96.nxml.txt.nlp	25322817	SENT195	8	8	33	33	capsaicin	Rho	PA448776	29984	0.837
NULL	Curr_Neuropharmacol_2014_Jan_12(1)_2-36.nxml.txt.nlp	24533013	SENT208	28	28	20	20	memantine	CB1	PA10364	1268	0.837
NULL	Eur_J_Endocrinol_2011_Jan_164(1)_69-74.nxml.txt.nlp	20961967	SENT33	21	21	11	11	pioglitazone	OPG	PA450970	690	0.837
NULL	Pan_Afr_Med_J_2012_Jul_9_12_67.nxml.txt.nlp	23024826	SENT7	8	8	4	4	doxorubicin	CHOP	PA449412	1649	0.837
NULL	Brain_Behav_2012_Mar_2(2)_155-177.nxml.txt.nlp	22574283	SENT461	18	18	6	6	paclitaxel	CB2	PA450761	1269	0.837
NULL	Oncotarget_2014_Jun_3_5(13)_4920-4928.nxml.txt.nlp	24952482	SENT98	5	5	10	10	crizotinib	HGF	PA165946122	3569;6654;3082	0.837
NULL	Acta_Pharmacol_Sin_2009_Jan_22_30(1)_107-112.nxml.txt.nlp	19098936	SENT95	15	15	20	20	pioglitazone	MCP-1	PA450970	6347	0.837
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT203	30	30	38	38	adalimumab	CD36	PA10004	948	0.837
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT360	35	35	11	11	ziprasidone	PRL	PA451974	5617	0.837
NULL	Nat_Commun_2014_Jun_25_5_4182.nxml.txt.nlp	24964370	SENT94	11	11	0	0	cisplatin	CT26	PA449014	168400	0.837
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1013.nxml.txt.nlp	24457957	SENT89	5	5	14	14	bortezomib	NOXA	PA10252	5366	0.837
NULL	Adolesc_Health_Med_Ther_2013_Aug_27_4_79-87.nxml.txt.nlp	24600298	SENT35	27	27	13	13	raltegravir	UGT1A1		54658	0.837
NULL	Clin_Interv_Aging_2015_Jan_6_10_157-174.nxml.txt.nlp	25609933	SENT251	35	35	24	24	tamoxifen	IMPACT	PA451581	55364	0.837
NULL	Int_J_Breast_Cancer_2011_Feb_14_2011_618757.nxml.txt.nlp	22332014	SENT150	8	8	6	6	anastrozole	ATAC	PA448432	6375	0.837
NULL	Evid_Based_Complement_Alternat_Med_2013_Mar_14_2013_429706.nxml.txt.nlp	23573127	SENT205	44	44	18	18	indomethacin	CD4	PA449982	920	0.837
NULL	BMJ_Open_2014_Aug_30_4(8)_e005986.nxml.txt.nlp	25180056	SENT111	0	0	13	13	carbamazepine	CYP1A2	PA448785	1544	0.837
NULL	Breast_Cancer_Res_2014_May_23_16(3)_R50.nxml.txt.nlp	24887458	SENT24	43	43	30	30	maytansine	DM1	PA165291473	338023;1760;28509	0.837
NULL	Acta_Pharmacol_Sin_2013_Apr_18_34(4)_555-560.nxml.txt.nlp	23503472	SENT6	21	21	13	13	cyclosporine	ABCB1	PA449167	5243	0.837
NULL	Oncotarget_2013_Aug_15_4(9)_1438-1448.nxml.txt.nlp	23988457	SENT119	28	28	12	12	lenalidomide	RINF	PA162363968	51523	0.837
NULL	Iran_J_Pharm_Res_2015_Winter_14(1)_27-34.nxml.txt.nlp	25561909	SENT66	13	13	3	3	rifampin	MSN	PA451250	4478	0.837
NULL	J_Cell_Biol_2001_Oct_29_155(3)_427-438.nxml.txt.nlp	11673478	SENT179	0	0	32	32	pp2	PP1		5540;5464	0.837
NULL	Br_J_Cancer_2010_Jun_29_103(1)_61-72.nxml.txt.nlp	20588279	SENT36	17	17	25	25	trastuzumab	HER-2	PA451743	2064	0.837
NULL	Endocrinol_Metab_(Seoul)_2013_Dec_12_28(4)_262-274.nxml.txt.nlp	24396690	SENT156	23	23	2	2	liraglutide	GLP-1	PA165958364	100125288	0.837
NULL	Biosci_Rep_2013_Sep_17_33(5)_e00068.nxml.txt.nlp	23919527	SENT215	25	25	28	28	guanidine	CXCL8	PA164781028	3576	0.837
NULL	Arthritis_Res_Ther_2005_May_18_7(Suppl_3)_S19-S25.nxml.txt.nlp	15960818	SENT226	11	11	5	5	vincristine	CHOP	PA451879	1649	0.837
NULL	Ann_Hematol_2010_Nov_25_89(11)_1115-1124.nxml.txt.nlp	20499237	SENT118	35	35	5	5	fludarabine	CD5	PA449655	921	0.837
NULL	J_Cell_Mol_Med_2014_Apr_20_18(4)_709-720.nxml.txt.nlp	24444314	SENT127	3	3	10	10	losartan	Met	PA450268	79811	0.837
NULL	Iran_J_Pharm_Res_2015_Winter_14(1)_321-328.nxml.txt.nlp	25561938	SENT21	4	4	24	24	forskolin	VASP	PA146096022	7408	0.837
NULL	Front_Pharmacol_2014_Nov_21_5_257.nxml.txt.nlp	25484865	SENT247	12	12	6	6	nilotinib	ABCB1	PA165958345	5243	0.837
NULL	Hematol_Rep_2012_Apr_13_4(2)_e7.nxml.txt.nlp	22826797	SENT41	6	6	9	9	hydroxyurea	gamma	PA449942	9913	0.837
NULL	Carcinogenesis_2010_Dec_27_31(12)_2049-2057.nxml.txt.nlp	20876285	SENT232	12	12	33	33	tamoxifen	HER2	PA451581	2064	0.837
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT419	12	12	24	24	heparin	FGF1	PA449855	2246	0.837
NULL	Clin_Pharmacokinet_2014_Aug_21_53(10)_931-941.nxml.txt.nlp	25141974	SENT179	15	15	11	11	carbamazepine	CYP3A	PA448785	1574	0.837
NULL	AMB_Express_2014_May_22_4_37.nxml.txt.nlp	25401060	SENT28	11	11	2	2	nicotine	S16	PA450626	6217	0.837
NULL	Pharmaceuticals_(Basel)_2014_May_14_7(5)_621-633.nxml.txt.nlp	24830987	SENT216	39	39	13	13	ethanol	FDG	PA448073	23583	0.837
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT10	10	10	1	1	phenprocoumon	VKORC1	PA450921	79001	0.837
NULL	Chem_Cent_J_2012_May_11_6_41.nxml.txt.nlp	22578215	SENT119	18	18	29	29	naringin	castor	PA151958360	54897	0.837
NULL	Exp_Ther_Med_2013_Dec_26_6(6)_1359-1364.nxml.txt.nlp	24255662	SENT14	15	15	6	6	dexmedetomidine	IL-6	PA449256	3569	0.837
NULL	Arthritis_Res_Ther_2012_Oct_29_14(5)_R233.nxml.txt.nlp	23107834	SENT108	12	12	2	2	zidovudine	COX	PA451954	1351	0.837
NULL	Evid_Based_Complement_Alternat_Med_2013_May_28_2013_629750.nxml.txt.nlp	23781265	SENT28	7	7	34	34	capsaicin	ATF4	PA448776	468	0.837
NULL	Cardiovasc_Diabetol_2005_May_15_4_6.nxml.txt.nlp	15892894	SENT128	15	15	8	8	losartan	DBP	PA450268	3295;1628;2638	0.837
NULL	Iran_J_Pharm_Res_2014_Summer_13(3)_853-862.nxml.txt.nlp	25276185	SENT24	33	33	16	16	mirtazapine	CYP3A4	PA450522	1576	0.837
NULL	Endocrinol_Metab_(Seoul)_2014_Sep_25_29(3)_379-387.nxml.txt.nlp	25309798	SENT105	2	2	9	9	resveratrol	CLOCK		9575	0.837
NULL	Breast_Cancer_Res_2014_Sep_12_16(5)_436.nxml.txt.nlp	25213081	SENT161	21	21	12	12	tamoxifen	ERK2	PA451581	5594	0.837
NULL	Lab_Invest_2011_Apr_14_91(4)_598-608.nxml.txt.nlp	21321535	SENT127	6	6	19	19	sorafenib	CD11b	PA7000	3684	0.837
NULL	Alcohol_Res_Health_2010_33(1-2)_76-86.nxml.txt.nlp	23579938	SENT80	0	0	3	3	resveratrol	SIRT1		23411	0.837
NULL	Mol_Biol_Cell_2013_Sep_15_24(18)_2849-2860.nxml.txt.nlp	23885123	SENT22	30	30	14	14	dextran	JAM-A	PA449261	50848	0.837
NULL	EMBO_Mol_Med_2013_Dec_8_5(12)_1821-1834.nxml.txt.nlp	24293316	SENT95	42	42	28	28	doxorubicin	UNC5B	PA449412	219699	0.836
NULL	Environ_Health_Perspect_2008_Jan_11_116(1)_57-63.nxml.txt.nlp	18197300	SENT161	17	17	20	20	chlorzoxazone	CYP2E1	PA448971	1571	0.836
NULL	BMB_Rep_2014_Jan_47(1)_33-38.nxml.txt.nlp	24209634	SENT117	38	38	31	31	cisplatin	CXCR4	PA449014	7852	0.836
NULL	Case_Rep_Gastroenterol_2012_Jul_5_6(2)_438-445.nxml.txt.nlp	22855659	SENT36	18	18	6	6	rituximab	PPL	PA451261	5493	0.836
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT140	15	15	5	5	perifosine	DR5	PA165291471	8795	0.836
NULL	Kidney_Int_Suppl_(2011)_2012_Mar_29_2(1)_69-88.nxml.txt.nlp	25018920	SENT360	8	8	12	12	theophylline	NAC	PA451647	22861	0.836
NULL	Breast_Cancer_Res_2012_Mar_9_14(2)_R41.nxml.txt.nlp	22405131	SENT11	0	0	22	22	estradiol	IL-17RA	PA449503	23765	0.836
NULL	J_Cell_Biol_1983_Apr_1_96(4)_1072-1081.nxml.txt.nlp	6403556	SENT5	10	10	12	12	trifluoperazine	TFP	PA451771	7034	0.836
NULL	Exp_Ther_Med_2014_Mar_10_7(3)_640-648.nxml.txt.nlp	24520260	SENT9	5	5	21	21	resveratrol	p38		10598;1432;7965	0.836
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_May_12_68(Pt_6)_o1668.nxml.txt.nlp	22719463	SENT67	7	7	4	4	ethanol	mol	PA448073	90527	0.836
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT104	27	27	22	22	erlotinib	MEK2	PA134687924	5605	0.836
NULL	Neural_Plast_2007_Sep_19_2007_26496.nxml.txt.nlp	18301726	SENT77	25	25	16	16	fluoxetine	TIEG1	PA449673	7071	0.836
NULL	Oxid_Med_Cell_Longev_2010_Mar-Apr_3(2)_101-108.nxml.txt.nlp	20716934	SENT42	29	29	38	38	pioglitazone	RAGE	PA450970	177	0.836
NULL	Mediators_Inflamm_2014_Nov_4_2014_708608.nxml.txt.nlp	25580060	SENT56	21	21	3	3	hyaluronidase	IL-8	PA164745713	3576	0.836
NULL	Iran_J_Public_Health_2011_Dec_31_40(4)_122-128.nxml.txt.nlp	23113111	SENT85	6	6	22	22	malathion	ANOVA	PA164748092	4858	0.836
NULL	Cell_Rep_2012_Jul_26_2(1)_185-197.nxml.txt.nlp	22840408	SENT719	37	37	9	9	tetracycline	GPI8	PA451640	10026	0.836
NULL	Leukemia_2013_Feb_31_27(2)_278-285.nxml.txt.nlp	22907049	SENT35	7	7	23	23	imatinib	KIT	PA10804	3815	0.836
NULL	Clin_Sci_(Lond)_2012_May_1_122(Pt_9)_421-428.nxml.txt.nlp	22092038	SENT190	23	23	29	29	doxycycline	AP-1	PA449415	2353;3727;2354;3725	0.836
NULL	Case_Rep_Dermatol_2011_Oct_11_3(3)_223-227.nxml.txt.nlp	22135629	SENT66	7	7	17	17	trastuzumab	HER2	PA451743	2064	0.836
NULL	Cancer_Microenviron_2009_Sep_26_2(Suppl_1)_19-204.nxml.txt.nlp	NULL	SENT2557	19	19	21	21	tamoxifen	ENL	PA451581	4298	0.836
NULL	Antimicrob_Agents_Chemother_2014_Nov_10_59(1)_505-513.nxml.txt.nlp	25385096	SENT242	5	5	20	20	primaquine	CYP3A4	PA451103	1576	0.836
NULL	Cancer_Cell_Int_2013_Feb_13_13_15.nxml.txt.nlp	23402326	SENT119	30	30	15	15	gefitinib	EGFR	PA131301952	1956	0.836
NULL	Oncol_Rep_2013_Mar_8_29(3)_917-924.nxml.txt.nlp	23314174	SENT32	17	17	2	2	sorafenib	HIF-1	PA7000	29072	0.836
NULL	Breast_Cancer_Res_2011_Jun_20_13(3)_R65.nxml.txt.nlp	21689417	SENT338	2	2	18	18	trastuzumab	AKT	PA451743	207	0.836
NULL	Arthritis_Res_Ther_2014_Dec_5_16(6)_500.nxml.txt.nlp	25475240	SENT43	25	25	16	16	methotrexate	ACPA	PA450428	5657	0.836
NULL	Biologics_2012_Sep_25_6_337-345.nxml.txt.nlp	23055691	SENT151	22	22	35	35	carboplatin	EGFR	PA448803	1956	0.836
NULL	Diabetes_Care_2012_Feb_16_35(2)_327-333.nxml.txt.nlp	22179958	SENT144	44	44	21	21	metformin	B12	PA450395	7126;4709	0.836
NULL	Acta_Pharmacol_Sin_2010_Jan_28_31(1)_10-18.nxml.txt.nlp	20037604	SENT128	25	25	23	23	valsartan	AT-1	PA451848	9197	0.836
NULL	J_Oncol_2012_Apr_10_2012_931071.nxml.txt.nlp	22570654	SENT49	18	18	26	26	plerixafor	CD34	PA165958410	947	0.836
NULL	Case_Rep_Hematol_2012_Mar_29_2012_868151.nxml.txt.nlp	22953079	SENT39	14	14	27	27	rituximab	CHOP	PA451261	1649	0.836
NULL	Case_Rep_Oncol_2010_May_7_3(2)_154-159.nxml.txt.nlp	20740189	SENT11	31	31	13	13	oxaliplatin	KRAS	PA131285527	3845	0.836
NULL	Case_Rep_Crit_Care_2014_Aug_19_2014_242703.nxml.txt.nlp	25215245	SENT170	10	10	4	4	nicardipine	APE	PA450620	55704;328	0.836
NULL	Endocrinology_2011_Jul_10_152(7)_2845-2856.nxml.txt.nlp	21558311	SENT269	3	3	18	18	estradiol	aromatase	PA449503	1588	0.836
NULL	J_Cardiothorac_Surg_2014_Jun_19_9_105.nxml.txt.nlp	24942178	SENT61	13	13	16	16	protamine	ACT	PA10366	12;11332;9457;641455	0.836
NULL	Endocr_Relat_Cancer_2014_Jun_21(3)_R209-R225.nxml.txt.nlp	24500760	SENT292	2	2	12	12	resveratrol	CD95		355	0.836
NULL	Exp_Ther_Med_2014_Apr_13_7(4)_799-803.nxml.txt.nlp	24669235	SENT70	8	8	11	11	metformin	GLP-1	PA450395	100125288	0.836
NULL	J_Mol_Signal_2011_Jul_20_6_7.nxml.txt.nlp	21774804	SENT287	31	31	12	12	dasatinib	EGFR	PA162372878	1956	0.836
NULL	Biosci_Rep_2014_Jun_5_34(3)_e00110.nxml.txt.nlp	24702277	SENT239	9	9	1	1	cisplatin	NAC1	PA449014	112939;6323	0.836
NULL	Mol_Cancer_2010_Apr_15_9_77.nxml.txt.nlp	20398291	SENT77	7	7	3	3	geldanamycin	Hsp90	PA152031327	3320	0.836
NULL	Oncotarget_2012_Oct_20_3(10)_1068-1111.nxml.txt.nlp	23085539	SENT535	22	22	11	11	gefitinib	PTEN	PA131301952	5728	0.836
NULL	Cancer_Cell_Int_2014_Feb_28_14_18.nxml.txt.nlp	24576043	SENT105	8	8	20	20	flavopiridol	Mcl-1	PA452627	4170	0.836
NULL	Exp_Diabetes_Res_2012_Sep_20_2012_936518.nxml.txt.nlp	23049542	SENT131	6	6	31	31	glucose	TRPV4	PA449773	59341	0.836
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S276-S278.nxml.txt.nlp	21525468	SENT20	2	2	16	16	metformin	GLP-1	PA450395	100125288	0.836
NULL	Biomed_Res_Int_2014_Jan_2_2014_126586.nxml.txt.nlp	24527434	SENT113	6	6	13	13	metformin	AMPK	PA450395	5563	0.836
NULL	Pharmacogn_Mag_2014_Oct-Dec_10(40)_536-540.nxml.txt.nlp	25422558	SENT118	31	31	25	25	ethanol	SLB	PA448073	26160	0.836
NULL	Curr_Cardiol_Rev_2009_Nov_5(4)_251-262.nxml.txt.nlp	21037841	SENT166	41	41	19	19	ibutilide	spatial	PA449958	219793	0.836
NULL	JAKSTAT_2013_Jul_1_2(3)_e25025.nxml.txt.nlp	24069563	SENT186	5	5	8	8	hydroxyurea	IFN	PA449942	3439	0.836
NULL	Nucleic_Acids_Res_2012_Jan_9_40(1)_181-195.nxml.txt.nlp	21908405	SENT359	18	18	9	9	camptothecin	BRCA1	PA153590860	672	0.836
NULL	J_Gastrointest_Surg_2012_Apr_13_16(4)_842-848.nxml.txt.nlp	22246855	SENT96	19	19	15	15	gemcitabine	BTC	PA449748	685	0.836
NULL	Oncotarget_2014_Aug_4_5(17)_7776-7787.nxml.txt.nlp	25277200	SENT50	4	4	13	13	carboplatin	ANXA4	PA448803	307	0.836
NULL	Braz_J_Microbiol_2014_Aug_29_45(2)_677-687.nxml.txt.nlp	25242958	SENT184	1	1	8	8	lipase	C10	PA450239	113246	0.836
NULL	Br_J_Cancer_2009_Jan_13_100(1)_19-23.nxml.txt.nlp	19018262	SENT143	26	26	29	29	sorafenib	SHARP	PA7000	23013	0.836
NULL	Indian_J_Pharm_Sci_2013_Jan-Feb_75(1)_94-98.nxml.txt.nlp	23901167	SENT30	10	10	34	34	phenacetin	CYP2B6	PA450897	1555	0.836
NULL	Exp_Ther_Med_2013_Jan_10_5(1)_11-16.nxml.txt.nlp	23251234	SENT168	18	18	10	10	cetuximab	UST	PA10040	10090	0.836
NULL	Front_Aging_Neurosci_2014_Sep_11_6_218.nxml.txt.nlp	25309423	SENT226	3	3	14	14	resveratrol	AMPK		5563	0.836
NULL	J_Mol_Signal_2010_May_10_5_4.nxml.txt.nlp	20459745	SENT61	2	2	6	6	cisplatin	p53	PA449014	7157	0.836
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT63	7	7	1	1	methotrexate	MSH2	PA450428	4436	0.836
NULL	FEBS_Open_Bio_2013_Dec_30_4_96-104.nxml.txt.nlp	24490130	SENT94	15	15	23	23	cisplatin	BRCA1	PA449014	672	0.836
NULL	Acta_Pharmacol_Sin_2010_Jun_4_31(6)_709-717.nxml.txt.nlp	20523342	SENT211	38	38	31	31	repaglinide	IGF2BP2	PA451234	10644	0.836
NULL	J_Biol_Chem_2013_Apr_26_288(17)_11865-11876.nxml.txt.nlp	23449983	SENT838	7	7	5	5	plerixafor	CXCR4	PA165958410	7852	0.836
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT290	0	0	16	16	olanzapine	PRL	PA450688	5617	0.836
NULL	Atherosclerosis_2010_Jul_211(1)_271-277.nxml.txt.nlp	20138279	SENT151	23	23	14	14	oxygen	eNOS	PA450744	4846	0.836
NULL	Biomed_Res_Int_2014_Jan_2_2014_682010.nxml.txt.nlp	24524084	SENT176	23	23	37	37	imatinib	CD28	PA10804	1493;940	0.836
NULL	J_Res_Med_Sci_2012_Feb_17(2)_159-163.nxml.txt.nlp	23264790	SENT100	41	41	26	26	imatinib	CD117	PA10804	3815	0.836
NULL	Gene_Regul_Syst_Bio_2014_Mar_4_8_63-73.nxml.txt.nlp	24634581	SENT101	0	0	9	9	minocycline	NANOS1	PA450519	340719	0.836
NULL	Oncotarget_2012_May_4_3(4)_395-398.nxml.txt.nlp	22565037	SENT9	29	29	43	43	metformin	HER2	PA450395	2064	0.836
NULL	Cell_Commun_Signal_2013_Nov_11_11_86.nxml.txt.nlp	24215724	SENT381	10	10	19	19	thrombin	PAR1	PA451674	79581;2149	0.836
NULL	Nucleic_Acids_Res_2005_Jun_8_33(10)_3283-3291.nxml.txt.nlp	15944449	SENT40	4	4	9	9	mechlorethamine	XRCC2	PA450336	7516	0.836
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT49	42	42	11	11	chlorzoxazone	CYP2C9	PA448971	1559	0.836
NULL	Acta_Pharmacol_Sin_2012_Jan_28_33(1)_75-81.nxml.txt.nlp	22120969	SENT141	7	7	5	5	exenatide	GLP-1	PA164749238	100125288	0.836
NULL	Clin_Epigenetics_2010_Sep_18_1(3-4)_101-116.nxml.txt.nlp	21258631	SENT228	11	11	20	20	curcumin	DNMT1	PA151958596	1786	0.836
NULL	Oncotarget_2013_Nov_24_4(12)_2186-2207.nxml.txt.nlp	24327604	SENT190	19	19	3	3	bortezomib	KLF4	PA10252	9314	0.836
NULL	Exp_Cell_Res_2011_Apr_15_317(7)_1028-1039.nxml.txt.nlp	21237154	SENT252	13	13	9	9	staurosporine	JNK	PA165109623	5599	0.836
NULL	Biomed_Res_Int_2014_Jun_26_2014_161346.nxml.txt.nlp	25054130	SENT225	7	7	21	21	curcumin	STZ	PA151958596	6484	0.836
NULL	Cancer_Cell_Int_2011_Aug_19_11_29.nxml.txt.nlp	21854619	SENT222	14	14	8	8	cisplatin	FANCD2	PA449014	2177	0.836
NULL	Mycopathologia_2013_Apr_2_175(3-4)_249-254.nxml.txt.nlp	23546772	SENT38	17	17	24	24	sertaconazole	DDC	PA164748328	1644	0.836
NULL	Acta_Pharmacol_Sin_2010_Apr_22_31(4)_450-454.nxml.txt.nlp	20305679	SENT5	22	22	17	17	repaglinide	NOS1AP	PA451234	9722	0.836
NULL	J_Exp_Bot_2012_Jan_6_63(1)_121-130.nxml.txt.nlp	21984651	SENT243	25	25	5	5	starch	PDI	PA451492	5034;64714;29943	0.836
NULL	Exp_Diabetes_Res_2011_Apr_26_2011_215764.nxml.txt.nlp	21584276	SENT23	5	5	1	1	exenatide	GLP-1	PA164749238	100125288	0.836
NULL	Cancers_(Basel)_2010_Dec_29_3(1)_79-90.nxml.txt.nlp	24212607	SENT108	18	18	24	24	gemcitabine	MAP3K7	PA449748	6885	0.836
NULL	Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.nxml.txt.nlp	24736980	SENT269	19	19	27	27	rosuvastatin	OATP1B1	PA134308647	10599	0.836
NULL	Glycobiology_2011_Jun_11_21(6)_813-823.nxml.txt.nlp	21317243	SENT77	25	25	6	6	galactose	EPO	PA449725	7076;8288;2056	0.836
NULL	Cell_Death_Dis_2012_Jun_21_3(6)_e327.nxml.txt.nlp	22717582	SENT23	16	16	8	8	vincristine	NOXA	PA451879	5366	0.836
NULL	Front_Oncol_2014_Oct_21_4_285.nxml.txt.nlp	25374842	SENT320	5	5	21	21	doxorubicin	p53	PA449412	7157	0.836
NULL	Mol_Cancer_2012_Jun_26_11_43.nxml.txt.nlp	22731636	SENT242	17	17	1	1	pp2	PP2		4888	0.836
NULL	Chin_J_Cancer_2012_Nov_31(11)_507-518.nxml.txt.nlp	22640626	SENT173	43	43	29	29	nilotinib	DDR1	PA165958345	780	0.836
NULL	Clin_Transl_Allergy_2014_Feb_28_4(Suppl_1)_P35.nxml.txt.nlp	25045492	SENT14	0	0	32	32	atorvastatin	CD40	PA448500	958	0.836
NULL	Evid_Based_Complement_Alternat_Med_2013_Mar_28_2013_845172.nxml.txt.nlp	23606892	SENT177	0	0	16	16	masoprocol	HSL	PA164746493	3991	0.836
NULL	Nat_Med_2010_Jun_23_16(6)_671-677.nxml.txt.nlp	20495567	SENT212	23	23	8	8	sorafenib	CREB3L2	PA7000	64764	0.836
NULL	J_Invest_Dermatol_2013_Aug_133(8)_1928-1929.nxml.txt.nlp	23856932	SENT31	8	8	24	24	vemurafenib	BRAF	PA165946873	673	0.836
NULL	J_Mol_Signal_2011_Aug_10_6_8.nxml.txt.nlp	21831305	SENT112	11	11	21	21	isoproterenol	AKAP5	PA450121	9495	0.836
NULL	Cancer_Cell_Int_2013_May_15_13_42.nxml.txt.nlp	23672670	SENT205	22	22	12	12	paclitaxel	RAIDD	PA450761	8738	0.836
NULL	Int_J_Mol_Sci_2014_Mar_20_15(3)_4965-4976.nxml.txt.nlp	24658440	SENT72	41	41	11	11	infliximab	P-gp	PA452639	5243	0.836
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT161	0	0	8	8	metformin	AMPK	PA450395	5563	0.836
NULL	Eur_J_Immunol_2012_Nov_18_42(11)_3049-3061.nxml.txt.nlp	22806397	SENT11	3	3	14	14	imiquimod	CD127	PA449972	3575	0.836
NULL	Adv_Hematol_2010_Dec_30_2010_627401.nxml.txt.nlp	21234094	SENT107	8	8	6	6	cyclophosphamide	CHOP	PA449165	1649	0.836
NULL	Int_J_Biol_Sci_2014_Jan_11_10(2)_142-148.nxml.txt.nlp	24520212	SENT103	31	31	25	25	tamoxifen	WWOX	PA451581	51741	0.836
NULL	Clin_Interv_Aging_2008_Sep_3(3)_483-489.nxml.txt.nlp	18982918	SENT152	4	4	27	27	alendronate	BSAP	PA448082	5079	0.836
NULL	J_Hum_Genet_2013_Jun_23_58(6)_339-345.nxml.txt.nlp	23697979	SENT114	30	30	41	41	prasugrel	CYP2C19	PA154410481	1557	0.836
NULL	Mol_Cancer_2009_Aug_25_8_66.nxml.txt.nlp	19706164	SENT262	15	15	30	30	celecoxib	FBS	PA448871	64319;26269	0.836
NULL	J_Korean_Med_Sci_2007_Jun_30_22(3)_557-559.nxml.txt.nlp	17596671	SENT53	22	22	18	18	warfarin	CYP2C9	PA451906	1559	0.836
NULL	Pharmaceutics_2011_Oct_12_3(4)_680-705.nxml.txt.nlp	24309303	SENT129	18	18	30	30	metformin	MATE2	PA450395	146802	0.836
NULL	Lancet_2011_Jun_9_377(9784)_2181-2192.nxml.txt.nlp	21663949	SENT7	14	14	1	1	simvastatin	SHARP	PA451363	23013	0.836
NULL	Ann_Oncol_2014_Oct_18_25(10)_1871-1888.nxml.txt.nlp	25234545	SENT317	10	10	7	7	tamoxifen	aromatase	PA451581	1588	0.836
NULL	Breast_Cancer_Res_2012_Feb_9_14(1)_R27.nxml.txt.nlp	22321971	SENT392	23	23	7	7	estradiol	aromatase	PA449503	1588	0.836
NULL	Oncologist_2010_Mar_9_15(3)_236-245.nxml.txt.nlp	20215359	SENT33	16	16	9	9	sunitinib	VEGFR	PA162372840	3791	0.836
NULL	Int_J_Mol_Sci_2014_Nov_7_15(11)_20500-20517.nxml.txt.nlp	25387078	SENT132	5	5	23	23	sorafenib	Mcl-1	PA7000	4170	0.836
NULL	Biomed_Res_Int_2014_Apr_10_2014_580852.nxml.txt.nlp	24812624	SENT166	0	0	3	3	resveratrol	PTEN		5728	0.836
NULL	Nucl_Recept_Signal_2009_Jan_16_7_e001.nxml.txt.nlp	19240808	SENT78	4	4	26	26	hyperforin	SXR	PA165985514	8856	0.836
NULL	Clin_Ophthalmol_2009_Jun_2_3_175-182.nxml.txt.nlp	19668562	SENT129	1	1	8	8	bevacizumab	VEGF-A	PA130232992	7422	0.836
NULL	Br_J_Pharmacol_2014_Jun_15_171(11)_2705-2725.nxml.txt.nlp	24467436	SENT82	8	8	1	1	procainamide	NAT2	PA451108	10;81539	0.836
NULL	Adv_Hematol_2012_Mar_8_2012_856341.nxml.txt.nlp	22496694	SENT92	9	9	16	16	ritonavir	P-gp	PA451260	5243	0.836
NULL	Diabetes_2013_Jul_14_62(7)_2595-2604.nxml.txt.nlp	23524641	SENT184	3	3	8	8	sitagliptin	GLP-1	PA164748978	100125288	0.836
NULL	J_Hematol_Oncol_2013_Nov_5_6_83.nxml.txt.nlp	24283248	SENT74	23	23	17	17	nutlin-3	PUMA		27113	0.836
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT95	6	6	17	17	imatinib	ABCG2	PA10804	9429	0.836
NULL	Braz_J_Microbiol_2011_Dec_1_Oct-Dec_42(4)_1300-1307.nxml.txt.nlp	24031756	SENT30	27	27	43	43	tioconazole	OTC	PA164746156	5009	0.836
NULL	Evid_Based_Complement_Alternat_Med_2013_Mar_28_2013_845172.nxml.txt.nlp	23606892	SENT177	5	5	16	16	lipase	HSL	PA450239	3991	0.836
NULL	Br_J_Pharmacol_2013_Jun_27_169(4)_933-948.nxml.txt.nlp	23517055	SENT10	23	23	31	31	bepridil	NCX	PA164754755	3196	0.836
NULL	Dev_Dyn_2011_Nov_18_240(11)_2520-2528.nxml.txt.nlp	22012594	SENT199	26	26	46	46	thrombin	CO2	PA451674	4513	0.836
NULL	Carcinogenesis_2013_Mar_7_34(3)_703-712.nxml.txt.nlp	23222814	SENT80	23	23	7	7	curcumin	p53	PA151958596	7157	0.836
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Apr_29_67(Pt_5)_o1251.nxml.txt.nlp	21754542	SENT67	28	28	7	7	ethanol	mol	PA448073	90527	0.836
NULL	Curr_Genomics_2014_Jun_15(3)_217-230.nxml.txt.nlp	24955029	SENT650	16	16	27	27	oxygen	ROS	PA450744	6098	0.836
NULL	Environ_Health_Perspect_2006_Sep_23_114(9)_1401-1406.nxml.txt.nlp	16966095	SENT165	44	44	34	34	arsenite	p53	PA452638	7157	0.836
NULL	Cell_Commun_Signal_2004_Jun_25_2_5.nxml.txt.nlp	15219238	SENT222	11	11	16	16	cisplatin	p53	PA449014	7157	0.836
NULL	Mol_Cancer_2010_Aug_16_9_217.nxml.txt.nlp	20712901	SENT29	4	4	14	14	curcumin	STAT3	PA151958596	6774	0.836
NULL	Arthritis_Res_Ther_2013_Sep_27_15(5)_R138.nxml.txt.nlp	24289726	SENT397	23	23	2	2	anakinra	IL-10	PA10799	3586	0.836
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_May_14_3(5)_e114.nxml.txt.nlp	24827872	SENT122	40	40	9	9	bortezomib	RAF1	PA10252	5894	0.836
NULL	Chem_Rev_2011_Oct_12_111(10)_5899-5921.nxml.txt.nlp	21923193	SENT542	14	14	5	5	ibuprofen	FAAH	PA449957	79152;2166	0.836
NULL	Aging_(Albany_NY)_2012_Dec_6_4(11)_823-842.nxml.txt.nlp	23235539	SENT180	34	34	2	2	bleomycin	SRM	PA448645	6723;6725	0.836
NULL	Breast_Cancer_Res_2011_Jun_21_13(3)_R66.nxml.txt.nlp	21693010	SENT44	0	0	14	14	sunitinib	KIT	PA162372840	3815	0.836
NULL	Cell_Death_Dis_2010_Oct_21_1(10)_e86.nxml.txt.nlp	21368859	SENT193	29	29	11	11	cisplatin	TRAIL	PA449014	8743	0.836
NULL	Arthritis_Res_Ther_2009_Apr_30_11(2)_R58.nxml.txt.nlp	19405951	SENT71	6	6	0	0	clodronate	RANKL	PA10239	8600	0.836
NULL	Cardiol_Ther_2013_Jun_1_2(1)_111-124.nxml.txt.nlp	25135294	SENT140	39	39	10	10	dabigatran	ACT		12;11332;9457;641455	0.836
NULL	Parasit_Vectors_2010_Nov_17_3_106.nxml.txt.nlp	21083888	SENT55	2	2	5	5	fasudil	Rho	PA165946121	29984	0.836
NULL	Indian_J_Pharmacol_2012_Sep-Oct_44(5)_624-628.nxml.txt.nlp	23112426	SENT97	8	8	13	13	pravastatin	CYP3A4	PA451089	1576	0.836
NULL	Oncogene_2010_Jan_7_29(1)_81-92.nxml.txt.nlp	19784067	SENT104	9	9	4	4	cisplatin	BRG1	PA449014	6597	0.836
NULL	Diabetes_2011_May_23_60(5)_1519-1527.nxml.txt.nlp	21430087	SENT151	4	4	0	0	lipase	HSL	PA450239	3991	0.836
NULL	Br_J_Cancer_2013_Jun_25_108(12)_2485-2494.nxml.txt.nlp	23695022	SENT119	16	16	4	4	vincristine	ABCB1	PA451879	5243	0.836
NULL	Br_J_Cancer_2011_Jun_28_105(1)_1-8.nxml.txt.nlp	21654681	SENT148	24	24	15	15	erlotinib	EGFR	PA134687924	1956	0.836
NULL	J_Neuroinflammation_2011_Dec_21_8_178.nxml.txt.nlp	22189096	SENT64	23	23	3	3	neomycin	TLR3	PA450608	7098	0.836
NULL	Br_J_Cancer_2011_Aug_23_105(5)_698-708.nxml.txt.nlp	21811256	SENT27	29	29	39	39	tamoxifen	aromatase	PA451581	1588	0.836
NULL	Korean_Circ_J_2014_Mar_12_44(2)_97-104.nxml.txt.nlp	24653739	SENT149	12	12	3	3	bosentan	IL-6	PA10034	3569	0.836
NULL	Ann_Surg_Oncol_2012_Apr_27_19(4)_1185-1191.nxml.txt.nlp	22031063	SENT177	8	8	5	5	tamoxifen	aromatase	PA451581	1588	0.836
NULL	AIDS_Res_Ther_2012_Oct_26_9_32.nxml.txt.nlp	23098156	SENT45	0	0	23	23	lopinavir	API	PA450264	5345	0.836
NULL	Cell_Death_Dis_2014_Apr_17_5(4)_e1182.nxml.txt.nlp	24743737	SENT109	32	32	3	3	capsaicin	TRPV1	PA448776	7442	0.836
NULL	Breast_Cancer_Res_2014_Sep_9_16(5)_433.nxml.txt.nlp	25212966	SENT320	2	2	9	9	aprotinin	ILEI	PA448472	10447	0.836
NULL	J_Immunother_Cancer_2014_Jul_15_2_24.nxml.txt.nlp	25089198	SENT77	16	16	18	18	imatinib	IFN	PA10804	3439	0.836
NULL	Nucleic_Acids_Res_2012_Jun_10_40(11)_4804-4815.nxml.txt.nlp	22328728	SENT162	8	8	6	6	resveratrol	SIRT1		23411	0.836
NULL	J_Cancer_Prev_2014_Mar_19(1)_39-46.nxml.txt.nlp	25337571	SENT21	28	28	35	35	ethanol	JNK	PA448073	5599	0.836
NULL	Mol_Cancer_2007_Oct_25_6_67.nxml.txt.nlp	17958915	SENT212	23	23	11	11	nilotinib	GM-CSF	PA165958345	1437	0.836
NULL	Nat_Commun_2013_Nov_27_4_2824.nxml.txt.nlp	24280686	SENT618	12	12	34	34	dextran	RhoB	PA449261	388	0.836
NULL	Osteoporos_Int_2008_Apr_12_19(4)_399-428.nxml.txt.nlp	18266020	SENT307	10	10	26	26	alendronate	PTH	PA448082	5741	0.836
NULL	Blood_Cancer_J_2013_Oct_4_3(10)_e150.nxml.txt.nlp	24096714	SENT157	35	35	8	8	bortezomib	IL2	PA10252	3558	0.836
NULL	Nat_Commun_2013_Apr_9_4_1684.nxml.txt.nlp	23575688	SENT126	6	6	11	11	forskolin	JNK2	PA146096022	5601	0.836
NULL	Br_J_Cancer_2012_Feb_14_106(4)_756-762.nxml.txt.nlp	22333708	SENT5	35	35	10	10	mitomycin	DSC1	PA450524	1825;1823	0.836
NULL	Front_Physiol_2012_Nov_19_3_410.nxml.txt.nlp	23181019	SENT386	18	18	14	14	trastuzumab	PTEN	PA451743	5728	0.836
NULL	Exp_Anim_2014_Aug_22_63(3)_277-287.nxml.txt.nlp	25077757	SENT95	17	17	9	9	resveratrol	EPM		2054	0.836
NULL	Breast_Cancer_Res_2011_Dec_16_13(6)_R131.nxml.txt.nlp	22177475	SENT12	20	20	36	36	cetuximab	HER2	PA10040	2064	0.836
NULL	Oncotarget_2012_May_23_3(5)_518-524.nxml.txt.nlp	22643838	SENT87	20	20	3	3	imatinib	MYL	PA10804	5371	0.836
NULL	Ann_Med_Health_Sci_Res_2012_Jul-Dec_2(2)_152-156.nxml.txt.nlp	23440669	SENT95	1	1	8	8	disopyramide	CYP3A4	PA449373	1576	0.836
NULL	J_Neuroinflammation_2011_Feb_4_8_10.nxml.txt.nlp	21294877	SENT172	32	32	20	20	capsaicin	TAC1	PA448776	6863	0.836
NULL	Arthritis_Res_Ther_2010_Oct_28_12(5)_219.nxml.txt.nlp	21062511	SENT137	7	7	20	20	infliximab	IFN	PA452639	3439	0.836
NULL	Nucl_Recept_Signal_2009_Jan_16_7_e001.nxml.txt.nlp	19240808	SENT405	6	6	13	13	phenytoin	SXR	PA450947	8856	0.836
NULL	Arch_Med_Sci_2014_Feb_24_10(1)_1-9.nxml.txt.nlp	24701207	SENT125	15	15	10	10	panitumumab	PIK3CA	PA162373091	5290	0.836
NULL	Neural_Plast_2007_Sep_19_2007_26496.nxml.txt.nlp	18301726	SENT82	22	22	14	14	fluoxetine	TIEG1	PA449673	7071	0.836
NULL	Iran_Red_Crescent_Med_J_2012_Dec_6_14(12)_782-786.nxml.txt.nlp	23483042	SENT37	25	25	20	20	teicoplanin	VISA	PA164746244	57506	0.836
NULL	Br_J_Pharmacol_2010_Sep_161(2)_288-307.nxml.txt.nlp	20735416	SENT125	28	28	12	12	pentobarbital	c-fos	PA450859	2353	0.836
NULL	Front_Behav_Neurosci_2010_Apr_5_4_14.nxml.txt.nlp	20407577	SENT297	10	10	4	4	cocaine	HDAC	PA449072	9734	0.836
NULL	Curr_Med_Chem_2013_Jun_20(19)_2415-2437.nxml.txt.nlp	23394552	SENT86	14	14	35	35	naproxen	COX	PA450595	1351	0.836
NULL	Diabetes_Care_2009_Nov_32(Suppl_2)_S223-S231.nxml.txt.nlp	19875556	SENT79	17	17	11	11	liraglutide	GLP-1	PA165958364	100125288	0.836
NULL	Eur_J_Med_Res_2014_Sep_16_19(1)_50.nxml.txt.nlp	25223338	SENT236	8	8	4	4	irinotecan	UGT1A1	PA450085	54658	0.836
NULL	Clinicoecon_Outcomes_Res_2014_Oct_17_6_451-461.nxml.txt.nlp	25378939	SENT128	16	16	19	19	vancomycin	HAP	PA451850	5915;10313	0.836
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT116	8	8	11	11	simvastatin	AKT	PA451363	207	0.836
NULL	Evid_Based_Complement_Alternat_Med_2011_Jan_9_2011_619650.nxml.txt.nlp	21799685	SENT30	11	11	16	16	ketanserin	5-HT2A	PA131053734	3356	0.836
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT88	19	19	2	2	nutlin-3	MDM2		4193	0.836
NULL	Mol_Cancer_2008_May_19_7_40.nxml.txt.nlp	18489772	SENT131	23	23	6	6	bortezomib	PIR	PA10252	8544	0.836
NULL	Oncol_Lett_2015_Jan_4_9(1)_91-95.nxml.txt.nlp	25435939	SENT73	16	16	33	33	mitomycin	IB2	PA450524	23542	0.836
NULL	Korean_J_Anesthesiol_2013_Dec_26_65(6)_501-507.nxml.txt.nlp	24427455	SENT129	43	43	11	11	neostigmine	NMB	PA450611	10457;4828	0.836
NULL	Br_J_Cancer_2010_Jun_29_103(1)_36-42.nxml.txt.nlp	20517311	SENT4	21	21	17	17	platinum	survivin	PA150595617	332	0.836
NULL	Mar_Drugs_2005_Nov_3_3(4)_119-125.nxml.txt.nlp	NULL	SENT3	5	5	30	30	phenol	IL-8	PA450913	3576	0.836
NULL	Evid_Based_Complement_Alternat_Med_2013_Aug_22_2013_423164.nxml.txt.nlp	24027594	SENT195	3	3	8	8	berberine	c-Jun	PA165860812	3725	0.836
NULL	Nucleic_Acids_Res_2005_Aug_5_33(14)_4466-4474.nxml.txt.nlp	16085756	SENT113	26	26	8	8	dextran	NHE	PA449261	285335	0.836
NULL	Indian_J_Pharm_Sci_2013_Nov-Dec_75(6)_680-687.nxml.txt.nlp	24591743	SENT35	20	20	30	30	gemfibrozil	CYP2C8	PA449750	1558	0.836
NULL	Clin_Exp_Gastroenterol_2012_May_14_5_49-59.nxml.txt.nlp	22649281	SENT89	9	9	20	20	rabeprazole	CYP2C19	PA451216	1557	0.836
NULL	Hematol_Rep_2011_Oct_28_3(3_Suppl)_e3.nxml.txt.nlp	22586511	SENT10	2	2	11	11	cyclophosphamide	CHOP	PA449165	1649	0.836
NULL	Drugs_R_D_2011_Sep_25_11(3)_227-249.nxml.txt.nlp	21902286	SENT83	5	5	16	16	decitabine	CD117	PA164749631	3815	0.836
NULL	Ann_Thorac_Med_2013_Apr-Jun_8(2)_109-115.nxml.txt.nlp	23741274	SENT169	6	6	4	4	docetaxel	CRT	PA449383	811	0.836
NULL	Biol_Open_2013_Aug_14_2(10)_1013-1021.nxml.txt.nlp	24167711	SENT178	5	5	14	14	ethanol	EVL	PA448073	51466	0.836
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Sep_13_70(Pt_10)_o1106.nxml.txt.nlp	25484697	SENT4	17	17	4	4	phenol	mol	PA450913	90527	0.836
NULL	Chin_J_Cancer_2012_Jun_31(6)_306-314.nxml.txt.nlp	22640627	SENT23	6	6	30	30	rituximab	CD10	PA451261	4311	0.836
NULL	Clinics_(Sao_Paulo)_2009_Oct_64(10)_961-966.nxml.txt.nlp	19841702	SENT34	2	2	23	23	imiquimod	IFN	PA449972	3439	0.836
NULL	Cancer_Cell_Int_2010_Oct_1_10_36.nxml.txt.nlp	20920299	SENT18	5	5	2	2	tamoxifen	survivin	PA451581	332	0.836
NULL	Br_J_Cancer_2009_Nov_3_101(9)_1585-1595.nxml.txt.nlp	19809435	SENT31	4	4	18	18	curcumin	Bcl-2	PA151958596	596	0.836
NULL	Case_Rep_Oncol_2013_Dec_12_6(3)_602-608.nxml.txt.nlp	24474924	SENT75	4	4	2	2	erlotinib	UGT1A1	PA134687924	54658	0.836
NULL	J_Gen_Physiol_1992_Jun_1_99(6)_985-1016.nxml.txt.nlp	1640223	SENT3	2	2	24	24	tetracaine	gamma	PA451638	9913	0.836
NULL	Clinics_(Sao_Paulo)_2013_Oct_68(10)_1325-1332.nxml.txt.nlp	24212839	SENT103	18	18	3	3	ribavirin	MxA	PA451241	4599	0.836
NULL	Front_Microbiol_2014_Mar_14_5_99.nxml.txt.nlp	24672516	SENT77	12	12	24	24	caspofungin	TLR4	PA164743013	7099	0.836
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1145.nxml.txt.nlp	24675463	SENT338	27	27	24	24	omalizumab	EGFR	PA164752253	1956	0.836
NULL	Mol_Cancer_2007_Aug_21_6_53.nxml.txt.nlp	17711579	SENT154	34	34	23	23	cisplatin	PDCD6	PA449014	10016	0.836
NULL	J_Young_Pharm_2010_Jul-Sep_2(3)_273-279.nxml.txt.nlp	21042485	SENT33	21	21	24	24	benzaldehyde	mol	PA448571	90527	0.836
NULL	Nucl_Recept_Signal_2007_May_17_5_e005.nxml.txt.nlp	17525795	SENT158	0	0	11	11	estradiol	SRC-3	PA449503	8202	0.836
NULL	Oncotarget_2012_Mar_31_3(3)_236-260.nxml.txt.nlp	22470194	SENT331	36	36	22	22	erlotinib	EGFR	PA134687924	1956	0.836
NULL	Behav_Brain_Funct_2012_Dec_19_8_61.nxml.txt.nlp	23253178	SENT205	36	36	2	2	gabapentin	Gen	PA449720	348654	0.836
NULL	Leukemia_2014_Mar_13_28(3)_629-641.nxml.txt.nlp	24263804	SENT203	24	24	11	11	imatinib	PAK1	PA10804	5585;5058	0.836
NULL	Case_Rep_Gastroenterol_2014_Jul_5_8(2)_240-244.nxml.txt.nlp	25120415	SENT49	10	10	7	7	ganciclovir	gamma	PA449733	9913	0.836
NULL	BMB_Rep_2013_Aug_46(8)_410-415.nxml.txt.nlp	23977989	SENT73	7	7	0	0	curcumin	HO-1	PA151958596	3162	0.836
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT202	8	8	18	18	ranibizumab	VEGFR1	PA164746012	2321	0.836
NULL	Breast_Cancer_Res_2002_Jun_21_4(5)_R9.nxml.txt.nlp	12223126	SENT15	30	30	5	5	tamoxifen	FasL	PA451581	356	0.836
NULL	F1000_Biol_Rep_2012_Mar_1_4_5.nxml.txt.nlp	22403588	SENT107	7	7	14	14	telaprevir	IFN	PA165958354	3439	0.836
NULL	Med_Sci_Monit_2014_Apr_11_20_594-600.nxml.txt.nlp	24721823	SENT75	15	15	0	0	heparin	PON1	PA449855	5444	0.836
NULL	Breast_Cancer_Res_Treat_2014_Apr_6_145(1)_33-44.nxml.txt.nlp	24706169	SENT113	27	27	23	23	trastuzumab	HER2	PA451743	2064	0.836
NULL	Gut_Liver_2011_Jun_24_5(2)_160-164.nxml.txt.nlp	21814595	SENT91	7	7	24	24	meperidine	ESD	PA450369	2098	0.836
NULL	Cancer_Res_Treat_2012_Sep_30_44(3)_151-156.nxml.txt.nlp	23091440	SENT102	29	29	0	0	gefitinib	Rho	PA131301952	29984	0.836
NULL	Front_Cell_Neurosci_2013_Dec_19_7_267.nxml.txt.nlp	24391544	SENT674	17	17	0	0	cyclophosphamide	P2X3	PA449165	5024	0.836
NULL	Br_J_Cancer_2010_Oct_12_103(8)_1284-1291.nxml.txt.nlp	20859285	SENT10	18	18	4	4	tamoxifen	BCAR4	PA451581	400500	0.836
NULL	Nat_Commun_2013_Sep_20_4_2444.nxml.txt.nlp	24051492	SENT46	25	25	3	3	nutlin-3	p53		7157	0.836
NULL	Cancers_(Basel)_2013_Nov_26_5(4)_1601-1618.nxml.txt.nlp	24287743	SENT168	35	35	26	26	gefitinib	Met	PA131301952	79811	0.836
NULL	Clin_Ophthalmol_2010_Apr_26_4_307-314.nxml.txt.nlp	20463798	SENT22	19	19	28	28	ranibizumab	San	PA164746012	80218	0.836
NULL	Exp_Ther_Med_2013_Apr_18_5(4)_1219-1225.nxml.txt.nlp	23596493	SENT97	10	10	28	28	cyclophosphamide	MBD2	PA449165	8932	0.836
NULL	Bioinform_Biol_Insights_2009_Oct_5_3_109-127.nxml.txt.nlp	20140064	SENT361	18	18	24	24	didanosine	P65	PA449301	64689;6857	0.836
NULL	Colomb_Med_(Cali)_44(2)_108-114.nxml.txt.nlp	24892456	SENT52	12	12	20	20	trastuzumab	San	PA451743	80218	0.836
NULL	J_Immunother_Cancer_2014_Jan_27_2_2.nxml.txt.nlp	24829759	SENT165	24	24	13	13	sunitinib	IL-21	PA162372840	59067;50616;27189	0.836
NULL	Mol_Cancer_2009_Aug_25_8_66.nxml.txt.nlp	19706164	SENT109	2	2	15	15	celecoxib	p53	PA448871	7157	0.836
NULL	Front_Immunol_2013_Nov_7_4_360.nxml.txt.nlp	24223576	SENT262	14	14	12	12	imiquimod	TLR7	PA449972	51284	0.836
NULL	Oncogene_2013_Sep_26_32(39)_10_1038_onc_2012_491.nxml.txt.nlp	23108394	SENT46	28	28	17	17	epirubicin	FOXM1	PA449476	2305	0.836
NULL	Croat_Med_J_2013_Apr_54(2)_171-179.nxml.txt.nlp	23630144	SENT144	26	26	14	14	taurine	STZ	PA451590	6484	0.836
NULL	FEBS_Open_Bio_2013_Jun_27_3_291-301.nxml.txt.nlp	23905012	SENT324	37	37	4	4	genistein	p15	PA165109660	10923;10573	0.836
NULL	Basic_Res_Cardiol_2012_Jul_24_107(4)_273.nxml.txt.nlp	22622703	SENT84	5	5	8	8	resveratrol	SIRT1		23411	0.836
NULL	Arthritis_Res_Ther_2011_Sep_21_13(5)_239.nxml.txt.nlp	21955617	SENT246	1	1	14	14	celecoxib	RANKL	PA448871	8600	0.836
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT1639	5	5	2	2	nevirapine	ABCC10	PA450616	89845	0.836
NULL	Sci_Rep_2015_Jan_6_5_7641.nxml.txt.nlp	25560734	SENT95	24	24	4	4	tamoxifen	CLTC	PA451581	1213	0.836
NULL	Breast_Cancer_Res_2007_Aug_8_9(4)_R50.nxml.txt.nlp	17686159	SENT12	3	3	12	12	gefitinib	HRG	PA131301952	3084;3273	0.836
NULL	Oncotarget_2014_Nov_11_5(22)_11490-11500.nxml.txt.nlp	25359780	SENT36	22	22	12	12	docetaxel	CXCR4	PA449383	7852	0.836
NULL	Physiol_Rep_2014_Aug_28_2(8)_e12143.nxml.txt.nlp	25168879	SENT16	3	3	8	8	staurosporine	COX	PA165109623	1351	0.836
NULL	Chonnam_Med_J_2013_Dec_23_49(3)_118-124.nxml.txt.nlp	24400214	SENT77	4	4	2	2	atorvastatin	DES	PA448500	1674	0.836
NULL	ISRN_Nutr_2014_Jan_16_2014_149549.nxml.txt.nlp	24967264	SENT31	11	11	14	14	echinacea	EPO	PA131550706	7076;8288;2056	0.836
NULL	Biomed_Res_Int_2013_Aug_7_2013_864012.nxml.txt.nlp	23991423	SENT173	4	4	12	12	cinacalcet	PTH	PA164776671	5741	0.836
NULL	J_Res_Med_Sci_2012_Oct_17(10)_928-933.nxml.txt.nlp	23825991	SENT99	40	40	10	10	tretinoin	CO2	PA451746	4513	0.836
NULL	Int_J_Nanomedicine_2012_May_7_7_2307-2314.nxml.txt.nlp	22661887	SENT140	19	19	8	8	gemcitabine	zeta	PA449748	9907	0.836
NULL	Oncologist_2011_Jan_6_16(1)_5-24.nxml.txt.nlp	21212434	SENT196	11	11	29	29	bleomycin	IFN	PA448645	3439	0.836
NULL	Indian_J_Pharmacol_2013_Jan-Feb_45(1)_54-60.nxml.txt.nlp	23543867	SENT194	34	34	16	16	terlipressin	NAC	PA164781020	22861	0.836
NULL	Int_J_Cell_Biol_2013_May_16_2013_639401.nxml.txt.nlp	23762063	SENT291	5	5	17	17	curcumin	HIF-1	PA151958596	29072	0.836
NULL	Genet_Mol_Biol_2009_Jan_16_Jan-Mar_32(1)_177-185.nxml.txt.nlp	21637665	SENT99	4	4	18	18	ethanol	ANOVA	PA448073	4858	0.836
NULL	Breast_Cancer_Res_2007_Jan_23_9(1)_R7.nxml.txt.nlp	17244352	SENT43	5	5	22	22	tamoxifen	SULT1A1	PA451581	6817	0.836
NULL	J_Cardiovasc_Dis_Res_2012_Oct-Dec_3(4)_319-322.nxml.txt.nlp	23233778	SENT46	16	16	8	8	simvastatin	CYP3A5	PA451363	1577	0.836
NULL	Arthritis_Res_Ther_2014_Apr_3_16(2)_R86.nxml.txt.nlp	24708674	SENT225	6	6	29	29	bosentan	Fli1	PA10034	2314	0.836
NULL	Int_J_Biomed_Sci_2008_Dec_4(4)_260-265.nxml.txt.nlp	19568323	SENT83	20	20	14	14	forskolin	BRCA1	PA146096022	672	0.836
NULL	Front_Oncol_2014_Jun_27_4_157.nxml.txt.nlp	25019058	SENT75	18	18	26	26	vinorelbine	EGFR	PA451881	1956	0.836
NULL	Am_J_Case_Rep_2014_Feb_24_15_85-89.nxml.txt.nlp	24587856	SENT60	19	19	16	16	anastrozole	aromatase	PA448432	1588	0.836
NULL	Int_J_Gen_Med_2011_Feb_15_4_131-139.nxml.txt.nlp	21475627	SENT157	7	7	14	14	olmesartan	AT1	PA164742950	9197;185	0.836
NULL	Oncotarget_2011_Sep_9_2(9)_658-668.nxml.txt.nlp	21911919	SENT56	5	5	9	9	cytarabine	HO-1	PA449177	3162	0.836
NULL	Ann_Hematol_2010_Sep_13_89(9)_861-871.nxml.txt.nlp	20387067	SENT180	33	33	22	22	dasatinib	TPO	PA162372878	7066;7173	0.836
NULL	Acta_Pharmacol_Sin_2012_Dec_27_33(12)_1469-1476.nxml.txt.nlp	22922343	SENT102	3	3	44	44	zolpidem	ANOVA	PA451976	4858	0.836
NULL	Front_Neurol_2011_Feb_14_1_160.nxml.txt.nlp	21359195	SENT142	9	9	2	2	sirolimus	DES	PA451365	1674	0.836
NULL	Mol_Pain_2012_Sep_24_8_73.nxml.txt.nlp	23006841	SENT124	0	0	6	6	ketoconazole	TRPV1	PA450146	7442	0.836
NULL	Aging_(Albany_NY)_2011_Apr_4_3(4)_348-362.nxml.txt.nlp	21483040	SENT194	9	9	33	33	metformin	AMPK	PA450395	5563	0.836
NULL	J_Signal_Transduct_2011_Jun_7_2011_982879.nxml.txt.nlp	21776391	SENT168	19	19	25	25	erlotinib	Met	PA134687924	79811	0.836
NULL	Oncogene_2014_May_8_33(19)_2478-2486.nxml.txt.nlp	23752180	SENT245	10	10	22	22	forskolin	EPAC	PA146096022	10411	0.836
NULL	Clin_Med_Insights_Cardiol_2010_Dec_1_4_117-128.nxml.txt.nlp	21151850	SENT181	11	11	33	33	clopidogrel	VASP	PA449053	7408	0.836
NULL	Biomed_Res_Int_2013_Aug_27_2013_960126.nxml.txt.nlp	24069608	SENT128	5	5	8	8	fluoxetine	MAP2	PA449673	4133;10988	0.836
NULL	Cancer_Cell_2011_Oct_18_20(4)_524-537.nxml.txt.nlp	22014577	SENT127	27	27	10	10	chymotrypsin	KEAP1	PA448994	9817	0.836
NULL	J_Thorac_Oncol_2014_Jun_30_9(6)_775-783.nxml.txt.nlp	24828661	SENT127	12	12	5	5	crizotinib	Met	PA165946122	79811	0.836
NULL	Diabetes_2009_Jan_58(1)_243-249.nxml.txt.nlp	18840785	SENT139	8	8	13	13	glucose	GLP-1	PA449773	100125288	0.836
NULL	Clin_Ophthalmol_2014_Dec_30_9_33-41.nxml.txt.nlp	25565766	SENT28	4	4	33	33	mitomycin	PRK	PA450524	1263	0.836
NULL	Front_Oncol_2014_May_23_4_99.nxml.txt.nlp	24904821	SENT291	34	34	31	31	natalizumab	CD49d	PA164747191	3676	0.836
NULL	Cell_Commun_Signal_2013_Jan_11_11_2.nxml.txt.nlp	23305203	SENT135	22	22	14	14	forskolin	TIMAP	PA146096022	26051	0.836
NULL	Front_Endocrinol_(Lausanne)_2013_Jul_12_4_88.nxml.txt.nlp	23874324	SENT140	24	24	16	16	tamoxifen	SULT1A1	PA451581	6817	0.836
NULL	BMJ_Open_2014_Oct_31_4(10)_e005781.nxml.txt.nlp	25361837	SENT106	38	38	30	30	ticagrelor	ADP	PA165374673	23038	0.836
NULL	Tuberc_Respir_Dis_(Seoul)_2014_Sep_30_77(3)_105-110.nxml.txt.nlp	25309604	SENT32	13	13	39	39	warfarin	CYP2C9	PA451906	1559	0.836
NULL	Cancer_Med_2012_Dec_26_1(3)_318-327.nxml.txt.nlp	23342281	SENT228	21	21	24	24	raloxifene	aromatase	PA451221	1588	0.836
NULL	Endocrinol_Metab_(Seoul)_2014_Sep_25_29(3)_379-387.nxml.txt.nlp	25309798	SENT113	6	6	19	19	resveratrol	BMAL1		406	0.836
NULL	J_Headache_Pain_2013_Apr_10_14(1)_33.nxml.txt.nlp	23574808	SENT115	25	25	4	4	capsaicin	CO2	PA448776	4513	0.836
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2675-2684.nxml.txt.nlp	24129246	SENT305	16	16	12	12	etoposide	KSR1	PA449552	8844	0.836
NULL	Oncotarget_2014_Nov_3_5(20)_10127-10139.nxml.txt.nlp	25333256	SENT8	11	11	3	3	vemurafenib	TRIM16	PA165946873	10626	0.836
NULL	Cancer_Cell_Int_2011_Nov_17_11_40.nxml.txt.nlp	22088142	SENT84	6	6	13	13	gemcitabine	MRP3	PA449748	8714	0.836
NULL	Mol_Cancer_2014_Feb_24_13_34.nxml.txt.nlp	24565056	SENT242	23	23	10	10	doxorubicin	San	PA449412	80218	0.836
NULL	Mol_Cancer_2010_May_18_9_110.nxml.txt.nlp	20482802	SENT27	46	46	27	27	bortezomib	p53	PA10252	7157	0.836
NULL	Exp_Neurol_2012_Jun_235(2)_528-538.nxml.txt.nlp	22417924	SENT140	29	29	35	35	rosiglitazone	ANOVA	PA451283	4858	0.836
NULL	Oncol_Lett_2014_Aug_16_8(2)_673-678.nxml.txt.nlp	25009649	SENT87	9	9	31	31	aprotinin	CO2	PA448472	4513	0.836
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1150.nxml.txt.nlp	24675468	SENT93	20	20	5	5	ethanol	AMPK	PA448073	5563	0.836
NULL	J_Lipid_Res_2015_Jan_56(1)_109-121.nxml.txt.nlp	25421061	SENT10	6	6	0	0	lipase	CGI-58	PA450239	51099	0.836
NULL	Cell_Res_2013_Jun_21_23(6)_746-758.nxml.txt.nlp	23689277	SENT40	6	6	9	9	resveratrol	SIRT1		23411	0.836
NULL	Diabetes_2009_Dec_31_58(12)_2851-2862.nxml.txt.nlp	19720788	SENT148	13	13	8	8	forskolin	CHOP	PA146096022	1649	0.836
NULL	J_Biomed_Biotechnol_2010_Mar_30_2010_307231.nxml.txt.nlp	20369072	SENT255	18	18	10	10	staurosporine	HMGB1	PA165109623	3146	0.836
NULL	Protein_Cell_2014_May_26_5(5)_343-347.nxml.txt.nlp	24668462	SENT85	0	0	9	9	heparin	FGF18	PA449855	8817	0.836
NULL	Mol_Cancer_2010_Apr_23_9_87.nxml.txt.nlp	20416058	SENT280	36	36	4	4	etoposide	TRAIL	PA449552	8743	0.836
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT287	0	0	22	22	pp2	Bcl-2		596	0.836
NULL	Cancer_Immunol_Immunother_2013_Aug_27_62(10)_1637-1648.nxml.txt.nlp	23982484	SENT38	36	36	31	31	lenalidomide	GM-CSF	PA162363968	1437	0.836
NULL	Nat_Commun_2012_Apr_10_3_771.nxml.txt.nlp	22491319	SENT204	30	30	7	7	bleomycin	CYLD	PA448645	1540	0.836
NULL	Case_Rep_Oncol_2012_Dec_6_5(3)_651-656.nxml.txt.nlp	23275781	SENT32	0	0	4	4	imatinib	KIT	PA10804	3815	0.836
NULL	AIDS_Res_Ther_2011_Oct_6_8_36.nxml.txt.nlp	21978457	SENT98	33	33	13	13	zinc	TNF	PA451956	7124	0.836
NULL	Mol_Cancer_2013_May_1_12_34.nxml.txt.nlp	23634843	SENT355	5	5	21	21	tamoxifen	EGFR	PA451581	1956	0.836
NULL	Onco_Targets_Ther_2014_Jun_9_7_947-956.nxml.txt.nlp	24959081	SENT56	9	9	12	12	fluorescein	CD4	PA164746009	920	0.836
NULL	Clinics_(Sao_Paulo)_2010_Jan_65(1)_29-34.nxml.txt.nlp	20126343	SENT94	8	8	24	24	ropivacaine	LPSB	PA451271	8991	0.836
NULL	J_Oncol_2011_Dec_15_2011_852970.nxml.txt.nlp	21209724	SENT205	10	10	15	15	temozolomide	p53	PA451609	7157	0.836
NULL	Nucleic_Acids_Res_2012_Sep_28_40(17)_8425-8439.nxml.txt.nlp	22753026	SENT382	25	25	5	5	mitomycin	FANCD2	PA450524	2177	0.836
NULL	Ann_Clin_Microbiol_Antimicrob_2005_Sep_13_4_13.nxml.txt.nlp	16159399	SENT196	38	38	17	17	ribavirin	IFN	PA451241	3439	0.836
NULL	Aging_(Albany_NY)_2009_Jun_3_1(6)_515-528.nxml.txt.nlp	20157535	SENT79	0	0	2	2	resveratrol	S6K1		6198	0.836
NULL	Clin_Mol_Hepatol_2014_Sep_25_20(3)_283-290.nxml.txt.nlp	25320732	SENT123	13	13	3	3	propranolol	EVL	PA451145	51466	0.836
NULL	Support_Care_Cancer_2012_Jul_6_20(7)_1533-1540.nxml.txt.nlp	21822636	SENT24	13	13	18	18	tamoxifen	aromatase	PA451581	1588	0.836
NULL	Front_Neuroanat_2010_Sep_14_4_131.nxml.txt.nlp	20890450	SENT114	0	0	9	9	levodopa	GAD65	PA450213	2572	0.836
NULL	Br_J_Cancer_2012_Jul_10_107(2)_230-233.nxml.txt.nlp	22735900	SENT93	11	11	13	13	tamoxifen	CYP2D6	PA451581	1565	0.836
NULL	Int_J_Environ_Res_Public_Health_2012_Sep_19_9(9)_3354-3364.nxml.txt.nlp	23202692	SENT405	9	9	6	6	resveratrol	CYP2E1		1571	0.836
NULL	Cell_Res_2011_Mar_11_21(3)_530-545.nxml.txt.nlp	21221130	SENT241	8	8	31	31	thrombin	CD42b	PA451674	2811	0.836
NULL	Curr_Gerontol_Geriatr_Res_2011_Aug_18_2011_316386.nxml.txt.nlp	21869884	SENT126	20	20	0	0	estradiol	CA1	PA449503	759	0.836
NULL	Mol_Cancer_2012_Jun_18_11_41.nxml.txt.nlp	22709873	SENT257	34	34	12	12	lapatinib	ERBB3	PA152241907	2065	0.836
NULL	Arch_Med_Sci_2013_Aug_30_9(4)_739-744.nxml.txt.nlp	24049538	SENT107	37	37	3	3	candesartan	PC-3	PA448765	692094	0.836
NULL	J_Allergy_(Cairo)_2011_Oct_24_2011_457169.nxml.txt.nlp	22121382	SENT10	0	0	11	11	salmeterol	IL-8	PA451300	3576	0.836
NULL	Cancer_Inform_2011_Oct_3_10_233-247.nxml.txt.nlp	22084564	SENT213	6	6	3	3	topotecan	p53	PA451729	7157	0.836
NULL	Clin_Transl_Allergy_2014_Feb_28_4(Suppl_1)_P35.nxml.txt.nlp	25045492	SENT14	0	0	34	34	atorvastatin	CD54	PA448500	3383	0.836
NULL	Case_Rep_Infect_Dis_2011_Oct_29_2011_167963.nxml.txt.nlp	22567460	SENT13	30	30	22	22	methylprednisolone	San	PA450466	80218	0.836
NULL	Ann_Hematol_2010_Nov_25_89(11)_1115-1124.nxml.txt.nlp	20499237	SENT258	8	8	22	22	atorvastatin	Bcl-2	PA448500	596	0.836
NULL	Exp_Ther_Med_2014_Sep_20_8(3)_968-972.nxml.txt.nlp	25120631	SENT122	2	2	13	13	naringin	ADP	PA151958360	23038	0.836
NULL	Exp_Anim_2014_Apr_26_63(2)_257-267.nxml.txt.nlp	24770651	SENT83	2	2	6	6	perindopril	APJ	PA450877	187	0.835
NULL	Int_J_Mol_Sci_2014_May_12_15(5)_8335-8351.nxml.txt.nlp	24823879	SENT105	0	0	3	3	curcumin	CD133	PA151958596	8842	0.835
NULL	Clin_Interv_Aging_2012_Dec_30_7_1-13.nxml.txt.nlp	22291468	SENT268	34	34	11	11	dronedarone	CYP3A4	PA153619853	1576	0.835
NULL	Oxid_Med_Cell_Longev_2013_Apr_18_2013_239854.nxml.txt.nlp	23710284	SENT85	14	14	7	7	zonisamide	HRD1	PA451978	84447	0.835
NULL	J_Biol_Chem_2013_Dec_6_288(49)_35387-35395.nxml.txt.nlp	24142790	SENT152	30	30	6	6	meclizine	PCYT2	PA450338	5833	0.835
NULL	J_Infect_Dis_2012_Apr_15_205(8)_1278-1286.nxml.txt.nlp	22396598	SENT158	14	14	18	18	atovaquone	DHODH	PA448502	1723	0.835
NULL	Biologics_2013_Dec_2_7_259-264.nxml.txt.nlp	24324327	SENT98	23	23	20	20	rituximab	TNF-alpha	PA451261	7124	0.835
NULL	Int_J_Mol_Sci_2012_Apr_16_13(4)_4831-4838.nxml.txt.nlp	22606012	SENT233	15	15	11	11	curcumin	p65	PA151958596	5970	0.835
NULL	Drugs_R_D_2014_Jun_6_14(2)_113-123.nxml.txt.nlp	24797400	SENT235	18	18	6	6	dabigatran	P-gp		5243	0.835
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT89	24	24	43	43	nutlin-3	GAPDH		2597	0.835
NULL	J_Immunol_Res_2014_Nov_30_2014_342693.nxml.txt.nlp	25762441	SENT532	0	0	2	2	valsartan	AT1	PA451848	9197;185	0.835
NULL	Cell_Death_Dis_2014_Apr_17_5(4)_e1182.nxml.txt.nlp	24743737	SENT218	4	4	2	2	capsaicin	TRPV1	PA448776	7442	0.835
NULL	J_Exp_Med_1994_Oct_1_180(4)_1457-1469.nxml.txt.nlp	7931078	SENT13	0	0	25	25	propranolol	FMLP	PA451145	2357	0.835
NULL	Cell_Death_Dis_2014_Mar_13_5(3)_e1126.nxml.txt.nlp	24625985	SENT64	19	19	7	7	bortezomib	URI	PA10252	8725	0.835
NULL	Br_J_Pharmacol_2014_May_171(10)_2659-2670.nxml.txt.nlp	24116661	SENT196	0	0	6	6	naringenin	TRPP2	PA151958361	5311	0.835
NULL	HSR_Proc_Intensive_Care_Cardiovasc_Anesth_2010_2(2)_119-127.nxml.txt.nlp	23440905	SENT42	8	8	0	0	heparin	ACT	PA449855	12;11332;9457;641455	0.835
NULL	J_Lipid_Res_2014_Dec_55(12)_2562-2575.nxml.txt.nlp	25316883	SENT23	12	12	4	4	lipase	CGI-58	PA450239	51099	0.835
NULL	J_Breast_Cancer_2012_Sep_28_15(3)_273-282.nxml.txt.nlp	23091539	SENT63	19	19	4	4	doxycycline	TRAIL	PA449415	8743	0.835
NULL	Cancer_Med_2013_Dec_31_2(6)_826-835.nxml.txt.nlp	24403256	SENT218	11	11	45	45	daunorubicin	p53	PA449212	7157	0.835
NULL	Front_Oncol_2013_Apr_8_3_74.nxml.txt.nlp	23579692	SENT90	3	3	15	15	cabozantinib	VEGFR2	PA165906891	3791	0.835
NULL	Cancers_(Basel)_2011_Aug_9_3(3)_3189-3205.nxml.txt.nlp	24212952	SENT89	14	14	4	4	hyaluronan	HYAL-1	PA165958431	3373	0.835
NULL	Nat_Commun_2014_Dec_8_5_5736.nxml.txt.nlp	25484020	SENT52	5	5	15	15	exemestane	TRPA1	PA449563	8989	0.835
NULL	Diabetes_2009_Mar_58(3)_579-589.nxml.txt.nlp	19074989	SENT97	28	28	11	11	fenofibrate	ANGPTL4	PA449594	51129	0.835
NULL	Oncol_Lett_2013_Oct_24_6(4)_970-976.nxml.txt.nlp	24137447	SENT3	10	10	17	17	tamoxifen	ADM	PA451581	133	0.835
NULL	Cardiovasc_Diabetol_2013_Jul_17_12_105.nxml.txt.nlp	23866022	SENT123	8	8	12	12	olmesartan	A-FABP	PA164742950	2167	0.835
NULL	J_Ophthalmol_2010_Jun_21_2010_175163.nxml.txt.nlp	20652057	SENT138	13	13	5	5	fluorescein	LPA	PA164746009	4018	0.835
NULL	Br_J_Haematol_2008_Mar_3_144(5)_677-685.nxml.txt.nlp	19055662	SENT96	6	6	0	0	vincristine	CHOP	PA451879	1649	0.835
NULL	Oncol_Lett_2013_Apr_28_5(4)_1149-1154.nxml.txt.nlp	23599754	SENT104	37	37	34	34	cisplatin	Dicer	PA449014	23405	0.835
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_P51.nxml.txt.nlp	NULL	SENT11	13	13	2	2	febuxostat	HLA-B	PA165958521	3106	0.835
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_May_12_68(Pt_6)_o1717.nxml.txt.nlp	22719506	SENT72	39	39	14	14	potassium	CS2	PA451047	64084	0.835
NULL	Br_J_Cancer_2003_Jun_2_88(11)_1755-1762.nxml.txt.nlp	12771992	SENT191	33	33	28	28	sulindac	EGF	PA451565	1950	0.835
NULL	Acta_Pharmacol_Sin_2010_Apr_8_31(4)_461-469.nxml.txt.nlp	20208553	SENT48	12	12	1	1	ethanol	adiponectin	PA448073	9370	0.835
NULL	J_Oncol_2012_Feb_6_2012_737981.nxml.txt.nlp	22481932	SENT101	41	41	5	5	paclitaxel	IL-6	PA450761	3569	0.835
NULL	Oncogene_2013_Sep_26_32(39)_10_1038_onc_2012_491.nxml.txt.nlp	23108394	SENT79	42	42	9	9	epirubicin	BRIP1	PA449476	64979;83990	0.835
NULL	Clin_Ophthalmol_2012_Jan_12_6_103-109.nxml.txt.nlp	22275814	SENT102	23	23	12	12	tafluprost	BAK	PA165958432	578	0.835
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT115	5	5	14	14	pertuzumab	HER2		2064	0.835
NULL	J_Headache_Pain_2010_Oct_22_11(5)_431-435.nxml.txt.nlp	20652353	SENT14	16	16	13	13	zolmitriptan	CYP3A4	PA451975	1576	0.835
NULL	Breast_Cancer_Res_2011_Mar_10_13(2)_R28.nxml.txt.nlp	21392397	SENT69	3	3	11	11	erlotinib	AKT	PA134687924	207	0.835
NULL	Mol_Cancer_2014_Jul_5_13_165.nxml.txt.nlp	24996221	SENT179	12	12	2	2	docetaxel	HMGB1	PA449383	3146	0.835
NULL	J_Cell_Mol_Med_2014_Aug_6_18(8)_1519-1539.nxml.txt.nlp	25100284	SENT26	0	0	16	16	afatinib	HER2	PA165981154	2064	0.835
NULL	BMB_Rep_2014_Mar_47(3)_167-172.nxml.txt.nlp	24499665	SENT115	13	13	25	25	nutlin-3	Bcl-2		596	0.835
NULL	AMB_Express_2011_Oct_22_1_33.nxml.txt.nlp	22018139	SENT142	0	0	26	26	nadh	Hua	PA164755085	1994	0.835
NULL	Onco_Targets_Ther_2014_May_28_7_841-852.nxml.txt.nlp	24920926	SENT145	0	0	16	16	gefitinib	EGFR	PA131301952	1956	0.835
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_55-78.nxml.txt.nlp	19305788	SENT158	6	6	15	15	memantine	GLT-1	PA10364	6506	0.835
NULL	Mol_Cancer_2009_Nov_24_8_109.nxml.txt.nlp	19930708	SENT189	5	5	27	27	exemestane	EGFR	PA449563	1956	0.835
NULL	Int_J_Biol_Sci_2013_Mar_7_9(3)_279-288.nxml.txt.nlp	23493630	SENT48	37	37	10	10	tocilizumab	IL-6	PA165292659	3569	0.835
NULL	Breast_Cancer_Res_2012_Mar_19_14(2)_R50.nxml.txt.nlp	22429397	SENT240	23	23	32	32	cisplatin	MFG-E8	PA449014	4240	0.835
NULL	Emerg_Infect_Dis_2011_Apr_17(4)_653-660.nxml.txt.nlp	21470455	SENT318	23	23	0	0	oseltamivir	Baz	PA450721	56288	0.835
NULL	J_Korean_Med_Sci_2009_Jan_29_24(Suppl_1)_S183-S188.nxml.txt.nlp	19194550	SENT140	2	2	8	8	celecoxib	CD2AP	PA448871	23607	0.835
NULL	Orphanet_J_Rare_Dis_2013_Oct_17_8_167.nxml.txt.nlp	24135440	SENT18	30	30	13	13	l-lysine	GCDH	PA450280	2639	0.835
NULL	J_Carcinog_2011_Nov_30_10_28.nxml.txt.nlp	22190870	SENT96	26	26	39	39	trastuzumab	PTEN	PA451743	5728	0.835
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT170	14	14	22	22	trastuzumab	HER2	PA451743	2064	0.835
NULL	Mol_Cancer_2012_Sep_25_11_73.nxml.txt.nlp	23009336	SENT168	10	10	12	12	dasatinib	PP2	PA162372878	4888	0.835
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT128	0	0	7	7	pp2	LYN		4067	0.835
NULL	Diabetes_Care_2009_Aug_26_32(8)_1411-1417.nxml.txt.nlp	19470837	SENT129	1	1	24	24	glucose	TP2	PA449773	7015;7142	0.835
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_33-43.nxml.txt.nlp	17912634	SENT133	10	10	17	17	letrozole	HER2	PA450196	2064	0.835
NULL	Acta_Pharmacol_Sin_2009_Oct_21_30(10)_1392-1398.nxml.txt.nlp	19767766	SENT14	2	2	25	25	atorvastatin	DPI	PA448500	1832	0.835
NULL	J_Breast_Cancer_2013_Jun_28_16(2)_164-170.nxml.txt.nlp	23843848	SENT150	15	15	11	11	doxorubicin	p53	PA449412	7157	0.835
NULL	J_Cancer_Res_Clin_Oncol_2012_Mar_31_138(3)_537-544.nxml.txt.nlp	22209975	SENT34	0	0	17	17	geldanamycin	Hsp90	PA152031327	3320	0.835
NULL	Ann_Clin_Transl_Neurol_2014_Dec_21_1(12)_996-1005.nxml.txt.nlp	25574474	SENT134	9	9	3	3	riluzole	P-gp	PA451251	5243	0.835
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT118	7	7	11	11	atorvastatin	RANKL	PA448500	8600	0.835
NULL	Clin_Neuroradiol_2012_Sep_18_22(3)_227-233.nxml.txt.nlp	22252289	SENT4	12	12	25	25	paclitaxel	ICAD	PA450761	1676	0.835
NULL	Breast_Cancer_Res_2011_Aug_31_13(4)_R84.nxml.txt.nlp	21884573	SENT141	27	27	22	22	lapatinib	HER2	PA152241907	2064	0.835
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Jul_23_6_103-113.nxml.txt.nlp	25114588	SENT42	24	24	21	21	pertuzumab	HER2		2064	0.835
NULL	Breast_Cancer_Res_2010_May_10_12(3)_R26.nxml.txt.nlp	20459744	SENT152	24	24	6	6	thiotepa	CYP2B6	PA451668	1555	0.835
NULL	Curr_Neuropharmacol_2013_Jul_11(4)_338-378.nxml.txt.nlp	24381528	SENT658	4	4	24	24	curcumin	p53	PA151958596	7157	0.835
NULL	Nat_Commun_2011_Jul_5_2_376.nxml.txt.nlp	21730957	SENT1474	23	23	11	11	zolpidem	GAD65	PA451976	2572	0.835
NULL	Mol_Syst_Biol_2009_Jul_28_5_289.nxml.txt.nlp	19638970	SENT37	5	5	11	11	resveratrol	HuR		1994	0.835
NULL	J_Cell_Biol_1998_Jan_26_140(2)_335-345.nxml.txt.nlp	9442109	SENT236	6	6	9	9	chloroquine	NHE	PA448948	285335	0.835
NULL	Comput_Math_Methods_Med_2013_Mar_20_2013_802512.nxml.txt.nlp	23573174	SENT37	3	3	17	17	tetracycline	MYC	PA451640	4609	0.835
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT222	8	8	2	2	sulindac	survivin	PA451565	332	0.835
NULL	J_Invest_Dermatol_2013_Jun_14_133(6)_1541-1549.nxml.txt.nlp	23407395	SENT194	22	22	4	4	imiquimod	CXCL1	PA449972	2919	0.835
NULL	Br_J_Cancer_2012_Dec_4_107(12)_1950-1955.nxml.txt.nlp	23169295	SENT15	20	20	4	4	oxaliplatin	ERCC1	PA131285527	2067	0.835
NULL	BMB_Rep_2013_Sep_46(9)_448-453.nxml.txt.nlp	24064059	SENT106	10	10	7	7	dextran	CD83	PA449261	9308	0.835
NULL	Endocr_Connect_2012_Jun_8_1(1)_1-12.nxml.txt.nlp	23781298	SENT191	6	6	10	10	fenofibrate	adiponectin	PA449594	9370	0.835
NULL	Tumour_Biol_2014_Aug_13_35(10)_9447-9457.nxml.txt.nlp	25117071	SENT355	3	3	28	28	lenalidomide	CD40	PA162363968	958	0.835
NULL	Int_J_Endocrinol_Metab_2013_Jul_1_Summer_11(3)_184-190.nxml.txt.nlp	24348591	SENT171	0	0	4	4	liraglutide	GLP-1	PA165958364	100125288	0.835
NULL	Mol_Cancer_2007_Oct_22_6_66.nxml.txt.nlp	17953743	SENT204	11	11	17	17	cisplatin	TRAIL	PA449014	8743	0.835
NULL	CNS_Drugs_2014_Jun_24_28(10)_875-886.nxml.txt.nlp	24958205	SENT101	16	16	29	29	sucralfate	ghrelin	PA451524	51738	0.835
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Sep_20_64(Pt_10)_m1288-m1289.nxml.txt.nlp	21201033	SENT65	37	37	23	23	ethanol	NO3	PA448073	4681	0.835
NULL	Oncotarget_2014_Jun_6_5(13)_4929-4934.nxml.txt.nlp	24952635	SENT84	2	2	13	13	thioridazine	PDK1	PA451666	5170;5163	0.835
NULL	Acta_Pharmacol_Sin_2009_Jul_3_30(7)_879-888.nxml.txt.nlp	19574993	SENT129	6	6	21	21	donepezil	IL-2	PA449394	3558	0.835
NULL	ScientificWorldJournal_2012_Apr_19_2012_804730.nxml.txt.nlp	22606063	SENT138	17	17	11	11	tafluprost	ANOVA	PA165958432	4858	0.835
NULL	EMBO_J_2009_Mar_18_28(6)_663-676.nxml.txt.nlp	19214186	SENT371	15	15	22	22	oxaliplatin	GLI1	PA131285527	2735	0.835
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1542-1553.nxml.txt.nlp	21970874	SENT224	14	14	22	22	pemetrexed	EGFR	PA10810	1956	0.835
NULL	Pharmaceuticals_(Basel)_2013_Nov_11_6(11)_1429-1450.nxml.txt.nlp	24287465	SENT264	18	18	28	28	vemurafenib	SMO	PA165946873	6608;54498	0.835
NULL	Int_J_Endocrinol_Metab_2013_Dec_21_Winter_11(1)_57-61.nxml.txt.nlp	23853622	SENT31	10	10	2	2	haloperidol	FGA	PA449841	2243	0.835
NULL	Br_J_Cancer_2011_Jun_28_105(1)_118-123.nxml.txt.nlp	21654685	SENT88	0	0	3	3	dasatinib	S100beta	PA162372878	6285	0.835
NULL	Case_Rep_Hematol_2013_Feb_6_2013_541783.nxml.txt.nlp	23476834	SENT36	9	9	18	18	cyclophosphamide	CHOP	PA449165	1649	0.835
NULL	Mol_Biol_Cell_2014_Mar_15_25(6)_948-964.nxml.txt.nlp	24451262	SENT438	28	28	6	6	glutaraldehyde	TPC1	PA449777	53373	0.835
NULL	Breast_Cancer_Res_2012_Jul_12_14(4)_R104.nxml.txt.nlp	22788954	SENT223	26	26	12	12	gefitinib	Met	PA131301952	79811	0.835
NULL	Clin_Med_Insights_Circ_Respir_Pulm_Med_2012_Jun_12_6_27-40.nxml.txt.nlp	22745565	SENT25	22	22	33	33	omalizumab	IL-13	PA164752253	3596	0.835
NULL	Cell_Death_Dis_2013_Oct_3_4(10)_e827.nxml.txt.nlp	24091670	SENT14	12	12	18	18	nilotinib	PI3K	PA165958345	5290	0.835
NULL	Target_Oncol_2013_Jun_27_8(2)_127-136.nxml.txt.nlp	23625191	SENT65	13	13	0	0	panitumumab	KRAS	PA162373091	3845	0.835
NULL	Mol_Cancer_2009_Dec_10_8_118.nxml.txt.nlp	20003259	SENT110	6	6	10	10	sorafenib	ERM	PA7000	2119	0.835
NULL	Arthritis_Res_Ther_2014_Jan_27_16(1)_R24.nxml.txt.nlp	24460746	SENT150	9	9	16	16	infliximab	ACR	PA452639	49	0.835
NULL	Endocr_Connect_2012_Jun_8_1(1)_1-12.nxml.txt.nlp	23781298	SENT43	4	4	19	19	fenofibrate	adiponectin	PA449594	9370	0.835
NULL	Cancer_Med_2014_Aug_7_3(4)_796-811.nxml.txt.nlp	24802970	SENT301	8	8	6	6	amiloride	CD49f	PA448368	3655	0.835
NULL	Mol_Cells_2014_Oct_31_37(10)_759-765.nxml.txt.nlp	25256221	SENT113	21	21	2	2	celecoxib	NDRG2	PA448871	57447	0.835
NULL	Br_J_Haematol_2014_Mar_13_164(1)_811-821.nxml.txt.nlp	24328678	SENT157	9	9	19	19	lenalidomide	IL2	PA162363968	3558	0.835
NULL	Eur_J_Clin_Pharmacol_2011_May_9_67(5)_477-482.nxml.txt.nlp	21305273	SENT117	25	25	27	27	dobutamine	DSE	PA449381	29940	0.835
NULL	Eur_J_Clin_Pharmacol_2008_Feb_26_64(2)_133-157.nxml.txt.nlp	18224312	SENT561	9	9	7	7	warfarin	CYP2C9	PA451906	1559	0.835
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1016.nxml.txt.nlp	24457960	SENT189	18	18	12	12	paclitaxel	TRAIL	PA450761	8743	0.835
NULL	ScientificWorldJournal_2013_Jun_19_2013_174392.nxml.txt.nlp	23853530	SENT171	25	25	11	11	doxazosin	c-FLIP	PA449407	8837	0.835
NULL	Eur_J_Clin_Pharmacol_2010_Nov_29_66(11)_1131-1136.nxml.txt.nlp	20669013	SENT139	26	26	36	36	erythromycin	CYP2C19	PA449493	1557	0.835
NULL	Behav_Brain_Funct_2014_Jun_16_10_21.nxml.txt.nlp	24934302	SENT217	2	2	11	11	pioglitazone	p65	PA450970	5970	0.835
NULL	Front_Endocrinol_(Lausanne)_2014_Sep_9_5_145.nxml.txt.nlp	25250015	SENT124	11	11	17	17	glucosamine	HBP	PA164747613	3069;50865;7884;566	0.835
NULL	Cardiovasc_Diabetol_2010_Nov_5_9_72.nxml.txt.nlp	21054861	SENT110	0	0	6	6	isoproterenol	ANOVA	PA450121	4858	0.835
NULL	Oncotarget_2011_Aug_30_2(8)_610-626.nxml.txt.nlp	21881167	SENT112	7	7	3	3	doxorubicin	Raf-1	PA449412	5894	0.835
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT75	12	12	8	8	erlotinib	EGFR	PA134687924	1956	0.835
NULL	Int_J_Endocrinol_Metab_2013_Dec_21_Winter_11(1)_57-61.nxml.txt.nlp	23853622	SENT38	11	11	20	20	olanzapine	PRL	PA450688	5617	0.835
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2751-2762.nxml.txt.nlp	24169358	SENT148	0	0	19	19	trastuzumab	ERBB2	PA451743	2064	0.835
NULL	Exp_Cell_Res_2011_Apr_15_317(7)_1028-1039.nxml.txt.nlp	21237154	SENT362	10	10	0	0	paclitaxel	JNK	PA450761	5599	0.835
NULL	Arthritis_Res_Ther_2014_Sep_18_16(5)_427.nxml.txt.nlp	25230745	SENT271	1	1	17	17	bevacizumab	ADAMTS5	PA130232992	11096	0.835
NULL	Breast_Cancer_Res_2013_Nov_29_15(6)_R114.nxml.txt.nlp	24289103	SENT345	26	26	8	8	tamoxifen	EGFR	PA451581	1956	0.835
NULL	Sci_Rep_2014_Nov_28_4_7237.nxml.txt.nlp	25429875	SENT114	15	15	7	7	hesperidin	p38	PA449867	10598;1432;7965	0.835
NULL	Mol_Cells_2014_Mar_31_37(3)_234-240.nxml.txt.nlp	24642709	SENT122	7	7	29	29	capsaicin	HO-1	PA448776	3162	0.835
NULL	Oncotarget_2014_Jun_30_5(12)_4011-4025.nxml.txt.nlp	24994117	SENT111	22	22	5	5	estradiol	ISG15	PA449503	9636	0.835
NULL	Adv_Ther_2014_Mar_5_31(3)_318-332.nxml.txt.nlp	24595638	SENT100	15	15	22	22	dronedarone	PPY	PA153619853	5539	0.835
NULL	Arthritis_Res_Ther_2005_May_18_7(Suppl_3)_S19-S25.nxml.txt.nlp	15960818	SENT166	15	15	26	26	rituximab	CHOP	PA451261	1649	0.835
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT541	6	6	31	31	sulpiride	PRL	PA164745485	5617	0.835
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT174	10	10	1	1	doxorubicin	AKT	PA449412	207	0.835
NULL	F1000_Med_Rep_2012_Jun_1_4_12.nxml.txt.nlp	22719795	SENT59	17	17	25	25	rifapentine	CYP3A	PA164783809	1574	0.835
NULL	Ecancermedicalscience_2009_Sep_24_3_153.nxml.txt.nlp	22276017	SENT102	5	5	10	10	platinum	p53	PA150595617	7157	0.835
NULL	Ann_Hematol_2014_Apr_1_93(8)_1371-1380.nxml.txt.nlp	24687382	SENT29	6	6	17	17	thalidomide	IKZF1	PA451644	10320	0.835
NULL	Curr_Cardiol_Rev_2012_May_8(2)_158-165.nxml.txt.nlp	22708914	SENT165	3	3	20	20	rivaroxaban	TKR	PA165958360	8277	0.835
NULL	ScientificWorldJournal_2014_Mar_12_2014_731462.nxml.txt.nlp	24715817	SENT173	20	20	30	30	diclofenac	IL-6	PA449293	3569	0.835
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Jun_27_5_15.nxml.txt.nlp	16803618	SENT13	16	16	26	26	ciprofloxacin	LTA	PA449009	4049	0.835
NULL	Diagn_Pathol_2014_Jul_10_9_143.nxml.txt.nlp	25012722	SENT130	22	22	25	25	cisplatin	PDCD4	PA449014	27250	0.835
NULL	Acta_Pharmacol_Sin_2013_Dec_18_34(12)_1508-1514.nxml.txt.nlp	24241347	SENT165	2	2	25	25	ketanserin	5-HT2A	PA131053734	3356	0.835
NULL	J_Exp_Clin_Cancer_Res_2009_Aug_19_28(1)_116.nxml.txt.nlp	19689822	SENT25	2	2	11	11	rituximab	CHOP	PA451261	1649	0.835
NULL	Cancer_Med_2013_Apr_6_2(2)_234-242.nxml.txt.nlp	23634291	SENT220	17	17	31	31	bevacizumab	MAX	PA130232992	4149	0.835
NULL	J_Gastroenterol_Hepatol_2014_Dec_18_29(12)_1996-2005.nxml.txt.nlp	24910341	SENT205	11	11	4	4	ribavirin	IL28B	PA451241	282617	0.835
NULL	Oncotarget_2014_Sep_10_5(20)_9877-9888.nxml.txt.nlp	25245676	SENT150	0	0	8	8	cetuximab	EGFR	PA10040	1956	0.835
NULL	Nat_Chem_Biol_2014_Feb_8_10(2)_99-105.nxml.txt.nlp	24316737	SENT308	19	19	5	5	ampicillin	NOT	PA448419	4929	0.835
NULL	Arch_Virol_2014_Dec_24_159(6)_1365-1371.nxml.txt.nlp	24366548	SENT190	10	10	3	3	ribavirin	IL28B	PA451241	282617	0.835
NULL	Diabetes_Obes_Metab_2011_Nov_13(11)_982-989.nxml.txt.nlp	21615670	SENT23	9	9	20	20	sitagliptin	GLP-1	PA164748978	100125288	0.835
NULL	Oncol_Lett_2013_Apr_28_5(4)_1149-1154.nxml.txt.nlp	23599754	SENT123	17	17	8	8	cisplatin	Dicer	PA449014	23405	0.835
NULL	Braz_J_Med_Biol_Res_2014_Feb_17_47(2)_135-143.nxml.txt.nlp	24519129	SENT174	14	14	28	28	ranitidine	EPM	PA451224	2054	0.835
NULL	Acta_Pharmacol_Sin_2011_May_18_32(5)_591-600.nxml.txt.nlp	21499286	SENT135	18	18	8	8	bezafibrate	AMPK	PA162364313	5563	0.835
NULL	J_Physiol_2011_Mar_1_589(Pt_5)_1081-1093.nxml.txt.nlp	21224236	SENT146	28	28	31	31	diazoxide	mol	PA449285	90527	0.835
NULL	J_Exp_Med_1994_Oct_1_180(4)_1457-1469.nxml.txt.nlp	7931078	SENT13	0	0	20	20	propranolol	DAG	PA451145	1605	0.835
NULL	J_Antimicrob_Chemother_2014_Mar_13_69(3)_651-663.nxml.txt.nlp	24235095	SENT122	17	17	10	10	pentamidine	AQP2	PA450850	359	0.835
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT91	22	22	8	8	cisplatin	MDM2	PA449014	4193	0.835
NULL	Pediatr_Cardiol_2010_Jan_14_31(1)_90-95.nxml.txt.nlp	19915892	SENT135	17	17	5	5	palivizumab	AAP	PA164748781	5345	0.835
NULL	J_Breast_Cancer_2013_Mar_31_16(1)_23-31.nxml.txt.nlp	23593078	SENT115	6	6	26	26	curcumin	MBD2	PA151958596	8932	0.835
NULL	Oncotarget_2014_Jun_8_5(17)_7446-7457.nxml.txt.nlp	25277184	SENT40	8	8	10	10	nutlin-3	p53		7157	0.835
NULL	Interdiscip_Toxicol_2011_Dec_4(4)_173-183.nxml.txt.nlp	22319251	SENT120	3	3	5	5	diethylstilbestrol	DES	PA449307	1674	0.835
NULL	J_Cancer_Prev_2014_Jun_19(2)_125-136.nxml.txt.nlp	25337581	SENT197	24	24	21	21	olaparib	p53		7157	0.835
NULL	Breast_Cancer_Res_Treat_2013_Jun_5_139(3)_649-655.nxml.txt.nlp	23736997	SENT213	11	11	8	8	tamoxifen	CYP2C19	PA451581	1557	0.835
NULL	Br_J_Haematol_2008_Jun_141(5)_659-671.nxml.txt.nlp	18410446	SENT221	10	10	26	26	cerulenin	JNK	PA164764551	5599	0.835
NULL	J_Histochem_Cytochem_2012_Oct_60(10)_749-760.nxml.txt.nlp	22821669	SENT35	6	6	18	18	hyaluronan	TSG-6	PA165958431	7130	0.835
NULL	Oncotarget_2014_Dec_4_5(22)_11365-11380.nxml.txt.nlp	25426548	SENT59	20	20	9	9	nutlin-3	p53		7157	0.835
NULL	Cancer_Cell_Int_2013_Nov_8_13_111.nxml.txt.nlp	24209962	SENT90	13	13	9	9	fluvastatin	A20	PA449688	7128;28935	0.835
NULL	Clin_Dev_Immunol_2013_May_22_2013_701305.nxml.txt.nlp	23762095	SENT75	7	7	9	9	cytarabine	MCL1	PA449177	4170	0.835
NULL	Cell_Death_Dis_2014_Mar_6_5(3)_e1101.nxml.txt.nlp	24603329	SENT98	1	1	15	15	cisplatin	Hsp90	PA449014	3320	0.835
NULL	Angiogenesis_2012_Sep_27_15(3)_361-376.nxml.txt.nlp	22451299	SENT59	9	9	40	40	l-glutamine	FBS	PA10090	64319;26269	0.835
NULL	J_Oncol_2012_Mar_26_2012_198412.nxml.txt.nlp	22536237	SENT67	12	12	29	29	trastuzumab	GEM	PA451743	2669	0.835
NULL	Adv_Prev_Med_2014_Jan_16_2014_534082.nxml.txt.nlp	24527218	SENT134	13	13	3	3	phenol	TPC	PA450913	8030;60386	0.835
NULL	Blood_Res_2014_Jun_25_49(2)_95-99.nxml.txt.nlp	25025010	SENT37	13	13	18	18	fludarabine	LIR	PA449655	10871	0.835
NULL	J_Carcinog_2013_Dec_31_12_22.nxml.txt.nlp	24574860	SENT84	47	47	29	29	afatinib	BTK	PA165981154	695	0.835
NULL	J_Int_AIDS_Soc_2010_Nov_8_13(Suppl_4)_P87.nxml.txt.nlp	NULL	SENT1	5	5	28	28	tenofovir	CD4	PA10204	920	0.835
NULL	Indian_J_Pharmacol_2012_Sep-Oct_44(5)_624-628.nxml.txt.nlp	23112426	SENT137	5	5	22	22	pravastatin	CYP3A4	PA451089	1576	0.835
NULL	Cancer_Med_2013_Aug_2_2(4)_571-582.nxml.txt.nlp	24156030	SENT178	38	38	18	18	curcumin	IL-6	PA151958596	3569	0.835
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Feb_15_5_3.nxml.txt.nlp	16480505	SENT136	24	24	29	29	felodipine	CYP3A4	PA449591	1576	0.835
NULL	Clinics_(Sao_Paulo)_2011_Aug_66(8)_1457-1462.nxml.txt.nlp	21915500	SENT110	5	5	30	30	rosuvastatin	NOS	PA134308647	4843	0.835
NULL	Oncotarget_2014_Mar_16_5(12)_4087-4102.nxml.txt.nlp	24961479	SENT166	15	15	11	11	hemin	PC3	PA449849	57332;7832;5122	0.835
NULL	Clin_Psychopharmacol_Neurosci_2012_Dec_20_10(3)_168-179.nxml.txt.nlp	23430396	SENT97	0	0	14	14	iptakalim	ANOVA	PA165949694	4858	0.835
NULL	Thorax_2010_Jul_13_65(7)_654-658.nxml.txt.nlp	20627927	SENT45	24	24	29	29	gentamicin	NAG	PA449753	51594;4669	0.835
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT195	23	23	19	19	quinidine	CYP3A4	PA451209	1576	0.835
NULL	Emerg_Infect_Dis_2012_Nov_18(11)_1802-1810.nxml.txt.nlp	23092584	SENT39	13	13	2	2	ethambutol	DST	PA164784021	667	0.835
NULL	Cardiovasc_Diabetol_2011_Feb_11_10_18.nxml.txt.nlp	21314919	SENT31	20	20	42	42	metformin	Met	PA450395	79811	0.835
NULL	Structure_2012_May_9_20-540(5-7)_841-849.nxml.txt.nlp	22579251	SENT86	36	36	16	16	formoterol	EL2	PA134687907	6708	0.835
NULL	Pharmaceuticals_(Basel)_2013_Aug_21_6(8)_988-1038.nxml.txt.nlp	24276379	SENT365	20	20	4	4	panitumumab	EGFR	PA162373091	1956	0.835
NULL	Oncotarget_2014_Jun_3_5(13)_4920-4928.nxml.txt.nlp	24952482	SENT130	4	4	16	16	crizotinib	ALK	PA165946122	238	0.835
NULL	Nucleic_Acids_Res_2005_Jun_8_33(10)_3283-3291.nxml.txt.nlp	15944449	SENT100	6	6	11	11	sjg-136	ERCC1		2067	0.835
NULL	Glycobiology_2009_Aug_11_19(8)_899-909.nxml.txt.nlp	19433864	SENT79	12	12	31	31	trypsin	CD98	PA451806	6520;8140	0.835
NULL	Br_J_Cancer_2012_Jun_26_107(1)_116-122.nxml.txt.nlp	22596240	SENT145	35	35	29	29	imatinib	TRAIL	PA10804	8743	0.835
NULL	Emerg_Infect_Dis_2011_Mar_17(3)_495-497.nxml.txt.nlp	21392442	SENT17	9	9	1	1	isoniazid	DST	PA450112	667	0.835
NULL	Clin_Cosmet_Investig_Dermatol_2013_Jan_14_6_29-36.nxml.txt.nlp	23355788	SENT171	38	38	28	28	desonide	CD68	PA164776996	968	0.835
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_105-115.nxml.txt.nlp	17912640	SENT45	21	21	32	32	pertuzumab	HER2		2064	0.835
NULL	J_Lipids_2011_Jan_13_2011_565316.nxml.txt.nlp	21490804	SENT121	6	6	18	18	etoposide	PERK	PA449552	9451	0.835
NULL	Core_Evid_2010_Oct_21_5_61-76.nxml.txt.nlp	21042543	SENT354	5	5	8	8	cetuximab	EGFR	PA10040	1956	0.835
NULL	Front_Immunol_2013_Mar_8_4_50.nxml.txt.nlp	23483669	SENT173	7	7	23	23	anakinra	IL-6	PA10799	3569	0.835
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT214	21	21	8	8	curcumin	DR4	PA151958596	8797	0.835
NULL	AIDS_Res_Ther_2013_May_1_10_10.nxml.txt.nlp	23634877	SENT187	34	34	11	11	atorvastatin	CD4	PA448500	920	0.835
NULL	J_RNAi_Gene_Silencing_2008_May_27_4(1)_289-294.nxml.txt.nlp	19771238	SENT27	41	41	10	10	trypsin	CO2	PA451806	4513	0.835
NULL	Front_Bioeng_Biotechnol_2015_Jan_5_2_76.nxml.txt.nlp	25601910	SENT113	1	1	13	13	naringenin	FBA	PA151958361	26273	0.835
NULL	Cancer_Cell_Int_2013_Jun_26_13_63.nxml.txt.nlp	23800022	SENT228	0	0	4	4	genistein	ATF3	PA165109660	467	0.835
NULL	Breast_Cancer_Res_2012_Feb_14_14(1)_R30.nxml.txt.nlp	22333315	SENT21	15	15	21	21	celecoxib	CXCR3	PA448871	2833	0.835
NULL	Eur_J_Clin_Pharmacol_2011_May_9_67(5)_477-482.nxml.txt.nlp	21305273	SENT112	18	18	22	22	dobutamine	DSE	PA449381	29940	0.835
NULL	Mol_Cancer_2010_Apr_23_9_87.nxml.txt.nlp	20416058	SENT181	31	31	29	29	doxorubicin	TRAIL	PA449412	8743	0.835
NULL	Int_Neurourol_J_2014_Sep_24_18(3)_115-125.nxml.txt.nlp	25279238	SENT125	2	2	6	6	berberine	PI3K	PA165860812	5290	0.835
NULL	Oncogene_2009_Dec_3_28(48)_4237-4248.nxml.txt.nlp	19734937	SENT265	11	11	18	18	thrombin	PAR-1	PA451674	2011;2149	0.835
NULL	Nat_Commun_2014_Dec_18_5_5815.nxml.txt.nlp	25519973	SENT81	29	29	32	32	tranylcypromine	LSD1	PA451741	23028	0.835
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1495-1502.nxml.txt.nlp	21989186	SENT112	12	12	7	7	panitumumab	HSI	PA162373091	57016	0.835
NULL	Iran_J_Ped_Hematol_Oncol_2014_Jul_20_4(3)_118-126.nxml.txt.nlp	25254091	SENT112	12	12	30	30	methotrexate	ABCA3	PA450428	21	0.835
NULL	Breast_Cancer_Res_2012_Aug_14_14(4)_R117.nxml.txt.nlp	22889108	SENT203	16	16	22	22	trastuzumab	HER2	PA451743	2064	0.835
NULL	Oncogene_2014_Jun_5_33(23)_3033-3042.nxml.txt.nlp	23851504	SENT104	9	9	13	13	doxycycline	AIB1	PA449415	8202	0.835
NULL	Front_Oncol_2013_Sep_25_3_256.nxml.txt.nlp	24093089	SENT312	39	39	16	16	paclitaxel	IL-2	PA450761	3558	0.835
NULL	Ann_Surg_Treat_Res_2014_Feb_22_86(2)_68-75.nxml.txt.nlp	24761411	SENT171	12	12	19	19	resveratrol	survivin		332	0.835
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT126	2	2	11	11	phenprocoumon	EPHX1	PA450921	2052	0.835
NULL	Croat_Med_J_2012_Jun_53(3)_214-223.nxml.txt.nlp	22661134	SENT65	34	34	6	6	yohimbine	ACTH	PA451946	5443	0.835
NULL	Cancer_Imaging_2012_May_25_12(1)_225-235.nxml.txt.nlp	22743083	SENT23	26	26	7	7	paclitaxel	VEGF-A	PA450761	7422	0.835
NULL	Cancers_(Basel)_2014_Dec_16_6(4)_2387-2403.nxml.txt.nlp	25521854	SENT110	25	25	5	5	cabozantinib	Met	PA165906891	79811	0.835
NULL	Oncol_Lett_2013_Oct_29_6(4)_1031-1038.nxml.txt.nlp	24137459	SENT8	6	6	8	8	cisplatin	DDP	PA449014	1678	0.835
NULL	Breast_Cancer_Res_2014_Oct_31_16(5)_447.nxml.txt.nlp	25358600	SENT173	8	8	13	13	tamoxifen	CXCR7	PA451581	57007	0.835
NULL	Br_J_Cancer_2009_Oct_20_101(8)_1253-1260.nxml.txt.nlp	19755984	SENT131	19	19	7	7	tamoxifen	PAX2	PA451581	5076	0.835
NULL	Br_J_Cancer_2012_Feb_28_106(5)_793-798.nxml.txt.nlp	22315057	SENT39	3	3	11	11	cetuximab	EGFR	PA10040	1956	0.835
NULL	Mol_Cancer_2014_Jun_24_13_157.nxml.txt.nlp	24958351	SENT4	8	8	0	0	lapatinib	HER2	PA152241907	2064	0.835
NULL	Br_J_Cancer_2012_Apr_24_106(9)_1469-1474.nxml.txt.nlp	22460270	SENT100	11	11	19	19	sunitinib	ANOVA	PA162372840	4858	0.835
NULL	Int_J_Hypertens_2012_Jun_26_2012_124758.nxml.txt.nlp	22792446	SENT169	15	15	22	22	losartan	AT2	PA450268	186	0.835
NULL	J_Hematol_Oncol_2010_May_2_3_18.nxml.txt.nlp	20433767	SENT178	19	19	23	23	paclitaxel	EGFR	PA450761	1956	0.835
NULL	J_Biol_Chem_2013_Dec_6_288(49)_35387-35395.nxml.txt.nlp	24142790	SENT20	4	4	2	2	meclizine	PCYT2	PA450338	5833	0.835
NULL	J_Immunother_2014_Jan_11_37(1)_36-42.nxml.txt.nlp	24316554	SENT5	9	9	11	11	gemcitabine	GEM	PA449748	2669	0.835
NULL	J_Hematol_Oncol_2009_Nov_22_2_49.nxml.txt.nlp	19930611	SENT50	13	13	29	29	cyclophosphamide	CHOP	PA449165	1649	0.835
NULL	Cancer_Cell_Int_2007_Mar_2_7_1.nxml.txt.nlp	17331262	SENT150	5	5	16	16	bromocriptine	p53	PA448671	7157	0.835
NULL	Cancer_Med_2013_Dec_22_2(6)_862-871.nxml.txt.nlp	24403259	SENT78	27	27	34	34	everolimus	p53	PA164746311	7157	0.835
NULL	J_Breast_Cancer_2013_Mar_31_16(1)_23-31.nxml.txt.nlp	23593078	SENT115	6	6	21	21	curcumin	HDAC1	PA151958596	3065	0.835
NULL	Front_Endocrinol_(Lausanne)_2014_Oct_2_5_158.nxml.txt.nlp	25324831	SENT151	27	27	12	12	carrageenan	NPFFR2	PA448814	10886	0.835
NULL	Mol_Biol_Rep_2012_May_20_39(5)_5253-5267.nxml.txt.nlp	22183301	SENT258	5	5	7	7	gliclazide	SUR1	PA10892	6833	0.835
NULL	Allergy_Asthma_Immunol_Res_2014_Nov_19_6(6)_548-557.nxml.txt.nlp	25374755	SENT112	2	2	20	20	lovastatin	L10	PA450272	6134	0.835
NULL	Int_J_Hypertens_2012_Feb_26_2012_957235.nxml.txt.nlp	22518298	SENT138	7	7	5	5	hemin	HO-1	PA449849	3162	0.835
NULL	Exp_Brain_Res_2014_Jun_27_232(8)_2637-2644.nxml.txt.nlp	24969614	SENT138	17	17	12	12	palonosetron	NK1	PA10352	11126	0.835
NULL	Biochemistry_2009_Jun_9_48(22)_4871-4880.nxml.txt.nlp	19364131	SENT240	20	20	32	32	papain	p44	PA450778	10561;2966	0.835
NULL	Exp_Anim_2014_Apr_26_63(2)_257-267.nxml.txt.nlp	24770651	SENT108	2	2	7	7	olmesartan	APJ	PA164742950	187	0.835
NULL	Clin_Interv_Aging_2014_Nov_18_9_1963-1980.nxml.txt.nlp	25429208	SENT145	0	0	4	4	metformin	DPP4	PA450395	1803	0.835
NULL	Biomed_Res_Int_2013_Dec_5_2013_642848.nxml.txt.nlp	24381940	SENT138	4	4	20	20	telmisartan	AT1	PA451605	9197;185	0.835
NULL	Cancer_Cell_Int_2013_May_15_13_42.nxml.txt.nlp	23672670	SENT188	2	2	10	10	paclitaxel	PIDD	PA450761	55367	0.835
NULL	Br_J_Cancer_2013_Feb_19_108(3)_570-578.nxml.txt.nlp	23299527	SENT140	10	10	14	14	acetohexamide	ALOX12	PA164777011	239	0.835
NULL	Crit_Care_2005_Sep_3_9(1)_23-24.nxml.txt.nlp	15693976	SENT9	21	21	0	0	dantrolene	CHS	PA449208	1130	0.835
NULL	Mol_Cancer_2009_Nov_24_8_109.nxml.txt.nlp	19930708	SENT165	10	10	12	12	estradiol	aromatase	PA449503	1588	0.835
NULL	Cell_Death_Differ_2010_Apr_16_17(4)_666-676.nxml.txt.nlp	19834494	SENT93	27	27	7	7	oxaliplatin	RAGE	PA131285527	177	0.835
NULL	Acta_Pharmacol_Sin_2011_Oct_12_32(10)_1259-1265.nxml.txt.nlp	21909126	SENT111	14	14	28	28	losartan	MCP-1	PA450268	6347	0.835
NULL	J_Gynecol_Oncol_2012_Jan_9_23(1)_35-42.nxml.txt.nlp	22355465	SENT17	8	8	4	4	cisplatin	CDK1	PA449014	983	0.835
NULL	Eur_J_Clin_Pharmacol_2012_Sep_15_68(9)_1267-1274.nxml.txt.nlp	22418828	SENT31	16	16	7	7	pantoprazole	CYP2C19	PA450774	1557	0.835
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Sep_8_68(Pt_10)_o2897-o2898.nxml.txt.nlp	23125693	SENT88	24	24	27	27	isoniazid	mol	PA450112	90527	0.835
NULL	Indian_J_Psychiatry_2007_Oct-Dec_49(4)_271-276.nxml.txt.nlp	20680140	SENT75	16	16	34	34	clozapine	spatial	PA449061	219793	0.835
NULL	Mol_Pain_2013_Jun_10_9_27.nxml.txt.nlp	23758830	SENT82	7	7	14	14	tetracaine	ASIC3	PA451638	9311	0.835
NULL	J_Hematol_Oncol_2013_Jan_17_6_8.nxml.txt.nlp	23327547	SENT80	13	13	25	25	sulindac	JNK1	PA451565	5599	0.835
NULL	Arch_Med_Sci_2012_Sep_8_8(4)_589-597.nxml.txt.nlp	23056066	SENT124	0	0	4	4	pitrakinra	IL-4	PA165983754	3565	0.835
NULL	J_Mol_Med_(Berl)_2014_May_10_92(7)_709-722.nxml.txt.nlp	24811491	SENT219	19	19	10	10	cetuximab	KRAS	PA10040	3845	0.835
NULL	Br_J_Cancer_2011_May_24_104(11)_1686-1690.nxml.txt.nlp	21540861	SENT124	14	14	3	3	imatinib	KIT	PA10804	3815	0.835
NULL	Exp_Ther_Med_2013_Apr_11_5(4)_1147-1152.nxml.txt.nlp	23599738	SENT98	10	10	3	3	fentanyl	OPRM1	PA449599	4988	0.835
NULL	Diabetes_2013_Jun_17_62(6)_2141-2150.nxml.txt.nlp	23378610	SENT213	39	39	12	12	betaine	BHMT	PA448603	635	0.835
NULL	Antimicrob_Agents_Chemother_2013_Dec_57(12)_5792-5807.nxml.txt.nlp	24002099	SENT737	9	9	18	18	primaquine	G6PD	PA451103	2539	0.835
NULL	Oncotarget_2014_Jun_3_5(13)_4920-4928.nxml.txt.nlp	24952482	SENT11	0	0	13	13	crizotinib	MET	PA165946122	4233	0.835
NULL	Biomed_Res_Int_2013_Jun_6_2013_626910.nxml.txt.nlp	23841079	SENT194	33	33	26	26	vincristine	CHOP	PA451879	1649	0.835
NULL	Biologics_2012_Jan_5_6_13-20.nxml.txt.nlp	22291463	SENT135	1	1	10	10	bevacizumab	VEGFR2	PA130232992	3791	0.835
NULL	Oncogene_2014_Feb_6_33(6)_713-723.nxml.txt.nlp	23435429	SENT100	20	20	16	16	etoposide	BRCA1	PA449552	672	0.835
NULL	Br_J_Cancer_2014_Jan_21_110(2)_384-391.nxml.txt.nlp	24346286	SENT131	25	25	15	15	trastuzumab	PTEN	PA451743	5728	0.835
NULL	J_Asthma_Allergy_2008_Sep_19_1_19-29.nxml.txt.nlp	21436982	SENT45	3	3	11	11	alfentanil	CYP3A4	PA448084	1576	0.835
NULL	Br_J_Cancer_2004_Mar_22_90(6)_1285-1292.nxml.txt.nlp	15026814	SENT117	14	14	11	11	cisplatin	p53	PA449014	7157	0.835
NULL	Acta_Pharmacol_Sin_2011_Mar_31_32(3)_295-302.nxml.txt.nlp	21278785	SENT167	1	1	8	8	evodiamine	IL-6	PA165860788	3569	0.835
NULL	Oxid_Med_Cell_Longev_2011_Oct_9_2011_756938.nxml.txt.nlp	22007271	SENT126	3	3	11	11	forskolin	PNMT	PA146096022	5409	0.835
NULL	Breast_Cancer_Res_2012_Jul_23_14(4)_R112.nxml.txt.nlp	22824341	SENT247	10	10	2	2	doxorubicin	RANK	PA449412	8792	0.835
NULL	EMBO_Mol_Med_2012_Mar_4(3)_218-233.nxml.txt.nlp	22294553	SENT210	17	17	4	4	erlotinib	GLI1	PA134687924	2735	0.835
NULL	Br_J_Cancer_1998_Jun_77(12)_2286-2290.nxml.txt.nlp	9649147	SENT13	5	5	0	0	doxorubicin	CHOP	PA449412	1649	0.835
NULL	Arthritis_Res_Ther_2012_Jun_12_14(3)_R141.nxml.txt.nlp	22691241	SENT178	48	48	36	36	abatacept	AKT	PA164747080	207	0.835
NULL	Arthritis_Res_Ther_2013_Jul_9_15(4)_R73.nxml.txt.nlp	23837669	SENT258	0	0	5	5	colchicine	IL-8	PA449092	3576	0.835
NULL	Semin_Nephrol_2013_Nov_33(6)_508-530.nxml.txt.nlp	24161037	SENT177	2	2	10	10	eculizumab	ADAMTS13	PA164776637	11093	0.835
NULL	J_Cell_Biol_2000_Jul_10_150(1)_1a-12.nxml.txt.nlp	10893249	SENT84	23	23	19	19	l-glutamine	DES	PA10090	1674	0.835
NULL	Acta_Pharmacol_Sin_2010_Mar_8_31(3)_382-386.nxml.txt.nlp	20140004	SENT26	10	10	0	0	pitavastatin	SLCO1B1	PA142650384	10599	0.835
NULL	Croat_Med_J_2012_Jun_53(3)_224-233.nxml.txt.nlp	22661135	SENT70	1	1	10	10	sulpiride	PRL	PA164745485	5617	0.835
NULL	Nat_Biotechnol_2010_Feb_31_28(2)_167-171.nxml.txt.nlp	20118917	SENT134	23	23	1	1	paraformaldehyde	IPS-1	PA450790	57506	0.835
NULL	Adv_Hematol_2012_Mar_25_2012_302570.nxml.txt.nlp	22536253	SENT191	4	4	24	24	bortezomib	CHOP	PA10252	1649	0.835
NULL	J_Histochem_Cytochem_2014_Nov_62(11)_813-826.nxml.txt.nlp	25163927	SENT68	6	6	0	0	nadh	GDH	PA164755085	51084;2746	0.835
NULL	Cancers_(Basel)_2014_Apr_3_6(2)_771-795.nxml.txt.nlp	24704793	SENT1499	16	16	7	7	camptothecin	BRCA1	PA153590860	672	0.835
NULL	Front_Genet_2014_Aug_8_5_233.nxml.txt.nlp	25152750	SENT327	12	12	20	20	doxorubicin	p53	PA449412	7157	0.835
NULL	eLife_2013_Sep_24_2_e00905.nxml.txt.nlp	24069528	SENT212	29	29	6	6	iodixanol	cavin-3	PA164783998	112464	0.835
NULL	BioData_Min_2008_Jul_17_1_2.nxml.txt.nlp	18822146	SENT210	23	23	12	12	ethanol	MTHFR	PA448073	4524	0.835
NULL	J_Invest_Dermatol_2012_May_16_132(5)_1435-1442.nxml.txt.nlp	22336948	SENT62	22	22	10	10	doxycycline	TLSP	PA449415	11012	0.835
NULL	J_Biol_Chem_2009_Aug_21_284(34)_22926-22937.nxml.txt.nlp	19520847	SENT237	2	2	5	5	amrinone	ADP	PA164746803	23038	0.835
NULL	Oncotarget_2011_Jan_25_2(1-2)_8-17.nxml.txt.nlp	21378407	SENT34	9	9	0	0	thrombin	PAR-1	PA451674	2011;2149	0.835
NULL	Indian_J_Endocrinol_Metab_2012_Mar-Apr_16(2)_177-182.nxml.txt.nlp	22470852	SENT95	6	6	8	8	cinacalcet	PTH	PA164776671	5741	0.835
NULL	Front_Oncol_2014_May_30_4_128.nxml.txt.nlp	24910845	SENT131	4	4	16	16	glibenclamide	TRAIL	PA449782	8743	0.835
NULL	Indian_J_Med_Res_2014_Feb_139(2)_205-215.nxml.txt.nlp	24718394	SENT122	11	11	5	5	artemether	ACT	PA165111698	12;11332;9457;641455	0.835
NULL	Clinics_(Sao_Paulo)_2014_Jan_69(1)_68-74.nxml.txt.nlp	24473562	SENT22	5	5	30	30	nutlin-3	p53		7157	0.835
NULL	Can_J_Infect_Dis_Med_Microbiol_2014_May-Jun_25(3)_155-158.nxml.txt.nlp	25285112	SENT80	25	25	29	29	cefuroxime	TMP	PA448868	2012	0.835
NULL	Br_J_Cancer_2010_Jan_5_102(1)_104-114.nxml.txt.nlp	20051961	SENT168	5	5	24	24	paclitaxel	PC3	PA450761	57332;7832;5122	0.835
NULL	Exp_Ther_Med_2013_Jul_25_6(1)_109-114.nxml.txt.nlp	23935730	SENT142	35	35	43	43	vincristine	CHOP	PA451879	1649	0.835
NULL	Ann_Rheum_Dis_2008_Oct_25_68(10)_1644-1650.nxml.txt.nlp	18957484	SENT152	8	8	18	18	leflunomide	IL-17	PA450192	3605	0.835
NULL	Biochem_Res_Int_2012_Feb_12_2012_346972.nxml.txt.nlp	22400115	SENT75	17	17	20	20	doxorubicin	CD44	PA449412	960	0.835
NULL	Oncotarget_2013_Mar_23_4(3)_463-473.nxml.txt.nlp	23531874	SENT186	37	37	28	28	cetuximab	EGFR	PA10040	1956	0.835
NULL	Aging_(Albany_NY)_2012_Jul_22_4(7)_480-498.nxml.txt.nlp	22837425	SENT87	13	13	1	1	metformin	AMPK	PA450395	5563	0.835
NULL	Oncol_Lett_2014_Jul_16_8(1)_211-217.nxml.txt.nlp	24959248	SENT119	4	4	25	25	cisplatin	ALDOA	PA449014	226	0.835
NULL	Cancer_Med_2013_Feb_3_2(1)_40-49.nxml.txt.nlp	24133626	SENT19	30	30	24	24	cilostazol	PDE3B	PA164746334	5140	0.835
NULL	ScientificWorldJournal_2013_Oct_22_2013_686304.nxml.txt.nlp	24250273	SENT94	20	20	16	16	sitagliptin	GLP-1	PA164748978	100125288	0.835
NULL	Cell_Microbiol_2013_Apr_20_15(4)_585-600.nxml.txt.nlp	23107115	SENT21	1	1	14	14	geldanamycin	Hsp90	PA152031327	3320	0.835
NULL	Alcohol_Res_Health_2007_30(1)_38-47.nxml.txt.nlp	17718399	SENT79	12	12	6	6	ethanol	ADH1B	PA448073	125	0.835
NULL	Asian-Australas_J_Anim_Sci_2014_Dec_27(12)_1783-1793.nxml.txt.nlp	25358373	SENT200	0	0	10	10	capsaicin	BAX	PA448776	581	0.835
NULL	J_Inflamm_(Lond)_2007_Mar_21_4_6.nxml.txt.nlp	17376223	SENT124	19	19	28	28	hydrocortisone	ANOVA	PA449905	4858	0.835
NULL	J_Immunother_Cancer_2013_Nov_7_1(Suppl_1)_P255.nxml.txt.nlp	NULL	SENT9	16	16	23	23	cyclophosphamide	OX40	PA449165	7293	0.835
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT126	2	2	15	15	phenprocoumon	PROC	PA450921	5624	0.835
NULL	Front_Immunol_2012_Jun_11_3_144.nxml.txt.nlp	22701453	SENT13	28	28	19	19	imiquimod	TLR4	PA449972	7099	0.835
NULL	Gut_Liver_2012_Jan_12_6(1)_29-40.nxml.txt.nlp	22375168	SENT89	19	19	14	14	doxorubicin	BCRP1	PA449412	317687	0.835
NULL	J_Cell_Biol_2003_Sep_1_162(5)_773-780.nxml.txt.nlp	12952931	SENT63	14	14	17	17	tetracycline	AAK1	PA451640	22848	0.835
NULL	Nat_Commun_2013_Sep_20_4_2444.nxml.txt.nlp	24051492	SENT49	13	13	4	4	nutlin-3	p53		7157	0.835
NULL	Cell_Death_Dis_2011_Aug_11_2(8)_e191.nxml.txt.nlp	21833029	SENT275	19	19	5	5	oxaliplatin	CT26	PA131285527	168400	0.835
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S349-S354.nxml.txt.nlp	21525481	SENT83	0	0	22	22	rimonabant	CB1	PA152407999	1268	0.835
NULL	Lab_Invest_2011_Oct_18_91(10)_1414-1426.nxml.txt.nlp	21769085	SENT40	0	0	3	3	gefitinib	EGFR	PA131301952	1956	0.835
NULL	Eur_J_Med_Res_2014_Jun_19_19(Suppl_1)_S25.nxml.txt.nlp	NULL	SENT20	15	15	31	31	oxygen	p47phox	PA450744	653361	0.835
NULL	Asian_J_Androl_2015_Oct_24_Jan-Feb_17(1)_61-67.nxml.txt.nlp	25370206	SENT116	26	26	1	1	sildenafil	SEP2	PA451346	23176;23157	0.835
NULL	Arch_Med_Sci_2013_Apr_20_9(2)_332-339.nxml.txt.nlp	23671446	SENT153	8	8	29	29	midazolam	p38	PA450496	10598;1432;7965	0.835
NULL	Ther_Clin_Risk_Manag_2007_Aug_3(4)_665-673.nxml.txt.nlp	18472989	SENT80	5	5	21	21	lapatinib	CYP2C19	PA152241907	1557	0.835
NULL	Oncotarget_2014_Oct_21_5(22)_11252-11268.nxml.txt.nlp	25361004	SENT297	22	22	11	11	metformin	CLIC1	PA450395	1192	0.835
NULL	Virchows_Arch_2012_Feb_16_460(2)_141-149.nxml.txt.nlp	22173329	SENT218	4	4	28	28	irinotecan	BRAF	PA450085	673	0.835
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_39-54.nxml.txt.nlp	19305787	SENT237	35	35	25	25	ethanol	NR1	PA448073	27158	0.835
NULL	Clin_Ophthalmol_2009_Jun_2_3_291-295.nxml.txt.nlp	19668581	SENT112	11	11	9	9	travoprost	BAK	PA164781371	578	0.835
NULL	Cancer_Cell_Int_2010_Sep_9_10_32.nxml.txt.nlp	20828393	SENT187	24	24	3	3	cisplatin	ATF3	PA449014	467	0.835
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Sep_4_66(Pt_10)_o2472.nxml.txt.nlp	21587473	SENT59	22	22	19	19	ethanol	mol	PA448073	90527	0.835
NULL	Cell_Death_Dis_2013_Oct_3_4(10)_e827.nxml.txt.nlp	24091670	SENT90	0	0	9	9	nilotinib	CD34	PA165958345	947	0.835
NULL	Clin_Med_Cardiol_2009_May_27_3_53-60.nxml.txt.nlp	20407620	SENT51	11	11	2	2	fluorescein	CD34	PA164746009	947	0.835
NULL	Int_J_Gen_Med_2009_Jul_30_2_129-140.nxml.txt.nlp	20360896	SENT150	23	23	25	25	tamoxifen	IMPACT	PA451581	55364	0.835
NULL	J_Korean_Med_Sci_2010_Sep_14_25(9)_1277-1283.nxml.txt.nlp	20808669	SENT122	4	4	9	9	pamidronate	IL-6	PA450767	3569	0.835
NULL	Cancer_Metastasis_Rev_2010_Dec_10_29(4)_581-594.nxml.txt.nlp	20830503	SENT341	9	9	0	0	tamoxifen	ATAC	PA451581	6375	0.835
NULL	Curr_Med_Chem_2011_Jun_18(18)_2686-2714.nxml.txt.nlp	21649578	SENT214	31	31	34	34	gefitinib	EGFR	PA131301952	1956	0.835
NULL	Cell_Res_2012_Aug_22_22(8)_1227-1245.nxml.txt.nlp	22613949	SENT115	29	29	17	17	bortezomib	KRAS	PA10252	3845	0.834
NULL	Mol_Cancer_2010_Aug_6_9_211.nxml.txt.nlp	20687965	SENT150	17	17	19	19	staurosporine	STA	PA165109623	2010;2656	0.834
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT131	15	15	24	24	simvastatin	survivin	PA451363	332	0.834
NULL	Toxins_(Basel)_2010_Oct_26_2(11)_2490-2518.nxml.txt.nlp	22069563	SENT192	24	24	16	16	cisplatin	IL-18	PA449014	3606	0.834
NULL	Mol_Cancer_2009_Apr_22_8_26.nxml.txt.nlp	19386116	SENT122	0	0	2	2	ritonavir	AKT	PA451260	207	0.834
NULL	Mol_Biol_Cell_2013_Jul_1_24(13)_2134-2145.nxml.txt.nlp	23657817	SENT272	20	20	11	11	paraformaldehyde	EGF	PA450790	1950	0.834
NULL	Kidney_Int_Suppl_(2011)_2013_Dec_27_3(5)_436-441.nxml.txt.nlp	25019026	SENT95	0	0	10	10	cinacalcet	PTH	PA164776671	5741	0.834
NULL	J_Neuroinflammation_2011_Aug_5_8_91.nxml.txt.nlp	21819568	SENT207	11	11	16	16	pioglitazone	CD68	PA450970	968	0.834
NULL	Eur_J_Endocrinol_2009_Nov_161(5)_655-662.nxml.txt.nlp	19729432	SENT28	24	24	15	15	metformin	adiponectin	PA450395	9370	0.834
NULL	Environ_Health_Perspect_2011_Dec_3_119(12)_1811-1816.nxml.txt.nlp	21813368	SENT203	4	4	6	6	diethylstilbestrol	DES	PA449307	1674	0.834
NULL	Chonnam_Med_J_2011_Aug_31_47(2)_124-126.nxml.txt.nlp	22111073	SENT44	5	5	43	43	clopidogrel	DES	PA449053	1674	0.834
NULL	Osteoporos_Int_2013_Jan_24_24(1)_219-226.nxml.txt.nlp	23093347	SENT52	0	0	33	33	teriparatide	San	PA451620	80218	0.834
NULL	Allergy_Asthma_Clin_Immunol_2009_Dec_17_5(1)_14.nxml.txt.nlp	20066054	SENT40	8	8	12	12	cetirizine	GM-CSF	PA448905	1437	0.834
NULL	Int_J_Cell_Biol_2014_Jan_22_2014_709828.nxml.txt.nlp	24578708	SENT90	11	11	8	8	choline	CTL1	PA448976	23446	0.834
NULL	Exp_Hematol_Oncol_2013_Jul_1_2_17.nxml.txt.nlp	23815814	SENT72	25	25	20	20	doxorubicin	ABCB5	PA449412	340273	0.834
NULL	Mol_Brain_2014_Aug_21_7_59.nxml.txt.nlp	25139109	SENT154	0	0	4	4	imiquimod	TLR7	PA449972	51284	0.834
NULL	Arthritis_Res_Ther_2014_Oct_30_16(5)_474.nxml.txt.nlp	25359291	SENT63	29	29	7	7	methotrexate	ACPA	PA450428	5657	0.834
NULL	Mol_Vis_2010_Oct_8_16_2033-2042.nxml.txt.nlp	21042558	SENT299	6	6	11	11	genistein	NFkappaB	PA165109660	4790	0.834
NULL	Chem_Cent_J_2013_Jul_31_7_133.nxml.txt.nlp	23899303	SENT0	16	16	31	31	moxifloxacin	DSC	PA450555	1825	0.834
NULL	Pharmaceuticals_(Basel)_2011_Oct_25_4(11)_1400-1422.nxml.txt.nlp	NULL	SENT220	14	14	0	0	oxaliplatin	TRAP1	PA131285527	9392;10131	0.834
NULL	J_Ginseng_Res_2011_Nov_35(4)_471-478.nxml.txt.nlp	23717094	SENT201	21	21	7	7	ethanol	CaCC	PA448073	1179	0.834
NULL	Br_J_Cancer_2009_Sep_15_101(6)_924-934.nxml.txt.nlp	19690550	SENT257	25	25	7	7	capecitabine	CRT	PA448771	811	0.834
NULL	Indian_J_Pharmacol_2014_Nov-Dec_46(6)_627-632.nxml.txt.nlp	25538335	SENT167	13	13	11	11	metformin	Q10	PA450395	27161	0.834
NULL	Mol_Cancer_2014_Jan_15_13_8.nxml.txt.nlp	24423412	SENT102	9	9	3	3	cisplatin	CD44	PA449014	960	0.834
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_May_14_65(Pt_6)_o1266.nxml.txt.nlp	21583130	SENT51	13	13	41	41	ethanol	mol	PA448073	90527	0.834
NULL	Oncotarget_2011_Sep_9_2(9)_658-668.nxml.txt.nlp	21911919	SENT110	19	19	5	5	bortezomib	HO-1	PA10252	3162	0.834
NULL	Br_J_Cancer_2003_Jun_16_88(12)_1979-1986.nxml.txt.nlp	12799646	SENT176	34	34	45	45	sn-38	mol		90527	0.834
NULL	Acta_Neuropathol_Commun_2014_Oct_21_2(1)_149.nxml.txt.nlp	NULL	SENT187	0	0	39	39	riluzole	ANOVA	PA451251	4858	0.834
NULL	J_Virol_2014_Apr_88(7)_3664-3677.nxml.txt.nlp	24429366	SENT570	9	9	3	3	temozolomide	BMP2	PA451609	650	0.834
NULL	Biomed_Res_Int_2014_May_20_2014_418975.nxml.txt.nlp	24967364	SENT120	20	20	25	25	lipase	adiponectin	PA450239	9370	0.834
NULL	Int_J_Mol_Imaging_2011_Oct_26_2011_874585.nxml.txt.nlp	21490735	SENT184	18	18	44	44	doxorubicin	FDG	PA449412	23583	0.834
NULL	Saudi_J_Anaesth_2013_Apr-Jun_7(2)_151-154.nxml.txt.nlp	23956714	SENT60	13	13	22	22	theophylline	NAC	PA451647	22861	0.834
NULL	Acta_Pharmacol_Sin_2011_Nov_10_32(11)_1402-1410.nxml.txt.nlp	21986579	SENT249	13	13	30	30	curcumin	CDK2	PA151958596	1017	0.834
NULL	Acta_Histochem_Cytochem_2012_Apr_26_45(2)_139-146.nxml.txt.nlp	22685356	SENT89	3	3	5	5	forskolin	AQP2	PA146096022	359	0.834
NULL	Colomb_Med_(Cali)_43(4)_305-311.nxml.txt.nlp	24893304	SENT85	22	22	0	0	ganciclovir	CD4	PA449733	920	0.834
NULL	Br_J_Cancer_2013_Jul_23_109(2)_502-511.nxml.txt.nlp	23799850	SENT202	15	15	11	11	gemcitabine	SMARCC1	PA449748	6599	0.834
NULL	J_Oncol_2009_Mar_24_2009_491985.nxml.txt.nlp	19325924	SENT165	17	17	3	3	genistein	CXCR4	PA165109660	7852	0.834
NULL	Mol_Biol_Cell_2014_Mar_15_25(6)_891-903.nxml.txt.nlp	24430874	SENT280	22	22	5	5	tetracycline	VRK1	PA451640	7443	0.834
NULL	Oncotarget_2013_Aug_26_4(10)_1662-1672.nxml.txt.nlp	24091566	SENT17	7	7	18	18	trastuzumab	HER3	PA451743	2065	0.834
NULL	Breast_Cancer_Res_2001_Nov_8_3(1)_8-10.nxml.txt.nlp	11250740	SENT12	31	31	37	37	trastuzumab	San	PA451743	80218	0.834
NULL	Indian_J_Pharmacol_2014_Nov-Dec_46(6)_627-632.nxml.txt.nlp	25538335	SENT0	27	27	21	21	metformin	Q10	PA450395	27161	0.834
NULL	Br_J_Cancer_2009_Sep_15_101(6)_957-966.nxml.txt.nlp	19738618	SENT15	11	11	2	2	dexrazoxane	THBS-1	PA449259	7057	0.834
NULL	Acta_Pharmacol_Sin_2012_Aug_23_33(8)_1095-1100.nxml.txt.nlp	22820908	SENT108	6	6	14	14	clarithromycin	CYP3A	PA449028	1574	0.834
NULL	Arthritis_Res_Ther_2011_Feb_16_13(1)_R25.nxml.txt.nlp	21324169	SENT150	24	24	18	18	etanercept	TNF	PA449515	7124	0.834
NULL	Acta_Pharmacol_Sin_2014_Aug_7_35(8)_1023-1030.nxml.txt.nlp	24998255	SENT111	10	10	14	14	octreotide	STAT3	PA450678	6774	0.834
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT93	16	16	34	34	atorvastatin	PIK3CA	PA448500	5290	0.834
NULL	Br_J_Cancer_2013_Mar_5_108(4)_973-982.nxml.txt.nlp	23299537	SENT127	11	11	18	18	doxorubicin	BTG2	PA449412	7832	0.834
NULL	BMB_Rep_2013_Jan_46(1)_59-64.nxml.txt.nlp	23351386	SENT61	19	19	11	11	auranofin	STAT3	PA448510	6774	0.834
NULL	Mol_Cancer_2007_Nov_17_6_73.nxml.txt.nlp	18021420	SENT45	16	16	27	27	bortezomib	Mcl-1	PA10252	4170	0.834
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT174	10	10	7	7	doxorubicin	B7-H1	PA449412	29126	0.834
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2014_Sep_27_70(Pt_10)_2740-2753.nxml.txt.nlp	25286857	SENT5	33	33	11	11	bsi-201	ADP		23038	0.834
NULL	J_Breast_Cancer_2013_Sep_30_16(3)_291-299.nxml.txt.nlp	24155758	SENT18	10	10	2	2	mitomycin	FANCF	PA450524	2188	0.834
NULL	Anemia_2012_Aug_12_2012_297641.nxml.txt.nlp	22924125	SENT149	3	3	42	42	deferasirox	EOS	PA164760843	260429	0.834
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S31-S40.nxml.txt.nlp	20680106	SENT184	13	13	4	4	cetuximab	KRAS	PA10040	3845	0.834
NULL	Cancer_Cell_Int_2011_Sep_27_11_34.nxml.txt.nlp	21951911	SENT169	40	40	5	5	l-glutamine	U87	PA10090	677775;641648	0.834
NULL	Breast_Cancer_Res_Treat_2013_Sep_1_141(2)_243-248.nxml.txt.nlp	23996142	SENT165	8	8	4	4	tamoxifen	CYP2D6	PA451581	1565	0.834
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT264	28	28	10	10	lapatinib	HER2	PA152241907	2064	0.834
NULL	Environ_Health_Perspect_1997_Apr_105(Suppl_3)_619-624.nxml.txt.nlp	9168005	SENT6	5	5	7	7	diethylstilbestrol	DES	PA449307	1674	0.834
NULL	Diabetes_Care_2011_Sep_19_34(9)_2108-2112.nxml.txt.nlp	21788628	SENT157	18	18	10	10	rosiglitazone	DREAM	PA451283	30818	0.834
NULL	Br_J_Cancer_2013_Jan_15_108(1)_82-90.nxml.txt.nlp	23321512	SENT156	39	39	32	32	paclitaxel	TUBB	PA450761	203068	0.834
NULL	Oncotarget_2011_Dec_15_2(12)_984-996.nxml.txt.nlp	22184287	SENT207	10	10	31	31	olaparib	TP53		7157	0.834
NULL	Acta_Vet_Scand_2003_Sep_30_44(3)_121-129.nxml.txt.nlp	15074625	SENT166	22	22	14	14	gentamicin	TMP	PA449753	2012	0.834
NULL	Oncol_Lett_2013_Feb_7_5(2)_440-446.nxml.txt.nlp	23420122	SENT109	8	8	19	19	gemcitabine	AKT	PA449748	207	0.834
NULL	Pak_J_Med_Sci_2013_May-Jun_29(3)_768-772.nxml.txt.nlp	24353625	SENT40	15	15	17	17	cefotaxime	CTX	PA448852	1593	0.834
NULL	Nat_Med_2012_Jul_18(7)_1118-1122.nxml.txt.nlp	22683780	SENT64	10	10	36	36	crizotinib	HGF	PA165946122	3569;6654;3082	0.834
NULL	Int_J_Mol_Sci_2012_Dec_5_13(12)_16624-16635.nxml.txt.nlp	23443122	SENT11	6	6	15	15	paclitaxel	MRP3	PA450761	8714	0.834
NULL	Mol_Cancer_2014_Jul_5_13_165.nxml.txt.nlp	24996221	SENT14	10	10	2	2	docetaxel	HMGB1	PA449383	3146	0.834
NULL	Int_J_Endocrinol_2013_May_2_2013_501851.nxml.txt.nlp	23737774	SENT212	7	7	27	27	estradiol	c-fos	PA449503	2353	0.834
NULL	J_Antimicrob_Chemother_2008_Nov_13_62(5)_1086-1093.nxml.txt.nlp	18703526	SENT86	7	7	9	9	cefotaxime	CTX	PA448852	1593	0.834
NULL	Clin_Dev_Immunol_2011_Jan_5_2011_587315.nxml.txt.nlp	21253470	SENT237	11	11	25	25	zoledronate	IFN	PA10235	3439	0.834
NULL	J_Mol_Signal_2010_May_10_5_4.nxml.txt.nlp	20459745	SENT16	13	13	16	16	cisplatin	p53	PA449014	7157	0.834
NULL	J_Clin_Biochem_Nutr_2007_Sep_29_41(2)_84-91.nxml.txt.nlp	18193101	SENT147	0	0	7	7	lansoprazole	IL-8	PA450180	3576	0.834
NULL	Cell_Death_Dis_2014_Jul_17_5(7)_e1324.nxml.txt.nlp	25032847	SENT87	18	18	24	24	doxycycline	HAND1	PA449415	9421	0.834
NULL	Breast_Cancer_Res_2010_Mar_5_12(2)_R16.nxml.txt.nlp	20205716	SENT233	17	17	9	9	lovastatin	RhoA	PA450272	387	0.834
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT278	10	10	3	3	lapatinib	HRG	PA152241907	3084;3273	0.834
NULL	Oncotarget_2014_Dec_4_5(22)_11365-11380.nxml.txt.nlp	25426548	SENT66	0	0	15	15	nutlin-3	TP53		7157	0.834
NULL	J_Cell_Mol_Med_2014_Jan_4_18(1)_38-48.nxml.txt.nlp	24188742	SENT227	4	4	28	28	hyaluronan	PAX3	PA165958431	5077	0.834
NULL	Antimicrob_Agents_Chemother_2014_Nov_10_59(1)_505-513.nxml.txt.nlp	25385096	SENT242	5	5	18	18	primaquine	CYP2D6	PA451103	1565	0.834
NULL	Indian_J_Anaesth_2014_Sep-Oct_58(5)_596-602.nxml.txt.nlp	25535422	SENT55	0	0	25	25	desmopressin	VIII	PA449237	1351	0.834
NULL	Acta_Pharmacol_Sin_2014_Aug_30_35(8)_1045-1054.nxml.txt.nlp	24976155	SENT97	0	0	2	2	resveratrol	STAT3		6774	0.834
NULL	Int_J_Med_Sci_2015_Jan_1_12(1)_78-82.nxml.txt.nlp	25552922	SENT26	18	18	0	0	diazepam	CYP2C19	PA449283	1557	0.834
NULL	Mol_Pain_2013_Jun_10_9_27.nxml.txt.nlp	23758830	SENT195	4	4	26	26	lidocaine	TRPV1	PA450226	7442	0.834
NULL	J_Oncol_2014_Feb_10_2014_808012.nxml.txt.nlp	24659999	SENT56	29	29	7	7	paraformaldehyde	CXCR4	PA450790	7852	0.834
NULL	Breast_Cancer_Res_2007_Dec_20_9(Suppl_2)_S11.nxml.txt.nlp	NULL	SENT19	28	28	12	12	tamoxifen	IMPACT	PA451581	55364	0.834
NULL	J_Hum_Genet_2013_Jun_16_58(6)_353-361.nxml.txt.nlp	23677058	SENT154	26	26	12	12	cytarabine	MAF	PA449177	4094	0.834
NULL	J_Ophthalmol_2012_Jan_9_2012_209538.nxml.txt.nlp	22272370	SENT180	15	15	7	7	ranibizumab	San	PA164746012	80218	0.834
NULL	Biomed_Res_Int_2014_Jun_2_2014_946492.nxml.txt.nlp	24991574	SENT82	7	7	21	21	olmesartan	p47phox	PA164742950	653361	0.834
NULL	FEBS_Open_Bio_2013_Dec_30_4_96-104.nxml.txt.nlp	24490130	SENT573	30	30	24	24	cisplatin	BRCA1	PA449014	672	0.834
NULL	Cancer_Cell_Int_2006_Aug_9_6_20.nxml.txt.nlp	16899133	SENT186	12	12	27	27	l-cysteine	p27	PA449173	5715;10534	0.834
NULL	Ann_Oncol_2014_Oct_18_25(10)_1871-1888.nxml.txt.nlp	25234545	SENT203	10	10	13	13	tamoxifen	aromatase	PA451581	1588	0.834
NULL	Br_J_Cancer_2013_Mar_19_108(5)_1052-1060.nxml.txt.nlp	23422754	SENT36	37	37	22	22	bevacizumab	VEGF-A	PA130232992	7422	0.834
NULL	Nucleic_Acids_Res_2011_Mar_22_39(4)_1576-1585.nxml.txt.nlp	20972222	SENT54	22	22	4	4	thrombin	TYW5	PA451674	129450	0.834
NULL	Arthritis_Res_2000_Sep_20_2(6)_504-512.nxml.txt.nlp	11056680	SENT63	4	4	2	2	thrombin	PAR1	PA451674	79581;2149	0.834
NULL	J_Biol_Inorg_Chem_2014_Oct_17_19(1)_17-27.nxml.txt.nlp	24132751	SENT22	25	25	18	18	cisplatin	CTR1	PA449014	1317	0.834
NULL	J_Cancer_2013_Aug_28_4(7)_585-596.nxml.txt.nlp	24069069	SENT127	20	20	11	11	verteporfin	p62	PA451871	8878;10657;23636	0.834
NULL	Scientifica_(Cairo)_2012_Jul_11_2012_306830.nxml.txt.nlp	24278684	SENT129	17	17	19	19	thrombin	PAR-1	PA451674	2011;2149	0.834
NULL	Cells_2014_Apr_8_3(2)_258-287.nxml.txt.nlp	24717323	SENT184	18	18	24	24	capsaicin	TRPV1	PA448776	7442	0.834
NULL	Adolesc_Health_Med_Ther_2014_Mar_26_5_35-48.nxml.txt.nlp	24729739	SENT138	32	32	5	5	etanercept	ACR	PA449515	49	0.834
NULL	Breast_Cancer_Res_2011_Nov_16_13(Suppl_2)_O11.nxml.txt.nlp	NULL	SENT9	4	4	12	12	lapatinib	HER2	PA152241907	2064	0.834
NULL	Cancer_Med_2013_Feb_3_2(1)_76-85.nxml.txt.nlp	24133630	SENT197	32	32	28	28	elacridar	P-gp		5243	0.834
NULL	J_Cell_Biol_2000_Feb_21_148(4)_811-824.nxml.txt.nlp	10684261	SENT4	17	17	24	24	thrombin	EGF	PA451674	1950	0.834
NULL	Oncotarget_2012_Dec_18_3(12)_1615-1628.nxml.txt.nlp	23271044	SENT219	11	11	15	15	temsirolimus	STAT3	PA164746890	6774	0.834
NULL	Br_J_Haematol_2014_Feb_16_164(4)_586-596.nxml.txt.nlp	24236640	SENT200	20	20	7	7	carboplatin	EPO	PA448803	7076;8288;2056	0.834
NULL	Acta_Pharmacol_Sin_2010_Jun_4_31(6)_709-717.nxml.txt.nlp	20523342	SENT240	17	17	9	9	repaglinide	IGF2BP2	PA451234	10644	0.834
NULL	Cancer_Metab_2014_Aug_18_2_13.nxml.txt.nlp	25225614	SENT37	23	23	25	25	heparin	EGF	PA449855	1950	0.834
NULL	Mol_Biol_Cell_2012_Nov_1_23(21)_4212-4225.nxml.txt.nlp	22956765	SENT87	15	15	5	5	thrombin	PP2	PA451674	4888	0.834
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT202	5	5	12	12	resveratrol	p53		7157	0.834
NULL	ChemistryOpen_2014_Jun_18_3(3)_115-123.nxml.txt.nlp	25050230	SENT266	46	46	16	16	heparin	mol	PA449855	90527	0.834
NULL	Biochim_Biophys_Acta_2014_Jul_1842(7)_959-970.nxml.txt.nlp	24594481	SENT812	34	34	25	25	lipase	HSL	PA450239	3991	0.834
NULL	Braz_J_Microbiol_2011_Mar_1_Jan-Mar_42(1)_22-29.nxml.txt.nlp	24031600	SENT152	6	6	1	1	lipase	Q10	PA450239	27161	0.834
NULL	Oncogene_2010_Sep_16_29(37)_5135-5145.nxml.txt.nlp	20622897	SENT76	5	5	8	8	cetuximab	STAT3	PA10040	6774	0.834
NULL	Diabetes_2014_Jan_13_63(1)_75-88.nxml.txt.nlp	24009260	SENT276	11	11	8	8	genistein	PI3K	PA165109660	5290	0.834
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT174	14	14	8	8	tacrolimus	RANKL	PA451578	8600	0.834
NULL	Arthritis_Res_Ther_2005_Aug_30_7(5)_215-224.nxml.txt.nlp	16207351	SENT203	5	5	11	11	chloroquine	IFN	PA448948	3439	0.834
NULL	Oncol_Lett_2014_Nov_12_8(5)_2203-2208.nxml.txt.nlp	25295109	SENT149	0	0	13	13	celecoxib	GLI1	PA448871	2735	0.834
NULL	J_Headache_Pain_2010_Feb_10_11(1)_5-12.nxml.txt.nlp	20012125	SENT199	10	10	2	2	zolmitriptan	5-HT1B	PA451975	3351	0.834
NULL	Nat_Med_2014_Jun_25_20(6)_676-681.nxml.txt.nlp	24859530	SENT44	5	5	16	16	fluorescein	CD11b	PA164746009	3684	0.834
NULL	Cell_Biol_Int_Rep_(2010)_2012_Jun_21_19(1)_e00017.nxml.txt.nlp	23124518	SENT83	25	25	34	34	etoposide	TRAIL	PA449552	8743	0.834
NULL	Curr_Control_Trials_Cardiovasc_Med_2001_May_31_2(3)_129-140.nxml.txt.nlp	11806786	SENT160	4	4	28	28	heparin	ACT	PA449855	12;11332;9457;641455	0.834
NULL	Cancers_(Basel)_2013_May_3_5(2)_491-510.nxml.txt.nlp	24216987	SENT158	9	9	7	7	creatine	ADP	PA164778930	23038	0.834
NULL	Ann_Rheum_Dis_2008_Jul_22_68(8)_1303-1309.nxml.txt.nlp	18647851	SENT140	24	24	20	20	adalimumab	IL6	PA10004	3569	0.834
NULL	Indian_J_Ophthalmol_2011_Mar-Apr_59(2)_137-141.nxml.txt.nlp	21350283	SENT184	18	18	26	26	cyanocobalamin	B12	PA451892	7126;4709	0.834
NULL	Br_J_Cancer_2013_Dec_10_109(12)_2954-2958.nxml.txt.nlp	24231949	SENT74	4	4	25	25	nutlin-3	p53		7157	0.834
NULL	Onco_Targets_Ther_2014_Mar_20_7_447-456.nxml.txt.nlp	24672247	SENT151	3	3	12	12	paclitaxel	CLU	PA450761	1191	0.834
NULL	Cell_Death_Dis_2014_Mar_13_5(3)_e1113.nxml.txt.nlp	24625972	SENT87	20	20	15	15	bleomycin	BI-1	PA448645	7009	0.834
NULL	Pharmaceuticals_(Basel)_2013_Nov_25_6(12)_1475-1506.nxml.txt.nlp	24287492	SENT1015	11	11	1	1	temozolomide	MSH6	PA451609	2956	0.834
NULL	Breast_Cancer_Res_2009_Jun_23_11(Suppl_1)_S15.nxml.txt.nlp	NULL	SENT12	31	31	9	9	tamoxifen	CYP2D6	PA451581	1565	0.834
NULL	Oncotarget_2014_Jun_6_5(13)_4935-4944.nxml.txt.nlp	24952732	SENT108	5	5	10	10	doxazosin	PDK1	PA449407	5170;5163	0.834
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT244	22	22	13	13	simvastatin	TNF	PA451363	7124	0.834
NULL	J_Adv_Pharm_Technol_Res_2010_Jul-Sep_1(3)_342-347.nxml.txt.nlp	22247869	SENT40	16	16	4	4	ethanol	mol	PA448073	90527	0.834
NULL	Am_J_Trop_Med_Hyg_2012_Mar_1_86(3)_403-408.nxml.txt.nlp	22403308	SENT97	23	23	39	39	artesunate	ACT	PA165111697	12;11332;9457;641455	0.834
NULL	Nat_Commun_2013_Apr_3_4_1652.nxml.txt.nlp	23552067	SENT71	11	11	2	2	ketamine	gamma	PA450144	9913	0.834
NULL	Cent_European_J_Urol_2013_Aug_13_66(2)_189-194.nxml.txt.nlp	24579025	SENT85	0	0	7	7	doxazosin	CD95	PA449407	355	0.834
NULL	Biomed_Res_Int_2013_Sep_5_2013_929531.nxml.txt.nlp	24083250	SENT99	4	4	9	9	hyaluronan	TGFB2	PA165958431	7042	0.834
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S31-S40.nxml.txt.nlp	20680106	SENT41	3	3	7	7	panitumumab	KRAS	PA162373091	3845	0.834
NULL	Oncotarget_2014_Nov_3_5(20)_10127-10139.nxml.txt.nlp	25333256	SENT173	14	14	26	26	vemurafenib	TRIM16	PA165946873	10626	0.834
NULL	Br_J_Cancer_2010_Feb_2_102(3)_520-529.nxml.txt.nlp	20029417	SENT34	18	18	7	7	cetuximab	IL-21	PA10040	59067;50616;27189	0.834
NULL	Cancers_(Basel)_2010_Jan_14_2(1)_1-19.nxml.txt.nlp	24281029	SENT1081	16	16	27	27	paclitaxel	San	PA450761	80218	0.834
NULL	Exp_Cell_Res_2011_Apr_15_317(7)_1028-1039.nxml.txt.nlp	21237154	SENT216	31	31	24	24	staurosporine	JNK	PA165109623	5599	0.834
NULL	Support_Care_Cancer_2014_Dec_14_22(3)_837-846.nxml.txt.nlp	24337717	SENT20	15	15	8	8	sn-38	UGT1A1		54658	0.834
NULL	Eur_J_Clin_Pharmacol_2014_Oct_8_70(12)_1433-1441.nxml.txt.nlp	25291992	SENT67	12	12	3	3	risperidone	FES	PA451257	2242	0.834
NULL	Exp_Brain_Res_2014_Jun_27_232(8)_2637-2644.nxml.txt.nlp	24969614	SENT148	7	7	0	0	palonosetron	NK1	PA10352	11126	0.834
NULL	Clin_Sci_(Lond)_2009_Nov_16_118(Pt_4)_269-279.nxml.txt.nlp	19698082	SENT129	0	0	6	6	ramipril	ACE2	PA451223	59272	0.834
NULL	J_Exp_Clin_Cancer_Res_2009_Jul_10_28(1)_99.nxml.txt.nlp	19591692	SENT6	24	24	36	36	tariquidar	ABCG2		9429	0.834
NULL	Ther_Clin_Risk_Manag_2006_Jun_2(2)_129-158.nxml.txt.nlp	18360588	SENT209	1	1	3	3	voriconazole	CYP3A4	PA10233	1576	0.834
NULL	Int_J_Mol_Sci_2014_Oct_8_15(10)_17974-17999.nxml.txt.nlp	25299695	SENT142	18	18	9	9	curcumin	HO-2	PA151958596	3163	0.834
NULL	Cell_Death_Dis_2012_Jun_21_3(6)_e327.nxml.txt.nlp	22717582	SENT8	7	7	15	15	doxorubicin	p53	PA449412	7157	0.834
NULL	Eur_J_Med_Res_2014_Apr_9_19(1)_19.nxml.txt.nlp	24717101	SENT43	12	12	23	23	cyclophosphamide	CHOP	PA449165	1649	0.834
NULL	Front_Synaptic_Neurosci_2013_Aug_20_5_4.nxml.txt.nlp	23986696	SENT371	0	0	3	3	fasudil	Rho	PA165946121	29984	0.834
NULL	Arthritis_Res_Ther_2007_Oct_9_9(5)_R104.nxml.txt.nlp	17925024	SENT144	2	2	11	11	glucosamine	p38	PA164747613	10598;1432;7965	0.834
NULL	Acta_Pharmacol_Sin_2010_Feb_5_31(2)_184-190.nxml.txt.nlp	20139901	SENT35	24	24	17	17	metformin	SLC22A2	PA450395	6582	0.834
NULL	Clin_Exp_Vaccine_Res_2014_Jul_20_3(2)_113-116.nxml.txt.nlp	25003083	SENT41	5	5	20	20	imiquimod	TLR9	PA449972	54106	0.834
NULL	J_Immunol_Res_2014_Jan_29_2014_879897.nxml.txt.nlp	24741628	SENT106	12	12	3	3	l-arginine	ARG1	PA448478	383;64129	0.834
NULL	Pharmaceuticals_(Basel)_2013_May_27_6(6)_716-727.nxml.txt.nlp	24276258	SENT469	0	0	9	9	minocycline	p27	PA450519	5715;10534	0.834
NULL	Basic_Clin_Neurosci_2014_Summer_5(3)_218-224.nxml.txt.nlp	25337383	SENT90	3	3	48	48	diazepam	EPM	PA449283	2054	0.834
NULL	Mol_Cancer_2009_Dec_23_8_129.nxml.txt.nlp	20030852	SENT184	1	1	4	4	curcumin	survivin	PA151958596	332	0.834
NULL	Cancers_(Basel)_2011_Apr_18_3(2)_2014-2031.nxml.txt.nlp	24212794	SENT80	7	7	11	11	panitumumab	EGFR	PA162373091	1956	0.834
NULL	Hum_Genomics_2004_Jan_1_1(2)_111-125.nxml.txt.nlp	15601539	SENT87	10	10	19	19	simvastatin	APOE	PA451363	348	0.834
NULL	Mol_Cells_2014_Sep_30_37(9)_664-671.nxml.txt.nlp	25234467	SENT166	7	7	4	4	cisplatin	miR-217	PA449014	406999	0.834
NULL	Int_J_Biol_Sci_2014_Feb_11_10(3)_245-256.nxml.txt.nlp	24643086	SENT277	11	11	36	36	paraformaldehyde	ZIP4	PA450790	55630	0.834
NULL	Sci_Rep_2014_Nov_28_4_7237.nxml.txt.nlp	25429875	SENT110	0	0	8	8	hesperidin	p38	PA449867	10598;1432;7965	0.834
NULL	Oncogenesis_2012_Apr_2_1(4)_e5.nxml.txt.nlp	23552603	SENT573	7	7	14	14	ns-398	DR5		8795	0.834
NULL	J_Korean_Med_Sci_2010_Dec_24_25(12)_1766-1770.nxml.txt.nlp	21165292	SENT9	19	19	6	6	glucose	GFR	PA449773	9771	0.834
NULL	Case_Rep_Oncol_2014_Feb_20_7(1)_126-131.nxml.txt.nlp	24707260	SENT3	34	34	26	26	gefitinib	EGFR	PA131301952	1956	0.834
NULL	Exp_Mol_Med_2012_Sep_30_44(9)_554-561.nxml.txt.nlp	22809871	SENT82	12	12	20	20	bevacizumab	San	PA130232992	80218	0.834
NULL	EJC_Suppl_2013_Sep_5_11(2)_45-59.nxml.txt.nlp	NULL	SENT553	26	26	14	14	oxaliplatin	CRT	PA131285527	811	0.834
NULL	Oncotarget_2013_Dec_28_5(6)_1475-1490.nxml.txt.nlp	24721996	SENT205	4	4	7	7	celecoxib	CD44	PA448871	960	0.834
NULL	Front_Behav_Neurosci_2012_Nov_22_6_78.nxml.txt.nlp	23189046	SENT85	8	8	1	1	ethanol	OX2R	PA448073	3062;131450	0.834
NULL	Cardiovasc_Res_2010_Oct_1_88(1)_67-74.nxml.txt.nlp	20400621	SENT86	3	3	9	9	calcein	ANOVA	PA132595336	4858	0.834
NULL	Curr_Immunol_Rev_2013_Feb_9(1)_13-22.nxml.txt.nlp	23853604	SENT172	22	22	7	7	cyclophosphamide	CHOP	PA449165	1649	0.834
NULL	Can_J_Infect_Dis_Med_Microbiol_2014_May-Jun_25(3)_155-158.nxml.txt.nlp	25285112	SENT87	13	13	17	17	clarithromycin	TMP	PA449028	2012	0.834
NULL	Br_J_Haematol_2014_Sep_17_166(6)_818-829.nxml.txt.nlp	24935654	SENT113	34	34	8	8	cyclophosphamide	IL2	PA449165	3558	0.834
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_127043.nxml.txt.nlp	23227093	SENT28	34	34	22	22	gemfibrozil	RYR	PA449750	6261	0.834
NULL	Clin_Ophthalmol_2009_Jun_2_3_291-295.nxml.txt.nlp	19668581	SENT5	17	17	15	15	travoprost	BAK	PA164781371	578	0.834
NULL	Aging_Cell_2012_Aug_11(4)_579-587.nxml.txt.nlp	22435726	SENT96	1	1	30	30	etoposide	CO2	PA449552	4513	0.834
NULL	Mol_Cancer_2010_Aug_23_9_222.nxml.txt.nlp	20731837	SENT175	30	30	25	25	gefitinib	ATM	PA131301952	472	0.834
NULL	Emerg_Infect_Dis_2013_Mar_19(3)_449-455.nxml.txt.nlp	23622714	SENT105	5	5	1	1	kanamycin	DST	PA450137	667	0.834
NULL	Respir_Med_Case_Rep_2013_Jul_17_10_10-12.nxml.txt.nlp	NULL	SENT63	9	9	16	16	erlotinib	EGFR	PA134687924	1956	0.834
NULL	Front_Neurosci_2014_Jan_10_7_270.nxml.txt.nlp	24454277	SENT160	23	23	28	28	resveratrol	SIRT1		23411	0.834
NULL	Reprod_Biol_Endocrinol_2013_Feb_26_11_15.nxml.txt.nlp	23442442	SENT193	5	5	13	13	l-arginine	BCL2	PA448478	596	0.834
NULL	Braz_J_Med_Biol_Res_2014_Nov_4_48(1)_13-24.nxml.txt.nlp	25493378	SENT97	8	8	18	18	nutlin-3	p53		7157	0.834
NULL	Indian_J_Med_Res_2014_Feb_139(2)_195-204.nxml.txt.nlp	24718393	SENT165	18	18	32	32	voriconazole	CYP3A4	PA10233	1576	0.834
NULL	Cardiovasc_Diabetol_2010_Oct_18_9_64.nxml.txt.nlp	20955583	SENT29	19	19	17	17	rosiglitazone	PPARgamma	PA451283	5468	0.834
NULL	J_Cell_Biol_1998_Jan_26_140(2)_335-345.nxml.txt.nlp	9442109	SENT176	15	15	21	21	chloroquine	NHE	PA448948	285335	0.834
NULL	Br_J_Pharmacol_2008_Nov_11_155(6)_896-905.nxml.txt.nlp	18695641	SENT195	2	2	13	13	alendronate	OPG	PA448082	690	0.834
NULL	Diabetes_2013_Jun_17_62(6)_1800-1807.nxml.txt.nlp	23704521	SENT139	7	7	27	27	metformin	LKB1	PA450395	6794	0.834
NULL	Br_J_Cancer_2004_Mar_22_90(6)_1285-1292.nxml.txt.nlp	15026814	SENT148	33	33	19	19	doxorubicin	p53	PA449412	7157	0.834
NULL	Cell_Death_Dis_2010_Nov_18_1(11)_e102.nxml.txt.nlp	21368867	SENT307	17	17	27	27	gentamicin	p63	PA449753	8626	0.834
NULL	Front_Behav_Neurosci_2011_Sep_6_5_53.nxml.txt.nlp	21922005	SENT332	9	9	4	4	ethanol	CB1	PA448073	1268	0.834
NULL	Indian_J_Endocrinol_Metab_2012_Mar_16(Suppl1)_S47-S56.nxml.txt.nlp	22701844	SENT34	5	5	11	11	liraglutide	GLP-1	PA165958364	100125288	0.834
NULL	Cell_Commun_Signal_2013_Oct_1_11_73.nxml.txt.nlp	24083678	SENT48	4	4	13	13	sulindac	AP-1	PA451565	2353;3727;2354;3725	0.834
NULL	Front_Endocrinol_(Lausanne)_2014_Oct_27_5_163.nxml.txt.nlp	25386163	SENT283	6	6	25	25	clozapine	ghrelin	PA449061	51738	0.834
NULL	Breast_Cancer_Res_2011_May_26_13(3)_209.nxml.txt.nlp	21635709	SENT112	39	39	30	30	tamoxifen	HER2	PA451581	2064	0.834
NULL	Int_J_Environ_Res_Public_Health_2012_Sep_19_9(9)_3354-3364.nxml.txt.nlp	23202692	SENT89	5	5	16	16	resveratrol	ANOVA		4858	0.834
NULL	Eur_J_Clin_Pharmacol_2010_Nov_29_66(11)_1131-1136.nxml.txt.nlp	20669013	SENT119	12	12	31	31	voriconazole	CYP2C19	PA10233	1557	0.834
NULL	Cell_Commun_Signal_2011_May_14_9_12.nxml.txt.nlp	21569606	SENT94	9	9	1	1	rosiglitazone	FGF2	PA451283	2247;2258	0.834
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2654-2664.nxml.txt.nlp	24136149	SENT131	14	14	37	37	doxorubicin	p53	PA449412	7157	0.834
NULL	Int_J_Biol_Sci_2011_Sep_8_7(8)_1077-1092.nxml.txt.nlp	21927577	SENT190	5	5	24	24	telmisartan	CHOP	PA451605	1649	0.834
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S258-S263.nxml.txt.nlp	21525465	SENT10	14	14	6	6	liraglutide	GLP-1	PA165958364	100125288	0.834
NULL	Breast_Cancer_Res_2005_May_24_7(5)_R589-R597.nxml.txt.nlp	16168102	SENT103	19	19	5	5	doxorubicin	HER2	PA449412	2064	0.834
NULL	Oncotarget_2011_Sep_9_2(9)_658-668.nxml.txt.nlp	21911919	SENT56	7	7	9	9	daunorubicin	HO-1	PA449212	3162	0.834
NULL	Eur_J_Clin_Pharmacol_2010_Nov_29_66(11)_1131-1136.nxml.txt.nlp	20669013	SENT14	13	13	24	24	voriconazole	CYP2C19	PA10233	1557	0.834
NULL	J_Res_Pharm_Pract_2013_Oct-Dec_2(4)_156-161.nxml.txt.nlp	24991625	SENT126	22	22	24	24	imatinib	IFN	PA10804	3439	0.834
NULL	J_Immune_Based_Ther_Vaccines_2005_Sep_2_3_6.nxml.txt.nlp	16138929	SENT164	4	4	25	25	alefacept	CD2	PA164748040	914	0.834
NULL	Crit_Care_2009_Jul_22_13(4)_169.nxml.txt.nlp	19664189	SENT3	41	41	18	18	dobutamine	AVP	PA449381	114548;551	0.834
NULL	Mol_Cancer_2007_Oct_25_6_67.nxml.txt.nlp	17958915	SENT162	16	16	20	20	nilotinib	GM-CSF	PA165958345	1437	0.834
NULL	J_Biol_Chem_2013_Dec_6_288(49)_35387-35395.nxml.txt.nlp	24142790	SENT246	13	13	4	4	meclizine	PCYT2	PA450338	5833	0.834
NULL	Acta_Neuropathol_Commun_2013_Jul_17_1_39.nxml.txt.nlp	24252174	SENT77	26	26	16	16	erlotinib	STZ	PA134687924	6484	0.834
NULL	Br_J_Cancer_2011_Jul_12_105(2)_189-193.nxml.txt.nlp	21694726	SENT99	14	14	29	29	tamoxifen	ATAC	PA451581	6375	0.834
NULL	Cells_2014_Apr_29_3(2)_331-362.nxml.txt.nlp	24785347	SENT96	5	5	24	24	capsaicin	NK1	PA448776	11126	0.834
NULL	Cell_Death_Dis_2014_Apr_17_5(4)_e1182.nxml.txt.nlp	24743737	SENT231	4	4	2	2	capsaicin	TRPV1	PA448776	7442	0.834
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT523	33	33	5	5	quetiapine	PRL	PA451201	5617	0.834
NULL	Oncotarget_2012_Nov_17_3(12)_1600-1614.nxml.txt.nlp	23307622	SENT83	30	30	7	7	doxorubicin	ATG12	PA449412	9140	0.834
NULL	J_Hematol_Oncol_2012_May_17_5_24.nxml.txt.nlp	22594538	SENT183	12	12	10	10	cyclophosphamide	CHOP	PA449165	1649	0.834
NULL	Br_J_Haematol_2014_Mar_13_164(1)_811-821.nxml.txt.nlp	24328678	SENT138	6	6	17	17	lenalidomide	Aiolos	PA162363968	22806	0.834
NULL	Cardiovasc_Diabetol_2006_Sep_26_5_20.nxml.txt.nlp	17002798	SENT52	11	11	41	41	aspirin	CAD	PA448497	1677;790	0.834
NULL	Ann_Dermatol_2014_Jun_12_26(3)_296-302.nxml.txt.nlp	24966627	SENT147	5	5	10	10	calcipotriol	HBD-2	PA448714	1673	0.834
NULL	Oncotarget_2014_Jun_7_5(14)_5257-5271.nxml.txt.nlp	24913448	SENT98	33	33	4	4	nilotinib	LASP1	PA165958345	3927	0.834
NULL	Br_J_Cancer_1996_Nov_74(10)_1564-1569.nxml.txt.nlp	8932336	SENT13	7	7	15	15	mitomycin	gamma	PA450524	9913	0.834
NULL	Acta_Pharmacol_Sin_2009_Sep_24_30(9)_1323-1329.nxml.txt.nlp	19701237	SENT104	4	4	0	0	clarithromycin	CYP3A	PA449028	1574	0.834
NULL	Evid_Based_Complement_Alternat_Med_2012_Dec_20_2012_908601.nxml.txt.nlp	23326293	SENT69	1	1	25	25	trypsin	CD133	PA451806	8842	0.834
NULL	Clin_Med_Insights_Oncol_2012_Dec_6_6_407-421.nxml.txt.nlp	23239933	SENT22	3	3	21	21	gefitinib	EGFR	PA131301952	1956	0.834
NULL	Cancer_Med_2014_Jun_14_3(3)_580-591.nxml.txt.nlp	24574330	SENT41	11	11	5	5	bevacizumab	VEGF-D	PA130232992	2277	0.834
NULL	Korean_Circ_J_2014_Jan_14_44(1)_42-44.nxml.txt.nlp	24497889	SENT45	39	39	26	26	heparin	P2Y12	PA449855	64805	0.834
NULL	N_Am_J_Med_Sci_2012_Dec_4(12)_638-640.nxml.txt.nlp	23272306	SENT13	5	5	1	1	exenatide	GLP-1	PA164749238	100125288	0.834
NULL	Cardiovasc_Drugs_Ther_2011_Jun_12_25(3)_223-232.nxml.txt.nlp	21562974	SENT82	14	14	3	3	esmolol	ANOVA	PA449500	4858	0.834
NULL	Toxins_(Basel)_2010_Oct_28_2(11)_2584-2592.nxml.txt.nlp	22069565	SENT264	21	21	10	10	phenprocoumon	CYP2C9	PA450921	1559	0.834
NULL	Mol_Cancer_2009_Nov_24_8_109.nxml.txt.nlp	19930708	SENT199	25	25	15	15	exemestane	EGFR	PA449563	1956	0.834
NULL	Oncoimmunology_2013_Jun_1_2(6)_e24677.nxml.txt.nlp	23894722	SENT99	5	5	27	27	cetuximab	IL-2	PA10040	3558	0.834
NULL	Br_J_Pharmacol_2010_Mar_8_159(5)_1092-1105.nxml.txt.nlp	20148890	SENT54	30	30	25	25	forskolin	P2Y12	PA146096022	64805	0.834
NULL	Lab_Invest_2011_Mar_15_91(3)_363-378.nxml.txt.nlp	21079581	SENT66	14	14	6	6	paraformaldehyde	CD90	PA450790	7070	0.834
NULL	Diabetes_Care_2008_Sep_31(9)_1736-1737.nxml.txt.nlp	18556340	SENT78	13	13	40	40	glucose	KCNJ11	PA449773	3767	0.834
NULL	Chemother_Res_Pract_2012_Aug_29_2012_817297.nxml.txt.nlp	22970367	SENT190	19	19	16	16	cetuximab	EGFR	PA10040	1956	0.834
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT134	12	12	3	3	chloroquine	BMPR-II	PA448948	659	0.834
NULL	Leukemia_2014_Jun_25_28(6)_1280-1288.nxml.txt.nlp	24270737	SENT202	26	26	7	7	azacitidine	PD-L2	PA451996	80380	0.834
NULL	Genetics_2012_Jun_191(2)_509-521.nxml.txt.nlp	22446320	SENT437	11	11	3	3	pilocarpine	IMPA1	PA450962	3612	0.834
NULL	Oncotarget_2014_Feb_7_5(3)_775-787.nxml.txt.nlp	24519956	SENT107	19	19	12	12	dasatinib	PC3	PA162372878	57332;7832;5122	0.834
NULL	Cancer_Cell_Int_2012_Jul_4_12_19.nxml.txt.nlp	22631225	SENT304	5	5	2	2	heparin	PPIA	PA449855	5478	0.834
NULL	Oncogene_2014_Apr_17_33(16)_2040-2052.nxml.txt.nlp	23708658	SENT233	34	34	12	12	hydrocortisone	CO2	PA449905	4513	0.834
NULL	J_Biomed_Biotechnol_2010_May_24_2010_686457.nxml.txt.nlp	20508815	SENT151	26	26	6	6	creatine	COL9A3	PA164778930	1299	0.834
NULL	Cells_2014_Apr_9_3(2)_288-303.nxml.txt.nlp	24722470	SENT83	24	24	30	30	hyperforin	TRPC6	PA165985514	7225	0.834
NULL	BMJ_2014_Oct_24_349_g6269.nxml.txt.nlp	NULL	SENT103	16	16	12	12	ticagrelor	P2Y12	PA165374673	64805	0.834
NULL	Oncogenesis_2014_Dec_15_3(12)_e133.nxml.txt.nlp	25500906	SENT107	20	20	25	25	trastuzumab	HER2	PA451743	2064	0.834
NULL	J_Cancer_Prev_2014_Mar_19(1)_39-46.nxml.txt.nlp	25337571	SENT89	18	18	6	6	ethanol	p38	PA448073	10598;1432;7965	0.834
NULL	J_Hematol_Oncol_2012_Sep_18_5_57.nxml.txt.nlp	22989009	SENT102	6	6	15	15	nutlin-3	p53		7157	0.834
NULL	Clin_Ophthalmol_2008_Jun_2(2)_355-368.nxml.txt.nlp	19668727	SENT43	18	18	26	26	amfenac	COX1	PA166049186	4512;5742	0.834
NULL	Mol_Cancer_2010_May_28_9_130.nxml.txt.nlp	20509890	SENT11	15	15	4	4	gemcitabine	TGFBI	PA449748	7045	0.834
NULL	Br_J_Cancer_2010_Feb_2_102(3)_541-552.nxml.txt.nlp	20087344	SENT185	22	22	9	9	paclitaxel	NRP1	PA450761	8829	0.834
NULL	Am_J_Case_Rep_2012_Jun_5_13_96-98.nxml.txt.nlp	23569499	SENT41	11	11	4	4	vincristine	CHOP	PA451879	1649	0.834
NULL	Behav_Brain_Funct_2007_Jun_13_3_29.nxml.txt.nlp	17567916	SENT54	38	38	27	27	propranolol	ANOVA	PA451145	4858	0.834
NULL	Crit_Care_2007_Mar_22_11(Suppl_2)_P122.nxml.txt.nlp	NULL	SENT11	5	5	14	14	mannitol	IL-6	PA450320	3569	0.834
NULL	EMBO_Mol_Med_2012_Jul_19_4(7)_647-659.nxml.txt.nlp	22514144	SENT132	10	10	8	8	trypsin	ADAM10	PA451806	102	0.834
NULL	Mol_Cancer_2008_Mar_26_7_27.nxml.txt.nlp	18366759	SENT228	12	12	7	7	etoposide	BNIP3	PA449552	664	0.834
NULL	Int_J_Mol_Sci_2012_Sep_28_13(10)_12461-12486.nxml.txt.nlp	23202908	SENT124	13	13	3	3	curcumin	p300	PA151958596	2033	0.834
NULL	Evid_Based_Complement_Alternat_Med_2013_Aug_22_2013_423164.nxml.txt.nlp	24027594	SENT196	19	19	13	13	berberine	AP-1	PA165860812	2353;3727;2354;3725	0.834
NULL	Ind_Psychiatry_J_2011_Jan-Jun_20(1)_25-31.nxml.txt.nlp	22969177	SENT200	10	10	0	0	olanzapine	BARS	PA450688	1487	0.834
NULL	Cell_Commun_Signal_2014_Sep_25_12(1)_61.nxml.txt.nlp	NULL	SENT427	27	27	18	18	doxycycline	INPP4B	PA449415	8821	0.834
NULL	Oncotarget_2010_Oct_9_1(6)_387-395.nxml.txt.nlp	21311095	SENT158	12	12	6	6	tamoxifen	CD133	PA451581	8842	0.834
NULL	Iran_J_Pharm_Res_2014_Autumn_13(4)_1393-1401.nxml.txt.nlp	25587329	SENT130	4	4	8	8	sulindac	MRP3	PA451565	8714	0.834
NULL	Eur_Respir_J_2013_May_27_41(5)_1107-1115.nxml.txt.nlp	23018904	SENT160	34	34	16	16	ciprofloxacin	DPI	PA449009	1832	0.834
NULL	J_Cell_Biol_2003_Dec_8_163(5)_1099-1109.nxml.txt.nlp	14662748	SENT87	22	22	5	5	forskolin	AQP2	PA146096022	359	0.834
NULL	Basic_Clin_Pharmacol_Toxicol_2013_Feb_5_112(2)_132-137.nxml.txt.nlp	22900583	SENT156	10	10	1	1	bupropion	CYP2B6	PA448687	1555	0.834
NULL	Neural_Plast_2012_May_20_2012_569149.nxml.txt.nlp	22685677	SENT37	35	35	7	7	lipase	iPLA2	PA450239	8398	0.834
NULL	Oncol_Lett_2013_Mar_11_5(3)_1010-1016.nxml.txt.nlp	23426784	SENT124	11	11	14	14	midazolam	TRPM7	PA450496	54822	0.834
NULL	Breast_Cancer_Res_2004_Nov_7_6(1)_39-52.nxml.txt.nlp	14680484	SENT195	38	38	17	17	tamoxifen	HER-2	PA451581	2064	0.834
NULL	Acta_Pharmacol_Sin_2012_May_16_33(5)_682-690.nxml.txt.nlp	22504904	SENT130	15	15	3	3	celecoxib	IL-6	PA448871	3569	0.834
NULL	Clin_Sarcoma_Res_2013_May_13_3_8.nxml.txt.nlp	23668619	SENT75	17	17	20	20	nilotinib	CSF1R	PA165958345	1436	0.834
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT16	28	28	8	8	capsaicin	p53	PA448776	7157	0.834
NULL	Mol_Cancer_2012_Apr_26_11_24.nxml.txt.nlp	22537161	SENT222	21	21	34	34	pp2	PP2		4888	0.834
NULL	Int_J_Alzheimers_Dis_2011_Dec_10_2011_832379.nxml.txt.nlp	22191060	SENT212	0	0	6	6	etanercept	TNF-alpha	PA449515	7124	0.834
NULL	Adv_Hematol_2012_Jul_24_2012_513702.nxml.txt.nlp	22888354	SENT145	4	4	17	17	lenalidomide	CD28	PA162363968	1493;940	0.834
NULL	Oncotarget_2010_Oct_25_1(7)_497-514.nxml.txt.nlp	21165163	SENT122	31	31	25	25	gefitinib	EGFR	PA131301952	1956	0.834
NULL	Clin_Ophthalmol_2014_Sep_15_8_1855-1858.nxml.txt.nlp	25258507	SENT6	23	23	33	33	tafluprost	BAK	PA165958432	578	0.834
NULL	J_Oncol_2013_Jun_5_2013_102735.nxml.txt.nlp	23840208	SENT270	8	8	14	14	resveratrol	p53		7157	0.834
NULL	Biosci_Rep_2014_Aug_6_34(4)_e00131.nxml.txt.nlp	24975826	SENT162	3	3	13	13	probenecid	TRPA1	PA451106	8989	0.834
NULL	Evid_Based_Complement_Alternat_Med_2011_Aug_18_2011_164139.nxml.txt.nlp	21941584	SENT197	22	22	43	43	donepezil	spatial	PA449394	219793	0.834
NULL	Expert_Rev_Mol_Med_2010_Nov_12_e37.nxml.txt.nlp	21114891	SENT478	8	8	20	20	hydroxocobalamin	cblC	PA164768689	25974	0.834
NULL	J_Gastroenterol_2014_Jun_19_49(6)_1001-1010.nxml.txt.nlp	23780559	SENT10	14	14	8	8	genistein	HCN	PA165109660	378938	0.834
NULL	Tob_Induc_Dis_2004_Mar_15_2(1)_1.nxml.txt.nlp	NULL	SENT299	18	18	33	33	methacholine	SP-A	PA165958382	653509	0.834
NULL	Osteoporos_Int_2014_Oct_10_25(3)_1173-1180.nxml.txt.nlp	24108429	SENT143	15	15	22	22	teriparatide	PTH	PA451620	5741	0.834
NULL	Mar_Drugs_2010_Mar_31_8(4)_1059-1079.nxml.txt.nlp	20479967	SENT168	7	7	24	24	paclitaxel	castor	PA450761	54897	0.834
NULL	Ann_Gastroenterol_2014_27(4)_313-319.nxml.txt.nlp	25331779	SENT145	7	7	18	18	infliximab	POR	PA452639	5447	0.834
NULL	Cardiovasc_Drugs_Ther_2013_Aug_9_27(6)_581-590.nxml.txt.nlp	23929366	SENT103	21	21	41	41	levosimendan	NAG	PA164749138	51594;4669	0.834
NULL	Breast_Cancer_Res_2012_May_14_14(3)_R77.nxml.txt.nlp	22583478	SENT53	4	4	9	9	estradiol	Dicer	PA449503	23405	0.834
NULL	Environ_Health_Perspect_2010_Jul_3_118(7)_936-942.nxml.txt.nlp	20199942	SENT202	31	31	11	11	arsenite	NKRF	PA452638	55922	0.834
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_May_14_65(Pt_6)_o1256.nxml.txt.nlp	21583121	SENT3	24	24	1	1	phenol	mol	PA450913	90527	0.833
NULL	Evid_Based_Complement_Alternat_Med_2013_Mar_14_2013_429706.nxml.txt.nlp	23573127	SENT156	16	16	8	8	indomethacin	IDS	PA449982	3423	0.833
NULL	Free_Radic_Biol_Med_2013_Aug_61(100)_438-452.nxml.txt.nlp	23608463	SENT856	19	19	4	4	apomorphine	HO-1	PA164781163	3162	0.833
NULL	Crit_Care_2002_Nov_9_6(1)_24-29.nxml.txt.nlp	11940263	SENT116	10	10	31	31	methylprednisolone	IL-6	PA450466	3569	0.833
NULL	Crit_Care_2010_Mar_15_14(2)_R30.nxml.txt.nlp	20226064	SENT271	31	31	1	1	remifentanil	IFN	PA451232	3439	0.833
NULL	Int_J_Endocrinol_Metab_2013_Dec_21_Winter_11(1)_52-56.nxml.txt.nlp	23853621	SENT150	24	24	16	16	imatinib	ACTH	PA10804	5443	0.833
NULL	J_Cell_Biol_1998_Jan_26_140(2)_431-446.nxml.txt.nlp	9442118	SENT0	24	24	21	21	hyaluronan	CD44	PA165958431	960	0.833
NULL	Cancer_Cell_Int_2009_Jan_8_9_3.nxml.txt.nlp	19128511	SENT47	38	38	19	19	oxaliplatin	PI3K	PA131285527	5290	0.833
NULL	Cell_Death_Differ_2010_Sep_5_17(9)_1511-1523.nxml.txt.nlp	20203690	SENT30	5	5	14	14	estradiol	c-fos	PA449503	2353	0.833
NULL	Genome_Announc_2013_May_30_1(3)_e00257-13.nxml.txt.nlp	23723394	SENT77	12	12	7	7	betaine	B12	PA448603	7126;4709	0.833
NULL	J_Med_Genet_2014_Sep_25_51(9)_563-572.nxml.txt.nlp	25062846	SENT339	12	12	23	23	ethanol	H19	PA448073	283120	0.833
NULL	Exp_Brain_Res_2014_Jun_27_232(8)_2637-2644.nxml.txt.nlp	24969614	SENT10	6	6	24	24	palonosetron	NK1	PA10352	11126	0.833
NULL	Oncotarget_2013_Oct_26_4(12)_2302-2316.nxml.txt.nlp	24327603	SENT18	10	10	1	1	bevacizumab	VEGF-A	PA130232992	7422	0.833
NULL	Oncotarget_2014_Aug_29_5(19)_8947-8958.nxml.txt.nlp	25333254	SENT112	4	4	22	22	cytarabine	CXCR7	PA449177	57007	0.833
NULL	Oncoimmunology_2013_Jul_1_2(7)_e24882.nxml.txt.nlp	24073370	SENT7	24	24	6	6	cisplatin	BTC	PA449014	685	0.833
NULL	Brain_2008_Nov_22_131(11)_3072-3080.nxml.txt.nlp	18945724	SENT165	31	31	21	21	rituximab	CD19	PA451261	930	0.833
NULL	Breast_Cancer_Res_2014_May_23_16(3)_R50.nxml.txt.nlp	24887458	SENT22	17	17	8	8	trastuzumab	HER2	PA451743	2064	0.833
NULL	Cancer_Cell_Int_2013_Mar_4_13_21.nxml.txt.nlp	23497288	SENT59	26	26	3	3	ifosfamide	EWS	PA449964	2130	0.833
NULL	Eur_J_Clin_Pharmacol_2007_Apr_21_63(4)_335-343.nxml.txt.nlp	17318526	SENT216	45	45	39	39	warfarin	VKORC1	PA451906	79001	0.833
NULL	Mol_Cancer_2010_Jun_7_9_139.nxml.txt.nlp	20529262	SENT214	12	12	5	5	cetuximab	EGFR	PA10040	1956	0.833
NULL	Int_J_Mol_Sci_2014_Oct_8_15(10)_17974-17999.nxml.txt.nlp	25299695	SENT130	22	22	1	1	curcumin	HO-1	PA151958596	3162	0.833
NULL	Gut_Liver_2012_Oct_18_6(4)_464-470.nxml.txt.nlp	23170151	SENT110	3	3	28	28	propofol	ESD	PA451141	2098	0.833
NULL	Cancer_Cell_Int_2006_Aug_9_6_20.nxml.txt.nlp	16899133	SENT186	19	19	27	27	l-cysteine	p27	PA449173	5715;10534	0.833
NULL	Cardiovasc_Diabetol_2010_Jul_27_9_31.nxml.txt.nlp	20663195	SENT107	3	3	14	14	irbesartan	FSP1	PA450084	6275;51062	0.833
NULL	Acta_Pharmacol_Sin_2010_Jun_4_31(6)_709-717.nxml.txt.nlp	20523342	SENT142	15	15	33	33	repaglinide	OATP1B1	PA451234	10599	0.833
NULL	Leukemia_2014_Jun_17_28(6)_1216-1226.nxml.txt.nlp	24301524	SENT138	16	16	21	21	bortezomib	ADM	PA10252	133	0.833
NULL	Cholesterol_2011_Jan_20_2011_176802.nxml.txt.nlp	21512589	SENT92	27	27	14	14	allopregnanolone	NPC1	PA142320763	4864	0.833
NULL	Mol_Clin_Oncol_2013_Sep_23_1(5)_845-850.nxml.txt.nlp	24649258	SENT26	35	35	0	0	glucosamine	HS6ST2	PA164747613	90161	0.833
NULL	Braz_J_Med_Biol_Res_2014_Sep_5_47(11)_929-939.nxml.txt.nlp	25296354	SENT119	16	16	4	4	afatinib	EGFR	PA165981154	1956	0.833
NULL	Arthritis_Res_Ther_2006_Dec_28_8(1)_R18.nxml.txt.nlp	16507118	SENT128	30	30	9	9	abatacept	IL-15	PA164747080	3600	0.833
NULL	Amyloid_2014_Sep_11_21(3)_175-184.nxml.txt.nlp	24918964	SENT129	3	3	6	6	anakinra	p65	PA10799	5970	0.833
NULL	Angiogenesis_2010_Dec_7_13(4)_305-315.nxml.txt.nlp	20927579	SENT143	18	18	24	24	resveratrol	p53		7157	0.833
NULL	Front_Oncol_2014_Sep_23_4_252.nxml.txt.nlp	25295225	SENT297	27	27	4	4	trastuzumab	PIK3CA	PA451743	5290	0.833
NULL	Cancer_Med_2014_Jun_14_3(3)_580-591.nxml.txt.nlp	24574330	SENT273	19	19	33	33	bevacizumab	MAX	PA130232992	4149	0.833
NULL	Br_J_Pharmacol_2008_Sep_9_155(1)_127-137.nxml.txt.nlp	18536750	SENT194	19	19	14	14	piroxicam	IL-10	PA450985	3586	0.833
NULL	Int_Neurourol_J_2014_Sep_24_18(3)_115-125.nxml.txt.nlp	25279238	SENT167	8	8	15	15	berberine	CA1	PA165860812	759	0.833
NULL	Diabetes_Metab_Syndr_Obes_2010_Jul_9_3_227-242.nxml.txt.nlp	21437091	SENT135	0	0	12	12	liraglutide	GLP-1	PA165958364	100125288	0.833
NULL	Front_Endocrinol_(Lausanne)_2013_Sep_2_4_111.nxml.txt.nlp	24065951	SENT233	13	13	8	8	estradiol	CLOCK	PA449503	9575	0.833
NULL	Int_J_Biol_Sci_2014_Jun_10_10(7)_654-663.nxml.txt.nlp	25013375	SENT116	12	12	5	5	nelfinavir	AKT	PA450606	207	0.833
NULL	Braz_J_Med_Biol_Res_2014_Feb_17_47(2)_101-109.nxml.txt.nlp	24519125	SENT210	26	26	12	12	isoproterenol	AP-1	PA450121	2353;3727;2354;3725	0.833
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT49	42	42	7	7	chlorzoxazone	CYP2C8	PA448971	1558	0.833
NULL	Clin_Epigenetics_2010_May_30_1(1-2)_13-24.nxml.txt.nlp	22704086	SENT192	2	2	5	5	resveratrol	SIRT1		23411	0.833
NULL	Acta_Pharmacol_Sin_2013_Feb_12_34(2)_255-261.nxml.txt.nlp	23147557	SENT126	38	38	26	26	pioglitazone	CYP2C8	PA450970	1558	0.833
NULL	Chin_J_Cancer_2011_Nov_30(11)_749-756.nxml.txt.nlp	22035855	SENT104	33	33	27	27	tamoxifen	HER2	PA451581	2064	0.833
NULL	Int_J_Breast_Cancer_2011_Sep_6_2011_352182.nxml.txt.nlp	22295219	SENT117	4	4	0	0	trastuzumab	MUC4	PA451743	4585	0.833
NULL	Reprod_Biol_Endocrinol_2004_Mar_24_2_13.nxml.txt.nlp	15040802	SENT77	24	24	10	10	potassium	VGAT	PA451047	140679	0.833
NULL	Breast_Cancer_Res_2004_Nov_7_6(1)_39-52.nxml.txt.nlp	14680484	SENT156	4	4	35	35	tamoxifen	p68	PA451581	1655	0.833
NULL	Curr_Neuropharmacol_2014_Jul_12(4)_342-352.nxml.txt.nlp	25342942	SENT85	28	28	9	9	ethanol	CCL2	PA448073	6347	0.833
NULL	J_Geriatr_Cardiol_2014_Mar_11(1)_26-31.nxml.txt.nlp	24748878	SENT44	6	6	3	3	clopidogrel	DES	PA449053	1674	0.833
NULL	J_Neuroinflammation_2010_Sep_7_7_51.nxml.txt.nlp	20822529	SENT147	6	6	24	24	hemin	HO-1	PA449849	3162	0.833
NULL	J_Int_Soc_Sports_Nutr_2015_Jan_21_12(1)_5.nxml.txt.nlp	NULL	SENT13	19	19	0	0	curcumin	IL-6	PA151958596	3569	0.833
NULL	Br_J_Pharmacol_2012_Jan_165(2)_390-400.nxml.txt.nlp	21671897	SENT45	11	11	34	34	suramin	P2X1	PA10292	5023	0.833
NULL	Drugs_Context_2012_Nov_19_2012_212242.nxml.txt.nlp	24432031	SENT86	26	26	19	19	temozolomide	IFN	PA451609	3439	0.833
NULL	Br_J_Cancer_2013_Feb_19_108(3)_668-675.nxml.txt.nlp	23348520	SENT9	24	24	16	16	panitumumab	KRAS	PA162373091	3845	0.833
NULL	Lab_Invest_2014_May_10_94(5)_503-516.nxml.txt.nlp	24614199	SENT201	15	15	44	44	curcumin	RAGE	PA151958596	177	0.833
NULL	Case_Rep_Infect_Dis_2012_Dec_23_2012_176864.nxml.txt.nlp	23320209	SENT30	16	16	31	31	colistin	HCAP	PA164760862	117159;9126	0.833
NULL	Cell_Death_Dis_2014_Jan_30_5(1)_e1030.nxml.txt.nlp	24481444	SENT329	5	5	0	0	sorafenib	PUMA	PA7000	27113	0.833
NULL	Exp_Ther_Med_2013_Jan_30_5(1)_308-314.nxml.txt.nlp	23251289	SENT148	28	28	4	4	irinotecan	ABCC2	PA450085	1244	0.833
NULL	Indian_J_Psychiatry_2008_Apr-Jun_50(2)_135-137.nxml.txt.nlp	19742212	SENT42	17	17	7	7	metformin	B12	PA450395	7126;4709	0.833
NULL	Cancer_Res_Treat_2014_Jan_15_46(1)_48-54.nxml.txt.nlp	24520223	SENT125	20	20	11	11	bevacizumab	KRAS	PA130232992	3845	0.833
NULL	J_Clin_Biochem_Nutr_2007_Jul_27_41(1)_32-42.nxml.txt.nlp	18392098	SENT145	37	37	14	14	curcumin	ROS	PA151958596	6098	0.833
NULL	Cardiovasc_Diabetol_2008_Dec_23_7_36.nxml.txt.nlp	19108709	SENT118	6	6	12	12	eptifibatide	JNK1	PA449483	5599	0.833
NULL	Neuropsychopharmacology_2009_Apr_2_34(5)_1135-1148.nxml.txt.nlp	18596687	SENT334	0	0	11	11	betaxolol	CRF	PA448611	1392;10882	0.833
NULL	Arthritis_Res_Ther_2014_Apr_30_16(2)_R90.nxml.txt.nlp	25167216	SENT100	25	25	6	6	adalimumab	STEPP	PA10004	222659	0.833
NULL	Oncol_Rep_2013_Apr_5_29(4)_1671-1677.nxml.txt.nlp	23404329	SENT165	19	19	31	31	curcumin	ACS	PA151958596	55902;84680	0.833
NULL	Exp_Diabetes_Res_2012_Dec_12_2012_716404.nxml.txt.nlp	22194737	SENT214	4	4	8	8	metformin	LKB1	PA450395	6794	0.833
NULL	J_Biol_Chem_2012_Dec_14_287(51)_43094-43107.nxml.txt.nlp	23118219	SENT956	8	8	13	13	hyaluronan	CD44	PA165958431	960	0.833
NULL	Diabetes_2013_Jun_20_62(6)_2122-2129.nxml.txt.nlp	23378607	SENT321	21	21	24	24	fenofibrate	PPARgamma	PA449594	5468	0.833
NULL	Nucleic_Acids_Res_2012_Jul_5_40(13)_5988-6000.nxml.txt.nlp	22492511	SENT119	35	35	18	18	flavopiridol	MYB	PA452627	4602	0.833
NULL	Oncotarget_2014_Nov_6_5(22)_11038-11053.nxml.txt.nlp	25402820	SENT185	18	18	20	20	gemcitabine	GEM	PA449748	2669	0.833
NULL	BMJ_Open_2014_Feb_27_4(2)_e004071.nxml.txt.nlp	24578536	SENT62	11	11	21	21	warfarin	TTR	PA451906	7276	0.833
NULL	Curr_Neuropharmacol_2014_Jul_12(4)_365-379.nxml.txt.nlp	25342944	SENT43	16	16	20	20	fluoxetine	5-HT1A	PA449673	3350	0.833
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2011_Mar_14_4_13-24.nxml.txt.nlp	22879790	SENT138	24	24	28	28	exenatide	PPG	PA164749238	5552	0.833
NULL	Scientifica_(Cairo)_2013_Nov_28_2013_518909.nxml.txt.nlp	24381790	SENT291	24	24	2	2	olanzapine	ghrelin	PA450688	51738	0.833
NULL	Diabetes_Metab_J_2012_Aug_20_36(4)_293-299.nxml.txt.nlp	22950061	SENT109	21	21	2	2	metformin	STAT3	PA450395	6774	0.833
NULL	Br_J_Cancer_1998_Nov_78(9)_1170-1174.nxml.txt.nlp	9820175	SENT13	24	24	9	9	coumarin	CYP3A4	PA134521193	1576	0.833
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT69	3	3	7	7	lapatinib	HER2	PA152241907	2064	0.833
NULL	Biomed_Res_Int_2014_Jun_26_2014_483501.nxml.txt.nlp	25057490	SENT11	6	6	25	25	resveratrol	p53		7157	0.833
NULL	J_Immunol_Res_2014_Feb_10_2014_264723.nxml.txt.nlp	24741582	SENT3	23	23	15	15	rituximab	CD16	PA451261	2215;2214	0.833
NULL	Front_Neurosci_2010_Jun_17_4_35.nxml.txt.nlp	20661455	SENT96	2	2	15	15	pindolol	5-HT1A	PA450966	3350	0.833
NULL	Evid_Based_Complement_Alternat_Med_2012_May_22_2012_340787.nxml.txt.nlp	22675379	SENT37	22	22	5	5	fluconazole	S26	PA449653	6231	0.833
NULL	J_Cell_Sci_2011_Mar_15_124(6)_921-932.nxml.txt.nlp	21378310	SENT147	4	4	6	6	chloroquine	RNF41	PA448948	10193	0.833
NULL	Mol_Vis_2012_Apr_11_18_901-908.nxml.txt.nlp	22539869	SENT200	3	3	13	13	curcumin	HO-1	PA151958596	3162	0.833
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Sep_30_70(Pt_10)_265-268.nxml.txt.nlp	25484670	SENT59	14	14	7	7	nitrile	PF6	PA450636	200162	0.833
NULL	Acta_Pharmacol_Sin_2014_Aug_7_35(8)_1023-1030.nxml.txt.nlp	24998255	SENT129	3	3	28	28	octreotide	SSTR2	PA450678	6752	0.833
NULL	J_Immunol_Res_2014_May_12_2014_897249.nxml.txt.nlp	24901013	SENT171	28	28	14	14	natalizumab	CD4	PA164747191	920	0.833
NULL	Mol_Cancer_2014_Jan_13_13_7.nxml.txt.nlp	24418169	SENT105	4	4	32	32	sorafenib	castor	PA7000	54897	0.833
NULL	J_Carcinog_2011_Dec_8_10_33.nxml.txt.nlp	22279418	SENT131	39	39	25	25	estradiol	CYP19A1	PA449503	1588	0.833
NULL	J_Bras_Pneumol_2013_Jan-Feb_39(1)_5-15.nxml.txt.nlp	23503480	SENT11	13	13	10	10	doxycycline	LAM	PA449415	7249;7248	0.833
NULL	Clin_Epigenetics_2010_Sep_18_1(3-4)_101-116.nxml.txt.nlp	21258631	SENT221	11	11	7	7	genistein	CCND2	PA165109660	894	0.833
NULL	Oncoimmunology_2012_Jul_1_1(4)_569-571.nxml.txt.nlp	22754790	SENT37	13	13	16	16	gemcitabine	CXCR2	PA449748	3579	0.833
NULL	Iran_J_Pharm_Res_2014_Autumn_13(4)_1393-1401.nxml.txt.nlp	25587329	SENT135	11	11	13	13	celecoxib	ABCG2	PA448871	9429	0.833
NULL	Br_J_Cancer_2010_Feb_2_102(3)_489-494.nxml.txt.nlp	20051955	SENT55	7	7	20	20	choline	mol	PA448976	90527	0.833
NULL	Psychiatr_Genet_2013_Aug_28_23(4)_153-162.nxml.txt.nlp	23811784	SENT154	15	15	31	31	clozapine	HTR7	PA449061	3363	0.833
NULL	Case_Rep_Med_2009_Aug_9_2009_378287.nxml.txt.nlp	19721707	SENT15	3	3	7	7	tadalafil	CYP3A	PA10333	1574	0.833
NULL	Cardiol_Res_Pract_2012_Aug_15_2012_713294.nxml.txt.nlp	22928146	SENT50	8	8	19	19	amifostine	Q10	PA448365	27161	0.833
NULL	Curr_Pharm_Des_2012_Apr_18(11)_1519-1530.nxml.txt.nlp	22364136	SENT106	8	8	15	15	lovastatin	IL-4	PA450272	3565	0.833
NULL	Oncotarget_2014_Aug_25_5(17)_7945-7959.nxml.txt.nlp	25277206	SENT373	5	5	13	13	sorafenib	VEGFR	PA7000	3791	0.833
NULL	Mol_Neurobiol_2010_Jun_2_41(2-3)_392-409.nxml.txt.nlp	20437209	SENT277	2	2	16	16	curcumin	PS1	PA151958596	5663	0.833
NULL	Cell_Res_2013_Jul_21_23(7)_915-930.nxml.txt.nlp	23689279	SENT152	7	7	22	22	ethanol	ALDH2	PA448073	217	0.833
NULL	Int_J_Endocrinol_2011_Aug_21_2011_742719.nxml.txt.nlp	21869886	SENT265	41	41	28	28	clopidogrel	DES	PA449053	1674	0.833
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT61	9	9	1	1	methotrexate	MSH2	PA450428	4436	0.833
NULL	J_Geriatr_Cardiol_2014_Jun_11(2)_151-157.nxml.txt.nlp	25009566	SENT126	9	9	17	17	cilostazol	CDP	PA164746334	1523	0.833
NULL	Front_Syst_Neurosci_2009_Nov_3_3_13.nxml.txt.nlp	20057934	SENT267	21	21	23	23	ketamine	PCP	PA450144	5547	0.833
NULL	Nucleic_Acids_Res_2013_Dec_4_41(22)_10124-10134.nxml.txt.nlp	24005039	SENT268	16	16	4	4	ethanol	CYC1	PA448073	1537	0.833
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT283	8	8	18	18	pertuzumab	HER2		2064	0.833
NULL	Nucleic_Acids_Res_2013_Dec_17_41(22)_10358-10370.nxml.txt.nlp	24049073	SENT372	9	9	4	4	camptothecin	FANCD2	PA153590860	2177	0.833
NULL	Br_J_Cancer_2013_Jul_23_109(2)_351-359.nxml.txt.nlp	23799854	SENT122	6	6	16	16	paclitaxel	BLT2	PA450761	56413	0.833
NULL	Exp_Diabetes_Res_2012_Jan_16_2012_230342.nxml.txt.nlp	22291696	SENT57	35	35	33	33	gliclazide	STZ	PA10892	6484	0.833
NULL	Chin_J_Cancer_2012_Feb_31(2)_110-118.nxml.txt.nlp	22098951	SENT27	20	20	40	40	imatinib	MRP1	PA10804	4437	0.833
NULL	Oncotarget_2011_Dec_31_2(12)_1314-1321.nxml.txt.nlp	22248929	SENT69	11	11	9	9	lapatinib	HER3	PA152241907	2065	0.833
NULL	Breast_Cancer_Res_2011_Feb_4_13(1)_R17.nxml.txt.nlp	21294885	SENT48	5	5	2	2	trastuzumab	HER2	PA451743	2064	0.833
NULL	Acta_Pharmacol_Sin_2009_Jul_22_30(7)_994-1000.nxml.txt.nlp	19543302	SENT5	4	4	0	0	heparin	BMP6	PA449855	654	0.833
NULL	AAPS_J_2011_Jun_1_13(3)_405-416.nxml.txt.nlp	21630127	SENT252	43	43	30	30	tocilizumab	CYP3A4	PA165292659	1576	0.833
NULL	J_Oncol_2009_May_6_2009_567486.nxml.txt.nlp	19424511	SENT45	0	0	5	5	gefitinib	EGFR	PA131301952	1956	0.833
NULL	Arthritis_Res_Ther_2010_Apr_29_12(2)_R73.nxml.txt.nlp	20429888	SENT248	21	21	13	13	bortezomib	c-Jun	PA10252	3725	0.833
NULL	Indian_J_Anaesth_2009_Apr_53(2)_219-222.nxml.txt.nlp	20640127	SENT61	9	9	4	4	protamine	ACT	PA10366	12;11332;9457;641455	0.833
NULL	Br_J_Clin_Pharmacol_2011_Oct_72(4)_647-657.nxml.txt.nlp	21518389	SENT30	25	25	7	7	thrombin	P2Y12	PA451674	64805	0.833
NULL	Int_J_Mol_Sci_2013_Apr_29_14(5)_9338-9364.nxml.txt.nlp	23629668	SENT125	35	35	21	21	sunitinib	KIT	PA162372840	3815	0.833
NULL	Arthritis_Rheumatol_2014_Jun_27_66(6)_1574-1582.nxml.txt.nlp	24577881	SENT100	10	10	0	0	oxygen	NAC	PA450744	22861	0.833
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT1663	7	7	2	2	gefitinib	ABCG2	PA131301952	9429	0.833
NULL	Lancet_2011_Dec_17_378(9809)_2081-2087.nxml.txt.nlp	22036019	SENT132	17	17	4	4	aspirin	MSH2	PA448497	4436	0.833
NULL	Evid_Based_Complement_Alternat_Med_2012_Sep_27_2012_753971.nxml.txt.nlp	23056142	SENT80	6	6	0	0	ethanol	TEPP	PA448073	374739	0.833
NULL	Endocrinol_Metab_(Seoul)_2013_Dec_12_28(4)_262-274.nxml.txt.nlp	24396690	SENT77	11	11	29	29	exenatide	GLP-1	PA164749238	100125288	0.833
NULL	Br_J_Pharmacol_2014_May_171(10)_2659-2670.nxml.txt.nlp	24116661	SENT17	23	23	2	2	naringenin	TRPP2	PA151958361	5311	0.833
NULL	EPMA_J_2013_Jan_28_4(1)_3.nxml.txt.nlp	23356214	SENT210	30	30	10	10	panitumumab	EGFR	PA162373091	1956	0.833
NULL	Biochem_Res_Int_2012_Mar_4_2012_875742.nxml.txt.nlp	22500233	SENT203	15	15	0	0	collagenase	MMP13	PA449107	4322	0.833
NULL	Expert_Rev_Mol_Med_2011_Nov_13_e35.nxml.txt.nlp	22088887	SENT243	2	2	5	5	thalidomide	CRBN	PA451644	51185	0.833
NULL	Nat_Neurosci_2013_Apr_17_16(4)_464-472.nxml.txt.nlp	23502536	SENT176	18	18	7	7	fluoxetine	GluA1	PA449673	2890	0.833
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1033-1038.nxml.txt.nlp	22374460	SENT35	17	17	24	24	capecitabine	HER2	PA448771	2064	0.833
NULL	Crit_Care_2011_Nov_30_15(6)_R289.nxml.txt.nlp	22129171	SENT169	6	6	11	11	dipyridamole	IL-10	PA449367	3586	0.833
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT537	26	26	15	15	pp2	TFF3		7033	0.833
NULL	Cancer_Cell_Int_2004_May_17_4_4.nxml.txt.nlp	15147581	SENT94	15	15	7	7	sulindac	EGF	PA451565	1950	0.833
NULL	Front_Neurol_2014_Sep_11_5_173.nxml.txt.nlp	25309501	SENT167	35	35	26	26	hyaluronan	CD44	PA165958431	960	0.833
NULL	Cancer_Biol_Med_2013_Dec_10(4)_192-205.nxml.txt.nlp	24349829	SENT94	6	6	19	19	gefitinib	EGFR	PA131301952	1956	0.833
NULL	Oncogene_2014_Aug_21_33(34)_4316-4329.nxml.txt.nlp	24362530	SENT25	12	12	20	20	paclitaxel	FOXM1	PA450761	2305	0.833
NULL	Curr_Hepat_Rep_2010_Nov_26_9(4)_231-238.nxml.txt.nlp	20949114	SENT15	17	17	2	2	telbivudine	IFN	PA164760861	3439	0.833
NULL	Cell_Cycle_2012_Nov_1_11(21)_3983-3996.nxml.txt.nlp	22987153	SENT206	14	14	7	7	cisplatin	DNA-PKcs	PA449014	5591	0.833
NULL	Front_Plant_Sci_2011_Jun_20_2_19.nxml.txt.nlp	22629260	SENT407	15	15	8	8	cisplatin	BRCA2	PA449014	675	0.833
NULL	J_Adv_Pract_Oncol_2012_May_1_May-Jun_3(3)_138-150.nxml.txt.nlp	25031940	SENT78	11	11	13	13	panitumumab	STEPP	PA162373091	222659	0.833
NULL	Diabetes_2009_Dec_9_58(12)_2828-2834.nxml.txt.nlp	19741164	SENT211	7	7	30	30	resveratrol	SIRT1		23411	0.833
NULL	J_Mol_Signal_2012_Aug_16_7_12.nxml.txt.nlp	22898329	SENT269	0	0	25	25	vorinostat	NOXA	PA164748224	5366	0.833
NULL	Nucleic_Acids_Res_2011_Dec_10_39(22)_9498-9507.nxml.txt.nlp	21835778	SENT178	14	14	25	25	nutlin-3	p53		7157	0.833
NULL	J_Geriatr_Cardiol_2014_Mar_11(1)_20-25.nxml.txt.nlp	24748877	SENT58	11	11	13	13	chlorpromazine	CPZ	PA448964	8532	0.833
NULL	Exp_Diabetes_Res_2012_May_14_2012_470851.nxml.txt.nlp	22666230	SENT203	32	32	25	25	liraglutide	GLP-1	PA165958364	100125288	0.833
NULL	Am_J_Transplant_2014_Jun_23_14(6)_1300-1309.nxml.txt.nlp	24842781	SENT72	0	0	19	19	thrombin	Gen	PA451674	348654	0.833
NULL	Onco_Targets_Ther_2014_Nov_28_7_2183-2195.nxml.txt.nlp	25506223	SENT45	14	14	31	31	doxorubicin	mol	PA449412	90527	0.833
NULL	Mediators_Inflamm_2011_Jun_7_2011_432080.nxml.txt.nlp	21772662	SENT148	7	7	25	25	rivaroxaban	MCP-1	PA165958360	6347	0.833
NULL	An_Bras_Dermatol_2014_Mar-Apr_89(2)_301-310.nxml.txt.nlp	24770508	SENT198	37	37	25	25	nilotinib	KIT	PA165958345	3815	0.833
NULL	Clin_Interv_Aging_2012_Sep_13_7_351-361.nxml.txt.nlp	23049247	SENT122	22	22	5	5	letrozole	aromatase	PA450196	1588	0.833
NULL	Evid_Based_Complement_Alternat_Med_2012_Sep_13_2012_940846.nxml.txt.nlp	23008744	SENT135	20	20	11	11	fluoxetine	CORT	PA449673	1325	0.833
NULL	Front_Neurosci_2011_Dec_5_5_131.nxml.txt.nlp	22164129	SENT90	10	10	31	31	midazolam	TSPO	PA450496	706	0.833
NULL	Oncol_Lett_2013_Apr_22_5(4)_1093-1100.nxml.txt.nlp	23599746	SENT221	37	37	28	28	vinblastine	CYP3A4	PA451877	1576	0.833
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_29_2013_590393.nxml.txt.nlp	23737838	SENT8	3	3	11	11	resveratrol	p53		7157	0.833
NULL	Curr_Med_Chem_2013_Apr_20(10)_1241-1285.nxml.txt.nlp	23409712	SENT987	10	10	6	6	carbachol	TRPC1	PA448784	7220	0.833
NULL	Cancer_Manag_Res_2011_Mar_3_3_57-64.nxml.txt.nlp	21556317	SENT165	5	5	20	20	bevacizumab	A30	PA130232992	28937	0.833
NULL	Cancer_Causes_Control_2010_Jul_4_21(7)_999-1007.nxml.txt.nlp	20204493	SENT2	10	10	12	12	diethylstilbestrol	DES	PA449307	1674	0.833
NULL	Breast_Cancer_Res_2010_May_18_12(Suppl_1)_P2.nxml.txt.nlp	NULL	SENT13	30	30	23	23	tamoxifen	FOXM1	PA451581	2305	0.833
NULL	Oncotarget_2013_Nov_22_5(4)_933-943.nxml.txt.nlp	24659749	SENT136	28	28	3	3	nutlin-3	AML2		864	0.833
NULL	Int_J_Mol_Sci_2014_Oct_23_15(10)_19253-19264.nxml.txt.nlp	25342320	SENT116	2	2	9	9	chloroquine	DRAM1	PA448948	55332	0.833
NULL	Oncoimmunology_2013_Dec_1_2(12)_e27215.nxml.txt.nlp	24501692	SENT32	41	41	11	11	gefitinib	STAT3	PA131301952	6774	0.833
NULL	Int_J_Biomed_Sci_2007_Dec_3(4)_279-286.nxml.txt.nlp	23675054	SENT142	41	41	5	5	ethanol	p65	PA448073	5970	0.833
NULL	Br_J_Cancer_2011_Jun_28_105(1)_44-52.nxml.txt.nlp	21629245	SENT147	1	1	16	16	cetuximab	EGFR	PA10040	1956	0.833
NULL	J_Cardiothorac_Surg_2014_Dec_31_9(1)_184.nxml.txt.nlp	NULL	SENT24	22	22	0	0	creatine	PMI	PA164778930	8834;5373	0.833
NULL	Endocrinology_2014_Oct_22_155(10)_3732-3738.nxml.txt.nlp	25051442	SENT123	40	40	20	20	sibutramine	POMC	PA451344	5443	0.833
NULL	J_Biomed_Sci_2013_Mar_15_20(1)_17.nxml.txt.nlp	23497194	SENT145	28	28	17	17	rivaroxaban	COX	PA165958360	1351	0.833
NULL	J_Thromb_Thrombolysis_2012_Feb_20_33(2)_143-153.nxml.txt.nlp	22183178	SENT66	3	3	13	13	ticagrelor	ADP	PA165374673	23038	0.833
NULL	Acta_Pharmacol_Sin_2013_Oct_7_34(10)_1317-1324.nxml.txt.nlp	23933652	SENT168	8	8	13	13	rosiglitazone	TNF	PA451283	7124	0.833
NULL	J_Carcinog_2011_Jul_19_10_17.nxml.txt.nlp	21799661	SENT157	9	9	43	43	metformin	AMPK	PA450395	5563	0.833
NULL	Int_J_Mol_Sci_2014_Sep_19_15(9)_16698-16718.nxml.txt.nlp	25244018	SENT1085	13	13	3	3	metformin	LKB1	PA450395	6794	0.833
NULL	Evid_Based_Complement_Alternat_Med_2014_Jul_10_2014_639563.nxml.txt.nlp	25120576	SENT30	8	8	24	24	estradiol	IL-6	PA449503	3569	0.833
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT96	5	5	15	15	chloroquine	BMPR-II	PA448948	659	0.833
NULL	J_Thromb_Thrombolysis_2011_Nov_26_32(4)_459-466.nxml.txt.nlp	21706290	SENT134	38	38	15	15	clopidogrel	VASP	PA449053	7408	0.833
NULL	Int_J_Breast_Cancer_2012_Oct_15_2012_809291.nxml.txt.nlp	22295251	SENT184	5	5	8	8	erlotinib	BRCA1	PA134687924	672	0.833
NULL	Acta_Pharmacol_Sin_2012_Jul_18_33(7)_861-872.nxml.txt.nlp	22705730	SENT185	5	5	17	17	lovastatin	PI3K	PA450272	5290	0.833
NULL	Acta_Pharmacol_Sin_2013_Apr_11_34(4)_473-479.nxml.txt.nlp	23474709	SENT26	14	14	6	6	phenytoin	MRP1	PA450947	4437	0.833
NULL	J_Int_Soc_Sports_Nutr_2011_Nov_7_8(Suppl_1)_P25.nxml.txt.nlp	NULL	SENT25	10	10	3	3	creatine	OTC	PA164778930	5009	0.833
NULL	Br_J_Cancer_2014_Nov_25_111(11)_2091-2102.nxml.txt.nlp	25349971	SENT23	3	3	19	19	imatinib	PDGFRA	PA10804	5156	0.833
NULL	Lab_Anim_Res_2012_Sep_26_28(3)_171-179.nxml.txt.nlp	23091517	SENT149	18	18	3	3	creatine	AMPK	PA164778930	5563	0.833
NULL	Br_J_Pharmacol_2014_Feb_24_171(1)_1019-1032.nxml.txt.nlp	24251620	SENT15	3	3	5	5	nifedipine	TRPM3	PA450631	80036	0.833
NULL	Diabetes_Care_2013_Jan_11_36(1)_90-97.nxml.txt.nlp	22933440	SENT235	14	14	27	27	metformin	BACE1	PA450395	23621	0.833
NULL	Oncoscience_2014_Aug_7_1(8)_540-549.nxml.txt.nlp	25594061	SENT70	11	11	21	21	cetuximab	KRAS	PA10040	3845	0.833
NULL	Sleep_Disord_2011_Jan_24_2011_964510.nxml.txt.nlp	23471148	SENT17	23	23	14	14	vasopressin	ACTH	PA451858	5443	0.833
NULL	Mol_Cancer_2014_Jan_13_13_7.nxml.txt.nlp	24418169	SENT10	0	0	9	9	sorafenib	STAT3	PA7000	6774	0.833
NULL	Cell_Commun_Signal_2009_Aug_13_7_19.nxml.txt.nlp	19678929	SENT70	3	3	17	17	cetuximab	KRAS	PA10040	3845	0.833
NULL	Biochemistry_2008_Aug_19_47(33)_8689-8696.nxml.txt.nlp	18642884	SENT31	17	17	30	30	nadh	XMP	PA164755085	2013	0.833
NULL	Exp_Hematol_Oncol_2014_Mar_11_3_7.nxml.txt.nlp	24618035	SENT147	2	2	15	15	imatinib	CXCL12	PA10804	6387	0.833
NULL	Ann_Hematol_2011_May_12_90(5)_557-568.nxml.txt.nlp	20938660	SENT206	12	12	32	32	plerixafor	CD34	PA165958410	947	0.833
NULL	Cancer_Cell_Int_2009_Sep_10_9_25.nxml.txt.nlp	19744341	SENT116	31	31	14	14	glucosamine	STAT3	PA164747613	6774	0.833
NULL	J_Breast_Cancer_2013_Sep_30_16(3)_266-273.nxml.txt.nlp	24155755	SENT146	3	3	14	14	lapatinib	HER2	PA152241907	2064	0.833
NULL	Exp_Hematol_Oncol_2012_Sep_24_1_30.nxml.txt.nlp	23210663	SENT25	7	7	9	9	rituximab	CHOP	PA451261	1649	0.833
NULL	Nat_Commun_2014_Dec_8_5_5736.nxml.txt.nlp	25484020	SENT233	13	13	21	21	letrozole	PAR2	PA450196	2150;55065;8856	0.833
NULL	Biomed_Res_Int_2013_Oct_27_2013_798261.nxml.txt.nlp	24282821	SENT216	0	0	10	10	ethanol	DAI	PA448073	81030	0.833
NULL	Anesth_Pain_Med_2014_Sep_9_4(4)_e14221.nxml.txt.nlp	25599022	SENT81	2	2	7	7	cisplatin	LPO	PA449014	4025	0.833
NULL	Protein_Cell_2014_Jun_19_5(6)_469-479.nxml.txt.nlp	24748116	SENT158	29	29	24	24	paclitaxel	EB1	PA450761	9167;22919;10982	0.833
NULL	Br_J_Cancer_1998_Sep_78(Suppl_4)_1-4.nxml.txt.nlp	9741780	SENT15	10	10	14	14	goserelin	aromatase	PA164747674	1588	0.833
NULL	J_Exp_Clin_Cancer_Res_2009_Oct_7_28(1)_134.nxml.txt.nlp	19811659	SENT10	18	18	2	2	imatinib	CD117	PA10804	3815	0.833
NULL	Cell_Death_Dis_2012_Mar_1_3(3)_e275.nxml.txt.nlp	22378068	SENT43	30	30	35	35	metformin	AMPK	PA450395	5563	0.833
NULL	Acta_Pharmacol_Sin_2010_Feb_5_31(2)_137-144.nxml.txt.nlp	20139896	SENT138	3	3	7	7	zileuton	p38	PA451955	10598;1432;7965	0.833
NULL	Spermatogenesis_2013_Apr_1_3(2)_e24194.nxml.txt.nlp	23885303	SENT117	9	9	11	11	staurosporine	STS	PA165109623	412	0.833
NULL	Vet_Res_2013_Jul_22_44(1)_61.nxml.txt.nlp	23876161	SENT250	7	7	9	9	etoposide	TRAIL	PA449552	8743	0.833
NULL	J_Carcinog_Mutagen_2013_May_27_Suppl_14_S14-004.nxml.txt.nlp	25328816	SENT139	3	3	15	15	cisplatin	XIAP	PA449014	331	0.833
NULL	Eur_J_Clin_Pharmacol_2014_May_27_70(8)_975-981.nxml.txt.nlp	24858823	SENT106	8	8	0	0	ciprofloxacin	CYP3A4	PA449009	1576	0.833
NULL	Acta_Pharmacol_Sin_2009_Jul_22_30(7)_956-964.nxml.txt.nlp	19543298	SENT171	16	16	6	6	ezetimibe	ABCB1	PA10816	5243	0.833
NULL	Diabetes_Metab_J_2012_Aug_20_36(4)_293-299.nxml.txt.nlp	22950061	SENT159	5	5	21	21	metformin	ANOVA	PA450395	4858	0.833
NULL	Int_J_Endocrinol_2010_May_26_2010_906163.nxml.txt.nlp	20585352	SENT80	24	24	9	9	cinacalcet	PTH	PA164776671	5741	0.833
NULL	J_Carcinog_2012_Sep_13_11_15.nxml.txt.nlp	23230392	SENT127	13	13	40	40	cetuximab	VEGFR	PA10040	3791	0.833
NULL	Breast_Cancer_Res_2010_Oct_22_12(Suppl_2)_S3.nxml.txt.nlp	21050424	SENT148	25	25	17	17	bsi-201	PARP1		142	0.833
NULL	Acta_Pharmacol_Sin_2012_May_4_33(5)_710-716.nxml.txt.nlp	22555373	SENT210	9	9	24	24	diazepam	DOM	PA449283	6663	0.833
NULL	Breast_Cancer_Res_2014_Sep_9_16(5)_433.nxml.txt.nlp	25212966	SENT377	2	2	4	4	aprotinin	ILEI	PA448472	10447	0.833
NULL	Cancers_(Basel)_2011_Apr_1_3(2)_1844-1860.nxml.txt.nlp	24212785	SENT12	12	12	35	35	bevacizumab	EGFR	PA130232992	1956	0.833
NULL	Mol_Cancer_2010_May_19_9_112.nxml.txt.nlp	20482842	SENT374	11	11	34	34	imatinib	p65	PA10804	5970	0.833
NULL	Biomed_Res_Int_2014_Jan_20_2014_789765.nxml.txt.nlp	24575414	SENT175	5	5	22	22	piroxicam	PRX	PA450985	9588;57716	0.833
NULL	Cell_Death_Dis_2014_Jan_16_5(1)_e1000.nxml.txt.nlp	24434508	SENT96	20	20	15	15	etoposide	p53	PA449552	7157	0.833
NULL	Cancer_Immunol_Immunother_2012_Jul_23_61(7)_1101-1111.nxml.txt.nlp	22193989	SENT195	5	5	14	14	oxaliplatin	STAT1	PA131285527	6772	0.833
NULL	Cardiol_Ther_2013_Jun_27_2(1)_1-16.nxml.txt.nlp	25135285	SENT210	41	41	26	26	metformin	GLP-1	PA450395	100125288	0.833
NULL	Behav_Brain_Funct_2009_Jan_15_5_3.nxml.txt.nlp	19146665	SENT178	32	32	1	1	ethanol	ANOVA	PA448073	4858	0.833
NULL	Cancers_(Basel)_2010_Feb_23_2(1)_88-113.nxml.txt.nlp	24281034	SENT1262	9	9	12	12	docetaxel	survivin	PA449383	332	0.833
NULL	Diabetes_Care_2012_Feb_16_35(2)_327-333.nxml.txt.nlp	22179958	SENT174	13	13	19	19	metformin	B12	PA450395	7126;4709	0.833
NULL	Breast_Cancer_Res_2008_Dec_5_10(6)_R104.nxml.txt.nlp	19061505	SENT191	32	32	17	17	estradiol	Bcl-2	PA449503	596	0.833
NULL	Alcohol_Res_Health_2008_31(4)_310-339.nxml.txt.nlp	20729980	SENT123	12	12	30	30	ethanol	5-HT1B	PA448073	3351	0.833
NULL	Br_J_Cancer_2012_Jun_5_106(12)_1997-2003.nxml.txt.nlp	22596232	SENT146	11	11	0	0	sorafenib	c-Jun	PA7000	3725	0.833
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT89	0	0	5	5	doxorubicin	B7-H1	PA449412	29126	0.833
NULL	Orphanet_J_Rare_Dis_2008_Nov_13_3_29.nxml.txt.nlp	19014533	SENT117	11	11	15	15	ergotamine	DPT	PA164747651	1805	0.833
NULL	Diabetes_Metab_J_2013_Aug_14_37(4)_240-248.nxml.txt.nlp	23991401	SENT124	10	10	17	17	ezetimibe	GLP-1	PA10816	100125288	0.833
NULL	Cancer_Metastasis_Rev_2010_Dec_10_29(4)_581-594.nxml.txt.nlp	20830503	SENT280	18	18	5	5	letrozole	STA	PA450196	2010;2656	0.833
NULL	Oncotarget_2014_Aug_29_5(17)_7217-7259.nxml.txt.nlp	25277175	SENT336	7	7	12	12	bicalutamide	AKT	PA164746255	207	0.833
NULL	Mol_Cancer_2008_Sep_12_7_70.nxml.txt.nlp	18789133	SENT14	4	4	8	8	belinostat	HDAC1		3065	0.833
NULL	Diabetes_Metab_J_2013_Oct_17_37(5)_315-325.nxml.txt.nlp	24199159	SENT197	6	6	14	14	resveratrol	SIRT1		23411	0.833
NULL	Cell_Death_Dis_2014_Mar_13_5(3)_e1111.nxml.txt.nlp	24625970	SENT22	31	31	10	10	gemcitabine	p53	PA449748	7157	0.833
NULL	Br_J_Cancer_2009_Mar_10_100(5)_758-763.nxml.txt.nlp	19259094	SENT140	25	25	3	3	decitabine	MLH1	PA164749631	4292	0.833
NULL	Cancer_Cell_Int_2012_Jun_18_12_30.nxml.txt.nlp	22709569	SENT86	17	17	6	6	paclitaxel	CALM1	PA450761	801	0.833
NULL	Environ_Health_Perspect_2006_Sep_23_114(9)_1401-1406.nxml.txt.nlp	16966095	SENT148	0	0	23	23	arsenite	p53	PA452638	7157	0.833
NULL	Breast_Cancer_Res_2005_Jul_18_7(5)_187-189.nxml.txt.nlp	16168136	SENT41	29	29	8	8	fulvestrant	PI3K	PA164747170	5290	0.833
NULL	Nat_Cell_Biol_2014_Jan_8_16(1)_10_1038_ncb2886.nxml.txt.nlp	24316673	SENT81	5	5	14	14	chloroquine	Vps34	PA448948	5289	0.833
NULL	Oncoimmunology_2014_Jan_3_3_e27588.nxml.txt.nlp	24800168	SENT74	28	28	12	12	imiquimod	MPL	PA449972	4352	0.833
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT14	8	8	19	19	atorvastatin	AKT	PA448500	207	0.833
NULL	Allergy_2015_Jan_28_70(1)_80-89.nxml.txt.nlp	25331546	SENT158	2	2	16	16	clodronate	IL-27	PA10239	246778;56005;53342	0.833
NULL	Int_J_Mol_Sci_2012_Sep_25_13(10)_12153-12168.nxml.txt.nlp	23202889	SENT497	2	2	26	26	irinotecan	BRAF	PA450085	673	0.833
NULL	Arthritis_Res_Ther_2012_Aug_15_14(4)_R186.nxml.txt.nlp	22894827	SENT94	30	30	6	6	etanercept	ACTH	PA449515	5443	0.833
NULL	Behav_Brain_Funct_2012_May_16_8_21.nxml.txt.nlp	22591917	SENT99	9	9	12	12	nadh	mol	PA164755085	90527	0.833
NULL	Bone_Marrow_Transplant_2009_Dec_20_44(11)_739-748.nxml.txt.nlp	19377515	SENT64	7	7	9	9	trimethoprim	TMP	PA451788	2012	0.833
NULL	Int_J_Breast_Cancer_2012_May_9_2012_415170.nxml.txt.nlp	22649737	SENT76	3	3	26	26	trastuzumab	MUC4	PA451743	4585	0.833
NULL	Breast_Cancer_Res_2007_Jan_23_9(1)_R7.nxml.txt.nlp	17244352	SENT132	6	6	12	12	tamoxifen	CYP2D6	PA451581	1565	0.833
NULL	Open_Biochem_J_2013_Feb_22_7_19-23.nxml.txt.nlp	23526382	SENT13	24	24	42	42	repaglinide	DM2	PA451234	28508	0.833
NULL	Ann_Oncol_2014_Oct_23_25(10)_1941-1948.nxml.txt.nlp	25057173	SENT108	2	2	11	11	docetaxel	EGFR	PA449383	1956	0.833
NULL	Semin_Immunopathol_2013_Jan_26_35(1)_39-52.nxml.txt.nlp	22829332	SENT197	12	12	30	30	etoposide	CHOP	PA449552	1649	0.833
NULL	Drug_Des_Devel_Ther_2014_Oct_14_8_1839-1849.nxml.txt.nlp	25342883	SENT80	14	14	39	39	paclitaxel	CO2	PA450761	4513	0.833
NULL	Nat_Med_2014_Mar_23_20(3)_291-295.nxml.txt.nlp	24562381	SENT83	3	3	25	25	fenoldopam	HMGB1	PA164784034	3146	0.833
NULL	Acta_Orthop_2010_Apr_6_81(2)_263-267.nxml.txt.nlp	20148646	SENT154	13	13	15	15	taurine	LIR	PA451590	10871	0.833
NULL	Br_J_Cancer_2009_Jan_27_100(2)_366-369.nxml.txt.nlp	19165200	SENT61	4	4	21	21	bortezomib	Apo2	PA10252	8797	0.833
NULL	Mol_Neurobiol_2010_Jun_2_41(2-3)_392-409.nxml.txt.nlp	20437209	SENT298	0	0	17	17	curcumin	COX	PA151958596	1351	0.833
NULL	Cell_Death_Dis_2014_Apr_24_5(4)_e1197.nxml.txt.nlp	24763054	SENT341	25	25	7	7	doxorubicin	RUNX3	PA449412	864	0.833
NULL	Ann_Dermatol_2011_Nov_3_23(4)_468-473.nxml.txt.nlp	22148014	SENT111	4	4	11	11	pimecrolimus	IL-2	PA164783790	3558	0.833
NULL	Int_J_Mol_Sci_2012_Sep_25_13(10)_12153-12168.nxml.txt.nlp	23202889	SENT99	23	23	13	13	panitumumab	KRAS	PA162373091	3845	0.833
NULL	Patient_Prefer_Adherence_2009_Nov_3_3_205-211.nxml.txt.nlp	19936163	SENT95	0	0	12	12	doxycycline	ENG	PA449415	2022	0.833
NULL	Int_J_Mol_Sci_2014_Oct_20_15(10)_18985-18999.nxml.txt.nlp	25334066	SENT124	4	4	10	10	genistein	HOTAIR	PA165109660	100124700	0.833
NULL	Br_J_Pharmacol_2011_Nov_164(5)_1522-1533.nxml.txt.nlp	21557728	SENT151	13	13	21	21	cangrelor	ADP	PA165945763	23038	0.833
NULL	Cell_Cycle_2012_Nov_1_11(21)_3983-3996.nxml.txt.nlp	22987153	SENT86	30	30	7	7	cisplatin	DNA2	PA449014	1763	0.833
NULL	Oncotarget_2014_Oct_16_5(20)_9546-9563.nxml.txt.nlp	25337673	SENT190	27	27	4	4	erlotinib	AXL	PA134687924	558	0.833
NULL	Bioinformation_2012_Jan_6_8(1)_13-19.nxml.txt.nlp	22359429	SENT98	2	2	7	7	curcumin	MRP1	PA151958596	4437	0.833
NULL	Case_Rep_Urol_2012_Aug_1_2012_178915.nxml.txt.nlp	22900222	SENT40	10	10	19	19	thyroglobulin	p53	PA164754910	7157	0.833
NULL	Diabetes_2013_May_16_62(5)_1537-1546.nxml.txt.nlp	23321073	SENT92	37	37	15	15	fluorescein	CD4	PA164746009	920	0.833
NULL	Open_AIDS_J_2014_Dec_29_8_66-78.nxml.txt.nlp	25624956	SENT413	5	5	20	20	chloroquine	CD4	PA448948	920	0.833
NULL	J_Cardiovasc_Electrophysiol_2010_Oct_21(10)_1153-1159.nxml.txt.nlp	20384647	SENT16	29	29	5	5	flecainide	spatial	PA449646	219793	0.833
NULL	Arch_Dis_Child_2008_Jul_1_93(7)_620-625.nxml.txt.nlp	18381346	SENT182	5	5	10	10	warfarin	CYP3A4	PA451906	1576	0.833
NULL	J_Hematol_Oncol_2011_Nov_4_4_44.nxml.txt.nlp	22053759	SENT69	22	22	11	11	thrombin	ADP	PA451674	23038	0.833
NULL	Indian_J_Pharmacol_2012_Sep-Oct_44(5)_629-633.nxml.txt.nlp	23112427	SENT106	2	2	14	14	metoprolol	ANOVA	PA450480	4858	0.833
NULL	J_Mol_Signal_2009_May_14_4_3.nxml.txt.nlp	19442290	SENT180	3	3	27	27	genistein	BRCA2	PA165109660	675	0.833
NULL	Endocrinol_Metab_(Seoul)_2014_Sep_25_29(3)_379-387.nxml.txt.nlp	25309798	SENT176	11	11	7	7	resveratrol	CLOCK		9575	0.833
NULL	Oncotarget_2012_May_4_3(4)_395-398.nxml.txt.nlp	22565037	SENT20	37	37	9	9	metformin	CD24	PA450395	100133941	0.833
NULL	Acta_Neuropathol_Commun_2014_Oct_21_2(1)_149.nxml.txt.nlp	NULL	SENT331	2	2	24	24	riluzole	gamma	PA451251	9913	0.833
NULL	F1000_Med_Rep_2012_Feb_1_4_4.nxml.txt.nlp	22312414	SENT57	9	9	13	13	vancomycin	VISA	PA451850	57506	0.833
NULL	Neural_Regen_Res_2013_May_5_8(13)_1180-1189.nxml.txt.nlp	25206412	SENT94	21	21	6	6	fasudil	RhoA	PA165946121	387	0.833
NULL	Acta_Pharmacol_Sin_2014_Jan_9_35(1)_1-10.nxml.txt.nlp	24317012	SENT70	24	24	32	32	cisplatin	MRP2	PA449014	100130958;57626;1244	0.833
NULL	EMBO_Mol_Med_2013_Aug_4_5(8)_1180-1195.nxml.txt.nlp	23828858	SENT9	21	21	11	11	rituximab	MYC	PA451261	4609	0.833
NULL	Oncoimmunology_2012_May_1_1(3)_271-278.nxml.txt.nlp	22737602	SENT5	26	26	12	12	oxaliplatin	TLR4	PA131285527	7099	0.833
NULL	Indian_J_Endocrinol_Metab_2012_Jan-Feb_16(1)_33-43.nxml.txt.nlp	22276251	SENT143	5	5	10	10	ramipril	DREAM	PA451223	30818	0.833
NULL	J_Gen_Physiol_2003_Jul_122(1)_45-61.nxml.txt.nlp	12835470	SENT9	23	23	10	10	capsaicin	VR1	PA448776	56664	0.833
NULL	Cell_Death_Dis_2013_Sep_5_4(9)_e791.nxml.txt.nlp	24008735	SENT54	0	0	27	27	gemcitabine	PUMA	PA449748	27113	0.833
NULL	Oncogene_2013_Sep_26_32(39)_10_1038_onc_2012_491.nxml.txt.nlp	23108394	SENT65	22	22	7	7	epirubicin	FOXM1	PA449476	2305	0.833
NULL	Clin_Interv_Aging_2013_Apr_29_8_467-483.nxml.txt.nlp	23766636	SENT4	6	6	20	20	ranibizumab	VEGF-A	PA164746012	7422	0.833
NULL	Clin_Ophthalmol_2010_Apr_26_4_275-283.nxml.txt.nlp	20463795	SENT133	0	0	13	13	ranibizumab	San	PA164746012	80218	0.833
NULL	Mol_Pain_2013_Nov_27_9_59.nxml.txt.nlp	24279796	SENT259	43	43	3	3	isoflurane	STZ	PA450106	6484	0.833
NULL	Chem_Cent_J_2012_Mar_17_6_18.nxml.txt.nlp	22424056	SENT26	11	11	39	39	glucose	MSC	PA449773	9242	0.833
NULL	Biologics_2009_Sep_15_3_419-428.nxml.txt.nlp	19774209	SENT145	9	9	14	14	gefitinib	IGF1R	PA131301952	3480	0.833
NULL	Support_Care_Cancer_2014_Oct_19_22(2)_469-477.nxml.txt.nlp	24141698	SENT31	16	16	34	34	palonosetron	HEC	PA10352	10403	0.833
NULL	Arthritis_Res_Ther_2010_May_28_12(3)_R105.nxml.txt.nlp	20509880	SENT172	24	24	20	20	celecoxib	p38	PA448871	10598;1432;7965	0.832
NULL	Endocr_Connect_2012_Jul_21_1(1)_37-47.nxml.txt.nlp	23781302	SENT181	5	5	14	14	mitotane	CYP3A4	PA164746157	1576	0.832
NULL	Curr_Neuropharmacol_2014_Jul_12(4)_365-379.nxml.txt.nlp	25342944	SENT192	23	23	29	29	fluoxetine	GluA2	PA449673	2891	0.832
NULL	J_Oncol_2013_Feb_17_2013_872957.nxml.txt.nlp	23476648	SENT210	16	16	13	13	cisplatin	SFN	PA449014	25996;2810	0.832
NULL	J_Biol_Chem_2008_Nov_14_283(46)_31679-31689.nxml.txt.nlp	18755684	SENT29	24	24	1	1	iron	FTH1	PA450087	2495	0.832
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT214	21	21	10	10	curcumin	DR5	PA151958596	8795	0.832
NULL	Cancer_Manag_Res_2012_Nov_9_4_383-395.nxml.txt.nlp	23204869	SENT99	32	32	0	0	carmustine	PC-3	PA448810	692094	0.832
NULL	Cancers_(Basel)_2011_Apr_1_3(2)_1844-1860.nxml.txt.nlp	24212785	SENT93	21	21	13	13	cetuximab	ACRC	PA10040	93953	0.832
NULL	J_Exp_Med_2000_May_15_191(10)_1789-1798.nxml.txt.nlp	10811871	SENT472	10	10	5	5	tetracycline	p53	PA451640	7157	0.832
NULL	Brief_Bioinform_2014_Jul_31_15(4)_648-659.nxml.txt.nlp	23376192	SENT228	28	28	18	18	cisplatin	KIT	PA449014	3815	0.832
NULL	Biosci_Rep_2012_Dec_20_33(1)_e00011.nxml.txt.nlp	23137297	SENT263	29	29	13	13	heparin	RPSA	PA449855	3921	0.832
NULL	Adv_Hematol_2014_Apr_1_2014_705290.nxml.txt.nlp	24799907	SENT92	26	26	0	0	ethanol	IL-22	PA448073	50616;53342	0.832
NULL	Biochim_Biophys_Acta_2013_Nov_1831(11)_1600-1608.nxml.txt.nlp	23867907	SENT173	13	13	7	7	l-arginine	NOS	PA448478	4843	0.832
NULL	Cancers_(Basel)_2011_Oct_14_3(4)_3894-3908.nxml.txt.nlp	24213116	SENT138	34	34	18	18	gefitinib	EGFR	PA131301952	1956	0.832
NULL	Oxid_Med_Cell_Longev_2013_Dec_5_2013_963520.nxml.txt.nlp	24381719	SENT272	2	2	20	20	fluoxetine	NFkappaB	PA449673	4790	0.832
NULL	Ther_Clin_Risk_Manag_2006_Jun_2(2)_129-158.nxml.txt.nlp	18360588	SENT185	1	1	3	3	voriconazole	CYP2C9	PA10233	1559	0.832
NULL	Breast_Cancer_Res_2007_Apr_13_9(2)_103.nxml.txt.nlp	17433116	SENT19	22	22	27	27	tamoxifen	CYP2D6	PA451581	1565	0.832
NULL	Diabetes_Obes_Metab_2012_Apr_14(4)_304-314.nxml.txt.nlp	22051096	SENT57	14	14	9	9	exenatide	GLP-1	PA164749238	100125288	0.832
NULL	Cent_European_J_Urol_2013_Aug_13_66(2)_150-151.nxml.txt.nlp	24579015	SENT14	24	24	12	12	resveratrol	ski		55733	0.832
NULL	Clin_Sarcoma_Res_2013_Mar_7_3_3.nxml.txt.nlp	23497641	SENT164	11	11	13	13	imatinib	PDGFRB	PA10804	5159	0.832
NULL	J_Carcinog_2014_Nov_27_13_13.nxml.txt.nlp	25525412	SENT109	22	22	17	17	oxaliplatin	KRAS	PA131285527	3845	0.832
NULL	Int_J_Med_Sci_2012_Dec_28_10(2)_110-118.nxml.txt.nlp	23329881	SENT54	26	26	13	13	epirubicin	NACT	PA449476	284111	0.832
NULL	Ann_Indian_Acad_Neurol_2014_Mar_17(Suppl_1)_S32-S36.nxml.txt.nlp	24791086	SENT113	16	16	7	7	midazolam	PTB	PA450496	58155	0.832
NULL	Epilepsy_Res_Treat_2010_Jun_22_2010_654265.nxml.txt.nlp	22937226	SENT182	20	20	10	10	etomidate	EAAT1	PA164743987	6507	0.832
NULL	Acta_Pharmacol_Sin_2011_Feb_4_32(2)_230-238.nxml.txt.nlp	21293475	SENT125	3	3	11	11	troglitazone	aP2	PA451799	2167	0.832
NULL	Indian_J_Endocrinol_Metab_2013_Jan-Feb_17(1)_19-30.nxml.txt.nlp	23776849	SENT155	17	17	9	9	diazoxide	ABCC8	PA449285	6833	0.832
NULL	Front_Oncol_2013_Oct_1_3_259.nxml.txt.nlp	24102047	SENT96	41	41	21	21	paclitaxel	VEGFR2	PA450761	3791	0.832
NULL	Front_Oncol_2014_Apr_9_4_75.nxml.txt.nlp	24782986	SENT272	40	40	26	26	paclitaxel	CXCR4	PA450761	7852	0.832
NULL	Bone_Marrow_Transplant_2011_Mar_24_46(3)_430-435.nxml.txt.nlp	20498647	SENT103	14	14	18	18	infliximab	IL-2	PA452639	3558	0.832
NULL	Pain_Ther_2014_Jun_13_3(1)_59-69.nxml.txt.nlp	25135388	SENT156	4	4	15	15	curcumin	HSD1	PA151958596	26871	0.832
NULL	Int_J_Biol_Sci_2013_Mar_7_9(3)_279-288.nxml.txt.nlp	23493630	SENT162	27	27	24	24	tocilizumab	IL-6	PA165292659	3569	0.832
NULL	Osteoporos_Int_2010_Oct_18_21(10)_1657-1680.nxml.txt.nlp	20480148	SENT523	7	7	20	20	alendronate	PTH	PA448082	5741	0.832
NULL	Nat_Commun_2013_Oct_25_4_2667.nxml.txt.nlp	24157709	SENT72	2	2	8	8	nutlin-3	ETO		862	0.832
NULL	Evid_Based_Complement_Alternat_Med_2011_Aug_11_2011_657056.nxml.txt.nlp	21876711	SENT9	20	20	6	6	ethanol	p38	PA448073	10598;1432;7965	0.832
NULL	Arq_Bras_Cardiol_2014_Jul_103(1)_33b-40.nxml.txt.nlp	25120083	SENT181	10	10	16	16	simvastatin	CYP2C8	PA451363	1558	0.832
NULL	Int_J_Biol_Sci_2012_Sep_6_8(8)_1109-1120.nxml.txt.nlp	22991499	SENT80	34	34	11	11	ethanol	IFN	PA448073	3439	0.832
NULL	Br_J_Cancer_1995_Apr_71(4)_670-675.nxml.txt.nlp	7710927	SENT12	4	4	10	10	verapamil	P-gp	PA451868	5243	0.832
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT191	6	6	25	25	ranibizumab	PlGF-2	PA164746012	5228	0.832
NULL	BMJ_Open_2014_Feb_27_4(2)_e004071.nxml.txt.nlp	24578536	SENT90	1	1	8	8	warfarin	TTR	PA451906	7276	0.832
NULL	Mol_Cancer_2007_Aug_21_6_53.nxml.txt.nlp	17711579	SENT15	9	9	2	2	cisplatin	LATS2	PA449014	26524	0.832
NULL	Eur_J_Neurosci_2011_Jul_34(2)_213-220.nxml.txt.nlp	21749490	SENT32	5	5	11	11	ivermectin	P2X4	PA450133	5025	0.832
NULL	J_Exp_Med_2000_May_1_191(9)_1487-1498.nxml.txt.nlp	10790424	SENT217	25	25	6	6	staurosporine	Bcl-2	PA165109623	596	0.832
NULL	J_Invest_Dermatol_2012_Jan_18_132(1)_163-169.nxml.txt.nlp	21850019	SENT84	5	5	11	11	imiquimod	CD4	PA449972	920	0.832
NULL	Nucleic_Acids_Res_2013_May_5_41(10)_5199-5209.nxml.txt.nlp	23563152	SENT49	9	9	23	23	galactose	GAL	PA449725	51083	0.832
NULL	Cancer_Res_Treat_2013_Mar_31_45(1)_55-62.nxml.txt.nlp	23613671	SENT111	16	16	7	7	oxaliplatin	KRAS	PA131285527	3845	0.832
NULL	Front_Chem_2014_Dec_23_2_113.nxml.txt.nlp	25566531	SENT424	0	0	10	10	curcumin	Bcl-2	PA151958596	596	0.832
NULL	Breast_Cancer_Res_2011_Jun_21_13(3)_R66.nxml.txt.nlp	21693010	SENT44	0	0	21	21	sunitinib	CSF1R	PA162372840	1436	0.832
NULL	Breast_Cancer_Res_2008_Feb_15_10(1)_R18.nxml.txt.nlp	18279516	SENT31	8	8	17	17	celecoxib	aromatase	PA448871	1588	0.832
NULL	Br_J_Haematol_2014_Feb_16_164(4)_586-596.nxml.txt.nlp	24236640	SENT161	16	16	31	31	carboplatin	EPO	PA448803	7076;8288;2056	0.832
NULL	J_Oncol_2012_Aug_24_2012_281261.nxml.txt.nlp	21876693	SENT68	13	13	18	18	bevacizumab	EGFR	PA130232992	1956	0.832
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jan_31_65(Pt_2)_o427-o428.nxml.txt.nlp	21582014	SENT76	10	10	26	26	acetone	mol	PA448025	90527	0.832
NULL	Environ_Health_Perspect_2010_Jul_3_118(7)_936-942.nxml.txt.nlp	20199942	SENT128	15	15	9	9	arsenite	mot-2	PA452638	3313	0.832
NULL	Nat_Med_2012_Jul_18(7)_1118-1122.nxml.txt.nlp	22683780	SENT10	11	11	26	26	crizotinib	MET	PA165946122	4233	0.832
NULL	Mol_Cancer_2009_Nov_24_8_109.nxml.txt.nlp	19930708	SENT17	0	0	9	9	exemestane	aromatase	PA449563	1588	0.832
NULL	Pharmaceuticals_(Basel)_2014_Apr_14_7(4)_453-463.nxml.txt.nlp	24736104	SENT9	9	9	29	29	diclofenac	GIT	PA449293	5034	0.832
NULL	J_Exp_Med_1952_Feb_29_95(3)_269-276.nxml.txt.nlp	14927792	SENT1	5	5	31	31	sulfadiazine	B12	PA451539	7126;4709	0.832
NULL	Br_J_Cancer_1997_76(4)_480-485.nxml.txt.nlp	9275025	SENT15	26	26	29	29	doxorubicin	p53	PA449412	7157	0.832
NULL	Br_J_Clin_Pharmacol_2012_Feb_73(2)_203-209.nxml.txt.nlp	21848574	SENT24	6	6	16	16	cisapride	5-HT4	PA449011	3360	0.832
NULL	Br_J_Cancer_2002_Jan_21_86(2)_179-184.nxml.txt.nlp	11870502	SENT23	19	19	37	37	cisplatin	IL-2	PA449014	3558	0.832
NULL	Crit_Care_2005_Aug_11_9(1)_86-91.nxml.txt.nlp	15693989	SENT109	5	5	20	20	dantrolene	CHS	PA449208	1130	0.832
NULL	Mol_Cancer_2013_Mar_5_12_17.nxml.txt.nlp	23497256	SENT193	24	24	13	13	sunitinib	p53	PA162372840	7157	0.832
NULL	Colorectal_Dis_2012_Feb_14(2)_e31-e47.nxml.txt.nlp	21848897	SENT151	18	18	11	11	cetuximab	KRAS	PA10040	3845	0.832
NULL	Ann_Oncol_2011_Mar_8_22(3)_503-514.nxml.txt.nlp	20616198	SENT220	14	14	38	38	letrozole	aromatase	PA450196	1588	0.832
NULL	Breast_Cancer_Res_2004_Jul_29_6(5)_204-210.nxml.txt.nlp	15318926	SENT102	15	15	7	7	tamoxifen	EGFR	PA451581	1956	0.832
NULL	Curr_Neuropharmacol_2012_Sep_10(3)_212-218.nxml.txt.nlp	23449551	SENT39	0	0	16	16	exenatide	GLP-1	PA164749238	100125288	0.832
NULL	Clin_Infect_Dis_2011_Jan_1_52(1)_31-40.nxml.txt.nlp	21148517	SENT230	21	21	28	28	vancomycin	HAP	PA451850	5915;10313	0.832
NULL	Clin_Exp_Metastasis_2014_Sep_17_31(1)_135-147.nxml.txt.nlp	24043563	SENT189	33	33	4	4	aprotinin	KLK4	PA448472	9622	0.832
NULL	J_Thorac_Oncol_2014_Feb_23_9(2)_189-194.nxml.txt.nlp	24419415	SENT91	17	17	32	32	gefitinib	EGFR	PA131301952	1956	0.832
NULL	Brain_Behav_2013_Mar_6_3(2)_114-133.nxml.txt.nlp	23533150	SENT197	26	26	13	13	ethanol	Hsp90	PA448073	3320	0.832
NULL	Br_J_Cancer_2010_Feb_16_102(4)_658-664.nxml.txt.nlp	20104222	SENT103	7	7	11	11	sunitinib	IFN	PA162372840	3439	0.832
NULL	Curr_Chem_Genomics_2010_Mar_1_4_1-8.nxml.txt.nlp	20448812	SENT103	42	42	18	18	methotrexate	OATP1B1	PA450428	10599	0.832
NULL	Bioinformation_2012_Jan_6_8(1)_13-19.nxml.txt.nlp	22359429	SENT117	5	5	3	3	curcumin	MRP1	PA151958596	4437	0.832
NULL	J_Immunol_Res_2014_Jul_13_2014_964069.nxml.txt.nlp	25126586	SENT7	7	7	3	3	tocilizumab	IL-6	PA165292659	3569	0.832
NULL	Osteoporos_Int_2014_Oct_10_25(3)_1173-1180.nxml.txt.nlp	24108429	SENT145	30	30	6	6	teriparatide	PTH	PA451620	5741	0.832
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT175	14	14	6	6	cisplatin	PUMA	PA449014	27113	0.832
NULL	Cardiovasc_Diabetol_2013_Oct_17_12_150.nxml.txt.nlp	24134550	SENT103	29	29	2	2	pioglitazone	activin	PA450970	83729	0.832
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT226	0	0	16	16	curcumin	MCP-1	PA151958596	6347	0.832
NULL	Mol_Biol_Cell_2012_Sep_1_23(17)_3473-3484.nxml.txt.nlp	22787275	SENT223	28	28	14	14	doxorubicin	ABCC1	PA449412	4363	0.832
NULL	Arch_Med_Sci_2013_Aug_30_9(4)_622-628.nxml.txt.nlp	24049520	SENT143	10	10	16	16	pravastatin	ADP	PA451089	23038	0.832
NULL	Arthritis_Res_Ther_2004_Feb_24_6(Suppl_1)_24.nxml.txt.nlp	NULL	SENT13	17	17	13	13	etanercept	OPG	PA449515	690	0.832
NULL	Bone_Marrow_Transplant_2013_Feb_24_48(2)_278-283.nxml.txt.nlp	23000644	SENT19	4	4	17	17	tacrolimus	TRM3	PA451578	6894	0.832
NULL	Clin_Pharmacol_2010_Dec_7_2_225-236.nxml.txt.nlp	22291509	SENT83	34	34	40	40	retigabine	UGT1A1	PA144997862	54658	0.832
NULL	Mol_Clin_Oncol_2013_Sep_18_1(5)_839-844.nxml.txt.nlp	24649257	SENT30	15	15	29	29	cyclophosphamide	NAC	PA449165	22861	0.832
NULL	Mol_Cancer_2010_Aug_23_9_222.nxml.txt.nlp	20731837	SENT175	0	0	3	3	gefitinib	ATM	PA131301952	472	0.832
NULL	Subst_Abuse_Rehabil_2013_Nov_6_4_75-82.nxml.txt.nlp	24648790	SENT88	23	23	0	0	chlorpheniramine	OTC	PA448960	5009	0.832
NULL	Proteome_Sci_2010_Jan_29_8_3.nxml.txt.nlp	20205825	SENT67	26	26	4	4	doxycycline	CO2	PA449415	4513	0.832
NULL	Open_Allergy_J_2010_3_91-101.nxml.txt.nlp	25018787	SENT185	21	21	9	9	omalizumab	IL-4	PA164752253	3565	0.832
NULL	Breast_Cancer_Res_2012_Jan_6_14(1)_R2.nxml.txt.nlp	22225778	SENT179	10	10	19	19	docetaxel	p65	PA449383	5970	0.832
NULL	Drugs_R_D_2011_Dec_27_11(4)_295-302.nxml.txt.nlp	22007990	SENT16	12	12	22	22	darunavir	CCR5	PA163522472	1234	0.832
NULL	Exp_Ther_Med_2014_May_5_7(5)_1420-1426.nxml.txt.nlp	24940450	SENT143	19	19	8	8	sorafenib	VEGFR	PA7000	3791	0.832
NULL	Neural_Regen_Res_2013_Mar_25_8(9)_825-832.nxml.txt.nlp	25206730	SENT23	2	2	16	16	isoflurane	P2X7	PA450106	5027	0.832
NULL	Oncoimmunology_2012_Oct_1_1(7)_1004-1016.nxml.txt.nlp	23170249	SENT68	18	18	0	0	trastuzumab	HER-2	PA451743	2064	0.832
NULL	Oncotarget_2013_Nov_7_4(12)_2550-2566.nxml.txt.nlp	24334291	SENT210	37	37	27	27	dasatinib	AMPK	PA162372878	5563	0.832
NULL	Cell_Commun_Signal_2013_Jul_4_11_47.nxml.txt.nlp	23826796	SENT107	9	9	13	13	rolipram	PDE4D	PA153906323	5144	0.832
NULL	Eur_J_Clin_Pharmacol_2014_Oct_8_70(12)_1433-1441.nxml.txt.nlp	25291992	SENT111	22	22	17	17	risperidone	B12	PA451257	7126;4709	0.832
NULL	Nat_Genet_2011_Feb_26_43(2)_153-158.nxml.txt.nlp	21186352	SENT43	17	17	15	15	geldanamycin	Hsp90	PA152031327	3320	0.832
NULL	Int_J_Chron_Obstruct_Pulmon_Dis_2006_Mar_1(1)_15-29.nxml.txt.nlp	18046899	SENT207	5	5	17	17	curcumin	COX	PA151958596	1351	0.832
NULL	Clinics_(Sao_Paulo)_2013_May_68(5)_694-701.nxml.txt.nlp	23778405	SENT140	11	11	24	24	curcumin	survivin	PA151958596	332	0.832
NULL	Eur_J_Haematol_2014_Nov_28_93(5)_369-376.nxml.txt.nlp	24797664	SENT126	8	8	14	14	thrombin	FVIII	PA451674	2157	0.832
NULL	Cell_Mol_Life_Sci_2012_Jul_31_69(14)_2327-2343.nxml.txt.nlp	22648375	SENT243	17	17	0	0	bleomycin	NOX4	PA448645	50507	0.832
NULL	Oncoimmunology_2012_May_1_1(3)_372-374.nxml.txt.nlp	22737619	SENT33	10	10	21	21	lenalidomide	IL-2	PA162363968	3558	0.832
NULL	J_Lipid_Res_2011_Feb_52(2)_299-307.nxml.txt.nlp	21078775	SENT672	2	2	10	10	fenofibrate	adiponectin	PA449594	9370	0.832
NULL	Pharmaceutics_2011_Oct_12_3(4)_680-705.nxml.txt.nlp	24309303	SENT115	10	10	8	8	verapamil	P-gp	PA451868	5243	0.832
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT121	4	4	2	2	sulindac	survivin	PA451565	332	0.832
NULL	Exp_Mol_Med_2012_Feb_29_44(2)_159-166.nxml.txt.nlp	22127053	SENT183	2	2	5	5	simvastatin	RhoA	PA451363	387	0.832
NULL	Cardiovasc_J_Afr_2009_Apr_20(2)_122-125.nxml.txt.nlp	19421648	SENT31	9	9	23	23	teicoplanin	DBL	PA164746244	4168	0.832
NULL	Cancer_Cell_Int_2011_Sep_23_11_33.nxml.txt.nlp	21943203	SENT249	4	4	9	9	trastuzumab	CD25	PA451743	3669;3559	0.832
NULL	Anal_Bioanal_Chem_2014_Jan_23_406(15)_3667-3680.nxml.txt.nlp	24452745	SENT171	19	19	5	5	ketoprofen	KET	PA450149	8626	0.832
NULL	Int_J_Mol_Sci_2012_Apr_25_13(5)_5307-5323.nxml.txt.nlp	22754298	SENT170	32	32	36	36	ampicillin	San	PA448419	80218	0.832
NULL	Oncol_Lett_2013_Aug_13_6(2)_507-512.nxml.txt.nlp	24137356	SENT137	28	28	41	41	tamoxifen	PUMA	PA451581	27113	0.832
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Aug_6_64(Pt_9)_o1710.nxml.txt.nlp	21201697	SENT62	33	33	13	13	ethanol	mol	PA448073	90527	0.832
NULL	Environ_Health_Perspect_2010_May_8_118(5)_640-646.nxml.txt.nlp	20061214	SENT67	14	14	9	9	fluorescein	CD4	PA164746009	920	0.832
NULL	Ann_Rheum_Dis_2008_Jul_22_68(8)_1303-1309.nxml.txt.nlp	18647851	SENT125	33	33	25	25	adalimumab	MMP3	PA10004	4314	0.832
NULL	F1000Prime_Rep_2014_Dec_1_6_117.nxml.txt.nlp	25580271	SENT61	21	21	25	25	erlotinib	EGFR	PA134687924	1956	0.832
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT34	36	36	32	32	cisplatin	TRAIL	PA449014	8743	0.832
NULL	Cell_J_2014_Nov_20_Winter_15(4)_348-355.nxml.txt.nlp	24381860	SENT129	20	20	7	7	estradiol	CYP1A2	PA449503	1544	0.832
NULL	Exp_Lung_Res_2013_Oct_1_39(8)_336-348.nxml.txt.nlp	23919450	SENT191	5	5	0	0	argatroban	PAR-1	PA164745516	2011;2149	0.832
NULL	Cardiovasc_Res_2012_Dec_1_96(3)_552-560.nxml.txt.nlp	22918977	SENT193	25	25	19	19	losartan	ANOVA	PA450268	4858	0.832
NULL	Int_J_Inflam_2011_Oct_30_2011_642612.nxml.txt.nlp	22121495	SENT50	15	15	9	9	lipase	FABP4	PA450239	2167	0.832
NULL	Pharmaceutics_2011_Sep_14_3(3)_615-635.nxml.txt.nlp	24310600	SENT82	22	22	2	2	gefitinib	ABCG2	PA131301952	9429	0.832
NULL	Oncol_Lett_2014_Sep_19_8(3)_1269-1274.nxml.txt.nlp	25120704	SENT123	37	37	18	18	cisplatin	Met	PA449014	79811	0.832
NULL	Indian_J_Community_Med_2008_Oct_33(4)_219-223.nxml.txt.nlp	19876493	SENT94	29	29	34	34	isoniazid	DST	PA450112	667	0.832
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT305	23	23	12	12	methotrexate	ABCC2	PA450428	1244	0.832
NULL	Ann_Hematol_2011_Dec_8_90(12)_1399-1407.nxml.txt.nlp	21476016	SENT89	26	26	13	13	cyclophosphamide	CHOP	PA449165	1649	0.832
NULL	Indian_J_Nephrol_2011_Jan-Mar_21(1)_44-47.nxml.txt.nlp	21655170	SENT58	17	17	11	11	vincristine	CHOP	PA451879	1649	0.832
NULL	Br_J_Cancer_2009_May_5_100(9)_1379-1384.nxml.txt.nlp	19401697	SENT37	32	32	34	34	bortezomib	EGFR	PA10252	1956	0.832
NULL	Oncotarget_2014_Aug_21_5(18)_8093-8106.nxml.txt.nlp	25193858	SENT4	8	8	15	15	ketoconazole	CYP3A	PA450146	1574	0.832
NULL	Acta_Pharmacol_Sin_2011_Oct_12_32(10)_1259-1265.nxml.txt.nlp	21909126	SENT111	37	37	28	28	losartan	MCP-1	PA450268	6347	0.832
NULL	Eur_J_Endocrinol_2010_May_162(5)_987-992.nxml.txt.nlp	20164212	SENT6	21	21	5	5	diazoxide	KCNJ11	PA449285	3767	0.832
NULL	Diabetes_2013_Jun_17_62(6)_1843-1854.nxml.txt.nlp	23349486	SENT235	5	5	39	39	pioglitazone	CCR2	PA450970	729230	0.832
NULL	Front_Oncol_2014_Sep_29_4_251.nxml.txt.nlp	25325012	SENT249	1	1	16	16	afatinib	EGFR	PA165981154	1956	0.832
NULL	Oncoimmunology_2014_Jan_17_3_e27574.nxml.txt.nlp	24800167	SENT22	43	43	24	24	cyclophosphamide	IL-6	PA449165	3569	0.832
NULL	Front_Oncol_2014_Sep_15_4_244.nxml.txt.nlp	25309870	SENT113	13	13	20	20	afatinib	EGFR	PA165981154	1956	0.832
NULL	Oncotarget_2013_Nov_24_4(12)_2430-2438.nxml.txt.nlp	24280348	SENT65	7	7	19	19	gefitinib	EGFR	PA131301952	1956	0.832
NULL	Environ_Health_Perspect_2006_Sep_23_114(9)_1401-1406.nxml.txt.nlp	16966095	SENT24	23	23	34	34	arsenite	p53	PA452638	7157	0.832
NULL	J_Inherit_Metab_Dis_2011_Apr_29_34(2)_315-325.nxml.txt.nlp	20668944	SENT193	9	9	11	11	resveratrol	SIRT1		23411	0.832
NULL	Scientifica_(Cairo)_2012_Dec_16_2012_402783.nxml.txt.nlp	24278688	SENT149	31	31	9	9	thrombin	MASP1	PA451674	5648	0.832
NULL	Exp_Ther_Med_2013_May_15_5(5)_1327-1331.nxml.txt.nlp	23737873	SENT149	4	4	6	6	imidapril	AQP2	PA452640	359	0.832
NULL	Biomed_Res_Int_2014_Mar_4_2014_836769.nxml.txt.nlp	24724101	SENT193	10	10	12	12	everolimus	EVL	PA164746311	51466	0.832
NULL	Diabetes_Metab_Syndr_Obes_2014_Jul_3_7_277-288.nxml.txt.nlp	25050071	SENT92	10	10	28	28	pioglitazone	PPG	PA450970	5552	0.832
NULL	Acta_Pharmacol_Sin_2013_Apr_18_34(4)_555-560.nxml.txt.nlp	23503472	SENT6	21	21	18	18	cyclosporine	NR1I2	PA449167	8856	0.832
NULL	Core_Evid_2009_Jun_15_4_181-189.nxml.txt.nlp	20694074	SENT21	0	0	19	19	tocilizumab	IL-6	PA165292659	3569	0.832
NULL	EMBO_Rep_2013_Jan_30_14(1)_49-56.nxml.txt.nlp	23196367	SENT17	9	9	3	3	ondansetron	5-HT3R	PA450705	3359	0.832
NULL	Arthritis_Res_Ther_2006_Apr_28_8(3)_R73.nxml.txt.nlp	16646979	SENT207	23	23	20	20	hyaluronan	OP-1	PA165958431	655	0.832
NULL	Br_J_Cancer_2010_Jun_29_103(1)_36-42.nxml.txt.nlp	20517311	SENT4	24	24	17	17	cisplatin	survivin	PA449014	332	0.832
NULL	Br_J_Cancer_2004_Mar_22_90(6)_1285-1292.nxml.txt.nlp	15026814	SENT87	39	39	12	12	doxorubicin	p53	PA449412	7157	0.832
NULL	Br_J_Cancer_2004_Mar_22_90(6)_1285-1292.nxml.txt.nlp	15026814	SENT24	17	17	13	13	doxorubicin	p53	PA449412	7157	0.832
NULL	Emerg_Infect_Dis_2013_Jan_19(1)_21-28.nxml.txt.nlp	23260763	SENT147	16	16	6	6	atovaquone	DHPS	PA448502	1725	0.832
NULL	J_Cardiovasc_Dis_Res_2011_Apr-Jun_2(2)_110-114.nxml.txt.nlp	21814415	SENT58	1	1	13	13	staurosporine	mol	PA165109623	90527	0.832
NULL	Oncotarget_2013_Dec_4_5(4)_944-958.nxml.txt.nlp	24659709	SENT162	28	28	8	8	cisplatin	JAG1	PA449014	182	0.832
NULL	Mol_Biol_Cell_2013_Aug_15_24(16)_2582-2592.nxml.txt.nlp	23783032	SENT101	23	23	26	26	bortezomib	FANCL	PA10252	55120	0.832
NULL	Clin_Psychopharmacol_Neurosci_2011_Apr_30_9(1)_36-43.nxml.txt.nlp	23431025	SENT109	9	9	25	25	aripiprazole	FLI	PA10026	2314	0.832
NULL	Breast_Cancer_(Auckl)_2011_Jul_27_5_175-199.nxml.txt.nlp	21863131	SENT8	23	23	27	27	trastuzumab	HER-2	PA451743	2064	0.832
NULL	Br_J_Cancer_1994_Sep_70(3)_409-414.nxml.txt.nlp	8080723	SENT8	25	25	11	11	cisplatin	CH1	PA449014	51430	0.832
NULL	J_Cell_Mol_Med_2014_Aug_9_18(8)_1549-1561.nxml.txt.nlp	24913911	SENT115	28	28	11	11	ketamine	CTR	PA450144	799	0.832
NULL	Int_J_Endocrinol_2010_Mar_2_2010_621687.nxml.txt.nlp	20204178	SENT8	26	26	12	12	paricalcitol	PTH	PA450798	5741	0.832
NULL	Acta_Pharmacol_Sin_2013_Feb_31_34(2)_231-238.nxml.txt.nlp	23274414	SENT166	14	14	29	29	amiloride	Bcl-2	PA448368	596	0.832
NULL	Oncogene_2009_Dec_3_28(48)_4237-4248.nxml.txt.nlp	19734937	SENT133	25	25	21	21	thrombin	PAR-1	PA451674	2011;2149	0.832
NULL	Breast_Cancer_Res_2007_Mar_2_9(2)_205.nxml.txt.nlp	NULL	SENT103	13	13	6	6	erlotinib	EGFR	PA134687924	1956	0.832
NULL	Aging_(Albany_NY)_2010_Dec_20_2(12)_959-968.nxml.txt.nlp	21191146	SENT13	27	27	11	11	cisplatin	p63	PA449014	8626	0.832
NULL	Mol_Cancer_2003_Jan_22_2_14.nxml.txt.nlp	12605717	SENT200	5	5	28	28	urokinase	Met	PA451836	79811	0.832
NULL	Br_J_Cancer_2013_Jun_11_108(11)_2304-2311.nxml.txt.nlp	23695020	SENT142	3	3	12	12	resveratrol	EEF1A2		1917	0.832
NULL	Arthritis_Res_Ther_2006_Jul_21_8(4)_R130.nxml.txt.nlp	16859540	SENT179	27	27	12	12	atorvastatin	CD59	PA448500	966	0.832
NULL	Gut_2012_Jan_21_61(1)_78-85.nxml.txt.nlp	21940721	SENT179	31	31	15	15	indomethacin	MAT	PA449982	4143	0.832
NULL	Balkan_J_Med_Genet_2013_Dec_3_16(2)_7-16.nxml.txt.nlp	24778557	SENT68	41	41	21	21	doxycycline	Oct4	PA449415	5460	0.832
NULL	Oncol_Lett_2014_May_11_7(5)_1401-1408.nxml.txt.nlp	24765145	SENT155	6	6	16	16	paclitaxel	HIF-1	PA450761	29072	0.832
NULL	Ann_Rheum_Dis_2014_Jul_1_73(7)_1405-1413.nxml.txt.nlp	23727633	SENT277	9	9	14	14	resveratrol	SIRT1		23411	0.832
NULL	Cells_2014_Apr_29_3(2)_331-362.nxml.txt.nlp	24785347	SENT66	12	12	9	9	capsaicin	TRPV1	PA448776	7442	0.832
NULL	Cell_Death_Dis_2012_Nov_15_3(11)_e422.nxml.txt.nlp	23152058	SENT11	27	27	5	5	cisplatin	ZNF143	PA449014	7702	0.832
NULL	Int_J_Mol_Sci_2014_Sep_22_15(9)_16800-16815.nxml.txt.nlp	25247578	SENT196	39	39	23	23	paraformaldehyde	IFN	PA450790	3439	0.832
NULL	Ann_Hematol_2011_May_12_90(5)_557-568.nxml.txt.nlp	20938660	SENT221	28	28	4	4	plerixafor	CD34	PA165958410	947	0.832
NULL	Alcohol_Res_Health_2008_31(1)_14-25.nxml.txt.nlp	23584748	SENT47	6	6	0	0	ethanol	CYP2E1	PA448073	1571	0.832
NULL	Oncotarget_2012_Dec_18_3(12)_1615-1628.nxml.txt.nlp	23271044	SENT219	6	6	15	15	clofarabine	STAT3	PA164754863	6774	0.832
NULL	Breast_Cancer_Res_2011_Nov_1_13(6)_224.nxml.txt.nlp	22114931	SENT129	32	32	30	30	trastuzumab	HER2	PA451743	2064	0.832
NULL	Endocrinol_Metab_(Seoul)_2014_Sep_25_29(3)_379-387.nxml.txt.nlp	25309798	SENT15	4	4	2	2	resveratrol	SIRT1		23411	0.832
NULL	Chem_Rev_2011_Oct_12_111(10)_5899-5921.nxml.txt.nlp	21923193	SENT536	19	19	11	11	ibuprofen	FAAH	PA449957	79152;2166	0.832
NULL	Ann_Rehabil_Med_2012_Aug_27_36(4)_466-473.nxml.txt.nlp	22977771	SENT22	26	26	22	22	triamcinolone	ILEI	PA451749	10447	0.832
NULL	Environ_Health_Perspect_2009_Nov_31_117(11)_1724-1729.nxml.txt.nlp	20049124	SENT33	13	13	9	9	s-adenosylmethionine	AS3MT	PA164754994	57412	0.832
NULL	Cancer_Immunol_Immunother_2013_Aug_27_62(10)_1637-1648.nxml.txt.nlp	23982484	SENT153	31	31	25	25	lenalidomide	IL-6	PA162363968	3569	0.832
NULL	Oncol_Lett_2014_May_18_7(5)_1499-1502.nxml.txt.nlp	24765164	SENT73	7	7	4	4	oxaliplatin	GSTP1	PA131285527	2950	0.832
NULL	Oncotarget_2013_Feb_26_4(2)_298-309.nxml.txt.nlp	23593653	SENT62	6	6	18	18	quinacrine	SFRP5	PA164745551	6425	0.832
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Dec_17_3(12)_e152.nxml.txt.nlp	25518025	SENT41	8	8	13	13	itraconazole	CYP2D6	PA450132	1565	0.832
NULL	Angiogenesis_2010_Dec_7_13(4)_305-315.nxml.txt.nlp	20927579	SENT126	5	5	22	22	resveratrol	p53		7157	0.832
NULL	Chemother_Res_Pract_2011_Dec_1_2011_715469.nxml.txt.nlp	22312557	SENT100	10	10	24	24	cisplatin	p53	PA449014	7157	0.832
NULL	Hum_Genomics_2011_May_1_5(4)_265-282.nxml.txt.nlp	21712189	SENT144	36	36	11	11	tenofovir	UGT1A1	PA10204	54658	0.832
NULL	Breast_Cancer_Res_2012_Aug_8_14(4)_R116.nxml.txt.nlp	22873525	SENT242	8	8	15	15	trastuzumab	HER2	PA451743	2064	0.832
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT120	19	19	11	11	doxorubicin	B7-H1	PA449412	29126	0.832
NULL	Emerg_Infect_Dis_2013_Jul_19(7)_1151-1152.nxml.txt.nlp	23763791	SENT19	35	35	19	19	pyrazinamide	DST	PA451182	667	0.832
NULL	Mol_Biol_Cell_2013_Sep_15_24(18)_2981-2989.nxml.txt.nlp	23864704	SENT210	21	21	37	37	l-glutamine	CO2	PA10090	4513	0.832
NULL	Cell_Death_Dis_2012_Mar_1_3(3)_e275.nxml.txt.nlp	22378068	SENT84	7	7	4	4	metformin	AMPK	PA450395	5563	0.832
NULL	Onco_Targets_Ther_2014_Jun_9_7_947-956.nxml.txt.nlp	24959081	SENT133	10	10	18	18	fluorescein	CD4	PA164746009	920	0.832
NULL	Ann_Rheum_Dis_2010_Jan_17_69(1)_88-96.nxml.txt.nlp	19297346	SENT6	8	8	12	12	tocilizumab	IL6	PA165292659	3569	0.832
NULL	Int_J_Hypertens_2012_Feb_8_2012_189512.nxml.txt.nlp	22518281	SENT123	9	9	19	19	hemin	RVR	PA449849	9975	0.832
NULL	Cell_Death_Dis_2014_Jan_16_5(1)_e1000.nxml.txt.nlp	24434508	SENT55	9	9	3	3	etoposide	p53	PA449552	7157	0.832
NULL	Mol_Cancer_2007_Dec_21_6_81.nxml.txt.nlp	18096084	SENT57	4	4	20	20	pp2	CD44		960	0.832
NULL	J_Oncol_2010_Jan_5_2010_257058.nxml.txt.nlp	20069126	SENT257	28	28	24	24	metformin	AMPK	PA450395	5563	0.832
NULL	Br_J_Cancer_2009_Oct_20_101(8)_1253-1260.nxml.txt.nlp	19755984	SENT131	19	19	3	3	tamoxifen	SRC-3	PA451581	8202	0.832
NULL	Br_J_Cancer_2012_Oct_9_107(8)_1409-1417.nxml.txt.nlp	23047593	SENT87	10	10	2	2	tamoxifen	MYCN	PA451581	4613	0.832
NULL	Mol_Cancer_2007_Aug_21_6_53.nxml.txt.nlp	17711579	SENT150	9	9	0	0	cisplatin	NEO1	PA449014	4756	0.832
NULL	J_Med_Chem_2014_Jan_23_57(2)_462-476.nxml.txt.nlp	24313754	SENT154	1	1	20	20	piperazine	CREBBP	PA450977	1387	0.832
NULL	Mol_Cancer_2012_Sep_25_11_73.nxml.txt.nlp	23009336	SENT167	28	28	30	30	dasatinib	PP2	PA162372878	4888	0.832
NULL	Diabetes_2009_Jan_58(1)_250-259.nxml.txt.nlp	18840786	SENT95	27	27	24	24	rosiglitazone	FGF21	PA451283	26291	0.832
NULL	Cancers_(Basel)_2012_Apr_25_4(2)_442-473.nxml.txt.nlp	24213319	SENT390	0	0	21	21	resveratrol	Bcl-2		596	0.832
NULL	Cancer_Immunol_Immunother_2012_Jul_23_61(7)_1101-1111.nxml.txt.nlp	22193989	SENT99	4	4	17	17	oxaliplatin	RANTES	PA131285527	6352	0.832
NULL	J_Virol_2014_Apr_88(7)_3664-3677.nxml.txt.nlp	24429366	SENT563	16	16	5	5	bortezomib	MAGE-C1	PA10252	9947	0.832
NULL	J_Immunol_Res_2014_Feb_10_2014_264723.nxml.txt.nlp	24741582	SENT10	23	23	18	18	rituximab	FCGR3A	PA451261	2214	0.832
NULL	Clin_Ophthalmol_2014_Jun_26_8_1213-1219.nxml.txt.nlp	25061267	SENT29	15	15	26	26	proparacaine	PRK	PA164776849	1263	0.832
NULL	Clin_Interv_Aging_2010_Nov_19_5_345-354.nxml.txt.nlp	21228900	SENT151	24	24	13	13	denosumab	PTH	PA166048634	5741	0.832
NULL	Arthritis_Res_Ther_2005_Mar_1_7(3)_R526-R535.nxml.txt.nlp	15899039	SENT260	18	18	12	12	nitroprusside	p38	PA451406	10598;1432;7965	0.832
NULL	Am_J_Physiol_Cell_Physiol_2014_Jan_15_306(2)_C89-C97.nxml.txt.nlp	24133067	SENT174	6	6	11	11	docetaxel	PC-3	PA449383	692094	0.832
NULL	Cancer_Metastasis_Rev_2011_Dec_20_30(3-4)_465-480.nxml.txt.nlp	22012553	SENT276	8	8	10	10	indomethacin	survivin	PA449982	332	0.832
NULL	J_Gastroenterol_2013_Feb_20_48(2)_177-181.nxml.txt.nlp	23254779	SENT2	22	22	26	26	buspirone	5-HT1A	PA448689	3350	0.832
NULL	Comput_Math_Methods_Med_2012_Jan_16_2012_792375.nxml.txt.nlp	22291855	SENT48	26	26	19	19	estradiol	E2F2	PA449503	1870	0.832
NULL	Oncotarget_2013_Aug_21_4(9)_1484-1495.nxml.txt.nlp	23986086	SENT132	18	18	8	8	metformin	PIK3CA	PA450395	5290	0.832
NULL	J_Neuroinflammation_2011_Dec_21_8_178.nxml.txt.nlp	22189096	SENT364	23	23	3	3	neomycin	TLR3	PA450608	7098	0.832
NULL	Arthritis_Res_Ther_2014_Jul_18_16(4)_R153.nxml.txt.nlp	25037855	SENT156	18	18	28	28	adalimumab	LTA	PA10004	4049	0.832
NULL	Arthritis_Res_Ther_2013_Feb_20_15(1)_R31.nxml.txt.nlp	23421940	SENT178	16	16	0	0	nitroprusside	IL-17	PA451406	3605	0.832
NULL	Oncologist_2010_Aug_29_15(8)_799-809.nxml.txt.nlp	20671105	SENT214	12	12	20	20	trastuzumab	HER-2	PA451743	2064	0.832
NULL	Cancer_Cell_Int_2013_Feb_12_13_14.nxml.txt.nlp	23402310	SENT192	21	21	8	8	celecoxib	p65	PA448871	5970	0.832
NULL	Ann_Surg_Treat_Res_2014_Apr_25_86(4)_220-225.nxml.txt.nlp	24783183	SENT25	2	2	14	14	sunitinib	VEGFR	PA162372840	3791	0.832
NULL	Int_J_Breast_Cancer_2012_Feb_26_2012_761917.nxml.txt.nlp	22482061	SENT190	7	7	20	20	saracatinib	HER3		2065	0.832
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Feb_10_66(Pt_3)_o568.nxml.txt.nlp	21580336	SENT56	23	23	4	4	ethanol	mol	PA448073	90527	0.832
NULL	Acta_Neuropathol_Commun_2013_Jul_17_1_39.nxml.txt.nlp	24252174	SENT143	5	5	2	2	erlotinib	Erb	PA134687924	2100	0.832
NULL	Cell_Commun_Signal_2013_Sep_18_11_69.nxml.txt.nlp	24047462	SENT34	14	14	4	4	doxorubicin	BTG2	PA449412	7832	0.832
NULL	Evid_Based_Complement_Alternat_Med_2011_Feb_10_2011_815390.nxml.txt.nlp	19752167	SENT134	28	28	7	7	hydrocortisone	IFN	PA449905	3439	0.832
NULL	Ther_Clin_Risk_Manag_2006_Mar_2(1)_87-98.nxml.txt.nlp	18360584	SENT106	5	5	2	2	sorafenib	VEGFR2	PA7000	3791	0.832
NULL	Int_J_Surg_Oncol_2012_Jun_12_2012_862879.nxml.txt.nlp	22778941	SENT6	46	46	15	15	cisplatin	c-Myc	PA449014	4609	0.832
NULL	Braz_J_Med_Biol_Res_2014_Jan_10_47(1)_11-18.nxml.txt.nlp	24519089	SENT28	12	12	23	23	lidocaine	ANG	PA450226	283	0.832
NULL	Cardiol_Res_Pract_2011_Apr_26_2011_874802.nxml.txt.nlp	21577272	SENT115	13	13	9	9	ketoconazole	CYP3A4	PA450146	1576	0.832
NULL	Oncogene_2009_Jan_15_28(2)_279-288.nxml.txt.nlp	18836480	SENT116	16	16	11	11	pp2	EGF		1950	0.832
NULL	Mol_Cancer_2009_Dec_23_8_129.nxml.txt.nlp	20030852	SENT11	14	14	30	30	curcumin	ABCA1	PA151958596	19	0.832
NULL	Braz_J_Med_Biol_Res_2013_Mar_15_46(3)_299-305.nxml.txt.nlp	23532269	SENT12	4	4	16	16	propofol	TLR4	PA451141	7099	0.832
NULL	Front_Chem_2014_Dec_23_2_113.nxml.txt.nlp	25566531	SENT217	0	0	10	10	curcumin	maspin	PA151958596	5268	0.832
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT47	17	17	5	5	nutlin-3	p53		7157	0.832
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1953-1985.nxml.txt.nlp	25268164	SENT662	11	11	1	1	temozolomide	MSH6	PA451609	2956	0.832
NULL	Lab_Invest_2010_Dec_9_90(12)_1794-1804.nxml.txt.nlp	20697377	SENT132	7	7	10	10	starch	MCD	PA451492	23417;4169;4582	0.832
NULL	Braz_J_Med_Biol_Res_2014_Mar_21_47(4)_273-278.nxml.txt.nlp	24676475	SENT73	17	17	24	24	doxorubicin	CIAPIN1	PA449412	57019	0.832
NULL	Nat_Commun_2013_Sep_17_4_2464.nxml.txt.nlp	24043118	SENT121	33	33	19	19	estradiol	TOX3	PA449503	27324	0.832
NULL	Case_Rep_Oncol_2009_Feb_26_2(1)_24-29.nxml.txt.nlp	20740141	SENT34	9	9	6	6	anastrozole	aromatase	PA448432	1588	0.832
NULL	Indian_J_Urol_2009_Oct-Dec_25(4)_427-436.nxml.txt.nlp	19955664	SENT102	9	9	27	27	temsirolimus	PTEN	PA164746890	5728	0.832
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT145	38	38	25	25	l-leucine	ATP5A	PA450197	498	0.832
NULL	Cancers_(Basel)_2014_Jul_8_6(3)_1487-1499.nxml.txt.nlp	25006835	SENT83	20	20	15	15	cisplatin	JNK	PA449014	5599	0.832
NULL	Eur_J_Clin_Pharmacol_2008_Feb_26_64(2)_133-157.nxml.txt.nlp	18224312	SENT74	17	17	12	12	clopidogrel	CYP2C19	PA449053	1557	0.832
NULL	Cancers_(Basel)_2012_Oct_29_4(4)_1146-1160.nxml.txt.nlp	24213502	SENT465	8	8	24	24	tamoxifen	ATAC	PA451581	6375	0.832
NULL	Pharmaceutics_2011_Oct_12_3(4)_680-705.nxml.txt.nlp	24309303	SENT782	2	2	13	13	gemfibrozil	SLCO1B1	PA449750	10599	0.832
NULL	Clin_Med_Insights_Oncol_2012_Nov_20_6_381-393.nxml.txt.nlp	23226079	SENT136	10	10	7	7	ketoconazole	CYP3A4	PA450146	1576	0.832
NULL	J_Inflamm_(Lond)_2005_Oct_31_2_14.nxml.txt.nlp	16259633	SENT296	5	5	15	15	staurosporine	M-CSF	PA165109623	1435	0.832
NULL	Eur_J_Epidemiol_2010_Oct_25_25(10)_677-692.nxml.txt.nlp	20872047	SENT236	16	16	12	12	l-methionine	B12	PA450423	7126;4709	0.832
NULL	Evid_Based_Complement_Alternat_Med_2013_Aug_12_2013_982689.nxml.txt.nlp	23997806	SENT224	6	6	12	12	tolbutamide	APE	PA451718	55704;328	0.832
NULL	Comb_Chem_High_Throughput_Screen_2010_Feb_13(2)_188-206.nxml.txt.nlp	20053163	SENT245	19	19	11	11	midazolam	CYP3A4	PA450496	1576	0.832
NULL	J_Gastroenterol_2013_Jan_27_48(1)_22-30.nxml.txt.nlp	23104468	SENT156	31	31	20	20	ribavirin	IL28B	PA451241	282617	0.832
NULL	Nat_Commun_2014_Dec_10_5_5715.nxml.txt.nlp	25493654	SENT252	0	0	3	3	lapatinib	EGFR	PA152241907	1956	0.832
NULL	Eur_J_Clin_Pharmacol_2012_Jan_8_68(1)_29-37.nxml.txt.nlp	21739267	SENT187	10	10	6	6	citalopram	CYP2C19	PA449015	1557	0.832
NULL	J_Exp_Med_1998_Jun_1_187(11)_1885-1892.nxml.txt.nlp	9607928	SENT113	2	2	5	5	thalidomide	IFN	PA451644	3439	0.832
NULL	Br_J_Cancer_1998_Jun_77(12)_2286-2290.nxml.txt.nlp	9649147	SENT13	7	7	0	0	vincristine	CHOP	PA451879	1649	0.832
NULL	Indian_J_Med_Res_2014_Apr_139(4)_572-578.nxml.txt.nlp	24927344	SENT78	6	6	14	14	acenocoumarol	CYP4F2	PA452632	8529	0.832
NULL	Nat_Chem_Biol_2010_Apr_28_6(4)_291-299.nxml.txt.nlp	20190765	SENT118	4	4	16	16	dasatinib	AKT	PA162372878	207	0.832
NULL	Indian_J_Psychiatry_2014_Jan_56(Suppl_1)_S63-S96.nxml.txt.nlp	NULL	SENT813	4	4	31	31	clozapine	OGC	PA449061	8402	0.832
NULL	Eur_J_Clin_Pharmacol_2010_Nov_29_66(11)_1131-1136.nxml.txt.nlp	20669013	SENT140	5	5	21	21	erythromycin	CYP2C19	PA449493	1557	0.832
NULL	Environ_Health_Perspect_2005_Aug_20_113(8)_1022-1026.nxml.txt.nlp	16079073	SENT24	27	27	29	29	diethylstilbestrol	DES	PA449307	1674	0.832
NULL	Br_J_Cancer_2011_Nov_22_105(11)_1654-1662.nxml.txt.nlp	22045187	SENT151	6	6	13	13	irinotecan	MTHFR	PA450085	4524	0.832
NULL	Cancer_Manag_Res_2013_Jun_27_5_133-146.nxml.txt.nlp	23869177	SENT124	19	19	22	22	lapatinib	EGFR	PA152241907	1956	0.832
NULL	Evid_Based_Complement_Alternat_Med_2013_May_13_2013_506324.nxml.txt.nlp	23818927	SENT182	9	9	30	30	doxorubicin	STAT3	PA449412	6774	0.832
NULL	Ann_Hematol_2015_Aug_3_94_35-43.nxml.txt.nlp	25085377	SENT242	15	15	17	17	rituximab	CHOP	PA451261	1649	0.832
NULL	Breast_Cancer_Res_2007_Aug_16_9(4)_305.nxml.txt.nlp	17705882	SENT7	30	30	8	8	tamoxifen	aromatase	PA451581	1588	0.832
NULL	Ann_Clin_Transl_Neurol_2014_Mar_4_1(3)_199-208.nxml.txt.nlp	25356398	SENT26	25	25	8	8	reserpine	LRRK2	PA451236	120892	0.832
NULL	Breast_Cancer_(Auckl)_2012_Mar_7_6_67-77.nxml.txt.nlp	22438669	SENT168	29	29	21	21	capecitabine	HER2	PA448771	2064	0.832
NULL	BMB_Rep_2014_Jul_47(7)_393-398.nxml.txt.nlp	24314142	SENT118	6	6	31	31	dipyridamole	NHE	PA449367	285335	0.832
NULL	Curr_Neuropharmacol_2008_Sep_6(3)_193-202.nxml.txt.nlp	19506720	SENT177	39	39	30	30	mirtazapine	ghrelin	PA450522	51738	0.832
NULL	Cancer_Med_2012_Dec_26_1(3)_318-327.nxml.txt.nlp	23342281	SENT142	2	2	4	4	tamoxifen	aromatase	PA451581	1588	0.832
NULL	Biosci_Rep_2012_Aug_1_32(Pt_4)_361-374.nxml.txt.nlp	22762204	SENT184	17	17	33	33	doxorubicin	PUMA	PA449412	27113	0.832
NULL	Biochem_Biophys_Res_Commun_2008_Sep_5_373(4)_584-588.nxml.txt.nlp	18586007	SENT94	26	26	33	33	curcumin	HO-1	PA151958596	3162	0.832
NULL	Mol_Brain_2014_Apr_22_7_29.nxml.txt.nlp	24754922	SENT24	7	7	11	11	paraformaldehyde	LRRK2	PA450790	120892	0.832
NULL	Ther_Clin_Risk_Manag_2007_Aug_3(4)_665-673.nxml.txt.nlp	18472989	SENT60	6	6	19	19	lapatinib	survivin	PA152241907	332	0.832
NULL	Int_J_Biomed_Sci_2014_Dec_10(4)_258-264.nxml.txt.nlp	25598757	SENT160	9	9	15	15	losartan	LOX-1	PA450268	4973	0.832
NULL	Mol_Biol_Cell_2014_Jun_1_25(11)_1782-1792.nxml.txt.nlp	24719457	SENT110	0	0	8	8	nicotine	p53	PA450626	7157	0.832
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT147	11	11	17	17	capsaicin	p53	PA448776	7157	0.832
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT293	12	12	18	18	curcumin	Bcl-2	PA151958596	596	0.832
NULL	Leukemia_2014_Aug_4_28(8)_1573-1585.nxml.txt.nlp	24496300	SENT220	10	10	4	4	fluvoxamine	CYP1A2	PA449690	1544	0.832
NULL	J_Nat_Sci_Biol_Med_2012_Jan-Jun_3(1)_65-70.nxml.txt.nlp	22690054	SENT106	20	20	3	3	lipase	PPL	PA450239	5493	0.832
NULL	Br_J_Pharmacol_2014_Oct_26_171(20)_4785-4796.nxml.txt.nlp	25074741	SENT5	13	13	19	19	guanfacine	NK1R	PA449825	6869	0.832
NULL	Eur_J_Cancer_2014_Sep_50(14)_2367-2374.nxml.txt.nlp	25027307	SENT135	12	12	9	9	tamoxifen	aromatase	PA451581	1588	0.832
NULL	Exp_Ther_Med_2013_Aug_6_6(2)_427-434.nxml.txt.nlp	24137203	SENT196	17	17	2	2	fosinopril	MCP-1	PA449710	6347	0.832
NULL	Cancers_(Basel)_2013_Nov_8_5(4)_1469-1484.nxml.txt.nlp	24217114	SENT38	17	17	2	2	temozolomide	HK2	PA451609	3796;3099;29911;3741	0.832
NULL	Cancer_Immunol_Immunother_2014_Feb_11_63(5)_419-435.nxml.txt.nlp	24514955	SENT57	31	31	42	42	sorafenib	IL-12B	PA7000	3593	0.832
NULL	Indian_J_Endocrinol_Metab_2011_Sep_15(Suppl3)_S188-S196.nxml.txt.nlp	22029023	SENT249	28	28	17	17	metyrapone	ACTH	PA450486	5443	0.832
NULL	Adv_Hematol_2012_Feb_6_2012_485943.nxml.txt.nlp	22400030	SENT181	13	13	20	20	pentamidine	CD4	PA450850	920	0.832
NULL	Nat_Genet_2011_Feb_26_43(2)_153-158.nxml.txt.nlp	21186352	SENT88	5	5	3	3	geldanamycin	Hsp90	PA152031327	3320	0.832
NULL	J_Exp_Bot_2011_Oct_4_62(14)_4787-4803.nxml.txt.nlp	21821598	SENT21	23	23	16	16	mannitol	M6PR	PA450320	4074	0.832
NULL	Cancer_Cell_Int_2011_Jun_1_11_15.nxml.txt.nlp	21631944	SENT148	8	8	2	2	etoposide	MICB	PA449552	4277	0.832
NULL	Vet_Res_2013_Oct_2_44(1)_89.nxml.txt.nlp	24088531	SENT190	5	5	14	14	hemin	HO-1	PA449849	3162	0.832
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT7	0	0	9	9	curcumin	survivin	PA151958596	332	0.832
NULL	Angiogenesis_2012_Jun_2_15(2)_275-286.nxml.txt.nlp	22382585	SENT42	6	6	18	18	metoclopramide	CTX	PA450475	1593	0.832
NULL	Mol_Cancer_2007_Oct_22_6_66.nxml.txt.nlp	17953743	SENT122	12	12	8	8	cisplatin	TRAIL	PA449014	8743	0.832
NULL	Mol_Cancer_2010_Aug_23_9_222.nxml.txt.nlp	20731837	SENT185	2	2	5	5	cetuximab	EGFR	PA10040	1956	0.832
NULL	Scientifica_(Cairo)_2012_Nov_25_2012_473829.nxml.txt.nlp	24278698	SENT242	18	18	25	25	oxaliplatin	ATP7A	PA131285527	538	0.832
NULL	Cancer_Cell_Int_2013_Jun_26_13_63.nxml.txt.nlp	23800022	SENT135	2	2	4	4	genistein	MDM2	PA165109660	4193	0.832
NULL	Ann_Hematol_2011_Feb_17_90(2)_173-183.nxml.txt.nlp	20714724	SENT231	3	3	13	13	resveratrol	CD95		355	0.832
NULL	J_Korean_Med_Sci_2013_Nov_31_28(11)_1595-1602.nxml.txt.nlp	24265521	SENT20	16	16	12	12	gefitinib	EGFR	PA131301952	1956	0.832
NULL	Leukemia_2014_Mar_13_28(3)_600-608.nxml.txt.nlp	24240203	SENT195	32	32	16	16	nutlin-3	p53		7157	0.832
NULL	Diabetes_Care_2013_Jul_12_36(7)_1913-1918.nxml.txt.nlp	23359361	SENT141	4	4	27	27	sitagliptin	GLP-1	PA164748978	100125288	0.832
NULL	Evid_Based_Complement_Alternat_Med_2014_Sep_3_2014_809083.nxml.txt.nlp	25276218	SENT7	11	11	5	5	berberine	IRAK	PA165860812	3654	0.832
NULL	Acta_Pharmacol_Sin_2012_Aug_23_33(8)_1095-1100.nxml.txt.nlp	22820908	SENT31	20	20	12	12	ilaprazole	CYP3A5	PA165947499	1577	0.832
NULL	Br_J_Cancer_2012_Sep_4_107(6)_947-955.nxml.txt.nlp	22892392	SENT37	1	1	8	8	tamoxifen	ERBB2	PA451581	2064	0.832
NULL	Br_J_Cancer_2012_Sep_25_107(7)_1044-1050.nxml.txt.nlp	22910317	SENT147	16	16	31	31	bevacizumab	CD31	PA130232992	5175	0.832
NULL	Br_J_Cancer_2000_Jun_82(11)_1827-1834.nxml.txt.nlp	10839298	SENT10	11	11	4	4	camptothecin	JNK1	PA153590860	5599	0.832
NULL	Biomed_Res_Int_2013_Jul_1_2013_964743.nxml.txt.nlp	23936861	SENT81	4	4	7	7	sorafenib	EGFR	PA7000	1956	0.831
NULL	Ann_Hematol_2010_Nov_25_89(11)_1115-1124.nxml.txt.nlp	20499237	SENT149	17	17	22	22	simvastatin	ZAP-70	PA451363	7535	0.831
NULL	Am_J_Case_Rep_2012_Jan_4_13_1-2.nxml.txt.nlp	23569471	SENT65	4	4	47	47	bevacizumab	LBA1	PA130232992	9881	0.831
NULL	Br_J_Cancer_2011_Apr_12_104(8)_1256-1261.nxml.txt.nlp	21448165	SENT154	18	18	12	12	sorafenib	IL-2	PA7000	3558	0.831
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT269	6	6	18	18	metformin	HIP	PA450395	6767;6159;64399;5068	0.831
NULL	Biomed_Res_Int_2013_Nov_10_2013_190178.nxml.txt.nlp	24312907	SENT63	26	26	0	0	heparin	PAPP-A	PA449855	5069	0.831
NULL	Ann_Oncol_2010_Feb_21(2)_217-222.nxml.txt.nlp	20110292	SENT131	11	11	18	18	erlotinib	KRAS	PA134687924	3845	0.831
NULL	Clin_Med_Insights_Cardiol_2011_Jun_28_5_55-66.nxml.txt.nlp	21792345	SENT90	0	0	22	22	carvedilol	BEST	PA448817	7439	0.831
NULL	Acta_Pharmacol_Sin_2012_Aug_23_33(8)_1095-1100.nxml.txt.nlp	22820908	SENT113	17	17	11	11	ilaprazole	CYP2C19	PA165947499	1557	0.831
NULL	Diabetes_2011_Nov_17_60(11)_2691-2700.nxml.txt.nlp	21896928	SENT265	14	14	22	22	resveratrol	AMPK		5563	0.831
NULL	J_Oncol_2013_Feb_17_2013_872957.nxml.txt.nlp	23476648	SENT136	19	19	16	16	cisplatin	SFN	PA449014	25996;2810	0.831
NULL	Breast_Cancer_Res_2008_Jul_24_10(4)_211.nxml.txt.nlp	18671839	SENT231	16	16	4	4	lapatinib	HER2	PA152241907	2064	0.831
NULL	J_Cell_Mol_Med_2014_Aug_1_18(8)_1599-1611.nxml.txt.nlp	24889822	SENT306	8	8	16	16	resveratrol	SIRT1		23411	0.831
NULL	J_Oncol_2010_Sep_16_2010_414726.nxml.txt.nlp	20886020	SENT39	12	12	10	10	cyclophosphamide	CHOP	PA449165	1649	0.831
NULL	Clin_Interv_Aging_2012_Dec_30_7_1-13.nxml.txt.nlp	22291468	SENT267	31	31	15	15	ritonavir	CYP3A4	PA451260	1576	0.831
NULL	Clin_Ophthalmol_2012_Aug_15_6_1315-1319.nxml.txt.nlp	22969276	SENT19	33	33	26	26	travoprost	BAK	PA164781371	578	0.831
NULL	Evid_Based_Complement_Alternat_Med_2014_Jul_7_2014_902516.nxml.txt.nlp	25097660	SENT166	2	2	6	6	fluoxetine	CORT	PA449673	1325	0.831
NULL	Oncotarget_2014_Mar_13_5(4)_1101-1110.nxml.txt.nlp	24658355	SENT119	33	33	13	13	tamoxifen	MKP-1	PA451581	1843	0.831
NULL	Oncotarget_2014_Oct_15_5(21)_10763-10777.nxml.txt.nlp	25333257	SENT35	28	28	16	16	oxaliplatin	FasL	PA131285527	356	0.831
NULL	Biosci_Rep_2014_Dec_12_34(6)_e00160.nxml.txt.nlp	25495645	SENT96	2	2	9	9	fenofibrate	ANGPTL3	PA449594	27329	0.831
NULL	Br_J_Cancer_2009_Jan_27_100(2)_251-258.nxml.txt.nlp	19165196	SENT22	13	13	19	19	oxaliplatin	ACRC	PA131285527	93953	0.831
NULL	Oncogene_2010_Jul_22_29(29)_4170-4182.nxml.txt.nlp	20498638	SENT11	41	41	4	4	cetuximab	EGF	PA10040	1950	0.831
NULL	Oxid_Med_Cell_Longev_2012_Apr_5_2012_983427.nxml.txt.nlp	22550557	SENT167	6	6	24	24	ethanol	MOF	PA448073	84148	0.831
NULL	Cancer_Cell_Int_2013_Jun_26_13_63.nxml.txt.nlp	23800022	SENT118	23	23	7	7	genistein	BCL2	PA165109660	596	0.831
NULL	J_Anaesthesiol_Clin_Pharmacol_2012_Jul-Sep_28(3)_339-343.nxml.txt.nlp	22869941	SENT80	6	6	16	16	fentanyl	STA	PA449599	2010;2656	0.831
NULL	Nat_Commun_2013_Nov_18_4_2799.nxml.txt.nlp	24240988	SENT241	19	19	31	31	sorafenib	ATG7	PA7000	10533	0.831
NULL	Drug_Des_Devel_Ther_2014_Dec_1_8_2391-2400.nxml.txt.nlp	25489237	SENT171	17	17	13	13	liraglutide	GLP-1	PA165958364	100125288	0.831
NULL	EPMA_J_2012_Sep_27_3(1)_10.nxml.txt.nlp	23016735	SENT143	27	27	16	16	warfarin	CYP4F2	PA451906	8529	0.831
NULL	J_Adv_Pract_Oncol_2014_Jan_1_Jan-Feb_5(1)_31-41.nxml.txt.nlp	25032031	SENT21	23	23	25	25	diethylstilbestrol	DES	PA449307	1674	0.831
NULL	Amyloid_2014_Sep_11_21(3)_175-184.nxml.txt.nlp	24918964	SENT106	11	11	16	16	anakinra	TTR	PA10799	7276	0.831
NULL	J_Gen_Physiol_1997_Dec_1_110(6)_643-654.nxml.txt.nlp	9382893	SENT8	19	19	9	9	diazoxide	SUR1	PA449285	6833	0.831
NULL	Cancer_Cell_Int_2013_Jun_10_13_58.nxml.txt.nlp	23758737	SENT41	0	0	14	14	rituximab	CHOP	PA451261	1649	0.831
NULL	J_Hematol_Oncol_2012_Feb_14_5_3.nxml.txt.nlp	22333219	SENT168	25	25	32	32	vemurafenib	BRAF	PA165946873	673	0.831
NULL	Br_J_Haematol_2014_Mar_13_164(1)_811-821.nxml.txt.nlp	24328678	SENT136	6	6	21	21	lenalidomide	Aiolos	PA162363968	22806	0.831
NULL	Cardiol_Ther_2013_Jun_7_2(1)_57-68.nxml.txt.nlp	25135289	SENT41	3	3	0	0	clopidogrel	P2Y12	PA449053	64805	0.831
NULL	Oncotarget_2012_Nov_17_3(12)_1600-1614.nxml.txt.nlp	23307622	SENT61	21	21	15	15	trastuzumab	HER2	PA451743	2064	0.831
NULL	Clinics_(Sao_Paulo)_2014_Feb_69(2)_145-149.nxml.txt.nlp	24519206	SENT148	12	12	9	9	olmesartan	AT1	PA164742950	9197;185	0.831
NULL	Arch_Gynecol_Obstet_2013_Apr_13_288(4)_889-899.nxml.txt.nlp	23584885	SENT220	5	5	14	14	sorafenib	TRAIL	PA7000	8743	0.831
NULL	Core_Evid_2009_Jun_15_4_149-158.nxml.txt.nlp	20694071	SENT236	14	14	3	3	maraviroc	CYP3A4	PA164768835	1576	0.831
NULL	Environ_Health_Perspect_1983_Mar_49_51-58.nxml.txt.nlp	6832097	SENT6	12	12	14	14	phenobarbital	DDT	PA450911	1652	0.831
NULL	Breast_Cancer_Res_2011_May_19_13(3)_R52.nxml.txt.nlp	21595894	SENT320	27	27	14	14	tamoxifen	EGFR	PA451581	1956	0.831
NULL	Br_J_Cancer_2012_Feb_28_106(5)_916-922.nxml.txt.nlp	22333602	SENT119	17	17	20	20	doxorubicin	HER2	PA449412	2064	0.831
NULL	Diabetes_Metab_Syndr_Obes_2010_Jul_9_3_227-242.nxml.txt.nlp	21437091	SENT179	16	16	9	9	sitagliptin	PPG	PA164748978	5552	0.831
NULL	Aging_(Albany_NY)_2012_Mar_4_4(3)_144-145.nxml.txt.nlp	22388573	SENT13	7	7	9	9	resveratrol	AMPK		5563	0.831
NULL	Clin_Pharmacokinet_2014_Aug_21_53(10)_931-941.nxml.txt.nlp	25141974	SENT178	6	6	10	10	triazolam	CYP3A	PA451753	1574	0.831
NULL	Int_J_Fertil_Steril_2014_Dec_22_Jan-Mar_7(4)_331-336.nxml.txt.nlp	24520503	SENT95	27	27	35	35	flutamide	adiponectin	PA449685	9370	0.831
NULL	Acta_Pharmacol_Sin_2009_Jun_5_30(6)_859-867.nxml.txt.nlp	19498425	SENT19	0	0	16	16	carbachol	CA3	PA448784	761	0.831
NULL	Hematol_Rep_2011_Aug_1_3(2)_e9.nxml.txt.nlp	22184541	SENT46	16	16	10	10	ifosfamide	SMILE	PA449964	160418	0.831
NULL	Front_Immunol_2013_Oct_28_4_346.nxml.txt.nlp	24194739	SENT70	26	26	2	2	vemurafenib	ACT	PA165946873	12;11332;9457;641455	0.831
NULL	J_Headache_Pain_2008_Oct_31_9(5)_277-288.nxml.txt.nlp	18668199	SENT78	5	5	0	0	propranolol	Yes	PA451145	7525	0.831
NULL	Breast_Cancer_Res_2011_Dec_16_13(6)_R131.nxml.txt.nlp	22177475	SENT12	13	13	46	46	erlotinib	AKT	PA134687924	207	0.831
NULL	Arthritis_Res_Ther_2013_Jul_9_15(4)_R73.nxml.txt.nlp	23837669	SENT249	3	3	13	13	colchicine	MICL	PA449092	160364	0.831
NULL	Mol_Cancer_2008_Aug_7_7_65.nxml.txt.nlp	18687124	SENT255	20	20	5	5	thrombin	RPA2	PA451674	6118;84172	0.831
NULL	Biochemistry_2014_Sep_16_53(36)_5804-5809.nxml.txt.nlp	25153692	SENT29	14	14	18	18	acetone	K19	PA448025	3880	0.831
NULL	Cancer_Manag_Res_2013_Nov_21_5_387-400.nxml.txt.nlp	24294007	SENT75	39	39	35	35	cetuximab	KRAS	PA10040	3845	0.831
NULL	Br_J_Cancer_2012_Jun_26_107(1)_53-62.nxml.txt.nlp	22677907	SENT33	11	11	29	29	bortezomib	PC-3	PA10252	692094	0.831
NULL	Mol_Imaging_Biol_2009_Sep_27_11(5)_364-368.nxml.txt.nlp	19326174	SENT15	13	13	0	0	diazepam	FDG	PA449283	23583	0.831
NULL	Gene_Regul_Syst_Bio_2014_Mar_4_8_63-73.nxml.txt.nlp	24634581	SENT98	0	0	9	9	minocycline	STAT3	PA450519	6774	0.831
NULL	Int_J_Fertil_Steril_2012_Jun_19_Apr-Jun_6(1)_31-36.nxml.txt.nlp	25505509	SENT8	19	19	21	21	metformin	Met	PA450395	79811	0.831
NULL	Breast_Cancer_Res_2010_Jun_28_12(3)_R43.nxml.txt.nlp	20579400	SENT116	45	45	25	25	doxorubicin	MAPT	PA449412	4137	0.831
NULL	Cell_Death_Dis_2014_Feb_27_5(2)_e1086.nxml.txt.nlp	24577084	SENT162	6	6	12	12	doxycycline	MLKL	PA449415	197259	0.831
NULL	Cancer_Cell_Int_2013_Mar_4_13_21.nxml.txt.nlp	23497288	SENT160	11	11	8	8	etoposide	EWS	PA449552	2130	0.831
NULL	Gut_Pathog_2012_Nov_30_4_16.nxml.txt.nlp	23194438	SENT65	9	9	7	7	chloramphenicol	UGT	PA448927	7361;7355	0.831
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT159	14	14	11	11	raltegravir	SLC22A6		9356	0.831
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2013_Dec_8_6_75-79.nxml.txt.nlp	24348081	SENT72	8	8	13	13	colesevelam	TGR5	PA449095	151306	0.831
NULL	Clin_Ophthalmol_2009_Jun_2_3_199-210.nxml.txt.nlp	19668566	SENT84	31	31	9	9	bromfenac	COX	PA448670	1351	0.831
NULL	Sci_Rep_2014_Dec_16_4_7500.nxml.txt.nlp	25511254	SENT121	8	8	26	26	hyperforin	NHE	PA165985514	285335	0.831
NULL	Oncoimmunology_2013_Jan_1_2(1)_e22890.nxml.txt.nlp	23483066	SENT49	4	4	19	19	vemurafenib	IFN	PA165946873	3439	0.831
NULL	Arthritis_Res_Ther_2006_Nov_14_8(6)_R170.nxml.txt.nlp	17101062	SENT39	25	25	44	44	collagenase	CO2	PA449107	4513	0.831
NULL	Osteoporos_Int_2012_Feb_4_23(Suppl_1)_S1-S23.nxml.txt.nlp	22311111	SENT388	13	13	10	10	tamoxifen	STAR	PA451581	6770;2984	0.831
NULL	Cancers_(Basel)_2013_May_27_5(2)_617-638.nxml.txt.nlp	24216994	SENT292	7	7	21	21	curcumin	MMP9	PA151958596	4318	0.831
NULL	Cancer_Cell_Int_2009_Jan_8_9_3.nxml.txt.nlp	19128511	SENT96	9	9	6	6	oxaliplatin	PI3K	PA131285527	5290	0.831
NULL	Cancers_(Basel)_2014_Sep_5_6(3)_1769-1792.nxml.txt.nlp	25198391	SENT93	14	14	2	2	imatinib	SOCS-3	PA10804	9021	0.831
NULL	Indian_J_Endocrinol_Metab_2012_Jul-Aug_16(4)_525-527.nxml.txt.nlp	22837910	SENT24	5	5	20	20	exenatide	GLP-1	PA164749238	100125288	0.831
NULL	JAKSTAT_2013_Jan_1_2(1)_e23576.nxml.txt.nlp	24058797	SENT57	13	13	7	7	staurosporine	IFN	PA165109623	3439	0.831
NULL	Biochimie_2010_Nov_92(11)_1546-1567.nxml.txt.nlp	20615447	SENT44	43	43	22	22	chymotrypsin	KLK1	PA448994	3816	0.831
NULL	Bioimpacts_2014_Sep_21_4(3)_113-116.nxml.txt.nlp	25337463	SENT71	32	32	3	3	lipase	MCU	PA450239	90550	0.831
NULL	J_Exp_Clin_Cancer_Res_2009_Jul_3_28(1)_97.nxml.txt.nlp	19575783	SENT132	22	22	30	30	doxorubicin	HER2	PA449412	2064	0.831
NULL	Biomed_Res_Int_2014_Jan_6_2014_520763.nxml.txt.nlp	24527450	SENT98	19	19	27	27	naringenin	CD4	PA151958361	920	0.831
NULL	Aging_(Albany_NY)_2012_Mar_12_4(3)_146-158.nxml.txt.nlp	22436213	SENT58	8	8	20	20	resveratrol	AMPK		5563	0.831
NULL	J_Hematol_Oncol_2013_Jul_9_6_49.nxml.txt.nlp	23837843	SENT83	2	2	13	13	cyclosporine	ABCG2	PA449167	9429	0.831
NULL	FASEB_J_2011_Apr_25(4)_1133-1144.nxml.txt.nlp	21163859	SENT272	0	0	12	12	imipramine	ASM	PA449969	6609;283120	0.831
NULL	Ann_Hematol_2014_Apr_1_93(8)_1371-1380.nxml.txt.nlp	24687382	SENT32	7	7	12	12	lenalidomide	IKZF3	PA162363968	22806	0.831
NULL	ScientificWorldJournal_2013_Jun_19_2013_174392.nxml.txt.nlp	23853530	SENT171	25	25	16	16	doxazosin	PC-3	PA449407	692094	0.831
NULL	Breast_Cancer_Res_2004_Jun_29_6(5)_R488-R498.nxml.txt.nlp	15318931	SENT196	8	8	19	19	estradiol	SULT1A1	PA449503	6817	0.831
NULL	Cancer_Metastasis_Rev_2010_Sep_24_29(3)_465-482.nxml.txt.nlp	20730632	SENT329	8	8	23	23	genistein	TRAMP	PA165109660	8718;23471;9189	0.831
NULL	Environ_Health_Perspect_1998_Jan_106(1)_23-26.nxml.txt.nlp	9417770	SENT5	1	1	33	33	estradiol	mol	PA449503	90527	0.831
NULL	J_Adv_Pract_Oncol_2012_May_1_May-Jun_3(3)_161-169.nxml.txt.nlp	25031942	SENT309	8	8	15	15	paclitaxel	TIC	PA450761	23550	0.831
NULL	Oncol_Lett_2013_Feb_9_5(2)_552-558.nxml.txt.nlp	23420128	SENT9	8	8	14	14	imatinib	KIT	PA10804	3815	0.831
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT172	13	13	18	18	metformin	AMPK	PA450395	5563	0.831
NULL	Br_J_Cancer_2010_Nov_2_103(11)_1671-1679.nxml.txt.nlp	21045835	SENT114	15	15	4	4	gemcitabine	CXCL12	PA449748	6387	0.831
NULL	Cancers_(Basel)_2014_Mar_26_6(2)_708-722.nxml.txt.nlp	24675568	SENT142	13	13	7	7	paclitaxel	STAT3	PA450761	6774	0.831
NULL	Int_J_Mol_Sci_2014_Sep_30_15(10)_17686-17704.nxml.txt.nlp	25272226	SENT103	15	15	18	18	cetuximab	EGFR	PA10040	1956	0.831
NULL	Onco_Targets_Ther_2014_Mar_24_7_491-500.nxml.txt.nlp	24711706	SENT97	33	33	11	11	trastuzumab	DM1	PA451743	338023;1760;28509	0.831
NULL	Virol_J_2011_Sep_21_8_445.nxml.txt.nlp	21936899	SENT14	12	12	10	10	ribavirin	IFN	PA451241	3439	0.831
NULL	J_Clin_Biochem_Nutr_2010_Mar_27_46(2)_126-134.nxml.txt.nlp	20216945	SENT64	29	29	22	22	taurine	NAC	PA451590	22861	0.831
NULL	Br_J_Pharmacol_2014_Oct_26_171(20)_4785-4796.nxml.txt.nlp	25074741	SENT230	0	0	28	28	guanfacine	NK1	PA449825	11126	0.831
NULL	J_Obes_2011_Dec_15_2011_928165.nxml.txt.nlp	21197151	SENT55	3	3	18	18	orlistat	GIT	PA164776864	5034	0.831
NULL	Acta_Neuropathol_Commun_2014_Feb_28_2_25.nxml.txt.nlp	24581221	SENT52	20	20	5	5	trypsin	E14	PA451806	4863	0.831
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S279-S284.nxml.txt.nlp	21525469	SENT44	0	0	12	12	exenatide	GLP-1	PA164749238	100125288	0.831
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT146	13	13	4	4	sulindac	survivin	PA451565	332	0.831
NULL	J_Mol_Signal_2008_Dec_1_3_18.nxml.txt.nlp	19046439	SENT68	11	11	32	32	metformin	CDK2	PA450395	1017	0.831
NULL	Scientifica_(Cairo)_2014_Aug_19_2014_901586.nxml.txt.nlp	25215263	SENT101	8	8	5	5	ketoconazole	CYP3A4	PA450146	1576	0.831
NULL	Apoptosis_2013_Oct_6_18(12)_1513-1525.nxml.txt.nlp	24096434	SENT5	20	20	32	32	staurosporine	PHB	PA165109623	5245	0.831
NULL	Curr_Neuropharmacol_2008_Sep_6(3)_215-234.nxml.txt.nlp	19506722	SENT73	15	15	7	7	paroxetine	5-HT1B	PA450801	3351	0.831
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT173	8	8	18	18	pertuzumab	HER2		2064	0.831
NULL	Breast_Cancer_Res_2004_Mar_11_6(3)_109-118.nxml.txt.nlp	15084231	SENT90	29	29	15	15	tamoxifen	SRC-3	PA451581	8202	0.831
NULL	J_Cell_Biol_2001_Mar_5_152(5)_971-984.nxml.txt.nlp	11238453	SENT407	11	11	19	19	thrombin	p85	PA451674	5296;5295;54776;23368	0.831
NULL	Ann_Hematol_2010_Sep_13_89(9)_861-871.nxml.txt.nlp	20387067	SENT180	33	33	19	19	dasatinib	IL-3	PA162372878	3562	0.831
NULL	Int_J_Environ_Res_Public_Health_2011_Jun_25_8(6)_1792-1804.nxml.txt.nlp	21776202	SENT318	15	15	2	2	oseltamivir	HCE1	PA450721	8732	0.831
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1709-1716.nxml.txt.nlp	19844235	SENT227	22	22	25	25	gemcitabine	B7-H3	PA449748	80381	0.831
NULL	Br_J_Cancer_2012_Feb_14_106(4)_756-762.nxml.txt.nlp	22333708	SENT5	35	35	5	5	mitomycin	DSG1	PA450524	1828	0.831
NULL	Arthritis_Res_Ther_2003_Sep_12_5(Suppl_3)_145.nxml.txt.nlp	NULL	SENT4	6	6	30	30	forskolin	IL-16	PA146096022	3603	0.831
NULL	Protein_J_2012_Aug_5_31(6)_511-518.nxml.txt.nlp	22763563	SENT110	14	14	23	23	fluorescein	MSR1	PA164746009	4481	0.831
NULL	Chem_Cent_J_2013_Sep_16_7_155.nxml.txt.nlp	24041114	SENT23	0	0	4	4	naringenin	mol	PA151958361	90527	0.831
NULL	Pediatr_Blood_Cancer_2012_Sep_59(3)_576-579.nxml.txt.nlp	22038978	SENT88	12	12	18	18	dasatinib	BTK	PA162372878	695	0.831
NULL	Int_J_Alzheimers_Dis_2012_Apr_4_2012_258454.nxml.txt.nlp	22548198	SENT70	30	30	38	38	estradiol	CEE	PA449503	51608	0.831
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_315-322.nxml.txt.nlp	20049735	SENT62	28	28	17	17	paclitaxel	PTEN	PA450761	5728	0.831
NULL	Oncotarget_2014_Jun_1_5(13)_4868-4880.nxml.txt.nlp	24947902	SENT203	6	6	19	19	afatinib	HER2	PA165981154	2064	0.831
NULL	Oncotarget_2010_Oct_22_1(7)_530-543.nxml.txt.nlp	21317449	SENT115	11	11	23	23	everolimus	PTEN	PA164746311	5728	0.831
NULL	Br_J_Pharmacol_2011_May_163(1)_141-172.nxml.txt.nlp	21265830	SENT263	7	7	3	3	fluorescein	IL-13	PA164746009	3596	0.831
NULL	Oncotarget_2012_Nov_17_4(1)_18-28.nxml.txt.nlp	23248157	SENT89	8	8	12	12	pargyline	U87	PA450797	677775;641648	0.831
NULL	Infect_Agent_Cancer_2012_Apr_19_7(Suppl_1)_P32.nxml.txt.nlp	NULL	SENT7	6	6	25	25	bortezomib	CHOP10	PA10252	1649	0.831
NULL	J_Cell_Biol_2003_Aug_18_162(4)_587-597.nxml.txt.nlp	12913114	SENT153	19	19	0	0	etoposide	p53	PA449552	7157	0.831
NULL	BMJ_Open_2013_Nov_8_3(11)_e003659.nxml.txt.nlp	24213096	SENT217	12	12	18	18	eplerenone	Rho	PA164749044	29984	0.831
NULL	BMJ_2011_Aug_4_343_d4588.nxml.txt.nlp	21816733	SENT287	32	32	21	21	clopidogrel	CYP2C19	PA449053	1557	0.831
NULL	Front_Pharmacol_2014_Oct_31_5_231.nxml.txt.nlp	25400580	SENT232	41	41	9	9	ethanol	Munc13-1	PA448073	23025	0.831
NULL	Vet_Res_2012_Jun_27_43(1)_54.nxml.txt.nlp	22738036	SENT99	3	3	21	21	mitomycin	CO2	PA450524	4513	0.831
NULL	Ann_Rheum_Dis_2011_Oct_12_71(4)_541-548.nxml.txt.nlp	21994233	SENT157	5	5	1	1	infliximab	IMPACT	PA452639	55364	0.831
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT209	10	10	19	19	bevacizumab	VEGFR2	PA130232992	3791	0.831
NULL	Ann_Hematol_2010_Oct_22_89(10)_971-978.nxml.txt.nlp	20567823	SENT99	11	11	1	1	filgrastim	CD34	PA449626	947	0.831
NULL	EJC_Suppl_2013_Sep_5_11(2)_3-22.nxml.txt.nlp	NULL	SENT338	20	20	4	4	tamoxifen	B14	PA451581	4700	0.831
NULL	Oncotarget_2012_Sep_28_3(10)_1169-1181.nxml.txt.nlp	23045411	SENT132	13	13	8	8	doxorubicin	JIP1	PA449412	9479	0.831
NULL	Archaea_2011_Oct_10_2011_693253.nxml.txt.nlp	22007151	SENT108	24	24	9	9	glucosamine	MT3	PA164747613	4504	0.831
NULL	Mol_Cancer_2008_Jun_5_7_50.nxml.txt.nlp	18534018	SENT97	18	18	12	12	bortezomib	p38	PA10252	10598;1432;7965	0.831
NULL	Breast_Cancer_Res_2007_Dec_20_9(Suppl_2)_S13.nxml.txt.nlp	NULL	SENT49	25	25	2	2	tamoxifen	IMPACT	PA451581	55364	0.831
NULL	Front_Immunol_2012_Jun_12_3_150.nxml.txt.nlp	22701456	SENT154	4	4	1	1	capsaicin	TRPV1	PA448776	7442	0.831
NULL	Br_J_Cancer_2012_Apr_10_106(8)_1395-1405.nxml.txt.nlp	22460269	SENT213	0	0	3	3	sulindac	ABCB1	PA451565	5243	0.831
NULL	Mol_Cancer_2014_Jun_4_13_141.nxml.txt.nlp	24894453	SENT22	28	28	1	1	cetuximab	EGFR	PA10040	1956	0.831
NULL	Oncol_Lett_2014_Mar_16_7(3)_827-833.nxml.txt.nlp	24527090	SENT169	13	13	8	8	cisplatin	IFN	PA449014	3439	0.831
NULL	BMJ_Open_2013_Sep_25_3(9)_e003054.nxml.txt.nlp	24071458	SENT69	15	15	6	6	paraformaldehyde	CD40	PA450790	958	0.831
NULL	Front_Oncol_2014_Oct_13_4_229.nxml.txt.nlp	25353005	SENT72	16	16	7	7	gefitinib	EGFR	PA131301952	1956	0.831
NULL	Br_J_Pharmacol_2008_Dec_25_155(7)_1056-1065.nxml.txt.nlp	18724386	SENT257	39	39	27	27	diazoxide	GLP-1	PA449285	100125288	0.831
NULL	Oxid_Med_Cell_Longev_2013_Jul_9_2013_574029.nxml.txt.nlp	23936610	SENT298	4	4	11	11	resveratrol	p50		958;4790	0.831
NULL	Nat_Biotechnol_2010_Jul_20_28(7)_727-732.nxml.txt.nlp	20562863	SENT12	11	11	18	18	thrombin	PAR1	PA451674	79581;2149	0.831
NULL	J_Exp_Med_2000_May_15_191(10)_1789-1798.nxml.txt.nlp	10811871	SENT91	31	31	40	40	tetracycline	p53	PA451640	7157	0.831
NULL	Ann_Hematol_2014_Sep_10_93(1)_1-11.nxml.txt.nlp	24018623	SENT128	5	5	7	7	lenalidomide	MDM2	PA162363968	4193	0.831
NULL	Aging_(Albany_NY)_2011_Jan_18_3(1)_33-43.nxml.txt.nlp	21248371	SENT7	12	12	2	2	zinc	HIF-1	PA451956	29072	0.831
NULL	Acta_Pharmacol_Sin_2013_Mar_11_34(3)_403-413.nxml.txt.nlp	23396374	SENT48	0	0	6	6	curcumin	AP-1	PA151958596	2353;3727;2354;3725	0.831
NULL	Biomed_Res_Int_2014_Apr_28_2014_549742.nxml.txt.nlp	24877113	SENT137	34	34	26	26	bevacizumab	BMP4	PA130232992	652	0.831
NULL	J_Gen_Physiol_2003_Jul_122(1)_5-16.nxml.txt.nlp	12810851	SENT486	17	17	0	0	betaine	p38	PA448603	10598;1432;7965	0.831
NULL	Breast_Cancer_(Auckl)_2011_Oct_9_5_209-226.nxml.txt.nlp	22084574	SENT277	24	24	21	21	tamoxifen	aromatase	PA451581	1588	0.831
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Apr_8_65(Pt_5)_o1004.nxml.txt.nlp	21583829	SENT72	15	15	21	21	piperazine	mol	PA450977	90527	0.831
NULL	Leukemia_2013_Apr_14_27(4)_803-812.nxml.txt.nlp	23238589	SENT153	40	40	38	38	nilotinib	IFN	PA165958345	3439	0.831
NULL	J_Oncol_2013_Feb_17_2013_872957.nxml.txt.nlp	23476648	SENT193	15	15	12	12	cisplatin	SFN	PA449014	25996;2810	0.831
NULL	Nat_Genet_2010_Mar_31_42(3)_245-249.nxml.txt.nlp	20118933	SENT58	15	15	10	10	camptothecin	TDP1	PA153590860	55775	0.831
NULL	Clin_Sci_(Lond)_2009_Nov_16_118(Pt_4)_269-279.nxml.txt.nlp	19698082	SENT104	30	30	18	18	ramipril	ACE2	PA451223	59272	0.831
NULL	Crit_Care_2011_Mar_3_15(2)_R82.nxml.txt.nlp	21371308	SENT110	7	7	15	15	heparin	ACT	PA449855	12;11332;9457;641455	0.831
NULL	J_Hematol_Oncol_2013_Oct_12_6_78.nxml.txt.nlp	24283803	SENT181	6	6	3	3	daunorubicin	STAT3	PA449212	6774	0.831
NULL	J_Breast_Cancer_2014_Dec_26_17(4)_332-338.nxml.txt.nlp	25548580	SENT107	23	23	14	14	capsaicin	TRPV1	PA448776	7442	0.831
NULL	Acta_Orthop_2010_Apr_6_81(2)_263-267.nxml.txt.nlp	20148646	SENT25	5	5	12	12	taurine	LIR	PA451590	10871	0.831
NULL	Cell_Commun_Signal_2011_May_15_9_13.nxml.txt.nlp	21569639	SENT292	9	9	25	25	quinacrine	p53	PA164745551	7157	0.831
NULL	JAKSTAT_2012_Oct_1_1(4)_292-299.nxml.txt.nlp	24058786	SENT169	27	27	36	36	phenol	STAT1	PA450913	6772	0.831
NULL	Adv_Hematol_2012_Mar_25_2012_302570.nxml.txt.nlp	22536253	SENT336	8	8	19	19	nutlin-3	p53		7157	0.831
NULL	Nucleic_Acids_Res_2013_Nov_27_41(21)_9786-9799.nxml.txt.nlp	23982513	SENT131	4	4	12	12	arsenite	TIAR	PA452638	7073	0.831
NULL	Physiol_Rep_2014_Aug_5_2(8)_e12110.nxml.txt.nlp	25096554	SENT234	36	36	18	18	lipase	CD36	PA450239	948	0.831
NULL	Aging_Cell_2009_Apr_8(2)_113-127.nxml.txt.nlp	19239417	SENT113	3	3	19	19	resveratrol	AMPK		5563	0.831
NULL	Cancer_Manag_Res_2014_Jun_20_6_279-289.nxml.txt.nlp	25018651	SENT82	19	19	26	26	dacarbazine	IFN	PA449197	3439	0.831
NULL	Evid_Based_Complement_Alternat_Med_2012_May_22_2012_340787.nxml.txt.nlp	22675379	SENT37	22	22	7	7	fluconazole	S27	PA449653	6232	0.831
NULL	Chin_J_Cancer_2012_Nov_31(11)_507-518.nxml.txt.nlp	22640626	SENT173	43	43	17	17	nilotinib	ARG	PA165958345	473;27	0.831
NULL	Allergy_Asthma_Immunol_Res_2014_Mar_13_6(2)_156-162.nxml.txt.nlp	24587953	SENT157	2	2	9	9	celecoxib	AAP	PA448871	5345	0.831
NULL	Breast_Cancer_Res_2011_Nov_23_13(6)_R116.nxml.txt.nlp	22113133	SENT369	3	3	11	11	estradiol	p53	PA449503	7157	0.831
NULL	Curr_Opin_Pharmacol_2013_Aug_13(4)_497-503.nxml.txt.nlp	23664091	SENT61	14	14	5	5	panitumumab	KRAS	PA162373091	3845	0.831
NULL	Diabetes_Metab_Syndr_Obes_2014_Aug_1_7_381-389.nxml.txt.nlp	25120374	SENT183	41	41	6	6	salsalate	adiponectin	PA164745462	9370	0.831
NULL	Am_J_Physiol_Endocrinol_Metab_2013_Nov_1_305(9)_E1134-E1144.nxml.txt.nlp	24022868	SENT91	9	9	16	16	lipase	FABP4	PA450239	2167	0.831
NULL	Biomed_Res_Int_2013_Jul_28_2013_724763.nxml.txt.nlp	23984402	SENT106	28	28	32	32	carrageenan	AD3	PA448814	11138	0.831
NULL	Acta_Pharmacol_Sin_2010_Mar_22_31(3)_329-340.nxml.txt.nlp	20173759	SENT78	31	31	13	13	ethanol	AMPK	PA448073	5563	0.831
NULL	Cancers_(Basel)_2013_Apr_8_5(2)_372-403.nxml.txt.nlp	24216982	SENT296	30	30	6	6	l-glutamine	L13	PA10090	28998;6137	0.831
NULL	Chem_Commun_(Camb)_2013_Jun_21_49(76)_8441-8443.nxml.txt.nlp	23770604	SENT22	4	4	28	28	geldanamycin	Hsp90	PA152031327	3320	0.831
NULL	Breast_Cancer_Res_2012_May_2_14(3)_R70.nxml.txt.nlp	22551440	SENT252	12	12	28	28	capecitabine	TP53	PA448771	7157	0.831
NULL	J_Psychopharmacol_2010_Nov_24(4_supplement)_91-118.nxml.txt.nlp	18801830	SENT352	23	23	28	28	quetiapine	ACTH	PA451201	5443	0.831
NULL	Br_J_Cancer_2012_Jun_5_106(12)_1960-1966.nxml.txt.nlp	22596237	SENT134	31	31	23	23	saracatinib	PC3		57332;7832;5122	0.831
NULL	Cancer_Cell_Int_2011_Nov_17_11_40.nxml.txt.nlp	22088142	SENT180	22	22	8	8	doxorubicin	MAPK14	PA449412	1432	0.831
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT213	17	17	11	11	midazolam	CYP3A	PA450496	1574	0.831
NULL	Kidney_Int_Suppl_(2011)_2013_Dec_27_3(5)_451-456.nxml.txt.nlp	25019029	SENT85	16	16	10	10	cinacalcet	PTH	PA164776671	5741	0.831
NULL	Ann_Rheum_Dis_2008_Jul_22_68(8)_1303-1309.nxml.txt.nlp	18647851	SENT151	8	8	25	25	adalimumab	MMP13	PA10004	4322	0.831
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT166	14	14	26	26	pertuzumab	HRG		3084;3273	0.831
NULL	Curr_Chem_Genomics_2010_Mar_19_4_9-18.nxml.txt.nlp	20502647	SENT69	28	28	7	7	doxycycline	MYOD	PA449415	4654	0.831
NULL	Diabetologia_2014_Sep_29_57(1)_192-203.nxml.txt.nlp	24078137	SENT195	2	2	29	29	metformin	CNGA1	PA450395	1259	0.831
NULL	Cancer_Cell_Int_2013_Sep_23_13_94.nxml.txt.nlp	24059699	SENT98	10	10	4	4	bevacizumab	VEGFR2	PA130232992	3791	0.831
NULL	Hum_Genomics_Proteomics_2010_Sep_13_2010_754919.nxml.txt.nlp	20981234	SENT96	32	32	14	14	phenprocoumon	VKORC1	PA450921	79001	0.831
NULL	Clin_Med_Circ_Respirat_Pulm_Med_2008_Apr_29_2_35-44.nxml.txt.nlp	21157520	SENT158	0	0	12	12	infliximab	gamma	PA452639	9913	0.831
NULL	J_Ophthalmol_2011_Nov_1_2011_743670.nxml.txt.nlp	22132313	SENT37	21	21	33	33	fluorescein	FAF	PA164746009	8239;2188	0.831
NULL	Br_J_Cancer_2010_Sep_7_103(6)_889-898.nxml.txt.nlp	20664599	SENT37	12	12	6	6	paclitaxel	EGFR	PA450761	1956	0.831
NULL	Ann_Oncol_2011_Mar_8_22(3)_503-514.nxml.txt.nlp	20616198	SENT67	8	8	15	15	aminoglutethimide	aromatase	PA448375	1588	0.831
NULL	Ann_Intensive_Care_2011_Sep_23_1_40.nxml.txt.nlp	21943500	SENT80	30	30	0	0	cyclosporine	EPO	PA449167	7076;8288;2056	0.831
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT812	4	4	20	20	glucose	GLUT9	PA449773	11182	0.831
NULL	Cancer_Cell_Int_2014_Jul_2_14_59.nxml.txt.nlp	25120382	SENT226	18	18	10	10	metformin	AMPK	PA450395	5563	0.831
NULL	Oncol_Rep_2014_Oct_7_32(4)_1369-1373.nxml.txt.nlp	25109605	SENT98	2	2	6	6	camptothecin	PC-3	PA153590860	692094	0.831
NULL	Cases_J_2009_Aug_24_2_7024.nxml.txt.nlp	19918503	SENT21	47	47	18	18	warfarin	CYP2C9	PA451906	1559	0.831
NULL	Oncotarget_2012_Aug_19_3(8)_890-903.nxml.txt.nlp	23097685	SENT139	9	9	26	26	ketoprofen	COX	PA450149	1351	0.831
NULL	Biosci_Rep_2013_Nov_25_33(6)_e00081.nxml.txt.nlp	24070327	SENT195	12	12	28	28	idarubicin	survivin	PA449961	332	0.831
NULL	Pharmaceuticals_(Basel)_2011_May_16_4(5)_726-740.nxml.txt.nlp	NULL	SENT192	4	4	7	7	estradiol	CA1	PA449503	759	0.831
NULL	Curr_Neuropharmacol_2014_Jan_12(1)_44-56.nxml.txt.nlp	24533015	SENT223	0	0	23	23	pregabalin	p65	PA164754814	5970	0.831
NULL	Infect_Dis_Ther_2014_Dec_24_3(2)_83-102.nxml.txt.nlp	25134686	SENT214	35	35	17	17	trimethoprim	OCT2	PA451788	6582;5452	0.831
NULL	J_Biol_Chem_2013_Feb_1_288(5)_3312-3321.nxml.txt.nlp	23255604	SENT200	3	3	6	6	mitomycin	IP6K1	PA450524	9807	0.831
NULL	Br_J_Pharmacol_2014_Jun_15_171(11)_2705-2725.nxml.txt.nlp	24467436	SENT8	14	14	6	6	hydralazine	NAT2	PA449894	10;81539	0.831
NULL	Oncogene_2013_Oct_10_32(41)_4903-4912.nxml.txt.nlp	23208499	SENT341	5	5	11	11	fulvestrant	ORF1	PA164747170	54806;51517	0.831
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_May_8_66(Pt_6)_o1299.nxml.txt.nlp	21579396	SENT4	1	1	11	11	piperazine	mol	PA450977	90527	0.831
NULL	Gut_Liver_2015_Jan_15_9(1)_52-58.nxml.txt.nlp	NULL	SENT41	14	14	1	1	midazolam	ESD	PA450496	2098	0.831
NULL	Nat_Med_2012_Jul_18(7)_1118-1122.nxml.txt.nlp	22683780	SENT25	10	10	17	17	crizotinib	HGF	PA165946122	3569;6654;3082	0.831
NULL	Mucosal_Immunol_2011_Nov_6_4(6)_648-657.nxml.txt.nlp	21734653	SENT94	25	25	23	23	azithromycin	HEC	PA448519	10403	0.831
NULL	Nucleic_Acids_Res_2011_May_10_39(9)_3607-3620.nxml.txt.nlp	21227924	SENT387	21	21	9	9	camptothecin	EM9	PA153590860	2068	0.831
NULL	Sensors_(Basel)_2013_Apr_9_13(4)_4674-4693.nxml.txt.nlp	23571670	SENT293	36	36	10	10	calcein	CD4	PA132595336	920	0.831
NULL	Int_J_Mol_Sci_2014_Jun_18_15(6)_11013-11029.nxml.txt.nlp	24945311	SENT112	7	7	10	10	celecoxib	STAT3	PA448871	6774	0.831
NULL	Bone_Joint_Res_2012_Oct_1_1(10)_272-280.nxml.txt.nlp	23610658	SENT75	28	28	13	13	methylprednisolone	UBC	PA450466	7316	0.831
NULL	Core_Evid_2011_Feb_8_6_23-29.nxml.txt.nlp	21468240	SENT17	12	12	9	9	plerixafor	CXCR4	PA165958410	7852	0.831
NULL	Front_Oncol_2014_Mar_18_4_55.nxml.txt.nlp	24672775	SENT75	13	13	16	16	azacitidine	CD33	PA451996	945	0.831
NULL	Arch_Med_Sci_2014_Oct_27_10(5)_920-932.nxml.txt.nlp	25395943	SENT173	0	0	12	12	clarithromycin	CYP3A4	PA449028	1576	0.831
NULL	ScientificWorldJournal_2013_Feb_10_2013_531465.nxml.txt.nlp	23476141	SENT58	18	18	1	1	halothane	RYR1	PA449845	6261	0.831
NULL	Case_Rep_Dermatol_2011_Oct_11_3(3)_223-227.nxml.txt.nlp	22135629	SENT65	10	10	16	16	paclitaxel	HER2	PA450761	2064	0.831
NULL	Virol_J_2012_Aug_23_9_171.nxml.txt.nlp	22917064	SENT23	22	22	30	30	zidovudine	IFN	PA451954	3439	0.831
NULL	Oxid_Med_Cell_Longev_2012_May_15_2012_984219.nxml.txt.nlp	22666523	SENT323	0	0	8	8	genistein	MCM2	PA165109660	4171	0.831
NULL	Chin_J_Cancer_2011_May_30(5)_351-356.nxml.txt.nlp	21527068	SENT108	19	19	13	13	vincristine	CHOP	PA451879	1649	0.831
NULL	Mol_Cancer_2012_Apr_26_11_24.nxml.txt.nlp	22537161	SENT139	15	15	21	21	pp2	MUC4		4585	0.831
NULL	Br_J_Clin_Pharmacol_2014_Aug_17_78(2)_353-363.nxml.txt.nlp	24528331	SENT51	37	37	26	26	warfarin	VKORC1	PA451906	79001	0.831
NULL	Arthritis_Res_Ther_2011_Sep_21_13(5)_239.nxml.txt.nlp	21955617	SENT51	27	27	4	4	sc-560	COX		1351	0.831
NULL	Neural_Plast_2007_Dec_11_2007_73079.nxml.txt.nlp	NULL	SENT3021	14	14	6	6	methylphenidate	TPH2	PA450464	6999;121278	0.831
NULL	Oncol_Lett_2014_Sep_19_8(3)_1269-1274.nxml.txt.nlp	25120704	SENT104	11	11	2	2	cisplatin	Met	PA449014	79811	0.831
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT30	5	5	18	18	atorvastatin	PIK3CA	PA448500	5290	0.831
NULL	Lab_Invest_2011_Apr_14_91(4)_598-608.nxml.txt.nlp	21321535	SENT239	0	0	14	14	sorafenib	CD11b	PA7000	3684	0.831
NULL	Cardiovasc_Diabetol_2013_Nov_6_12_163.nxml.txt.nlp	24195788	SENT32	5	5	17	17	bezafibrate	gamma	PA162364313	9913	0.831
NULL	EMBO_Mol_Med_2013_Feb_9_5(2)_309-325.nxml.txt.nlp	23300147	SENT189	13	13	16	16	geldanamycin	HER2	PA152031327	2064	0.831
NULL	Front_Immunol_2014_Aug_11_5_361.nxml.txt.nlp	25157249	SENT329	10	10	19	19	heparin	IL-2	PA449855	3558	0.831
NULL	Oncotarget_2010_Oct_9_1(6)_447-452.nxml.txt.nlp	21311100	SENT139	12	12	4	4	cisplatin	ERCC1	PA449014	2067	0.831
NULL	Mol_Cancer_2012_Oct_22_11_80.nxml.txt.nlp	23088607	SENT114	11	11	19	19	fulvestrant	YC1	PA164747170	5937	0.831
NULL	Breast_Cancer_Res_2009_Jul_30_11(4)_R56.nxml.txt.nlp	19643025	SENT276	7	7	9	9	celecoxib	IL-17	PA448871	3605	0.831
NULL	Support_Care_Cancer_2012_Mar_20_20(3)_647-652.nxml.txt.nlp	22101611	SENT21	12	12	10	10	cyclophosphamide	CHOP	PA449165	1649	0.831
NULL	Amino_Acids_2010_May_1_38(5)_1283-1299.nxml.txt.nlp	19882216	SENT386	7	7	10	10	imiquimod	TLR7	PA449972	51284	0.831
NULL	F1000_Med_Rep_2009_Feb_24_1_13.nxml.txt.nlp	20948769	SENT79	33	33	42	42	chlorambucil	CHOP	PA448926	1649	0.831
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Nov_14_65(Pt_12)_o3083.nxml.txt.nlp	21578813	SENT69	13	13	19	19	benzaldehyde	mol	PA448571	90527	0.831
NULL	J_Med_Case_Reports_2011_Oct_21_5_518.nxml.txt.nlp	22017919	SENT18	27	27	6	6	thrombin	PTPE	PA451674	5791	0.831
NULL	Mol_Syst_Biol_2010_Jul_13_6_387.nxml.txt.nlp	20631681	SENT228	22	22	0	0	nadh	ADP	PA164755085	23038	0.831
NULL	J_Basic_Clin_Pharm_2010_Dec_15_2(1)_21-25.nxml.txt.nlp	24825998	SENT3	14	14	17	17	rofecoxib	mol	PA451268	90527	0.831
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_13_2014_849783.nxml.txt.nlp	25477998	SENT109	2	2	13	13	berberine	IL-6	PA165860812	3569	0.831
NULL	Cell_Commun_Signal_2013_Nov_11_11_86.nxml.txt.nlp	24215724	SENT552	3	3	34	34	thrombin	NF-kappaB	PA451674	4790	0.831
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT199	0	0	20	20	methotrexate	MSH2	PA450428	4436	0.831
NULL	Patient_Prefer_Adherence_2014_Apr_8_8_463-471.nxml.txt.nlp	24748775	SENT137	28	28	2	2	glucose	RANKL	PA449773	8600	0.831
NULL	Biochimie_2011_Oct_93(10)_1747-1754.nxml.txt.nlp	21703329	SENT162	26	26	14	14	galactose	GALE	PA449725	2582	0.831
NULL	J_Korean_Med_Sci_2014_Jan_26_29(1)_48-52.nxml.txt.nlp	24431905	SENT79	19	19	9	9	thyroglobulin	RAI	PA164754910	10848;6050	0.831
NULL	J_Histochem_Cytochem_2013_Mar_61(3)_185-198.nxml.txt.nlp	23204112	SENT279	25	25	22	22	atorvastatin	Rho	PA448500	29984	0.831
NULL	Diabetes_Metab_J_2013_Oct_17_37(5)_315-325.nxml.txt.nlp	24199159	SENT14	5	5	1	1	resveratrol	SIRT1		23411	0.831
NULL	Ann_Neurol_2011_Feb_69(2)_312-319.nxml.txt.nlp	21387376	SENT63	24	24	17	17	vasopressin	NPY	PA451858	4852	0.831
NULL	Front_Neuroanat_2014_Oct_20_8_116.nxml.txt.nlp	25368556	SENT283	7	7	0	0	minocycline	MMP9	PA450519	4318	0.831
NULL	J_Vis_Exp_2010_Jan_12_(35)_1701.nxml.txt.nlp	20068548	SENT12	15	15	24	24	chloramphenicol	KLRG1	PA448927	10219	0.831
NULL	J_Gen_Physiol_2000_Jun_1_115(6)_685-696.nxml.txt.nlp	10828243	SENT194	6	6	1	1	genistein	OLF	PA165109660	83857	0.831
NULL	J_Clin_Biochem_Nutr_2009_Sep_28_45(2)_163-170.nxml.txt.nlp	19794924	SENT21	0	0	3	3	celecoxib	COX2	PA448871	4513;5743	0.831
NULL	Oncotarget_2013_Mar_26_4(3)_397-412.nxml.txt.nlp	23651630	SENT308	20	20	18	18	cyclophosphamide	CHOP	PA449165	1649	0.831
NULL	Br_J_Cancer_2010_Feb_2_102(3)_553-560.nxml.txt.nlp	20051956	SENT76	24	24	32	32	pemetrexed	B12	PA10810	7126;4709	0.831
NULL	Int_J_Environ_Res_Public_Health_2010_Apr_30_7(4)_1448-1466.nxml.txt.nlp	20617039	SENT52	0	0	6	6	ethanol	NR1	PA448073	27158	0.831
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Apr_13_69(Pt_5)_o732.nxml.txt.nlp	23723884	SENT81	39	39	7	7	ethanol	mol	PA448073	90527	0.831
NULL	Front_Oncol_2014_Apr_22_4_86.nxml.txt.nlp	24795863	SENT199	15	15	6	6	gemcitabine	p53	PA449748	7157	0.831
NULL	Iran_J_Pharm_Res_2013_Summer_12(3)_457-469.nxml.txt.nlp	24250652	SENT209	3	3	6	6	indomethacin	COX	PA449982	1351	0.831
NULL	Nat_Commun_2014_Dec_18_5_5815.nxml.txt.nlp	25519973	SENT10	2	2	4	4	tranylcypromine	LSD1	PA451741	23028	0.831
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S349-S354.nxml.txt.nlp	21525481	SENT118	4	4	1	1	metformin	GLP-1	PA450395	100125288	0.831
NULL	Mol_Cancer_2012_Apr_26_11_26.nxml.txt.nlp	22537224	SENT142	13	13	17	17	cisplatin	FANCF	PA449014	2188	0.831
NULL	Subst_Abuse_Treat_Prev_Policy_2010_Apr_29_5_7.nxml.txt.nlp	20429943	SENT74	19	19	30	30	diclofenac	UGT2B15	PA449293	7366	0.831
NULL	Crit_Care_2011_Oct_25_15(5)_R255.nxml.txt.nlp	22026977	SENT64	16	16	3	3	ethanol	AVP	PA448073	114548;551	0.831
NULL	Front_Genet_2014_Sep_10_5_317.nxml.txt.nlp	25309576	SENT123	17	17	22	22	vorinostat	HDAC6	PA164748224	10013	0.831
NULL	Braz_J_Med_Biol_Res_2013_Dec_2_46(12)_1000-1006.nxml.txt.nlp	24345907	SENT106	28	28	17	17	vasopressin	SON	PA451858	6651	0.831
NULL	Chin_J_Cancer_2012_Oct_31(10)_457-462.nxml.txt.nlp	NULL	SENT155	8	8	0	0	cisplatin	NAC1	PA449014	112939;6323	0.831
NULL	Drug_Target_Insights_2013_Aug_19_7_27-34.nxml.txt.nlp	24023511	SENT38	43	43	36	36	daunorubicin	P-gp	PA449212	5243	0.831
NULL	Oncol_Lett_2014_Mar_16_7(3)_827-833.nxml.txt.nlp	24527090	SENT83	23	23	18	18	cisplatin	IFN	PA449014	3439	0.831
NULL	Mol_Cancer_2007_Oct_11_6_63.nxml.txt.nlp	17931419	SENT19	12	12	22	22	cetuximab	HIF-1	PA10040	29072	0.831
NULL	Diabetes_2011_Jun_21_60(6)_1770-1778.nxml.txt.nlp	21562078	SENT265	8	8	6	6	metformin	AMPK	PA450395	5563	0.831
NULL	J_Biol_Chem_2013_Jul_19_288(29)_21412-21421.nxml.txt.nlp	23740251	SENT108	1	1	9	9	suramin	P2X1	PA10292	5023	0.831
NULL	Basic_Res_Cardiol_2012_Mar_19_107(2)_242.nxml.txt.nlp	22258067	SENT271	24	24	21	21	indomethacin	COX2	PA449982	4513;5743	0.831
NULL	Gut_Liver_2013_Jan_5_7(1)_106-111.nxml.txt.nlp	23423146	SENT45	24	24	4	4	gemcitabine	CRT	PA449748	811	0.831
NULL	Arthritis_Res_Ther_2003_Apr_28_5(4)_R186-R192.nxml.txt.nlp	12823853	SENT100	18	18	10	10	genistein	TSG-6	PA165109660	7130	0.831
NULL	Mol_Cancer_2007_Oct_25_6_67.nxml.txt.nlp	17958915	SENT214	19	19	12	12	imatinib	IL-3	PA10804	3562	0.831
NULL	Mol_Pain_2012_Sep_27_8_75.nxml.txt.nlp	23013719	SENT266	12	12	15	15	capsaicin	TRPV1	PA448776	7442	0.831
NULL	Breast_Cancer_Res_2014_Oct_31_16(5)_447.nxml.txt.nlp	25358600	SENT271	19	19	28	28	tamoxifen	CXCR4	PA451581	7852	0.831
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R91.nxml.txt.nlp	22541814	SENT131	30	30	18	18	thrombin	PAR4	PA451674	9002;5074	0.831
NULL	Diabetes_Care_2010_May_15_33(5)_1134-1139.nxml.txt.nlp	20185740	SENT177	22	22	19	19	ezetimibe	IL-6	PA10816	3569	0.831
NULL	Br_J_Cancer_2012_Sep_25_107(7)_1044-1050.nxml.txt.nlp	22910317	SENT130	18	18	2	2	vatalanib	CD31	PA7001	5175	0.831
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1013.nxml.txt.nlp	24457957	SENT125	3	3	19	19	bortezomib	NOXA	PA10252	5366	0.831
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT252	6	6	10	10	perifosine	DR5	PA165291471	8795	0.831
NULL	Oncotarget_2014_Aug_4_5(17)_7776-7787.nxml.txt.nlp	25277200	SENT28	25	25	11	11	etoposide	p50	PA449552	958;4790	0.831
NULL	Ann_Surg_Treat_Res_2014_Feb_22_86(2)_68-75.nxml.txt.nlp	24761411	SENT178	27	27	9	9	resveratrol	survivin		332	0.831
NULL	Mol_Cancer_2010_Jun_27_9_168.nxml.txt.nlp	20579391	SENT179	5	5	42	42	dasatinib	FOXM1	PA162372878	2305	0.831
NULL	Ann_Hematol_2010_Sep_13_89(9)_861-871.nxml.txt.nlp	20387067	SENT29	34	34	20	20	dasatinib	CD34	PA162372878	947	0.831
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT253	29	29	16	16	atorvastatin	CD36	PA448500	948	0.831
NULL	Mol_Cancer_2007_Oct_22_6_66.nxml.txt.nlp	17953743	SENT199	29	29	31	31	cisplatin	FasL	PA449014	356	0.831
NULL	Mol_Cancer_2014_Jun_30_13_160.nxml.txt.nlp	24976026	SENT9	21	21	18	18	bortezomib	AGR2	PA10252	10551	0.831
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT131	6	6	2	2	doxorubicin	SLK	PA449412	9748;2534	0.831
NULL	Mol_Vis_2012_Oct_11_18_2509-2517.nxml.txt.nlp	23112566	SENT172	8	8	6	6	bevacizumab	VEGF-A	PA130232992	7422	0.831
NULL	Front_Endocrinol_(Lausanne)_2011_Nov_10_2_65.nxml.txt.nlp	22649380	SENT102	12	12	14	14	estradiol	aromatase	PA449503	1588	0.831
NULL	Onco_Targets_Ther_2014_Dec_4_7_2249-2255.nxml.txt.nlp	25587220	SENT106	6	6	23	23	doxorubicin	P-gp	PA449412	5243	0.831
NULL	Cancer_Med_2013_Feb_3_2(1)_76-85.nxml.txt.nlp	24133630	SENT197	38	38	9	9	vemurafenib	P-gp	PA165946873	5243	0.831
NULL	Int_J_Biol_Sci_2014_Apr_8_10(4)_457-465.nxml.txt.nlp	24719563	SENT140	23	23	14	14	genistein	MEK1	PA165109660	5604	0.831
NULL	Mol_Cancer_2007_Oct_22_6_66.nxml.txt.nlp	17953743	SENT196	2	2	18	18	cisplatin	survivin	PA449014	332	0.831
NULL	J_Neuroinflammation_2011_Feb_4_8_10.nxml.txt.nlp	21294877	SENT79	4	4	10	10	capsaicin	TRPV1	PA448776	7442	0.831
NULL	Int_J_Anal_Chem_2012_Feb_8_2012_546282.nxml.txt.nlp	22505920	SENT3	35	35	20	20	terazosin	PF6	PA451612	200162	0.831
NULL	Breast_Cancer_Res_2010_May_10_12(3)_R26.nxml.txt.nlp	20459744	SENT12	21	21	0	0	tamoxifen	CYP2D6	PA451581	1565	0.831
NULL	Stroke_Res_Treat_2011_Nov_10_2011_212485.nxml.txt.nlp	22135769	SENT112	12	12	1	1	warfarin	VKORC1	PA451906	79001	0.831
NULL	Insights_Imaging_2013_Dec_20_5(1)_41-51.nxml.txt.nlp	24357453	SENT132	12	12	17	17	thyroglobulin	TTF1	PA164754910	7080;7270	0.831
NULL	J_Biomed_Biotechnol_2011_Jul_6_2011_783528.nxml.txt.nlp	21785566	SENT149	13	13	10	10	saquinavir	P-gp	PA451305	5243	0.831
NULL	Drug_Saf_2014_Feb_19_37(4)_201-211.nxml.txt.nlp	24550106	SENT308	3	3	13	13	tacrolimus	CYP2C19	PA451578	1557	0.831
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT13	3	3	19	19	curcumin	TRAIL	PA151958596	8743	0.831
NULL	J_Young_Pharm_2012_Jul-Sep_4(3)_138-145.nxml.txt.nlp	23112532	SENT189	29	29	12	12	norfloxacin	CO2	PA450654	4513	0.831
NULL	Oncotarget_2014_Jun_3_5(13)_4920-4928.nxml.txt.nlp	24952482	SENT98	19	19	10	10	crizotinib	HGF	PA165946122	3569;6654;3082	0.831
NULL	Curr_Clin_Pharmacol_2013_May_8(2)_135-155.nxml.txt.nlp	23062036	SENT92	19	19	16	16	raloxifene	SULT	PA451221	6816	0.831
NULL	Int_J_Mol_Sci_2014_Mar_6_15(3)_4049-4059.nxml.txt.nlp	24663080	SENT22	7	7	27	27	dexmedetomidine	IL-6	PA449256	3569	0.831
NULL	Behav_Sci_(Basel)_2012_Jun_21_2(2)_135-171.nxml.txt.nlp	23077729	SENT135	25	25	21	21	vasopressin	ACTH	PA451858	5443	0.831
NULL	Ann_Oncol_2011_Mar_8_22(3)_503-514.nxml.txt.nlp	20616198	SENT309	2	2	17	17	anastrozole	ATAC	PA448432	6375	0.83
NULL	Int_J_Biol_Sci_2014_Jun_10_10(7)_654-663.nxml.txt.nlp	25013375	SENT116	12	12	3	3	nelfinavir	HER2	PA450606	2064	0.83
NULL	Nat_Med_2011_Dec_4_18(1)_111-119.nxml.txt.nlp	22138751	SENT134	28	28	18	18	doxycycline	WT1	PA449415	7490	0.83
NULL	Cancer_Cell_Int_2004_Aug_17_4_5.nxml.txt.nlp	15315711	SENT84	31	31	10	10	genistein	PC3	PA165109660	57332;7832;5122	0.83
NULL	J_Hematol_Oncol_2009_Apr_22_2_18.nxml.txt.nlp	19386128	SENT161	19	19	27	27	cetuximab	KRAS	PA10040	3845	0.83
NULL	Croat_Med_J_2013_Apr_54(2)_171-179.nxml.txt.nlp	23630144	SENT105	26	26	14	14	taurine	STZ	PA451590	6484	0.83
NULL	Int_J_Endocrinol_2014_Apr_30_2014_451035.nxml.txt.nlp	24883060	SENT250	11	11	3	3	simvastatin	JNK	PA451363	5599	0.83
NULL	Cell_Res_2012_Aug_22_22(8)_1227-1245.nxml.txt.nlp	22613949	SENT115	29	29	21	21	bortezomib	KRAS	PA10252	3845	0.83
NULL	Eur_J_Clin_Pharmacol_2013_May_14_69(5)_1091-1101.nxml.txt.nlp	23150149	SENT16	14	14	9	9	isoniazid	NAT2	PA450112	10;81539	0.83
NULL	Oncotarget_2014_Oct_21_5(22)_11709-11722.nxml.txt.nlp	25365944	SENT221	4	4	21	21	metformin	JNK	PA450395	5599	0.83
NULL	Cancer_Manag_Res_2013_Jan_17_5_15-20.nxml.txt.nlp	23378782	SENT65	17	17	12	12	erlotinib	Met	PA134687924	79811	0.83
NULL	Breast_Cancer_Res_2011_Mar_11_13(2)_R29.nxml.txt.nlp	21396094	SENT208	9	9	16	16	fulvestrant	HER2	PA164747170	2064	0.83
NULL	Br_J_Cancer_2014_Nov_25_111(11)_2091-2102.nxml.txt.nlp	25349971	SENT35	15	15	21	21	imatinib	KIT	PA10804	3815	0.83
NULL	South_Asian_J_Cancer_2014_Jul-Sep_3(3)_175-178.nxml.txt.nlp	25136526	SENT106	6	6	16	16	cetuximab	EGFR	PA10040	1956	0.83
NULL	J_Mol_Med_2008_Sep_4_86(9)_1045-1056.nxml.txt.nlp	18600309	SENT197	5	5	14	14	salmeterol	MKP-1	PA451300	1843	0.83
NULL	Cell_Death_Dis_2014_Jan_9_5(1)_e988.nxml.txt.nlp	24407241	SENT345	11	11	21	21	sorafenib	CD41	PA7000	3674	0.83
NULL	J_Immunol_Res_2014_Mar_9_2014_549315.nxml.txt.nlp	24741606	SENT184	3	3	8	8	rituximab	ABO	PA451261	28	0.83
NULL	Breast_Cancer_Res_2004_Jun_29_6(5)_R488-R498.nxml.txt.nlp	15318931	SENT75	2	2	12	12	estradiol	San	PA449503	80218	0.83
NULL	J_Breast_Cancer_2013_Mar_31_16(1)_117-121.nxml.txt.nlp	23593092	SENT65	5	5	9	9	letrozole	aromatase	PA450196	1588	0.83
NULL	Br_J_Cancer_2012_Oct_9_107(8)_1268-1276.nxml.txt.nlp	22996612	SENT144	10	10	14	14	axitinib	CYP2C8	PA164924493	1558	0.83
NULL	Br_J_Cancer_2012_Jul_24_107(3)_435-441.nxml.txt.nlp	22767144	SENT146	28	28	13	13	oxaliplatin	TEF	PA131285527	7008	0.83
NULL	Hum_Mol_Genet_2013_Jun_1_22(11)_2247-2262.nxml.txt.nlp	23424202	SENT308	32	32	8	8	imipramine	AMPH	PA449969	273	0.83
NULL	Oncotarget_2013_Nov_7_4(12)_2550-2566.nxml.txt.nlp	24334291	SENT220	18	18	23	23	cyclophosphamide	CHOP	PA449165	1649	0.83
NULL	Cells_2014_Apr_29_3(2)_331-362.nxml.txt.nlp	24785347	SENT143	10	10	7	7	capsaicin	TRPV1	PA448776	7442	0.83
NULL	Breast_Cancer_Res_2009_Sep_29_11(5)_209.nxml.txt.nlp	19818165	SENT225	26	26	37	37	tamoxifen	JNK	PA451581	5599	0.83
NULL	J_Korean_Neurosurg_Soc_2013_Oct_31_54(4)_280-288.nxml.txt.nlp	24294450	SENT184	21	21	28	28	acetazolamide	ACZ	PA448018	27445	0.83
NULL	Front_Neurosci_2010_Mar_19_4_22.nxml.txt.nlp	20582262	SENT12	5	5	24	24	bethanechol	P2X2	PA448613	22953	0.83
NULL	Eur_J_Med_Res_2010_Apr_8_15(4)_145-151.nxml.txt.nlp	20554495	SENT7	15	15	8	8	abacavir	HLA-B	PA448004	3106	0.83
NULL	EMBO_J_2014_Jul_17_33(14)_1514-1526.nxml.txt.nlp	24872509	SENT351	14	14	22	22	zinc	CYC1	PA451956	1537	0.83
NULL	Acta_Pharmacol_Sin_2010_Nov_18_31(11)_1447-1453.nxml.txt.nlp	20953204	SENT148	9	9	21	21	rimonabant	IL-6	PA152407999	3569	0.83
NULL	Clinics_(Sao_Paulo)_2013_May_68(5)_694-701.nxml.txt.nlp	23778405	SENT139	5	5	18	18	curcumin	survivin	PA151958596	332	0.83
NULL	Front_Physiol_2012_Oct_19_3_56.nxml.txt.nlp	23091461	SENT298	2	2	19	19	clodronate	IL-6	PA10239	3569	0.83
NULL	J_Hematol_Oncol_2009_Feb_23_2_9.nxml.txt.nlp	19236713	SENT41	14	14	4	4	cetuximab	KRAS	PA10040	3845	0.83
NULL	Curr_Neuropharmacol_2010_Sep_8(3)_287-304.nxml.txt.nlp	21358978	SENT33	22	22	7	7	riluzole	CRF1	PA451251	1394	0.83
NULL	Cell_Death_Dis_2014_Jul_3_5(7)_e1311.nxml.txt.nlp	24991763	SENT63	10	10	16	16	ketamine	GluN1	PA450144	2902	0.83
NULL	Neurobiol_Aging_2012_Nov_33(11)_2692-2703.nxml.txt.nlp	22405041	SENT371	11	11	4	4	phencyclidine	gamma	PA128406980	9913	0.83
NULL	Cell_Regen_(Lond)_2013_Apr_30_2(1)_3.nxml.txt.nlp	25408875	SENT90	6	6	19	19	staurosporine	SNX16	PA165109623	64089	0.83
NULL	Respir_Med_Case_Rep_2013_Apr_24_9_8-10.nxml.txt.nlp	NULL	SENT178	0	0	12	12	erlotinib	EGFR	PA134687924	1956	0.83
NULL	Nat_Commun_2014_5_3128.nxml.txt.nlp	24451681	SENT37	40	40	35	35	gemcitabine	RRM2	PA449748	6241	0.83
NULL	J_Pain_Res_2014_Oct_17_7_589-608.nxml.txt.nlp	25378948	SENT59	34	34	26	26	oxymorphone	CYP2D6	PA450748	1565	0.83
NULL	Biomed_Res_Int_2014_Apr_13_2014_738625.nxml.txt.nlp	24822215	SENT220	2	2	9	9	montelukast	IL-13	PA450546	3596	0.83
NULL	Cancer_Inform_2014_Nov_3_13(Suppl_5)_89-100.nxml.txt.nlp	25392696	SENT61	16	16	8	8	trastuzumab	HER2	PA451743	2064	0.83
NULL	Leukemia_2013_Nov_8_27(11)_2209-2219.nxml.txt.nlp	23563238	SENT54	20	20	32	32	hydrocortisone	CO2	PA449905	4513	0.83
NULL	Curr_Neuropharmacol_2012_Mar_10(1)_53-63.nxml.txt.nlp	22942878	SENT107	1	1	24	24	vasopressin	OXT	PA451858	5020	0.83
NULL	Pharmaceuticals_(Basel)_2013_Nov_25_6(12)_1475-1506.nxml.txt.nlp	24287492	SENT312	28	28	17	17	bevacizumab	U87	PA130232992	677775;641648	0.83
NULL	Cancers_(Basel)_2013_May_27_5(2)_617-638.nxml.txt.nlp	24216994	SENT135	7	7	18	18	curcumin	MMP9	PA151958596	4318	0.83
NULL	Front_Behav_Neurosci_2012_Sep_18_6_61.nxml.txt.nlp	23049505	SENT66	0	0	27	27	donepezil	San	PA449394	80218	0.83
NULL	Mol_Biol_Cell_2012_Nov_1_23(21)_4212-4225.nxml.txt.nlp	22956765	SENT143	19	19	9	9	thrombin	SHP2	PA451674	5781	0.83
NULL	Arthritis_Res_Ther_2009_Aug_28_11(4)_R131.nxml.txt.nlp	19715572	SENT88	3	3	6	6	rituximab	CD19	PA451261	930	0.83
NULL	Arthritis_Res_Ther_2006_Mar_6_8(2)_R53.nxml.txt.nlp	16519795	SENT22	2	2	38	38	methotrexate	IL-10	PA450428	3586	0.83
NULL	Adv_Biomed_Res_2014_Sep_8_3_189.nxml.txt.nlp	25298958	SENT75	28	28	30	30	omeprazole	NAC	PA450704	22861	0.83
NULL	Diabetes_Care_2010_Jul_33(7)_1674-1685.nxml.txt.nlp	20587728	SENT287	30	30	22	22	liraglutide	GLP-1	PA165958364	100125288	0.83
NULL	BMB_Rep_2014_Jul_47(7)_376-381.nxml.txt.nlp	24286332	SENT71	25	25	9	9	thrombin	PPG	PA451674	5552	0.83
NULL	Case_Rep_Oncol_2014_Jun_18_7(2)_393-400.nxml.txt.nlp	25076890	SENT45	36	36	31	31	gefitinib	EGFR	PA131301952	1956	0.83
NULL	Nat_Neurosci_2012_Sep_5_15(9)_1245-1254.nxml.txt.nlp	22864611	SENT171	29	29	12	12	clozapine	mGlu2	PA449061	2912	0.83
NULL	J_Gen_Physiol_2009_Apr_133(4)_421-438.nxml.txt.nlp	19289574	SENT245	27	27	12	12	forskolin	SLC26A9	PA146096022	115019	0.83
NULL	Adolesc_Health_Med_Ther_2012_Jun_20_3_85-93.nxml.txt.nlp	24600289	SENT185	17	17	21	21	methotrexate	TNF	PA450428	7124	0.83
NULL	Int_J_Biol_Sci_2011_Nov_5_8(1)_1-14.nxml.txt.nlp	22211100	SENT134	0	0	9	9	evodiamine	PTEN	PA165860788	5728	0.83
NULL	Int_J_Mol_Sci_2012_Dec_7_13(12)_16751-16768.nxml.txt.nlp	23222680	SENT167	14	14	9	9	phenelzine	LSD1	PA450903	23028	0.83
NULL	Mol_Cells_2014_Mar_31_37(3)_234-240.nxml.txt.nlp	24642709	SENT118	7	7	13	13	capsaicin	HO-1	PA448776	3162	0.83
NULL	FEBS_Open_Bio_2011_Dec_27_2_1-5.nxml.txt.nlp	23650573	SENT108	26	26	4	4	sunitinib	MDM2	PA162372840	4193	0.83
NULL	Patient_Prefer_Adherence_2013_Mar_27_7_245-258.nxml.txt.nlp	23569364	SENT90	44	44	31	31	tamoxifen	aromatase	PA451581	1588	0.83
NULL	Br_J_Cancer_2010_Jan_5_102(1)_80-86.nxml.txt.nlp	19920817	SENT143	18	18	15	15	sunitinib	IFN	PA162372840	3439	0.83
NULL	J_Cancer_2013_Nov_23_4(9)_736-754.nxml.txt.nlp	24312144	SENT218	8	8	28	28	bevacizumab	VEGFR	PA130232992	3791	0.83
NULL	Clin_Exp_Otorhinolaryngol_2011_Mar_17_4(1)_18-23.nxml.txt.nlp	21461058	SENT97	16	16	6	6	furosemide	KCC2	PA449719	57468	0.83
NULL	Oncoimmunology_2013_Dec_1_2(12)_e26689.nxml.txt.nlp	24527364	SENT22	11	11	2	2	doxorubicin	STAT1	PA449412	6772	0.83
NULL	Mol_Cell_Biochem_2013_Jul_20_383(1-2)_95-102.nxml.txt.nlp	23873331	SENT47	26	26	14	14	resveratrol	CYP1A1		1543	0.83
NULL	Int_J_Mol_Sci_2014_Jun_18_15(6)_11013-11029.nxml.txt.nlp	24945311	SENT676	1	1	11	11	celecoxib	EGFR	PA448871	1956	0.83
NULL	Biologics_2010_Nov_9_4_289-298.nxml.txt.nlp	21116327	SENT66	21	21	28	28	panitumumab	EGFR	PA162373091	1956	0.83
NULL	Front_Behav_Neurosci_2009_Jan_27_3_1.nxml.txt.nlp	19194528	SENT384	12	12	2	2	haloperidol	spatial	PA449841	219793	0.83
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT293	12	12	32	32	curcumin	PUMA	PA151958596	27113	0.83
NULL	J_Asthma_Allergy_2010_Aug_13_3_33-42.nxml.txt.nlp	21437038	SENT93	27	27	30	30	salmeterol	DPI	PA451300	1832	0.83
NULL	J_Geriatr_Cardiol_2014_Mar_11(1)_63-73.nxml.txt.nlp	24748884	SENT192	24	24	14	14	fenoldopam	PKD	PA164784034	5587	0.83
NULL	Endocrinol_Diabetes_Metab_Case_Rep_2014_Mar_1_2014_140001.nxml.txt.nlp	24683487	SENT62	3	3	6	6	cabergoline	ACTH	PA448708	5443	0.83
NULL	Breast_Cancer_Res_2008_Dec_18_10(Suppl_4)_S25.nxml.txt.nlp	19128439	SENT23	3	3	9	9	anastrozole	aromatase	PA448432	1588	0.83
NULL	Oncotarget_2013_Apr_10_4(4)_622-635.nxml.txt.nlp	23599172	SENT76	10	10	13	13	gefitinib	EGF	PA131301952	1950	0.83
NULL	EMBO_Mol_Med_2012_Jun_13_4(6)_515-527.nxml.txt.nlp	22416035	SENT184	2	2	18	18	olaparib	NOXA		5366	0.83
NULL	Mol_Cells_2014_Feb_28_37(2)_89-94.nxml.txt.nlp	24598992	SENT139	17	17	0	0	etoposide	Fis1	PA449552	51024	0.83
NULL	Ann_Rheum_Dis_2011_Apr_22_70(8)_1395-1400.nxml.txt.nlp	21515602	SENT185	22	22	11	11	warfarin	VKORC1	PA451906	79001	0.83
NULL	Mol_Cancer_2013_Mar_5_12_17.nxml.txt.nlp	23497256	SENT68	9	9	0	0	sunitinib	p53	PA162372840	7157	0.83
NULL	Oncotarget_2013_Aug_21_4(9)_1484-1495.nxml.txt.nlp	23986086	SENT123	18	18	8	8	metformin	PIK3CA	PA450395	5290	0.83
NULL	Autophagy_2013_Mar_1_9(3)_287-302.nxml.txt.nlp	23221969	SENT436	8	8	13	13	fulvestrant	IFN	PA164747170	3439	0.83
NULL	Biomed_Res_Int_2014_Jan_29_2014_458592.nxml.txt.nlp	24592391	SENT34	16	16	9	9	curcumin	HO-1	PA151958596	3162	0.83
NULL	Cell_Commun_Signal_2013_Oct_1_11_73.nxml.txt.nlp	24083678	SENT168	15	15	27	27	sulindac	AP-1	PA451565	2353;3727;2354;3725	0.83
NULL	Br_J_Cancer_2012_Nov_6_107(10)_1714-1721.nxml.txt.nlp	23073173	SENT96	22	22	32	32	bicalutamide	RUNX2	PA164746255	860	0.83
NULL	Biologics_2009_Jul_13_3_289-301.nxml.txt.nlp	19707416	SENT147	31	31	11	11	tamoxifen	HER2	PA451581	2064	0.83
NULL	Arthritis_Res_Ther_2008_Mar_17_10(2)_R33.nxml.txt.nlp	18346273	SENT162	4	4	10	10	infliximab	HMGB1	PA452639	3146	0.83
NULL	Int_J_Cell_Biol_2013_Nov_17_2013_769536.nxml.txt.nlp	24348564	SENT197	25	25	10	10	l-leucine	HSD1	PA450197	26871	0.83
NULL	Arthritis_Res_Ther_2012_Sep_24_14(5)_R200.nxml.txt.nlp	23006144	SENT114	4	4	20	20	alefacept	CD68	PA164748040	968	0.83
NULL	J_Med_Case_Reports_2011_May_3_5_168.nxml.txt.nlp	21539737	SENT54	13	13	8	8	doxorubicin	CHOP	PA449412	1649	0.83
NULL	Front_Pharmacol_2014_May_27_5_115.nxml.txt.nlp	24904418	SENT1583	0	0	2	2	hemin	NLRP3	PA449849	114548	0.83
NULL	Cancer_Manag_Res_2014_Jun_20_6_279-289.nxml.txt.nlp	25018651	SENT82	16	16	26	26	cisplatin	IFN	PA449014	3439	0.83
NULL	Anat_Cell_Biol_2011_Mar_31_44(1)_14-24.nxml.txt.nlp	21519545	SENT100	21	21	2	2	cyclophosphamide	CK8	PA449165	3856	0.83
NULL	Oncotarget_2013_Jul_21_4(8)_1266-1279.nxml.txt.nlp	23907540	SENT87	14	14	5	5	doxycycline	GAPDH	PA449415	2597	0.83
NULL	Oncotarget_2012_May_4_3(4)_395-398.nxml.txt.nlp	22565037	SENT9	31	31	11	11	trastuzumab	CD24	PA451743	100133941	0.83
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_39-54.nxml.txt.nlp	19305787	SENT512	12	12	8	8	ethanol	RACK1	PA448073	10399	0.83
NULL	J_Adv_Pract_Oncol_2012_May_1_May-Jun_3(3)_184-190.nxml.txt.nlp	25031945	SENT10	17	17	15	15	cyclophosphamide	CHOP	PA449165	1649	0.83
NULL	Atten_Defic_Hyperact_Disord_2010_Dec_30_2(4)_213-220.nxml.txt.nlp	21258431	SENT19	25	25	41	41	methylphenidate	ATX	PA450464	5168;23049	0.83
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Mar_21_68(Pt_4)_o1129.nxml.txt.nlp	22589984	SENT65	42	42	27	27	acetone	mol	PA448025	90527	0.83
NULL	Oncotarget_2013_Feb_27_4(2)_329-345.nxml.txt.nlp	23593654	SENT285	12	12	3	3	trastuzumab	CD44	PA451743	960	0.83
NULL	Cancers_(Basel)_2010_Dec_29_3(1)_79-90.nxml.txt.nlp	24212607	SENT108	18	18	22	22	gemcitabine	GRAF	PA449748	23092	0.83
NULL	EMBO_Mol_Med_2012_Sep_22_4(9)_860-862.nxml.txt.nlp	22911657	SENT25	20	20	36	36	glucosamine	MD-2	PA164747613	23643	0.83
NULL	Acta_Pharmacol_Sin_2012_Jan_28_33(1)_75-81.nxml.txt.nlp	22120969	SENT91	3	3	5	5	exenatide	GLP-1	PA164749238	100125288	0.83
NULL	Br_J_Cancer_2010_Oct_26_103(9)_1331-1334.nxml.txt.nlp	20877352	SENT18	21	21	3	3	trastuzumab	GM-CSF	PA451743	1437	0.83
NULL	Breast_Cancer_Res_2004_Oct_6_6(6)_262-268.nxml.txt.nlp	15535857	SENT148	36	36	43	43	tamoxifen	aromatase	PA451581	1588	0.83
NULL	Nat_Med_2014_Mar_23_20(3)_291-295.nxml.txt.nlp	24562381	SENT84	19	19	2	2	fenoldopam	HMGB1	PA164784034	3146	0.83
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT170	3	3	12	12	tacrolimus	IL-6	PA451578	3569	0.83
NULL	EMBO_J_2009_Apr_22_28(8)_1043-1054.nxml.txt.nlp	19300439	SENT116	26	26	11	11	genistein	p38	PA165109660	10598;1432;7965	0.83
NULL	Biol_Proced_Online_2003_Feb_17_5_43-52.nxml.txt.nlp	12734557	SENT131	8	8	13	13	bupivacaine	IFNA6	PA135057240	3443	0.83
NULL	J_Cancer_Prev_2014_Jun_19(2)_111-117.nxml.txt.nlp	25337579	SENT151	4	4	8	8	bortezomib	AKR1C3	PA10252	8644	0.83
NULL	Clin_Ophthalmol_2009_Jun_2_3_291-295.nxml.txt.nlp	19668581	SENT109	29	29	14	14	travoprost	BAK	PA164781371	578	0.83
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT37	28	28	0	0	cisplatin	UNG	PA449014	7374	0.83
NULL	Breast_Cancer_Res_2011_Jan_7_13(1)_R1.nxml.txt.nlp	21214929	SENT93	5	5	9	9	cisplatin	p53	PA449014	7157	0.83
NULL	Endocr_Relat_Cancer_2013_Aug_20(5)_677-689.nxml.txt.nlp	23913484	SENT212	9	9	5	5	docetaxel	IFN	PA449383	3439	0.83
NULL	Br_J_Cancer_2003_Mar_24_88(6)_822-827.nxml.txt.nlp	12644816	SENT34	27	27	17	17	thalidomide	PSA	PA451644	29968;9520;354	0.83
NULL	J_Immunother_Cancer_2014_Jan_27_2_2.nxml.txt.nlp	24829759	SENT100	15	15	1	1	sorafenib	IL-21	PA7000	59067;50616;27189	0.83
NULL	Asia_Pac_Allergy_2012_Jul_25_2(3)_203-209.nxml.txt.nlp	22872823	SENT41	11	11	22	22	carbamazepine	HLA-B	PA448785	3106	0.83
NULL	Breast_Cancer_(Auckl)_2009_Sep_2_3_61-75.nxml.txt.nlp	19809577	SENT113	18	18	14	14	curcumin	BRCA1	PA151958596	672	0.83
NULL	Glycobiology_2014_Dec_15_24(12)_1291-1300.nxml.txt.nlp	25028392	SENT143	36	36	4	4	lipase	mincle	PA450239	26253	0.83
NULL	Breast_Cancer_Res_2005_Aug_1_7(5)_R796-R807.nxml.txt.nlp	16168126	SENT277	16	16	22	22	celecoxib	HER-2	PA448871	2064	0.83
NULL	Aging_(Albany_NY)_2009_Jun_3_1(6)_515-528.nxml.txt.nlp	20157535	SENT99	30	30	22	22	resveratrol	SIRT1		23411	0.83
NULL	Indian_J_Pharmacol_2013_Jan-Feb_45(1)_54-60.nxml.txt.nlp	23543867	SENT16	36	36	16	16	terlipressin	NAC	PA164781020	22861	0.83
NULL	Oncotarget_2012_Sep_28_3(10)_1169-1181.nxml.txt.nlp	23045411	SENT187	13	13	18	18	doxorubicin	JNK	PA449412	5599	0.83
NULL	Adv_Biomed_Res_2014_Oct_21_3_219.nxml.txt.nlp	25371876	SENT200	29	29	18	18	estradiol	spatial	PA449503	219793	0.83
NULL	J_Cell_Biol_1987_Apr_1_104(4)_897-903.nxml.txt.nlp	2435741	SENT9	18	18	14	14	chymotrypsin	CAP2	PA448994	5271;10486	0.83
NULL	Br_J_Cancer_2011_Aug_23_105(5)_618-627.nxml.txt.nlp	21829197	SENT97	18	18	25	25	lapatinib	EGFR	PA152241907	1956	0.83
NULL	Springerplus_2015_Jan_23_4_29.nxml.txt.nlp	25628986	SENT42	11	11	19	19	dapsone	G6PD	PA449211	2539	0.83
NULL	Genetics_2014_Jan_11_196(1)_321-347.nxml.txt.nlp	24240528	SENT462	10	10	0	0	haloperidol	HPD	PA449841	3242	0.83
NULL	Case_Rep_Dermatol_2011_May_20_3(2)_113-117.nxml.txt.nlp	21677889	SENT41	32	32	17	17	prednicarbate	COL1A1	PA164749394	1277	0.83
NULL	Br_J_Cancer_2013_Jul_23_109(2)_342-350.nxml.txt.nlp	23807172	SENT185	3	3	5	5	sorafenib	Mcl-1	PA7000	4170	0.83
NULL	Oncogene_2010_Jun_24_29(25)_3619-3629.nxml.txt.nlp	20418905	SENT265	20	20	13	13	doxycycline	TRE17	PA449415	9098	0.83
NULL	Breast_Cancer_Res_2007_Aug_8_9(4)_R50.nxml.txt.nlp	17686159	SENT202	4	4	6	6	gefitinib	HRG	PA131301952	3084;3273	0.83
NULL	Arthritis_Res_Ther_2008_Jan_7_10(1)_R1.nxml.txt.nlp	18179697	SENT160	40	40	18	18	oxaliplatin	HMGB1	PA131285527	3146	0.83
NULL	Cancer_Res_Treat_2012_Sep_30_44(3)_195-201.nxml.txt.nlp	23091446	SENT106	4	4	9	9	etoposide	JNK	PA449552	5599	0.83
NULL	J_Cell_Mol_Med_2013_May_12_17(5)_636-647.nxml.txt.nlp	23577651	SENT116	2	2	11	11	everolimus	ADP	PA164746311	23038	0.83
NULL	Mol_Brain_2013_May_4_6_22.nxml.txt.nlp	23641686	SENT148	19	19	5	5	memantine	NR2D	PA10364	2906	0.83
NULL	Curr_Gerontol_Geriatr_Res_2011_Aug_18_2011_316386.nxml.txt.nlp	21869884	SENT126	20	20	4	4	estradiol	CA3	PA449503	761	0.83
NULL	Arthritis_Res_Ther_2010_Jan_8_12(1)_R4.nxml.txt.nlp	20064200	SENT218	16	16	40	40	fluorescein	COX2	PA164746009	4513;5743	0.83
NULL	Oncoscience_2014_Aug_7_1(8)_540-549.nxml.txt.nlp	25594061	SENT70	16	16	21	21	bevacizumab	KRAS	PA130232992	3845	0.83
NULL	Oncotarget_2014_Sep_3_5(19)_9362-9381.nxml.txt.nlp	25313139	SENT114	10	10	18	18	orlistat	SREBP1	PA164776864	6720	0.83
NULL	Arthritis_Res_Ther_2009_Aug_28_11(4)_R131.nxml.txt.nlp	19715572	SENT91	0	0	4	4	rituximab	CD19	PA451261	930	0.83
NULL	Oncotarget_2011_Nov_9_2(11)_850-861.nxml.txt.nlp	22081665	SENT129	10	10	3	3	idarubicin	DNMT3A	PA449961	1788	0.83
NULL	Cardiovasc_Diabetol_2005_Oct_5_4_16.nxml.txt.nlp	16207378	SENT223	14	14	7	7	glucosamine	perlecan	PA164747613	3339	0.83
NULL	Behav_Neurol_2014_Aug_7_2014_294149.nxml.txt.nlp	25177106	SENT83	24	24	13	13	memantine	ANOVA	PA10364	4858	0.83
NULL	Cell_Biol_Int_Rep_(2010)_2013_Dec_30_20(2)_13-23.nxml.txt.nlp	25505515	SENT41	15	15	0	0	l-glutamine	P19	PA10090	51561	0.83
NULL	Breast_Cancer_(Auckl)_2014_Mar_23_8_51-56.nxml.txt.nlp	24678242	SENT4	3	3	0	0	carboplatin	BRCA1	PA448803	672	0.83
NULL	Clin_Ophthalmol_2008_Jun_2(2)_355-368.nxml.txt.nlp	19668727	SENT43	7	7	28	28	nepafenac	COX2	PA165958407	4513;5743	0.83
NULL	Brain_Behav_2013_Mar_6_3(2)_114-133.nxml.txt.nlp	23533150	SENT240	4	4	0	0	ethanol	HSF1	PA448073	3297	0.83
NULL	Ann_Rheum_Dis_2012_Sep_71(9)_1510-1516.nxml.txt.nlp	22440821	SENT244	10	10	21	21	etanercept	adiponectin	PA449515	9370	0.83
NULL	Pharmaceuticals_(Basel)_2012_Oct_23_5(10)_1128-1146.nxml.txt.nlp	24281261	SENT619	10	10	0	0	trabectedin	TRAIL	PA165958349	8743	0.83
NULL	Evid_Based_Complement_Alternat_Med_2015_Jan_6_2015_736431.nxml.txt.nlp	25632290	SENT456	16	16	7	7	midazolam	CYP3A	PA450496	1574	0.83
NULL	Cardiol_Res_Pract_2013_Jan_31_2013_128795.nxml.txt.nlp	23431496	SENT149	19	19	5	5	clopidogrel	CYP2C19	PA449053	1557	0.83
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S18-S30.nxml.txt.nlp	20680104	SENT82	21	21	18	18	panitumumab	EGFR	PA162373091	1956	0.83
NULL	ISRN_Neurosci_2013_Jul_7_2013_179272.nxml.txt.nlp	24967304	SENT18	14	14	8	8	vasopressin	OXT	PA451858	5020	0.83
NULL	Br_J_Haematol_2009_Nov_2_147(3)_396-410.nxml.txt.nlp	19758122	SENT36	20	20	8	8	dasatinib	p53	PA162372878	7157	0.83
NULL	Curr_Opin_Allergy_Clin_Immunol_2013_Dec_6_13(6)_669-676.nxml.txt.nlp	24169433	SENT79	4	4	14	14	galactose	IL-10	PA449725	3586	0.83
NULL	J_Headache_Pain_2012_Nov_16_13(8)_677-684.nxml.txt.nlp	23070400	SENT105	9	9	22	22	nabilone	DAI	PA164746998	81030	0.83
NULL	Biol_Open_2014_Jul_25_3(8)_777-784.nxml.txt.nlp	25063200	SENT228	26	26	13	13	l-glutamine	B27	PA10090	56246	0.83
NULL	Ann_Gastroenterol_2012_25(2)_100-105.nxml.txt.nlp	24714229	SENT56	35	35	39	39	ciprofloxacin	BID	PA449009	637	0.83
NULL	J_Cell_Biol_2002_Jun_24_157(7)_1151-1160.nxml.txt.nlp	12082077	SENT102	23	23	32	32	trypsin	COX	PA451806	1351	0.83
NULL	Br_J_Cancer_2013_May_14_108(9)_1862-1869.nxml.txt.nlp	23579219	SENT25	13	13	10	10	bevacizumab	ANXA11	PA130232992	311	0.83
NULL	JAKSTAT_2014_Jun_12_3_e29554.nxml.txt.nlp	25105067	SENT108	7	7	21	21	propofol	STAT3	PA451141	6774	0.83
NULL	Front_Pharmacol_2014_May_27_5_115.nxml.txt.nlp	24904418	SENT2011	0	0	8	8	hemin	TLR4	PA449849	7099	0.83
NULL	J_Cancer_2014_Jan_1_5(1)_25-30.nxml.txt.nlp	24396495	SENT151	19	19	8	8	bevacizumab	CA125	PA130232992	4077;94025	0.83
NULL	Evid_Based_Complement_Alternat_Med_2011_Jan_9_2011_619650.nxml.txt.nlp	21799685	SENT30	11	11	18	18	ketanserin	5-HT2C	PA131053734	3358	0.83
NULL	Iran_J_Pharm_Res_2013_Winter_12(Suppl)_71-76.nxml.txt.nlp	24250674	SENT31	32	32	15	15	fluoxetine	CYP2D6	PA449673	1565	0.83
NULL	Crit_Care_2003_Dec_20_7(1)_23-38.nxml.txt.nlp	12617738	SENT316	16	16	26	26	thrombin	VIII	PA451674	1351	0.83
NULL	Case_Rep_Oncol_2010_Jul_31_3(2)_282-286.nxml.txt.nlp	21347194	SENT41	32	32	25	25	irinotecan	KRAS	PA450085	3845	0.83
NULL	Allergy_Asthma_Clin_Immunol_2009_Dec_17_5(1)_14.nxml.txt.nlp	20066054	SENT50	7	7	37	37	desloratadine	IL-4	PA164776964	3565	0.83
NULL	Braz_J_Med_Biol_Res_2013_Jun_25_46(6)_528-532.nxml.txt.nlp	23802228	SENT86	6	6	21	21	rosiglitazone	PON1	PA451283	5444	0.83
NULL	Acta_Pharmacol_Sin_2010_Jun_4_31(6)_741-745.nxml.txt.nlp	20523344	SENT93	23	23	42	42	gemcitabine	Bcl-2	PA449748	596	0.83
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Dec_11_70(Pt_1)_o31.nxml.txt.nlp	24526978	SENT73	8	8	11	11	benzaldehyde	mol	PA448571	90527	0.83
NULL	Curr_Gerontol_Geriatr_Res_2010_Jun_20_2010_348174.nxml.txt.nlp	20672050	SENT28	6	6	3	3	lapatinib	EGFR	PA152241907	1956	0.83
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2751-2762.nxml.txt.nlp	24169358	SENT181	0	0	21	21	fulvestrant	BAF47	PA164747170	6598	0.83
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_7-17.nxml.txt.nlp	17912633	SENT376	39	39	31	31	tamoxifen	AMH	PA451581	268	0.83
NULL	Biomed_Res_Int_2013_Dec_31_2013_273498.nxml.txt.nlp	23484100	SENT9	16	16	11	11	genistein	OTC	PA165109660	5009	0.83
NULL	J_Invest_Dermatol_2014_May_13_134(5)_1220-1229.nxml.txt.nlp	24401997	SENT169	24	24	3	3	paraformaldehyde	TIG3	PA450790	5920	0.83
NULL	Evid_Based_Complement_Alternat_Med_2011_Feb_13_2011_236186.nxml.txt.nlp	21607013	SENT124	0	0	16	16	scopolamine	spatial	PA451308	219793	0.83
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1063.nxml.txt.nlp	24556678	SENT74	5	5	11	11	thioridazine	c-FLIP	PA451666	8837	0.83
NULL	Br_J_Cancer_2004_Mar_8_90(5)_944-949.nxml.txt.nlp	14997187	SENT22	19	19	8	8	tamoxifen	aromatase	PA451581	1588	0.83
NULL	Oncol_Lett_2013_Mar_8_5(3)_805-812.nxml.txt.nlp	23426281	SENT13	10	10	22	22	gemcitabine	survivin	PA449748	332	0.83
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT49	42	42	9	9	chlorzoxazone	CYP2A6	PA448971	1548	0.83
NULL	Breast_Cancer_Res_2004_Jul_29_6(5)_204-210.nxml.txt.nlp	15318926	SENT116	9	9	24	24	gefitinib	HER2	PA131301952	2064	0.83
NULL	Exp_Ther_Med_2013_Mar_17_5(3)_797-802.nxml.txt.nlp	23403698	SENT10	29	29	20	20	triciribine	PI3K	PA165958661	5290	0.83
NULL	Biologics_2012_Jul_13_6_221-231.nxml.txt.nlp	22904614	SENT189	12	12	3	3	cetuximab	KRAS	PA10040	3845	0.83
NULL	Acta_Pharmacol_Sin_2009_Jul_22_30(7)_956-964.nxml.txt.nlp	19543298	SENT171	16	16	8	8	ezetimibe	ABCC2	PA10816	1244	0.83
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT160	26	26	6	6	erlotinib	EGFR	PA134687924	1956	0.83
NULL	F1000Prime_Rep_2014_Aug_1_6_66.nxml.txt.nlp	25165565	SENT112	15	15	37	37	trastuzumab	PI3K	PA451743	5290	0.83
NULL	Oncotarget_2014_Oct_21_5(22)_11252-11268.nxml.txt.nlp	25361004	SENT33	17	17	13	13	metformin	CLIC1	PA450395	1192	0.83
NULL	Curr_Clin_Pharmacol_2013_May_8(2)_135-155.nxml.txt.nlp	23062036	SENT219	23	23	14	14	tamoxifen	ERBB2	PA451581	2064	0.83
NULL	Thorax_2009_Sep_3_64(9)_798-805.nxml.txt.nlp	19497921	SENT61	21	21	7	7	paraformaldehyde	TLR2	PA450790	7097	0.83
NULL	Chin_J_Cancer_2011_Nov_30(11)_749-756.nxml.txt.nlp	22035855	SENT22	28	28	43	43	tamoxifen	aromatase	PA451581	1588	0.83
NULL	J_Immunol_Res_2014_Jul_16_2014_696812.nxml.txt.nlp	25133198	SENT32	23	23	18	18	rifaximin	CD103	PA164752443	3682	0.83
NULL	Front_Oncol_2013_Nov_18_3_282.nxml.txt.nlp	24303367	SENT595	9	9	5	5	gemcitabine	HMGA1	PA449748	3159	0.83
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1059-1066.nxml.txt.nlp	21364577	SENT59	16	16	18	18	letrozole	aromatase	PA450196	1588	0.83
NULL	Clin_Transl_Allergy_2014_Feb_28_4(Suppl_1)_P35.nxml.txt.nlp	25045492	SENT14	0	0	28	28	atorvastatin	CD83	PA448500	9308	0.83
NULL	Aging_(Albany_NY)_2011_Apr_6_3(4)_444-449.nxml.txt.nlp	21483037	SENT71	19	19	6	6	resveratrol	SIRT1		23411	0.83
NULL	Vet_Res_2013_Jan_11_44(1)_2.nxml.txt.nlp	23311865	SENT71	12	12	34	34	clindamycin	CO2	PA449035	4513	0.83
NULL	Mol_Neurobiol_2010_Jun_2_41(2-3)_392-409.nxml.txt.nlp	20437209	SENT296	3	3	30	30	curcumin	cPLA2	PA151958596	10524	0.83
NULL	Sensors_(Basel)_2010_Feb_12_10(2)_1355-1376.nxml.txt.nlp	22205872	SENT1173	22	22	15	15	fluorescein	GRP1	PA164746009	9265	0.83
NULL	Kidney_Int_Suppl_(2011)_2013_Dec_27_3(5)_462-468.nxml.txt.nlp	25019031	SENT60	4	4	35	35	cinacalcet	FGF23	PA164776671	8074	0.83
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT377	14	14	23	23	lapatinib	HRG	PA152241907	3084;3273	0.83
NULL	ScientificWorldJournal_2013_Sep_19_2013_809891.nxml.txt.nlp	24170983	SENT130	6	6	25	25	ketorolac	CD54	PA450150	3383	0.83
NULL	Oncogene_2010_Jul_8_29(27)_3953-3963.nxml.txt.nlp	20440263	SENT31	10	10	0	0	sugar	ROS	PA451529	6098	0.83
NULL	Oncotarget_2014_Jun_6_5(13)_4935-4944.nxml.txt.nlp	24952732	SENT120	0	0	3	3	doxazosin	HIF-1	PA449407	29072	0.83
NULL	Br_J_Cancer_2013_Mar_5_108(4)_826-830.nxml.txt.nlp	23412108	SENT116	11	11	6	6	gefitinib	EGFR	PA131301952	1956	0.83
NULL	Cancer_Cell_Int_2012_Jun_18_12_30.nxml.txt.nlp	22709569	SENT98	19	19	0	0	doxorubicin	PLCG2	PA449412	5336	0.83
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT44	2	2	22	22	pertuzumab	HER-2		2064	0.83
NULL	Cancer_Immunol_Immunother_2008_Jul_7_57(7)_931-950.nxml.txt.nlp	18256831	SENT434	15	15	1	1	ifosfamide	IL-2	PA449964	3558	0.83
NULL	Mol_Imaging_Biol_2009_Jul_31_11(4)_241-245.nxml.txt.nlp	19333655	SENT124	36	36	6	6	aprepitant	NK1	PA164747039	11126	0.83
NULL	Case_Rep_Med_2013_Jun_5_2013_315479.nxml.txt.nlp	23861685	SENT16	0	0	4	4	celecoxib	COX	PA448871	1351	0.83
NULL	Anesth_Essays_Res_2010_Jul-Dec_4(2)_96-101.nxml.txt.nlp	NULL	SENT58	1	1	18	18	protamine	ACT	PA10366	12;11332;9457;641455	0.83
NULL	Chin_J_Cancer_2012_Jul_31(7)_319-326.nxml.txt.nlp	22257382	SENT141	13	13	0	0	cisplatin	STAT3	PA449014	6774	0.83
NULL	Ann_Hematol_2011_May_12_90(5)_557-568.nxml.txt.nlp	20938660	SENT136	12	12	3	3	plerixafor	CD34	PA165958410	947	0.83
NULL	Cancer_Cell_Int_2009_Sep_10_9_25.nxml.txt.nlp	19744341	SENT203	13	13	30	30	glucosamine	STAT3	PA164747613	6774	0.83
NULL	Indian_J_Endocrinol_Metab_2013_Jul-Aug_17(4)_636-646.nxml.txt.nlp	23961479	SENT240	15	15	6	6	simvastatin	SGS	PA451363	2200	0.83
NULL	Indian_J_Endocrinol_Metab_2012_Jul-Aug_16(4)_675-676.nxml.txt.nlp	22837952	SENT32	8	8	13	13	metformin	B12	PA450395	7126;4709	0.83
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT59	23	23	11	11	bevacizumab	VEGF-A	PA130232992	7422	0.83
NULL	Front_Endocrinol_(Lausanne)_2013_Jun_10_4_69.nxml.txt.nlp	23772224	SENT953	2	2	12	12	rosiglitazone	ghrelin	PA451283	51738	0.83
NULL	Endocrinol_Metab_(Seoul)_2013_Sep_13_28(3)_157-163.nxml.txt.nlp	24396673	SENT89	0	0	13	13	levothyroxine	RAI	PA450221	10848;6050	0.83
NULL	Oncotarget_2012_Nov_17_4(1)_18-28.nxml.txt.nlp	23248157	SENT74	8	8	15	15	pargyline	p53	PA450797	7157	0.83
NULL	Tumour_Biol_2014_Aug_12_35(8)_7807-7819.nxml.txt.nlp	24817012	SENT33	7	7	26	26	cisplatin	ERCC1	PA449014	2067	0.83
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT31	7	7	15	15	celecoxib	survivin	PA448871	332	0.83
NULL	Mol_Cancer_2008_Mar_6_7_24.nxml.txt.nlp	18325101	SENT93	4	4	8	8	cisplatin	FANCD2	PA449014	2177	0.83
NULL	Oncotarget_2014_Feb_25_5(5)_1304-1314.nxml.txt.nlp	24675421	SENT26	40	40	33	33	cisplatin	JNK	PA449014	5599	0.83
NULL	Br_J_Cancer_2009_Mar_10_100(5)_758-763.nxml.txt.nlp	19259094	SENT109	17	17	32	32	belinostat	MLH1		4292	0.83
NULL	Oncoimmunology_2012_Nov_1_1(8)_1422-1424.nxml.txt.nlp	23243615	SENT24	38	38	19	19	estradiol	aromatase	PA449503	1588	0.83
NULL	Int_Clin_Psychopharmacol_2014_Jul_26_29(4)_206-211.nxml.txt.nlp	24374906	SENT123	9	9	17	17	doxepin	CYP2C19	PA449409	1557	0.83
NULL	Cancer_Med_2013_Dec_22_2(6)_862-871.nxml.txt.nlp	24403259	SENT240	6	6	14	14	everolimus	VEGFR	PA164746311	3791	0.83
NULL	Br_J_Cancer_2013_Mar_5_108(4)_755-761.nxml.txt.nlp	23322204	SENT59	27	27	30	30	hyaluronan	CD44	PA165958431	960	0.83
NULL	F1000Res_2013_Mar_5_2_74.nxml.txt.nlp	24358880	SENT264	1	1	21	21	benzaldehyde	TRPA1	PA448571	8989	0.83
NULL	Cancer_Cell_Int_2010_Oct_25_10_40.nxml.txt.nlp	20974006	SENT110	46	46	30	30	paraformaldehyde	FADD	PA450790	8772	0.83
NULL	Exp_Ther_Med_2012_Oct_3_4(4)_594-604.nxml.txt.nlp	23170111	SENT99	27	27	12	12	propranolol	SAPK	PA451145	5601	0.83
NULL	Arthritis_Res_Ther_2006_Jul_20_8(4)_R129.nxml.txt.nlp	16859536	SENT32	21	21	24	24	rituximab	CD22	PA451261	933	0.83
NULL	Drugs_R_D_2011_Mar_27_11(1)_13-27.nxml.txt.nlp	21142290	SENT218	8	8	23	23	hyaluronan	NF-kappaB	PA165958431	4790	0.83
NULL	Emerg_Infect_Dis_2012_Jan_18(1)_113-116.nxml.txt.nlp	22260877	SENT11	27	27	42	42	rifampin	CA4	PA451250	762	0.83
NULL	Arthritis_Res_Ther_2010_Feb_9_12(1)_R21.nxml.txt.nlp	20144213	SENT194	4	4	13	13	naproxen	5-LOX	PA450595	240	0.83
NULL	Arthritis_Rheumatol_2014_Jun_27_66(6)_1574-1582.nxml.txt.nlp	24577881	SENT111	0	0	12	12	hydralazine	CD4	PA449894	920	0.83
NULL	J_Lipids_2011_Jan_13_2011_565316.nxml.txt.nlp	21490804	SENT118	9	9	21	21	sorafenib	CD95	PA7000	355	0.83
NULL	Int_J_Breast_Cancer_2011_Sep_6_2011_352182.nxml.txt.nlp	22295219	SENT268	0	0	15	15	pertuzumab	EGFR		1956	0.83
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1495-1502.nxml.txt.nlp	21989186	SENT195	19	19	23	23	leucovorin	HSI	PA450198	57016	0.83
NULL	J_Occup_Med_Toxicol_2008_Feb_27_3(Suppl_1)_S6.nxml.txt.nlp	18315837	SENT71	7	7	12	12	salmeterol	IFN	PA451300	3439	0.83
NULL	Int_J_Mol_Sci_2014_Oct_20_15(10)_18985-18999.nxml.txt.nlp	25334066	SENT177	32	32	41	41	cisplatin	HOTAIR	PA449014	100124700	0.83
NULL	Endocrinol_Metab_(Seoul)_2014_Dec_29_29(4)_553-560.nxml.txt.nlp	25325265	SENT39	13	13	22	22	lipase	PERK	PA450239	9451	0.83
NULL	Anesthesiol_Res_Pract_2013_Sep_23_2013_297141.nxml.txt.nlp	24174934	SENT346	8	8	22	22	capsaicin	TRPV1	PA448776	7442	0.83
NULL	Arthritis_Res_Ther_2003_Sep_12_5(Suppl_3)_11.nxml.txt.nlp	NULL	SENT7	20	20	0	0	neomycin	IL-17	PA450608	3605	0.83
NULL	Acta_Pharmacol_Sin_2014_Jan_9_35(1)_1-10.nxml.txt.nlp	24317012	SENT157	13	13	6	6	irinotecan	UGT1A1	PA450085	54658	0.83
NULL	Cardiovasc_Diabetol_2010_Nov_5_9_72.nxml.txt.nlp	21054861	SENT110	0	0	17	17	isoproterenol	LSD	PA450121	1776	0.83
NULL	Ann_Neurol_2013_Oct_24_74(4)_527-536.nxml.txt.nlp	23794460	SENT99	7	7	20	20	metyrapone	ACTH	PA450486	5443	0.83
NULL	Int_J_Biol_Sci_2015_Jan_1_11(1)_48-58.nxml.txt.nlp	25552929	SENT152	6	6	10	10	paclitaxel	TSP-1	PA450761	7057	0.83
NULL	Int_J_Inflam_2010_Aug_9_2010_151097.nxml.txt.nlp	21152121	SENT334	20	20	5	5	thrombin	CXCR4	PA451674	7852	0.83
NULL	Arthritis_Res_Ther_2009_Jan_3_11(1)_R1.nxml.txt.nlp	19121222	SENT37	18	18	8	8	estradiol	IFN	PA449503	3439	0.83
NULL	J_Oncol_2011_Dec_23_2011_591427.nxml.txt.nlp	21253528	SENT96	8	8	16	16	paclitaxel	AKT2	PA450761	208	0.83
NULL	Cell_Death_Dis_2014_Mar_6_5(3)_e1108.nxml.txt.nlp	24603336	SENT180	16	16	10	10	cetuximab	CYP3A4	PA10040	1576	0.83
NULL	Mediators_Inflamm_2010_May_17_2010_841343.nxml.txt.nlp	20490358	SENT136	5	5	15	15	candesartan	MCP-1	PA448765	6347	0.83
NULL	EJC_Suppl_2013_Sep_5_11(2)_92-96.nxml.txt.nlp	NULL	SENT118	30	30	21	21	vemurafenib	BRAF	PA165946873	673	0.83
NULL	Scientifica_(Cairo)_2012_Nov_25_2012_478631.nxml.txt.nlp	24278700	SENT287	9	9	11	11	boceprevir	BOC	PA165948902	91653	0.83
NULL	Indian_J_Pharmacol_2014_Sep-Oct_46(5)_549-550.nxml.txt.nlp	25298588	SENT64	29	29	3	3	warfarin	CYP2C9	PA451906	1559	0.83
NULL	Biochim_Biophys_Acta_2014_Apr_1841(4)_588-594.nxml.txt.nlp	24440819	SENT26	2	2	19	19	lipase	desnutrin	PA450239	57104	0.83
NULL	Oncotarget_2011_Dec_31_2(12)_1314-1321.nxml.txt.nlp	22248929	SENT140	13	13	21	21	lapatinib	HER3	PA152241907	2065	0.83
NULL	Diabetes_Care_2012_Jun_11_35(6)_1225-1231.nxml.txt.nlp	22432104	SENT210	24	24	11	11	metformin	GLP-1	PA450395	100125288	0.83
NULL	Int_J_Mol_Imaging_2011_Oct_26_2011_874585.nxml.txt.nlp	21490735	SENT160	18	18	8	8	doxorubicin	FDG	PA449412	23583	0.83
NULL	Mol_Cancer_2014_Aug_16_13(1)_193.nxml.txt.nlp	NULL	SENT105	9	9	3	3	cisplatin	RKIP	PA449014	5037	0.83
NULL	Cancer_Cell_Int_2011_Nov_17_11_40.nxml.txt.nlp	22088142	SENT153	23	23	7	7	gefitinib	MRP1	PA131301952	4437	0.83
NULL	Acta_Pharmacol_Sin_2012_Oct_3_33(10)_1311-1318.nxml.txt.nlp	22941289	SENT179	15	15	20	20	sorafenib	VEGFR2	PA7000	3791	0.83
NULL	Anesth_Essays_Res_2014_Sep-Dec_8(3)_307-312.nxml.txt.nlp	NULL	SENT49	3	3	24	24	bupivacaine	Era	PA135057240	2099	0.83
NULL	Oncoimmunology_2013_Jun_1_2(6)_e24677.nxml.txt.nlp	23894722	SENT145	26	26	39	39	cetuximab	CD83	PA10040	9308	0.83
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT191	20	20	10	10	methotrexate	MSH2	PA450428	4436	0.83
NULL	Theranostics_2014_Feb_22_4(5)_514-533.nxml.txt.nlp	24672583	SENT206	15	15	7	7	sirolimus	DES	PA451365	1674	0.83
NULL	Acta_Pharmacol_Sin_2010_May_12_31(5)_578-584.nxml.txt.nlp	20383171	SENT117	2	2	12	12	berberine	JNK	PA165860812	5599	0.83
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S31-S40.nxml.txt.nlp	20680106	SENT31	6	6	4	4	cetuximab	EGFR	PA10040	1956	0.83
NULL	Mol_Cancer_2008_Mar_6_7_24.nxml.txt.nlp	18325101	SENT102	13	13	26	26	cisplatin	BRCA1	PA449014	672	0.83
NULL	Pharmaceuticals_(Basel)_2014_Mar_5_7(3)_311-338.nxml.txt.nlp	24603603	SENT69	10	10	7	7	cetuximab	EGFR	PA10040	1956	0.83
NULL	Clinics_(Sao_Paulo)_2012_Feb_67(2)_135-143.nxml.txt.nlp	22358238	SENT132	27	27	15	15	collagenase	I-1	PA449107	11188	0.83
NULL	Br_J_Cancer_2012_Sep_25_107(7)_1075-1082.nxml.txt.nlp	22918394	SENT35	0	0	8	8	lapatinib	HER-2	PA152241907	2064	0.83
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Oct_23_66(Pt_11)_o2923.nxml.txt.nlp	21589097	SENT6	16	16	47	47	benzaldehyde	mol	PA448571	90527	0.83
NULL	J_Clin_Biochem_Nutr_2009_Sep_28_45(2)_125-130.nxml.txt.nlp	19794918	SENT64	4	4	8	8	lansoprazole	HO-1	PA450180	3162	0.83
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT50	4	4	28	28	trastuzumab	HER2	PA451743	2064	0.83
NULL	Int_J_Chron_Obstruct_Pulmon_Dis_2007_Jun_2(2)_157-167.nxml.txt.nlp	18044688	SENT9	16	16	2	2	tiotropium	TDI	PA164769056	100038246	0.83
NULL	Oncol_Lett_2013_Jul_29_6(1)_118-124.nxml.txt.nlp	23946788	SENT79	9	9	3	3	tamoxifen	aromatase	PA451581	1588	0.83
NULL	Acta_Histochem_Cytochem_2013_Dec_28_46(6)_187-197.nxml.txt.nlp	24610966	SENT126	8	8	12	12	pilocarpine	AQP5	PA450962	362	0.83
NULL	J_Biomed_Biotechnol_2011_Dec_6_2011_856985.nxml.txt.nlp	21188173	SENT206	8	8	14	14	tamoxifen	HDAC4	PA451581	9759	0.83
NULL	Eur_J_Clin_Pharmacol_2008_Jul_16_64(7)_683-690.nxml.txt.nlp	18415093	SENT127	3	3	15	15	artesunate	ACT	PA165111697	12;11332;9457;641455	0.83
NULL	Pharmaceuticals_(Basel)_2013_Feb_7_6(2)_269-286.nxml.txt.nlp	24275951	SENT914	35	35	17	17	cisplatin	c-IAP1	PA449014	329	0.83
NULL	J_Cardiothorac_Surg_2009_Sep_17_4_50.nxml.txt.nlp	19758462	SENT198	9	9	15	15	amifostine	PTH	PA448365	5741	0.83
NULL	Br_J_Cancer_1996_Dec_74(11)_1719-1729.nxml.txt.nlp	8956784	SENT10	14	14	16	16	epirubicin	EPI	PA449476	7035	0.83
NULL	Cancers_(Basel)_2014_Apr_16_6(2)_926-957.nxml.txt.nlp	24743778	SENT318	0	0	6	6	ponatinib	STAT3	PA165980594	6774	0.83
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT163	29	29	9	9	cisplatin	p53	PA449014	7157	0.83
NULL	Mol_Cancer_2009_Jun_9_8_37.nxml.txt.nlp	19508729	SENT49	2	2	7	7	gemcitabine	HO-1	PA449748	3162	0.83
NULL	Breast_Cancer_(Auckl)_2011_Jul_27_5_175-199.nxml.txt.nlp	21863131	SENT325	13	13	29	29	capecitabine	San	PA448771	80218	0.83
NULL	Indian_J_Pharm_Sci_2008_Jul-Aug_70(4)_494-497.nxml.txt.nlp	20046778	SENT89	14	14	12	12	risperidone	RIS	PA451257	51285	0.83
NULL	Osteoporos_Int_2009_Sep_21_20(9)_1499-1506.nxml.txt.nlp	19156348	SENT28	9	9	24	24	olanzapine	5-HT2A	PA450688	3356	0.83
NULL	Oncotarget_2014_Oct_21_5(22)_11252-11268.nxml.txt.nlp	25361004	SENT119	0	0	2	2	metformin	CLIC1	PA450395	1192	0.83
NULL	Diabetes_Metab_J_2012_Aug_20_36(4)_293-299.nxml.txt.nlp	22950061	SENT146	12	12	22	22	metformin	NPY	PA450395	4852	0.829
NULL	J_Autoimmune_Dis_2005_May_3_2_4.nxml.txt.nlp	15869713	SENT196	7	7	0	0	lovastatin	NAC	PA450272	22861	0.829
NULL	Carcinogenesis_2014_Sep_1_35(9)_1983-1992.nxml.txt.nlp	24692066	SENT500	5	5	11	11	urokinase	HuR	PA451836	1994	0.829
NULL	Oncogene_2010_Jan_7_29(1)_81-92.nxml.txt.nlp	19784067	SENT262	11	11	6	6	cisplatin	BRG1	PA449014	6597	0.829
NULL	Diabetes_Care_2010_May_3_33(5)_1028-1030.nxml.txt.nlp	20200309	SENT24	5	5	13	13	exenatide	San	PA164749238	80218	0.829
NULL	Mol_Cancer_2012_Jan_6_11_2.nxml.txt.nlp	22226043	SENT285	23	23	39	39	tamoxifen	EGFR	PA451581	1956	0.829
NULL	Comp_Hepatol_2004_Jan_14_3(Suppl_1)_S37.nxml.txt.nlp	14960189	SENT90	2	2	8	8	thalidomide	CD14	PA451644	929	0.829
NULL	Biomed_Res_Int_2014_Jun_25_2014_764981.nxml.txt.nlp	25057499	SENT185	12	12	28	28	sorafenib	Mcl-1	PA7000	4170	0.829
NULL	J_Hematol_Oncol_2009_Jul_27_2_31.nxml.txt.nlp	19635146	SENT167	15	15	33	33	imatinib	Mcl-1	PA10804	4170	0.829
NULL	Oncologist_2011_Jan_6_16(1)_5-24.nxml.txt.nlp	21212434	SENT196	11	11	25	25	bleomycin	IFN	PA448645	3439	0.829
NULL	Diabetes_Care_2010_Jul_31_33(7)_1544-1548.nxml.txt.nlp	20357370	SENT95	11	11	28	28	metformin	STK11	PA450395	6794	0.829
NULL	Diabetes_2013_Jun_17_62(6)_1843-1854.nxml.txt.nlp	23349486	SENT206	7	7	18	18	pioglitazone	DC-SIGN	PA450970	30835	0.829
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_13_2013_468537.nxml.txt.nlp	23956772	SENT141	7	7	32	32	cisplatin	BAX	PA449014	581	0.829
NULL	Bioinformation_2012_Jan_6_8(1)_13-19.nxml.txt.nlp	22359429	SENT171	27	27	0	0	calcein	MRP1	PA132595336	4437	0.829
NULL	Exp_Diabetes_Res_2012_Oct_15_2012_465282.nxml.txt.nlp	23118742	SENT85	14	14	3	3	metformin	FGF21	PA450395	26291	0.829
NULL	Ther_Clin_Risk_Manag_2006_Dec_2(4)_365-375.nxml.txt.nlp	18360649	SENT142	22	22	4	4	abatacept	ACR	PA164747080	49	0.829
NULL	Chemother_Res_Pract_2011_Dec_1_2011_715469.nxml.txt.nlp	22312557	SENT130	15	15	11	11	cisplatin	p53	PA449014	7157	0.829
NULL	Indian_J_Nephrol_2011_Oct-Dec_21(4)_286-288.nxml.txt.nlp	22022093	SENT67	24	24	26	26	cyclosporine	IL-2	PA449167	3558	0.829
NULL	J_Vis_Exp_2014_Jul_4_(89)_51847.nxml.txt.nlp	25045833	SENT123	8	8	2	2	ethanol	CARS	PA448073	833	0.829
NULL	J_Signal_Transduct_2010_Sep_1_2010_643642.nxml.txt.nlp	21637354	SENT56	25	25	31	31	pp2	ghrelin		51738	0.829
NULL	J_Am_Heart_Assoc_2013_Apr_24_2(2)_e000131.nxml.txt.nlp	23537811	SENT64	23	23	16	16	clopidogrel	CYP2C19	PA449053	1557	0.829
NULL	Acta_Pharmacol_Sin_2014_Aug_30_35(8)_1045-1054.nxml.txt.nlp	24976155	SENT128	6	6	2	2	resveratrol	SIRT1		23411	0.829
NULL	Aging_(Albany_NY)_2009_Feb_18_1(3)_335-349.nxml.txt.nlp	20195489	SENT113	9	9	20	20	etoposide	p65	PA449552	5970	0.829
NULL	Exp_Lung_Res_2013_Oct_1_39(8)_336-348.nxml.txt.nlp	23919450	SENT152	20	20	0	0	thrombin	PAR-1	PA451674	2011;2149	0.829
NULL	Curr_Neuropharmacol_2008_Jun_6(2)_151-163.nxml.txt.nlp	19305794	SENT119	9	9	16	16	capsaicin	TRPV1	PA448776	7442	0.829
NULL	Clin_Pharmacol_2011_Jun_22_3_13-25.nxml.txt.nlp	22287853	SENT25	9	9	11	11	saxagliptin	CYP1A2	PA165958362	1544	0.829
NULL	Toxins_(Basel)_2010_Oct_26_2(11)_2490-2518.nxml.txt.nlp	22069563	SENT185	6	6	22	22	cisplatin	p38	PA449014	10598;1432;7965	0.829
NULL	Neural_Regen_Res_2014_Mar_15_9(6)_622-629.nxml.txt.nlp	25206865	SENT119	8	8	17	17	vasopressin	c-Jun	PA451858	3725	0.829
NULL	Mol_Cancer_2014_Jun_27_13_159.nxml.txt.nlp	24972933	SENT132	3	3	22	22	cisplatin	CTRL	PA449014	1506	0.829
NULL	Onco_Targets_Ther_2014_Nov_21_7_2143-2146.nxml.txt.nlp	25473295	SENT41	7	7	39	39	irinotecan	UGT	PA450085	7361;7355	0.829
NULL	Sci_Rep_2014_Sep_9_4_6307.nxml.txt.nlp	25200751	SENT331	0	0	17	17	febuxostat	JNK	PA165958521	5599	0.829
NULL	Case_Rep_Gastrointest_Med_2013_Aug_21_2013_285457.nxml.txt.nlp	24027646	SENT76	29	29	18	18	aspirin	CAD	PA448497	1677;790	0.829
NULL	Front_Genet_2014_Jun_6_5_164.nxml.txt.nlp	24936207	SENT1916	15	15	4	4	rasagiline	GDNF	PA164764584	2668	0.829
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT142	10	10	14	14	perifosine	DR4	PA165291471	8797	0.829
NULL	Nucl_Recept_Signal_2010_Apr_16_8_e004.nxml.txt.nlp	20419060	SENT76	5	5	23	23	rosiglitazone	PIAS1	PA451283	8554	0.829
NULL	Br_J_Cancer_1998_77(3)_434-439.nxml.txt.nlp	9472640	SENT8	33	33	43	43	cisplatin	p53	PA449014	7157	0.829
NULL	Int_J_Nanomedicine_2012_May_7_7_2307-2314.nxml.txt.nlp	22661887	SENT162	3	3	0	0	gemcitabine	F10	PA449748	2159	0.829
NULL	Breast_Cancer_Res_2010_Apr_30_12(2)_203.nxml.txt.nlp	20459590	SENT269	16	16	7	7	carboplatin	BRCA1	PA448803	672	0.829
NULL	Nat_Med_2010_Jun_23_16(6)_671-677.nxml.txt.nlp	20495567	SENT71	5	5	20	20	sorafenib	MCL1	PA7000	4170	0.829
NULL	Cell_Death_Dis_2014_Jan_16_5(1)_e1000.nxml.txt.nlp	24434508	SENT96	20	20	6	6	etoposide	p53	PA449552	7157	0.829
NULL	Indian_J_Pharmacol_2014_May-Jun_46(3)_328-333.nxml.txt.nlp	24987182	SENT157	7	7	26	26	clopidogrel	EPO	PA449053	7076;8288;2056	0.829
NULL	Mol_Cancer_2012_Jul_25_11_47.nxml.txt.nlp	22830443	SENT109	0	0	3	3	panitumumab	EGFR	PA162373091	1956	0.829
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1542-1553.nxml.txt.nlp	21970874	SENT259	28	28	33	33	gefitinib	c-Jun	PA131301952	3725	0.829
NULL	Clin_Mol_Hepatol_2014_Sep_25_20(3)_283-290.nxml.txt.nlp	25320732	SENT120	12	12	15	15	propranolol	EVL	PA451145	51466	0.829
NULL	Ann_Hematol_2014_Apr_1_93(8)_1371-1380.nxml.txt.nlp	24687382	SENT29	1	1	17	17	lenalidomide	IKZF1	PA162363968	10320	0.829
NULL	Oxid_Med_Cell_Longev_2013_Jun_2_2013_793525.nxml.txt.nlp	23819014	SENT8	5	5	2	2	resveratrol	SGBS		2719	0.829
NULL	Acta_Pharmacol_Sin_2014_Sep_25_35(9)_1199-1206.nxml.txt.nlp	25152024	SENT104	5	5	18	18	cisplatin	p38	PA449014	10598;1432;7965	0.829
NULL	Mol_Cell_2013_Apr_11_50(1)_149-156.nxml.txt.nlp	23582260	SENT53	18	18	11	11	staurosporine	IFN	PA165109623	3439	0.829
NULL	Br_J_Cancer_2009_Oct_6_101(7)_1155-1161.nxml.txt.nlp	19738614	SENT126	14	14	6	6	gemcitabine	MUC4	PA449748	4585	0.829
NULL	Adv_Hematol_2012_Aug_2_2012_842945.nxml.txt.nlp	22919394	SENT144	7	7	9	9	lenalidomide	OPG	PA162363968	690	0.829
NULL	Mol_Cancer_2010_Jun_25_9_166.nxml.txt.nlp	20579378	SENT238	5	5	8	8	gefitinib	APBA2	PA131301952	321	0.829
NULL	J_Am_Heart_Assoc_2013_Dec_19_2(6)_e000407.nxml.txt.nlp	24166492	SENT163	20	20	16	16	doxorubicin	p53	PA449412	7157	0.829
NULL	Iran_J_Pharm_Res_2014_Autumn_13(4)_1393-1401.nxml.txt.nlp	25587329	SENT132	3	3	9	9	celecoxib	COX	PA448871	1351	0.829
NULL	Oncotarget_2013_May_11_4(6)_830-843.nxml.txt.nlp	23919981	SENT5	10	10	13	13	temsirolimus	PI3K	PA164746890	5290	0.829
NULL	Cell_Commun_Signal_2013_Oct_1_11_73.nxml.txt.nlp	24083678	SENT126	22	22	26	26	sulindac	A20	PA451565	7128;28935	0.829
NULL	Biomed_Opt_Express_2011_Mar_2_2(4)_771-780.nxml.txt.nlp	21483602	SENT53	37	37	32	32	doxycycline	TYR	PA449415	7299	0.829
NULL	Mol_Cancer_2014_Jun_4_13_141.nxml.txt.nlp	24894453	SENT11	23	23	17	17	cetuximab	EGFR	PA10040	1956	0.829
NULL	Mol_Cancer_2009_Jun_23_8_39.nxml.txt.nlp	19549337	SENT54	20	20	15	15	etoposide	TRAIL	PA449552	8743	0.829
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT123	15	15	32	32	adalimumab	CD36	PA10004	948	0.829
NULL	Exp_Neurobiol_2014_Jun_13_23(2)_148-154.nxml.txt.nlp	24963279	SENT24	16	16	5	5	thrombin	gamma	PA451674	9913	0.829
NULL	Clin_Epidemiol_2014_May_13_6_169-182.nxml.txt.nlp	24872723	SENT186	23	23	7	7	fluconazole	CD4	PA449653	920	0.829
NULL	Front_Aging_Neurosci_2014_Sep_11_6_218.nxml.txt.nlp	25309423	SENT171	0	0	22	22	resveratrol	AMPK		5563	0.829
NULL	Bioinorg_Chem_Appl_2014_Sep_15_2014_718175.nxml.txt.nlp	25332694	SENT44	31	31	9	9	ethanol	mol	PA448073	90527	0.829
NULL	Cardiol_Res_Pract_2013_Jan_31_2013_128795.nxml.txt.nlp	23431496	SENT162	7	7	18	18	clopidogrel	CYP2C19	PA449053	1557	0.829
NULL	Cancer_Cell_Int_2010_Sep_9_10_32.nxml.txt.nlp	20828393	SENT125	24	24	11	11	cisplatin	ATF3	PA449014	467	0.829
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT113	9	9	19	19	neratinib	HER2	PA165291472	2064	0.829
NULL	Clin_Infect_Dis_2013_May_1_56(9)_1330-1339.nxml.txt.nlp	23362284	SENT44	34	34	11	11	stavudine	CD4	PA451494	920	0.829
NULL	Cancer_Cell_Int_2014_Jan_29_14_10.nxml.txt.nlp	24472145	SENT186	7	7	26	26	doxorubicin	EGFR	PA449412	1956	0.829
NULL	Clin_Psychopharmacol_Neurosci_2014_Apr_24_12(1)_37-40.nxml.txt.nlp	24851119	SENT57	11	11	18	18	duloxetine	NAT	PA10066	6046	0.829
NULL	CNS_Spectr_2014_Dec_18_19(6)_528-534.nxml.txt.nlp	24642260	SENT109	9	9	27	27	aripiprazole	NNT	PA10026	23530	0.829
NULL	FEBS_Open_Bio_2014_Aug_30_4_763-776.nxml.txt.nlp	25349781	SENT138	12	12	20	20	curcumin	TFEB	PA151958596	7942	0.829
NULL	Oncotarget_2011_Mar_23_2(3)_165-177.nxml.txt.nlp	21444946	SENT181	4	4	16	16	cetuximab	KRAS	PA10040	3845	0.829
NULL	Open_Cardiovasc_Med_J_2011_Jun_20_5_136-147.nxml.txt.nlp	21760856	SENT41	25	25	18	18	pioglitazone	adiponectin	PA450970	9370	0.829
NULL	Allergy_Asthma_Clin_Immunol_2010_Mar_17_6(1)_5.nxml.txt.nlp	20236545	SENT84	28	28	5	5	cyclosporine	IL-5	PA449167	3567	0.829
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT1424	1	1	9	9	heparin	HGF	PA449855	3569;6654;3082	0.829
NULL	Chin_J_Cancer_2012_Feb_31(2)_110-118.nxml.txt.nlp	22098951	SENT27	34	34	40	40	imatinib	MRP1	PA10804	4437	0.829
NULL	Acta_Pharmacol_Sin_2010_Dec_3_31(12)_1635-1642.nxml.txt.nlp	21127497	SENT155	27	27	10	10	phenylbutazone	UGT	PA450932	7361;7355	0.829
NULL	Br_J_Cancer_2010_Oct_26_103(9)_1331-1334.nxml.txt.nlp	20877352	SENT37	22	22	20	20	trastuzumab	GM-CSF	PA451743	1437	0.829
NULL	Breast_Cancer_(Auckl)_2014_Mar_23_8_51-56.nxml.txt.nlp	24678242	SENT22	37	37	33	33	carboplatin	BRCA1	PA448803	672	0.829
NULL	Acta_Pharmacol_Sin_2010_Dec_3_31(12)_1635-1642.nxml.txt.nlp	21127497	SENT159	0	0	2	2	phenylbutazone	UGT	PA450932	7361;7355	0.829
NULL	Exp_Lung_Res_2013_Oct_1_39(8)_336-348.nxml.txt.nlp	23919450	SENT152	6	6	0	0	argatroban	PAR-1	PA164745516	2011;2149	0.829
NULL	J_Mol_Med_(Berl)_2013_Aug_17_91(11)_1257-1271.nxml.txt.nlp	23955016	SENT120	2	2	19	19	thrombin	PAR-1	PA451674	2011;2149	0.829
NULL	Breast_Cancer_Res_2014_Sep_11_16(5)_430.nxml.txt.nlp	25212826	SENT38	0	0	4	4	fulvestrant	AKT	PA164747170	207	0.829
NULL	J_Korean_Neurosurg_Soc_2014_Jul_31_56(1)_1-4.nxml.txt.nlp	25289117	SENT21	0	0	10	10	curcumin	p38	PA151958596	10598;1432;7965	0.829
NULL	Cardiol_Res_Pract_2012_Apr_22_2012_181394.nxml.txt.nlp	22577589	SENT49	29	29	10	10	chloroquine	TLR9	PA448948	54106	0.829
NULL	Crit_Care_2011_Nov_30_15(6)_235.nxml.txt.nlp	22216838	SENT118	18	18	26	26	hyaluronidase	NLRP3	PA164745713	114548	0.829
NULL	Front_Pharmacol_2014_May_9_5_103.nxml.txt.nlp	24847272	SENT223	17	17	0	0	midazolam	POR	PA450496	5447	0.829
NULL	Indian_J_Pharmacol_2012_Sep-Oct_44(5)_629-633.nxml.txt.nlp	23112427	SENT115	2	2	14	14	metoprolol	ANOVA	PA450480	4858	0.829
NULL	BMJ_Open_2013_Nov_4_3(11)_e003556.nxml.txt.nlp	24189081	SENT298	15	15	21	21	docetaxel	TOP2A	PA449383	7153	0.829
NULL	Arthritis_Res_Ther_2009_Jun_29_11(3)_R100.nxml.txt.nlp	19563672	SENT191	7	7	12	12	infliximab	IFN	PA452639	3439	0.829
NULL	Biomed_Res_Int_2013_Sep_4_2013_185362.nxml.txt.nlp	24093091	SENT115	38	38	35	35	cyclophosphamide	CHOP	PA449165	1649	0.829
NULL	Am_J_Case_Rep_2014_Nov_3_15_480-484.nxml.txt.nlp	25380070	SENT79	4	4	21	21	crizotinib	CEA	PA165946122	5670;1087	0.829
NULL	Front_Oncol_2014_May_7_4_103.nxml.txt.nlp	24847446	SENT53	22	22	3	3	erlotinib	EGFR	PA134687924	1956	0.829
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT111	17	17	25	25	l-methionine	S6K1	PA450423	6198	0.829
NULL	J_Mammary_Gland_Biol_Neoplasia_2010_Mar_27_15(1)_5-17.nxml.txt.nlp	20101446	SENT180	9	9	26	26	tamoxifen	HuR	PA451581	1994	0.829
NULL	Acta_Neuropathol_Commun_2014_Oct_21_2(1)_149.nxml.txt.nlp	NULL	SENT349	7	7	19	19	riluzole	gamma	PA451251	9913	0.829
NULL	Int_J_Biol_Sci_2011_Nov_5_8(1)_1-14.nxml.txt.nlp	22211100	SENT134	0	0	5	5	evodiamine	PI3K	PA165860788	5290	0.829
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT165	20	20	22	22	neratinib	HER2	PA165291472	2064	0.829
NULL	Oxid_Med_Cell_Longev_2013_Jun_2_2013_793525.nxml.txt.nlp	23819014	SENT204	42	42	31	31	resveratrol	AMPK		5563	0.829
NULL	Crit_Care_2011_Nov_30_15(6)_R289.nxml.txt.nlp	22129171	SENT96	0	0	4	4	dipyridamole	IL-10	PA449367	3586	0.829
NULL	Clin_Pediatr_Endocrinol_2009_May_1_18(2)_65-72.nxml.txt.nlp	24790382	SENT75	11	11	4	4	cabergoline	PRL	PA448708	5617	0.829
NULL	Crit_Care_2009_Dec_1_13(6)_233.nxml.txt.nlp	20017891	SENT141	9	9	21	21	methylprednisolone	PES	PA450466	23481	0.829
NULL	Nat_Med_2011_Dec_18_18(1)_120-127.nxml.txt.nlp	22179318	SENT86	3	3	16	16	hemin	HO-1	PA449849	3162	0.829
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT533	27	27	16	16	pp2	TFF3		7033	0.829
NULL	Behav_Brain_Funct_2006_Aug_23_2_30.nxml.txt.nlp	16925830	SENT582	28	28	16	16	methylphenidate	DAT1	PA450464	55885	0.829
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT13	11	11	6	6	imatinib	ABCG2	PA10804	9429	0.829
NULL	Br_J_Pharmacol_2012_Jan_165(2)_380-389.nxml.txt.nlp	21585347	SENT111	20	20	8	8	rosiglitazone	ATGL	PA451283	57104	0.829
NULL	Nat_Commun_2013_Apr_23_4_1758.nxml.txt.nlp	23612299	SENT77	28	28	5	5	isoproterenol	SOD1	PA450121	6647	0.829
NULL	Eur_J_Endocrinol_2010_May_162(5)_987-992.nxml.txt.nlp	20164212	SENT4	18	18	9	9	diazoxide	HNF4A	PA449285	3172	0.829
NULL	Mol_Cell_Biochem_2014_Oct_9_385(1-2)_265-275.nxml.txt.nlp	24104452	SENT189	13	13	1	1	bortezomib	U87	PA10252	677775;641648	0.829
NULL	J_Obes_2010_Jan_14_2010_970865.nxml.txt.nlp	20798864	SENT37	28	28	21	21	metformin	AMPK	PA450395	5563	0.829
NULL	Cardiovasc_Diabetol_2010_Jul_27_9_31.nxml.txt.nlp	20663195	SENT14	30	30	11	11	irbesartan	FSP1	PA450084	6275;51062	0.829
NULL	Acta_Pharmacol_Sin_2012_Dec_29_33(12)_1518-1524.nxml.txt.nlp	23103625	SENT143	21	21	14	14	telmisartan	ACE	PA451605	1636	0.829
NULL	Ther_Clin_Risk_Manag_2007_Dec_3(6)_973-974.nxml.txt.nlp	18516313	SENT34	13	13	26	26	adalimumab	p75	PA10004	7133;11168	0.829
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT49	26	26	13	13	paclitaxel	CYP2D6	PA450761	1565	0.829
NULL	Cancers_(Basel)_2013_Jan_21_5(1)_64-91.nxml.txt.nlp	24216699	SENT131	19	19	15	15	gefitinib	EGFR	PA131301952	1956	0.829
NULL	Mol_Cancer_2009_Apr_16_8_24.nxml.txt.nlp	19371427	SENT292	16	16	10	10	cisplatin	CHK1	PA449014	1111	0.829
NULL	Ecancermedicalscience_2008_Aug_15_2_91.nxml.txt.nlp	22275974	SENT240	10	10	2	2	temozolomide	CD4	PA451609	920	0.829
NULL	Case_Rep_Oncol_2010_Jun_30_4(2)_327-335.nxml.txt.nlp	21738504	SENT4	31	31	18	18	epirubicin	HCC	PA449476	84668	0.829
NULL	Glycoconj_J_2012_Apr_14_29(2-3)_93-105.nxml.txt.nlp	22246380	SENT181	20	20	8	8	galactose	MAA	PA449725	4080	0.829
NULL	Clin_Med_Insights_Cardiol_2010_Dec_1_4_117-128.nxml.txt.nlp	21151850	SENT120	14	14	11	11	clopidogrel	CYP3A4	PA449053	1576	0.829
NULL	Oncotarget_2010_Oct_25_1(7)_497-514.nxml.txt.nlp	21165163	SENT309	29	29	17	17	neratinib	EGFR	PA165291472	1956	0.829
NULL	Indian_J_Endocrinol_Metab_2012_Dec_16(Suppl_2)_S474-S476.nxml.txt.nlp	23565471	SENT76	14	14	0	0	glimepiride	PPG	PA449761	5552	0.829
NULL	J_Biol_2008_Nov_7_7(9)_33.nxml.txt.nlp	19014407	SENT102	16	16	2	2	arsenite	ArsB	PA452638	57152	0.829
NULL	Br_J_Cancer_2012_Jul_10_107(2)_230-233.nxml.txt.nlp	22735900	SENT77	18	18	6	6	tamoxifen	CYP2D6	PA451581	1565	0.829
NULL	Oncotarget_2011_Dec_31_2(12)_1265-1278.nxml.txt.nlp	22246208	SENT29	26	26	28	28	cisplatin	DDP	PA449014	1678	0.829
NULL	Breast_Cancer_(Auckl)_2011_Jul_27_5_175-199.nxml.txt.nlp	21863131	SENT372	21	21	13	13	cisplatin	HER2	PA449014	2064	0.829
NULL	Hum_Genomics_2009_Jan_1_3(2)_128-142.nxml.txt.nlp	19164090	SENT264	9	9	17	17	carboplatin	PAK1	PA448803	5585;5058	0.829
NULL	Oncoimmunology_2013_Oct_1_2(10)_e25771.nxml.txt.nlp	24286020	SENT37	35	35	19	19	lenalidomide	CD4	PA162363968	920	0.829
NULL	Onco_Targets_Ther_2014_Sep_23_7_1653-1661.nxml.txt.nlp	25285015	SENT135	26	26	37	37	sn-38	UGT1A1		54658	0.829
NULL	Nature_2008_Oct_23_455(7216)_1129-1133.nxml.txt.nlp	18948956	SENT182	8	8	5	5	triciribine	AKT	PA165958661	207	0.829
NULL	Nat_Med_2013_Nov_27_19(11)_10_1038_nm_3352.nxml.txt.nlp	24162815	SENT180	33	33	6	6	gefitinib	MPRIP	PA131301952	23164	0.829
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT23	11	11	6	6	cisplatin	p53	PA449014	7157	0.829
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jan_31_65(Pt_2)_o427-o428.nxml.txt.nlp	21582014	SENT76	29	29	7	7	acetone	mol	PA448025	90527	0.829
NULL	J_Cell_Mol_Med_2014_Nov_11_18(11)_2275-2286.nxml.txt.nlp	25208472	SENT228	3	3	20	20	cisplatin	p53	PA449014	7157	0.829
NULL	Acta_Pharmacol_Sin_2011_Jul_9_32(7)_879-887.nxml.txt.nlp	21552292	SENT159	0	0	9	9	metformin	AMPK	PA450395	5563	0.829
NULL	Exp_Ther_Med_2013_Jan_10_5(1)_287-291.nxml.txt.nlp	23251285	SENT112	11	11	16	16	aspirin	APS	PA448497	10603	0.829
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1066.nxml.txt.nlp	24556681	SENT214	36	36	14	14	ethanol	ATG12	PA448073	9140	0.829
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT112	0	0	17	17	curcumin	cIAP2	PA151958596	330	0.829
NULL	Oncotarget_2014_Feb_23_5(3)_802-814.nxml.txt.nlp	24583651	SENT222	24	24	4	4	l-glutamine	CT26	PA10090	168400	0.829
NULL	J_Biol_Chem_2013_Oct_11_288(41)_29642-29653.nxml.txt.nlp	24005673	SENT726	16	16	3	3	trypsin	TSG-6	PA451806	7130	0.829
NULL	Int_J_Gen_Med_2013_Dec_4_6_877-895.nxml.txt.nlp	24403842	SENT58	16	16	22	22	exenatide	PPG	PA164749238	5552	0.829
NULL	J_Cell_Mol_Med_2014_May_7_18(5)_766-779.nxml.txt.nlp	24606538	SENT290	19	19	6	6	methylprednisolone	EGFR	PA450466	1956	0.829
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT100	6	6	12	12	pertuzumab	HER3		2065	0.829
NULL	Arthritis_Res_Ther_2012_Jul_27_14(4)_R175.nxml.txt.nlp	22838733	SENT11	32	32	18	18	adalimumab	CD14	PA10004	929	0.829
NULL	Mol_Biol_Cell_2013_Jul_15_24(14)_2285-2298.nxml.txt.nlp	23720763	SENT135	25	25	27	27	chlorpromazine	CPZ	PA448964	8532	0.829
NULL	Crit_Care_2010_Aug_12_14(4)_229.nxml.txt.nlp	20836899	SENT85	6	6	9	9	isoflurane	TREK-1	PA450106	3776	0.829
NULL	Semin_Immunol_2011_Feb_23(1)_28-41.nxml.txt.nlp	21295490	SENT234	21	21	11	11	etanercept	DC-LAMP	PA449515	27074	0.829
NULL	Gut_Liver_2011_Dec_21_5(4)_406-417.nxml.txt.nlp	22195237	SENT52	13	13	7	7	telaprevir	RVR	PA165958354	9975	0.829
NULL	Br_J_Cancer_1999_Mar_79(7-8)_1104-1110.nxml.txt.nlp	10098743	SENT10	13	13	21	21	cisplatin	JNK	PA449014	5599	0.829
NULL	Diabetes_2013_Jun_17_62(6)_1843-1854.nxml.txt.nlp	23349486	SENT185	19	19	36	36	pioglitazone	CD68	PA450970	968	0.829
NULL	J_Breast_Cancer_2013_Jun_28_16(2)_220-228.nxml.txt.nlp	23843857	SENT122	7	7	12	12	tamoxifen	aromatase	PA451581	1588	0.829
NULL	J_Gynecol_Oncol_2013_Jan_8_24(1)_83-91.nxml.txt.nlp	23346317	SENT73	25	25	18	18	cisplatin	AGO	PA449014	55294	0.829
NULL	Nat_Commun_2014_Dec_8_5_5736.nxml.txt.nlp	25484020	SENT89	20	20	26	26	letrozole	TRPA1	PA450196	8989	0.829
NULL	Breast_Cancer_Res_2008_Dec_16_10(6)_R105.nxml.txt.nlp	19087274	SENT12	18	18	37	37	creatine	KRT19	PA164778930	3880	0.829
NULL	Trials_2013_May_4_14_125.nxml.txt.nlp	23782591	SENT208	28	28	17	17	rivastigmine	CYP2D6	PA451262	1565	0.829
NULL	Front_Neurol_2014_Feb_18_5_17.nxml.txt.nlp	24600432	SENT135	8	8	14	14	levetiracetam	CD178	PA450206	356	0.829
NULL	Oncol_Lett_2014_Apr_12_7(4)_1049-1052.nxml.txt.nlp	24944667	SENT52	14	14	6	6	bevacizumab	GEM	PA130232992	2669	0.829
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Feb_17_68(Pt_3)_o768.nxml.txt.nlp	22412642	SENT62	13	13	22	22	benzaldehyde	mol	PA448571	90527	0.829
NULL	Oxid_Med_Cell_Longev_2013_Jul_9_2013_574029.nxml.txt.nlp	23936610	SENT253	4	4	15	15	resveratrol	CD83		9308	0.829
NULL	Eur_J_Med_Res_2014_Apr_9_19(1)_19.nxml.txt.nlp	24717101	SENT43	14	14	23	23	doxorubicin	CHOP	PA449412	1649	0.829
NULL	J_Mol_Signal_2007_Feb_26_2_2.nxml.txt.nlp	17319972	SENT79	7	7	28	28	thrombin	EGFR	PA451674	1956	0.829
NULL	Epigenetics_Chromatin_2014_Jan_20_7_2.nxml.txt.nlp	24443974	SENT24	25	25	5	5	protamine	PRM2	PA10366	5620	0.829
NULL	Nat_Med_2013_Oct_8_19(10)_1313-1317.nxml.txt.nlp	24013700	SENT66	4	4	0	0	ribavirin	IFN	PA451241	3439	0.829
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1717-1723.nxml.txt.nlp	19844230	SENT126	15	15	7	7	sunitinib	GM-CSF	PA162372840	1437	0.829
NULL	Br_J_Cancer_2010_Jun_29_103(1)_61-72.nxml.txt.nlp	20588279	SENT106	12	12	27	27	trastuzumab	EGF	PA451743	1950	0.829
NULL	Environ_Health_Perspect_1999_May_107(5)_397-405.nxml.txt.nlp	10210696	SENT2	3	3	5	5	diethylstilbestrol	DES	PA449307	1674	0.829
NULL	Mol_Cancer_2013_May_4_12_37.nxml.txt.nlp	23642048	SENT186	5	5	3	3	curcumin	GADD153	PA151958596	1649	0.829
NULL	Biomed_Res_Int_2013_Apr_11_2013_469363.nxml.txt.nlp	23691504	SENT52	38	38	19	19	zinc	CPU	PA451956	1361	0.829
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT45	18	18	13	13	ritonavir	CYP2B6	PA451260	1555	0.829
NULL	Br_J_Cancer_2011_Dec_6_105(12)_1920-1926.nxml.txt.nlp	22095222	SENT9	25	25	6	6	gefitinib	PTEN	PA131301952	5728	0.829
NULL	Aging_(Albany_NY)_2012_Dec_6_4(11)_823-842.nxml.txt.nlp	23235539	SENT180	15	15	2	2	bleomycin	SRM	PA448645	6723;6725	0.829
NULL	Diabetes_2009_Feb_58(2)_344-351.nxml.txt.nlp	19008341	SENT160	15	15	5	5	resveratrol	IFN		3439	0.829
NULL	Arthritis_Res_Ther_2008_Jan_7_10(1)_R1.nxml.txt.nlp	18179697	SENT22	3	3	13	13	oxaliplatin	HMGB1	PA131285527	3146	0.829
NULL	Viruses_2014_Feb_18_6(2)_875-892.nxml.txt.nlp	24553110	SENT190	14	14	31	31	erlotinib	IFN	PA134687924	3439	0.829
NULL	Braz_J_Med_Biol_Res_2013_Apr_12_46(4)_327-338.nxml.txt.nlp	23579631	SENT168	10	10	20	20	rimonabant	AVP	PA152407999	114548;551	0.829
NULL	Case_Rep_Oncol_Med_2014_Dec_23_2014_597291.nxml.txt.nlp	25587475	SENT125	19	19	26	26	vincristine	TNF-alpha	PA451879	7124	0.829
NULL	Environ_Health_Perspect_2010_Jun_25_118(6)_864-870.nxml.txt.nlp	20100676	SENT220	11	11	4	4	arsenite	INS-1	PA452638	2305	0.829
NULL	CNS_Drugs_2012_Dec_13_26(12)_1033-1049.nxml.txt.nlp	23192413	SENT398	13	13	19	19	imipramine	Gen	PA449969	348654	0.829
NULL	Br_J_Cancer_2012_May_8_106(10)_1689-1696.nxml.txt.nlp	22531631	SENT210	6	6	0	0	atorvastatin	PC-3	PA448500	692094	0.829
NULL	Mol_Biol_Cell_2014_Jan_1_25(1)_76-86.nxml.txt.nlp	24173717	SENT288	11	11	4	4	paclitaxel	TUBB6	PA450761	84617	0.829
NULL	Ann_Thorac_Med_2009_Oct-Dec_4(4)_213-215.nxml.txt.nlp	19881169	SENT74	6	6	15	15	clarithromycin	RGM	PA449028	56963	0.829
NULL	Arthritis_Res_Ther_2009_Aug_3_11(4)_238.nxml.txt.nlp	19678909	SENT42	0	0	2	2	hydroquinone	IFN	PA449924	3439	0.829
NULL	Diabetes_2009_Dec_31_58(12)_2851-2862.nxml.txt.nlp	19720788	SENT272	7	7	32	32	forskolin	IRE1	PA146096022	2081	0.829
NULL	Br_J_Cancer_2012_Sep_4_107(6)_947-955.nxml.txt.nlp	22892392	SENT106	9	9	7	7	tamoxifen	EGFR	PA451581	1956	0.829
NULL	Indian_J_Endocrinol_Metab_2012_Dec_16(Suppl_2)_S474-S476.nxml.txt.nlp	23565471	SENT76	7	7	0	0	sitagliptin	PPG	PA164748978	5552	0.829
NULL	Oncol_Lett_2014_May_27_7(5)_1327-1332.nxml.txt.nlp	24765133	SENT69	10	10	21	21	camptothecin	c-FLIP	PA153590860	8837	0.829
NULL	Curr_Cardiol_Rev_2014_May_10(2)_161-171.nxml.txt.nlp	24527681	SENT135	5	5	18	18	losartan	AGTR2	PA450268	186	0.829
NULL	Nucleic_Acids_Res_2005_Jun_8_33(10)_3283-3291.nxml.txt.nlp	15944449	SENT98	3	3	12	12	melphalan	XRCC2	PA450354	7516	0.829
NULL	Arthritis_Res_Ther_2010_Jan_22_12(1)_R11.nxml.txt.nlp	20096109	SENT178	9	9	21	21	infliximab	IFN	PA452639	3439	0.829
NULL	Orphanet_J_Rare_Dis_2008_Jun_25_3_17.nxml.txt.nlp	18578866	SENT339	14	14	22	22	metyrapone	ACTH	PA450486	5443	0.829
NULL	Aging_(Albany_NY)_2011_Jan_18_3(1)_33-43.nxml.txt.nlp	21248371	SENT129	11	11	38	38	zinc	HIF-1	PA451956	29072	0.829
NULL	Cell_Commun_Signal_2003_Nov_24_1_5.nxml.txt.nlp	14636425	SENT78	29	29	6	6	heparin	CCN5	PA449855	8839	0.829
NULL	Diabetes_Metab_Syndr_Obes_2010_Aug_24_3_297-299.nxml.txt.nlp	21437098	SENT35	26	26	19	19	exenatide	GLP-1	PA164749238	100125288	0.829
NULL	Toxins_(Basel)_2010_Oct_28_2(11)_2584-2592.nxml.txt.nlp	22069565	SENT286	10	10	8	8	warfarin	CYP2C9	PA451906	1559	0.829
NULL	BioDrugs_2014_Aug_18_28(1)_27-39.nxml.txt.nlp	23955284	SENT132	5	5	11	11	belinostat	survivin		332	0.829
NULL	Cells_2014_Apr_8_3(2)_258-287.nxml.txt.nlp	24717323	SENT705	3	3	5	5	capsaicin	VR1	PA448776	56664	0.829
NULL	Environ_Health_Perspect_2007_Dec_8_115(Suppl_1)_129-136.nxml.txt.nlp	18174961	SENT117	10	10	30	30	lindane	p53	PA164754914	7157	0.829
NULL	Br_J_Pharmacol_2011_Apr_162(8)_1832-1842.nxml.txt.nlp	21232033	SENT18	3	3	0	0	resveratrol	SIRT1		23411	0.829
NULL	Int_J_Cell_Biol_2012_Mar_27_2012_189794.nxml.txt.nlp	22536246	SENT98	33	33	7	7	etoposide	Vps34	PA449552	5289	0.829
NULL	Toxins_(Basel)_2010_Oct_26_2(11)_2490-2518.nxml.txt.nlp	22069563	SENT137	4	4	2	2	cisplatin	p53	PA449014	7157	0.829
NULL	Mol_Brain_2013_Dec_16_6_56.nxml.txt.nlp	24330819	SENT188	12	12	2	2	dantrolene	c-fos	PA449208	2353	0.829
NULL	Breast_Cancer_Res_2007_Jul_5_9(4)_R41.nxml.txt.nlp	17612393	SENT39	18	18	26	26	nimesulide	Bcl-2	PA137179528	596	0.829
NULL	Aging_(Albany_NY)_2013_Mar_8_5(3)_142-143.nxml.txt.nlp	23474671	SENT23	31	31	35	35	resveratrol	SIRT1		23411	0.829
NULL	Acta_Pharmacol_Sin_2009_Apr_9_30(4)_467-477.nxml.txt.nlp	19270721	SENT225	2	2	8	8	cisplatin	IL-24	PA449014	11009	0.829
NULL	Case_Rep_Hematol_2014_Feb_10_2014_641483.nxml.txt.nlp	24660077	SENT77	10	10	19	19	cyclophosphamide	CHOP	PA449165	1649	0.829
NULL	Cell_Biol_Int_Rep_(2010)_2012_Jun_21_19(1)_e00017.nxml.txt.nlp	23124518	SENT4	6	6	20	20	etoposide	TRAIL-R2	PA449552	8795	0.829
NULL	Cell_Death_Dis_2010_May_13_1(5)_e41.nxml.txt.nlp	21364648	SENT55	29	29	20	20	etoposide	p65	PA449552	5970	0.829
NULL	Mol_Clin_Oncol_2013_Jul_27_1(4)_768-772.nxml.txt.nlp	24649244	SENT25	11	11	13	13	gemcitabine	GEM	PA449748	2669	0.829
NULL	Breast_Cancer_Res_2010_Oct_22_12(Suppl_2)_S1.nxml.txt.nlp	21050422	SENT93	5	5	16	16	gefitinib	EGFR	PA131301952	1956	0.829
NULL	Mol_Cancer_2013_Sep_11_12_104.nxml.txt.nlp	24025152	SENT19	8	8	4	4	gemcitabine	STAT3	PA449748	6774	0.829
NULL	Drugs_R_D_2011_Sep_25_11(3)_227-249.nxml.txt.nlp	21902286	SENT88	1	1	5	5	decitabine	CD71	PA164749631	7037	0.829
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1063.nxml.txt.nlp	24556678	SENT89	6	6	20	20	thioridazine	Mcl-1	PA451666	4170	0.829
NULL	Allergy_Asthma_Immunol_Res_2014_Mar_15_6(2)_126-130.nxml.txt.nlp	24587948	SENT89	7	7	16	16	salbutamol	TTN	PA448068	7273	0.829
NULL	J_Cancer_2013_Nov_21_4(9)_727-735.nxml.txt.nlp	24312143	SENT114	9	9	3	3	cisplatin	SRPK1	PA449014	6732	0.829
NULL	J_Clin_Biochem_Nutr_2009_Jan_27_44(1)_79-84.nxml.txt.nlp	19177192	SENT77	10	10	5	5	curcumin	HO-1	PA151958596	3162	0.829
NULL	Br_J_Cancer_2014_Jan_21_110(2)_384-391.nxml.txt.nlp	24346286	SENT108	14	14	22	22	trastuzumab	HER3	PA451743	2065	0.829
NULL	Mol_Cancer_2010_Aug_23_9_222.nxml.txt.nlp	20731837	SENT186	2	2	19	19	cetuximab	EGFR	PA10040	1956	0.829
NULL	Cancer_Res_Treat_2011_Sep_30_43(3)_148-153.nxml.txt.nlp	22022291	SENT122	23	23	14	14	sn-38	UGT1A1		54658	0.829
NULL	Cancer_Immunol_Immunother_2013_Aug_27_62(10)_1637-1648.nxml.txt.nlp	23982484	SENT38	36	36	26	26	lenalidomide	IL-2	PA162363968	3558	0.829
NULL	Arthritis_Res_Ther_2007_Jun_29_9(Suppl_1)_S2.nxml.txt.nlp	17634141	SENT109	12	12	9	9	denosumab	RANKL	PA166048634	8600	0.829
NULL	Infect_Drug_Resist_2010_Mar_11_3_45-51.nxml.txt.nlp	21694893	SENT115	26	26	16	16	halofantrine	CYP3A4	PA449839	1576	0.829
NULL	Clin_Pediatr_Endocrinol_2007_Dec_7_16(1)_1-9.nxml.txt.nlp	24790338	SENT88	4	4	20	20	hydrocortisone	ACTH	PA449905	5443	0.829
NULL	Br_J_Cancer_2009_Oct_20_101(8)_1290-1297.nxml.txt.nlp	19755992	SENT200	32	32	1	1	glucose	HIF-1	PA449773	29072	0.829
NULL	Curr_Neuropharmacol_2013_Jul_11(4)_338-378.nxml.txt.nlp	24381528	SENT582	12	12	17	17	curcumin	JNK	PA151958596	5599	0.829
NULL	BMB_Rep_2013_Jan_46(1)_59-64.nxml.txt.nlp	23351386	SENT335	3	3	19	19	auranofin	NF-kappaB	PA448510	4790	0.829
NULL	Br_J_Cancer_2010_Jun_29_103(1)_61-72.nxml.txt.nlp	20588279	SENT249	13	13	30	30	trastuzumab	Rho	PA451743	29984	0.829
NULL	Mol_Cancer_2014_Jan_15_13_9.nxml.txt.nlp	24428911	SENT115	17	17	32	32	gefitinib	SRSF2	PA131301952	6427	0.829
NULL	Core_Evid_2014_Feb_25_9_27-39.nxml.txt.nlp	24596542	SENT202	19	19	12	12	micafungin	CD4	PA164781026	920	0.829
NULL	Crit_Care_1999_Dec_23_4(Suppl_A)_4.nxml.txt.nlp	NULL	SENT10	14	14	2	2	heparin	ACT	PA449855	12;11332;9457;641455	0.829
NULL	Mol_Vis_2011_Dec_16_17_3300-3308.nxml.txt.nlp	22194656	SENT208	28	28	15	15	brimonidine	ERG	PA448665	2078	0.829
NULL	Ann_Oncol_2012_Dec_2_23(12)_3007-3016.nxml.txt.nlp	22865781	SENT163	15	15	21	21	trastuzumab	PTEN	PA451743	5728	0.829
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT288	15	15	3	3	warfarin	CYP2C9	PA451906	1559	0.829
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT55	12	12	8	8	cisplatin	CTR2	PA449014	1318	0.829
NULL	Cancer_Cell_Int_2006_Aug_9_6_20.nxml.txt.nlp	16899133	SENT58	21	21	12	12	genistein	p27	PA165109660	5715;10534	0.829
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT16	5	5	10	10	dasatinib	JNK	PA162372878	5599	0.829
NULL	Mediators_Inflamm_2001_Jun_10(3)_125-133.nxml.txt.nlp	11545249	SENT15	0	0	11	11	metyrapone	CTX	PA450486	1593	0.829
NULL	Front_Neurosci_2012_May_30_6_77.nxml.txt.nlp	22661925	SENT150	0	0	15	15	ethanol	DCX	PA448073	1641	0.829
NULL	Ther_Clin_Risk_Manag_2007_Dec_3(6)_1027-1033.nxml.txt.nlp	18516257	SENT155	13	13	17	17	temozolomide	MGMT	PA451609	4255	0.829
NULL	Eur_J_Endocrinol_2014_Mar_170(3)_451-459.nxml.txt.nlp	24362411	SENT192	10	10	12	12	liraglutide	SFRP5	PA165958364	6425	0.829
NULL	Antimicrob_Agents_Chemother_2014_Nov_10_59(1)_490-497.nxml.txt.nlp	25385107	SENT68	3	3	5	5	atovaquone	ATV	PA448502	4683	0.829
NULL	Channels_(Austin)_2010_Jan_1_4(1)_22-41.nxml.txt.nlp	19934650	SENT39	14	14	19	19	quinidine	Slo3	PA451209	157855	0.829
NULL	Ecancermedicalscience_2009_Oct_29_3_157.nxml.txt.nlp	22276018	SENT416	14	14	1	1	tamoxifen	ATAC	PA451581	6375	0.829
NULL	Oncotarget_2013_Nov_23_5(1)_196-210.nxml.txt.nlp	24344116	SENT102	10	10	14	14	doxorubicin	p65	PA449412	5970	0.829
NULL	J_Cardiothorac_Surg_2012_Sep_27_7_97.nxml.txt.nlp	23013706	SENT147	32	32	29	29	warfarin	CYP4F2	PA451906	8529	0.829
NULL	Oncotarget_2010_Oct_25_1(7)_497-514.nxml.txt.nlp	21165163	SENT122	31	31	11	11	gefitinib	EGFR	PA131301952	1956	0.829
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jun_25_67(Pt_7)_o1787.nxml.txt.nlp	21837160	SENT60	0	0	8	8	clopidogrel	ADP	PA449053	23038	0.829
NULL	Acta_Neuropathol_2010_Nov_17_120(5)_567-584.nxml.txt.nlp	20714900	SENT269	14	14	4	4	temozolomide	MSH6	PA451609	2956	0.829
NULL	Nucleic_Acids_Res_2014_Jan_26_42(Database_issue)_D1147-D1153.nxml.txt.nlp	24285301	SENT33	10	10	2	2	enfuvirtide	AVP	PA164744517	114548;551	0.829
NULL	Acta_Pharmacol_Sin_2011_Sep_5_32(9)_1128-1137.nxml.txt.nlp	21892192	SENT275	4	4	1	1	hydroxyzine	HERG	PA449943	3757	0.829
NULL	J_Infect_Dis_2011_Feb_15_203(4)_464-472.nxml.txt.nlp	21216867	SENT6	10	10	4	4	pyrimethamine	CTX	PA451193	1593	0.829
NULL	Viruses_2014_Apr_14_6(4)_1715-1758.nxml.txt.nlp	24736215	SENT323	11	11	19	19	hydroxychloroquine	CD4	PA164777036	920	0.829
NULL	J_Biomed_Biotechnol_2011_Jun_13_2011_861920.nxml.txt.nlp	21716670	SENT204	5	5	24	24	hydrocortisone	KIR	PA449905	2669	0.829
NULL	BMB_Rep_2014_Nov_47(11)_637-642.nxml.txt.nlp	24602608	SENT71	30	30	6	6	sulodexide	GAPDH	PA164746343	2597	0.829
NULL	Cancer_Cell_Int_2014_Jul_2_14_59.nxml.txt.nlp	25120382	SENT124	27	27	10	10	metformin	N-myc	PA450395	4613	0.829
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT173	22	22	27	27	ranibizumab	PlGF-2	PA164746012	5228	0.829
NULL	Br_J_Cancer_2012_Nov_6_107(10)_1714-1721.nxml.txt.nlp	23073173	SENT150	17	17	10	10	bicalutamide	RUNX2	PA164746255	860	0.829
NULL	Br_J_Cancer_2013_Dec_10_109(12)_3067-3072.nxml.txt.nlp	24263065	SENT43	0	0	16	16	irinotecan	BRAF	PA450085	673	0.829
NULL	J_Hematol_Oncol_2009_Aug_12_2_36.nxml.txt.nlp	19674465	SENT103	21	21	7	7	lenalidomide	IFN	PA162363968	3439	0.829
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_75-89.nxml.txt.nlp	17912638	SENT267	40	40	5	5	anastrozole	ATAC	PA448432	6375	0.829
NULL	Cell_Div_2012_Dec_26_7_26.nxml.txt.nlp	23268747	SENT114	0	0	33	33	bortezomib	E2F4	PA10252	1874	0.829
NULL	Diabetes_2009_Jan_58(1)_104-115.nxml.txt.nlp	18835938	SENT165	2	2	23	23	rosiglitazone	MCP-2	PA451283	6355	0.829
NULL	Front_Genet_2012_Oct_26_3_213.nxml.txt.nlp	23112805	SENT383	0	0	6	6	omeprazole	CYP1A1	PA450704	1543	0.829
NULL	Environ_Health_Perspect_2010_Sep_28_118(9)_1267-1272.nxml.txt.nlp	20427257	SENT203	15	15	10	10	estradiol	BPA	PA449503	667	0.829
NULL	Chin_J_Cancer_2012_Jul_31(7)_319-326.nxml.txt.nlp	22257382	SENT104	16	16	4	4	gefitinib	EGFR	PA131301952	1956	0.829
NULL	Trials_2013_Apr_23_14_105.nxml.txt.nlp	23782520	SENT269	12	12	15	15	fluoxetine	Gen	PA449673	348654	0.829
NULL	Oncogene_2013_Oct_24_32(43)_5176-5185.nxml.txt.nlp	23208500	SENT193	16	16	2	2	celecoxib	p53	PA448871	7157	0.829
NULL	Cell_Res_2011_Mar_11_21(3)_530-545.nxml.txt.nlp	21221130	SENT238	20	20	8	8	thrombin	RGDS	PA451674	5900	0.829
NULL	Alcohol_Res_2013_35(1)_57-67.nxml.txt.nlp	24313165	SENT133	2	2	11	11	ethanol	TLR4	PA448073	7099	0.829
NULL	Environ_Health_Perspect_2005_Aug_15_113(8)_1009-1014.nxml.txt.nlp	16079071	SENT197	2	2	7	7	losartan	p38	PA450268	10598;1432;7965	0.829
NULL	J_Gynecol_Oncol_2014_Jul_3_25(3)_249-259.nxml.txt.nlp	25045438	SENT208	21	21	5	5	cisplatin	EGFR	PA449014	1956	0.829
NULL	Am_J_Cardiovasc_Drugs_2014_Oct_31_14(2)_79-87.nxml.txt.nlp	24174174	SENT26	0	0	7	7	pravastatin	adiponectin	PA451089	9370	0.829
NULL	Biomed_Opt_Express_2011_Nov_15_2(12)_3321-3333.nxml.txt.nlp	22162822	SENT154	7	7	16	16	ethanol	Sb1	PA448073	92799	0.829
NULL	Int_J_Mol_Sci_2014_Jun_5_15(6)_10083-10100.nxml.txt.nlp	24905407	SENT68	20	20	14	14	tetracycline	TRB	PA451640	6957	0.829
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT138	13	13	0	0	imatinib	ABCB1	PA10804	5243	0.829
NULL	Cancer_Cell_Int_2004_Aug_17_4_5.nxml.txt.nlp	15315711	SENT62	0	0	10	10	genistein	PC3	PA165109660	57332;7832;5122	0.829
NULL	Evid_Based_Complement_Alternat_Med_2013_Mar_19_2013_184358.nxml.txt.nlp	23573117	SENT222	22	22	17	17	resveratrol	AMPK		5563	0.829
NULL	Mol_Biol_Cell_2013_Jun_15_24(12)_1996-2007.nxml.txt.nlp	23637462	SENT305	10	10	36	36	phenol	p75	PA450913	7133;11168	0.829
NULL	Front_Oncol_2013_Nov_15_3_281.nxml.txt.nlp	24298448	SENT213	21	21	13	13	vemurafenib	BRAF	PA165946873	673	0.829
NULL	Biomed_Res_Int_2013_Jul_31_2013_692071.nxml.txt.nlp	23984399	SENT213	6	6	4	4	tropisetron	OCT1	PA161925594	5451;6580	0.829
NULL	J_Mol_Med_(Berl)_2014_May_10_92(7)_709-722.nxml.txt.nlp	24811491	SENT301	6	6	9	9	cetuximab	EGFR	PA10040	1956	0.829
NULL	Braz_J_Med_Biol_Res_2014_Feb_17_47(2)_101-109.nxml.txt.nlp	24519125	SENT135	15	15	5	5	phentolamine	IL-6	PA450926	3569	0.829
NULL	J_Cell_Biol_2002_May_13_157(4)_645-655.nxml.txt.nlp	11994317	SENT127	26	26	9	9	galactose	SLY1	PA449725	23256	0.829
NULL	FEBS_Open_Bio_2012_Aug_22_2_279-283.nxml.txt.nlp	23650611	SENT96	14	14	27	27	raloxifene	IFN	PA451221	3439	0.829
NULL	Int_J_Endocrinol_2013_Sep_11_2013_518046.nxml.txt.nlp	24101924	SENT149	21	21	11	11	naloxone	ghrelin	PA450586	51738	0.829
NULL	Breast_Cancer_(Auckl)_2011_Oct_9_5_209-226.nxml.txt.nlp	22084574	SENT250	18	18	10	10	tamoxifen	aromatase	PA451581	1588	0.829
NULL	Curr_Pharm_Biotechnol_2012_May_13(6)_969-986.nxml.txt.nlp	22039792	SENT113	3	3	12	12	ivermectin	MDR1	PA450133	5243	0.829
NULL	Onco_Targets_Ther_2014_Sep_9_7_1571-1582.nxml.txt.nlp	25228815	SENT172	9	9	30	30	sunitinib	VEGFR1	PA162372840	2321	0.829
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT144	9	9	19	19	gefitinib	PTEN	PA131301952	5728	0.829
NULL	Clin_Epidemiol_2010_Aug_9_2_29-36.nxml.txt.nlp	20865100	SENT35	37	37	40	40	escitalopram	B10	PA10074	5169	0.829
NULL	Oncol_Rep_2014_Sep_20_32(3)_875-886.nxml.txt.nlp	24969320	SENT172	3	3	13	13	vemurafenib	BRAF	PA165946873	673	0.829
NULL	Acta_Pharmacol_Sin_2011_Jul_13_32(7)_967-972.nxml.txt.nlp	21666702	SENT141	47	47	44	44	ticlopidine	P-gp	PA451686	5243	0.829
NULL	J_Headache_Pain_2009_Apr_6_10(2)_85-91.nxml.txt.nlp	19266171	SENT264	3	3	13	13	eletriptan	5-HT1B	PA134687947	3351	0.829
NULL	Diabetes_2009_Feb_58(2)_329-336.nxml.txt.nlp	19171749	SENT128	5	5	10	10	imatinib	JNK	PA10804	5599	0.829
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT108	0	0	9	9	neratinib	EGFR	PA165291472	1956	0.829
NULL	J_Brachial_Plex_Peripher_Nerve_Inj_2008_Mar_19_3_8.nxml.txt.nlp	18353188	SENT199	4	4	19	19	capsaicin	SSeCKS	PA448776	9590	0.829
NULL	J_Vis_Exp_2010_Nov_6_(45)_2032.nxml.txt.nlp	21085105	SENT48	13	13	1	1	trypsin	RPE	PA451806	6120	0.829
NULL	Nat_Neurosci_2013_Apr_17_16(4)_464-472.nxml.txt.nlp	23502536	SENT49	7	7	24	24	fluoxetine	CA1	PA449673	759	0.829
NULL	Arthritis_Res_Ther_2004_Oct_13_6(6)_265-278.nxml.txt.nlp	15535839	SENT274	29	29	6	6	metronidazole	HIF-1	PA450484	29072	0.829
NULL	Exp_Ther_Med_2013_Oct_30_6(4)_1015-1021.nxml.txt.nlp	24137308	SENT25	25	25	12	12	urokinase	BCS	PA451836	617	0.829
NULL	Breast_Cancer_Res_Treat_2014_Apr_9_145(1)_73-82.nxml.txt.nlp	24715380	SENT24	12	12	6	6	tamoxifen	CXCL10	PA451581	3627	0.829
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jun_5_66(Pt_7)_o1550.nxml.txt.nlp	21587795	SENT58	36	36	19	19	ethanol	mol	PA448073	90527	0.829
NULL	Neuro_Oncol_2010_Apr_27_12(4)_389-400.nxml.txt.nlp	20308316	SENT133	14	14	5	5	chloroquine	p53	PA448948	7157	0.829
NULL	Breast_Cancer_Res_2010_Jun_28_12(3)_R43.nxml.txt.nlp	20579400	SENT180	5	5	10	10	tamoxifen	MAPT	PA451581	4137	0.829
NULL	Mol_Cancer_2010_Mar_2_9_46.nxml.txt.nlp	20196838	SENT202	6	6	18	18	irinotecan	MDR1	PA450085	5243	0.829
NULL	Case_Rep_Med_2010_Jul_6_2010_426804.nxml.txt.nlp	20671989	SENT57	24	24	22	22	capecitabine	CYP2C9	PA448771	1559	0.829
NULL	Ital_J_Pediatr_2013_Oct_14_39_64.nxml.txt.nlp	24124913	SENT88	20	20	31	31	etanercept	TNF-alpha	PA449515	7124	0.829
NULL	J_Biomed_Sci_2013_Mar_15_20(1)_17.nxml.txt.nlp	23497194	SENT142	28	28	7	7	rivaroxaban	COX	PA165958360	1351	0.829
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT182	1	1	10	10	glucose	EGFR	PA449773	1956	0.829
NULL	Diabetes_2009_Dec_31_58(12)_2851-2862.nxml.txt.nlp	19720788	SENT132	9	9	0	0	forskolin	CHOP	PA146096022	1649	0.829
NULL	Mol_Med_Rep_2015_Feb_5_11(2)_805-814.nxml.txt.nlp	25373883	SENT249	12	12	3	3	colchicine	APE	PA449092	55704;328	0.829
NULL	Acta_Pharmacol_Sin_2009_Dec_4_30(12)_1585-1593.nxml.txt.nlp	19960004	SENT71	7	7	10	10	nifedipine	mol	PA450631	90527	0.828
NULL	Nucleic_Acids_Res_2005_Jun_8_33(10)_3283-3291.nxml.txt.nlp	15944449	SENT98	3	3	14	14	melphalan	XRCC3	PA450354	7517	0.828
NULL	Mol_Cancer_2013_Sep_11_12_104.nxml.txt.nlp	24025152	SENT121	12	12	24	24	gemcitabine	STAT3	PA449748	6774	0.828
NULL	Diabetes_Care_2012_Apr_13_35(4)_868-872.nxml.txt.nlp	22357182	SENT117	15	15	7	7	rosiglitazone	DREAM	PA451283	30818	0.828
NULL	Oncotarget_2014_Aug_8_5(17)_7936-7944.nxml.txt.nlp	25277205	SENT20	11	11	18	18	vemurafenib	BRAF	PA165946873	673	0.828
NULL	Lipids_Health_Dis_2011_Dec_30_10_246.nxml.txt.nlp	22208561	SENT78	35	35	21	21	ethanol	HO-1	PA448073	3162	0.828
NULL	Case_Rep_Obstet_Gynecol_2013_May_2_2013_492754.nxml.txt.nlp	23738169	SENT12	17	17	21	21	etoposide	EMA	PA449552	2108	0.828
NULL	Mol_Vis_2011_Dec_27_17_3415-3422.nxml.txt.nlp	22219637	SENT14	3	3	13	13	estradiol	p38	PA449503	10598;1432;7965	0.828
NULL	Aging_(Albany_NY)_2012_Feb_11_4(2)_98-115.nxml.txt.nlp	22328600	SENT488	5	5	16	16	etanercept	adiponectin	PA449515	9370	0.828
NULL	Mol_Cancer_2009_Aug_25_8_66.nxml.txt.nlp	19706164	SENT36	6	6	2	2	aspirin	COX	PA448497	1351	0.828
NULL	Int_J_Biol_Sci_2012_Feb_9_8(3)_310-327.nxml.txt.nlp	22355267	SENT131	11	11	19	19	simvastatin	PCSK9	PA451363	255738	0.828
NULL	Nat_Neurosci_2012_Sep_5_15(9)_1245-1254.nxml.txt.nlp	22864611	SENT43	23	23	17	17	risperidone	mGlu2	PA451257	2912	0.828
NULL	Oncogene_2010_Jul_22_29(29)_4170-4182.nxml.txt.nlp	20498638	SENT91	12	12	3	3	cetuximab	EGFR	PA10040	1956	0.828
NULL	Cancer_Cell_Int_2010_Aug_13_10_26.nxml.txt.nlp	20707917	SENT101	2	2	6	6	doxorubicin	RhoA	PA449412	387	0.828
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT149	5	5	38	38	perifosine	p38	PA165291471	10598;1432;7965	0.828
NULL	Arthritis_Res_Ther_2007_Oct_9_9(5)_R104.nxml.txt.nlp	17925024	SENT186	5	5	25	25	glucosamine	JNK	PA164747613	5599	0.828
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_315-322.nxml.txt.nlp	20049735	SENT169	35	35	27	27	olaparib	PTEN		5728	0.828
NULL	Br_J_Cancer_2011_Apr_12_104(8)_1278-1287.nxml.txt.nlp	21487429	SENT141	9	9	6	6	cisplatin	DR5	PA449014	8795	0.828
NULL	Insights_Imaging_2011_Mar_25_2(3)_235-246.nxml.txt.nlp	22347950	SENT171	46	46	21	21	choline	MRS	PA448976	8011	0.828
NULL	J_Int_Soc_Sports_Nutr_2009_Feb_19_6_6.nxml.txt.nlp	19228401	SENT9	2	2	15	15	creatine	CEE	PA164778930	51608	0.828
NULL	Biosci_Rep_2014_Dec_12_34(6)_e00162.nxml.txt.nlp	25385088	SENT167	16	16	6	6	chymotrypsin	XPA	PA448994	7507	0.828
NULL	Cancer_Res_Treat_2014_Jul_15_46(3)_234-242.nxml.txt.nlp	25038758	SENT157	3	3	6	6	paclitaxel	P-gp	PA450761	5243	0.828
NULL	J_Cell_Biol_1997_Mar_24_136(6)_1249-1261.nxml.txt.nlp	9087441	SENT63	29	29	1	1	glutaraldehyde	PLP	PA449777	25824;5744	0.828
NULL	Int_J_Hypertens_2012_Feb_8_2012_189512.nxml.txt.nlp	22518281	SENT156	6	6	3	3	hemin	HO-1	PA449849	3162	0.828
NULL	Biologics_2012_Dec_17_6_429-464.nxml.txt.nlp	23269860	SENT246	6	6	24	24	tocilizumab	ACR	PA165292659	49	0.828
NULL	Cell_Death_Dis_2014_Mar_13_5(3)_e1112.nxml.txt.nlp	24625971	SENT10	20	20	17	17	curcumin	CHOP	PA151958596	1649	0.828
NULL	Mol_Biol_Rep_2013_May_11_40(8)_5013-5026.nxml.txt.nlp	23666059	SENT252	28	28	17	17	resveratrol	PLK1		5347	0.828
NULL	Allergy_Asthma_Immunol_Res_2013_Jul_27_5(4)_216-223.nxml.txt.nlp	23814675	SENT47	15	15	37	37	l-glutamine	CO2	PA10090	4513	0.828
NULL	Cancer_Cell_Int_2006_Mar_23_6_6.nxml.txt.nlp	16556298	SENT8	3	3	10	10	paclitaxel	FDG	PA450761	23583	0.828
NULL	Indian_J_Pharm_Sci_2013_Nov-Dec_75(6)_680-687.nxml.txt.nlp	24591743	SENT35	20	20	17	17	gemfibrozil	CYP2C9	PA449750	1559	0.828
NULL	Mol_Cancer_2008_Jun_30_7_60.nxml.txt.nlp	18590557	SENT168	15	15	22	22	camptothecin	TRAIL	PA153590860	8743	0.828
NULL	Nature_2009_Apr_2_458(7238)_591-596.nxml.txt.nlp	19234442	SENT76	23	23	38	38	etoposide	JNK1	PA449552	5599	0.828
NULL	Gut_Liver_2013_May_9_7(3)_329-334.nxml.txt.nlp	23710315	SENT9	4	4	6	6	lamivudine	LAM	PA450163	7249;7248	0.828
NULL	J_Invest_Dermatol_2014_Feb_10_134(2)_319-325.nxml.txt.nlp	24108405	SENT84	24	24	2	2	vemurafenib	BRAF	PA165946873	673	0.828
NULL	Onco_Targets_Ther_2014_Sep_5_7_1551-1562.nxml.txt.nlp	25228814	SENT179	8	8	1	1	bevacizumab	MMP9	PA130232992	4318	0.828
NULL	ScientificWorldJournal_2014_Dec_30_2014_979648.nxml.txt.nlp	25610915	SENT140	24	24	16	16	imipenem	IMP-1	PA449968	10642	0.828
NULL	Lipids_Health_Dis_2011_Feb_28_10_38.nxml.txt.nlp	21352602	SENT95	5	5	15	15	atorvastatin	PCSK9	PA448500	255738	0.828
NULL	Br_J_Cancer_1998_Sep_78(6)_745-751.nxml.txt.nlp	9743293	SENT6	30	30	15	15	topotecan	p53	PA451729	7157	0.828
NULL	Br_J_Cancer_2010_Oct_26_103(9)_1380-1390.nxml.txt.nlp	20877355	SENT168	0	0	17	17	etoposide	DR5	PA449552	8795	0.828
NULL	Mol_Cancer_2012_Jun_18_11_41.nxml.txt.nlp	22709873	SENT8	33	33	26	26	lapatinib	HER2	PA152241907	2064	0.828
NULL	J_Cardiothorac_Surg_2013_Apr_29_8_115.nxml.txt.nlp	23628179	SENT38	9	9	13	13	bivalirudin	ACT	PA10032	12;11332;9457;641455	0.828
NULL	J_Adv_Pract_Oncol_2013_Jul_1_Jul-Aug_4(4)_263-268.nxml.txt.nlp	25032007	SENT45	19	19	11	11	tacrolimus	CYP2C19	PA451578	1557	0.828
NULL	Mol_Biol_Cell_2014_Jan_1_25(1)_76-86.nxml.txt.nlp	24173717	SENT201	8	8	13	13	paclitaxel	TUBB6	PA450761	84617	0.828
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1150.nxml.txt.nlp	24675468	SENT97	43	43	9	9	ethanol	AMPK	PA448073	5563	0.828
NULL	Mol_Vis_2014_May_2_20_616-628.nxml.txt.nlp	24826069	SENT238	0	0	3	3	curcumin	JNK	PA151958596	5599	0.828
NULL	Breast_Cancer_Res_2012_Mar_9_14(2)_R41.nxml.txt.nlp	22405131	SENT11	0	0	20	20	estradiol	IL-17	PA449503	3605	0.828
NULL	Neuroscience_2009_Jun_30_161(2-3)_572-577.nxml.txt.nlp	19327387	SENT502	7	7	10	10	capsaicin	TRPV1	PA448776	7442	0.828
NULL	Br_J_Pharmacol_2014_Aug_17_171(15)_3651-3665.nxml.txt.nlp	24712679	SENT271	31	31	29	29	liraglutide	GLP-1	PA165958364	100125288	0.828
NULL	Oncol_Lett_2014_Mar_10_7(3)_771-777.nxml.txt.nlp	24527085	SENT86	18	18	11	11	trypsin	CO2	PA451806	4513	0.828
NULL	Oncoscience_2014_Jul_3_1(6)_407-422.nxml.txt.nlp	25594039	SENT199	19	19	7	7	olaparib	BRCA1		672	0.828
NULL	Clin_Ophthalmol_2012_Apr_27_6_637-644.nxml.txt.nlp	22570544	SENT14	4	4	34	34	bromfenac	COX	PA448670	1351	0.828
NULL	Neuropsychopharmacology_2011_Apr_2_36(5)_1033-1046.nxml.txt.nlp	21289603	SENT373	8	8	13	13	ethanol	MSN	PA448073	4478	0.828
NULL	Sci_Rep_2014_Dec_8_4_7355.nxml.txt.nlp	25483453	SENT12	23	23	35	35	raloxifene	aromatase	PA451221	1588	0.828
NULL	Cell_Cycle_2013_Dec_15_12(24)_3718-3719.nxml.txt.nlp	24189534	SENT16	23	23	37	37	bortezomib	SOCS-1	PA10252	8651	0.828
NULL	ScientificWorldJournal_2012_Aug_13_2012_496453.nxml.txt.nlp	22927782	SENT48	35	35	23	23	pioglitazone	GLP-1	PA450970	100125288	0.828
NULL	J_Hematol_Oncol_2011_Jan_21_4_5.nxml.txt.nlp	21255411	SENT152	26	26	18	18	paclitaxel	EGFR	PA450761	1956	0.828
NULL	Diabetes_Care_2011_Oct_15_34(10)_2323-2328.nxml.txt.nlp	21949223	SENT183	18	18	8	8	metformin	LKB1	PA450395	6794	0.828
NULL	Neuropsychopharmacology_2011_Apr_2_36(5)_1033-1046.nxml.txt.nlp	21289603	SENT248	4	4	25	25	ethanol	IRK1	PA448073	3759	0.828
NULL	Int_J_Mol_Sci_2014_Oct_6_15(10)_17886-17900.nxml.txt.nlp	25290095	SENT153	6	6	20	20	resveratrol	p38		10598;1432;7965	0.828
NULL	Front_Oncol_2014_Aug_11_4_204.nxml.txt.nlp	25157335	SENT73	11	11	3	3	erlotinib	EGFR	PA134687924	1956	0.828
NULL	Breast_Cancer_Res_2011_May_25_13(3)_107.nxml.txt.nlp	21635706	SENT7	2	2	8	8	denosumab	RANKL	PA166048634	8600	0.828
NULL	Clinics_(Sao_Paulo)_2014_Jan_69(1)_68-74.nxml.txt.nlp	24473562	SENT91	5	5	24	24	nutlin-3	SOCS-1		8651	0.828
NULL	Clin_Exp_Reprod_Med_2011_Jun_30_38(2)_98-102.nxml.txt.nlp	22384426	SENT81	37	37	17	17	pioglitazone	IL-6	PA450970	3569	0.828
NULL	Cancer_Manag_Res_2011_Aug_10_3_273-285.nxml.txt.nlp	21931501	SENT145	15	15	31	31	sunitinib	IFN	PA162372840	3439	0.828
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2012_Dec_5_1(12)_e17.nxml.txt.nlp	23887441	SENT169	14	14	11	11	ketoconazole	CYP3A4	PA450146	1576	0.828
NULL	Br_J_Cancer_2012_Apr_24_106(9)_1543-1550.nxml.txt.nlp	22531721	SENT69	18	18	29	29	trastuzumab	CD55	PA451743	1604	0.828
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1149.nxml.txt.nlp	24675467	SENT6	20	20	17	17	trastuzumab	DM1	PA451743	338023;1760;28509	0.828
NULL	Front_Neurol_2011_Nov_21_2_68.nxml.txt.nlp	22125548	SENT2943	3	3	0	0	minocycline	TNF-alpha	PA450519	7124	0.828
NULL	Front_Endocrinol_(Lausanne)_2013_Jul_12_4_88.nxml.txt.nlp	23874324	SENT140	24	24	14	14	tamoxifen	CYP2D6	PA451581	1565	0.828
NULL	J_Cardiothorac_Surg_2013_Mar_16_8_49.nxml.txt.nlp	23497457	SENT8	17	17	6	6	vasopressin	IBP	PA451858	706;50619	0.828
NULL	Iran_J_Basic_Med_Sci_2012_Nov-Dec_15(6)_1202-1209.nxml.txt.nlp	23653852	SENT160	3	3	7	7	metformin	AMPK	PA450395	5563	0.828
NULL	Arch_Gynecol_Obstet_2013_Mar_8_287(3)_563-570.nxml.txt.nlp	23135210	SENT38	28	28	8	8	cisplatin	MRP2	PA449014	100130958;57626;1244	0.828
NULL	Diabetol_Metab_Syndr_2014_Mar_31_6_47.nxml.txt.nlp	24684779	SENT166	18	18	7	7	pioglitazone	adiponectin	PA450970	9370	0.828
NULL	J_Biomed_Biotechnol_2010_Nov_2_2010_232016.nxml.txt.nlp	21052559	SENT148	9	9	12	12	theophylline	IL-2	PA451647	3558	0.828
NULL	J_Korean_Neurosurg_Soc_2013_Oct_31_54(4)_280-288.nxml.txt.nlp	24294450	SENT32	24	24	26	26	acetazolamide	ACZ	PA448018	27445	0.828
NULL	Cell_Oncol_(Dordr)_2011_Apr_19_34(2)_71-88.nxml.txt.nlp	21336636	SENT74	20	20	7	7	mitomycin	BRCA2	PA450524	675	0.828
NULL	Br_J_Cancer_2010_Oct_26_103(9)_1331-1334.nxml.txt.nlp	20877352	SENT30	15	15	5	5	trastuzumab	HER2	PA451743	2064	0.828
NULL	Anesth_Essays_Res_2011_Jul-Dec_5(2)_182-186.nxml.txt.nlp	NULL	SENT24	18	18	33	33	ondansetron	CYP2D6	PA450705	1565	0.828
NULL	Ann_Hematol_2014_Mar_18_93(8)_1335-1344.nxml.txt.nlp	24638841	SENT92	32	32	19	19	vincristine	CHOP	PA451879	1649	0.828
NULL	Avicenna_J_Phytomed_2013_Summer_3(3)_201-204.nxml.txt.nlp	25050275	SENT30	0	0	7	7	ketoconazole	CYP3A4	PA450146	1576	0.828
NULL	BMB_Rep_2014_Sep_47(9)_500-505.nxml.txt.nlp	24393525	SENT294	14	14	9	9	cisplatin	PER3	PA449014	8863	0.828
NULL	Oncotarget_2012_Dec_18_3(12)_1615-1628.nxml.txt.nlp	23271044	SENT153	14	14	24	24	clofarabine	TOR	PA164754863	6097	0.828
NULL	Breast_Cancer_Res_2005_Jul_18_7(5)_187-189.nxml.txt.nlp	16168136	SENT41	29	29	23	23	fulvestrant	HER2	PA164747170	2064	0.828
NULL	ISRN_Oxidative_Med_2013_2013_831596.nxml.txt.nlp	25506596	SENT26	5	5	7	7	hemin	CD91	PA449849	4035	0.828
NULL	Nucleic_Acids_Res_2010_Oct_28_38(19)_6418-6432.nxml.txt.nlp	20511593	SENT231	43	43	4	4	collagenase	AP-1	PA449107	2353;3727;2354;3725	0.828
NULL	Oxid_Med_Cell_Longev_2013_Jul_9_2013_574029.nxml.txt.nlp	23936610	SENT157	4	4	29	29	resveratrol	CD86		942	0.828
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT1261	26	26	18	18	elacridar	ABCG2		9429	0.828
NULL	J_Korean_Med_Sci_2011_Jul_20_26(7)_893-899.nxml.txt.nlp	21738342	SENT153	14	14	4	4	resveratrol	CD97		976	0.828
NULL	Arthritis_Res_Ther_2010_Dec_17_12(6)_221.nxml.txt.nlp	21205283	SENT194	7	7	10	10	methotrexate	ACR	PA450428	49	0.828
NULL	J_Gynecol_Oncol_2013_Jan_8_24(1)_66-82.nxml.txt.nlp	23346316	SENT245	19	19	8	8	letrozole	HER2	PA450196	2064	0.828
NULL	Cell_Cycle_2013_Jun_15_12(12)_1811-1812.nxml.txt.nlp	23708513	SENT5	16	16	24	24	cyclophosphamide	CHOP	PA449165	1649	0.828
NULL	Oncotarget_2010_Nov_19_1(7)_596-605.nxml.txt.nlp	21317455	SENT59	11	11	13	13	oxaliplatin	EGF	PA131285527	1950	0.828
NULL	Nat_Commun_2014_Dec_12_5_5775.nxml.txt.nlp	25503391	SENT250	35	35	6	6	isoflurane	PC3	PA450106	57332;7832;5122	0.828
NULL	Breast_Cancer_Res_2007_May_30_9(3)_R34.nxml.txt.nlp	17537232	SENT166	10	10	31	31	doxorubicin	TP53	PA449412	7157	0.828
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Aug_10_69(Pt_9)_o1411-o1412.nxml.txt.nlp	24427048	SENT68	36	36	29	29	ethanol	mol	PA448073	90527	0.828
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Sep_30_66(Pt_10)_o2686.nxml.txt.nlp	21587654	SENT54	9	9	12	12	benzaldehyde	mol	PA448571	90527	0.828
NULL	Mol_Pain_2013_Feb_15_9_3.nxml.txt.nlp	23413875	SENT7	3	3	23	23	resveratrol	TRPA1		8989	0.828
NULL	Clin_Med_Insights_Oncol_2012_May_16_6_205-217.nxml.txt.nlp	22654526	SENT197	23	23	21	21	plerixafor	CXCR4	PA165958410	7852	0.828
NULL	Clin_Dev_Immunol_2013_Sep_17_2013_791262.nxml.txt.nlp	24151519	SENT120	26	26	43	43	heparin	IL10	PA449855	3586	0.828
NULL	Int_J_Mol_Sci_2014_Sep_11_15(9)_16057-16068.nxml.txt.nlp	25216338	SENT95	8	8	23	23	fluorescein	CT26	PA164746009	168400	0.828
NULL	Tuberc_Respir_Dis_(Seoul)_2012_Dec_28_73(6)_303-311.nxml.txt.nlp	23319992	SENT29	13	13	3	3	gefitinib	EGFR	PA131301952	1956	0.828
NULL	Mol_Cancer_2009_May_15_8_28.nxml.txt.nlp	19445670	SENT186	24	24	20	20	doxorubicin	Bcl-2	PA449412	596	0.828
NULL	Chem_Cent_J_2013_Sep_23_7_159.nxml.txt.nlp	24059652	SENT47	16	16	2	2	ethanol	flower	PA448073	11094	0.828
NULL	Oncotarget_2014_Oct_15_5(21)_10763-10777.nxml.txt.nlp	25333257	SENT72	5	5	1	1	tariquidar	ABCB1		5243	0.828
NULL	Front_Neural_Circuits_2014_Feb_3_8_3.nxml.txt.nlp	24550784	SENT234	23	23	8	8	vasopressin	SON	PA451858	6651	0.828
NULL	Acta_Neuropathol_Commun_2013_Jul_15_1_37.nxml.txt.nlp	24252779	SENT154	16	16	6	6	natalizumab	CRT	PA164747191	811	0.828
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2675-2684.nxml.txt.nlp	24129246	SENT237	26	26	3	3	etoposide	KSR1	PA449552	8844	0.828
NULL	Curr_Cardiol_Rev_2012_May_8(2)_158-165.nxml.txt.nlp	22708914	SENT123	9	9	12	12	ritonavir	CYP3A4	PA451260	1576	0.828
NULL	Cardiovasc_Diabetol_2013_Oct_17_12_150.nxml.txt.nlp	24134550	SENT7	40	40	6	6	pioglitazone	activin	PA450970	83729	0.828
NULL	Int_J_Hypertens_2012_Feb_8_2012_414128.nxml.txt.nlp	22518283	SENT46	17	17	5	5	losartan	ACE2	PA450268	59272	0.828
NULL	Oncotarget_2012_Jan_28_3(1)_78-83.nxml.txt.nlp	22289679	SENT22	10	10	15	15	paclitaxel	FOR	PA450761	51741	0.828
NULL	Ann_Lab_Med_2012_Jul_20_32(4)_270-275.nxml.txt.nlp	22779068	SENT105	24	24	35	35	imipenem	ACC-1	PA449968	597	0.828
NULL	Nat_Commun_2013_Aug_14_4_2312.nxml.txt.nlp	23942241	SENT233	13	13	7	7	heparin	FGF2	PA449855	2247;2258	0.828
NULL	Oncotarget_2011_Dec_31_2(12)_1279-1290.nxml.txt.nlp	22249125	SENT7	14	14	29	29	cyclophosphamide	BMAL1	PA449165	406	0.828
NULL	Breast_Cancer_Res_2006_Nov_27_8(6)_R66.nxml.txt.nlp	17129383	SENT33	9	9	17	17	paclitaxel	p27	PA450761	5715;10534	0.828
NULL	Oncoimmunology_2013_Jan_1_2(1)_e22890.nxml.txt.nlp	23483066	SENT4	10	10	25	25	vemurafenib	IFN	PA165946873	3439	0.828
NULL	Oncoscience_2013_Dec_11_1(1)_21-29.nxml.txt.nlp	25593981	SENT120	7	7	26	26	disulfiram	HSP27	PA449376	3315	0.828
NULL	J_Int_Soc_Sports_Nutr_2009_Feb_19_6_6.nxml.txt.nlp	19228401	SENT165	13	13	27	27	creatine	CEE	PA164778930	51608	0.828
NULL	Anesthesiol_Res_Pract_2012_Nov_24_2012_921405.nxml.txt.nlp	22162685	SENT140	15	15	4	4	lidocaine	NPY	PA450226	4852	0.828
NULL	Cell_Death_Dis_2014_Jul_10_5(7)_e1318.nxml.txt.nlp	25010984	SENT136	31	31	24	24	nutlin-3	RITA		55422;84934	0.828
NULL	Int_J_Surg_Oncol_2012_Jun_12_2012_862879.nxml.txt.nlp	22778941	SENT4	0	0	27	27	cisplatin	p53	PA449014	7157	0.828
NULL	Int_J_Environ_Res_Public_Health_2014_Apr_22_11(4)_4441-4448.nxml.txt.nlp	24758897	SENT77	15	15	17	17	bleomycin	BLM	PA448645	641	0.828
NULL	Breast_Cancer_Res_2012_Apr_17_14(2)_R62.nxml.txt.nlp	22510516	SENT233	35	35	29	29	lapatinib	HER2	PA152241907	2064	0.828
NULL	Curr_Neuropharmacol_2008_Sep_6(3)_215-234.nxml.txt.nlp	19506722	SENT277	34	34	2	2	fluoxetine	AVP	PA449673	114548;551	0.828
NULL	Arch_Med_Sci_2014_Oct_27_10(5)_1007-1018.nxml.txt.nlp	25395954	SENT223	26	26	35	35	trastuzumab	Yes	PA451743	7525	0.828
NULL	Nat_Commun_2013_Apr_23_4_1758.nxml.txt.nlp	23612299	SENT560	25	25	8	8	isoproterenol	SOD1	PA450121	6647	0.828
NULL	Cell_Cycle_2012_Nov_1_11(21)_4069-4078.nxml.txt.nlp	23095523	SENT75	5	5	11	11	imatinib	PERK	PA10804	9451	0.828
NULL	Pharmaceutics_2012_Sep_12_4(3)_430-441.nxml.txt.nlp	24300301	SENT27	31	31	38	38	efavirenz	API	PA449441	5345	0.828
NULL	Chin_J_Cancer_2012_Feb_31(2)_73-99.nxml.txt.nlp	22098950	SENT403	22	22	30	30	trastuzumab	AKT	PA451743	207	0.828
NULL	Front_Hum_Neurosci_2013_Mar_26_7_88.nxml.txt.nlp	23532620	SENT529	4	4	10	10	ketamine	gamma	PA450144	9913	0.828
NULL	Chem_Cent_J_2013_Sep_12_7_153.nxml.txt.nlp	24028654	SENT339	4	4	6	6	nimesulide	COX	PA137179528	1351	0.828
NULL	Exp_Ther_Med_2013_Dec_26_6(6)_1359-1364.nxml.txt.nlp	24255662	SENT136	18	18	28	28	dexmedetomidine	IL-6	PA449256	3569	0.828
NULL	Front_Behav_Neurosci_2014_Oct_30_8_366.nxml.txt.nlp	25400560	SENT100	29	29	15	15	ethanol	GAPDH	PA448073	2597	0.828
NULL	Am_J_Trop_Med_Hyg_2010_Apr_82(4)_525-528.nxml.txt.nlp	20348493	SENT78	13	13	7	7	artemisinin	ACT	PA165111696	12;11332;9457;641455	0.828
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT192	16	16	7	7	cisplatin	AKT	PA449014	207	0.828
NULL	J_Int_Soc_Sports_Nutr_2009_Feb_19_6_6.nxml.txt.nlp	19228401	SENT9	2	2	31	31	creatine	CEE	PA164778930	51608	0.828
NULL	Int_Arch_Med_2010_Dec_8_3_35.nxml.txt.nlp	21143863	SENT35	10	10	5	5	erythromycin	Q10	PA449493	27161	0.828
NULL	Ann_Indian_Acad_Neurol_2010_Apr-Jun_13(2)_136-138.nxml.txt.nlp	20814499	SENT71	20	20	28	28	fluconazole	CD4	PA449653	920	0.828
NULL	Clin_Interv_Aging_2008_Mar_3(1)_45-50.nxml.txt.nlp	18488877	SENT59	12	12	1	1	tamoxifen	STAR	PA451581	6770;2984	0.828
NULL	Breast_Cancer_Res_2001_Mar_26_3(3)_180-182.nxml.txt.nlp	11305952	SENT19	24	24	21	21	tamoxifen	aromatase	PA451581	1588	0.828
NULL	Asian_J_Androl_2014_Apr_1_May-Jun_16(3)_359-363.nxml.txt.nlp	24713836	SENT120	12	12	18	18	docetaxel	HSP27	PA449383	3315	0.828
NULL	Cancer_Metab_2013_Jan_23_1_3.nxml.txt.nlp	24280005	SENT533	32	32	8	8	ethanol	SREBP2	PA448073	6721	0.828
NULL	J_Gastroenterol_2014_Apr_17_49(1)_126-137.nxml.txt.nlp	23591768	SENT290	11	11	3	3	ribavirin	IL28B	PA451241	282617	0.828
NULL	Front_Endocrinol_(Lausanne)_2013_Nov_11_4_166.nxml.txt.nlp	24273531	SENT248	12	12	24	24	losartan	AT1	PA450268	9197;185	0.828
NULL	Evol_Bioinform_Online_2007_Dec_11_3_333-340.nxml.txt.nlp	19461981	SENT17	26	26	13	13	glucose	PEP	PA449773	5047	0.828
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_91-103.nxml.txt.nlp	17912639	SENT497	3	3	13	13	estradiol	aromatase	PA449503	1588	0.828
NULL	Cancer_Manag_Res_2014_Oct_6_6_389-395.nxml.txt.nlp	25336989	SENT44	33	33	19	19	anastrozole	HER2	PA448432	2064	0.828
NULL	Harm_Reduct_J_2012_Jan_25_9_8.nxml.txt.nlp	22276954	SENT35	7	7	0	0	buprenorphine	OAT	PA448685	4942	0.828
NULL	Br_J_Cancer_2006_Feb_13_94(3)_407-426.nxml.txt.nlp	16434996	SENT263	13	13	4	4	genistein	BRCA1	PA165109660	672	0.828
NULL	Cancer_Med_2014_Jun_28_3(3)_719-730.nxml.txt.nlp	24683044	SENT243	30	30	15	15	metformin	Dicer	PA450395	23405	0.828
NULL	Chemother_Res_Pract_2011_Dec_1_2011_715469.nxml.txt.nlp	22312557	SENT8	24	24	2	2	cisplatin	p53	PA449014	7157	0.828
NULL	Oncol_Lett_2014_Mar_16_7(3)_827-833.nxml.txt.nlp	24527090	SENT6	9	9	11	11	cisplatin	IFN	PA449014	3439	0.828
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT77	4	4	15	15	curcumin	DR5	PA151958596	8795	0.828
NULL	Nat_Commun_2013_Aug_15_4_2130.nxml.txt.nlp	23945651	SENT129	11	11	5	5	etoposide	survivin	PA449552	332	0.828
NULL	Clin_Pharmacol_2010_Sep_6_2_155-162.nxml.txt.nlp	22291500	SENT134	10	10	14	14	clopidogrel	IPA	PA449053	3160	0.828
NULL	Br_J_Cancer_2004_Mar_22_90(6)_1285-1292.nxml.txt.nlp	15026814	SENT87	39	39	23	23	doxorubicin	p53	PA449412	7157	0.828
NULL	Mol_Biol_Rep_2013_May_11_40(8)_5013-5026.nxml.txt.nlp	23666059	SENT257	10	10	12	12	resveratrol	p53		7157	0.828
NULL	Br_J_Cancer_2012_May_22_106(11)_1718-1721.nxml.txt.nlp	22531628	SENT17	3	3	10	10	bevacizumab	VEGF-A	PA130232992	7422	0.828
NULL	Zoomorphology_2011_Dec_28_130(4)_289-303.nxml.txt.nlp	22131642	SENT74	6	6	18	18	ethanol	CO2	PA448073	4513	0.828
NULL	Oncotarget_2014_Oct_18_5(22)_11604-11619.nxml.txt.nlp	25344099	SENT144	10	10	2	2	cisplatin	RYBP	PA449014	23429	0.828
NULL	Front_Immunol_2011_Aug_29_2_38.nxml.txt.nlp	22566828	SENT32	35	35	31	31	basiliximab	alpha-chain	PA164747126	2217	0.828
NULL	Mol_Cancer_2010_Oct_12_9_269.nxml.txt.nlp	20939893	SENT80	3	3	14	14	isoproterenol	STAT3	PA450121	6774	0.828
NULL	Br_J_Cancer_2012_Jul_24_107(3)_435-441.nxml.txt.nlp	22767144	SENT28	36	36	32	32	cisplatin	TTP	PA449014	7538;11093	0.828
NULL	Nucleic_Acids_Res_2011_Mar_23_39(4)_e20.nxml.txt.nlp	21106497	SENT280	21	21	9	9	arsenite	c-fos	PA452638	2353	0.828
NULL	Virulence_2013_Jan_1_4(1)_3-66.nxml.txt.nlp	23076359	SENT872	15	15	1	1	chymotrypsin	HtrA	PA448994	5654	0.828
NULL	Cardiovasc_Diabetol_2013_Nov_12_12_169.nxml.txt.nlp	24215514	SENT127	9	9	29	29	valsartan	AT2	PA451848	186	0.828
NULL	Cell_Death_Dis_2014_Feb_13_5(2)_e1055.nxml.txt.nlp	24525731	SENT69	3	3	20	20	cisplatin	XRCC1	PA449014	7515	0.828
NULL	J_Biol_2009_Apr_15_8(3)_30.nxml.txt.nlp	19435483	SENT49	45	45	30	30	imatinib	NQO2	PA10804	4835	0.828
NULL	J_Hepatol_2013_Aug_59(2)_318-326.nxml.txt.nlp	23624001	SENT150	27	27	24	24	oxaliplatin	VEGF-A	PA131285527	7422	0.828
NULL	Front_Genet_2014_Oct_31_5_379.nxml.txt.nlp	25400658	SENT344	17	17	10	10	doxorubicin	PAK3	PA449412	8874;5063	0.828
NULL	Int_J_Mol_Sci_2014_Nov_7_15(11)_20500-20517.nxml.txt.nlp	25387078	SENT135	14	14	35	35	sorafenib	ADP	PA7000	23038	0.828
NULL	Cancers_(Basel)_2014_Nov_25_6(4)_2313-2329.nxml.txt.nlp	25534569	SENT389	0	0	7	7	cabozantinib	MET	PA165906891	4233	0.828
NULL	Cell_Res_2013_Jul_21_23(7)_915-930.nxml.txt.nlp	23689279	SENT153	6	6	4	4	ethanol	ALDH2	PA448073	217	0.828
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT17	0	0	9	9	lapatinib	HER2	PA152241907	2064	0.828
NULL	Braz_J_Med_Biol_Res_2012_Sep_21_45(12)_1240-1243.nxml.txt.nlp	22983178	SENT36	32	32	15	15	indomethacin	CB1	PA449982	1268	0.828
NULL	Breast_Cancer_Res_2004_Jan_29_6(2)_84-87.nxml.txt.nlp	14979912	SENT27	5	5	18	18	tamoxifen	aromatase	PA451581	1588	0.828
NULL	Mol_Cancer_2008_Jun_3_7_47.nxml.txt.nlp	18519000	SENT172	3	3	9	9	gefitinib	EGF	PA131301952	1950	0.828
NULL	Hum_Reprod_2008_Oct_16_23(10)_2273-2281.nxml.txt.nlp	18635530	SENT87	5	5	14	14	etoposide	CTB	PA449552	9468	0.828
NULL	Acta_Pharmacol_Sin_2009_Dec_4_30(12)_1674-1687.nxml.txt.nlp	19960012	SENT231	41	41	18	18	glucosamine	CO2	PA164747613	4513	0.828
NULL	Chem_Res_Toxicol_2013_Oct_21_26(10)_1570-1578.nxml.txt.nlp	24047243	SENT492	22	22	8	8	estradiol	UGT1A9	PA449503	54600	0.828
NULL	Nucleic_Acids_Res_2013_Nov_27_41(21)_9786-9799.nxml.txt.nlp	23982513	SENT289	27	27	36	36	arsenite	TIAR	PA452638	7073	0.828
NULL	Eur_J_Med_Res_2009_Nov_24_14(Suppl_3)_36-42.nxml.txt.nlp	19959415	SENT34	25	25	14	14	tenofovir	gamma	PA10204	9913	0.828
NULL	J_Neuroinflammation_2010_Sep_7_7_51.nxml.txt.nlp	20822529	SENT106	10	10	13	13	hemin	HO-1	PA449849	3162	0.828
NULL	Clin_Dev_Immunol_2011_Nov_3_2011_320571.nxml.txt.nlp	22110523	SENT201	28	28	18	18	etoposide	ALDH1A1	PA449552	216	0.828
NULL	Cell_Death_Dis_2014_Feb_13_5(2)_e1055.nxml.txt.nlp	24525731	SENT40	21	21	11	11	cisplatin	XRCC1	PA449014	7515	0.828
NULL	J_Asthma_Allergy_2008_Sep_19_1_19-29.nxml.txt.nlp	21436982	SENT59	31	31	1	1	fexofenadine	MDR1	PA449621	5243	0.828
NULL	Mol_Brain_2013_Dec_16_6_56.nxml.txt.nlp	24330819	SENT200	21	21	12	12	dantrolene	c-fos	PA449208	2353	0.828
NULL	Mol_Biol_Cell_2013_Sep_15_24(18)_2795-2806.nxml.txt.nlp	23904266	SENT97	23	23	12	12	hydroxyurea	GRK5	PA449942	2869	0.828
NULL	Int_J_Womens_Health_2012_Oct_10_4_543-549.nxml.txt.nlp	23091400	SENT54	2	2	6	6	resveratrol	aromatase		1588	0.828
NULL	J_Int_AIDS_Soc_2012_Oct_22_15(Suppl_3)_18438.nxml.txt.nlp	NULL	SENT350	21	21	24	24	glimepiride	P2X7	PA449761	5027	0.828
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT84	18	18	11	11	trastuzumab	STAT3	PA451743	6774	0.828
NULL	Environ_Health_Perspect_2006_Apr_21_114(Suppl_1)_69-75.nxml.txt.nlp	16818249	SENT123	16	16	32	32	estradiol	ANOVA	PA449503	4858	0.828
NULL	Int_J_Mol_Sci_2014_Sep_9_15(9)_15924-15950.nxml.txt.nlp	25207602	SENT117	18	18	25	25	trazodone	5-HT2C	PA451744	3358	0.828
NULL	Nucleic_Acids_Res_2011_Dec_31_39(22)_9536-9548.nxml.txt.nlp	21880590	SENT228	11	11	17	17	etoposide	BRCA1	PA449552	672	0.828
NULL	Evid_Based_Complement_Alternat_Med_2013_Mar_14_2013_429706.nxml.txt.nlp	23573127	SENT136	12	12	6	6	indomethacin	DAI	PA449982	81030	0.828
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1149.nxml.txt.nlp	24675467	SENT104	1	1	24	24	trastuzumab	DM1	PA451743	338023;1760;28509	0.828
NULL	Breast_Cancer_(Auckl)_2009_Sep_2_3_61-75.nxml.txt.nlp	19809577	SENT243	0	0	4	4	curcumin	p65	PA151958596	5970	0.828
NULL	EMBO_Mol_Med_2013_Mar_4_5(3)_366-383.nxml.txt.nlp	23381944	SENT368	43	43	15	15	ethanol	p27	PA448073	5715;10534	0.828
NULL	Arthritis_Res_Ther_2011_Feb_8_13(1)_R17.nxml.txt.nlp	21303509	SENT213	33	33	1	1	leflunomide	FSTL1	PA450192	11167	0.828
NULL	Int_J_Mol_Sci_2014_Nov_21_15(11)_21433-21454.nxml.txt.nlp	25421240	SENT240	15	15	1	1	pp2	EGF		1950	0.828
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT218	7	7	14	14	chloroquine	BMPR-II	PA448948	659	0.828
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT331	2	2	35	35	risperidone	PRL	PA451257	5617	0.828
NULL	Exp_Mol_Med_2012_Apr_30_44(4)_281-292.nxml.txt.nlp	22228119	SENT60	12	12	16	16	genistein	activin	PA165109660	83729	0.828
NULL	Front_Neural_Circuits_2014_Oct_2_8_123.nxml.txt.nlp	25324730	SENT170	16	16	8	8	diazepam	UBE3A	PA449283	7337	0.828
NULL	Int_J_Biol_Sci_2012_Feb_9_8(3)_310-327.nxml.txt.nlp	22355267	SENT47	23	23	27	27	simvastatin	PCSK9	PA451363	255738	0.828
NULL	Oncotarget_2014_Aug_29_5(19)_8947-8958.nxml.txt.nlp	25333254	SENT158	17	17	26	26	plerixafor	CXCR4	PA165958410	7852	0.828
NULL	Biosci_Rep_2014_Apr_15_34(2)_e00105.nxml.txt.nlp	24617546	SENT94	5	5	22	22	metformin	AMPK	PA450395	5563	0.828
NULL	Bioinformation_2012_Jan_6_8(1)_13-19.nxml.txt.nlp	22359429	SENT175	5	5	2	2	calcein	MRP1	PA132595336	4437	0.828
NULL	Clin_Dev_Immunol_2011_Nov_3_2011_320571.nxml.txt.nlp	22110523	SENT201	28	28	13	13	etoposide	POU5F1	PA449552	5460	0.828
NULL	Diabetes_Metab_J_2014_Jun_17_38(3)_211-219.nxml.txt.nlp	25003075	SENT76	10	10	3	3	sitagliptin	PPG	PA164748978	5552	0.828
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT135	15	15	12	12	methotrexate	MSH2	PA450428	4436	0.828
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT1906	8	8	10	10	acetaminophen	CYP3A4	PA448015	1576	0.828
NULL	Oncologist_2010_Mar_9_15(3)_236-245.nxml.txt.nlp	20215359	SENT116	39	39	45	45	temsirolimus	IFN	PA164746890	3439	0.828
NULL	Indian_J_Dermatol_2014_Nov-Dec_59(6)_531-546.nxml.txt.nlp	25484380	SENT442	1	1	8	8	isotretinoin	EGFR	PA450128	1956	0.828
NULL	BMB_Rep_2013_Aug_46(8)_410-415.nxml.txt.nlp	23977989	SENT59	4	4	0	0	curcumin	HO-1	PA151958596	3162	0.828
NULL	Diabetes_Care_2010_Apr_12_33(4)_826-832.nxml.txt.nlp	20067954	SENT164	0	0	6	6	cyclosporine	IL-2	PA449167	3558	0.828
NULL	Mol_Vis_2014_May_13_20_649-660.nxml.txt.nlp	24868139	SENT28	0	0	24	24	ranibizumab	VEGFR1	PA164746012	2321	0.828
NULL	Front_Immunol_2012_Jul_4_3_185.nxml.txt.nlp	22783258	SENT211	4	4	14	14	curcumin	IL-5	PA151958596	3567	0.828
NULL	Oncol_Lett_2014_Apr_22_7(4)_1191-1196.nxml.txt.nlp	24944691	SENT116	12	12	9	9	paclitaxel	PC-3	PA450761	692094	0.828
NULL	Acta_Pharmacol_Sin_2010_May_12_31(5)_578-584.nxml.txt.nlp	20383171	SENT167	7	7	12	12	berberine	ORP150	PA165860812	10525	0.828
NULL	Breast_Cancer_Res_2010_Jul_19_12(4)_R51.nxml.txt.nlp	20642837	SENT120	23	23	15	15	hydrocortisone	EGF	PA449905	1950	0.828
NULL	Diabetes_2009_Jan_58(1)_250-259.nxml.txt.nlp	18840786	SENT265	36	36	24	24	rosiglitazone	FGF21	PA451283	26291	0.828
NULL	Breast_Cancer_Res_2010_Jun_28_12(3)_R44.nxml.txt.nlp	20584310	SENT205	2	2	12	12	doxycycline	ERBB2	PA449415	2064	0.828
NULL	Front_Oncol_2014_Jun_18_4_153.nxml.txt.nlp	24995158	SENT175	4	4	19	19	doxorubicin	p53	PA449412	7157	0.828
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT108	0	0	17	17	neratinib	PTEN	PA165291472	5728	0.828
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT112	37	37	11	11	carboplatin	ASC	PA448803	29108	0.828
NULL	Exp_Neurol_2012_Jun_235(2)_528-538.nxml.txt.nlp	22417924	SENT136	7	7	34	34	rosiglitazone	ANOVA	PA451283	4858	0.828
NULL	Breast_Cancer_Res_2000_May_24_2(4)_302-303.nxml.txt.nlp	11403011	SENT76	37	37	27	27	doxorubicin	p53	PA449412	7157	0.828
NULL	Clin_Exp_Gastroenterol_2011_Jul_15_4_163-172.nxml.txt.nlp	21904462	SENT40	6	6	25	25	adalimumab	CDAI	PA10004	146059	0.828
NULL	Cancer_Manag_Res_2012_Nov_9_4_383-395.nxml.txt.nlp	23204869	SENT125	25	25	32	32	carmustine	PC-3	PA448810	692094	0.828
NULL	Oncotarget_2014_Nov_3_5(20)_10127-10139.nxml.txt.nlp	25333256	SENT148	35	35	28	28	vemurafenib	BRAF	PA165946873	673	0.828
NULL	Biomed_Res_Int_2014_Feb_23_2014_168949.nxml.txt.nlp	24707474	SENT19	0	0	18	18	lapatinib	EGFR	PA152241907	1956	0.828
NULL	Nucleic_Acids_Res_2005_Jun_8_33(10)_3283-3291.nxml.txt.nlp	15944449	SENT444	12	12	26	26	sjg-136	XPB		2071	0.828
NULL	EJC_Suppl_2013_Sep_5_11(2)_3-22.nxml.txt.nlp	NULL	SENT1021	8	8	24	24	tamoxifen	ATAC	PA451581	6375	0.828
NULL	Leukemia_2014_Jun_17_28(6)_1216-1226.nxml.txt.nlp	24301524	SENT201	0	0	12	12	bortezomib	p65	PA10252	5970	0.828
NULL	Calcif_Tissue_Int_2010_Dec_16_87(6)_485-492.nxml.txt.nlp	20953593	SENT24	34	34	4	4	teriparatide	PTH	PA451620	5741	0.828
NULL	Oncotarget_2010_Oct_22_1(7)_530-543.nxml.txt.nlp	21317449	SENT98	8	8	13	13	gefitinib	HER2	PA131301952	2064	0.828
NULL	Contemp_Oncol_(Pozn)_2013_Apr_29_17(2)_137-143.nxml.txt.nlp	23788980	SENT203	1	1	12	12	octreotide	ACTH	PA450678	5443	0.828
NULL	Exp_Ther_Med_2013_Nov_6_6(5)_1089-1095.nxml.txt.nlp	24223627	SENT32	31	31	2	2	cyclophosphamide	NAC	PA449165	22861	0.828
NULL	Evid_Based_Complement_Alternat_Med_2013_Mar_26_2013_625892.nxml.txt.nlp	23589719	SENT254	0	0	3	3	probenecid	TAS2R16	PA451106	50833	0.828
NULL	Proteome_Sci_2009_Nov_5_7_41.nxml.txt.nlp	19889238	SENT127	17	17	4	4	creatine	CLIC4	PA164778930	25932	0.828
NULL	Virol_J_2012_Feb_16_9_45.nxml.txt.nlp	22340040	SENT143	15	15	18	18	heparin	sialoadhesin	PA449855	6614	0.828
NULL	J_Inherit_Metab_Dis_2011_Apr_3_34(2)_367-376.nxml.txt.nlp	21290187	SENT204	23	23	16	16	galactose	GALT	PA449725	2592	0.828
NULL	Drug_Saf_2014_Feb_19_37(4)_201-211.nxml.txt.nlp	24550106	SENT259	7	7	11	11	omeprazole	CYP2C19	PA450704	1557	0.828
NULL	Ann_Hematol_2011_May_12_90(5)_557-568.nxml.txt.nlp	20938660	SENT221	28	28	19	19	plerixafor	CD34	PA165958410	947	0.828
NULL	Int_J_Mol_Sci_2014_Nov_10_15(11)_20607-20637.nxml.txt.nlp	25391045	SENT224	8	8	5	5	simvastatin	Rho	PA451363	29984	0.828
NULL	Br_J_Cancer_2004_Mar_22_90(6)_1285-1292.nxml.txt.nlp	15026814	SENT87	41	41	1	1	cisplatin	p53	PA449014	7157	0.828
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Feb_10_68(Pt_3)_o667-o668.nxml.txt.nlp	22412567	SENT5	9	9	21	21	clarithromycin	mol	PA449028	90527	0.828
NULL	FEBS_Open_Bio_2014_Sep_6_4_777-787.nxml.txt.nlp	25349782	SENT142	29	29	14	14	napqi	CYP2E1		1571	0.828
NULL	Cell_Death_Dis_2013_Jul_11_4(7)_e719.nxml.txt.nlp	23846221	SENT56	38	38	28	28	cisplatin	XIAP	PA449014	331	0.828
NULL	Cancer_Cell_Int_2011_May_15_11_13.nxml.txt.nlp	21569620	SENT84	14	14	6	6	bortezomib	PC-3	PA10252	692094	0.828
NULL	EMBO_Mol_Med_2012_Oct_30_4(10)_1087-1096.nxml.txt.nlp	22933245	SENT98	9	9	29	29	olaparib	BRCA2		675	0.828
NULL	Oncol_Lett_2013_Mar_8_5(3)_805-812.nxml.txt.nlp	23426281	SENT13	10	10	8	8	gemcitabine	B7-H3	PA449748	80381	0.828
NULL	Int_J_Womens_Health_2012_Oct_12_4_551-557.nxml.txt.nlp	23091401	SENT36	27	27	16	16	estradiol	aromatase	PA449503	1588	0.828
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT236	27	27	38	38	metformin	AMPK	PA450395	5563	0.828
NULL	Ther_Clin_Risk_Manag_2007_Dec_3(6)_973-974.nxml.txt.nlp	18516313	SENT34	6	6	26	26	infliximab	p75	PA452639	7133;11168	0.828
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT87	24	24	8	8	erlotinib	AKT	PA134687924	207	0.828
NULL	Cancers_(Basel)_2010_Dec_29_3(1)_79-90.nxml.txt.nlp	24212607	SENT108	18	18	29	29	gemcitabine	PAK7	PA449748	57144	0.828
NULL	Breast_Cancer_Res_2011_Jan_17_13(1)_R5.nxml.txt.nlp	21241485	SENT316	33	33	36	36	estradiol	Brn-3b	PA449503	5458	0.828
NULL	Onco_Targets_Ther_2014_Sep_23_7_1653-1661.nxml.txt.nlp	25285015	SENT122	10	10	3	3	sn-38	UGT1A1		54658	0.828
NULL	Front_Neural_Circuits_2013_Oct_2_7_155.nxml.txt.nlp	24106462	SENT186	7	7	15	15	apomorphine	gamma	PA164781163	9913	0.828
NULL	Front_Endocrinol_(Lausanne)_2014_Feb_25_5_22.nxml.txt.nlp	24611062	SENT154	12	12	20	20	estradiol	RhoA	PA449503	387	0.828
NULL	Nat_Med_2011_Dec_11_18(1)_74-82.nxml.txt.nlp	22157681	SENT103	13	13	32	32	gefitinib	EGFR	PA131301952	1956	0.828
NULL	Leukemia_2013_Jan_11_27(1)_32-40.nxml.txt.nlp	22781593	SENT244	19	19	15	15	ponatinib	FGFR1	PA165980594	2260	0.828
NULL	Pharmaceuticals_(Basel)_2014_Jan_9_7(1)_46-57.nxml.txt.nlp	24451403	SENT114	0	0	2	2	ritonavir	AKT	PA451260	207	0.828
NULL	Diabetes_2013_May_16_62(5)_1697-1708.nxml.txt.nlp	23364453	SENT8	9	9	18	18	vildagliptin	GLP-1	PA165958346	100125288	0.828
NULL	Breast_Cancer_Res_2012_Jul_23_14(4)_R112.nxml.txt.nlp	22824341	SENT247	10	10	19	19	doxorubicin	RANK	PA449412	8792	0.828
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT151	15	15	3	3	glucose	ERK	PA449773	5594	0.828
NULL	Arq_Bras_Cardiol_2014_Nov_103(5)_403-409.nxml.txt.nlp	25229355	SENT125	29	29	27	27	metoprolol	PZP	PA450480	5858	0.828
NULL	BioData_Min_2008_Jul_17_1_2.nxml.txt.nlp	18822146	SENT122	12	12	7	7	ethanol	APOE	PA448073	348	0.828
NULL	Crit_Care_2008_Dec_17_12(6)_R159.nxml.txt.nlp	19091080	SENT120	22	22	6	6	rolipram	CD14	PA153906323	929	0.828
NULL	Case_Rep_Endocrinol_2012_Feb_9_2012_842357.nxml.txt.nlp	22953073	SENT17	27	27	12	12	thyroglobulin	TPO	PA164754910	7066;7173	0.828
NULL	J_Mol_Signal_2010_Aug_13_5_13.nxml.txt.nlp	20704760	SENT108	8	8	23	23	staurosporine	c-Jun	PA165109623	3725	0.828
NULL	Br_J_Cancer_2011_Apr_12_104(8)_1342-1348.nxml.txt.nlp	21427727	SENT20	12	12	37	37	trastuzumab	HER2	PA451743	2064	0.828
NULL	Breast_Cancer_Res_2010_Mar_5_12(2)_R16.nxml.txt.nlp	20205716	SENT283	20	20	33	33	lovastatin	AKT	PA450272	207	0.828
NULL	eLife_2014_May_20_3_e01763.nxml.txt.nlp	24844244	SENT349	40	40	28	28	doxycycline	MELK	PA449415	9833	0.828
NULL	Int_J_Mol_Sci_2012_Sep_20_13(9)_12000-12016.nxml.txt.nlp	23109896	SENT54	23	23	13	13	gefitinib	EGFR	PA131301952	1956	0.828
NULL	Mol_Syst_Biol_2009_Jul_28_5_288.nxml.txt.nlp	19638969	SENT171	4	4	26	26	resveratrol	HuR		1994	0.828
NULL	Front_Cell_Neurosci_2015_Jan_15_8_459.nxml.txt.nlp	25642166	SENT71	3	3	6	6	hemin	HO-1	PA449849	3162	0.828
NULL	Oncotarget_2010_Oct_25_1(7)_497-514.nxml.txt.nlp	21165163	SENT254	38	38	30	30	erlotinib	EGFR	PA134687924	1956	0.828
NULL	J_Psychopharmacol_2014_Oct_28(10)_891-902.nxml.txt.nlp	25122043	SENT155	27	27	8	8	escitalopram	CA1	PA10074	759	0.828
NULL	Cancer_Cell_Int_2013_Jun_26_13_63.nxml.txt.nlp	23800022	SENT115	24	24	14	14	genistein	XIAP	PA165109660	331	0.828
NULL	Surg_Today_2014_Apr_17_44(2)_219-226.nxml.txt.nlp	23591833	SENT60	10	10	5	5	cisplatin	HAI	PA449014	6692;6768	0.828
NULL	J_Oncol_2012_Apr_10_2012_931071.nxml.txt.nlp	22570654	SENT56	19	19	31	31	plerixafor	CD34	PA165958410	947	0.828
NULL	Arthritis_Res_Ther_2009_Oct_14_11(5)_245.nxml.txt.nlp	19849817	SENT191	26	26	5	5	abatacept	ACR	PA164747080	49	0.828
NULL	J_Cell_Biol_2001_Mar_19_152(6)_1135-1144.nxml.txt.nlp	11257115	SENT224	21	21	10	10	lipase	DGK	PA450239	8526;1607	0.828
NULL	Br_J_Clin_Pharmacol_2013_Aug_23_76(2)_299-315.nxml.txt.nlp	23701319	SENT150	5	5	18	18	alemtuzumab	IL-10	PA164783958	3586	0.828
NULL	Exp_Ther_Med_2014_Nov_15_8(5)_1351-1356.nxml.txt.nlp	25289022	SENT9	4	4	26	26	tetracycline	ZAP	PA451640	56829;56252	0.828
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_408-414.nxml.txt.nlp	21372831	SENT138	4	4	1	1	cyclophosphamide	CHOP	PA449165	1649	0.828
NULL	Oncotarget_2012_May_18_3(5)_525-534.nxml.txt.nlp	22619113	SENT10	44	44	12	12	fludarabine	BIRC5	PA449655	332	0.828
NULL	Case_Rep_Hematol_2013_Feb_3_2013_837906.nxml.txt.nlp	23431487	SENT10	2	2	10	10	desmopressin	FVIII	PA449237	2157	0.828
NULL	Neural_Regen_Res_2013_Nov_25_8(33)_3095-3106.nxml.txt.nlp	25206630	SENT237	15	15	5	5	paraformaldehyde	C17	PA450790	54360	0.828
NULL	Int_J_Nanomedicine_2012_Oct_9_7_5395-5404.nxml.txt.nlp	23091382	SENT7	2	2	23	23	curcumin	zeta	PA151958596	9907	0.828
NULL	Aging_(Albany_NY)_2009_Jun_3_1(6)_515-528.nxml.txt.nlp	20157535	SENT220	17	17	3	3	resveratrol	MDC		6367	0.828
NULL	Oncol_Lett_2013_Feb_3_5(2)_505-510.nxml.txt.nlp	23420812	SENT112	15	15	6	6	cisplatin	AEG-1	PA449014	92140	0.827
NULL	J_Clin_Biochem_Nutr_2011_Nov_29_49(3)_216-221.nxml.txt.nlp	22128222	SENT129	23	23	10	10	clopidogrel	CYP2C19	PA449053	1557	0.827
NULL	Cell_Commun_Signal_2013_Nov_5_11_83.nxml.txt.nlp	24192293	SENT57	24	24	12	12	doxycycline	IL-6	PA449415	3569	0.827
NULL	Oncotarget_2013_Jul_7_4(7)_1065-1074.nxml.txt.nlp	23867252	SENT5	21	21	17	17	geldanamycin	Hsp90	PA152031327	3320	0.827
NULL	J_Gen_Physiol_2013_Aug_142(2)_137-155.nxml.txt.nlp	23858003	SENT374	3	3	13	13	mibefradil	ACTH	PA450492	5443	0.827
NULL	J_Hematol_Oncol_2011_Feb_7_4_6.nxml.txt.nlp	21299849	SENT91	15	15	19	19	dasatinib	RSP6	PA162372878	81492	0.827
NULL	J_Invest_Dermatol_2013_Apr_29_133(4)_881-889.nxml.txt.nlp	23190891	SENT211	14	14	0	0	ethanol	PGD2	PA448073	27306	0.827
NULL	Diabetes_2011_Mar_21_60(3)_757-765.nxml.txt.nlp	21282370	SENT171	16	16	8	8	isoproterenol	PTRF	PA450121	284119	0.827
NULL	J_Gen_Physiol_2000_Jun_1_115(6)_685-696.nxml.txt.nlp	10828243	SENT194	6	6	11	11	genistein	OLF	PA165109660	83857	0.827
NULL	J_Biol_Chem_2009_Oct_16_284(42)_28885-28895.nxml.txt.nlp	19687008	SENT140	0	0	3	3	berberine	PCSK9	PA165860812	255738	0.827
NULL	Front_Oncol_2013_Nov_15_3_281.nxml.txt.nlp	24298448	SENT193	21	21	40	40	leucovorin	BRAF	PA450198	673	0.827
NULL	Open_Virol_J_2008_Mar_28_2_24-31.nxml.txt.nlp	19440461	SENT119	2	2	9	9	benztropine	MARCKS	PA448591	4082	0.827
NULL	Diabetes_Care_2013_Aug_17_36(Suppl_2)_S245-S252.nxml.txt.nlp	23882053	SENT73	27	27	22	22	liraglutide	GLP-1	PA165958364	100125288	0.827
NULL	J_Int_AIDS_Soc_2011_Oct_11_14_48.nxml.txt.nlp	21988905	SENT129	42	42	13	13	fluconazole	ART	PA449653	181	0.827
NULL	Exp_Diabetes_Res_2011_Dec_27_2011_604989.nxml.txt.nlp	21253359	SENT176	17	17	11	11	clonidine	GLP-1	PA449051	100125288	0.827
NULL	Orphanet_J_Rare_Dis_2014_Jan_27_9_13.nxml.txt.nlp	24461084	SENT124	4	4	12	12	cetuximab	KRAS	PA10040	3845	0.827
NULL	Oncotarget_2013_Jul_21_4(8)_1253-1265.nxml.txt.nlp	23896512	SENT200	17	17	25	25	gefitinib	EGFR	PA131301952	1956	0.827
NULL	J_Biol_Chem_2010_Apr_23_285(17)_13285-13293.nxml.txt.nlp	20181944	SENT128	5	5	0	0	galactose	Langerin	PA449725	50489	0.827
NULL	J_Vet_Med_Sci_2014_Oct_16_76(10)_1383-1387.nxml.txt.nlp	24931645	SENT77	4	4	18	18	sitagliptin	GLP-1	PA164748978	100125288	0.827
NULL	Br_J_Cancer_2009_Mar_24_100(6)_941-949.nxml.txt.nlp	19240716	SENT114	6	6	11	11	gefitinib	Met	PA131301952	79811	0.827
NULL	Int_J_Trichology_2014_Apr-Jun_6(2)_50-53.nxml.txt.nlp	25191037	SENT45	12	12	4	4	glucose	FBS	PA449773	64319;26269	0.827
NULL	Acta_Pharmacol_Sin_2013_Jun_8_34(6)_830-836.nxml.txt.nlp	23564080	SENT108	2	2	11	11	simvastatin	HMGB1	PA451363	3146	0.827
NULL	J_Oncol_2013_Apr_29_2013_854121.nxml.txt.nlp	23737784	SENT44	2	2	7	7	trastuzumab	HER3	PA451743	2065	0.827
NULL	Acta_Pharmacol_Sin_2011_Jul_13_32(7)_967-972.nxml.txt.nlp	21666702	SENT131	11	11	6	6	ticlopidine	P-gp	PA451686	5243	0.827
NULL	Eur_J_Clin_Pharmacol_2012_Apr_8_68(4)_363-370.nxml.txt.nlp	21984116	SENT232	9	9	4	4	tamoxifen	CYP2D6	PA451581	1565	0.827
NULL	Crit_Care_2011_Aug_11_15(4)_226.nxml.txt.nlp	21892977	SENT269	1	1	20	20	vasopressin	ACTH	PA451858	5443	0.827
NULL	Cancer_Med_2013_Dec_3_2(6)_774-783.nxml.txt.nlp	24403251	SENT165	15	15	17	17	tamoxifen	aromatase	PA451581	1588	0.827
NULL	Arthritis_Res_Ther_2013_Apr_17_15(2)_R51.nxml.txt.nlp	23594962	SENT195	2	2	11	11	muraglitazar	IL-6	PA162356187	3569	0.827
NULL	Ecancermedicalscience_2009_Oct_29_3_157.nxml.txt.nlp	22276018	SENT71	17	17	2	2	tamoxifen	HER3	PA451581	2065	0.827
NULL	Ann_Rheum_Dis_2013_Apr_21_72(4)_482-492.nxml.txt.nlp	23172750	SENT71	46	46	11	11	rituximab	CDAI	PA451261	146059	0.827
NULL	Mol_Cancer_2012_Oct_22_11_80.nxml.txt.nlp	23088607	SENT72	17	17	22	22	estradiol	YC1	PA449503	5937	0.827
NULL	Front_Neurosci_2014_Apr_8_8_63.nxml.txt.nlp	24782698	SENT285	18	18	22	22	fluoxetine	5-HT2A	PA449673	3356	0.827
NULL	Clin_Interv_Aging_2012_Dec_30_7_1-13.nxml.txt.nlp	22291468	SENT57	7	7	26	26	phenytoin	CYP3A4	PA450947	1576	0.827
NULL	Neural_Dev_2013_Mar_7_8_4.nxml.txt.nlp	23497494	SENT115	11	11	4	4	cimetidine	FGFR1	PA449001	2260	0.827
NULL	Leukemia_2014_Apr_14_28(4)_961-964.nxml.txt.nlp	24418991	SENT46	26	26	30	30	nilotinib	P-gp	PA165958345	5243	0.827
NULL	Int_J_Bipolar_Disord_2013_Jul_4_1_10.nxml.txt.nlp	25505677	SENT130	22	22	4	4	quetiapine	NNT	PA451201	23530	0.827
NULL	J_Cancer_2013_Jun_21_4(5)_391-401.nxml.txt.nlp	23833684	SENT17	13	13	17	17	trastuzumab	EC-1	PA451743	4819	0.827
NULL	Clin_Interv_Aging_2009_May_14_4_109-113.nxml.txt.nlp	19503773	SENT63	8	8	11	11	tolcapone	COMT	PA451720	1312	0.827
NULL	Ann_Oncol_2011_Dec_17_22(12)_2610-2615.nxml.txt.nlp	21415234	SENT181	14	14	9	9	trastuzumab	HER2	PA451743	2064	0.827
NULL	Diabetes_Care_2013_Jul_12_36(7)_1926-1932.nxml.txt.nlp	23378624	SENT148	19	19	9	9	tacrolimus	RTR	PA451578	2649	0.827
NULL	Acta_Pharmacol_Sin_2011_Nov_10_32(11)_1402-1410.nxml.txt.nlp	21986579	SENT155	3	3	30	30	curcumin	CDK2	PA151958596	1017	0.827
NULL	Mol_Cancer_2012_Jul_25_11_47.nxml.txt.nlp	22830443	SENT54	26	26	43	43	panitumumab	EGF	PA162373091	1950	0.827
NULL	EJC_Suppl_2013_Sep_5_11(2)_92-96.nxml.txt.nlp	NULL	SENT122	10	10	3	3	imatinib	BRAF	PA10804	673	0.827
NULL	Int_J_Gen_Med_2010_Oct_5_3_305-311.nxml.txt.nlp	21042569	SENT95	40	40	36	36	eltrombopag	TPO	PA165981594	7066;7173	0.827
NULL	Arthritis_Res_2002_May_24_4(Suppl_2)_S34-S40.nxml.txt.nlp	12110156	SENT50	1	1	37	37	infliximab	ACR	PA452639	49	0.827
NULL	Exp_Ther_Med_2013_Apr_29_5(4)_1093-1096.nxml.txt.nlp	23596475	SENT5	13	13	24	24	ketamine	IL-6	PA450144	3569	0.827
NULL	Blood_Cancer_J_2012_Oct_12_2(10)_e93.nxml.txt.nlp	23064741	SENT37	13	13	11	11	cyclophosphamide	CHOP	PA449165	1649	0.827
NULL	Mol_Biol_Cell_2012_Sep_1_23(17)_3473-3484.nxml.txt.nlp	22787275	SENT33	22	22	5	5	doxorubicin	ABCC1	PA449412	4363	0.827
NULL	J_Clin_Biochem_Nutr_2008_Mar_1_42(2)_158-166.nxml.txt.nlp	18385834	SENT25	7	7	3	3	ephedrine	DAI	PA449466	81030	0.827
NULL	Cancers_(Basel)_2010_Jan_14_2(1)_1-19.nxml.txt.nlp	24281029	SENT1075	15	15	28	28	capecitabine	San	PA448771	80218	0.827
NULL	Toxins_(Basel)_2010_Oct_28_2(11)_2584-2592.nxml.txt.nlp	22069565	SENT66	24	24	19	19	warfarin	CYP2C9	PA451906	1559	0.827
NULL	J_Cell_Mol_Med_2014_Dec_9_18(12)_2425-2436.nxml.txt.nlp	25297942	SENT177	32	32	23	23	cisplatin	HOTAIR	PA449014	100124700	0.827
NULL	Oxid_Med_Cell_Longev_2013_Apr_21_2013_412576.nxml.txt.nlp	23710286	SENT9	15	15	5	5	curcumin	KEAP1	PA151958596	9817	0.827
NULL	Ann_Surg_Oncol_2010_Apr_20_17(4)_1168-1176.nxml.txt.nlp	19936839	SENT190	18	18	2	2	panitumumab	STEPP	PA162373091	222659	0.827
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1495-1502.nxml.txt.nlp	21989186	SENT191	24	24	28	28	leucovorin	HSI	PA450198	57016	0.827
NULL	Neuro_Oncol_2010_Apr_27_12(4)_389-400.nxml.txt.nlp	20308316	SENT190	11	11	8	8	chloroquine	p53	PA448948	7157	0.827
NULL	Acta_Pharmacol_Sin_2010_Mar_8_31(3)_382-386.nxml.txt.nlp	20140004	SENT13	15	15	0	0	pitavastatin	SLCO1B1	PA142650384	10599	0.827
NULL	Mol_Cancer_2010_Dec_20_9_317.nxml.txt.nlp	21172025	SENT33	24	24	11	11	trastuzumab	HER2	PA451743	2064	0.827
NULL	Biol_Open_2013_Aug_14_2(10)_1013-1021.nxml.txt.nlp	24167711	SENT171	30	30	9	9	ethanol	EVL	PA448073	51466	0.827
NULL	Diabetes_Care_2012_Feb_16_35(2)_327-333.nxml.txt.nlp	22179958	SENT143	47	47	19	19	metformin	B12	PA450395	7126;4709	0.827
NULL	Oncotarget_2013_Feb_25_4(2)_310-315.nxml.txt.nlp	23470635	SENT15	10	10	21	21	sunitinib	KIT	PA162372840	3815	0.827
NULL	AAPS_J_2014_Jun_11_16(5)_1029-1037.nxml.txt.nlp	24917180	SENT171	13	13	11	11	quinidine	P-gp	PA451209	5243	0.827
NULL	Cell_Commun_Signal_2011_May_15_9_13.nxml.txt.nlp	21569639	SENT311	7	7	20	20	quinacrine	p65	PA164745551	5970	0.827
NULL	Cancer_Immunol_Immunother_2013_May_16_62(5)_897-908.nxml.txt.nlp	23589107	SENT1	11	11	16	16	cyclophosphamide	CD4	PA449165	920	0.827
NULL	Clin_Pharmacol_2010_Sep_6_2_155-162.nxml.txt.nlp	22291500	SENT59	28	28	14	14	clopidogrel	CYP2C19	PA449053	1557	0.827
NULL	Ital_J_Pediatr_2014_Jun_7_40_55.nxml.txt.nlp	24906390	SENT151	3	3	18	18	denosumab	RANKL	PA166048634	8600	0.827
NULL	Indian_J_Nucl_Med_2015_Jan-Mar_30(1)_21-25.nxml.txt.nlp	25589801	SENT88	3	3	6	6	gefitinib	EGFR	PA131301952	1956	0.827
NULL	Cell_Microbiol_2013_Dec_7_15(12)_2080-2092.nxml.txt.nlp	23870035	SENT237	21	21	11	11	l-glutamine	F12	PA10090	2161	0.827
NULL	Breast_Cancer_(Auckl)_2012_Nov_19_6_191-207.nxml.txt.nlp	23226023	SENT278	37	37	44	44	carboplatin	HER-2	PA448803	2064	0.827
NULL	Thorax_2009_Sep_22_64(9)_763-769.nxml.txt.nlp	19237390	SENT55	19	19	35	35	salmeterol	ANOVA	PA451300	4858	0.827
NULL	Br_J_Pharmacol_2011_Feb_162(4)_989-999.nxml.txt.nlp	21054342	SENT220	10	10	19	19	ketoconazole	CYP3A4	PA450146	1576	0.827
NULL	CNS_Neurosci_Ther_2011_Feb_17(1)_66-79.nxml.txt.nlp	20370806	SENT269	11	11	25	25	capsaicin	TRPV1	PA448776	7442	0.827
NULL	AAPS_J_2012_Dec_7_15(2)_308-315.nxml.txt.nlp	23224752	SENT21	6	6	17	17	atazanavir	UGT1A1	PA10251	54658	0.827
NULL	Cardiovasc_J_Afr_2009_Apr_20(2)_127-134.nxml.txt.nlp	19421649	SENT168	24	24	39	39	ramipril	AIRE	PA451223	326	0.827
NULL	Nat_Genet_2013_Jul_2_45(7)_747-755.nxml.txt.nlp	23727860	SENT382	28	28	18	18	dutasteride	XIAP	PA164749300	331	0.827
NULL	Int_J_Endocrinol_Metab_2013_Jul_1_Summer_11(3)_184-190.nxml.txt.nlp	24348591	SENT194	7	7	14	14	liraglutide	INS-1	PA165958364	2305	0.827
NULL	J_Hematol_Oncol_2012_Sep_18_5_57.nxml.txt.nlp	22989009	SENT93	7	7	17	17	nutlin-3	p53		7157	0.827
NULL	Drugs_R_D_2011_Jun_27_11(2)_101-111.nxml.txt.nlp	21679003	SENT9	10	10	17	17	bevacizumab	VEGF-A	PA130232992	7422	0.827
NULL	Drugs_R_D_2010_Sep_27_10(3)_165-178.nxml.txt.nlp	20945947	SENT53	7	7	14	14	ridaforolimus	KRAS	PA165291475	3845	0.827
NULL	Diabetes_Care_2011_Aug_16_34(8)_1854-1859.nxml.txt.nlp	21715518	SENT167	33	33	14	14	estradiol	aromatase	PA449503	1588	0.827
NULL	Oncotarget_2014_Aug_29_5(17)_7217-7259.nxml.txt.nlp	25277175	SENT301	23	23	25	25	pazopanib	VEGFR	PA165291492	3791	0.827
NULL	Iran_J_Psychiatry_2013_Oct_8(4)_195-200.nxml.txt.nlp	25628714	SENT5	24	24	12	12	reboxetine	6-16	PA144614921	2537	0.827
NULL	Br_J_Haematol_2014_Feb_16_164(4)_586-596.nxml.txt.nlp	24236640	SENT161	16	16	33	33	carboplatin	CARB	PA448803	9482	0.827
NULL	Acta_Pharmacol_Sin_2012_Jul_18_33(7)_861-872.nxml.txt.nlp	22705730	SENT196	8	8	18	18	atorvastatin	PI3K	PA448500	5290	0.827
NULL	Mol_Cancer_2009_Nov_10_8_99.nxml.txt.nlp	19903356	SENT113	8	8	22	22	imatinib	IGFBP3	PA10804	3486	0.827
NULL	Ann_Gen_Psychiatry_2010_Apr_22_9(Suppl_1)_S83.nxml.txt.nlp	NULL	SENT5	17	17	20	20	carbamazepine	AC1	PA448785	107	0.827
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT253	29	29	2	2	atorvastatin	CD36	PA448500	948	0.827
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_4_2013_378657.nxml.txt.nlp	23662132	SENT495	27	27	15	15	saxagliptin	GLP-1	PA165958362	100125288	0.827
NULL	Indian_J_Pharmacol_2008_Oct_40(Suppl_2)_S112-S142.nxml.txt.nlp	21593965	SENT1381	15	15	25	25	perindopril	STZ	PA450877	6484	0.827
NULL	AIDS_Res_Treat_2012_Mar_26_2012_948059.nxml.txt.nlp	22536498	SENT155	13	13	23	23	emtricitabine	CD4	PA10069	920	0.827
NULL	Ann_Hematol_2011_Dec_8_90(12)_1399-1407.nxml.txt.nlp	21476016	SENT89	8	8	13	13	mitoxantrone	CHOP	PA450526	1649	0.827
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT187	18	18	11	11	tacrolimus	OPG	PA451578	690	0.827
NULL	Oncotarget_2014_Jun_30_5(12)_4011-4025.nxml.txt.nlp	24994117	SENT111	22	22	3	3	estradiol	IRF7	PA449503	3665	0.827
NULL	Front_Endocrinol_(Lausanne)_2013_Jun_12_4_71.nxml.txt.nlp	23781214	SENT1236	3	3	0	0	etanercept	TNF-alpha	PA449515	7124	0.827
NULL	Exp_Lung_Res_2013_Oct_1_39(8)_336-348.nxml.txt.nlp	23919450	SENT121	18	18	12	12	argatroban	PAR-1	PA164745516	2011;2149	0.827
NULL	Korean_Circ_J_2013_Oct_30_43(10)_699-701.nxml.txt.nlp	24255655	SENT66	21	21	13	13	amiodarone	APT	PA448383	653639	0.827
NULL	Pediatr_Nephrol_2008_Sep_16_23(9)_1517-1521.nxml.txt.nlp	18483746	SENT73	25	25	33	33	heparin	C3b	PA449855	718	0.827
NULL	Clin_Pharmacol_2011_Jun_22_3_13-25.nxml.txt.nlp	22287853	SENT181	16	16	28	28	saxagliptin	CYP3A4	PA165958362	1576	0.827
NULL	Cell_Rep_2012_Jul_26_2(1)_10-18.nxml.txt.nlp	22840391	SENT188	12	12	0	0	paraformaldehyde	C17	PA450790	54360	0.827
NULL	Cancer_Cell_Int_2005_Jun_1_5_18.nxml.txt.nlp	15929791	SENT50	10	10	14	14	bortezomib	p53	PA10252	7157	0.827
NULL	Front_Behav_Neurosci_2014_Oct_1_8_306.nxml.txt.nlp	25324743	SENT143	6	6	27	27	risperidone	5-HT7	PA451257	3363	0.827
NULL	Sci_Rep_2015_Jan_6_5_7642.nxml.txt.nlp	25560837	SENT431	32	32	37	37	rimonabant	CB2	PA152407999	1269	0.827
NULL	Nature_2007_Jan_25_445(7126)_437-441.nxml.txt.nlp	17206155	SENT44	9	9	15	15	gefitinib	HER3	PA131301952	2065	0.827
NULL	J_Immunother_Cancer_2013_Sep_23_1_16.nxml.txt.nlp	24829752	SENT19	23	23	5	5	methylcholanthrene	gamma	PA165816878	9913	0.827
NULL	Indian_J_Ophthalmol_2014_Apr_62(4)_511-512.nxml.txt.nlp	23571236	SENT8	24	24	9	9	triamcinolone	ERM	PA451749	2119	0.827
NULL	Ecancermedicalscience_2008_Feb_18_2_75.nxml.txt.nlp	22275966	SENT112	20	20	6	6	erlotinib	EGFR	PA134687924	1956	0.827
NULL	Cell_Death_Dis_2014_Jan_9_5(1)_e986.nxml.txt.nlp	24407239	SENT76	16	16	9	9	fludarabine	STAT1	PA449655	6772	0.827
NULL	Endocrinology_2012_Jul_5_153(7)_3190-3198.nxml.txt.nlp	22669896	SENT96	13	13	20	20	genistein	PI3K	PA165109660	5290	0.827
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Apr_16_64(Pt_5)_o862.nxml.txt.nlp	21202349	SENT59	20	20	12	12	ethanol	mol	PA448073	90527	0.827
NULL	AAPS_J_2014_Jun_11_16(5)_1029-1037.nxml.txt.nlp	24917180	SENT116	2	2	36	36	quinidine	ANOVA	PA451209	4858	0.827
NULL	Front_Oncol_2014_Jun_23_4_162.nxml.txt.nlp	25003082	SENT30	20	20	2	2	estradiol	AKR1C3	PA449503	8644	0.827
NULL	Genome_Biol_2008_May_9_9(5)_221.nxml.txt.nlp	18492217	SENT47	16	16	12	12	cisplatin	p53	PA449014	7157	0.827
NULL	Mol_Cancer_2012_Apr_26_11_26.nxml.txt.nlp	22537224	SENT354	24	24	19	19	cisplatin	FANCF	PA449014	2188	0.827
NULL	Oncotarget_2014_Jun_18_5(14)_5428-5438.nxml.txt.nlp	24980817	SENT64	6	6	3	3	cetuximab	EGFR	PA10040	1956	0.827
NULL	Oncol_Lett_2014_Mar_16_7(3)_827-833.nxml.txt.nlp	24527090	SENT168	13	13	8	8	cisplatin	IFN	PA449014	3439	0.827
NULL	Biomed_Res_Int_2014_Jun_25_2014_764981.nxml.txt.nlp	25057499	SENT114	0	0	5	5	crizotinib	Met	PA165946122	79811	0.827
NULL	Pharmaceuticals_(Basel)_2014_Sep_4_7(9)_913-942.nxml.txt.nlp	25192192	SENT303	3	3	18	18	resveratrol	Bcl-2		596	0.827
NULL	Indian_J_Pharm_Sci_2008_Mar-Apr_70(2)_251-255.nxml.txt.nlp	20046726	SENT80	13	13	19	19	olanzapine	TLC	PA450688	3933	0.827
NULL	Clin_Psychopharmacol_Neurosci_2014_Apr_24_12(1)_54-64.nxml.txt.nlp	24851122	SENT122	9	9	3	3	methamphetamine	MAPK4	PA450403	5596	0.827
NULL	Oncotarget_2014_Mar_13_5(4)_1101-1110.nxml.txt.nlp	24658355	SENT65	12	12	4	4	tamoxifen	MKP-2	PA451581	1846	0.827
NULL	Breast_Cancer_Res_2012_Nov_6_14(6)_325.nxml.txt.nlp	23131146	SENT14	7	7	17	17	doxorubicin	TP53	PA449412	7157	0.827
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT205	0	0	19	19	telatinib	ABCG2	PA165980595	9429	0.827
NULL	Front_Oncol_2014_Oct_31_4_306.nxml.txt.nlp	25401091	SENT200	5	5	45	45	fluorescein	mol	PA164746009	90527	0.827
NULL	Breast_Cancer_Res_2007_Dec_17_9(6)_R87.nxml.txt.nlp	18086299	SENT16	4	4	13	13	trastuzumab	San	PA451743	80218	0.827
NULL	Cardiovasc_Res_2012_Dec_1_96(3)_552-560.nxml.txt.nlp	22918977	SENT64	25	25	8	8	hydralazine	JAM-A	PA449894	50848	0.827
NULL	Breast_Cancer_Res_2013_Oct_8_15(5)_R94.nxml.txt.nlp	24099325	SENT118	18	18	16	16	trastuzumab	NACT	PA451743	284111	0.827
NULL	Clin_Proteomics_2014_Jan_6_11(1)_2.nxml.txt.nlp	24393573	SENT273	15	15	5	5	capsaicin	ENOX2	PA448776	10495	0.827
NULL	Front_Oncol_2014_Oct_21_4_285.nxml.txt.nlp	25374842	SENT703	9	9	15	15	nutlin-3	p53		7157	0.827
NULL	Onco_Targets_Ther_2014_Sep_9_7_1571-1582.nxml.txt.nlp	25228815	SENT113	0	0	6	6	sunitinib	VEGFR2	PA162372840	3791	0.827
NULL	Arch_Trauma_Res_2013_Aug_1_2(2)_97-98.nxml.txt.nlp	24396803	SENT18	7	7	9	9	gabapentin	P-gp	PA449720	5243	0.827
NULL	J_Res_Med_Sci_2012_Mar_17(3)_313.nxml.txt.nlp	23267388	SENT16	7	7	2	2	aprotinin	BART	PA448472	7809;23568	0.827
NULL	Cancers_(Basel)_2011_Aug_15_3(3)_3331-3352.nxml.txt.nlp	24212957	SENT264	16	16	10	10	erlotinib	EGFR	PA134687924	1956	0.827
NULL	J_Cell_Mol_Med_2014_Sep_1_18(9)_1895-1907.nxml.txt.nlp	25088572	SENT46	19	19	37	37	dextran	EGF	PA449261	1950	0.827
NULL	Cancers_(Basel)_2010_Apr_20_2(2)_611-623.nxml.txt.nlp	24281084	SENT32	10	10	21	21	l-tryptophan	NK-1	PA10323	27087	0.827
NULL	Acta_Pharmacol_Sin_2010_Apr_8_31(4)_461-469.nxml.txt.nlp	20208553	SENT48	21	21	24	24	ethanol	adiponectin	PA448073	9370	0.827
NULL	Cardiovasc_Diabetol_2013_May_4_12_73.nxml.txt.nlp	23642288	SENT11	4	4	12	12	acarbose	GLP-1	PA448010	100125288	0.827
NULL	Cases_J_2009_Nov_18_2_205.nxml.txt.nlp	19946449	SENT71	1	1	5	5	clarithromycin	CYP3A	PA449028	1574	0.827
NULL	J_Mol_Signal_2010_Jul_12_5_8.nxml.txt.nlp	20624308	SENT117	13	13	16	16	dasatinib	Met	PA162372878	79811	0.827
NULL	Drug_Des_Devel_Ther_2014_Sep_26_8_1595-1611.nxml.txt.nlp	25302015	SENT115	11	11	33	33	erlotinib	EGFR	PA134687924	1956	0.827
NULL	Indian_J_Psychol_Med_2013_Jul-Sep_35(3)_290-298.nxml.txt.nlp	24249933	SENT146	2	2	19	19	buspirone	ADX	PA448689	2230	0.827
NULL	Cell_Death_Dis_2014_Jul_17_5(7)_e1338.nxml.txt.nlp	25032861	SENT89	12	12	19	19	pp2	STAT3		6774	0.827
NULL	Cardiovasc_Ther_2009_27(4)_259-274.nxml.txt.nlp	19604248	SENT139	39	39	20	20	clopidogrel	IPA	PA449053	3160	0.827
NULL	Br_J_Ophthalmol_2010_May_94(5)_639-642.nxml.txt.nlp	20447966	SENT96	19	19	33	33	fluorometholone	MYOC	PA164781355	4653	0.827
NULL	Evid_Based_Complement_Alternat_Med_2014_Jun_16_2014_371475.nxml.txt.nlp	25024728	SENT126	23	23	18	18	atropine	IRS1	PA448505	3667	0.827
NULL	Acta_Pharmacol_Sin_2012_Jun_6_33(6)_798-808.nxml.txt.nlp	22669117	SENT211	7	7	3	3	heparin	HCS	PA449855	3141;54205	0.827
NULL	Cancer_Cell_Int_2011_Aug_19_11_29.nxml.txt.nlp	21854619	SENT220	11	11	30	30	cisplatin	BRCA1	PA449014	672	0.827
NULL	Cancer_Cell_Int_2013_Oct_22_13_103.nxml.txt.nlp	24148306	SENT184	16	16	3	3	etoposide	PRL	PA449552	5617	0.827
NULL	Breast_Cancer_Res_2007_Dec_20_9(Suppl_2)_S13.nxml.txt.nlp	NULL	SENT49	7	7	2	2	tamoxifen	IMPACT	PA451581	55364	0.827
NULL	J_Exp_Bot_2012_Nov_23_63(18)_6393-6405.nxml.txt.nlp	23095993	SENT172	2	2	15	15	ethanol	CO2	PA448073	4513	0.827
NULL	Br_J_Cancer_2012_Jul_24_107(3)_516-526.nxml.txt.nlp	22782351	SENT299	36	36	24	24	tamoxifen	CDKN1A	PA451581	1026	0.827
NULL	J_Cell_Biol_1999_Feb_22_144(4)_789-801.nxml.txt.nlp	10037799	SENT56	28	28	45	45	ethanol	CD44	PA448073	960	0.827
NULL	Diabetes_2008_Oct_57(10)_2801-2808.nxml.txt.nlp	18633115	SENT162	27	27	14	14	sulfasalazine	p50	PA451547	958;4790	0.827
NULL	Nat_Commun_2012_3_1147.nxml.txt.nlp	23093184	SENT222	24	24	16	16	tetracycline	ND5	PA451640	4540	0.827
NULL	Cell_Death_Dis_2012_Jun_21_3(6)_e330.nxml.txt.nlp	22717585	SENT32	35	35	41	41	simvastatin	RhoA	PA451363	387	0.827
NULL	Comb_Chem_High_Throughput_Screen_2010_Feb_13(2)_188-206.nxml.txt.nlp	20053163	SENT245	13	13	11	11	simvastatin	CYP3A4	PA451363	1576	0.827
NULL	Front_Mol_Neurosci_2012_Nov_12_5_99.nxml.txt.nlp	23162427	SENT117	33	33	7	7	cocaine	NR1	PA449072	27158	0.827
NULL	Acta_Pharmacol_Sin_2009_Dec_4_30(12)_1659-1665.nxml.txt.nlp	19960011	SENT30	13	13	26	26	bortezomib	B10	PA10252	5169	0.827
NULL	J_Biol_Chem_2009_Feb_27_284(9)_5645-5653.nxml.txt.nlp	19095655	SENT217	12	12	30	30	dipyridamole	AMPK	PA449367	5563	0.827
NULL	Br_J_Cancer_2009_Nov_3_101(9)_1585-1595.nxml.txt.nlp	19809435	SENT311	19	19	23	23	curcumin	MDC	PA151958596	6367	0.827
NULL	Hum_Genomics_2009_Dec_1_4(2)_91-106.nxml.txt.nlp	20038497	SENT203	4	4	13	13	galantamine	APOE	PA449726	348	0.827
NULL	ScientificWorldJournal_2014_Mar_4_2014_468982.nxml.txt.nlp	24737971	SENT37	0	0	7	7	heparin	San	PA449855	80218	0.827
NULL	Oncotarget_2014_Feb_25_5(5)_1304-1314.nxml.txt.nlp	24675421	SENT153	9	9	6	6	cisplatin	JNK	PA449014	5599	0.827
NULL	Br_J_Cancer_2012_Nov_6_107(10)_1692-1701.nxml.txt.nlp	23037716	SENT201	41	41	22	22	paclitaxel	P-gp	PA450761	5243	0.827
NULL	Appl_Clin_Genet_2012_Jun_18_5_37-41.nxml.txt.nlp	23776379	SENT75	35	35	16	16	diflunisal	TTR	PA449313	7276	0.827
NULL	Nucleic_Acids_Res_2011_Mar_17_39(6)_2144-2152.nxml.txt.nlp	21087997	SENT184	23	23	36	36	etoposide	CtIP	PA449552	5932	0.827
NULL	Scientifica_(Cairo)_2014_Apr_6_2014_394270.nxml.txt.nlp	24808974	SENT126	38	38	21	21	halothane	CO2	PA449845	4513	0.827
NULL	Clinics_2008_Aug_63(4)_479-482.nxml.txt.nlp	18719758	SENT49	15	15	20	20	enalapril	AT1	PA449456	9197;185	0.827
NULL	Front_Neurosci_2013_Feb_13_7_13.nxml.txt.nlp	23407595	SENT131	0	0	12	12	estradiol	CORT	PA449503	1325	0.827
NULL	Cancer_Cell_Int_2013_May_15_13_42.nxml.txt.nlp	23672670	SENT99	2	2	24	24	paclitaxel	golgin-160	PA450761	2802	0.827
NULL	Clin_Mol_Allergy_2007_Jan_25_5_1.nxml.txt.nlp	17254346	SENT14	2	2	16	16	curcumin	CD86	PA151958596	942	0.827
NULL	Mol_Cancer_2008_May_19_7_40.nxml.txt.nlp	18489772	SENT201	16	16	6	6	bortezomib	PIR	PA10252	8544	0.827
NULL	Chemother_Res_Pract_2011_Apr_18_2011_619321.nxml.txt.nlp	22312555	SENT62	32	32	9	9	daptomycin	VISA	PA164768820	57506	0.827
NULL	Iran_J_Neurol_2011_10(1-2)_16-18.nxml.txt.nlp	24250837	SENT60	4	4	17	17	clopidogrel	HLP	PA449053	6499;9001;3002	0.827
NULL	Indian_J_Ophthalmol_2007_Nov-Dec_55(6)_460-462.nxml.txt.nlp	17951906	SENT16	13	13	24	24	bevacizumab	San	PA130232992	80218	0.827
NULL	Cancer_Res_Treat_2012_Sep_30_44(3)_202-209.nxml.txt.nlp	23091447	SENT121	22	22	9	9	gefitinib	EGFR	PA131301952	1956	0.827
NULL	Int_J_Mol_Sci_2012_Feb_10_13(2)_1886-1918.nxml.txt.nlp	22408430	SENT241	0	0	8	8	temsirolimus	VEGFR	PA164746890	3791	0.827
NULL	Br_J_Cancer_2011_Mar_15_104(6)_941-947.nxml.txt.nlp	21407223	SENT125	13	13	8	8	sorafenib	survivin	PA7000	332	0.827
NULL	Clin_Pediatr_Endocrinol_2014_Apr_22_23(2)_27-34.nxml.txt.nlp	24790384	SENT107	19	19	29	29	hydrocortisone	ACTH	PA449905	5443	0.827
NULL	Cancers_(Basel)_2014_Jun_27_6(3)_1298-1327.nxml.txt.nlp	24978435	SENT897	1	1	3	3	genistein	p38	PA165109660	10598;1432;7965	0.827
NULL	Aging_(Albany_NY)_2012_Apr_16_4(4)_247-255.nxml.txt.nlp	22511639	SENT82	12	12	40	40	metformin	p300	PA450395	2033	0.827
NULL	Oncotarget_2013_Nov_15_5(6)_1458-1474.nxml.txt.nlp	24681547	SENT213	20	20	13	13	celecoxib	CDH11	PA448871	1009	0.827
NULL	J_Clin_Immunol_2007_May_14_27(3)_275-283.nxml.txt.nlp	17510806	SENT181	11	11	29	29	rosiglitazone	IL-10	PA451283	3586	0.827
NULL	J_Cell_Biol_2001_Apr_30_153(3)_613-620.nxml.txt.nlp	11331310	SENT63	13	13	36	36	etoposide	53BP1	PA449552	7158	0.827
NULL	Iran_J_Pharm_Res_2014_Spring_13(2)_635-639.nxml.txt.nlp	25237359	SENT18	10	10	20	20	midazolam	CYP2D6	PA450496	1565	0.827
NULL	Cancer_Cell_Int_2005_Jul_24_5_22.nxml.txt.nlp	16042792	SENT41	11	11	18	18	vincristine	NAC	PA451879	22861	0.827
NULL	Cancer_Cell_Int_2010_Sep_9_10_32.nxml.txt.nlp	20828393	SENT139	34	34	2	2	cisplatin	ATF3	PA449014	467	0.827
NULL	Br_J_Cancer_2012_Sep_25_107(7)_1009-1016.nxml.txt.nlp	22948724	SENT54	0	0	21	21	sunitinib	AKT	PA162372840	207	0.827
NULL	Iran_J_Pharm_Res_2014_Spring_13(2)_635-639.nxml.txt.nlp	25237359	SENT18	37	37	7	7	chlorzoxazone	CYP2E1	PA448971	1571	0.827
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Jun_25_3(6)_e120.nxml.txt.nlp	24964282	SENT3	26	26	10	10	rifampin	CYP3A4	PA451250	1576	0.827
NULL	Br_J_Cancer_2011_Aug_9_105(4)_523-533.nxml.txt.nlp	21792199	SENT132	22	22	28	28	erlotinib	EGF	PA134687924	1950	0.827
NULL	Ther_Clin_Risk_Manag_2006_Mar_2(1)_59-75.nxml.txt.nlp	18360582	SENT224	19	19	21	21	telithromycin	CYP3A4	PA10202	1576	0.827
NULL	J_Carcinog_2014_Nov_27_13_13.nxml.txt.nlp	25525412	SENT86	17	17	29	29	fluorouracil	EGFR	PA128406956	1956	0.827
NULL	Evid_Based_Complement_Alternat_Med_2014_Oct_19_2014_628712.nxml.txt.nlp	25389442	SENT313	6	6	11	11	erlotinib	p27	PA134687924	5715;10534	0.827
NULL	Pharmaceuticals_(Basel)_2013_Aug_21_6(8)_988-1038.nxml.txt.nlp	24276379	SENT485	19	19	14	14	vemurafenib	PTEN	PA165946873	5728	0.827
NULL	Mediators_Inflamm_2014_Nov_4_2014_708608.nxml.txt.nlp	25580060	SENT14	18	18	0	0	roxithromycin	IL-8	PA164750505	3576	0.827
NULL	HSR_Proc_Intensive_Care_Cardiovasc_Anesth_2010_2(1)_27-33.nxml.txt.nlp	23439767	SENT35	1	1	12	12	heparin	ACT	PA449855	12;11332;9457;641455	0.827
NULL	J_Bras_Pneumol_2014_May-Jun_40(3)_238-243.nxml.txt.nlp	25029646	SENT126	9	9	12	12	methylprednisolone	LPO	PA450466	4025	0.827
NULL	Allergy_Asthma_Immunol_Res_2010_Oct_12_2(4)_235-246.nxml.txt.nlp	20885908	SENT84	13	13	10	10	capsaicin	TRPV1	PA448776	7442	0.827
NULL	Breast_Cancer_Res_2012_Jul_12_14(4)_R104.nxml.txt.nlp	22788954	SENT222	14	14	0	0	gefitinib	Met	PA131301952	79811	0.827
NULL	Environ_Health_Perspect_2008_Apr_16_116(4)_426-433.nxml.txt.nlp	18414622	SENT140	0	0	23	23	resveratrol	p53		7157	0.827
NULL	Springerplus_2014_Sep_9_3_510.nxml.txt.nlp	25279302	SENT29	0	0	8	8	creatine	ADP	PA164778930	23038	0.827
NULL	Acta_Pharmacol_Sin_2014_Sep_25_35(9)_1199-1206.nxml.txt.nlp	25152024	SENT104	5	5	23	23	cisplatin	JNK	PA449014	5599	0.827
NULL	Ann_Hematol_2014_Apr_1_93(8)_1371-1380.nxml.txt.nlp	24687382	SENT187	18	18	33	33	lenalidomide	CCND1	PA162363968	595	0.827
NULL	Clin_Ophthalmol_2010_Apr_26_4_349-358.nxml.txt.nlp	20463804	SENT168	14	14	26	26	bimatoprost	C-1	PA164748867	5203	0.827
NULL	Nucleic_Acids_Res_2011_Dec_10_39(22)_9498-9507.nxml.txt.nlp	21835778	SENT182	10	10	12	12	nutlin-3	PUMA		27113	0.827
NULL	Braz_J_Med_Biol_Res_2012_Mar_2_45(3)_250-255.nxml.txt.nlp	22370705	SENT13	6	6	32	32	mecamylamine	ADM	PA450334	133	0.827
NULL	Cancer_Cell_Int_2013_Mar_4_13_21.nxml.txt.nlp	23497288	SENT109	12	12	8	8	doxorubicin	EWS	PA449412	2130	0.827
NULL	Chem_Sci_2014_Dec_1_6(1)_237-245.nxml.txt.nlp	25580214	SENT127	21	21	4	4	disulfiram	ALDH4A1	PA449376	8659	0.827
NULL	Mol_Biol_Cell_2012_Jul_1_23(13)_2468-2480.nxml.txt.nlp	22573889	SENT314	4	4	18	18	dextran	Rho	PA449261	29984	0.827
NULL	Arthritis_Res_Ther_2003_Sep_3_5(6)_R317-R328.nxml.txt.nlp	14680506	SENT99	4	4	10	10	rolipram	IL-10	PA153906323	3586	0.827
NULL	Tumour_Biol_2011_Oct_16_32(5)_965-976.nxml.txt.nlp	21678067	SENT109	4	4	11	11	urokinase	MMP1	PA451836	4312	0.827
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2011_Mar_14_4_13-24.nxml.txt.nlp	22879790	SENT77	10	10	33	33	liraglutide	PPG	PA165958364	5552	0.827
NULL	Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.nxml.txt.nlp	24736980	SENT32	28	28	13	13	rosuvastatin	OATP-C	PA134308647	10599	0.827
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Mar_19_65(Pt_4)_o783.nxml.txt.nlp	21582508	SENT61	25	25	31	31	gabapentin	mol	PA449720	90527	0.827
NULL	Environ_Health_Perspect_2007_Feb_20_115(2)_243-247.nxml.txt.nlp	17384772	SENT173	26	26	12	12	flutamide	EGF	PA449685	1950	0.827
NULL	AIDS_Res_Treat_2011_Jul_25_2011_743597.nxml.txt.nlp	21804938	SENT29	27	27	8	8	lamivudine	CD4	PA450163	920	0.827
NULL	Front_Cell_Neurosci_2014_Feb_4_8_26.nxml.txt.nlp	24550782	SENT564	0	0	8	8	taurine	KCC2	PA451590	57468	0.827
NULL	J_Carcinog_2011_Nov_30_10_28.nxml.txt.nlp	22190870	SENT105	8	8	12	12	trastuzumab	PTEN	PA451743	5728	0.827
NULL	Cardiovasc_Ultrasound_2009_Nov_27_7_56.nxml.txt.nlp	19943937	SENT141	23	23	20	20	ezetimibe	TDI	PA10816	100038246	0.827
NULL	Indian_J_Endocrinol_Metab_2013_Jul-Aug_17(4)_636-646.nxml.txt.nlp	23961479	SENT146	6	6	4	4	rifampin	CYP2C9	PA451250	1559	0.827
NULL	Cell_Death_Dis_2012_Jul_19_3(7)_e355.nxml.txt.nlp	22825473	SENT119	13	13	4	4	paraformaldehyde	RPGRIP1	PA450790	57096	0.827
NULL	J_Med_Chem_2014_Feb_27_57(4)_1599-1608.nxml.txt.nlp	24471466	SENT390	22	22	15	15	vemurafenib	FGFR3	PA165946873	2261	0.827
NULL	Iran_J_Neurol_2013_12(4)_149-156.nxml.txt.nlp	24250925	SENT3	25	25	13	13	natalizumab	IFN	PA164747191	3439	0.827
NULL	Cancer_Cell_Int_2013_Sep_23_13_94.nxml.txt.nlp	24059699	SENT14	17	17	14	14	bevacizumab	VEGFA	PA130232992	7422	0.827
NULL	Commun_Integr_Biol_2014_Jan_8_6(6)_e27595.nxml.txt.nlp	24753792	SENT87	9	9	11	11	thrombin	ADP	PA451674	23038	0.827
NULL	Br_J_Clin_Pharmacol_2014_Nov_20_78(5)_1050-1057.nxml.txt.nlp	24962564	SENT3	19	19	16	16	ketoconazole	CYP3A4	PA450146	1576	0.827
NULL	Br_J_Haematol_2014_Feb_16_164(4)_586-596.nxml.txt.nlp	24236640	SENT200	20	20	9	9	carboplatin	HAMP	PA448803	57817	0.827
NULL	Drugs_R_D_2014_Sep_28_14(3)_159-164.nxml.txt.nlp	24973042	SENT47	32	32	28	28	omeprazole	CYP2C	PA450704	1562	0.827
NULL	J_Ophthalmol_2011_Jun_16_2011_159436.nxml.txt.nlp	21772983	SENT61	0	0	16	16	ranibizumab	VEGF-A	PA164746012	7422	0.827
NULL	Case_Rep_Med_2012_Dec_3_2012_163173.nxml.txt.nlp	23326270	SENT97	31	31	28	28	bezafibrate	CPT2	PA162364313	1376	0.827
NULL	Br_J_Cancer_2010_Feb_2_102(3)_520-529.nxml.txt.nlp	20029417	SENT146	20	20	3	3	trastuzumab	IL-21	PA451743	59067;50616;27189	0.827
NULL	Int_J_Mol_Sci_2012_Feb_17_13(2)_2219-2238.nxml.txt.nlp	22408449	SENT554	0	0	8	8	nicotine	IL-8	PA450626	3576	0.827
NULL	Ther_Clin_Risk_Manag_2007_Jun_3(2)_277-289.nxml.txt.nlp	18360636	SENT89	6	6	12	12	fluoxetine	5-HT2C	PA449673	3358	0.827
NULL	J_Clin_Biochem_Nutr_2007_Jan_27_40(1)_13-23.nxml.txt.nlp	18437209	SENT575	5	5	19	19	trypsin	p38	PA451806	10598;1432;7965	0.827
NULL	J_RNAi_Gene_Silencing_2009_Mar_9_5(1)_321-330.nxml.txt.nlp	19771229	SENT160	7	7	13	13	gemcitabine	RRM1	PA449748	6240	0.827
NULL	Int_J_Biol_Sci_2011_Nov_5_8(1)_1-14.nxml.txt.nlp	22211100	SENT136	0	0	10	10	evodiamine	PI3K	PA165860788	5290	0.827
NULL	Leukemia_2013_Dec_21_27(12)_2376-2379.nxml.txt.nlp	23612016	SENT83	17	17	7	7	fludarabine	BII	PA449655	777	0.827
NULL	Scientifica_(Cairo)_2013_Feb_7_2013_249101.nxml.txt.nlp	24278770	SENT144	16	16	12	12	natalizumab	IFN	PA164747191	3439	0.827
NULL	Br_J_Haematol_2008_Jun_141(5)_659-671.nxml.txt.nlp	18410446	SENT157	3	3	11	11	cerulenin	IRE1	PA164764551	2081	0.827
NULL	Calcif_Tissue_Int_2014_Aug_21_94(2)_170-175.nxml.txt.nlp	23963633	SENT122	21	21	16	16	teriparatide	PTH	PA451620	5741	0.827
NULL	Mol_Microbiol_2014_May_28_92(3)_453-470.nxml.txt.nlp	24533860	SENT109	11	11	6	6	tetracycline	HMI	PA451640	3160	0.827
NULL	Open_Access_J_Urol_2011_May_10_3_69-82.nxml.txt.nlp	24198638	SENT66	20	20	5	5	paclitaxel	CYP2B6	PA450761	1555	0.827
NULL	Can_J_Infect_Dis_Med_Microbiol_2014_Nov-Dec_25(6)_311-320.nxml.txt.nlp	25587293	SENT86	20	20	5	5	ribavirin	RVR	PA451241	9975	0.827
NULL	Front_Genet_2012_Nov_5_3_236.nxml.txt.nlp	23133441	SENT318	11	11	3	3	cyclosporine	CYP3A5	PA449167	1577	0.827
NULL	Drugs_2014_Sep_2_74(14)_1587-1603.nxml.txt.nlp	25178252	SENT96	12	12	0	0	rivaroxaban	CYP3A4	PA165958360	1576	0.827
NULL	Cells_2014_Sep_29_3(4)_939-962.nxml.txt.nlp	25268281	SENT233	29	29	6	6	cyclophosphamide	TRPC1	PA449165	7220	0.827
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT376	19	19	4	4	pp2	CDH1		51343;999	0.827
NULL	Environ_Health_Perspect_2005_Mar_113(3)_A178-A181.nxml.txt.nlp	15743707	SENT45	7	7	10	10	ethanol	CO2	PA448073	4513	0.827
NULL	Cell_Mol_Life_Sci_2011_May_26_68(10)_1785-1798.nxml.txt.nlp	20976523	SENT220	2	2	29	29	collagenase	p53	PA449107	7157	0.827
NULL	Int_J_Mol_Imaging_2011_Oct_26_2011_874585.nxml.txt.nlp	21490735	SENT130	7	7	23	23	tamoxifen	FDG	PA451581	23583	0.827
NULL	Aging_(Albany_NY)_2012_Jul_22_4(7)_480-498.nxml.txt.nlp	22837425	SENT26	8	8	12	12	metformin	AMPK	PA450395	5563	0.827
NULL	Exp_Ther_Med_2013_Nov_13_6(5)_1317-1321.nxml.txt.nlp	24223665	SENT67	0	0	3	3	curcumin	CD133	PA151958596	8842	0.827
NULL	Ther_Clin_Risk_Manag_2006_Dec_2(4)_337-346.nxml.txt.nlp	18360646	SENT196	12	12	21	21	timolol	BAK	PA451690	578	0.827
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT98	9	9	20	20	ranibizumab	VEGFR1	PA164746012	2321	0.827
NULL	Indian_J_Dermatol_2010_Apr-Jun_55(2)_161-170.nxml.txt.nlp	20606887	SENT6	4	4	16	16	ustekinumab	IL-23	PA166048654	51561	0.827
NULL	Oxid_Med_Cell_Longev_2013_Jun_2_2013_793525.nxml.txt.nlp	23819014	SENT199	16	16	19	19	resveratrol	TNF		7124	0.827
NULL	Blood_Cancer_J_2014_Mar_7_4(3)_e190.nxml.txt.nlp	24608734	SENT98	4	4	14	14	doxorubicin	CHOP	PA449412	1649	0.827
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Jul_9_3(7)_e124.nxml.txt.nlp	25006781	SENT82	32	32	35	35	rosuvastatin	OATP1B1	PA134308647	10599	0.827
NULL	Adv_Hematol_2010_May_16_2010_672137.nxml.txt.nlp	20490274	SENT3	27	27	18	18	idarubicin	AIDA	PA449961	64853	0.827
NULL	J_Invest_Dermatol_2013_Jul_13_133(7)_1742-1751.nxml.txt.nlp	23407402	SENT255	37	37	8	8	etanercept	TREM-1	PA449515	54210	0.827
NULL	J_Biol_Chem_2011_Oct_7_286(40)_34998-35006.nxml.txt.nlp	21757733	SENT28	27	27	21	21	lipase	PLIN1	PA450239	5346	0.827
NULL	Physiol_Rep_2014_Aug_28_2(8)_e12143.nxml.txt.nlp	25168879	SENT46	18	18	14	14	staurosporine	COX	PA165109623	1351	0.827
NULL	Curr_Med_Chem_2011_Jun_18(18)_2686-2714.nxml.txt.nlp	21649578	SENT608	26	26	16	16	bevacizumab	PI3K	PA130232992	5290	0.827
NULL	EMBO_Mol_Med_2012_Sep_7_4(9)_896-909.nxml.txt.nlp	22887866	SENT243	10	10	12	12	lovastatin	c-Myc	PA450272	4609	0.827
NULL	Oncogene_2013_Sep_26_32(39)_10_1038_onc_2012_491.nxml.txt.nlp	23108394	SENT42	16	16	3	3	epirubicin	FOXM1	PA449476	2305	0.827
NULL	Mol_Cancer_2012_Jun_18_11_41.nxml.txt.nlp	22709873	SENT328	20	20	24	24	lapatinib	NR3C1	PA152241907	2908	0.827
NULL	Oncotarget_2013_Aug_24_4(10)_1618-1631.nxml.txt.nlp	24113128	SENT130	8	8	24	24	sorafenib	p53	PA7000	7157	0.827
NULL	Cell_J_2012_Dec_22_Winter_13(4)_265-274.nxml.txt.nlp	23507995	SENT246	18	18	22	22	ethanol	spatial	PA448073	219793	0.827
NULL	Allergy_Asthma_Clin_Immunol_2014_Oct_24_10(1)_50.nxml.txt.nlp	25352908	SENT189	18	18	13	13	icatibant	C1-INH	PA164749185	710	0.827
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_75-89.nxml.txt.nlp	17912638	SENT267	17	17	5	5	tamoxifen	ATAC	PA451581	6375	0.827
NULL	Leukemia_2014_Mar_20_28(3)_554-565.nxml.txt.nlp	24280866	SENT167	9	9	16	16	imatinib	BCL2	PA10804	596	0.827
NULL	Breast_Cancer_Res_2012_May_18_14(3)_R78.nxml.txt.nlp	22608253	SENT210	6	6	20	20	nilotinib	GREB1	PA165958345	9687	0.827
NULL	Oncotarget_2010_May_1_1(1)_48-58.nxml.txt.nlp	21293053	SENT118	23	23	6	6	cisplatin	ID4	PA449014	3400	0.827
NULL	Tuberc_Respir_Dis_(Seoul)_2013_Nov_29_75(5)_188-198.nxml.txt.nlp	24348666	SENT42	0	0	6	6	gefitinib	HER3	PA131301952	2065	0.827
NULL	Leukemia_2014_Jun_17_28(6)_1216-1226.nxml.txt.nlp	24301524	SENT6	3	3	17	17	bortezomib	RUNX3	PA10252	864	0.827
NULL	Oncotarget_2010_Oct_15_1(7)_515-529.nxml.txt.nlp	21317448	SENT74	13	13	4	4	cisplatin	BTC	PA449014	685	0.827
NULL	AIDS_Res_Ther_2009_Apr_9_6_3.nxml.txt.nlp	19358725	SENT57	27	27	37	37	fosamprenavir	BID	PA10084	637	0.827
NULL	Int_J_Gen_Med_2009_Dec_29_2_209-217.nxml.txt.nlp	20360906	SENT139	22	22	9	9	pergolide	PRL	PA450873	5617	0.827
NULL	Br_J_Cancer_2004_Mar_22_90(6)_1285-1292.nxml.txt.nlp	15026814	SENT145	4	4	0	0	doxorubicin	p53	PA449412	7157	0.827
NULL	Mol_Vis_2012_Nov_12_18_2658-2672.nxml.txt.nlp	23170059	SENT286	28	28	11	11	forskolin	CNTF	PA146096022	1270	0.827
NULL	Breast_Cancer_Res_Treat_2014_Apr_9_145(1)_73-82.nxml.txt.nlp	24715380	SENT2	37	37	6	6	tamoxifen	CXCL10	PA451581	3627	0.827
NULL	Br_J_Cancer_2012_Apr_24_106(9)_1486-1494.nxml.txt.nlp	22472882	SENT119	6	6	21	21	rosiglitazone	HPSE	PA451283	10855	0.827
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Nov_27_66(Pt_12)_o3337.nxml.txt.nlp	21589611	SENT46	3	3	6	6	benzaldehyde	mol	PA448571	90527	0.827
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT194	3	3	7	7	tacrolimus	STAT3	PA451578	6774	0.827
NULL	J_Cancer_2011_May_25_2_317-323.nxml.txt.nlp	21716848	SENT67	4	4	7	7	lapatinib	HER2	PA152241907	2064	0.827
NULL	J_Allergy_(Cairo)_2011_Dec_11_2011_742710.nxml.txt.nlp	22220184	SENT177	21	21	25	25	isoproterenol	ASM	PA450121	6609;283120	0.827
NULL	Oncotarget_2011_Sep_9_2(9)_658-668.nxml.txt.nlp	21911919	SENT57	25	25	16	16	cytarabine	HO-1	PA449177	3162	0.827
NULL	Gut_Pathog_2009_Dec_23_1_25.nxml.txt.nlp	20030828	SENT45	29	29	1	1	amikacin	K10	PA164744372	3858	0.827
NULL	Cancers_(Basel)_2014_Nov_14_6(4)_2275-2295.nxml.txt.nlp	25405526	SENT83	25	25	13	13	vincristine	CHOP	PA451879	1649	0.827
NULL	Viruses_2014_Oct_23_6(10)_4024-4046.nxml.txt.nlp	25341665	SENT116	6	6	17	17	heparin	xCT	PA449855	23657	0.827
NULL	Br_J_Cancer_1996_Dec_74(11)_1719-1729.nxml.txt.nlp	8956784	SENT10	24	24	8	8	daunorubicin	ACL	PA449212	47	0.827
NULL	Front_Synaptic_Neurosci_2012_Sep_27_4_4.nxml.txt.nlp	23133416	SENT87	17	17	30	30	spermine	CA1	PA164781199	759	0.827
NULL	Breast_Cancer_Res_2012_Feb_14_14(1)_R30.nxml.txt.nlp	22333315	SENT157	8	8	6	6	indomethacin	CXCL9	PA449982	4283	0.827
NULL	Angiogenesis_2013_Apr_10_16(2)_373-386.nxml.txt.nlp	23143659	SENT7	7	7	4	4	vinblastine	LDM	PA451877	1595	0.827
NULL	J_Biomed_Sci_2012_Nov_21_19(1)_99.nxml.txt.nlp	23170833	SENT165	12	12	25	25	atorvastatin	CXCR4	PA448500	7852	0.827
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT65	35	35	17	17	metformin	OCT1	PA450395	5451;6580	0.827
NULL	Ann_Thorac_Med_2013_Apr-Jun_8(2)_109-115.nxml.txt.nlp	23741274	SENT15	8	8	1	1	docetaxel	CRT	PA449383	811	0.827
NULL	Nutr_J_2014_Jan_24_13_11.nxml.txt.nlp	24461029	SENT172	3	3	34	34	curcumin	CTR	PA151958596	799	0.826
NULL	Niger_Med_J_2012_Jul-Sep_53(3)_172-174.nxml.txt.nlp	23293420	SENT64	35	35	32	32	anastrozole	aromatase	PA448432	1588	0.826
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT284	8	8	14	14	clozapine	PRL	PA449061	5617	0.826
NULL	Cardiovasc_Diabetol_2013_Oct_17_12_150.nxml.txt.nlp	24134550	SENT37	18	18	1	1	pioglitazone	activin	PA450970	83729	0.826
NULL	Nat_Commun_2014_Nov_25_5_5548.nxml.txt.nlp	25420520	SENT15	12	12	1	1	cabazitaxel	ERG	PA165958401	2078	0.826
NULL	Biomed_Eng_Online_2006_Jun_21_5_42.nxml.txt.nlp	16790065	SENT463	10	10	4	4	dobutamine	FFR	PA449381	738	0.826
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT49	42	42	16	16	chlorzoxazone	CYP2E1	PA448971	1571	0.826
NULL	F1000Res_2013_Feb_28_2_65.nxml.txt.nlp	24358861	SENT261	0	0	13	13	naloxone	TLR4	PA450586	7099	0.826
NULL	Arthritis_Res_Ther_2011_Feb_8_13(1)_R17.nxml.txt.nlp	21303509	SENT213	31	31	1	1	infliximab	FSTL1	PA452639	11167	0.826
NULL	AIDS_Res_Treat_2012_Mar_21_2012_186987.nxml.txt.nlp	22536495	SENT146	10	10	18	18	etravirine	DUET	PA166014703	8997	0.826
NULL	Front_Endocrinol_(Lausanne)_2014_Oct_9_5_166.nxml.txt.nlp	25346724	SENT201	26	26	19	19	resveratrol	AMPK		5563	0.826
NULL	Diabetes_Care_2013_Mar_13_36(3)_498-504.nxml.txt.nlp	23139373	SENT22	0	0	12	12	exenatide	GLP-1	PA164749238	100125288	0.826
NULL	Biol_Open_2013_Aug_6_2(10)_1022-1031.nxml.txt.nlp	24167712	SENT287	6	6	12	12	doxycycline	PLK1	PA449415	5347	0.826
NULL	Aging_(Albany_NY)_2010_Apr_30_2(4)_183-184.nxml.txt.nlp	20436227	SENT11	1	1	10	10	resveratrol	CD4		920	0.826
NULL	Physiol_Rep_2014_Oct_24_2(10)_e12175.nxml.txt.nlp	25344477	SENT18	32	32	17	17	thrombin	Rho	PA451674	29984	0.826
NULL	J_Biol_2009_Apr_15_8(3)_30.nxml.txt.nlp	19435483	SENT38	3	3	8	8	imatinib	NQO2	PA10804	4835	0.826
NULL	Ann_Hematol_2011_Dec_8_90(12)_1399-1407.nxml.txt.nlp	21476016	SENT89	30	30	13	13	vincristine	CHOP	PA451879	1649	0.826
NULL	Mol_Cancer_2009_Dec_23_8_129.nxml.txt.nlp	20030852	SENT11	14	14	3	3	curcumin	ABCA1	PA151958596	19	0.826
NULL	Front_Cell_Neurosci_2015_Jan_15_8_459.nxml.txt.nlp	25642166	SENT111	13	13	11	11	hemin	HO-1	PA449849	3162	0.826
NULL	Front_Microbiol_2014_Mar_14_5_99.nxml.txt.nlp	24672516	SENT86	12	12	39	39	caspofungin	TLR9	PA164743013	54106	0.826
NULL	Oncotarget_2014_Aug_19_5(18)_8737-8749.nxml.txt.nlp	25228590	SENT174	13	13	7	7	crizotinib	MYCN	PA165946122	4613	0.826
NULL	Cells_2014_May_23_3(2)_517-545.nxml.txt.nlp	24861977	SENT207	14	14	11	11	capsaicin	TRPV1	PA448776	7442	0.826
NULL	Acta_Physiol_(Oxf)_2008_Apr_192(4)_505-517.nxml.txt.nlp	17973950	SENT115	16	16	3	3	propranolol	PES	PA451145	23481	0.826
NULL	EMBO_J_2009_Apr_22_28(8)_1043-1054.nxml.txt.nlp	19300439	SENT116	24	24	11	11	pp2	p38		10598;1432;7965	0.826
NULL	Hum_Mol_Genet_2011_Jun_1_20(11)_2171-2181.nxml.txt.nlp	21389083	SENT649	6	6	1	1	camptothecin	FANCD2	PA153590860	2177	0.826
NULL	J_Exp_Clin_Cancer_Res_2008_Sep_12_27(1)_37.nxml.txt.nlp	18789152	SENT141	0	0	10	10	docetaxel	survivin	PA449383	332	0.826
NULL	J_Sens_Technol_2013_Sep_3(3)_10_4236_jst_2013_33015.nxml.txt.nlp	24409399	SENT85	6	6	20	20	ketamine	DC2	PA450144	58505	0.826
NULL	Oncotarget_2013_May_11_4(6)_830-843.nxml.txt.nlp	23919981	SENT48	13	13	19	19	temsirolimus	PI3K	PA164746890	5290	0.826
NULL	Core_Evid_2009_Jun_15_4_171-179.nxml.txt.nlp	20694073	SENT209	5	5	17	17	nortriptyline	STAR	PA450657	6770;2984	0.826
NULL	Br_J_Pharmacol_2014_Oct_26_171(20)_4785-4796.nxml.txt.nlp	25074741	SENT13	10	10	21	21	guanfacine	EPM	PA449825	2054	0.826
NULL	Exp_Ther_Med_2014_Nov_17_8(5)_1484-1488.nxml.txt.nlp	25289046	SENT3	25	25	27	27	cisplatin	DDP	PA449014	1678	0.826
NULL	Cell_Cycle_2012_Dec_15_11(24)_4661-4672.nxml.txt.nlp	23187802	SENT93	0	0	7	7	doxorubicin	p107	PA449412	5933	0.826
NULL	Biomed_Res_Int_2013_May_8_2013_703130.nxml.txt.nlp	23738330	SENT130	13	13	33	33	lipase	SP75	PA450239	6674	0.826
NULL	Cell_Death_Differ_2009_May_27_16(5)_758-769.nxml.txt.nlp	19247369	SENT51	10	10	13	13	doxorubicin	p53	PA449412	7157	0.826
NULL	J_Oncol_2013_Feb_17_2013_872957.nxml.txt.nlp	23476648	SENT114	28	28	13	13	cisplatin	SFN	PA449014	25996;2810	0.826
NULL	J_Mol_Signal_2008_Mar_31_3_8.nxml.txt.nlp	18377662	SENT140	7	7	20	20	pp2	KDR		3791	0.826
NULL	Diagn_Pathol_2013_Nov_21_8_191.nxml.txt.nlp	24261710	SENT22	0	0	18	18	trastuzumab	ERBB2	PA451743	2064	0.826
NULL	Cells_2014_Sep_12_3(3)_914-938.nxml.txt.nlp	25222270	SENT22	25	25	0	0	capsaicin	TRPV1	PA448776	7442	0.826
NULL	Indian_J_Hum_Genet_2013_Oct-Dec_19(4)_472-474.nxml.txt.nlp	24497716	SENT43	10	10	7	7	tamoxifen	aromatase	PA451581	1588	0.826
NULL	Ann_Dermatol_2014_Dec_26_26(6)_706-712.nxml.txt.nlp	25473222	SENT4	7	7	25	25	isotretinoin	EPO	PA450128	7076;8288;2056	0.826
NULL	Br_J_Cancer_2009_Sep_15_101(6)_875-878.nxml.txt.nlp	19672259	SENT87	42	42	9	9	tamoxifen	San	PA451581	80218	0.826
NULL	Diabetes_2011_Mar_21_60(3)_1008-1018.nxml.txt.nlp	21282362	SENT218	24	24	16	16	lipase	LPL	PA450239	4023	0.826
NULL	Basic_Clin_Pharmacol_Toxicol_2013_Feb_5_112(2)_132-137.nxml.txt.nlp	22900583	SENT157	22	22	14	14	ritonavir	CYP2B6	PA451260	1555	0.826
NULL	Thorax_2010_Jul_13_65(7)_654-658.nxml.txt.nlp	20627927	SENT47	7	7	27	27	colistin	NAG	PA164760862	51594;4669	0.826
NULL	Gastric_Cancer_2014_Apr_7_17(1)_1-12.nxml.txt.nlp	23563986	SENT7	14	14	10	10	lapatinib	HER2	PA152241907	2064	0.826
NULL	Cardiovasc_Diabetol_2011_Feb_11_10_18.nxml.txt.nlp	21314919	SENT90	33	33	5	5	glibenclamide	Met	PA449782	79811	0.826
NULL	Nat_Commun_2014_Nov_19_5_5479.nxml.txt.nlp	25407222	SENT81	5	5	14	14	dextran	YTS	PA449261	8565	0.826
NULL	Diabetes_Care_2012_Jan_13_35(Suppl_1)_S11-S63.nxml.txt.nlp	22187469	SENT1913	15	15	7	7	rosiglitazone	DREAM	PA451283	30818	0.826
NULL	Case_Rep_Transplant_2012_Aug_30_2012_672923.nxml.txt.nlp	23259137	SENT67	11	11	7	7	voriconazole	IPA	PA10233	3160	0.826
NULL	Korean_Circ_J_2013_Jul_31_43(7)_443-452.nxml.txt.nlp	23964290	SENT161	6	6	1	1	sirolimus	DES	PA451365	1674	0.826
NULL	Cardiol_Ther_2013_Jun_7_2(1)_57-68.nxml.txt.nlp	25135289	SENT177	18	18	13	13	ticagrelor	P2Y12	PA165374673	64805	0.826
NULL	Acta_Pharmacol_Sin_2011_May_18_32(5)_591-600.nxml.txt.nlp	21499286	SENT258	29	29	42	42	bezafibrate	AMPK	PA162364313	5563	0.826
NULL	Korean_J_Anesthesiol_2013_Jan_21_64(1)_47-53.nxml.txt.nlp	23372886	SENT85	16	16	31	31	bupivacaine	PTG	PA135057240	5507	0.826
NULL	Biomed_Res_Int_2014_Jan_29_2014_831845.nxml.txt.nlp	24605337	SENT102	10	10	8	8	bupivacaine	S6K1	PA135057240	6198	0.826
NULL	Genetics_2012_Jul_191(3)_765-780.nxml.txt.nlp	22505622	SENT322	5	5	11	11	ethanol	Tra1	PA448073	8295	0.826
NULL	Front_Neurol_2013_Oct_30_4_169.nxml.txt.nlp	24198809	SENT321	17	17	21	21	methylprednisolone	IL-17	PA450466	3605	0.826
NULL	Diabetes_2011_Nov_17_60(11)_2691-2700.nxml.txt.nlp	21896928	SENT168	9	9	19	19	resveratrol	SIRT1		23411	0.826
NULL	Pain_Res_Treat_2012_Apr_23_2012_295926.nxml.txt.nlp	22577544	SENT139	10	10	20	20	dexketoprofen	ARC	PA166049175	8996;23237	0.826
NULL	Br_J_Pharmacol_2014_May_171(10)_2659-2670.nxml.txt.nlp	24116661	SENT144	5	5	0	0	naringenin	TRPP2	PA151958361	5311	0.826
NULL	J_Breast_Cancer_2013_Sep_30_16(3)_291-299.nxml.txt.nlp	24155758	SENT18	10	10	18	18	mitomycin	FANCF	PA450524	2188	0.826
NULL	EPMA_J_2012_Sep_27_3(1)_10.nxml.txt.nlp	23016735	SENT242	21	21	7	7	warfarin	CYP2C9	PA451906	1559	0.826
NULL	Nat_Commun_2014_Dec_17_5_5809.nxml.txt.nlp	25517963	SENT270	21	21	35	35	dextran	CO2	PA449261	4513	0.826
NULL	Cancer_Cell_Int_2007_Sep_10_7_14.nxml.txt.nlp	17845729	SENT164	14	14	23	23	decitabine	PDCD5	PA164749631	9141	0.826
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT174	11	11	8	8	tacrolimus	RANKL	PA451578	8600	0.826
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1495-1502.nxml.txt.nlp	21989186	SENT201	16	16	28	28	leucovorin	HSI	PA450198	57016	0.826
NULL	Ther_Clin_Risk_Manag_2007_Dec_3(6)_1009-1020.nxml.txt.nlp	18516316	SENT134	26	26	6	6	palonosetron	HEC	PA10352	10403	0.826
NULL	Arthritis_Res_Ther_2005_Mar_16_7(Suppl_2)_S21-S25.nxml.txt.nlp	15833145	SENT59	27	27	13	13	abatacept	ACR	PA164747080	49	0.826
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT336	2	2	7	7	lapatinib	HER3	PA152241907	2065	0.826
NULL	Int_J_Biomed_Sci_2006_Dec_2(4)_333-336.nxml.txt.nlp	23675001	SENT89	3	3	29	29	telmisartan	gamma	PA451605	9913	0.826
NULL	Aging_(Albany_NY)_2009_Jul_2_1(7)_674-677.nxml.txt.nlp	20157549	SENT78	2	2	4	4	metformin	CXCL5	PA450395	6374	0.826
NULL	Cancers_(Basel)_2010_Dec_30_3(1)_106-125.nxml.txt.nlp	24212609	SENT26	35	35	2	2	gemcitabine	DCK	PA449748	1633	0.826
NULL	Front_Oncol_2014_Mar_3_4_34.nxml.txt.nlp	24624361	SENT224	22	22	13	13	cisplatin	BRCA2	PA449014	675	0.826
NULL	Diabetes_Care_2009_Aug_26_32(8)_1411-1417.nxml.txt.nlp	19470837	SENT129	1	1	21	21	glucose	TP1	PA449773	7011	0.826
NULL	Cancer_Cell_Int_2005_Jul_24_5_22.nxml.txt.nlp	16042792	SENT104	21	21	12	12	vincristine	MRP1	PA451879	4437	0.826
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT125	11	11	8	8	atorvastatin	RANKL	PA448500	8600	0.826
NULL	Commun_Integr_Biol_2012_Nov_1_5(6)_557-565.nxml.txt.nlp	23336025	SENT143	4	4	17	17	gemcitabine	USP9X	PA449748	8239	0.826
NULL	Curr_Oncol_2009_Jul_16(Suppl_2)_S14-S23.nxml.txt.nlp	19672417	SENT205	33	33	9	9	letrozole	ATAC	PA450196	6375	0.826
NULL	Br_J_Pharmacol_2014_Dec_5_171(23)_5209-5224.nxml.txt.nlp	25041479	SENT160	8	8	37	37	atropine	ANOVA	PA448505	4858	0.826
NULL	FEBS_Open_Bio_2014_Jun_7_4_554-559.nxml.txt.nlp	25009769	SENT231	8	8	3	3	hyaluronidase	CD44	PA164745713	960	0.826
NULL	Hematol_Rep_2014_Jun_19_6(2)_5356.nxml.txt.nlp	25013716	SENT30	11	11	1	1	creatine	CD25	PA164778930	3669;3559	0.826
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1150.nxml.txt.nlp	24675468	SENT112	6	6	28	28	ethanol	adiponectin	PA448073	9370	0.826
NULL	Clin_Ophthalmol_2011_Jun_9_5_771-781.nxml.txt.nlp	21750610	SENT3	31	31	25	25	bevacizumab	San	PA130232992	80218	0.826
NULL	Cancers_(Basel)_2011_Apr_1_3(2)_1844-1860.nxml.txt.nlp	24212785	SENT87	17	17	24	24	cetuximab	ACRC	PA10040	93953	0.826
NULL	Br_J_Cancer_2011_Jun_7_104(12)_1828-1835.nxml.txt.nlp	21559012	SENT136	13	13	4	4	tamoxifen	HDAC2	PA451581	3066	0.826
NULL	Physiol_Rep_2014_Sep_28_2(9)_e12130.nxml.txt.nlp	25263201	SENT33	2	2	29	29	doxorubicin	ROS	PA449412	6098	0.826
NULL	J_Cancer_2013_Jan_11_4(2)_117-132.nxml.txt.nlp	23386910	SENT227	8	8	39	39	trastuzumab	HER3	PA451743	2065	0.826
NULL	Breast_Cancer_(Auckl)_2011_Oct_9_5_209-226.nxml.txt.nlp	22084574	SENT27	12	12	2	2	exemestane	aromatase	PA449563	1588	0.826
NULL	Toxins_(Basel)_2010_May_28_2(6)_1207-1224.nxml.txt.nlp	22069634	SENT99	14	14	2	2	daunorubicin	MRP1	PA449212	4437	0.826
NULL	Biologics_2012_Dec_17_6_429-464.nxml.txt.nlp	23269860	SENT163	1	1	27	27	etanercept	ACR	PA449515	49	0.826
NULL	Diabetes_2013_Jul_14_62(7)_2500-2508.nxml.txt.nlp	23454692	SENT59	10	10	0	0	fluorescein	RAGE	PA164746009	177	0.826
NULL	Mol_Cancer_2006_Oct_17_5_45.nxml.txt.nlp	17044934	SENT153	27	27	16	16	resveratrol	COX		1351	0.826
NULL	Br_J_Cancer_2010_Sep_7_103(6)_889-898.nxml.txt.nlp	20664599	SENT159	10	10	14	14	paclitaxel	HER-2	PA450761	2064	0.826
NULL	Cancer_Cell_Int_2012_Nov_23_12_49.nxml.txt.nlp	23176676	SENT28	0	0	22	22	imatinib	CML	PA10804	613	0.826
NULL	Cell_Death_Dis_2014_Mar_13_5(3)_e1118.nxml.txt.nlp	24625977	SENT289	21	21	7	7	etoposide	UBXN2A	PA449552	165324	0.826
NULL	Breast_Cancer_Res_2007_Jan_23_9(1)_R7.nxml.txt.nlp	17244352	SENT205	8	8	14	14	tamoxifen	UGT2B15	PA451581	7366	0.826
NULL	Clin_Interv_Aging_2010_Dec_3_5_403-416.nxml.txt.nlp	21152242	SENT177	8	8	10	10	telmisartan	ACE	PA451605	1636	0.826
NULL	Oncol_Lett_2013_Mar_11_5(3)_1010-1016.nxml.txt.nlp	23426784	SENT6	4	4	18	18	midazolam	TRPM7	PA450496	54822	0.826
NULL	Br_J_Cancer_2012_Sep_25_107(7)_1059-1068.nxml.txt.nlp	22935581	SENT228	7	7	0	0	sunitinib	IFN	PA162372840	3439	0.826
NULL	Curr_Neuropharmacol_2008_Jun_6(2)_151-163.nxml.txt.nlp	19305794	SENT168	4	4	1	1	capsaicin	TRPV1	PA448776	7442	0.826
NULL	Allergy_Asthma_Clin_Immunol_2010_Mar_17_6(1)_5.nxml.txt.nlp	20236545	SENT84	28	28	3	3	cyclosporine	IL-4	PA449167	3565	0.826
NULL	Cancer_Cell_Int_2010_Sep_9_10_32.nxml.txt.nlp	20828393	SENT193	17	17	10	10	cisplatin	ATF3	PA449014	467	0.826
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT1240	7	7	14	14	collagenase	ECM	PA449107	22915	0.826
NULL	Cancer_Immunol_Immunother_2013_May_16_62(5)_897-908.nxml.txt.nlp	23589107	SENT263	1	1	10	10	cyclophosphamide	CD4	PA449165	920	0.826
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_P98.nxml.txt.nlp	NULL	SENT22	2	2	0	0	lornoxicam	DPT	PA165958395	1805	0.826
NULL	J_Neuroinflammation_2010_Sep_7_7_51.nxml.txt.nlp	20822529	SENT101	3	3	5	5	hemin	HO-1	PA449849	3162	0.826
NULL	Evid_Based_Complement_Alternat_Med_2013_Aug_20_2013_547837.nxml.txt.nlp	24023578	SENT70	6	6	8	8	methacholine	MCH	PA165958382	5367	0.826
NULL	Environ_Health_Perspect_2005_Jun_10_113(6)_659-664.nxml.txt.nlp	15929885	SENT41	6	6	21	21	arsenite	JNK3	PA452638	5602	0.826
NULL	Oncotarget_2014_Sep_3_5(19)_9362-9381.nxml.txt.nlp	25313139	SENT119	17	17	9	9	orlistat	PLA2G6	PA164776864	8398	0.826
NULL	Oxid_Med_Cell_Longev_2011_Oct_9_2011_756938.nxml.txt.nlp	22007271	SENT171	27	27	18	18	forskolin	PNMT	PA146096022	5409	0.826
NULL	Cell_Death_Dis_2014_Apr_17_5(4)_e1182.nxml.txt.nlp	24743737	SENT48	4	4	2	2	capsaicin	TRPV1	PA448776	7442	0.826
NULL	Biomed_Res_Int_2014_Aug_6_2014_967826.nxml.txt.nlp	25165721	SENT362	13	13	8	8	cisplatin	NQO1	PA449014	1728	0.826
NULL	Breast_Cancer_Res_2007_Aug_10_9(4)_R52.nxml.txt.nlp	17692126	SENT14	19	19	23	23	exemestane	aromatase	PA449563	1588	0.826
NULL	Mol_Cancer_2010_Mar_2_9_47.nxml.txt.nlp	20196847	SENT79	27	27	24	24	paclitaxel	SFN	PA450761	25996;2810	0.826
NULL	J_Neurodev_Disord_2009_Jun_9_1(2)_158-171.nxml.txt.nlp	19960097	SENT354	5	5	17	17	clomipramine	Gen	PA449048	348654	0.826
NULL	Acta_Pharmacol_Sin_2010_Apr_22_31(4)_450-454.nxml.txt.nlp	20305679	SENT108	10	10	18	18	repaglinide	NOS	PA451234	4843	0.826
NULL	Chem_Rev_2011_Oct_12_111(10)_5899-5921.nxml.txt.nlp	21923193	SENT536	23	23	11	11	naproxen	FAAH	PA450595	79152;2166	0.826
NULL	Arthritis_Res_Ther_2007_Sep_23_9(5)_R96.nxml.txt.nlp	17888176	SENT213	31	31	23	23	etanercept	RANKL	PA449515	8600	0.826
NULL	Int_J_Gen_Med_2013_Dec_4_6_877-895.nxml.txt.nlp	24403842	SENT58	6	6	22	22	exenatide	PPG	PA164749238	5552	0.826
NULL	Clin_Dev_Immunol_2007_Nov_22_2007_75805.nxml.txt.nlp	18320012	SENT38	17	17	9	9	warfarin	OPG	PA451906	690	0.826
NULL	Alcohol_Res_Health_2011_34(1)_106-120.nxml.txt.nlp	23580048	SENT98	14	14	23	23	ethanol	CA3	PA448073	761	0.826
NULL	Oncotarget_2011_Dec_31_2(12)_1314-1321.nxml.txt.nlp	22248929	SENT147	11	11	9	9	lapatinib	HER3	PA152241907	2065	0.826
NULL	Oxid_Med_Cell_Longev_2012_May_15_2012_984219.nxml.txt.nlp	22666523	SENT322	9	9	25	25	genistein	MCM2	PA165109660	4171	0.826
NULL	Int_Neurourol_J_2014_Sep_24_18(3)_115-125.nxml.txt.nlp	25279238	SENT132	2	2	9	9	berberine	Bcl-2	PA165860812	596	0.826
NULL	J_Korean_Med_Sci_2013_Aug_31_28(8)_1238-1243.nxml.txt.nlp	23960454	SENT163	2	2	6	6	amiloride	ASIC3	PA448368	9311	0.826
NULL	Br_J_Haematol_2014_Feb_16_164(4)_586-596.nxml.txt.nlp	24236640	SENT200	20	20	25	25	carboplatin	HAMP	PA448803	57817	0.826
NULL	Endocrinol_Metab_(Seoul)_2014_Sep_25_29(3)_363-370.nxml.txt.nlp	25309796	SENT59	0	0	8	8	metformin	San	PA450395	80218	0.826
NULL	Arthritis_Res_Ther_2006_Aug_18_8(5)_R142.nxml.txt.nlp	16919164	SENT139	1	1	14	14	collagenase	OSM	PA449107	5008	0.826
NULL	Arthritis_Res_Ther_2005_Jan_21_7(2)_55-61.nxml.txt.nlp	15743490	SENT129	29	29	16	16	atorvastatin	IFN	PA448500	3439	0.826
NULL	Mol_Cells_2014_Sep_30_37(9)_664-671.nxml.txt.nlp	25234467	SENT209	4	4	13	13	cisplatin	KRAS	PA449014	3845	0.826
NULL	Drug_Des_Devel_Ther_2014_Oct_31_8_2121-2128.nxml.txt.nlp	25382970	SENT87	24	24	30	30	curcumin	TTR	PA151958596	7276	0.826
NULL	Cases_J_2008_Sep_18_1_157.nxml.txt.nlp	18801174	SENT22	14	14	11	11	ribavirin	IFN	PA451241	3439	0.826
NULL	Ann_Indian_Acad_Neurol_2009_Apr-Jun_12(2)_89-98.nxml.txt.nlp	20142853	SENT202	22	22	28	28	lamotrigine	MRP5	PA450164	10057	0.826
NULL	Case_Rep_Dermatol_2014_Feb_12_6(1)_37-42.nxml.txt.nlp	24707248	SENT11	13	13	6	6	doxorubicin	CHOP	PA449412	1649	0.826
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT207	26	26	21	21	sitagliptin	HIP	PA164748978	6767;6159;64399;5068	0.826
NULL	Clin_Pharmacol_2011_Jun_22_3_13-25.nxml.txt.nlp	22287853	SENT183	6	6	10	10	saxagliptin	CYP3A4	PA165958362	1576	0.826
NULL	Int_J_Mol_Sci_2007_Jan_29_8(1)_13-28.nxml.txt.nlp	NULL	SENT74	25	25	3	3	galactose	NAG	PA449725	51594;4669	0.826
NULL	Int_J_Hypertens_2012_Oct_21_2012_593530.nxml.txt.nlp	23133743	SENT10	3	3	0	0	hemin	HO-1	PA449849	3162	0.826
NULL	Acta_Histochem_Cytochem_2009_Apr_28_42(2)_23-28.nxml.txt.nlp	19492024	SENT4	27	27	29	29	diethylstilbestrol	DES	PA449307	1674	0.826
NULL	Gene_Regul_Syst_Bio_2014_Mar_4_8_63-73.nxml.txt.nlp	24634581	SENT248	3	3	22	22	minocycline	STAT3	PA450519	6774	0.826
NULL	Exp_Diabetes_Res_2011_Jun_23_2011_898913.nxml.txt.nlp	21747834	SENT36	7	7	15	15	metformin	GLP-1	PA450395	100125288	0.826
NULL	Front_Endocrinol_(Lausanne)_2014_Feb_26_5_17.nxml.txt.nlp	24616713	SENT28	7	7	5	5	vasopressin	OXT	PA451858	5020	0.826
NULL	Emerg_Infect_Dis_2014_Apr_20(4)_612-619.nxml.txt.nlp	24655615	SENT50	32	32	28	28	ciprofloxacin	GISP	PA449009	83998	0.826
NULL	Diabetes_Care_2010_May_15_33(5)_1134-1139.nxml.txt.nlp	20185740	SENT177	22	22	6	6	ezetimibe	IL-6	PA10816	3569	0.826
NULL	Oncoimmunology_2012_Aug_1_1(5)_609-617.nxml.txt.nlp	22934253	SENT111	33	33	26	26	vemurafenib	BRAF	PA165946873	673	0.826
NULL	Blood_Cancer_J_2013_Oct_18_3(10)_e153.nxml.txt.nlp	24141622	SENT81	5	5	7	7	fludarabine	Mcl-1	PA449655	4170	0.826
NULL	Eur_J_Med_Res_2009_Nov_24_14(Suppl_3)_17-21.nxml.txt.nlp	19959412	SENT31	12	12	21	21	raltegravir	UGT		7361;7355	0.826
NULL	Oncol_Lett_2013_Jul_8_6(1)_261-267.nxml.txt.nlp	23946815	SENT195	27	27	16	16	tamoxifen	PUMA	PA451581	27113	0.826
NULL	ISRN_Obes_2012_Nov_18_2012_437198.nxml.txt.nlp	24527263	SENT150	22	22	12	12	nadh	BMAL1	PA164755085	406	0.826
NULL	Clinics_(Sao_Paulo)_2012_Apr_67(4)_335-340.nxml.txt.nlp	22522758	SENT128	9	9	32	32	paroxetine	HTR2A	PA450801	3356	0.826
NULL	Int_J_Biol_Sci_2011_Sep_8_7(8)_1077-1092.nxml.txt.nlp	21927577	SENT125	2	2	9	9	telmisartan	ANG	PA451605	283	0.826
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2675-2684.nxml.txt.nlp	24129246	SENT235	22	22	10	10	etoposide	KSR1	PA449552	8844	0.826
NULL	Br_J_Cancer_2011_Jun_28_105(1)_118-123.nxml.txt.nlp	21654685	SENT12	0	0	8	8	dasatinib	S100beta	PA162372878	6285	0.826
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2675-2684.nxml.txt.nlp	24129246	SENT197	24	24	4	4	etoposide	KSR1	PA449552	8844	0.826
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT159	10	10	30	30	phenprocoumon	VKORC1	PA450921	79001	0.826
NULL	Int_J_Med_Sci_2014_Feb_7_11(4)_321-326.nxml.txt.nlp	24578608	SENT15	13	13	5	5	cisplatin	CRT	PA449014	811	0.826
NULL	Int_J_Breast_Cancer_2011_Jul_12_2011_232435.nxml.txt.nlp	22295213	SENT86	17	17	8	8	estradiol	SRC3	PA449503	8202	0.826
NULL	Mol_Cancer_2010_Jun_25_9_166.nxml.txt.nlp	20579378	SENT50	34	34	26	26	gefitinib	EGFR	PA131301952	1956	0.826
NULL	Oncol_Lett_2014_May_24_7(5)_1594-1598.nxml.txt.nlp	24765183	SENT38	21	21	19	19	oxaliplatin	Gem	PA131285527	51053	0.826
NULL	Clinics_(Sao_Paulo)_2010_Dec_65(12)_1357-1361.nxml.txt.nlp	21340227	SENT65	13	13	39	39	phenol	PON1	PA450913	5444	0.826
NULL	Ann_Gen_Psychiatry_2014_Sep_24_13_27.nxml.txt.nlp	25478001	SENT182	0	0	20	20	creatine	GAMT	PA164778930	2593	0.826
NULL	Mol_Cancer_2012_Jun_18_11_41.nxml.txt.nlp	22709873	SENT338	5	5	0	0	lapatinib	FON	PA152241907	741	0.826
NULL	J_Invest_Dermatol_2013_Feb_20_133(2)_344-353.nxml.txt.nlp	22992803	SENT30	1	1	8	8	tamoxifen	spatial	PA451581	219793	0.826
NULL	Behav_Brain_Funct_2009_Jun_4_5_23.nxml.txt.nlp	19497110	SENT54	3	3	22	22	ethanol	P29	PA448073	5657	0.826
NULL	Ann_Clin_Transl_Neurol_2014_Dec_21_1(12)_996-1005.nxml.txt.nlp	25574474	SENT128	17	17	12	12	elacridar	P-gp		5243	0.826
NULL	Breast_Cancer_(Auckl)_2011_Jan_13_5_1-14.nxml.txt.nlp	21494397	SENT170	0	0	33	33	ixabepilone	castor		54897	0.826
NULL	Exp_Hematol_Oncol_2014_Feb_17_3_6.nxml.txt.nlp	24528501	SENT7	1	1	18	18	dasatinib	CD19	PA162372878	930	0.826
NULL	Hum_Mol_Genet_2012_Jan_15_21(2)_300-310.nxml.txt.nlp	21979946	SENT13	8	8	3	3	nadh	p53	PA164755085	7157	0.826
NULL	Breast_Cancer_Res_2011_Apr_21_13(2)_R46.nxml.txt.nlp	21510863	SENT110	5	5	9	9	trastuzumab	HER2	PA451743	2064	0.826
NULL	Lipids_Health_Dis_2011_Feb_12_10_31.nxml.txt.nlp	21314960	SENT179	4	4	2	2	hemin	HO-1	PA449849	3162	0.826
NULL	Breast_Cancer_Res_Treat_2014_Nov_11_148(3)_563-570.nxml.txt.nlp	25385180	SENT58	5	5	10	10	carboplatin	PTH	PA448803	5741	0.826
NULL	Front_Chem_2014_Mar_14_2_12.nxml.txt.nlp	24790981	SENT508	3	3	5	5	curcumin	p300	PA151958596	2033	0.826
NULL	Breast_Cancer_Res_2012_May_23_14(3)_R85.nxml.txt.nlp	22621393	SENT369	14	14	26	26	trastuzumab	JMJD6	PA451743	23210	0.826
NULL	Br_J_Cancer_2012_Jul_24_107(3)_516-526.nxml.txt.nlp	22782351	SENT108	37	37	20	20	tamoxifen	p53	PA451581	7157	0.826
NULL	Oncol_Lett_2013_Mar_14_5(3)_756-760.nxml.txt.nlp	23426872	SENT14	17	17	8	8	cisplatin	AKT	PA449014	207	0.826
NULL	Acta_Otolaryngol_2010_Nov_30_130(11)_1278-1286.nxml.txt.nlp	20586674	SENT244	24	24	17	17	methimazole	TRPV1	PA450422	7442	0.826
NULL	Case_Rep_Oncol_2014_Apr_25_7(1)_277-284.nxml.txt.nlp	24926257	SENT11	34	34	19	19	lenalidomide	B12	PA162363968	7126;4709	0.826
NULL	J_Korean_Med_Sci_2013_Feb_29_28(2)_308-314.nxml.txt.nlp	23399960	SENT121	4	4	7	7	gabapentin	IL-10	PA449720	3586	0.826
NULL	FEBS_Open_Bio_2014_Jul_5_4_659-671.nxml.txt.nlp	25161875	SENT263	11	11	2	2	etoposide	XIAP	PA449552	331	0.826
NULL	Acta_Neuropathol_Commun_2014_Oct_21_2(1)_149.nxml.txt.nlp	NULL	SENT241	1	1	9	9	riluzole	p38	PA451251	10598;1432;7965	0.826
NULL	Pharm_Pract_(Granada)_2009_Mar_15_Jan-Mar_7(1)_54-58.nxml.txt.nlp	25147593	SENT79	0	0	19	19	clonazepam	gamma	PA449050	9913	0.826
NULL	Breast_Cancer_Res_2007_Dec_8_9(6)_R85.nxml.txt.nlp	18067675	SENT142	26	26	16	16	sulfinpyrazone	L15	PA451550	6138;91057	0.826
NULL	Br_J_Cancer_2011_Apr_26_104(9)_1426-1433.nxml.txt.nlp	21468049	SENT89	35	35	9	9	ethanol	CO2	PA448073	4513	0.826
NULL	Cell_Commun_Signal_2014_Sep_25_12(1)_61.nxml.txt.nlp	NULL	SENT283	0	0	13	13	tetracycline	PC-3	PA451640	692094	0.826
NULL	Breast_Cancer_Res_Treat_2012_Jun_3_133(3)_865-880.nxml.txt.nlp	22048815	SENT11	23	23	3	3	carboplatin	RAD17	PA448803	5884	0.826
NULL	Cancer_Med_2013_Aug_2_2(4)_571-582.nxml.txt.nlp	24156030	SENT43	5	5	16	16	curcumin	IL-6	PA151958596	3569	0.826
NULL	Cancer_Cell_Int_2011_Dec_2_11_42.nxml.txt.nlp	22136382	SENT82	13	13	26	26	bicalutamide	DR5	PA164746255	8795	0.826
NULL	Eur_J_Clin_Pharmacol_2011_Dec_23_67(12)_1231-1241.nxml.txt.nlp	21698374	SENT173	38	38	6	6	tacrolimus	CYP3A5	PA451578	1577	0.826
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT16	5	5	8	8	dasatinib	LYN	PA162372878	4067	0.826
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT198	15	15	33	33	adalimumab	DPI	PA10004	1832	0.826
NULL	J_Biol_Chem_2013_May_10_288(19)_13345-13355.nxml.txt.nlp	23515308	SENT107	13	13	1	1	paraformaldehyde	p50	PA450790	958;4790	0.826
NULL	Cases_J_2009_Jul_30_2_7134.nxml.txt.nlp	19829918	SENT16	26	26	12	12	carbidopa	DDC	PA448794	1644	0.826
NULL	Atherosclerosis_2011_Nov_219(1)_109-115.nxml.txt.nlp	21820657	SENT183	5	5	25	25	probucol	CETP	PA451107	1071	0.826
NULL	Gene_Regul_Syst_Bio_2014_Mar_4_8_63-73.nxml.txt.nlp	24634581	SENT113	3	3	13	13	minocycline	NANOS1	PA450519	340719	0.826
NULL	Breast_Cancer_Res_2010_Mar_5_12(2)_R16.nxml.txt.nlp	20205716	SENT233	29	29	9	9	lovastatin	RhoA	PA450272	387	0.826
NULL	F1000Res_2013_Jul_9_2_151.nxml.txt.nlp	24555069	SENT187	10	10	18	18	memantine	spatial	PA10364	219793	0.826
NULL	Genome_Announc_2014_Jan_23_2(1)_e01183-13.nxml.txt.nlp	24459265	SENT7	25	25	32	32	ethanol	CO2	PA448073	4513	0.826
NULL	Ann_Thorac_Med_2013_Apr-Jun_8(2)_109-115.nxml.txt.nlp	23741274	SENT15	3	3	1	1	docetaxel	CRT	PA449383	811	0.826
NULL	J_Mol_Signal_2011_May_16_6_4.nxml.txt.nlp	21575178	SENT175	11	11	15	15	forskolin	HSP27	PA146096022	3315	0.826
NULL	J_Cell_Biol_1998_Jan_26_140(2)_335-345.nxml.txt.nlp	9442109	SENT204	22	22	28	28	chloroquine	NHE	PA448948	285335	0.826
NULL	J_Hematol_Oncol_2013_Jun_3_6_38.nxml.txt.nlp	23731980	SENT100	20	20	10	10	trastuzumab	HER2	PA451743	2064	0.826
NULL	Mol_Cancer_2010_Dec_2_9_309.nxml.txt.nlp	21122157	SENT401	23	23	13	13	paclitaxel	IL-6	PA450761	3569	0.826
NULL	Mol_Cancer_2007_Oct_22_6_66.nxml.txt.nlp	17953743	SENT154	10	10	13	13	cisplatin	TRAIL	PA449014	8743	0.826
NULL	Cardiol_Res_Pract_2011_May_10_2011_816897.nxml.txt.nlp	21629798	SENT206	18	18	34	34	diltiazem	CYP3A4	PA449334	1576	0.826
NULL	Int_J_Biomed_Sci_2007_Jun_3(2)_104-111.nxml.txt.nlp	23675031	SENT174	12	12	22	22	suramin	IL-6	PA10292	3569	0.826
NULL	Biosci_Rep_2012_Aug_1_32(Pt_4)_361-374.nxml.txt.nlp	22762204	SENT191	21	21	8	8	carmustine	CD44	PA448810	960	0.826
NULL	Oncotarget_2013_Jul_18_4(10)_1582-1591.nxml.txt.nlp	24123600	SENT121	24	24	10	10	imatinib	ABCG2	PA10804	9429	0.826
NULL	Aging_(Albany_NY)_2010_Dec_20_2(12)_959-968.nxml.txt.nlp	21191146	SENT74	5	5	25	25	cisplatin	NOS2	PA449014	339345;4843	0.826
NULL	Curr_Neuropharmacol_2010_Sep_8(3)_254-267.nxml.txt.nlp	21358975	SENT236	15	15	5	5	carbamazepine	CYP3A4	PA448785	1576	0.826
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT105	23	23	16	16	pp2	PP2		4888	0.826
NULL	Curr_Neuropharmacol_2008_Jun_6(2)_151-163.nxml.txt.nlp	19305794	SENT468	4	4	6	6	capsaicin	VR1	PA448776	56664	0.826
NULL	Nanoscale_Res_Lett_2014_Feb_15_9(1)_76.nxml.txt.nlp	24528570	SENT141	21	21	28	28	hydroquinone	mol	PA449924	90527	0.826
NULL	Core_Evid_2007_Nov_30_2(2)_81-88.nxml.txt.nlp	21221177	SENT234	0	0	30	30	irinotecan	EGFR	PA450085	1956	0.826
NULL	Curr_Biol_2009_Oct_13_19(19)_1648-1653.nxml.txt.nlp	19765991	SENT113	26	26	11	11	paraformaldehyde	STIM1	PA450790	6786	0.826
NULL	Breast_Cancer_Res_2004_Nov_25_6(1)_E8.nxml.txt.nlp	14680493	SENT45	36	36	23	23	tamoxifen	STAR	PA451581	6770;2984	0.826
NULL	Nat_Chem_Biol_2010_Apr_28_6(4)_291-299.nxml.txt.nlp	20190765	SENT10	25	25	20	20	dasatinib	EGFR	PA162372878	1956	0.826
NULL	Breast_Cancer_Res_2012_Jul_12_14(4)_R104.nxml.txt.nlp	22788954	SENT201	14	14	4	4	gefitinib	Met	PA131301952	79811	0.826
NULL	Biomed_Res_Int_2013_Jul_15_2013_458571.nxml.txt.nlp	23956983	SENT14	28	28	3	3	l-serine	SHMT	PA451330	6470	0.826
NULL	Cell_Death_Dis_2013_Jun_27_4(6)_e696.nxml.txt.nlp	23807225	SENT98	12	12	16	16	doxycycline	ACL	PA449415	47	0.826
NULL	Pharmaceutics_2011_Oct_12_3(4)_680-705.nxml.txt.nlp	24309303	SENT73	9	9	17	17	glibenclamide	CYP3A4	PA449782	1576	0.826
NULL	J_Cell_Mol_Med_2014_Apr_20_18(4)_709-720.nxml.txt.nlp	24444314	SENT213	2	2	9	9	losartan	Met	PA450268	79811	0.826
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT77	4	4	13	13	curcumin	DR4	PA151958596	8797	0.826
NULL	Oncol_Lett_2013_Feb_3_5(2)_505-510.nxml.txt.nlp	23420812	SENT111	5	5	11	11	cisplatin	AEG-1	PA449014	92140	0.826
NULL	Eur_J_Med_Res_2009_Nov_24_14(Suppl_3)_22-29.nxml.txt.nlp	19959413	SENT21	34	34	23	23	raltegravir	CCR5		1234	0.826
NULL	EMBO_Mol_Med_2012_Jun_13_4(6)_515-527.nxml.txt.nlp	22416035	SENT179	10	10	23	23	olaparib	NOXA		5366	0.826
NULL	J_Gastroenterol_2014_Mar_30_49(3)_492-501.nxml.txt.nlp	23543311	SENT231	13	13	5	5	ribavirin	IL28B	PA451241	282617	0.826
NULL	Cancer_Med_2013_Feb_3_2(1)_11-20.nxml.txt.nlp	24133623	SENT355	12	12	0	0	cetuximab	KRAS	PA10040	3845	0.826
NULL	N_Am_J_Med_Sci_2014_Jul_6(7)_342-345.nxml.txt.nlp	25077084	SENT111	15	15	8	8	vincristine	CAV	PA451879	763;858	0.826
NULL	Clin_Cosmet_Investig_Dermatol_2014_Sep_2_7_243-249.nxml.txt.nlp	25214798	SENT54	24	24	1	1	ustekinumab	ACR	PA166048654	49	0.826
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT123	10	10	18	18	metformin	HIF-1	PA450395	29072	0.826
NULL	Mol_Cancer_2009_Nov_10_8_99.nxml.txt.nlp	19903356	SENT52	5	5	45	45	imatinib	IGFBP3	PA10804	3486	0.826
NULL	Chonnam_Med_J_2011_Apr_26_47(1)_27-30.nxml.txt.nlp	22111053	SENT25	30	30	20	20	trypsin	CO2	PA451806	4513	0.826
NULL	Breast_Cancer_Res_2011_Apr_15_13(2)_R44.nxml.txt.nlp	21496232	SENT82	15	15	7	7	erlotinib	San	PA134687924	80218	0.826
NULL	Exp_Hematol_Oncol_2014_Dec_17_3(1)_30.nxml.txt.nlp	NULL	SENT132	0	0	9	9	rivaroxaban	IL-10	PA165958360	3586	0.826
NULL	J_Inflamm_(Lond)_2008_Jul_29_5_11.nxml.txt.nlp	18664275	SENT133	8	8	11	11	ciprofloxacin	IL-8	PA449009	3576	0.826
NULL	Biomed_Res_Int_2013_Jan_21_2013_581631.nxml.txt.nlp	23484133	SENT81	18	18	22	22	infliximab	GM-CSF	PA452639	1437	0.826
NULL	EJC_Suppl_2013_Sep_5_11(2)_296-298.nxml.txt.nlp	NULL	SENT33	0	0	12	12	cetuximab	EGFR	PA10040	1956	0.826
NULL	Stroke_Res_Treat_2011_Nov_10_2011_212485.nxml.txt.nlp	22135769	SENT150	16	16	22	22	clopidogrel	ADP	PA449053	23038	0.826
NULL	Crit_Care_2005_May_23_9(4)_409-413.nxml.txt.nlp	16137392	SENT100	4	4	18	18	tobramycin	IL-6	PA451704	3569	0.826
NULL	Pharmaceuticals_(Basel)_2012_Aug_10_5(8)_802-836.nxml.txt.nlp	24280676	SENT25	12	12	20	20	ribavirin	CNT1	PA451241	9154	0.826
NULL	J_Gynecol_Oncol_2013_Jul_4_24(3)_265-272.nxml.txt.nlp	23875077	SENT105	13	13	22	22	thrombin	IL-6	PA451674	3569	0.826
NULL	Cancer_Manag_Res_2013_Nov_21_5_387-400.nxml.txt.nlp	24294007	SENT92	14	14	8	8	cetuximab	BRAF	PA10040	673	0.826
NULL	Breast_Cancer_Res_2007_Aug_8_9(4)_R50.nxml.txt.nlp	17686159	SENT265	9	9	14	14	gefitinib	AKT	PA131301952	207	0.826
NULL	Ann_Hematol_2011_May_12_90(5)_557-568.nxml.txt.nlp	20938660	SENT232	16	16	23	23	plerixafor	CD34	PA165958410	947	0.826
NULL	Braz_J_Med_Biol_Res_2013_Mar_15_46(3)_299-305.nxml.txt.nlp	23532269	SENT175	12	12	33	33	propofol	CD14	PA451141	929	0.826
NULL	J_Cardiothorac_Surg_2013_Nov_18_8_214.nxml.txt.nlp	24245511	SENT55	13	13	8	8	aspirin	ACE	PA448497	1636	0.826
NULL	J_Oncol_2012_Sep_5_2012_141236.nxml.txt.nlp	21904550	SENT157	26	26	14	14	sunitinib	VEGF-A	PA162372840	7422	0.826
NULL	J_Thorac_Oncol_2014_Feb_23_9(2)_189-194.nxml.txt.nlp	24419415	SENT95	23	23	31	31	gefitinib	EGFR	PA131301952	1956	0.826
NULL	Eur_Respir_J_2013_May_27_41(5)_1107-1115.nxml.txt.nlp	23018904	SENT160	15	15	35	35	ciprofloxacin	DPI	PA449009	1832	0.826
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT39	14	14	11	11	lapatinib	EGFR	PA152241907	1956	0.826
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1522-1532.nxml.txt.nlp	21997136	SENT152	15	15	23	23	lapatinib	ABCG2	PA152241907	9429	0.826
NULL	Ann_Intensive_Care_2011_Dec_30_1_53.nxml.txt.nlp	22208725	SENT89	24	24	14	14	potassium	CLP	PA451047	23406;810;8048	0.826
NULL	Diabetes_Care_2012_Feb_16_35(2)_327-333.nxml.txt.nlp	22179958	SENT92	7	7	23	23	metformin	B12	PA450395	7126;4709	0.826
NULL	Nucleic_Acids_Res_2013_May_12_41(9)_e101.nxml.txt.nlp	23482392	SENT381	6	6	12	12	bortezomib	AKR1B1	PA10252	231	0.826
NULL	Br_J_Cancer_2011_Nov_22_105(11)_1640-1645.nxml.txt.nlp	22027711	SENT149	0	0	8	8	sorafenib	VEGFR2	PA7000	3791	0.826
NULL	Asian-Australas_J_Anim_Sci_2014_Dec_27(12)_1783-1793.nxml.txt.nlp	25358373	SENT13	26	26	3	3	capsaicin	gamma	PA448776	9913	0.826
NULL	Case_Rep_Oncol_Med_2014_Aug_27_2014_165670.nxml.txt.nlp	25247100	SENT77	16	16	21	21	cyclophosphamide	IFN	PA449165	3439	0.826
NULL	Nat_Commun_2014_Dec_8_5_5736.nxml.txt.nlp	25484020	SENT122	27	27	9	9	letrozole	TRPA1	PA450196	8989	0.826
NULL	Am_J_Case_Rep_2014_Feb_26_15_90-93.nxml.txt.nlp	24605181	SENT108	12	12	15	15	itraconazole	CYP3A4	PA450132	1576	0.826
NULL	J_Korean_Med_Sci_2009_Jan_29_24(Suppl_1)_S161-S169.nxml.txt.nlp	19194547	SENT33	26	26	5	5	hydrochlorothiazide	TRPV5	PA449899	56302	0.826
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT227	2	2	18	18	docetaxel	B7-H1	PA449383	29126	0.826
NULL	Open_Access_J_Urol_2011_Apr_26_3_43-48.nxml.txt.nlp	24198635	SENT37	3	3	10	10	temsirolimus	FKBP-12	PA164746890	2280	0.826
NULL	Ann_Med_2011_Nov_5_43(7)_531-544.nxml.txt.nlp	21815879	SENT24	30	30	21	21	thrombin	ADP	PA451674	23038	0.826
NULL	Virol_J_2010_Feb_11_7_36.nxml.txt.nlp	20149251	SENT40	8	8	3	3	ribavirin	IFN	PA451241	3439	0.826
NULL	Clin_Epidemiol_2010_Aug_9_2_29-36.nxml.txt.nlp	20865100	SENT35	18	18	40	40	fluvoxamine	B10	PA449690	5169	0.826
NULL	Pharmaceuticals_(Basel)_2012_Jun_28_5(7)_674-689.nxml.txt.nlp	24281706	SENT571	6	6	14	14	geldanamycin	PP1	PA152031327	5540;5464	0.826
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S349-S354.nxml.txt.nlp	21525481	SENT112	7	7	0	0	exenatide	GLP-1	PA164749238	100125288	0.826
NULL	Lipids_Health_Dis_2011_Feb_28_10_38.nxml.txt.nlp	21352602	SENT122	3	3	7	7	fenofibrate	PCSK9	PA449594	255738	0.826
NULL	J_Cell_Biol_2003_Dec_8_163(5)_1045-1055.nxml.txt.nlp	14657236	SENT292	15	15	24	24	l-glutamine	FBS	PA10090	64319;26269	0.826
NULL	Oncotarget_2013_Nov_23_5(1)_196-210.nxml.txt.nlp	24344116	SENT204	18	18	5	5	doxorubicin	p53	PA449412	7157	0.826
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT50	28	28	2	2	nutlin-3	p53		7157	0.826
NULL	Ther_Clin_Risk_Manag_2006_Sep_2(3)_235-249.nxml.txt.nlp	18360599	SENT321	16	16	5	5	alendronate	PTH	PA448082	5741	0.826
NULL	Pain_2013_Jan_154(1)_124-134.nxml.txt.nlp	23273106	SENT611	23	23	3	3	capsaicin	ANOVA	PA448776	4858	0.826
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT50	6	6	28	28	anastrozole	HER2	PA448432	2064	0.826
NULL	Ann_Hematol_2011_Feb_17_90(2)_173-183.nxml.txt.nlp	20714724	SENT130	10	10	18	18	resveratrol	ZAP-70		7535	0.826
NULL	Br_J_Cancer_2010_Jan_5_102(1)_134-143.nxml.txt.nlp	19920829	SENT211	30	30	15	15	pertuzumab	IL-2		3558	0.826
NULL	Breast_Cancer_Res_2005_Jul_18_7(5)_187-189.nxml.txt.nlp	16168136	SENT45	12	12	7	7	gefitinib	HER2	PA131301952	2064	0.826
NULL	Nucleic_Acids_Res_2011_Dec_2_39(22)_9731-9745.nxml.txt.nlp	21890904	SENT101	17	17	38	38	kanamycin	MPP10	PA450137	10199	0.826
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_39-54.nxml.txt.nlp	19305787	SENT541	11	11	13	13	ethanol	NR1	PA448073	27158	0.826
NULL	Cardiovasc_Diabetol_2013_May_4_12_73.nxml.txt.nlp	23642288	SENT137	15	15	8	8	acarbose	GLP-1	PA448010	100125288	0.826
NULL	Int_J_Biol_Sci_2014_Jan_20_10(2)_171-180.nxml.txt.nlp	24520215	SENT17	0	0	15	15	cerulenin	L-FABP	PA164764551	2168	0.826
NULL	BMB_Rep_2013_Nov_46(11)_544-549.nxml.txt.nlp	24152910	SENT80	21	21	6	6	thrombin	PAR-1	PA451674	2011;2149	0.826
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT123	4	4	12	12	doxorubicin	SLK	PA449412	9748;2534	0.826
NULL	Oncotarget_2014_Jun_8_5(13)_5040-5053.nxml.txt.nlp	24970815	SENT167	31	31	27	27	cisplatin	EGF	PA449014	1950	0.826
NULL	Front_Endocrinol_(Lausanne)_2013_May_16_4_51.nxml.txt.nlp	23720652	SENT15	37	37	24	24	diclofenac	UGT2B17	PA449293	7367	0.826
NULL	Breast_Cancer_Res_Treat_2012_Jun_18_133(3)_937-947.nxml.txt.nlp	22094936	SENT186	41	41	23	23	tamoxifen	CCNE2	PA451581	9134	0.825
NULL	Core_Evid_2007_Nov_30_2(2)_121-129.nxml.txt.nlp	21221180	SENT195	10	10	21	21	rituximab	PRIMA	PA451261	145270	0.825
NULL	Evid_Based_Complement_Alternat_Med_2013_May_23_2013_632121.nxml.txt.nlp	23762150	SENT104	4	4	11	11	resveratrol	MITF		4286	0.825
NULL	Environ_Health_Perspect_2013_Oct_1_121(10)_A298-A303.nxml.txt.nlp	24218659	SENT204	16	16	18	18	diethylstilbestrol	DES	PA449307	1674	0.825
NULL	Int_J_Anal_Chem_2012_Feb_8_2012_546282.nxml.txt.nlp	22505920	SENT103	29	29	19	19	terazosin	PF6	PA451612	200162	0.825
NULL	Arthritis_Res_Ther_2012_Jun_25_14(3)_215.nxml.txt.nlp	22731694	SENT143	4	4	22	22	rituximab	IFN	PA451261	3439	0.825
NULL	Calcif_Tissue_Int_2011_Jul_28_89(1)_10-20.nxml.txt.nlp	21526395	SENT54	13	13	18	18	doxycycline	PMI	PA449415	8834;5373	0.825
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT1406	9	9	1	1	paclitaxel	MRP2	PA450761	100130958;57626;1244	0.825
NULL	Mol_Cancer_2009_Jul_3_8_43.nxml.txt.nlp	19575780	SENT88	3	3	8	8	colchicine	survivin	PA449092	332	0.825
NULL	Oncol_Lett_2013_Mar_8_5(3)_805-812.nxml.txt.nlp	23426281	SENT168	22	22	3	3	gemcitabine	B7-H3	PA449748	80381	0.825
NULL	Arthritis_Res_Ther_2006_Apr_12_8(Suppl_1)_S4.nxml.txt.nlp	16820043	SENT62	0	0	18	18	pyrazinamide	URAT1	PA451182	116085	0.825
NULL	Int_J_Endocrinol_2014_Feb_13_2014_329456.nxml.txt.nlp	24688539	SENT223	11	11	29	29	vardenafil	IP-10	PA10229	3627	0.825
NULL	Biomed_Res_Int_2013_Sep_5_2013_929531.nxml.txt.nlp	24083250	SENT51	15	15	22	22	hyaluronan	CD44	PA165958431	960	0.825
NULL	Indian_J_Nephrol_2012_Nov-Dec_22(6)_462-465.nxml.txt.nlp	23439779	SENT55	10	10	21	21	itraconazole	API	PA450132	5345	0.825
NULL	Breast_Cancer_Res_2001_Oct_11_3(6)_380-384.nxml.txt.nlp	11737889	SENT87	9	9	17	17	paclitaxel	HER-2	PA450761	2064	0.825
NULL	Drug_Saf_2014_Feb_19_37(4)_201-211.nxml.txt.nlp	24550106	SENT27	36	36	18	18	omeprazole	CYP2C19	PA450704	1557	0.825
NULL	Sci_Rep_2014_Dec_17_4_7461.nxml.txt.nlp	25514838	SENT31	44	44	25	25	vincristine	Bcl-2	PA451879	596	0.825
NULL	Oncoimmunology_2013_Dec_1_2(12)_e26689.nxml.txt.nlp	24527364	SENT55	20	20	9	9	lapatinib	STAT1	PA152241907	6772	0.825
NULL	Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.nxml.txt.nlp	24736980	SENT187	22	22	31	31	rosuvastatin	OATP1B1	PA134308647	10599	0.825
NULL	Mol_Cancer_2014_Jan_15_13_8.nxml.txt.nlp	24423412	SENT91	16	16	9	9	cisplatin	CD44	PA449014	960	0.825
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2587-2596.nxml.txt.nlp	24129237	SENT183	19	19	6	6	doxorubicin	NOTCH1	PA449412	4851	0.825
NULL	Expert_Rev_Mol_Med_2009_May_11_e16.nxml.txt.nlp	19467172	SENT449	14	14	7	7	artesunate	NAC	PA165111697	22861	0.825
NULL	Eur_J_Clin_Pharmacol_2013_Mar_5_69(3)_467-475.nxml.txt.nlp	22864379	SENT40	29	29	15	15	warfarin	CYP4F2	PA451906	8529	0.825
NULL	Case_Rep_Gastrointest_Med_2014_Jul_1_2014_579352.nxml.txt.nlp	25093126	SENT43	6	6	10	10	rituximab	CHOP	PA451261	1649	0.825
NULL	Eur_J_Med_Res_2011_Aug_8_16(8)_342-348.nxml.txt.nlp	21813377	SENT199	27	27	7	7	sirolimus	CYP3A	PA451365	1574	0.825
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT2406	38	38	31	31	amiodarone	CYP3A4	PA448383	1576	0.825
NULL	Int_J_Breast_Cancer_2011_Sep_6_2011_352182.nxml.txt.nlp	22295219	SENT144	8	8	18	18	trastuzumab	PI3K	PA451743	5290	0.825
NULL	Front_Endocrinol_(Lausanne)_2014_Apr_14_5_55.nxml.txt.nlp	24782833	SENT76	18	18	24	24	collagenase	EGF	PA449107	1950	0.825
NULL	J_Physiol_2013_Sep_1_591(17)_4167-4188.nxml.txt.nlp	23836691	SENT473	7	7	1	1	flecainide	CAST	PA449646	10849;26059;831	0.825
NULL	Int_J_Alzheimers_Dis_2012_Feb_1_2012_109324.nxml.txt.nlp	22506129	SENT134	4	4	31	31	simvastatin	ZO-1	PA451363	7082	0.825
NULL	J_Gastrointest_Surg_2012_Apr_13_16(4)_842-848.nxml.txt.nlp	22246855	SENT94	24	24	6	6	erlotinib	EGFR	PA134687924	1956	0.825
NULL	Oncotarget_2014_Dec_4_5(22)_11365-11380.nxml.txt.nlp	25426548	SENT35	22	22	41	41	nutlin-3	TP53		7157	0.825
NULL	Mol_Cancer_2012_Jul_25_11_47.nxml.txt.nlp	22830443	SENT147	20	20	32	32	panitumumab	EGFR	PA162373091	1956	0.825
NULL	Cell_Death_Dis_2013_Jul_11_4(7)_e719.nxml.txt.nlp	23846221	SENT62	22	22	20	20	cisplatin	TRAIL	PA449014	8743	0.825
NULL	Cancer_Res_Treat_2012_Sep_30_44(3)_195-201.nxml.txt.nlp	23091446	SENT125	24	24	6	6	irinotecan	MKP-1	PA450085	1843	0.825
NULL	Cancers_(Basel)_2014_Oct_24_6(4)_2187-2223.nxml.txt.nlp	25347122	SENT1182	7	7	4	4	cetuximab	EGFR	PA10040	1956	0.825
NULL	Oncotarget_2014_Oct_21_5(22)_11225-11236.nxml.txt.nlp	25373490	SENT25	17	17	9	9	urokinase	maspin	PA451836	5268	0.825
NULL	Croat_Med_J_2012_Jun_53(3)_214-223.nxml.txt.nlp	22661134	SENT65	32	32	6	6	reserpine	ACTH	PA451236	5443	0.825
NULL	Bull_Math_Biol_2014_Dec_14_76(2)_401-430.nxml.txt.nlp	24338592	SENT321	22	22	26	26	etoposide	CHOP	PA449552	1649	0.825
NULL	Biomed_Res_Int_2013_Aug_13_2013_659254.nxml.txt.nlp	24000324	SENT253	13	13	27	27	ethanol	DAC	PA448073	13	0.825
NULL	J_Hematol_Oncol_2010_May_2_3_18.nxml.txt.nlp	20433767	SENT123	27	27	11	11	cetuximab	EGFR	PA10040	1956	0.825
NULL	Neuro_Oncol_2010_Apr_27_12(4)_389-400.nxml.txt.nlp	20308316	SENT117	13	13	20	20	chloroquine	p53	PA448948	7157	0.825
NULL	Front_Synaptic_Neurosci_2012_Oct_16_4_5.nxml.txt.nlp	23087642	SENT737	5	5	13	13	furosemide	CA3	PA449719	761	0.825
NULL	Arthritis_Res_Ther_2010_Jun_2_12(3)_R107.nxml.txt.nlp	20525198	SENT221	27	27	12	12	rolipram	TNF	PA153906323	7124	0.825
NULL	Exp_Diabetes_Res_2011_Jun_4_2011_489708.nxml.txt.nlp	21747829	SENT28	19	19	9	9	aliskiren	GLP-1	PA143487910	100125288	0.825
NULL	Diabetes_Care_2008_Nov_31(11)_2169-2176.nxml.txt.nlp	18678611	SENT116	28	28	17	17	rimonabant	adiponectin	PA152407999	9370	0.825
NULL	Arthritis_Rheum_2013_Sep_26_65(9)_2290-2300.nxml.txt.nlp	23740547	SENT200	19	19	11	11	doxycycline	S100A9	PA449415	6280	0.825
NULL	J_Immunother_Cancer_2014_Jan_27_2_2.nxml.txt.nlp	24829759	SENT101	22	22	14	14	sorafenib	IL-21	PA7000	59067;50616;27189	0.825
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT253	25	25	18	18	cisplatin	E2F1	PA449014	1869	0.825
NULL	Anat_Cell_Biol_2012_Jun_30_45(2)_73-78.nxml.txt.nlp	22822460	SENT85	15	15	26	26	cisplatin	HIF-1	PA449014	29072	0.825
NULL	Pharmaceutics_2011_Nov_4_3(4)_793-829.nxml.txt.nlp	24309309	SENT293	10	10	1	1	curcumin	Ray	PA151958596	26751	0.825
NULL	Arch_Med_Sci_2010_Apr_30_6(2)_160-167.nxml.txt.nlp	22371740	SENT171	4	4	0	0	collagenase	MMP1	PA449107	4312	0.825
NULL	Oncoimmunology_2012_Oct_1_1(7)_1004-1016.nxml.txt.nlp	23170249	SENT216	26	26	36	36	paclitaxel	HER-2	PA450761	2064	0.825
NULL	Mol_Cancer_2007_Jan_14_6_5.nxml.txt.nlp	17222355	SENT26	23	23	5	5	doxorubicin	HMGA2	PA449412	8091	0.825
NULL	Pharmaceutics_2010_Sep_9_2(3)_291-299.nxml.txt.nlp	NULL	SENT92	19	19	11	11	tacrolimus	CYP3A4	PA451578	1576	0.825
NULL	J_Inherit_Metab_Dis_2010_Oct_3_33(5)_625-632.nxml.txt.nlp	20814828	SENT107	2	2	9	9	simvastatin	RhoA	PA451363	387	0.825
NULL	Iran_J_Basic_Med_Sci_2012_Jan-Feb_15(1)_678-682.nxml.txt.nlp	23493931	SENT41	12	12	35	35	cefotaxime	MAST	PA448852	51324	0.825
NULL	Pain_Res_Treat_2011_Aug_14_2011_864605.nxml.txt.nlp	22110933	SENT115	10	10	26	26	oxycodone	PLP	PA450741	25824;5744	0.825
NULL	Ann_N_Y_Acad_Sci_2010_Sep_1206(1)_110-129.nxml.txt.nlp	20860685	SENT452	9	9	24	24	copper	GHR	PA449114	2690	0.825
NULL	Anal_Bioanal_Chem_2007_Nov_22_389(6)_1967-1977.nxml.txt.nlp	17899035	SENT95	27	27	10	10	ethanol	mol	PA448073	90527	0.825
NULL	Clin_Oral_Investig_2007_Dec_10_11(4)_391-399.nxml.txt.nlp	17690922	SENT64	22	22	13	13	doxycycline	BOP	PA449415	611;150572	0.825
NULL	Arch_Med_Sci_2013_Dec_30_9(6)_1090-1096.nxml.txt.nlp	24482655	SENT122	3	3	6	6	tacrolimus	CD4	PA451578	920	0.825
NULL	Mol_Cancer_2014_Jul_15_13_172.nxml.txt.nlp	25027955	SENT144	18	18	5	5	doxycycline	DUSP4	PA449415	1846	0.825
NULL	Cell_Death_Dis_2014_Jul_3_5(7)_e1316.nxml.txt.nlp	24991768	SENT54	6	6	10	10	pemetrexed	ATF4	PA10810	468	0.825
NULL	Aging_(Albany_NY)_2014_May_17_6(5)_369-379.nxml.txt.nlp	24860943	SENT97	8	8	2	2	l-arginine	S6K1	PA448478	6198	0.825
NULL	J_Exp_Clin_Cancer_Res_2009_Feb_13_28(1)_17.nxml.txt.nlp	19216775	SENT15	13	13	7	7	cisplatin	CCND1	PA449014	595	0.825
NULL	Acta_Pharmacol_Sin_2011_Jun_23_32(6)_675-684.nxml.txt.nlp	21602838	SENT125	7	7	0	0	simvastatin	ClC-3	PA451363	1182	0.825
NULL	Front_Cell_Neurosci_2014_Jul_8_8_190.nxml.txt.nlp	25071449	SENT77	38	38	11	11	paraformaldehyde	CO2	PA450790	4513	0.825
NULL	Evid_Based_Complement_Alternat_Med_2012_Aug_28_2012_147896.nxml.txt.nlp	22969822	SENT119	8	8	40	40	ethanol	IL-8	PA448073	3576	0.825
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1075.nxml.txt.nlp	24556690	SENT124	22	22	27	27	spermine	SMO	PA164781199	6608;54498	0.825
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Mar_24_68(Pt_4)_o1147-o1148.nxml.txt.nlp	22606094	SENT6	23	23	1	1	piperazine	mol	PA450977	90527	0.825
NULL	ScientificWorldJournal_2014_Mar_23_2014_104246.nxml.txt.nlp	24782658	SENT63	23	23	47	47	l-glutamine	CO2	PA10090	4513	0.825
NULL	Eur_J_Clin_Pharmacol_2012_Sep_15_68(9)_1267-1274.nxml.txt.nlp	22418828	SENT204	29	29	8	8	amoxicillin	MDR1	PA448406	5243	0.825
NULL	Daru_2011_19(5)_338-343.nxml.txt.nlp	22615679	SENT11	34	34	46	46	piperazine	5-HT1A	PA450977	3350	0.825
NULL	J_Cardiovasc_Dis_Res_2012_Oct-Dec_3(4)_319-322.nxml.txt.nlp	23233778	SENT13	26	26	29	29	azithromycin	CYP3A4	PA448519	1576	0.825
NULL	J_Biomed_Opt_2013_Dec_23_18(12)_120504.nxml.txt.nlp	24365954	SENT74	5	5	12	12	verteporfin	spatial	PA451871	219793	0.825
NULL	Indian_J_Med_Res_2013_Nov_138(5)_755-761.nxml.txt.nlp	24434328	SENT81	30	30	13	13	trastuzumab	CD16	PA451743	2215;2214	0.825
NULL	J_Korean_Med_Sci_2013_Aug_31_28(8)_1238-1243.nxml.txt.nlp	23960454	SENT165	0	0	8	8	amiloride	ASIC3	PA448368	9311	0.825
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2008_Jun_1_64(Pt_6)_611-619.nxml.txt.nlp	18560148	SENT91	12	12	14	14	heparin	CXCR3	PA449855	2833	0.825
NULL	J_Clin_Exp_Pathol_2012_May_17_Suppl_4_7327.nxml.txt.nlp	25379357	SENT47	10	10	2	2	resveratrol	SIRT1		23411	0.825
NULL	Mol_Neurodegener_2011_Aug_8_6_57.nxml.txt.nlp	21819629	SENT61	12	12	2	2	arsenite	JNK	PA452638	5599	0.825
NULL	J_Gen_Physiol_2004_Aug_124(2)_125-137.nxml.txt.nlp	15277574	SENT71	26	26	3	3	forskolin	CFTR	PA146096022	1080	0.825
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2007_Jan_1_63(Pt_1)_1-8.nxml.txt.nlp	17164520	SENT45	27	27	24	24	trypsin	PTI	PA451806	5269	0.825
NULL	ScientificWorldJournal_2012_Apr_19_2012_804730.nxml.txt.nlp	22606063	SENT138	8	8	11	11	latanoprost	ANOVA	PA164774763	4858	0.825
NULL	Cancer_Biol_Med_2012_Mar_9(1)_18-22.nxml.txt.nlp	23691449	SENT79	11	11	17	17	gefitinib	EGFR	PA131301952	1956	0.825
NULL	Drug_Saf_2014_Feb_19_37(4)_201-211.nxml.txt.nlp	24550106	SENT163	28	28	15	15	rabeprazole	CYP2C19	PA451216	1557	0.825
NULL	Breast_Cancer_(Auckl)_2012_Oct_25_6_159-171.nxml.txt.nlp	23133315	SENT78	9	9	24	24	docetaxel	HER2	PA449383	2064	0.825
NULL	Arthritis_Res_Ther_2005_Jul_21_7(5)_R1124-R1132.nxml.txt.nlp	16207329	SENT201	35	35	3	3	staurosporine	p65	PA165109623	5970	0.825
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_55-78.nxml.txt.nlp	19305788	SENT884	8	8	19	19	memantine	c-fos	PA10364	2353	0.825
NULL	Br_J_Cancer_2010_Dec_7_103(12)_1815-1821.nxml.txt.nlp	21063408	SENT98	36	36	13	13	etoposide	6-16	PA449552	2537	0.825
NULL	J_Exp_Bot_2009_Apr_2_60(6)_1691-1702.nxml.txt.nlp	19342428	SENT144	17	17	4	4	ethanol	PCA	PA448073	28982	0.825
NULL	EMBO_J_2014_Feb_3_33(3)_181-197.nxml.txt.nlp	24442637	SENT176	22	22	5	5	doxorubicin	FAT1	PA449412	2195	0.825
NULL	Clin_Psychopharmacol_Neurosci_2011_Apr_30_9(1)_36-43.nxml.txt.nlp	23431025	SENT109	15	15	25	25	haloperidol	FLI	PA449841	2314	0.825
NULL	Leukemia_2013_Jan_11_27(1)_32-40.nxml.txt.nlp	22781593	SENT105	11	11	23	23	ponatinib	BBC2	PA165980594	572	0.825
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT303	23	23	13	13	risperidone	PRL	PA451257	5617	0.825
NULL	Br_J_Cancer_1997_75(11)_1593-1600.nxml.txt.nlp	9184173	SENT13	14	14	23	23	quinacrine	PC-3	PA164745551	692094	0.825
NULL	FEBS_Open_Bio_2014_Oct_22_4_905-914.nxml.txt.nlp	25383314	SENT95	0	0	16	16	physostigmine	L-FABP	PA450957	2168	0.825
NULL	Indian_J_Crit_Care_Med_2008_Oct-Dec_12(4)_181-189.nxml.txt.nlp	19742267	SENT90	22	22	29	29	anakinra	ACR	PA10799	49	0.825
NULL	Diabetes_Care_2009_Nov_32(Suppl_2)_S322-S325.nxml.txt.nlp	19875573	SENT105	0	0	4	4	liraglutide	GLP-1	PA165958364	100125288	0.825
NULL	Arthritis_Res_Ther_2009_Oct_14_11(5)_245.nxml.txt.nlp	19849817	SENT161	26	26	44	44	chloroquine	IFN	PA448948	3439	0.825
NULL	Curr_Rev_Musculoskelet_Med_2009_Mar_10_2(1)_56-64.nxml.txt.nlp	19468919	SENT53	23	23	5	5	heparin	OPG	PA449855	690	0.825
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT1245	2	2	11	11	tenofovir	ABCB1	PA10204	5243	0.825
NULL	Oncol_Rep_2012_Sep_15_28(3)_763-767.nxml.txt.nlp	22710607	SENT28	23	23	38	38	gemcitabine	PS2	PA449748	5664	0.825
NULL	Br_J_Cancer_2009_Jul_21_101(2)_269-277.nxml.txt.nlp	19603033	SENT108	17	17	5	5	cisplatin	MLH1	PA449014	4292	0.825
NULL	Br_J_Cancer_2011_Jul_26_105(3)_372-381.nxml.txt.nlp	21730979	SENT6	11	11	7	7	cisplatin	CDK2	PA449014	1017	0.825
NULL	Hum_Genomics_2009_Dec_1_4(2)_91-106.nxml.txt.nlp	20038497	SENT198	14	14	10	10	tacrine	GSTT1	PA451576	2952	0.825
NULL	Arthritis_Res_Ther_2009_Jun_29_11(3)_R100.nxml.txt.nlp	19563672	SENT147	34	34	20	20	infliximab	IFN	PA452639	3439	0.825
NULL	J_Thromb_Haemost_2014_May_22_12(5)_726-735.nxml.txt.nlp	24581425	SENT188	22	22	16	16	thrombin	ARF6	PA451674	382	0.825
NULL	Br_J_Cancer_2012_May_8_106(10)_1689-1696.nxml.txt.nlp	22531631	SENT210	16	16	0	0	pravastatin	PC-3	PA451089	692094	0.825
NULL	Nat_Commun_2013_Aug_15_4_2130.nxml.txt.nlp	23945651	SENT7	13	13	27	27	etoposide	ATG5	PA449552	9474	0.825
NULL	Cell_Death_Dis_2013_Oct_3_4(10)_e827.nxml.txt.nlp	24091670	SENT88	17	17	19	19	nilotinib	CD34	PA165958345	947	0.825
NULL	J_Biol_2009_Apr_15_8(3)_30.nxml.txt.nlp	19435483	SENT35	4	4	21	21	dasatinib	NQO2	PA162372878	4835	0.825
NULL	Int_Dairy_J_2010_Apr_20(4)_236-242.nxml.txt.nlp	20204054	SENT84	8	8	4	4	tolbutamide	GLP-1	PA451718	100125288	0.825
NULL	Clinics_(Sao_Paulo)_2013_May_68(5)_694-701.nxml.txt.nlp	23778405	SENT135	5	5	17	17	curcumin	MDR1	PA151958596	5243	0.825
NULL	Nucleic_Acids_Res_2012_Jul_5_40(13)_5988-6000.nxml.txt.nlp	22492511	SENT121	11	11	15	15	flavopiridol	MYB	PA452627	4602	0.825
NULL	J_Cancer_2013_Aug_28_4(7)_585-596.nxml.txt.nlp	24069069	SENT217	26	26	6	6	verteporfin	LC3	PA451871	84557	0.825
NULL	Cancers_(Basel)_2012_Sep_6_4(3)_873-903.nxml.txt.nlp	24213471	SENT345	14	14	7	7	hyaluronidase	HYAL1	PA164745713	3373	0.825
NULL	Cholesterol_2011_Feb_22_2011_503028.nxml.txt.nlp	21490773	SENT135	5	5	18	18	methotrexate	ABCA1	PA450428	19	0.825
NULL	J_Oncol_2010_Feb_22_2010_891059.nxml.txt.nlp	20182637	SENT132	37	37	33	33	cisplatin	ERCC1	PA449014	2067	0.825
NULL	J_Cell_Biol_1997_Jun_30_137(7)_1639-1649.nxml.txt.nlp	9199177	SENT113	30	30	5	5	paraformaldehyde	ZAP-70	PA450790	7535	0.825
NULL	Oncotarget_2014_Jun_19_5(15)_6540-6551.nxml.txt.nlp	25153728	SENT160	5	5	10	10	paclitaxel	HIF-1	PA450761	29072	0.825
NULL	Front_Physiol_2011_Jul_19_2_40.nxml.txt.nlp	21811470	SENT257	13	13	5	5	candesartan	RVR	PA448765	9975	0.825
NULL	Int_J_Fertil_Steril_2014_Jul_8_Jul-Sep_8(2)_119-128.nxml.txt.nlp	25083175	SENT33	10	10	3	3	l-cysteine	NAC	PA449173	22861	0.825
NULL	Oncol_Lett_2013_Feb_22_5(2)_641-644.nxml.txt.nlp	23419988	SENT120	2	2	11	11	paclitaxel	CT7	PA450761	9947	0.825
NULL	Cancers_(Basel)_2010_Dec_29_3(1)_79-90.nxml.txt.nlp	24212607	SENT108	18	18	20	20	gemcitabine	AK1	PA449748	203	0.825
NULL	Cancer_Res_Treat_2012_Jun_30_44(2)_74-84.nxml.txt.nlp	22802745	SENT225	41	41	43	43	crizotinib	EGFR	PA165946122	1956	0.825
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Jul_27_69(Pt_8)_o1331.nxml.txt.nlp	24109402	SENT72	21	21	6	6	ethanol	mol	PA448073	90527	0.825
NULL	J_Biol_2008_Apr_22_7(4)_11.nxml.txt.nlp	18439322	SENT31	11	11	19	19	methotrexate	spatial	PA450428	219793	0.825
NULL	Nucleic_Acids_Res_2012_Jul_30_40(13)_6319-6337.nxml.txt.nlp	22467215	SENT83	23	23	2	2	trypsin	HER2	PA451806	2064	0.825
NULL	Mol_Cell_Proteomics_2012_Feb_6_11(2)_M111_015222.nxml.txt.nlp	22147731	SENT335	4	4	12	12	cetuximab	JUN	PA10040	3725	0.825
NULL	J_Gen_Physiol_2009_Mar_133(3)_227-229.nxml.txt.nlp	19237586	SENT149	10	10	23	23	capsaicin	TRPA1	PA448776	8989	0.825
NULL	Oncoimmunology_2013_Jan_1_2(1)_e22890.nxml.txt.nlp	23483066	SENT62	32	32	13	13	vemurafenib	BRAF	PA165946873	673	0.825
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_23_2013_941093.nxml.txt.nlp	23864901	SENT233	2	2	4	4	amiodarone	CYP2C9	PA448383	1559	0.825
NULL	Clin_Ophthalmol_2009_Jun_2_3_291-295.nxml.txt.nlp	19668581	SENT12	29	29	27	27	travoprost	BAK	PA164781371	578	0.825
NULL	Mol_Clin_Oncol_2013_Sep_23_1(5)_869-874.nxml.txt.nlp	24649263	SENT4	17	17	19	19	gemcitabine	GEM	PA449748	2669	0.825
NULL	J_Cell_Biol_2003_Dec_22_163(6)_1385-1395.nxml.txt.nlp	14676308	SENT169	4	4	12	12	thrombin	RhoA	PA451674	387	0.825
NULL	Chemother_Res_Pract_2011_Feb_27_2011_175054.nxml.txt.nlp	22295203	SENT60	24	24	45	45	cisplatin	MBT	PA449014	5657	0.825
NULL	Nat_Commun_2013_4_10_1038_ncomms3183.nxml.txt.nlp	23873306	SENT92	3	3	29	29	doxycycline	NGN2	PA449415	63973	0.825
NULL	AAPS_J_2011_May_11_13(3)_365-377.nxml.txt.nlp	21560017	SENT180	19	19	4	4	ethanol	AKR1C2	PA448073	1646	0.825
NULL	Aging_Cell_2010_Dec_9(6)_979-990.nxml.txt.nlp	20883524	SENT218	20	20	3	3	paraformaldehyde	p65	PA450790	5970	0.825
NULL	ScientificWorldJournal_2014_Dec_9_2014_808320.nxml.txt.nlp	25548793	SENT23	1	1	16	16	heparin	ACT	PA449855	12;11332;9457;641455	0.825
NULL	J_Hematol_Oncol_2012_Aug_16_5_52.nxml.txt.nlp	22897982	SENT28	3	3	24	24	cetuximab	EGFR	PA10040	1956	0.825
NULL	Cell_Biol_Int_Rep_(2010)_2012_Jun_21_19(1)_e00017.nxml.txt.nlp	23124518	SENT5	30	30	18	18	etoposide	Mcl-1	PA449552	4170	0.825
NULL	Lab_Invest_2014_May_10_94(5)_536-544.nxml.txt.nlp	24614194	SENT129	10	10	27	27	captopril	CD11b	PA448780	3684	0.825
NULL	Nat_Commun_2014_Jun_19_5_4037.nxml.txt.nlp	24941968	SENT122	4	4	21	21	vanillin	PAD1	PA451852	29943	0.825
NULL	Cancer_Res_Treat_2014_Jul_15_46(3)_234-242.nxml.txt.nlp	25038758	SENT133	20	20	11	11	paclitaxel	P-gp	PA450761	5243	0.825
NULL	Evid_Based_Complement_Alternat_Med_2013_May_16_2013_857929.nxml.txt.nlp	23762164	SENT126	22	22	34	34	doxorubicin	p53	PA449412	7157	0.825
NULL	Oncotarget_2011_Aug_23_2(8)_599-609.nxml.txt.nlp	21865609	SENT89	13	13	6	6	cetuximab	CAL	PA10040	54751;57120	0.825
NULL	J_Thromb_Haemost_2010_Mar_8(3)_577-587.nxml.txt.nlp	20040043	SENT129	4	4	19	19	rosiglitazone	mol	PA451283	90527	0.825
NULL	Br_J_Cancer_1996_May_73(9)_1063-1068.nxml.txt.nlp	8624264	SENT9	21	21	32	32	staurosporine	P-gp	PA165109623	5243	0.825
NULL	Neural_Regen_Res_2013_Jul_15_8(20)_1853-1862.nxml.txt.nlp	25206494	SENT24	5	5	22	22	ethanol	p38	PA448073	10598;1432;7965	0.825
NULL	Cough_2006_Dec_15_2_10.nxml.txt.nlp	17173683	SENT196	3	3	5	5	capsaicin	VR1	PA448776	56664	0.825
NULL	Cancer_Causes_Control_2013_Aug_18_24(8)_1605-1614.nxml.txt.nlp	23775025	SENT243	31	31	21	21	cyclophosphamide	GSTP1	PA449165	2950	0.825
NULL	Front_Genet_2012_Oct_26_3_213.nxml.txt.nlp	23112805	SENT37	10	10	14	14	rifabutin	CYP3A4	PA451249	1576	0.825
NULL	Breast_Cancer_(Auckl)_2012_Mar_7_6_67-77.nxml.txt.nlp	22438669	SENT34	10	10	12	12	letrozole	HER2	PA450196	2064	0.825
NULL	Ann_Rheum_Dis_2008_Aug_29_67(8)_1096-1103.nxml.txt.nlp	18055472	SENT189	6	6	29	29	infliximab	ACR	PA452639	49	0.825
NULL	J_Community_Health_2014_Apr_23_39(6)_1040-1044.nxml.txt.nlp	24756837	SENT85	12	12	24	24	palivizumab	AAP	PA164748781	5345	0.825
NULL	Br_J_Cancer_2012_May_8_106(10)_1689-1696.nxml.txt.nlp	22531631	SENT153	9	9	11	11	lovastatin	EGFR	PA450272	1956	0.825
NULL	Breast_Cancer_Res_2012_Dec_5_14(6)_R153.nxml.txt.nlp	23216744	SENT16	26	26	29	29	fulvestrant	p53	PA164747170	7157	0.825
NULL	Case_Rep_Rheumatol_2014_Jul_24_2014_246852.nxml.txt.nlp	25152825	SENT55	1	1	8	8	ustekinumab	p40	PA166048654	3921;339541;10314	0.825
NULL	Biochemistry_2011_May_3_50(17)_3408-3410.nxml.txt.nlp	21425834	SENT52	25	25	22	22	nadh	VDAC2	PA164755085	7417	0.825
NULL	J_Cell_Biol_2001_Apr_2_153(1)_207-220.nxml.txt.nlp	11285286	SENT139	7	7	4	4	carbachol	DGK	PA448784	8526;1607	0.825
NULL	Lipids_Health_Dis_2011_Jan_18_10_8.nxml.txt.nlp	21241519	SENT33	7	7	17	17	simvastatin	ABCA1	PA451363	19	0.825
NULL	J_Invest_Dermatol_2013_Aug_133(8)_1928-1929.nxml.txt.nlp	23856932	SENT35	9	9	2	2	vemurafenib	STAT3	PA165946873	6774	0.825
NULL	Int_J_Med_Sci_2012_Dec_28_10(2)_110-118.nxml.txt.nlp	23329881	SENT54	24	24	13	13	docetaxel	NACT	PA449383	284111	0.825
NULL	Braz_J_Microbiol_2014_Apr_11_45(1)_209-214.nxml.txt.nlp	24948933	SENT20	29	29	25	25	ribavirin	IFN	PA451241	3439	0.825
NULL	Oncol_Lett_2014_Mar_16_7(3)_827-833.nxml.txt.nlp	24527090	SENT114	7	7	9	9	cisplatin	IFN	PA449014	3439	0.825
NULL	Br_J_Cancer_2013_Sep_3_109(5)_1085-1092.nxml.txt.nlp	23942080	SENT147	21	21	10	10	docetaxel	PI3K	PA449383	5290	0.825
NULL	Braz_J_Med_Biol_Res_2014_Sep_5_47(11)_929-939.nxml.txt.nlp	25296354	SENT78	12	12	6	6	gefitinib	EGFR	PA131301952	1956	0.825
NULL	Oncogenesis_2012_Apr_2_1(4)_e5.nxml.txt.nlp	23552603	SENT568	40	40	8	8	celecoxib	BAX	PA448871	581	0.825
NULL	Front_Endocrinol_(Lausanne)_2013_Nov_25_4_176.nxml.txt.nlp	24324456	SENT236	21	21	8	8	furosemide	NKCC1	PA449719	6558	0.825
NULL	Br_J_Cancer_2012_Jul_10_107(2)_375-381.nxml.txt.nlp	22644305	SENT136	15	15	17	17	estradiol	CACNA2D3	PA449503	55799	0.825
NULL	Biomed_Res_Int_2014_May_4_2014_351252.nxml.txt.nlp	24877084	SENT45	4	4	16	16	carmustine	FTM	PA448810	23322	0.825
NULL	Front_Immunol_2013_Nov_7_4_360.nxml.txt.nlp	24223576	SENT179	7	7	2	2	imiquimod	NOXA	PA449972	5366	0.825
NULL	Biol_Open_2013_Aug_6_2(10)_1022-1031.nxml.txt.nlp	24167712	SENT287	6	6	23	23	doxycycline	PLK1	PA449415	5347	0.825
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT280	0	0	5	5	nutlin-3	p53		7157	0.825
NULL	J_Thromb_Haemost_2007_May_1_5(5)_910-917.nxml.txt.nlp	17362227	SENT124	24	24	46	46	thrombin	P2X1	PA451674	5023	0.825
NULL	Oncol_Lett_2014_Oct_28_8(4)_1563-1566.nxml.txt.nlp	25202368	SENT6	2	2	6	6	erlotinib	EGFR	PA134687924	1956	0.825
NULL	Front_Immunol_2012_Jun_11_3_144.nxml.txt.nlp	22701453	SENT1531	14	14	12	12	imiquimod	TLR7	PA449972	51284	0.825
NULL	Biomed_Res_Int_2014_Mar_6_2014_712893.nxml.txt.nlp	24734240	SENT128	3	3	6	6	ethanol	HIF-1alpha	PA448073	3091	0.825
NULL	Oncogenesis_2014_Dec_15_3(12)_e133.nxml.txt.nlp	25500906	SENT9	29	29	4	4	trastuzumab	HER3	PA451743	2065	0.825
NULL	Asia_Pac_Allergy_2013_Oct_31_3(4)_215-223.nxml.txt.nlp	24260726	SENT117	23	23	16	16	allopurinol	HLA-B	PA448320	3106	0.825
NULL	Front_Neural_Circuits_2015_Jan_12_8_150.nxml.txt.nlp	25628540	SENT198	0	0	45	45	atropine	ANOVA	PA448505	4858	0.825
NULL	BioData_Min_2012_Dec_12_5_21.nxml.txt.nlp	23234571	SENT93	12	12	31	31	temozolomide	CHN2	PA451609	1124	0.825
NULL	Acta_Pharmacol_Sin_2010_Jul_21_31(7)_855-860.nxml.txt.nlp	20562904	SENT130	33	33	16	16	fluconazole	CDR1	PA449653	1038	0.825
NULL	Stroke_Res_Treat_2009_Dec_20_2010_386389.nxml.txt.nlp	20700422	SENT217	6	6	11	11	ebselen	NAC	PA161660841	22861	0.825
NULL	Nat_Genet_2011_Feb_26_43(2)_117-120.nxml.txt.nlp	21186350	SENT90	4	4	2	2	metformin	AMPK	PA450395	5563	0.825
NULL	eLife_2014_Mar_4_3_e01630.nxml.txt.nlp	24596151	SENT297	23	23	13	13	trypsin	CDK1	PA451806	983	0.825
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Dec_10_3(12)_e151.nxml.txt.nlp	25494035	SENT5	1	1	19	19	pravastatin	OATP1B1	PA451089	10599	0.825
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Feb_17_6_29-36.nxml.txt.nlp	24648767	SENT129	15	15	12	12	tamoxifen	CYP2D6	PA451581	1565	0.825
NULL	Mol_Biol_Cell_2012_Sep_15_23(18)_3532-3541.nxml.txt.nlp	22855526	SENT198	7	7	32	32	colchicine	SP5	PA449092	389058	0.825
NULL	Biomed_Res_Int_2014_Jan_29_2014_831845.nxml.txt.nlp	24605337	SENT154	27	27	3	3	bupivacaine	S6K1	PA135057240	6198	0.825
NULL	Oncoscience_2014_Nov_15_1(11)_674-705.nxml.txt.nlp	25593996	SENT357	13	13	31	31	cisplatin	EGFR	PA449014	1956	0.825
NULL	Psychiatr_Genet_2013_Aug_28_23(4)_153-162.nxml.txt.nlp	23811784	SENT205	12	12	8	8	clozapine	ADRB2	PA449061	154	0.825
NULL	J_Korean_Assoc_Oral_Maxillofac_Surg_2014_Aug_26_40(4)_195-198.nxml.txt.nlp	25247150	SENT82	11	11	3	3	metronidazole	CST	PA450484	9514	0.825
NULL	Indian_J_Pharmacol_2012_Sep-Oct_44(5)_629-633.nxml.txt.nlp	23112427	SENT129	2	2	14	14	metoprolol	ANOVA	PA450480	4858	0.825
NULL	Interdiscip_Perspect_Infect_Dis_2014_May_7_2014_849432.nxml.txt.nlp	24895495	SENT128	16	16	14	14	ritonavir	CYP3A4	PA451260	1576	0.825
NULL	Cancer_Metab_2013_Jan_23_1_3.nxml.txt.nlp	24280005	SENT362	35	35	2	2	doxycycline	U87	PA449415	677775;641648	0.825
NULL	Cell_Death_Dis_2010_Nov_18_1(11)_e102.nxml.txt.nlp	21368867	SENT298	0	0	15	15	gentamicin	CLIMP-63	PA449753	10970	0.825
NULL	Acta_Pharmacol_Sin_2009_Feb_26_30(2)_175-183.nxml.txt.nlp	19169269	SENT145	4	4	24	24	iptakalim	NUP54	PA165949694	53371	0.825
NULL	Case_Rep_Ophthalmol_2014_Jul_5_5(2)_195-202.nxml.txt.nlp	25120475	SENT68	11	11	18	18	bevacizumab	San	PA130232992	80218	0.825
NULL	Oncoimmunology_2013_Jun_1_2(6)_e24677.nxml.txt.nlp	23894722	SENT145	26	26	14	14	cetuximab	TLR3	PA10040	7098	0.825
NULL	Curr_Neuropharmacol_2014_Mar_12(2)_100-107.nxml.txt.nlp	24669205	SENT237	6	6	9	9	haloperidol	parkin	PA449841	5071	0.825
NULL	Environ_Health_Perspect_2006_Sep_23_114(9)_1401-1406.nxml.txt.nlp	16966095	SENT189	4	4	18	18	arsenite	p53	PA452638	7157	0.825
NULL	EPMA_J_2012_Sep_27_3(1)_10.nxml.txt.nlp	23016735	SENT234	30	30	9	9	warfarin	CYP2C9	PA451906	1559	0.825
NULL	F1000_Biol_Rep_2009_Sep_8_1_70.nxml.txt.nlp	20948617	SENT103	25	25	42	42	canakinumab	NALP3	PA165958358	114548	0.825
NULL	Int_J_Vasc_Med_2013_Mar_31_2013_543141.nxml.txt.nlp	23606968	SENT161	4	4	15	15	etanercept	IL-6	PA449515	3569	0.825
NULL	Arthritis_Res_2002_May_24_4(Suppl_2)_S34-S40.nxml.txt.nlp	12110156	SENT64	15	15	25	25	etanercept	ACR	PA449515	49	0.825
NULL	J_Res_Pharm_Pract_2014_Jul-Sep_3(3)_94-99.nxml.txt.nlp	25328899	SENT68	6	6	16	16	meperidine	ANOVA	PA450369	4858	0.825
NULL	Case_Rep_Nephrol_Urol_2012_Apr_11_2(1)_20-24.nxml.txt.nlp	23197951	SENT66	17	17	12	12	colchicine	NAC	PA449092	22861	0.825
NULL	Int_J_Biol_Sci_2013_Mar_7_9(3)_279-288.nxml.txt.nlp	23493630	SENT166	19	19	12	12	tocilizumab	CD4	PA165292659	920	0.825
NULL	Front_Immunol_2012_Jul_4_3_185.nxml.txt.nlp	22783258	SENT211	4	4	9	9	curcumin	IL-10	PA151958596	3586	0.825
NULL	Cancers_(Basel)_2010_Apr_14_2(2)_523-548.nxml.txt.nlp	24281081	SENT317	8	8	27	27	erlotinib	HER2	PA134687924	2064	0.825
NULL	Clin_Ophthalmol_2014_Apr_16_8_773-776.nxml.txt.nlp	24790406	SENT49	16	16	25	25	bevacizumab	San	PA130232992	80218	0.825
NULL	Nat_Commun_2014_Nov_25_5_5548.nxml.txt.nlp	25420520	SENT631	21	21	17	17	cabazitaxel	ERG	PA165958401	2078	0.825
NULL	Oncotarget_2012_May_4_3(4)_395-398.nxml.txt.nlp	22565037	SENT25	15	15	2	2	metformin	CD24	PA450395	100133941	0.825
NULL	Breast_Cancer_Res_2010_Nov_16_12(6)_R96.nxml.txt.nlp	21080941	SENT232	0	0	4	4	lapatinib	HER2	PA152241907	2064	0.825
NULL	Mol_Cancer_2010_Jun_27_9_168.nxml.txt.nlp	20579391	SENT121	4	4	15	15	dasatinib	TTK	PA162372878	7272	0.825
NULL	Diabetes_Care_2010_Jul_33(7)_1674-1685.nxml.txt.nlp	20587728	SENT436	20	20	10	10	metformin	LKB1	PA450395	6794	0.825
NULL	Oncotarget_2011_Dec_21_2(12)_1134-1144.nxml.txt.nlp	22193779	SENT117	28	28	7	7	gefitinib	PC3	PA131301952	57332;7832;5122	0.825
NULL	Indian_J_Pharm_Sci_2014_Mar-Apr_76(2)_166-169.nxml.txt.nlp	24843191	SENT29	0	0	20	20	nebivolol	HEC	PA151958426	10403	0.825
NULL	Breast_Cancer_Res_Treat_2012_Jun_18_133(3)_937-947.nxml.txt.nlp	22094936	SENT206	6	6	12	12	tamoxifen	CDC2	PA451581	5424	0.825
NULL	Cell_Res_2014_Nov_30_24(11)_1354-1366.nxml.txt.nlp	25267403	SENT196	25	25	14	14	ethanol	ALK	PA448073	238	0.825
NULL	Clin_Ophthalmol_2010_Oct_21_4_1229-1236.nxml.txt.nlp	21060677	SENT92	23	23	25	25	latanoprost	BAK	PA164774763	578	0.825
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1059-1066.nxml.txt.nlp	21364577	SENT32	31	31	38	38	anastrozole	aromatase	PA448432	1588	0.825
NULL	Case_Rep_Gastrointest_Med_2014_Jul_1_2014_579352.nxml.txt.nlp	25093126	SENT43	12	12	10	10	rituximab	CHOP	PA451261	1649	0.825
NULL	Curr_Mol_Med_2014_Jun_14(5)_603-615.nxml.txt.nlp	24894176	SENT201	29	29	7	7	staurosporine	BI-1	PA165109623	7009	0.825
NULL	Oxid_Med_Cell_Longev_2010_Mar-Apr_3(2)_86-100.nxml.txt.nlp	20716933	SENT86	1	1	7	7	phenol	JNK	PA450913	5599	0.825
NULL	Oncotarget_2011_Jan_25_2(1-2)_8-17.nxml.txt.nlp	21378407	SENT47	4	4	2	2	thrombin	PAR-1	PA451674	2011;2149	0.825
NULL	Mol_Biol_Int_2012_Apr_9_2012_196715.nxml.txt.nlp	22577552	SENT164	7	7	13	13	staurosporine	MST2	PA165109623	6788	0.825
NULL	Onco_Targets_Ther_2014_Sep_24_7_1663-1687.nxml.txt.nlp	25285016	SENT244	43	43	22	22	paclitaxel	VEGF-A	PA450761	7422	0.825
NULL	Curr_Neuropharmacol_2007_Sep_5(3)_195-201.nxml.txt.nlp	19305802	SENT217	19	19	30	30	phenol	CA1	PA450913	759	0.825
NULL	Aging_(Albany_NY)_2012_Jul_22_4(7)_480-498.nxml.txt.nlp	22837425	SENT29	7	7	16	16	metformin	B12	PA450395	7126;4709	0.825
NULL	Anal_Bioanal_Chem_2013_Aug_28_405(20)_6529-6541.nxml.txt.nlp	23812853	SENT240	13	13	6	6	lamotrigine	NUA	PA450164	23224	0.825
NULL	Cancers_(Basel)_2014_Oct_24_6(4)_2187-2223.nxml.txt.nlp	25347122	SENT288	33	33	13	13	dasatinib	CAV1	PA162372878	857	0.825
NULL	Pharmaceuticals_(Basel)_2013_Aug_21_6(8)_988-1038.nxml.txt.nlp	24276379	SENT2132	27	27	9	9	leucovorin	UGT1A9	PA450198	54600	0.825
NULL	Br_J_Cancer_2009_Nov_3_101(9)_1585-1595.nxml.txt.nlp	19809435	SENT90	1	1	12	12	curcumin	MDC	PA151958596	6367	0.825
NULL	J_Korean_Assoc_Oral_Maxillofac_Surg_2014_Dec_26_40(6)_291-296.nxml.txt.nlp	25551094	SENT126	4	4	20	20	alendronate	RANKL	PA448082	8600	0.825
NULL	J_Nutr_Metab_2011_Oct_1_2011_525094.nxml.txt.nlp	21977315	SENT177	6	6	8	8	resveratrol	SIRT1		23411	0.825
NULL	Exp_Ther_Med_2013_Jun_2_5(6)_1737-1739.nxml.txt.nlp	23837064	SENT89	9	9	1	1	fosfomycin	MICG	PA164748039	352967	0.825
NULL	Mol_Cancer_2014_Jul_5_13_165.nxml.txt.nlp	24996221	SENT223	16	16	5	5	docetaxel	HMGB1	PA449383	3146	0.825
NULL	Cancer_Manag_Res_2011_May_10_3_157-175.nxml.txt.nlp	21625399	SENT54	15	15	24	24	tolbutamide	CYP3A4	PA451718	1576	0.825
NULL	Carcinogenesis_2011_Nov_1_32(11)_1724-1733.nxml.txt.nlp	21890461	SENT192	28	28	35	35	estradiol	BPA	PA449503	667	0.825
NULL	Case_Rep_Oncol_Med_2013_Nov_4_2013_625243.nxml.txt.nlp	24303221	SENT97	27	27	31	31	gefitinib	EGFR	PA131301952	1956	0.825
NULL	Biomed_Res_Int_2014_Jun_26_2014_483501.nxml.txt.nlp	25057490	SENT169	11	11	27	27	resveratrol	p53		7157	0.825
NULL	Nat_Med_2011_Aug_28_17(9)_1094-1100.nxml.txt.nlp	21873989	SENT25	1	1	16	16	imatinib	IFN	PA10804	3439	0.825
NULL	Front_Oncol_2013_Oct_9_3_261.nxml.txt.nlp	24130964	SENT259	25	25	7	7	decitabine	NY-ESO-1	PA164749631	1485	0.825
NULL	Mol_Biol_Cell_2012_Sep_1_23(17)_3357-3369.nxml.txt.nlp	22809628	SENT253	16	16	0	0	l-glutamine	PC3	PA10090	57332;7832;5122	0.825
NULL	Breast_Cancer_Res_2009_Jul_28_11(4)_R54.nxml.txt.nlp	19638208	SENT164	30	30	21	21	estradiol	aromatase	PA449503	1588	0.825
NULL	J_Neurosci_Rural_Pract_2010_Jul-Dec_1(2)_63-66.nxml.txt.nlp	21808505	SENT24	21	21	12	12	zalcitabine	gamma	PA451950	9913	0.825
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Feb_28_65(Pt_3)_o641.nxml.txt.nlp	21582290	SENT57	11	11	27	27	ethanol	mol	PA448073	90527	0.825
NULL	Br_J_Cancer_2012_Dec_4_107(12)_1950-1955.nxml.txt.nlp	23169295	SENT167	4	4	13	13	oxaliplatin	DPD	PA131285527	1806	0.825
NULL	Oncogene_2010_Sep_16_29(37)_5193-5203.nxml.txt.nlp	20581867	SENT127	8	8	25	25	lapatinib	HRG	PA152241907	3084;3273	0.825
NULL	Clin_Exp_Metastasis_2013_May_15_30(7)_867-876.nxml.txt.nlp	23673558	SENT191	21	21	7	7	vemurafenib	BRAF	PA165946873	673	0.825
NULL	J_Biomed_Biotechnol_2010_Mar_31_2010_159152.nxml.txt.nlp	20379363	SENT137	0	0	2	2	metformin	AMPK	PA450395	5563	0.825
NULL	J_Gen_Physiol_2008_Nov_132(5)_481-486.nxml.txt.nlp	18955590	SENT100	12	12	3	3	capsaicin	TRPV1	PA448776	7442	0.825
NULL	Nat_Biotechnol_2011_Aug_10_29(9)_824-828.nxml.txt.nlp	21832997	SENT231	13	13	32	32	choline	SOD1	PA448976	6647	0.825
NULL	Curr_Neuropharmacol_2014_Jul_12(4)_365-379.nxml.txt.nlp	25342944	SENT293	4	4	10	10	ethanol	S100B	PA448073	6285	0.825
NULL	Case_Rep_Hematol_2014_Feb_6_2014_806541.nxml.txt.nlp	24649385	SENT72	6	6	3	3	rituximab	AAT	PA451261	5265	0.825
NULL	Oncol_Lett_2014_Jan_1_7(1)_125-130.nxml.txt.nlp	24348833	SENT5	27	27	18	18	docetaxel	IFN	PA449383	3439	0.825
NULL	Angew_Chem_Int_Ed_Engl_2013_Jan_2_52(1)_325-330.nxml.txt.nlp	23080482	SENT30	1	1	26	26	thrombin	ACPP	PA451674	55	0.825
NULL	Br_J_Cancer_2010_Jan_5_102(1)_80-86.nxml.txt.nlp	19920817	SENT147	8	8	12	12	sunitinib	IFN	PA162372840	3439	0.825
NULL	Front_Neurosci_2011_Jul_26_5_92.nxml.txt.nlp	21845173	SENT106	35	35	11	11	ketorolac	NRM	PA450150	11270	0.825
NULL	Front_Chem_2014_Nov_26_2_105.nxml.txt.nlp	25505783	SENT214	17	17	9	9	alemtuzumab	HER2	PA164783958	2064	0.825
NULL	Acta_Pharmacol_Sin_2009_Sep_24_30(9)_1220-1226.nxml.txt.nlp	19701239	SENT12	7	7	41	41	cyclosporine	KCNQ4	PA449167	9132	0.825
NULL	BMB_Rep_2014_Apr_47(4)_221-226.nxml.txt.nlp	24286312	SENT75	12	12	17	17	nutlin-3	p53		7157	0.825
NULL	J_Med_Life_2011_Nov_14_4(4)_432-439.nxml.txt.nlp	22514580	SENT108	12	12	3	3	atazanavir	ATV	PA10251	4683	0.825
NULL	Arch_Med_Sci_2011_Jun_11_7(3)_388-396.nxml.txt.nlp	22312373	SENT147	12	12	15	15	simvastatin	CYP3A	PA451363	1574	0.825
NULL	Biomed_Res_Int_2013_Jul_31_2013_692071.nxml.txt.nlp	23984399	SENT4	35	35	15	15	metformin	OCT1	PA450395	5451;6580	0.825
NULL	Indian_J_Med_Res_2012_Sep_136(3)_391-403.nxml.txt.nlp	23041732	SENT190	12	12	35	35	sorafenib	HCC	PA7000	84668	0.825
NULL	J_Immunother_2014_Feb_21_37(2)_105-114.nxml.txt.nlp	24509173	SENT153	13	13	8	8	gemcitabine	WT1	PA449748	7490	0.825
NULL	Aging_(Albany_NY)_2011_Jan_18_3(1)_33-43.nxml.txt.nlp	21248371	SENT43	16	16	24	24	bleomycin	p53	PA448645	7157	0.825
NULL	Cell_Death_Dis_2014_Feb_13_5(2)_e1055.nxml.txt.nlp	24525731	SENT123	12	12	28	28	cisplatin	XRCC1	PA449014	7515	0.825
NULL	Arthritis_Res_Ther_2012_Apr_30_14(2)_R96.nxml.txt.nlp	22546471	SENT232	34	34	12	12	methotrexate	IL-6	PA450428	3569	0.825
NULL	Clin_Dev_Immunol_2013_Oct_1_2013_764395.nxml.txt.nlp	24194774	SENT250	3	3	12	12	terbutaline	IFN	PA451616	3439	0.825
NULL	Clin_Med_Insights_Oncol_2011_Sep_21_5_265-314.nxml.txt.nlp	22084619	SENT119	32	32	0	0	oxygen	HIF-1	PA450744	29072	0.825
NULL	Mol_Cell_Biochem_2015_Oct_8_398(1-2)_165-173.nxml.txt.nlp	25292312	SENT109	23	23	14	14	bortezomib	HIF-1	PA10252	29072	0.825
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_2_2014_659343.nxml.txt.nlp	25530786	SENT58	3	3	28	28	isoflurane	hole	PA450106	80757	0.825
NULL	Mol_Cancer_2012_Jul_25_11_47.nxml.txt.nlp	22830443	SENT145	23	23	40	40	panitumumab	EGFR	PA162373091	1956	0.825
NULL	Cell_Death_Differ_2010_Mar_16_17(3)_499-512.nxml.txt.nlp	19834490	SENT118	0	0	23	23	bevacizumab	VEGFR2	PA130232992	3791	0.825
NULL	Breast_Cancer_Res_2011_Apr_15_13(2)_R44.nxml.txt.nlp	21496232	SENT239	5	5	10	10	lapatinib	EGF	PA152241907	1950	0.825
NULL	Mol_Cell_Biochem_2014_Oct_9_385(1-2)_265-275.nxml.txt.nlp	24104452	SENT199	18	18	1	1	bortezomib	U87	PA10252	677775;641648	0.825
NULL	J_Breast_Cancer_2013_Jun_28_16(2)_133-137.nxml.txt.nlp	23843843	SENT33	18	18	33	33	curcumin	Bcl-2	PA151958596	596	0.825
NULL	Br_J_Cancer_1999_Feb_79(3-4)_509-514.nxml.txt.nlp	10027321	SENT12	23	23	8	8	marimastat	CEA	PA164748329	5670;1087	0.825
NULL	Cancer_Cell_Int_2014_Jun_13_14_51.nxml.txt.nlp	24959102	SENT38	17	17	15	15	celecoxib	5-LOX	PA448871	240	0.825
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT157	26	26	18	18	docetaxel	HER2	PA449383	2064	0.825
NULL	J_Cell_Biol_2005_Jul_4_170(1)_49-59.nxml.txt.nlp	15983061	SENT156	19	19	5	5	fluorescein	HIF1	PA164746009	3091	0.825
NULL	Cancer_Cell_Int_2009_Sep_12_9_26.nxml.txt.nlp	19747396	SENT146	8	8	2	2	warfarin	OPG	PA451906	690	0.825
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT135	39	39	25	25	atorvastatin	PI3K	PA448500	5290	0.825
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT148	16	16	13	13	nutlin-3	MDM2		4193	0.825
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Dec_10_3(12)_e151.nxml.txt.nlp	25494035	SENT71	28	28	30	30	rosuvastatin	OATP1B1	PA134308647	10599	0.824
NULL	Cardiovasc_Drugs_Ther_2011_Oct_2_25(5)_379-391.nxml.txt.nlp	21805404	SENT305	21	21	10	10	rosuvastatin	LOX-1	PA134308647	4973	0.824
NULL	Br_J_Cancer_2011_Jul_26_105(3)_372-381.nxml.txt.nlp	21730979	SENT104	3	3	17	17	cisplatin	p53	PA449014	7157	0.824
NULL	Cancers_(Basel)_2014_Nov_14_6(4)_2275-2295.nxml.txt.nlp	25405526	SENT201	17	17	25	25	cyclophosphamide	CHOP	PA449165	1649	0.824
NULL	Int_J_Breast_Cancer_2012_Feb_26_2012_761917.nxml.txt.nlp	22482061	SENT190	7	7	16	16	saracatinib	HER2		2064	0.824
NULL	J_Clin_Gastroenterol_2014_Sep_24_48(8)_679-686.nxml.txt.nlp	24921215	SENT237	15	15	8	8	ribavirin	IL28B	PA451241	282617	0.824
NULL	Front_Mol_Neurosci_2012_Nov_12_5_99.nxml.txt.nlp	23162427	SENT1399	18	18	11	11	cocaine	c-Jun	PA449072	3725	0.824
NULL	J_Invest_Dermatol_2012_Oct_24_132(10)_2440-2450.nxml.txt.nlp	22622430	SENT78	24	24	10	10	paclitaxel	IL-8	PA450761	3576	0.824
NULL	Pharmaceuticals_(Basel)_2011_Nov_11_4(11)_1503-1517.nxml.txt.nlp	NULL	SENT3	25	25	23	23	capsaicin	TRPV1	PA448776	7442	0.824
NULL	Int_J_Biol_Sci_2011_May_24_7(5)_673-684.nxml.txt.nlp	21647250	SENT137	4	4	12	12	berberine	AMPK	PA165860812	5563	0.824
NULL	JAKSTAT_2012_Jul_1_1(3)_197-199.nxml.txt.nlp	24058771	SENT59	7	7	17	17	fulvestrant	NF-kappaB	PA164747170	4790	0.824
NULL	Virol_J_2011_Nov_28_8_523.nxml.txt.nlp	22122911	SENT184	11	11	20	20	heparin	DARC	PA449855	2532	0.824
NULL	Diabetes_Care_2009_Feb_32(2)_e13-e19.nxml.txt.nlp	19171729	SENT68	7	7	2	2	acarbose	STOP	PA448010	4135	0.824
NULL	BMB_Rep_2014_Jan_47(1)_33-38.nxml.txt.nlp	24209634	SENT84	27	27	13	13	cisplatin	CXCR4	PA449014	7852	0.824
NULL	Oncol_Rep_2013_Mar_8_29(3)_917-924.nxml.txt.nlp	23314174	SENT154	11	11	20	20	sorafenib	CD24	PA7000	100133941	0.824
NULL	Biomed_Res_Int_2013_Aug_14_2013_275805.nxml.txt.nlp	24288671	SENT50	12	12	10	10	cyclophosphamide	CHOP	PA449165	1649	0.824
NULL	Biologics_2010_May_25_4_91-101.nxml.txt.nlp	20531964	SENT171	4	4	12	12	everolimus	VEGFR	PA164746311	3791	0.824
NULL	Front_Neural_Circuits_2014_Mar_25_8_27.nxml.txt.nlp	24723854	SENT157	14	14	31	31	diazepam	BIC	PA449283	114614	0.824
NULL	Diabetes_Care_2012_Feb_16_35(2)_327-333.nxml.txt.nlp	22179958	SENT114	5	5	16	16	metformin	B12	PA450395	7126;4709	0.824
NULL	FASEB_J_2011_Apr_25(4)_1133-1144.nxml.txt.nlp	21163859	SENT274	12	12	14	14	imipramine	ASM	PA449969	6609;283120	0.824
NULL	J_Mol_Med_(Berl)_2014_May_10_92(7)_709-722.nxml.txt.nlp	24811491	SENT229	9	9	28	28	leucovorin	BRAF	PA450198	673	0.824
NULL	Clin_Dev_Immunol_2013_Sep_17_2013_791262.nxml.txt.nlp	24151519	SENT176	0	0	25	25	heparin	TLR2	PA449855	7097	0.824
NULL	Curr_Hematol_Malig_Rep_2012_Sep_27_7(3)_235-240.nxml.txt.nlp	22538464	SENT33	21	21	12	12	vindesine	CHOP	PA10232	1649	0.824
NULL	Breast_Cancer_Res_2008_Mar_17_10(2)_204.nxml.txt.nlp	18373885	SENT128	17	17	0	0	thrombin	PAR-1	PA451674	2011;2149	0.824
NULL	Acta_Pharmacol_Sin_2011_Oct_12_32(10)_1259-1265.nxml.txt.nlp	21909126	SENT128	11	11	18	18	fluvastatin	MCP-1	PA449688	6347	0.824
NULL	Br_J_Anaesth_2011_Oct_17_107(4)_490-502.nxml.txt.nlp	21852280	SENT49	4	4	2	2	capsaicin	TRPV1	PA448776	7442	0.824
NULL	Mol_Cancer_2010_Aug_20_9_220.nxml.txt.nlp	20727180	SENT145	13	13	35	35	nicotine	p53	PA450626	7157	0.824
NULL	J_Clin_Biochem_Nutr_2011_Mar_26_48(2)_154-160.nxml.txt.nlp	21373269	SENT11	21	21	3	3	dextran	TBK1	PA449261	29110	0.824
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT236	27	27	2	2	metformin	LKB1	PA450395	6794	0.824
NULL	Int_J_Biol_Sci_2014_Jan_11_10(2)_142-148.nxml.txt.nlp	24520212	SENT115	8	8	4	4	tamoxifen	WWOX	PA451581	51741	0.824
NULL	J_Biol_Eng_2009_Oct_16_3_18.nxml.txt.nlp	19835592	SENT50	0	0	17	17	tetracycline	CPZ	PA451640	8532	0.824
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_3_2012_908562.nxml.txt.nlp	23082087	SENT149	0	0	19	19	hesperidin	IL-5	PA449867	3567	0.824
NULL	Br_J_Pharmacol_2008_Dec_25_155(7)_1056-1065.nxml.txt.nlp	18724386	SENT254	28	28	45	45	nitrendipine	GLP-1	PA146096020	100125288	0.824
NULL	Br_J_Pharmacol_2011_Apr_162(8)_1832-1842.nxml.txt.nlp	21232033	SENT156	5	5	3	3	resveratrol	SIRT1		23411	0.824
NULL	J_Cell_Mol_Med_2014_Sep_7_18(9)_1785-1796.nxml.txt.nlp	24909956	SENT244	3	3	29	29	cangrelor	CD44	PA165945763	960	0.824
NULL	Autophagy_2013_Mar_1_9(3)_287-302.nxml.txt.nlp	23221969	SENT436	8	8	20	20	fulvestrant	BCL2	PA164747170	596	0.824
NULL	Ann_Rheum_Dis_2010_Jun_1_69(6)_1158-1161.nxml.txt.nlp	20439295	SENT27	11	11	38	38	rituximab	San	PA451261	80218	0.824
NULL	Diabetes_Care_2013_Aug_17_36(Suppl_2)_S162-S174.nxml.txt.nlp	23882042	SENT336	8	8	15	15	pioglitazone	Met	PA450970	79811	0.824
NULL	Oncotarget_2014_Jun_27_5(13)_4694-4708.nxml.txt.nlp	25051361	SENT136	15	15	6	6	fludarabine	MEC1	PA449655	545	0.824
NULL	Cancer_Cell_Int_2010_Apr_29_10_12.nxml.txt.nlp	20429927	SENT118	14	14	3	3	arsenite	HRI	PA452638	27102	0.824
NULL	J_Ayurveda_Integr_Med_2010_Oct-Dec_1(4)_257-265.nxml.txt.nlp	21731372	SENT183	14	14	19	19	curcumin	IL-6	PA151958596	3569	0.824
NULL	Front_Pharmacol_2014_Dec_2_5_252.nxml.txt.nlp	25520658	SENT1609	21	21	14	14	vemurafenib	FGFR3	PA165946873	2261	0.824
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT120	1	1	27	27	curcumin	TRAIL	PA151958596	8743	0.824
NULL	Oncotarget_2013_Oct_19_4(11)_2045-2056.nxml.txt.nlp	24185104	SENT68	7	7	3	3	cisplatin	14-3-3	PA449014	10971	0.824
NULL	J_Cell_Biol_1988_Mar_1_106(3)_797-803.nxml.txt.nlp	3279054	SENT6	3	3	15	15	creatine	EGF	PA164778930	1950	0.824
NULL	Acta_Pharmacol_Sin_2012_Jul_18_33(7)_861-872.nxml.txt.nlp	22705730	SENT112	35	35	26	26	atorvastatin	PDK1	PA448500	5170;5163	0.824
NULL	Evid_Based_Complement_Alternat_Med_2013_Mar_28_2013_514908.nxml.txt.nlp	23606881	SENT518	2	2	15	15	scopolamine	BMX	PA451308	660	0.824
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT287	24	24	17	17	ranibizumab	VEGF-A	PA164746012	7422	0.824
NULL	Crit_Care_2010_Mar_15_14(2)_R30.nxml.txt.nlp	20226064	SENT271	36	36	1	1	fentanyl	IFN	PA449599	3439	0.824
NULL	J_Biomed_Sci_2012_Nov_21_19(1)_99.nxml.txt.nlp	23170833	SENT165	34	34	17	17	atorvastatin	CXCR4	PA448500	7852	0.824
NULL	Mar_Drugs_2009_Jul_17_7(3)_331-340.nxml.txt.nlp	19841717	SENT44	12	12	14	14	trabectedin	FDG	PA165958349	23583	0.824
NULL	Cell_Cycle_2012_Nov_1_11(21)_3983-3996.nxml.txt.nlp	22987153	SENT182	16	16	0	0	mitomycin	DNA2	PA450524	1763	0.824
NULL	Ann_Oncol_2011_Dec_17_22(12)_2610-2615.nxml.txt.nlp	21415234	SENT185	21	21	5	5	lapatinib	EGFR	PA152241907	1956	0.824
NULL	Br_J_Pharmacol_2012_Apr_165(8)_2611-2619.nxml.txt.nlp	21718301	SENT202	33	33	16	16	rimonabant	GPR55	PA152407999	9290	0.824
NULL	Mol_Vis_2012_Apr_11_18_901-908.nxml.txt.nlp	22539869	SENT200	3	3	7	7	curcumin	HO-1	PA151958596	3162	0.824
NULL	Cell_Commun_Signal_2013_Nov_11_11_86.nxml.txt.nlp	24215724	SENT307	9	9	6	6	thrombin	P2Y12	PA451674	64805	0.824
NULL	Int_J_Mol_Sci_2014_Oct_24_15(11)_19406-19416.nxml.txt.nlp	25347278	SENT381	8	8	14	14	ethanol	AUTS2	PA448073	26053	0.824
NULL	Clinics_(Sao_Paulo)_2014_Jan_69(1)_68-74.nxml.txt.nlp	24473562	SENT89	14	14	20	20	nutlin-3	p53		7157	0.824
NULL	Front_Oncol_2013_Nov_15_3_281.nxml.txt.nlp	24298448	SENT193	18	18	38	38	fluorouracil	KRAS	PA128406956	3845	0.824
NULL	Mol_Brain_2013_Feb_12_6_8.nxml.txt.nlp	23402298	SENT293	31	31	25	25	fentanyl	ABCB1	PA449599	5243	0.824
NULL	Oncotarget_2014_Aug_19_5(18)_8737-8749.nxml.txt.nlp	25228590	SENT85	14	14	34	34	crizotinib	MYCN	PA165946122	4613	0.824
NULL	Cancer_Immunol_Immunother_2013_Aug_27_62(10)_1637-1648.nxml.txt.nlp	23982484	SENT127	33	33	14	14	lenalidomide	IL-6	PA162363968	3569	0.824
NULL	Clin_Med_Insights_Cardiol_2010_Dec_1_4_117-128.nxml.txt.nlp	21151850	SENT38	23	23	18	18	clopidogrel	ADP	PA449053	23038	0.824
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1522-1532.nxml.txt.nlp	21997136	SENT248	26	26	15	15	lapatinib	p53	PA152241907	7157	0.824
NULL	Open_Neurol_J_2013_May_31_7_23-31.nxml.txt.nlp	23894259	SENT33	27	27	15	15	sertindole	FGA	PA164784002	2243	0.824
NULL	Nat_Commun_2014_Dec_18_5_5815.nxml.txt.nlp	25519973	SENT30	7	7	4	4	tranylcypromine	LSD1	PA451741	23028	0.824
NULL	Curr_Med_Chem_2014_May_21(14)_1595-1606.nxml.txt.nlp	23992330	SENT175	26	26	37	37	sunitinib	IL-8	PA162372840	3576	0.824
NULL	Case_Rep_Oncol_2013_Jul_20_6(2)_382-386.nxml.txt.nlp	23904849	SENT15	3	3	14	14	cetuximab	EGFR	PA10040	1956	0.824
NULL	Arthritis_Res_Ther_2007_Sep_23_9(5)_R96.nxml.txt.nlp	17888176	SENT134	27	27	7	7	etanercept	OPG	PA449515	690	0.824
NULL	Pharm_Pract_(Granada)_2011_Mar_15_Jan-Mar_9(1)_1-10.nxml.txt.nlp	25132883	SENT146	9	9	19	19	enoxaparin	SPAF	PA449463	166378	0.824
NULL	Case_Rep_Oncol_2010_May_7_3(2)_154-159.nxml.txt.nlp	20740189	SENT16	0	0	16	16	panitumumab	KRAS	PA162373091	3845	0.824
NULL	Int_J_Endocrinol_2010_Mar_2_2010_621687.nxml.txt.nlp	20204178	SENT100	1	1	10	10	paricalcitol	PTH	PA450798	5741	0.824
NULL	Bone_Marrow_Res_2011_Sep_21_2011_976793.nxml.txt.nlp	22046574	SENT57	7	7	16	16	abatacept	CD28	PA164747080	1493;940	0.824
NULL	Bioeng_Bugs_2012_May_1_3(3)_147-156.nxml.txt.nlp	22572786	SENT72	13	13	4	4	ethanol	GPD	PA448073	2532	0.824
NULL	Breast_Cancer_Res_2007_Jan_23_9(1)_R7.nxml.txt.nlp	17244352	SENT201	19	19	14	14	tamoxifen	CYP2D6	PA451581	1565	0.824
NULL	Int_J_Mol_Sci_2014_Oct_6_15(10)_17886-17900.nxml.txt.nlp	25290095	SENT109	27	27	11	11	resveratrol	p38		10598;1432;7965	0.824
NULL	J_Ophthalmol_2011_Oct_20_2011_252549.nxml.txt.nlp	22046503	SENT114	8	8	30	30	ranibizumab	FZD4	PA164746012	8322	0.824
NULL	ScientificWorldJournal_2013_Apr_24_2013_928197.nxml.txt.nlp	23737732	SENT100	3	3	12	12	pioglitazone	ACR	PA450970	49	0.824
NULL	Mol_Cancer_2010_May_17_9_108.nxml.txt.nlp	20478051	SENT19	6	6	1	1	deferoxamine	HIF-1	PA164746490	29072	0.824
NULL	Oncotarget_2012_Sep_28_3(10)_1169-1181.nxml.txt.nlp	23045411	SENT6	15	15	3	3	doxorubicin	JNK	PA449412	5599	0.824
NULL	Diabetes_Care_2013_Mar_13_36(3)_498-504.nxml.txt.nlp	23139373	SENT22	0	0	4	4	exenatide	GLP-1	PA164749238	100125288	0.824
NULL	J_Korean_Med_Sci_2011_Dec_29_26(12)_1556-1562.nxml.txt.nlp	22147991	SENT95	25	25	23	23	rituximab	CHOP	PA451261	1649	0.824
NULL	Mol_Cell_Biol_2013_Oct_33(20)_4041-4050.nxml.txt.nlp	23959798	SENT149	0	0	8	8	hydroxyurea	CTR1	PA449942	1317	0.824
NULL	Oncotarget_2014_Jun_11_5(21)_10407-10420.nxml.txt.nlp	25431951	SENT206	27	27	34	34	imatinib	EGFR	PA10804	1956	0.824
NULL	Lab_Invest_2011_Apr_14_91(4)_598-608.nxml.txt.nlp	21321535	SENT127	6	6	16	16	sorafenib	CD25	PA7000	3669;3559	0.824
NULL	Br_J_Cancer_2011_Jun_28_105(1)_53-57.nxml.txt.nlp	21654688	SENT129	8	8	20	20	irinotecan	UGT1A1	PA450085	54658	0.824
NULL	Braz_J_Med_Biol_Res_2012_Feb_17_45(3)_244-249.nxml.txt.nlp	22331137	SENT34	20	20	13	13	cisplatin	PAG	PA449014	55824	0.824
NULL	Thorax_2012_Mar_28_67(3)_229-237.nxml.txt.nlp	21957094	SENT215	12	12	5	5	carbachol	RhoA	PA448784	387	0.824
NULL	Br_J_Cancer_2010_Jan_5_102(1)_80-86.nxml.txt.nlp	19920817	SENT107	25	25	29	29	bevacizumab	IFN	PA130232992	3439	0.824
NULL	Nat_Commun_2014_Nov_25_5_5548.nxml.txt.nlp	25420520	SENT46	12	12	6	6	cabazitaxel	ERG	PA165958401	2078	0.824
NULL	J_Hematol_Oncol_2008_Oct_23_1_19.nxml.txt.nlp	18947412	SENT115	40	40	24	24	alemtuzumab	TPO	PA164783958	7066;7173	0.824
NULL	Alcohol_Res_2013_35(1)_77-85.nxml.txt.nlp	24313167	SENT98	6	6	35	35	ethanol	NANOG	PA448073	79923	0.824
NULL	Diabetes_Care_2013_Jul_12_36(7)_e92-e93.nxml.txt.nlp	23801816	SENT25	7	7	10	10	cilostazol	SMAP	PA164746334	22920;10944;10902	0.824
NULL	Nucleic_Acids_Res_2011_Sep_7_39(17)_7465-7476.nxml.txt.nlp	21653549	SENT182	3	3	5	5	etoposide	DEK	PA449552	7913	0.824
NULL	Semin_Immunopathol_2013_Jan_26_35(1)_39-52.nxml.txt.nlp	22829332	SENT197	5	5	30	30	vinblastine	CHOP	PA451877	1649	0.824
NULL	J_Exp_Clin_Cancer_Res_2009_Feb_15_28(1)_19.nxml.txt.nlp	19216799	SENT138	22	22	7	7	cisplatin	AEG-1	PA449014	92140	0.824
NULL	Cell_Death_Dis_2014_Jan_30_5(1)_e1038.nxml.txt.nlp	24481452	SENT70	7	7	22	22	raloxifene	ARNT	PA451221	405	0.824
NULL	Front_Microbiol_2014_Nov_19_5_631.nxml.txt.nlp	25477872	SENT102	19	19	22	22	flunitrazepam	TSPO	PA164781320	706	0.824
NULL	Breast_Cancer_Res_2011_Mar_14_13(2)_205.nxml.txt.nlp	21457526	SENT33	12	12	2	2	anastrozole	ATAC	PA448432	6375	0.824
NULL	Autophagy_2013_Apr_1_9(4)_609-611.nxml.txt.nlp	23328265	SENT13	13	13	3	3	l-cysteine	DES1	PA449173	8560	0.824
NULL	Folia_Microbiol_(Praha)_2014_Aug_16_59(6)_543-552.nxml.txt.nlp	25128200	SENT170	16	16	7	7	daptomycin	TDO	PA164768820	6999	0.824
NULL	Diabetes_2013_Oct_17_62(10)_3547-3552.nxml.txt.nlp	23863812	SENT61	9	9	16	16	valsartan	ANOVA	PA451848	4858	0.824
NULL	Springerplus_2014_Sep_9_3_510.nxml.txt.nlp	25279302	SENT216	25	25	29	29	creatine	GAMT	PA164778930	2593	0.824
NULL	Front_Neurosci_2014_Jan_10_7_270.nxml.txt.nlp	24454277	SENT14	0	0	3	3	resveratrol	SIRT1		23411	0.824
NULL	Acta_Pharmacol_Sin_2011_Jul_13_32(7)_967-972.nxml.txt.nlp	21666702	SENT147	21	21	36	36	losartan	CYP2C9	PA450268	1559	0.824
NULL	Int_J_Mol_Sci_2014_Jun_23_15(6)_11190-11203.nxml.txt.nlp	24960362	SENT24	0	0	3	3	resveratrol	AMPK		5563	0.824
NULL	eLife_2014_Nov_21_3_e03641.nxml.txt.nlp	25415239	SENT199	3	3	9	9	doxycycline	MLYCD	PA449415	23417	0.824
NULL	Biomed_Res_Int_2014_Jun_24_2014_132702.nxml.txt.nlp	25050322	SENT168	27	27	23	23	metformin	AMPK	PA450395	5563	0.824
NULL	Mol_Cancer_2014_Jun_27_13_159.nxml.txt.nlp	24972933	SENT164	22	22	24	24	gemcitabine	Gem	PA449748	51053	0.824
NULL	Case_Rep_Oncol_2009_May_9_2(2)_77-83.nxml.txt.nlp	20740167	SENT69	7	7	26	26	vinorelbine	HER-2	PA451881	2064	0.824
NULL	Ann_Gastroenterol_2013_26(1)_29-36.nxml.txt.nlp	24714698	SENT150	0	0	20	20	sunitinib	VEGFR	PA162372840	3791	0.824
NULL	Angiogenesis_2012_Dec_28_15(4)_623-641.nxml.txt.nlp	22843200	SENT168	24	24	28	28	sunitinib	CD31	PA162372840	5175	0.824
NULL	Spine_(Phila_Pa_1976)_2013_Nov_15_38(24)_2079-2084.nxml.txt.nlp	24026150	SENT62	18	18	4	4	paraformaldehyde	E16	PA450790	8140	0.824
NULL	Br_J_Cancer_2011_Apr_12_104(8)_1256-1261.nxml.txt.nlp	21448165	SENT120	21	21	40	40	sorafenib	IL-2	PA7000	3558	0.824
NULL	Br_J_Pharmacol_2014_May_171(10)_2659-2670.nxml.txt.nlp	24116661	SENT227	19	19	14	14	naringenin	TRPP2	PA151958361	5311	0.824
NULL	Cell_Death_Dis_2014_Jul_17_5(7)_e1338.nxml.txt.nlp	25032861	SENT112	15	15	22	22	pp2	Mcl-1		4170	0.824
NULL	Cancer_Cell_Int_2005_Jul_29_5_24.nxml.txt.nlp	16053526	SENT127	6	6	25	25	estradiol	beta-catenin	PA449503	1499	0.824
NULL	Hum_Genomics_2010_Oct_1_5(1)_61-72.nxml.txt.nlp	21106490	SENT60	12	12	17	17	midazolam	CYP3A	PA450496	1574	0.824
NULL	J_Cell_Mol_Med_2014_Sep_7_18(9)_1785-1796.nxml.txt.nlp	24909956	SENT244	3	3	13	13	cangrelor	GPR17	PA165945763	2840	0.824
NULL	Clin_Infect_Dis_2011_Jan_1_52(1)_31-40.nxml.txt.nlp	21148517	SENT28	16	16	27	27	vancomycin	HAP	PA451850	5915;10313	0.824
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Dec_17_3(12)_e152.nxml.txt.nlp	25518025	SENT48	15	15	6	6	itraconazole	CYP2D6	PA450132	1565	0.824
NULL	Br_J_Cancer_2003_Mar_10_88(5)_754-759.nxml.txt.nlp	12618886	SENT153	16	16	24	24	amifostine	p53	PA448365	7157	0.824
NULL	N_Am_J_Med_Sci_2013_Jun_5(6)_386-391.nxml.txt.nlp	23923114	SENT25	5	5	8	8	vemurafenib	BRAF	PA165946873	673	0.824
NULL	Hum_Genomics_2009_Jan_1_3(2)_128-142.nxml.txt.nlp	19164090	SENT193	20	20	12	12	carboplatin	CD44	PA448803	960	0.824
NULL	J_Cell_Biol_1998_Nov_16_143(4)_1003-1012.nxml.txt.nlp	9817757	SENT121	19	19	4	4	gentamicin	IFN	PA449753	3439	0.824
NULL	Iran_J_Pharm_Res_2014_Autumn_13(4)_1393-1401.nxml.txt.nlp	25587329	SENT11	5	5	7	7	celecoxib	ABCG2	PA448871	9429	0.824
NULL	Open_Cardiovasc_Med_J_2014_Feb_7_8_12-17.nxml.txt.nlp	24653785	SENT134	5	5	10	10	simvastatin	CYP3A5	PA451363	1577	0.824
NULL	Mol_Cancer_2014_Jul_5_13_165.nxml.txt.nlp	24996221	SENT124	23	23	10	10	docetaxel	HMGB1	PA449383	3146	0.824
NULL	Kidney_Int_Suppl_(2011)_2013_Dec_27_3(4)_392-409.nxml.txt.nlp	NULL	SENT644	11	11	2	2	cisplatin	OCT1	PA449014	5451;6580	0.824
NULL	Br_J_Cancer_2012_Jan_3_106(1)_107-115.nxml.txt.nlp	22116303	SENT107	12	12	6	6	vorinostat	AKT	PA164748224	207	0.824
NULL	J_Cell_Biol_2004_Apr_12_165(1)_77-86.nxml.txt.nlp	15067018	SENT52	32	32	10	10	collagenase	AP-1	PA449107	2353;3727;2354;3725	0.824
NULL	Acta_Neuropathol_2010_Aug_8_120(2)_223-236.nxml.txt.nlp	20532539	SENT52	1	1	17	17	isoflurane	hole	PA450106	80757	0.824
NULL	Nucleic_Acids_Res_2011_Sep_17_39(16)_e107.nxml.txt.nlp	21685448	SENT94	20	20	2	2	neomycin	AAVS1	PA450608	17	0.824
NULL	Arthritis_Res_Ther_2003_Jan_20_5(2)_68-75.nxml.txt.nlp	12718746	SENT268	3	3	6	6	imiquimod	IFN	PA449972	3439	0.824
NULL	Acta_Pharmacol_Sin_2014_Jun_5_35(6)_727-737.nxml.txt.nlp	24793312	SENT15	34	34	39	39	telmisartan	B27	PA451605	56246	0.824
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT110	17	17	28	28	curcumin	cIAP1	PA151958596	329	0.824
NULL	Oncol_Lett_2014_May_26_7(5)_1345-1351.nxml.txt.nlp	24765136	SENT170	4	4	11	11	sorafenib	Mcl-1	PA7000	4170	0.824
NULL	Oncogenesis_2012_Apr_2_1(4)_e5.nxml.txt.nlp	23552603	SENT568	40	40	6	6	celecoxib	Bcl-2	PA448871	596	0.824
NULL	Breast_Cancer_Res_2010_Jun_28_12(3)_R43.nxml.txt.nlp	20579400	SENT265	12	12	4	4	fulvestrant	MAPT	PA164747170	4137	0.824
NULL	J_Korean_Med_Sci_2013_Feb_29_28(2)_308-314.nxml.txt.nlp	23399960	SENT149	21	21	26	26	gabapentin	IL-10	PA449720	3586	0.824
NULL	Cancers_(Basel)_2014_Mar_13_6(1)_580-594.nxml.txt.nlp	24633083	SENT116	37	37	21	21	propranolol	p53	PA451145	7157	0.824
NULL	EMBO_Mol_Med_2012_Jun_13_4(6)_515-527.nxml.txt.nlp	22416035	SENT45	39	39	3	3	olaparib	p53		7157	0.824
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT18	4	4	15	15	tacrolimus	STAT3	PA451578	6774	0.824
NULL	Clin_Med_Insights_Oncol_2012_Apr_3_6_179-187.nxml.txt.nlp	22518088	SENT66	26	26	18	18	pertuzumab	HER2		2064	0.824
NULL	Arthritis_Res_Ther_2014_Sep_18_16(5)_427.nxml.txt.nlp	25230745	SENT271	1	1	5	5	bevacizumab	IL1B	PA130232992	3553	0.824
NULL	Cancer_Cell_Int_2010_May_11_10_16.nxml.txt.nlp	20459793	SENT87	6	6	23	23	cisplatin	ABCC5	PA449014	10057	0.824
NULL	Am_J_Physiol_Endocrinol_Metab_2013_Nov_1_305(9)_E1134-E1144.nxml.txt.nlp	24022868	SENT9	36	36	30	30	glucose	HSD1	PA449773	26871	0.824
NULL	Hum_Genomics_2008_Sep_1_3(1)_7-16.nxml.txt.nlp	19129086	SENT195	15	15	12	12	fluvoxamine	CYP2C8	PA449690	1558	0.824
NULL	Acta_Pharmacol_Sin_2014_Sep_4_35(9)_1157-1166.nxml.txt.nlp	25088002	SENT124	4	4	12	12	curcumin	STAT3	PA151958596	6774	0.824
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT8	26	26	20	20	heparin	FGF1	PA449855	2246	0.824
NULL	J_Vis_Exp_2010_Aug_1_(42)_2036.nxml.txt.nlp	20729802	SENT33	16	16	25	25	collagenase	CO2	PA449107	4513	0.824
NULL	Indian_J_Endocrinol_Metab_2013_Jan-Feb_17(1)_69-75.nxml.txt.nlp	23776855	SENT28	24	24	11	11	ribavirin	IFN	PA451241	3439	0.824
NULL	Nat_Chem_Biol_2010_Apr_28_6(4)_291-299.nxml.txt.nlp	20190765	SENT146	7	7	20	20	dasatinib	EGFR	PA162372878	1956	0.824
NULL	Oncol_Lett_2013_Mar_8_5(3)_805-812.nxml.txt.nlp	23426281	SENT168	22	22	8	8	gemcitabine	B7-H3	PA449748	80381	0.824
NULL	Tumour_Biol_2014_Mar_12_35(3)_2053-2062.nxml.txt.nlp	24122205	SENT74	47	47	3	3	ethanol	CD44	PA448073	960	0.824
NULL	Cell_Death_Dis_2014_Feb_27_5(2)_e1086.nxml.txt.nlp	24577084	SENT169	6	6	10	10	doxycycline	MLKL	PA449415	197259	0.824
NULL	Nutr_J_2014_Feb_14_13_17.nxml.txt.nlp	24524207	SENT143	34	34	43	43	lipase	CD36	PA450239	948	0.824
NULL	Blood_Press_Monit_2014_Jun_9_19(3)_123-128.nxml.txt.nlp	24637789	SENT132	16	16	7	7	amlodipine	ACS1	PA448388	2180	0.824
NULL	J_Korean_Med_Sci_2007_Apr_30_22(2)_235-241.nxml.txt.nlp	17449930	SENT23	6	6	22	22	fenofibrate	FAT	PA449594	948	0.824
NULL	J_Thromb_Haemost_2014_May_22_12(5)_748-760.nxml.txt.nlp	24612393	SENT24	4	4	30	30	thrombin	PI3	PA451674	5266	0.824
NULL	J_Exp_Clin_Cancer_Res_2009_Feb_13_28(1)_17.nxml.txt.nlp	19216775	SENT191	16	16	24	24	cisplatin	TP53	PA449014	7157	0.824
NULL	Front_Immunol_2014_Aug_11_5_361.nxml.txt.nlp	25157249	SENT329	10	10	23	23	heparin	IL-17	PA449855	3605	0.824
NULL	Clin_Interv_Aging_2014_Nov_18_9_1963-1980.nxml.txt.nlp	25429208	SENT140	2	2	4	4	pioglitazone	DPP4	PA450970	1803	0.824
NULL	Front_Neurosci_2014_Nov_10_8_364.nxml.txt.nlp	25426018	SENT261	30	30	2	2	dextran	ANOVA	PA449261	4858	0.824
NULL	Front_Oncol_2014_Apr_9_4_75.nxml.txt.nlp	24782986	SENT209	37	37	25	25	paclitaxel	CXCR4	PA450761	7852	0.824
NULL	Mol_Cancer_2012_Dec_12_11_91.nxml.txt.nlp	23234355	SENT74	4	4	12	12	erlotinib	HER2	PA134687924	2064	0.824
NULL	J_Cardiovasc_Dis_Res_2012_Jan-Mar_3(1)_5-11.nxml.txt.nlp	22346138	SENT111	6	6	18	18	glimepiride	IL-6	PA449761	3569	0.824
NULL	J_Korean_Med_Sci_2010_Nov_26_25(11)_1626-1632.nxml.txt.nlp	21060752	SENT118	8	8	10	10	forskolin	JNK	PA146096022	5599	0.824
NULL	J_Hematol_Oncol_2013_Jul_18_6_53.nxml.txt.nlp	23866964	SENT116	14	14	16	16	bortezomib	BOR	PA10252	55143	0.824
NULL	Drug_Saf_2014_Feb_19_37(4)_201-211.nxml.txt.nlp	24550106	SENT86	18	18	12	12	omeprazole	CYP2C19	PA450704	1557	0.824
NULL	Mol_Cells_2014_Sep_30_37(9)_664-671.nxml.txt.nlp	25234467	SENT43	14	14	11	11	cisplatin	miR-217	PA449014	406999	0.824
NULL	Mucosal_Immunol_2014_May_13_7(3)_730-740.nxml.txt.nlp	24220298	SENT57	7	7	27	27	papain	DR3	PA450778	8718	0.824
NULL	EMBO_Rep_2013_Jan_30_14(1)_49-56.nxml.txt.nlp	23196367	SENT28	18	18	34	34	varenicline	5-HT3R	PA164781343	3359	0.824
NULL	Clin_Interv_Aging_2012_Sep_13_7_351-361.nxml.txt.nlp	23049247	SENT122	7	7	5	5	letrozole	aromatase	PA450196	1588	0.824
NULL	J_Headache_Pain_2011_Feb_23_12(1)_81-88.nxml.txt.nlp	20862509	SENT143	12	12	16	16	rizatriptan	5-HT1D	PA451264	3352	0.824
NULL	J_Nutr_Metab_2011_Oct_1_2011_525094.nxml.txt.nlp	21977315	SENT5	3	3	19	19	resveratrol	SIRT1		23411	0.824
NULL	J_Vet_Med_Sci_2014_Jun_27_76(6)_847-853.nxml.txt.nlp	24572631	SENT75	10	10	2	2	sevoflurane	ANOVA	PA451341	4858	0.824
NULL	Alcohol_Res_Health_2011_34(1)_76-85.nxml.txt.nlp	23580044	SENT189	0	0	28	28	ethanol	L1CAM	PA448073	3897	0.824
NULL	Chemother_Res_Pract_2012_Dec_20_2012_743193.nxml.txt.nlp	23320171	SENT119	3	3	12	12	lapatinib	HER2	PA152241907	2064	0.824
NULL	Hum_Mol_Genet_2014_Apr_15_23(8)_2055-2077.nxml.txt.nlp	24282027	SENT251	29	29	9	9	galactose	LRRK2	PA449725	120892	0.824
NULL	J_Lipid_Res_2014_Oct_55(10)_2103-2112.nxml.txt.nlp	25139399	SENT613	2	2	12	12	atorvastatin	APOE	PA448500	348	0.824
NULL	Adv_Hematol_2012_Aug_2_2012_842945.nxml.txt.nlp	22919394	SENT112	6	6	21	21	lenalidomide	IL-2	PA162363968	3558	0.824
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_39-54.nxml.txt.nlp	19305787	SENT215	3	3	11	11	ethanol	NR1	PA448073	27158	0.824
NULL	Br_J_Pharmacol_2011_Mar_162(5)_1029-1044.nxml.txt.nlp	20958290	SENT184	26	26	9	9	carbachol	NMS	PA448784	129521	0.824
NULL	Diabetes_2011_Nov_17_60(11)_2691-2700.nxml.txt.nlp	21896928	SENT130	14	14	11	11	resveratrol	CTRL		1506	0.824
NULL	J_Nat_Prod_2011_Apr_25_74(4)_567-573.nxml.txt.nlp	21348461	SENT53	3	3	9	9	verapamil	MDR1	PA451868	5243	0.824
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT224	5	5	35	35	atorvastatin	RANKL	PA448500	8600	0.824
NULL	Int_J_Mol_Sci_2013_Aug_15_14(8)_16836-16850.nxml.txt.nlp	23955267	SENT174	10	10	16	16	trastuzumab	HER2	PA451743	2064	0.824
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2675-2684.nxml.txt.nlp	24129246	SENT198	37	37	33	33	etoposide	KSR1	PA449552	8844	0.824
NULL	Nat_Commun_2011_Jul_19_2_402.nxml.txt.nlp	21772273	SENT173	15	15	2	2	doxorubicin	CHK2	PA449412	11200	0.824
NULL	Int_J_Mol_Sci_2012_Feb_1_13(2)_1512-1523.nxml.txt.nlp	22408405	SENT145	11	11	15	15	olmesartan	LOX-1	PA164742950	4973	0.824
NULL	Front_Oncol_2014_Sep_29_4_256.nxml.txt.nlp	25325013	SENT59	7	7	22	22	afatinib	EGFR	PA165981154	1956	0.824
NULL	Biomed_Res_Int_2013_Jun_19_2013_230805.nxml.txt.nlp	23862137	SENT227	33	33	42	42	bortezomib	IL-10	PA10252	3586	0.824
NULL	Trials_2013_Nov_29_14(Suppl_1)_O77.nxml.txt.nlp	NULL	SENT5	14	14	16	16	rituximab	CHOP	PA451261	1649	0.824
NULL	Arq_Bras_Cardiol_2013_Nov_101(5)_379-387.nxml.txt.nlp	24100691	SENT33	26	26	22	22	everolimus	DES	PA164746311	1674	0.824
NULL	Oncotarget_2011_Sep_9_2(9)_658-668.nxml.txt.nlp	21911919	SENT55	22	22	6	6	daunorubicin	HO-1	PA449212	3162	0.824
NULL	J_Gen_Physiol_1997_Feb_1_109(2)_229-243.nxml.txt.nlp	9041451	SENT15	10	10	34	34	spermine	IRK1	PA164781199	3759	0.824
NULL	Pharmaceuticals_(Basel)_2012_Jun_28_5(7)_674-689.nxml.txt.nlp	24281706	SENT34	5	5	17	17	pertuzumab	EGFR		1956	0.824
NULL	Mediators_Inflamm_1999_8(3)_147-151.nxml.txt.nlp	10704052	SENT2	28	28	5	5	chymotrypsin	SLPI	PA448994	6590	0.824
NULL	Cancer_Microenviron_2009_Sep_26_2(Suppl_1)_19-204.nxml.txt.nlp	NULL	SENT703	18	18	0	0	etoposide	IL-6	PA449552	3569	0.824
NULL	Endocrinol_Diabetes_Metab_Case_Rep_2014_Mar_1_2014_140001.nxml.txt.nlp	24683487	SENT54	13	13	6	6	cabergoline	ACTH	PA448708	5443	0.824
NULL	Vet_Res_2013_Oct_2_44(1)_89.nxml.txt.nlp	24088531	SENT260	6	6	11	11	hemin	HO-1	PA449849	3162	0.824
NULL	Med_Sci_Monit_2013_Dec_23_19_1195-1210.nxml.txt.nlp	24362017	SENT175	6	6	20	20	vasopressin	AQP2	PA451858	359	0.824
NULL	Anticancer_Agents_Med_Chem_2012_Feb_12(2)_163-171.nxml.txt.nlp	22043994	SENT183	17	17	11	11	cetuximab	BRAF	PA10040	673	0.824
NULL	Breast_Cancer_(Auckl)_2014_May_12_8_81-88.nxml.txt.nlp	24855372	SENT75	10	10	15	15	trastuzumab	HER2	PA451743	2064	0.824
NULL	Front_Oncol_2014_Sep_23_4_264.nxml.txt.nlp	25295231	SENT239	2	2	8	8	lenalidomide	MDM2	PA162363968	4193	0.824
NULL	Mol_Vis_2012_Sep_24_18_2388-2397.nxml.txt.nlp	23049239	SENT111	5	5	13	13	verapamil	MDR1	PA451868	5243	0.824
NULL	CNS_Drugs_2013_May_27_27(5)_335-343.nxml.txt.nlp	23533009	SENT124	24	24	33	33	ziprasidone	FGA	PA451974	2243	0.824
NULL	Cancers_(Basel)_2011_Sep_13_3(3)_3506-3524.nxml.txt.nlp	24212966	SENT83	8	8	14	14	erlotinib	EGFR	PA134687924	1956	0.824
NULL	Cardiovasc_Diabetol_2010_Nov_16_9_76.nxml.txt.nlp	21080957	SENT320	4	4	13	13	exenatide	GLP-1	PA164749238	100125288	0.824
NULL	J_Anaesthesiol_Clin_Pharmacol_2012_Jan-Mar_28(1)_92-100.nxml.txt.nlp	22345954	SENT121	22	22	12	12	desflurane	CO2	PA164749136	4513	0.824
NULL	Iran_J_Pharm_Res_2014_Spring_13(2)_635-639.nxml.txt.nlp	25237359	SENT18	37	37	39	39	chlorzoxazone	CYP2E1	PA448971	1571	0.824
NULL	Arthritis_Res_Ther_2012_Jan_23_14(1)_R17.nxml.txt.nlp	22269139	SENT8	11	11	13	13	diethylstilbestrol	DES	PA449307	1674	0.824
NULL	J_Gen_Physiol_2009_Feb_133(2)_171-188.nxml.txt.nlp	19171770	SENT624	10	10	22	22	pentobarbital	gamma	PA450859	9913	0.824
NULL	Br_J_Cancer_2011_Apr_12_104(8)_1256-1261.nxml.txt.nlp	21448165	SENT161	10	10	15	15	sorafenib	IL-2	PA7000	3558	0.824
NULL	Diabetes_Metab_Syndr_Obes_2014_Jul_17_7_313-319.nxml.txt.nlp	25092992	SENT127	16	16	6	6	pioglitazone	adiponectin	PA450970	9370	0.824
NULL	Int_J_Med_Sci_2013_Mar_19_10(5)_599-606.nxml.txt.nlp	23569422	SENT12	3	3	16	16	propofol	JNK	PA451141	5599	0.824
NULL	Open_Biochem_J_2011_Sep_23_5_45-51.nxml.txt.nlp	21966325	SENT109	5	5	19	19	diclofenac	p50	PA449293	958;4790	0.824
NULL	Mol_Imaging_Biol_2009_Jul_31_11(4)_241-245.nxml.txt.nlp	19333655	SENT88	5	5	22	22	aprepitant	NK1	PA164747039	11126	0.824
NULL	Acta_Pharmacol_Sin_2010_Mar_22_31(3)_329-340.nxml.txt.nlp	20173759	SENT207	30	30	39	39	ethanol	AMPK	PA448073	5563	0.824
NULL	Int_J_Mol_Sci_2014_Jun_18_15(6)_11013-11029.nxml.txt.nlp	24945311	SENT37	7	7	11	11	celecoxib	STAT3	PA448871	6774	0.824
NULL	ScientificWorldJournal_2014_Nov_27_2014_837543.nxml.txt.nlp	25544963	SENT286	15	15	13	13	imatinib	ABCB1	PA10804	5243	0.824
NULL	Diabetes_2009_Jan_58(1)_215-226.nxml.txt.nlp	18840783	SENT158	3	3	11	11	fasudil	FasL	PA165946121	356	0.824
NULL	Curr_Neuropharmacol_2008_Sep_6(3)_193-202.nxml.txt.nlp	19506720	SENT172	10	10	32	32	olanzapine	ghrelin	PA450688	51738	0.824
NULL	Behav_Brain_Funct_2005_Jul_15_1_9.nxml.txt.nlp	16022733	SENT175	28	28	16	16	guanfacine	NET1	PA449825	55119;10276	0.824
NULL	Acta_Neuropathol_2015_Oct_17_129_81-96.nxml.txt.nlp	25322817	SENT158	29	29	36	36	capsaicin	TRPV1	PA448776	7442	0.824
NULL	Osteoporos_Int_2012_Feb_4_23(Suppl_1)_S1-S23.nxml.txt.nlp	22311111	SENT480	12	12	14	14	teriparatide	PTH	PA451620	5741	0.824
NULL	J_Hematol_Oncol_2009_Apr_22_2_18.nxml.txt.nlp	19386128	SENT160	11	11	20	20	cetuximab	KRAS	PA10040	3845	0.824
NULL	Gut_Liver_2013_Jan_5_7(1)_35-40.nxml.txt.nlp	23423603	SENT135	15	15	9	9	imatinib	KIT	PA10804	3815	0.824
NULL	Ann_Hematol_2010_Nov_25_89(11)_1115-1124.nxml.txt.nlp	20499237	SENT119	35	35	5	5	cladribine	CD5	PA449027	921	0.824
NULL	Mol_Biol_Cell_2013_Dec_15_24(24)_3805-3818.nxml.txt.nlp	24152730	SENT12	3	3	16	16	estradiol	HDAC2	PA449503	3066	0.824
NULL	Oncotarget_2014_Aug_19_5(18)_8729-8736.nxml.txt.nlp	25238266	SENT105	26	26	4	4	docetaxel	EGF	PA449383	1950	0.824
NULL	Arthritis_Res_Ther_2011_Nov_1_13(6)_R182.nxml.txt.nlp	22044682	SENT62	10	10	29	29	collagenase	CD4	PA449107	920	0.824
NULL	Clin_Ophthalmol_2011_Feb_8_5_161-165.nxml.txt.nlp	21383943	SENT38	16	16	23	23	ranibizumab	San	PA164746012	80218	0.824
NULL	J_Headache_Pain_2014_Dec_8_15(1)_85.nxml.txt.nlp	25488888	SENT84	22	22	35	35	eletriptan	5-HT1B	PA134687947	3351	0.824
NULL	F1000Res_2014_Aug_19_3_198.nxml.txt.nlp	25400908	SENT524	20	20	41	41	anastrozole	IMPACT	PA448432	55364	0.824
NULL	J_Cancer_Res_Clin_Oncol_2015_Aug_3_141_61-68.nxml.txt.nlp	25086987	SENT21	11	11	6	6	afatinib	EGFR	PA165981154	1956	0.824
NULL	Drugs_R_D_2011_Jun_27_11(2)_113-126.nxml.txt.nlp	21679004	SENT44	21	21	30	30	temsirolimus	IFN	PA164746890	3439	0.824
NULL	J_Hematol_Oncol_2012_Jun_18_5_31.nxml.txt.nlp	22709792	SENT78	0	0	8	8	sunitinib	VEGFR	PA162372840	3791	0.824
NULL	Ther_Clin_Risk_Manag_2006_Sep_2(3)_281-295.nxml.txt.nlp	18360603	SENT251	7	7	28	28	raloxifene	NNT	PA451221	23530	0.824
NULL	Onco_Targets_Ther_2014_Nov_28_7_2183-2195.nxml.txt.nlp	25506223	SENT45	14	14	34	34	doxorubicin	mol	PA449412	90527	0.824
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT332	14	14	17	17	rolipram	IL-6	PA153906323	3569	0.824
NULL	Clin_Med_Insights_Oncol_2012_May_16_6_205-217.nxml.txt.nlp	22654526	SENT248	27	27	17	17	ribavirin	EGFR	PA451241	1956	0.824
NULL	Br_J_Cancer_2013_Aug_6_109(3)_686-693.nxml.txt.nlp	23839492	SENT201	21	21	2	2	sunitinib	ANOVA	PA162372840	4858	0.824
NULL	J_Biomed_Biotechnol_2011_Jan_5_2011_197636.nxml.txt.nlp	21274264	SENT179	0	0	2	2	metformin	AMPK	PA450395	5563	0.824
NULL	Clin_Cosmet_Investig_Dermatol_2013_Jan_14_6_29-36.nxml.txt.nlp	23355788	SENT171	38	38	6	6	desonide	CD68	PA164776996	968	0.824
NULL	Proteins_2013_Aug_1_81(8)_1457-1465.nxml.txt.nlp	23589421	SENT127	13	13	32	32	l-alanine	AGT	PA448055	183;189	0.824
NULL	Br_J_Cancer_1995_May_71(5)_931-936.nxml.txt.nlp	7734315	SENT15	28	28	2	2	epirubicin	MRK	PA449476	22858	0.824
NULL	Clin_Ophthalmol_2010_Oct_28_4_1249-1252.nxml.txt.nlp	21151329	SENT23	35	35	29	29	bevacizumab	San	PA130232992	80218	0.824
NULL	Sci_Rep_2014_Dec_19_4_7571.nxml.txt.nlp	25524368	SENT70	8	8	32	32	diethylstilbestrol	mer	PA449307	10461	0.824
NULL	Front_Neurol_2013_May_15_4_53.nxml.txt.nlp	23720649	SENT266	11	11	8	8	geldanamycin	Hsp90	PA152031327	3320	0.824
NULL	Clin_Pharmacol_2013_Dec_9_5_185-192.nxml.txt.nlp	24353446	SENT86	10	10	7	7	clopidogrel	ARNT	PA449053	405	0.824
NULL	Br_J_Cancer_2000_Dec_83(12)_1762-1768.nxml.txt.nlp	11104578	SENT6	25	25	11	11	paclitaxel	P-gp	PA450761	5243	0.824
NULL	Front_Comput_Neurosci_2014_Oct_17_8_133.nxml.txt.nlp	25368573	SENT571	4	4	10	10	ketamine	gamma	PA450144	9913	0.824
NULL	Diabetes_Metab_J_2013_Oct_17_37(5)_315-325.nxml.txt.nlp	24199159	SENT193	22	22	20	20	resveratrol	SIRT1		23411	0.824
NULL	Behav_Brain_Funct_2009_Jun_4_5_23.nxml.txt.nlp	19497110	SENT16	11	11	1	1	ethanol	P90	PA448073	821	0.824
NULL	Pharmaceutics_2011_Feb_7_3(1)_53-72.nxml.txt.nlp	24310425	SENT200	25	25	0	0	captopril	CYP2D6	PA448780	1565	0.824
NULL	Biomed_Res_Int_2014_Mar_9_2014_687835.nxml.txt.nlp	24734239	SENT27	9	9	6	6	lidocaine	CTB	PA450226	9468	0.824
NULL	Neural_Dev_2013_Mar_7_8_4.nxml.txt.nlp	23497494	SENT75	27	27	16	16	chlorpheniramine	MAP2	PA448960	4133;10988	0.824
NULL	Cancers_(Basel)_2011_Apr_26_3(2)_2195-2213.nxml.txt.nlp	24212804	SENT190	21	21	34	34	cyclophosphamide	IL-10	PA449165	3586	0.824
NULL	J_Geriatr_Cardiol_2014_Mar_11(1)_63-73.nxml.txt.nlp	24748884	SENT104	19	19	16	16	fenoldopam	PKD	PA164784034	5587	0.824
NULL	J_Biomed_Biotechnol_2011_Dec_6_2011_475641.nxml.txt.nlp	21188171	SENT236	17	17	0	0	vorinostat	HR23B	PA164748224	5887	0.824
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1522-1532.nxml.txt.nlp	21997136	SENT113	9	9	6	6	gefitinib	EGFR	PA131301952	1956	0.824
NULL	Indian_J_Psychol_Med_2012_Jul-Sep_34(3)_247-254.nxml.txt.nlp	23439746	SENT78	15	15	8	8	risperidone	FGA	PA451257	2243	0.824
NULL	Pharmaceutics_2011_Sep_14_3(3)_615-635.nxml.txt.nlp	24310600	SENT641	25	25	18	18	elacridar	ABCG2		9429	0.824
NULL	J_Adv_Pract_Oncol_2013_Jul_1_Jul-Aug_4(4)_238-250.nxml.txt.nlp	25032004	SENT242	36	36	8	8	imatinib	CML	PA10804	613	0.824
NULL	Int_J_Biol_Sci_2015_Jan_1_11(2)_144-155.nxml.txt.nlp	25561897	SENT24	19	19	8	8	cisplatin	POLB	PA449014	5423	0.824
NULL	Exp_Ther_Med_2012_Sep_12_4(3)_475-480.nxml.txt.nlp	23181121	SENT163	12	12	22	22	vincristine	CHOP	PA451879	1649	0.824
NULL	Cell_Death_Dis_2010_Nov_18_1(11)_e102.nxml.txt.nlp	21368867	SENT151	1	1	18	18	gentamicin	14-3-3	PA449753	10971	0.824
NULL	Oncotarget_2014_Oct_21_5(21)_10916-10933.nxml.txt.nlp	25373734	SENT351	25	25	27	27	heparin	EGF	PA449855	1950	0.824
NULL	Springerplus_2014_Sep_17_3_535.nxml.txt.nlp	25279326	SENT154	34	34	13	13	everolimus	aromatase	PA164746311	1588	0.824
NULL	Breast_Cancer_Res_2007_Aug_8_9(4)_R50.nxml.txt.nlp	17686159	SENT83	12	12	5	5	gefitinib	HRG	PA131301952	3084;3273	0.824
NULL	Int_Neurourol_J_2014_Sep_24_18(3)_115-125.nxml.txt.nlp	25279238	SENT194	2	2	13	13	berberine	CD11b	PA165860812	3684	0.824
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2675-2684.nxml.txt.nlp	24129246	SENT187	23	23	19	19	etoposide	KSR1	PA449552	8844	0.824
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT253	27	27	18	18	nutlin-3	E2F1		1869	0.823
NULL	Semin_Immunol_2011_Feb_23(1)_28-41.nxml.txt.nlp	21295490	SENT245	21	21	12	12	ustekinumab	IL-23	PA166048654	51561	0.823
NULL	Br_J_Cancer_2009_Jul_7_101(1)_38-47.nxml.txt.nlp	19513066	SENT221	0	0	20	20	dasatinib	PI3K	PA162372878	5290	0.823
NULL	Clin_Exp_Otorhinolaryngol_2011_Mar_17_4(1)_1-10.nxml.txt.nlp	21461056	SENT161	13	13	26	26	cetuximab	EGFR	PA10040	1956	0.823
NULL	Crit_Care_2011_Mar_22_15(2)_211.nxml.txt.nlp	21457505	SENT69	26	26	19	19	heparin	PF4	PA449855	5196	0.823
NULL	Front_Immunol_2013_Oct_28_4_346.nxml.txt.nlp	24194739	SENT72	31	31	12	12	vemurafenib	IFN	PA165946873	3439	0.823
NULL	Antimicrob_Agents_Chemother_2014_Aug_58(8)_4971-4973.nxml.txt.nlp	24913169	SENT78	20	20	28	28	artemisinin	G6PD	PA165111696	2539	0.823
NULL	Diabetologia_2010_Jan_21_53(1)_21-26.nxml.txt.nlp	19844672	SENT138	8	8	11	11	sitagliptin	HIP	PA164748978	6767;6159;64399;5068	0.823
NULL	Oncotarget_2014_Jun_6_5(13)_4935-4944.nxml.txt.nlp	24952732	SENT180	5	5	11	11	doxazosin	PI3K	PA449407	5290	0.823
NULL	Arthritis_Res_Ther_2014_Apr_3_16(2)_R86.nxml.txt.nlp	24708674	SENT263	10	10	16	16	bosentan	Fli1	PA10034	2314	0.823
NULL	Protein_Cell_2014_Dec_21_5(12)_899-911.nxml.txt.nlp	25411122	SENT140	9	9	26	26	imiquimod	IL-6	PA449972	3569	0.823
NULL	Eur_J_Clin_Pharmacol_2012_Sep_15_68(9)_1267-1274.nxml.txt.nlp	22418828	SENT44	9	9	25	25	pantoprazole	CYP2C19	PA450774	1557	0.823
NULL	Onco_Targets_Ther_2014_Sep_23_7_1689-1704.nxml.txt.nlp	25285017	SENT109	32	32	27	27	erlotinib	EGFR	PA134687924	1956	0.823
NULL	Indian_J_Pharmacol_2013_May-Jun_45(3)_274-277.nxml.txt.nlp	23833372	SENT126	33	33	36	36	colchicine	CA1	PA449092	759	0.823
NULL	J_Infect_Dis_2014_May_1_209(9)_1469-1478.nxml.txt.nlp	24286983	SENT203	19	19	11	11	oxacillin	VAN	PA450725	10318	0.823
NULL	J_Young_Pharm_2010_Oct-Dec_2(4)_428-429.nxml.txt.nlp	21264109	SENT5	16	16	35	35	metformin	B12	PA450395	7126;4709	0.823
NULL	An_Bras_Dermatol_2014_Mar-Apr_89(2)_266-273.nxml.txt.nlp	24770503	SENT139	27	27	47	47	thalidomide	ENL	PA451644	4298	0.823
NULL	Biomed_Res_Int_2014_Apr_29_2014_186864.nxml.txt.nlp	24877064	SENT175	24	24	8	8	curcumin	IFN	PA151958596	3439	0.823
NULL	Diabetes_2011_Mar_21_60(3)_876-883.nxml.txt.nlp	21307078	SENT99	16	16	5	5	trypsin	CD31	PA451806	5175	0.823
NULL	Biomed_Res_Int_2013_Dec_31_2013_273498.nxml.txt.nlp	23484100	SENT105	1	1	23	23	genistein	OTC	PA165109660	5009	0.823
NULL	Evid_Based_Complement_Alternat_Med_2004_Sep_1(2)_207-209.nxml.txt.nlp	15480447	SENT43	35	35	29	29	cisplatin	HER-2	PA449014	2064	0.823
NULL	Arthritis_Res_Ther_2005_Feb_17_7(Suppl_1)_P74.nxml.txt.nlp	NULL	SENT21	1	1	14	14	losartan	ANOVA	PA450268	4858	0.823
NULL	J_Immunother_Cancer_2013_Jul_15_1_10.nxml.txt.nlp	24829747	SENT116	4	4	16	16	cimetidine	FasL	PA449001	356	0.823
NULL	Cell_Death_Dis_2010_Nov_18_1(11)_e102.nxml.txt.nlp	21368867	SENT90	12	12	8	8	gentamicin	CLIMP-63	PA449753	10970	0.823
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT93	3	3	8	8	methotrexate	MSH2	PA450428	4436	0.823
NULL	Front_Cell_Neurosci_2015_Jan_13_8_465.nxml.txt.nlp	25628539	SENT765	11	11	0	0	fasudil	Rho	PA165946121	29984	0.823
NULL	Diabetes_2009_Aug_28_58(8)_1816-1825.nxml.txt.nlp	19401425	SENT161	41	41	22	22	nimodipine	GLP-1	PA450633	100125288	0.823
NULL	Gastroenterol_Hepatol_Bed_Bench_2011_Autumn_4(4)_171-174.nxml.txt.nlp	24834179	SENT48	18	18	15	15	ribavirin	IFN	PA451241	3439	0.823
NULL	Br_J_Haematol_2014_Jul_25_166(1)_77-83.nxml.txt.nlp	24661044	SENT21	2	2	6	6	rituximab	CHOP	PA451261	1649	0.823
NULL	J_Oncol_2012_Jul_30_2012_370272.nxml.txt.nlp	22899920	SENT76	20	20	27	27	rituximab	FDG	PA451261	23583	0.823
NULL	Int_J_Endocrinol_Metab_2014_Jul_1_12(3)_e15503.nxml.txt.nlp	25237319	SENT172	3	3	9	9	rosiglitazone	adiponectin	PA451283	9370	0.823
NULL	J_Clin_Biochem_Nutr_2007_Jul_27_41(1)_32-42.nxml.txt.nlp	18392098	SENT165	13	13	7	7	arsenite	PARP	PA452638	142	0.823
NULL	Exp_Ther_Med_2013_Dec_26_6(6)_1359-1364.nxml.txt.nlp	24255662	SENT178	5	5	16	16	dexmedetomidine	TLR4	PA449256	7099	0.823
NULL	Curr_Colorectal_Cancer_Rep_2012_Mar_14_8(1)_66-81.nxml.txt.nlp	22389639	SENT179	2	2	7	7	curcumin	AP-1	PA151958596	2353;3727;2354;3725	0.823
NULL	J_Cancer_Res_Clin_Oncol_2011_Sep_8_137(9)_1317-1327.nxml.txt.nlp	21739182	SENT143	9	9	12	12	trastuzumab	HER2	PA451743	2064	0.823
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT12	22	22	28	28	curcumin	TRAIL	PA151958596	8743	0.823
NULL	Oncol_Rep_2014_Apr_28_31(4)_1605-1612.nxml.txt.nlp	24481648	SENT10	12	12	23	23	ponatinib	MRP7	PA165980594	89845;1080	0.823
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT18	18	18	5	5	metformin	HIF-1	PA450395	29072	0.823
NULL	Core_Evid_2007_Nov_30_2(2)_121-129.nxml.txt.nlp	21221180	SENT230	42	42	32	32	rituximab	CHOP	PA451261	1649	0.823
NULL	Int_J_Biol_Sci_2014_Jun_1_10(6)_588-595.nxml.txt.nlp	24948871	SENT63	15	15	3	3	estradiol	CYP17A1	PA449503	1586	0.823
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1137-1144.nxml.txt.nlp	20234366	SENT165	38	38	29	29	cetuximab	MKP-1	PA10040	1843	0.823
NULL	Indian_J_Pharmacol_2008_Oct_40(Suppl_2)_S112-S142.nxml.txt.nlp	21593965	SENT1377	8	8	18	18	perindopril	STZ	PA450877	6484	0.823
NULL	Kidney_Int_Suppl_(2011)_2012_Mar_29_2(1)_69-88.nxml.txt.nlp	25018920	SENT129	29	29	14	14	mannitol	NAC	PA450320	22861	0.823
NULL	Exp_Ther_Med_2013_Nov_18_6(5)_1177-1183.nxml.txt.nlp	24223641	SENT164	0	0	20	20	propofol	BMP2	PA451141	650	0.823
NULL	Cancer_Cell_Int_2013_May_15_13_42.nxml.txt.nlp	23672670	SENT193	12	12	0	0	paclitaxel	PIDD	PA450761	55367	0.823
NULL	BMB_Rep_2013_Jan_46(1)_59-64.nxml.txt.nlp	23351386	SENT327	1	1	9	9	auranofin	JAK1	PA448510	3716	0.823
NULL	Oncol_Lett_2014_Mar_2_7(3)_791-796.nxml.txt.nlp	24527087	SENT170	38	38	3	3	imatinib	CD34	PA10804	947	0.823
NULL	Br_J_Cancer_2012_Feb_14_106(4)_646-650.nxml.txt.nlp	22240794	SENT63	31	31	20	20	sunitinib	IFN	PA162372840	3439	0.823
NULL	Mol_Cancer_2010_Nov_8_9_291.nxml.txt.nlp	21059223	SENT103	36	36	27	27	paclitaxel	ABCB1	PA450761	5243	0.823
NULL	Cells_2014_Sep_12_3(3)_914-938.nxml.txt.nlp	25222270	SENT85	38	38	9	9	capsaicin	TRPM1	PA448776	4308	0.823
NULL	Biol_Open_2014_Nov_13_3(12)_1164-1172.nxml.txt.nlp	25395667	SENT94	16	16	11	11	capsaicin	TRPV1	PA448776	7442	0.823
NULL	Ann_Hematol_2010_Sep_13_89(9)_861-871.nxml.txt.nlp	20387067	SENT225	19	19	15	15	dasatinib	GM-CSF	PA162372878	1437	0.823
NULL	Allergy_Asthma_Immunol_Res_2014_Nov_19_6(6)_548-557.nxml.txt.nlp	25374755	SENT147	0	0	33	33	simvastatin	Rho	PA451363	29984	0.823
NULL	F1000Res_2014_Aug_19_3_198.nxml.txt.nlp	25400908	SENT109	5	5	1	1	tamoxifen	ATAC	PA451581	6375	0.823
NULL	Front_Mol_Neurosci_2008_Apr_8_1_6.nxml.txt.nlp	18946539	SENT764	10	10	3	3	phencyclidine	gamma	PA128406980	9913	0.823
NULL	Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.nxml.txt.nlp	24736980	SENT178	4	4	13	13	rosuvastatin	OATP1B1	PA134308647	10599	0.823
NULL	J_Oncol_2013_Apr_29_2013_854121.nxml.txt.nlp	23737784	SENT79	13	13	26	26	trastuzumab	BCS	PA451743	617	0.823
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT13	22	22	28	28	curcumin	TRAIL	PA151958596	8743	0.823
NULL	Diabetes_Care_2009_Oct_10_32(10)_1880-1886.nxml.txt.nlp	19592625	SENT186	0	0	9	9	exenatide	GLP-1	PA164749238	100125288	0.823
NULL	Arthritis_Res_Ther_2009_Jan_7_11(1)_101.nxml.txt.nlp	19183433	SENT25	9	9	12	12	adalimumab	MMP3	PA10004	4314	0.823
NULL	Pak_J_Med_Sci_2013_May-Jun_29(3)_768-772.nxml.txt.nlp	24353625	SENT37	34	34	36	36	cefotaxime	CTX	PA448852	1593	0.823
NULL	Clin_Interv_Aging_2012_Sep_17_7_363-372.nxml.txt.nlp	23049248	SENT57	20	20	15	15	denosumab	RANK	PA166048634	8792	0.823
NULL	Int_J_Environ_Res_Public_Health_2013_Sep_17_10(9)_4352-4389.nxml.txt.nlp	24048206	SENT291	12	12	17	17	choline	B12	PA448976	7126;4709	0.823
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2014_Sep_17_7_25-30.nxml.txt.nlp	25288892	SENT52	7	7	20	20	metformin	GLP-1	PA450395	100125288	0.823
NULL	Biomed_Res_Int_2014_Apr_23_2014_421415.nxml.txt.nlp	24864241	SENT136	9	9	11	11	etoposide	ETO	PA449552	862	0.823
NULL	Drug_Des_Devel_Ther_2014_Sep_23_8_1527-1538.nxml.txt.nlp	25284985	SENT110	22	22	11	11	celecoxib	IFN	PA448871	3439	0.823
NULL	Pharm_Pract_(Granada)_2011_Mar_15_Jan-Mar_9(1)_1-10.nxml.txt.nlp	25132883	SENT151	4	4	15	15	enoxaparin	SPAF	PA449463	166378	0.823
NULL	Exp_Ther_Med_2013_Mar_24_5(3)_902-906.nxml.txt.nlp	23408108	SENT9	6	6	13	13	anastrozole	aromatase	PA448432	1588	0.823
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT409	5	5	2	2	ziprasidone	PRL	PA451974	5617	0.823
NULL	J_Invest_Dermatol_2015_Feb_9_135(2)_389-399.nxml.txt.nlp	25184961	SENT40	21	21	17	17	clodronate	IL-6	PA10239	3569	0.823
NULL	Environ_Health_Perspect_2010_Jun_25_118(6)_864-870.nxml.txt.nlp	20100676	SENT20	11	11	2	2	arsenite	INS-1	PA452638	2305	0.823
NULL	Int_J_Circumpolar_Health_2013_Aug_5_72_10_3402_ijch_v72i0_20854.nxml.txt.nlp	23984273	SENT170	13	13	19	19	cefotaxime	TMP	PA448852	2012	0.823
NULL	Oncotarget_2014_Dec_4_5(22)_11365-11380.nxml.txt.nlp	25426548	SENT133	12	12	3	3	nutlin-3	p53		7157	0.823
NULL	F1000_Med_Rep_2009_Sep_28_1_75.nxml.txt.nlp	20948704	SENT28	6	6	15	15	cisplatin	BRCA1	PA449014	672	0.823
NULL	Br_J_Cancer_2011_Apr_12_104(8)_1256-1261.nxml.txt.nlp	21448165	SENT11	26	26	20	20	sorafenib	IL-2	PA7000	3558	0.823
NULL	Clin_Drug_Investig_2015_Dec_16_35_141-147.nxml.txt.nlp	25511640	SENT75	26	26	35	35	miglitol	GLP-1	PA164776726	100125288	0.823
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2013_Dec_8_6_75-79.nxml.txt.nlp	24348081	SENT72	8	8	29	29	colesevelam	GLP-1	PA449095	100125288	0.823
NULL	Nucleic_Acids_Res_2005_Apr_22_33(7)_2310-2317.nxml.txt.nlp	15849317	SENT148	7	7	10	10	geldanamycin	Hsp90	PA152031327	3320	0.823
NULL	Anat_Res_Int_2012_Jan_22_2012_951836.nxml.txt.nlp	22567317	SENT29	6	6	19	19	ethanol	LIPI	PA448073	149998	0.823
NULL	Oncotarget_2011_Dec_31_2(12)_1314-1321.nxml.txt.nlp	22248929	SENT146	15	15	21	21	lapatinib	HER3	PA152241907	2065	0.823
NULL	Alzheimers_Res_Ther_2013_Oct_24_5(5)_50.nxml.txt.nlp	24401551	SENT238	2	2	20	20	donepezil	spatial	PA449394	219793	0.823
NULL	J_Exp_Med_2000_Mar_6_191(5)_859-870.nxml.txt.nlp	10704466	SENT38	16	16	22	22	neomycin	p38	PA450608	10598;1432;7965	0.823
NULL	Oncotarget_2014_Mar_13_5(5)_1326-1337.nxml.txt.nlp	24658369	SENT158	17	17	10	10	hydroxyurea	MCM3	PA449942	4172	0.823
NULL	Aging_(Albany_NY)_2009_Jun_22_1(6)_529-541.nxml.txt.nlp	20157536	SENT137	2	2	6	6	resveratrol	STAC		6769	0.823
NULL	J_Immunother_Cancer_2013_Nov_7_1(Suppl_1)_P91.nxml.txt.nlp	NULL	SENT8	0	0	10	10	docetaxel	HMGB1	PA449383	3146	0.823
NULL	Clinics_(Sao_Paulo)_2014_Jan_69(1)_68-74.nxml.txt.nlp	24473562	SENT91	44	44	39	39	nutlin-3	SOCS-1		8651	0.823
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Jan_15_70(Pt_2)_o140.nxml.txt.nlp	24764866	SENT75	20	20	34	34	ethanol	mol	PA448073	90527	0.823
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Jun_19_69(Pt_7)_m402-m403.nxml.txt.nlp	24046574	SENT58	4	4	17	17	cimetidine	NO3	PA449001	4681	0.823
NULL	Neural_Plast_2007_Jan_1_2007_30585.nxml.txt.nlp	25148070	SENT2668	13	13	18	18	fluoxetine	CA1	PA449673	759	0.823
NULL	J_Immunol_Res_2014_Jan_9_2014_525913.nxml.txt.nlp	24741604	SENT68	19	19	17	17	hydrocortisone	IL-15	PA449905	3600	0.823
NULL	Exp_Ther_Med_2012_Sep_12_4(3)_475-480.nxml.txt.nlp	23181121	SENT170	22	22	32	32	vincristine	CHOP	PA451879	1649	0.823
NULL	Oncotarget_2011_Dec_31_2(12)_1314-1321.nxml.txt.nlp	22248929	SENT68	15	15	21	21	lapatinib	HER3	PA152241907	2065	0.823
NULL	Arthritis_Res_Ther_2005_Jan_21_7(2)_55-61.nxml.txt.nlp	15743490	SENT106	8	8	35	35	atorvastatin	CD83	PA448500	9308	0.823
NULL	J_Biol_Chem_2008_Nov_14_283(46)_31679-31689.nxml.txt.nlp	18755684	SENT233	34	34	3	3	iron	FTH1	PA450087	2495	0.823
NULL	Nano_Rev_2010_Feb_22_1_10_3402_nano_v1i0_4883.nxml.txt.nlp	22110854	SENT216	23	23	32	32	iron	MRI	PA450087	78996	0.823
NULL	Mol_Pain_2014_Apr_9_10_24.nxml.txt.nlp	24716552	SENT171	29	29	15	15	capsaicin	NK1R	PA448776	6869	0.823
NULL	J_Gynecol_Oncol_2012_Jan_9_23(1)_53-64.nxml.txt.nlp	22355468	SENT67	21	21	7	7	olaparib	BRCA1		672	0.823
NULL	EMBO_Mol_Med_2013_Mar_5_5(3)_384-396.nxml.txt.nlp	23495140	SENT104	19	19	11	11	tetracycline	HES5	PA451640	388585	0.823
NULL	Infect_Drug_Resist_2011_Mar_2_4_77-86.nxml.txt.nlp	21694911	SENT5	0	0	10	10	tigecycline	CABP	PA164746412	6277	0.823
NULL	Biomed_Res_Int_2014_Feb_6_2014_323594.nxml.txt.nlp	24689036	SENT363	17	17	5	5	raloxifene	PC3	PA451221	57332;7832;5122	0.823
NULL	Cell_Death_Dis_2010_Nov_18_1(11)_e101.nxml.txt.nlp	21368866	SENT88	5	5	11	11	cisplatin	Bcl-2	PA449014	596	0.823
NULL	Cancer_Med_2013_Feb_3_2(1)_76-85.nxml.txt.nlp	24133630	SENT197	32	32	9	9	elacridar	P-gp		5243	0.823
NULL	Evid_Based_Complement_Alternat_Med_2014_May_8_2014_682717.nxml.txt.nlp	24949079	SENT98	39	39	16	16	berberine	spatial	PA165860812	219793	0.823
NULL	Environ_Health_Perspect_2007_Jan_19_115(1)_113-115.nxml.txt.nlp	17366829	SENT49	8	8	3	3	creatine	B12	PA164778930	7126;4709	0.823
NULL	Eur_J_Haematol_2014_Feb_25_92(2)_127-136.nxml.txt.nlp	24118452	SENT35	19	19	17	17	anagrelide	CRT	PA164742986	811	0.823
NULL	Crit_Care_2010_Apr_19_14(2)_R70.nxml.txt.nlp	20403177	SENT251	3	3	13	13	thrombin	cPLA2	PA451674	10524	0.823
NULL	Pharmaceuticals_(Basel)_2012_Sep_20_5(9)_1032-1043.nxml.txt.nlp	24280704	SENT30	8	8	15	15	vancomycin	VISA	PA451850	57506	0.823
NULL	BMB_Rep_2013_Nov_46(11)_544-549.nxml.txt.nlp	24152910	SENT32	5	5	11	11	thrombin	PAR-1	PA451674	2011;2149	0.823
NULL	Reprod_Biol_Endocrinol_2003_Aug_6_1_54.nxml.txt.nlp	12932297	SENT307	20	20	15	15	hyaluronidase	SPAM1	PA164745713	6677	0.823
NULL	Endocrinol_Diabetes_Metab_Case_Rep_2014_Sep_1_2014_140072.nxml.txt.nlp	25332771	SENT61	2	2	8	8	sitagliptin	GLP1	PA164748978	100125288;2641	0.823
NULL	J_Cell_Biol_1997_Jun_16_137(6)_1445-1457.nxml.txt.nlp	9182674	SENT72	14	14	32	32	hydroxyurea	EGF	PA449942	1950	0.823
NULL	Mol_Cancer_2013_Mar_5_12_17.nxml.txt.nlp	23497256	SENT279	15	15	18	18	doxorubicin	p53	PA449412	7157	0.823
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT470	23	23	15	15	iloperidone	PRL	PA161199368	5617	0.823
NULL	J_Oncol_2010_Dec_15_2010_821717.nxml.txt.nlp	20049172	SENT167	15	15	5	5	paclitaxel	TUBB3	PA450761	10381	0.823
NULL	Oncogene_2013_Sep_26_32(39)_10_1038_onc_2012_491.nxml.txt.nlp	23108394	SENT79	42	42	36	36	epirubicin	FOXM1	PA449476	2305	0.823
NULL	Indian_J_Urol_2008_Jul-Sep_24(3)_289-294.nxml.txt.nlp	19468456	SENT152	3	3	9	9	desmopressin	AVP	PA449237	114548;551	0.823
NULL	Addict_Health_2014_Winter-Spring_6(1-2)_54-64.nxml.txt.nlp	25140218	SENT119	19	19	12	12	diazepam	spatial	PA449283	219793	0.823
NULL	Crit_Care_2011_Nov_30_15(6)_R289.nxml.txt.nlp	22129171	SENT172	15	15	18	18	dipyridamole	IL-10	PA449367	3586	0.823
NULL	Environ_Health_Perspect_1996_Dec_104(Suppl_6)_1177-1182.nxml.txt.nlp	9118890	SENT5	7	7	42	42	hydroquinone	NQO1	PA449924	1728	0.823
NULL	Croat_Med_J_2012_Jun_53(3)_214-223.nxml.txt.nlp	22661134	SENT11	10	10	18	18	reserpine	ACTH	PA451236	5443	0.823
NULL	Mol_Brain_2014_Jan_9_7_2.nxml.txt.nlp	24405574	SENT16	0	0	9	9	clonazepam	gamma	PA449050	9913	0.823
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1063.nxml.txt.nlp	24556678	SENT47	7	7	14	14	thioridazine	c-FLIP	PA451666	8837	0.823
NULL	Brain_Sci_2014_May_6_4(2)_356-375.nxml.txt.nlp	24961766	SENT335	10	10	18	18	isoflurane	spatial	PA450106	219793	0.823
NULL	J_Clin_Biochem_Nutr_2010_Mar_27_46(2)_126-134.nxml.txt.nlp	20216945	SENT72	15	15	7	7	s-adenosylmethionine	Met	PA164754994	79811	0.823
NULL	Neuropsychopharmacology_2009_Apr_2_34(5)_1135-1148.nxml.txt.nlp	18596687	SENT330	2	2	8	8	betaxolol	CRF	PA448611	1392;10882	0.823
NULL	Eur_J_Endocrinol_2010_May_162(5)_987-992.nxml.txt.nlp	20164212	SENT6	21	21	12	12	diazoxide	HNF4A	PA449285	3172	0.823
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Jul_23_6_103-113.nxml.txt.nlp	25114588	SENT38	7	7	17	17	trastuzumab	HER2	PA451743	2064	0.823
NULL	Curr_Neuropharmacol_2013_May_11(3)_263-275.nxml.txt.nlp	24179463	SENT128	2	2	11	11	fluoxetine	CB1	PA449673	1268	0.823
NULL	Cancer_Cell_Int_2005_Jul_29_5_24.nxml.txt.nlp	16053526	SENT7	8	8	27	27	estradiol	beta-catenin	PA449503	1499	0.823
NULL	Braz_J_Med_Biol_Res_2012_Jul_20_45(10)_935-941.nxml.txt.nlp	22801415	SENT58	4	4	22	22	pioglitazone	adiponectin	PA450970	9370	0.823
NULL	Front_Microbiol_2014_Mar_3_5_70.nxml.txt.nlp	24624123	SENT51	10	10	12	12	ticarcillin	TIC	PA451684	23550	0.823
NULL	Calcif_Tissue_Int_2010_Dec_16_87(6)_485-492.nxml.txt.nlp	20953593	SENT49	19	19	13	13	teriparatide	PTH	PA451620	5741	0.823
NULL	Int_J_Gen_Med_2012_Nov_9_5_935-942.nxml.txt.nlp	23204857	SENT135	23	23	16	16	isoflurane	AIDA	PA450106	64853	0.823
NULL	ScientificWorldJournal_2012_Jun_18_2012_564939.nxml.txt.nlp	22778699	SENT70	17	17	4	4	tramadol	IL-6	PA451735	3569	0.823
NULL	Clin_Med_Insights_Oncol_2012_May_16_6_205-217.nxml.txt.nlp	22654526	SENT248	16	16	32	32	tigecycline	VEGFR	PA164746412	3791	0.823
NULL	Biomed_Imaging_Interv_J_2010_Jul_1_6(3)_e23.nxml.txt.nlp	21611042	SENT158	12	12	19	19	paclitaxel	TIC	PA450761	23550	0.823
NULL	J_Cancer_2014_Jul_4_5(7)_559-571.nxml.txt.nlp	25057307	SENT230	14	14	0	0	tamoxifen	STAT3	PA451581	6774	0.823
NULL	Nucleic_Acids_Res_2010_Oct_28_38(19)_6418-6432.nxml.txt.nlp	20511593	SENT90	14	14	27	27	collagenase	AP-1	PA449107	2353;3727;2354;3725	0.823
NULL	Cancer_Metastasis_Rev_2010_Jun_28_29(2)_317-329.nxml.txt.nlp	20422276	SENT212	18	18	9	9	anakinra	IL-6	PA10799	3569	0.823
NULL	Nat_Chem_Biol_2010_Jun_2_6(6)_411-417.nxml.txt.nlp	20436487	SENT121	18	18	15	15	curcumin	Oct4	PA151958596	5460	0.823
NULL	Clin_Dev_Immunol_2011_Mar_28_2011_370872.nxml.txt.nlp	21461372	SENT7	9	9	19	19	doxycycline	IL-1B	PA449415	3553	0.823
NULL	Acta_Pharmacol_Sin_2011_Jul_13_32(7)_967-972.nxml.txt.nlp	21666702	SENT141	47	47	27	27	ticlopidine	CYP2C	PA451686	1562	0.823
NULL	J_Biomed_Sci_2014_Nov_18_21(1)_99.nxml.txt.nlp	25407417	SENT16	10	10	23	23	oseltamivir	CCR2	PA450721	729230	0.823
NULL	Mol_Biol_Cell_2013_Jun_1_24(11)_1619-1637.nxml.txt.nlp	23576546	SENT113	11	11	15	15	trypsin	SIMPLE	PA451806	9516	0.823
NULL	Int_J_Mol_Sci_2014_Jun_18_15(6)_11013-11029.nxml.txt.nlp	24945311	SENT535	1	1	15	15	celecoxib	STAT3	PA448871	6774	0.823
NULL	Cancer_Res_Treat_2013_Mar_31_45(1)_63-69.nxml.txt.nlp	23613672	SENT124	18	18	7	7	cisplatin	ERCC1	PA449014	2067	0.823
NULL	Oncotarget_2014_Mar_16_5(9)_2513-2528.nxml.txt.nlp	24810336	SENT74	20	20	16	16	vemurafenib	TPC1	PA165946873	53373	0.823
NULL	Nucleic_Acids_Res_2005_Jun_8_33(10)_3283-3291.nxml.txt.nlp	15944449	SENT100	6	6	15	15	sjg-136	XRCC3		7517	0.823
NULL	Cases_J_2009_Aug_24_2_7024.nxml.txt.nlp	19918503	SENT28	13	13	23	23	thrombin	VIII	PA451674	1351	0.823
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT523	35	35	5	5	aripiprazole	PRL	PA10026	5617	0.823
NULL	Neuropsychopharmacology_2009_Dec_12_34(13)_2675-2690.nxml.txt.nlp	19675535	SENT292	31	31	6	6	clozapine	c-fos	PA449061	2353	0.823
NULL	Mol_Cancer_2007_Mar_7_6_18.nxml.txt.nlp	17343740	SENT325	22	22	16	16	genistein	PC3	PA165109660	57332;7832;5122	0.823
NULL	J_Hematol_Oncol_2013_Jan_17_6_7.nxml.txt.nlp	23327530	SENT171	6	6	17	17	colchicine	Mcl-1	PA449092	4170	0.823
NULL	Mol_Med_Rep_2015_Jan_22_11(1)_83-90.nxml.txt.nlp	25338529	SENT3	12	12	19	19	octreotide	HO-1	PA450678	3162	0.823
NULL	Ther_Clin_Risk_Manag_2005_Mar_1(1)_3-13.nxml.txt.nlp	18360537	SENT36	4	4	2	2	ritonavir	CYP3A	PA451260	1574	0.823
NULL	J_Korean_Med_Sci_2012_Sep_22_27(9)_1037-1043.nxml.txt.nlp	22969249	SENT93	22	22	37	37	paricalcitol	p27	PA450798	5715;10534	0.823
NULL	Br_J_Haematol_2014_Mar_13_164(1)_811-821.nxml.txt.nlp	24328678	SENT157	9	9	25	25	lenalidomide	Aiolos	PA162363968	22806	0.823
NULL	Diabetes_2011_Mar_21_60(3)_757-765.nxml.txt.nlp	21282370	SENT161	24	24	33	33	isoproterenol	PTRF	PA450121	284119	0.823
NULL	Br_J_Clin_Pharmacol_2013_Aug_23_76(2)_299-315.nxml.txt.nlp	23701319	SENT175	0	0	10	10	alemtuzumab	IFN	PA164783958	3439	0.823
NULL	J_Cancer_2013_Nov_23_4(9)_736-754.nxml.txt.nlp	24312144	SENT234	4	4	12	12	bevacizumab	VEGFR	PA130232992	3791	0.823
NULL	Mol_Cancer_2010_Apr_23_9_87.nxml.txt.nlp	20416058	SENT145	13	13	11	11	doxorubicin	TRAIL	PA449412	8743	0.823
NULL	Front_Cell_Neurosci_2013_Aug_13_7_119.nxml.txt.nlp	23964197	SENT101	42	42	3	3	aprotinin	P19	PA448472	51561	0.823
NULL	Evid_Based_Complement_Alternat_Med_2014_May_12_2014_804746.nxml.txt.nlp	24899911	SENT157	6	6	15	15	metoclopramide	PC6	PA450475	5125	0.823
NULL	Diabetes_2011_Nov_17_60(11)_2810-2819.nxml.txt.nlp	21911750	SENT299	0	0	17	17	metformin	AMPK	PA450395	5563	0.823
NULL	Front_Oncol_2014_Sep_22_4_258.nxml.txt.nlp	25295228	SENT115	13	13	9	9	erlotinib	EGFR	PA134687924	1956	0.823
NULL	Sensors_(Basel)_2013_Feb_28_13(3)_2895-2910.nxml.txt.nlp	23449119	SENT123	17	17	42	42	pp2	PP1		5540;5464	0.823
NULL	Genetics_2011_Dec_189(4)_1177-1201.nxml.txt.nlp	22174183	SENT665	23	23	13	13	tetracaine	TORC1	PA451638	23373	0.823
NULL	EMBO_Mol_Med_2010_Mar_2(3)_98-110.nxml.txt.nlp	20201032	SENT255	15	15	5	5	imatinib	IFN	PA10804	3439	0.823
NULL	Front_Oncol_2014_Sep_29_4_251.nxml.txt.nlp	25325012	SENT249	1	1	21	21	afatinib	ERBB4	PA165981154	2066	0.823
NULL	Mol_Med_Rep_2015_Jan_22_11(1)_83-90.nxml.txt.nlp	25338529	SENT10	3	3	6	6	octreotide	HO-1	PA450678	3162	0.823
NULL	Mol_Cancer_2013_Sep_11_12_104.nxml.txt.nlp	24025152	SENT234	19	19	23	23	gemcitabine	STAT3	PA449748	6774	0.823
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1067.nxml.txt.nlp	24556682	SENT102	4	4	13	13	cytarabine	CNT1	PA449177	9154	0.823
NULL	Biochem_Res_Int_2012_May_9_2012_290971.nxml.txt.nlp	22649731	SENT179	22	22	3	3	staurosporine	ANOVA	PA165109623	4858	0.823
NULL	Iran_J_Reprod_Med_2013_Nov_11(11)_883-890.nxml.txt.nlp	24639712	SENT136	5	5	9	9	estradiol	aromatase	PA449503	1588	0.823
NULL	Br_J_Pharmacol_2014_Oct_26_171(20)_4785-4796.nxml.txt.nlp	25074741	SENT154	3	3	7	7	guanfacine	NK1R	PA449825	6869	0.823
NULL	Indian_J_Pharm_Sci_2014_Mar-Apr_76(2)_125-131.nxml.txt.nlp	24843185	SENT171	4	4	7	7	resveratrol	spatial		219793	0.823
NULL	Mol_Pain_2013_Sep_8_9_46.nxml.txt.nlp	24010880	SENT130	19	19	10	10	capsaicin	GluN1	PA448776	2902	0.823
NULL	Oncologist_2010_Feb_15_15(2)_122-129.nxml.txt.nlp	20156908	SENT137	23	23	4	4	lapatinib	HER-2	PA152241907	2064	0.823
NULL	Breast_Cancer_Res_2010_Jul_22_12(4)_R53.nxml.txt.nlp	20649975	SENT15	10	10	15	15	tamoxifen	HOXB13	PA451581	10481	0.823
NULL	EPMA_J_2013_Jan_28_4(1)_3.nxml.txt.nlp	23356214	SENT352	15	15	34	34	panitumumab	KRAS	PA162373091	3845	0.823
NULL	J_Med_Case_Reports_2011_Mar_28_5_117.nxml.txt.nlp	21443773	SENT20	15	15	3	3	sitagliptin	GLP-1	PA164748978	100125288	0.823
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT117	10	10	34	34	perifosine	GAPDH	PA165291471	2597	0.823
NULL	Cancer_Imaging_2012_May_7_12(1)_126-135.nxml.txt.nlp	22572545	SENT21	0	0	31	31	imatinib	PDGFRA	PA10804	5156	0.823
NULL	Cardiovasc_Diabetol_2010_Nov_16_9_76.nxml.txt.nlp	21080957	SENT323	13	13	23	23	exenatide	GLP-1	PA164749238	100125288	0.823
NULL	Int_J_Mol_Sci_2014_Mar_6_15(3)_4049-4059.nxml.txt.nlp	24663080	SENT31	4	4	11	11	dexmedetomidine	IL-6	PA449256	3569	0.823
NULL	Exp_Ther_Med_2013_Mar_8_5(3)_707-710.nxml.txt.nlp	23404433	SENT82	16	16	18	18	cisplatin	Bcl-2	PA449014	596	0.823
NULL	Biomed_Res_Int_2013_Aug_6_2013_602987.nxml.txt.nlp	24027759	SENT230	19	19	3	3	mitomycin	SMF	PA450524	22993	0.823
NULL	Mol_Vis_2011_Dec_27_17_3415-3422.nxml.txt.nlp	22219637	SENT14	3	3	32	32	estradiol	JNK	PA449503	5599	0.823
NULL	Nat_Biotechnol_2013_Jul_30_31(7)_630-637.nxml.txt.nlp	23811600	SENT140	14	14	5	5	staurosporine	CDC37	PA165109623	11140	0.823
NULL	Arthritis_Res_Ther_2011_Feb_8_13(1)_R17.nxml.txt.nlp	21303509	SENT213	24	24	1	1	infliximab	FSTL1	PA452639	11167	0.823
NULL	Cancers_(Basel)_2011_Apr_18_3(2)_2014-2031.nxml.txt.nlp	24212794	SENT82	14	14	8	8	cetuximab	EGFR	PA10040	1956	0.823
NULL	Saudi_J_Anaesth_2013_Apr-Jun_7(2)_151-154.nxml.txt.nlp	23956714	SENT101	11	11	7	7	theophylline	NAC	PA451647	22861	0.823
NULL	Nat_Methods_2011_Jun_24_8(6)_487-493.nxml.txt.nlp	21516115	SENT158	6	6	17	17	gefitinib	ERK	PA131301952	5594	0.823
NULL	Virol_J_2011_Nov_28_8_523.nxml.txt.nlp	22122911	SENT216	16	16	27	27	heparin	RANTES	PA449855	6352	0.823
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT96	15	15	11	11	trastuzumab	STAT3	PA451743	6774	0.823
NULL	Cell_Cycle_2012_Nov_1_11(21)_3983-3996.nxml.txt.nlp	22987153	SENT7	6	6	15	15	cisplatin	DNA2	PA449014	1763	0.823
NULL	Clin_Exp_Otorhinolaryngol_2011_Dec_15_4(4)_177-183.nxml.txt.nlp	22232712	SENT178	3	3	10	10	doxycycline	p38	PA449415	10598;1432;7965	0.823
NULL	Breast_Cancer_Res_Treat_2013_Aug_20_141(1)_43-53.nxml.txt.nlp	23959396	SENT31	46	46	21	21	trastuzumab	HER2	PA451743	2064	0.823
NULL	Cancer_Causes_Control_2013_Aug_18_24(8)_1605-1614.nxml.txt.nlp	23775025	SENT243	31	31	13	13	cyclophosphamide	CYP2C19	PA449165	1557	0.823
NULL	Cancers_(Basel)_2014_May_16_6(2)_1180-1194.nxml.txt.nlp	24840048	SENT61	0	0	31	31	imatinib	KIT	PA10804	3815	0.823
NULL	Tumour_Biol_2011_Oct_16_32(5)_965-976.nxml.txt.nlp	21678067	SENT109	4	4	15	15	urokinase	TIMP3	PA451836	7078	0.823
NULL	Diabetes_Care_2011_Apr_21_34(4)_916-922.nxml.txt.nlp	21447663	SENT235	7	7	11	11	rosiglitazone	gamma	PA451283	9913	0.823
NULL	Core_Evid_2010_Oct_21_5_61-76.nxml.txt.nlp	21042543	SENT157	26	26	17	17	panitumumab	EGFR	PA162373091	1956	0.823
NULL	J_Oncol_2009_Mar_24_2009_491985.nxml.txt.nlp	19325924	SENT168	16	16	3	3	genistein	CXCR4	PA165109660	7852	0.823
NULL	Neural_Regen_Res_2013_May_5_8(13)_1180-1189.nxml.txt.nlp	25206412	SENT36	3	3	0	0	fasudil	Rho	PA165946121	29984	0.823
NULL	Neural_Regen_Res_2014_Nov_1_9(21)_1897-1901.nxml.txt.nlp	25558239	SENT73	27	27	13	13	diazepam	CA1	PA449283	759	0.823
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT166	31	31	1	1	midazolam	TDI	PA450496	100038246	0.823
NULL	Exp_Ther_Med_2014_Mar_10_7(3)_640-648.nxml.txt.nlp	24520260	SENT12	4	4	16	16	resveratrol	p38		10598;1432;7965	0.823
NULL	Clin_Epidemiol_2014_May_12_6_155-168.nxml.txt.nlp	24872722	SENT82	4	4	1	1	diclofenac	OTC	PA449293	5009	0.823
NULL	Breast_Cancer_Res_2005_Jan_28_7(3)_R284-R290.nxml.txt.nlp	15987423	SENT89	20	20	16	16	tamoxifen	SULT1A1	PA451581	6817	0.823
NULL	Chin_J_Cancer_2012_Mar_31(3)_150-158.nxml.txt.nlp	22360854	SENT22	9	9	0	0	mitoxantrone	ABCG2	PA450526	9429	0.823
NULL	J_Cell_Biol_1998_Mar_23_140(6)_1331-1346.nxml.txt.nlp	9508767	SENT380	25	25	16	16	chloramphenicol	POMC	PA448927	5443	0.823
NULL	Toxins_(Basel)_2010_Oct_28_2(11)_2584-2592.nxml.txt.nlp	22069565	SENT105	25	25	16	16	warfarin	CYP2C9	PA451906	1559	0.823
NULL	J_Oncol_2012_Feb_6_2012_345164.nxml.txt.nlp	22481922	SENT75	29	29	18	18	daclizumab	CD25	PA164764446	3669;3559	0.823
NULL	Virol_J_2011_May_24_8_256.nxml.txt.nlp	21609474	SENT202	14	14	6	6	paraformaldehyde	DEF	PA450790	27042	0.823
NULL	Mol_Cancer_2014_Feb_20_13_31.nxml.txt.nlp	24555568	SENT5	38	38	3	3	temozolomide	NKCC1	PA451609	6558	0.823
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Apr_24_66(Pt_5)_o1135-o1136.nxml.txt.nlp	21579184	SENT66	15	15	3	3	ethanol	CS2	PA448073	64084	0.823
NULL	Case_Rep_Transplant_2014_Jan_2_2014_548243.nxml.txt.nlp	24575309	SENT91	3	3	10	10	sirolimus	CYP3A4	PA451365	1576	0.823
NULL	Clin_Med_Insights_Oncol_2013_Oct_29_7_269-277.nxml.txt.nlp	24250243	SENT33	6	6	17	17	axitinib	VEGFR	PA164924493	3791	0.823
NULL	Leukemia_2014_Jun_25_28(6)_1280-1288.nxml.txt.nlp	24270737	SENT209	19	19	5	5	decitabine	PD-L1	PA164749631	29126	0.823
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT196	6	6	13	13	cisplatin	JNK	PA449014	5599	0.823
NULL	Eur_J_Med_Res_2009_Dec_7_14(Suppl_4)_32-37.nxml.txt.nlp	20156721	SENT33	4	4	9	9	ketanserin	5-HT2A	PA131053734	3356	0.823
NULL	F1000_Med_Rep_2009_Dec_9_1_93.nxml.txt.nlp	20948684	SENT82	22	22	13	13	doxycycline	LAM	PA449415	7249;7248	0.823
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2007_Dec_6_64(Pt_1)_o161.nxml.txt.nlp	21200727	SENT62	20	20	12	12	ethanol	mol	PA448073	90527	0.823
NULL	Toxins_(Basel)_2010_Oct_26_2(11)_2490-2518.nxml.txt.nlp	22069563	SENT220	24	24	17	17	cisplatin	TLR4	PA449014	7099	0.823
NULL	Diabetes_Metab_J_2013_Oct_17_37(5)_315-325.nxml.txt.nlp	24199159	SENT196	8	8	11	11	resveratrol	SIRT1		23411	0.823
NULL	Pharmaceuticals_(Basel)_2013_Apr_26_6(5)_579-603.nxml.txt.nlp	24276168	SENT245	4	4	19	19	fluorescein	DHFR	PA164746009	1719	0.823
NULL	Curr_Opin_Endocrinol_Diabetes_Obes_2014_Oct_28_21(5)_394-404.nxml.txt.nlp	25122493	SENT162	12	12	18	18	thyroglobulin	RAI	PA164754910	10848;6050	0.823
NULL	Br_J_Pharmacol_2012_Jan_165(2)_390-400.nxml.txt.nlp	21671897	SENT284	19	19	3	3	suramin	P2X2	PA10292	22953	0.823
NULL	Arthritis_Res_Ther_2014_Jul_18_16(4)_R153.nxml.txt.nlp	25037855	SENT108	37	37	16	16	adalimumab	CD14	PA10004	929	0.823
NULL	Biologics_2012_Jul_13_6_221-231.nxml.txt.nlp	22904614	SENT38	12	12	25	25	cetuximab	EGFR	PA10040	1956	0.823
NULL	J_Biol_Chem_2013_Jul_19_288(29)_21412-21421.nxml.txt.nlp	23740251	SENT105	12	12	3	3	suramin	P2X2	PA10292	22953	0.823
NULL	Nat_Chem_Biol_2010_Apr_28_6(4)_291-299.nxml.txt.nlp	20190765	SENT190	8	8	17	17	dasatinib	AKT	PA162372878	207	0.823
NULL	Br_J_Cancer_2011_Sep_6_105(6)_807-813.nxml.txt.nlp	21847121	SENT86	33	33	11	11	lapatinib	HER3	PA152241907	2065	0.823
NULL	Cancer_Med_2013_Feb_3_2(1)_11-20.nxml.txt.nlp	24133623	SENT291	2	2	26	26	irinotecan	BRAF	PA450085	673	0.823
NULL	Curr_Oncol_2009_Jan_16(1)_27-48.nxml.txt.nlp	19229369	SENT268	20	20	26	26	docetaxel	EGFR	PA449383	1956	0.823
NULL	FEBS_Open_Bio_2014_Jul_8_4_672-682.nxml.txt.nlp	25180151	SENT205	16	16	0	0	nadh	ADP	PA164755085	23038	0.823
NULL	Carcinogenesis_2011_Nov_1_32(11)_1724-1733.nxml.txt.nlp	21890461	SENT12	20	20	5	5	tamoxifen	BPA	PA451581	667	0.823
NULL	Aging_(Albany_NY)_2010_Dec_20_2(12)_959-968.nxml.txt.nlp	21191146	SENT128	31	31	21	21	cisplatin	LKB1	PA449014	6794	0.823
NULL	Biomed_Res_Int_2014_May_14_2014_642798.nxml.txt.nlp	24955366	SENT59	23	23	32	32	hyaluronan	EGF	PA165958431	1950	0.823
NULL	Acta_Pharmacol_Sin_2010_Jul_28_31(7)_867-873.nxml.txt.nlp	20581857	SENT19	13	13	10	10	docetaxel	PC3	PA449383	57332;7832;5122	0.823
NULL	Br_J_Cancer_2012_Jan_3_106(1)_148-156.nxml.txt.nlp	22045191	SENT130	6	6	21	21	erlotinib	EGFR	PA134687924	1956	0.823
NULL	Biosci_Rep_2013_Aug_14_33(4)_e00057.nxml.txt.nlp	23837802	SENT120	22	22	25	25	cisplatin	IL6	PA449014	3569	0.823
NULL	Cough_2009_Dec_16_5_11.nxml.txt.nlp	20015366	SENT155	18	18	5	5	guaifenesin	OTC	PA449818	5009	0.823
NULL	Mol_Cancer_2012_Jun_26_11_43.nxml.txt.nlp	22731636	SENT130	27	27	13	13	pp2	PP2		4888	0.823
NULL	Cancer_Cell_Int_2014_Jan_29_14_10.nxml.txt.nlp	24472145	SENT10	23	23	5	5	doxorubicin	HER-2	PA449412	2064	0.823
NULL	J_Cell_Mol_Med_2013_Dec_6_17(12)_1588-1597.nxml.txt.nlp	24199964	SENT241	29	29	36	36	doxycycline	APT	PA449415	653639	0.823
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Jul_5_64(Pt_8)_o1398.nxml.txt.nlp	21203118	SENT60	20	20	3	3	ethanol	mol	PA448073	90527	0.823
NULL	Exp_Mol_Med_2012_Apr_30_44(4)_281-292.nxml.txt.nlp	22228119	SENT40	15	15	24	24	genistein	P15	PA165109660	1030;29107	0.823
NULL	Cell_Death_Differ_2009_Aug_17_16(8)_1167-1179.nxml.txt.nlp	19373248	SENT69	5	5	14	14	mk-571	MRP1		4437	0.823
NULL	Nucleic_Acids_Res_2011_Dec_31_39(22)_9536-9548.nxml.txt.nlp	21880590	SENT211	20	20	26	26	paclitaxel	BRCA1	PA450761	672	0.823
NULL	Adv_Hematol_2012_Mar_8_2012_856341.nxml.txt.nlp	22496694	SENT152	23	23	38	38	enoxaparin	TKR	PA449463	8277	0.823
NULL	Diagn_Pathol_2013_May_9_8_76.nxml.txt.nlp	23656792	SENT31	3	3	9	9	trastuzumab	HER2	PA451743	2064	0.823
NULL	Br_J_Cancer_2012_Feb_14_106(4)_685-692.nxml.txt.nlp	22294184	SENT118	12	12	18	18	lovastatin	p27	PA450272	5715;10534	0.823
NULL	Oncoscience_2014_Jun_4_1(6)_446-456.nxml.txt.nlp	25594043	SENT20	5	5	3	3	metformin	AMPK	PA450395	5563	0.823
NULL	Int_J_Trichology_2014_Jul-Sep_6(3)_113-139.nxml.txt.nlp	NULL	SENT281	4	4	9	9	metformin	gamma	PA450395	9913	0.823
NULL	Case_Rep_Endocrinol_2011_Oct_29_2011_370583.nxml.txt.nlp	22937282	SENT29	17	17	23	23	cinacalcet	PTH	PA164776671	5741	0.823
NULL	Mol_Biol_Cell_2013_Aug_15_24(16)_2582-2592.nxml.txt.nlp	23783032	SENT116	13	13	19	19	bortezomib	FANCL	PA10252	55120	0.823
NULL	Br_J_Cancer_2012_Jan_3_106(1)_25-31.nxml.txt.nlp	22127284	SENT27	0	0	10	10	lapatinib	HER2	PA152241907	2064	0.823
NULL	Oncotarget_2013_Jul_21_4(8)_1266-1279.nxml.txt.nlp	23907540	SENT129	7	7	10	10	doxycycline	PTEN	PA449415	5728	0.823
NULL	Ann_Dermatol_2011_Oct_31_23(Suppl_2)_S169-S174.nxml.txt.nlp	22148042	SENT104	28	28	11	11	cisplatin	CHOP	PA449014	1649	0.823
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_33-43.nxml.txt.nlp	17912634	SENT196	22	22	18	18	tamoxifen	HER2	PA451581	2064	0.823
NULL	Biochem_Biophys_Res_Commun_2011_Sep_9_412(4)_747-751.nxml.txt.nlp	21871446	SENT105	37	37	13	13	mannitol	MARCKS	PA450320	4082	0.823
NULL	Cancer_Immunol_Immunother_2013_Aug_27_62(10)_1637-1648.nxml.txt.nlp	23982484	SENT287	4	4	12	12	lenalidomide	CD40	PA162363968	958	0.823
NULL	Br_J_Cancer_2011_Sep_6_105(6)_807-813.nxml.txt.nlp	21847121	SENT86	31	31	9	9	gefitinib	HER2	PA131301952	2064	0.823
NULL	Nat_Commun_2012_Feb_14_3_672.nxml.txt.nlp	22334075	SENT385	12	12	1	1	rosiglitazone	PTEN	PA451283	5728	0.823
NULL	Clin_Interv_Aging_2008_Mar_3(1)_55-70.nxml.txt.nlp	18488879	SENT133	11	11	2	2	bucindolol	BEST	PA165945764	7439	0.823
NULL	Int_J_Vasc_Med_2013_Jun_26_2013_456852.nxml.txt.nlp	23878738	SENT115	10	10	29	29	losartan	AT1	PA450268	9197;185	0.823
NULL	Pharmaceuticals_(Basel)_2013_Aug_21_6(8)_988-1038.nxml.txt.nlp	24276379	SENT370	7	7	28	28	panitumumab	EGFR	PA162373091	1956	0.823
NULL	eLife_2014_May_20_3_e01763.nxml.txt.nlp	24844244	SENT349	40	40	22	22	doxycycline	MELK	PA449415	9833	0.823
NULL	Breast_Cancer_Res_2005_Jan_28_7(3)_R284-R290.nxml.txt.nlp	15987423	SENT8	20	20	6	6	tamoxifen	CYP2D6	PA451581	1565	0.823
NULL	Breast_Cancer_Res_2002_Aug_27_4(6)_213-217.nxml.txt.nlp	12473165	SENT141	12	12	4	4	tamoxifen	ATAC	PA451581	6375	0.823
NULL	Cerebrospinal_Fluid_Res_2006_Dec_21_3_13.nxml.txt.nlp	17184532	SENT142	39	39	9	9	dextran	CO2	PA449261	4513	0.822
NULL	Amino_Acids_2012_Oct_10_43(4)_1751-1759.nxml.txt.nlp	22407485	SENT71	12	12	6	6	carrageenan	DAG	PA448814	1605	0.822
NULL	J_Cell_Biol_1998_Nov_16_143(4)_901-910.nxml.txt.nlp	9817749	SENT35	0	0	8	8	geldanamycin	Hsp90	PA152031327	3320	0.822
NULL	Oncogene_2014_Feb_6_33(6)_713-723.nxml.txt.nlp	23435429	SENT99	28	28	10	10	etoposide	BRCA1	PA449552	672	0.822
NULL	Br_J_Cancer_2010_Sep_7_103(6)_852-860.nxml.txt.nlp	20736946	SENT195	19	19	31	31	doxycycline	A-2	PA449415	27239	0.822
NULL	Br_J_Cancer_2012_Oct_9_107(8)_1327-1336.nxml.txt.nlp	22990650	SENT179	20	20	12	12	carboplatin	ERBB2	PA448803	2064	0.822
NULL	Arthritis_Res_Ther_2008_Mar_17_10(2)_R33.nxml.txt.nlp	18346273	SENT150	6	6	0	0	infliximab	HMGB1	PA452639	3146	0.822
NULL	Front_Immunol_2012_Jan_12_2_98.nxml.txt.nlp	22566887	SENT198	15	15	7	7	tocilizumab	IL-6	PA165292659	3569	0.822
NULL	Oncotarget_2013_Aug_29_4(10)_1673-1685.nxml.txt.nlp	24127549	SENT98	17	17	11	11	bortezomib	SIRT1	PA10252	23411	0.822
NULL	Br_J_Cancer_2009_Jul_21_101(2)_269-277.nxml.txt.nlp	19603033	SENT36	8	8	0	0	cisplatin	MLH1	PA449014	4292	0.822
NULL	Cell_Death_Dis_2014_Jul_3_5(7)_e1311.nxml.txt.nlp	24991763	SENT286	20	20	8	8	ketamine	BAX	PA450144	581	0.822
NULL	Nat_Commun_2013_4_1332.nxml.txt.nlp	23299882	SENT173	4	4	22	22	ebselen	San	PA161660841	80218	0.822
NULL	Osteoporos_Int_2010_Oct_18_21(10)_1657-1680.nxml.txt.nlp	20480148	SENT107	35	35	32	32	medroxyprogesterone	CEE	PA450344	51608	0.822
NULL	Breast_Cancer_Res_2007_Jul_22_9(4)_R45.nxml.txt.nlp	17659092	SENT103	17	17	0	0	choline	FDG	PA448976	23583	0.822
NULL	Brain_Res_2013_Jul_12_1521(100)_1-15.nxml.txt.nlp	22789905	SENT70	6	6	37	37	verapamil	P-gp	PA451868	5243	0.822
NULL	Breast_Cancer_(Auckl)_2014_Mar_23_8_51-56.nxml.txt.nlp	24678242	SENT98	18	18	14	14	carboplatin	BRCA1	PA448803	672	0.822
NULL	Nat_Genet_2011_Oct_23_43(12)_1232-1236.nxml.txt.nlp	22019782	SENT83	28	28	9	9	heparin	CFH	PA449855	3075	0.822
NULL	Case_Rep_Oncol_2012_Jan_7_5(1)_1-8.nxml.txt.nlp	22379470	SENT101	10	10	6	6	cinacalcet	PTH	PA164776671	5741	0.822
NULL	An_Bras_Dermatol_2014_Mar-Apr_89(2)_266-273.nxml.txt.nlp	24770503	SENT143	12	12	5	5	thalidomide	ENL	PA451644	4298	0.822
NULL	Chin_J_Cancer_2011_Oct_30(10)_701-711.nxml.txt.nlp	21959047	SENT207	18	18	11	11	cetuximab	EGFR	PA10040	1956	0.822
NULL	Case_Rep_Neurol_2010_Nov_12_2(3)_139-144.nxml.txt.nlp	21113284	SENT68	8	8	15	15	rituximab	San	PA451261	80218	0.822
NULL	Mol_Cancer_2008_Sep_12_7_70.nxml.txt.nlp	18789133	SENT10	13	13	9	9	belinostat	HDAC1		3065	0.822
NULL	J_Thromb_Haemost_2010_Mar_8(3)_577-587.nxml.txt.nlp	20040043	SENT117	25	25	28	28	rosiglitazone	mol	PA451283	90527	0.822
NULL	J_Cell_Biol_2003_Dec_8_163(5)_1099-1109.nxml.txt.nlp	14662748	SENT122	22	22	7	7	forskolin	AQP2	PA146096022	359	0.822
NULL	J_Clin_Biochem_Nutr_2008_Nov_31_43(3)_167-174.nxml.txt.nlp	19015751	SENT118	13	13	0	0	galactose	GAL	PA449725	51083	0.822
NULL	Int_J_Endocrinol_2013_Nov_13_2013_686315.nxml.txt.nlp	24324494	SENT222	12	12	29	29	rosiglitazone	CYP2C8	PA451283	1558	0.822
NULL	ScientificWorldJournal_2013_Oct_1_2013_654829.nxml.txt.nlp	24198725	SENT279	6	6	15	15	naproxen	NF1	PA450595	4763	0.822
NULL	Ann_Hematol_2011_Dec_8_90(12)_1399-1407.nxml.txt.nlp	21476016	SENT89	19	19	13	13	vincristine	CHOP	PA451879	1649	0.822
NULL	Ecancermedicalscience_2010_Aug_27_4_167.nxml.txt.nlp	22276028	SENT99	22	22	14	14	trastuzumab	HER-2	PA451743	2064	0.822
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT48	23	23	16	16	metformin	p53	PA450395	7157	0.822
NULL	Environ_Health_Perspect_2010_Jul_3_118(7)_936-942.nxml.txt.nlp	20199942	SENT170	32	32	5	5	arsenite	NKRF	PA452638	55922	0.822
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT1161	5	5	2	2	nevirapine	ABCC10	PA450616	89845	0.822
NULL	J_Hematol_Oncol_2013_Jul_9_6_49.nxml.txt.nlp	23837843	SENT228	15	15	21	21	verapamil	Rho	PA451868	29984	0.822
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT102	4	4	18	18	cisplatin	p53	PA449014	7157	0.822
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT229	0	0	4	4	chloroquine	BMPR-II	PA448948	659	0.822
NULL	Exp_Mol_Med_2012_Sep_30_44(9)_536-544.nxml.txt.nlp	22771771	SENT88	31	31	12	12	celecoxib	p53	PA448871	7157	0.822
NULL	F1000_Med_Rep_2010_Jun_23_2_45.nxml.txt.nlp	20948839	SENT31	22	22	24	24	zoledronate	IL-2	PA10235	3558	0.822
NULL	Indian_Dermatol_Online_J_2013_Jul-Sep_4(3)_246-249.nxml.txt.nlp	23984250	SENT38	30	30	26	26	gefitinib	EGFR	PA131301952	1956	0.822
NULL	Iran_J_Pharm_Res_2013_Winter_12(Suppl)_37-46.nxml.txt.nlp	24250670	SENT131	0	0	29	29	etoposide	P-gp	PA449552	5243	0.822
NULL	Brain_Pathol_2009_Jan_19(1)_132-143.nxml.txt.nlp	19076778	SENT262	12	12	9	9	perifosine	AKT	PA165291471	207	0.822
NULL	Arthritis_Res_Ther_2009_Aug_28_11(4)_R131.nxml.txt.nlp	19715572	SENT152	37	37	13	13	rituximab	CD19	PA451261	930	0.822
NULL	Target_Oncol_2013_Jun_27_8(2)_127-136.nxml.txt.nlp	23625191	SENT84	18	18	14	14	panitumumab	KRAS	PA162373091	3845	0.822
NULL	Mol_Cancer_2013_May_24_12_47.nxml.txt.nlp	23705854	SENT249	13	13	16	16	naproxen	MRP1	PA450595	4437	0.822
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1495-1502.nxml.txt.nlp	21989186	SENT201	24	24	28	28	leucovorin	HSI	PA450198	57016	0.822
NULL	Ther_Clin_Risk_Manag_2006_Dec_2(4)_365-375.nxml.txt.nlp	18360649	SENT108	19	19	2	2	methotrexate	ACR	PA450428	49	0.822
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Dec_23_68(Pt_1)_o228.nxml.txt.nlp	22259509	SENT67	13	13	4	4	ethanol	mol	PA448073	90527	0.822
NULL	Clin_Exp_Gastroenterol_2012_May_14_5_49-59.nxml.txt.nlp	22649281	SENT89	12	12	20	20	pantoprazole	CYP2C19	PA450774	1557	0.822
NULL	Diabetes_2013_Mar_14_62(3)_953-964.nxml.txt.nlp	23223176	SENT196	25	25	27	27	paroxetine	PRX	PA450801	9588;57716	0.822
NULL	J_Biol_Chem_2012_Apr_27_287(18)_14644-14658.nxml.txt.nlp	22375002	SENT350	21	21	16	16	forskolin	CC2D1A	PA146096022	54862	0.822
NULL	Asian_Spine_J_2014_Jun_9_8(3)_361-364.nxml.txt.nlp	24967052	SENT66	20	20	13	13	thrombin	ADP	PA451674	23038	0.822
NULL	Front_Endocrinol_(Lausanne)_2013_Jul_29_4_94.nxml.txt.nlp	23908645	SENT176	21	21	8	8	estradiol	UGT2B17	PA449503	7367	0.822
NULL	J_Res_Med_Sci_2011_Sep_16(9)_1176-1182.nxml.txt.nlp	22973386	SENT37	22	22	27	27	bupivacaine	ACL	PA135057240	47	0.822
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_96-101.nxml.txt.nlp	25568845	SENT47	6	6	3	3	trastuzumab	HER-2	PA451743	2064	0.822
NULL	Indian_J_Hum_Genet_2014_Apr-Jun_20(2)_175-184.nxml.txt.nlp	25400347	SENT9	39	39	33	33	warfarin	CYP2C9	PA451906	1559	0.822
NULL	Clin_Pharmacol_2012_Feb_20_4_13-20.nxml.txt.nlp	22427735	SENT45	27	27	9	9	clopidogrel	San	PA449053	80218	0.822
NULL	Oncotarget_2011_Dec_31_2(12)_935-947.nxml.txt.nlp	22249213	SENT226	5	5	10	10	paclitaxel	MCAK	PA450761	11004	0.822
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_33-43.nxml.txt.nlp	17912634	SENT134	3	3	18	18	tamoxifen	HER2	PA451581	2064	0.822
NULL	Support_Care_Cancer_2014_Dec_14_22(3)_837-846.nxml.txt.nlp	24337717	SENT20	21	21	10	10	irinotecan	UGT1A9	PA450085	54600	0.822
NULL	Int_J_Surg_Oncol_2010_May_30_2010_581540.nxml.txt.nlp	22312490	SENT157	4	4	6	6	thyroglobulin	TTF-1	PA164754910	7080	0.822
NULL	EMBO_Mol_Med_2012_Jul_19_4(7)_647-659.nxml.txt.nlp	22514144	SENT135	9	9	13	13	trypsin	ADAM10	PA451806	102	0.822
NULL	Ann_Indian_Acad_Neurol_2008_Oct-Dec_11(4)_245-247.nxml.txt.nlp	19893682	SENT51	35	35	45	45	nevirapine	CD4	PA450616	920	0.822
NULL	AIDS_Res_Ther_2013_May_1_10_10.nxml.txt.nlp	23634877	SENT126	38	38	28	28	atorvastatin	CD4	PA448500	920	0.822
NULL	Mol_Pain_2013_Jun_10_9_27.nxml.txt.nlp	23758830	SENT112	10	10	7	7	tetracaine	ASIC1	PA451638	41	0.822
NULL	Oncol_Rep_2012_Apr_16_27(4)_971-978.nxml.txt.nlp	22266706	SENT145	4	4	10	10	cisplatin	Mcl-1	PA449014	4170	0.822
NULL	Front_Chem_2014_Dec_23_2_113.nxml.txt.nlp	25566531	SENT159	11	11	13	13	curcumin	IL-8	PA151958596	3576	0.822
NULL	Acta_Pharmacol_Sin_2012_Jan_3_33(1)_49-56.nxml.txt.nlp	22212430	SENT117	13	13	28	28	thrombin	AP-1	PA451674	2353;3727;2354;3725	0.822
NULL	Br_J_Cancer_2014_Nov_25_111(11)_2091-2102.nxml.txt.nlp	25349971	SENT216	26	26	20	20	imatinib	PTPN18	PA10804	26469	0.822
NULL	Acta_Pharmacol_Sin_2014_Jun_4_35(6)_752-757.nxml.txt.nlp	24902786	SENT94	16	16	5	5	tamoxifen	STL2	PA451581	1301	0.822
NULL	Thorax_2009_Sep_3_64(9)_798-805.nxml.txt.nlp	19497921	SENT61	21	21	5	5	paraformaldehyde	CD11b	PA450790	3684	0.822
NULL	Evid_Based_Complement_Alternat_Med_2012_Dec_20_2012_908601.nxml.txt.nlp	23326293	SENT29	40	40	22	22	oxaliplatin	HCC	PA131285527	84668	0.822
NULL	Front_Oncol_2014_Mar_25_4_54.nxml.txt.nlp	24724051	SENT346	9	9	24	24	imatinib	BCL6	PA10804	604	0.822
NULL	Indian_J_Endocrinol_Metab_2011_Oct_15(Suppl4)_S374-S379.nxml.txt.nlp	22145142	SENT92	13	13	10	10	nitrendipine	ABCD2	PA146096020	225	0.822
NULL	Int_J_Vasc_Med_2012_Aug_22_2012_201027.nxml.txt.nlp	21876813	SENT259	11	11	9	9	lovastatin	CYP3A4	PA450272	1576	0.822
NULL	J_Med_Case_Reports_2011_Oct_21_5_518.nxml.txt.nlp	22017919	SENT18	27	27	10	10	thrombin	HAP	PA451674	5915;10313	0.822
NULL	Ther_Clin_Risk_Manag_2007_Mar_3(1)_133-148.nxml.txt.nlp	18360621	SENT15	25	25	30	30	etanercept	p75	PA449515	7133;11168	0.822
NULL	Br_J_Cancer_1985_Nov_52(5)_757-763.nxml.txt.nlp	3933536	SENT9	13	13	20	20	trypsin	gamma	PA451806	9913	0.822
NULL	Biomed_Res_Int_2014_Jun_24_2014_132702.nxml.txt.nlp	25050322	SENT171	5	5	26	26	metformin	LKB1	PA450395	6794	0.822
NULL	J_Hematol_Oncol_2010_Aug_26_3_28.nxml.txt.nlp	20796291	SENT49	2	2	40	40	fluorescein	San	PA164746009	80218	0.822
NULL	Cancer_Cell_Int_2009_Sep_10_9_25.nxml.txt.nlp	19744341	SENT11	0	0	15	15	glucosamine	STAT3	PA164747613	6774	0.822
NULL	J_Gen_Physiol_1991_Aug_1_98(2)_315-347.nxml.txt.nlp	1658193	SENT11	1	1	31	31	creatine	gamma	PA164778930	9913	0.822
NULL	Front_Neurol_2014_Feb_18_5_17.nxml.txt.nlp	24600432	SENT159	6	6	25	25	levetiracetam	CD95	PA450206	355	0.822
NULL	Mol_Cancer_2008_May_21_7_42.nxml.txt.nlp	18492291	SENT14	0	0	8	8	gefitinib	EGFR	PA131301952	1956	0.822
NULL	J_Nutr_Metab_2011_Oct_1_2011_525094.nxml.txt.nlp	21977315	SENT144	1	1	21	21	resveratrol	SIRT1		23411	0.822
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT608	3	3	5	5	quetiapine	PRL	PA451201	5617	0.822
NULL	Front_Oncol_2014_Mar_6_4_40.nxml.txt.nlp	24639951	SENT409	12	12	15	15	cisplatin	P-gp	PA449014	5243	0.822
NULL	J_Anim_Sci_Biotechnol_2013_Dec_26_4(1)_54.nxml.txt.nlp	24369099	SENT51	22	22	15	15	formaldehyde	LAB	PA449703	7462	0.822
NULL	Hum_Genomics_2009_Jan_1_3(2)_101-102.nxml.txt.nlp	19164086	SENT12	18	18	7	7	ethanol	ALDH2	PA448073	217	0.822
NULL	Anemia_2012_Aug_12_2012_297641.nxml.txt.nlp	22924125	SENT145	3	3	21	21	deferasirox	EOS	PA164760843	260429	0.822
NULL	Oncotarget_2012_Nov_17_4(1)_18-28.nxml.txt.nlp	23248157	SENT77	5	5	18	18	pargyline	U87	PA450797	677775;641648	0.822
NULL	Int_J_Biomed_Sci_2008_Dec_4(4)_260-265.nxml.txt.nlp	19568323	SENT80	0	0	21	21	forskolin	aromatase	PA146096022	1588	0.822
NULL	Front_Pharmacol_2014_May_30_5_132.nxml.txt.nlp	24910615	SENT134	8	8	25	25	estradiol	PDE7B	PA449503	27115	0.822
NULL	Breast_Cancer_Res_2005_May_24_7(5)_R589-R597.nxml.txt.nlp	16168102	SENT112	37	37	14	14	doxorubicin	HER3	PA449412	2065	0.822
NULL	Arch_Toxicol_2014_Nov_5_88(12)_2135-2190.nxml.txt.nlp	25370008	SENT719	3	3	0	0	benzphetamine	CYP2W1	PA448586	54905	0.822
NULL	J_Clin_Immunol_2007_May_14_27(3)_275-283.nxml.txt.nlp	17510806	SENT151	23	23	12	12	rosiglitazone	IFN	PA451283	3439	0.822
NULL	Cell_Cycle_2012_Nov_1_11(21)_4069-4078.nxml.txt.nlp	23095523	SENT151	32	32	19	19	imatinib	IRE1	PA10804	2081	0.822
NULL	Oncol_Lett_2015_Jan_4_9(1)_91-95.nxml.txt.nlp	25435939	SENT73	12	12	8	8	bleomycin	NACT	PA448645	284111	0.822
NULL	Int_Semin_Surg_Oncol_2008_Apr_28_5_9.nxml.txt.nlp	18442393	SENT91	14	14	7	7	tamoxifen	HER-2	PA451581	2064	0.822
NULL	Infect_Drug_Resist_2014_Aug_19_7_223-228.nxml.txt.nlp	25187730	SENT24	12	12	14	14	ciprofloxacin	CPX	PA449009	1371;10682;1377	0.822
NULL	Case_Rep_Obstet_Gynecol_2011_Sep_22_2011_896964.nxml.txt.nlp	22567519	SENT22	35	35	15	15	nevirapine	CD4	PA450616	920	0.822
NULL	Diabetes_Metab_Syndr_Obes_2010_Dec_6_3_421-429.nxml.txt.nlp	21437112	SENT28	6	6	13	13	curcumin	STZ	PA151958596	6484	0.822
NULL	Mol_Cancer_2014_Jun_27_13_159.nxml.txt.nlp	24972933	SENT132	11	11	22	22	cyclophosphamide	CTRL	PA449165	1506	0.822
NULL	Clin_Transl_Allergy_2013_Sep_2_3_29.nxml.txt.nlp	24004581	SENT7	24	24	6	6	omalizumab	IL-4	PA164752253	3565	0.822
NULL	Mol_Cancer_2010_Aug_16_9_217.nxml.txt.nlp	20712901	SENT5	15	15	19	19	curcumin	STAT3	PA151958596	6774	0.822
NULL	Endocr_Relat_Cancer_2014_Apr_21(2)_311-326.nxml.txt.nlp	24478054	SENT141	24	24	13	13	denosumab	RANKL	PA166048634	8600	0.822
NULL	Braz_J_Microbiol_2008_Jun_1_Apr-Jun_39(2)_325-332.nxml.txt.nlp	24031225	SENT16	6	6	8	8	ethanol	CO2	PA448073	4513	0.822
NULL	Br_J_Cancer_2012_Oct_9_107(8)_1327-1336.nxml.txt.nlp	22990650	SENT179	16	16	41	41	pertuzumab	ERBB2		2064	0.822
NULL	Asia_Pac_Allergy_2013_Jul_30_3(3)_194-199.nxml.txt.nlp	23956966	SENT76	5	5	19	19	methacholine	STAT6	PA165958382	6778	0.822
NULL	Cancer_Causes_Control_2012_Jan_21_23(1)_207-211.nxml.txt.nlp	22015647	SENT12	19	19	21	21	diethylstilbestrol	DES	PA449307	1674	0.822
NULL	Oxid_Med_Cell_Longev_2013_Dec_5_2013_963520.nxml.txt.nlp	24381719	SENT272	2	2	27	27	fluoxetine	TNF	PA449673	7124	0.822
NULL	J_Cell_Biol_2001_Aug_6_154(3)_599-610.nxml.txt.nlp	11481345	SENT72	10	10	36	36	doxycycline	ARNO	PA449415	9266	0.822
NULL	Oncotarget_2012_May_4_3(4)_395-398.nxml.txt.nlp	22565037	SENT25	15	15	0	0	metformin	CD44	PA450395	960	0.822
NULL	Chem_Rev_2011_Oct_12_111(10)_5899-5921.nxml.txt.nlp	21923193	SENT536	27	27	11	11	diclofenac	FAAH	PA449293	79152;2166	0.822
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_25_2013_127075.nxml.txt.nlp	23878590	SENT134	14	14	25	25	genistein	GDNF	PA165109660	2668	0.822
NULL	Cancers_(Basel)_2011_Aug_9_3(3)_3189-3205.nxml.txt.nlp	24212952	SENT126	30	30	15	15	hyaluronan	TSG-6	PA165958431	7130	0.822
NULL	Front_Neurol_2013_Oct_7_4_157.nxml.txt.nlp	24109476	SENT487	26	26	28	28	midazolam	5-HT1A	PA450496	3350	0.822
NULL	Biosci_Rep_2012_Aug_1_32(Pt_4)_361-374.nxml.txt.nlp	22762204	SENT1100	15	15	1	1	trastuzumab	PTEN	PA451743	5728	0.822
NULL	Arthritis_Res_Ther_2003_Mar_19_5(3)_131-135.nxml.txt.nlp	12723978	SENT146	14	14	8	8	rituximab	B19	PA451261	59271	0.822
NULL	Oncogenesis_2014_Dec_15_3(12)_e133.nxml.txt.nlp	25500906	SENT127	14	14	16	16	trastuzumab	HER2	PA451743	2064	0.822
NULL	Case_Rep_Oncol_Med_2014_Dec_23_2014_597291.nxml.txt.nlp	25587475	SENT125	15	15	26	26	dacarbazine	TNF-alpha	PA449197	7124	0.822
NULL	Neuroscience_2009_Jun_30_161(2-3)_572-577.nxml.txt.nlp	19327387	SENT38	12	12	32	32	collagenase	CO2	PA449107	4513	0.822
NULL	Breast_Cancer_Res_2014_Sep_28_16(5)_449.nxml.txt.nlp	25260534	SENT82	31	31	8	8	fluorescein	NPM	PA164746009	4869	0.822
NULL	Cell_Death_Dis_2013_Sep_5_4(9)_e791.nxml.txt.nlp	24008735	SENT137	3	3	10	10	gemcitabine	p53	PA449748	7157	0.822
NULL	Can_J_Infect_Dis_Med_Microbiol_2014_May-Jun_25(3)_155-158.nxml.txt.nlp	25285112	SENT80	21	21	29	29	doxycycline	TMP	PA449415	2012	0.822
NULL	Anal_Biochem_2014_Jun_1_454(100)_17-22.nxml.txt.nlp	24637157	SENT373	4	4	2	2	suramin	TDP1	PA10292	55775	0.822
NULL	Nat_Neurosci_2012_Sep_5_15(9)_1245-1254.nxml.txt.nlp	22864611	SENT216	6	6	14	14	clozapine	HDAC2	PA449061	3066	0.822
NULL	Oncotarget_2012_Nov_17_4(1)_18-28.nxml.txt.nlp	23248157	SENT142	35	35	32	32	pargyline	U87	PA450797	677775;641648	0.822
NULL	Adipocyte_2013_Jan_1_2(1)_28-32.nxml.txt.nlp	23700549	SENT70	20	20	35	35	valsartan	p65	PA451848	5970	0.822
NULL	Aging_(Albany_NY)_2012_Jan_30_4(1)_40-48.nxml.txt.nlp	22289652	SENT231	27	27	4	4	paraformaldehyde	SPARC	PA450790	6678	0.822
NULL	Onco_Targets_Ther_2014_May_28_7_841-852.nxml.txt.nlp	24920926	SENT53	12	12	39	39	gefitinib	EGFR	PA131301952	1956	0.822
NULL	Aging_(Albany_NY)_2009_Mar_31_1(4)_412-424.nxml.txt.nlp	20195491	SENT129	8	8	32	32	resveratrol	AMPK		5563	0.822
NULL	Cell_Commun_Signal_2014_Jan_14_12_6.nxml.txt.nlp	24423080	SENT165	5	5	22	22	curcumin	p38	PA151958596	10598;1432;7965	0.822
NULL	J_Headache_Pain_2001_Jun_2(1)_3-11.nxml.txt.nlp	NULL	SENT1	10	10	25	25	rizatriptan	5-HT1B	PA451264	3351	0.822
NULL	Int_J_Mol_Sci_2014_Oct_20_15(10)_18840-18855.nxml.txt.nlp	25334060	SENT156	31	31	29	29	heparin	OPG	PA449855	690	0.822
NULL	Oxid_Med_Cell_Longev_2013_Apr_21_2013_412576.nxml.txt.nlp	23710286	SENT247	15	15	7	7	curcumin	KEAP1	PA151958596	9817	0.822
NULL	Front_Cell_Neurosci_2013_Aug_30_7_139.nxml.txt.nlp	24009559	SENT224	11	11	31	31	pilocarpine	P2X7	PA450962	5027	0.822
NULL	Drug_Des_Devel_Ther_2014_Oct_14_8_1839-1849.nxml.txt.nlp	25342883	SENT80	6	6	39	39	paclitaxel	CO2	PA450761	4513	0.822
NULL	J_Cell_Biol_1998_Jul_13_142(1)_153-165.nxml.txt.nlp	9660870	SENT347	17	17	25	25	colchicine	B10	PA449092	5169	0.822
NULL	Curr_Oncol_2009_May_16(Suppl_1)_S52-S59.nxml.txt.nlp	19478903	SENT145	15	15	6	6	nifedipine	CYP3A4	PA450631	1576	0.822
NULL	Ann_Clin_Microbiol_Antimicrob_2005_Apr_1_4_6.nxml.txt.nlp	15804353	SENT104	21	21	6	6	pyrazinamide	EMB	PA451182	133418	0.822
NULL	Curr_Neuropharmacol_2014_Jan_12(1)_44-56.nxml.txt.nlp	24533015	SENT194	6	6	11	11	pregabalin	EAAT3	PA164754814	6505	0.822
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Dec_17_3(12)_e152.nxml.txt.nlp	25518025	SENT66	30	30	32	32	oxymorphone	CYP2D6	PA450748	1565	0.822
NULL	Clin_Ophthalmol_2008_Jun_2(2)_339-346.nxml.txt.nlp	19668725	SENT125	23	23	18	18	ranibizumab	VEGF-A	PA164746012	7422	0.822
NULL	Ann_Rheum_Dis_2008_Jul_22_68(8)_1303-1309.nxml.txt.nlp	18647851	SENT128	29	29	20	20	adalimumab	MMP3	PA10004	4314	0.822
NULL	Diabetologia_2010_Jun_27_53(6)_1142-1150.nxml.txt.nlp	20349036	SENT190	5	5	11	11	spermine	AMPK	PA164781199	5563	0.822
NULL	Front_Endocrinol_(Lausanne)_2013_May_16_4_51.nxml.txt.nlp	23720652	SENT51	5	5	21	21	diclofenac	UGT2B17	PA449293	7367	0.822
NULL	Acta_Pharmacol_Sin_2009_Jul_22_30(7)_956-964.nxml.txt.nlp	19543298	SENT129	3	3	15	15	simvastatin	ABCB1	PA451363	5243	0.822
NULL	Calcif_Tissue_Int_2011_Aug_3_89(2)_91-104.nxml.txt.nlp	21637997	SENT51	14	14	31	31	risedronate	HIP	PA451255	6767;6159;64399;5068	0.822
NULL	Biochemistry_2011_May_3_50(17)_3408-3410.nxml.txt.nlp	21425834	SENT46	4	4	15	15	nadh	VDAC2	PA164755085	7417	0.822
NULL	Calcif_Tissue_Int_2014_Aug_21_94(2)_170-175.nxml.txt.nlp	23963633	SENT128	9	9	4	4	teriparatide	PTH	PA451620	5741	0.822
NULL	J_Biol_Chem_2012_Apr_27_287(18)_14644-14658.nxml.txt.nlp	22375002	SENT301	9	9	4	4	forskolin	CC2D1A	PA146096022	54862	0.822
NULL	Oncol_Lett_2014_Nov_11_8(5)_2103-2109.nxml.txt.nlp	25295098	SENT146	22	22	18	18	docetaxel	p53	PA449383	7157	0.822
NULL	Mol_Cancer_2010_Apr_23_9_87.nxml.txt.nlp	20416058	SENT11	8	8	19	19	etoposide	TRAIL	PA449552	8743	0.822
NULL	BMJ_Open_2013_Nov_4_3(11)_e003556.nxml.txt.nlp	24189081	SENT298	10	10	21	21	cyclophosphamide	TOP2A	PA449165	7153	0.822
NULL	Genome_Med_2009_Sep_29_1(9)_88.nxml.txt.nlp	19754960	SENT156	26	26	15	15	warfarin	VKORC1	PA451906	79001	0.822
NULL	J_Cell_Mol_Med_2013_Mar_14_17(3)_337-349.nxml.txt.nlp	23490035	SENT123	5	5	27	27	amiloride	ASIC2	PA448368	40	0.822
NULL	Arthritis_Res_Ther_2009_Jan_30_11(1)_207.nxml.txt.nlp	19232067	SENT236	20	20	27	27	infliximab	IFN	PA452639	3439	0.822
NULL	Oncotarget_2013_Nov_4_5(1)_161-172.nxml.txt.nlp	24389287	SENT177	29	29	8	8	propranolol	p53	PA451145	7157	0.822
NULL	Breast_Cancer_Res_2012_Jun_19_14(3)_209.nxml.txt.nlp	22713170	SENT47	0	0	13	13	lapatinib	HER2	PA152241907	2064	0.822
NULL	Front_Physiol_2011_Jun_30_2_33.nxml.txt.nlp	21747769	SENT198	0	0	3	3	berberine	p38	PA165860812	10598;1432;7965	0.822
NULL	Toxins_(Basel)_2010_Oct_26_2(11)_2490-2518.nxml.txt.nlp	22069563	SENT192	24	24	18	18	cisplatin	CX3CL1	PA449014	6376	0.822
NULL	Cancer_Med_2014_Apr_27_3(2)_245-251.nxml.txt.nlp	24464861	SENT31	21	21	16	16	metformin	HIF1	PA450395	3091	0.822
NULL	Int_J_Cell_Biol_2013_Sep_12_2013_153634.nxml.txt.nlp	24159334	SENT140	12	12	14	14	cisplatin	MDM2	PA449014	4193	0.822
NULL	Diabetes_2009_Apr_23_58(4)_917-925.nxml.txt.nlp	19168598	SENT176	13	13	4	4	trypsin	FOXO1	PA451806	2308	0.822
NULL	Front_Neuroanat_2011_Jul_12_5_38.nxml.txt.nlp	21808606	SENT870	13	13	2	2	clozapine	c-fos	PA449061	2353	0.822
NULL	Oncogene_2014_Mar_20_33(12)_1495-1505.nxml.txt.nlp	23604115	SENT200	9	9	16	16	nilotinib	RAD51	PA165958345	5888	0.822
NULL	Front_Neural_Circuits_2014_Jul_4_8_77.nxml.txt.nlp	25071458	SENT64	14	14	1	1	isoflurane	SOD1	PA450106	6647	0.822
NULL	Curr_Med_Chem_2014_May_21(14)_1595-1606.nxml.txt.nlp	23992330	SENT79	33	33	43	43	vemurafenib	EGFR	PA165946873	1956	0.822
NULL	Reprod_Biol_Endocrinol_2003_Oct_9_1_74.nxml.txt.nlp	14613550	SENT96	13	13	16	16	ns-398	COX		1351	0.822
NULL	Environ_Health_Perspect_2010_Jun_25_118(6)_864-870.nxml.txt.nlp	20100676	SENT236	19	19	12	12	arsenite	INS-1	PA452638	2305	0.822
NULL	Environ_Health_Perspect_2011_Apr_16_119(4)_534-541.nxml.txt.nlp	21081300	SENT237	3	3	14	14	ketoconazole	PGD2	PA450146	27306	0.822
NULL	Br_J_Cancer_2012_May_8_106(10)_1689-1696.nxml.txt.nlp	22531631	SENT163	15	15	21	21	pravastatin	PC-3	PA451089	692094	0.822
NULL	Chemother_Res_Pract_2011_Dec_1_2011_715469.nxml.txt.nlp	22312557	SENT8	24	24	11	11	cisplatin	p53	PA449014	7157	0.822
NULL	Croat_Med_J_2012_Aug_53(4)_314-320.nxml.txt.nlp	22911523	SENT64	39	39	24	24	warfarin	CYP4F2	PA451906	8529	0.822
NULL	Cancers_(Basel)_2010_Aug_18_2(3)_1576-1596.nxml.txt.nlp	24281174	SENT223	5	5	34	34	etoposide	CD38	PA449552	952	0.822
NULL	J_Mol_Signal_2010_May_10_5_4.nxml.txt.nlp	20459745	SENT55	16	16	1	1	cisplatin	p53	PA449014	7157	0.822
NULL	Br_J_Clin_Pharmacol_2011_Oct_72(4)_647-657.nxml.txt.nlp	21518389	SENT95	19	19	7	7	clopidogrel	CYP2C19	PA449053	1557	0.822
NULL	Int_J_Endocrinol_2011_Aug_21_2011_742719.nxml.txt.nlp	21869886	SENT262	4	4	31	31	cilostazol	DES	PA164746334	1674	0.822
NULL	Mol_Vis_2012_Nov_29_18_2839-2846.nxml.txt.nlp	23233786	SENT125	3	3	8	8	geldanamycin	Hsp90	PA152031327	3320	0.822
NULL	J_Biol_Chem_2012_Apr_20_287(17)_13868-13876.nxml.txt.nlp	22389490	SENT8	24	24	10	10	capsaicin	TRPV1	PA448776	7442	0.822
NULL	Cardiovasc_Diabetol_2013_Oct_17_12_150.nxml.txt.nlp	24134550	SENT96	2	2	7	7	pioglitazone	activin	PA450970	83729	0.822
NULL	Br_J_Cancer_2013_Jun_25_108(12)_2426-2432.nxml.txt.nlp	23756869	SENT102	8	8	29	29	trastuzumab	HER-2	PA451743	2064	0.822
NULL	Arthritis_Res_Ther_2008_Jan_7_10(1)_R1.nxml.txt.nlp	18179697	SENT160	40	40	3	3	oxaliplatin	HMGB1	PA131285527	3146	0.822
NULL	Int_J_Breast_Cancer_2012_Dec_18_2012_502092.nxml.txt.nlp	23320178	SENT180	0	0	3	3	flavopiridol	CDK1	PA452627	983	0.822
NULL	Pharmaceuticals_(Basel)_2014_Jan_9_7(1)_46-57.nxml.txt.nlp	24451403	SENT146	26	26	38	38	ritonavir	Bcl-2	PA451260	596	0.822
NULL	Br_J_Cancer_2004_Mar_22_90(6)_1285-1292.nxml.txt.nlp	15026814	SENT200	6	6	3	3	doxorubicin	p53	PA449412	7157	0.822
NULL	Mol_Biol_Cell_2013_Jul_15_24(14)_2186-2200.nxml.txt.nlp	23699397	SENT320	12	12	20	20	bortezomib	TRAIL	PA10252	8743	0.822
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Apr_17_6_43-57.nxml.txt.nlp	24833916	SENT338	6	6	11	11	epirubicin	HER2	PA449476	2064	0.822
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT222	28	28	22	22	nutlin-3	p53		7157	0.822
NULL	Biol_Open_2014_Nov_13_3(12)_1164-1172.nxml.txt.nlp	25395667	SENT94	16	16	14	14	capsaicin	TRPV1	PA448776	7442	0.822
NULL	Cell_Mol_Life_Sci_2012_Dec_5_69(23)_3895-3909.nxml.txt.nlp	22562579	SENT105	5	5	7	7	diethylstilbestrol	DES	PA449307	1674	0.822
NULL	Front_Endocrinol_(Lausanne)_2013_Jan_7_3_180.nxml.txt.nlp	23316185	SENT154	8	8	26	26	glucose	CRF2	PA449773	1395	0.822
NULL	Int_J_Cell_Biol_2010_Jan_17_2010_930509.nxml.txt.nlp	20145727	SENT373	13	13	25	25	bortezomib	ATF4	PA10252	468	0.822
NULL	Brain_Sci_2014_May_6_4(2)_356-375.nxml.txt.nlp	24961766	SENT210	7	7	15	15	propofol	CA3	PA451141	761	0.822
NULL	Iran_J_Pharm_Res_2013_Winter_12(1)_141-146.nxml.txt.nlp	24250582	SENT109	13	13	0	0	rifampin	NAC	PA451250	22861	0.822
NULL	Oncogene_2011_Apr_21_30(16)_1855-1867.nxml.txt.nlp	21151168	SENT298	21	21	17	17	chloroquine	IL3	PA448948	3562	0.822
NULL	Mol_Cancer_2010_May_20_9_115.nxml.txt.nlp	20487546	SENT240	32	32	12	12	fludarabine	PLK2	PA449655	10769	0.822
NULL	eLife_2014_May_20_3_e02523.nxml.txt.nlp	24844246	SENT358	14	14	37	37	sorafenib	ATF4	PA7000	468	0.822
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_91-103.nxml.txt.nlp	17912639	SENT104	8	8	16	16	anastrozole	HER2	PA448432	2064	0.822
NULL	Oncol_Lett_2013_Mar_10_5(3)_1068-1074.nxml.txt.nlp	23426189	SENT218	0	0	7	7	4-methylumbelliferone	HAS2	PA154081778	3037	0.822
NULL	Oncotarget_2012_Oct_20_3(10)_1068-1111.nxml.txt.nlp	23085539	SENT73	5	5	12	12	sorafenib	BRAF	PA7000	673	0.822
NULL	Acta_Pharmacol_Sin_2012_May_4_33(5)_710-716.nxml.txt.nlp	22555373	SENT210	9	9	33	33	diazepam	DOM	PA449283	6663	0.822
NULL	Nucleic_Acids_Res_2013_Nov_27_41(21)_9786-9799.nxml.txt.nlp	23982513	SENT174	6	6	11	11	arsenite	TIAR	PA452638	7073	0.822
NULL	Ann_Oncol_2011_Mar_8_22(3)_503-514.nxml.txt.nlp	20616198	SENT5	31	31	15	15	exemestane	aromatase	PA449563	1588	0.822
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT1231	19	19	16	16	collagenase	ECM	PA449107	22915	0.822
NULL	Cell_Death_Dis_2014_Jan_30_5(1)_e1030.nxml.txt.nlp	24481444	SENT103	13	13	4	4	sorafenib	PUMA	PA7000	27113	0.822
NULL	Biosci_Rep_2014_Aug_6_34(4)_e00131.nxml.txt.nlp	24975826	SENT41	17	17	23	23	sulfinpyrazone	TRPA1	PA451550	8989	0.822
NULL	Pain_2013_Dec_154(12)_2606-2615.nxml.txt.nlp	23707280	SENT170	10	10	3	3	capsaicin	NPY	PA448776	4852	0.822
NULL	J_Korean_Med_Sci_2011_Feb_24_26(2)_304-307.nxml.txt.nlp	21286027	SENT45	26	26	10	10	ifosfamide	CHOP	PA449964	1649	0.822
NULL	Cell_Death_Dis_2010_Nov_18_1(11)_e102.nxml.txt.nlp	21368867	SENT21	12	12	19	19	gentamicin	14-3-3	PA449753	10971	0.822
NULL	J_Oncol_2013_Apr_29_2013_854121.nxml.txt.nlp	23737784	SENT150	15	15	29	29	trastuzumab	CD40	PA451743	958	0.822
NULL	Case_Rep_Pathol_2014_Jul_15_2014_313974.nxml.txt.nlp	25133003	SENT66	15	15	24	24	thyroglobulin	CD10	PA164754910	4311	0.822
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT207	23	23	32	32	adalimumab	CD36	PA10004	948	0.822
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT146	2	2	10	10	l-cysteine	ATP5A	PA449173	498	0.822
NULL	Arthritis_Res_Ther_2013_Dec_5_15(6)_R208.nxml.txt.nlp	24314202	SENT253	25	25	15	15	infliximab	IL-8	PA452639	3576	0.822
NULL	Cancer_Cell_2014_Oct_13_26(4)_495-508.nxml.txt.nlp	25314077	SENT622	26	26	10	10	bortezomib	CD138	PA10252	6382	0.822
NULL	Br_J_Cancer_2010_Oct_26_103(9)_1380-1390.nxml.txt.nlp	20877355	SENT37	13	13	11	11	bortezomib	TRAIL	PA10252	8743	0.822
NULL	Cancer_Med_2014_Apr_7_3(2)_349-361.nxml.txt.nlp	24515895	SENT183	28	28	10	10	doxycycline	HSC3	PA449415	150353	0.822
NULL	Indian_J_Dermatol_2011_May-Jun_56(3)_306-308.nxml.txt.nlp	21772594	SENT69	32	32	11	11	cyclosporine	CHP	PA449167	11261	0.822
NULL	J_Hematol_Oncol_2012_Jul_2_5_35.nxml.txt.nlp	22747660	SENT17	22	22	10	10	vemurafenib	HER-2	PA165946873	2064	0.822
NULL	Infect_Drug_Resist_2010_Mar_11_3_45-51.nxml.txt.nlp	21694893	SENT112	9	9	11	11	posaconazole	CYP3A4	PA151958574	1576	0.822
NULL	BMJ_Open_2013_Dec_18_3(12)_e003815.nxml.txt.nlp	24353255	SENT5	25	25	22	22	levonorgestrel	UPA	PA450218	118471;5328	0.822
NULL	Clinics_(Sao_Paulo)_2014_Jan_69(1)_68-74.nxml.txt.nlp	24473562	SENT89	36	36	39	39	nutlin-3	SOCS-1		8651	0.822
NULL	J_Hematol_Oncol_2014_Apr_28_7_37.nxml.txt.nlp	24775308	SENT132	16	16	5	5	imatinib	JAK2	PA10804	3717	0.822
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1137-1144.nxml.txt.nlp	20234366	SENT151	30	30	22	22	cetuximab	KRAS	PA10040	3845	0.822
NULL	Breast_Cancer_Res_2012_Jul_23_14(4)_R112.nxml.txt.nlp	22824341	SENT241	17	17	25	25	doxorubicin	RANKL	PA449412	8600	0.822
NULL	Oxid_Med_Cell_Longev_2013_Jun_2_2013_793525.nxml.txt.nlp	23819014	SENT124	13	13	5	5	resveratrol	AMPK		5563	0.822
NULL	Int_J_Med_Sci_2013_Mar_19_10(5)_599-606.nxml.txt.nlp	23569422	SENT65	6	6	23	23	propofol	HO-1	PA451141	3162	0.822
NULL	Cancer_Immunol_Immunother_2015_Oct_7_64_61-73.nxml.txt.nlp	25287778	SENT259	4	4	9	9	lenalidomide	IL-2	PA162363968	3558	0.822
NULL	Diabetes_Care_2013_Jun_15_36(6)_e80.nxml.txt.nlp	23704688	SENT10	23	23	29	29	sitagliptin	GLP-1	PA164748978	100125288	0.822
NULL	Mol_Cell_2013_Mar_7_49(5)_922-933.nxml.txt.nlp	23375502	SENT114	5	5	10	10	tamoxifen	FMN2	PA451581	56776	0.822
NULL	Cancers_(Basel)_2010_Sep_9_2(3)_1661-1682.nxml.txt.nlp	24281180	SENT1189	17	17	2	2	doxorubicin	NF-kappaB	PA449412	4790	0.822
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1013.nxml.txt.nlp	24457957	SENT309	22	22	12	12	bortezomib	NOXA	PA10252	5366	0.822
NULL	Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_1029-1037.nxml.txt.nlp	25049660	SENT12	23	23	20	20	l-cysteine	MC1R	PA449173	4157	0.822
NULL	Crit_Care_2007_Mar_12_11(2)_207.nxml.txt.nlp	17367544	SENT84	5	5	14	14	desipramine	ACLS	PA449233	46;2737	0.822
NULL	J_Breast_Cancer_2011_Mar_31_14(1)_20-27.nxml.txt.nlp	21847390	SENT152	23	23	30	30	estradiol	CLDN6	PA449503	9074	0.822
NULL	Mol_Breed_2012_Oct_8_30(3)_1237-1252.nxml.txt.nlp	23024595	SENT143	33	33	40	40	acetone	ANOVA	PA448025	4858	0.822
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT158	31	31	11	11	metformin	AMPK	PA450395	5563	0.822
NULL	Front_Immunol_2012_May_7_3_101.nxml.txt.nlp	22783250	SENT241	4	4	13	13	papain	IL-2	PA450778	3558	0.822
NULL	J_Carcinog_2013_Dec_31_12_22.nxml.txt.nlp	24574860	SENT235	30	30	9	9	docetaxel	LKB1	PA449383	6794	0.822
NULL	Biomed_Res_Int_2014_Jun_26_2014_161346.nxml.txt.nlp	25054130	SENT30	11	11	27	27	curcumin	NOX2	PA151958596	1536	0.822
NULL	Clin_Exp_Gastroenterol_2013_Aug_5_6_139-148.nxml.txt.nlp	23950655	SENT112	1	1	8	8	thrombin	PAR-1	PA451674	2011;2149	0.822
NULL	Indian_J_Pharmacol_2014_Jul-Aug_46(4)_416-419.nxml.txt.nlp	25097281	SENT77	10	10	29	29	ethanol	DES	PA448073	1674	0.822
NULL	Int_J_Biol_Sci_2013_Mar_7_9(3)_279-288.nxml.txt.nlp	23493630	SENT107	0	0	11	11	tocilizumab	CD4	PA165292659	920	0.822
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT128	16	16	20	20	perifosine	TRAIL	PA165291471	8743	0.822
NULL	Front_Physiol_2011_Jun_30_2_33.nxml.txt.nlp	21747769	SENT261	18	18	8	8	berberine	EGF	PA165860812	1950	0.822
NULL	Br_J_Cancer_1995_May_71(5)_931-936.nxml.txt.nlp	7734315	SENT15	28	28	9	9	epirubicin	P-gp	PA449476	5243	0.822
NULL	Oncotarget_2013_Dec_18_5(2)_375-385.nxml.txt.nlp	24495868	SENT121	18	18	11	11	fludarabine	MCL1	PA449655	4170	0.822
NULL	Breast_Cancer_Res_2004_Oct_8_6(6)_281-282.nxml.txt.nlp	NULL	SENT23	33	33	19	19	estradiol	aromatase	PA449503	1588	0.822
NULL	N_Am_J_Med_Sci_2013_Jul_5(7)_432-437.nxml.txt.nlp	24020054	SENT63	22	22	20	20	cyclophosphamide	CHOP	PA449165	1649	0.822
NULL	Blood_Res_2014_Jun_25_49(2)_95-99.nxml.txt.nlp	25025010	SENT37	11	11	18	18	cytarabine	LIR	PA449177	10871	0.822
NULL	J_Occup_Med_Toxicol_2008_Feb_27_3(Suppl_1)_S6.nxml.txt.nlp	18315837	SENT91	7	7	19	19	pranlukast	IL-4	PA134698661	3565	0.822
NULL	Oncoscience_2014_Apr_30_1(4)_283-286.nxml.txt.nlp	25594020	SENT6	31	31	17	17	doxorubicin	STAT6	PA449412	6778	0.822
NULL	Front_Oncol_2014_Sep_23_4_263.nxml.txt.nlp	25295230	SENT217	22	22	0	0	etoposide	FLT3	PA449552	2322	0.822
NULL	Pan_Afr_Med_J_2014_Jul_6_18_205.nxml.txt.nlp	25419332	SENT46	8	8	6	6	cyclophosphamide	CHOP	PA449165	1649	0.822
NULL	Acta_Pharmacol_Sin_2012_Jul_18_33(7)_861-872.nxml.txt.nlp	22705730	SENT129	11	11	6	6	atorvastatin	PI3K	PA448500	5290	0.822
NULL	Mol_Cancer_2013_Apr_22_12_29.nxml.txt.nlp	23601052	SENT122	9	9	5	5	hydroxyurea	FRA3B	PA449942	2385;2272	0.822
NULL	Commun_Integr_Biol_2012_Jul_1_5(4)_312-315.nxml.txt.nlp	23060950	SENT33	11	11	15	15	heparin	FGF10	PA449855	2255	0.822
NULL	Arthritis_Res_Ther_2005_Mar_1_7(3)_R545-R551.nxml.txt.nlp	15899041	SENT58	13	13	37	37	infliximab	ACR	PA452639	49	0.822
NULL	Mol_Cells_2014_Mar_31_37(3)_234-240.nxml.txt.nlp	24642709	SENT393	10	10	6	6	cisplatin	ANOVA	PA449014	4858	0.822
NULL	Indian_J_Med_Res_2012_Sep_136(3)_391-403.nxml.txt.nlp	23041732	SENT189	15	15	21	21	bevacizumab	HCC	PA130232992	84668	0.822
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT148	0	0	7	7	ritonavir	SLC22A8	PA451260	9376	0.822
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Jul_21_9_20.nxml.txt.nlp	20663145	SENT69	12	12	1	1	gentamicin	LBH	PA449753	81606;221491	0.822
NULL	Ther_Clin_Risk_Manag_2007_Aug_3(4)_533-542.nxml.txt.nlp	18472974	SENT181	6	6	37	37	posaconazole	CYP2E1	PA151958574	1571	0.822
NULL	Br_J_Cancer_2012_Feb_14_106(4)_685-692.nxml.txt.nlp	22294184	SENT125	32	32	41	41	docetaxel	survivin	PA449383	332	0.822
NULL	Front_Neuroanat_2014_Sep_10_8_90.nxml.txt.nlp	25309337	SENT50	44	44	4	4	paraformaldehyde	E14	PA450790	4863	0.822
NULL	Breast_Cancer_Res_2007_Aug_10_9(4)_R52.nxml.txt.nlp	17692126	SENT4	11	11	4	4	exemestane	aromatase	PA449563	1588	0.822
NULL	Clin_Interv_Aging_2010_Dec_3_5_403-416.nxml.txt.nlp	21152242	SENT54	30	30	20	20	indapamide	ACE	PA449975	1636	0.822
NULL	Oncol_Lett_2014_Jun_8_7(6)_1903-1910.nxml.txt.nlp	24932256	SENT130	16	16	27	27	cisplatin	Bcl-2	PA449014	596	0.822
NULL	Neural_Regen_Res_2013_Jul_15_8(20)_1853-1862.nxml.txt.nlp	25206494	SENT169	34	34	22	22	ethanol	JNK	PA448073	5599	0.822
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT11	1	1	16	16	metformin	AMPK	PA450395	5563	0.822
NULL	Oncotarget_2014_Jun_11_5(21)_10407-10420.nxml.txt.nlp	25431951	SENT206	37	37	13	13	gefitinib	KIT	PA131301952	3815	0.822
NULL	Br_J_Cancer_2009_Oct_20_101(8)_1357-1364.nxml.txt.nlp	19755993	SENT33	0	0	9	9	trastuzumab	PTEN	PA451743	5728	0.822
NULL	Exp_Ther_Med_2014_Sep_20_8(3)_968-972.nxml.txt.nlp	25120631	SENT112	0	0	8	8	naringin	ADP	PA151958360	23038	0.822
NULL	F1000_Med_Rep_2010_May_24_2_40.nxml.txt.nlp	20948844	SENT45	5	5	15	15	heparin	APC	PA449855	324	0.822
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT185	8	8	13	13	tacrolimus	OPG	PA451578	690	0.822
NULL	Dermatol_Pract_Concept_2011_Jan_31_1(1)_33-47.nxml.txt.nlp	24396718	SENT407	8	8	20	20	carbamazepine	por	PA448785	64840	0.822
NULL	Contemp_Oncol_(Pozn)_2012_Jan_4_16(6)_480-484.nxml.txt.nlp	23788933	SENT142	10	10	29	29	crizotinib	ROS1	PA165946122	6098	0.822
NULL	Oxid_Med_Cell_Longev_2008_Oct-Dec_1(1)_39-45.nxml.txt.nlp	19794907	SENT48	6	6	20	20	taurine	MCH	PA451590	5367	0.822
NULL	Int_J_Mol_Sci_2012_Sep_5_13(9)_11012-11026.nxml.txt.nlp	23109835	SENT537	13	13	3	3	cisplatin	DDB2	PA449014	1643	0.822
NULL	Cancer_Cell_Int_2005_Aug_24_5_28.nxml.txt.nlp	16120219	SENT165	10	10	15	15	etoposide	MDM2	PA449552	4193	0.822
NULL	Arthritis_Res_Ther_2010_Apr_29_12(2)_R73.nxml.txt.nlp	20429888	SENT8	32	32	5	5	bortezomib	COL1A1	PA10252	1277	0.822
NULL	Breast_Cancer_Res_2012_Jan_6_14(1)_R2.nxml.txt.nlp	22225778	SENT179	10	10	24	24	docetaxel	p50	PA449383	958;4790	0.822
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT73	3	3	16	16	trastuzumab	HER2	PA451743	2064	0.822
NULL	Dermatoendocrinol_2013_Apr_1_5(2)_252-263.nxml.txt.nlp	24194965	SENT84	34	34	17	17	metformin	MATE2	PA450395	146802	0.822
NULL	Ann_Rheum_Dis_2008_Oct_16_68(8)_1277-1284.nxml.txt.nlp	18930987	SENT170	12	12	7	7	methotrexate	TNF	PA450428	7124	0.822
NULL	Lab_Invest_2011_Sep_23_91(9)_1396-1409.nxml.txt.nlp	21606925	SENT141	0	0	21	21	genistein	ZO-1	PA165109660	7082	0.822
NULL	Front_Pharmacol_2014_Nov_25_5_256.nxml.txt.nlp	25505414	SENT111	12	12	33	33	ketamine	KCC2	PA450144	57468	0.822
NULL	Acta_Pharmacol_Sin_2009_Sep_17_30(9)_1316-1322.nxml.txt.nlp	19684609	SENT15	4	4	6	6	rosiglitazone	PTEN	PA451283	5728	0.822
NULL	Neural_Dev_2010_Dec_1_5_31.nxml.txt.nlp	21122105	SENT218	24	24	28	28	l-glutamine	San	PA10090	80218	0.822
NULL	Biomed_Res_Int_2013_Jun_19_2013_230805.nxml.txt.nlp	23862137	SENT232	6	6	3	3	bortezomib	IL-10	PA10252	3586	0.822
NULL	Cancer_Cell_Int_2011_Nov_17_11_40.nxml.txt.nlp	22088142	SENT88	16	16	9	9	gemcitabine	MRP2	PA449748	100130958;57626;1244	0.822
NULL	Behav_Brain_Funct_2014_Mar_11_10_6.nxml.txt.nlp	24618126	SENT230	10	10	7	7	meloxicam	COX2	PA450353	4513;5743	0.822
NULL	Oncotarget_2013_Jun_8_4(5)_792-801.nxml.txt.nlp	23801022	SENT182	23	23	13	13	trypsin	Tech	PA451806	57449	0.822
NULL	Virol_J_2011_Sep_21_8_444.nxml.txt.nlp	21936898	SENT19	2	2	4	4	lamivudine	LAM	PA450163	7249;7248	0.822
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT33	17	17	31	31	lapatinib	HER2	PA152241907	2064	0.822
NULL	Br_J_Cancer_2013_Sep_3_109(5)_1206-1213.nxml.txt.nlp	23887603	SENT48	29	29	15	15	doxorubicin	EDA	PA449412	1896	0.822
NULL	Mol_Cancer_2012_Sep_21_11_72.nxml.txt.nlp	22995644	SENT48	19	19	10	10	imatinib	PRL-3	PA10804	11156	0.822
NULL	Arthritis_Res_Ther_2012_Jan_17_14(1)_R11.nxml.txt.nlp	22251436	SENT5	40	40	18	18	methotrexate	CCR5	PA450428	1234	0.822
NULL	J_Gynecol_Oncol_2014_Jan_8_25(1)_22-29.nxml.txt.nlp	24459577	SENT148	32	32	28	28	methotrexate	NACT	PA450428	284111	0.822
NULL	Curr_Chem_Genomics_2010_Mar_1_4_1-8.nxml.txt.nlp	20448812	SENT31	10	10	14	14	fluorescein	OATP1B1	PA164746009	10599	0.822
NULL	J_Med_Chem_2014_Feb_13_57(3)_539-566.nxml.txt.nlp	24025027	SENT1350	6	6	24	24	raltegravir	TRIO		7204	0.822
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1063.nxml.txt.nlp	24556678	SENT65	21	21	15	15	thioridazine	Mcl-1	PA451666	4170	0.822
NULL	Dement_Geriatr_Cogn_Dis_Extra_2014_Nov_15_4(3)_450-456.nxml.txt.nlp	25538729	SENT114	6	6	9	9	donepezil	APOE	PA449394	348	0.822
NULL	Br_J_Cancer_1996_Dec_74(12)_2036-2041.nxml.txt.nlp	8980410	SENT11	4	4	29	29	cisplatin	AAP	PA449014	5345	0.822
NULL	Breast_Cancer_Res_2008_Dec_5_10(6)_R104.nxml.txt.nlp	19061505	SENT210	1	1	22	22	estradiol	Bcl-2	PA449503	596	0.822
NULL	Mol_Cancer_2010_May_20_9_115.nxml.txt.nlp	20487546	SENT285	23	23	12	12	fludarabine	MYC	PA449655	4609	0.822
NULL	Cancers_(Basel)_2014_Apr_9_6(2)_829-859.nxml.txt.nlp	24722453	SENT1961	1	1	9	9	auranofin	JAK1	PA448510	3716	0.821
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT134	0	0	20	20	resveratrol	Bcl-2		596	0.821
NULL	BMB_Rep_2013_Jan_46(1)_59-64.nxml.txt.nlp	23351386	SENT9	2	2	12	12	auranofin	STAT3	PA448510	6774	0.821
NULL	Arthritis_Res_Ther_2014_Jan_29_16(1)_R31.nxml.txt.nlp	24472667	SENT218	3	3	0	0	resveratrol	SIRT1		23411	0.821
NULL	Med_Sci_Monit_2012_May_1_18(5)_BR181-BR187.nxml.txt.nlp	22534700	SENT41	13	13	6	6	ethanol	ghrelin	PA448073	51738	0.821
NULL	Br_J_Haematol_2008_Jun_141(5)_659-671.nxml.txt.nlp	18410446	SENT135	8	8	16	16	cerulenin	Apo2	PA164764551	8797	0.821
NULL	Indian_J_Endocrinol_Metab_2011_Apr-Jun_15(2)_143-144.nxml.txt.nlp	21731879	SENT15	15	15	5	5	estradiol	aromatase	PA449503	1588	0.821
NULL	Clin_Interv_Aging_2013_Sep_16_8_1229-1236.nxml.txt.nlp	24072968	SENT83	22	22	20	20	cyclophosphamide	CHOP	PA449165	1649	0.821
NULL	Oncotarget_2013_Nov_22_5(4)_933-943.nxml.txt.nlp	24659749	SENT56	20	20	25	25	nutlin-3	AML3		860	0.821
NULL	Drugs_R_D_2014_Sep_31_14(3)_177-184.nxml.txt.nlp	25079671	SENT105	6	6	21	21	acarbose	MCP-1	PA448010	6347	0.821
NULL	Cell_Death_Differ_2010_Mar_16_17(3)_439-451.nxml.txt.nlp	19834489	SENT203	27	27	46	46	forskolin	FBS	PA146096022	64319;26269	0.821
NULL	Ann_Dermatol_2014_Feb_17_26(1)_1-10.nxml.txt.nlp	24648680	SENT55	5	5	15	15	fluorescein	CD90	PA164746009	7070	0.821
NULL	Acta_Histochem_Cytochem_2008_Jun_27_41(3)_59-64.nxml.txt.nlp	18636112	SENT25	15	15	27	27	trastuzumab	HER-2	PA451743	2064	0.821
NULL	Cancers_(Basel)_2011_Aug_5_3(3)_3114-3142.nxml.txt.nlp	24212948	SENT746	25	25	30	30	cyclophosphamide	CD4	PA449165	920	0.821
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Dec_17_3(12)_e152.nxml.txt.nlp	25518025	SENT31	5	5	9	9	oxycodone	CYP3A4	PA450741	1576	0.821
NULL	Ther_Clin_Risk_Manag_2006_Jun_2(2)_129-158.nxml.txt.nlp	18360588	SENT206	4	4	10	10	glipizide	CYP3A4	PA449762	1576	0.821
NULL	J_Inherit_Metab_Dis_2010_Oct_3_33(5)_625-632.nxml.txt.nlp	20814828	SENT104	3	3	7	7	simvastatin	GGTI	PA451363	5229	0.821
NULL	Clinics_(Sao_Paulo)_2013_May_68(5)_694-701.nxml.txt.nlp	23778405	SENT135	5	5	19	19	curcumin	survivin	PA151958596	332	0.821
NULL	Cell_Death_Dis_2014_Mar_13_5(3)_e1112.nxml.txt.nlp	24625971	SENT64	29	29	13	13	curcumin	Alix	PA151958596	10015	0.821
NULL	J_Cell_Biol_2003_Dec_22_163(6)_1385-1395.nxml.txt.nlp	14676308	SENT50	3	3	17	17	thrombin	RhoA	PA451674	387	0.821
NULL	Cancer_Causes_Control_2013_Aug_18_24(8)_1605-1614.nxml.txt.nlp	23775025	SENT64	33	33	24	24	doxorubicin	GSTP1	PA449412	2950	0.821
NULL	Int_J_Hypertens_2012_Oct_21_2012_593530.nxml.txt.nlp	23133743	SENT9	3	3	0	0	hemin	HO-1	PA449849	3162	0.821
NULL	Br_J_Cancer_2010_Sep_7_103(6)_889-898.nxml.txt.nlp	20664599	SENT146	16	16	8	8	paclitaxel	HER-2	PA450761	2064	0.821
NULL	Oncotarget_2014_Aug_29_5(19)_8947-8958.nxml.txt.nlp	25333254	SENT51	15	15	9	9	plerixafor	CXCR4	PA165958410	7852	0.821
NULL	Front_Oncol_2014_Sep_15_4_244.nxml.txt.nlp	25309870	SENT103	9	9	17	17	afatinib	EGFR	PA165981154	1956	0.821
NULL	Mol_Cancer_2008_Jun_5_7_50.nxml.txt.nlp	18534018	SENT145	16	16	9	9	bortezomib	p38	PA10252	10598;1432;7965	0.821
NULL	EMBO_Mol_Med_2013_Feb_9_5(2)_309-325.nxml.txt.nlp	23300147	SENT235	0	0	4	4	trastuzumab	HER2	PA451743	2064	0.821
NULL	Front_Oncol_2014_Apr_9_4_75.nxml.txt.nlp	24782986	SENT52	22	22	12	12	paclitaxel	CD117	PA450761	3815	0.821
NULL	Carcinogenesis_2013_Feb_3_34(2)_351-360.nxml.txt.nlp	23125222	SENT279	23	23	9	9	curcumin	Eg5	PA151958596	3832	0.821
NULL	Mol_Med_Rep_2014_Oct_23_10(4)_1717-1724.nxml.txt.nlp	25069516	SENT91	17	17	8	8	resveratrol	PC-3		692094	0.821
NULL	Antimicrob_Agents_Chemother_2014_Oct_58(10)_5900-5908.nxml.txt.nlp	25070091	SENT4	26	26	23	23	metoprolol	CYP2D6	PA450480	1565	0.821
NULL	J_Biomed_Biotechnol_2011_Dec_6_2011_856985.nxml.txt.nlp	21188173	SENT279	26	26	23	23	letrozole	aromatase	PA450196	1588	0.821
NULL	J_Headache_Pain_2013_Nov_19_14(1)_91.nxml.txt.nlp	24251800	SENT41	11	11	0	0	acetazolamide	NEU	PA448018	2064	0.821
NULL	Biomed_Res_Int_2014_Feb_4_2014_975927.nxml.txt.nlp	24689066	SENT76	15	15	1	1	denosumab	BIM	PA166048634	10018	0.821
NULL	Int_J_Mol_Sci_2012_Sep_25_13(10)_12153-12168.nxml.txt.nlp	23202889	SENT497	4	4	24	24	fluorouracil	KRAS	PA128406956	3845	0.821
NULL	Front_Cell_Neurosci_2013_Dec_18_7_250.nxml.txt.nlp	24391538	SENT1040	14	14	7	7	suramin	P2X1	PA10292	5023	0.821
NULL	Exp_Diabetes_Res_2012_Oct_15_2012_465282.nxml.txt.nlp	23118742	SENT149	3	3	7	7	metformin	FGF21	PA450395	26291	0.821
NULL	Adv_Hematol_2010_Dec_30_2010_627401.nxml.txt.nlp	21234094	SENT114	34	34	21	21	etoposide	SMILE	PA449552	160418	0.821
NULL	Oncotarget_2014_Jun_1_5(13)_4868-4880.nxml.txt.nlp	24947902	SENT187	4	4	14	14	afatinib	HER2	PA165981154	2064	0.821
NULL	Cancers_(Basel)_2010_Apr_9_2(2)_397-419.nxml.txt.nlp	24281076	SENT266	13	13	18	18	dacarbazine	EGFR	PA449197	1956	0.821
NULL	J_Oncol_2012_May_8_2012_703858.nxml.txt.nlp	22645612	SENT123	8	8	27	27	trastuzumab	HER2	PA451743	2064	0.821
NULL	Adv_Hematol_2012_Jul_24_2012_513702.nxml.txt.nlp	22888354	SENT49	2	2	8	8	lenalidomide	IFN	PA162363968	3439	0.821
NULL	Cell_Death_Dis_2012_Nov_15_3(11)_e422.nxml.txt.nlp	23152058	SENT11	27	27	15	15	cisplatin	ZNF143	PA449014	7702	0.821
NULL	Nat_Med_2011_Dec_11_18(1)_74-82.nxml.txt.nlp	22157681	SENT52	3	3	14	14	gefitinib	BIM	PA131301952	10018	0.821
NULL	ASN_Neuro_2014_Aug_26_6(4)_1759091414544472.nxml.txt.nlp	25289647	SENT283	4	4	16	16	arsenite	FUS	PA452638	2521	0.821
NULL	EMBO_J_2010_Nov_17_29(22)_3869-3878.nxml.txt.nlp	21037554	SENT185	18	18	3	3	paraformaldehyde	HCN2	PA450790	610	0.821
NULL	Indian_J_Med_Res_2014_Jan_139(1)_27-65.nxml.txt.nlp	24604039	SENT302	23	23	12	12	levodopa	SLC22A1	PA450213	6580	0.821
NULL	J_Allergy_(Cairo)_2011_Apr_6_2011_479129.nxml.txt.nlp	21603171	SENT72	5	5	19	19	tacrolimus	IL-6	PA451578	3569	0.821
NULL	Hum_Mol_Genet_2010_Feb_15_19(4)_634-647.nxml.txt.nlp	20015957	SENT300	13	13	1	1	paraformaldehyde	CO2	PA450790	4513	0.821
NULL	J_Cell_Biol_2001_Oct_15_155(2)_207-216.nxml.txt.nlp	11591730	SENT65	20	20	26	26	camptothecin	GAPDH	PA153590860	2597	0.821
NULL	J_Oncol_2009_May_6_2009_567486.nxml.txt.nlp	19424511	SENT107	5	5	14	14	panitumumab	EGFR	PA162373091	1956	0.821
NULL	Anemia_2011_Mar_3_2011_740235.nxml.txt.nlp	21490765	SENT178	10	10	7	7	zafirlukast	CysLT1	PA451949	10800	0.821
NULL	EMBO_Mol_Med_2012_Jun_13_4(6)_515-527.nxml.txt.nlp	22416035	SENT7	14	14	5	5	olaparib	p53		7157	0.821
NULL	Arthritis_Res_Ther_2005_Jan_21_7(2)_55-61.nxml.txt.nlp	15743490	SENT106	8	8	39	39	atorvastatin	CD86	PA448500	942	0.821
NULL	Crit_Care_2011_Nov_23_15(6)_R278.nxml.txt.nlp	22112587	SENT174	4	4	28	28	phenylephrine	LIR	PA450935	10871	0.821
NULL	Br_J_Cancer_2011_Aug_23_105(5)_698-708.nxml.txt.nlp	21811256	SENT27	29	29	35	35	tamoxifen	aromatase	PA451581	1588	0.821
NULL	Indian_J_Pharmacol_2008_Oct_40(Suppl_2)_S112-S142.nxml.txt.nlp	21593965	SENT224	14	14	27	27	apomorphine	CB1	PA164781163	1268	0.821
NULL	Acta_Pharmacol_Sin_2010_Sep_16_31(9)_1133-1140.nxml.txt.nlp	20711219	SENT48	0	0	14	14	adalimumab	p55	PA10004	6624;2078;8503;5718	0.821
NULL	J_Viral_Hepat_2010_Feb_17(2)_139-147.nxml.txt.nlp	19674282	SENT136	2	2	18	18	ribavirin	RVR	PA451241	9975	0.821
NULL	Ann_Hematol_2011_Dec_8_90(12)_1399-1407.nxml.txt.nlp	21476016	SENT89	6	6	13	13	fludarabine	CHOP	PA449655	1649	0.821
NULL	Cardiovasc_J_Afr_2010_Oct_21(5)_280-285.nxml.txt.nlp	20972517	SENT150	9	9	20	20	coumarin	CYP3A4	PA134521193	1576	0.821
NULL	Cardiol_Res_Pract_2013_Feb_19_2013_195456.nxml.txt.nlp	23533940	SENT108	6	6	12	12	clopidogrel	CYP2C9	PA449053	1559	0.821
NULL	Mol_Vis_2011_Feb_1_17_341-354.nxml.txt.nlp	21297898	SENT34	28	28	14	14	l-glutamine	F12	PA10090	2161	0.821
NULL	Ecancermedicalscience_2009_Aug_5_3_144.nxml.txt.nlp	22276009	SENT22	7	7	15	15	cyclophosphamide	CHOP	PA449165	1649	0.821
NULL	Oncotarget_2014_Dec_4_5(22)_11365-11380.nxml.txt.nlp	25426548	SENT59	2	2	22	22	nutlin-3	p53		7157	0.821
NULL	Mol_Biol_Cell_2014_May_15_25(10)_1641-1652.nxml.txt.nlp	24648491	SENT146	1	1	9	9	cisplatin	NPM1	PA449014	4869	0.821
NULL	Oxid_Med_Cell_Longev_2012_Oct_31_2012_792705.nxml.txt.nlp	23213349	SENT39	10	10	42	42	l-leucine	CO2	PA450197	4513	0.821
NULL	Interdiscip_Perspect_Infect_Dis_2014_May_7_2014_849432.nxml.txt.nlp	24895495	SENT56	15	15	4	4	cosyntropin	ACTH	PA164749052	5443	0.821
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT263	8	8	4	4	warfarin	GGCX	PA451906	2677	0.821
NULL	Mol_Cancer_2010_Aug_20_9_220.nxml.txt.nlp	20727180	SENT152	40	40	31	31	curcumin	p53	PA151958596	7157	0.821
NULL	Cancers_(Basel)_2014_Jan_27_6(1)_226-239.nxml.txt.nlp	24473088	SENT364	6	6	1	1	temozolomide	MSH6	PA451609	2956	0.821
NULL	J_Gen_Physiol_1993_Nov_1_102(5)_817-831.nxml.txt.nlp	7507974	SENT2	14	14	1	1	amiloride	spatial	PA448368	219793	0.821
NULL	Open_Access_J_Urol_2011_May_10_3_69-82.nxml.txt.nlp	24198638	SENT71	23	23	8	8	carbamazepine	CYP3A4	PA448785	1576	0.821
NULL	Cancer_Cell_Int_2014_Feb_4_14_13.nxml.txt.nlp	24495648	SENT127	21	21	11	11	doxorubicin	Bcl-2	PA449412	596	0.821
NULL	Asian-Australas_J_Anim_Sci_2012_Aug_25(8)_1145-1152.nxml.txt.nlp	25049674	SENT171	20	20	18	18	choline	B12	PA448976	7126;4709	0.821
NULL	Oncotarget_2012_Oct_3_3(10)_1182-1193.nxml.txt.nlp	23045412	SENT158	19	19	11	11	imatinib	SIRT1	PA10804	23411	0.821
NULL	Mol_Vis_2011_Dec_24_17_3384-3391.nxml.txt.nlp	22219634	SENT104	3	3	18	18	mannitol	TLR4	PA450320	7099	0.821
NULL	Exp_Ther_Med_2013_Mar_8_5(3)_707-710.nxml.txt.nlp	23404433	SENT83	9	9	11	11	cisplatin	Bcl-2	PA449014	596	0.821
NULL	J_Biomed_Biotechnol_2011_Jul_6_2011_783528.nxml.txt.nlp	21785566	SENT229	0	0	13	13	sulfamethoxazole	NAT	PA451544	6046	0.821
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT218	11	11	9	9	metformin	EGFR	PA450395	1956	0.821
NULL	Cell_Death_Dis_2014_Jul_3_5(7)_e1316.nxml.txt.nlp	24991768	SENT234	0	0	11	11	pemetrexed	Mcl-1	PA10810	4170	0.821
NULL	Protein_Eng_Des_Sel_2014_Apr_28_27(4)_97-109.nxml.txt.nlp	24586053	SENT276	23	23	18	18	trastuzumab	CEA	PA451743	5670;1087	0.821
NULL	Nat_Commun_2013_Aug_15_4_2130.nxml.txt.nlp	23945651	SENT56	8	8	3	3	cisplatin	ATG5	PA449014	9474	0.821
NULL	Cardiovasc_Res_2012_Dec_1_96(3)_552-560.nxml.txt.nlp	22918977	SENT227	10	10	23	23	losartan	ANG	PA450268	283	0.821
NULL	Int_Arch_Med_2009_Jul_31_2_22.nxml.txt.nlp	19646226	SENT62	24	24	11	11	dextran	PTH	PA449261	5741	0.821
NULL	Cancer_Metab_2014_May_28_2(Suppl_1)_O16.nxml.txt.nlp	NULL	SENT10	0	0	2	2	metformin	AMPK	PA450395	5563	0.821
NULL	Anc_Sci_Life_2012_Oct-Dec_32(2)_93-98.nxml.txt.nlp	24167334	SENT118	6	6	11	11	cyclophosphamide	AR7	PA449165	7067	0.821
NULL	Ann_Rheum_Dis_2008_Oct_25_68(10)_1644-1650.nxml.txt.nlp	18957484	SENT89	4	4	17	17	leflunomide	CD69	PA450192	969	0.821
NULL	FASEB_J_2010_Jan_24(1)_286-295.nxml.txt.nlp	19720623	SENT267	25	25	0	0	l-cysteine	SNO	PA449173	6498	0.821
NULL	Cost_Eff_Resour_Alloc_2014_May_3_12_12.nxml.txt.nlp	24910539	SENT165	15	15	22	22	sorafenib	gamma	PA7000	9913	0.821
NULL	Cancer_Cell_2007_Dec_11_12(6)_514-527.nxml.txt.nlp	18068629	SENT551	10	10	17	17	paclitaxel	p53	PA450761	7157	0.821
NULL	Ann_Rheum_Dis_2011_Nov_25_71(5)_687-693.nxml.txt.nlp	22121130	SENT144	29	29	10	10	abatacept	IL-6	PA164747080	3569	0.821
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT7	16	16	10	10	trastuzumab	STAT3	PA451743	6774	0.821
NULL	Mol_Cancer_2009_Dec_10_8_118.nxml.txt.nlp	20003259	SENT128	2	2	11	11	sorafenib	MMP2	PA7000	4313	0.821
NULL	Environ_Health_Perspect_2005_Oct_14_113(10)_1330-1335.nxml.txt.nlp	16203242	SENT112	22	22	25	25	arsenite	MLC	PA452638	23209	0.821
NULL	J_Cell_Biol_2008_Jul_28_182(2)_327-340.nxml.txt.nlp	18644889	SENT254	6	6	25	25	estradiol	AKT	PA449503	207	0.821
NULL	Clin_Pharmacol_2013_Nov_19_5_167-174.nxml.txt.nlp	24277991	SENT128	36	36	16	16	berberine	OTC	PA165860812	5009	0.821
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S18-S30.nxml.txt.nlp	20680104	SENT30	34	34	18	18	bevacizumab	EGFR	PA130232992	1956	0.821
NULL	Anat_Cell_Biol_2011_Sep_29_44(3)_169-175.nxml.txt.nlp	22025968	SENT70	16	16	4	4	ethanol	CLU	PA448073	1191	0.821
NULL	J_Lipid_Res_2015_Jan_56(1)_109-121.nxml.txt.nlp	25421061	SENT35	35	35	23	23	lipase	CGI-58	PA450239	51099	0.821
NULL	Cell_Death_Dis_2012_Mar_1_3(3)_e275.nxml.txt.nlp	22378068	SENT43	30	30	9	9	metformin	AMPK	PA450395	5563	0.821
NULL	Oncol_Lett_2013_Sep_15_6(3)_705-708.nxml.txt.nlp	24137394	SENT132	25	25	13	13	erlotinib	EGFR	PA134687924	1956	0.821
NULL	Ann_Oncol_2011_Mar_8_22(3)_503-514.nxml.txt.nlp	20616198	SENT55	11	11	20	20	letrozole	aromatase	PA450196	1588	0.821
NULL	Mol_Pain_2012_Sep_22_8_71.nxml.txt.nlp	22998838	SENT102	10	10	5	5	cisplatin	CB1	PA449014	1268	0.821
NULL	Cancer_Metab_2013_Jan_23_1_3.nxml.txt.nlp	24280005	SENT362	35	35	32	32	doxycycline	SREBP1	PA449415	6720	0.821
NULL	Breast_Cancer_Res_Treat_2013_May_12_139(1)_107-113.nxml.txt.nlp	23580070	SENT25	35	35	28	28	trastuzumab	HER2	PA451743	2064	0.821
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_127043.nxml.txt.nlp	23227093	SENT7	16	16	5	5	lovastatin	RYR	PA450272	6261	0.821
NULL	Cell_J_2014_May_25_Summer_16(2)_163-170.nxml.txt.nlp	24567946	SENT58	3	3	15	15	naloxone	CA1	PA450586	759	0.821
NULL	Behav_Neurol_2014_Nov_16_2014_360978.nxml.txt.nlp	25477708	SENT415	3	3	21	21	nicotine	CB1	PA450626	1268	0.821
NULL	Mol_Cancer_2008_Mar_26_7_27.nxml.txt.nlp	18366759	SENT110	8	8	13	13	etoposide	HIF-1	PA449552	29072	0.821
NULL	Oncol_Lett_2014_Mar_19_7(3)_674-678.nxml.txt.nlp	24527071	SENT104	19	19	4	4	cisplatin	AKR1C2	PA449014	1646	0.821
NULL	Int_J_Cell_Biol_2013_Sep_12_2013_153634.nxml.txt.nlp	24159334	SENT140	12	12	22	22	cisplatin	EWS	PA449014	2130	0.821
NULL	Breast_Cancer_Res_2013_Nov_29_15(6)_R114.nxml.txt.nlp	24289103	SENT36	11	11	19	19	tamoxifen	EGFR	PA451581	1956	0.821
NULL	Mol_Cancer_2012_Apr_26_11_26.nxml.txt.nlp	22537224	SENT16	18	18	22	22	bortezomib	CHK1	PA10252	1111	0.821
NULL	AIDS_2013_Sep_24_27(15)_2413-2423.nxml.txt.nlp	24037210	SENT302	14	14	3	3	efavirenz	CYP2B6	PA449441	1555	0.821
NULL	J_Breast_Cancer_2013_Sep_30_16(3)_274-284.nxml.txt.nlp	24155756	SENT46	16	16	14	14	doxorubicin	ACT	PA449412	12;11332;9457;641455	0.821
NULL	Br_J_Cancer_1999_Dec_81(8)_1285-1293.nxml.txt.nlp	10604724	SENT13	14	14	31	31	sn-38	p53		7157	0.821
NULL	Cell_Death_Dis_2010_May_13_1(5)_e41.nxml.txt.nlp	21364648	SENT141	6	6	14	14	etoposide	DR4	PA449552	8797	0.821
NULL	J_Biol_Chem_2008_Nov_14_283(46)_31679-31689.nxml.txt.nlp	18755684	SENT295	20	20	2	2	iron	FTL	PA450087	2512	0.821
NULL	Cancers_(Basel)_2014_Jul_22_6(3)_1540-1552.nxml.txt.nlp	25055117	SENT140	1	1	11	11	gefitinib	EGFR	PA131301952	1956	0.821
NULL	Evid_Based_Complement_Alternat_Med_2012_Dec_17_2012_857123.nxml.txt.nlp	23365602	SENT7	4	4	2	2	capsaicin	TRPV1	PA448776	7442	0.821
NULL	Breast_Cancer_Res_2007_Oct_8_9(5)_R68.nxml.txt.nlp	17922920	SENT209	17	17	30	30	trastuzumab	HER2	PA451743	2064	0.821
NULL	Int_J_Hypertens_2013_Mar_19_2013_175428.nxml.txt.nlp	23573410	SENT332	30	30	4	4	vasopressin	AT2	PA451858	186	0.821
NULL	Environ_Health_Perspect_2008_Mar_26_116(3)_322-328.nxml.txt.nlp	18335098	SENT102	28	28	7	7	estradiol	PMI	PA449503	8834;5373	0.821
NULL	Br_J_Cancer_2009_Mar_10_100(5)_758-763.nxml.txt.nlp	19259094	SENT136	22	22	0	0	decitabine	MLH1	PA164749631	4292	0.821
NULL	Br_J_Cancer_2013_Feb_19_108(3)_557-563.nxml.txt.nlp	23361053	SENT58	29	29	3	3	estradiol	HRG	PA449503	3084;3273	0.821
NULL	Oncotarget_2011_Sep_9_2(9)_658-668.nxml.txt.nlp	21911919	SENT5	33	33	27	27	daunorubicin	HO-1	PA449212	3162	0.821
NULL	Breast_Cancer_Res_2007_Aug_8_9(4)_R50.nxml.txt.nlp	17686159	SENT203	5	5	10	10	gefitinib	HRG	PA131301952	3084;3273	0.821
NULL	Mol_Cancer_2014_Apr_29_13_96.nxml.txt.nlp	24779681	SENT226	24	24	20	20	trastuzumab	HER2	PA451743	2064	0.821
NULL	Cancer_Metab_2013_Mar_21_1_12.nxml.txt.nlp	24280230	SENT290	22	22	43	43	urea	ASL	PA451831	435	0.821
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT236	5	5	12	12	curcumin	TRAIL	PA151958596	8743	0.821
NULL	Oxid_Med_Cell_Longev_2012_May_27_2012_609421.nxml.txt.nlp	22693652	SENT108	8	8	20	20	fluoxetine	Bcl-2	PA449673	596	0.821
NULL	J_Vis_Exp_2011_Jul_23_(53)_2851.nxml.txt.nlp	21808228	SENT32	31	31	11	11	milrinone	CO2	PA164749171	4513	0.821
NULL	Int_J_Biol_Sci_2011_Jun_9_7(6)_753-761.nxml.txt.nlp	21698001	SENT45	24	24	19	19	doxycycline	LRRK2	PA449415	120892	0.821
NULL	Br_J_Cancer_2013_Oct_15_109(8)_2051-2057.nxml.txt.nlp	24064969	SENT85	8	8	27	27	capecitabine	SOC	PA448771	91544	0.821
NULL	Br_J_Cancer_2009_Jul_21_101(2)_269-277.nxml.txt.nlp	19603033	SENT152	32	32	22	22	cisplatin	XIAP	PA449014	331	0.821
NULL	Angiogenesis_2010_Dec_7_13(4)_305-315.nxml.txt.nlp	20927579	SENT229	7	7	40	40	resveratrol	TSP1		7057	0.821
NULL	J_Mol_Signal_2009_Sep_25_4_7.nxml.txt.nlp	19781057	SENT428	23	23	15	15	vasopressin	CXCR4	PA451858	7852	0.821
NULL	Ann_Oncol_2014_Oct_18_25(10)_1871-1888.nxml.txt.nlp	25234545	SENT203	24	24	13	13	fulvestrant	aromatase	PA164747170	1588	0.821
NULL	J_Korean_Med_Sci_2013_Feb_29_28(2)_308-314.nxml.txt.nlp	23399960	SENT163	2	2	28	28	gabapentin	IL-10	PA449720	3586	0.821
NULL	Aging_(Albany_NY)_2011_Jan_18_3(1)_33-43.nxml.txt.nlp	21248371	SENT46	18	18	6	6	bleomycin	p53	PA448645	7157	0.821
NULL	Clinics_(Sao_Paulo)_2013_Feb_68(2)_253-262.nxml.txt.nlp	23525324	SENT238	15	15	9	9	genistein	Gen	PA165109660	348654	0.821
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT186	5	5	0	0	cisplatin	IBP	PA449014	706;50619	0.821
NULL	Behav_Brain_Funct_2008_Aug_15_4_37.nxml.txt.nlp	18702828	SENT135	18	18	12	12	methamphetamine	FZD3	PA450403	7976;8326	0.821
NULL	Cancer_Cell_Int_2014_Apr_17_14_34.nxml.txt.nlp	24739220	SENT196	25	25	13	13	bicalutamide	HNRNPK	PA164746255	3190	0.821
NULL	Br_J_Cancer_2012_Dec_4_107(12)_1950-1955.nxml.txt.nlp	23169295	SENT149	25	25	11	11	oxaliplatin	DPD	PA131285527	1806	0.821
NULL	Br_J_Cancer_2012_May_8_106(10)_1689-1696.nxml.txt.nlp	22531631	SENT153	9	9	16	16	lovastatin	AKT	PA450272	207	0.821
NULL	Front_Cell_Neurosci_2015_Jan_6_8_426.nxml.txt.nlp	25610369	SENT651	4	4	12	12	lipase	CB1	PA450239	1268	0.821
NULL	Ann_Oncol_2011_Mar_8_22(3)_503-514.nxml.txt.nlp	20616198	SENT210	15	15	21	21	letrozole	aromatase	PA450196	1588	0.821
NULL	Surg_Today_2012_Jan_6_42(1)_8-28.nxml.txt.nlp	22139128	SENT170	34	34	18	18	docetaxel	survivin	PA449383	332	0.821
NULL	Evol_Med_Public_Health_2013_May_15_2013(1)_118-134.nxml.txt.nlp	24481193	SENT228	7	7	18	18	amodiaquine	CYP2C8	PA448404	1558	0.821
NULL	Infect_Dis_Ther_2013_Dec_8_2(2)_95-110.nxml.txt.nlp	25134474	SENT159	37	37	11	11	tigecycline	VISA	PA164746412	57506	0.821
NULL	Ann_Oncol_2009_Nov_23_20(11)_1803-1812.nxml.txt.nlp	19549706	SENT41	3	3	11	11	sunitinib	IFN	PA162372840	3439	0.821
NULL	Cancer_Cell_Int_2011_Nov_17_11_40.nxml.txt.nlp	22088142	SENT154	3	3	11	11	gemcitabine	MRP2	PA449748	100130958;57626;1244	0.821
NULL	Clin_Transl_Allergy_2013_Sep_2_3_29.nxml.txt.nlp	24004581	SENT204	42	42	33	33	omalizumab	IL-4	PA164752253	3565	0.821
NULL	Breast_Cancer_Res_2011_Mar_11_13(2)_R29.nxml.txt.nlp	21396094	SENT215	35	35	17	17	pertuzumab	HRG		3084;3273	0.821
NULL	Channels_(Austin)_2010_Jan_1_4(1)_22-41.nxml.txt.nlp	19934650	SENT15	15	15	6	6	quinidine	Slo3	PA451209	157855	0.821
NULL	Oxid_Med_Cell_Longev_2010_Mar-Apr_3(2)_101-108.nxml.txt.nlp	20716934	SENT44	12	12	28	28	nifedipine	RAGE	PA450631	177	0.821
NULL	Clin_Drug_Investig_2015_Dec_16_35_141-147.nxml.txt.nlp	25511640	SENT75	26	26	11	11	miglitol	GLP-1	PA164776726	100125288	0.821
NULL	Arthritis_Res_Ther_2007_Oct_9_9(5)_R104.nxml.txt.nlp	17925024	SENT12	0	0	6	6	glucosamine	p38	PA164747613	10598;1432;7965	0.821
NULL	Int_J_Biomater_2014_Jul_2_2014_924278.nxml.txt.nlp	25101127	SENT173	20	20	12	12	curcumin	GIT	PA151958596	5034	0.821
NULL	Evid_Based_Complement_Alternat_Med_2013_May_13_2013_506324.nxml.txt.nlp	23818927	SENT11	21	21	7	7	doxorubicin	STAT3	PA449412	6774	0.821
NULL	Int_J_Mol_Sci_2012_Feb_10_13(2)_1886-1918.nxml.txt.nlp	22408430	SENT240	3	3	16	16	temsirolimus	VEGFR	PA164746890	3791	0.821
NULL	J_Cell_Biol_1998_Jan_26_140(2)_335-345.nxml.txt.nlp	9442109	SENT176	9	9	21	21	chloroquine	NHE	PA448948	285335	0.821
NULL	Breast_Cancer_Res_2014_Sep_9_16(5)_433.nxml.txt.nlp	25212966	SENT9	3	3	22	22	urokinase	ILEI	PA451836	10447	0.821
NULL	Oncotarget_2012_Nov_16_3(11)_1439-1454.nxml.txt.nlp	23183822	SENT182	8	8	13	13	temozolomide	CD133	PA451609	8842	0.821
NULL	Int_J_Mol_Sci_2012_Apr_16_13(4)_4831-4838.nxml.txt.nlp	22606012	SENT108	1	1	16	16	curcumin	p65	PA151958596	5970	0.821
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S101-S106.nxml.txt.nlp	21525438	SENT184	8	8	0	0	torcetrapib	JAMA	PA145007158	50848	0.821
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT42	20	20	14	14	trastuzumab	HER3	PA451743	2065	0.821
NULL	Nat_Med_2010_Jun_23_16(6)_671-677.nxml.txt.nlp	20495567	SENT112	4	4	10	10	sorafenib	ATF5	PA7000	22809	0.821
NULL	Nat_Chem_Biol_2010_Apr_28_6(4)_291-299.nxml.txt.nlp	20190765	SENT128	19	19	37	37	dasatinib	EGFR	PA162372878	1956	0.821
NULL	Acta_Pharmacol_Sin_2012_Jan_28_33(1)_66-74.nxml.txt.nlp	22120966	SENT186	3	3	11	11	genistein	RANKL	PA165109660	8600	0.821
NULL	Br_J_Cancer_2011_Jul_26_105(3)_372-381.nxml.txt.nlp	21730979	SENT144	18	18	22	22	cisplatin	CDK2	PA449014	1017	0.821
NULL	Br_J_Cancer_1998_Sep_78(6)_745-751.nxml.txt.nlp	9743293	SENT6	12	12	15	15	camptothecin	p53	PA153590860	7157	0.821
NULL	J_Headache_Pain_2014_Sep_18_15(Suppl_1)_F28.nxml.txt.nlp	NULL	SENT19	29	29	37	37	telmisartan	P-gp	PA451605	5243	0.821
NULL	Oncotarget_2014_Nov_3_5(20)_10127-10139.nxml.txt.nlp	25333256	SENT147	23	23	26	26	vemurafenib	TRIM16	PA165946873	10626	0.821
NULL	J_Invest_Dermatol_2013_Dec_30_133(12)_10_1038_jid_2013_237.nxml.txt.nlp	23732752	SENT114	2	2	28	28	etanercept	IL-6	PA449515	3569	0.821
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_91-103.nxml.txt.nlp	17912639	SENT72	14	14	33	33	letrozole	HER2	PA450196	2064	0.821
NULL	Clin_Infect_Dis_2013_Jan_15_56(2)_258-266.nxml.txt.nlp	23024295	SENT199	6	6	30	30	ribavirin	BII	PA451241	777	0.821
NULL	Cardiovasc_Diabetol_2006_Aug_30_5_17.nxml.txt.nlp	16939660	SENT105	2	2	11	11	metformin	IL-6	PA450395	3569	0.821
NULL	Front_Neuroendocrinol_2012_Jan_33(1)_45-66.nxml.txt.nlp	21802439	SENT1638	23	23	13	13	vasopressin	AT1	PA451858	9197;185	0.821
NULL	Clin_Pharmacokinet_2014_Sep_3_53(1)_1-16.nxml.txt.nlp	23999929	SENT278	5	5	16	16	rivaroxaban	CYP3A4	PA165958360	1576	0.821
NULL	Br_J_Cancer_2012_Jul_24_107(3)_516-526.nxml.txt.nlp	22782351	SENT132	20	20	8	8	tamoxifen	TIGAR	PA451581	57103	0.821
NULL	Onco_Targets_Ther_2014_Jul_1_7_1185-1193.nxml.txt.nlp	25061320	SENT153	9	9	20	20	docetaxel	EGFR	PA449383	1956	0.821
NULL	Breast_Cancer_Res_2007_Jan_23_9(1)_R7.nxml.txt.nlp	17244352	SENT197	8	8	14	14	tamoxifen	CYP3A5	PA451581	1577	0.821
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_19_2013_746486.nxml.txt.nlp	23861712	SENT147	16	16	6	6	irinotecan	UGT	PA450085	7361;7355	0.821
NULL	Int_J_Mol_Sci_2013_Apr_29_14(5)_9338-9364.nxml.txt.nlp	23629668	SENT90	36	36	10	10	bevacizumab	IL6	PA130232992	3569	0.821
NULL	Front_Neurosci_2011_Jul_26_5_92.nxml.txt.nlp	21845173	SENT101	35	35	11	11	ketorolac	NRM	PA450150	11270	0.821
NULL	Mol_Med_Rep_2015_Jan_16_11(1)_189-195.nxml.txt.nlp	25323748	SENT88	13	13	7	7	cisplatin	p62	PA449014	8878;10657;23636	0.821
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT94	35	35	29	29	l-methionine	p27	PA450423	5715;10534	0.821
NULL	Oncotarget_2014_Feb_21_5(10)_3012-3022.nxml.txt.nlp	24931142	SENT176	24	24	14	14	paclitaxel	MCL1	PA450761	4170	0.821
NULL	Int_J_Biol_Sci_2015_Jan_1_11(2)_144-155.nxml.txt.nlp	25561897	SENT184	22	22	28	28	epirubicin	POLB	PA449476	5423	0.821
NULL	Int_J_Mol_Sci_2014_Jun_3_15(6)_9826-9843.nxml.txt.nlp	24897020	SENT311	11	11	3	3	ribavirin	IL28B	PA451241	282617	0.821
NULL	N_Am_J_Med_Sci_2013_Sep_5(9)_541-545.nxml.txt.nlp	24251272	SENT24	12	12	3	3	fluconazole	NAC	PA449653	22861	0.821
NULL	Br_J_Pharmacol_2011_Aug_163(8)_1626-1638.nxml.txt.nlp	21410464	SENT46	4	4	37	37	forskolin	CA1	PA146096022	759	0.821
NULL	Br_J_Cancer_2013_Jul_23_109(2)_342-350.nxml.txt.nlp	23807172	SENT113	21	21	12	12	sorafenib	Bcl-2	PA7000	596	0.821
NULL	Case_Rep_Ophthalmol_2013_Sep_21_4(3)_122-128.nxml.txt.nlp	24163679	SENT61	16	16	0	0	triamcinolone	Ray	PA451749	26751	0.821
NULL	Acta_Pharmacol_Sin_2009_Oct_21_30(10)_1392-1398.nxml.txt.nlp	19767766	SENT112	20	20	3	3	l-arginine	eNOS	PA448478	4846	0.821
NULL	Mol_Brain_2014_May_15_7_37.nxml.txt.nlp	24886748	SENT125	30	30	8	8	vorinostat	NFKB1	PA164748224	4790	0.821
NULL	Curr_Neuropharmacol_2012_Sep_10(3)_263-271.nxml.txt.nlp	23449968	SENT121	29	29	9	9	atomoxetine	LPHN3	PA134688071	23284	0.821
NULL	ISRN_Neurol_2014_Jan_21_2014_515716.nxml.txt.nlp	24579051	SENT147	0	0	5	5	hyperforin	TRPC6	PA165985514	7225	0.821
NULL	J_Cell_Mol_Med_2014_Apr_20_18(4)_709-720.nxml.txt.nlp	24444314	SENT219	10	10	2	2	losartan	AMPK	PA450268	5563	0.821
NULL	Alcohol_Res_Health_2007_30(1)_5-13.nxml.txt.nlp	17718394	SENT90	23	23	13	13	ethanol	ADH1C	PA448073	126	0.821
NULL	Oncogene_2010_Sep_23_29(38)_5299-5310.nxml.txt.nlp	20622903	SENT251	23	23	12	12	melphalan	HMGB1	PA450354	3146	0.821
NULL	Br_J_Cancer_2013_Oct_15_109(8)_2096-2105.nxml.txt.nlp	24064970	SENT193	24	24	6	6	cisplatin	ERCC1	PA449014	2067	0.821
NULL	Hum_Mol_Genet_2013_Nov_15_22(22)_4616-4626.nxml.txt.nlp	23814041	SENT181	0	0	16	16	simvastatin	neuroserpin	PA451363	5274	0.821
NULL	Front_Neurosci_2010_Jun_17_4_35.nxml.txt.nlp	20661455	SENT664	3	3	9	9	milnacipran	5-HT1A	PA164752812	3350	0.821
NULL	Breast_Cancer_Res_2010_May_18_12(Suppl_1)_P20.nxml.txt.nlp	NULL	SENT15	12	12	18	18	hydroxyurea	AP-2	PA449942	7020	0.821
NULL	Acta_Pharmacol_Sin_2009_Sep_17_30(9)_1316-1322.nxml.txt.nlp	19684609	SENT165	27	27	4	4	rosiglitazone	PTEN	PA451283	5728	0.821
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT13	11	11	2	2	imatinib	CML	PA10804	613	0.821
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT156	14	14	16	16	curcumin	TRAIL	PA151958596	8743	0.821
NULL	Breast_Cancer_Res_2001_Mar_26_3(3)_180-182.nxml.txt.nlp	11305952	SENT33	9	9	2	2	tamoxifen	STAR	PA451581	6770;2984	0.821
NULL	Cell_Death_Dis_2014_Apr_17_5(4)_e1182.nxml.txt.nlp	24743737	SENT231	4	4	8	8	capsaicin	AMPK	PA448776	5563	0.821
NULL	Br_J_Pharmacol_2014_Oct_26_171(20)_4785-4796.nxml.txt.nlp	25074741	SENT265	3	3	8	8	guanfacine	NK1R	PA449825	6869	0.821
NULL	Br_J_Cancer_2009_Jul_21_101(2)_238-243.nxml.txt.nlp	19568242	SENT123	24	24	11	11	sunitinib	IFN	PA162372840	3439	0.821
NULL	Front_Oncol_2013_Nov_27_3_290.nxml.txt.nlp	24350055	SENT89	6	6	29	29	cisplatin	JNK	PA449014	5599	0.821
NULL	J_Am_Heart_Assoc_2013_Dec_19_2(6)_e000439.nxml.txt.nlp	24334905	SENT134	10	10	2	2	doxorubicin	ANOVA	PA449412	4858	0.821
NULL	Pharmaceutics_2011_Feb_7_3(1)_53-72.nxml.txt.nlp	24310425	SENT236	9	9	26	26	isoniazid	NAT	PA450112	6046	0.821
NULL	Mol_Cancer_2014_Jan_15_13_8.nxml.txt.nlp	24423412	SENT99	10	10	7	7	cisplatin	CD44	PA449014	960	0.821
NULL	Cancers_(Basel)_2010_Apr_13_2(2)_436-482.nxml.txt.nlp	21297902	SENT460	23	23	6	6	indomethacin	EP1	PA449982	5731	0.821
NULL	Mol_Cell_Proteomics_2014_Mar_20_13(3)_701-715.nxml.txt.nlp	24361865	SENT1166	5	5	9	9	gemcitabine	AKR1B10	PA449748	57016	0.821
NULL	Mol_Cancer_2004_Jul_8_3_18.nxml.txt.nlp	15242522	SENT173	18	18	9	9	doxorubicin	p53	PA449412	7157	0.821
NULL	J_Cell_Mol_Med_2014_Jan_4_18(1)_38-48.nxml.txt.nlp	24188742	SENT152	11	11	5	5	etoposide	PAX3	PA449552	5077	0.821
NULL	J_Korean_Med_Sci_2006_Dec_31_21(6)_1037-1040.nxml.txt.nlp	17179683	SENT90	2	2	22	22	omeprazole	BAM	PA450704	9126	0.821
NULL	Indian_J_Med_Res_2013_Nov_138(5)_577-590.nxml.txt.nlp	24434313	SENT153	19	19	23	23	etoposide	gamma	PA449552	9913	0.821
NULL	Pak_J_Med_Sci_2013_Jan-Mar_29(1)_97-102.nxml.txt.nlp	24353516	SENT96	20	20	25	25	clopidogrel	ADP	PA449053	23038	0.821
NULL	BMB_Rep_2013_Aug_46(8)_410-415.nxml.txt.nlp	23977989	SENT101	8	8	17	17	curcumin	HO-1	PA151958596	3162	0.821
NULL	Mol_Cancer_2009_Apr_22_8_26.nxml.txt.nlp	19386116	SENT125	3	3	19	19	ritonavir	AKT	PA451260	207	0.821
NULL	Infect_Dis_Obstet_Gynecol_2014_Sep_25_2014_961375.nxml.txt.nlp	25328370	SENT197	24	24	0	0	ritonavir	ATV	PA451260	4683	0.821
NULL	Breast_Cancer_Res_2011_Mar_10_13(2)_R28.nxml.txt.nlp	21392397	SENT234	0	0	22	22	erlotinib	YB-1	PA134687924	4904	0.821
NULL	Arthritis_Res_Ther_2009_Aug_28_11(4)_R131.nxml.txt.nlp	19715572	SENT149	14	14	25	25	rituximab	CD27	PA451261	939	0.821
NULL	Oncoscience_2014_Oct_5_1(10)_624-633.nxml.txt.nlp	25593992	SENT65	40	40	19	19	doxycycline	PCTAIRE1	PA449415	5127	0.821
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT95	5	5	14	14	celecoxib	IL-6	PA448871	3569	0.821
NULL	Support_Care_Cancer_2009_Sep_10_17(9)_1187-1193.nxml.txt.nlp	19205754	SENT84	13	13	0	0	dolasetron	CYP2D6	PA449390	1565	0.821
NULL	Br_J_Cancer_2012_Apr_10_106(8)_1406-1414.nxml.txt.nlp	22491422	SENT5	34	34	20	20	cetuximab	AREG	PA10040	374	0.821
NULL	Cases_J_2009_Jul_23_2_8552.nxml.txt.nlp	19830081	SENT46	6	6	20	20	docetaxel	CD4	PA449383	920	0.821
NULL	Breast_Cancer_Res_Treat_2012_Jun_18_133(3)_937-947.nxml.txt.nlp	22094936	SENT14	31	31	19	19	tamoxifen	EZH2	PA451581	2146	0.821
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT138	4	4	0	0	cisplatin	IBP	PA449014	706;50619	0.821
NULL	Onco_Targets_Ther_2014_Dec_3_7_2227-2236.nxml.txt.nlp	25506226	SENT135	6	6	37	37	capromab	PSMA	PA164745489	2346	0.821
NULL	Ann_Thorac_Med_2013_Apr-Jun_8(2)_109-115.nxml.txt.nlp	23741274	SENT21	13	13	4	4	cisplatin	CRT	PA449014	811	0.821
NULL	Br_J_Cancer_2013_Sep_3_109(5)_1085-1092.nxml.txt.nlp	23942080	SENT144	21	21	29	29	docetaxel	PIK3CA	PA449383	5290	0.821
NULL	Oncol_Rep_2014_Feb_13_31(2)_581-588.nxml.txt.nlp	24337105	SENT191	20	20	9	9	capsaicin	ATF4	PA448776	468	0.821
NULL	Diabetes_Metab_Syndr_Obes_2010_Mar_29_3_31-41.nxml.txt.nlp	21437074	SENT155	5	5	16	16	sitagliptin	GLP-1	PA164748978	100125288	0.821
NULL	Biomed_Res_Int_2013_Oct_27_2013_798261.nxml.txt.nlp	24282821	SENT194	3	3	5	5	ethanol	AQP4	PA448073	361	0.821
NULL	Arch_Med_Sci_2012_Jul_4_8(3)_509-514.nxml.txt.nlp	22852008	SENT80	10	10	19	19	salbutamol	PED	PA448068	8682	0.821
NULL	Clin_Interv_Aging_2013_Jul_16_8_889-897.nxml.txt.nlp	23898224	SENT7	47	47	38	38	gemcitabine	SIRT1	PA449748	23411	0.821
NULL	Breast_Cancer_Res_2011_Nov_1_13(6)_224.nxml.txt.nlp	22114931	SENT128	14	14	5	5	trastuzumab	PTEN	PA451743	5728	0.821
NULL	Cell_Death_Dis_2014_Jul_10_5(7)_e1318.nxml.txt.nlp	25010984	SENT39	4	4	11	11	nutlin-3	RITA		55422;84934	0.821
NULL	Endocrine_2012_Dec_14_42(3)_622-636.nxml.txt.nlp	22695986	SENT63	21	21	19	19	forskolin	PTH	PA146096022	5741	0.821
NULL	Mol_Cancer_2010_Nov_25_9_305.nxml.txt.nlp	21108789	SENT79	9	9	4	4	doxorubicin	PTEN	PA449412	5728	0.821
NULL	Br_J_Cancer_2010_Oct_26_103(9)_1380-1390.nxml.txt.nlp	20877355	SENT191	6	6	17	17	bortezomib	DR5	PA10252	8795	0.821
NULL	Br_J_Cancer_2012_Sep_4_107(6)_947-955.nxml.txt.nlp	22892392	SENT37	1	1	13	13	tamoxifen	ERBB3	PA451581	2065	0.821
NULL	Acta_Vet_Scand_2011_Feb_22_53(1)_12.nxml.txt.nlp	21342526	SENT42	6	6	16	16	flutamide	PD2	PA449685	54623	0.821
NULL	Anal_Bioanal_Chem_2009_Oct_30_395(4)_893-905.nxml.txt.nlp	19484227	SENT143	2	2	17	17	amoxicillin	OTC	PA448406	5009	0.821
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_105-115.nxml.txt.nlp	17912640	SENT72	7	7	13	13	fulvestrant	HER2	PA164747170	2064	0.821
NULL	Clin_Mol_Hepatol_2014_Sep_25_20(3)_283-290.nxml.txt.nlp	25320732	SENT95	37	37	31	31	propranolol	EVL	PA451145	51466	0.821
NULL	Int_J_Biomed_Sci_2013_Sep_9(3)_112-122.nxml.txt.nlp	24170986	SENT137	3	3	32	32	imatinib	zeta	PA10804	9907	0.821
NULL	Oncol_Lett_2013_Sep_3_6(3)_807-810.nxml.txt.nlp	24137415	SENT29	35	35	5	5	l-glutamine	p53	PA10090	7157	0.821
NULL	ASN_Neuro_2010_Oct_4_2(5)_e00046.nxml.txt.nlp	20957077	SENT152	2	2	26	26	ganciclovir	E12	PA449733	64100	0.821
NULL	Oncotarget_2014_Aug_25_5(17)_7945-7959.nxml.txt.nlp	25277206	SENT28	19	19	25	25	cabozantinib	VEGFR2	PA165906891	3791	0.821
NULL	Oncogene_2013_Sep_12_32(37)_4355-4365.nxml.txt.nlp	23108409	SENT11	4	4	17	17	hyaluronan	CD44	PA165958431	960	0.821
NULL	Mol_Cancer_2013_Sep_27_12_111.nxml.txt.nlp	24070020	SENT245	0	0	13	13	bezafibrate	AMPK	PA162364313	5563	0.821
NULL	Ther_Clin_Risk_Manag_2007_Jun_3(2)_277-289.nxml.txt.nlp	18360636	SENT89	8	8	12	12	paroxetine	5-HT2C	PA450801	3358	0.821
NULL	Oncogene_2013_Sep_26_32(39)_10_1038_onc_2012_491.nxml.txt.nlp	23108394	SENT83	18	18	10	10	epirubicin	BRIP1	PA449476	64979;83990	0.821
NULL	Oncotarget_2012_Nov_17_4(1)_18-28.nxml.txt.nlp	23248157	SENT77	5	5	14	14	pargyline	PUMA	PA450797	27113	0.821
NULL	Oncotarget_2014_Jun_3_5(13)_4920-4928.nxml.txt.nlp	24952482	SENT11	0	0	11	11	crizotinib	ALK	PA165946122	238	0.821
NULL	Angiogenesis_2010_Dec_7_13(4)_305-315.nxml.txt.nlp	20927579	SENT38	4	4	34	34	resveratrol	TSP1		7057	0.821
NULL	J_Gastrointest_Cancer_2013_Aug_7_44(4)_385-392.nxml.txt.nlp	23921604	SENT159	10	10	34	34	imatinib	ATG12	PA10804	9140	0.821
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT109	0	0	7	7	chloroquine	BMPR-II	PA448948	659	0.821
NULL	J_Inflamm_(Lond)_2005_Oct_31_2_14.nxml.txt.nlp	16259633	SENT309	4	4	12	12	staurosporine	CCR2	PA165109623	729230	0.821
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_24_2012_673132.nxml.txt.nlp	23133498	SENT112	10	10	0	0	ciprofloxacin	P-gp	PA449009	5243	0.821
NULL	Patient_Prefer_Adherence_2013_Mar_27_7_245-258.nxml.txt.nlp	23569364	SENT88	24	24	19	19	letrozole	aromatase	PA450196	1588	0.821
NULL	J_Korean_Med_Sci_2011_Dec_29_26(12)_1556-1562.nxml.txt.nlp	22147991	SENT32	23	23	32	32	cyclophosphamide	CHOP	PA449165	1649	0.821
NULL	Child_Adolesc_Psychiatry_Ment_Health_2009_Aug_24_3_21.nxml.txt.nlp	19703299	SENT240	39	39	34	34	atomoxetine	CHIP	PA134688071	10273	0.821
NULL	Br_J_Pharmacol_2010_Sep_161(2)_308-320.nxml.txt.nlp	20735417	SENT114	9	9	7	7	rimonabant	GPR55	PA152407999	9290	0.821
NULL	Rare_Tumors_2010_Dec_31_2(4)_e63.nxml.txt.nlp	21234255	SENT33	33	33	6	6	etoposide	CHOP	PA449552	1649	0.821
NULL	Br_J_Cancer_2009_Jul_21_101(2)_238-243.nxml.txt.nlp	19568242	SENT4	17	17	25	25	bevacizumab	IFN	PA130232992	3439	0.821
NULL	Cancer_Cell_Int_2005_Aug_24_5_28.nxml.txt.nlp	16120219	SENT69	7	7	11	11	etoposide	p53	PA449552	7157	0.821
NULL	Int_J_Biol_Sci_2014_Jan_11_10(2)_142-148.nxml.txt.nlp	24520212	SENT112	11	11	2	2	tamoxifen	WWOX	PA451581	51741	0.821
NULL	Cancer_Growth_Metastasis_2013_Aug_8_6_35-52.nxml.txt.nlp	24665206	SENT75	30	30	8	8	cisplatin	FANCD2	PA449014	2177	0.821
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT331	2	2	15	15	risperidone	PRL	PA451257	5617	0.821
NULL	Br_J_Haematol_2014_Feb_16_164(4)_586-596.nxml.txt.nlp	24236640	SENT161	16	16	25	25	carboplatin	EPO	PA448803	7076;8288;2056	0.821
NULL	Exp_Diabetes_Res_2007_Apr_12_2007_15803.nxml.txt.nlp	17641739	SENT137	16	16	23	23	curcumin	STZ	PA151958596	6484	0.821
NULL	Am_J_Trop_Med_Hyg_2012_Nov_7_87(5)_783-784.nxml.txt.nlp	23136171	SENT16	11	11	39	39	mefloquine	ACT	PA450348	12;11332;9457;641455	0.821
NULL	Arch_Drug_Inf_2008_Sep_1(2)_50-55.nxml.txt.nlp	19915714	SENT57	0	0	32	32	fentanyl	API	PA449599	5345	0.821
NULL	AIDS_Res_Ther_2014_May_19_11_13.nxml.txt.nlp	24894206	SENT315	21	21	30	30	methamphetamine	IL-6	PA450403	3569	0.821
NULL	Arthritis_Res_Ther_2005_Jan_12_7(2)_R256-R267.nxml.txt.nlp	15743472	SENT54	12	12	46	46	l-glutamine	CO2	PA10090	4513	0.821
NULL	J_Cardiovasc_Electrophysiol_2012_Jun_11_23(6)_574-575.nxml.txt.nlp	22494548	SENT56	22	22	25	25	heparin	ACT	PA449855	12;11332;9457;641455	0.821
NULL	AAPS_J_2011_Jun_1_13(3)_405-416.nxml.txt.nlp	21630127	SENT334	16	16	30	30	trastuzumab	HER2	PA451743	2064	0.821
NULL	Protein_Eng_Des_Sel_2011_Jul_3_24(7)_565-578.nxml.txt.nlp	21642284	SENT214	25	25	15	15	trimethoprim	DHFR	PA451788	1719	0.821
NULL	Cancer_Cell_2007_Dec_11_12(6)_514-527.nxml.txt.nlp	18068629	SENT28	24	24	6	6	paclitaxel	TGFBI	PA450761	7045	0.821
NULL	Arch_Med_Sci_2013_Aug_30_9(4)_724-730.nxml.txt.nlp	24049536	SENT5	6	6	14	14	genistein	PTH	PA165109660	5741	0.821
NULL	Lab_Invest_2011_Sep_23_91(9)_1396-1409.nxml.txt.nlp	21606925	SENT53	11	11	9	9	genistein	PP2	PA165109660	4888	0.821
NULL	Eur_J_Nucl_Med_Mol_Imaging_2010_Feb_24_37(2)_386-398.nxml.txt.nlp	19777175	SENT107	0	0	19	19	adalimumab	GM-CSF	PA10004	1437	0.821
NULL	Br_J_Cancer_2011_Apr_12_104(8)_1256-1261.nxml.txt.nlp	21448165	SENT161	10	10	29	29	sorafenib	IL-2	PA7000	3558	0.821
NULL	Acta_Histochem_Cytochem_2013_Dec_28_46(6)_187-197.nxml.txt.nlp	24610966	SENT20	16	16	22	22	isoproterenol	AQP5	PA450121	362	0.821
NULL	Biomed_Res_Int_2014_Jan_29_2014_458592.nxml.txt.nlp	24592391	SENT171	25	25	11	11	curcumin	HO-1	PA151958596	3162	0.821
NULL	J_Hematol_Oncol_2013_Oct_12_6_78.nxml.txt.nlp	24283803	SENT170	7	7	4	4	daunorubicin	STAT3	PA449212	6774	0.82
NULL	Arthritis_Res_Ther_2010_Jun_28_12(3)_210.nxml.txt.nlp	20609263	SENT46	21	21	36	36	l-arginine	IFN	PA448478	3439	0.82
NULL	Int_J_Biol_Sci_2013_Mar_7_9(3)_279-288.nxml.txt.nlp	23493630	SENT213	0	0	5	5	tocilizumab	IL-21	PA165292659	59067;50616;27189	0.82
NULL	Ther_Clin_Risk_Manag_2006_Mar_2(1)_59-75.nxml.txt.nlp	18360582	SENT248	12	12	8	8	telithromycin	CYP3A4	PA10202	1576	0.82
NULL	Mar_Drugs_2014_Mar_7_12(3)_1377-1389.nxml.txt.nlp	24608973	SENT39	23	23	29	29	topotecan	CDK4	PA451729	1019	0.82
NULL	J_Vet_Med_Sci_2014_Oct_16_76(10)_1383-1387.nxml.txt.nlp	24931645	SENT70	46	46	20	20	liraglutide	GLP-1	PA165958364	100125288	0.82
NULL	J_Hematol_Oncol_2011_Apr_20_4_17.nxml.txt.nlp	21507255	SENT53	41	41	26	26	cisplatin	HDAC	PA449014	9734	0.82
NULL	Front_Behav_Neurosci_2014_May_27_8_191.nxml.txt.nlp	24904342	SENT63	18	18	28	28	vasopressin	AVP	PA451858	114548;551	0.82
NULL	Arthritis_Rheum_2013_Jan_1_65(12)_3130-3140.nxml.txt.nlp	23983046	SENT275	14	14	7	7	collagenase	SFN	PA449107	25996;2810	0.82
NULL	Indian_J_Anaesth_2014_Jul-Aug_58(4)_423-429.nxml.txt.nlp	25197110	SENT43	27	27	3	3	ondansetron	ODF4	PA450705	146852	0.82
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT124	11	11	5	5	imatinib	ABCG2	PA10804	9429	0.82
NULL	J_Oncol_2010_Feb_17_2010_514310.nxml.txt.nlp	20182531	SENT248	0	0	14	14	metformin	AMPK	PA450395	5563	0.82
NULL	Nucleic_Acids_Res_2005_Jun_8_33(10)_3283-3291.nxml.txt.nlp	15944449	SENT100	6	6	13	13	sjg-136	XRCC2		7516	0.82
NULL	Oxid_Med_Cell_Longev_2013_Nov_17_2013_136570.nxml.txt.nlp	24349608	SENT7	12	12	26	26	coumarin	p40phox	PA134521193	4689	0.82
NULL	Ann_Surg_Treat_Res_2014_Feb_22_86(2)_68-75.nxml.txt.nlp	24761411	SENT122	10	10	13	13	resveratrol	survivin		332	0.82
NULL	Anal_Biochem_2014_Jun_1_454(100)_17-22.nxml.txt.nlp	24637157	SENT20	28	28	33	33	camptothecin	TOP1	PA153590860	7150	0.82
NULL	Br_J_Cancer_2013_Mar_19_108(5)_1079-1091.nxml.txt.nlp	23449353	SENT171	13	13	20	20	docetaxel	MIC-1	PA449383	29919;9518	0.82
NULL	J_Exp_Med_1980_Feb_1_151(2)_314-327.nxml.txt.nlp	6766175	SENT8	8	8	27	27	glutaraldehyde	B10	PA449777	5169	0.82
NULL	Curr_Neuropharmacol_2014_Mar_12(2)_186-192.nxml.txt.nlp	24669211	SENT254	0	0	11	11	metformin	Met	PA450395	79811	0.82
NULL	Mol_Biol_Cell_2012_Sep_1_23(17)_3473-3484.nxml.txt.nlp	22787275	SENT128	7	7	3	3	doxorubicin	ABCC1	PA449412	4363	0.82
NULL	Clinics_(Sao_Paulo)_2010_Jan_65(1)_29-34.nxml.txt.nlp	20126343	SENT94	28	28	24	24	ropivacaine	LPSB	PA451271	8991	0.82
NULL	J_Biomed_Sci_2014_Jan_24_21(1)_7.nxml.txt.nlp	24456003	SENT28	14	14	0	0	oxygen	HIF-1	PA450744	29072	0.82
NULL	EMBO_Mol_Med_2012_Jul_11_4(7)_577-593.nxml.txt.nlp	22496117	SENT238	6	6	12	12	staurosporine	PAP-1	PA165109623	6100	0.82
NULL	Oncoimmunology_2014_Jan_1_3_e27360.nxml.txt.nlp	24711956	SENT36	2	2	0	0	l-arginine	ARG1	PA448478	383;64129	0.82
NULL	Clin_Med_Insights_Cardiol_2011_Oct_6_5_103-119.nxml.txt.nlp	22084608	SENT316	3	3	16	16	dronedarone	HERG	PA153619853	3757	0.82
NULL	Acta_Pharmacol_Sin_2012_Aug_23_33(8)_1095-1100.nxml.txt.nlp	22820908	SENT110	4	4	10	10	esomeprazole	CYP3A	PA10075	1574	0.82
NULL	Diabetes_2011_Jun_21_60(6)_1797-1804.nxml.txt.nlp	21536946	SENT196	10	10	15	15	diazoxide	SUR1	PA449285	6833	0.82
NULL	Front_Immunol_2013_Nov_7_4_360.nxml.txt.nlp	24223576	SENT218	8	8	0	0	imiquimod	CCR7	PA449972	1236	0.82
NULL	Breast_Cancer_Res_2014_Sep_28_16(5)_446.nxml.txt.nlp	25467785	SENT155	11	11	16	16	tamoxifen	STAR	PA451581	6770;2984	0.82
NULL	Curr_Med_Chem_2013_Jan_21(3)_261-269.nxml.txt.nlp	24164192	SENT90	7	7	5	5	etanercept	TNFRSF1A	PA449515	7132	0.82
NULL	Reprod_Biol_Endocrinol_2013_Oct_21_11_99.nxml.txt.nlp	24144083	SENT165	25	25	14	14	estradiol	adiponectin	PA449503	9370	0.82
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1821-1889.nxml.txt.nlp	25268160	SENT305	25	25	7	7	tamoxifen	FDG	PA451581	23583	0.82
NULL	Neuropsychopharmacology_2009_Sep_3_34(10)_2227-2236.nxml.txt.nlp	19494805	SENT34	6	6	17	17	bupropion	STAR	PA448687	6770;2984	0.82
NULL	Front_Oncol_2013_Oct_29_3_269.nxml.txt.nlp	24195060	SENT92	33	33	12	12	cisplatin	THBS1	PA449014	7057	0.82
NULL	Arthritis_Res_Ther_2008_Jan_7_10(1)_R1.nxml.txt.nlp	18179697	SENT186	13	13	20	20	oxaliplatin	HMGB1	PA131285527	3146	0.82
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT66	2	2	9	9	ranibizumab	San	PA164746012	80218	0.82
NULL	Mol_Clin_Oncol_2013_Jul_27_1(4)_768-772.nxml.txt.nlp	24649244	SENT3	35	35	37	37	gemcitabine	GEM	PA449748	2669	0.82
NULL	Gut_Liver_2012_Oct_18_6(4)_464-470.nxml.txt.nlp	23170151	SENT135	9	9	44	44	propofol	ESD	PA451141	2098	0.82
NULL	Int_J_Hypertens_2012_Feb_1_2012_859235.nxml.txt.nlp	22518295	SENT292	10	10	3	3	cisplatin	HO-1	PA449014	3162	0.82
NULL	J_Immunother_Cancer_2014_Mar_12_2(Suppl_2)_P18.nxml.txt.nlp	NULL	SENT5	0	0	4	4	alemtuzumab	CD52	PA164783958	1043	0.82
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT7	0	0	21	21	curcumin	PUMA	PA151958596	27113	0.82
NULL	Diabetes_Care_2013_May_13_36(5)_1074-1082.nxml.txt.nlp	23275352	SENT214	8	8	17	17	liraglutide	ZAG	PA165958364	563	0.82
NULL	Cell_Death_Dis_2012_Mar_1_3(3)_e275.nxml.txt.nlp	22378068	SENT26	3	3	1	1	metformin	AMPK	PA450395	5563	0.82
NULL	Oncotarget_2014_Oct_21_5(22)_11723-11736.nxml.txt.nlp	25375091	SENT152	4	4	1	1	everolimus	MTOR	PA164746311	2475	0.82
NULL	Br_J_Cancer_2012_Jul_24_107(3)_435-441.nxml.txt.nlp	22767144	SENT146	34	34	13	13	docetaxel	TEF	PA449383	7008	0.82
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_13_2014_849783.nxml.txt.nlp	25477998	SENT104	1	1	41	41	berberine	Bcl-2	PA165860812	596	0.82
NULL	Br_J_Cancer_2010_Jan_19_102(2)_403-413.nxml.txt.nlp	19997104	SENT72	28	28	14	14	paraformaldehyde	CO2	PA450790	4513	0.82
NULL	Lung_2010_Jan_16_188(Suppl_1)_99-103.nxml.txt.nlp	19756864	SENT40	15	15	3	3	mannitol	PGD2	PA450320	27306	0.82
NULL	COPD_2014_Dec_30_11(6)_705-717.nxml.txt.nlp	24787454	SENT31	8	8	2	2	l-cysteine	NAC	PA449173	22861	0.82
NULL	J_Hematol_Oncol_2008_Aug_11_1_11.nxml.txt.nlp	18694493	SENT135	10	10	12	12	bevacizumab	IFN	PA130232992	3439	0.82
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT208	16	16	21	21	phenprocoumon	VKORC1	PA450921	79001	0.82
NULL	J_Cancer_2013_Jul_2_4(6)_447-457.nxml.txt.nlp	23901343	SENT257	22	22	29	29	verapamil	ABCG2	PA451868	9429	0.82
NULL	Oncotarget_2012_Sep_28_3(10)_1169-1181.nxml.txt.nlp	23045411	SENT106	11	11	21	21	doxorubicin	JIP1	PA449412	9479	0.82
NULL	Ann_Rehabil_Med_2012_Dec_28_36(6)_857-860.nxml.txt.nlp	23342320	SENT64	11	11	5	5	warfarin	VKORC1	PA451906	79001	0.82
NULL	Mol_Cancer_2010_Nov_8_9_291.nxml.txt.nlp	21059223	SENT146	31	31	9	9	paclitaxel	Bcl-2	PA450761	596	0.82
NULL	Curr_Chem_Genomics_2010_Mar_1_4_1-8.nxml.txt.nlp	20448812	SENT31	10	10	16	16	fluorescein	OATP1B3	PA164746009	28234	0.82
NULL	Cancer_Biol_Med_2013_Dec_10(4)_206-213.nxml.txt.nlp	24349830	SENT177	3	3	18	18	bortezomib	p53	PA10252	7157	0.82
NULL	Arthritis_Res_Ther_2009_Jan_26_11(1)_R12.nxml.txt.nlp	19171052	SENT245	19	19	25	25	dipyridamole	ACTH	PA449367	5443	0.82
NULL	Biomed_Res_Int_2014_Feb_4_2014_975927.nxml.txt.nlp	24689066	SENT67	20	20	5	5	denosumab	BIM	PA166048634	10018	0.82
NULL	ASN_Neuro_2009_Apr_14_1(1)_e00005.nxml.txt.nlp	19570022	SENT35	11	11	37	37	mefloquine	PP2	PA450348	4888	0.82
NULL	F1000_Med_Rep_2010_Jul_22_2_53.nxml.txt.nlp	21173853	SENT28	19	19	30	30	moxifloxacin	IL-8	PA450555	3576	0.82
NULL	J_Cell_Biol_1986_Sep_1_103(3)_1091-1100.nxml.txt.nlp	3488995	SENT7	5	5	7	7	trypsin	C3b	PA451806	718	0.82
NULL	Exp_Cell_Res_2013_Apr_1_319(6)_800-809.nxml.txt.nlp	23247073	SENT193	0	0	9	9	curcumin	ITGA5	PA151958596	3678	0.82
NULL	Sensors_(Basel)_2010_Nov_9_10(11)_9982-9993.nxml.txt.nlp	22163451	SENT94	20	20	12	12	ethanol	mol	PA448073	90527	0.82
NULL	Ann_Hematol_2014_Sep_12_93(1)_13-32.nxml.txt.nlp	24026426	SENT357	13	13	27	27	posaconazole	BII	PA151958574	777	0.82
NULL	J_Adv_Pract_Oncol_2012_May_1_May-Jun_3(3)_138-150.nxml.txt.nlp	25031940	SENT390	5	5	7	7	panitumumab	STEPP	PA162373091	222659	0.82
NULL	Nucleic_Acids_Res_2005_Jun_8_33(10)_3283-3291.nxml.txt.nlp	15944449	SENT187	7	7	21	21	sjg-136	XRCC2		7516	0.82
NULL	Onco_Targets_Ther_2014_Sep_9_7_1571-1582.nxml.txt.nlp	25228815	SENT128	11	11	22	22	pazopanib	VEGFR2	PA165291492	3791	0.82
NULL	Amino_Acids_2012_Oct_10_43(4)_1751-1759.nxml.txt.nlp	22407485	SENT106	29	29	24	24	carrageenan	ghrelin	PA448814	51738	0.82
NULL	Indian_J_Pharmacol_2008_Jan-Feb_40(1)_10-14.nxml.txt.nlp	21264154	SENT159	0	0	15	15	vildagliptin	GLP-1	PA165958346	100125288	0.82
NULL	Cell_Mol_Life_Sci_2012_Jan_11_69(1)_149-163.nxml.txt.nlp	21667063	SENT193	4	4	40	40	curcumin	ATP7A	PA151958596	538	0.82
NULL	Curr_Neuropharmacol_2010_Sep_8(3)_305-315.nxml.txt.nlp	21358979	SENT307	9	9	3	3	rituximab	HERMES	PA451261	11030	0.82
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT175	6	6	15	15	atorvastatin	TNF	PA448500	7124	0.82
NULL	Neural_Regen_Res_2014_Apr_15_9(8)_878-887.nxml.txt.nlp	25206906	SENT97	14	14	11	11	capsaicin	TRPV1	PA448776	7442	0.82
NULL	Tuberc_Respir_Dis_(Seoul)_2012_Dec_28_73(6)_303-311.nxml.txt.nlp	23319992	SENT29	13	13	25	25	gefitinib	EGFR	PA131301952	1956	0.82
NULL	Org_Biomol_Chem_2008_Nov_7_6(21)_3977-3982.nxml.txt.nlp	18931805	SENT148	19	19	2	2	guanidine	EPO	PA164781028	7076;8288;2056	0.82
NULL	Acta_Orthop_2011_Apr_5_82(2)_211-216.nxml.txt.nlp	21434784	SENT50	6	6	25	25	methotrexate	CDP	PA450428	1523	0.82
NULL	Mol_Pain_2013_Dec_9_9_64.nxml.txt.nlp	24313960	SENT54	15	15	25	25	bupivacaine	RAPA	PA135057240	55809	0.82
NULL	Clin_Pharmacol_2011_Jun_22_3_13-25.nxml.txt.nlp	22287853	SENT209	25	25	22	22	ketoconazole	CYP3A4	PA450146	1576	0.82
NULL	J_Clin_Biochem_Nutr_2011_Mar_26_48(2)_126-133.nxml.txt.nlp	21373265	SENT140	6	6	12	12	hemin	CD25	PA449849	3669;3559	0.82
NULL	Exp_Hematol_Oncol_2012_Jun_18_1_14.nxml.txt.nlp	23210689	SENT143	30	30	1	1	imatinib	KIT	PA10804	3815	0.82
NULL	Int_J_Environ_Res_Public_Health_2010_May_27_7(5)_1872-1888.nxml.txt.nlp	20622998	SENT91	20	20	35	35	ethanol	AMPK	PA448073	5563	0.82
NULL	Diabetes_Obes_Metab_2010_Aug_12(8)_700-708.nxml.txt.nlp	20590747	SENT199	19	19	12	12	voglibose	PPG	PA164752433	5552	0.82
NULL	Indian_J_Med_Res_2011_Sep_134(3)_295-301.nxml.txt.nlp	21985811	SENT123	45	45	35	35	phenytoin	ABCB1	PA450947	5243	0.82
NULL	Breast_Cancer_Res_2007_Oct_26_9(5)_112.nxml.txt.nlp	17980056	SENT69	18	18	6	6	tamoxifen	HER2	PA451581	2064	0.82
NULL	Br_J_Pharmacol_2014_Jan_23_171(2)_523-535.nxml.txt.nlp	24372553	SENT224	4	4	30	30	metformin	SIRT1	PA450395	23411	0.82
NULL	Nat_Biotechnol_2013_Jul_30_31(7)_630-637.nxml.txt.nlp	23811600	SENT355	22	22	26	26	erlotinib	EGFR	PA134687924	1956	0.82
NULL	J_Cell_Sci_2013_Sep_1_126(17)_3873-3883.nxml.txt.nlp	23843614	SENT168	10	10	5	5	forskolin	RhoA	PA146096022	387	0.82
NULL	Br_J_Cancer_2011_Apr_12_104(8)_1278-1287.nxml.txt.nlp	21487429	SENT174	18	18	22	22	cisplatin	p53	PA449014	7157	0.82
NULL	Int_J_Mol_Sci_2010_Nov_26_11(12)_4826-4842.nxml.txt.nlp	21614176	SENT243	8	8	0	0	cisplatin	Sak	PA449014	10733	0.82
NULL	Endocr_Connect_2012_Jun_8_1(1)_1-12.nxml.txt.nlp	23781298	SENT13	26	26	15	15	fenofibrate	adiponectin	PA449594	9370	0.82
NULL	J_Young_Pharm_2012_Jul-Sep_4(3)_138-145.nxml.txt.nlp	23112532	SENT189	29	29	7	7	norfloxacin	CO2	PA450654	4513	0.82
NULL	Eur_J_Clin_Pharmacol_2011_May_2_67(Suppl_1)_87-107.nxml.txt.nlp	21287160	SENT327	5	5	20	20	sn-38	UGT1A1		54658	0.82
NULL	J_Mol_Med_(Berl)_2013_Aug_17_91(11)_1257-1271.nxml.txt.nlp	23955016	SENT181	36	36	3	3	thrombin	p38	PA451674	10598;1432;7965	0.82
NULL	J_Mol_Med_2011_Apr_16_89(4)_321-329.nxml.txt.nlp	21079906	SENT202	4	4	6	6	capsaicin	VR1	PA448776	56664	0.82
NULL	Onco_Targets_Ther_2014_Mar_20_7_447-456.nxml.txt.nlp	24672247	SENT151	17	17	12	12	paclitaxel	CLU	PA450761	1191	0.82
NULL	Int_J_Breast_Cancer_2012_Oct_4_2012_439023.nxml.txt.nlp	23091732	SENT152	7	7	9	9	trastuzumab	HER2	PA451743	2064	0.82
NULL	Cancer_Cell_Int_2013_Mar_4_13_21.nxml.txt.nlp	23497288	SENT27	14	14	28	28	doxorubicin	P-gp	PA449412	5243	0.82
NULL	Nat_Commun_2014_Aug_4_5_4535.nxml.txt.nlp	25088745	SENT460	12	12	2	2	metformin	LKB1	PA450395	6794	0.82
NULL	J_Gastroenterol_2013_Jun_6_48(6)_681-688.nxml.txt.nlp	23463401	SENT111	20	20	2	2	sorafenib	SHARP	PA7000	23013	0.82
NULL	Oncoimmunology_2014_Jun_3_3_e29030.nxml.txt.nlp	25083328	SENT56	11	11	21	21	temozolomide	IFN	PA451609	3439	0.82
NULL	Breast_Cancer_Res_2010_Mar_5_12(2)_R16.nxml.txt.nlp	20205716	SENT185	24	24	21	21	lovastatin	G3BP1	PA450272	10146	0.82
NULL	Arthritis_Res_Ther_2005_Apr_1_7(3)_R694-R703.nxml.txt.nlp	15899055	SENT201	38	38	14	14	leflunomide	GM-CSF	PA450192	1437	0.82
NULL	Mol_Neurodegener_2011_Aug_8_6_57.nxml.txt.nlp	21819629	SENT243	19	19	4	4	arsenite	TDP-43	PA452638	23435	0.82
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT255	14	14	18	18	olanzapine	PRL	PA450688	5617	0.82
NULL	Arthritis_Res_Ther_2013_Mar_4_15(2)_R39.nxml.txt.nlp	23497717	SENT199	12	12	19	19	imiquimod	IFN	PA449972	3439	0.82
NULL	Int_J_Mol_Sci_2014_Sep_30_15(10)_17733-17750.nxml.txt.nlp	25272228	SENT27	12	12	22	22	oxygen	HIF-1	PA450744	29072	0.82
NULL	Int_J_Surg_Oncol_2012_Aug_27_2012_180574.nxml.txt.nlp	22970358	SENT27	17	17	7	7	anastrozole	IMPACT	PA448432	55364	0.82
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1137-1144.nxml.txt.nlp	20234366	SENT140	19	19	1	1	cetuximab	KRAS	PA10040	3845	0.82
NULL	Biomed_Res_Int_2013_Sep_4_2013_419176.nxml.txt.nlp	24093097	SENT114	2	2	5	5	perifosine	AKT	PA165291471	207	0.82
NULL	Breast_Cancer_Res_2005_May_24_7(5)_R589-R597.nxml.txt.nlp	16168102	SENT88	35	35	23	23	trastuzumab	HER2	PA451743	2064	0.82
NULL	Nat_Commun_2012_Jan_17_3_626.nxml.txt.nlp	22252550	SENT276	13	13	3	3	paraformaldehyde	ABL1	PA450790	25	0.82
NULL	Case_Rep_Oncol_2014_Feb_20_7(1)_126-131.nxml.txt.nlp	24707260	SENT18	30	30	36	36	gefitinib	EGFR	PA131301952	1956	0.82
NULL	Biomed_Res_Int_2014_Feb_6_2014_323594.nxml.txt.nlp	24689036	SENT309	36	36	31	31	raloxifene	PC3	PA451221	57332;7832;5122	0.82
NULL	Front_Oncol_2014_Apr_8_4_71.nxml.txt.nlp	24782983	SENT208	28	28	22	22	carboplatin	HOXA11	PA448803	3207	0.82
NULL	Breast_Cancer_Res_2007_Jan_23_9(1)_R7.nxml.txt.nlp	17244352	SENT149	30	30	16	16	tamoxifen	SULT1A1	PA451581	6817	0.82
NULL	Cell_Death_Dis_2010_Nov_18_1(11)_e101.nxml.txt.nlp	21368866	SENT89	13	13	31	31	cisplatin	Bcl-2	PA449014	596	0.82
NULL	Evid_Based_Complement_Alternat_Med_2014_May_8_2014_364819.nxml.txt.nlp	24899907	SENT160	3	3	28	28	tacrolimus	FKBP52	PA451578	2288	0.82
NULL	Oncotarget_2014_Jun_22_5(13)_4581-4602.nxml.txt.nlp	25015035	SENT89	41	41	22	22	sn-38	AKT		207	0.82
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_55-78.nxml.txt.nlp	19305788	SENT508	14	14	24	24	memantine	DDC	PA10364	1644	0.82
NULL	Exp_Diabetes_Res_2012_Oct_29_2012_894605.nxml.txt.nlp	22110482	SENT118	1	1	14	14	heparin	RAGE	PA449855	177	0.82
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1063.nxml.txt.nlp	24556678	SENT71	5	5	23	23	thioridazine	Mcl-1	PA451666	4170	0.82
NULL	Mol_Cancer_2010_Apr_23_9_87.nxml.txt.nlp	20416058	SENT146	28	28	26	26	etoposide	TRAIL	PA449552	8743	0.82
NULL	Oncotarget_2014_May_27_5(19)_9049-9064.nxml.txt.nlp	24979294	SENT236	13	13	11	11	fulvestrant	HER2	PA164747170	2064	0.82
NULL	Contemp_Oncol_(Pozn)_2012_May_29_16(2)_95-103.nxml.txt.nlp	23788862	SENT249	10	10	7	7	gefitinib	SYK	PA131301952	6850	0.82
NULL	Onco_Targets_Ther_2014_May_28_7_841-852.nxml.txt.nlp	24920926	SENT64	32	32	40	40	gefitinib	EGFR	PA131301952	1956	0.82
NULL	J_Nutr_Metab_2012_Apr_10_2012_431574.nxml.txt.nlp	22570769	SENT193	19	19	27	27	sertraline	P14	PA451333	11102;;6280;56259	0.82
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT9	8	8	13	13	pertuzumab	HER2		2064	0.82
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT235	8	8	16	16	ranibizumab	PlGF-2	PA164746012	5228	0.82
NULL	Exp_Ther_Med_2014_Mar_19_7(3)_669-674.nxml.txt.nlp	24520265	SENT29	21	21	8	8	thalidomide	BLM	PA451644	641	0.82
NULL	Addict_Sci_Clin_Pract_2012_Oct_29_7(1)_22.nxml.txt.nlp	23186008	SENT86	13	13	28	28	buprenorphine	CD4	PA448685	920	0.82
NULL	Neuro_Oncol_2010_Apr_27_12(4)_389-400.nxml.txt.nlp	20308316	SENT110	17	17	12	12	chloroquine	p53	PA448948	7157	0.82
NULL	Comput_Struct_Biotechnol_J_2013_Oct_18_6_e201303014.nxml.txt.nlp	24688722	SENT128	4	4	18	18	camptothecin	PARP-1	PA153590860	25976	0.82
NULL	Arthritis_Res_Ther_2009_Jun_29_11(3)_R100.nxml.txt.nlp	19563672	SENT168	11	11	19	19	infliximab	CD19	PA452639	930	0.82
NULL	Int_J_Biol_Sci_2014_Jun_10_10(7)_654-663.nxml.txt.nlp	25013375	SENT107	5	5	7	7	nelfinavir	AKT	PA450606	207	0.82
NULL	Breast_Cancer_Res_2010_Apr_30_12(2)_203.nxml.txt.nlp	20459590	SENT270	25	25	13	13	cisplatin	BRCA2	PA449014	675	0.82
NULL	Korean_J_Thorac_Cardiovasc_Surg_2014_Oct_5_47(5)_478-482.nxml.txt.nlp	25346905	SENT68	11	11	5	5	imatinib	PDGFRB	PA10804	5159	0.82
NULL	Int_J_Breast_Cancer_2012_May_9_2012_415170.nxml.txt.nlp	22649737	SENT77	13	13	24	24	trastuzumab	MUC1	PA451743	4582	0.82
NULL	J_Ophthalmol_2011_Nov_1_2011_743670.nxml.txt.nlp	22132313	SENT44	7	7	13	13	fluorescein	FAF	PA164746009	8239;2188	0.82
NULL	Br_J_Anaesth_2014_Jul_22_113(1)_157-167.nxml.txt.nlp	24154701	SENT264	14	14	7	7	halothane	TREK-1	PA449845	3776	0.82
NULL	Open_Ophthalmol_J_2011_Apr_28_5_27-31.nxml.txt.nlp	21633720	SENT108	10	10	7	7	guanabenz	ERG	PA164774903	2078	0.82
NULL	Mol_Cell_Endocrinol_2011_Aug_22_343(1-2)_71-78.nxml.txt.nlp	21704120	SENT150	25	25	8	8	lipase	NEFA	PA450239	4925	0.82
NULL	Br_J_Cancer_2011_Apr_12_104(8)_1256-1261.nxml.txt.nlp	21448165	SENT161	39	39	29	29	sorafenib	IL-2	PA7000	3558	0.82
NULL	Cells_2014_May_23_3(2)_517-545.nxml.txt.nlp	24861977	SENT725	3	3	5	5	capsaicin	VR1	PA448776	56664	0.82
NULL	Anal_Chem_2014_Mar_18_86(6)_2867-2870.nxml.txt.nlp	24579851	SENT63	1	1	22	22	hemin	HBG2	PA449849	3048	0.82
NULL	Diabetes_2013_Oct_17_62(10)_3500-3513.nxml.txt.nlp	23884882	SENT269	17	17	9	9	resveratrol	PDX1		8050;3651	0.82
NULL	J_Hematol_Oncol_2012_Oct_10_5_62.nxml.txt.nlp	23050865	SENT48	26	26	34	34	erlotinib	EGFR	PA134687924	1956	0.82
NULL	Oncol_Rep_2013_Jun_3_29(6)_2101-2108.nxml.txt.nlp	23563985	SENT118	32	32	17	17	cisplatin	Bcl-2	PA449014	596	0.82
NULL	Int_J_Environ_Res_Public_Health_2010_Jul_28_7(7)_2745-2788.nxml.txt.nlp	20717537	SENT370	14	14	20	20	arsenite	PDH	PA452638	54704	0.82
NULL	Br_J_Cancer_2011_Apr_12_104(8)_1256-1261.nxml.txt.nlp	21448165	SENT161	39	39	15	15	sorafenib	IL-2	PA7000	3558	0.82
NULL	Indian_J_Nephrol_2012_Jan-Feb_22(1)_48-51.nxml.txt.nlp	22279344	SENT87	24	24	19	19	ticlopidine	ADAMTS13	PA451686	11093	0.82
NULL	J_Vis_Exp_2014_Jun_28_(88)_51278.nxml.txt.nlp	24998179	SENT183	11	11	2	2	verapamil	P-gp	PA451868	5243	0.82
NULL	Open_Neurol_J_2013_May_31_7_23-31.nxml.txt.nlp	23894259	SENT33	12	12	15	15	haloperidol	FGA	PA449841	2243	0.82
NULL	EMBO_Mol_Med_2011_Nov_3(11)_623-636.nxml.txt.nlp	21953712	SENT185	27	27	8	8	trastuzumab	HER2	PA451743	2064	0.82
NULL	Biol_Proced_Online_2003_Feb_17_5_43-52.nxml.txt.nlp	12734557	SENT49	6	6	26	26	bupivacaine	IFN	PA135057240	3439	0.82
NULL	Front_Behav_Neurosci_2010_Jun_10_4_32.nxml.txt.nlp	20589092	SENT151	34	34	6	6	ethanol	ANOVA	PA448073	4858	0.82
NULL	Oncol_Lett_2013_Feb_27_5(2)_483-488.nxml.txt.nlp	23420047	SENT203	21	21	12	12	cetuximab	BRAF	PA10040	673	0.82
NULL	Nucleic_Acids_Res_2013_Dec_12_41(22)_10312-10322.nxml.txt.nlp	24038355	SENT86	31	31	9	9	paraformaldehyde	MSH2	PA450790	4436	0.82
NULL	Chin_J_Cancer_2012_Nov_31(11)_507-518.nxml.txt.nlp	22640626	SENT173	11	11	22	22	nilotinib	NQO2	PA165958345	4835	0.82
NULL	Breast_Cancer_Res_2007_Jan_23_9(1)_R7.nxml.txt.nlp	17244352	SENT197	19	19	3	3	tamoxifen	CYP3A5	PA451581	1577	0.82
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT249	12	12	5	5	trastuzumab	HER2	PA451743	2064	0.82
NULL	Blood_Cancer_J_2013_Sep_13_3(9)_e146.nxml.txt.nlp	24036945	SENT41	0	0	14	14	ribavirin	AKT	PA451241	207	0.82
NULL	Reprod_Biol_Endocrinol_2003_Aug_6_1_54.nxml.txt.nlp	12932297	SENT289	12	12	20	20	hyaluronidase	SPAM1	PA164745713	6677	0.82
NULL	Exp_Mol_Med_2012_May_31_44(5)_311-318.nxml.txt.nlp	22282402	SENT77	36	36	19	19	cilostazol	MCP-1	PA164746334	6347	0.82
NULL	Br_J_Cancer_2012_Jan_3_106(1)_6-13.nxml.txt.nlp	22215104	SENT152	9	9	40	40	pertuzumab	San		80218	0.82
NULL	Br_J_Pharmacol_2014_Feb_24_171(1)_1019-1032.nxml.txt.nlp	24251620	SENT269	2	2	8	8	nifedipine	TRPM3	PA450631	80036	0.82
NULL	Diabetes_2013_Sep_15_62(9)_3232-3240.nxml.txt.nlp	23835329	SENT159	13	13	2	2	olanzapine	GLP-1	PA450688	100125288	0.82
NULL	Nucleic_Acids_Res_2013_Feb_21_41(4)_e54.nxml.txt.nlp	23262224	SENT283	29	29	7	7	galactose	GAL4	PA449725	3960	0.82
NULL	Eur_Arch_Psychiatry_Clin_Neurosci_2006_Dec_7_256(8)_464-475.nxml.txt.nlp	16960655	SENT487	3	3	17	17	haloperidol	Gen	PA449841	348654	0.82
NULL	J_Mol_Med_(Berl)_2014_Jan_10_92(5)_497-507.nxml.txt.nlp	24408111	SENT183	0	0	2	2	pioglitazone	HIF-1	PA450970	29072	0.82
NULL	Front_Immunol_2013_Sep_17_4_281.nxml.txt.nlp	24062747	SENT380	28	28	24	24	atorvastatin	IFN	PA448500	3439	0.82
NULL	Int_J_Med_Sci_2014_Sep_6_11(11)_1185-1200.nxml.txt.nlp	25249787	SENT147	11	11	4	4	liraglutide	GLP-1	PA165958364	100125288	0.82
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT220	4	4	11	11	capsaicin	MDM2	PA448776	4193	0.82
NULL	Case_Rep_Dermatol_2013_Apr_16_5(1)_115-119.nxml.txt.nlp	23687489	SENT66	27	27	15	15	rituximab	CD19	PA451261	930	0.82
NULL	Clin_Ophthalmol_2014_Aug_12_8_1479-1486.nxml.txt.nlp	25143708	SENT42	7	7	16	16	bevacizumab	San	PA130232992	80218	0.82
NULL	Nat_Biotechnol_2009_Jun_17_27(6)_567-571.nxml.txt.nlp	19448630	SENT232	3	3	16	16	imiquimod	IFN	PA449972	3439	0.82
NULL	Cell_Commun_Signal_2004_Jun_30_2_6.nxml.txt.nlp	15228623	SENT95	16	16	38	38	mibefradil	TTN	PA450492	7273	0.82
NULL	J_Korean_Med_Sci_2010_Dec_24_25(12)_1792-1797.nxml.txt.nlp	21165296	SENT26	13	13	21	21	desmopressin	AVP	PA449237	114548;551	0.82
NULL	J_Immune_Based_Ther_Vaccines_2006_Nov_28_4_7.nxml.txt.nlp	17132168	SENT7	7	7	16	16	didanosine	GM-CSF	PA449301	1437	0.82
NULL	Exp_Ther_Med_2013_Dec_26_6(6)_1359-1364.nxml.txt.nlp	24255662	SENT136	18	18	35	35	dexmedetomidine	TLR4	PA449256	7099	0.82
NULL	Braz_J_Med_Biol_Res_2013_Apr_5_46(4)_375-381.nxml.txt.nlp	23558858	SENT178	8	8	6	6	thrombin	ADAMTS13	PA451674	11093	0.82
NULL	Am_J_Trop_Med_Hyg_2012_Nov_7_87(5)_783-784.nxml.txt.nlp	23136171	SENT24	1	1	15	15	mefloquine	ACT	PA450348	12;11332;9457;641455	0.82
NULL	Braz_J_Med_Biol_Res_2013_Aug_13_46(8)_650-658.nxml.txt.nlp	23969971	SENT32	35	35	11	11	cisplatin	STAT3	PA449014	6774	0.82
NULL	Int_J_Mol_Sci_2014_Mar_20_15(3)_4965-4976.nxml.txt.nlp	24658440	SENT35	17	17	6	6	tacrolimus	P-gp	PA451578	5243	0.82
NULL	Ann_Thorac_Med_2014_Jul-Sep_9(Suppl_1)_S79-S91.nxml.txt.nlp	25077002	SENT307	25	25	7	7	sildenafil	CYP3A4	PA451346	1576	0.82
NULL	Cancer_Med_2014_Feb_10_3(1)_134-142.nxml.txt.nlp	24407937	SENT182	10	10	5	5	letrozole	aromatase	PA450196	1588	0.82
NULL	Arthritis_Res_Ther_2012_Jul_27_14(4)_R175.nxml.txt.nlp	22838733	SENT11	32	32	13	13	adalimumab	CD14	PA10004	929	0.82
NULL	Eur_J_Med_Res_2010_Aug_20_15(8)_337-344.nxml.txt.nlp	20947470	SENT114	6	6	4	4	methotrexate	BLM	PA450428	641	0.82
NULL	J_Oncol_2013_Apr_29_2013_854121.nxml.txt.nlp	23737784	SENT150	17	17	29	29	paclitaxel	CD40	PA450761	958	0.82
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT198	30	30	23	23	adalimumab	DPI	PA10004	1832	0.82
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT304	0	0	3	3	metformin	HIF-1	PA450395	29072	0.82
NULL	Onco_Targets_Ther_2014_Sep_23_7_1647-1652.nxml.txt.nlp	25285014	SENT66	3	3	15	15	bevacizumab	VEGFR	PA130232992	3791	0.82
NULL	Biologics_2012_Jan_5_6_13-20.nxml.txt.nlp	22291463	SENT116	0	0	13	13	trastuzumab	DM1	PA451743	338023;1760;28509	0.82
NULL	Neural_Regen_Res_2013_Jul_15_8(20)_1853-1862.nxml.txt.nlp	25206494	SENT113	28	28	15	15	ethanol	JNK	PA448073	5599	0.82
NULL	Breast_Cancer_Res_2012_Jan_6_14(1)_R2.nxml.txt.nlp	22225778	SENT179	35	35	24	24	docetaxel	p50	PA449383	958;4790	0.82
NULL	Br_J_Cancer_2012_Jan_3_106(1)_6-13.nxml.txt.nlp	22215104	SENT18	6	6	9	9	pertuzumab	DM1		338023;1760;28509	0.82
NULL	Environ_Health_Perspect_2000_Feb_108(2)_97-103.nxml.txt.nlp	10656848	SENT5	20	20	9	9	estradiol	RIP140	PA449503	8204	0.82
NULL	Pharmaceuticals_(Basel)_2013_May_23_6(6)_689-699.nxml.txt.nlp	24276256	SENT133	18	18	8	8	nicardipine	PTB	PA450620	58155	0.82
NULL	Br_J_Cancer_2012_Dec_4_107(12)_1950-1955.nxml.txt.nlp	23169295	SENT26	3	3	22	22	tegafur	DPD	PA452620	1806	0.82
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT333	16	16	38	38	risperidone	PRL	PA451257	5617	0.82
NULL	Ann_Dermatol_2012_Aug_25_24(3)_295-305.nxml.txt.nlp	22879713	SENT39	8	8	11	11	estradiol	aromatase	PA449503	1588	0.82
NULL	Front_Oncol_2014_Apr_2_4_70.nxml.txt.nlp	24765614	SENT71	22	22	35	35	bevacizumab	VEGFR	PA130232992	3791	0.82
NULL	J_Gen_Physiol_2004_Apr_123(4)_427-439.nxml.txt.nlp	15024039	SENT436	9	9	16	16	genistein	PP2	PA165109660	4888	0.82
NULL	Diabetes_2009_Jan_58(1)_174-184.nxml.txt.nlp	18984736	SENT16	12	12	17	17	tranilast	TRPV2	PA131890628	51393	0.82
NULL	Crit_Care_2003_Feb_28_7(3)_226-232.nxml.txt.nlp	12793872	SENT98	43	43	31	31	doxorubicin	P19	PA449412	51561	0.82
NULL	Arthritis_Res_Ther_2012_Jun_12_14(3)_R142.nxml.txt.nlp	22691272	SENT100	0	0	6	6	mianserin	TLR3	PA134687937	7098	0.82
NULL	J_Ind_Microbiol_Biotechnol_2013_Jul_30_40(10)_1153-1160.nxml.txt.nlp	23896974	SENT176	28	28	0	0	kanamycin	PGK1	PA450137	5230	0.82
NULL	Comput_Struct_Biotechnol_J_2013_Nov_27_6_e201303017.nxml.txt.nlp	24688725	SENT282	12	12	15	15	denosumab	RANK	PA166048634	8792	0.82
NULL	J_Adv_Pract_Oncol_2012_Nov_1_Nov-Dec_3(6)_391-394.nxml.txt.nlp	25031970	SENT19	3	3	9	9	trastuzumab	HER2	PA451743	2064	0.82
NULL	Indian_J_Psychol_Med_2013_Apr-Jun_35(2)_135-140.nxml.txt.nlp	24049223	SENT157	31	31	9	9	benztropine	Gen	PA448591	348654	0.82
NULL	Open_Biochem_J_2013_Apr_19_7_44-53.nxml.txt.nlp	23730364	SENT38	34	34	23	23	resveratrol	San		80218	0.82
NULL	BMJ_2011_Jul_26_343_d4366.nxml.txt.nlp	21791491	SENT124	8	8	18	18	urea	ACE	PA451831	1636	0.82
NULL	J_Oncol_2009_Mar_24_2009_491985.nxml.txt.nlp	19325924	SENT6	21	21	24	24	genistein	CXCR4	PA165109660	7852	0.82
NULL	Iran_J_Basic_Med_Sci_2012_Jul-Aug_15(4)_907-915.nxml.txt.nlp	23493917	SENT92	2	2	18	18	propranolol	ANOVA	PA451145	4858	0.82
NULL	FEBS_Open_Bio_2011_Dec_27_2_1-5.nxml.txt.nlp	23650573	SENT104	20	20	33	33	sunitinib	MDM2	PA162372840	4193	0.82
NULL	Oncotarget_2011_Dec_20_2(12)_1094-1108.nxml.txt.nlp	22190353	SENT88	20	20	9	9	doxorubicin	MDM2	PA449412	4193	0.82
NULL	Insights_Imaging_2013_Jan_29_4(2)_163-175.nxml.txt.nlp	23359240	SENT153	7	7	0	0	paclitaxel	HER2	PA450761	2064	0.82
NULL	Int_Endod_J_2011_Dec_44(12)_1145-1154.nxml.txt.nlp	21902700	SENT46	18	18	13	13	ethanol	HEMA	PA448073	2157	0.82
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_13_2012_636848.nxml.txt.nlp	23258994	SENT168	11	11	21	21	carrageenan	TRPV4	PA448814	59341	0.82
NULL	Int_J_Gen_Med_2012_Nov_9_5_935-942.nxml.txt.nlp	23204857	SENT127	28	28	21	21	isoflurane	AIDA	PA450106	64853	0.82
NULL	Kidney_Int_Suppl_(2011)_2013_Dec_27_3(4)_392-409.nxml.txt.nlp	NULL	SENT510	7	7	14	14	cinacalcet	EPO	PA164776671	7076;8288;2056	0.82
NULL	Cancers_(Basel)_2011_Oct_26_3(4)_4024-4045.nxml.txt.nlp	24213123	SENT115	8	8	25	25	curcumin	mol	PA151958596	90527	0.82
NULL	Cancer_Manag_Res_2012_Jan_18_4_1-8.nxml.txt.nlp	22346364	SENT18	29	29	16	16	vemurafenib	IL-2	PA165946873	3558	0.82
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT347	27	27	16	16	pp2	TFF3		7033	0.82
NULL	J_Biol_Chem_2008_Nov_7_283(45)_31005-31011.nxml.txt.nlp	18765663	SENT179	1	1	9	9	baclofen	CA1	PA448533	759	0.82
NULL	J_Histochem_Cytochem_2014_Nov_62(11)_802-812.nxml.txt.nlp	25124006	SENT38	2	2	6	6	l-isoleucine	ADP	PA164750430	23038	0.82
NULL	Indian_J_Psychiatry_2010_Jan_52(Suppl1)_S317-S340.nxml.txt.nlp	21836703	SENT290	26	26	11	11	chlorpromazine	CPZ	PA448964	8532	0.82
NULL	Clin_Exp_Gastroenterol_2012_May_14_5_49-59.nxml.txt.nlp	22649281	SENT89	9	9	22	22	rabeprazole	CYP3A4	PA451216	1576	0.82
NULL	Breast_Cancer_Res_2010_Oct_14_12(5)_R84.nxml.txt.nlp	20946630	SENT300	35	35	27	27	choline	Hsp90	PA448976	3320	0.82
NULL	Indian_J_Psychiatry_2010_Jan_52(Suppl1)_S317-S340.nxml.txt.nlp	21836703	SENT117	20	20	27	27	thioproperazine	CPZ	PA164754875	8532	0.82
NULL	Case_Rep_Med_2012_Mar_19_2012_747658.nxml.txt.nlp	22481954	SENT63	0	0	19	19	sildenafil	PKG	PA451346	5592	0.82
NULL	Br_J_Cancer_2010_Jun_29_103(1)_61-72.nxml.txt.nlp	20588279	SENT213	9	9	29	29	trastuzumab	PTEN	PA451743	5728	0.82
NULL	Oncol_Lett_2014_Mar_2_7(3)_791-796.nxml.txt.nlp	24527087	SENT107	19	19	30	30	imatinib	CD34	PA10804	947	0.82
NULL	eLife_2014_May_29_3_e02805.nxml.txt.nlp	24876127	SENT956	13	13	9	9	tamoxifen	E2F1	PA451581	1869	0.82
NULL	J_Korean_Med_Sci_2008_Aug_25_23(4)_685-690.nxml.txt.nlp	18756058	SENT5	26	26	18	18	olanzapine	ghrelin	PA450688	51738	0.82
NULL	J_Nutr_Metab_2011_Oct_1_2011_525094.nxml.txt.nlp	21977315	SENT145	3	3	16	16	resveratrol	SIRT1		23411	0.82
NULL	Arthritis_Res_Ther_2005_Mar_16_7(Suppl_2)_S21-S25.nxml.txt.nlp	15833145	SENT59	27	27	17	17	abatacept	ACR	PA164747080	49	0.82
NULL	Int_J_Cell_Biol_2013_Jul_1_2013_973584.nxml.txt.nlp	23935627	SENT19	7	7	22	22	trastuzumab	HER-2	PA451743	2064	0.82
NULL	Cell_Commun_Signal_2011_May_15_9_13.nxml.txt.nlp	21569639	SENT290	8	8	36	36	quinacrine	MDM2	PA164745551	4193	0.82
NULL	Mol_Cell_Biochem_2014_Jan_3_389(1-2)_177-185.nxml.txt.nlp	24385108	SENT55	30	30	16	16	streptomycin	FBS	PA451512	64319;26269	0.82
NULL	Ther_Clin_Risk_Manag_2007_Jun_3(2)_259-268.nxml.txt.nlp	18360634	SENT111	38	38	4	4	natalizumab	DMT	PA164747191	2039	0.82
NULL	Acta_Pharmacol_Sin_2009_Sep_17_30(9)_1316-1322.nxml.txt.nlp	19684609	SENT114	9	9	11	11	rosiglitazone	PTEN	PA451283	5728	0.82
NULL	Biosci_Rep_2013_Jun_5_33(3)_e00041.nxml.txt.nlp	23577625	SENT19	2	2	6	6	disulfiram	DDC	PA449376	1644	0.82
NULL	Support_Care_Cancer_2014_Oct_19_22(2)_469-477.nxml.txt.nlp	24141698	SENT142	18	18	39	39	palonosetron	HEC	PA10352	10403	0.82
NULL	Oncol_Lett_2013_Feb_27_5(2)_435-439.nxml.txt.nlp	23420613	SENT96	32	32	15	15	gefitinib	EGFR	PA131301952	1956	0.82
NULL	Cell_Commun_Signal_2003_Nov_24_1_5.nxml.txt.nlp	14636425	SENT77	17	17	9	9	heparin	CCN5	PA449855	8839	0.82
NULL	Infect_Dis_Ther_2014_Dec_5_3(2)_69-81.nxml.txt.nlp	25475412	SENT204	12	12	1	1	daptomycin	CAL	PA164768820	54751;57120	0.82
NULL	Cell_Cycle_2013_Dec_15_12(24)_3759-3769.nxml.txt.nlp	24107633	SENT10	18	18	25	25	metformin	HER2	PA450395	2064	0.82
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_18_2013_636580.nxml.txt.nlp	23853662	SENT132	39	39	26	26	phenol	TPC	PA450913	8030;60386	0.82
NULL	Aquat_Biosyst_2012_Aug_31_8_19.nxml.txt.nlp	22938529	SENT112	2	2	14	14	oxygen	mol	PA450744	90527	0.82
NULL	Mol_Cancer_2008_Jun_30_7_60.nxml.txt.nlp	18590557	SENT73	16	16	34	34	etoposide	TRAIL	PA449552	8743	0.82
NULL	Anat_Cell_Biol_2014_Jun_20_47(2)_83-90.nxml.txt.nlp	24987544	SENT183	10	10	24	24	lipase	adiponectin	PA450239	9370	0.82
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT354	8	8	12	12	heparin	FGF1	PA449855	2246	0.82
NULL	Breast_Cancer_Res_2007_Dec_20_9(Suppl_2)_S19.nxml.txt.nlp	NULL	SENT9	18	18	11	11	tamoxifen	IMPACT	PA451581	55364	0.82
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_7-17.nxml.txt.nlp	17912633	SENT75	13	13	16	16	aminoglutethimide	aromatase	PA448375	1588	0.82
NULL	Acta_Pharmacol_Sin_2014_Jun_4_35(6)_792-805.nxml.txt.nlp	24902787	SENT34	16	16	6	6	pravastatin	CYP2D6	PA451089	1565	0.82
NULL	Acta_Pharmacol_Sin_2014_Aug_21_35(8)_994-1004.nxml.txt.nlp	25042549	SENT173	12	12	8	8	pravastatin	PCSK9	PA451089	255738	0.82
NULL	Diabetes_Care_2011_Jul_17_34(7)_e115-e120.nxml.txt.nlp	21709286	SENT182	19	19	9	9	metformin	LKB1	PA450395	6794	0.82
NULL	Oxid_Med_Cell_Longev_2013_Jun_2_2013_793525.nxml.txt.nlp	23819014	SENT10	39	39	7	7	resveratrol	AMPK		5563	0.82
NULL	J_Nutr_Metab_2011_Oct_1_2011_525094.nxml.txt.nlp	21977315	SENT177	14	14	8	8	resveratrol	SIRT1		23411	0.82
NULL	Anc_Sci_Life_2014_Jan-Mar_33(3)_172-175.nxml.txt.nlp	25538353	SENT45	8	8	31	31	diclofenac	ARK	PA449293	54778	0.82
NULL	Ital_J_Pediatr_2011_Dec_19_37_58.nxml.txt.nlp	22182677	SENT169	11	11	9	9	acetazolamide	LGS	PA448018	51557	0.82
NULL	Korean_J_Anesthesiol_2013_Dec_26_65(6)_583-584.nxml.txt.nlp	24427469	SENT39	12	12	7	7	propofol	CO2	PA451141	4513	0.82
NULL	Nat_Med_2010_Jun_23_16(6)_671-677.nxml.txt.nlp	20495567	SENT68	13	13	5	5	sorafenib	ATF5	PA7000	22809	0.82
NULL	Target_Oncol_2013_Jun_27_8(2)_127-136.nxml.txt.nlp	23625191	SENT87	9	9	11	11	panitumumab	KRAS	PA162373091	3845	0.82
NULL	Breast_Cancer_Res_2011_Aug_16_13(4)_313.nxml.txt.nlp	21884643	SENT31	26	26	19	19	hyaluronan	CD44	PA165958431	960	0.82
NULL	Cancer_Med_2014_Apr_27_3(2)_293-299.nxml.txt.nlp	24464780	SENT142	14	14	26	26	capecitabine	TYMS	PA448771	7298	0.82
NULL	Arthritis_Res_Ther_2009_Feb_3_11(1)_R15.nxml.txt.nlp	19192274	SENT223	18	18	34	34	diclofenac	IL-8	PA449293	3576	0.82
NULL	Hum_Genomics_2009_Jan_1_3(2)_128-142.nxml.txt.nlp	19164090	SENT257	25	25	15	15	carboplatin	DKFZP586H2123	PA448803	25891	0.82
NULL	Breast_Cancer_(Auckl)_2011_Apr_13_5_53-65.nxml.txt.nlp	21603258	SENT130	7	7	3	3	trastuzumab	HER2	PA451743	2064	0.82
NULL	JRSM_Cardiovasc_Dis_2012_Sep_24_1(6)_cvd_2012_012015.nxml.txt.nlp	24175073	SENT23	30	30	13	13	clopidogrel	ABCB1	PA449053	5243	0.82
NULL	Leukemia_2014_Mar_13_28(3)_600-608.nxml.txt.nlp	24240203	SENT195	32	32	7	7	nutlin-3	AT2		186	0.82
NULL	Front_Oncol_2014_May_7_4_103.nxml.txt.nlp	24847446	SENT53	24	24	3	3	bevacizumab	EGFR	PA130232992	1956	0.82
NULL	Crit_Care_2008_Nov_26_12(Suppl_6)_S4.nxml.txt.nlp	19105797	SENT40	12	12	24	24	thrombin	IL-6	PA451674	3569	0.82
NULL	J_Immunother_Cancer_2014_Nov_6_2(Suppl_3)_P210.nxml.txt.nlp	NULL	SENT8	0	0	9	9	curcumin	IL8	PA151958596	3576	0.82
NULL	Oncotarget_2011_Sep_9_2(9)_658-668.nxml.txt.nlp	21911919	SENT93	6	6	10	10	cytarabine	HO-1	PA449177	3162	0.82
NULL	Braz_J_Med_Biol_Res_2012_Mar_2_45(3)_250-255.nxml.txt.nlp	22370705	SENT93	10	10	42	42	mecamylamine	ADM	PA450334	133	0.82
NULL	Iran_J_Basic_Med_Sci_2013_Apr_16(4)_610-614.nxml.txt.nlp	24250937	SENT118	4	4	15	15	coumarin	CYP2A6	PA134521193	1548	0.82
NULL	Int_J_Biol_Sci_2013_Mar_7_9(3)_279-288.nxml.txt.nlp	23493630	SENT15	17	17	1	1	tocilizumab	IL-6	PA165292659	3569	0.82
NULL	Acta_Pharmacol_Sin_2010_Mar_22_31(3)_329-340.nxml.txt.nlp	20173759	SENT143	6	6	9	9	ethanol	MEF2D	PA448073	4209	0.82
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1013.nxml.txt.nlp	24457957	SENT130	8	8	17	17	orlistat	NOXA	PA164776864	5366	0.82
NULL	Acta_Pharmacol_Sin_2013_Sep_5_34(9)_1156-1163.nxml.txt.nlp	23892270	SENT140	23	23	30	30	lipase	adiponectin	PA450239	9370	0.82
NULL	Arthritis_Res_Ther_2005_Mar_16_7(Suppl_2)_S21-S25.nxml.txt.nlp	15833145	SENT89	4	4	17	17	abatacept	ACR	PA164747080	49	0.82
NULL	Oxid_Med_Cell_Longev_2013_Jun_13_2013_694014.nxml.txt.nlp	23844277	SENT69	22	22	4	4	ethanol	TMP	PA448073	2012	0.82
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT93	7	7	10	10	resveratrol	TRAIL		8743	0.82
NULL	Pain_2014_Nov_155(11)_2306-2322.nxml.txt.nlp	25168672	SENT150	2	2	9	9	capsaicin	TRPV1	PA448776	7442	0.82
NULL	Br_J_Cancer_2013_Sep_3_109(5)_1214-1222.nxml.txt.nlp	23922104	SENT165	12	12	26	26	doxorubicin	IDH1	PA449412	3417	0.82
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT249	4	4	7	7	adalimumab	CD36	PA10004	948	0.82
NULL	Cell_Death_Dis_2014_Jan_9_5(1)_e986.nxml.txt.nlp	24407239	SENT76	16	16	14	14	fludarabine	STAT1	PA449655	6772	0.82
NULL	An_Bras_Dermatol_2013_Mar-Apr_88(2)_283-286.nxml.txt.nlp	23739718	SENT9	23	23	25	25	methimazole	MTM	PA450422	326343	0.819
NULL	Front_Physiol_2013_May_15_4_103.nxml.txt.nlp	23720630	SENT312	3	3	11	11	l-carnitine	PC3	PA450154	57332;7832;5122	0.819
NULL	Ann_Rheum_Dis_2008_Nov_14_67(11)_1516-1523.nxml.txt.nlp	18625622	SENT160	28	28	31	31	tocilizumab	IL-6	PA165292659	3569	0.819
NULL	Breast_Cancer_Res_2007_Mar_2_9(2)_205.nxml.txt.nlp	NULL	SENT26	18	18	31	31	ekb-569	HER-2		2064	0.819
NULL	Springerplus_2014_Sep_11_3_516.nxml.txt.nlp	25279308	SENT159	22	22	13	13	ethanol	CS-2	PA448073	58529;1443	0.819
NULL	Oncotarget_2014_May_27_5(19)_9049-9064.nxml.txt.nlp	24979294	SENT188	2	2	13	13	dasatinib	AKT	PA162372878	207	0.819
NULL	Adv_Virol_2012_Dec_11_2012_702839.nxml.txt.nlp	22312364	SENT149	21	21	19	19	cyclophosphamide	IL-2	PA449165	3558	0.819
NULL	Indian_J_Med_Res_2011_Sep_134(3)_295-301.nxml.txt.nlp	21985811	SENT122	29	29	23	23	phenytoin	MRP2	PA450947	100130958;57626;1244	0.819
NULL	AIDS_Res_Ther_2013_Dec_13_10_33.nxml.txt.nlp	24330617	SENT45	32	32	21	21	atazanavir	CCR5	PA10251	1234	0.819
NULL	Int_J_Vasc_Med_2012_Sep_11_2012_524235.nxml.txt.nlp	21915378	SENT135	26	26	6	6	thrombin	STAT3	PA451674	6774	0.819
NULL	Adv_Hematol_2012_Aug_2_2012_842945.nxml.txt.nlp	22919394	SENT74	0	0	12	12	lenalidomide	IL-6	PA162363968	3569	0.819
NULL	Indian_J_Endocrinol_Metab_2012_Jul-Aug_16(4)_604-608.nxml.txt.nlp	22837924	SENT111	22	22	15	15	metformin	PPG	PA450395	5552	0.819
NULL	Cancer_Cell_Int_2013_Feb_14_13_16.nxml.txt.nlp	23409704	SENT89	20	20	30	30	pp2	LOX		4015	0.819
NULL	Oncol_Lett_2014_Jun_21_7(6)_2073-2078.nxml.txt.nlp	24932291	SENT96	27	27	8	8	gemcitabine	ERCC1	PA449748	2067	0.819
NULL	Exp_Diabetes_Res_2012_Oct_15_2012_465282.nxml.txt.nlp	23118742	SENT92	22	22	11	11	metformin	FGF21	PA450395	26291	0.819
NULL	Int_J_Biol_Sci_2015_Jan_1_11(1)_48-58.nxml.txt.nlp	25552929	SENT302	6	6	0	0	paclitaxel	TSP-1	PA450761	7057	0.819
NULL	Cancers_(Basel)_2011_Apr_1_3(2)_1844-1860.nxml.txt.nlp	24212785	SENT350	5	5	7	7	panitumumab	STEPP	PA162373091	222659	0.819
NULL	Front_Chem_2014_Mar_14_2_12.nxml.txt.nlp	24790981	SENT151	11	11	7	7	curcumin	GATA4	PA151958596	2626	0.819
NULL	J_Cancer_Prev_2013_Jun_18(2)_123-134.nxml.txt.nlp	25337538	SENT144	29	29	6	6	ns-398	HER-2		2064	0.819
NULL	J_Invest_Dermatol_2012_Oct_24_132(10)_2440-2450.nxml.txt.nlp	22622430	SENT40	0	0	5	5	paclitaxel	ABCB1	PA450761	5243	0.819
NULL	Biomed_Res_Int_2013_Feb_5_2013_478713.nxml.txt.nlp	23484122	SENT285	18	18	9	9	sugar	MUC5AC	PA451529	4586	0.819
NULL	Cancer_Cell_Int_2009_Sep_10_9_25.nxml.txt.nlp	19744341	SENT197	16	16	27	27	glucosamine	STAT3	PA164747613	6774	0.819
NULL	Allergy_Asthma_Immunol_Res_2014_Nov_19_6(6)_548-557.nxml.txt.nlp	25374755	SENT144	4	4	7	7	lovastatin	IL-13	PA450272	3596	0.819
NULL	Breast_Cancer_Res_2007_Oct_26_9(5)_112.nxml.txt.nlp	17980056	SENT82	13	13	15	15	trastuzumab	HER2	PA451743	2064	0.819
NULL	Breast_Cancer_Res_2007_Jan_23_9(1)_R7.nxml.txt.nlp	17244352	SENT201	8	8	3	3	tamoxifen	CYP2D6	PA451581	1565	0.819
NULL	Front_Pharmacol_2014_Nov_25_5_256.nxml.txt.nlp	25505414	SENT1077	20	20	9	9	zolpidem	KCC2	PA451976	57468	0.819
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT404	23	23	4	4	irinotecan	KRAS	PA450085	3845	0.819
NULL	Adv_Appl_Bioinforma_Chem_2008_Oct_30_1_85-98.nxml.txt.nlp	21918608	SENT158	4	4	11	11	bortezomib	SPARC	PA10252	6678	0.819
NULL	Br_J_Cancer_2009_Sep_15_101(6)_957-966.nxml.txt.nlp	19738618	SENT136	14	14	5	5	dexrazoxane	THBS-1	PA449259	7057	0.819
NULL	Ital_J_Pediatr_2014_Feb_13_40_17.nxml.txt.nlp	24524345	SENT99	19	19	35	35	cyclosporine	CHP	PA449167	11261	0.819
NULL	J_Radiat_Res_2014_Mar_1_55(2)_359-363.nxml.txt.nlp	24187329	SENT43	26	26	0	0	cyclophosphamide	CHOP	PA449165	1649	0.819
NULL	Ann_Oncol_2014_Apr_26_25(4)_801-807.nxml.txt.nlp	24577117	SENT135	30	30	24	24	cetuximab	EGFR	PA10040	1956	0.819
NULL	Contemp_Oncol_(Pozn)_2012_Nov_20_16(5)_401-406.nxml.txt.nlp	23788917	SENT28	16	16	26	26	cetuximab	EGFR	PA10040	1956	0.819
NULL	Cardiovasc_Diabetol_2013_Jun_7_12_84.nxml.txt.nlp	23759020	SENT122	14	14	35	35	dipyridamole	LSR	PA449367	51599	0.819
NULL	Br_J_Cancer_1997_75(6)_884-891.nxml.txt.nlp	9062411	SENT19	17	17	7	7	tamoxifen	P-gp	PA451581	5243	0.819
NULL	Environ_Health_Perspect_2008_Apr_16_116(4)_426-433.nxml.txt.nlp	18414622	SENT140	0	0	26	26	resveratrol	p27		5715;10534	0.819
NULL	Gastric_Cancer_2014_Dec_8_17(4)_630-637.nxml.txt.nlp	24318670	SENT192	5	5	25	25	fluorouracil	KRAS	PA128406956	3845	0.819
NULL	Oncotarget_2013_Dec_28_5(6)_1475-1490.nxml.txt.nlp	24721996	SENT174	25	25	14	14	celecoxib	CD133	PA448871	8842	0.819
NULL	Crit_Care_2011_Nov_30_15(6)_235.nxml.txt.nlp	22216838	SENT262	9	9	4	4	bleomycin	RAGE	PA448645	177	0.819
NULL	Cell_Death_Dis_2014_Jul_10_5(7)_e1321.nxml.txt.nlp	25010987	SENT73	9	9	3	3	staurosporine	HuR	PA165109623	1994	0.819
NULL	J_Biol_Chem_2013_Mar_22_288(12)_8279-8288.nxml.txt.nlp	23400816	SENT236	26	26	32	32	chloroquine	PCSK9	PA448948	255738	0.819
NULL	Brain_Sci_2013_Jun_14_3(2)_941-963.nxml.txt.nlp	24961432	SENT116	2	2	10	10	ethanol	AP-1	PA448073	2353;3727;2354;3725	0.819
NULL	Endocrinol_Metab_(Seoul)_2013_Dec_12_28(4)_262-274.nxml.txt.nlp	24396690	SENT164	13	13	31	31	liraglutide	GLP-1	PA165958364	100125288	0.819
NULL	Target_Oncol_2013_Mar_30_8(1)_27-33.nxml.txt.nlp	23361373	SENT35	18	18	27	27	docetaxel	EGFR	PA449383	1956	0.819
NULL	J_Gen_Physiol_2003_Mar_121(3)_181-197.nxml.txt.nlp	12601083	SENT383	38	38	33	33	forskolin	GLP-1	PA146096022	100125288	0.819
NULL	Cell_Death_Dis_2010_Nov_18_1(11)_e101.nxml.txt.nlp	21368866	SENT31	16	16	9	9	cisplatin	PC3	PA449014	57332;7832;5122	0.819
NULL	Breast_Cancer_Res_2011_Jun_10_13(3)_211.nxml.txt.nlp	21672282	SENT75	6	6	2	2	trastuzumab	HER2	PA451743	2064	0.819
NULL	Oncotarget_2014_Jun_8_5(17)_7446-7457.nxml.txt.nlp	25277184	SENT43	18	18	8	8	nutlin-3	TRIM8		81603	0.819
NULL	Biomed_Res_Int_2014_May_29_2014_768758.nxml.txt.nlp	24971349	SENT103	14	14	2	2	bevacizumab	CXCR4	PA130232992	7852	0.819
NULL	Front_Immunol_2013_Sep_4_4_201.nxml.txt.nlp	24027567	SENT50	9	9	39	39	hyaluronan	IL-10	PA165958431	3586	0.819
NULL	Clin_Med_Insights_Oncol_2012_May_16_6_205-217.nxml.txt.nlp	22654526	SENT179	9	9	2	2	sorafenib	FLT3	PA7000	2322	0.819
NULL	Bull_Math_Biol_2014_Dec_14_76(2)_401-430.nxml.txt.nlp	24338592	SENT321	22	22	17	17	etoposide	CHOP	PA449552	1649	0.819
NULL	Biomed_Res_Int_2014_Jun_25_2014_764981.nxml.txt.nlp	25057499	SENT185	16	16	37	37	sorafenib	SHP-1	PA7000	5777	0.819
NULL	Cancers_(Basel)_2014_Nov_14_6(4)_2275-2295.nxml.txt.nlp	25405526	SENT231	28	28	14	14	bleomycin	CHOP	PA448645	1649	0.819
NULL	Nucleic_Acids_Res_2013_Dec_12_41(22)_10170-10184.nxml.txt.nlp	24038356	SENT364	28	28	5	5	protamine	PTB	PA10366	58155	0.819
NULL	Oncol_Rep_2013_Apr_5_29(4)_1671-1677.nxml.txt.nlp	23404329	SENT6	16	16	34	34	curcumin	MIA	PA151958596	8190	0.819
NULL	Oncotarget_2013_Dec_28_5(6)_1475-1490.nxml.txt.nlp	24721996	SENT156	10	10	2	2	celecoxib	PTEN	PA448871	5728	0.819
NULL	Br_J_Cancer_1996_May_73(9)_1063-1068.nxml.txt.nlp	8624264	SENT15	0	0	16	16	staurosporine	P-gp	PA165109623	5243	0.819
NULL	Br_J_Cancer_2012_Jul_24_107(3)_435-441.nxml.txt.nlp	22767144	SENT146	15	15	13	13	docetaxel	TEF	PA449383	7008	0.819
NULL	Mol_Cancer_2010_Nov_22_9_298.nxml.txt.nlp	21092190	SENT36	11	11	4	4	pentazocine	SRM	PA164744326	6723;6725	0.819
NULL	Front_Behav_Neurosci_2014_Nov_7_8_371.nxml.txt.nlp	25426037	SENT135	19	19	8	8	fluphenazine	CPZ	PA449676	8532	0.819
NULL	Sci_Rep_2014_Nov_28_4_7237.nxml.txt.nlp	25429875	SENT108	3	3	21	21	hesperidin	JNK	PA449867	5599	0.819
NULL	Ther_Clin_Risk_Manag_2007_Jun_3(2)_259-268.nxml.txt.nlp	18360634	SENT60	14	14	24	24	natalizumab	IFN	PA164747191	3439	0.819
NULL	Front_Neurosci_2014_Jan_10_7_270.nxml.txt.nlp	24454277	SENT81	17	17	14	14	resveratrol	SIRT1		23411	0.819
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT134	3	3	6	6	phenformin	AMPK	PA1000	5563	0.819
NULL	Front_Microbiol_2013_Aug_19_4_241.nxml.txt.nlp	23966991	SENT247	13	13	11	11	ceftriaxone	GLT-1	PA448866	6506	0.819
NULL	Clin_Exp_Otorhinolaryngol_2011_Mar_17_4(1)_18-23.nxml.txt.nlp	21461058	SENT78	17	17	8	8	bumetanide	NKCC1	PA448682	6558	0.819
NULL	Exp_Ther_Med_2013_Mar_8_5(3)_707-710.nxml.txt.nlp	23404433	SENT137	8	8	5	5	cisplatin	OST	PA449014	1650;23263	0.819
NULL	Int_J_Mol_Sci_2014_Sep_30_15(10)_17686-17704.nxml.txt.nlp	25272226	SENT87	13	13	21	21	cetuximab	VEGF-D	PA10040	2277	0.819
NULL	Avicenna_J_Phytomed_2013_Spring_3(2)_159-170.nxml.txt.nlp	25050270	SENT139	2	2	14	14	doxorubicin	TDI	PA449412	100038246	0.819
NULL	J_Invest_Dermatol_2012_Feb_13_132(2)_485-487.nxml.txt.nlp	21993562	SENT11	6	6	0	0	cisplatin	CLPTM1L	PA449014	81037	0.819
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT182	0	0	2	2	tacrolimus	RANKL	PA451578	8600	0.819
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Sep_18_69(Pt_10)_o1545.nxml.txt.nlp	24098230	SENT70	10	10	20	20	benzaldehyde	mol	PA448571	90527	0.819
NULL	Nat_Commun_2014_Jun_20_5_4122.nxml.txt.nlp	24947823	SENT389	2	2	37	37	capsaicin	TRPV1	PA448776	7442	0.819
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT263	3	3	14	14	tacrolimus	STAT3	PA451578	6774	0.819
NULL	Patient_Prefer_Adherence_2008_Feb_2_2_387-392.nxml.txt.nlp	19920986	SENT20	0	0	11	11	cyclosporine	gamma	PA449167	9913	0.819
NULL	Onco_Targets_Ther_2014_Sep_24_7_1663-1687.nxml.txt.nlp	25285016	SENT244	43	43	25	25	paclitaxel	NRP1	PA450761	8829	0.819
NULL	Ann_Indian_Acad_Neurol_2009_Apr-Jun_12(2)_89-98.nxml.txt.nlp	20142853	SENT202	22	22	26	26	lamotrigine	MRP2	PA450164	100130958;57626;1244	0.819
NULL	Exp_Hematol_Oncol_2013_Dec_6_2_32.nxml.txt.nlp	24314093	SENT107	38	38	22	22	everolimus	NNT	PA164746311	23530	0.819
NULL	J_Cell_Mol_Med_2014_Sep_7_18(9)_1785-1796.nxml.txt.nlp	24909956	SENT245	1	1	31	31	cangrelor	GPR17	PA165945763	2840	0.819
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT207	40	40	17	17	sitagliptin	HIP	PA164748978	6767;6159;64399;5068	0.819
NULL	Clin_Epidemiol_2010_Aug_9_2_29-36.nxml.txt.nlp	20865100	SENT35	24	24	40	40	fluoxetine	B10	PA449673	5169	0.819
NULL	Asia_Pac_Allergy_2013_Oct_31_3(4)_231-240.nxml.txt.nlp	24260728	SENT77	14	14	9	9	theophylline	CYP1A2	PA451647	1544	0.819
NULL	Adv_Appl_Bioinform_Chem_2012_Sep_6_5_61-79.nxml.txt.nlp	23055752	SENT139	24	24	3	3	thrombin	DHFR	PA451674	1719	0.819
NULL	Int_J_Mol_Imaging_2011_Oct_26_2011_874585.nxml.txt.nlp	21490735	SENT14	21	21	3	3	doxorubicin	FDG	PA449412	23583	0.819
NULL	J_Cell_Mol_Med_2013_Feb_10_17(2)_252-264.nxml.txt.nlp	23301798	SENT58	10	10	21	21	mitomycin	IL-2	PA450524	3558	0.819
NULL	Oncoimmunology_2012_Oct_1_1(7)_1004-1016.nxml.txt.nlp	23170249	SENT68	16	16	0	0	paclitaxel	HER-2	PA450761	2064	0.819
NULL	Environ_Microbiol_2008_Feb_10(2)_281-288.nxml.txt.nlp	18199122	SENT116	24	24	28	28	ethanol	CO2	PA448073	4513	0.819
NULL	BMJ_Open_2014_Oct_31_4(10)_e005781.nxml.txt.nlp	25361837	SENT289	12	12	4	4	clopidogrel	PAR-1	PA449053	2011;2149	0.819
NULL	J_Mol_Signal_2010_Jul_12_5_8.nxml.txt.nlp	20624308	SENT32	21	21	43	43	gefitinib	Met	PA131301952	79811	0.819
NULL	Cancer_Cell_Int_2009_Sep_10_9_25.nxml.txt.nlp	19744341	SENT124	5	5	8	8	glucosamine	STAT3	PA164747613	6774	0.819
NULL	Oncotarget_2014_Mar_13_5(4)_1101-1110.nxml.txt.nlp	24658355	SENT11	9	9	4	4	tamoxifen	MKP-2	PA451581	1846	0.819
NULL	Oncotarget_2011_Jan_28_3(1)_31-43.nxml.txt.nlp	22289787	SENT145	7	7	4	4	gefitinib	EGFR	PA131301952	1956	0.819
NULL	Curr_Oncol_2009_Jul_16(Suppl_2)_S14-S23.nxml.txt.nlp	19672417	SENT160	18	18	5	5	anastrozole	ATAC	PA448432	6375	0.819
NULL	Front_Neurosci_2014_Dec_5_8_398.nxml.txt.nlp	25538552	SENT120	6	6	20	20	glucose	gamma	PA449773	9913	0.819
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_29_2013_590393.nxml.txt.nlp	23737838	SENT199	18	18	21	21	resveratrol	p53		7157	0.819
NULL	Clin_Med_Insights_Oncol_2012_Mar_12_6_153-164.nxml.txt.nlp	22550404	SENT81	20	20	28	28	rituximab	Raf-1	PA451261	5894	0.819
NULL	Mycorrhiza_2012_Feb_28_22(2)_149-156.nxml.txt.nlp	21626142	SENT140	29	29	20	20	hyperforin	AMF	PA165985514	2821	0.819
NULL	Neural_Regen_Res_2013_Jul_15_8(20)_1853-1862.nxml.txt.nlp	25206494	SENT69	22	22	7	7	ethanol	p53	PA448073	7157	0.819
NULL	Neuropsychopharmacology_2009_Jul_25_34(8)_1968-1978.nxml.txt.nlp	19322168	SENT258	22	22	25	25	clozapine	PI3K	PA449061	5290	0.819
NULL	Cancer_Cell_Int_2013_Apr_16_13_36.nxml.txt.nlp	23590596	SENT102	11	11	8	8	doxorubicin	TRAIL	PA449412	8743	0.819
NULL	Cancer_Cell_Int_2011_Oct_31_11_37.nxml.txt.nlp	22040460	SENT72	19	19	42	42	gentamicin	CO2	PA449753	4513	0.819
NULL	Front_Pharmacol_2014_Nov_28_5_255.nxml.txt.nlp	25506327	SENT1068	2	2	16	16	sumatriptan	5-HT1B	PA451566	3351	0.819
NULL	Br_J_Cancer_2013_Mar_19_108(5)_1126-1132.nxml.txt.nlp	23511629	SENT36	22	22	6	6	sunitinib	VEGFR3	PA162372840	2324	0.819
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_May_31_69(Pt_6)_o980.nxml.txt.nlp	23795133	SENT64	0	0	29	29	rupatadine	TNF-alpha		7124	0.819
NULL	Clin_Ophthalmol_2014_Apr_28_8_807-812.nxml.txt.nlp	24812486	SENT74	14	14	23	23	bevacizumab	CRT	PA130232992	811	0.819
NULL	Curr_Oncol_2008_Oct_15(5)_229-233.nxml.txt.nlp	19008997	SENT136	10	10	13	13	chlorambucil	Yes	PA448926	7525	0.819
NULL	Oncoimmunology_2013_Jan_1_2(1)_e22890.nxml.txt.nlp	23483066	SENT85	12	12	28	28	sorafenib	IFN	PA7000	3439	0.819
NULL	Biochimie_2014_Jun_101(100)_67-74.nxml.txt.nlp	24394625	SENT67	17	17	34	34	l-glutamine	CO2	PA10090	4513	0.819
NULL	Oncogene_2009_Feb_5_28(5)_625-637.nxml.txt.nlp	19015636	SENT36	3	3	17	17	doxycycline	PTCH1	PA449415	5727	0.819
NULL	Mol_Clin_Oncol_2013_Jul_27_1(4)_768-772.nxml.txt.nlp	24649244	SENT193	9	9	11	11	gemcitabine	GEM	PA449748	2669	0.819
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT5	0	0	6	6	ranibizumab	VEGF-A	PA164746012	7422	0.819
NULL	Br_J_Cancer_2011_Jul_12_105(2)_255-262.nxml.txt.nlp	21694725	SENT88	25	25	5	5	irinotecan	EGFR	PA450085	1956	0.819
NULL	Int_J_Mol_Imaging_2011_Oct_26_2011_874585.nxml.txt.nlp	21490735	SENT130	9	9	23	23	doxorubicin	FDG	PA449412	23583	0.819
NULL	J_Cell_Biol_1998_Jun_1_141(5)_1121-1134.nxml.txt.nlp	9606205	SENT105	1	1	19	19	glutaraldehyde	IL-2	PA449777	3558	0.819
NULL	Cell_Death_Dis_2010_Nov_18_1(11)_e102.nxml.txt.nlp	21368867	SENT307	17	17	39	39	gentamicin	p63	PA449753	8626	0.819
NULL	Breast_Cancer_Res_2013_Oct_22_15(5)_R98.nxml.txt.nlp	24148581	SENT52	23	23	26	26	tamoxifen	aromatase	PA451581	1588	0.819
NULL	J_Lipids_2011_Dec_6_2011_167958.nxml.txt.nlp	22191036	SENT3	12	12	23	23	simvastatin	STZ	PA451363	6484	0.819
NULL	Clin_Drug_Investig_2013_Jul_24_33(9)_621-631.nxml.txt.nlp	23881565	SENT32	25	25	36	36	pioglitazone	gamma	PA450970	9913	0.819
NULL	Mol_Cancer_2008_Jul_24_7_64.nxml.txt.nlp	18652674	SENT134	20	20	4	4	paclitaxel	XIAP	PA450761	331	0.819
NULL	Mol_Brain_2014_Mar_29_7_21.nxml.txt.nlp	24678719	SENT392	11	11	4	4	picrotoxin	CA1	PA164777007	759	0.819
NULL	BMB_Rep_2014_Nov_47(11)_649-654.nxml.txt.nlp	25301019	SENT87	7	7	13	13	l-serine	IL-10	PA451330	3586	0.819
NULL	Eur_J_Haematol_2013_Feb_22_90(2)_89-98.nxml.txt.nlp	23181448	SENT122	0	0	10	10	imatinib	KIT	PA10804	3815	0.819
NULL	Amyloid_2014_Sep_11_21(3)_175-184.nxml.txt.nlp	24918964	SENT87	7	7	10	10	anakinra	TTR	PA10799	7276	0.819
NULL	J_Cell_Biol_2002_Sep_16_158(6)_1133-1144.nxml.txt.nlp	12235127	SENT7	34	34	39	39	hyaluronan	CD44	PA165958431	960	0.819
NULL	J_Adv_Pract_Oncol_2014_Mar_1_Mar-Apr_5(2)_134-139.nxml.txt.nlp	25032047	SENT47	6	6	12	12	trastuzumab	HER2	PA451743	2064	0.819
NULL	Infect_Drug_Resist_2010_Nov_23_3_133-145.nxml.txt.nlp	21694902	SENT285	10	10	3	3	ribavirin	IL28B	PA451241	282617	0.819
NULL	Front_Neural_Circuits_2014_Mar_17_8_21.nxml.txt.nlp	24672433	SENT833	22	22	6	6	choline	5-HT2C	PA448976	3358	0.819
NULL	Ther_Clin_Risk_Manag_2007_Jun_3(3)_401-410.nxml.txt.nlp	18488071	SENT42	8	8	30	30	misoprostol	ACR	PA450523	49	0.819
NULL	Int_J_Biol_Sci_2013_Nov_21_9(10)_1089-1098.nxml.txt.nlp	24339730	SENT24	10	10	14	14	genistein	SMAD5	PA165109660	4090	0.819
NULL	Diabetes_2009_Dec_31_58(12)_2851-2862.nxml.txt.nlp	19720788	SENT285	8	8	11	11	forskolin	Bcl-2	PA146096022	596	0.819
NULL	EMBO_Mol_Med_2013_Mar_12_5(3)_441-455.nxml.txt.nlp	23401241	SENT37	16	16	18	18	streptozocin	STZ	PA451514	6484	0.819
NULL	Cardiovasc_Diabetol_2013_Oct_17_12_150.nxml.txt.nlp	24134550	SENT7	40	40	16	16	pioglitazone	activin	PA450970	83729	0.819
NULL	Ann_Rheum_Dis_2011_Oct_19_71(3)_351-357.nxml.txt.nlp	22012969	SENT184	36	36	26	26	rituximab	ACPA	PA451261	5657	0.819
NULL	ScientificWorldJournal_2012_May_1_2012_489830.nxml.txt.nlp	22623900	SENT138	30	30	9	9	s-adenosylmethionine	B12	PA164754994	7126;4709	0.819
NULL	J_Biol_Chem_2010_Aug_20_285(34)_26211-26222.nxml.txt.nlp	20554518	SENT137	23	23	1	1	paraformaldehyde	ZO-1	PA450790	7082	0.819
NULL	Mol_Cancer_2009_Jun_23_8_39.nxml.txt.nlp	19549337	SENT36	17	17	8	8	paclitaxel	survivin	PA450761	332	0.819
NULL	Interdiscip_Toxicol_2012_Dec_5(4)_192-200.nxml.txt.nlp	23554563	SENT373	31	31	3	3	ceftriaxone	ALAD	PA448866	210	0.819
NULL	Oncotarget_2014_Oct_18_5(21)_10206-10221.nxml.txt.nlp	25344914	SENT40	1	1	32	32	vemurafenib	BRAF	PA165946873	673	0.819
NULL	Biomed_Res_Int_2013_May_27_2013_597282.nxml.txt.nlp	23781504	SENT95	4	4	32	32	cyanocobalamin	B12	PA451892	7126;4709	0.819
NULL	Indian_J_Pharmacol_2014_Nov-Dec_46(6)_627-632.nxml.txt.nlp	25538335	SENT163	18	18	16	16	metformin	Q10	PA450395	27161	0.819
NULL	J_Thorac_Oncol_2014_Sep_22_9(9)_1345-1353.nxml.txt.nlp	25122430	SENT75	37	37	29	29	gefitinib	EGFR	PA131301952	1956	0.819
NULL	Mol_Cell_Proteomics_2012_Feb_6_11(2)_M111_015222.nxml.txt.nlp	22147731	SENT165	4	4	20	20	cetuximab	EGF	PA10040	1950	0.819
NULL	Acta_Pharmacol_Sin_2012_May_2_33(5)_615-624.nxml.txt.nlp	22465948	SENT157	5	5	20	20	ethanol	PRG	PA448073	5544	0.819
NULL	Cardiovasc_Ther_2009_27(4)_259-274.nxml.txt.nlp	19604248	SENT94	4	4	14	14	ticagrelor	ADP	PA165374673	23038	0.819
NULL	Mol_Cancer_2007_Oct_11_6_63.nxml.txt.nlp	17931419	SENT128	20	20	32	32	cetuximab	HIF-1	PA10040	29072	0.819
NULL	Chem_Res_Toxicol_2011_Aug_15_24(8)_1275-1282.nxml.txt.nlp	21749116	SENT38	3	3	15	15	geldanamycin	Hsp90	PA152031327	3320	0.819
NULL	Croat_Med_J_2014_Jun_55(3)_206-217.nxml.txt.nlp	24891279	SENT80	10	10	34	34	doxorubicin	p53	PA449412	7157	0.819
NULL	Curr_Cardiol_Rev_2008_Nov_4(4)_293-299.nxml.txt.nlp	20066137	SENT34	21	21	26	26	heparin	ACT	PA449855	12;11332;9457;641455	0.819
NULL	Cancer_Res_Treat_2013_Sep_30_45(3)_178-185.nxml.txt.nlp	24155676	SENT126	5	5	8	8	gefitinib	EGFR	PA131301952	1956	0.819
NULL	J_Clin_Biochem_Nutr_2009_Sep_28_45(2)_125-130.nxml.txt.nlp	19794918	SENT96	2	2	10	10	lansoprazole	HO-1	PA450180	3162	0.819
NULL	Mucosal_Immunol_2013_Nov_10_6(6)_1179-1190.nxml.txt.nlp	23571504	SENT59	9	9	11	11	auranofin	TRX	PA448510	7295	0.819
NULL	Breast_Cancer_Res_2009_Oct_28_11(5)_211.nxml.txt.nlp	19889200	SENT284	14	14	5	5	letrozole	HER-2	PA450196	2064	0.819
NULL	Br_J_Cancer_2009_Mar_24_100(6)_870-873.nxml.txt.nlp	19293806	SENT64	13	13	2	2	gemcitabine	CDA	PA449748	978	0.819
NULL	J_Exp_Clin_Cancer_Res_2009_Nov_24_28(1)_144.nxml.txt.nlp	19930704	SENT121	47	47	3	3	melphalan	P-gp	PA450354	5243	0.819
NULL	Indian_J_Pharm_Sci_2014_Jan-Feb_76(1)_72-77.nxml.txt.nlp	24799741	SENT82	29	29	7	7	glipizide	CYP2C9	PA449762	1559	0.819
NULL	Oncotarget_2014_Jun_6_5(13)_4935-4944.nxml.txt.nlp	24952732	SENT116	5	5	10	10	doxazosin	HIF-1	PA449407	29072	0.819
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT137	14	14	21	21	paclitaxel	ABCB1	PA450761	5243	0.819
NULL	Drugs_Context_2012_Nov_19_2012_212242.nxml.txt.nlp	24432031	SENT128	8	8	20	20	tamoxifen	IFN	PA451581	3439	0.819
NULL	Int_J_Mol_Sci_2014_Sep_5_15(9)_15778-15790.nxml.txt.nlp	25198901	SENT544	1	1	9	9	thrombin	CCL2	PA451674	6347	0.819
NULL	Cell_Mol_Life_Sci_2012_Jan_11_69(1)_149-163.nxml.txt.nlp	21667063	SENT193	4	4	21	21	curcumin	ATP7B	PA151958596	540	0.819
NULL	Biologics_2012_Jul_17_6_207-219.nxml.txt.nlp	22904613	SENT276	4	4	21	21	sorafenib	SHARP	PA7000	23013	0.819
NULL	Indian_J_Pharmacol_2008_Oct_40(Suppl_2)_S97-S112.nxml.txt.nlp	21593984	SENT594	15	15	36	36	minocycline	STZ	PA450519	6484	0.819
NULL	Mol_Cancer_2014_Jul_5_13_165.nxml.txt.nlp	24996221	SENT216	15	15	8	8	docetaxel	HMGB1	PA449383	3146	0.819
NULL	Cell_Death_Dis_2010_Nov_18_1(11)_e102.nxml.txt.nlp	21368867	SENT80	10	10	18	18	gentamicin	CLIMP-63	PA449753	10970	0.819
NULL	Clin_Pharmacol_2011_Jun_22_3_13-25.nxml.txt.nlp	22287853	SENT207	16	16	24	24	saxagliptin	CYP3A4	PA165958362	1576	0.819
NULL	Arthritis_Res_Ther_2008_Oct_17_10(Suppl_2)_S4.nxml.txt.nlp	19007429	SENT112	6	6	10	10	indomethacin	NCX	PA449982	3196	0.819
NULL	Acta_Pharmacol_Sin_2010_Mar_22_31(3)_329-340.nxml.txt.nlp	20173759	SENT207	30	30	24	24	ethanol	AMPK	PA448073	5563	0.819
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT94	5	5	12	12	atorvastatin	IL-6	PA448500	3569	0.819
NULL	Mol_Vis_2011_Apr_27_17_1044-1055.nxml.txt.nlp	21552499	SENT11	2	2	22	22	bevacizumab	apelin	PA130232992	8862	0.819
NULL	Br_J_Cancer_2012_May_8_106(10)_1689-1696.nxml.txt.nlp	22531631	SENT210	10	10	0	0	simvastatin	PC-3	PA451363	692094	0.819
NULL	Diabetes_Care_2009_Nov_32(Suppl_2)_S362-S367.nxml.txt.nlp	19875582	SENT87	28	28	32	32	deferoxamine	RBP4	PA164746490	5433;5950	0.819
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_3_2012_908562.nxml.txt.nlp	23082087	SENT178	24	24	15	15	hesperidin	IL-4	PA449867	3565	0.819
NULL	Cancer_Res_Treat_2012_Sep_30_44(3)_195-201.nxml.txt.nlp	23091446	SENT96	19	19	3	3	doxorubicin	MKP-1	PA449412	1843	0.819
NULL	Mol_Cancer_2012_Dec_12_11_91.nxml.txt.nlp	23234355	SENT172	17	17	10	10	trastuzumab	HER2	PA451743	2064	0.819
NULL	Evid_Based_Complement_Alternat_Med_2013_Mar_26_2013_974313.nxml.txt.nlp	23589723	SENT7	6	6	11	11	metformin	HIF1	PA450395	3091	0.819
NULL	F1000_Biol_Rep_2012_Mar_1_4_5.nxml.txt.nlp	22403588	SENT115	11	11	9	9	ribavirin	IFN	PA451241	3439	0.819
NULL	Crit_Care_2011_Jun_24_15(3)_R153.nxml.txt.nlp	21702944	SENT202	20	20	14	14	dexmedetomidine	PI3K	PA449256	5290	0.819
NULL	Oncotarget_2014_Mar_13_5(4)_1101-1110.nxml.txt.nlp	24658355	SENT3	7	7	9	9	tamoxifen	MKP-2	PA451581	1846	0.819
NULL	Core_Evid_2010_Oct_21_5_61-76.nxml.txt.nlp	21042543	SENT252	32	32	42	42	cetuximab	PIK3CA	PA10040	5290	0.819
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_12_2013_946451.nxml.txt.nlp	23843890	SENT203	8	8	5	5	metformin	AMPK	PA450395	5563	0.819
NULL	Asia_Pac_Allergy_2014_Jan_31_4(1)_3-13.nxml.txt.nlp	24527404	SENT51	26	26	6	6	capsaicin	TRPV1	PA448776	7442	0.819
NULL	Cells_2014_Apr_8_3(2)_258-287.nxml.txt.nlp	24717323	SENT97	13	13	2	2	capsaicin	TRPV1	PA448776	7442	0.819
NULL	Drug_Saf_2014_Feb_19_37(4)_201-211.nxml.txt.nlp	24550106	SENT262	20	20	25	25	fluvoxamine	CYP2C19	PA449690	1557	0.819
NULL	J_Lipids_2011_Jan_13_2011_565316.nxml.txt.nlp	21490804	SENT191	9	9	4	4	camptothecin	PC3	PA153590860	57332;7832;5122	0.819
NULL	Cardiol_Res_Pract_2013_Feb_21_2013_127270.nxml.txt.nlp	23509665	SENT173	34	34	23	23	clopidogrel	ADP	PA449053	23038	0.819
NULL	Mol_Vis_2010_Sep_4_16_1823-1831.nxml.txt.nlp	21045919	SENT199	9	9	2	2	l-carnitine	OCTN1	PA450154	6583	0.819
NULL	Arthritis_Res_Ther_2014_Jul_18_16(4)_R153.nxml.txt.nlp	25037855	SENT226	15	15	7	7	adalimumab	CD14	PA10004	929	0.819
NULL	Biomed_Res_Int_2014_Jun_3_2014_656370.nxml.txt.nlp	24995318	SENT87	16	16	29	29	quetiapine	FGA	PA451201	2243	0.819
NULL	J_Physiol_2014_Feb_1_592(3)_537-549.nxml.txt.nlp	24297847	SENT136	8	8	28	28	bethanechol	ANOVA	PA448613	4858	0.819
NULL	Pharmaceutics_2011_Jan_13_3(1)_34-52.nxml.txt.nlp	21949900	SENT154	10	10	16	16	cisplatin	EGF	PA449014	1950	0.819
NULL	Oncotarget_2013_Nov_15_5(6)_1458-1474.nxml.txt.nlp	24681547	SENT6	4	4	9	9	celecoxib	CDH11	PA448871	1009	0.819
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT164	29	29	7	7	ritonavir	ABCB1	PA451260	5243	0.819
NULL	Oxid_Med_Cell_Longev_2013_Nov_28_2013_568093.nxml.txt.nlp	24379901	SENT50	23	23	21	21	resveratrol	SIRT1		23411	0.819
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_25_2013_127075.nxml.txt.nlp	23878590	SENT121	8	8	22	22	genistein	GDNF	PA165109660	2668	0.819
NULL	Sensors_(Basel)_2013_Dec_27_14(1)_458-467.nxml.txt.nlp	24379050	SENT91	10	10	7	7	glucose	SPR	PA449773	6697;6869	0.819
NULL	Environ_Health_Perspect_2009_Feb_19_117(2)_155-158.nxml.txt.nlp	19270781	SENT89	14	14	6	6	atropine	CO2	PA448505	4513	0.819
NULL	Br_J_Cancer_2009_Mar_24_100(6)_941-949.nxml.txt.nlp	19240716	SENT147	17	17	38	38	gefitinib	Met	PA131301952	79811	0.819
NULL	Breast_Cancer_Res_Treat_2014_Sep_25_148(1)_81-90.nxml.txt.nlp	25253174	SENT133	2	2	16	16	metformin	HER2	PA450395	2064	0.819
NULL	J_Cell_Mol_Med_2014_Jan_4_18(1)_38-48.nxml.txt.nlp	24188742	SENT137	14	14	32	32	vincristine	PAX3	PA451879	5077	0.819
NULL	Cell_Commun_Signal_2014_Nov_25_12(1)_55.nxml.txt.nlp	NULL	SENT91	3	3	9	9	vanillin	SF-1	PA451852	2516	0.819
NULL	Gastroenterol_Hepatol_Bed_Bench_2013_Winter_6(1)_6-13.nxml.txt.nlp	24834238	SENT68	6	6	3	3	cetuximab	BRAF	PA10040	673	0.819
NULL	Breast_Cancer_Res_2005_Jul_20_7(5)_205-211.nxml.txt.nlp	16168139	SENT125	8	8	12	12	lapatinib	EGF	PA152241907	1950	0.819
NULL	J_Orthop_Sci_2014_Oct_13_19(6)_933-939.nxml.txt.nlp	25308211	SENT27	5	5	24	24	curcumin	COX	PA151958596	1351	0.819
NULL	J_Mol_Med_(Berl)_2014_May_10_92(7)_709-722.nxml.txt.nlp	24811491	SENT65	14	14	5	5	lapatinib	HER2	PA152241907	2064	0.819
NULL	Clin_Ophthalmol_2009_Jun_2_3_57-67.nxml.txt.nlp	19668545	SENT9	14	14	24	24	cyclosporine	KCS	PA449167	3771	0.819
NULL	Acta_Pharmacol_Sin_2010_May_26_31(5)_554-559.nxml.txt.nlp	20418892	SENT157	2	2	4	4	bleomycin	BLM	PA448645	641	0.819
NULL	Cancers_(Basel)_2012_May_29_4(2)_531-548.nxml.txt.nlp	24213323	SENT117	2	2	0	0	hyaluronan	COL1A1	PA165958431	1277	0.819
NULL	Iran_J_Basic_Med_Sci_2012_May-Jun_15(3)_803-810.nxml.txt.nlp	23492756	SENT137	36	36	9	9	ethanol	CB1	PA448073	1268	0.819
NULL	Viruses_2014_Mar_7_6(3)_1078-1090.nxml.txt.nlp	24608085	SENT60	16	16	33	33	imatinib	CD9	PA10804	928	0.819
NULL	Mol_Cell_Proteomics_2013_Aug_14_12(8)_2313-2323.nxml.txt.nlp	23674616	SENT202	29	29	40	40	levamisole	ALPL	PA450205	249	0.819
NULL	Indian_J_Med_Res_2013_Jan_137(1)_191-196.nxml.txt.nlp	23481072	SENT99	7	7	10	10	daptomycin	VISA	PA164768820	57506	0.819
NULL	Eur_J_Clin_Pharmacol_2011_Dec_23_67(12)_1231-1241.nxml.txt.nlp	21698374	SENT298	15	15	3	3	tacrolimus	CYP3A5	PA451578	1577	0.819
NULL	Pharmaceuticals_(Basel)_2013_Oct_11_6(10)_1304-1321.nxml.txt.nlp	24275851	SENT454	0	0	4	4	liraglutide	GLP-1	PA165958364	100125288	0.819
NULL	Int_J_Biomed_Sci_2014_Dec_10(4)_236-242.nxml.txt.nlp	25598753	SENT126	34	34	15	15	chlorpropamide	NUT	PA448966	256646	0.819
NULL	Clin_Epigenetics_2010_Sep_18_1(3-4)_101-116.nxml.txt.nlp	21258631	SENT221	21	21	7	7	genistein	CCND2	PA165109660	894	0.819
NULL	Carcinogenesis_2014_May_13_35(5)_1055-1066.nxml.txt.nlp	24419232	SENT262	0	0	14	14	metformin	CD31	PA450395	5175	0.819
NULL	Int_J_Mol_Sci_2013_Apr_29_14(5)_9338-9364.nxml.txt.nlp	23629668	SENT90	36	36	8	8	bevacizumab	KDR	PA130232992	3791	0.819
NULL	Basic_Res_Cardiol_2015_Jan_20_110_4.nxml.txt.nlp	25600226	SENT209	16	16	6	6	pravastatin	PCSK9	PA451089	255738	0.819
NULL	Mol_Cancer_2010_Apr_15_9_77.nxml.txt.nlp	20398291	SENT30	28	28	24	24	cisplatin	survivin	PA449014	332	0.819
NULL	Sci_Rep_2014_Dec_17_4_7035.nxml.txt.nlp	25516351	SENT273	12	12	21	21	cisplatin	SPARC	PA449014	6678	0.819
NULL	Int_J_Breast_Cancer_2012_Dec_19_2012_654698.nxml.txt.nlp	22295247	SENT135	10	10	7	7	letrozole	aromatase	PA450196	1588	0.819
NULL	Comp_Hepatol_2010_Feb_18_9_4.nxml.txt.nlp	20167095	SENT31	13	13	0	0	heparin	GPC3	PA449855	2719	0.819
NULL	Front_Chem_2014_Dec_23_2_113.nxml.txt.nlp	25566531	SENT171	0	0	17	17	curcumin	PP5	PA151958596	7980;5536	0.819
NULL	Cancer_Cell_Int_2013_Apr_16_13_36.nxml.txt.nlp	23590596	SENT130	16	16	14	14	doxorubicin	TRAIL	PA449412	8743	0.819
NULL	Acta_Pharmacol_Sin_2012_May_16_33(5)_682-690.nxml.txt.nlp	22504904	SENT181	9	9	16	16	celecoxib	c-Myc	PA448871	4609	0.819
NULL	Mol_Brain_2014_Apr_21_7_28.nxml.txt.nlp	24751148	SENT250	12	12	19	19	minocycline	TLR4	PA450519	7099	0.819
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Oct_20_68(Pt_11)_o3193.nxml.txt.nlp	23284504	SENT73	4	4	14	14	antipyrine	C10	PA448453	113246	0.819
NULL	Case_Rep_Psychiatry_2012_Aug_8_2012_313906.nxml.txt.nlp	22934217	SENT61	33	33	6	6	donepezil	FAST	PA449394	10922	0.819
NULL	Calcif_Tissue_Int_2010_Dec_16_87(6)_485-492.nxml.txt.nlp	20953593	SENT54	14	14	24	24	teriparatide	PTH	PA451620	5741	0.819
NULL	Mol_Cancer_2009_Mar_5_8_14.nxml.txt.nlp	19265551	SENT78	7	7	34	34	camptothecin	p53	PA153590860	7157	0.819
NULL	Front_Oncol_2013_Oct_29_3_269.nxml.txt.nlp	24195060	SENT120	22	22	5	5	cisplatin	THBS1	PA449014	7057	0.819
NULL	J_Anaesthesiol_Clin_Pharmacol_2012_Jan-Mar_28(1)_106-110.nxml.txt.nlp	22345956	SENT80	11	11	28	28	heparin	ACT	PA449855	12;11332;9457;641455	0.819
NULL	Cell_Res_2014_Feb_12_24(2)_143-160.nxml.txt.nlp	24217768	SENT68	16	16	28	28	heparin	FGFR1	PA449855	2260	0.819
NULL	Clin_Interv_Aging_2009_May_14_4_179-186.nxml.txt.nlp	19503779	SENT135	14	14	11	11	selegiline	COMT	PA451316	1312	0.819
NULL	J_Vet_Med_Sci_2014_May_13_76(5)_629-636.nxml.txt.nlp	24419976	SENT179	17	17	7	7	indomethacin	EP4	PA449982	5734	0.819
NULL	EMBO_Mol_Med_2013_Dec_8_5(12)_1821-1834.nxml.txt.nlp	24293316	SENT119	9	9	11	11	doxorubicin	DAPK	PA449412	1612	0.819
NULL	Front_Pharmacol_2014_May_30_5_132.nxml.txt.nlp	24910615	SENT134	6	6	25	25	estradiol	PDE7B	PA449503	27115	0.819
NULL	Breast_Cancer_Res_2008_Feb_28_10(1)_R20.nxml.txt.nlp	18307763	SENT10	2	2	12	12	trastuzumab	HER2	PA451743	2064	0.819
NULL	Rare_Dis_2013_Oct_7_1_e26690.nxml.txt.nlp	25003011	SENT121	4	4	7	7	laronidase	ERT	PA164776670	1999	0.819
NULL	Oncoimmunology_2012_Dec_1_1(9)_1661-1663.nxml.txt.nlp	23264929	SENT30	8	8	14	14	imiquimod	TRAIL	PA449972	8743	0.819
NULL	Arthritis_Res_Ther_2009_Dec_11_11(6)_R187.nxml.txt.nlp	20003323	SENT8	35	35	39	39	anakinra	RANKL	PA10799	8600	0.819
NULL	Oncoimmunology_2013_Jun_1_2(6)_e24462.nxml.txt.nlp	23894707	SENT55	2	2	29	29	vemurafenib	PD-L1	PA165946873	29126	0.819
NULL	Ann_Hematol_2014_Aug_17_93(3)_403-409.nxml.txt.nlp	23955074	SENT216	15	15	20	20	rituximab	CHOP	PA451261	1649	0.819
NULL	Exp_Ther_Med_2014_Nov_15_8(5)_1351-1356.nxml.txt.nlp	25289022	SENT10	22	22	11	11	tetracycline	ZAP	PA451640	56829;56252	0.819
NULL	Cell_Regen_(Lond)_2013_Apr_30_2(1)_3.nxml.txt.nlp	25408875	SENT88	6	6	21	21	colchicine	SNX16	PA449092	64089	0.819
NULL	An_Bras_Dermatol_2013_Nov-Dec_88(6_Suppl_1)_120-123.nxml.txt.nlp	24346897	SENT25	7	7	16	16	calcipotriol	CO2	PA448714	4513	0.819
NULL	Indian_J_Med_Res_2014_Jan_139(1)_117-124.nxml.txt.nlp	24604047	SENT176	7	7	29	29	fluvastatin	RhoA	PA449688	387	0.819
NULL	FEBS_Open_Bio_2012_May_23_2_103-112.nxml.txt.nlp	23650588	SENT379	7	7	0	0	bortezomib	JNK	PA10252	5599	0.819
NULL	Oxid_Med_Cell_Longev_2012_May_30_2012_452902.nxml.txt.nlp	22701146	SENT246	2	2	26	26	cyclophosphamide	OCTN2	PA449165	6584	0.819
NULL	Oxid_Med_Cell_Longev_2012_Jun_3_2012_914273.nxml.txt.nlp	22701758	SENT150	16	16	29	29	hesperetin	IFN	PA164742902	3439	0.819
NULL	Cancer_Imaging_2012_May_7_12(1)_163-172.nxml.txt.nlp	22571819	SENT94	24	24	8	8	erlotinib	EGFR	PA134687924	1956	0.819
NULL	Indian_J_Pharm_Sci_2013_Nov-Dec_75(6)_649-656.nxml.txt.nlp	24591739	SENT179	29	29	13	13	tacrine	flower	PA451576	11094	0.819
NULL	Cancer_Cell_Int_2012_Jul_4_12_19.nxml.txt.nlp	22631225	SENT181	34	34	11	11	heparin	BSG	PA449855	682	0.819
NULL	Cell_Death_Dis_2013_Jul_25_4(7)_e740.nxml.txt.nlp	23887631	SENT68	7	7	10	10	vorinostat	CD133	PA164748224	8842	0.819
NULL	Br_J_Cancer_1995_Feb_71(2)_366-370.nxml.txt.nlp	7530988	SENT0	16	16	9	9	cisplatin	MVP	PA449014	9961	0.819
NULL	Front_Oncol_2014_Mar_25_4_54.nxml.txt.nlp	24724051	SENT562	5	5	15	15	imatinib	CD34	PA10804	947	0.819
NULL	Int_J_Breast_Cancer_2012_May_9_2012_415170.nxml.txt.nlp	22649737	SENT150	0	0	15	15	neratinib	HER2	PA165291472	2064	0.819
NULL	Oncol_Lett_2014_Sep_11_8(3)_1222-1228.nxml.txt.nlp	25120693	SENT4	43	43	20	20	olaparib	XRCC2		7516	0.819
NULL	Ann_Rheum_Dis_2010_Jun_1_69(6)_1158-1161.nxml.txt.nlp	20439295	SENT27	11	11	28	28	rituximab	San	PA451261	80218	0.819
NULL	Sensors_(Basel)_2012_Dec_28_13(1)_500-515.nxml.txt.nlp	23275085	SENT130	7	7	12	12	isoflurane	ARC	PA450106	8996;23237	0.819
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT824	19	19	2	2	glucose	GLUT8	PA449773	29988;154091	0.819
NULL	Br_J_Cancer_2009_Jun_2_100(11)_1697-1703.nxml.txt.nlp	19384299	SENT96	25	25	18	18	indomethacin	FOXP3	PA449982	50943	0.819
NULL	Br_J_Cancer_2010_Nov_9_103(10)_1588-1596.nxml.txt.nlp	20978505	SENT224	9	9	4	4	temozolomide	PARP-1	PA451609	25976	0.819
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT171	3	3	20	20	atorvastatin	TNF	PA448500	7124	0.819
NULL	Asia_Pac_Allergy_2013_Oct_31_3(4)_266-280.nxml.txt.nlp	24260732	SENT104	22	22	5	5	amoxicillin	CD203c	PA448406	5169	0.819
NULL	Biosensors_(Basel)_2013_Jun_28_3(3)_238-258.nxml.txt.nlp	25506422	SENT254	22	22	27	27	etoposide	p53	PA449552	7157	0.819
NULL	Cancer_Cell_Int_2012_Jun_18_12_30.nxml.txt.nlp	22709569	SENT69	17	17	6	6	doxorubicin	CALM1	PA449412	801	0.819
NULL	Mol_Cancer_2010_Dec_2_9_309.nxml.txt.nlp	21122157	SENT121	10	10	4	4	paclitaxel	IL-6	PA450761	3569	0.819
NULL	Front_Neuroanat_2011_Jul_12_5_38.nxml.txt.nlp	21808606	SENT169	5	5	18	18	haloperidol	DARPP-32	PA449841	84152	0.819
NULL	Breast_Cancer_(Auckl)_2009_Sep_2_3_61-75.nxml.txt.nlp	19809577	SENT4	8	8	31	31	curcumin	BRCA1	PA151958596	672	0.819
NULL	Eur_J_Clin_Pharmacol_2011_May_9_67(5)_477-482.nxml.txt.nlp	21305273	SENT29	28	28	25	25	dobutamine	DBP	PA449381	3295;1628;2638	0.819
NULL	Br_J_Pharmacol_2012_Jan_165(2)_380-389.nxml.txt.nlp	21585347	SENT153	24	24	12	12	rosiglitazone	ATGL	PA451283	57104	0.819
NULL	Ann_Oncol_2010_Jul_23_21(7)_1436-1441.nxml.txt.nlp	20032126	SENT207	4	4	9	9	trastuzumab	HER2	PA451743	2064	0.819
NULL	Diabetes_Metab_J_2014_Apr_18_38(2)_100-106.nxml.txt.nlp	24851203	SENT41	10	10	5	5	glucose	MET	PA449773	4233	0.819
NULL	Front_Endocrinol_(Lausanne)_2014_Oct_9_5_161.nxml.txt.nlp	25346723	SENT417	10	10	12	12	liraglutide	GLP-1	PA165958364	100125288	0.819
NULL	Diabetes_Care_2010_Aug_33(8)_1908-1910.nxml.txt.nlp	20668159	SENT63	12	12	4	4	rosiglitazone	DREAM	PA451283	30818	0.819
NULL	Acta_Pharmacol_Sin_2012_Jan_28_33(1)_75-81.nxml.txt.nlp	22120969	SENT14	9	9	30	30	sitagliptin	GLP-1	PA164748978	100125288	0.819
NULL	J_Cancer_Prev_2014_Mar_19(1)_39-46.nxml.txt.nlp	25337571	SENT97	29	29	5	5	ethanol	p53	PA448073	7157	0.819
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT187	17	17	11	11	warfarin	VKORC1	PA451906	79001	0.819
NULL	Alcohol_Res_Health_2007_30(1)_38-47.nxml.txt.nlp	17718399	SENT173	16	16	27	27	ethanol	CYP2E1	PA448073	1571	0.819
NULL	Aging_(Albany_NY)_2014_May_4_6(6)_440-453.nxml.txt.nlp	25013207	SENT117	23	23	32	32	cyclosporine	VGF	PA449167	7425	0.819
NULL	Oncotarget_2012_Sep_11_3(9)_1026-1035.nxml.txt.nlp	22976441	SENT89	4	4	22	22	etoposide	CKI	PA449552	1119	0.819
NULL	J_Gastroenterol_2014_Sep_25_49(8)_1253-1263.nxml.txt.nlp	24065124	SENT273	10	10	3	3	ribavirin	IL28B	PA451241	282617	0.819
NULL	Environ_Health_Perspect_2009_Feb_8_117(2)_175-180.nxml.txt.nlp	19270784	SENT145	9	9	0	0	cisplatin	BPA	PA449014	667	0.819
NULL	Biosci_Rep_2012_Aug_1_32(Pt_4)_361-374.nxml.txt.nlp	22762204	SENT1116	12	12	2	2	trastuzumab	PIK3CA	PA451743	5290	0.818
NULL	Acta_Orthop_2011_Apr_5_82(2)_211-216.nxml.txt.nlp	21434784	SENT50	23	23	16	16	cisplatin	ADM	PA449014	133	0.818
NULL	Mol_Cancer_2010_Aug_23_9_222.nxml.txt.nlp	20731837	SENT186	24	24	19	19	gefitinib	EGFR	PA131301952	1956	0.818
NULL	Arthritis_Res_Ther_2003_Dec_2_5(Suppl_4)_S12-S16.nxml.txt.nlp	15180892	SENT75	24	24	32	32	vincristine	CHOP	PA451879	1649	0.818
NULL	Eur_J_Clin_Pharmacol_2011_Dec_23_67(12)_1231-1241.nxml.txt.nlp	21698374	SENT218	37	37	13	13	tacrolimus	CYP3A5	PA451578	1577	0.818
NULL	Eur_J_Med_Chem_2011_Nov_46(11)_5456-5464.nxml.txt.nlp	21940073	SENT93	25	25	11	11	cisplatin	CH1	PA449014	51430	0.818
NULL	Biologics_2013_Apr_26_7_91-101.nxml.txt.nlp	23671386	SENT149	14	14	42	42	crizotinib	ROS1	PA165946122	6098	0.818
NULL	Clin_Exp_Gastroenterol_2011_Jul_15_4_163-172.nxml.txt.nlp	21904462	SENT90	18	18	9	9	infliximab	OLC	PA452639	26679	0.818
NULL	Indian_J_Pharmacol_2014_Sep-Oct_46(5)_553-554.nxml.txt.nlp	25298590	SENT49	13	13	10	10	adalimumab	VIII	PA10004	1351	0.818
NULL	Acta_Pharmacol_Sin_2010_Nov_18_31(11)_1447-1453.nxml.txt.nlp	20953204	SENT76	23	23	12	12	rimonabant	IL-6	PA152407999	3569	0.818
NULL	Oncotarget_2014_Jun_8_5(13)_5040-5053.nxml.txt.nlp	24970815	SENT150	23	23	26	26	cisplatin	LOX	PA449014	4015	0.818
NULL	Clin_Dev_Immunol_2013_Nov_14_2013_697525.nxml.txt.nlp	24324510	SENT9	23	23	14	14	abatacept	ACR	PA164747080	49	0.818
NULL	Cell_J_2012_Dec_22_Winter_13(4)_281-289.nxml.txt.nlp	23507624	SENT171	25	25	4	4	propranolol	IFN	PA451145	3439	0.818
NULL	Br_J_Cancer_2012_Sep_4_107(6)_947-955.nxml.txt.nlp	22892392	SENT70	25	25	8	8	tamoxifen	BCAR4	PA451581	400500	0.818
NULL	Indian_J_Orthop_2010_Jul-Sep_44(3)_246-251.nxml.txt.nlp	20697475	SENT51	8	8	2	2	ethanol	DBM	PA448073	1621	0.818
NULL	Evid_Based_Complement_Alternat_Med_2013_Mar_28_2013_514908.nxml.txt.nlp	23606881	SENT505	2	2	15	15	scopolamine	BMX	PA451308	660	0.818
NULL	Hum_Reprod_2008_Oct_16_23(10)_2273-2281.nxml.txt.nlp	18635530	SENT154	2	2	18	18	etoposide	CTB	PA449552	9468	0.818
NULL	Diabetologia_2010_Aug_27_53(8)_1714-1721.nxml.txt.nlp	20422397	SENT160	21	21	40	40	nadh	ADP	PA164755085	23038	0.818
NULL	Blood_Cancer_J_2013_Nov_22_3(11)_e163.nxml.txt.nlp	24270325	SENT14	45	45	40	40	vemurafenib	BRAF	PA165946873	673	0.818
NULL	Cancer_Med_2014_Apr_7_3(2)_349-361.nxml.txt.nlp	24515895	SENT199	13	13	6	6	doxycycline	HSC3	PA449415	150353	0.818
NULL	Cardiovasc_Ther_2009_27(4)_259-274.nxml.txt.nlp	19604248	SENT48	48	48	38	38	ticagrelor	P2Y12	PA165374673	64805	0.818
NULL	Br_J_Cancer_2012_Oct_9_107(8)_1327-1336.nxml.txt.nlp	22990650	SENT179	16	16	12	12	pertuzumab	ERBB2		2064	0.818
NULL	Br_J_Cancer_2011_Jul_26_105(3)_366-371.nxml.txt.nlp	21750556	SENT6	19	19	30	30	trastuzumab	T-bet	PA451743	30009	0.818
NULL	Front_Genet_2012_Oct_10_3_206.nxml.txt.nlp	23087703	SENT482	9	9	3	3	proguanil	CYP2C19	PA451124	1557	0.818
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Apr_15_6_37-41.nxml.txt.nlp	24833915	SENT20	11	11	23	23	trastuzumab	DM1	PA451743	338023;1760;28509	0.818
NULL	Cancer_Cell_Int_2005_Jul_24_5_22.nxml.txt.nlp	16042792	SENT9	5	5	12	12	vincristine	NAC	PA451879	22861	0.818
NULL	Tumour_Biol_2011_Feb_6_32(1)_145-157.nxml.txt.nlp	20820980	SENT251	2	2	25	25	estradiol	COMT	PA449503	1312	0.818
NULL	Int_J_Womens_Health_2012_Oct_10_4_543-549.nxml.txt.nlp	23091400	SENT94	16	16	2	2	drospirenone	aromatase	PA164749409	1588	0.818
NULL	Cases_J_2009_Jun_26_2_6384.nxml.txt.nlp	19829800	SENT16	12	12	10	10	cyclophosphamide	CHOP	PA449165	1649	0.818
NULL	Endocr_Relat_Cancer_2013_Aug_20(5)_677-689.nxml.txt.nlp	23913484	SENT33	9	9	0	0	bicalutamide	IL6	PA164746255	3569	0.818
NULL	Acta_Pharmacol_Sin_2010_Jun_4_31(6)_709-717.nxml.txt.nlp	20523342	SENT211	38	38	17	17	repaglinide	PPG	PA451234	5552	0.818
NULL	Arthritis_2010_Nov_24_2010_687547.nxml.txt.nlp	22046510	SENT133	11	11	17	17	colchicine	ACTH	PA449092	5443	0.818
NULL	J_Hematol_Oncol_2013_Sep_5_6_66.nxml.txt.nlp	24010946	SENT212	19	19	25	25	cisplatin	CRT	PA449014	811	0.818
NULL	Clin_Pharmacol_2013_Apr_19_5_67-83.nxml.txt.nlp	23650452	SENT29	9	9	4	4	ritonavir	CYP3A4	PA451260	1576	0.818
NULL	Multidiscip_Respir_Med_2012_Aug_29_7(1)_26.nxml.txt.nlp	22958272	SENT74	16	16	13	13	fluconazole	CYP3A4	PA449653	1576	0.818
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT243	8	8	21	21	cetuximab	BRAF	PA10040	673	0.818
NULL	Diabetes_Care_2010_Aug_27_33(8)_1734-1737.nxml.txt.nlp	20424219	SENT69	17	17	6	6	liraglutide	IL-6	PA165958364	3569	0.818
NULL	Eur_J_Endocrinol_2011_Jan_164(1)_69-74.nxml.txt.nlp	20961967	SENT125	4	4	10	10	metformin	OPG	PA450395	690	0.818
NULL	Adv_Bioinformatics_2012_Jun_6_2012_582765.nxml.txt.nlp	22719757	SENT126	7	7	32	32	thrombin	EGF	PA451674	1950	0.818
NULL	Br_J_Cancer_2012_Jul_24_107(3)_516-526.nxml.txt.nlp	22782351	SENT299	36	36	10	10	tamoxifen	p27	PA451581	5715;10534	0.818
NULL	Iran_J_Pharm_Res_2014_Spring_13(2)_635-639.nxml.txt.nlp	25237359	SENT18	10	10	34	34	midazolam	CYP1A2	PA450496	1544	0.818
NULL	Oncoimmunology_2014_May_29_3_e28925.nxml.txt.nlp	25083322	SENT120	6	6	16	16	dasatinib	CD4	PA162372878	920	0.818
NULL	Drug_Des_Devel_Ther_2014_Oct_31_8_2121-2128.nxml.txt.nlp	25382970	SENT87	24	24	11	11	curcumin	TTR	PA151958596	7276	0.818
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT161	26	26	29	29	vinorelbine	ASC	PA451881	29108	0.818
NULL	J_Oncol_2013_Apr_29_2013_854121.nxml.txt.nlp	23737784	SENT120	22	22	36	36	lapatinib	PI3K	PA152241907	5290	0.818
NULL	J_Biol_Chem_2009_Sep_18_284(38)_26096-26105.nxml.txt.nlp	19628870	SENT118	24	24	3	3	pp2	PP2		4888	0.818
NULL	Evid_Based_Complement_Alternat_Med_2013_May_26_2013_161628.nxml.txt.nlp	23781255	SENT253	4	4	12	12	sunitinib	MEK1	PA162372840	5604	0.818
NULL	Biomed_Res_Int_2014_Jun_26_2014_483501.nxml.txt.nlp	25057490	SENT229	25	25	9	9	resveratrol	PGC1		10891	0.818
NULL	Cancer_Cell_Int_2012_Jan_18_12_1.nxml.txt.nlp	22257483	SENT47	22	22	8	8	l-glutamine	F12	PA10090	2161	0.818
NULL	Orphanet_J_Rare_Dis_2013_Sep_13_8_142.nxml.txt.nlp	24034279	SENT171	4	4	9	9	vasopressin	AVPR2	PA451858	554	0.818
NULL	Int_J_Gen_Med_2011_Jul_20_4_539-545.nxml.txt.nlp	21845063	SENT94	32	32	36	36	miglitol	adiponectin	PA164776726	9370	0.818
NULL	Int_J_Mol_Sci_2014_Sep_22_15(9)_16800-16815.nxml.txt.nlp	25247578	SENT196	39	39	27	27	paraformaldehyde	MNX	PA450790	3892	0.818
NULL	Brain_Behav_2013_Mar_6_3(2)_114-133.nxml.txt.nlp	23533150	SENT242	21	21	24	24	ethanol	HSF1	PA448073	3297	0.818
NULL	Acta_Pharmacol_Sin_2011_Oct_15_32(10)_1233-1238.nxml.txt.nlp	21841815	SENT11	2	2	18	18	atropine	CTX	PA448505	1593	0.818
NULL	Ann_Indian_Acad_Neurol_2011_Jul_14(Suppl1)_S11-S13.nxml.txt.nlp	21847317	SENT8	16	16	39	39	pramipexole	COMT	PA164742949	1312	0.818
NULL	Clin_Orthop_Surg_2014_Sep_5_6(3)_324-328.nxml.txt.nlp	25177459	SENT54	12	12	25	25	lidocaine	TFEB	PA450226	7942	0.818
NULL	Indian_J_Nephrol_2011_Oct-Dec_21(4)_258-263.nxml.txt.nlp	22022086	SENT162	16	16	3	3	azathioprine	IL-2	PA448515	3558	0.818
NULL	Bioinorg_Chem_Appl_2014_Mar_4_2014_347167.nxml.txt.nlp	24860280	SENT54	23	23	7	7	zinc	MAA	PA451956	4080	0.818
NULL	Patient_Prefer_Adherence_2010_Sep_7_4_313-324.nxml.txt.nlp	20859458	SENT42	0	0	12	12	liraglutide	GLP-1	PA165958364	100125288	0.818
NULL	Oncol_Lett_2014_Apr_22_7(4)_1191-1196.nxml.txt.nlp	24944691	SENT132	32	32	16	16	docetaxel	MDR1	PA449383	5243	0.818
NULL	Arch_Osteoporos_2009_Dec_18_4(1-2)_1-8.nxml.txt.nlp	20234790	SENT76	16	16	28	28	alendronate	PTH	PA448082	5741	0.818
NULL	Mol_Cancer_2009_Oct_1_8_81.nxml.txt.nlp	19796390	SENT73	11	11	32	32	celecoxib	Bcl-2	PA448871	596	0.818
NULL	Mol_Cancer_2009_Aug_25_8_66.nxml.txt.nlp	19706164	SENT88	13	13	11	11	celecoxib	p53	PA448871	7157	0.818
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT195	5	5	0	0	cisplatin	IBP	PA449014	706;50619	0.818
NULL	Biomed_Res_Int_2014_Feb_19_2014_240642.nxml.txt.nlp	24701565	SENT66	12	12	5	5	doxorubicin	TNF-alpha	PA449412	7124	0.818
NULL	Ann_Dermatol_2014_Apr_30_26(2)_221-230.nxml.txt.nlp	24882978	SENT135	10	10	3	3	imiquimod	IFN	PA449972	3439	0.818
NULL	ScientificWorldJournal_2013_Sep_19_2013_809891.nxml.txt.nlp	24170983	SENT116	20	20	4	4	ketorolac	ANOVA	PA450150	4858	0.818
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT87	23	23	14	14	pemetrexed	UNG	PA10810	7374	0.818
NULL	BMJ_Open_2013_Sep_25_3(9)_e003455.nxml.txt.nlp	24071460	SENT115	3	3	8	8	diclofenac	OTC	PA449293	5009	0.818
NULL	Bone_Joint_Res_2013_Dec_1_2(12)_270-275.nxml.txt.nlp	24333946	SENT182	16	16	27	27	hyaluronan	CD44	PA165958431	960	0.818
NULL	Int_J_Mol_Sci_2012_Feb_24_13(3)_2578-2589.nxml.txt.nlp	22489112	SENT64	12	12	17	17	maprotiline	GAT3	PA450322	6538	0.818
NULL	Korean_J_Radiol_2010_Feb_22_Mar-Apr_11(2)_234-238.nxml.txt.nlp	20191072	SENT62	22	22	13	13	vincristine	CHOP	PA451879	1649	0.818
NULL	Clin_Dev_Immunol_2007_Jan_20_2007_76396.nxml.txt.nlp	18317531	SENT6	35	35	25	25	sertraline	MCP-1	PA451333	6347	0.818
NULL	Acta_Pharmacol_Sin_2010_Jul_28_31(7)_867-873.nxml.txt.nlp	20581857	SENT158	17	17	22	22	docetaxel	PC3	PA449383	57332;7832;5122	0.818
NULL	Tumour_Biol_2014_Aug_12_35(8)_7807-7819.nxml.txt.nlp	24817012	SENT270	23	23	38	38	cisplatin	ERCC1	PA449014	2067	0.818
NULL	J_Korean_Med_Sci_2013_May_2_28(5)_700-708.nxml.txt.nlp	23678261	SENT123	3	3	8	8	losartan	NCX	PA450268	3196	0.818
NULL	Oncotarget_2013_Nov_7_4(12)_2550-2566.nxml.txt.nlp	24334291	SENT220	11	11	23	23	cyclophosphamide	CHOP	PA449165	1649	0.818
NULL	Lipids_Health_Dis_2011_Jan_18_10_8.nxml.txt.nlp	21241519	SENT33	7	7	24	24	simvastatin	SR-BI	PA451363	949	0.818
NULL	Aging_(Albany_NY)_2009_Jun_22_1(6)_529-541.nxml.txt.nlp	20157536	SENT80	2	2	6	6	resveratrol	STAC		6769	0.818
NULL	Oxid_Med_Cell_Longev_2012_May_9_2012_835970.nxml.txt.nlp	22655115	SENT119	10	10	4	4	rosiglitazone	Q10	PA451283	27161	0.818
NULL	Exp_Ther_Med_2014_Nov_29_8(5)_1473-1478.nxml.txt.nlp	25289044	SENT32	11	11	16	16	heparin	AZU	PA449855	566	0.818
NULL	Curr_Genomics_2014_Jun_15(3)_217-230.nxml.txt.nlp	24955029	SENT8	24	24	6	6	oxygen	ROS	PA450744	6098	0.818
NULL	Biomed_Res_Int_2013_Jun_17_2013_312656.nxml.txt.nlp	23844360	SENT155	3	3	12	12	plerixafor	CD34	PA165958410	947	0.818
NULL	Nat_Med_2014_Jun_11_20(6)_616-623.nxml.txt.nlp	24813252	SENT63	14	14	20	20	galactose	AMPK	PA449725	5563	0.818
NULL	J_Mol_Signal_2011_May_16_6_4.nxml.txt.nlp	21575178	SENT171	7	7	19	19	arsenite	MK3	PA452638	3738	0.818
NULL	J_Biol_Chem_2013_Jul_19_288(29)_21412-21421.nxml.txt.nlp	23740251	SENT12	6	6	25	25	suramin	P2X1	PA10292	5023	0.818
NULL	Acta_Pharmacol_Sin_2012_Feb_3_33(2)_173-181.nxml.txt.nlp	22301857	SENT245	11	11	5	5	sibutramine	Yes	PA451344	7525	0.818
NULL	Oncotarget_2014_Sep_16_5(20)_9966-9979.nxml.txt.nlp	25294818	SENT159	8	8	18	18	glipizide	CD31	PA449762	5175	0.818
NULL	Br_J_Haematol_2009_Feb_144(3)_367-375.nxml.txt.nlp	19036078	SENT69	10	10	19	19	chlorambucil	CHOP	PA448926	1649	0.818
NULL	Arthritis_Res_Ther_2010_Sep_8_12(5)_R167.nxml.txt.nlp	20825639	SENT171	11	11	14	14	resveratrol	JNK		5599	0.818
NULL	Environ_Health_Perspect_1983_Apr_50_163-168.nxml.txt.nlp	6135607	SENT5	4	4	20	20	amobarbital	PHB	PA448401	5245	0.818
NULL	Ann_Oncol_2011_Mar_8_22(3)_503-514.nxml.txt.nlp	20616198	SENT126	14	14	17	17	tamoxifen	aromatase	PA451581	1588	0.818
NULL	Mol_Cancer_2007_Oct_11_6_63.nxml.txt.nlp	17931419	SENT108	46	46	35	35	gefitinib	STAT3	PA131301952	6774	0.818
NULL	Nat_Commun_2014_Dec_8_5_5736.nxml.txt.nlp	25484020	SENT233	11	11	3	3	exemestane	PAR2	PA449563	2150;55065;8856	0.818
NULL	Braz_J_Med_Biol_Res_2013_Jun_12_46(6)_546-554.nxml.txt.nlp	23780424	SENT201	35	35	10	10	cisplatin	BCL2	PA449014	596	0.818
NULL	Indian_J_Med_Res_2013_Jan_137(1)_203-209.nxml.txt.nlp	23481074	SENT23	34	34	12	12	acenocoumarol	VKORC1	PA452632	79001	0.818
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT193	11	11	6	6	adalimumab	CD36	PA10004	948	0.818
NULL	Arch_Med_Sci_2014_Aug_29_10(4)_643-650.nxml.txt.nlp	25276146	SENT21	8	8	4	4	sirolimus	DES	PA451365	1674	0.818
NULL	Diabetes_Care_2011_Jul_17_34(7)_1601-1604.nxml.txt.nlp	21709296	SENT80	15	15	7	7	rosiglitazone	DREAM	PA451283	30818	0.818
NULL	BMB_Rep_2013_Aug_46(8)_410-415.nxml.txt.nlp	23977989	SENT29	0	0	2	2	curcumin	HO-1	PA151958596	3162	0.818
NULL	Mol_Biol_Cell_2012_Nov_1_23(21)_4212-4225.nxml.txt.nlp	22956765	SENT299	8	8	14	14	thrombin	SHP2	PA451674	5781	0.818
NULL	Pharmaceutics_2012_Dec_13_4(4)_607-640.nxml.txt.nlp	24300373	SENT431	30	30	9	9	naproxen	CERT	PA450595	10087	0.818
NULL	Ann_Hematol_2011_Dec_8_90(12)_1399-1407.nxml.txt.nlp	21476016	SENT89	46	46	13	13	vincristine	CHOP	PA451879	1649	0.818
NULL	Indian_J_Pharmacol_2013_Sep-Oct_45(5)_458-463.nxml.txt.nlp	24130379	SENT94	2	2	9	9	carvedilol	Bcl-2	PA448817	596	0.818
NULL	Mol_Syst_Biol_2009_Jul_28_5_288.nxml.txt.nlp	19638969	SENT170	4	4	9	9	resveratrol	HuR		1994	0.818
NULL	EMBO_Mol_Med_2013_Mar_5_5(3)_384-396.nxml.txt.nlp	23495140	SENT104	19	19	9	9	tetracycline	HEY1	PA451640	23462	0.818
NULL	Int_J_Endocrinol_2011_Mar_6_2011_415719.nxml.txt.nlp	21461394	SENT60	4	4	12	12	cinacalcet	PTH	PA164776671	5741	0.818
NULL	BMJ_2011_Jul_26_343_d4366.nxml.txt.nlp	21791491	SENT176	1	1	12	12	potassium	ACE	PA451047	1636	0.818
NULL	Mol_Cancer_2012_Dec_12_11_91.nxml.txt.nlp	23234355	SENT18	4	4	9	9	erlotinib	EGFR	PA134687924	1956	0.818
NULL	Saudi_J_Anaesth_2013_Apr-Jun_7(2)_151-154.nxml.txt.nlp	23956714	SENT55	21	21	23	23	theophylline	NAC	PA451647	22861	0.818
NULL	J_Gastroenterol_2014_Dec_24_49(12)_1536-1547.nxml.txt.nlp	24366288	SENT131	28	28	41	41	omeprazole	CYP2C19	PA450704	1557	0.818
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1063.nxml.txt.nlp	24556678	SENT52	4	4	6	6	thioridazine	TRAIL	PA451666	8743	0.818
NULL	Cancer_Manag_Res_2012_Jul_26_4_195-205.nxml.txt.nlp	22904641	SENT12	1	1	24	24	amiloride	NHE	PA448368	285335	0.818
NULL	Curr_Control_Trials_Cardiovasc_Med_2001_May_31_2(3)_129-140.nxml.txt.nlp	11806786	SENT91	17	17	1	1	enoxaparin	NICE-4	PA449463	9898	0.818
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT304	3	3	20	20	resveratrol	AMPK		5563	0.818
NULL	Exp_Ther_Med_2013_Jan_10_5(1)_11-16.nxml.txt.nlp	23251234	SENT163	16	16	8	8	cetuximab	UST	PA10040	10090	0.818
NULL	Neural_Dev_2009_Nov_2_4_40.nxml.txt.nlp	19883498	SENT285	35	35	22	22	paraformaldehyde	E14	PA450790	4863	0.818
NULL	Oncotarget_2012_Sep_28_3(10)_1169-1181.nxml.txt.nlp	23045411	SENT91	18	18	20	20	doxorubicin	JIP1	PA449412	9479	0.818
NULL	Aging_(Albany_NY)_2009_Feb_18_1(3)_335-349.nxml.txt.nlp	20195489	SENT51	29	29	20	20	etoposide	p65	PA449552	5970	0.818
NULL	Am_J_Trop_Med_Hyg_2012_Nov_7_87(5)_783-784.nxml.txt.nlp	23136171	SENT21	5	5	14	14	artemisinin	ACT	PA165111696	12;11332;9457;641455	0.818
NULL	Clin_Ophthalmol_2010_Apr_26_4_369-374.nxml.txt.nlp	20463807	SENT65	38	38	29	29	pegaptanib	PED	PA164771236	8682	0.818
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT172	19	19	10	10	atorvastatin	TNF	PA448500	7124	0.818
NULL	Diabetes_2013_Jun_17_62(6)_2141-2150.nxml.txt.nlp	23378610	SENT213	22	22	28	28	betaine	BHMT	PA448603	635	0.818
NULL	Core_Evid_2010_Jul_27_5_1-10.nxml.txt.nlp	20694135	SENT263	21	21	5	5	levodopa	CLE	PA450213	51637	0.818
NULL	Oncotarget_2014_Nov_11_5(22)_11490-11500.nxml.txt.nlp	25359780	SENT2	12	12	5	5	docetaxel	CXCL12	PA449383	6387	0.818
NULL	Acta_Pharmacol_Sin_2009_Jul_22_30(7)_956-964.nxml.txt.nlp	19543298	SENT5	7	7	16	16	atorvastatin	ABCB1	PA448500	5243	0.818
NULL	Diabetes_2009_Dec_9_58(12)_2828-2834.nxml.txt.nlp	19741164	SENT269	8	8	16	16	glucose	SIRT1	PA449773	23411	0.818
NULL	Blood_Cancer_J_2013_Jun_7_3(6)_e120.nxml.txt.nlp	23749045	SENT156	8	8	4	4	bortezomib	IGF1R	PA10252	3480	0.818
NULL	J_Hematol_Oncol_2011_Feb_7_4_6.nxml.txt.nlp	21299849	SENT120	34	34	10	10	imatinib	RPS6	PA10804	6194	0.818
NULL	Cancer_Cell_Int_2011_Mar_10_11_6.nxml.txt.nlp	21392380	SENT40	16	16	2	2	fluorescein	HERG	PA164746009	3757	0.818
NULL	Cancer_Causes_Control_2013_Aug_18_24(8)_1605-1614.nxml.txt.nlp	23775025	SENT54	20	20	39	39	tamoxifen	UBC	PA451581	7316	0.818
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1063.nxml.txt.nlp	24556678	SENT104	7	7	35	35	thioridazine	Mcl-1	PA451666	4170	0.818
NULL	Oncotarget_2012_Nov_14_3(12)_1557-1565.nxml.txt.nlp	23238683	SENT79	1	1	11	11	ponatinib	CRKL	PA165980594	1399	0.818
NULL	Semin_Immunol_2011_Feb_23(1)_28-41.nxml.txt.nlp	21295490	SENT975	6	6	12	12	infliximab	CD4	PA452639	920	0.818
NULL	Age_(Dordr)_2011_Dec_11_33(4)_565-578.nxml.txt.nlp	21222044	SENT97	14	14	32	32	estradiol	ANOVA	PA449503	4858	0.818
NULL	Biomed_Res_Int_2013_Sep_4_2013_906912.nxml.txt.nlp	24093107	SENT165	18	18	1	1	ciprofloxacin	MICC	PA449009	100129192	0.818
NULL	Arthritis_Res_Ther_2008_Apr_16_10(2)_R43.nxml.txt.nlp	18416822	SENT227	5	5	24	24	sr144528	ERK2		5594	0.818
NULL	Arch_Med_Sci_2010_Aug_30_6(4)_505-512.nxml.txt.nlp	22371792	SENT123	31	31	19	19	ethanol	IL-6	PA448073	3569	0.818
NULL	Arch_Med_Sci_2014_Oct_27_10(5)_1007-1018.nxml.txt.nlp	25395954	SENT223	26	26	34	34	trastuzumab	Yes	PA451743	7525	0.818
NULL	Curr_Med_Chem_2012_Sep_19(26)_4399-4413.nxml.txt.nlp	22830345	SENT237	21	21	9	9	ketoconazole	CYP3A4	PA450146	1576	0.818
NULL	J_Cell_Mol_Med_2013_Nov_19_17(11)_1371-1384.nxml.txt.nlp	24251854	SENT35	4	4	19	19	palifermin	FGF7	PA164744014	2252	0.818
NULL	Cell_Death_Dis_2010_Nov_18_1(11)_e102.nxml.txt.nlp	21368867	SENT80	10	10	3	3	gentamicin	CLIMP-63	PA449753	10970	0.818
NULL	Cancer_Cell_2007_Dec_11_12(6)_514-527.nxml.txt.nlp	18068629	SENT11	12	12	7	7	paclitaxel	TGFBI	PA450761	7045	0.818
NULL	Front_Neurol_2013_Nov_6_4_176.nxml.txt.nlp	24223570	SENT183	35	35	37	37	pirenzepine	PIR	PA10159	8544	0.818
NULL	Diabetes_2011_Mar_21_60(3)_876-883.nxml.txt.nlp	21307078	SENT99	16	16	13	13	trypsin	CD31	PA451806	5175	0.818
NULL	Ther_Clin_Risk_Manag_2006_Mar_2(1)_87-98.nxml.txt.nlp	18360584	SENT221	0	0	12	12	sorafenib	CRAF	PA7000	5894	0.818
NULL	Diabetes_Care_2011_Apr_21_34(4)_e36-e42.nxml.txt.nlp	21447655	SENT203	21	21	7	7	rosiglitazone	DREAM	PA451283	30818	0.818
NULL	J_Korean_Med_Sci_2007_Oct_31_22(5)_868-872.nxml.txt.nlp	17982237	SENT50	5	5	29	29	pimecrolimus	ANOVA	PA164783790	4858	0.818
NULL	Front_Oncol_2014_Mar_25_4_54.nxml.txt.nlp	24724051	SENT325	17	17	12	12	nilotinib	BCL6	PA165958345	604	0.818
NULL	Clin_Ophthalmol_2010_Apr_26_4_369-374.nxml.txt.nlp	20463807	SENT60	20	20	31	31	bevacizumab	PED	PA130232992	8682	0.818
NULL	Breast_Cancer_Res_2005_Apr_12_7(4)_R570-R579.nxml.txt.nlp	15987464	SENT118	11	11	17	17	gefitinib	EGFR	PA131301952	1956	0.818
NULL	Hum_Genomics_2014_Sep_30_8(1)_17.nxml.txt.nlp	25265995	SENT245	6	6	18	18	estradiol	CYP19A1	PA449503	1588	0.818
NULL	J_Clin_Biochem_Nutr_2009_Jul_30_45(1)_9-13.nxml.txt.nlp	19590701	SENT4	6	6	35	35	lansoprazole	HO-1	PA450180	3162	0.818
NULL	Clin_Med_Insights_Circ_Respir_Pulm_Med_2011_Oct_18_5_57-70.nxml.txt.nlp	22084617	SENT131	7	7	2	2	salmeterol	EOS	PA451300	260429	0.818
NULL	Genome_Med_2010_Aug_11_2(8)_53.nxml.txt.nlp	20701793	SENT242	12	12	20	20	everolimus	VEGFR	PA164746311	3791	0.818
NULL	ScientificWorldJournal_2014_Nov_27_2014_837543.nxml.txt.nlp	25544963	SENT291	9	9	2	2	imatinib	MDR1	PA10804	5243	0.818
NULL	Acta_Histochem_Cytochem_2006_Dec_28_39(6)_163-172.nxml.txt.nlp	17327903	SENT44	6	6	29	29	sevoflurane	ERK	PA451341	5594	0.818
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1063.nxml.txt.nlp	24556678	SENT42	4	4	14	14	thioridazine	TRAIL	PA451666	8743	0.818
NULL	Biochem_Biophys_Res_Commun_2008_Sep_5_373(4)_584-588.nxml.txt.nlp	18586007	SENT105	11	11	5	5	curcumin	HO-1	PA151958596	3162	0.818
NULL	Acta_Pharmacol_Sin_2013_Feb_31_34(2)_231-238.nxml.txt.nlp	23274414	SENT166	14	14	11	11	amiloride	Bcl-2	PA448368	596	0.818
NULL	Breast_Cancer_Res_2011_Jun_21_13(3)_R66.nxml.txt.nlp	21693010	SENT141	0	0	10	10	sunitinib	VEGF-D	PA162372840	2277	0.818
NULL	Environ_Health_Perspect_2007_Dec_8_115(Suppl_1)_77-83.nxml.txt.nlp	18174954	SENT73	16	16	0	0	genistein	TPO	PA165109660	7066;7173	0.818
NULL	Cell_Death_Dis_2011_Apr_28_2(4)_e152.nxml.txt.nlp	21525939	SENT136	29	29	6	6	gentamicin	PBI	PA449753	27350;26952	0.818
NULL	Front_Endocrinol_(Lausanne)_2014_Oct_9_5_161.nxml.txt.nlp	25346723	SENT417	10	10	6	6	liraglutide	GLP-1	PA165958364	100125288	0.818
NULL	Environ_Health_Perspect_2005_Oct_14_113(10)_1330-1335.nxml.txt.nlp	16203242	SENT158	3	3	9	9	arsenite	MLC	PA452638	23209	0.818
NULL	Viruses_2014_Feb_13_6(2)_727-751.nxml.txt.nlp	24531333	SENT276	37	37	16	16	ampicillin	MAX	PA448419	4149	0.818
NULL	J_Mol_Psychiatry_2014_Jan_24_2(1)_1.nxml.txt.nlp	25408912	SENT246	4	4	16	16	clomipramine	Gen	PA449048	348654	0.818
NULL	Int_J_Mol_Sci_2014_Oct_20_15(10)_18840-18855.nxml.txt.nlp	25334060	SENT156	8	8	13	13	heparin	OPG	PA449855	690	0.818
NULL	Br_J_Cancer_2012_Sep_4_107(6)_956-960.nxml.txt.nlp	22892393	SENT22	0	0	12	12	lapatinib	HER2	PA152241907	2064	0.818
NULL	Crit_Care_2011_Jun_24_15(3)_R153.nxml.txt.nlp	21702944	SENT166	2	2	9	9	dexmedetomidine	TLR4	PA449256	7099	0.818
NULL	Front_Endocrinol_(Lausanne)_2014_Oct_9_5_161.nxml.txt.nlp	25346723	SENT417	8	8	12	12	exenatide	GLP-1	PA164749238	100125288	0.818
NULL	Case_Rep_Oncol_2012_Mar_17_5(1)_125-133.nxml.txt.nlp	22666200	SENT76	36	36	16	16	trastuzumab	ACT	PA451743	12;11332;9457;641455	0.818
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1063.nxml.txt.nlp	24556678	SENT74	5	5	16	16	thioridazine	Mcl-1	PA451666	4170	0.818
NULL	Clin_Pharmacokinet_2014_Sep_3_53(1)_1-16.nxml.txt.nlp	23999929	SENT284	35	35	20	20	rivaroxaban	CYP3A4	PA165958360	1576	0.818
NULL	J_Cell_Mol_Med_2013_Jan_11_17(1)_134-146.nxml.txt.nlp	23305490	SENT307	7	7	11	11	curcumin	TREK-1	PA151958596	3776	0.818
NULL	Clin_Med_Insights_Oncol_2012_Feb_28_6_125-135.nxml.txt.nlp	22408376	SENT53	10	10	0	0	panitumumab	KRAS	PA162373091	3845	0.818
NULL	Cancer_Med_2013_Aug_10_2(4)_496-506.nxml.txt.nlp	24156022	SENT260	15	15	9	9	cetuximab	EGFR	PA10040	1956	0.818
NULL	Oncotarget_2014_Mar_20_5(5)_1157-1161.nxml.txt.nlp	24727648	SENT68	12	12	6	6	imatinib	PI3K	PA10804	5290	0.818
NULL	Breast_Cancer_Res_Treat_2013_Jun_5_139(3)_649-655.nxml.txt.nlp	23736997	SENT160	10	10	15	15	tamoxifen	aromatase	PA451581	1588	0.818
NULL	Br_J_Cancer_2013_Jun_25_108(12)_2426-2432.nxml.txt.nlp	23756869	SENT47	31	31	5	5	bevacizumab	HER-2	PA130232992	2064	0.818
NULL	Front_Neuroendocrinol_2014_Aug_35(3)_370-384.nxml.txt.nlp	24607323	SENT170	18	18	20	20	estradiol	aromatase	PA449503	1588	0.818
NULL	Diabetes_Care_2010_Apr_19_33(4)_847-853.nxml.txt.nlp	20086254	SENT139	27	27	1	1	allopurinol	SP-D	PA448320	6441	0.818
NULL	J_Immunother_Cancer_2014_Nov_6_2(Suppl_3)_P77.nxml.txt.nlp	NULL	SENT6	3	3	15	15	vemurafenib	IL-2	PA165946873	3558	0.818
NULL	Acta_Pharmacol_Sin_2012_May_4_33(5)_644-651.nxml.txt.nlp	22555371	SENT20	0	0	11	11	sulodexide	eNOS	PA164746343	4846	0.818
NULL	Evid_Based_Complement_Alternat_Med_2013_Aug_12_2013_982689.nxml.txt.nlp	23997806	SENT5	21	21	7	7	tolbutamide	APE	PA451718	55704;328	0.818
NULL	Breast_Cancer_Res_2013_Nov_8_15(6)_R107.nxml.txt.nlp	24207099	SENT88	12	12	14	14	etoposide	NAC	PA449552	22861	0.818
NULL	Cell_Death_Dis_2014_Mar_13_5(3)_e1118.nxml.txt.nlp	24625977	SENT79	28	28	6	6	etoposide	UBXN2A	PA449552	165324	0.818
NULL	Ann_Rheum_Dis_2014_Jun_19_73(6)_1000-1006.nxml.txt.nlp	24553909	SENT8	1	1	10	10	ustekinumab	IL-23	PA166048654	51561	0.818
NULL	J_Vet_Med_Sci_2014_Nov_22_76(11)_1443-1450.nxml.txt.nlp	25452258	SENT55	6	6	1	1	fluorescein	CD62L	PA164746009	6402	0.818
NULL	Acta_Orthop_2010_Apr_6_81(2)_263-267.nxml.txt.nlp	20148646	SENT6	5	5	11	11	taurine	LIR	PA451590	10871	0.818
NULL	Mol_Biol_Cell_2012_Mar_15_23(6)_996-1009.nxml.txt.nlp	22278744	SENT114	5	5	30	30	forskolin	14-3-3	PA146096022	10971	0.818
NULL	Cancer_Med_2014_Oct_23_3(5)_1146-1158.nxml.txt.nlp	25052069	SENT65	4	4	0	0	ethanol	EGF	PA448073	1950	0.818
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT208	4	4	6	6	adalimumab	CD36	PA10004	948	0.818
NULL	Oncotarget_2013_Dec_18_5(2)_375-385.nxml.txt.nlp	24495868	SENT157	32	32	12	12	fludarabine	XIAP	PA449655	331	0.818
NULL	Ann_Lab_Med_2014_Sep_21_34(5)_399-401.nxml.txt.nlp	25187896	SENT42	18	18	30	30	dasatinib	ABL1	PA162372878	25	0.818
NULL	Arthritis_Res_Ther_2005_Jun_9_7(4)_145-154.nxml.txt.nlp	15987497	SENT172	17	17	8	8	methotrexate	IFN	PA450428	3439	0.818
NULL	Breast_Cancer_Res_2014_May_28_16(3)_R53.nxml.txt.nlp	24886537	SENT343	22	22	36	36	tamoxifen	VAV3	PA451581	10451	0.818
NULL	Adv_Hematol_2011_Jan_18_2011_439456.nxml.txt.nlp	21318045	SENT284	24	24	12	12	bortezomib	XIAP	PA10252	331	0.818
NULL	J_Cell_Biol_2006_Sep_25_174(7)_951-961.nxml.txt.nlp	16982803	SENT183	8	8	11	11	dextran	S13	PA449261	6207	0.818
NULL	Ann_Dermatol_2011_Aug_6_23(3)_329-337.nxml.txt.nlp	21909203	SENT81	13	13	27	27	vincristine	CHOP	PA451879	1649	0.818
NULL	Diabetes_2013_Jun_17_62(6)_1843-1854.nxml.txt.nlp	23349486	SENT22	10	10	14	14	hyaluronan	CD44	PA165958431	960	0.818
NULL	Oncotarget_2013_Jul_28_4(9)_1365-1372.nxml.txt.nlp	23965755	SENT88	15	15	6	6	doxorubicin	U87	PA449412	677775;641648	0.818
NULL	Biochem_Res_Int_2012_Jun_25_2012_518437.nxml.txt.nlp	22792465	SENT110	8	8	20	20	doxycycline	RGS5	PA449415	8490	0.818
NULL	Clin_Sci_(Lond)_2012_May_1_122(Pt_10)_473-483.nxml.txt.nlp	22150224	SENT21	0	0	11	11	exenatide	GLP-1	PA164749238	100125288	0.818
NULL	Cancers_(Basel)_2014_Apr_4_6(2)_796-812.nxml.txt.nlp	24713998	SENT165	2	2	10	10	hemin	PEX	PA449849	5251	0.818
NULL	Case_Rep_Rheumatol_2011_Dec_15_2011_185657.nxml.txt.nlp	22937439	SENT87	8	8	0	0	etanercept	TNF-alpha	PA449515	7124	0.818
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S258-S263.nxml.txt.nlp	21525465	SENT193	8	8	13	13	liraglutide	GLP-1	PA165958364	100125288	0.818
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT904	18	18	12	12	resveratrol	NMNAT1		64802	0.818
NULL	Acta_Pharmacol_Sin_2012_Jan_3_33(1)_49-56.nxml.txt.nlp	22212430	SENT12	0	0	9	9	thrombin	c-Jun	PA451674	3725	0.818
NULL	Int_J_Biol_Sci_2011_Nov_5_8(1)_1-14.nxml.txt.nlp	22211100	SENT35	2	2	12	12	evodiamine	PTEN	PA165860788	5728	0.818
NULL	J_Clin_Biochem_Nutr_2011_Jul_30_49(1)_20-24.nxml.txt.nlp	21765602	SENT98	23	23	14	14	ethanol	IL-6	PA448073	3569	0.818
NULL	Biol_Proced_Online_2003_Feb_17_5_43-52.nxml.txt.nlp	12734557	SENT139	16	16	30	30	bupivacaine	IFNA6	PA135057240	3443	0.818
NULL	Indian_J_Endocrinol_Metab_2011_Jan-Mar_15(1)_9-17.nxml.txt.nlp	21584160	SENT185	20	20	8	8	metformin	GLP-1	PA450395	100125288	0.818
NULL	Case_Rep_Oncol_2012_Aug_9_5(2)_428-433.nxml.txt.nlp	22949905	SENT71	9	9	15	15	cetuximab	KRAS	PA10040	3845	0.818
NULL	Nat_Neurosci_2013_Apr_3_16(4)_394-406.nxml.txt.nlp	23455607	SENT493	16	16	5	5	trypsin	LRRK2	PA451806	120892	0.818
NULL	J_Headache_Pain_2011_Apr_5_12(2)_127-133.nxml.txt.nlp	21298314	SENT97	37	37	4	4	amitriptyline	OTC	PA448385	5009	0.818
NULL	Front_Endocrinol_(Lausanne)_2014_Feb_25_5_22.nxml.txt.nlp	24611062	SENT260	2	2	26	26	estradiol	EGF	PA449503	1950	0.818
NULL	Clin_Ophthalmol_2009_Jun_2_3_291-295.nxml.txt.nlp	19668581	SENT109	29	29	31	31	travoprost	BAK	PA164781371	578	0.818
NULL	Arthritis_Res_Ther_2013_Nov_28_15(6)_R202.nxml.txt.nlp	24283517	SENT166	16	16	24	24	curcumin	p53	PA151958596	7157	0.818
NULL	Hum_Mol_Genet_2013_Nov_15_22(22)_4616-4626.nxml.txt.nlp	23814041	SENT123	8	8	26	26	doxycycline	neuroserpin	PA449415	5274	0.818
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT65	19	19	6	6	pemetrexed	UNG	PA10810	7374	0.818
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_39-54.nxml.txt.nlp	19305787	SENT377	7	7	17	17	ethanol	NR1	PA448073	27158	0.818
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT18	4	4	22	22	tacrolimus	SOCS3	PA451578	9021	0.818
NULL	Biomed_Res_Int_2013_Aug_6_2013_909613.nxml.txt.nlp	24027765	SENT334	36	36	45	45	metronidazole	EEN	PA450484	6455	0.818
NULL	Gene_Regul_Syst_Bio_2014_Mar_4_8_63-73.nxml.txt.nlp	24634581	SENT94	11	11	18	18	minocycline	MT1-MMP	PA450519	4323	0.818
NULL	Hum_Mol_Genet_2013_Feb_15_22(4)_795-803.nxml.txt.nlp	23175443	SENT218	33	33	16	16	heparin	FGF1	PA449855	2246	0.818
NULL	J_Biol_Chem_2009_Apr_3_284(14)_9558-9565.nxml.txt.nlp	19202191	SENT101	7	7	1	1	camptothecin	CtIP	PA153590860	5932	0.818
NULL	Exp_Ther_Med_2013_Jan_10_5(1)_11-16.nxml.txt.nlp	23251234	SENT152	18	18	0	0	cetuximab	CNTRL	PA10040	11064	0.818
NULL	Ann_Oncol_2014_Apr_10_25(4)_808-815.nxml.txt.nlp	24615500	SENT8	6	6	28	28	everolimus	aromatase	PA164746311	1588	0.818
NULL	Breast_Cancer_Res_2010_Oct_14_12(5)_R84.nxml.txt.nlp	20946630	SENT271	10	10	31	31	choline	SLC5A7	PA448976	60482	0.818
NULL	Br_J_Cancer_2013_Jun_25_108(12)_2549-2556.nxml.txt.nlp	23703247	SENT119	20	20	32	32	bevacizumab	TRG	PA130232992	6965	0.818
NULL	Curr_Pharm_Des_2008_Dec_14(34)_3637-3655.nxml.txt.nlp	19075740	SENT500	32	32	16	16	chloroquine	MPG	PA448948	4350	0.818
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Nov_4_65(Pt_12)_o2983.nxml.txt.nlp	21578723	SENT65	6	6	32	32	hydroxyurea	mol	PA449942	90527	0.818
NULL	Int_J_Environ_Res_Public_Health_2010_Feb_12_7(2)_565-582.nxml.txt.nlp	20616991	SENT171	4	4	15	15	copper	STP	PA449114	9322	0.818
NULL	Clin_Dev_Immunol_2011_Dec_22_2011_691956.nxml.txt.nlp	21234109	SENT70	13	13	24	24	ethionamide	IFN	PA164768738	3439	0.818
NULL	Pain_Ther_2012_Dec_11_1(1)_3.nxml.txt.nlp	25134932	SENT197	17	17	4	4	carrageenan	TNF-alpha	PA448814	7124	0.818
NULL	Curr_Chem_Genomics_2010_Mar_19_4_9-18.nxml.txt.nlp	20502647	SENT149	14	14	10	10	triciribine	DM1	PA165958661	338023;1760;28509	0.818
NULL	Amyloid_2014_Sep_11_21(3)_175-184.nxml.txt.nlp	24918964	SENT172	3	3	9	9	anakinra	TTR	PA10799	7276	0.818
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT455	6	6	2	2	ribavirin	CNT1	PA451241	9154	0.818
NULL	Adv_Virol_2012_May_16_2012_508967.nxml.txt.nlp	22666249	SENT225	20	20	11	11	abacavir	HLA-B	PA448004	3106	0.818
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT293	7	7	5	5	cisplatin	JNK	PA449014	5599	0.818
NULL	Mol_Cancer_2010_Jun_27_9_168.nxml.txt.nlp	20579391	SENT70	8	8	22	22	sorafenib	TEC	PA7000	7006	0.818
NULL	Indian_J_Pharm_Sci_2014_Mar-Apr_76(2)_125-131.nxml.txt.nlp	24843185	SENT172	19	19	6	6	resveratrol	spatial		219793	0.818
NULL	Exp_Ther_Med_2014_Sep_14_8(3)_836-840.nxml.txt.nlp	25120610	SENT12	3	3	30	30	fasudil	RhoA	PA165946121	387	0.818
NULL	Br_J_Cancer_2009_Oct_6_101(7)_1162-1167.nxml.txt.nlp	19724276	SENT8	21	21	23	23	axitinib	Gem	PA164924493	51053	0.818
NULL	Front_Physiol_2013_Dec_24_4_386.nxml.txt.nlp	24399968	SENT221	34	34	27	27	glibenclamide	SUR1	PA449782	6833	0.818
NULL	Comp_Hepatol_2005_Feb_8_4_2.nxml.txt.nlp	15701172	SENT150	8	8	12	12	ketoconazole	CYP3A	PA450146	1574	0.818
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_75-89.nxml.txt.nlp	17912638	SENT501	27	27	15	15	estradiol	MAF	PA449503	4094	0.818
NULL	Oncotarget_2013_Dec_18_5(2)_375-385.nxml.txt.nlp	24495868	SENT116	24	24	9	9	fludarabine	XIAP	PA449655	331	0.818
NULL	Diabetes_2013_Oct_17_62(10)_3500-3513.nxml.txt.nlp	23884882	SENT10	32	32	20	20	resveratrol	NKX6-1		4825	0.818
NULL	Endocr_Connect_2012_Jun_8_1(1)_1-12.nxml.txt.nlp	23781298	SENT188	9	9	16	16	meloxicam	adiponectin	PA450353	9370	0.818
NULL	Indian_J_Med_Res_2012_Aug_136(2)_249-259.nxml.txt.nlp	22960892	SENT30	8	8	2	2	sn-38	UGT1A1		54658	0.818
NULL	Braz_J_Microbiol_2009_Jun_1_Apr-Jun_40(2)_358-366.nxml.txt.nlp	24031373	SENT51	2	2	16	16	lipase	mol	PA450239	90527	0.818
NULL	J_Clin_Biochem_Nutr_2007_Sep_29_41(2)_84-91.nxml.txt.nlp	18193101	SENT136	3	3	14	14	lansoprazole	TNF	PA450180	7124	0.818
NULL	Brain_Sci_2013_Jun_19_3(2)_964-991.nxml.txt.nlp	24961433	SENT87	16	16	5	5	ethanol	ngn1	PA448073	4762	0.818
NULL	Br_J_Dermatol_2014_Feb_18_170(1)_342-351.nxml.txt.nlp	24547721	SENT140	46	46	5	5	pantoprazole	CLE	PA450774	51637	0.818
NULL	Cell_Death_Dis_2013_Sep_5_4(9)_e791.nxml.txt.nlp	24008735	SENT44	9	9	12	12	gemcitabine	Bcl-2	PA449748	596	0.818
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_7-17.nxml.txt.nlp	17912633	SENT376	4	4	31	31	tamoxifen	AMH	PA451581	268	0.818
NULL	Cell_Death_Dis_2013_Jan_31_4(1)_e480.nxml.txt.nlp	23370280	SENT108	8	8	3	3	doxycycline	WWOX	PA449415	51741	0.818
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Nov_20_64(Pt_12)_o2385.nxml.txt.nlp	21581356	SENT62	33	33	13	13	ethanol	mol	PA448073	90527	0.818
NULL	J_Gen_Physiol_2004_Apr_123(4)_427-439.nxml.txt.nlp	15024039	SENT486	7	7	9	9	genistein	PP2	PA165109660	4888	0.818
NULL	Cancer_Cell_Int_2004_Aug_17_4_5.nxml.txt.nlp	15315711	SENT51	0	0	14	14	genistein	PC3	PA165109660	57332;7832;5122	0.818
NULL	Cancer_Cell_Int_2004_Mar_19_4_3.nxml.txt.nlp	15035672	SENT34	10	10	3	3	etoposide	PC3	PA449552	57332;7832;5122	0.818
NULL	Biologics_2014_Apr_17_8_169-182.nxml.txt.nlp	24790410	SENT227	9	9	28	28	etanercept	ACR	PA449515	49	0.818
NULL	Biomed_Res_Int_2013_Jul_31_2013_692071.nxml.txt.nlp	23984399	SENT205	28	28	13	13	sorafenib	OCT1	PA7000	5451;6580	0.818
NULL	Cancer_Cell_Int_2011_Sep_23_11_33.nxml.txt.nlp	21943203	SENT249	4	4	14	14	trastuzumab	CD4	PA451743	920	0.818
NULL	Mol_Biol_Cell_2013_Sep_1_24(17)_2689-2702.nxml.txt.nlp	23825023	SENT94	11	11	23	23	chloroquine	ANOVA	PA448948	4858	0.818
NULL	F1000_Med_Rep_2009_Dec_9_1_93.nxml.txt.nlp	20948684	SENT87	11	11	5	5	doxycycline	LAM	PA449415	7249;7248	0.818
NULL	Chem_Senses_2008_Sep_5_33(7)_665-680.nxml.txt.nlp	18603652	SENT91	19	19	0	0	ethanol	TRPV1	PA448073	7442	0.818
NULL	Ther_Clin_Risk_Manag_2006_Sep_2(3)_235-249.nxml.txt.nlp	18360599	SENT300	7	7	3	3	alendronate	PTH	PA448082	5741	0.818
NULL	Neural_Dev_2009_Jan_16_4_3.nxml.txt.nlp	19149881	SENT59	27	27	14	14	paraformaldehyde	E12	PA450790	64100	0.818
NULL	Drugs_R_D_2010_Sep_27_10(3)_179-202.nxml.txt.nlp	20945948	SENT474	17	17	40	40	telaprevir	IFN	PA165958354	3439	0.818
NULL	Front_Genet_2015_Jan_14_5_469.nxml.txt.nlp	25642242	SENT240	38	38	25	25	paromomycin	MRPS12	PA164784023	6183	0.818
NULL	Iran_J_Pharm_Res_2014_Spring_13(2)_567-573.nxml.txt.nlp	25237352	SENT132	11	11	3	3	econazole	c-Myc	PA164746010	4609	0.818
NULL	Exp_Ther_Med_2014_Nov_11_8(5)_1660-1664.nxml.txt.nlp	25289077	SENT28	5	5	11	11	resveratrol	OTC		5009	0.818
NULL	Acta_Pharmacol_Sin_2009_Dec_4_30(12)_1585-1593.nxml.txt.nlp	19960004	SENT54	7	7	22	22	prazosin	mol	PA451093	90527	0.818
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1137-1144.nxml.txt.nlp	20234366	SENT40	29	29	12	12	cetuximab	BRAF	PA10040	673	0.818
NULL	Case_Rep_Gastroenterol_2010_Jul_26_4(2)_250-260.nxml.txt.nlp	20805952	SENT112	34	34	22	22	imatinib	KIT	PA10804	3815	0.818
NULL	ScientificWorldJournal_2012_Jun_18_2012_564939.nxml.txt.nlp	22778699	SENT70	35	35	4	4	tramadol	IL-6	PA451735	3569	0.818
NULL	Biol_Open_2013_Apr_8_2(5)_499-504.nxml.txt.nlp	23789099	SENT241	7	7	31	31	paraformaldehyde	MAP2	PA450790	4133;10988	0.818
NULL	Breast_Cancer_Res_2012_Apr_4_14(2)_R57.nxml.txt.nlp	22475046	SENT44	15	15	1	1	tamoxifen	ATAC	PA451581	6375	0.818
NULL	CNS_Drugs_2014_Jun_24_28(10)_875-886.nxml.txt.nlp	24958205	SENT146	10	10	6	6	liraglutide	GLP-1	PA165958364	100125288	0.818
NULL	Clin_Cosmet_Investig_Dermatol_2011_Jul_1_4_93-99.nxml.txt.nlp	21760744	SENT79	23	23	1	1	ustekinumab	ACR	PA166048654	49	0.818
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT250	20	20	10	10	doxorubicin	SLK	PA449412	9748;2534	0.818
NULL	Oncogenesis_2012_Apr_2_1(4)_e5.nxml.txt.nlp	23552603	SENT241	21	21	37	37	celecoxib	BIM	PA448871	10018	0.818
NULL	Acta_Pharmacol_Sin_2013_Feb_12_34(2)_255-261.nxml.txt.nlp	23147557	SENT87	24	24	13	13	pioglitazone	PTPRD	PA450970	5789	0.818
NULL	J_Thorac_Oncol_2014_Jun_30_9(6)_805-811.nxml.txt.nlp	24787964	SENT146	22	22	35	35	carboplatin	EGFR	PA448803	1956	0.817
NULL	Evid_Based_Complement_Alternat_Med_2014_Sep_3_2014_809083.nxml.txt.nlp	25276218	SENT164	9	9	23	23	berberine	IL-6	PA165860812	3569	0.817
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT57	18	18	5	5	vinblastine	MVP	PA451877	9961	0.817
NULL	Open_Access_J_Urol_2011_May_10_3_69-82.nxml.txt.nlp	24198638	SENT66	7	7	5	5	bupropion	CYP2B6	PA448687	1555	0.817
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT197	11	11	6	6	adalimumab	CD36	PA10004	948	0.817
NULL	Allergy_Asthma_Clin_Immunol_2012_Nov_2_8(Suppl_1)_A3.nxml.txt.nlp	NULL	SENT10	6	6	11	11	cetirizine	SPT	PA448905	189	0.817
NULL	Oncol_Rep_2013_Apr_23_29(4)_1268-1274.nxml.txt.nlp	23354756	SENT160	11	11	6	6	paclitaxel	SLC25A43	PA450761	203427	0.817
NULL	Iran_J_Basic_Med_Sci_2013_Jun_16(6)_772-780.nxml.txt.nlp	23997903	SENT51	31	31	15	15	metformin	B12	PA450395	7126;4709	0.817
NULL	J_Thyroid_Res_2011_Apr_11_2011_413026.nxml.txt.nlp	21603170	SENT98	11	11	3	3	hydrocortisone	ACTH	PA449905	5443	0.817
NULL	Cardiovasc_Diabetol_2013_Jun_18_12_90.nxml.txt.nlp	23777457	SENT96	16	16	25	25	sitagliptin	GLP-1	PA164748978	100125288	0.817
NULL	Acta_Pharmacol_Sin_2010_Oct_27_31(10)_1389-1394.nxml.txt.nlp	20871620	SENT149	11	11	15	15	carbachol	JNK	PA448784	5599	0.817
NULL	Arch_Med_Sci_2012_Sep_8_8(4)_589-597.nxml.txt.nlp	23056066	SENT87	20	20	30	30	zileuton	BDP	PA451955	10620;152926	0.817
NULL	Ann_Oncol_2011_Jun_25_22(6)_1392-1403.nxml.txt.nlp	21266519	SENT238	4	4	42	42	idarubicin	VIII	PA449961	1351	0.817
NULL	Biomed_Res_Int_2014_Feb_23_2014_297808.nxml.txt.nlp	24707480	SENT154	8	8	23	23	ofloxacin	HA-2	PA450684	64005	0.817
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S349-S354.nxml.txt.nlp	21525481	SENT116	14	14	25	25	exenatide	GLP-1	PA164749238	100125288	0.817
NULL	Mol_Cancer_2007_Sep_26_6_61.nxml.txt.nlp	17894897	SENT122	23	23	13	13	etoposide	p53	PA449552	7157	0.817
NULL	Mol_Biol_Cell_2012_Nov_1_23(21)_4203-4211.nxml.txt.nlp	22933573	SENT53	32	32	16	16	galactose	DIA2	PA449725	1730	0.817
NULL	Oncogenesis_2014_May_12_3(5)_e102.nxml.txt.nlp	24819061	SENT98	45	45	21	21	nadh	SIRT1	PA164755085	23411	0.817
NULL	Mol_Cancer_2013_Sep_11_12_104.nxml.txt.nlp	24025152	SENT53	3	3	11	11	gemcitabine	STAT3	PA449748	6774	0.817
NULL	AAPS_J_2012_Dec_7_15(2)_308-315.nxml.txt.nlp	23224752	SENT194	7	7	18	18	atazanavir	OATP1B1	PA10251	10599	0.817
NULL	Int_J_Biol_Sci_2013_Mar_7_9(3)_279-288.nxml.txt.nlp	23493630	SENT172	10	10	15	15	tocilizumab	IL-17	PA165292659	3605	0.817
NULL	Contemp_Oncol_(Pozn)_2012_Nov_20_16(5)_363-370.nxml.txt.nlp	23788912	SENT60	0	0	5	5	sorafenib	BRAF	PA7000	673	0.817
NULL	Patient_Prefer_Adherence_2009_Nov_3_3_173-177.nxml.txt.nlp	19936159	SENT73	36	36	34	34	amiodarone	CLCR	PA448383	11330	0.817
NULL	Cancer_Biol_Med_2012_Sep_9(3)_202-204.nxml.txt.nlp	23691480	SENT43	9	9	3	3	vincristine	CHOP	PA451879	1649	0.817
NULL	Korean_Circ_J_2013_Oct_30_43(10)_699-701.nxml.txt.nlp	24255655	SENT5	2	2	8	8	amiodarone	APT	PA448383	653639	0.817
NULL	Pharmaceutics_2011_Nov_18_3(4)_865-913.nxml.txt.nlp	24309312	SENT2010	8	8	5	5	clarithromycin	CYP3A	PA449028	1574	0.817
NULL	Nat_Commun_2014_Dec_10_5_5715.nxml.txt.nlp	25493654	SENT443	0	0	2	2	fluvastatin	FLT3	PA449688	2322	0.817
NULL	Pharmaceuticals_(Basel)_2013_Nov_4_6(11)_1347-1360.nxml.txt.nlp	24287461	SENT77	14	14	24	24	losartan	URAT1	PA450268	116085	0.817
NULL	Arch_Med_Sci_2010_Dec_29_6(6)_964-970.nxml.txt.nlp	22427774	SENT166	19	19	5	5	methotrexate	IL-18	PA450428	3606	0.817
NULL	Ann_Clin_Transl_Neurol_2014_Dec_3_1(12)_1024-1035.nxml.txt.nlp	25574476	SENT189	10	10	24	24	staurosporine	ANOVA	PA165109623	4858	0.817
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT1699	3	3	19	19	fosamprenavir	ATV	PA10084	4683	0.817
NULL	Kidney_Int_Suppl_(2011)_2013_Dec_27_3(5)_436-441.nxml.txt.nlp	25019026	SENT131	9	9	21	21	cinacalcet	PTH	PA164776671	5741	0.817
NULL	Oncotarget_2011_May_13_2(5)_401-406.nxml.txt.nlp	21576761	SENT82	19	19	16	16	trastuzumab	HER2	PA451743	2064	0.817
NULL	Oxid_Med_Cell_Longev_2012_Aug_23_2012_139327.nxml.txt.nlp	22966413	SENT152	12	12	18	18	doxorubicin	METL	PA449412	55798	0.817
NULL	J_Hum_Genet_2013_Jun_2_58(6)_306-312.nxml.txt.nlp	23635953	SENT188	17	17	10	10	tamoxifen	CYP2D6	PA451581	1565	0.817
NULL	Cancers_(Basel)_2014_Oct_21_6(4)_2137-2154.nxml.txt.nlp	25337831	SENT23	28	28	19	19	gemcitabine	EGFR	PA449748	1956	0.817
NULL	Ann_Hematol_2011_Dec_8_90(12)_1399-1407.nxml.txt.nlp	21476016	SENT89	15	15	13	13	cyclophosphamide	CHOP	PA449165	1649	0.817
NULL	Cancer_Cell_Int_2014_Jul_2_14_59.nxml.txt.nlp	25120382	SENT21	11	11	39	39	metformin	TIC	PA450395	23550	0.817
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT275	3	3	9	9	resveratrol	ROS		6098	0.817
NULL	Front_Immunol_2011_Aug_29_2_38.nxml.txt.nlp	22566828	SENT32	33	33	31	31	daclizumab	alpha-chain	PA164764446	2217	0.817
NULL	Cancer_Microenviron_2009_Sep_26_2(Suppl_1)_19-204.nxml.txt.nlp	NULL	SENT703	18	18	36	36	etoposide	Bcl-2	PA449552	596	0.817
NULL	Oncotarget_2013_Nov_15_5(6)_1458-1474.nxml.txt.nlp	24681547	SENT6	4	4	18	18	celecoxib	CDH11	PA448871	1009	0.817
NULL	Lipids_Health_Dis_2011_Jan_18_10_8.nxml.txt.nlp	21241519	SENT33	7	7	26	26	simvastatin	ABCG5	PA451363	64240	0.817
NULL	Clin_Infect_Dis_2013_May_1_56(9)_1330-1339.nxml.txt.nlp	23362284	SENT95	16	16	9	9	nevirapine	HLA-DQB1	PA450616	3119	0.817
NULL	J_Thromb_Haemost_2010_Mar_8(3)_577-587.nxml.txt.nlp	20040043	SENT146	10	10	32	32	rosiglitazone	mol	PA451283	90527	0.817
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_24_2012_673132.nxml.txt.nlp	23133498	SENT125	16	16	18	18	carbamazepine	CYP3A	PA448785	1574	0.817
NULL	J_Oncol_2012_Jun_4_2012_928127.nxml.txt.nlp	22701483	SENT107	8	8	22	22	metformin	p53	PA450395	7157	0.817
NULL	Exp_Ther_Med_2014_Mar_10_7(3)_640-648.nxml.txt.nlp	24520260	SENT49	13	13	35	35	resveratrol	PI3K		5290	0.817
NULL	Pharmaceutics_2011_Nov_18_3(4)_865-913.nxml.txt.nlp	24309312	SENT1995	2	2	7	7	clarithromycin	CYP2C19	PA449028	1557	0.817
NULL	Hum_Genomics_2009_Jan_1_3(2)_169-190.nxml.txt.nlp	19164093	SENT133	27	27	13	13	warfarin	CYP2C9	PA451906	1559	0.817
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT31	5	5	7	7	erlotinib	CYP3A	PA134687924	1574	0.817
NULL	Front_Neurosci_2012_May_30_6_77.nxml.txt.nlp	22661925	SENT203	31	31	12	12	ethanol	DCX	PA448073	1641	0.817
NULL	Drugs_2014_Oct_25_74(17)_1993-2013.nxml.txt.nlp	25344022	SENT535	11	11	4	4	rituximab	PD1	PA451261	9825;6622;5133	0.817
NULL	Ann_Hematol_2011_Dec_8_90(12)_1399-1407.nxml.txt.nlp	21476016	SENT89	38	38	13	13	methotrexate	CHOP	PA450428	1649	0.817
NULL	Mediators_Inflamm_2010_Jun_21_2010_592760.nxml.txt.nlp	20652060	SENT165	13	13	7	7	sitagliptin	HIP	PA164748978	6767;6159;64399;5068	0.817
NULL	Acta_Pharmacol_Sin_2009_Oct_21_30(10)_1392-1398.nxml.txt.nlp	19767766	SENT140	9	9	14	14	atorvastatin	p38	PA448500	10598;1432;7965	0.817
NULL	Clin_Pharmacol_2010_Sep_6_2_155-162.nxml.txt.nlp	22291500	SENT63	13	13	4	4	clopidogrel	CYP2C19	PA449053	1557	0.817
NULL	Int_J_Mol_Sci_2014_Oct_6_15(10)_17886-17900.nxml.txt.nlp	25290095	SENT166	0	0	12	12	resveratrol	p38		10598;1432;7965	0.817
NULL	Case_Rep_Transplant_2014_Jan_2_2014_548243.nxml.txt.nlp	24575309	SENT12	11	11	28	28	sirolimus	CYP3A4	PA451365	1576	0.817
NULL	Breast_Cancer_(Auckl)_2009_Sep_2_3_61-75.nxml.txt.nlp	19809577	SENT145	16	16	12	12	curcumin	BRCA1	PA151958596	672	0.817
NULL	Front_Oncol_2012_Oct_31_2_157.nxml.txt.nlp	23120745	SENT18	41	41	29	29	temozolomide	p53	PA451609	7157	0.817
NULL	Curr_Oncol_2009_Jul_16(Suppl_2)_S14-S23.nxml.txt.nlp	19672417	SENT140	25	25	9	9	tamoxifen	ATAC	PA451581	6375	0.817
NULL	Clin_Transl_Allergy_2014_Feb_28_4(Suppl_1)_P35.nxml.txt.nlp	25045492	SENT16	27	27	5	5	atorvastatin	IFN	PA448500	3439	0.817
NULL	Oxid_Med_Cell_Longev_2012_May_28_2012_386527.nxml.txt.nlp	22690271	SENT151	14	14	25	25	resveratrol	SIRT1		23411	0.817
NULL	Arthritis_Res_Ther_2003_Apr_28_5(4)_R186-R192.nxml.txt.nlp	12823853	SENT100	18	18	34	34	genistein	TSG-6	PA165109660	7130	0.817
NULL	Cancer_Metab_2013_Jul_24_1_16.nxml.txt.nlp	24280319	SENT250	20	20	15	15	nadh	ADP	PA164755085	23038	0.817
NULL	Mol_Cancer_2012_Aug_8_11_53.nxml.txt.nlp	22871047	SENT296	12	12	30	30	cisplatin	HIN-1	PA449014	92304	0.817
NULL	Inflammation_2014_Apr_6_37(5)_1476-1485.nxml.txt.nlp	24706026	SENT135	0	0	11	11	curcumin	GATA3	PA151958596	2625	0.817
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT52	5	5	26	26	ritonavir	CYP3A4	PA451260	1576	0.817
NULL	Pharmaceuticals_(Basel)_2013_Aug_21_6(8)_988-1038.nxml.txt.nlp	24276379	SENT486	13	13	16	16	vemurafenib	EGFR	PA165946873	1956	0.817
NULL	Oncol_Lett_2015_Jan_4_9(1)_91-95.nxml.txt.nlp	25435939	SENT82	13	13	11	11	cisplatin	NACT	PA449014	284111	0.817
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1717-1723.nxml.txt.nlp	19844230	SENT133	20	20	13	13	sunitinib	GM-CSF	PA162372840	1437	0.817
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_105-115.nxml.txt.nlp	17912640	SENT44	29	29	25	25	tamoxifen	HER2	PA451581	2064	0.817
NULL	Iran_J_Basic_Med_Sci_2012_Jan-Feb_15(1)_669-677.nxml.txt.nlp	23493035	SENT209	25	25	5	5	paclitaxel	aromatase	PA450761	1588	0.817
NULL	FEBS_Open_Bio_2013_Dec_30_4_96-104.nxml.txt.nlp	24490130	SENT76	0	0	20	20	cisplatin	BRCA1	PA449014	672	0.817
NULL	J_Biomed_Sci_2014_Apr_17_21(1)_30.nxml.txt.nlp	24742230	SENT164	7	7	13	13	lovastatin	OPG	PA450272	690	0.817
NULL	Allergy_Asthma_Clin_Immunol_2010_Mar_17_6(1)_5.nxml.txt.nlp	20236545	SENT84	28	28	7	7	cyclosporine	IL-13	PA449167	3596	0.817
NULL	Br_J_Pharmacol_2014_May_171(10)_2659-2670.nxml.txt.nlp	24116661	SENT185	0	0	5	5	naringenin	TRPP2	PA151958361	5311	0.817
NULL	Cancer_Immunol_Immunother_2012_Jul_23_61(7)_1101-1111.nxml.txt.nlp	22193989	SENT202	15	15	5	5	oxaliplatin	STAT6	PA131285527	6778	0.817
NULL	Oxid_Med_Cell_Longev_2013_Jun_2_2013_793525.nxml.txt.nlp	23819014	SENT133	35	35	6	6	resveratrol	AMPK		5563	0.817
NULL	Indian_J_Med_Res_2011_Sep_134(3)_295-301.nxml.txt.nlp	21985811	SENT29	11	11	7	7	phenytoin	CYP2C9	PA450947	1559	0.817
NULL	Biomed_Res_Int_2013_Dec_19_2013_817279.nxml.txt.nlp	24455727	SENT126	14	14	29	29	paclitaxel	EGFR	PA450761	1956	0.817
NULL	Front_Oncol_2014_Sep_23_4_263.nxml.txt.nlp	25295230	SENT407	5	5	14	14	plerixafor	FLT3	PA165958410	2322	0.817
NULL	eLife_2014_Apr_15_3_e01694.nxml.txt.nlp	24737860	SENT272	20	20	37	37	doxycycline	ATF4	PA449415	468	0.817
NULL	Biomed_Res_Int_2014_Jun_25_2014_203693.nxml.txt.nlp	25089265	SENT205	32	32	21	21	sunitinib	ASK1	PA162372840	4217	0.817
NULL	J_Clin_Biochem_Nutr_2007_Jul_27_41(1)_32-42.nxml.txt.nlp	18392098	SENT146	38	38	24	24	curcumin	ROS	PA151958596	6098	0.817
NULL	Indian_J_Nucl_Med_2014_Apr-Jun_29(2)_65-73.nxml.txt.nlp	24761056	SENT85	3	3	27	27	erlotinib	FDG	PA134687924	23583	0.817
NULL	Br_J_Cancer_2004_May_17_90(10)_2032-2041.nxml.txt.nlp	15138490	SENT113	34	34	9	9	trastuzumab	HER-2	PA451743	2064	0.817
NULL	Curr_Opin_Endocrinol_Diabetes_Obes_2014_Oct_28_21(5)_394-404.nxml.txt.nlp	25122493	SENT101	22	22	5	5	thyroglobulin	RAI	PA164754910	10848;6050	0.817
NULL	Int_J_Biol_Sci_2014_Jun_10_10(7)_654-663.nxml.txt.nlp	25013375	SENT217	7	7	25	25	nelfinavir	HER2	PA450606	2064	0.817
NULL	Br_J_Cancer_1999_Mar_79(7-8)_1067-1073.nxml.txt.nlp	10098738	SENT3	20	20	7	7	doxorubicin	IL-2	PA449412	3558	0.817
NULL	Eur_Biophys_J_2008_Apr_9_37(4)_509-514.nxml.txt.nlp	17687549	SENT57	31	31	17	17	l-glutamine	CO2	PA10090	4513	0.817
NULL	Acta_Pharmacol_Sin_2014_Jun_4_35(6)_792-805.nxml.txt.nlp	24902787	SENT288	15	15	6	6	pravastatin	STZ	PA451089	6484	0.817
NULL	F1000Res_2013_Mar_5_2_74.nxml.txt.nlp	24358880	SENT33	3	3	19	19	capsaicin	TRPV1	PA448776	7442	0.817
NULL	Cardiovasc_Diabetol_2010_Oct_18_9_64.nxml.txt.nlp	20955583	SENT124	6	6	1	1	telmisartan	PPARgamma	PA451605	5468	0.817
NULL	Nucleic_Acids_Res_2011_Dec_31_39(22)_9536-9548.nxml.txt.nlp	21880590	SENT165	22	22	18	18	etoposide	BRCA1	PA449552	672	0.817
NULL	J_Invest_Dermatol_2012_Nov_21_132(11)_2642-2651.nxml.txt.nlp	22718118	SENT201	6	6	4	4	imiquimod	TLR7	PA449972	51284	0.817
NULL	Sci_Rep_2014_Sep_9_4_6307.nxml.txt.nlp	25200751	SENT331	0	0	10	10	febuxostat	MCP-1	PA165958521	6347	0.817
NULL	Cancers_(Basel)_2012_Oct_29_4(4)_1146-1160.nxml.txt.nlp	24213502	SENT465	28	28	24	24	tamoxifen	ATAC	PA451581	6375	0.817
NULL	Anticancer_Agents_Med_Chem_2012_Feb_12(2)_163-171.nxml.txt.nlp	22043994	SENT330	11	11	0	0	cetuximab	BRAF	PA10040	673	0.817
NULL	Adv_Hematol_2012_Mar_8_2012_856341.nxml.txt.nlp	22496694	SENT212	8	8	13	13	enoxaparin	TKR	PA449463	8277	0.817
NULL	Trials_2014_May_1_15_151.nxml.txt.nlp	24885437	SENT6	5	5	12	12	ticagrelor	P2Y12	PA165374673	64805	0.817
NULL	J_Biomed_Sci_2013_Mar_15_20(1)_17.nxml.txt.nlp	23497194	SENT142	3	3	7	7	indomethacin	COX	PA449982	1351	0.817
NULL	J_Cardiovasc_Magn_Reson_2009_Dec_15_11(1)_53.nxml.txt.nlp	20003520	SENT351	29	29	0	0	pravastatin	ATV	PA451089	4683	0.817
NULL	Breast_Cancer_Res_2004_Aug_5_6(5)_R601-R607.nxml.txt.nlp	15318941	SENT122	30	30	8	8	cisplatin	p27	PA449014	5715;10534	0.817
NULL	J_Mol_Med_2011_Jul_23_89(7)_667-676.nxml.txt.nlp	21431325	SENT59	27	27	14	14	curcumin	adiponectin	PA151958596	9370	0.817
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT195	4	4	7	7	nilotinib	ABCB1	PA165958345	5243	0.817
NULL	Front_Cell_Neurosci_2014_Jul_18_8_185.nxml.txt.nlp	25100946	SENT225	6	6	8	8	pp2	Isl-1		3670	0.817
NULL	Arthritis_Res_Ther_2013_Apr_17_15(2)_R51.nxml.txt.nlp	23594962	SENT282	6	6	13	13	muraglitazar	STAT1	PA162356187	6772	0.817
NULL	Braz_J_Med_Biol_Res_2014_Feb_17_47(2)_101-109.nxml.txt.nlp	24519125	SENT136	15	15	5	5	isoproterenol	IL-6	PA450121	3569	0.817
NULL	Br_J_Cancer_2013_Mar_5_108(4)_983-992.nxml.txt.nlp	23361057	SENT107	18	18	22	22	cytarabine	MLH1	PA449177	4292	0.817
NULL	J_Headache_Pain_2009_Apr_27_10(2)_105-110.nxml.txt.nlp	19172228	SENT146	6	6	8	8	dihydroergotamine	c-fos	PA164743028	2353	0.817
NULL	Breast_Cancer_Res_2012_Aug_31_14(4)_212.nxml.txt.nlp	22963717	SENT86	21	21	2	2	tamoxifen	AIB1	PA451581	8202	0.817
NULL	Breast_Cancer_Res_2009_Oct_29_11(5)_R77.nxml.txt.nlp	19874578	SENT233	20	20	33	33	trastuzumab	CDK4	PA451743	1019	0.817
NULL	Arthritis_Res_Ther_2012_May_1_14(3)_R102.nxml.txt.nlp	22548780	SENT112	23	23	2	2	pioglitazone	adiponectin	PA450970	9370	0.817
NULL	Int_J_Med_Sci_2013_Mar_1_10(4)_427-433.nxml.txt.nlp	23471472	SENT33	25	25	27	27	lamivudine	LAM	PA450163	7249;7248	0.817
NULL	Endocr_Relat_Cancer_2014_Apr_21(2)_311-326.nxml.txt.nlp	24478054	SENT141	24	24	17	17	denosumab	OPG	PA166048634	690	0.817
NULL	Acta_Pharmacol_Sin_2010_Feb_5_31(2)_137-144.nxml.txt.nlp	20139896	SENT117	26	26	29	29	zileuton	5-LOX	PA451955	240	0.817
NULL	Ann_Oncol_2011_Aug_27_22(8)_1736-1747.nxml.txt.nlp	21709140	SENT189	10	10	19	19	trastuzumab	HER2	PA451743	2064	0.817
NULL	J_Korean_Med_Sci_2010_May_22_25(5)_766-771.nxml.txt.nlp	20436715	SENT151	13	13	8	8	tacrolimus	IL-4	PA451578	3565	0.817
NULL	Exp_Anim_2014_Apr_26_63(2)_257-267.nxml.txt.nlp	24770651	SENT214	21	21	13	13	olmesartan	ACE	PA164742950	1636	0.817
NULL	Br_J_Cancer_2006_Dec_4_95(11)_1483-1489.nxml.txt.nlp	17106442	SENT4	12	12	27	27	gefitinib	EGFR	PA131301952	1956	0.817
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT118	11	11	6	6	adalimumab	CD36	PA10004	948	0.817
NULL	Br_J_Cancer_2003_Mar_24_88(6)_910-917.nxml.txt.nlp	12644829	SENT92	29	29	34	34	doxycycline	TRAIL	PA449415	8743	0.817
NULL	Crit_Care_2008_Aug_9_12(4)_R103.nxml.txt.nlp	18691424	SENT31	31	31	10	10	bleomycin	IP-10	PA448645	3627	0.817
NULL	Crit_Care_2010_Jul_9_14(4)_R131.nxml.txt.nlp	20615266	SENT55	7	7	35	35	aprotinin	ACTH	PA448472	5443	0.817
NULL	Mol_Pain_2014_Feb_6_10_10.nxml.txt.nlp	24499354	SENT358	11	11	3	3	paraformaldehyde	CD68	PA450790	968	0.817
NULL	Oncogenesis_2014_Sep_22_3(9)_e119.nxml.txt.nlp	25244493	SENT190	20	20	10	10	paraformaldehyde	CO2	PA450790	4513	0.817
NULL	Gene_Regul_Syst_Bio_2014_Mar_4_8_63-73.nxml.txt.nlp	24634581	SENT94	11	11	28	28	minocycline	STAT3	PA450519	6774	0.817
NULL	Arthritis_Res_Ther_2013_May_29_15(3)_R64.nxml.txt.nlp	23718630	SENT186	2	2	4	4	canakinumab	S100A12	PA165958358	6283	0.817
NULL	Arthritis_Res_Ther_2008_Oct_15_10(Suppl_1)_S5.nxml.txt.nlp	19007425	SENT129	6	6	8	8	abatacept	ACR	PA164747080	49	0.817
NULL	Hum_Genomics_Proteomics_2010_Sep_13_2010_754919.nxml.txt.nlp	20981234	SENT94	38	38	16	16	acenocoumarol	CYP2C9	PA452632	1559	0.817
NULL	Br_J_Clin_Pharmacol_2014_Sep_20_78(3)_509-523.nxml.txt.nlp	25279405	SENT34	12	12	18	18	tacrolimus	6-16	PA451578	2537	0.817
NULL	Enzyme_Res_2010_Jun_28_2010_734182.nxml.txt.nlp	21048869	SENT70	9	9	23	23	oxygen	COD	PA450744	6628	0.817
NULL	Cancer_Med_2013_Jun_23_2(3)_296-304.nxml.txt.nlp	23930206	SENT183	33	33	10	10	erlotinib	HER2	PA134687924	2064	0.817
NULL	Endocr_Relat_Cancer_2014_Jun_21(3)_R209-R225.nxml.txt.nlp	24500760	SENT62	30	30	17	17	resveratrol	IGF1		3479	0.817
NULL	Iran_J_Pharm_Res_2013_Summer_12(3)_445-455.nxml.txt.nlp	24250651	SENT45	10	10	39	39	l-glutamine	CO2	PA10090	4513	0.817
NULL	Mucosal_Immunol_2013_Nov_10_6(6)_1179-1190.nxml.txt.nlp	23571504	SENT427	23	23	14	14	auranofin	GRX	PA448510	2745	0.817
NULL	Biomed_Res_Int_2014_May_12_2014_247054.nxml.txt.nlp	24900958	SENT112	8	8	14	14	indomethacin	COX	PA449982	1351	0.817
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Dec_17_3(12)_e152.nxml.txt.nlp	25518025	SENT31	20	20	22	22	oxymorphone	CYP2D6	PA450748	1565	0.817
NULL	EPMA_J_2012_Sep_27_3(1)_10.nxml.txt.nlp	23016735	SENT234	30	30	12	12	warfarin	CYP2C9	PA451906	1559	0.817
NULL	J_Vis_Exp_2010_Jul_2_(41)_2034.nxml.txt.nlp	20644507	SENT18	16	16	12	12	doxycycline	IGF2BP1	PA449415	10642	0.817
NULL	Pharm_Methods_2011_Jul-Sep_2(3)_203-208.nxml.txt.nlp	23781457	SENT96	16	16	10	10	mannitol	PTH	PA450320	5741	0.817
NULL	Support_Care_Cancer_2010_May_27_18(5)_529-541.nxml.txt.nlp	20191292	SENT105	19	19	17	17	sargramostim	GM-CSF	PA164748631	1437	0.817
NULL	Lab_Invest_2011_Apr_14_91(4)_598-608.nxml.txt.nlp	21321535	SENT132	19	19	21	21	sorafenib	CD11b	PA7000	3684	0.817
NULL	Breast_Cancer_Res_2004_Sep_27_6(6)_246-254.nxml.txt.nlp	15535854	SENT121	18	18	28	28	tamoxifen	UGT1A1	PA451581	54658	0.817
NULL	Acta_Pharmacol_Sin_2012_May_16_33(5)_682-690.nxml.txt.nlp	22504904	SENT191	0	0	23	23	celecoxib	IL-6	PA448871	3569	0.817
NULL	Open_Ophthalmol_J_2010_Jun_22_4_28-29.nxml.txt.nlp	20871754	SENT18	29	29	20	20	ranibizumab	San	PA164746012	80218	0.817
NULL	Curr_Control_Trials_Cardiovasc_Med_2001_May_31_2(3)_129-140.nxml.txt.nlp	11806786	SENT89	20	20	26	26	enoxaparin	NICE-4	PA449463	9898	0.817
NULL	J_Young_Pharm_2010_Jul-Sep_2(3)_326-331.nxml.txt.nlp	21042495	SENT127	31	31	28	28	pravastatin	CYP2C9	PA451089	1559	0.817
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1542-1553.nxml.txt.nlp	21970874	SENT236	18	18	8	8	carboplatin	EGFR	PA448803	1956	0.817
NULL	Biomed_Res_Int_2013_Dec_31_2013_273498.nxml.txt.nlp	23484100	SENT182	9	9	34	34	genistein	OTC	PA165109660	5009	0.817
NULL	Orphanet_J_Rare_Dis_2014_Sep_2_9(1)_130.nxml.txt.nlp	NULL	SENT254	20	20	1	1	hydroxocobalamin	B12	PA164768689	7126;4709	0.817
NULL	Br_J_Cancer_2013_Mar_5_108(4)_983-992.nxml.txt.nlp	23361057	SENT262	13	13	11	11	cytarabine	NAC	PA449177	22861	0.817
NULL	Arthritis_Res_Ther_2013_Feb_20_15(1)_R31.nxml.txt.nlp	23421940	SENT16	19	19	12	12	nitroprusside	IL-17	PA451406	3605	0.817
NULL	Int_J_Med_Sci_2012_Dec_28_10(2)_110-118.nxml.txt.nlp	23329881	SENT54	9	9	13	13	docetaxel	NACT	PA449383	284111	0.817
NULL	Kidney_Int_Suppl_(2011)_2013_Dec_27_3(5)_451-456.nxml.txt.nlp	25019029	SENT76	11	11	5	5	cinacalcet	PTH	PA164776671	5741	0.817
NULL	Diabetes_2013_Nov_18_62(11)_3751-3759.nxml.txt.nlp	23897951	SENT166	7	7	28	28	rosiglitazone	FGF21	PA451283	26291	0.817
NULL	Br_J_Cancer_2010_Sep_28_103(7)_987-992.nxml.txt.nlp	20823884	SENT166	35	35	41	41	carbamazepine	CYP3A4	PA448785	1576	0.817
NULL	Neuro_Oncol_2010_Apr_27_12(4)_389-400.nxml.txt.nlp	20308316	SENT133	14	14	10	10	chloroquine	p53	PA448948	7157	0.817
NULL	Cell_Commun_Signal_2012_Dec_20_10_43.nxml.txt.nlp	23253402	SENT549	15	15	17	17	rituximab	CHOP	PA451261	1649	0.817
NULL	Leukemia_2013_Jan_11_27(1)_32-40.nxml.txt.nlp	22781593	SENT158	0	0	10	10	ponatinib	CD34	PA165980594	947	0.817
NULL	Diabetol_Metab_Syndr_2014_May_18_6_56.nxml.txt.nlp	24860622	SENT167	43	43	21	21	atorvastatin	adiponectin	PA448500	9370	0.817
NULL	J_Asthma_Allergy_2010_Jul_28_3_75-86.nxml.txt.nlp	21437042	SENT111	1	1	21	21	methacholine	San	PA165958382	80218	0.817
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT244	4	4	19	19	perifosine	JNK	PA165291471	5599	0.817
NULL	Daru_2011_19(6)_455-461.nxml.txt.nlp	23008692	SENT149	8	8	27	27	mitoxantrone	survivin	PA450526	332	0.817
NULL	Cardiovasc_Diabetol_2006_Sep_26_5_20.nxml.txt.nlp	17002798	SENT30	13	13	7	7	gemfibrozil	HHS	PA449750	2591	0.817
NULL	Front_Endocrinol_(Lausanne)_2014_Nov_28_5_201.nxml.txt.nlp	25506340	SENT522	21	21	10	10	acamprosate	GATA4	PA10344	2626	0.817
NULL	Biochemistry_2011_May_3_50(17)_3408-3410.nxml.txt.nlp	21425834	SENT52	5	5	22	22	nadh	VDAC2	PA164755085	7417	0.817
NULL	Neuropsychopharmacology_2009_Jul_11_34(8)_1946-1957.nxml.txt.nlp	19279569	SENT11	36	36	10	10	cocaine	DOR	PA449072	58476	0.817
NULL	Mol_Cancer_2012_Mar_21_11_13.nxml.txt.nlp	22436134	SENT96	9	9	2	2	doxorubicin	HuR	PA449412	1994	0.817
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT145	7	7	2	2	sulindac	survivin	PA451565	332	0.817
NULL	Br_J_Anaesth_2014_Jul_22_113(1)_157-167.nxml.txt.nlp	24154701	SENT225	10	10	2	2	sevoflurane	TREK-1	PA451341	3776	0.817
NULL	Oncol_Lett_2014_Jul_12_8(1)_223-229.nxml.txt.nlp	24959250	SENT95	2	2	13	13	captopril	NEFA	PA448780	4925	0.817
NULL	Br_J_Cancer_2010_Feb_2_102(3)_520-529.nxml.txt.nlp	20029417	SENT34	16	16	7	7	trastuzumab	IL-21	PA451743	59067;50616;27189	0.817
NULL	Nucleic_Acids_Res_2014_Jan_2_42(Database_issue)_D178-D183.nxml.txt.nlp	24302579	SENT142	5	5	17	17	imatinib	GATA2	PA10804	2624	0.817
NULL	Blood_Res_2014_Mar_24_49(1)_15-21.nxml.txt.nlp	24724062	SENT165	33	33	22	22	cyclophosphamide	CHOP	PA449165	1649	0.817
NULL	Clinics_(Sao_Paulo)_2012_Feb_67(2)_157-162.nxml.txt.nlp	22358241	SENT108	13	13	3	3	hydroxychloroquine	IFN	PA164777036	3439	0.817
NULL	Support_Care_Cancer_2011_Oct_12_19(10)_1609-1617.nxml.txt.nlp	20835873	SENT93	24	24	2	2	cisplatin	FAS	PA449014	355;2194	0.817
NULL	Ann_Surg_Oncol_2010_Apr_20_17(4)_1168-1176.nxml.txt.nlp	19936839	SENT72	4	4	12	12	cetuximab	KRAS	PA10040	3845	0.817
NULL	Nat_Commun_2013_Apr_23_4_1758.nxml.txt.nlp	23612299	SENT563	6	6	10	10	isoproterenol	SOD1	PA450121	6647	0.817
NULL	Indian_J_Pharmacol_2008_Nov-Dec_40(6)_256-260.nxml.txt.nlp	21279181	SENT5	19	19	28	28	ethanol	flower	PA448073	11094	0.817
NULL	Arthritis_Rheum_2013_Sep_26_65(9)_2290-2300.nxml.txt.nlp	23740547	SENT194	27	27	32	32	doxycycline	S100A9	PA449415	6280	0.817
NULL	Epigenetics_Chromatin_2014_Jun_26_7_12.nxml.txt.nlp	25028596	SENT125	46	46	31	31	doxycycline	ATF7IP	PA449415	55729	0.817
NULL	Int_Cardiovasc_Res_J_2012_Sep_15_6(3)_70-74.nxml.txt.nlp	24757595	SENT41	15	15	4	4	heparin	ACT	PA449855	12;11332;9457;641455	0.817
NULL	Oncotarget_2010_Oct_25_1(7)_497-514.nxml.txt.nlp	21165163	SENT198	23	23	15	15	imatinib	EGFR	PA10804	1956	0.817
NULL	Breast_Cancer_Res_2012_Jul_12_14(4)_R104.nxml.txt.nlp	22788954	SENT240	26	26	18	18	gefitinib	EGFR	PA131301952	1956	0.817
NULL	Arch_Gynecol_Obstet_2012_May_30_285(5)_1447-1453.nxml.txt.nlp	22127553	SENT28	4	4	2	2	paclitaxel	TEC	PA450761	7006	0.817
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT150	36	36	39	39	vinorelbine	MVP	PA451881	9961	0.817
NULL	Arthritis_Res_Ther_2011_Feb_28_13(1)_205.nxml.txt.nlp	21371351	SENT180	17	17	6	6	rituximab	BAFF	PA451261	10673	0.817
NULL	Br_J_Cancer_2013_Jul_23_109(2)_502-511.nxml.txt.nlp	23799850	SENT167	23	23	5	5	gemcitabine	SMARCC1	PA449748	6599	0.817
NULL	Cell_Biochem_Biophys_2013_Jan_13_66(3)_499-512.nxml.txt.nlp	23314884	SENT380	16	16	5	5	resveratrol	DR4		8797	0.817
NULL	J_Cancer_2011_Mar_8_2_142-152.nxml.txt.nlp	21475719	SENT142	10	10	0	0	cisplatin	ERCC1	PA449014	2067	0.817
NULL	Cardiovasc_Diabetol_2010_Oct_18_9_64.nxml.txt.nlp	20955583	SENT137	0	0	22	22	rosiglitazone	MMP9	PA451283	4318	0.817
NULL	Basic_Clin_Neurosci_2014_Winter_5(1)_66-73.nxml.txt.nlp	25436086	SENT72	6	6	24	24	lidocaine	LHA	PA450226	1081	0.817
NULL	Hum_Mol_Genet_2008_Jul_15_17(14)_2101-2107.nxml.txt.nlp	18413323	SENT114	14	14	10	10	ezetimibe	NPC1L1	PA10816	29881	0.817
NULL	Cancer_Imaging_2005_Nov_23_5(Spec_No_A)_S113-S119.nxml.txt.nlp	16361126	SENT94	8	8	1	1	vincristine	CHOP	PA451879	1649	0.817
NULL	Mol_Cancer_2012_Jul_12_11_45.nxml.txt.nlp	22788833	SENT134	34	34	31	31	cisplatin	EGFR	PA449014	1956	0.817
NULL	Aging_(Albany_NY)_2012_Jul_22_4(7)_480-498.nxml.txt.nlp	22837425	SENT5	0	0	16	16	metformin	AMPK	PA450395	5563	0.817
NULL	J_Cell_Biol_1997_Jun_30_137(7)_1663-1681.nxml.txt.nlp	9199179	SENT381	20	20	14	14	trypsin	RGDS	PA451806	5900	0.817
NULL	Clin_Epigenetics_2010_Nov_9_1(3-4)_117-136.nxml.txt.nlp	21258646	SENT277	20	20	17	17	erlotinib	EGFR	PA134687924	1956	0.817
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT8	25	25	19	19	simvastatin	survivin	PA451363	332	0.817
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT272	11	11	6	6	adalimumab	CD36	PA10004	948	0.817
NULL	Cell_Res_2014_Jul_9_24(7)_820-841.nxml.txt.nlp	24810299	SENT131	15	15	12	12	doxycycline	RBP-J	PA449415	3516	0.817
NULL	Curr_Neuropharmacol_2010_Sep_8(3)_254-267.nxml.txt.nlp	21358975	SENT326	6	6	13	13	lorazepam	UGT2B7	PA450267	7364	0.817
NULL	Breast_Cancer_Res_2012_Feb_6_14(1)_R22.nxml.txt.nlp	22309939	SENT318	18	18	12	12	imatinib	PLK1	PA10804	5347	0.817
NULL	Int_J_Vasc_Med_2014_Nov_17_2014_254270.nxml.txt.nlp	25485154	SENT453	1	1	15	15	probenecid	AQP4	PA451106	361	0.817
NULL	Curr_Oncol_2010_Feb_17(1)_81-86.nxml.txt.nlp	20179808	SENT25	15	15	3	3	estradiol	aromatase	PA449503	1588	0.817
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1522-1532.nxml.txt.nlp	21997136	SENT256	6	6	17	17	lapatinib	UGT1A1	PA152241907	54658	0.817
NULL	Neural_Regen_Res_2013_Nov_25_8(33)_3095-3106.nxml.txt.nlp	25206630	SENT273	32	32	4	4	paraformaldehyde	C17	PA450790	54360	0.817
NULL	Front_Oncol_2014_May_26_4_123.nxml.txt.nlp	24904834	SENT370	11	11	14	14	resveratrol	AMPK		5563	0.817
NULL	Biologics_2014_Dec_4_8_281-291.nxml.txt.nlp	25506209	SENT115	20	20	28	28	vemurafenib	BRAF	PA165946873	673	0.817
NULL	Nat_Med_2010_Nov_24_16(11)_1299-1304.nxml.txt.nlp	20972434	SENT187	12	12	5	5	chloroquine	ASM	PA448948	6609;283120	0.817
NULL	J_Oncol_2010_Sep_16_2010_414726.nxml.txt.nlp	20886020	SENT39	14	14	10	10	doxorubicin	CHOP	PA449412	1649	0.817
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_408-414.nxml.txt.nlp	21372831	SENT31	18	18	25	25	doxorubicin	spatial	PA449412	219793	0.817
NULL	Int_J_Environ_Res_Public_Health_2012_Jun_31_9(6)_2075-2091.nxml.txt.nlp	22829791	SENT94	7	7	10	10	etoposide	TOP2B	PA449552	7155	0.817
NULL	J_Clin_Biochem_Nutr_2010_Mar_27_46(2)_126-134.nxml.txt.nlp	20216945	SENT66	7	7	21	21	taurine	Met	PA451590	79811	0.817
NULL	Part_Fibre_Toxicol_2013_Aug_13_10_39.nxml.txt.nlp	23937860	SENT136	0	0	3	3	anakinra	NLRP3	PA10799	114548	0.817
NULL	Diabetes_2013_Mar_14_62(3)_953-964.nxml.txt.nlp	23223176	SENT196	25	25	12	12	paroxetine	STZ	PA450801	6484	0.817
NULL	Arch_Osteoporos_2013_Sep_13_8(1-2)_144.nxml.txt.nlp	24030479	SENT1004	11	11	30	30	ibandronate	PTH	PA10270	5741	0.817
NULL	Br_J_Cancer_2013_Aug_6_109(3)_686-693.nxml.txt.nlp	23839492	SENT80	21	21	32	32	everolimus	HIF-1	PA164746311	29072	0.817
NULL	Cell_Commun_Signal_2013_Jul_4_11_47.nxml.txt.nlp	23826796	SENT53	21	21	11	11	forskolin	CC2D1A	PA146096022	54862	0.817
NULL	Br_J_Cancer_2006_Feb_13_94(3)_363-371.nxml.txt.nlp	16465172	SENT46	18	18	27	27	oxaliplatin	CRT	PA131285527	811	0.817
NULL	Open_Access_J_Urol_2011_May_10_3_69-82.nxml.txt.nlp	24198638	SENT66	7	7	27	27	bupropion	CYP2C9	PA448687	1559	0.817
NULL	J_Int_Soc_Sports_Nutr_2010_Dec_15_7_39.nxml.txt.nlp	21156078	SENT167	10	10	1	1	choline	CRAM	PA448976	56896	0.817
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Jun_27_5_15.nxml.txt.nlp	16803618	SENT244	11	11	3	3	gentamicin	LTA	PA449753	4049	0.817
NULL	J_Breast_Cancer_2012_Sep_28_15(3)_288-295.nxml.txt.nlp	23091541	SENT163	10	10	29	29	tamoxifen	HER-2	PA451581	2064	0.817
NULL	Tumour_Biol_2012_Jun_21_33(3)_607-615.nxml.txt.nlp	22270450	SENT41	22	22	18	18	neratinib	HER2	PA165291472	2064	0.817
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT118	19	19	2	2	perifosine	DR5	PA165291471	8795	0.817
NULL	Nat_Neurosci_2012_Sep_5_15(9)_1245-1254.nxml.txt.nlp	22864611	SENT104	3	3	10	10	clozapine	mGlu2	PA449061	2912	0.817
NULL	Drugs_R_D_2010_Nov_25_10(4)_213-217.nxml.txt.nlp	21171667	SENT96	8	8	12	12	azathioprine	CD4	PA448515	920	0.817
NULL	Mol_Cancer_2012_Jul_12_11_45.nxml.txt.nlp	22788833	SENT9	24	24	10	10	cisplatin	EGFR	PA449014	1956	0.817
NULL	Indian_J_Endocrinol_Metab_2011_Oct_15(Suppl4)_S322-S328.nxml.txt.nlp	22145135	SENT57	0	0	8	8	octreotide	ACTH	PA450678	5443	0.817
NULL	J_Viral_Hepat_2012_Feb_19(2)_e112-e119.nxml.txt.nlp	22239508	SENT176	20	20	24	24	boceprevir	solo	PA165948902	55701	0.817
NULL	J_Hematol_Oncol_2013_Mar_27_6_23.nxml.txt.nlp	23531342	SENT75	7	7	23	23	doxorubicin	p53	PA449412	7157	0.817
NULL	Bone_Marrow_Transplant_2011_Mar_24_46(3)_430-435.nxml.txt.nlp	20498647	SENT25	0	0	10	10	daclizumab	IL-2	PA164764446	3558	0.817
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R91.nxml.txt.nlp	22541814	SENT142	32	32	19	19	thrombin	HO-1	PA451674	3162	0.817
NULL	Nat_Commun_2011_Jul_19_2_402.nxml.txt.nlp	21772273	SENT38	28	28	8	8	doxorubicin	survivin	PA449412	332	0.817
NULL	Biologics_2010_Nov_9_4_289-298.nxml.txt.nlp	21116327	SENT66	19	19	28	28	cetuximab	EGFR	PA10040	1956	0.817
NULL	Niger_Med_J_2013_Mar-Apr_54(2)_100-106.nxml.txt.nlp	23798795	SENT12	14	14	19	19	indomethacin	PTEN	PA449982	5728	0.817
NULL	Curr_Med_Chem_2013_Apr_20(10)_1241-1285.nxml.txt.nlp	23409712	SENT1147	10	10	7	7	carbamazepine	CA1	PA448785	759	0.817
NULL	Clin_Med_Insights_Case_Rep_2010_Sep_27_3_55-58.nxml.txt.nlp	21769255	SENT7	3	3	12	12	vasopressin	AVP	PA451858	114548;551	0.817
NULL	J_Gynecol_Oncol_2011_Mar_31_22(1)_9-17.nxml.txt.nlp	21607090	SENT92	24	24	26	26	cyclophosphamide	PCFT	PA449165	113235	0.817
NULL	Ann_Surg_Treat_Res_2014_Feb_22_86(2)_68-75.nxml.txt.nlp	24761411	SENT151	19	19	16	16	oxaliplatin	survivin	PA131285527	332	0.817
NULL	Diagn_Pathol_2013_Nov_25_8_192.nxml.txt.nlp	24274261	SENT89	2	2	6	6	dacarbazine	IL-2	PA449197	3558	0.817
NULL	Eur_J_Clin_Microbiol_Infect_Dis_2013_Jun_13_32(6)_745-754.nxml.txt.nlp	23314745	SENT4	21	21	15	15	ribavirin	IL-28B	PA451241	282617	0.817
NULL	ARYA_Atheroscler_2013_Nov_9(6)_357-362.nxml.txt.nlp	24575139	SENT146	11	11	17	17	naringin	AKT	PA151958360	207	0.817
NULL	J_Biol_Chem_2013_Jul_19_288(29)_21412-21421.nxml.txt.nlp	23740251	SENT105	12	12	1	1	suramin	P2X1	PA10292	5023	0.817
NULL	Oncotarget_2013_Jan_14_4(1)_118-127.nxml.txt.nlp	23435217	SENT184	16	16	12	12	cetuximab	EGFR	PA10040	1956	0.817
NULL	Br_J_Clin_Pharmacol_2013_Aug_23_76(2)_299-315.nxml.txt.nlp	23701319	SENT150	5	5	14	14	alemtuzumab	IL-2	PA164783958	3558	0.817
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1063.nxml.txt.nlp	24556678	SENT50	4	4	12	12	thioridazine	Mcl-1	PA451666	4170	0.817
NULL	Diabetologia_2010_Jun_27_53(6)_1142-1150.nxml.txt.nlp	20349036	SENT213	16	16	21	21	spermine	AMPK	PA164781199	5563	0.817
NULL	Br_J_Cancer_2013_Feb_19_108(3)_668-675.nxml.txt.nlp	23348520	SENT123	16	16	5	5	cetuximab	KRAS	PA10040	3845	0.817
NULL	Breast_Cancer_Res_Treat_2007_Oct_27_105(Suppl_1)_19-29.nxml.txt.nlp	17333340	SENT179	11	11	4	4	tamoxifen	aromatase	PA451581	1588	0.817
NULL	Cancers_(Basel)_2010_May_26_2(2)_955-969.nxml.txt.nlp	24281101	SENT59	26	26	7	7	dacarbazine	BHD	PA449197	201163	0.817
NULL	Indian_J_Crit_Care_Med_2014_Sep_18(9)_575-584.nxml.txt.nlp	25249742	SENT206	18	18	14	14	rocuronium	NMB	PA164754992	10457;4828	0.817
NULL	Arthritis_Res_Ther_2014_Jul_2_16(4)_R138.nxml.txt.nlp	24989778	SENT144	10	10	19	19	methotrexate	MDA5	PA450428	64135	0.817
NULL	Int_J_Gen_Med_2010_Oct_5_3_305-311.nxml.txt.nlp	21042569	SENT95	40	40	28	28	eltrombopag	TPO	PA165981594	7066;7173	0.817
NULL	Front_Oncol_2013_Aug_5_3_195.nxml.txt.nlp	23936763	SENT210	14	14	26	26	erlotinib	EGFR	PA134687924	1956	0.817
NULL	J_Biomed_Sci_2013_Jul_22_20(1)_51.nxml.txt.nlp	23876213	SENT96	13	13	4	4	paraformaldehyde	CD31	PA450790	5175	0.817
NULL	Cancer_Cell_Int_2009_Jan_8_9_3.nxml.txt.nlp	19128511	SENT194	13	13	25	25	oxaliplatin	VEGFR	PA131285527	3791	0.817
NULL	Cancer_Metab_2015_Jan_29_3(1)_2.nxml.txt.nlp	NULL	SENT42	22	22	24	24	gemcitabine	GEM	PA449748	2669	0.817
NULL	Mol_Cancer_2010_Jun_25_9_166.nxml.txt.nlp	20579378	SENT244	23	23	16	16	gefitinib	EGF	PA131301952	1950	0.817
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT95	20	20	3	3	imatinib	ABCG2	PA10804	9429	0.817
NULL	Indian_J_Dermatol_2011_Mar-Apr_56(2)_165-170.nxml.txt.nlp	21716541	SENT53	13	13	1	1	methotrexate	VIII	PA450428	1351	0.817
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_21-38.nxml.txt.nlp	19305786	SENT255	3	3	30	30	cyclophosphamide	TRPA1	PA449165	8989	0.817
NULL	Environ_Health_Perspect_2005_Jun_24_113(6)_680-687.nxml.txt.nlp	15929889	SENT45	9	9	2	2	phenol	SULT1B1	PA450913	27284	0.817
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Oct_26_69(Pt_11)_o1701.nxml.txt.nlp	24454127	SENT61	42	42	28	28	resveratrol	SIRT1		23411	0.817
NULL	Iran_J_Pharm_Res_2013_Winter_12(Suppl)_169-174.nxml.txt.nlp	24250685	SENT89	14	14	6	6	clopidogrel	ADP	PA449053	23038	0.817
NULL	Br_J_Cancer_2012_Sep_25_107(7)_1044-1050.nxml.txt.nlp	22910317	SENT147	16	16	33	33	bevacizumab	CD34	PA130232992	947	0.817
NULL	JAKSTAT_2013_Oct_1_2(4)_e24911.nxml.txt.nlp	24416641	SENT51	12	12	8	8	estradiol	JAK2	PA449503	3717	0.817
NULL	Int_J_Nanomedicine_2008_Mar_3(1)_31-49.nxml.txt.nlp	18488414	SENT327	44	44	29	29	galactose	mol	PA449725	90527	0.816
NULL	J_Oncol_2010_Jun_22_2010_939407.nxml.txt.nlp	20652010	SENT33	6	6	0	0	heparin	CXCL7	PA449855	5473	0.816
NULL	Brain_2008_Nov_22_131(11)_3072-3080.nxml.txt.nlp	18945724	SENT89	7	7	0	0	rituximab	CD19	PA451261	930	0.816
NULL	Curr_Neuropharmacol_2013_Jul_11(4)_338-378.nxml.txt.nlp	24381528	SENT307	4	4	31	31	curcumin	F18	PA151958596	10046	0.816
NULL	J_Viral_Hepat_2007_Jun_1_14(6)_371-386.nxml.txt.nlp	17501757	SENT154	25	25	19	19	ribavirin	IFN	PA451241	3439	0.816
NULL	Exp_Mol_Med_2012_May_31_44(5)_311-318.nxml.txt.nlp	22282402	SENT9	36	36	11	11	cilostazol	MCP-1	PA164746334	6347	0.816
NULL	Cell_Mol_Neurobiol_2010_Nov_9_30(8)_1395-1400.nxml.txt.nlp	21061160	SENT47	34	34	2	2	cyproheptadine	EDN1	PA164749366	1906	0.816
NULL	Diabetes_2009_Aug_28_58(8)_1826-1834.nxml.txt.nlp	19401415	SENT205	10	10	6	6	lipase	adiponutrin	PA450239	80339	0.816
NULL	Korean_J_Anesthesiol_2013_Dec_26_65(6)_552-558.nxml.txt.nlp	24427462	SENT73	8	8	3	3	vecuronium	ANOVA	PA164748865	4858	0.816
NULL	Arthritis_Res_Ther_2014_Apr_3_16(2)_R86.nxml.txt.nlp	24708674	SENT200	2	2	11	11	bosentan	FLI1	PA10034	2313	0.816
NULL	J_Oncol_2012_Feb_6_2012_737981.nxml.txt.nlp	22481932	SENT83	26	26	37	37	doxorubicin	MUC16	PA449412	94025	0.816
NULL	Br_J_Cancer_2013_Jun_11_108(11)_2272-2280.nxml.txt.nlp	23681187	SENT118	26	26	1	1	celecoxib	p38	PA448871	10598;1432;7965	0.816
NULL	Aging_(Albany_NY)_2012_Dec_6_4(11)_823-842.nxml.txt.nlp	23235539	SENT253	11	11	3	3	trypsin	SRM	PA451806	6723;6725	0.816
NULL	Mol_Cancer_2014_Jul_5_13_165.nxml.txt.nlp	24996221	SENT125	33	33	4	4	docetaxel	HMGB1	PA449383	3146	0.816
NULL	Cancers_(Basel)_2010_Jan_14_2(1)_1-19.nxml.txt.nlp	24281029	SENT1030	11	11	26	26	vinorelbine	San	PA451881	80218	0.816
NULL	Front_Physiol_2012_Oct_19_3_56.nxml.txt.nlp	23091461	SENT298	2	2	21	21	clodronate	IL-10	PA10239	3586	0.816
NULL	Case_Rep_Endocrinol_2013_Sep_8_2013_415810.nxml.txt.nlp	24083038	SENT62	5	5	9	9	trimethoprim	CYP2C8	PA451788	1558	0.816
NULL	J_Cell_Biol_2008_Jul_28_182(2)_381-393.nxml.txt.nlp	18663145	SENT202	19	19	22	22	trypsin	GIV	PA451806	55704	0.816
NULL	Evid_Based_Complement_Alternat_Med_2012_Dec_17_2012_857123.nxml.txt.nlp	23365602	SENT118	16	16	22	22	capsaicin	TRPV1	PA448776	7442	0.816
NULL	Front_Endocrinol_(Lausanne)_2014_Apr_3_5_42.nxml.txt.nlp	24772106	SENT84	16	16	31	31	hexachlorophene	GLT-1	PA449871	6506	0.816
NULL	Front_Behav_Neurosci_2014_Oct_30_8_366.nxml.txt.nlp	25400560	SENT100	33	33	15	15	ethanol	GAPDH	PA448073	2597	0.816
NULL	Clin_Transl_Allergy_2014_Jan_15_4_3.nxml.txt.nlp	24428928	SENT161	18	18	11	11	methacholine	CD4	PA165958382	920	0.816
NULL	Ther_Clin_Risk_Manag_2007_Jun_3(3)_467-474.nxml.txt.nlp	18488080	SENT123	0	0	3	3	omeprazole	CYP1A2	PA450704	1544	0.816
NULL	Front_Physiol_2013_Nov_14_4_323.nxml.txt.nlp	24294204	SENT256	19	19	2	2	metoprolol	ADRB1	PA450480	153	0.816
NULL	Acta_Histochem_Cytochem_2011_Apr_28_44(2)_51-60.nxml.txt.nlp	21614166	SENT10	0	0	13	13	thalidomide	PCNA	PA451644	5111	0.816
NULL	Indian_J_Endocrinol_Metab_2013_Mar-Apr_17(2)_344-348.nxml.txt.nlp	23776919	SENT75	13	13	28	28	methylprednisolone	TSHR	PA450466	7253	0.816
NULL	Biosci_Rep_2012_Aug_1_32(Pt_4)_361-374.nxml.txt.nlp	22762204	SENT1116	12	12	0	0	trastuzumab	PTEN	PA451743	5728	0.816
NULL	Br_J_Cancer_2012_Feb_14_106(4)_629-632.nxml.txt.nlp	22240783	SENT74	25	25	15	15	pazopanib	AGO	PA165291492	55294	0.816
NULL	Oncotarget_2012_Jul_13_3(6)_601-607.nxml.txt.nlp	22802145	SENT28	3	3	15	15	doxorubicin	p53	PA449412	7157	0.816
NULL	Mol_Cancer_2009_Nov_10_8_99.nxml.txt.nlp	19903356	SENT113	8	8	3	3	imatinib	IGFBP3	PA10804	3486	0.816
NULL	Cell_Mol_Life_Sci_2011_Nov_2_68(21)_3573-3587.nxml.txt.nlp	21365278	SENT41	30	30	0	0	iloprost	PGD2	PA164746843	27306	0.816
NULL	Drug_Healthc_Patient_Saf_2012_Nov_29_4_173-180.nxml.txt.nlp	23236256	SENT66	6	6	22	22	aripiprazole	FGA	PA10026	2243	0.816
NULL	Exp_Diabetes_Res_2012_May_28_2012_924168.nxml.txt.nlp	22693487	SENT90	23	23	27	27	exenatide	GLP-1	PA164749238	100125288	0.816
NULL	Indian_J_Pharm_Sci_2013_Jan-Feb_75(1)_94-98.nxml.txt.nlp	23901167	SENT69	12	12	39	39	phenacetin	CYP2B6	PA450897	1555	0.816
NULL	Mol_Syst_Biol_2010_Jul_27_6_391.nxml.txt.nlp	20664637	SENT312	20	20	8	8	trypsin	B27	PA451806	56246	0.816
NULL	Clin_Toxicol_(Phila)_2007_Jun_20_Jun-Aug_45(5)_565-570.nxml.txt.nlp	17558630	SENT157	28	28	30	30	methacholine	Rho	PA165958382	29984	0.816
NULL	Br_J_Cancer_2011_Jun_7_104(12)_1848-1853.nxml.txt.nlp	21610704	SENT82	18	18	7	7	panitumumab	TOX	PA162373091	9760	0.816
NULL	Mol_Cancer_2008_Mar_6_7_24.nxml.txt.nlp	18325101	SENT91	20	20	1	1	cisplatin	FANCD2	PA449014	2177	0.816
NULL	J_Mol_Signal_2006_Dec_6_1_8.nxml.txt.nlp	17224083	SENT134	22	22	19	19	thrombin	Rho	PA451674	29984	0.816
NULL	Front_Immunol_2012_Jan_12_2_98.nxml.txt.nlp	22566887	SENT877	24	24	10	10	ibandronate	RANKL	PA10270	8600	0.816
NULL	J_Clin_Hypertens_(Greenwich)_2014_Jun_25_16(6)_442-450.nxml.txt.nlp	24766515	SENT148	6	6	13	13	olmesartan	DBP	PA164742950	3295;1628;2638	0.816
NULL	J_Inherit_Metab_Dis_2012_Jan_10_35(1)_141-149.nxml.txt.nlp	21556832	SENT75	13	13	20	20	creatine	SLC6A8	PA164778930	6535	0.816
NULL	Leukemia_2013_Jan_11_27(1)_32-40.nxml.txt.nlp	22781593	SENT225	13	13	23	23	ponatinib	FGFR1	PA165980594	2260	0.816
NULL	Breast_Cancer_Res_2010_Aug_23_12(4)_R64.nxml.txt.nlp	20731819	SENT40	7	7	17	17	debrisoquine	CYP2D6	PA452616	1565	0.816
NULL	Ann_Rheum_Dis_2013_Oct_26_72(10)_1738-1742.nxml.txt.nlp	23894061	SENT143	24	24	14	14	methotrexate	IL-17A	PA450428	3605	0.816
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT1070	18	18	12	12	resveratrol	NMNAT1		64802	0.816
NULL	Front_Endocrinol_(Lausanne)_2011_Nov_10_2_65.nxml.txt.nlp	22649380	SENT60	12	12	32	32	estradiol	CORT	PA449503	1325	0.816
NULL	Br_J_Cancer_2012_Jun_26_107(1)_43-52.nxml.txt.nlp	22644306	SENT56	15	15	18	18	verapamil	mol	PA451868	90527	0.816
NULL	Infect_Drug_Resist_2010_Apr_26_3_15-23.nxml.txt.nlp	21694890	SENT206	6	6	25	25	raltegravir	TRIO		7204	0.816
NULL	Breast_Cancer_Res_Treat_2012_Jul_28_134(1)_267-276.nxml.txt.nlp	22453754	SENT220	7	7	3	3	tamoxifen	ATAC	PA451581	6375	0.816
NULL	J_Exp_Clin_Cancer_Res_2009_Oct_7_28(1)_134.nxml.txt.nlp	19811659	SENT89	3	3	23	23	imatinib	DDR1	PA10804	780	0.816
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_16_2014_926087.nxml.txt.nlp	25478000	SENT96	11	11	20	20	fenofibrate	PCSK9	PA449594	255738	0.816
NULL	Indian_Dermatol_Online_J_2011_Jan-Jun_2(1)_43-45.nxml.txt.nlp	23130220	SENT26	23	23	29	29	thalidomide	CO2	PA451644	4513	0.816
NULL	Neuropsychopharmacology_2009_Apr_2_34(5)_1135-1148.nxml.txt.nlp	18596687	SENT15	26	26	5	5	cocaine	CRF	PA449072	1392;10882	0.816
NULL	Mol_Biol_Cell_2013_Sep_15_24(18)_2981-2989.nxml.txt.nlp	23864704	SENT198	33	33	47	47	l-glutamine	CO2	PA10090	4513	0.816
NULL	Environ_Health_Perspect_2006_Sep_23_114(9)_1401-1406.nxml.txt.nlp	16966095	SENT167	7	7	10	10	arsenite	p53	PA452638	7157	0.816
NULL	J_Autom_Methods_Manag_Chem_2008_Apr_5_2008_502953.nxml.txt.nlp	19365566	SENT2008	3	3	12	12	methamphetamine	FAST	PA450403	10922	0.816
NULL	Arthritis_Res_Ther_2012_Jul_27_14(4)_R176.nxml.txt.nlp	22838845	SENT201	3	3	5	5	acetazolamide	CA1	PA448018	759	0.816
NULL	Eur_J_Hosp_Pharm_Sci_Pract_2013_Aug_21_20(4)_227-231.nxml.txt.nlp	23888248	SENT156	16	16	8	8	denosumab	ETO	PA166048634	862	0.816
NULL	Mol_Cancer_2012_Apr_26_11_26.nxml.txt.nlp	22537224	SENT114	14	14	18	18	cisplatin	FANCF	PA449014	2188	0.816
NULL	Exp_Ther_Med_2013_Apr_5_5(4)_1259-1263.nxml.txt.nlp	23596498	SENT97	5	5	19	19	propofol	TRPV1	PA451141	7442	0.816
NULL	FEBS_J_2009_Oct_276(19)_5571-5578.nxml.txt.nlp	19702827	SENT44	0	0	3	3	gefitinib	EGFR	PA131301952	1956	0.816
NULL	Cardiovasc_Ultrasound_2004_Dec_6_2_26.nxml.txt.nlp	15581428	SENT109	19	19	21	21	dipyridamole	DIP	PA449367	23151;1831	0.816
NULL	Cardiovasc_Ther_2009_27(4)_259-274.nxml.txt.nlp	19604248	SENT47	0	0	28	28	ticagrelor	ADP	PA165374673	23038	0.816
NULL	Acta_Neuropathol_Commun_2014_Sep_4_2(1)_93.nxml.txt.nlp	NULL	SENT340	29	29	21	21	tamoxifen	STAT3	PA451581	6774	0.816
NULL	Arthritis_Rheumatol_2014_May_66(5)_1363-1371.nxml.txt.nlp	24782192	SENT46	37	37	14	14	etanercept	ACR	PA449515	49	0.816
NULL	Antimicrob_Agents_Chemother_2014_Oct_58(10)_5900-5908.nxml.txt.nlp	25070091	SENT56	6	6	11	11	metoprolol	CYP2D6	PA450480	1565	0.816
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT144	6	6	21	21	atorvastatin	PIK3CA	PA448500	5290	0.816
NULL	Br_J_Cancer_2013_Oct_15_109(8)_2051-2057.nxml.txt.nlp	24064969	SENT85	23	23	27	27	bevacizumab	SOC	PA130232992	91544	0.816
NULL	Breast_Cancer_Res_2000_Feb_18_2(2)_E005.nxml.txt.nlp	NULL	SENT41	35	35	12	12	paclitaxel	San	PA450761	80218	0.816
NULL	Oncogenesis_2014_Dec_15_3(12)_e133.nxml.txt.nlp	25500906	SENT127	14	14	18	18	trastuzumab	HER3	PA451743	2065	0.816
NULL	J_Hematol_Oncol_2013_Jan_4_6_1.nxml.txt.nlp	23286345	SENT15	0	0	8	8	cetuximab	EGFR	PA10040	1956	0.816
NULL	Ann_Lab_Med_2012_Jul_20_32(4)_298-303.nxml.txt.nlp	22779073	SENT86	19	19	10	10	clarithromycin	EMB	PA449028	133418	0.816
NULL	Front_Oncol_2014_Jun_11_4_145.nxml.txt.nlp	24967214	SENT373	21	21	4	4	cyclophosphamide	CD4	PA449165	920	0.816
NULL	J_Thromb_Haemost_2014_May_22_12(5)_726-735.nxml.txt.nlp	24581425	SENT149	9	9	19	19	thrombin	ADP	PA451674	23038	0.816
NULL	Front_Behav_Neurosci_2014_Oct_6_8_343.nxml.txt.nlp	25339876	SENT875	17	17	2	2	ketamine	B12	PA450144	7126;4709	0.816
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jan_22_67(Pt_2)_o472-o473.nxml.txt.nlp	21523131	SENT69	31	31	15	15	ethanol	mol	PA448073	90527	0.816
NULL	Viruses_2014_Sep_25_6(9)_3643-3651.nxml.txt.nlp	25256394	SENT62	27	27	35	35	maraviroc	CXCR4	PA164768835	7852	0.816
NULL	Breast_Cancer_Res_2011_Jan_17_13(1)_R5.nxml.txt.nlp	21241485	SENT208	32	32	7	7	tamoxifen	Brn-3b	PA451581	5458	0.816
NULL	Eur_J_Clin_Pharmacol_2012_Sep_15_68(9)_1267-1274.nxml.txt.nlp	22418828	SENT150	15	15	21	21	omeprazole	CYP2C19	PA450704	1557	0.816
NULL	EMBO_Mol_Med_2013_Jan_29_5(1)_137-148.nxml.txt.nlp	23197407	SENT110	1	1	27	27	losartan	TR3	PA450268	8718;3164;10587	0.816
NULL	Clin_Med_Insights_Oncol_2012_Feb_28_6_125-135.nxml.txt.nlp	22408376	SENT53	10	10	34	34	panitumumab	KRAS	PA162373091	3845	0.816
NULL	Braz_J_Med_Biol_Res_2013_Mar_15_46(3)_299-305.nxml.txt.nlp	23532269	SENT11	24	24	31	31	propofol	CD14	PA451141	929	0.816
NULL	Front_Immunol_2012_Jan_24_3_3.nxml.txt.nlp	22566889	SENT1346	19	19	8	8	rituximab	CD55	PA451261	1604	0.816
NULL	Cancers_(Basel)_2014_Jan_21_6(1)_166-178.nxml.txt.nlp	24452144	SENT329	14	14	5	5	paclitaxel	p53	PA450761	7157	0.816
NULL	Onco_Targets_Ther_2014_Jun_11_7_969-983.nxml.txt.nlp	24959084	SENT115	7	7	20	20	ketoconazole	CYP3A4	PA450146	1576	0.816
NULL	Trials_2012_Sep_8_13_160.nxml.txt.nlp	22958580	SENT5	20	20	12	12	vecuronium	LSR	PA164748865	51599	0.816
NULL	Front_Chem_2014_Dec_23_2_113.nxml.txt.nlp	25566531	SENT396	0	0	12	12	curcumin	HLJ1	PA151958596	11080	0.816
NULL	Onco_Targets_Ther_2014_Sep_9_7_1571-1582.nxml.txt.nlp	25228815	SENT120	12	12	5	5	sunitinib	VEGFR2	PA162372840	3791	0.816
NULL	Mol_Cancer_2010_Aug_23_9_222.nxml.txt.nlp	20731837	SENT87	5	5	11	11	gefitinib	ATM	PA131301952	472	0.816
NULL	J_Biol_Chem_2012_Apr_20_287(17)_14122-14135.nxml.txt.nlp	22351750	SENT870	13	13	18	18	hyaluronan	HC2	PA165958431	360184;3053;5682	0.816
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT57	14	14	5	5	mitomycin	MVP	PA450524	9961	0.816
NULL	Braz_J_Med_Biol_Res_2014_Feb_17_47(2)_101-109.nxml.txt.nlp	24519125	SENT134	15	15	5	5	propranolol	IL-6	PA451145	3569	0.816
NULL	J_Vet_Med_Sci_2014_Oct_16_76(10)_1383-1387.nxml.txt.nlp	24931645	SENT78	13	13	21	21	sitagliptin	GLP-1	PA164748978	100125288	0.816
NULL	Ann_Clin_Transl_Neurol_2014_Dec_21_1(12)_996-1005.nxml.txt.nlp	25574474	SENT186	15	15	3	3	riluzole	P-gp	PA451251	5243	0.816
NULL	Arthritis_Res_Ther_2008_Oct_15_10(Suppl_1)_S5.nxml.txt.nlp	19007425	SENT113	26	26	17	17	abatacept	ACR	PA164747080	49	0.816
NULL	Oncotarget_2013_Apr_21_4(4)_500-501.nxml.txt.nlp	23660238	SENT11	6	6	14	14	imatinib	JAK2	PA10804	3717	0.816
NULL	F1000Res_2013_Oct_10_2_134.nxml.txt.nlp	24358901	SENT301	24	24	18	18	vemurafenib	BRAF	PA165946873	673	0.816
NULL	Br_J_Cancer_2012_Oct_9_107(8)_1277-1285.nxml.txt.nlp	22990652	SENT164	32	32	23	23	paclitaxel	CYP2C8	PA450761	1558	0.816
NULL	Pharmaceuticals_(Basel)_2014_Sep_19_7(9)_954-989.nxml.txt.nlp	25244509	SENT80	19	19	1	1	ethanol	GIT	PA448073	5034	0.816
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S251-S257.nxml.txt.nlp	21525464	SENT50	18	18	33	33	metformin	GLP-1	PA450395	100125288	0.816
NULL	Int_J_Environ_Res_Public_Health_2013_Sep_17_10(9)_4352-4389.nxml.txt.nlp	24048206	SENT291	14	14	17	17	betaine	B12	PA448603	7126;4709	0.816
NULL	Diabetes_2009_Jan_58(1)_174-184.nxml.txt.nlp	18984736	SENT376	36	36	46	46	nifedipine	TRPV2	PA450631	51393	0.816
NULL	Reprod_Biol_Endocrinol_2003_Sep_25_1_61.nxml.txt.nlp	14561223	SENT27	29	29	7	7	estradiol	SON	PA449503	6651	0.816
NULL	Int_J_Biol_Sci_2014_Jan_20_10(2)_171-180.nxml.txt.nlp	24520215	SENT276	11	11	19	19	cerulenin	L-FABP	PA164764551	2168	0.816
NULL	Br_J_Cancer_2010_Oct_12_103(8)_1309-1310.nxml.txt.nlp	NULL	SENT12	17	17	7	7	sunitinib	IFN	PA162372840	3439	0.816
NULL	Chem_Rev_2011_Oct_12_111(10)_5899-5921.nxml.txt.nlp	21923193	SENT536	25	25	11	11	ketoprofen	FAAH	PA450149	79152;2166	0.816
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT159	10	10	25	25	phenprocoumon	VKORC1	PA450921	79001	0.816
NULL	Evid_Based_Complement_Alternat_Med_2012_Feb_12_2012_472897.nxml.txt.nlp	22454667	SENT20	0	0	8	8	hesperetin	mol	PA164742902	90527	0.816
NULL	BMB_Rep_2013_Oct_46(10)_484-489.nxml.txt.nlp	24148768	SENT360	10	10	6	6	thrombin	PAR-1	PA451674	2011;2149	0.816
NULL	Front_Endocrinol_(Lausanne)_2011_Dec_21_2_84.nxml.txt.nlp	22654830	SENT37	19	19	9	9	lipase	ATGL	PA450239	57104	0.816
NULL	Nucleic_Acids_Res_2005_Jun_30_33(11)_3678-3690.nxml.txt.nlp	15994460	SENT254	15	15	2	2	cisplatin	Hel308	PA449014	113510	0.816
NULL	Breast_Cancer_Res_2004_Oct_6_6(6)_262-268.nxml.txt.nlp	15535857	SENT148	34	34	43	43	tipifarnib	aromatase	PA165110778	1588	0.816
NULL	Aging_(Albany_NY)_2009_Jun_3_1(6)_515-528.nxml.txt.nlp	20157535	SENT131	23	23	10	10	resveratrol	S6K1		6198	0.816
NULL	J_Clin_Exp_Pathol_2012_May_17_Suppl_4_7327.nxml.txt.nlp	25379357	SENT37	3	3	29	29	resveratrol	AMPK		5563	0.816
NULL	Eur_J_Clin_Pharmacol_2008_Feb_26_64(2)_133-157.nxml.txt.nlp	18224312	SENT288	23	23	13	13	methotrexate	TPMT	PA450428	7172	0.816
NULL	Cancer_Cell_Int_2013_Jun_26_13_63.nxml.txt.nlp	23800022	SENT228	0	0	24	24	genistein	p53	PA165109660	7157	0.816
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT110	17	17	26	26	curcumin	survivin	PA151958596	332	0.816
NULL	Cancers_(Basel)_2013_Sep_25_5(4)_1199-1211.nxml.txt.nlp	24202441	SENT455	10	10	15	15	paclitaxel	p53	PA450761	7157	0.816
NULL	Br_J_Cancer_2012_Jan_3_106(1)_18-24.nxml.txt.nlp	22108516	SENT94	10	10	4	4	irinotecan	TDP1	PA450085	55775	0.816
NULL	J_Cell_Mol_Med_2014_Apr_20_18(4)_709-720.nxml.txt.nlp	24444314	SENT106	3	3	5	5	metformin	Met	PA450395	79811	0.816
NULL	Br_J_Cancer_2009_Oct_20_101(8)_1253-1260.nxml.txt.nlp	19755984	SENT192	2	2	18	18	anastrozole	HER-2	PA448432	2064	0.816
NULL	Arthritis_Res_Ther_2014_Jul_18_16(4)_R153.nxml.txt.nlp	25037855	SENT197	12	12	20	20	methotrexate	CD14	PA450428	929	0.816
NULL	Cardiovasc_Diabetol_2013_Oct_17_12_150.nxml.txt.nlp	24134550	SENT103	31	31	2	2	metformin	activin	PA450395	83729	0.816
NULL	eLife_2014_May_7_3_e02444.nxml.txt.nlp	24894464	SENT525	18	18	7	7	bexarotene	ABCA1	PA164752250	19	0.816
NULL	J_Cell_Biol_2005_Jul_4_170(1)_73-79.nxml.txt.nlp	15998800	SENT39	22	22	6	6	thrombin	NAC	PA451674	22861	0.816
NULL	Mol_Vis_2012_Apr_11_18_901-908.nxml.txt.nlp	22539869	SENT132	7	7	11	11	curcumin	HO-1	PA151958596	3162	0.816
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT7	32	32	12	12	ranibizumab	VEGFR1	PA164746012	2321	0.816
NULL	Eur_J_Clin_Pharmacol_2014_Oct_8_70(12)_1433-1441.nxml.txt.nlp	25291992	SENT12	2	2	9	9	olanzapine	B12	PA450688	7126;4709	0.816
NULL	Oncoimmunology_2013_Jan_1_2(1)_e22890.nxml.txt.nlp	23483066	SENT78	10	10	13	13	vemurafenib	IFN	PA165946873	3439	0.816
NULL	Ann_Neurosci_2014_Jul_21(3)_97-103.nxml.txt.nlp	25206073	SENT51	14	14	11	11	bumetanide	NKCC1	PA448682	6558	0.816
NULL	Biol_Open_2012_Sep_28_1(12)_1204-1214.nxml.txt.nlp	23259055	SENT149	12	12	15	15	staurosporine	GRASP65	PA165109623	64689	0.816
NULL	eLife_2014_Apr_22_3_e02450.nxml.txt.nlp	24755292	SENT570	43	43	5	5	ethanol	mol	PA448073	90527	0.816
NULL	Anal_Bioanal_Chem_2010_Apr_26_396(8)_3027-3040.nxml.txt.nlp	20186537	SENT191	38	38	19	19	phenol	CO2	PA450913	4513	0.816
NULL	Arthritis_Res_Ther_2010_Apr_26_12(2)_207.nxml.txt.nlp	20423534	SENT187	3	3	9	9	hydroxychloroquine	TLR3	PA164777036	7098	0.816
NULL	Mol_Cancer_2013_Mar_5_12_17.nxml.txt.nlp	23497256	SENT193	24	24	3	3	sunitinib	HDMX	PA162372840	4194;4193	0.816
NULL	Ann_Indian_Acad_Neurol_2011_Jul_14(Suppl1)_S11-S13.nxml.txt.nlp	21847317	SENT8	18	18	39	39	ropinirole	COMT	PA164749035	1312	0.816
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT120	1	1	6	6	curcumin	p65	PA151958596	5970	0.816
NULL	ScientificWorldJournal_2013_Oct_27_2013_939830.nxml.txt.nlp	24288514	SENT156	9	9	16	16	carrageenan	ANOVA	PA448814	4858	0.816
NULL	Cancer_Metab_2014_May_28_2(Suppl_1)_P14.nxml.txt.nlp	NULL	SENT17	42	42	18	18	vemurafenib	PFKFB3	PA165946873	5209	0.816
NULL	Acta_Pharmacol_Sin_2010_Sep_9_31(9)_1181-1188.nxml.txt.nlp	20694025	SENT147	22	22	33	33	cetuximab	KRAS	PA10040	3845	0.816
NULL	Clin_Sci_(Lond)_2009_Nov_16_118(Pt_4)_269-279.nxml.txt.nlp	19698082	SENT106	0	0	7	7	ramipril	ACE2	PA451223	59272	0.816
NULL	Arthritis_Res_Ther_2014_Nov_30_16(6)_497.nxml.txt.nlp	25433812	SENT64	9	9	2	2	fluorescein	CD4	PA164746009	920	0.816
NULL	Cardiovasc_Diabetol_2010_Nov_16_9_76.nxml.txt.nlp	21080957	SENT27	23	23	21	21	exenatide	GLP-1	PA164749238	100125288	0.816
NULL	J_Thromb_Haemost_2013_Jan_11(1)_132-141.nxml.txt.nlp	23205847	SENT188	2	2	10	10	thrombin	FVIII	PA451674	2157	0.816
NULL	Chem_Cent_J_2013_Jul_31_7_133.nxml.txt.nlp	23899303	SENT0	18	18	31	31	norfloxacin	DSC	PA450654	1825	0.816
NULL	Br_J_Cancer_2009_Jul_21_101(2)_238-243.nxml.txt.nlp	19568242	SENT42	11	11	15	15	bevacizumab	IFN	PA130232992	3439	0.816
NULL	Front_Behav_Neurosci_2009_Jun_29_3_10.nxml.txt.nlp	19587848	SENT1457	2	2	4	4	diethylstilbestrol	DES	PA449307	1674	0.816
NULL	Nucleic_Acids_Res_2012_Jun_10_40(11)_4804-4815.nxml.txt.nlp	22328728	SENT224	19	19	8	8	hemin	SIRT1	PA449849	23411	0.816
NULL	Mol_Cancer_2007_Oct_22_6_66.nxml.txt.nlp	17953743	SENT156	5	5	15	15	cisplatin	FasL	PA449014	356	0.816
NULL	Nat_Med_2010_Sep_29_16(9)_1001-1008.nxml.txt.nlp	20802499	SENT65	16	16	14	14	cerulenin	ARC	PA164764551	8996;23237	0.816
NULL	Mol_Cells_2014_Dec_31_37(12)_899a-906.nxml.txt.nlp	25431425	SENT202	10	10	25	25	curcumin	EP2	PA151958596	5732;10407	0.816
NULL	Mol_Cancer_2010_Apr_21_9_83.nxml.txt.nlp	20409325	SENT95	10	10	21	21	doxycycline	MYCN	PA449415	4613	0.816
NULL	J_Cell_Biol_2005_Nov_21_171(4)_729-738.nxml.txt.nlp	16286510	SENT215	22	22	28	28	heparin	MMP7	PA449855	4316	0.816
NULL	Front_Oncol_2013_Oct_1_3_237.nxml.txt.nlp	24098868	SENT114	20	20	7	7	doxorubicin	CA125	PA449412	4077;94025	0.816
NULL	Front_Oncol_2014_Sep_11_4_245.nxml.txt.nlp	25309871	SENT43	0	0	24	24	thrombin	LPA	PA451674	4018	0.816
NULL	Parasit_Vectors_2011_Aug_24_4_164.nxml.txt.nlp	21864384	SENT116	19	19	42	42	artesunate	LAMP	PA165111697	4045;27074	0.816
NULL	Breast_Cancer_Res_2010_Jul_22_12(4)_R53.nxml.txt.nlp	20649975	SENT128	21	21	24	24	tamoxifen	HOXB13	PA451581	10481	0.816
NULL	Exp_Hematol_Oncol_2013_Nov_8_2_30.nxml.txt.nlp	24499550	SENT137	6	6	15	15	vemurafenib	BRAF	PA165946873	673	0.816
NULL	Neuropsychologia_2011_Jul_49(9)_2755-2765.nxml.txt.nlp	21689671	SENT55	14	14	28	28	donepezil	LPA	PA449394	4018	0.816
NULL	Genome_Med_2009_Oct_27_1(10)_99.nxml.txt.nlp	19863774	SENT93	34	34	29	29	gemcitabine	p53	PA449748	7157	0.816
NULL	J_Oncol_2013_Feb_17_2013_872957.nxml.txt.nlp	23476648	SENT187	21	21	18	18	cisplatin	SFN	PA449014	25996;2810	0.816
NULL	Arthritis_Res_Ther_2010_Jun_2_12(3)_R107.nxml.txt.nlp	20525198	SENT118	0	0	3	3	rolipram	TNF	PA153906323	7124	0.816
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_45-53.nxml.txt.nlp	17912635	SENT36	23	23	11	11	anastrozole	aromatase	PA448432	1588	0.816
NULL	Cancer_Med_2013_Aug_10_2(4)_496-506.nxml.txt.nlp	24156022	SENT260	15	15	6	6	cetuximab	BRAF	PA10040	673	0.816
NULL	Pan_Afr_Med_J_2012_Jul_9_12_67.nxml.txt.nlp	23024826	SENT63	12	12	8	8	doxorubicin	CHOP	PA449412	1649	0.816
NULL	Mol_Med_Rep_2015_Feb_29_11(2)_865-870.nxml.txt.nlp	25352342	SENT143	30	30	17	17	mannitol	RANKL	PA450320	8600	0.816
NULL	Oncol_Rep_2012_Apr_11_27(4)_1292-1298.nxml.txt.nlp	22246465	SENT28	4	4	13	13	cisplatin	DAPK	PA449014	1612	0.816
NULL	Br_J_Cancer_2013_Mar_19_108(5)_1079-1091.nxml.txt.nlp	23449353	SENT171	13	13	25	25	docetaxel	PC3	PA449383	57332;7832;5122	0.816
NULL	Scientifica_(Cairo)_2012_Nov_25_2012_473829.nxml.txt.nlp	24278698	SENT335	30	30	7	7	cisplatin	OCT3	PA449014	5460;6581	0.816
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_May_3_64(Pt_6)_o961.nxml.txt.nlp	21202691	SENT3	20	20	4	4	ethanol	mol	PA448073	90527	0.816
NULL	J_Korean_Med_Sci_2013_Nov_31_28(11)_1609-1614.nxml.txt.nlp	24265523	SENT109	23	23	12	12	everolimus	DES	PA164746311	1674	0.816
NULL	ACS_Med_Chem_Lett_2011_May_16_2(7)_549-554.nxml.txt.nlp	21765967	SENT56	34	34	31	31	maraviroc	CCR5	PA164768835	1234	0.816
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT123	16	16	18	18	metformin	HIF-1	PA450395	29072	0.816
NULL	Evid_Based_Complement_Alternat_Med_2013_Aug_1_2013_527561.nxml.txt.nlp	23983790	SENT33	29	29	20	20	teriparatide	RANKL	PA451620	8600	0.816
NULL	J_Ayurveda_Integr_Med_2010_Oct-Dec_1(4)_257-265.nxml.txt.nlp	21731372	SENT169	2	2	19	19	curcumin	COX	PA151958596	1351	0.816
NULL	Croat_Med_J_2012_Jun_53(3)_214-223.nxml.txt.nlp	22661134	SENT64	6	6	20	20	yohimbine	ACTH	PA451946	5443	0.816
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Mar_25_65(Pt_4)_o840.nxml.txt.nlp	21582559	SENT65	33	33	13	13	ethanol	mol	PA448073	90527	0.816
NULL	Mol_Cancer_2008_Jul_24_7_64.nxml.txt.nlp	18652674	SENT134	16	16	4	4	cisplatin	XIAP	PA449014	331	0.816
NULL	Basic_Clin_Neurosci_2014_Winter_5(1)_66-73.nxml.txt.nlp	25436086	SENT179	7	7	4	4	lidocaine	LHA	PA450226	1081	0.816
NULL	Acta_Pharmacol_Sin_2010_Apr_15_31(4)_493-500.nxml.txt.nlp	20228829	SENT148	19	19	6	6	bupivacaine	p38	PA135057240	10598;1432;7965	0.816
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT263	8	8	2	2	warfarin	VKORC1	PA451906	79001	0.816
NULL	Breast_Cancer_Res_2009_Nov_18_11(6)_R85.nxml.txt.nlp	19922614	SENT103	25	25	21	21	tamoxifen	BCS	PA451581	617	0.816
NULL	Indian_J_Med_Res_2014_Feb_139(2)_195-204.nxml.txt.nlp	24718393	SENT165	16	16	32	32	itraconazole	CYP3A4	PA450132	1576	0.816
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_1-20.nxml.txt.nlp	19305785	SENT660	0	0	5	5	estradiol	KCC2	PA449503	57468	0.816
NULL	J_Infect_Dis_2012_Mar_1_205(5)_853-863.nxml.txt.nlp	22301630	SENT264	12	12	10	10	imiquimod	TLR7	PA449972	51284	0.816
NULL	Int_J_Biomed_Sci_2007_Jun_3(2)_104-111.nxml.txt.nlp	23675031	SENT174	12	12	18	18	suramin	TNF-alpha	PA10292	7124	0.816
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT213	5	5	12	12	perifosine	DR5	PA165291471	8795	0.816
NULL	AMB_Express_2012_Dec_13_2_67.nxml.txt.nlp	23237525	SENT166	11	11	4	4	mupirocin	CEN1	PA164764568	1068	0.816
NULL	Curr_Neuropharmacol_2013_Jul_11(4)_338-378.nxml.txt.nlp	24381528	SENT368	3	3	6	6	curcumin	HO-1	PA151958596	3162	0.816
NULL	J_Korean_Med_Sci_2010_Aug_21_25(8)_1222-1227.nxml.txt.nlp	20676337	SENT61	25	25	3	3	propofol	LPA	PA451141	4018	0.816
NULL	Nat_Commun_2014_5_3128.nxml.txt.nlp	24451681	SENT37	23	23	35	35	methotrexate	RRM2	PA450428	6241	0.816
NULL	Breast_Cancer_Res_2005_May_27_7(Suppl_1)_S19.nxml.txt.nlp	NULL	SENT8	33	33	23	23	tamoxifen	ATAC	PA451581	6375	0.816
NULL	EMBO_Mol_Med_2009_Jul_1(4)_223-235.nxml.txt.nlp	20049724	SENT199	30	30	25	25	fenofibrate	APLP1	PA449594	333	0.816
NULL	J_Ophthalmol_2013_Dec_18_2013_135798.nxml.txt.nlp	24455194	SENT77	8	8	19	19	tropicamide	ERG	PA164749389	2078	0.816
NULL	Cell_Death_Dis_2014_Jan_30_5(1)_e1030.nxml.txt.nlp	24481444	SENT65	1	1	19	19	sorafenib	Mcl-1	PA7000	4170	0.816
NULL	Allergy_Asthma_Clin_Immunol_2007_Mar_15_3(1)_1-9.nxml.txt.nlp	20525147	SENT132	6	6	0	0	trypsin	IFN	PA451806	3439	0.816
NULL	Front_Immunol_2013_Oct_2_4_306.nxml.txt.nlp	24106491	SENT132	3	3	5	5	cyclophosphamide	CTX	PA449165	1593	0.816
NULL	Acta_Pharmacol_Sin_2014_Sep_25_35(9)_1199-1206.nxml.txt.nlp	25152024	SENT33	18	18	22	22	cisplatin	mig-2	PA449014	10979	0.816
NULL	Acta_Pharmacol_Sin_2011_Oct_15_32(10)_1303-1308.nxml.txt.nlp	21841812	SENT128	13	13	2	2	losartan	CYP2C9	PA450268	1559	0.816
NULL	Clin_Ophthalmol_2010_Apr_26_4_369-374.nxml.txt.nlp	20463807	SENT2	18	18	31	31	bevacizumab	PED	PA130232992	8682	0.816
NULL	Biomed_Res_Int_2013_Dec_19_2013_817279.nxml.txt.nlp	24455727	SENT126	21	21	29	29	carboplatin	EGFR	PA448803	1956	0.816
NULL	Ther_Clin_Risk_Manag_2007_Aug_3(4)_569-578.nxml.txt.nlp	18472978	SENT122	18	18	10	10	metoprolol	MDC	PA450480	6367	0.816
NULL	Int_J_Biol_Sci_2014_Feb_20_10(3)_268-277.nxml.txt.nlp	24644425	SENT105	0	0	29	29	metformin	AMPK	PA450395	5563	0.816
NULL	Mol_Cells_2014_Mar_31_37(3)_234-240.nxml.txt.nlp	24642709	SENT408	10	10	6	6	cisplatin	ANOVA	PA449014	4858	0.816
NULL	Clin_Drug_Investig_2013_Aug_23_33(10)_727-736.nxml.txt.nlp	23975654	SENT170	24	24	16	16	dextromethorphan	CYP3A4	PA449273	1576	0.816
NULL	Cancer_Metab_2014_May_28_2(Suppl_1)_P14.nxml.txt.nlp	NULL	SENT17	42	42	16	16	vemurafenib	HIF-1	PA165946873	29072	0.816
NULL	Adv_Hematol_2013_Dec_24_2013_695754.nxml.txt.nlp	24454381	SENT306	11	11	23	23	imatinib	ABCG2	PA10804	9429	0.816
NULL	Crit_Care_2002_Nov_9_6(1)_24-29.nxml.txt.nlp	11940263	SENT118	24	24	39	39	methylprednisolone	IL-6	PA450466	3569	0.816
NULL	Breast_Cancer_Res_2007_Jan_23_9(1)_R7.nxml.txt.nlp	17244352	SENT193	19	19	14	14	tamoxifen	SULT1A1	PA451581	6817	0.816
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Nov_30_67(Pt_12)_o3471-o3472.nxml.txt.nlp	22199946	SENT72	29	29	13	13	ethanol	mol	PA448073	90527	0.816
NULL	Oncoimmunology_2014_Jan_17_3_e27574.nxml.txt.nlp	24800167	SENT26	25	25	28	28	cyclophosphamide	TH1	PA449165	51497	0.816
NULL	Int_J_Biol_Sci_2014_Jun_5_10(6)_614-619.nxml.txt.nlp	24948874	SENT121	13	13	2	2	paclitaxel	FOXO1	PA450761	2308	0.816
NULL	Front_Neurosci_2014_Feb_7_8_14.nxml.txt.nlp	24570653	SENT51	21	21	25	25	capsaicin	TRPM8	PA448776	79054	0.816
NULL	Mol_Cancer_2010_Oct_12_9_269.nxml.txt.nlp	20939893	SENT7	21	21	3	3	isoproterenol	STAT3	PA450121	6774	0.816
NULL	Diabetes_2009_Jan_58(1)_243-249.nxml.txt.nlp	18840785	SENT144	0	0	10	10	glucose	GLP-1	PA449773	100125288	0.816
NULL	F1000Res_2014_Apr_3_3_83.nxml.txt.nlp	24860645	SENT366	3	3	16	16	diazepam	CYP3A	PA449283	1574	0.816
NULL	Cancer_Cell_Int_2010_May_11_10_16.nxml.txt.nlp	20459793	SENT107	14	14	6	6	cisplatin	CDKN1A	PA449014	1026	0.816
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT194	2	2	9	9	doxorubicin	B7-H1	PA449412	29126	0.816
NULL	Acta_Pharmacol_Sin_2009_Sep_24_30(9)_1330-1336.nxml.txt.nlp	19701234	SENT21	24	24	9	9	ilaprazole	CYP3A5	PA165947499	1577	0.816
NULL	Ther_Clin_Risk_Manag_2006_Mar_2(1)_87-98.nxml.txt.nlp	18360584	SENT212	7	7	9	9	bevacizumab	IFN	PA130232992	3439	0.816
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Oct_17_65(Pt_11)_o2776.nxml.txt.nlp	21578369	SENT56	44	44	11	11	ethanol	mol	PA448073	90527	0.816
NULL	J_Clin_Biochem_Nutr_2009_Jan_27_44(1)_79-84.nxml.txt.nlp	19177192	SENT78	20	20	13	13	curcumin	HO-1	PA151958596	3162	0.816
NULL	Br_J_Cancer_2010_Oct_26_103(9)_1325-1330.nxml.txt.nlp	20940720	SENT156	22	22	13	13	docetaxel	CRT	PA449383	811	0.816
NULL	Int_J_Cell_Biol_2012_May_30_2012_403870.nxml.txt.nlp	22693510	SENT121	29	29	14	14	ethanol	HAP	PA448073	5915;10313	0.816
NULL	Biotechnol_Res_Int_2013_Feb_26_2013_103960.nxml.txt.nlp	23533780	SENT117	1	1	17	17	lipase	mol	PA450239	90527	0.816
NULL	Nat_Commun_2013_Aug_15_4_2130.nxml.txt.nlp	23945651	SENT116	11	11	18	18	etoposide	ATG5	PA449552	9474	0.816
NULL	Diabetes_2013_Oct_17_62(10)_3500-3513.nxml.txt.nlp	23884882	SENT10	32	32	25	25	resveratrol	PDX1		8050;3651	0.816
NULL	J_Hum_Genet_2013_Jun_2_58(6)_306-312.nxml.txt.nlp	23635953	SENT84	4	4	7	7	estradiol	TCL1A	PA449503	8115	0.816
NULL	Diabetes_2011_Nov_17_60(11)_2691-2700.nxml.txt.nlp	21896928	SENT160	19	19	8	8	resveratrol	AMPK		5563	0.816
NULL	Cancer_Cell_Int_2004_Nov_21_4_7.nxml.txt.nlp	15555067	SENT147	11	11	2	2	collagenase	AAT	PA449107	5265	0.816
NULL	Oncol_Lett_2013_Oct_24_6(4)_985-989.nxml.txt.nlp	24137450	SENT129	28	28	33	33	ifosfamide	ADM	PA449964	133	0.816
NULL	Mol_Brain_2014_May_15_7_37.nxml.txt.nlp	24886748	SENT235	1	1	21	21	vorinostat	RHEB	PA164748224	6008;6009	0.816
NULL	J_Inflamm_(Lond)_2008_Dec_5_5_23.nxml.txt.nlp	19061493	SENT190	4	4	11	11	hemin	HO-1	PA449849	3162	0.816
NULL	Biomed_Res_Int_2014_Jan_2_2014_126586.nxml.txt.nlp	24527434	SENT112	8	8	10	10	metformin	AMPK	PA450395	5563	0.816
NULL	Aging_(Albany_NY)_2009_Sep_10_1(9)_803-817.nxml.txt.nlp	20157568	SENT24	11	11	0	0	zinc	TTP	PA451956	7538;11093	0.816
NULL	J_Cell_Biol_2000_Jan_24_148(2)_325-332.nxml.txt.nlp	10648565	SENT58	23	23	0	0	ethanol	E14	PA448073	4863	0.816
NULL	Mediators_Inflamm_1998_7(6)_417-420.nxml.txt.nlp	9927235	SENT3	21	21	34	34	heparin	C5a	PA449855	727	0.816
NULL	Oxid_Med_Cell_Longev_2011_May_23_2011_213286.nxml.txt.nlp	NULL	SENT28	17	17	27	27	ethanol	CYP2E1	PA448073	1571	0.816
NULL	J_Korean_Med_Sci_2014_Jul_11_29(7)_965-972.nxml.txt.nlp	25045229	SENT94	12	12	4	4	metformin	B12	PA450395	7126;4709	0.816
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT161	15	15	18	18	dasatinib	CSK	PA162372878	1445	0.816
NULL	Br_J_Cancer_2010_Jun_29_103(1)_12-17.nxml.txt.nlp	20588278	SENT189	6	6	31	31	carboplatin	mol	PA448803	90527	0.816
NULL	Front_Microbiol_2013_Aug_19_4_241.nxml.txt.nlp	23966991	SENT241	6	6	22	22	ceftriaxone	SLC7A11	PA448866	23657	0.816
NULL	Nat_Commun_2014_Nov_25_5_5548.nxml.txt.nlp	25420520	SENT618	14	14	19	19	cabazitaxel	ERG	PA165958401	2078	0.816
NULL	ISRN_Otolaryngol_2012_Nov_14_2012_797619.nxml.txt.nlp	23762619	SENT80	22	22	26	26	gefitinib	EGF	PA131301952	1950	0.816
NULL	Cell_Commun_Signal_2009_Aug_27_7_20.nxml.txt.nlp	19712465	SENT307	5	5	11	11	carbachol	ERK2	PA448784	5594	0.816
NULL	J_Invest_Dermatol_2013_Aug_133(8)_1928-1929.nxml.txt.nlp	23856932	SENT39	18	18	25	25	vemurafenib	STAT3	PA165946873	6774	0.816
NULL	Oncologist_2011_Feb_25_16(2)_155-164.nxml.txt.nlp	21266401	SENT18	7	7	3	3	trastuzumab	HER-2	PA451743	2064	0.816
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT128	5	5	16	16	resveratrol	PARP		142	0.816
NULL	JRSM_Cardiovasc_Dis_2012_Sep_24_1(6)_cvd_2012_012015.nxml.txt.nlp	24175073	SENT35	8	8	3	3	clopidogrel	CYP2C19	PA449053	1557	0.816
NULL	Front_Neurosci_2014_Nov_10_8_364.nxml.txt.nlp	25426018	SENT261	29	29	2	2	fluorescein	ANOVA	PA164746009	4858	0.816
NULL	Ann_Hematol_2010_Sep_13_89(9)_861-871.nxml.txt.nlp	20387067	SENT209	14	14	22	22	dasatinib	GM-CSF	PA162372878	1437	0.816
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Dec_17_3(12)_e152.nxml.txt.nlp	25518025	SENT46	3	3	11	11	oxymorphone	CYP3A4	PA450748	1576	0.816
NULL	Blood_Cancer_J_2014_Aug_8_4(8)_e237.nxml.txt.nlp	25105536	SENT11	9	9	7	7	sorafenib	CYP3A4	PA7000	1576	0.816
NULL	Br_J_Cancer_2004_Mar_22_90(6)_1285-1292.nxml.txt.nlp	15026814	SENT200	16	16	3	3	doxorubicin	p53	PA449412	7157	0.816
NULL	Oncotarget_2014_Jun_11_5(21)_10407-10420.nxml.txt.nlp	25431951	SENT206	27	27	23	23	imatinib	BRAF	PA10804	673	0.816
NULL	Br_J_Cancer_2013_Feb_19_108(3)_557-563.nxml.txt.nlp	23361053	SENT226	3	3	12	12	tamoxifen	PAK1	PA451581	5585;5058	0.816
NULL	Crit_Care_2011_Nov_23_15(6)_R278.nxml.txt.nlp	22112587	SENT174	0	0	28	28	ephedrine	LIR	PA449466	10871	0.816
NULL	Acta_Psychiatr_Scand_2014_Sep_21_130(3)_163-180.nxml.txt.nlp	24649967	SENT232	12	12	16	16	s-adenosylmethionine	B12	PA164754994	7126;4709	0.816
NULL	Arthritis_Res_Ther_2010_Jan_29_12(1)_R18.nxml.txt.nlp	20113495	SENT139	2	2	15	15	glucosamine	p65	PA164747613	5970	0.816
NULL	Br_J_Pharmacol_2010_Aug_160(8)_1997-2007.nxml.txt.nlp	20649597	SENT119	7	7	12	12	pp2	NOS2		339345;4843	0.816
NULL	J_Breast_Cancer_2013_Jun_28_16(2)_138-145.nxml.txt.nlp	23843844	SENT111	17	17	28	28	tamoxifen	STAT3	PA451581	6774	0.816
NULL	Oncol_Lett_2013_Feb_7_5(2)_440-446.nxml.txt.nlp	23420122	SENT109	8	8	27	27	gemcitabine	Bcl-2	PA449748	596	0.816
NULL	Br_J_Cancer_2012_Oct_9_107(8)_1327-1336.nxml.txt.nlp	22990650	SENT179	20	20	41	41	carboplatin	ERBB2	PA448803	2064	0.816
NULL	Case_Rep_Hematol_2014_Dec_11_2014_743856.nxml.txt.nlp	25580315	SENT38	5	5	26	26	cyclophosphamide	CHOP	PA449165	1649	0.816
NULL	Dement_Geriatr_Cogn_Dis_Extra_2014_Nov_15_4(3)_450-456.nxml.txt.nlp	25538729	SENT4	35	35	27	27	donepezil	APOE	PA449394	348	0.816
NULL	Eur_J_Clin_Pharmacol_2012_Sep_15_68(9)_1267-1274.nxml.txt.nlp	22418828	SENT9	28	28	36	36	pantoprazole	CYP2C19	PA450774	1557	0.816
NULL	Acta_Pharmacol_Sin_2009_Sep_24_30(9)_1262-1275.nxml.txt.nlp	19701231	SENT141	16	16	6	6	lovastatin	INSIG2	PA450272	51141	0.816
NULL	Oncotarget_2013_Jun_4_4(5)_772-784.nxml.txt.nlp	23800712	SENT6	29	29	12	12	dasatinib	EGFR	PA162372878	1956	0.816
NULL	Braz_J_Med_Biol_Res_2014_Sep_5_47(11)_1008-1015.nxml.txt.nlp	25296365	SENT27	29	29	0	0	tamoxifen	TMX	PA451581	81542	0.816
NULL	Breast_Cancer_Res_2007_Jan_23_9(1)_R7.nxml.txt.nlp	17244352	SENT201	8	8	14	14	tamoxifen	CYP2D6	PA451581	1565	0.816
NULL	J_Cell_Sci_2011_Jul_1_124(13)_2310-2320.nxml.txt.nlp	21652632	SENT96	14	14	7	7	l-methionine	PRMT1	PA450423	3276	0.816
NULL	Case_Rep_Oncol_Med_2013_Nov_26_2013_862585.nxml.txt.nlp	24371535	SENT9	7	7	16	16	cyclophosphamide	CHOP	PA449165	1649	0.816
NULL	Indian_J_Pharmacol_2014_Nov-Dec_46(6)_627-632.nxml.txt.nlp	25538335	SENT4	16	16	11	11	metformin	Q10	PA450395	27161	0.816
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT10	6	6	21	21	gefitinib	KRAS	PA131301952	3845	0.816
NULL	Cell_Death_Dis_2010_Feb_4_1(2)_e23.nxml.txt.nlp	21364631	SENT100	28	28	17	17	desipramine	ZAP70	PA449233	7535	0.816
NULL	Mol_Imaging_Radionucl_Ther_2013_Aug_1_22(2)_49-55.nxml.txt.nlp	24003397	SENT34	18	18	6	6	octreotide	ACTH	PA450678	5443	0.816
NULL	Eur_J_Med_Res_2009_Dec_7_14(Suppl_4)_71-77.nxml.txt.nlp	20156730	SENT139	7	7	23	23	tobramycin	PARI	PA451704	55010	0.816
NULL	Br_J_Cancer_2012_Sep_4_107(6)_947-955.nxml.txt.nlp	22892392	SENT209	15	15	11	11	trastuzumab	ERBB2	PA451743	2064	0.816
NULL	Front_Immunol_2013_Nov_8_4_363.nxml.txt.nlp	24265631	SENT255	11	11	23	23	dacarbazine	CXCL9	PA449197	4283	0.816
NULL	J_Exp_Clin_Cancer_Res_2009_Feb_13_28(1)_17.nxml.txt.nlp	19216775	SENT15	13	13	5	5	cisplatin	TP53	PA449014	7157	0.816
NULL	Case_Rep_Ophthalmol_2010_Aug_18_1(1)_36-41.nxml.txt.nlp	21369348	SENT40	19	19	15	15	bevacizumab	hole	PA130232992	80757	0.816
NULL	J_Cell_Biol_1998_Nov_30_143(5)_1317-1328.nxml.txt.nlp	9832559	SENT119	26	26	36	36	trypsin	EGF	PA451806	1950	0.816
NULL	Mol_Syst_Biol_2011_Apr_26_7_486.nxml.txt.nlp	21525872	SENT137	29	29	26	26	gefitinib	EGFR	PA131301952	1956	0.816
NULL	Br_J_Cancer_2011_Apr_12_104(8)_1241-1245.nxml.txt.nlp	21364581	SENT80	24	24	20	20	pertuzumab	EGFR		1956	0.816
NULL	Oncotarget_2014_Mar_13_5(4)_1101-1110.nxml.txt.nlp	24658355	SENT167	36	36	16	16	tamoxifen	MKP-2	PA451581	1846	0.816
NULL	Protein_Cell_2014_Jun_19_5(6)_469-479.nxml.txt.nlp	24748116	SENT106	11	11	6	6	paclitaxel	EB1	PA450761	9167;22919;10982	0.816
NULL	Nucl_Recept_Signal_2009_Dec_31_7_e012.nxml.txt.nlp	20087433	SENT194	0	0	20	20	indomethacin	cGKII	PA449982	5593	0.816
NULL	Mol_Cancer_2009_Dec_23_8_129.nxml.txt.nlp	20030852	SENT199	1	1	4	4	curcumin	survivin	PA151958596	332	0.816
NULL	Br_J_Cancer_2009_Jul_21_101(2)_269-277.nxml.txt.nlp	19603033	SENT156	13	13	8	8	cisplatin	XIAP	PA449014	331	0.816
NULL	Cell_Commun_Signal_2014_Sep_25_12(1)_61.nxml.txt.nlp	NULL	SENT355	24	24	0	0	doxycycline	PC-3	PA449415	692094	0.816
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT220	4	4	9	9	capsaicin	p53	PA448776	7157	0.816
NULL	Mol_Cancer_2013_Mar_2_12_16.nxml.txt.nlp	23452820	SENT139	18	18	8	8	chloroquine	PI3K	PA448948	5290	0.816
NULL	Mol_Cancer_2014_Jul_5_13_165.nxml.txt.nlp	24996221	SENT112	20	20	8	8	docetaxel	HMGB1	PA449383	3146	0.816
NULL	Int_J_Med_Sci_2015_Jan_5_12(2)_135-140.nxml.txt.nlp	25589889	SENT89	7	7	21	21	aripiprazole	NMS	PA10026	129521	0.816
NULL	Braz_J_Med_Biol_Res_2014_Jan_10_47(1)_60-69.nxml.txt.nlp	24519092	SENT162	33	33	15	15	doxorubicin	YWHAZ	PA449412	7534	0.816
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT115	17	17	23	23	neratinib	HER2	PA165291472	2064	0.816
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Sep_14_67(Pt_10)_o2646.nxml.txt.nlp	22064771	SENT67	6	6	9	9	phenol	mol	PA450913	90527	0.816
NULL	Curr_Pharm_Des_2008_Dec_14(34)_3637-3655.nxml.txt.nlp	19075740	SENT500	32	32	8	8	chloroquine	MPG	PA448948	4350	0.816
NULL	Clin_Drug_Investig_2015_Dec_16_35_141-147.nxml.txt.nlp	25511640	SENT91	3	3	15	15	miglitol	GLP-1	PA164776726	100125288	0.816
NULL	J_Occup_Med_Toxicol_2008_Feb_27_3(Suppl_1)_S6.nxml.txt.nlp	18315837	SENT93	5	5	19	19	montelukast	IL-5	PA450546	3567	0.816
NULL	Br_J_Cancer_2012_Jan_17_106(2)_284-289.nxml.txt.nlp	22215065	SENT130	11	11	8	8	atrasentan	IFN	PA143414738	3439	0.816
NULL	Oncoimmunology_2013_Oct_1_2(10)_e26333.nxml.txt.nlp	24251081	SENT62	0	0	5	5	pertuzumab	HER2		2064	0.816
NULL	Oncogene_2014_Aug_28_33(35)_4407-4417.nxml.txt.nlp	24469038	SENT44	26	26	17	17	cisplatin	p53	PA449014	7157	0.816
NULL	J_Inflamm_(Lond)_2004_Sep_30_1_3.nxml.txt.nlp	15813980	SENT92	5	5	8	8	losartan	AT1	PA450268	9197;185	0.816
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_4_2013_378657.nxml.txt.nlp	23662132	SENT495	23	23	15	15	sitagliptin	GLP-1	PA164748978	100125288	0.815
NULL	Clin_Pharmacol_2013_Dec_10_5_193-199.nxml.txt.nlp	24353447	SENT82	15	15	12	12	fexofenadine	CYP3A4	PA449621	1576	0.815
NULL	Clin_Pharmacol_2011_Jun_22_3_13-25.nxml.txt.nlp	22287853	SENT186	27	27	18	18	saxagliptin	CYP3A4	PA165958362	1576	0.815
NULL	Cent_European_J_Urol_2013_Aug_13_66(2)_144-149.nxml.txt.nlp	24579014	SENT41	23	23	34	34	cytarabine	survivin	PA449177	332	0.815
NULL	Acta_Pharmacol_Sin_2009_Oct_21_30(10)_1392-1398.nxml.txt.nlp	19767766	SENT14	2	2	27	27	atorvastatin	NAC	PA448500	22861	0.815
NULL	Breast_Cancer_Res_2010_May_18_12(Suppl_1)_P41.nxml.txt.nlp	NULL	SENT16	20	20	7	7	doxorubicin	MCPH1	PA449412	79648	0.815
NULL	Mol_Cancer_2007_Oct_22_6_66.nxml.txt.nlp	17953743	SENT157	16	16	19	19	cisplatin	TRAIL	PA449014	8743	0.815
NULL	Nat_Commun_2010_Nov_16_1_117.nxml.txt.nlp	21081915	SENT218	1	1	33	33	minocycline	C17	PA450519	54360	0.815
NULL	J_Breast_Cancer_2013_Jun_28_16(2)_133-137.nxml.txt.nlp	23843843	SENT34	4	4	9	9	curcumin	Bcl-2	PA151958596	596	0.815
NULL	Oncotarget_2014_Jun_6_5(13)_4935-4944.nxml.txt.nlp	24952732	SENT82	11	11	36	36	doxazosin	PI3K	PA449407	5290	0.815
NULL	Int_J_Mol_Sci_2014_Oct_8_15(10)_17974-17999.nxml.txt.nlp	25299695	SENT119	4	4	13	13	curcumin	HO-1	PA151958596	3162	0.815
NULL	Oncogene_2013_Sep_26_32(39)_10_1038_onc_2012_491.nxml.txt.nlp	23108394	SENT46	12	12	17	17	epirubicin	FOXM1	PA449476	2305	0.815
NULL	Exp_Diabetes_Res_2011_Jun_23_2011_898913.nxml.txt.nlp	21747834	SENT196	0	0	5	5	liraglutide	GLP-1	PA165958364	100125288	0.815
NULL	Oncotarget_2014_Aug_29_5(19)_8947-8958.nxml.txt.nlp	25333254	SENT112	8	8	16	16	plerixafor	CD49d	PA165958410	3676	0.815
NULL	Mol_Cancer_2014_Feb_4_13_21.nxml.txt.nlp	24495750	SENT120	13	13	7	7	oxaliplatin	AKT	PA131285527	207	0.815
NULL	J_Cell_Mol_Med_2013_Sep_24_17(9)_1065-1087.nxml.txt.nlp	24151975	SENT176	23	23	12	12	palifermin	CD4	PA164744014	920	0.815
NULL	J_Korean_Med_Sci_2007_Apr_30_22(2)_283-289.nxml.txt.nlp	17449938	SENT97	0	0	5	5	minoxidil	Bcl-2	PA450521	596	0.815
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT378	34	34	28	28	resveratrol	SIRT1		23411	0.815
NULL	Blood_Cancer_J_2013_Jun_7_3(6)_e120.nxml.txt.nlp	23749045	SENT228	3	3	12	12	imatinib	JAG2	PA10804	3714	0.815
NULL	Cardiovasc_Diabetol_2006_Sep_26_5_20.nxml.txt.nlp	17002798	SENT114	23	23	17	17	cholestyramine	CAD	PA448974	1677;790	0.815
NULL	Int_J_Environ_Res_Public_Health_2011_Jul_30_8(7)_2747-2757.nxml.txt.nlp	21845156	SENT56	12	12	3	3	trypsin	CTRC	PA451806	11330	0.815
NULL	Pharmaceutics_2010_Jul_2_2(3)_275-290.nxml.txt.nlp	NULL	SENT272	6	6	18	18	theophylline	ANOVA	PA451647	4858	0.815
NULL	Nat_Commun_2014_Nov_25_5_5548.nxml.txt.nlp	25420520	SENT424	17	17	9	9	doxorubicin	MDR1	PA449412	5243	0.815
NULL	Int_J_Mol_Sci_2014_Sep_5_15(9)_15754-15765.nxml.txt.nlp	25198898	SENT69	6	6	17	17	curcumin	MKK4	PA151958596	6416	0.815
NULL	Mol_Cancer_2014_Aug_16_13(1)_193.nxml.txt.nlp	NULL	SENT130	14	14	45	45	cisplatin	RKIP	PA449014	5037	0.815
NULL	J_Biol_Chem_2013_Jul_19_288(29)_21412-21421.nxml.txt.nlp	23740251	SENT12	6	6	31	31	suramin	P2X2	PA10292	22953	0.815
NULL	J_Med_Case_Rep_2013_May_31_7_144.nxml.txt.nlp	23724918	SENT37	19	19	3	3	mannitol	NAC	PA450320	22861	0.815
NULL	J_Asthma_Allergy_2008_Sep_19_1_19-29.nxml.txt.nlp	21436982	SENT59	11	11	1	1	itraconazole	MDR1	PA450132	5243	0.815
NULL	Acta_Crystallogr_F_Struct_Biol_Commun_2014_Mar_25_70(Pt_4)_444-449.nxml.txt.nlp	24699735	SENT186	7	7	1	1	thrombin	TSH2B	PA451674	255626	0.815
NULL	Mol_Cancer_2009_Nov_19_8_107.nxml.txt.nlp	19925653	SENT278	9	9	0	0	gefitinib	EGFR	PA131301952	1956	0.815
NULL	Indian_J_Anaesth_2012_Jan-Feb_56(1)_89-90.nxml.txt.nlp	22529433	SENT5	7	7	16	16	tramadol	CYP2D6	PA451735	1565	0.815
NULL	J_Cell_Biol_2001_Apr_2_153(1)_207-220.nxml.txt.nlp	11285286	SENT101	3	3	17	17	carbachol	DAG	PA448784	1605	0.815
NULL	Clin_Pharmacokinet_2014_Sep_3_53(1)_1-16.nxml.txt.nlp	23999929	SENT269	15	15	7	7	rivaroxaban	CYP3A4	PA165958360	1576	0.815
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT48	36	36	24	24	erlotinib	AMPK	PA134687924	5563	0.815
NULL	Cardiovasc_Diabetol_2010_Jul_27_9_31.nxml.txt.nlp	20663195	SENT14	30	30	23	23	irbesartan	CD31	PA450084	5175	0.815
NULL	Trials_2014_Oct_27_15(1)_412.nxml.txt.nlp	NULL	SENT65	10	10	19	19	chloroquine	IL-6	PA448948	3569	0.815
NULL	Hum_Genomics_Proteomics_2010_Sep_13_2010_754919.nxml.txt.nlp	20981234	SENT98	6	6	15	15	phenprocoumon	CYP2C9	PA450921	1559	0.815
NULL	J_Gen_Physiol_2004_Apr_123(4)_427-439.nxml.txt.nlp	15024039	SENT488	14	14	16	16	genistein	PP2	PA165109660	4888	0.815
NULL	Diabetes_Obes_Metab_2012_Apr_14(4)_304-314.nxml.txt.nlp	22051096	SENT148	5	5	0	0	liraglutide	GLP-1	PA165958364	100125288	0.815
NULL	Br_J_Pharmacol_2011_May_163(2)_261-271.nxml.txt.nlp	21054345	SENT131	25	25	11	11	forskolin	GLP-1	PA146096022	100125288	0.815
NULL	Oncol_Lett_2014_Apr_22_7(4)_1191-1196.nxml.txt.nlp	24944691	SENT115	22	22	10	10	vinblastine	MDR1	PA451877	5243	0.815
NULL	Multidiscip_Respir_Med_2013_Sep_4_8(1)_59.nxml.txt.nlp	24135224	SENT128	29	29	16	16	voriconazole	IPA	PA10233	3160	0.815
NULL	Nat_Med_2012_Jan_15_18(2)_286-290.nxml.txt.nlp	22245782	SENT55	19	19	8	8	indomethacin	PKG	PA449982	5592	0.815
NULL	Iran_J_Pharm_Res_2013_Summer_12(3)_521-527.nxml.txt.nlp	24250658	SENT28	6	6	25	25	methamphetamine	Bcl-2	PA450403	596	0.815
NULL	Arthritis_Res_Ther_2010_Feb_24_12(1)_R32.nxml.txt.nlp	20181277	SENT10	7	7	18	18	imatinib	M-CSF	PA10804	1435	0.815
NULL	Oncotarget_2014_Sep_9_5(20)_9811-9822.nxml.txt.nlp	25238146	SENT194	8	8	16	16	collagenase	CD133	PA449107	8842	0.815
NULL	EMBO_Mol_Med_2013_Aug_4_5(8)_1180-1195.nxml.txt.nlp	23828858	SENT11	15	15	7	7	rituximab	MYC	PA451261	4609	0.815
NULL	Cells_2014_Apr_29_3(2)_331-362.nxml.txt.nlp	24785347	SENT273	0	0	30	30	lidocaine	TRPA1	PA450226	8989	0.815
NULL	Br_J_Cancer_2013_May_14_108(9)_1807-1809.nxml.txt.nlp	23612454	SENT54	32	32	26	26	trastuzumab	PIK3CA	PA451743	5290	0.815
NULL	Cancer_Cell_Int_2013_May_15_13_42.nxml.txt.nlp	23672670	SENT184	24	24	3	3	paclitaxel	PIDD	PA450761	55367	0.815
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT39	10	10	37	37	capsaicin	p53	PA448776	7157	0.815
NULL	J_Headache_Pain_2013_Apr_10_14(1)_33.nxml.txt.nlp	23574808	SENT186	9	9	2	2	capsaicin	CO2	PA448776	4513	0.815
NULL	Cancer_Cell_Int_2005_Aug_23_5_27.nxml.txt.nlp	16117829	SENT141	16	16	7	7	doxycycline	p53	PA449415	7157	0.815
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT281	14	14	30	30	nutlin-3	DR5		8795	0.815
NULL	Acta_Pharmacol_Sin_2011_Jul_13_32(7)_967-972.nxml.txt.nlp	21666702	SENT139	5	5	12	12	ticlopidine	CYP2C19	PA451686	1557	0.815
NULL	Curr_Cardiol_Rev_2012_May_8(2)_158-165.nxml.txt.nlp	22708914	SENT198	12	12	20	20	enoxaparin	TKR	PA449463	8277	0.815
NULL	Arthritis_Res_Ther_2008_Jan_7_10(1)_R1.nxml.txt.nlp	18179697	SENT170	15	15	6	6	oxaliplatin	HMGB1	PA131285527	3146	0.815
NULL	Br_J_Cancer_1981_Apr_43(4)_451-457.nxml.txt.nlp	7236488	SENT11	6	6	25	25	cyclophosphamide	DEF	PA449165	27042	0.815
NULL	J_Oncol_2009_Mar_24_2009_491985.nxml.txt.nlp	19325924	SENT165	17	17	5	5	genistein	CXCL12	PA165109660	6387	0.815
NULL	Chem_Cent_J_2013_Jul_31_7_133.nxml.txt.nlp	23899303	SENT4	15	15	7	7	ofloxacin	MOX	PA450684	26002	0.815
NULL	Cancer_Immunol_Immunother_2013_Aug_27_62(10)_1637-1648.nxml.txt.nlp	23982484	SENT181	0	0	9	9	lenalidomide	STAT3	PA162363968	6774	0.815
NULL	Drug_Saf_2014_Feb_19_37(4)_201-211.nxml.txt.nlp	24550106	SENT132	16	16	10	10	phenytoin	CYP2C19	PA450947	1557	0.815
NULL	J_Lipid_Res_2014_Dec_55(12)_2562-2575.nxml.txt.nlp	25316883	SENT25	11	11	26	26	lipase	ATGL	PA450239	57104	0.815
NULL	Viruses_2009_Nov_30_1(3)_1073-1088.nxml.txt.nlp	21994583	SENT197	13	13	6	6	ribavirin	IL28B	PA451241	282617	0.815
NULL	BMB_Rep_2014_May_47(5)_274-279.nxml.txt.nlp	24286313	SENT99	15	15	4	4	bortezomib	CD52	PA10252	1043	0.815
NULL	J_Oncol_2013_Apr_29_2013_854121.nxml.txt.nlp	23737784	SENT120	24	24	39	39	capecitabine	PTEN	PA448771	5728	0.815
NULL	Front_Immunol_2012_May_4_3_98.nxml.txt.nlp	22566974	SENT29	9	9	16	16	doxorubicin	CHOP	PA449412	1649	0.815
NULL	Arthritis_Res_Ther_2014_Oct_30_16(5)_474.nxml.txt.nlp	25359291	SENT63	18	18	7	7	methotrexate	ACPA	PA450428	5657	0.815
NULL	Oncol_Lett_2013_Mar_19_5(3)_923-928.nxml.txt.nlp	23426648	SENT191	8	8	3	3	celecoxib	COX	PA448871	1351	0.815
NULL	Am_J_Trop_Med_Hyg_2014_Mar_5_90(3)_530-534.nxml.txt.nlp	24420779	SENT46	7	7	14	14	nevirapine	CD4	PA450616	920	0.815
NULL	Chem_Res_Toxicol_2012_Nov_19_25(11)_2567-2576.nxml.txt.nlp	23016703	SENT391	23	23	11	11	isoniazid	CYP2E1	PA450112	1571	0.815
NULL	J_Hum_Genet_2013_Jun_16_58(6)_353-361.nxml.txt.nlp	23677058	SENT158	0	0	6	6	fludarabine	CNT3	PA449655	64078	0.815
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT80	8	8	10	10	nutlin-3	IBP		706;50619	0.815
NULL	Eur_J_Endocrinol_2012_Jun_166(6)_1049-1060.nxml.txt.nlp	22457234	SENT232	36	36	24	24	sorafenib	BCL2	PA7000	596	0.815
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT151	38	38	19	19	glucose	EGFR	PA449773	1956	0.815
NULL	Acta_Pharmacol_Sin_2013_Jan_19_34(1)_146-156.nxml.txt.nlp	23160340	SENT173	8	8	19	19	vinblastine	CYP3A4	PA451877	1576	0.815
NULL	Environ_Health_Perspect_2008_Sep_16_116(9)_1203-1210.nxml.txt.nlp	18795164	SENT71	25	25	9	9	ethanol	VIII	PA448073	1351	0.815
NULL	Cancer_Cell_Int_2013_Feb_8_13_11.nxml.txt.nlp	23394616	SENT151	36	36	10	10	geldanamycin	Hsp90	PA152031327	3320	0.815
NULL	Arthritis_Res_Ther_2006_May_5_8(3)_R83.nxml.txt.nlp	16677395	SENT131	2	2	10	10	rituximab	CD40L	PA451261	959	0.815
NULL	Br_J_Cancer_2010_Feb_16_102(4)_774-782.nxml.txt.nlp	20087350	SENT134	32	32	19	19	tetracycline	CLCN4	PA451640	1183	0.815
NULL	Indian_J_Endocrinol_Metab_2015_Jan-Feb_19(1)_30-38.nxml.txt.nlp	25593823	SENT106	18	18	12	12	sitagliptin	adiponectin	PA164748978	9370	0.815
NULL	Breast_Cancer_Res_2008_May_12_10(3)_R43.nxml.txt.nlp	18471300	SENT151	2	2	22	22	estradiol	p53	PA449503	7157	0.815
NULL	Adv_Appl_Bioinforma_Chem_2008_Oct_30_1_85-98.nxml.txt.nlp	21918608	SENT175	4	4	8	8	bortezomib	SPARC	PA10252	6678	0.815
NULL	Breast_Cancer_(Auckl)_2014_May_12_8_81-88.nxml.txt.nlp	24855372	SENT3	27	27	19	19	pertuzumab	HER2		2064	0.815
NULL	J_Nat_Med_2015_Aug_7_69_1-21.nxml.txt.nlp	25099952	SENT209	13	13	44	44	ethanol	CA1	PA448073	759	0.815
NULL	Arthritis_Res_Ther_2008_Mar_17_10(2)_R33.nxml.txt.nlp	18346273	SENT122	9	9	30	30	infliximab	CD163	PA452639	9332	0.815
NULL	Brain_Res_2013_Jul_12_1521(100)_1-15.nxml.txt.nlp	22789905	SENT835	14	14	44	44	verapamil	P-gp	PA451868	5243	0.815
NULL	Carcinogenesis_2010_Dec_27_31(12)_2049-2057.nxml.txt.nlp	20876285	SENT239	27	27	23	23	tamoxifen	HER2	PA451581	2064	0.815
NULL	Br_J_Cancer_2012_Aug_21_107(5)_823-830.nxml.txt.nlp	22836512	SENT164	10	10	13	13	pemetrexed	EGFR	PA10810	1956	0.815
NULL	Br_J_Cancer_2012_Dec_4_107(12)_1950-1955.nxml.txt.nlp	23169295	SENT26	3	3	15	15	tegafur	CDHP	PA452620	1001	0.815
NULL	Diabetes_2011_Jun_21_60(6)_1797-1804.nxml.txt.nlp	21536946	SENT75	5	5	38	38	diazoxide	San	PA449285	80218	0.815
NULL	Mol_Imaging_Radionucl_Ther_2012_Dec_20_21(3)_110-113.nxml.txt.nlp	23486376	SENT9	19	19	7	7	glucose	FDG	PA449773	23583	0.815
NULL	Exp_Ther_Med_2014_Sep_14_8(3)_836-840.nxml.txt.nlp	25120610	SENT88	4	4	21	21	fasudil	ROCK1	PA165946121	6093	0.815
NULL	Calcif_Tissue_Int_2014_Aug_21_94(2)_170-175.nxml.txt.nlp	23963633	SENT122	1	1	26	26	teriparatide	PTH	PA451620	5741	0.815
NULL	Oncol_Lett_2014_May_4_7(5)_1352-1362.nxml.txt.nlp	24765137	SENT187	34	34	15	15	cisplatin	HMGB1	PA449014	3146	0.815
NULL	Pharmaceutics_2011_Aug_10_3(3)_474-484.nxml.txt.nlp	24310591	SENT16	0	0	8	8	cyanocobalamin	B12	PA451892	7126;4709	0.815
NULL	Diabetes_2011_Jul_20_60(7)_1907-1916.nxml.txt.nlp	21593200	SENT247	27	27	38	38	glucose	TNF	PA449773	7124	0.815
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT1674	34	34	24	24	troglitazone	UGT	PA451799	7361;7355	0.815
NULL	Br_J_Cancer_2011_Aug_23_105(5)_658-665.nxml.txt.nlp	21829201	SENT56	37	37	39	39	capecitabine	DCX	PA448771	1641	0.815
NULL	Onco_Targets_Ther_2014_Sep_5_7_1551-1562.nxml.txt.nlp	25228814	SENT127	34	34	13	13	bevacizumab	MMP9	PA130232992	4318	0.815
NULL	Eur_J_Med_Res_2011_Jun_21_16(6)_265-274.nxml.txt.nlp	21810561	SENT207	14	14	8	8	cisplatin	DDP	PA449014	1678	0.815
NULL	Chem_Cent_J_2013_Sep_23_7_159.nxml.txt.nlp	24059652	SENT122	30	30	2	2	ethanol	flower	PA448073	11094	0.815
NULL	J_Cell_Biol_1997_Mar_24_136(6)_1213-1226.nxml.txt.nlp	9087438	SENT61	2	2	13	13	creatine	San	PA164778930	80218	0.815
NULL	Acta_Pharmacol_Sin_2009_Jul_22_30(7)_956-964.nxml.txt.nlp	19543298	SENT172	4	4	6	6	simvastatin	ABCC2	PA451363	1244	0.815
NULL	Hum_Mol_Genet_2013_Nov_15_22(22)_4616-4626.nxml.txt.nlp	23814041	SENT123	8	8	14	14	doxycycline	neuroserpin	PA449415	5274	0.815
NULL	Clin_Epidemiol_2009_Aug_9_1_19-26.nxml.txt.nlp	20865083	SENT16	31	31	0	0	haloperidol	Ray	PA449841	26751	0.815
NULL	J_Invest_Dermatol_2012_Nov_21_132(11)_2642-2651.nxml.txt.nlp	22718118	SENT51	12	12	17	17	collagenase	CD11b	PA449107	3684	0.815
NULL	Core_Evid_2009_Jun_15_4_25-36.nxml.txt.nlp	20694062	SENT185	24	24	10	10	febuxostat	FACT	PA165958521	11198	0.815
NULL	Oncoimmunology_2013_May_1_2(5)_e24320.nxml.txt.nlp	23762807	SENT10	8	8	13	13	vemurafenib	BRAF	PA165946873	673	0.815
NULL	Cancer_Cell_Int_2013_Apr_30_13_38.nxml.txt.nlp	23631593	SENT368	22	22	17	17	gefitinib	EGFR	PA131301952	1956	0.815
NULL	Cancers_(Basel)_2013_Nov_7_5(4)_1456-1468.nxml.txt.nlp	24213559	SENT553	21	21	40	40	irinotecan	SNO	PA450085	6498	0.815
NULL	Onco_Targets_Ther_2014_Sep_9_7_1571-1582.nxml.txt.nlp	25228815	SENT106	15	15	10	10	sunitinib	VEGFR1	PA162372840	2321	0.815
NULL	Apoptosis_2014_Aug_26_19(11)_1603-1615.nxml.txt.nlp	25156145	SENT180	6	6	0	0	mitomycin	TRAIL	PA450524	8743	0.815
NULL	J_Korean_Med_Sci_2001_Dec_16(6)_809-813.nxml.txt.nlp	11748369	SENT12	19	19	22	22	acetazolamide	EA2	PA448018	773	0.815
NULL	Reprod_Biol_Endocrinol_2003_Oct_7_1_71.nxml.txt.nlp	14577832	SENT108	0	0	25	25	cisplatin	p38	PA449014	10598;1432;7965	0.815
NULL	Br_J_Cancer_2013_Mar_19_108(5)_1079-1091.nxml.txt.nlp	23449353	SENT117	8	8	21	21	docetaxel	MIC-1	PA449383	29919;9518	0.815
NULL	Diabetes_2009_Dec_31_58(12)_2851-2862.nxml.txt.nlp	19720788	SENT272	7	7	35	35	forskolin	PERK	PA146096022	9451	0.815
NULL	Open_Biochem_J_2011_Sep_23_5_45-51.nxml.txt.nlp	21966325	SENT125	9	9	13	13	indomethacin	PERK	PA449982	9451	0.815
NULL	J_Exp_Clin_Cancer_Res_2008_Sep_26_27(1)_48.nxml.txt.nlp	18822137	SENT126	23	23	12	12	cisplatin	XIAP	PA449014	331	0.815
NULL	Sensors_(Basel)_2013_Aug_16_13(8)_10711-10724.nxml.txt.nlp	23959236	SENT78	30	30	3	3	ethanol	GOX	PA448073	54363	0.815
NULL	Cell_Death_Dis_2014_Jan_9_5(1)_e988.nxml.txt.nlp	24407241	SENT102	27	27	13	13	sorafenib	PSTPIP2	PA7000	9050	0.815
NULL	Nucleic_Acids_Res_2007_Jul_10_35(13)_e93.nxml.txt.nlp	17626049	SENT56	32	32	0	0	galactose	DFF40	PA449725	1677	0.815
NULL	Chem_Cent_J_2012_May_11_6_41.nxml.txt.nlp	22578215	SENT61	7	7	21	21	naringin	castor	PA151958360	54897	0.815
NULL	Clinics_(Sao_Paulo)_2013_May_68(5)_694-701.nxml.txt.nlp	23778405	SENT136	9	9	15	15	curcumin	MDR1	PA151958596	5243	0.815
NULL	J_Biol_Chem_2013_Dec_6_288(49)_35387-35395.nxml.txt.nlp	24142790	SENT161	8	8	12	12	meclizine	PCYT2	PA450338	5833	0.815
NULL	Cancers_(Basel)_2011_Apr_1_3(2)_1844-1860.nxml.txt.nlp	24212785	SENT566	12	12	6	6	cetuximab	EGFR	PA10040	1956	0.815
NULL	Diabetes_Obes_Metab_2011_Apr_13(4)_348-356.nxml.txt.nlp	21205128	SENT93	12	12	3	3	liraglutide	PPG	PA165958364	5552	0.815
NULL	Crit_Care_2011_Nov_23_15(6)_R278.nxml.txt.nlp	22112587	SENT174	0	0	14	14	ephedrine	LIR	PA449466	10871	0.815
NULL	Libyan_J_Med_2008_Mar_1_3(1)_42-48.nxml.txt.nlp	21499481	SENT253	20	20	17	17	amodiaquine	ACT	PA448404	12;11332;9457;641455	0.815
NULL	Genome_Med_2009_Oct_27_1(10)_99.nxml.txt.nlp	19863774	SENT53	22	22	10	10	etoposide	E2F1	PA449552	1869	0.815
NULL	Biologics_2012_Oct_25_6_371-378.nxml.txt.nlp	23118526	SENT184	2	2	7	7	ustekinumab	IL-23	PA166048654	51561	0.815
NULL	Colorectal_Dis_2012_Feb_14(2)_e31-e47.nxml.txt.nlp	21848897	SENT118	22	22	11	11	panitumumab	KRAS	PA162373091	3845	0.815
NULL	J_Hematol_Oncol_2010_Mar_13_3_10.nxml.txt.nlp	20226083	SENT133	14	14	7	7	gemcitabine	RRM1	PA449748	6240	0.815
NULL	Mol_Cancer_2010_May_18_9_110.nxml.txt.nlp	20482802	SENT152	5	5	9	9	bortezomib	p53	PA10252	7157	0.815
NULL	Mol_Vis_2011_Feb_1_17_332-340.nxml.txt.nlp	21297899	SENT214	2	2	11	11	telmisartan	NAC	PA451605	22861	0.815
NULL	Breast_Cancer_Res_2004_Nov_25_6(1)_E8.nxml.txt.nlp	14680493	SENT45	41	41	23	23	raloxifene	STAR	PA451221	6770;2984	0.815
NULL	Pharmaceuticals_(Basel)_2013_Aug_21_6(8)_988-1038.nxml.txt.nlp	24276379	SENT2544	13	13	7	7	cetuximab	EGFR	PA10040	1956	0.815
NULL	Nat_Neurosci_2012_Nov_14_15(11)_1547-1555.nxml.txt.nlp	23064379	SENT213	9	9	16	16	paraformaldehyde	PSD95	PA450790	1742	0.815
NULL	J_Cell_Biol_2002_Oct_28_159(2)_291-302.nxml.txt.nlp	12391024	SENT120	15	15	34	34	carbachol	DAG	PA448784	1605	0.815
NULL	BMB_Rep_2014_May_47(5)_274-279.nxml.txt.nlp	24286313	SENT68	16	16	11	11	bortezomib	CD138	PA10252	6382	0.815
NULL	Patient_Prefer_Adherence_2009_Nov_3_3_51-59.nxml.txt.nlp	19936145	SENT223	4	4	1	1	entacapone	COMT	PA164748726	1312	0.815
NULL	Cancer_Cell_Int_2012_Jun_18_12_30.nxml.txt.nlp	22709569	SENT93	17	17	6	6	paclitaxel	CALM1	PA450761	801	0.815
NULL	Ann_Rheum_Dis_2013_Apr_21_72(4)_482-492.nxml.txt.nlp	23172750	SENT71	44	44	11	11	abatacept	CDAI	PA164747080	146059	0.815
NULL	Cell_Logist_2012_Apr_1_2(2)_117-125.nxml.txt.nlp	23162743	SENT99	8	8	14	14	curcumin	PAK1	PA151958596	5585;5058	0.815
NULL	Cancers_(Basel)_2011_Sep_28_3(4)_3762-3772.nxml.txt.nlp	24213110	SENT352	0	0	5	5	atorvastatin	PC-3	PA448500	692094	0.815
NULL	Orphanet_J_Rare_Dis_2007_Jan_4_2_1.nxml.txt.nlp	17204147	SENT89	21	21	32	32	trypsin	SPINK1	PA451806	6690	0.815
NULL	Oncogene_2014_Aug_21_33(34)_4316-4329.nxml.txt.nlp	24362530	SENT46	13	13	17	17	epirubicin	SUMO1	PA449476	7341	0.815
NULL	Br_J_Cancer_2012_Nov_6_107(10)_1714-1721.nxml.txt.nlp	23073173	SENT101	36	36	26	26	bicalutamide	RUNX2	PA164746255	860	0.815
NULL	Int_J_Med_Sci_2015_Jan_5_12(2)_135-140.nxml.txt.nlp	25589889	SENT89	5	5	21	21	haloperidol	NMS	PA449841	129521	0.815
NULL	Diabetes_2009_Feb_58(2)_344-351.nxml.txt.nlp	19008341	SENT169	4	4	6	6	resveratrol	SIRT1		23411	0.815
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1063.nxml.txt.nlp	24556678	SENT45	0	0	7	7	thioridazine	Mcl-1	PA451666	4170	0.815
NULL	Acta_Pharmacol_Sin_2013_Mar_5_34(3)_329-335.nxml.txt.nlp	23459091	SENT74	17	17	30	30	sibutramine	ERG	PA451344	2078	0.815
NULL	J_Thromb_Haemost_2014_May_22_12(5)_726-735.nxml.txt.nlp	24581425	SENT234	9	9	16	16	thrombin	ARF6	PA451674	382	0.815
NULL	J_Cell_Mol_Med_2014_Sep_7_18(9)_1785-1796.nxml.txt.nlp	24909956	SENT242	25	25	23	23	cangrelor	GPR17	PA165945763	2840	0.815
NULL	Curr_Neuropharmacol_2012_Jun_10(2)_97-123.nxml.txt.nlp	23204981	SENT190	10	10	20	20	venlafaxine	IFN	PA451866	3439	0.815
NULL	Mol_Vis_2012_Jul_18_18_1973-1982.nxml.txt.nlp	22876124	SENT119	30	30	0	0	streptomycin	HCE	PA451512	8732	0.815
NULL	Chin_J_Cancer_2012_Feb_31(2)_58-72.nxml.txt.nlp	22098952	SENT246	26	26	38	38	vincristine	MRP7	PA451879	89845;1080	0.815
NULL	Front_Endocrinol_(Lausanne)_2013_Sep_2_4_111.nxml.txt.nlp	24065951	SENT196	28	28	7	7	estradiol	CYP19A1	PA449503	1588	0.815
NULL	Adv_Ther_2013_Oct_25_30(10)_870-884.nxml.txt.nlp	24158787	SENT212	6	6	14	14	exemestane	aromatase	PA449563	1588	0.815
NULL	HSR_Proc_Intensive_Care_Cardiovasc_Anesth_2010_2(2)_81-91.nxml.txt.nlp	23440622	SENT135	4	4	12	12	ticagrelor	P2Y12	PA165374673	64805	0.815
NULL	Int_J_Biol_Sci_2014_Jan_20_10(2)_171-180.nxml.txt.nlp	24520215	SENT20	26	26	19	19	cerulenin	L-FABP	PA164764551	2168	0.815
NULL	Ann_Thorac_Med_2013_Apr-Jun_8(2)_109-115.nxml.txt.nlp	23741274	SENT169	11	11	4	4	docetaxel	CRT	PA449383	811	0.815
NULL	Cancer_Med_2013_Apr_6_2(2)_234-242.nxml.txt.nlp	23634291	SENT175	27	27	14	14	bevacizumab	VEGF-A	PA130232992	7422	0.815
NULL	Contemp_Oncol_(Pozn)_2012_Jul_6_16(3)_223-229.nxml.txt.nlp	23788884	SENT78	0	0	13	13	metformin	LKB1	PA450395	6794	0.815
NULL	J_Int_Soc_Sports_Nutr_2009_Feb_19_6_6.nxml.txt.nlp	19228401	SENT237	15	15	21	21	creatine	CRT	PA164778930	811	0.815
NULL	Nat_Commun_2011_Oct_25_2_513.nxml.txt.nlp	22027593	SENT76	15	15	3	3	doxorubicin	RBM38	PA449412	55544	0.815
NULL	Iran_Red_Crescent_Med_J_2012_Aug_30_14(8)_466-469.nxml.txt.nlp	23105981	SENT148	13	13	24	24	ribavirin	IFN	PA451241	3439	0.815
NULL	Nat_Biotechnol_2010_Aug_2_28(8)_839-847.nxml.txt.nlp	20601939	SENT187	17	17	30	30	hydrocortisone	IL-3	PA449905	3562	0.815
NULL	Infect_Drug_Resist_2010_Apr_26_3_15-23.nxml.txt.nlp	21694890	SENT130	32	32	24	24	etravirine	TRIO	PA166014703	7204	0.815
NULL	Patient_Prefer_Adherence_2008_Feb_2_2_387-392.nxml.txt.nlp	19920986	SENT148	9	9	17	17	methotrexate	IFN	PA450428	3439	0.815
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT473	30	30	17	17	iloperidone	PRL	PA161199368	5617	0.815
NULL	Curr_Opin_Pharmacol_2013_Aug_13(4)_497-503.nxml.txt.nlp	23664091	SENT294	13	13	15	15	panitumumab	KRAS	PA162373091	3845	0.815
NULL	J_Breast_Cancer_2013_Jun_28_16(2)_178-183.nxml.txt.nlp	23843850	SENT98	4	4	35	35	trastuzumab	BAX	PA451743	581	0.815
NULL	Nat_Neurosci_2012_Mar_4_15(4)_565-573.nxml.txt.nlp	22388960	SENT107	20	20	2	2	isoflurane	Hv1	PA450106	84329	0.815
NULL	Breast_Cancer_Res_2010_Oct_22_12(Suppl_2)_S2.nxml.txt.nlp	21050423	SENT99	22	22	9	9	doxorubicin	MSH2	PA449412	4436	0.815
NULL	Mol_Cancer_2009_Aug_25_8_66.nxml.txt.nlp	19706164	SENT196	12	12	14	14	celecoxib	p53	PA448871	7157	0.815
NULL	Front_Oncol_2014_Apr_21_4_82.nxml.txt.nlp	24795859	SENT311	4	4	8	8	ofatumumab	CHOP	PA165291493	1649	0.815
NULL	Cell_Res_2013_Jul_21_23(7)_915-930.nxml.txt.nlp	23689279	SENT42	23	23	30	30	ethanol	ALDH2	PA448073	217	0.815
NULL	J_Aging_Res_2011_Sep_28_2011_251517.nxml.txt.nlp	21969914	SENT171	37	37	40	40	letrozole	aromatase	PA450196	1588	0.815
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT190	3	3	13	13	resveratrol	AIF		9131	0.815
NULL	Front_Mol_Neurosci_2012_Feb_24_5_22.nxml.txt.nlp	22375105	SENT95	21	21	13	13	cyclothiazide	GluA1	PA449168	2890	0.815
NULL	Oncoimmunology_2014_Apr_25_3_e28497.nxml.txt.nlp	25050215	SENT136	34	34	24	24	doxorubicin	MICA	PA449412	100507436	0.815
NULL	Mol_Syst_Biol_2009_Jul_28_5_289.nxml.txt.nlp	19638970	SENT55	34	34	45	45	resveratrol	SIRT1		23411	0.815
NULL	Gut_2008_Nov_2_57(11)_1509-1517.nxml.txt.nlp	18596194	SENT185	7	7	15	15	curcumin	p38	PA151958596	10598;1432;7965	0.815
NULL	J_Mol_Med_(Berl)_2014_May_10_92(7)_709-722.nxml.txt.nlp	24811491	SENT229	4	4	28	28	irinotecan	BRAF	PA450085	673	0.815
NULL	J_Gen_Physiol_2000_Jun_1_115(6)_685-696.nxml.txt.nlp	10828243	SENT442	5	5	35	35	genistein	OLF	PA165109660	83857	0.815
NULL	Acta_Pharmacol_Sin_2012_May_4_33(5)_710-716.nxml.txt.nlp	22555373	SENT210	9	9	28	28	diazepam	DOM	PA449283	6663	0.815
NULL	eLife_2013_Nov_5_2_e00969.nxml.txt.nlp	24192036	SENT15	28	28	33	33	vemurafenib	ERK	PA165946873	5594	0.815
NULL	Eur_J_Clin_Pharmacol_2013_Jan_11_69(6)_1275-1283.nxml.txt.nlp	23307232	SENT242	7	7	4	4	warfarin	VKORC1	PA451906	79001	0.815
NULL	Diabetes_2008_Sep_57(9)_2272-2279.nxml.txt.nlp	18519799	SENT134	29	29	6	6	rosiglitazone	PDK4	PA451283	5166	0.815
NULL	Oncotarget_2014_Dec_4_5(22)_11365-11380.nxml.txt.nlp	25426548	SENT59	20	20	22	22	nutlin-3	p53		7157	0.815
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Feb_17_68(Pt_3)_o700-o701.nxml.txt.nlp	22412590	SENT10	4	4	26	26	erythromycin	mol	PA449493	90527	0.815
NULL	EMBO_J_2009_Oct_21_28(20)_3157-3170.nxml.txt.nlp	19745813	SENT212	16	16	5	5	l-glutamine	AK7	PA10090	122481	0.815
NULL	Arthritis_Res_Ther_2005_May_18_7(Suppl_3)_S19-S25.nxml.txt.nlp	15960818	SENT164	33	33	28	28	rituximab	CHOP	PA451261	1649	0.815
NULL	Tumour_Biol_2012_Jun_21_33(3)_607-615.nxml.txt.nlp	22270450	SENT41	22	22	16	16	neratinib	EGFR	PA165291472	1956	0.815
NULL	Cancers_(Basel)_2011_Apr_1_3(2)_1844-1860.nxml.txt.nlp	24212785	SENT566	12	12	4	4	cetuximab	BRAF	PA10040	673	0.815
NULL	Cardiovasc_Diabetol_2010_May_21_9_20.nxml.txt.nlp	20492655	SENT136	22	22	18	18	ezetimibe	NPC1L1	PA10816	29881	0.815
NULL	Cost_Eff_Resour_Alloc_2005_Jan_25_3_2.nxml.txt.nlp	15670330	SENT130	23	23	15	15	nifedipine	NNT	PA450631	23530	0.815
NULL	Breast_Cancer_Res_2004_May_7_6(4)_R338-R351.nxml.txt.nlp	15217501	SENT214	17	17	35	35	estradiol	CYP1A2	PA449503	1544	0.815
NULL	Daru_2011_19(2)_138-144.nxml.txt.nlp	22615650	SENT3	25	25	19	19	heparin	FGF20	PA449855	26281	0.815
NULL	Braz_J_Med_Biol_Res_2012_Jul_20_45(10)_935-941.nxml.txt.nlp	22801415	SENT141	36	36	10	10	pioglitazone	adiponectin	PA450970	9370	0.815
NULL	Cancer_Cell_Int_2013_May_15_13_42.nxml.txt.nlp	23672670	SENT188	2	2	16	16	paclitaxel	PIDD	PA450761	55367	0.815
NULL	Int_J_Mol_Sci_2014_Mar_25_15(4)_5199-5220.nxml.txt.nlp	24670474	SENT110	33	33	16	16	choline	BMP-9	PA448976	2658	0.815
NULL	Case_Rep_Urol_2012_Aug_1_2012_178915.nxml.txt.nlp	22900222	SENT40	10	10	16	16	thyroglobulin	TTF-1	PA164754910	7080	0.815
NULL	Anesthesiol_Res_Pract_2011_Jul_27_2011_927421.nxml.txt.nlp	21808645	SENT54	4	4	15	15	dobutamine	CFI	PA449381	3426	0.815
NULL	Evid_Based_Complement_Alternat_Med_2012_Dec_30_2012_508902.nxml.txt.nlp	23346204	SENT180	10	10	3	3	mesalazine	EGF	PA450384	1950	0.815
NULL	Eur_J_Haematol_2009_May_82(5)_339-349.nxml.txt.nlp	19187276	SENT30	0	0	33	33	rivaroxaban	TKR	PA165958360	8277	0.815
NULL	Eur_J_Dent_2014_Oct-Dec_8(4)_521-527.nxml.txt.nlp	25512735	SENT43	14	14	24	24	metronidazole	San	PA450484	80218	0.815
NULL	Clin_Interv_Aging_2013_Sep_16_8_1229-1236.nxml.txt.nlp	24072968	SENT83	13	13	20	20	rituximab	CHOP	PA451261	1649	0.815
NULL	Ann_Rheum_Dis_2009_Jan_28_68(1)_69-74.nxml.txt.nlp	18375541	SENT162	30	30	14	14	etanercept	HLA-DRB1	PA449515	3123	0.815
NULL	Br_J_Cancer_2004_Mar_5_90(Suppl_1)_S15-S18.nxml.txt.nlp	15094760	SENT106	23	23	6	6	anastrozole	FACT	PA448432	11198	0.815
NULL	Oncotarget_2013_Nov_24_4(12)_2186-2207.nxml.txt.nlp	24327604	SENT237	12	12	31	31	lenalidomide	CD44	PA162363968	960	0.815
NULL	Nucleic_Acids_Res_2013_May_5_41(10)_5210-5222.nxml.txt.nlp	23563151	SENT241	29	29	7	7	arsenite	p53	PA452638	7157	0.815
NULL	FEBS_Open_Bio_2014_Nov_12_4_1015-1020.nxml.txt.nlp	25473598	SENT18	34	34	20	20	galactose	GH2	PA449725	2689	0.815
NULL	Mol_Cancer_2008_Jun_4_7_49.nxml.txt.nlp	18533032	SENT113	25	25	3	3	tamoxifen	MUC1	PA451581	4582	0.815
NULL	Int_J_Mol_Sci_2013_Apr_29_14(5)_9408-9423.nxml.txt.nlp	23629672	SENT498	23	23	31	31	olmesartan	SMP30	PA164742950	9104	0.815
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Nov_27_66(Pt_12)_o3337.nxml.txt.nlp	21589611	SENT46	3	3	13	13	benzaldehyde	mol	PA448571	90527	0.815
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1196-1204.nxml.txt.nlp	22315058	SENT146	36	36	6	6	gefitinib	HER2	PA131301952	2064	0.815
NULL	Curr_Biol_2009_Feb_24_19(4)_297-304.nxml.txt.nlp	19217292	SENT72	29	29	18	18	vasopressin	ID2	PA451858	3398	0.815
NULL	J_Biol_Chem_2012_Apr_20_287(17)_13868-13876.nxml.txt.nlp	22389490	SENT72	6	6	19	19	capsaicin	TRPV1	PA448776	7442	0.815
NULL	Evid_Based_Complement_Alternat_Med_2014_May_18_2014_156276.nxml.txt.nlp	24963318	SENT108	0	0	7	7	hesperidin	SOD1	PA449867	6647	0.815
NULL	Lipids_Health_Dis_2011_Dec_30_10_246.nxml.txt.nlp	22208561	SENT68	3	3	8	8	ethanol	PI3K	PA448073	5290	0.815
NULL	F1000Res_2014_Jul_25_3_171.nxml.txt.nlp	25165538	SENT35	1	1	31	31	cosyntropin	ACTH	PA164749052	5443	0.815
NULL	Nat_Neurosci_2014_Jun_4_17(6)_813-821.nxml.txt.nlp	24793032	SENT430	7	7	3	3	topotecan	E12	PA451729	64100	0.815
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT202	10	10	14	14	bevacizumab	PlGF-2	PA130232992	5228	0.815
NULL	Open_Biochem_J_2007_Jun_15_1_1-6.nxml.txt.nlp	18949066	SENT60	18	18	5	5	suramin	HIF-1	PA10292	29072	0.815
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT94	19	19	26	26	chloroquine	BMPR-II	PA448948	659	0.815
NULL	Breast_Cancer_Res_2005_Nov_11_7(6)_255-257.nxml.txt.nlp	16457700	SENT23	27	27	12	12	tamoxifen	ATAC	PA451581	6375	0.815
NULL	Clin_Interv_Aging_2009_May_14_4_191-196.nxml.txt.nlp	19503781	SENT167	8	8	23	23	solifenacin	STAR	PA164783810	6770;2984	0.815
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT210	0	0	23	23	doxorubicin	B7-H1	PA449412	29126	0.815
NULL	J_Biomed_Biotechnol_2011_Feb_15_2011_523481.nxml.txt.nlp	21403879	SENT33	0	0	8	8	suramin	SIRT1	PA10292	23411	0.815
NULL	Arthritis_Res_Ther_2011_Mar_16_13(2)_R44.nxml.txt.nlp	21410959	SENT182	2	2	7	7	glucosamine	RANKL	PA164747613	8600	0.815
NULL	Rare_Tumors_2009_Jul_22_1(1)_e4.nxml.txt.nlp	21139898	SENT56	10	10	16	16	bevacizumab	San	PA130232992	80218	0.815
NULL	Oncotarget_2013_Jun_5_4(6)_884-889.nxml.txt.nlp	23800680	SENT66	35	35	6	6	temsirolimus	PTPRD	PA164746890	5789	0.815
NULL	Acta_Pharmacol_Sin_2014_Jun_4_35(6)_752-757.nxml.txt.nlp	24902786	SENT98	20	20	5	5	tamoxifen	STL2	PA451581	1301	0.815
NULL	J_Hematol_Oncol_2014_Aug_21_7_59.nxml.txt.nlp	25139202	SENT80	14	14	16	16	tacrolimus	CD25	PA451578	3669;3559	0.815
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT782	14	14	3	3	maraviroc	CYP3A4	PA164768835	1576	0.815
NULL	Cell_Commun_Signal_2013_Nov_11_11_86.nxml.txt.nlp	24215724	SENT60	26	26	5	5	thrombin	PAR1	PA451674	79581;2149	0.815
NULL	Acta_Pharmacol_Sin_2013_Jun_8_34(6)_830-836.nxml.txt.nlp	23564080	SENT109	17	17	24	24	simvastatin	RAGE	PA451363	177	0.815
NULL	Oncol_Lett_2014_Jan_29_7(1)_183-188.nxml.txt.nlp	24348845	SENT148	8	8	0	0	cisplatin	PDCD4	PA449014	27250	0.815
NULL	J_Korean_Assoc_Oral_Maxillofac_Surg_2014_Dec_26_40(6)_291-296.nxml.txt.nlp	25551094	SENT90	2	2	6	6	alendronate	RANKL	PA448082	8600	0.815
NULL	Arthritis_Res_Ther_2007_Mar_12_9(2)_R28.nxml.txt.nlp	17352828	SENT66	28	28	14	14	anakinra	MSU	PA10799	593	0.815
NULL	Gene_Regul_Syst_Bio_2014_Mar_4_8_63-73.nxml.txt.nlp	24634581	SENT103	13	13	6	6	minocycline	STAT3	PA450519	6774	0.815
NULL	Cell_Cycle_2013_Sep_15_12(18)_3025-3036.nxml.txt.nlp	23974102	SENT26	33	33	21	21	infliximab	CD4	PA452639	920	0.815
NULL	Br_J_Cancer_2011_Aug_23_105(5)_649-657.nxml.txt.nlp	21811251	SENT164	24	24	21	21	gefitinib	IGF1R	PA131301952	3480	0.815
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT78	15	15	27	27	chloroquine	BMPR-II	PA448948	659	0.815
NULL	Clin_Epidemiol_2010_Aug_9_2_145-151.nxml.txt.nlp	20865112	SENT117	6	6	24	24	raltegravir	TRIO		7204	0.815
NULL	Cancers_(Basel)_2011_Apr_1_3(2)_1844-1860.nxml.txt.nlp	24212785	SENT620	2	2	9	9	cetuximab	BRAF	PA10040	673	0.815
NULL	Front_Pharmacol_2014_Oct_27_5_233.nxml.txt.nlp	25386143	SENT198	32	32	29	29	ustekinumab	IL-23	PA166048654	51561	0.815
NULL	Acta_Pharmacol_Sin_2014_Jan_9_35(1)_1-10.nxml.txt.nlp	24317012	SENT156	6	6	0	0	sn-38	UGT1A1		54658	0.815
NULL	Sleep_Disord_2014_Jul_10_2014_767181.nxml.txt.nlp	25126427	SENT109	11	11	31	31	levodopa	LDE	PA450213	7957	0.815
NULL	Commun_Integr_Biol_2013_Nov_1_6(6)_e26316.nxml.txt.nlp	24567774	SENT25	13	13	30	30	doxorubicin	TPPP1	PA449412	11076	0.815
NULL	Diabetes_2011_Nov_17_60(11)_2691-2700.nxml.txt.nlp	21896928	SENT167	7	7	0	0	resveratrol	SIRT1		23411	0.815
NULL	Oncotarget_2013_Aug_25_4(10)_1647-1661.nxml.txt.nlp	24072592	SENT55	39	39	16	16	staurosporine	S6K1	PA165109623	6198	0.815
NULL	Pharmaceuticals_(Basel)_2012_Sep_12_5(9)_991-1007.nxml.txt.nlp	24280701	SENT122	11	11	6	6	doxorubicin	ACPP	PA449412	55	0.815
NULL	Environ_Health_Perspect_2005_Jun_24_113(6)_680-687.nxml.txt.nlp	15929889	SENT182	27	27	11	11	estradiol	SULT1A1	PA449503	6817	0.815
NULL	Br_J_Cancer_2013_Feb_19_108(3)_557-563.nxml.txt.nlp	23361053	SENT41	23	23	6	6	tamoxifen	HER-2	PA451581	2064	0.815
NULL	Chin_J_Cancer_2012_Sep_31(9)_413-420.nxml.txt.nlp	22776233	SENT134	2	2	7	7	glucose	HIF1A	PA449773	3091	0.815
NULL	Case_Rep_Med_2013_Nov_4_2013_813167.nxml.txt.nlp	24307906	SENT20	9	9	16	16	thyroglobulin	TPO	PA164754910	7066;7173	0.815
NULL	Clin_Mol_Allergy_2007_Jan_25_5_1.nxml.txt.nlp	17254346	SENT188	0	0	14	14	curcumin	IL-5	PA151958596	3567	0.815
NULL	Curr_Oncol_2009_Jan_16(1)_27-48.nxml.txt.nlp	19229369	SENT268	20	20	30	30	docetaxel	EGFR	PA449383	1956	0.815
NULL	Oncotarget_2011_Aug_30_2(8)_610-626.nxml.txt.nlp	21881167	SENT189	38	38	11	11	doxorubicin	Raf-1	PA449412	5894	0.815
NULL	Curr_Oncol_2009_Jul_16(Suppl_2)_S14-S23.nxml.txt.nlp	19672417	SENT152	5	5	2	2	anastrozole	ATAC	PA448432	6375	0.815
NULL	Oncotarget_2014_Feb_7_5(3)_775-787.nxml.txt.nlp	24519956	SENT104	3	3	10	10	docetaxel	PC3	PA449383	57332;7832;5122	0.815
NULL	J_Korean_Med_Sci_2009_Jan_29_24(Suppl_1)_S170-S175.nxml.txt.nlp	19194548	SENT135	9	9	2	2	cisplatin	EPO	PA449014	7076;8288;2056	0.815
NULL	Mol_Cancer_2013_May_24_12_45.nxml.txt.nlp	23705792	SENT256	16	16	13	13	doxorubicin	ICBP90	PA449412	54887;29128	0.815
NULL	eLife_2013_Oct_29_2_e01236.nxml.txt.nlp	24171104	SENT457	11	11	4	4	bortezomib	HSF1	PA10252	3297	0.815
NULL	J_Thorac_Oncol_2014_Feb_23_9(2)_189-194.nxml.txt.nlp	24419415	SENT89	5	5	9	9	gefitinib	EGFR	PA131301952	1956	0.815
NULL	Br_J_Cancer_2011_Nov_22_105(11)_1708-1718.nxml.txt.nlp	22045188	SENT278	13	13	26	26	fluorescein	CD19	PA164746009	930	0.815
NULL	Pharmaceutics_2011_Jul_11_3(3)_354-378.nxml.txt.nlp	24310585	SENT200	1	1	36	36	fluorescein	LCE	PA164746009	79071	0.815
NULL	Anal_Biochem_2014_Jun_1_454(100)_17-22.nxml.txt.nlp	24637157	SENT9	15	15	11	11	camptothecin	TOP1	PA153590860	7150	0.815
NULL	Oncol_Lett_2014_May_11_7(5)_1401-1408.nxml.txt.nlp	24765145	SENT162	6	6	18	18	paclitaxel	HIF-1	PA450761	29072	0.815
NULL	Breast_Cancer_Res_Treat_2012_Jun_15_133(3)_1057-1065.nxml.txt.nlp	22418700	SENT164	0	0	6	6	lapatinib	HER2	PA152241907	2064	0.815
NULL	Adv_Urol_2012_Sep_14_2012_190624.nxml.txt.nlp	21922019	SENT29	2	2	4	4	diethylstilbestrol	DES	PA449307	1674	0.815
NULL	J_Cell_Mol_Med_2014_Jan_4_18(1)_38-48.nxml.txt.nlp	24188742	SENT137	12	12	0	0	etoposide	PAX3	PA449552	5077	0.815
NULL	Indian_J_Endocrinol_Metab_2013_Dec_17(Suppl_3)_S696-S699.nxml.txt.nlp	24910842	SENT51	3	3	10	10	metoclopramide	PRL	PA450475	5617	0.815
NULL	Mol_Vis_2012_Oct_5_18_2454-2467.nxml.txt.nlp	23077404	SENT10	6	6	22	22	bevacizumab	VEGF-A	PA130232992	7422	0.815
NULL	Biomed_Res_Int_2013_May_2_2013_210604.nxml.txt.nlp	23738323	SENT46	36	36	26	26	trypsin	CO2	PA451806	4513	0.815
NULL	ACS_Chem_Biol_2011_Feb_18_6(2)_169-175.nxml.txt.nlp	20886892	SENT2	10	10	24	24	indomethacin	AKR1C3	PA449982	8644	0.815
NULL	Clin_Drug_Investig_2015_Dec_16_35_141-147.nxml.txt.nlp	25511640	SENT71	10	10	5	5	miglitol	GLP-1	PA164776726	100125288	0.815
NULL	Front_Neurosci_2012_May_30_6_77.nxml.txt.nlp	22661925	SENT258	18	18	37	37	ethanol	DCX	PA448073	1641	0.815
NULL	Mol_Cancer_2009_Dec_23_8_129.nxml.txt.nlp	20030852	SENT201	0	0	4	4	curcumin	ABCA1	PA151958596	19	0.815
NULL	Cardiovasc_Drugs_Ther_2011_Oct_2_25(5)_379-391.nxml.txt.nlp	21805404	SENT312	5	5	10	10	gliclazide	LOX-1	PA10892	4973	0.815
NULL	Case_Rep_Transplant_2014_Jan_2_2014_548243.nxml.txt.nlp	24575309	SENT12	11	11	7	7	sirolimus	CYP3A	PA451365	1574	0.815
NULL	Mol_Cancer_2013_May_24_12_46.nxml.txt.nlp	23705826	SENT114	26	26	13	13	sunitinib	FLT3	PA162372840	2322	0.815
NULL	Nat_Commun_2010_Nov_16_1_117.nxml.txt.nlp	21081915	SENT218	1	1	29	29	minocycline	C21	PA450519	79718	0.815
NULL	Cancer_Cell_Int_2007_Sep_10_7_14.nxml.txt.nlp	17845729	SENT164	14	14	28	28	decitabine	TNFAIP3	PA164749631	7128	0.815
NULL	F1000Res_2013_Mar_5_2_74.nxml.txt.nlp	24358880	SENT264	1	1	15	15	benzaldehyde	TRPV1	PA448571	7442	0.815
NULL	Int_J_Biomed_Sci_2014_Sep_10(3)_217-220.nxml.txt.nlp	25324704	SENT28	18	18	10	10	amiodarone	APT	PA448383	653639	0.815
NULL	J_Clin_Biochem_Nutr_2010_Mar_27_46(2)_126-134.nxml.txt.nlp	20216945	SENT42	20	20	10	10	taurine	Met	PA451590	79811	0.815
NULL	Breast_Cancer_Res_2007_Feb_28_9(1)_204.nxml.txt.nlp	17338830	SENT134	30	30	11	11	bromocriptine	PRL	PA448671	5617	0.814
NULL	Clin_Interv_Aging_2013_Jul_16_8_889-897.nxml.txt.nlp	23898224	SENT7	40	40	44	44	gemcitabine	SIRT1	PA449748	23411	0.814
NULL	Carcinogenesis_2014_May_13_35(5)_1055-1066.nxml.txt.nlp	24419232	SENT310	5	5	7	7	metformin	CYP1B1	PA450395	1545	0.814
NULL	Diabetes_Care_2010_Jun_18_33(6)_1304-1308.nxml.txt.nlp	20299480	SENT31	8	8	21	21	metformin	HER-2	PA450395	2064	0.814
NULL	Exp_Brain_Res_2014_Jun_27_232(8)_2637-2644.nxml.txt.nlp	24969614	SENT135	20	20	34	34	palonosetron	NK1	PA10352	11126	0.814
NULL	Biomed_Res_Int_2014_May_11_2014_578137.nxml.txt.nlp	24900972	SENT24	29	29	19	19	amifostine	gamma	PA448365	9913	0.814
NULL	F1000Prime_Rep_2014_Dec_1_6_117.nxml.txt.nlp	25580271	SENT75	35	35	21	21	afatinib	EGFR	PA165981154	1956	0.814
NULL	Ann_Surg_Oncol_2010_Jan_20_17(1)_14-17.nxml.txt.nlp	19841980	SENT27	3	3	34	34	trastuzumab	ERBB2	PA451743	2064	0.814
NULL	Exp_Mol_Med_2012_Apr_30_44(4)_281-292.nxml.txt.nlp	22228119	SENT65	12	12	16	16	genistein	activin	PA165109660	83729	0.814
NULL	Epilepsia_2012_Jun_21_53(Suppl_1)_18-25.nxml.txt.nlp	22612805	SENT92	0	0	9	9	bumetanide	NKCC1	PA448682	6558	0.814
NULL	EMBO_Rep_2012_Jan_25_13(1)_44-51.nxml.txt.nlp	22116401	SENT44	11	11	15	15	cisplatin	SYCP3	PA449014	50511	0.814
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT114	21	21	16	16	trastuzumab	HER2	PA451743	2064	0.814
NULL	Mol_Cells_2014_Sep_30_37(9)_664-671.nxml.txt.nlp	25234467	SENT270	7	7	10	10	cisplatin	KRAS	PA449014	3845	0.814
NULL	FEBS_Open_Bio_2014_Jan_6_4_77-89.nxml.txt.nlp	24490132	SENT182	9	9	16	16	ebselen	NAC	PA161660841	22861	0.814
NULL	Arthritis_Res_Ther_2014_Jul_24_16(4)_R157.nxml.txt.nlp	25059342	SENT232	9	9	32	32	bleomycin	IL-6	PA448645	3569	0.814
NULL	J_Occup_Med_Toxicol_2008_Feb_27_3(Suppl_1)_S6.nxml.txt.nlp	18315837	SENT91	7	7	21	21	pranlukast	GM-CSF	PA134698661	1437	0.814
NULL	Front_Oncol_2014_Jun_12_4_144.nxml.txt.nlp	24971229	SENT297	10	10	18	18	cisplatin	p53	PA449014	7157	0.814
NULL	Indian_J_Pharmacol_2013_Jan-Feb_45(1)_54-60.nxml.txt.nlp	23543867	SENT148	20	20	15	15	bosentan	NAC	PA10034	22861	0.814
NULL	Br_J_Cancer_2013_Mar_19_108(5)_1052-1060.nxml.txt.nlp	23422754	SENT39	12	12	34	34	capecitabine	VEGF-A	PA448771	7422	0.814
NULL	Front_Endocrinol_(Lausanne)_2015_Jan_9_5_235.nxml.txt.nlp	25620956	SENT139	10	10	16	16	glucosamine	OGT	PA164747613	8473	0.814
NULL	Evid_Based_Complement_Alternat_Med_2013_May_13_2013_506324.nxml.txt.nlp	23818927	SENT260	26	26	11	11	doxorubicin	SHP-2	PA449412	5781	0.814
NULL	Anticancer_Agents_Med_Chem_2014_Jul_14(6)_840-851.nxml.txt.nlp	24066799	SENT445	14	14	18	18	azathioprine	CD4	PA448515	920	0.814
NULL	J_Gen_Physiol_2010_Apr_135(4)_333-353.nxml.txt.nlp	20231374	SENT415	2	2	6	6	amitriptyline	P2X4	PA448385	5025	0.814
NULL	J_Cardiothorac_Surg_2013_Apr_29_8_115.nxml.txt.nlp	23628179	SENT18	3	3	20	20	bivalirudin	ACT	PA10032	12;11332;9457;641455	0.814
NULL	Cell_Cycle_2012_Nov_1_11(21)_3983-3996.nxml.txt.nlp	22987153	SENT169	16	16	3	3	mitomycin	FANCD2	PA450524	2177	0.814
NULL	J_Cell_Biol_2002_Jun_24_157(7)_1267-1278.nxml.txt.nlp	12082084	SENT236	22	22	0	0	thrombin	AC6	PA451674	112	0.814
NULL	Clin_Drug_Investig_2015_Dec_16_35_141-147.nxml.txt.nlp	25511640	SENT90	26	26	10	10	miglitol	GLP-1	PA164776726	100125288	0.814
NULL	Diabetes_2013_Oct_17_62(10)_3500-3513.nxml.txt.nlp	23884882	SENT271	4	4	12	12	resveratrol	PDX1		8050;3651	0.814
NULL	Breast_Cancer_Res_2010_Aug_9_12(4)_R62.nxml.txt.nlp	20696059	SENT293	13	13	17	17	trastuzumab	HER2	PA451743	2064	0.814
NULL	Aging_(Albany_NY)_2011_Jan_18_3(1)_33-43.nxml.txt.nlp	21248371	SENT125	4	4	14	14	zinc	HIF-1	PA451956	29072	0.814
NULL	Core_Evid_2011_Sep_8_6_67-79.nxml.txt.nlp	22022289	SENT242	20	20	7	7	metformin	GLP-1	PA450395	100125288	0.814
NULL	Diabetes_2011_Mar_21_60(3)_1008-1018.nxml.txt.nlp	21282362	SENT218	24	24	18	18	lipase	ANGPTL3	PA450239	27329	0.814
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT0	18	18	11	11	perifosine	DR5	PA165291471	8795	0.814
NULL	Nat_Commun_2014_Nov_19_5_5479.nxml.txt.nlp	25407222	SENT211	17	17	2	2	fluorescein	spatial	PA164746009	219793	0.814
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT206	0	0	9	9	simvastatin	RANKL	PA451363	8600	0.814
NULL	Exp_Ther_Med_2014_Jun_27_7(6)_1752-1756.nxml.txt.nlp	24926379	SENT71	5	5	11	11	vildagliptin	PPG	PA165958346	5552	0.814
NULL	Nature_2008_Oct_23_455(7216)_1076-1081.nxml.txt.nlp	18948948	SENT229	8	8	16	16	staurosporine	BAX	PA165109623	581	0.814
NULL	Ann_Oncol_2013_Apr_31_24(4)_1067-1073.nxml.txt.nlp	23117073	SENT21	4	4	10	10	aprepitant	NK1	PA164747039	11126	0.814
NULL	Oxid_Med_Cell_Longev_2010_Jan-Feb_3(1)_53-60.nxml.txt.nlp	20716928	SENT133	26	26	42	42	gentamicin	CO2	PA449753	4513	0.814
NULL	J_Oncol_2009_Jul_14_2009_804108.nxml.txt.nlp	19636422	SENT184	22	22	41	41	irinotecan	EGFR	PA450085	1956	0.814
NULL	Curr_Cardiol_Rev_2010_Aug_6(3)_238-244.nxml.txt.nlp	21804783	SENT163	28	28	33	33	sildenafil	GMP	PA451346	22978	0.814
NULL	J_Hematol_Oncol_2009_Feb_23_2_9.nxml.txt.nlp	19236713	SENT65	12	12	4	4	bevacizumab	KRAS	PA130232992	3845	0.814
NULL	Case_Rep_Crit_Care_2014_Aug_19_2014_242703.nxml.txt.nlp	25215245	SENT75	14	14	7	7	nicardipine	APE	PA450620	55704;328	0.814
NULL	Ann_Nucl_Med_2014_Jul_8_28(9)_836-850.nxml.txt.nlp	25001261	SENT12	7	7	21	21	acetazolamide	spatial	PA448018	219793	0.814
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Jul_20_69(Pt_8)_o1276.nxml.txt.nlp	24109358	SENT72	10	10	20	20	benzaldehyde	mol	PA448571	90527	0.814
NULL	Breast_Cancer_Res_2008_Dec_18_10(Suppl_4)_S26.nxml.txt.nlp	19128440	SENT13	8	8	4	4	tamoxifen	ATAC	PA451581	6375	0.814
NULL	Ital_J_Pediatr_2014_Nov_23_40(1)_93.nxml.txt.nlp	NULL	SENT39	0	0	18	18	resveratrol	IL-5		3567	0.814
NULL	Breast_Cancer_Res_2011_Apr_14_13(2)_R43.nxml.txt.nlp	21492444	SENT35	28	28	4	4	tamoxifen	HER2	PA451581	2064	0.814
NULL	Mol_Vis_2012_Sep_24_18_2388-2397.nxml.txt.nlp	23049239	SENT43	14	14	33	33	collagenase	CO2	PA449107	4513	0.814
NULL	Cancers_(Basel)_2010_Jan_14_2(1)_1-19.nxml.txt.nlp	24281029	SENT759	4	4	14	14	lapatinib	HER2	PA152241907	2064	0.814
NULL	Basic_Res_Cardiol_2011_Jan_20_106(1)_51-63.nxml.txt.nlp	20725733	SENT8	5	5	17	17	rolipram	PLB	PA153906323	151056	0.814
NULL	Oncogene_2010_Sep_16_29(37)_5135-5145.nxml.txt.nlp	20622897	SENT17	17	17	14	14	cetuximab	EGFR	PA10040	1956	0.814
NULL	Mucosal_Immunol_2012_May_8_5(3)_232-239.nxml.txt.nlp	22318493	SENT45	33	33	21	21	dextran	CD11c	PA449261	3687	0.814
NULL	Front_Oncol_2014_Apr_9_4_75.nxml.txt.nlp	24782986	SENT235	29	29	14	14	paclitaxel	CD117	PA450761	3815	0.814
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT12	20	20	9	9	pemetrexed	UNG	PA10810	7374	0.814
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT119	5	5	7	7	curcumin	TRAIL	PA151958596	8743	0.814
NULL	Int_J_Mol_Sci_2010_Sep_13_11(9)_3195-3208.nxml.txt.nlp	20957088	SENT43	9	9	4	4	lipase	AT2	PA450239	186	0.814
NULL	Multidiscip_Respir_Med_2011_Oct_31_6(5)_313-317.nxml.txt.nlp	22958860	SENT15	13	13	10	10	sirolimus	LAM	PA451365	7249;7248	0.814
NULL	Exp_Ther_Med_2015_Feb_3_9(2)_377-383.nxml.txt.nlp	25574201	SENT85	2	2	5	5	curcumin	TSP-1	PA151958596	7057	0.814
NULL	Pharmaceutics_2011_Nov_18_3(4)_865-913.nxml.txt.nlp	24309312	SENT120	4	4	11	11	atorvastatin	CYP3A4	PA448500	1576	0.814
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT5	2	2	6	6	bevacizumab	VEGF-A	PA130232992	7422	0.814
NULL	Behav_Brain_Funct_2013_Jan_10_9_4.nxml.txt.nlp	23305134	SENT13	0	0	19	19	biperiden	hole	PA448626	80757	0.814
NULL	Cancers_(Basel)_2013_Jun_5_5(2)_676-713.nxml.txt.nlp	24216997	SENT359	23	23	27	27	decitabine	SPARC	PA164749631	6678	0.814
NULL	Br_J_Clin_Pharmacol_2013_Aug_23_76(2)_299-315.nxml.txt.nlp	23701319	SENT7	13	13	30	30	trastuzumab	IL-2	PA451743	3558	0.814
NULL	Breast_Cancer_Res_2002_Jun_21_4(5)_R9.nxml.txt.nlp	12223126	SENT132	9	9	14	14	tamoxifen	FasL	PA451581	356	0.814
NULL	Nucleic_Acids_Res_2010_Oct_28_38(19)_6418-6432.nxml.txt.nlp	20511593	SENT175	41	41	14	14	collagenase	AP-1	PA449107	2353;3727;2354;3725	0.814
NULL	J_Hematol_Oncol_2013_Mar_27_6_23.nxml.txt.nlp	23531342	SENT85	6	6	2	2	fludarabine	RITA	PA449655	55422;84934	0.814
NULL	Curr_Neuropharmacol_2009_Mar_7(1)_9-36.nxml.txt.nlp	19721815	SENT1125	5	5	19	19	methamphetamine	alpha-synuclein	PA450403	6622	0.814
NULL	Trials_2013_Nov_29_14(Suppl_1)_O77.nxml.txt.nlp	NULL	SENT5	10	10	16	16	bortezomib	CHOP	PA10252	1649	0.814
NULL	Oncol_Lett_2014_Jun_8_7(6)_1903-1910.nxml.txt.nlp	24932256	SENT182	22	22	20	20	cisplatin	CRT	PA449014	811	0.814
NULL	J_Biol_Chem_2009_Oct_16_284(42)_28885-28895.nxml.txt.nlp	19687008	SENT284	10	10	16	16	simvastatin	SREBP2	PA451363	6721	0.814
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Nov_26_3(11)_e149.nxml.txt.nlp	25426564	SENT349	24	24	10	10	atorvastatin	PCSK9	PA448500	255738	0.814
NULL	Oncotarget_2013_Nov_7_4(12)_2550-2566.nxml.txt.nlp	24334291	SENT274	8	8	20	20	dasatinib	NAC	PA162372878	22861	0.814
NULL	Breast_Cancer_Res_2007_Aug_8_9(4)_R50.nxml.txt.nlp	17686159	SENT256	26	26	17	17	trastuzumab	HRG	PA451743	3084;3273	0.814
NULL	Br_J_Cancer_2013_Feb_19_108(3)_557-563.nxml.txt.nlp	23361053	SENT16	5	5	0	0	tamoxifen	IPA	PA451581	3160	0.814
NULL	J_Biol_Chem_2009_Jan_2_284(1)_77-84.nxml.txt.nlp	18854318	SENT49	21	21	17	17	metformin	AMPK	PA450395	5563	0.814
NULL	Cell_Death_Dis_2014_Apr_17_5(4)_e1182.nxml.txt.nlp	24743737	SENT37	4	4	2	2	capsaicin	TRPV1	PA448776	7442	0.814
NULL	Breast_Cancer_Res_2012_Mar_15_14(2)_R47.nxml.txt.nlp	22420423	SENT133	13	13	20	20	paclitaxel	CHEK2	PA450761	11200	0.814
NULL	Br_J_Cancer_2013_Jun_25_108(12)_2417-2418.nxml.txt.nlp	23801031	SENT18	11	11	20	20	bevacizumab	TRG	PA130232992	6965	0.814
NULL	Mol_Cell_Proteomics_2012_Feb_6_11(2)_M111_015222.nxml.txt.nlp	22147731	SENT360	22	22	15	15	gefitinib	EGF	PA131301952	1950	0.814
NULL	Cancer_Sci_2012_Sep_4_103(9)_1679-1687.nxml.txt.nlp	22625227	SENT80	17	17	8	8	methotrexate	BCS	PA450428	617	0.814
NULL	J_Gen_Physiol_2005_Jul_126(1)_1.nxml.txt.nlp	NULL	SENT1050	4	4	15	15	fluorescein	SERCA2	PA164746009	488	0.814
NULL	Mol_Biol_Cell_2012_Nov_1_23(21)_4212-4225.nxml.txt.nlp	22956765	SENT205	11	11	19	19	thrombin	SHP2	PA451674	5781	0.814
NULL	Channels_(Austin)_2010_Jan_1_4(1)_22-41.nxml.txt.nlp	19934650	SENT393	10	10	8	8	quinidine	Slo3	PA451209	157855	0.814
NULL	Ann_Clin_Transl_Neurol_2014_Dec_21_1(12)_996-1005.nxml.txt.nlp	25574474	SENT123	28	28	16	16	riluzole	P-gp	PA451251	5243	0.814
NULL	Mol_Cells_2014_Sep_30_37(9)_699-704.nxml.txt.nlp	25245523	SENT6	11	11	9	9	cisplatin	MTA1	PA449014	9112	0.814
NULL	J_Neurol_2013_Jul_9_260(10)_2556-2561.nxml.txt.nlp	23835634	SENT79	5	5	13	13	varenicline	SARA	PA164781343	9372	0.814
NULL	Ther_Clin_Risk_Manag_2006_Jun_2(2)_129-158.nxml.txt.nlp	18360588	SENT197	5	5	2	2	rifabutin	CYP3A4	PA451249	1576	0.814
NULL	J_Biomed_Biotechnol_2007_May_27_2007_97654.nxml.txt.nlp	17641727	SENT127	18	18	4	4	thrombin	G17	PA451674	5089;10991	0.814
NULL	Leukemia_2013_Jan_11_27(1)_32-40.nxml.txt.nlp	22781593	SENT230	0	0	7	7	ponatinib	FGFR1	PA165980594	2260	0.814
NULL	Int_J_Breast_Cancer_2011_Sep_6_2011_352182.nxml.txt.nlp	22295219	SENT106	15	15	7	7	trastuzumab	HER2	PA451743	2064	0.814
NULL	Indian_J_Med_Res_2012_Dec_136(6)_907-925.nxml.txt.nlp	23391787	SENT513	4	4	6	6	chloroquine	ACT	PA448948	12;11332;9457;641455	0.814
NULL	Adolesc_Health_Med_Ther_2012_Jun_20_3_85-93.nxml.txt.nlp	24600289	SENT5	0	0	7	7	adalimumab	TNF	PA10004	7124	0.814
NULL	Oncotarget_2014_Feb_7_5(3)_775-787.nxml.txt.nlp	24519956	SENT102	4	4	11	11	docetaxel	PC3	PA449383	57332;7832;5122	0.814
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1063.nxml.txt.nlp	24556678	SENT49	19	19	23	23	thioridazine	c-FLIP	PA451666	8837	0.814
NULL	EMBO_Mol_Med_2012_Aug_16_4(8)_743-760.nxml.txt.nlp	22593025	SENT200	13	13	36	36	docetaxel	EGFR	PA449383	1956	0.814
NULL	J_Lipid_Res_2014_Mar_55(3)_385-397.nxml.txt.nlp	24347527	SENT14	14	14	2	2	lipase	IL-4	PA450239	3565	0.814
NULL	F1000Res_2014_Jun_4_3_76.nxml.txt.nlp	25075293	SENT19	11	11	14	14	ustekinumab	TNF-alpha	PA166048654	7124	0.814
NULL	Angiogenesis_2010_Dec_7_13(4)_305-315.nxml.txt.nlp	20927579	SENT125	6	6	3	3	resveratrol	TSP1		7057	0.814
NULL	Antimicrob_Agents_Chemother_2014_Oct_58(10)_5900-5908.nxml.txt.nlp	25070091	SENT272	20	20	17	17	metoprolol	CYP2D6	PA450480	1565	0.814
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT11	0	0	18	18	atorvastatin	RANKL	PA448500	8600	0.814
NULL	Nat_Commun_2013_Sep_20_4_2444.nxml.txt.nlp	24051492	SENT47	31	31	16	16	nutlin-3	p53		7157	0.814
NULL	J_Mol_Signal_2009_Sep_2_4_6.nxml.txt.nlp	19725972	SENT174	31	31	25	25	staurosporine	p38	PA165109623	10598;1432;7965	0.814
NULL	Ecancermedicalscience_2008_Feb_18_2_75.nxml.txt.nlp	22275966	SENT156	30	30	15	15	cisplatin	ERCC1	PA449014	2067	0.814
NULL	Neuroscience_2013_Oct_10_250(100)_493-506.nxml.txt.nlp	23892006	SENT625	3	3	5	5	ethanol	ZO-1	PA448073	7082	0.814
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT352	23	23	41	41	pp2	STAT3		6774	0.814
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT188	5	5	13	13	resveratrol	AIF		9131	0.814
NULL	Exp_Diabetes_Res_2008_Apr_24_2008_371716.nxml.txt.nlp	18483609	SENT107	0	0	16	16	fluorescein	mol	PA164746009	90527	0.814
NULL	Philos_Trans_R_Soc_Lond_B_Biol_Sci_2009_Feb_12_364(1515)_357-367.nxml.txt.nlp	18977732	SENT580	5	5	16	16	dextran	P28	PA449261	9446;7802;9527	0.814
NULL	Clin_Epidemiol_2010_Aug_9_2_29-36.nxml.txt.nlp	20865100	SENT35	30	30	40	40	paroxetine	B10	PA450801	5169	0.814
NULL	Atten_Defic_Hyperact_Disord_2010_Dec_30_2(4)_213-220.nxml.txt.nlp	21258431	SENT1	17	17	29	29	methylphenidate	ATX	PA450464	5168;23049	0.814
NULL	J_Cell_Mol_Med_2013_Nov_23_17(11)_1422-1433.nxml.txt.nlp	24112466	SENT235	19	19	9	9	cetuximab	EGFR	PA10040	1956	0.814
NULL	Arthritis_Res_Ther_2003_Jan_14_5(2)_54-67.nxml.txt.nlp	12718745	SENT371	8	8	0	0	hyaluronan	ACL	PA165958431	47	0.814
NULL	Anaesthesia_2010_Nov_65(11)_1153-1161.nxml.txt.nlp	20963925	SENT146	20	20	17	17	clopidogrel	P2Y12	PA449053	64805	0.814
NULL	Breast_Cancer_Res_2007_May_14_9(3)_R29.nxml.txt.nlp	17501995	SENT136	0	0	21	21	estradiol	CD38	PA449503	952	0.814
NULL	Sensors_(Basel)_2010_Jan_22_10(1)_890-900.nxml.txt.nlp	22315574	SENT91	13	13	37	37	dextran	IFN	PA449261	3439	0.814
NULL	Acta_Pharmacol_Sin_2009_Oct_21_30(10)_1392-1398.nxml.txt.nlp	19767766	SENT39	5	5	12	12	atorvastatin	p38	PA448500	10598;1432;7965	0.814
NULL	Cell_Death_Dis_2014_Apr_24_5(4)_e1197.nxml.txt.nlp	24763054	SENT81	14	14	4	4	cisplatin	ARC	PA449014	8996;23237	0.814
NULL	Leukemia_2013_Jan_11_27(1)_32-40.nxml.txt.nlp	22781593	SENT110	9	9	12	12	ponatinib	FGFR1	PA165980594	2260	0.814
NULL	J_Korean_Med_Sci_2009_Jan_29_24(Suppl_1)_S170-S175.nxml.txt.nlp	19194548	SENT76	12	12	6	6	cisplatin	EPO	PA449014	7076;8288;2056	0.814
NULL	Mol_Cancer_2012_Jul_12_11_45.nxml.txt.nlp	22788833	SENT85	2	2	10	10	cisplatin	EGFR	PA449014	1956	0.814
NULL	Core_Evid_2012_Dec_11_7_131-143.nxml.txt.nlp	23271985	SENT112	18	18	39	39	linezolid	hole	PA450233	80757	0.814
NULL	BMB_Rep_2014_Nov_47(11)_649-654.nxml.txt.nlp	25301019	SENT129	11	11	15	15	l-serine	TLR4	PA451330	7099	0.814
NULL	Pak_J_Med_Sci_2013_May-Jun_29(3)_768-772.nxml.txt.nlp	24353625	SENT40	8	8	17	17	ceftazidime	CTX	PA448861	1593	0.814
NULL	Acta_Naturae_2013_Jul-Sep_5(3)_92-98.nxml.txt.nlp	24303205	SENT20	25	25	4	4	l-methionine	MGL	PA450423	11343	0.814
NULL	Biomed_Res_Int_2013_Sep_8_2013_808713.nxml.txt.nlp	24083242	SENT197	30	30	9	9	propofol	STR	PA451141	6779	0.814
NULL	J_Antimicrob_Chemother_2009_Feb_28_63(2)_389-395.nxml.txt.nlp	19042940	SENT117	34	34	21	21	trimethoprim	UTI	PA451788	259	0.814
NULL	Front_Neurol_2014_May_9_5_69.nxml.txt.nlp	24847308	SENT187	2	2	17	17	curcumin	IFN	PA151958596	3439	0.814
NULL	CNS_Drugs_2014_Jun_24_28(10)_875-886.nxml.txt.nlp	24958205	SENT167	10	10	2	2	yohimbine	NPY	PA451946	4852	0.814
NULL	Indian_J_Pharm_Sci_2013_Jan-Feb_75(1)_31-35.nxml.txt.nlp	23901158	SENT49	14	14	5	5	dicloxacillin	DCX	PA164749649	1641	0.814
NULL	Amino_Acids_2012_Oct_10_43(4)_1751-1759.nxml.txt.nlp	22407485	SENT70	20	20	10	10	carrageenan	ghrelin	PA448814	51738	0.814
NULL	Ann_Rheum_Dis_2011_Jun_27_70(9)_1631-1640.nxml.txt.nlp	21708910	SENT220	31	31	20	20	etanercept	San	PA449515	80218	0.814
NULL	Nat_Med_2013_Dec_10_19(12)_10_1038_nm_3385.nxml.txt.nlp	24216752	SENT38	3	3	9	9	thrombin	PAR1	PA451674	79581;2149	0.814
NULL	Mol_Cancer_2013_Nov_11_12_134.nxml.txt.nlp	24215614	SENT186	4	4	10	10	lapatinib	PTEN	PA152241907	5728	0.814
NULL	J_Clin_Biochem_Nutr_2007_Jan_27_40(1)_13-23.nxml.txt.nlp	18437209	SENT575	5	5	0	0	trypsin	PAR2	PA451806	2150;55065;8856	0.814
NULL	Allergy_Asthma_Immunol_Res_2014_Nov_19_6(6)_548-557.nxml.txt.nlp	25374755	SENT147	0	0	5	5	simvastatin	Rho	PA451363	29984	0.814
NULL	J_Inflamm_(Lond)_2007_Mar_21_4_6.nxml.txt.nlp	17376223	SENT121	27	27	36	36	hydrocortisone	ANOVA	PA449905	4858	0.814
NULL	Clin_Exp_Otorhinolaryngol_2011_Jun_31_4(2)_77-82.nxml.txt.nlp	21716954	SENT159	13	13	5	5	cisplatin	Bcl-2	PA449014	596	0.814
NULL	Am_J_Trop_Med_Hyg_2014_Oct_1_91(4)_854-861.nxml.txt.nlp	25071003	SENT224	11	11	2	2	primaquine	G6PD	PA451103	2539	0.814
NULL	Aging_(Albany_NY)_2009_Jun_3_1(6)_515-528.nxml.txt.nlp	20157535	SENT67	32	32	10	10	resveratrol	SIRT1		23411	0.814
NULL	F1000Res_2014_Aug_19_3_198.nxml.txt.nlp	25400908	SENT195	0	0	11	11	lapatinib	EGFR	PA152241907	1956	0.814
NULL	Arthritis_Res_Ther_2011_Feb_16_13(1)_R25.nxml.txt.nlp	21324169	SENT98	26	26	20	20	etanercept	TNF	PA449515	7124	0.814
NULL	Cancers_(Basel)_2013_Dec_4_5(4)_1655-1675.nxml.txt.nlp	24305655	SENT118	16	16	13	13	doxorubicin	p53	PA449412	7157	0.814
NULL	Front_Neurosci_2014_Jan_10_7_270.nxml.txt.nlp	24454277	SENT19	6	6	12	12	resveratrol	PI3		5266	0.814
NULL	J_Cell_Mol_Med_2014_Dec_6_18(12)_2331-2339.nxml.txt.nlp	25284457	SENT151	6	6	25	25	bleomycin	RAGE	PA448645	177	0.814
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT272	5	5	15	15	pemetrexed	UNG	PA10810	7374	0.814
NULL	Breast_Cancer_Res_2005_Jan_12_7(2)_48-51.nxml.txt.nlp	15743510	SENT84	15	15	7	7	tamoxifen	ATAC	PA451581	6375	0.814
NULL	Mol_Cancer_2006_Sep_5_5_34.nxml.txt.nlp	16953886	SENT40	13	13	1	1	doxorubicin	TRAIL	PA449412	8743	0.814
NULL	J_Physiol_2014_Nov_15_592(22)_5093-5107.nxml.txt.nlp	25239460	SENT243	2	2	11	11	sc-560	PAG		55824	0.814
NULL	Autophagy_2013_Mar_1_9(3)_287-302.nxml.txt.nlp	23221969	SENT436	8	8	18	18	fulvestrant	NF-kappaB	PA164747170	4790	0.814
NULL	Crit_Care_2008_Feb_21_12(1)_R20.nxml.txt.nlp	18291025	SENT183	24	24	5	5	felypressin	AVP	PA164744374	114548;551	0.814
NULL	Blood_Res_2013_Jun_25_48(2)_115-120.nxml.txt.nlp	23826580	SENT19	17	17	15	15	cyclophosphamide	CHOP	PA449165	1649	0.814
NULL	Neuropsychopharmacology_2009_Jul_25_34(8)_1968-1978.nxml.txt.nlp	19322168	SENT223	8	8	18	18	clozapine	PI3K	PA449061	5290	0.814
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Jul_26_64(Pt_8)_o1586.nxml.txt.nlp	21203284	SENT64	33	33	6	6	ethanol	mol	PA448073	90527	0.814
NULL	Eur_J_Clin_Pharmacol_2011_Dec_23_67(12)_1231-1241.nxml.txt.nlp	21698374	SENT297	12	12	4	4	cyclosporine	CYP3A5	PA449167	1577	0.814
NULL	Blood_Cancer_J_2014_Feb_7_4(2)_e180.nxml.txt.nlp	24510029	SENT22	43	43	17	17	rituximab	CD19	PA451261	930	0.814
NULL	Mol_Med_Rep_2015_Jan_22_11(1)_83-90.nxml.txt.nlp	25338529	SENT135	10	10	25	25	octreotide	HO-1	PA450678	3162	0.814
NULL	Biomed_Res_Int_2013_Aug_6_2013_602987.nxml.txt.nlp	24027759	SENT264	7	7	9	9	cisplatin	SMF	PA449014	22993	0.814
NULL	Clin_Med_Insights_Cardiol_2010_Dec_1_4_117-128.nxml.txt.nlp	21151850	SENT206	3	3	23	23	prasugrel	CYP2C19	PA154410481	1557	0.814
NULL	Oncotarget_2010_Oct_25_1(7)_497-514.nxml.txt.nlp	21165163	SENT115	12	12	3	3	erlotinib	EGFR	PA134687924	1956	0.814
NULL	Pharmaceutics_2011_Nov_18_3(4)_865-913.nxml.txt.nlp	24309312	SENT163	3	3	40	40	raltegravir	UGT1A1		54658	0.814
NULL	AIDS_2014_Oct_23_28(16)_2395-2405.nxml.txt.nlp	25389551	SENT239	11	11	20	20	efavirenz	CD4	PA449441	920	0.814
NULL	Asian-Australas_J_Anim_Sci_2014_Dec_27(12)_1783-1793.nxml.txt.nlp	25358373	SENT141	9	9	1	1	capsaicin	CASP3	PA448776	836	0.814
NULL	Oncotarget_2011_Dec_31_2(12)_1314-1321.nxml.txt.nlp	22248929	SENT78	9	9	2	2	lapatinib	HER3	PA152241907	2065	0.814
NULL	Nucl_Recept_Signal_2009_Jan_16_7_e001.nxml.txt.nlp	19240808	SENT378	23	23	9	9	dextran	SXR	PA449261	8856	0.814
NULL	Med_Sci_Monit_2012_Jul_1_18(7)_CS57-CS62.nxml.txt.nlp	22739739	SENT103	35	35	15	15	sulfapyridine	CYP3A4	PA164779050	1576	0.814
NULL	Br_J_Cancer_2013_Jul_23_109(2)_332-341.nxml.txt.nlp	23807171	SENT57	26	26	34	34	bevacizumab	IFN	PA130232992	3439	0.814
NULL	Front_Endocrinol_(Lausanne)_2014_Feb_4_5_10.nxml.txt.nlp	24550888	SENT385	11	11	20	20	gefitinib	CD133	PA131301952	8842	0.814
NULL	CNS_Neurosci_Ther_2009_Spring_15(1)_32-51.nxml.txt.nlp	19228178	SENT72	3	3	6	6	ramelteon	MT3	PA164744896	4504	0.814
NULL	Diabetes_Metab_Syndr_Obes_2014_Jun_24_7_229-239.nxml.txt.nlp	25018644	SENT216	15	15	18	18	metformin	GLP-1	PA450395	100125288	0.814
NULL	Pharmaceuticals_(Basel)_2013_Nov_11_6(11)_1407-1428.nxml.txt.nlp	24287464	SENT215	18	18	4	4	tanespimycin	Hsp90	PA165291490	3320	0.814
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1986-2011.nxml.txt.nlp	25268165	SENT1196	1	1	10	10	sorafenib	STAT3	PA7000	6774	0.814
NULL	Breast_Cancer_Res_Treat_2014_Apr_6_145(1)_33-44.nxml.txt.nlp	24706169	SENT50	4	4	1	1	trastuzumab	HER2	PA451743	2064	0.814
NULL	Hum_Genomics_Proteomics_2010_Sep_13_2010_754919.nxml.txt.nlp	20981234	SENT97	20	20	9	9	warfarin	VKORC1	PA451906	79001	0.814
NULL	Oncotarget_2013_Jun_4_4(5)_772-784.nxml.txt.nlp	23800712	SENT6	33	33	12	12	bortezomib	EGFR	PA10252	1956	0.814
NULL	Orphanet_J_Rare_Dis_2014_Sep_26_9(1)_145.nxml.txt.nlp	NULL	SENT14	36	36	34	34	denosumab	RANKL	PA166048634	8600	0.814
NULL	J_Mol_Signal_2011_Aug_10_6_8.nxml.txt.nlp	21831305	SENT171	9	9	14	14	isoproterenol	AKAP12	PA450121	9590	0.814
NULL	Case_Rep_Nephrol_Urol_2014_Feb_18_4(1)_25-30.nxml.txt.nlp	24707280	SENT15	1	1	23	23	heparin	ACT	PA449855	12;11332;9457;641455	0.814
NULL	Nat_Commun_2013_Apr_9_4_1684.nxml.txt.nlp	23575688	SENT585	13	13	19	19	rolipram	CYLD	PA153906323	1540	0.814
NULL	Front_Immunol_2014_Aug_13_5_387.nxml.txt.nlp	25165466	SENT247	28	28	13	13	medroxyprogesterone	CD11b	PA450344	3684	0.814
NULL	Open_Med_Chem_J_2011_Sep_9_5_82-92.nxml.txt.nlp	21966329	SENT339	8	8	11	11	liraglutide	GLP-1	PA165958364	100125288	0.814
NULL	Environ_Health_Perspect_2010_Jun_25_118(6)_864-870.nxml.txt.nlp	20100676	SENT242	25	25	18	18	arsenite	INS-1	PA452638	2305	0.814
NULL	Front_Oncol_2014_Jun_18_4_159.nxml.txt.nlp	24995161	SENT151	17	17	7	7	estradiol	HSD1	PA449503	26871	0.814
NULL	Iran_J_Public_Health_2012_Jan_31_41(1)_37-44.nxml.txt.nlp	23113120	SENT161	15	15	9	9	imatinib	survivin	PA10804	332	0.814
NULL	Front_Behav_Neurosci_2014_Oct_6_8_343.nxml.txt.nlp	25339876	SENT1022	11	11	1	1	ketamine	B12	PA450144	7126;4709	0.814
NULL	Oncotarget_2014_Oct_18_5(22)_11588-11603.nxml.txt.nlp	25473890	SENT173	31	31	41	41	l-glutamine	CO2	PA10090	4513	0.814
NULL	Biosci_Rep_2012_Aug_1_32(Pt_4)_361-374.nxml.txt.nlp	22762204	SENT186	14	14	4	4	paclitaxel	TAZ	PA450761	25937;6901	0.814
NULL	Nat_Med_2013_Nov_27_19(11)_10_1038_nm_3364.nxml.txt.nlp	24162813	SENT52	18	18	0	0	imatinib	PTH	PA10804	5741	0.814
NULL	Carbohydr_Res_2014_Mar_31_387(100)_54-58.nxml.txt.nlp	24589444	SENT239	4	4	11	11	trypsin	GPI	PA451806	10007;2821	0.814
NULL	EPMA_J_2013_Jun_7_4(1)_14.nxml.txt.nlp	23742177	SENT1048	0	0	28	28	bosentan	OBF	PA10034	284359	0.814
NULL	Front_Immunol_2014_Aug_28_5_409.nxml.txt.nlp	25221554	SENT378	17	17	13	13	l-phenylalanine	IL4I1	PA450931	259307	0.814
NULL	Front_Endocrinol_(Lausanne)_2013_Oct_11_4_140.nxml.txt.nlp	24130552	SENT58	37	37	11	11	paraformaldehyde	P35	PA450790	2220	0.814
NULL	Angiogenesis_2010_Dec_7_13(4)_305-315.nxml.txt.nlp	20927579	SENT163	2	2	8	8	resveratrol	p53		7157	0.814
NULL	Br_J_Cancer_2012_Nov_20_107(11)_1844-1852.nxml.txt.nlp	23169337	SENT292	6	6	11	11	bortezomib	AKT	PA10252	207	0.814
NULL	Br_J_Cancer_2011_Aug_9_105(4)_469-474.nxml.txt.nlp	21712825	SENT87	32	32	1	1	epirubicin	MX2	PA449476	4600	0.814
NULL	FEBS_Open_Bio_2014_Jan_21_4_153-161.nxml.txt.nlp	24490140	SENT245	27	27	3	3	doxorubicin	WT1	PA449412	7490	0.814
NULL	Curr_Genomics_2014_Jun_15(3)_217-230.nxml.txt.nlp	24955029	SENT297	14	14	33	33	nadh	ROS	PA164755085	6098	0.814
NULL	Cancer_Cell_Int_2009_Feb_17_9_4.nxml.txt.nlp	19222856	SENT195	20	20	31	31	cisplatin	p53	PA449014	7157	0.814
NULL	Oncotarget_2014_Jun_6_5(12)_4516-4528.nxml.txt.nlp	24980831	SENT148	8	8	2	2	temozolomide	CCL2	PA451609	6347	0.814
NULL	J_Adv_Pract_Oncol_2013_Jul_1_Jul-Aug_4(4)_263-268.nxml.txt.nlp	25032007	SENT154	12	12	20	20	tramadol	CYP2D6	PA451735	1565	0.814
NULL	Breast_Cancer_Res_Treat_2012_Jun_18_133(3)_937-947.nxml.txt.nlp	22094936	SENT44	25	25	14	14	tamoxifen	EZH2	PA451581	2146	0.814
NULL	J_Exp_Clin_Cancer_Res_2009_Jul_10_28(1)_99.nxml.txt.nlp	19591692	SENT115	40	40	29	29	imatinib	ABCB1	PA10804	5243	0.814
NULL	ASN_Neuro_2009_Oct_21_1(4)_e00018.nxml.txt.nlp	19807694	SENT166	27	27	41	41	ganciclovir	E14	PA449733	4863	0.814
NULL	Behav_Brain_Funct_2012_Feb_28_8_11.nxml.txt.nlp	22369141	SENT29	19	19	8	8	olanzapine	AAP	PA450688	5345	0.814
NULL	J_Asthma_Allergy_2008_Sep_19_1_19-29.nxml.txt.nlp	21436982	SENT109	8	8	29	29	fexofenadine	LFA-1	PA449621	3683;3689	0.814
NULL	Mol_Cancer_2010_Mar_10_9_56.nxml.txt.nlp	20219102	SENT81	5	5	21	21	bortezomib	CXCL2	PA10252	2920	0.814
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_29_2012_164689.nxml.txt.nlp	22203865	SENT218	16	16	12	12	camptothecin	MAX	PA153590860	4149	0.814
NULL	Infect_Dis_Ther_2013_Dec_19_2(2)_83-93.nxml.txt.nlp	25134473	SENT195	6	6	25	25	raltegravir	TRIO		7204	0.814
NULL	J_Immunother_Cancer_2014_Jan_27_2_2.nxml.txt.nlp	24829759	SENT172	27	27	2	2	axitinib	IL-21	PA164924493	59067;50616;27189	0.814
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT13	0	0	11	11	tacrolimus	STAT3	PA451578	6774	0.814
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_7-17.nxml.txt.nlp	17912633	SENT368	9	9	4	4	fulvestrant	aromatase	PA164747170	1588	0.814
NULL	Blood_Cancer_J_2013_Jul_19_3(7)_e128.nxml.txt.nlp	23872707	SENT189	17	17	19	19	cyclophosphamide	CTX	PA449165	1593	0.814
NULL	Breast_Cancer_Res_2004_Oct_24_6(1)_R8-R17.nxml.txt.nlp	14680495	SENT181	24	24	33	33	tamoxifen	BRCA1	PA451581	672	0.814
NULL	Int_J_Biol_Sci_2014_Jan_20_10(2)_171-180.nxml.txt.nlp	24520215	SENT165	0	0	9	9	cerulenin	L-FABP	PA164764551	2168	0.814
NULL	Ann_Surg_Oncol_2014_Feb_13_21(5)_1575-1582.nxml.txt.nlp	24522992	SENT170	5	5	18	18	tamoxifen	ATAC	PA451581	6375	0.814
NULL	J_Clin_Biochem_Nutr_2009_Jan_27_44(1)_79-84.nxml.txt.nlp	19177192	SENT81	36	36	26	26	curcumin	HO-1	PA151958596	3162	0.814
NULL	Br_J_Cancer_2012_Jan_3_106(1)_107-115.nxml.txt.nlp	22116303	SENT122	7	7	25	25	vorinostat	AKT	PA164748224	207	0.814
NULL	Breast_Cancer_Res_2011_Mar_10_13(2)_R28.nxml.txt.nlp	21392397	SENT215	3	3	6	6	erlotinib	YB-1	PA134687924	4904	0.814
NULL	Int_J_Med_Sci_2013_Mar_19_10(5)_599-606.nxml.txt.nlp	23569422	SENT56	5	5	17	17	propofol	HO-1	PA451141	3162	0.814
NULL	Brain_Sci_2014_May_6_4(2)_356-375.nxml.txt.nlp	24961766	SENT346	10	10	20	20	propofol	G18	PA451141	1154;63940	0.814
NULL	Arthritis_Res_Ther_2003_Jan_20_5(2)_68-75.nxml.txt.nlp	12718746	SENT268	3	3	14	14	imiquimod	TLR1	PA449972	7096	0.814
NULL	Int_J_Trichology_2014_Jul-Sep_6(3)_113-139.nxml.txt.nlp	NULL	SENT281	13	13	9	9	pioglitazone	gamma	PA450970	9913	0.814
NULL	EJC_Suppl_2013_Sep_5_11(2)_3-22.nxml.txt.nlp	NULL	SENT1172	24	24	5	5	letrozole	aromatase	PA450196	1588	0.814
NULL	Evid_Based_Complement_Alternat_Med_2013_May_13_2013_506324.nxml.txt.nlp	23818927	SENT149	7	7	24	24	doxorubicin	JNK	PA449412	5599	0.814
NULL	J_Vis_Exp_2014_Jul_4_(89)_51847.nxml.txt.nlp	25045833	SENT125	26	26	5	5	theophylline	CARS	PA451647	833	0.814
NULL	Vet_Res_2013_Oct_2_44(1)_89.nxml.txt.nlp	24088531	SENT159	1	1	11	11	hemin	IL-10	PA449849	3586	0.814
NULL	Br_J_Cancer_2012_Jul_24_107(3)_516-526.nxml.txt.nlp	22782351	SENT299	36	36	12	12	tamoxifen	p57	PA451581	11151	0.814
NULL	EMBO_J_2009_Apr_22_28(8)_1043-1054.nxml.txt.nlp	19300439	SENT149	5	5	2	2	pp2	p38		10598;1432;7965	0.814
NULL	Diabetol_Metab_Syndr_2014_Mar_31_6_47.nxml.txt.nlp	24684779	SENT101	4	4	7	7	pioglitazone	IL-6	PA450970	3569	0.814
NULL	J_Cereb_Blood_Flow_Metab_2014_Oct_23_34(10)_1688-1694.nxml.txt.nlp	25052553	SENT180	46	46	25	25	losartan	SMAD2	PA450268	4087	0.814
NULL	Cancer_Cell_Int_2012_Jun_18_12_30.nxml.txt.nlp	22709569	SENT52	17	17	6	6	cisplatin	CALM1	PA449014	801	0.814
NULL	Multidiscip_Respir_Med_2012_Nov_23_7(1)_48.nxml.txt.nlp	23174134	SENT83	7	7	5	5	imatinib	DLST	PA10804	1743	0.814
NULL	Cancer_Med_2014_Oct_2_3(5)_1385-1395.nxml.txt.nlp	24890702	SENT153	5	5	25	25	fluorouracil	KRAS	PA128406956	3845	0.814
NULL	Int_J_Biol_Sci_2011_Sep_8_7(8)_1077-1092.nxml.txt.nlp	21927577	SENT20	16	16	8	8	telmisartan	ANG	PA451605	283	0.814
NULL	Biomed_Res_Int_2014_Feb_6_2014_323594.nxml.txt.nlp	24689036	SENT221	8	8	15	15	raloxifene	PC3	PA451221	57332;7832;5122	0.814
NULL	Breast_Cancer_Res_2005_May_24_7(5)_R589-R597.nxml.txt.nlp	16168102	SENT144	9	9	29	29	trastuzumab	HER2	PA451743	2064	0.814
NULL	Onco_Targets_Ther_2014_Mar_20_7_447-456.nxml.txt.nlp	24672247	SENT139	8	8	2	2	gemcitabine	CLU	PA449748	1191	0.814
NULL	Cancer_2014_Jul_1_120(13)_2006-2015.nxml.txt.nlp	24705963	SENT158	2	2	14	14	vismodegib	PTCH1		5727	0.814
NULL	Clin_Dev_Immunol_2013_Oct_27_2013_758159.nxml.txt.nlp	24282430	SENT85	16	16	10	10	fluorescein	GAPDH	PA164746009	2597	0.814
NULL	Eur_J_Clin_Pharmacol_2011_May_9_67(5)_477-482.nxml.txt.nlp	21305273	SENT121	5	5	18	18	atropine	ADRB1	PA448505	153	0.814
NULL	Mol_Imaging_Radionucl_Ther_2013_Aug_1_22(2)_36-41.nxml.txt.nlp	24003395	SENT99	27	27	17	17	propylthiouracil	RAI	PA451156	10848;6050	0.814
NULL	Mol_Cancer_2010_Apr_23_9_87.nxml.txt.nlp	20416058	SENT146	16	16	14	14	doxorubicin	TRAIL	PA449412	8743	0.814
NULL	Chem_Cent_J_2012_Nov_23_6_141.nxml.txt.nlp	23174002	SENT162	22	22	5	5	paraformaldehyde	PC3	PA450790	57332;7832;5122	0.814
NULL	Oncol_Lett_2013_Oct_26_6(4)_1063-1067.nxml.txt.nlp	24137465	SENT98	7	7	19	19	afatinib	HER2	PA165981154	2064	0.814
NULL	Drugs_R_D_2014_Dec_6_14(4)_315-324.nxml.txt.nlp	25480348	SENT5	16	16	26	26	alfacalcidol	BMD	PA164746469	1756;7439	0.814
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Dec_7_70(Pt_1)_o25-o26.nxml.txt.nlp	24526973	SENT8	18	18	33	33	piperazine	mol	PA450977	90527	0.814
NULL	Indian_J_Med_Res_2014_Feb_139(2)_195-204.nxml.txt.nlp	24718393	SENT165	16	16	30	30	itraconazole	CYP2C9	PA450132	1559	0.814
NULL	Mucosal_Immunol_2013_Nov_10_6(6)_1179-1190.nxml.txt.nlp	23571504	SENT425	6	6	3	3	auranofin	TRX	PA448510	7295	0.814
NULL	Clin_Sci_(Lond)_2011_Nov_1_121(Pt_10)_449-458.nxml.txt.nlp	21671887	SENT194	31	31	34	34	simvastatin	AMPK	PA451363	5563	0.813
NULL	Mol_Biol_Cell_2014_Mar_15_25(6)_739-752.nxml.txt.nlp	24430869	SENT153	22	22	8	8	pp2	EGFR		1956	0.813
NULL	Emerg_Infect_Dis_2011_Mar_17(3)_566a-567.nxml.txt.nlp	NULL	SENT17	10	10	18	18	ofloxacin	DST	PA450684	667	0.813
NULL	Diagn_Pathol_2013_Feb_18_8_27.nxml.txt.nlp	23419122	SENT171	20	20	10	10	gefitinib	EGFR	PA131301952	1956	0.813
NULL	Breast_Cancer_Res_2012_Apr_4_14(2)_R57.nxml.txt.nlp	22475046	SENT13	24	24	3	3	anastrozole	CCND1	PA448432	595	0.813
NULL	Br_J_Haematol_2014_Mar_13_164(1)_811-821.nxml.txt.nlp	24328678	SENT145	5	5	0	0	lenalidomide	Aiolos	PA162363968	22806	0.813
NULL	Exp_Lung_Res_2013_Oct_1_39(8)_336-348.nxml.txt.nlp	23919450	SENT128	4	4	14	14	thrombin	PAR-1	PA451674	2011;2149	0.813
NULL	Alcohol_Res_Health_2007_30(1)_38-47.nxml.txt.nlp	17718399	SENT176	18	18	8	8	ethanol	CYP2E1	PA448073	1571	0.813
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT225	7	7	9	9	curcumin	TRAIL	PA151958596	8743	0.813
NULL	Indian_J_Pharm_Sci_2013_Jan-Feb_75(1)_94-98.nxml.txt.nlp	23901167	SENT69	14	14	35	35	omeprazole	CYP1A2	PA450704	1544	0.813
NULL	Oncotarget_2011_Sep_9_2(9)_658-668.nxml.txt.nlp	21911919	SENT79	7	7	11	11	cytarabine	HO-1	PA449177	3162	0.813
NULL	Aging_(Albany_NY)_2010_Aug_5_2(8)_527-534.nxml.txt.nlp	20689156	SENT89	8	8	6	6	resveratrol	SIRT1		23411	0.813
NULL	Oncotarget_2013_Mar_23_4(3)_463-473.nxml.txt.nlp	23531874	SENT186	37	37	35	35	cetuximab	EGFR	PA10040	1956	0.813
NULL	Case_Rep_Dermatol_2013_Mar_12_5(1)_69-72.nxml.txt.nlp	23626542	SENT35	11	11	9	9	vemurafenib	BRAF	PA165946873	673	0.813
NULL	J_Breast_Cancer_2013_Jun_28_16(2)_164-170.nxml.txt.nlp	23843848	SENT111	2	2	10	10	doxorubicin	p53	PA449412	7157	0.813
NULL	Int_J_Med_Sci_2013_Jan_3_10(2)_141-147.nxml.txt.nlp	23329885	SENT34	6	6	1	1	creatine	GAMT	PA164778930	2593	0.813
NULL	Int_J_Mol_Sci_2014_Sep_2_15(9)_15512-15529.nxml.txt.nlp	25184950	SENT227	6	6	13	13	resveratrol	IL-10		3586	0.813
NULL	Mol_Vis_2007_Jun_11_13_833-839.nxml.txt.nlp	17615544	SENT19	2	2	18	18	betaxolol	B27	PA448611	56246	0.813
NULL	ScientificWorldJournal_2014_Feb_11_2014_898361.nxml.txt.nlp	24678280	SENT114	19	19	29	29	curcumin	IL-4	PA151958596	3565	0.813
NULL	Arthritis_Res_Ther_2008_Mar_17_10(2)_R33.nxml.txt.nlp	18346273	SENT124	7	7	1	1	infliximab	HMGB1	PA452639	3146	0.813
NULL	AIDS_Res_Treat_2012_Nov_8_2012_595762.nxml.txt.nlp	23193464	SENT89	18	18	1	1	maraviroc	DUET	PA164768835	8997	0.813
NULL	Autoimmune_Dis_2013_Aug_28_2013_613086.nxml.txt.nlp	24069534	SENT22	34	34	22	22	infliximab	p40	PA452639	3921;339541;10314	0.813
NULL	Acta_Pharmacol_Sin_2012_Jan_12_33(1)_27-33.nxml.txt.nlp	22158109	SENT127	5	5	13	13	propofol	AMPK	PA451141	5563	0.813
NULL	J_Biomed_Sci_2013_Jul_2_20(1)_46.nxml.txt.nlp	23815815	SENT232	12	12	23	23	indomethacin	EPAC	PA449982	10411	0.813
NULL	Infect_Dis_Ther_2013_Dec_19_2(2)_83-93.nxml.txt.nlp	25134473	SENT204	12	12	20	20	raltegravir	TRIO		7204	0.813
NULL	Virol_J_2011_May_15_8_230.nxml.txt.nlp	21569631	SENT116	20	20	2	2	enfuvirtide	MT4	PA164744517	84560	0.813
NULL	Br_J_Cancer_2011_Aug_23_105(5)_658-665.nxml.txt.nlp	21829201	SENT7	10	10	16	16	docetaxel	DCX	PA449383	1641	0.813
NULL	J_Cardiothorac_Surg_2014_Dec_18_9(1)_196.nxml.txt.nlp	NULL	SENT145	20	20	11	11	heparin	ACT	PA449855	12;11332;9457;641455	0.813
NULL	Diabetes_Metab_Syndr_Obes_2010_May_17_3_165-172.nxml.txt.nlp	21437086	SENT123	0	0	4	4	liraglutide	GLP-1	PA165958364	100125288	0.813
NULL	Int_J_Med_Sci_2012_Dec_6_10(1)_8-18.nxml.txt.nlp	23289000	SENT46	29	29	45	45	l-glutamine	CO2	PA10090	4513	0.813
NULL	Cancers_(Basel)_2010_Dec_30_3(1)_106-125.nxml.txt.nlp	24212609	SENT396	8	8	19	19	gemcitabine	ABCC5	PA449748	10057	0.813
NULL	J_Infect_Dis_2014_May_1_209(9)_1469-1478.nxml.txt.nlp	24286983	SENT203	9	9	11	11	vancomycin	VAN	PA451850	10318	0.813
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT159	17	17	22	22	nutlin-3	PUMA		27113	0.813
NULL	Aging_(Albany_NY)_2013_Feb_21_5(2)_94-95.nxml.txt.nlp	23518473	SENT22	24	24	19	19	resveratrol	SIRT1		23411	0.813
NULL	Mol_Imaging_Biol_2009_Jul_31_11(4)_241-245.nxml.txt.nlp	19333655	SENT110	10	10	17	17	aprepitant	NK1	PA164747039	11126	0.813
NULL	Brain_Behav_2013_Mar_6_3(2)_114-133.nxml.txt.nlp	23533150	SENT308	19	19	9	9	ethanol	ARG	PA448073	473;27	0.813
NULL	Diabetes_Care_2010_Apr_19_33(4)_914-919.nxml.txt.nlp	20086255	SENT181	14	14	6	6	rosiglitazone	DREAM	PA451283	30818	0.813
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT439	24	24	12	12	quetiapine	PRL	PA451201	5617	0.813
NULL	Breast_Cancer_Res_2010_Sep_6_12(5)_R69.nxml.txt.nlp	20819206	SENT94	7	7	19	19	paraformaldehyde	GM130	PA450790	2801	0.813
NULL	J_Clin_Biochem_Nutr_2009_Jan_27_44(1)_79-84.nxml.txt.nlp	19177192	SENT81	36	36	9	9	curcumin	HO-1	PA151958596	3162	0.813
NULL	Anticancer_Agents_Med_Chem_2012_Feb_12(2)_163-171.nxml.txt.nlp	22043994	SENT53	11	11	20	20	irinotecan	EGFR	PA450085	1956	0.813
NULL	Antibiotics_(Basel)_2014_Jul_1_3(3)_285-316.nxml.txt.nlp	25364574	SENT180	20	20	9	9	meropenem	IMP-1	PA164764445	10642	0.813
NULL	Eur_Heart_J_2012_May_23_33(9)_1067-1075.nxml.txt.nlp	22362515	SENT37	14	14	5	5	isoflurane	CTR	PA450106	799	0.813
NULL	Br_J_Cancer_2010_Jan_5_102(1)_234-235.nxml.txt.nlp	NULL	SENT8	21	21	27	27	sunitinib	IFN	PA162372840	3439	0.813
NULL	Braz_J_Med_Biol_Res_2014_Mar_21_47(4)_273-278.nxml.txt.nlp	24676475	SENT73	17	17	40	40	doxorubicin	ADM	PA449412	133	0.813
NULL	J_Gastroenterol_2013_Jan_23_48(1)_31-72.nxml.txt.nlp	23090001	SENT1761	16	16	13	13	infliximab	TNF-alpha	PA452639	7124	0.813
NULL	J_Obes_2012_Sep_10_2012_956137.nxml.txt.nlp	22997570	SENT215	0	0	11	11	hyperforin	CRF1	PA165985514	1394	0.813
NULL	Diabetes_2011_Jun_21_60(6)_1770-1778.nxml.txt.nlp	21562078	SENT126	6	6	4	4	metformin	AMPK	PA450395	5563	0.813
NULL	Oncotarget_2014_Mar_26_5(21)_10342-10355.nxml.txt.nlp	25431950	SENT84	4	4	27	27	doxorubicin	EZH2	PA449412	2146	0.813
NULL	Antiviral_Res_2009_May_82(2)_A99-A109.nxml.txt.nlp	19176219	SENT1122	33	33	0	0	nelfinavir	OAT1	PA450606	9356	0.813
NULL	Curr_Neuropharmacol_2013_Dec_11(6)_560-591.nxml.txt.nlp	24396334	SENT303	7	7	10	10	paroxetine	CRF1	PA450801	1394	0.813
NULL	Diabetes_Care_2010_Oct_13_33(10)_2250-2253.nxml.txt.nlp	20628086	SENT16	13	13	4	4	rosiglitazone	NFATC2	PA451283	4773	0.813
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Mar_11_65(Pt_4)_o740.nxml.txt.nlp	21582473	SENT80	10	10	22	22	naphthol	mol	PA154081779	90527	0.813
NULL	Curr_Heart_Fail_Rep_2011_Dec_13_8(4)_242-251.nxml.txt.nlp	21842146	SENT139	39	39	24	24	saxagliptin	GLP-1	PA165958362	100125288	0.813
NULL	Mol_Cancer_2010_Dec_7_9_311.nxml.txt.nlp	21138557	SENT200	10	10	7	7	etoposide	p53	PA449552	7157	0.813
NULL	Behav_Brain_Funct_2007_Aug_18_3_41.nxml.txt.nlp	17705872	SENT193	6	6	21	21	paroxetine	CO2	PA450801	4513	0.813
NULL	Curr_Neuropharmacol_2008_Jun_6(2)_151-163.nxml.txt.nlp	19305794	SENT28	25	25	18	18	capsaicin	TRPV1	PA448776	7442	0.813
NULL	Int_J_Vasc_Med_2014_Jul_22_2014_659617.nxml.txt.nlp	25140254	SENT153	26	26	19	19	isoflurane	AVP	PA450106	114548;551	0.813
NULL	EMBO_Mol_Med_2013_Jul_16_5(7)_1019-1034.nxml.txt.nlp	23681745	SENT112	0	0	10	10	lapatinib	ERBB4	PA152241907	2066	0.813
NULL	Asian-Australas_J_Anim_Sci_2012_May_1_25(5)_635-641.nxml.txt.nlp	25049607	SENT77	2	2	18	18	estradiol	aromatase	PA449503	1588	0.813
NULL	Curr_Opin_Infect_Dis_2013_Dec_6_26(6)_538-544.nxml.txt.nlp	24126716	SENT148	14	14	19	19	amikacin	PARI	PA164744372	55010	0.813
NULL	Pharmaceutics_2011_Nov_18_3(4)_865-913.nxml.txt.nlp	24309312	SENT505	12	12	6	6	nafcillin	CYP3A4	PA450576	1576	0.813
NULL	Oncotarget_2014_Aug_29_5(19)_8947-8958.nxml.txt.nlp	25333254	SENT128	10	10	21	21	cytarabine	CXCR7	PA449177	57007	0.813
NULL	Mol_Brain_2014_May_15_7_37.nxml.txt.nlp	24886748	SENT125	30	30	10	10	vorinostat	RHEB	PA164748224	6008;6009	0.813
NULL	Br_J_Cancer_2003_Mar_24_88(6)_863-870.nxml.txt.nlp	12644823	SENT188	38	38	6	6	tamoxifen	maspin	PA451581	5268	0.813
NULL	Diabetes_Metab_J_2013_Oct_17_37(5)_315-325.nxml.txt.nlp	24199159	SENT194	44	44	12	12	resveratrol	SIRT1		23411	0.813
NULL	J_Oncol_2010_Nov_19_2010_568938.nxml.txt.nlp	20037743	SENT117	0	0	6	6	pertuzumab	HER2		2064	0.813
NULL	Cancers_(Basel)_2010_Mar_30_2(2)_338-363.nxml.txt.nlp	24281073	SENT983	8	8	5	5	doxorubicin	RLIP76	PA449412	10928	0.813
NULL	J_Cell_Biol_2008_Jul_28_182(2)_327-340.nxml.txt.nlp	18644889	SENT103	0	0	12	12	estradiol	CRM1	PA449503	7514	0.813
NULL	Mol_Cancer_2014_Jul_5_13_165.nxml.txt.nlp	24996221	SENT143	18	18	9	9	docetaxel	HMGB1	PA449383	3146	0.813
NULL	Oncol_Rep_2012_Apr_30_27(4)_1266-1276.nxml.txt.nlp	22209942	SENT219	30	30	35	35	tamoxifen	CDK10	PA451581	8558	0.813
NULL	Breast_Cancer_Res_2005_Jun_17_7(Suppl_2)_P2_08.nxml.txt.nlp	NULL	SENT3	19	19	26	26	tamoxifen	AKT	PA451581	207	0.813
NULL	Int_J_Biol_Sci_2015_Jan_1_11(1)_48-58.nxml.txt.nlp	25552929	SENT294	0	0	8	8	paclitaxel	TSP-1	PA450761	7057	0.813
NULL	Blood_Res_2013_Dec_24_48(4)_274-281.nxml.txt.nlp	24466552	SENT46	22	22	33	33	cyclophosphamide	CHOP	PA449165	1649	0.813
NULL	Mol_Vis_2010_Oct_8_16_2033-2042.nxml.txt.nlp	21042558	SENT248	2	2	33	33	genistein	p38	PA165109660	10598;1432;7965	0.813
NULL	Arthritis_Res_Ther_2009_May_19_11(3)_225.nxml.txt.nlp	19490600	SENT188	0	0	6	6	abatacept	CTLA4	PA164747080	1493	0.813
NULL	Carcinogenesis_2014_May_13_35(5)_1055-1066.nxml.txt.nlp	24419232	SENT176	11	11	7	7	metformin	CCL2	PA450395	6347	0.813
NULL	Eur_J_Clin_Pharmacol_2011_May_9_67(5)_477-482.nxml.txt.nlp	21305273	SENT12	11	11	14	14	atropine	DSE	PA448505	29940	0.813
NULL	Clin_Interv_Aging_2012_Dec_30_7_1-13.nxml.txt.nlp	22291468	SENT56	16	16	26	26	dronedarone	CYP3A4	PA153619853	1576	0.813
NULL	Arthritis_Res_Ther_2009_Oct_14_11(5)_251.nxml.txt.nlp	19849819	SENT298	16	16	35	35	alendronate	PTH	PA448082	5741	0.813
NULL	Arthritis_Res_Ther_2010_Apr_29_12(2)_R73.nxml.txt.nlp	20429888	SENT158	24	24	11	11	bortezomib	COL1A2	PA10252	1278	0.813
NULL	Evid_Based_Complement_Alternat_Med_2011_May_24_2011_841564.nxml.txt.nlp	21716682	SENT112	28	28	7	7	epirubicin	JNK	PA449476	5599	0.813
NULL	Cancer_Biol_Med_2012_Mar_9(1)_18-22.nxml.txt.nlp	23691449	SENT54	3	3	9	9	gefitinib	EGFR	PA131301952	1956	0.813
NULL	Cancers_(Basel)_2012_Oct_29_4(4)_1146-1160.nxml.txt.nlp	24213502	SENT465	0	0	24	24	anastrozole	ATAC	PA448432	6375	0.813
NULL	Braz_J_Med_Biol_Res_2014_Oct_24_48(1)_65-76.nxml.txt.nlp	25493385	SENT163	26	26	37	37	l-arginine	AT2	PA448478	186	0.813
NULL	Cancers_(Basel)_2010_Sep_9_2(3)_1661-1682.nxml.txt.nlp	24281180	SENT210	33	33	20	20	gemcitabine	Bcl-2	PA449748	596	0.813
NULL	J_Hematol_Oncol_2012_Oct_11_5_64.nxml.txt.nlp	23057966	SENT189	7	7	11	11	ofatumumab	CHOP	PA165291493	1649	0.813
NULL	Nat_Chem_Biol_2013_Oct_25_9(10)_10_1038_nchembio_1333.nxml.txt.nlp	23974117	SENT182	19	19	15	15	gentamicin	CNTF	PA449753	1270	0.813
NULL	Oxid_Med_Cell_Longev_2013_Jun_2_2013_793525.nxml.txt.nlp	23819014	SENT204	42	42	33	33	resveratrol	PI3K		5290	0.813
NULL	Cell_Res_2014_Jul_9_24(7)_820-841.nxml.txt.nlp	24810299	SENT129	31	31	14	14	doxycycline	RBP-J	PA449415	3516	0.813
NULL	Br_J_Cancer_2013_Mar_19_108(5)_1079-1091.nxml.txt.nlp	23449353	SENT219	13	13	25	25	docetaxel	MIC-1	PA449383	29919;9518	0.813
NULL	Clin_Med_Insights_Circ_Respir_Pulm_Med_2013_Apr_9_7_7-15.nxml.txt.nlp	23641160	SENT73	0	0	15	15	roflumilast	CYP1A1	PA165948052	1543	0.813
NULL	Nat_Med_2011_Sep_25_17(10)_1242-1250.nxml.txt.nlp	21946538	SENT130	24	24	21	21	erlotinib	EGFR	PA134687924	1956	0.813
NULL	Case_Rep_Infect_Dis_2011_Sep_22_2011_981316.nxml.txt.nlp	22567485	SENT107	7	7	29	29	vancomycin	OSSA	PA451850	23196	0.813
NULL	Iran_J_Basic_Med_Sci_2012_Sep-Oct_15(5)_1102-1105.nxml.txt.nlp	23492757	SENT28	14	14	18	18	celecoxib	COX	PA448871	1351	0.813
NULL	Semin_Immunopathol_2013_Jan_26_35(1)_39-52.nxml.txt.nlp	22829332	SENT197	14	14	30	30	cytarabine	CHOP	PA449177	1649	0.813
NULL	Oncotarget_2011_Dec_31_2(12)_1314-1321.nxml.txt.nlp	22248929	SENT58	17	17	24	24	lapatinib	HER3	PA152241907	2065	0.813
NULL	Breast_Cancer_Res_Treat_2014_Jan_9_143(3)_493-505.nxml.txt.nlp	24402830	SENT4	6	6	19	19	capecitabine	HER2	PA448771	2064	0.813
NULL	Diagn_Pathol_2014_Aug_9_9(1)_153.nxml.txt.nlp	NULL	SENT27	12	12	38	38	gefitinib	PIK3CA	PA131301952	5290	0.813
NULL	Ann_Hematol_2010_Sep_13_89(9)_861-871.nxml.txt.nlp	20387067	SENT226	15	15	20	20	dasatinib	GM-CSF	PA162372878	1437	0.813
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Dec_10_3(12)_e151.nxml.txt.nlp	25494035	SENT252	6	6	23	23	gemfibrozil	OATP2B1	PA449750	11309	0.813
NULL	Angiogenesis_2010_Dec_7_13(4)_305-315.nxml.txt.nlp	20927579	SENT143	18	18	8	8	resveratrol	p53		7157	0.813
NULL	Mol_Cancer_2007_Sep_26_6_61.nxml.txt.nlp	17894897	SENT151	13	13	6	6	etoposide	p53	PA449552	7157	0.813
NULL	Arthritis_Res_Ther_2011_Oct_7_13(5)_R161.nxml.txt.nlp	21982514	SENT17	13	13	25	25	etanercept	EGF	PA449515	1950	0.813
NULL	JAKSTAT_2013_Oct_1_2(4)_e25352.nxml.txt.nlp	24498539	SENT57	18	18	4	4	fluorescein	CD4	PA164746009	920	0.813
NULL	EMBO_Mol_Med_2013_Mar_5_5(3)_384-396.nxml.txt.nlp	23495140	SENT104	19	19	7	7	tetracycline	HES1	PA451640	3280;8209	0.813
NULL	Int_J_Mol_Sci_2014_Mar_20_15(3)_4965-4976.nxml.txt.nlp	24658440	SENT585	6	6	11	11	tacrolimus	RANKL	PA451578	8600	0.813
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1676-1682.nxml.txt.nlp	19844234	SENT151	13	13	31	31	lapatinib	HER2	PA152241907	2064	0.813
NULL	Ann_Hematol_2010_Nov_25_89(11)_1115-1124.nxml.txt.nlp	20499237	SENT181	17	17	25	25	simvastatin	CD5	PA451363	921	0.813
NULL	Mol_Cancer_2008_Jan_25_7_14.nxml.txt.nlp	18221502	SENT203	37	37	26	26	oxaliplatin	PSAT1	PA131285527	29968	0.813
NULL	Cancer_Cell_Int_2013_Sep_23_13_94.nxml.txt.nlp	24059699	SENT138	27	27	4	4	bevacizumab	VEGFA	PA130232992	7422	0.813
NULL	Cardiol_Res_Pract_2011_Apr_26_2011_837841.nxml.txt.nlp	21577267	SENT46	20	20	24	24	protamine	ACT	PA10366	12;11332;9457;641455	0.813
NULL	J_Asthma_Allergy_2008_Sep_19_1_19-29.nxml.txt.nlp	21436982	SENT110	43	43	21	21	fexofenadine	I-TAC	PA449621	6373	0.813
NULL	Mar_Drugs_2012_Dec_12_10(12)_2795-2816.nxml.txt.nlp	23235364	SENT246	7	7	24	24	carrageenan	IL-2	PA448814	3558	0.813
NULL	Br_J_Cancer_2010_Jun_29_103(1)_52-60.nxml.txt.nlp	20531411	SENT31	17	17	25	25	gemcitabine	MTD	PA449748	4493	0.813
NULL	Mol_Cancer_2007_Oct_22_6_66.nxml.txt.nlp	17953743	SENT158	6	6	0	0	cisplatin	NAC	PA449014	22861	0.813
NULL	Mol_Biol_Evol_2014_Nov_25_31(11)_3040-3056.nxml.txt.nlp	25158795	SENT86	4	4	30	30	thrombin	F10	PA451674	2159	0.813
NULL	Lab_Invest_2012_Oct_20_92(10)_1492-1502.nxml.txt.nlp	22906986	SENT55	10	10	4	4	ketamine	CO2	PA450144	4513	0.813
NULL	Cancers_(Basel)_2010_Dec_30_3(1)_106-125.nxml.txt.nlp	24212609	SENT49	14	14	2	2	gemcitabine	MUC4	PA449748	4585	0.813
NULL	Oncotarget_2010_Oct_12_1(7)_674-684.nxml.txt.nlp	21317462	SENT75	7	7	29	29	estradiol	SFRP2	PA449503	6423	0.813
NULL	Cost_Eff_Resour_Alloc_2006_May_31_4_9.nxml.txt.nlp	16737538	SENT127	41	41	19	19	rofecoxib	OTC	PA451268	5009	0.813
NULL	Diabetologia_2010_Jun_27_53(6)_1142-1150.nxml.txt.nlp	20349036	SENT143	7	7	13	13	spermine	AMPK	PA164781199	5563	0.813
NULL	Breast_Cancer_Res_2012_Aug_31_14(4)_212.nxml.txt.nlp	22963717	SENT273	5	5	17	17	bortezomib	IL-6	PA10252	3569	0.813
NULL	Arthritis_Res_Ther_2013_Jul_9_15(4)_R73.nxml.txt.nlp	23837669	SENT303	40	40	36	36	colchicine	MICL	PA449092	160364	0.813
NULL	JAKSTAT_2013_Jul_1_2(3)_e25025.nxml.txt.nlp	24069563	SENT186	15	15	8	8	cladribine	IFN	PA449027	3439	0.813
NULL	Oncotarget_2014_Oct_21_5(22)_11709-11722.nxml.txt.nlp	25365944	SENT228	12	12	25	25	metformin	Rho	PA450395	29984	0.813
NULL	Biochem_Biophys_Res_Commun_2008_Sep_5_373(4)_584-588.nxml.txt.nlp	18586007	SENT123	2	2	7	7	curcumin	p38	PA151958596	10598;1432;7965	0.813
NULL	Cell_Death_Dis_2013_Oct_3_4(10)_e834.nxml.txt.nlp	24091677	SENT218	10	10	6	6	vinblastine	Mcl-1	PA451877	4170	0.813
NULL	Front_Neurosci_2011_Jan_14_4_207.nxml.txt.nlp	21258618	SENT113	0	0	19	19	ethanol	HET	PA448073	6294	0.813
NULL	J_Young_Pharm_2010_Jan-Mar_2(1)_54-58.nxml.txt.nlp	21331192	SENT110	2	2	6	6	trypsin	DAI	PA451806	81030	0.813
NULL	Evid_Based_Complement_Alternat_Med_2013_May_16_2013_857929.nxml.txt.nlp	23762164	SENT166	14	14	2	2	resveratrol	LC3		84557	0.813
NULL	Aging_(Albany_NY)_2011_Jan_18_3(1)_33-43.nxml.txt.nlp	21248371	SENT23	2	2	25	25	oxygen	HIF-1	PA450744	29072	0.813
NULL	Ther_Clin_Risk_Manag_2007_Jun_3(2)_259-268.nxml.txt.nlp	18360634	SENT60	0	0	11	11	natalizumab	IFN	PA164747191	3439	0.813
NULL	Onco_Targets_Ther_2014_Sep_9_7_1571-1582.nxml.txt.nlp	25228815	SENT170	17	17	38	38	sunitinib	VEGFR2	PA162372840	3791	0.813
NULL	Int_J_Biol_Sci_2011_May_19_7(5)_645-650.nxml.txt.nlp	21647332	SENT97	11	11	6	6	metformin	AMPK	PA450395	5563	0.813
NULL	Mol_Biol_Cell_2012_Nov_1_23(21)_4212-4225.nxml.txt.nlp	22956765	SENT88	8	8	1	1	thrombin	SHP2	PA451674	5781	0.813
NULL	J_Cell_Biol_1997_Jul_28_138(2)_323-330.nxml.txt.nlp	9230074	SENT58	16	16	28	28	indomethacin	ADP	PA449982	23038	0.813
NULL	Chin_J_Cancer_2011_May_30(5)_327-335.nxml.txt.nlp	21527065	SENT15	5	5	26	26	lapatinib	PIK3CA	PA152241907	5290	0.813
NULL	J_Mol_Signal_2010_Jul_12_5_8.nxml.txt.nlp	20624308	SENT32	21	21	41	41	gefitinib	EGFR	PA131301952	1956	0.813
NULL	Mol_Cancer_2009_Nov_19_8_108.nxml.txt.nlp	19925669	SENT263	4	4	15	15	doxorubicin	CRT	PA449412	811	0.813
NULL	Diabetes_2009_Apr_9_58(4)_965-974.nxml.txt.nlp	19136651	SENT136	5	5	14	14	nadh	AMPK	PA164755085	5563	0.813
NULL	Diabetes_Obes_Metab_2010_May_12(5)_437-441.nxml.txt.nlp	20415692	SENT32	17	17	23	23	metformin	GLA	PA450395	9027;2717	0.813
NULL	J_Korean_Assoc_Oral_Maxillofac_Surg_2014_Dec_26_40(6)_291-296.nxml.txt.nlp	25551094	SENT36	30	30	22	22	alendronate	M-CSF	PA448082	1435	0.813
NULL	Cell_Div_2012_Dec_26_7_26.nxml.txt.nlp	23268747	SENT114	0	0	3	3	bortezomib	JNK	PA10252	5599	0.813
NULL	J_Gastrointest_Cancer_2013_Aug_7_44(4)_385-392.nxml.txt.nlp	23921604	SENT159	10	10	32	32	imatinib	ATG7	PA10804	10533	0.813
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT54	0	0	10	10	resveratrol	p53		7157	0.813
NULL	Exp_Ther_Med_2014_Sep_20_8(3)_968-972.nxml.txt.nlp	25120631	SENT10	4	4	16	16	naringin	PF4	PA151958360	5196	0.813
NULL	Drugs_R_D_2011_Jun_27_11(2)_101-111.nxml.txt.nlp	21679003	SENT104	26	26	32	32	bevacizumab	BRAF	PA130232992	673	0.813
NULL	Front_Oncol_2013_Nov_15_3_281.nxml.txt.nlp	24298448	SENT78	24	24	33	33	panitumumab	BRAF	PA162373091	673	0.813
NULL	eLife_2013_Oct_29_2_e01222.nxml.txt.nlp	24171103	SENT465	25	25	1	1	doxycycline	LBH	PA449415	81606;221491	0.813
NULL	Pharmaceuticals_(Basel)_2011_Nov_11_4(11)_1503-1517.nxml.txt.nlp	NULL	SENT272	3	3	5	5	capsaicin	VR1	PA448776	56664	0.813
NULL	J_Mol_Signal_2010_May_10_5_4.nxml.txt.nlp	20459745	SENT147	19	19	23	23	cisplatin	p53	PA449014	7157	0.813
NULL	Korean_J_Anesthesiol_2013_Dec_26_65(6)_501-507.nxml.txt.nlp	24427455	SENT57	32	32	16	16	rocuronium	NMB	PA164754992	10457;4828	0.813
NULL	Evid_Based_Complement_Alternat_Med_2012_Dec_20_2012_908601.nxml.txt.nlp	23326293	SENT24	14	14	18	18	daunorubicin	CD34	PA449212	947	0.813
NULL	Int_J_Alzheimers_Dis_2012_Apr_4_2012_258454.nxml.txt.nlp	22548198	SENT70	30	30	35	35	estradiol	CEE	PA449503	51608	0.813
NULL	Br_J_Cancer_2010_Sep_7_103(6)_796-801.nxml.txt.nlp	20823888	SENT106	10	10	39	39	erlotinib	D29	PA134687924	55520	0.813
NULL	Nat_Med_2013_Oct_8_19(10)_1313-1317.nxml.txt.nlp	24013700	SENT16	13	13	9	9	ribavirin	IFN	PA451241	3439	0.813
NULL	J_Gen_Physiol_2008_Nov_132(5)_521-535.nxml.txt.nlp	18852303	SENT269	17	17	14	14	trypsin	CAP2	PA451806	5271;10486	0.813
NULL	Scientifica_(Cairo)_2012_Dec_23_2012_857516.nxml.txt.nlp	24278747	SENT362	0	0	2	2	bortezomib	PKR	PA10252	5610	0.813
NULL	Chemother_Res_Pract_2011_Dec_1_2011_715469.nxml.txt.nlp	22312557	SENT150	18	18	22	22	cisplatin	p53	PA449014	7157	0.813
NULL	Indian_J_Pharmacol_2008_Mar-Apr_40(2)_84-86.nxml.txt.nlp	21279172	SENT6	11	11	5	5	erythromycin	CYP3A4	PA449493	1576	0.813
NULL	Front_Neurosci_2012_May_30_6_77.nxml.txt.nlp	22661925	SENT202	2	2	12	12	ethanol	DCX	PA448073	1641	0.813
NULL	Cell_Mol_Life_Sci_2011_Nov_2_68(21)_3573-3587.nxml.txt.nlp	21365278	SENT167	32	32	23	23	iloprost	EP4	PA164746843	5734	0.813
NULL	Clin_Ophthalmol_2014_May_20_8_999-1002.nxml.txt.nlp	24899797	SENT31	7	7	14	14	bevacizumab	San	PA130232992	80218	0.813
NULL	EMBO_Mol_Med_2012_Oct_30_4(10)_1087-1096.nxml.txt.nlp	22933245	SENT98	9	9	34	34	olaparib	BRCA2		675	0.813
NULL	Biomed_Res_Int_2013_Dec_29_2013_868321.nxml.txt.nlp	24459673	SENT82	16	16	9	9	acetazolamide	NAC	PA448018	22861	0.813
NULL	Clin_Epigenetics_2011_Dec_5_3(1)_8.nxml.txt.nlp	22414275	SENT208	2	2	5	5	ribavirin	ESR1	PA451241	2099	0.813
NULL	Nat_Commun_2014_Aug_6_5_4602.nxml.txt.nlp	25098764	SENT639	25	25	15	15	chloroquine	TRAF2	PA448948	7186	0.813
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT111	24	24	19	19	atorvastatin	IL-6	PA448500	3569	0.813
NULL	Diabetes_Care_2013_Jul_12_36(7)_2126-2132.nxml.txt.nlp	23645884	SENT56	14	14	5	5	lipase	GLP-1	PA450239	100125288	0.813
NULL	Arthritis_Res_2002_Nov_14_4(2)_139-144.nxml.txt.nlp	11879550	SENT115	10	10	22	22	streptomycin	BRL	PA451512	23774	0.813
NULL	J_Biol_Chem_2014_Dec_26_289(52)_36018-36030.nxml.txt.nlp	25336647	SENT485	18	18	9	9	s-adenosylmethionine	CBS	PA164754994	875	0.813
NULL	Case_Rep_Oncol_Med_2014_Dec_23_2014_597291.nxml.txt.nlp	25587475	SENT125	17	17	26	26	gemcitabine	TNF-alpha	PA449748	7124	0.813
NULL	Br_J_Cancer_2014_Jul_15_111(2)_318-325.nxml.txt.nlp	24874484	SENT37	29	29	40	40	choline	CDP	PA448976	1523	0.813
NULL	Clin_Med_Insights_Arthritis_Musculoskelet_Disord_2013_Apr_4_6_11-18.nxml.txt.nlp	23645988	SENT106	13	13	8	8	misoprostol	COX	PA450523	1351	0.813
NULL	Int_J_Mol_Sci_2013_Apr_26_14(5)_9182-9204.nxml.txt.nlp	23624607	SENT88	29	29	3	3	oxygen	AFM	PA450744	173	0.813
NULL	Oncol_Lett_2014_Nov_12_8(5)_2203-2208.nxml.txt.nlp	25295109	SENT128	11	11	6	6	celecoxib	GLI1	PA448871	2735	0.813
NULL	Oncogene_2013_Sep_26_32(39)_10_1038_onc_2012_501.nxml.txt.nlp	23160376	SENT234	24	24	40	40	l-glutamine	CO2	PA10090	4513	0.813
NULL	Breast_Cancer_Res_Treat_2012_Dec_26_136(3)_907-909.nxml.txt.nlp	23099437	SENT4	21	21	8	8	tamoxifen	HOXB13	PA451581	10481	0.813
NULL	Br_J_Cancer_2004_Mar_22_90(6)_1285-1292.nxml.txt.nlp	15026814	SENT42	23	23	18	18	doxorubicin	p53	PA449412	7157	0.813
NULL	Cancer_Cell_Int_2012_Jun_18_12_30.nxml.txt.nlp	22709569	SENT75	17	17	6	6	doxorubicin	CALM1	PA449412	801	0.813
NULL	Anticancer_Agents_Med_Chem_2012_Feb_12(2)_163-171.nxml.txt.nlp	22043994	SENT242	15	15	9	9	cetuximab	EGFR	PA10040	1956	0.813
NULL	Breast_Cancer_Res_2008_Jul_28_10(4)_R65.nxml.txt.nlp	18662380	SENT193	28	28	19	19	trastuzumab	ESR1	PA451743	2099	0.813
NULL	Br_J_Pharmacol_2014_Jan_23_171(2)_523-535.nxml.txt.nlp	24372553	SENT163	6	6	13	13	metformin	SIRT1	PA450395	23411	0.813
NULL	Mol_Cancer_2010_Mar_2_9_46.nxml.txt.nlp	20196838	SENT139	17	17	7	7	irinotecan	p53	PA450085	7157	0.813
NULL	Oncotarget_2014_Jun_6_5(13)_4935-4944.nxml.txt.nlp	24952732	SENT5	0	0	42	42	doxazosin	HIF-1	PA449407	29072	0.813
NULL	Pharmaceuticals_(Basel)_2013_Aug_21_6(8)_988-1038.nxml.txt.nlp	24276379	SENT365	18	18	4	4	cetuximab	EGFR	PA10040	1956	0.813
NULL	Pharmaceuticals_(Basel)_2011_Nov_11_4(11)_1503-1517.nxml.txt.nlp	NULL	SENT7	9	9	7	7	capsaicin	TRPV1	PA448776	7442	0.813
NULL	Mol_Pain_2012_Sep_22_8_71.nxml.txt.nlp	22998838	SENT9	27	27	5	5	cisplatin	CXCR4	PA449014	7852	0.813
NULL	J_Gastroenterol_2014_Dec_24_49(12)_1536-1547.nxml.txt.nlp	24366288	SENT125	25	25	38	38	omeprazole	CYP2C19	PA450704	1557	0.813
NULL	Carcinogenesis_2010_Dec_27_31(12)_2049-2057.nxml.txt.nlp	20876285	SENT232	12	12	23	23	tamoxifen	HER2	PA451581	2064	0.813
NULL	Clin_Interv_Aging_2015_Jan_6_10_157-174.nxml.txt.nlp	25609933	SENT251	21	21	24	24	tamoxifen	IMPACT	PA451581	55364	0.813
NULL	Chin_J_Cancer_2012_Sep_31(9)_413-420.nxml.txt.nlp	22776233	SENT103	26	26	0	0	glucose	NRF2	PA449773	2551;4780	0.813
NULL	Acta_Pharmacol_Sin_2009_Nov_5_30(11)_1522-1528.nxml.txt.nlp	19890360	SENT132	3	3	17	17	fenoterol	CD14	PA10079	929	0.813
NULL	Oncol_Lett_2013_Apr_22_5(4)_1093-1100.nxml.txt.nlp	23599746	SENT70	16	16	14	14	doxorubicin	P-gp	PA449412	5243	0.813
NULL	Oncotarget_2010_Nov_22_1(7)_606-619.nxml.txt.nlp	21317456	SENT155	23	23	9	9	doxorubicin	BRCA2	PA449412	675	0.813
NULL	Oncotarget_2013_Jan_27_4(1)_153-162.nxml.txt.nlp	23847722	SENT10	16	16	23	23	oxaliplatin	HER-2	PA131285527	2064	0.813
NULL	Open_Ophthalmol_J_2013_Feb_1_7_4-10.nxml.txt.nlp	23459241	SENT112	30	30	37	37	bevacizumab	San	PA130232992	80218	0.813
NULL	Oncotarget_2011_Sep_9_2(9)_658-668.nxml.txt.nlp	21911919	SENT55	20	20	6	6	cytarabine	HO-1	PA449177	3162	0.813
NULL	Braz_J_Med_Biol_Res_2014_Sep_5_47(11)_929-939.nxml.txt.nlp	25296354	SENT84	5	5	21	21	erlotinib	EGFR	PA134687924	1956	0.813
NULL	Arthritis_Res_Ther_2010_Jul_6_12(4)_R129.nxml.txt.nlp	20604932	SENT213	31	31	12	12	collagenase	IL-6	PA449107	3569	0.813
NULL	Arthritis_Res_Ther_2006_Feb_8_8(2)_R44.nxml.txt.nlp	16507143	SENT41	29	29	48	48	l-glutamine	CO2	PA10090	4513	0.813
NULL	J_Mol_Signal_2006_Dec_6_1_8.nxml.txt.nlp	17224083	SENT127	18	18	15	15	thrombin	Rho	PA451674	29984	0.813
NULL	Mol_Cancer_2007_Aug_21_6_53.nxml.txt.nlp	17711579	SENT154	34	34	11	11	cisplatin	BAG4	PA449014	9530	0.813
NULL	Cell_Death_Dis_2013_Oct_3_4(10)_e831.nxml.txt.nlp	24091674	SENT148	18	18	14	14	trypsin	CO2	PA451806	4513	0.813
NULL	Nat_Med_2011_Oct_2_17(10)_1304-1309.nxml.txt.nlp	21963515	SENT36	0	0	8	8	tacrolimus	WNK4	PA451578	65266	0.813
NULL	Clin_Exp_Otorhinolaryngol_2011_Jun_31_4(2)_77-82.nxml.txt.nlp	21716954	SENT121	11	11	3	3	cisplatin	Bcl-2	PA449014	596	0.813
NULL	J_Oncol_2013_Apr_29_2013_854121.nxml.txt.nlp	23737784	SENT174	9	9	6	6	lapatinib	HER2	PA152241907	2064	0.813
NULL	Oncol_Lett_2013_Mar_11_5(3)_1010-1016.nxml.txt.nlp	23426784	SENT168	5	5	30	30	midazolam	CDK4	PA450496	1019	0.813
NULL	Cell_Death_Dis_2014_Jul_3_5(7)_e1311.nxml.txt.nlp	24991763	SENT295	2	2	16	16	ketamine	LHX6	PA450144	26468	0.813
NULL	Cell_Biol_Int_Rep_(2010)_2012_Jun_21_19(1)_e00017.nxml.txt.nlp	23124518	SENT26	4	4	7	7	etoposide	TRAIL	PA449552	8743	0.813
NULL	Open_Access_J_Urol_2011_May_10_3_69-82.nxml.txt.nlp	24198638	SENT66	7	7	18	18	bupropion	CYP2C8	PA448687	1558	0.813
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_May_19_68(Pt_6)_o1772-o1773.nxml.txt.nlp	22719551	SENT8	1	1	34	34	piperazine	mol	PA450977	90527	0.813
NULL	Pharmaceuticals_(Basel)_2011_Nov_10_4(11)_1488-1502.nxml.txt.nlp	NULL	SENT347	5	5	11	11	geldanamycin	Raf-1	PA152031327	5894	0.813
NULL	Arthritis_Res_Ther_2014_Sep_24_16(5)_434.nxml.txt.nlp	25249397	SENT96	1	1	9	9	adalimumab	CXCL13	PA10004	10563	0.813
NULL	Exp_Ther_Med_2014_Aug_4_8(2)_657-661.nxml.txt.nlp	25009636	SENT104	30	30	18	18	propofol	CCL2	PA451141	6347	0.813
NULL	Nucleic_Acids_Res_2011_Dec_10_39(22)_9498-9507.nxml.txt.nlp	21835778	SENT181	24	24	19	19	nutlin-3	p53		7157	0.813
NULL	Mol_Vis_2007_Jul_9_13_1083-1093.nxml.txt.nlp	17653053	SENT153	2	2	24	24	minocycline	IL-10	PA450519	3586	0.813
NULL	Oncogenesis_2012_Apr_2_1(4)_e5.nxml.txt.nlp	23552603	SENT257	0	0	11	11	celecoxib	DR4	PA448871	8797	0.813
NULL	BMB_Rep_2013_Feb_46(2)_92-96.nxml.txt.nlp	23433111	SENT5	16	16	10	10	etoposide	BRCA1	PA449552	672	0.813
NULL	J_Biol_Chem_2013_Jul_19_288(29)_21412-21421.nxml.txt.nlp	23740251	SENT484	7	7	10	10	suramin	P2X1	PA10292	5023	0.813
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT208	7	7	13	13	bevacizumab	VEGFR2	PA130232992	3791	0.813
NULL	Curr_Pain_Headache_Rep_2011_Aug_12_15(4)_271-279.nxml.txt.nlp	21479998	SENT149	20	20	22	22	oxymorphone	CYP2D6	PA450748	1565	0.813
NULL	Cardiol_Res_Pract_2013_Jan_31_2013_128795.nxml.txt.nlp	23431496	SENT163	18	18	8	8	clopidogrel	CYP2C19	PA449053	1557	0.813
NULL	J_Adv_Pharm_Technol_Res_2012_Jan-Mar_3(1)_47-51.nxml.txt.nlp	22470893	SENT57	20	20	10	10	glibenclamide	STZ	PA449782	6484	0.813
NULL	Br_J_Cancer_2009_Oct_20_101(8)_1253-1260.nxml.txt.nlp	19755984	SENT192	2	2	8	8	anastrozole	SRC-3	PA448432	8202	0.813
NULL	Diabetologia_2010_Jul_2_53(7)_1270-1287.nxml.txt.nlp	20361178	SENT273	20	20	23	23	pioglitazone	adiponectin	PA450970	9370	0.813
NULL	J_Cancer_Prev_2014_Dec_19(4)_288-300.nxml.txt.nlp	25574464	SENT34	27	27	0	0	ethanol	ERF	PA448073	2077	0.813
NULL	J_Hematol_Oncol_2012_May_17_5_24.nxml.txt.nlp	22594538	SENT149	41	41	11	11	vorinostat	p65	PA164748224	5970	0.813
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT20	21	21	30	30	maytansine	HER2	PA165291473	2064	0.813
NULL	Viruses_2014_Feb_18_6(2)_875-892.nxml.txt.nlp	24553110	SENT127	6	6	15	15	erlotinib	CLDN1	PA134687924	9076	0.813
NULL	Indian_J_Endocrinol_Metab_2013_May-Jun_17(3)_472-479.nxml.txt.nlp	23869305	SENT44	7	7	9	9	atorvastatin	ATV	PA448500	4683	0.813
NULL	Cell_Death_Dis_2012_Jun_7_3(6)_e319.nxml.txt.nlp	22673193	SENT84	19	19	6	6	cisplatin	Mcl-1	PA449014	4170	0.813
NULL	Evid_Based_Complement_Alternat_Med_2012_Aug_28_2012_147896.nxml.txt.nlp	22969822	SENT119	8	8	43	43	ethanol	MCP-1	PA448073	6347	0.813
NULL	Anal_Chem_Insights_2008_Mar_25_3_45-60.nxml.txt.nlp	19609389	SENT200	14	14	11	11	pravastatin	HMGCR	PA451089	3156	0.813
NULL	Onco_Targets_Ther_2014_Nov_21_7_2143-2146.nxml.txt.nlp	25473295	SENT3	19	19	35	35	irinotecan	UGT	PA450085	7361;7355	0.813
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT253	26	26	19	19	lapatinib	EGF	PA152241907	1950	0.813
NULL	Gynecol_Endocrinol_2014_Jun_27_30(6)_444-450.nxml.txt.nlp	24576226	SENT73	24	24	9	9	estradiol	AMH	PA449503	268	0.813
NULL	Aging_(Albany_NY)_2009_Jun_3_1(6)_515-528.nxml.txt.nlp	20157535	SENT228	23	23	8	8	resveratrol	SIRT1		23411	0.813
NULL	J_Oncol_2012_Sep_5_2012_128608.nxml.txt.nlp	21904549	SENT187	19	19	11	11	semaxanib	MVD	PA131887911	4597	0.813
NULL	Int_J_Surg_Oncol_2012_May_17_2012_406830.nxml.txt.nlp	22675625	SENT111	9	9	16	16	cetuximab	KRAS	PA10040	3845	0.813
NULL	Support_Care_Cancer_2009_Sep_10_17(9)_1187-1193.nxml.txt.nlp	19205754	SENT28	21	21	8	8	granisetron	CYP1A1	PA449809	1543	0.813
NULL	Anesthesiol_Res_Pract_2012_Nov_24_2012_921405.nxml.txt.nlp	22162685	SENT115	14	14	25	25	lidocaine	NPY	PA450226	4852	0.813
NULL	Case_Rep_Rheumatol_2011_Dec_15_2011_185657.nxml.txt.nlp	22937439	SENT57	8	8	29	29	etanercept	TNF-alpha	PA449515	7124	0.813
NULL	Mol_Cancer_2013_Sep_11_12_105.nxml.txt.nlp	24025188	SENT25	29	29	14	14	staurosporine	Mcl-1	PA165109623	4170	0.813
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT537	26	26	44	44	pp2	STAT3		6774	0.813
NULL	Front_Oncol_2014_May_26_4_123.nxml.txt.nlp	24904834	SENT264	5	5	7	7	bortezomib	PSM	PA10252	2346	0.813
NULL	Antiviral_Res_2009_May_82(2)_A99-A109.nxml.txt.nlp	19176219	SENT283	21	21	14	14	saquinavir	P-gp	PA451305	5243	0.813
NULL	Ann_N_Y_Acad_Sci_2012_Aug_30_1264(1)_49-63.nxml.txt.nlp	22548651	SENT53	18	18	42	42	glucose	BDNF	PA449773	627	0.813
NULL	Chin_J_Cancer_2012_Jul_31(7)_319-326.nxml.txt.nlp	22257382	SENT104	20	20	4	4	lapatinib	EGFR	PA152241907	1956	0.813
NULL	Front_Oncol_2014_Sep_3_4_221.nxml.txt.nlp	25232533	SENT199	7	7	19	19	tamoxifen	PAX2	PA451581	5076	0.813
NULL	Exp_Ther_Med_2013_Jun_3_5(6)_1631-1636.nxml.txt.nlp	23837045	SENT9	0	0	10	10	propranolol	ANGPTL2	PA451145	23452	0.813
NULL	Breast_Cancer_Res_2009_Jul_15_11(4)_207.nxml.txt.nlp	19664181	SENT172	44	44	22	22	trastuzumab	PTEN	PA451743	5728	0.813
NULL	Ann_Surg_Oncol_2014_Sep_25_21(2)_597-604.nxml.txt.nlp	24065387	SENT222	5	5	3	3	cetuximab	HER-2	PA10040	2064	0.813
NULL	Front_Surg_2015_Jan_5_1_50.nxml.txt.nlp	25593974	SENT194	17	17	21	21	simvastatin	KRAS	PA451363	3845	0.813
NULL	Cancer_Metastasis_Rev_2010_Dec_10_29(4)_581-594.nxml.txt.nlp	20830503	SENT345	16	16	31	31	anastrozole	ARNO	PA448432	9266	0.813
NULL	Protein_Cell_2014_Jun_19_5(6)_469-479.nxml.txt.nlp	24748116	SENT61	3	3	0	0	paclitaxel	EB1	PA450761	9167;22919;10982	0.813
NULL	Mol_Cancer_2009_Dec_14_8_121.nxml.txt.nlp	20003443	SENT50	19	19	11	11	estradiol	AKR1C3	PA449503	8644	0.813
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jun_23_66(Pt_7)_o1766.nxml.txt.nlp	21587980	SENT58	4	4	34	34	isopropamide	mol	PA164781398	90527	0.813
NULL	Evid_Based_Complement_Alternat_Med_2011_Feb_14_2011_429843.nxml.txt.nlp	21869897	SENT136	34	34	19	19	ethanol	CORT	PA448073	1325	0.813
NULL	J_Cell_Mol_Med_2014_Jan_19_18(1)_156-169.nxml.txt.nlp	24251962	SENT45	7	7	9	9	bleomycin	BLM	PA448645	641	0.813
NULL	Front_Oncol_2014_May_16_4_108.nxml.txt.nlp	24904824	SENT88	27	27	21	21	dasatinib	ABL1	PA162372878	25	0.813
NULL	Cancers_(Basel)_2010_Jan_14_2(1)_1-19.nxml.txt.nlp	24281029	SENT373	11	11	23	23	bevacizumab	San	PA130232992	80218	0.813
NULL	Curr_Opin_Infect_Dis_2013_Dec_6_26(6)_538-544.nxml.txt.nlp	24126716	SENT214	11	11	17	17	amikacin	PARI	PA164744372	55010	0.813
NULL	Oxid_Med_Cell_Longev_2013_Apr_21_2013_412576.nxml.txt.nlp	23710286	SENT110	14	14	6	6	curcumin	NRF1	PA151958596	4899;4779	0.813
NULL	Arthritis_Res_Ther_2003_Sep_23_5(6)_251-265.nxml.txt.nlp	14680500	SENT29	1	1	8	8	vasopressin	ACTH	PA451858	5443	0.813
NULL	Cancer_Med_2014_Oct_3_3(5)_1416-1429.nxml.txt.nlp	24890561	SENT185	20	20	0	0	paclitaxel	San	PA450761	80218	0.813
NULL	Front_Oncol_2013_Aug_12_3_206.nxml.txt.nlp	23964347	SENT23	31	31	8	8	paclitaxel	BRCA2	PA450761	675	0.813
NULL	Drugs_R_D_2011_Jun_27_11(2)_113-126.nxml.txt.nlp	21679004	SENT39	37	37	48	48	everolimus	IFN	PA164746311	3439	0.813
NULL	Br_J_Cancer_2010_Jun_29_103(1)_61-72.nxml.txt.nlp	20588279	SENT272	8	8	1	1	trastuzumab	PTEN	PA451743	5728	0.813
NULL	J_Biol_Chem_2009_Jan_9_284(2)_784-791.nxml.txt.nlp	19008230	SENT193	11	11	7	7	forskolin	CO2	PA146096022	4513	0.813
NULL	Chromatographia_2014_Oct_9_77(21-22)_1489-1495.nxml.txt.nlp	25400288	SENT43	36	36	12	12	cefuroxime	ESI	PA448868	5266	0.813
NULL	Breast_Cancer_Res_2010_Mar_5_12(2)_R16.nxml.txt.nlp	20205716	SENT340	18	18	25	25	lovastatin	DJ-1	PA450272	11315	0.813
NULL	Apoptosis_2010_Oct_19_15(10)_1223-1233.nxml.txt.nlp	20563668	SENT33	12	12	39	39	l-glutamine	CO2	PA10090	4513	0.813
NULL	Case_Rep_Hematol_2012_Dec_12_2012_180204.nxml.txt.nlp	23304578	SENT38	10	10	3	3	doxorubicin	CHOP	PA449412	1649	0.813
NULL	Cell_Death_Dis_2014_Jan_30_5(1)_e1038.nxml.txt.nlp	24481452	SENT69	6	6	14	14	raloxifene	ARNT	PA451221	405	0.813
NULL	Cardiol_Res_Pract_2013_Jan_31_2013_128795.nxml.txt.nlp	23431496	SENT158	11	11	23	23	clopidogrel	CYP2C19	PA449053	1557	0.813
NULL	Br_J_Pharmacol_2014_Sep_28_171(18)_4255-4272.nxml.txt.nlp	24846338	SENT291	3	3	18	18	escitalopram	gamma	PA10074	9913	0.813
NULL	Front_Endocrinol_(Lausanne)_2014_Aug_18_5_129.nxml.txt.nlp	25183960	SENT140	7	7	1	1	octreotide	ghrelin	PA450678	51738	0.813
NULL	J_Gynecol_Oncol_2013_Jan_8_24(1)_66-82.nxml.txt.nlp	23346316	SENT245	21	21	8	8	anastrozole	HER2	PA448432	2064	0.813
NULL	Cell_Death_Differ_2010_Mar_16_17(3)_499-512.nxml.txt.nlp	19834490	SENT121	6	6	29	29	bevacizumab	VEGFR1	PA130232992	2321	0.813
NULL	Br_J_Cancer_1981_Jun_43(6)_832-841.nxml.txt.nlp	6788061	SENT4	0	0	10	10	perphenazine	PRL	PA450882	5617	0.813
NULL	Nucleic_Acids_Res_2012_Jun_29_40(11)_e83.nxml.txt.nlp	22379138	SENT101	31	31	42	42	l-glutamine	CO2	PA10090	4513	0.813
NULL	Clinics_(Sao_Paulo)_2014_Jan_69(Suppl_1)_55-72.nxml.txt.nlp	24860861	SENT288	34	34	30	30	abatacept	B7-1	PA164747080	941	0.813
NULL	Osteoporos_Int_2011_Jan_11_22(1)_21-26.nxml.txt.nlp	20458571	SENT177	20	20	9	9	risedronate	IMPACT	PA451255	55364	0.813
NULL	Arthritis_Res_Ther_2008_Mar_17_10(2)_R33.nxml.txt.nlp	18346273	SENT186	32	32	9	9	infliximab	HMGB1	PA452639	3146	0.813
NULL	Arch_Virol_2014_Dec_24_159(6)_1365-1371.nxml.txt.nlp	24366548	SENT6	28	28	2	2	ribavirin	IL-28B	PA451241	282617	0.813
NULL	J_Cell_Mol_Med_2014_Dec_6_18(12)_2331-2339.nxml.txt.nlp	25284457	SENT151	6	6	12	12	bleomycin	HMGB1	PA448645	3146	0.813
NULL	Mol_Neurodegener_2011_Nov_25_6_81.nxml.txt.nlp	22118545	SENT61	2	2	10	10	dantrolene	MSN	PA449208	4478	0.813
NULL	Oncogene_2010_Sep_16_29(37)_5193-5203.nxml.txt.nlp	20581867	SENT123	3	3	33	33	trastuzumab	HRG	PA451743	3084;3273	0.813
NULL	Adv_Urol_2011_Jun_7_2011_820816.nxml.txt.nlp	21687579	SENT116	20	20	3	3	fesoterodine	FACT	PA165958376	11198	0.812
NULL	Br_J_Cancer_2013_May_28_108(10)_2039-2044.nxml.txt.nlp	23652306	SENT11	16	16	3	3	carboplatin	SRC3	PA448803	8202	0.812
NULL	Exp_Diabetes_Res_2012_Sep_20_2012_936518.nxml.txt.nlp	23049542	SENT131	19	19	31	31	glucose	TRPV4	PA449773	59341	0.812
NULL	Bioinformation_2012_Jan_6_8(1)_13-19.nxml.txt.nlp	22359429	SENT171	14	14	0	0	curcumin	MRP1	PA151958596	4437	0.812
NULL	Arthritis_Res_Ther_2008_Jan_18_10(1)_R8.nxml.txt.nlp	18205921	SENT60	34	34	23	23	hyaluronan	IL-17	PA165958431	3605	0.812
NULL	Open_Cardiovasc_Med_J_2011_Feb_15_5_15-21.nxml.txt.nlp	21660251	SENT136	22	22	20	20	sr144528	CB2		1269	0.812
NULL	Pharmaceutics_2011_Oct_12_3(4)_680-705.nxml.txt.nlp	24309303	SENT1025	25	25	8	8	rosiglitazone	OATP1B3	PA451283	28234	0.812
NULL	Mol_Cancer_2014_Jun_5_13_143.nxml.txt.nlp	24898067	SENT19	11	11	6	6	gefitinib	HER-2	PA131301952	2064	0.812
NULL	Clinics_(Sao_Paulo)_2013_May_68(5)_694-701.nxml.txt.nlp	23778405	SENT188	22	22	31	31	curcumin	P-gp	PA151958596	5243	0.812
NULL	Clin_Ophthalmol_2009_Jun_2_3_291-295.nxml.txt.nlp	19668581	SENT12	29	29	31	31	travoprost	BAK	PA164781371	578	0.812
NULL	J_Biol_Chem_2011_Sep_30_286(39)_33931-33941.nxml.txt.nlp	21795714	SENT71	20	20	11	11	galactose	SDAP	PA449725	4706	0.812
NULL	N_Am_J_Med_Sci_2013_Nov_5(11)_666-668.nxml.txt.nlp	24404547	SENT69	37	37	39	39	hyaluronan	LYVE-1	PA165958431	10894	0.812
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1554-1562.nxml.txt.nlp	21970876	SENT206	7	7	16	16	erlotinib	EGFR	PA134687924	1956	0.812
NULL	Pharmaceuticals_(Basel)_2012_Feb_2_5(2)_114-132.nxml.txt.nlp	24288084	SENT101	33	33	6	6	carrageenan	TRPV1	PA448814	7442	0.812
NULL	Nat_Chem_Biol_2010_Apr_28_6(4)_291-299.nxml.txt.nlp	20190765	SENT149	4	4	21	21	dasatinib	AKT	PA162372878	207	0.812
NULL	Int_J_Endocrinol_2010_Mar_2_2010_621687.nxml.txt.nlp	20204178	SENT9	36	36	23	23	paricalcitol	PTH	PA450798	5741	0.812
NULL	Biomed_Res_Int_2013_Dec_10_2013_783698.nxml.txt.nlp	24386640	SENT62	13	13	4	4	rifampin	DST	PA451250	667	0.812
NULL	Clin_Ophthalmol_2010_Nov_23_4_1355-1359.nxml.txt.nlp	21179218	SENT65	22	22	33	33	travoprost	BAK	PA164781371	578	0.812
NULL	Indian_J_Med_Res_2014_Apr_139(4)_572-578.nxml.txt.nlp	24927344	SENT78	6	6	20	20	acenocoumarol	GGCX	PA452632	2677	0.812
NULL	Mol_Cancer_2012_Mar_21_11_13.nxml.txt.nlp	22436134	SENT263	37	37	7	7	doxorubicin	HuR	PA449412	1994	0.812
NULL	Br_J_Cancer_2010_Jul_13_103(2)_265-274.nxml.txt.nlp	20551953	SENT202	22	22	24	24	cisplatin	JNK	PA449014	5599	0.812
NULL	Cardiovasc_Res_2011_Apr_1_90(1)_140-147.nxml.txt.nlp	21071431	SENT8	0	0	27	27	resveratrol	EGF		1950	0.812
NULL	J_Med_Radiat_Sci_2014_Sep_22_61(3)_202-209.nxml.txt.nlp	NULL	SENT48	6	6	0	0	daclizumab	IL-2	PA164764446	3558	0.812
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1224-1233.nxml.txt.nlp	22353810	SENT295	10	10	20	20	etoposide	MRP-1	PA449552	928	0.812
NULL	Open_Access_J_Urol_2011_May_10_3_69-82.nxml.txt.nlp	24198638	SENT66	24	24	5	5	repaglinide	CYP2B6	PA451234	1555	0.812
NULL	Cancer_Inform_2008_Jun_10_6_315-355.nxml.txt.nlp	19259415	SENT385	6	6	9	9	cisplatin	MT1L	PA449014	4500	0.812
NULL	Cancer_Med_2013_Oct_19_2(5)_646-653.nxml.txt.nlp	24403230	SENT81	5	5	16	16	trastuzumab	GADD45	PA451743	1647	0.812
NULL	Int_J_Endocrinol_2014_Feb_13_2014_329456.nxml.txt.nlp	24688539	SENT223	11	11	25	25	vardenafil	IL-8	PA10229	3576	0.812
NULL	Infect_Dis_Ther_2013_Dec_2_2(2)_123-144.nxml.txt.nlp	25134476	SENT127	34	34	3	3	pyrazinamide	DST	PA451182	667	0.812
NULL	Exp_Ther_Med_2014_Apr_13_7(4)_799-803.nxml.txt.nlp	24669235	SENT79	3	3	13	13	vildagliptin	PPG	PA165958346	5552	0.812
NULL	J_Mol_Signal_2010_May_10_5_4.nxml.txt.nlp	20459745	SENT147	6	6	23	23	cisplatin	p53	PA449014	7157	0.812
NULL	Acta_Pharmacol_Sin_2009_May_6_30(5)_576-581.nxml.txt.nlp	19349965	SENT149	2	2	10	10	genistein	Bcl-2	PA165109660	596	0.812
NULL	Breast_Cancer_Res_Treat_2013_Apr_12_138(2)_427-435.nxml.txt.nlp	23479422	SENT22	3	3	13	13	trastuzumab	HER2	PA451743	2064	0.812
NULL	Eur_J_Clin_Pharmacol_2014_Mar_22_70(6)_685-693.nxml.txt.nlp	24658827	SENT244	17	17	6	6	midazolam	POR	PA450496	5447	0.812
NULL	Ther_Clin_Risk_Manag_2007_Jun_3(3)_449-459.nxml.txt.nlp	18488069	SENT196	27	27	14	14	frovatriptan	RIZ	PA164754891	7799	0.812
NULL	Arthritis_Res_Ther_2013_Jul_24_15(Suppl_3)_S6.nxml.txt.nlp	24267478	SENT144	10	10	33	33	cimetidine	CYP2C19	PA449001	1557	0.812
NULL	Cell_Div_2013_Jul_25_8_10.nxml.txt.nlp	23886499	SENT54	13	13	8	8	tamoxifen	CDK6	PA451581	1021	0.812
NULL	Front_Genet_2012_Nov_9_3_223.nxml.txt.nlp	23162566	SENT14	0	0	19	19	fentanyl	NeuroD	PA449599	4760	0.812
NULL	Ann_Lab_Med_2013_Sep_8_33(5)_349-352.nxml.txt.nlp	24003425	SENT83	17	17	29	29	isoniazid	EMB	PA450112	133418	0.812
NULL	Front_Oncol_2013_Nov_15_3_281.nxml.txt.nlp	24298448	SENT78	26	26	33	33	cetuximab	BRAF	PA10040	673	0.812
NULL	Indian_J_Anaesth_2014_Nov-Dec_58(6)_693-699.nxml.txt.nlp	25624531	SENT28	0	0	6	6	gabapentin	gamma	PA449720	9913	0.812
NULL	Target_Oncol_2010_Jun_14_5(2)_95-112.nxml.txt.nlp	20625845	SENT445	5	5	9	9	sorafenib	IFN	PA7000	3439	0.812
NULL	J_Clin_Biochem_Nutr_2007_Sep_29_41(2)_115-123.nxml.txt.nlp	18193105	SENT46	5	5	28	28	fluorescein	San	PA164746009	80218	0.812
NULL	Pharmaceuticals_(Basel)_2011_May_24_4(5)_770-781.nxml.txt.nlp	NULL	SENT118	0	0	31	31	carvedilol	IL-10	PA448817	3586	0.812
NULL	Multidiscip_Respir_Med_2013_Jun_21_8(1)_40.nxml.txt.nlp	23800154	SENT32	12	12	15	15	creatine	Q10	PA164778930	27161	0.812
NULL	Mol_Vis_2012_Jul_25_18_2053-2066.nxml.txt.nlp	22876133	SENT318	6	6	15	15	bortezomib	JNK	PA10252	5599	0.812
NULL	Arthritis_Res_Ther_2003_May_14_5(4)_R210-R213.nxml.txt.nlp	12823856	SENT51	9	9	31	31	fluorescein	San	PA164746009	80218	0.812
NULL	Front_Neurol_2011_Dec_16_2_72.nxml.txt.nlp	22203815	SENT158	9	9	12	12	protamine	VSOP	PA10366	84329	0.812
NULL	Cancer_Imaging_2011_Jan_11_11(1)_259-265.nxml.txt.nlp	22245974	SENT102	8	8	17	17	sunitinib	VEGF-A	PA162372840	7422	0.812
NULL	Int_J_Endocrinol_2010_May_26_2010_906163.nxml.txt.nlp	20585352	SENT81	7	7	2	2	cinacalcet	PTH	PA164776671	5741	0.812
NULL	Br_J_Cancer_2009_Jan_27_100(2)_334-343.nxml.txt.nlp	19142186	SENT199	14	14	19	19	gefitinib	EGF	PA131301952	1950	0.812
NULL	Diabetes_Care_2008_Jul_31(7)_1427-1432.nxml.txt.nlp	18390799	SENT218	16	16	2	2	metformin	RBP4	PA450395	5433;5950	0.812
NULL	Curr_Immunol_Rev_2013_Feb_9(1)_13-22.nxml.txt.nlp	23853604	SENT172	13	13	7	7	vincristine	CHOP	PA451879	1649	0.812
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jul_10_66(Pt_8)_o1979-o1980.nxml.txt.nlp	21588296	SENT78	0	0	24	24	opipramol	mol	PA144614922	90527	0.812
NULL	Clin_Sci_(Lond)_2011_Nov_1_121(Pt_10)_449-458.nxml.txt.nlp	21671887	SENT33	14	14	43	43	simvastatin	AMPK	PA451363	5563	0.812
NULL	Acta_Pharmacol_Sin_2011_Oct_15_32(10)_1303-1308.nxml.txt.nlp	21841812	SENT6	20	20	11	11	losartan	CYP2C9	PA450268	1559	0.812
NULL	Aging_(Albany_NY)_2010_Jul_17_2(7)_415-431.nxml.txt.nlp	20634564	SENT26	2	2	7	7	resveratrol	SIRT1		23411	0.812
NULL	Eur_J_Clin_Pharmacol_2012_Sep_15_68(9)_1267-1274.nxml.txt.nlp	22418828	SENT150	17	17	21	21	mephenytoin	CYP2C19	PA450373	1557	0.812
NULL	Br_J_Cancer_2012_Sep_4_107(6)_956-960.nxml.txt.nlp	22892393	SENT4	17	17	10	10	trastuzumab	HER2	PA451743	2064	0.812
NULL	Clinics_(Sao_Paulo)_2014_Feb_69(2)_145-149.nxml.txt.nlp	24519206	SENT147	9	9	14	14	olmesartan	MCP-1	PA164742950	6347	0.812
NULL	Ann_Saudi_Med_2011_Jul-Aug_31(4)_402-406.nxml.txt.nlp	21727749	SENT26	6	6	8	8	liraglutide	GLP-1	PA165958364	100125288	0.812
NULL	Eur_J_Epidemiol_2007_Nov_23_22(11)_819-829.nxml.txt.nlp	17955331	SENT690	9	9	25	25	acenocoumarol	PAGM	PA452632	5238	0.812
NULL	Arthritis_Res_Ther_2005_Mar_30_7(3)_111-113.nxml.txt.nlp	15899059	SENT13	29	29	41	41	etanercept	IL-6	PA449515	3569	0.812
NULL	Biomed_Res_Int_2013_Jan_8_2013_250462.nxml.txt.nlp	23484098	SENT45	16	16	4	4	estradiol	aromatase	PA449503	1588	0.812
NULL	Biomed_Res_Int_2014_Feb_6_2014_323594.nxml.txt.nlp	24689036	SENT290	12	12	3	3	raloxifene	PC3	PA451221	57332;7832;5122	0.812
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2007_Jan_1_63(Pt_1)_1-8.nxml.txt.nlp	17164520	SENT45	18	18	5	5	thrombin	PTI	PA451674	5269	0.812
NULL	Eur_J_Neurosci_2010_Jun_31(12)_2234-2246.nxml.txt.nlp	20529124	SENT175	4	4	29	29	carbachol	CB1	PA448784	1268	0.812
NULL	Case_Rep_Oncol_Med_2014_Dec_23_2014_597291.nxml.txt.nlp	25587475	SENT125	21	21	26	26	docetaxel	TNF-alpha	PA449383	7124	0.812
NULL	J_Headache_Pain_2001_Jun_2(1)_3-11.nxml.txt.nlp	NULL	SENT1	14	14	25	25	almotriptan	5-HT1B	PA10246	3351	0.812
NULL	Breast_Cancer_Res_2007_Jan_23_9(1)_R7.nxml.txt.nlp	17244352	SENT197	19	19	14	14	tamoxifen	CYP3A5	PA451581	1577	0.812
NULL	J_Cancer_Prev_2014_Jun_19(2)_111-117.nxml.txt.nlp	25337579	SENT151	4	4	6	6	bortezomib	AKR1C1	PA10252	1645	0.812
NULL	Int_J_Mol_Sci_2012_Sep_25_13(10)_12153-12168.nxml.txt.nlp	23202889	SENT497	7	7	26	26	leucovorin	BRAF	PA450198	673	0.812
NULL	J_Hematol_Oncol_2013_Jul_9_6_49.nxml.txt.nlp	23837843	SENT83	2	2	0	0	cyclosporine	P-gp	PA449167	5243	0.812
NULL	Oncotarget_2013_Oct_19_4(11)_2045-2056.nxml.txt.nlp	24185104	SENT4	5	5	14	14	cisplatin	14-3-3	PA449014	10971	0.812
NULL	Oncol_Rep_2013_May_21_29(5)_1721-1729.nxml.txt.nlp	23440494	SENT22	12	12	8	8	cisplatin	FANCF	PA449014	2188	0.812
NULL	Cancers_(Basel)_2014_Jul_8_6(3)_1487-1499.nxml.txt.nlp	25006835	SENT78	17	17	23	23	cisplatin	AMPK	PA449014	5563	0.812
NULL	Acta_Pharmacol_Sin_2012_Jan_28_33(1)_66-74.nxml.txt.nlp	22120966	SENT183	6	6	17	17	genistein	OPG	PA165109660	690	0.812
NULL	J_Exerc_Rehabil_2013_Jun_30_9(3)_348-353.nxml.txt.nlp	24278883	SENT46	1	1	8	8	glucose	STZ	PA449773	6484	0.812
NULL	Biologics_2012_Feb_1_6_31-35.nxml.txt.nlp	22355257	SENT13	7	7	26	26	rituximab	IL-7	PA451261	3574	0.812
NULL	ScientificWorldJournal_2013_Jun_6_2013_649485.nxml.txt.nlp	23844408	SENT70	30	30	19	19	ethanol	mol	PA448073	90527	0.812
NULL	J_Vet_Med_Sci_2014_Aug_1_76(8)_1105-1110.nxml.txt.nlp	24784441	SENT17	24	24	30	30	estradiol	aromatase	PA449503	1588	0.812
NULL	J_Thyroid_Res_2011_Apr_11_2011_413026.nxml.txt.nlp	21603170	SENT212	10	10	2	2	hydrocortisone	ACTH	PA449905	5443	0.812
NULL	N_Am_J_Med_Sci_2012_Apr_4(4)_174-179.nxml.txt.nlp	22536560	SENT113	6	6	17	17	doxorubicin	AKT	PA449412	207	0.812
NULL	F1000Res_2014_Mar_4_2_252.nxml.txt.nlp	24715962	SENT53	34	34	20	20	heparin	EGF	PA449855	1950	0.812
NULL	J_Am_Heart_Assoc_2013_Dec_19_2(6)_e000355.nxml.txt.nlp	24190878	SENT159	15	15	18	18	isoproterenol	HK2	PA450121	3796;3099;29911;3741	0.812
NULL	Diabetes_2013_Mar_14_62(3)_864-874.nxml.txt.nlp	23321074	SENT248	44	44	26	26	tamoxifen	aP2	PA451581	2167	0.812
NULL	EMBO_Mol_Med_2013_Dec_8_5(12)_1821-1834.nxml.txt.nlp	24293316	SENT184	15	15	7	7	doxorubicin	p53	PA449412	7157	0.812
NULL	Br_J_Cancer_2009_Sep_15_101(6)_957-966.nxml.txt.nlp	19738618	SENT148	12	12	5	5	dexrazoxane	THBS-1	PA449259	7057	0.812
NULL	Cancer_Res_Treat_2014_Jan_15_46(1)_48-54.nxml.txt.nlp	24520223	SENT11	15	15	2	2	bevacizumab	KRAS	PA130232992	3845	0.812
NULL	J_Inflamm_(Lond)_2005_Oct_31_2_14.nxml.txt.nlp	16259633	SENT275	4	4	9	9	staurosporine	CCR2	PA165109623	729230	0.812
NULL	Clin_Exp_Otorhinolaryngol_2014_Jun_21_7(2)_79-86.nxml.txt.nlp	24917902	SENT54	27	27	18	18	ceftazidime	TOB	PA448861	10140	0.812
NULL	Chin_J_Cancer_2012_Feb_31(2)_58-72.nxml.txt.nlp	22098952	SENT223	15	15	6	6	cisplatin	MRP6	PA449014	368;6283	0.812
NULL	Clin_Pediatr_Endocrinol_2009_May_1_18(2)_65-72.nxml.txt.nlp	24790382	SENT69	6	6	1	1	cabergoline	PRL	PA448708	5617	0.812
NULL	Front_Immunol_2014_Aug_28_5_409.nxml.txt.nlp	25221554	SENT26	7	7	22	22	sirolimus	raptor	PA451365	57521	0.812
NULL	Carcinogenesis_2010_Dec_27_31(12)_2049-2057.nxml.txt.nlp	20876285	SENT336	21	21	33	33	tamoxifen	Bcl-2	PA451581	596	0.812
NULL	Exp_Ther_Med_2013_Dec_26_6(6)_1359-1364.nxml.txt.nlp	24255662	SENT178	27	27	16	16	dexmedetomidine	TLR4	PA449256	7099	0.812
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1046.nxml.txt.nlp	24503538	SENT86	19	19	37	37	irinotecan	FGFR4	PA450085	2264	0.812
NULL	J_Exp_Clin_Cancer_Res_2009_Jun_2_28(1)_72.nxml.txt.nlp	19490637	SENT9	27	27	23	23	verapamil	ADM	PA451868	133	0.812
NULL	Oncotarget_2014_Feb_27_5(5)_1315-1325.nxml.txt.nlp	24675476	SENT15	20	20	3	3	s-adenosylmethionine	PEMT	PA164754994	10400	0.812
NULL	Environ_Health_Perspect_2005_Oct_14_113(10)_1330-1335.nxml.txt.nlp	16203242	SENT163	7	7	10	10	arsenite	MLC	PA452638	23209	0.812
NULL	J_Oncol_2012_Feb_15_2012_168303.nxml.txt.nlp	22481917	SENT32	11	11	24	24	doxorubicin	HCC	PA449412	84668	0.812
NULL	Arthritis_Res_Ther_2011_Mar_16_13(2)_R44.nxml.txt.nlp	21410959	SENT315	4	4	9	9	glucosamine	IFN	PA164747613	3439	0.812
NULL	Front_Immunol_2013_Sep_26_4_292.nxml.txt.nlp	24133490	SENT313	32	32	15	15	cyclophosphamide	CD4	PA449165	920	0.812
NULL	Oncotarget_2014_Jun_1_5(13)_4868-4880.nxml.txt.nlp	24947902	SENT68	3	3	10	10	afatinib	HER2	PA165981154	2064	0.812
NULL	J_Anaesthesiol_Clin_Pharmacol_2012_Oct-Dec_28(4)_423-425.nxml.txt.nlp	23225917	SENT54	1	1	13	13	desflurane	CO2	PA164749136	4513	0.812
NULL	Case_Rep_Oncol_Med_2014_Dec_23_2014_597291.nxml.txt.nlp	25587475	SENT125	13	13	26	26	ifosfamide	TNF-alpha	PA449964	7124	0.812
NULL	J_Physiol_2009_Feb_15_587(Pt_4)_731-744.nxml.txt.nlp	19074966	SENT153	39	39	36	36	taurine	PAT1	PA451590	10513;206358	0.812
NULL	Acta_Pharmacol_Sin_2010_Oct_27_31(10)_1389-1394.nxml.txt.nlp	20871620	SENT145	23	23	18	18	carbachol	JNK	PA448784	5599	0.812
NULL	Ann_Dermatol_2014_Dec_26_26(6)_706-712.nxml.txt.nlp	25473222	SENT115	15	15	7	7	isotretinoin	EPO	PA450128	7076;8288;2056	0.812
NULL	Biomed_Res_Int_2014_Jan_19_2014_215872.nxml.txt.nlp	24575401	SENT162	7	7	15	15	artemisinin	TC1	PA165111696	6947	0.812
NULL	J_Cancer_2013_Sep_10_4(8)_614-625.nxml.txt.nlp	24155773	SENT260	33	33	37	37	doxorubicin	BTZ	PA449412	22794	0.812
NULL	Mol_Biol_Cell_2012_Sep_1_23(17)_3357-3369.nxml.txt.nlp	22809628	SENT67	11	11	4	4	triciribine	PC3	PA165958661	57332;7832;5122	0.812
NULL	Cell_Death_Dis_2013_Sep_19_4(9)_e810.nxml.txt.nlp	24052078	SENT262	2	2	14	14	erlotinib	EGFR	PA134687924	1956	0.812
NULL	Oncol_Lett_2014_Jul_25_8(1)_367-373.nxml.txt.nlp	24959278	SENT4	24	24	38	38	phenol	DDP	PA450913	1678	0.812
NULL	Alzheimers_Res_Ther_2012_Nov_26_4(6)_50.nxml.txt.nlp	23181523	SENT417	16	16	13	13	memantine	APOE	PA10364	348	0.812
NULL	Oncoscience_2014_Jun_19_1(7)_478-479.nxml.txt.nlp	25594047	SENT20	5	5	3	3	elacridar	P-gp		5243	0.812
NULL	Carcinogenesis_2013_Mar_7_34(3)_703-712.nxml.txt.nlp	23222814	SENT80	5	5	7	7	curcumin	p53	PA151958596	7157	0.812
NULL	Front_Oncol_2014_Oct_21_4_285.nxml.txt.nlp	25374842	SENT257	24	24	18	18	cisplatin	p53	PA449014	7157	0.812
NULL	Virchows_Arch_2012_Feb_16_460(2)_141-149.nxml.txt.nlp	22173329	SENT218	6	6	26	26	fluorouracil	KRAS	PA128406956	3845	0.812
NULL	Croat_Med_J_2012_Aug_53(4)_314-320.nxml.txt.nlp	22911523	SENT193	24	24	13	13	warfarin	VKORC1	PA451906	79001	0.812
NULL	Cell_Death_Dis_2012_Mar_15_3(3)_e283.nxml.txt.nlp	22419112	SENT23	17	17	27	27	doxorubicin	CSIG	PA449412	26156	0.812
NULL	Cancer_Immunol_Immunother_2010_Sep_29_59(9)_1379-1387.nxml.txt.nlp	20512327	SENT156	12	12	44	44	calcein	p68	PA132595336	1655	0.812
NULL	Onco_Targets_Ther_2014_Sep_9_7_1571-1582.nxml.txt.nlp	25228815	SENT162	3	3	9	9	sunitinib	VEGFR2	PA162372840	3791	0.812
NULL	Br_J_Cancer_2002_Jan_21_86(2)_179-184.nxml.txt.nlp	11870502	SENT23	23	23	37	37	dacarbazine	IL-2	PA449197	3558	0.812
NULL	Mol_Cancer_2006_Sep_5_5_34.nxml.txt.nlp	16953886	SENT5	22	22	9	9	doxorubicin	XIAP	PA449412	331	0.812
NULL	Open_Cardiovasc_Med_J_2008_May_21_2_31-35.nxml.txt.nlp	18949096	SENT49	36	36	11	11	l-glutamine	ATF6	PA10090	22926	0.812
NULL	Psychiatr_Genet_2013_Aug_28_23(4)_153-162.nxml.txt.nlp	23811784	SENT168	10	10	22	22	clozapine	ANOVA	PA449061	4858	0.812
NULL	Exp_Ther_Med_2013_Jul_25_6(1)_109-114.nxml.txt.nlp	23935730	SENT137	22	22	24	24	rituximab	CHOP	PA451261	1649	0.812
NULL	Aging_(Albany_NY)_2012_Mar_12_4(3)_146-158.nxml.txt.nlp	22436213	SENT157	10	10	18	18	resveratrol	SIRT1		23411	0.812
NULL	Evid_Based_Complement_Alternat_Med_2011_Jan_20_2011_751671.nxml.txt.nlp	21318106	SENT24	13	13	5	5	tacrolimus	P-gp	PA451578	5243	0.812
NULL	Front_Immunol_2013_Sep_17_4_280.nxml.txt.nlp	24062746	SENT64	22	22	3	3	dextran	TLR5	PA449261	7100	0.812
NULL	Drugs_Context_2013_Jan_3_2013_212245.nxml.txt.nlp	24432034	SENT50	4	4	21	21	duloxetine	CYP1A2	PA10066	1544	0.812
NULL	Chemother_Res_Pract_2011_Feb_27_2011_175054.nxml.txt.nlp	22295203	SENT123	3	3	15	15	cisplatin	MBT	PA449014	5657	0.812
NULL	Mol_Vis_2012_Oct_5_18_2454-2467.nxml.txt.nlp	23077404	SENT146	7	7	12	12	bevacizumab	VEGF-A	PA130232992	7422	0.812
NULL	Evid_Based_Complement_Alternat_Med_2013_May_28_2013_629750.nxml.txt.nlp	23781265	SENT147	8	8	17	17	capsaicin	GADD153	PA448776	1649	0.812
NULL	Acta_Pharmacol_Sin_2012_May_4_33(5)_644-651.nxml.txt.nlp	22555371	SENT37	14	14	10	10	irbesartan	CRF	PA450084	1392;10882	0.812
NULL	Case_Rep_Med_2014_Apr_13_2014_139170.nxml.txt.nlp	24822067	SENT124	3	3	7	7	levothyroxine	HGB	PA450221	114757	0.812
NULL	Nucleic_Acids_Res_2012_Jul_30_40(13)_6319-6337.nxml.txt.nlp	22467215	SENT266	15	15	10	10	cisplatin	HER2	PA449014	2064	0.812
NULL	Int_J_Mol_Sci_2013_Apr_12_14(4)_8062-8072.nxml.txt.nlp	23584024	SENT44	24	24	9	9	hydralazine	HYD	PA449894	51366	0.812
NULL	Diabetes_2013_Nov_18_62(11)_3863-3873.nxml.txt.nlp	23884892	SENT278	6	6	2	2	collagenase	MT1-MMP	PA449107	4323	0.812
NULL	J_Vet_Sci_2006_Mar_31_7(1)_53-58.nxml.txt.nlp	16434850	SENT57	22	22	2	2	lipase	API	PA450239	5345	0.812
NULL	Oncol_Rep_2015_Feb_11_33(2)_526-532.nxml.txt.nlp	25501339	SENT134	25	25	23	23	gefitinib	EGFR	PA131301952	1956	0.812
NULL	J_Cardiothorac_Surg_2010_Apr_19_5_26.nxml.txt.nlp	20403156	SENT143	39	39	28	28	etomidate	RAI	PA164743987	10848;6050	0.812
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Oct_20_66(Pt_11)_o2853.nxml.txt.nlp	21589038	SENT49	19	19	34	34	ethanol	mol	PA448073	90527	0.812
NULL	Front_Neurosci_2010_Nov_19_4_192.nxml.txt.nlp	21151361	SENT929	0	0	8	8	mirtazapine	5-HT1A	PA450522	3350	0.812
NULL	Acta_Pharmacol_Sin_2010_Nov_18_31(11)_1447-1453.nxml.txt.nlp	20953204	SENT104	13	13	24	24	rimonabant	IL-6	PA152407999	3569	0.812
NULL	Int_J_Environ_Res_Public_Health_2010_Apr_30_7(4)_1448-1466.nxml.txt.nlp	20617039	SENT42	4	4	10	10	ethanol	DRD2	PA448073	1813	0.812
NULL	Biosci_Rep_2012_Jun_1_32(Pt_3)_315-321.nxml.txt.nlp	22394266	SENT58	41	41	26	26	picrotoxin	CO2	PA164777007	4513	0.812
NULL	BMB_Rep_2014_Sep_47(9)_483-487.nxml.txt.nlp	25027595	SENT35	27	27	31	31	gefitinib	EGFR	PA131301952	1956	0.812
NULL	Oncotarget_2013_Nov_24_5(1)_11-28.nxml.txt.nlp	24429466	SENT317	7	7	13	13	bortezomib	CRM1	PA10252	7514	0.812
NULL	Ann_Hematol_2014_Sep_10_93(1)_1-11.nxml.txt.nlp	24018623	SENT106	30	30	10	10	lenalidomide	CD34	PA162363968	947	0.812
NULL	Cell_Cycle_2012_Nov_1_11(21)_4069-4078.nxml.txt.nlp	23095523	SENT77	19	19	5	5	imatinib	PERK	PA10804	9451	0.812
NULL	Clin_Med_Insights_Oncol_2013_Oct_29_7_269-277.nxml.txt.nlp	24250243	SENT113	22	22	5	5	axitinib	VEGFR	PA164924493	3791	0.812
NULL	Reprod_Biol_Endocrinol_2004_Aug_4_2_59.nxml.txt.nlp	15294019	SENT19	6	6	8	8	forskolin	EGF	PA146096022	1950	0.812
NULL	Reprod_Biol_Endocrinol_2013_Feb_26_11_15.nxml.txt.nlp	23442442	SENT194	5	5	12	12	l-arginine	BCL2	PA448478	596	0.812
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2014_Sep_27_70(Pt_10)_2740-2753.nxml.txt.nlp	25286857	SENT588	3	3	25	25	bsi-201	TNKS2		80351	0.812
NULL	Chemother_Res_Pract_2011_Apr_7_2011_393976.nxml.txt.nlp	22312553	SENT39	33	33	12	12	artemether	CYP3A4	PA165111698	1576	0.812
NULL	Core_Evid_2011_Sep_8_6_67-79.nxml.txt.nlp	22022289	SENT185	24	24	28	28	liraglutide	GLP-1	PA165958364	100125288	0.812
NULL	Int_J_Mol_Sci_2012_Apr_16_13(4)_4831-4838.nxml.txt.nlp	22606012	SENT6	4	4	24	24	curcumin	JNK	PA151958596	5599	0.812
NULL	Br_J_Cancer_2012_Jan_3_106(1)_107-115.nxml.txt.nlp	22116303	SENT101	28	28	7	7	vorinostat	PI3K	PA164748224	5290	0.812
NULL	Ital_J_Pediatr_2011_May_14_37_21.nxml.txt.nlp	21569539	SENT1	13	13	34	34	carbamazepine	NAG	PA448785	51594;4669	0.812
NULL	J_Cell_Biol_1999_Jan_25_144(2)_373-384.nxml.txt.nlp	9922462	SENT39	0	0	16	16	trypsin	TIMP1	PA451806	7076	0.812
NULL	Exp_Hematol_Oncol_2014_Mar_25_3_10.nxml.txt.nlp	24666795	SENT28	19	19	21	21	decitabine	DAC	PA164749631	13	0.812
NULL	Ann_Oncol_2010_Mar_28_21(3)_498-505.nxml.txt.nlp	19717534	SENT227	10	10	2	2	tamoxifen	aromatase	PA451581	1588	0.812
NULL	Indian_J_Pharm_Sci_2013_Jan-Feb_75(1)_94-98.nxml.txt.nlp	23901167	SENT30	8	8	34	34	tolbutamide	CYP2B6	PA451718	1555	0.812
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT104	4	4	10	10	metformin	AKT	PA450395	207	0.812
NULL	Nucleic_Acids_Res_2005_Jun_8_33(10)_3283-3291.nxml.txt.nlp	15944449	SENT98	3	3	10	10	melphalan	ERCC1	PA450354	2067	0.812
NULL	Diabetes_2013_Jul_14_62(7)_2595-2604.nxml.txt.nlp	23524641	SENT186	5	5	34	34	exenatide	GLP-1	PA164749238	100125288	0.812
NULL	Cardiovasc_Diabetol_2013_May_4_12_73.nxml.txt.nlp	23642288	SENT128	2	2	5	5	acarbose	GLP-1	PA448010	100125288	0.812
NULL	BMJ_Open_2013_Nov_4_3(11)_e003995.nxml.txt.nlp	24189085	SENT379	6	6	11	11	liraglutide	GLP-1	PA165958364	100125288	0.812
NULL	Clinicoecon_Outcomes_Res_2014_Oct_17_6_451-461.nxml.txt.nlp	25378939	SENT127	9	9	13	13	vancomycin	HAP	PA451850	5915;10313	0.812
NULL	JRSM_Cardiovasc_Dis_2013_Oct_4_2_2048004013506452.nxml.txt.nlp	NULL	SENT366	17	17	19	19	thrombin	ADP	PA451674	23038	0.812
NULL	Diabetes_Care_2009_Nov_32(Suppl_2)_S223-S231.nxml.txt.nlp	19875556	SENT79	29	29	11	11	vildagliptin	GLP-1	PA165958346	100125288	0.812
NULL	Crit_Care_2010_Apr_19_14(2)_R70.nxml.txt.nlp	20403177	SENT261	8	8	15	15	thrombin	MEK1	PA451674	5604	0.812
NULL	Cell_Death_Dis_2014_Feb_13_5(2)_e1055.nxml.txt.nlp	24525731	SENT328	19	19	34	34	cisplatin	XRCC1	PA449014	7515	0.812
NULL	Acta_Pharmacol_Sin_2012_Oct_17_33(10)_1301-1310.nxml.txt.nlp	22983390	SENT122	17	17	3	3	cisplatin	Bcl-2	PA449014	596	0.812
NULL	Diabetes_Obes_Metab_2012_Apr_14(4)_304-314.nxml.txt.nlp	22051096	SENT141	3	3	25	25	liraglutide	PPG	PA165958364	5552	0.812
NULL	Biomed_Res_Int_2014_Jan_29_2014_458592.nxml.txt.nlp	24592391	SENT159	14	14	11	11	curcumin	HO-1	PA151958596	3162	0.812
NULL	J_Korean_Med_Sci_2009_Jun_16_24(3)_525-528.nxml.txt.nlp	19543522	SENT59	20	20	22	22	rituximab	CHOP	PA451261	1649	0.812
NULL	Diabetes_2013_Sep_15_62(9)_3232-3240.nxml.txt.nlp	23835329	SENT129	15	15	0	0	olanzapine	ANOVA	PA450688	4858	0.812
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Sep_14_67(Pt_10)_o2646.nxml.txt.nlp	22064771	SENT67	6	6	3	3	phenol	mol	PA450913	90527	0.812
NULL	Arch_Toxicol_2014_Nov_5_88(12)_2135-2190.nxml.txt.nlp	25370008	SENT137	0	0	30	30	ethanol	ADH4	PA448073	127	0.812
NULL	Int_J_Biomed_Sci_2008_Jun_4(2)_82-88.nxml.txt.nlp	23675072	SENT15	10	10	6	6	ribavirin	IFN	PA451241	3439	0.812
NULL	Carcinogenesis_2010_Jan_27_31(1)_2-8.nxml.txt.nlp	19861649	SENT104	25	25	16	16	gefitinib	AKT	PA131301952	207	0.812
NULL	Clin_Med_Insights_Oncol_2012_May_16_6_205-217.nxml.txt.nlp	22654526	SENT248	27	27	32	32	ribavirin	VEGFR	PA451241	3791	0.812
NULL	Oncotarget_2014_Aug_27_5(17)_7328-7341.nxml.txt.nlp	25193862	SENT215	37	37	16	16	dasatinib	EPHB1	PA162372878	2047	0.812
NULL	Diabetes_2013_Sep_15_62(9)_3103-3113.nxml.txt.nlp	23775766	SENT165	32	32	11	11	glucosamine	PRLR	PA164747613	5618	0.812
NULL	JAKSTAT_2013_Jul_1_2(3)_e24574.nxml.txt.nlp	24069558	SENT89	18	18	24	24	doxycycline	JAK2	PA449415	3717	0.812
NULL	Neural_Plast_2012_May_20_2012_124548.nxml.txt.nlp	22685676	SENT55	2	2	17	17	minocycline	FMR1	PA450519	2332	0.812
NULL	Acta_Pharmacol_Sin_2014_Jun_4_35(6)_752-757.nxml.txt.nlp	24902786	SENT92	15	15	9	9	letrozole	STZ	PA450196	6484	0.812
NULL	BMJ_2014_Apr_15_348_g2366.nxml.txt.nlp	24736555	SENT454	18	18	5	5	metformin	GLP-1	PA450395	100125288	0.812
NULL	J_Biol_Chem_2013_Nov_15_288(46)_33049-33059.nxml.txt.nlp	24089524	SENT675	3	3	16	16	nicotine	survivin	PA450626	332	0.812
NULL	Blood_Cancer_J_2014_May_30_4(5)_e215.nxml.txt.nlp	24879116	SENT110	23	23	16	16	doxycycline	BANK1	PA449415	55024	0.812
NULL	Adv_Appl_Bioinforma_Chem_2008_Oct_30_1_85-98.nxml.txt.nlp	21918608	SENT75	12	12	14	14	bortezomib	SPARC	PA10252	6678	0.812
NULL	J_Int_AIDS_Soc_2012_Oct_22_15(Suppl_3)_18439.nxml.txt.nlp	NULL	SENT683	8	8	31	31	isoniazid	IPT	PA450112	54802	0.812
NULL	Mol_Biol_Rep_2012_May_20_39(5)_5253-5267.nxml.txt.nlp	22183301	SENT66	5	5	14	14	gliclazide	NAC	PA10892	22861	0.812
NULL	Cardiovasc_Diabetol_2007_Aug_15_6_20.nxml.txt.nlp	17697384	SENT29	6	6	0	0	ramipril	DREAM	PA451223	30818	0.812
NULL	J_Physiol_2011_Dec_15_589(Pt_24)_5965-5986.nxml.txt.nlp	22041182	SENT328	28	28	17	17	clotrimazole	ACTH	PA449057	5443	0.812
NULL	Cardiovasc_Ther_2012_Aug_17_30(4)_e174-e182.nxml.txt.nlp	21883999	SENT159	9	9	18	18	prasugrel	PAR-1	PA154410481	2011;2149	0.812
NULL	Ann_Rheum_Dis_2013_Apr_11_72(4)_583-589.nxml.txt.nlp	23144446	SENT171	12	12	14	14	tocilizumab	TNF-alpha	PA165292659	7124	0.812
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_24_2012_673132.nxml.txt.nlp	23133498	SENT117	2	2	18	18	berberine	P-gp	PA165860812	5243	0.812
NULL	Indian_J_Nephrol_2013_Sep-Oct_23(5)_332-337.nxml.txt.nlp	24049267	SENT111	35	35	8	8	iron	CAD	PA450087	1677;790	0.812
NULL	Physiol_Rep_2014_Nov_4_2(11)_e12197.nxml.txt.nlp	25367695	SENT76	24	24	0	0	nitrogen	PCP	PA450643	5547	0.812
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Dec_15_69(Pt_1)_o85-o86.nxml.txt.nlp	23476467	SENT68	1	1	18	18	ethanol	C21	PA448073	79718	0.812
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Jun_25_3(6)_e120.nxml.txt.nlp	24964282	SENT25	37	37	34	34	rifampin	CYP3A4	PA451250	1576	0.812
NULL	Exp_Ther_Med_2013_Jan_10_5(1)_11-16.nxml.txt.nlp	23251234	SENT168	18	18	0	0	cetuximab	CNTRL	PA10040	11064	0.812
NULL	Mol_Cancer_2009_Feb_25_8_10.nxml.txt.nlp	19243593	SENT166	4	4	26	26	paclitaxel	NEDD1	PA450761	121441	0.812
NULL	Clin_Ophthalmol_2009_Jun_2_3_117-122.nxml.txt.nlp	19668554	SENT43	2	2	28	28	brimonidine	ERG	PA448665	2078	0.812
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1150.nxml.txt.nlp	24675468	SENT102	19	19	15	15	ethanol	PARP-1	PA448073	25976	0.812
NULL	Front_Neuroendocrinol_2014_Aug_35(3)_370-384.nxml.txt.nlp	24607323	SENT1553	15	15	30	30	estradiol	GDX	PA449503	8266	0.812
NULL	Arthritis_Res_Ther_2004_Jun_21_6(Suppl_2)_S19-S23.nxml.txt.nlp	15228617	SENT85	8	8	22	22	adalimumab	ACR	PA10004	49	0.812
NULL	Cancer_Cell_Int_2013_Jun_26_13_63.nxml.txt.nlp	23800022	SENT13	3	3	8	8	genistein	XIAP	PA165109660	331	0.812
NULL	Orphanet_J_Rare_Dis_2007_Jan_23_2_6.nxml.txt.nlp	17244349	SENT101	23	23	15	15	ifosfamide	CDP	PA449964	1523	0.812
NULL	Oncogene_2014_Jun_26_33(26)_3422-3431.nxml.txt.nlp	23912457	SENT97	0	0	7	7	trastuzumab	p27	PA451743	5715;10534	0.812
NULL	Indian_J_Med_Paediatr_Oncol_2014_Oct-Dec_35(4)_276-280.nxml.txt.nlp	25538405	SENT96	9	9	2	2	thioguanine	TPMT	PA451663	7172	0.812
NULL	Support_Care_Cancer_2014_Dec_14_22(3)_837-846.nxml.txt.nlp	24337717	SENT20	15	15	26	26	sn-38	UGT1A1		54658	0.812
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT190	6	6	11	11	curcumin	Bcl-2	PA151958596	596	0.812
NULL	Braz_J_Med_Biol_Res_2014_Jan_10_47(1)_60-69.nxml.txt.nlp	24519092	SENT28	23	23	34	34	doxorubicin	YWHAZ	PA449412	7534	0.812
NULL	Acta_Pharmacol_Sin_2014_Aug_7_35(8)_1023-1030.nxml.txt.nlp	24998255	SENT184	19	19	5	5	octreotide	E14	PA450678	4863	0.812
NULL	J_Breast_Cancer_2013_Sep_30_16(3)_274-284.nxml.txt.nlp	24155756	SENT46	8	8	14	14	docetaxel	ACT	PA449383	12;11332;9457;641455	0.812
NULL	Apoptosis_2012_Sep_30_17(9)_989-997.nxml.txt.nlp	22460505	SENT150	3	3	9	9	thioridazine	PI3K	PA451666	5290	0.812
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT39	0	0	26	26	metformin	EGFR	PA450395	1956	0.812
NULL	Oncol_Rep_2014_Apr_28_31(4)_1605-1612.nxml.txt.nlp	24481648	SENT130	8	8	18	18	ponatinib	MRP7	PA165980594	89845;1080	0.812
NULL	Case_Rep_Gastrointest_Med_2013_Dec_4_2013_182962.nxml.txt.nlp	24368948	SENT96	12	12	8	8	cisapride	5-HT4	PA449011	3360	0.812
NULL	Chem_Rev_2014_Jun_11_114(11)_5753-5774.nxml.txt.nlp	24758331	SENT121	28	28	5	5	vinblastine	P-gp	PA451877	5243	0.812
NULL	Int_J_Mol_Sci_2014_Mar_26_15(4)_5323-5336.nxml.txt.nlp	24675699	SENT415	0	0	16	16	sunitinib	Bcl-2	PA162372840	596	0.812
NULL	J_Clin_Biochem_Nutr_2008_May_29_42(3)_197-203.nxml.txt.nlp	18545641	SENT88	15	15	22	22	curcumin	p38	PA151958596	10598;1432;7965	0.812
NULL	Pain_Res_Treat_2013_Jan_30_2013_217864.nxml.txt.nlp	23431433	SENT77	17	17	3	3	amiloride	NHE	PA448368	285335	0.812
NULL	Mol_Biol_Cell_2012_Oct_15_23(20)_4008-4019.nxml.txt.nlp	22918940	SENT366	15	15	34	34	l-glutamine	CO2	PA10090	4513	0.812
NULL	Diabetes_2011_May_23_60(5)_1446-1457.nxml.txt.nlp	21471511	SENT273	0	0	12	12	naringenin	SREBP1	PA151958361	6720	0.812
NULL	Diabetologia_2014_Sep_29_57(1)_192-203.nxml.txt.nlp	24078137	SENT199	24	24	31	31	metformin	IPA	PA450395	3160	0.812
NULL	Acta_Pharmacol_Sin_2013_Apr_18_34(4)_555-560.nxml.txt.nlp	23503472	SENT151	10	10	2	2	cyclosporine	NFKB1	PA449167	4790	0.812
NULL	Acta_Pharmacol_Sin_2009_May_13_30(5)_628-636.nxml.txt.nlp	19363519	SENT35	2	2	4	4	camptothecin	TPT	PA153590860	23590;6469	0.812
NULL	Biochemistry_2008_Aug_19_47(33)_8689-8696.nxml.txt.nlp	18642884	SENT87	16	16	24	24	nadh	XMP	PA164755085	2013	0.812
NULL	Front_Oncol_2014_Apr_22_4_86.nxml.txt.nlp	24795863	SENT307	14	14	5	5	olaparib	PARP1		142	0.812
NULL	Anesthesiol_Res_Pract_2013_Sep_23_2013_297141.nxml.txt.nlp	24174934	SENT349	12	12	9	9	capsaicin	TRPV1	PA448776	7442	0.812
NULL	Int_J_Mol_Sci_2014_Nov_18_15(11)_21331-21347.nxml.txt.nlp	25411798	SENT557	17	17	6	6	ropivacaine	Bcl-2	PA451271	596	0.812
NULL	Br_J_Cancer_2011_Aug_23_105(5)_649-657.nxml.txt.nlp	21811251	SENT180	34	34	16	16	gefitinib	IGF1R	PA131301952	3480	0.812
NULL	Ann_Neurosci_2011_Apr_18(2)_76-83.nxml.txt.nlp	25205926	SENT6	24	24	6	6	rasagiline	COMT	PA164764584	1312	0.812
NULL	Evid_Based_Complement_Alternat_Med_2013_Mar_28_2013_514908.nxml.txt.nlp	23606881	SENT527	2	2	15	15	scopolamine	BMX	PA451308	660	0.812
NULL	Mol_Cancer_2012_Apr_26_11_26.nxml.txt.nlp	22537224	SENT366	24	24	19	19	cisplatin	FANCF	PA449014	2188	0.812
NULL	J_Cell_Biol_1999_Dec_27_147(7)_1493-1502.nxml.txt.nlp	10613907	SENT156	17	17	10	10	galactose	ANT-1	PA449725	24148	0.812
NULL	EPMA_J_2010_Jun_9_1(2)_217-227.nxml.txt.nlp	23199060	SENT351	4	4	9	9	l-arginine	SOD1	PA448478	6647	0.812
NULL	Indian_J_Dermatol_2014_Nov-Dec_59(6)_632a.nxml.txt.nlp	25484418	SENT29	9	9	39	39	bevacizumab	IFN	PA130232992	3439	0.812
NULL	Ann_Surg_Oncol_2010_Jan_20_17(1)_14-17.nxml.txt.nlp	19841980	SENT75	7	7	18	18	lapatinib	EGFR	PA152241907	1956	0.812
NULL	Int_J_Mol_Sci_2014_Oct_17_15(10)_18762-18775.nxml.txt.nlp	25329617	SENT478	0	0	11	11	paclitaxel	EGFR	PA450761	1956	0.812
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Mar_31_68(Pt_4)_m508.nxml.txt.nlp	22589860	SENT62	9	9	19	19	thiabendazole	mol	PA164746466	90527	0.812
NULL	Mol_Med_Rep_2015_Jan_23_11(1)_159-165.nxml.txt.nlp	25352084	SENT28	10	10	25	25	fluorescein	San	PA164746009	80218	0.812
NULL	Clin_Endosc_2011_Sep_30_44(1)_22-26.nxml.txt.nlp	22741108	SENT116	20	20	36	36	midazolam	ESD	PA450496	2098	0.812
NULL	Nat_Commun_2014_Dec_8_5_5736.nxml.txt.nlp	25484020	SENT330	4	4	17	17	tamoxifen	ATAC	PA451581	6375	0.812
NULL	Mol_Clin_Oncol_2013_Sep_23_1(5)_869-874.nxml.txt.nlp	24649263	SENT20	3	3	5	5	gemcitabine	GEM	PA449748	2669	0.812
NULL	Arthritis_Res_Ther_2008_Jan_18_10(1)_R8.nxml.txt.nlp	18205921	SENT34	34	34	16	16	tadalafil	MRP5	PA10333	10057	0.812
NULL	Biomed_Res_Int_2013_Jul_31_2013_692071.nxml.txt.nlp	23984399	SENT181	22	22	9	9	mitoxantrone	OCT1	PA450526	5451;6580	0.812
NULL	Support_Care_Cancer_2009_Sep_10_17(9)_1177-1185.nxml.txt.nlp	19205755	SENT93	14	14	41	41	ondansetron	HEC	PA450705	10403	0.812
NULL	Case_Rep_Med_2014_Nov_12_2014_231651.nxml.txt.nlp	25477968	SENT103	30	30	11	11	methimazole	AIT	PA450422	160728	0.812
NULL	Mol_Biol_Int_2014_Sep_7_2014_852748.nxml.txt.nlp	25276427	SENT150	7	7	9	9	capecitabine	HER2	PA448771	2064	0.812
NULL	Reprod_Biol_Endocrinol_2013_May_15_11_42.nxml.txt.nlp	23675907	SENT123	14	14	9	9	protamine	DAZL	PA10366	1618	0.812
NULL	Mol_Vis_2011_Feb_1_17_332-340.nxml.txt.nlp	21297899	SENT14	0	0	4	4	benazepril	DPI	PA448561	1832	0.812
NULL	Virol_J_2010_Oct_20_7_279.nxml.txt.nlp	20961433	SENT157	10	10	25	25	trypsin	GP2	PA451806	2813	0.812
NULL	Mol_Neurodegener_2011_Aug_8_6_57.nxml.txt.nlp	21819629	SENT359	13	13	32	32	arsenite	HuR	PA452638	1994	0.812
NULL	Chin_J_Cancer_2012_Feb_31(2)_51-57.nxml.txt.nlp	22257384	SENT42	35	35	13	13	xr9051	P-gp		5243	0.812
NULL	Breast_Cancer_Res_2008_Dec_5_10(6)_R104.nxml.txt.nlp	19061505	SENT289	9	9	22	22	estradiol	JNK	PA449503	5599	0.812
NULL	Neuro_Oncol_2010_Apr_27_12(4)_389-400.nxml.txt.nlp	20308316	SENT70	5	5	25	25	chloroquine	p53	PA448948	7157	0.812
NULL	Nucleic_Acids_Res_2010_Oct_28_38(19)_6418-6432.nxml.txt.nlp	20511593	SENT181	2	2	17	17	collagenase	AP-1	PA449107	2353;3727;2354;3725	0.812
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT280	25	25	3	3	irinotecan	PTEN	PA450085	5728	0.812
NULL	J_Biol_Chem_2014_Dec_26_289(52)_36018-36030.nxml.txt.nlp	25336647	SENT20	16	16	30	30	sulfur	PLP	PA451558	25824;5744	0.812
NULL	Oncoscience_2014_Jun_1_1(5)_383-391.nxml.txt.nlp	25594033	SENT85	30	30	13	13	paclitaxel	BRCA1	PA450761	672	0.812
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT161	4	4	6	6	lapatinib	ABCB1	PA152241907	5243	0.812
NULL	Cell_Death_Dis_2014_Feb_13_5(2)_e1055.nxml.txt.nlp	24525731	SENT312	0	0	5	5	irinotecan	XRCC1	PA450085	7515	0.812
NULL	Open_Biol_2014_Feb_4(2)_130217.nxml.txt.nlp	24522884	SENT279	18	18	5	5	trabectedin	CUL4A	PA165958349	8451	0.812
NULL	Genome_Biol_2011_May_25_12(5)_R46.nxml.txt.nlp	21609475	SENT61	10	10	0	0	cisplatin	MAST4	PA449014	375449	0.812
NULL	Cell_Death_Differ_2010_Oct_30_17(10)_1624-1635.nxml.txt.nlp	20431602	SENT167	5	5	10	10	paclitaxel	Bcl-2	PA450761	596	0.812
NULL	Cell_Death_Dis_2013_Oct_3_4(10)_e828.nxml.txt.nlp	24091671	SENT271	28	28	15	15	cetuximab	CD44	PA10040	960	0.812
NULL	Ann_Lab_Med_2012_Jul_20_32(4)_298-303.nxml.txt.nlp	22779073	SENT86	44	44	10	10	ciprofloxacin	EMB	PA449009	133418	0.811
NULL	Ann_Indian_Acad_Neurol_2008_Oct-Dec_11(4)_245-247.nxml.txt.nlp	19893682	SENT51	29	29	45	45	lamivudine	CD4	PA450163	920	0.811
NULL	Diabetes_Care_2009_Nov_32(Suppl_2)_S362-S367.nxml.txt.nlp	19875582	SENT103	13	13	16	16	rimonabant	adiponectin	PA152407999	9370	0.811
NULL	J_Clin_Biochem_Nutr_2009_Sep_28_45(2)_125-130.nxml.txt.nlp	19794918	SENT9	4	4	18	18	lansoprazole	HO-1	PA450180	3162	0.811
NULL	Database_(Oxford)_2014_Dec_23_2014_bau124.nxml.txt.nlp	25539768	SENT127	7	7	5	5	celecoxib	AKT	PA448871	207	0.811
NULL	Oncol_Rep_2013_Jan_1_29(1)_13-20.nxml.txt.nlp	23128605	SENT26	26	26	2	2	galactose	FUT9	PA449725	10690	0.811
NULL	Indian_J_Pharmacol_2008_Oct_40(Suppl_2)_S112-S142.nxml.txt.nlp	21593965	SENT809	0	0	12	12	pioglitazone	STZ	PA450970	6484	0.811
NULL	Acta_Pharmacol_Sin_2012_May_16_33(5)_682-690.nxml.txt.nlp	22504904	SENT130	15	15	6	6	celecoxib	STAT3	PA448871	6774	0.811
NULL	J_Gen_Intern_Med_2009_May_21_24(5)_656-664.nxml.txt.nlp	19306050	SENT203	4	4	21	21	warfarin	CYP2C9	PA451906	1559	0.811
NULL	Clin_Drug_Investig_2013_Aug_23_33(10)_727-736.nxml.txt.nlp	23975654	SENT43	14	14	10	10	bupropion	CYP2C19	PA448687	1557	0.811
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT141	23	23	10	10	simvastatin	survivin	PA451363	332	0.811
NULL	Nat_Biotechnol_2010_Jul_20_28(7)_727-732.nxml.txt.nlp	20562863	SENT67	35	35	14	14	thrombin	GPVI	PA451674	51206	0.811
NULL	Clin_Psychopharmacol_Neurosci_2013_Dec_24_11(3)_144-151.nxml.txt.nlp	24465251	SENT13	0	0	6	6	haloperidol	IL-4	PA449841	3565	0.811
NULL	Orphanet_J_Rare_Dis_2014_Oct_29_9(1)_162.nxml.txt.nlp	NULL	SENT253	25	25	19	19	gemfibrozil	CYP3A4	PA449750	1576	0.811
NULL	Int_J_Nanomedicine_2009_Apr_20_4_107-114.nxml.txt.nlp	19516889	SENT136	16	16	6	6	cisplatin	Bcl-2	PA449014	596	0.811
NULL	EPMA_J_2012_Sep_27_3(1)_10.nxml.txt.nlp	23016735	SENT193	19	19	12	12	warfarin	APOE	PA451906	348	0.811
NULL	Evid_Based_Complement_Alternat_Med_2013_May_15_2013_601838.nxml.txt.nlp	23762147	SENT104	23	23	13	13	glibenclamide	STZ	PA449782	6484	0.811
NULL	Int_J_Alzheimers_Dis_2010_Dec_27_2011_231595.nxml.txt.nlp	21234401	SENT106	4	4	22	22	iron	APP	PA450087	351	0.811
NULL	Mol_Cancer_2008_Jan_7_7_2.nxml.txt.nlp	18179710	SENT111	26	26	34	34	hyaluronan	TSG-6	PA165958431	7130	0.811
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1066.nxml.txt.nlp	24556681	SENT204	35	35	18	18	ethanol	PSME2	PA448073	5721	0.811
NULL	Hum_Genomics_2013_Oct_30_7(1)_22.nxml.txt.nlp	24172014	SENT204	2	2	9	9	heparin	SERPIND1	PA449855	3053	0.811
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Oct_14_6_159-168.nxml.txt.nlp	25339848	SENT126	13	13	17	17	trastuzumab	GP2	PA451743	2813	0.811
NULL	Arthritis_Res_2002_Sep_16_4(6)_R12.nxml.txt.nlp	12453315	SENT100	34	34	37	37	glucose	CRP	PA449773	1401;140913	0.811
NULL	Oncoimmunology_2014_Jun_3_3_e29030.nxml.txt.nlp	25083328	SENT61	19	19	39	39	sunitinib	IFN	PA162372840	3439	0.811
NULL	Eur_J_Clin_Pharmacol_2011_May_8_67(5)_493-506.nxml.txt.nlp	21140139	SENT208	24	24	29	29	oxycodone	CYP3A4	PA450741	1576	0.811
NULL	Br_J_Cancer_2010_Jan_19_102(2)_268-275.nxml.txt.nlp	20010948	SENT142	14	14	26	26	sunitinib	CD133	PA162372840	8842	0.811
NULL	J_Nutr_Metab_2011_Oct_1_2011_525094.nxml.txt.nlp	21977315	SENT185	3	3	12	12	resveratrol	SIRT4		23409	0.811
NULL	Environ_Health_2013_Mar_26_12_26.nxml.txt.nlp	23530988	SENT15	22	22	27	27	estradiol	JNK	PA449503	5599	0.811
NULL	Diabetes_2013_Jun_17_62(6)_1913-1922.nxml.txt.nlp	23349495	SENT216	15	15	6	6	sildenafil	VASP	PA451346	7408	0.811
NULL	Biomed_Res_Int_2014_Jan_2_2014_126586.nxml.txt.nlp	24527434	SENT128	2	2	17	17	metformin	CD133	PA450395	8842	0.811
NULL	J_Breast_Cancer_2013_Jun_28_16(2)_220-228.nxml.txt.nlp	23843857	SENT217	15	15	19	19	tamoxifen	aromatase	PA451581	1588	0.811
NULL	J_Neurosci_Methods_2009_Oct_15_183(2)_107-113.nxml.txt.nlp	19524611	SENT94	9	9	35	35	carbachol	DSI	PA448784	5034	0.811
NULL	Oncogene_2014_Feb_6_33(6)_713-723.nxml.txt.nlp	23435429	SENT94	11	11	38	38	etoposide	BRCA1	PA449552	672	0.811
NULL	J_Korean_Med_Sci_2010_Feb_19_25(2)_240-244.nxml.txt.nlp	20119577	SENT16	19	19	4	4	bleomycin	NAC	PA448645	22861	0.811
NULL	Open_Access_J_Urol_2011_Jun_15_3_95-104.nxml.txt.nlp	24198641	SENT73	30	30	18	18	lovastatin	gamma	PA450272	9913	0.811
NULL	Iran_J_Pharm_Res_2013_Winter_12(1)_175-184.nxml.txt.nlp	24250586	SENT23	0	0	13	13	diclofenac	COX	PA449293	1351	0.811
NULL	Arthritis_Res_Ther_2011_Feb_16_13(1)_R25.nxml.txt.nlp	21324169	SENT153	27	27	16	16	tocilizumab	TNF	PA165292659	7124	0.811
NULL	Cardiovasc_Drugs_Ther_2013_Jul_26_27(6)_521-530.nxml.txt.nlp	23887740	SENT239	4	4	6	6	clopidogrel	P2Y12	PA449053	64805	0.811
NULL	Carcinogenesis_2010_Dec_27_31(12)_2049-2057.nxml.txt.nlp	20876285	SENT4	3	3	24	24	tamoxifen	HER2	PA451581	2064	0.811
NULL	J_Breast_Cancer_2011_Mar_31_14(1)_20-27.nxml.txt.nlp	21847390	SENT149	13	13	15	15	estradiol	CLDN6	PA449503	9074	0.811
NULL	Curr_Neuropharmacol_2013_Dec_11(6)_652-663.nxml.txt.nlp	24396340	SENT190	10	10	2	2	capsaicin	TRPV1	PA448776	7442	0.811
NULL	AIDS_Res_Treat_2011_Aug_28_2011_349165.nxml.txt.nlp	21904672	SENT105	11	11	27	27	etravirine	CD4	PA166014703	920	0.811
NULL	J_Cell_Mol_Med_2013_Jun_15_17(6)_792-799.nxml.txt.nlp	23672538	SENT64	32	32	22	22	fluorescein	CD19	PA164746009	930	0.811
NULL	Oncotarget_2011_Sep_9_2(9)_658-668.nxml.txt.nlp	21911919	SENT61	25	25	29	29	daunorubicin	HO-1	PA449212	3162	0.811
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_25_2013_650134.nxml.txt.nlp	23878602	SENT113	12	12	15	15	galactose	mol	PA449725	90527	0.811
NULL	Ther_Clin_Risk_Manag_2005_Jun_1(2)_141-150.nxml.txt.nlp	18360553	SENT184	21	21	18	18	heparin	ACT	PA449855	12;11332;9457;641455	0.811
NULL	Nucleic_Acids_Res_2007_Jan_7_35(1)_186-192.nxml.txt.nlp	17158155	SENT21	6	6	11	11	cytarabine	TRO	PA449177	7216	0.811
NULL	J_Clin_Biochem_Nutr_2010_Mar_27_46(2)_126-134.nxml.txt.nlp	20216945	SENT322	23	23	15	15	taurine	NAC	PA451590	22861	0.811
NULL	Adolesc_Health_Med_Ther_2014_Mar_26_5_35-48.nxml.txt.nlp	24729739	SENT31	27	27	32	32	anakinra	IL-6	PA10799	3569	0.811
NULL	Exp_Cell_Res_2011_Apr_15_317(7)_1028-1039.nxml.txt.nlp	21237154	SENT187	7	7	2	2	staurosporine	JNK	PA165109623	5599	0.811
NULL	Biotechnol_Res_Int_2013_Dec_1_2013_253286.nxml.txt.nlp	24363937	SENT136	17	17	36	36	sugar	DAP	PA451529	23549;3375;1611	0.811
NULL	Int_J_Biol_Sci_2015_Jan_1_11(1)_48-58.nxml.txt.nlp	25552929	SENT171	4	4	8	8	paclitaxel	TSP-1	PA450761	7057	0.811
NULL	Curr_Hepat_Rep_2010_May_21_9(2)_75-90.nxml.txt.nlp	20461127	SENT174	0	0	12	12	entecavir	LAM	PA164784025	7249;7248	0.811
NULL	Biochemistry_2010_Apr_20_49(15)_3216-3224.nxml.txt.nlp	20225868	SENT228	31	31	14	14	trastuzumab	EGF	PA451743	1950	0.811
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT183	12	12	37	37	glucose	PP2	PA449773	4888	0.811
NULL	Front_Microbiol_2013_Aug_19_4_241.nxml.txt.nlp	23966991	SENT1133	0	0	11	11	telithromycin	NF-kappaB	PA10202	4790	0.811
NULL	ScientificWorldJournal_2012_Apr_30_2012_327071.nxml.txt.nlp	22654592	SENT148	3	3	33	33	ethanol	LPO	PA448073	4025	0.811
NULL	Ther_Clin_Risk_Manag_2005_Mar_1(1)_3-13.nxml.txt.nlp	18360537	SENT111	12	12	34	34	mibefradil	CYP3A	PA450492	1574	0.811
NULL	Br_J_Cancer_2014_Jan_21_110(2)_384-391.nxml.txt.nlp	24346286	SENT130	31	31	18	18	trastuzumab	PTEN	PA451743	5728	0.811
NULL	Acta_Pharmacol_Sin_2012_Aug_23_33(8)_1023-1029.nxml.txt.nlp	22820911	SENT89	21	21	15	15	glibenclamide	PAG	PA449782	55824	0.811
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1013.nxml.txt.nlp	24457957	SENT317	13	13	35	35	orlistat	NOXA	PA164776864	5366	0.811
NULL	Curr_Neuropharmacol_2010_Sep_8(3)_287-304.nxml.txt.nlp	21358978	SENT68	15	15	21	21	ramelteon	5-HT2C	PA164744896	3358	0.811
NULL	Cardiovasc_Diabetol_2013_Nov_12_12_169.nxml.txt.nlp	24215514	SENT289	0	0	13	13	aliskiren	ANG	PA143487910	283	0.811
NULL	Onco_Targets_Ther_2014_Sep_9_7_1571-1582.nxml.txt.nlp	25228815	SENT170	17	17	10	10	sunitinib	VEGFR2	PA162372840	3791	0.811
NULL	Ann_Rheum_Dis_2009_Nov_23_69(3)_510-516.nxml.txt.nlp	19933744	SENT181	1	1	11	11	abatacept	ACR	PA164747080	49	0.811
NULL	Nat_Neurosci_2012_Sep_5_15(9)_1245-1254.nxml.txt.nlp	22864611	SENT171	29	29	25	25	clozapine	mGlu2	PA449061	2912	0.811
NULL	J_Mol_Signal_2010_May_10_5_4.nxml.txt.nlp	20459745	SENT14	22	22	2	2	cisplatin	p53	PA449014	7157	0.811
NULL	J_Antimicrob_Chemother_2014_Mar_13_69(3)_651-663.nxml.txt.nlp	24235095	SENT176	6	6	23	23	pentamidine	AQP2	PA450850	359	0.811
NULL	Mediators_Inflamm_2011_Jun_7_2011_432080.nxml.txt.nlp	21772662	SENT108	6	6	17	17	rivaroxaban	MCP-1	PA165958360	6347	0.811
NULL	Breast_Cancer_Res_Treat_2013_Jan_6_137(1)_167-174.nxml.txt.nlp	23129173	SENT163	6	6	15	15	estradiol	aromatase	PA449503	1588	0.811
NULL	J_Cancer_Prev_2014_Jun_19(2)_111-117.nxml.txt.nlp	25337579	SENT151	4	4	10	10	bortezomib	AKR1B1	PA10252	231	0.811
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Mar_5_67(Pt_4)_o779.nxml.txt.nlp	21754070	SENT63	31	31	25	25	ethanol	mol	PA448073	90527	0.811
NULL	J_Hematol_Oncol_2013_Jan_4_6_1.nxml.txt.nlp	23286345	SENT149	27	27	7	7	irinotecan	FCGR2A	PA450085	2212	0.811
NULL	Exp_Diabetes_Res_2012_Dec_12_2012_716404.nxml.txt.nlp	22194737	SENT112	5	5	3	3	metformin	AMPK	PA450395	5563	0.811
NULL	Nat_Commun_2013_4_1332.nxml.txt.nlp	23299882	SENT264	3	3	11	11	ebselen	5-HT2A	PA161660841	3356	0.811
NULL	Cancer_Med_2013_Jun_25_2(3)_277-285.nxml.txt.nlp	23930204	SENT121	14	14	19	19	bevacizumab	PTEN	PA130232992	5728	0.811
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Jun_25_3(6)_e120.nxml.txt.nlp	24964282	SENT7	8	8	3	3	ketoconazole	CYP3A4	PA450146	1576	0.811
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT224	5	5	15	15	atorvastatin	ERK	PA448500	5594	0.811
NULL	Surg_Today_2012_Jan_6_42(1)_8-28.nxml.txt.nlp	22139128	SENT414	5	5	10	10	mitomycin	PSK	PA450524	9344	0.811
NULL	Case_Rep_Obstet_Gynecol_2013_May_2_2013_492754.nxml.txt.nlp	23738169	SENT12	19	19	21	21	cisplatin	EMA	PA449014	2108	0.811
NULL	Acta_Neuropathol_Commun_2013_Jul_17_1_39.nxml.txt.nlp	24252174	SENT201	5	5	2	2	erlotinib	Erb	PA134687924	2100	0.811
NULL	Diabetes_Care_2009_Nov_32(Suppl_2)_S362-S367.nxml.txt.nlp	19875582	SENT137	0	0	7	7	simvastatin	adiponectin	PA451363	9370	0.811
NULL	Arch_Pharm_Res_2014_Jan_7_37(6)_783-792.nxml.txt.nlp	24395528	SENT59	12	12	8	8	ethanol	AM2	PA448073	79924	0.811
NULL	Comp_Hepatol_2004_Jan_14_3(Suppl_1)_S46.nxml.txt.nlp	14960198	SENT81	4	4	2	2	allopurinol	AAP	PA448320	5345	0.811
NULL	Cancer_Res_Treat_2011_Jun_30_43(2)_124-130.nxml.txt.nlp	21811429	SENT33	25	25	19	19	bortezomib	TRAIL	PA10252	8743	0.811
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT100	16	16	7	7	resveratrol	TRAIL		8743	0.811
NULL	J_Invest_Dermatol_2014_Feb_10_134(2)_319-325.nxml.txt.nlp	24108405	SENT24	21	21	9	9	dacarbazine	BRAF	PA449197	673	0.811
NULL	Br_J_Cancer_2011_Apr_12_104(8)_1256-1261.nxml.txt.nlp	21448165	SENT159	22	22	16	16	sorafenib	IL-2	PA7000	3558	0.811
NULL	Cancer_Cell_Int_2013_Jun_26_13_63.nxml.txt.nlp	23800022	SENT213	12	12	24	24	genistein	p53	PA165109660	7157	0.811
NULL	Br_J_Cancer_2010_Jun_29_103(1)_18-28.nxml.txt.nlp	20551952	SENT35	5	5	3	3	vatalanib	VEGFR	PA7001	3791	0.811
NULL	Oxid_Med_Cell_Longev_2013_Jun_11_2013_870472.nxml.txt.nlp	23840921	SENT71	3	3	9	9	chloroquine	HO-1	PA448948	3162	0.811
NULL	Pharmaceuticals_(Basel)_2011_Jan_26_4(2)_285-342.nxml.txt.nlp	NULL	SENT2318	28	28	1	1	venlafaxine	5-HT1A	PA451866	3350	0.811
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT118	3	3	15	15	curcumin	IL-8	PA151958596	3576	0.811
NULL	Arthritis_Res_Ther_2012_May_1_14(3)_R99.nxml.txt.nlp	22546542	SENT125	24	24	3	3	infliximab	IFN	PA452639	3439	0.811
NULL	Pharmaceuticals_(Basel)_2011_Mar_14_4(3)_509-523.nxml.txt.nlp	NULL	SENT40	0	0	10	10	maraviroc	CCR5	PA164768835	1234	0.811
NULL	Acta_Pharmacol_Sin_2010_Nov_18_31(11)_1447-1453.nxml.txt.nlp	20953204	SENT133	16	16	3	3	rimonabant	IL-6	PA152407999	3569	0.811
NULL	J_Ophthalmic_Inflamm_Infect_2012_May_14_2(4)_231-233.nxml.txt.nlp	22581347	SENT4	20	20	13	13	adalimumab	TNF	PA10004	7124	0.811
NULL	Front_Plant_Sci_2012_Mar_19_3_54.nxml.txt.nlp	22639652	SENT126	25	25	17	17	propranolol	DGK	PA451145	8526;1607	0.811
NULL	Indian_J_Pharmacol_2014_Jul-Aug_46(4)_453-454.nxml.txt.nlp	25097292	SENT52	20	20	12	12	olanzapine	BPAD	PA450688	4095	0.811
NULL	Diabetologia_2010_Jun_27_53(6)_1142-1150.nxml.txt.nlp	20349036	SENT148	2	2	13	13	spermine	AMPK	PA164781199	5563	0.811
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Jun_27_5_15.nxml.txt.nlp	16803618	SENT255	8	8	19	19	ciprofloxacin	LTA	PA449009	4049	0.811
NULL	J_Young_Pharm_2010_Oct-Dec_2(4)_428-429.nxml.txt.nlp	21264109	SENT44	21	21	6	6	metformin	B12	PA450395	7126;4709	0.811
NULL	J_Cell_Biol_1997_Mar_10_136(5)_995-1005.nxml.txt.nlp	9060465	SENT75	9	9	11	11	dextran	mol	PA449261	90527	0.811
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Nov_13_64(Pt_12)_o2332.nxml.txt.nlp	21581307	SENT64	27	27	1	1	ethanol	mol	PA448073	90527	0.811
NULL	Clin_Genet_2014_Jan_1_86(1)_21-28.nxml.txt.nlp	24684508	SENT105	11	11	36	36	cisplatin	TPMT	PA449014	7172	0.811
NULL	Oxid_Med_Cell_Longev_2013_Jun_6_2013_462361.nxml.txt.nlp	23840917	SENT294	15	15	48	48	probucol	p47phox	PA451107	653361	0.811
NULL	Curr_Genomics_2014_Jun_15(3)_217-230.nxml.txt.nlp	24955029	SENT245	31	31	43	43	oxygen	ROS	PA450744	6098	0.811
NULL	Gut_Liver_2012_Apr_17_6(2)_139-148.nxml.txt.nlp	22570744	SENT149	23	23	14	14	sorafenib	SHARP	PA7000	23013	0.811
NULL	Indian_J_Pharm_Sci_2013_Jan-Feb_75(1)_94-98.nxml.txt.nlp	23901167	SENT30	14	14	32	32	bupropion	CYP2C19	PA448687	1557	0.811
NULL	Target_Oncol_2013_Jun_27_8(2)_127-136.nxml.txt.nlp	23625191	SENT126	9	9	16	16	panitumumab	KRAS	PA162373091	3845	0.811
NULL	Interdiscip_Toxicol_2011_Sep_4(3)_132-143.nxml.txt.nlp	22058654	SENT202	28	28	32	32	alprazolam	IL-2	PA448333	3558	0.811
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT171	19	19	15	15	trastuzumab	STAT3	PA451743	6774	0.811
NULL	Mol_Cancer_2013_Sep_11_12_104.nxml.txt.nlp	24025152	SENT228	9	9	3	3	gemcitabine	STAT3	PA449748	6774	0.811
NULL	Core_Evid_2010_Oct_21_5_77-90.nxml.txt.nlp	21042544	SENT63	11	11	17	17	aprepitant	NK1	PA164747039	11126	0.811
NULL	J_Cell_Biol_2004_Jun_7_165(5)_653-662.nxml.txt.nlp	15173192	SENT176	24	24	39	39	amiloride	GAD1	PA448368	2571	0.811
NULL	EMBO_J_2013_Jul_17_32(14)_2015-2028.nxml.txt.nlp	23792428	SENT280	36	36	32	32	l-glutamine	B27	PA10090	56246	0.811
NULL	Mol_Cancer_2007_Nov_17_6_73.nxml.txt.nlp	18021420	SENT73	47	47	38	38	bortezomib	Hsp90	PA10252	3320	0.811
NULL	Ann_Rheum_Dis_2014_Mar_11_73(3)_536-543.nxml.txt.nlp	23316080	SENT195	38	38	33	33	adalimumab	STAR	PA10004	6770;2984	0.811
NULL	Acta_Pharmacol_Sin_2010_Nov_18_31(11)_1447-1453.nxml.txt.nlp	20953204	SENT104	18	18	24	24	rimonabant	IL-6	PA152407999	3569	0.811
NULL	EPMA_J_2013_Feb_19_4(1)_6.nxml.txt.nlp	23418957	SENT69	6	6	8	8	trastuzumab	aromatase	PA451743	1588	0.811
NULL	J_Mol_Signal_2009_Apr_28_4_2.nxml.txt.nlp	19400946	SENT101	22	22	2	2	estradiol	PRL	PA449503	5617	0.811
NULL	Br_J_Cancer_2011_Jul_26_105(3)_407-412.nxml.txt.nlp	21730976	SENT68	0	0	4	4	pha-665752	STAT3		6774	0.811
NULL	Aging_(Albany_NY)_2012_Jul_22_4(7)_480-498.nxml.txt.nlp	22837425	SENT34	23	23	29	29	metformin	B12	PA450395	7126;4709	0.811
NULL	Acta_Pharmacol_Sin_2013_Jun_8_34(6)_830-836.nxml.txt.nlp	23564080	SENT139	20	20	26	26	simvastatin	HMGB1	PA451363	3146	0.811
NULL	Indian_J_Anaesth_2009_Oct_53(5)_582-591.nxml.txt.nlp	20640109	SENT84	5	5	27	27	clopidogrel	ADP	PA449053	23038	0.811
NULL	Exp_Ther_Med_2013_Jul_25_6(1)_109-114.nxml.txt.nlp	23935730	SENT137	11	11	24	24	cyclophosphamide	CHOP	PA449165	1649	0.811
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_29_2013_590393.nxml.txt.nlp	23737838	SENT224	2	2	11	11	resveratrol	p53		7157	0.811
NULL	Mol_Cancer_2010_Aug_20_9_220.nxml.txt.nlp	20727180	SENT140	6	6	10	10	nicotine	p53	PA450626	7157	0.811
NULL	Breast_Cancer_Res_2010_Apr_16_12(2)_R24.nxml.txt.nlp	20398352	SENT64	18	18	14	14	tamoxifen	ATAC	PA451581	6375	0.811
NULL	Cell_Death_Dis_2014_Jul_10_5(7)_e1318.nxml.txt.nlp	25010984	SENT42	9	9	6	6	nutlin-3	p53		7157	0.811
NULL	Oncoimmunology_2012_Oct_1_1(7)_1004-1016.nxml.txt.nlp	23170249	SENT97	11	11	6	6	paclitaxel	HER-2	PA450761	2064	0.811
NULL	Mol_Cells_2014_Mar_31_37(3)_234-240.nxml.txt.nlp	24642709	SENT131	8	8	6	6	capsaicin	HO-1	PA448776	3162	0.811
NULL	J_Lipid_Res_2014_Oct_55(10)_2103-2112.nxml.txt.nlp	25139399	SENT613	2	2	8	8	atorvastatin	CETP	PA448500	1071	0.811
NULL	Int_J_Mol_Sci_2014_Nov_4_15(11)_20022-20044.nxml.txt.nlp	25375187	SENT189	9	9	29	29	metformin	adiponectin	PA450395	9370	0.811
NULL	Front_Neurosci_2015_Jan_6_8_437.nxml.txt.nlp	25610366	SENT58	19	19	21	21	pramipexole	PPX	PA164742949	5531	0.811
NULL	EJC_Suppl_2013_Sep_5_11(2)_3-22.nxml.txt.nlp	NULL	SENT1045	12	12	27	27	anastrozole	ARNO	PA448432	9266	0.811
NULL	Cell_Death_Dis_2012_Jun_21_3(6)_e330.nxml.txt.nlp	22717585	SENT47	10	10	21	21	simvastatin	LC3	PA451363	84557	0.811
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT98	5	5	2	2	curcumin	PC-3	PA151958596	692094	0.811
NULL	JAKSTAT_2012_Jul_1_1(3)_197-199.nxml.txt.nlp	24058771	SENT59	7	7	12	12	fulvestrant	IFN	PA164747170	3439	0.811
NULL	J_Viral_Hepat_2012_Feb_19(2)_e112-e119.nxml.txt.nlp	22239508	SENT176	30	30	24	24	telaprevir	solo	PA165958354	55701	0.811
NULL	Ann_Thorac_Med_2014_Jul-Sep_9(Suppl_1)_S79-S91.nxml.txt.nlp	25077002	SENT307	10	10	7	7	bosentan	CYP3A4	PA10034	1576	0.811
NULL	Mol_Cell_Proteomics_2014_Jun_9_13(6)_1598-1610.nxml.txt.nlp	24719452	SENT226	33	33	18	18	galactose	BG1	PA449725	23205	0.811
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT46	13	13	10	10	chloroquine	BMPR-II	PA448948	659	0.811
NULL	Eur_J_Clin_Pharmacol_2012_Jan_8_68(1)_29-37.nxml.txt.nlp	21739267	SENT0	35	35	23	23	paroxetine	CYP2D6	PA450801	1565	0.811
NULL	Cardiovasc_Diabetol_2013_May_29_12_80.nxml.txt.nlp	23718574	SENT203	0	0	16	16	mannitol	CD86	PA450320	942	0.811
NULL	Nat_Biotechnol_2010_Jul_20_28(7)_727-732.nxml.txt.nlp	20562863	SENT61	4	4	2	2	thrombin	GPVI	PA451674	51206	0.811
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT190	35	35	25	25	heparin	EEA1	PA449855	8411	0.811
NULL	Mol_Biol_Cell_2012_Mar_15_23(6)_996-1009.nxml.txt.nlp	22278744	SENT213	2	2	21	21	forskolin	14-3-3	PA146096022	10971	0.811
NULL	Biomed_Res_Int_2014_Aug_4_2014_571376.nxml.txt.nlp	25162016	SENT15	10	10	22	22	eplerenone	CYP3A4	PA164749044	1576	0.811
NULL	Adv_Appl_Bioinforma_Chem_2008_Oct_30_1_85-98.nxml.txt.nlp	21918608	SENT83	4	4	8	8	bortezomib	SPARC	PA10252	6678	0.811
NULL	J_Korean_Med_Sci_2010_Jun_24_25(6)_817-823.nxml.txt.nlp	20514299	SENT89	3	3	14	14	clindamycin	VIII	PA449035	1351	0.811
NULL	Mol_Biol_Cell_2014_May_1_25(9)_1411-1420.nxml.txt.nlp	24623724	SENT116	5	5	30	30	tetracycline	ATF6	PA451640	22926	0.811
NULL	Cardiovasc_Diabetol_2013_May_4_12_73.nxml.txt.nlp	23642288	SENT137	15	15	36	36	acarbose	GLP-1	PA448010	100125288	0.811
NULL	Curr_Neuropharmacol_2011_Dec_9(4)_530-552.nxml.txt.nlp	22654714	SENT647	24	24	35	35	ketamine	BDNF	PA450144	627	0.811
NULL	J_Invest_Dermatol_2013_Sep_31_133(9)_2247-2254.nxml.txt.nlp	23370537	SENT115	3	3	8	8	chloroquine	PUMA	PA448948	27113	0.811
NULL	Iran_J_Pharm_Res_2014_Spring_13(2)_683-693.nxml.txt.nlp	25237365	SENT9	8	8	23	23	tranilast	CXCL12	PA131890628	6387	0.811
NULL	J_Inflamm_(Lond)_2006_Mar_28_3_4.nxml.txt.nlp	16569220	SENT203	12	12	20	20	indomethacin	FMLP	PA449982	2357	0.811
NULL	Pancreas_2014_Nov_24_43(8)_1223-1231.nxml.txt.nlp	25275271	SENT91	10	10	23	23	lipase	GLP-1	PA450239	100125288	0.811
NULL	J_Cell_Biol_2005_Nov_21_171(4)_729-738.nxml.txt.nlp	16286510	SENT183	7	7	15	15	heparin	FGF2	PA449855	2247;2258	0.811
NULL	Front_Genet_2012_Nov_5_3_236.nxml.txt.nlp	23133441	SENT15	12	12	22	22	efavirenz	ABCB1	PA449441	5243	0.811
NULL	ScientificWorldJournal_2012_Mar_12_2012_619080.nxml.txt.nlp	22536149	SENT35	38	38	0	0	copper	TEM	PA449114	64102	0.811
NULL	J_Gen_Physiol_2009_May_133(5)_511-524.nxml.txt.nlp	19398777	SENT211	5	5	10	10	nifedipine	DHPR	PA450631	5860	0.811
NULL	Sensors_(Basel)_2013_Jan_7_13(1)_758-768.nxml.txt.nlp	23296332	SENT44	10	10	26	26	ethanol	mol	PA448073	90527	0.811
NULL	Orphanet_J_Rare_Dis_2014_Jul_22_9_117.nxml.txt.nlp	25200064	SENT152	8	8	24	24	bezafibrate	MADD	PA162364313	8567;2108	0.811
NULL	Oncotarget_2012_Jul_13_3(6)_601-607.nxml.txt.nlp	22802145	SENT33	3	3	10	10	doxorubicin	p53	PA449412	7157	0.811
NULL	Breast_Cancer_Res_2012_May_10_14(3)_309.nxml.txt.nlp	22574877	SENT11	22	22	13	13	tamoxifen	aromatase	PA451581	1588	0.811
NULL	Mol_Cells_2014_Mar_31_37(3)_234-240.nxml.txt.nlp	24642709	SENT152	17	17	25	25	capsaicin	HO-1	PA448776	3162	0.811
NULL	Int_J_Cell_Biol_2010_Jan_17_2010_930509.nxml.txt.nlp	20145727	SENT368	16	16	27	27	bortezomib	CHOP	PA10252	1649	0.811
NULL	Neuropsychopharmacology_2009_May_3_34(6)_1504-1513.nxml.txt.nlp	19052543	SENT35	11	11	2	2	cocaine	CB1	PA449072	1268	0.811
NULL	Arthritis_Res_Ther_2014_Sep_18_16(5)_427.nxml.txt.nlp	25230745	SENT146	35	35	24	24	bevacizumab	MMP3	PA130232992	4314	0.811
NULL	EPMA_J_2014_Feb_11_5(Suppl_1)_A42.nxml.txt.nlp	NULL	SENT8	20	20	44	44	cetuximab	KRAS	PA10040	3845	0.811
NULL	Cancer_Sci_2012_Nov_17_103(11)_1907-1912.nxml.txt.nlp	22809142	SENT92	9	9	3	3	tanespimycin	Hsp90	PA165291490	3320	0.811
NULL	J_Gen_Physiol_2009_Sep_134(3)_243-258.nxml.txt.nlp	19720962	SENT765	5	5	11	11	capsaicin	VR1	PA448776	56664	0.811
NULL	Acta_Pharmacol_Sin_2012_Jun_6_33(6)_798-808.nxml.txt.nlp	22669117	SENT158	8	8	16	16	heparin	14-3-3	PA449855	10971	0.811
NULL	Oncotarget_2012_Dec_17_4(1)_48-63.nxml.txt.nlp	23295955	SENT223	19	19	13	13	methotrexate	MTHFD2	PA450428	10797	0.811
NULL	Mol_Cancer_2010_Nov_2_9_289.nxml.txt.nlp	21044322	SENT60	38	38	14	14	paclitaxel	FBS	PA450761	64319;26269	0.811
NULL	Aging_(Albany_NY)_2009_Oct_13_1(10)_842-844.nxml.txt.nlp	20157556	SENT38	3	3	6	6	nutlin-3	p53		7157	0.811
NULL	Breast_Cancer_Res_2011_Mar_11_13(2)_R30.nxml.txt.nlp	21396117	SENT236	48	48	23	23	erlotinib	BRCA1	PA134687924	672	0.811
NULL	Br_J_Cancer_1988_Jun_57(6)_548-552.nxml.txt.nlp	3044430	SENT8	20	20	13	13	carboplatin	CHIP	PA448803	10273	0.811
NULL	Ann_Rheum_Dis_2008_Jun_2_68(5)_654-657.nxml.txt.nlp	18519424	SENT103	18	18	7	7	tocilizumab	IL6	PA165292659	3569	0.811
NULL	J_Hematol_Oncol_2009_Feb_23_2_9.nxml.txt.nlp	19236713	SENT53	3	3	16	16	cetuximab	KRAS	PA10040	3845	0.811
NULL	Breast_Cancer_Res_2010_May_12_12(3)_R27.nxml.txt.nlp	20462431	SENT313	12	12	4	4	trastuzumab	HER2	PA451743	2064	0.811
NULL	Front_Oncol_2013_Oct_9_3_261.nxml.txt.nlp	24130964	SENT205	14	14	5	5	erlotinib	EGFR	PA134687924	1956	0.811
NULL	Diabetes_Metab_J_2012_Jun_14_36(3)_207-210.nxml.txt.nlp	22737660	SENT58	12	12	5	5	clofibrate	HSD1	PA449045	26871	0.811
NULL	Int_J_Med_Sci_2013_Mar_19_10(5)_599-606.nxml.txt.nlp	23569422	SENT27	6	6	10	10	propofol	HO-1	PA451141	3162	0.811
NULL	Eur_J_Neurosci_2009_Aug_30(3)_347-354.nxml.txt.nlp	19614749	SENT137	5	5	40	40	scopolamine	gamma	PA451308	9913	0.811
NULL	Mol_Cancer_2010_Oct_13_9_270.nxml.txt.nlp	20942909	SENT283	1	1	19	19	trypsin	San	PA451806	80218	0.811
NULL	Ann_Clin_Microbiol_Antimicrob_2005_Apr_1_4_6.nxml.txt.nlp	15804353	SENT115	32	32	34	34	metronidazole	Met	PA450484	79811	0.811
NULL	Hum_Genomics_2009_Jan_1_3(2)_128-142.nxml.txt.nlp	19164090	SENT236	40	40	11	11	carboplatin	CD44	PA448803	960	0.811
NULL	Breast_Cancer_(Auckl)_2009_Sep_2_3_61-75.nxml.txt.nlp	19809577	SENT96	11	11	25	25	curcumin	BRCA1	PA151958596	672	0.811
NULL	Acta_Pharmacol_Sin_2014_Jun_5_35(6)_814-824.nxml.txt.nlp	24793310	SENT183	17	17	21	21	geldanamycin	Hsp90	PA152031327	3320	0.811
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT283	9	9	17	17	resveratrol	TRAIL		8743	0.811
NULL	Br_J_Pharmacol_2014_Feb_24_171(1)_1019-1032.nxml.txt.nlp	24251620	SENT279	14	14	9	9	nimodipine	TRPM3	PA450633	80036	0.811
NULL	Cell_Death_Dis_2014_Mar_6_5(3)_e1108.nxml.txt.nlp	24603336	SENT61	12	12	5	5	cetuximab	CYP3A4	PA10040	1576	0.811
NULL	Mol_Cell_Proteomics_2012_Feb_6_11(2)_M111_015222.nxml.txt.nlp	22147731	SENT165	4	4	12	12	cetuximab	EGFR	PA10040	1956	0.811
NULL	Pharmaceuticals_(Basel)_2013_Aug_21_6(8)_988-1038.nxml.txt.nlp	24276379	SENT499	8	8	15	15	oxaliplatin	CD166	PA131285527	214	0.811
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT170	25	25	18	18	lapatinib	HER2	PA152241907	2064	0.811
NULL	Viruses_2014_Feb_6_6(2)_582-605.nxml.txt.nlp	24509811	SENT170	13	13	30	30	trypsin	San	PA451806	80218	0.811
NULL	J_Oncol_2010_Dec_14_2010_426956.nxml.txt.nlp	20049170	SENT298	29	29	41	41	genistein	CXCL12	PA165109660	6387	0.811
NULL	Core_Evid_2010_Oct_22_5_91-105.nxml.txt.nlp	21468365	SENT314	4	4	10	10	pitavastatin	Q10	PA142650384	27161	0.811
NULL	Br_J_Cancer_2002_Feb_1_86(3)_443-448.nxml.txt.nlp	11875713	SENT124	10	10	16	16	ciprofloxacin	Bcl-2	PA449009	596	0.811
NULL	Clin_Interv_Aging_2014_Oct_21_9_1783-1791.nxml.txt.nlp	25364236	SENT145	22	22	34	34	donepezil	APOE	PA449394	348	0.811
NULL	Springerplus_2014_Sep_17_3_535.nxml.txt.nlp	25279326	SENT154	34	34	30	30	everolimus	aromatase	PA164746311	1588	0.811
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT207	7	7	14	14	tacrolimus	SOCS3	PA451578	9021	0.811
NULL	Int_J_Mol_Sci_2013_Apr_2_14(4)_7193-7230.nxml.txt.nlp	23549262	SENT29	17	17	36	36	indomethacin	FPR2	PA449982	2358	0.811
NULL	Oncologist_2010_Nov_4_15(11)_1135-1146.nxml.txt.nlp	21051659	SENT150	3	3	28	28	sunitinib	IFN	PA162372840	3439	0.811
NULL	Allergy_2014_Jul_29_69(7)_817-827.nxml.txt.nlp	24773466	SENT214	29	29	27	27	theophylline	PI3K	PA451647	5290	0.811
NULL	Mol_Cancer_2010_Nov_25_9_305.nxml.txt.nlp	21108789	SENT75	21	21	8	8	doxorubicin	PTEN	PA449412	5728	0.811
NULL	Biomed_Res_Int_2014_Jan_2_2014_682010.nxml.txt.nlp	24524084	SENT5	0	0	18	18	imatinib	ZAP70	PA10804	7535	0.811
NULL	Indian_J_Med_Res_2011_Mar_133(3)_257-266.nxml.txt.nlp	21441678	SENT107	35	35	18	18	rifampin	TST	PA451250	7263	0.811
NULL	Case_Rep_Med_2014_May_4_2014_964082.nxml.txt.nlp	24876846	SENT26	15	15	12	12	lenalidomide	BOR	PA162363968	55143	0.811
NULL	Acta_Orthop_2010_Dec_26_81(6)_748-755.nxml.txt.nlp	21067431	SENT75	38	38	17	17	rofecoxib	ANOVA	PA451268	4858	0.811
NULL	Front_Aging_Neurosci_2010_Feb_3_2_2.nxml.txt.nlp	20552042	SENT92	17	17	6	6	nimodipine	CA1	PA450633	759	0.811
NULL	Oncotarget_2010_Nov_19_1(7)_472-482.nxml.txt.nlp	21317446	SENT91	13	13	6	6	rituximab	CD52	PA451261	1043	0.811
NULL	Cell_Death_Dis_2014_Apr_17_5(4)_e1182.nxml.txt.nlp	24743737	SENT34	0	0	32	32	capsaicin	TRPV1	PA448776	7442	0.811
NULL	J_Biomed_Biotechnol_2011_Jul_6_2011_783528.nxml.txt.nlp	21785566	SENT195	5	5	0	0	dextromethorphan	CYP2D6	PA449273	1565	0.811
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Mar_25_65(Pt_4)_o840.nxml.txt.nlp	21582559	SENT65	33	33	6	6	ethanol	mol	PA448073	90527	0.811
NULL	ACS_Nano_2013_Oct_22_7(10)_9001-9009.nxml.txt.nlp	24015809	SENT75	2	2	10	10	bivalirudin	ANOVA	PA10032	4858	0.811
NULL	Acta_Pharmacol_Sin_2013_Mar_21_34(3)_352-359.nxml.txt.nlp	23334241	SENT15	3	3	11	11	eplerenone	NOX4	PA164749044	50507	0.811
NULL	Mol_Cancer_2008_Sep_12_7_70.nxml.txt.nlp	18789133	SENT67	13	13	2	2	belinostat	HDAC1		3065	0.811
NULL	Exp_Ther_Med_2013_May_15_5(5)_1327-1331.nxml.txt.nlp	23737873	SENT13	12	12	8	8	imidapril	AVP	PA452640	114548;551	0.811
NULL	Cancers_(Basel)_2013_Nov_8_5(4)_1504-1521.nxml.txt.nlp	24217116	SENT22	22	22	15	15	gefitinib	EGFR	PA131301952	1956	0.811
NULL	Cancers_(Basel)_2010_Apr_9_2(2)_397-419.nxml.txt.nlp	24281076	SENT973	3	3	15	15	curcumin	c-Jun	PA151958596	3725	0.811
NULL	Oncol_Rep_2012_Apr_30_27(4)_1163-1169.nxml.txt.nlp	22210010	SENT50	4	4	24	24	fluorescein	CD86	PA164746009	942	0.811
NULL	Oncol_Lett_2013_Dec_7_6(6)_1624-1630.nxml.txt.nlp	24260056	SENT29	16	16	6	6	cisplatin	DUSP6	PA449014	1848	0.811
NULL	Osteoporos_Int_2012_Feb_4_23(Suppl_1)_S1-S23.nxml.txt.nlp	22311111	SENT435	6	6	11	11	denosumab	RANK	PA166048634	8792	0.811
NULL	Curr_Rheumatol_Rep_2010_Feb_8_12(1)_45-52.nxml.txt.nlp	20425533	SENT38	23	23	11	11	thrombin	VIII	PA451674	1351	0.811
NULL	Int_J_Fertil_Steril_2014_Jul_8_Jul-Sep_8(2)_183-192.nxml.txt.nlp	25083184	SENT42	25	25	0	0	hyaluronan	TLR4	PA165958431	7099	0.811
NULL	Oncotarget_2012_Oct_20_3(10)_1068-1111.nxml.txt.nlp	23085539	SENT33	5	5	12	12	sorafenib	Raf-1	PA7000	5894	0.811
NULL	J_Headache_Pain_2013_Apr_10_14(1)_33.nxml.txt.nlp	23574808	SENT182	30	30	17	17	capsaicin	CO2	PA448776	4513	0.811
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT211	10	10	5	5	tacrolimus	SOCS3	PA451578	9021	0.811
NULL	Ann_Pediatr_Endocrinol_Metab_2014_Jun_30_19(2)_57-68.nxml.txt.nlp	25077087	SENT277	1	1	9	9	octreotide	SSTR2	PA450678	6752	0.811
NULL	J_Thromb_Haemost_2011_Oct_9(10)_2103-2105.nxml.txt.nlp	21812912	SENT18	5	5	16	16	ticagrelor	ADP	PA165374673	23038	0.811
NULL	Mol_Cells_2014_Oct_31_37(10)_759-765.nxml.txt.nlp	25256221	SENT101	43	43	23	23	curcumin	NDRG2	PA151958596	57447	0.811
NULL	Front_Neurosci_2013_Jan_31_7_3.nxml.txt.nlp	23386808	SENT206	26	26	33	33	capsaicin	TRPV1	PA448776	7442	0.811
NULL	Int_J_Nanomedicine_2012_Sep_21_7_5091-5106.nxml.txt.nlp	23049256	SENT135	11	11	3	3	heparin	SMCC	PA449855	6876;1264	0.811
NULL	Front_Neurol_2014_Sep_3_5_169.nxml.txt.nlp	25232349	SENT209	7	7	4	4	estradiol	aromatase	PA449503	1588	0.811
NULL	Am_J_Cardiovasc_Drugs_2014_Oct_31_14(2)_79-87.nxml.txt.nlp	24174174	SENT210	8	8	11	11	pravastatin	adiponectin	PA451089	9370	0.811
NULL	Breast_Cancer_(Auckl)_2014_May_12_8_81-88.nxml.txt.nlp	24855372	SENT138	0	0	21	21	trastuzumab	HER3	PA451743	2065	0.811
NULL	Infect_Dis_Obstet_Gynecol_2012_Jul_1_2012_636474.nxml.txt.nlp	22811591	SENT165	11	11	1	1	fluconazole	CDR1	PA449653	1038	0.811
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_3_2012_856029.nxml.txt.nlp	23091559	SENT237	2	2	7	7	cetrorelix	PC-3	PA164764506	692094	0.811
NULL	Endocr_Relat_Cancer_2014_Apr_21(2)_311-326.nxml.txt.nlp	24478054	SENT26	0	0	14	14	cabozantinib	KIT	PA165906891	3815	0.811
NULL	Mol_Cancer_2012_Dec_12_11_91.nxml.txt.nlp	23234355	SENT303	27	27	16	16	cetuximab	EGFR	PA10040	1956	0.811
NULL	Int_J_Mol_Sci_2014_Sep_29_15(10)_17411-17441.nxml.txt.nlp	25268615	SENT217	25	25	10	10	paclitaxel	STAT3	PA450761	6774	0.811
NULL	Org_Med_Chem_Lett_2012_Oct_24_2_33.nxml.txt.nlp	23095284	SENT113	6	6	4	4	galactose	SN1	PA449725	10991	0.811
NULL	Eur_J_Clin_Pharmacol_2011_May_9_67(5)_477-482.nxml.txt.nlp	21305273	SENT29	28	28	30	30	dobutamine	DSE	PA449381	29940	0.811
NULL	Cell_Cycle_2012_Aug_15_11(16)_3067-3078.nxml.txt.nlp	22871739	SENT258	12	12	5	5	epirubicin	FOXM1	PA449476	2305	0.811
NULL	Cell_Mol_Immunol_2008_Dec_5(6)_425-431.nxml.txt.nlp	19118508	SENT4	38	38	30	30	dextran	IL-25	PA449261	64806;56005	0.811
NULL	Acta_Pharmacol_Sin_2010_Feb_5_31(2)_137-144.nxml.txt.nlp	20139896	SENT176	4	4	7	7	zileuton	ROS	PA451955	6098	0.811
NULL	Eur_Arch_Psychiatry_Clin_Neurosci_2012_Dec_28_262(8)_667-676.nxml.txt.nlp	22454241	SENT289	3	3	11	11	risperidone	Gen	PA451257	348654	0.811
NULL	Oncotarget_2013_Aug_30_4(10)_1698-1711.nxml.txt.nlp	24091605	SENT180	5	5	25	25	hyaluronan	MDR1	PA165958431	5243	0.811
NULL	Int_J_Fertil_Steril_2012_Jun_19_Apr-Jun_6(1)_31-36.nxml.txt.nlp	25505509	SENT32	10	10	12	12	metformin	Met	PA450395	79811	0.811
NULL	Diagn_Pathol_2013_Feb_4_8_16.nxml.txt.nlp	23379953	SENT61	9	9	18	18	cyclophosphamide	CHOP	PA449165	1649	0.811
NULL	Neural_Regen_Res_2014_Mar_15_9(6)_622-629.nxml.txt.nlp	25206865	SENT35	11	11	17	17	vasopressin	c-Jun	PA451858	3725	0.811
NULL	Arch_Gynecol_Obstet_2012_May_30_285(5)_1447-1453.nxml.txt.nlp	22127553	SENT29	32	32	17	17	paclitaxel	TEC	PA450761	7006	0.811
NULL	Front_Aging_Neurosci_2015_Jan_6_6_342.nxml.txt.nlp	25610395	SENT171	4	4	9	9	imatinib	GSAP	PA10804	54103	0.811
NULL	Aging_(Albany_NY)_2013_Feb_21_5(2)_94-95.nxml.txt.nlp	23518473	SENT22	14	14	38	38	resveratrol	p53		7157	0.811
NULL	Biologics_2012_Dec_17_6_429-464.nxml.txt.nlp	23269860	SENT246	6	6	30	30	tocilizumab	ACR	PA165292659	49	0.811
NULL	Acta_Pharmacol_Sin_2011_Oct_15_32(10)_1233-1238.nxml.txt.nlp	21841815	SENT149	12	12	3	3	atropine	CTX	PA448505	1593	0.811
NULL	Oxid_Med_Cell_Longev_2013_Jun_2_2013_793525.nxml.txt.nlp	23819014	SENT173	2	2	4	4	resveratrol	TNF		7124	0.811
NULL	J_Geriatr_Cardiol_2014_Jun_11(2)_151-157.nxml.txt.nlp	25009566	SENT126	9	9	13	13	cilostazol	CDP	PA164746334	1523	0.811
NULL	Br_J_Cancer_2009_Jan_27_100(2)_251-258.nxml.txt.nlp	19165196	SENT20	38	38	15	15	cetuximab	ACRC	PA10040	93953	0.811
NULL	J_Biol_Chem_2012_Apr_13_287(16)_12952-12965.nxml.txt.nlp	22371491	SENT223	2	2	10	10	terazosin	CXCR2	PA451612	3579	0.811
NULL	Cancer_Cell_Int_2013_Nov_8_13_111.nxml.txt.nlp	24209962	SENT137	10	10	22	22	fluvastatin	A20	PA449688	7128;28935	0.811
NULL	Cancers_(Basel)_2011_Sep_2_3(3)_3461-3495.nxml.txt.nlp	24212964	SENT381	4	4	2	2	imiquimod	TLR7	PA449972	51284	0.811
NULL	Eur_J_Clin_Pharmacol_2011_Dec_23_67(12)_1231-1241.nxml.txt.nlp	21698374	SENT259	11	11	2	2	tacrolimus	CYP3A5	PA451578	1577	0.811
NULL	Brain_Sci_2014_May_6_4(2)_356-375.nxml.txt.nlp	24961766	SENT223	3	3	12	12	propofol	NeuN	PA451141	146713	0.811
NULL	Biosensors_(Basel)_2013_Jun_28_3(3)_238-258.nxml.txt.nlp	25506422	SENT260	6	6	10	10	etoposide	TP53	PA449552	7157	0.811
NULL	Oncol_Lett_2014_May_26_7(5)_1345-1351.nxml.txt.nlp	24765136	SENT106	20	20	31	31	bortezomib	VEGF-A	PA10252	7422	0.811
NULL	J_Neural_Transm_2014_Mar_27_121(10)_1221-1232.nxml.txt.nlp	24671607	SENT237	5	5	18	18	ethanol	PSD-95	PA448073	1742	0.811
NULL	Br_J_Cancer_2012_Apr_10_106(8)_1395-1405.nxml.txt.nlp	22460269	SENT118	0	0	3	3	sulindac	ABCB1	PA451565	5243	0.81
NULL	Int_J_Endocrinol_Metab_2013_Oct_21_11(4)_e9860.nxml.txt.nlp	24719635	SENT189	20	20	15	15	estradiol	aromatase	PA449503	1588	0.81
NULL	Behav_Brain_Funct_2010_Oct_7_6_57.nxml.txt.nlp	20929549	SENT151	34	34	16	16	atomoxetine	SLC6A2	PA134688071	6530	0.81
NULL	EJC_Suppl_2013_Sep_5_11(2)_3-22.nxml.txt.nlp	NULL	SENT388	23	23	6	6	trastuzumab	HER2	PA451743	2064	0.81
NULL	J_Cell_Biol_1999_Jan_25_144(2)_267-279.nxml.txt.nlp	9922453	SENT227	10	10	15	15	trypsin	p32	PA451806	708	0.81
NULL	Cell_Cycle_2012_Nov_1_11(21)_4069-4078.nxml.txt.nlp	23095523	SENT71	21	21	11	11	imatinib	PERK	PA10804	9451	0.81
NULL	Ther_Clin_Risk_Manag_2007_Aug_3(4)_665-673.nxml.txt.nlp	18472989	SENT60	11	11	19	19	gefitinib	survivin	PA131301952	332	0.81
NULL	Allergy_Asthma_Immunol_Res_2014_Nov_28_6(6)_567-572.nxml.txt.nlp	25374757	SENT85	5	5	21	21	fexofenadine	p38	PA449621	10598;1432;7965	0.81
NULL	Biomed_Res_Int_2014_Jan_20_2014_948427.nxml.txt.nlp	24563867	SENT101	3	3	24	24	buspirone	STZ	PA448689	6484	0.81
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT709	5	5	28	28	risperidone	Gen	PA451257	348654	0.81
NULL	Br_J_Cancer_2009_Jul_7_101(1)_38-47.nxml.txt.nlp	19513066	SENT27	4	4	12	12	dasatinib	p38	PA162372878	10598;1432;7965	0.81
NULL	Acta_Pharmacol_Sin_2011_Jul_20_32(7)_888-894.nxml.txt.nlp	21685926	SENT106	11	11	0	0	nadh	NDUFA10	PA164755085	4705	0.81
NULL	Iran_J_Basic_Med_Sci_2012_Nov-Dec_15(6)_1110-1126.nxml.txt.nlp	23653839	SENT262	21	21	40	40	fluorescein	CD31	PA164746009	5175	0.81
NULL	J_Cell_Biol_2001_Feb_19_152(4)_729-740.nxml.txt.nlp	11266464	SENT124	3	3	5	5	bleomycin	BLM	PA448645	641	0.81
NULL	Oncotarget_2013_Nov_24_4(12)_2430-2438.nxml.txt.nlp	24280348	SENT65	25	25	9	9	gefitinib	EGFR	PA131301952	1956	0.81
NULL	Adv_Urol_2010_Jul_20_2010_687043.nxml.txt.nlp	20721275	SENT106	16	16	25	25	bevacizumab	IFN	PA130232992	3439	0.81
NULL	Breast_Cancer_Res_2013_Oct_22_15(5)_R98.nxml.txt.nlp	24148581	SENT52	18	18	26	26	tamoxifen	aromatase	PA451581	1588	0.81
NULL	Oncoimmunology_2013_May_1_2(5)_e24520.nxml.txt.nlp	23762811	SENT308	30	30	11	11	mitoxantrone	aromatase	PA450526	1588	0.81
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT154	21	21	19	19	pp2	PP1		5540;5464	0.81
NULL	J_Headache_Pain_2008_Feb_24_9(1)_13-18.nxml.txt.nlp	18217199	SENT129	4	4	10	10	nortriptyline	CYP3A4	PA450657	1576	0.81
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT333	16	16	28	28	risperidone	PRL	PA451257	5617	0.81
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT182	0	0	12	12	tacrolimus	OPG	PA451578	690	0.81
NULL	Ann_Hematol_2011_May_12_90(5)_557-568.nxml.txt.nlp	20938660	SENT218	18	18	24	24	plerixafor	CD34	PA165958410	947	0.81
NULL	Cell_Commun_Signal_2013_Oct_1_11_73.nxml.txt.nlp	24083678	SENT20	8	8	18	18	sulindac	AP-1	PA451565	2353;3727;2354;3725	0.81
NULL	AIDS_Res_Treat_2011_Jun_7_2011_354908.nxml.txt.nlp	21716719	SENT226	0	0	14	14	tenofovir	POLG	PA10204	5428	0.81
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R91.nxml.txt.nlp	22541814	SENT238	24	24	27	27	thrombin	HO-1	PA451674	3162	0.81
NULL	Acta_Pharmacol_Sin_2011_Jul_9_32(7)_879-887.nxml.txt.nlp	21552292	SENT85	11	11	18	18	metformin	AMPK	PA450395	5563	0.81
NULL	Chem_Cent_J_2012_Jan_22_6_7.nxml.txt.nlp	22264235	SENT193	8	8	20	20	chloramphenicol	PC1	PA448927	5122	0.81
NULL	Orphanet_J_Rare_Dis_2014_Jul_15_9_89.nxml.txt.nlp	25022842	SENT67	23	23	7	7	choline	ATX	PA448976	5168;23049	0.81
NULL	Oncotarget_2014_Oct_21_5(22)_11252-11268.nxml.txt.nlp	25361004	SENT283	7	7	11	11	metformin	CLIC1	PA450395	1192	0.81
NULL	Acta_Orthop_2011_Apr_5_82(2)_211-216.nxml.txt.nlp	21434784	SENT50	6	6	16	16	methotrexate	ADM	PA450428	133	0.81
NULL	Cardiovasc_Psychiatry_Neurol_2011_Feb_16_2011_646958.nxml.txt.nlp	21350722	SENT114	20	20	28	28	calcein	ROS	PA132595336	6098	0.81
NULL	Oncoimmunology_2012_Mar_1_1(2)_214-216.nxml.txt.nlp	22720246	SENT37	6	6	26	26	imatinib	CD34	PA10804	947	0.81
NULL	Nat_Commun_2014_Dec_8_5_5736.nxml.txt.nlp	25484020	SENT233	13	13	3	3	letrozole	PAR2	PA450196	2150;55065;8856	0.81
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT336	0	0	7	7	trastuzumab	HER3	PA451743	2065	0.81
NULL	Channels_(Austin)_2010_Jan_1_4(1)_22-41.nxml.txt.nlp	19934650	SENT14	8	8	18	18	quinidine	Slo3	PA451209	157855	0.81
NULL	Breast_Cancer_Res_2005_Jan_26_7(2)_R256-R266.nxml.txt.nlp	15743506	SENT29	40	40	22	22	fluorouracil	HER-2	PA128406956	2064	0.81
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1699-1708.nxml.txt.nlp	19861960	SENT77	36	36	19	19	ethanol	mol	PA448073	90527	0.81
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT254	3	3	13	13	methotrexate	MSH2	PA450428	4436	0.81
NULL	Clin_Med_Insights_Oncol_2012_Mar_19_6_165-178.nxml.txt.nlp	22474408	SENT220	9	9	12	12	cisplatin	GM-CSF	PA449014	1437	0.81
NULL	Diabetes_2011_Nov_17_60(11)_2691-2700.nxml.txt.nlp	21896928	SENT33	12	12	7	7	resveratrol	SIRT1		23411	0.81
NULL	Cancer_Med_2014_Oct_2_3(5)_1256-1265.nxml.txt.nlp	24890382	SENT22	11	11	6	6	trastuzumab	DM1	PA451743	338023;1760;28509	0.81
NULL	Curr_Neuropharmacol_2012_Mar_10(1)_12-48.nxml.txt.nlp	22942876	SENT801	6	6	27	27	imipramine	mGlu1	PA449969	2911	0.81
NULL	Drug_Des_Devel_Ther_2014_Sep_18_8_1419-1427.nxml.txt.nlp	25258511	SENT66	16	16	22	22	naltrexone	POMC	PA450588	5443	0.81
NULL	Br_J_Cancer_2011_Jul_26_105(3)_372-381.nxml.txt.nlp	21730979	SENT162	12	12	16	16	cisplatin	ATR	PA449014	390502;84168;545	0.81
NULL	Nature_2012_Feb_22_483(7391)_618-622.nxml.txt.nlp	22367539	SENT122	26	26	7	7	fluorescein	UBC13	PA164746009	7334	0.81
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Apr_25_68(Pt_5)_o1527-o1528.nxml.txt.nlp	22590392	SENT3	11	11	28	28	phenol	mol	PA450913	90527	0.81
NULL	Cases_J_2009_Jul_30_2_7134.nxml.txt.nlp	19829918	SENT56	25	25	27	27	levodopa	LCE	PA450213	79071	0.81
NULL	Anticancer_Agents_Med_Chem_2012_Feb_12(2)_163-171.nxml.txt.nlp	22043994	SENT181	9	9	3	3	panitumumab	BRAF	PA162373091	673	0.81
NULL	Cancer_Cell_Int_2013_May_15_13_42.nxml.txt.nlp	23672670	SENT201	2	2	10	10	paclitaxel	RAIDD	PA450761	8738	0.81
NULL	Br_J_Cancer_2010_Nov_2_103(11)_1680-1691.nxml.txt.nlp	21045833	SENT186	8	8	34	34	vorinostat	p53	PA164748224	7157	0.81
NULL	Int_J_Mol_Sci_2012_Feb_24_13(3)_2578-2589.nxml.txt.nlp	22489112	SENT61	6	6	14	14	trimipramine	GAT1	PA451791	6529	0.81
NULL	Clin_Pharmacol_2011_Jun_22_3_13-25.nxml.txt.nlp	22287853	SENT188	28	28	10	10	saxagliptin	OATP1B1	PA165958362	10599	0.81
NULL	J_Cancer_2013_Jun_21_4(5)_391-401.nxml.txt.nlp	23833684	SENT168	4	4	1	1	trastuzumab	EC-1	PA451743	4819	0.81
NULL	Int_J_Mol_Sci_2012_Aug_23_13(8)_10608-10629.nxml.txt.nlp	22949883	SENT188	0	0	14	14	bromocriptine	NQO1	PA448671	1728	0.81
NULL	Biochem_Res_Int_2012_Feb_12_2012_346972.nxml.txt.nlp	22400115	SENT198	6	6	30	30	hyaluronan	MDR1	PA165958431	5243	0.81
NULL	Int_J_Biol_Sci_2011_Sep_8_7(8)_1077-1092.nxml.txt.nlp	21927577	SENT240	2	2	10	10	telmisartan	p47phox	PA451605	653361	0.81
NULL	Cancers_(Basel)_2014_Jul_22_6(3)_1540-1552.nxml.txt.nlp	25055117	SENT405	17	17	1	1	crizotinib	Met	PA165946122	79811	0.81
NULL	Mol_Cancer_2009_Nov_24_8_109.nxml.txt.nlp	19930708	SENT179	11	11	4	4	exemestane	aromatase	PA449563	1588	0.81
NULL	Clin_Ophthalmol_2009_Jun_2_3_291-295.nxml.txt.nlp	19668581	SENT58	25	25	27	27	latanoprost	BAK	PA164774763	578	0.81
NULL	Br_J_Pharmacol_2014_Feb_24_171(1)_1019-1032.nxml.txt.nlp	24251620	SENT279	12	12	9	9	nicardipine	TRPM3	PA450620	80036	0.81
NULL	Alcohol_Res_Health_2007_30(1)_48-54.nxml.txt.nlp	17718401	SENT102	9	9	26	26	ethanol	AP-1	PA448073	2353;3727;2354;3725	0.81
NULL	Cardiol_Res_Pract_2012_Jan_29_2012_852829.nxml.txt.nlp	22400124	SENT129	11	11	27	27	losartan	AT2	PA450268	186	0.81
NULL	Breast_Cancer_Res_2012_Dec_5_14(6)_R153.nxml.txt.nlp	23216744	SENT119	20	20	12	12	auranofin	SNO	PA448510	6498	0.81
NULL	Crit_Care_2008_Nov_12_12(6)_235.nxml.txt.nlp	19040780	SENT177	27	27	13	13	quinidine	CYP3A4	PA451209	1576	0.81
NULL	EMBO_Rep_2013_Nov_13_14(11)_1008-1016.nxml.txt.nlp	24030283	SENT129	17	17	3	3	l-glutamine	THP1	PA10090	2736	0.81
NULL	Curr_Chem_Genomics_2010_Dec_21_4_84-91.nxml.txt.nlp	21331312	SENT97	19	19	40	40	carbachol	RhoA	PA448784	387	0.81
NULL	Cell_Death_Dis_2013_Jun_13_4(6)_e663.nxml.txt.nlp	23764844	SENT125	21	21	0	0	iron	HIF1	PA450087	3091	0.81
NULL	Nucleic_Acids_Res_2011_Sep_27_39(16)_7249-7262.nxml.txt.nlp	21622951	SENT172	22	22	5	5	choline	ADAR	PA448976	103	0.81
NULL	Pediatr_Cardiol_2010_Jan_14_31(1)_90-95.nxml.txt.nlp	19915892	SENT40	35	35	21	21	palivizumab	Era	PA164748781	2099	0.81
NULL	Mol_Imaging_Biol_2009_Jul_31_11(4)_241-245.nxml.txt.nlp	19333655	SENT11	0	0	14	14	aprepitant	NK1	PA164747039	11126	0.81
NULL	J_Carcinog_Mutagen_2013_May_27_Suppl_14_S14-004.nxml.txt.nlp	25328816	SENT119	17	17	22	22	etoposide	TRAIL	PA449552	8743	0.81
NULL	Oncotarget_2013_Nov_4_5(1)_161-172.nxml.txt.nlp	24389287	SENT4	0	0	13	13	propranolol	MYCN	PA451145	4613	0.81
NULL	Ann_Rheum_Dis_2009_Jul_4_68(7)_1220-1227.nxml.txt.nlp	18772191	SENT132	8	8	14	14	abatacept	IL-6	PA164747080	3569	0.81
NULL	Acta_Physiol_(Oxf)_2012_Feb_204(2)_267-276.nxml.txt.nlp	21418147	SENT10	6	6	11	11	lipase	ABHD6	PA450239	57406	0.81
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT523	17	17	5	5	paliperidone	PRL	PA163518919	5617	0.81
NULL	Oncoscience_2014_Mar_12_1(2)_167-179.nxml.txt.nlp	25126591	SENT201	26	26	11	11	doxorubicin	TLE3	PA449412	7090	0.81
NULL	J_Neuroinflammation_2010_Sep_7_7_51.nxml.txt.nlp	20822529	SENT42	8	8	20	20	hemin	HO-1	PA449849	3162	0.81
NULL	J_Cell_Mol_Med_2013_Dec_6_17(12)_1588-1597.nxml.txt.nlp	24199964	SENT227	22	22	24	24	dobutamine	APT	PA449381	653639	0.81
NULL	Hum_Mol_Genet_2013_Nov_15_22(22)_4646-4652.nxml.txt.nlp	23825109	SENT161	29	29	16	16	l-glutamine	B27	PA10090	56246	0.81
NULL	Indian_J_Pharm_Sci_2014_Mar-Apr_76(2)_125-131.nxml.txt.nlp	24843185	SENT179	8	8	14	14	resveratrol	S100B		6285	0.81
NULL	J_Breast_Cancer_2011_Dec_27_14(4)_276-282.nxml.txt.nlp	22323913	SENT20	11	11	27	27	lapatinib	HER2	PA152241907	2064	0.81
NULL	Pharm_Methods_2011_Jul-Sep_2(3)_178-183.nxml.txt.nlp	23781452	SENT19	14	14	0	0	meloxicam	LOR	PA450353	4014	0.81
NULL	Biomed_Res_Int_2014_Jun_26_2014_964010.nxml.txt.nlp	25054157	SENT222	19	19	28	28	tacrolimus	San	PA451578	80218	0.81
NULL	Cancer_Manag_Res_2014_Sep_10_6_349-356.nxml.txt.nlp	25228821	SENT77	7	7	3	3	sunitinib	KIT	PA162372840	3815	0.81
NULL	Crit_Care_2011_Aug_11_15(4)_226.nxml.txt.nlp	21892977	SENT57	41	41	12	12	vasopressin	P2X2	PA451858	22953	0.81
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT207	40	40	21	21	sitagliptin	HIP	PA164748978	6767;6159;64399;5068	0.81
NULL	Eur_J_Med_Res_2009_Jul_22_14(7)_309-314.nxml.txt.nlp	19661014	SENT178	4	4	19	19	azithromycin	IL-8	PA448519	3576	0.81
NULL	Oncogenesis_2014_Dec_8_3(12)_e131.nxml.txt.nlp	25486523	SENT101	7	7	27	27	l-glutamine	CO2	PA10090	4513	0.81
NULL	Oncogene_2010_Sep_23_29(38)_5299-5310.nxml.txt.nlp	20622903	SENT101	15	15	4	4	melphalan	HMGB1	PA450354	3146	0.81
NULL	Lab_Invest_2011_Sep_23_91(9)_1396-1409.nxml.txt.nlp	21606925	SENT141	2	2	21	21	pp2	ZO-1		7082	0.81
NULL	Breast_Cancer_Res_2014_Sep_11_16(5)_430.nxml.txt.nlp	25212826	SENT341	14	14	37	37	fulvestrant	PTEN	PA164747170	5728	0.81
NULL	Open_Ophthalmol_J_2010_Jun_22_4_28-29.nxml.txt.nlp	20871754	SENT18	12	12	20	20	bevacizumab	San	PA130232992	80218	0.81
NULL	Indian_J_Pharmacol_2014_May-Jun_46(3)_281-285.nxml.txt.nlp	24987174	SENT69	15	15	0	0	sildenafil	SPAP	PA451346	10158	0.81
NULL	Int_J_Surg_Oncol_2012_Jun_12_2012_862879.nxml.txt.nlp	22778941	SENT15	8	8	28	28	cisplatin	BIN1	PA449014	274	0.81
NULL	Ann_Neurosci_2014_Jul_21(3)_97-103.nxml.txt.nlp	25206073	SENT223	15	15	12	12	bumetanide	NKCC1	PA448682	6558	0.81
NULL	Curr_Respir_Care_Rep_2014_Jul_6_3(3)_121-132.nxml.txt.nlp	25089228	SENT444	6	6	11	11	cilomilast	p38	PA165948031	10598;1432;7965	0.81
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT523	19	19	5	5	risperidone	PRL	PA451257	5617	0.81
NULL	Diabetes_Care_2011_Jun_20_34(6)_1406-1411.nxml.txt.nlp	21515837	SENT135	16	16	22	22	glucose	LVM	PA449773	23209	0.81
NULL	Iran_J_Pharm_Res_2014_Autumn_13(4)_1393-1401.nxml.txt.nlp	25587329	SENT128	22	22	28	28	naproxen	ABCG2	PA450595	9429	0.81
NULL	EMBO_Mol_Med_2013_Jan_29_5(1)_137-148.nxml.txt.nlp	23197407	SENT110	18	18	27	27	losartan	TR3	PA450268	8718;3164;10587	0.81
NULL	Br_J_Cancer_2009_Jul_7_101(1)_116-123.nxml.txt.nlp	19491899	SENT6	16	16	12	12	irinotecan	CRT	PA450085	811	0.81
NULL	Breast_Cancer_Res_2008_Jul_24_10(4)_211.nxml.txt.nlp	18671839	SENT81	31	31	24	24	tamoxifen	AP-1	PA451581	2353;3727;2354;3725	0.81
NULL	Pharm_Pract_(Granada)_2011_Mar_15_Jan-Mar_9(1)_1-10.nxml.txt.nlp	25132883	SENT60	1	1	28	28	dabigatran	TKR		8277	0.81
NULL	Oncotarget_2014_Feb_25_5(5)_1304-1314.nxml.txt.nlp	24675421	SENT32	26	26	9	9	cisplatin	RIP1	PA449014	10928;7386	0.81
NULL	Lipids_Health_Dis_2011_Jan_18_10_8.nxml.txt.nlp	21241519	SENT33	7	7	21	21	simvastatin	SR-BI	PA451363	949	0.81
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT146	5	5	12	12	perifosine	DR4	PA165291471	8797	0.81
NULL	Oncotarget_2014_Feb_25_5(5)_1304-1314.nxml.txt.nlp	24675421	SENT136	20	20	12	12	cisplatin	RIP1	PA449014	10928;7386	0.81
NULL	Theranostics_2013_Jun_25_3(7)_496-506.nxml.txt.nlp	23843897	SENT100	31	31	15	15	cetuximab	EGFR	PA10040	1956	0.81
NULL	Oncoimmunology_2013_Jan_1_2(1)_e22890.nxml.txt.nlp	23483066	SENT187	9	9	15	15	vemurafenib	IFN	PA165946873	3439	0.81
NULL	Endocrinol_Metab_(Seoul)_2013_Dec_12_28(4)_262-274.nxml.txt.nlp	24396690	SENT107	20	20	9	9	exenatide	GLP-1	PA164749238	100125288	0.81
NULL	Ann_Indian_Acad_Neurol_2010_Jan-Mar_13(1)_6-13.nxml.txt.nlp	20436740	SENT263	36	36	13	13	thrombin	P2Y12	PA451674	64805	0.81
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1033-1038.nxml.txt.nlp	22374460	SENT8	17	17	25	25	capecitabine	HER2	PA448771	2064	0.81
NULL	J_Biol_Chem_2013_Dec_6_288(49)_35387-35395.nxml.txt.nlp	24142790	SENT166	8	8	13	13	meclizine	PCYT2	PA450338	5833	0.81
NULL	Int_J_Biomed_Sci_2013_Sep_9(3)_153-161.nxml.txt.nlp	24170990	SENT180	4	4	13	13	bezafibrate	ABCA1	PA162364313	19	0.81
NULL	Breast_Cancer_Res_2011_Apr_21_13(2)_R46.nxml.txt.nlp	21510863	SENT34	14	14	10	10	maytansine	DM1	PA165291473	338023;1760;28509	0.81
NULL	J_Korean_Med_Sci_2007_Dec_20_22(6)_1055-1059.nxml.txt.nlp	18162722	SENT32	26	26	19	19	pantoprazole	ESD	PA450774	2098	0.81
NULL	Nat_Med_2010_Jun_23_16(6)_671-677.nxml.txt.nlp	20495567	SENT112	4	4	8	8	sorafenib	CREB3L2	PA7000	64764	0.81
NULL	Cancer_Med_2013_Jun_25_2(3)_277-285.nxml.txt.nlp	23930204	SENT40	18	18	11	11	bevacizumab	BRAF	PA130232992	673	0.81
NULL	Diabetes_Care_2012_Jun_11_35(6)_1364-1379.nxml.txt.nlp	22517736	SENT194	20	20	30	30	metformin	GLP-1	PA450395	100125288	0.81
NULL	Drugs_Context_2012_Nov_19_2012_212242.nxml.txt.nlp	24432031	SENT128	2	2	15	15	carmustine	IL-2	PA448810	3558	0.81
NULL	Curr_Cardiol_Rev_2012_Aug_8(3)_239-249.nxml.txt.nlp	22935021	SENT257	21	21	15	15	ticagrelor	P2Y12	PA165374673	64805	0.81
NULL	Diabetes_Care_2011_Jun_20_34(6)_e61-e99.nxml.txt.nlp	21617108	SENT699	9	9	23	23	nitroprusside	NOT	PA451406	4929	0.81
NULL	Iran_J_Pharm_Res_2014_Spring_13(2)_635-639.nxml.txt.nlp	25237359	SENT18	10	10	12	12	midazolam	CYP3A	PA450496	1574	0.81
NULL	Biomed_Res_Int_2014_Jun_25_2014_764981.nxml.txt.nlp	25057499	SENT126	6	6	18	18	sorafenib	AKT	PA7000	207	0.81
NULL	Drugs_Context_2012_Nov_19_2012_212242.nxml.txt.nlp	24432031	SENT129	6	6	9	9	famotidine	IL-2	PA449586	3558	0.81
NULL	Arthritis_Res_Ther_2014_Apr_11_16(2)_R93.nxml.txt.nlp	24725461	SENT39	13	13	22	22	estradiol	CYP19A1	PA449503	1588	0.81
NULL	Hum_Mol_Genet_2008_Aug_1_17(15)_2293-2309.nxml.txt.nlp	18424448	SENT205	25	25	10	10	estradiol	ESR1	PA449503	2099	0.81
NULL	F1000Prime_Rep_2014_Dec_1_6_117.nxml.txt.nlp	25580271	SENT54	6	6	19	19	erlotinib	EGFR	PA134687924	1956	0.81
NULL	Contemp_Oncol_(Pozn)_2012_Nov_20_16(5)_416-419.nxml.txt.nlp	23788920	SENT17	15	15	13	13	enoxaparin	CRT	PA449463	811	0.81
NULL	Arthritis_Res_Ther_2008_Jan_7_10(1)_R1.nxml.txt.nlp	18179697	SENT172	4	4	14	14	oxaliplatin	HMGB1	PA131285527	3146	0.81
NULL	Trials_2012_Aug_31_13_156.nxml.txt.nlp	22937736	SENT180	28	28	34	34	azithromycin	IL-6	PA448519	3569	0.81
NULL	J_Hum_Genet_2012_Jul_24_57(7)_459-464.nxml.txt.nlp	22622361	SENT91	4	4	15	15	heparin	CFHR5	PA449855	81494	0.81
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R91.nxml.txt.nlp	22541814	SENT44	4	4	23	23	thrombin	HO-1	PA451674	3162	0.81
NULL	Aging_(Albany_NY)_2014_Jan_14_6(1)_70-81.nxml.txt.nlp	24429382	SENT203	10	10	4	4	etoposide	WRN	PA449552	7486	0.81
NULL	Breast_Cancer_Res_2007_Aug_8_9(4)_R50.nxml.txt.nlp	17686159	SENT263	16	16	8	8	gefitinib	HRG	PA131301952	3084;3273	0.81
NULL	Cells_2014_Apr_29_3(2)_331-362.nxml.txt.nlp	24785347	SENT1069	3	3	0	0	lidocaine	TRPA1	PA450226	8989	0.81
NULL	Aging_(Albany_NY)_2011_Apr_4_3(4)_348-362.nxml.txt.nlp	21483040	SENT195	19	19	12	12	metformin	S6K1	PA450395	6198	0.81
NULL	Acta_Pharmacol_Sin_2012_Apr_12_33(4)_542-550.nxml.txt.nlp	22407228	SENT158	13	13	26	26	perifosine	ATG5	PA165291471	9474	0.81
NULL	Front_Neural_Circuits_2014_Sep_5_8_108.nxml.txt.nlp	25249942	SENT136	41	41	8	8	verapamil	rd1	PA451868	5158	0.81
NULL	J_Appl_Crystallogr_2014_Sep_4_47(Pt_5)_1606-1613.nxml.txt.nlp	25294980	SENT46	26	26	21	21	ethanol	mol	PA448073	90527	0.81
NULL	Br_J_Cancer_2009_Jul_21_101(2)_238-243.nxml.txt.nlp	19568242	SENT123	13	13	32	32	sunitinib	IFN	PA162372840	3439	0.81
NULL	Mol_Biol_Rep_2013_May_11_40(8)_5013-5026.nxml.txt.nlp	23666059	SENT257	10	10	19	19	resveratrol	MDM2		4193	0.81
NULL	Indian_Dermatol_Online_J_2014_Jul-Sep_5(3)_239-249.nxml.txt.nlp	25165638	SENT294	12	12	6	6	cyproheptadine	AMN	PA164749366	215;81693	0.81
NULL	Int_J_Mol_Sci_2007_Aug_2_8(8)_749-759.nxml.txt.nlp	NULL	SENT190	2	2	7	7	benzaldehyde	CO2	PA448571	4513	0.81
NULL	Cancer_Med_2014_Oct_2_3(5)_1385-1395.nxml.txt.nlp	24890702	SENT153	3	3	27	27	irinotecan	BRAF	PA450085	673	0.81
NULL	Ann_Rheum_Dis_2013_Apr_11_72(4)_583-589.nxml.txt.nlp	23144446	SENT151	31	31	37	37	tocilizumab	DREAM	PA165292659	30818	0.81
NULL	Mol_Brain_2014_Apr_21_7_28.nxml.txt.nlp	24751148	SENT135	2	2	14	14	minocycline	TLR4	PA450519	7099	0.81
NULL	Amino_Acids_2011_May_22_40(5)_1369-1383.nxml.txt.nlp	21424716	SENT107	13	13	27	27	creatine	CEE	PA164778930	51608	0.81
NULL	Indian_J_Pharm_Sci_2014_Jan-Feb_76(1)_72-77.nxml.txt.nlp	24799741	SENT41	14	14	24	24	glimepiride	CYP2C9	PA449761	1559	0.81
NULL	Oncotarget_2013_Nov_23_5(1)_196-210.nxml.txt.nlp	24344116	SENT180	9	9	3	3	doxorubicin	p53	PA449412	7157	0.81
NULL	Oncotarget_2013_Nov_22_5(4)_933-943.nxml.txt.nlp	24659749	SENT123	10	10	0	0	nutlin-3	p53		7157	0.81
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Jul_23_3(7)_e126.nxml.txt.nlp	25054314	SENT206	9	9	1	1	paclitaxel	MRP2	PA450761	100130958;57626;1244	0.81
NULL	Front_Psychiatry_2014_Jul_31_5_92.nxml.txt.nlp	25132823	SENT645	10	10	3	3	methamphetamine	CB1	PA450403	1268	0.81
NULL	J_Adv_Pharm_Technol_Res_2011_Jan-Mar_2(1)_51-55.nxml.txt.nlp	22171293	SENT80	2	2	9	9	metformin	mol	PA450395	90527	0.81
NULL	Iran_Red_Crescent_Med_J_2014_Jul_5_16(7)_e16664.nxml.txt.nlp	25237570	SENT207	12	12	8	8	olmesartan	AT1	PA164742950	9197;185	0.81
NULL	Ther_Clin_Risk_Manag_2006_Sep_2(3)_235-249.nxml.txt.nlp	18360599	SENT300	13	13	10	10	alendronate	PTH	PA448082	5741	0.81
NULL	Mol_Cancer_2012_Dec_10_11_88.nxml.txt.nlp	23227827	SENT172	5	5	29	29	trypsin	FBS	PA451806	64319;26269	0.81
NULL	J_Immunother_Cancer_2014_Feb_24_2(Suppl_1)_O1.nxml.txt.nlp	NULL	SENT10	15	15	10	10	bortezomib	DLL1	PA10252	28514	0.81
NULL	Front_Mol_Neurosci_2012_Mar_15_5_33.nxml.txt.nlp	22435049	SENT13	4	4	14	14	haloperidol	AKT1	PA449841	207	0.81
NULL	J_Clin_Biochem_Nutr_2010_Jan_29_46(1)_1-13.nxml.txt.nlp	20104259	SENT85	33	33	16	16	pp2	NAC		22861	0.81
NULL	Aging_(Albany_NY)_2009_Jun_3_1(6)_515-528.nxml.txt.nlp	20157535	SENT65	33	33	21	21	resveratrol	SIRT1		23411	0.81
NULL	Oncotarget_2011_Jan_25_2(1-2)_8-17.nxml.txt.nlp	21378407	SENT34	3	3	13	13	thrombin	PAR-1	PA451674	2011;2149	0.81
NULL	Gastroenterol_Hepatol_Bed_Bench_2013_Winter_6(1)_6-13.nxml.txt.nlp	24834238	SENT68	8	8	3	3	panitumumab	BRAF	PA162373091	673	0.81
NULL	Environ_Health_Perspect_2005_Jan_30_113(1)_17-24.nxml.txt.nlp	15626642	SENT144	0	0	3	3	verapamil	P-gp	PA451868	5243	0.81
NULL	Br_J_Cancer_2012_Jan_3_106(1)_32-38.nxml.txt.nlp	22108523	SENT137	31	31	37	37	trastuzumab	HER2	PA451743	2064	0.81
NULL	Int_J_Biol_Sci_2013_Dec_22_10(1)_90-102.nxml.txt.nlp	24391455	SENT197	31	31	2	2	mechlorethamine	MKP-1	PA450336	1843	0.81
NULL	ScientificWorldJournal_2013_Jun_19_2013_174392.nxml.txt.nlp	23853530	SENT174	18	18	7	7	doxazosin	c-FLIP	PA449407	8837	0.81
NULL	EJNMMI_Res_2011_Nov_10_1_25.nxml.txt.nlp	22214344	SENT50	19	19	14	14	carbidopa	COMT	PA448794	1312	0.81
NULL	Am_J_Trop_Med_Hyg_2014_Oct_1_91(4)_833-843.nxml.txt.nlp	25048375	SENT145	13	13	17	17	artesunate	ACT	PA165111697	12;11332;9457;641455	0.81
NULL	Bone_Marrow_Res_2011_Jul_13_2011_303487.nxml.txt.nlp	22046559	SENT281	5	5	23	23	thiotepa	CD34	PA451668	947	0.81
NULL	Front_Behav_Neurosci_2011_Oct_5_5_63.nxml.txt.nlp	22007164	SENT1366	9	9	1	1	phencyclidine	CB1	PA128406980	1268	0.81
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1063.nxml.txt.nlp	24556678	SENT14	6	6	21	21	thioridazine	c-FLIP	PA451666	8837	0.81
NULL	J_Psychopharmacol_2010_Jan_24(1)_27-38.nxml.txt.nlp	19204064	SENT340	4	4	0	0	amphetamine	NK-1	PA448408	27087	0.81
NULL	Mol_Biol_Cell_2012_Nov_15_23(22)_4373-4382.nxml.txt.nlp	22993213	SENT96	17	17	0	0	ethanol	NDE1	PA448073	54820	0.81
NULL	Aging_(Albany_NY)_2010_Sep_18_2(9)_535-537.nxml.txt.nlp	20876940	SENT15	7	7	30	30	doxorubicin	CDKN1A	PA449412	1026	0.81
NULL	Cancer_Immunol_Immunother_2012_Jul_23_61(7)_1101-1111.nxml.txt.nlp	22193989	SENT168	26	26	15	15	oxaliplatin	IFN	PA131285527	3439	0.81
NULL	Dement_Geriatr_Cogn_Dis_Extra_2012_Aug_16_2(1)_304-311.nxml.txt.nlp	22962554	SENT12	12	12	23	23	celecoxib	APOE	PA448871	348	0.81
NULL	Br_J_Pharmacol_2014_May_171(10)_2659-2670.nxml.txt.nlp	24116661	SENT318	11	11	3	3	naringenin	TRPP2	PA151958361	5311	0.81
NULL	Br_J_Cancer_2009_Jul_21_101(2)_269-277.nxml.txt.nlp	19603033	SENT156	13	13	25	25	cisplatin	MLH1	PA449014	4292	0.81
NULL	Cancer_Cell_Int_2009_Jan_8_9_3.nxml.txt.nlp	19128511	SENT96	33	33	20	20	oxaliplatin	PI3K	PA131285527	5290	0.81
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT135	5	5	25	25	atorvastatin	PI3K	PA448500	5290	0.81
NULL	Ann_Rheum_Dis_2013_Aug_21_72(8)_1287-1294.nxml.txt.nlp	22915624	SENT186	42	42	27	27	abatacept	MRI	PA164747080	78996	0.81
NULL	Evid_Based_Complement_Alternat_Med_2011_May_24_2011_841564.nxml.txt.nlp	21716682	SENT112	28	28	11	11	epirubicin	p38	PA449476	10598;1432;7965	0.81
NULL	Oxid_Med_Cell_Longev_2012_Jan_19_2012_390678.nxml.txt.nlp	22315655	SENT55	9	9	11	11	gliclazide	NAC	PA10892	22861	0.81
NULL	Br_J_Cancer_1998_Nov_78(9)_1170-1174.nxml.txt.nlp	9820175	SENT13	12	12	21	21	paclitaxel	CYP1A2	PA450761	1544	0.81
NULL	Mol_Vis_2007_Apr_5_13_578-587.nxml.txt.nlp	17438523	SENT190	8	8	26	26	staurosporine	BiP	PA165109623	3309	0.81
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT94	24	24	26	26	curcumin	TRAIL	PA151958596	8743	0.81
NULL	Nucleic_Acids_Res_2013_Nov_16_41(20)_9349-9360.nxml.txt.nlp	23956219	SENT202	25	25	6	6	cisplatin	RMI1	PA449014	80010	0.81
NULL	Acta_Diabetol_2012_Feb_15_49(1)_17-24.nxml.txt.nlp	21234613	SENT0	17	17	10	10	glucose	adiponectin	PA449773	9370	0.81
NULL	Curr_Hepat_Rep_2010_Nov_26_9(4)_231-238.nxml.txt.nlp	20949114	SENT15	24	24	2	2	tenofovir	IFN	PA10204	3439	0.81
NULL	Mol_Vis_2012_Oct_5_18_2454-2467.nxml.txt.nlp	23077404	SENT192	9	9	4	4	bevacizumab	HIF-1	PA130232992	29072	0.81
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_19_2013_746486.nxml.txt.nlp	23861712	SENT148	24	24	9	9	irinotecan	UGT1A1	PA450085	54658	0.81
NULL	Br_J_Cancer_2009_Mar_10_100(5)_834-839.nxml.txt.nlp	19174821	SENT108	15	15	19	19	amoxicillin	TMP	PA448406	2012	0.81
NULL	Cell_Death_Dis_2014_Jul_3_5(7)_e1316.nxml.txt.nlp	24991768	SENT28	4	4	22	22	pemetrexed	ATF3	PA10810	467	0.81
NULL	Pharmaceuticals_(Basel)_2012_Aug_30_5(9)_890-898.nxml.txt.nlp	24280696	SENT51	30	30	36	36	geldanamycin	Hsp90	PA152031327	3320	0.81
NULL	Mol_Cell_Biochem_2014_Jul_26_396(1-2)_221-228.nxml.txt.nlp	25063218	SENT5	10	10	33	33	resveratrol	EGFR		1956	0.81
NULL	Cancer_Immunol_Immunother_2012_Jul_23_61(7)_1101-1111.nxml.txt.nlp	22193989	SENT108	5	5	12	12	oxaliplatin	IFN	PA131285527	3439	0.81
NULL	Physiol_Rep_2014_Sep_4_2(9)_e12136.nxml.txt.nlp	25194023	SENT43	0	0	14	14	pancuronium	SNA	PA450771	6615	0.81
NULL	Onco_Targets_Ther_2014_Dec_3_7_2227-2236.nxml.txt.nlp	25506226	SENT105	32	32	43	43	trastuzumab	ADC	PA451743	113451	0.81
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT166	42	42	1	1	trastuzumab	STAT3	PA451743	6774	0.81
NULL	Int_J_Mol_Cell_Med_2014_Summer_3(3)_183-189.nxml.txt.nlp	25317405	SENT95	4	4	15	15	estradiol	ARC	PA449503	8996;23237	0.81
NULL	Ann_Lab_Med_2012_Jul_20_32(4)_298-303.nxml.txt.nlp	22779073	SENT86	21	21	37	37	ciprofloxacin	EMB	PA449009	133418	0.81
NULL	Exp_Diabetes_Res_2009_Dec_28_2009_278762.nxml.txt.nlp	20069052	SENT64	9	9	18	18	glimepiride	SUR1	PA449761	6833	0.81
NULL	Sensors_(Basel)_2011_May_4_11(5)_4990-5004.nxml.txt.nlp	22163886	SENT73	33	33	2	2	oxygen	CFD	PA450744	1675	0.81
NULL	Cancers_(Basel)_2014_Aug_12_6(3)_1631-1669.nxml.txt.nlp	25119536	SENT1244	7	7	3	3	imatinib	IFN	PA10804	3439	0.81
NULL	Nat_Med_2011_May_1_17(5)_604-609.nxml.txt.nlp	21532597	SENT60	7	7	9	9	daclizumab	IL-2	PA164764446	3558	0.81
NULL	Ther_Clin_Risk_Manag_2006_Jun_2(2)_129-158.nxml.txt.nlp	18360588	SENT216	0	0	5	5	warfarin	CYP3A4	PA451906	1576	0.81
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT44	23	23	20	20	nutlin-3	p53		7157	0.81
NULL	Mol_Cancer_2010_Dec_20_9_317.nxml.txt.nlp	21172025	SENT229	11	11	13	13	tamoxifen	TXNIP	PA451581	10628	0.81
NULL	Biologics_2013_Apr_15_7_77-90.nxml.txt.nlp	23723688	SENT78	11	11	22	22	cetuximab	CRT	PA10040	811	0.81
NULL	Eur_J_Histochem_2010_Jun_14_54(2)_e15.nxml.txt.nlp	20558338	SENT150	18	18	25	25	flutamide	PD2	PA449685	54623	0.81
NULL	Acta_Pharmacol_Sin_2010_Nov_18_31(11)_1447-1453.nxml.txt.nlp	20953204	SENT104	13	13	11	11	rimonabant	IL-6	PA152407999	3569	0.81
NULL	Eur_J_Nutr_2015_Oct_9_54_1-24.nxml.txt.nlp	25296886	SENT171	10	10	0	0	galactose	GLUT8	PA449725	29988;154091	0.81
NULL	Mol_Cancer_2010_May_18_9_110.nxml.txt.nlp	20482802	SENT31	15	15	8	8	chymotrypsin	PSMB5	PA448994	5693	0.81
NULL	J_Hum_Genet_2013_Jun_16_58(6)_353-361.nxml.txt.nlp	23677058	SENT175	14	14	9	9	cytarabine	SLC28A3	PA449177	64078	0.81
NULL	Indian_J_Pharmacol_2012_Sep-Oct_44(5)_566-570.nxml.txt.nlp	23112414	SENT139	11	11	27	27	losartan	ALP	PA450268	6590;10850;27295;80150;470;26033	0.81
NULL	Diabetes_Care_2010_Jan_33(Suppl_1)_S11-S61.nxml.txt.nlp	20042772	SENT1972	16	16	8	8	rosiglitazone	DREAM	PA451283	30818	0.81
NULL	Mol_Cytogenet_2013_Sep_20_6_39.nxml.txt.nlp	24053143	SENT8	23	23	8	8	imatinib	ETV6	PA10804	2120	0.81
NULL	Eur_J_Clin_Pharmacol_2007_Apr_21_63(4)_335-343.nxml.txt.nlp	17318526	SENT231	7	7	3	3	warfarin	GGCX	PA451906	2677	0.81
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Aug_11_66(Pt_9)_o2297-o2298.nxml.txt.nlp	21588649	SENT5	1	1	23	23	nifedipine	mol	PA450631	90527	0.81
NULL	Breast_Cancer_Res_2012_Jul_6_14(4)_R102.nxml.txt.nlp	22770227	SENT154	6	6	8	8	tamoxifen	aromatase	PA451581	1588	0.81
NULL	Br_J_Haematol_2008_Mar_3_144(5)_677-685.nxml.txt.nlp	19055662	SENT20	7	7	15	15	cyclophosphamide	CHOP	PA449165	1649	0.81
NULL	Biologics_2009_Oct_12_3_469-474.nxml.txt.nlp	19851472	SENT98	34	34	6	6	mometasone	IL-5	PA450541	3567	0.81
NULL	Clin_Pharmacokinet_2014_Sep_3_53(1)_1-16.nxml.txt.nlp	23999929	SENT288	38	38	24	24	rivaroxaban	CYP3A4	PA165958360	1576	0.81
NULL	Indian_J_Ophthalmol_2009_May-Jun_57(3)_234-236.nxml.txt.nlp	19384023	SENT55	10	10	3	3	clonazepam	ACTH	PA449050	5443	0.81
NULL	Cell_Cycle_2013_Sep_15_12(18)_3013-3024.nxml.txt.nlp	23974104	SENT134	5	5	21	21	disulfiram	CD24	PA449376	100133941	0.81
NULL	Cancer_Med_2012_Aug_15_1(1)_28-38.nxml.txt.nlp	23342251	SENT242	18	18	4	4	pertuzumab	HER3		2065	0.81
NULL	J_Physiol_2011_Aug_1_589(Pt_15)_3691-3702.nxml.txt.nlp	21669978	SENT80	26	26	34	34	choline	IPL	PA448976	7262	0.81
NULL	Int_J_Breast_Cancer_2011_Jan_20_2011_807380.nxml.txt.nlp	22332017	SENT75	0	0	21	21	clotrimazole	ABCC11	PA449057	85320	0.81
NULL	Eur_J_Pharmacol_2008_Feb_12_580(3-3)_291-297.nxml.txt.nlp	18082160	SENT340	7	7	11	11	granisetron	5-HT3A	PA449809	3359	0.81
NULL	BMB_Rep_2013_Aug_46(8)_410-415.nxml.txt.nlp	23977989	SENT8	4	4	26	26	curcumin	HO-1	PA151958596	3162	0.81
NULL	J_Gen_Intern_Med_2009_May_21_24(5)_656-664.nxml.txt.nlp	19306050	SENT517	16	16	13	13	warfarin	CYP2C9	PA451906	1559	0.81
NULL	Philos_Trans_A_Math_Phys_Eng_Sci_2014_Dec_28_372(2031)_20140055.nxml.txt.nlp	25404673	SENT241	24	24	14	14	ethanol	CO2	PA448073	4513	0.81
NULL	Database_(Oxford)_2014_Dec_23_2014_bau124.nxml.txt.nlp	25539768	SENT320	6	6	21	21	metformin	LKB1	PA450395	6794	0.81
NULL	Mol_Cancer_2010_Oct_12_9_269.nxml.txt.nlp	20939893	SENT211	8	8	15	15	isoproterenol	STAT3	PA450121	6774	0.81
NULL	Br_J_Cancer_2010_Jul_13_103(2)_186-195.nxml.txt.nlp	20588277	SENT167	15	15	44	44	nutlin-3	p53		7157	0.81
NULL	J_Biol_Chem_2009_Aug_7_284(32)_21347-21359.nxml.txt.nlp	19520849	SENT168	17	17	12	12	s-adenosylmethionine	PRMT5	PA164754994	10419	0.81
NULL	Mol_Brain_2014_Apr_21_7_28.nxml.txt.nlp	24751148	SENT146	3	3	12	12	minocycline	p65	PA450519	5970	0.81
NULL	Case_Rep_Endocrinol_2013_Dec_22_2013_675298.nxml.txt.nlp	24455332	SENT38	3	3	26	26	cisplatin	ACTH	PA449014	5443	0.81
NULL	Breast_Cancer_Res_Treat_2014_Apr_6_145(1)_33-44.nxml.txt.nlp	24706169	SENT53	9	9	2	2	trastuzumab	HER2	PA451743	2064	0.81
NULL	J_Korean_Med_Sci_2010_Jun_24_25(6)_829-834.nxml.txt.nlp	20514301	SENT107	4	4	34	34	papain	p38	PA450778	10598;1432;7965	0.81
NULL	Int_J_Bipolar_Disord_2013_Jul_4_1_10.nxml.txt.nlp	25505677	SENT130	14	14	4	4	quetiapine	NNT	PA451201	23530	0.81
NULL	Chem_Res_Toxicol_2013_Oct_21_26(10)_1570-1578.nxml.txt.nlp	24047243	SENT492	22	22	6	6	estradiol	UGT1A8	PA449503	54576	0.81
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT233	24	24	21	21	doxorubicin	B7-H1	PA449412	29126	0.81
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Feb_10_68(Pt_3)_o661.nxml.txt.nlp	22412563	SENT4	6	6	20	20	arteether	mol	PA165260403	90527	0.81
NULL	J_Cancer_Prev_2013_Jun_18(2)_186-191.nxml.txt.nlp	25337545	SENT102	37	37	1	1	curcumin	STAT3	PA151958596	6774	0.81
NULL	Oncotarget_2014_Jun_3_5(13)_4920-4928.nxml.txt.nlp	24952482	SENT132	7	7	15	15	crizotinib	ALK	PA165946122	238	0.81
NULL	J_Cell_Biol_2002_Sep_16_158(6)_1017-1027.nxml.txt.nlp	12221072	SENT49	0	0	13	13	methotrexate	TOM	PA450428	24148	0.81
NULL	Acta_Pharmacol_Sin_2013_Oct_7_34(10)_1359-1366.nxml.txt.nlp	23933653	SENT4	14	14	21	21	retigabine	KCNQ2	PA144997862	3785	0.81
NULL	Environ_Health_Perspect_2005_Aug_15_113(8)_1009-1014.nxml.txt.nlp	16079071	SENT12	17	17	11	11	losartan	p38	PA450268	10598;1432;7965	0.81
NULL	Cancer_Med_2013_Apr_6_2(2)_234-242.nxml.txt.nlp	23634291	SENT163	23	23	10	10	bevacizumab	VEGF-D	PA130232992	2277	0.81
NULL	Cancer_Med_2014_Oct_2_3(5)_1385-1395.nxml.txt.nlp	24890702	SENT153	8	8	27	27	leucovorin	BRAF	PA450198	673	0.81
NULL	J_Infect_Dis_2012_Jul_15_206(2)_229-237.nxml.txt.nlp	22291195	SENT144	8	8	16	16	pentamidine	B28	PA450850	54069	0.81
NULL	J_Cell_Biol_2005_Jul_4_170(1)_61-72.nxml.txt.nlp	15998799	SENT644	6	6	14	14	geldanamycin	PP1	PA152031327	5540;5464	0.81
NULL	Iran_J_Reprod_Med_2012_Jan_10(1)_33-40.nxml.txt.nlp	25242972	SENT182	24	24	4	4	letrozole	aromatase	PA450196	1588	0.81
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1067-1070.nxml.txt.nlp	21386841	SENT81	8	8	24	24	capecitabine	STZ	PA448771	6484	0.81
NULL	Br_J_Pharmacol_2013_Jun_27_169(4)_736-747.nxml.txt.nlp	23489111	SENT122	11	11	25	25	granisetron	5-HT3A	PA449809	3359	0.81
NULL	J_Anim_Sci_Biotechnol_2013_Jun_26_4(1)_23.nxml.txt.nlp	23800120	SENT54	8	8	4	4	estradiol	ESR1	PA449503	2099	0.81
NULL	Cancers_(Basel)_2010_Dec_29_3(1)_79-90.nxml.txt.nlp	24212607	SENT110	28	28	12	12	gemcitabine	CHK1	PA449748	1111	0.81
NULL	J_Biomed_Sci_2014_Feb_12_21(1)_14.nxml.txt.nlp	24521134	SENT52	8	8	3	3	heparin	PSGL-1	PA449855	6404	0.81
NULL	Iran_J_Basic_Med_Sci_2013_Apr_16(4)_610-614.nxml.txt.nlp	24250937	SENT59	2	2	15	15	coumarin	CYP2A6	PA134521193	1548	0.81
NULL	Trials_2014_Sep_7_15(1)_352.nxml.txt.nlp	NULL	SENT72	0	0	23	23	atorvastatin	PMI	PA448500	8834;5373	0.81
NULL	Adv_Hematol_2011_Apr_10_2011_960137.nxml.txt.nlp	21547266	SENT68	8	8	31	31	rituximab	NHL	PA451261	51750	0.81
NULL	Front_Mol_Neurosci_2013_Apr_10_6_7.nxml.txt.nlp	23596389	SENT285	17	17	11	11	furosemide	KCC2	PA449719	57468	0.81
NULL	J_Exp_Clin_Cancer_Res_2009_Jun_16_28(1)_83.nxml.txt.nlp	19531250	SENT23	9	9	11	11	gemcitabine	GEM	PA449748	2669	0.81
NULL	J_Exp_Clin_Cancer_Res_2010_Aug_11_29(1)_110.nxml.txt.nlp	20701792	SENT29	30	30	4	4	staurosporine	CSE1L	PA165109623	1434	0.81
NULL	Br_J_Cancer_2012_Aug_21_107(5)_793-799.nxml.txt.nlp	22850551	SENT22	5	5	13	13	trastuzumab	San	PA451743	80218	0.81
NULL	Acta_Pharmacol_Sin_2009_Nov_5_30(11)_1505-1512.nxml.txt.nlp	19890358	SENT131	4	4	0	0	metformin	AMPK	PA450395	5563	0.81
NULL	J_Inherit_Metab_Dis_2013_Mar_13_36(2)_363-371.nxml.txt.nlp	22971959	SENT84	6	6	9	9	gentamicin	ARSB	PA449753	411	0.81
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_39-54.nxml.txt.nlp	19305787	SENT233	19	19	9	9	ethanol	PP1	PA448073	5540;5464	0.81
NULL	Clin_Pharmacokinet_2014_Sep_3_53(1)_1-16.nxml.txt.nlp	23999929	SENT279	3	3	6	6	rivaroxaban	CYP3A4	PA165958360	1576	0.81
NULL	Oncotarget_2014_Jun_6_5(13)_4929-4934.nxml.txt.nlp	24952635	SENT83	13	13	9	9	thioridazine	PI3K	PA451666	5290	0.81
NULL	J_Gastrointest_Surg_2013_Jun_18_17(11)_1997-2006.nxml.txt.nlp	23775094	SENT4	29	29	4	4	imatinib	KIT	PA10804	3815	0.81
NULL	Nat_Commun_2014_Aug_6_5_4602.nxml.txt.nlp	25098764	SENT639	25	25	17	17	chloroquine	HGK	PA448948	9448	0.81
NULL	J_Cell_Mol_Med_2014_Dec_9_18(12)_2499-2511.nxml.txt.nlp	24912879	SENT293	12	12	7	7	docetaxel	DACH1	PA449383	1602	0.81
NULL	Front_Physiol_2013_Nov_14_4_323.nxml.txt.nlp	24294204	SENT94	32	32	4	4	bisoprolol	CYP1A2	PA448641	1544	0.81
NULL	Br_J_Pharmacol_2014_Feb_24_171(1)_1019-1032.nxml.txt.nlp	24251620	SENT116	2	2	5	5	nifedipine	TRPM3	PA450631	80036	0.81
NULL	Oncogene_2009_Dec_3_28(48)_4306-4316.nxml.txt.nlp	19749790	SENT162	17	17	13	13	heparin	FGF1	PA449855	2246	0.81
NULL	Int_J_Mol_Sci_2014_Mar_11_15(3)_4299-4317.nxml.txt.nlp	24619224	SENT185	28	28	20	20	streptomycin	FBS	PA451512	64319;26269	0.81
NULL	J_Gen_Intern_Med_2009_May_26_24(5)_690-691.nxml.txt.nlp	19322614	SENT8	23	23	14	14	warfarin	CYP2C9	PA451906	1559	0.81
NULL	Crit_Care_2010_Aug_5_14(4)_R150.nxml.txt.nlp	20687920	SENT99	14	14	20	20	dextran	CARS	PA449261	833	0.81
NULL	Cancer_Immunol_Immunother_2011_Jan_22_60(1)_37-47.nxml.txt.nlp	20859626	SENT71	17	17	40	40	fluorescein	CD54	PA164746009	3383	0.809
NULL	Cancer_Med_2013_Feb_3_2(1)_76-85.nxml.txt.nlp	24133630	SENT197	18	18	9	9	vemurafenib	P-gp	PA165946873	5243	0.809
NULL	Evid_Based_Complement_Alternat_Med_2014_May_8_2014_494528.nxml.txt.nlp	24949077	SENT5	10	10	12	12	cyclophosphamide	CTX	PA449165	1593	0.809
NULL	Indian_J_Dermatol_2012_Mar-Apr_57(2)_157-158.nxml.txt.nlp	22615522	SENT26	9	9	5	5	doxorubicin	CHOP	PA449412	1649	0.809
NULL	Int_J_Biol_Sci_2015_Jan_1_11(2)_144-155.nxml.txt.nlp	25561897	SENT24	21	21	8	8	epirubicin	POLB	PA449476	5423	0.809
NULL	J_Biol_2003_Sep_24_2(4)_28.nxml.txt.nlp	14511394	SENT129	13	13	4	4	phenformin	LKB1	PA1000	6794	0.809
NULL	Oxid_Med_Cell_Longev_2013_Nov_28_2013_568093.nxml.txt.nlp	24379901	SENT79	0	0	15	15	resveratrol	AMPK		5563	0.809
NULL	J_Biol_Chem_2012_Apr_27_287(18)_14644-14658.nxml.txt.nlp	22375002	SENT80	24	24	18	18	neomycin	CC2D1A	PA450608	54862	0.809
NULL	Breast_Cancer_Res_2011_Dec_16_13(6)_R131.nxml.txt.nlp	22177475	SENT275	35	35	21	21	gefitinib	HER2	PA131301952	2064	0.809
NULL	Breast_Cancer_Res_2014_Jul_29_16(4)_412.nxml.txt.nlp	25410383	SENT329	10	10	22	22	bevacizumab	Hsp90	PA130232992	3320	0.809
NULL	Arthritis_Res_Ther_2013_Jan_23_15(1)_R19.nxml.txt.nlp	23343403	SENT109	11	11	3	3	paraformaldehyde	CCN4	PA450790	8840	0.809
NULL	Antimicrob_Agents_Chemother_2013_Oct_57(10)_4882-4893.nxml.txt.nlp	23877697	SENT252	15	15	0	0	tetracycline	CARP1	PA451640	55749	0.809
NULL	Mol_Cancer_2012_Jul_25_11_46.nxml.txt.nlp	22830422	SENT86	17	17	30	30	rolipram	ZO-1	PA153906323	7082	0.809
NULL	Clinics_(Sao_Paulo)_2012_Sep_67(9)_1093-1099.nxml.txt.nlp	23018309	SENT179	3	3	17	17	sorafenib	Mcl-1	PA7000	4170	0.809
NULL	Diabetes_Metab_J_2013_Feb_15_37(1)_72-80.nxml.txt.nlp	23439802	SENT29	10	10	4	4	vildagliptin	GLP-1	PA165958346	100125288	0.809
NULL	J_Exp_Med_2000_Mar_6_191(5)_859-870.nxml.txt.nlp	10704466	SENT38	16	16	4	4	neomycin	p38	PA450608	10598;1432;7965	0.809
NULL	Nat_Med_2011_May_1_17(5)_604-609.nxml.txt.nlp	21532597	SENT74	12	12	18	18	daclizumab	IL-2	PA164764446	3558	0.809
NULL	Front_Neurosci_2014_Jan_10_7_270.nxml.txt.nlp	24454277	SENT87	6	6	8	8	resveratrol	SIRT1		23411	0.809
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_55-78.nxml.txt.nlp	19305788	SENT819	32	32	19	19	loperamide	mGlu5	PA450262	2915	0.809
NULL	Infect_Dis_Ther_2014_Dec_5_3(2)_69-81.nxml.txt.nlp	25475412	SENT80	29	29	24	24	colistin	DAP	PA164760862	23549;3375;1611	0.809
NULL	Nature_2012_Apr_25_484(7395)_524-528.nxml.txt.nlp	22538616	SENT117	5	5	9	9	ciprofloxacin	PD1	PA449009	9825;6622;5133	0.809
NULL	Breast_Cancer_Res_2007_Jul_5_9(4)_R41.nxml.txt.nlp	17612393	SENT192	12	12	18	18	indomethacin	PGD2	PA449982	27306	0.809
NULL	J_Thorac_Oncol_2015_Jan_29_10(1)_156-163.nxml.txt.nlp	25247337	SENT263	41	41	23	23	gefitinib	BSC	PA131301952	6558	0.809
NULL	Ann_Pediatr_Endocrinol_Metab_2013_Dec_31_18(4)_161-167.nxml.txt.nlp	24904871	SENT124	0	0	3	3	exenatide	GLP-1	PA164749238	100125288	0.809
NULL	J_Hematol_Oncol_2013_Mar_27_6_23.nxml.txt.nlp	23531342	SENT102	32	32	40	40	cisplatin	RITA	PA449014	55422;84934	0.809
NULL	Cell_Death_Dis_2014_Mar_13_5(3)_e1119.nxml.txt.nlp	24625978	SENT119	10	10	25	25	hyaluronan	HAPLN1	PA165958431	1404	0.809
NULL	Br_J_Cancer_2011_Mar_1_104(5)_750-755.nxml.txt.nlp	21326243	SENT127	8	8	34	34	temozolomide	MPG	PA451609	4350	0.809
NULL	Gastric_Cancer_2014_Dec_8_17(4)_630-637.nxml.txt.nlp	24318670	SENT192	8	8	27	27	leucovorin	BRAF	PA450198	673	0.809
NULL	BMJ_2010_Feb_8_340_c693.nxml.txt.nlp	20142325	SENT258	27	27	45	45	desipramine	CYP1A2	PA449233	1544	0.809
NULL	Acta_Pharmacol_Sin_2011_Nov_10_32(11)_1402-1410.nxml.txt.nlp	21986579	SENT122	4	4	36	36	curcumin	CDK2	PA151958596	1017	0.809
NULL	Cancer_Cell_Int_2012_Jun_18_12_30.nxml.txt.nlp	22709569	SENT59	17	17	6	6	cisplatin	CALM1	PA449014	801	0.809
NULL	Iran_J_Pharm_Res_2015_Winter_14(1)_321-328.nxml.txt.nlp	25561938	SENT105	21	21	25	25	forskolin	VASP	PA146096022	7408	0.809
NULL	J_Cell_Biol_2001_Apr_30_153(3)_613-620.nxml.txt.nlp	11331310	SENT65	33	33	13	13	paclitaxel	53BP1	PA450761	7158	0.809
NULL	Cancer_Manag_Res_2013_Jun_11_5_103-115.nxml.txt.nlp	23807861	SENT67	3	3	11	11	bevacizumab	PlGF-2	PA130232992	5228	0.809
NULL	Biologics_2012_Sep_25_6_337-345.nxml.txt.nlp	23055691	SENT99	10	10	18	18	afatinib	EGFR	PA165981154	1956	0.809
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1137-1144.nxml.txt.nlp	20234366	SENT35	21	21	16	16	cetuximab	KRAS	PA10040	3845	0.809
NULL	Front_Immunol_2014_Aug_22_5_406.nxml.txt.nlp	25202312	SENT177	9	9	27	27	eculizumab	C3a	PA164776637	718	0.809
NULL	Front_Mol_Neurosci_2012_Nov_12_5_99.nxml.txt.nlp	23162427	SENT161	25	25	34	34	cocaine	MSN	PA449072	4478	0.809
NULL	Arthritis_Res_Ther_2005_Jan_21_7(2)_55-61.nxml.txt.nlp	15743490	SENT106	8	8	37	37	atorvastatin	CD40	PA448500	958	0.809
NULL	J_Cell_Mol_Med_2014_Feb_25_18(2)_305-313.nxml.txt.nlp	24266867	SENT177	2	2	7	7	tamoxifen	FasL	PA451581	356	0.809
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT479	24	24	16	16	iloperidone	PRL	PA161199368	5617	0.809
NULL	Exp_Ther_Med_2014_Mar_2_7(3)_635-639.nxml.txt.nlp	24520259	SENT84	8	8	6	6	vincristine	P-gp	PA451879	5243	0.809
NULL	Oncotarget_2012_Sep_28_3(10)_1169-1181.nxml.txt.nlp	23045411	SENT198	15	15	8	8	doxorubicin	JIP1	PA449412	9479	0.809
NULL	J_Immune_Based_Ther_Vaccines_2011_Oct_24_9_7.nxml.txt.nlp	22024351	SENT23	0	0	9	9	cetuximab	EGFR	PA10040	1956	0.809
NULL	Br_J_Cancer_2006_Feb_13_94(3)_407-426.nxml.txt.nlp	16434996	SENT121	35	35	7	7	genistein	BRCA1	PA165109660	672	0.809
NULL	J_Mol_Signal_2012_Aug_16_7_12.nxml.txt.nlp	22898329	SENT248	1	1	17	17	temozolomide	NOXA	PA451609	5366	0.809
NULL	Neuro_Oncol_2011_Jan_25_13(1)_70-83.nxml.txt.nlp	20978004	SENT263	13	13	9	9	etoposide	CD133	PA449552	8842	0.809
NULL	Ann_Surg_Oncol_2010_Apr_20_17(4)_1168-1176.nxml.txt.nlp	19936839	SENT104	17	17	9	9	panitumumab	KRAS	PA162373091	3845	0.809
NULL	J_Korean_Med_Sci_2013_Aug_31_28(8)_1213-1219.nxml.txt.nlp	23960450	SENT164	5	5	19	19	ribavirin	ITPA	PA451241	3704	0.809
NULL	Diabetes_2009_Feb_58(2)_344-351.nxml.txt.nlp	19008341	SENT304	16	16	7	7	resveratrol	IFN		3439	0.809
NULL	Osteoporos_Int_2012_Jan_3_23(1)_327-337.nxml.txt.nlp	21892677	SENT275	29	29	26	26	denosumab	RANKL	PA166048634	8600	0.809
NULL	Indian_J_Dermatol_2011_Mar-Apr_56(2)_137-144.nxml.txt.nlp	21716938	SENT125	14	14	1	1	abacavir	HCP5	PA448004	360158;10866	0.809
NULL	Nucleic_Acids_Res_2005_Jun_8_33(10)_3283-3291.nxml.txt.nlp	15944449	SENT40	4	4	11	11	mechlorethamine	XRCC3	PA450336	7517	0.809
NULL	Gastric_Cancer_2013_Jul_12_16(3)_345-354.nxml.txt.nlp	22968820	SENT6	13	13	7	7	oxaliplatin	FANCJ	PA131285527	83990	0.809
NULL	Mol_Cancer_2013_Nov_11_12_134.nxml.txt.nlp	24215614	SENT186	4	4	23	23	lapatinib	PTEN	PA152241907	5728	0.809
NULL	Tumour_Biol_2012_Dec_14_33(6)_2209-2216.nxml.txt.nlp	22890830	SENT159	15	15	6	6	cetuximab	BRAF	PA10040	673	0.809
NULL	Front_Cell_Neurosci_2014_Jul_29_8_213.nxml.txt.nlp	25120434	SENT248	27	27	3	3	bortezomib	IRE1	PA10252	2081	0.809
NULL	N_Am_J_Med_Sci_2014_Dec_6(12)_625-632.nxml.txt.nlp	25599050	SENT6	10	10	38	38	ramipril	STZ	PA451223	6484	0.809
NULL	Oncol_Rep_2013_Apr_23_29(4)_1268-1274.nxml.txt.nlp	23354756	SENT14	9	9	2	2	trastuzumab	SLC25A43	PA451743	203427	0.809
NULL	Oncoimmunology_2014_May_29_3_e28925.nxml.txt.nlp	25083322	SENT29	6	6	18	18	imatinib	CD4	PA10804	920	0.809
NULL	Breast_Cancer_Res_2007_Mar_2_9(2)_205.nxml.txt.nlp	NULL	SENT128	22	22	10	10	trastuzumab	survivin	PA451743	332	0.809
NULL	Arthritis_Res_Ther_2008_Mar_17_10(2)_R33.nxml.txt.nlp	18346273	SENT40	5	5	12	12	oxaliplatin	HMGB1	PA131285527	3146	0.809
NULL	Chromatographia_2014_Oct_9_77(21-22)_1489-1495.nxml.txt.nlp	25400288	SENT115	37	37	19	19	cefuroxime	mol	PA448868	90527	0.809
NULL	Chem_Res_Toxicol_2010_Jul_19_23(7)_1151-1162.nxml.txt.nlp	20536192	SENT528	12	12	6	6	mitomycin	p53	PA450524	7157	0.809
NULL	Breast_Cancer_Res_2014_May_5_16(3)_R45.nxml.txt.nlp	24887236	SENT235	12	12	36	36	lapatinib	EGFR	PA152241907	1956	0.809
NULL	Arthritis_Rheum_2010_Dec_62(12)_3666-3676.nxml.txt.nlp	20722027	SENT73	3	3	0	0	lipase	FAAH	PA450239	79152;2166	0.809
NULL	Indian_J_Nephrol_2014_Jul-Aug_24(4)_203-205.nxml.txt.nlp	25097331	SENT39	38	38	43	43	hydrochlorothiazide	AVP	PA449899	114548;551	0.809
NULL	Front_Cell_Neurosci_2014_Jul_18_8_185.nxml.txt.nlp	25100946	SENT404	19	19	11	11	pp2	Isl-1		3670	0.809
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Jun_25_3(6)_e120.nxml.txt.nlp	24964282	SENT44	23	23	16	16	rifampin	CYP3A4	PA451250	1576	0.809
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT5	7	7	21	21	adalimumab	CD36	PA10004	948	0.809
NULL	J_Cell_Biol_2008_Jul_14_182(1)_15-17.nxml.txt.nlp	18606854	SENT30	6	6	19	19	chloroquine	TRAF2	PA448948	7186	0.809
NULL	Indian_J_Med_Res_2010_Dec_132(6)_676-682.nxml.txt.nlp	21245614	SENT100	23	23	30	30	zinc	p53	PA451956	7157	0.809
NULL	Mol_Cancer_2012_Dec_12_11_91.nxml.txt.nlp	23234355	SENT18	4	4	11	11	erlotinib	HER2	PA134687924	2064	0.809
NULL	Int_J_Mol_Sci_2014_Sep_26_15(10)_17204-17220.nxml.txt.nlp	25264738	SENT123	6	6	23	23	sildenafil	MPG	PA451346	4350	0.809
NULL	Cancer_Med_2014_Apr_7_3(2)_349-361.nxml.txt.nlp	24515895	SENT289	21	21	0	0	doxycycline	HSC3	PA449415	150353	0.809
NULL	ARYA_Atheroscler_2014_Jan_10(1)_1-5.nxml.txt.nlp	24963306	SENT3	35	35	16	16	atorvastatin	Q10	PA448500	27161	0.809
NULL	Mol_Imaging_Biol_2013_Apr_11_15(2)_136-147.nxml.txt.nlp	22886728	SENT263	14	14	22	22	orlistat	AACS	PA164776864	65985	0.809
NULL	J_Adv_Pharm_Technol_Res_2012_Oct-Dec_3(4)_202-209.nxml.txt.nlp	23378940	SENT171	28	28	24	24	alprazolam	CYP3A4	PA448333	1576	0.809
NULL	AIDS_Res_Ther_2013_May_1_10_10.nxml.txt.nlp	23634877	SENT11	7	7	26	26	lovastatin	CCR5	PA450272	1234	0.809
NULL	Int_J_Biol_Sci_2011_Sep_8_7(8)_1077-1092.nxml.txt.nlp	21927577	SENT131	3	3	10	10	telmisartan	ANG	PA451605	283	0.809
NULL	Hum_Genomics_2008_Sep_1_3(1)_53-70.nxml.txt.nlp	19129090	SENT188	9	9	16	16	perifosine	U95	PA165291471	619570	0.809
NULL	Oncotarget_2014_Sep_2_5(19)_9308-9321.nxml.txt.nlp	25301721	SENT92	9	9	6	6	rolipram	MRP4	PA153906323	10257	0.809
NULL	Cancer_Cell_Int_2005_Aug_23_5_27.nxml.txt.nlp	16117829	SENT4	17	17	2	2	tetracycline	p53	PA451640	7157	0.809
NULL	Gut_Pathog_2009_Jun_25_1_13.nxml.txt.nlp	19555480	SENT178	16	16	11	11	ampicillin	LBA	PA448419	987	0.809
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT91	9	9	12	12	resveratrol	TRAIL		8743	0.809
NULL	Database_(Oxford)_2013_Mar_13_2013_bat012.nxml.txt.nlp	23487186	SENT47	17	17	10	10	ethanol	PE-2	PA448073	2077	0.809
NULL	J_Gen_Physiol_2004_Jul_124(1)_1b.nxml.txt.nlp	NULL	SENT939	5	5	14	14	nimodipine	c-fos	PA450633	2353	0.809
NULL	Curr_Med_Chem_2012_Sep_19(26)_4399-4413.nxml.txt.nlp	22830345	SENT237	23	23	9	9	erythromycin	CYP3A4	PA449493	1576	0.809
NULL	Front_Aging_Neurosci_2014_Sep_11_6_218.nxml.txt.nlp	25309423	SENT171	0	0	20	20	resveratrol	NRF2		2551;4780	0.809
NULL	Oncogene_2010_Mar_11_29(10)_1509-1518.nxml.txt.nlp	19946334	SENT298	19	19	9	9	bortezomib	pS2	PA10252	7031	0.809
NULL	Oncol_Lett_2014_Nov_14_8(5)_2086-2092.nxml.txt.nlp	25295095	SENT5	36	36	32	32	gemcitabine	LKB1	PA449748	6794	0.809
NULL	J_Immunother_Cancer_2014_Jan_27_2_2.nxml.txt.nlp	24829759	SENT169	9	9	6	6	sorafenib	IFN	PA7000	3439	0.809
NULL	Hum_Reprod_Update_2009_Jan_27_May-Jun_15(3)_323-339.nxml.txt.nlp	19174449	SENT349	5	5	10	10	tamoxifen	CYP2D6	PA451581	1565	0.809
NULL	J_Hematol_Oncol_2013_Oct_1_6_75.nxml.txt.nlp	24279871	SENT173	21	21	11	11	cyclophosphamide	CD11b	PA449165	3684	0.809
NULL	Int_J_Endocrinol_2014_Jan_23_2014_108419.nxml.txt.nlp	24587801	SENT144	20	20	14	14	telmisartan	gamma	PA451605	9913	0.809
NULL	Cancers_(Basel)_2013_Nov_1_5(4)_1379-1412.nxml.txt.nlp	24202450	SENT178	0	0	3	3	celecoxib	CCL2	PA448871	6347	0.809
NULL	Open_Med_Chem_J_2013_Oct_31_7_23-29.nxml.txt.nlp	24222802	SENT73	0	0	11	11	perifosine	JNK	PA165291471	5599	0.809
NULL	BMB_Rep_2013_Jun_46(6)_295-304.nxml.txt.nlp	23790972	SENT34	2	2	16	16	amiloride	ASIC3	PA448368	9311	0.809
NULL	Open_Ophthalmol_J_2011_Apr_28_5_27-31.nxml.txt.nlp	21633720	SENT122	8	8	3	3	guanabenz	ERG	PA164774903	2078	0.809
NULL	Cardiovasc_J_Afr_2013_Apr_24(3)_78-81.nxml.txt.nlp	23736131	SENT18	25	25	14	14	hemin	HO-1	PA449849	3162	0.809
NULL	Cancer_Causes_Control_2013_Aug_18_24(8)_1605-1614.nxml.txt.nlp	23775025	SENT64	33	33	43	43	doxorubicin	GSTP1	PA449412	2950	0.809
NULL	Chem_Cent_J_2013_Jan_14_7_6.nxml.txt.nlp	23316796	SENT56	4	4	6	6	gatifloxacin	GTX	PA449738	84504	0.809
NULL	Breast_Cancer_Res_2012_Jul_12_14(4)_R104.nxml.txt.nlp	22788954	SENT241	25	25	17	17	gefitinib	Met	PA131301952	79811	0.809
NULL	Arthritis_Res_Ther_2005_Feb_18_7(3)_R476-R484.nxml.txt.nlp	15899034	SENT117	4	4	7	7	thrombin	IL-6	PA451674	3569	0.809
NULL	Oncotarget_2013_Nov_23_5(1)_196-210.nxml.txt.nlp	24344116	SENT136	11	11	20	20	doxorubicin	TNFAIP3	PA449412	7128	0.809
NULL	Orphanet_J_Rare_Dis_2014_Aug_8_9(1)_126.nxml.txt.nlp	NULL	SENT143	30	30	12	12	ixabepilone	p53		7157	0.809
NULL	Neural_Regen_Res_2014_Mar_15_9(6)_622-629.nxml.txt.nlp	25206865	SENT70	10	10	0	0	vasopressin	c-Jun	PA451858	3725	0.809
NULL	Breast_Cancer_(Auckl)_2012_Mar_7_6_67-77.nxml.txt.nlp	22438669	SENT66	4	4	6	6	trastuzumab	HER2	PA451743	2064	0.809
NULL	Oncoimmunology_2013_Sep_1_2(9)_e25773.nxml.txt.nlp	24319639	SENT32	15	15	6	6	alemtuzumab	SIRP	PA164783958	140885	0.809
NULL	Oncotarget_2014_Oct_16_5(22)_11442-11451.nxml.txt.nlp	25347345	SENT75	12	12	24	24	oxaliplatin	gamma	PA131285527	9913	0.809
NULL	J_Korean_Med_Sci_2007_Sep_30_22(Suppl)_S98-S103.nxml.txt.nlp	17923763	SENT25	15	15	27	27	irinotecan	EGFR	PA450085	1956	0.809
NULL	Amino_Acids_2012_May_25_42(5)_1529-1539.nxml.txt.nlp	21437784	SENT99	5	5	10	10	taurine	STZ	PA451590	6484	0.809
NULL	Oncogenesis_2014_Dec_15_3(12)_e133.nxml.txt.nlp	25500906	SENT37	14	14	17	17	trastuzumab	HER2	PA451743	2064	0.809
NULL	Arthritis_Res_Ther_2014_Sep_18_16(5)_427.nxml.txt.nlp	25230745	SENT148	20	20	10	10	bevacizumab	MMP13	PA130232992	4322	0.809
NULL	Br_J_Cancer_2011_Apr_12_104(8)_1270-1277.nxml.txt.nlp	21407219	SENT204	2	2	6	6	bevacizumab	VEGF-A	PA130232992	7422	0.809
NULL	Arthritis_Res_Ther_2009_Feb_23_11(1)_216.nxml.txt.nlp	19291269	SENT90	27	27	16	16	etanercept	ACR	PA449515	49	0.809
NULL	Mol_Cancer_2009_Nov_19_8_108.nxml.txt.nlp	19925669	SENT30	8	8	2	2	doxorubicin	CRT	PA449412	811	0.809
NULL	Cancer_Immunol_Immunother_2012_May_28_61(5)_655-665.nxml.txt.nlp	22033581	SENT220	12	12	7	7	bevacizumab	ML-IAP	PA130232992	79444	0.809
NULL	J_Adv_Pract_Oncol_2012_Jul_1_Jul-Aug_3(4)_245-248.nxml.txt.nlp	25031952	SENT88	26	26	5	5	letrozole	aromatase	PA450196	1588	0.809
NULL	Braz_J_Med_Biol_Res_2014_Oct_14_47(12)_1062-1067.nxml.txt.nlp	25387673	SENT111	4	4	17	17	propofol	PI3K	PA451141	5290	0.809
NULL	Br_J_Cancer_2013_Feb_5_108(2)_469-476.nxml.txt.nlp	23169292	SENT128	24	24	5	5	erlotinib	KRAS	PA134687924	3845	0.809
NULL	Acta_Pharmacol_Sin_2010_Sep_9_31(9)_1181-1188.nxml.txt.nlp	20694025	SENT164	7	7	22	22	gefitinib	ERBB3	PA131301952	2065	0.809
NULL	Br_J_Cancer_2012_Jan_17_106(2)_348-357.nxml.txt.nlp	22146521	SENT179	22	22	14	14	gemcitabine	IFN	PA449748	3439	0.809
NULL	Int_J_Gen_Med_2011_Apr_19_4_333-343.nxml.txt.nlp	21674026	SENT302	3	3	18	18	ciprofloxacin	AK1	PA449009	203	0.809
NULL	Biologics_2012_Sep_25_6_337-345.nxml.txt.nlp	23055691	SENT5	31	31	12	12	afatinib	EGFR	PA165981154	1956	0.809
NULL	Crit_Care_2000_Mar_21_4(Suppl_1)_P27.nxml.txt.nlp	NULL	SENT5	15	15	34	34	thrombin	ATIII	PA451674	462	0.809
NULL	BMB_Rep_2013_Jan_46(1)_59-64.nxml.txt.nlp	23351386	SENT327	1	1	11	11	auranofin	STAT3	PA448510	6774	0.809
NULL	Front_Mol_Neurosci_2008_Apr_8_1_6.nxml.txt.nlp	18946539	SENT935	4	4	10	10	ketamine	gamma	PA450144	9913	0.809
NULL	Allergy_Asthma_Clin_Immunol_2012_May_20_8(1)_6.nxml.txt.nlp	22607519	SENT101	9	9	18	18	alemtuzumab	IL-6	PA164783958	3569	0.809
NULL	Onco_Targets_Ther_2014_Sep_9_7_1571-1582.nxml.txt.nlp	25228815	SENT262	20	20	9	9	sunitinib	VEGFR1	PA162372840	2321	0.809
NULL	Clin_Epigenetics_2010_Sep_18_1(3-4)_101-116.nxml.txt.nlp	21258631	SENT216	13	13	17	17	genistein	GSTP1	PA165109660	2950	0.809
NULL	Breast_Cancer_Res_2008_Dec_16_10(6)_R105.nxml.txt.nlp	19087274	SENT12	18	18	31	31	creatine	KRT8	PA164778930	3856	0.809
NULL	Case_Rep_Rheumatol_2014_Apr_15_2014_949317.nxml.txt.nlp	24839574	SENT45	2	2	5	5	ustekinumab	p40	PA166048654	3921;339541;10314	0.809
NULL	Cell_Death_Differ_2010_Mar_16_17(3)_499-512.nxml.txt.nlp	19834490	SENT117	5	5	12	12	bevacizumab	VEGFR2	PA130232992	3791	0.809
NULL	Nat_Commun_2013_Nov_28_4_2852.nxml.txt.nlp	24284943	SENT290	26	26	1	1	fluorescein	NeuN	PA164746009	146713	0.809
NULL	J_Antimicrob_Chemother_2009_Nov_18_64(5)_910-928.nxml.txt.nlp	19767318	SENT111	16	16	8	8	maraviroc	CD4	PA164768835	920	0.809
NULL	Oncogene_2010_Jun_24_29(25)_3619-3629.nxml.txt.nlp	20418905	SENT265	20	20	8	8	doxycycline	TRE17	PA449415	9098	0.809
NULL	J_Cell_Mol_Med_2014_May_14_18(5)_811-823.nxml.txt.nlp	24628949	SENT235	12	12	23	23	docetaxel	FOXM1	PA449383	2305	0.809
NULL	Autoimmune_Dis_2013_Jul_10_2013_728529.nxml.txt.nlp	23936634	SENT164	8	8	15	15	rituximab	p38	PA451261	10598;1432;7965	0.809
NULL	Arthritis_Res_Ther_2011_Jul_6_13(4)_228.nxml.txt.nlp	21745419	SENT45	0	0	3	3	tocilizumab	IL-6	PA165292659	3569	0.809
NULL	Open_Med_Chem_J_2013_Nov_23_7_30-38.nxml.txt.nlp	24319502	SENT239	7	7	1	1	captopril	PLIF	PA448780	2495	0.809
NULL	Cancer_Cell_Int_2014_Jan_29_14_10.nxml.txt.nlp	24472145	SENT186	7	7	13	13	doxorubicin	EGFR	PA449412	1956	0.809
NULL	Int_J_Mol_Sci_2014_Sep_2_15(9)_15512-15529.nxml.txt.nlp	25184950	SENT190	10	10	22	22	resveratrol	IL-10		3586	0.809
NULL	Nat_Commun_2014_Nov_25_5_5582.nxml.txt.nlp	25420773	SENT108	5	5	27	27	erlotinib	EGFR	PA134687924	1956	0.809
NULL	Osteoporos_Int_2009_Sep_16_20(9)_1631.nxml.txt.nlp	19085029	SENT3	33	33	35	35	teriparatide	PTH	PA451620	5741	0.809
NULL	Iran_J_Basic_Med_Sci_2012_Mar-Apr_15(2)_709-718.nxml.txt.nlp	23493500	SENT151	13	13	29	29	celecoxib	COX	PA448871	1351	0.809
NULL	Biosci_Rep_2013_Jul_16_33(4)_e00050.nxml.txt.nlp	23725357	SENT640	3	3	17	17	bortezomib	PSMB5	PA10252	5693	0.809
NULL	Front_Chem_2014_Mar_14_2_12.nxml.txt.nlp	24790981	SENT94	2	2	4	4	curcumin	P19	PA151958596	51561	0.809
NULL	Arch_Gynecol_Obstet_2012_May_30_285(5)_1447-1453.nxml.txt.nlp	22127553	SENT28	8	8	2	2	carboplatin	TEC	PA448803	7006	0.809
NULL	Carcinogenesis_2013_Feb_3_34(2)_351-360.nxml.txt.nlp	23125222	SENT39	5	5	24	24	curcumin	NAC	PA151958596	22861	0.809
NULL	J_Cell_Biol_2002_May_28_157(5)_749-760.nxml.txt.nlp	12034769	SENT279	22	22	32	32	colchicine	MAST	PA449092	51324	0.809
NULL	Cancers_(Basel)_2014_Apr_9_6(2)_829-859.nxml.txt.nlp	24722453	SENT203	3	3	6	6	capsaicin	JAK1	PA448776	3716	0.809
NULL	Exp_Diabetes_Res_2012_Mar_15_2012_146194.nxml.txt.nlp	22474415	SENT9	0	0	7	7	valsartan	GLP-1	PA451848	100125288	0.809
NULL	J_Cell_Biol_2004_Apr_26_165(2)_175-180.nxml.txt.nlp	15096524	SENT73	9	9	26	26	forskolin	VASP	PA146096022	7408	0.809
NULL	Int_J_Biol_Sci_2014_Feb_6_10(2)_212-224.nxml.txt.nlp	24550689	SENT82	11	11	27	27	temozolomide	MDC	PA451609	6367	0.809
NULL	Indian_J_Dermatol_2014_Nov-Dec_59(6)_630b.nxml.txt.nlp	25484410	SENT23	5	5	12	12	isotretinoin	B12	PA450128	7126;4709	0.809
NULL	Cancer_Cell_Int_2013_Feb_12_13_14.nxml.txt.nlp	23402310	SENT183	36	36	13	13	celecoxib	p65	PA448871	5970	0.809
NULL	Cancer_Med_2013_Dec_22_2(6)_862-871.nxml.txt.nlp	24403259	SENT78	27	27	3	3	everolimus	c-Jun	PA164746311	3725	0.809
NULL	Leukemia_2013_Jan_11_27(1)_32-40.nxml.txt.nlp	22781593	SENT107	0	0	7	7	ponatinib	FGFR1	PA165980594	2260	0.809
NULL	Case_Rep_Pathol_2013_Feb_21_2013_687427.nxml.txt.nlp	23533895	SENT51	12	12	17	17	thyroglobulin	CD117	PA164754910	3815	0.809
NULL	Org_Med_Chem_Lett_2012_Oct_24_2_33.nxml.txt.nlp	23095284	SENT13	19	19	13	13	galactose	flower	PA449725	11094	0.809
NULL	Arch_Med_Sci_2012_Sep_8_8(4)_659-671.nxml.txt.nlp	23056078	SENT198	26	26	14	14	daunorubicin	MDR1	PA449212	5243	0.809
NULL	Br_J_Cancer_2010_Jul_27_103(3)_332-339.nxml.txt.nlp	20628389	SENT25	31	31	33	33	trastuzumab	HER2	PA451743	2064	0.809
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT148	8	8	2	2	methotrexate	MSH2	PA450428	4436	0.809
NULL	Clin_Infect_Dis_2013_May_1_56(9)_1330-1339.nxml.txt.nlp	23362284	SENT184	20	20	14	14	nevirapine	HLA-C	PA450616	3107	0.809
NULL	Lab_Invest_2009_Nov_7_89(11)_1275-1290.nxml.txt.nlp	19736547	SENT149	14	14	11	11	carrageenan	LOX-1	PA448814	4973	0.809
NULL	Oncogene_2014_Apr_24_33(17)_2215-2224.nxml.txt.nlp	23708665	SENT220	25	25	5	5	estradiol	BCL6	PA449503	604	0.809
NULL	J_Korean_Med_Sci_2014_Jul_11_29(7)_965-972.nxml.txt.nlp	25045229	SENT135	2	2	19	19	metformin	B12	PA450395	7126;4709	0.809
NULL	J_Hematol_Oncol_2009_Jul_30_2_32.nxml.txt.nlp	19642997	SENT94	16	16	32	32	daunorubicin	GM-CSF	PA449212	1437	0.809
NULL	J_Inherit_Metab_Dis_2010_Oct_3_33(5)_625-632.nxml.txt.nlp	20814828	SENT108	35	35	25	25	simvastatin	RhoA	PA451363	387	0.809
NULL	Mol_Clin_Oncol_2013_Jul_15_1(4)_661-667.nxml.txt.nlp	24649225	SENT28	18	18	0	0	methotrexate	OAT2	PA450428	10864	0.809
NULL	Nucleic_Acids_Res_2012_Apr_16_40(8)_3511-3523.nxml.txt.nlp	22180533	SENT224	26	26	12	12	hydroxyurea	E2F7	PA449942	144455	0.809
NULL	Trials_2013_Dec_10_14_424.nxml.txt.nlp	24325953	SENT37	16	16	19	19	bupivacaine	TAP	PA135057240	8615;2317;10482;23541	0.809
NULL	Cell_Res_2014_Jul_9_24(7)_820-841.nxml.txt.nlp	24810299	SENT131	41	41	31	31	doxycycline	CD34	PA449415	947	0.809
NULL	Cancer_Med_2013_Feb_3_2(1)_40-49.nxml.txt.nlp	24133626	SENT7	14	14	11	11	cilostazol	PDE3B	PA164746334	5140	0.809
NULL	Viruses_2014_Jul_31_6(8)_2960-2973.nxml.txt.nlp	25089538	SENT326	4	4	11	11	efavirenz	CD4	PA449441	920	0.809
NULL	Mol_Cancer_2012_Dec_12_11_91.nxml.txt.nlp	23234355	SENT200	4	4	14	14	erlotinib	EGFR	PA134687924	1956	0.809
NULL	Cardiovasc_Res_2012_Mar_15_93(4)_674-681.nxml.txt.nlp	22166712	SENT192	9	9	3	3	simvastatin	CYP3A	PA451363	1574	0.809
NULL	Cancer_Cell_Int_2010_Sep_9_10_32.nxml.txt.nlp	20828393	SENT216	13	13	15	15	cisplatin	ATF3	PA449014	467	0.809
NULL	J_Korean_Med_Sci_2014_Jul_11_29(7)_1018-1020.nxml.txt.nlp	25045238	SENT71	5	5	8	8	praziquantel	gamma	PA164764583	9913	0.809
NULL	J_Anim_Sci_Biotechnol_2013_Jun_26_4(1)_23.nxml.txt.nlp	23800120	SENT54	8	8	14	14	estradiol	ESR1	PA449503	2099	0.809
NULL	Neuro_Oncol_2010_Apr_27_12(4)_389-400.nxml.txt.nlp	20308316	SENT115	3	3	8	8	chloroquine	p53	PA448948	7157	0.809
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT145	28	28	24	24	metformin	p53	PA450395	7157	0.809
NULL	Oncol_Lett_2014_May_11_7(5)_1401-1408.nxml.txt.nlp	24765145	SENT144	13	13	26	26	paclitaxel	HIF-1	PA450761	29072	0.809
NULL	J_Res_Med_Sci_2012_Jan_17(1)_22-31.nxml.txt.nlp	23248653	SENT67	41	41	26	26	thiopental	ANOVA	PA451664	4858	0.809
NULL	EJNMMI_Res_2011_Jun_20_1_7.nxml.txt.nlp	22214546	SENT34	26	26	13	13	rituximab	CHOP	PA451261	1649	0.809
NULL	J_Korean_Med_Sci_1998_Dec_13(6)_685-688.nxml.txt.nlp	9886182	SENT13	10	10	27	27	epirubicin	GM-CSF	PA449476	1437	0.809
NULL	Comp_Hepatol_2004_Jan_14_3(Suppl_1)_S37.nxml.txt.nlp	14960189	SENT81	2	2	5	5	thalidomide	TNF-alpha	PA451644	7124	0.809
NULL	Br_J_Pharmacol_2008_Oct_18_155(4)_596-605.nxml.txt.nlp	18852694	SENT150	8	8	6	6	fenofibrate	SREBP2	PA449594	6721	0.809
NULL	Mol_Biol_Cell_2013_Jul_15_24(14)_2285-2298.nxml.txt.nlp	23720763	SENT139	21	21	23	23	chlorpromazine	CPZ	PA448964	8532	0.809
NULL	Int_J_Biol_Sci_2015_Jan_1_11(1)_48-58.nxml.txt.nlp	25552929	SENT206	3	3	0	0	paclitaxel	LDM	PA450761	1595	0.809
NULL	Mol_Cancer_2009_Nov_10_8_99.nxml.txt.nlp	19903356	SENT111	19	19	10	10	imatinib	IGFBP3	PA10804	3486	0.809
NULL	Cancer_Microenviron_2008_Dec_20_1(1)_103-111.nxml.txt.nlp	19308689	SENT57	6	6	10	10	thrombin	PAR-1	PA451674	2011;2149	0.809
NULL	Oxid_Med_Cell_Longev_2011_Oct_9_2011_756938.nxml.txt.nlp	22007271	SENT164	17	17	29	29	forskolin	PNMT	PA146096022	5409	0.809
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT250	28	28	19	19	simvastatin	TNF	PA451363	7124	0.809
NULL	Oncol_Lett_2013_Feb_7_5(2)_440-446.nxml.txt.nlp	23420122	SENT247	32	32	16	16	sorafenib	Gem	PA7000	51053	0.809
NULL	Clin_Psychopharmacol_Neurosci_2011_Apr_30_9(1)_36-43.nxml.txt.nlp	23431025	SENT108	12	12	18	18	haloperidol	HIP	PA449841	6767;6159;64399;5068	0.809
NULL	Oxid_Med_Cell_Longev_2012_Jun_3_2012_914273.nxml.txt.nlp	22701758	SENT203	23	23	37	37	resveratrol	AMPK		5563	0.809
NULL	J_Adv_Pract_Oncol_2014_Jan_1_Jan-Feb_5(1)_57-60.nxml.txt.nlp	25032035	SENT76	12	12	8	8	tamoxifen	ATAC	PA451581	6375	0.809
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT107	24	24	1	1	nifedipine	CYP3A	PA450631	1574	0.809
NULL	J_Hematol_Oncol_2008_Oct_1_1_16.nxml.txt.nlp	18828924	SENT227	19	19	30	30	paclitaxel	HER2	PA450761	2064	0.809
NULL	Int_J_Mol_Sci_2014_Mar_5_15(3)_3970-3988.nxml.txt.nlp	24603537	SENT48	14	14	5	5	curcumin	MCH	PA151958596	5367	0.809
NULL	Mediators_Inflamm_2011_Jun_7_2011_432080.nxml.txt.nlp	21772662	SENT176	37	37	17	17	rivaroxaban	IL-6	PA165958360	3569	0.809
NULL	EMBO_Mol_Med_2012_Jul_11_4(7)_577-593.nxml.txt.nlp	22496117	SENT262	19	19	15	15	clofazimine	PAP-1	PA164748759	6100	0.809
NULL	Br_J_Pharmacol_2011_May_163(1)_141-172.nxml.txt.nlp	21265830	SENT304	21	21	0	0	thrombin	PAR-1	PA451674	2011;2149	0.809
NULL	Acta_Physiol_(Oxf)_2008_Apr_192(4)_505-517.nxml.txt.nlp	17973950	SENT112	36	36	0	0	propranolol	PES	PA451145	23481	0.809
NULL	Curr_Cardiol_Rev_2011_Aug_7(3)_163-183.nxml.txt.nlp	22758615	SENT347	5	5	2	2	terlipressin	AVP	PA164781020	114548;551	0.809
NULL	Aging_(Albany_NY)_2014_Jan_14_6(1)_70-81.nxml.txt.nlp	24429382	SENT40	16	16	9	9	etoposide	WRN	PA449552	7486	0.809
NULL	Clin_Med_Insights_Cardiol_2011_Jun_28_5_55-66.nxml.txt.nlp	21792345	SENT174	21	21	15	15	carvedilol	CYP2D6	PA448817	1565	0.809
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1063.nxml.txt.nlp	24556678	SENT39	9	9	11	11	thioridazine	TRAIL	PA451666	8743	0.809
NULL	Biochem_Res_Int_2012_Mar_20_2012_951539.nxml.txt.nlp	22482055	SENT164	9	9	7	7	doxorubicin	PP1	PA449412	5540;5464	0.809
NULL	Case_Rep_Pediatr_2013_Feb_20_2013_727824.nxml.txt.nlp	23509655	SENT86	21	21	1	1	daptomycin	BSAC	PA164768820	57591	0.809
NULL	Oncotarget_2014_Aug_29_5(18)_8052-8082.nxml.txt.nlp	25211298	SENT497	38	38	24	24	itraconazole	COX	PA450132	1351	0.809
NULL	J_Korean_Assoc_Oral_Maxillofac_Surg_2014_Dec_26_40(6)_291-296.nxml.txt.nlp	25551094	SENT138	2	2	6	6	alendronate	RANKL	PA448082	8600	0.809
NULL	Oncotarget_2014_Aug_19_5(18)_8737-8749.nxml.txt.nlp	25228590	SENT107	15	15	21	21	crizotinib	MYCN	PA165946122	4613	0.809
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT177	21	21	15	15	chloroquine	BMP9	PA448948	2658	0.809
NULL	Arthritis_Res_Ther_2006_Jul_21_8(4)_R130.nxml.txt.nlp	16859540	SENT180	14	14	17	17	pravastatin	HIF-1	PA451089	29072	0.809
NULL	Arthritis_Res_Ther_2014_Apr_11_16(2)_R93.nxml.txt.nlp	24725461	SENT39	13	13	18	18	estradiol	aromatase	PA449503	1588	0.809
NULL	Clin_Ophthalmol_2014_Dec_31_9_57-62.nxml.txt.nlp	25584018	SENT61	0	0	29	29	cyclosporine	DES	PA449167	1674	0.809
NULL	Exp_Mol_Med_2012_Sep_30_44(9)_545-553.nxml.txt.nlp	22809901	SENT67	13	13	11	11	clozapine	PRDM16	PA449061	63976	0.809
NULL	Indian_J_Endocrinol_Metab_2014_Jul-Aug_18(4)_546-551.nxml.txt.nlp	25143915	SENT69	40	40	6	6	denosumab	OPG	PA166048634	690	0.809
NULL	Mol_Cancer_2010_Dec_7_9_311.nxml.txt.nlp	21138557	SENT81	1	1	12	12	etoposide	p53	PA449552	7157	0.809
NULL	Ann_Surg_Treat_Res_2014_Feb_22_86(2)_68-75.nxml.txt.nlp	24761411	SENT173	6	6	20	20	resveratrol	survivin		332	0.809
NULL	Vet_Res_2013_Oct_2_44(1)_89.nxml.txt.nlp	24088531	SENT177	5	5	11	11	hemin	IFN	PA449849	3439	0.809
NULL	Arch_Med_Sci_2013_Apr_20_9(2)_332-339.nxml.txt.nlp	23671446	SENT161	7	7	22	22	midazolam	JNK	PA450496	5599	0.809
NULL	EMBO_Mol_Med_2013_Jul_30_5(7)_932-948.nxml.txt.nlp	23723167	SENT248	5	5	15	15	pilocarpine	MMP13	PA450962	4322	0.809
NULL	Toxins_(Basel)_2010_Oct_26_2(11)_2490-2518.nxml.txt.nlp	22069563	SENT192	24	24	20	20	cisplatin	IL-6	PA449014	3569	0.809
NULL	Breast_Cancer_(Auckl)_2012_Mar_7_6_67-77.nxml.txt.nlp	22438669	SENT168	37	37	21	21	letrozole	HER2	PA450196	2064	0.809
NULL	Hum_Genomics_2011_Oct_1_5(6)_577-622.nxml.txt.nlp	22155605	SENT619	13	13	5	5	tamoxifen	CYP2D6	PA451581	1565	0.809
NULL	EMBO_J_2014_Jul_17_33(14)_1514-1526.nxml.txt.nlp	24872509	SENT88	1	1	27	27	zinc	S3A	PA451956	6189	0.809
NULL	Indian_J_Anaesth_2013_Sep-Oct_57(5)_446-454.nxml.txt.nlp	24249877	SENT196	6	6	18	18	enflurane	CO2	PA449461	4513	0.809
NULL	Cancer_Cell_2007_Dec_11_12(6)_514-527.nxml.txt.nlp	18068629	SENT53	4	4	13	13	paclitaxel	TGFBI	PA450761	7045	0.809
NULL	Breast_Cancer_Res_2008_Mar_27_10(2)_R27.nxml.txt.nlp	18371219	SENT41	16	16	30	30	cyclophosphamide	TFEC	PA449165	22797	0.809
NULL	J_Cardiovasc_Thorac_Res_2014_Jun_30_6(2)_97-100.nxml.txt.nlp	25031824	SENT37	18	18	12	12	heparin	ACT	PA449855	12;11332;9457;641455	0.809
NULL	Oncogene_2009_Apr_23_28(16)_1821-1832.nxml.txt.nlp	19305428	SENT219	20	20	29	29	erlotinib	PP2	PA134687924	4888	0.809
NULL	Cancer_Manag_Res_2011_May_9_3_117-141.nxml.txt.nlp	21625397	SENT522	0	0	11	11	vorinostat	TRAF1	PA164748224	7185	0.809
NULL	Int_J_Biol_Sci_2014_Feb_20_10(3)_268-277.nxml.txt.nlp	24644425	SENT246	0	0	2	2	metformin	AMPK	PA450395	5563	0.809
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1013.nxml.txt.nlp	24457957	SENT318	3	3	12	12	orlistat	NOXA	PA164776864	5366	0.809
NULL	Oncotarget_2011_Mar_10_2(3)_186-196.nxml.txt.nlp	21406729	SENT8	13	13	21	21	orlistat	SREBP1	PA164776864	6720	0.809
NULL	Anesthesiol_Res_Pract_2013_Sep_23_2013_297141.nxml.txt.nlp	24174934	SENT84	8	8	15	15	bupivacaine	mol	PA135057240	90527	0.809
NULL	Adv_Hematol_2010_Dec_30_2010_627401.nxml.txt.nlp	21234094	SENT126	7	7	2	2	methotrexate	SMILE	PA450428	160418	0.809
NULL	Gut_Liver_2013_Sep_14_7(5)_585-593.nxml.txt.nlp	24073317	SENT134	14	14	29	29	ribavirin	IFN	PA451241	3439	0.809
NULL	Oncogene_2010_Sep_23_29(38)_5286-5298.nxml.txt.nlp	20603611	SENT59	25	25	14	14	pha-665752	Met		79811	0.809
NULL	Biomed_Res_Int_2014_May_20_2014_418975.nxml.txt.nlp	24967364	SENT200	0	0	9	9	resveratrol	gamma		9913	0.809
NULL	Eur_J_Clin_Pharmacol_2011_May_9_67(5)_477-482.nxml.txt.nlp	21305273	SENT101	5	5	19	19	atropine	DBP	PA448505	3295;1628;2638	0.809
NULL	Front_Pharmacol_2014_Oct_31_5_231.nxml.txt.nlp	25400580	SENT4606	4	4	1	1	gemcitabine	MUC4	PA449748	4585	0.809
NULL	Sensors_(Basel)_2011_May_4_11(5)_4990-5004.nxml.txt.nlp	22163886	SENT116	17	17	7	7	oxygen	CFD	PA450744	1675	0.809
NULL	Lancet_2011_Jun_18_377(9783)_2103-2114.nxml.txt.nlp	21641636	SENT4	22	22	6	6	cetuximab	MRC	PA10040	4345	0.809
NULL	Nat_Commun_2013_Aug_15_4_2130.nxml.txt.nlp	23945651	SENT115	8	8	5	5	etoposide	ATG5	PA449552	9474	0.809
NULL	Aging_(Albany_NY)_2013_Feb_21_5(2)_94-95.nxml.txt.nlp	23518473	SENT12	10	10	14	14	resveratrol	SIRT1		23411	0.809
NULL	Ann_Rheum_Dis_2008_Aug_29_67(8)_1096-1103.nxml.txt.nlp	18055472	SENT191	19	19	9	9	infliximab	ACR	PA452639	49	0.809
NULL	J_Mol_Signal_2006_Dec_6_1_8.nxml.txt.nlp	17224083	SENT88	14	14	8	8	thrombin	Rho	PA451674	29984	0.809
NULL	Case_Rep_Transplant_2011_Jun_27_2011_251930.nxml.txt.nlp	23198254	SENT23	5	5	20	20	etoposide	CD34	PA449552	947	0.809
NULL	Front_Endocrinol_(Lausanne)_2011_Nov_10_2_72.nxml.txt.nlp	22649383	SENT211	0	0	13	13	ethanol	ACTH	PA448073	5443	0.809
NULL	Arthritis_Res_Ther_2005_Feb_17_7(Suppl_1)_P74.nxml.txt.nlp	NULL	SENT18	27	27	24	24	losartan	mol	PA450268	90527	0.809
NULL	J_Exp_Med_1994_Mar_1_179(3)_931-942.nxml.txt.nlp	8113685	SENT7	7	7	33	33	forskolin	IL-2	PA146096022	3558	0.809
NULL	Cancer_Med_2014_Feb_10_3(1)_134-142.nxml.txt.nlp	24407937	SENT228	8	8	29	29	anastrozole	IMPACT	PA448432	55364	0.809
NULL	Oncotarget_2013_Nov_22_5(4)_933-943.nxml.txt.nlp	24659749	SENT136	28	28	5	5	nutlin-3	AML3		860	0.809
NULL	Comp_Hepatol_2004_Jan_14_3(Suppl_1)_S9.nxml.txt.nlp	14960161	SENT15	7	7	0	0	l-cysteine	NAC	PA449173	22861	0.809
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Mar_6_65(Pt_4)_o714-o715.nxml.txt.nlp	21582451	SENT83	10	10	22	22	naphthol	mol	PA154081779	90527	0.809
NULL	J_Cerebrovasc_Endovasc_Neurosurg_2012_Mar_31_14(1)_44-49.nxml.txt.nlp	23210029	SENT8	9	9	11	11	acetazolamide	ACZ	PA448018	27445	0.809
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1196-1204.nxml.txt.nlp	22315058	SENT35	9	9	12	12	gefitinib	EGFR	PA131301952	1956	0.809
NULL	Front_Oncol_2013_Sep_23_3_250.nxml.txt.nlp	24069582	SENT363	27	27	23	23	tamoxifen	ATAC	PA451581	6375	0.809
NULL	J_Hematol_Oncol_2012_May_15_5_23.nxml.txt.nlp	22587422	SENT81	11	11	7	7	dasatinib	ALL	PA162372878	613	0.809
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT83	11	11	21	21	atorvastatin	IL-6	PA448500	3569	0.809
NULL	Sci_Rep_2014_Nov_28_4_7237.nxml.txt.nlp	25429875	SENT96	0	0	23	23	hesperidin	p38	PA449867	10598;1432;7965	0.809
NULL	Indian_J_Pharmacol_2014_Sep-Oct_46(5)_549-550.nxml.txt.nlp	25298588	SENT54	29	29	15	15	warfarin	VKORC1	PA451906	79001	0.809
NULL	Ann_Rheum_Dis_2011_Oct_1_70(10)_1826-1830.nxml.txt.nlp	21893583	SENT88	5	5	10	10	abatacept	ACR	PA164747080	49	0.809
NULL	Oncoimmunology_2012_Oct_1_1(7)_1004-1016.nxml.txt.nlp	23170249	SENT53	18	18	12	12	trastuzumab	HER-2	PA451743	2064	0.809
NULL	Exp_Neurobiol_2013_Mar_31_22(1)_45-50.nxml.txt.nlp	23585722	SENT108	4	4	11	11	fluoxetine	EPO	PA449673	7076;8288;2056	0.809
NULL	Antiviral_Res_2009_May_82(2)_A99-A109.nxml.txt.nlp	19176219	SENT1102	29	29	34	34	zidovudine	P-gp	PA451954	5243	0.809
NULL	Breast_Cancer_Res_Treat_2014_Jan_9_143(3)_493-505.nxml.txt.nlp	24402830	SENT122	8	8	2	2	lapatinib	TTR	PA152241907	7276	0.809
NULL	Case_Rep_Pulmonol_2014_Jul_15_2014_837612.nxml.txt.nlp	25126437	SENT6	8	8	22	22	ambrisentan	PTPA	PA165860521	5524	0.809
NULL	Biomed_Res_Int_2014_Jan_29_2014_458592.nxml.txt.nlp	24592391	SENT16	1	1	10	10	curcumin	HO-1	PA151958596	3162	0.809
NULL	Oncotarget_2014_Aug_29_5(17)_7217-7259.nxml.txt.nlp	25277175	SENT301	23	23	17	17	pazopanib	FLT3	PA165291492	2322	0.809
NULL	ISRN_Neurol_2014_Jan_22_2014_861091.nxml.txt.nlp	24587917	SENT17	7	7	27	27	natalizumab	DMT	PA164747191	2039	0.809
NULL	Onco_Targets_Ther_2014_Mar_24_7_491-500.nxml.txt.nlp	24711706	SENT92	14	14	25	25	trastuzumab	DM1	PA451743	338023;1760;28509	0.809
NULL	Mol_Neurodegener_2011_Aug_8_6_57.nxml.txt.nlp	21819629	SENT345	17	17	6	6	arsenite	TDP-43	PA452638	23435	0.809
NULL	J_Biol_Chem_2010_Apr_23_285(17)_12979-12989.nxml.txt.nlp	20189985	SENT251	7	7	9	9	forskolin	PTH	PA146096022	5741	0.808
NULL	Ital_J_Pediatr_2011_Dec_19_37_58.nxml.txt.nlp	22182677	SENT213	8	8	0	0	flunitrazepam	CLB	PA164781320	171425	0.808
NULL	J_Cell_Mol_Med_2014_Oct_11_18(10)_2031-2043.nxml.txt.nlp	25109475	SENT324	5	5	7	7	valsartan	AMPK	PA451848	5563	0.808
NULL	Oncotarget_2013_Nov_24_5(1)_11-28.nxml.txt.nlp	24429466	SENT251	25	25	14	14	erlotinib	FOXO1	PA134687924	2308	0.808
NULL	Ann_Hematol_2011_May_12_90(5)_557-568.nxml.txt.nlp	20938660	SENT218	18	18	6	6	plerixafor	CD34	PA165958410	947	0.808
NULL	Arthritis_Res_Ther_2008_Nov_19_10(6)_R136.nxml.txt.nlp	19019215	SENT48	3	3	9	9	nimesulide	COX	PA137179528	1351	0.808
NULL	Nat_Chem_Biol_2010_Apr_28_6(4)_291-299.nxml.txt.nlp	20190765	SENT162	5	5	26	26	dasatinib	EGFR	PA162372878	1956	0.808
NULL	J_Cell_Mol_Med_2014_Dec_7_18(12)_2536-2552.nxml.txt.nlp	25287328	SENT274	15	15	0	0	estradiol	PKD1	PA449503	5310	0.808
NULL	Breast_Cancer_Res_2009_Mar_19_11(2)_204.nxml.txt.nlp	19344489	SENT242	26	26	28	28	paclitaxel	HER2	PA450761	2064	0.808
NULL	Br_J_Cancer_2004_Mar_8_90(5)_1003-1010.nxml.txt.nlp	14997197	SENT127	17	17	4	4	tegafur	PSK	PA452620	9344	0.808
NULL	Exp_Ther_Med_2013_Nov_13_6(5)_1277-1282.nxml.txt.nlp	24223658	SENT134	9	9	0	0	collagenase	MMP2	PA449107	4313	0.808
NULL	Open_Access_J_Urol_2011_May_10_3_69-82.nxml.txt.nlp	24198638	SENT71	21	21	8	8	phenytoin	CYP3A4	PA450947	1576	0.808
NULL	Breast_Cancer_Res_2005_Nov_11_7(6)_255-257.nxml.txt.nlp	16457700	SENT47	11	11	14	14	tamoxifen	aromatase	PA451581	1588	0.808
NULL	Pharmaceuticals_(Basel)_2014_Apr_14_7(4)_453-463.nxml.txt.nlp	24736104	SENT9	35	35	29	29	diclofenac	GIT	PA449293	5034	0.808
NULL	J_Neuroinflammation_2011_Feb_4_8_10.nxml.txt.nlp	21294877	SENT69	4	4	2	2	capsaicin	TAC1	PA448776	6863	0.808
NULL	Biomed_Res_Int_2014_Jan_20_2014_948427.nxml.txt.nlp	24563867	SENT107	2	2	20	20	buspirone	STZ	PA448689	6484	0.808
NULL	Arthritis_Res_Ther_2005_Nov_29_7(1)_R139-R148.nxml.txt.nlp	15642134	SENT30	28	28	16	16	cyclosporine	IL-17	PA449167	3605	0.808
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT131	3	3	0	0	trastuzumab	STAT3	PA451743	6774	0.808
NULL	Int_J_Environ_Res_Public_Health_2011_Jun_23_8(6)_2533-2555.nxml.txt.nlp	21776245	SENT471	5	5	17	17	curcumin	AP-1	PA151958596	2353;3727;2354;3725	0.808
NULL	Breast_Cancer_Res_Treat_2013_Feb_3_138(1)_249-259.nxml.txt.nlp	23378108	SENT199	20	20	23	23	raloxifene	aromatase	PA451221	1588	0.808
NULL	Int_J_Biol_Sci_2012_Oct_24_8(9)_1237-1247.nxml.txt.nlp	23136552	SENT168	4	4	28	28	tocilizumab	IL-6	PA165292659	3569	0.808
NULL	Neural_Plast_2007_Jan_1_2007_30585.nxml.txt.nlp	25148070	SENT1844	18	18	1	1	mimosine	Rho	PA164752445	29984	0.808
NULL	Cell_Death_Dis_2014_Mar_13_5(3)_e1113.nxml.txt.nlp	24625972	SENT105	8	8	15	15	bleomycin	BI-1	PA448645	7009	0.808
NULL	Mol_Pain_2013_Jun_10_9_27.nxml.txt.nlp	23758830	SENT219	18	18	4	4	tetracaine	ASIC3	PA451638	9311	0.808
NULL	Int_J_Mol_Sci_2014_Mar_6_15(3)_4049-4059.nxml.txt.nlp	24663080	SENT62	42	42	23	23	dexmedetomidine	IL-6	PA449256	3569	0.808
NULL	Biomed_Res_Int_2014_May_20_2014_418975.nxml.txt.nlp	24967364	SENT250	3	3	10	10	taurine	adiponectin	PA451590	9370	0.808
NULL	ScientificWorldJournal_2013_Apr_18_2013_978394.nxml.txt.nlp	23710154	SENT108	28	28	30	30	leucovorin	IFL	PA450198	3439	0.808
NULL	Clin_Pharmacokinet_2014_Jul_24_53(1)_73-87.nxml.txt.nlp	23881596	SENT29	34	34	22	22	rosuvastatin	UGT	PA134308647	7361;7355	0.808
NULL	Ann_Saudi_Med_2011_May-Jun_31(3)_279-283.nxml.txt.nlp	21623058	SENT23	26	26	20	20	daclizumab	IL-2	PA164764446	3558	0.808
NULL	Hum_Genomics_2008_Sep_1_3(1)_7-16.nxml.txt.nlp	19129086	SENT195	20	20	3	3	rosiglitazone	CYP2C8	PA451283	1558	0.808
NULL	J_Phys_Ther_Sci_2014_May_29_26(5)_789-792.nxml.txt.nlp	24926154	SENT84	21	21	26	26	phenylephrine	p42	PA450935	5706;23552	0.808
NULL	Int_J_Endocrinol_2014_Mar_11_2014_927317.nxml.txt.nlp	24738001	SENT21	9	9	4	4	liraglutide	GLP-1	PA165958364	100125288	0.808
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT96	9	9	12	12	resveratrol	TRAIL		8743	0.808
NULL	J_Biomed_Sci_2014_Feb_3_21(1)_10.nxml.txt.nlp	24490900	SENT199	5	5	18	18	alendronate	RANKL	PA448082	8600	0.808
NULL	Clin_Orthop_Surg_2014_Sep_5_6(3)_324-328.nxml.txt.nlp	25177459	SENT54	17	17	25	25	triamcinolone	TFEB	PA451749	7942	0.808
NULL	J_Headache_Pain_2010_Apr_6_11(2)_151-156.nxml.txt.nlp	20213484	SENT16	7	7	24	24	almotriptan	CYP3A4	PA10246	1576	0.808
NULL	J_Hematol_Oncol_2009_Jul_27_2_31.nxml.txt.nlp	19635146	SENT167	15	15	35	35	imatinib	p21CIP1	PA10804	1026	0.808
NULL	Chin_J_Cancer_2012_Nov_31(11)_507-518.nxml.txt.nlp	22640626	SENT176	11	11	22	22	dasatinib	DDR1	PA162372878	780	0.808
NULL	Curr_Neuropharmacol_2008_Jun_6(2)_151-163.nxml.txt.nlp	19305794	SENT456	2	2	10	10	capsaicin	TRPV1	PA448776	7442	0.808
NULL	Mol_Vis_2007_Jun_14_13_873-880.nxml.txt.nlp	17615538	SENT56	15	15	4	4	glutaraldehyde	CO2	PA449777	4513	0.808
NULL	J_Thromb_Thrombolysis_2009_Aug_9_28(2)_230-237.nxml.txt.nlp	18998199	SENT90	0	0	8	8	abciximab	ADP	PA448006	23038	0.808
NULL	Nat_Commun_2013_Apr_3_4_1652.nxml.txt.nlp	23552067	SENT419	15	15	5	5	ketamine	gamma	PA450144	9913	0.808
NULL	Drugs_R_D_2011_Jun_27_11(2)_101-111.nxml.txt.nlp	21679003	SENT60	18	18	25	25	panitumumab	KRAS	PA162373091	3845	0.808
NULL	Pharm_Pract_(Granada)_2011_Mar_15_Jan-Mar_9(1)_1-10.nxml.txt.nlp	25132883	SENT151	6	6	15	15	dabigatran	SPAF		166378	0.808
NULL	Evid_Based_Complement_Alternat_Med_2012_Aug_28_2012_147896.nxml.txt.nlp	22969822	SENT119	8	8	38	38	ethanol	IL-6	PA448073	3569	0.808
NULL	Ann_Dermatol_2013_Nov_30_25(4)_500-502.nxml.txt.nlp	24371403	SENT24	6	6	17	17	imatinib	LDE	PA10804	7957	0.808
NULL	BMJ_2014_Apr_24_348_g2780.nxml.txt.nlp	24764569	SENT33	31	31	19	19	saxagliptin	GLP-1	PA165958362	100125288	0.808
NULL	Int_J_Alzheimers_Dis_2010_Jul_20_2010_825918.nxml.txt.nlp	20798900	SENT60	12	12	3	3	carbachol	PSEN1	PA448784	5663	0.808
NULL	Br_J_Cancer_2004_Mar_22_90(6)_1285-1292.nxml.txt.nlp	15026814	SENT143	3	3	12	12	doxorubicin	p53	PA449412	7157	0.808
NULL	J_Anaesthesiol_Clin_Pharmacol_2011_Oct-Dec_27(4)_489-494.nxml.txt.nlp	22096282	SENT123	3	3	16	16	ketamine	ACTH	PA450144	5443	0.808
NULL	Mol_Cancer_2010_Jun_27_9_168.nxml.txt.nlp	20579391	SENT121	4	4	13	13	dasatinib	MKI67	PA162372878	4288	0.808
NULL	Nat_Med_2013_Dec_10_19(12)_10_1038_nm_3385.nxml.txt.nlp	24216752	SENT39	13	13	15	15	thrombin	PAR4	PA451674	9002;5074	0.808
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT320	22	22	7	7	panitumumab	KRAS	PA162373091	3845	0.808
NULL	Cell_Death_Dis_2013_Jun_6_4(6)_e654.nxml.txt.nlp	23744354	SENT38	14	14	3	3	vincristine	B4GALT5	PA451879	9334	0.808
NULL	Autoimmune_Dis_2013_Jul_10_2013_728529.nxml.txt.nlp	23936634	SENT167	9	9	14	14	rituximab	NF-kappaB	PA451261	4790	0.808
NULL	Reprod_Biol_Endocrinol_2013_Feb_26_11_15.nxml.txt.nlp	23442442	SENT149	1	1	6	6	l-arginine	BCL2	PA448478	596	0.808
NULL	Arthritis_Res_Ther_2005_May_18_7(Suppl_3)_S19-S25.nxml.txt.nlp	15960818	SENT164	33	33	31	31	rituximab	CHOP	PA451261	1649	0.808
NULL	Cell_Death_Dis_2014_Apr_24_5(4)_e1197.nxml.txt.nlp	24763054	SENT325	16	16	12	12	cisplatin	ARC	PA449014	8996;23237	0.808
NULL	Chem_Cent_J_2013_Mar_27_7_57.nxml.txt.nlp	23537428	SENT33	8	8	15	15	exemestane	PC3	PA449563	57332;7832;5122	0.808
NULL	Ann_Lab_Med_2013_Sep_8_33(5)_326-330.nxml.txt.nlp	24003422	SENT47	20	20	37	37	vancomycin	CO2	PA451850	4513	0.808
NULL	Br_J_Cancer_2012_Sep_4_107(6)_947-955.nxml.txt.nlp	22892392	SENT207	31	31	41	41	lapatinib	BCAR4	PA152241907	400500	0.808
NULL	Breast_Cancer_Res_2000_May_24_2(4)_302-303.nxml.txt.nlp	11403011	SENT76	37	37	29	29	doxorubicin	PTEN	PA449412	5728	0.808
NULL	J_Cancer_2014_Jul_4_5(7)_559-571.nxml.txt.nlp	25057307	SENT402	13	13	10	10	tamoxifen	CYP2C19	PA451581	1557	0.808
NULL	J_Biomed_Biotechnol_2004_Jun_30_2004(2)_106-112.nxml.txt.nlp	15240921	SENT105	39	39	29	29	busulfan	SAGE	PA448691	55511	0.808
NULL	Exp_Ther_Med_2014_Sep_20_8(3)_968-972.nxml.txt.nlp	25120631	SENT7	16	16	9	9	naringin	PF4	PA151958360	5196	0.808
NULL	Acta_Pharmacol_Sin_2012_Jan_28_33(1)_66-74.nxml.txt.nlp	22120966	SENT174	22	22	32	32	genistein	OPG	PA165109660	690	0.808
NULL	Hum_Genomics_2008_Sep_1_3(1)_7-16.nxml.txt.nlp	19129086	SENT150	5	5	21	21	rosiglitazone	CYP2C8	PA451283	1558	0.808
NULL	Aging_(Albany_NY)_2013_Feb_21_5(2)_94-95.nxml.txt.nlp	23518473	SENT16	0	0	3	3	resveratrol	SIRT1		23411	0.808
NULL	Cardiovasc_J_Afr_2009_Apr_20(2)_127-134.nxml.txt.nlp	19421649	SENT121	15	15	7	7	perindopril	NNT	PA450877	23530	0.808
NULL	Front_Pharmacol_2014_Nov_25_5_256.nxml.txt.nlp	25505414	SENT109	6	6	11	11	zolpidem	KCC2	PA451976	57468	0.808
NULL	Breast_Cancer_Res_2011_Dec_16_13(6)_R131.nxml.txt.nlp	22177475	SENT199	6	6	11	11	erlotinib	HER2	PA134687924	2064	0.808
NULL	Subst_Abuse_Rehabil_2013_Nov_6_4_75-82.nxml.txt.nlp	24648790	SENT88	9	9	0	0	dextromethorphan	OTC	PA449273	5009	0.808
NULL	J_Res_Med_Sci_2012_Nov_17(11)_1092-1093.nxml.txt.nlp	23833589	SENT21	5	5	13	13	curcumin	JNK	PA151958596	5599	0.808
NULL	Int_J_Mol_Sci_2014_Nov_7_15(11)_20500-20517.nxml.txt.nlp	25387078	SENT132	7	7	33	33	vorinostat	c-FLIP	PA164748224	8837	0.808
NULL	J_Inflamm_(Lond)_2005_Oct_31_2_14.nxml.txt.nlp	16259633	SENT250	4	4	8	8	staurosporine	CCR2	PA165109623	729230	0.808
NULL	Front_Chem_2014_Mar_14_2_12.nxml.txt.nlp	24790981	SENT195	0	0	6	6	curcumin	GATA4	PA151958596	2626	0.808
NULL	Int_J_Endocrinol_2014_Mar_11_2014_927317.nxml.txt.nlp	24738001	SENT23	11	11	6	6	exenatide	GLP-1	PA164749238	100125288	0.808
NULL	Autophagy_2012_May_1_8(5)_853-855.nxml.txt.nlp	22617440	SENT51	17	17	0	0	nilotinib	MIR30A	PA165958345	407029	0.808
NULL	Curr_Neuropharmacol_2010_Sep_8(3)_254-267.nxml.txt.nlp	21358975	SENT177	31	31	7	7	clobazam	CYP3A4	PA10888	1576	0.808
NULL	Cell_Death_Dis_2014_Jul_17_5(7)_e1333.nxml.txt.nlp	25032856	SENT82	17	17	19	19	candesartan	ASK1	PA448765	4217	0.808
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT104	14	14	22	22	metformin	MEK2	PA450395	5605	0.808
NULL	Front_Pharmacol_2014_Nov_21_5_257.nxml.txt.nlp	25484865	SENT247	12	12	8	8	nilotinib	ABCG2	PA165958345	9429	0.808
NULL	Cancer_Immunol_Immunother_2013_Jul_20_62(9)_1533-1545.nxml.txt.nlp	23873089	SENT150	2	2	17	17	gemcitabine	CD4	PA449748	920	0.808
NULL	Front_Pharmacol_2014_Sep_17_5_212.nxml.txt.nlp	25278898	SENT41	17	17	7	7	escitalopram	P21	PA10074	1026;9338	0.808
NULL	Multidiscip_Respir_Med_2014_Nov_4_9(1)_54.nxml.txt.nlp	25419460	SENT111	33	33	3	3	betaine	ANOVA	PA448603	4858	0.808
NULL	J_Invest_Dermatol_2014_Jan_21_134(1)_10_1038_jid_2013_279.nxml.txt.nlp	23792457	SENT129	12	12	17	17	bexarotene	IFN	PA164752250	3439	0.808
NULL	Iran_J_Neurol_2014_Apr_3_13(2)_108-109.nxml.txt.nlp	25295156	SENT15	34	34	21	21	creatine	SLC6A8	PA164778930	6535	0.808
NULL	Eur_J_Clin_Pharmacol_2011_May_2_67(Suppl_1)_87-107.nxml.txt.nlp	21287160	SENT324	9	9	2	2	irinotecan	UGT1A	PA450085	7361;54658	0.808
NULL	Mol_Vis_2012_Apr_11_18_901-908.nxml.txt.nlp	22539869	SENT201	16	16	14	14	curcumin	HO-1	PA151958596	3162	0.808
NULL	Int_J_Hypertens_2012_Feb_22_2012_127910.nxml.txt.nlp	22518279	SENT117	9	9	14	14	ns-398	COX		1351	0.808
NULL	F1000Prime_Rep_2014_Dec_1_6_117.nxml.txt.nlp	25580271	SENT15	5	5	21	21	cisplatin	EGFR	PA449014	1956	0.808
NULL	Mol_Cancer_2009_Aug_25_8_66.nxml.txt.nlp	19706164	SENT134	9	9	2	2	celecoxib	p53	PA448871	7157	0.808
NULL	Crit_Care_2010_Mar_1_14(Suppl_1)_P80.nxml.txt.nlp	NULL	SENT5	25	25	38	38	vancomycin	HAP	PA451850	5915;10313	0.808
NULL	Acta_Pharmacol_Sin_2011_Nov_10_32(11)_1402-1410.nxml.txt.nlp	21986579	SENT155	3	3	32	32	curcumin	CDK4	PA151958596	1019	0.808
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jan_29_67(Pt_2)_m282.nxml.txt.nlp	21522927	SENT60	41	41	7	7	ethanol	NO3	PA448073	4681	0.808
NULL	Nat_Med_2010_Nov_24_16(11)_1299-1304.nxml.txt.nlp	20972434	SENT26	13	13	30	30	chloroquine	ASM	PA448948	6609;283120	0.808
NULL	J_Mol_Psychiatry_2014_Jan_24_2(1)_1.nxml.txt.nlp	25408912	SENT246	6	6	16	16	desipramine	Gen	PA449233	348654	0.808
NULL	J_Hematol_Oncol_2008_Oct_23_1_19.nxml.txt.nlp	18947412	SENT129	12	12	21	21	alemtuzumab	CD52	PA164783958	1043	0.808
NULL	Arthritis_2012_Oct_11_2012_713618.nxml.txt.nlp	23133751	SENT155	27	27	8	8	adalimumab	CDAI	PA10004	146059	0.808
NULL	Environ_Health_Perspect_2007_Jul_5_115(7)_1094-1100.nxml.txt.nlp	17637928	SENT159	13	13	19	19	staurosporine	JNK	PA165109623	5599	0.808
NULL	Diabetes_Care_2010_May_15_33(5)_1134-1139.nxml.txt.nlp	20185740	SENT152	7	7	14	14	ezetimibe	adiponectin	PA10816	9370	0.808
NULL	Mol_Biol_Cell_2012_Sep_1_23(17)_3473-3484.nxml.txt.nlp	22787275	SENT156	14	14	27	27	doxorubicin	ABCC1	PA449412	4363	0.808
NULL	Clin_Infect_Dis_2013_Jan_15_56(2)_258-266.nxml.txt.nlp	23024295	SENT201	3	3	26	26	ribavirin	BII	PA451241	777	0.808
NULL	Evid_Based_Complement_Alternat_Med_2011_Feb_14_2011_429843.nxml.txt.nlp	21869897	SENT136	6	6	19	19	ethanol	CORT	PA448073	1325	0.808
NULL	Int_J_Surg_Oncol_2012_May_17_2012_347385.nxml.txt.nlp	22675624	SENT238	12	12	14	14	tamoxifen	BCS	PA451581	617	0.808
NULL	Vet_Res_2013_Oct_2_44(1)_89.nxml.txt.nlp	24088531	SENT176	1	1	8	8	hemin	IL-10	PA449849	3586	0.808
NULL	Inflamm_Res_2010_Sep_26_59(9)_699-709.nxml.txt.nlp	20339899	SENT29	13	13	19	19	trypsin	PAR3	PA451806	56288;2151	0.808
NULL	Breast_Cancer_Res_2009_Oct_28_11(5)_211.nxml.txt.nlp	19889200	SENT220	20	20	38	38	tamoxifen	CYP2D6	PA451581	1565	0.808
NULL	EMBO_J_2014_Feb_3_33(3)_181-197.nxml.txt.nlp	24442637	SENT425	29	29	10	10	paraformaldehyde	TRAIL	PA450790	8743	0.808
NULL	Arthritis_Res_Ther_2010_Oct_28_12(5)_219.nxml.txt.nlp	21062511	SENT138	7	7	15	15	infliximab	IFN	PA452639	3439	0.808
NULL	Breast_Cancer_Res_Treat_2013_Aug_20_141(1)_43-53.nxml.txt.nlp	23959396	SENT29	23	23	35	35	pertuzumab	HER3		2065	0.808
NULL	Multidiscip_Respir_Med_2014_Oct_15_9(1)_50.nxml.txt.nlp	25364503	SENT266	6	6	16	16	salmeterol	FEV	PA451300	54738	0.808
NULL	Ecancermedicalscience_2011_Dec_1_5_237.nxml.txt.nlp	22276069	SENT33	10	10	5	5	fulvestrant	CEA	PA164747170	5670;1087	0.808
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT92	6	6	14	14	imatinib	ABCG2	PA10804	9429	0.808
NULL	Cancers_(Basel)_2014_Sep_5_6(3)_1769-1792.nxml.txt.nlp	25198391	SENT655	15	15	10	10	trastuzumab	PTEN	PA451743	5728	0.808
NULL	Front_Behav_Neurosci_2011_Sep_8_5_56.nxml.txt.nlp	21927600	SENT1279	9	9	2	2	caffeine	DARPP-32	PA448710	84152	0.808
NULL	Oncogene_2014_Feb_6_33(6)_734-744.nxml.txt.nlp	23376847	SENT177	17	17	11	11	doxorubicin	p53	PA449412	7157	0.808
NULL	Neuro_Oncol_2010_Apr_27_12(4)_389-400.nxml.txt.nlp	20308316	SENT108	34	34	28	28	chloroquine	p53	PA448948	7157	0.808
NULL	J_Hematol_Oncol_2012_Apr_25_5(Suppl_1)_A1.nxml.txt.nlp	22738713	SENT21	2	2	5	5	trastuzumab	HER2	PA451743	2064	0.808
NULL	Exp_Mol_Med_2012_Apr_30_44(4)_281-292.nxml.txt.nlp	22228119	SENT195	18	18	6	6	genistein	activin	PA165109660	83729	0.808
NULL	Acta_Pharmacol_Sin_2011_Oct_12_32(10)_1259-1265.nxml.txt.nlp	21909126	SENT94	3	3	7	7	fluvastatin	MCP-1	PA449688	6347	0.808
NULL	Ann_Med_2013_Mar_28_45(2)_194-202.nxml.txt.nlp	22928964	SENT176	0	0	6	6	cholestyramine	CYP7A1	PA448974	1581	0.808
NULL	Cerebrospinal_Fluid_Res_2010_Sep_22_7_15.nxml.txt.nlp	20860832	SENT256	26	26	23	23	acetazolamide	AQP4	PA448018	361	0.808
NULL	Int_J_Breast_Cancer_2012_May_9_2012_415170.nxml.txt.nlp	22649737	SENT44	26	26	31	31	trastuzumab	PTEN	PA451743	5728	0.808
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT88	36	36	32	32	efavirenz	CYP2C19	PA449441	1557	0.808
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Oct_31_65(Pt_11)_o2919.nxml.txt.nlp	21578497	SENT54	21	21	36	36	ethanol	mol	PA448073	90527	0.808
NULL	Oxid_Med_Cell_Longev_2013_Jun_2_2013_793525.nxml.txt.nlp	23819014	SENT140	15	15	0	0	resveratrol	ROS		6098	0.808
NULL	Int_J_Mol_Sci_2014_Oct_8_15(10)_17974-17999.nxml.txt.nlp	25299695	SENT12	6	6	10	10	curcumin	HO-1	PA151958596	3162	0.808
NULL	Br_J_Cancer_2009_Mar_10_100(5)_758-763.nxml.txt.nlp	19259094	SENT71	2	2	21	21	decitabine	MLH1	PA164749631	4292	0.808
NULL	Front_Immunol_2014_Aug_11_5_361.nxml.txt.nlp	25157249	SENT329	10	10	28	28	heparin	CD4	PA449855	920	0.808
NULL	Br_J_Cancer_2010_Jun_8_102(12)_1699-1706.nxml.txt.nlp	20485286	SENT80	42	42	14	14	sunitinib	San	PA162372840	80218	0.808
NULL	Cell_J_2014_Oct_4_Autumn_16(3)_255-262.nxml.txt.nlp	24611150	SENT152	8	8	4	4	mitomycin	IL-27	PA450524	246778;56005;53342	0.808
NULL	Ann_Rheum_Dis_2012_Sep_71(9)_1510-1516.nxml.txt.nlp	22440821	SENT89	2	2	31	31	adalimumab	adiponectin	PA10004	9370	0.808
NULL	Br_J_Cancer_1998_Oct_78(8)_1058-1060.nxml.txt.nlp	9792150	SENT6	2	2	40	40	floxuridine	HAI	PA449652	6692;6768	0.808
NULL	Nat_Commun_2013_Oct_1_4_2516.nxml.txt.nlp	24084631	SENT68	7	7	22	22	hyaluronan	AT1	PA165958431	9197;185	0.808
NULL	Diabetes_2013_Jun_17_62(6)_1913-1922.nxml.txt.nlp	23349495	SENT181	7	7	5	5	sildenafil	VASP	PA451346	7408	0.808
NULL	Arthritis_Res_Ther_2005_Jun_9_7(4)_145-154.nxml.txt.nlp	15987497	SENT172	17	17	25	25	methotrexate	IFN	PA450428	3439	0.808
NULL	Sci_Rep_2014_Dec_4_4_7310.nxml.txt.nlp	25472472	SENT128	26	26	9	9	decitabine	CD34	PA164749631	947	0.808
NULL	Indian_J_Pharmacol_2008_Oct_40(Suppl_2)_S97-S112.nxml.txt.nlp	21593984	SENT451	3	3	16	16	benazepril	STZ	PA448561	6484	0.808
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT263	28	28	23	23	adalimumab	CD36	PA10004	948	0.808
NULL	Adv_Virol_2012_Oct_29_2012_186512.nxml.txt.nlp	22312362	SENT27	32	32	9	9	decitabine	TET2	PA164749631	54790	0.808
NULL	Biomed_Res_Int_2013_Jun_10_2013_568671.nxml.txt.nlp	23841076	SENT33	3	3	13	13	chloroquine	NAC	PA448948	22861	0.808
NULL	J_Immunol_Res_2014_Mar_24_2014_320674.nxml.txt.nlp	24741588	SENT67	30	30	24	24	thrombin	FVIII	PA451674	2157	0.808
NULL	Br_J_Pharmacol_2014_Jan_23_171(2)_523-535.nxml.txt.nlp	24372553	SENT137	18	18	12	12	metformin	SIRT1	PA450395	23411	0.808
NULL	Cardiovasc_Drugs_Ther_2014_Aug_28_28(5)_477-488.nxml.txt.nlp	25163464	SENT84	12	12	6	6	vasopressin	ACTH	PA451858	5443	0.808
NULL	Osteopath_Med_Prim_Care_2009_Jan_6_3_1.nxml.txt.nlp	19126235	SENT56	10	10	5	5	naproxen	OTC	PA450595	5009	0.808
NULL	Mol_Biol_Rep_2014_Jan_19_41(2)_957-965.nxml.txt.nlp	24442315	SENT155	13	13	30	30	estradiol	KIT	PA449503	3815	0.808
NULL	Breast_Cancer_Res_2004_Aug_5_6(5)_R601-R607.nxml.txt.nlp	15318941	SENT147	42	42	16	16	docetaxel	BAX	PA449383	581	0.808
NULL	Environ_Health_Perspect_2006_Sep_23_114(9)_1401-1406.nxml.txt.nlp	16966095	SENT207	5	5	3	3	arsenite	ID1	PA452638	3397	0.808
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT33	5	5	30	30	sitagliptin	HIP	PA164748978	6767;6159;64399;5068	0.808
NULL	Alzheimers_Res_Ther_2013_Jan_3_5(1)_2.nxml.txt.nlp	23286718	SENT145	37	37	6	6	galantamine	APOE	PA449726	348	0.808
NULL	Indian_J_Pharm_Sci_2008_Jan-Feb_70(1)_102-105.nxml.txt.nlp	20390092	SENT40	17	17	32	32	lansoprazole	DOM	PA450180	6663	0.808
NULL	Clin_Exp_Otorhinolaryngol_2011_Dec_15_4(4)_177-183.nxml.txt.nlp	22232712	SENT107	0	0	4	4	doxycycline	MUC5B	PA449415	727897	0.808
NULL	Nucleic_Acids_Res_2005_May_19_33(9)_2859-2867.nxml.txt.nlp	15905475	SENT208	32	32	24	24	temozolomide	MPG	PA451609	4350	0.808
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT55	15	15	41	41	curcumin	TRAIL	PA151958596	8743	0.808
NULL	Nat_Commun_2013_Apr_9_4_1684.nxml.txt.nlp	23575688	SENT126	6	6	14	14	forskolin	JNK1	PA146096022	5599	0.808
NULL	J_Oncol_2010_Sep_16_2010_414726.nxml.txt.nlp	20886020	SENT39	17	17	10	10	vincristine	CHOP	PA451879	1649	0.808
NULL	JAKSTAT_2014_Jun_12_3_e29554.nxml.txt.nlp	25105067	SENT128	10	10	15	15	propofol	STAT3	PA451141	6774	0.808
NULL	EMBO_Mol_Med_2013_Dec_8_5(12)_1821-1834.nxml.txt.nlp	24293316	SENT184	15	15	17	17	doxorubicin	p53	PA449412	7157	0.808
NULL	Nat_Commun_2014_Jun_9_5_3986.nxml.txt.nlp	24909159	SENT18	26	26	9	9	imiquimod	IL-17	PA449972	3605	0.808
NULL	J_Hematol_Oncol_2008_May_28_1_3.nxml.txt.nlp	18577255	SENT137	5	5	38	38	sulindac	CHAMP	PA451565	283489;54456	0.808
NULL	Case_Rep_Transplant_2011_Jun_27_2011_251930.nxml.txt.nlp	23198254	SENT23	10	10	20	20	melphalan	CD34	PA450354	947	0.808
NULL	Oncotarget_2013_Jun_4_4(5)_772-784.nxml.txt.nlp	23800712	SENT6	25	25	12	12	bevacizumab	EGFR	PA130232992	1956	0.808
NULL	Biofactors_2014_May_6_40(3)_277-283.nxml.txt.nlp	24353111	SENT80	8	8	6	6	choline	CDP	PA448976	1523	0.808
NULL	Eur_J_Med_Res_2014_Nov_22_19(1)_64.nxml.txt.nlp	25416032	SENT100	18	18	16	16	cyclophosphamide	CHOP	PA449165	1649	0.808
NULL	Cells_2012_May_10_1(2)_100-110.nxml.txt.nlp	24710417	SENT83	21	21	17	17	basiliximab	IL-2	PA164747126	3558	0.808
NULL	Patient_Prefer_Adherence_2008_Feb_2_2_167-175.nxml.txt.nlp	19920959	SENT40	25	25	21	21	clopidogrel	DES	PA449053	1674	0.808
NULL	Nature_2012_Dec_20_492(7429)_387-392.nxml.txt.nlp	23222541	SENT6	0	0	3	3	thrombin	PAR1	PA451674	79581;2149	0.808
NULL	Cancer_Microenviron_2008_Dec_19_1(1)_85-91.nxml.txt.nlp	19308687	SENT123	9	9	16	16	collagenase	IL-8	PA449107	3576	0.808
NULL	Oncoimmunology_2012_Oct_1_1(7)_1048-1060.nxml.txt.nlp	23170253	SENT25	13	13	10	10	pertuzumab	HER-2		2064	0.808
NULL	Acta_Pharmacol_Sin_2014_Aug_21_35(8)_1082-1092.nxml.txt.nlp	25047514	SENT101	9	9	2	2	estradiol	aromatase	PA449503	1588	0.808
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT118	19	19	6	6	perifosine	DR4	PA165291471	8797	0.808
NULL	Acta_Pharmacol_Sin_2009_Jul_22_30(7)_956-964.nxml.txt.nlp	19543298	SENT162	7	7	21	21	simvastatin	ABCB1	PA451363	5243	0.808
NULL	Br_J_Pharmacol_2014_Feb_24_171(1)_1019-1032.nxml.txt.nlp	24251620	SENT48	20	20	13	13	nimodipine	TRPM3	PA450633	80036	0.808
NULL	Ann_Surg_Oncol_2012_Apr_27_19(4)_1185-1191.nxml.txt.nlp	22031063	SENT108	23	23	26	26	tamoxifen	aromatase	PA451581	1588	0.808
NULL	Aging_Cell_2010_Oct_9(5)_667-684.nxml.txt.nlp	20701600	SENT281	2	2	19	19	stavudine	p16	PA451494	1029	0.808
NULL	J_Clin_Biochem_Nutr_2008_May_29_42(3)_197-203.nxml.txt.nlp	18545641	SENT86	6	6	9	9	curcumin	HO-1	PA151958596	3162	0.808
NULL	Lab_Invest_2010_Mar_18_90(3)_374-382.nxml.txt.nlp	20084057	SENT58	4	4	37	37	phenol	VEGF-A	PA450913	7422	0.808
NULL	Oncotarget_2014_Aug_12_5(20)_9710-9726.nxml.txt.nlp	25339152	SENT223	16	16	9	9	pp2	PTEN		5728	0.808
NULL	Neural_Regen_Res_2013_Jul_15_8(20)_1853-1862.nxml.txt.nlp	25206494	SENT136	31	31	5	5	ethanol	p53	PA448073	7157	0.808
NULL	AIDS_Res_Ther_2014_Jul_29_11_21.nxml.txt.nlp	25104966	SENT112	23	23	30	30	ribavirin	CD4	PA451241	920	0.808
NULL	J_Hematol_Oncol_2011_Dec_1_4_49.nxml.txt.nlp	22128838	SENT131	9	9	6	6	bortezomib	Mcl-1	PA10252	4170	0.808
NULL	Cancers_(Basel)_2011_Nov_10_3(4)_4139-4150.nxml.txt.nlp	24213130	SENT74	9	9	26	26	cyclophosphamide	NY-ESO-1	PA449165	1485	0.808
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT369	14	14	38	38	resveratrol	p65		5970	0.808
NULL	Acta_Pharmacol_Sin_2012_May_16_33(5)_594-605.nxml.txt.nlp	22504905	SENT66	7	7	0	0	paraformaldehyde	ARC	PA450790	8996;23237	0.808
NULL	Nucleic_Acids_Res_2011_Sep_7_39(17)_7465-7476.nxml.txt.nlp	21653549	SENT188	10	10	24	24	etoposide	SC35	PA449552	6427	0.808
NULL	FEBS_Open_Bio_2013_Sep_30_3_406-410.nxml.txt.nlp	24251103	SENT25	34	34	10	10	nadh	PGR5	PA164755085	390212	0.808
NULL	J_Cell_Mol_Med_2013_Jun_15_17(6)_792-799.nxml.txt.nlp	23672538	SENT64	32	32	14	14	fluorescein	CD235a	PA164746009	2993	0.808
NULL	Indian_Dermatol_Online_J_2011_Jan-Jun_2(1)_28-30.nxml.txt.nlp	23130212	SENT59	28	28	18	18	dapsone	EED	PA449211	8726	0.808
NULL	J_Gen_Physiol_1997_Apr_1_109(4)_477-490.nxml.txt.nlp	9101406	SENT166	10	10	22	22	staurosporine	GIRK1	PA165109623	3760	0.808
NULL	Int_J_Mol_Sci_2014_May_12_15(5)_8335-8351.nxml.txt.nlp	24823879	SENT131	19	19	14	14	bevacizumab	U87	PA130232992	677775;641648	0.808
NULL	Br_J_Cancer_2004_Mar_22_90(6)_1285-1292.nxml.txt.nlp	15026814	SENT205	0	0	16	16	doxorubicin	p53	PA449412	7157	0.808
NULL	Arthritis_Res_Ther_2011_Mar_16_13(2)_R44.nxml.txt.nlp	21410959	SENT190	2	2	7	7	glucosamine	RANKL	PA164747613	8600	0.808
NULL	Br_J_Cancer_2010_Sep_7_103(6)_889-898.nxml.txt.nlp	20664599	SENT198	17	17	19	19	paclitaxel	HER-2	PA450761	2064	0.808
NULL	Trials_2013_Apr_23_14_105.nxml.txt.nlp	23782520	SENT260	23	23	7	7	citalopram	Gen	PA449015	348654	0.808
NULL	Eur_J_Haematol_2013_Feb_22_90(2)_89-98.nxml.txt.nlp	23181448	SENT122	0	0	6	6	imatinib	KIT	PA10804	3815	0.808
NULL	Arthritis_Res_Ther_2009_Feb_23_11(1)_216.nxml.txt.nlp	19291269	SENT107	20	20	31	31	etanercept	ACR	PA449515	49	0.808
NULL	Cell_Cycle_2013_Dec_15_12(24)_3759-3769.nxml.txt.nlp	24107633	SENT87	0	0	8	8	metformin	E2F1	PA450395	1869	0.808
NULL	J_Cereb_Blood_Flow_Metab_2014_Oct_23_34(10)_1688-1694.nxml.txt.nlp	25052553	SENT102	3	3	6	6	losartan	SMAD1	PA450268	2617;4086	0.808
NULL	Oncogene_2014_Feb_6_33(6)_713-723.nxml.txt.nlp	23435429	SENT54	28	28	2	2	mitomycin	BRCA1	PA450524	672	0.808
NULL	Pharmaceuticals_(Basel)_2011_Nov_10_4(11)_1488-1502.nxml.txt.nlp	NULL	SENT406	13	13	3	3	genistein	Bcl-2	PA165109660	596	0.808
NULL	Mediators_Inflamm_2001_Feb_10(1)_33-36.nxml.txt.nlp	11324902	SENT4	11	11	25	25	indomethacin	MUC5AC	PA449982	4586	0.808
NULL	BMB_Rep_2013_Jan_46(1)_59-64.nxml.txt.nlp	23351386	SENT63	4	4	6	6	auranofin	STAT3	PA448510	6774	0.808
NULL	Lab_Invest_2011_Mar_15_91(3)_363-378.nxml.txt.nlp	21079581	SENT177	34	34	28	28	hyaluronan	C10	PA165958431	113246	0.808
NULL	Br_J_Clin_Pharmacol_2014_Nov_20_78(5)_981-995.nxml.txt.nlp	24802902	SENT140	9	9	15	15	vigabatrin	mol	PA10231	90527	0.808
NULL	Breast_Cancer_Res_2007_Mar_2_9(2)_205.nxml.txt.nlp	NULL	SENT26	18	18	22	22	ekb-569	HER-2		2064	0.808
NULL	Nat_Med_2012_Jul_18(7)_1118-1122.nxml.txt.nlp	22683780	SENT25	10	10	7	7	crizotinib	MET	PA165946122	4233	0.808
NULL	Cancer_Cell_Int_2009_Sep_10_9_25.nxml.txt.nlp	19744341	SENT41	3	3	21	21	glucosamine	STAT3	PA164747613	6774	0.808
NULL	Cancers_(Basel)_2013_Apr_2_5(2)_320-333.nxml.txt.nlp	24216979	SENT146	23	23	3	3	temsirolimus	HIF1	PA164746890	3091	0.808
NULL	F1000Prime_Rep_2014_Dec_1_6_117.nxml.txt.nlp	25580271	SENT143	12	12	5	5	erlotinib	EGFR	PA134687924	1956	0.808
NULL	Dermatoendocrinol_2012_Jan_1_4(1)_58-64.nxml.txt.nlp	22870354	SENT16	13	13	4	4	estradiol	aromatase	PA449503	1588	0.808
NULL	Cancers_(Basel)_2014_Feb_10_6(1)_376-395.nxml.txt.nlp	24518612	SENT340	3	3	0	0	temozolomide	STAT3	PA451609	6774	0.808
NULL	Oncotarget_2014_Nov_2_5(21)_10222-10236.nxml.txt.nlp	25400118	SENT224	26	26	24	24	trastuzumab	HER2	PA451743	2064	0.808
NULL	J_Mol_Med_2008_Jul_2_86(7)_747-759.nxml.txt.nlp	18246321	SENT228	7	7	20	20	curcumin	AP-1	PA151958596	2353;3727;2354;3725	0.808
NULL	Contemp_Oncol_(Pozn)_2012_Jan_4_16(6)_461-466.nxml.txt.nlp	23788931	SENT76	37	37	22	22	vincristine	CTX	PA451879	1593	0.808
NULL	Biomed_Res_Int_2014_Jan_20_2014_789765.nxml.txt.nlp	24575414	SENT29	13	13	15	15	piroxicam	PRX	PA450985	9588;57716	0.808
NULL	J_Exp_Med_1998_Jun_15_187(12)_2055-2063.nxml.txt.nlp	9625765	SENT56	37	37	24	24	l-glutamine	HL-1	PA10090	55600	0.808
NULL	Extremophiles_2009_Nov_23_13(6)_885-894.nxml.txt.nlp	19701714	SENT133	29	29	24	24	ethanol	mol	PA448073	90527	0.808
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Apr_17_6_43-57.nxml.txt.nlp	24833916	SENT97	10	10	29	29	exemestane	aromatase	PA449563	1588	0.808
NULL	Br_J_Cancer_2012_Aug_7_107(4)_707-712.nxml.txt.nlp	22828609	SENT127	23	23	10	10	celecoxib	MUC1	PA448871	4582	0.808
NULL	Oncotarget_2013_Jul_7_4(7)_1065-1074.nxml.txt.nlp	23867252	SENT44	7	7	19	19	trypsin	Hsp90	PA451806	3320	0.808
NULL	EMBO_Mol_Med_2013_Aug_5_5(8)_1213-1226.nxml.txt.nlp	23918228	SENT47	13	13	30	30	cetuximab	EGFR	PA10040	1956	0.808
NULL	Br_J_Cancer_2012_Jul_24_107(3)_516-526.nxml.txt.nlp	22782351	SENT307	0	0	13	13	tamoxifen	TIGAR	PA451581	57103	0.808
NULL	EMBO_Mol_Med_2012_Jun_15_4(6)_472-485.nxml.txt.nlp	22419550	SENT249	6	6	1	1	thyroglobulin	IGFBP3	PA164754910	3486	0.808
NULL	Clinics_(Sao_Paulo)_2014_Jan_69(1)_68-74.nxml.txt.nlp	24473562	SENT22	5	5	19	19	nutlin-3	p53		7157	0.808
NULL	Front_Oncol_2014_Oct_13_4_255.nxml.txt.nlp	25353006	SENT280	10	10	2	2	sorafenib	SHARP	PA7000	23013	0.808
NULL	J_Mol_Med_(Berl)_2014_May_10_92(7)_709-722.nxml.txt.nlp	24811491	SENT248	15	15	6	6	cetuximab	BRAF	PA10040	673	0.808
NULL	Patient_Prefer_Adherence_2008_Feb_2_2_387-392.nxml.txt.nlp	19920986	SENT20	4	4	11	11	azathioprine	gamma	PA448515	9913	0.808
NULL	Cells_2014_Apr_9_3(2)_288-303.nxml.txt.nlp	24722470	SENT145	24	24	18	18	pilocarpine	TRPC5	PA450962	7224	0.808
NULL	Br_J_Cancer_2013_Mar_5_108(4)_983-992.nxml.txt.nlp	23361057	SENT231	35	35	26	26	cytarabine	MLH1	PA449177	4292	0.808
NULL	J_Immunol_Res_2014_Jul_13_2014_964069.nxml.txt.nlp	25126586	SENT116	9	9	31	31	imiquimod	IL-17	PA449972	3605	0.808
NULL	Drugs_R_D_2013_Sep_28_13(3)_191-197.nxml.txt.nlp	23982688	SENT235	9	9	15	15	naproxen	CYP2C9	PA450595	1559	0.808
NULL	An_Bras_Dermatol_2013_May-Jun_88(3)_355-360.nxml.txt.nlp	23793207	SENT106	22	22	25	25	thrombin	PAR-1	PA451674	2011;2149	0.808
NULL	Exp_Mol_Med_2012_May_31_44(5)_319-329.nxml.txt.nlp	22314196	SENT13	15	15	6	6	methacholine	VDBP	PA165958382	2638	0.808
NULL	Clin_Epigenetics_2011_Jan_15_2(2)_339-348.nxml.txt.nlp	22704346	SENT195	33	33	13	13	urokinase	MBD1	PA451836	4152	0.808
NULL	J_Cell_Mol_Med_2013_Nov_9_17(11)_1484-1493.nxml.txt.nlp	24015932	SENT226	4	4	10	10	berberine	c-Myc	PA165860812	4609	0.808
NULL	Br_J_Pharmacol_2012_Jan_165(2)_380-389.nxml.txt.nlp	21585347	SENT103	8	8	17	17	rosiglitazone	ATGL	PA451283	57104	0.808
NULL	Int_J_Mol_Imaging_2011_Oct_12_2011_694179.nxml.txt.nlp	22013519	SENT23	34	34	5	5	zolmitriptan	5-HT1A	PA451975	3350	0.808
NULL	Clin_Pharmacokinet_2014_Jul_24_53(1)_73-87.nxml.txt.nlp	23881596	SENT137	25	25	12	12	rosuvastatin	OATP1B1	PA134308647	10599	0.808
NULL	Clin_Med_Insights_Oncol_2012_Nov_20_6_381-393.nxml.txt.nlp	23226079	SENT139	23	23	14	14	carbamazepine	CYP3A4	PA448785	1576	0.808
NULL	Clin_Dev_Immunol_2013_Nov_26_2013_325481.nxml.txt.nlp	24371447	SENT12	3	3	17	17	propofol	IL-6	PA451141	3569	0.808
NULL	Cell_Commun_Signal_2010_Jun_24_8_14.nxml.txt.nlp	20576134	SENT43	7	7	14	14	heparin	FRS2	PA449855	10818	0.808
NULL	Oxid_Med_Cell_Longev_2013_Nov_28_2013_568093.nxml.txt.nlp	24379901	SENT48	32	32	21	21	resveratrol	SIRT1		23411	0.808
NULL	Ann_Hematol_2011_Feb_17_90(2)_173-183.nxml.txt.nlp	20714724	SENT131	10	10	15	15	resveratrol	CD38		952	0.808
NULL	Blood_Cancer_J_2014_Oct_10_4(10)_e249.nxml.txt.nlp	25303368	SENT52	22	22	10	10	rituximab	San	PA451261	80218	0.808
NULL	Oncol_Lett_2013_Jun_29_5(6)_1943-1947.nxml.txt.nlp	23833672	SENT158	3	3	17	17	celecoxib	AKT	PA448871	207	0.808
NULL	Int_J_Mol_Sci_2014_Sep_29_15(10)_17411-17441.nxml.txt.nlp	25268615	SENT273	0	0	5	5	estradiol	CD147	PA449503	682	0.808
NULL	Exp_Neurobiol_2013_Jun_27_22(2)_116-123.nxml.txt.nlp	23833560	SENT123	8	8	17	17	tamoxifen	CA3	PA451581	761	0.808
NULL	Evid_Based_Complement_Alternat_Med_2012_May_22_2012_965947.nxml.txt.nlp	22675393	SENT47	13	13	10	10	cyclophosphamide	VIII	PA449165	1351	0.808
NULL	Arthritis_Res_Ther_2014_Oct_4_16(5)_460.nxml.txt.nlp	25280749	SENT204	16	16	11	11	infliximab	OPG	PA452639	690	0.808
NULL	Cells_2014_May_23_3(2)_517-545.nxml.txt.nlp	24861977	SENT223	12	12	16	16	capsaicin	TRPV1	PA448776	7442	0.808
NULL	Cell_Death_Dis_2010_Oct_21_1(10)_e86.nxml.txt.nlp	21368859	SENT61	7	7	16	16	doxorubicin	JNK	PA449412	5599	0.808
NULL	Mol_Cancer_2014_Jan_13_13_7.nxml.txt.nlp	24418169	SENT177	5	5	7	7	sorafenib	SHP-1	PA7000	5777	0.808
NULL	Acta_Pharmacol_Sin_2014_Sep_4_35(9)_1157-1166.nxml.txt.nlp	25088002	SENT169	2	2	7	7	curcumin	STAT3	PA151958596	6774	0.808
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT146	5	5	10	10	perifosine	DR5	PA165291471	8795	0.808
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT112	41	41	11	11	cisplatin	ASC	PA449014	29108	0.808
NULL	Int_J_Biol_Sci_2012_Feb_9_8(3)_310-327.nxml.txt.nlp	22355267	SENT437	2	2	17	17	simvastatin	PCSK9	PA451363	255738	0.808
NULL	Clin_Interv_Aging_2008_Sep_3(3)_453-472.nxml.txt.nlp	18982916	SENT360	11	11	15	15	ethambutol	CD4	PA164784021	920	0.808
NULL	Cancer_Metastasis_Rev_2011_Jun_23_30(2)_185-197.nxml.txt.nlp	21340664	SENT144	19	19	6	6	gemcitabine	CHK2	PA449748	11200	0.808
NULL	EMBO_Mol_Med_2011_May_3(5)_266-278.nxml.txt.nlp	21438154	SENT96	2	2	9	9	oxaliplatin	TRPM8	PA131285527	79054	0.808
NULL	Curr_Chem_Genomics_2010_Mar_1_4_1-8.nxml.txt.nlp	20448812	SENT27	31	31	28	28	methotrexate	OATP1B3	PA450428	28234	0.808
NULL	Biomed_Res_Int_2014_Jun_26_2014_483501.nxml.txt.nlp	25057490	SENT169	11	11	18	18	resveratrol	Bcl-2		596	0.808
NULL	Chem_Res_Toxicol_2013_Oct_21_26(10)_1570-1578.nxml.txt.nlp	24047243	SENT492	22	22	11	11	estradiol	UGT2B7	PA449503	7364	0.808
NULL	Oncotarget_2014_Jun_9_5(13)_5076-5086.nxml.txt.nlp	24970803	SENT27	30	30	4	4	camptothecin	PARP-1	PA153590860	25976	0.808
NULL	Anat_Cell_Biol_2011_Mar_31_44(1)_14-24.nxml.txt.nlp	21519545	SENT110	23	23	7	7	cyclophosphamide	CK8	PA449165	3856	0.808
NULL	Nucleic_Acids_Res_2011_Jun_23_39(11)_4795-4807.nxml.txt.nlp	21345934	SENT239	5	5	2	2	fluorescein	AP2M1	PA164746009	1173	0.808
NULL	Onco_Targets_Ther_2014_Jun_9_7_947-956.nxml.txt.nlp	24959081	SENT133	10	10	24	24	fluorescein	CD25	PA164746009	3669;3559	0.808
NULL	J_Viral_Hepat_2010_Feb_17(2)_139-147.nxml.txt.nlp	19674282	SENT133	0	0	6	6	ribavirin	RVR	PA451241	9975	0.808
NULL	Br_J_Haematol_2014_Mar_13_164(1)_811-821.nxml.txt.nlp	24328678	SENT182	30	30	15	15	lenalidomide	IL2	PA162363968	3558	0.808
NULL	Front_Chem_2014_Mar_14_2_12.nxml.txt.nlp	24790981	SENT98	4	4	14	14	curcumin	GATA4	PA151958596	2626	0.808
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_13_2014_849783.nxml.txt.nlp	25477998	SENT132	7	7	10	10	isoproterenol	HMGB1	PA450121	3146	0.808
NULL	Basic_Clin_Neurosci_2014_Winter_5(1)_74-79.nxml.txt.nlp	25436087	SENT138	3	3	7	7	fluoxetine	AQP4	PA449673	361	0.808
NULL	Br_J_Cancer_2009_Jul_21_101(2)_350-356.nxml.txt.nlp	19513075	SENT126	4	4	13	13	doxorubicin	p53	PA449412	7157	0.807
NULL	Evid_Based_Complement_Alternat_Med_2012_Dec_20_2012_908601.nxml.txt.nlp	23326293	SENT24	14	14	20	20	daunorubicin	CD38	PA449212	952	0.807
NULL	Int_J_Mol_Sci_2013_Apr_29_14(5)_9408-9423.nxml.txt.nlp	23629672	SENT498	23	23	13	13	olmesartan	SMP30	PA164742950	9104	0.807
NULL	Can_J_Infect_Dis_Med_Microbiol_2014_Nov-Dec_25(6)_311-320.nxml.txt.nlp	25587293	SENT371	28	28	30	30	boceprevir	BOC	PA165948902	91653	0.807
NULL	Eur_J_Clin_Pharmacol_2011_May_9_67(5)_477-482.nxml.txt.nlp	21305273	SENT121	5	5	35	35	atropine	DSE	PA448505	29940	0.807
NULL	J_Cell_Biol_1998_Jan_26_140(2)_335-345.nxml.txt.nlp	9442109	SENT340	8	8	4	4	chloroquine	NHE	PA448948	285335	0.807
NULL	Eur_J_Clin_Pharmacol_2014_Oct_8_70(12)_1433-1441.nxml.txt.nlp	25291992	SENT7	43	43	23	23	olanzapine	B12	PA450688	7126;4709	0.807
NULL	Breast_Cancer_Res_2008_Apr_29_10(2)_206.nxml.txt.nlp	18492214	SENT115	14	14	19	19	tamoxifen	aromatase	PA451581	1588	0.807
NULL	Bone_Joint_Res_2014_Mar_1_3(3)_51-59.nxml.txt.nlp	24615710	SENT199	3	3	22	22	resveratrol	RUNX2		860	0.807
NULL	Oncogene_2010_Sep_16_29(37)_5193-5203.nxml.txt.nlp	20581867	SENT171	26	26	3	3	trastuzumab	p110	PA451743	9733	0.807
NULL	J_Exp_Clin_Cancer_Res_2010_Aug_11_29(1)_110.nxml.txt.nlp	20701792	SENT39	11	11	1	1	cisplatin	CSE1L	PA449014	1434	0.807
NULL	Pediatr_Cardiol_2010_Jan_14_31(1)_90-95.nxml.txt.nlp	19915892	SENT113	11	11	18	18	palivizumab	AAP	PA164748781	5345	0.807
NULL	Exp_Cell_Res_2011_May_1_317(8)_1093-1107.nxml.txt.nlp	21320486	SENT176	20	20	6	6	bortezomib	APPL1	PA10252	26060	0.807
NULL	Nat_Commun_2013_Apr_9_4_1684.nxml.txt.nlp	23575688	SENT135	16	16	7	7	rolipram	CYLD	PA153906323	1540	0.807
NULL	J_Hematol_Oncol_2010_Mar_23_3_11.nxml.txt.nlp	20331897	SENT161	31	31	38	38	oxaliplatin	LARC	PA131285527	6364	0.807
NULL	Fibrogenesis_Tissue_Repair_2012_Apr_13_5_5.nxml.txt.nlp	22502865	SENT95	34	34	19	19	troglitazone	CCN2	PA451799	1490	0.807
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jan_31_65(Pt_2)_o427-o428.nxml.txt.nlp	21582014	SENT76	22	22	7	7	potassium	mol	PA451047	90527	0.807
NULL	Cancer_Cell_Int_2004_Mar_19_4_3.nxml.txt.nlp	15035672	SENT80	10	10	3	3	etoposide	PC3	PA449552	57332;7832;5122	0.807
NULL	Drug_Des_Devel_Ther_2014_Oct_31_8_2121-2128.nxml.txt.nlp	25382970	SENT87	24	24	2	2	curcumin	LC3	PA151958596	84557	0.807
NULL	J_Gynecol_Oncol_2013_Jan_8_24(1)_66-82.nxml.txt.nlp	23346316	SENT55	38	38	12	12	bevacizumab	BBP	PA130232992	83941	0.807
NULL	EPMA_J_2011_Sep_24_2(Suppl_1)_143-150.nxml.txt.nlp	NULL	SENT237	39	39	32	32	natalizumab	IFN	PA164747191	3439	0.807
NULL	Clin_Dev_Immunol_2013_Sep_24_2013_814973.nxml.txt.nlp	24174972	SENT91	27	27	19	19	daclizumab	IL-2	PA164764446	3558	0.807
NULL	Front_Endocrinol_(Lausanne)_2014_Oct_27_5_163.nxml.txt.nlp	25386163	SENT283	15	15	25	25	quetiapine	ghrelin	PA451201	51738	0.807
NULL	Gastric_Cancer_2013_Jul_12_16(3)_345-354.nxml.txt.nlp	22968820	SENT178	21	21	9	9	oxaliplatin	FANCG	PA131285527	2189	0.807
NULL	EMBO_Mol_Med_2011_May_3(5)_266-278.nxml.txt.nlp	21438154	SENT89	6	6	25	25	oxaliplatin	TRPM8	PA131285527	79054	0.807
NULL	Breast_Cancer_Res_2012_Feb_14_14(1)_R30.nxml.txt.nlp	22333315	SENT172	17	17	4	4	celecoxib	CXCL10	PA448871	3627	0.807
NULL	Pharmaceuticals_(Basel)_2013_Aug_2_6(8)_915-928.nxml.txt.nlp	24276376	SENT281	3	3	24	24	bivalirudin	JAMA	PA10032	50848	0.807
NULL	Ann_Oncol_2009_Aug_17_20(8)_1319-1329.nxml.txt.nlp	19535820	SENT224	3	3	9	9	tamoxifen	CYP2D6	PA451581	1565	0.807
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1890-1904.nxml.txt.nlp	25268161	SENT67	11	11	3	3	thrombin	KLK5	PA451674	25818	0.807
NULL	Br_J_Cancer_2006_Feb_13_94(3)_407-426.nxml.txt.nlp	16434996	SENT4	7	7	18	18	genistein	BRCA1	PA165109660	672	0.807
NULL	Ann_Rheum_Dis_2008_Aug_12_68(6)_922-929.nxml.txt.nlp	18701556	SENT235	38	38	33	33	adalimumab	STAR	PA10004	6770;2984	0.807
NULL	J_Mol_Signal_2007_Feb_26_2_2.nxml.txt.nlp	17319972	SENT205	7	7	19	19	thrombin	CDK2	PA451674	1017	0.807
NULL	Nat_Commun_2013_4_1963.nxml.txt.nlp	23739639	SENT291	17	17	25	25	heparin	C3b	PA449855	718	0.807
NULL	J_Hematol_Oncol_2010_Sep_9_3_31.nxml.txt.nlp	20828403	SENT8	3	3	14	14	trastuzumab	HER2	PA451743	2064	0.807
NULL	Br_J_Cancer_2009_Jul_21_101(2)_238-243.nxml.txt.nlp	19568242	SENT19	12	12	14	14	bevacizumab	IFN	PA130232992	3439	0.807
NULL	J_Exp_Clin_Cancer_Res_2009_Aug_19_28(1)_116.nxml.txt.nlp	19689822	SENT22	26	26	34	34	cyclophosphamide	CHOP	PA449165	1649	0.807
NULL	Surg_Neurol_Int_2010_Oct_20_1_66.nxml.txt.nlp	21125011	SENT37	29	29	22	22	epirubicin	FUS	PA449476	2521	0.807
NULL	J_Hematol_Oncol_2013_Jun_3_6_38.nxml.txt.nlp	23731980	SENT183	16	16	18	18	trastuzumab	HER2	PA451743	2064	0.807
NULL	Angiogenesis_2010_Dec_7_13(4)_305-315.nxml.txt.nlp	20927579	SENT126	5	5	14	14	resveratrol	p53		7157	0.807
NULL	Int_J_Biol_Sci_2014_Jan_20_10(2)_171-180.nxml.txt.nlp	24520215	SENT143	7	7	17	17	cerulenin	L-FABP	PA164764551	2168	0.807
NULL	Case_Rep_Dermatol_2014_Sep_25_6(3)_227-231.nxml.txt.nlp	25408651	SENT47	12	12	18	18	acitretin	EGFR	PA448039	1956	0.807
NULL	Comp_Hepatol_2005_Feb_8_4_2.nxml.txt.nlp	15701172	SENT12	25	25	13	13	ketoconazole	CYP3A	PA450146	1574	0.807
NULL	Iran_J_Pharm_Res_2015_Winter_14(1)_321-328.nxml.txt.nlp	25561938	SENT78	7	7	11	11	forskolin	VASP	PA146096022	7408	0.807
NULL	Virol_J_2010_Feb_1_7_24.nxml.txt.nlp	20122152	SENT225	25	25	42	42	chlorpromazine	EPS15	PA448964	2060	0.807
NULL	J_Immunol_Res_2014_May_12_2014_897249.nxml.txt.nlp	24901013	SENT129	23	23	14	14	natalizumab	PTEN	PA164747191	5728	0.807
NULL	Mol_Cancer_2013_May_24_12_46.nxml.txt.nlp	23705826	SENT114	18	18	13	13	imatinib	FLT3	PA10804	2322	0.807
NULL	Cancer_Med_2012_Dec_26_1(3)_318-327.nxml.txt.nlp	23342281	SENT154	2	2	4	4	tamoxifen	aromatase	PA451581	1588	0.807
NULL	Case_Rep_Med_2014_Sep_16_2014_107064.nxml.txt.nlp	25371679	SENT5	0	0	3	3	zolpidem	gamma	PA451976	9913	0.807
NULL	Mol_Cancer_2012_Jul_25_11_46.nxml.txt.nlp	22830422	SENT133	7	7	11	11	rolipram	AKT	PA153906323	207	0.807
NULL	Biomed_Res_Int_2013_Aug_6_2013_909613.nxml.txt.nlp	24027765	SENT8	19	19	15	15	hydrocortisone	EEN	PA449905	6455	0.807
NULL	Am_J_Case_Rep_2014_Feb_10_15_63-68.nxml.txt.nlp	24587851	SENT52	17	17	1	1	taurine	BAAT	PA451590	570	0.807
NULL	Diabetes_Care_2009_Dec_3_32(12)_2156-2160.nxml.txt.nlp	19729522	SENT162	28	28	1	1	bupropion	Gen	PA448687	348654	0.807
NULL	Evid_Based_Complement_Alternat_Med_2013_Mar_14_2013_429706.nxml.txt.nlp	23573127	SENT140	16	16	10	10	indomethacin	CD90	PA449982	7070	0.807
NULL	Behav_Sci_(Basel)_2012_Jun_21_2(2)_135-171.nxml.txt.nlp	23077729	SENT396	31	31	21	21	desipramine	CRHR1	PA449233	1394	0.807
NULL	Int_J_Mol_Sci_2014_Nov_4_15(11)_20022-20044.nxml.txt.nlp	25375187	SENT187	9	9	15	15	metformin	AMPK	PA450395	5563	0.807
NULL	J_Signal_Transduct_2011_Jun_7_2011_982879.nxml.txt.nlp	21776391	SENT151	17	17	25	25	cetuximab	STAT3	PA10040	6774	0.807
NULL	Clin_Exp_Gastroenterol_2012_Sep_17_5_151-157.nxml.txt.nlp	23028235	SENT105	18	18	0	0	omeprazole	Mal	PA450704	114609	0.807
NULL	J_Biol_Eng_2009_Oct_16_3_18.nxml.txt.nlp	19835592	SENT50	13	13	17	17	ofloxacin	CPZ	PA450684	8532	0.807
NULL	Mol_Cancer_2004_May_4_3_14.nxml.txt.nlp	15125777	SENT223	29	29	35	35	ethanol	CHK2	PA448073	11200	0.807
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT7	0	0	5	5	curcumin	Bcl-2	PA151958596	596	0.807
NULL	Clin_Psychopharmacol_Neurosci_2013_Dec_24_11(3)_144-151.nxml.txt.nlp	24465251	SENT82	1	1	37	37	haloperidol	IL-4	PA449841	3565	0.807
NULL	Cancer_Cell_Int_2010_Sep_9_10_32.nxml.txt.nlp	20828393	SENT152	20	20	43	43	cisplatin	ATF3	PA449014	467	0.807
NULL	Indian_J_Ophthalmol_2011_Jul-Aug_59(4)_306-308.nxml.txt.nlp	21666317	SENT60	3	3	16	16	ranibizumab	VEGF-A	PA164746012	7422	0.807
NULL	Breast_Cancer_(Auckl)_2011_Oct_9_5_209-226.nxml.txt.nlp	22084574	SENT195	4	4	17	17	tamoxifen	ATAC	PA451581	6375	0.807
NULL	J_Hematol_Oncol_2009_Jul_30_2_32.nxml.txt.nlp	19642997	SENT94	18	18	32	32	idarubicin	GM-CSF	PA449961	1437	0.807
NULL	Cancers_(Basel)_2014_Nov_14_6(4)_2275-2295.nxml.txt.nlp	25405526	SENT204	22	22	18	18	etoposide	CHOP	PA449552	1649	0.807
NULL	Acta_Pharmacol_Sin_2012_Apr_12_33(4)_542-550.nxml.txt.nlp	22407228	SENT35	0	0	25	25	perifosine	CD34	PA165291471	947	0.807
NULL	Oncotarget_2010_Nov_19_1(7)_472-482.nxml.txt.nlp	21317446	SENT301	0	0	4	4	dasatinib	EGFR	PA162372878	1956	0.807
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT91	20	20	4	4	dasatinib	ABCB1	PA162372878	5243	0.807
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jul_11_65(Pt_8)_o1817.nxml.txt.nlp	21583520	SENT3	39	39	15	15	piperazine	mol	PA450977	90527	0.807
NULL	Mediators_Inflamm_2011_Jun_7_2011_432080.nxml.txt.nlp	21772662	SENT176	37	37	12	12	rivaroxaban	MCP-1	PA165958360	6347	0.807
NULL	Ann_Oncol_2011_Aug_27_22(8)_1736-1747.nxml.txt.nlp	21709140	SENT78	18	18	13	13	denosumab	RANK	PA166048634	8792	0.807
NULL	Int_J_Endocrinol_2013_Mar_27_2013_125932.nxml.txt.nlp	23606836	SENT132	16	16	2	2	trypsin	OPG	PA451806	690	0.807
NULL	Niger_Med_J_2011_Jul-Sep_52(3)_167-172.nxml.txt.nlp	22083028	SENT40	37	37	17	17	fluconazole	CD4	PA449653	920	0.807
NULL	Arthritis_Res_Ther_2005_Mar_16_7(Suppl_2)_S21-S25.nxml.txt.nlp	15833145	SENT93	27	27	9	9	abatacept	ACR	PA164747080	49	0.807
NULL	Subst_Abuse_Rehabil_2011_Mar_16_2_11-20.nxml.txt.nlp	24474851	SENT39	30	30	13	13	ketamine	CYP2B6	PA450144	1555	0.807
NULL	Pak_J_Med_Sci_2013_Nov-Dec_29(6)_1459-1461.nxml.txt.nlp	24550976	SENT57	13	13	23	23	heparin	ACT	PA449855	12;11332;9457;641455	0.807
NULL	Biomed_Res_Int_2014_Jan_20_2014_789765.nxml.txt.nlp	24575414	SENT5	22	22	24	24	piroxicam	PRX	PA450985	9588;57716	0.807
NULL	Oncotarget_2013_Nov_19_5(2)_309-325.nxml.txt.nlp	24525395	SENT335	7	7	34	34	flavopiridol	Mcl-1	PA452627	4170	0.807
NULL	Mol_Cancer_2010_Nov_8_9_291.nxml.txt.nlp	21059223	SENT254	11	11	24	24	paclitaxel	CPP32	PA450761	836	0.807
NULL	J_Exp_Clin_Cancer_Res_2009_Jul_10_28(1)_99.nxml.txt.nlp	19591692	SENT114	6	6	4	4	tariquidar	ABCG2		9429	0.807
NULL	Ann_Neurosci_2011_Apr_18(2)_48-55.nxml.txt.nlp	25205921	SENT247	34	34	16	16	riluzole	GLT-1	PA451251	6506	0.807
NULL	Breast_Cancer_Res_2008_Jul_24_10(4)_211.nxml.txt.nlp	18671839	SENT139	5	5	10	10	flavopiridol	survivin	PA452627	332	0.807
NULL	Acta_Neuropathol_Commun_2014_Oct_21_2(1)_149.nxml.txt.nlp	NULL	SENT185	15	15	2	2	riluzole	gamma	PA451251	9913	0.807
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_23_2013_941093.nxml.txt.nlp	23864901	SENT248	14	14	17	17	fluvoxamine	CYP1A2	PA449690	1544	0.807
NULL	Environ_Health_Perspect_2008_Apr_16_116(4)_426-433.nxml.txt.nlp	18414622	SENT166	5	5	11	11	resveratrol	PI3K		5290	0.807
NULL	Epigenetics_Chromatin_2014_Sep_11_7_24.nxml.txt.nlp	25276231	SENT36	13	13	9	9	tamoxifen	Mili	PA451581	55124	0.807
NULL	Oncotarget_2013_Dec_28_5(6)_1475-1490.nxml.txt.nlp	24721996	SENT205	4	4	9	9	celecoxib	CD133	PA448871	8842	0.807
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1126-1134.nxml.txt.nlp	21364592	SENT118	5	5	26	26	nicotine	CYP2A6	PA450626	1548	0.807
NULL	J_Obes_2011_Feb_8_2011_636181.nxml.txt.nlp	21331293	SENT152	16	16	19	19	diethylpropion	BID	PA164778098	637	0.807
NULL	Environ_Health_Perspect_2008_Jan_5_116(1)_1-6.nxml.txt.nlp	18197291	SENT172	9	9	7	7	arsenite	ROS	PA452638	6098	0.807
NULL	Diabetes_Care_2012_Dec_14_35(12)_e84.nxml.txt.nlp	23173145	SENT4	14	14	24	24	metformin	B12	PA450395	7126;4709	0.807
NULL	Cancer_Med_2013_Jun_25_2(3)_277-285.nxml.txt.nlp	23930204	SENT40	18	18	6	6	bevacizumab	PTEN	PA130232992	5728	0.807
NULL	Clin_Med_Insights_Oncol_2012_Aug_16_6_287-303.nxml.txt.nlp	22933844	SENT7	18	18	11	11	denosumab	aromatase	PA166048634	1588	0.807
NULL	Indian_J_Psychiatry_2009_Oct-Dec_51(4)_324-326.nxml.txt.nlp	20048463	SENT21	22	22	1	1	chlorpromazine	duo	PA448964	8997	0.807
NULL	Cancer_Manag_Res_2013_Jun_11_5_103-115.nxml.txt.nlp	23807861	SENT63	19	19	11	11	bevacizumab	VEGF-A	PA130232992	7422	0.807
NULL	Breast_Cancer_Res_2005_May_24_7(5)_R589-R597.nxml.txt.nlp	16168102	SENT215	29	29	14	14	doxorubicin	HER3	PA449412	2065	0.807
NULL	BMB_Rep_2013_Jan_46(1)_17-24.nxml.txt.nlp	23351379	SENT148	3	3	10	10	imiquimod	TLR7	PA449972	51284	0.807
NULL	Front_Behav_Neurosci_2013_Dec_18_7_203.nxml.txt.nlp	24385956	SENT280	24	24	17	17	memantine	spatial	PA10364	219793	0.807
NULL	Oncogenesis_2012_Apr_2_1(4)_e5.nxml.txt.nlp	23552603	SENT257	0	0	18	18	celecoxib	DR5	PA448871	8795	0.807
NULL	Virchows_Arch_2006_Sep_25_449(3)_281-287.nxml.txt.nlp	16865406	SENT152	19	19	21	21	cetuximab	EGFR	PA10040	1956	0.807
NULL	Cell_Death_Dis_2014_Feb_13_5(2)_e1055.nxml.txt.nlp	24525731	SENT62	0	0	5	5	irinotecan	XRCC1	PA450085	7515	0.807
NULL	Evid_Based_Complement_Alternat_Med_2011_Mar_10_2011_561396.nxml.txt.nlp	21792360	SENT122	11	11	7	7	losartan	CD40L	PA450268	959	0.807
NULL	EPMA_J_2012_Sep_27_3(1)_10.nxml.txt.nlp	23016735	SENT139	29	29	19	19	warfarin	MAF	PA451906	4094	0.807
NULL	Endocrinol_Metab_(Seoul)_2013_Dec_12_28(4)_262-274.nxml.txt.nlp	24396690	SENT77	11	11	37	37	exenatide	GLP-1	PA164749238	100125288	0.807
NULL	Trials_2013_Aug_19_14_261.nxml.txt.nlp	23958221	SENT379	14	14	16	16	pertuzumab	HER2		2064	0.807
NULL	Nat_Med_2012_Jul_18(7)_1118-1122.nxml.txt.nlp	22683780	SENT10	11	11	19	19	crizotinib	HGF	PA165946122	3569;6654;3082	0.807
NULL	Eur_J_Clin_Pharmacol_2012_Jan_8_68(1)_29-37.nxml.txt.nlp	21739267	SENT9	2	2	19	19	fluvoxamine	CYP2D6	PA449690	1565	0.807
NULL	Arthritis_Res_Ther_2004_Nov_4_6(1)_R39-R45.nxml.txt.nlp	14979936	SENT103	18	18	26	26	collagenase	IL-18	PA449107	3606	0.807
NULL	J_Gastroenterol_Hepatol_2014_Mar_19_29(3)_545-553.nxml.txt.nlp	24090188	SENT197	19	19	12	12	ribavirin	IL28B	PA451241	282617	0.807
NULL	Curr_Neuropharmacol_2013_Jan_11(1)_59-79.nxml.txt.nlp	23814539	SENT532	32	32	19	19	tetrabenazine	FTL	PA140222719	2512	0.807
NULL	Cancer_Cell_Int_2013_Oct_11_13_97.nxml.txt.nlp	24119761	SENT108	10	10	28	28	trastuzumab	EGF	PA451743	1950	0.807
NULL	Biomed_Res_Int_2014_Jun_25_2014_764981.nxml.txt.nlp	25057499	SENT226	0	0	4	4	crizotinib	Met	PA165946122	79811	0.807
NULL	Clin_Exp_Otorhinolaryngol_2011_Dec_15_4(4)_177-183.nxml.txt.nlp	22232712	SENT16	0	0	4	4	doxycycline	p38	PA449415	10598;1432;7965	0.807
NULL	Int_J_Med_Sci_2015_Jan_1_12(1)_63-71.nxml.txt.nlp	25552920	SENT116	3	3	17	17	berberine	WNT11	PA165860812	7481	0.807
NULL	Arthritis_Res_Ther_2008_Oct_15_10(Suppl_1)_S2.nxml.txt.nlp	19007422	SENT152	0	0	18	18	abatacept	CTLA4	PA164747080	1493	0.807
NULL	Infect_Drug_Resist_2010_Oct_13_3_103-114.nxml.txt.nlp	21694899	SENT82	24	24	4	4	raltegravir	CD4		920	0.807
NULL	J_Breast_Cancer_2013_Jun_28_16(2)_164-170.nxml.txt.nlp	23843848	SENT110	2	2	12	12	doxorubicin	PTEN	PA449412	5728	0.807
NULL	Scientifica_(Cairo)_2012_Dec_25_2012_561761.nxml.txt.nlp	24278716	SENT72	15	15	6	6	paclitaxel	TRPA1	PA450761	8989	0.807
NULL	Oncol_Rep_2013_Oct_22_30(4)_1535-1541.nxml.txt.nlp	23877481	SENT149	33	33	6	6	etoricoxib	VEGFR	PA164776853	3791	0.807
NULL	BMJ_Open_2014_Sep_17_4(9)_e005651.nxml.txt.nlp	25231491	SENT342	22	22	10	10	propofol	c-Jun	PA451141	3725	0.807
NULL	Int_J_Mol_Sci_2013_Apr_29_14(5)_9338-9364.nxml.txt.nlp	23629668	SENT1172	31	31	3	3	irinotecan	CD133	PA450085	8842	0.807
NULL	Oncotarget_2013_Jun_29_4(9)_1338-1348.nxml.txt.nlp	23907514	SENT122	19	19	11	11	doxorubicin	PSMA5	PA449412	5686	0.807
NULL	Cell_Cycle_2012_Apr_15_11(8)_1487.nxml.txt.nlp	22544077	SENT23	33	33	26	26	metformin	AMPK	PA450395	5563	0.807
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT210	0	0	47	47	doxorubicin	B7-H1	PA449412	29126	0.807
NULL	Aging_(Albany_NY)_2011_Apr_4_3(4)_348-362.nxml.txt.nlp	21483040	SENT18	6	6	19	19	metformin	S6K1	PA450395	6198	0.807
NULL	Infect_Dis_Obstet_Gynecol_2011_Oct_27_2011_353297.nxml.txt.nlp	22114461	SENT84	3	3	13	13	hyaluronidase	ADAMTS1	PA164745713	9510	0.807
NULL	ASN_Neuro_2010_Oct_4_2(5)_e00046.nxml.txt.nlp	20957077	SENT454	5	5	8	8	ganciclovir	E14	PA449733	4863	0.807
NULL	FEBS_Open_Bio_2014_Jan_6_4_77-89.nxml.txt.nlp	24490132	SENT199	15	15	34	34	ebselen	GDH	PA161660841	51084;2746	0.807
NULL	Vet_Res_2013_Jan_24_44(1)_5.nxml.txt.nlp	23347398	SENT108	32	32	13	13	gentamicin	CO2	PA449753	4513	0.807
NULL	Acta_Pharmacol_Sin_2009_Feb_5_30(2)_228-234.nxml.txt.nlp	19122672	SENT27	9	9	7	7	isoflurane	HO-1	PA450106	3162	0.807
NULL	ScientificWorldJournal_2014_Feb_6_2014_328513.nxml.txt.nlp	24683330	SENT91	14	14	32	32	propofol	IL-8	PA451141	3576	0.807
NULL	Br_J_Cancer_2010_Oct_26_103(9)_1331-1334.nxml.txt.nlp	20877352	SENT76	5	5	3	3	trastuzumab	GM-CSF	PA451743	1437	0.807
NULL	Clin_Pediatr_Endocrinol_2009_May_1_18(2)_65-72.nxml.txt.nlp	24790382	SENT110	0	0	9	9	cabergoline	PRL	PA448708	5617	0.807
NULL	Indian_J_Nucl_Med_2013_Dec_28(Suppl_1)_S16-S20.nxml.txt.nlp	NULL	SENT166	13	13	23	23	curcumin	gamma	PA151958596	9913	0.807
NULL	Biologics_2012_Feb_1_6_31-35.nxml.txt.nlp	22355257	SENT66	33	33	23	23	rituximab	IL-10	PA451261	3586	0.807
NULL	Hematol_Rep_2013_Apr_4_5(1)_21-25.nxml.txt.nlp	23888242	SENT105	16	16	31	31	amifostine	HCST	PA448365	10870	0.807
NULL	Breast_Cancer_Res_2007_Mar_2_9(2)_205.nxml.txt.nlp	NULL	SENT26	37	37	22	22	gefitinib	HER-2	PA131301952	2064	0.807
NULL	Front_Endocrinol_(Lausanne)_2014_Aug_18_5_129.nxml.txt.nlp	25183960	SENT94	31	31	6	6	cabergoline	DRD2	PA448708	1813	0.807
NULL	Cancer_Causes_Control_2013_Aug_18_24(8)_1605-1614.nxml.txt.nlp	23775025	SENT64	33	33	20	20	doxorubicin	GSTM1	PA449412	2944	0.807
NULL	Oxid_Med_Cell_Longev_2013_Nov_28_2013_568093.nxml.txt.nlp	24379901	SENT77	0	0	11	11	resveratrol	AMPK		5563	0.807
NULL	Drugs_R_D_2010_May_27_10(1)_9-24.nxml.txt.nlp	20509711	SENT377	3	3	21	21	gemfibrozil	CYP2C8	PA449750	1558	0.807
NULL	Case_Rep_Dermatol_2013_Dec_21_5(3)_379-381.nxml.txt.nlp	24516409	SENT7	7	7	13	13	ribavirin	IFN	PA451241	3439	0.807
NULL	Cancer_Med_2013_Aug_30_2(4)_457-467.nxml.txt.nlp	24156018	SENT230	17	17	33	33	gemcitabine	gamma	PA449748	9913	0.807
NULL	BMB_Rep_2014_Jul_47(7)_376-381.nxml.txt.nlp	24286332	SENT366	10	10	6	6	thrombin	PAR-1	PA451674	2011;2149	0.807
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Nov_29_64(Pt_12)_o2487.nxml.txt.nlp	21581451	SENT57	12	12	27	27	ethanol	mol	PA448073	90527	0.807
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1821-1889.nxml.txt.nlp	25268160	SENT305	25	25	28	28	tamoxifen	FDG	PA451581	23583	0.807
NULL	Acta_Pharmacol_Sin_2013_Sep_5_34(9)_1192-1200.nxml.txt.nlp	23685957	SENT137	4	4	10	10	curcumin	AP-2	PA151958596	7020	0.807
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT92	5	5	12	12	resveratrol	TRAIL		8743	0.807
NULL	Clin_Transl_Allergy_2014_Feb_10_4_6.nxml.txt.nlp	24512828	SENT69	10	10	15	15	methacholine	Aiolos	PA165958382	22806	0.807
NULL	Cancer_Med_2014_Apr_27_3(2)_310-321.nxml.txt.nlp	24464839	SENT364	20	20	28	28	everolimus	VEGFR	PA164746311	3791	0.807
NULL	J_Korean_Med_Sci_2009_Jan_29_24(Suppl_1)_S183-S188.nxml.txt.nlp	19194550	SENT10	27	27	37	37	celecoxib	LOX	PA448871	4015	0.807
NULL	Mol_Cell_Proteomics_2013_Jan_22_12(1)_158-171.nxml.txt.nlp	23090970	SENT255	16	16	26	26	trastuzumab	FGFR1	PA451743	2260	0.807
NULL	Breast_Cancer_Res_2010_May_6_12(3)_R25.nxml.txt.nlp	20459607	SENT24	14	14	5	5	trastuzumab	HER2	PA451743	2064	0.807
NULL	Int_J_Gen_Med_2010_Oct_5_3_313-320.nxml.txt.nlp	21042570	SENT116	9	9	3	3	natalizumab	CD4	PA164747191	920	0.807
NULL	Breast_Cancer_Res_2012_Jul_19_14(4)_R109.nxml.txt.nlp	22812567	SENT211	27	27	3	3	cisplatin	CHK1	PA449014	1111	0.807
NULL	Mol_Biol_Cell_2013_Dec_15_24(24)_3939-3944.nxml.txt.nlp	24152728	SENT63	12	12	29	29	tamoxifen	CCN2	PA451581	1490	0.807
NULL	Mol_Cell_2014_May_8_54(3)_445-459.nxml.txt.nlp	24746700	SENT135	11	11	22	22	etoposide	BCLAF1	PA449552	9774	0.807
NULL	Emerg_Infect_Dis_2012_Jan_18(1)_113-116.nxml.txt.nlp	22260877	SENT11	29	29	40	40	ethionamide	CA1	PA164768738	759	0.807
NULL	Oncotarget_2014_Aug_29_5(19)_8947-8958.nxml.txt.nlp	25333254	SENT221	11	11	35	35	plerixafor	FLT3	PA165958410	2322	0.807
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_91-103.nxml.txt.nlp	17912639	SENT107	14	14	8	8	letrozole	HER2	PA450196	2064	0.807
NULL	Mol_Vis_2011_Apr_6_17_854-863.nxml.txt.nlp	21527993	SENT214	12	12	8	8	lornoxicam	COX	PA165958395	1351	0.807
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT49	23	23	13	13	phenacetin	CYP2D6	PA450897	1565	0.807
NULL	Environ_Health_Perspect_2007_Mar_19_115(3)_346-353.nxml.txt.nlp	17431482	SENT243	15	15	8	8	arsenite	FBS	PA452638	64319;26269	0.807
NULL	Br_J_Cancer_2009_May_5_100(9)_1379-1384.nxml.txt.nlp	19401697	SENT43	14	14	34	34	bortezomib	EGFR	PA10252	1956	0.807
NULL	Nucleic_Acids_Res_2005_Jun_8_33(10)_3283-3291.nxml.txt.nlp	15944449	SENT444	7	7	41	41	melphalan	ERCC1	PA450354	2067	0.807
NULL	Nat_Commun_2014_Nov_19_5_5479.nxml.txt.nlp	25407222	SENT538	18	18	7	7	dextran	YTS	PA449261	8565	0.807
NULL	Mol_Cancer_2013_Mar_5_12_17.nxml.txt.nlp	23497256	SENT8	37	37	3	3	sunitinib	p53	PA162372840	7157	0.807
NULL	Arch_Plast_Surg_2012_Sep_12_39(5)_540-545.nxml.txt.nlp	23094252	SENT53	9	9	22	22	propofol	TCI	PA451141	6947	0.807
NULL	Cancer_Med_2013_Aug_10_2(4)_496-506.nxml.txt.nlp	24156022	SENT23	16	16	9	9	cetuximab	PTEN	PA10040	5728	0.807
NULL	Oncol_Lett_2013_Feb_16_5(2)_559-563.nxml.txt.nlp	23420289	SENT32	20	20	28	28	trastuzumab	HER2	PA451743	2064	0.807
NULL	Eur_Arch_Psychiatry_Clin_Neurosci_2006_Dec_7_256(8)_464-475.nxml.txt.nlp	16960655	SENT487	35	35	17	17	haloperidol	Gen	PA449841	348654	0.807
NULL	Neuropsychopharmacology_2009_Sep_13_34(10)_2197-2207.nxml.txt.nlp	19440190	SENT199	4	4	7	7	fluoxetine	P21	PA449673	1026;9338	0.807
NULL	Case_Rep_Hematol_2013_Feb_6_2013_541783.nxml.txt.nlp	23476834	SENT37	14	14	6	6	pyrimethamine	CHOP	PA451193	1649	0.807
NULL	Br_J_Cancer_1995_Aug_72(2)_418-423.nxml.txt.nlp	7640227	SENT0	16	16	25	25	verapamil	MDR1	PA451868	5243	0.807
NULL	Evid_Based_Complement_Alternat_Med_2013_Mar_26_2013_625892.nxml.txt.nlp	23589719	SENT250	0	0	4	4	probenecid	TAS2R16	PA451106	50833	0.807
NULL	J_Med_Genet_2013_Sep_24_50(9)_567-578.nxml.txt.nlp	23709754	SENT147	5	5	17	17	staurosporine	IFN	PA165109623	3439	0.807
NULL	Eur_J_Pharmacol_2012_Jul_5_686(1-3)_22-31.nxml.txt.nlp	22564863	SENT131	14	14	4	4	memantine	GluN3A	PA10364	116443	0.807
NULL	Cardiovasc_Diabetol_2013_Mar_28_12_53.nxml.txt.nlp	23537430	SENT21	9	9	13	13	rosiglitazone	gamma	PA451283	9913	0.807
NULL	Chin_J_Cancer_2011_Oct_30(10)_690-700.nxml.txt.nlp	21959046	SENT125	10	10	12	12	topotecan	TPT	PA451729	23590;6469	0.807
NULL	Breast_Cancer_Res_2008_Mar_29_10(2)_R28.nxml.txt.nlp	18373870	SENT135	19	19	23	23	estradiol	c-Myc	PA449503	4609	0.807
NULL	Br_J_Cancer_2012_May_8_106(10)_1689-1696.nxml.txt.nlp	22531631	SENT154	0	0	9	9	lovastatin	RhoA	PA450272	387	0.807
NULL	J_Mol_Med_(Berl)_2014_May_10_92(7)_709-722.nxml.txt.nlp	24811491	SENT127	18	18	30	30	panitumumab	HER2	PA162373091	2064	0.807
NULL	Braz_J_Med_Biol_Res_2013_Aug_13_46(8)_650-658.nxml.txt.nlp	23969971	SENT191	20	20	35	35	oxaliplatin	STAT3	PA131285527	6774	0.807
NULL	Oncogenesis_2014_Dec_15_3(12)_e133.nxml.txt.nlp	25500906	SENT72	25	25	17	17	trastuzumab	HER2	PA451743	2064	0.807
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1126-1134.nxml.txt.nlp	21364592	SENT134	22	22	8	8	cisplatin	CYP2A6	PA449014	1548	0.807
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Oct_31_66(Pt_11)_o2999.nxml.txt.nlp	21589160	SENT65	18	18	12	12	ethanol	mol	PA448073	90527	0.807
NULL	J_Hematol_Oncol_2011_Jun_14_4_29.nxml.txt.nlp	21672194	SENT132	5	5	16	16	pazopanib	VEGFR	PA165291492	3791	0.807
NULL	Indian_J_Pharm_Sci_2008_Jan-Feb_70(1)_102-105.nxml.txt.nlp	20390092	SENT40	30	30	19	19	domperidone	LAN	PA134711056	9993	0.807
NULL	Int_J_Vasc_Med_2013_Mar_31_2013_543141.nxml.txt.nlp	23606968	SENT176	4	4	13	13	methylprednisolone	IL-17	PA450466	3605	0.807
NULL	Exp_Ther_Med_2012_Sep_12_4(3)_475-480.nxml.txt.nlp	23181121	SENT156	6	6	16	16	vincristine	CHOP	PA451879	1649	0.807
NULL	Oncogene_2014_Sep_11_33(37)_4613-4622.nxml.txt.nlp	24662828	SENT205	11	11	22	22	paraformaldehyde	CD63	PA450790	967	0.807
NULL	J_Biol_Chem_2009_Jul_10_284(28)_18904-18912.nxml.txt.nlp	19473990	SENT62	31	31	2	2	l-glutamine	P19	PA10090	51561	0.807
NULL	Oncoimmunology_2013_Sep_1_2(9)_e25962.nxml.txt.nlp	24327938	SENT36	20	20	7	7	cyclophosphamide	OX40	PA449165	7293	0.807
NULL	Eur_J_Clin_Pharmacol_2008_Feb_26_64(2)_133-157.nxml.txt.nlp	18224312	SENT288	20	20	13	13	thioguanine	TPMT	PA451663	7172	0.807
NULL	Oncogene_2013_Nov_28_32(48)_5439-5448.nxml.txt.nlp	23563182	SENT137	29	29	41	41	etoposide	TRAIL	PA449552	8743	0.807
NULL	Int_J_Endocrinol_2013_Nov_13_2013_686315.nxml.txt.nlp	24324494	SENT72	29	29	8	8	repaglinide	CYP2C9	PA451234	1559	0.807
NULL	Oncoimmunology_2013_Dec_1_2(12)_e26837.nxml.txt.nlp	24501687	SENT18	22	22	14	14	clodronate	CD40	PA10239	958	0.807
NULL	Front_Microbiol_2014_Mar_14_5_99.nxml.txt.nlp	24672516	SENT86	30	30	39	39	caspofungin	TLR9	PA164743013	54106	0.807
NULL	J_Clin_Biochem_Nutr_2007_Sep_29_41(2)_84-91.nxml.txt.nlp	18193101	SENT117	25	25	7	7	lansoprazole	MCP-1	PA450180	6347	0.807
NULL	Mediators_Inflamm_2011_Jun_28_2011_949072.nxml.txt.nlp	21772670	SENT144	10	10	21	21	estradiol	APOE	PA449503	348	0.807
NULL	Breast_Cancer_Res_2007_Jan_23_9(1)_R7.nxml.txt.nlp	17244352	SENT142	19	19	12	12	tamoxifen	CYP3A5	PA451581	1577	0.807
NULL	Adipocyte_2013_Jan_1_2(1)_17-27.nxml.txt.nlp	23599907	SENT237	6	6	26	26	acetone	SDS	PA448025	51119;10993	0.807
NULL	Hum_Mol_Genet_2008_Jun_1_17(11)_1527-1539.nxml.txt.nlp	18267959	SENT135	25	25	28	28	doxycycline	neuroserpin	PA449415	5274	0.807
NULL	Mol_Cancer_2014_Jun_5_13_143.nxml.txt.nlp	24898067	SENT37	19	19	15	15	maytansine	DM1	PA165291473	338023;1760;28509	0.807
NULL	Oncotarget_2014_Jun_8_5(17)_7446-7457.nxml.txt.nlp	25277184	SENT33	21	21	5	5	cisplatin	TRIM8	PA449014	81603	0.807
NULL	Ann_Indian_Acad_Neurol_2010_Jan-Mar_13(1)_6-13.nxml.txt.nlp	20436740	SENT263	18	18	39	39	prasugrel	PAR-1	PA154410481	2011;2149	0.807
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_May_31_68(Pt_6)_o1953.nxml.txt.nlp	22719702	SENT69	14	14	23	23	ethanol	mol	PA448073	90527	0.807
NULL	EMBO_Mol_Med_2012_Sep_7_4(9)_896-909.nxml.txt.nlp	22887866	SENT185	0	0	12	12	lovastatin	c-Myc	PA450272	4609	0.807
NULL	Oncoimmunology_2012_May_1_1(3)_271-278.nxml.txt.nlp	22737602	SENT5	26	26	17	17	oxaliplatin	P2RX7	PA131285527	5027	0.807
NULL	Ann_Rheum_Dis_2008_Oct_25_68(10)_1644-1650.nxml.txt.nlp	18957484	SENT131	0	0	5	5	leflunomide	STAT6	PA450192	6778	0.807
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1013.nxml.txt.nlp	24457957	SENT125	13	13	19	19	orlistat	NOXA	PA164776864	5366	0.807
NULL	Oncoscience_2014_Mar_12_1(2)_167-179.nxml.txt.nlp	25126591	SENT228	33	33	5	5	temsirolimus	PTEN	PA164746890	5728	0.807
NULL	Br_J_Haematol_2014_Feb_16_164(4)_586-596.nxml.txt.nlp	24236640	SENT161	27	27	9	9	carboplatin	EPO	PA448803	7076;8288;2056	0.807
NULL	Nat_Med_2010_Jun_23_16(6)_671-677.nxml.txt.nlp	20495567	SENT71	5	5	29	29	sorafenib	BCL2	PA7000	596	0.807
NULL	Mol_Neurodegener_2011_Aug_8_6_57.nxml.txt.nlp	21819629	SENT13	13	13	4	4	arsenite	TDP-43	PA452638	23435	0.807
NULL	Iran_J_Reprod_Med_2013_Jul_11(7)_565-576.nxml.txt.nlp	24639792	SENT16	9	9	21	21	nonoxynol-9	SP-D	PA450648	6441	0.807
NULL	Int_J_Biol_Sci_2013_Oct_12_9(10)_1013-1020.nxml.txt.nlp	24250246	SENT142	25	25	19	19	imatinib	CPX	PA10804	1371;10682;1377	0.807
NULL	Clin_Interv_Aging_2011_Jul_7_6_193-198.nxml.txt.nlp	21822374	SENT56	15	15	32	32	clopidogrel	DES	PA449053	1674	0.807
NULL	Chem_Cent_J_2012_Sep_20_6_105.nxml.txt.nlp	22995678	SENT94	12	12	17	17	cefixime	C10	PA164768821	113246	0.807
NULL	Toxins_(Basel)_2010_Mar_31_2(4)_517-551.nxml.txt.nlp	22069598	SENT1541	15	15	4	4	resveratrol	DR4		8797	0.807
NULL	Int_J_Mol_Sci_2014_Sep_23_15(9)_16911-16935.nxml.txt.nlp	25250910	SENT107	3	3	37	37	potassium	mol	PA451047	90527	0.807
NULL	Case_Rep_Gastroenterol_2012_Jul_5_6(2)_438-445.nxml.txt.nlp	22855659	SENT36	20	20	6	6	cyclophosphamide	PPL	PA449165	5493	0.807
NULL	Breast_Cancer_Res_Treat_2014_Dec_19_143(2)_351-358.nxml.txt.nlp	24352574	SENT17	3	3	12	12	docetaxel	HER-2	PA449383	2064	0.807
NULL	Br_J_Cancer_2011_Apr_12_104(8)_1256-1261.nxml.txt.nlp	21448165	SENT138	21	21	13	13	sorafenib	IL-2	PA7000	3558	0.807
NULL	Tuberc_Respir_Dis_(Seoul)_2013_Dec_24_75(6)_231-235.nxml.txt.nlp	24416052	SENT47	20	20	11	11	dasatinib	EGFR	PA162372878	1956	0.807
NULL	Virol_J_2010_Oct_12_7_265.nxml.txt.nlp	20939906	SENT13	4	4	1	1	ribavirin	IFN	PA451241	3439	0.807
NULL	J_Hematol_Oncol_2009_Apr_22_2_18.nxml.txt.nlp	19386128	SENT93	8	8	31	31	cetuximab	KRAS	PA10040	3845	0.807
NULL	Exp_Diabetes_Res_2012_Oct_15_2012_465282.nxml.txt.nlp	23118742	SENT131	25	25	32	32	metformin	FGF21	PA450395	26291	0.807
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT107	13	13	24	24	celecoxib	IL-6	PA448871	3569	0.807
NULL	Oncotarget_2011_Dec_31_2(12)_1322-1328.nxml.txt.nlp	22249159	SENT52	13	13	28	28	metformin	AMPK	PA450395	5563	0.807
NULL	J_Korean_Assoc_Oral_Maxillofac_Surg_2014_Dec_26_40(6)_291-296.nxml.txt.nlp	25551094	SENT142	2	2	6	6	alendronate	M-CSF	PA448082	1435	0.807
NULL	Pharmaceuticals_(Basel)_2011_Jun_30_4(7)_976-991.nxml.txt.nlp	NULL	SENT43	5	5	9	9	rimonabant	CB1	PA152407999	1268	0.807
NULL	Clin_Drug_Investig_2015_Dec_4_35_45-51.nxml.txt.nlp	25471740	SENT118	15	15	31	31	icosapent	CYP3A4	PA164746077	1576	0.807
NULL	J_Mol_Signal_2012_May_14_7_4.nxml.txt.nlp	22583680	SENT191	1	1	32	32	rolipram	AKAP5	PA153906323	9495	0.807
NULL	Ann_Med_Surg_(Lond)_2014_Jun_19_3(3)_60-64.nxml.txt.nlp	25568788	SENT16	0	0	20	20	neostigmine	NNT	PA450611	23530	0.807
NULL	Eur_J_Endocrinol_2009_Nov_161(5)_655-662.nxml.txt.nlp	19729432	SENT28	24	24	13	13	metformin	ghrelin	PA450395	51738	0.807
NULL	Ann_Oncol_2014_Apr_26_25(4)_801-807.nxml.txt.nlp	24577117	SENT22	23	23	31	31	cetuximab	p16	PA10040	1029	0.807
NULL	Cardiol_Res_Pract_2013_Jan_31_2013_128795.nxml.txt.nlp	23431496	SENT16	2	2	29	29	clopidogrel	CYP2C19	PA449053	1557	0.807
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jun_11_67(Pt_7)_m884-m885.nxml.txt.nlp	21836877	SENT71	14	14	2	2	l-tyrosine	NO3	PA451822	4681	0.807
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_May_14_65(Pt_6)_o1266.nxml.txt.nlp	21583130	SENT51	35	35	31	31	benzaldehyde	mol	PA448571	90527	0.807
NULL	Ann_Oncol_2011_Mar_8_22(3)_503-514.nxml.txt.nlp	20616198	SENT302	7	7	28	28	anastrozole	IMPACT	PA448432	55364	0.807
NULL	Nat_Commun_2014_Nov_25_5_5548.nxml.txt.nlp	25420520	SENT57	12	12	3	3	cabazitaxel	ERG	PA165958401	2078	0.807
NULL	Indian_J_Pharmacol_2014_Sep-Oct_46(5)_549-550.nxml.txt.nlp	25298588	SENT64	29	29	5	5	warfarin	VKORC1	PA451906	79001	0.807
NULL	Eur_J_Clin_Pharmacol_2011_May_9_67(5)_477-482.nxml.txt.nlp	21305273	SENT121	31	31	18	18	atropine	ADRB1	PA448505	153	0.807
NULL	Biomed_Res_Int_2013_Jul_31_2013_692071.nxml.txt.nlp	23984399	SENT122	18	18	6	6	l-arginine	OCT1	PA448478	5451;6580	0.807
NULL	Adipocyte_2012_Jul_1_1(3)_123-131.nxml.txt.nlp	23145367	SENT136	30	30	12	12	lipase	CGI-58	PA450239	51099	0.807
NULL	Eur_J_Med_Res_2009_Nov_24_14(Suppl_3)_17-21.nxml.txt.nlp	19959412	SENT12	26	26	17	17	raltegravir	UGT		7361;7355	0.807
NULL	J_Cell_Mol_Med_2013_Jun_15_17(6)_792-799.nxml.txt.nlp	23672538	SENT64	32	32	18	18	fluorescein	CD66b	PA164746009	1088	0.807
NULL	Genet_Sel_Evol_2014_Mar_4_46(1)_19.nxml.txt.nlp	24592996	SENT152	2	2	18	18	taurine	MYL12A	PA451590	10627	0.807
NULL	J_Adv_Pract_Oncol_2012_Jul_1_Jul-Aug_3(4)_245-248.nxml.txt.nlp	25031952	SENT122	8	8	4	4	tamoxifen	ATAC	PA451581	6375	0.807
NULL	Front_Neurosci_2011_Jan_20_5_3.nxml.txt.nlp	21270945	SENT223	2	2	12	12	ethanol	ANOVA	PA448073	4858	0.807
NULL	Exp_Ther_Med_2014_Apr_13_7(4)_923-928.nxml.txt.nlp	24669252	SENT12	21	21	15	15	estradiol	PRL	PA449503	5617	0.807
NULL	Crit_Care_1999_Dec_23_4(Suppl_A)_4.nxml.txt.nlp	NULL	SENT18	19	19	15	15	heparin	ACT	PA449855	12;11332;9457;641455	0.807
NULL	Chin_J_Cancer_2011_Oct_30(10)_690-700.nxml.txt.nlp	21959046	SENT69	17	17	5	5	paraformaldehyde	TPT	PA450790	23590;6469	0.807
NULL	J_Immunol_Res_2014_Jul_21_2014_297073.nxml.txt.nlp	25143957	SENT62	13	13	2	2	glucosamine	KIR2DL4	PA164747613	3805	0.807
NULL	Front_Oncol_2014_Nov_10_4_318.nxml.txt.nlp	25426449	SENT111	0	0	9	9	perifosine	AKT	PA165291471	207	0.807
NULL	Sci_Rep_2014_Dec_12_4_7405.nxml.txt.nlp	25502009	SENT391	33	33	14	14	l-leucine	p38	PA450197	10598;1432;7965	0.807
NULL	Neuropsychopharmacology_2009_May_1_34(6)_1443-1453.nxml.txt.nlp	18830237	SENT66	7	7	11	11	ethanol	hole	PA448073	80757	0.807
NULL	Acta_Pharmacol_Sin_2013_Jun_5_34(6)_805-810.nxml.txt.nlp	23736005	SENT13	22	22	44	44	piperazine	MDM2	PA450977	4193	0.807
NULL	Inflammation_2014_Sep_5_37(1)_1-9.nxml.txt.nlp	24005897	SENT152	17	17	6	6	diclofenac	COX	PA449293	1351	0.807
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Aug_17_67(Pt_9)_o2362-o2363.nxml.txt.nlp	22064645	SENT3	18	18	2	2	benzaldehyde	mol	PA448571	90527	0.807
NULL	Br_J_Cancer_2013_Jun_25_108(12)_2464-2469.nxml.txt.nlp	23695016	SENT4	12	12	19	19	paclitaxel	CRT	PA450761	811	0.807
NULL	Indian_J_Endocrinol_Metab_2013_Dec_17(Suppl_3)_S696-S699.nxml.txt.nlp	24910842	SENT82	3	3	11	11	estradiol	PRL	PA449503	5617	0.807
NULL	Chemother_Res_Pract_2012_Dec_20_2012_743193.nxml.txt.nlp	23320171	SENT49	13	13	19	19	docetaxel	HER2	PA449383	2064	0.807
NULL	J_Breast_Cancer_2013_Jun_28_16(2)_220-228.nxml.txt.nlp	23843857	SENT195	25	25	27	27	tamoxifen	aromatase	PA451581	1588	0.807
NULL	Br_J_Cancer_2010_Jun_8_102(12)_1707-1716.nxml.txt.nlp	20461078	SENT181	26	26	3	3	bortezomib	PARP	PA10252	142	0.807
NULL	Breast_Cancer_Res_2007_Dec_20_9(Suppl_2)_S13.nxml.txt.nlp	NULL	SENT51	12	12	31	31	tamoxifen	ATAC	PA451581	6375	0.807
NULL	Front_Physiol_2012_Sep_28_3_385.nxml.txt.nlp	23060810	SENT85	16	16	0	0	haloperidol	H-FABP	PA449841	2170	0.807
NULL	Clin_Exp_Gastroenterol_2012_Sep_17_5_151-157.nxml.txt.nlp	23028235	SENT105	12	12	0	0	metronidazole	Mal	PA450484	114609	0.807
NULL	J_Breast_Cancer_2013_Mar_31_16(1)_23-31.nxml.txt.nlp	23593078	SENT150	18	18	25	25	curcumin	DNMT1	PA151958596	1786	0.807
NULL	Int_J_Nephrol_2011_Feb_27_2011_716526.nxml.txt.nlp	22518309	SENT9	34	34	12	12	paricalcitol	Era	PA450798	2099	0.807
NULL	Eur_J_Clin_Pharmacol_2014_Oct_8_70(12)_1433-1441.nxml.txt.nlp	25291992	SENT7	45	45	23	23	risperidone	B12	PA451257	7126;4709	0.807
NULL	Cell_Cycle_2012_Nov_1_11(21)_3983-3996.nxml.txt.nlp	22987153	SENT212	8	8	2	2	cisplatin	EXO1	PA449014	9156	0.807
NULL	J_Cardiothorac_Surg_2013_May_6_8_122.nxml.txt.nlp	23641948	SENT46	17	17	4	4	heparin	ACT	PA449855	12;11332;9457;641455	0.807
NULL	Fibrogenesis_Tissue_Repair_2011_Jan_6_4_1.nxml.txt.nlp	21211003	SENT186	18	18	3	3	collagenase	ECM	PA449107	22915	0.807
NULL	Acta_Pharmacol_Sin_2011_Nov_3_32(11)_1364-1372.nxml.txt.nlp	21963898	SENT236	11	11	16	16	berberine	TLR4	PA165860812	7099	0.807
NULL	Cell_Commun_Signal_2014_May_15_12_34.nxml.txt.nlp	24885272	SENT179	9	9	4	4	heparin	FGF2	PA449855	2247;2258	0.807
NULL	Mol_Cancer_2010_May_20_9_115.nxml.txt.nlp	20487546	SENT86	27	27	11	11	fludarabine	CLL-1	PA449655	160364	0.807
NULL	Nat_Med_2011_May_1_17(5)_604-609.nxml.txt.nlp	21532597	SENT123	15	15	5	5	daclizumab	IL-7	PA164764446	3574	0.807
NULL	Cell_Tissue_Res_2013_May_17_354(1)_259-271.nxml.txt.nlp	23681253	SENT57	17	17	22	22	methylphenidate	AMPH	PA450464	273	0.807
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT115	25	25	32	32	cisplatin	p53	PA449014	7157	0.807
NULL	Cancer_Cell_Int_2005_Jul_24_5_22.nxml.txt.nlp	16042792	SENT173	18	18	22	22	vincristine	NAC	PA451879	22861	0.807
NULL	Acta_Pharmacol_Sin_2010_May_5_31(5)_540-545.nxml.txt.nlp	20364157	SENT184	0	0	5	5	hemin	HO-1	PA449849	3162	0.807
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT150	11	11	20	20	pp2	ERK		5594	0.807
NULL	Arthritis_Res_Ther_2012_Jun_25_14(3)_215.nxml.txt.nlp	22731694	SENT143	7	7	22	22	cyclosporine	IFN	PA449167	3439	0.807
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1075.nxml.txt.nlp	24556690	SENT137	29	29	34	34	spermine	SSAT	PA164781199	6303	0.807
NULL	Nature_2012_Jan_11_481(7382)_463-468.nxml.txt.nlp	22237023	SENT326	26	26	4	4	forskolin	UCP1	PA146096022	7350	0.807
NULL	Br_J_Haematol_2014_Mar_6_164(6)_759-766.nxml.txt.nlp	24387053	SENT208	14	14	9	9	eculizumab	PEX	PA164776637	5251	0.807
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT295	3	3	0	0	cetuximab	EGFR	PA10040	1956	0.807
NULL	Clin_Kidney_J_2013_Jun_11_6(3)_287-294.nxml.txt.nlp	23717787	SENT152	8	8	32	32	cinacalcet	PTH	PA164776671	5741	0.807
NULL	Evid_Based_Complement_Alternat_Med_2013_May_28_2013_464508.nxml.txt.nlp	23781262	SENT159	27	27	9	9	amiodarone	FKBP12	PA448383	2280	0.807
NULL	Mol_Cancer_2006_Sep_5_5_34.nxml.txt.nlp	16953886	SENT19	25	25	0	0	doxorubicin	XIAP	PA449412	331	0.807
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1150.nxml.txt.nlp	24675468	SENT52	15	15	8	8	ethanol	Bcl-2	PA448073	596	0.807
NULL	Hum_Genomics_2009_Jan_1_3(2)_169-190.nxml.txt.nlp	19164093	SENT29	4	4	0	0	diazepam	CYP2C19	PA449283	1557	0.807
NULL	Chemother_Res_Pract_2012_Aug_29_2012_817297.nxml.txt.nlp	22970367	SENT95	9	9	14	14	gefitinib	EGFR	PA131301952	1956	0.806
NULL	Breast_Cancer_Res_2011_Jan_17_13(1)_R5.nxml.txt.nlp	21241485	SENT323	28	28	33	33	tamoxifen	EGF	PA451581	1950	0.806
NULL	J_Gen_Physiol_2009_May_133(5)_525-546.nxml.txt.nlp	19398778	SENT556	10	10	7	7	capsaicin	TRPV1	PA448776	7442	0.806
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT173	18	18	12	12	sulindac	survivin	PA451565	332	0.806
NULL	Int_J_Nanomedicine_2012_Sep_21_7_5091-5106.nxml.txt.nlp	23049256	SENT7	11	11	2	2	protamine	SOD1	PA10366	6647	0.806
NULL	Cell_Death_Dis_2014_Feb_13_5(2)_e1055.nxml.txt.nlp	24525731	SENT123	12	12	2	2	cisplatin	XRCC1	PA449014	7515	0.806
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT87	25	25	14	14	atorvastatin	survivin	PA448500	332	0.806
NULL	Oncoimmunology_2013_Dec_1_2(12)_e27215.nxml.txt.nlp	24501692	SENT32	31	31	5	5	panitumumab	STAT1	PA162373091	6772	0.806
NULL	Br_J_Cancer_2009_Nov_3_101(9)_1620-1629.nxml.txt.nlp	19809428	SENT185	14	14	5	5	geldanamycin	PC3	PA152031327	57332;7832;5122	0.806
NULL	Neural_Regen_Res_2013_Jul_15_8(20)_1853-1862.nxml.txt.nlp	25206494	SENT169	14	14	7	7	ethanol	JNK	PA448073	5599	0.806
NULL	Evid_Based_Complement_Alternat_Med_2011_Jan_4_2011_392627.nxml.txt.nlp	19542183	SENT130	2	2	18	18	glibenclamide	mol	PA449782	90527	0.806
NULL	Cough_2010_Aug_9_6_7.nxml.txt.nlp	20696045	SENT26	9	9	6	6	indomethacin	COX	PA449982	1351	0.806
NULL	Ann_Indian_Acad_Neurol_2010_Apr-Jun_13(2)_136-138.nxml.txt.nlp	20814499	SENT43	22	22	0	0	voriconazole	CD4	PA10233	920	0.806
NULL	EMBO_Mol_Med_2011_May_3(5)_266-278.nxml.txt.nlp	21438154	SENT113	0	0	8	8	oxaliplatin	HCN1	PA131285527	348980	0.806
NULL	Breast_Cancer_Res_2010_Oct_22_12(Suppl_2)_S1.nxml.txt.nlp	21050422	SENT109	20	20	25	25	maytansine	DM1	PA165291473	338023;1760;28509	0.806
NULL	eLife_2013_Nov_5_2_e00969.nxml.txt.nlp	24192036	SENT340	9	9	20	20	vemurafenib	ERK	PA165946873	5594	0.806
NULL	Curr_Opin_Infect_Dis_2013_Dec_6_26(6)_538-544.nxml.txt.nlp	24126716	SENT143	13	13	18	18	fosfomycin	PARI	PA164748039	55010	0.806
NULL	Arthritis_Res_Ther_2012_May_1_14(3)_R99.nxml.txt.nlp	22546542	SENT6	34	34	5	5	infliximab	CD4	PA452639	920	0.806
NULL	J_Gen_Physiol_2000_Jun_1_115(6)_685-696.nxml.txt.nlp	10828243	SENT6	8	8	24	24	genistein	OLF	PA165109660	83857	0.806
NULL	Br_J_Pharmacol_2012_Jan_165(2)_390-400.nxml.txt.nlp	21671897	SENT180	0	0	4	4	suramin	P2X1	PA10292	5023	0.806
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT116	40	40	31	31	pemetrexed	UNG	PA10810	7374	0.806
NULL	AIDS_Res_Ther_2014_Aug_4_11_25.nxml.txt.nlp	25120580	SENT10	3	3	0	0	atazanavir	CYP3A4	PA10251	1576	0.806
NULL	Drugs_R_D_2014_Sep_31_14(3)_177-184.nxml.txt.nlp	25079671	SENT132	3	3	22	22	miglitol	MCP-1	PA164776726	6347	0.806
NULL	Int_J_Biol_Sci_2012_Oct_25_8(9)_1281-1290.nxml.txt.nlp	23136556	SENT85	40	40	25	25	methacholine	IL-4	PA165958382	3565	0.806
NULL	JAKSTAT_2014_Jun_12_3_e29554.nxml.txt.nlp	25105067	SENT25	3	3	6	6	propofol	Bcl-2	PA451141	596	0.806
NULL	Diabetes_Obes_Metab_2010_Aug_12(8)_700-708.nxml.txt.nlp	20590747	SENT135	7	7	0	0	vildagliptin	PPG	PA165958346	5552	0.806
NULL	Aging_(Albany_NY)_2010_Jan_11_2(1)_7-27.nxml.txt.nlp	20228939	SENT113	21	21	2	2	nadh	NPAS2	PA164755085	4862	0.806
NULL	Int_J_Biol_Sci_2015_Jan_1_11(2)_144-155.nxml.txt.nlp	25561897	SENT184	20	20	28	28	cisplatin	POLB	PA449014	5423	0.806
NULL	Breast_Cancer_Res_Treat_2012_Apr_3_132(3)_895-915.nxml.txt.nlp	22048814	SENT354	8	8	29	29	anastrozole	IMPACT	PA448432	55364	0.806
NULL	Front_Neuroanat_2011_Jul_12_5_38.nxml.txt.nlp	21808606	SENT186	35	35	28	28	haloperidol	MSK1	PA449841	9252	0.806
NULL	Contemp_Oncol_(Pozn)_2012_Jan_4_16(6)_582-585.nxml.txt.nlp	23788948	SENT108	6	6	15	15	lapatinib	HER2	PA152241907	2064	0.806
NULL	Int_J_Biol_Sci_2012_Jul_7_8(6)_913-934.nxml.txt.nlp	22811614	SENT417	27	27	23	23	exenatide	GLP-1	PA164749238	100125288	0.806
NULL	J_Cell_Sci_2014_Nov_1_127(21)_4602-4619.nxml.txt.nlp	25189622	SENT481	9	9	25	25	thrombin	GRAF2	PA451674	79658	0.806
NULL	Curr_Oncol_2009_Jul_16(Suppl_2)_S14-S23.nxml.txt.nlp	19672417	SENT160	22	22	5	5	tamoxifen	ATAC	PA451581	6375	0.806
NULL	Br_J_Haematol_2014_Mar_13_164(1)_811-821.nxml.txt.nlp	24328678	SENT215	6	6	21	21	lenalidomide	Aiolos	PA162363968	22806	0.806
NULL	Front_Microbiol_2015_Jan_12_5_776.nxml.txt.nlp	25628615	SENT74	23	23	16	16	nitrogen	DSE	PA450643	29940	0.806
NULL	Clin_Psychopharmacol_Neurosci_2011_Apr_30_9(1)_36-43.nxml.txt.nlp	23431025	SENT75	28	28	10	10	aripiprazole	ANOVA	PA10026	4858	0.806
NULL	Int_J_Nanomedicine_2008_Mar_3(1)_31-49.nxml.txt.nlp	18488414	SENT316	0	0	9	9	galactose	SPG	PA449725	55764	0.806
NULL	ScientificWorldJournal_2012_Apr_26_2012_358102.nxml.txt.nlp	22645419	SENT158	18	18	10	10	losartan	PRL	PA450268	5617	0.806
NULL	J_Clin_Gastroenterol_2014_Sep_24_48(8)_679-686.nxml.txt.nlp	24921215	SENT242	18	18	7	7	ribavirin	IL28B	PA451241	282617	0.806
NULL	Arch_Drug_Inf_2011_Mar_4(1)_1-9.nxml.txt.nlp	21572514	SENT132	10	10	3	3	vinblastine	P-gp	PA451877	5243	0.806
NULL	Iran_J_Pharm_Res_2013_Summer_12(3)_457-469.nxml.txt.nlp	24250652	SENT42	0	0	4	4	indomethacin	COX	PA449982	1351	0.806
NULL	Core_Evid_2010_Jul_27_5_1-10.nxml.txt.nlp	20694135	SENT166	14	14	7	7	entacapone	CLE	PA164748726	51637	0.806
NULL	Oxid_Med_Cell_Longev_2013_Apr_21_2013_412576.nxml.txt.nlp	23710286	SENT6	3	3	9	9	curcumin	NRF2	PA151958596	2551;4780	0.806
NULL	Oncotarget_2014_Jun_3_5(13)_4920-4928.nxml.txt.nlp	24952482	SENT96	9	9	14	14	crizotinib	HGF	PA165946122	3569;6654;3082	0.806
NULL	J_Gen_Physiol_2003_Mar_121(3)_181-197.nxml.txt.nlp	12601083	SENT329	3	3	11	11	glibenclamide	SUR1	PA449782	6833	0.806
NULL	Eur_J_Clin_Pharmacol_2010_Nov_29_66(11)_1131-1136.nxml.txt.nlp	20669013	SENT130	39	39	34	34	voriconazole	CYP3A4	PA10233	1576	0.806
NULL	Biomed_Res_Int_2014_Jan_12_2014_276918.nxml.txt.nlp	24524073	SENT98	20	20	35	35	venlafaxine	CYP2C19	PA451866	1557	0.806
NULL	Front_Immunol_2013_Sep_11_4_272.nxml.txt.nlp	24062740	SENT179	15	15	33	33	dextran	HIF-1	PA449261	29072	0.806
NULL	Indian_Dermatol_Online_J_2011_Jul-Dec_2(2)_111-119.nxml.txt.nlp	23130241	SENT326	10	10	0	0	methotrexate	FAE	PA450428	2178	0.806
NULL	Evol_Med_Public_Health_2013_May_15_2013(1)_118-134.nxml.txt.nlp	24481193	SENT228	7	7	14	14	amodiaquine	CYP1A1	PA448404	1543	0.806
NULL	Pharmaceuticals_(Basel)_2012_Sep_12_5(9)_1008-1020.nxml.txt.nlp	24280702	SENT594	9	9	12	12	docetaxel	survivin	PA449383	332	0.806
NULL	Chemother_Res_Pract_2012_Aug_29_2012_817297.nxml.txt.nlp	22970367	SENT40	18	18	14	14	erlotinib	EGFR	PA134687924	1956	0.806
NULL	J_Mol_Signal_2011_May_16_6_4.nxml.txt.nlp	21575178	SENT171	7	7	11	11	arsenite	HSP27	PA452638	3315	0.806
NULL	J_Inflamm_(Lond)_2005_Oct_31_2_14.nxml.txt.nlp	16259633	SENT312	20	20	34	34	staurosporine	PKG	PA165109623	5592	0.806
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_May_21_3(5)_e115.nxml.txt.nlp	24850445	SENT221	17	17	20	20	trastuzumab	HER-2	PA451743	2064	0.806
NULL	Oncotarget_2012_Nov_17_3(12)_1600-1614.nxml.txt.nlp	23307622	SENT6	26	26	9	9	lapatinib	ATG12	PA152241907	9140	0.806
NULL	Exp_Lung_Res_2013_Oct_1_39(8)_336-348.nxml.txt.nlp	23919450	SENT199	9	9	4	4	thrombin	PAR-1	PA451674	2011;2149	0.806
NULL	Curr_Heart_Fail_Rep_2011_Dec_13_8(4)_242-251.nxml.txt.nlp	21842146	SENT139	26	26	24	24	exenatide	GLP-1	PA164749238	100125288	0.806
NULL	J_Gen_Physiol_2003_Jan_121(1)_3-16.nxml.txt.nlp	12508050	SENT279	10	10	17	17	nifedipine	c-fos	PA450631	2353	0.806
NULL	Ann_Oncol_2011_Mar_8_22(3)_503-514.nxml.txt.nlp	20616198	SENT102	7	7	1	1	tamoxifen	ATAC	PA451581	6375	0.806
NULL	Clin_Cosmet_Investig_Dermatol_2013_Mar_14_6_75-80.nxml.txt.nlp	23515267	SENT52	16	16	9	9	etanercept	IL-17	PA449515	3605	0.806
NULL	Curr_Opin_Pharmacol_2013_Aug_13(4)_497-503.nxml.txt.nlp	23664091	SENT62	17	17	29	29	panitumumab	KRAS	PA162373091	3845	0.806
NULL	Front_Oncol_2014_Sep_11_4_245.nxml.txt.nlp	25309871	SENT43	20	20	22	22	thrombin	PAR1	PA451674	79581;2149	0.806
NULL	Cancers_(Basel)_2012_Oct_29_4(4)_1146-1160.nxml.txt.nlp	24213502	SENT246	16	16	21	21	tamoxifen	aromatase	PA451581	1588	0.806
NULL	Ann_Hematol_2014_Sep_10_93(1)_1-11.nxml.txt.nlp	24018623	SENT162	16	16	32	32	lenalidomide	FLT3	PA162363968	2322	0.806
NULL	Br_J_Cancer_2013_Jul_23_109(2)_502-511.nxml.txt.nlp	23799850	SENT171	23	23	19	19	gemcitabine	SMARCC1	PA449748	6599	0.806
NULL	Indian_J_Med_Paediatr_Oncol_2014_Jan-Mar_35(1)_1-2.nxml.txt.nlp	25006275	SENT23	7	7	19	19	exemestane	aromatase	PA449563	1588	0.806
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT305	0	0	28	28	metformin	HIF-1	PA450395	29072	0.806
NULL	Br_J_Cancer_2011_Aug_23_105(5)_649-657.nxml.txt.nlp	21811251	SENT152	24	24	17	17	gefitinib	IGF1R	PA131301952	3480	0.806
NULL	Mol_Cancer_2009_Jul_14_8_48.nxml.txt.nlp	19602291	SENT29	18	18	6	6	vincristine	BRCA2	PA451879	675	0.806
NULL	Oncotarget_2014_Nov_3_5(20)_10127-10139.nxml.txt.nlp	25333256	SENT147	6	6	9	9	vemurafenib	TRIM16	PA165946873	10626	0.806
NULL	Cell_Death_Dis_2010_Nov_18_1(11)_e101.nxml.txt.nlp	21368866	SENT89	35	35	31	31	cisplatin	Bcl-2	PA449014	596	0.806
NULL	Diabetes_Care_2009_Apr_8_32(4)_720-725.nxml.txt.nlp	19131464	SENT12	26	26	1	1	metformin	ACR	PA450395	49	0.806
NULL	J_Cell_Mol_Med_2014_Apr_20_18(4)_709-720.nxml.txt.nlp	24444314	SENT246	5	5	38	38	metformin	p53	PA450395	7157	0.806
NULL	COPD_2008_Jun_13_5(3)_187-200.nxml.txt.nlp	18568843	SENT160	17	17	27	27	salmeterol	NNT	PA451300	23530	0.806
NULL	Virol_J_2008_Sep_26_5_109.nxml.txt.nlp	18822145	SENT160	7	7	20	20	ribavirin	BIM	PA451241	10018	0.806
NULL	J_Health_Commun_2014_May_6_19(sup1)_254-66.nxml.txt.nlp	25315597	SENT939	7	7	32	32	chlorhexidine	S15	PA164776863	6209	0.806
NULL	Patient_Prefer_Adherence_2013_Mar_27_7_245-258.nxml.txt.nlp	23569364	SENT7	11	11	15	15	exemestane	aromatase	PA449563	1588	0.806
NULL	Exp_Ther_Med_2014_Nov_17_8(5)_1484-1488.nxml.txt.nlp	25289046	SENT133	16	16	27	27	cisplatin	ECRG2	PA449014	84651	0.806
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Aug_6_64(Pt_9)_o1710.nxml.txt.nlp	21201697	SENT62	33	33	6	6	ethanol	mol	PA448073	90527	0.806
NULL	Cell_Death_Dis_2014_Feb_27_5(2)_e1084.nxml.txt.nlp	24577082	SENT128	11	11	1	1	paraformaldehyde	HMGB1	PA450790	3146	0.806
NULL	Evid_Based_Complement_Alternat_Med_2014_Jan_9_2014_506735.nxml.txt.nlp	24523822	SENT77	12	12	10	10	fluoxetine	GTS	PA449673	2973	0.806
NULL	Ann_Gastroenterol_2014_27(4)_380-386.nxml.txt.nlp	25331321	SENT27	29	29	10	10	entecavir	IFN	PA164784025	3439	0.806
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT113	13	13	2	2	imatinib	ABCB1	PA10804	5243	0.806
NULL	Cases_J_2009_Jul_29_2_6449.nxml.txt.nlp	19829805	SENT62	25	25	16	16	cabergoline	PRL	PA448708	5617	0.806
NULL	Front_Pharmacol_2014_Oct_31_5_231.nxml.txt.nlp	25400580	SENT5510	10	10	2	2	metoprolol	BCS	PA450480	617	0.806
NULL	Br_J_Cancer_2009_Sep_15_101(6)_957-966.nxml.txt.nlp	19738618	SENT184	14	14	4	4	heparin	p53	PA449855	7157	0.806
NULL	Acta_Pharmacol_Sin_2010_Jul_21_31(7)_855-860.nxml.txt.nlp	20562904	SENT12	20	20	7	7	fluconazole	CDR2	PA449653	1039	0.806
NULL	Breast_Cancer_Res_2008_Jul_24_10(4)_211.nxml.txt.nlp	18671839	SENT228	0	0	7	7	lapatinib	HER2	PA152241907	2064	0.806
NULL	Mol_Cell_Proteomics_2014_Jun_9_13(6)_1598-1610.nxml.txt.nlp	24719452	SENT226	21	21	30	30	galactose	BG1	PA449725	23205	0.806
NULL	Br_J_Cancer_2009_Jul_7_101(1)_116-123.nxml.txt.nlp	19491899	SENT20	8	8	20	20	tegafur	CDHP	PA452620	1001	0.806
NULL	Case_Rep_Nephrol_2014_Mar_5_2014_845372.nxml.txt.nlp	24711939	SENT63	4	4	7	7	phenazopyridine	HMP	PA164746899	10989	0.806
NULL	Br_J_Anaesth_2011_Oct_17_107(4)_490-502.nxml.txt.nlp	21852280	SENT67	24	24	5	5	capsaicin	TRPV1	PA448776	7442	0.806
NULL	Br_J_Cancer_2013_Mar_5_108(4)_848-858.nxml.txt.nlp	23403820	SENT88	34	34	2	2	kanamycin	survivin	PA450137	332	0.806
NULL	Diabetes_2009_Jan_58(1)_209-214.nxml.txt.nlp	18829988	SENT206	25	25	0	0	simvastatin	JAMA	PA451363	50848	0.806
NULL	Clin_Interv_Aging_2013_Jul_16_8_889-897.nxml.txt.nlp	23898224	SENT25	0	0	8	8	gemcitabine	Tech	PA449748	57449	0.806
NULL	Open_Biol_2014_Jan_4(1)_130138.nxml.txt.nlp	24403013	SENT278	4	4	15	15	etoposide	PP1	PA449552	5540;5464	0.806
NULL	ScientificWorldJournal_2014_Mar_3_2014_781857.nxml.txt.nlp	24729754	SENT234	6	6	15	15	rosiglitazone	CD40L	PA451283	959	0.806
NULL	Anat_Cell_Biol_2010_Sep_30_43(3)_194-200.nxml.txt.nlp	21212859	SENT14	20	20	15	15	ethanol	PLP	PA448073	25824;5744	0.806
NULL	Crit_Care_2000_Mar_21_4(Suppl_1)_P27.nxml.txt.nlp	NULL	SENT5	15	15	5	5	thrombin	ATIII	PA451674	462	0.806
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Mar_5_67(Pt_4)_o779.nxml.txt.nlp	21754070	SENT63	31	31	18	18	ethanol	mol	PA448073	90527	0.806
NULL	Clin_Exp_Reprod_Med_2013_Jun_30_40(2)_67-75.nxml.txt.nlp	23875162	SENT11	42	42	31	31	rosiglitazone	COX	PA451283	1351	0.806
NULL	J_Cell_Biol_2001_Aug_6_154(3)_599-610.nxml.txt.nlp	11481345	SENT72	10	10	26	26	doxycycline	ARNO	PA449415	9266	0.806
NULL	Cough_2010_Aug_9_6_7.nxml.txt.nlp	20696045	SENT102	19	19	6	6	capsaicin	COX	PA448776	1351	0.806
NULL	J_Hematol_Oncol_2012_Sep_18_5_57.nxml.txt.nlp	22989009	SENT144	14	14	22	22	nutlin-3	HDM2		4193	0.806
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT20	12	12	17	17	trastuzumab	DM1	PA451743	338023;1760;28509	0.806
NULL	Diagn_Pathol_2014_Jul_10_9_143.nxml.txt.nlp	25012722	SENT125	23	23	9	9	cisplatin	PDCD4	PA449014	27250	0.806
NULL	Br_J_Pharmacol_2011_Apr_162(8)_1832-1842.nxml.txt.nlp	21232033	SENT271	4	4	2	2	resveratrol	SIRT1		23411	0.806
NULL	Front_Behav_Neurosci_2011_Sep_13_5_57.nxml.txt.nlp	21949506	SENT1480	0	0	6	6	clozapine	spatial	PA449061	219793	0.806
NULL	Brain_Behav_2013_Mar_6_3(2)_114-133.nxml.txt.nlp	23533150	SENT168	0	0	2	2	ethanol	HSF1	PA448073	3297	0.806
NULL	Br_J_Cancer_2009_Jan_13_100(1)_37-43.nxml.txt.nlp	19088724	SENT3	3	3	10	10	capecitabine	Gem	PA448771	51053	0.806
NULL	Sci_Rep_2014_Dec_4_4_7310.nxml.txt.nlp	25472472	SENT381	14	14	22	22	decitabine	CD34	PA164749631	947	0.806
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT233	11	11	6	6	adalimumab	CD36	PA10004	948	0.806
NULL	J_Biol_2009_Apr_15_8(3)_30.nxml.txt.nlp	19435483	SENT34	38	38	23	23	imatinib	NQO2	PA10804	4835	0.806
NULL	Mol_Cancer_2012_Jun_18_11_41.nxml.txt.nlp	22709873	SENT328	20	20	22	22	lapatinib	RB1CC1	PA152241907	9821	0.806
NULL	Open_Biochem_J_2011_Sep_23_5_45-51.nxml.txt.nlp	21966325	SENT197	10	10	3	3	indomethacin	PERK	PA449982	9451	0.806
NULL	Onco_Targets_Ther_2014_Sep_18_7_1625-1630.nxml.txt.nlp	25258543	SENT19	19	19	2	2	paclitaxel	PVT1	PA450761	5820	0.806
NULL	Oncotarget_2012_Sep_28_3(10)_1169-1181.nxml.txt.nlp	23045411	SENT91	18	18	24	24	doxorubicin	JIP1	PA449412	9479	0.806
NULL	Cancer_Immunol_Immunother_2012_Jul_23_61(7)_1101-1111.nxml.txt.nlp	22193989	SENT229	22	22	13	13	oxaliplatin	CD80	PA131285527	941	0.806
NULL	Clinicoecon_Outcomes_Res_2014_Oct_17_6_451-461.nxml.txt.nlp	25378939	SENT28	30	30	21	21	vancomycin	HAP	PA451850	5915;10313	0.806
NULL	Oncogene_2009_Feb_5_28(5)_625-637.nxml.txt.nlp	19015636	SENT36	3	3	21	21	doxycycline	GLI2	PA449415	2736	0.806
NULL	Breast_Cancer_Res_2011_Jan_21_13(1)_R9.nxml.txt.nlp	21255398	SENT207	19	19	32	32	cyclophosphamide	RAD21	PA449165	5885	0.806
NULL	BMB_Rep_2014_Jul_47(7)_376-381.nxml.txt.nlp	24286332	SENT70	23	23	12	12	thrombin	PPG	PA451674	5552	0.806
NULL	Arch_Gynecol_Obstet_2013_Mar_8_287(3)_563-570.nxml.txt.nlp	23135210	SENT38	30	30	8	8	carboplatin	MRP2	PA448803	100130958;57626;1244	0.806
NULL	Breast_Cancer_Res_2011_Nov_1_13(6)_R109.nxml.txt.nlp	22044691	SENT319	16	16	6	6	docetaxel	HER2	PA449383	2064	0.806
NULL	Biomed_Res_Int_2014_Feb_23_2014_168949.nxml.txt.nlp	24707474	SENT30	35	35	31	31	gefitinib	EGFR	PA131301952	1956	0.806
NULL	Molecules_2013_Apr_5_18(4)_4054-4080.nxml.txt.nlp	23563857	SENT238	13	13	11	11	verapamil	P-gp	PA451868	5243	0.806
NULL	J_Immune_Based_Ther_Vaccines_2004_Nov_12_2_9.nxml.txt.nlp	15541175	SENT84	24	24	0	0	paraformaldehyde	San	PA450790	80218	0.806
NULL	Front_Hum_Neurosci_2013_May_20_7_211.nxml.txt.nlp	23730283	SENT718	8	8	17	17	rivastigmine	spatial	PA451262	219793	0.806
NULL	Adv_Pharmacol_Sci_2013_Dec_5_2013_387071.nxml.txt.nlp	24381587	SENT115	18	18	0	0	curcumin	TNF	PA151958596	7124	0.806
NULL	Front_Neurosci_2014_Jan_10_7_270.nxml.txt.nlp	24454277	SENT19	30	30	12	12	resveratrol	PI3		5266	0.806
NULL	Oncotarget_2013_Dec_21_5(9)_2404-2417.nxml.txt.nlp	24811221	SENT351	6	6	2	2	bleomycin	PARP-1	PA448645	25976	0.806
NULL	Clinics_(Sao_Paulo)_2014_Feb_69(2)_145-149.nxml.txt.nlp	24519206	SENT141	0	0	5	5	candesartan	AT-1	PA448765	9197	0.806
NULL	J_Headache_Pain_2010_Feb_18_11(1)_13-19.nxml.txt.nlp	20020170	SENT76	11	11	25	25	sumatriptan	OTC	PA451566	5009	0.806
NULL	Breast_Cancer_Res_2013_Oct_22_15(5)_R98.nxml.txt.nlp	24148581	SENT52	13	13	26	26	tamoxifen	aromatase	PA451581	1588	0.806
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Sep_24_3(9)_e137.nxml.txt.nlp	25250527	SENT62	20	20	30	30	ketoprofen	COX	PA450149	1351	0.806
NULL	J_Mol_Signal_2012_May_14_7_4.nxml.txt.nlp	22583680	SENT228	9	9	18	18	rolipram	ERK1	PA153906323	5595	0.806
NULL	Arthritis_Res_Ther_2006_Jul_21_8(4)_R130.nxml.txt.nlp	16859540	SENT102	11	11	13	13	lovastatin	CD59	PA450272	966	0.806
NULL	Arthritis_Res_Ther_2010_Jan_8_12(1)_R4.nxml.txt.nlp	20064200	SENT69	25	25	22	22	diclofenac	COX2	PA449293	4513;5743	0.806
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Dec_18_67(Pt_1)_o184-o185.nxml.txt.nlp	21522689	SENT67	30	30	23	23	ethanol	mol	PA448073	90527	0.806
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT378	34	34	12	12	resveratrol	CBP		55824;1387	0.806
NULL	Breast_Cancer_Res_2010_May_10_12(3)_R26.nxml.txt.nlp	20459744	SENT151	0	0	3	3	thiotepa	CYP2B6	PA451668	1555	0.806
NULL	Diabetes_2009_Jan_58(1)_250-259.nxml.txt.nlp	18840786	SENT279	36	36	24	24	rosiglitazone	FGF21	PA451283	26291	0.806
NULL	Biomed_Res_Int_2014_Jan_29_2014_361020.nxml.txt.nlp	24605326	SENT147	4	4	25	25	genistein	CDK4	PA165109660	1019	0.806
NULL	Biosci_Rep_2012_Aug_1_32(Pt_4)_361-374.nxml.txt.nlp	22762204	SENT209	35	35	5	5	paclitaxel	p53	PA450761	7157	0.806
NULL	Adv_Hematol_2009_Jun_22_2009_251915.nxml.txt.nlp	19946423	SENT122	27	27	15	15	hemin	HRI	PA449849	27102	0.806
NULL	J_Skin_Cancer_2013_Feb_24_2013_735282.nxml.txt.nlp	23533766	SENT34	30	30	34	34	vinblastine	IL-2	PA451877	3558	0.806
NULL	Virol_J_2009_Dec_29_6_231.nxml.txt.nlp	20040105	SENT26	10	10	38	38	tamoxifen	PKR	PA451581	5610	0.806
NULL	Pharmaceuticals_(Basel)_2011_May_17_4(5)_741-757.nxml.txt.nlp	NULL	SENT28	0	0	28	28	ethanol	TGN	PA448073	7038	0.806
NULL	Environ_Health_Perspect_2009_Feb_8_117(2)_175-180.nxml.txt.nlp	19270784	SENT213	16	16	3	3	doxorubicin	BPA	PA449412	667	0.806
NULL	Br_J_Cancer_2006_Feb_13_94(3)_407-426.nxml.txt.nlp	16434996	SENT229	13	13	20	20	genistein	BRCA1	PA165109660	672	0.806
NULL	Aging_(Albany_NY)_2011_Aug_21_3(8)_716-732.nxml.txt.nlp	21869457	SENT51	11	11	3	3	spermine	PAO	PA164781199	196743;54498	0.806
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT182	5	5	15	15	ranibizumab	VEGFR1	PA164746012	2321	0.806
NULL	Oncol_Lett_2013_Feb_7_5(2)_411-416.nxml.txt.nlp	23420500	SENT86	4	4	2	2	atorvastatin	AMPK	PA448500	5563	0.806
NULL	Front_Microbiol_2015_Jan_5_5_732.nxml.txt.nlp	25601857	SENT14	21	21	42	42	s-adenosylmethionine	NRP	PA164754994	8829;4673;10133	0.806
NULL	Mol_Pain_2013_Jun_10_9_27.nxml.txt.nlp	23758830	SENT67	6	6	9	9	tetracaine	ASIC3	PA451638	9311	0.806
NULL	Oncotarget_2012_Sep_28_3(10)_1169-1181.nxml.txt.nlp	23045411	SENT198	32	32	8	8	doxorubicin	JIP1	PA449412	9479	0.806
NULL	Cell_Mol_Life_Sci_2011_Jan_17_68(2)_289-301.nxml.txt.nlp	20640477	SENT163	30	30	25	25	staurosporine	ADP	PA165109623	23038	0.806
NULL	Arthritis_Res_Ther_2011_Jul_6_13(4)_228.nxml.txt.nlp	21745419	SENT45	0	0	32	32	tocilizumab	IL-6	PA165292659	3569	0.806
NULL	J_Histochem_Cytochem_2012_Oct_60(10)_749-760.nxml.txt.nlp	22821669	SENT236	14	14	7	7	hyaluronan	TSG-6	PA165958431	7130	0.806
NULL	Exp_Ther_Med_2014_Nov_29_8(5)_1473-1478.nxml.txt.nlp	25289044	SENT13	0	0	13	13	heparin	AZU	PA449855	566	0.806
NULL	Int_J_Biol_Sci_2011_May_24_7(5)_664-672.nxml.txt.nlp	21647249	SENT104	34	34	4	4	tamoxifen	SRC-3	PA451581	8202	0.806
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1013.nxml.txt.nlp	24457957	SENT89	7	7	14	14	orlistat	NOXA	PA164776864	5366	0.806
NULL	Exp_Ther_Med_2012_Sep_12_4(3)_475-480.nxml.txt.nlp	23181121	SENT170	18	18	16	16	cyclophosphamide	CHOP	PA449165	1649	0.806
NULL	J_Adv_Pharm_Technol_Res_2012_Oct-Dec_3(4)_202-209.nxml.txt.nlp	23378940	SENT166	16	16	9	9	phenytoin	CYP2C9	PA450947	1559	0.806
NULL	Oncotarget_2014_Oct_21_5(22)_11709-11722.nxml.txt.nlp	25365944	SENT222	8	8	15	15	metformin	AMPK	PA450395	5563	0.806
NULL	ISRN_Neurosci_2014_Apr_14_2014_163459.nxml.txt.nlp	24967313	SENT240	30	30	8	8	lamotrigine	ANOVA	PA450164	4858	0.806
NULL	Clin_Transl_Allergy_2014_Feb_28_4(Suppl_1)_P35.nxml.txt.nlp	25045492	SENT14	0	0	36	36	atorvastatin	CD25	PA448500	3669;3559	0.806
NULL	J_Hepatol_2013_Aug_59(2)_318-326.nxml.txt.nlp	23624001	SENT213	32	32	39	39	oxaliplatin	VEGF-A	PA131285527	7422	0.806
NULL	Int_J_Med_Sci_2012_Dec_28_10(2)_110-118.nxml.txt.nlp	23329881	SENT54	11	11	13	13	epirubicin	NACT	PA449476	284111	0.806
NULL	BMB_Rep_2014_May_47(5)_274-279.nxml.txt.nlp	24286313	SENT125	31	31	24	24	bortezomib	CD138	PA10252	6382	0.806
NULL	Arthritis_Res_Ther_2009_Aug_24_11(4)_R127.nxml.txt.nlp	19703304	SENT144	6	6	22	22	adalimumab	OASIS	PA10004	90993	0.806
NULL	Infect_Dis_Ther_2013_Dec_19_2(2)_83-93.nxml.txt.nlp	25134473	SENT195	8	8	25	25	etravirine	TRIO	PA166014703	7204	0.806
NULL	Surg_Today_2014_Oct_19_44(10)_1841-1846.nxml.txt.nlp	24142101	SENT154	7	7	3	3	tamoxifen	ATAC	PA451581	6375	0.806
NULL	EMBO_Mol_Med_2012_Jun_13_4(6)_515-527.nxml.txt.nlp	22416035	SENT144	41	41	37	37	olaparib	p53		7157	0.806
NULL	J_Korean_Med_Sci_2007_Apr_30_22(2)_283-289.nxml.txt.nlp	17449938	SENT137	4	4	18	18	minoxidil	Bcl-2	PA450521	596	0.806
NULL	Exp_Ther_Med_2013_Dec_15_6(6)_1565-1569.nxml.txt.nlp	24255692	SENT10	3	3	15	15	atorvastatin	adiponectin	PA448500	9370	0.806
NULL	Clin_Mol_Allergy_2007_Jan_25_5_1.nxml.txt.nlp	17254346	SENT222	0	0	12	12	curcumin	OAT	PA151958596	4942	0.806
NULL	Carcinogenesis_2014_May_13_35(5)_1055-1066.nxml.txt.nlp	24419232	SENT273	12	12	21	21	metformin	CD34	PA450395	947	0.806
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT110	5	5	13	13	celecoxib	IL-6	PA448871	3569	0.806
NULL	Adolesc_Health_Med_Ther_2014_Nov_27_5_211-221.nxml.txt.nlp	25473324	SENT43	0	0	9	9	aripiprazole	5-HT2A	PA10026	3356	0.806
NULL	Case_Rep_Infect_Dis_2012_Aug_15_2012_463569.nxml.txt.nlp	22928129	SENT31	9	9	11	11	octreotide	IL-2	PA450678	3558	0.806
NULL	Hum_Mol_Genet_2008_Jul_15_17(14)_2101-2107.nxml.txt.nlp	18413323	SENT243	14	14	4	4	ezetimibe	NPC1L1	PA10816	29881	0.806
NULL	Clin_Infect_Dis_2012_Aug_1_55(Suppl_2)_S71-S76.nxml.txt.nlp	22752868	SENT67	19	19	14	14	bacitracin	NAP1	PA448531	4673;64343;9476;3576;51531	0.806
NULL	J_Cell_Biol_2001_Apr_2_153(1)_207-220.nxml.txt.nlp	11285286	SENT168	10	10	12	12	carbachol	CD69	PA448784	969	0.806
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1449-1456.nxml.txt.nlp	24077631	SENT6	25	25	13	13	tolbutamide	CYP2C9	PA451718	1559	0.806
NULL	Mol_Vis_2012_Jan_17_18_114-120.nxml.txt.nlp	22275802	SENT151	20	20	1	1	cisplatin	SIRT1	PA449014	23411	0.806
NULL	Oncogene_2013_Sep_12_32(37)_4355-4365.nxml.txt.nlp	23108409	SENT53	17	17	14	14	hyaluronan	HAS2	PA165958431	3037	0.806
NULL	Indian_J_Pharmacol_2014_Sep-Oct_46(5)_549-550.nxml.txt.nlp	25298588	SENT64	9	9	5	5	warfarin	VKORC1	PA451906	79001	0.806
NULL	Mol_Biol_Int_2012_Jun_26_2012_256982.nxml.txt.nlp	22792462	SENT163	21	21	25	25	enfuvirtide	CCR5	PA164744517	1234	0.806
NULL	J_Cell_Biol_2006_Sep_25_174(7)_985-996.nxml.txt.nlp	16982800	SENT82	26	26	20	20	ciprofloxacin	CD95	PA449009	355	0.806
NULL	Indian_J_Ophthalmol_2011_Jan-Feb_59(1)_73-74.nxml.txt.nlp	21157086	SENT3	9	9	15	15	bevacizumab	San	PA130232992	80218	0.806
NULL	J_Breast_Cancer_2011_Jun_18_14(2)_135-139.nxml.txt.nlp	21847409	SENT21	29	29	36	36	anastrozole	aromatase	PA448432	1588	0.806
NULL	Acta_Pharmacol_Sin_2010_Oct_13_31(10)_1350-1358.nxml.txt.nlp	20835264	SENT149	0	0	23	23	simvastatin	gamma	PA451363	9913	0.806
NULL	Front_Behav_Neurosci_2014_Nov_18_8_394.nxml.txt.nlp	25477794	SENT161	6	6	8	8	carbachol	CASK	PA448784	8573	0.806
NULL	Semin_Immunopathol_2012_Jan_4_34(1)_93-106.nxml.txt.nlp	21845431	SENT188	15	15	12	12	thrombin	PAR-1	PA451674	2011;2149	0.806
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_7-17.nxml.txt.nlp	17912633	SENT368	42	42	37	37	fulvestrant	aromatase	PA164747170	1588	0.806
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT115	1	1	7	7	glucose	EGFR	PA449773	1956	0.806
NULL	Onco_Targets_Ther_2014_Sep_23_7_1689-1704.nxml.txt.nlp	25285017	SENT109	30	30	11	11	gefitinib	EGFR	PA131301952	1956	0.806
NULL	Cancer_Med_2013_Feb_3_2(1)_11-20.nxml.txt.nlp	24133623	SENT445	15	15	6	6	cetuximab	NRAS	PA10040	4893	0.806
NULL	Gut_2013_Sep_7_62(9)_1340-1346.nxml.txt.nlp	23135762	SENT161	18	18	11	11	ribavirin	IL28B	PA451241	282617	0.806
NULL	Oncotarget_2014_Jun_1_5(13)_4868-4880.nxml.txt.nlp	24947902	SENT338	21	21	5	5	irinotecan	HER-2	PA450085	2064	0.806
NULL	Oxid_Med_Cell_Longev_2013_Jul_9_2013_574029.nxml.txt.nlp	23936610	SENT253	4	4	35	35	resveratrol	CD86		942	0.806
NULL	Pharmaceutics_2011_Oct_12_3(4)_680-705.nxml.txt.nlp	24309303	SENT96	10	10	14	14	metformin	EGFR	PA450395	1956	0.806
NULL	Reprod_Biol_Endocrinol_2003_Apr_1_1_31.nxml.txt.nlp	12740033	SENT187	39	39	28	28	estradiol	StAR	PA449503	6770	0.806
NULL	Mol_Cancer_2003_Jan_7_2_6.nxml.txt.nlp	12605713	SENT343	7	7	16	16	cisplatin	p53	PA449014	7157	0.806
NULL	J_Clin_Biochem_Nutr_2007_Jan_27_40(1)_13-23.nxml.txt.nlp	18437209	SENT575	5	5	12	12	trypsin	IL-8	PA451806	3576	0.806
NULL	Cerebrospinal_Fluid_Res_2010_Aug_12_7_11.nxml.txt.nlp	20704740	SENT241	27	27	18	18	calcein	P-gp	PA132595336	5243	0.806
NULL	Clin_Dev_Immunol_2011_Nov_3_2011_320571.nxml.txt.nlp	22110523	SENT201	26	26	13	13	irinotecan	POU5F1	PA450085	5460	0.806
NULL	Acta_Histochem_Cytochem_2007_Jul_3_40(3)_93-99.nxml.txt.nlp	17653301	SENT64	18	18	28	28	ethanol	CO2	PA448073	4513	0.806
NULL	Biomed_Res_Int_2013_Mar_18_2013_720975.nxml.txt.nlp	23586055	SENT4	23	23	18	18	ceftazidime	CXCL8	PA448861	3576	0.806
NULL	Trials_2012_Aug_25_13_148.nxml.txt.nlp	22920307	SENT127	47	47	28	28	clopidogrel	ADP	PA449053	23038	0.806
NULL	Cell_Cycle_2012_Nov_1_11(21)_3983-3996.nxml.txt.nlp	22987153	SENT7	6	6	8	8	cisplatin	FANCD2	PA449014	2177	0.806
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT273	9	9	14	14	resveratrol	ROS		6098	0.806
NULL	Multidiscip_Respir_Med_2014_May_26_9(1)_29.nxml.txt.nlp	24917931	SENT138	17	17	21	21	terbutaline	AQP1	PA451616	358	0.806
NULL	Ann_Rheum_Dis_2011_Oct_12_71(4)_541-548.nxml.txt.nlp	21994233	SENT44	4	4	26	26	methotrexate	ACR	PA450428	49	0.806
NULL	Drug_Healthc_Patient_Saf_2012_Nov_29_4_173-180.nxml.txt.nlp	23236256	SENT66	38	38	22	22	amisulpride	FGA	PA162565877	2243	0.806
NULL	J_Biomed_Sci_2014_Feb_12_21(1)_14.nxml.txt.nlp	24521134	SENT52	8	8	1	1	heparin	SCARB2	PA449855	950	0.806
NULL	Cancer_Metab_2014_May_28_2(Suppl_1)_P28.nxml.txt.nlp	NULL	SENT18	21	21	5	5	metformin	TSC1	PA450395	7248	0.806
NULL	Cancer_Immunol_Immunother_2011_Jun_25_60(6)_793-808.nxml.txt.nlp	21350947	SENT264	28	28	30	30	temsirolimus	IFN	PA164746890	3439	0.806
NULL	Oncotarget_2014_Jun_30_5(12)_4011-4025.nxml.txt.nlp	24994117	SENT105	10	10	4	4	estradiol	WNT4	PA449503	54361	0.806
NULL	Iran_J_Reprod_Med_2014_Sep_12(9)_623-632.nxml.txt.nlp	25469135	SENT103	7	7	23	23	estradiol	ANOVA	PA449503	4858	0.806
NULL	Ann_Lab_Med_2012_Jul_20_32(4)_298-303.nxml.txt.nlp	22779073	SENT86	21	21	10	10	ciprofloxacin	EMB	PA449009	133418	0.806
NULL	Int_J_Biol_Sci_2012_Feb_9_8(3)_310-327.nxml.txt.nlp	22355267	SENT449	12	12	4	4	simvastatin	PCSK9	PA451363	255738	0.806
NULL	Ann_Lab_Med_2014_Sep_21_34(5)_399-401.nxml.txt.nlp	25187896	SENT52	24	24	4	4	imatinib	ABL1	PA10804	25	0.806
NULL	Int_J_Endocrinol_Metab_2013_Jul_1_Summer_11(3)_184-190.nxml.txt.nlp	24348591	SENT135	29	29	26	26	liraglutide	INS-1	PA165958364	2305	0.806
NULL	Diabetes_2009_Jan_58(1)_104-115.nxml.txt.nlp	18835938	SENT165	2	2	10	10	rosiglitazone	MCP-1	PA451283	6347	0.806
NULL	Breast_Cancer_Res_2009_Jun_29_11(3)_R41.nxml.txt.nlp	19563669	SENT19	27	27	5	5	lapatinib	XIAP	PA152241907	331	0.806
NULL	Oncotarget_2011_Sep_9_2(9)_658-668.nxml.txt.nlp	21911919	SENT98	9	9	4	4	cytarabine	NAC	PA449177	22861	0.806
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT297	15	15	13	13	resveratrol	IL-6		3569	0.806
NULL	Braz_J_Med_Biol_Res_2013_Aug_13_46(8)_650-658.nxml.txt.nlp	23969971	SENT204	28	28	23	23	cisplatin	survivin	PA449014	332	0.806
NULL	Core_Evid_2010_Oct_21_5_61-76.nxml.txt.nlp	21042543	SENT56	21	21	31	31	oxaliplatin	EGFR	PA131285527	1956	0.806
NULL	Cell_Commun_Signal_2011_May_15_9_13.nxml.txt.nlp	21569639	SENT334	3	3	17	17	quinacrine	AKT	PA164745551	207	0.806
NULL	Breast_Cancer_Res_2014_Sep_11_16(5)_430.nxml.txt.nlp	25212826	SENT504	11	11	19	19	fulvestrant	HER-2	PA164747170	2064	0.806
NULL	Front_Neural_Circuits_2013_Oct_18_7_149.nxml.txt.nlp	24151456	SENT614	6	6	15	15	estradiol	CA1	PA449503	759	0.806
NULL	Evid_Based_Complement_Alternat_Med_2014_Jul_24_2014_604152.nxml.txt.nlp	25147575	SENT92	7	7	9	9	cyclophosphamide	CTX	PA449165	1593	0.806
NULL	Arthritis_Res_Ther_2003_Sep_12_5(Suppl_3)_145.nxml.txt.nlp	NULL	SENT4	28	28	14	14	staurosporine	IL-16	PA165109623	3603	0.806
NULL	Cardiovasc_Diabetol_2005_Oct_5_4_16.nxml.txt.nlp	16207378	SENT45	21	21	24	24	dextran	mol	PA449261	90527	0.806
NULL	Breast_Cancer_Res_2007_Jan_23_9(1)_R7.nxml.txt.nlp	17244352	SENT193	8	8	3	3	tamoxifen	SULT1A1	PA451581	6817	0.806
NULL	Br_J_Cancer_1995_Feb_71(2)_294-299.nxml.txt.nlp	7841043	SENT9	5	5	9	9	vinblastine	P-gp	PA451877	5243	0.806
NULL	Clin_Interv_Aging_2013_Jul_16_8_889-897.nxml.txt.nlp	23898224	SENT10	7	7	28	28	gemcitabine	SIRT1	PA449748	23411	0.806
NULL	Antiviral_Res_2009_May_82(2)_A99-A109.nxml.txt.nlp	19176219	SENT78	14	14	1	1	delavirdine	P-gp	PA449223	5243	0.806
NULL	Ther_Clin_Risk_Manag_2007_Mar_3(1)_133-148.nxml.txt.nlp	18360621	SENT33	0	0	13	13	adalimumab	p55	PA10004	6624;2078;8503;5718	0.806
NULL	J_Cancer_Prev_2013_Jun_18(2)_186-191.nxml.txt.nlp	25337545	SENT145	2	2	13	13	curcumin	CDK4	PA151958596	1019	0.806
NULL	Asian-Australas_J_Anim_Sci_2013_Nov_26(11)_1545-1552.nxml.txt.nlp	25049740	SENT26	25	25	6	6	trypsin	TNFAIP6	PA451806	7130	0.806
NULL	Nat_Commun_2014_Nov_25_5_5548.nxml.txt.nlp	25420520	SENT46	14	14	6	6	docetaxel	ERG	PA449383	2078	0.806
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT223	5	5	12	12	cisplatin	DR5	PA449014	8795	0.806
NULL	Diabetes_Metab_J_2013_Oct_17_37(5)_315-325.nxml.txt.nlp	24199159	SENT99	10	10	6	6	resveratrol	SIRT1		23411	0.806
NULL	Aging_(Albany_NY)_2009_Feb_18_1(3)_335-349.nxml.txt.nlp	20195489	SENT195	30	30	18	18	etoposide	p65	PA449552	5970	0.806
NULL	Acta_Pharmacol_Sin_2012_Feb_2_33(2)_230-236.nxml.txt.nlp	22212389	SENT15	9	9	20	20	vasopressin	AQP2	PA451858	359	0.806
NULL	J_Cell_Mol_Med_2014_Aug_6_18(8)_1519-1539.nxml.txt.nlp	25100284	SENT178	11	11	16	16	gefitinib	EGFR	PA131301952	1956	0.806
NULL	Diabetes_Metab_J_2012_Aug_20_36(4)_293-299.nxml.txt.nlp	22950061	SENT147	8	8	20	20	metformin	NPY	PA450395	4852	0.806
NULL	Cell_Death_Dis_2014_Jul_17_5(7)_e1333.nxml.txt.nlp	25032856	SENT218	12	12	7	7	candesartan	EAAC1	PA448765	6505	0.806
NULL	Ann_Hematol_2014_Mar_18_93(8)_1335-1344.nxml.txt.nlp	24638841	SENT50	12	12	4	4	rituximab	CLB	PA451261	171425	0.806
NULL	Hum_Genomics_2009_Jan_1_3(2)_103-105.nxml.txt.nlp	19164087	SENT42	1	1	14	14	ethanol	CYP2E1	PA448073	1571	0.806
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Dec_20_65(Pt_1)_m100-m101.nxml.txt.nlp	21581468	SENT4	10	10	3	3	ethanol	mol	PA448073	90527	0.806
NULL	Hum_Reprod_Update_2008_Sep_23_Nov-Dec_14(6)_571-582.nxml.txt.nlp	18812422	SENT62	5	5	27	27	letrozole	aromatase	PA450196	1588	0.806
NULL	Oncotarget_2014_Aug_19_5(18)_8737-8749.nxml.txt.nlp	25228590	SENT83	22	22	5	5	crizotinib	MYCN	PA165946122	4613	0.806
NULL	Front_Genet_2014_Nov_14_5_391.nxml.txt.nlp	25452763	SENT71	23	23	6	6	cisplatin	ERCC2	PA449014	2068	0.806
NULL	Oncotarget_2013_Nov_23_5(1)_196-210.nxml.txt.nlp	24344116	SENT148	16	16	23	23	doxorubicin	p53	PA449412	7157	0.806
NULL	J_Ginseng_Res_2011_Nov_35(4)_436-441.nxml.txt.nlp	23717089	SENT134	2	2	30	30	caffeine	CAGC	PA448710	6283	0.806
NULL	Cancer_Cell_Int_2013_Jan_15_13_3.nxml.txt.nlp	23320839	SENT16	15	15	19	19	gemcitabine	MRP1	PA449748	4437	0.806
NULL	Int_J_Mol_Sci_2014_Jun_17_15(6)_10892-10907.nxml.txt.nlp	24941251	SENT159	14	14	31	31	nadh	mol	PA164755085	90527	0.806
NULL	J_Gen_Physiol_2008_Nov_132(5)_521-535.nxml.txt.nlp	18852303	SENT87	11	11	18	18	trypsin	CAP2	PA451806	5271;10486	0.806
NULL	Mol_Cell_Neurosci_2009_Oct_42(3)_219-225.nxml.txt.nlp	19607921	SENT116	21	21	4	4	collagenase	P21	PA449107	1026;9338	0.806
NULL	Neuropsychopharmacology_2011_Apr_2_36(5)_1033-1046.nxml.txt.nlp	21289603	SENT388	4	4	7	7	ethanol	MSN	PA448073	4478	0.806
NULL	Arthritis_Res_Ther_2008_Apr_16_10(2)_R43.nxml.txt.nlp	18416822	SENT240	8	8	22	22	sr144528	ERK1		5595	0.806
NULL	Ann_Clin_Transl_Neurol_2014_Dec_21_1(12)_996-1005.nxml.txt.nlp	25574474	SENT120	5	5	21	21	riluzole	P-gp	PA451251	5243	0.806
NULL	Diabetes_Care_2010_Apr_12_33(4)_742-744.nxml.txt.nlp	20067964	SENT5	10	10	2	2	pioglitazone	ghrelin	PA450970	51738	0.806
NULL	Crit_Rev_Toxicol_2013_Mar_13_43(3)_200-219.nxml.txt.nlp	23405971	SENT387	8	8	13	13	estradiol	aromatase	PA449503	1588	0.806
NULL	Ann_Rheum_Dis_2009_Jan_18_68(1)_25-32.nxml.txt.nlp	18203761	SENT204	38	38	33	33	adalimumab	STAR	PA10004	6770;2984	0.806
NULL	Aging_(Albany_NY)_2010_Dec_20_2(12)_959-968.nxml.txt.nlp	21191146	SENT74	5	5	8	8	cisplatin	Rpn13	PA449014	11047	0.806
NULL	Contemp_Oncol_(Pozn)_2012_Nov_20_16(5)_401-406.nxml.txt.nlp	23788917	SENT59	17	17	12	12	neratinib	EGFR	PA165291472	1956	0.806
NULL	Biologics_2012_Dec_17_6_429-464.nxml.txt.nlp	23269860	SENT163	1	1	11	11	etanercept	ACR	PA449515	49	0.806
NULL	Nat_Neurosci_2012_Sep_5_15(9)_1245-1254.nxml.txt.nlp	22864611	SENT43	21	21	17	17	clozapine	mGlu2	PA449061	2912	0.806
NULL	Cancer_Causes_Control_2013_Aug_18_24(8)_1605-1614.nxml.txt.nlp	23775025	SENT64	33	33	41	41	doxorubicin	GSTM2	PA449412	2946	0.806
NULL	Mol_Brain_2014_Apr_21_7_28.nxml.txt.nlp	24751148	SENT20	14	14	18	18	minocycline	TLR4	PA450519	7099	0.806
NULL	Comp_Hepatol_2005_Feb_8_4_2.nxml.txt.nlp	15701172	SENT170	8	8	14	14	ketoconazole	CYP3A	PA450146	1574	0.806
NULL	Springerplus_2014_Sep_9_3_510.nxml.txt.nlp	25279302	SENT105	11	11	0	0	creatine	GATM	PA164778930	2628	0.806
NULL	Acta_Pharmacol_Sin_2012_Dec_29_33(12)_1518-1524.nxml.txt.nlp	23103625	SENT128	9	9	4	4	telmisartan	ACE2	PA451605	59272	0.806
NULL	Iran_Red_Crescent_Med_J_2014_Jan_5_16(1)_e9641.nxml.txt.nlp	24719720	SENT48	30	30	12	12	clopidogrel	ACT	PA449053	12;11332;9457;641455	0.806
NULL	Pharmaceutics_2011_Oct_12_3(4)_680-705.nxml.txt.nlp	24309303	SENT80	23	23	30	30	repaglinide	OATP1B1	PA451234	10599	0.806
NULL	Indian_J_Med_Paediatr_Oncol_2013_Jul-Sep_34(3)_151-153.nxml.txt.nlp	24516296	SENT13	5	5	24	24	imatinib	ELN	PA10804	2006	0.806
NULL	Cardiol_Res_Pract_2013_Feb_19_2013_195456.nxml.txt.nlp	23533940	SENT38	8	8	18	18	clopidogrel	IPA	PA449053	3160	0.806
NULL	Exp_Ther_Med_2015_Jan_5_9(1)_84-88.nxml.txt.nlp	25452780	SENT83	14	14	11	11	vildagliptin	GLP-1	PA165958346	100125288	0.806
NULL	Br_J_Cancer_2010_Sep_28_103(7)_1019-1024.nxml.txt.nlp	20842128	SENT22	19	19	8	8	cetuximab	KRAS	PA10040	3845	0.806
NULL	Front_Neurol_2012_Apr_27_3_62.nxml.txt.nlp	22557989	SENT353	2	2	12	12	modafinil	COMT	PA450530	1312	0.806
NULL	Biol_Open_2014_Jul_25_3(8)_741-758.nxml.txt.nlp	25063196	SENT493	18	18	11	11	ethanol	NF1	PA448073	4763	0.806
NULL	Oncogene_2010_Jul_8_29(27)_3896-3907.nxml.txt.nlp	20453888	SENT139	16	16	11	11	trastuzumab	p27	PA451743	5715;10534	0.806
NULL	Case_Rep_Pediatr_2013_Feb_20_2013_727824.nxml.txt.nlp	23509655	SENT86	24	24	1	1	linezolid	BSAC	PA450233	57591	0.806
NULL	Cell_Host_Microbe_2010_Sep_16_8(3)_225-235.nxml.txt.nlp	20833374	SENT314	3	3	5	5	thrombin	MKP-1	PA451674	1843	0.806
NULL	Cancers_(Basel)_2010_Apr_20_2(2)_611-623.nxml.txt.nlp	24281084	SENT32	10	10	3	3	l-tryptophan	NK-1	PA10323	27087	0.806
NULL	Case_Rep_Nephrol_Urol_2014_Apr_12_4(1)_75-81.nxml.txt.nlp	24847349	SENT19	7	7	42	42	amiodarone	APT	PA448383	653639	0.806
NULL	Int_J_Surg_Oncol_2012_Jun_12_2012_862879.nxml.txt.nlp	22778941	SENT124	40	40	33	33	cisplatin	PARP1	PA449014	142	0.806
NULL	Adolesc_Health_Med_Ther_2014_Nov_27_5_211-221.nxml.txt.nlp	25473324	SENT7	0	0	5	5	aripiprazole	5-HT2A	PA10026	3356	0.806
NULL	Diabetes_2013_Jun_20_62(6)_2122-2129.nxml.txt.nlp	23378607	SENT321	26	26	24	24	pioglitazone	PPARgamma	PA450970	5468	0.806
NULL	Arch_Microbiol_2012_Apr_24_194(4)_255-268.nxml.txt.nlp	21947170	SENT273	12	12	22	22	ceftriaxone	MN1	PA448866	4330	0.806
NULL	Br_J_Cancer_2013_Jul_23_109(2)_351-359.nxml.txt.nlp	23799854	SENT146	10	10	24	24	paclitaxel	P-gp	PA450761	5243	0.806
NULL	Oncotarget_2014_Mar_16_5(12)_4087-4102.nxml.txt.nlp	24961479	SENT75	9	9	6	6	hemin	PC3	PA449849	57332;7832;5122	0.806
NULL	Breast_Cancer_Res_2010_Mar_5_12(2)_R16.nxml.txt.nlp	20205716	SENT185	24	24	40	40	lovastatin	CDC42	PA450272	998	0.806
NULL	Oncotarget_2014_Nov_6_5(22)_11038-11053.nxml.txt.nlp	25402820	SENT189	21	21	23	23	gemcitabine	GEM	PA449748	2669	0.805
NULL	Hum_Genomics_2008_Sep_1_3(1)_7-16.nxml.txt.nlp	19129086	SENT175	24	24	21	21	rosiglitazone	SLCO1B1	PA451283	10599	0.805
NULL	J_Neuroinflammation_2011_Feb_4_8_10.nxml.txt.nlp	21294877	SENT79	4	4	2	2	capsaicin	TAC1	PA448776	6863	0.805
NULL	Br_J_Cancer_2011_Jun_7_104(12)_1828-1835.nxml.txt.nlp	21559012	SENT167	4	4	10	10	tamoxifen	EGFR	PA451581	1956	0.805
NULL	Oncoscience_2014_Mar_12_1(2)_167-179.nxml.txt.nlp	25126591	SENT228	35	35	11	11	everolimus	PI3K	PA164746311	5290	0.805
NULL	Med_Sci_Monit_2014_Aug_1_20_1345-1352.nxml.txt.nlp	25080850	SENT134	0	0	6	6	rosiglitazone	AQP7	PA451283	364	0.805
NULL	Clin_Dev_Immunol_2011_Nov_3_2011_320571.nxml.txt.nlp	22110523	SENT201	26	26	18	18	irinotecan	ALDH1A1	PA450085	216	0.805
NULL	Diabetes_2013_Jul_14_62(7)_2545-2558.nxml.txt.nlp	23423573	SENT294	10	10	27	27	camptothecin	CXCL12	PA153590860	6387	0.805
NULL	Breast_Cancer_Res_2007_Aug_8_9(4)_R50.nxml.txt.nlp	17686159	SENT172	4	4	12	12	gefitinib	EGFR	PA131301952	1956	0.805
NULL	Br_J_Cancer_2010_Nov_2_103(11)_1671-1679.nxml.txt.nlp	21045835	SENT117	28	28	19	19	gemcitabine	CXCR4	PA449748	7852	0.805
NULL	Oncotarget_2013_Nov_24_4(12)_2430-2438.nxml.txt.nlp	24280348	SENT100	7	7	5	5	gefitinib	STAT3	PA131301952	6774	0.805
NULL	Curr_Med_Chem_2013_Jan_21(3)_261-269.nxml.txt.nlp	24164192	SENT90	7	7	10	10	etanercept	TNFRSF1B	PA449515	7133	0.805
NULL	Cancer_Cell_Int_2013_Feb_8_13_11.nxml.txt.nlp	23394616	SENT129	20	20	11	11	geldanamycin	Hsp90	PA152031327	3320	0.805
NULL	Br_J_Cancer_2012_Sep_4_107(6)_947-955.nxml.txt.nlp	22892392	SENT175	21	21	28	28	lapatinib	ERBB2	PA152241907	2064	0.805
NULL	Indian_J_Pharmacol_2008_Feb_40(Suppl1)_S1-S2.nxml.txt.nlp	21369404	SENT27	7	7	17	17	aprotinin	BART	PA448472	7809;23568	0.805
NULL	Avicenna_J_Phytomed_2013_Summer_3(3)_201-204.nxml.txt.nlp	25050275	SENT48	20	20	9	9	terfenadine	CYP3A4	PA451619	1576	0.805
NULL	Acta_Pharmacol_Sin_2014_Jun_5_35(6)_716-726.nxml.txt.nlp	24793311	SENT163	3	3	24	24	atorvastatin	IL-6	PA448500	3569	0.805
NULL	Breast_Cancer_Res_2012_Mar_14_14(2)_R46.nxml.txt.nlp	22417870	SENT196	20	20	27	27	trastuzumab	HER2	PA451743	2064	0.805
NULL	Cancer_Cell_Int_2012_Nov_13_12_45.nxml.txt.nlp	23148684	SENT27	26	26	8	8	gemcitabine	WEE1	PA449748	7465	0.805
NULL	Aging_(Albany_NY)_2011_Dec_12_3(11)_1063-1077.nxml.txt.nlp	22170748	SENT112	4	4	21	21	metformin	p53	PA450395	7157	0.805
NULL	Indian_J_Pharmacol_2008_Oct_40(Suppl_2)_S97-S112.nxml.txt.nlp	21593984	SENT73	22	22	26	26	minocycline	COX	PA450519	1351	0.805
NULL	J_Immunother_2014_Feb_21_37(2)_105-114.nxml.txt.nlp	24509173	SENT8	28	28	22	22	gemcitabine	WT1	PA449748	7490	0.805
NULL	Diabetes_2008_Sep_57(9)_2332-2340.nxml.txt.nlp	18567824	SENT218	2	2	27	27	atropine	ghrelin	PA448505	51738	0.805
NULL	Curr_Biol_2012_Dec_18_22(24)_2285-2293.nxml.txt.nlp	23142042	SENT444	5	5	11	11	riluzole	SNA	PA451251	6615	0.805
NULL	Mol_Cancer_2013_Sep_11_12_104.nxml.txt.nlp	24025152	SENT242	10	10	2	2	gemcitabine	STAT3	PA449748	6774	0.805
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT818	7	7	0	0	glucose	GLUT9	PA449773	11182	0.805
NULL	Front_Aging_Neurosci_2010_May_18_2_20.nxml.txt.nlp	20589102	SENT63	18	18	5	5	indomethacin	COX	PA449982	1351	0.805
NULL	J_Gen_Physiol_2000_Jun_1_115(6)_685-696.nxml.txt.nlp	10828243	SENT116	21	21	24	24	genistein	OLF	PA165109660	83857	0.805
NULL	Mol_Vis_2012_May_1_18_1115-1122.nxml.txt.nlp	22605923	SENT100	42	42	4	4	estradiol	IL-6	PA449503	3569	0.805
NULL	Infect_Drug_Resist_2009_Jun_8_2_27-40.nxml.txt.nlp	21694885	SENT164	15	15	38	38	erythromycin	San	PA449493	80218	0.805
NULL	Eur_J_Clin_Pharmacol_2011_May_2_67(Suppl_1)_87-107.nxml.txt.nlp	21287160	SENT353	5	5	12	12	imatinib	MDM2	PA10804	4193	0.805
NULL	Int_J_Breast_Cancer_2011_Sep_22_2011_923250.nxml.txt.nlp	22295239	SENT103	3	3	15	15	vorinostat	CYP1A1	PA164748224	1543	0.805
NULL	Arthritis_Res_Ther_2010_Feb_24_12(1)_R32.nxml.txt.nlp	20181277	SENT206	23	23	12	12	imatinib	M-CSF	PA10804	1435	0.805
NULL	Int_J_Med_Sci_2014_Jan_11_11(3)_226-233.nxml.txt.nlp	24516345	SENT186	0	0	11	11	dexmedetomidine	IL-6	PA449256	3569	0.805
NULL	Carcinogenesis_2014_May_13_35(5)_1055-1066.nxml.txt.nlp	24419232	SENT273	12	12	23	23	metformin	CD31	PA450395	5175	0.805
NULL	Cardiol_Res_Pract_2013_Jan_31_2013_128795.nxml.txt.nlp	23431496	SENT147	18	18	6	6	clopidogrel	CYP2C19	PA449053	1557	0.805
NULL	Hum_Genomics_2009_Jan_1_3(2)_128-142.nxml.txt.nlp	19164090	SENT211	9	9	14	14	carboplatin	CD44	PA448803	960	0.805
NULL	Diabetes_Metab_Syndr_Obes_2013_Sep_2_6_317-325.nxml.txt.nlp	24039439	SENT56	19	19	26	26	voglibose	GLP-1	PA164752433	100125288	0.805
NULL	Cancer_Immunol_Immunother_2013_Aug_27_62(10)_1637-1648.nxml.txt.nlp	23982484	SENT168	30	30	14	14	lenalidomide	IL-2	PA162363968	3558	0.805
NULL	Support_Care_Cancer_2011_Oct_8_19(10)_1505-1510.nxml.txt.nlp	20694798	SENT88	23	23	39	39	metoclopramide	NK-1	PA450475	27087	0.805
NULL	Cancer_Med_2014_Oct_2_3(5)_1256-1265.nxml.txt.nlp	24890382	SENT19	0	0	27	27	trastuzumab	DM1	PA451743	338023;1760;28509	0.805
NULL	Environ_Health_Perspect_2000_May_108(5)_403-412.nxml.txt.nlp	10811566	SENT10	9	9	13	13	genistein	pS2	PA165109660	7031	0.805
NULL	Comput_Struct_Biotechnol_J_2013_Mar_12_4_e201301008.nxml.txt.nlp	24688689	SENT168	33	33	2	2	ethanol	NAT	PA448073	6046	0.805
NULL	Target_Oncol_2013_Jun_27_8(2)_127-136.nxml.txt.nlp	23625191	SENT48	23	23	28	28	panitumumab	KRAS	PA162373091	3845	0.805
NULL	J_Korean_Med_Sci_2013_Feb_29_28(2)_308-314.nxml.txt.nlp	23399960	SENT115	7	7	17	17	gabapentin	IL-10	PA449720	3586	0.805
NULL	J_Gen_Physiol_2008_Nov_132(5)_521-535.nxml.txt.nlp	18852303	SENT95	5	5	3	3	trypsin	CAP2	PA451806	5271;10486	0.805
NULL	J_Korean_Med_Sci_2011_Feb_24_26(2)_304-307.nxml.txt.nlp	21286027	SENT45	12	12	10	10	cyclophosphamide	CHOP	PA449165	1649	0.805
NULL	Front_Neurol_2014_Feb_18_5_17.nxml.txt.nlp	24600432	SENT104	7	7	23	23	levetiracetam	C17	PA450206	54360	0.805
NULL	Oncogene_2014_Feb_6_33(6)_713-723.nxml.txt.nlp	23435429	SENT84	39	39	35	35	etoposide	BRCA1	PA449552	672	0.805
NULL	Acta_Pharmacol_Sin_2014_Aug_21_35(8)_1082-1092.nxml.txt.nlp	25047514	SENT264	6	6	30	30	letrozole	aromatase	PA450196	1588	0.805
NULL	Pharmaceuticals_(Basel)_2014_Jan_27_7(2)_169-191.nxml.txt.nlp	24473270	SENT978	8	8	19	19	gemcitabine	ABCC5	PA449748	10057	0.805
NULL	Br_J_Pharmacol_2014_Jan_23_171(2)_523-535.nxml.txt.nlp	24372553	SENT163	25	25	17	17	metformin	SIRT1	PA450395	23411	0.805
NULL	Int_J_Environ_Res_Public_Health_2011_Mar_1_8(3)_683-697.nxml.txt.nlp	21556173	SENT81	10	10	23	23	rituximab	HER-2	PA451261	2064	0.805
NULL	Arthritis_Res_Ther_2009_Jul_23_11(4)_236.nxml.txt.nlp	19664185	SENT66	2	2	12	12	benzbromarone	GLUT9	PA134852920	11182	0.805
NULL	Exp_Ther_Med_2013_Apr_5_5(4)_1259-1263.nxml.txt.nlp	23596498	SENT94	0	0	23	23	propofol	TRPV1	PA451141	7442	0.805
NULL	J_Mol_Med_(Berl)_2013_Apr_10_91(4)_473-483.nxml.txt.nlp	23052483	SENT105	17	17	12	12	bevacizumab	LC3	PA130232992	84557	0.805
NULL	Biomed_Res_Int_2014_Jan_29_2014_831845.nxml.txt.nlp	24605337	SENT207	29	29	8	8	bupivacaine	S6K1	PA135057240	6198	0.805
NULL	J_Carcinog_2012_Sep_13_11_15.nxml.txt.nlp	23230392	SENT127	22	22	40	40	gefitinib	VEGFR	PA131301952	3791	0.805
NULL	Core_Evid_2009_Jun_15_4_93-111.nxml.txt.nlp	20694068	SENT156	13	13	15	15	procarbazine	PCB	PA451112	5091	0.805
NULL	Mol_Cells_2014_Aug_31_37(8)_585-591.nxml.txt.nlp	25134539	SENT111	11	11	18	18	indacaterol	ADRB2	PA165958348	154	0.805
NULL	Breast_Cancer_Res_Treat_2013_Oct_8_141(3)_437-446.nxml.txt.nlp	24101324	SENT272	11	11	15	15	trastuzumab	HER-2	PA451743	2064	0.805
NULL	Clin_Med_Insights_Cardiol_2013_Aug_11_7_127-140.nxml.txt.nlp	23997577	SENT17	26	26	9	9	dronedarone	CYP3A4	PA153619853	1576	0.805
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Sep_20_70(Pt_10)_228-230.nxml.txt.nlp	25484659	SENT7	5	5	12	12	trometamol	mol	PA451802	90527	0.805
NULL	Pharmaceuticals_(Basel)_2013_Aug_2_6(8)_915-928.nxml.txt.nlp	24276376	SENT67	11	11	0	0	thrombin	PAR-1	PA451674	2011;2149	0.805
NULL	Ann_Oncol_2011_Mar_8_22(3)_503-514.nxml.txt.nlp	20616198	SENT309	4	4	17	17	tamoxifen	ATAC	PA451581	6375	0.805
NULL	Oncogene_2013_Sep_12_32(37)_4355-4365.nxml.txt.nlp	23108409	SENT101	14	14	7	7	hyaluronan	HAS2	PA165958431	3037	0.805
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Nov_23_67(Pt_12)_o3399.nxml.txt.nlp	22199886	SENT62	14	14	10	10	ethanol	mol	PA448073	90527	0.805
NULL	Breast_Cancer_Res_2007_Aug_8_9(4)_R50.nxml.txt.nlp	17686159	SENT246	19	19	43	43	gefitinib	AKT	PA131301952	207	0.805
NULL	Biochem_Biophys_Res_Commun_2008_Sep_5_373(4)_584-588.nxml.txt.nlp	18586007	SENT105	11	11	16	16	curcumin	HO-1	PA151958596	3162	0.805
NULL	Int_J_Mol_Sci_2014_Oct_23_15(10)_19265-19280.nxml.txt.nlp	25342321	SENT62	12	12	3	3	sc-560	CD34		947	0.805
NULL	J_Biomed_Sci_2013_Mar_15_20(1)_17.nxml.txt.nlp	23497194	SENT129	11	11	26	26	rivaroxaban	COX	PA165958360	1351	0.805
NULL	Mol_Cancer_2012_Apr_26_11_26.nxml.txt.nlp	22537224	SENT69	5	5	16	16	bortezomib	FANCD2	PA10252	2177	0.805
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_13_2013_468537.nxml.txt.nlp	23956772	SENT141	7	7	14	14	cisplatin	p53	PA449014	7157	0.805
NULL	Diagn_Pathol_2013_Nov_25_8_192.nxml.txt.nlp	24274261	SENT89	12	12	6	6	carboplatin	IL-2	PA448803	3558	0.805
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT145	19	19	13	13	perifosine	DR4	PA165291471	8797	0.805
NULL	Curr_Neuropharmacol_2013_Jul_11(4)_338-378.nxml.txt.nlp	24381528	SENT669	12	12	28	28	curcumin	U87	PA151958596	677775;641648	0.805
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT186	9	9	19	19	curcumin	Bcl-2	PA151958596	596	0.805
NULL	Ann_Hematol_2011_May_12_90(5)_557-568.nxml.txt.nlp	20938660	SENT217	17	17	9	9	plerixafor	CD34	PA165958410	947	0.805
NULL	Br_J_Cancer_2012_Jan_3_106(1)_32-38.nxml.txt.nlp	22108523	SENT18	26	26	7	7	trastuzumab	HER2	PA451743	2064	0.805
NULL	Biomed_Res_Int_2013_May_22_2013_430791.nxml.txt.nlp	23762845	SENT5	23	23	14	14	fasudil	STZ	PA165946121	6484	0.805
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Dec_17_3(12)_e152.nxml.txt.nlp	25518025	SENT31	18	18	22	22	oxycodone	CYP2D6	PA450741	1565	0.805
NULL	Arthritis_Res_Ther_2012_Apr_16_14(2)_R76.nxml.txt.nlp	22507741	SENT170	12	12	8	8	estradiol	IL-10	PA449503	3586	0.805
NULL	Lab_Invest_2011_Jan_9_91(1)_138-146.nxml.txt.nlp	20697379	SENT8	17	17	4	4	thyroglobulin	p63	PA164754910	8626	0.805
NULL	Oncologist_2011_Jan_6_16(1)_5-24.nxml.txt.nlp	21212434	SENT196	15	15	25	25	lomustine	IFN	PA164749407	3439	0.805
NULL	Eur_J_Endocrinol_2014_Mar_170(3)_451-459.nxml.txt.nlp	24362411	SENT169	11	11	8	8	orlistat	GLP1	PA164776864	100125288;2641	0.805
NULL	Int_J_Med_Sci_2013_Jun_14_10(8)_995-1002.nxml.txt.nlp	23801886	SENT106	9	9	20	20	doxycycline	ILK	PA449415	3611	0.805
NULL	Acta_Pharmacol_Sin_2011_Jul_13_32(7)_967-972.nxml.txt.nlp	21666702	SENT141	31	31	44	44	losartan	P-gp	PA450268	5243	0.805
NULL	Br_J_Pharmacol_2014_Oct_26_171(20)_4785-4796.nxml.txt.nlp	25074741	SENT260	0	0	15	15	guanfacine	EPM	PA449825	2054	0.805
NULL	G3_(Bethesda)_2014_Nov_11_5(1)_35-44.nxml.txt.nlp	25387827	SENT65	9	9	2	2	neomycin	MTAP	PA450608	4507	0.805
NULL	Br_J_Cancer_2009_Mar_10_100(5)_758-763.nxml.txt.nlp	19259094	SENT69	12	12	2	2	decitabine	MLH1	PA164749631	4292	0.805
NULL	Onco_Targets_Ther_2014_Mar_20_7_457-467.nxml.txt.nlp	24672248	SENT90	15	15	17	17	imatinib	PDGFRA	PA10804	5156	0.805
NULL	Biomed_Eng_Online_2007_Apr_20_6_14.nxml.txt.nlp	17448235	SENT81	18	18	8	8	nadh	ADP	PA164755085	23038	0.805
NULL	Mol_Cancer_2009_Oct_8_8_83.nxml.txt.nlp	19814803	SENT165	0	0	18	18	triciribine	CTRL	PA165958661	1506	0.805
NULL	Nat_Commun_2011_Aug_9_2_424.nxml.txt.nlp	21829186	SENT152	35	35	37	37	decitabine	DAC	PA164749631	13	0.805
NULL	Oncotarget_2011_Dec_31_2(12)_1322-1328.nxml.txt.nlp	22249159	SENT50	12	12	25	25	metformin	TSC2	PA450395	7249	0.805
NULL	Hum_Mol_Genet_2013_Nov_15_22(22)_4616-4626.nxml.txt.nlp	23814041	SENT142	4	4	25	25	doxycycline	neuroserpin	PA449415	5274	0.805
NULL	Exp_Ther_Med_2013_Sep_11_6(3)_803-807.nxml.txt.nlp	24137269	SENT45	7	7	5	5	cyclosporine	EPO	PA449167	7076;8288;2056	0.805
NULL	Br_J_Cancer_2014_Oct_14_111(8)_1552-1561.nxml.txt.nlp	25117814	SENT55	24	24	41	41	l-glutamine	CO2	PA10090	4513	0.805
NULL	Acta_Pharmacol_Sin_2010_Jan_5_31(1)_93-101.nxml.txt.nlp	20048748	SENT53	21	21	44	44	cisplatin	CO2	PA449014	4513	0.805
NULL	Breast_Cancer_Res_2011_May_26_13(3)_209.nxml.txt.nlp	21635709	SENT181	14	14	4	4	tamoxifen	CYP2D6	PA451581	1565	0.805
NULL	Oncotarget_2011_Jun_15_2(6)_518-524.nxml.txt.nlp	21680956	SENT39	0	0	11	11	pyrimethamine	STAT3	PA451193	6774	0.805
NULL	BMJ_Open_2014_Feb_13_4(2)_e003960.nxml.txt.nlp	24525389	SENT14	14	14	0	0	warfarin	OAT	PA451906	4942	0.805
NULL	Diabetes_2013_Nov_18_62(11)_3851-3862.nxml.txt.nlp	23884890	SENT204	2	2	9	9	metformin	AMPK	PA450395	5563	0.805
NULL	Int_J_Med_Sci_2015_Jan_1_12(1)_63-71.nxml.txt.nlp	25552920	SENT184	32	32	17	17	berberine	PC-3	PA165860812	692094	0.805
NULL	Mol_Pain_2013_Mar_4_9_9.nxml.txt.nlp	23497345	SENT319	27	27	10	10	trypsin	CO2	PA451806	4513	0.805
NULL	Genome_Med_2010_Jun_14_2(6)_37.nxml.txt.nlp	20546595	SENT266	11	11	16	16	doxorubicin	p53	PA449412	7157	0.805
NULL	J_Cell_Mol_Med_2014_Sep_7_18(9)_1785-1796.nxml.txt.nlp	24909956	SENT179	14	14	10	10	cangrelor	GPR17	PA165945763	2840	0.805
NULL	Diabetes_2009_Feb_58(2)_344-351.nxml.txt.nlp	19008341	SENT311	19	19	10	10	resveratrol	IFN		3439	0.805
NULL	Core_Evid_2014_Feb_25_9_27-39.nxml.txt.nlp	24596542	SENT202	27	27	12	12	fluconazole	CD4	PA449653	920	0.805
NULL	Allergy_Asthma_Clin_Immunol_2010_Sep_16_6(1)_27.nxml.txt.nlp	20846390	SENT192	9	9	27	27	methacholine	BRI	PA165958382	9445	0.805
NULL	Ital_J_Pediatr_2011_Aug_22_37_39.nxml.txt.nlp	21859484	SENT53	24	24	11	11	salbutamol	BDP	PA448068	10620;152926	0.805
NULL	Breast_Cancer_Res_2011_May_11_13(3)_R50.nxml.txt.nlp	21569367	SENT26	21	21	16	16	estradiol	aromatase	PA449503	1588	0.805
NULL	J_Lipid_Res_2014_Oct_55(10)_2103-2112.nxml.txt.nlp	25139399	SENT678	2	2	11	11	aliskiren	APOE	PA143487910	348	0.805
NULL	Breast_Cancer_Res_2008_Feb_20_10(1)_202.nxml.txt.nlp	18304378	SENT79	15	15	25	25	nadh	PTEN	PA164755085	5728	0.805
NULL	Acta_Neuropathol_Commun_2014_Jan_2_2_3.nxml.txt.nlp	24383546	SENT270	13	13	8	8	resveratrol	SIRT1		23411	0.805
NULL	Evid_Based_Complement_Alternat_Med_2013_May_29_2013_385219.nxml.txt.nlp	23818925	SENT235	7	7	19	19	chloroquine	LC3	PA448948	84557	0.805
NULL	Evid_Based_Complement_Alternat_Med_2011_Mar_9_2011_750230.nxml.txt.nlp	21423639	SENT90	29	29	7	7	trypsin	HS7	PA451806	349198	0.805
NULL	J_Int_Soc_Sports_Nutr_2009_Feb_19_6_6.nxml.txt.nlp	19228401	SENT239	17	17	32	32	creatine	CRT	PA164778930	811	0.805
NULL	Open_Virol_J_2014_Mar_7_8_1-8.nxml.txt.nlp	24799968	SENT101	14	14	28	28	telaprevir	PKR	PA165958354	5610	0.805
NULL	Br_J_Cancer_2012_May_8_106(10)_1587-1590.nxml.txt.nlp	22568998	SENT80	16	16	22	22	sunitinib	IFN	PA162372840	3439	0.805
NULL	J_Hematol_Oncol_2011_Nov_4_4_44.nxml.txt.nlp	22053759	SENT103	2	2	10	10	thrombin	PAR4	PA451674	9002;5074	0.805
NULL	Eur_J_Neurosci_2009_Aug_30(3)_347-354.nxml.txt.nlp	19614749	SENT137	5	5	26	26	scopolamine	gamma	PA451308	9913	0.805
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Oct_29_70(Pt_11)_o1207-o1208.nxml.txt.nlp	25484832	SENT81	44	44	25	25	ethanol	mol	PA448073	90527	0.805
NULL	Gene_Regul_Syst_Bio_2014_Mar_4_8_63-73.nxml.txt.nlp	24634581	SENT248	3	3	19	19	minocycline	MT1-MMP	PA450519	4323	0.805
NULL	J_Exp_Med_1998_Jun_1_187(11)_1885-1892.nxml.txt.nlp	9607928	SENT110	6	6	25	25	thalidomide	IL-2	PA451644	3558	0.805
NULL	Head_Face_Med_2006_May_25_2_15.nxml.txt.nlp	16725028	SENT96	19	19	3	3	amitriptyline	LEP	PA448385	3952	0.805
NULL	BMB_Rep_2014_May_47(5)_268-273.nxml.txt.nlp	24286315	SENT86	16	16	6	6	trastuzumab	PTEN	PA451743	5728	0.805
NULL	Cancers_(Basel)_2011_Aug_5_3(3)_3114-3142.nxml.txt.nlp	24212948	SENT746	25	25	32	32	cyclophosphamide	CD25	PA449165	3669;3559	0.805
NULL	J_Mol_Signal_2011_Aug_10_6_8.nxml.txt.nlp	21831305	SENT112	11	11	34	34	isoproterenol	AKAP12	PA450121	9590	0.805
NULL	Oncotarget_2012_Sep_28_3(10)_1169-1181.nxml.txt.nlp	23045411	SENT184	2	2	7	7	doxorubicin	p53	PA449412	7157	0.805
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Dec_10_65(Pt_1)_o74.nxml.txt.nlp	21581713	SENT60	25	25	40	40	ethanol	mol	PA448073	90527	0.805
NULL	J_Invest_Dermatol_2013_Aug_133(8)_1928-1929.nxml.txt.nlp	23856932	SENT37	19	19	9	9	vemurafenib	STAT3	PA165946873	6774	0.805
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT370	14	14	11	11	resveratrol	SIRT2		22933	0.805
NULL	Biomed_Res_Int_2013_Sep_4_2013_906912.nxml.txt.nlp	24093107	SENT158	18	18	1	1	ciprofloxacin	MICC	PA449009	100129192	0.805
NULL	Curr_Med_Chem_2011_Dec_18(35)_5476-5482.nxml.txt.nlp	22087839	SENT118	3	3	16	16	cisplatin	p53	PA449014	7157	0.805
NULL	Diabetologia_2010_Jan_6_53(1)_1-6.nxml.txt.nlp	19894028	SENT157	7	7	10	10	sitagliptin	HIP	PA164748978	6767;6159;64399;5068	0.805
NULL	Eur_J_Immunol_2014_Jun_10_44(6)_1759-1769.nxml.txt.nlp	24595810	SENT8	0	0	22	22	fludrocortisone	CXCR4	PA164743961	7852	0.805
NULL	J_Cell_Biol_2001_Oct_29_155(3)_447-458.nxml.txt.nlp	11684709	SENT314	6	6	4	4	pp2	PP1		5540;5464	0.805
NULL	Cell_Cycle_2012_Dec_15_11(24)_4661-4672.nxml.txt.nlp	23187802	SENT157	7	7	2	2	doxorubicin	p130	PA449412	5934	0.805
NULL	J_Biol_Chem_2012_Apr_13_287(16)_12952-12965.nxml.txt.nlp	22371491	SENT63	21	21	12	12	labetalol	MCP-1	PA164743150	6347	0.805
NULL	BioData_Min_2013_Jan_8_6_1.nxml.txt.nlp	23294634	SENT223	25	25	10	10	methotrexate	MTHFD2	PA450428	10797	0.805
NULL	Breast_Cancer_Res_Treat_2013_Jan_6_137(1)_167-174.nxml.txt.nlp	23129173	SENT25	0	0	13	13	letrozole	CYP19A1	PA450196	1588	0.805
NULL	Oncol_Lett_2014_Jun_3_7(6)_2083-2088.nxml.txt.nlp	24932293	SENT25	8	8	10	10	cyclophosphamide	CTX	PA449165	1593	0.805
NULL	Front_Chem_2013_Jul_12_1_10.nxml.txt.nlp	24790939	SENT61	25	25	15	15	hydroquinone	mol	PA449924	90527	0.805
NULL	J_Invest_Dermatol_2014_Jul_31_134(7)_1903-1911.nxml.txt.nlp	24487305	SENT145	14	14	25	25	fluorescein	CD4	PA164746009	920	0.805
NULL	Mol_Cell_Proteomics_2014_Mar_20_13(3)_701-715.nxml.txt.nlp	24361865	SENT1166	3	3	9	9	carboplatin	AKR1B10	PA448803	57016	0.805
NULL	Int_J_Mol_Sci_2014_Jun_26_15(7)_11416-11434.nxml.txt.nlp	24972137	SENT87	2	2	8	8	sitagliptin	AMPK	PA164748978	5563	0.805
NULL	J_Oncol_2010_Dec_23_2010_372547.nxml.txt.nlp	20072701	SENT72	29	29	24	24	erlotinib	EGFR	PA134687924	1956	0.805
NULL	Breast_Cancer_Res_2005_Apr_8_7(4)_R436-R443.nxml.txt.nlp	15987448	SENT65	14	14	11	11	fluorescein	NB-3	PA164746009	27255	0.805
NULL	J_Clin_Biochem_Nutr_2010_Mar_27_46(2)_126-134.nxml.txt.nlp	20216945	SENT322	23	23	10	10	taurine	Met	PA451590	79811	0.805
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1196-1204.nxml.txt.nlp	22315058	SENT141	14	14	3	3	gefitinib	EGFR	PA131301952	1956	0.805
NULL	Front_Genet_2012_Oct_10_3_206.nxml.txt.nlp	23087703	SENT456	21	21	11	11	mephenytoin	CYP2C19	PA450373	1557	0.805
NULL	Genome_Med_2010_Sep_13_2(9)_64.nxml.txt.nlp	20831840	SENT110	33	33	29	29	lipase	APOA5	PA450239	116519	0.805
NULL	Cardiovasc_Drugs_Ther_2011_Jun_12_25(3)_223-232.nxml.txt.nlp	21562974	SENT7	3	3	27	27	esmolol	AKT	PA449500	207	0.805
NULL	Br_J_Cancer_2012_Aug_7_107(4)_639-645.nxml.txt.nlp	22805326	SENT166	41	41	16	16	pazopanib	VEGFR1	PA165291492	2321	0.805
NULL	Case_Rep_Endocrinol_2013_Aug_7_2013_617042.nxml.txt.nlp	23991341	SENT79	5	5	34	34	hydrocortisone	ACTH	PA449905	5443	0.805
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT229	7	7	9	9	capsaicin	p53	PA448776	7157	0.805
NULL	Cancers_(Basel)_2013_Feb_22_5(1)_218-233.nxml.txt.nlp	24216705	SENT239	14	14	24	24	doxorubicin	PI3K	PA449412	5290	0.805
NULL	Arthritis_Res_Ther_2005_Jan_21_7(2)_55-61.nxml.txt.nlp	15743490	SENT109	0	0	6	6	atorvastatin	IFN	PA448500	3439	0.805
NULL	Diabetes_Metab_Syndr_Obes_2014_Jun_24_7_229-239.nxml.txt.nlp	25018644	SENT246	25	25	29	29	exenatide	GLP-1	PA164749238	100125288	0.805
NULL	J_Oncol_2012_Aug_24_2012_281261.nxml.txt.nlp	21876693	SENT144	19	19	10	10	thalidomide	MVD	PA451644	4597	0.805
NULL	Basic_Clin_Neurosci_2014_Spring_5(2)_124-130.nxml.txt.nlp	25337370	SENT271	2	2	9	9	berberine	CA1	PA165860812	759	0.805
NULL	Drugs_R_D_2014_Jun_15_14(2)_85-94.nxml.txt.nlp	24733439	SENT269	5	5	12	12	lorazepam	UGT2B7	PA450267	7364	0.805
NULL	J_Oral_Pathol_Med_2013_Jul_18_42(6)_499-506.nxml.txt.nlp	23331485	SENT14	4	4	18	18	indomethacin	IL-6	PA449982	3569	0.805
NULL	Cancer_Cell_Int_2004_Aug_17_4_5.nxml.txt.nlp	15315711	SENT15	11	11	5	5	genistein	NQO1	PA165109660	1728	0.805
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_79-96.nxml.txt.nlp	19305789	SENT219	21	21	26	26	vanillin	TRPV3	PA451852	162514	0.805
NULL	Osteoporos_Int_2012_Feb_4_23(Suppl_1)_S1-S23.nxml.txt.nlp	22311111	SENT435	6	6	18	18	denosumab	RANK	PA166048634	8792	0.805
NULL	Clin_Mol_Hepatol_2013_Sep_30_19(3)_288-299.nxml.txt.nlp	24133667	SENT185	19	19	12	12	sorafenib	SHARP	PA7000	23013	0.805
NULL	Cancers_(Basel)_2010_May_28_2(2)_1040-1065.nxml.txt.nlp	24281106	SENT39	23	23	17	17	trastuzumab	aromatase	PA451743	1588	0.805
NULL	Exp_Ther_Med_2013_Feb_29_5(2)_527-532.nxml.txt.nlp	23404385	SENT106	4	4	37	37	tacrolimus	CYP3A5	PA451578	1577	0.805
NULL	J_Cachexia_Sarcopenia_Muscle_2010_Sep_26_1(1)_43-128.nxml.txt.nlp	22477519	SENT2078	9	9	22	22	irbesartan	gamma	PA450084	9913	0.805
NULL	Cancer_Causes_Control_2013_Aug_18_24(8)_1605-1614.nxml.txt.nlp	23775025	SENT64	33	33	16	16	doxorubicin	CYP3A4	PA449412	1576	0.805
NULL	Evid_Based_Complement_Alternat_Med_2013_May_13_2013_506324.nxml.txt.nlp	23818927	SENT13	8	8	16	16	doxorubicin	STAT3	PA449412	6774	0.805
NULL	Int_J_Mol_Sci_2014_Mar_5_15(3)_3989-4006.nxml.txt.nlp	24603538	SENT32	5	5	20	20	l-arginine	DDAH	PA448478	23576	0.805
NULL	Clin_Ophthalmol_2008_Sep_2(3)_613-621.nxml.txt.nlp	19668762	SENT29	0	0	35	35	travoprost	BAK	PA164781371	578	0.805
NULL	Br_J_Cancer_2010_Feb_2_102(3)_520-529.nxml.txt.nlp	20029417	SENT135	25	25	7	7	cetuximab	IL-21	PA10040	59067;50616;27189	0.805
NULL	Cancer_Metab_2014_May_28_2(Suppl_1)_P65.nxml.txt.nlp	NULL	SENT19	22	22	32	32	resveratrol	SIRT1		23411	0.805
NULL	Int_J_Biomed_Sci_2013_Sep_9(3)_112-122.nxml.txt.nlp	24170986	SENT137	3	3	21	21	imatinib	ABL1	PA10804	25	0.805
NULL	Biosci_Rep_2013_Nov_25_33(6)_e00081.nxml.txt.nlp	24070327	SENT510	1	1	19	19	imatinib	ABCB1	PA10804	5243	0.805
NULL	Appl_Plant_Sci_2015_Jan_5_3(1)_apps_1400086.nxml.txt.nlp	25606353	SENT94	3	3	25	25	vancomycin	UNK	PA451850	85451	0.805
NULL	Cancer_Res_Treat_2014_Jan_15_46(1)_98-103.nxml.txt.nlp	24520229	SENT36	23	23	27	27	tamoxifen	aromatase	PA451581	1588	0.805
NULL	Cancer_Immunol_Immunother_2011_Jun_25_60(6)_793-808.nxml.txt.nlp	21350947	SENT219	13	13	10	10	sorafenib	IFN	PA7000	3439	0.805
NULL	Case_Rep_Oncol_2010_Apr_22_3(2)_98-105.nxml.txt.nlp	20740181	SENT13	0	0	9	9	erlotinib	EGFR	PA134687924	1956	0.805
NULL	Biol_Open_2014_Nov_13_3(12)_1164-1172.nxml.txt.nlp	25395667	SENT95	17	17	10	10	capsaicin	TRPV1	PA448776	7442	0.805
NULL	Curr_Neuropharmacol_2013_Jul_11(4)_338-378.nxml.txt.nlp	24381528	SENT439	3	3	16	16	curcumin	JNK	PA151958596	5599	0.805
NULL	Breast_Cancer_Res_Treat_2012_Jun_18_133(3)_937-947.nxml.txt.nlp	22094936	SENT1	27	27	20	20	tamoxifen	EZH2	PA451581	2146	0.805
NULL	J_Biol_2009_Apr_15_8(3)_30.nxml.txt.nlp	19435483	SENT49	14	14	30	30	imatinib	NQO2	PA10804	4835	0.805
NULL	Cancers_(Basel)_2010_Feb_23_2(1)_88-113.nxml.txt.nlp	24281034	SENT1438	8	8	23	23	cetuximab	San	PA10040	80218	0.805
NULL	Indian_J_Endocrinol_Metab_2011_Jan-Mar_15(1)_9-17.nxml.txt.nlp	21584160	SENT110	20	20	16	16	liraglutide	PPG	PA165958364	5552	0.805
NULL	Br_J_Pharmacol_2008_Dec_25_155(7)_1056-1065.nxml.txt.nlp	18724386	SENT254	28	28	37	37	nitrendipine	GLP-1	PA146096020	100125288	0.805
NULL	Indian_J_Med_Res_2012_Aug_136(2)_249-259.nxml.txt.nlp	22960892	SENT127	33	33	13	13	sn-38	UGT1A1		54658	0.805
NULL	Cough_2005_Oct_19_1_10.nxml.txt.nlp	16270907	SENT6	31	31	27	27	omeprazole	GOR	PA450704	254958	0.805
NULL	Front_Oncol_2013_Sep_6_3_218.nxml.txt.nlp	24032106	SENT11	26	26	38	38	fludarabine	NPM1	PA449655	4869	0.805
NULL	Br_J_Cancer_2004_Mar_8_90(5)_1059-1068.nxml.txt.nlp	14997208	SENT13	7	7	9	9	losartan	AT1	PA450268	9197;185	0.805
NULL	Pharmaceutics_2010_Jun_2_2(2)_258-274.nxml.txt.nlp	NULL	SENT173	40	40	28	28	risperidone	ABCB1	PA451257	5243	0.805
NULL	Ann_Hematol_2014_Sep_10_93(1)_1-11.nxml.txt.nlp	24018623	SENT162	16	16	30	30	lenalidomide	IL1R2	PA162363968	7850	0.805
NULL	Blood_Cancer_J_2012_Oct_19_2(10)_e95.nxml.txt.nlp	23085780	SENT95	10	10	15	15	ponatinib	CML	PA165980594	613	0.805
NULL	Oncotarget_2014_Aug_19_5(18)_8737-8749.nxml.txt.nlp	25228590	SENT157	28	28	24	24	crizotinib	PI3K	PA165946122	5290	0.805
NULL	Br_J_Cancer_2013_Mar_19_108(5)_1079-1091.nxml.txt.nlp	23449353	SENT116	16	16	19	19	docetaxel	PC3	PA449383	57332;7832;5122	0.805
NULL	Clinics_(Sao_Paulo)_2013_May_68(5)_694-701.nxml.txt.nlp	23778405	SENT139	5	5	9	9	curcumin	survivin	PA151958596	332	0.805
NULL	Front_Behav_Neurosci_2011_Sep_8_5_56.nxml.txt.nlp	21927600	SENT208	7	7	4	4	cocaine	CPP	PA449072	340451	0.805
NULL	Br_J_Cancer_2011_Jun_28_105(1)_1-8.nxml.txt.nlp	21654681	SENT80	9	9	28	28	gefitinib	EGFR	PA131301952	1956	0.805
NULL	Core_Evid_2011_Mar_17_6_31-42.nxml.txt.nlp	21468241	SENT229	6	6	4	4	ticagrelor	P2Y12	PA165374673	64805	0.805
NULL	Br_J_Cancer_2010_Feb_2_102(3)_541-552.nxml.txt.nlp	20087344	SENT154	30	30	6	6	paclitaxel	NRP1	PA450761	8829	0.805
NULL	Breast_Cancer_Res_2008_May_12_10(3)_R43.nxml.txt.nlp	18471300	SENT76	2	2	17	17	estradiol	p53	PA449503	7157	0.805
NULL	J_Cell_Biol_1998_Nov_16_143(4)_1087-1099.nxml.txt.nlp	9817764	SENT69	23	23	17	17	collagenase	AP-1	PA449107	2353;3727;2354;3725	0.805
NULL	Nat_Chem_2013_Mar_17_5(3)_221-227.nxml.txt.nlp	23422564	SENT125	32	32	8	8	heparin	mol	PA449855	90527	0.805
NULL	J_Anim_Sci_Biotechnol_2013_Jul_30_4(1)_27.nxml.txt.nlp	23899038	SENT197	3	3	41	41	l-cysteine	IL-10	PA449173	3586	0.805
NULL	Br_J_Clin_Pharmacol_2011_Oct_72(4)_647-657.nxml.txt.nlp	21518389	SENT29	12	12	25	25	thrombin	ADP	PA451674	23038	0.805
NULL	Epilepsy_Res_Treat_2010_Jun_22_2010_654265.nxml.txt.nlp	22937226	SENT164	15	15	5	5	etomidate	FOE	PA164743987	23063	0.805
NULL	Evid_Based_Complement_Alternat_Med_2012_Sep_18_2012_674101.nxml.txt.nlp	23028394	SENT160	6	6	18	18	donepezil	CA2	PA449394	760	0.805
NULL	Ann_Oncol_2014_Apr_26_25(4)_801-807.nxml.txt.nlp	24577117	SENT144	17	17	25	25	cetuximab	p16	PA10040	1029	0.805
NULL	Osteoporos_Int_2012_May_19_23(5)_1613-1622.nxml.txt.nlp	21769661	SENT217	0	0	12	12	teriparatide	PTH	PA451620	5741	0.805
NULL	Orphanet_J_Rare_Dis_2007_Apr_15_2_19.nxml.txt.nlp	17433111	SENT213	27	27	3	3	propylthiouracil	CD2BP1	PA451156	9051	0.805
NULL	Clin_Med_Case_Rep_2009_Jul_31_2_43-49.nxml.txt.nlp	24179373	SENT94	30	30	9	9	vincristine	CD33	PA451879	945	0.805
NULL	J_Gen_Physiol_2009_Dec_134(6)_471-488.nxml.txt.nlp	19917732	SENT820	5	5	11	11	capsaicin	VR1	PA448776	56664	0.805
NULL	Cancer_Immunol_Immunother_2013_Aug_27_62(10)_1637-1648.nxml.txt.nlp	23982484	SENT153	31	31	15	15	lenalidomide	IL-2	PA162363968	3558	0.805
NULL	Basic_Clin_Neurosci_2014_Summer_5(3)_218-224.nxml.txt.nlp	25337383	SENT7	28	28	14	14	prazosin	CB1	PA451093	1268	0.805
NULL	Virol_J_2011_May_25_8_259.nxml.txt.nlp	21612593	SENT70	13	13	9	9	fluorescein	CD4	PA164746009	920	0.805
NULL	Cancer_Cell_Int_2005_Aug_23_5_27.nxml.txt.nlp	16117829	SENT118	4	4	17	17	doxycycline	T13	PA449415	29123	0.805
NULL	Br_J_Cancer_2013_Jul_23_109(2)_351-359.nxml.txt.nlp	23799854	SENT228	12	12	1	1	paclitaxel	BLT2	PA450761	56413	0.805
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT99	10	10	40	40	nutlin-3	MDM2		4193	0.805
NULL	Oncoscience_2014_Apr_30_1(4)_283-286.nxml.txt.nlp	25594020	SENT6	31	31	14	14	doxorubicin	BCL6	PA449412	604	0.805
NULL	Cancer_Causes_Control_2013_Aug_18_24(8)_1605-1614.nxml.txt.nlp	23775025	SENT64	33	33	4	4	doxorubicin	CYP1A1	PA449412	1543	0.805
NULL	Oncotarget_2011_Dec_31_2(12)_935-947.nxml.txt.nlp	22249213	SENT241	11	11	8	8	paclitaxel	MCAK	PA450761	11004	0.805
NULL	Cancer_Manag_Res_2013_Nov_21_5_387-400.nxml.txt.nlp	24294007	SENT192	14	14	22	22	irinotecan	DPD	PA450085	1806	0.805
NULL	Pharmaceuticals_(Basel)_2012_Jul_25_5(8)_779-801.nxml.txt.nlp	24280675	SENT250	11	11	17	17	geldanamycin	Hsp90	PA152031327	3320	0.805
NULL	Oncol_Rep_2014_Jun_9_31(6)_2482-2492.nxml.txt.nlp	24718854	SENT42	10	10	22	22	paclitaxel	GEM	PA450761	2669	0.805
NULL	Br_J_Cancer_1996_Dec_74(11)_1719-1729.nxml.txt.nlp	8956784	SENT10	24	24	16	16	daunorubicin	EPI	PA449212	7035	0.805
NULL	Ann_Surg_Oncol_2014_Feb_13_21(5)_1575-1582.nxml.txt.nlp	24522992	SENT174	8	8	29	29	anastrozole	IMPACT	PA448432	55364	0.805
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_29_2013_590393.nxml.txt.nlp	23737838	SENT311	3	3	8	8	resveratrol	Oct4		5460	0.805
NULL	Oncotarget_2014_Jun_19_5(15)_6540-6551.nxml.txt.nlp	25153728	SENT120	4	4	24	24	paclitaxel	Bcl-2	PA450761	596	0.805
NULL	Nat_Commun_2013_4_1449.nxml.txt.nlp	23385593	SENT104	16	16	7	7	nadh	BRCA1	PA164755085	672	0.805
NULL	Arthritis_Res_Ther_2010_Jan_8_12(1)_R4.nxml.txt.nlp	20064200	SENT71	21	21	29	29	fluorescein	COX2	PA164746009	4513;5743	0.805
NULL	Diabetes_Care_2012_Feb_16_35(2)_327-333.nxml.txt.nlp	22179958	SENT80	12	12	5	5	metformin	B12	PA450395	7126;4709	0.805
NULL	J_Biol_Chem_2012_Apr_20_287(17)_14192-14200.nxml.txt.nlp	22378781	SENT50	37	37	12	12	glutaraldehyde	STAT3	PA449777	6774	0.805
NULL	Oncol_Lett_2014_Jul_16_8(1)_211-217.nxml.txt.nlp	24959248	SENT119	4	4	18	18	cisplatin	ANGPTL4	PA449014	51129	0.805
NULL	J_Biol_Chem_2009_Apr_3_284(14)_9558-9565.nxml.txt.nlp	19202191	SENT69	43	43	15	15	camptothecin	CtIP	PA153590860	5932	0.805
NULL	Front_Psychol_2014_Sep_17_5_919.nxml.txt.nlp	25278909	SENT325	11	11	3	3	buprenorphine	DRD2	PA448685	1813	0.805
NULL	Allergy_Asthma_Immunol_Res_2011_Oct_20_3(4)_245-250.nxml.txt.nlp	21966604	SENT67	24	24	1	1	methacholine	ANOVA	PA165958382	4858	0.805
NULL	Mol_Cell_Proteomics_2014_Dec_22_13(12)_3320-3331.nxml.txt.nlp	25149096	SENT54	24	24	40	40	dextran	CO2	PA449261	4513	0.805
NULL	Mol_Cancer_2010_Apr_15_9_77.nxml.txt.nlp	20398291	SENT77	7	7	11	11	geldanamycin	survivin	PA152031327	332	0.805
NULL	Mol_Cancer_2010_Nov_25_9_305.nxml.txt.nlp	21108789	SENT77	21	21	33	33	doxorubicin	PI3K	PA449412	5290	0.805
NULL	Virulence_2014_Jan_1_5(1)_36-44.nxml.txt.nlp	23774844	SENT139	0	0	3	3	thrombin	PAR1	PA451674	79581;2149	0.805
NULL	Ann_Rehabil_Med_2012_Oct_31_36(5)_633-639.nxml.txt.nlp	23185727	SENT46	26	26	6	6	lidocaine	SGB	PA450226	2719	0.805
NULL	Pharmacogn_Rev_2013_Jul-Dec_7(14)_81-91.nxml.txt.nlp	24347915	SENT130	6	6	18	18	curcumin	SDH	PA151958596	1757;10993	0.805
NULL	Indian_J_Pharm_Sci_2008_Mar-Apr_70(2)_145-153.nxml.txt.nlp	20046703	SENT28	9	9	17	17	cyclosporine	P-gp	PA449167	5243	0.805
NULL	Leukemia_2014_Mar_13_28(3)_600-608.nxml.txt.nlp	24240203	SENT224	10	10	20	20	nutlin-3	BAX		581	0.805
NULL	J_Young_Pharm_2010_Oct-Dec_2(4)_428-429.nxml.txt.nlp	21264109	SENT53	21	21	12	12	metformin	B12	PA450395	7126;4709	0.805
NULL	Oncotarget_2014_Feb_7_5(3)_775-787.nxml.txt.nlp	24519956	SENT152	4	4	11	11	dasatinib	PC3	PA162372878	57332;7832;5122	0.805
NULL	Cancer_Med_2013_Dec_27_2(6)_751-762.nxml.txt.nlp	24403249	SENT296	11	11	21	21	paclitaxel	CD44	PA450761	960	0.805
NULL	Nucleic_Acids_Res_2013_May_12_41(9)_e101.nxml.txt.nlp	23482392	SENT381	6	6	10	10	bortezomib	AKR1C3	PA10252	8644	0.805
NULL	Breast_Cancer_Res_2014_Dec_19_16(6)_499.nxml.txt.nlp	25522654	SENT250	16	16	13	13	estradiol	CYP19A1	PA449503	1588	0.805
NULL	Aging_(Albany_NY)_2009_Mar_31_1(4)_412-424.nxml.txt.nlp	20195491	SENT88	2	2	10	10	resveratrol	TXNIP		10628	0.805
NULL	J_Adv_Pract_Oncol_2013_Jul_1_Jul-Aug_4(4)_238-250.nxml.txt.nlp	25032004	SENT160	17	17	3	3	imatinib	CYP3A4	PA10804	1576	0.805
NULL	J_Radiat_Res_2014_Mar_1_55(2)_359-363.nxml.txt.nlp	24187329	SENT14	14	14	22	22	cyclophosphamide	CHOP	PA449165	1649	0.805
NULL	Open_Allergy_J_2010_3_91-101.nxml.txt.nlp	25018787	SENT271	2	2	8	8	omalizumab	IL-4	PA164752253	3565	0.805
NULL	Environ_Health_Perspect_2010_Sep_28_118(9)_1267-1272.nxml.txt.nlp	20427257	SENT208	15	15	10	10	estradiol	BPA	PA449503	667	0.805
NULL	Chemother_Res_Pract_2011_Sep_21_2011_839742.nxml.txt.nlp	22295206	SENT90	33	33	20	20	cetuximab	EGFR	PA10040	1956	0.805
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Jun_25_3(6)_e120.nxml.txt.nlp	24964282	SENT320	12	12	8	8	ketoconazole	CYP3A4	PA450146	1576	0.805
NULL	Arthritis_Res_Ther_2009_Jan_30_11(1)_205.nxml.txt.nlp	19232061	SENT45	40	40	0	0	etanercept	ACR	PA449515	49	0.805
NULL	Can_Geriatr_J_2013_Jun_3_16(2)_66-103.nxml.txt.nlp	NULL	SENT672	40	40	4	4	memantine	NMA	PA10364	25805	0.805
NULL	Oncogene_2009_Apr_2_28(13)_1616-1625.nxml.txt.nlp	19219073	SENT126	6	6	20	20	nutlin-3	p53		7157	0.805
NULL	Comp_Funct_Genomics_2012_Feb_6_2012_876893.nxml.txt.nlp	22400011	SENT148	10	10	22	22	zinc	CPSF4	PA451956	10898	0.805
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT100	17	17	26	26	l-leucine	4E-BP1	PA450197	1978	0.805
NULL	J_Cell_Biol_1999_Feb_8_144(3)_447-458.nxml.txt.nlp	9971740	SENT312	16	16	19	19	dextran	mol	PA449261	90527	0.805
NULL	Oncotarget_2011_Sep_9_2(9)_658-668.nxml.txt.nlp	21911919	SENT104	31	31	26	26	daunorubicin	NAC	PA449212	22861	0.805
NULL	Cell_Commun_Signal_2014_Dec_24_12(1)_78.nxml.txt.nlp	NULL	SENT357	14	14	1	1	losartan	MYH7	PA450268	4625	0.805
NULL	Clin_Mol_Hepatol_2013_Sep_30_19(3)_300-304.nxml.txt.nlp	24133668	SENT55	5	5	2	2	entecavir	NUC	PA164784025	4924	0.805
NULL	J_Res_Med_Sci_2012_May_17(5)_487-490.nxml.txt.nlp	23626617	SENT83	13	13	20	20	vincristine	CHOP	PA451879	1649	0.805
NULL	Cells_2014_Jan_27_3(1)_53-78.nxml.txt.nlp	24709902	SENT1462	15	15	1	1	trastuzumab	PTEN	PA451743	5728	0.805
NULL	Br_J_Cancer_2013_Aug_6_109(3)_589-596.nxml.txt.nlp	23868011	SENT117	27	27	11	11	tamoxifen	ATAC	PA451581	6375	0.805
NULL	Front_Neurosci_2014_Aug_14_8_242.nxml.txt.nlp	25177264	SENT42	14	14	24	24	estradiol	aromatase	PA449503	1588	0.805
NULL	Oncol_Lett_2013_Mar_18_5(3)_969-971.nxml.txt.nlp	23426888	SENT83	28	28	15	15	capecitabine	TYMS	PA448771	7298	0.805
NULL	Front_Cell_Neurosci_2014_Jan_30_8_14.nxml.txt.nlp	24523673	SENT195	5	5	28	28	isoflurane	PSEN1	PA450106	5663	0.805
NULL	J_Cancer_Prev_2013_Jun_18(2)_186-191.nxml.txt.nlp	25337545	SENT148	2	2	7	7	curcumin	p53	PA151958596	7157	0.805
NULL	Oxid_Med_Cell_Longev_2011_Oct_9_2011_756938.nxml.txt.nlp	22007271	SENT153	28	28	37	37	forskolin	PNMT	PA146096022	5409	0.805
NULL	J_Hematol_Oncol_2012_Sep_18_5_57.nxml.txt.nlp	22989009	SENT93	7	7	22	22	nutlin-3	HDM2		4193	0.805
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_11_2014_780385.nxml.txt.nlp	25435891	SENT12	16	16	23	23	lipase	HSL	PA450239	3991	0.805
NULL	Adv_Hematol_2010_Aug_25_2010_268921.nxml.txt.nlp	20862197	SENT147	2	2	5	5	imatinib	IFN	PA10804	3439	0.805
NULL	Stroke_Res_Treat_2011_Jun_22_2011_607852.nxml.txt.nlp	21822469	SENT499	2	2	13	13	rivaroxaban	CYP3A4	PA165958360	1576	0.804
NULL	Cell_Death_Differ_2010_Mar_16_17(3)_499-512.nxml.txt.nlp	19834490	SENT116	25	25	10	10	bevacizumab	VEGFR1	PA130232992	2321	0.804
NULL	Diabetes_Metab_Syndr_Obes_2014_Jun_24_7_229-239.nxml.txt.nlp	25018644	SENT211	0	0	20	20	exenatide	GLP-1	PA164749238	100125288	0.804
NULL	Acta_Pharmacol_Sin_2010_Mar_22_31(3)_329-340.nxml.txt.nlp	20173759	SENT138	11	11	28	28	ethanol	MEF2A	PA448073	4205	0.804
NULL	Arthritis_Res_Ther_2010_May_28_12(3)_R105.nxml.txt.nlp	20509880	SENT94	28	28	1	1	celecoxib	p38	PA448871	10598;1432;7965	0.804
NULL	Brain_2014_Sep_2_137(9)_2480-2492.nxml.txt.nlp	24993959	SENT220	24	24	13	13	trihexyphenidyl	Yes	PA164747026	7525	0.804
NULL	Oncogene_2014_Sep_18_33(38)_4685-4696.nxml.txt.nlp	24121268	SENT69	27	27	32	32	nutlin-3	p53		7157	0.804
NULL	Support_Care_Cancer_2012_Sep_17_20(9)_1991-1997.nxml.txt.nlp	22089428	SENT135	16	16	19	19	trastuzumab	HER-2	PA451743	2064	0.804
NULL	J_Exp_Med_2000_Nov_20_192(10)_1479-1490.nxml.txt.nlp	11085749	SENT43	37	37	4	4	streptomycin	HOXB4	PA451512	3214	0.804
NULL	Breast_Cancer_Res_2003_Jan_20_5(2)_R37-R44.nxml.txt.nlp	12631397	SENT236	10	10	7	7	tamoxifen	p53	PA451581	7157	0.804
NULL	Cerebellum_2010_Dec_25_9(4)_537-547.nxml.txt.nlp	20658325	SENT62	13	13	1	1	paraformaldehyde	E12	PA450790	64100	0.804
NULL	Br_J_Cancer_2012_Jan_17_106(2)_284-289.nxml.txt.nlp	22215065	SENT163	27	27	16	16	bevacizumab	IFN	PA130232992	3439	0.804
NULL	Semin_Immunol_2011_Feb_23(1)_28-41.nxml.txt.nlp	21295490	SENT975	27	27	12	12	ustekinumab	CD4	PA166048654	920	0.804
NULL	Cell_Commun_Signal_2013_Oct_1_11_73.nxml.txt.nlp	24083678	SENT257	8	8	16	16	sulindac	AP-1	PA451565	2353;3727;2354;3725	0.804
NULL	Br_J_Cancer_2012_Jul_24_107(3)_516-526.nxml.txt.nlp	22782351	SENT299	36	36	22	22	tamoxifen	CHEK2	PA451581	11200	0.804
NULL	Cancer_Med_2013_Feb_3_2(1)_11-20.nxml.txt.nlp	24133623	SENT22	33	33	12	12	panitumumab	KRAS	PA162373091	3845	0.804
NULL	Br_J_Cancer_2012_Sep_4_107(6)_967-976.nxml.txt.nlp	22892391	SENT138	29	29	12	12	etoposide	BCL2	PA449552	596	0.804
NULL	eLife_2013_Nov_5_2_e00969.nxml.txt.nlp	24192036	SENT210	0	0	8	8	vemurafenib	JNK	PA165946873	5599	0.804
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_127043.nxml.txt.nlp	23227093	SENT17	9	9	2	2	lovastatin	RYR	PA450272	6261	0.804
NULL	Breast_Cancer_Res_2011_Dec_16_13(6)_R131.nxml.txt.nlp	22177475	SENT199	6	6	13	13	erlotinib	AKT	PA134687924	207	0.804
NULL	Korean_J_Anesthesiol_2013_Dec_26_65(6)_501-507.nxml.txt.nlp	24427455	SENT11	26	26	16	16	rocuronium	NMB	PA164754992	10457;4828	0.804
NULL	J_Hematol_Oncol_2009_Feb_23_2_9.nxml.txt.nlp	19236713	SENT69	9	9	4	4	cetuximab	KRAS	PA10040	3845	0.804
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT371	0	0	6	6	cisplatin	p53	PA449014	7157	0.804
NULL	J_Appl_Crystallogr_2014_Sep_4_47(Pt_5)_1606-1613.nxml.txt.nlp	25294980	SENT46	26	26	12	12	ethanol	mol	PA448073	90527	0.804
NULL	Exp_Anim_2014_Apr_26_63(2)_257-267.nxml.txt.nlp	24770651	SENT108	2	2	5	5	olmesartan	apelin	PA164742950	8862	0.804
NULL	Clin_Ophthalmol_2011_Apr_18_5_495-502.nxml.txt.nlp	21573098	SENT161	0	0	8	8	gatifloxacin	BAK	PA449738	578	0.804
NULL	Diabetes_Obes_Metab_2012_Apr_14(4)_304-314.nxml.txt.nlp	22051096	SENT57	12	12	9	9	liraglutide	GLP-1	PA165958364	100125288	0.804
NULL	Br_J_Haematol_2008_Jun_141(5)_659-671.nxml.txt.nlp	18410446	SENT136	0	0	10	10	cerulenin	Apo2	PA164764551	8797	0.804
NULL	J_Mol_Med_(Berl)_2014_Jan_10_92(5)_497-507.nxml.txt.nlp	24408111	SENT5	3	3	27	27	pioglitazone	HIF-1	PA450970	29072	0.804
NULL	Mol_Cancer_2012_Dec_12_11_91.nxml.txt.nlp	23234355	SENT303	27	27	4	4	cetuximab	EGFR	PA10040	1956	0.804
NULL	J_Headache_Pain_2009_Dec_1_10(6)_395-406.nxml.txt.nlp	19795182	SENT165	18	18	15	15	rofecoxib	COX	PA451268	1351	0.804
NULL	J_Adv_Pract_Oncol_2012_Jan_1_Jan-Feb_3(1)_49-54.nxml.txt.nlp	25031928	SENT38	10	10	23	23	plerixafor	CD34	PA165958410	947	0.804
NULL	Endocrine_2012_Dec_14_42(3)_622-636.nxml.txt.nlp	22695986	SENT149	7	7	2	2	forskolin	PTH	PA146096022	5741	0.804
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT206	33	33	29	29	amiodarone	CYP3A4	PA448383	1576	0.804
NULL	Oncol_Lett_2014_Mar_16_7(3)_827-833.nxml.txt.nlp	24527090	SENT86	27	27	32	32	cisplatin	IFN	PA449014	3439	0.804
NULL	Ann_N_Y_Acad_Sci_2013_Apr_6_1281(1)_36-50.nxml.txt.nlp	23387439	SENT204	4	4	34	34	pioglitazone	Yes	PA450970	7525	0.804
NULL	Evid_Based_Complement_Alternat_Med_2012_Dec_6_2012_164219.nxml.txt.nlp	23304193	SENT30	15	15	4	4	vildagliptin	GLP-1	PA165958346	100125288	0.804
NULL	Exp_Ther_Med_2012_Sep_12_4(3)_475-480.nxml.txt.nlp	23181121	SENT159	6	6	16	16	vincristine	CHOP	PA451879	1649	0.804
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT305	8	8	4	4	erlotinib	EGFR	PA134687924	1956	0.804
NULL	Oncotarget_2014_Feb_14_5(5)_1279-1289.nxml.txt.nlp	24658133	SENT217	16	16	1	1	cisplatin	p53	PA449014	7157	0.804
NULL	Neural_Regen_Res_2014_Mar_15_9(6)_622-629.nxml.txt.nlp	25206865	SENT68	26	26	0	0	vasopressin	c-Jun	PA451858	3725	0.804
NULL	Aging_Cell_2010_Oct_9(5)_667-684.nxml.txt.nlp	20701600	SENT281	4	4	19	19	zidovudine	p16	PA451954	1029	0.804
NULL	Curr_Neuropharmacol_2011_Dec_9(4)_530-552.nxml.txt.nlp	22654714	SENT725	23	23	6	6	sertraline	BDNF	PA451333	627	0.804
NULL	Mol_Vis_2011_Jun_9_17_1564-1576.nxml.txt.nlp	21738386	SENT2	5	5	7	7	ethambutol	EMB	PA164784021	133418	0.804
NULL	Mol_Neurodegener_2011_Aug_8_6_57.nxml.txt.nlp	21819629	SENT226	24	24	44	44	arsenite	TDP-43	PA452638	23435	0.804
NULL	Neural_Regen_Res_2013_Jul_15_8(20)_1853-1862.nxml.txt.nlp	25206494	SENT169	14	14	22	22	ethanol	JNK	PA448073	5599	0.804
NULL	Br_J_Cancer_2012_Jan_3_106(1)_6-13.nxml.txt.nlp	22215104	SENT152	9	9	31	31	pertuzumab	San		80218	0.804
NULL	Crit_Care_2012_Nov_22_16(6)_238.nxml.txt.nlp	23171712	SENT218	28	28	0	0	ebselen	SP-A	PA161660841	653509	0.804
NULL	Scientifica_(Cairo)_2012_Dec_23_2012_606104.nxml.txt.nlp	24278719	SENT90	4	4	6	6	arsenite	HSF1	PA452638	3297	0.804
NULL	Open_Biochem_J_2011_Sep_23_5_45-51.nxml.txt.nlp	21966325	SENT89	0	0	7	7	diclofenac	PERK	PA449293	9451	0.804
NULL	Mol_Pain_2014_Aug_15_10_53.nxml.txt.nlp	25127716	SENT78	2	2	9	9	paclitaxel	SDH	PA450761	1757;10993	0.804
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1449-1456.nxml.txt.nlp	24077631	SENT116	28	28	17	17	tolbutamide	CYP2C9	PA451718	1559	0.804
NULL	Front_Oncol_2014_Jun_3_4_132.nxml.txt.nlp	24918087	SENT376	27	27	21	21	fluorouracil	TP53	PA128406956	7157	0.804
NULL	J_Cell_Biol_2005_Nov_21_171(4)_729-738.nxml.txt.nlp	16286510	SENT186	14	14	22	22	heparin	MMP7	PA449855	4316	0.804
NULL	Cell_Death_Differ_2010_Mar_16_17(3)_499-512.nxml.txt.nlp	19834490	SENT156	11	11	19	19	bevacizumab	VEGFR2	PA130232992	3791	0.804
NULL	Oncol_Rep_2014_Feb_13_31(2)_581-588.nxml.txt.nlp	24337105	SENT159	3	3	9	9	capsaicin	XBP1	PA448776	7494	0.804
NULL	Cancer_Cell_Int_2003_Mar_25_3_4.nxml.txt.nlp	12787470	SENT191	10	10	22	22	ethanol	EGF	PA448073	1950	0.804
NULL	Biologics_2009_Oct_12_3_469-474.nxml.txt.nlp	19851472	SENT103	26	26	3	3	montelukast	IL-5	PA450546	3567	0.804
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT49	34	34	13	13	diclofenac	CYP2D6	PA449293	1565	0.804
NULL	J_Cell_Biol_1998_Jul_13_142(1)_101-115.nxml.txt.nlp	9660866	SENT48	17	17	40	40	doxycycline	CO2	PA449415	4513	0.804
NULL	J_Gen_Physiol_2008_Nov_132(5)_521-535.nxml.txt.nlp	18852303	SENT245	22	22	17	17	trypsin	CAP2	PA451806	5271;10486	0.804
NULL	Basic_Clin_Neurosci_2013_Winter_4(1)_42-49.nxml.txt.nlp	25337327	SENT96	9	9	5	5	scopolamine	spatial	PA451308	219793	0.804
NULL	Iran_J_Pharm_Res_2014_Autumn_13(4)_1393-1401.nxml.txt.nlp	25587329	SENT104	24	24	32	32	celecoxib	ABCG2	PA448871	9429	0.804
NULL	Indian_J_Nucl_Med_2011_Jul-Sep_26(Suppl1)_S12-S15.nxml.txt.nlp	NULL	SENT8	12	12	31	31	ethanol	FDG	PA448073	23583	0.804
NULL	Mol_Cancer_2014_Jul_5_13_165.nxml.txt.nlp	24996221	SENT219	18	18	8	8	docetaxel	HMGB1	PA449383	3146	0.804
NULL	Indian_J_Pharmacol_2014_Sep-Oct_46(5)_549-550.nxml.txt.nlp	25298588	SENT58	14	14	25	25	warfarin	VKORC1	PA451906	79001	0.804
NULL	Pharmaceuticals_(Basel)_2013_Aug_21_6(8)_988-1038.nxml.txt.nlp	24276379	SENT102	27	27	4	4	oxaliplatin	TYMS	PA131285527	7298	0.804
NULL	J_Cardiovasc_Dis_Res_2012_Oct-Dec_3(4)_319-322.nxml.txt.nlp	23233778	SENT42	0	0	24	24	azithromycin	CYP3A4	PA448519	1576	0.804
NULL	Breast_Cancer_Res_2012_Feb_14_14(1)_R30.nxml.txt.nlp	22333315	SENT16	22	22	5	5	indomethacin	CXCL9	PA449982	4283	0.804
NULL	Br_J_Cancer_2010_Oct_26_103(9)_1380-1390.nxml.txt.nlp	20877355	SENT176	11	11	2	2	vincristine	ASK1	PA451879	4217	0.804
NULL	Int_J_Mol_Sci_2013_Apr_8_14(4)_7542-7570.nxml.txt.nlp	23567270	SENT215	9	9	4	4	tranylcypromine	PGIS	PA451741	5740	0.804
NULL	J_Psychopharmacol_2010_Nov_24(4_supplement)_91-118.nxml.txt.nlp	18801830	SENT352	21	21	28	28	olanzapine	ACTH	PA450688	5443	0.804
NULL	Indian_J_Pharmacol_2008_Oct_40(Suppl_2)_S97-S112.nxml.txt.nlp	21593984	SENT663	17	17	14	14	captopril	HYD	PA448780	51366	0.804
NULL	Int_J_Gen_Med_2011_Jul_20_4_539-545.nxml.txt.nlp	21845063	SENT148	10	10	2	2	pitavastatin	adiponectin	PA142650384	9370	0.804
NULL	Clin_Mol_Allergy_2009_Mar_12_7_5.nxml.txt.nlp	19284628	SENT152	17	17	35	35	salmeterol	IL-5	PA451300	3567	0.804
NULL	Front_Endocrinol_(Lausanne)_2014_Jan_16_5_1.nxml.txt.nlp	24474947	SENT61	24	24	17	17	estradiol	GPER	PA449503	2852	0.804
NULL	Mol_Cancer_2013_May_24_12_47.nxml.txt.nlp	23705854	SENT249	11	11	19	19	nimesulide	P-gp	PA137179528	5243	0.804
NULL	Nat_Genet_2014_Feb_12_46(2)_166-170.nxml.txt.nlp	24413734	SENT277	7	7	10	10	dasatinib	FYN	PA162372878	2534	0.804
NULL	Indian_J_Pharm_Sci_2013_May-Jun_75(3)_302-309.nxml.txt.nlp	24082346	SENT163	15	15	28	28	diclofenac	API	PA449293	5345	0.804
NULL	Brief_Bioinform_2014_Jul_31_15(4)_648-659.nxml.txt.nlp	23376192	SENT245	13	13	21	21	methotrexate	TYMS	PA450428	7298	0.804
NULL	Acta_Pharmacol_Sin_2014_Jun_4_35(6)_792-805.nxml.txt.nlp	24902787	SENT192	2	2	9	9	paroxetine	INS-1	PA450801	2305	0.804
NULL	Curr_Pharm_Biotechnol_2012_May_13(6)_969-986.nxml.txt.nlp	22039792	SENT260	10	10	8	8	omeprazole	P-gp	PA450704	5243	0.804
NULL	Aging_(Albany_NY)_2011_Mar_10_3(3)_192-222.nxml.txt.nlp	21422497	SENT545	8	8	22	22	metformin	PI3K	PA450395	5290	0.804
NULL	Biomed_Res_Int_2014_Jan_20_2014_948427.nxml.txt.nlp	24563867	SENT19	18	18	2	2	glucose	5-HT1A	PA449773	3350	0.804
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1449-1456.nxml.txt.nlp	24077631	SENT115	10	10	3	3	tolbutamide	CYP2C9	PA451718	1559	0.804
NULL	Br_J_Cancer_2011_Nov_22_105(11)_1708-1718.nxml.txt.nlp	22045188	SENT308	13	13	19	19	fluorescein	CD138	PA164746009	6382	0.804
NULL	Oncotarget_2014_Nov_11_5(22)_10963-10964.nxml.txt.nlp	25460503	SENT14	15	15	10	10	trastuzumab	ADAM17	PA451743	6868	0.804
NULL	Clin_Epigenetics_2010_Sep_18_1(3-4)_101-116.nxml.txt.nlp	21258631	SENT208	6	6	19	19	genistein	p16INK4a	PA165109660	1029	0.804
NULL	Br_J_Cancer_2010_Jul_13_103(2)_159-164.nxml.txt.nlp	20551951	SENT16	9	9	19	19	oxaliplatin	EGFR	PA131285527	1956	0.804
NULL	Oncogene_2013_Sep_26_32(39)_10_1038_onc_2012_491.nxml.txt.nlp	23108394	SENT299	4	4	0	0	epirubicin	FOXM1	PA449476	2305	0.804
NULL	Nucleic_Acids_Res_2005_Aug_12_33(14)_4584-4592.nxml.txt.nlp	16100380	SENT117	8	8	4	4	paromomycin	GCN2	PA164784023	440275	0.804
NULL	Cell_Death_Dis_2014_Jul_3_5(7)_e1311.nxml.txt.nlp	24991763	SENT349	14	14	28	28	ketamine	P15	PA450144	1030;29107	0.804
NULL	Br_J_Cancer_2011_Aug_9_105(4)_565-574.nxml.txt.nlp	21730974	SENT51	7	7	5	5	doxycycline	MSX2	PA449415	4488	0.804
NULL	Breast_Cancer_Res_2001_Oct_1_3(6)_361-364.nxml.txt.nlp	11737886	SENT27	19	19	43	43	doxorubicin	HER-2	PA449412	2064	0.804
NULL	Nucleic_Acids_Res_2008_Feb_20_36(3)_998-1008.nxml.txt.nlp	18096616	SENT32	4	4	2	2	heparin	PKR	PA449855	5610	0.804
NULL	F1000Prime_Rep_2014_Apr_1_6_21.nxml.txt.nlp	24765526	SENT100	28	28	25	25	methotrexate	IL-6	PA450428	3569	0.804
NULL	Cell_Death_Dis_2013_Oct_3_4(10)_e828.nxml.txt.nlp	24091671	SENT91	29	29	12	12	cetuximab	CD54	PA10040	3383	0.804
NULL	Front_Oncol_2013_Sep_23_3_250.nxml.txt.nlp	24069582	SENT366	16	16	29	29	tamoxifen	ATAC	PA451581	6375	0.804
NULL	Chem_Cent_J_2013_Jul_31_7_133.nxml.txt.nlp	23899303	SENT19	15	15	7	7	ofloxacin	MOX	PA450684	26002	0.804
NULL	Exp_Diabetes_Res_2011_Dec_27_2011_604989.nxml.txt.nlp	21253359	SENT139	15	15	3	3	clonidine	GLP-1	PA449051	100125288	0.804
NULL	Cell_Death_Dis_2014_Feb_13_5(2)_e1060.nxml.txt.nlp	24525736	SENT169	25	25	13	13	paraformaldehyde	TRAIL	PA450790	8743	0.804
NULL	Leukemia_2014_Jun_17_28(6)_1216-1226.nxml.txt.nlp	24301524	SENT6	3	3	13	13	bortezomib	Hes1	PA10252	3280	0.804
NULL	Biochim_Biophys_Acta_2014_Jul_1842(7)_959-970.nxml.txt.nlp	24594481	SENT812	38	38	25	25	lipase	HSL	PA450239	3991	0.804
NULL	BMB_Rep_2014_Oct_47(10)_575-580.nxml.txt.nlp	24499675	SENT7	18	18	2	2	arsenite	p53	PA452638	7157	0.804
NULL	Cancer_Cell_Int_2010_Apr_29_10_12.nxml.txt.nlp	20429927	SENT183	16	16	9	9	bortezomib	HRI	PA10252	27102	0.804
NULL	Mol_Cancer_2009_Nov_24_8_109.nxml.txt.nlp	19930708	SENT194	16	16	8	8	exemestane	aromatase	PA449563	1588	0.804
NULL	Eur_J_Clin_Pharmacol_2010_Nov_29_66(11)_1131-1136.nxml.txt.nlp	20669013	SENT133	41	41	17	17	erythromycin	CYP2C19	PA449493	1557	0.804
NULL	Diabetes_Care_2010_Sep_33(9)_2123-2125.nxml.txt.nlp	20805284	SENT11	1	1	30	30	metformin	GLP-1	PA450395	100125288	0.804
NULL	Ann_Gastroenterol_2013_26(3)_233-238.nxml.txt.nlp	NULL	SENT121	16	16	1	1	infliximab	NAT	PA452639	6046	0.804
NULL	Br_J_Cancer_2011_Jul_26_105(3)_372-381.nxml.txt.nlp	21730979	SENT154	18	18	25	25	cisplatin	p53	PA449014	7157	0.804
NULL	J_Hematol_Oncol_2010_Mar_13_3_10.nxml.txt.nlp	20226083	SENT19	14	14	7	7	gemcitabine	RRM1	PA449748	6240	0.804
NULL	Mol_Cancer_2009_Aug_25_8_66.nxml.txt.nlp	19706164	SENT76	15	15	17	17	celecoxib	p53	PA448871	7157	0.804
NULL	J_Gastrointest_Surg_2012_Apr_13_16(4)_842-848.nxml.txt.nlp	22246855	SENT94	27	27	12	12	bevacizumab	EGFR	PA130232992	1956	0.804
NULL	Cancer_Metastasis_Rev_2014_Nov_7_33(4)_1095-1108.nxml.txt.nlp	25376898	SENT383	3	3	19	19	pantoprazole	MRP1	PA450774	4437	0.804
NULL	Cancer_Manag_Res_2013_Jul_31_5_187-195.nxml.txt.nlp	23986650	SENT61	26	26	20	20	trastuzumab	HER2	PA451743	2064	0.804
NULL	Cell_Death_Dis_2010_May_13_1(5)_e41.nxml.txt.nlp	21364648	SENT4	13	13	16	16	etoposide	p53	PA449552	7157	0.804
NULL	Acta_Pharmacol_Sin_2009_Apr_3_30(4)_478-484.nxml.txt.nlp	19343062	SENT40	13	13	22	22	cyclosporine	CYP3A4	PA449167	1576	0.804
NULL	Front_Neurosci_2014_Feb_14_8_23.nxml.txt.nlp	24592205	SENT165	39	39	41	41	capsaicin	TRPV1	PA448776	7442	0.804
NULL	Int_J_Surg_Oncol_2012_Jun_12_2012_862879.nxml.txt.nlp	22778941	SENT17	15	15	25	25	cisplatin	BIN1	PA449014	274	0.804
NULL	J_Korean_Med_Sci_2011_Aug_27_26(8)_1007-1013.nxml.txt.nlp	21860550	SENT123	33	33	14	14	tamoxifen	CYP2D6	PA451581	1565	0.804
NULL	Neural_Regen_Res_2014_Nov_1_9(21)_1897-1901.nxml.txt.nlp	25558239	SENT18	4	4	20	20	diazepam	CA1	PA449283	759	0.804
NULL	Br_J_Cancer_2009_Mar_24_100(6)_941-949.nxml.txt.nlp	19240716	SENT160	29	29	36	36	pertuzumab	EGFR		1956	0.804
NULL	EJC_Suppl_2013_Sep_5_11(2)_45-59.nxml.txt.nlp	NULL	SENT242	23	23	34	34	oxaliplatin	CRT	PA131285527	811	0.804
NULL	Nat_Biotechnol_2010_Mar_14_28(3)_249-255.nxml.txt.nlp	20160716	SENT94	2	2	21	21	meclizine	ANOVA	PA450338	4858	0.804
NULL	Front_Chem_2014_Mar_14_2_12.nxml.txt.nlp	24790981	SENT115	0	0	20	20	curcumin	GATA4	PA151958596	2626	0.804
NULL	Diabetes_2013_Sep_15_62(9)_3232-3240.nxml.txt.nlp	23835329	SENT8	0	0	3	3	aripiprazole	AAP	PA10026	5345	0.804
NULL	Inflamm_Res_2009_Dec_21_58(12)_873-880.nxml.txt.nlp	19544046	SENT112	29	29	5	5	ketanserin	5-HT1A	PA131053734	3350	0.804
NULL	Front_Neural_Circuits_2014_Jun_17_8_65.nxml.txt.nlp	24987336	SENT179	26	26	24	24	furosemide	KCC2	PA449719	57468	0.804
NULL	Dis_Markers_2012_Feb_1_32(1)_43-50.nxml.txt.nlp	22297601	SENT4	19	19	6	6	efavirenz	MDR1	PA449441	5243	0.804
NULL	Pharmaceutics_2011_Nov_18_3(4)_865-913.nxml.txt.nlp	24309312	SENT479	10	10	16	16	lidocaine	CYP1A2	PA450226	1544	0.804
NULL	Cell_Commun_Signal_2014_Mar_10_12_13.nxml.txt.nlp	24606867	SENT151	27	27	36	36	lipase	IL-6	PA450239	3569	0.804
NULL	Allergy_Asthma_Immunol_Res_2014_Nov_19_6(6)_548-557.nxml.txt.nlp	25374755	SENT79	2	2	11	11	lovastatin	MUC5AC	PA450272	4586	0.804
NULL	Braz_J_Med_Biol_Res_2012_Apr_27_45(6)_510-516.nxml.txt.nlp	22527124	SENT11	10	10	12	12	doxorubicin	ADM	PA449412	133	0.804
NULL	Clin_Sci_(Lond)_2011_Nov_1_121(Pt_10)_449-458.nxml.txt.nlp	21671887	SENT114	25	25	32	32	simvastatin	ANOVA	PA451363	4858	0.804
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT202	8	8	12	12	ranibizumab	VEGF-A	PA164746012	7422	0.804
NULL	Front_Mol_Neurosci_2012_Nov_12_5_99.nxml.txt.nlp	23162427	SENT272	31	31	7	7	cocaine	CBP	PA449072	55824;1387	0.804
NULL	Cancer_Microenviron_2009_Sep_26_2(Suppl_1)_19-204.nxml.txt.nlp	NULL	SENT2564	28	28	10	10	tamoxifen	ENL	PA451581	4298	0.804
NULL	Clin_Med_Insights_Oncol_2011_Sep_21_5_315-323.nxml.txt.nlp	22084620	SENT16	4	4	18	18	gemcitabine	IL-2	PA449748	3558	0.804
NULL	Clin_Ophthalmol_2014_Dec_30_9_33-41.nxml.txt.nlp	25565766	SENT19	6	6	18	18	mitomycin	PRK	PA450524	1263	0.804
NULL	Hum_Genomics_Proteomics_2010_Sep_13_2010_754919.nxml.txt.nlp	20981234	SENT96	30	30	16	16	acenocoumarol	CYP2C9	PA452632	1559	0.804
NULL	Clin_Ophthalmol_2011_Feb_27_5_275-279.nxml.txt.nlp	21468333	SENT121	25	25	3	3	voriconazole	ARTEMIS	PA10233	64421	0.804
NULL	J_Skin_Cancer_2013_Apr_22_2013_632028.nxml.txt.nlp	23710361	SENT242	7	7	25	25	cisplatin	Bcl-2	PA449014	596	0.804
NULL	Brain_Sci_2013_Apr_26_3(2)_670-703.nxml.txt.nlp	24961420	SENT922	3	3	9	9	ethanol	14-3-3	PA448073	10971	0.804
NULL	Nature_2012_Feb_22_483(7391)_618-622.nxml.txt.nlp	22367539	SENT122	26	26	5	5	fluorescein	OTUB1	PA164746009	55611	0.804
NULL	Oncotarget_2014_Jun_19_5(15)_6540-6551.nxml.txt.nlp	25153728	SENT22	0	0	15	15	paclitaxel	Bcl-2	PA450761	596	0.804
NULL	Clinics_(Sao_Paulo)_2012_Dec_67(12)_1479-1482.nxml.txt.nlp	23295604	SENT80	19	19	8	8	risperidone	FGA	PA451257	2243	0.804
NULL	Front_Genet_2012_Nov_22_3_249.nxml.txt.nlp	23189085	SENT115	17	17	26	26	etoposide	WNT5B	PA449552	81029	0.804
NULL	Ann_Hematol_2010_Sep_13_89(9)_861-871.nxml.txt.nlp	20387067	SENT29	34	34	7	7	dasatinib	CD34	PA162372878	947	0.804
NULL	J_Mol_Med_(Berl)_2014_May_10_92(7)_709-722.nxml.txt.nlp	24811491	SENT229	6	6	26	26	fluorouracil	KRAS	PA128406956	3845	0.804
NULL	Oncol_Lett_2014_Nov_12_8(5)_2203-2208.nxml.txt.nlp	25295109	SENT131	26	26	21	21	celecoxib	GLI1	PA448871	2735	0.804
NULL	Int_J_Mol_Sci_2013_Apr_10_14(4)_7742-7756.nxml.txt.nlp	23574936	SENT828	11	11	3	3	carboplatin	ENPP2	PA448803	5168	0.804
NULL	Aging_(Albany_NY)_2010_Dec_20_2(12)_959-968.nxml.txt.nlp	21191146	SENT87	5	5	13	13	cisplatin	Rpn13	PA449014	11047	0.804
NULL	Scientifica_(Cairo)_2012_Dec_23_2012_857516.nxml.txt.nlp	24278747	SENT267	9	9	33	33	bortezomib	CHOP	PA10252	1649	0.804
NULL	Inorganica_Chim_Acta_2012_Dec_1_393(7)_252-260.nxml.txt.nlp	23471093	SENT60	31	31	7	7	ethanol	HL1	PA448073	1767	0.804
NULL	Oncol_Lett_2014_Jul_12_8(1)_223-229.nxml.txt.nlp	24959250	SENT90	2	2	11	11	captopril	IL-18	PA448780	3606	0.804
NULL	J_Immunother_Cancer_2013_Jul_15_1_10.nxml.txt.nlp	24829747	SENT176	12	12	2	2	platinum	STAT3	PA150595617	6774	0.804
NULL	Case_Rep_Rheumatol_2014_Dec_8_2014_271548.nxml.txt.nlp	25548710	SENT64	11	11	14	14	thrombin	VIII	PA451674	1351	0.804
NULL	Eur_J_Clin_Pharmacol_2014_Mar_22_70(6)_685-693.nxml.txt.nlp	24658827	SENT45	16	16	32	32	midazolam	POR	PA450496	5447	0.804
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1059-1066.nxml.txt.nlp	21364577	SENT59	7	7	9	9	aminoglutethimide	aromatase	PA448375	1588	0.804
NULL	Mol_Cancer_2013_May_24_12_45.nxml.txt.nlp	23705792	SENT148	4	4	8	8	thyroglobulin	DUOX2	PA164754910	50506	0.804
NULL	Cancers_(Basel)_2014_Mar_6_6(1)_494-525.nxml.txt.nlp	24662938	SENT1920	13	13	4	4	cetuximab	BRAF	PA10040	673	0.804
NULL	J_Invest_Dermatol_2014_Jan_21_134(1)_10_1038_jid_2013_279.nxml.txt.nlp	23792457	SENT129	12	12	14	14	bexarotene	IFN	PA164752250	3439	0.804
NULL	Braz_J_Med_Biol_Res_2013_Sep_6_46(9)_746-751.nxml.txt.nlp	24036910	SENT140	21	21	42	42	genistein	HL-1	PA165109660	55600	0.804
NULL	Cancer_Cell_Int_2009_Sep_10_9_25.nxml.txt.nlp	19744341	SENT11	0	0	4	4	glucosamine	STAT3	PA164747613	6774	0.804
NULL	FEBS_Lett_2014_Sep_17_588(18)_3382-3389.nxml.txt.nlp	25093298	SENT112	21	21	0	0	l-glutamine	HEK	PA10090	2042	0.804
NULL	J_Mol_Signal_2009_May_14_4_3.nxml.txt.nlp	19442290	SENT181	26	26	19	19	genistein	BRCA2	PA165109660	675	0.804
NULL	Case_Rep_Endocrinol_2013_Dec_22_2013_675298.nxml.txt.nlp	24455332	SENT12	3	3	26	26	cisplatin	ACTH	PA449014	5443	0.804
NULL	Virol_J_2011_Nov_28_8_523.nxml.txt.nlp	22122911	SENT132	16	16	37	37	heparin	DARC	PA449855	2532	0.804
NULL	Mol_Cancer_2014_Feb_24_13_35.nxml.txt.nlp	24565101	SENT172	5	5	12	12	doxorubicin	p65	PA449412	5970	0.804
NULL	Endocrinol_Metab_(Seoul)_2013_Dec_12_28(4)_262-274.nxml.txt.nlp	24396690	SENT156	32	32	2	2	exenatide	GLP-1	PA164749238	100125288	0.804
NULL	Genet_Mol_Biol_2009_Sep_1_Jul-Sep_32(3)_516-520.nxml.txt.nlp	21637514	SENT82	12	12	4	4	estradiol	IGF1	PA449503	3479	0.804
NULL	Oncoimmunology_2014_Jun_3_3_e29030.nxml.txt.nlp	25083328	SENT80	5	5	37	37	paclitaxel	NHL	PA450761	51750	0.804
NULL	Adv_Appl_Bioinform_Chem_2014_Mar_24_7_1-9.nxml.txt.nlp	24711707	SENT86	8	8	12	12	verapamil	P-gp	PA451868	5243	0.804
NULL	Curr_Rheumatol_Rep_2010_Oct_30_12(5)_370-378.nxml.txt.nlp	20676807	SENT94	19	19	26	26	etanercept	p38	PA449515	10598;1432;7965	0.804
NULL	Drug_Saf_2014_Feb_19_37(4)_201-211.nxml.txt.nlp	24550106	SENT69	10	10	25	25	ritonavir	CYP3A4	PA451260	1576	0.804
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT54	32	32	14	14	metformin	p53	PA450395	7157	0.804
NULL	Front_Aging_Neurosci_2014_Sep_22_6_246.nxml.txt.nlp	25295003	SENT1433	11	11	4	4	resveratrol	AMPK		5563	0.804
NULL	Subst_Abuse_Rehabil_2011_Jun_1_2_113-123.nxml.txt.nlp	21731898	SENT144	10	10	0	0	prazepam	Stella	PA164776668	359787	0.804
NULL	Exp_Anim_2014_Apr_26_63(2)_257-267.nxml.txt.nlp	24770651	SENT105	2	2	5	5	olmesartan	apelin	PA164742950	8862	0.804
NULL	FEBS_Open_Bio_2014_Jan_6_4_77-89.nxml.txt.nlp	24490132	SENT113	4	4	7	7	ebselen	GDH	PA161660841	51084;2746	0.804
NULL	Cancer_Med_2013_Aug_10_2(4)_496-506.nxml.txt.nlp	24156022	SENT260	15	15	4	4	cetuximab	PTEN	PA10040	5728	0.804
NULL	Clin_Exp_Otorhinolaryngol_2011_Jun_31_4(2)_77-82.nxml.txt.nlp	21716954	SENT159	32	32	5	5	cisplatin	Bcl-2	PA449014	596	0.804
NULL	Environ_Health_Perspect_2011_Dec_3_119(12)_1811-1816.nxml.txt.nlp	21813368	SENT212	10	10	12	12	diethylstilbestrol	DES	PA449307	1674	0.804
NULL	Front_Pharmacol_2014_Oct_20_5_230.nxml.txt.nlp	25368579	SENT20	4	4	12	12	berberine	IL-6	PA165860812	3569	0.804
NULL	Clin_Transl_Allergy_2013_Sep_2_3_29.nxml.txt.nlp	24004581	SENT112	25	25	31	31	omalizumab	IL-4	PA164752253	3565	0.804
NULL	Aging_(Albany_NY)_2011_Jan_18_3(1)_33-43.nxml.txt.nlp	21248371	SENT112	26	26	20	20	zinc	HIF-1	PA451956	29072	0.804
NULL	Angiogenesis_2010_Dec_7_13(4)_305-315.nxml.txt.nlp	20927579	SENT197	6	6	15	15	resveratrol	HIF-1		29072	0.804
NULL	Ann_Med_2011_Nov_5_43(7)_531-544.nxml.txt.nlp	21815879	SENT39	15	15	10	10	thrombin	P2Y12	PA451674	64805	0.804
NULL	Arch_Drug_Inf_2008_Jul_1(1)_14-22.nxml.txt.nlp	20157364	SENT148	0	0	14	14	pravastatin	IL-6	PA451089	3569	0.804
NULL	Eur_Respir_J_2013_Dec_30_42(6)_1484-1494.nxml.txt.nlp	23722616	SENT124	16	16	4	4	tiotropium	TDI	PA164769056	100038246	0.804
NULL	J_Antimicrob_Chemother_2009_Feb_28_63(2)_389-395.nxml.txt.nlp	19042940	SENT120	21	21	8	8	trimethoprim	UTI	PA451788	259	0.804
NULL	Int_J_Biol_Sci_2014_Jan_20_10(2)_171-180.nxml.txt.nlp	24520215	SENT47	21	21	25	25	cerulenin	L-FABP	PA164764551	2168	0.804
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT139	10	10	0	0	imatinib	ABCB1	PA10804	5243	0.804
NULL	Breast_Cancer_Res_Treat_2014_Nov_11_148(3)_563-570.nxml.txt.nlp	25385180	SENT58	1	1	10	10	pertuzumab	PTH		5741	0.804
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1063.nxml.txt.nlp	24556678	SENT84	7	7	25	25	thioridazine	c-FLIP	PA451666	8837	0.804
NULL	Breast_Cancer_Res_2012_Mar_14_14(2)_R45.nxml.txt.nlp	22417809	SENT413	32	32	9	9	tamoxifen	RhoA	PA451581	387	0.804
NULL	Springerplus_2013_Jun_15_2_263.nxml.txt.nlp	23875127	SENT121	17	17	1	1	heparin	IL-24	PA449855	11009	0.804
NULL	Adv_Hematol_2012_Feb_6_2012_485943.nxml.txt.nlp	22400030	SENT90	25	25	27	27	rituximab	CHOP	PA451261	1649	0.804
NULL	Cancer_Med_2013_Aug_30_2(4)_457-467.nxml.txt.nlp	24156018	SENT113	14	14	24	24	marimastat	U87	PA164748329	677775;641648	0.804
NULL	Mol_Brain_2013_Apr_9_6_16.nxml.txt.nlp	23570271	SENT236	9	9	14	14	rofecoxib	cPLA2	PA451268	10524	0.804
NULL	Eur_J_Med_Res_2009_Nov_24_14(Suppl_3)_36-42.nxml.txt.nlp	19959415	SENT34	5	5	14	14	stavudine	gamma	PA451494	9913	0.804
NULL	Ann_Oncol_2014_Oct_23_25(10)_1941-1948.nxml.txt.nlp	25057173	SENT14	23	23	14	14	docetaxel	EGFR	PA449383	1956	0.804
NULL	Indian_J_Endocrinol_Metab_2011_Sep_15(Suppl3)_S253-S254.nxml.txt.nlp	22029035	SENT64	44	44	3	3	vasopressin	ACTH	PA451858	5443	0.804
NULL	J_Clin_Biochem_Nutr_2010_Jan_29_46(1)_87-92.nxml.txt.nlp	20104270	SENT4	34	34	19	19	hesperidin	STZ	PA449867	6484	0.804
NULL	Int_J_Environ_Res_Public_Health_2006_Sep_30_3(3)_252-261.nxml.txt.nlp	16968971	SENT255	0	0	7	7	resveratrol	CYP1B1		1545	0.804
NULL	Br_J_Cancer_2012_May_8_106(10)_1587-1590.nxml.txt.nlp	22568998	SENT77	14	14	7	7	sunitinib	IFN	PA162372840	3439	0.804
NULL	J_Gen_Physiol_1923_Sep_20_6(1)_73-76.nxml.txt.nlp	19872052	SENT8	12	12	27	27	phenol	PDF	PA450913	64146;9518	0.804
NULL	Br_J_Pharmacol_2014_May_171(10)_2659-2670.nxml.txt.nlp	24116661	SENT226	16	16	11	11	naringenin	TRPP2	PA151958361	5311	0.804
NULL	Front_Oncol_2013_Aug_5_3_201.nxml.txt.nlp	23936765	SENT426	13	13	22	22	staurosporine	CDK2	PA165109623	1017	0.804
NULL	EMBO_Mol_Med_2012_Jun_13_4(6)_515-527.nxml.txt.nlp	22416035	SENT189	3	3	10	10	olaparib	p53		7157	0.804
NULL	Ann_Med_2014_Nov_21_46(7)_475-489.nxml.txt.nlp	25045928	SENT148	30	30	21	21	thrombin	ADP	PA451674	23038	0.804
NULL	Br_J_Haematol_2014_Mar_13_164(1)_811-821.nxml.txt.nlp	24328678	SENT220	4	4	8	8	lenalidomide	Aiolos	PA162363968	22806	0.804
NULL	J_Headache_Pain_2008_Feb_23_9(1)_5-12.nxml.txt.nlp	18217201	SENT46	2	2	14	14	sumatriptan	5-HT1B	PA451566	3351	0.804
NULL	Cell_Death_Dis_2013_Oct_3_4(10)_e828.nxml.txt.nlp	24091671	SENT271	23	23	17	17	cetuximab	CD54	PA10040	3383	0.804
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT170	17	17	24	24	heparin	FGF1	PA449855	2246	0.804
NULL	Viruses_2014_Feb_18_6(2)_875-892.nxml.txt.nlp	24553110	SENT190	14	14	23	23	erlotinib	IFN	PA134687924	3439	0.804
NULL	Mol_Pain_2013_Feb_15_9_3.nxml.txt.nlp	23413875	SENT184	0	0	3	3	resveratrol	TRPA1		8989	0.804
NULL	Indian_J_Pharmacol_2014_Jan-Feb_46(1)_3-12.nxml.txt.nlp	24550577	SENT221	13	13	7	7	erythromycin	CYP3A4	PA449493	1576	0.804
NULL	Clin_Med_Insights_Oncol_2012_Dec_6_6_407-421.nxml.txt.nlp	23239933	SENT61	9	9	15	15	erlotinib	EGFR	PA134687924	1956	0.804
NULL	Pharmaceutics_2012_Nov_7_4(4)_563-589.nxml.txt.nlp	24300371	SENT1188	5	5	13	13	everolimus	VEGFR	PA164746311	3791	0.804
NULL	Oncogene_2010_May_20_29(20)_2962-2972.nxml.txt.nlp	20228846	SENT252	10	10	6	6	doxycycline	HIF-1	PA449415	29072	0.804
NULL	Indian_J_Psychol_Med_2013_Apr-Jun_35(2)_135-140.nxml.txt.nlp	24049223	SENT157	19	19	9	9	haloperidol	Gen	PA449841	348654	0.804
NULL	J_Gen_Physiol_2009_Apr_133(4)_421-438.nxml.txt.nlp	19289574	SENT258	29	29	11	11	forskolin	SLC26A9	PA146096022	115019	0.804
NULL	Br_J_Cancer_2014_Nov_25_111(11)_2091-2102.nxml.txt.nlp	25349971	SENT160	10	10	27	27	imatinib	KIT	PA10804	3815	0.804
NULL	Cardiovasc_Res_2010_Mar_1_85(4)_825-835.nxml.txt.nlp	19840952	SENT88	16	16	6	6	staurosporine	CX3CL1	PA165109623	6376	0.804
NULL	Cell_Commun_Signal_2013_Apr_22_11_30.nxml.txt.nlp	23607741	SENT16	37	37	21	21	dasatinib	PIP1	PA162372878	55003	0.804
NULL	Virol_J_2011_May_25_8_258.nxml.txt.nlp	21609495	SENT17	24	24	12	12	ribavirin	IFN	PA451241	3439	0.804
NULL	Mol_Cancer_2014_Jun_13_13_149.nxml.txt.nlp	24925061	SENT15	4	4	7	7	metformin	PDK1	PA450395	5170;5163	0.804
NULL	Indian_J_Crit_Care_Med_2010_Oct-Dec_14(4)_188-195.nxml.txt.nlp	21572750	SENT106	15	15	7	7	thrombin	PAR-1	PA451674	2011;2149	0.804
NULL	J_Korean_Med_Sci_2010_Jun_24_25(6)_829-834.nxml.txt.nlp	20514301	SENT94	9	9	35	35	papain	IL-25	PA450778	64806;56005	0.804
NULL	Br_J_Cancer_2009_Jan_13_100(1)_19-23.nxml.txt.nlp	19018262	SENT68	0	0	3	3	cetuximab	EGFR	PA10040	1956	0.804
NULL	Br_J_Cancer_2013_Feb_19_108(3)_557-563.nxml.txt.nlp	23361053	SENT119	18	18	11	11	tamoxifen	PAK1	PA451581	5585;5058	0.804
NULL	Biomed_Res_Int_2013_Aug_6_2013_602987.nxml.txt.nlp	24027759	SENT271	11	11	9	9	paclitaxel	SMF	PA450761	22993	0.804
NULL	Oncol_Lett_2014_Nov_10_8(5)_2333-2339.nxml.txt.nlp	25295120	SENT135	2	2	17	17	sorafenib	ADM	PA7000	133	0.804
NULL	Cancer_Manag_Res_2012_Nov_9_4_383-395.nxml.txt.nlp	23204869	SENT90	34	34	26	26	carmustine	PC-3	PA448810	692094	0.804
NULL	Oxid_Med_Cell_Longev_2013_Jun_11_2013_870472.nxml.txt.nlp	23840921	SENT8	3	3	19	19	chloroquine	CD163	PA448948	9332	0.804
NULL	Curr_Neuropharmacol_2008_Sep_6(3)_215-234.nxml.txt.nlp	19506722	SENT234	0	0	15	15	fluoxetine	5-HTT	PA449673	6532	0.804
NULL	Braz_J_Med_Biol_Res_2012_Mar_2_45(3)_250-255.nxml.txt.nlp	22370705	SENT30	10	10	4	4	vasopressin	SON	PA451858	6651	0.804
NULL	Evid_Based_Complement_Alternat_Med_2012_Feb_12_2012_472897.nxml.txt.nlp	22454667	SENT146	0	0	17	17	hesperetin	IL-5	PA164742902	3567	0.804
NULL	J_Oncol_2010_Aug_24_2010_654348.nxml.txt.nlp	20871846	SENT179	6	6	20	20	tamoxifen	ATAC	PA451581	6375	0.804
NULL	Sex_Transm_Infect_2011_Dec_87(Suppl_2)_ii39-ii43.nxml.txt.nlp	22110154	SENT106	14	14	21	21	azithromycin	San	PA448519	80218	0.804
NULL	Open_Microbiol_J_2008_Jun_19_2_89-93.nxml.txt.nlp	19088917	SENT30	31	31	0	0	spectinomycin	SEM1	PA164781342	7979	0.804
NULL	Evid_Based_Complement_Alternat_Med_2012_Dec_20_2012_908601.nxml.txt.nlp	23326293	SENT69	1	1	27	27	trypsin	CD24	PA451806	100133941	0.804
NULL	Exp_Ther_Med_2015_Jan_5_9(1)_84-88.nxml.txt.nlp	25452780	SENT73	17	17	6	6	vildagliptin	GLP-1	PA165958346	100125288	0.804
NULL	Asian-Australas_J_Anim_Sci_2014_Dec_27(12)_1783-1793.nxml.txt.nlp	25358373	SENT204	3	3	10	10	capsaicin	BAX	PA448776	581	0.804
NULL	Ann_Gastroenterol_2014_27(3)_250-257.nxml.txt.nlp	24974978	SENT179	12	12	6	6	naloxone	gamma	PA450586	9913	0.804
NULL	Asia_Pac_J_Clin_Oncol_2014_Dec_16_10(4)_297-307.nxml.txt.nlp	25227602	SENT6	15	15	2	2	trastuzumab	HER2	PA451743	2064	0.804
NULL	Cell_Death_Dis_2012_Jun_7_3(6)_e319.nxml.txt.nlp	22673193	SENT10	11	11	23	23	cisplatin	Mcl-1	PA449014	4170	0.804
NULL	Aging_(Albany_NY)_2011_Apr_6_3(4)_444-449.nxml.txt.nlp	21483037	SENT71	3	3	11	11	resveratrol	SIRT1		23411	0.804
NULL	Cancer_Manag_Res_2011_May_10_3_157-175.nxml.txt.nlp	21625399	SENT293	24	24	18	18	itraconazole	CYP3A	PA450132	1574	0.804
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Mar_31_68(Pt_4)_m508.nxml.txt.nlp	22589860	SENT62	9	9	12	12	thiabendazole	mol	PA164746466	90527	0.804
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT616	13	13	30	30	risperidone	PRL	PA451257	5617	0.804
NULL	Infection_2013_Sep_14_41(Suppl_2)_91-115.nxml.txt.nlp	24037688	SENT738	9	9	4	4	ganciclovir	CD4	PA449733	920	0.804
NULL	J_Biol_Chem_2010_Aug_20_285(34)_25928-25940.nxml.txt.nlp	20547488	SENT147	24	24	6	6	cisplatin	p38	PA449014	10598;1432;7965	0.804
NULL	Asian-Australas_J_Anim_Sci_2014_Dec_27(12)_1783-1793.nxml.txt.nlp	25358373	SENT204	3	3	26	26	capsaicin	FABP4	PA448776	2167	0.804
NULL	Anticancer_Agents_Med_Chem_2012_Feb_12(2)_163-171.nxml.txt.nlp	22043994	SENT242	15	15	6	6	cetuximab	BRAF	PA10040	673	0.804
NULL	J_Biol_2003_Oct_22_2(4)_26.nxml.txt.nlp	14575531	SENT63	13	13	19	19	phenformin	AMPK	PA1000	5563	0.804
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT1906	8	8	13	13	acetaminophen	CYP1A2	PA448015	1544	0.804
NULL	Clinics_(Sao_Paulo)_2010_Aug_65(8)_803b-807.nxml.txt.nlp	20835559	SENT15	34	34	13	13	estradiol	spatial	PA449503	219793	0.804
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT152	7	7	15	15	perifosine	DR5	PA165291471	8795	0.804
NULL	Mol_Cancer_2014_Feb_20_13_32.nxml.txt.nlp	24555657	SENT156	12	12	7	7	cisplatin	SET	PA449014	6418	0.804
NULL	Iran_J_Pharm_Res_2014_Spring_13(2)_635-639.nxml.txt.nlp	25237359	SENT18	10	10	39	39	midazolam	CYP2E1	PA450496	1571	0.804
NULL	Front_Oncol_2014_May_1_4_80.nxml.txt.nlp	24822169	SENT315	15	15	27	27	genistein	DNMT1	PA165109660	1786	0.804
NULL	Int_J_Vasc_Med_2012_Feb_14_2012_569654.nxml.txt.nlp	22489274	SENT319	17	17	32	32	nadh	RAGE	PA164755085	177	0.804
NULL	Cancer_Cell_Int_2007_Sep_10_7_14.nxml.txt.nlp	17845729	SENT164	14	14	21	21	decitabine	PAWR	PA164749631	5074	0.804
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1145.nxml.txt.nlp	24675463	SENT229	18	18	5	5	cetuximab	EGFR	PA10040	1956	0.804
NULL	Ther_Clin_Risk_Manag_2007_Jun_3(3)_467-474.nxml.txt.nlp	18488080	SENT123	10	10	3	3	rasagiline	CYP1A2	PA164764584	1544	0.804
NULL	Br_J_Pharmacol_2014_Oct_26_171(20)_4785-4796.nxml.txt.nlp	25074741	SENT41	20	20	30	30	guanfacine	NK1R	PA449825	6869	0.804
NULL	Case_Rep_Gastroenterol_2011_May_3_5(2)_262-266.nxml.txt.nlp	21887126	SENT46	17	17	0	0	methylprednisolone	CHOP	PA450466	1649	0.804
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT178	14	14	5	5	doxorubicin	B7-H1	PA449412	29126	0.804
NULL	Ann_Gen_Psychiatry_2010_Apr_22_9(Suppl_1)_S83.nxml.txt.nlp	NULL	SENT5	17	17	22	22	carbamazepine	AC5	PA448785	111	0.804
NULL	EMBO_Rep_2013_Dec_18_14(12)_1113-1119.nxml.txt.nlp	24136413	SENT10	18	18	30	30	spermine	Hsp90	PA164781199	3320	0.804
NULL	Cancer_Cell_Int_2013_Feb_14_13_16.nxml.txt.nlp	23409704	SENT90	3	3	26	26	pp2	LOX		4015	0.804
NULL	Carcinogenesis_2011_Nov_1_32(11)_1724-1733.nxml.txt.nlp	21890461	SENT242	35	35	18	18	oxygen	ROS	PA450744	6098	0.803
NULL	Cancer_Cell_Int_2006_Aug_9_6_20.nxml.txt.nlp	16899133	SENT57	4	4	12	12	genistein	p27	PA165109660	5715;10534	0.803
NULL	Int_J_Med_Sci_2012_Jan_11_9(2)_148-156.nxml.txt.nlp	22253562	SENT56	19	19	0	0	ethambutol	DST	PA164784021	667	0.803
NULL	Indian_J_Med_Paediatr_Oncol_2013_Oct-Dec_34(4)_292-298.nxml.txt.nlp	24604960	SENT47	18	18	0	0	vincristine	CHOP	PA451879	1649	0.803
NULL	Cell_Cycle_2012_Dec_15_11(24)_4642-4649.nxml.txt.nlp	23187803	SENT23	7	7	13	13	nutlin-3	p53		7157	0.803
NULL	Int_J_Biomed_Sci_2006_Jun_2(2)_114-120.nxml.txt.nlp	23674973	SENT102	9	9	14	14	hydrocortisone	IFN	PA449905	3439	0.803
NULL	Cerebrospinal_Fluid_Res_2010_Aug_13_7_13.nxml.txt.nlp	20707896	SENT4	7	7	12	12	vasopressin	FGF2	PA451858	2247;2258	0.803
NULL	Inflammation_2012_Apr_24_35(2)_566-573.nxml.txt.nlp	21607702	SENT147	13	13	15	15	thrombin	VASP	PA451674	7408	0.803
NULL	Int_J_Environ_Res_Public_Health_2010_Jul_12_7(7)_2845-2852.nxml.txt.nlp	20717544	SENT16	15	15	13	13	estradiol	DES	PA449503	1674	0.803
NULL	Pharmaceuticals_(Basel)_2014_Jun_25_7(7)_754-764.nxml.txt.nlp	24967535	SENT70	27	27	15	15	aprotinin	ghrelin	PA448472	51738	0.803
NULL	Oncoimmunology_2012_Aug_1_1(5)_773-776.nxml.txt.nlp	22934279	SENT7	0	0	15	15	imatinib	KIT	PA10804	3815	0.803
NULL	Oncotarget_2012_Mar_31_3(3)_236-260.nxml.txt.nlp	22470194	SENT331	24	24	22	22	cetuximab	EGFR	PA10040	1956	0.803
NULL	Cancers_(Basel)_2013_Nov_26_5(4)_1601-1618.nxml.txt.nlp	24287743	SENT206	5	5	7	7	crizotinib	EGFR	PA165946122	1956	0.803
NULL	BMB_Rep_2013_Nov_46(11)_544-549.nxml.txt.nlp	24152910	SENT52	32	32	30	30	thrombin	PAR-1	PA451674	2011;2149	0.803
NULL	J_Biol_Chem_2008_Nov_14_283(46)_31679-31689.nxml.txt.nlp	18755684	SENT29	36	36	18	18	iron	FTL	PA450087	2512	0.803
NULL	J_Cell_Biol_1983_Oct_1_97(4)_1156-1168.nxml.txt.nlp	6684660	SENT4	18	18	8	8	lipase	spatial	PA450239	219793	0.803
NULL	Mol_Cancer_2012_Aug_6_11_52.nxml.txt.nlp	22867098	SENT90	2	2	31	31	pargyline	KDM1A	PA450797	23028	0.803
NULL	J_Lipids_2011_Jan_13_2011_565316.nxml.txt.nlp	21490804	SENT118	9	9	29	29	sorafenib	PERK	PA7000	9451	0.803
NULL	Biosci_Microflora_2011_Nov_17_30(4)_135-140.nxml.txt.nlp	25045319	SENT30	10	10	28	28	genistein	flower	PA165109660	11094	0.803
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_650809.nxml.txt.nlp	23258995	SENT184	28	28	32	32	taurine	AQP2	PA451590	359	0.803
NULL	Cancers_(Basel)_2014_Nov_26_6(4)_2330-2342.nxml.txt.nlp	25534570	SENT506	12	12	5	5	cisplatin	EGFR	PA449014	1956	0.803
NULL	Evid_Based_Complement_Alternat_Med_2013_May_26_2013_349790.nxml.txt.nlp	23762123	SENT108	7	7	2	2	rosiglitazone	LSP1	PA451283	4046	0.803
NULL	Mol_Cancer_2009_Nov_10_8_99.nxml.txt.nlp	19903356	SENT84	6	6	2	2	imatinib	IGFBP3	PA10804	3486	0.803
NULL	Osteoporos_Int_2012_Feb_4_23(Suppl_1)_S1-S23.nxml.txt.nlp	22311111	SENT763	21	21	18	18	denosumab	RANKL	PA166048634	8600	0.803
NULL	Front_Genet_2014_Nov_14_5_391.nxml.txt.nlp	25452763	SENT1139	14	14	5	5	cisplatin	COMT	PA449014	1312	0.803
NULL	Biomed_Res_Int_2013_Jul_31_2013_692071.nxml.txt.nlp	23984399	SENT122	8	8	6	6	choline	OCT1	PA448976	5451;6580	0.803
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT93	29	29	5	5	sitagliptin	HIP	PA164748978	6767;6159;64399;5068	0.803
NULL	Cell_Cycle_2012_Nov_1_11(21)_3983-3996.nxml.txt.nlp	22987153	SENT182	16	16	5	5	mitomycin	FANCD2	PA450524	2177	0.803
NULL	Cell_Commun_Signal_2013_Oct_1_11_73.nxml.txt.nlp	24083678	SENT147	25	25	17	17	sulindac	AP-1	PA451565	2353;3727;2354;3725	0.803
NULL	Oncotarget_2013_Nov_4_5(1)_161-172.nxml.txt.nlp	24389287	SENT31	0	0	24	24	propranolol	p53	PA451145	7157	0.803
NULL	Eur_J_Cancer_2014_Sep_50(14)_2367-2374.nxml.txt.nlp	25027307	SENT135	12	12	28	28	tamoxifen	aromatase	PA451581	1588	0.803
NULL	Mol_Vis_2012_Jun_22_18_1696-1700.nxml.txt.nlp	22773907	SENT132	17	17	6	6	colchicine	ABCB1	PA449092	5243	0.803
NULL	Br_J_Pharmacol_2014_Feb_24_171(1)_1019-1032.nxml.txt.nlp	24251620	SENT277	12	12	17	17	nimodipine	TRPM3	PA450633	80036	0.803
NULL	Ann_Lab_Med_2013_May_17_33(3)_196-199.nxml.txt.nlp	23667847	SENT20	14	14	5	5	methotrexate	CD4	PA450428	920	0.803
NULL	Viruses_2014_Feb_18_6(2)_856-874.nxml.txt.nlp	24553109	SENT535	3	3	10	10	cetuximab	KRAS	PA10040	3845	0.803
NULL	Int_J_Environ_Res_Public_Health_2006_Sep_30_3(3)_252-261.nxml.txt.nlp	16968971	SENT255	0	0	5	5	resveratrol	CYP1A1		1543	0.803
NULL	J_Immunother_Cancer_2014_Nov_6_2(Suppl_3)_P78.nxml.txt.nlp	NULL	SENT16	12	12	17	17	aldesleukin	IL-2	PA448081	3558	0.803
NULL	Diabetes_2008_Sep_57(9)_2470-2479.nxml.txt.nlp	18511847	SENT11	13	13	16	16	pioglitazone	adiponectin	PA450970	9370	0.803
NULL	Br_J_Cancer_1988_Nov_58(5)_640-643.nxml.txt.nlp	3064798	SENT10	17	17	12	12	chlorambucil	JM8	PA448926	778	0.803
NULL	Breast_Cancer_Res_2010_May_10_12(3)_R26.nxml.txt.nlp	20459744	SENT99	4	4	19	19	doxorubicin	HDC	PA449412	3067;51696	0.803
NULL	J_Cell_Mol_Med_2013_Jan_10_17(1)_30-54.nxml.txt.nlp	23301832	SENT123	21	21	4	4	bortezomib	HIF-1	PA10252	29072	0.803
NULL	J_Asthma_Allergy_2008_Sep_19_1_19-29.nxml.txt.nlp	21436982	SENT110	0	0	23	23	fexofenadine	MDC	PA449621	6367	0.803
NULL	Br_J_Cancer_1990_Dec_62(6)_891-896.nxml.txt.nlp	2124136	SENT16	18	18	34	34	mitomycin	HAI	PA450524	6692;6768	0.803
NULL	Int_Semin_Surg_Oncol_2006_Sep_18_3_31.nxml.txt.nlp	16981992	SENT40	12	12	15	15	anastrozole	ATAC	PA448432	6375	0.803
NULL	Ann_Rehabil_Med_2012_Aug_27_36(4)_466-473.nxml.txt.nlp	22977771	SENT10	5	5	23	23	hyaluronidase	ILEI	PA164745713	10447	0.803
NULL	Curr_Clin_Pharmacol_2008_Sep_3(3)_198-203.nxml.txt.nlp	18781906	SENT5	8	8	0	0	carbamazepine	CYP3A4	PA448785	1576	0.803
NULL	Braz_J_Med_Biol_Res_2012_Apr_27_45(7)_637-643.nxml.txt.nlp	22527128	SENT49	20	20	22	22	vancomycin	VAN	PA451850	10318	0.803
NULL	Cardiovasc_Res_2012_Dec_1_96(3)_552-560.nxml.txt.nlp	22918977	SENT198	2	2	6	6	losartan	JAM-A	PA450268	50848	0.803
NULL	Arthritis_Res_Ther_2011_Jul_6_13(4)_228.nxml.txt.nlp	21745419	SENT45	0	0	17	17	tocilizumab	IL-6	PA165292659	3569	0.803
NULL	Drugs_Context_2012_Nov_19_2012_212242.nxml.txt.nlp	24432031	SENT128	2	2	17	17	carmustine	IL-2	PA448810	3558	0.803
NULL	Diabetes_Care_2013_Jul_12_36(7)_2098-2106.nxml.txt.nlp	23695817	SENT274	20	20	25	25	liraglutide	GLP-1	PA165958364	100125288	0.803
NULL	Acta_Neuropathol_Commun_2013_Jul_11_1_34.nxml.txt.nlp	24252661	SENT325	20	20	4	4	pentobarbital	spatial	PA450859	219793	0.803
NULL	Clin_Med_Insights_Oncol_2012_May_16_6_205-217.nxml.txt.nlp	22654526	SENT248	34	34	17	17	pazopanib	EGFR	PA165291492	1956	0.803
NULL	Breast_Cancer_Res_2011_Jun_21_13(3)_R66.nxml.txt.nlp	21693010	SENT12	6	6	17	17	sunitinib	VEGF-D	PA162372840	2277	0.803
NULL	Br_J_Cancer_2010_May_11_102(10)_1503-1510.nxml.txt.nlp	20461093	SENT179	9	9	13	13	tamoxifen	HER2	PA451581	2064	0.803
NULL	Biomed_Res_Int_2013_Dec_10_2013_565218.nxml.txt.nlp	24386638	SENT237	33	33	13	13	imipramine	DIO2	PA449969	1734	0.803
NULL	Biomed_Res_Int_2014_Jan_16_2014_706302.nxml.txt.nlp	24551852	SENT66	10	10	0	0	ethanol	CYP2E1	PA448073	1571	0.803
NULL	Mol_Cancer_2014_Aug_20_13(1)_194.nxml.txt.nlp	NULL	SENT28	10	10	23	23	vemurafenib	CRAF	PA165946873	5894	0.803
NULL	Cell_Res_2009_Aug_19(8)_950-961.nxml.txt.nlp	19546888	SENT247	12	12	16	16	camptothecin	Cbl-b	PA153590860	868	0.803
NULL	Front_Behav_Neurosci_2011_Nov_8_5_76.nxml.txt.nlp	22073033	SENT150	26	26	12	12	ketamine	PSD-95	PA450144	1742	0.803
NULL	Tuberc_Respir_Dis_(Seoul)_2013_Dec_24_75(6)_236-237.nxml.txt.nlp	24416053	SENT64	7	7	12	12	crizotinib	ROS1	PA165946122	6098	0.803
NULL	Biomed_Res_Int_2014_Feb_23_2014_168949.nxml.txt.nlp	24707474	SENT20	25	25	32	32	lapatinib	EGFR	PA152241907	1956	0.803
NULL	Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.nxml.txt.nlp	24736980	SENT223	26	26	15	15	rosuvastatin	OATP1B1	PA134308647	10599	0.803
NULL	Clin_Ophthalmol_2009_Jun_2_3_291-295.nxml.txt.nlp	19668581	SENT27	33	33	31	31	travoprost	BAK	PA164781371	578	0.803
NULL	Cardiovasc_Diabetol_2010_Jul_27_9_31.nxml.txt.nlp	20663195	SENT73	3	3	9	9	irbesartan	FSP1	PA450084	6275;51062	0.803
NULL	Exp_Ther_Med_2013_Mar_8_5(3)_707-710.nxml.txt.nlp	23404433	SENT133	8	8	5	5	cisplatin	OST	PA449014	1650;23263	0.803
NULL	J_Equine_Sci_2014_Jun_25_25(2)_37-43.nxml.txt.nlp	25013357	SENT131	31	31	19	19	dextran	TLR2	PA449261	7097	0.803
NULL	Oncogene_2010_Sep_16_29(37)_5193-5203.nxml.txt.nlp	20581867	SENT10	18	18	0	0	lapatinib	HRG	PA152241907	3084;3273	0.803
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT1733	11	11	6	6	etravirine	ATV	PA166014703	4683	0.803
NULL	Hum_Reprod_Update_2009_Jan_27_May-Jun_15(3)_323-339.nxml.txt.nlp	19174449	SENT349	15	15	10	10	fluoxetine	CYP2D6	PA449673	1565	0.803
NULL	Iran_J_Pharm_Res_2014_Autumn_13(4)_1393-1401.nxml.txt.nlp	25587329	SENT110	7	7	10	10	celecoxib	ABCG2	PA448871	9429	0.803
NULL	J_Gastroenterol_2014_Dec_24_49(12)_1536-1547.nxml.txt.nlp	24366288	SENT161	22	22	8	8	omeprazole	CYP2C19	PA450704	1557	0.803
NULL	Ther_Clin_Risk_Manag_2005_Jun_1(2)_125-140.nxml.txt.nlp	18360552	SENT185	12	12	9	9	etanercept	TNF-alpha	PA449515	7124	0.803
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT408	6	6	3	3	ziprasidone	PRL	PA451974	5617	0.803
NULL	Front_Aging_Neurosci_2014_Nov_27_6_322.nxml.txt.nlp	25505884	SENT474	10	10	14	14	dipyridamole	CA1	PA449367	759	0.803
NULL	Arthritis_Res_Ther_2009_Aug_17_11(4)_R123.nxml.txt.nlp	19686595	SENT180	27	27	14	14	rituximab	CD38	PA451261	952	0.803
NULL	Oncotarget_2014_Sep_5_5(17)_7216.nxml.txt.nlp	25277174	SENT9	39	39	9	9	rituximab	STAT6	PA451261	6778	0.803
NULL	Br_J_Cancer_2009_Mar_10_100(5)_758-763.nxml.txt.nlp	19259094	SENT77	4	4	8	8	decitabine	MLH1	PA164749631	4292	0.803
NULL	Brain_Behav_2013_Mar_6_3(2)_114-133.nxml.txt.nlp	23533150	SENT182	3	3	18	18	ethanol	HSF1	PA448073	3297	0.803
NULL	Ann_Oncol_2010_Mar_28_21(3)_498-505.nxml.txt.nlp	19717534	SENT219	18	18	31	31	tamoxifen	ATAC	PA451581	6375	0.803
NULL	J_Cancer_2013_Nov_23_4(9)_736-754.nxml.txt.nlp	24312144	SENT82	22	22	7	7	paclitaxel	EGFR	PA450761	1956	0.803
NULL	Addict_Sci_Clin_Pract_2014_Sep_13_9(1)_20.nxml.txt.nlp	25217046	SENT4	27	27	20	20	naltrexone	OPRM1	PA450588	4988	0.803
NULL	Int_J_Endocrinol_2011_Aug_21_2011_742719.nxml.txt.nlp	21869886	SENT262	45	45	31	31	clopidogrel	DES	PA449053	1674	0.803
NULL	Int_J_Nanomedicine_2007_Mar_2(1)_13-18.nxml.txt.nlp	17722507	SENT112	9	9	4	4	aprepitant	CYP2C9	PA164747039	1559	0.803
NULL	Cell_Biol_Int_Rep_(2010)_2012_Jun_21_19(1)_e00017.nxml.txt.nlp	23124518	SENT186	17	17	19	19	etoposide	TRAIL	PA449552	8743	0.803
NULL	Front_Immunol_2012_Jan_24_3_3.nxml.txt.nlp	22566889	SENT769	16	16	18	18	rituximab	CHOP	PA451261	1649	0.803
NULL	J_Cell_Mol_Med_2014_Mar_22_18(3)_480-491.nxml.txt.nlp	24450440	SENT72	27	27	34	34	bevacizumab	EDD	PA130232992	51366	0.803
NULL	Arthritis_Res_Ther_2013_Mar_4_15(2)_R39.nxml.txt.nlp	23497717	SENT88	27	27	11	11	imiquimod	CO2	PA449972	4513	0.803
NULL	Arthritis_Res_Ther_2003_Sep_3_5(6)_R317-R328.nxml.txt.nlp	14680506	SENT192	10	10	19	19	rolipram	IL-10	PA153906323	3586	0.803
NULL	Oxid_Med_Cell_Longev_2012_Sep_25_2012_935738.nxml.txt.nlp	23050041	SENT160	18	18	25	25	sildenafil	PKG	PA451346	5592	0.803
NULL	Cancers_(Basel)_2014_Nov_14_6(4)_2275-2295.nxml.txt.nlp	25405526	SENT231	16	16	14	14	ifosfamide	CHOP	PA449964	1649	0.803
NULL	Curr_Cardiol_Rev_2008_Nov_4(4)_287-292.nxml.txt.nlp	20066136	SENT76	15	15	9	9	ramipril	adiponectin	PA451223	9370	0.803
NULL	Cancer_Cell_Int_2005_Aug_24_5_28.nxml.txt.nlp	16120219	SENT158	24	24	16	16	etoposide	MDM2	PA449552	4193	0.803
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT137	15	15	23	23	l-leucine	p27	PA450197	5715;10534	0.803
NULL	Ann_Oncol_2009_Aug_17_20(8)_1319-1329.nxml.txt.nlp	19535820	SENT196	14	14	10	10	tamoxifen	aromatase	PA451581	1588	0.803
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1495-1502.nxml.txt.nlp	21989186	SENT79	7	7	23	23	panitumumab	HSI	PA162373091	57016	0.803
NULL	Crit_Care_2010_Mar_1_14(Suppl_1)_P79.nxml.txt.nlp	NULL	SENT3	14	14	16	16	vancomycin	VAN	PA451850	10318	0.803
NULL	Pediatr_Infect_Dis_J_2014_Jan_12_33(1)_50-56.nxml.txt.nlp	23811744	SENT16	20	20	9	9	fosamprenavir	CD4	PA10084	920	0.803
NULL	Oxid_Med_Cell_Longev_2013_Nov_28_2013_568093.nxml.txt.nlp	24379901	SENT70	5	5	16	16	resveratrol	AMPK		5563	0.803
NULL	Acta_Pharmacol_Sin_2011_Jul_6_32(7)_921-929.nxml.txt.nlp	21643005	SENT57	16	16	13	13	indomethacin	LOX	PA449982	4015	0.803
NULL	Biomed_Res_Int_2013_Jul_1_2013_964743.nxml.txt.nlp	23936861	SENT76	0	0	18	18	sorafenib	VEGFR	PA7000	3791	0.803
NULL	Indian_J_Endocrinol_Metab_2012_Dec_16(Suppl_2)_S408-S410.nxml.txt.nlp	23565445	SENT69	14	14	29	29	paricalcitol	PTH	PA450798	5741	0.803
NULL	Biomed_Res_Int_2014_Feb_19_2014_240642.nxml.txt.nlp	24701565	SENT114	3	3	34	34	sunitinib	FLT3	PA162372840	2322	0.803
NULL	Clin_Ophthalmol_2010_Apr_26_4_307-314.nxml.txt.nlp	20463798	SENT78	13	13	31	31	ranibizumab	HER2	PA164746012	2064	0.803
NULL	J_Hematol_Oncol_2012_Sep_18_5_57.nxml.txt.nlp	22989009	SENT266	30	30	34	34	nutlin-3	HDM2		4193	0.803
NULL	Biomed_Res_Int_2014_May_12_2014_261745.nxml.txt.nlp	24900960	SENT124	8	8	19	19	indomethacin	COX	PA449982	1351	0.803
NULL	Ann_Rheum_Dis_2008_Oct_25_68(10)_1644-1650.nxml.txt.nlp	18957484	SENT89	4	4	19	19	leflunomide	CD54	PA450192	3383	0.803
NULL	Acta_Orthop_2009_Dec_4_80(6)_660-665.nxml.txt.nlp	19995316	SENT41	14	14	20	20	cefuroxime	TED	PA448868	27112	0.803
NULL	Front_Genet_2012_Sep_12_3_171.nxml.txt.nlp	22988450	SENT511	14	14	2	2	bleomycin	RAD21	PA448645	5885	0.803
NULL	Cough_2010_Aug_10_6_8.nxml.txt.nlp	20698995	SENT205	20	20	24	24	dextromethorphan	CYP2D6	PA449273	1565	0.803
NULL	Mol_Cancer_2009_Jul_3_8_43.nxml.txt.nlp	19575780	SENT140	21	21	7	7	colchicine	survivin	PA449092	332	0.803
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT294	2	2	13	13	olanzapine	PRL	PA450688	5617	0.803
NULL	Nat_Neurosci_2014_May_23_17(5)_732-737.nxml.txt.nlp	24657967	SENT216	7	7	28	28	scopolamine	ANOVA	PA451308	4858	0.803
NULL	J_Cardiothorac_Surg_2014_Feb_17_9_35.nxml.txt.nlp	24533613	SENT160	22	22	5	5	heparin	IL-6	PA449855	3569	0.803
NULL	Clin_Exp_Reprod_Med_2013_Jun_30_40(2)_67-75.nxml.txt.nlp	23875162	SENT52	4	4	13	13	rosiglitazone	San	PA451283	80218	0.803
NULL	Iran_J_Basic_Med_Sci_2012_Nov-Dec_15(6)_1202-1209.nxml.txt.nlp	23653852	SENT147	0	0	3	3	metformin	AMPK	PA450395	5563	0.803
NULL	Ann_Oncol_2014_Oct_18_25(10)_1871-1888.nxml.txt.nlp	25234545	SENT203	24	24	33	33	fulvestrant	aromatase	PA164747170	1588	0.803
NULL	J_Neuroinflammation_2011_Feb_4_8_10.nxml.txt.nlp	21294877	SENT69	4	4	10	10	capsaicin	TRPV1	PA448776	7442	0.803
NULL	J_Gen_Physiol_2013_Aug_142(2)_137-155.nxml.txt.nlp	23858003	SENT368	7	7	11	11	mibefradil	ACTH	PA450492	5443	0.803
NULL	Mol_Pain_2013_Mar_4_9_9.nxml.txt.nlp	23497345	SENT16	11	11	9	9	capsaicin	TRPV1	PA448776	7442	0.803
NULL	Cell_Commun_Signal_2013_Nov_11_11_86.nxml.txt.nlp	24215724	SENT205	10	10	13	13	thrombin	EGFR	PA451674	1956	0.803
NULL	Oncotarget_2014_Jun_11_5(21)_10407-10420.nxml.txt.nlp	25431951	SENT206	16	16	34	34	imatinib	EGFR	PA10804	1956	0.803
NULL	J_Int_AIDS_Soc_2010_Nov_8_13(Suppl_4)_P78.nxml.txt.nlp	NULL	SENT14	8	8	15	15	tenofovir	CD4	PA10204	920	0.803
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT202	10	10	20	20	bevacizumab	VEGFR2	PA130232992	3791	0.803
NULL	Bioinformation_2012_Jan_6_8(1)_13-19.nxml.txt.nlp	22359429	SENT94	8	8	3	3	curcumin	MRP1	PA151958596	4437	0.803
NULL	Protein_Cell_2014_May_26_5(5)_343-347.nxml.txt.nlp	24668462	SENT80	11	11	4	4	heparin	FGF18	PA449855	8817	0.803
NULL	Target_Oncol_2013_Jun_27_8(2)_127-136.nxml.txt.nlp	23625191	SENT116	17	17	24	24	panitumumab	KRAS	PA162373091	3845	0.803
NULL	Mar_Drugs_2011_Jun_14_9(6)_1038-1055.nxml.txt.nlp	21747747	SENT61	17	17	48	48	l-glutamine	CO2	PA10090	4513	0.803
NULL	Diabetes_2009_Apr_9_58(4)_965-974.nxml.txt.nlp	19136651	SENT33	25	25	14	14	nadh	NQO1	PA164755085	1728	0.803
NULL	Cancers_(Basel)_2013_Dec_19_6(1)_1-27.nxml.txt.nlp	24378750	SENT158	10	10	19	19	semaxanib	VEGFR2	PA131887911	3791	0.803
NULL	J_Biol_2003_Sep_24_2(4)_28.nxml.txt.nlp	14511394	SENT149	20	20	10	10	phenformin	AMPK	PA1000	5563	0.803
NULL	Nucleic_Acids_Res_2013_Nov_16_41(20)_9349-9360.nxml.txt.nlp	23956219	SENT202	25	25	8	8	cisplatin	OB1	PA449014	84525	0.803
NULL	Nat_Methods_2011_Jun_24_8(6)_487-493.nxml.txt.nlp	21516115	SENT74	16	16	35	35	gefitinib	EGF	PA131301952	1950	0.803
NULL	Neuropsychopharmacology_2009_May_1_34(6)_1443-1453.nxml.txt.nlp	18830237	SENT5	11	11	33	33	flupenthixol	AP-5	PA10268	91056	0.803
NULL	Onco_Targets_Ther_2014_Mar_24_7_491-500.nxml.txt.nlp	24711706	SENT151	31	31	9	9	trastuzumab	ERBB2	PA451743	2064	0.803
NULL	Int_J_Womens_Health_2010_Aug_9_1_11-20.nxml.txt.nlp	21072271	SENT147	29	29	25	25	tamoxifen	STAR	PA451581	6770;2984	0.803
NULL	Braz_J_Med_Biol_Res_2013_Mar_15_46(3)_299-305.nxml.txt.nlp	23532269	SENT126	2	2	6	6	propofol	TLR4	PA451141	7099	0.803
NULL	Nucleic_Acids_Res_2005_Dec_2_33(21)_6769-6781.nxml.txt.nlp	16326861	SENT28	23	23	6	6	hydroxyurea	WRN	PA449942	7486	0.803
NULL	Arthritis_Res_Ther_2013_Apr_17_15(2)_R51.nxml.txt.nlp	23594962	SENT218	0	0	15	15	muraglitazar	p65	PA162356187	5970	0.803
NULL	Br_J_Cancer_2010_Sep_7_103(6)_889-898.nxml.txt.nlp	20664599	SENT162	16	16	9	9	paclitaxel	AKT	PA450761	207	0.803
NULL	Evid_Based_Complement_Alternat_Med_2013_May_13_2013_506324.nxml.txt.nlp	23818927	SENT185	19	19	11	11	doxorubicin	STAT3	PA449412	6774	0.803
NULL	Acta_Naturae_2011_Jul-Sep_3(3)_12-28.nxml.txt.nlp	22649690	SENT315	48	48	20	20	ritonavir	CD4	PA451260	920	0.803
NULL	Int_J_Med_Sci_2015_Jan_12_12(2)_187-200.nxml.txt.nlp	25589895	SENT213	17	17	19	19	paclitaxel	EGFR	PA450761	1956	0.803
NULL	Br_J_Cancer_2010_Mar_2_102(5)_815-826.nxml.txt.nlp	20145614	SENT24	17	17	15	15	lapatinib	HER2	PA152241907	2064	0.803
NULL	Springerplus_2013_Dec_21_2_684.nxml.txt.nlp	24422179	SENT52	40	40	1	1	ketamine	P97	PA450144	5708	0.803
NULL	Gene_Regul_Syst_Bio_2014_Mar_4_8_63-73.nxml.txt.nlp	24634581	SENT96	24	24	13	13	minocycline	MT1-MMP	PA450519	4323	0.803
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT264	8	8	3	3	adalimumab	CD36	PA10004	948	0.803
NULL	Neuropsychopharmacology_2011_Apr_2_36(5)_1033-1046.nxml.txt.nlp	21289603	SENT201	5	5	7	7	ethanol	MSN	PA448073	4478	0.803
NULL	Oncol_Lett_2013_Mar_8_5(3)_805-812.nxml.txt.nlp	23426281	SENT126	15	15	6	6	gemcitabine	B7-H3	PA449748	80381	0.803
NULL	Reprod_Biol_Endocrinol_2003_Oct_7_1_66.nxml.txt.nlp	14609433	SENT97	29	29	14	14	cisplatin	MDM2	PA449014	4193	0.803
NULL	Front_Immunol_2012_Jul_16_3_205.nxml.txt.nlp	22811680	SENT104	7	7	12	12	paraformaldehyde	ADP	PA450790	23038	0.803
NULL	Int_J_Nanomedicine_2009_Apr_20_4_99-105.nxml.txt.nlp	19516888	SENT40	17	17	11	11	paclitaxel	castor	PA450761	54897	0.803
NULL	J_Biol_Chem_2013_Nov_22_288(47)_34217-34229.nxml.txt.nlp	24106270	SENT173	23	23	33	33	abciximab	RhoG	PA448006	391	0.803
NULL	Int_J_Med_Sci_2013_Mar_23_10(5)_634-640.nxml.txt.nlp	23569426	SENT27	38	38	19	19	gemcitabine	NTRK1	PA449748	4914	0.803
NULL	Environ_Health_Perspect_2007_Dec_8_115(Suppl_1)_84-90.nxml.txt.nlp	18174955	SENT91	41	41	34	34	diethylstilbestrol	BBP	PA449307	83941	0.803
NULL	Case_Rep_Pathol_2013_Feb_21_2013_687427.nxml.txt.nlp	23533895	SENT51	12	12	20	20	thyroglobulin	CK20	PA164754910	54474	0.803
NULL	Br_J_Cancer_2011_Aug_9_105(4)_523-533.nxml.txt.nlp	21792199	SENT277	10	10	17	17	erlotinib	EGF	PA134687924	1950	0.803
NULL	Bioinformation_2012_Jan_6_8(1)_13-19.nxml.txt.nlp	22359429	SENT138	2	2	6	6	indomethacin	MRP1	PA449982	4437	0.803
NULL	eLife_2014_May_7_3_e02444.nxml.txt.nlp	24894464	SENT327	37	37	1	1	bexarotene	ABCA1	PA164752250	19	0.803
NULL	Curr_Neuropharmacol_2008_Sep_6(3)_215-234.nxml.txt.nlp	19506722	SENT70	1	1	21	21	fluoxetine	5-HT1B	PA449673	3351	0.803
NULL	Oncoimmunology_2014_Jan_1_3_e27414.nxml.txt.nlp	24701376	SENT28	25	25	13	13	vorinostat	IFN	PA164748224	3439	0.803
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT171	22	22	13	13	phenprocoumon	CYP2C9	PA450921	1559	0.803
NULL	Int_J_Nanomedicine_2012_Oct_25_7_5565-5575.nxml.txt.nlp	23118538	SENT136	37	37	9	9	fenofibrate	CO2	PA449594	4513	0.803
NULL	Ther_Clin_Risk_Manag_2005_Jun_1(2)_107-114.nxml.txt.nlp	18360550	SENT25	8	8	24	24	paclitaxel	Yes	PA450761	7525	0.803
NULL	Gene_Regul_Syst_Bio_2014_Apr_3_8_97-111.nxml.txt.nlp	24737933	SENT191	11	11	3	3	lipase	ANGPTL4	PA450239	51129	0.803
NULL	Cardiovasc_Ther_2009_27(4)_259-274.nxml.txt.nlp	19604248	SENT94	20	20	14	14	clopidogrel	ADP	PA449053	23038	0.803
NULL	Biomed_Res_Int_2014_Jan_29_2014_831845.nxml.txt.nlp	24605337	SENT144	31	31	8	8	bupivacaine	DRAK2	PA135057240	9262	0.803
NULL	Biol_Direct_2010_Nov_2_5_61.nxml.txt.nlp	21040590	SENT275	10	10	8	8	pp2	PP1		5540;5464	0.803
NULL	Cancer_Med_2014_Feb_10_3(1)_134-142.nxml.txt.nlp	24407937	SENT246	5	5	18	18	tamoxifen	ATAC	PA451581	6375	0.803
NULL	Br_J_Cancer_2013_Feb_19_108(3)_668-675.nxml.txt.nlp	23348520	SENT114	19	19	11	11	panitumumab	KRAS	PA162373091	3845	0.803
NULL	Cancer_Cell_Int_2005_Jul_24_5_22.nxml.txt.nlp	16042792	SENT72	16	16	28	28	vincristine	NAC	PA451879	22861	0.803
NULL	Eur_J_Clin_Pharmacol_2008_Jul_16_64(7)_683-690.nxml.txt.nlp	18415093	SENT127	13	13	15	15	amodiaquine	ACT	PA448404	12;11332;9457;641455	0.803
NULL	Mol_Cancer_2013_Oct_8_12_119.nxml.txt.nlp	24103454	SENT201	32	32	40	40	nutlin-3	p53		7157	0.803
NULL	Front_Oncol_2014_Nov_10_4_316.nxml.txt.nlp	25426448	SENT21	20	20	14	14	cisplatin	CRT	PA449014	811	0.803
NULL	EMBO_Rep_2013_Jan_30_14(1)_49-56.nxml.txt.nlp	23196367	SENT112	11	11	27	27	granisetron	5-HT3R	PA449809	3359	0.803
NULL	Oxid_Med_Cell_Longev_2011_Oct_12_2011_596240.nxml.txt.nlp	22013497	SENT79	11	11	32	32	oxygen	ROS	PA450744	6098	0.803
NULL	Adv_Hematol_2012_Mar_26_2012_932658.nxml.txt.nlp	22548067	SENT77	22	22	38	38	cytarabine	CHOP	PA449177	1649	0.803
NULL	Aging_(Albany_NY)_2010_Sep_18_2(9)_535-537.nxml.txt.nlp	20876940	SENT13	8	8	16	16	doxorubicin	CDKN1A	PA449412	1026	0.803
NULL	Arthritis_Res_Ther_2008_Jan_18_10(1)_R8.nxml.txt.nlp	18205921	SENT34	32	32	16	16	vardenafil	MRP5	PA10229	10057	0.803
NULL	Cancers_(Basel)_2014_Jul_8_6(3)_1487-1499.nxml.txt.nlp	25006835	SENT106	14	14	4	4	cisplatin	HGF	PA449014	3569;6654;3082	0.803
NULL	Mol_Cancer_2012_Jul_25_11_47.nxml.txt.nlp	22830443	SENT35	10	10	16	16	panitumumab	EGFR	PA162373091	1956	0.803
NULL	Br_J_Cancer_2006_Dec_4_95(11)_1459-1466.nxml.txt.nlp	17117182	SENT49	10	10	2	2	aluminium	VLP	PA164760864	391104	0.803
NULL	Br_J_Cancer_2014_Dec_9_111(12)_2205-2213.nxml.txt.nlp	25268373	SENT199	19	19	16	16	bevacizumab	spatial	PA130232992	219793	0.803
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT54	46	46	4	4	vinorelbine	MRC	PA451881	4345	0.803
NULL	J_Korean_Med_Sci_2006_Jun_21_21(3)_412-417.nxml.txt.nlp	16778381	SENT82	45	45	9	9	methacholine	ANOVA	PA165958382	4858	0.803
NULL	Mol_Med_Rep_2015_Jan_22_11(1)_83-90.nxml.txt.nlp	25338529	SENT149	12	12	5	5	octreotide	HO-1	PA450678	3162	0.803
NULL	Ann_Rehabil_Med_2012_Oct_31_36(5)_633-639.nxml.txt.nlp	23185727	SENT46	26	26	11	11	lidocaine	SGB	PA450226	2719	0.803
NULL	Oncotarget_2014_Dec_4_5(22)_11365-11380.nxml.txt.nlp	25426548	SENT249	7	7	3	3	nutlin-3	p53		7157	0.803
NULL	Oncol_Lett_2014_Jun_24_7(6)_1951-1953.nxml.txt.nlp	24932266	SENT62	14	14	8	8	trastuzumab	HER-2	PA451743	2064	0.803
NULL	Arch_Med_Sci_2013_Oct_31_9(5)_936-943.nxml.txt.nlp	24273582	SENT37	25	25	37	37	glimepiride	SUR1	PA449761	6833	0.803
NULL	Reprod_Biol_Endocrinol_2003_Aug_6_1_54.nxml.txt.nlp	12932297	SENT21	43	43	38	38	hyaluronidase	SPAM1	PA164745713	6677	0.803
NULL	Eur_J_Nutr_2012_Aug_15_51(5)_513-528.nxml.txt.nlp	22584415	SENT272	18	18	12	12	adalimumab	adiponectin	PA10004	9370	0.803
NULL	Cancers_(Basel)_2014_Nov_26_6(4)_2330-2342.nxml.txt.nlp	25534570	SENT194	20	20	11	11	paclitaxel	NRP1	PA450761	8829	0.803
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT135	17	17	4	4	cisplatin	IBP	PA449014	706;50619	0.803
NULL	Acta_Pharmacol_Sin_2010_Feb_5_31(2)_150-159.nxml.txt.nlp	20139897	SENT43	34	34	7	7	indomethacin	PAR4	PA449982	9002;5074	0.803
NULL	Breast_Cancer_Res_2007_Dec_20_9(Suppl_2)_S13.nxml.txt.nlp	NULL	SENT49	33	33	2	2	tamoxifen	IMPACT	PA451581	55364	0.803
NULL	Biosci_Rep_2012_Aug_1_32(Pt_4)_361-374.nxml.txt.nlp	22762204	SENT150	30	30	21	21	trastuzumab	PI3K	PA451743	5290	0.803
NULL	Mol_Cancer_2013_Mar_5_12_17.nxml.txt.nlp	23497256	SENT8	0	0	19	19	sunitinib	HDM2	PA162372840	4193	0.803
NULL	Oncol_Rep_2014_Jul_13_32(1)_419-424.nxml.txt.nlp	24841903	SENT30	10	10	29	29	irinotecan	N-myc	PA450085	4613	0.803
NULL	Curr_Med_Chem_2011_Dec_18(35)_5424-5429.nxml.txt.nlp	22087835	SENT101	31	31	39	39	atorvastatin	FKBP51	PA448500	2289	0.803
NULL	J_Neuroinflammation_2010_Sep_7_7_51.nxml.txt.nlp	20822529	SENT156	14	14	7	7	hemin	p38	PA449849	10598;1432;7965	0.803
NULL	Oncotarget_2012_Aug_19_3(8)_890-903.nxml.txt.nlp	23097685	SENT139	32	32	26	26	naproxen	COX	PA450595	1351	0.803
NULL	Mol_Vis_2014_Nov_4_20_1518-1526.nxml.txt.nlp	25489225	SENT116	7	7	15	15	fenofibrate	IL-17	PA449594	3605	0.803
NULL	Int_J_Environ_Res_Public_Health_2011_Mar_1_8(3)_683-697.nxml.txt.nlp	21556173	SENT81	26	26	23	23	trastuzumab	HER-2	PA451743	2064	0.803
NULL	Cancer_Cell_Int_2010_Apr_29_10_12.nxml.txt.nlp	20429927	SENT84	24	24	7	7	bortezomib	HRI	PA10252	27102	0.803
NULL	Gut_Liver_2011_Jun_24_5(2)_160-164.nxml.txt.nlp	21814595	SENT91	5	5	24	24	midazolam	ESD	PA450496	2098	0.803
NULL	Case_Rep_Neurol_Med_2013_Jul_1_2013_451206.nxml.txt.nlp	23936696	SENT48	14	14	6	6	verapamil	CYP3A4	PA451868	1576	0.803
NULL	AMB_Express_2014_Mar_20_4_31.nxml.txt.nlp	24949266	SENT178	11	11	31	31	sugar	ESI	PA451529	5266	0.803
NULL	J_Korean_Med_Sci_1996_Jun_11(3)_250-257.nxml.txt.nlp	8843008	SENT7	10	10	2	2	diltiazem	NIF	PA449334	6280	0.803
NULL	Evid_Based_Complement_Alternat_Med_2013_May_23_2013_413906.nxml.txt.nlp	23762131	SENT19	16	16	13	13	lipase	adiponectin	PA450239	9370	0.803
NULL	Sensors_(Basel)_2012_May_18_12(5)_6520-6537.nxml.txt.nlp	22778656	SENT163	24	24	37	37	ifosfamide	CYP1A2	PA449964	1544	0.803
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Sep_26_68(Pt_10)_o3019-o3020.nxml.txt.nlp	23125788	SENT5	13	13	1	1	phenol	mol	PA450913	90527	0.803
NULL	Cell_Death_Dis_2014_Feb_27_5(2)_e1090.nxml.txt.nlp	24577088	SENT32	10	10	8	8	deferoxamine	HIF-1	PA164746490	29072	0.803
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT60	21	21	6	6	bevacizumab	VEGF-A	PA130232992	7422	0.803
NULL	Mar_Drugs_2011_Dec_13_9(12)_2622-2642.nxml.txt.nlp	22363243	SENT209	10	10	23	23	mitomycin	HSP60	PA450524	3329	0.803
NULL	Oncol_Lett_2014_Oct_28_8(4)_1563-1566.nxml.txt.nlp	25202368	SENT104	37	37	39	39	gefitinib	EGFR	PA131301952	1956	0.803
NULL	J_Anaesthesiol_Clin_Pharmacol_2011_Jul-Sep_27(3)_380-382.nxml.txt.nlp	21897513	SENT24	6	6	18	18	rocuronium	Tech	PA164754992	57449	0.803
NULL	J_Viral_Hepat_2009_May_16(5)_315-324.nxml.txt.nlp	19243499	SENT101	27	27	0	0	imiquimod	IFN	PA449972	3439	0.803
NULL	Br_J_Cancer_2009_Jan_27_100(2)_251-258.nxml.txt.nlp	19165196	SENT20	40	40	11	11	irinotecan	EGFR	PA450085	1956	0.803
NULL	Exp_Transl_Stroke_Med_2009_Oct_21_1_4.nxml.txt.nlp	20142991	SENT92	19	19	2	2	collagenase	EPO	PA449107	7076;8288;2056	0.803
NULL	Leukemia_2013_Apr_14_27(4)_803-812.nxml.txt.nlp	23238589	SENT183	11	11	17	17	imatinib	IFN	PA10804	3439	0.803
NULL	Nutr_J_2014_Jan_24_13_11.nxml.txt.nlp	24461029	SENT137	24	24	42	42	curcumin	CTR	PA151958596	799	0.803
NULL	Amyloid_2014_Sep_11_21(3)_175-184.nxml.txt.nlp	24918964	SENT86	0	0	12	12	anakinra	TTR	PA10799	7276	0.803
NULL	Clin_Drug_Investig_2015_Dec_4_35_45-51.nxml.txt.nlp	25471740	SENT32	12	12	31	31	icosapent	CYP3A4	PA164746077	1576	0.803
NULL	Cancer_Cell_Int_2005_Aug_23_5_27.nxml.txt.nlp	16117829	SENT156	9	9	14	14	doxycycline	p53	PA449415	7157	0.803
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Feb_17_6_29-36.nxml.txt.nlp	24648767	SENT116	6	6	13	13	tamoxifen	BRCA2	PA451581	675	0.803
NULL	Scientifica_(Cairo)_2012_Dec_25_2012_561761.nxml.txt.nlp	24278716	SENT448	0	0	10	10	naloxone	PAG	PA450586	55824	0.803
NULL	Front_Neuroeng_2013_Feb_25_6_1.nxml.txt.nlp	23443302	SENT66	26	26	16	16	midazolam	gamma	PA450496	9913	0.803
NULL	Oncotarget_2011_Sep_9_2(9)_658-668.nxml.txt.nlp	21911919	SENT93	8	8	10	10	daunorubicin	HO-1	PA449212	3162	0.803
NULL	Diabetes_2013_May_16_62(5)_1697-1708.nxml.txt.nlp	23364453	SENT27	17	17	7	7	exenatide	GLP-1	PA164749238	100125288	0.803
NULL	Evid_Based_Complement_Alternat_Med_2012_Dec_11_2012_310872.nxml.txt.nlp	23304196	SENT150	5	5	7	7	raloxifene	aromatase	PA451221	1588	0.803
NULL	Nucleic_Acids_Res_2011_Mar_20_39(6)_2234-2248.nxml.txt.nlp	21097889	SENT102	27	27	6	6	fluorouracil	PAK1IP1	PA128406956	55003	0.803
NULL	Front_Cell_Neurosci_2014_Jan_30_8_14.nxml.txt.nlp	24523673	SENT80	10	10	36	36	isoflurane	CO2	PA450106	4513	0.803
NULL	Case_Rep_Transplant_2011_Jan_5_2011_210178.nxml.txt.nlp	23213600	SENT39	15	15	11	11	nevirapine	CYP3A	PA450616	1574	0.803
NULL	Br_J_Cancer_2004_May_4_90(9)_1733-1739.nxml.txt.nlp	15150604	SENT90	4	4	1	1	tamoxifen	aromatase	PA451581	1588	0.803
NULL	Eur_J_Endocrinol_2010_May_162(5)_987-992.nxml.txt.nlp	20164212	SENT31	3	3	12	12	diazoxide	HADH	PA449285	3033	0.803
NULL	Front_Microbiol_2015_Jan_12_5_776.nxml.txt.nlp	25628615	SENT246	4	4	27	27	nitrogen	DSE	PA450643	29940	0.803
NULL	Oncotarget_2014_Jun_8_5(17)_7446-7457.nxml.txt.nlp	25277184	SENT43	16	16	8	8	cisplatin	TRIM8	PA449014	81603	0.803
NULL	Exp_Ther_Med_2013_Mar_21_5(3)_987-991.nxml.txt.nlp	23407636	SENT90	18	18	12	12	losartan	IL-8	PA450268	3576	0.803
NULL	Asia_Pac_Allergy_2014_Apr_29_4(2)_126-128.nxml.txt.nlp	24809019	SENT31	5	5	12	12	omalizumab	San	PA164752253	80218	0.803
NULL	Ann_Rheum_Dis_2008_Dec_9_68(6)_789-796.nxml.txt.nlp	19066176	SENT203	40	40	35	35	adalimumab	STAR	PA10004	6770;2984	0.803
NULL	Br_J_Pharmacol_2011_Oct_164(3)_866-883.nxml.txt.nlp	21323893	SENT320	17	17	30	30	thrombin	NOX1	PA451674	27035	0.803
NULL	Breast_Cancer_Res_Treat_2012_Jul_28_134(1)_267-276.nxml.txt.nlp	22453754	SENT162	10	10	13	13	tamoxifen	aromatase	PA451581	1588	0.803
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT155	5	5	12	12	trastuzumab	HER3	PA451743	2065	0.803
NULL	Mol_Cell_Biochem_2013_Jul_20_383(1-2)_95-102.nxml.txt.nlp	23873331	SENT8	22	22	9	9	resveratrol	CYP1A1		1543	0.803
NULL	Antimicrob_Agents_Chemother_2014_Dec_58(12)_7340-7346.nxml.txt.nlp	25267661	SENT230	9	9	18	18	primaquine	G6PD	PA451103	2539	0.803
NULL	J_Gastroenterol_2014_Dec_24_49(12)_1536-1547.nxml.txt.nlp	24366288	SENT153	38	38	41	41	rabeprazole	CYP2C19	PA451216	1557	0.803
NULL	Clin_Med_Insights_Oncol_2012_Dec_6_6_407-421.nxml.txt.nlp	23239933	SENT114	7	7	4	4	gefitinib	EGFR	PA131301952	1956	0.803
NULL	Mol_Cancer_2014_Aug_20_13(1)_194.nxml.txt.nlp	NULL	SENT103	19	19	6	6	vemurafenib	AKT1	PA165946873	207	0.803
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT55	12	12	17	17	cisplatin	CTR2	PA449014	1318	0.803
NULL	Arthritis_Res_Ther_2013_Nov_1_15(6)_R176.nxml.txt.nlp	24456929	SENT274	8	8	13	13	pp2	MSU		593	0.803
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Nov_4_65(Pt_12)_o2983.nxml.txt.nlp	21578723	SENT65	6	6	9	9	hydroxyurea	mol	PA449942	90527	0.803
NULL	Cell_Death_Dis_2014_Feb_13_5(2)_e1055.nxml.txt.nlp	24525731	SENT77	8	8	21	21	cisplatin	XRCC1	PA449014	7515	0.803
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S258-S263.nxml.txt.nlp	21525465	SENT202	10	10	15	15	liraglutide	GLP-1	PA165958364	100125288	0.803
NULL	Springerplus_2013_Dec_18_2_679.nxml.txt.nlp	24386625	SENT86	14	14	25	25	vemurafenib	BRAF	PA165946873	673	0.803
NULL	EMBO_Mol_Med_2013_Aug_4_5(8)_1180-1195.nxml.txt.nlp	23828858	SENT124	19	19	9	9	rituximab	MYC	PA451261	4609	0.803
NULL	EMBO_Mol_Med_2012_Dec_15_4(12)_1276-1293.nxml.txt.nlp	23065753	SENT435	8	8	12	12	cisplatin	AIM2	PA449014	9447	0.803
NULL	J_Neurosci_Res_2010_Jun_88(8)_1829-1840.nxml.txt.nlp	20091774	SENT18	4	4	21	21	l-serine	DAO	PA451330	26;1610	0.803
NULL	J_Gen_Physiol_2000_Jun_1_115(6)_685-696.nxml.txt.nlp	10828243	SENT442	5	5	26	26	genistein	OLF	PA165109660	83857	0.803
NULL	Clin_Endocrinol_(Oxf)_2009_Aug_71(2)_171-175.nxml.txt.nlp	19170705	SENT82	10	10	19	19	hydrocortisone	ACTH	PA449905	5443	0.803
NULL	Clin_Ophthalmol_2014_Mar_27_8_629-635.nxml.txt.nlp	24729678	SENT88	16	16	23	23	bevacizumab	San	PA130232992	80218	0.803
NULL	Exp_Transl_Stroke_Med_2014_Jun_21_6_8.nxml.txt.nlp	24991402	SENT106	19	19	26	26	chloroquine	ANOVA	PA448948	4858	0.803
NULL	Br_J_Cancer_2010_Jun_29_103(1)_61-72.nxml.txt.nlp	20588279	SENT255	17	17	19	19	trastuzumab	PTEN	PA451743	5728	0.803
NULL	Cancer_Cell_Int_2009_Jun_1_9_15.nxml.txt.nlp	19480719	SENT62	23	23	46	46	l-glutamine	CO2	PA10090	4513	0.803
NULL	Br_J_Dermatol_2009_Feb_160(2)_438-441.nxml.txt.nlp	19016697	SENT22	37	37	30	30	methotrexate	MTHFR	PA450428	4524	0.803
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT30	8	8	20	20	gefitinib	PTEN	PA131301952	5728	0.803
NULL	Indian_J_Pharmacol_2008_Oct_40(Suppl_2)_S211-S221.nxml.txt.nlp	21593975	SENT559	12	12	9	9	reboxetine	CLE	PA144614921	51637	0.803
NULL	Oxid_Med_Cell_Longev_2012_Aug_13_2012_741468.nxml.txt.nlp	22928085	SENT318	13	13	16	16	resveratrol	AMPK		5563	0.803
NULL	Nature_2008_Nov_13_456(7219)_269-273.nxml.txt.nlp	18849969	SENT100	8	8	13	13	resveratrol	CRTC2		200186	0.802
NULL	Br_J_Cancer_2013_Mar_19_108(5)_1079-1091.nxml.txt.nlp	23449353	SENT172	30	30	10	10	mitoxantrone	PC3	PA450526	57332;7832;5122	0.802
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT134	12	12	19	19	phenformin	CCL16	PA1000	6360	0.802
NULL	Clinics_(Sao_Paulo)_2013_Oct_68(10)_1325-1332.nxml.txt.nlp	24212839	SENT14	39	39	24	24	ribavirin	IL28B	PA451241	282617	0.802
NULL	Int_J_Vasc_Med_2011_Aug_11_2011_867964.nxml.txt.nlp	21860799	SENT85	5	5	16	16	cilostazol	DES	PA164746334	1674	0.802
NULL	Mol_Cancer_2014_Jun_24_13_157.nxml.txt.nlp	24958351	SENT44	16	16	12	12	trastuzumab	EGFR	PA451743	1956	0.802
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Nov_4_65(Pt_12)_o2983.nxml.txt.nlp	21578723	SENT65	6	6	16	16	hydroxyurea	mol	PA449942	90527	0.802
NULL	Br_J_Cancer_2010_May_11_102(10)_1456-1460.nxml.txt.nlp	20461090	SENT92	23	23	10	10	temsirolimus	IFN	PA164746890	3439	0.802
NULL	Avicenna_J_Phytomed_2014_Nov-Dec_4(6)_371-376.nxml.txt.nlp	25386400	SENT54	12	12	5	5	ethanol	flower	PA448073	11094	0.802
NULL	Front_Neurosci_2010_Nov_19_4_192.nxml.txt.nlp	21151361	SENT596	12	12	5	5	vilazodone	5-HT1A	PA165958365	3350	0.802
NULL	Br_J_Cancer_2013_Sep_3_109(5)_1157-1164.nxml.txt.nlp	23942075	SENT144	16	16	8	8	pertuzumab	HER2		2064	0.802
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT49	23	23	5	5	phenacetin	CYP1A2	PA450897	1544	0.802
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT224	5	5	10	10	atorvastatin	p38	PA448500	10598;1432;7965	0.802
NULL	Br_J_Cancer_2011_Aug_23_105(5)_649-657.nxml.txt.nlp	21811251	SENT228	15	15	4	4	gefitinib	IGF1R	PA131301952	3480	0.802
NULL	EMBO_Mol_Med_2012_Jun_15_4(6)_472-485.nxml.txt.nlp	22419550	SENT190	11	11	6	6	thyroglobulin	IGFBP3	PA164754910	3486	0.802
NULL	Br_J_Cancer_2013_May_28_108(10)_2063-2069.nxml.txt.nlp	23591198	SENT185	14	14	8	8	gemcitabine	IL-6	PA449748	3569	0.802
NULL	Cardiovasc_Diabetol_2005_May_15_4_6.nxml.txt.nlp	15892894	SENT60	6	6	24	24	telmisartan	ANOVA	PA451605	4858	0.802
NULL	Cell_Death_Dis_2014_Mar_13_5(3)_e1119.nxml.txt.nlp	24625978	SENT152	15	15	6	6	paraformaldehyde	CO2	PA450790	4513	0.802
NULL	Front_Oncol_2013_Aug_5_3_201.nxml.txt.nlp	23936765	SENT284	4	4	8	8	staurosporine	RSK1	PA165109623	6195	0.802
NULL	Br_J_Cancer_2012_Feb_14_106(4)_685-692.nxml.txt.nlp	22294184	SENT130	22	22	10	10	docetaxel	JNK	PA449383	5599	0.802
NULL	Int_J_Womens_Health_2012_Sep_3_4_455-469.nxml.txt.nlp	23071416	SENT221	6	6	8	8	alendronate	FIT-1	PA448082	9173	0.802
NULL	Br_J_Clin_Pharmacol_2011_Oct_72(4)_647-657.nxml.txt.nlp	21518389	SENT185	19	19	17	17	ticagrelor	P2Y12	PA165374673	64805	0.802
NULL	J_Oncol_2009_Mar_10_2009_831626.nxml.txt.nlp	20300583	SENT15	10	10	4	4	panitumumab	EGFR	PA162373091	1956	0.802
NULL	Cell_Death_Dis_2010_May_13_1(5)_e41.nxml.txt.nlp	21364648	SENT100	18	18	4	4	etoposide	p53	PA449552	7157	0.802
NULL	J_Hematol_Oncol_2010_Mar_23_3_11.nxml.txt.nlp	20331897	SENT18	24	24	12	12	cisplatin	HER2	PA449014	2064	0.802
NULL	Nat_Chem_Biol_2010_Apr_14_6(4)_258-260.nxml.txt.nlp	20228793	SENT75	16	16	27	27	oxygen	ROS	PA450744	6098	0.802
NULL	Int_J_Biol_Sci_2012_Oct_24_8(9)_1227-1236.nxml.txt.nlp	23136551	SENT72	15	15	8	8	tocilizumab	IL-6	PA165292659	3569	0.802
NULL	Drugs_R_D_2011_Jun_27_11(2)_101-111.nxml.txt.nlp	21679003	SENT104	26	26	30	30	bevacizumab	KRAS	PA130232992	3845	0.802
NULL	Biomed_Res_Int_2014_Feb_6_2014_323594.nxml.txt.nlp	24689036	SENT192	7	7	20	20	raloxifene	PC3	PA451221	57332;7832;5122	0.802
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_23_2013_941093.nxml.txt.nlp	23864901	SENT299	21	21	13	13	omeprazole	CYP2C19	PA450704	1557	0.802
NULL	Daru_2011_19(2)_138-144.nxml.txt.nlp	22615650	SENT74	6	6	23	23	heparin	FGF20	PA449855	26281	0.802
NULL	J_Thromb_Haemost_2014_May_22_12(5)_748-760.nxml.txt.nlp	24612393	SENT22	16	16	8	8	thrombin	ADP	PA451674	23038	0.802
NULL	Croat_Med_J_2012_Jun_53(3)_214-223.nxml.txt.nlp	22661134	SENT100	36	36	43	43	diazepam	ACTH	PA449283	5443	0.802
NULL	Br_J_Haematol_2008_Mar_3_144(5)_677-685.nxml.txt.nlp	19055662	SENT87	2	2	13	13	doxorubicin	CHOP	PA449412	1649	0.802
NULL	Arthritis_Res_Ther_2009_Apr_30_11(2)_R58.nxml.txt.nlp	19405951	SENT23	17	17	10	10	clodronate	RANKL	PA10239	8600	0.802
NULL	Core_Evid_2010_Jul_27_5_1-10.nxml.txt.nlp	20694135	SENT245	21	21	12	12	levodopa	CLE	PA450213	51637	0.802
NULL	J_Cell_Mol_Med_2014_Aug_1_18(8)_1599-1611.nxml.txt.nlp	24889822	SENT12	5	5	7	7	resveratrol	p62		8878;10657;23636	0.802
NULL	Ann_Hematol_2010_Sep_13_89(9)_861-871.nxml.txt.nlp	20387067	SENT202	8	8	22	22	dasatinib	GM-CSF	PA162372878	1437	0.802
NULL	Clin_Mol_Hepatol_2014_Sep_25_20(3)_283-290.nxml.txt.nlp	25320732	SENT116	18	18	12	12	propranolol	EVL	PA451145	51466	0.802
NULL	J_Adv_Pract_Oncol_2013_Sep_1_Sep-Oct_4(5)_348-352.nxml.txt.nlp	25032013	SENT16	0	0	17	17	bevacizumab	VEGF-A	PA130232992	7422	0.802
NULL	Open_AIDS_J_2008_Dec_18_2_89-93.nxml.txt.nlp	19274065	SENT59	17	17	4	4	nevirapine	CD4	PA450616	920	0.802
NULL	Mol_Biol_Cell_2013_Feb_1_24(3)_331-341.nxml.txt.nlp	23197474	SENT347	22	22	4	4	l-glutamine	PC6	PA10090	5125	0.802
NULL	Nat_Biotechnol_2013_Jul_30_31(7)_630-637.nxml.txt.nlp	23811600	SENT177	3	3	22	22	crizotinib	AXL	PA165946122	558	0.802
NULL	Arthritis_Res_Ther_2011_Feb_8_13(1)_R17.nxml.txt.nlp	21303509	SENT213	18	18	1	1	infliximab	FSTL1	PA452639	11167	0.802
NULL	J_Biol_Chem_2008_Dec_19_283(51)_35419-35427.nxml.txt.nlp	18955485	SENT43	45	45	33	33	thrombin	GPVI	PA451674	51206	0.802
NULL	Diabetes_Care_2010_Aug_33(8)_e103-e108.nxml.txt.nlp	20668144	SENT158	10	10	13	13	fenofibrate	Q10	PA449594	27161	0.802
NULL	J_Physiol_2009_Feb_15_587(Pt_4)_731-744.nxml.txt.nlp	19074966	SENT155	3	3	22	22	taurine	PAT1	PA451590	10513;206358	0.802
NULL	Lab_Invest_2011_Jan_9_91(1)_138-146.nxml.txt.nlp	20697379	SENT5	34	34	4	4	thyroglobulin	UBB	PA164754910	7314	0.802
NULL	J_Int_Soc_Sports_Nutr_2015_Jan_21_12(1)_5.nxml.txt.nlp	NULL	SENT15	11	11	2	2	curcumin	ANOVA	PA151958596	4858	0.802
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Nov_21_65(Pt_12)_o3140.nxml.txt.nlp	21578861	SENT60	31	31	12	12	ethanol	mol	PA448073	90527	0.802
NULL	Neural_Regen_Res_2014_Apr_15_9(8)_878-887.nxml.txt.nlp	25206906	SENT181	25	25	23	23	capsaicin	TRPV1	PA448776	7442	0.802
NULL	Mol_Cancer_2009_Nov_24_8_109.nxml.txt.nlp	19930708	SENT178	4	4	10	10	exemestane	aromatase	PA449563	1588	0.802
NULL	J_Hum_Genet_2013_Jun_16_58(6)_353-361.nxml.txt.nlp	23677058	SENT168	35	35	27	27	cytarabine	RRM2	PA449177	6241	0.802
NULL	J_Cancer_2014_Jan_5_5(1)_69-78.nxml.txt.nlp	24396499	SENT125	9	9	32	32	carboplatin	BCS	PA448803	617	0.802
NULL	J_Cell_Biol_1997_May_19_137(4)_881-890.nxml.txt.nlp	9151690	SENT181	10	10	8	8	chymotrypsin	MAP2	PA448994	4133;10988	0.802
NULL	Acta_Pharmacol_Sin_2012_Jun_6_33(6)_798-808.nxml.txt.nlp	22669117	SENT184	25	25	44	44	heparin	14-3-3	PA449855	10971	0.802
NULL	Arthritis_Res_2002_Sep_16_4(6)_R12.nxml.txt.nlp	12453315	SENT133	22	22	14	14	glucose	CRP	PA449773	1401;140913	0.802
NULL	Braz_J_Med_Biol_Res_2014_Jan_10_47(1)_60-69.nxml.txt.nlp	24519092	SENT9	21	21	34	34	doxorubicin	YWHAZ	PA449412	7534	0.802
NULL	Ther_Clin_Risk_Manag_2006_Dec_2(4)_389-400.nxml.txt.nlp	18360651	SENT168	22	22	17	17	infliximab	IMPACT	PA452639	55364	0.802
NULL	Front_Oncol_2014_May_19_4_113.nxml.txt.nlp	24904827	SENT95	6	6	0	0	enoxacin	TRBP	PA449462	23054;6896	0.802
NULL	Exp_Mol_Med_2012_Apr_30_44(4)_281-292.nxml.txt.nlp	22228119	SENT70	21	21	4	4	genistein	IPA	PA165109660	3160	0.802
NULL	Int_J_Biomed_Sci_2014_Dec_10(4)_229-235.nxml.txt.nlp	25598752	SENT171	13	13	9	9	abatacept	IL-17	PA164747080	3605	0.802
NULL	Cancer_Med_2014_Jun_19_3(3)_555-564.nxml.txt.nlp	24648042	SENT76	5	5	14	14	alemtuzumab	p53	PA164783958	7157	0.802
NULL	Oncotarget_2014_Oct_18_5(22)_11641-11652.nxml.txt.nlp	25361002	SENT70	21	21	2	2	cisplatin	NAC	PA449014	22861	0.802
NULL	Drug_Target_Insights_2013_Aug_19_7_27-34.nxml.txt.nlp	24023511	SENT40	22	22	9	9	cyclosporine	P-gp	PA449167	5243	0.802
NULL	J_Headache_Pain_2001_Jun_2(1)_3-11.nxml.txt.nlp	NULL	SENT1	12	12	25	25	eletriptan	5-HT1B	PA134687947	3351	0.802
NULL	Oncol_Rep_2012_Apr_16_27(4)_971-978.nxml.txt.nlp	22266706	SENT149	14	14	4	4	cisplatin	Mcl-1	PA449014	4170	0.802
NULL	Front_Oncol_2013_Sep_11_3_228.nxml.txt.nlp	24062981	SENT443	24	24	18	18	vemurafenib	BRAF	PA165946873	673	0.802
NULL	Mol_Vis_2014_Nov_4_20_1518-1526.nxml.txt.nlp	25489225	SENT121	7	7	14	14	fenofibrate	IL-17	PA449594	3605	0.802
NULL	Br_J_Cancer_2006_Dec_4_95(11)_1504-1513.nxml.txt.nlp	17088902	SENT193	21	21	9	9	gefitinib	HER2	PA131301952	2064	0.802
NULL	Nature_2008_Oct_16_455(7215)_979-983.nxml.txt.nlp	18794898	SENT53	21	21	1	1	heparin	CDO	PA449855	50937	0.802
NULL	Biomed_Res_Int_2014_Jun_24_2014_132702.nxml.txt.nlp	25050322	SENT162	18	18	4	4	metformin	p53	PA450395	7157	0.802
NULL	Fibrogenesis_Tissue_Repair_2010_Nov_11_3_22.nxml.txt.nlp	21070635	SENT74	16	16	26	26	pioglitazone	adiponectin	PA450970	9370	0.802
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R91.nxml.txt.nlp	22541814	SENT131	30	30	16	16	thrombin	PAR3	PA451674	56288;2151	0.802
NULL	Breast_Cancer_Res_2013_Nov_6_15(6)_R105.nxml.txt.nlp	24192331	SENT36	19	19	22	22	tamoxifen	aromatase	PA451581	1588	0.802
NULL	J_Cell_Biol_2005_Nov_21_171(4)_729-738.nxml.txt.nlp	16286510	SENT215	22	22	35	35	heparin	glypican	PA449855	2817	0.802
NULL	Oncotarget_2014_Jun_1_5(13)_4881-4894.nxml.txt.nlp	24952679	SENT191	21	21	9	9	gemcitabine	IRE1	PA449748	2081	0.802
NULL	Int_J_Nanomedicine_2009_Apr_20_4_99-105.nxml.txt.nlp	19516888	SENT80	21	21	19	19	paclitaxel	castor	PA450761	54897	0.802
NULL	Mol_Cells_2014_Mar_31_37(3)_234-240.nxml.txt.nlp	24642709	SENT118	7	7	35	35	capsaicin	HO-1	PA448776	3162	0.802
NULL	ScientificWorldJournal_2012_Apr_26_2012_358102.nxml.txt.nlp	22645419	SENT182	22	22	30	30	captopril	DES	PA448780	1674	0.802
NULL	Ann_Dermatol_2014_Jun_12_26(3)_363-373.nxml.txt.nlp	24966637	SENT42	18	18	22	22	imiquimod	San	PA449972	80218	0.802
NULL	Ann_Rehabil_Med_2012_Dec_28_36(6)_857-860.nxml.txt.nlp	23342320	SENT57	9	9	4	4	warfarin	CYP2C9	PA451906	1559	0.802
NULL	Diabetes_Care_2009_Nov_3_32(11)_2111-2113.nxml.txt.nlp	19651918	SENT47	7	7	24	24	fenofibrate	HDL2	PA449594	57338	0.802
NULL	Indian_J_Med_Res_2011_Apr_133(4)_434-441.nxml.txt.nlp	21537099	SENT160	25	25	21	21	lansoprazole	EGF	PA450180	1950	0.802
NULL	Br_J_Cancer_2013_May_28_108(10)_2039-2044.nxml.txt.nlp	23652306	SENT86	25	25	20	20	tamoxifen	SRC3	PA451581	8202	0.802
NULL	Appl_Microbiol_Biotechnol_2014_Feb_18_98(8)_3829-3840.nxml.txt.nlp	24535257	SENT11	21	21	9	9	ethanol	CAT-1	PA448073	6541	0.802
NULL	J_Int_AIDS_Soc_2011_Nov_11_14_53.nxml.txt.nlp	22078415	SENT111	12	12	17	17	fluorescein	CD4	PA164746009	920	0.802
NULL	Br_J_Haematol_2014_Mar_13_164(1)_811-821.nxml.txt.nlp	24328678	SENT157	9	9	14	14	lenalidomide	Aiolos	PA162363968	22806	0.802
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT140	31	31	33	33	perifosine	DR5	PA165291471	8795	0.802
NULL	Int_J_Appl_Basic_Med_Res_2012_Jul-Dec_2(2)_77-83.nxml.txt.nlp	23776817	SENT119	16	16	11	11	ketoconazole	CYP3A4	PA450146	1576	0.802
NULL	Breast_Cancer_Res_2011_May_25_13(3)_107.nxml.txt.nlp	21635706	SENT20	29	29	9	9	denosumab	RANKL	PA166048634	8600	0.802
NULL	BMJ_Open_2014_Nov_27_4(11)_e006255.nxml.txt.nlp	25431223	SENT173	22	22	15	15	ribavirin	IL28B	PA451241	282617	0.802
NULL	Bone_Marrow_Transplant_2011_Mar_24_46(3)_430-435.nxml.txt.nlp	20498647	SENT25	26	26	20	20	infliximab	IL2	PA452639	3558	0.802
NULL	Autophagy_2013_Sep_1_9(9)_1418-1430.nxml.txt.nlp	23748697	SENT25	5	5	7	7	staurosporine	STS	PA165109623	412	0.802
NULL	Sci_Rep_2014_Nov_28_4_7237.nxml.txt.nlp	25429875	SENT114	26	26	40	40	hesperidin	p38	PA449867	10598;1432;7965	0.802
NULL	J_Korean_Med_Sci_2007_Apr_30_22(2)_283-289.nxml.txt.nlp	17449938	SENT98	17	17	27	27	minoxidil	Bcl-2	PA450521	596	0.802
NULL	Oncoimmunology_2013_Dec_1_2(12)_e27215.nxml.txt.nlp	24501692	SENT32	41	41	5	5	gefitinib	STAT1	PA131301952	6772	0.802
NULL	Case_Rep_Oncol_2013_Sep_10_6(3)_450-455.nxml.txt.nlp	24163659	SENT54	0	0	7	7	trastuzumab	HER2	PA451743	2064	0.802
NULL	Biologics_2012_Jun_20_6_147-154.nxml.txt.nlp	22807625	SENT35	10	10	4	4	pazopanib	VEGFR	PA165291492	3791	0.802
NULL	Biologics_2014_Apr_17_8_169-182.nxml.txt.nlp	24790410	SENT93	16	16	32	32	etanercept	ACR	PA449515	49	0.802
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT158	4	4	17	17	l-cysteine	SIRT3	PA449173	23410	0.802
NULL	Chin_J_Cancer_2011_May_30(5)_327-335.nxml.txt.nlp	21527065	SENT180	33	33	20	20	trastuzumab	PTEN	PA451743	5728	0.802
NULL	Front_Neurosci_2014_Jun_24_8_176.nxml.txt.nlp	25009459	SENT389	14	14	6	6	ivermectin	P2X4	PA450133	5025	0.802
NULL	Sci_Rep_2014_Dec_23_4_7592.nxml.txt.nlp	25534230	SENT57	32	32	25	25	estradiol	CO2	PA449503	4513	0.802
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_55-78.nxml.txt.nlp	19305788	SENT488	27	27	18	18	memantine	EPM	PA10364	2054	0.802
NULL	EMBO_Mol_Med_2012_Jun_13_4(6)_515-527.nxml.txt.nlp	22416035	SENT232	2	2	17	17	olaparib	NOXA		5366	0.802
NULL	Cancer_Cell_Int_2013_May_15_13_42.nxml.txt.nlp	23672670	SENT179	22	22	7	7	paclitaxel	p53	PA450761	7157	0.802
NULL	Cerebrospinal_Fluid_Res_2006_Dec_21_3(Suppl_1)_S41.nxml.txt.nlp	NULL	SENT6	4	4	10	10	heparin	OTS	PA449855	5012	0.802
NULL	Curr_Neuropharmacol_2010_Dec_8(4)_409-421.nxml.txt.nlp	21629447	SENT177	13	13	18	18	diazepam	LZP	PA449283	170392	0.802
NULL	Cancer_Med_2013_Feb_3_2(1)_11-20.nxml.txt.nlp	24133623	SENT299	2	2	9	9	cetuximab	KRAS	PA10040	3845	0.802
NULL	Adv_Prev_Med_2013_Jun_12_2013_346372.nxml.txt.nlp	23840957	SENT132	16	16	6	6	methadone	OST	PA450401	1650;23263	0.802
NULL	Breast_Cancer_Res_2014_May_30_16(3)_R55.nxml.txt.nlp	24886669	SENT15	24	24	10	10	doxorubicin	survivin	PA449412	332	0.802
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_3_2012_908562.nxml.txt.nlp	23082087	SENT149	0	0	15	15	hesperidin	IL-2	PA449867	3558	0.802
NULL	Exp_Diabetes_Res_2012_Sep_20_2012_936518.nxml.txt.nlp	23049542	SENT12	5	5	13	13	glucose	TRPV4	PA449773	59341	0.802
NULL	Front_Neural_Circuits_2014_Dec_19_8_147.nxml.txt.nlp	25565973	SENT84	12	12	31	31	fluorescein	SP6	PA164746009	80320	0.802
NULL	Iran_J_Pharm_Res_2013_Winter_12(1)_141-146.nxml.txt.nlp	24250582	SENT6	12	12	35	35	rifampin	NAC	PA451250	22861	0.802
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Nov_20_64(Pt_12)_o2385.nxml.txt.nlp	21581356	SENT62	33	33	6	6	ethanol	mol	PA448073	90527	0.802
NULL	Europace_2012_Dec_6_14(12)_1700-1707.nxml.txt.nlp	22772054	SENT128	16	16	29	29	heparin	Yes	PA449855	7525	0.802
NULL	Oncotarget_2011_Sep_9_2(9)_658-668.nxml.txt.nlp	21911919	SENT114	8	8	2	2	cytarabine	HO-1	PA449177	3162	0.802
NULL	Cell_Biochem_Biophys_2014_Jun_28_70(2)_1459-1467.nxml.txt.nlp	24972691	SENT43	39	39	20	20	trypsin	CO2	PA451806	4513	0.802
NULL	Nanoscale_Res_Lett_2009_Apr_21_4(7)_732-737.nxml.txt.nlp	20596446	SENT26	0	0	13	13	mitomycin	Xin	PA450524	165904	0.802
NULL	Biosci_Rep_2012_Dec_20_33(1)_e00011.nxml.txt.nlp	23137297	SENT144	8	8	2	2	heparin	RPSA	PA449855	3921	0.802
NULL	Cancers_(Basel)_2012_Nov_2_4(4)_1161-1179.nxml.txt.nlp	24213503	SENT39	30	30	13	13	daunorubicin	DNMT3A	PA449212	1788	0.802
NULL	Diabetologia_2010_Feb_4_53(2)_254-262.nxml.txt.nlp	19908023	SENT309	5	5	23	23	lisinopril	TES	PA450242	26136	0.802
NULL	Am_J_Trop_Med_Hyg_2014_Aug_6_91(2)_424-434.nxml.txt.nlp	24799369	SENT308	15	15	10	10	amoxicillin	ACT	PA448406	12;11332;9457;641455	0.802
NULL	J_Cell_Biol_2001_Aug_6_154(3)_599-610.nxml.txt.nlp	11481345	SENT129	21	21	10	10	doxycycline	ARF6	PA449415	382	0.802
NULL	EMBO_Mol_Med_2012_Jun_15_4(6)_472-485.nxml.txt.nlp	22419550	SENT18	40	40	1	1	thyroglobulin	TROP2	PA164754910	4070	0.802
NULL	Br_J_Cancer_2013_Feb_19_108(3)_557-563.nxml.txt.nlp	23361053	SENT125	43	43	13	13	tamoxifen	PAK1	PA451581	5585;5058	0.802
NULL	F1000Prime_Rep_2014_Aug_1_6_65.nxml.txt.nlp	25165564	SENT42	3	3	30	30	alemtuzumab	TP53	PA164783958	7157	0.802
NULL	J_Young_Pharm_2010_Apr-Jun_2(2)_169-172.nxml.txt.nlp	21264121	SENT29	10	10	27	27	ethanol	mol	PA448073	90527	0.802
NULL	Evid_Based_Complement_Alternat_Med_2011_Mar_1_2011_207034.nxml.txt.nlp	21423686	SENT144	11	11	25	25	clopidogrel	CYP2C9	PA449053	1559	0.802
NULL	Oncotarget_2014_Oct_18_5(22)_11588-11603.nxml.txt.nlp	25473890	SENT121	10	10	3	3	imatinib	AMACR	PA10804	23600	0.802
NULL	Onco_Targets_Ther_2014_May_28_7_841-852.nxml.txt.nlp	24920926	SENT98	9	9	23	23	afatinib	EGFR	PA165981154	1956	0.802
NULL	J_Immunol_Res_2014_May_8_2014_565320.nxml.txt.nlp	24901010	SENT66	8	8	30	30	phenytoin	HLA-B	PA450947	3106	0.802
NULL	Front_Neurol_2014_Sep_11_5_173.nxml.txt.nlp	25309501	SENT16	4	4	27	27	hyaluronan	RHAMM	PA165958431	3161	0.802
NULL	Oncotarget_2014_Oct_31_5(20)_9756-9769.nxml.txt.nlp	25230151	SENT147	2	2	13	13	glutaraldehyde	p53	PA449777	7157	0.802
NULL	J_Hematol_Oncol_2012_Sep_18_5_57.nxml.txt.nlp	22989009	SENT266	30	30	23	23	nutlin-3	HDM2		4193	0.802
NULL	J_Inherit_Metab_Dis_2010_Oct_3_33(5)_625-632.nxml.txt.nlp	20814828	SENT111	35	35	19	19	simvastatin	RhoA	PA451363	387	0.802
NULL	Ann_Rheum_Dis_2008_May_21_68(2)_175-182.nxml.txt.nlp	18495735	SENT13	27	27	11	11	infliximab	CTX	PA452639	1593	0.802
NULL	Mol_Biol_Cell_2013_Jan_15_24(2)_129-144.nxml.txt.nlp	23154999	SENT37	30	30	37	37	trastuzumab	San	PA451743	80218	0.802
NULL	EMBO_Mol_Med_2011_Jul_3(7)_370-384.nxml.txt.nlp	21591259	SENT26	0	0	8	8	thrombin	PAR1	PA451674	79581;2149	0.802
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT111	6	6	23	23	ethanol	TNF	PA448073	7124	0.802
NULL	Tuberc_Res_Treat_2013_Mar_27_2013_285094.nxml.txt.nlp	23634300	SENT31	17	17	4	4	isoniazid	PTB	PA450112	58155	0.802
NULL	Clinicoecon_Outcomes_Res_2014_Oct_17_6_451-461.nxml.txt.nlp	25378939	SENT30	10	10	25	25	vancomycin	HAP	PA451850	5915;10313	0.802
NULL	Mol_Cancer_2010_May_18_9_110.nxml.txt.nlp	20482802	SENT105	32	32	11	11	cisplatin	MRP1	PA449014	4437	0.802
NULL	Cancers_(Basel)_2013_Oct_23_5(4)_1306-1331.nxml.txt.nlp	24202447	SENT1209	9	9	15	15	temozolomide	p53	PA451609	7157	0.802
NULL	Mol_Cancer_2013_Mar_5_12_17.nxml.txt.nlp	23497256	SENT66	23	23	11	11	sunitinib	p53	PA162372840	7157	0.802
NULL	Pharmacogn_Rev_2013_Jul-Dec_7(14)_157-169.nxml.txt.nlp	24347924	SENT262	27	27	18	18	nystatin	flower	PA450666	11094	0.802
NULL	Acta_Vet_Scand_2011_Feb_22_53(1)_12.nxml.txt.nlp	21342526	SENT6	5	5	35	35	flutamide	PD2	PA449685	54623	0.802
NULL	Nat_Commun_2014_Nov_25_5_5548.nxml.txt.nlp	25420520	SENT391	4	4	13	13	curcumin	HIF-1	PA151958596	29072	0.802
NULL	J_Antimicrob_Chemother_2014_Apr_27_69(4)_907-910.nxml.txt.nlp	24284779	SENT73	26	26	11	11	oxacillin	BSAC	PA450725	57591	0.802
NULL	Mol_Cancer_2012_Jun_18_11_41.nxml.txt.nlp	22709873	SENT328	20	20	12	12	lapatinib	CCND1	PA152241907	595	0.802
NULL	Oncol_Rep_2013_Apr_23_29(4)_1268-1274.nxml.txt.nlp	23354756	SENT113	7	7	17	17	trastuzumab	SLC25A43	PA451743	203427	0.802
NULL	Mol_Cells_2014_Dec_31_37(12)_899a-906.nxml.txt.nlp	25431425	SENT181	0	0	7	7	curcumin	p65	PA151958596	5970	0.802
NULL	Nature_2008_Nov_13_456(7219)_269-273.nxml.txt.nlp	18849969	SENT100	8	8	2	2	resveratrol	SIRT1		23411	0.802
NULL	Lipids_Health_Dis_2011_Jan_18_10_8.nxml.txt.nlp	21241519	SENT116	3	3	11	11	simvastatin	ABCG1	PA451363	9619	0.802
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT167	28	28	16	16	trastuzumab	STAT3	PA451743	6774	0.802
NULL	Br_J_Pharmacol_2008_Dec_25_155(7)_1056-1065.nxml.txt.nlp	18724386	SENT257	39	39	37	37	diazoxide	GLP-1	PA449285	100125288	0.802
NULL	Front_Oncol_2014_Sep_15_4_244.nxml.txt.nlp	25309870	SENT162	20	20	33	33	gemcitabine	EGFR	PA449748	1956	0.802
NULL	Mol_Cancer_2014_Jun_27_13_159.nxml.txt.nlp	24972933	SENT94	7	7	39	39	doxorubicin	BTK	PA449412	695	0.802
NULL	Eur_J_Haematol_2013_Feb_22_90(2)_89-98.nxml.txt.nlp	23181448	SENT177	10	10	17	17	ponatinib	KIT	PA165980594	3815	0.802
NULL	J_Breast_Cancer_2013_Sep_30_16(3)_266-273.nxml.txt.nlp	24155755	SENT146	3	3	21	21	lapatinib	HER2	PA152241907	2064	0.802
NULL	Exp_Cell_Res_2009_Nov_15_315(19)_3433-3441.nxml.txt.nlp	19716819	SENT188	8	8	2	2	hyaluronidase	CD44	PA164745713	960	0.802
NULL	Oncotarget_2014_Feb_3_5(9)_2436-2449.nxml.txt.nlp	24810959	SENT69	14	14	27	27	paraformaldehyde	CD31	PA450790	5175	0.802
NULL	Cancers_(Basel)_2014_Apr_9_6(2)_829-859.nxml.txt.nlp	24722453	SENT192	23	23	5	5	docetaxel	IL-6	PA449383	3569	0.802
NULL	Eur_J_Clin_Microbiol_Infect_Dis_2013_Jun_13_32(6)_745-754.nxml.txt.nlp	23314745	SENT249	13	13	6	6	ribavirin	IL28B	PA451241	282617	0.802
NULL	Core_Evid_2014_Apr_23_9_61-67.nxml.txt.nlp	24790591	SENT53	11	11	25	25	cabozantinib	PC-3	PA165906891	692094	0.802
NULL	Oncotarget_2013_Nov_7_4(12)_2550-2566.nxml.txt.nlp	24334291	SENT20	20	20	32	32	dasatinib	PI3K	PA162372878	5290	0.802
NULL	Nat_Methods_2013_Aug_30_10(8)_768-773.nxml.txt.nlp	23817070	SENT280	27	27	10	10	l-lysine	DDC	PA450280	1644	0.802
NULL	Br_J_Cancer_2010_Jul_13_103(2)_196-200.nxml.txt.nlp	20571495	SENT133	41	41	33	33	sunitinib	EGFR	PA162372840	1956	0.802
NULL	Mol_Biol_Rep_2013_Sep_28_40(10)_5573-5585.nxml.txt.nlp	24078156	SENT19	16	16	11	11	iron	HFE	PA450087	3077	0.802
NULL	Br_J_Cancer_1996_Mar_73(5)_596-602.nxml.txt.nlp	8605092	SENT14	1	1	20	20	doxorubicin	PSN1	PA449412	51251	0.802
NULL	Crit_Care_2006_Dec_7_10(6)_239.nxml.txt.nlp	17169139	SENT72	12	12	6	6	thrombin	PAR1	PA451674	79581;2149	0.802
NULL	Theranostics_2013_Jun_25_3(7)_496-506.nxml.txt.nlp	23843897	SENT33	24	24	8	8	capecitabine	HER-2	PA448771	2064	0.802
NULL	J_Invest_Dermatol_2014_Jan_25_134(1)_268-271.nxml.txt.nlp	23812303	SENT47	9	9	12	12	ustekinumab	p40	PA166048654	3921;339541;10314	0.802
NULL	J_Oncol_2011_Apr_14_2011_853931.nxml.txt.nlp	21559248	SENT189	40	40	22	22	panitumumab	VEGFR1	PA162373091	2321	0.802
NULL	Arthritis_Res_Ther_2012_Dec_3_14(6)_R262.nxml.txt.nlp	23206933	SENT91	22	22	5	5	tocilizumab	IL-6	PA165292659	3569	0.802
NULL	Cases_J_2009_Apr_28_2_6602.nxml.txt.nlp	19829828	SENT67	14	14	20	20	colchicine	CYP3A4	PA449092	1576	0.802
NULL	Acta_Pharmacol_Sin_2010_Jun_4_31(6)_753-758.nxml.txt.nlp	20523346	SENT117	40	40	5	5	quinidine	P-gp	PA451209	5243	0.802
NULL	Target_Oncol_2013_Jun_27_8(2)_127-136.nxml.txt.nlp	23625191	SENT43	34	34	21	21	panitumumab	KRAS	PA162373091	3845	0.802
NULL	Ann_Rheum_Dis_2011_Jun_27_70(9)_1631-1640.nxml.txt.nlp	21708910	SENT192	40	40	35	35	adalimumab	STAR	PA10004	6770;2984	0.802
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1126-1134.nxml.txt.nlp	21364592	SENT118	5	5	15	15	nicotine	CYP2A6	PA450626	1548	0.802
NULL	Cancer_Cell_Int_2009_Sep_10_9_25.nxml.txt.nlp	19744341	SENT172	12	12	35	35	glucosamine	PC-3	PA164747613	692094	0.802
NULL	J_Ophthalmic_Inflamm_Infect_2013_Jan_11_3_8.nxml.txt.nlp	23514541	SENT165	7	7	0	0	atorvastatin	ATV	PA448500	4683	0.802
NULL	JRSM_Cardiovasc_Dis_2012_Sep_24_1(6)_cvd_2012_012015.nxml.txt.nlp	24175073	SENT23	30	30	21	21	clopidogrel	ABCB1	PA449053	5243	0.802
NULL	Clin_Interv_Aging_2009_Jun_29_4_289-303.nxml.txt.nlp	19750231	SENT214	16	16	0	0	alendronate	Men	PA448082	8178	0.802
NULL	J_Biol_Chem_2008_Jun_20_283(25)_17194-17204.nxml.txt.nlp	18442977	SENT149	23	23	16	16	fluoxetine	5-HT1A	PA449673	3350	0.802
NULL	Curr_Neuropharmacol_2012_Jun_10(2)_97-123.nxml.txt.nlp	23204981	SENT754	9	9	17	17	agomelatine	5-HT1A	PA165958363	3350	0.802
NULL	J_Invest_Dermatol_2012_Sep_19_132(9)_2198-2205.nxml.txt.nlp	22513780	SENT116	1	1	25	25	isotretinoin	IL-10	PA450128	3586	0.802
NULL	J_Exp_Med_2000_Nov_20_192(10)_1403-1414.nxml.txt.nlp	11085743	SENT102	14	14	4	4	staurosporine	Bcl-2	PA165109623	596	0.802
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Sep_30_67(Pt_10)_o2750.nxml.txt.nlp	22058808	SENT52	23	23	38	38	ethanol	mol	PA448073	90527	0.802
NULL	Oncol_Lett_2013_Mar_18_5(3)_969-971.nxml.txt.nlp	23426888	SENT83	28	28	9	9	capecitabine	TYMP	PA448771	1890	0.802
NULL	Arthritis_Res_Ther_2010_Oct_28_12(5)_219.nxml.txt.nlp	21062511	SENT140	13	13	22	22	infliximab	IFN	PA452639	3439	0.802
NULL	Evid_Based_Complement_Alternat_Med_2013_Mar_10_2013_203845.nxml.txt.nlp	23554826	SENT197	15	15	8	8	azithromycin	San	PA448519	80218	0.802
NULL	Hum_Mol_Genet_2013_Nov_15_22(22)_4602-4615.nxml.txt.nlp	23814040	SENT144	31	31	21	21	l-cysteine	COX	PA449173	1351	0.802
NULL	Oncogene_2009_Feb_5_28(5)_742-751.nxml.txt.nlp	19043454	SENT117	23	23	30	30	camptothecin	TOP1	PA153590860	7150	0.802
NULL	Environ_Health_Perspect_2006_Jan_20_114(1)_51-58.nxml.txt.nlp	16393658	SENT79	21	21	24	24	fluorescein	CD14	PA164746009	929	0.802
NULL	Curr_Biol_2009_Feb_24_19(4)_297-304.nxml.txt.nlp	19217292	SENT392	20	20	7	7	vasopressin	CLOCK	PA451858	9575	0.802
NULL	Cell_Death_Dis_2014_Feb_13_5(2)_e1055.nxml.txt.nlp	24525731	SENT73	23	23	4	4	irinotecan	XRCC1	PA450085	7515	0.802
NULL	Cell_Commun_Signal_2013_Nov_11_11_86.nxml.txt.nlp	24215724	SENT496	6	6	9	9	thrombin	EGFR	PA451674	1956	0.802
NULL	Br_J_Clin_Pharmacol_2013_Aug_23_76(2)_299-315.nxml.txt.nlp	23701319	SENT150	5	5	16	16	alemtuzumab	IL-5	PA164783958	3567	0.802
NULL	J_Cell_Sci_2013_Sep_1_126(17)_3873-3883.nxml.txt.nlp	23843614	SENT168	10	10	23	23	forskolin	RhoA	PA146096022	387	0.802
NULL	J_Occup_Med_Toxicol_2008_Feb_27_3(Suppl_1)_S6.nxml.txt.nlp	18315837	SENT67	6	6	10	10	salbutamol	IL-5	PA448068	3567	0.802
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_P103.nxml.txt.nlp	NULL	SENT16	27	27	17	17	ampicillin	MDM	PA448419	57152	0.802
NULL	Breast_Cancer_Res_2007_Aug_8_9(4)_R50.nxml.txt.nlp	17686159	SENT40	16	16	8	8	gefitinib	HRG	PA131301952	3084;3273	0.802
NULL	Open_Ophthalmol_J_2010_Jun_22_4_28-29.nxml.txt.nlp	20871754	SENT18	29	29	37	37	ranibizumab	San	PA164746012	80218	0.802
NULL	EJC_Suppl_2013_Sep_5_11(2)_45-59.nxml.txt.nlp	NULL	SENT196	13	13	16	16	irinotecan	CRT	PA450085	811	0.802
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1145.nxml.txt.nlp	24675463	SENT120	20	20	27	27	cetuximab	EGFR	PA10040	1956	0.802
NULL	Cancers_(Basel)_2011_Apr_1_3(2)_1844-1860.nxml.txt.nlp	24212785	SENT55	11	11	27	27	cetuximab	EGFR	PA10040	1956	0.802
NULL	EMBO_Mol_Med_2013_Jul_6_5(7)_905-915.nxml.txt.nlp	23740690	SENT181	6	6	13	13	lipase	CGI-58	PA450239	51099	0.802
NULL	Acta_Pharmacol_Sin_2012_Dec_17_33(12)_1441-1458.nxml.txt.nlp	22983389	SENT368	4	4	26	26	paclitaxel	JNK	PA450761	5599	0.802
NULL	Bioinformation_2012_Jan_6_8(1)_13-19.nxml.txt.nlp	22359429	SENT5	18	18	11	11	curcumin	MRP1	PA151958596	4437	0.802
NULL	J_Cell_Mol_Med_2014_Apr_20_18(4)_709-720.nxml.txt.nlp	24444314	SENT219	0	0	2	2	metformin	AMPK	PA450395	5563	0.802
NULL	J_Cell_Mol_Med_2014_Jan_31_18(1)_59-68.nxml.txt.nlp	24304442	SENT50	26	26	38	38	l-glutamine	CO2	PA10090	4513	0.802
NULL	Cancer_Cell_2007_Dec_11_12(6)_514-527.nxml.txt.nlp	18068629	SENT40	10	10	25	25	paclitaxel	TGFBI	PA450761	7045	0.802
NULL	Pain_Res_Treat_2012_Apr_23_2012_295926.nxml.txt.nlp	22577544	SENT139	24	24	20	20	diclofenac	ARC	PA449293	8996;23237	0.802
NULL	Front_Neurosci_2014_Jan_10_7_270.nxml.txt.nlp	24454277	SENT15	22	22	20	20	resveratrol	SIRT1		23411	0.802
NULL	Oxid_Med_Cell_Longev_2013_Jun_2_2013_793525.nxml.txt.nlp	23819014	SENT247	18	18	34	34	resveratrol	SIRT1		23411	0.802
NULL	Evid_Based_Complement_Alternat_Med_2013_Mar_10_2013_203845.nxml.txt.nlp	23554826	SENT187	15	15	8	8	azithromycin	San	PA448519	80218	0.802
NULL	Oncogene_2010_Sep_16_29(37)_5182-5192.nxml.txt.nlp	20581861	SENT106	6	6	8	8	celecoxib	ATF3	PA448871	467	0.802
NULL	Clinics_(Sao_Paulo)_2013_Feb_68(2)_253-262.nxml.txt.nlp	23525324	SENT221	14	14	8	8	genistein	Gen	PA165109660	348654	0.802
NULL	J_Hematol_Oncol_2009_Jul_30_2_32.nxml.txt.nlp	19642997	SENT94	21	21	32	32	mitoxantrone	GM-CSF	PA450526	1437	0.802
NULL	Anticancer_Agents_Med_Chem_2012_Feb_12(2)_163-171.nxml.txt.nlp	22043994	SENT148	11	11	4	4	cetuximab	KRAS	PA10040	3845	0.802
NULL	Case_Rep_Hematol_2014_Dec_24_2014_460574.nxml.txt.nlp	25610674	SENT4	21	21	14	14	methotrexate	PHL	PA450428	613	0.802
NULL	Int_J_Mol_Sci_2010_Nov_19_11(11)_4741-4749.nxml.txt.nlp	21151468	SENT168	16	16	5	5	cisplatin	CTR2	PA449014	1318	0.802
NULL	Antiviral_Res_2009_May_82(2)_A99-A109.nxml.txt.nlp	19176219	SENT283	19	19	8	8	nelfinavir	P85	PA450606	8874	0.802
NULL	Diabetes_Care_2009_Apr_32(4)_531-540.nxml.txt.nlp	19336638	SENT27	5	5	11	11	thrombin	PAR-1	PA451674	2011;2149	0.802
NULL	J_Occup_Med_Toxicol_2008_Feb_27_3(Suppl_1)_S6.nxml.txt.nlp	18315837	SENT91	7	7	17	17	pranlukast	IL-3	PA134698661	3562	0.802
NULL	Ther_Clin_Risk_Manag_2007_Aug_3(4)_665-673.nxml.txt.nlp	18472989	SENT137	26	26	14	14	lapatinib	EGF	PA152241907	1950	0.802
NULL	Front_Neurol_2010_Jul_12_1_11.nxml.txt.nlp	21206763	SENT83	27	27	25	25	riluzole	GDNF	PA451251	2668	0.802
NULL	J_Breast_Cancer_2011_Mar_31_14(1)_20-27.nxml.txt.nlp	21847390	SENT152	23	23	5	5	estradiol	CLDN6	PA449503	9074	0.802
NULL	Int_J_Mol_Sci_2014_Oct_8_15(10)_17974-17999.nxml.txt.nlp	25299695	SENT358	3	3	0	0	curcumin	HO-1	PA151958596	3162	0.802
NULL	Front_Oncol_2014_Sep_15_4_244.nxml.txt.nlp	25309870	SENT157	18	18	27	27	gefitinib	EGFR	PA131301952	1956	0.802
NULL	J_Infect_Dis_2011_May_1_203(9)_1204-1214.nxml.txt.nlp	21459813	SENT13	0	0	21	21	darunavir	CCR5	PA163522472	1234	0.802
NULL	Mol_Cancer_2010_Aug_20_9_220.nxml.txt.nlp	20727180	SENT38	16	16	21	21	nicotine	p53	PA450626	7157	0.802
NULL	Oncol_Lett_2014_Jun_28_7(6)_2093-2098.nxml.txt.nlp	24932295	SENT68	19	19	11	11	resveratrol	PI3K		5290	0.802
NULL	Indian_J_Pharm_Sci_2014_Jan-Feb_76(1)_72-77.nxml.txt.nlp	24799741	SENT81	20	20	3	3	glipizide	CYP2C9	PA449762	1559	0.802
NULL	Front_Public_Health_2013_Nov_14_1_50.nxml.txt.nlp	24350219	SENT199	15	15	27	27	hydrocortisone	IL-8	PA449905	3576	0.802
NULL	J_Biol_Chem_2013_Oct_11_288(41)_29642-29653.nxml.txt.nlp	24005673	SENT694	13	13	18	18	hyaluronan	HC2	PA165958431	360184;3053;5682	0.802
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1709-1716.nxml.txt.nlp	19844235	SENT225	5	5	2	2	gemcitabine	B7-H3	PA449748	80381	0.802
NULL	Ther_Clin_Risk_Manag_2006_Jun_2(2)_129-158.nxml.txt.nlp	18360588	SENT203	0	0	3	3	sirolimus	CYP3A4	PA451365	1576	0.802
NULL	Cardiovasc_Diabetol_2013_Mar_23_12_48.nxml.txt.nlp	23522121	SENT72	12	12	18	18	exenatide	NNT	PA164749238	23530	0.802
NULL	Eur_J_Clin_Pharmacol_2012_Sep_15_68(9)_1267-1274.nxml.txt.nlp	22418828	SENT32	10	10	7	7	pantoprazole	CYP2C19	PA450774	1557	0.802
NULL	AIDS_Res_Ther_2011_Oct_6_8_36.nxml.txt.nlp	21978457	SENT218	21	21	7	7	zinc	TNF	PA451956	7124	0.802
NULL	Mol_Cell_2014_May_8_54(3)_445-459.nxml.txt.nlp	24746700	SENT476	29	29	12	12	etoposide	BRCA1	PA449552	672	0.802
NULL	EMBO_Mol_Med_2009_May_1(2)_99-111.nxml.txt.nlp	20049710	SENT20	5	5	35	35	nadh	ADP	PA164755085	23038	0.802
NULL	Mol_Cell_Neurosci_2011_Oct_48(2-18)_151-160.nxml.txt.nlp	21803157	SENT67	14	14	27	27	forskolin	IL6	PA146096022	3569	0.802
NULL	Curr_Neuropharmacol_2010_Sep_8(3)_287-304.nxml.txt.nlp	21358978	SENT249	7	7	15	15	agomelatine	5-HT1A	PA165958363	3350	0.802
NULL	Nat_Commun_2012_Dec_11_3_1271.nxml.txt.nlp	23232401	SENT184	2	2	8	8	trastuzumab	HSF1	PA451743	3297	0.802
NULL	Ann_Neurosci_2013_Apr_20(2)_67-70.nxml.txt.nlp	25206016	SENT37	19	19	6	6	tamoxifen	NeuN	PA451581	146713	0.802
NULL	Oncogene_2010_Nov_18_29(46)_6115-6124.nxml.txt.nlp	20729912	SENT81	21	21	18	18	doxorubicin	ABCB5	PA449412	340273	0.802
NULL	Breast_Cancer_Res_2007_Dec_20_9(Suppl_2)_S25.nxml.txt.nlp	NULL	SENT20	8	8	3	3	gefitinib	aromatase	PA131301952	1588	0.802
NULL	Hum_Genomics_2008_Sep_1_3(1)_7-16.nxml.txt.nlp	19129086	SENT174	26	26	17	17	pioglitazone	SLCO1B1	PA450970	10599	0.802
NULL	EMBO_Mol_Med_2012_Apr_4(4)_298-312.nxml.txt.nlp	22331558	SENT263	11	11	18	18	mi-63	p53		7157	0.802
NULL	J_Cell_Mol_Med_2014_Aug_1_18(8)_1599-1611.nxml.txt.nlp	24889822	SENT188	0	0	2	2	resveratrol	SIRT1		23411	0.802
NULL	Eur_J_Neurosci_2008_Jun_27(11)_2783-2802.nxml.txt.nlp	18588525	SENT715	20	20	14	14	potassium	CB1	PA451047	1268	0.802
NULL	J_Invest_Dermatol_2013_Jul_13_133(7)_1742-1751.nxml.txt.nlp	23407402	SENT109	13	13	29	29	ustekinumab	TREM-1	PA166048654	54210	0.802
NULL	Endocrine_2012_Dec_14_42(3)_622-636.nxml.txt.nlp	22695986	SENT66	16	16	14	14	forskolin	PTH	PA146096022	5741	0.802
NULL	J_Brachial_Plex_Peripher_Nerve_Inj_2008_Mar_19_3_8.nxml.txt.nlp	18353188	SENT211	6	6	14	14	capsaicin	SSeCKS	PA448776	9590	0.802
NULL	Clin_Dev_Immunol_2011_Mar_28_2011_370872.nxml.txt.nlp	21461372	SENT7	9	9	17	17	doxycycline	IL-6	PA449415	3569	0.802
NULL	Eur_J_Med_Res_2011_Apr_28_16(4)_180-186.nxml.txt.nlp	21486732	SENT151	8	8	12	12	anidulafungin	DAC	PA164742938	13	0.802
NULL	Infect_Agent_Cancer_2009_Jun_17_4(Suppl_2)_O9.nxml.txt.nlp	NULL	SENT3	3	3	16	16	rituximab	CD4	PA451261	920	0.802
NULL	Cancer_Immunol_Immunother_2012_Jul_23_61(7)_1101-1111.nxml.txt.nlp	22193989	SENT91	34	34	15	15	oxaliplatin	TLR3	PA131285527	7098	0.802
NULL	Biomed_Res_Int_2013_Aug_6_2013_602987.nxml.txt.nlp	24027759	SENT272	14	14	18	18	paclitaxel	SMF	PA450761	22993	0.802
NULL	Mol_Cancer_2009_Nov_10_8_99.nxml.txt.nlp	19903356	SENT42	37	37	27	27	imatinib	IGFBP3	PA10804	3486	0.802
NULL	Mol_Cell_2014_May_8_54(3)_445-459.nxml.txt.nlp	24746700	SENT135	11	11	19	19	etoposide	BRCA1	PA449552	672	0.802
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_4_2013_542081.nxml.txt.nlp	23861706	SENT72	14	14	4	4	isoflurane	FDG	PA450106	23583	0.802
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_127043.nxml.txt.nlp	23227093	SENT170	20	20	9	9	lovastatin	P-gp	PA450272	5243	0.802
NULL	Br_J_Cancer_2009_May_19_100(10)_1581-1588.nxml.txt.nlp	19401694	SENT165	31	31	22	22	methotrexate	GALT	PA450428	2592	0.802
NULL	Acta_Pharmacol_Sin_2012_Jan_3_33(1)_49-56.nxml.txt.nlp	22212430	SENT183	19	19	0	0	thrombin	A10	PA451674	28870	0.802
NULL	J_Korean_Med_Sci_2011_Aug_27_26(8)_1007-1013.nxml.txt.nlp	21860550	SENT28	26	26	18	18	tamoxifen	CYP2D6	PA451581	1565	0.802
NULL	J_Occup_Med_Toxicol_2008_Feb_27_3(Suppl_1)_S6.nxml.txt.nlp	18315837	SENT94	4	4	14	14	montelukast	IFN	PA450546	3439	0.802
NULL	Oncotarget_2012_Dec_17_4(1)_48-63.nxml.txt.nlp	23295955	SENT187	36	36	2	2	cisplatin	MTHFD2	PA449014	10797	0.802
NULL	Pharmaceuticals_(Basel)_2013_Nov_4_6(11)_1361-1380.nxml.txt.nlp	24287462	SENT733	10	10	16	16	cisplatin	HER2	PA449014	2064	0.802
NULL	Chem_Cent_J_2013_Sep_16_7_156.nxml.txt.nlp	24041151	SENT70	27	27	5	5	oxygen	LPP	PA450744	4026	0.802
NULL	Indian_J_Pharm_Sci_2013_Jan-Feb_75(1)_94-98.nxml.txt.nlp	23901167	SENT87	34	34	17	17	omeprazole	CYP1A2	PA450704	1544	0.802
NULL	Mol_Cancer_2010_May_26_9_123.nxml.txt.nlp	20504344	SENT153	34	34	19	19	fludarabine	p53	PA449655	7157	0.802
NULL	Acta_Pharmacol_Sin_2010_Dec_3_31(12)_1635-1642.nxml.txt.nlp	21127497	SENT155	7	7	10	10	fluconazole	UGT	PA449653	7361;7355	0.802
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT18	11	11	6	6	pp2	PP2		4888	0.802
NULL	ACS_Med_Chem_Lett_2011_May_16_2(7)_549-554.nxml.txt.nlp	21765967	SENT94	27	27	20	20	maraviroc	CCR5	PA164768835	1234	0.802
NULL	Tuberc_Respir_Dis_(Seoul)_2013_Mar_29_74(3)_129-133.nxml.txt.nlp	23579627	SENT27	14	14	18	18	gefitinib	EGFR	PA131301952	1956	0.802
NULL	Neuro_Oncol_2010_Apr_27_12(4)_389-400.nxml.txt.nlp	20308316	SENT19	4	4	21	21	chloroquine	p53	PA448948	7157	0.802
NULL	Oncol_Rep_2013_Apr_31_29(4)_1275-1284.nxml.txt.nlp	23381931	SENT218	7	7	14	14	riluzole	GRM1	PA451251	2911	0.802
NULL	Front_Cell_Neurosci_2013_Aug_29_7_130.nxml.txt.nlp	24009554	SENT164	20	20	11	11	pilocarpine	NPY	PA450962	4852	0.802
NULL	Case_Rep_Surg_2012_Sep_17_2012_230538.nxml.txt.nlp	23024879	SENT30	45	45	25	25	vancomycin	CHOP	PA451850	1649	0.802
NULL	Biomed_Res_Int_2014_Jun_25_2014_764981.nxml.txt.nlp	25057499	SENT157	20	20	38	38	sorafenib	Met	PA7000	79811	0.801
NULL	Cancer_Causes_Control_2013_Aug_18_24(8)_1605-1614.nxml.txt.nlp	23775025	SENT64	33	33	12	12	doxorubicin	CYP2C9	PA449412	1559	0.801
NULL	Iran_J_Basic_Med_Sci_2013_Jan_16(1)_91-100.nxml.txt.nlp	23638297	SENT141	9	9	19	19	scopolamine	EPM	PA451308	2054	0.801
NULL	Hum_Mol_Genet_2012_Jul_1_21(13)_2845-2854.nxml.txt.nlp	22434822	SENT218	29	29	16	16	l-glutamine	B27	PA10090	56246	0.801
NULL	Cancers_(Basel)_2011_Apr_1_3(2)_1844-1860.nxml.txt.nlp	24212785	SENT579	23	23	2	2	cetuximab	PTEN	PA10040	5728	0.801
NULL	J_Biol_Chem_2013_Nov_15_288(46)_33049-33059.nxml.txt.nlp	24089524	SENT675	3	3	14	14	nicotine	XIAP	PA450626	331	0.801
NULL	Int_J_Endocrinol_Metab_2012_Sep_30_Autumn_10(4)_646-647.nxml.txt.nlp	23843842	SENT16	10	10	28	28	raloxifene	PTH	PA451221	5741	0.801
NULL	Oncol_Lett_2014_May_6_7(5)_1695-1700.nxml.txt.nlp	24765203	SENT51	17	17	26	26	fluorescein	CD34	PA164746009	947	0.801
NULL	Acta_Pharmacol_Sin_2013_Jul_5_34(7)_939-950.nxml.txt.nlp	23603982	SENT291	13	13	18	18	curcumin	NAC	PA151958596	22861	0.801
NULL	Arthritis_Res_Ther_2003_Dec_2_5(Suppl_4)_S12-S16.nxml.txt.nlp	15180892	SENT75	20	20	32	32	cyclophosphamide	CHOP	PA449165	1649	0.801
NULL	Nat_Chem_Biol_2009_Jan_23_5(1)_37-44.nxml.txt.nlp	19029917	SENT68	18	18	5	5	lipase	CB1	PA450239	1268	0.801
NULL	Adv_Hematol_2012_Mar_8_2012_856341.nxml.txt.nlp	22496694	SENT149	17	17	27	27	enoxaparin	TKR	PA449463	8277	0.801
NULL	Pain_2011_Aug_152(8)_1899-1908.nxml.txt.nlp	21600693	SENT492	11	11	35	35	capsaicin	ADP	PA448776	23038	0.801
NULL	Acta_Pharmacol_Sin_2009_Jul_22_30(7)_956-964.nxml.txt.nlp	19543298	SENT172	22	22	6	6	simvastatin	ABCC2	PA451363	1244	0.801
NULL	Clin_Interv_Aging_2015_Jan_14_10_269-275.nxml.txt.nlp	25609939	SENT77	8	8	18	18	sertraline	CYP2D6	PA451333	1565	0.801
NULL	Breast_Cancer_Res_2007_Oct_26_9(5)_112.nxml.txt.nlp	17980056	SENT91	41	41	43	43	lapatinib	aromatase	PA152241907	1588	0.801
NULL	Breast_Cancer_Res_2009_Nov_18_11(6)_R85.nxml.txt.nlp	19922614	SENT103	25	25	33	33	tamoxifen	BCS	PA451581	617	0.801
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT8	26	26	9	9	heparin	FGF1	PA449855	2246	0.801
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1150.nxml.txt.nlp	24675468	SENT8	2	2	38	38	ethanol	Bcl-2	PA448073	596	0.801
NULL	Br_J_Cancer_2012_Apr_24_106(9)_1543-1550.nxml.txt.nlp	22531721	SENT81	34	34	26	26	trastuzumab	CD59	PA451743	966	0.801
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT158	3	3	5	5	perifosine	DR5	PA165291471	8795	0.801
NULL	Biomed_Res_Int_2014_Jan_20_2014_948427.nxml.txt.nlp	24563867	SENT39	13	13	6	6	glucose	STZ	PA449773	6484	0.801
NULL	Clin_Drug_Investig_2013_Aug_23_33(10)_727-736.nxml.txt.nlp	23975654	SENT180	46	46	21	21	bupropion	CYP2D6	PA448687	1565	0.801
NULL	Ann_Oncol_2013_Nov_12_24(11)_2892-2897.nxml.txt.nlp	24030098	SENT73	13	13	7	7	vincristine	CHOP	PA451879	1649	0.801
NULL	Thorax_2012_Sep_11_67(9)_796-803.nxml.txt.nlp	22496351	SENT110	17	17	3	3	bleomycin	TRAIL	PA448645	8743	0.801
NULL	Front_Neurosci_2013_Jul_31_7_120.nxml.txt.nlp	23914151	SENT179	8	8	26	26	choline	B12	PA448976	7126;4709	0.801
NULL	Clin_Interv_Aging_2014_Nov_18_9_1963-1980.nxml.txt.nlp	25429208	SENT125	1	1	9	9	metformin	DPP4	PA450395	1803	0.801
NULL	Nucleic_Acids_Res_2008_Feb_26_36(2)_435-443.nxml.txt.nlp	18039708	SENT128	13	13	38	38	hyaluronan	SP1	PA165958431	6667	0.801
NULL	Nat_Biotechnol_2010_Mar_14_28(3)_249-255.nxml.txt.nlp	20160716	SENT168	28	28	3	3	deferoxamine	HIF-1	PA164746490	29072	0.801
NULL	Br_J_Cancer_2012_Jun_5_106(12)_1997-2003.nxml.txt.nlp	22596232	SENT8	12	12	17	17	sorafenib	JNK	PA7000	5599	0.801
NULL	Core_Evid_2010_Oct_21_5_61-76.nxml.txt.nlp	21042543	SENT366	2	2	29	29	panitumumab	KRAS	PA162373091	3845	0.801
NULL	Front_Immunol_2012_May_16_3_118.nxml.txt.nlp	22623923	SENT1613	11	11	19	19	infliximab	IL-6	PA452639	3569	0.801
NULL	Evid_Based_Complement_Alternat_Med_2013_May_27_2013_582493.nxml.txt.nlp	23781264	SENT41	15	15	4	4	ethanol	CO2	PA448073	4513	0.801
NULL	Adv_Hematol_2012_Nov_20_2012_861060.nxml.txt.nlp	23251161	SENT70	0	0	23	23	lenalidomide	IL-2	PA162363968	3558	0.801
NULL	Cell_Div_2012_Dec_26_7_26.nxml.txt.nlp	23268747	SENT114	0	0	29	29	bortezomib	CDK2	PA10252	1017	0.801
NULL	J_Immunother_Cancer_2013_Jun_27_1_8.nxml.txt.nlp	24829746	SENT223	10	10	5	5	gemcitabine	CD40	PA449748	958	0.801
NULL	Gene_Regul_Syst_Bio_2014_Mar_4_8_63-73.nxml.txt.nlp	24634581	SENT116	10	10	5	5	minocycline	NANOS1	PA450519	340719	0.801
NULL	Nat_Med_2011_Dec_4_18(1)_111-119.nxml.txt.nlp	22138751	SENT94	22	22	31	31	doxycycline	WT1	PA449415	7490	0.801
NULL	J_Carcinog_2014_Nov_27_13_13.nxml.txt.nlp	25525412	SENT76	5	5	11	11	cetuximab	KRAS	PA10040	3845	0.801
NULL	Clin_Exp_Reprod_Med_2013_Sep_30_40(3)_115-121.nxml.txt.nlp	24179868	SENT27	5	5	7	7	letrozole	aromatase	PA450196	1588	0.801
NULL	Asian_Spine_J_2008_Dec_31_2(2)_109-113.nxml.txt.nlp	20404966	SENT91	0	0	13	13	gefitinib	RANKL	PA131301952	8600	0.801
NULL	Breast_Cancer_Res_2008_May_12_10(3)_R43.nxml.txt.nlp	18471300	SENT134	2	2	17	17	estradiol	p53	PA449503	7157	0.801
NULL	Pharmaceutics_2011_Aug_24_3(3)_510-524.nxml.txt.nlp	24310594	SENT107	0	0	27	27	trastuzumab	HER-2	PA451743	2064	0.801
NULL	Mar_Drugs_2014_Jun_27_12(7)_3818-3837.nxml.txt.nlp	24979269	SENT209	23	23	33	33	mitoxantrone	MRP1	PA450526	4437	0.801
NULL	Asia_Pac_Allergy_2013_Jul_30_3(3)_194-199.nxml.txt.nlp	23956966	SENT75	2	2	8	8	methacholine	STAT6	PA165958382	6778	0.801
NULL	Front_Aging_Neurosci_2011_May_20_3_7.nxml.txt.nlp	21647396	SENT3458	0	0	16	16	milnacipran	CA1	PA164752812	759	0.801
NULL	Channels_(Austin)_2010_Jan_1_4(1)_22-41.nxml.txt.nlp	19934650	SENT14	8	8	6	6	quinidine	Slo3	PA451209	157855	0.801
NULL	Pain_2014_Nov_155(11)_2243-2252.nxml.txt.nlp	24978826	SENT280	3	3	8	8	propofol	TRPV1	PA451141	7442	0.801
NULL	Nat_Commun_2011_Jul_5_2_380.nxml.txt.nlp	21730960	SENT188	40	40	15	15	pentazocine	PGRMC1	PA164744326	10857	0.801
NULL	Neural_Plast_2007_Jan_1_2007_30585.nxml.txt.nlp	25148070	SENT4563	22	22	12	12	urokinase	UPAR	PA451836	5329	0.801
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT369	14	14	0	0	resveratrol	TNF		7124	0.801
NULL	J_Gen_Physiol_2003_Mar_121(3)_181-197.nxml.txt.nlp	12601083	SENT127	6	6	15	15	forskolin	GLP-1	PA146096022	100125288	0.801
NULL	Pharmaceuticals_(Basel)_2013_Nov_11_6(11)_1407-1428.nxml.txt.nlp	24287464	SENT215	24	24	4	4	alvespimycin	Hsp90	PA165291491	3320	0.801
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT263	20	20	12	12	heparin	FGF1	PA449855	2246	0.801
NULL	Int_J_Endocrinol_2014_Mar_12_2014_847827.nxml.txt.nlp	24744784	SENT142	6	6	0	0	geldanamycin	TLR4	PA152031327	7099	0.801
NULL	EPMA_J_2010_Sep_22_1(3)_377-387.nxml.txt.nlp	23199082	SENT129	17	17	3	3	doxorubicin	HER2	PA449412	2064	0.801
NULL	Virol_J_2011_May_17_8_234.nxml.txt.nlp	21575275	SENT102	14	14	11	11	ribavirin	IFN	PA451241	3439	0.801
NULL	Neurosci_Biobehav_Rev_2010_Jan_34(1-3)_50-72.nxml.txt.nlp	19615404	SENT312	9	9	4	4	ketanserin	5-HT2A	PA131053734	3356	0.801
NULL	Alcohol_Res_2012_34(4)_459-467.nxml.txt.nlp	23584112	SENT105	15	15	30	30	naloxone	ACTH	PA450586	5443	0.801
NULL	Crit_Care_2006_Feb_3_10(1)_R24.nxml.txt.nlp	16469128	SENT195	19	19	27	27	heparin	MARS	PA449855	4141	0.801
NULL	Biomed_Res_Int_2014_May_12_2014_484731.nxml.txt.nlp	24900967	SENT40	19	19	15	15	l-glutamine	B27	PA10090	56246	0.801
NULL	Nat_Commun_2013_Sep_20_4_2444.nxml.txt.nlp	24051492	SENT136	7	7	15	15	nutlin-3	p53		7157	0.801
NULL	Mol_Cancer_2012_Sep_25_11_73.nxml.txt.nlp	23009336	SENT143	20	20	0	0	dasatinib	EGFR	PA162372878	1956	0.801
NULL	J_Hematol_Oncol_2013_Jan_15_6_5.nxml.txt.nlp	23320987	SENT123	24	24	26	26	heparin	PI-PLC	PA449855	2923	0.801
NULL	J_Immunol_Res_2014_Jul_16_2014_240396.nxml.txt.nlp	25133193	SENT197	14	14	40	40	mannitol	TRB3	PA450320	50838;57761	0.801
NULL	Biologics_2009_Jul_13_3_289-301.nxml.txt.nlp	19707416	SENT81	25	25	14	14	trastuzumab	HER2	PA451743	2064	0.801
NULL	Clin_Med_Insights_Oncol_2013_Aug_19_7_209-219.nxml.txt.nlp	24179412	SENT83	26	26	30	30	thalidomide	BTD	PA451644	686	0.801
NULL	Breast_Cancer_Res_2006_Jun_15_8(3)_R28.nxml.txt.nlp	16776850	SENT178	17	17	13	13	urokinase	HER-2	PA451836	2064	0.801
NULL	Oncotarget_2013_Dec_28_5(6)_1475-1490.nxml.txt.nlp	24721996	SENT225	6	6	29	29	celecoxib	PTEN	PA448871	5728	0.801
NULL	Int_Endod_J_2011_Dec_44(12)_1145-1154.nxml.txt.nlp	21902700	SENT46	7	7	13	13	ethanol	HEMA	PA448073	2157	0.801
NULL	Case_Rep_Ophthalmol_Med_2013_Sep_12_2013_213124.nxml.txt.nlp	24109538	SENT46	17	17	11	11	erlotinib	EGFR	PA134687924	1956	0.801
NULL	J_Biol_Chem_2013_Dec_6_288(49)_35387-35395.nxml.txt.nlp	24142790	SENT152	3	3	19	19	meclizine	PCYT2	PA450338	5833	0.801
NULL	Oncotarget_2012_Nov_17_4(1)_18-28.nxml.txt.nlp	23248157	SENT142	3	3	32	32	pargyline	U87	PA450797	677775;641648	0.801
NULL	Oncotarget_2014_Jun_7_5(14)_5257-5271.nxml.txt.nlp	24913448	SENT104	35	35	12	12	nilotinib	LASP1	PA165958345	3927	0.801
NULL	Acta_Pharmacol_Sin_2009_May_5_30(5)_530-536.nxml.txt.nlp	19417732	SENT63	34	34	22	22	fluorescein	CD34	PA164746009	947	0.801
NULL	Cancers_(Basel)_2014_Apr_16_6(2)_926-957.nxml.txt.nlp	24743778	SENT337	0	0	4	4	curcumin	STAT3	PA151958596	6774	0.801
NULL	Contemp_Oncol_(Pozn)_2012_Jul_6_16(3)_223-229.nxml.txt.nlp	23788884	SENT78	0	0	11	11	metformin	AMPK	PA450395	5563	0.801
NULL	Curr_Neuropharmacol_2012_Mar_10(1)_49-52.nxml.txt.nlp	22942877	SENT39	2	2	12	12	sibutramine	ARC	PA451344	8996;23237	0.801
NULL	Cancer_Cell_Int_2004_Aug_17_4_5.nxml.txt.nlp	15315711	SENT11	12	12	33	33	genistein	PC3	PA165109660	57332;7832;5122	0.801
NULL	Clin_Med_Insights_Oncol_2013_Jul_4_7_159-163.nxml.txt.nlp	23885182	SENT86	13	13	46	46	doxorubicin	CHOP	PA449412	1649	0.801
NULL	Case_Rep_Med_2009_Aug_4_2009_148795.nxml.txt.nlp	19721708	SENT69	32	32	7	7	lansoprazole	CCS	PA450180	9973	0.801
NULL	Int_J_Gen_Med_2011_Apr_12_4_299-311.nxml.txt.nlp	21556316	SENT151	6	6	12	12	ethanol	TLR4	PA448073	7099	0.801
NULL	Curr_Neuropharmacol_2008_Jun_6(2)_151-163.nxml.txt.nlp	19305794	SENT279	14	14	11	11	capsaicin	TRPV1	PA448776	7442	0.801
NULL	Cancer_Cell_Int_2006_Mar_23_6_6.nxml.txt.nlp	16556298	SENT118	0	0	10	10	tamoxifen	FDG	PA451581	23583	0.801
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT45	17	17	1	1	pertuzumab	HER-2		2064	0.801
NULL	Exp_Diabetes_Res_2012_Oct_26_2012_820989.nxml.txt.nlp	22110480	SENT176	3	3	8	8	rosiglitazone	LYRM1	PA451283	57149	0.801
NULL	Brain_Behav_2013_Mar_6_3(2)_114-133.nxml.txt.nlp	23533150	SENT197	26	26	9	9	ethanol	Hsp40	PA448073	3337	0.801
NULL	Biochimie_2011_Oct_93(10)_1747-1754.nxml.txt.nlp	21703329	SENT44	20	20	17	17	galactose	GALE	PA449725	2582	0.801
NULL	J_Cardiothorac_Surg_2011_Feb_8_6_14.nxml.txt.nlp	21303502	SENT136	15	15	18	18	pentoxifylline	CO2	PA450864	4513	0.801
NULL	Breast_Cancer_Res_2012_Mar_14_14(2)_R45.nxml.txt.nlp	22417809	SENT359	31	31	20	20	tamoxifen	EGFR	PA451581	1956	0.801
NULL	Angiogenesis_2013_Apr_10_16(2)_373-386.nxml.txt.nlp	23143659	SENT44	10	10	28	28	etoposide	LDM	PA449552	1595	0.801
NULL	Arthritis_Res_Ther_2009_Feb_23_11(1)_216.nxml.txt.nlp	19291269	SENT107	20	20	35	35	etanercept	ACR	PA449515	49	0.801
NULL	Int_J_Mol_Sci_2012_Apr_16_13(4)_4831-4838.nxml.txt.nlp	22606012	SENT40	1	1	13	13	curcumin	p65	PA151958596	5970	0.801
NULL	Mol_Cancer_2014_Jun_19_13_154.nxml.txt.nlp	24941944	SENT13	35	35	21	21	dacarbazine	NRAS	PA449197	4893	0.801
NULL	Cancer_Metab_2013_Aug_14_1_18.nxml.txt.nlp	24280377	SENT80	18	18	31	31	creatine	ADP	PA164778930	23038	0.801
NULL	Mol_Cancer_2014_Jan_28_13_17.nxml.txt.nlp	24472312	SENT219	5	5	16	16	ponatinib	FGFR1	PA165980594	2260	0.801
NULL	Oncotarget_2014_Aug_29_5(18)_8052-8082.nxml.txt.nlp	25211298	SENT456	7	7	17	17	sertraline	AKT	PA451333	207	0.801
NULL	Mol_Pain_2012_Sep_22_8_71.nxml.txt.nlp	22998838	SENT164	31	31	9	9	paclitaxel	CXCR4	PA450761	7852	0.801
NULL	Mol_Cancer_2014_Jun_19_13_154.nxml.txt.nlp	24941944	SENT13	35	35	23	23	dacarbazine	BRAF	PA449197	673	0.801
NULL	Breast_Cancer_(Auckl)_2009_Sep_2_3_61-75.nxml.txt.nlp	19809577	SENT236	6	6	2	2	curcumin	BRCA1	PA151958596	672	0.801
NULL	Eur_J_Haematol_2014_Nov_28_93(5)_369-376.nxml.txt.nlp	24797664	SENT20	30	30	36	36	thrombin	VWF	PA451674	7450	0.801
NULL	J_Gastroenterol_2013_Mar_9_48(3)_382-390.nxml.txt.nlp	22875473	SENT201	10	10	3	3	ribavirin	IL28B	PA451241	282617	0.801
NULL	Cardiovasc_Diabetol_2013_Mar_4_12_42.nxml.txt.nlp	23452502	SENT228	5	5	8	8	isoflurane	GLP1	PA450106	100125288;2641	0.801
NULL	Front_Endocrinol_(Lausanne)_2013_Jun_10_4_69.nxml.txt.nlp	23772224	SENT953	4	4	12	12	metformin	ghrelin	PA450395	51738	0.801
NULL	Breast_Cancer_Res_2008_Dec_5_10(6)_R104.nxml.txt.nlp	19061505	SENT230	26	26	2	2	estradiol	c-Jun	PA449503	3725	0.801
NULL	Cancer_Cell_Int_2004_Mar_19_4_3.nxml.txt.nlp	15035672	SENT77	0	0	6	6	camptothecin	PC-3	PA153590860	692094	0.801
NULL	Braz_J_Med_Biol_Res_2012_Sep_21_45(12)_1240-1243.nxml.txt.nlp	22983178	SENT68	25	25	19	19	indomethacin	DIP	PA449982	23151;1831	0.801
NULL	Mol_Syst_Biol_2010_Feb_16_6_347.nxml.txt.nlp	20160708	SENT83	30	30	23	23	doxycycline	TRF2	PA449415	7014;9519	0.801
NULL	Biosci_Rep_2012_Aug_1_32(Pt_4)_361-374.nxml.txt.nlp	22762204	SENT156	12	12	3	3	trastuzumab	PTEN	PA451743	5728	0.801
NULL	Breast_Cancer_Res_2004_Oct_6_6(6)_262-268.nxml.txt.nlp	15535857	SENT148	12	12	43	43	tamoxifen	aromatase	PA451581	1588	0.801
NULL	J_Breast_Cancer_2013_Jun_28_16(2)_164-170.nxml.txt.nlp	23843848	SENT111	2	2	12	12	doxorubicin	PTEN	PA449412	5728	0.801
NULL	Infection_2013_Sep_14_41(Suppl_2)_91-115.nxml.txt.nlp	24037688	SENT142	2	2	28	28	pentamidine	G6PD	PA450850	2539	0.801
NULL	Mol_Microbiol_2014_Mar_23_91(5)_918-934.nxml.txt.nlp	24372851	SENT16	1	1	36	36	artemisinin	ACT	PA165111696	12;11332;9457;641455	0.801
NULL	Iran_J_Pharm_Res_2015_Winter_14(1)_279-289.nxml.txt.nlp	25561934	SENT169	25	25	31	31	isoproterenol	ANOVA	PA450121	4858	0.801
NULL	Oncotarget_2012_May_9_3(4)_490-501.nxml.txt.nlp	22577154	SENT126	10	10	22	22	decitabine	BCL2L10	PA164749631	10017	0.801
NULL	Endocrinology_2011_Feb_5_152(2)_405-413.nxml.txt.nlp	21209017	SENT156	5	5	16	16	glucosamine	GLP-1	PA164747613	100125288	0.801
NULL	J_Res_Med_Sci_2011_Jun_16(6)_814-820.nxml.txt.nlp	22091312	SENT66	2	2	4	4	cyclophosphamide	CTX	PA449165	1593	0.801
NULL	Br_J_Cancer_2012_Jul_24_107(3)_516-526.nxml.txt.nlp	22782351	SENT299	36	36	20	20	tamoxifen	BRCA1	PA451581	672	0.801
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT611	11	11	5	5	metformin	HIF-1	PA450395	29072	0.801
NULL	J_Cardiothorac_Surg_2014_May_9_9_81.nxml.txt.nlp	24885948	SENT176	11	11	24	24	sorafenib	GATA4	PA7000	2626	0.801
NULL	J_Mol_Signal_2011_Aug_12_6_9.nxml.txt.nlp	21838893	SENT292	6	6	18	18	formoterol	SSTR5	PA134687907	6755	0.801
NULL	Indian_J_Pharm_Sci_2013_Nov-Dec_75(6)_680-687.nxml.txt.nlp	24591743	SENT38	6	6	14	14	gemfibrozil	CYP2C8	PA449750	1558	0.801
NULL	Front_Genet_2012_Nov_2_3_229.nxml.txt.nlp	23130019	SENT45	21	21	7	7	tamoxifen	CYP3A	PA451581	1574	0.801
NULL	Mol_Cancer_2009_Nov_27_8_111.nxml.txt.nlp	19943940	SENT42	14	14	36	36	l-glutamine	CO2	PA10090	4513	0.801
NULL	J_Korean_Assoc_Oral_Maxillofac_Surg_2014_Dec_26_40(6)_291-296.nxml.txt.nlp	25551094	SENT134	2	2	6	6	alendronate	OPG	PA448082	690	0.801
NULL	Environ_Monit_Assess_2014_Jul_5_186(10)_6505-6520.nxml.txt.nlp	24994617	SENT31	7	7	20	20	oxygen	Bravo	PA450744	4897	0.801
NULL	J_Cachexia_Sarcopenia_Muscle_2011_Dec_8_2(4)_209-261.nxml.txt.nlp	22476871	SENT95	6	6	0	0	resveratrol	SIRT1		23411	0.801
NULL	Sci_Rep_2015_Jan_19_5_7830.nxml.txt.nlp	25597938	SENT366	1	1	11	11	triamcinolone	IL-6	PA451749	3569	0.801
NULL	Cardiovasc_Ther_2009_27(4)_259-274.nxml.txt.nlp	19604248	SENT132	21	21	1	1	ticagrelor	IPA	PA165374673	3160	0.801
NULL	Iran_J_Pharm_Res_2014_Summer_13(3)_919-926.nxml.txt.nlp	25276192	SENT28	15	15	24	24	doxorubicin	p53	PA449412	7157	0.801
NULL	Breast_Cancer_Res_Treat_2014_Mar_2_144(2)_371-378.nxml.txt.nlp	24584875	SENT235	4	4	17	17	tamoxifen	ATAC	PA451581	6375	0.801
NULL	Mol_Cancer_2010_Aug_20_9_220.nxml.txt.nlp	20727180	SENT152	40	40	7	7	curcumin	p53	PA151958596	7157	0.801
NULL	Oncol_Lett_2014_Sep_19_8(3)_1269-1274.nxml.txt.nlp	25120704	SENT46	41	41	14	14	ethanol	Met	PA448073	79811	0.801
NULL	Cell_Death_Dis_2013_Oct_3_4(10)_e828.nxml.txt.nlp	24091671	SENT271	28	28	11	11	cetuximab	CD54	PA10040	3383	0.801
NULL	Case_Rep_Oncol_2013_Jan_29_6(1)_72-77.nxml.txt.nlp	23466899	SENT52	13	13	3	3	gemcitabine	GTX	PA449748	84504	0.801
NULL	Breast_Cancer_Res_Treat_2014_Nov_24_143(1)_125-133.nxml.txt.nlp	24272078	SENT183	9	9	15	15	exemestane	aromatase	PA449563	1588	0.801
NULL	Cancers_(Basel)_2014_Mar_25_6(2)_663-683.nxml.txt.nlp	24670367	SENT898	0	0	20	20	tocilizumab	IL-6	PA165292659	3569	0.801
NULL	Oncotarget_2011_Mar_10_2(3)_186-196.nxml.txt.nlp	21406729	SENT177	28	28	11	11	streptomycin	FBS	PA451512	64319;26269	0.801
NULL	Genome_Announc_2014_Oct_16_2(5)_e01017-14.nxml.txt.nlp	25323711	SENT21	18	18	6	6	pyrazinamide	DST	PA451182	667	0.801
NULL	Carcinogenesis_2012_Nov_8_33(11)_2007-2017.nxml.txt.nlp	22822097	SENT859	11	11	5	5	mitoxantrone	MDM2	PA450526	4193	0.801
NULL	Case_Rep_Hematol_2014_Dec_11_2014_743856.nxml.txt.nlp	25580315	SENT38	28	28	26	26	etoposide	CHOP	PA449552	1649	0.801
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1890-1904.nxml.txt.nlp	25268161	SENT67	11	11	14	14	thrombin	KLK4	PA451674	9622	0.801
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S272-S275.nxml.txt.nlp	21525467	SENT144	0	0	6	6	liraglutide	GLP-1	PA165958364	100125288	0.801
NULL	Int_J_Nanomedicine_2012_Sep_13_7_4917-4926.nxml.txt.nlp	23028220	SENT136	31	31	22	22	calcein	mol	PA132595336	90527	0.801
NULL	AIDS_Res_Treat_2012_Mar_5_2012_703604.nxml.txt.nlp	22500218	SENT106	5	5	14	14	artesunate	UGT	PA165111697	7361;7355	0.801
NULL	Antimicrob_Agents_Chemother_2014_Dec_58(12)_7340-7346.nxml.txt.nlp	25267661	SENT202	26	26	9	9	primaquine	CYP2C19	PA451103	1557	0.801
NULL	Arthritis_Res_Ther_2006_Feb_28_8(2)_R49.nxml.txt.nlp	16507174	SENT39	18	18	22	22	fluorescein	CD40	PA164746009	958	0.801
NULL	Clin_Pharmacol_2010_Jun_22_2_105-110.nxml.txt.nlp	22291493	SENT14	11	11	14	14	sibutramine	GNB3	PA451344	2784	0.801
NULL	Cancers_(Basel)_2011_Mar_3_3(1)_1042-1080.nxml.txt.nlp	24212653	SENT427	10	10	8	8	trastuzumab	VEGFR	PA451743	3791	0.801
NULL	Gut_2011_Feb_4_60(2)_166-176.nxml.txt.nlp	21205878	SENT169	30	30	25	25	tamoxifen	RBP-J	PA451581	3516	0.801
NULL	Arch_Med_Sci_2013_Jun_20_9(3)_479-486.nxml.txt.nlp	23847670	SENT178	19	19	27	27	cisplatin	fractalkine	PA449014	6376	0.801
NULL	EJC_Suppl_2013_Sep_5_11(2)_3-22.nxml.txt.nlp	NULL	SENT894	21	21	13	13	cisplatin	HER2	PA449014	2064	0.801
NULL	Exp_Diabetes_Res_2012_Dec_26_2012_230624.nxml.txt.nlp	23365557	SENT166	2	2	6	6	liraglutide	GLP-1	PA165958364	100125288	0.801
NULL	J_Geriatr_Cardiol_2013_Dec_10(4)_355-360.nxml.txt.nlp	24454329	SENT56	1	1	11	11	heparin	ACT	PA449855	12;11332;9457;641455	0.801
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT119	35	35	31	31	nilotinib	ABCG2	PA165958345	9429	0.801
NULL	J_Invest_Dermatol_2013_Jun_14_133(6)_1541-1549.nxml.txt.nlp	23407395	SENT130	27	27	23	23	imiquimod	CXCL2	PA449972	2920	0.801
NULL	Oncotarget_2012_May_19_3(5)_535-545.nxml.txt.nlp	22619121	SENT108	6	6	13	13	camptothecin	TPT	PA153590860	23590;6469	0.801
NULL	Acta_Oncol_2014_Oct_9_53(10)_1347-1355.nxml.txt.nlp	24909504	SENT189	20	20	11	11	epirubicin	TP53	PA449476	7157	0.801
NULL	Cancer_Cell_Int_2006_Mar_23_6_6.nxml.txt.nlp	16556298	SENT168	14	14	7	7	doxorubicin	FDG	PA449412	23583	0.801
NULL	Iran_J_Pharm_Res_2014_Autumn_13(4)_1431-1436.nxml.txt.nlp	25587334	SENT79	36	36	41	41	lidocaine	ANOVA	PA450226	4858	0.801
NULL	J_Korean_Med_Sci_2013_Jul_3_28(7)_1005-1014.nxml.txt.nlp	23853482	SENT143	9	9	6	6	gefitinib	EGFR	PA131301952	1956	0.801
NULL	Mol_Cancer_2010_Oct_12_9_269.nxml.txt.nlp	20939893	SENT66	0	0	7	7	isoproterenol	STAT3	PA450121	6774	0.801
NULL	J_Biomed_Biotechnol_2011_Jul_6_2011_783528.nxml.txt.nlp	21785566	SENT150	15	15	9	9	saquinavir	P-gp	PA451305	5243	0.801
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1145.nxml.txt.nlp	24675463	SENT116	4	4	19	19	erlotinib	EGF	PA134687924	1950	0.801
NULL	Oncol_Rep_2012_Sep_26_28(3)_777-784.nxml.txt.nlp	22751903	SENT181	0	0	4	4	celecoxib	VEGF-A	PA448871	7422	0.801
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1013.nxml.txt.nlp	24457957	SENT88	0	0	4	4	orlistat	NOXA	PA164776864	5366	0.801
NULL	Int_J_Med_Chem_2012_Sep_25_2012_196921.nxml.txt.nlp	25374683	SENT150	23	23	40	40	hemin	FBS	PA449849	64319;26269	0.801
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Mar_10_68(Pt_4)_o1000.nxml.txt.nlp	22589876	SENT67	5	5	15	15	nitrile	C11	PA450636	1109	0.801
NULL	Int_J_Biol_Sci_2012_Sep_6_8(8)_1109-1120.nxml.txt.nlp	22991499	SENT57	23	23	17	17	l-arginine	ARG	PA448478	473;27	0.801
NULL	Drug_Target_Insights_2012_Apr_11_6_1-11.nxml.txt.nlp	22523472	SENT77	4	4	29	29	resveratrol	GAPDH		2597	0.801
NULL	Evid_Based_Complement_Alternat_Med_2013_May_16_2013_857929.nxml.txt.nlp	23762164	SENT126	22	22	16	16	doxorubicin	p53	PA449412	7157	0.801
NULL	Hum_Genomics_2008_Sep_1_3(1)_7-16.nxml.txt.nlp	19129086	SENT174	24	24	17	17	rosiglitazone	SLCO1B1	PA451283	10599	0.801
NULL	Vet_Res_Forum_2012_Summer_3(3)_159-165.nxml.txt.nlp	25610563	SENT41	11	11	21	21	lidocaine	hole	PA450226	80757	0.801
NULL	Front_Endocrinol_(Lausanne)_2011_Dec_21_2_84.nxml.txt.nlp	22654830	SENT37	12	12	9	9	lipase	ATGL	PA450239	57104	0.801
NULL	Arch_Med_Sci_2013_Oct_31_9(5)_936-943.nxml.txt.nlp	24273582	SENT37	27	27	39	39	repaglinide	SUR2	PA451234	10060	0.801
NULL	Int_J_Mol_Imaging_2012_Oct_2_2012_379807.nxml.txt.nlp	23091717	SENT230	22	22	14	14	cilengitide	VEGF-A	PA164924491	7422	0.801
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT1552	11	11	2	2	tariquidar	MRP7		89845;1080	0.801
NULL	Mol_Cancer_2010_Dec_7_9_311.nxml.txt.nlp	21138557	SENT160	4	4	14	14	etoposide	MCT-1	PA449552	28985	0.801
NULL	Indian_J_Med_Res_2012_Jul_136(1)_54-59.nxml.txt.nlp	22885264	SENT6	4	4	26	26	cisplatin	IFN	PA449014	3439	0.801
NULL	Oxid_Med_Cell_Longev_2013_Apr_21_2013_412576.nxml.txt.nlp	23710286	SENT238	2	2	7	7	curcumin	NRF2	PA151958596	2551;4780	0.801
NULL	Thorax_2014_Jul_24_69(7)_638-647.nxml.txt.nlp	24567297	SENT86	42	42	33	33	doxycycline	TRAIL	PA449415	8743	0.801
NULL	J_Oncol_2013_Apr_29_2013_854121.nxml.txt.nlp	23737784	SENT65	0	0	6	6	pertuzumab	HER2		2064	0.801
NULL	AAPS_J_2012_Jan_4_14(1)_87-96.nxml.txt.nlp	22215264	SENT25	0	0	8	8	quinidine	P-gp	PA451209	5243	0.801
NULL	BMJ_2009_Aug_18_339_b2942.nxml.txt.nlp	19690342	SENT196	9	9	26	26	rosiglitazone	gamma	PA451283	9913	0.801
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT118	14	14	23	23	capsaicin	p53	PA448776	7157	0.801
NULL	Mol_Cancer_2013_May_24_12_47.nxml.txt.nlp	23705854	SENT270	27	27	15	15	celecoxib	COX	PA448871	1351	0.801
NULL	Biosci_Rep_2014_Jan_31_34(1)_e00092.nxml.txt.nlp	24393046	SENT150	22	22	25	25	chloroquine	LAMP2	PA448948	3920	0.801
NULL	J_Biol_Chem_2013_Feb_1_288(5)_3512-3522.nxml.txt.nlp	23239883	SENT331	19	19	4	4	calcein	mol	PA132595336	90527	0.801
NULL	Front_Oncol_2014_Apr_9_4_75.nxml.txt.nlp	24782986	SENT296	24	24	3	3	paclitaxel	CD117	PA450761	3815	0.801
NULL	Alcohol_Res_Health_2008_31(4)_310-339.nxml.txt.nlp	20729980	SENT248	3	3	18	18	ethanol	CA1	PA448073	759	0.801
NULL	Mar_Drugs_2014_Dec_18_12(12)_6125-6141.nxml.txt.nlp	25528957	SENT264	16	16	6	6	dicumarol	NQO1	PA449298	1728	0.801
NULL	Oncol_Rep_2013_Apr_5_29(4)_1671-1677.nxml.txt.nlp	23404329	SENT35	14	14	26	26	aspirin	SFN	PA448497	25996;2810	0.801
NULL	Front_Genet_2013_Dec_16_4_281.nxml.txt.nlp	24379827	SENT319	35	35	24	24	l-proline	HTR7	PA451125	3363	0.801
NULL	Eur_J_Haematol_2014_Feb_25_92(2)_127-136.nxml.txt.nlp	24118452	SENT17	23	23	21	21	anagrelide	CRT	PA164742986	811	0.801
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT296	28	28	18	18	gefitinib	PIK3CA	PA131301952	5290	0.801
NULL	Oncol_Lett_2014_May_4_7(5)_1352-1362.nxml.txt.nlp	24765137	SENT187	32	32	15	15	doxorubicin	HMGB1	PA449412	3146	0.801
NULL	Springerplus_2013_Jan_11_2_5.nxml.txt.nlp	23520572	SENT22	10	10	4	4	estradiol	aromatase	PA449503	1588	0.801
NULL	Clin_Ophthalmol_2014_Mar_2_8_343-346.nxml.txt.nlp	24591809	SENT109	11	11	15	15	ranibizumab	PED	PA164746012	8682	0.801
NULL	Mol_Immunol_2009_Mar_46(6)_1229-1239.nxml.txt.nlp	19135256	SENT174	7	7	3	3	trypsin	DC2	PA451806	58505	0.801
NULL	Adv_Prev_Med_2012_Sep_20_2012_507571.nxml.txt.nlp	21991452	SENT184	6	6	18	18	hydroxocobalamin	B12	PA164768689	7126;4709	0.801
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT385	5	5	27	27	resveratrol	SRC3		8202	0.801
NULL	J_Anim_Sci_Biotechnol_2013_Dec_26_4(1)_54.nxml.txt.nlp	24369099	SENT51	22	22	27	27	formaldehyde	LAB	PA449703	7462	0.801
NULL	J_Korean_Med_Sci_2010_Feb_19_25(2)_240-244.nxml.txt.nlp	20119577	SENT23	5	5	1	1	cisplatin	NAC	PA449014	22861	0.801
NULL	Br_J_Cancer_2012_Jan_17_106(2)_284-289.nxml.txt.nlp	22215065	SENT34	11	11	17	17	atrasentan	IFN	PA143414738	3439	0.801
NULL	Cardiol_Res_Pract_2013_Feb_19_2013_195456.nxml.txt.nlp	23533940	SENT108	6	6	10	10	clopidogrel	CYP2B6	PA449053	1555	0.801
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT137	0	0	13	13	perifosine	DR4	PA165291471	8797	0.801
NULL	Evid_Based_Complement_Alternat_Med_2012_Feb_12_2012_472897.nxml.txt.nlp	22454667	SENT146	0	0	19	19	hesperetin	IFN	PA164742902	3439	0.801
NULL	BMB_Rep_2013_Nov_46(11)_544-549.nxml.txt.nlp	24152910	SENT303	1	1	26	26	thrombin	PAR-1	PA451674	2011;2149	0.801
NULL	Breast_Cancer_Res_2008_Dec_18_10(Suppl_4)_S20.nxml.txt.nlp	19128434	SENT27	22	22	7	7	anastrozole	FACT	PA448432	11198	0.801
NULL	Evid_Based_Complement_Alternat_Med_2012_Sep_4_2012_485042.nxml.txt.nlp	22988474	SENT97	31	31	22	22	docetaxel	CYP3A4	PA449383	1576	0.801
NULL	Cancer_Cell_Int_2007_Sep_10_7_14.nxml.txt.nlp	17845729	SENT164	14	14	17	17	decitabine	GADD45A	PA164749631	1647	0.801
NULL	Cancers_(Basel)_2014_Aug_12_6(3)_1631-1669.nxml.txt.nlp	25119536	SENT329	15	15	19	19	imatinib	Met	PA10804	79811	0.801
NULL	Indian_J_Med_Res_2012_May_135(5)_672-674.nxml.txt.nlp	22771598	SENT6	33	33	30	30	ofloxacin	ETO	PA450684	862	0.801
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jul_22_65(Pt_8)_o1944.nxml.txt.nlp	21583625	SENT59	11	11	26	26	ethanol	mol	PA448073	90527	0.801
NULL	Evid_Based_Complement_Alternat_Med_2013_Aug_12_2013_982689.nxml.txt.nlp	23997806	SENT40	17	17	3	3	tolbutamide	APE	PA451718	55704;328	0.801
NULL	Case_Rep_Hematol_2013_Nov_6_2013_520712.nxml.txt.nlp	24307957	SENT39	4	4	14	14	deferasirox	EPO	PA164760843	7076;8288;2056	0.801
NULL	Cancer_Cell_Int_2014_Jun_16_14_53.nxml.txt.nlp	24966801	SENT68	13	13	42	42	metformin	CO2	PA450395	4513	0.801
NULL	Aging_(Albany_NY)_2009_Feb_18_1(3)_335-349.nxml.txt.nlp	20195489	SENT217	27	27	11	11	etoposide	p65	PA449552	5970	0.801
NULL	Clin_Psychopharmacol_Neurosci_2013_Dec_24_11(3)_144-151.nxml.txt.nlp	24465251	SENT13	19	19	25	25	clozapine	IL-4	PA449061	3565	0.801
NULL	Oncoscience_2014_Mar_12_1(2)_158-166.nxml.txt.nlp	25594008	SENT24	22	22	20	20	trastuzumab	HER2	PA451743	2064	0.801
NULL	Environ_Health_Perspect_2010_Dec_12_118(12)_1707-1713.nxml.txt.nlp	20705543	SENT190	8	8	0	0	bleomycin	XRCC1	PA448645	7515	0.801
NULL	Biomed_Res_Int_2014_Apr_13_2014_738625.nxml.txt.nlp	24822215	SENT134	4	4	7	7	montelukast	IL-13	PA450546	3596	0.801
NULL	J_Oncol_2009_Jun_14_2009_814140.nxml.txt.nlp	19547715	SENT22	27	27	33	33	doxorubicin	MDR1	PA449412	5243	0.801
NULL	Environ_Health_Perspect_2005_Aug_15_113(8)_1009-1014.nxml.txt.nlp	16079071	SENT99	2	2	7	7	losartan	p38	PA450268	10598;1432;7965	0.801
NULL	Br_J_Cancer_1996_Oct_74(7)_1046-1050.nxml.txt.nlp	8855972	SENT11	16	16	23	23	doxorubicin	MDR1	PA449412	5243	0.801
NULL	Breast_Cancer_Res_2012_Feb_14_14(1)_R30.nxml.txt.nlp	22333315	SENT227	15	15	10	10	celecoxib	CXCL10	PA448871	3627	0.801
NULL	Aging_(Albany_NY)_2010_Dec_20_2(12)_959-968.nxml.txt.nlp	21191146	SENT85	15	15	4	4	cisplatin	Rpn13	PA449014	11047	0.801
NULL	Cancer_Cell_Int_2013_Jan_15_13_3.nxml.txt.nlp	23320839	SENT35	2	2	13	13	gemcitabine	MRP1	PA449748	4437	0.801
NULL	Arthritis_Res_Ther_2007_Sep_7_9(5)_R87.nxml.txt.nlp	17825098	SENT106	14	14	25	25	methotrexate	CD4	PA450428	920	0.801
NULL	Indian_J_Med_Res_2014_Feb_139(2)_195-204.nxml.txt.nlp	24718393	SENT165	16	16	28	28	itraconazole	CYP3A4	PA450132	1576	0.801
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Jul_23_3(7)_e126.nxml.txt.nlp	25054314	SENT88	30	30	18	18	docetaxel	MRP2	PA449383	100130958;57626;1244	0.801
NULL	Breast_Cancer_Res_2002_May_15_4(4)_133-136.nxml.txt.nlp	12100736	SENT83	11	11	2	2	estradiol	aromatase	PA449503	1588	0.801
NULL	Neural_Regen_Res_2014_Feb_15_9(4)_420-429.nxml.txt.nlp	25206830	SENT57	8	8	30	30	pentobarbital	gamma	PA450859	9913	0.801
NULL	Breast_Cancer_Res_2003_Mar_14_5(3)_R77-R81.nxml.txt.nlp	12793904	SENT70	24	24	5	5	urokinase	LRP1	PA451836	10438;4035	0.801
NULL	Biomed_Res_Int_2014_Aug_6_2014_967826.nxml.txt.nlp	25165721	SENT210	19	19	14	14	cisplatin	TNF-alpha	PA449014	7124	0.801
NULL	Cell_Death_Dis_2010_Oct_21_1(10)_e86.nxml.txt.nlp	21368859	SENT51	11	11	9	9	doxorubicin	TRAIL	PA449412	8743	0.801
NULL	Mol_Biol_Cell_2012_Sep_1_23(17)_3290-3298.nxml.txt.nlp	22809627	SENT222	6	6	15	15	geldanamycin	HSF1	PA152031327	3297	0.801
NULL	Br_J_Cancer_2013_May_14_108(9)_1862-1869.nxml.txt.nlp	23579219	SENT82	17	17	4	4	cetuximab	ISX	PA10040	91464	0.801
NULL	Mol_Cancer_2010_Nov_8_9_291.nxml.txt.nlp	21059223	SENT22	4	4	0	0	zinc	ZNF217	PA451956	7764	0.801
NULL	Cardiovasc_Res_2012_Dec_1_96(3)_552-560.nxml.txt.nlp	22918977	SENT64	20	20	5	5	losartan	ANG	PA450268	283	0.801
NULL	Cytotechnology_2013_Jan_6_65(1)_59-70.nxml.txt.nlp	22669602	SENT73	16	16	14	14	staurosporine	TRAIL	PA165109623	8743	0.801
NULL	Int_J_Mol_Sci_2014_Sep_22_15(9)_16848-16884.nxml.txt.nlp	25247581	SENT302	8	8	3	3	resveratrol	SIRT1		23411	0.801
NULL	Tanaffos_2012_11(4)_23-29.nxml.txt.nlp	25191434	SENT106	8	8	13	13	nadh	NO3	PA164755085	4681	0.801
NULL	Cancers_(Basel)_2013_May_27_5(2)_617-638.nxml.txt.nlp	24216994	SENT171	13	13	18	18	curcumin	PC3	PA151958596	57332;7832;5122	0.801
NULL	Onco_Targets_Ther_2014_Sep_9_7_1571-1582.nxml.txt.nlp	25228815	SENT152	6	6	3	3	sunitinib	VEGFR1	PA162372840	2321	0.801
NULL	Br_J_Cancer_2011_Jul_26_105(3)_372-381.nxml.txt.nlp	21730979	SENT80	2	2	14	14	hydroxyurea	CHK1	PA449942	1111	0.801
NULL	Clin_Transl_Allergy_2014_Jan_15_4_3.nxml.txt.nlp	24428928	SENT159	6	6	9	9	methacholine	IL-17	PA165958382	3605	0.801
NULL	Aging_(Albany_NY)_2010_Dec_14_2(12)_945-958.nxml.txt.nlp	21164223	SENT157	0	0	7	7	metformin	HER-2	PA450395	2064	0.801
NULL	J_Immunotoxicol_2013_Jan_11_10(1)_75-82.nxml.txt.nlp	22967038	SENT101	25	25	27	27	muromonab	IFN	PA164743097	3439	0.801
NULL	Cell_Mol_Life_Sci_2011_Feb_24_68(3)_369-395.nxml.txt.nlp	21107637	SENT550	3	3	12	12	arsenite	HLA-G	PA452638	3135	0.801
NULL	Comp_Funct_Genomics_2012_Feb_6_2012_876893.nxml.txt.nlp	22400011	SENT297	17	17	0	0	zinc	PCF11	PA451956	51585	0.801
NULL	HSR_Proc_Intensive_Care_Cardiovasc_Anesth_2009_1(1)_45-53.nxml.txt.nlp	23439587	SENT32	9	9	3	3	heparin	LHB	PA449855	3972	0.801
NULL	J_Mol_Signal_2013_Dec_30_8_15.nxml.txt.nlp	24377906	SENT252	18	18	10	10	bevacizumab	IL24	PA130232992	11009	0.801
NULL	Breast_Cancer_Res_2014_May_5_16(3)_R45.nxml.txt.nlp	24887236	SENT218	6	6	0	0	lapatinib	EGFR	PA152241907	1956	0.801
NULL	Mol_Cancer_2009_Dec_23_8_129.nxml.txt.nlp	20030852	SENT186	0	0	4	4	curcumin	ABCA1	PA151958596	19	0.801
NULL	Eur_J_Neurosci_2014_Feb_4_39(3)_363-374.nxml.txt.nlp	24494677	SENT379	16	16	18	18	capsaicin	VR1	PA448776	56664	0.801
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT161	0	0	3	3	metformin	HIF-1	PA450395	29072	0.801
NULL	Oncol_Rep_2014_Jan_8_31(1)_19-26.nxml.txt.nlp	24213840	SENT129	23	23	8	8	decitabine	p15	PA164749631	10923;10573	0.801
NULL	Cancers_(Basel)_2014_Feb_13_6(1)_396-415.nxml.txt.nlp	24531055	SENT91	17	17	13	13	cisplatin	p53	PA449014	7157	0.801
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT365	9	9	18	18	pp2	CDH1		51343;999	0.801
NULL	Cell_Death_Dis_2013_Jun_27_4(6)_e696.nxml.txt.nlp	23807225	SENT186	22	22	3	3	tamoxifen	PI3K	PA451581	5290	0.801
NULL	J_Immunother_Cancer_2013_Jul_15_1_10.nxml.txt.nlp	24829747	SENT42	9	9	24	24	tadalafil	ARG1	PA10333	383;64129	0.801
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jun_17_65(Pt_7)_o1596.nxml.txt.nlp	21582870	SENT68	41	41	6	6	ethanol	mol	PA448073	90527	0.801
NULL	Ann_Oncol_2013_Aug_12_24(8)_1994-1999.nxml.txt.nlp	23670096	SENT136	8	8	1	1	tamoxifen	STEPP	PA451581	222659	0.801
NULL	eLife_2013_Nov_5_2_e00969.nxml.txt.nlp	24192036	SENT71	20	20	18	18	doxorubicin	JNK	PA449412	5599	0.801
NULL	Int_J_Mol_Sci_2014_Mar_20_15(3)_4965-4976.nxml.txt.nlp	24658440	SENT35	13	13	6	6	verapamil	P-gp	PA451868	5243	0.801
NULL	Exp_Diabetes_Res_2012_Jun_26_2012_801610.nxml.txt.nlp	22792092	SENT120	5	5	16	16	estradiol	IL-6	PA449503	3569	0.801
NULL	Front_Pharmacol_2014_Oct_27_5_228.nxml.txt.nlp	25452728	SENT203	6	6	8	8	ethanol	p190RhoGAP	PA448073	2909	0.801
NULL	Mol_Vis_2007_Jul_9_13_1083-1093.nxml.txt.nlp	17653053	SENT144	4	4	21	21	minocycline	eotaxin	PA450519	6356	0.801
NULL	Mediators_Inflamm_2001_Aug_10(4)_199-208.nxml.txt.nlp	11577996	SENT6	1	1	10	10	methotrexate	TNF-alpha	PA450428	7124	0.801
NULL	Br_J_Cancer_2013_Mar_5_108(4)_973-982.nxml.txt.nlp	23299537	SENT126	18	18	11	11	doxorubicin	BTG2	PA449412	7832	0.801
NULL	Br_J_Cancer_2012_Jul_24_107(3)_435-441.nxml.txt.nlp	22767144	SENT146	36	36	13	13	oxaliplatin	TEF	PA131285527	7008	0.801
NULL	Breast_Cancer_Res_2012_May_23_14(3)_R82.nxml.txt.nlp	22621306	SENT104	2	2	4	4	trastuzumab	HER2	PA451743	2064	0.801
NULL	J_Antimicrob_Chemother_2014_Jul_14_69(7)_1945-1953.nxml.txt.nlp	24633206	SENT195	17	17	11	11	tigecycline	RGM	PA164746412	56963	0.801
NULL	Front_Public_Health_2013_Nov_14_1_50.nxml.txt.nlp	24350219	SENT12	20	20	24	24	hydrocortisone	TREM-1	PA449905	54210	0.801
NULL	Acta_Pharmacol_Sin_2010_Sep_16_31(9)_1095-1102.nxml.txt.nlp	20711228	SENT15	5	5	12	12	thrombin	ADP	PA451674	23038	0.801
NULL	Exp_Diabetes_Res_2011_Jun_20_2011_601047.nxml.txt.nlp	21747830	SENT88	32	32	20	20	liraglutide	GLP-1	PA165958364	100125288	0.801
NULL	Front_Neurosci_2014_Jun_24_8_176.nxml.txt.nlp	25009459	SENT200	17	17	5	5	ivermectin	P2X4	PA450133	5025	0.801
NULL	Oncologist_2010_Feb_15_15(2)_122-129.nxml.txt.nlp	20156908	SENT21	24	24	34	34	letrozole	HER-2	PA450196	2064	0.801
NULL	Acta_Pharmacol_Sin_2014_Aug_7_35(8)_1023-1030.nxml.txt.nlp	24998255	SENT129	3	3	40	40	octreotide	STAT3	PA450678	6774	0.801
NULL	Mol_Cancer_2008_Mar_6_7_24.nxml.txt.nlp	18325101	SENT21	44	44	8	8	cisplatin	BRCA1	PA449014	672	0.801
NULL	Environ_Health_Perspect_2006_Jun_114(6)_A352-A358.nxml.txt.nlp	16759972	SENT34	33	33	17	17	estradiol	aromatase	PA449503	1588	0.801
NULL	J_Adv_Pharm_Technol_Res_2012_Oct-Dec_3(4)_202-209.nxml.txt.nlp	23378940	SENT157	37	37	33	33	aprepitant	NK-1	PA164747039	27087	0.801
NULL	J_Clin_Biochem_Nutr_2007_May_25_40(3)_163-173.nxml.txt.nlp	18398493	SENT95	28	28	4	4	glibenclamide	SACS	PA449782	26278	0.801
NULL	Trials_2012_Sep_8_13_160.nxml.txt.nlp	22958580	SENT47	28	28	8	8	vecuronium	LSR	PA164748865	51599	0.801
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT129	25	25	3	3	simvastatin	AKT	PA451363	207	0.8
NULL	Int_J_Inflam_2014_Dec_24_2014_690596.nxml.txt.nlp	25610704	SENT167	0	0	9	9	diclofenac	LPO	PA449293	4025	0.8
NULL	Diabetes_2011_Nov_17_60(11)_2928-2938.nxml.txt.nlp	21885868	SENT122	9	9	12	12	curcumin	IL-6	PA151958596	3569	0.8
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT104	14	14	10	10	metformin	AKT	PA450395	207	0.8
NULL	J_Neuroengineering_Rehabil_2006_Jul_19_3_16.nxml.txt.nlp	16854224	SENT162	18	18	12	12	acetazolamide	CO2	PA448018	4513	0.8
NULL	J_Antimicrob_Chemother_2014_Feb_29_69(2)_368-374.nxml.txt.nlp	24080503	SENT40	13	13	6	6	trimethoprim	BSAC	PA451788	57591	0.8
NULL	J_Breast_Cancer_2011_Mar_31_14(1)_20-27.nxml.txt.nlp	21847390	SENT139	12	12	14	14	estradiol	CLDN6	PA449503	9074	0.8
NULL	J_Korean_Med_Sci_2006_Jun_21_21(3)_460-468.nxml.txt.nlp	16778390	SENT80	23	23	18	18	tamoxifen	p53	PA451581	7157	0.8
NULL	Oncotarget_2013_Dec_28_5(6)_1475-1490.nxml.txt.nlp	24721996	SENT196	8	8	0	0	celecoxib	PTEN	PA448871	5728	0.8
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT280	0	0	9	9	nutlin-3	MDM2		4193	0.8
NULL	Drug_Target_Insights_2007_Aug_17_2_197-207.nxml.txt.nlp	21901074	SENT74	0	0	17	17	suramin	EGF	PA10292	1950	0.8
NULL	Aging_(Albany_NY)_2011_Apr_26_3(4)_363-367.nxml.txt.nlp	21721170	SENT62	15	15	24	24	lipase	AMPK	PA450239	5563	0.8
NULL	Nucleic_Acids_Res_2011_Dec_31_39(22)_9536-9548.nxml.txt.nlp	21880590	SENT170	12	12	23	23	etoposide	BRCA1	PA449552	672	0.8
NULL	Arthritis_Res_Ther_2010_Apr_29_12(2)_R73.nxml.txt.nlp	20429888	SENT8	32	32	7	7	bortezomib	COL1A2	PA10252	1278	0.8
NULL	J_Hematol_Oncol_2012_May_15_5_23.nxml.txt.nlp	22587422	SENT61	14	14	37	37	dasatinib	ALL	PA162372878	613	0.8
NULL	Eur_J_Immunol_2013_Feb_21_43(2)_488-498.nxml.txt.nlp	23169007	SENT254	6	6	33	33	collagenase	CD32	PA449107	2213;2212	0.8
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT209	8	8	13	13	ranibizumab	VEGFR2	PA164746012	3791	0.8
NULL	Front_Mol_Neurosci_2012_Nov_12_5_99.nxml.txt.nlp	23162427	SENT260	15	15	30	30	cocaine	HDAC5	PA449072	10014	0.8
NULL	Amyloid_2014_Sep_11_21(3)_175-184.nxml.txt.nlp	24918964	SENT154	24	24	30	30	anakinra	TTR	PA10799	7276	0.8
NULL	Korean_Circ_J_2014_Mar_12_44(2)_82-88.nxml.txt.nlp	24653737	SENT38	26	26	31	31	prasugrel	ADP	PA154410481	23038	0.8
NULL	Blood_Cancer_J_2012_Sep_7_2(9)_e89.nxml.txt.nlp	22961061	SENT94	16	16	24	24	bortezomib	FGFR3	PA10252	2261	0.8
NULL	Oncologist_2010_Aug_29_15(8)_799-809.nxml.txt.nlp	20671105	SENT176	18	18	23	23	trastuzumab	HER-2	PA451743	2064	0.8
NULL	Drugs_R_D_2010_Sep_27_10(3)_165-178.nxml.txt.nlp	20945947	SENT212	6	6	2	2	ridaforolimus	HIF-1	PA165291475	29072	0.8
NULL	Reprod_Biol_Endocrinol_2013_Jul_16_11_65.nxml.txt.nlp	23855623	SENT209	32	32	24	24	estradiol	activin	PA449503	83729	0.8
NULL	Neural_Dev_2009_Dec_4_4_43.nxml.txt.nlp	19961580	SENT311	12	12	16	16	paraformaldehyde	E14	PA450790	4863	0.8
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2011_Jan_12_4_1-12.nxml.txt.nlp	22879789	SENT87	16	16	12	12	saxagliptin	GLP-1	PA165958362	100125288	0.8
NULL	Cancer_Immunol_Immunother_2011_Jun_25_60(6)_793-808.nxml.txt.nlp	21350947	SENT165	16	16	13	13	sorafenib	IFN	PA7000	3439	0.8
NULL	Mediators_Inflamm_2010_Jun_21_2010_194896.nxml.txt.nlp	20652055	SENT179	8	8	14	14	berberine	AP-1	PA165860812	2353;3727;2354;3725	0.8
NULL	Acta_Pharmacol_Sin_2011_Oct_15_32(10)_1233-1238.nxml.txt.nlp	21841815	SENT82	8	8	18	18	atropine	CTX	PA448505	1593	0.8
NULL	Mol_Neurobiol_2010_Jun_2_41(2-3)_392-409.nxml.txt.nlp	20437209	SENT300	22	22	32	32	curcumin	cPLA2	PA151958596	10524	0.8
NULL	Acta_Pharmacol_Sin_2009_May_13_30(5)_628-636.nxml.txt.nlp	19363519	SENT3	11	11	13	13	topotecan	TPT	PA451729	23590;6469	0.8
NULL	Mar_Drugs_2008_Oct_8_6(4)_528-549.nxml.txt.nlp	19172193	SENT165	18	18	7	7	probenecid	CO2	PA451106	4513	0.8
NULL	Indian_J_Med_Res_2012_Aug_136(2)_249-259.nxml.txt.nlp	22960892	SENT117	14	14	6	6	irinotecan	UGT1A1	PA450085	54658	0.8
NULL	Mol_Cancer_2009_Dec_23_8_129.nxml.txt.nlp	20030852	SENT198	5	5	12	12	curcumin	survivin	PA151958596	332	0.8
NULL	Curr_Chem_Genomics_2010_Mar_19_4_9-18.nxml.txt.nlp	20502647	SENT149	26	26	10	10	triciribine	DM1	PA165958661	338023;1760;28509	0.8
NULL	Case_Rep_Infect_Dis_2011_Sep_22_2011_981316.nxml.txt.nlp	22567485	SENT107	5	5	29	29	teicoplanin	OSSA	PA164746244	23196	0.8
NULL	Iran_J_Pharm_Res_2014_Winter_13(1)_279-282.nxml.txt.nlp	24734081	SENT100	17	17	8	8	tacrolimus	MDR1	PA451578	5243	0.8
NULL	Oncol_Lett_2013_Feb_27_5(2)_483-488.nxml.txt.nlp	23420047	SENT203	21	21	10	10	cetuximab	PTEN	PA10040	5728	0.8
NULL	Virol_J_2011_May_24_8_255.nxml.txt.nlp	21609431	SENT75	15	15	7	7	l-glutamine	F12	PA10090	2161	0.8
NULL	Arthritis_Res_Ther_2005_Oct_18_7(6)_R1412-R1420.nxml.txt.nlp	16277694	SENT74	22	22	28	28	l-glutamine	IL-2	PA10090	3558	0.8
NULL	Acta_Neuropathol_2010_Feb_21_119(2)_157-175.nxml.txt.nlp	19936768	SENT202	12	12	21	21	troglitazone	STAT3	PA451799	6774	0.8
NULL	Cancers_(Basel)_2011_May_9_3(2)_2286-2301.nxml.txt.nlp	24212810	SENT184	3	3	9	9	sorafenib	Raf-1	PA7000	5894	0.8
NULL	Trials_2013_Aug_14_14_255.nxml.txt.nlp	23945130	SENT35	29	29	26	26	sulfadoxine	IPT	PA451540	54802	0.8
NULL	Basic_Res_Cardiol_2011_Nov_5_106(6)_1269-1281.nxml.txt.nlp	22057716	SENT51	18	18	37	37	midazolam	EDA	PA450496	1896	0.8
NULL	Ann_Rheum_Dis_2008_Oct_25_68(10)_1644-1650.nxml.txt.nlp	18957484	SENT16	2	2	10	10	leflunomide	IL-17	PA450192	3605	0.8
NULL	Med_Sci_Monit_2013_Sep_9_19_751-756.nxml.txt.nlp	24019010	SENT161	14	14	7	7	entecavir	LAM	PA164784025	7249;7248	0.8
NULL	Arthritis_Res_Ther_2003_Oct_28_5(1)_8-11.nxml.txt.nlp	12716442	SENT60	20	20	4	4	rofecoxib	Ray	PA451268	26751	0.8
NULL	Drugs_R_D_2014_Sep_28_14(3)_159-164.nxml.txt.nlp	24973042	SENT32	23	23	19	19	rosiglitazone	CYP2C9	PA451283	1559	0.8
NULL	Cancer_Cell_Int_2006_Jun_23_6_17.nxml.txt.nlp	16792817	SENT132	15	15	4	4	docetaxel	p53	PA449383	7157	0.8
NULL	Mol_Biol_Cell_2012_Jul_1_23(13)_2571-2582.nxml.txt.nlp	22573884	SENT180	12	12	2	2	dextran	EGF	PA449261	1950	0.8
NULL	Ann_Rheum_Dis_2010_Jan_17_69(1)_88-96.nxml.txt.nlp	19297346	SENT175	4	4	19	19	tocilizumab	IL6R	PA165292659	3570	0.8
NULL	Mediators_Inflamm_2010_Jun_21_2010_194896.nxml.txt.nlp	20652055	SENT140	11	11	17	17	berberine	CCL2	PA165860812	6347	0.8
NULL	J_Korean_Assoc_Oral_Maxillofac_Surg_2014_Dec_26_40(6)_291-296.nxml.txt.nlp	25551094	SENT84	2	2	6	6	alendronate	OPG	PA448082	690	0.8
NULL	Mol_Cancer_2008_Jun_30_7_60.nxml.txt.nlp	18590557	SENT72	27	27	39	39	paclitaxel	TRAIL	PA450761	8743	0.8
NULL	Br_J_Cancer_2012_Jul_24_107(3)_435-441.nxml.txt.nlp	22767144	SENT146	26	26	13	13	docetaxel	TEF	PA449383	7008	0.8
NULL	N_Am_J_Med_Sci_2011_Apr_3(4)_206-208.nxml.txt.nlp	22540093	SENT56	16	16	13	13	pentoxifylline	TNF-alpha	PA450864	7124	0.8
NULL	Int_J_Endocrinol_2014_Feb_13_2014_329456.nxml.txt.nlp	24688539	SENT223	9	9	29	29	tadalafil	IP-10	PA10333	3627	0.8
NULL	Oncotarget_2014_Jun_19_5(15)_6540-6551.nxml.txt.nlp	25153728	SENT141	10	10	5	5	paclitaxel	PI3K	PA450761	5290	0.8
NULL	Oncogene_2013_Sep_26_32(39)_10_1038_onc_2012_491.nxml.txt.nlp	23108394	SENT138	12	12	3	3	epirubicin	BRIP1	PA449476	64979;83990	0.8
NULL	Arthritis_Res_Ther_2014_Oct_30_16(5)_467.nxml.txt.nlp	25359150	SENT327	32	32	27	27	adalimumab	STAR	PA10004	6770;2984	0.8
NULL	Cardiovasc_Diabetol_2010_Jul_27_9_31.nxml.txt.nlp	20663195	SENT76	3	3	9	9	irbesartan	FSP1	PA450084	6275;51062	0.8
NULL	Breast_Cancer_Res_2004_Nov_7_6(1)_39-52.nxml.txt.nlp	14680484	SENT243	3	3	5	5	raloxifene	STAR	PA451221	6770;2984	0.8
NULL	Biochemistry_2012_Sep_25_51(38)_7456-7464.nxml.txt.nlp	22947085	SENT54	11	11	18	18	thyroglobulin	gamma	PA164754910	9913	0.8
NULL	J_Young_Pharm_2010_Oct-Dec_2(4)_428-429.nxml.txt.nlp	21264109	SENT28	14	14	5	5	metformin	B12	PA450395	7126;4709	0.8
NULL	Mol_Cancer_2010_Dec_2_9_309.nxml.txt.nlp	21122157	SENT399	24	24	20	20	paclitaxel	IL-6	PA450761	3569	0.8
NULL	Nucl_Recept_Signal_2009_Jan_16_7_e001.nxml.txt.nlp	19240808	SENT410	35	35	29	29	cisplatin	SXR	PA449014	8856	0.8
NULL	F1000_Med_Rep_2010_Nov_11_2_79.nxml.txt.nlp	21170368	SENT101	13	13	3	3	propofol	CO2	PA451141	4513	0.8
NULL	Breast_Cancer_Res_2010_Jun_28_12(3)_R43.nxml.txt.nlp	20579400	SENT166	0	0	26	26	tamoxifen	MAPT	PA451581	4137	0.8
NULL	Springerplus_2014_Sep_9_3_510.nxml.txt.nlp	25279302	SENT185	15	15	7	7	creatine	GATM	PA164778930	2628	0.8
NULL	J_Breast_Cancer_2013_Sep_30_16(3)_274-284.nxml.txt.nlp	24155756	SENT46	10	10	14	14	doxorubicin	ACT	PA449412	12;11332;9457;641455	0.8
NULL	Evid_Based_Complement_Alternat_Med_2013_Mar_26_2013_974313.nxml.txt.nlp	23589723	SENT172	27	27	32	32	metformin	HIF1	PA450395	3091	0.8
NULL	Oncol_Lett_2013_Aug_20_6(2)_329-335.nxml.txt.nlp	24137325	SENT48	42	42	36	36	ethanol	PP2	PA448073	4888	0.8
NULL	J_Invest_Dermatol_2014_May_28_134(5)_1265-1275.nxml.txt.nlp	24288007	SENT262	14	14	3	3	doxycycline	CD205	PA449415	4065	0.8
NULL	Cancer_Manag_Res_2011_Sep_9_3_301-309.nxml.txt.nlp	21931504	SENT81	9	9	4	4	spermine	CXCR4	PA164781199	7852	0.8
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1495-1502.nxml.txt.nlp	21989186	SENT191	22	22	28	28	fluorouracil	HSI	PA128406956	57016	0.8
NULL	Ann_Oncol_2013_Aug_12_24(8)_1994-1999.nxml.txt.nlp	23670096	SENT89	36	36	7	7	tamoxifen	AIB1	PA451581	8202	0.8
NULL	Br_J_Cancer_2003_Mar_10_88(5)_788-795.nxml.txt.nlp	12618891	SENT172	14	14	25	25	bosentan	FasL	PA10034	356	0.8
NULL	Oncol_Lett_2014_Mar_2_7(3)_791-796.nxml.txt.nlp	24527087	SENT161	29	29	13	13	imatinib	CD34	PA10804	947	0.8
NULL	Diabetes_2011_Mar_21_60(3)_757-765.nxml.txt.nlp	21282370	SENT166	5	5	8	8	isoproterenol	PTRF	PA450121	284119	0.8
NULL	J_Hematol_Oncol_2012_Sep_18_5_57.nxml.txt.nlp	22989009	SENT403	8	8	3	3	berberine	MDM2	PA165860812	4193	0.8
NULL	Blood_Res_2014_Dec_23_49(4)_253-258.nxml.txt.nlp	25548759	SENT114	28	28	25	25	melphalan	CHOP	PA450354	1649	0.8
NULL	Pharmaceuticals_(Basel)_2012_Sep_10_5(9)_944-962.nxml.txt.nlp	24280699	SENT396	13	13	9	9	geldanamycin	Hsp90	PA152031327	3320	0.8
NULL	Br_J_Cancer_2003_Mar_10_88(5)_754-759.nxml.txt.nlp	12618886	SENT107	17	17	3	3	amifostine	p53	PA448365	7157	0.8
NULL	Biofactors_2014_May_6_40(3)_277-283.nxml.txt.nlp	24353111	SENT46	21	21	11	11	choline	BHMT	PA448976	635	0.8
NULL	Br_J_Cancer_2011_Apr_12_104(8)_1241-1245.nxml.txt.nlp	21364581	SENT42	14	14	6	6	erlotinib	EGFR	PA134687924	1956	0.8
NULL	J_Hematol_Oncol_2013_Sep_5_6_66.nxml.txt.nlp	24010946	SENT301	19	19	6	6	panitumumab	CRT	PA162373091	811	0.8
NULL	Arthritis_Res_Ther_2010_Apr_29_12(2)_R73.nxml.txt.nlp	20429888	SENT119	5	5	21	21	bortezomib	COL1A2	PA10252	1278	0.8
NULL	Cardiovasc_Diabetol_2005_Dec_1_4_18.nxml.txt.nlp	16321162	SENT21	16	16	6	6	aspirin	ADA	PA448497	100	0.8
NULL	Mol_Cancer_2009_Nov_10_8_99.nxml.txt.nlp	19903356	SENT117	21	21	3	3	gefitinib	IGFBP3	PA131301952	3486	0.8
NULL	J_Hematol_Oncol_2013_Jul_18_6_53.nxml.txt.nlp	23866964	SENT79	22	22	13	13	temsirolimus	HDAC1	PA164746890	3065	0.8
NULL	Int_J_Biol_Sci_2011_May_24_7(5)_673-684.nxml.txt.nlp	21647250	SENT175	1	1	13	13	metformin	AMPK	PA450395	5563	0.8
NULL	Front_Immunol_2013_Oct_28_4_346.nxml.txt.nlp	24194739	SENT149	24	24	18	18	vemurafenib	BRAF	PA165946873	673	0.8
NULL	J_Immunotoxicol_2013_Jan_11_10(1)_75-82.nxml.txt.nlp	22967038	SENT102	12	12	5	5	rituximab	CD4	PA451261	920	0.8
NULL	Indian_J_Med_Res_2014_Jan_139(1)_76-82.nxml.txt.nlp	24604041	SENT45	14	14	24	24	albendazole	EPG	PA164746058	255324	0.8
NULL	J_Biol_Chem_2008_Nov_14_283(46)_31679-31689.nxml.txt.nlp	18755684	SENT8	11	11	16	16	iron	FTL	PA450087	2512	0.8
NULL	J_Cardiothorac_Surg_2014_May_9_9_81.nxml.txt.nlp	24885948	SENT176	28	28	24	24	sorafenib	GATA4	PA7000	2626	0.8
NULL	Front_Neuroenergetics_2013_Mar_27_5_2.nxml.txt.nlp	23543638	SENT420	0	0	4	4	liraglutide	GLP-1	PA165958364	100125288	0.8
NULL	Acta_Naturae_2011_Oct-Dec_3(4)_12-29.nxml.txt.nlp	22649701	SENT327	3	3	10	10	doxorubicin	A10	PA449412	28870	0.8
NULL	J_Korean_Med_Sci_2006_Apr_20_21(2)_199-207.nxml.txt.nlp	16614501	SENT33	22	22	13	13	methotrexate	IL-2	PA450428	3558	0.8
NULL	Leukemia_2013_Jan_11_27(1)_32-40.nxml.txt.nlp	22781593	SENT254	0	0	9	9	ponatinib	CD34	PA165980594	947	0.8
NULL	Int_J_Cell_Biol_2013_Feb_17_2013_162094.nxml.txt.nlp	23476651	SENT19	5	5	2	2	hemin	HO-1	PA449849	3162	0.8
NULL	Orphanet_J_Rare_Dis_2010_Dec_16_5_39.nxml.txt.nlp	21162721	SENT78	15	15	4	4	carbamazepine	HLA-B	PA448785	3106	0.8
NULL	J_Clin_Biochem_Nutr_2009_Jan_27_44(1)_79-84.nxml.txt.nlp	19177192	SENT7	5	5	12	12	curcumin	HO-1	PA151958596	3162	0.8
NULL	Toxins_(Basel)_2010_Oct_26_2(11)_2490-2518.nxml.txt.nlp	22069563	SENT140	6	6	3	3	cisplatin	p53	PA449014	7157	0.8
NULL	Oncotarget_2013_Nov_15_5(6)_1458-1474.nxml.txt.nlp	24681547	SENT109	23	23	35	35	celecoxib	CDH11	PA448871	1009	0.8
NULL	J_Cardiovasc_Dis_Res_2010_Oct-Dec_1(4)_171-176.nxml.txt.nlp	21264180	SENT110	0	0	6	6	resveratrol	AMPK		5563	0.8
NULL	Int_J_Fertil_Steril_2014_Mar_9_Apr-Jun_8(1)_59-66.nxml.txt.nlp	24695956	SENT86	12	12	18	18	fluorescein	CD4	PA164746009	920	0.8
NULL	Oncologist_2010_Mar_3_15(3)_216-235.nxml.txt.nlp	20200040	SENT258	7	7	3	3	sunitinib	HER-2	PA162372840	2064	0.8
NULL	Ann_Rheum_Dis_2008_Nov_14_67(11)_1516-1523.nxml.txt.nlp	18625622	SENT146	9	9	19	19	tocilizumab	TNF	PA165292659	7124	0.8
NULL	Korean_J_Anesthesiol_2013_Jan_21_64(1)_54-60.nxml.txt.nlp	23372887	SENT28	10	10	12	12	hydrocortisone	CRT	PA449905	811	0.8
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT343	14	14	5	5	heparin	FGF1	PA449855	2246	0.8
NULL	Curr_Oncol_2009_Jul_16(Suppl_2)_S1-S13.nxml.txt.nlp	19672416	SENT71	0	0	18	18	tamoxifen	aromatase	PA451581	1588	0.8
NULL	Biochim_Biophys_Acta_2014_Jul_1842(7)_959-970.nxml.txt.nlp	24594481	SENT812	34	34	7	7	lipase	ATGL	PA450239	57104	0.8
NULL	Br_J_Pharmacol_2008_Oct_18_155(4)_596-605.nxml.txt.nlp	18852694	SENT178	6	6	18	18	fenofibrate	SREBP2	PA449594	6721	0.8
NULL	Cell_Biochem_Biophys_2013_May_28_67(1)_25-43.nxml.txt.nlp	23712866	SENT273	34	34	9	9	etoposide	p53	PA449552	7157	0.8
NULL	EMBO_Mol_Med_2013_Apr_25_5(4)_531-547.nxml.txt.nlp	23526793	SENT172	8	8	17	17	rosiglitazone	MAP2	PA451283	4133;10988	0.8
NULL	J_Mol_Signal_2014_Mar_6_9_1.nxml.txt.nlp	24597858	SENT103	2	2	5	5	carvedilol	EGFR	PA448817	1956	0.8
NULL	Front_Behav_Neurosci_2012_Nov_22_6_78.nxml.txt.nlp	23189046	SENT81	29	29	10	10	ethanol	OX1R	PA448073	3061	0.8
NULL	Cancer_Cell_Int_2011_May_15_11_13.nxml.txt.nlp	21569620	SENT52	11	11	3	3	bortezomib	PC-3	PA10252	692094	0.8
NULL	Br_J_Pharmacol_2012_Oct_167(3)_505-514.nxml.txt.nlp	22506619	SENT154	36	36	38	38	indomethacin	COX	PA449982	1351	0.8
NULL	Clin_Dev_Immunol_2013_Nov_14_2013_697525.nxml.txt.nlp	24324510	SENT37	22	22	40	40	abatacept	ACR	PA164747080	49	0.8
NULL	Cancer_Cell_Int_2013_Jun_26_13_63.nxml.txt.nlp	23800022	SENT223	7	7	9	9	genistein	MDM2	PA165109660	4193	0.8
NULL	Clin_Dev_Immunol_2013_May_23_2013_475415.nxml.txt.nlp	23762089	SENT146	9	9	17	17	heparin	EGF	PA449855	1950	0.8
NULL	Acta_Pharmacol_Sin_2014_Aug_21_35(8)_994-1004.nxml.txt.nlp	25042549	SENT174	17	17	29	29	pravastatin	PCSK9	PA451089	255738	0.8
NULL	BMB_Rep_2013_Aug_46(8)_410-415.nxml.txt.nlp	23977989	SENT224	10	10	3	3	curcumin	NF-kappaB	PA151958596	4790	0.8
NULL	Expert_Rev_Mol_Med_2011_Nov_13_e35.nxml.txt.nlp	22088887	SENT243	2	2	10	10	thalidomide	CRBN	PA451644	51185	0.8
NULL	Ann_Med_Health_Sci_Res_2012_Jul-Dec_2(2)_191-198.nxml.txt.nlp	23439914	SENT189	24	24	11	11	fluconazole	CDR1	PA449653	1038	0.8
NULL	J_Gastroenterol_2013_Jan_27_48(1)_22-30.nxml.txt.nlp	23104468	SENT292	10	10	3	3	ribavirin	IL28B	PA451241	282617	0.8
NULL	Exp_Ther_Med_2013_May_8_5(5)_1491-1495.nxml.txt.nlp	23737905	SENT102	0	0	10	10	hemin	HO-1	PA449849	3162	0.8
NULL	Cell_Commun_Signal_2013_Jan_11_11_2.nxml.txt.nlp	23305203	SENT158	13	13	4	4	forskolin	TIMAP	PA146096022	26051	0.8
NULL	Acta_Pharmacol_Sin_2009_Nov_12_30(11)_1566-1572.nxml.txt.nlp	19820718	SENT155	24	24	33	33	ketoconazole	P-gp	PA450146	5243	0.8
NULL	Braz_J_Med_Biol_Res_2012_Feb_17_45(3)_244-249.nxml.txt.nlp	22331137	SENT145	33	33	6	6	gentamicin	PAG	PA449753	55824	0.8
NULL	Breast_Cancer_Res_Treat_2012_Jun_18_133(3)_937-947.nxml.txt.nlp	22094936	SENT186	41	41	21	21	tamoxifen	CCNB1	PA451581	891	0.8
NULL	Alcohol_Res_Health_2010_33(3)_203-218.nxml.txt.nlp	23584062	SENT257	2	2	11	11	ethanol	CD4	PA448073	920	0.8
NULL	Cardiovasc_Res_2012_Feb_1_93(2)_291-301.nxml.txt.nlp	22116619	SENT43	17	17	8	8	paraformaldehyde	E14	PA450790	4863	0.8
NULL	Cancer_Med_2012_Dec_26_1(3)_318-327.nxml.txt.nlp	23342281	SENT228	19	19	24	24	tamoxifen	aromatase	PA451581	1588	0.8
NULL	Cell_Res_2011_Mar_11_21(3)_530-545.nxml.txt.nlp	21221130	SENT241	8	8	35	35	thrombin	PAC-1	PA451674	1844	0.8
NULL	Case_Rep_Ophthalmol_Med_2012_Feb_14_2012_894062.nxml.txt.nlp	22606505	SENT35	20	20	18	18	cyclophosphamide	CHOP	PA449165	1649	0.8
NULL	Cough_2006_Dec_15_2_10.nxml.txt.nlp	17173683	SENT28	22	22	11	11	capsaicin	TRPV1	PA448776	7442	0.8
NULL	J_Cell_Mol_Med_2014_Dec_7_18(12)_2536-2552.nxml.txt.nlp	25287328	SENT278	13	13	0	0	tamoxifen	PKD1	PA451581	5310	0.8
NULL	Nat_Commun_2013_Apr_9_4_1684.nxml.txt.nlp	23575688	SENT145	9	9	18	18	rolipram	CYLD	PA153906323	1540	0.8
NULL	Acta_Pharmacol_Sin_2010_Oct_13_31(10)_1350-1358.nxml.txt.nlp	20835264	SENT156	2	2	24	24	simvastatin	gamma	PA451363	9913	0.8
NULL	Mol_Cancer_2012_Dec_12_11_91.nxml.txt.nlp	23234355	SENT41	12	12	22	22	cetuximab	EGFR	PA10040	1956	0.8
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1063.nxml.txt.nlp	24556678	SENT44	1	1	6	6	thioridazine	c-FLIP	PA451666	8837	0.8
NULL	J_Infect_Dis_2011_May_1_203(9)_1204-1214.nxml.txt.nlp	21459813	SENT298	6	6	24	24	raltegravir	TRIO		7204	0.8
NULL	Nat_Commun_2013_Oct_25_4_2667.nxml.txt.nlp	24157709	SENT313	30	30	18	18	cisplatin	mol	PA449014	90527	0.8
NULL	Arthritis_Res_2000_Jun_8_2(5)_348-355.nxml.txt.nlp	11094447	SENT25	12	12	0	0	collagenase	IL-6	PA449107	3569	0.8
NULL	J_Mol_Signal_2010_Aug_18_5_14.nxml.txt.nlp	20718984	SENT408	4	4	17	17	resveratrol	TRAIL		8743	0.8
NULL	Br_J_Cancer_1998_Oct_78(8)_1024-1029.nxml.txt.nlp	9792145	SENT15	22	22	4	4	etoposide	CD34	PA449552	947	0.8
NULL	Cardiovasc_Diabetol_2008_Aug_11_7_24.nxml.txt.nlp	18694484	SENT213	12	12	17	17	exenatide	Ray	PA164749238	26751	0.8
NULL	J_Biol_Chem_2013_Nov_22_288(47)_34217-34229.nxml.txt.nlp	24106270	SENT274	16	16	27	27	thrombin	RhoG	PA451674	391	0.8
NULL	CNS_Neurosci_Ther_2009_Jun_15(2)_157-182.nxml.txt.nlp	19298613	SENT468	11	11	26	26	nadh	Q10	PA164755085	27161	0.8
NULL	Acta_Pharmacol_Sin_2010_Jan_21_31(1)_35-42.nxml.txt.nlp	20023693	SENT188	2	2	10	10	atorvastatin	p65	PA448500	5970	0.8
NULL	Front_Genet_2013_Aug_29_4_163.nxml.txt.nlp	24009622	SENT102	12	12	23	23	ethanol	DDP	PA448073	1678	0.8
NULL	Acta_Pharmacol_Sin_2014_Jun_5_35(6)_727-737.nxml.txt.nlp	24793312	SENT99	25	25	35	35	telmisartan	B27	PA451605	56246	0.8
NULL	Breast_Cancer_Res_2007_Aug_8_9(4)_R50.nxml.txt.nlp	17686159	SENT265	9	9	12	12	gefitinib	HRG	PA131301952	3084;3273	0.8
NULL	Int_Semin_Surg_Oncol_2008_Apr_28_5_9.nxml.txt.nlp	18442393	SENT122	22	22	16	16	tamoxifen	HER-2	PA451581	2064	0.8
NULL	Acta_Pharmacol_Sin_2012_Jun_14_33(6)_761-766.nxml.txt.nlp	22580739	SENT40	0	0	5	5	neostigmine	San	PA450611	80218	0.8
NULL	Core_Evid_2011_Feb_8_6_23-29.nxml.txt.nlp	21468240	SENT46	44	44	21	21	plerixafor	CD34	PA165958410	947	0.8
NULL	EMBO_Mol_Med_2013_Aug_4_5(8)_1247-1262.nxml.txt.nlp	23737459	SENT4	24	24	30	30	nilotinib	parkin	PA165958345	5071	0.8
NULL	Mol_Cancer_2010_Aug_20_9_220.nxml.txt.nlp	20727180	SENT230	7	7	14	14	nicotine	p53	PA450626	7157	0.8
NULL	Ther_Clin_Risk_Manag_2005_Mar_1(1)_3-13.nxml.txt.nlp	18360537	SENT91	19	19	26	26	midazolam	CYP3A	PA450496	1574	0.8
NULL	Breast_Cancer_Res_2005_Dec_17_7(1)_41-42.nxml.txt.nlp	15642182	SENT33	27	27	14	14	carboplatin	HER2	PA448803	2064	0.8
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT523	23	23	5	5	ziprasidone	PRL	PA451974	5617	0.8
NULL	Contemp_Oncol_(Pozn)_2013_Apr_29_17(2)_137-143.nxml.txt.nlp	23788980	SENT183	27	27	34	34	cabergoline	PRL	PA448708	5617	0.8
NULL	Oncol_Lett_2013_Apr_28_5(4)_1149-1154.nxml.txt.nlp	23599754	SENT104	37	37	2	2	cisplatin	Dicer	PA449014	23405	0.8
NULL	Int_J_Biol_Sci_2012_Feb_9_8(3)_310-327.nxml.txt.nlp	22355267	SENT156	18	18	23	23	simvastatin	PCSK9	PA451363	255738	0.8
NULL	Oncoscience_2014_Jun_6_1(6)_423-426.nxml.txt.nlp	25594040	SENT44	10	10	45	45	imatinib	PI3K	PA10804	5290	0.8
NULL	Arthritis_2012_Dec_27_2012_764621.nxml.txt.nlp	23326663	SENT139	16	16	23	23	infliximab	ACL	PA452639	47	0.8
NULL	Comput_Math_Methods_Med_2014_Oct_13_2014_867289.nxml.txt.nlp	25371703	SENT3	6	6	15	15	vorinostat	HDAC	PA164748224	9734	0.8
NULL	Asian_J_Androl_2014_Jan_17_Mar-Apr_16(2)_274-279.nxml.txt.nlp	24457841	SENT125	5	5	29	29	dutasteride	ARTS	PA164749300	5414	0.8
NULL	Adv_Biomed_Res_2014_Jan_27_3_53.nxml.txt.nlp	24627861	SENT33	24	24	32	32	heparin	VIII	PA449855	1351	0.8
NULL	Acta_Pharmacol_Sin_2012_Jul_18_33(7)_861-872.nxml.txt.nlp	22705730	SENT181	6	6	8	8	atorvastatin	PDK1	PA448500	5170;5163	0.8
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT189	23	23	15	15	trastuzumab	KRT5	PA451743	3852	0.8
NULL	Arthritis_Res_Ther_2008_Apr_16_10(2)_R43.nxml.txt.nlp	18416822	SENT240	8	8	27	27	sr144528	ERK2		5594	0.8
NULL	Cancer_Microenviron_2009_Sep_26_2(Suppl_1)_19-204.nxml.txt.nlp	NULL	SENT1017	10	10	6	6	celecoxib	COX	PA448871	1351	0.8
NULL	Cell_Cycle_2014_Jan_15_13(2)_249-267.nxml.txt.nlp	24200965	SENT458	25	25	20	20	berberine	MDM2	PA165860812	4193	0.8
NULL	J_Gynecol_Oncol_2014_Oct_7_25(4)_328-333.nxml.txt.nlp	25142624	SENT90	13	13	7	7	cisplatin	AMH	PA449014	268	0.8
NULL	Br_J_Cancer_2011_Dec_6_105(12)_1839-1849.nxml.txt.nlp	22045192	SENT102	0	0	22	22	hyaluronan	HABP	PA165958431	3026	0.8
NULL	J_Gastroenterol_2013_Jan_27_48(1)_22-30.nxml.txt.nlp	23104468	SENT156	31	31	23	23	ribavirin	RVR	PA451241	9975	0.8
NULL	Indian_J_Pharmacol_2013_Jan-Feb_45(1)_9-12.nxml.txt.nlp	23543259	SENT3	14	14	5	5	salbutamol	eNOS	PA448068	4846	0.8
NULL	Int_J_Mol_Sci_2014_Oct_8_15(10)_17974-17999.nxml.txt.nlp	25299695	SENT253	10	10	17	17	curcumin	HO-1	PA151958596	3162	0.8
NULL	J_Biol_Chem_2013_Dec_6_288(49)_35387-35395.nxml.txt.nlp	24142790	SENT242	5	5	15	15	meclizine	PCYT2	PA450338	5833	0.8
NULL	Neuro_Oncol_2010_Aug_14_12(8)_882-889.nxml.txt.nlp	20472883	SENT143	5	5	28	28	everolimus	EGFR	PA164746311	1956	0.8
NULL	Arthritis_Res_2002_Aug_6_4(5)_307-321.nxml.txt.nlp	12223105	SENT355	15	15	31	31	infliximab	IFN	PA452639	3439	0.8
NULL	Diabetes_2009_Apr_23_58(4)_917-925.nxml.txt.nlp	19168598	SENT48	1	1	22	22	trypsin	San	PA451806	80218	0.8
NULL	Adv_Hematol_2012_Mar_8_2012_856341.nxml.txt.nlp	22496694	SENT92	3	3	14	14	rivaroxaban	CYP3A4	PA165958360	1576	0.8
NULL	Cancer_Med_2013_Feb_3_2(1)_11-20.nxml.txt.nlp	24133623	SENT385	7	7	16	16	cetuximab	KRAS	PA10040	3845	0.8
NULL	Gut_Liver_2015_Jan_9(1)_18-27.nxml.txt.nlp	NULL	SENT56	18	18	4	4	infliximab	ACT	PA452639	12;11332;9457;641455	0.8
NULL	Diabetes_Care_2012_Feb_16_35(2)_327-333.nxml.txt.nlp	22179958	SENT112	35	35	12	12	metformin	B12	PA450395	7126;4709	0.8
NULL	Cell_Oncol_(Dordr)_2011_Apr_19_34(2)_71-88.nxml.txt.nlp	21336636	SENT74	20	20	5	5	mitomycin	BRCA1	PA450524	672	0.8
NULL	Neural_Regen_Res_2014_Nov_1_9(21)_1897-1901.nxml.txt.nlp	25558239	SENT127	5	5	15	15	diazepam	CA1	PA449283	759	0.8
NULL	J_Med_Life_2011_Feb_15_4(1)_11-20.nxml.txt.nlp	21505570	SENT183	12	12	19	19	indomethacin	CB1	PA449982	1268	0.8
NULL	Eur_J_Histochem_2010_Jun_14_54(2)_e15.nxml.txt.nlp	20558338	SENT162	3	3	9	9	flutamide	PD2	PA449685	54623	0.8
NULL	Diabetes_2011_Mar_21_60(3)_757-765.nxml.txt.nlp	21282370	SENT159	21	21	5	5	isoproterenol	PTRF	PA450121	284119	0.8
NULL	Front_Cell_Neurosci_2014_Feb_6_8_27.nxml.txt.nlp	24567703	SENT1065	0	0	6	6	taurine	KCC2	PA451590	57468	0.8
NULL	Nat_Commun_2013_Sep_20_4_2444.nxml.txt.nlp	24051492	SENT145	10	10	3	3	nutlin-3	p53		7157	0.8
NULL	J_Biol_Chem_2012_Aug_24_287(35)_30000-30013.nxml.txt.nlp	22773837	SENT14	25	25	5	5	thrombin	GPVI	PA451674	51206	0.8
NULL	Cent_European_J_Urol_2013_Dec_19_66(4)_394-404.nxml.txt.nlp	24757527	SENT172	20	20	18	18	bevacizumab	IFN	PA130232992	3439	0.8
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT366	3	3	11	11	ziprasidone	PRL	PA451974	5617	0.8
NULL	Oncotarget_2011_Apr_27_2(4)_284-286.nxml.txt.nlp	21525531	SENT13	20	20	12	12	geldanamycin	Hsp90	PA152031327	3320	0.8
NULL	Int_J_Circumpolar_Health_2013_Aug_5_72_10_3402_ijch_v72i0_20854.nxml.txt.nlp	23984273	SENT170	15	15	19	19	ceftriaxone	TMP	PA448866	2012	0.8
NULL	Drug_Des_Devel_Ther_2014_Sep_23_8_1527-1538.nxml.txt.nlp	25284985	SENT95	5	5	3	3	celecoxib	IFN	PA448871	3439	0.8
NULL	Gastric_Cancer_2014_Dec_8_17(4)_630-637.nxml.txt.nlp	24318670	SENT192	3	3	27	27	irinotecan	BRAF	PA450085	673	0.8
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT194	15	15	42	42	adalimumab	CD36	PA10004	948	0.8
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT7	32	32	19	19	ranibizumab	VEGF-A	PA164746012	7422	0.8
NULL	J_Cancer_Prev_2014_Mar_19(1)_39-46.nxml.txt.nlp	25337571	SENT94	16	16	23	23	ethanol	p38	PA448073	10598;1432;7965	0.8
NULL	Indian_J_Pharm_Sci_2014_Mar-Apr_76(2)_125-131.nxml.txt.nlp	24843185	SENT177	17	17	5	5	resveratrol	S100B		6285	0.8
NULL	Arthritis_Res_Ther_2014_Mar_11_16(2)_R65.nxml.txt.nlp	24612997	SENT304	8	8	19	19	valsartan	IL-8	PA451848	3576	0.8
NULL	J_Cell_Mol_Med_2014_Nov_12_18(11)_2198-2212.nxml.txt.nlp	25215580	SENT12	15	15	17	17	bleomycin	BLM	PA448645	641	0.8
NULL	Indian_J_Med_Paediatr_Oncol_2014_Oct-Dec_35(4)_271-275.nxml.txt.nlp	25538404	SENT126	9	9	6	6	vemurafenib	BRAF	PA165946873	673	0.8
NULL	Clin_Med_Insights_Oncol_2012_Feb_28_6_125-135.nxml.txt.nlp	22408376	SENT53	10	10	31	31	panitumumab	KRAS	PA162373091	3845	0.8
NULL	Indian_J_Endocrinol_Metab_2012_May-Jun_16(3)_343-348.nxml.txt.nlp	22629497	SENT173	13	13	8	8	teriparatide	Tech	PA451620	57449	0.8
NULL	Int_J_Mol_Sci_2014_Nov_5_15(11)_20169-20208.nxml.txt.nlp	25380523	SENT1854	4	4	7	7	fenofibrate	Q10	PA449594	27161	0.8
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_9_2013_456747.nxml.txt.nlp	23653662	SENT127	2	2	31	31	berberine	NFKB1	PA165860812	4790	0.8
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R91.nxml.txt.nlp	22541814	SENT117	0	0	2	2	thrombin	HO-1	PA451674	3162	0.8
NULL	Diabetes_Care_2010_Dec_30_33(12)_2549-2551.nxml.txt.nlp	20805256	SENT57	10	10	0	0	metformin	ADM	PA450395	133	0.8
NULL	Iran_J_Pharm_Res_2014_Autumn_13(4)_1393-1401.nxml.txt.nlp	25587329	SENT122	11	11	13	13	celecoxib	ABCG2	PA448871	9429	0.8
NULL	Br_J_Cancer_2013_Apr_16_108(7)_1408-1414.nxml.txt.nlp	23511562	SENT143	17	17	13	13	tamoxifen	aromatase	PA451581	1588	0.8
NULL	Case_Rep_Med_2009_Dec_9_2009_315687.nxml.txt.nlp	20029646	SENT16	3	3	13	13	ketoconazole	C17	PA450146	54360	0.8
NULL	Curr_Heart_Fail_Rep_2011_Dec_13_8(4)_242-251.nxml.txt.nlp	21842146	SENT139	35	35	24	24	sitagliptin	GLP-1	PA164748978	100125288	0.8
NULL	Basic_Clin_Pharmacol_Toxicol_2013_Feb_5_112(2)_132-137.nxml.txt.nlp	22900583	SENT154	17	17	5	5	midazolam	CYP3A	PA450496	1574	0.8
NULL	Oncol_Lett_2014_Jun_4_7(6)_2175-2179.nxml.txt.nlp	24932311	SENT93	17	17	14	14	choline	PEMT	PA448976	10400	0.8
NULL	Pharm_Pract_(Granada)_2011_Mar_15_Jan-Mar_9(1)_1-10.nxml.txt.nlp	25132883	SENT146	11	11	19	19	dabigatran	SPAF		166378	0.8
NULL	Colorectal_Dis_2012_Feb_14(2)_e31-e47.nxml.txt.nlp	21848897	SENT121	11	11	27	27	cetuximab	KRAS	PA10040	3845	0.8
NULL	Br_J_Haematol_2014_Mar_13_164(1)_811-821.nxml.txt.nlp	24328678	SENT23	5	5	13	13	lenalidomide	IL2	PA162363968	3558	0.8
NULL	Oncol_Lett_2013_Feb_7_5(2)_440-446.nxml.txt.nlp	23420122	SENT109	15	15	27	27	gemcitabine	Bcl-2	PA449748	596	0.8
NULL	Braz_J_Med_Biol_Res_2012_Jul_20_45(10)_935-941.nxml.txt.nlp	22801415	SENT175	7	7	12	12	pioglitazone	adiponectin	PA450970	9370	0.8
NULL	FEBS_Open_Bio_2014_Jan_6_4_77-89.nxml.txt.nlp	24490132	SENT750	22	22	29	29	ebselen	NAC	PA161660841	22861	0.8
NULL	Br_J_Cancer_2006_Feb_13_94(3)_407-426.nxml.txt.nlp	16434996	SENT265	16	16	24	24	genistein	BRCA1	PA165109660	672	0.8
NULL	J_Gynecol_Oncol_2014_Jul_3_25(3)_249-259.nxml.txt.nlp	25045438	SENT145	12	12	16	16	carboplatin	WEE1	PA448803	7465	0.8
NULL	Oncol_Rep_2013_Apr_23_29(4)_1268-1274.nxml.txt.nlp	23354756	SENT171	26	26	9	9	paclitaxel	SLC25A43	PA450761	203427	0.8
NULL	J_Cardiothorac_Surg_2012_Jun_28_7_61.nxml.txt.nlp	22741616	SENT108	7	7	4	4	amiodarone	NAC	PA448383	22861	0.8
NULL	Chem_Cent_J_2013_Sep_23_7_159.nxml.txt.nlp	24059652	SENT122	16	16	2	2	ethanol	flower	PA448073	11094	0.8
NULL	Pharm_Pract_(Granada)_2009_Mar_15_Jan-Mar_7(1)_54-58.nxml.txt.nlp	25147593	SENT83	0	0	7	7	clonazepam	gamma	PA449050	9913	0.8
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT170	14	14	26	26	trastuzumab	HER3	PA451743	2065	0.8
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT100	8	8	32	32	trastuzumab	PI3K	PA451743	5290	0.8
NULL	Int_J_Mol_Imaging_2011_Oct_26_2011_874585.nxml.txt.nlp	21490735	SENT204	37	37	0	0	docetaxel	FDG	PA449383	23583	0.8
NULL	Br_J_Pharmacol_2008_Oct_18_155(4)_596-605.nxml.txt.nlp	18852694	SENT149	16	16	21	21	fenofibrate	SREBP2	PA449594	6721	0.8
NULL	F1000Res_2014_Jun_4_3_76.nxml.txt.nlp	25075293	SENT61	7	7	14	14	ustekinumab	IL-23	PA166048654	51561	0.8
NULL	EMBO_Mol_Med_2011_May_3(5)_266-278.nxml.txt.nlp	21438154	SENT244	25	25	28	28	oxaliplatin	HCN1	PA131285527	348980	0.8
NULL	Breast_Cancer_Res_2010_Jun_28_12(3)_R43.nxml.txt.nlp	20579400	SENT286	9	9	2	2	fulvestrant	MAPT	PA164747170	4137	0.8
NULL	Mol_Vis_2012_Apr_11_18_901-908.nxml.txt.nlp	22539869	SENT83	8	8	2	2	curcumin	HO-1	PA151958596	3162	0.8
NULL	EMBO_Mol_Med_2013_May_22_5(5)_776-794.nxml.txt.nlp	23606583	SENT175	17	17	28	28	maraviroc	CCR5	PA164768835	1234	0.8
NULL	Breast_Cancer_(Auckl)_2011_Oct_9_5_209-226.nxml.txt.nlp	22084574	SENT252	7	7	3	3	tamoxifen	ATAC	PA451581	6375	0.8
NULL	Core_Evid_2010_Jul_27_5_1-10.nxml.txt.nlp	20694135	SENT165	13	13	9	9	entacapone	CLE	PA164748726	51637	0.8
NULL	Arthritis_Res_Ther_2013_Oct_30_15(5)_R171.nxml.txt.nlp	24286269	SENT77	35	35	8	8	tocilizumab	GML	PA165292659	2765	0.8
NULL	Clin_Exp_Otorhinolaryngol_2011_Dec_15_4(4)_177-183.nxml.txt.nlp	22232712	SENT129	3	3	10	10	doxycycline	p38	PA449415	10598;1432;7965	0.8
NULL	Crit_Care_2011_Mar_11_15(Suppl_1)_P251.nxml.txt.nlp	NULL	SENT20	10	10	22	22	thrombin	PAR-1	PA451674	2011;2149	0.8
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2675-2684.nxml.txt.nlp	24129246	SENT205	7	7	13	13	etoposide	SIRT1	PA449552	23411	0.8
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT208	0	0	21	21	tacrolimus	RANKL	PA451578	8600	0.8
NULL	J_Cardiothorac_Surg_2012_Sep_27_7_97.nxml.txt.nlp	23013706	SENT30	24	24	3	3	warfarin	CYP4F2	PA451906	8529	0.8
NULL	Br_J_Cancer_2010_Nov_2_103(11)_1637-1643.nxml.txt.nlp	21045832	SENT178	6	6	8	8	sirolimus	VEGFR	PA451365	3791	0.8
NULL	Breast_Cancer_Res_2012_Aug_8_14(4)_R116.nxml.txt.nlp	22873525	SENT150	14	14	6	6	trastuzumab	HER2	PA451743	2064	0.8
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_May_22_66(Pt_6)_o1397.nxml.txt.nlp	21579476	SENT47	24	24	39	39	ethanol	mol	PA448073	90527	0.8
NULL	Orphanet_J_Rare_Dis_2012_Apr_19_7_21.nxml.txt.nlp	22515166	SENT6	0	0	22	22	bezafibrate	COX	PA162364313	1351	0.8
NULL	Oncogene_2010_May_20_29(20)_2983-2995.nxml.txt.nlp	20208560	SENT8	15	15	4	4	tamoxifen	FOXM1	PA451581	2305	0.799
NULL	Acta_Pharmacol_Sin_2012_Oct_3_33(10)_1311-1318.nxml.txt.nlp	22941289	SENT187	0	0	10	10	sorafenib	VEGFR2	PA7000	3791	0.799
NULL	Breast_Cancer_Res_2012_Feb_14_14(1)_R30.nxml.txt.nlp	22333315	SENT21	15	15	28	28	celecoxib	COX	PA448871	1351	0.799
NULL	Mol_Cancer_2012_Apr_5_11_20.nxml.txt.nlp	22480225	SENT222	27	27	2	2	temozolomide	HSP27	PA451609	3315	0.799
NULL	Cell_Cycle_2013_Sep_1_12(17)_2876-2887.nxml.txt.nlp	23966160	SENT130	34	34	9	9	paclitaxel	TUBGCP2	PA450761	10844	0.799
NULL	Breast_Cancer_Res_2007_Nov_1_9(6)_R75.nxml.txt.nlp	17976236	SENT173	24	24	21	21	letrozole	aromatase	PA450196	1588	0.799
NULL	Oncol_Rep_2013_Mar_8_29(3)_917-924.nxml.txt.nlp	23314174	SENT187	21	21	25	25	sorafenib	HIF-1	PA7000	29072	0.799
NULL	Nucleic_Acids_Res_2005_Apr_11_33(7)_2061-2077.nxml.txt.nlp	15824059	SENT76	20	20	9	9	thrombin	p53	PA451674	7157	0.799
NULL	Ann_Gastroenterol_2014_27(4)_380-386.nxml.txt.nlp	25331321	SENT27	22	22	14	14	lamivudine	IFN	PA450163	3439	0.799
NULL	J_Antimicrob_Chemother_2009_Feb_28_63(2)_389-395.nxml.txt.nlp	19042940	SENT104	21	21	30	30	trimethoprim	UTI	PA451788	259	0.799
NULL	Acta_Pharmacol_Sin_2012_May_16_33(5)_682-690.nxml.txt.nlp	22504904	SENT172	22	22	15	15	celecoxib	Mcl-1	PA448871	4170	0.799
NULL	Ann_Lab_Med_2013_May_17_33(3)_229-232.nxml.txt.nlp	23667855	SENT54	43	43	27	27	hydroxyurea	MPN	PA449942	83886	0.799
NULL	Int_Clin_Psychopharmacol_2014_Nov_3_29(6)_351-356.nxml.txt.nlp	24978955	SENT127	8	8	12	12	vilazodone	STAR	PA165958365	6770;2984	0.799
NULL	Clin_Interv_Aging_2008_Mar_3(1)_45-50.nxml.txt.nlp	18488877	SENT52	10	10	15	15	tamoxifen	STAR	PA451581	6770;2984	0.799
NULL	Breast_Cancer_Res_2012_Feb_8_14(1)_R26.nxml.txt.nlp	22316048	SENT261	15	15	17	17	tamoxifen	aromatase	PA451581	1588	0.799
NULL	Front_Neurol_2013_May_1_4_10.nxml.txt.nlp	23641231	SENT176	6	6	17	17	natalizumab	IFN	PA164747191	3439	0.799
NULL	Br_J_Pharmacol_2012_Jan_165(2)_390-400.nxml.txt.nlp	21671897	SENT181	5	5	2	2	suramin	P2X1	PA10292	5023	0.799
NULL	J_Cancer_Prev_2014_Jun_19(2)_97-102.nxml.txt.nlp	25337577	SENT95	12	12	4	4	gemcitabine	IL-6	PA449748	3569	0.799
NULL	J_Carcinog_2013_Aug_8_12_16.nxml.txt.nlp	24082825	SENT101	19	19	9	9	phenformin	LKB1	PA1000	6794	0.799
NULL	Int_J_Gen_Med_2012_Nov_23_5_983-990.nxml.txt.nlp	23226071	SENT45	15	15	7	7	lamivudine	ART	PA450163	181	0.799
NULL	Exp_Diabetes_Res_2012_Jul_19_2012_242984.nxml.txt.nlp	21785581	SENT57	0	0	15	15	rosiglitazone	adiponectin	PA451283	9370	0.799
NULL	Cardiovasc_Res_2012_Dec_1_96(3)_552-560.nxml.txt.nlp	22918977	SENT268	7	7	20	20	hydralazine	JAM-A	PA449894	50848	0.799
NULL	Indian_J_Pharmacol_2008_Aug_40(4)_137-143.nxml.txt.nlp	20040945	SENT157	32	32	10	10	warfarin	CYP2C9	PA451906	1559	0.799
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT286	8	8	11	11	ranibizumab	VEGF-A	PA164746012	7422	0.799
NULL	Braz_J_Med_Biol_Res_2013_Mar_15_46(3)_299-305.nxml.txt.nlp	23532269	SENT183	7	7	28	28	propofol	CD14	PA451141	929	0.799
NULL	Jpn_Clin_Med_2010_Oct_19_1_5-11.nxml.txt.nlp	23946675	SENT4	16	16	22	22	exenatide	GLP-1	PA164749238	100125288	0.799
NULL	Cancers_(Basel)_2012_Mar_27_4(2)_340-353.nxml.txt.nlp	24213314	SENT35	13	13	30	30	sunitinib	VEGFA	PA162372840	7422	0.799
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1063.nxml.txt.nlp	24556678	SENT256	5	5	7	7	thioridazine	TRAIL	PA451666	8743	0.799
NULL	Clin_Med_Insights_Cardiol_2010_Dec_1_4_117-128.nxml.txt.nlp	21151850	SENT206	19	19	23	23	clopidogrel	CYP2C19	PA449053	1557	0.799
NULL	J_Biomed_Sci_2014_May_24_21(1)_51.nxml.txt.nlp	24885898	SENT39	11	11	20	20	taurine	spatial	PA451590	219793	0.799
NULL	Oncoimmunology_2013_Dec_1_2(12)_e27215.nxml.txt.nlp	24501692	SENT32	39	39	11	11	erlotinib	STAT3	PA134687924	6774	0.799
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT381	7	7	13	13	dasatinib	BTK	PA162372878	695	0.799
NULL	Cancers_(Basel)_2014_Mar_6_6(1)_494-525.nxml.txt.nlp	24662938	SENT579	1	1	9	9	auranofin	JAK1	PA448510	3716	0.799
NULL	J_Cell_Biol_1995_May_1_129(3)_831-842.nxml.txt.nlp	7537275	SENT4	16	16	29	29	thrombin	p85	PA451674	5296;5295;54776;23368	0.799
NULL	Toxins_(Basel)_2010_Oct_28_2(11)_2584-2592.nxml.txt.nlp	22069565	SENT67	6	6	16	16	warfarin	CYP2C9	PA451906	1559	0.799
NULL	J_Clin_Exp_Pathol_2012_May_17_Suppl_4_7327.nxml.txt.nlp	25379357	SENT30	21	21	4	4	resveratrol	AMPK		5563	0.799
NULL	Mol_Cancer_2006_Oct_17_5_45.nxml.txt.nlp	17044934	SENT16	4	4	9	9	resveratrol	COX		1351	0.799
NULL	Br_J_Cancer_2010_Jul_13_103(2)_159-164.nxml.txt.nlp	20551951	SENT16	11	11	19	19	irinotecan	EGFR	PA450085	1956	0.799
NULL	Diabetes_Metab_Syndr_Obes_2014_Jul_17_7_313-319.nxml.txt.nlp	25092992	SENT92	34	34	10	10	pioglitazone	adiponectin	PA450970	9370	0.799
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_6_2014_270930.nxml.txt.nlp	25431606	SENT184	29	29	9	9	curcumin	IL-6	PA151958596	3569	0.799
NULL	Exp_Diabetes_Res_2012_Sep_20_2012_936518.nxml.txt.nlp	23049542	SENT134	16	16	19	19	glucose	TRPV4	PA449773	59341	0.799
NULL	J_Cell_Biol_1998_Jul_27_142(2)_523-535.nxml.txt.nlp	9679149	SENT7	23	23	6	6	phenylephrine	p38	PA450935	10598;1432;7965	0.799
NULL	Cancer_Manag_Res_2013_Nov_21_5_387-400.nxml.txt.nlp	24294007	SENT116	12	12	29	29	vemurafenib	EGFR	PA165946873	1956	0.799
NULL	Int_J_Breast_Cancer_2012_May_9_2012_415170.nxml.txt.nlp	22649737	SENT161	10	10	28	28	lapatinib	HER2	PA152241907	2064	0.799
NULL	Int_Immunopharmacol_2013_Mar_15(3)_638-645.nxml.txt.nlp	23434857	SENT321	1	1	7	7	abatacept	CD64	PA164747080	2209	0.799
NULL	Int_J_Environ_Res_Public_Health_2012_Sep_19_9(9)_3354-3364.nxml.txt.nlp	23202692	SENT292	7	7	5	5	resveratrol	NQO1		1728	0.799
NULL	Biomed_Res_Int_2014_Apr_13_2014_187989.nxml.txt.nlp	24818130	SENT115	6	6	4	4	capsaicin	TRPV1	PA448776	7442	0.799
NULL	Acta_Naturae_2011_Jan-Mar_3(1)_20-28.nxml.txt.nlp	22649671	SENT44	5	5	18	18	trastuzumab	HER2	PA451743	2064	0.799
NULL	Int_J_Biol_Sci_2013_Nov_21_9(10)_1089-1098.nxml.txt.nlp	24339730	SENT24	10	10	16	16	genistein	RUNX2	PA165109660	860	0.799
NULL	Mediators_Inflamm_2010_Jun_21_2010_194896.nxml.txt.nlp	20652055	SENT183	25	25	0	0	berberine	AP-1	PA165860812	2353;3727;2354;3725	0.799
NULL	J_Cell_Biol_1999_Feb_22_144(4)_789-801.nxml.txt.nlp	10037799	SENT56	28	28	43	43	ethanol	LYVE-1	PA448073	10894	0.799
NULL	Arthritis_Res_Ther_2006_Feb_28_8(2)_R49.nxml.txt.nlp	16507174	SENT39	18	18	10	10	fluorescein	CD80	PA164746009	941	0.799
NULL	Paediatr_Drugs_2013_Apr_20_15(2)_119-131.nxml.txt.nlp	23512128	SENT168	2	2	33	33	pantoprazole	ANOVA	PA450774	4858	0.799
NULL	Curr_Control_Trials_Cardiovasc_Med_2001_Jul_23_2(4)_195-204.nxml.txt.nlp	11806795	SENT52	13	13	0	0	bezafibrate	Men	PA162364313	8178	0.799
NULL	Breast_Cancer_Res_2011_Mar_11_13(2)_R29.nxml.txt.nlp	21396094	SENT146	32	32	9	9	fulvestrant	HRG	PA164747170	3084;3273	0.799
NULL	Acta_Pharmacol_Sin_2014_Jun_4_35(6)_792-805.nxml.txt.nlp	24902787	SENT248	7	7	16	16	paroxetine	INS-1	PA450801	2305	0.799
NULL	Emerg_Infect_Dis_2011_Mar_17(3)_495-497.nxml.txt.nlp	21392442	SENT53	8	8	3	3	capreomycin	DST	PA164746226	667	0.799
NULL	Evid_Based_Complement_Alternat_Med_2007_Jun_23_4(2)_181-190.nxml.txt.nlp	17549234	SENT64	2	2	4	4	curcumin	AP-1	PA151958596	2353;3727;2354;3725	0.799
NULL	Anesth_Essays_Res_2014_May-Aug_8(2)_192-196.nxml.txt.nlp	NULL	SENT97	5	5	8	8	diclofenac	COX	PA449293	1351	0.799
NULL	FEBS_Open_Bio_2011_Dec_27_2_1-5.nxml.txt.nlp	23650573	SENT300	22	22	2	2	sunitinib	MDM2	PA162372840	4193	0.799
NULL	J_Cell_Biol_2001_May_14_153(4)_785-794.nxml.txt.nlp	11352939	SENT92	2	2	8	8	tetracycline	EPM	PA451640	2054	0.799
NULL	Front_Oncol_2014_Apr_9_4_75.nxml.txt.nlp	24782986	SENT127	15	15	9	9	paclitaxel	CA125	PA450761	4077;94025	0.799
NULL	Cancer_Cell_Int_2013_Dec_23_13_123.nxml.txt.nlp	24365069	SENT27	37	37	24	24	simvastatin	CD34	PA451363	947	0.799
NULL	Biomed_Res_Int_2013_Jul_1_2013_964743.nxml.txt.nlp	23936861	SENT145	29	29	23	23	erlotinib	EGFR	PA134687924	1956	0.799
NULL	Ther_Clin_Risk_Manag_2007_Jun_3(3)_401-410.nxml.txt.nlp	18488071	SENT54	13	13	15	15	tramadol	ACR	PA451735	49	0.799
NULL	Environ_Health_Perspect_2005_Aug_15_113(8)_1009-1014.nxml.txt.nlp	16079071	SENT119	2	2	7	7	captopril	p38	PA448780	10598;1432;7965	0.799
NULL	Oncoscience_2014_Oct_22_1(10)_614-623.nxml.txt.nlp	25593991	SENT95	38	38	7	7	panitumumab	KRAS	PA162373091	3845	0.799
NULL	Physiol_Rep_2014_Oct_24_2(10)_e12175.nxml.txt.nlp	25344477	SENT35	32	32	17	17	thrombin	Rho	PA451674	29984	0.799
NULL	Br_J_Pharmacol_2011_Apr_162(8)_1832-1842.nxml.txt.nlp	21232033	SENT192	9	9	21	21	ethanol	SAP97	PA448073	1739	0.799
NULL	BMB_Rep_2013_Nov_46(11)_544-549.nxml.txt.nlp	24152910	SENT41	6	6	21	21	thrombin	PAR-1	PA451674	2011;2149	0.799
NULL	Pain_2014_Oct_155(10)_2097-2107.nxml.txt.nlp	25083927	SENT214	5	5	3	3	capsaicin	TRPV1	PA448776	7442	0.799
NULL	Clin_Med_Insights_Oncol_2013_Feb_28_7_53-73.nxml.txt.nlp	23492937	SENT35	6	6	15	15	bortezomib	JNK	PA10252	5599	0.799
NULL	Diagn_Pathol_2013_Nov_25_8_192.nxml.txt.nlp	24274261	SENT89	2	2	14	14	dacarbazine	IFN	PA449197	3439	0.799
NULL	Front_Oncol_2013_Nov_15_3_281.nxml.txt.nlp	24298448	SENT194	15	15	22	22	cetuximab	KRAS	PA10040	3845	0.799
NULL	Ann_Hematol_2014_Apr_1_93(8)_1371-1380.nxml.txt.nlp	24687382	SENT29	6	6	22	22	thalidomide	IKZF3	PA451644	22806	0.799
NULL	Breast_Cancer_Res_2009_Oct_28_11(5)_211.nxml.txt.nlp	19889200	SENT240	30	30	34	34	tamoxifen	HER2	PA451581	2064	0.799
NULL	Biologics_2012_Feb_1_6_31-35.nxml.txt.nlp	22355257	SENT3	11	11	32	32	rituximab	IL-10	PA451261	3586	0.799
NULL	Case_Rep_Rheumatol_2012_Dec_24_2012_270315.nxml.txt.nlp	23424706	SENT7	0	0	11	11	tocilizumab	IL-8	PA165292659	3576	0.799
NULL	J_Exp_Med_1998_Jun_1_187(11)_1885-1892.nxml.txt.nlp	9607928	SENT146	2	2	12	12	thalidomide	CD4	PA451644	920	0.799
NULL	Indian_J_Pharmacol_2013_Jan-Feb_45(1)_54-60.nxml.txt.nlp	23543867	SENT194	5	5	16	16	terlipressin	NAC	PA164781020	22861	0.799
NULL	Oncogene_2014_Aug_28_33(35)_4407-4417.nxml.txt.nlp	24469038	SENT42	18	18	8	8	cisplatin	14-3-3	PA449014	10971	0.799
NULL	J_Cell_Mol_Med_2014_Aug_6_18(8)_1519-1539.nxml.txt.nlp	25100284	SENT26	0	0	14	14	afatinib	EGFR	PA165981154	1956	0.799
NULL	Diabetes_Care_2010_Jul_33(7)_1691-1692.nxml.txt.nlp	20587731	SENT30	16	16	22	22	exenatide	GLP-1	PA164749238	100125288	0.799
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT222	10	10	2	2	simvastatin	survivin	PA451363	332	0.799
NULL	J_Cancer_Prev_2014_Mar_19(1)_39-46.nxml.txt.nlp	25337571	SENT88	8	8	3	3	ethanol	p38	PA448073	10598;1432;7965	0.799
NULL	Avicenna_J_Med_2013_Apr-Jun_3(2)_37-47.nxml.txt.nlp	23930241	SENT201	10	10	16	16	azathioprine	CD4	PA448515	920	0.799
NULL	F1000_Med_Rep_2009_Feb_24_1_13.nxml.txt.nlp	20948769	SENT79	21	21	42	42	vincristine	CHOP	PA451879	1649	0.799
NULL	Oncoscience_2014_Mar_12_1(2)_158-166.nxml.txt.nlp	25594008	SENT47	23	23	16	16	dasatinib	PTRF	PA162372878	284119	0.799
NULL	Mol_Cancer_2008_Jun_30_7_60.nxml.txt.nlp	18590557	SENT168	7	7	22	22	paclitaxel	TRAIL	PA450761	8743	0.799
NULL	J_Hematol_Oncol_2013_Jul_18_6_53.nxml.txt.nlp	23866964	SENT141	3	3	7	7	temsirolimus	MTOR	PA164746890	2475	0.799
NULL	Br_J_Cancer_2013_Feb_19_108(3)_557-563.nxml.txt.nlp	23361053	SENT193	33	33	27	27	tamoxifen	PAK1	PA451581	5585;5058	0.799
NULL	Cell_Death_Dis_2011_Aug_11_2(8)_e190.nxml.txt.nlp	21833028	SENT125	9	9	26	26	lovastatin	DDB2	PA450272	1643	0.799
NULL	Leukemia_2013_Apr_14_27(4)_803-812.nxml.txt.nlp	23238589	SENT56	5	5	8	8	imatinib	IFN	PA10804	3439	0.799
NULL	Oncol_Lett_2014_Jul_12_8(1)_223-229.nxml.txt.nlp	24959250	SENT153	2	2	13	13	captopril	MCP-1	PA448780	6347	0.799
NULL	CNS_Drugs_2014_Jun_24_28(10)_875-886.nxml.txt.nlp	24958205	SENT150	9	9	2	2	liraglutide	GLP-1	PA165958364	100125288	0.799
NULL	Oncol_Lett_2013_Feb_7_5(2)_440-446.nxml.txt.nlp	23420122	SENT5	13	13	20	20	gemcitabine	EGFR	PA449748	1956	0.799
NULL	J_Clin_Biochem_Nutr_2009_Nov_28_45(3)_285-291.nxml.txt.nlp	19902018	SENT106	0	0	20	20	hesperetin	XDH	PA164742902	7498	0.799
NULL	Cardiovasc_Diabetol_2010_Jun_24_9_27.nxml.txt.nlp	20576156	SENT51	25	25	5	5	dobutamine	TDI	PA449381	100038246	0.799
NULL	Eplasty_2008_May_16_8_e27.nxml.txt.nlp	18552974	SENT160	0	0	4	4	hydroxocobalamin	B12	PA164768689	7126;4709	0.799
NULL	Clin_Ophthalmol_2010_Apr_26_4_369-374.nxml.txt.nlp	20463807	SENT2	4	4	31	31	pegaptanib	PED	PA164771236	8682	0.799
NULL	Arthritis_Rheumatol_2014_Jun_27_66(6)_1574-1582.nxml.txt.nlp	24577881	SENT151	16	16	4	4	hydralazine	ERK	PA449894	5594	0.799
NULL	Eur_J_Clin_Pharmacol_2012_Jan_7_68(1)_55-64.nxml.txt.nlp	21735164	SENT247	6	6	1	1	oxycodone	CYP2D6	PA450741	1565	0.799
NULL	J_Cell_Biol_2002_Jun_24_157(7)_1267-1278.nxml.txt.nlp	12082084	SENT180	16	16	9	9	thrombin	AC8	PA451674	114	0.799
NULL	J_Viral_Hepat_2009_May_16(5)_315-324.nxml.txt.nlp	19243499	SENT85	19	19	5	5	imiquimod	IFN	PA449972	3439	0.799
NULL	Carcinogenesis_2014_Sep_1_35(9)_1983-1992.nxml.txt.nlp	24692066	SENT45	32	32	16	16	hydrocortisone	F12	PA449905	2161	0.799
NULL	J_Nat_Sci_Biol_Med_2011_Jan-Jun_2(1)_26-37.nxml.txt.nlp	22470231	SENT101	17	17	23	23	tamoxifen	DCX	PA451581	1641	0.799
NULL	Oncogene_2009_Jan_15_28(2)_279-288.nxml.txt.nlp	18836480	SENT117	2	2	28	28	pp2	PP2		4888	0.799
NULL	Breast_Cancer_Res_2011_Jan_26_13(1)_R10.nxml.txt.nlp	21269472	SENT198	9	9	7	7	estradiol	PPARGC1B	PA449503	133522	0.799
NULL	Eur_J_Med_Res_2009_Dec_7_14(Suppl_4)_71-77.nxml.txt.nlp	20156730	SENT141	14	14	25	25	tobramycin	gamma	PA451704	9913	0.799
NULL	J_Vet_Emerg_Crit_Care_(San_Antonio)_2013_Mar_8_23(2)_134-162.nxml.txt.nlp	23566108	SENT148	48	48	19	19	calcidiol	PTH	PA164745614	5741	0.799
NULL	Oncotarget_2013_Jul_14_4(8)_1185-1198.nxml.txt.nlp	23852390	SENT5	36	36	13	13	tanespimycin	TRAIL	PA165291490	8743	0.799
NULL	BMJ_Open_2012_Sep_15_2(5)_e001260.nxml.txt.nlp	22983874	SENT205	10	10	6	6	propiomazine	OTC	PA164778685	5009	0.799
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT117	12	12	20	20	celecoxib	IL-6	PA448871	3569	0.799
NULL	Acta_Histochem_Cytochem_2012_Apr_26_45(2)_139-146.nxml.txt.nlp	22685356	SENT105	15	15	5	5	forskolin	AQP2	PA146096022	359	0.799
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT132	19	19	14	14	methotrexate	MSH2	PA450428	4436	0.799
NULL	J_Res_Med_Sci_2010_Nov-Dec_15(6)_331-343.nxml.txt.nlp	21526106	SENT26	9	9	1	1	l-arginine	HDEL	PA448478	10945	0.799
NULL	Cell_Death_Differ_2010_Oct_30_17(10)_1624-1635.nxml.txt.nlp	20431602	SENT59	8	8	29	29	paclitaxel	Bcl-2	PA450761	596	0.799
NULL	Arthritis_Res_Ther_2010_Jul_6_12(4)_R129.nxml.txt.nlp	20604932	SENT213	31	31	20	20	collagenase	CCL2	PA449107	6347	0.799
NULL	Exp_Diabetes_Res_2011_Apr_6_2011_928523.nxml.txt.nlp	21603181	SENT152	22	22	20	20	bromocriptine	DRD2	PA448671	1813	0.799
NULL	Int_J_Surg_Oncol_2012_Aug_27_2012_180574.nxml.txt.nlp	22970358	SENT26	29	29	26	26	tamoxifen	aromatase	PA451581	1588	0.799
NULL	Oncogene_2013_Sep_26_32(39)_10_1038_onc_2012_491.nxml.txt.nlp	23108394	SENT123	13	13	4	4	epirubicin	FOXM1	PA449476	2305	0.799
NULL	Acta_Neuropathol_Commun_2013_May_20_1_17.nxml.txt.nlp	24252689	SENT6	35	35	22	22	celecoxib	CD36	PA448871	948	0.799
NULL	Mol_Cancer_2010_Aug_20_9_220.nxml.txt.nlp	20727180	SENT145	13	13	17	17	nicotine	p53	PA450626	7157	0.799
NULL	Exp_Ther_Med_2013_Nov_13_6(5)_1317-1321.nxml.txt.nlp	24223665	SENT170	9	9	13	13	cisplatin	CD133	PA449014	8842	0.799
NULL	Front_Immunol_2013_Sep_4_4_270.nxml.txt.nlp	24027572	SENT57	15	15	19	19	l-glutamine	BCS	PA10090	617	0.799
NULL	Scientifica_(Cairo)_2012_Sep_11_2012_927352.nxml.txt.nlp	24278757	SENT350	25	25	4	4	atorvastatin	PCSK9	PA448500	255738	0.799
NULL	Cancer_Microenviron_2009_Sep_26_2(Suppl_1)_19-204.nxml.txt.nlp	NULL	SENT2423	11	11	20	20	urokinase	MDR1	PA451836	5243	0.799
NULL	Front_Microbiol_2012_May_29_3_185.nxml.txt.nlp	22661972	SENT123	37	37	14	14	nadh	RNF	PA164755085	11074	0.799
NULL	Clin_Exp_Metastasis_2013_Apr_27_30(4)_447-455.nxml.txt.nlp	23187934	SENT9	7	7	5	5	cetuximab	HAI	PA10040	6692;6768	0.799
NULL	Oncogene_2013_Sep_26_32(39)_10_1038_onc_2012_491.nxml.txt.nlp	23108394	SENT83	18	18	4	4	epirubicin	FOXM1	PA449476	2305	0.799
NULL	Orphanet_J_Rare_Dis_2013_Aug_23_8_127.nxml.txt.nlp	23972085	SENT39	17	17	21	21	ifosfamide	NF1	PA449964	4763	0.799
NULL	Nucleic_Acids_Res_2011_Mar_17_39(6)_2144-2152.nxml.txt.nlp	21087997	SENT143	21	21	28	28	etoposide	CtIP	PA449552	5932	0.799
NULL	J_Adv_Pract_Oncol_2012_Jan_1_Jan-Feb_3(1)_49-54.nxml.txt.nlp	25031928	SENT58	2	2	10	10	plerixafor	CD34	PA165958410	947	0.799
NULL	Carcinogenesis_2013_Mar_7_34(3)_703-712.nxml.txt.nlp	23222814	SENT126	0	0	14	14	curcumin	AKT	PA151958596	207	0.799
NULL	Allergy_Asthma_Clin_Immunol_2005_Sep_15_1(3)_101-116.nxml.txt.nlp	20529221	SENT247	13	13	4	4	desloratadine	ANOVA	PA164776964	4858	0.799
NULL	Basic_Clin_Neurosci_2014_Winter_5(1)_66-73.nxml.txt.nlp	25436086	SENT17	9	9	3	3	lidocaine	OX1R	PA450226	3061	0.799
NULL	Interdiscip_Toxicol_2009_Dec_28_2(4)_211-218.nxml.txt.nlp	21217857	SENT130	0	0	7	7	genistein	c-fos	PA165109660	2353	0.799
NULL	Case_Rep_Nephrol_Urol_2014_Apr_12_4(1)_75-81.nxml.txt.nlp	24847349	SENT6	16	16	9	9	amiodarone	APT	PA448383	653639	0.799
NULL	Mol_Cancer_2014_Jun_5_13_143.nxml.txt.nlp	24898067	SENT7	13	13	19	19	trastuzumab	DM1	PA451743	338023;1760;28509	0.799
NULL	Indian_J_Endocrinol_Metab_2012_Mar-Apr_16(2)_158-163.nxml.txt.nlp	22470850	SENT121	15	15	3	3	vasopressin	AQP2	PA451858	359	0.799
NULL	Curr_Med_Chem_2013_Jan_20(3)_438-447.nxml.txt.nlp	23157636	SENT115	11	11	4	4	olanzapine	FGA	PA450688	2243	0.799
NULL	Int_J_Biol_Sci_2005_Dec_1_1(4)_146-151.nxml.txt.nlp	18167569	SENT88	22	22	41	41	zinc	IMAC	PA451956	10344	0.799
NULL	Biomed_Res_Int_2014_Aug_6_2014_967826.nxml.txt.nlp	25165721	SENT249	12	12	3	3	cisplatin	PARP-1	PA449014	25976	0.799
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT273	18	18	23	23	irinotecan	KRAS	PA450085	3845	0.799
NULL	Cancers_(Basel)_2010_Jan_14_2(1)_1-19.nxml.txt.nlp	24281029	SENT1014	11	11	30	30	capecitabine	San	PA448771	80218	0.799
NULL	Acta_Pharmacol_Sin_2012_Dec_29_33(12)_1518-1524.nxml.txt.nlp	23103625	SENT198	2	2	8	8	telmisartan	ACE	PA451605	1636	0.799
NULL	Cancer_Cell_Int_2013_Sep_3_13_89.nxml.txt.nlp	24004445	SENT130	3	3	10	10	camptothecin	TPT	PA153590860	23590;6469	0.799
NULL	Oncogenesis_2014_Oct_20_3(10)_e122.nxml.txt.nlp	25329721	SENT31	30	30	23	23	doxycycline	IL-3	PA449415	3562	0.799
NULL	Indian_J_Dermatol_2013_May-Jun_58(3)_247c.nxml.txt.nlp	23723524	SENT25	6	6	4	4	cyclophosphamide	CHOP	PA449165	1649	0.799
NULL	Exp_Ther_Med_2012_Oct_3_4(4)_594-604.nxml.txt.nlp	23170111	SENT99	27	27	20	20	propranolol	ATF4	PA451145	468	0.799
NULL	Oncoimmunology_2012_May_1_1(3)_279-286.nxml.txt.nlp	22737603	SENT117	21	21	29	29	doxorubicin	CD47	PA449412	961	0.799
NULL	Biomed_Res_Int_2013_Apr_23_2013_282913.nxml.txt.nlp	23710439	SENT307	9	9	22	22	imiquimod	CD4	PA449972	920	0.799
NULL	Oncotarget_2013_Nov_23_5(1)_196-210.nxml.txt.nlp	24344116	SENT37	24	24	16	16	doxorubicin	p65	PA449412	5970	0.799
NULL	Vet_Res_2013_Dec_11_44(1)_121.nxml.txt.nlp	24330735	SENT144	11	11	23	23	carbachol	ATP4A	PA448784	495	0.799
NULL	Cancers_(Basel)_2014_Sep_30_6(4)_2035-2048.nxml.txt.nlp	25271833	SENT120	22	22	4	4	gefitinib	IL-2	PA131301952	3558	0.799
NULL	Br_J_Cancer_2004_Mar_22_90(6)_1285-1292.nxml.txt.nlp	15026814	SENT194	13	13	6	6	doxorubicin	p53	PA449412	7157	0.799
NULL	Anemia_2012_Nov_8_2012_607436.nxml.txt.nlp	23198140	SENT158	2	2	5	5	capsaicin	TRPV1	PA448776	7442	0.799
NULL	Diabetes_2009_Jan_58(1)_174-184.nxml.txt.nlp	18984736	SENT245	15	15	20	20	tranilast	TRPV2	PA131890628	51393	0.799
NULL	Mol_Med_Rep_2015_Feb_29_11(2)_865-870.nxml.txt.nlp	25352342	SENT121	32	32	19	19	mannitol	RANKL	PA450320	8600	0.799
NULL	Cell_Mol_Life_Sci_2011_Aug_11_68(16)_2667-2688.nxml.txt.nlp	21560073	SENT232	15	15	21	21	thrombin	GPVI	PA451674	51206	0.799
NULL	Acta_Pharmacol_Sin_2010_Feb_5_31(2)_184-190.nxml.txt.nlp	20139901	SENT118	24	24	5	5	metformin	SLC22A2	PA450395	6582	0.799
NULL	J_Carcinog_2013_Jun_29_12_11.nxml.txt.nlp	23858299	SENT193	22	22	40	40	diethylstilbestrol	DES	PA449307	1674	0.799
NULL	Oncologist_2010_Feb_15_15(2)_122-129.nxml.txt.nlp	20156908	SENT31	36	36	11	11	anastrozole	HER-2	PA448432	2064	0.799
NULL	Br_J_Cancer_2010_Sep_7_103(6)_845-851.nxml.txt.nlp	20700125	SENT5	32	32	24	24	cisplatin	ERCC1	PA449014	2067	0.799
NULL	Diabetes_Metab_J_2014_Apr_18_38(2)_100-106.nxml.txt.nlp	24851203	SENT33	9	9	1	1	acetone	MET	PA448025	4233	0.799
NULL	Oncologist_2010_Mar_9_15(3)_236-245.nxml.txt.nlp	20215359	SENT211	4	4	12	12	everolimus	VEGFR	PA164746311	3791	0.799
NULL	Br_J_Pharmacol_2013_Jun_27_169(4)_736-747.nxml.txt.nlp	23489111	SENT169	15	15	22	22	mefloquine	5-HT3A	PA450348	3359	0.799
NULL	Cardiovasc_Diabetol_2010_Nov_16_9_76.nxml.txt.nlp	21080957	SENT329	15	15	10	10	exenatide	GLP-1	PA164749238	100125288	0.799
NULL	Int_J_Gen_Med_2011_Jul_20_4_539-545.nxml.txt.nlp	21845063	SENT16	11	11	20	20	miglitol	adiponectin	PA164776726	9370	0.799
NULL	Breast_Cancer_Res_2012_Feb_14_14(1)_R30.nxml.txt.nlp	22333315	SENT227	15	15	8	8	celecoxib	CXCL9	PA448871	4283	0.799
NULL	Evid_Based_Complement_Alternat_Med_2012_Feb_12_2012_472897.nxml.txt.nlp	22454667	SENT184	14	14	11	11	roflumilast	PDE4B	PA165948052	5142	0.799
NULL	Tuberc_Respir_Dis_(Seoul)_2013_Aug_30_75(2)_59-66.nxml.txt.nlp	24023558	SENT167	6	6	12	12	docetaxel	FOXO1	PA449383	2308	0.799
NULL	Food_Nutr_Res_2011_Jan_14_55_10_3402_fnr_v55i0_5455.nxml.txt.nlp	21249160	SENT45	11	11	33	33	spermine	SNO	PA164781199	6498	0.799
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_May_20_65(Pt_6)_o1346.nxml.txt.nlp	21583198	SENT57	20	20	3	3	ethanol	mol	PA448073	90527	0.799
NULL	Cardiovasc_Diabetol_2013_Jan_31_12_28.nxml.txt.nlp	23368770	SENT264	15	15	7	7	metformin	AMPK	PA450395	5563	0.799
NULL	Arthritis_Res_Ther_2014_May_9_16(3)_R110.nxml.txt.nlp	24886698	SENT285	21	21	17	17	trypsin	ADAMTS-4	PA451806	9508	0.799
NULL	Carcinogenesis_2014_May_13_35(5)_1055-1066.nxml.txt.nlp	24419232	SENT327	24	24	42	42	metformin	AMPK	PA450395	5563	0.799
NULL	Case_Rep_Hematol_2013_Feb_3_2013_837906.nxml.txt.nlp	23431487	SENT5	2	2	10	10	desmopressin	FVIII	PA449237	2157	0.799
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT124	25	25	13	13	simvastatin	AKT	PA451363	207	0.799
NULL	Cardiovasc_Diabetol_2010_Sep_23_9_57.nxml.txt.nlp	20863381	SENT24	7	7	15	15	pioglitazone	DM2	PA450970	28508	0.799
NULL	J_Virol_2014_Oct_15_89(1)_14-24.nxml.txt.nlp	25320323	SENT71	38	38	7	7	phenol	CD4	PA450913	920	0.799
NULL	Oncoimmunology_2012_May_1_1(3)_271-278.nxml.txt.nlp	22737602	SENT7	13	13	0	0	oxaliplatin	TLR4	PA131285527	7099	0.799
NULL	J_Gen_Intern_Med_2009_May_21_24(5)_656-664.nxml.txt.nlp	19306050	SENT327	13	13	9	9	warfarin	VKORC1	PA451906	79001	0.799
NULL	Neural_Regen_Res_2013_May_5_8(13)_1180-1189.nxml.txt.nlp	25206412	SENT27	3	3	16	16	fasudil	RhoA	PA165946121	387	0.799
NULL	Exp_Cell_Res_2011_Apr_15_317(7)_1028-1039.nxml.txt.nlp	21237154	SENT11	6	6	17	17	staurosporine	JIP1	PA165109623	9479	0.799
NULL	Case_Rep_Ophthalmol_Med_2011_Jan_31_2011_679751.nxml.txt.nlp	22606470	SENT30	2	2	14	14	bevacizumab	hole	PA130232992	80757	0.799
NULL	Oncotarget_2013_Nov_7_4(12)_2550-2566.nxml.txt.nlp	24334291	SENT220	9	9	23	23	fludarabine	CHOP	PA449655	1649	0.799
NULL	Sensors_(Basel)_2012_Feb_1_12(2)_1383-1397.nxml.txt.nlp	22438715	SENT33	9	9	29	29	trypsin	CO2	PA451806	4513	0.799
NULL	Pain_Ther_2013_Dec_19_2(2)_121-128.nxml.txt.nlp	25135150	SENT58	33	33	5	5	fentanyl	ANOVA	PA449599	4858	0.799
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT278	14	14	6	6	resveratrol	ROS		6098	0.799
NULL	Toxins_(Basel)_2010_Oct_26_2(11)_2490-2518.nxml.txt.nlp	22069563	SENT137	4	4	7	7	cisplatin	PIDD	PA449014	55367	0.799
NULL	Brain_Sci_2013_Jun_3_3(2)_877-907.nxml.txt.nlp	24961429	SENT137	13	13	8	8	taurine	MELAS	PA451590	4219	0.799
NULL	Br_J_Cancer_2012_Apr_10_106(8)_1406-1414.nxml.txt.nlp	22491422	SENT5	34	34	25	25	cetuximab	EREG	PA10040	2069	0.799
NULL	J_Gen_Physiol_1964_Jul_1_47(6)_1117-1127.nxml.txt.nlp	14192549	SENT0	23	23	1	1	physostigmine	Gen	PA450957	348654	0.799
NULL	Genome_Med_2010_Nov_30_2(11)_85.nxml.txt.nlp	21122163	SENT162	18	18	9	9	imatinib	MDR1	PA10804	5243	0.799
NULL	Clin_Epigenetics_2011_Mar_1_2(2)_187-196.nxml.txt.nlp	22704336	SENT36	4	4	6	6	diethylstilbestrol	DES	PA449307	1674	0.799
NULL	Oncotarget_2014_Oct_21_5(22)_11252-11268.nxml.txt.nlp	25361004	SENT41	0	0	4	4	metformin	CLIC1	PA450395	1192	0.799
NULL	Evid_Based_Complement_Alternat_Med_2012_Dec_20_2012_908601.nxml.txt.nlp	23326293	SENT171	18	18	14	14	oxaliplatin	HCC	PA131285527	84668	0.799
NULL	Oncotarget_2011_Mar_27_2(3)_209-221.nxml.txt.nlp	21444945	SENT160	13	13	2	2	bortezomib	p53	PA10252	7157	0.799
NULL	Br_J_Cancer_1997_76(8)_1029-1034.nxml.txt.nlp	9376262	SENT16	18	18	5	5	daunorubicin	P-gp	PA449212	5243	0.799
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT155	11	11	5	5	metformin	AMPK	PA450395	5563	0.799
NULL	Pharmaceutics_2012_Jan_31_4(1)_104-129.nxml.txt.nlp	24300183	SENT334	41	41	36	36	lidocaine	SMO	PA450226	6608;54498	0.799
NULL	J_Hum_Genet_2013_Jun_16_58(6)_353-361.nxml.txt.nlp	23677058	SENT169	43	43	33	33	cytarabine	RRM1	PA449177	6240	0.799
NULL	Indian_J_Pharmacol_2013_Sep-Oct_45(5)_447-452.nxml.txt.nlp	24130377	SENT177	34	34	17	17	nevirapine	CD4	PA450616	920	0.799
NULL	Ann_Rheum_Dis_2008_Jun_2_68(5)_654-657.nxml.txt.nlp	18519424	SENT115	15	15	3	3	tocilizumab	IL6	PA165292659	3569	0.799
NULL	Indian_J_Anaesth_2014_Sep-Oct_58(5)_565-572.nxml.txt.nlp	25535418	SENT183	38	38	16	16	tirofiban	P2Y12	PA451698	64805	0.799
NULL	Curr_Neuropharmacol_2008_Dec_6(4)_311-321.nxml.txt.nlp	19587852	SENT54	5	5	16	16	fluoxetine	CA3	PA449673	761	0.799
NULL	Nucleic_Acids_Res_2011_Oct_30_39(18)_7908-7919.nxml.txt.nlp	21724609	SENT396	12	12	18	18	flavopiridol	CDK9	PA452627	1025	0.799
NULL	Braz_J_Med_Biol_Res_2013_Aug_13_46(8)_650-658.nxml.txt.nlp	23969971	SENT32	18	18	11	11	cisplatin	STAT3	PA449014	6774	0.799
NULL	Cell_Commun_Signal_2004_Jun_25_2_5.nxml.txt.nlp	15219238	SENT222	11	11	19	19	cisplatin	JNK	PA449014	5599	0.799
NULL	Pharmaceuticals_(Basel)_2011_Oct_25_4(11)_1400-1422.nxml.txt.nlp	NULL	SENT76	9	9	0	0	hydroquinone	NQO1	PA449924	1728	0.799
NULL	Environ_Health_Perspect_2009_Feb_8_117(2)_175-180.nxml.txt.nlp	19270784	SENT18	20	20	9	9	cisplatin	BPA	PA449014	667	0.799
NULL	Int_J_Hypertens_2012_Feb_8_2012_189512.nxml.txt.nlp	22518281	SENT128	10	10	5	5	hemin	HO-1	PA449849	3162	0.799
NULL	Cell_Death_Dis_2013_Jul_18_4(7)_e730.nxml.txt.nlp	23868063	SENT274	3	3	0	0	bortezomib	PES	PA10252	23481	0.799
NULL	Evid_Based_Complement_Alternat_Med_2014_May_8_2014_364819.nxml.txt.nlp	24899907	SENT50	25	25	22	22	tacrolimus	FKBP52	PA451578	2288	0.799
NULL	Endocr_Relat_Cancer_2014_Jun_21(3)_R209-R225.nxml.txt.nlp	24500760	SENT204	7	7	16	16	resveratrol	TRAMP		8718;23471;9189	0.799
NULL	Mol_Vis_2012_Oct_5_18_2454-2467.nxml.txt.nlp	23077404	SENT14	6	6	11	11	bevacizumab	VEGF-A	PA130232992	7422	0.799
NULL	Apoptosis_2014_Apr_23_19(7)_1055-1068.nxml.txt.nlp	24756955	SENT166	16	16	13	13	nutlin-3	MDM2		4193	0.799
NULL	Orphanet_J_Rare_Dis_2014_Oct_29_9(1)_162.nxml.txt.nlp	NULL	SENT119	34	34	14	14	metyrapone	ACTH	PA450486	5443	0.799
NULL	Cell_Res_2014_Jun_18_24(6)_665-679.nxml.txt.nlp	24638034	SENT119	23	23	25	25	heparin	EGF	PA449855	1950	0.799
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT197	3	3	6	6	tacrolimus	IL-6	PA451578	3569	0.799
NULL	Front_Endocrinol_(Lausanne)_2014_Oct_9_5_166.nxml.txt.nlp	25346724	SENT182	3	3	14	14	resveratrol	SIRT1		23411	0.799
NULL	EMBO_Mol_Med_2013_Mar_5_5(3)_384-396.nxml.txt.nlp	23495140	SENT114	14	14	30	30	tetracycline	CD44	PA451640	960	0.799
NULL	Oncogene_2014_Jul_3_33(27)_3528-3537.nxml.txt.nlp	23975428	SENT127	4	4	0	0	copper	LOX	PA449114	4015	0.799
NULL	Mol_Cancer_2009_Jul_31_8_57.nxml.txt.nlp	19646263	SENT208	23	23	27	27	docetaxel	IL-8	PA449383	3576	0.799
NULL	Biomed_Res_Int_2013_Nov_5_2013_703626.nxml.txt.nlp	24298554	SENT131	5	5	17	17	ethanol	BAX	PA448073	581	0.799
NULL	Cardiol_Res_Pract_2011_May_10_2011_816897.nxml.txt.nlp	21629798	SENT206	15	15	34	34	verapamil	CYP3A4	PA451868	1576	0.799
NULL	J_Cell_Mol_Med_2013_Mar_7_17(3)_407-418.nxml.txt.nlp	23388056	SENT108	15	15	24	24	fluorescein	DLL4	PA164746009	54567	0.799
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_29_2013_590393.nxml.txt.nlp	23737838	SENT193	5	5	19	19	resveratrol	p53		7157	0.799
NULL	Environ_Health_Perspect_2008_Mar_26_116(3)_322-328.nxml.txt.nlp	18335098	SENT102	28	28	13	13	estradiol	PMI	PA449503	8834;5373	0.799
NULL	Nat_Commun_2014_5_3361.nxml.txt.nlp	24553445	SENT186	8	8	10	10	vorinostat	Hsp90	PA164748224	3320	0.799
NULL	Front_Oncol_2014_Sep_23_4_264.nxml.txt.nlp	25295231	SENT105	3	3	23	23	lenalidomide	MDM2	PA162363968	4193	0.799
NULL	Breast_Cancer_Res_Treat_2012_Apr_15_132(2)_653-660.nxml.txt.nlp	22083231	SENT86	8	8	5	5	estradiol	MIB1	PA449503	57534	0.799
NULL	Int_J_Mol_Sci_2012_Dec_5_13(12)_16624-16635.nxml.txt.nlp	23443122	SENT63	0	0	7	7	carboplatin	MDR1	PA448803	5243	0.799
NULL	Scientifica_(Cairo)_2013_Feb_21_2013_405876.nxml.txt.nlp	24278777	SENT153	6	6	15	15	clodronate	IL-13	PA10239	3596	0.799
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Nov_14_65(Pt_12)_m1584.nxml.txt.nlp	21578614	SENT59	13	13	4	4	ethanol	NO3	PA448073	4681	0.799
NULL	J_Adv_Pract_Oncol_2012_May_1_May-Jun_3(3)_138-150.nxml.txt.nlp	25031940	SENT74	17	17	36	36	tetracycline	EGFR	PA451640	1956	0.799
NULL	Br_J_Pharmacol_2012_Jan_165(2)_390-400.nxml.txt.nlp	21671897	SENT18	31	31	27	27	suramin	P2X1	PA10292	5023	0.799
NULL	J_Bras_Pneumol_2014_Jul-Aug_40(4)_327-363.nxml.txt.nlp	25210957	SENT1633	0	0	5	5	propofol	por	PA451141	64840	0.799
NULL	Int_Neurourol_J_2014_Sep_24_18(3)_115-125.nxml.txt.nlp	25279238	SENT217	2	2	6	6	berberine	Bcl-2	PA165860812	596	0.799
NULL	Br_J_Cancer_2009_Sep_15_101(6)_875-878.nxml.txt.nlp	19672259	SENT34	24	24	26	26	tamoxifen	ATAC	PA451581	6375	0.799
NULL	Breast_Cancer_Res_2008_Jun_9_10(3)_R52.nxml.txt.nlp	18541018	SENT140	23	23	27	27	fluorescein	CD44	PA164746009	960	0.799
NULL	Oxid_Med_Cell_Longev_2011_May_23_2011_213286.nxml.txt.nlp	NULL	SENT73	16	16	35	35	ethanol	CYP2E1	PA448073	1571	0.799
NULL	Oncotarget_2014_Oct_16_5(22)_11442-11451.nxml.txt.nlp	25347345	SENT68	9	9	19	19	oxaliplatin	CT26	PA131285527	168400	0.799
NULL	Support_Care_Cancer_2011_Aug_1_19(8)_1079-1095.nxml.txt.nlp	21630130	SENT358	5	5	7	7	panitumumab	STEPP	PA162373091	222659	0.799
NULL	Breast_Cancer_(Auckl)_2011_Oct_9_5_209-226.nxml.txt.nlp	22084574	SENT197	10	10	25	25	anastrozole	ARNO	PA448432	9266	0.799
NULL	J_Cell_Biol_2001_Apr_2_153(1)_207-220.nxml.txt.nlp	11285286	SENT120	16	16	7	7	carbachol	CD69	PA448784	969	0.799
NULL	Breast_Cancer_Res_2010_Jun_28_12(3)_R43.nxml.txt.nlp	20579400	SENT286	9	9	11	11	fulvestrant	MAPT	PA164747170	4137	0.799
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1145.nxml.txt.nlp	24675463	SENT338	21	21	24	24	cetuximab	EGFR	PA10040	1956	0.799
NULL	Cancer_Med_2014_Jun_25_3(3)_674-680.nxml.txt.nlp	24668895	SENT196	35	35	19	19	irinotecan	HER-2	PA450085	2064	0.799
NULL	Mol_Cancer_2012_Aug_8_11_53.nxml.txt.nlp	22871047	SENT228	14	14	6	6	paclitaxel	HIN-1	PA450761	92304	0.799
NULL	Ann_Rheum_Dis_2008_Sep_11_68(7)_1146-1152.nxml.txt.nlp	18794178	SENT207	43	43	38	38	adalimumab	STAR	PA10004	6770;2984	0.799
NULL	Cancer_Cell_Int_2006_Mar_30_6_9.nxml.txt.nlp	16573823	SENT256	8	8	14	14	lovastatin	KDR	PA450272	3791	0.799
NULL	Chem_Cent_J_2013_Jul_31_7_133.nxml.txt.nlp	23899303	SENT0	14	14	31	31	ciprofloxacin	DSC	PA449009	1825	0.799
NULL	Diabetes_2011_Nov_17_60(11)_2691-2700.nxml.txt.nlp	21896928	SENT145	9	9	22	22	resveratrol	SIRT1		23411	0.799
NULL	Acta_Pharmacol_Sin_2011_Jul_9_32(7)_879-887.nxml.txt.nlp	21552292	SENT141	8	8	15	15	metformin	AMPK	PA450395	5563	0.799
NULL	Front_Endocrinol_(Lausanne)_2013_Sep_2_4_111.nxml.txt.nlp	24065951	SENT118	13	13	20	20	estradiol	ARC	PA449503	8996;23237	0.799
NULL	J_Cell_Biol_2001_Oct_1_155(1)_133-144.nxml.txt.nlp	11581290	SENT196	34	34	38	38	pp2	PP2		4888	0.799
NULL	Cardiovasc_Res_2011_Apr_1_90(1)_140-147.nxml.txt.nlp	21071431	SENT85	0	0	14	14	resveratrol	ROS		6098	0.799
NULL	Inflamm_Res_2009_Dec_21_58(12)_873-880.nxml.txt.nlp	19544046	SENT112	11	11	27	27	pindolol	5-HT2A	PA450966	3356	0.799
NULL	Mol_Clin_Oncol_2013_Sep_23_1(5)_875-878.nxml.txt.nlp	24649264	SENT76	14	14	21	21	gefitinib	EGFR	PA131301952	1956	0.799
NULL	Evid_Based_Complement_Alternat_Med_2011_Jan_4_2011_392627.nxml.txt.nlp	19542183	SENT116	24	24	19	19	phenylephrine	mol	PA450935	90527	0.799
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT15	25	25	15	15	simvastatin	survivin	PA451363	332	0.799
NULL	Braz_J_Microbiol_2011_Dec_1_Oct-Dec_42(4)_1384-1389.nxml.txt.nlp	24031767	SENT36	12	12	4	4	nitrogen	BSG	PA450643	682	0.799
NULL	Gut_Liver_2011_Sep_18_5(3)_356-362.nxml.txt.nlp	21927666	SENT24	24	24	10	10	ribavirin	IFN	PA451241	3439	0.799
NULL	Biochim_Biophys_Acta_2013_Jul_1832(7)_905-910.nxml.txt.nlp	23032152	SENT55	23	23	29	29	methylergonovine	5-HT2B	PA450461	3357	0.799
NULL	Crit_Care_2003_Mar_3_7(Suppl_2)_P047.nxml.txt.nlp	NULL	SENT23	6	6	13	13	vasopressin	CO2	PA451858	4513	0.799
NULL	Front_Genet_2012_Nov_5_3_236.nxml.txt.nlp	23133441	SENT144	1	1	8	8	efavirenz	API	PA449441	5345	0.799
NULL	Pharmaceutics_2011_Nov_18_3(4)_865-913.nxml.txt.nlp	24309312	SENT1229	14	14	3	3	maraviroc	CYP3A4	PA164768835	1576	0.799
NULL	Clin_Ophthalmol_2008_Jun_2(2)_355-368.nxml.txt.nlp	19668727	SENT81	16	16	26	26	bromfenac	COX1	PA448670	4512;5742	0.799
NULL	Mol_Cancer_2009_Nov_13_8_101.nxml.txt.nlp	19912650	SENT11	18	18	11	11	camptothecin	Mcl-1	PA153590860	4170	0.799
NULL	Arthritis_Res_Ther_2013_Nov_1_15(6)_R176.nxml.txt.nlp	24456929	SENT274	21	21	13	13	pp2	MSU		593	0.799
NULL	J_Neurochem_2014_May_15_129(3)_366-376.nxml.txt.nlp	24266881	SENT90	23	23	25	25	vasopressin	AVP	PA451858	114548;551	0.799
NULL	Diabetes_2013_Sep_15_62(9)_3103-3113.nxml.txt.nlp	23775766	SENT167	8	8	2	2	glucosamine	PRLR	PA164747613	5618	0.799
NULL	Case_Rep_Hematol_2012_May_7_2012_806476.nxml.txt.nlp	22953078	SENT102	32	32	24	24	rituximab	PEX	PA451261	5251	0.799
NULL	Environ_Health_Perspect_2005_Jun_24_113(6)_680-687.nxml.txt.nlp	15929889	SENT45	9	9	0	0	phenol	SULT1A1	PA450913	6817	0.799
NULL	J_Oncol_2012_May_28_2012_280386.nxml.txt.nlp	22690216	SENT50	13	13	0	0	l-glutamine	PC-3	PA10090	692094	0.799
NULL	Oxid_Med_Cell_Longev_2013_Jun_11_2013_870472.nxml.txt.nlp	23840921	SENT90	5	5	20	20	chloroquine	HO-1	PA448948	3162	0.799
NULL	AIDS_Res_Treat_2014_Nov_9_2014_724958.nxml.txt.nlp	25431661	SENT18	42	42	19	19	nevirapine	ATV	PA450616	4683	0.799
NULL	J_Clin_Exp_Pathol_2012_May_17_Suppl_4_7327.nxml.txt.nlp	25379357	SENT138	7	7	20	20	metformin	REDD1	PA450395	54541	0.799
NULL	Indian_J_Psychol_Med_2014_Jan-Mar_36(1)_66-70.nxml.txt.nlp	24701014	SENT99	7	7	23	23	risperidone	CARS	PA451257	833	0.799
NULL	Diabetes_Care_2013_Aug_17_36(Suppl_2)_S245-S252.nxml.txt.nlp	23882053	SENT3	12	12	26	26	exenatide	GLP	PA164749238	342096	0.799
NULL	J_Mol_Signal_2006_Dec_6_1_8.nxml.txt.nlp	17224083	SENT125	10	10	18	18	thrombin	Rho	PA451674	29984	0.799
NULL	Breast_Cancer_Res_2012_Apr_4_14(2)_R57.nxml.txt.nlp	22475046	SENT13	26	26	3	3	tamoxifen	CCND1	PA451581	595	0.799
NULL	Chem_Cent_J_2013_Jan_14_7_6.nxml.txt.nlp	23316796	SENT66	4	4	6	6	gatifloxacin	GTX	PA449738	84504	0.799
NULL	Cancer_Immunol_Immunother_2012_Jul_23_61(7)_1101-1111.nxml.txt.nlp	22193989	SENT99	4	4	15	15	oxaliplatin	IP-10	PA131285527	3627	0.799
NULL	Exp_Ther_Med_2013_Mar_13_5(3)_683-688.nxml.txt.nlp	23408155	SENT32	31	31	8	8	creatine	spatial	PA164778930	219793	0.799
NULL	Acta_Pharmacol_Sin_2012_Aug_23_33(8)_1095-1100.nxml.txt.nlp	22820908	SENT108	36	36	14	14	lansoprazole	CYP3A	PA450180	1574	0.799
NULL	Asian_J_Androl_2014_Jan_28_May-Jun_16(3)_437-441.nxml.txt.nlp	24480925	SENT137	13	13	7	7	panitumumab	EGFR	PA162373091	1956	0.799
NULL	Protein_J_2012_Aug_5_31(6)_511-518.nxml.txt.nlp	22763563	SENT9	24	24	15	15	atorvastatin	CD36	PA448500	948	0.799
NULL	Crit_Care_2004_May_25_8(4)_243-252.nxml.txt.nlp	15312206	SENT66	5	5	11	11	fentanyl	ACTH	PA449599	5443	0.799
NULL	Mol_Brain_2014_Apr_21_7_28.nxml.txt.nlp	24751148	SENT47	14	14	24	24	minocycline	TLR4	PA450519	7099	0.799
NULL	BMB_Rep_2013_Aug_46(8)_410-415.nxml.txt.nlp	23977989	SENT43	0	0	2	2	curcumin	HO-1	PA151958596	3162	0.799
NULL	Evid_Based_Complement_Alternat_Med_2012_Feb_12_2012_472897.nxml.txt.nlp	22454667	SENT128	0	0	17	17	hesperetin	IL-4	PA164742902	3565	0.799
NULL	EMBO_Mol_Med_2012_Dec_15_4(12)_1276-1293.nxml.txt.nlp	23065753	SENT156	13	13	17	17	cisplatin	NLRP3	PA449014	114548	0.799
NULL	Mol_Neurodegener_2011_Aug_16_6_58.nxml.txt.nlp	21846363	SENT133	34	34	13	13	candesartan	AT2	PA448765	186	0.799
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1065.nxml.txt.nlp	24556680	SENT61	15	15	1	1	nadh	LDHA	PA164755085	3939	0.799
NULL	Case_Rep_Dermatol_2011_Feb_5_3(1)_13-17.nxml.txt.nlp	21931572	SENT50	5	5	9	9	bexarotene	p55	PA164752250	6624;2078;8503;5718	0.799
NULL	J_Cell_Biol_1997_Jun_16_137(6)_1229-1241.nxml.txt.nlp	9182658	SENT154	9	9	18	18	glucosamine	CT1	PA164747613	1489;6535	0.799
NULL	Int_J_Mol_Sci_2012_Sep_26_13(10)_12336-12348.nxml.txt.nlp	23202901	SENT56	13	13	1	1	phenol	P90	PA450913	821	0.799
NULL	Br_J_Cancer_2010_Dec_7_103(12)_1822-1830.nxml.txt.nlp	21063405	SENT32	30	30	15	15	cisplatin	RAD50	PA449014	10111	0.799
NULL	J_Gynecol_Oncol_2013_Jul_4_24(3)_265-272.nxml.txt.nlp	23875077	SENT97	2	2	9	9	thrombin	DKK1	PA451674	22943	0.799
NULL	J_Neural_Transm_2014_Feb_19_121(7)_707-715.nxml.txt.nlp	24549572	SENT206	42	42	27	27	clobazam	CB1	PA10888	1268	0.799
NULL	Oxid_Med_Cell_Longev_2011_Aug_15_2011_824597.nxml.txt.nlp	21904648	SENT18	20	20	17	17	irinotecan	TPT	PA450085	23590;6469	0.799
NULL	Cancer_Med_2013_Aug_2_2(4)_571-582.nxml.txt.nlp	24156030	SENT12	1	1	13	13	curcumin	IL-6	PA151958596	3569	0.799
NULL	Int_J_Med_Sci_2014_Jul_29_11(10)_1015-1021.nxml.txt.nlp	25136257	SENT102	6	6	10	10	troglitazone	ABCA1	PA451799	19	0.799
NULL	J_Thorac_Oncol_2014_Feb_23_9(2)_231-238.nxml.txt.nlp	24419421	SENT190	12	12	37	37	gefitinib	EGFR	PA131301952	1956	0.799
NULL	Front_Chem_2014_Jul_4_2_44.nxml.txt.nlp	25072052	SENT40	32	32	36	36	lipase	PPL	PA450239	5493	0.799
NULL	J_Med_Life_2011_Feb_15_4(1)_11-20.nxml.txt.nlp	21505570	SENT183	12	12	21	21	indomethacin	CB2	PA449982	1269	0.799
NULL	Br_J_Cancer_1985_Jul_52(1)_7-13.nxml.txt.nlp	3893507	SENT5	22	22	24	24	carboplatin	JM8	PA448803	778	0.799
NULL	J_Mol_Signal_2007_Jul_16_2_6.nxml.txt.nlp	17634137	SENT214	14	14	0	0	doxycycline	CLU	PA449415	1191	0.798
NULL	Biomed_Res_Int_2013_Sep_4_2013_419176.nxml.txt.nlp	24093097	SENT69	24	24	12	12	sunitinib	FGF2	PA162372840	2247;2258	0.798
NULL	Cancer_Cell_Int_2014_Jul_2_14_59.nxml.txt.nlp	25120382	SENT209	15	15	20	20	doxorubicin	MDR1	PA449412	5243	0.798
NULL	Cardiovasc_Diabetol_2010_Jul_27_9_31.nxml.txt.nlp	20663195	SENT82	3	3	9	9	irbesartan	FSP1	PA450084	6275;51062	0.798
NULL	Dermatoendocrinol_2013_Apr_1_5(2)_252-263.nxml.txt.nlp	24194965	SENT146	0	0	25	25	metformin	LKB1	PA450395	6794	0.798
NULL	ScientificWorldJournal_2012_Aug_1_2012_387923.nxml.txt.nlp	22919313	SENT47	9	9	19	19	fluorescein	CD11b	PA164746009	3684	0.798
NULL	Toxins_(Basel)_2010_Oct_26_2(11)_2490-2518.nxml.txt.nlp	22069563	SENT62	19	19	5	5	cisplatin	OCT2	PA449014	6582;5452	0.798
NULL	J_Vis_Exp_2014_Mar_28_(85)_51300.nxml.txt.nlp	24747269	SENT382	13	13	20	20	thrombin	Rho	PA451674	29984	0.798
NULL	Arthritis_Res_Ther_2007_Mar_3_9(2)_R23.nxml.txt.nlp	17335581	SENT34	26	26	40	40	trimethoprim	CD4	PA451788	920	0.798
NULL	Front_Behav_Neurosci_2012_Oct_11_6_67.nxml.txt.nlp	23087629	SENT179	5	5	16	16	hydrocortisone	ANOVA	PA449905	4858	0.798
NULL	Cancer_Med_2013_Aug_10_2(4)_488-495.nxml.txt.nlp	24156021	SENT43	16	16	18	18	gemcitabine	GEM	PA449748	2669	0.798
NULL	Ann_Surg_Oncol_2010_Apr_20_17(4)_1168-1176.nxml.txt.nlp	19936839	SENT173	2	2	31	31	panitumumab	KRAS	PA162373091	3845	0.798
NULL	Cancer_Med_2013_Jun_25_2(3)_277-285.nxml.txt.nlp	23930204	SENT139	40	40	23	23	bevacizumab	PTEN	PA130232992	5728	0.798
NULL	Mol_Cancer_2008_Jun_5_7_50.nxml.txt.nlp	18534018	SENT159	5	5	10	10	bortezomib	p38	PA10252	10598;1432;7965	0.798
NULL	Curr_Oncol_2009_Sep_16(5)_32-47.nxml.txt.nlp	19862360	SENT31	33	33	39	39	tositumomab	gamma	PA164748364	9913	0.798
NULL	Croat_Med_J_2012_Dec_53(6)_558-567.nxml.txt.nlp	23275321	SENT133	28	28	26	26	perifosine	MT3	PA165291471	4504	0.798
NULL	Drugs_Aging_2014_May_6_31(6)_413-424.nxml.txt.nlp	24797286	SENT37	0	0	8	8	denosumab	RANKL	PA166048634	8600	0.798
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S279-S284.nxml.txt.nlp	21525469	SENT136	34	34	17	17	exenatide	GLP-1	PA164749238	100125288	0.798
NULL	Nat_Cell_Biol_2014_May_6_16(5)_401-414.nxml.txt.nlp	24705551	SENT86	6	6	18	18	lindane	EEA1	PA164754914	8411	0.798
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S177-S183.nxml.txt.nlp	21525452	SENT230	8	8	16	16	exenatide	GLP-1	PA164749238	100125288	0.798
NULL	Int_J_Hypertens_2014_Jan_12_2014_381082.nxml.txt.nlp	24678415	SENT173	7	7	4	4	cinacalcet	FGF23	PA164776671	8074	0.798
NULL	Diabetes_Care_2010_Feb_33(2)_e20-e25.nxml.txt.nlp	20103551	SENT68	0	0	4	4	liraglutide	GLP-1	PA165958364	100125288	0.798
NULL	Oncol_Lett_2014_Jul_12_8(1)_223-229.nxml.txt.nlp	24959250	SENT98	3	3	16	16	captopril	NEFA	PA448780	4925	0.798
NULL	Arthritis_Res_Ther_2013_Dec_30_15(6)_R223.nxml.txt.nlp	24373218	SENT166	0	0	14	14	carprofen	FN1	PA164781361	2335	0.798
NULL	Angiogenesis_2010_Dec_7_13(4)_305-315.nxml.txt.nlp	20927579	SENT197	6	6	8	8	resveratrol	p53		7157	0.798
NULL	Mol_Biol_Cell_2012_Mar_15_23(6)_966.nxml.txt.nlp	NULL	SENT33	8	8	13	13	paclitaxel	Bcl-2	PA450761	596	0.798
NULL	Evid_Based_Complement_Alternat_Med_2014_May_8_2014_494528.nxml.txt.nlp	24949077	SENT15	25	25	27	27	cyclophosphamide	CTX	PA449165	1593	0.798
NULL	Neuropsychopharmacology_2011_Apr_2_36(5)_1033-1046.nxml.txt.nlp	21289603	SENT362	23	23	26	26	ethanol	MSN	PA448073	4478	0.798
NULL	Eur_J_Clin_Microbiol_Infect_Dis_2012_Apr_29_31(4)_571-574.nxml.txt.nlp	21796345	SENT23	15	15	17	17	lamivudine	LAM	PA450163	7249;7248	0.798
NULL	Cancers_(Basel)_2010_May_26_2(2)_955-969.nxml.txt.nlp	24281101	SENT863	5	5	15	15	tanespimycin	Hsp90	PA165291490	3320	0.798
NULL	Cancer_Med_2013_Feb_3_2(1)_11-20.nxml.txt.nlp	24133623	SENT291	4	4	24	24	fluorouracil	KRAS	PA128406956	3845	0.798
NULL	Br_J_Cancer_2011_Jun_28_105(1)_118-123.nxml.txt.nlp	21654685	SENT11	6	6	18	18	dasatinib	S100beta	PA162372878	6285	0.798
NULL	J_Hematol_Oncol_2010_Oct_27_3_42.nxml.txt.nlp	20979652	SENT172	26	26	12	12	carboplatin	EGFR	PA448803	1956	0.798
NULL	Lab_Invest_2009_Nov_7_89(11)_1275-1290.nxml.txt.nlp	19736547	SENT334	3	3	6	6	curcumin	p53	PA151958596	7157	0.798
NULL	Toxins_(Basel)_2010_Mar_31_2(4)_517-551.nxml.txt.nlp	22069598	SENT371	5	5	19	19	resveratrol	CD95		355	0.798
NULL	Oxid_Med_Cell_Longev_2012_Nov_28_2012_162934.nxml.txt.nlp	23251719	SENT32	9	9	15	15	creatine	Bcl-2	PA164778930	596	0.798
NULL	Leukemia_2014_Jun_25_28(6)_1280-1288.nxml.txt.nlp	24270737	SENT121	7	7	14	14	decitabine	PD-L2	PA164749631	80380	0.798
NULL	Front_Genet_2012_Oct_26_3_213.nxml.txt.nlp	23112805	SENT584	8	8	5	5	oltipraz	CYP1A2		1544	0.798
NULL	Environ_Health_Perspect_2010_Jul_3_118(7)_936-942.nxml.txt.nlp	20199942	SENT15	15	15	9	9	arsenite	p53	PA452638	7157	0.798
NULL	Eur_J_Immunol_2014_Jun_10_44(6)_1759-1769.nxml.txt.nlp	24595810	SENT71	23	23	11	11	fludrocortisone	CD4	PA164743961	920	0.798
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT229	13	13	25	25	doxorubicin	B7-H1	PA449412	29126	0.798
NULL	Nat_Genet_2011_Jun_5_43(7)_621-629.nxml.txt.nlp	21642992	SENT103	21	21	13	13	doxorubicin	CDKN1A	PA449412	1026	0.798
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT200	10	10	6	6	sitagliptin	HIP	PA164748978	6767;6159;64399;5068	0.798
NULL	Stroke_Res_Treat_2009_Dec_20_2010_386389.nxml.txt.nlp	20700422	SENT159	22	22	26	26	resveratrol	NAC		22861	0.798
NULL	Front_Neurosci_2014_Nov_10_8_364.nxml.txt.nlp	25426018	SENT241	0	0	6	6	fluorescein	OAT3	PA164746009	9376	0.798
NULL	Oncotarget_2014_Mar_13_5(4)_1101-1110.nxml.txt.nlp	24658355	SENT119	33	33	15	15	tamoxifen	MKP-2	PA451581	1846	0.798
NULL	Br_J_Cancer_1997_76(8)_1029-1034.nxml.txt.nlp	9376262	SENT17	18	18	6	6	daunorubicin	P-gp	PA449212	5243	0.798
NULL	Oncogene_2010_Jun_10_29(23)_3335-3348.nxml.txt.nlp	20383197	SENT90	3	3	12	12	cetuximab	HER2	PA10040	2064	0.798
NULL	Br_J_Cancer_1998_Sep_78(Suppl_4)_12-15.nxml.txt.nlp	9741783	SENT6	22	22	17	17	aminoglutethimide	aromatase	PA448375	1588	0.798
NULL	Bioinform_Biol_Insights_2013_Sep_18_7_289-306.nxml.txt.nlp	24092970	SENT209	24	24	30	30	carboplatin	PRAME	PA448803	23532	0.798
NULL	Eur_J_Epidemiol_2011_Aug_30_26(8)_657-686.nxml.txt.nlp	21877163	SENT498	26	26	29	29	tamoxifen	CYP2C19	PA451581	1557	0.798
NULL	Daru_2012_Sep_3_20(1)_24.nxml.txt.nlp	23351176	SENT160	22	22	26	26	itopride	EPO	PA152432599	7076;8288;2056	0.798
NULL	Clin_Ophthalmol_2014_Jun_26_8_1213-1219.nxml.txt.nlp	25061267	SENT96	12	12	1	1	proparacaine	PRK	PA164776849	1263	0.798
NULL	Clinics_(Sao_Paulo)_2013_Feb_68(2)_253-262.nxml.txt.nlp	23525324	SENT217	14	14	8	8	genistein	Gen	PA165109660	348654	0.798
NULL	J_Neurosci_Methods_2009_Oct_15_183(2)_107-113.nxml.txt.nlp	19524611	SENT95	14	14	22	22	carbachol	CA1	PA448784	759	0.798
NULL	Cell_Cycle_2013_Dec_15_12(24)_3791-3803.nxml.txt.nlp	24107631	SENT106	20	20	14	14	doxorubicin	YB-1	PA449412	4904	0.798
NULL	Theranostics_2014_Aug_15_4(11)_1072-1084.nxml.txt.nlp	25250092	SENT190	16	16	20	20	trastuzumab	HER2	PA451743	2064	0.798
NULL	Exp_Ther_Med_2015_Jan_11_9(1)_17-24.nxml.txt.nlp	25452770	SENT201	19	19	3	3	irinotecan	HER-2	PA450085	2064	0.798
NULL	J_Cell_Biol_1998_Jul_13_142(1)_101-115.nxml.txt.nlp	9660866	SENT137	28	28	5	5	dextran	RhoA	PA449261	387	0.798
NULL	Mol_Cells_2014_Mar_31_37(3)_234-240.nxml.txt.nlp	24642709	SENT127	0	0	6	6	cisplatin	NOX4	PA449014	50507	0.798
NULL	Oncogene_2011_Apr_21_30(16)_1892-1900.nxml.txt.nlp	21217782	SENT168	18	18	8	8	phenol	LITAF	PA450913	9516	0.798
NULL	Diabetes_Care_2009_Nov_32(Suppl_2)_S223-S231.nxml.txt.nlp	19875556	SENT127	23	23	8	8	liraglutide	AMIGO	PA165958364	57463	0.798
NULL	Front_Neural_Circuits_2013_Aug_13_7_136.nxml.txt.nlp	23964205	SENT479	0	0	8	8	taurine	KCC2	PA451590	57468	0.798
NULL	Neural_Regen_Res_2013_Jul_5_8(19)_1803-1813.nxml.txt.nlp	25206477	SENT161	8	8	25	25	cilostazol	spatial	PA164746334	219793	0.798
NULL	Biomed_Res_Int_2013_Sep_4_2013_906912.nxml.txt.nlp	24093107	SENT157	0	0	20	20	ciprofloxacin	MICA	PA449009	100507436	0.798
NULL	Vet_Res_2012_Dec_4_43(1)_81.nxml.txt.nlp	23210796	SENT80	3	3	8	8	cisplatin	p53	PA449014	7157	0.798
NULL	J_Adv_Pract_Oncol_2012_Jan_1_Jan-Feb_3(1)_49-54.nxml.txt.nlp	25031928	SENT43	16	16	37	37	plerixafor	CD34	PA165958410	947	0.798
NULL	J_Exp_Clin_Cancer_Res_2009_Feb_15_28(1)_19.nxml.txt.nlp	19216799	SENT169	11	11	5	5	cisplatin	AEG-1	PA449014	92140	0.798
NULL	Br_J_Cancer_2013_Jul_23_109(2)_342-350.nxml.txt.nlp	23807172	SENT183	5	5	18	18	sorafenib	Bcl-2	PA7000	596	0.798
NULL	Nat_Genet_2013_Sep_28_45(9)_1004-1012.nxml.txt.nlp	23892607	SENT72	16	16	19	19	doxycycline	PC2	PA449415	5126;5311;8535	0.798
NULL	Br_J_Cancer_2011_Apr_12_104(8)_1256-1261.nxml.txt.nlp	21448165	SENT11	18	18	20	20	sorafenib	IL-2	PA7000	3558	0.798
NULL	J_Cell_Biol_2004_Apr_12_165(1)_77-86.nxml.txt.nlp	15067018	SENT52	32	32	26	26	collagenase	AP-1	PA449107	2353;3727;2354;3725	0.798
NULL	Arq_Bras_Cardiol_2014_Nov_103(5)_403-409.nxml.txt.nlp	25229355	SENT124	7	7	1	1	diltiazem	PZP	PA449334	5858	0.798
NULL	Oncotarget_2010_Oct_30_1(7)_639-650.nxml.txt.nlp	21317459	SENT52	6	6	10	10	nutlin-3	p53		7157	0.798
NULL	Curr_Neuropharmacol_2014_May_12(3)_219-238.nxml.txt.nlp	24851087	SENT312	16	16	11	11	clozapine	PSD-95	PA449061	1742	0.798
NULL	Neural_Develop_2008_Nov_5_3_32.nxml.txt.nlp	18986540	SENT301	9	9	2	2	paraformaldehyde	P14	PA450790	11102;;6280;56259	0.798
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2010_Apr_26_3_37-42.nxml.txt.nlp	22879785	SENT142	42	42	9	9	nitroprusside	PTH	PA451406	5741	0.798
NULL	Cancer_Manag_Res_2011_Aug_10_3_273-285.nxml.txt.nlp	21931501	SENT142	15	15	20	20	sorafenib	IFN	PA7000	3439	0.798
NULL	Ther_Clin_Risk_Manag_2005_Mar_1(1)_3-13.nxml.txt.nlp	18360537	SENT24	14	14	6	6	erythromycin	CYP3A4	PA449493	1576	0.798
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_79-96.nxml.txt.nlp	19305789	SENT219	0	0	14	14	vanillin	TRPV3	PA451852	162514	0.798
NULL	Biomed_Res_Int_2013_Sep_4_2013_906912.nxml.txt.nlp	24093107	SENT164	0	0	20	20	ciprofloxacin	MICA	PA449009	100507436	0.798
NULL	J_Gen_Physiol_2009_Apr_133(4)_421-438.nxml.txt.nlp	19289574	SENT258	29	29	3	3	forskolin	SLC26A9	PA146096022	115019	0.798
NULL	J_Biomed_Sci_2014_May_24_21(1)_51.nxml.txt.nlp	24885898	SENT102	5	5	10	10	taurine	spatial	PA451590	219793	0.798
NULL	Mol_Cancer_2008_Jun_4_7_49.nxml.txt.nlp	18533032	SENT113	25	25	0	0	tamoxifen	GATA3	PA451581	2625	0.798
NULL	Front_Pharmacol_2014_Oct_28_5_235.nxml.txt.nlp	25389405	SENT879	8	8	3	3	isotretinoin	GM-CSF	PA450128	1437	0.798
NULL	J_Cell_Biol_1984_Oct_1_99(4)_1259-1265.nxml.txt.nlp	6090469	SENT10	10	10	15	15	chloroquine	EGF	PA448948	1950	0.798
NULL	Ther_Clin_Risk_Manag_2006_Sep_2(3)_235-249.nxml.txt.nlp	18360599	SENT335	13	13	15	15	teriparatide	PTH	PA451620	5741	0.798
NULL	Viruses_2014_Jan_27_6(2)_391-403.nxml.txt.nlp	24473338	SENT130	19	19	43	43	l-glutamine	CO2	PA10090	4513	0.798
NULL	Comp_Hepatol_2004_Jan_14_3(Suppl_1)_S37.nxml.txt.nlp	14960189	SENT111	15	15	5	5	thalidomide	TNF-alpha	PA451644	7124	0.798
NULL	Br_J_Cancer_2012_Jan_3_106(1)_107-115.nxml.txt.nlp	22116303	SENT122	7	7	30	30	vorinostat	VIII	PA164748224	1351	0.798
NULL	Diagn_Pathol_2006_Aug_15_1_19.nxml.txt.nlp	16911776	SENT54	24	24	33	33	gefitinib	EGFR	PA131301952	1956	0.798
NULL	Clin_Ophthalmol_2012_Aug_10_6_1287-1291.nxml.txt.nlp	22927741	SENT69	23	23	15	15	ranibizumab	hole	PA164746012	80757	0.798
NULL	Mol_Cancer_2012_Aug_24_11_61.nxml.txt.nlp	22917467	SENT201	10	10	24	24	doxorubicin	PTEN	PA449412	5728	0.798
NULL	Br_J_Cancer_2012_Aug_21_107(5)_823-830.nxml.txt.nlp	22836512	SENT164	8	8	13	13	bevacizumab	EGFR	PA130232992	1956	0.798
NULL	Int_J_Gen_Med_2012_Nov_23_5_983-990.nxml.txt.nlp	23226071	SENT45	17	17	7	7	zidovudine	ART	PA451954	181	0.798
NULL	J_Pain_Res_2014_May_8_7_255-263.nxml.txt.nlp	24855388	SENT67	5	5	33	33	collagenase	GMP	PA449107	22978	0.798
NULL	Neuro_Oncol_2010_Mar_6_12(3)_233-242.nxml.txt.nlp	20167811	SENT139	12	12	8	8	bevacizumab	MMP2	PA130232992	4313	0.798
NULL	Cell_Death_Dis_2010_Oct_21_1(10)_e86.nxml.txt.nlp	21368859	SENT209	14	14	21	21	doxorubicin	TRAIL	PA449412	8743	0.798
NULL	Diabetes_2009_Feb_58(2)_344-351.nxml.txt.nlp	19008341	SENT13	7	7	3	3	resveratrol	SIRT1		23411	0.798
NULL	Mol_Cancer_2008_Jan_10_7_4.nxml.txt.nlp	18186929	SENT128	8	8	12	12	trastuzumab	HER-2	PA451743	2064	0.798
NULL	Mol_Cancer_2010_Aug_23_9_222.nxml.txt.nlp	20731837	SENT185	2	2	17	17	cetuximab	EGFR	PA10040	1956	0.798
NULL	Alcohol_Res_Health_2010_33(1-2)_76-86.nxml.txt.nlp	23579938	SENT81	9	9	13	13	resveratrol	SIRT1		23411	0.798
NULL	Clinics_(Sao_Paulo)_2010_Jul_65(7)_723-728.nxml.txt.nlp	20668631	SENT12	29	29	20	20	atenolol	AT1	PA448499	9197;185	0.798
NULL	Acta_Pharmacol_Sin_2011_Oct_12_32(10)_1259-1265.nxml.txt.nlp	21909126	SENT106	20	20	10	10	fluvastatin	p38	PA449688	10598;1432;7965	0.798
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT198	9	9	28	28	curcumin	DR5	PA151958596	8795	0.798
NULL	ISRN_Neurosci_2013_Sep_5_2013_759640.nxml.txt.nlp	24959565	SENT146	6	6	9	9	etomidate	ANOVA	PA164743987	4858	0.798
NULL	Mol_Pain_2014_Feb_6_10_10.nxml.txt.nlp	24499354	SENT229	12	12	16	16	naloxone	END	PA450586	2022	0.798
NULL	J_Clin_Biochem_Nutr_2010_Mar_27_46(2)_126-134.nxml.txt.nlp	20216945	SENT64	29	29	20	20	taurine	Met	PA451590	79811	0.798
NULL	Indian_J_Nephrol_2012_Mar-Apr_22(2)_139-142.nxml.txt.nlp	22787319	SENT111	17	17	15	15	cyclosporine	CYP3A4	PA449167	1576	0.798
NULL	Crit_Care_2003_Mar_3_7(Suppl_2)_P047.nxml.txt.nlp	NULL	SENT19	10	10	18	18	vasopressin	CO2	PA451858	4513	0.798
NULL	Ann_Dermatol_2011_Dec_27_23(Suppl_3)_S360-S363.nxml.txt.nlp	22346278	SENT68	18	18	22	22	imatinib	CML	PA10804	613	0.798
NULL	Br_J_Cancer_2012_Nov_20_107(11)_1844-1852.nxml.txt.nlp	23169337	SENT229	13	13	9	9	bortezomib	AKT	PA10252	207	0.798
NULL	Int_J_Breast_Cancer_2012_May_9_2012_415170.nxml.txt.nlp	22649737	SENT77	13	13	27	27	trastuzumab	MUC1	PA451743	4582	0.798
NULL	Behav_Brain_Funct_2008_Aug_15_4_37.nxml.txt.nlp	18702828	SENT33	26	26	21	21	methamphetamine	FZD3	PA450403	7976;8326	0.798
NULL	Avicenna_J_Med_Biotechnol_2014_Jan-Mar_6(1)_10-20.nxml.txt.nlp	24523953	SENT185	2	2	9	9	trypsin	CD105	PA451806	2022	0.798
NULL	Clin_Ophthalmol_2010_Apr_26_4_233-241.nxml.txt.nlp	20463789	SENT143	2	2	4	4	dorzolamide	AVP	PA164748765	114548;551	0.798
NULL	Hematol_Rep_2011_Oct_28_3(3_Suppl)_e5.nxml.txt.nlp	22586513	SENT34	17	17	12	12	vincristine	CHOP	PA451879	1649	0.798
NULL	J_Oncol_2013_Apr_29_2013_854121.nxml.txt.nlp	23737784	SENT120	24	24	32	32	capecitabine	PI3K	PA448771	5290	0.798
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1066.nxml.txt.nlp	24556681	SENT7	4	4	19	19	ethanol	TLR4	PA448073	7099	0.798
NULL	Clin_Drug_Investig_2013_Apr_20_33(4)_243-254.nxml.txt.nlp	23512639	SENT263	10	10	24	24	desipramine	CYP3A4	PA449233	1576	0.798
NULL	Oncotarget_2010_Oct_25_1(7)_497-514.nxml.txt.nlp	21165163	SENT134	21	21	36	36	erlotinib	SRC-3	PA134687924	8202	0.798
NULL	Oncotarget_2013_Jun_26_4(7)_1008-1018.nxml.txt.nlp	23900284	SENT156	33	33	27	27	bortezomib	SLAMF7	PA10252	57823	0.798
NULL	Patient_Prefer_Adherence_2010_Mar_24_4_51-60.nxml.txt.nlp	20361065	SENT83	40	40	26	26	warfarin	Men	PA451906	8178	0.798
NULL	Front_Public_Health_2014_Nov_19_2_242.nxml.txt.nlp	25478555	SENT46	24	24	9	9	clozapine	CYP1A2	PA449061	1544	0.798
NULL	Br_J_Cancer_2011_Jul_26_105(3)_372-381.nxml.txt.nlp	21730979	SENT80	6	6	14	14	etoposide	CHK1	PA449552	1111	0.798
NULL	Oncol_Lett_2013_Feb_27_5(2)_483-488.nxml.txt.nlp	23420047	SENT115	30	30	16	16	panitumumab	KRAS	PA162373091	3845	0.798
NULL	Aging_(Albany_NY)_2014_May_17_6(5)_369-379.nxml.txt.nlp	24860943	SENT108	8	8	2	2	l-arginine	S6K1	PA448478	6198	0.798
NULL	Arthritis_Res_Ther_2012_Sep_24_14(5)_R200.nxml.txt.nlp	23006144	SENT155	0	0	17	17	alefacept	CD4	PA164748040	920	0.798
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Nov_19_67(Pt_12)_o3365.nxml.txt.nlp	22199859	SENT64	11	11	26	26	ethanol	mol	PA448073	90527	0.798
NULL	Br_J_Anaesth_2010_Nov_17_105(5)_576-582.nxml.txt.nlp	20716565	SENT145	19	19	5	5	thrombin	hole	PA451674	80757	0.798
NULL	Chem_Senses_2008_Sep_5_33(7)_665-680.nxml.txt.nlp	18603652	SENT442	21	21	13	13	ethanol	TRPV1	PA448073	7442	0.798
NULL	Br_J_Pharmacol_2012_Jan_165(2)_390-400.nxml.txt.nlp	21671897	SENT202	11	11	14	14	suramin	P2X1	PA10292	5023	0.798
NULL	Nucleic_Acids_Res_2011_Dec_2_39(22)_9549-9558.nxml.txt.nlp	21890893	SENT75	6	6	4	4	resveratrol	SIRT1		23411	0.798
NULL	J_Breast_Cancer_2014_Sep_30_17(3)_287-290.nxml.txt.nlp	25320628	SENT66	5	5	2	2	temsirolimus	HIF-1	PA164746890	29072	0.798
NULL	Eur_J_Clin_Pharmacol_2012_Sep_15_68(9)_1267-1274.nxml.txt.nlp	22418828	SENT95	29	29	35	35	pantoprazole	CYP2C19	PA450774	1557	0.798
NULL	Eur_Arch_Psychiatry_Clin_Neurosci_2010_Nov_14_260(Suppl_2)_81-89.nxml.txt.nlp	20945070	SENT137	8	8	3	3	clozapine	CPX1	PA449061	56265	0.798
NULL	J_Thromb_Haemost_2007_May_5(5)_1010-1018.nxml.txt.nlp	17355572	SENT225	35	35	28	28	thrombin	VWF	PA451674	7450	0.798
NULL	Cancers_(Basel)_2012_Sep_25_4(4)_969-988.nxml.txt.nlp	24213497	SENT200	13	13	8	8	fulvestrant	EGFR	PA164747170	1956	0.798
NULL	J_Headache_Pain_2014_Sep_18_15(Suppl_1)_G16.nxml.txt.nlp	NULL	SENT6	28	28	0	0	sumatriptan	TRPV1	PA451566	7442	0.798
NULL	Mol_Cancer_2010_Aug_23_9_222.nxml.txt.nlp	20731837	SENT185	29	29	17	17	gefitinib	EGFR	PA131301952	1956	0.798
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT226	11	11	5	5	nutlin-3	p53		7157	0.798
NULL	Br_J_Cancer_2004_Mar_5_90(Suppl_1)_S11-S14.nxml.txt.nlp	15094759	SENT17	15	15	10	10	anastrozole	aromatase	PA448432	1588	0.798
NULL	Cancer_Immunol_Immunother_2013_Aug_27_62(10)_1637-1648.nxml.txt.nlp	23982484	SENT40	11	11	27	27	lenalidomide	IL-6	PA162363968	3569	0.798
NULL	Biologics_2009_Oct_12_3_469-474.nxml.txt.nlp	19851472	SENT98	37	37	6	6	desloratadine	IL-5	PA164776964	3567	0.798
NULL	Pharmaceuticals_(Basel)_2012_Feb_24_5(3)_279-296.nxml.txt.nlp	24281379	SENT183	12	12	32	32	rivaroxaban	ADP	PA165958360	23038	0.798
NULL	Nucleic_Acids_Res_2012_Sep_4_40(16)_8119-8128.nxml.txt.nlp	22669903	SENT159	23	23	17	17	thrombin	TGT	PA451674	9097;81890	0.798
NULL	Nat_Med_2010_Sep_22_16(9)_998-1000.nxml.txt.nlp	20729864	SENT30	16	16	9	9	sorafenib	LRRK2	PA7000	120892	0.798
NULL	Core_Evid_2010_Oct_21_5_61-76.nxml.txt.nlp	21042543	SENT56	19	19	31	31	irinotecan	EGFR	PA450085	1956	0.798
NULL	Oncotarget_2011_Sep_9_2(9)_658-668.nxml.txt.nlp	21911919	SENT5	15	15	27	27	cytarabine	HO-1	PA449177	3162	0.798
NULL	Braz_J_Med_Biol_Res_2014_Mar_3_47(3)_245-251.nxml.txt.nlp	24554037	SENT112	16	16	2	2	atorvastatin	IFN	PA448500	3439	0.798
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2012_Nov_7_1(11)_e13.nxml.txt.nlp	23835795	SENT290	7	7	0	0	simvastatin	SLCO1B1	PA451363	10599	0.798
NULL	Nucleic_Acids_Res_2011_Aug_31_39(14)_5935-5944.nxml.txt.nlp	21459848	SENT60	10	10	1	1	paraformaldehyde	PICH	PA450790	54821	0.798
NULL	Infect_Dis_Rep_2012_Jan_2_4(1)_e9.nxml.txt.nlp	24470939	SENT222	15	15	7	7	clindamycin	CD4	PA449035	920	0.798
NULL	Sci_Rep_2014_Nov_28_4_7237.nxml.txt.nlp	25429875	SENT96	0	0	7	7	hesperidin	p38	PA449867	10598;1432;7965	0.798
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT214	13	13	40	40	heparin	FGF1	PA449855	2246	0.798
NULL	Breast_Cancer_Res_2010_May_18_12(Suppl_1)_P48.nxml.txt.nlp	NULL	SENT5	10	10	0	0	tamoxifen	CYP2D6	PA451581	1565	0.798
NULL	Aging_(Albany_NY)_2010_Dec_20_2(12)_959-968.nxml.txt.nlp	21191146	SENT87	5	5	15	15	cisplatin	UCH37	PA449014	51377	0.798
NULL	J_Invest_Dermatol_2012_Nov_21_132(11)_2642-2651.nxml.txt.nlp	22718118	SENT245	13	13	3	3	collagenase	CD11b	PA449107	3684	0.798
NULL	Br_J_Cancer_2012_Jan_17_106(2)_254-261.nxml.txt.nlp	22166799	SENT110	27	27	9	9	camptothecin	TOP2A	PA153590860	7153	0.798
NULL	Mol_Cancer_2010_Mar_10_9_56.nxml.txt.nlp	20219102	SENT81	5	5	19	19	bortezomib	CXCL1	PA10252	2919	0.798
NULL	Genome_Biol_2007_Sep_26_8(9)_227.nxml.txt.nlp	17903313	SENT31	25	25	6	6	protamine	PRM1	PA10366	5619	0.798
NULL	Arthritis_Res_Ther_2007_Oct_10_9(5)_R105.nxml.txt.nlp	17927818	SENT139	2	2	13	13	pp2	p57		11151	0.798
NULL	Clin_Sci_(Lond)_2011_Nov_1_121(Pt_10)_449-458.nxml.txt.nlp	21671887	SENT164	0	0	8	8	simvastatin	AMPK	PA451363	5563	0.798
NULL	Br_J_Cancer_2009_Jul_21_101(2)_238-243.nxml.txt.nlp	19568242	SENT10	7	7	11	11	bevacizumab	IFN	PA130232992	3439	0.798
NULL	Cancers_(Basel)_2014_Mar_6_6(1)_494-525.nxml.txt.nlp	24662938	SENT98	18	18	22	22	dasatinib	STAT3	PA162372878	6774	0.798
NULL	Int_J_Mol_Imaging_2011_Oct_26_2011_874585.nxml.txt.nlp	21490735	SENT98	21	21	7	7	doxorubicin	FDG	PA449412	23583	0.798
NULL	Indian_J_Pharmacol_2013_May-Jun_45(3)_298-300.nxml.txt.nlp	23833379	SENT13	13	13	23	23	nevirapine	CD4	PA450616	920	0.798
NULL	Indian_J_Nephrol_2011_Apr-Jun_21(2)_128-131.nxml.txt.nlp	21769179	SENT82	6	6	16	16	cyclosporine	CD4	PA449167	920	0.798
NULL	J_Hematol_Oncol_2013_Nov_5_6_83.nxml.txt.nlp	24283248	SENT220	10	10	3	3	etoposide	TP53	PA449552	7157	0.798
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Jun_25_3(6)_e120.nxml.txt.nlp	24964282	SENT40	11	11	9	9	rifampin	CYP3A4	PA451250	1576	0.798
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S279-S284.nxml.txt.nlp	21525469	SENT184	4	4	9	9	liraglutide	GLP-1	PA165958364	100125288	0.798
NULL	Cancer_Manag_Res_2012_Jul_31_4_207-214.nxml.txt.nlp	22904642	SENT32	18	18	24	24	everolimus	S6K1	PA164746311	6198	0.798
NULL	Basic_Res_Cardiol_2012_Mar_19_107(2)_242.nxml.txt.nlp	22258067	SENT271	24	24	19	19	indomethacin	COX1	PA449982	4512;5742	0.798
NULL	Angiogenesis_2010_Dec_7_13(4)_305-315.nxml.txt.nlp	20927579	SENT125	6	6	1	1	resveratrol	p53		7157	0.798
NULL	Arch_Drug_Inf_2011_Mar_4(1)_1-9.nxml.txt.nlp	21572514	SENT207	5	5	25	25	ciprofloxacin	P-gp	PA449009	5243	0.798
NULL	Int_J_Biol_Sci_2014_Sep_6_10(9)_990-996.nxml.txt.nlp	25210497	SENT173	15	15	25	25	heparin	CPZ	PA449855	8532	0.798
NULL	Biosci_Rep_2012_Aug_1_32(Pt_4)_361-374.nxml.txt.nlp	22762204	SENT150	11	11	21	21	trastuzumab	PI3K	PA451743	5290	0.798
NULL	Mol_Cancer_2014_Jan_13_13_7.nxml.txt.nlp	24418169	SENT292	9	9	2	2	sorafenib	STAT3	PA7000	6774	0.798
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT330	8	8	16	16	risperidone	PRL	PA451257	5617	0.798
NULL	J_Cell_Mol_Med_2014_Apr_20_18(4)_709-720.nxml.txt.nlp	24444314	SENT167	22	22	8	8	metformin	p53	PA450395	7157	0.798
NULL	Oncotarget_2012_May_6_3(4)_435-449.nxml.txt.nlp	22564965	SENT86	18	18	10	10	chloroquine	LC3	PA448948	84557	0.798
NULL	Cancer_Manag_Res_2011_Aug_10_3_273-285.nxml.txt.nlp	21931501	SENT211	9	9	14	14	sunitinib	IFN	PA162372840	3439	0.798
NULL	Arch_Med_Sci_2011_Aug_2_7(4)_597-603.nxml.txt.nlp	22291794	SENT111	16	16	6	6	clenbuterol	Bcl-2	PA164745640	596	0.798
NULL	Front_Neural_Circuits_2009_Aug_20_3_8.nxml.txt.nlp	19738924	SENT191	23	23	12	12	ethanol	PDF	PA448073	64146;9518	0.798
NULL	Diabetes_Care_2013_Aug_17_36(Suppl_2)_S245-S252.nxml.txt.nlp	23882053	SENT184	3	3	26	26	lipase	GLP-1	PA450239	100125288	0.798
NULL	J_Cell_Biol_1983_Nov_1_97(5)_1375-1380.nxml.txt.nlp	6415064	SENT1	5	5	7	7	trifluoperazine	TFP	PA451771	7034	0.798
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1495-1502.nxml.txt.nlp	21989186	SENT14	3	3	16	16	panitumumab	KRAS	PA162373091	3845	0.798
NULL	Oncotarget_2014_Jun_30_5(12)_4011-4025.nxml.txt.nlp	24994117	SENT104	23	23	43	43	estradiol	ISG15	PA449503	9636	0.798
NULL	EMBO_Mol_Med_2012_Jul_11_4(7)_577-593.nxml.txt.nlp	22496117	SENT72	32	32	27	27	clofazimine	PAP-1	PA164748759	6100	0.798
NULL	Front_Neurol_2014_Apr_16_5_51.nxml.txt.nlp	24795691	SENT136	41	41	8	8	losartan	ANOVA	PA450268	4858	0.798
NULL	Br_J_Cancer_2009_Mar_24_100(6)_941-949.nxml.txt.nlp	19240716	SENT126	37	37	30	30	gefitinib	EGFR	PA131301952	1956	0.798
NULL	Nat_Commun_2014_Nov_19_5_5479.nxml.txt.nlp	25407222	SENT33	10	10	30	30	dextran	YTS	PA449261	8565	0.798
NULL	J_Korean_Med_Sci_2011_Jul_20_26(7)_893-899.nxml.txt.nlp	21738342	SENT10	4	4	16	16	genistein	CD97	PA165109660	976	0.798
NULL	Anticancer_Agents_Med_Chem_2014_Oct_14(8)_1121-1127.nxml.txt.nlp	24893730	SENT136	13	13	29	29	erlotinib	EGFR	PA134687924	1956	0.798
NULL	Clin_Interv_Aging_2012_Jul_12_7_235-247.nxml.txt.nlp	22866001	SENT133	22	22	20	20	alendronate	PTH	PA448082	5741	0.798
NULL	Emerg_Infect_Dis_2012_Nov_18(11)_1802-1810.nxml.txt.nlp	23092584	SENT39	7	7	2	2	isoniazid	DST	PA450112	667	0.798
NULL	Lab_Anim_Res_2013_Dec_20_29(4)_221-225.nxml.txt.nlp	24396387	SENT19	31	31	28	28	thrombin	ADP	PA451674	23038	0.798
NULL	Cell_Commun_Signal_2014_Oct_5_12(1)_54.nxml.txt.nlp	NULL	SENT98	22	22	14	14	fasudil	MRCK	PA165946121	8476	0.798
NULL	Biomed_Res_Int_2014_Aug_6_2014_967826.nxml.txt.nlp	25165721	SENT206	14	14	5	5	cisplatin	TNF-alpha	PA449014	7124	0.798
NULL	Diabetes_2008_Sep_57(9)_2272-2279.nxml.txt.nlp	18519799	SENT43	11	11	4	4	rosiglitazone	PEPCK-C	PA451283	5105	0.798
NULL	Int_J_Gen_Med_2009_Jul_30_2_129-140.nxml.txt.nlp	20360896	SENT28	22	22	11	11	tamoxifen	aromatase	PA451581	1588	0.798
NULL	Oncotarget_2011_Aug_23_2(8)_599-609.nxml.txt.nlp	21865609	SENT130	16	16	11	11	cetuximab	EGFR	PA10040	1956	0.798
NULL	Angiogenesis_2012_Dec_28_15(4)_623-641.nxml.txt.nlp	22843200	SENT280	28	28	4	4	sunitinib	CD31	PA162372840	5175	0.798
NULL	Mol_Cancer_2013_May_16_12_42.nxml.txt.nlp	23680104	SENT125	43	43	19	19	cisplatin	Mcl-1	PA449014	4170	0.798
NULL	J_Nanopart_Res_2013_Oct_9_15(11)_2026.nxml.txt.nlp	24307859	SENT133	22	22	25	25	benzaldehyde	mol	PA448571	90527	0.798
NULL	Chem_Cent_J_2012_Sep_20_6_105.nxml.txt.nlp	22995678	SENT109	14	14	19	19	cefixime	C10	PA164768821	113246	0.798
NULL	Acta_Pharmacol_Sin_2013_Feb_31_34(2)_231-238.nxml.txt.nlp	23274414	SENT17	7	7	24	24	amiloride	Bcl-2	PA448368	596	0.798
NULL	Biochem_Res_Int_2012_Mar_4_2012_685267.nxml.txt.nlp	22496978	SENT211	13	13	18	18	thrombin	AKT	PA451674	207	0.798
NULL	Neuropsychopharmacology_2009_Dec_19_34(13)_2710-2720.nxml.txt.nlp	19693002	SENT65	9	9	3	3	clozapine	NAC	PA449061	22861	0.798
NULL	Breast_Cancer_Res_2011_Apr_14_13(2)_R43.nxml.txt.nlp	21492444	SENT309	9	9	6	6	tamoxifen	p53	PA451581	7157	0.798
NULL	Diabetes_Care_2010_Jan_21_33(1)_156-161.nxml.txt.nlp	19846797	SENT183	18	18	27	27	metformin	B12	PA450395	7126;4709	0.798
NULL	J_Occup_Med_Toxicol_2008_Feb_27_3(Suppl_1)_S6.nxml.txt.nlp	18315837	SENT85	6	6	8	8	theophylline	CD4	PA451647	920	0.798
NULL	Clin_Med_Insights_Circ_Respir_Pulm_Med_2012_Jun_12_6_27-40.nxml.txt.nlp	22745565	SENT25	22	22	31	31	omalizumab	IL-4	PA164752253	3565	0.798
NULL	Br_J_Cancer_2010_Oct_26_103(9)_1415-1421.nxml.txt.nlp	20924373	SENT27	5	5	29	29	oxaliplatin	TLR4	PA131285527	7099	0.798
NULL	Oncotarget_2014_Oct_21_5(22)_11180-11192.nxml.txt.nlp	25361003	SENT130	11	11	19	19	doxycycline	NTRK1	PA449415	4914	0.798
NULL	Br_J_Cancer_2003_Mar_10_88(5)_754-759.nxml.txt.nlp	12618886	SENT100	10	10	2	2	amifostine	p53	PA448365	7157	0.798
NULL	Breast_Cancer_Res_2005_May_24_7(5)_R589-R597.nxml.txt.nlp	16168102	SENT88	20	20	23	23	doxorubicin	HER2	PA449412	2064	0.798
NULL	Oncotarget_2014_Oct_18_5(22)_11604-11619.nxml.txt.nlp	25344099	SENT231	18	18	13	13	cisplatin	RYBP	PA449014	23429	0.798
NULL	Curr_Neuropharmacol_2012_Mar_10(1)_49-52.nxml.txt.nlp	22942877	SENT49	9	9	29	29	sibutramine	5-HT1A	PA451344	3350	0.798
NULL	Curr_Opin_Pharmacol_2012_Dec_12(6)_653-658.nxml.txt.nlp	23063456	SENT523	12	12	7	7	dextran	GPR55	PA449261	9290	0.798
NULL	Case_Rep_Ophthalmol_Med_2011_Dec_22_2011_645089.nxml.txt.nlp	22606469	SENT59	0	0	18	18	sildenafil	GMP	PA451346	22978	0.798
NULL	Br_J_Haematol_2008_Jun_141(5)_659-671.nxml.txt.nlp	18410446	SENT110	2	2	9	9	cerulenin	CD138	PA164764551	6382	0.798
NULL	Am_J_Case_Rep_2012_May_23_13_79-85.nxml.txt.nlp	23569495	SENT97	13	13	11	11	cyclophosphamide	CHOP	PA449165	1649	0.798
NULL	Arthritis_Res_Ther_2010_Jul_22_12(4)_R149.nxml.txt.nlp	20649960	SENT64	7	7	18	18	rosiglitazone	CO2	PA451283	4513	0.798
NULL	Med_Sci_Monit_2012_Jan_1_18(1)_RA1-RA11.nxml.txt.nlp	22207127	SENT213	3	3	0	0	denosumab	RANKL	PA166048634	8600	0.798
NULL	Int_J_Nanomedicine_2009_Nov_23_4_251-259.nxml.txt.nlp	20011242	SENT143	10	10	7	7	docetaxel	survivin	PA449383	332	0.798
NULL	Pharmaceuticals_(Basel)_2014_Jan_9_7(1)_46-57.nxml.txt.nlp	24451403	SENT20	15	15	27	27	ritonavir	AKT	PA451260	207	0.798
NULL	Clin_Mol_Hepatol_2014_Sep_25_20(3)_283-290.nxml.txt.nlp	25320732	SENT120	12	12	8	8	propranolol	EVL	PA451145	51466	0.798
NULL	Exp_Ther_Med_2013_Jun_2_5(6)_1613-1618.nxml.txt.nlp	23837041	SENT84	18	18	33	33	glutaraldehyde	CO2	PA449777	4513	0.798
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT151	6	6	20	20	lapatinib	HER2	PA152241907	2064	0.798
NULL	J_Asthma_Allergy_2008_Sep_19_1_19-29.nxml.txt.nlp	21436982	SENT110	43	43	26	26	fexofenadine	TARC	PA449621	6361	0.798
NULL	Indian_J_Endocrinol_Metab_2012_May-Jun_16(3)_343-348.nxml.txt.nlp	22629497	SENT28	15	15	5	5	preotact	PTH	PA165958355	5741	0.798
NULL	Front_Cell_Neurosci_2014_Jan_29_8_3.nxml.txt.nlp	24523669	SENT473	13	13	15	15	ethanol	P2X4	PA448073	5025	0.798
NULL	Front_Chem_2014_Sep_24_2_79.nxml.txt.nlp	25309898	SENT602	26	26	41	41	ethanol	CO2	PA448073	4513	0.798
NULL	Cell_Death_Differ_2010_Oct_19_17(10)_1566-1576.nxml.txt.nlp	20300112	SENT115	20	20	0	0	etoposide	CAML	PA449552	819	0.798
NULL	Appl_Microbiol_Biotechnol_2012_Sep_31_95(6)_1427-1436.nxml.txt.nlp	22846902	SENT164	14	14	4	4	zinc	ADH	PA451956	551	0.798
NULL	Biomed_Res_Int_2013_Apr_18_2013_538790.nxml.txt.nlp	23691505	SENT32	12	12	33	33	nadh	mol	PA164755085	90527	0.798
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Dec_22_69(Pt_1)_o142-o143.nxml.txt.nlp	23476398	SENT79	0	0	6	6	cinnarizine	mol	PA164749342	90527	0.798
NULL	Environ_Health_Perspect_2010_Jul_3_118(7)_936-942.nxml.txt.nlp	20199942	SENT158	26	26	9	9	arsenite	p53	PA452638	7157	0.798
NULL	J_Clin_Biochem_Nutr_2011_Mar_26_48(2)_126-133.nxml.txt.nlp	21373265	SENT119	15	15	3	3	lansoprazole	HO-1	PA450180	3162	0.798
NULL	Biol_Proced_Online_2004_Dec_16_6_263-267.nxml.txt.nlp	15605107	SENT151	25	25	18	18	heparin	MCT3	PA449855	9123;23539	0.798
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT83	28	28	6	6	atorvastatin	IL-6	PA448500	3569	0.798
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT48	36	36	10	10	erlotinib	PI3K	PA134687924	5290	0.798
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT12	14	14	21	21	atorvastatin	CD14	PA448500	929	0.798
NULL	Mol_Cancer_2010_Jun_7_9_139.nxml.txt.nlp	20529262	SENT22	0	0	28	28	bevacizumab	EGFR	PA130232992	1956	0.798
NULL	Epidemiol_Rev_2011_Jul_27_33(1)_46-62.nxml.txt.nlp	21622851	SENT298	8	8	0	0	rosiglitazone	DREAM	PA451283	30818	0.798
NULL	ScientificWorldJournal_2012_Jan_29_2012_454059.nxml.txt.nlp	22666124	SENT79	24	24	16	16	cefazolin	TMP	PA448839	2012	0.798
NULL	Cancer_Immunol_Immunother_2013_Aug_27_62(10)_1637-1648.nxml.txt.nlp	23982484	SENT165	0	0	25	25	lenalidomide	CD56	PA162363968	4684	0.798
NULL	J_Cell_Biol_1998_Apr_6_141(1)_135-142.nxml.txt.nlp	9531553	SENT124	6	6	4	4	collagenase	SMG	PA449107	23034	0.798
NULL	Hum_Reprod_Update_2009_Jan_27_May-Jun_15(3)_323-339.nxml.txt.nlp	19174449	SENT349	13	13	10	10	paroxetine	CYP2D6	PA450801	1565	0.798
NULL	Mol_Cells_2014_Mar_31_37(3)_234-240.nxml.txt.nlp	24642709	SENT395	2	2	8	8	capsaicin	HO-1	PA448776	3162	0.798
NULL	J_Cell_Mol_Med_2013_Dec_6_17(12)_1588-1597.nxml.txt.nlp	24199964	SENT8	3	3	20	20	doxycycline	APT	PA449415	653639	0.798
NULL	Breast_Cancer_Res_2011_Apr_14_13(2)_R43.nxml.txt.nlp	21492444	SENT16	33	33	14	14	tamoxifen	PTEN	PA451581	5728	0.798
NULL	Nature_2012_Apr_25_484(7395)_524-528.nxml.txt.nlp	22538616	SENT112	6	6	20	20	ciprofloxacin	IL-10	PA449009	3586	0.798
NULL	Oncotarget_2014_Mar_16_5(12)_4087-4102.nxml.txt.nlp	24961479	SENT245	41	41	7	7	hemin	HO-1	PA449849	3162	0.798
NULL	Nat_Commun_2014_Nov_25_5_5548.nxml.txt.nlp	25420520	SENT291	10	10	3	3	docetaxel	EB1	PA449383	9167;22919;10982	0.798
NULL	Am_J_Physiol_Endocrinol_Metab_2013_Jul_15_305(2)_E263-E270.nxml.txt.nlp	23715727	SENT162	0	0	24	24	taurine	ANOVA	PA451590	4858	0.798
NULL	Clin_Exp_Metastasis_2013_Apr_27_30(4)_447-455.nxml.txt.nlp	23187934	SENT40	11	11	7	7	bevacizumab	HAI	PA130232992	6692;6768	0.798
NULL	Mol_Cells_2014_Mar_31_37(3)_234-240.nxml.txt.nlp	24642709	SENT111	5	5	10	10	capsaicin	NOX4	PA448776	50507	0.798
NULL	Mol_Cancer_2009_Nov_10_8_99.nxml.txt.nlp	19903356	SENT8	6	6	14	14	imatinib	IGFBP3	PA10804	3486	0.798
NULL	Oncogene_2014_Mar_20_33(12)_1590-1600.nxml.txt.nlp	23542178	SENT13	11	11	28	28	crizotinib	BRAF	PA165946122	673	0.798
NULL	EMBO_Mol_Med_2013_Feb_22_5(2)_280-293.nxml.txt.nlp	23239471	SENT333	5	5	2	2	cyclosporine	NAC	PA449167	22861	0.798
NULL	Arthritis_Res_Ther_2014_Apr_3_16(2)_R86.nxml.txt.nlp	24708674	SENT286	26	26	36	36	bosentan	Fli1	PA10034	2314	0.798
NULL	Eur_J_Clin_Pharmacol_2014_Oct_8_70(12)_1433-1441.nxml.txt.nlp	25291992	SENT140	18	18	8	8	olanzapine	OCM	PA450688	654231	0.798
NULL	Arthritis_Res_Ther_2007_Sep_11_9(5)_R92.nxml.txt.nlp	17848196	SENT117	4	4	35	35	galactose	spatial	PA449725	219793	0.798
NULL	Eur_J_Med_Res_2009_Dec_7_14(Suppl_4)_108-111.nxml.txt.nlp	20156738	SENT75	26	26	4	4	formoterol	FKBP51	PA134687907	2289	0.798
NULL	Pharm_Pract_(Granada)_2011_Mar_15_Jan-Mar_9(1)_1-10.nxml.txt.nlp	25132883	SENT153	9	9	18	18	dabigatran	SPAF		166378	0.798
NULL	Cancer_Cell_2007_Dec_11_12(6)_514-527.nxml.txt.nlp	18068629	SENT150	4	4	12	12	paclitaxel	TGFBI	PA450761	7045	0.798
NULL	Int_Semin_Surg_Oncol_2006_Sep_18_3_31.nxml.txt.nlp	16981992	SENT18	5	5	1	1	tamoxifen	ATAC	PA451581	6375	0.798
NULL	Esophagus_2013_Mar_19_10(1)_27-29.nxml.txt.nlp	23482402	SENT28	13	13	20	20	cisplatin	TEF	PA449014	7008	0.798
NULL	J_Carcinog_2011_Nov_30_10_28.nxml.txt.nlp	22190870	SENT121	10	10	24	24	trastuzumab	p27	PA451743	5715;10534	0.798
NULL	Cells_2014_Apr_29_3(2)_331-362.nxml.txt.nlp	24785347	SENT158	29	29	24	24	capsaicin	TRPV1	PA448776	7442	0.798
NULL	Biomed_Res_Int_2014_May_28_2014_203601.nxml.txt.nlp	24991539	SENT146	10	10	6	6	trastuzumab	HER2	PA451743	2064	0.798
NULL	Oxid_Med_Cell_Longev_2013_Jun_2_2013_793525.nxml.txt.nlp	23819014	SENT133	35	35	19	19	resveratrol	AMPK		5563	0.798
NULL	Mol_Cancer_2012_Oct_5_11_75.nxml.txt.nlp	23039341	SENT27	12	12	10	10	vemurafenib	BRAF	PA165946873	673	0.798
NULL	Mol_Cancer_2010_Dec_20_9_317.nxml.txt.nlp	21172025	SENT140	18	18	8	8	tamoxifen	HER2	PA451581	2064	0.798
NULL	Exp_Hematol_2009_Oct_37(10)_1238-1249_e5.nxml.txt.nlp	19619605	SENT466	20	20	3	3	fluorescein	CXCR4	PA164746009	7852	0.798
NULL	J_Biol_Chem_2009_Oct_16_284(42)_28885-28895.nxml.txt.nlp	19687008	SENT284	10	10	29	29	simvastatin	SREBP2	PA451363	6721	0.798
NULL	Cancer_Metastasis_Rev_2014_Nov_7_33(4)_1095-1108.nxml.txt.nlp	25376898	SENT195	6	6	9	9	coumarin	CA9	PA134521193	768	0.798
NULL	Br_J_Cancer_2004_Mar_22_90(6)_1285-1292.nxml.txt.nlp	15026814	SENT23	17	17	12	12	doxorubicin	p53	PA449412	7157	0.797
NULL	Oncol_Rep_2014_Dec_6_32(6)_2343-2348.nxml.txt.nlp	25333575	SENT92	11	11	16	16	vinblastine	JNK	PA451877	5599	0.797
NULL	Oncotarget_2014_Oct_9_5(20)_9564-9576.nxml.txt.nlp	25333255	SENT174	7	7	17	17	flavopiridol	GM-CSF	PA452627	1437	0.797
NULL	Exp_Ther_Med_2013_Mar_21_5(3)_987-991.nxml.txt.nlp	23407636	SENT61	0	0	12	12	losartan	IL-8	PA450268	3576	0.797
NULL	Br_J_Cancer_2012_Jan_17_106(2)_428.nxml.txt.nlp	NULL	SENT20	26	26	15	15	gefitinib	EGFR	PA131301952	1956	0.797
NULL	Int_J_Endocrinol_2013_Nov_13_2013_686315.nxml.txt.nlp	24324494	SENT170	31	31	13	13	metformin	OCT1	PA450395	5451;6580	0.797
NULL	Infect_Dis_Ther_2014_Dec_5_3(2)_69-81.nxml.txt.nlp	25475412	SENT80	22	22	8	8	daptomycin	VAN	PA164768820	10318	0.797
NULL	Arch_Med_Sci_2011_Jun_11_7(3)_388-396.nxml.txt.nlp	22312373	SENT154	24	24	18	18	saquinavir	CYP3A	PA451305	1574	0.797
NULL	Indian_J_Med_Res_2012_Dec_136(6)_979-984.nxml.txt.nlp	23391793	SENT135	16	16	18	18	ethambutol	EMB	PA164784021	133418	0.797
NULL	Br_J_Cancer_2012_Sep_4_107(6)_947-955.nxml.txt.nlp	22892392	SENT92	7	7	15	15	tamoxifen	ERBB3	PA451581	2065	0.797
NULL	J_Antimicrob_Chemother_2014_Mar_13_69(3)_651-663.nxml.txt.nlp	24235095	SENT107	9	9	2	2	melarsoprol	AQP2	PA10136	359	0.797
NULL	Breast_Cancer_Res_2002_Jul_30_4(5)_205.nxml.txt.nlp	12238488	SENT19	7	7	0	0	geldanamycin	Hsp90	PA152031327	3320	0.797
NULL	eLife_2013_Nov_5_2_e01319.nxml.txt.nlp	24192038	SENT625	9	9	11	11	isoproterenol	AKAP18	PA450121	9465	0.797
NULL	Biol_Open_2014_Nov_21_3(12)_1207-1216.nxml.txt.nlp	25416063	SENT81	5	5	15	15	zinc	NANOS2	PA451956	339345	0.797
NULL	Br_J_Cancer_2009_Nov_3_101(9)_1549-1554.nxml.txt.nlp	19809436	SENT31	28	28	15	15	ifosfamide	ADM	PA449964	133	0.797
NULL	J_Korean_Med_Sci_2007_Dec_20_22(6)_1055-1059.nxml.txt.nlp	18162722	SENT27	14	14	24	24	pantoprazole	ESD	PA450774	2098	0.797
NULL	J_Cell_Biol_2003_Aug_18_162(4)_599-612.nxml.txt.nlp	12925707	SENT86	0	0	11	11	staurosporine	mol	PA165109623	90527	0.797
NULL	Int_J_Biomed_Sci_2007_Jun_3(2)_104-111.nxml.txt.nlp	23675031	SENT174	12	12	20	20	suramin	IL-2	PA10292	3558	0.797
NULL	Adv_Urol_2008_Jul_15_2008_479495.nxml.txt.nlp	18645622	SENT185	18	18	33	33	cisplatin	Bcl-2	PA449014	596	0.797
NULL	Br_J_Clin_Pharmacol_2010_Dec_70(6)_807-814.nxml.txt.nlp	21175436	SENT43	4	4	8	8	liraglutide	GLP-1	PA165958364	100125288	0.797
NULL	Evid_Based_Complement_Alternat_Med_2012_Feb_12_2012_743075.nxml.txt.nlp	22454682	SENT186	4	4	13	13	forskolin	MDC	PA146096022	6367	0.797
NULL	Oncotarget_2013_Nov_7_4(12)_2550-2566.nxml.txt.nlp	24334291	SENT220	29	29	23	23	vincristine	CHOP	PA451879	1649	0.797
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Nov_20_66(Pt_12)_o3256.nxml.txt.nlp	21589540	SENT47	18	18	33	33	ethanol	mol	PA448073	90527	0.797
NULL	Oncol_Lett_2013_Jul_8_6(1)_161-168.nxml.txt.nlp	23946797	SENT153	15	15	7	7	tamoxifen	PTEN	PA451581	5728	0.797
NULL	Ther_Clin_Risk_Manag_2005_Jun_1(2)_107-114.nxml.txt.nlp	18360550	SENT25	8	8	17	17	paclitaxel	Yes	PA450761	7525	0.797
NULL	Oncotarget_2014_Oct_21_5(22)_11252-11268.nxml.txt.nlp	25361004	SENT265	3	3	9	9	metformin	CLIC1	PA450395	1192	0.797
NULL	J_Vis_Exp_2008_Sep_11_(19)_911.nxml.txt.nlp	19066536	SENT61	5	5	19	19	papain	CO2	PA450778	4513	0.797
NULL	Chem_Cent_J_2012_Sep_20_6_105.nxml.txt.nlp	22995678	SENT31	0	0	24	24	moxifloxacin	MOX	PA450555	26002	0.797
NULL	Int_J_Mol_Imaging_2011_Oct_26_2011_874585.nxml.txt.nlp	21490735	SENT78	0	0	19	19	glucose	OMG	PA449773	4974	0.797
NULL	J_Korean_Med_Sci_2014_Jan_26_29(1)_53-60.nxml.txt.nlp	24431906	SENT169	23	23	21	21	cyclophosphamide	CHOP	PA449165	1649	0.797
NULL	Ann_Rheum_Dis_2008_Jul_22_68(8)_1303-1309.nxml.txt.nlp	18647851	SENT125	33	33	10	10	adalimumab	CD163	PA10004	9332	0.797
NULL	Oncotarget_2014_Oct_21_5(22)_11252-11268.nxml.txt.nlp	25361004	SENT264	3	3	5	5	metformin	CLIC1	PA450395	1192	0.797
NULL	Nat_Genet_2011_Feb_26_43(2)_153-158.nxml.txt.nlp	21186352	SENT82	14	14	5	5	geldanamycin	Hsp90	PA152031327	3320	0.797
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1059-1066.nxml.txt.nlp	21364577	SENT38	6	6	2	2	letrozole	aromatase	PA450196	1588	0.797
NULL	Cardiovasc_Diabetol_2013_Oct_17_12_150.nxml.txt.nlp	24134550	SENT15	2	2	4	4	metformin	activin	PA450395	83729	0.797
NULL	Front_Physiol_2015_Jan_5_5_507.nxml.txt.nlp	25601839	SENT136	14	14	0	0	tamoxifen	NFAT5	PA451581	10725	0.797
NULL	Ann_Hematol_2012_Sep_28_91(9)_1499-1500.nxml.txt.nlp	22281990	SENT12	7	7	14	14	doxorubicin	CHOP	PA449412	1649	0.797
NULL	Int_J_Mol_Sci_2014_Mar_20_15(3)_4977-4993.nxml.txt.nlp	24658441	SENT682	1	1	19	19	resveratrol	SIRT1		23411	0.797
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1542-1553.nxml.txt.nlp	21970874	SENT266	4	4	6	6	carboplatin	EGFR	PA448803	1956	0.797
NULL	Clin_Transl_Allergy_2013_Sep_2_3_29.nxml.txt.nlp	24004581	SENT112	25	25	18	18	omalizumab	IL-4	PA164752253	3565	0.797
NULL	Cell_Death_Dis_2014_Feb_13_5(2)_e1055.nxml.txt.nlp	24525731	SENT329	19	19	33	33	cisplatin	XRCC1	PA449014	7515	0.797
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Sep_19_65(Pt_10)_o2496.nxml.txt.nlp	21577946	SENT67	6	6	12	12	isoniazid	mol	PA450112	90527	0.797
NULL	Biomed_Res_Int_2014_Aug_6_2014_967826.nxml.txt.nlp	25165721	SENT287	42	42	35	35	cisplatin	CD4	PA449014	920	0.797
NULL	Br_J_Cancer_2013_Jul_23_109(2)_351-359.nxml.txt.nlp	23799854	SENT14	31	31	29	29	paclitaxel	BLT2	PA450761	56413	0.797
NULL	Cardiovasc_Diabetol_2011_Aug_4_10_72.nxml.txt.nlp	21816063	SENT134	6	6	31	31	allopurinol	adiponectin	PA448320	9370	0.797
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1986-2011.nxml.txt.nlp	25268165	SENT166	26	26	6	6	cisplatin	STAT3	PA449014	6774	0.797
NULL	Aging_(Albany_NY)_2009_Jun_3_1(6)_515-528.nxml.txt.nlp	20157535	SENT228	23	23	3	3	resveratrol	MDC		6367	0.797
NULL	Neural_Regen_Res_2014_Jan_15_9(2)_119-128.nxml.txt.nlp	25206792	SENT240	20	20	16	16	l-glutamine	B27	PA10090	56246	0.797
NULL	Reprod_Biol_Endocrinol_2004_Jan_7_2_2.nxml.txt.nlp	14711377	SENT164	7	7	4	4	thrombin	PAR1	PA451674	79581;2149	0.797
NULL	Int_J_Alzheimers_Dis_2012_Jul_15_2012_489428.nxml.txt.nlp	22844635	SENT59	16	16	34	34	bexarotene	ABCA1	PA164752250	19	0.797
NULL	Indian_J_Med_Res_2012_Aug_136(2)_249-259.nxml.txt.nlp	22960892	SENT127	33	33	17	17	sn-38	UGT1A1		54658	0.797
NULL	Oncoimmunology_2013_Apr_1_2(4)_e24117.nxml.txt.nlp	23734336	SENT89	0	0	14	14	curcumin	STAT3	PA151958596	6774	0.797
NULL	Ann_Rheum_Dis_2010_Oct_27_70(2)_299-304.nxml.txt.nlp	20980704	SENT135	2	2	17	17	infliximab	FCGR3B	PA452639	2215	0.797
NULL	Cell_Death_Dis_2014_Jul_10_5(7)_e1318.nxml.txt.nlp	25010984	SENT251	6	6	8	8	nutlin-3	RITA		55422;84934	0.797
NULL	Nat_Commun_2013_Oct_1_4_2516.nxml.txt.nlp	24084631	SENT9	6	6	25	25	losartan	CCN2	PA450268	1490	0.797
NULL	Mol_Cancer_2009_Feb_28_8_11.nxml.txt.nlp	19250552	SENT49	12	12	8	8	hydroxyurea	RRM2	PA449942	6241	0.797
NULL	J_Hematol_Oncol_2008_Oct_23_1_19.nxml.txt.nlp	18947412	SENT125	15	15	19	19	alemtuzumab	CD34	PA164783958	947	0.797
NULL	BMB_Rep_2013_Aug_46(8)_410-415.nxml.txt.nlp	23977989	SENT57	8	8	0	0	curcumin	HO-1	PA151958596	3162	0.797
NULL	Cancers_(Basel)_2013_May_27_5(2)_617-638.nxml.txt.nlp	24216994	SENT135	7	7	4	4	curcumin	MMP9	PA151958596	4318	0.797
NULL	Oncol_Lett_2013_Sep_8_6(3)_789-794.nxml.txt.nlp	24137412	SENT144	34	34	26	26	cisplatin	survivin	PA449014	332	0.797
NULL	Cancer_Manag_Res_2011_May_9_3_117-141.nxml.txt.nlp	21625397	SENT522	0	0	9	9	vorinostat	PAK1	PA164748224	5585;5058	0.797
NULL	Cell_Death_Dis_2010_Feb_4_1(2)_e23.nxml.txt.nlp	21364631	SENT272	37	37	9	9	imipramine	c-Jun	PA449969	3725	0.797
NULL	Case_Rep_Endocrinol_2012_Jun_28_2012_427565.nxml.txt.nlp	22937294	SENT62	4	4	24	24	octreotide	GLP-1	PA450678	100125288	0.797
NULL	Environ_Health_Perspect_2006_Sep_23_114(9)_1401-1406.nxml.txt.nlp	16966095	SENT24	9	9	30	30	arsenite	ID1	PA452638	3397	0.797
NULL	Acta_Histochem_Cytochem_2014_Aug_29_47(4)_155-164.nxml.txt.nlp	25392569	SENT120	6	6	8	8	diethylstilbestrol	DES	PA449307	1674	0.797
NULL	Springerplus_2015_Jan_23_4_29.nxml.txt.nlp	25628986	SENT20	6	6	21	21	dapsone	G6PD	PA449211	2539	0.797
NULL	Hum_Genomics_2011_Jul_1_5(5)_485-496.nxml.txt.nlp	21807603	SENT223	26	26	24	24	rosiglitazone	gamma	PA451283	9913	0.797
NULL	J_Emerg_Trauma_Shock_2012_Oct-Dec_5(4)_279-284.nxml.txt.nlp	23248494	SENT65	6	6	12	12	ketamine	OST	PA450144	1650;23263	0.797
NULL	Cancer_Manag_Res_2012_Jul_31_4_207-214.nxml.txt.nlp	22904642	SENT32	16	16	9	9	octreotide	INS-1	PA450678	2305	0.797
NULL	Br_J_Cancer_2010_Jan_5_102(1)_80-86.nxml.txt.nlp	19920817	SENT66	13	13	15	15	bevacizumab	IFN	PA130232992	3439	0.797
NULL	Diabetes_Care_2010_Oct_13_33(10)_2250-2253.nxml.txt.nlp	20628086	SENT8	15	15	7	7	rosiglitazone	DREAM	PA451283	30818	0.797
NULL	Indian_J_Endocrinol_Metab_2012_Jul-Aug_16(4)_668-670.nxml.txt.nlp	22837947	SENT40	2	2	16	16	thyroglobulin	FDG	PA164754910	23583	0.797
NULL	Diabetes_2013_Oct_17_62(10)_3547-3552.nxml.txt.nlp	23863812	SENT58	9	9	16	16	pravastatin	ANOVA	PA451089	4858	0.797
NULL	Cancer_Med_2014_Apr_27_3(2)_293-299.nxml.txt.nlp	24464780	SENT142	14	14	29	29	capecitabine	DPYD	PA448771	1806	0.797
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT86	7	7	14	14	atorvastatin	survivin	PA448500	332	0.797
NULL	Colomb_Med_(Cali)_45(1)_39-44.nxml.txt.nlp	24970958	SENT24	33	33	27	27	ampicillin	TMP	PA448419	2012	0.797
NULL	Curr_Neuropharmacol_2014_Jan_12(1)_44-56.nxml.txt.nlp	24533015	SENT19	0	0	24	24	pregabalin	gamma	PA164754814	9913	0.797
NULL	Eur_J_Pharm_Sci_2012_Jul_16_46(4)_244-258.nxml.txt.nlp	22085636	SENT50	15	15	8	8	pertuzumab	PDK1		5170;5163	0.797
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1063.nxml.txt.nlp	24556678	SENT9	3	3	10	10	thioridazine	Mcl-1	PA451666	4170	0.797
NULL	Gut_Pathog_2010_Dec_7_2_17.nxml.txt.nlp	21138594	SENT39	30	30	32	32	oxytetracycline	OTC	PA450757	5009	0.797
NULL	Breast_Cancer_Res_2009_Nov_18_11(6)_R85.nxml.txt.nlp	19922614	SENT103	25	25	8	8	tamoxifen	BCS	PA451581	617	0.797
NULL	Arch_Med_Sci_2012_Dec_20_8(6)_970-977.nxml.txt.nlp	23319968	SENT61	22	22	32	32	tamoxifen	CAL	PA451581	54751;57120	0.797
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1495-1502.nxml.txt.nlp	21989186	SENT86	12	12	7	7	panitumumab	HSI	PA162373091	57016	0.797
NULL	Arthritis_Res_Ther_2007_Oct_10_9(5)_R105.nxml.txt.nlp	17927818	SENT8	3	3	36	36	pp2	p57		11151	0.797
NULL	F1000Res_2013_Oct_3_2_202.nxml.txt.nlp	24795806	SENT122	11	11	14	14	cetuximab	EGFR	PA10040	1956	0.797
NULL	Oncotarget_2011_Mar_27_2(3)_209-221.nxml.txt.nlp	21444945	SENT137	10	10	8	8	bortezomib	p53	PA10252	7157	0.797
NULL	Breast_Cancer_Res_2009_Oct_28_11(5)_211.nxml.txt.nlp	19889200	SENT123	18	18	7	7	anastrozole	ARNO	PA448432	9266	0.797
NULL	EPMA_J_2011_Sep_24_2(Suppl_1)_119-130.nxml.txt.nlp	NULL	SENT146	26	26	9	9	warfarin	CYP2C9	PA451906	1559	0.797
NULL	Toxins_(Basel)_2010_Oct_26_2(11)_2490-2518.nxml.txt.nlp	22069563	SENT133	0	0	3	3	cisplatin	p53	PA449014	7157	0.797
NULL	Indian_J_Pharm_Sci_2009_Nov-Dec_71(6)_622-629.nxml.txt.nlp	20376214	SENT36	13	13	21	21	l-proline	BCS	PA451125	617	0.797
NULL	J_Biol_Chem_2009_Apr_3_284(14)_9558-9565.nxml.txt.nlp	19202191	SENT69	43	43	6	6	camptothecin	CtIP	PA153590860	5932	0.797
NULL	Int_J_Mol_Cell_Med_2014_Autumn_3(4)_207-215.nxml.txt.nlp	25635247	SENT23	8	8	5	5	ribavirin	IFN	PA451241	3439	0.797
NULL	Mol_Vis_2011_Aug_18_17_2221-2227.nxml.txt.nlp	21897744	SENT84	20	20	6	6	penicillamine	NAC	PA450840	22861	0.797
NULL	BMB_Rep_2014_Nov_47(11)_649-654.nxml.txt.nlp	25301019	SENT127	20	20	14	14	l-serine	TLR4	PA451330	7099	0.797
NULL	Biomed_Res_Int_2014_May_13_2014_872139.nxml.txt.nlp	24963489	SENT87	8	8	0	0	methotrexate	MRP2	PA450428	100130958;57626;1244	0.797
NULL	Oncoimmunology_2014_Jan_3_3_e27357.nxml.txt.nlp	24790790	SENT206	21	21	1	1	temozolomide	CD4	PA451609	920	0.797
NULL	Curr_Neuropharmacol_2014_Mar_12(2)_186-192.nxml.txt.nlp	24669211	SENT33	33	33	46	46	metformin	Met	PA450395	79811	0.797
NULL	J_Mol_Signal_2012_Aug_16_7_12.nxml.txt.nlp	22898329	SENT248	1	1	10	10	temozolomide	NOXA	PA451609	5366	0.797
NULL	Front_Neural_Circuits_2013_Oct_21_7_165.nxml.txt.nlp	24155693	SENT217	29	29	5	5	paraformaldehyde	CA3	PA450790	761	0.797
NULL	Biol_Proced_Online_2003_May_1_5_108-115.nxml.txt.nlp	14569610	SENT243	29	29	9	9	nadh	ADP	PA164755085	23038	0.797
NULL	Indian_J_Pharm_Sci_2013_May-Jun_75(3)_302-309.nxml.txt.nlp	24082346	SENT56	14	14	23	23	diclofenac	SRMS	PA449293	6725	0.797
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT65	35	35	19	19	metformin	OCT2	PA450395	6582;5452	0.797
NULL	Lipids_Health_Dis_2011_Jan_28_10_25.nxml.txt.nlp	21272376	SENT43	9	9	24	24	scopolamine	spatial	PA451308	219793	0.797
NULL	Breast_Cancer_Res_2011_Jan_11_13(1)_R3.nxml.txt.nlp	21223569	SENT152	12	12	35	35	etoposide	p53	PA449552	7157	0.797
NULL	Cell_Death_Dis_2014_Apr_17_5(4)_e1182.nxml.txt.nlp	24743737	SENT40	12	12	10	10	capsaicin	TRPV1	PA448776	7442	0.797
NULL	Oncol_Lett_2013_Mar_8_5(3)_805-812.nxml.txt.nlp	23426281	SENT196	24	24	8	8	gemcitabine	B7-H3	PA449748	80381	0.797
NULL	Int_J_Breast_Cancer_2011_Jul_3_2011_912102.nxml.txt.nlp	22295238	SENT139	11	11	0	0	fulvestrant	IRF1	PA164747170	3659	0.797
NULL	Onco_Targets_Ther_2014_Mar_24_7_491-500.nxml.txt.nlp	24711706	SENT92	29	29	25	25	maytansine	DM1	PA165291473	338023;1760;28509	0.797
NULL	J_Carcinog_2011_Jun_17_10_16.nxml.txt.nlp	NULL	SENT74	25	25	2	2	resveratrol	p53		7157	0.797
NULL	Biomed_Res_Int_2013_Dec_5_2013_642848.nxml.txt.nlp	24381940	SENT165	3	3	8	8	telmisartan	IL-6	PA451605	3569	0.797
NULL	Br_J_Cancer_1998_Nov_78(9)_1170-1174.nxml.txt.nlp	9820175	SENT13	40	40	21	21	bufuralol	CYP1A2	PA166110256	1544	0.797
NULL	Curr_Oncol_2009_Jul_16(Suppl_2)_S14-S23.nxml.txt.nlp	19672417	SENT120	18	18	15	15	venlafaxine	CYP2D6	PA451866	1565	0.797
NULL	Biomed_Res_Int_2014_May_20_2014_418975.nxml.txt.nlp	24967364	SENT200	0	0	16	16	resveratrol	SIRT1		23411	0.797
NULL	Infection_2010_Oct_21_38(5)_357-362.nxml.txt.nlp	20652354	SENT116	28	28	11	11	moxifloxacin	HCAP	PA450555	117159;9126	0.797
NULL	Fibrogenesis_Tissue_Repair_2012_Jul_23_5_11.nxml.txt.nlp	22824096	SENT385	2	2	28	28	bleomycin	MCP-1	PA448645	6347	0.797
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT7	34	34	19	19	bevacizumab	VEGF-A	PA130232992	7422	0.797
NULL	FASEB_J_2013_Jul_27(7)_2880-2892.nxml.txt.nlp	23543682	SENT115	4	4	18	18	choline	ABCA1	PA448976	19	0.797
NULL	eLife_2014_Apr_15_3_e01694.nxml.txt.nlp	24737860	SENT272	20	20	41	41	doxycycline	ATF6	PA449415	22926	0.797
NULL	J_Cell_Biol_1998_Jan_26_140(2)_335-345.nxml.txt.nlp	9442109	SENT185	36	36	12	12	guanidine	NHE	PA164781028	285335	0.797
NULL	Ann_Dermatol_2011_Oct_31_23(Suppl_2)_S169-S174.nxml.txt.nlp	22148042	SENT104	37	37	11	11	dacarbazine	CHOP	PA449197	1649	0.797
NULL	Dermatoendocrinol_2013_Apr_1_5(2)_252-263.nxml.txt.nlp	24194965	SENT87	23	23	8	8	metformin	OCT1	PA450395	5451;6580	0.797
NULL	Breast_Cancer_Res_2010_Oct_22_12(Suppl_2)_S1.nxml.txt.nlp	21050422	SENT10	12	12	9	9	trastuzumab	HER2	PA451743	2064	0.797
NULL	Front_Neurol_2014_Feb_18_5_17.nxml.txt.nlp	24600432	SENT180	19	19	29	29	levetiracetam	CA3	PA450206	761	0.797
NULL	Exp_Ther_Med_2014_Oct_4_8(4)_1301-1307.nxml.txt.nlp	25187844	SENT159	25	25	5	5	hyaluronan	TLR4	PA165958431	7099	0.797
NULL	Int_J_Endocrinol_2014_Jul_9_2014_649016.nxml.txt.nlp	25114682	SENT28	8	8	23	23	thyroglobulin	THW	PA164754910	64065	0.797
NULL	Cell_Death_Dis_2010_May_13_1(5)_e41.nxml.txt.nlp	21364648	SENT72	18	18	24	24	etoposide	p53	PA449552	7157	0.797
NULL	Aging_(Albany_NY)_2012_Jan_30_4(1)_40-48.nxml.txt.nlp	22289652	SENT231	27	27	18	18	paraformaldehyde	ITGA5	PA450790	3678	0.797
NULL	J_Hematol_Oncol_2012_Aug_13_5_49.nxml.txt.nlp	22889180	SENT33	20	20	12	12	rituximab	CHOP	PA451261	1649	0.797
NULL	Cell_Death_Dis_2012_Mar_15_3(3)_e283.nxml.txt.nlp	22419112	SENT28	11	11	2	2	doxorubicin	CSIG	PA449412	26156	0.797
NULL	Case_Rep_Ophthalmol_Med_2013_Sep_12_2013_213124.nxml.txt.nlp	24109538	SENT46	22	22	11	11	bevacizumab	EGFR	PA130232992	1956	0.797
NULL	Arthritis_Res_Ther_2014_Apr_11_16(2)_R93.nxml.txt.nlp	24725461	SENT156	21	21	10	10	letrozole	aromatase	PA450196	1588	0.797
NULL	Nat_Genet_2011_Jan_12_43(1)_27-33.nxml.txt.nlp	21151129	SENT164	9	9	3	3	tamoxifen	FOXA1	PA451581	3169	0.797
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT2432	10	10	15	15	acetaminophen	CYP2E1	PA448015	1571	0.797
NULL	Leukemia_2014_Jun_25_28(6)_1280-1288.nxml.txt.nlp	24270737	SENT24	32	32	20	20	cytarabine	DAC	PA449177	13	0.797
NULL	Nat_Commun_2014_Dec_9_5_5711.nxml.txt.nlp	25487825	SENT503	14	14	4	4	methotrexate	DHFR	PA450428	1719	0.797
NULL	Autophagy_2012_May_1_8(5)_853-855.nxml.txt.nlp	22617440	SENT35	23	23	14	14	imatinib	BECN1	PA10804	8678	0.797
NULL	Br_J_Cancer_1994_Sep_70(3)_449-452.nxml.txt.nlp	8080729	SENT8	12	12	17	17	tamoxifen	DDP	PA451581	1678	0.797
NULL	Oncogenesis_2012_Apr_2_1(4)_e5.nxml.txt.nlp	23552603	SENT234	22	22	36	36	ns-398	BIM		10018	0.797
NULL	J_Biomed_Biotechnol_2010_Oct_4_2010_641025.nxml.txt.nlp	20976270	SENT95	25	25	45	45	thrombin	P18	PA451674	7975;10168	0.797
NULL	Front_Mol_Neurosci_2012_Nov_12_5_99.nxml.txt.nlp	23162427	SENT768	0	0	10	10	amphetamine	c-fos	PA448408	2353	0.797
NULL	Breast_Cancer_Res_2003_May_30_5(4)_206-207.nxml.txt.nlp	12817993	SENT3	11	11	23	23	trastuzumab	HER2	PA451743	2064	0.797
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2014_Sep_27_70(Pt_10)_2740-2753.nxml.txt.nlp	25286857	SENT313	13	13	17	17	bsi-201	TNKS2		80351	0.797
NULL	Exp_Diabetes_Res_2012_Nov_1_2012_892706.nxml.txt.nlp	23197976	SENT184	30	30	17	17	vildagliptin	HIF-1	PA165958346	29072	0.797
NULL	Exp_Diabetes_Res_2012_May_28_2012_924168.nxml.txt.nlp	22693487	SENT66	23	23	13	13	exenatide	GLP-1	PA164749238	100125288	0.797
NULL	Nat_Methods_2009_Jul_14_6(7)_493-495.nxml.txt.nlp	19525957	SENT96	15	15	0	0	neomycin	JM8	PA450608	778	0.797
NULL	Cancer_Cell_Int_2009_Feb_17_9_4.nxml.txt.nlp	19222856	SENT220	29	29	15	15	paclitaxel	p53	PA450761	7157	0.797
NULL	Int_J_Biol_Sci_2011_Sep_8_7(8)_1077-1092.nxml.txt.nlp	21927577	SENT240	2	2	12	12	telmisartan	p67phox	PA451605	4688	0.797
NULL	J_Biol_Chem_2012_Aug_24_287(35)_30000-30013.nxml.txt.nlp	22773837	SENT333	35	35	23	23	thrombin	GPVI	PA451674	51206	0.797
NULL	J_Cell_Biol_2003_Dec_22_163(6)_1385-1395.nxml.txt.nlp	14676308	SENT264	0	0	28	28	thrombin	RhoA	PA451674	387	0.797
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT616	11	11	30	30	amisulpride	PRL	PA162565877	5617	0.797
NULL	Iran_J_Neurol_2013_12(4)_129-135.nxml.txt.nlp	24250922	SENT35	7	7	19	19	trypsin	B-50	PA451806	2596	0.797
NULL	Cell_Death_Dis_2014_Jul_3_5(7)_e1311.nxml.txt.nlp	24991763	SENT295	2	2	14	14	ketamine	DLX1	PA450144	1745	0.797
NULL	Front_Microbiol_2012_May_24_3_187.nxml.txt.nlp	22783238	SENT13	17	17	9	9	hydroxyurea	ISC1	PA449942	6610	0.797
NULL	Int_J_Cell_Biol_2010_Jan_17_2010_930509.nxml.txt.nlp	20145727	SENT367	13	13	21	21	bortezomib	CHOP	PA10252	1649	0.797
NULL	Br_J_Cancer_2009_Jul_21_101(2)_269-277.nxml.txt.nlp	19603033	SENT136	20	20	37	37	cisplatin	MLH1	PA449014	4292	0.797
NULL	J_Cell_Mol_Med_2013_Dec_6_17(12)_1588-1597.nxml.txt.nlp	24199964	SENT241	23	23	36	36	dobutamine	APT	PA449381	653639	0.797
NULL	Oncotarget_2011_Mar_27_2(3)_209-221.nxml.txt.nlp	21444945	SENT134	3	3	23	23	bortezomib	p53	PA10252	7157	0.797
NULL	Ann_Clin_Transl_Neurol_2014_Dec_21_1(12)_996-1005.nxml.txt.nlp	25574474	SENT147	24	24	5	5	riluzole	P-gp	PA451251	5243	0.797
NULL	Environ_Health_Perspect_2007_Dec_8_115(Suppl_1)_77-83.nxml.txt.nlp	18174954	SENT201	4	4	19	19	genistein	TTR	PA165109660	7276	0.797
NULL	Diabetes_2013_Oct_17_62(10)_3582-3588.nxml.txt.nlp	23801580	SENT178	6	6	31	31	ebselen	PDX-1	PA161660841	3651	0.797
NULL	Clinics_2008_Oct_63(5)_651b-660.nxml.txt.nlp	18925326	SENT173	10	10	16	16	chlorpromazine	TNF-alpha	PA448964	7124	0.797
NULL	Diabetes_Obes_Metab_2011_Nov_13(11)_982-989.nxml.txt.nlp	21615670	SENT22	31	31	10	10	sitagliptin	GLP-1	PA164748978	100125288	0.797
NULL	Mol_Cancer_2008_Jun_5_7_50.nxml.txt.nlp	18534018	SENT72	26	26	21	21	bortezomib	survivin	PA10252	332	0.797
NULL	Int_J_Surg_Oncol_2012_Jun_12_2012_862879.nxml.txt.nlp	22778941	SENT128	10	10	0	0	cisplatin	c-Myc	PA449014	4609	0.797
NULL	J_Biol_Chem_2008_Oct_31_283(44)_29841-29846.nxml.txt.nlp	18765669	SENT184	0	0	3	3	suramin	P2X2	PA10292	22953	0.797
NULL	J_Med_Case_Reports_2011_Mar_19_5_112.nxml.txt.nlp	21418592	SENT94	3	3	11	11	venlafaxine	p40	PA451866	3921;339541;10314	0.797
NULL	Mol_Brain_2014_Mar_5_7_15.nxml.txt.nlp	24594013	SENT343	41	41	10	10	physostigmine	GluA2	PA450957	2891	0.797
NULL	Arthritis_Res_Ther_2013_Oct_2_15(5)_R141.nxml.txt.nlp	24286116	SENT184	10	10	22	22	infliximab	IL-6	PA452639	3569	0.797
NULL	Am_J_Trop_Med_Hyg_2014_Jul_2_91(1)_1-2.nxml.txt.nlp	24752684	SENT35	26	26	34	34	primaquine	G6PD	PA451103	2539	0.797
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT105	0	0	5	5	capsaicin	p53	PA448776	7157	0.797
NULL	Oncol_Lett_2013_Mar_11_5(3)_1010-1016.nxml.txt.nlp	23426784	SENT168	5	5	28	28	midazolam	CDK2	PA450496	1017	0.797
NULL	Int_J_Nanomedicine_2012_Oct_25_7_5565-5575.nxml.txt.nlp	23118538	SENT12	32	32	20	20	fenofibrate	CO2	PA449594	4513	0.797
NULL	Diabetologia_2008_May_12_51(5)_802-810.nxml.txt.nlp	18335204	SENT275	35	35	12	12	diazoxide	Gen	PA449285	348654	0.797
NULL	Cancer_Cell_Int_2010_May_11_10_16.nxml.txt.nlp	20459793	SENT10	10	10	16	16	cisplatin	ABCC5	PA449014	10057	0.797
NULL	Croat_Med_J_2012_Aug_53(4)_314-320.nxml.txt.nlp	22911523	SENT209	23	23	14	14	cetuximab	NRAS	PA10040	4893	0.797
NULL	Breast_Cancer_Res_2011_Jan_11_13(1)_R3.nxml.txt.nlp	21223569	SENT138	3	3	36	36	etoposide	p53	PA449552	7157	0.797
NULL	Oncol_Lett_2014_Jun_8_7(6)_1903-1910.nxml.txt.nlp	24932256	SENT18	10	10	21	21	cisplatin	Bcl-2	PA449014	596	0.797
NULL	Virol_J_2010_Nov_27_7_349.nxml.txt.nlp	21110887	SENT87	16	16	6	6	paraformaldehyde	DEF	PA450790	27042	0.797
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jun_27_68(Pt_7)_o2237.nxml.txt.nlp	22798893	SENT75	38	38	28	28	ethanol	mol	PA448073	90527	0.797
NULL	Breast_Cancer_Res_2010_Oct_22_12(Suppl_2)_S1.nxml.txt.nlp	21050422	SENT133	16	16	10	10	gefitinib	EGFR	PA131301952	1956	0.797
NULL	Core_Evid_2011_Mar_17_6_31-42.nxml.txt.nlp	21468241	SENT108	4	4	8	8	ticagrelor	IPA	PA165374673	3160	0.797
NULL	Arch_Med_Sci_2014_Aug_29_10(4)_643-650.nxml.txt.nlp	25276146	SENT21	8	8	16	16	sirolimus	PES	PA451365	23481	0.797
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1137-1144.nxml.txt.nlp	20234366	SENT134	32	32	24	24	cetuximab	MKP-1	PA10040	1843	0.797
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT42	4	4	34	34	curcumin	TRAIL	PA151958596	8743	0.797
NULL	J_Mol_Signal_2010_Jul_12_5_8.nxml.txt.nlp	20624308	SENT52	17	17	11	11	gefitinib	Met	PA131301952	79811	0.797
NULL	Cancer_Cell_2007_Dec_11_12(6)_514-527.nxml.txt.nlp	18068629	SENT5	11	11	5	5	paclitaxel	TGFBI	PA450761	7045	0.797
NULL	ISRN_Neurosci_2013_Sep_5_2013_759640.nxml.txt.nlp	24959565	SENT147	6	6	9	9	etomidate	ANOVA	PA164743987	4858	0.797
NULL	Diabetes_2011_Jan_4_60(1)_119-126.nxml.txt.nlp	20921208	SENT251	18	18	4	4	glucose	TRPM2	PA449773	7226	0.797
NULL	J_Immunotoxicol_2013_Jan_11_10(1)_75-82.nxml.txt.nlp	22967038	SENT101	25	25	31	31	muromonab	CD4	PA164743097	920	0.797
NULL	Ann_Rheum_Dis_2008_Sep_11_68(7)_1146-1152.nxml.txt.nlp	18794178	SENT159	29	29	23	23	adalimumab	ACR	PA10004	49	0.797
NULL	Pharmaceutics_2010_Jun_2_2(2)_258-274.nxml.txt.nlp	NULL	SENT177	36	36	21	21	risperidone	P-gp	PA451257	5243	0.797
NULL	Front_Behav_Neurosci_2014_May_27_8_157.nxml.txt.nlp	24904329	SENT532	13	13	16	16	scopolamine	spatial	PA451308	219793	0.797
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT381	7	7	24	24	dasatinib	p38	PA162372878	10598;1432;7965	0.797
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT12	17	17	4	4	neratinib	HRG	PA165291472	3084;3273	0.797
NULL	Arthritis_Res_Ther_2013_Jul_24_15(Suppl_3)_S6.nxml.txt.nlp	24267478	SENT144	28	28	33	33	clopidogrel	CYP2C19	PA449053	1557	0.797
NULL	Clin_Epigenetics_2010_Sep_18_1(3-4)_101-116.nxml.txt.nlp	21258631	SENT228	6	6	20	20	curcumin	DNMT1	PA151958596	1786	0.797
NULL	Eur_J_Neurosci_2008_Jun_27(12)_3151-3160.nxml.txt.nlp	18598259	SENT207	12	12	10	10	capsaicin	TRPV1	PA448776	7442	0.797
NULL	J_Cell_Mol_Med_2013_Jun_4_17(6)_754-765.nxml.txt.nlp	NULL	SENT69	9	9	26	26	fluorescein	San	PA164746009	80218	0.797
NULL	Mol_Cell_Biochem_2014_Oct_9_385(1-2)_265-275.nxml.txt.nlp	24104452	SENT170	22	22	8	8	bortezomib	LC3	PA10252	84557	0.797
NULL	Front_Neurosci_2014_Nov_10_8_364.nxml.txt.nlp	25426018	SENT261	13	13	2	2	dextran	ANOVA	PA449261	4858	0.797
NULL	Indian_J_Pharmacol_2013_Jan-Feb_45(1)_54-60.nxml.txt.nlp	23543867	SENT16	5	5	16	16	terlipressin	NAC	PA164781020	22861	0.797
NULL	Mol_Biol_Cell_2012_Jun_1_23(11)_2017-2027.nxml.txt.nlp	22496424	SENT101	2	2	16	16	warfarin	PRDX4	PA451906	10549	0.797
NULL	Front_Cell_Neurosci_2014_Jul_18_8_185.nxml.txt.nlp	25100946	SENT225	6	6	36	36	pp2	Isl-1		3670	0.797
NULL	Ann_Clin_Transl_Neurol_2014_Jan_20_1(1)_15-26.nxml.txt.nlp	25356379	SENT99	26	26	34	34	isoflurane	P15	PA450106	1030;29107	0.797
NULL	Int_J_Mol_Sci_2014_Oct_13_15(10)_18362-18380.nxml.txt.nlp	25314299	SENT485	6	6	9	9	capsaicin	TRPV1	PA448776	7442	0.797
NULL	Biologics_2012_Dec_17_6_429-464.nxml.txt.nlp	23269860	SENT163	1	1	21	21	etanercept	ACR	PA449515	49	0.797
NULL	Cell_Death_Dis_2012_Jun_7_3(6)_e319.nxml.txt.nlp	22673193	SENT35	7	7	9	9	cisplatin	Mcl-1	PA449014	4170	0.797
NULL	Environ_Health_Perspect_2007_May_5_115(5)_720-727.nxml.txt.nlp	17520059	SENT280	24	24	14	14	ethanol	SF-1	PA448073	2516	0.797
NULL	J_Biol_2003_Sep_24_2(4)_28.nxml.txt.nlp	14511394	SENT14	5	5	9	9	phenformin	AMPK	PA1000	5563	0.797
NULL	Breast_Cancer_Res_Treat_2012_Apr_25_132(3)_1049-1062.nxml.txt.nlp	22198468	SENT230	20	20	36	36	trastuzumab	HER2	PA451743	2064	0.797
NULL	Case_Rep_Oncol_Med_2012_Nov_3_2012_819809.nxml.txt.nlp	23198202	SENT33	24	24	13	13	thyroglobulin	CK7	PA164754910	3855	0.797
NULL	Drug_Des_Devel_Ther_2014_Oct_31_8_2121-2128.nxml.txt.nlp	25382970	SENT21	26	26	17	17	curcumin	TTR	PA151958596	7276	0.797
NULL	Clin_Ophthalmol_2012_Mar_8_6_377-383.nxml.txt.nlp	22457587	SENT103	18	18	8	8	hydroxychloroquine	ERG	PA164777036	2078	0.797
NULL	Chin_J_Cancer_2011_Sep_30(9)_645-654.nxml.txt.nlp	21880186	SENT177	7	7	33	33	cisplatin	NACT	PA449014	284111	0.797
NULL	J_Cell_Mol_Med_2015_Jan_30_19(1)_210-226.nxml.txt.nlp	25266063	SENT149	30	30	8	8	forskolin	MYCN	PA146096022	4613	0.797
NULL	Oncotarget_2011_Dec_31_2(12)_935-947.nxml.txt.nlp	22249213	SENT238	25	25	29	29	paclitaxel	MCAK	PA450761	11004	0.797
NULL	Clin_Epigenetics_2010_Sep_18_1(3-4)_101-116.nxml.txt.nlp	21258631	SENT244	4	4	16	16	curcumin	COX2	PA151958596	4513;5743	0.797
NULL	Cancers_(Basel)_2012_Apr_5_4(2)_354-378.nxml.txt.nlp	24213315	SENT163	4	4	24	24	sorafenib	Mcl-1	PA7000	4170	0.797
NULL	J_Biol_Eng_2009_Oct_16_3_18.nxml.txt.nlp	19835592	SENT152	2	2	4	4	chlorpromazine	CPZ	PA448964	8532	0.797
NULL	Aging_(Albany_NY)_2014_Jan_14_6(1)_70-81.nxml.txt.nlp	24429382	SENT77	25	25	11	11	bleomycin	WRN	PA448645	7486	0.797
NULL	Diabetes_2013_Nov_18_62(11)_3909-3919.nxml.txt.nlp	23835339	SENT254	12	12	16	16	gliclazide	SUR1	PA10892	6833	0.797
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Aug_25_66(Pt_9)_o2400.nxml.txt.nlp	21588732	SENT69	22	22	15	15	ethanol	mol	PA448073	90527	0.797
NULL	Ann_Indian_Acad_Neurol_2013_Jul-Sep_16(3)_338-341.nxml.txt.nlp	24101812	SENT116	12	12	8	8	pyridostigmine	Dok-7	PA451185	285489	0.797
NULL	Braz_J_Med_Biol_Res_2014_Oct_14_47(12)_1062-1067.nxml.txt.nlp	25387673	SENT106	2	2	8	8	propofol	PI3K	PA451141	5290	0.797
NULL	Breast_Cancer_Res_Treat_2013_Feb_3_138(1)_249-259.nxml.txt.nlp	23378108	SENT199	18	18	23	23	tamoxifen	aromatase	PA451581	1588	0.797
NULL	Breast_Cancer_Res_2011_Jun_29_13(3)_R70.nxml.txt.nlp	21707964	SENT175	17	17	21	21	tamoxifen	14-3-3	PA451581	10971	0.797
NULL	Infect_Drug_Resist_2010_Nov_23_3_133-145.nxml.txt.nlp	21694902	SENT323	6	6	3	3	ribavirin	IFN	PA451241	3439	0.797
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Mar_28_68(Pt_4)_o1220.nxml.txt.nlp	22606157	SENT57	19	19	34	34	ethanol	mol	PA448073	90527	0.797
NULL	Acta_Pharmacol_Sin_2010_Sep_23_31(9)_1208-1212.nxml.txt.nlp	20729871	SENT86	14	14	18	18	creatine	AMPK	PA164778930	5563	0.797
NULL	Asian_J_Androl_2015_Aug_29_Jan-Feb_17(1)_32-39.nxml.txt.nlp	25219908	SENT157	14	14	0	0	tadalafil	Men	PA10333	8178	0.797
NULL	J_Immunol_Res_2014_May_12_2014_897249.nxml.txt.nlp	24901013	SENT129	23	23	16	16	natalizumab	BIM	PA164747191	10018	0.797
NULL	Int_J_Mol_Sci_2014_Jun_25_15(7)_11234-11244.nxml.txt.nlp	24968266	SENT149	5	5	17	17	docetaxel	PC-3	PA449383	692094	0.797
NULL	Ind_Psychiatry_J_2011_Jul-Dec_20(2)_142-144.nxml.txt.nlp	23271873	SENT64	0	0	7	7	aripiprazole	5-HT2A	PA10026	3356	0.797
NULL	Oncol_Lett_2013_Jul_29_6(1)_118-124.nxml.txt.nlp	23946788	SENT79	16	16	3	3	tamoxifen	aromatase	PA451581	1588	0.797
NULL	Cell_Res_2014_Jul_9_24(7)_820-841.nxml.txt.nlp	24810299	SENT131	41	41	12	12	doxycycline	RBP-J	PA449415	3516	0.797
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT82	3	3	22	22	nutlin-3	p53		7157	0.797
NULL	Cell_Death_Dis_2010_Oct_21_1(10)_e86.nxml.txt.nlp	21368859	SENT85	11	11	9	9	doxorubicin	TRAIL	PA449412	8743	0.797
NULL	Mol_Cancer_2014_Jan_13_13_7.nxml.txt.nlp	24418169	SENT105	24	24	32	32	sorafenib	castor	PA7000	54897	0.797
NULL	Oncoscience_2014_Mar_12_1(2)_158-166.nxml.txt.nlp	25594008	SENT128	7	7	1	1	dasatinib	ANXA1	PA162372878	301	0.797
NULL	J_Biol_2009_Apr_15_8(3)_30.nxml.txt.nlp	19435483	SENT31	22	22	12	12	imatinib	NQO2	PA10804	4835	0.797
NULL	Int_J_Mol_Sci_2014_Sep_22_15(9)_16800-16815.nxml.txt.nlp	25247578	SENT43	19	19	21	21	minoxidil	MNX	PA450521	3892	0.797
NULL	Cancer_Manag_Res_2013_Jul_31_5_197-203.nxml.txt.nlp	23940421	SENT120	0	0	7	7	vismodegib	SMO		6608;54498	0.797
NULL	F1000Res_2014_Aug_19_3_198.nxml.txt.nlp	25400908	SENT392	15	15	11	11	tamoxifen	ATAC	PA451581	6375	0.797
NULL	Curr_Control_Trials_Cardiovasc_Med_2001_Jul_17_2(4)_187-194.nxml.txt.nlp	11806794	SENT230	14	14	22	22	eptifibatide	IMPACT	PA449483	55364	0.797
NULL	Cell_Biol_Int_Rep_(2010)_2012_Jun_21_19(1)_e00017.nxml.txt.nlp	23124518	SENT5	6	6	8	8	etoposide	TRAIL	PA449552	8743	0.797
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT253	25	25	34	34	cisplatin	p53	PA449014	7157	0.797
NULL	Acta_Pharmacol_Sin_2012_Jul_18_33(7)_941-952.nxml.txt.nlp	22705729	SENT51	28	28	0	0	l-glutamine	INS-1	PA10090	2305	0.797
NULL	J_Cancer_2013_Jul_1_4(5)_433-446.nxml.txt.nlp	23833688	SENT234	34	34	4	4	tamoxifen	STAR	PA451581	6770;2984	0.797
NULL	Mol_Cancer_2006_Oct_17_5_45.nxml.txt.nlp	17044934	SENT76	13	13	10	10	resveratrol	COX		1351	0.797
NULL	Oncogenesis_2012_Apr_2_1(4)_e5.nxml.txt.nlp	23552603	SENT234	20	20	36	36	celecoxib	BIM	PA448871	10018	0.797
NULL	Oncotarget_2014_Oct_21_5(22)_11709-11722.nxml.txt.nlp	25365944	SENT143	11	11	5	5	metformin	Rho	PA450395	29984	0.797
NULL	Oncogene_2010_Jan_7_29(1)_81-92.nxml.txt.nlp	19784067	SENT18	19	19	2	2	cisplatin	BRG1	PA449014	6597	0.797
NULL	Ann_Oncol_2011_Aug_27_22(8)_1736-1747.nxml.txt.nlp	21709140	SENT354	11	11	23	23	trastuzumab	San	PA451743	80218	0.797
NULL	Front_Aging_Neurosci_2010_May_18_2_16.nxml.txt.nlp	20559464	SENT210	2	2	22	22	sulindac	COX	PA451565	1351	0.797
NULL	Clin_Ophthalmol_2010_Nov_23_4_1355-1359.nxml.txt.nlp	21179218	SENT37	12	12	6	6	travoprost	BAK	PA164781371	578	0.797
NULL	Arthritis_Res_Ther_2009_Nov_13_11(6)_R172.nxml.txt.nlp	19912653	SENT201	13	13	16	16	simvastatin	IVD	PA451363	3712	0.797
NULL	Br_J_Cancer_1997_75(2)_161-168.nxml.txt.nlp	9010020	SENT5	18	18	29	29	vincristine	PC4	PA451879	10923;54760;3475	0.797
NULL	Database_(Oxford)_2013_Jul_18_2013_bat049.nxml.txt.nlp	23868908	SENT84	10	10	4	4	imatinib	NQO2	PA10804	4835	0.797
NULL	Breast_Cancer_Res_2004_Dec_15_6(2)_R63-R74.nxml.txt.nlp	14979919	SENT248	32	32	30	30	oltipraz	CYP1A1		1543	0.797
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT91	4	4	31	31	methotrexate	MLH1	PA450428	4292	0.797
NULL	Patient_Prefer_Adherence_2013_Mar_27_7_245-258.nxml.txt.nlp	23569364	SENT69	16	16	9	9	fulvestrant	aromatase	PA164747170	1588	0.797
NULL	Biochimie_2015_Jan_108_40-47.nxml.txt.nlp	25447146	SENT194	21	21	16	16	thiamylal	TFP	PA164746997	7034	0.797
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Jul_27_69(Pt_8)_o1331.nxml.txt.nlp	24109402	SENT72	21	21	13	13	ethanol	mol	PA448073	90527	0.797
NULL	Arthritis_Res_Ther_2006_Apr_12_8(Suppl_1)_S3.nxml.txt.nlp	16820042	SENT144	10	10	32	32	colchicine	MSU	PA449092	593	0.797
NULL	Int_J_Cell_Biol_2013_Nov_13_2013_674751.nxml.txt.nlp	24324498	SENT106	9	9	37	37	guanabenz	TDP-43	PA164774903	23435	0.797
NULL	Indian_J_Crit_Care_Med_2013_May-Jun_17(3)_129-134.nxml.txt.nlp	24082608	SENT107	11	11	21	21	colistin	CRA	PA164760862	51747;10903	0.797
NULL	Diabetes_Care_2010_Jul_31_33(7)_1544-1548.nxml.txt.nlp	20357370	SENT93	13	13	5	5	metformin	STK11	PA450395	6794	0.797
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT499	11	11	8	8	irinotecan	ABCG2	PA450085	9429	0.797
NULL	Oncotarget_2014_Jun_8_5(13)_5040-5053.nxml.txt.nlp	24970815	SENT202	27	27	9	9	cisplatin	PUMA	PA449014	27113	0.797
NULL	Oncotarget_2014_Aug_29_5(19)_8947-8958.nxml.txt.nlp	25333254	SENT104	14	14	29	29	plerixafor	CXCR4	PA165958410	7852	0.797
NULL	J_Adv_Pract_Oncol_2014_Jan_1_Jan-Feb_5(1)_57-60.nxml.txt.nlp	25032035	SENT76	30	30	8	8	tamoxifen	ATAC	PA451581	6375	0.797
NULL	Chin_J_Cancer_2011_Sep_30(9)_645-654.nxml.txt.nlp	21880186	SENT178	12	12	18	18	cisplatin	NACT	PA449014	284111	0.797
NULL	Indian_J_Dermatol_2012_Mar-Apr_57(2)_157-158.nxml.txt.nlp	22615522	SENT26	11	11	5	5	vincristine	CHOP	PA451879	1649	0.797
NULL	Diabetes_2013_Nov_18_62(11)_3851-3862.nxml.txt.nlp	23884890	SENT202	2	2	21	21	metformin	AMPK	PA450395	5563	0.797
NULL	Front_Endocrinol_(Lausanne)_2014_Oct_9_5_161.nxml.txt.nlp	25346723	SENT417	8	8	6	6	exenatide	GLP-1	PA164749238	100125288	0.797
NULL	Diabetes_Metab_Syndr_Obes_2010_Jul_9_3_243-252.nxml.txt.nlp	21437092	SENT137	12	12	14	14	pioglitazone	adiponectin	PA450970	9370	0.797
NULL	Int_J_Mol_Sci_2014_Sep_2_15(9)_15512-15529.nxml.txt.nlp	25184950	SENT113	1	1	20	20	resveratrol	p65		5970	0.797
NULL	Eur_J_Clin_Pharmacol_2013_Jan_11_69(6)_1275-1283.nxml.txt.nlp	23307232	SENT81	9	9	6	6	warfarin	VKORC1	PA451906	79001	0.797
NULL	Case_Rep_Hematol_2013_Oct_10_2013_840253.nxml.txt.nlp	24224107	SENT56	11	11	18	18	doxorubicin	CHOP	PA449412	1649	0.797
NULL	Asian-Australas_J_Anim_Sci_2014_Dec_27(12)_1763-1772.nxml.txt.nlp	25358371	SENT170	15	15	10	10	l-histidine	CARNS1	PA449882	57571	0.797
NULL	Oncol_Rep_2013_Apr_23_29(4)_1268-1274.nxml.txt.nlp	23354756	SENT101	11	11	6	6	paclitaxel	SLC25A43	PA450761	203427	0.797
NULL	J_Neuroinflammation_2011_Feb_4_8_10.nxml.txt.nlp	21294877	SENT162	23	23	14	14	capsaicin	NK1	PA448776	11126	0.797
NULL	Mol_Vis_2011_Oct_19_17_2724-2737.nxml.txt.nlp	22065926	SENT288	7	7	18	18	paclitaxel	E2F1	PA450761	1869	0.797
NULL	Pain_2012_Apr_153(4)_775-783.nxml.txt.nlp	22325744	SENT440	9	9	15	15	naloxone	P21	PA450586	1026;9338	0.797
NULL	Osteoarthritis_Cartilage_2010_Apr_18(4)_555-562.nxml.txt.nlp	20060953	SENT141	13	13	31	31	clenbuterol	MNX	PA164745640	3892	0.797
NULL	Mol_Cancer_2014_Feb_24_13_35.nxml.txt.nlp	24565101	SENT106	3	3	12	12	doxorubicin	p65	PA449412	5970	0.797
NULL	Acta_Neuropathol_2015_Oct_17_129_115-131.nxml.txt.nlp	25322816	SENT271	7	7	10	10	bevacizumab	LDHA	PA130232992	3939	0.797
NULL	BMB_Rep_2014_Jul_47(7)_376-381.nxml.txt.nlp	24286332	SENT53	11	11	5	5	heparin	PPG	PA449855	5552	0.797
NULL	Eur_J_Immunol_2014_Jun_10_44(6)_1759-1769.nxml.txt.nlp	24595810	SENT140	4	4	8	8	fludrocortisone	CXCR4	PA164743961	7852	0.797
NULL	Nat_Commun_2013_4_10_1038_ncomms3183.nxml.txt.nlp	23873306	SENT92	3	3	12	12	doxycycline	NGN2	PA449415	63973	0.797
NULL	Front_Physiol_2013_Nov_14_4_323.nxml.txt.nlp	24294204	SENT200	19	19	8	8	metoprolol	CYP2D6	PA450480	1565	0.797
NULL	Acta_Pharmacol_Sin_2012_Jun_14_33(6)_823-831.nxml.txt.nlp	22580738	SENT26	22	22	2	2	doxorubicin	P-gp	PA449412	5243	0.797
NULL	Cases_J_2008_Jun_5_1_15.nxml.txt.nlp	18577260	SENT78	12	12	20	20	cyclophosphamide	CHOP	PA449165	1649	0.796
NULL	Breast_Cancer_Res_2011_Jun_29_13(3)_R70.nxml.txt.nlp	21707964	SENT175	17	17	0	0	tamoxifen	14-3-3	PA451581	10971	0.796
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT376	6	6	0	0	lapatinib	HRG	PA152241907	3084;3273	0.796
NULL	Cancer_Cell_Int_2007_Sep_10_7_14.nxml.txt.nlp	17845729	SENT166	17	17	0	0	decitabine	GADD45A	PA164749631	1647	0.796
NULL	Gut_Liver_2012_Oct_18_6(4)_464-470.nxml.txt.nlp	23170151	SENT110	24	24	28	28	propofol	ESD	PA451141	2098	0.796
NULL	Indian_J_Med_Res_2012_Dec_136(6)_926-941.nxml.txt.nlp	23391788	SENT206	17	17	25	25	clopidogrel	P2Y12	PA449053	64805	0.796
NULL	Drugs_R_D_2011_Jun_27_11(2)_113-126.nxml.txt.nlp	21679004	SENT39	22	22	48	48	pazopanib	IFN	PA165291492	3439	0.796
NULL	Cell_Oncol_(Dordr)_2012_Jun_12_35(3)_189-196.nxml.txt.nlp	22528563	SENT24	10	10	23	23	erlotinib	EGFR	PA134687924	1956	0.796
NULL	Indian_J_Med_Res_2014_Aug_140(2)_227-230.nxml.txt.nlp	25297355	SENT21	9	9	16	16	ketoprofen	COX	PA450149	1351	0.796
NULL	Pharmaceuticals_(Basel)_2011_Oct_25_4(11)_1400-1422.nxml.txt.nlp	NULL	SENT81	30	30	4	4	nadh	NQO1	PA164755085	1728	0.796
NULL	Behav_Brain_Funct_2012_Jun_11_8_30.nxml.txt.nlp	22686184	SENT203	7	7	4	4	diazepam	CORT	PA449283	1325	0.796
NULL	Iran_J_Pharm_Res_2013_Summer_12(3)_457-469.nxml.txt.nlp	24250652	SENT132	6	6	12	12	indomethacin	spatial	PA449982	219793	0.796
NULL	Clin_Pharmacol_2013_Dec_9_5_185-192.nxml.txt.nlp	24353446	SENT76	8	8	27	27	clopidogrel	CYP3A4	PA449053	1576	0.796
NULL	Autoimmune_Dis_2012_Dec_6_2012_784364.nxml.txt.nlp	23304459	SENT271	17	17	8	8	natalizumab	CSM1	PA164747191	1674	0.796
NULL	Clin_Med_Insights_Oncol_2011_Jul_28_5_235-257.nxml.txt.nlp	21836819	SENT479	13	13	4	4	paclitaxel	p53	PA450761	7157	0.796
NULL	Cell_Biochem_Biophys_2013_May_28_67(1)_25-43.nxml.txt.nlp	23712866	SENT128	16	16	2	2	paclitaxel	USP2	PA450761	9099	0.796
NULL	Atten_Defic_Hyperact_Disord_2010_Dec_30_2(4)_213-220.nxml.txt.nlp	21258431	SENT1	27	27	29	29	atomoxetine	ATX	PA134688071	5168;23049	0.796
NULL	EJNMMI_Res_2011_Jun_7_1_1.nxml.txt.nlp	21845232	SENT34	26	26	11	11	oxaliplatin	EGFR	PA131285527	1956	0.796
NULL	Aging_(Albany_NY)_2011_Jan_18_3(1)_33-43.nxml.txt.nlp	21248371	SENT129	11	11	40	40	zinc	p53	PA451956	7157	0.796
NULL	Ital_J_Pediatr_2011_Dec_19_37_58.nxml.txt.nlp	22182677	SENT162	12	12	17	17	diazepam	LZP	PA449283	170392	0.796
NULL	Breast_Cancer_Res_2009_Oct_12_11(5)_R74.nxml.txt.nlp	19821999	SENT259	2	2	19	19	bortezomib	p53	PA10252	7157	0.796
NULL	Oncotarget_2014_Nov_3_5(20)_10127-10139.nxml.txt.nlp	25333256	SENT176	15	15	23	23	vemurafenib	TRIM16	PA165946873	10626	0.796
NULL	Hum_Genomics_Proteomics_2010_Sep_13_2010_754919.nxml.txt.nlp	20981234	SENT92	24	24	16	16	phenprocoumon	CYP2C9	PA450921	1559	0.796
NULL	Ann_Oncol_2013_Aug_12_24(8)_1994-1999.nxml.txt.nlp	23670096	SENT106	18	18	12	12	tamoxifen	AIB1	PA451581	8202	0.796
NULL	Int_J_Endocrinol_2011_Aug_21_2011_742719.nxml.txt.nlp	21869886	SENT139	32	32	12	12	clopidogrel	DES	PA449053	1674	0.796
NULL	Breast_Cancer_Res_2011_Jan_17_13(1)_R5.nxml.txt.nlp	21241485	SENT323	28	28	35	35	tamoxifen	NGF	PA451581	4803	0.796
NULL	Diabetes_Care_2013_May_13_36(5)_1074-1082.nxml.txt.nlp	23275352	SENT19	0	0	8	8	liraglutide	ZAG	PA165958364	563	0.796
NULL	Oncotarget_2014_Aug_19_5(18)_8737-8749.nxml.txt.nlp	25228590	SENT167	21	21	31	31	crizotinib	MYCN	PA165946122	4613	0.796
NULL	Breast_Cancer_Res_2007_Mar_2_9(2)_205.nxml.txt.nlp	NULL	SENT26	37	37	31	31	gefitinib	HER-2	PA131301952	2064	0.796
NULL	Curr_Neuropharmacol_2010_Dec_8(4)_409-421.nxml.txt.nlp	21629447	SENT222	8	8	0	0	flunitrazepam	CLB	PA164781320	171425	0.796
NULL	Clin_Med_Insights_Cardiol_2011_Oct_6_5_103-119.nxml.txt.nlp	22084608	SENT40	11	11	34	34	dronedarone	CYP3A4	PA153619853	1576	0.796
NULL	Acta_Pharmacol_Sin_2011_Jun_23_32(6)_834-839.nxml.txt.nlp	21602836	SENT36	0	0	7	7	forskolin	F12	PA146096022	2161	0.796
NULL	Br_J_Cancer_2009_May_19_100(10)_1540-1548.nxml.txt.nlp	19384300	SENT103	26	26	20	20	trypsin	TATI	PA451806	6690	0.796
NULL	Clin_Dev_Immunol_2013_May_23_2013_575936.nxml.txt.nlp	23762093	SENT98	10	10	19	19	denosumab	RANKL	PA166048634	8600	0.796
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S31-S40.nxml.txt.nlp	20680106	SENT37	17	17	15	15	cetuximab	EGFR	PA10040	1956	0.796
NULL	Oncotarget_2014_Aug_29_5(17)_7217-7259.nxml.txt.nlp	25277175	SENT795	3	3	22	22	metformin	SIRT1	PA450395	23411	0.796
NULL	Clin_Mol_Hepatol_2014_Sep_25_20(3)_283-290.nxml.txt.nlp	25320732	SENT74	31	31	29	29	propranolol	EVL	PA451145	51466	0.796
NULL	Oncotarget_2013_Dec_28_5(6)_1475-1490.nxml.txt.nlp	24721996	SENT192	3	3	6	6	celecoxib	PTEN	PA448871	5728	0.796
NULL	Cancer_Immunol_Immunother_2013_Aug_27_62(10)_1637-1648.nxml.txt.nlp	23982484	SENT181	0	0	6	6	lenalidomide	IL-6	PA162363968	3569	0.796
NULL	Arch_Med_Sci_2011_Dec_31_7(6)_977-983.nxml.txt.nlp	22328880	SENT123	0	0	9	9	heparin	PAPP-A	PA449855	5069	0.796
NULL	Mol_Neurodegener_2011_Jun_22_6_43.nxml.txt.nlp	21696630	SENT136	6	6	12	12	vasopressin	PKD1	PA451858	5310	0.796
NULL	Acta_Orthop_2011_Apr_5_82(2)_211-216.nxml.txt.nlp	21434784	SENT50	23	23	25	25	cisplatin	CDP	PA449014	1523	0.796
NULL	Acta_Histochem_Cytochem_2013_Oct_30_46(5)_129-136.nxml.txt.nlp	24194626	SENT54	10	10	7	7	thyroglobulin	TTF-1	PA164754910	7080	0.796
NULL	Sci_Rep_2014_Dec_4_4_7310.nxml.txt.nlp	25472472	SENT128	14	14	9	9	decitabine	CD34	PA164749631	947	0.796
NULL	Cardiovasc_Toxicol_2013_May_1_13(4)_307-315.nxml.txt.nlp	23632742	SENT202	20	20	46	46	rosiglitazone	SOD1	PA451283	6647	0.796
NULL	Chem_Cent_J_2012_Jan_22_6_7.nxml.txt.nlp	22264235	SENT193	8	8	25	25	chloramphenicol	PC2	PA448927	5126;5311;8535	0.796
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT213	11	11	2	2	simvastatin	survivin	PA451363	332	0.796
NULL	ISRN_AIDS_2012_Dec_1_2012_621565.nxml.txt.nlp	24052880	SENT144	9	9	11	11	atazanavir	ATV	PA10251	4683	0.796
NULL	Indian_J_Pharm_Sci_2014_Mar-Apr_76(2)_116-124.nxml.txt.nlp	24843184	SENT16	17	17	19	19	trimethoprim	TMP	PA451788	2012	0.796
NULL	Arthritis_Res_Ther_2004_Sep_22_6(6)_R514-R520.nxml.txt.nlp	15535829	SENT24	23	23	37	37	hyaluronan	PH-20	PA165958431	6677	0.796
NULL	Oncotarget_2014_Jun_1_5(13)_4868-4880.nxml.txt.nlp	24947902	SENT8	0	0	22	22	afatinib	HER2	PA165981154	2064	0.796
NULL	Arq_Bras_Cardiol_2014_Mar_102(3)_211-218.nxml.txt.nlp	24676223	SENT85	26	26	15	15	ethanol	ANOVA	PA448073	4858	0.796
NULL	Indian_Dermatol_Online_J_2014_Oct-Dec_5(4)_510-516.nxml.txt.nlp	25396144	SENT35	5	5	18	18	pentoxifylline	IL-6	PA450864	3569	0.796
NULL	Exp_Ther_Med_2013_Jan_19_5(1)_23-27.nxml.txt.nlp	23251236	SENT136	31	31	2	2	curcumin	EGFR	PA151958596	1956	0.796
NULL	Arthritis_Res_Ther_2013_Dec_5_15(6)_R208.nxml.txt.nlp	24314202	SENT253	25	25	13	13	infliximab	IL-6	PA452639	3569	0.796
NULL	Cell_Commun_Signal_2013_Oct_1_11_73.nxml.txt.nlp	24083678	SENT73	33	33	18	18	sulindac	A20	PA451565	7128;28935	0.796
NULL	Breast_Cancer_Res_2006_Nov_6_8(6)_215.nxml.txt.nlp	17096862	SENT175	16	16	25	25	trastuzumab	HER2	PA451743	2064	0.796
NULL	Arthritis_Res_Ther_2005_Feb_18_7(3)_R476-R484.nxml.txt.nlp	15899034	SENT237	6	6	19	19	thrombin	IL-6	PA451674	3569	0.796
NULL	Clinics_(Sao_Paulo)_2013_Feb_68(2)_253-262.nxml.txt.nlp	23525324	SENT213	14	14	8	8	genistein	Gen	PA165109660	348654	0.796
NULL	Biochimie_2014_Jan_96(100)_106-112.nxml.txt.nlp	23827855	SENT34	7	7	0	0	lipase	ATGL	PA450239	57104	0.796
NULL	Neuropsychopharmacology_2009_Apr_2_34(5)_1135-1148.nxml.txt.nlp	18596687	SENT251	10	10	37	37	cocaine	CRF	PA449072	1392;10882	0.796
NULL	Mol_Biol_Int_2014_Sep_7_2014_852748.nxml.txt.nlp	25276427	SENT137	8	8	3	3	trastuzumab	HER2	PA451743	2064	0.796
NULL	Cancer_Cell_Int_2010_Apr_29_10_12.nxml.txt.nlp	20429927	SENT191	12	12	10	10	arsenite	HRI	PA452638	27102	0.796
NULL	Acta_Pharmacol_Sin_2010_Jul_21_31(7)_855-860.nxml.txt.nlp	20562904	SENT145	7	7	13	13	fluconazole	CDR1	PA449653	1038	0.796
NULL	Pharmaceutics_2011_Nov_18_3(4)_865-913.nxml.txt.nlp	24309312	SENT320	19	19	34	34	glibenclamide	P-gp	PA449782	5243	0.796
NULL	Mol_Cancer_2012_Dec_12_11_91.nxml.txt.nlp	23234355	SENT86	7	7	28	28	erlotinib	EGFR	PA134687924	1956	0.796
NULL	Oncotarget_2012_Oct_20_3(10)_1236-1245.nxml.txt.nlp	23100449	SENT88	14	14	1	1	doxorubicin	NGAL	PA449412	3934	0.796
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1699-1708.nxml.txt.nlp	19861960	SENT167	5	5	15	15	dasatinib	Yes	PA162372878	7525	0.796
NULL	Cell_Death_Dis_2013_Jun_6_4(6)_e654.nxml.txt.nlp	23744354	SENT38	14	14	1	1	vincristine	B4GALT1	PA451879	2683	0.796
NULL	Oncotarget_2013_Feb_27_4(2)_329-345.nxml.txt.nlp	23593654	SENT178	31	31	29	29	paclitaxel	CD44	PA450761	960	0.796
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Oct_31_65(Pt_11)_o2959.nxml.txt.nlp	21578530	SENT47	20	20	35	35	ethanol	mol	PA448073	90527	0.796
NULL	J_Cardiothorac_Surg_2011_Aug_30_6_103.nxml.txt.nlp	21878108	SENT108	8	8	0	0	aprotinin	Ray	PA448472	26751	0.796
NULL	Diabetes_Care_2012_Feb_16_35(2)_327-333.nxml.txt.nlp	22179958	SENT11	5	5	11	11	metformin	B12	PA450395	7126;4709	0.796
NULL	Arthritis_Res_2002_Nov_14_4(2)_139-144.nxml.txt.nlp	11879550	SENT116	14	14	2	2	collagenase	F10	PA449107	2159	0.796
NULL	Nat_Biotechnol_2013_Jul_30_31(7)_630-637.nxml.txt.nlp	23811600	SENT177	3	3	20	20	crizotinib	ABL1	PA165946122	25	0.796
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2675-2684.nxml.txt.nlp	24129246	SENT237	26	26	30	30	etoposide	KSR1	PA449552	8844	0.796
NULL	Pan_Afr_Med_J_2014_Jul_6_18_205.nxml.txt.nlp	25419332	SENT49	18	18	16	16	rituximab	CHOP	PA451261	1649	0.796
NULL	Int_J_Endocrinol_2013_May_23_2013_828532.nxml.txt.nlp	23762054	SENT75	11	11	18	18	estradiol	aromatase	PA449503	1588	0.796
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Oct_9_66(Pt_11)_o2728.nxml.txt.nlp	21588938	SENT55	18	18	33	33	ethanol	mol	PA448073	90527	0.796
NULL	Cell_Commun_Signal_2014_Sep_25_12(1)_61.nxml.txt.nlp	NULL	SENT71	12	12	16	16	doxycycline	PC-3	PA449415	692094	0.796
NULL	Ther_Clin_Risk_Manag_2007_Dec_3(6)_1027-1033.nxml.txt.nlp	18516257	SENT145	17	17	4	4	temozolomide	MGMT	PA451609	4255	0.796
NULL	Cancer_Metab_2013_Mar_7_1_10.nxml.txt.nlp	24280167	SENT130	7	7	9	9	resveratrol	SIRT1		23411	0.796
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_May_22_66(Pt_6)_o1399.nxml.txt.nlp	21579478	SENT47	19	19	34	34	ethanol	mol	PA448073	90527	0.796
NULL	Mol_Cancer_2012_Jul_12_11_45.nxml.txt.nlp	22788833	SENT122	15	15	6	6	cisplatin	EGFR	PA449014	1956	0.796
NULL	Cancer_Metastasis_Rev_2010_Dec_10_29(4)_581-594.nxml.txt.nlp	20830503	SENT313	17	17	30	30	tamoxifen	ATAC	PA451581	6375	0.796
NULL	J_Int_Soc_Sports_Nutr_2010_Feb_3_7_8.nxml.txt.nlp	20181080	SENT12	14	14	39	39	vasopressin	ACTH	PA451858	5443	0.796
NULL	Oncotarget_2014_Jun_3_5(13)_4920-4928.nxml.txt.nlp	24952482	SENT95	0	0	7	7	crizotinib	ROS1	PA165946122	6098	0.796
NULL	Adv_Hematol_2012_Nov_20_2012_861060.nxml.txt.nlp	23251161	SENT13	18	18	16	16	cyclophosphamide	CHOP	PA449165	1649	0.796
NULL	Indian_J_Endocrinol_Metab_2014_Jul-Aug_18(4)_546-551.nxml.txt.nlp	25143915	SENT61	14	14	2	2	denosumab	RANKL	PA166048634	8600	0.796
NULL	Hum_Reprod_2010_Sep_8_25(9)_2374-2386.nxml.txt.nlp	20616356	SENT52	10	10	16	16	hyaluronidase	SAGE	PA164745713	55511	0.796
NULL	Cancer_Inform_2008_Jun_10_6_315-355.nxml.txt.nlp	19259415	SENT383	14	14	20	20	cisplatin	MT1L	PA449014	4500	0.796
NULL	JRSM_Cardiovasc_Dis_2012_Sep_24_1(6)_cvd_2012_012015.nxml.txt.nlp	24175073	SENT23	30	30	2	2	clopidogrel	P-gp	PA449053	5243	0.796
NULL	Br_J_Cancer_2013_Jul_23_109(2)_342-350.nxml.txt.nlp	23807172	SENT113	21	21	28	28	sorafenib	Bcl-2	PA7000	596	0.796
NULL	Cell_Cycle_2013_May_1_12(9)_1371-1384.nxml.txt.nlp	23574725	SENT18	16	16	24	24	metformin	MCT1	PA450395	6566	0.796
NULL	J_Cancer_2013_Sep_27_4(8)_662-670.nxml.txt.nlp	24155778	SENT25	10	10	16	16	cisplatin	UCHL1	PA449014	7345	0.796
NULL	Oxid_Med_Cell_Longev_2013_Jul_9_2013_574029.nxml.txt.nlp	23936610	SENT157	4	4	27	27	resveratrol	CD40		958	0.796
NULL	Diabetes_Care_2010_Apr_12_33(4)_861-868.nxml.txt.nlp	20067962	SENT266	8	8	14	14	simvastatin	adiponectin	PA451363	9370	0.796
NULL	Surg_Today_2014_Apr_17_44(2)_219-226.nxml.txt.nlp	23591833	SENT61	22	22	20	20	cisplatin	HAI	PA449014	6692;6768	0.796
NULL	Cell_Commun_Signal_2013_Nov_11_11_86.nxml.txt.nlp	24215724	SENT552	3	3	30	30	thrombin	PAR-1	PA451674	2011;2149	0.796
NULL	Emerg_Infect_Dis_2011_May_17(5)_771-777.nxml.txt.nlp	21529383	SENT143	6	6	0	0	primaquine	G6PD	PA451103	2539	0.796
NULL	Allergy_Asthma_Immunol_Res_2014_Nov_28_6(6)_567-572.nxml.txt.nlp	25374757	SENT85	5	5	33	33	fexofenadine	c-Jun	PA449621	3725	0.796
NULL	Open_Orthop_J_2008_Oct_24_2_137-144.nxml.txt.nlp	19478889	SENT163	9	9	6	6	heparin	glypican	PA449855	2817	0.796
NULL	Mediators_Inflamm_2011_Jun_7_2011_432080.nxml.txt.nlp	21772662	SENT114	14	14	28	28	rivaroxaban	MCP-1	PA165958360	6347	0.796
NULL	Lab_Invest_2009_Nov_7_89(11)_1275-1290.nxml.txt.nlp	19736547	SENT382	9	9	4	4	curcumin	LOX-1	PA151958596	4973	0.796
NULL	J_Oncol_2012_Mar_26_2012_986725.nxml.txt.nlp	22545054	SENT147	0	0	10	10	sunitinib	KDR	PA162372840	3791	0.796
NULL	Ann_Hematol_2014_Apr_1_93(8)_1371-1380.nxml.txt.nlp	24687382	SENT29	1	1	22	22	lenalidomide	IKZF3	PA162363968	22806	0.796
NULL	Calcif_Tissue_Int_2011_Aug_3_89(2)_91-104.nxml.txt.nlp	21637997	SENT429	4	4	1	1	denosumab	RANKL	PA166048634	8600	0.796
NULL	Subst_Abuse_Treat_Prev_Policy_2007_Oct_31_2_32.nxml.txt.nlp	17974020	SENT343	36	36	20	20	methamphetamine	NMU	PA450403	10874	0.796
NULL	Int_J_Mol_Sci_2014_Jun_5_15(6)_10116-10135.nxml.txt.nlp	24905409	SENT200	5	5	19	19	resveratrol	IL-17		3605	0.796
NULL	AIDS_Res_Ther_2014_Aug_4_11_25.nxml.txt.nlp	25120580	SENT29	10	10	8	8	esomeprazole	CYP2C19	PA10075	1557	0.796
NULL	Exp_Diabetes_Res_2012_Oct_19_2012_628978.nxml.txt.nlp	22028701	SENT149	25	25	17	17	glucose	ROS	PA449773	6098	0.796
NULL	Biol_Proced_Online_2003_Feb_17_5_43-52.nxml.txt.nlp	12734557	SENT130	7	7	11	11	bupivacaine	IFNA6	PA135057240	3443	0.796
NULL	Oncotarget_2013_Nov_24_4(12)_2186-2207.nxml.txt.nlp	24327604	SENT130	34	34	4	4	etoposide	MDM2	PA449552	4193	0.796
NULL	Front_Oncol_2014_Jun_18_4_153.nxml.txt.nlp	24995158	SENT546	36	36	22	22	doxorubicin	p53	PA449412	7157	0.796
NULL	Br_J_Cancer_2012_Sep_25_107(7)_1059-1068.nxml.txt.nlp	22935581	SENT74	27	27	25	25	sunitinib	IFN	PA162372840	3439	0.796
NULL	Nat_Methods_2012_Oct_9_9(10)_1005-1012.nxml.txt.nlp	22961245	SENT338	8	8	15	15	phenol	B27	PA450913	56246	0.796
NULL	J_Cell_Biol_2007_Apr_23_177(2)_265-275.nxml.txt.nlp	17452530	SENT223	34	34	29	29	imiquimod	TLR7	PA449972	51284	0.796
NULL	J_Cancer_Prev_2014_Mar_19(1)_39-46.nxml.txt.nlp	25337571	SENT92	4	4	14	14	ethanol	JNK	PA448073	5599	0.796
NULL	Support_Care_Cancer_2014_Oct_19_22(2)_469-477.nxml.txt.nlp	24141698	SENT31	41	41	34	34	palonosetron	HEC	PA10352	10403	0.796
NULL	Exp_Lung_Res_2013_Oct_1_39(8)_336-348.nxml.txt.nlp	23919450	SENT121	0	0	12	12	thrombin	PAR-1	PA451674	2011;2149	0.796
NULL	Behav_Neurol_2014_Mar_11_2014_304203.nxml.txt.nlp	24825955	SENT38	16	16	31	31	levodopa	COMT	PA450213	1312	0.796
NULL	Open_Virol_J_2012_Nov_26_6_97-102.nxml.txt.nlp	23230455	SENT12	8	8	3	3	ribavirin	IFN	PA451241	3439	0.796
NULL	Ann_Oncol_2011_Mar_8_22(3)_503-514.nxml.txt.nlp	20616198	SENT315	10	10	25	25	anastrozole	ARNO	PA448432	9266	0.796
NULL	Mol_Med_Rep_2015_Feb_29_11(2)_865-870.nxml.txt.nlp	25352342	SENT135	31	31	18	18	mannitol	RANKL	PA450320	8600	0.796
NULL	Cell_Death_Dis_2014_Jul_3_5(7)_e1310.nxml.txt.nlp	24991762	SENT94	13	13	2	2	temsirolimus	CXCL12	PA164746890	6387	0.796
NULL	Cancer_Cell_Int_2013_Feb_12_13_14.nxml.txt.nlp	23402310	SENT135	0	0	3	3	celecoxib	XIAP	PA448871	331	0.796
NULL	Inorganica_Chim_Acta_2012_Dec_1_393(7)_252-260.nxml.txt.nlp	23471093	SENT60	31	31	17	17	ethanol	HL1	PA448073	1767	0.796
NULL	Biologics_2014_Apr_23_8_183-192.nxml.txt.nlp	24790411	SENT112	20	20	11	11	afatinib	EGFR	PA165981154	1956	0.796
NULL	Curr_Neuropharmacol_2013_Mar_11(2)_160-170.nxml.txt.nlp	23997751	SENT102	40	40	18	18	pilocarpine	5-HT2C	PA450962	3358	0.796
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT6	1	1	26	26	metformin	AKT	PA450395	207	0.796
NULL	Diabetes_2011_Jul_20_60(7)_1990-1999.nxml.txt.nlp	21617181	SENT187	27	27	13	13	geldanamycin	IL-6	PA152031327	3569	0.796
NULL	Leukemia_2013_Jan_11_27(1)_32-40.nxml.txt.nlp	22781593	SENT219	0	0	6	6	ponatinib	FGFR1	PA165980594	2260	0.796
NULL	J_Invest_Dermatol_2012_Oct_24_132(10)_2440-2450.nxml.txt.nlp	22622430	SENT73	8	8	10	10	temozolomide	IL-8	PA451609	3576	0.796
NULL	J_Cell_Mol_Med_2014_Apr_20_18(4)_709-720.nxml.txt.nlp	24444314	SENT23	2	2	12	12	metformin	AMPK	PA450395	5563	0.796
NULL	Ther_Clin_Risk_Manag_2006_Jun_2(2)_129-158.nxml.txt.nlp	18360588	SENT166	0	0	3	3	imatinib	CYP3A4	PA10804	1576	0.796
NULL	Clin_Interv_Aging_2009_May_14_4_109-113.nxml.txt.nlp	19503773	SENT22	30	30	10	10	levodopa	COMT	PA450213	1312	0.796
NULL	J_Headache_Pain_2008_Feb_24_9(1)_13-18.nxml.txt.nlp	18217199	SENT129	4	4	6	6	nortriptyline	CYP1A2	PA450657	1544	0.796
NULL	Breast_Cancer_Res_2011_Sep_13_13(5)_R87.nxml.txt.nlp	21914172	SENT168	16	16	10	10	neratinib	HER2	PA165291472	2064	0.796
NULL	Leukemia_2013_Feb_14_27(2)_362-369.nxml.txt.nlp	22955330	SENT175	3	3	6	6	sirolimus	NRM	PA451365	11270	0.796
NULL	Exp_Mol_Med_2012_Sep_30_44(9)_536-544.nxml.txt.nlp	22771771	SENT56	23	23	11	11	celecoxib	p53	PA448871	7157	0.796
NULL	Br_J_Cancer_2010_Jan_5_102(1)_80-86.nxml.txt.nlp	19920817	SENT57	48	48	45	45	sunitinib	IFN	PA162372840	3439	0.796
NULL	Breast_Cancer_Res_2010_Jun_28_12(3)_R43.nxml.txt.nlp	20579400	SENT166	10	10	15	15	estradiol	MAPT	PA449503	4137	0.796
NULL	Oncotarget_2011_Dec_21_2(12)_1134-1144.nxml.txt.nlp	22193779	SENT117	24	24	7	7	gefitinib	PC3	PA131301952	57332;7832;5122	0.796
NULL	JAKSTAT_2012_Jul_1_1(3)_197-199.nxml.txt.nlp	24058771	SENT59	7	7	10	10	fulvestrant	STAT1	PA164747170	6772	0.796
NULL	J_Hematol_Oncol_2013_Jul_9_6_49.nxml.txt.nlp	23837843	SENT281	32	32	16	16	cyclosporine	P-gp	PA449167	5243	0.796
NULL	Core_Evid_2011_Feb_8_6_23-29.nxml.txt.nlp	21468240	SENT99	0	0	6	6	lenalidomide	CD34	PA162363968	947	0.796
NULL	Oxid_Med_Cell_Longev_2013_Sep_5_2013_104024.nxml.txt.nlp	24089628	SENT100	13	13	11	11	hemin	HO-1	PA449849	3162	0.796
NULL	Crit_Care_2011_Aug_11_15(4)_226.nxml.txt.nlp	21892977	SENT275	10	10	5	5	vasopressin	LNPEP	PA451858	4012	0.796
NULL	Mol_Cell_Endocrinol_2012_Sep_5_360(1-2)_52-58.nxml.txt.nlp	21664423	SENT185	8	8	6	6	docetaxel	IL-6	PA449383	3569	0.796
NULL	Mol_Cancer_2012_Dec_12_11_91.nxml.txt.nlp	23234355	SENT199	13	13	19	19	trastuzumab	EGFR	PA451743	1956	0.796
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT103	19	19	8	8	resveratrol	DR4		8797	0.796
NULL	Br_J_Cancer_2009_Sep_15_101(6)_957-966.nxml.txt.nlp	19738618	SENT129	0	0	2	2	dexrazoxane	THBS-1	PA449259	7057	0.796
NULL	Arthritis_Res_Ther_2008_Mar_17_10(2)_R33.nxml.txt.nlp	18346273	SENT187	23	23	14	14	infliximab	HMGB1	PA452639	3146	0.796
NULL	Br_J_Cancer_2013_Dec_10_109(12)_2965-2972.nxml.txt.nlp	24149178	SENT7	27	27	15	15	cyclophosphamide	HER2	PA449165	2064	0.796
NULL	Fibrogenesis_Tissue_Repair_2010_Sep_3_3_18.nxml.txt.nlp	20815874	SENT4	15	15	12	12	bleomycin	CCR7	PA448645	1236	0.796
NULL	Int_J_Cell_Biol_2014_Jan_22_2014_709828.nxml.txt.nlp	24578708	SENT104	22	22	30	30	s-adenosylmethionine	PEMT	PA164754994	10400	0.796
NULL	Acta_Pharmacol_Sin_2009_Dec_4_30(12)_1607-1615.nxml.txt.nlp	19960007	SENT72	21	21	23	23	streptozocin	STZ	PA451514	6484	0.796
NULL	Exp_Anim_2014_Aug_22_63(3)_277-287.nxml.txt.nlp	25077757	SENT841	0	0	5	5	resveratrol	SIRT1		23411	0.796
NULL	Adolesc_Health_Med_Ther_2013_Aug_27_4_79-87.nxml.txt.nlp	24600298	SENT44	2	2	13	13	raltegravir	UGT1A1		54658	0.796
NULL	Br_J_Cancer_2006_Dec_4_95(11)_1483-1489.nxml.txt.nlp	17106442	SENT145	6	6	8	8	gefitinib	TTP	PA131301952	7538;11093	0.796
NULL	JAKSTAT_2012_Oct_1_1(4)_292-299.nxml.txt.nlp	24058786	SENT146	3	3	13	13	pimozide	CD34	PA450965	947	0.796
NULL	Acta_Pharmacol_Sin_2014_Jan_9_35(1)_1-10.nxml.txt.nlp	24317012	SENT143	27	27	6	6	capecitabine	DPYD	PA448771	1806	0.796
NULL	Mol_Cancer_2014_Jun_30_13_160.nxml.txt.nlp	24976026	SENT150	16	16	6	6	bortezomib	AGR2	PA10252	10551	0.796
NULL	Cell_Death_Dis_2014_Feb_13_5(2)_e1055.nxml.txt.nlp	24525731	SENT295	19	19	7	7	cisplatin	XRCC1	PA449014	7515	0.796
NULL	BMB_Rep_2013_Nov_46(11)_544-549.nxml.txt.nlp	24152910	SENT43	2	2	5	5	thrombin	HMGB1	PA451674	3146	0.796
NULL	Curr_Med_Chem_2013_Apr_20(10)_1241-1285.nxml.txt.nlp	23409712	SENT987	10	10	15	15	carbachol	TRPC1	PA448784	7220	0.796
NULL	Oxid_Med_Cell_Longev_2012_Jan_19_2012_390678.nxml.txt.nlp	22315655	SENT89	7	7	12	12	gliclazide	NAC	PA10892	22861	0.796
NULL	Pan_Afr_Med_J_2012_May_6_12_5.nxml.txt.nlp	22826730	SENT45	14	14	12	12	cyclophosphamide	CHOP	PA449165	1649	0.796
NULL	Br_J_Cancer_1998_77(3)_359-365.nxml.txt.nlp	9472629	SENT11	5	5	1	1	verapamil	P-gp	PA451868	5243	0.796
NULL	Oncotarget_2013_Dec_28_5(6)_1475-1490.nxml.txt.nlp	24721996	SENT208	4	4	10	10	celecoxib	CD133	PA448871	8842	0.796
NULL	Br_J_Cancer_1996_Mar_73(5)_596-602.nxml.txt.nlp	8605092	SENT14	11	11	20	20	verapamil	PSN1	PA451868	51251	0.796
NULL	Open_Biochem_J_2007_Jun_15_1_1-6.nxml.txt.nlp	18949066	SENT3	7	7	12	12	suramin	HIF-1	PA10292	29072	0.796
NULL	J_Gynecol_Oncol_2012_Jan_9_23(1)_35-42.nxml.txt.nlp	22355465	SENT131	19	19	3	3	cisplatin	CDK1	PA449014	983	0.796
NULL	Front_Oncol_2014_Sep_22_4_258.nxml.txt.nlp	25295228	SENT211	20	20	33	33	gemcitabine	EGFR	PA449748	1956	0.796
NULL	Mol_Biol_Cell_2013_Jul_1_24(13)_2124-2133.nxml.txt.nlp	23657815	SENT21	4	4	8	8	choline	DAG	PA448976	1605	0.796
NULL	Exp_Hematol_Oncol_2012_Jun_18_1_14.nxml.txt.nlp	23210689	SENT181	21	21	34	34	imatinib	KIT	PA10804	3815	0.796
NULL	Clin_Nutr_Res_2014_Jan_27_3(1)_1-8.nxml.txt.nlp	24527414	SENT104	25	25	21	21	betaine	B12	PA448603	7126;4709	0.796
NULL	Chem_Res_Toxicol_2010_Jul_19_23(7)_1151-1162.nxml.txt.nlp	20536192	SENT64	16	16	23	23	doxycycline	p53	PA449415	7157	0.796
NULL	Mol_Cancer_2007_Aug_21_6_53.nxml.txt.nlp	17711579	SENT398	29	29	7	7	cisplatin	MDM2	PA449014	4193	0.796
NULL	J_Neurophysiol_2013_May_1_109(9)_2393-2403.nxml.txt.nlp	23427303	SENT225	23	23	16	16	capsaicin	TRPV1	PA448776	7442	0.796
NULL	Front_Chem_2013_Dec_31_1_40.nxml.txt.nlp	24790967	SENT1179	16	16	13	13	ethanol	CO2	PA448073	4513	0.796
NULL	Cell_Death_Differ_2011_Oct_8_18(10)_1598-1607.nxml.txt.nlp	21475306	SENT314	6	6	0	0	camptothecin	ATG13	PA153590860	9776	0.796
NULL	Diabetes_2013_Mar_14_62(3)_931-943.nxml.txt.nlp	23172920	SENT232	20	20	6	6	pioglitazone	CD36	PA450970	948	0.796
NULL	Evid_Based_Complement_Alternat_Med_2012_Dec_17_2012_857123.nxml.txt.nlp	23365602	SENT152	23	23	18	18	capsaicin	TRPV1	PA448776	7442	0.796
NULL	Oncotarget_2013_Nov_15_4(11)_1866-1867.nxml.txt.nlp	24272818	SENT36	18	18	30	30	trastuzumab	San	PA451743	80218	0.796
NULL	Exp_Hematol_Oncol_2012_Sep_11_1_27.nxml.txt.nlp	23210501	SENT61	12	12	7	7	lenalidomide	IL-2	PA162363968	3558	0.796
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT111	11	11	23	23	pertuzumab	HER2		2064	0.796
NULL	Oncoscience_2014_Mar_12_1(2)_167-179.nxml.txt.nlp	25126591	SENT228	33	33	38	38	temsirolimus	PI3K	PA164746890	5290	0.796
NULL	Br_J_Clin_Pharmacol_2013_Aug_23_76(2)_299-315.nxml.txt.nlp	23701319	SENT173	0	0	4	4	alemtuzumab	CD4	PA164783958	920	0.796
NULL	Curr_Oncol_2009_Jan_16(1)_16-26.nxml.txt.nlp	19229368	SENT60	18	18	5	5	cetuximab	KRAS	PA10040	3845	0.796
NULL	Curr_Neuropharmacol_2008_Sep_6(3)_215-234.nxml.txt.nlp	19506722	SENT628	13	13	7	7	paroxetine	5-HT1A	PA450801	3350	0.796
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT8	9	9	0	0	imatinib	ABCB1	PA10804	5243	0.796
NULL	Front_Genet_2012_Sep_6_3_173.nxml.txt.nlp	22973297	SENT183	16	16	5	5	gemcitabine	MAF	PA449748	4094	0.796
NULL	Nat_Med_2013_Sep_11_19(9)_1153-1156.nxml.txt.nlp	23933983	SENT71	5	5	18	18	vasopressin	FGF21	PA451858	26291	0.796
NULL	Ann_Rheum_Dis_2013_Aug_21_72(8)_1287-1294.nxml.txt.nlp	22915624	SENT124	30	30	7	7	abatacept	MRI	PA164747080	78996	0.796
NULL	Front_Neurosci_2013_Feb_13_7_13.nxml.txt.nlp	23407595	SENT131	0	0	35	35	estradiol	CORT	PA449503	1325	0.796
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Mar_6_66(Pt_4)_o750.nxml.txt.nlp	21580595	SENT54	10	10	20	20	rocuronium	Tuba	PA164754992	23268	0.796
NULL	Biologics_2012_Dec_17_6_429-464.nxml.txt.nlp	23269860	SENT11	13	13	18	18	adalimumab	ACR	PA10004	49	0.796
NULL	Cell_Death_Dis_2014_Apr_24_5(4)_e1190.nxml.txt.nlp	24763047	SENT85	28	28	22	22	chloroquine	NAC	PA448948	22861	0.796
NULL	Br_J_Cancer_2004_Mar_5_90(Suppl_1)_S15-S18.nxml.txt.nlp	15094760	SENT41	3	3	12	12	fulvestrant	c-myb	PA164747170	4602	0.796
NULL	Nucleic_Acids_Res_2011_Mar_4_39(5)_1843-1854.nxml.txt.nlp	21051342	SENT52	10	10	3	3	carbenicillin	IFN	PA448788	3439	0.796
NULL	J_Cell_Biol_1999_Jan_11_144(1)_71-82.nxml.txt.nlp	9885245	SENT177	12	12	4	4	galactose	PRK1	PA449725	5585;84432	0.796
NULL	Indian_J_Med_Res_2014_Aug_140(2)_262-270.nxml.txt.nlp	25297360	SENT97	14	14	1	1	ceftriaxone	P19	PA448866	51561	0.796
NULL	J_Clin_Biochem_Nutr_2007_Jan_27_40(1)_13-23.nxml.txt.nlp	18437209	SENT576	12	12	6	6	trypsin	IL-8	PA451806	3576	0.796
NULL	Sensors_(Basel)_2011_May_4_11(5)_4990-5004.nxml.txt.nlp	22163886	SENT97	1	1	15	15	oxygen	CO2	PA450744	4513	0.796
NULL	Asian-Australas_J_Anim_Sci_2014_Mar_27(3)_414-421.nxml.txt.nlp	25049969	SENT137	21	21	31	31	rosiglitazone	PPARG	PA451283	5468	0.796
NULL	Acta_Biomater_2012_Jan_8(1)_313-320.nxml.txt.nlp	21884829	SENT77	19	19	26	26	acetone	mol	PA448025	90527	0.796
NULL	Biochemistry_2014_Feb_4_53(4)_796-805.nxml.txt.nlp	24460375	SENT197	7	7	28	28	cycloserine	PLP	PA164764600	25824;5744	0.796
NULL	Ann_Oncol_2012_Dec_2_23(12)_3007-3016.nxml.txt.nlp	22865781	SENT163	15	15	19	19	trastuzumab	PIK3CA	PA451743	5290	0.796
NULL	Ann_Thorac_Med_2013_Apr-Jun_8(2)_109-115.nxml.txt.nlp	23741274	SENT167	23	23	32	32	cisplatin	CRT	PA449014	811	0.796
NULL	Br_J_Cancer_2013_Mar_19_108(5)_997-1003.nxml.txt.nlp	23385734	SENT146	6	6	0	0	tocilizumab	IL-6	PA165292659	3569	0.796
NULL	Int_J_Hypertens_2012_Feb_8_2012_189512.nxml.txt.nlp	22518281	SENT58	11	11	8	8	hemin	HO-1	PA449849	3162	0.796
NULL	Clinicoecon_Outcomes_Res_2014_Oct_17_6_451-461.nxml.txt.nlp	25378939	SENT28	30	30	34	34	vancomycin	HAP	PA451850	5915;10313	0.796
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT15	7	7	11	11	tacrolimus	RANKL	PA451578	8600	0.796
NULL	J_Cell_Biol_2001_Apr_2_153(1)_207-220.nxml.txt.nlp	11285286	SENT123	0	0	16	16	carbachol	CD69	PA448784	969	0.796
NULL	Br_J_Cancer_2013_Jan_15_108(1)_82-90.nxml.txt.nlp	23321512	SENT156	39	39	9	9	paclitaxel	TUBB3	PA450761	10381	0.796
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT249	4	4	2	2	pp2	PP1		5540;5464	0.796
NULL	J_Clin_Biochem_Nutr_2010_Jan_29_46(1)_87-92.nxml.txt.nlp	20104270	SENT112	12	12	3	3	hesperidin	adiponectin	PA449867	9370	0.796
NULL	Front_Cell_Neurosci_2015_Jan_15_8_459.nxml.txt.nlp	25642166	SENT80	12	12	9	9	hemin	HO-1	PA449849	3162	0.796
NULL	Mol_Vis_2012_May_11_18_1260-1270.nxml.txt.nlp	22665973	SENT190	9	9	11	11	topotecan	TPT	PA451729	23590;6469	0.796
NULL	Sci_Rep_2014_Dec_3_4_7294.nxml.txt.nlp	25465236	SENT533	24	24	9	9	gefitinib	EGFR	PA131301952	1956	0.796
NULL	Cell_Regen_(Lond)_2012_Jun_28_1(1)_3.nxml.txt.nlp	25408866	SENT136	20	20	5	5	calcein	MSC	PA132595336	9242	0.796
NULL	J_Heart_Lung_Transplant_2010_Jun_29(6)_610-615.nxml.txt.nlp	20227301	SENT30	14	14	8	8	sildenafil	RAC	PA451346	207	0.796
NULL	Osteoporos_Int_2013_Jan_10_24(1)_227-235.nxml.txt.nlp	22776860	SENT107	6	6	16	16	denosumab	BSAP	PA166048634	5079	0.796
NULL	Nat_Commun_2013_Aug_15_4_2130.nxml.txt.nlp	23945651	SENT42	11	11	21	21	etoposide	ATG5	PA449552	9474	0.796
NULL	Oncoimmunology_2013_Dec_1_2(12)_e27090.nxml.txt.nlp	24501689	SENT143	12	12	10	10	curcumin	STAT3	PA151958596	6774	0.796
NULL	Acta_Pharmacol_Sin_2012_Jan_12_33(1)_27-33.nxml.txt.nlp	22158109	SENT124	17	17	21	21	propofol	AMPK	PA451141	5563	0.796
NULL	ScientificWorldJournal_2014_Mar_17_2014_709801.nxml.txt.nlp	24778598	SENT66	6	6	19	19	neostigmine	NMT	PA450611	4836	0.796
NULL	Blood_Res_2014_Mar_24_49(1)_15-21.nxml.txt.nlp	24724062	SENT165	42	42	22	22	ifosfamide	CHOP	PA449964	1649	0.796
NULL	J_Thyroid_Res_2010_Apr_13_2010_279468.nxml.txt.nlp	21048836	SENT392	8	8	27	27	sorafenib	VEGFR	PA7000	3791	0.796
NULL	BMJ_Open_2014_Nov_7_4(11)_e006140.nxml.txt.nlp	25380812	SENT227	27	27	14	14	methotrexate	NF-kappaB	PA450428	4790	0.796
NULL	Curr_Pharm_Des_2011_Feb_17(6)_578-590.nxml.txt.nlp	21391908	SENT179	6	6	30	30	nutlin-3	p53		7157	0.796
NULL	Breast_Cancer_Res_2010_Jul_22_12(4)_R53.nxml.txt.nlp	20649975	SENT3	13	13	5	5	tamoxifen	HOXB13	PA451581	10481	0.796
NULL	Curr_Health_Sci_J_2014_Dec_29_Jan-Mar_40(1)_62-66.nxml.txt.nlp	24791209	SENT19	13	13	10	10	furosemide	ACE	PA449719	1636	0.796
NULL	Cancer_Immunol_Immunother_2012_Jul_23_61(7)_1101-1111.nxml.txt.nlp	22193989	SENT202	15	15	3	3	oxaliplatin	STAT2	PA131285527	6773	0.796
NULL	Mol_Cancer_2012_Dec_12_11_91.nxml.txt.nlp	23234355	SENT196	41	41	23	23	trastuzumab	EGFR	PA451743	1956	0.796
NULL	Diabetes_2013_Mar_14_62(3)_789-800.nxml.txt.nlp	22966074	SENT269	41	41	6	6	forskolin	TCF7L2	PA146096022	6934	0.796
NULL	J_Inflamm_(Lond)_2006_May_4_3_8.nxml.txt.nlp	16674821	SENT91	2	2	4	4	pp2	SKI-1		8720	0.796
NULL	Evid_Based_Complement_Alternat_Med_2013_May_28_2013_464508.nxml.txt.nlp	23781262	SENT155	6	6	10	10	amiodarone	PLB	PA448383	151056	0.796
NULL	Br_J_Cancer_2012_Feb_14_106(4)_685-692.nxml.txt.nlp	22294184	SENT252	17	17	35	35	docetaxel	p27	PA449383	5715;10534	0.796
NULL	Indian_J_Pharm_Sci_2014_Jan-Feb_76(1)_72-77.nxml.txt.nlp	24799741	SENT117	11	11	8	8	losartan	CYP2C9	PA450268	1559	0.796
NULL	Nat_Med_2012_Feb_19_18(3)_446-451.nxml.txt.nlp	22344296	SENT36	5	5	3	3	darunavir	ATV	PA163522472	4683	0.796
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Oct_31_65(Pt_11)_o2963.nxml.txt.nlp	21578534	SENT47	3	3	6	6	benzaldehyde	mol	PA448571	90527	0.796
NULL	Front_Neurosci_2014_Jan_10_7_270.nxml.txt.nlp	24454277	SENT92	4	4	6	6	resveratrol	SIRT1		23411	0.796
NULL	Oncotarget_2014_Sep_16_5(20)_9980-9991.nxml.txt.nlp	25296971	SENT186	25	25	17	17	oxaliplatin	p53	PA131285527	7157	0.796
NULL	J_Carcinog_2011_Nov_30_10_28.nxml.txt.nlp	22190870	SENT225	13	13	33	33	trastuzumab	STYK1	PA451743	55359	0.796
NULL	Lipids_Health_Dis_2011_Dec_30_10_246.nxml.txt.nlp	22208561	SENT123	17	17	9	9	ethanol	HO-1	PA448073	3162	0.796
NULL	J_Korean_Med_Sci_2009_Jun_16_24(3)_525-528.nxml.txt.nlp	19543522	SENT14	8	8	6	6	cyclophosphamide	CHOP	PA449165	1649	0.796
NULL	Cancer_Cell_Int_2011_Dec_29_11_44.nxml.txt.nlp	22206574	SENT113	13	13	10	10	irinotecan	p65	PA450085	5970	0.796
NULL	J_Hematol_Oncol_2013_Nov_22_6_88.nxml.txt.nlp	24261963	SENT328	8	8	14	14	carboplatin	PI3K	PA448803	5290	0.796
NULL	Int_J_Biomed_Sci_2008_Dec_4(4)_260-265.nxml.txt.nlp	19568323	SENT80	0	0	16	16	forskolin	BRCA1	PA146096022	672	0.796
NULL	Exp_Diabetes_Res_2012_Oct_15_2012_465282.nxml.txt.nlp	23118742	SENT128	5	5	9	9	metformin	FGF21	PA450395	26291	0.796
NULL	Front_Neurol_2014_Jun_12_5_95.nxml.txt.nlp	24971074	SENT315	21	21	35	35	levodopa	NR1	PA450213	27158	0.796
NULL	EMBO_Mol_Med_2011_May_3(5)_266-278.nxml.txt.nlp	21438154	SENT133	8	8	1	1	oxaliplatin	TRPA1	PA131285527	8989	0.796
NULL	J_Hematol_Oncol_2013_Jan_15_6_5.nxml.txt.nlp	23320987	SENT134	6	6	3	3	heparin	PI-PLC	PA449855	2923	0.796
NULL	Aging_(Albany_NY)_2014_Oct_30_6(10)_788-819.nxml.txt.nlp	25411230	SENT245	4	4	0	0	entacapone	COMT	PA164748726	1312	0.796
NULL	Ann_Hematol_2014_Sep_10_93(1)_1-11.nxml.txt.nlp	24018623	SENT7	13	13	35	35	lenalidomide	SPARC	PA162363968	6678	0.796
NULL	Mol_Vis_2007_Jul_9_13_1083-1093.nxml.txt.nlp	17653053	SENT144	4	4	23	23	minocycline	RANTES	PA450519	6352	0.796
NULL	J_Hum_Genet_2013_Jun_16_58(6)_353-361.nxml.txt.nlp	23677058	SENT154	26	26	17	17	cytarabine	SLC28A3	PA449177	64078	0.796
NULL	Diabetes_2013_Nov_18_62(11)_3751-3759.nxml.txt.nlp	23897951	SENT168	9	9	16	16	rosiglitazone	FGF21	PA451283	26291	0.796
NULL	Oncotarget_2013_Feb_27_4(2)_178-179.nxml.txt.nlp	23563503	SENT12	9	9	15	15	nutlin-3	Wip1		8493	0.796
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jan_22_67(Pt_2)_o472-o473.nxml.txt.nlp	21523131	SENT69	31	31	6	6	ethanol	mol	PA448073	90527	0.795
NULL	Adv_Pharmacol_Sci_2013_Dec_26_2013_510298.nxml.txt.nlp	24454346	SENT210	1	1	10	10	ethanol	flower	PA448073	11094	0.795
NULL	Cardiovasc_Diabetol_2013_Jun_18_12_90.nxml.txt.nlp	23777457	SENT159	14	14	31	31	liraglutide	ATF4	PA165958364	468	0.795
NULL	Leukemia_2013_Jan_11_27(1)_32-40.nxml.txt.nlp	22781593	SENT93	0	0	3	3	ponatinib	FGFR1	PA165980594	2260	0.795
NULL	Nat_Med_2012_Jan_8_18(2)_227-234.nxml.txt.nlp	22231558	SENT114	8	8	13	13	etoposide	RNF20	PA449552	56254	0.795
NULL	Br_J_Cancer_2009_Jul_21_101(2)_238-243.nxml.txt.nlp	19568242	SENT109	0	0	8	8	sunitinib	IFN	PA162372840	3439	0.795
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_7-17.nxml.txt.nlp	17912633	SENT88	8	8	14	14	letrozole	aromatase	PA450196	1588	0.795
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1495-1502.nxml.txt.nlp	21989186	SENT135	3	3	25	25	panitumumab	KRAS	PA162373091	3845	0.795
NULL	EMBO_Mol_Med_2011_May_3(5)_266-278.nxml.txt.nlp	21438154	SENT229	9	9	6	6	oxaliplatin	TRAAK	PA131285527	50801	0.795
NULL	Korean_Circ_J_2013_May_31_43(5)_343-346.nxml.txt.nlp	23755082	SENT5	10	10	25	25	prasugrel	DES	PA154410481	1674	0.795
NULL	Cell_Death_Dis_2014_Mar_13_5(3)_e1125.nxml.txt.nlp	24625984	SENT19	19	19	27	27	suramin	CD95	PA10292	355	0.795
NULL	J_Invest_Dermatol_2013_Sep_31_133(9)_2247-2254.nxml.txt.nlp	23370537	SENT68	8	8	19	19	etoposide	PUMA	PA449552	27113	0.795
NULL	J_Biol_2003_Oct_22_2(4)_26.nxml.txt.nlp	14575531	SENT61	18	18	28	28	phenformin	LKB1	PA1000	6794	0.795
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jul_16_67(Pt_8)_o2069.nxml.txt.nlp	22091093	SENT52	24	24	39	39	ethanol	mol	PA448073	90527	0.795
NULL	Genet_Mol_Biol_2009_Dec_1_Oct-Dec_32(4)_802-810.nxml.txt.nlp	21637458	SENT167	3	3	16	16	theobromine	AC1	PA451646	107	0.795
NULL	Clin_Med_Insights_Oncol_2012_Dec_6_6_407-421.nxml.txt.nlp	23239933	SENT152	27	27	23	23	gefitinib	EGFR	PA131301952	1956	0.795
NULL	Cancers_(Basel)_2014_Apr_16_6(2)_926-957.nxml.txt.nlp	24743778	SENT326	3	3	6	6	dasatinib	STAT3	PA162372878	6774	0.795
NULL	Oncotarget_2013_Apr_8_4(4)_584-599.nxml.txt.nlp	23603840	SENT25	34	34	4	4	vemurafenib	BRAF	PA165946873	673	0.795
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT121	0	0	9	9	simvastatin	RANKL	PA451363	8600	0.795
NULL	BMJ_Open_2014_Feb_27_4(2)_e004071.nxml.txt.nlp	24578536	SENT199	8	8	19	19	warfarin	TTR	PA451906	7276	0.795
NULL	Cell_Res_2011_Mar_11_21(3)_530-545.nxml.txt.nlp	21221130	SENT418	9	9	4	4	thrombin	RGDS	PA451674	5900	0.795
NULL	Cancer_Cell_Int_2011_Nov_17_11_40.nxml.txt.nlp	22088142	SENT42	26	26	0	0	gemcitabine	EGF	PA449748	1950	0.795
NULL	Front_Oncol_2014_Mar_24_4_47.nxml.txt.nlp	24716189	SENT190	0	0	7	7	sorafenib	VEGFR2	PA7000	3791	0.795
NULL	Mol_Cancer_2006_Sep_5_5_34.nxml.txt.nlp	16953886	SENT97	13	13	19	19	doxorubicin	XIAP	PA449412	331	0.795
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1033-1038.nxml.txt.nlp	22374460	SENT174	10	10	15	15	trastuzumab	PI3K	PA451743	5290	0.795
NULL	Pharmaceuticals_(Basel)_2013_Mar_26_6(4)_469-479.nxml.txt.nlp	24276118	SENT145	22	22	12	12	ethanol	DARPP-32	PA448073	84152	0.795
NULL	Acta_Pharmacol_Sin_2010_Aug_5_31(8)_938-943.nxml.txt.nlp	20686519	SENT200	6	6	0	0	reserpine	GML	PA451236	2765	0.795
NULL	J_Cell_Biol_1999_Feb_22_144(4)_631-643.nxml.txt.nlp	10037786	SENT42	28	28	11	11	streptomycin	F10	PA451512	2159	0.795
NULL	Anal_Bioanal_Chem_2012_Feb_16_402(4)_1611-1623.nxml.txt.nlp	22173207	SENT209	19	19	0	0	amantadine	SRM	PA448360	6723;6725	0.795
NULL	Evid_Based_Complement_Alternat_Med_2012_Dec_20_2012_908601.nxml.txt.nlp	23326293	SENT274	0	0	18	18	oxaliplatin	EMT	PA131285527	3702;6581	0.795
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT207	23	23	16	16	adalimumab	DPI	PA10004	1832	0.795
NULL	Biotechnol_Res_Int_2014_Nov_3_2014_654853.nxml.txt.nlp	25530885	SENT93	15	15	8	8	ethanol	FAN	PA448073	8439	0.795
NULL	Basic_Clin_Neurosci_2014_Winter_5(1)_74-79.nxml.txt.nlp	25436087	SENT88	29	29	33	33	fluoxetine	HPRT1	PA449673	3251	0.795
NULL	Arthritis_Res_Ther_2005_Mar_9_7(3)_93.nxml.txt.nlp	15899057	SENT102	11	11	23	23	methotrexate	CD25	PA450428	3669;3559	0.795
NULL	Mol_Syst_Biol_2009_Jul_28_5_288.nxml.txt.nlp	19638969	SENT169	9	9	15	15	resveratrol	HuR		1994	0.795
NULL	Biologics_2009_Jul_13_3_289-301.nxml.txt.nlp	19707416	SENT199	20	20	25	25	docetaxel	HER2	PA449383	2064	0.795
NULL	Ann_Neurosci_2013_Jan_20(1)_24-29.nxml.txt.nlp	25206006	SENT125	5	5	9	9	scopolamine	spatial	PA451308	219793	0.795
NULL	Arthritis_Res_Ther_2010_Apr_1_12(2)_R60.nxml.txt.nlp	20359365	SENT5	28	28	11	11	bleomycin	SPARC	PA448645	6678	0.795
NULL	Cell_Death_Dis_2013_Jul_25_4(7)_e738.nxml.txt.nlp	23887629	SENT214	0	0	17	17	vorinostat	JAK2	PA164748224	3717	0.795
NULL	Arthritis_Res_Ther_2011_Feb_23_13(1)_R33.nxml.txt.nlp	21345222	SENT149	0	0	33	33	adalimumab	IFN	PA10004	3439	0.795
NULL	N_Am_J_Med_Sci_2011_Apr_3(4)_167-175.nxml.txt.nlp	22540086	SENT187	3	3	24	24	vatalanib	KDR	PA7001	3791	0.795
NULL	FEBS_J_2009_Jan_276(1)_199-209.nxml.txt.nlp	19032597	SENT162	25	25	23	23	geldanamycin	ADP	PA152031327	23038	0.795
NULL	Front_Immunol_2013_May_13_4_105.nxml.txt.nlp	23717308	SENT1199	10	10	5	5	ganciclovir	CD4	PA449733	920	0.795
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT235	1	1	13	13	curcumin	TRAIL	PA151958596	8743	0.795
NULL	Curr_Neuropharmacol_2014_Jul_12(4)_342-352.nxml.txt.nlp	25342942	SENT84	13	13	18	18	desipramine	CCL2	PA449233	6347	0.795
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Mar_7_68(Pt_4)_o968.nxml.txt.nlp	22590024	SENT74	26	26	10	10	ethanol	mol	PA448073	90527	0.795
NULL	Mol_Cancer_2008_Jan_25_7_14.nxml.txt.nlp	18221502	SENT121	15	15	7	7	oxaliplatin	PSAT1	PA131285527	29968	0.795
NULL	Clin_Ophthalmol_2011_Aug_19_5_1177-1183.nxml.txt.nlp	21887101	SENT185	4	4	1	1	triamcinolone	hole	PA451749	80757	0.795
NULL	Cancer_Immunol_Immunother_2011_Jun_25_60(6)_793-808.nxml.txt.nlp	21350947	SENT164	9	9	38	38	sorafenib	IFN	PA7000	3439	0.795
NULL	Clin_Exp_Otorhinolaryngol_2011_Dec_15_4(4)_177-183.nxml.txt.nlp	22232712	SENT134	5	5	19	19	doxycycline	p38	PA449415	10598;1432;7965	0.795
NULL	Oncol_Rep_2013_Apr_23_29(4)_1268-1274.nxml.txt.nlp	23354756	SENT145	7	7	2	2	trastuzumab	SLC25A43	PA451743	203427	0.795
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT375	0	0	17	17	resveratrol	SRC3		8202	0.795
NULL	Biomed_Res_Int_2013_Dec_31_2013_273498.nxml.txt.nlp	23484100	SENT142	26	26	30	30	genistein	OTC	PA165109660	5009	0.795
NULL	Neural_Regen_Res_2013_Jul_15_8(20)_1853-1862.nxml.txt.nlp	25206494	SENT112	0	0	6	6	ethanol	JNK	PA448073	5599	0.795
NULL	Viruses_2014_Sep_17_6(9)_3438-3449.nxml.txt.nlp	25256392	SENT139	8	8	4	4	oseltamivir	N10	PA450721	3164	0.795
NULL	BMJ_2010_Feb_8_340_c693.nxml.txt.nlp	20142325	SENT258	27	27	43	43	desipramine	CYP2C9	PA449233	1559	0.795
NULL	J_Biol_Chem_2008_Nov_14_283(46)_31679-31689.nxml.txt.nlp	18755684	SENT233	12	12	3	3	iron	FTH1	PA450087	2495	0.795
NULL	Basic_Clin_Pharmacol_Toxicol_2013_Feb_5_112(2)_132-137.nxml.txt.nlp	22900583	SENT12	32	32	25	25	bupropion	CYP3A4	PA448687	1576	0.795
NULL	Oncologist_2010_Mar_9_15(3)_236-245.nxml.txt.nlp	20215359	SENT87	4	4	6	6	bevacizumab	IFN	PA130232992	3439	0.795
NULL	Int_J_Environ_Res_Public_Health_2010_Jul_28_7(7)_2745-2788.nxml.txt.nlp	20717537	SENT409	9	9	5	5	mannitol	NAC	PA450320	22861	0.795
NULL	EJC_Suppl_2013_Sep_5_11(2)_45-59.nxml.txt.nlp	NULL	SENT242	21	21	34	34	capecitabine	CRT	PA448771	811	0.795
NULL	Neural_Dev_2009_Dec_2_4_42.nxml.txt.nlp	19954518	SENT107	28	28	1	1	glutaraldehyde	P18	PA449777	7975;10168	0.795
NULL	Open_Ophthalmol_J_2011_Apr_28_5_27-31.nxml.txt.nlp	21633720	SENT13	10	10	7	7	guanabenz	ERG	PA164774903	2078	0.795
NULL	J_Allergy_(Cairo)_2011_Oct_24_2011_457169.nxml.txt.nlp	22121382	SENT10	0	0	9	9	salmeterol	IL-6	PA451300	3569	0.795
NULL	Mol_Cancer_2013_Sep_11_12_104.nxml.txt.nlp	24025152	SENT209	17	17	0	0	gemcitabine	STAT3	PA449748	6774	0.795
NULL	Vet_Res_2013_Oct_2_44(1)_89.nxml.txt.nlp	24088531	SENT9	27	27	30	30	hemin	HO-1	PA449849	3162	0.795
NULL	Pharmaceuticals_(Basel)_2013_Nov_11_6(11)_1429-1450.nxml.txt.nlp	24287465	SENT259	7	7	1	1	vemurafenib	SMO	PA165946873	6608;54498	0.795
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT147	5	5	2	2	curcumin	PC-3	PA151958596	692094	0.795
NULL	Int_J_Endocrinol_2014_Jun_25_2014_534904.nxml.txt.nlp	25053942	SENT94	26	26	36	36	amiodarone	AIT	PA448383	160728	0.795
NULL	Antimicrob_Resist_Infect_Control_2012_May_30_1_21.nxml.txt.nlp	22958440	SENT192	13	13	0	0	ampicillin	TC1	PA448419	6947	0.795
NULL	Breast_Cancer_(Auckl)_2012_Nov_19_6_191-207.nxml.txt.nlp	23226023	SENT192	30	30	12	12	trastuzumab	HER2	PA451743	2064	0.795
NULL	Drugs_R_D_2011_Jun_27_11(2)_113-126.nxml.txt.nlp	21679004	SENT39	44	44	48	48	bevacizumab	IFN	PA130232992	3439	0.795
NULL	J_Oncol_2010_Jan_14_2010_740472.nxml.txt.nlp	20130818	SENT148	23	23	30	30	pertuzumab	ERBB3		2065	0.795
NULL	J_Res_Med_Sci_2010_Nov-Dec_15(6)_331-343.nxml.txt.nlp	21526106	SENT173	7	7	15	15	l-arginine	HDEL	PA448478	10945	0.795
NULL	J_Cell_Mol_Med_2014_Apr_20_18(4)_709-720.nxml.txt.nlp	24444314	SENT258	3	3	17	17	losartan	AMPK	PA450268	5563	0.795
NULL	Ann_Clin_Microbiol_Antimicrob_2007_Oct_30_6_13.nxml.txt.nlp	17967199	SENT17	13	13	19	19	vancomycin	VISA	PA451850	57506	0.795
NULL	Clin_Med_Insights_Oncol_2012_Jan_11_6_75-84.nxml.txt.nlp	22346367	SENT83	8	8	12	12	ketoconazole	ACTH	PA450146	5443	0.795
NULL	Int_J_Mol_Sci_2014_Jun_26_15(7)_11416-11434.nxml.txt.nlp	24972137	SENT515	3	3	13	13	sitagliptin	AMPK	PA164748978	5563	0.795
NULL	Cancer_Cell_Int_2014_Jun_11_14_49.nxml.txt.nlp	24991192	SENT128	26	26	21	21	berberine	AMPK	PA165860812	5563	0.795
NULL	Acta_Pharmacol_Sin_2010_Feb_5_31(2)_184-190.nxml.txt.nlp	20139901	SENT19	24	24	7	7	metformin	SLC22A2	PA450395	6582	0.795
NULL	J_Gen_Physiol_2003_Mar_121(3)_181-197.nxml.txt.nlp	12601083	SENT382	30	30	26	26	forskolin	GLP-1	PA146096022	100125288	0.795
NULL	J_Thromb_Thrombolysis_2012_Feb_20_33(2)_143-153.nxml.txt.nlp	22183178	SENT293	4	4	1	1	clopidogrel	P2Y12	PA449053	64805	0.795
NULL	J_Cancer_2012_Nov_30_4(1)_3-11.nxml.txt.nlp	23386900	SENT143	8	8	19	19	gemcitabine	CCL2	PA449748	6347	0.795
NULL	Open_Biochem_J_2011_Sep_23_5_45-51.nxml.txt.nlp	21966325	SENT81	30	30	33	33	indomethacin	IRE1	PA449982	2081	0.795
NULL	J_Headache_Pain_2008_Oct_31_9(5)_277-288.nxml.txt.nlp	18668199	SENT63	5	5	10	10	propranolol	Yes	PA451145	7525	0.795
NULL	Anal_Chem_2014_Mar_18_86(6)_2867-2870.nxml.txt.nlp	24579851	SENT60	15	15	21	21	hemin	HBG2	PA449849	3048	0.795
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_29_2013_590393.nxml.txt.nlp	23737838	SENT194	6	6	15	15	resveratrol	p53		7157	0.795
NULL	Lab_Anim_Res_2012_Jun_26_28(2)_109-114.nxml.txt.nlp	22787484	SENT55	5	5	21	21	reserpine	MKP-1	PA451236	1843	0.795
NULL	J_Breast_Cancer_2013_Jun_28_16(2)_133-137.nxml.txt.nlp	23843843	SENT95	3	3	36	36	curcumin	CDK4	PA151958596	1019	0.795
NULL	Cell_Div_2012_Feb_9_7_4.nxml.txt.nlp	22321970	SENT177	16	16	19	19	galactose	CDH1	PA449725	51343;999	0.795
NULL	Acta_Pharmacol_Sin_2012_Feb_3_33(2)_173-181.nxml.txt.nlp	22301857	SENT245	11	11	1	1	sibutramine	Yes	PA451344	7525	0.795
NULL	Ann_Rheum_Dis_2008_Jul_26_67(7)_917-925.nxml.txt.nlp	17965121	SENT94	29	29	16	16	rituximab	ACPA	PA451261	5657	0.795
NULL	Mol_Cancer_2008_Jun_3_7_47.nxml.txt.nlp	18519000	SENT100	17	17	22	22	gefitinib	EGFR	PA131301952	1956	0.795
NULL	J_Gen_Physiol_2000_Jun_1_115(6)_685-696.nxml.txt.nlp	10828243	SENT159	5	5	1	1	genistein	OLF	PA165109660	83857	0.795
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT307	13	13	16	16	nutlin-3	PUMA		27113	0.795
NULL	Breast_Cancer_Res_2012_Mar_14_14(2)_R45.nxml.txt.nlp	22417809	SENT461	12	12	20	20	fulvestrant	HER-2	PA164747170	2064	0.795
NULL	Cell_Cycle_2012_Apr_15_11(8)_1487.nxml.txt.nlp	22544077	SENT23	7	7	26	26	phenformin	AMPK	PA1000	5563	0.795
NULL	Cardiovasc_Diabetol_2013_Mar_18_12_46.nxml.txt.nlp	23497197	SENT18	7	7	19	19	metformin	APPL1	PA450395	26060	0.795
NULL	Indian_J_Anaesth_2013_Jul-Aug_57(4)_336-337.nxml.txt.nlp	24163445	SENT32	15	15	5	5	ondansetron	CYP2D6	PA450705	1565	0.795
NULL	Front_Endocrinol_(Lausanne)_2011_Dec_21_2_84.nxml.txt.nlp	22654830	SENT23	26	26	11	11	lipase	UCP1	PA450239	7350	0.795
NULL	Arthritis_Res_Ther_2009_Jul_17_11(4)_R111.nxml.txt.nlp	19615053	SENT223	12	12	8	8	bleomycin	IL-2	PA448645	3558	0.795
NULL	Oncotarget_2014_Aug_19_5(18)_8737-8749.nxml.txt.nlp	25228590	SENT5	10	10	21	21	crizotinib	RPS6	PA165946122	6194	0.795
NULL	Blood_Res_2014_Dec_23_49(4)_253-258.nxml.txt.nlp	25548759	SENT145	13	13	10	10	melphalan	CHOP	PA450354	1649	0.795
NULL	Br_J_Haematol_2014_Feb_16_164(4)_469-480.nxml.txt.nlp	24372186	SENT8	13	13	16	16	primaquine	G6PD	PA451103	2539	0.795
NULL	J_Physiol_2011_Oct_15_589(Pt_20)_4921-4934.nxml.txt.nlp	21859823	SENT205	22	22	15	15	carbachol	CA3	PA448784	761	0.795
NULL	Cancer_Cell_Int_2006_Jan_25_6_1.nxml.txt.nlp	16436212	SENT116	31	31	6	6	streptomycin	U87	PA451512	677775;641648	0.795
NULL	Atten_Defic_Hyperact_Disord_2014_Jul_14_6(3)_175-202.nxml.txt.nlp	25017045	SENT309	22	22	14	14	citalopram	COMT	PA449015	1312	0.795
NULL	J_Exp_Med_1980_Dec_1_152(6)_1699-1708.nxml.txt.nlp	7452150	SENT3	1	1	23	23	trypsin	gp160	PA451806	2028	0.795
NULL	Breast_Cancer_Res_2004_May_7_6(4)_R352-R365.nxml.txt.nlp	15217502	SENT228	12	12	5	5	estradiol	CYP1A2	PA449503	1544	0.795
NULL	Biomed_Res_Int_2014_May_14_2014_642798.nxml.txt.nlp	24955366	SENT52	29	29	11	11	hyaluronan	ACAN	PA165958431	176	0.795
NULL	J_Cell_Mol_Med_2014_Dec_7_18(12)_2536-2552.nxml.txt.nlp	25287328	SENT10	22	22	0	0	estradiol	PKD1	PA449503	5310	0.795
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Feb_23_69(Pt_3)_m165-m166.nxml.txt.nlp	23476507	SENT71	7	7	41	41	phenol	mer	PA450913	10461	0.795
NULL	Oncogene_2010_Sep_16_29(37)_5193-5203.nxml.txt.nlp	20581867	SENT175	12	12	6	6	lapatinib	PI3K	PA152241907	5290	0.795
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Aug_13_64(Pt_9)_o1743.nxml.txt.nlp	21201725	SENT57	21	21	36	36	ethanol	mol	PA448073	90527	0.795
NULL	Arthritis_Res_Ther_2014_Apr_3_16(2)_R86.nxml.txt.nlp	24708674	SENT275	6	6	9	9	bosentan	Fli1	PA10034	2314	0.795
NULL	Chemother_Res_Pract_2011_Dec_1_2011_715469.nxml.txt.nlp	22312557	SENT150	18	18	25	25	cisplatin	p53	PA449014	7157	0.795
NULL	J_Thromb_Haemost_2014_May_22_12(5)_748-760.nxml.txt.nlp	24612393	SENT199	7	7	15	15	thrombin	ADP	PA451674	23038	0.795
NULL	Acta_Neuropathol_Commun_2013_Aug_9_1_49.nxml.txt.nlp	24252504	SENT235	5	5	10	10	arsenite	TDP-43	PA452638	23435	0.795
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT154	13	13	22	22	metformin	PTEN	PA450395	5728	0.795
NULL	Mol_Cancer_2010_Jun_27_9_168.nxml.txt.nlp	20579391	SENT70	5	5	22	22	nilotinib	TEC	PA165958345	7006	0.795
NULL	Mol_Cancer_2008_Mar_26_7_27.nxml.txt.nlp	18366759	SENT80	7	7	15	15	etoposide	BIRC3	PA449552	330	0.795
NULL	J_Mol_Signal_2011_May_9_6_3.nxml.txt.nlp	21554706	SENT80	29	29	12	12	isoproterenol	AKAP12	PA450121	9590	0.795
NULL	Mol_Cancer_2009_Nov_10_8_99.nxml.txt.nlp	19903356	SENT31	20	20	14	14	imatinib	IGFBP3	PA10804	3486	0.795
NULL	Arthritis_Res_Ther_2013_Jul_9_15(4)_R73.nxml.txt.nlp	23837669	SENT262	3	3	9	9	colchicine	IL-8	PA449092	3576	0.795
NULL	Biomed_Res_Int_2014_Feb_19_2014_240642.nxml.txt.nlp	24701565	SENT62	8	8	11	11	doxorubicin	APOA1	PA449412	335	0.795
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_3_2014_473213.nxml.txt.nlp	25538791	SENT19	4	4	33	33	ethanol	CYP3A4	PA448073	1576	0.795
NULL	Braz_J_Med_Biol_Res_2014_Sep_5_47(11)_929-939.nxml.txt.nlp	25296354	SENT144	20	20	9	9	afatinib	EGFR	PA165981154	1956	0.795
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT252	28	28	18	18	aripiprazole	PRL	PA10026	5617	0.795
NULL	Crit_Care_2012_Nov_22_16(6)_238.nxml.txt.nlp	23171712	SENT218	28	28	2	2	ebselen	SP-D	PA161660841	6441	0.795
NULL	J_Cardiothorac_Surg_2014_Nov_23_9(1)_175.nxml.txt.nlp	NULL	SENT41	8	8	21	21	bupivacaine	EDA	PA135057240	1896	0.795
NULL	Cardiovasc_Diabetol_2013_Jun_7_12_84.nxml.txt.nlp	23759020	SENT169	17	17	13	13	dipyridamole	LSR	PA449367	51599	0.795
NULL	J_Radiat_Res_2014_Jan_14_55(1)_113-120.nxml.txt.nlp	23772086	SENT40	27	27	21	21	sorafenib	HCC	PA7000	84668	0.795
NULL	Paediatr_Drugs_2014_Feb_27_16(3)_199-211.nxml.txt.nlp	24574047	SENT136	12	12	15	15	doxylamine	PLP	PA449419	25824;5744	0.795
NULL	Sensors_(Basel)_2010_May_19_10(5)_5031-5053.nxml.txt.nlp	22399922	SENT164	4	4	21	21	resveratrol	HNF4A		3172	0.795
NULL	Mol_Cancer_2012_Apr_26_11_26.nxml.txt.nlp	22537224	SENT141	26	26	42	42	geldanamycin	FANCF	PA152031327	2188	0.795
NULL	Biomed_Res_Int_2013_Jun_6_2013_928271.nxml.txt.nlp	23841099	SENT25	29	29	38	38	ticagrelor	ADP	PA165374673	23038	0.795
NULL	Mol_Biol_Cell_2014_Jan_1_25(1)_76-86.nxml.txt.nlp	24173717	SENT287	9	9	23	23	colchicine	NLRP3	PA449092	114548	0.795
NULL	Oncotarget_2013_Feb_26_4(2)_298-309.nxml.txt.nlp	23593653	SENT169	8	8	10	10	quinacrine	DNMT1	PA164745551	1786	0.795
NULL	Int_J_Environ_Res_Public_Health_2010_Feb_11_7(2)_473-493.nxml.txt.nlp	20616986	SENT353	7	7	1	1	ethanol	CRF1	PA448073	1394	0.795
NULL	Orphanet_J_Rare_Dis_2012_Sep_25_7_71.nxml.txt.nlp	23009155	SENT43	2	2	13	13	plerixafor	CXCR4	PA165958410	7852	0.795
NULL	Arthritis_Res_Ther_2013_Feb_20_15(1)_R31.nxml.txt.nlp	23421940	SENT42	22	22	40	40	collagenase	CO2	PA449107	4513	0.795
NULL	Case_Rep_Psychiatry_2012_Aug_15_2012_592784.nxml.txt.nlp	22934219	SENT87	7	7	9	9	omeprazole	GIT	PA450704	5034	0.795
NULL	Cent_European_J_Urol_2013_Dec_19_66(4)_394-404.nxml.txt.nlp	24757527	SENT177	45	45	40	40	temsirolimus	MARK	PA164746890	4139	0.795
NULL	Int_J_Endocrinol_Metab_2014_Apr_1_12(2)_e15297.nxml.txt.nlp	24910643	SENT12	9	9	22	22	collagenase	adiponectin	PA449107	9370	0.795
NULL	Br_J_Cancer_2010_Jun_8_102(12)_1699-1706.nxml.txt.nlp	20485286	SENT147	15	15	6	6	sunitinib	CYP3A	PA162372840	1574	0.795
NULL	Biosci_Rep_2012_Aug_1_32(Pt_4)_361-374.nxml.txt.nlp	22762204	SENT164	30	30	10	10	carboplatin	BRCA1	PA448803	672	0.795
NULL	Cancer_Immunol_Immunother_2011_Jan_22_60(1)_37-47.nxml.txt.nlp	20859626	SENT71	17	17	24	24	fluorescein	CD14	PA164746009	929	0.795
NULL	Cell_Commun_Signal_2013_Nov_11_11_86.nxml.txt.nlp	24215724	SENT335	28	28	5	5	thrombin	PAR1	PA451674	79581;2149	0.795
NULL	Am_J_Rhinol_Allergy_2013_Nov-Dec_27(6)_482-489.nxml.txt.nlp	24274224	SENT147	6	6	22	22	zafirlukast	LTA	PA451949	4049	0.795
NULL	Int_J_Environ_Res_Public_Health_2005_May_30_2(1)_138-146.nxml.txt.nlp	16708425	SENT313	1	1	7	7	ritonavir	CYP3A	PA451260	1574	0.795
NULL	Int_J_Mol_Sci_2012_Aug_13_13(8)_10091-10112.nxml.txt.nlp	22949849	SENT666	32	32	23	23	lipase	PPL	PA450239	5493	0.795
NULL	Cardiovasc_Drugs_Ther_2010_Feb_25_24(1)_85-87.nxml.txt.nlp	20182781	SENT24	3	3	25	25	cyclosporine	ANOVA	PA449167	4858	0.795
NULL	Acta_Pharmacol_Sin_2012_Feb_3_33(2)_145-147.nxml.txt.nlp	22301854	SENT31	16	16	20	20	liraglutide	GLP-1	PA165958364	100125288	0.795
NULL	Mol_Biol_Int_2011_Jun_8_2011_571242.nxml.txt.nlp	22091408	SENT296	37	37	7	7	arsenite	ODC	PA452638	4953;89874	0.795
NULL	J_Oncol_2013_Apr_29_2013_854121.nxml.txt.nlp	23737784	SENT42	0	0	20	20	lapatinib	HER2	PA152241907	2064	0.795
NULL	Int_J_Mol_Sci_2014_Nov_25_15(12)_21703-21722.nxml.txt.nlp	25429431	SENT148	18	18	25	25	cisplatin	IL-6	PA449014	3569	0.795
NULL	Int_J_Biol_Sci_2014_Jun_21_10(7)_702-714.nxml.txt.nlp	25013379	SENT143	24	24	39	39	gefitinib	EGFR	PA131301952	1956	0.795
NULL	J_Adv_Pract_Oncol_2013_May_1_May-Jun_4(3)_176-181.nxml.txt.nlp	25031998	SENT146	36	36	26	26	tamoxifen	p53	PA451581	7157	0.795
NULL	Diabetes_Care_2008_Nov_31(11)_2169-2176.nxml.txt.nlp	18678611	SENT98	9	9	18	18	rimonabant	adiponectin	PA152407999	9370	0.795
NULL	Pharmaceutics_2011_Dec_9_3(4)_932-953.nxml.txt.nlp	24309315	SENT69	18	18	0	0	capsaicin	TRPV1	PA448776	7442	0.795
NULL	Pharmaceuticals_(Basel)_2013_Apr_3_6(4)_480-499.nxml.txt.nlp	24276119	SENT143	25	25	14	14	fluoxetine	GluN2B	PA449673	2904	0.795
NULL	Ann_Rheum_Dis_2014_Sep_3_73(9)_1616-1625.nxml.txt.nlp	24699939	SENT8	35	35	10	10	methotrexate	IL-6	PA450428	3569	0.795
NULL	Aging_(Albany_NY)_2012_Nov_24_4(11)_742-754.nxml.txt.nlp	23178507	SENT5	31	31	25	25	dextran	Langerin	PA449261	50489	0.795
NULL	J_Skin_Cancer_2012_Dec_13_2012_147863.nxml.txt.nlp	23316365	SENT135	11	11	4	4	curcumin	IL6	PA151958596	3569	0.795
NULL	J_Antimicrob_Chemother_2008_Nov_13_62(5)_1086-1093.nxml.txt.nlp	18703526	SENT86	23	23	9	9	ceftazidime	CTX	PA448861	1593	0.795
NULL	Oncol_Lett_2014_Mar_2_7(3)_791-796.nxml.txt.nlp	24527087	SENT161	41	41	13	13	imatinib	CD34	PA10804	947	0.795
NULL	Ann_Indian_Acad_Neurol_2014_Mar_17(Suppl_1)_S32-S36.nxml.txt.nlp	24791086	SENT113	18	18	7	7	propofol	PTB	PA451141	58155	0.795
NULL	Am_J_Case_Rep_2013_Jul_1_14_226-229.nxml.txt.nlp	23847709	SENT90	4	4	6	6	levofloxacin	gamma	PA450214	9913	0.795
NULL	J_Mol_Signal_2006_Dec_6_1_8.nxml.txt.nlp	17224083	SENT39	11	11	14	14	thrombin	Rho	PA451674	29984	0.795
NULL	Indian_J_Pharm_Sci_2008_Jul-Aug_70(4)_431-439.nxml.txt.nlp	20046766	SENT97	12	12	29	29	propranolol	P-gp	PA451145	5243	0.795
NULL	BMJ_2011_Mar_17_342_d1309.nxml.txt.nlp	21415101	SENT231	9	9	26	26	rosiglitazone	gamma	PA451283	9913	0.795
NULL	Ther_Clin_Risk_Manag_2007_Aug_3(4)_665-673.nxml.txt.nlp	18472989	SENT175	3	3	34	34	ketoconazole	CYP3A4	PA450146	1576	0.795
NULL	Exp_Ther_Med_2013_Jun_2_5(6)_1737-1739.nxml.txt.nlp	23837064	SENT89	11	11	1	1	minocycline	MICG	PA450519	352967	0.795
NULL	J_Biol_Chem_2009_Jul_24_284(30)_20011-20021.nxml.txt.nlp	19473976	SENT192	0	0	21	21	trypsin	MCT1	PA451806	6566	0.795
NULL	J_Cell_Biol_2003_Sep_1_162(5)_877-888.nxml.txt.nlp	12952938	SENT55	14	14	27	27	staurosporine	IL-3	PA165109623	3562	0.795
NULL	Int_J_Fertil_Steril_2011_Dec_22_Oct-Dec_5(3)_186-192.nxml.txt.nlp	25101163	SENT37	11	11	2	2	l-carnitine	B12	PA450154	7126;4709	0.795
NULL	Biosci_Rep_2013_Sep_4_33(5)_e00064.nxml.txt.nlp	23889169	SENT131	4	4	2	2	thrombin	PAR1	PA451674	79581;2149	0.795
NULL	Ann_Clin_Microbiol_Antimicrob_2015_Jan_16_14(1)_4.nxml.txt.nlp	NULL	SENT39	6	6	3	3	ceftazidime	CTX	PA448861	1593	0.795
NULL	Diabetes_Metab_J_2013_Aug_14_37(4)_252-261.nxml.txt.nlp	23991403	SENT117	7	7	5	5	estradiol	adiponectin	PA449503	9370	0.795
NULL	Eur_J_Immunol_2013_Apr_11_43(5)_1153-1161.nxml.txt.nlp	23400868	SENT170	16	16	9	9	chloroquine	MARCH1	PA448948	55016	0.795
NULL	Crit_Care_2011_Mar_11_15(Suppl_1)_P91.nxml.txt.nlp	NULL	SENT2	6	6	3	3	terlipressin	AVP	PA164781020	114548;551	0.795
NULL	Br_J_Cancer_2013_Jun_25_108(12)_2464-2469.nxml.txt.nlp	23695016	SENT164	16	16	20	20	paclitaxel	CRT	PA450761	811	0.795
NULL	Front_Neurosci_2013_Sep_17_7_167.nxml.txt.nlp	24062637	SENT174	26	26	8	8	vasopressin	ghrelin	PA451858	51738	0.795
NULL	Target_Oncol_2013_Jun_27_8(2)_127-136.nxml.txt.nlp	23625191	SENT126	9	9	21	21	panitumumab	KRAS	PA162373091	3845	0.795
NULL	J_Antimicrob_Chemother_2010_Aug_19_65(8)_1702-1711.nxml.txt.nlp	20562429	SENT172	13	13	24	24	gentamicin	BSAC	PA449753	57591	0.795
NULL	J_Cardiothorac_Surg_2010_Apr_19_5_26.nxml.txt.nlp	20403156	SENT143	22	22	28	28	etomidate	RAI	PA164743987	10848;6050	0.795
NULL	Anat_Cell_Biol_2010_Sep_30_43(3)_194-200.nxml.txt.nlp	21212859	SENT112	25	25	38	38	ethanol	PLP	PA448073	25824;5744	0.795
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1135-1143.nxml.txt.nlp	21364580	SENT151	9	9	3	3	trastuzumab	ERBB2	PA451743	2064	0.795
NULL	Diabetes_Obes_Metab_2011_Apr_13(4)_348-356.nxml.txt.nlp	21205128	SENT169	15	15	19	19	glimepiride	GLP-1	PA449761	100125288	0.795
NULL	Acta_Pharmacol_Sin_2012_Oct_3_33(10)_1311-1318.nxml.txt.nlp	22941289	SENT97	0	0	22	22	sorafenib	VEGFR2	PA7000	3791	0.795
NULL	Apoptosis_2013_May_14_18(10)_1145-1153.nxml.txt.nlp	23670020	SENT83	0	0	20	20	staurosporine	Bcl-2	PA165109623	596	0.795
NULL	Drug_Target_Insights_2013_Aug_19_7_27-34.nxml.txt.nlp	24023511	SENT143	10	10	44	44	r101933	P-gp		5243	0.795
NULL	Carcinogenesis_2010_Dec_27_31(12)_2049-2057.nxml.txt.nlp	20876285	SENT111	6	6	20	20	tamoxifen	HER2	PA451581	2064	0.795
NULL	Oncogene_2010_Nov_18_29(46)_6160-6171.nxml.txt.nlp	20729916	SENT96	22	22	7	7	cisplatin	YAP	PA449014	55249	0.795
NULL	Front_Genet_2012_Nov_22_3_249.nxml.txt.nlp	23189085	SENT151	32	32	16	16	s-adenosylmethionine	TPMT	PA164754994	7172	0.795
NULL	Stroke_Res_Treat_2009_Dec_20_2010_386389.nxml.txt.nlp	20700422	SENT266	5	5	15	15	resveratrol	MCP-1		6347	0.795
NULL	Semin_Immunopathol_2013_Jan_26_35(1)_39-52.nxml.txt.nlp	22829332	SENT197	7	7	18	18	dacarbazine	CHOP	PA449197	1649	0.795
NULL	Adipocyte_2012_Jul_1_1(3)_182-187.nxml.txt.nlp	23700531	SENT46	15	15	20	20	lipase	CGI-58	PA450239	51099	0.795
NULL	Arch_Plast_Surg_2013_Mar_11_40(2)_141-153.nxml.txt.nlp	23529264	SENT214	15	15	22	22	abatacept	CD80	PA164747080	941	0.795
NULL	Aging_(Albany_NY)_2009_Sep_10_1(9)_803-817.nxml.txt.nlp	20157568	SENT37	10	10	16	16	tetracycline	TTP	PA451640	7538;11093	0.795
NULL	Case_Rep_Crit_Care_2014_Aug_19_2014_242703.nxml.txt.nlp	25215245	SENT214	13	13	20	20	nicardipine	APE	PA450620	55704;328	0.795
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT210	20	20	13	13	cisplatin	MDM2	PA449014	4193	0.795
NULL	Br_J_Ophthalmol_2010_May_94(5)_639-642.nxml.txt.nlp	20447966	SENT100	11	11	8	8	fluorometholone	MYOC	PA164781355	4653	0.795
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_11_2014_274786.nxml.txt.nlp	25505920	SENT164	13	13	26	26	oxaliplatin	ERCC1	PA131285527	2067	0.795
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jan_26_67(Pt_2)_o500-o501.nxml.txt.nlp	21523154	SENT79	0	0	6	6	cinnarizine	mol	PA164749342	90527	0.795
NULL	Br_J_Cancer_2011_Nov_22_105(11)_1708-1718.nxml.txt.nlp	22045188	SENT278	13	13	19	19	fluorescein	CD138	PA164746009	6382	0.795
NULL	J_Biol_2003_Sep_24_2(4)_28.nxml.txt.nlp	14511394	SENT13	8	8	12	12	phenformin	AMPK	PA1000	5563	0.795
NULL	J_Hematol_Oncol_2014_Aug_20_7_62.nxml.txt.nlp	25139395	SENT174	34	34	24	24	cisplatin	p53	PA449014	7157	0.795
NULL	J_Cell_Mol_Med_2014_Jul_30_18(7)_1444-1459.nxml.txt.nlp	24779367	SENT144	21	21	23	23	heparin	EGF	PA449855	1950	0.795
NULL	J_Mol_Med_2008_Sep_4_86(9)_1045-1056.nxml.txt.nlp	18600309	SENT268	8	8	17	17	salmeterol	p38	PA451300	10598;1432;7965	0.795
NULL	Mol_Clin_Oncol_2013_Sep_24_1(5)_918-924.nxml.txt.nlp	24649271	SENT156	3	3	7	7	gemcitabine	EGFR	PA449748	1956	0.795
NULL	Biochem_Res_Int_2012_Aug_15_2012_940405.nxml.txt.nlp	22928112	SENT115	25	25	23	23	gefitinib	EGFR	PA131301952	1956	0.795
NULL	Colomb_Med_(Cali)_44(1)_42-45.nxml.txt.nlp	24892321	SENT99	19	19	29	29	cyanocobalamin	B12	PA451892	7126;4709	0.795
NULL	J_Brachial_Plex_Peripher_Nerve_Inj_2008_Mar_19_3_8.nxml.txt.nlp	18353188	SENT207	1	1	22	22	capsaicin	SSeCKS	PA448776	9590	0.795
NULL	J_Headache_Pain_2008_Oct_8_9(5)_317-323.nxml.txt.nlp	18688693	SENT182	4	4	8	8	sumatriptan	c-fos	PA451566	2353	0.795
NULL	Bioinformation_2012_Mar_31_8(6)_276-280.nxml.txt.nlp	22493536	SENT104	6	6	0	0	lipase	BCHE	PA450239	590	0.795
NULL	Br_J_Cancer_2011_Apr_12_104(8)_1278-1287.nxml.txt.nlp	21487429	SENT14	27	27	4	4	cisplatin	c-FLIP	PA449014	8837	0.795
NULL	Physiol_Rep_2014_Sep_28_2(9)_e12160.nxml.txt.nlp	25263209	SENT167	21	21	36	36	capsaicin	TRPV1	PA448776	7442	0.795
NULL	Eur_J_Haematol_2014_Feb_25_92(2)_127-136.nxml.txt.nlp	24118452	SENT62	18	18	14	14	anagrelide	CRT	PA164742986	811	0.795
NULL	Br_J_Pharmacol_2014_Jan_23_171(2)_523-535.nxml.txt.nlp	24372553	SENT233	2	2	6	6	metformin	SIRT1	PA450395	23411	0.795
NULL	Case_Rep_Gastroenterol_2009_Nov_21_3(3)_372-376.nxml.txt.nlp	21103256	SENT14	13	13	10	10	ribavirin	IFN	PA451241	3439	0.795
NULL	JRSM_Cardiovasc_Dis_2012_May_31_1(2)_cvd_2012_012007.nxml.txt.nlp	24175064	SENT135	10	10	5	5	thrombin	ADP	PA451674	23038	0.795
NULL	Oncotarget_2013_Aug_8_4(8)_1130-1142.nxml.txt.nlp	24029073	SENT163	13	13	3	3	platinum	NRF2	PA150595617	2551;4780	0.795
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT96	21	21	16	16	perifosine	TRAIL	PA165291471	8743	0.795
NULL	J_Gen_Physiol_2003_Jan_121(1)_3-16.nxml.txt.nlp	12508050	SENT278	5	5	10	10	nifedipine	c-fos	PA450631	2353	0.795
NULL	Br_J_Clin_Pharmacol_2011_Oct_72(4)_647-657.nxml.txt.nlp	21518389	SENT30	25	25	1	1	thrombin	ADP	PA451674	23038	0.795
NULL	Eur_J_Med_Res_2009_Nov_24_14(Suppl_3)_5-16.nxml.txt.nlp	19959411	SENT243	24	24	16	16	raltegravir	N155		9631	0.795
NULL	Mol_Cancer_2009_Nov_19_8_108.nxml.txt.nlp	19925669	SENT260	8	8	4	4	doxorubicin	CRT	PA449412	811	0.795
NULL	Braz_J_Med_Biol_Res_2013_Aug_10_46(7)_589-600.nxml.txt.nlp	23903679	SENT61	16	16	47	47	pancuronium	CO2	PA450771	4513	0.795
NULL	Angew_Chem_Int_Ed_Engl_2013_Jan_2_52(1)_325-330.nxml.txt.nlp	23080482	SENT21	23	23	33	33	thrombin	spatial	PA451674	219793	0.795
NULL	Psychiatry_Investig_2010_Sep_13_7(3)_215-219.nxml.txt.nlp	20927311	SENT107	9	9	5	5	paroxetine	FDG	PA450801	23583	0.795
NULL	Endocr_Relat_Cancer_2014_Apr_21(2)_311-326.nxml.txt.nlp	24478054	SENT26	0	0	12	12	cabozantinib	VEGFR2	PA165906891	3791	0.795
NULL	Nat_Commun_2014_Nov_26_5_5538.nxml.txt.nlp	25423963	SENT61	26	26	30	30	tetracycline	Oct4	PA451640	5460	0.795
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT204	36	36	29	29	cetuximab	KRAS	PA10040	3845	0.795
NULL	J_Cell_Mol_Med_2014_Jan_4_18(1)_38-48.nxml.txt.nlp	24188742	SENT9	13	13	0	0	vincristine	PAX3	PA451879	5077	0.795
NULL	Breast_Cancer_Res_2005_Apr_12_7(4)_R570-R579.nxml.txt.nlp	15987464	SENT118	30	30	17	17	gefitinib	EGFR	PA131301952	1956	0.795
NULL	Oncotarget_2014_Aug_29_5(17)_7217-7259.nxml.txt.nlp	25277175	SENT288	6	6	12	12	lapatinib	EGFR	PA152241907	1956	0.795
NULL	Leukemia_2014_Jan_12_28(1)_15-33.nxml.txt.nlp	23778311	SENT252	27	27	3	3	imatinib	p53	PA10804	7157	0.795
NULL	Cell_Death_Dis_2013_Jun_13_4(6)_e664.nxml.txt.nlp	23764845	SENT50	11	11	15	15	nadh	ACPA	PA164755085	5657	0.795
NULL	Oncotarget_2011_Dec_31_2(12)_1314-1321.nxml.txt.nlp	22248929	SENT136	17	17	24	24	lapatinib	HER3	PA152241907	2065	0.795
NULL	Brain_Res_2013_Jul_12_1521(100)_1-15.nxml.txt.nlp	22789905	SENT835	0	0	12	12	colchicine	P-gp	PA449092	5243	0.795
NULL	Behav_Neurol_2014_Nov_16_2014_360978.nxml.txt.nlp	25477708	SENT177	15	15	17	17	nicotine	P28	PA450626	9446;7802;9527	0.795
NULL	Int_J_Fertil_Steril_2013_Mar_3_Jan-Mar_6(4)_304-309.nxml.txt.nlp	24520455	SENT136	13	13	35	35	estradiol	RFRP	PA449503	64111	0.795
NULL	Front_Oncol_2014_May_15_4_112.nxml.txt.nlp	24860788	SENT56	35	35	13	13	imatinib	CD49e	PA10804	3678	0.795
NULL	Mol_Cancer_2012_Apr_26_11_26.nxml.txt.nlp	22537224	SENT13	26	26	36	36	cisplatin	FANCF	PA449014	2188	0.795
NULL	Environ_Health_Perspect_2008_Jan_5_116(1)_1-6.nxml.txt.nlp	18197291	SENT208	28	28	23	23	arsenite	p85	PA452638	5296;5295;54776;23368	0.794
NULL	Exp_Ther_Med_2015_Jan_5_9(1)_84-88.nxml.txt.nlp	25452780	SENT73	23	23	6	6	voglibose	GLP-1	PA164752433	100125288	0.794
NULL	Int_J_Mol_Sci_2012_Feb_1_13(2)_1512-1523.nxml.txt.nlp	22408405	SENT141	9	9	17	17	olmesartan	LOX-1	PA164742950	4973	0.794
NULL	Cancers_(Basel)_2013_Jul_4_5(3)_838-856.nxml.txt.nlp	24202322	SENT207	19	19	28	28	doxorubicin	p53	PA449412	7157	0.794
NULL	Int_J_Mol_Sci_2010_Oct_14_11(10)_3922-3932.nxml.txt.nlp	21152309	SENT57	7	7	11	11	ethanol	E14	PA448073	4863	0.794
NULL	Br_J_Cancer_2012_Feb_14_106(4)_748-755.nxml.txt.nlp	22240781	SENT136	21	21	14	14	cetuximab	KRAS	PA10040	3845	0.794
NULL	Indian_J_Anaesth_2014_Nov-Dec_58(6)_765-766.nxml.txt.nlp	25624549	SENT38	0	0	9	9	baclofen	gamma	PA448533	9913	0.794
NULL	Int_J_Mol_Sci_2014_Sep_23_15(9)_16911-16935.nxml.txt.nlp	25250910	SENT60	41	41	27	27	phenobarbital	gamma	PA450911	9913	0.794
NULL	J_Cell_Mol_Med_2013_Mar_14_17(3)_337-349.nxml.txt.nlp	23490035	SENT123	5	5	29	29	amiloride	ASIC3	PA448368	9311	0.794
NULL	Acta_Pharmacol_Sin_2011_May_18_32(5)_591-600.nxml.txt.nlp	21499286	SENT44	15	15	18	18	bezafibrate	AMPK	PA162364313	5563	0.794
NULL	Lab_Invest_2012_Nov_10_92(11)_1541-1552.nxml.txt.nlp	22964851	SENT209	11	11	6	6	hemin	HO-1	PA449849	3162	0.794
NULL	J_Cell_Biol_2003_Dec_8_163(5)_1111-1121.nxml.txt.nlp	14662749	SENT161	12	12	22	22	doxycycline	ARF6	PA449415	382	0.794
NULL	Oncol_Lett_2013_Mar_28_5(3)_935-942.nxml.txt.nlp	23426424	SENT118	35	35	24	24	oxaliplatin	ERCC1	PA131285527	2067	0.794
NULL	J_Obes_2011_Sep_30_2011_431985.nxml.txt.nlp	20953366	SENT247	4	4	21	21	exenatide	GLP-1	PA164749238	100125288	0.794
NULL	Breast_Cancer_Res_2010_Jun_28_12(3)_R43.nxml.txt.nlp	20579400	SENT265	12	12	17	17	fulvestrant	MAPT	PA164747170	4137	0.794
NULL	Cancer_Cell_Int_2010_Sep_9_10_32.nxml.txt.nlp	20828393	SENT157	15	15	33	33	cisplatin	ATF3	PA449014	467	0.794
NULL	Cancer_Cell_Int_2013_Feb_12_13_14.nxml.txt.nlp	23402310	SENT5	28	28	20	20	celecoxib	p65	PA448871	5970	0.794
NULL	Front_Oncol_2014_Apr_8_4_71.nxml.txt.nlp	24782983	SENT518	16	16	19	19	minocycline	NF-kappaB	PA450519	4790	0.794
NULL	Cancer_Cell_Int_2011_Jun_1_11_15.nxml.txt.nlp	21631944	SENT150	22	22	13	13	etoposide	MICA	PA449552	100507436	0.794
NULL	Diabetes_2011_Jun_21_60(6)_1734-1742.nxml.txt.nlp	21498783	SENT24	13	13	26	26	lipase	DAG	PA450239	1605	0.794
NULL	F1000Res_2013_Mar_5_2_74.nxml.txt.nlp	24358880	SENT266	14	14	5	5	benzaldehyde	TRPV1	PA448571	7442	0.794
NULL	J_Hematol_Oncol_2013_Jun_3_6_38.nxml.txt.nlp	23731980	SENT182	9	9	20	20	neratinib	HER-2	PA165291472	2064	0.794
NULL	EPMA_J_2012_Sep_27_3(1)_10.nxml.txt.nlp	23016735	SENT66	25	25	17	17	warfarin	VKORC1	PA451906	79001	0.794
NULL	Cell_Commun_Signal_2010_Jun_24_8_14.nxml.txt.nlp	20576134	SENT50	31	31	27	27	heparin	FGF2	PA449855	2247;2258	0.794
NULL	Ann_Surg_Oncol_2010_Jan_20_17(1)_14-17.nxml.txt.nlp	19841980	SENT78	45	45	34	34	trastuzumab	PI3K	PA451743	5290	0.794
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1676-1682.nxml.txt.nlp	19844234	SENT147	0	0	8	8	lapatinib	PIK3CA	PA152241907	5290	0.794
NULL	J_Infect_Dis_2014_Jun_1_209(11)_1792-1800.nxml.txt.nlp	24357629	SENT31	20	20	23	23	praziquantel	SWA	PA164764583	50618	0.794
NULL	J_Korean_Med_Sci_2008_Aug_25_23(4)_685-690.nxml.txt.nlp	18756058	SENT10	13	13	9	9	olanzapine	ghrelin	PA450688	51738	0.794
NULL	J_Inherit_Metab_Dis_2010_Oct_3_33(5)_625-632.nxml.txt.nlp	20814828	SENT77	13	13	19	19	simvastatin	RhoA	PA451363	387	0.794
NULL	Orphanet_J_Rare_Dis_2007_Jan_4_2_1.nxml.txt.nlp	17204147	SENT135	25	25	18	18	trypsin	SPINK1	PA451806	6690	0.794
NULL	Clin_Ophthalmol_2014_Jun_26_8_1213-1219.nxml.txt.nlp	25061267	SENT62	8	8	0	0	ketorolac	PRK	PA450150	1263	0.794
NULL	Psychiatr_Genet_2013_Aug_28_23(4)_153-162.nxml.txt.nlp	23811784	SENT29	5	5	17	17	olanzapine	5-HT2A	PA450688	3356	0.794
NULL	EJC_Suppl_2013_Sep_5_11(2)_3-22.nxml.txt.nlp	NULL	SENT1063	4	4	17	17	tamoxifen	ATAC	PA451581	6375	0.794
NULL	Protein_Cell_2014_Jul_2_5(7)_544-551.nxml.txt.nlp	24691905	SENT94	17	17	13	13	doxorubicin	p53	PA449412	7157	0.794
NULL	Child_Adolesc_Psychiatry_Ment_Health_2013_Oct_11_7_34.nxml.txt.nlp	24119376	SENT211	24	24	4	4	methylphenidate	NHS	PA450464	4810	0.794
NULL	Neuroscience_2013_Oct_10_250(100)_493-506.nxml.txt.nlp	23892006	SENT632	20	20	8	8	ethanol	ZO-1	PA448073	7082	0.794
NULL	Ann_Lab_Med_2012_Jul_20_32(4)_298-303.nxml.txt.nlp	22779073	SENT86	19	19	37	37	clarithromycin	EMB	PA449028	133418	0.794
NULL	J_Cell_Mol_Med_2014_Oct_11_18(10)_2031-2043.nxml.txt.nlp	25109475	SENT184	29	29	27	27	valsartan	AMPK	PA451848	5563	0.794
NULL	J_Cell_Biol_1998_Aug_10_142(3)_625-633.nxml.txt.nlp	9700154	SENT89	4	4	10	10	estradiol	Raf-1	PA449503	5894	0.794
NULL	Diabetes_2011_Nov_17_60(11)_2928-2938.nxml.txt.nlp	21885868	SENT240	0	0	9	9	curcumin	TLR-4	PA151958596	7099	0.794
NULL	Int_J_Mol_Sci_2014_Sep_5_15(9)_15767-15777.nxml.txt.nlp	25198900	SENT302	7	7	3	3	cisplatin	ABCG2	PA449014	9429	0.794
NULL	J_Cancer_Epidemiol_2012_Apr_12_2012_529357.nxml.txt.nlp	22570656	SENT3	27	27	15	15	aprepitant	HEC	PA164747039	10403	0.794
NULL	Front_Public_Health_2013_Nov_14_1_50.nxml.txt.nlp	24350219	SENT199	15	15	24	24	hydrocortisone	IL-6	PA449905	3569	0.794
NULL	Diabetes_Care_2010_Oct_13_33(10)_2250-2253.nxml.txt.nlp	20628086	SENT112	14	14	6	6	rosiglitazone	DREAM	PA451283	30818	0.794
NULL	Pharm_Pract_(Granada)_2011_Mar_15_Jan-Mar_9(1)_1-10.nxml.txt.nlp	25132883	SENT146	7	7	19	19	warfarin	SPAF	PA451906	166378	0.794
NULL	Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.nxml.txt.nlp	24736980	SENT230	20	20	12	12	rosuvastatin	SLCO1B1	PA134308647	10599	0.794
NULL	Chem_Cent_J_2012_Dec_12_6_155.nxml.txt.nlp	23234331	SENT43	5	5	7	7	methotrexate	CTH	PA450428	1491;23584	0.794
NULL	J_Cancer_Prev_2013_Dec_18(4)_346-350.nxml.txt.nlp	25337564	SENT91	2	2	8	8	mannitol	IL-8	PA450320	3576	0.794
NULL	Arthritis_Res_Ther_2014_Jul_18_16(4)_R153.nxml.txt.nlp	25037855	SENT114	26	26	10	10	adalimumab	CD14	PA10004	929	0.794
NULL	Pharmaceutics_2010_Jul_2_2(3)_275-290.nxml.txt.nlp	NULL	SENT271	7	7	19	19	theophylline	ANOVA	PA451647	4858	0.794
NULL	Evid_Based_Complement_Alternat_Med_2012_May_9_2012_928234.nxml.txt.nlp	22649479	SENT39	0	0	26	26	atorvastatin	SREBP2	PA448500	6721	0.794
NULL	Evid_Based_Complement_Alternat_Med_2013_Dec_16_2013_747240.nxml.txt.nlp	24454513	SENT196	24	24	37	37	ethanol	DBT	PA448073	1629	0.794
NULL	Cancer_Biol_Med_2013_Mar_10(1)_36-42.nxml.txt.nlp	23691443	SENT85	16	16	28	28	fludarabine	CHOP	PA449655	1649	0.794
NULL	Case_Rep_Oncol_Med_2011_Dec_8_2011_805893.nxml.txt.nlp	22606447	SENT47	23	23	17	17	vincristine	CHOP	PA451879	1649	0.794
NULL	Allergy_Asthma_Immunol_Res_2014_Nov_19_6(6)_548-557.nxml.txt.nlp	25374755	SENT85	10	10	18	18	lovastatin	MUC5AC	PA450272	4586	0.794
NULL	Cell_Cycle_2012_Nov_1_11(21)_3917-3918.nxml.txt.nlp	23032263	SENT8	42	42	8	8	etoposide	p38	PA449552	10598;1432;7965	0.794
NULL	Arthritis_Res_Ther_2008_Mar_17_10(2)_R33.nxml.txt.nlp	18346273	SENT180	16	16	13	13	infliximab	HMGB1	PA452639	3146	0.794
NULL	J_Cell_Biol_2004_Jan_19_164(2)_169-174.nxml.txt.nlp	14718521	SENT109	10	10	4	4	dextran	MARCKS	PA449261	4082	0.794
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1063.nxml.txt.nlp	24556678	SENT49	19	19	28	28	thioridazine	Mcl-1	PA451666	4170	0.794
NULL	Br_J_Cancer_2010_Jan_5_102(1)_134-143.nxml.txt.nlp	19920829	SENT184	13	13	7	7	pertuzumab	IL-2		3558	0.794
NULL	Indian_J_Ophthalmol_2011_May-Jun_59(3)_264b-266.nxml.txt.nlp	21586865	SENT14	6	6	11	11	triamcinolone	hole	PA451749	80757	0.794
NULL	Mol_Cancer_2014_Jun_24_13_157.nxml.txt.nlp	24958351	SENT36	8	8	23	23	lapatinib	HER2	PA152241907	2064	0.794
NULL	Int_J_Environ_Res_Public_Health_2012_Aug_3_9(8)_2788-2800.nxml.txt.nlp	23066397	SENT279	25	25	14	14	chlorzoxazone	NQO1	PA448971	1728	0.794
NULL	Adolesc_Health_Med_Ther_2014_Sep_26_5_171-182.nxml.txt.nlp	25298741	SENT209	28	28	1	1	ziprasidone	IMPACT	PA451974	55364	0.794
NULL	Oncotarget_2013_Aug_21_4(9)_1484-1495.nxml.txt.nlp	23986086	SENT166	18	18	6	6	cetuximab	PIK3CA	PA10040	5290	0.794
NULL	Arthritis_Res_Ther_2010_Sep_8_12(5)_R167.nxml.txt.nlp	20825639	SENT180	8	8	11	11	resveratrol	AP-1		2353;3727;2354;3725	0.794
NULL	Arthritis_Res_Ther_2011_Feb_4_13(1)_R14.nxml.txt.nlp	21294864	SENT9	13	13	11	11	indomethacin	IL-17	PA449982	3605	0.794
NULL	Cancers_(Basel)_2014_Feb_26_6(1)_436-458.nxml.txt.nlp	24577242	SENT986	37	37	19	19	cisplatin	c-IAP1	PA449014	329	0.794
NULL	Biologics_2014_Feb_15_8_67-81.nxml.txt.nlp	24600203	SENT162	20	20	5	5	adalimumab	IFN	PA10004	3439	0.794
NULL	Community_Ment_Health_J_2011_Apr_25_47(2)_123-135.nxml.txt.nlp	20658320	SENT366	22	22	3	3	quetiapine	CAGE	PA451201	168400	0.794
NULL	Mol_Cancer_2014_Jul_5_13_165.nxml.txt.nlp	24996221	SENT207	3	3	5	5	docetaxel	HMGB1	PA449383	3146	0.794
NULL	J_Cell_Mol_Med_2013_Jan_11_17(1)_134-146.nxml.txt.nlp	23305490	SENT338	0	0	8	8	lidocaine	TASK	PA450226	3777	0.794
NULL	J_Biol_Chem_2011_Oct_7_286(40)_34998-35006.nxml.txt.nlp	21757733	SENT32	7	7	20	20	lipase	PLIN1	PA450239	5346	0.794
NULL	Pharmaceuticals_(Basel)_2011_Nov_10_4(11)_1488-1502.nxml.txt.nlp	NULL	SENT198	15	15	1	1	trastuzumab	PTEN	PA451743	5728	0.794
NULL	Int_J_Emerg_Med_2010_May_12_3(2)_133-134.nxml.txt.nlp	20606823	SENT18	7	7	9	9	pralidoxime	PAM	PA164744926	5066;23077	0.794
NULL	Int_J_Breast_Cancer_2013_Dec_12_2013_659723.nxml.txt.nlp	24416595	SENT22	19	19	11	11	metformin	LKB1	PA450395	6794	0.794
NULL	Acta_Pharmacol_Sin_2011_Oct_15_32(10)_1303-1308.nxml.txt.nlp	21841812	SENT32	41	41	5	5	losartan	CYP2C9	PA450268	1559	0.794
NULL	J_Oncol_2009_May_6_2009_567486.nxml.txt.nlp	19424511	SENT77	9	9	11	11	panitumumab	KRAS	PA162373091	3845	0.794
NULL	J_Cardiothorac_Surg_2012_Sep_27_7_97.nxml.txt.nlp	23013706	SENT163	29	29	21	21	warfarin	CYP4F2	PA451906	8529	0.794
NULL	Scientifica_(Cairo)_2013_Apr_2_2013_415279.nxml.txt.nlp	24278778	SENT264	22	22	3	3	pentazocine	MC1R	PA164744326	4157	0.794
NULL	Arthritis_Res_Ther_2003_Jul_16_5(5)_R292-R300.nxml.txt.nlp	12932293	SENT34	27	27	33	33	l-glutamine	IL-2	PA10090	3558	0.794
NULL	Behav_Brain_Funct_2012_Jul_10_8_20.nxml.txt.nlp	22559224	SENT190	7	7	3	3	baclofen	ANOVA	PA448533	4858	0.794
NULL	Physiol_Rep_2014_Nov_4_2(11)_e12197.nxml.txt.nlp	25367695	SENT76	23	23	0	0	urea	PCP	PA451831	5547	0.794
NULL	Oncoimmunology_2013_Jan_1_2(1)_e22890.nxml.txt.nlp	23483066	SENT85	5	5	28	28	dacarbazine	IFN	PA449197	3439	0.794
NULL	Int_J_Biol_Sci_2015_Jan_1_11(1)_48-58.nxml.txt.nlp	25552929	SENT196	8	8	36	36	paclitaxel	THBS1	PA450761	7057	0.794
NULL	Mediators_Inflamm_2010_May_18_2010_359732.nxml.txt.nlp	20508722	SENT107	2	2	31	31	hemin	AP-2	PA449849	7020	0.794
NULL	Evid_Based_Complement_Alternat_Med_2013_Nov_5_2013_492976.nxml.txt.nlp	24302966	SENT200	5	5	16	16	ethanol	BAX	PA448073	581	0.794
NULL	Gynecol_Oncol_Case_Rep_2013_Dec_28_8_4-6.nxml.txt.nlp	24567884	SENT38	6	6	3	3	irinotecan	NAC	PA450085	22861	0.794
NULL	FEBS_Open_Bio_2014_Oct_22_4_905-914.nxml.txt.nlp	25383314	SENT14	9	9	24	24	physostigmine	L-FABP	PA450957	2168	0.794
NULL	Clin_Exp_Metastasis_2013_Apr_27_30(4)_447-455.nxml.txt.nlp	23187934	SENT9	12	12	5	5	bevacizumab	HAI	PA130232992	6692;6768	0.794
NULL	Indian_J_Anaesth_2009_Apr_53(2)_193-196.nxml.txt.nlp	20640122	SENT72	15	15	1	1	isoflurane	CO2	PA450106	4513	0.794
NULL	Oncotarget_2014_Mar_13_5(4)_1101-1110.nxml.txt.nlp	24658355	SENT65	12	12	2	2	tamoxifen	MKP-1	PA451581	1843	0.794
NULL	Gut_Pathog_2010_Dec_7_2_17.nxml.txt.nlp	21138594	SENT39	16	16	32	32	chloramphenicol	OTC	PA448927	5009	0.794
NULL	Arthritis_Res_Ther_2006_Apr_12_8(Suppl_1)_S3.nxml.txt.nlp	16820042	SENT132	35	35	25	25	triamcinolone	ACTH	PA451749	5443	0.794
NULL	Arthritis_Res_Ther_2011_Feb_28_13(1)_205.nxml.txt.nlp	21371351	SENT171	34	34	17	17	rituximab	BAFF	PA451261	10673	0.794
NULL	BioDrugs_2014_Aug_18_28(1)_27-39.nxml.txt.nlp	23955284	SENT74	6	6	15	15	geldanamycin	survivin	PA152031327	332	0.794
NULL	Aging_(Albany_NY)_2011_Aug_21_3(8)_716-732.nxml.txt.nlp	21869457	SENT47	1	1	17	17	spermine	PAO	PA164781199	196743;54498	0.794
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT49	26	26	5	5	paclitaxel	CYP1A2	PA450761	1544	0.794
NULL	Am_J_Clin_Dermatol_2013_Feb_14_14(1)_27-47.nxml.txt.nlp	23329078	SENT400	3	3	7	7	pimecrolimus	Bcl-2	PA164783790	596	0.794
NULL	Environ_Health_Perspect_2012_Mar_31_120(3)_332-339.nxml.txt.nlp	22042266	SENT54	6	6	2	2	lipase	FIAF	PA450239	51129	0.794
NULL	Antiviral_Res_2009_May_82(2)_A99-A109.nxml.txt.nlp	19176219	SENT1124	25	25	1	1	zalcitabine	OCT1	PA451950	5451;6580	0.794
NULL	Support_Care_Cancer_2009_Sep_10_17(9)_1187-1193.nxml.txt.nlp	19205754	SENT174	39	39	36	36	aprepitant	NK1	PA164747039	11126	0.794
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Feb_6_69(Pt_3)_o345.nxml.txt.nlp	23476538	SENT63	12	12	23	23	coumarin	C15	PA134521193	51316	0.794
NULL	Front_Aging_Neurosci_2010_May_18_2_16.nxml.txt.nlp	20559464	SENT210	2	2	14	14	sulindac	COX	PA451565	1351	0.794
NULL	Ann_Gen_Psychiatry_2008_Aug_18_7_11.nxml.txt.nlp	18706108	SENT71	23	23	13	13	ethanol	ANOVA	PA448073	4858	0.794
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Jul_20_9_19.nxml.txt.nlp	20646305	SENT64	35	35	27	27	ciprofloxacin	CTX	PA449009	1593	0.794
NULL	Yale_J_Biol_Med_1978_Jan-Feb_51(1)_19-26.nxml.txt.nlp	676348	SENT6	15	15	0	0	nadh	ADP	PA164755085	23038	0.794
NULL	Iran_J_Basic_Med_Sci_2012_Mar-Apr_15(2)_709-718.nxml.txt.nlp	23493500	SENT139	8	8	12	12	indomethacin	spatial	PA449982	219793	0.794
NULL	Breast_Cancer_Res_2004_Oct_6_6(6)_262-268.nxml.txt.nlp	15535857	SENT148	26	26	43	43	tamoxifen	aromatase	PA451581	1588	0.794
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2014_Nov_22_70(Pt_12)_3177-3186.nxml.txt.nlp	25478836	SENT24	17	17	7	7	l-serine	PLP	PA451330	25824;5744	0.794
NULL	Arthritis_Res_Ther_2005_Dec_10_7(1)_R174-R188.nxml.txt.nlp	15642138	SENT252	18	18	12	12	collagenase	IL-4	PA449107	3565	0.794
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT119	11	11	22	22	gefitinib	KRAS	PA131301952	3845	0.794
NULL	Iran_J_Pharm_Res_2014_Autumn_13(4)_1393-1401.nxml.txt.nlp	25587329	SENT103	2	2	7	7	celecoxib	ABCG2	PA448871	9429	0.794
NULL	Biochem_Res_Int_2012_Jun_25_2012_518437.nxml.txt.nlp	22792465	SENT108	31	31	7	7	doxycycline	RGS5	PA449415	8490	0.794
NULL	Eur_J_Nutr_2009_Jun_24_48(4)_229-234.nxml.txt.nlp	19238310	SENT142	14	14	7	7	capsaicin	ghrelin	PA448776	51738	0.794
NULL	Oncol_Rep_2012_Apr_13_27(4)_979-986.nxml.txt.nlp	22179630	SENT51	24	24	14	14	vinorelbine	DDP	PA451881	1678	0.794
NULL	J_Cell_Biol_2001_Mar_19_152(6)_1169-1182.nxml.txt.nlp	11257118	SENT247	20	20	11	11	heparin	TSP-1	PA449855	7057	0.794
NULL	Lab_Invest_2014_May_10_94(5)_503-516.nxml.txt.nlp	24614199	SENT241	13	13	29	29	curcumin	RAGE	PA151958596	177	0.794
NULL	Daru_2011_19(2)_138-144.nxml.txt.nlp	22615650	SENT24	10	10	20	20	heparin	FGF20	PA449855	26281	0.794
NULL	Case_Rep_Gastroenterol_2014_Jun_4_8(2)_199-205.nxml.txt.nlp	25028576	SENT24	17	17	4	4	cyclophosphamide	CHOP	PA449165	1649	0.794
NULL	Clin_Med_Insights_Oncol_2012_Mar_12_6_153-164.nxml.txt.nlp	22550404	SENT28	11	11	9	9	cyclophosphamide	CHOP	PA449165	1649	0.794
NULL	Iran_J_Pharm_Res_2013_Winter_12(Suppl)_37-46.nxml.txt.nlp	24250670	SENT123	0	0	6	6	verapamil	P-gp	PA451868	5243	0.794
NULL	Oncotarget_2012_Nov_16_3(11)_1439-1454.nxml.txt.nlp	23183822	SENT205	25	25	22	22	vinblastine	P-gp	PA451877	5243	0.794
NULL	Eur_J_Nucl_Med_Mol_Imaging_2008_May_22_35(5)_1008-1018.nxml.txt.nlp	18157531	SENT33	19	19	14	14	pertuzumab	HER2		2064	0.794
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT208	5	5	13	13	ranibizumab	VEGFR2	PA164746012	3791	0.794
NULL	Int_J_Mol_Sci_2012_Dec_7_13(12)_16751-16768.nxml.txt.nlp	23222680	SENT357	3	3	15	15	nadh	Spartan	PA164755085	83932	0.794
NULL	Mol_Cancer_2014_Jun_5_13_143.nxml.txt.nlp	24898067	SENT115	11	11	13	13	gefitinib	HER-2	PA131301952	2064	0.794
NULL	Int_J_Endocrinol_2014_Apr_28_2014_751859.nxml.txt.nlp	24872814	SENT57	13	13	32	32	taurine	BAAT	PA451590	570	0.794
NULL	J_Nat_Prod_2014_Apr_25_77(4)_842-847.nxml.txt.nlp	24597776	SENT104	28	28	23	23	phenol	CO2	PA450913	4513	0.794
NULL	Cell_Biol_Int_Rep_(2010)_2012_Jun_21_19(1)_e00017.nxml.txt.nlp	23124518	SENT84	13	13	4	4	etoposide	TRAIL	PA449552	8743	0.794
NULL	Int_J_Surg_Oncol_2011_Aug_8_2011_374012.nxml.txt.nlp	22312502	SENT159	3	3	15	15	tamoxifen	BRCA1	PA451581	672	0.794
NULL	Indian_J_Anaesth_2011_May-Jun_55(3)_271-273.nxml.txt.nlp	21808400	SENT64	21	21	9	9	phenytoin	COX	PA450947	1351	0.794
NULL	Indian_J_Anaesth_2012_Jul-Aug_56(4)_430-431.nxml.txt.nlp	23087482	SENT25	41	41	30	30	heparin	ACT	PA449855	12;11332;9457;641455	0.794
NULL	Oncotarget_2013_Aug_25_4(10)_1647-1661.nxml.txt.nlp	24072592	SENT70	3	3	6	6	staurosporine	S6K1	PA165109623	6198	0.794
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2014_May_23_70(Pt_6)_1517-1527.nxml.txt.nlp	24914963	SENT107	13	13	15	15	l-serine	PLP	PA451330	25824;5744	0.794
NULL	Exp_Diabetes_Res_2012_Sep_27_2012_210821.nxml.txt.nlp	23056035	SENT118	3	3	14	14	metformin	AMPK	PA450395	5563	0.794
NULL	J_Cell_Mol_Med_2014_Dec_9_18(12)_2499-2511.nxml.txt.nlp	24912879	SENT288	9	9	6	6	docetaxel	DACH1	PA449383	1602	0.794
NULL	J_Carcinog_2013_Dec_31_12_22.nxml.txt.nlp	24574860	SENT281	12	12	19	19	cabozantinib	EGFR	PA165906891	1956	0.794
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_315-322.nxml.txt.nlp	20049735	SENT63	19	19	6	6	cisplatin	PTEN	PA449014	5728	0.794
NULL	J_Immunol_Res_2014_May_12_2014_897249.nxml.txt.nlp	24901013	SENT250	11	11	1	1	natalizumab	CD4	PA164747191	920	0.794
NULL	Oncogene_2010_Sep_23_29(38)_5299-5310.nxml.txt.nlp	20622903	SENT101	20	20	4	4	paclitaxel	HMGB1	PA450761	3146	0.794
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Sep_14_67(Pt_10)_o2575.nxml.txt.nlp	22058741	SENT57	28	28	43	43	ethanol	mol	PA448073	90527	0.794
NULL	J_Histochem_Cytochem_2012_Oct_60(10)_749-760.nxml.txt.nlp	22821669	SENT11	4	4	8	8	hyaluronan	TSG-6	PA165958431	7130	0.794
NULL	Mol_Cancer_2012_Dec_12_11_91.nxml.txt.nlp	23234355	SENT172	15	15	8	8	gefitinib	EGFR	PA131301952	1956	0.794
NULL	J_Int_AIDS_Soc_2012_Oct_22_15(Suppl_3)_18439.nxml.txt.nlp	NULL	SENT288	25	25	11	11	fluconazole	CD4	PA449653	920	0.794
NULL	Angiogenesis_2010_Dec_7_13(4)_305-315.nxml.txt.nlp	20927579	SENT32	2	2	12	12	resveratrol	HIF-1		29072	0.794
NULL	Clinics_(Sao_Paulo)_2013_Feb_68(2)_253-262.nxml.txt.nlp	23525324	SENT244	15	15	9	9	genistein	Gen	PA165109660	348654	0.794
NULL	Clin_Dev_Immunol_2011_Dec_5_2011_894704.nxml.txt.nlp	22190975	SENT110	19	19	7	7	cetuximab	KRAS	PA10040	3845	0.794
NULL	Br_J_Pharmacol_2014_Oct_26_171(20)_4785-4796.nxml.txt.nlp	25074741	SENT13	10	10	2	2	guanfacine	NK1R	PA449825	6869	0.794
NULL	J_Gen_Physiol_2012_Oct_140(4)_421-433.nxml.txt.nlp	23008435	SENT366	4	4	30	30	forskolin	Stella	PA146096022	359787	0.794
NULL	Core_Evid_2010_Oct_21_5_61-76.nxml.txt.nlp	21042543	SENT421	20	20	4	4	panitumumab	KRAS	PA162373091	3845	0.794
NULL	Acta_Pharmacol_Sin_2012_Oct_17_33(10)_1301-1310.nxml.txt.nlp	22983390	SENT17	25	25	21	21	cisplatin	migfilin	PA449014	54751	0.794
NULL	J_Cell_Mol_Med_2014_Dec_9_18(12)_2499-2511.nxml.txt.nlp	24912879	SENT239	11	11	8	8	docetaxel	DACH1	PA449383	1602	0.794
NULL	Antimicrob_Agents_Chemother_2014_Nov_10_59(1)_490-497.nxml.txt.nlp	25385107	SENT80	12	12	0	0	lumefantrine	ATV	PA165111722	4683	0.794
NULL	Breast_Cancer_Res_2011_Jan_26_13(1)_R10.nxml.txt.nlp	21269472	SENT225	21	21	30	30	estradiol	PPARGC1B	PA449503	133522	0.794
NULL	Iran_Red_Crescent_Med_J_2013_Mar_5_15(3)_249-253.nxml.txt.nlp	23984007	SENT147	5	5	11	11	oxcarbazepine	B12	PA450732	7126;4709	0.794
NULL	Neural_Dev_2009_Dec_2_4_42.nxml.txt.nlp	19954518	SENT107	28	28	8	8	glutaraldehyde	P18	PA449777	7975;10168	0.794
NULL	Acta_Pharmacol_Sin_2013_Jan_3_34(1)_119-128.nxml.txt.nlp	23202804	SENT129	9	9	7	7	rimonabant	CB1	PA152407999	1268	0.794
NULL	Asian-Australas_J_Anim_Sci_2012_Feb_1_25(2)_207-212.nxml.txt.nlp	25049553	SENT114	20	20	4	4	urea	CO2	PA451831	4513	0.794
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT523	27	27	5	5	olanzapine	PRL	PA450688	5617	0.794
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_21_2012_234987.nxml.txt.nlp	23133491	SENT230	25	25	7	7	ethanol	CD14	PA448073	929	0.794
NULL	Ann_Clin_Microbiol_Antimicrob_2005_Apr_1_4_6.nxml.txt.nlp	15804353	SENT82	13	13	5	5	isoniazid	Met	PA450112	79811	0.794
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT110	26	26	20	20	glucose	EGFR	PA449773	1956	0.794
NULL	Exp_Lung_Res_2013_Oct_1_39(8)_336-348.nxml.txt.nlp	23919450	SENT208	4	4	1	1	thrombin	PAR-1	PA451674	2011;2149	0.794
NULL	Atherosclerosis_2011_Nov_219(1)_109-115.nxml.txt.nlp	21820657	SENT78	14	14	1	1	anacetrapib	CETP	PA165960688	1071	0.794
NULL	Cell_Death_Dis_2014_Jul_3_5(7)_e1316.nxml.txt.nlp	24991768	SENT234	0	0	8	8	pemetrexed	Mcl-1	PA10810	4170	0.794
NULL	EMBO_J_2009_Mar_18_28(6)_663-676.nxml.txt.nlp	19214186	SENT373	14	14	8	8	oxaliplatin	p53	PA131285527	7157	0.794
NULL	Int_J_Surg_Oncol_2011_Aug_22_2011_658767.nxml.txt.nlp	22312516	SENT122	5	5	7	7	erlotinib	EGFR	PA134687924	1956	0.794
NULL	Front_Neurosci_2014_Nov_24_8_380.nxml.txt.nlp	25505380	SENT312	29	29	38	38	estradiol	COMT	PA449503	1312	0.794
NULL	J_Biol_Chem_2013_Feb_8_288(6)_3918-3928.nxml.txt.nlp	23239877	SENT135	24	24	27	27	thrombin	PAR4	PA451674	9002;5074	0.794
NULL	J_Mol_Med_2008_Sep_4_86(9)_1045-1056.nxml.txt.nlp	18600309	SENT176	5	5	14	14	salmeterol	c-fos	PA451300	2353	0.794
NULL	Braz_J_Med_Biol_Res_2012_Mar_9_45(4)_357-365.nxml.txt.nlp	22392189	SENT139	10	10	8	8	capsaicin	TRPV1	PA448776	7442	0.794
NULL	Diabetes_Care_2010_Mar_15_33(3)_608-613.nxml.txt.nlp	20009095	SENT172	12	12	4	4	rosiglitazone	DREAM	PA451283	30818	0.794
NULL	J_Immunol_Res_2014_May_8_2014_565320.nxml.txt.nlp	24901010	SENT80	29	29	26	26	allopurinol	HLA-B	PA448320	3106	0.794
NULL	Biomed_Res_Int_2013_Nov_26_2013_843657.nxml.txt.nlp	24371833	SENT23	8	8	3	3	exenatide	GLP-1	PA164749238	100125288	0.794
NULL	Oncotarget_2011_Dec_22_2(12)_1176-1190.nxml.txt.nlp	22202492	SENT128	13	13	17	17	simvastatin	PLA2G7	PA451363	7941	0.794
NULL	Biomed_Res_Int_2013_Nov_26_2013_843657.nxml.txt.nlp	24371833	SENT230	7	7	5	5	sitagliptin	GLP-1	PA164748978	100125288	0.794
NULL	J_Psychopharmacol_2010_Nov_24(4_supplement_Supplement_editor_Professor_TG_Dinan)_37-50.nxml.txt.nlp	20923919	SENT273	23	23	11	11	olanzapine	CYP1A2	PA450688	1544	0.794
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT299	19	19	12	12	risperidone	PRL	PA451257	5617	0.794
NULL	Breast_Cancer_Res_2012_May_3_14(3)_R71.nxml.txt.nlp	22554015	SENT274	20	20	9	9	trastuzumab	HER2	PA451743	2064	0.794
NULL	Indian_J_Med_Res_2013_Jan_137(1)_203-209.nxml.txt.nlp	23481074	SENT17	20	20	8	8	acenocoumarol	CYP2C9	PA452632	1559	0.794
NULL	J_Inherit_Metab_Dis_2010_Oct_3_33(5)_625-632.nxml.txt.nlp	20814828	SENT74	2	2	8	8	simvastatin	RhoA	PA451363	387	0.794
NULL	J_Hematol_Oncol_2012_Jun_18_5_31.nxml.txt.nlp	22709792	SENT78	0	0	14	14	sunitinib	KIT	PA162372840	3815	0.794
NULL	Adv_Hematol_2009_Jul_7_2009_495863.nxml.txt.nlp	19960059	SENT185	8	8	2	2	letrozole	aromatase	PA450196	1588	0.794
NULL	Eur_J_Immunol_2014_Jun_10_44(6)_1759-1769.nxml.txt.nlp	24595810	SENT29	0	0	11	11	fludrocortisone	CXCR4	PA164743961	7852	0.794
NULL	Acta_Pharmacol_Sin_2010_Mar_22_31(3)_329-340.nxml.txt.nlp	20173759	SENT154	28	28	31	31	ethanol	AMPK	PA448073	5563	0.794
NULL	Eur_J_Med_Res_2010_Apr_8_15(4)_145-151.nxml.txt.nlp	20554495	SENT63	10	10	13	13	abacavir	HLA-B	PA448004	3106	0.794
NULL	Oncotarget_2014_Aug_31_5(19)_9239-9255.nxml.txt.nlp	25238453	SENT58	24	24	20	20	rituximab	EGFR	PA451261	1956	0.794
NULL	EMBO_J_2009_Apr_22_28(8)_1043-1054.nxml.txt.nlp	19300439	SENT116	26	26	24	24	genistein	PP2	PA165109660	4888	0.794
NULL	Breast_Cancer_Res_2007_Mar_2_9(2)_205.nxml.txt.nlp	NULL	SENT29	2	2	12	12	canertinib	EGFR	PA134687925	1956	0.794
NULL	J_Korean_Med_Sci_2010_Sep_14_25(9)_1277-1283.nxml.txt.nlp	20808669	SENT166	2	2	18	18	pamidronate	IFN	PA450767	3439	0.794
NULL	Cancer_Cell_Int_2013_Mar_4_13_21.nxml.txt.nlp	23497288	SENT176	22	22	6	6	doxorubicin	EWS	PA449412	2130	0.794
NULL	Clin_Dev_Immunol_2007_Dec_9_2007_93462.nxml.txt.nlp	18317535	SENT148	8	8	20	20	paraformaldehyde	CD4	PA450790	920	0.794
NULL	Clin_Exp_Reprod_Med_2013_Jun_30_40(2)_67-75.nxml.txt.nlp	23875162	SENT213	5	5	19	19	rosiglitazone	aromatase	PA451283	1588	0.794
NULL	J_Invest_Dermatol_2012_Sep_19_132(9)_2198-2205.nxml.txt.nlp	22513780	SENT48	3	3	8	8	isotretinoin	TLR-4	PA450128	7099	0.794
NULL	EMBO_Mol_Med_2012_Jun_13_4(6)_515-527.nxml.txt.nlp	22416035	SENT83	20	20	13	13	olaparib	p53		7157	0.794
NULL	Breast_Cancer_Res_Treat_2012_Jun_18_133(3)_937-947.nxml.txt.nlp	22094936	SENT186	41	41	13	13	tamoxifen	CCNE1	PA451581	898	0.794
NULL	Adv_Virol_2012_Jul_19_2012_267483.nxml.txt.nlp	22851970	SENT103	20	20	15	15	ribavirin	IFN	PA451241	3439	0.794
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT49	31	31	5	5	coumarin	CYP1A2	PA134521193	1544	0.794
NULL	Aging_(Albany_NY)_2011_Apr_6_3(4)_444-449.nxml.txt.nlp	21483037	SENT66	12	12	1	1	resveratrol	AMPK		5563	0.794
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT194	4	4	10	10	deferoxamine	HIF-1	PA164746490	29072	0.794
NULL	Curr_Neuropharmacol_2013_Jul_11(4)_338-378.nxml.txt.nlp	24381528	SENT582	12	12	19	19	curcumin	c-Jun	PA151958596	3725	0.794
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT266	19	19	6	6	methotrexate	MSH2	PA450428	4436	0.794
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT73	4	4	14	14	atorvastatin	AKT	PA448500	207	0.794
NULL	Cancer_Cell_Int_2013_Jun_26_13_63.nxml.txt.nlp	23800022	SENT12	23	23	13	13	genistein	XIAP	PA165109660	331	0.794
NULL	Pharmaceutics_2012_Jan_31_4(1)_93-103.nxml.txt.nlp	24300182	SENT29	0	0	14	14	amlodipine	API	PA448388	5345	0.794
NULL	Front_Psychol_2013_May_14_4_254.nxml.txt.nlp	23717290	SENT287	5	5	1	1	ondansetron	p50	PA450705	958;4790	0.794
NULL	Cancer_Causes_Control_2013_Aug_18_24(8)_1605-1614.nxml.txt.nlp	23775025	SENT64	33	33	14	14	doxorubicin	CYP2D6	PA449412	1565	0.794
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT185	11	11	6	6	adalimumab	CD36	PA10004	948	0.794
NULL	Cancer_Res_Treat_2013_Dec_31_45(4)_251-262.nxml.txt.nlp	24453997	SENT99	24	24	5	5	cisplatin	ASS1	PA449014	445	0.794
NULL	Cancer_Manag_Res_2014_Jun_20_6_279-289.nxml.txt.nlp	25018651	SENT82	14	14	28	28	tamoxifen	IL-2	PA451581	3558	0.794
NULL	Biologics_2009_Jul_13_3_289-301.nxml.txt.nlp	19707416	SENT187	22	22	29	29	pertuzumab	HER2		2064	0.794
NULL	Acta_Physiol_(Oxf)_2010_Feb_198(2)_143-158.nxml.txt.nlp	19886909	SENT242	0	0	42	42	nifedipine	PES	PA450631	23481	0.794
NULL	Clin_Med_Insights_Arthritis_Musculoskelet_Disord_2012_Mar_5_5_27-42.nxml.txt.nlp	22438671	SENT3	14	14	6	6	tocilizumab	IL-6	PA165292659	3569	0.794
NULL	Crit_Care_2012_Jul_26_16(4)_228.nxml.txt.nlp	22839302	SENT68	31	31	38	38	thrombin	CD40	PA451674	958	0.794
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Mar_26_3(3)_e107.nxml.txt.nlp	24670388	SENT81	10	10	19	19	warfarin	CYP2C9	PA451906	1559	0.794
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1150.nxml.txt.nlp	24675468	SENT103	4	4	31	31	ethanol	adiponectin	PA448073	9370	0.794
NULL	Oncogene_2010_Jun_3_29(22)_3208-3216.nxml.txt.nlp	20383201	SENT105	3	3	28	28	dasatinib	KLK2	PA162372878	3817	0.794
NULL	Biomed_Res_Int_2013_Aug_6_2013_909613.nxml.txt.nlp	24027765	SENT8	17	17	22	22	metronidazole	EEN	PA450484	6455	0.794
NULL	Acta_Pharmacol_Sin_2012_Jan_3_33(1)_49-56.nxml.txt.nlp	22212430	SENT102	4	4	7	7	thrombin	JNK	PA451674	5599	0.794
NULL	Mol_Cancer_2006_Oct_17_5_45.nxml.txt.nlp	17044934	SENT150	8	8	11	11	resveratrol	COX		1351	0.794
NULL	Int_J_Biol_Sci_2014_Jan_20_10(2)_171-180.nxml.txt.nlp	24520215	SENT142	4	4	8	8	cerulenin	L-FABP	PA164764551	2168	0.794
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_91-103.nxml.txt.nlp	17912639	SENT104	6	6	16	16	letrozole	HER2	PA450196	2064	0.794
NULL	Oncogene_2014_Aug_21_33(34)_4316-4329.nxml.txt.nlp	24362530	SENT46	13	13	0	0	epirubicin	FOXM1	PA449476	2305	0.794
NULL	Nat_Commun_2014_Nov_25_5_5548.nxml.txt.nlp	25420520	SENT119	38	38	11	11	cabazitaxel	DTE	PA165958401	199699	0.794
NULL	N_Am_J_Med_Sci_2014_Dec_6(12)_625-632.nxml.txt.nlp	25599050	SENT6	17	17	38	38	telmisartan	STZ	PA451605	6484	0.794
NULL	Cancer_Cell_Int_2013_Feb_12_13_14.nxml.txt.nlp	23402310	SENT33	9	9	12	12	celecoxib	p65	PA448871	5970	0.794
NULL	Nat_Commun_2014_5_3078.nxml.txt.nlp	24452013	SENT283	12	12	5	5	l-lysine	DAZAP1	PA450280	26528	0.794
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT173	12	12	22	22	cisplatin	AMPK	PA449014	5563	0.794
NULL	Br_J_Cancer_1996_May_73(9)_1063-1068.nxml.txt.nlp	8624264	SENT9	3	3	32	32	staurosporine	P-gp	PA165109623	5243	0.794
NULL	Case_Rep_Psychiatry_2013_May_16_2013_136194.nxml.txt.nlp	23762720	SENT13	12	12	10	10	haloperidol	FGA	PA449841	2243	0.794
NULL	Br_J_Clin_Pharmacol_2013_Aug_23_76(2)_299-315.nxml.txt.nlp	23701319	SENT150	5	5	12	12	alemtuzumab	IFN	PA164783958	3439	0.794
NULL	Alcohol_Res_2013_35(1)_25-35.nxml.txt.nlp	24313162	SENT52	2	2	0	0	betaine	BHMT	PA448603	635	0.794
NULL	Gut_Liver_2011_Jun_24_5(2)_160-164.nxml.txt.nlp	21814595	SENT107	39	39	43	43	midazolam	ESD	PA450496	2098	0.794
NULL	Core_Evid_2008_Jun_3(1)_13-30.nxml.txt.nlp	20694081	SENT221	12	12	15	15	vildagliptin	GLP-1	PA165958346	100125288	0.794
NULL	Chin_J_Cancer_2011_May_30(5)_327-335.nxml.txt.nlp	21527065	SENT15	7	7	26	26	capecitabine	PIK3CA	PA448771	5290	0.794
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT394	20	20	23	23	heparin	FGF2	PA449855	2247;2258	0.794
NULL	Front_Neurosci_2014_Jul_1_8_168.nxml.txt.nlp	25018691	SENT592	12	12	3	3	methamphetamine	gamma	PA450403	9913	0.794
NULL	Orphanet_J_Rare_Dis_2007_Jan_4_2_1.nxml.txt.nlp	17204147	SENT89	6	6	32	32	trypsin	SPINK1	PA451806	6690	0.794
NULL	Clin_Interv_Aging_2012_Dec_30_7_1-13.nxml.txt.nlp	22291468	SENT267	18	18	15	15	ketoconazole	CYP3A4	PA450146	1576	0.794
NULL	Clinics_(Sao_Paulo)_2011_Jun_66(6)_1109-1111.nxml.txt.nlp	21808885	SENT31	31	31	19	19	fluorouracil	CO2	PA128406956	4513	0.794
NULL	Acta_Neuropathol_2015_Oct_17_129_81-96.nxml.txt.nlp	25322817	SENT141	24	24	22	22	capsaicin	TRPV1	PA448776	7442	0.794
NULL	Neural_Plast_2007_Dec_11_2007_73079.nxml.txt.nlp	NULL	SENT3377	16	16	5	5	fluoxetine	U87	PA449673	677775;641648	0.794
NULL	Acta_Orthop_2011_Apr_5_82(2)_211-216.nxml.txt.nlp	21434784	SENT22	15	15	3	3	doxorubicin	VIII	PA449412	1351	0.794
NULL	BMJ_Open_2014_Oct_16_4(10)_e005859.nxml.txt.nlp	25324322	SENT116	17	17	21	21	gliclazide	A10	PA10892	28870	0.794
NULL	Acta_Pharmacol_Sin_2012_May_16_33(5)_682-690.nxml.txt.nlp	22504904	SENT234	5	5	14	14	celecoxib	IL-6	PA448871	3569	0.794
NULL	Open_Access_J_Urol_2011_May_10_3_69-82.nxml.txt.nlp	24198638	SENT60	12	12	27	27	midazolam	CYP2C19	PA450496	1557	0.794
NULL	Core_Evid_2010_Oct_21_5_61-76.nxml.txt.nlp	21042543	SENT75	9	9	11	11	irinotecan	IFL	PA450085	3439	0.794
NULL	Br_J_Cancer_1996_Oct_74(7)_1046-1050.nxml.txt.nlp	8855972	SENT11	16	16	8	8	doxorubicin	MDR1	PA449412	5243	0.794
NULL	Cells_2014_Jan_8_3(1)_36-52.nxml.txt.nlp	24501683	SENT206	4	4	9	9	hydrocortisone	HSD2	PA449905	6060	0.794
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Feb_15_5_3.nxml.txt.nlp	16480505	SENT44	17	17	5	5	paclitaxel	CYP3A4	PA450761	1576	0.794
NULL	J_Biol_Chem_2008_Nov_14_283(46)_31679-31689.nxml.txt.nlp	18755684	SENT29	39	39	18	18	iron	FTL	PA450087	2512	0.794
NULL	Front_Oncol_2014_Mar_14_4_52.nxml.txt.nlp	24672773	SENT144	9	9	13	13	rosiglitazone	gamma	PA451283	9913	0.794
NULL	Cell_Death_Differ_2010_Mar_16_17(3)_499-512.nxml.txt.nlp	19834490	SENT118	0	0	21	21	bevacizumab	VEGFR1	PA130232992	2321	0.794
NULL	Front_Neural_Circuits_2009_Aug_20_3_8.nxml.txt.nlp	19738924	SENT194	17	17	11	11	ethanol	PDF	PA448073	64146;9518	0.794
NULL	Pharmaceuticals_(Basel)_2011_Nov_11_4(11)_1503-1517.nxml.txt.nlp	NULL	SENT41	23	23	15	15	capsaicin	TRPV1	PA448776	7442	0.794
NULL	J_Inflamm_(Lond)_2008_May_20_5_6.nxml.txt.nlp	18492254	SENT10	8	8	14	14	heparin	CD16	PA449855	2215;2214	0.794
NULL	Cancers_(Basel)_2011_Aug_15_3(3)_3331-3352.nxml.txt.nlp	24212957	SENT238	18	18	32	32	bevacizumab	CD133	PA130232992	8842	0.794
NULL	Cancers_(Basel)_2010_Sep_9_2(3)_1661-1682.nxml.txt.nlp	24281180	SENT1076	16	16	1	1	collagenase	EMMPRIN	PA449107	682	0.794
NULL	Diabetes_2013_Sep_15_62(9)_3232-3240.nxml.txt.nlp	23835329	SENT160	29	29	2	2	aripiprazole	GLP-1	PA10026	100125288	0.794
NULL	Clin_Interv_Aging_2009_May_14_4_197-205.nxml.txt.nlp	19503782	SENT291	15	15	6	6	cytarabine	MDR1	PA449177	5243	0.794
NULL	Front_Genet_2012_Nov_22_3_249.nxml.txt.nlp	23189085	SENT412	3	3	7	7	vincristine	CYP3A5	PA451879	1577	0.794
NULL	Blood_Cancer_J_2013_Jul_19_3(7)_e128.nxml.txt.nlp	23872707	SENT49	4	4	6	6	cyclophosphamide	CTX	PA449165	1593	0.794
NULL	Pharmaceuticals_(Basel)_2013_Aug_21_6(8)_988-1038.nxml.txt.nlp	24276379	SENT2132	30	30	4	4	irinotecan	UGT1A1	PA450085	54658	0.794
NULL	Cell_Death_Dis_2012_Jun_21_3(6)_e327.nxml.txt.nlp	22717582	SENT218	21	21	37	37	vincristine	p53	PA451879	7157	0.794
NULL	J_Gastrointest_Cancer_2010_Mar_28_41(1)_60-70.nxml.txt.nlp	19946763	SENT316	34	34	12	12	imatinib	ABCG2	PA10804	9429	0.794
NULL	Clin_Psychopharmacol_Neurosci_2011_Apr_30_9(1)_36-43.nxml.txt.nlp	23431025	SENT108	10	10	18	18	aripiprazole	HIP	PA10026	6767;6159;64399;5068	0.794
NULL	Eur_J_Haematol_2014_Feb_25_92(2)_127-136.nxml.txt.nlp	24118452	SENT74	11	11	7	7	anagrelide	CRT	PA164742986	811	0.794
NULL	Br_J_Cancer_1995_May_71(5)_931-936.nxml.txt.nlp	7734315	SENT15	26	26	2	2	daunorubicin	MRK	PA449212	22858	0.794
NULL	Nat_Commun_2014_Dec_8_5_5736.nxml.txt.nlp	25484020	SENT19	12	12	30	30	anastrozole	aromatase	PA448432	1588	0.794
NULL	Clin_Sci_(Lond)_2012_Aug_1_123(Pt_4)_241-249.nxml.txt.nlp	22369073	SENT12	0	0	21	21	donepezil	PI3K	PA449394	5290	0.794
NULL	J_Hematol_Oncol_2013_Jan_17_6_8.nxml.txt.nlp	23327547	SENT80	13	13	19	19	sulindac	p27	PA451565	5715;10534	0.794
NULL	Diabetes_Care_2009_Nov_32(Suppl_2)_S223-S231.nxml.txt.nlp	19875556	SENT79	15	15	11	11	exenatide	GLP-1	PA164749238	100125288	0.794
NULL	Int_J_Mol_Sci_2012_Dec_6_13(12)_16718-16736.nxml.txt.nlp	23222638	SENT160	39	39	26	26	l-glutamine	F12	PA10090	2161	0.794
NULL	Exp_Cell_Res_2013_Apr_1_319(6)_800-809.nxml.txt.nlp	23247073	SENT195	6	6	11	11	curcumin	ITGA5	PA151958596	3678	0.794
NULL	Asia_Pac_Allergy_2012_Jan_31_2(1)_15-25.nxml.txt.nlp	22348203	SENT157	37	37	23	23	theophylline	CD4	PA451647	920	0.794
NULL	Indian_J_Pharm_Sci_2013_Jan-Feb_75(1)_94-98.nxml.txt.nlp	23901167	SENT30	14	14	30	30	bupropion	CYP1A2	PA448687	1544	0.794
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT81	42	42	39	39	trastuzumab	STAT3	PA451743	6774	0.794
NULL	Drugs_R_D_2014_Sep_31_14(3)_177-184.nxml.txt.nlp	25079671	SENT13	8	8	22	22	voglibose	MCP-1	PA164752433	6347	0.794
NULL	Clin_Exp_Gastroenterol_2014_Aug_11_7_261-272.nxml.txt.nlp	25143751	SENT202	9	9	2	2	tocilizumab	IL-6	PA165292659	3569	0.794
NULL	Mol_Cancer_2004_Nov_17_3_31.nxml.txt.nlp	15548330	SENT105	6	6	19	19	etoposide	PC-3	PA449552	692094	0.794
NULL	Exp_Ther_Med_2013_Jul_29_6(1)_33-36.nxml.txt.nlp	23935714	SENT96	10	10	13	13	rituximab	CHOP	PA451261	1649	0.793
NULL	Cardiol_Ther_2013_Jun_26_2(1)_69-84.nxml.txt.nlp	25135290	SENT104	5	5	1	1	paclitaxel	DES	PA450761	1674	0.793
NULL	Front_Physiol_2012_Oct_29_3_409.nxml.txt.nlp	23112775	SENT16	3	3	31	31	forskolin	AMPK	PA146096022	5563	0.793
NULL	Cardiovasc_Diabetol_2013_Jun_7_12_84.nxml.txt.nlp	23759020	SENT165	11	11	7	7	dipyridamole	LSR	PA449367	51599	0.793
NULL	Clin_Med_Insights_Cardiol_2011_Sep_19_5_85-101.nxml.txt.nlp	22084607	SENT184	16	16	23	23	rosiglitazone	CYP2C8	PA451283	1558	0.793
NULL	Ann_Gastroenterol_2013_26(3)_226-232.nxml.txt.nlp	24714278	SENT70	22	22	4	4	clarithromycin	IVD	PA449028	3712	0.793
NULL	Exp_Hematol_2014_Dec_42(12)_1053-1058_e1.nxml.txt.nlp	25127743	SENT17	5	5	18	18	potassium	KCNE2	PA451047	9992	0.793
NULL	J_Cell_Mol_Med_2014_Apr_20_18(4)_709-720.nxml.txt.nlp	24444314	SENT239	19	19	21	21	candesartan	AMPK	PA448765	5563	0.793
NULL	Cell_Commun_Signal_2013_Nov_11_11_86.nxml.txt.nlp	24215724	SENT259	30	30	27	27	thrombin	PAR1	PA451674	79581;2149	0.793
NULL	Front_Aging_Neurosci_2011_May_20_3_7.nxml.txt.nlp	21647396	SENT3440	0	0	10	10	methamphetamine	CA1	PA450403	759	0.793
NULL	Clin_Pharmacokinet_2014_Aug_21_53(10)_931-941.nxml.txt.nlp	25141974	SENT257	18	18	7	7	atorvastatin	CYP3A4	PA448500	1576	0.793
NULL	J_Cell_Mol_Med_2013_Jun_15_17(6)_792-799.nxml.txt.nlp	23672538	SENT64	32	32	20	20	fluorescein	CD24	PA164746009	100133941	0.793
NULL	Ann_Rheum_Dis_2009_Jan_21_68(1)_57-62.nxml.txt.nlp	18292102	SENT204	23	23	8	8	etanercept	HLA-DRB1	PA449515	3123	0.793
NULL	Mol_Cancer_2006_Sep_5_5_34.nxml.txt.nlp	16953886	SENT9	13	13	11	11	doxorubicin	TRAIL	PA449412	8743	0.793
NULL	Clin_Med_Oncol_2008_Apr_1_2_209-219.nxml.txt.nlp	21892281	SENT154	0	0	10	10	doxorubicin	p53	PA449412	7157	0.793
NULL	Int_J_Med_Sci_2014_Jul_29_11(10)_1015-1021.nxml.txt.nlp	25136257	SENT102	4	4	10	10	rosiglitazone	ABCA1	PA451283	19	0.793
NULL	Br_J_Cancer_2002_Jan_21_86(2)_179-184.nxml.txt.nlp	11870502	SENT23	23	23	40	40	dacarbazine	IFN	PA449197	3439	0.793
NULL	Exp_Diabetes_Res_2012_Mar_4_2012_653678.nxml.txt.nlp	22474428	SENT3	38	38	32	32	repaglinide	gamma	PA451234	9913	0.793
NULL	Diabetes_Care_2010_Mar_23_33(3)_485-489.nxml.txt.nlp	20032276	SENT165	15	15	0	0	citalopram	Gen	PA449015	348654	0.793
NULL	Mol_Cancer_2008_Jun_5_7_50.nxml.txt.nlp	18534018	SENT72	26	26	19	19	bortezomib	XIAP	PA10252	331	0.793
NULL	Int_J_Endocrinol_2010_Mar_2_2010_621687.nxml.txt.nlp	20204178	SENT8	26	26	17	17	paricalcitol	PTH	PA450798	5741	0.793
NULL	Arthritis_Res_Ther_2012_Jun_29_14(3)_216.nxml.txt.nlp	22747923	SENT43	3	3	1	1	metformin	AMPK	PA450395	5563	0.793
NULL	Pharm_Methods_2011_Jul-Sep_2(3)_178-183.nxml.txt.nlp	23781452	SENT3	17	17	19	19	lornoxicam	LOR	PA165958395	4014	0.793
NULL	Mol_Biol_Int_2014_Aug_17_2014_287430.nxml.txt.nlp	25197572	SENT183	27	27	12	12	spectinomycin	SOC	PA164781342	91544	0.793
NULL	Curr_Hypertens_Rep_2014_Jan_11_16(2)_416.nxml.txt.nlp	24414230	SENT150	5	5	3	3	olmesartan	C21	PA164742950	79718	0.793
NULL	Exp_Ther_Med_2013_Jan_10_5(1)_11-16.nxml.txt.nlp	23251234	SENT163	16	16	0	0	cetuximab	CNTRL	PA10040	11064	0.793
NULL	Cardiovasc_Res_2012_Dec_1_96(3)_552-560.nxml.txt.nlp	22918977	SENT198	4	4	14	14	hydralazine	JAM-A	PA449894	50848	0.793
NULL	Indian_J_Anaesth_2012_Mar-Apr_56(2)_129-134.nxml.txt.nlp	22701202	SENT116	4	4	14	14	ropivacaine	CEA	PA451271	5670;1087	0.793
NULL	Int_J_Biol_Sci_2011_May_19_7(5)_645-650.nxml.txt.nlp	21647332	SENT11	6	6	0	0	metformin	AMPK	PA450395	5563	0.793
NULL	Sci_Rep_2014_Nov_28_4_7237.nxml.txt.nlp	25429875	SENT110	0	0	11	11	hesperidin	p38	PA449867	10598;1432;7965	0.793
NULL	Brain_2014_Apr_27_137(4)_1145-1155.nxml.txt.nlp	24578545	SENT226	26	26	2	2	citalopram	ANOVA	PA449015	4858	0.793
NULL	Oncotarget_2012_Aug_10_3(8)_744-758.nxml.txt.nlp	22889873	SENT84	14	14	23	23	trastuzumab	IGF1R	PA451743	3480	0.793
NULL	Endocrinol_Metab_(Seoul)_2014_Sep_25_29(3)_379-387.nxml.txt.nlp	25309798	SENT119	8	8	19	19	resveratrol	SIRT1		23411	0.793
NULL	Oxid_Med_Cell_Longev_2013_Dec_5_2013_963520.nxml.txt.nlp	24381719	SENT215	4	4	12	12	telmisartan	BDNF	PA451605	627	0.793
NULL	Cancer_Cell_Int_2010_May_11_10_16.nxml.txt.nlp	20459793	SENT91	5	5	30	30	cisplatin	CDKN1A	PA449014	1026	0.793
NULL	Oncotarget_2012_May_18_3(5)_525-534.nxml.txt.nlp	22619113	SENT49	15	15	8	8	fludarabine	CD40L	PA449655	959	0.793
NULL	J_Cereb_Blood_Flow_Metab_2011_Oct_20_31(10)_2030-2040.nxml.txt.nlp	21505475	SENT207	9	9	7	7	cilostazol	Bcl-2	PA164746334	596	0.793
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT126	19	19	10	10	tenofovir	ABCC2	PA10204	1244	0.793
NULL	Cell_Commun_Signal_2006_Oct_18_4_7.nxml.txt.nlp	17049074	SENT384	10	10	0	0	heparin	EGFR	PA449855	1956	0.793
NULL	Protein_Cell_2015_Jan_9_6(1)_55-67.nxml.txt.nlp	25482408	SENT235	13	13	3	3	l-proline	WT1	PA451125	7490	0.793
NULL	Breast_Cancer_Res_Treat_2014_Jul_20_146(3)_627-636.nxml.txt.nlp	25038878	SENT236	5	5	18	18	tamoxifen	ATAC	PA451581	6375	0.793
NULL	Cardiol_Ther_2013_Jun_26_2(1)_69-84.nxml.txt.nlp	25135290	SENT104	17	17	13	13	everolimus	DES	PA164746311	1674	0.793
NULL	Acta_Crystallogr_Sect_F_Struct_Biol_Cryst_Commun_2011_Aug_16_67(Pt_9)_1070-1077.nxml.txt.nlp	21904052	SENT143	23	23	19	19	pemetrexed	DHFR	PA10810	1719	0.793
NULL	Cancer_Immunol_Immunother_2011_Jun_25_60(6)_793-808.nxml.txt.nlp	21350947	SENT194	24	24	22	22	sorafenib	IFN	PA7000	3439	0.793
NULL	Front_Hum_Neurosci_2009_Oct_20_3_33.nxml.txt.nlp	19876408	SENT715	4	4	10	10	ketamine	gamma	PA450144	9913	0.793
NULL	Breast_Cancer_(Auckl)_2009_Sep_2_3_61-75.nxml.txt.nlp	19809577	SENT95	0	0	13	13	curcumin	p65	PA151958596	5970	0.793
NULL	Cell_Commun_Signal_2009_Feb_26_7(Suppl_1)_A63.nxml.txt.nlp	NULL	SENT20	11	11	4	4	pp2	GRHL3		57822	0.793
NULL	Mol_Cancer_2008_Mar_26_7_27.nxml.txt.nlp	18366759	SENT80	7	7	17	17	etoposide	IGFBP4	PA449552	3487	0.793
NULL	Biomed_Res_Int_2014_Jan_29_2014_458592.nxml.txt.nlp	24592391	SENT33	3	3	15	15	curcumin	HO-1	PA151958596	3162	0.793
NULL	Osteoporos_Int_2010_Oct_18_21(10)_1657-1680.nxml.txt.nlp	20480148	SENT322	28	28	21	21	teriparatide	PTH	PA451620	5741	0.793
NULL	Curr_Mol_Med_2014_Jun_14(5)_603-615.nxml.txt.nlp	24894176	SENT201	27	27	7	7	etoposide	BI-1	PA449552	7009	0.793
NULL	Zoomorphology_2012_Dec_26_131(4)_303-324.nxml.txt.nlp	23144528	SENT64	10	10	23	23	ethanol	CO2	PA448073	4513	0.793
NULL	Br_J_Cancer_2011_Jun_28_105(1)_118-123.nxml.txt.nlp	21654685	SENT156	3	3	20	20	dasatinib	ANOVA	PA162372878	4858	0.793
NULL	Acta_Pharmacol_Sin_2011_May_25_32(5)_664-672.nxml.txt.nlp	21516131	SENT73	6	6	44	44	cytarabine	MS2	PA449177	101	0.793
NULL	Endocrinol_Metab_(Seoul)_2013_Dec_12_28(4)_262-274.nxml.txt.nlp	24396690	SENT156	30	30	2	2	exenatide	GLP-1	PA164749238	100125288	0.793
NULL	Int_J_Biol_Sci_2014_Sep_10_10(9)_1024-1038.nxml.txt.nlp	25285035	SENT338	6	6	43	43	haloperidol	Yes	PA449841	7525	0.793
NULL	Clin_Transl_Allergy_2013_Sep_2_3_29.nxml.txt.nlp	24004581	SENT130	3	3	22	22	omalizumab	IL-4	PA164752253	3565	0.793
NULL	Oncotarget_2012_May_19_3(5)_535-545.nxml.txt.nlp	22619121	SENT62	20	20	8	8	topotecan	MYCN	PA451729	4613	0.793
NULL	Biologics_2012_Apr_11_6_83-87.nxml.txt.nlp	22532776	SENT41	10	10	22	22	fluorescein	CD16	PA164746009	2215;2214	0.793
NULL	J_Neurosci_Rural_Pract_2012_Jan-Apr_3(1)_105-106.nxml.txt.nlp	22346220	SENT14	4	4	18	18	curcumin	p50	PA151958596	958;4790	0.793
NULL	Br_J_Cancer_2010_Jan_19_102(2)_361-368.nxml.txt.nlp	20010949	SENT149	2	2	23	23	doxorubicin	L15	PA449412	6138;91057	0.793
NULL	Int_J_Endocrinol_2013_May_2_2013_501851.nxml.txt.nlp	23737774	SENT106	23	23	25	25	diethylstilbestrol	DES	PA449307	1674	0.793
NULL	Psychiatry_Investig_2012_Jun_30_9(2)_187-190.nxml.txt.nlp	22707971	SENT81	6	6	8	8	capsaicin	POMC	PA448776	5443	0.793
NULL	Acta_Pharmacol_Sin_2011_Jun_3_32(6)_817-823.nxml.txt.nlp	21642950	SENT142	0	0	10	10	propofol	HCN2	PA451141	610	0.793
NULL	Ann_Indian_Acad_Neurol_2013_Apr-Jun_16(2)_208-210.nxml.txt.nlp	23956565	SENT84	22	22	12	12	ephedrine	Dok-7	PA449466	285489	0.793
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT43	6	6	11	11	curcumin	TRAIL	PA151958596	8743	0.793
NULL	Front_Oncol_2014_Sep_23_4_264.nxml.txt.nlp	25295231	SENT105	3	3	27	27	lenalidomide	p53	PA162363968	7157	0.793
NULL	Behav_Brain_Funct_2012_Feb_13_8_9.nxml.txt.nlp	22329956	SENT102	12	12	31	31	gabapentin	PMP22	PA449720	5376;5827	0.793
NULL	Curr_HIV_Res_2014_May_12(3)_174-188.nxml.txt.nlp	24862327	SENT178	17	17	32	32	hemin	HO-1	PA449849	3162	0.793
NULL	Ann_Rheum_Dis_2014_Jun_4_73(6)_1020-1026.nxml.txt.nlp	24595547	SENT161	16	16	30	30	methotrexate	B12	PA450428	7126;4709	0.793
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT143	6	6	41	41	perifosine	DR4	PA165291471	8797	0.793
NULL	Arthritis_Res_Ther_2007_Oct_9_9(5)_R104.nxml.txt.nlp	17925024	SENT28	43	43	28	28	glucosamine	JNK	PA164747613	5599	0.793
NULL	J_Oncol_2012_Sep_26_2012_540791.nxml.txt.nlp	21961001	SENT143	17	17	27	27	sunitinib	CA125	PA162372840	4077;94025	0.793
NULL	Oncotarget_2013_Mar_23_4(3)_463-473.nxml.txt.nlp	23531874	SENT169	24	24	14	14	erlotinib	EGFR	PA134687924	1956	0.793
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT169	12	12	15	15	metformin	HIF-1	PA450395	29072	0.793
NULL	J_Cell_Biol_2002_Oct_14_159(1)_181-189.nxml.txt.nlp	12379807	SENT262	23	23	8	8	fluorescein	CD11b	PA164746009	3684	0.793
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2011_Jun_7_4_29-37.nxml.txt.nlp	22879792	SENT37	8	8	4	4	gemfibrozil	CYP3A4	PA449750	1576	0.793
NULL	J_Biomed_Biotechnol_2002_2(1)_14-21.nxml.txt.nlp	12488595	SENT157	8	8	15	15	lipase	HSL	PA450239	3991	0.793
NULL	Environ_Health_Perspect_2004_Jun_17_112(9)_944-949.nxml.txt.nlp	15198913	SENT104	41	41	18	18	malathion	PCB	PA164748092	5091	0.793
NULL	Eur_J_Clin_Pharmacol_2013_Mar_11_69(3)_327-339.nxml.txt.nlp	22782539	SENT193	5	5	28	28	clopidogrel	IPA	PA449053	3160	0.793
NULL	Springerplus_2015_Jan_23_4_29.nxml.txt.nlp	25628986	SENT63	24	24	12	12	dapsone	G6PD	PA449211	2539	0.793
NULL	Breast_Cancer_Res_2012_Jul_19_14(4)_R109.nxml.txt.nlp	22812567	SENT296	23	23	6	6	gemcitabine	CHK1	PA449748	1111	0.793
NULL	Mar_Drugs_2014_Nov_24_12(11)_5677-5697.nxml.txt.nlp	25421323	SENT617	13	13	7	7	taurine	TNF-alpha	PA451590	7124	0.793
NULL	Cancer_Res_Treat_2013_Sep_30_45(3)_172-177.nxml.txt.nlp	24155675	SENT112	0	0	4	4	aprepitant	NK-1	PA164747039	27087	0.793
NULL	Cell_Death_Dis_2010_Jul_1_1(7)_e51.nxml.txt.nlp	21364656	SENT10	17	17	12	12	gentamicin	survivin	PA449753	332	0.793
NULL	J_Korean_Med_Sci_2006_Feb_20_21(1)_52-57.nxml.txt.nlp	16479065	SENT9	13	13	1	1	capecitabine	LARC	PA448771	6364	0.793
NULL	BMB_Rep_2013_Nov_46(11)_544-549.nxml.txt.nlp	24152910	SENT24	7	7	5	5	thrombin	PAR-1	PA451674	2011;2149	0.793
NULL	Front_Endocrinol_(Lausanne)_2011_Mar_3_2_6.nxml.txt.nlp	21633718	SENT118	4	4	7	7	tetracycline	GPCR	PA451640	151306;165140	0.793
NULL	Curr_Pain_Headache_Rep_2011_Aug_12_15(4)_271-279.nxml.txt.nlp	21479998	SENT100	8	8	14	14	voriconazole	CYP3A4	PA10233	1576	0.793
NULL	Nucleic_Acids_Res_2011_Oct_30_39(18)_7908-7919.nxml.txt.nlp	21724609	SENT396	12	12	23	23	flavopiridol	AIRE	PA452627	326	0.793
NULL	Cancer_Biol_Med_2013_Dec_10(4)_192-205.nxml.txt.nlp	24349829	SENT309	21	21	12	12	cetuximab	NRAS	PA10040	4893	0.793
NULL	Br_J_Cancer_2010_Jun_29_103(1)_6-11.nxml.txt.nlp	20551960	SENT28	28	28	15	15	ifosfamide	ADM	PA449964	133	0.793
NULL	Curr_Control_Trials_Cardiovasc_Med_2001_Feb_2_2(1)_20-23.nxml.txt.nlp	11806769	SENT69	18	18	6	6	bucindolol	BEST	PA165945764	7439	0.793
NULL	Mol_Cancer_2009_Jul_31_8_54.nxml.txt.nlp	19646236	SENT162	27	27	16	16	nadh	GAPDH	PA164755085	2597	0.793
NULL	J_Hematol_Oncol_2010_Mar_23_3_11.nxml.txt.nlp	20331897	SENT161	28	28	38	38	capecitabine	LARC	PA448771	6364	0.793
NULL	Cardiovasc_Diabetol_2005_May_15_4_6.nxml.txt.nlp	15892894	SENT147	10	10	6	6	telmisartan	AT1	PA451605	9197;185	0.793
NULL	Front_Immunol_2012_Jan_12_2_98.nxml.txt.nlp	22566887	SENT2133	0	0	5	5	celecoxib	survivin	PA448871	332	0.793
NULL	Curr_Hepat_Rep_2010_May_21_9(2)_75-90.nxml.txt.nlp	20461127	SENT300	19	19	12	12	tenofovir	LAM	PA10204	7249;7248	0.793
NULL	Front_Chem_2014_Mar_14_2_12.nxml.txt.nlp	24790981	SENT150	23	23	11	11	curcumin	GATA4	PA151958596	2626	0.793
NULL	Lipids_Health_Dis_2011_Jan_18_10_8.nxml.txt.nlp	21241519	SENT33	7	7	28	28	simvastatin	ABCG8	PA451363	64241	0.793
NULL	Front_Bioeng_Biotechnol_2014_Jun_12_2_20.nxml.txt.nlp	25152893	SENT254	18	18	11	11	fluorescein	spatial	PA164746009	219793	0.793
NULL	J_Immunotoxicol_2013_Jan_11_10(1)_75-82.nxml.txt.nlp	22967038	SENT94	5	5	21	21	rituximab	CD4	PA451261	920	0.793
NULL	Br_J_Cancer_2010_Oct_26_103(9)_1331-1334.nxml.txt.nlp	20877352	SENT49	3	3	1	1	trastuzumab	GM-CSF	PA451743	1437	0.793
NULL	Int_J_Mol_Sci_2012_Apr_16_13(4)_4831-4838.nxml.txt.nlp	22606012	SENT177	8	8	19	19	oxaliplatin	EGFR	PA131285527	1956	0.793
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1137-1144.nxml.txt.nlp	20234366	SENT121	10	10	19	19	cetuximab	BRAF	PA10040	673	0.793
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT147	21	21	18	18	doxorubicin	B7-H1	PA449412	29126	0.793
NULL	Ther_Clin_Risk_Manag_2007_Dec_3(6)_1009-1020.nxml.txt.nlp	18516316	SENT139	36	36	1	1	palonosetron	HEC	PA10352	10403	0.793
NULL	J_Korean_Assoc_Oral_Maxillofac_Surg_2014_Dec_26_40(6)_291-296.nxml.txt.nlp	25551094	SENT126	4	4	11	11	alendronate	RANKL	PA448082	8600	0.793
NULL	Int_J_Med_Sci_2014_Jan_11_11(3)_226-233.nxml.txt.nlp	24516345	SENT142	2	2	10	10	dexmedetomidine	IL-6	PA449256	3569	0.793
NULL	Clin_Interv_Aging_2008_Sep_3(3)_503-509.nxml.txt.nlp	18982920	SENT147	7	7	3	3	tolterodine	STAR	PA164746757	6770;2984	0.793
NULL	Cells_2014_Jun_11_3(2)_616-626.nxml.txt.nlp	24921186	SENT231	3	3	12	12	capsaicin	TRPA1	PA448776	8989	0.793
NULL	Indian_J_Pharm_Sci_2014_Mar-Apr_76(2)_166-169.nxml.txt.nlp	24843191	SENT30	10	10	6	6	ethanol	HEC	PA448073	10403	0.793
NULL	Cancer_Microenviron_2013_Jan_22_6(3)_231-240.nxml.txt.nlp	23335094	SENT77	28	28	4	4	simvastatin	PC-3	PA451363	692094	0.793
NULL	Case_Rep_Oncol_2013_Sep_12_6(3)_456-461.nxml.txt.nlp	24163660	SENT75	9	9	14	14	cetuximab	BAX	PA10040	581	0.793
NULL	J_Biol_Chem_2009_Sep_11_284(37)_24965-24971.nxml.txt.nlp	19592485	SENT103	22	22	7	7	forskolin	NKCC2	PA146096022	6557	0.793
NULL	Cells_2013_Oct_11_2(4)_689-714.nxml.txt.nlp	24709876	SENT190	0	0	15	15	buprenorphine	ORL1	PA448685	4987	0.793
NULL	Hum_Genomics_Proteomics_2010_Sep_13_2010_754919.nxml.txt.nlp	20981234	SENT96	32	32	16	16	phenprocoumon	CYP2C9	PA450921	1559	0.793
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT87	21	21	4	4	nutlin-3	FasL		356	0.793
NULL	AIDS_Res_Treat_2011_Jul_25_2011_743597.nxml.txt.nlp	21804938	SENT29	29	29	8	8	zidovudine	CD4	PA451954	920	0.793
NULL	J_Oncol_2012_Aug_9_2012_685213.nxml.txt.nlp	22934113	SENT212	22	22	3	3	ketoconazole	ACTH	PA450146	5443	0.793
NULL	Diabetes_Care_2012_Feb_16_35(2)_327-333.nxml.txt.nlp	22179958	SENT172	13	13	23	23	metformin	B12	PA450395	7126;4709	0.793
NULL	Mol_Cancer_2014_Jun_24_13_157.nxml.txt.nlp	24958351	SENT16	26	26	19	19	lapatinib	HER2	PA152241907	2064	0.793
NULL	Oncotarget_2013_Jul_21_4(8)_1266-1279.nxml.txt.nlp	23907540	SENT167	10	10	17	17	doxycycline	PTEN	PA449415	5728	0.793
NULL	Ulster_Med_J_2008_Jan_77(1)_60-64.nxml.txt.nlp	NULL	SENT30	13	13	9	9	metformin	DPPIV	PA450395	2191;1803	0.793
NULL	J_Immunol_Methods_2012_Oct_31_384(1-2)_92-102.nxml.txt.nlp	22867744	SENT152	16	16	25	25	trypsin	SDS	PA451806	51119;10993	0.793
NULL	Ann_Dermatol_2014_Feb_17_26(1)_1-10.nxml.txt.nlp	24648680	SENT55	5	5	11	11	fluorescein	CD29	PA164746009	3688	0.793
NULL	Trials_2012_Dec_13_13_239.nxml.txt.nlp	23237631	SENT34	26	26	34	34	amiodarone	VKORC1	PA448383	79001	0.793
NULL	Front_Pharmacol_2014_Nov_26_5_258.nxml.txt.nlp	25505415	SENT505	9	9	17	17	zolpidem	CYP3A	PA451976	1574	0.793
NULL	Asian-Australas_J_Anim_Sci_2014_Dec_27(12)_1783-1793.nxml.txt.nlp	25358373	SENT130	23	23	10	10	capsaicin	FABP4	PA448776	2167	0.793
NULL	Acta_Pharmacol_Sin_2011_Nov_10_32(11)_1402-1410.nxml.txt.nlp	21986579	SENT249	13	13	33	33	curcumin	CDK4	PA151958596	1019	0.793
NULL	Int_J_Womens_Health_2014_Aug_11_6_745-757.nxml.txt.nlp	25143757	SENT58	25	25	32	32	estradiol	CEE	PA449503	51608	0.793
NULL	Clin_Exp_Gastroenterol_2013_Aug_5_6_139-148.nxml.txt.nlp	23950655	SENT43	36	36	15	15	thrombin	ADP	PA451674	23038	0.793
NULL	Front_Genet_2013_Aug_29_4_163.nxml.txt.nlp	24009622	SENT49	19	19	7	7	ethanol	ABCG2	PA448073	9429	0.793
NULL	Biomed_Res_Int_2014_Feb_23_2014_297808.nxml.txt.nlp	24707480	SENT154	8	8	18	18	ofloxacin	HA-1	PA450684	23526	0.793
NULL	Mol_Cancer_2007_Oct_11_6_63.nxml.txt.nlp	17931419	SENT77	17	17	8	8	gefitinib	EGFR	PA131301952	1956	0.793
NULL	Case_Rep_Ophthalmol_2011_Dec_13_2(3)_367-375.nxml.txt.nlp	22220161	SENT89	12	12	7	7	infliximab	OCT3	PA452639	5460;6581	0.793
NULL	Cell_Cycle_2013_Sep_15_12(18)_3001-3012.nxml.txt.nlp	23974110	SENT189	20	20	37	37	l-glutamine	CO2	PA10090	4513	0.793
NULL	Mol_Cancer_2009_Jun_23_8_39.nxml.txt.nlp	19549337	SENT215	10	10	7	7	resveratrol	PC-3		692094	0.793
NULL	J_Exp_Med_1996_Jul_1_184(1)_41-50.nxml.txt.nlp	8691148	SENT4	22	22	28	28	heparin	CD31	PA449855	5175	0.793
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT523	25	25	5	5	iloperidone	PRL	PA161199368	5617	0.793
NULL	Br_J_Cancer_2013_Jun_25_108(12)_2485-2494.nxml.txt.nlp	23695022	SENT120	0	0	15	15	propranolol	P-gp	PA451145	5243	0.793
NULL	Breast_Cancer_(Auckl)_2012_Mar_7_6_67-77.nxml.txt.nlp	22438669	SENT85	18	18	38	38	capecitabine	HER2	PA448771	2064	0.793
NULL	J_Hematol_Oncol_2009_Apr_22_2_18.nxml.txt.nlp	19386128	SENT93	18	18	31	31	irinotecan	KRAS	PA450085	3845	0.793
NULL	Oncotarget_2010_Oct_25_1(7)_497-514.nxml.txt.nlp	21165163	SENT322	12	12	33	33	erlotinib	EGFR	PA134687924	1956	0.793
NULL	Oncotarget_2013_Jul_21_4(8)_1253-1265.nxml.txt.nlp	23896512	SENT179	24	24	36	36	erlotinib	EGFR	PA134687924	1956	0.793
NULL	Mol_Pain_2013_Jun_10_9_27.nxml.txt.nlp	23758830	SENT10	4	4	12	12	tetracaine	ASIC3	PA451638	9311	0.793
NULL	Mol_Cancer_2009_Jun_8_8_34.nxml.txt.nlp	19500427	SENT172	6	6	23	23	gemcitabine	MCM10	PA449748	55388	0.793
NULL	Diabetes_Metab_Syndr_Obes_2014_Sep_4_7_401-407.nxml.txt.nlp	25214797	SENT106	27	27	9	9	rosuvastatin	LPO	PA134308647	4025	0.793
NULL	Front_Behav_Neurosci_2012_Nov_9_6_75.nxml.txt.nlp	23162448	SENT621	12	12	8	8	ethanol	mGlu5	PA448073	2915	0.793
NULL	J_Asthma_Allergy_2008_Sep_19_1_19-29.nxml.txt.nlp	21436982	SENT110	43	43	19	19	fexofenadine	RANTES	PA449621	6352	0.793
NULL	Mol_Cancer_2012_Dec_12_11_91.nxml.txt.nlp	23234355	SENT200	4	4	16	16	erlotinib	HER2	PA134687924	2064	0.793
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT8	19	19	3	3	nutlin-3	p53		7157	0.793
NULL	EJNMMI_Res_2011_Jul_29_1_12.nxml.txt.nlp	22214199	SENT170	26	26	38	38	cyclosporine	P-gp	PA449167	5243	0.793
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_29_2013_590393.nxml.txt.nlp	23737838	SENT180	20	20	6	6	resveratrol	Oct4		5460	0.793
NULL	Exp_Ther_Med_2013_Apr_11_5(4)_1147-1152.nxml.txt.nlp	23599738	SENT136	21	21	14	14	fentanyl	OPRM1	PA449599	4988	0.793
NULL	AIDS_2014_Jun_1_28(9)_1333-1339.nxml.txt.nlp	24583670	SENT151	8	8	19	19	zidovudine	CD4	PA451954	920	0.793
NULL	Bioinformation_2012_Jan_6_8(1)_13-19.nxml.txt.nlp	22359429	SENT99	8	8	13	13	curcumin	MRP1	PA151958596	4437	0.793
NULL	Cancers_(Basel)_2011_Apr_18_3(2)_2014-2031.nxml.txt.nlp	24212794	SENT78	0	0	15	15	cetuximab	EGF	PA10040	1950	0.793
NULL	Clin_Psychopharmacol_Neurosci_2012_Aug_31_10(2)_71-77.nxml.txt.nlp	23431082	SENT75	15	15	8	8	risperidone	MEIS2	PA451257	4212	0.793
NULL	Nat_Med_2011_Sep_11_17(10)_1235-1241.nxml.txt.nlp	21909103	SENT126	7	7	11	11	denosumab	RANKL	PA166048634	8600	0.793
NULL	J_Immunother_Cancer_2013_Nov_7_1(Suppl_1)_P88.nxml.txt.nlp	NULL	SENT12	28	28	10	10	bortezomib	Hes1	PA10252	3280	0.793
NULL	Mol_Pain_2012_Sep_22_8_71.nxml.txt.nlp	22998838	SENT164	29	29	9	9	cisplatin	CXCR4	PA449014	7852	0.793
NULL	Clin_Transl_Allergy_2014_Feb_28_4(Suppl_1)_P35.nxml.txt.nlp	25045492	SENT14	0	0	26	26	atorvastatin	CD80	PA448500	941	0.793
NULL	Carcinogenesis_2010_Dec_27_31(12)_2049-2057.nxml.txt.nlp	20876285	SENT234	15	15	10	10	tamoxifen	HER2	PA451581	2064	0.793
NULL	Int_J_Biol_Sci_2011_May_24_7(5)_673-684.nxml.txt.nlp	21647250	SENT202	5	5	1	1	berberine	AMPK	PA165860812	5563	0.793
NULL	J_Gen_Physiol_2003_Mar_121(3)_245-260.nxml.txt.nlp	12601087	SENT10	19	19	23	23	spermine	TRPV6	PA164781199	55503	0.793
NULL	BMB_Rep_2014_Apr_47(4)_221-226.nxml.txt.nlp	24286312	SENT101	4	4	13	13	nutlin-3	p53		7157	0.793
NULL	Ther_Clin_Risk_Manag_2006_Sep_2(3)_235-249.nxml.txt.nlp	18360599	SENT299	7	7	21	21	alendronate	PTH	PA448082	5741	0.793
NULL	Mol_Cancer_2014_Jun_27_13_159.nxml.txt.nlp	24972933	SENT94	15	15	39	39	cladribine	BTK	PA449027	695	0.793
NULL	Indian_J_Anaesth_2013_May-Jun_57(3)_253-258.nxml.txt.nlp	23983283	SENT46	19	19	8	8	glycopyrrolate	NIBP	PA164754882	83696	0.793
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT90	5	5	8	8	perifosine	TRAIL	PA165291471	8743	0.793
NULL	Br_J_Cancer_2010_Jul_13_103(2)_186-195.nxml.txt.nlp	20588277	SENT179	0	0	5	5	nutlin-3	p53		7157	0.793
NULL	An_Bras_Dermatol_2013_Nov-Dec_88(6_Suppl_1)_158-161.nxml.txt.nlp	24346907	SENT50	9	9	3	3	vincristine	CHOP	PA451879	1649	0.793
NULL	Int_J_Biol_Sci_2014_Feb_20_10(3)_268-277.nxml.txt.nlp	24644425	SENT108	5	5	23	23	metformin	AMPK	PA450395	5563	0.793
NULL	Cancers_(Basel)_2012_Oct_26_4(4)_1106-1146.nxml.txt.nlp	24213501	SENT402	10	10	2	2	docetaxel	PC-3	PA449383	692094	0.793
NULL	Arch_Drug_Inf_2008_Jul_1(1)_14-22.nxml.txt.nlp	20157364	SENT14	3	3	33	33	pravastatin	MCP-1	PA451089	6347	0.793
NULL	Cancers_(Basel)_2014_Sep_30_6(4)_2035-2048.nxml.txt.nlp	25271833	SENT23	16	16	6	6	gefitinib	RANTES	PA131301952	6352	0.793
NULL	Acta_Pharmacol_Sin_2009_Aug_13_30(8)_1099-1106.nxml.txt.nlp	19597524	SENT159	31	31	16	16	isoproterenol	p67phox	PA450121	4688	0.793
NULL	Braz_J_Med_Biol_Res_2013_Aug_13_46(8)_650-658.nxml.txt.nlp	23969971	SENT14	26	26	1	1	cisplatin	STAT3	PA449014	6774	0.793
NULL	Clin_Ophthalmol_2009_Jun_2_3_291-295.nxml.txt.nlp	19668581	SENT60	21	21	23	23	latanoprost	BAK	PA164774763	578	0.793
NULL	Cancers_(Basel)_2012_Oct_29_4(4)_1146-1160.nxml.txt.nlp	24213502	SENT246	18	18	21	21	raloxifene	aromatase	PA451221	1588	0.793
NULL	Lipids_Health_Dis_2011_Feb_12_10_31.nxml.txt.nlp	21314960	SENT128	2	2	7	7	hemin	HO-1	PA449849	3162	0.793
NULL	Nucleic_Acids_Res_2012_Jul_30_40(13)_6319-6337.nxml.txt.nlp	22467215	SENT11	10	10	23	23	cisplatin	HER2	PA449014	2064	0.793
NULL	Cardiovasc_Diabetol_2011_Dec_1_10_109.nxml.txt.nlp	22132774	SENT30	12	12	1	1	liraglutide	GLP-1	PA165958364	100125288	0.793
NULL	Int_J_Biol_Sci_2011_May_24_7(5)_673-684.nxml.txt.nlp	21647250	SENT38	7	7	13	13	berberine	AMPK	PA165860812	5563	0.793
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT195	32	32	19	19	verapamil	CYP3A4	PA451868	1576	0.793
NULL	Tob_Induc_Dis_2004_Mar_15_2(1)_1.nxml.txt.nlp	NULL	SENT262	34	34	14	14	oxygen	SP-A	PA450744	653509	0.793
NULL	Indian_J_Psychol_Med_2012_Jul-Sep_34(3)_247-254.nxml.txt.nlp	23439746	SENT78	6	6	8	8	haloperidol	FGA	PA449841	2243	0.793
NULL	Genome_Med_2010_Feb_22_2(2)_13.nxml.txt.nlp	20236491	SENT54	21	21	15	15	irinotecan	TPMT	PA450085	7172	0.793
NULL	J_Signal_Transduct_2011_Jan_5_2011_821615.nxml.txt.nlp	21637381	SENT134	10	10	5	5	estradiol	p38	PA449503	10598;1432;7965	0.793
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Oct_28_65(Pt_11)_o2899.nxml.txt.nlp	21578481	SENT63	6	6	12	12	isoniazid	mol	PA450112	90527	0.793
NULL	Diabetes_Care_2009_Sep_28_32(9)_1649-1655.nxml.txt.nlp	19478198	SENT165	7	7	15	15	saxagliptin	PPG	PA165958362	5552	0.793
NULL	J_Clin_Exp_Pathol_2012_May_17_Suppl_4_7327.nxml.txt.nlp	25379357	SENT192	12	12	15	15	resveratrol	AMPK		5563	0.793
NULL	Cancers_(Basel)_2011_Mar_3_3(1)_1014-1041.nxml.txt.nlp	24212652	SENT586	14	14	4	4	genistein	Bcl-2	PA165109660	596	0.793
NULL	Trials_2014_Sep_7_15(1)_352.nxml.txt.nlp	NULL	SENT6	31	31	23	23	atorvastatin	PMI	PA448500	8834;5373	0.793
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT295	27	27	9	9	chloroquine	BMPR-II	PA448948	659	0.793
NULL	Br_J_Pharmacol_2011_May_163(2)_261-271.nxml.txt.nlp	21054345	SENT251	35	35	6	6	rolipram	GLP-1	PA153906323	100125288	0.793
NULL	Case_Rep_Hematol_2013_Jun_11_2013_680459.nxml.txt.nlp	23840983	SENT104	7	7	1	1	choline	B12	PA448976	7126;4709	0.793
NULL	Ther_Clin_Risk_Manag_2007_Jun_3(3)_363-379.nxml.txt.nlp	18488081	SENT103	10	10	17	17	omeprazole	CYP2C19	PA450704	1557	0.793
NULL	Pharm_Pract_(Granada)_2011_Mar_15_Jan-Mar_9(1)_1-10.nxml.txt.nlp	25132883	SENT161	3	3	13	13	dabigatran	SPAF		166378	0.793
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_May_26_66(Pt_6)_o1471.nxml.txt.nlp	21579539	SENT54	20	20	35	35	ethanol	mol	PA448073	90527	0.793
NULL	J_Mol_Signal_2010_Jun_11_5_6.nxml.txt.nlp	20540776	SENT56	5	5	25	25	etoposide	SSBP2	PA449552	23635	0.793
NULL	Cancer_Cell_Int_2013_Jan_15_13_3.nxml.txt.nlp	23320839	SENT35	4	4	15	15	doxorubicin	MRP3	PA449412	8714	0.793
NULL	Cancer_Cell_Int_2014_Jan_29_14_10.nxml.txt.nlp	24472145	SENT10	23	23	42	42	doxorubicin	HER-2	PA449412	2064	0.793
NULL	Bone_Marrow_Transplant_2011_Jul_11_46(7)_943-949.nxml.txt.nlp	20935680	SENT107	20	20	28	28	plerixafor	CD34	PA165958410	947	0.793
NULL	Evid_Based_Complement_Alternat_Med_2013_Aug_12_2013_982689.nxml.txt.nlp	23997806	SENT232	15	15	3	3	tolbutamide	CYP2C	PA451718	1562	0.793
NULL	Subst_Abuse_Treat_Prev_Policy_2007_Feb_1_2_5.nxml.txt.nlp	17270050	SENT17	28	28	25	25	ribavirin	IFN	PA451241	3439	0.793
NULL	Nat_Med_2010_Nov_24_16(11)_1299-1304.nxml.txt.nlp	20972434	SENT199	3	3	27	27	isoproterenol	ASM	PA450121	6609;283120	0.793
NULL	Eur_J_Histochem_2011_Mar_24_55(1)_e6.nxml.txt.nlp	21556121	SENT133	2	2	7	7	heparin	HRG	PA449855	3084;3273	0.793
NULL	Br_J_Cancer_2010_Mar_16_102(6)_1003-1009.nxml.txt.nlp	20179710	SENT130	8	8	18	18	thiotepa	CYP2B6	PA451668	1555	0.793
NULL	Basic_Res_Cardiol_2014_Oct_31_109(6)_451.nxml.txt.nlp	25358972	SENT7	24	24	2	2	phenylephrine	FHL2	PA450935	2274	0.793
NULL	Oncotarget_2014_Jun_6_5(13)_4945-4958.nxml.txt.nlp	24970814	SENT117	23	23	30	30	cisplatin	PTB	PA449014	58155	0.793
NULL	Indian_J_Endocrinol_Metab_2013_Sep-Oct_17(5)_910-912.nxml.txt.nlp	24083176	SENT43	12	12	18	18	propofol	PTH	PA451141	5741	0.793
NULL	J_Oncol_2013_Feb_17_2013_872957.nxml.txt.nlp	23476648	SENT104	22	22	15	15	cisplatin	SFN	PA449014	25996;2810	0.793
NULL	Mol_Cell_Biochem_2014_Jul_26_396(1-2)_221-228.nxml.txt.nlp	25063218	SENT95	3	3	7	7	resveratrol	EGFR		1956	0.793
NULL	Acta_Pharmacol_Sin_2010_Jul_28_31(7)_867-873.nxml.txt.nlp	20581857	SENT38	10	10	8	8	docetaxel	PC3	PA449383	57332;7832;5122	0.793
NULL	Exp_Brain_Res_2014_Jun_27_232(8)_2637-2644.nxml.txt.nlp	24969614	SENT169	9	9	2	2	palonosetron	NK1	PA10352	11126	0.793
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Sep_30_70(Pt_10)_265-268.nxml.txt.nlp	25484670	SENT61	3	3	24	24	nitrile	mol	PA450636	90527	0.793
NULL	Diabetes_Care_2010_Jul_31_33(7)_1544-1548.nxml.txt.nlp	20357370	SENT18	15	15	8	8	metformin	STK11	PA450395	6794	0.793
NULL	eLife_2013_May_28_2_e00658.nxml.txt.nlp	23741618	SENT71	24	24	19	19	paraformaldehyde	MUC5AC	PA450790	4586	0.793
NULL	Breast_Cancer_Res_2003_Feb_5_5(2)_113-116.nxml.txt.nlp	12631392	SENT103	15	15	23	23	paclitaxel	HER-2	PA450761	2064	0.793
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT1753	10	10	20	20	maraviroc	ATV	PA164768835	4683	0.793
NULL	Braz_J_Med_Biol_Res_2013_Aug_13_46(8)_650-658.nxml.txt.nlp	23969971	SENT180	10	10	3	3	oxaliplatin	STAT3	PA131285527	6774	0.793
NULL	FEBS_Open_Bio_2012_May_11_2_98-102.nxml.txt.nlp	23650587	SENT199	11	11	4	4	ribavirin	IL28B	PA451241	282617	0.793
NULL	J_Lipid_Res_2013_May_54(5)_1410-1420.nxml.txt.nlp	23419260	SENT166	7	7	19	19	tetracycline	IDOL	PA451640	29116	0.793
NULL	Cancers_(Basel)_2010_Aug_18_2(3)_1576-1596.nxml.txt.nlp	24281174	SENT224	18	18	30	30	doxorubicin	Bcl-2	PA449412	596	0.793
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Jul_27_69(Pt_8)_o1344.nxml.txt.nlp	24109411	SENT73	0	0	6	6	flunarizine	mol	PA164776636	90527	0.793
NULL	Breast_Cancer_Res_2012_Feb_21_14(1)_R35.nxml.txt.nlp	22353783	SENT372	20	20	17	17	metformin	AMPK	PA450395	5563	0.793
NULL	Cell_Death_Dis_2014_Jul_3_5(7)_e1311.nxml.txt.nlp	24991763	SENT344	14	14	26	26	ketamine	P15	PA450144	1030;29107	0.793
NULL	Virol_J_2012_Aug_9_9_157.nxml.txt.nlp	22877244	SENT30	33	33	17	17	collagenase	San	PA449107	80218	0.793
NULL	Front_Genet_2012_Oct_26_3_213.nxml.txt.nlp	23112805	SENT478	6	6	2	2	oltipraz	CYP1A2		1544	0.793
NULL	Front_Neurosci_2011_Jan_20_5_3.nxml.txt.nlp	21270945	SENT176	7	7	37	37	ethanol	ANOVA	PA448073	4858	0.793
NULL	Breast_Cancer_Res_2004_May_7_6(4)_R352-R365.nxml.txt.nlp	15217502	SENT229	18	18	26	26	estradiol	CYP1A2	PA449503	1544	0.793
NULL	Vet_Res_2013_Sep_9_44(1)_82.nxml.txt.nlp	24016341	SENT183	25	25	20	20	imiquimod	TLR7	PA449972	51284	0.793
NULL	J_Exp_Clin_Cancer_Res_2009_Oct_7_28(1)_134.nxml.txt.nlp	19811659	SENT89	3	3	31	31	imatinib	NQO2	PA10804	4835	0.793
NULL	Oncol_Rep_2013_Oct_22_30(4)_1535-1541.nxml.txt.nlp	23877481	SENT41	26	26	15	15	panitumumab	EGFR	PA162373091	1956	0.793
NULL	FEBS_Open_Bio_2012_Aug_22_2_279-283.nxml.txt.nlp	23650611	SENT367	6	6	10	10	raloxifene	IFN	PA451221	3439	0.793
NULL	Breast_Cancer_Res_Treat_2014_Dec_19_143(2)_351-358.nxml.txt.nlp	24352574	SENT172	5	5	21	21	vinorelbine	HER-2	PA451881	2064	0.793
NULL	Br_J_Cancer_2012_Aug_7_107(4)_646-651.nxml.txt.nlp	22805323	SENT142	5	5	17	17	denosumab	RANK	PA166048634	8792	0.793
NULL	Environ_Health_Perspect_2006_Aug_10_114(8)_1154-1157.nxml.txt.nlp	16882518	SENT105	6	6	12	12	papain	Gen	PA450778	348654	0.793
NULL	Eur_J_Clin_Pharmacol_2010_Nov_29_66(11)_1131-1136.nxml.txt.nlp	20669013	SENT105	16	16	19	19	voriconazole	CYP2C19	PA10233	1557	0.793
NULL	J_Cardiovasc_Med_(Hagerstown)_2014_Dec_7_15(12)_873-879.nxml.txt.nlp	25304034	SENT107	15	15	6	6	dabigatran	NMA		25805	0.793
NULL	J_Cell_Biol_2002_Sep_16_158(6)_1067-1078.nxml.txt.nlp	12235124	SENT155	23	23	7	7	galactose	TCF4	PA449725	6925	0.793
NULL	Acta_Neuropathol_Commun_2014_Oct_21_2(1)_149.nxml.txt.nlp	NULL	SENT362	6	6	11	11	riluzole	p38	PA451251	10598;1432;7965	0.793
NULL	Depress_Res_Treat_2012_Dec_18_2012_752563.nxml.txt.nlp	23320155	SENT148	1	1	6	6	perifosine	AKT	PA165291471	207	0.793
NULL	Front_Oncol_2014_Sep_16_4_238.nxml.txt.nlp	25279350	SENT196	20	20	33	33	gemcitabine	EGFR	PA449748	1956	0.793
NULL	Case_Rep_Nephrol_Urol_2013_Dec_14_3(2)_139-146.nxml.txt.nlp	24570684	SENT89	5	5	20	20	thrombin	C5a	PA451674	727	0.793
NULL	Patient_Prefer_Adherence_2013_Sep_11_7_891-895.nxml.txt.nlp	24049440	SENT52	32	32	39	39	ritonavir	ART	PA451260	181	0.793
NULL	Emerg_Med_Int_2012_Apr_1_2012_852051.nxml.txt.nlp	22545217	SENT81	20	20	5	5	clonidine	ACLS	PA449051	46;2737	0.793
NULL	Ann_Rheum_Dis_2011_Sep_12_70(11)_2003-2007.nxml.txt.nlp	21914628	SENT106	15	15	8	8	infliximab	ACR	PA452639	49	0.793
NULL	Arthritis_Res_Ther_2010_Jul_6_12(4)_R129.nxml.txt.nlp	20604932	SENT213	31	31	24	24	collagenase	CCL5	PA449107	6352	0.793
NULL	Br_J_Cancer_2003_Mar_10_88(5)_788-795.nxml.txt.nlp	12618891	SENT172	14	14	17	17	bosentan	FasL	PA10034	356	0.793
NULL	Cancer_Immunol_Immunother_2011_Jul_24_60(7)_943-951.nxml.txt.nlp	21431918	SENT168	5	5	19	19	doxorubicin	CD34	PA449412	947	0.793
NULL	Cardiovasc_Diabetol_2013_Oct_17_12_150.nxml.txt.nlp	24134550	SENT142	19	19	30	30	pioglitazone	activin	PA450970	83729	0.793
NULL	Cell_Death_Differ_2010_Apr_16_17(4)_666-676.nxml.txt.nlp	19834494	SENT90	21	21	7	7	oxaliplatin	p53	PA131285527	7157	0.793
NULL	Cancers_(Basel)_2012_Nov_2_4(4)_1161-1179.nxml.txt.nlp	24213503	SENT58	14	14	22	22	sorafenib	FLT3	PA7000	2322	0.793
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1021.nxml.txt.nlp	24457965	SENT261	27	27	17	17	cisplatin	NAC	PA449014	22861	0.793
NULL	Cancer_Cell_Int_2013_Jun_26_13_63.nxml.txt.nlp	23800022	SENT213	12	12	27	27	genistein	NOXA	PA165109660	5366	0.793
NULL	Oxid_Med_Cell_Longev_2012_Jun_3_2012_914273.nxml.txt.nlp	22701758	SENT151	3	3	19	19	resveratrol	IL-6		3569	0.793
NULL	Vet_Res_Forum_2013_Winter_4(1)_19-24.nxml.txt.nlp	25593681	SENT108	6	6	1	1	diclofenac	B12	PA449293	7126;4709	0.793
NULL	Psychol_Res_Behav_Manag_2010_Dec_6_3_109-118.nxml.txt.nlp	22110334	SENT114	32	32	13	13	fluoxetine	CYP2C19	PA449673	1557	0.793
NULL	Case_Rep_Med_2010_Dec_26_2010_403237.nxml.txt.nlp	21209804	SENT16	20	20	14	14	vincristine	CHOP	PA451879	1649	0.793
NULL	Mol_Cancer_2014_Jan_28_13_17.nxml.txt.nlp	24472312	SENT219	5	5	14	14	ponatinib	KIT	PA165980594	3815	0.793
NULL	Clin_Pharmacol_2012_Feb_20_4_13-20.nxml.txt.nlp	22427735	SENT118	21	21	36	36	clopidogrel	PON1	PA449053	5444	0.793
NULL	Br_J_Cancer_2013_Mar_19_108(5)_1079-1091.nxml.txt.nlp	23449353	SENT26	33	33	12	12	docetaxel	MIC-1	PA449383	29919;9518	0.793
NULL	Aging_(Albany_NY)_2011_Dec_12_3(11)_1063-1077.nxml.txt.nlp	22170748	SENT143	2	2	14	14	metformin	p53	PA450395	7157	0.792
NULL	Cancer_Cell_Int_2008_Jan_4_8_1.nxml.txt.nlp	18177496	SENT68	18	18	7	7	gefitinib	EWS	PA131301952	2130	0.792
NULL	Neural_Regen_Res_2014_Mar_1_9(5)_540-548.nxml.txt.nlp	25206852	SENT175	26	26	21	21	choline	HSP27	PA448976	3315	0.792
NULL	J_Clin_Biochem_Nutr_2008_May_29_42(3)_197-203.nxml.txt.nlp	18545641	SENT88	18	18	12	12	curcumin	HO-1	PA151958596	3162	0.792
NULL	Daru_2012_Dec_5_20(1)_87.nxml.txt.nlp	23351503	SENT155	29	29	35	35	isoproterenol	ANOVA	PA450121	4858	0.792
NULL	Eur_J_Histochem_2010_Jun_14_54(2)_e15.nxml.txt.nlp	20558338	SENT158	18	18	25	25	flutamide	PD2	PA449685	54623	0.792
NULL	Cell_Cycle_2013_Nov_15_12(22)_3490-3499.nxml.txt.nlp	24240433	SENT109	22	22	6	6	metformin	FDG	PA450395	23583	0.792
NULL	Indian_J_Dermatol_2012_Nov-Dec_57(6)_449-458.nxml.txt.nlp	23248363	SENT277	6	6	16	16	imiquimod	IFN	PA449972	3439	0.792
NULL	Arch_Med_Sci_2014_Aug_29_10(4)_717-724.nxml.txt.nlp	25276156	SENT148	2	2	5	5	erlotinib	EGFR	PA134687924	1956	0.792
NULL	Neural_Regen_Res_2014_Nov_1_9(21)_1878-1879.nxml.txt.nlp	25558234	SENT50	33	33	23	23	memantine	GluN2B	PA10364	2904	0.792
NULL	Onco_Targets_Ther_2014_Sep_19_7_1631-1639.nxml.txt.nlp	25278770	SENT76	14	14	17	17	docetaxel	BRAF	PA449383	673	0.792
NULL	Cells_2014_Sep_29_3(4)_939-962.nxml.txt.nlp	25268281	SENT233	29	29	11	11	cyclophosphamide	TRPC4	PA449165	7223	0.792
NULL	Mol_Cancer_2006_Oct_17_5_45.nxml.txt.nlp	17044934	SENT100	24	24	35	35	resveratrol	COX		1351	0.792
NULL	Clin_Pharmacol_2013_Apr_19_5_67-83.nxml.txt.nlp	23650452	SENT28	30	30	11	11	ticagrelor	CYP3A5	PA165374673	1577	0.792
NULL	Breast_Cancer_Res_2007_Dec_20_9(Suppl_2)_S22.nxml.txt.nlp	NULL	SENT21	30	30	24	24	fulvestrant	aromatase	PA164747170	1588	0.792
NULL	Oxid_Med_Cell_Longev_2012_Jan_19_2012_390678.nxml.txt.nlp	22315655	SENT93	14	14	4	4	gliclazide	NAC	PA10892	22861	0.792
NULL	Oncotarget_2013_Feb_26_4(2)_298-309.nxml.txt.nlp	23593653	SENT205	9	9	24	24	quinacrine	DNMT1	PA164745551	1786	0.792
NULL	Front_Oncol_2014_Mar_25_4_54.nxml.txt.nlp	24724051	SENT729	15	15	33	33	imatinib	ABCB1	PA10804	5243	0.792
NULL	Oncotarget_2013_Nov_26_4(12)_2502-2511.nxml.txt.nlp	24318446	SENT135	15	15	13	13	doxycycline	PHGDH	PA449415	26227	0.792
NULL	Clin_Epidemiol_2014_May_12_6_155-168.nxml.txt.nlp	24872722	SENT109	4	4	38	38	naproxen	OTC	PA450595	5009	0.792
NULL	Acta_Oncol_2013_May_13_52(4)_776-782.nxml.txt.nlp	23480638	SENT215	3	3	9	9	imatinib	AKT	PA10804	207	0.792
NULL	Springerplus_2013_Jan_11_2_5.nxml.txt.nlp	23520572	SENT123	34	34	44	44	tamoxifen	aromatase	PA451581	1588	0.792
NULL	Oncotarget_2014_Jun_1_5(13)_4868-4880.nxml.txt.nlp	24947902	SENT201	17	17	13	13	afatinib	HER2	PA165981154	2064	0.792
NULL	Nanoscale_Res_Lett_2012_Oct_24_7(1)_589.nxml.txt.nlp	23095345	SENT79	32	32	9	9	zinc	TEM	PA451956	64102	0.792
NULL	Acta_Pharmacol_Sin_2014_Aug_7_35(8)_1015-1022.nxml.txt.nlp	24998256	SENT133	24	24	4	4	ethanol	ALDH2	PA448073	217	0.792
NULL	Mol_Cancer_2013_May_1_12_34.nxml.txt.nlp	23634843	SENT246	17	17	41	41	phenol	CO2	PA450913	4513	0.792
NULL	Hum_Mol_Genet_2014_Apr_15_23(8)_2055-2077.nxml.txt.nlp	24282027	SENT254	24	24	5	5	ethanol	DNM1	PA448073	1759	0.792
NULL	Mucosal_Immunol_2013_May_19_6(3)_474-484.nxml.txt.nlp	22990623	SENT112	10	10	25	25	isoflurane	San	PA450106	80218	0.792
NULL	Arthritis_Res_Ther_2014_Jan_16_16(1)_R12.nxml.txt.nlp	24428870	SENT177	16	16	8	8	methotrexate	survivin	PA450428	332	0.792
NULL	J_Breast_Cancer_2012_Sep_28_15(3)_288-295.nxml.txt.nlp	23091541	SENT163	10	10	7	7	tamoxifen	p53	PA451581	7157	0.792
NULL	Ind_Psychiatry_J_2014_Jan-Jun_23(1)_27-35.nxml.txt.nlp	25535442	SENT109	20	20	3	3	olanzapine	SAPS	PA450688	8935	0.792
NULL	Cancer_Cell_Int_2010_Sep_9_10_32.nxml.txt.nlp	20828393	SENT164	24	24	34	34	cisplatin	p38	PA449014	10598;1432;7965	0.792
NULL	Crit_Care_2009_Jun_23_13(3)_R98.nxml.txt.nlp	19549333	SENT46	37	37	25	25	dobutamine	AVP	PA449381	114548;551	0.792
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_28_2012_937605.nxml.txt.nlp	23304227	SENT133	5	5	13	13	resveratrol	GDNF		2668	0.792
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jun_30_68(Pt_7)_m987-m988.nxml.txt.nlp	22807803	SENT76	26	26	10	10	ethanol	NO3	PA448073	4681	0.792
NULL	Brain_2008_Nov_22_131(11)_3072-3080.nxml.txt.nlp	18945724	SENT165	31	31	14	14	rituximab	AQP4	PA451261	361	0.792
NULL	Cancer_Immunol_Immunother_2012_Jul_23_61(7)_1101-1111.nxml.txt.nlp	22193989	SENT168	26	26	10	10	oxaliplatin	CD86	PA131285527	942	0.792
NULL	J_Biol_Chem_2008_Jun_6_283(23)_16147-16161.nxml.txt.nlp	18381290	SENT250	7	7	19	19	tetracycline	p67	PA451640	945;10988	0.792
NULL	Oncotarget_2014_Jun_30_5(14)_5637-5650.nxml.txt.nlp	25026298	SENT188	7	7	16	16	cisplatin	BRCA1	PA449014	672	0.792
NULL	Oncoscience_2014_Mar_12_1(2)_158-166.nxml.txt.nlp	25594008	SENT24	32	32	20	20	dasatinib	HER2	PA162372878	2064	0.792
NULL	Protein_Cell_2014_Apr_14_5(4)_265-296.nxml.txt.nlp	24622842	SENT63	20	20	36	36	s-adenosylmethionine	DNMT3A	PA164754994	1788	0.792
NULL	Cancer_Med_2012_Aug_15_1(1)_28-38.nxml.txt.nlp	23342251	SENT218	8	8	20	20	trastuzumab	HER2	PA451743	2064	0.792
NULL	Nucl_Recept_Signal_2009_Jan_16_7_e001.nxml.txt.nlp	19240808	SENT412	25	25	8	8	paclitaxel	CYP3A4	PA450761	1576	0.792
NULL	Cancers_(Basel)_2013_Jun_5_5(2)_676-713.nxml.txt.nlp	24216997	SENT2358	0	0	2	2	sorafenib	CD95	PA7000	355	0.792
NULL	Breast_Cancer_Res_2007_Aug_8_9(4)_R50.nxml.txt.nlp	17686159	SENT245	23	23	33	33	gefitinib	HRG	PA131301952	3084;3273	0.792
NULL	Oncotarget_2013_Jun_4_4(5)_772-784.nxml.txt.nlp	23800712	SENT6	38	38	12	12	sirolimus	EGFR	PA451365	1956	0.792
NULL	Int_J_Bipolar_Disord_2013_Jul_4_1_10.nxml.txt.nlp	25505677	SENT88	24	24	33	33	quetiapine	NNT	PA451201	23530	0.792
NULL	Onco_Targets_Ther_2014_Nov_28_7_2183-2195.nxml.txt.nlp	25506223	SENT105	7	7	20	20	doxorubicin	MICA	PA449412	100507436	0.792
NULL	J_Carcinog_2011_Nov_30_10_28.nxml.txt.nlp	22190870	SENT225	13	13	28	28	trastuzumab	DYRK1A	PA451743	1859	0.792
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT43	3	3	7	7	atorvastatin	KRAS	PA448500	3845	0.792
NULL	Pharm_Pract_(Granada)_2011_Mar_15_Jan-Mar_9(1)_1-10.nxml.txt.nlp	25132883	SENT121	28	28	34	34	warfarin	SPAF	PA451906	166378	0.792
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT117	0	0	3	3	metformin	HIF-1	PA450395	29072	0.792
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT256	6	6	12	12	nutlin-3	MDM2		4193	0.792
NULL	Contemp_Oncol_(Pozn)_2013_Apr_29_17(2)_128-133.nxml.txt.nlp	23788978	SENT44	19	19	35	35	oxymorphone	CYP3A4	PA450748	1576	0.792
NULL	Diabetes_Care_2013_Jul_12_36(7)_2126-2132.nxml.txt.nlp	23645884	SENT113	14	14	10	10	liraglutide	GLP-1	PA165958364	100125288	0.792
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT40	15	15	10	10	metformin	EGFR	PA450395	1956	0.792
NULL	Indian_J_Pharm_Sci_2013_Nov-Dec_75(6)_680-687.nxml.txt.nlp	24591743	SENT35	20	20	15	15	gemfibrozil	CYP2C8	PA449750	1558	0.792
NULL	J_Oncol_2010_Aug_24_2010_654348.nxml.txt.nlp	20871846	SENT69	18	18	2	2	tamoxifen	ATAC	PA451581	6375	0.792
NULL	J_Cell_Biol_2002_Mar_4_156(5)_905-919.nxml.txt.nlp	11864993	SENT340	10	10	15	15	phenylephrine	p42	PA450935	5706;23552	0.792
NULL	Cell_Death_Dis_2014_Jul_3_5(7)_e1316.nxml.txt.nlp	24991768	SENT53	16	16	11	11	pemetrexed	ATF3	PA10810	467	0.792
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT148	3	3	9	9	lopinavir	ABCC4	PA450264	10257	0.792
NULL	J_Korean_Med_Sci_2010_Feb_19_25(2)_304-308.nxml.txt.nlp	20119588	SENT35	37	37	46	46	amikacin	EMB	PA164744372	133418	0.792
NULL	Br_J_Cancer_2011_Jun_28_105(1)_1-8.nxml.txt.nlp	21654681	SENT80	9	9	22	22	gefitinib	EGFR	PA131301952	1956	0.792
NULL	Breast_Cancer_Res_2010_Aug_9_12(4)_R62.nxml.txt.nlp	20696059	SENT158	39	39	21	21	trastuzumab	HRG	PA451743	3084;3273	0.792
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT1545	2	2	11	11	paclitaxel	CYP2C8	PA450761	1558	0.792
NULL	Braz_J_Med_Biol_Res_2014_Sep_5_47(11)_929-939.nxml.txt.nlp	25296354	SENT163	43	43	29	29	afatinib	EGFR	PA165981154	1956	0.792
NULL	Biomed_Res_Int_2014_Jan_6_2014_426929.nxml.txt.nlp	24672788	SENT194	6	6	2	2	ethanol	C23	PA448073	4691	0.792
NULL	Cancer_Immunol_Immunother_2008_Oct_20_57(10)_1439-1449.nxml.txt.nlp	18286285	SENT86	15	15	5	5	heparin	IL-21	PA449855	59067;50616;27189	0.792
NULL	Oncotarget_2013_Feb_26_4(2)_298-309.nxml.txt.nlp	23593653	SENT174	15	15	2	2	quinacrine	DNMT1	PA164745551	1786	0.792
NULL	J_Physiol_2009_Feb_15_587(Pt_4)_731-744.nxml.txt.nlp	19074966	SENT189	38	38	6	6	taurine	PAT1	PA451590	10513;206358	0.792
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT178	16	16	19	19	cisplatin	p53	PA449014	7157	0.792
NULL	J_Carcinog_2014_Nov_27_13_13.nxml.txt.nlp	25525412	SENT72	43	43	36	36	cetuximab	KRAS	PA10040	3845	0.792
NULL	Oncol_Rep_2014_Feb_13_31(2)_581-588.nxml.txt.nlp	24337105	SENT152	19	19	16	16	capsaicin	CHOP	PA448776	1649	0.792
NULL	Diabetes_Care_2013_Aug_17_36(Suppl_2)_S292-S300.nxml.txt.nlp	23882062	SENT71	7	7	21	21	metformin	GLP	PA450395	342096	0.792
NULL	Bioanal_Rev_2012_Mar_17_4(1)_1-30.nxml.txt.nlp	22389661	SENT883	2	2	20	20	fluorescein	SERS	PA164746009	6301;54938	0.792
NULL	F1000Res_2013_Jul_9_2_152.nxml.txt.nlp	24555070	SENT42	11	11	18	18	sunitinib	KIT	PA162372840	3815	0.792
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT285	10	10	23	23	gefitinib	PTEN	PA131301952	5728	0.792
NULL	Nat_Med_2011_Aug_28_17(9)_1094-1100.nxml.txt.nlp	21873989	SENT140	17	17	30	30	imatinib	KIT	PA10804	3815	0.792
NULL	Cardiovasc_Ther_2009_27(3)_151-158.nxml.txt.nlp	19604249	SENT6	15	15	11	11	valsartan	AT1	PA451848	9197;185	0.792
NULL	J_Cachexia_Sarcopenia_Muscle_2010_Dec_17_1(2)_159-167.nxml.txt.nlp	21475701	SENT46	19	19	4	4	lipase	ghrelin	PA450239	51738	0.792
NULL	Blood_Cancer_J_2013_Oct_18_3(10)_e153.nxml.txt.nlp	24141622	SENT89	21	21	17	17	fludarabine	XIAP	PA449655	331	0.792
NULL	Oxid_Med_Cell_Longev_2013_Jun_2_2013_793525.nxml.txt.nlp	23819014	SENT137	1	1	16	16	resveratrol	SGBS		2719	0.792
NULL	Cell_Death_Dis_2014_Apr_17_5(4)_e1182.nxml.txt.nlp	24743737	SENT71	13	13	11	11	capsaicin	TRPV1	PA448776	7442	0.792
NULL	Mol_Cancer_2012_Apr_26_11_26.nxml.txt.nlp	22537224	SENT13	5	5	36	36	bortezomib	FANCF	PA10252	2188	0.792
NULL	Mol_Biol_Cell_2014_Apr_1_25(7)_965-976.nxml.txt.nlp	24478450	SENT154	45	45	28	28	chloramphenicol	COX	PA448927	1351	0.792
NULL	Child_Adolesc_Psychiatry_Ment_Health_2013_Jun_19_7_19.nxml.txt.nlp	23777626	SENT135	42	42	12	12	atomoxetine	ATX	PA134688071	5168;23049	0.792
NULL	J_Adv_Pharm_Technol_Res_2012_Jul-Sep_3(3)_160-170.nxml.txt.nlp	23057002	SENT15	0	0	43	43	pioglitazone	gamma	PA450970	9913	0.792
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT1602	16	16	6	6	nelfinavir	ABCC2	PA450606	1244	0.792
NULL	AIDS_Res_Ther_2013_May_1_10_10.nxml.txt.nlp	23634877	SENT126	38	38	25	25	atorvastatin	CXCR4	PA448500	7852	0.792
NULL	Cancers_(Basel)_2010_Nov_29_2(4)_2026-2043.nxml.txt.nlp	24281216	SENT35	12	12	4	4	gemcitabine	p53	PA449748	7157	0.792
NULL	J_Thromb_Haemost_2007_May_5(5)_1010-1018.nxml.txt.nlp	17355572	SENT281	38	38	12	12	thrombin	VWF	PA451674	7450	0.792
NULL	Evid_Based_Complement_Alternat_Med_2011_Mar_13_2011_913898.nxml.txt.nlp	21785639	SENT200	11	11	19	19	curcumin	SULT	PA151958596	6816	0.792
NULL	Indian_J_Nephrol_2014_Mar-Apr_24(2)_124-126.nxml.txt.nlp	24701048	SENT25	18	18	10	10	methylprednisolone	ACR	PA450466	49	0.792
NULL	Mol_Cancer_2010_Nov_8_9_291.nxml.txt.nlp	21059223	SENT7	16	16	7	7	paclitaxel	ZNF217	PA450761	7764	0.792
NULL	Indian_J_Pharmacol_2008_Nov-Dec_40(6)_251-255.nxml.txt.nlp	21279180	SENT122	7	7	0	0	ciprofloxacin	ACT	PA449009	12;11332;9457;641455	0.792
NULL	Small_GTPases_2012_Apr_1_3(2)_97-101.nxml.txt.nlp	22790196	SENT67	25	25	19	19	tamoxifen	TC21	PA451581	22800	0.792
NULL	Atherosclerosis_2011_Nov_219(1)_109-115.nxml.txt.nlp	21820657	SENT183	5	5	13	13	probucol	CETP	PA451107	1071	0.792
NULL	Sensors_(Basel)_2013_Dec_27_14(1)_458-467.nxml.txt.nlp	24379050	SENT74	12	12	21	21	glucose	TLS	PA449773	2521	0.792
NULL	Front_Genet_2014_Jul_25_5_242.nxml.txt.nlp	25120559	SENT102	21	21	2	2	bortezomib	IRE1	PA10252	2081	0.792
NULL	Viruses_2009_Dec_11_1(3)_1209-1239.nxml.txt.nlp	21994591	SENT119	4	4	6	6	atazanavir	ATV	PA10251	4683	0.792
NULL	Breast_Cancer_Res_2004_Jun_29_6(5)_R488-R498.nxml.txt.nlp	15318931	SENT155	7	7	16	16	estradiol	UGT2B7	PA449503	7364	0.792
NULL	Br_J_Cancer_2011_Apr_12_104(8)_1256-1261.nxml.txt.nlp	21448165	SENT26	10	10	12	12	sorafenib	IL-2	PA7000	3558	0.792
NULL	J_Headache_Pain_2011_Aug_29_12(4)_411-417.nxml.txt.nlp	21626018	SENT116	1	1	17	17	sumatriptan	c-fos	PA451566	2353	0.792
NULL	Glycobiology_2013_Jul_18_23(7)_853-864.nxml.txt.nlp	23507965	SENT130	15	15	27	27	galactose	MGL	PA449725	11343	0.792
NULL	Cardiovasc_Diabetol_2013_May_4_12_73.nxml.txt.nlp	23642288	SENT115	16	16	6	6	acarbose	GLP-1	PA448010	100125288	0.792
NULL	Mol_Cancer_2010_Nov_8_9_291.nxml.txt.nlp	21059223	SENT190	14	14	7	7	paclitaxel	ZNF217	PA450761	7764	0.792
NULL	Oncol_Lett_2013_Oct_26_6(4)_1063-1067.nxml.txt.nlp	24137465	SENT96	11	11	6	6	lapatinib	HER2	PA152241907	2064	0.792
NULL	Cancer_Immunol_Immunother_2012_Jul_23_61(7)_1101-1111.nxml.txt.nlp	22193989	SENT168	26	26	12	12	oxaliplatin	PD-L1	PA131285527	29126	0.792
NULL	J_Gynecol_Oncol_2012_Jan_9_23(1)_53-64.nxml.txt.nlp	22355468	SENT69	11	11	24	24	olaparib	BRCA1		672	0.792
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_3_2012_908562.nxml.txt.nlp	23082087	SENT149	0	0	17	17	hesperidin	IL-4	PA449867	3565	0.792
NULL	J_Korean_Med_Sci_2007_Feb_28_22(1)_26-29.nxml.txt.nlp	17297247	SENT21	35	35	24	24	pyrazinamide	DST	PA451182	667	0.792
NULL	Indian_J_Pharm_Sci_2014_Jan-Feb_76(1)_62-71.nxml.txt.nlp	24799740	SENT33	5	5	8	8	nevirapine	BCS	PA450616	617	0.792
NULL	EPMA_J_2012_Sep_27_3(1)_10.nxml.txt.nlp	23016735	SENT288	8	8	4	4	warfarin	GGCX	PA451906	2677	0.792
NULL	J_Mol_Signal_2008_Dec_1_3_18.nxml.txt.nlp	19046439	SENT32	2	2	10	10	metformin	LKB1	PA450395	6794	0.792
NULL	Mol_Cell_Biochem_2014_Oct_9_385(1-2)_265-275.nxml.txt.nlp	24104452	SENT232	13	13	27	27	bortezomib	U87	PA10252	677775;641648	0.792
NULL	Int_J_Endocrinol_2014_Mar_11_2014_927317.nxml.txt.nlp	24738001	SENT80	5	5	2	2	liraglutide	GLP-1	PA165958364	100125288	0.792
NULL	Aging_(Albany_NY)_2009_Jun_3_1(6)_515-528.nxml.txt.nlp	20157535	SENT99	30	30	16	16	resveratrol	SIRT1		23411	0.792
NULL	Aging_(Albany_NY)_2013_Feb_21_5(2)_94-95.nxml.txt.nlp	23518473	SENT21	2	2	4	4	resveratrol	SIRT1		23411	0.792
NULL	Mol_Med_Rep_2015_Jan_20_11(1)_37-42.nxml.txt.nlp	25333459	SENT3	17	17	24	24	tacrolimus	IL-15	PA451578	3600	0.792
NULL	Autoimmune_Dis_2013_Nov_5_2013_716813.nxml.txt.nlp	24294521	SENT85	16	16	6	6	semaxanib	VEGFR	PA131887911	3791	0.792
NULL	Cancers_(Basel)_2010_Jan_14_2(1)_1-19.nxml.txt.nlp	24281029	SENT1081	14	14	27	27	cisplatin	San	PA449014	80218	0.792
NULL	Case_Rep_Ophthalmol_2011_Jan_7_2(1)_5-9.nxml.txt.nlp	21532994	SENT40	37	37	34	34	ribavirin	IFN	PA451241	3439	0.792
NULL	Asian_Spine_J_2013_Sep_4_7(3)_196-203.nxml.txt.nlp	24066215	SENT43	34	34	22	22	cefuroxime	I-1	PA448868	11188	0.792
NULL	Infect_Dis_Ther_2014_Dec_24_3(2)_83-102.nxml.txt.nlp	25134686	SENT222	16	16	29	29	rifampin	CYP3A4	PA451250	1576	0.792
NULL	Breast_Cancer_Res_2013_Oct_31_15(5)_R102.nxml.txt.nlp	24176089	SENT329	17	17	8	8	vincristine	GSTP1	PA451879	2950	0.792
NULL	Amino_Acids_2012_Oct_10_43(4)_1751-1759.nxml.txt.nlp	22407485	SENT104	31	31	4	4	carrageenan	ghrelin	PA448814	51738	0.792
NULL	Cancer_Imaging_2010_Jul_6_10(1)_137-143.nxml.txt.nlp	20605762	SENT111	26	26	21	21	gefitinib	FDG	PA131301952	23583	0.792
NULL	Croat_Med_J_2011_Feb_52(1)_41-47.nxml.txt.nlp	21328719	SENT145	25	25	1	1	olanzapine	Gen	PA450688	348654	0.792
NULL	Psychol_Res_Behav_Manag_2010_Dec_6_3_109-118.nxml.txt.nlp	22110334	SENT114	32	32	15	15	fluoxetine	CYP2C9	PA449673	1559	0.792
NULL	J_Thorac_Oncol_2015_Jan_29_10(1)_156-163.nxml.txt.nlp	25247337	SENT263	6	6	28	28	afatinib	BSC	PA165981154	6558	0.792
NULL	Hum_Mol_Genet_2013_Nov_15_22(22)_4616-4626.nxml.txt.nlp	23814041	SENT175	11	11	9	9	simvastatin	neuroserpin	PA451363	5274	0.792
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT112	19	19	13	13	glucose	EGFR	PA449773	1956	0.792
NULL	Acta_Pharmacol_Sin_2014_Jun_4_35(6)_752-757.nxml.txt.nlp	24902786	SENT88	3	3	16	16	letrozole	STL2	PA450196	1301	0.792
NULL	Biomed_Res_Int_2014_Apr_28_2014_549742.nxml.txt.nlp	24877113	SENT137	34	34	22	22	bevacizumab	BMP4	PA130232992	652	0.792
NULL	J_Vet_Med_Sci_2014_Jun_15_76(6)_813-817.nxml.txt.nlp	24531829	SENT115	5	5	20	20	doxycycline	DPT	PA449415	1805	0.792
NULL	Exp_Mol_Med_2012_Sep_30_44(9)_536-544.nxml.txt.nlp	22771771	SENT7	16	16	11	11	ns-398	COX		1351	0.792
NULL	J_Exp_Med_2000_Mar_6_191(5)_859-870.nxml.txt.nlp	10704466	SENT701	20	20	12	12	neomycin	p38	PA450608	10598;1432;7965	0.792
NULL	Clin_Cosmet_Investig_Dermatol_2010_Sep_17_3_119-126.nxml.txt.nlp	21437066	SENT66	0	0	24	24	diclofenac	COX	PA449293	1351	0.792
NULL	J_Hematol_Oncol_2009_Apr_22_2_18.nxml.txt.nlp	19386128	SENT67	7	7	0	0	panitumumab	KRAS	PA162373091	3845	0.792
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Mar_23_69(Pt_4)_o558-o559.nxml.txt.nlp	23634097	SENT83	16	16	31	31	vanillin	mol	PA451852	90527	0.792
NULL	Biochemistry_2008_Aug_19_47(33)_8689-8696.nxml.txt.nlp	18642884	SENT87	16	16	27	27	nadh	GMP	PA164755085	22978	0.792
NULL	Indian_J_Ophthalmol_2007_Nov-Dec_55(6)_417-420.nxml.txt.nlp	17951896	SENT24	0	0	8	8	bevacizumab	VEGF-A	PA130232992	7422	0.792
NULL	Diabetes_2009_Mar_58(3)_641-651.nxml.txt.nlp	19073764	SENT154	29	29	18	18	forskolin	CD4	PA146096022	920	0.792
NULL	Breast_Cancer_Res_2010_Apr_16_12(2)_R24.nxml.txt.nlp	20398352	SENT151	18	18	7	7	anastrozole	ATAC	PA448432	6375	0.792
NULL	Biomed_Res_Int_2013_May_27_2013_597282.nxml.txt.nlp	23781504	SENT120	38	38	15	15	nadh	SDH	PA164755085	1757;10993	0.792
NULL	EJC_Suppl_2013_Sep_5_11(2)_3-22.nxml.txt.nlp	NULL	SENT1021	0	0	24	24	anastrozole	ATAC	PA448432	6375	0.792
NULL	Diabetes_2011_Jul_20_60(7)_1990-1999.nxml.txt.nlp	21617181	SENT200	29	29	13	13	rosiglitazone	SOCS3	PA451283	9021	0.792
NULL	Endocr_Connect_2012_Jun_8_1(1)_1-12.nxml.txt.nlp	23781298	SENT129	11	11	4	4	fenofibrate	adiponectin	PA449594	9370	0.792
NULL	Osteopath_Med_Prim_Care_2010_Aug_11_4_5.nxml.txt.nlp	20701768	SENT56	27	27	8	8	clopidogrel	ACE	PA449053	1636	0.792
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Sep_30_67(Pt_10)_o2811.nxml.txt.nlp	22065696	SENT63	22	22	28	28	piperazine	mol	PA450977	90527	0.792
NULL	Breast_Cancer_Res_2001_Oct_1_3(6)_361-364.nxml.txt.nlp	11737886	SENT27	30	30	43	43	methotrexate	HER-2	PA450428	2064	0.792
NULL	Neuropsychopharmacology_2009_Jul_25_34(8)_1968-1978.nxml.txt.nlp	19322168	SENT238	2	2	7	7	clozapine	PI3K	PA449061	5290	0.792
NULL	Arthritis_Res_Ther_2005_Feb_21_7(3)_R439-R444.nxml.txt.nlp	15899030	SENT152	41	41	34	34	infliximab	TP1	PA452639	7011	0.792
NULL	Mol_Cancer_2010_Aug_20_9_220.nxml.txt.nlp	20727180	SENT223	15	15	8	8	nicotine	p53	PA450626	7157	0.792
NULL	Pharmaceuticals_(Basel)_2013_Aug_6_6(8)_929-959.nxml.txt.nlp	24276377	SENT102	26	26	3	3	oxaliplatin	CXCR2	PA131285527	3579	0.792
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT80	3	3	21	21	cetuximab	KRAS	PA10040	3845	0.792
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT281	4	4	0	0	vinblastine	MVP	PA451877	9961	0.792
NULL	Cell_Death_Dis_2014_Mar_13_5(3)_e1126.nxml.txt.nlp	24625985	SENT62	11	11	4	4	bortezomib	URI	PA10252	8725	0.792
NULL	Indian_Dermatol_Online_J_2013_Oct-Dec_4(4)_365-368.nxml.txt.nlp	24350028	SENT76	27	27	11	11	erythromycin	P-gp	PA449493	5243	0.792
NULL	Aging_(Albany_NY)_2009_Sep_25_1(10)_845-854.nxml.txt.nlp	20157557	SENT161	15	15	12	12	doxorubicin	p53	PA449412	7157	0.792
NULL	J_Exp_Clin_Cancer_Res_2009_Nov_3_28(1)_141.nxml.txt.nlp	19883517	SENT42	0	0	16	16	fluorescein	CD105	PA164746009	2022	0.792
NULL	Clin_Pharmacokinet_2014_Sep_3_53(1)_1-16.nxml.txt.nlp	23999929	SENT284	11	11	20	20	fluconazole	CYP3A4	PA449653	1576	0.792
NULL	Br_J_Pharmacol_2008_Dec_25_155(7)_1056-1065.nxml.txt.nlp	18724386	SENT254	28	28	26	26	nitrendipine	GLP-1	PA146096020	100125288	0.792
NULL	Arthritis_Res_Ther_2013_Nov_1_15(6)_R176.nxml.txt.nlp	24456929	SENT264	3	3	12	12	colchicine	MSU	PA449092	593	0.792
NULL	Arthritis_Res_Ther_2007_May_30_9(3)_212.nxml.txt.nlp	17561993	SENT116	27	27	25	25	capsaicin	TRPV1	PA448776	7442	0.792
NULL	Alzheimers_Res_Ther_2013_Jan_3_5(1)_2.nxml.txt.nlp	23286718	SENT79	20	20	5	5	galantamine	ANOVA	PA449726	4858	0.792
NULL	J_Cell_Biol_2002_Jun_24_157(7)_1151-1160.nxml.txt.nlp	12082077	SENT170	0	0	18	18	trypsin	COX	PA451806	1351	0.792
NULL	Mol_Biol_Evol_2008_Sep_8_25(9)_2031-2041.nxml.txt.nlp	18614525	SENT78	12	12	25	25	ampicillin	mol	PA448419	90527	0.792
NULL	Cancer_Microenviron_2008_Dec_19_1(1)_85-91.nxml.txt.nlp	19308687	SENT123	9	9	0	0	collagenase	IL-8	PA449107	3576	0.792
NULL	Algorithms_Mol_Biol_2010_Jul_15_5_29.nxml.txt.nlp	20633297	SENT239	5	5	11	11	sildenafil	PDE4B	PA451346	5142	0.792
NULL	Arch_Toxicol_2011_Feb_12_85(2)_79-117.nxml.txt.nlp	21225242	SENT519	12	12	25	25	trastuzumab	HER-2	PA451743	2064	0.792
NULL	Cancer_Immunol_Immunother_2011_Jan_21_60(1)_75-85.nxml.txt.nlp	20857100	SENT45	23	23	10	10	fludarabine	CO2	PA449655	4513	0.792
NULL	Biologics_2009_Sep_15_3_419-428.nxml.txt.nlp	19774209	SENT150	25	25	36	36	gemcitabine	IGF1R	PA449748	3480	0.792
NULL	J_Biomed_Biotechnol_2010_Mar_2_2010_793843.nxml.txt.nlp	20204133	SENT25	6	6	25	25	trypsin	PAR-1	PA451806	2011;2149	0.792
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_7_2013_219472.nxml.txt.nlp	23662119	SENT29	9	9	32	32	cisplatin	HER2	PA449014	2064	0.792
NULL	Behav_Brain_Funct_2009_Jun_4_5_23.nxml.txt.nlp	19497110	SENT76	17	17	23	23	ethanol	P15	PA448073	1030;29107	0.792
NULL	Brain_Sci_2014_May_6_4(2)_356-375.nxml.txt.nlp	24961766	SENT224	33	33	15	15	propofol	CA1	PA451141	759	0.792
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT236	40	40	35	35	metformin	LKB1	PA450395	6794	0.792
NULL	Pharmaceuticals_(Basel)_2013_Aug_21_6(8)_988-1038.nxml.txt.nlp	24276379	SENT1222	20	20	2	2	leucovorin	p53	PA450198	7157	0.792
NULL	Cancer_Cell_Int_2005_Aug_23_5_27.nxml.txt.nlp	16117829	SENT8	23	23	17	17	doxycycline	p53	PA449415	7157	0.792
NULL	Oncoimmunology_2012_Jul_1_1(4)_569-571.nxml.txt.nlp	22754790	SENT37	13	13	10	10	gemcitabine	CXCR2	PA449748	3579	0.792
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1063.nxml.txt.nlp	24556678	SENT44	1	1	28	28	thioridazine	Mcl-1	PA451666	4170	0.792
NULL	Oncogene_2014_May_1_33(18)_2307-2316.nxml.txt.nlp	23686305	SENT52	10	10	7	7	trypsin	PAR2	PA451806	2150;55065;8856	0.792
NULL	J_Oncol_2010_May_4_2010_373491.nxml.txt.nlp	20454582	SENT134	12	12	32	32	temozolomide	TRG	PA451609	6965	0.792
NULL	Acta_Pharmacol_Sin_2013_Apr_5_34(4)_581.nxml.txt.nlp	NULL	SENT7	5	5	14	14	celecoxib	IL-6	PA448871	3569	0.792
NULL	Ann_Indian_Acad_Neurol_2014_Jan-Mar_17(1)_106-107.nxml.txt.nlp	24753674	SENT58	12	12	18	18	anagrelide	JAK2	PA164742986	3717	0.792
NULL	J_Gen_Physiol_2009_Feb_133(2)_171-188.nxml.txt.nlp	19171770	SENT763	12	12	18	18	pentobarbital	CA1	PA450859	759	0.792
NULL	Oncogenesis_2012_Apr_2_1(4)_e5.nxml.txt.nlp	23552603	SENT241	23	23	37	37	ns-398	BIM		10018	0.792
NULL	Adv_Hematol_2012_Mar_26_2012_932658.nxml.txt.nlp	22548067	SENT87	23	23	18	18	vincristine	CHOP	PA451879	1649	0.792
NULL	Aging_(Albany_NY)_2012_Mar_12_4(3)_146-158.nxml.txt.nlp	22436213	SENT55	13	13	11	11	resveratrol	SIRT1		23411	0.792
NULL	Mol_Cancer_2009_Nov_24_8_109.nxml.txt.nlp	19930708	SENT209	19	19	4	4	exemestane	aromatase	PA449563	1588	0.792
NULL	J_Adv_Pract_Oncol_2013_Jul_1_Jul-Aug_4(4)_238-250.nxml.txt.nlp	25032004	SENT115	9	9	20	20	imatinib	CML	PA10804	613	0.792
NULL	Adolesc_Health_Med_Ther_2014_Mar_26_5_35-48.nxml.txt.nlp	24729739	SENT31	35	35	32	32	tocilizumab	IL-6	PA165292659	3569	0.792
NULL	Andrology_(Los_Angel)_2013_Nov_4_2_108.nxml.txt.nlp	24900949	SENT161	15	15	3	3	sildenafil	NOS	PA451346	4843	0.792
NULL	Indian_J_Endocrinol_Metab_2012_Dec_16(Suppl_2)_S474-S476.nxml.txt.nlp	23565471	SENT42	12	12	39	39	metformin	PPG	PA450395	5552	0.792
NULL	Oxid_Med_Cell_Longev_2010_Nov-Dec_3(6)_434-441.nxml.txt.nlp	21307644	SENT176	13	13	38	38	resveratrol	CTR		799	0.792
NULL	Front_Mol_Neurosci_2012_Sep_6_5_91.nxml.txt.nlp	22973190	SENT1311	0	0	9	9	ethanol	CRF1	PA448073	1394	0.792
NULL	Int_J_Mol_Sci_2014_Oct_23_15(10)_19265-19280.nxml.txt.nlp	25342321	SENT58	24	24	13	13	sc-560	CD34		947	0.792
NULL	Oxid_Med_Cell_Longev_2013_Jun_2_2013_793525.nxml.txt.nlp	23819014	SENT204	8	8	21	21	resveratrol	ROS		6098	0.792
NULL	EMBO_Mol_Med_2013_Aug_4_5(8)_1180-1195.nxml.txt.nlp	23828858	SENT193	6	6	14	14	rituximab	MYC	PA451261	4609	0.792
NULL	Oncotarget_2013_Nov_19_5(1)_95-102.nxml.txt.nlp	24395633	SENT84	19	19	1	1	sirolimus	IPA	PA451365	3160	0.792
NULL	Cell_Death_Dis_2014_Jul_3_5(7)_e1316.nxml.txt.nlp	24991768	SENT89	7	7	12	12	pemetrexed	ATF4	PA10810	468	0.792
NULL	J_Gen_Physiol_1991_Aug_1_98(2)_315-347.nxml.txt.nlp	1658193	SENT11	1	1	13	13	creatine	gamma	PA164778930	9913	0.792
NULL	Arthritis_Res_Ther_2012_Jun_25_14(3)_215.nxml.txt.nlp	22731694	SENT143	4	4	24	24	rituximab	RIBA	PA451261	6014	0.792
NULL	Front_Immunol_2012_Jul_18_3_209.nxml.txt.nlp	22826711	SENT111	20	20	8	8	cyclosporine	WAS	PA449167	7454	0.792
NULL	Pharmaceuticals_(Basel)_2011_Nov_10_4(11)_1488-1502.nxml.txt.nlp	NULL	SENT109	12	12	35	35	geldanamycin	HER2	PA152031327	2064	0.792
NULL	FEBS_Open_Bio_2014_Jan_6_4_77-89.nxml.txt.nlp	24490132	SENT209	7	7	9	9	ebselen	GDH	PA161660841	51084;2746	0.792
NULL	Acta_Pharmacol_Sin_2011_Oct_15_32(10)_1303-1308.nxml.txt.nlp	21841812	SENT138	12	12	0	0	losartan	CYP2C9	PA450268	1559	0.792
NULL	Front_Immunol_2013_May_13_4_111.nxml.txt.nlp	23717309	SENT1380	0	0	5	5	thrombin	AP-1	PA451674	2353;3727;2354;3725	0.792
NULL	Front_Neural_Circuits_2013_Oct_24_7_170.nxml.txt.nlp	24167475	SENT922	0	0	9	9	taurine	KCC2	PA451590	57468	0.792
NULL	Br_J_Cancer_2009_Jul_21_101(2)_312-319.nxml.txt.nlp	19568237	SENT107	4	4	2	2	pp2	PP1		5540;5464	0.792
NULL	Nat_Chem_Biol_2010_Apr_28_6(4)_291-299.nxml.txt.nlp	20190765	SENT53	6	6	16	16	dasatinib	DDR1	PA162372878	780	0.792
NULL	Orphanet_J_Rare_Dis_2013_Sep_13_8_142.nxml.txt.nlp	24034279	SENT10	2	2	0	0	metoclopramide	AVP	PA450475	114548;551	0.792
NULL	Aging_(Albany_NY)_2011_Apr_4_3(4)_348-362.nxml.txt.nlp	21483040	SENT22	7	7	5	5	metformin	AMPK	PA450395	5563	0.792
NULL	Biomed_Res_Int_2013_Sep_4_2013_906912.nxml.txt.nlp	24093107	SENT164	0	0	22	22	ciprofloxacin	MICC	PA449009	100129192	0.792
NULL	J_Mol_Med_2008_Sep_4_86(9)_1045-1056.nxml.txt.nlp	18600309	SENT271	1	1	16	16	salmeterol	p65	PA451300	5970	0.792
NULL	J_Hematol_Oncol_2009_Dec_23_2_50.nxml.txt.nlp	20030851	SENT301	17	17	11	11	cyclophosphamide	CHOP	PA449165	1649	0.792
NULL	Indian_J_Pharm_Sci_2014_Mar-Apr_76(2)_125-131.nxml.txt.nlp	24843185	SENT164	10	10	27	27	resveratrol	S100B		6285	0.792
NULL	Acta_Neuropathol_Commun_2014_Oct_21_2(1)_149.nxml.txt.nlp	NULL	SENT240	7	7	16	16	riluzole	p38	PA451251	10598;1432;7965	0.792
NULL	Oncoimmunology_2013_Jan_1_2(1)_e22890.nxml.txt.nlp	23483066	SENT104	3	3	13	13	vemurafenib	IFN	PA165946873	3439	0.792
NULL	J_Cell_Biol_1998_Jul_13_142(1)_101-115.nxml.txt.nlp	9660866	SENT137	38	38	5	5	dextran	RhoA	PA449261	387	0.792
NULL	Cancer_Res_Treat_2014_Jan_15_46(1)_48-54.nxml.txt.nlp	24520223	SENT89	29	29	20	20	bevacizumab	KRAS	PA130232992	3845	0.792
NULL	Indian_J_Nucl_Med_2013_Oct-Dec_28(4)_200-206.nxml.txt.nlp	24379528	SENT137	3	3	8	8	ethanol	FDG	PA448073	23583	0.792
NULL	Cancer_Manag_Res_2014_Jun_20_6_279-289.nxml.txt.nlp	25018651	SENT82	19	19	28	28	dacarbazine	IL-2	PA449197	3558	0.792
NULL	Cancer_Biol_Med_2012_Sep_9(3)_202-204.nxml.txt.nlp	23691480	SENT43	5	5	3	3	cyclophosphamide	CHOP	PA449165	1649	0.792
NULL	J_Cancer_2014_Jan_5_5(2)_86-97.nxml.txt.nlp	24494026	SENT123	6	6	28	28	celecoxib	CD31	PA448871	5175	0.792
NULL	Cancer_Cell_Int_2009_Jan_8_9_3.nxml.txt.nlp	19128511	SENT194	13	13	27	27	oxaliplatin	EGFR	PA131285527	1956	0.792
NULL	Amino_Acids_2011_Mar_8_40(3)_885-893.nxml.txt.nlp	20824293	SENT65	32	32	3	3	neomycin	OGT	PA450608	8473	0.792
NULL	Cancers_(Basel)_2013_Jun_5_5(2)_676-713.nxml.txt.nlp	24216997	SENT2715	10	10	5	5	vorinostat	p53	PA164748224	7157	0.792
NULL	ScientificWorldJournal_2012_Apr_1_2012_671728.nxml.txt.nlp	22547992	SENT174	16	16	22	22	fluvastatin	ANOVA	PA449688	4858	0.792
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT85	6	6	16	16	atorvastatin	p110	PA448500	9733	0.792
NULL	Int_Semin_Surg_Oncol_2008_Apr_28_5_9.nxml.txt.nlp	18442393	SENT89	14	14	8	8	tamoxifen	HER2	PA451581	2064	0.792
NULL	J_Carcinog_2012_Sep_13_11_15.nxml.txt.nlp	23230392	SENT137	47	47	42	42	gemcitabine	TP53INP1	PA449748	94241	0.792
NULL	Cell_Death_Dis_2014_Jul_10_5(7)_e1318.nxml.txt.nlp	25010984	SENT41	14	14	12	12	nutlin-3	RITA		55422;84934	0.792
NULL	J_Headache_Pain_2011_Aug_29_12(4)_411-417.nxml.txt.nlp	21626018	SENT116	3	3	17	17	naratriptan	c-fos	PA450597	2353	0.792
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT300	20	20	32	32	bevacizumab	VEGFR2	PA130232992	3791	0.792
NULL	Avicenna_J_Med_2011_Jul-Sep_1(1)_12-17.nxml.txt.nlp	23210004	SENT149	7	7	5	5	thalidomide	GM-CSF	PA451644	1437	0.792
NULL	Arthritis_Res_Ther_2008_Jan_7_10(1)_R1.nxml.txt.nlp	18179697	SENT213	7	7	18	18	oxaliplatin	HMGB1	PA131285527	3146	0.792
NULL	Int_J_Biomed_Sci_2006_Dec_2(4)_360-374.nxml.txt.nlp	23675005	SENT84	14	14	23	23	estradiol	PRG	PA449503	5544	0.792
NULL	J_Clin_Exp_Pathol_2012_May_17_Suppl_4_7327.nxml.txt.nlp	25379357	SENT30	21	21	1	1	resveratrol	SIRT1		23411	0.792
NULL	Oncotarget_2012_Dec_18_3(12)_1615-1628.nxml.txt.nlp	23271044	SENT210	32	32	42	42	clofarabine	STAT3	PA164754863	6774	0.792
NULL	Oxid_Med_Cell_Longev_2012_Sep_16_2012_728547.nxml.txt.nlp	23029599	SENT57	9	9	12	12	resveratrol	SIRT1		23411	0.792
NULL	J_Korean_Neurosurg_Soc_2013_Mar_31_53(3)_139-144.nxml.txt.nlp	23634262	SENT106	2	2	12	12	isoflurane	CA3	PA450106	761	0.792
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2675-2684.nxml.txt.nlp	24129246	SENT173	33	33	17	17	etoposide	KSR1	PA449552	8844	0.792
NULL	Cancer_Cell_Int_2013_Aug_27_13_87.nxml.txt.nlp	23977838	SENT122	22	22	6	6	tamoxifen	LC3	PA451581	84557	0.792
NULL	ASN_Neuro_2009_Oct_21_1(4)_e00018.nxml.txt.nlp	19807694	SENT224	25	25	19	19	ganciclovir	E12	PA449733	64100	0.792
NULL	Cancer_Cell_Int_2005_Jul_24_5_22.nxml.txt.nlp	16042792	SENT42	0	0	32	32	vincristine	NAC	PA451879	22861	0.792
NULL	J_Biol_Chem_2013_Jul_19_288(29)_21412-21421.nxml.txt.nlp	23740251	SENT469	18	18	11	11	suramin	P2X1	PA10292	5023	0.792
NULL	Indian_J_Med_Res_2013_Nov_138(5)_632-647.nxml.txt.nlp	24434318	SENT168	3	3	19	19	l-tryptophan	IFN	PA10323	3439	0.792
NULL	Crit_Care_2011_Aug_11_15(4)_226.nxml.txt.nlp	21892977	SENT339	23	23	16	16	vasopressin	LNPEP	PA451858	4012	0.792
NULL	Cancer_Med_2014_Jun_28_3(3)_719-730.nxml.txt.nlp	24683044	SENT243	30	30	18	18	metformin	c-Myc	PA450395	4609	0.792
NULL	Front_Surg_2015_Jan_5_1_50.nxml.txt.nlp	25593974	SENT192	8	8	0	0	panitumumab	KRAS	PA162373091	3845	0.792
NULL	Adolesc_Health_Med_Ther_2012_Jun_20_3_85-93.nxml.txt.nlp	24600289	SENT36	3	3	9	9	adalimumab	TNF	PA10004	7124	0.792
NULL	JAKSTAT_2013_Jul_1_2(3)_e24812.nxml.txt.nlp	24069562	SENT10	22	22	11	11	pp2	STAT3		6774	0.792
NULL	J_Gynecol_Oncol_2013_Jan_8_24(1)_66-82.nxml.txt.nlp	23346316	SENT245	13	13	15	15	trastuzumab	aromatase	PA451743	1588	0.792
NULL	Cell_Commun_Signal_2003_Nov_24_1_5.nxml.txt.nlp	14636425	SENT78	29	29	23	23	heparin	CCN5	PA449855	8839	0.792
NULL	Front_Oncol_2013_Sep_11_3_228.nxml.txt.nlp	24062981	SENT186	17	17	30	30	temozolomide	PARP1	PA451609	142	0.792
NULL	ScientificWorldJournal_2013_Feb_5_2013_842343.nxml.txt.nlp	23476149	SENT25	1	1	11	11	ethanol	AMPK	PA448073	5563	0.792
NULL	J_Cardiovasc_Dis_Res_2010_Oct-Dec_1(4)_165-170.nxml.txt.nlp	21264179	SENT113	4	4	16	16	pravastatin	RhoA	PA451089	387	0.792
NULL	Clin_Pediatr_Endocrinol_2007_Nov_17_16(4)_81-84.nxml.txt.nlp	24790350	SENT8	7	7	12	12	levodopa	PRL	PA450213	5617	0.792
NULL	J_Hum_Genet_2013_Jun_2_58(6)_306-312.nxml.txt.nlp	23635953	SENT188	19	19	10	10	raloxifene	CYP2D6	PA451221	1565	0.792
NULL	Front_Neurosci_2013_Jan_10_6_191.nxml.txt.nlp	23335875	SENT1099	6	6	18	18	capsaicin	VR1	PA448776	56664	0.792
NULL	Orphanet_J_Rare_Dis_2010_Dec_1_5_33.nxml.txt.nlp	21122093	SENT175	9	9	0	0	lipase	ABHD5	PA450239	51099	0.792
NULL	Mol_Neurodegener_2011_Aug_16_6_58.nxml.txt.nlp	21846363	SENT133	7	7	13	13	candesartan	AT2	PA448765	186	0.792
NULL	Breast_Cancer_Res_2001_Oct_1_3(6)_361-364.nxml.txt.nlp	11737886	SENT27	28	28	43	43	cyclophosphamide	HER-2	PA449165	2064	0.792
NULL	Cancer_Immunol_Immunother_2011_Jun_25_60(6)_793-808.nxml.txt.nlp	21350947	SENT318	4	4	8	8	sorafenib	IFN	PA7000	3439	0.792
NULL	Oncotarget_2014_Jun_22_5(13)_4581-4602.nxml.txt.nlp	25015035	SENT307	12	12	17	17	bortezomib	AKT	PA10252	207	0.792
NULL	Clin_Interv_Aging_2010_Nov_15_5_323-331.nxml.txt.nlp	21228897	SENT122	10	10	22	22	sertraline	Gen	PA451333	348654	0.792
NULL	Ther_Clin_Risk_Manag_2006_Jun_2(2)_129-158.nxml.txt.nlp	18360588	SENT185	0	0	3	3	phenytoin	CYP2C9	PA450947	1559	0.792
NULL	Evid_Based_Complement_Alternat_Med_2011_Mar_9_2011_750230.nxml.txt.nlp	21423639	SENT250	18	18	2	2	resveratrol	HS7		349198	0.792
NULL	Behav_Brain_Funct_2014_Feb_13_10_5.nxml.txt.nlp	24524628	SENT58	6	6	16	16	capsaicin	TRPV1	PA448776	7442	0.792
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R91.nxml.txt.nlp	22541814	SENT252	3	3	5	5	thrombin	HO-1	PA451674	3162	0.792
NULL	Oncogene_2009_Apr_23_28(16)_1821-1832.nxml.txt.nlp	19305428	SENT215	19	19	41	41	erlotinib	EGF	PA134687924	1950	0.792
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_P103.nxml.txt.nlp	NULL	SENT16	27	27	12	12	ampicillin	PPL	PA448419	5493	0.792
NULL	Curr_Health_Sci_J_2014_Dec_29_Jan-Mar_40(1)_12-17.nxml.txt.nlp	24791199	SENT58	23	23	20	20	sibutramine	5-HT2C	PA451344	3358	0.792
NULL	Chin_J_Cancer_2011_May_30(5)_293-302.nxml.txt.nlp	21527062	SENT67	21	21	36	36	trastuzumab	HER3	PA451743	2065	0.792
NULL	Nucleic_Acids_Res_2012_Jul_1_40(12)_5775-5786.nxml.txt.nlp	22383579	SENT38	12	12	15	15	theophylline	MS2	PA451647	101	0.792
NULL	Aging_(Albany_NY)_2013_Feb_21_5(2)_94-95.nxml.txt.nlp	23518473	SENT9	19	19	11	11	resveratrol	SIRT1		23411	0.792
NULL	Oncotarget_2012_Jul_10_3(6)_640-650.nxml.txt.nlp	22791660	SENT114	6	6	39	39	curcumin	MDR1	PA151958596	5243	0.792
NULL	J_Infect_Dis_2014_Jan_1_209(1)_120-129.nxml.txt.nlp	23943850	SENT164	13	13	5	5	levamisole	PRR24	PA450205	255783	0.791
NULL	Onco_Targets_Ther_2014_Dec_3_7_2227-2236.nxml.txt.nlp	25506226	SENT103	0	0	7	7	trastuzumab	ADC	PA451743	113451	0.791
NULL	Breast_Cancer_Res_2006_Oct_24_8(5)_R59.nxml.txt.nlp	17062128	SENT103	16	16	32	32	dextran	CXCR4	PA449261	7852	0.791
NULL	Cell_Death_Dis_2014_Mar_13_5(3)_e1119.nxml.txt.nlp	24625978	SENT135	18	18	0	0	hyaluronan	HAPLN1	PA165958431	1404	0.791
NULL	Genome_Biol_2005_May_17_6(6)_R49.nxml.txt.nlp	15960801	SENT90	24	24	8	8	nadh	COX5A	PA164755085	9377	0.791
NULL	Paediatr_Drugs_2014_Feb_27_16(3)_199-211.nxml.txt.nlp	24574047	SENT84	6	6	3	3	doxylamine	OTC	PA449419	5009	0.791
NULL	Front_Endocrinol_(Lausanne)_2013_Oct_29_4_161.nxml.txt.nlp	24194732	SENT145	14	14	19	19	estradiol	AT1	PA449503	9197;185	0.791
NULL	Chem_Cent_J_2013_Sep_23_7_159.nxml.txt.nlp	24059652	SENT47	30	30	2	2	ethanol	flower	PA448073	11094	0.791
NULL	Crit_Care_2010_Mar_15_14(2)_R30.nxml.txt.nlp	20226064	SENT279	0	0	6	6	propofol	IFN	PA451141	3439	0.791
NULL	J_Hematol_Oncol_2008_Oct_1_1_16.nxml.txt.nlp	18828924	SENT88	0	0	6	6	trastuzumab	HER2	PA451743	2064	0.791
NULL	Iran_J_Public_Health_2011_Dec_31_40(4)_99-104.nxml.txt.nlp	23113108	SENT26	9	9	15	15	galactose	GALT	PA449725	2592	0.791
NULL	Curr_Neuropharmacol_2008_Jun_6(2)_151-163.nxml.txt.nlp	19305794	SENT220	21	21	6	6	capsaicin	TRPV1	PA448776	7442	0.791
NULL	Acta_Pharmacol_Sin_2013_Apr_11_34(4)_570-580.nxml.txt.nlp	23396375	SENT186	3	3	5	5	tegafur	CDHP	PA452620	1001	0.791
NULL	Cancer_Inform_2007_Feb_10_3_93-114.nxml.txt.nlp	19455237	SENT16	28	28	20	20	gefitinib	p53	PA131301952	7157	0.791
NULL	Br_J_Cancer_2013_Jun_25_108(12)_2485-2494.nxml.txt.nlp	23695022	SENT115	12	12	20	20	propranolol	P-gp	PA451145	5243	0.791
NULL	Int_J_Nanomedicine_2012_Oct_25_7_5565-5575.nxml.txt.nlp	23118538	SENT92	23	23	2	2	fenofibrate	INCA	PA449594	440068	0.791
NULL	Breast_Cancer_Res_2011_Jun_27_13(3)_212.nxml.txt.nlp	21787441	SENT213	29	29	31	31	tamoxifen	aromatase	PA451581	1588	0.791
NULL	Trials_2013_Aug_14_14_255.nxml.txt.nlp	23945130	SENT35	31	31	26	26	pyrimethamine	IPT	PA451193	54802	0.791
NULL	Chin_J_Cancer_2012_Aug_31(8)_381-391.nxml.txt.nlp	22739263	SENT31	28	28	6	6	ethanol	CO2	PA448073	4513	0.791
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT193	31	31	24	24	perifosine	DR5	PA165291471	8795	0.791
NULL	Mol_Cancer_2012_Jul_25_11_47.nxml.txt.nlp	22830443	SENT35	10	10	21	21	panitumumab	EGFR	PA162373091	1956	0.791
NULL	Int_J_Lab_Hematol_2013_Dec_30_35(6)_652-657.nxml.txt.nlp	23718922	SENT14	12	12	0	0	thrombin	TGT	PA451674	9097;81890	0.791
NULL	J_Carcinog_2014_Nov_27_13_13.nxml.txt.nlp	25525412	SENT59	25	25	8	8	irinotecan	EGFR	PA450085	1956	0.791
NULL	Open_Cardiovasc_Med_J_2011_Jun_20_5_136-147.nxml.txt.nlp	21760856	SENT167	19	19	3	3	fenofibrate	ghrelin	PA449594	51738	0.791
NULL	Mol_Cancer_2012_Apr_26_11_26.nxml.txt.nlp	22537224	SENT141	35	35	42	42	cisplatin	FANCF	PA449014	2188	0.791
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1709-1716.nxml.txt.nlp	19844235	SENT227	6	6	8	8	gemcitabine	B7-H3	PA449748	80381	0.791
NULL	Br_J_Cancer_2011_Jan_4_104(1)_91-100.nxml.txt.nlp	21139584	SENT133	35	35	27	27	geldanamycin	Hsp90	PA152031327	3320	0.791
NULL	Biomed_Res_Int_2014_Jan_2_2014_126586.nxml.txt.nlp	24527434	SENT112	8	8	21	21	metformin	p53	PA450395	7157	0.791
NULL	Target_Oncol_2013_Jun_27_8(2)_127-136.nxml.txt.nlp	23625191	SENT154	24	24	15	15	cetuximab	NRAS	PA10040	4893	0.791
NULL	Chem_Cent_J_2013_Sep_4_7_147.nxml.txt.nlp	24006941	SENT128	2	2	10	10	lipase	LOX	PA450239	4015	0.791
NULL	Pharmaceuticals_(Basel)_2012_Feb_23_5(3)_249-278.nxml.txt.nlp	24281378	SENT1751	3	3	12	12	capsaicin	TRPA1	PA448776	8989	0.791
NULL	Drugs_2014_Apr_17_74(6)_659-674.nxml.txt.nlp	24740824	SENT426	2	2	5	5	natalizumab	CD4	PA164747191	920	0.791
NULL	Biomed_Res_Int_2014_Jun_26_2014_161346.nxml.txt.nlp	25054130	SENT232	41	41	30	30	curcumin	STZ	PA151958596	6484	0.791
NULL	J_Biomed_Sci_2014_Jul_31_21(1)_69.nxml.txt.nlp	25077570	SENT156	20	20	5	5	mitomycin	IL-4	PA450524	3565	0.791
NULL	Nat_Commun_2014_Dec_8_5_5736.nxml.txt.nlp	25484020	SENT146	3	3	10	10	letrozole	TRPA1	PA450196	8989	0.791
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1495-1502.nxml.txt.nlp	21989186	SENT137	6	6	21	21	panitumumab	KRAS	PA162373091	3845	0.791
NULL	Endocrinol_Diabetes_Metab_Case_Rep_2014_Sep_1_2014_140072.nxml.txt.nlp	25332771	SENT66	7	7	4	4	sitagliptin	DPP4	PA164748978	1803	0.791
NULL	Oncotarget_2014_Oct_21_5(22)_11180-11192.nxml.txt.nlp	25361003	SENT114	7	7	3	3	tetracycline	NTRK1	PA451640	4914	0.791
NULL	Int_J_Cell_Biol_2014_Nov_17_2014_280638.nxml.txt.nlp	25477962	SENT587	3	3	8	8	paclitaxel	CDK2	PA450761	1017	0.791
NULL	Ann_Rheum_Dis_2012_Sep_71(9)_1510-1516.nxml.txt.nlp	22440821	SENT234	11	11	18	18	infliximab	adiponectin	PA452639	9370	0.791
NULL	Acta_Pharmacol_Sin_2010_Sep_16_31(9)_1075-1084.nxml.txt.nlp	20711221	SENT77	16	16	21	21	thrombin	AMPK	PA451674	5563	0.791
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_55-78.nxml.txt.nlp	19305788	SENT160	0	0	20	20	memantine	spatial	PA10364	219793	0.791
NULL	Br_J_Pharmacol_2008_Oct_18_155(4)_596-605.nxml.txt.nlp	18852694	SENT149	16	16	11	11	fenofibrate	SREBP2	PA449594	6721	0.791
NULL	J_Thorac_Oncol_2014_Oct_23_9(10)_1443-1448.nxml.txt.nlp	25521397	SENT103	12	12	9	9	erlotinib	EGFR	PA134687924	1956	0.791
NULL	Diabetes_Care_2009_Apr_32(4)_531-540.nxml.txt.nlp	19336638	SENT239	8	8	16	16	clopidogrel	P2Y12	PA449053	64805	0.791
NULL	Orphanet_J_Rare_Dis_2014_Aug_8_9(1)_126.nxml.txt.nlp	NULL	SENT165	8	8	20	20	doxorubicin	ANOVA	PA449412	4858	0.791
NULL	J_Clin_Biochem_Nutr_2007_Jan_27_40(1)_13-23.nxml.txt.nlp	18437209	SENT573	0	0	2	2	trypsin	PAR2	PA451806	2150;55065;8856	0.791
NULL	Biomed_Res_Int_2013_Dec_16_2013_741403.nxml.txt.nlp	24455721	SENT60	28	28	9	9	metronidazole	CYP3A4	PA450484	1576	0.791
NULL	Cancer_Cell_Int_2006_Aug_9_6_20.nxml.txt.nlp	16899133	SENT141	16	16	10	10	triciribine	PI3K	PA165958661	5290	0.791
NULL	BMJ_2013_Sep_17_347_f5307.nxml.txt.nlp	24046285	SENT26	27	27	25	25	ticagrelor	CYP1A2	PA165374673	1544	0.791
NULL	Endocr_Rev_2013_Jun_10_34(3)_339-376.nxml.txt.nlp	23575763	SENT1714	5	5	14	14	imatinib	KIT	PA10804	3815	0.791
NULL	Biochim_Biophys_Acta_2014_Jul_1842(7)_959-970.nxml.txt.nlp	24594481	SENT812	38	38	7	7	lipase	ATGL	PA450239	57104	0.791
NULL	Int_J_Breast_Cancer_2011_Jan_20_2011_807380.nxml.txt.nlp	22332017	SENT129	6	6	2	2	clotrimazole	ABCC11	PA449057	85320	0.791
NULL	Comp_Hepatol_2005_Feb_8_4_2.nxml.txt.nlp	15701172	SENT14	3	3	12	12	ketoconazole	CYP3A	PA450146	1574	0.791
NULL	Reprod_Biol_Endocrinol_2013_Sep_3_11_85.nxml.txt.nlp	24004880	SENT299	13	13	5	5	galactose	KLK3	PA449725	354	0.791
NULL	Arthritis_Res_Ther_2009_Jun_29_11(3)_R100.nxml.txt.nlp	19563672	SENT158	5	5	10	10	infliximab	IFN	PA452639	3439	0.791
NULL	Oncol_Lett_2013_Apr_28_5(4)_1305-1310.nxml.txt.nlp	23599784	SENT151	2	2	7	7	tamoxifen	aromatase	PA451581	1588	0.791
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1063.nxml.txt.nlp	24556678	SENT83	4	4	11	11	thioridazine	Mcl-1	PA451666	4170	0.791
NULL	J_Cancer_2013_Nov_23_4(9)_736-754.nxml.txt.nlp	24312144	SENT34	0	0	4	4	erlotinib	EGFR	PA134687924	1956	0.791
NULL	Anticancer_Agents_Med_Chem_2012_Feb_12(2)_163-171.nxml.txt.nlp	22043994	SENT256	20	20	7	7	cetuximab	KRAS	PA10040	3845	0.791
NULL	Biomed_Res_Int_2013_Apr_18_2013_538790.nxml.txt.nlp	23691505	SENT32	12	12	32	32	nadh	mol	PA164755085	90527	0.791
NULL	Ther_Clin_Risk_Manag_2005_Jun_1(2)_107-114.nxml.txt.nlp	18360550	SENT25	2	2	30	30	paclitaxel	Yes	PA450761	7525	0.791
NULL	Support_Care_Cancer_2009_Sep_10_17(9)_1187-1193.nxml.txt.nlp	19205754	SENT140	18	18	10	10	palonosetron	NK-1	PA10352	27087	0.791
NULL	N_Am_J_Med_Sci_2011_Jan_3(1)_1-12.nxml.txt.nlp	22540056	SENT135	40	40	28	28	gemcitabine	MRP5	PA449748	10057	0.791
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Mar_27_66(Pt_4)_o924.nxml.txt.nlp	21580734	SENT52	18	18	33	33	ethanol	mol	PA448073	90527	0.791
NULL	Cell_Cycle_2012_Nov_1_11(21)_3983-3996.nxml.txt.nlp	22987153	SENT7	6	6	3	3	cisplatin	FANCD2	PA449014	2177	0.791
NULL	Front_Chem_2014_Mar_14_2_12.nxml.txt.nlp	24790981	SENT97	1	1	9	9	curcumin	MEF2C	PA151958596	4208	0.791
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT126	15	15	10	10	tenofovir	ABCC2	PA10204	1244	0.791
NULL	Cardiovasc_Diabetol_2011_Dec_22_10_115.nxml.txt.nlp	22189184	SENT15	23	23	27	27	miglitol	GLP-1	PA164776726	100125288	0.791
NULL	Int_J_Gen_Med_2012_Jun_18_5_535-540.nxml.txt.nlp	22807641	SENT64	18	18	9	9	pitavastatin	adiponectin	PA142650384	9370	0.791
NULL	Br_J_Cancer_2011_Jul_26_105(3)_372-381.nxml.txt.nlp	21730979	SENT11	18	18	7	7	cisplatin	ATR	PA449014	390502;84168;545	0.791
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1059-1066.nxml.txt.nlp	21364577	SENT101	18	18	25	25	letrozole	TTR	PA450196	7276	0.791
NULL	ScientificWorldJournal_2012_Mar_12_2012_793823.nxml.txt.nlp	22500143	SENT174	19	19	14	14	lipase	KLF5	PA450239	688	0.791
NULL	Int_J_Biomed_Sci_2007_Sep_3(3)_176-184.nxml.txt.nlp	23675041	SENT114	0	0	5	5	celecoxib	Bcl-2	PA448871	596	0.791
NULL	Adv_Hematol_2012_Feb_6_2012_485943.nxml.txt.nlp	22400030	SENT181	15	15	20	20	atovaquone	CD4	PA448502	920	0.791
NULL	Physiol_Rep_2014_Sep_11_2(9)_e12144.nxml.txt.nlp	25214522	SENT91	8	8	28	28	resveratrol	RVR		9975	0.791
NULL	Ann_Lab_Med_2014_Nov_28_34(6)_439-445.nxml.txt.nlp	25368819	SENT55	13	13	11	11	clindamycin	VAN	PA449035	10318	0.791
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2013_Dec_8_6_75-79.nxml.txt.nlp	24348081	SENT9	4	4	13	13	colesevelam	GLP-1	PA449095	100125288	0.791
NULL	J_Vis_Exp_2011_Feb_19_(48)_2541.nxml.txt.nlp	21372791	SENT60	29	29	17	17	ethanol	ANOVA	PA448073	4858	0.791
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1013.nxml.txt.nlp	24457957	SENT126	5	5	24	24	bortezomib	NOXA	PA10252	5366	0.791
NULL	Oncotarget_2014_Mar_13_5(4)_1101-1110.nxml.txt.nlp	24658355	SENT2	18	18	24	24	tamoxifen	MKP-1	PA451581	1843	0.791
NULL	JAKSTAT_2013_Jul_1_2(3)_e25025.nxml.txt.nlp	24069563	SENT186	17	17	8	8	decitabine	IFN	PA164749631	3439	0.791
NULL	Cancer_Causes_Control_2013_Aug_18_24(8)_1605-1614.nxml.txt.nlp	23775025	SENT243	31	31	25	25	cyclophosphamide	ALDH3A1	PA449165	218	0.791
NULL	Cell_Death_Dis_2013_Sep_5_4(9)_e791.nxml.txt.nlp	24008735	SENT37	5	5	26	26	gemcitabine	PUMA	PA449748	27113	0.791
NULL	Clin_Med_Insights_Oncol_2013_Feb_21_7_41-51.nxml.txt.nlp	23471238	SENT75	7	7	14	14	trastuzumab	HER2	PA451743	2064	0.791
NULL	Mol_Biol_Cell_2012_Sep_15_23(18)_3499-3510.nxml.txt.nlp	22833567	SENT129	0	0	13	13	arsenite	HRI	PA452638	27102	0.791
NULL	Breast_Cancer_Res_2009_Jan_16_11(1)_201.nxml.txt.nlp	19216727	SENT152	40	40	27	27	docetaxel	HER2	PA449383	2064	0.791
NULL	Oncotarget_2014_Feb_8_5(6)_1609-1620.nxml.txt.nlp	24742492	SENT212	5	5	9	9	doxorubicin	LGMN	PA449412	5641	0.791
NULL	ScientificWorldJournal_2014_Mar_12_2014_731462.nxml.txt.nlp	24715817	SENT182	8	8	25	25	diclofenac	IL-6	PA449293	3569	0.791
NULL	Mol_Cancer_2012_Jul_12_11_45.nxml.txt.nlp	22788833	SENT134	16	16	10	10	cisplatin	EGFR	PA449014	1956	0.791
NULL	Neuro_Oncol_2011_Nov_22_13(11)_1178-1191.nxml.txt.nlp	21940738	SENT180	9	9	4	4	imatinib	SOX2	PA10804	6657	0.791
NULL	J_Vet_Med_Sci_2014_Mar_1_76(3)_323-330.nxml.txt.nlp	24189582	SENT12	9	9	6	6	leflunomide	ATV	PA450192	4683	0.791
NULL	Mol_Cancer_2009_Nov_19_8_108.nxml.txt.nlp	19925669	SENT108	2	2	24	24	doxorubicin	MRP3	PA449412	8714	0.791
NULL	Oncotarget_2013_Nov_23_5(1)_196-210.nxml.txt.nlp	24344116	SENT204	18	18	24	24	doxorubicin	p53	PA449412	7157	0.791
NULL	Evid_Based_Complement_Alternat_Med_2011_Dec_30_2011_129045.nxml.txt.nlp	21234313	SENT38	0	0	4	4	metformin	AMPK	PA450395	5563	0.791
NULL	Hum_Genomics_2009_Dec_1_4(2)_91-106.nxml.txt.nlp	20038497	SENT195	2	2	7	7	tacrine	CYP1A2	PA451576	1544	0.791
NULL	Int_J_Mol_Sci_2014_Nov_5_15(11)_20134-20157.nxml.txt.nlp	25380521	SENT49	19	19	2	2	porfimer	BTC	PA164752658	685	0.791
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Oct_31_65(Pt_11)_o2934.nxml.txt.nlp	21578510	SENT48	20	20	35	35	ethanol	mol	PA448073	90527	0.791
NULL	Biochem_Res_Int_2012_Mar_20_2012_951539.nxml.txt.nlp	22482055	SENT213	8	8	2	2	doxorubicin	CARP	PA449412	27063;80013;767	0.791
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT120	16	16	25	25	capsaicin	p53	PA448776	7157	0.791
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_7-17.nxml.txt.nlp	17912633	SENT92	13	13	5	5	letrozole	ACTH	PA450196	5443	0.791
NULL	Adv_Appl_Bioinforma_Chem_2008_Oct_30_1_85-98.nxml.txt.nlp	21918608	SENT176	15	15	19	19	bortezomib	SPARC	PA10252	6678	0.791
NULL	Cell_Commun_Signal_2013_Jul_4_11_47.nxml.txt.nlp	23826796	SENT92	24	24	7	7	forskolin	CC2D1A	PA146096022	54862	0.791
NULL	Exp_Neurobiol_2014_Sep_18_23(3)_207-214.nxml.txt.nlp	25258567	SENT66	21	21	27	27	filgrastim	CD133	PA449626	8842	0.791
NULL	Diabetes_2013_Jun_17_62(6)_1913-1922.nxml.txt.nlp	23349495	SENT7	8	8	2	2	sildenafil	VASP	PA451346	7408	0.791
NULL	Support_Care_Cancer_2011_Oct_8_19(10)_1505-1510.nxml.txt.nlp	20694798	SENT59	31	31	26	26	cyclophosphamide	CHOP	PA449165	1649	0.791
NULL	Cell_Oncol_(Dordr)_2011_Apr_11_34(2)_89-95.nxml.txt.nlp	21394646	SENT193	26	26	7	7	paclitaxel	HER2	PA450761	2064	0.791
NULL	Indian_J_Endocrinol_Metab_2011_Apr-Jun_15(2)_137-139.nxml.txt.nlp	21731877	SENT42	20	20	9	9	cabergoline	HTR2B	PA448708	3357	0.791
NULL	Indian_J_Endocrinol_Metab_2013_Nov-Dec_17(6)_996-1004.nxml.txt.nlp	24381874	SENT160	0	0	30	30	bromocriptine	PRL	PA448671	5617	0.791
NULL	Int_J_Genomics_2013_Nov_4_2013_464720.nxml.txt.nlp	24364026	SENT133	14	14	11	11	cisplatin	PARP1	PA449014	142	0.791
NULL	Ann_Thorac_Med_2014_Apr-Jun_9(2)_124-126.nxml.txt.nlp	24791177	SENT77	1	1	30	30	sirolimus	TSC2	PA451365	7249	0.791
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT69	20	20	5	5	methotrexate	ABCC10	PA450428	89845	0.791
NULL	J_Immunol_Res_2014_Apr_3_2014_796856.nxml.txt.nlp	24804271	SENT211	13	13	2	2	temozolomide	ACT	PA451609	12;11332;9457;641455	0.791
NULL	Lipids_Health_Dis_2011_Jan_18_10_8.nxml.txt.nlp	21241519	SENT33	7	7	32	32	simvastatin	ABCB11	PA451363	8647	0.791
NULL	Biomed_Res_Int_2013_Aug_6_2013_909613.nxml.txt.nlp	24027765	SENT8	17	17	15	15	metronidazole	EEN	PA450484	6455	0.791
NULL	J_Carcinog_2011_Nov_30_10_25.nxml.txt.nlp	22190867	SENT242	15	15	4	4	tamoxifen	N-CoR	PA451581	9611	0.791
NULL	Front_Aging_Neurosci_2010_Mar_19_2_11.nxml.txt.nlp	20552049	SENT315	0	0	8	8	estradiol	GluN1	PA449503	2902	0.791
NULL	Dermatoendocrinol_2012_Jul_1_4(3)_285-297.nxml.txt.nlp	23467430	SENT291	25	25	10	10	resveratrol	COX		1351	0.791
NULL	Acta_Pharmacol_Sin_2014_Sep_4_35(9)_1137-1149.nxml.txt.nlp	25088000	SENT154	19	19	23	23	pilocarpine	FKBP1A	PA450962	2280	0.791
NULL	Front_Neurosci_2014_Jul_1_8_168.nxml.txt.nlp	25018691	SENT698	4	4	10	10	ketamine	gamma	PA450144	9913	0.791
NULL	Crit_Care_2010_Aug_11_14(4)_R153.nxml.txt.nlp	20701787	SENT62	3	3	12	12	exenatide	San	PA164749238	80218	0.791
NULL	J_Oncol_2013_Feb_17_2013_872957.nxml.txt.nlp	23476648	SENT35	12	12	4	4	cisplatin	SFN	PA449014	25996;2810	0.791
NULL	Cell_Commun_Signal_2009_Aug_13_7_19.nxml.txt.nlp	19678929	SENT38	34	34	25	25	erlotinib	EGFR	PA134687924	1956	0.791
NULL	J_Hematol_Oncol_2010_May_2_3_18.nxml.txt.nlp	20433767	SENT96	11	11	2	2	erlotinib	EGFR	PA134687924	1956	0.791
NULL	Ann_Med_2013_Feb_25_45(1)_4-16.nxml.txt.nlp	21867371	SENT223	7	7	24	24	bezafibrate	COX	PA162364313	1351	0.791
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT79	2	2	15	15	atorvastatin	survivin	PA448500	332	0.791
NULL	Evid_Based_Complement_Alternat_Med_2011_Feb_14_2011_248231.nxml.txt.nlp	19233878	SENT312	20	20	18	18	rosiglitazone	DBT	PA451283	1629	0.791
NULL	Environ_Health_Perspect_2008_Apr_29_116(4)_514-519.nxml.txt.nlp	18414636	SENT63	8	8	28	28	fluorescein	San	PA164746009	80218	0.791
NULL	Toxins_(Basel)_2010_Mar_31_2(4)_517-551.nxml.txt.nlp	22069598	SENT1601	0	0	11	11	resveratrol	SIRT1		23411	0.791
NULL	Nucleic_Acids_Res_2013_Apr_18_41(7)_4144-4158.nxml.txt.nlp	23423352	SENT178	29	29	17	17	galactose	CDC5	PA449725	988	0.791
NULL	Comput_Struct_Biotechnol_J_2012_Oct_2_2_e201209003.nxml.txt.nlp	24688644	SENT148	3	3	12	12	l-threonine	PLP	PA451673	25824;5744	0.791
NULL	Comp_Hepatol_2004_Jan_14_3(Suppl_1)_S46.nxml.txt.nlp	14960198	SENT67	30	30	41	41	allopurinol	AAP	PA448320	5345	0.791
NULL	Exp_Ther_Med_2014_Oct_24_8(4)_1092-1096.nxml.txt.nlp	25187802	SENT72	0	0	11	11	carvedilol	Bcl-2	PA448817	596	0.791
NULL	Indian_J_Nephrol_2010_Jul_20(3)_146-151.nxml.txt.nlp	21072155	SENT123	19	19	12	12	tacrolimus	MDR1	PA451578	5243	0.791
NULL	Core_Evid_2007_Nov_30_2(2)_121-129.nxml.txt.nlp	21221180	SENT146	8	8	10	10	rituximab	CHOP	PA451261	1649	0.791
NULL	J_Immunol_Res_2014_May_12_2014_897249.nxml.txt.nlp	24901013	SENT157	4	4	15	15	natalizumab	miR-17-92	PA164747191	407975	0.791
NULL	Breast_Cancer_(Auckl)_2011_Apr_13_5_53-65.nxml.txt.nlp	21603258	SENT25	16	16	10	10	ethanol	castor	PA448073	54897	0.791
NULL	Springerplus_2015_Jan_23_4_29.nxml.txt.nlp	25628986	SENT33	6	6	15	15	dapsone	G6PD	PA449211	2539	0.791
NULL	Am_J_Trop_Med_Hyg_2012_Mar_1_86(3)_489-495.nxml.txt.nlp	22403324	SENT177	33	33	38	38	ritonavir	P-gp	PA451260	5243	0.791
NULL	Front_Genet_2012_Sep_3_3_169.nxml.txt.nlp	22969794	SENT183	13	13	19	19	estradiol	pS2	PA449503	7031	0.791
NULL	Evid_Based_Complement_Alternat_Med_2012_Feb_12_2012_472897.nxml.txt.nlp	22454667	SENT146	0	0	13	13	hesperetin	IL-2	PA164742902	3558	0.791
NULL	Pharmaceutics_2012_Dec_13_4(4)_607-640.nxml.txt.nlp	24300373	SENT431	25	25	9	9	rofecoxib	CERT	PA451268	10087	0.791
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT152	8	8	11	11	metformin	HIF-1	PA450395	29072	0.791
NULL	Aging_(Albany_NY)_2009_May_22_1(6)_557-572.nxml.txt.nlp	20195383	SENT17	3	3	21	21	creatine	ADP	PA164778930	23038	0.791
NULL	Breast_Cancer_Res_2007_Jan_23_9(1)_R7.nxml.txt.nlp	17244352	SENT137	10	10	7	7	tamoxifen	CYP3A5	PA451581	1577	0.791
NULL	Int_J_Biol_Sci_2014_Jun_21_10(7)_702-714.nxml.txt.nlp	25013379	SENT37	13	13	23	23	cetuximab	HER2	PA10040	2064	0.791
NULL	Mol_Cancer_2010_Jun_25_9_166.nxml.txt.nlp	20579378	SENT269	12	12	10	10	gefitinib	EGF	PA131301952	1950	0.791
NULL	Oncol_Lett_2013_Mar_10_5(3)_1068-1074.nxml.txt.nlp	23426189	SENT218	0	0	9	9	4-methylumbelliferone	HAS3	PA154081778	3038	0.791
NULL	Int_J_Mol_Sci_2014_Jun_5_15(6)_10116-10135.nxml.txt.nlp	24905409	SENT200	5	5	14	14	resveratrol	IL-6		3569	0.791
NULL	Evid_Based_Complement_Alternat_Med_2012_Aug_27_2012_361516.nxml.txt.nlp	22969825	SENT91	26	26	15	15	vinblastine	P-gp	PA451877	5243	0.791
NULL	Arthritis_Res_Ther_2011_Feb_8_13(1)_R17.nxml.txt.nlp	21303509	SENT211	14	14	6	6	infliximab	FSTL1	PA452639	11167	0.791
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT3159	9	9	18	18	diclofenac	CYP2C8	PA449293	1558	0.791
NULL	Diabetes_Care_2012_Apr_13_35(4)_797-802.nxml.txt.nlp	22323413	SENT48	15	15	4	4	colistin	B12	PA164760862	7126;4709	0.791
NULL	Biosci_Rep_2012_Aug_1_32(Pt_4)_361-374.nxml.txt.nlp	22762204	SENT186	30	30	4	4	paclitaxel	TAZ	PA450761	25937;6901	0.791
NULL	Emerg_Infect_Dis_2011_Oct_17(10)_1966-1968.nxml.txt.nlp	22000388	SENT9	37	37	6	6	emtricitabine	CD4	PA10069	920	0.791
NULL	Int_J_Mol_Sci_2012_Dec_5_13(12)_16658-16667.nxml.txt.nlp	23443124	SENT240	7	7	2	2	cisplatin	ERCC1	PA449014	2067	0.791
NULL	Interdiscip_Toxicol_2011_Mar_4(1)_33-39.nxml.txt.nlp	21577282	SENT112	5	5	8	8	methotrexate	Q10	PA450428	27161	0.791
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT11	24	24	31	31	neratinib	HER3	PA165291472	2065	0.791
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Nov_19_67(Pt_12)_o3364.nxml.txt.nlp	22199858	SENT64	3	3	6	6	benzaldehyde	mol	PA448571	90527	0.791
NULL	Antimicrob_Agents_Chemother_2014_Nov_10_59(1)_490-497.nxml.txt.nlp	25385107	SENT300	15	15	24	24	primaquine	G6PD	PA451103	2539	0.791
NULL	Endocr_Connect_2012_Jun_8_1(1)_1-12.nxml.txt.nlp	23781298	SENT155	4	4	16	16	fenofibrate	adiponectin	PA449594	9370	0.791
NULL	Indian_J_Med_Res_2013_Jan_137(1)_203-209.nxml.txt.nlp	23481074	SENT142	22	22	10	10	acenocoumarol	CYP2C9	PA452632	1559	0.791
NULL	Ther_Clin_Risk_Manag_2007_Aug_3(4)_665-673.nxml.txt.nlp	18472989	SENT60	9	9	19	19	trastuzumab	survivin	PA451743	332	0.791
NULL	Breast_Cancer_Res_Treat_2012_Jun_18_133(3)_937-947.nxml.txt.nlp	22094936	SENT206	6	6	14	14	tamoxifen	EZH2	PA451581	2146	0.791
NULL	J_Headache_Pain_2008_Oct_31_9(5)_277-288.nxml.txt.nlp	18668199	SENT63	5	5	38	38	propranolol	Yes	PA451145	7525	0.791
NULL	Arthritis_Res_Ther_2010_Apr_1_12(2)_R60.nxml.txt.nlp	20359365	SENT217	21	21	5	5	bleomycin	SPARC	PA448645	6678	0.791
NULL	J_Biomed_Sci_2014_Jul_22_21(1)_65.nxml.txt.nlp	25047949	SENT12	17	17	32	32	docetaxel	PC-3	PA449383	692094	0.791
NULL	Indian_J_Med_Res_2014_Feb_139(2)_195-204.nxml.txt.nlp	24718393	SENT165	18	18	28	28	voriconazole	CYP3A4	PA10233	1576	0.791
NULL	Indian_J_Med_Res_2014_Apr_139(4)_572-578.nxml.txt.nlp	24927344	SENT119	8	8	13	13	warfarin	GGCX	PA451906	2677	0.791
NULL	J_Mol_Signal_2008_Mar_31_3_8.nxml.txt.nlp	18377662	SENT141	7	7	28	28	pp2	KDR		3791	0.791
NULL	Front_Integr_Neurosci_2012_May_11_6_16.nxml.txt.nlp	22593737	SENT348	12	12	8	8	olanzapine	Met	PA450688	79811	0.791
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Aug_29_65(Pt_9)_o2301.nxml.txt.nlp	21577690	SENT60	25	25	14	14	ethanol	mol	PA448073	90527	0.791
NULL	Oxid_Med_Cell_Longev_2012_May_13_2012_250825.nxml.txt.nlp	22666518	SENT30	22	22	41	41	glucose	MCI	PA449773	345643	0.791
NULL	Int_J_Endocrinol_Metab_2013_Jul_1_Summer_11(3)_184-190.nxml.txt.nlp	24348591	SENT124	23	23	20	20	liraglutide	INS-1	PA165958364	2305	0.791
NULL	Nat_Med_2013_Nov_27_19(11)_10_1038_nm_3364.nxml.txt.nlp	24162813	SENT188	20	20	0	0	imatinib	PTH	PA10804	5741	0.791
NULL	Front_Immunol_2012_Jan_24_3_3.nxml.txt.nlp	22566889	SENT103	13	13	16	16	rituximab	Bcl-2	PA451261	596	0.791
NULL	Br_J_Cancer_2013_Mar_19_108(5)_1052-1060.nxml.txt.nlp	23422754	SENT64	14	14	25	25	bevacizumab	VEGF-A	PA130232992	7422	0.791
NULL	J_Carcinog_2013_Dec_31_12_22.nxml.txt.nlp	24574860	SENT6	16	16	21	21	erlotinib	EGFR	PA134687924	1956	0.791
NULL	J_Neuroinflammation_2010_Sep_7_7_51.nxml.txt.nlp	20822529	SENT187	21	21	3	3	hemin	p38	PA449849	10598;1432;7965	0.791
NULL	EMBO_Mol_Med_2013_Aug_5_5(8)_1213-1226.nxml.txt.nlp	23918228	SENT189	7	7	10	10	cetuximab	EGFR	PA10040	1956	0.791
NULL	Tuberc_Respir_Dis_(Seoul)_2014_Mar_29_76(3)_114-119.nxml.txt.nlp	24734098	SENT126	32	32	19	19	gefitinib	EGFR	PA131301952	1956	0.791
NULL	Scientifica_(Cairo)_2012_Jul_11_2012_306830.nxml.txt.nlp	24278684	SENT140	4	4	2	2	thrombin	PAR-1	PA451674	2011;2149	0.791
NULL	Cancer_Manag_Res_2012_Nov_9_4_383-395.nxml.txt.nlp	23204869	SENT130	5	5	11	11	carmustine	PC-3	PA448810	692094	0.791
NULL	Exp_Ther_Med_2014_Sep_20_8(3)_968-972.nxml.txt.nlp	25120631	SENT130	2	2	8	8	naringin	PF4	PA151958360	5196	0.791
NULL	Diabetes_2009_Feb_58(2)_344-351.nxml.txt.nlp	19008341	SENT169	4	4	1	1	resveratrol	SIRT1		23411	0.791
NULL	Surg_Endosc_2010_Feb_2_24(2)_304-334.nxml.txt.nlp	19572178	SENT921	2	2	16	16	sargramostim	VEGFR1	PA164748631	2321	0.791
NULL	Clin_Pharmacokinet_2014_Sep_3_53(1)_1-16.nxml.txt.nlp	23999929	SENT287	40	40	8	8	rivaroxaban	CYP3A4	PA165958360	1576	0.791
NULL	Cancer_Imaging_2005_Nov_23_5(Spec_No_A)_S113-S119.nxml.txt.nlp	16361126	SENT94	4	4	1	1	cyclophosphamide	CHOP	PA449165	1649	0.791
NULL	Biomed_Res_Int_2013_Sep_5_2013_929531.nxml.txt.nlp	24083250	SENT56	8	8	17	17	hyaluronan	HAS2	PA165958431	3037	0.791
NULL	Mol_Cancer_2013_May_24_12_46.nxml.txt.nlp	23705826	SENT114	18	18	11	11	imatinib	ABL1	PA10804	25	0.791
NULL	Hum_Genomics_Proteomics_2010_Apr_13_2010_164906.nxml.txt.nlp	20981232	SENT257	27	27	4	4	thrombin	IL-6	PA451674	3569	0.791
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Apr_15_6_37-41.nxml.txt.nlp	24833915	SENT20	28	28	23	23	maytansine	DM1	PA165291473	338023;1760;28509	0.791
NULL	Core_Evid_2010_Oct_21_5_77-90.nxml.txt.nlp	21042544	SENT231	7	7	5	5	aprepitant	NK1	PA164747039	11126	0.791
NULL	Br_J_Cancer_1998_Jul_78(2)_240-245.nxml.txt.nlp	9683300	SENT17	16	16	8	8	clodronate	BMD	PA10239	1756;7439	0.791
NULL	Nucleic_Acids_Res_2013_Nov_27_41(21)_9786-9799.nxml.txt.nlp	23982513	SENT229	16	16	4	4	arsenite	ADAR1	PA452638	103	0.791
NULL	Biomed_Res_Int_2014_Jan_19_2014_215872.nxml.txt.nlp	24575401	SENT162	7	7	19	19	artemisinin	TC2	PA165111696	6948	0.791
NULL	Hum_Genomics_Proteomics_2010_Apr_13_2010_164906.nxml.txt.nlp	20981232	SENT254	10	10	22	22	gabapentin	p38	PA449720	10598;1432;7965	0.791
NULL	Acta_Neuropathol_2012_Mar_16_123(3)_369-380.nxml.txt.nlp	22083253	SENT56	12	12	22	22	lovastatin	NF1	PA450272	4763	0.791
NULL	Diabetes_2009_Feb_58(2)_344-351.nxml.txt.nlp	19008341	SENT219	4	4	25	25	resveratrol	SIRT1		23411	0.791
NULL	Adolesc_Health_Med_Ther_2014_Sep_26_5_171-182.nxml.txt.nlp	25298741	SENT210	7	7	9	9	perphenazine	IMPACT	PA450882	55364	0.791
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Sep_20_70(Pt_10)_228-230.nxml.txt.nlp	25484659	SENT25	5	5	12	12	trometamol	mol	PA451802	90527	0.791
NULL	Brain_Behav_2013_Mar_6_3(2)_114-133.nxml.txt.nlp	23533150	SENT243	9	9	14	14	ethanol	HSF1	PA448073	3297	0.791
NULL	Br_J_Cancer_2014_Mar_4_110(5)_1221-1227.nxml.txt.nlp	24496456	SENT28	9	9	5	5	panitumumab	EGFR	PA162373091	1956	0.791
NULL	J_Psychopharmacol_2010_Jan_24(1)_27-38.nxml.txt.nlp	19204064	SENT387	13	13	18	18	cocaine	NK1	PA449072	11126	0.791
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1150.nxml.txt.nlp	24675468	SENT91	25	25	23	23	ethanol	adiponectin	PA448073	9370	0.791
NULL	Leukemia_2013_Feb_31_27(2)_278-285.nxml.txt.nlp	22907049	SENT26	21	21	10	10	sunitinib	KIT	PA162372840	3815	0.791
NULL	Cell_Death_Dis_2012_Jun_28_3(6)_e336.nxml.txt.nlp	22739988	SENT33	3	3	22	22	estradiol	BRCA1	PA449503	672	0.791
NULL	J_Cardiovasc_Dis_Res_2010_Oct-Dec_1(4)_171-176.nxml.txt.nlp	21264180	SENT111	18	18	11	11	resveratrol	AMPK		5563	0.791
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_29_2013_590393.nxml.txt.nlp	23737838	SENT193	25	25	19	19	resveratrol	p53		7157	0.791
NULL	Psychiatry_Investig_2010_Dec_30_7(4)_236-242.nxml.txt.nlp	21253406	SENT78	29	29	17	17	citalopram	CA1	PA449015	759	0.791
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Apr_21_68(Pt_5)_o1466.nxml.txt.nlp	22590340	SENT66	16	16	6	6	ethanol	mol	PA448073	90527	0.791
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2654-2664.nxml.txt.nlp	24136149	SENT256	27	27	7	7	doxorubicin	DNA-PKcs	PA449412	5591	0.791
NULL	Oncol_Lett_2014_May_27_7(5)_1327-1332.nxml.txt.nlp	24765133	SENT69	14	14	30	30	cisplatin	TRAIL	PA449014	8743	0.791
NULL	Front_Immunol_2013_Nov_21_4_393.nxml.txt.nlp	24312100	SENT139	0	0	23	23	bleomycin	NLRP3	PA448645	114548	0.791
NULL	Oncoscience_2013_Dec_11_1(1)_30-38.nxml.txt.nlp	25593982	SENT6	15	15	4	4	glucose	Met	PA449773	79811	0.791
NULL	Am_J_Physiol_Endocrinol_Metab_2013_Nov_1_305(9)_E1134-E1144.nxml.txt.nlp	24022868	SENT91	9	9	19	19	lipase	UCP1	PA450239	7350	0.791
NULL	Allergy_Asthma_Immunol_Res_2010_Apr_24_2(2)_134-140.nxml.txt.nlp	20358028	SENT98	9	9	27	27	methacholine	IL-13	PA165958382	3596	0.791
NULL	Endocr_Connect_2012_Jun_21_1(1)_22-30.nxml.txt.nlp	23781300	SENT166	9	9	15	15	olmesartan	AGTR1	PA164742950	185	0.791
NULL	Biomed_Res_Int_2013_Sep_5_2013_929531.nxml.txt.nlp	24083250	SENT56	8	8	15	15	hyaluronan	HAS1	PA165958431	3036	0.791
NULL	Front_Immunol_2012_Mar_12_3_44.nxml.txt.nlp	22566926	SENT74	13	13	21	21	imiquimod	LC3	PA449972	84557	0.791
NULL	Breast_Cancer_Res_2010_May_12_12(3)_R27.nxml.txt.nlp	20462431	SENT43	18	18	8	8	hydrocortisone	F12	PA449905	2161	0.791
NULL	Nucleic_Acids_Res_2006_Jun_1_34(10)_e73.nxml.txt.nlp	16740739	SENT62	17	17	0	0	l-glutamine	PC3	PA10090	57332;7832;5122	0.791
NULL	Cell_Tissue_Res_2012_Nov_3_350(2)_289-303.nxml.txt.nlp	22864984	SENT81	32	32	13	13	paraformaldehyde	San	PA450790	80218	0.791
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Apr_18_68(Pt_5)_o1407.nxml.txt.nlp	22590295	SENT62	18	18	8	8	ethanol	mol	PA448073	90527	0.791
NULL	Br_J_Cancer_2011_Apr_12_104(8)_1256-1261.nxml.txt.nlp	21448165	SENT131	25	25	14	14	bevacizumab	IFN	PA130232992	3439	0.791
NULL	Mol_Cell_Endocrinol_2013_Jan_30_365(2)_303-308.nxml.txt.nlp	23178796	SENT382	4	4	12	12	lipase	CB1	PA450239	1268	0.791
NULL	Allergy_Asthma_Immunol_Res_2014_Mar_13_6(2)_156-162.nxml.txt.nlp	24587953	SENT157	2	2	16	16	celecoxib	AAP	PA448871	5345	0.791
NULL	Case_Rep_Pediatr_2011_Nov_24_2011_562620.nxml.txt.nlp	22606516	SENT6	29	29	21	21	vancomycin	IFN	PA451850	3439	0.791
NULL	Biologics_2013_Apr_15_7_77-90.nxml.txt.nlp	23723688	SENT111	18	18	16	16	cetuximab	CRT	PA10040	811	0.791
NULL	Oncotarget_2011_Mar_27_2(3)_209-221.nxml.txt.nlp	21444945	SENT155	9	9	17	17	bortezomib	p53	PA10252	7157	0.791
NULL	Mol_Brain_2014_May_15_7_37.nxml.txt.nlp	24886748	SENT235	1	1	19	19	vorinostat	NFKB1	PA164748224	4790	0.791
NULL	Osteoporos_Int_2014_Aug_15_25(10)_2359-2381.nxml.txt.nlp	25182228	SENT532	6	6	22	22	teriparatide	BMD	PA451620	1756;7439	0.791
NULL	Br_J_Clin_Pharmacol_2013_Apr_10_75(4)_979-989.nxml.txt.nlp	22882281	SENT31	32	32	29	29	exenatide	GLP-1	PA164749238	100125288	0.791
NULL	Cancer_Imaging_2008_Nov_25_8(1)_199-205.nxml.txt.nlp	19028612	SENT97	7	7	3	3	trastuzumab	HER2	PA451743	2064	0.791
NULL	Br_J_Cancer_2009_Mar_24_100(6)_923-931.nxml.txt.nlp	19259085	SENT174	28	28	15	15	imatinib	FDG	PA10804	23583	0.791
NULL	Biomed_Res_Int_2014_Jan_29_2014_831845.nxml.txt.nlp	24605337	SENT122	12	12	9	9	bupivacaine	S6K1	PA135057240	6198	0.791
NULL	Int_J_Mol_Sci_2012_Sep_25_13(10)_12153-12168.nxml.txt.nlp	23202889	SENT534	15	15	6	6	cetuximab	NRAS	PA10040	4893	0.791
NULL	Eur_J_Clin_Pharmacol_2014_Sep_27_70(1)_65-77.nxml.txt.nlp	24071959	SENT364	13	13	4	4	tacrolimus	CYP3A4	PA451578	1576	0.791
NULL	Evid_Based_Complement_Alternat_Med_2012_Feb_12_2012_472897.nxml.txt.nlp	22454667	SENT128	0	0	19	19	hesperetin	IL-5	PA164742902	3567	0.791
NULL	Acta_Pharmacol_Sin_2010_Feb_5_31(2)_137-144.nxml.txt.nlp	20139896	SENT7	3	3	15	15	zileuton	5-LOX	PA451955	240	0.791
NULL	Eur_J_Pediatr_2013_Aug_17_172(8)_997-1005.nxml.txt.nlp	22801769	SENT200	12	12	31	31	losartan	FBN1	PA450268	2200	0.791
NULL	Int_J_Mol_Sci_2014_Jun_18_15(6)_11013-11029.nxml.txt.nlp	24945311	SENT562	1	1	5	5	celecoxib	CD133	PA448871	8842	0.791
NULL	Front_Oncol_2014_Sep_29_4_256.nxml.txt.nlp	25325013	SENT162	20	20	33	33	gemcitabine	EGFR	PA449748	1956	0.791
NULL	Acta_Pharmacol_Sin_2009_Jul_3_30(7)_889-898.nxml.txt.nlp	19574994	SENT279	25	25	19	19	pp2	EGFR		1956	0.791
NULL	Tumour_Biol_2012_Oct_19_33(5)_1619-1628.nxml.txt.nlp	22610942	SENT248	8	8	3	3	atorvastatin	RhoA	PA448500	387	0.791
NULL	Breast_Cancer_Res_2012_Aug_8_14(4)_R116.nxml.txt.nlp	22873525	SENT155	10	10	16	16	trastuzumab	HER2	PA451743	2064	0.791
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT112	0	0	6	6	curcumin	XIAP	PA151958596	331	0.791
NULL	Arthritis_Res_Ther_2012_Jun_12_14(3)_R142.nxml.txt.nlp	22691272	SENT103	0	0	15	15	mianserin	TLR4	PA134687937	7099	0.791
NULL	Leukemia_2013_Dec_27_27(12)_2322-2331.nxml.txt.nlp	24072044	SENT179	29	29	37	37	plerixafor	HSPC	PA165958410	5688	0.791
NULL	Br_J_Cancer_2012_Feb_14_106(4)_685-692.nxml.txt.nlp	22294184	SENT195	15	15	8	8	lovastatin	Mcl-1	PA450272	4170	0.791
NULL	Oncologist_2010_Sep_26_15(9)_944-953.nxml.txt.nlp	20798196	SENT43	15	15	11	11	letrozole	HER-2	PA450196	2064	0.791
NULL	EJC_Suppl_2013_Sep_5_11(2)_299-300.nxml.txt.nlp	NULL	SENT28	10	10	12	12	tamoxifen	aromatase	PA451581	1588	0.791
NULL	Br_J_Cancer_2011_Mar_15_104(6)_899-902.nxml.txt.nlp	21343938	SENT63	15	15	17	17	tamoxifen	aromatase	PA451581	1588	0.791
NULL	Cell_Commun_Signal_2004_Jun_25_2_5.nxml.txt.nlp	15219238	SENT70	6	6	18	18	resveratrol	PC3		57332;7832;5122	0.791
NULL	Evid_Based_Complement_Alternat_Med_2011_Jan_9_2011_619650.nxml.txt.nlp	21799685	SENT142	23	23	32	32	ketanserin	5-HT2A	PA131053734	3356	0.791
NULL	Breast_Cancer_Res_2011_Mar_11_13(2)_R29.nxml.txt.nlp	21396094	SENT39	4	4	25	25	fulvestrant	HRG	PA164747170	3084;3273	0.791
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT15	0	0	2	2	perifosine	DR5	PA165291471	8795	0.791
NULL	Clin_Ophthalmol_2011_Apr_18_5_495-502.nxml.txt.nlp	21573098	SENT223	11	11	19	19	gatifloxacin	BAK	PA449738	578	0.791
NULL	Ann_Oncol_2009_Aug_20(Suppl_6)_vi35-vi40.nxml.txt.nlp	19617296	SENT164	4	4	14	14	tanespimycin	Hsp90	PA165291490	3320	0.791
NULL	Br_J_Pharmacol_2008_Sep_9_155(1)_127-137.nxml.txt.nlp	18536750	SENT179	5	5	12	12	piroxicam	IL-10	PA450985	3586	0.791
NULL	Nat_Commun_2014_Dec_8_5_5736.nxml.txt.nlp	25484020	SENT52	9	9	15	15	anastrozole	TRPA1	PA448432	8989	0.791
NULL	Cancers_(Basel)_2010_Jun_14_2(2)_1288-1311.nxml.txt.nlp	24281116	SENT47	18	18	7	7	oxygen	ROS	PA450744	6098	0.791
NULL	Indian_J_Psychiatry_2010_Jan_52(Suppl1)_S317-S340.nxml.txt.nlp	21836703	SENT290	26	26	36	36	chlorpromazine	CPZ	PA448964	8532	0.791
NULL	Front_Genet_2014_Mar_26_5_50.nxml.txt.nlp	24723935	SENT102	24	24	40	40	carbamazepine	TPMT	PA448785	7172	0.791
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT207	11	11	17	17	perifosine	DR5	PA165291471	8795	0.791
NULL	Br_J_Cancer_2010_Nov_2_103(11)_1680-1691.nxml.txt.nlp	21045833	SENT133	29	29	2	2	vorinostat	KRAS	PA164748224	3845	0.791
NULL	Breast_Cancer_Res_Treat_2014_Sep_13_147(3)_631-638.nxml.txt.nlp	25216762	SENT115	25	25	8	8	capecitabine	HER-2	PA448771	2064	0.791
NULL	Mol_Biol_Cell_2012_Sep_1_23(17)_3407-3419.nxml.txt.nlp	22809629	SENT447	3	3	36	36	dextran	SP5	PA449261	389058	0.791
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT175	8	8	4	4	sitagliptin	HIP	PA164748978	6767;6159;64399;5068	0.791
NULL	Environ_Health_Perspect_2008_Oct_27_116(10)_1315-1321.nxml.txt.nlp	18941571	SENT65	9	9	19	19	phenol	F12	PA450913	2161	0.791
NULL	J_Exp_Clin_Cancer_Res_2009_Aug_8_28(1)_110.nxml.txt.nlp	19664237	SENT5	14	14	16	16	cisplatin	DDP	PA449014	1678	0.791
NULL	Clin_Transl_Allergy_2013_May_3_3(Suppl_1)_P1.nxml.txt.nlp	NULL	SENT8	11	11	16	16	omalizumab	SAA	PA164752253	6287	0.791
NULL	Clin_Interv_Aging_2012_Sep_17_7_363-372.nxml.txt.nlp	23049248	SENT57	20	20	26	26	denosumab	RANKL	PA166048634	8600	0.791
NULL	Int_J_Med_Sci_2013_Jun_15_10(8)_1015-1021.nxml.txt.nlp	23801888	SENT96	26	26	5	5	ribavirin	IL28B	PA451241	282617	0.791
NULL	Diabetes_Care_2009_Sep_5_32(9)_1589-1590.nxml.txt.nlp	19502536	SENT71	24	24	34	34	metformin	B12	PA450395	7126;4709	0.791
NULL	Brain_Sci_2014_May_6_4(2)_356-375.nxml.txt.nlp	24961766	SENT207	17	17	10	10	propofol	CA3	PA451141	761	0.791
NULL	Mol_Cancer_2014_Aug_22_13(1)_195.nxml.txt.nlp	NULL	SENT127	33	33	15	15	cisplatin	TBL1XR1	PA449014	79718	0.791
NULL	Clin_Med_Oncol_2008_Mar_1_2_135-144.nxml.txt.nlp	21892276	SENT103	20	20	23	23	capecitabine	CRT	PA448771	811	0.79
NULL	Front_Chem_2014_Oct_14_2_87.nxml.txt.nlp	25353019	SENT172	16	16	7	7	thalidomide	Bcl-2	PA451644	596	0.79
NULL	J_Clin_Biochem_Nutr_2007_Sep_29_41(2)_84-91.nxml.txt.nlp	18193101	SENT117	25	25	5	5	lansoprazole	IL-8	PA450180	3576	0.79
NULL	J_Cell_Biol_1999_Jan_11_144(1)_71-82.nxml.txt.nlp	9885245	SENT177	12	12	28	28	galactose	PRK1	PA449725	5585;84432	0.79
NULL	EMBO_Mol_Med_2011_Apr_3(4)_235-245.nxml.txt.nlp	21374818	SENT133	22	22	13	13	doxycycline	CLDN5	PA449415	7122	0.79
NULL	Mol_Pain_2013_Jul_31_9_38.nxml.txt.nlp	23898828	SENT145	14	14	18	18	capsaicin	p38	PA448776	10598;1432;7965	0.79
NULL	Biomed_Res_Int_2013_Feb_28_2013_215283.nxml.txt.nlp	23555077	SENT209	28	28	15	15	galactose	IL-23	PA449725	51561	0.79
NULL	J_Cell_Mol_Med_2013_Jan_11_17(1)_134-146.nxml.txt.nlp	23305490	SENT337	28	28	26	26	curcumin	TREK-1	PA151958596	3776	0.79
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Nov_20_64(Pt_12)_o2370.nxml.txt.nlp	21581342	SENT55	20	20	35	35	ethanol	mol	PA448073	90527	0.79
NULL	Mol_Syst_Biol_2010_Apr_13_6_359.nxml.txt.nlp	20393579	SENT289	13	13	1	1	formaldehyde	IL-4	PA449703	3565	0.79
NULL	J_Hematol_Oncol_2008_Oct_23_1_19.nxml.txt.nlp	18947412	SENT111	24	24	8	8	alemtuzumab	CD34	PA164783958	947	0.79
NULL	Breast_Cancer_Res_2012_Jul_19_14(4)_R108.nxml.txt.nlp	22812534	SENT49	11	11	7	7	pargyline	PELP1	PA450797	27043	0.79
NULL	J_Mol_Med_2011_Jul_23_89(7)_667-676.nxml.txt.nlp	21431325	SENT59	30	30	6	6	berberine	AMPK	PA165860812	5563	0.79
NULL	Front_Neurosci_2011_Dec_5_5_131.nxml.txt.nlp	22164129	SENT614	0	0	13	13	ethanol	ACTH	PA448073	5443	0.79
NULL	Clin_Interv_Aging_2015_Jan_6_10_157-174.nxml.txt.nlp	25609933	SENT251	28	28	8	8	anastrozole	BCS	PA448432	617	0.79
NULL	Diabetes_Care_2011_Sep_19_34(9)_2041-2047.nxml.txt.nlp	21868779	SENT258	8	8	13	13	liraglutide	GLP-1	PA165958364	100125288	0.79
NULL	Oncotarget_2014_Feb_7_5(3)_775-787.nxml.txt.nlp	24519956	SENT151	17	17	2	2	docetaxel	PC3	PA449383	57332;7832;5122	0.79
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1063.nxml.txt.nlp	24556678	SENT87	0	0	5	5	thioridazine	c-FLIP	PA451666	8837	0.79
NULL	Clin_Med_Insights_Oncol_2012_Apr_23_6_189-197.nxml.txt.nlp	22563251	SENT25	3	3	16	16	imatinib	KIT	PA10804	3815	0.79
NULL	Cells_2014_Jun_26_3(3)_662-673.nxml.txt.nlp	24971848	SENT316	6	6	8	8	capsaicin	TRPV1	PA448776	7442	0.79
NULL	Cancer_Immunol_Immunother_2012_Jul_23_61(7)_1101-1111.nxml.txt.nlp	22193989	SENT168	26	26	8	8	oxaliplatin	CD80	PA131285527	941	0.79
NULL	ScientificWorldJournal_2014_Feb_4_2014_978351.nxml.txt.nlp	24688450	SENT71	19	19	16	16	tocilizumab	IL-6	PA165292659	3569	0.79
NULL	Psychol_Res_Behav_Manag_2010_Dec_6_3_109-118.nxml.txt.nlp	22110334	SENT114	34	34	11	11	paroxetine	CYP1A2	PA450801	1544	0.79
NULL	J_Oncol_2009_May_6_2009_567486.nxml.txt.nlp	19424511	SENT75	12	12	14	14	cetuximab	KRAS	PA10040	3845	0.79
NULL	Oxid_Med_Cell_Longev_2012_Aug_23_2012_139327.nxml.txt.nlp	22966413	SENT36	6	6	30	30	methimazole	METL	PA450422	55798	0.79
NULL	Front_Microbiol_2014_Mar_3_5_70.nxml.txt.nlp	24624123	SENT98	22	22	24	24	tobramycin	TOB	PA451704	10140	0.79
NULL	Clin_Med_Insights_Cardiol_2013_May_7_7_87-95.nxml.txt.nlp	23700377	SENT25	9	9	34	34	heparin	ACT	PA449855	12;11332;9457;641455	0.79
NULL	Basic_Clin_Pharmacol_Toxicol_2013_Feb_5_112(2)_132-137.nxml.txt.nlp	22900583	SENT153	13	13	9	9	ritonavir	CYP3A	PA451260	1574	0.79
NULL	Mol_Vis_2012_Oct_5_18_2454-2467.nxml.txt.nlp	23077404	SENT10	6	6	27	27	bevacizumab	HIF-1	PA130232992	29072	0.79
NULL	Arch_Plast_Surg_2014_Nov_3_41(6)_620-629.nxml.txt.nlp	25396172	SENT53	22	22	12	12	triamcinolone	CO2	PA451749	4513	0.79
NULL	Fibrogenesis_Tissue_Repair_2010_Jan_5_3_2.nxml.txt.nlp	20051102	SENT166	33	33	17	17	bleomycin	BMP7	PA448645	655	0.79
NULL	Indian_J_Ophthalmol_2011_Jul-Aug_59(4)_273-277.nxml.txt.nlp	21666310	SENT53	8	8	15	15	doxorubicin	CHOP	PA449412	1649	0.79
NULL	F1000_Med_Rep_2012_Feb_1_4_4.nxml.txt.nlp	22312414	SENT40	14	14	28	28	vancomycin	VISA	PA451850	57506	0.79
NULL	ASN_Neuro_2011_Mar_24_3(1)_e00053.nxml.txt.nlp	21345173	SENT36	36	36	18	18	trypsin	F12	PA451806	2161	0.79
NULL	Oncotarget_2011_Dec_31_2(12)_935-947.nxml.txt.nlp	22249213	SENT237	8	8	18	18	vinblastine	MCAK	PA451877	11004	0.79
NULL	Environ_Health_Perspect_1990_Apr_85_89-94.nxml.txt.nlp	2384071	SENT11	3	3	5	5	oxygen	NAC	PA450744	22861	0.79
NULL	Nat_Commun_2014_Nov_25_5_5437.nxml.txt.nlp	25421715	SENT467	16	16	3	3	cisplatin	zeta	PA449014	9907	0.79
NULL	Environ_Health_Perspect_2010_Jun_25_118(6)_864-870.nxml.txt.nlp	20100676	SENT158	16	16	7	7	arsenite	INS-1	PA452638	2305	0.79
NULL	Int_J_Impot_Res_2010_Mar_26_22(2)_120-126.nxml.txt.nlp	19940852	SENT50	16	16	33	33	forskolin	mol	PA146096022	90527	0.79
NULL	Nucleic_Acids_Res_2011_Oct_9_39(19)_8355-8365.nxml.txt.nlp	21745816	SENT164	32	32	6	6	doxycycline	USP7	PA449415	7874	0.79
NULL	J_Clin_Biochem_Nutr_2010_Jan_29_46(1)_87-92.nxml.txt.nlp	20104270	SENT7	1	1	25	25	hesperidin	adiponectin	PA449867	9370	0.79
NULL	Eur_J_Med_Res_2010_Feb_26_15(2)_81-83.nxml.txt.nlp	20452889	SENT9	9	9	26	26	tenofovir	CD4	PA10204	920	0.79
NULL	J_Vet_Med_Sci_2014_Oct_16_76(10)_1383-1387.nxml.txt.nlp	24931645	SENT21	0	0	20	20	sitagliptin	GLP-1	PA164748978	100125288	0.79
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT138	26	26	17	17	atorvastatin	TNF	PA448500	7124	0.79
NULL	Breast_Cancer_Res_2011_Jun_27_13(3)_212.nxml.txt.nlp	21787441	SENT209	19	19	2	2	tamoxifen	aromatase	PA451581	1588	0.79
NULL	Adv_Biomed_Res_2014_Nov_29_3_232.nxml.txt.nlp	25538918	SENT156	15	15	34	34	ketamine	ACL	PA450144	47	0.79
NULL	Iran_Red_Crescent_Med_J_2014_Feb_7_16(2)_e15277.nxml.txt.nlp	24719748	SENT152	35	35	30	30	clopidogrel	ADP	PA449053	23038	0.79
NULL	Arch_Med_Sci_2013_Aug_30_9(4)_589-593.nxml.txt.nlp	24049515	SENT95	31	31	11	11	tamoxifen	PHD3	PA451581	112399	0.79
NULL	Mol_Cancer_2009_Nov_24_8_109.nxml.txt.nlp	19930708	SENT209	19	19	22	22	exemestane	EGFR	PA449563	1956	0.79
NULL	J_Korean_Assoc_Oral_Maxillofac_Surg_2014_Dec_26_40(6)_291-296.nxml.txt.nlp	25551094	SENT126	4	4	9	9	alendronate	M-CSF	PA448082	1435	0.79
NULL	Mol_Cell_Proteomics_2013_Jan_15_12(1)_245-262.nxml.txt.nlp	23071098	SENT606	18	18	6	6	cetuximab	PTEN	PA10040	5728	0.79
NULL	Cardiovasc_Diabetol_2005_May_15_4_6.nxml.txt.nlp	15892894	SENT147	12	12	6	6	glucose	AT1	PA449773	9197;185	0.79
NULL	Oxid_Med_Cell_Longev_2012_Nov_14_2012_856085.nxml.txt.nlp	23213350	SENT171	11	11	17	17	losartan	p47phox	PA450268	653361	0.79
NULL	Ann_Oncol_2011_Mar_8_22(3)_503-514.nxml.txt.nlp	20616198	SENT67	29	29	15	15	anastrozole	aromatase	PA448432	1588	0.79
NULL	Cell_Commun_Signal_2014_Nov_25_12(1)_55.nxml.txt.nlp	NULL	SENT240	6	6	3	3	doxycycline	SF-1	PA449415	2516	0.79
NULL	Clin_Ophthalmol_2010_Oct_21_4_1229-1236.nxml.txt.nlp	21060677	SENT91	22	22	20	20	latanoprost	BAK	PA164774763	578	0.79
NULL	Cancers_(Basel)_2014_Apr_16_6(2)_926-957.nxml.txt.nlp	24743778	SENT258	2	2	12	12	curcumin	STAT3	PA151958596	6774	0.79
NULL	Environ_Health_Perspect_2008_Mar_26_116(3)_322-328.nxml.txt.nlp	18335098	SENT108	26	26	14	14	estradiol	PMI	PA449503	8834;5373	0.79
NULL	J_Oncol_2012_Apr_10_2012_931071.nxml.txt.nlp	22570654	SENT10	20	20	10	10	plerixafor	CD34	PA165958410	947	0.79
NULL	World_Allergy_Organ_J_2012_Feb_17_5(Suppl_2)_S130d-S131.nxml.txt.nlp	NULL	SENT4	14	14	12	12	ribavirin	IFN	PA451241	3439	0.79
NULL	Chonnam_Med_J_2013_Apr_25_49(1)_31-37.nxml.txt.nlp	23678475	SENT11	8	8	2	2	rosuvastatin	adiponectin	PA134308647	9370	0.79
NULL	Indian_J_Psychiatry_2014_Jan_56(Suppl_1)_S63-S96.nxml.txt.nlp	NULL	SENT814	11	11	23	23	propranolol	OGC	PA451145	8402	0.79
NULL	J_Gen_Physiol_2013_Aug_142(2)_137-155.nxml.txt.nlp	23858003	SENT462	16	16	28	28	mibefradil	ACTH	PA450492	5443	0.79
NULL	Cell_Death_Dis_2014_Apr_17_5(4)_e1182.nxml.txt.nlp	24743737	SENT211	4	4	2	2	capsaicin	TRPV1	PA448776	7442	0.79
NULL	Arch_Drug_Inf_2008_Jul_1(1)_14-22.nxml.txt.nlp	20157364	SENT143	3	3	7	7	pravastatin	IL-6	PA451089	3569	0.79
NULL	Ann_Hematol_2010_Nov_25_89(11)_1115-1124.nxml.txt.nlp	20499237	SENT118	25	25	5	5	fludarabine	CD5	PA449655	921	0.79
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT12	22	22	19	19	curcumin	TRAIL	PA151958596	8743	0.79
NULL	Cell_Host_Microbe_2011_May_19_9(5)_436-443.nxml.txt.nlp	21575914	SENT52	37	37	34	34	imiquimod	TLR4	PA449972	7099	0.79
NULL	Iran_J_Neurol_2011_10(1-2)_19-21.nxml.txt.nlp	24250838	SENT60	16	16	37	37	levodopa	COMT	PA450213	1312	0.79
NULL	Exp_Neurobiol_2014_Jun_13_23(2)_138-147.nxml.txt.nlp	24963278	SENT153	16	16	26	26	hemin	TLR2	PA449849	7097	0.79
NULL	Cell_Res_2014_Jul_9_24(7)_820-841.nxml.txt.nlp	24810299	SENT293	23	23	16	16	doxycycline	Hes1	PA449415	3280	0.79
NULL	Int_J_Mol_Sci_2013_Aug_14_14(8)_16719-16731.nxml.txt.nlp	23949634	SENT3	6	6	28	28	thrombin	TPC	PA451674	8030;60386	0.79
NULL	Mol_Cancer_2009_Nov_24_8_109.nxml.txt.nlp	19930708	SENT179	11	11	33	33	exemestane	aromatase	PA449563	1588	0.79
NULL	Mol_Cancer_2008_Jun_30_7_60.nxml.txt.nlp	18590557	SENT73	18	18	34	34	tamoxifen	TRAIL	PA451581	8743	0.79
NULL	Br_J_Cancer_2013_Mar_19_108(5)_1052-1060.nxml.txt.nlp	23422754	SENT114	13	13	7	7	bevacizumab	VEGF-A	PA130232992	7422	0.79
NULL	Biomed_Res_Int_2014_Jun_3_2014_620434.nxml.txt.nlp	24995315	SENT150	29	29	26	26	ethanol	mol	PA448073	90527	0.79
NULL	Behav_Brain_Funct_2012_Feb_13_8_9.nxml.txt.nlp	22329956	SENT102	22	22	31	31	ezetimibe	PMP22	PA10816	5376;5827	0.79
NULL	J_Cancer_2012_Nov_30_4(1)_3-11.nxml.txt.nlp	23386900	SENT116	8	8	31	31	sildenafil	CCL3	PA451346	6348	0.79
NULL	Arthritis_Res_Ther_2012_Dec_3_14(6)_R262.nxml.txt.nlp	23206933	SENT212	2	2	9	9	tocilizumab	IL-6	PA165292659	3569	0.79
NULL	Mucosal_Immunol_2012_May_22_5(3)_320-331.nxml.txt.nlp	22354319	SENT83	26	26	12	12	heparin	CEACAM1	PA449855	634	0.79
NULL	J_Cell_Mol_Med_2013_May_20_17(5)_648-656.nxml.txt.nlp	23601074	SENT132	4	4	6	6	gefitinib	AKT	PA131301952	207	0.79
NULL	Oxid_Med_Cell_Longev_2012_May_28_2012_632959.nxml.txt.nlp	22690272	SENT60	0	0	22	22	curcumin	Bcl-2	PA151958596	596	0.79
NULL	Mol_Cancer_2012_Dec_12_11_91.nxml.txt.nlp	23234355	SENT106	16	16	7	7	cetuximab	EGFR	PA10040	1956	0.79
NULL	Acta_Histochem_Cytochem_2013_Dec_28_46(6)_187-197.nxml.txt.nlp	24610966	SENT171	37	37	46	46	pilocarpine	AQP5	PA450962	362	0.79
NULL	Mol_Vis_2012_Oct_5_18_2454-2467.nxml.txt.nlp	23077404	SENT27	1	1	8	8	bevacizumab	VEGF-A	PA130232992	7422	0.79
NULL	Ann_Surg_Oncol_2014_Feb_13_21(5)_1575-1582.nxml.txt.nlp	24522992	SENT173	8	8	5	5	tamoxifen	aromatase	PA451581	1588	0.79
NULL	Acta_Naturae_2013_Jul-Sep_5(3)_92-98.nxml.txt.nlp	24303205	SENT122	25	25	5	5	thrombin	MGL	PA451674	11343	0.79
NULL	EPMA_J_2013_Feb_18_4(1)_5.nxml.txt.nlp	23418936	SENT184	16	16	7	7	levodopa	COMT	PA450213	1312	0.79
NULL	Breast_Cancer_Res_2004_Mar_26_6(3)_R252-R263.nxml.txt.nlp	15084249	SENT179	16	16	5	5	tamoxifen	NAT1	PA451581	9;1982	0.79
NULL	Br_J_Cancer_1988_Mar_57(3)_271-276.nxml.txt.nlp	3258523	SENT10	31	31	14	14	melphalan	IL-2	PA450354	3558	0.79
NULL	Int_J_Biol_Sci_2013_Mar_7_9(3)_279-288.nxml.txt.nlp	23493630	SENT129	21	21	6	6	tocilizumab	IL-21	PA165292659	59067;50616;27189	0.79
NULL	Cancer_Cell_Int_2014_Jun_16_14_53.nxml.txt.nlp	24966801	SENT139	11	11	21	21	metformin	p53	PA450395	7157	0.79
NULL	EMBO_Mol_Med_2009_Jul_1(4)_211-222.nxml.txt.nlp	20049723	SENT294	13	13	16	16	l-glutamine	GM-CSF	PA10090	1437	0.79
NULL	J_Clin_Exp_Pathol_2012_May_17_Suppl_4_7327.nxml.txt.nlp	25379357	SENT37	3	3	33	33	resveratrol	CAMKK		10645	0.79
NULL	Oncotarget_2013_Nov_15_4(11)_1866-1867.nxml.txt.nlp	24272818	SENT3	10	10	2	2	lapatinib	HER2	PA152241907	2064	0.79
NULL	Basic_Clin_Neurosci_2013_Autumn_4(4)_323-328.nxml.txt.nlp	25337364	SENT136	6	6	9	9	colchicine	CA1	PA449092	759	0.79
NULL	BMJ_Open_2014_Oct_10_4(10)_e005708.nxml.txt.nlp	25304189	SENT48	9	9	13	13	clozapine	FGA	PA449061	2243	0.79
NULL	J_Korean_Med_Sci_2010_Jun_24_25(6)_829-834.nxml.txt.nlp	20514301	SENT74	9	9	15	15	papain	IL-25	PA450778	64806;56005	0.79
NULL	Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.nxml.txt.nlp	24736980	SENT181	3	3	10	10	rosuvastatin	OATP1B1	PA134308647	10599	0.79
NULL	Cancer_Sci_2012_Nov_17_103(11)_1907-1912.nxml.txt.nlp	22809142	SENT59	20	20	27	27	denosumab	DKK1	PA166048634	22943	0.79
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT179	8	8	39	39	metformin	HIF-1	PA450395	29072	0.79
NULL	Gene_Regul_Syst_Bio_2014_Mar_4_8_63-73.nxml.txt.nlp	24634581	SENT98	0	0	3	3	minocycline	NANOS1	PA450519	340719	0.79
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT38	21	21	10	10	cisplatin	MVP	PA449014	9961	0.79
NULL	Indian_J_Pharm_Sci_2013_May-Jun_75(3)_310-323.nxml.txt.nlp	24082347	SENT70	35	35	46	46	ethanol	TLC	PA448073	3933	0.79
NULL	Oncotarget_2014_Oct_21_5(22)_11252-11268.nxml.txt.nlp	25361004	SENT93	4	4	34	34	metformin	ANOVA	PA450395	4858	0.79
NULL	Indian_J_Med_Res_2013_Dec_138(6)_919-921.nxml.txt.nlp	24521636	SENT52	22	22	2	2	bleomycin	IL-4	PA448645	3565	0.79
NULL	Breast_Cancer_Res_2008_Jul_8_10(4)_R56.nxml.txt.nlp	18611244	SENT200	15	15	28	28	letrozole	aromatase	PA450196	1588	0.79
NULL	Oncotarget_2013_Jul_5_4(7)_984-994.nxml.txt.nlp	23846322	SENT73	7	7	13	13	suramin	SIRT1	PA10292	23411	0.79
NULL	Neural_Dev_2013_Apr_25_8_7.nxml.txt.nlp	23618343	SENT274	8	8	23	23	l-glutamine	B27	PA10090	56246	0.79
NULL	J_Hematol_Oncol_2009_Jan_21_2_2.nxml.txt.nlp	19159467	SENT116	0	0	18	18	panitumumab	EGFR	PA162373091	1956	0.79
NULL	Arthritis_Res_Ther_2011_Sep_21_13(5)_239.nxml.txt.nlp	21955617	SENT164	7	7	9	9	celecoxib	CBX	PA448871	10951	0.79
NULL	Arthritis_Res_Ther_2011_Feb_11_13(1)_R21.nxml.txt.nlp	21314928	SENT126	38	38	14	14	hydroxychloroquine	CD4	PA164777036	920	0.79
NULL	J_Obes_2011_Dec_26_2011_765473.nxml.txt.nlp	21274277	SENT161	3	3	1	1	exenatide	GLP-1	PA164749238	100125288	0.79
NULL	Int_J_Mol_Imaging_2011_Oct_26_2011_874585.nxml.txt.nlp	21490735	SENT160	23	23	8	8	glucose	FDG	PA449773	23583	0.79
NULL	Mol_Vis_2012_May_11_18_1260-1270.nxml.txt.nlp	22665973	SENT88	16	16	18	18	topotecan	TPT	PA451729	23590;6469	0.79
NULL	Nucleic_Acids_Res_2012_Jul_19_40(13)_5910-5925.nxml.txt.nlp	22434882	SENT327	10	10	20	20	etoposide	HBZ	PA449552	3050	0.79
NULL	Oncoimmunology_2012_Oct_1_1(7)_1004-1016.nxml.txt.nlp	23170249	SENT106	6	6	8	8	paclitaxel	HER-2	PA450761	2064	0.79
NULL	Br_J_Cancer_2010_Jun_29_103(1)_61-72.nxml.txt.nlp	20588279	SENT213	9	9	26	26	trastuzumab	RhoB	PA451743	388	0.79
NULL	Cardiovasc_Ther_2012_Jun_19_30(3)_e146-e155.nxml.txt.nlp	21167014	SENT35	0	0	5	5	liraglutide	GLP-1	PA165958364	100125288	0.79
NULL	Mol_Biol_Cell_2013_Aug_15_24(16)_2582-2592.nxml.txt.nlp	23783032	SENT125	19	19	14	14	bortezomib	FANCL	PA10252	55120	0.79
NULL	Int_J_Environ_Res_Public_Health_2010_Feb_12_7(2)_565-582.nxml.txt.nlp	20616991	SENT168	17	17	10	10	copper	STP	PA449114	9322	0.79
NULL	Eur_J_Clin_Pharmacol_2012_Apr_14_68(4)_371-377.nxml.txt.nlp	21997404	SENT155	4	4	14	14	leflunomide	IL-10	PA450192	3586	0.79
NULL	Front_Endocrinol_(Lausanne)_2014_Feb_25_5_22.nxml.txt.nlp	24611062	SENT277	7	7	5	5	estradiol	PAK1	PA449503	5585;5058	0.79
NULL	Clin_Epigenetics_2011_Dec_5_3(1)_8.nxml.txt.nlp	22414275	SENT4	17	17	1	1	tamoxifen	ESR1	PA451581	2099	0.79
NULL	Braz_J_Med_Biol_Res_2014_May_9_47(6)_478-482.nxml.txt.nlp	24770568	SENT131	27	27	15	15	cisplatin	CD133	PA449014	8842	0.79
NULL	Cell_Mol_Neurobiol_2010_Nov_9_30(8)_1395-1400.nxml.txt.nlp	21061160	SENT47	34	34	0	0	cyproheptadine	CHGA	PA164749366	1113	0.79
NULL	Cancer_Manag_Res_2013_Jun_7_5_91-101.nxml.txt.nlp	23785245	SENT100	7	7	22	22	crizotinib	EGFR	PA165946122	1956	0.79
NULL	Mol_Neurobiol_2010_Jun_2_41(2-3)_392-409.nxml.txt.nlp	20437209	SENT298	0	0	19	19	curcumin	LOX	PA151958596	4015	0.79
NULL	Nucleic_Acids_Res_2013_May_5_41(10)_5210-5222.nxml.txt.nlp	23563151	SENT212	24	24	14	14	arsenite	GADD45	PA452638	1647	0.79
NULL	Hum_Mol_Genet_2013_Nov_15_22(22)_4616-4626.nxml.txt.nlp	23814041	SENT158	9	9	15	15	simvastatin	gp78	PA451363	267	0.79
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT104	18	18	23	23	cetuximab	KRAS	PA10040	3845	0.79
NULL	J_Gynecol_Oncol_2011_Mar_31_22(1)_9-17.nxml.txt.nlp	21607090	SENT92	10	10	26	26	paclitaxel	PCFT	PA450761	113235	0.79
NULL	Behav_Brain_Funct_2012_Jul_10_8_20.nxml.txt.nlp	22559224	SENT175	7	7	3	3	baclofen	ANOVA	PA448533	4858	0.79
NULL	Arthritis_Res_Ther_2011_Mar_16_13(2)_R44.nxml.txt.nlp	21410959	SENT149	2	2	9	9	glucosamine	RANKL	PA164747613	8600	0.79
NULL	Cancers_(Basel)_2011_Aug_5_3(3)_3114-3142.nxml.txt.nlp	24212948	SENT712	0	0	10	10	cyclophosphamide	CD44	PA449165	960	0.79
NULL	Diabetes_Metab_J_2013_Oct_17_37(5)_315-325.nxml.txt.nlp	24199159	SENT162	25	25	14	14	resveratrol	SIRT1		23411	0.79
NULL	Clinics_(Sao_Paulo)_2010_Mar_65(3)_311-316.nxml.txt.nlp	20360923	SENT85	5	5	0	0	l-cysteine	NAC	PA449173	22861	0.79
NULL	Biomed_Res_Int_2014_Mar_6_2014_712893.nxml.txt.nlp	24734240	SENT122	3	3	6	6	ethanol	HIF-1alpha	PA448073	3091	0.79
NULL	Enzyme_Res_2009_Nov_1_2010_165878.nxml.txt.nlp	21048860	SENT227	6	6	22	22	asparaginase	Met	PA448492	79811	0.79
NULL	Cancer_Growth_Metastasis_2013_Nov_27_6_61-80.nxml.txt.nlp	24665208	SENT247	11	11	24	24	plerixafor	CXCR4	PA165958410	7852	0.79
NULL	Channels_(Austin)_2010_Jan_1_4(1)_22-41.nxml.txt.nlp	19934650	SENT40	8	8	6	6	quinidine	Slo3	PA451209	157855	0.79
NULL	Allergy_Asthma_Immunol_Res_2010_Jul_19_2(3)_177-182.nxml.txt.nlp	20592916	SENT99	8	8	13	13	tiotropium	ADRB2	PA164769056	154	0.79
NULL	Onco_Targets_Ther_2014_Mar_24_7_491-500.nxml.txt.nlp	24711706	SENT97	13	13	11	11	trastuzumab	DM1	PA451743	338023;1760;28509	0.79
NULL	Environ_Health_Perspect_2005_Aug_15_113(8)_1009-1014.nxml.txt.nlp	16079071	SENT115	2	2	12	12	losartan	p38	PA450268	10598;1432;7965	0.79
NULL	Curr_Genomics_2013_Nov_14(7)_453-467.nxml.txt.nlp	24396277	SENT322	23	23	15	15	glucose	PCSK1	PA449773	5122	0.79
NULL	Pharmaceutics_2011_Dec_9_3(4)_932-953.nxml.txt.nlp	24309315	SENT164	5	5	8	8	amiloride	ASIC1	PA448368	41	0.79
NULL	J_Biol_Eng_2009_Oct_16_3_18.nxml.txt.nlp	19835592	SENT138	37	37	39	39	chlorpromazine	CPZ	PA448964	8532	0.79
NULL	Diabetes_2013_Jun_17_62(6)_1913-1922.nxml.txt.nlp	23349495	SENT172	4	4	2	2	sildenafil	VASP	PA451346	7408	0.79
NULL	J_Carcinog_2014_Feb_20_13_4.nxml.txt.nlp	24737952	SENT54	0	0	17	17	trastuzumab	HER2	PA451743	2064	0.79
NULL	Cardiovasc_Diabetol_2005_Oct_5_4_16.nxml.txt.nlp	16207378	SENT163	34	34	22	22	glucosamine	perlecan	PA164747613	3339	0.79
NULL	Diabetes_2013_Nov_18_62(11)_3851-3862.nxml.txt.nlp	23884890	SENT229	11	11	7	7	metformin	AMPK	PA450395	5563	0.79
NULL	Psychiatr_Genet_2013_Aug_28_23(4)_153-162.nxml.txt.nlp	23811784	SENT186	11	11	20	20	clozapine	5-HT2A	PA449061	3356	0.79
NULL	Breast_Cancer_Res_2005_Jan_28_7(3)_R284-R290.nxml.txt.nlp	15987423	SENT36	22	22	12	12	tamoxifen	CYP2D6	PA451581	1565	0.79
NULL	Cancer_Med_2012_Dec_26_1(3)_318-327.nxml.txt.nlp	23342281	SENT131	2	2	4	4	tamoxifen	aromatase	PA451581	1588	0.79
NULL	Gut_Liver_2011_Jun_24_5(2)_117-132.nxml.txt.nlp	21814590	SENT159	7	7	4	4	ribavirin	IFN	PA451241	3439	0.79
NULL	Ann_Clin_Microbiol_Antimicrob_2010_May_27_9_16.nxml.txt.nlp	20504376	SENT148	27	27	40	40	ciprofloxacin	SP2	PA449009	6668	0.79
NULL	Sensors_(Basel)_2013_Jan_16_13(1)_1064-1075.nxml.txt.nlp	23325167	SENT49	6	6	12	12	hemin	mol	PA449849	90527	0.79
NULL	Case_Rep_Hematol_2013_Nov_6_2013_520712.nxml.txt.nlp	24307957	SENT35	2	2	4	4	hydroxyurea	EPO	PA449942	7076;8288;2056	0.79
NULL	Ann_Oncol_2009_Aug_17_20(8)_1319-1329.nxml.txt.nlp	19535820	SENT349	29	29	43	43	carboplatin	San	PA448803	80218	0.79
NULL	Exp_Ther_Med_2014_Nov_29_8(5)_1473-1478.nxml.txt.nlp	25289044	SENT81	6	6	16	16	paraformaldehyde	AZU	PA450790	566	0.79
NULL	J_Korean_Neurosurg_Soc_2014_Jul_31_56(1)_1-4.nxml.txt.nlp	25289117	SENT74	2	2	15	15	curcumin	p38	PA151958596	10598;1432;7965	0.79
NULL	Ann_Dermatol_2014_Aug_31_26(4)_517-520.nxml.txt.nlp	25143685	SENT25	8	8	11	11	tazarotene	TIG3	PA164746821	5920	0.79
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1013.nxml.txt.nlp	24457957	SENT98	24	24	21	21	orlistat	NOXA	PA164776864	5366	0.79
NULL	J_Ophthalmol_2012_Dec_18_2012_483034.nxml.txt.nlp	22220269	SENT325	13	13	30	30	bevacizumab	PLGF	PA130232992	5228	0.79
NULL	Age_(Dordr)_2011_Dec_11_33(4)_565-578.nxml.txt.nlp	21222044	SENT147	10	10	13	13	estradiol	Rho	PA449503	29984	0.79
NULL	Arthritis_Res_Ther_2014_Apr_3_16(2)_R86.nxml.txt.nlp	24708674	SENT274	16	16	28	28	bosentan	Fli1	PA10034	2314	0.79
NULL	Theranostics_2013_Jun_24_3(7)_448-466.nxml.txt.nlp	23843893	SENT65	1	1	6	6	choline	FDG	PA448976	23583	0.79
NULL	Front_Mol_Neurosci_2013_Dec_2_6_44.nxml.txt.nlp	24348325	SENT1537	15	15	9	9	haloperidol	c-fos	PA449841	2353	0.79
NULL	Front_Neurosci_2011_Jan_20_5_3.nxml.txt.nlp	21270945	SENT177	0	0	10	10	ethanol	ANOVA	PA448073	4858	0.79
NULL	Infect_Dis_Ther_2014_Dec_20_3(2)_269-279.nxml.txt.nlp	25410773	SENT54	0	0	17	17	cefazolin	gamma	PA448839	9913	0.79
NULL	Evid_Based_Complement_Alternat_Med_2012_May_7_2012_242810.nxml.txt.nlp	22645625	SENT194	13	13	10	10	rifampin	HNF4	PA451250	3172	0.79
NULL	Oncol_Lett_2014_Nov_14_8(5)_2086-2092.nxml.txt.nlp	25295095	SENT7	31	31	1	1	gemcitabine	LKB1	PA449748	6794	0.79
NULL	Comp_Hepatol_2005_Feb_8_4_2.nxml.txt.nlp	15701172	SENT75	4	4	11	11	ketoconazole	CYP3A	PA450146	1574	0.79
NULL	Br_J_Clin_Pharmacol_2011_Oct_72(4)_647-657.nxml.txt.nlp	21518389	SENT175	8	8	5	5	dipyridamole	P2Y12	PA449367	64805	0.79
NULL	Allergy_Asthma_Immunol_Res_2014_Mar_15_6(2)_126-130.nxml.txt.nlp	24587948	SENT105	23	23	0	0	salbutamol	TTN	PA448068	7273	0.79
NULL	Nat_Chem_Biol_2010_Feb_6(2)_117-124.nxml.txt.nlp	20081827	SENT160	2	2	26	26	piperazine	p110	PA450977	9733	0.79
NULL	Oncotarget_2014_Dec_4_5(22)_11365-11380.nxml.txt.nlp	25426548	SENT139	10	10	7	7	nutlin-3	p53		7157	0.79
NULL	Br_J_Cancer_2013_May_28_108(10)_1957-1963.nxml.txt.nlp	23640393	SENT25	7	7	3	3	bleomycin	NACT	PA448645	284111	0.79
NULL	J_Cell_Biol_2004_Jan_19_164(2)_169-174.nxml.txt.nlp	14718521	SENT87	14	14	0	0	dextran	MARCKS	PA449261	4082	0.79
NULL	Diabetes_2009_Apr_16_58(4)_975-983.nxml.txt.nlp	19151200	SENT163	6	6	26	26	liraglutide	LIR	PA165958364	10871	0.79
NULL	Thorax_2014_Jul_24_69(7)_638-647.nxml.txt.nlp	24567297	SENT87	12	12	3	3	doxycycline	TRAIL	PA449415	8743	0.79
NULL	Carbohydr_Polym_2014_Oct_13_111(100)_505-513.nxml.txt.nlp	25037381	SENT95	0	0	12	12	ethanol	CO2	PA448073	4513	0.79
NULL	Aging_(Albany_NY)_2009_Jun_3_1(6)_515-528.nxml.txt.nlp	20157535	SENT93	0	0	2	2	resveratrol	S6K1		6198	0.79
NULL	Cancers_(Basel)_2011_Aug_5_3(3)_3114-3142.nxml.txt.nlp	24212948	SENT1560	18	18	5	5	cyclophosphamide	MUC1	PA449165	4582	0.79
NULL	Evid_Based_Complement_Alternat_Med_2013_May_27_2013_582493.nxml.txt.nlp	23781264	SENT43	16	16	4	4	ethanol	CO2	PA448073	4513	0.79
NULL	Interdiscip_Toxicol_2011_Dec_4(4)_191-197.nxml.txt.nlp	22319253	SENT65	25	25	13	13	phenylephrine	FMLP	PA450935	2357	0.79
NULL	Arch_Med_Sci_2011_Jun_11_7(3)_388-396.nxml.txt.nlp	22312373	SENT141	13	13	25	25	nifedipine	CYP3A	PA450631	1574	0.79
NULL	Clin_Pharmacokinet_2014_Sep_3_53(1)_1-16.nxml.txt.nlp	23999929	SENT269	38	38	9	9	rivaroxaban	CYP2J2	PA165958360	1573	0.79
NULL	Clin_Sci_(Lond)_2012_Oct_1_123(Pt_8)_473-486.nxml.txt.nlp	22757958	SENT166	0	0	15	15	glucosamine	RhoA	PA164747613	387	0.79
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Dec_17_3(12)_e152.nxml.txt.nlp	25518025	SENT77	31	31	10	10	oxycodone	P-gp	PA450741	5243	0.79
NULL	Eur_J_Med_Res_2010_Feb_26_15(2)_47-53.nxml.txt.nlp	20452883	SENT145	23	23	14	14	etomidate	ESG	PA164743987	7089;7088;7090;7091	0.79
NULL	Biomed_Res_Int_2013_Jul_18_2013_603782.nxml.txt.nlp	23971041	SENT138	6	6	13	13	latanoprost	BAK	PA164774763	578	0.79
NULL	Cardiol_Res_Pract_2011_Apr_26_2011_837841.nxml.txt.nlp	21577267	SENT46	20	20	31	31	protamine	ACT	PA10366	12;11332;9457;641455	0.79
NULL	J_Lipid_Res_2014_Oct_55(10)_2103-2112.nxml.txt.nlp	25139399	SENT43	20	20	32	32	atorvastatin	APOE	PA448500	348	0.79
NULL	Front_Oncol_2014_Sep_23_4_264.nxml.txt.nlp	25295231	SENT105	3	3	19	19	lenalidomide	MDM2	PA162363968	4193	0.79
NULL	Oxid_Med_Cell_Longev_2012_May_27_2012_609421.nxml.txt.nlp	22693652	SENT96	11	11	28	28	amitriptyline	Bcl-2	PA448385	596	0.79
NULL	J_Biol_Chem_2013_Nov_15_288(46)_33049-33059.nxml.txt.nlp	24089524	SENT215	2	2	17	17	nicotine	CAM	PA450626	889	0.79
NULL	Endocrinol_Diabetes_Metab_Case_Rep_2014_Mar_1_2014_140001.nxml.txt.nlp	24683487	SENT73	11	11	6	6	bromocriptine	ACTH	PA448671	5443	0.79
NULL	Exp_Ther_Med_2013_Mar_18_5(3)_932-936.nxml.txt.nlp	23407381	SENT17	11	11	18	18	tegafur	CDHP	PA452620	1001	0.79
NULL	Biochimie_2010_Nov_92(11)_1546-1567.nxml.txt.nlp	20615447	SENT2452	39	39	2	2	trypsin	KLK6	PA451806	5653	0.79
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_3_2012_856029.nxml.txt.nlp	23091559	SENT358	23	23	10	10	paclitaxel	PC-3	PA450761	692094	0.79
NULL	J_Gen_Physiol_2004_Apr_123(4)_427-439.nxml.txt.nlp	15024039	SENT476	8	8	18	18	genistein	EGFR	PA165109660	1956	0.79
NULL	Crit_Care_2008_Mar_13_12(Suppl_2)_P407.nxml.txt.nlp	NULL	SENT4	7	7	33	33	vasopressin	AVP	PA451858	114548;551	0.79
NULL	Cancer_Cell_2007_Dec_11_12(6)_514-527.nxml.txt.nlp	18068629	SENT585	16	16	8	8	paclitaxel	TGFBI	PA450761	7045	0.79
NULL	Front_Physiol_2012_Oct_4_3_396.nxml.txt.nlp	23060820	SENT325	26	26	14	14	lidocaine	c-fos	PA450226	2353	0.79
NULL	Case_Rep_Oncol_2014_Jun_18_7(2)_393-400.nxml.txt.nlp	25076890	SENT91	24	24	22	22	erlotinib	EGFR	PA134687924	1956	0.79
NULL	ScientificWorldJournal_2012_May_1_2012_520524.nxml.txt.nlp	22623908	SENT134	7	7	19	19	praziquantel	IL-10	PA164764583	3586	0.79
NULL	Oncotarget_2014_Aug_29_5(19)_8947-8958.nxml.txt.nlp	25333254	SENT128	10	10	18	18	cytarabine	CD49d	PA449177	3676	0.79
NULL	Mol_Biol_Cell_2013_Sep_1_24(17)_2678-2688.nxml.txt.nlp	23864716	SENT259	15	15	7	7	thrombin	Rho	PA451674	29984	0.79
NULL	Oncotarget_2014_Jun_1_5(13)_4868-4880.nxml.txt.nlp	24947902	SENT105	8	8	22	22	afatinib	HER2	PA165981154	2064	0.79
NULL	J_Cell_Biol_1995_Nov_1_131(3)_791-805.nxml.txt.nlp	7593197	SENT7	7	7	21	21	genistein	JNK	PA165109660	5599	0.79
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT112	5	5	11	11	neratinib	HER2	PA165291472	2064	0.79
NULL	Cell_Death_Dis_2010_Nov_4_1(11)_e96.nxml.txt.nlp	21368872	SENT62	40	40	9	9	resveratrol	SIRT1		23411	0.79
NULL	Diabetes_Care_2008_Dec_31(12)_2294-2300.nxml.txt.nlp	18809627	SENT119	8	8	14	14	ramipril	ACR	PA451223	49	0.79
NULL	Breast_Cancer_Res_2007_Jul_5_9(4)_R41.nxml.txt.nlp	17612393	SENT176	16	16	11	11	celecoxib	Bcl-2	PA448871	596	0.79
NULL	Open_Dent_J_2014_May_30_8_109-124.nxml.txt.nlp	24976875	SENT374	3	3	14	14	minocycline	RANKL	PA450519	8600	0.79
NULL	Front_Genet_2012_Nov_5_3_236.nxml.txt.nlp	23133441	SENT76	10	10	1	1	efavirenz	ABCB1	PA449441	5243	0.79
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT94	6	6	32	32	curcumin	PC-3	PA151958596	692094	0.79
NULL	Int_J_Biol_Sci_2014_Jan_11_10(2)_142-148.nxml.txt.nlp	24520212	SENT114	18	18	15	15	tamoxifen	WWOX	PA451581	51741	0.79
NULL	Anat_Cell_Biol_2011_Mar_31_44(1)_14-24.nxml.txt.nlp	21519545	SENT102	22	22	7	7	cyclophosphamide	CK8	PA449165	3856	0.79
NULL	Biosci_Rep_2012_Dec_1_32(Pt_6)_631-639.nxml.txt.nlp	NULL	SENT31	10	10	6	6	leflunomide	DHODH	PA450192	1723	0.79
NULL	Indian_J_Pharm_Sci_2013_Jan-Feb_75(1)_94-98.nxml.txt.nlp	23901167	SENT30	14	14	28	28	bupropion	CYP2C9	PA448687	1559	0.79
NULL	Arthritis_Res_Ther_2013_Jul_9_15(4)_R73.nxml.txt.nlp	23837669	SENT322	3	3	14	14	colchicine	MICL	PA449092	160364	0.79
NULL	Iran_J_Pharm_Res_2013_Winter_12(1)_141-146.nxml.txt.nlp	24250582	SENT11	19	19	11	11	rifampin	NAC	PA451250	22861	0.79
NULL	Aging_(Albany_NY)_2009_Dec_29_2(1)_63-68.nxml.txt.nlp	20228936	SENT80	7	7	20	20	nadh	SIRT1	PA164755085	23411	0.79
NULL	J_Hematol_Oncol_2013_Jun_3_6_38.nxml.txt.nlp	23731980	SENT172	12	12	19	19	afatinib	HER2	PA165981154	2064	0.79
NULL	Arthritis_Res_Ther_2013_Sep_12_15(5)_R117.nxml.txt.nlp	24028544	SENT189	16	16	9	9	cyclophosphamide	VDI	PA449165	7420	0.79
NULL	Clin_Ophthalmol_2014_Jun_28_8_1241-1252.nxml.txt.nlp	25061271	SENT136	3	3	11	11	latanoprost	BAK	PA164774763	578	0.79
NULL	Biologics_2009_Sep_15_3_419-428.nxml.txt.nlp	19774209	SENT145	9	9	4	4	gefitinib	EGFR	PA131301952	1956	0.79
NULL	Open_Biochem_J_2011_Sep_23_5_45-51.nxml.txt.nlp	21966325	SENT7	2	2	13	13	diclofenac	IRE1	PA449293	2081	0.79
NULL	Daru_2012_Aug_30_20(1)_21.nxml.txt.nlp	23351981	SENT26	2	2	12	12	propranolol	P-gp	PA451145	5243	0.79
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT1706	0	0	23	23	atazanavir	ATV	PA10251	4683	0.79
NULL	Br_J_Cancer_2010_Feb_2_102(3)_520-529.nxml.txt.nlp	20029417	SENT6	2	2	41	41	trastuzumab	IL-21	PA451743	59067;50616;27189	0.79
NULL	Clin_Epidemiol_2014_Nov_20_6_423-432.nxml.txt.nlp	25429239	SENT42	12	12	22	22	crizotinib	EGFR	PA165946122	1956	0.79
NULL	Acta_Pharmacol_Sin_2009_Sep_24_30(9)_1262-1275.nxml.txt.nlp	19701231	SENT226	20	20	6	6	lovastatin	TM4SF1	PA450272	4071	0.79
NULL	Clin_Interv_Aging_2012_Dec_30_7_1-13.nxml.txt.nlp	22291468	SENT267	26	26	15	15	clarithromycin	CYP3A4	PA449028	1576	0.79
NULL	Comp_Hepatol_2011_Nov_14_10_10.nxml.txt.nlp	22081873	SENT12	22	22	0	0	choline	Cocoa	PA448976	57658	0.79
NULL	Biomed_Res_Int_2014_Jun_25_2014_764981.nxml.txt.nlp	25057499	SENT185	16	16	28	28	sorafenib	Mcl-1	PA7000	4170	0.79
NULL	Environ_Sci_Pollut_Res_Int_2012_Jun_2_19(5)_1605-1611.nxml.txt.nlp	22134861	SENT20	18	18	29	29	nitrogen	PAH	PA450643	5053	0.79
NULL	Exp_Diabetes_Res_2011_Jun_22_2011_279530.nxml.txt.nlp	21747825	SENT107	5	5	16	16	sitagliptin	GLP-1	PA164748978	100125288	0.79
NULL	J_Cell_Biol_1981_Feb_1_88(2)_422-429.nxml.txt.nlp	6259180	SENT7	10	10	8	8	trypsin	EGF	PA451806	1950	0.79
NULL	Diabetes_2011_Jun_21_60(6)_1770-1778.nxml.txt.nlp	21562078	SENT228	4	4	2	2	metformin	AMPK	PA450395	5563	0.79
NULL	Ecancermedicalscience_2009_Oct_29_3_157.nxml.txt.nlp	22276018	SENT71	22	22	12	12	gefitinib	HER3	PA131301952	2065	0.79
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1063.nxml.txt.nlp	24556678	SENT273	6	6	8	8	thioridazine	TRAIL	PA451666	8743	0.79
NULL	Carcinogenesis_2010_Dec_27_31(12)_2049-2057.nxml.txt.nlp	20876285	SENT311	10	10	18	18	fulvestrant	HER-2	PA164747170	2064	0.79
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Dec_3_65(Pt_1)_o9.nxml.txt.nlp	21581727	SENT57	33	33	29	29	ethanol	mol	PA448073	90527	0.79
NULL	Cancer_Med_2014_Apr_22_3(2)_225-244.nxml.txt.nlp	24449499	SENT20	35	35	12	12	bevacizumab	VEGFR	PA130232992	3791	0.79
NULL	Arthritis_Res_2000_Apr_12_2(3)_189-202.nxml.txt.nlp	11094428	SENT475	17	17	3	3	rolipram	TNF-alpha	PA153906323	7124	0.79
NULL	Leukemia_2013_Feb_3_27(2)_315-324.nxml.txt.nlp	22751450	SENT193	21	21	26	26	sorafenib	Mcl-1	PA7000	4170	0.79
NULL	Cell_Commun_Signal_2014_Mar_10_12_13.nxml.txt.nlp	24606867	SENT151	27	27	45	45	lipase	IL-6	PA450239	3569	0.79
NULL	Clinics_(Sao_Paulo)_2013_May_68(5)_694-701.nxml.txt.nlp	23778405	SENT135	5	5	9	9	curcumin	survivin	PA151958596	332	0.79
NULL	Cancers_(Basel)_2012_Oct_12_4(4)_989-1035.nxml.txt.nlp	24213498	SENT435	42	42	25	25	gemcitabine	CD24	PA449748	100133941	0.79
NULL	Ann_Lab_Med_2013_Sep_8_33(5)_349-352.nxml.txt.nlp	24003425	SENT83	23	23	29	29	pyrazinamide	EMB	PA451182	133418	0.79
NULL	Arthritis_Res_Ther_2013_Aug_30_15(4)_R100.nxml.txt.nlp	24000795	SENT140	19	19	4	4	methotrexate	CD22	PA450428	933	0.79
NULL	Br_J_Cancer_1999_Apr_80(1-2)_17-24.nxml.txt.nlp	10389972	SENT7	5	5	43	43	2-methoxyestradiol	N-myc	PA134967247	4613	0.79
NULL	Hum_Reprod_2013_Feb_30_28(2)_306-314.nxml.txt.nlp	23203216	SENT135	28	28	13	13	hyaluronan	HBA	PA165958431	85340	0.79
NULL	Biomed_Res_Int_2013_Sep_4_2013_906912.nxml.txt.nlp	24093107	SENT157	0	0	22	22	ciprofloxacin	MICC	PA449009	100129192	0.79
NULL	Lipids_Health_Dis_2011_Feb_28_10_38.nxml.txt.nlp	21352602	SENT89	6	6	18	18	atorvastatin	PCSK9	PA448500	255738	0.79
NULL	Case_Rep_Med_2012_Oct_30_2012_897097.nxml.txt.nlp	23197987	SENT185	18	18	21	21	ranibizumab	PED	PA164746012	8682	0.79
NULL	F1000_Med_Rep_2009_Jan_21_1_8.nxml.txt.nlp	20948699	SENT16	40	40	42	42	clopidogrel	NNT	PA449053	23530	0.79
NULL	J_Geriatr_Cardiol_2012_Jun_9(2)_180-184.nxml.txt.nlp	22916066	SENT125	3	3	20	20	rosuvastatin	Rho	PA134308647	29984	0.79
NULL	Nat_Commun_2014_Apr_29_5_3723.nxml.txt.nlp	24781344	SENT88	25	25	1	1	ethanol	CO2	PA448073	4513	0.79
NULL	BMJ_2013_Nov_6_347_f6530.nxml.txt.nlp	24196498	SENT192	11	11	1	1	everolimus	DES	PA164746311	1674	0.79
NULL	J_Thromb_Thrombolysis_2012_Feb_20_33(2)_143-153.nxml.txt.nlp	22183178	SENT27	24	24	5	5	thrombin	ADP	PA451674	23038	0.79
NULL	Gut_Liver_2015_Jan_9(1)_18-27.nxml.txt.nlp	NULL	SENT56	18	18	7	7	infliximab	ACT	PA452639	12;11332;9457;641455	0.79
NULL	Am_J_Trop_Med_Hyg_2012_Jul_1_87(1)_190-191.nxml.txt.nlp	22764313	SENT18	30	30	22	22	primaquine	G6PD	PA451103	2539	0.79
NULL	Br_J_Clin_Pharmacol_2012_Apr_7_73(4)_518-535.nxml.txt.nlp	22053916	SENT62	17	17	9	9	mibefradil	CYP3A4	PA450492	1576	0.79
NULL	Cell_Commun_Signal_2013_Apr_24_11_31.nxml.txt.nlp	23618389	SENT134	15	15	13	13	pp2	PP1		5540;5464	0.79
NULL	Biomed_Res_Int_2014_Feb_13_2014_519189.nxml.txt.nlp	24689043	SENT20	4	4	8	8	hyaluronan	CD44	PA165958431	960	0.79
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT565	11	11	5	5	metformin	HIF-1	PA450395	29072	0.79
NULL	Biosci_Rep_2013_Sep_4_33(5)_e00064.nxml.txt.nlp	23889169	SENT916	13	13	6	6	thrombin	PAR-1	PA451674	2011;2149	0.79
NULL	Mol_Cancer_2009_Aug_25_8_66.nxml.txt.nlp	19706164	SENT36	11	11	4	4	nimesulide	COX	PA137179528	1351	0.79
NULL	Front_Oncol_2014_Aug_11_4_204.nxml.txt.nlp	25157335	SENT255	13	13	22	22	gefitinib	EGFR	PA131301952	1956	0.79
NULL	Brain_2013_Jul_24_136(7)_2279-2297.nxml.txt.nlp	23801741	SENT166	1	1	6	6	tamoxifen	NRG1	PA451581	3084	0.79
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT7	0	0	11	11	curcumin	XIAP	PA151958596	331	0.789
NULL	Oncogene_2009_Jan_15_28(2)_279-288.nxml.txt.nlp	18836480	SENT117	2	2	12	12	pp2	EGF		1950	0.789
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT161	17	17	4	4	trastuzumab	MUC4	PA451743	4585	0.789
NULL	Eur_J_Endocrinol_2014_Mar_170(3)_451-459.nxml.txt.nlp	24362411	SENT152	9	9	6	6	liraglutide	GLP1	PA165958364	100125288;2641	0.789
NULL	ISRN_Oxidative_Med_2013_2013_831596.nxml.txt.nlp	25506596	SENT158	17	17	27	27	hemin	TLR4	PA449849	7099	0.789
NULL	Diabetes_Obes_Metab_2012_Apr_14(4)_304-314.nxml.txt.nlp	22051096	SENT141	5	5	25	25	exenatide	PPG	PA164749238	5552	0.789
NULL	J_Gen_Intern_Med_2009_May_21_24(5)_656-664.nxml.txt.nlp	19306050	SENT331	7	7	1	1	warfarin	VKORC1	PA451906	79001	0.789
NULL	Cell_Biochem_Biophys_2013_Mar_12_67(2)_695-702.nxml.txt.nlp	23479335	SENT149	18	18	24	24	lipase	PLTP	PA450239	5360	0.789
NULL	Iran_J_Reprod_Med_2013_Oct_11(10)_791-800.nxml.txt.nlp	24639699	SENT124	45	45	29	29	cyclophosphamide	TDI	PA449165	100038246	0.789
NULL	Diabetes_2008_Sep_57(9)_2332-2340.nxml.txt.nlp	18567824	SENT116	11	11	27	27	atropine	ANOVA	PA448505	4858	0.789
NULL	Crit_Care_2010_Mar_1_14(Suppl_1)_P69.nxml.txt.nlp	NULL	SENT7	12	12	9	9	oseltamivir	MOF	PA450721	84148	0.789
NULL	J_Oral_Pathol_Med_2013_Jul_18_42(6)_491-498.nxml.txt.nlp	23331383	SENT47	7	7	24	24	trypsin	F12	PA451806	2161	0.789
NULL	Front_Oncol_2013_Oct_1_3_259.nxml.txt.nlp	24102047	SENT71	6	6	11	11	bevacizumab	FDG	PA130232992	23583	0.789
NULL	Evid_Based_Complement_Alternat_Med_2014_Oct_29_2014_594354.nxml.txt.nlp	25530784	SENT6	10	10	1	1	trifluoperazine	UGT	PA451771	7361;7355	0.789
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Aug_27_67(Pt_9)_o2492.nxml.txt.nlp	22059042	SENT56	23	23	38	38	ethanol	mol	PA448073	90527	0.789
NULL	Cardiovasc_Diabetol_2013_Jun_19_12_92.nxml.txt.nlp	23777506	SENT263	19	19	5	5	miglitol	GLP-1	PA164776726	100125288	0.789
NULL	Oncotarget_2011_Aug_30_2(8)_610-626.nxml.txt.nlp	21881167	SENT121	38	38	28	28	tamoxifen	Raf-1	PA451581	5894	0.789
NULL	Acta_Neuropathol_Commun_2013_Sep_16_1_61.nxml.txt.nlp	24252310	SENT12	22	22	6	6	oxygen	APP	PA450744	351	0.789
NULL	Diabetes_2009_Apr_16_58(4)_975-983.nxml.txt.nlp	19151200	SENT184	0	0	8	8	liraglutide	HO-1	PA165958364	3162	0.789
NULL	Arthritis_Res_Ther_2013_Jan_10_15(1)_R10.nxml.txt.nlp	23305385	SENT133	8	8	40	40	estradiol	p38	PA449503	10598;1432;7965	0.789
NULL	Oxid_Med_Cell_Longev_2012_May_28_2012_386527.nxml.txt.nlp	22690271	SENT151	14	14	33	33	resveratrol	gamma		9913	0.789
NULL	Mol_Biol_Int_2012_Jun_26_2012_256982.nxml.txt.nlp	22792462	SENT95	11	11	13	13	atazanavir	ATV	PA10251	4683	0.789
NULL	Arthritis_Res_Ther_2005_Mar_9_7(3)_93.nxml.txt.nlp	15899057	SENT72	25	25	11	11	methotrexate	CD4	PA450428	920	0.789
NULL	Curr_Neuropharmacol_2014_Jul_12(4)_365-379.nxml.txt.nlp	25342944	SENT113	11	11	16	16	fluoxetine	cPLA2	PA449673	10524	0.789
NULL	Exp_Hematol_Oncol_2012_Dec_10_1_39.nxml.txt.nlp	23227903	SENT162	29	29	32	32	methotrexate	MTHFR	PA450428	4524	0.789
NULL	Cardiovasc_Diabetol_2013_Mar_23_12_48.nxml.txt.nlp	23522121	SENT40	6	6	10	10	exenatide	GLP-1	PA164749238	100125288	0.789
NULL	Arthritis_Res_Ther_2009_Apr_23_11(2)_R57.nxml.txt.nlp	19389237	SENT223	0	0	11	11	adalimumab	CD68	PA10004	968	0.789
NULL	Case_Rep_Hematol_2013_Jun_11_2013_680459.nxml.txt.nlp	23840983	SENT12	19	19	47	47	hydroxocobalamin	B12	PA164768689	7126;4709	0.789
NULL	Clin_Med_Insights_Oncol_2011_Jul_28_5_235-257.nxml.txt.nlp	21836819	SENT431	7	7	17	17	chloroquine	ARH1	PA448948	141	0.789
NULL	Diabetes_2008_Sep_57(9)_2470-2479.nxml.txt.nlp	18511847	SENT141	21	21	14	14	pioglitazone	adiponectin	PA450970	9370	0.789
NULL	Aging_(Albany_NY)_2011_Oct_23_3(10)_934-942.nxml.txt.nlp	22024462	SENT80	41	41	12	12	lipase	POMC	PA450239	5443	0.789
NULL	Oncotarget_2014_Jun_3_5(13)_4920-4928.nxml.txt.nlp	24952482	SENT116	0	0	19	19	crizotinib	SCF	PA165946122	4254	0.789
NULL	Exp_Hematol_Oncol_2013_Jul_1_2_17.nxml.txt.nlp	23815814	SENT70	19	19	3	3	doxorubicin	CD133	PA449412	8842	0.789
NULL	Int_J_Gen_Med_2012_May_4_5_403-411.nxml.txt.nlp	22615536	SENT105	16	16	1	1	metformin	RBP4	PA450395	5433;5950	0.789
NULL	Bioimpacts_2014_Feb_27_4(1)_21-27.nxml.txt.nlp	24790895	SENT130	27	27	33	33	isoproterenol	ANOVA	PA450121	4858	0.789
NULL	Open_Access_J_Urol_2011_Apr_26_3_43-48.nxml.txt.nlp	24198635	SENT37	1	1	10	10	everolimus	FKBP-12	PA164746311	2280	0.789
NULL	Int_J_Nanomedicine_2009_Apr_1_4_1-7.nxml.txt.nlp	19421366	SENT146	23	23	10	10	paclitaxel	castor	PA450761	54897	0.789
NULL	Onco_Targets_Ther_2014_Jun_19_7_1025-1032.nxml.txt.nlp	24971016	SENT99	9	9	6	6	pazopanib	VEGFR	PA165291492	3791	0.789
NULL	Blood_Res_2014_Dec_23_49(4)_253-258.nxml.txt.nlp	25548759	SENT75	7	7	17	17	vincristine	CHOP	PA451879	1649	0.789
NULL	J_Inflamm_(Lond)_2006_Feb_22_3_2.nxml.txt.nlp	16504062	SENT117	39	39	41	41	bleomycin	BLM	PA448645	641	0.789
NULL	Mol_Cancer_2011_Sep_7_10_109.nxml.txt.nlp	21899742	SENT297	18	18	8	8	etoposide	TRAIL-R2	PA449552	8795	0.789
NULL	J_Am_Heart_Assoc_2013_Dec_19_2(6)_e000376.nxml.txt.nlp	24308935	SENT314	27	27	24	24	crizotinib	Met	PA165946122	79811	0.789
NULL	ISRN_Otolaryngol_2012_Nov_14_2012_797619.nxml.txt.nlp	23762619	SENT193	0	0	19	19	gefitinib	EGF	PA131301952	1950	0.789
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT198	9	9	26	26	curcumin	DR4	PA151958596	8797	0.789
NULL	Exp_Ther_Med_2014_Sep_26_8(3)_899-906.nxml.txt.nlp	25120621	SENT174	7	7	18	18	estradiol	HIF-1	PA449503	29072	0.789
NULL	J_Cell_Biol_2008_Jul_28_182(2)_381-393.nxml.txt.nlp	18663145	SENT360	28	28	14	14	l-glutamine	San	PA10090	80218	0.789
NULL	J_Neurodev_Disord_2009_Jun_9_1(2)_158-171.nxml.txt.nlp	19960097	SENT354	7	7	17	17	desipramine	Gen	PA449233	348654	0.789
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT1733	2	2	6	6	fosamprenavir	ATV	PA10084	4683	0.789
NULL	Drugs_R_D_2011_Mar_27_11(1)_37-51.nxml.txt.nlp	21410294	SENT203	36	36	33	33	itraconazole	CYP3A4	PA450132	1576	0.789
NULL	Korean_J_Anesthesiol_2013_Jan_21_64(1)_54-60.nxml.txt.nlp	23372887	SENT5	10	10	12	12	hydrocortisone	CRT	PA449905	811	0.789
NULL	Comp_Hepatol_2005_Feb_8_4_2.nxml.txt.nlp	15701172	SENT178	4	4	25	25	ketoconazole	CYP3A4	PA450146	1576	0.789
NULL	Orphanet_J_Rare_Dis_2007_Jan_23_2_6.nxml.txt.nlp	17244349	SENT101	23	23	20	20	ifosfamide	ADM	PA449964	133	0.789
NULL	J_Hematol_Oncol_2011_Jan_21_4_5.nxml.txt.nlp	21255411	SENT175	0	0	29	29	paclitaxel	EGFR	PA450761	1956	0.789
NULL	Cancer_Cell_Int_2009_Jan_8_9_3.nxml.txt.nlp	19128511	SENT11	3	3	10	10	oxaliplatin	PI3K	PA131285527	5290	0.789
NULL	Br_J_Cancer_2012_Feb_14_106(4)_685-692.nxml.txt.nlp	22294184	SENT252	6	6	35	35	lovastatin	p27	PA450272	5715;10534	0.789
NULL	J_Headache_Pain_2014_Sep_18_15(Suppl_1)_G16.nxml.txt.nlp	NULL	SENT7	0	0	5	5	capsaicin	TRPV1	PA448776	7442	0.789
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT48	38	38	4	4	metformin	EGFR	PA450395	1956	0.789
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_May_22_69(Pt_6)_o929.nxml.txt.nlp	23795097	SENT4	14	14	4	4	nitrile	mol	PA450636	90527	0.789
NULL	J_Hematol_Oncol_2012_Apr_25_5(Suppl_1)_A1.nxml.txt.nlp	22738713	SENT14	8	8	20	20	trastuzumab	HER2	PA451743	2064	0.789
NULL	Oncol_Rep_2012_Apr_30_27(4)_923-928.nxml.txt.nlp	22209766	SENT27	8	8	23	23	docetaxel	EGFR	PA449383	1956	0.789
NULL	Clin_Med_Insights_Oncol_2012_Aug_16_6_287-303.nxml.txt.nlp	22933844	SENT222	9	9	18	18	denosumab	aromatase	PA166048634	1588	0.789
NULL	Int_J_Mol_Sci_2007_Aug_27_8(8)_884-893.nxml.txt.nlp	NULL	SENT71	12	12	23	23	ethanol	CO2	PA448073	4513	0.789
NULL	Braz_J_Med_Biol_Res_2014_Sep_5_47(11)_929-939.nxml.txt.nlp	25296354	SENT171	30	30	22	22	afatinib	EGFR	PA165981154	1956	0.789
NULL	J_Breast_Cancer_2013_Jun_28_16(2)_164-170.nxml.txt.nlp	23843848	SENT14	0	0	9	9	doxorubicin	p53	PA449412	7157	0.789
NULL	Ann_Oncol_2011_Mar_8_22(3)_503-514.nxml.txt.nlp	20616198	SENT308	7	7	3	3	tamoxifen	ATAC	PA451581	6375	0.789
NULL	Diabetes_Metab_Syndr_Obes_2010_Jul_20_3_263-273.nxml.txt.nlp	21437094	SENT54	5	5	1	1	exenatide	GLP-1	PA164749238	100125288	0.789
NULL	Mol_Cancer_2007_Sep_18_6_56.nxml.txt.nlp	17877814	SENT121	5	5	9	9	erlotinib	EGFR	PA134687924	1956	0.789
NULL	Clin_Drug_Investig_2015_Dec_4_35_45-51.nxml.txt.nlp	25471740	SENT146	32	32	28	28	omeprazole	CYP2C8	PA450704	1558	0.789
NULL	Fibrogenesis_Tissue_Repair_2010_Aug_5_3_13.nxml.txt.nlp	20687922	SENT332	25	25	21	21	bevacizumab	VEGF-A	PA130232992	7422	0.789
NULL	Evid_Based_Complement_Alternat_Med_2015_Jan_6_2015_736431.nxml.txt.nlp	25632290	SENT82	9	9	20	20	midazolam	CYP3A4	PA450496	1576	0.789
NULL	Pharmaceuticals_(Basel)_2014_Sep_4_7(9)_913-942.nxml.txt.nlp	25192192	SENT109	21	21	10	10	resveratrol	UCP3		7352	0.789
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jan_8_67(Pt_2)_o240.nxml.txt.nlp	21522934	SENT56	18	18	32	32	ethanol	mol	PA448073	90527	0.789
NULL	Evid_Based_Complement_Alternat_Med_2012_May_7_2012_242810.nxml.txt.nlp	22645625	SENT189	28	28	21	21	rifampin	CYP3A4	PA451250	1576	0.789
NULL	Arch_Drug_Inf_2008_Jul_1(1)_14-22.nxml.txt.nlp	20157364	SENT15	0	0	6	6	pravastatin	MCP-1	PA451089	6347	0.789
NULL	Clin_Med_Insights_Oncol_2011_Nov_9_5_365-379.nxml.txt.nlp	22174597	SENT67	33	33	2	2	imatinib	KIT	PA10804	3815	0.789
NULL	Acta_Neuropathol_2015_Oct_17_129_81-96.nxml.txt.nlp	25322817	SENT310	0	0	2	2	capsaicin	TRPV1	PA448776	7442	0.789
NULL	Front_Cell_Neurosci_2012_Oct_26_6_48.nxml.txt.nlp	23112762	SENT56	19	19	8	8	capsaicin	VR1	PA448776	56664	0.789
NULL	Breast_Cancer_Res_2007_May_30_9(3)_R34.nxml.txt.nlp	17537232	SENT166	15	15	31	31	cisplatin	TP53	PA449014	7157	0.789
NULL	Front_Genet_2012_Nov_9_3_223.nxml.txt.nlp	23162566	SENT1156	12	12	2	2	fentanyl	NeuroD	PA449599	4760	0.789
NULL	Pharmaceuticals_(Basel)_2011_Jan_26_4(2)_285-342.nxml.txt.nlp	NULL	SENT279	21	21	18	18	fluoxetine	5-HT2C	PA449673	3358	0.789
NULL	Cardiovasc_Diabetol_2013_May_30_12(Suppl_1)_S2.nxml.txt.nlp	23819752	SENT98	29	29	36	36	pitavastatin	adiponectin	PA142650384	9370	0.789
NULL	Emerg_Infect_Dis_2013_Jul_19(7)_1151-1152.nxml.txt.nlp	23763791	SENT19	26	26	19	19	isoniazid	DST	PA450112	667	0.789
NULL	Oncotarget_2012_Aug_19_3(8)_890-903.nxml.txt.nlp	23097685	SENT139	15	15	26	26	celecoxib	COX	PA448871	1351	0.789
NULL	Acta_Pharmacol_Sin_2012_Jul_4_33(7)_897-908.nxml.txt.nlp	22659625	SENT6	9	9	11	11	bleomycin	BLM	PA448645	641	0.789
NULL	Toxins_(Basel)_2011_Jun_10_3(6)_551-565.nxml.txt.nlp	22069725	SENT102	21	21	12	12	choline	PTMA	PA448976	5757	0.789
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jan_18_68(Pt_2)_o448.nxml.txt.nlp	22347059	SENT4	18	18	5	5	phenol	mol	PA450913	90527	0.789
NULL	Am_J_Trop_Med_Hyg_2014_Jul_2_91(1)_1-2.nxml.txt.nlp	24752684	SENT36	12	12	8	8	primaquine	G6PD	PA451103	2539	0.789
NULL	Adv_Hematol_2010_Dec_30_2010_627401.nxml.txt.nlp	21234094	SENT126	17	17	2	2	etoposide	SMILE	PA449552	160418	0.789
NULL	Oxid_Med_Cell_Longev_2013_Jun_11_2013_870472.nxml.txt.nlp	23840921	SENT235	0	0	5	5	chloroquine	HO-1	PA448948	3162	0.789
NULL	Diabetes_Care_2012_Feb_16_35(2)_327-333.nxml.txt.nlp	22179958	SENT171	9	9	22	22	metformin	B12	PA450395	7126;4709	0.789
NULL	J_Headache_Pain_2009_Apr_27_10(2)_105-110.nxml.txt.nlp	19172228	SENT99	17	17	10	10	capsaicin	c-fos	PA448776	2353	0.789
NULL	Oncogene_2010_May_20_29(20)_2983-2995.nxml.txt.nlp	20208560	SENT148	15	15	4	4	tamoxifen	FOXM1	PA451581	2305	0.789
NULL	Nat_Neurosci_2014_Jan_8_17(1)_114-120.nxml.txt.nlp	24316890	SENT85	22	22	3	3	vanillin	OR10G4	PA451852	390264	0.789
NULL	Br_J_Cancer_2013_Mar_5_108(4)_983-992.nxml.txt.nlp	23361057	SENT162	11	11	3	3	cytarabine	NAC	PA449177	22861	0.789
NULL	Indian_J_Pharm_Sci_2013_Mar-Apr_75(2)_217-221.nxml.txt.nlp	24019572	SENT111	3	3	18	18	metformin	BGL	PA450395	987	0.789
NULL	Cell_Death_Differ_2010_Oct_30_17(10)_1624-1635.nxml.txt.nlp	20431602	SENT374	8	8	4	4	paclitaxel	Bcl-2	PA450761	596	0.789
NULL	Cancers_(Basel)_2010_Dec_30_3(1)_106-125.nxml.txt.nlp	24212609	SENT144	36	36	29	29	gemcitabine	MRP5	PA449748	10057	0.789
NULL	Eur_J_Clin_Pharmacol_2011_Dec_23_67(12)_1231-1241.nxml.txt.nlp	21698374	SENT218	25	25	13	13	tacrolimus	CYP3A5	PA451578	1577	0.789
NULL	Oncol_Lett_2013_Jun_3_5(6)_1765-1770.nxml.txt.nlp	23833638	SENT157	0	0	13	13	everolimus	HIF-1	PA164746311	29072	0.789
NULL	J_Physiol_2011_Dec_15_589(Pt_24)_5965-5986.nxml.txt.nlp	22041182	SENT328	28	28	6	6	clotrimazole	ACTH	PA449057	5443	0.789
NULL	Mol_Cancer_2004_May_4_3_14.nxml.txt.nlp	15125777	SENT119	15	15	23	23	s-adenosylmethionine	CHK2	PA164754994	11200	0.789
NULL	J_Cell_Biol_1997_Jun_30_137(7)_1627-1638.nxml.txt.nlp	9199176	SENT45	24	24	13	13	ethanol	FRG	PA448073	9855	0.789
NULL	Indian_J_Dermatol_2013_Sep-Oct_58(5)_410d.nxml.txt.nlp	24082224	SENT41	33	33	15	15	dapsone	G6PD	PA449211	2539	0.789
NULL	Breast_Cancer_Res_Treat_2013_Aug_20_141(1)_43-53.nxml.txt.nlp	23959396	SENT29	23	23	33	33	pertuzumab	HER2		2064	0.789
NULL	Curr_Neuropharmacol_2013_May_11(3)_263-275.nxml.txt.nlp	24179463	SENT127	3	3	7	7	imipramine	CB1	PA449969	1268	0.789
NULL	Front_Neurosci_2014_Jan_10_7_270.nxml.txt.nlp	24454277	SENT38	21	21	19	19	resveratrol	SIRT1		23411	0.789
NULL	Arch_Gynecol_Obstet_2012_May_30_285(5)_1447-1453.nxml.txt.nlp	22127553	SENT29	41	41	17	17	carboplatin	TEC	PA448803	7006	0.789
NULL	Cell_Commun_Signal_2013_Sep_18_11_69.nxml.txt.nlp	24047462	SENT21	16	16	5	5	doxorubicin	BTG2	PA449412	7832	0.789
NULL	Clin_Endocrinol_(Oxf)_2011_Jul_75(1)_12-26.nxml.txt.nlp	21521344	SENT248	28	28	18	18	hydrocortisone	ACTH	PA449905	5443	0.789
NULL	Breast_Cancer_Res_2011_Jul_8_13(4)_213.nxml.txt.nlp	21867571	SENT155	14	14	21	21	chloroquine	HIF1	PA448948	3091	0.789
NULL	Apoptosis_2010_Apr_20_15(4)_401-411.nxml.txt.nlp	20091232	SENT39	18	18	43	43	l-glutamine	CO2	PA10090	4513	0.789
NULL	Mol_Biol_Cell_2012_Nov_1_23(21)_4212-4225.nxml.txt.nlp	22956765	SENT130	15	15	28	28	thrombin	SHP2	PA451674	5781	0.789
NULL	Biomed_Res_Int_2014_May_11_2014_578137.nxml.txt.nlp	24900972	SENT124	20	20	24	24	amifostine	gamma	PA448365	9913	0.789
NULL	Clin_Transl_Allergy_2013_Sep_2_3_29.nxml.txt.nlp	24004581	SENT181	25	25	18	18	omalizumab	IL-4	PA164752253	3565	0.789
NULL	Clin_Ophthalmol_2010_Oct_21_4_1229-1236.nxml.txt.nlp	21060677	SENT88	42	42	17	17	latanoprost	BAK	PA164774763	578	0.789
NULL	FEBS_Open_Bio_2014_May_9_4_458-467.nxml.txt.nlp	24918061	SENT378	1	1	5	5	celecoxib	CD133	PA448871	8842	0.789
NULL	Crit_Care_2006_Dec_7_10(6)_239.nxml.txt.nlp	17169139	SENT53	0	0	3	3	thrombin	PAR1	PA451674	79581;2149	0.789
NULL	Behav_Brain_Funct_2013_Nov_26_9_43.nxml.txt.nlp	24279870	SENT256	12	12	19	19	ethanol	EPM	PA448073	2054	0.789
NULL	Oncotarget_2013_Nov_15_4(11)_1866-1867.nxml.txt.nlp	24272818	SENT36	22	22	30	30	docetaxel	San	PA449383	80218	0.789
NULL	Biologics_2010_Dec_6_4_299-313.nxml.txt.nlp	21209725	SENT313	6	6	12	12	miglustat	OGT	PA10140	8473	0.789
NULL	Emerg_Infect_Dis_2012_Jan_18(1)_176-178.nxml.txt.nlp	22261434	SENT15	8	8	20	20	isoniazid	EMB	PA450112	133418	0.789
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT1432	3	3	18	18	methotrexate	MRP1	PA450428	4437	0.789
NULL	J_Invest_Dermatol_2015_Feb_9_135(2)_389-399.nxml.txt.nlp	25184961	SENT239	33	33	22	22	rosiglitazone	IL-6	PA451283	3569	0.789
NULL	Biosci_Rep_2014_Aug_6_34(4)_e00131.nxml.txt.nlp	24975826	SENT149	8	8	14	14	pp2	TRPA1		8989	0.789
NULL	Infect_Drug_Resist_2012_Aug_8_5_121-127.nxml.txt.nlp	22893749	SENT38	8	8	12	12	ribavirin	URI	PA451241	8725	0.789
NULL	Oxid_Med_Cell_Longev_2013_Nov_28_2013_568093.nxml.txt.nlp	24379901	SENT157	0	0	36	36	resveratrol	SIRT1		23411	0.789
NULL	Front_Neurosci_2011_Feb_22_5_20.nxml.txt.nlp	21373362	SENT184	11	11	0	0	cyclophosphamide	IL-6	PA449165	3569	0.789
NULL	Environ_Health_Perspect_2008_Apr_14_116(4)_474-480.nxml.txt.nlp	18414629	SENT128	29	29	18	18	estradiol	PCB	PA449503	5091	0.789
NULL	FEBS_Open_Bio_2011_Dec_27_2_1-5.nxml.txt.nlp	23650573	SENT142	6	6	25	25	sunitinib	MDM2	PA162372840	4193	0.789
NULL	Pharmacogn_Mag_2014_Jul-Sep_10(39)_374-383.nxml.txt.nlp	25210328	SENT138	14	14	1	1	evodiamine	PC1	PA165860788	5122	0.789
NULL	Biomed_Res_Int_2013_Dec_30_2013_737264.nxml.txt.nlp	23509769	SENT107	13	13	3	3	curcumin	SNK	PA151958596	10769	0.789
NULL	Alcohol_Res_2013_35(1)_47-55.nxml.txt.nlp	24313164	SENT50	1	1	16	16	ethanol	miR-217	PA448073	406999	0.789
NULL	Mol_Brain_2014_Aug_21_7_59.nxml.txt.nlp	25139109	SENT83	24	24	5	5	chloroquine	HRH4	PA448948	59340	0.789
NULL	Exp_Ther_Med_2014_Sep_20_8(3)_968-972.nxml.txt.nlp	25120631	SENT124	9	9	23	23	naringin	ADP	PA151958360	23038	0.789
NULL	Exp_Hematol_Oncol_2012_Sep_4_1_25.nxml.txt.nlp	23211188	SENT23	14	14	0	0	cisplatin	BIRC6	PA449014	57448	0.789
NULL	Patient_Prefer_Adherence_2011_Dec_23_6_1-9.nxml.txt.nlp	22272064	SENT3	6	6	8	8	telmisartan	ACE	PA451605	1636	0.789
NULL	Support_Care_Cancer_2014_Dec_14_22(3)_837-846.nxml.txt.nlp	24337717	SENT20	21	21	8	8	irinotecan	UGT1A1	PA450085	54658	0.789
NULL	J_Carcinog_Mutagen_2013_May_27_Suppl_14_S14-004.nxml.txt.nlp	25328816	SENT139	3	3	17	17	cisplatin	cIAP2	PA449014	330	0.789
NULL	BMB_Rep_2014_Jan_47(1)_33-38.nxml.txt.nlp	24209634	SENT76	13	13	5	5	cisplatin	CXCR4	PA449014	7852	0.789
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT227	7	7	27	27	heparin	FGF1	PA449855	2246	0.789
NULL	J_Oncol_2012_Mar_26_2012_198412.nxml.txt.nlp	22536237	SENT11	0	0	24	24	trastuzumab	HER2	PA451743	2064	0.789
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2675-2684.nxml.txt.nlp	24129246	SENT194	11	11	2	2	etoposide	KSR1	PA449552	8844	0.789
NULL	Oncotarget_2013_Nov_24_4(12)_2430-2438.nxml.txt.nlp	24280348	SENT116	26	26	7	7	gefitinib	STAT3	PA131301952	6774	0.789
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT281	14	14	24	24	nutlin-3	p53		7157	0.789
NULL	Indian_J_Pharm_Sci_2012_Jul-Aug_74(4)_319-330.nxml.txt.nlp	23626387	SENT269	12	12	2	2	glipizide	ANOVA	PA449762	4858	0.789
NULL	Protein_Cell_2014_Apr_4_5(4)_307-316.nxml.txt.nlp	24585413	SENT157	10	10	41	41	fluorescein	San	PA164746009	80218	0.789
NULL	J_Cell_Mol_Med_2014_Oct_11_18(10)_2031-2043.nxml.txt.nlp	25109475	SENT272	6	6	14	14	valsartan	STZ	PA451848	6484	0.789
NULL	J_Oncol_2009_Mar_24_2009_491985.nxml.txt.nlp	19325924	SENT6	21	21	26	26	genistein	CXCL12	PA165109660	6387	0.789
NULL	J_Invest_Dermatol_2012_Nov_21_132(11)_2642-2651.nxml.txt.nlp	22718118	SENT56	11	11	17	17	collagenase	CD11c	PA449107	3687	0.789
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_23_2013_185158.nxml.txt.nlp	23864881	SENT233	5	5	14	14	vorinostat	p53	PA164748224	7157	0.789
NULL	Aquat_Biosyst_2012_Feb_2_8_5.nxml.txt.nlp	22480362	SENT91	13	13	0	0	mannitol	API	PA450320	5345	0.789
NULL	Arthritis_Res_Ther_2008_Jan_7_10(1)_R1.nxml.txt.nlp	18179697	SENT178	12	12	7	7	oxaliplatin	HMGB1	PA131285527	3146	0.789
NULL	Evid_Based_Complement_Alternat_Med_2013_May_28_2013_629750.nxml.txt.nlp	23781265	SENT195	11	11	2	2	capsaicin	GADD153	PA448776	1649	0.789
NULL	Acta_Pharmacol_Sin_2014_Jun_5_35(6)_727-737.nxml.txt.nlp	24793312	SENT13	6	6	14	14	telmisartan	B27	PA451605	56246	0.789
NULL	Br_J_Pharmacol_2008_Sep_9_155(1)_127-137.nxml.txt.nlp	18536750	SENT304	17	17	5	5	piroxicam	IL-10	PA450985	3586	0.789
NULL	Evid_Based_Complement_Alternat_Med_2013_Aug_12_2013_982689.nxml.txt.nlp	23997806	SENT11	12	12	4	4	tolbutamide	APE	PA451718	55704;328	0.789
NULL	Cell_Death_Dis_2014_Jul_3_5(7)_e1316.nxml.txt.nlp	24991768	SENT53	16	16	13	13	pemetrexed	ATF4	PA10810	468	0.789
NULL	J_Biomed_Biotechnol_2011_Jul_6_2011_783528.nxml.txt.nlp	21785566	SENT302	6	6	0	0	indinavir	CYP3A4	PA449977	1576	0.789
NULL	Cancer_Cell_Int_2013_Jun_17_13_61.nxml.txt.nlp	23773282	SENT465	16	16	12	12	etoposide	NF-kappaB	PA449552	4790	0.789
NULL	Biosci_Rep_2012_Aug_1_32(Pt_4)_361-374.nxml.txt.nlp	22762204	SENT959	11	11	18	18	paclitaxel	p53	PA450761	7157	0.789
NULL	Oncoimmunology_2012_Oct_1_1(7)_1004-1016.nxml.txt.nlp	23170249	SENT53	16	16	12	12	paclitaxel	HER-2	PA450761	2064	0.789
NULL	Oncoimmunology_2012_Dec_1_1(9)_1661-1663.nxml.txt.nlp	23264929	SENT2	19	19	39	39	imiquimod	CCL2	PA449972	6347	0.789
NULL	Oncotarget_2011_Mar_23_2(3)_165-177.nxml.txt.nlp	21444946	SENT232	25	25	35	35	gemcitabine	EGFR	PA449748	1956	0.789
NULL	Leukemia_2014_Jun_25_28(6)_1280-1288.nxml.txt.nlp	24270737	SENT205	26	26	8	8	azacitidine	PD-L2	PA451996	80380	0.789
NULL	Br_J_Cancer_2013_Jul_9_109(1)_92-99.nxml.txt.nlp	23778521	SENT56	25	25	20	20	paclitaxel	CO2	PA450761	4513	0.789
NULL	Curr_HIV_Res_2014_May_12(3)_174-188.nxml.txt.nlp	24862327	SENT148	25	25	27	27	hemin	HO-1	PA449849	3162	0.789
NULL	J_Inherit_Metab_Dis_2012_Jan_10_35(1)_141-149.nxml.txt.nlp	21556832	SENT20	17	17	3	3	creatine	GAMT	PA164778930	2593	0.789
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT154	18	18	6	6	atorvastatin	OPG	PA448500	690	0.789
NULL	Clinics_(Sao_Paulo)_2013_Feb_68(2)_253-262.nxml.txt.nlp	23525324	SENT238	15	15	24	24	genistein	Gen	PA165109660	348654	0.789
NULL	Br_J_Pharmacol_2008_Sep_9_155(1)_127-137.nxml.txt.nlp	18536750	SENT196	31	31	26	26	piroxicam	IL-10	PA450985	3586	0.789
NULL	Support_Care_Cancer_2009_Sep_10_17(9)_1187-1193.nxml.txt.nlp	19205754	SENT134	22	22	18	18	aprepitant	NK-1	PA164747039	27087	0.789
NULL	Breast_Cancer_Res_2007_Mar_2_9(2)_205.nxml.txt.nlp	NULL	SENT26	27	27	31	31	lapatinib	HER-2	PA152241907	2064	0.789
NULL	Oncotarget_2014_Nov_3_5(20)_10127-10139.nxml.txt.nlp	25333256	SENT175	14	14	21	21	vemurafenib	TRIM16	PA165946873	10626	0.789
NULL	Nucleic_Acids_Res_2005_Apr_22_33(7)_2310-2317.nxml.txt.nlp	15849317	SENT13	14	14	25	25	geldanamycin	Hsp90	PA152031327	3320	0.789
NULL	Mol_Cancer_2014_Jun_5_13_143.nxml.txt.nlp	24898067	SENT180	7	7	9	9	lapatinib	HER-2	PA152241907	2064	0.789
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT138	28	28	13	13	trastuzumab	HER3	PA451743	2065	0.789
NULL	Cell_Death_Dis_2014_Feb_13_5(2)_e1055.nxml.txt.nlp	24525731	SENT96	6	6	14	14	irinotecan	XRCC1	PA450085	7515	0.789
NULL	Evid_Based_Complement_Alternat_Med_2013_May_22_2013_921012.nxml.txt.nlp	23762167	SENT13	4	4	13	13	ethanol	AMPK	PA448073	5563	0.789
NULL	J_Cell_Biol_1998_Nov_2_143(3)_815-825.nxml.txt.nlp	9813099	SENT60	18	18	2	2	paraformaldehyde	E16	PA450790	8140	0.789
NULL	Breast_Cancer_Res_2012_Feb_9_14(1)_R27.nxml.txt.nlp	22321971	SENT392	5	5	7	7	tamoxifen	aromatase	PA451581	1588	0.789
NULL	Diabetes_2009_Feb_58(2)_344-351.nxml.txt.nlp	19008341	SENT216	16	16	14	14	resveratrol	SIRT1		23411	0.789
NULL	Acta_Oncol_2014_Oct_9_53(10)_1347-1355.nxml.txt.nlp	24909504	SENT117	14	14	33	33	doxorubicin	TP53	PA449412	7157	0.789
NULL	Oncotarget_2014_Jun_3_5(13)_4920-4928.nxml.txt.nlp	24952482	SENT130	32	32	11	11	crizotinib	ALK	PA165946122	238	0.789
NULL	Drug_Saf_2014_Feb_19_37(4)_201-211.nxml.txt.nlp	24550106	SENT259	2	2	11	11	clarithromycin	CYP2C19	PA449028	1557	0.789
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Dec_17_3(12)_e152.nxml.txt.nlp	25518025	SENT66	8	8	12	12	oxycodone	CYP3A4	PA450741	1576	0.789
NULL	Nat_Commun_2013_Apr_23_4_1758.nxml.txt.nlp	23612299	SENT86	3	3	6	6	isoproterenol	SOD1	PA450121	6647	0.789
NULL	Chin_J_Cancer_2011_May_30(5)_293-302.nxml.txt.nlp	21527062	SENT55	0	0	3	3	trastuzumab	HER2	PA451743	2064	0.789
NULL	J_Thromb_Haemost_2011_Oct_9(10)_2103-2105.nxml.txt.nlp	21812912	SENT17	4	4	20	20	ticagrelor	mol	PA165374673	90527	0.789
NULL	Br_J_Cancer_2011_Jun_28_105(1)_118-123.nxml.txt.nlp	21654685	SENT92	2	2	11	11	dasatinib	S100beta	PA162372878	6285	0.789
NULL	J_Hum_Reprod_Sci_2011_Jan-Apr_4(1)_2-7.nxml.txt.nlp	21772731	SENT18	21	21	23	23	estradiol	aromatase	PA449503	1588	0.789
NULL	Br_J_Cancer_2002_Jan_21_86(2)_218-221.nxml.txt.nlp	11870509	SENT5	11	11	28	28	tamoxifen	BRCA2	PA451581	675	0.789
NULL	J_Inflamm_(Lond)_2006_Jul_12_3_10.nxml.txt.nlp	16834783	SENT231	13	13	21	21	mometasone	GM-CSF	PA450541	1437	0.789
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S320-S324.nxml.txt.nlp	21525476	SENT135	15	15	10	10	ramipril	DREAM	PA451223	30818	0.789
NULL	Ther_Clin_Risk_Manag_2007_Dec_3(6)_1009-1020.nxml.txt.nlp	18516316	SENT76	25	25	37	37	palonosetron	HEC	PA10352	10403	0.789
NULL	J_Int_AIDS_Soc_2012_Oct_9_15(2)_17324.nxml.txt.nlp	23078767	SENT140	37	37	19	19	fluconazole	CD4	PA449653	920	0.789
NULL	Curr_Cardiol_Rev_2009_Aug_5(3)_166-176.nxml.txt.nlp	20676275	SENT182	9	9	13	13	ofloxacin	HERG	PA450684	3757	0.789
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_May_11_67(Pt_6)_o1383.nxml.txt.nlp	21754773	SENT5	5	5	17	17	ethanol	mol	PA448073	90527	0.789
NULL	J_Biomed_Biotechnol_2011_Jul_3_2011_343791.nxml.txt.nlp	21799660	SENT96	21	21	5	5	ethanol	COD	PA448073	6628	0.789
NULL	Mol_Vis_2012_May_1_18_1115-1122.nxml.txt.nlp	22605923	SENT75	33	33	10	10	estradiol	IL-6	PA449503	3569	0.789
NULL	Onco_Targets_Ther_2014_Sep_9_7_1571-1582.nxml.txt.nlp	25228815	SENT128	11	11	20	20	pazopanib	VEGFR1	PA165291492	2321	0.789
NULL	Indian_J_Pharmacol_2008_Oct_40(Suppl_2)_S221-S236.nxml.txt.nlp	21593976	SENT93	8	8	0	0	carrageenan	NCBE	PA448814	57282	0.789
NULL	Open_Access_J_Urol_2011_May_10_3_69-82.nxml.txt.nlp	24198638	SENT60	18	18	14	14	dextromethorphan	CYP3A4	PA449273	1576	0.789
NULL	Indian_J_Anaesth_2011_May-Jun_55(3)_318-320.nxml.txt.nlp	21808420	SENT40	14	14	8	8	tramadol	CO2	PA451735	4513	0.789
NULL	J_Cell_Mol_Med_2014_Aug_17_18(8)_1491-1508.nxml.txt.nlp	24237862	SENT289	25	25	23	23	ranibizumab	VEGF-A	PA164746012	7422	0.789
NULL	BMB_Rep_2013_Nov_46(11)_544-549.nxml.txt.nlp	24152910	SENT294	10	10	6	6	thrombin	PAR-1	PA451674	2011;2149	0.789
NULL	J_Breast_Cancer_2013_Jun_28_16(2)_164-170.nxml.txt.nlp	23843848	SENT14	0	0	38	38	doxorubicin	PTEN	PA449412	5728	0.789
NULL	Oncol_Rep_2014_Mar_30_31(3)_1043-1050.nxml.txt.nlp	24378760	SENT34	7	7	13	13	doxycycline	p53	PA449415	7157	0.789
NULL	Cells_2014_May_23_3(2)_517-545.nxml.txt.nlp	24861977	SENT178	8	8	4	4	cisplatin	TRPV1	PA449014	7442	0.789
NULL	Acta_Pharmacol_Sin_2009_Jan_8_30(1)_1-24.nxml.txt.nlp	19060915	SENT111	5	5	18	18	milrinone	NCX	PA164749171	3196	0.789
NULL	Protein_Cell_2014_Jun_7_5(6)_457-468.nxml.txt.nlp	24801752	SENT150	12	12	20	20	geldanamycin	EGFR	PA152031327	1956	0.789
NULL	Indian_J_Pharmacol_2014_Mar-Apr_46(2)_147-151.nxml.txt.nlp	24741183	SENT126	8	8	23	23	ketamine	IL-6	PA450144	3569	0.789
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Sep_11_66(Pt_10)_o2550.nxml.txt.nlp	21587538	SENT55	18	18	33	33	ethanol	mol	PA448073	90527	0.789
NULL	Nucleic_Acids_Res_2013_Feb_21_41(4)_e54.nxml.txt.nlp	23262224	SENT91	14	14	4	4	galactose	GAL	PA449725	51083	0.789
NULL	Int_J_Biol_Sci_2011_Sep_8_7(8)_1077-1092.nxml.txt.nlp	21927577	SENT230	2	2	10	10	telmisartan	ANG	PA451605	283	0.789
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Sep_25_66(Pt_10)_o2620.nxml.txt.nlp	21587594	SENT62	11	11	26	26	ethanol	mol	PA448073	90527	0.789
NULL	J_Gen_Physiol_2000_Jun_1_115(6)_685-696.nxml.txt.nlp	10828243	SENT159	5	5	14	14	genistein	OLF	PA165109660	83857	0.789
NULL	Oncotarget_2012_Nov_14_3(12)_1557-1565.nxml.txt.nlp	23238683	SENT76	3	3	9	9	imatinib	CRKL	PA10804	1399	0.789
NULL	Oncotarget_2014_Aug_4_5(17)_7776-7787.nxml.txt.nlp	25277200	SENT28	25	25	18	18	etoposide	ANXA4	PA449552	307	0.789
NULL	Int_J_Environ_Res_Public_Health_2014_Apr_22_11(4)_4441-4448.nxml.txt.nlp	24758897	SENT35	32	32	34	34	bleomycin	BLM	PA448645	641	0.789
NULL	Oxid_Med_Cell_Longev_2013_Jul_10_2013_286524.nxml.txt.nlp	23936606	SENT183	23	23	13	13	curcumin	NRF2	PA151958596	2551;4780	0.789
NULL	Oncol_Lett_2013_Mar_11_5(3)_1010-1016.nxml.txt.nlp	23426784	SENT182	15	15	7	7	midazolam	TRPM7	PA450496	54822	0.789
NULL	Cancer_Cell_Int_2012_Nov_14_12_46.nxml.txt.nlp	23151005	SENT49	38	38	3	3	gentamicin	PC-3	PA449753	692094	0.789
NULL	Pharmaceuticals_(Basel)_2011_Jan_26_4(2)_285-342.nxml.txt.nlp	NULL	SENT279	27	27	18	18	fluvoxamine	5-HT2C	PA449690	3358	0.789
NULL	Nat_Med_2012_Jul_18(7)_1118-1122.nxml.txt.nlp	22683780	SENT10	11	11	8	8	crizotinib	MET	PA165946122	4233	0.789
NULL	Cancer_Metab_2014_May_28_2(Suppl_1)_P65.nxml.txt.nlp	NULL	SENT27	11	11	17	17	resveratrol	NAMPT		10135	0.789
NULL	Infect_Drug_Resist_2010_Nov_23_3_133-145.nxml.txt.nlp	21694902	SENT2	13	13	6	6	ribavirin	SOC	PA451241	91544	0.789
NULL	Infect_Drug_Resist_2011_Feb_3_4_43-53.nxml.txt.nlp	21694908	SENT188	25	25	3	3	voriconazole	ARTEMIS	PA10233	64421	0.789
NULL	Oncotarget_2013_Aug_31_4(11)_1894-1903.nxml.txt.nlp	24177167	SENT167	31	31	11	11	hydrocortisone	F12	PA449905	2161	0.789
NULL	Exp_Ther_Med_2013_Jul_25_6(1)_109-114.nxml.txt.nlp	23935730	SENT142	31	31	29	29	cyclophosphamide	CHOP	PA449165	1649	0.789
NULL	Cancer_Med_2014_Apr_7_3(2)_362-375.nxml.txt.nlp	24515916	SENT263	22	22	9	9	zoledronate	IFN	PA10235	3439	0.789
NULL	Cancer_Inform_2010_Apr_27_9_93-103.nxml.txt.nlp	20467479	SENT76	11	11	18	18	tamoxifen	CYP2D6	PA451581	1565	0.789
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT214	12	12	10	10	curcumin	DR5	PA151958596	8795	0.789
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT98	9	9	22	22	ranibizumab	VEGFR2	PA164746012	3791	0.789
NULL	Evid_Based_Complement_Alternat_Med_2013_Mar_26_2013_625892.nxml.txt.nlp	23589719	SENT179	0	0	15	15	probenecid	TAS2R16	PA451106	50833	0.789
NULL	Sci_Rep_2014_Dec_3_4_7201.nxml.txt.nlp	25467193	SENT271	16	16	0	0	docetaxel	NRF2	PA449383	2551;4780	0.789
NULL	Cent_European_J_Urol_2012_Dec_11_65(4)_227-229.nxml.txt.nlp	24578969	SENT60	19	19	26	26	gemcitabine	IFN	PA449748	3439	0.789
NULL	Croat_Med_J_2013_Apr_54(2)_171-179.nxml.txt.nlp	23630144	SENT136	0	0	8	8	taurine	HO-1	PA451590	3162	0.789
NULL	Subst_Abuse_Treat_Prev_Policy_2008_Jun_20_3_17.nxml.txt.nlp	18570665	SENT109	17	17	9	9	buprenorphine	OTP	PA448685	23440	0.789
NULL	Arthritis_Res_Ther_2010_Feb_24_12(1)_R32.nxml.txt.nlp	20181277	SENT213	48	48	37	37	imatinib	M-CSF	PA10804	1435	0.789
NULL	Oncogene_2013_Sep_26_32(39)_10_1038_onc_2012_491.nxml.txt.nlp	23108394	SENT221	21	21	14	14	epirubicin	FOXM1	PA449476	2305	0.789
NULL	Oncotarget_2013_Nov_24_5(1)_11-28.nxml.txt.nlp	24429466	SENT317	7	7	18	18	bortezomib	CRM1	PA10252	7514	0.789
NULL	Breast_Cancer_Res_2007_Dec_18_9(6)_R88.nxml.txt.nlp	18088411	SENT35	19	19	6	6	oxygen	NIR	PA450744	26155	0.789
NULL	J_Hematol_Oncol_2013_Jan_4_6_1.nxml.txt.nlp	23286345	SENT118	17	17	22	22	rituximab	FCGR3A	PA451261	2214	0.789
NULL	J_Hematol_Oncol_2013_Jun_3_6_38.nxml.txt.nlp	23731980	SENT79	18	18	6	6	trastuzumab	HER2	PA451743	2064	0.789
NULL	Arthritis_Res_Ther_2010_Feb_9_12(1)_R21.nxml.txt.nlp	20144213	SENT253	3	3	5	5	naproxen	5-LOX	PA450595	240	0.789
NULL	Biochemistry_2014_Feb_4_53(4)_664-674.nxml.txt.nlp	24490974	SENT98	9	9	29	29	l-cysteine	NMA	PA449173	25805	0.789
NULL	Int_J_Cell_Biol_2013_Sep_3_2013_642853.nxml.txt.nlp	24082883	SENT143	0	0	31	31	camptothecin	MDM2	PA153590860	4193	0.789
NULL	J_Med_Genet_2011_Jan_12_48(1)_24-31.nxml.txt.nlp	20837493	SENT120	38	38	19	19	amiloride	SCNN1A	PA448368	6337	0.789
NULL	Open_AIDS_J_2008_Dec_18_2_89-93.nxml.txt.nlp	19274065	SENT88	3	3	23	23	nevirapine	CD4	PA450616	920	0.789
NULL	FEBS_Open_Bio_2014_Jan_21_4_153-161.nxml.txt.nlp	24490140	SENT245	29	29	3	3	cisplatin	WT1	PA449014	7490	0.789
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Aug_13_64(Pt_9)_o1755.nxml.txt.nlp	21201737	SENT56	31	31	36	36	curcumin	HSD1	PA151958596	26871	0.789
NULL	J_Cell_Mol_Med_2013_Jun_15_17(6)_792-799.nxml.txt.nlp	23672538	SENT64	32	32	26	26	fluorescein	CD16	PA164746009	2215;2214	0.789
NULL	Ital_J_Pediatr_2010_Apr_21_36_33.nxml.txt.nlp	20406498	SENT277	5	5	17	17	montelukast	Yes	PA450546	7525	0.789
NULL	Indian_J_Med_Res_2011_Sep_134(3)_295-301.nxml.txt.nlp	21985811	SENT28	38	38	28	28	phenytoin	CYP2C19	PA450947	1557	0.789
NULL	Chin_J_Cancer_2012_Feb_31(2)_110-118.nxml.txt.nlp	22098951	SENT179	1	1	19	19	imatinib	P-gp	PA10804	5243	0.789
NULL	Mar_Drugs_2014_Oct_17_12(10)_5209-5221.nxml.txt.nlp	25329704	SENT19	34	34	43	43	verapamil	P-gp	PA451868	5243	0.789
NULL	Clinics_2009_Mar_64(3)_215-221.nxml.txt.nlp	19330248	SENT58	9	9	33	33	propofol	San	PA451141	80218	0.789
NULL	Core_Evid_2010_Jul_27_5_1-10.nxml.txt.nlp	20694135	SENT11	15	15	0	0	entacapone	CLE	PA164748726	51637	0.789
NULL	Drug_Target_Insights_2013_Aug_19_7_27-34.nxml.txt.nlp	24023511	SENT86	19	19	11	11	ciprofloxacin	P-gp	PA449009	5243	0.789
NULL	Acta_Pharmacol_Sin_2011_Sep_15_32(9)_1159-1164.nxml.txt.nlp	21841808	SENT61	21	21	39	39	paraformaldehyde	CD34	PA450790	947	0.789
NULL	Oncotarget_2013_Nov_24_4(12)_2430-2438.nxml.txt.nlp	24280348	SENT41	3	3	16	16	gefitinib	PI3K	PA131301952	5290	0.789
NULL	Br_J_Cancer_2009_Jan_13_100(1)_37-43.nxml.txt.nlp	19088724	SENT3	8	8	10	10	gemcitabine	Gem	PA449748	51053	0.789
NULL	Cell_Death_Dis_2013_Sep_5_4(9)_e791.nxml.txt.nlp	24008735	SENT40	2	2	24	24	gemcitabine	Bcl-2	PA449748	596	0.789
NULL	J_Cardiothorac_Surg_2013_Jul_18_8_176.nxml.txt.nlp	23866777	SENT126	9	9	5	5	thrombin	VIII	PA451674	1351	0.789
NULL	Infect_Drug_Resist_2010_Oct_13_3_103-114.nxml.txt.nlp	21694899	SENT238	6	6	26	26	raltegravir	TRIO		7204	0.789
NULL	Lab_Invest_2011_Jul_4_91(7)_1007-1017.nxml.txt.nlp	21464819	SENT70	31	31	19	19	neomycin	GPR55	PA450608	9290	0.789
NULL	Bioimpacts_2014_Feb_27_4(1)_21-27.nxml.txt.nlp	24790895	SENT138	16	16	22	22	isoproterenol	ANOVA	PA450121	4858	0.789
NULL	Blood_Res_2014_Sep_25_49(3)_162-169.nxml.txt.nlp	25325035	SENT21	26	26	33	33	vincristine	CHOP	PA451879	1649	0.789
NULL	J_Inherit_Metab_Dis_2012_Jan_10_35(1)_141-149.nxml.txt.nlp	21556832	SENT167	9	9	16	16	creatine	CRTR	PA164778930	6535	0.789
NULL	Mol_Cancer_2012_Jul_12_11_45.nxml.txt.nlp	22788833	SENT105	10	10	36	36	cisplatin	EGFR	PA449014	1956	0.789
NULL	Cases_J_2008_Oct_29_1_283.nxml.txt.nlp	18959805	SENT32	16	16	27	27	abacavir	CD4	PA448004	920	0.789
NULL	Mol_Vis_2011_May_4_17_1172-1181.nxml.txt.nlp	21617754	SENT137	4	4	12	12	staurosporine	FKBP51	PA165109623	2289	0.789
NULL	Breast_Cancer_Res_2010_Jun_28_12(3)_R43.nxml.txt.nlp	20579400	SENT19	5	5	2	2	fulvestrant	MAPT	PA164747170	4137	0.789
NULL	Diabetes_2011_Jul_20_60(7)_1917-1925.nxml.txt.nlp	21593202	SENT117	17	17	6	6	troglitazone	DPP4	PA451799	1803	0.789
NULL	Pharmaceuticals_(Basel)_2013_Nov_25_6(12)_1475-1506.nxml.txt.nlp	24287492	SENT1015	7	7	1	1	temozolomide	MSH6	PA451609	2956	0.789
NULL	Cancer_Res_Treat_2014_Jan_15_46(1)_48-54.nxml.txt.nlp	24520223	SENT45	21	21	12	12	bevacizumab	KRAS	PA130232992	3845	0.789
NULL	Indian_J_Pharm_Sci_2014_Jul-Aug_76(4)_299-307.nxml.txt.nlp	25284927	SENT146	22	22	16	16	phenylbutazone	2-19	PA450932	60343	0.789
NULL	Br_J_Cancer_2012_Jan_31_106(3)_482-489.nxml.txt.nlp	22233925	SENT37	27	27	7	7	carboplatin	PEO1	PA448803	56652	0.789
NULL	Iran_J_Neurol_2013_12(4)_157-165.nxml.txt.nlp	24250926	SENT78	6	6	19	19	carbamazepine	LGS	PA448785	51557	0.789
NULL	Diabetes_Care_2013_Aug_17_36(Suppl_2)_S127-S138.nxml.txt.nlp	23882037	SENT98	15	15	2	2	metformin	GLP-1	PA450395	100125288	0.789
NULL	Evid_Based_Complement_Alternat_Med_2012_Dec_20_2012_908601.nxml.txt.nlp	23326293	SENT29	40	40	38	38	oxaliplatin	HCC	PA131285527	84668	0.789
NULL	Hum_Mol_Genet_2013_Jun_1_22(11)_2247-2262.nxml.txt.nlp	23424202	SENT308	36	36	8	8	sertraline	AMPH	PA451333	273	0.789
NULL	Int_J_Biol_Sci_2013_Apr_22_9(4)_350-360.nxml.txt.nlp	23630447	SENT30	37	37	15	15	doxorubicin	TCL1A	PA449412	8115	0.788
NULL	Ann_Indian_Acad_Neurol_2010_Jan-Mar_13(1)_6-13.nxml.txt.nlp	20436740	SENT263	36	36	39	39	thrombin	PAR-1	PA451674	2011;2149	0.788
NULL	Breast_Cancer_Res_2009_Jan_16_11(1)_201.nxml.txt.nlp	19216727	SENT152	40	40	9	9	docetaxel	HER2	PA449383	2064	0.788
NULL	Curr_Cardiol_Rev_2011_Nov_7(4)_245-249.nxml.txt.nlp	22758625	SENT66	3	3	13	13	telmisartan	IL-6	PA451605	3569	0.788
NULL	J_Oncol_2012_Mar_11_2012_382159.nxml.txt.nlp	22481926	SENT94	20	20	2	2	cisplatin	PI3K	PA449014	5290	0.788
NULL	Nat_Commun_2014_Nov_25_5_5548.nxml.txt.nlp	25420520	SENT46	12	12	25	25	cabazitaxel	ERG	PA165958401	2078	0.788
NULL	Breast_Cancer_Res_2007_Jan_23_9(1)_R7.nxml.txt.nlp	17244352	SENT143	6	6	11	11	tamoxifen	CYP3A5	PA451581	1577	0.788
NULL	Exp_Ther_Med_2013_Feb_13_5(2)_581-585.nxml.txt.nlp	23403473	SENT95	3	3	7	7	etanercept	HMGB1	PA449515	3146	0.788
NULL	Nat_Commun_2013_Sep_4_4_2338.nxml.txt.nlp	24005565	SENT552	24	24	3	3	bleomycin	HELQ	PA448645	113510	0.788
NULL	Evid_Based_Complement_Alternat_Med_2013_Aug_28_2013_516017.nxml.txt.nlp	24066014	SENT141	4	4	19	19	telmisartan	p47phox	PA451605	653361	0.788
NULL	Mol_Cancer_2009_Oct_1_8_81.nxml.txt.nlp	19796390	SENT216	9	9	27	27	celecoxib	Bcl-2	PA448871	596	0.788
NULL	Int_J_Environ_Res_Public_Health_2011_Mar_1_8(3)_683-697.nxml.txt.nlp	21556173	SENT81	19	19	23	23	cetuximab	HER-2	PA10040	2064	0.788
NULL	Avicenna_J_Med_2011_Jul-Sep_1(1)_12-17.nxml.txt.nlp	23210004	SENT171	4	4	12	12	docetaxel	GM-CSF	PA449383	1437	0.788
NULL	J_Gen_Physiol_2008_Nov_132(5)_521-535.nxml.txt.nlp	18852303	SENT94	17	17	11	11	trypsin	CAP2	PA451806	5271;10486	0.788
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT91	4	4	9	9	methotrexate	MSH2	PA450428	4436	0.788
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT53	8	8	18	18	chloroquine	BMPR-II	PA448948	659	0.788
NULL	Arch_Toxicol_2014_Nov_5_88(12)_2135-2190.nxml.txt.nlp	25370008	SENT740	8	8	4	4	cyclosporine	CYP3A4	PA449167	1576	0.788
NULL	Alcohol_Res_2013_35(1)_6-16.nxml.txt.nlp	24313160	SENT263	14	14	29	29	nadh	SIRT1	PA164755085	23411	0.788
NULL	J_Thromb_Thrombolysis_2011_Nov_26_32(4)_459-466.nxml.txt.nlp	21706290	SENT39	26	26	4	4	clopidogrel	CYP2C19	PA449053	1557	0.788
NULL	Br_J_Cancer_2013_May_28_108(10)_2063-2069.nxml.txt.nlp	23591198	SENT190	13	13	7	7	gemcitabine	IL-6	PA449748	3569	0.788
NULL	Eur_J_Clin_Pharmacol_2010_Nov_29_66(11)_1131-1136.nxml.txt.nlp	20669013	SENT14	6	6	24	24	erythromycin	CYP2C19	PA449493	1557	0.788
NULL	Environ_Health_Perspect_2010_Sep_28_118(9)_1267-1272.nxml.txt.nlp	20427257	SENT117	16	16	6	6	estradiol	BPA	PA449503	667	0.788
NULL	Indian_J_Med_Res_2011_Jan_133(1)_15-26.nxml.txt.nlp	21321416	SENT184	15	15	21	21	cyclosporine	gamma	PA449167	9913	0.788
NULL	J_Cereb_Blood_Flow_Metab_2011_Oct_20_31(10)_2030-2040.nxml.txt.nlp	21505475	SENT210	19	19	24	24	cilostazol	Bcl-2	PA164746334	596	0.788
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jul_14_66(Pt_8)_o2007.nxml.txt.nlp	21588321	SENT7	23	23	4	4	coumarin	mol	PA134521193	90527	0.788
NULL	Iran_J_Neurol_2011_10(1-2)_19-21.nxml.txt.nlp	24250838	SENT60	24	24	37	37	amantadine	COMT	PA448360	1312	0.788
NULL	J_Hum_Genet_2013_Jun_16_58(6)_353-361.nxml.txt.nlp	23677058	SENT124	18	18	34	34	etoposide	ABCC3	PA449552	8714	0.788
NULL	Arthritis_Res_2001_Nov_2_3(1)_54-64.nxml.txt.nlp	11178127	SENT34	19	19	32	32	fluorescein	San	PA164746009	80218	0.788
NULL	Eur_J_Dent_2011_Jan_5(1)_77-83.nxml.txt.nlp	21228958	SENT36	13	13	22	22	chlorhexidine	HEMA	PA164776863	2157	0.788
NULL	Cell_Res_2013_Jun_21_23(6)_746-758.nxml.txt.nlp	23689277	SENT92	8	8	14	14	resveratrol	SIRT1		23411	0.788
NULL	Diabetes_Care_2011_Sep_19_34(9)_1902-1907.nxml.txt.nlp	21788624	SENT174	15	15	10	10	ramipril	DREAM	PA451223	30818	0.788
NULL	Acta_Pharmacol_Sin_2010_Apr_8_31(4)_461-469.nxml.txt.nlp	20208553	SENT5	5	5	11	11	ethanol	adiponectin	PA448073	9370	0.788
NULL	Br_J_Cancer_2004_Mar_22_90(6)_1285-1292.nxml.txt.nlp	15026814	SENT23	19	19	12	12	cisplatin	p53	PA449014	7157	0.788
NULL	Case_Rep_Psychiatry_2013_Feb_28_2013_718950.nxml.txt.nlp	23533901	SENT60	17	17	38	38	alprazolam	5-HT2A	PA448333	3356	0.788
NULL	Oncoimmunology_2014_Jan_17_3_e27574.nxml.txt.nlp	24800167	SENT22	43	43	32	32	cyclophosphamide	IL-23	PA449165	51561	0.788
NULL	Oncogene_2013_Sep_26_32(39)_10_1038_onc_2012_491.nxml.txt.nlp	23108394	SENT68	17	17	6	6	epirubicin	FOXM1	PA449476	2305	0.788
NULL	Front_Endocrinol_(Lausanne)_2013_Sep_3_4_118.nxml.txt.nlp	24027561	SENT141	22	22	13	13	isoproterenol	ghrelin	PA450121	51738	0.788
NULL	Oncotarget_2011_Dec_21_2(12)_1134-1144.nxml.txt.nlp	22193779	SENT117	12	12	7	7	gefitinib	PC3	PA131301952	57332;7832;5122	0.788
NULL	Biomed_Res_Int_2013_Oct_27_2013_798261.nxml.txt.nlp	24282821	SENT216	0	0	5	5	ethanol	AQP4	PA448073	361	0.788
NULL	J_Cell_Sci_2014_Nov_1_127(21)_4728-4739.nxml.txt.nlp	25179605	SENT260	22	22	29	29	bortezomib	SGTA	PA10252	6449	0.788
NULL	Curr_Biol_2009_Feb_24_19(4)_297-304.nxml.txt.nlp	19217292	SENT392	20	20	9	9	vasopressin	BMAL1	PA451858	406	0.788
NULL	J_Viral_Hepat_2009_May_16(5)_315-324.nxml.txt.nlp	19243499	SENT101	19	19	0	0	imiquimod	IFN	PA449972	3439	0.788
NULL	J_Allergy_(Cairo)_2011_Dec_11_2011_742710.nxml.txt.nlp	22220184	SENT28	3	3	10	10	methacholine	ASM	PA165958382	6609;283120	0.788
NULL	Biomed_Res_Int_2014_Jan_2_2014_682010.nxml.txt.nlp	24524084	SENT9	8	8	20	20	imatinib	IL-2	PA10804	3558	0.788
NULL	Br_J_Cancer_2013_Feb_5_108(2)_469-476.nxml.txt.nlp	23169292	SENT7	9	9	34	34	capecitabine	TTF2	PA448771	8458	0.788
NULL	Case_Rep_Transplant_2014_Jan_2_2014_548243.nxml.txt.nlp	24575309	SENT60	8	8	19	19	sirolimus	CYP3A	PA451365	1574	0.788
NULL	Ann_Med_Health_Sci_Res_2012_Jul-Dec_2(2)_134-139.nxml.txt.nlp	23440331	SENT18	15	15	3	3	atropine	GIT	PA448505	5034	0.788
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT1078	4	4	14	14	resveratrol	IL-6		3569	0.788
NULL	Curr_Neuropharmacol_2010_Sep_8(3)_254-267.nxml.txt.nlp	21358975	SENT191	8	8	32	32	oxcarbazepine	CYP3A4	PA450732	1576	0.788
NULL	Cancers_(Basel)_2011_Sep_13_3(3)_3557-3584.nxml.txt.nlp	22163073	SENT273	21	21	5	5	kanamycin	PC3	PA450137	57332;7832;5122	0.788
NULL	Br_J_Haematol_2008_Jun_141(5)_659-671.nxml.txt.nlp	18410446	SENT193	4	4	13	13	cerulenin	IL-6	PA164764551	3569	0.788
NULL	Crit_Care_2011_Jun_24_15(3)_R153.nxml.txt.nlp	21702944	SENT168	5	5	11	11	dexmedetomidine	HMGB1	PA449256	3146	0.788
NULL	Proteome_Sci_2009_May_28_7_20.nxml.txt.nlp	19476632	SENT168	27	27	16	16	galactose	NDUFA9	PA449725	4704	0.788
NULL	Front_Endocrinol_(Lausanne)_2011_Aug_26_2_17.nxml.txt.nlp	22649365	SENT730	6	6	12	12	losartan	ANG	PA450268	283	0.788
NULL	Indian_J_Ophthalmol_2011_Sep-Oct_59(5)_403a.nxml.txt.nlp	21836356	SENT18	18	18	14	14	nifedipine	CYP3A	PA450631	1574	0.788
NULL	Case_Rep_Med_2014_Nov_12_2014_231651.nxml.txt.nlp	25477968	SENT117	10	10	26	26	amiodarone	AIT	PA448383	160728	0.788
NULL	Biosci_Rep_2012_Dec_1_32(Pt_6)_511-519.nxml.txt.nlp	NULL	SENT315	0	0	10	10	lovastatin	gamma	PA450272	9913	0.788
NULL	Daru_2013_Apr_10_21(1)_29.nxml.txt.nlp	23575006	SENT18	16	16	7	7	tretinoin	USP35	PA451746	57558	0.788
NULL	Acta_Pharmacol_Sin_2010_Nov_18_31(11)_1447-1453.nxml.txt.nlp	20953204	SENT8	0	0	12	12	rimonabant	IL-6	PA152407999	3569	0.788
NULL	Br_J_Cancer_2011_Dec_6_105(12)_1839-1849.nxml.txt.nlp	22045192	SENT190	0	0	9	9	4-methylumbelliferone	CD44	PA154081778	960	0.788
NULL	Cell_Cycle_2012_Nov_1_11(21)_3983-3996.nxml.txt.nlp	22987153	SENT220	41	41	27	27	cisplatin	DNA2	PA449014	1763	0.788
NULL	Cell_Cycle_2012_Dec_15_11(24)_4661-4672.nxml.txt.nlp	23187802	SENT93	0	0	5	5	doxorubicin	p130	PA449412	5934	0.788
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1059-1066.nxml.txt.nlp	21364577	SENT3	27	27	10	10	exemestane	aromatase	PA449563	1588	0.788
NULL	Acta_Pharmacol_Sin_2010_Nov_18_31(11)_1447-1453.nxml.txt.nlp	20953204	SENT119	4	4	6	6	rimonabant	CB2	PA152407999	1269	0.788
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S177-S183.nxml.txt.nlp	21525452	SENT117	0	0	3	3	liraglutide	GLP-1	PA165958364	100125288	0.788
NULL	Mol_Cancer_2010_Jun_25_9_166.nxml.txt.nlp	20579378	SENT214	4	4	16	16	gefitinib	p53	PA131301952	7157	0.788
NULL	Cancer_Cell_Int_2013_Mar_4_13_21.nxml.txt.nlp	23497288	SENT14	20	20	6	6	doxorubicin	EWS	PA449412	2130	0.788
NULL	Toxins_(Basel)_2010_Oct_26_2(11)_2490-2518.nxml.txt.nlp	22069563	SENT206	22	22	6	6	cisplatin	IP-10	PA449014	3627	0.788
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT119	21	21	34	34	nutlin-3	MDM2		4193	0.788
NULL	Pharmaceutics_2011_Nov_18_3(4)_865-913.nxml.txt.nlp	24309312	SENT336	17	17	25	25	midazolam	CYP3A	PA450496	1574	0.788
NULL	Br_J_Cancer_2010_Oct_26_103(9)_1331-1334.nxml.txt.nlp	20877352	SENT36	6	6	4	4	trastuzumab	GM-CSF	PA451743	1437	0.788
NULL	Exp_Ther_Med_2013_Jan_10_5(1)_11-16.nxml.txt.nlp	23251234	SENT7	5	5	9	9	cetuximab	EGFR	PA10040	1956	0.788
NULL	Clin_Ophthalmol_2009_Jun_2_3_291-295.nxml.txt.nlp	19668581	SENT109	24	24	31	31	latanoprost	BAK	PA164774763	578	0.788
NULL	BMB_Rep_2013_Nov_46(11)_544-549.nxml.txt.nlp	24152910	SENT62	17	17	26	26	thrombin	p38	PA451674	10598;1432;7965	0.788
NULL	Virchows_Arch_2012_Feb_16_460(2)_141-149.nxml.txt.nlp	22173329	SENT228	20	20	11	11	cetuximab	NRAS	PA10040	4893	0.788
NULL	Front_Cell_Neurosci_2013_Aug_29_7_130.nxml.txt.nlp	24009554	SENT165	25	25	15	15	pilocarpine	NPY	PA450962	4852	0.788
NULL	Mediators_Inflamm_2011_Jul_3_2011_373589.nxml.txt.nlp	21765616	SENT82	6	6	13	13	genistein	IL-8	PA165109660	3576	0.788
NULL	Neural_Dev_2013_Mar_7_8_4.nxml.txt.nlp	23497494	SENT13	16	16	8	8	chlorpheniramine	FOXP2	PA448960	93986	0.788
NULL	Mol_Cancer_2012_Apr_26_11_26.nxml.txt.nlp	22537224	SENT125	16	16	23	23	cisplatin	FANCF	PA449014	2188	0.788
NULL	Exp_Hematol_Oncol_2012_Dec_10_1_39.nxml.txt.nlp	23227903	SENT163	5	5	18	18	clofarabine	CR2	PA164754863	1380	0.788
NULL	Ecancermedicalscience_2009_Jun_4_3_136.nxml.txt.nlp	22276003	SENT101	19	19	6	6	vincristine	MM1	PA451879	23654	0.788
NULL	Adv_Appl_Bioinforma_Chem_2008_Oct_30_1_85-98.nxml.txt.nlp	21918608	SENT53	18	18	5	5	bortezomib	SPARC	PA10252	6678	0.788
NULL	Front_Oncol_2014_Mar_24_4_47.nxml.txt.nlp	24716189	SENT190	0	0	15	15	sorafenib	BRAF	PA7000	673	0.788
NULL	Front_Neurosci_2014_Jun_24_8_176.nxml.txt.nlp	25009459	SENT200	21	21	5	5	ethanol	P2X4	PA448073	5025	0.788
NULL	Br_J_Cancer_1993_Apr_67(4)_668-673.nxml.txt.nlp	8471423	SENT12	11	11	2	2	doxorubicin	HAP	PA449412	5915;10313	0.788
NULL	Cell_Div_2012_Dec_26_7_26.nxml.txt.nlp	23268747	SENT114	0	0	20	20	bortezomib	p27	PA10252	5715;10534	0.788
NULL	Multidiscip_Respir_Med_2011_Oct_31_6(5)_291-298.nxml.txt.nlp	22958759	SENT6	24	24	18	18	methacholine	ACT	PA165958382	12;11332;9457;641455	0.788
NULL	Cell_Commun_Signal_2013_Oct_1_11_73.nxml.txt.nlp	24083678	SENT47	18	18	13	13	sulindac	COX	PA451565	1351	0.788
NULL	J_Hematol_Oncol_2009_Aug_12_2_36.nxml.txt.nlp	19674465	SENT103	14	14	39	39	rituximab	IL-2	PA451261	3558	0.788
NULL	Biosci_Rep_2013_Jun_5_33(3)_e00041.nxml.txt.nlp	23577625	SENT543	18	18	13	13	collagenase	MEK1	PA449107	5604	0.788
NULL	Cancer_Immunol_Immunother_2011_Jan_21_60(1)_75-85.nxml.txt.nlp	20857100	SENT206	25	25	11	11	fludarabine	TH1	PA449655	51497	0.788
NULL	Front_Genet_2012_Oct_19_3_220.nxml.txt.nlp	23091481	SENT36	18	18	20	20	bleomycin	BLM	PA448645	641	0.788
NULL	Int_J_Biomed_Sci_2014_Dec_10(4)_236-242.nxml.txt.nlp	25598753	SENT126	34	34	10	10	chlorpropamide	DUT	PA448966	1854	0.788
NULL	Int_J_Mol_Sci_2013_Apr_11_14(4)_7959-7978.nxml.txt.nlp	23579957	SENT182	36	36	11	11	ethanol	CO2	PA448073	4513	0.788
NULL	Brain_2014_Aug_20_137(8)_2178-2192.nxml.txt.nlp	24951641	SENT250	35	35	12	12	choline	MAP2	PA448976	4133;10988	0.788
NULL	Eur_J_Haematol_2014_Feb_25_92(2)_127-136.nxml.txt.nlp	24118452	SENT143	30	30	27	27	anagrelide	CRT	PA164742986	811	0.788
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Apr_7_9_12.nxml.txt.nlp	20374640	SENT10	19	19	5	5	tetracycline	TEM	PA451640	64102	0.788
NULL	Oncotarget_2013_Apr_10_4(4)_622-635.nxml.txt.nlp	23599172	SENT76	8	8	22	22	lapatinib	PI3	PA152241907	5266	0.788
NULL	Cell_Commun_Signal_2013_Dec_23_11_100.nxml.txt.nlp	24364863	SENT173	28	28	13	13	pp2	EGF		1950	0.788
NULL	Hum_Genomics_Proteomics_2010_Aug_3_2010_159761.nxml.txt.nlp	20981231	SENT127	8	8	18	18	lithium	AP-1	PA450243	2353;3727;2354;3725	0.788
NULL	Clin_Microbiol_Infect_2014_Jun_21_20(6)_536-541.nxml.txt.nlp	24107197	SENT11	22	22	4	4	isoniazid	DST	PA450112	667	0.788
NULL	Breast_Cancer_(Auckl)_2011_Jul_27_5_175-199.nxml.txt.nlp	21863131	SENT394	5	5	2	2	cetuximab	EGFR	PA10040	1956	0.788
NULL	Anesth_Pain_Med_2014_Sep_9_4(4)_e14221.nxml.txt.nlp	25599022	SENT12	4	4	13	13	cisplatin	LPO	PA449014	4025	0.788
NULL	Oncol_Lett_2013_Mar_11_5(3)_1010-1016.nxml.txt.nlp	23426784	SENT168	5	5	32	32	midazolam	CDK6	PA450496	1021	0.788
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_May_22_66(Pt_6)_o1398.nxml.txt.nlp	21579477	SENT47	18	18	33	33	ethanol	mol	PA448073	90527	0.788
NULL	Front_Cell_Neurosci_2013_Apr_23_7_50.nxml.txt.nlp	23630466	SENT12	26	26	19	19	haloperidol	DMT	PA449841	2039	0.788
NULL	ScientificWorldJournal_2013_Jun_5_2013_704912.nxml.txt.nlp	23844410	SENT21	13	13	15	15	boceprevir	BOC	PA165948902	91653	0.788
NULL	Breast_Cancer_Res_Treat_2014_Apr_10_145(2)_371-379.nxml.txt.nlp	24718774	SENT249	7	7	23	23	estradiol	aromatase	PA449503	1588	0.788
NULL	Avicenna_J_Med_2012_Jul-Sep_2(3)_65-70.nxml.txt.nlp	23826549	SENT61	16	16	8	8	amiodarone	ARCH	PA448383	339487	0.788
NULL	EMBO_Mol_Med_2013_Aug_4_5(8)_1247-1262.nxml.txt.nlp	23737459	SENT152	0	0	32	32	nilotinib	parkin	PA165958345	5071	0.788
NULL	J_Mol_Med_(Berl)_2014_May_10_92(7)_709-722.nxml.txt.nlp	24811491	SENT96	16	16	20	20	vemurafenib	BRAF	PA165946873	673	0.788
NULL	Acta_Pharmacol_Sin_2009_Jul_22_30(7)_956-964.nxml.txt.nlp	19543298	SENT34	12	12	23	23	atorvastatin	SLCO1B1	PA448500	10599	0.788
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT120	3	3	12	12	metformin	HIP	PA450395	6767;6159;64399;5068	0.788
NULL	Cancers_(Basel)_2014_Oct_24_6(4)_2187-2223.nxml.txt.nlp	25347122	SENT699	5	5	35	35	epirubicin	MA5	PA449476	29944	0.788
NULL	JRSM_Cardiovasc_Dis_2012_Sep_24_1(6)_cvd_2012_012015.nxml.txt.nlp	24175073	SENT43	16	16	22	22	clopidogrel	CYP2C19	PA449053	1557	0.788
NULL	Arthritis_Res_2002_Aug_6_4(5)_307-321.nxml.txt.nlp	12223105	SENT524	6	6	12	12	infliximab	B27	PA452639	56246	0.788
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Nov_13_64(Pt_12)_o2332.nxml.txt.nlp	21581307	SENT64	27	27	7	7	ethanol	mol	PA448073	90527	0.788
NULL	J_Mol_Signal_2011_May_16_6_4.nxml.txt.nlp	21575178	SENT175	7	7	15	15	arsenite	HSP27	PA452638	3315	0.788
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1063.nxml.txt.nlp	24556678	SENT67	24	24	7	7	thioridazine	c-FLIP	PA451666	8837	0.788
NULL	Evid_Based_Complement_Alternat_Med_2012_Sep_4_2012_485042.nxml.txt.nlp	22988474	SENT126	18	18	26	26	vincristine	P-gp	PA451879	5243	0.788
NULL	Br_J_Pharmacol_2011_May_163(1)_125-140.nxml.txt.nlp	21175577	SENT221	12	12	4	4	sildenafil	TRPC6	PA451346	7225	0.788
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT231	3	3	8	8	cisplatin	p53	PA449014	7157	0.788
NULL	Drug_Target_Insights_2013_Aug_19_7_27-34.nxml.txt.nlp	24023511	SENT83	34	34	9	9	telithromycin	P-gp	PA10202	5243	0.788
NULL	Arthritis_Res_Ther_2008_Sep_24_10(5)_R115.nxml.txt.nlp	18816401	SENT181	19	19	5	5	etanercept	BMP7	PA449515	655	0.788
NULL	Acta_Pharmacol_Sin_2012_Jan_3_33(1)_82-90.nxml.txt.nlp	22212431	SENT113	2	2	12	12	rosiglitazone	adiponectin	PA451283	9370	0.788
NULL	Ann_Rheum_Dis_2012_Sep_71(9)_1510-1516.nxml.txt.nlp	22440821	SENT11	33	33	3	3	adalimumab	adiponectin	PA10004	9370	0.788
NULL	J_Carcinog_2011_Dec_22_10_36.nxml.txt.nlp	22279421	SENT111	29	29	10	10	doxorubicin	RANKL	PA449412	8600	0.788
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1986-2011.nxml.txt.nlp	25268165	SENT166	28	28	33	33	doxorubicin	CD133	PA449412	8842	0.788
NULL	Pharmaceuticals_(Basel)_2013_Nov_4_6(11)_1347-1360.nxml.txt.nlp	24287461	SENT77	14	14	7	7	losartan	URAT1	PA450268	116085	0.788
NULL	Carcinogenesis_2011_Nov_1_32(11)_1724-1733.nxml.txt.nlp	21890461	SENT124	15	15	9	9	estradiol	BPA	PA449503	667	0.788
NULL	Diabetes_Care_2013_May_13_36(5)_1074-1082.nxml.txt.nlp	23275352	SENT217	17	17	20	20	liraglutide	ZAG	PA165958364	563	0.788
NULL	Environ_Health_Perspect_2005_Oct_14_113(10)_1330-1335.nxml.txt.nlp	16203242	SENT115	11	11	28	28	phenylephrine	MLC	PA450935	23209	0.788
NULL	Oncol_Lett_2014_Jan_20_7(1)_260-266.nxml.txt.nlp	24348860	SENT141	23	23	18	18	cisplatin	CRT	PA449014	811	0.788
NULL	Open_Biochem_J_2013_Feb_22_7_19-23.nxml.txt.nlp	23526382	SENT93	26	26	19	19	repaglinide	DM2	PA451234	28508	0.788
NULL	Diabetes_2009_Apr_23_58(4)_917-925.nxml.txt.nlp	19168598	SENT94	7	7	0	0	trypsin	FOXO1	PA451806	2308	0.788
NULL	Cell_Cycle_2013_May_15_12(10)_1492-1500.nxml.txt.nlp	23598717	SENT94	25	25	18	18	doxorubicin	ROCK1	PA449412	6093	0.788
NULL	Clin_Sci_(Lond)_2011_Apr_1_120(Pt_8)_335-345.nxml.txt.nlp	21091432	SENT103	0	0	31	31	ramipril	ACE2	PA451223	59272	0.788
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT121	26	26	10	10	cisplatin	MDM2	PA449014	4193	0.788
NULL	eLife_2014_May_27_3_e02200.nxml.txt.nlp	24867637	SENT5	5	5	2	2	nutlin-3	MDM2		4193	0.788
NULL	Cancer_Causes_Control_2013_Aug_18_24(8)_1605-1614.nxml.txt.nlp	23775025	SENT64	33	33	22	22	doxorubicin	GSTM2	PA449412	2946	0.788
NULL	Evid_Based_Complement_Alternat_Med_2013_Dec_12_2013_324618.nxml.txt.nlp	24416065	SENT113	36	36	21	21	nevirapine	P-gp	PA450616	5243	0.788
NULL	J_Biol_Chem_2010_Aug_20_285(34)_25913-25927.nxml.txt.nlp	20452970	SENT158	31	31	5	5	iloprost	cPLA2	PA164746843	10524	0.788
NULL	Oncol_Lett_2014_Mar_16_7(3)_827-833.nxml.txt.nlp	24527090	SENT81	14	14	11	11	cisplatin	IFN	PA449014	3439	0.788
NULL	Arthritis_Res_Ther_2011_Sep_21_13(5)_239.nxml.txt.nlp	21955617	SENT168	0	0	4	4	celecoxib	RANKL	PA448871	8600	0.788
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT106	44	44	11	11	lapatinib	HER2	PA152241907	2064	0.788
NULL	Onco_Targets_Ther_2014_Sep_9_7_1571-1582.nxml.txt.nlp	25228815	SENT200	18	18	5	5	sunitinib	VEGFR2	PA162372840	3791	0.788
NULL	Blood_Cancer_J_2014_Mar_7_4(3)_e190.nxml.txt.nlp	24608734	SENT98	16	16	14	14	cyclophosphamide	CHOP	PA449165	1649	0.788
NULL	Cell_Death_Dis_2014_Feb_13_5(2)_e1055.nxml.txt.nlp	24525731	SENT132	26	26	6	6	cisplatin	TXNL1	PA449014	9352	0.788
NULL	Mol_Cancer_2007_Apr_2_6_26.nxml.txt.nlp	17407576	SENT96	19	19	30	30	cisplatin	p53	PA449014	7157	0.788
NULL	Br_J_Cancer_2006_Dec_4_95(11)_1483-1489.nxml.txt.nlp	17106442	SENT145	16	16	19	19	gefitinib	MST	PA131301952	55154;4357;4294	0.788
NULL	Front_Genet_2012_Oct_26_3_213.nxml.txt.nlp	23112805	SENT257	12	12	20	20	furafylline	CYP1A2	PA452614	1544	0.788
NULL	Acta_Neuropathol_2012_Aug_18_124(2)_273-283.nxml.txt.nlp	22526018	SENT204	24	24	21	21	salbutamol	RYR1	PA448068	6261	0.788
NULL	Curr_Neuropharmacol_2010_Dec_8(4)_409-421.nxml.txt.nlp	21629447	SENT177	25	25	9	9	primidone	CLB	PA451105	171425	0.788
NULL	J_Mol_Med_(Berl)_2014_May_10_92(7)_709-722.nxml.txt.nlp	24811491	SENT248	15	15	4	4	cetuximab	PTEN	PA10040	5728	0.788
NULL	J_Int_AIDS_Soc_2013_Apr_30_16(1)_18059.nxml.txt.nlp	23639243	SENT0	26	26	37	37	zidovudine	CD4	PA451954	920	0.788
NULL	Int_J_Biol_Sci_2012_Sep_6_8(8)_1109-1120.nxml.txt.nlp	22991499	SENT143	19	19	16	16	l-arginine	ARG	PA448478	473;27	0.788
NULL	J_Gen_Physiol_2012_Nov_140(5)_541-555.nxml.txt.nlp	23109716	SENT21	5	5	3	3	capsaicin	TRPV1	PA448776	7442	0.788
NULL	Diabetes_Care_2010_Apr_12_33(4)_861-868.nxml.txt.nlp	20067962	SENT136	16	16	22	22	hyaluronan	TLR2	PA165958431	7097	0.788
NULL	Crit_Care_2011_Mar_22_15(2)_208.nxml.txt.nlp	21457506	SENT103	5	5	11	11	bleomycin	RAGE	PA448645	177	0.788
NULL	Aging_(Albany_NY)_2009_Jun_3_1(6)_515-528.nxml.txt.nlp	20157535	SENT103	13	13	5	5	resveratrol	S6K1		6198	0.788
NULL	Ann_Surg_Oncol_2011_Jun_14_18(6)_1657-1664.nxml.txt.nlp	21153885	SENT215	4	4	17	17	tamoxifen	ATAC	PA451581	6375	0.788
NULL	Biomed_Res_Int_2013_Aug_6_2013_909613.nxml.txt.nlp	24027765	SENT8	24	24	15	15	metronidazole	EEN	PA450484	6455	0.788
NULL	Anesth_Pain_Med_2013_Dec_27_4(1)_e11906.nxml.txt.nlp	24660144	SENT76	21	21	11	11	rituximab	FVIII	PA451261	2157	0.788
NULL	Front_Genet_2012_Oct_10_3_206.nxml.txt.nlp	23087703	SENT514	15	15	3	3	omeprazole	CYP2C19	PA450704	1557	0.788
NULL	Oncotarget_2014_Jun_20_5(14)_5246-5256.nxml.txt.nlp	25026301	SENT26	22	22	14	14	crizotinib	Met	PA165946122	79811	0.788
NULL	Anesth_Essays_Res_2012_Jan-Jun_6(1)_62-69.nxml.txt.nlp	NULL	SENT104	9	9	36	36	oxygen	TOF	PA450744	55079	0.788
NULL	J_Breast_Cancer_2013_Jun_28_16(2)_133-137.nxml.txt.nlp	23843843	SENT45	0	0	23	23	curcumin	p65	PA151958596	5970	0.788
NULL	Oncogene_2009_Apr_2_28(13)_1616-1625.nxml.txt.nlp	19219073	SENT126	6	6	13	13	nutlin-3	MDM2		4193	0.788
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT198	4	4	28	28	sitagliptin	10C	PA164748978	64333	0.788
NULL	Front_Synaptic_Neurosci_2012_Sep_27_4_4.nxml.txt.nlp	23133416	SENT87	12	12	30	30	spermine	CA1	PA164781199	759	0.788
NULL	Mol_Cancer_2013_Mar_5_12_17.nxml.txt.nlp	23497256	SENT8	37	37	19	19	sunitinib	HDM2	PA162372840	4193	0.788
NULL	J_Immunotoxicol_2013_Jan_11_10(1)_75-82.nxml.txt.nlp	22967038	SENT101	10	10	31	31	rituximab	CD4	PA451261	920	0.788
NULL	JAKSTAT_2013_Jul_1_2(3)_e24812.nxml.txt.nlp	24069562	SENT60	4	4	18	18	pp2	STAT3		6774	0.788
NULL	J_Hematol_Oncol_2011_Apr_20_4_16.nxml.txt.nlp	21504625	SENT316	10	10	8	8	nutlin-3	MDM2		4193	0.788
NULL	Int_J_Ayurveda_Res_2010_Apr-Jun_1(2)_128-131.nxml.txt.nlp	20814529	SENT20	28	28	30	30	diethylstilbestrol	DES	PA449307	1674	0.788
NULL	Oncol_Lett_2014_Jul_25_8(1)_313-316.nxml.txt.nlp	24959268	SENT9	13	13	6	6	sulindac	JNK1	PA451565	5599	0.788
NULL	J_Immunother_2014_Apr_12_37(3)_180-186.nxml.txt.nlp	24598448	SENT92	16	16	14	14	sorafenib	IL-2	PA7000	3558	0.788
NULL	Acta_Pharmacol_Sin_2012_Jul_18_33(7)_861-872.nxml.txt.nlp	22705730	SENT118	25	25	32	32	atorvastatin	PTEN	PA448500	5728	0.788
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT41	1	1	4	4	capsaicin	p53	PA448776	7157	0.788
NULL	Int_J_Surg_Oncol_2012_May_17_2012_406830.nxml.txt.nlp	22675625	SENT188	32	32	36	36	oxaliplatin	CRT	PA131285527	811	0.788
NULL	Front_Immunol_2013_Sep_17_4_281.nxml.txt.nlp	24062747	SENT118	13	13	2	2	imiquimod	TLR8	PA449972	51311	0.788
NULL	Arthritis_Res_Ther_2009_Jan_30_11(1)_205.nxml.txt.nlp	19232061	SENT33	22	22	11	11	methotrexate	ACR	PA450428	49	0.788
NULL	Mol_Cancer_2007_Apr_16_6_30.nxml.txt.nlp	17437646	SENT26	22	22	13	13	gefitinib	PTEN	PA131301952	5728	0.788
NULL	Cancer_Cell_Int_2010_Sep_9_10_32.nxml.txt.nlp	20828393	SENT186	10	10	0	0	cisplatin	ATF3	PA449014	467	0.788
NULL	Breast_Cancer_Res_2012_Dec_5_14(6)_R153.nxml.txt.nlp	23216744	SENT286	8	8	20	20	estradiol	p38	PA449503	10598;1432;7965	0.788
NULL	Cell_Commun_Signal_2013_Oct_1_11_73.nxml.txt.nlp	24083678	SENT100	14	14	30	30	sulindac	IL-8	PA451565	3576	0.788
NULL	Arthritis_Res_Ther_2008_Jan_18_10(1)_R8.nxml.txt.nlp	18205921	SENT32	13	13	21	21	hyaluronan	MRP5	PA165958431	10057	0.788
NULL	Oncol_Rep_2012_Sep_15_28(3)_763-767.nxml.txt.nlp	22710607	SENT99	6	6	11	11	gemcitabine	EGFR	PA449748	1956	0.788
NULL	J_Invest_Dermatol_2012_Sep_19_132(9)_2198-2205.nxml.txt.nlp	22513780	SENT84	0	0	5	5	isotretinoin	IL-2	PA450128	3558	0.788
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Jun_7_64(Pt_7)_o1181.nxml.txt.nlp	21202824	SENT70	33	33	17	17	ethanol	mol	PA448073	90527	0.788
NULL	Eur_J_Haematol_2013_Feb_22_90(2)_89-98.nxml.txt.nlp	23181448	SENT110	9	9	2	2	hydroxyurea	IFN	PA449942	3439	0.788
NULL	Diabetes_Care_2010_Oct_13_33(10)_2250-2253.nxml.txt.nlp	20628086	SENT23	9	9	14	14	ramipril	DREAM	PA451223	30818	0.788
NULL	Hum_Reprod_2014_Oct_10_29(10)_2302-2316.nxml.txt.nlp	25139174	SENT353	35	35	17	17	metformin	AKT	PA450395	207	0.788
NULL	Exp_Ther_Med_2013_Jul_15_6(1)_275-279.nxml.txt.nlp	23935760	SENT163	9	9	5	5	parecoxib	COX	PA166049193	1351	0.788
NULL	Cancers_(Basel)_2013_Apr_11_5(2)_404-417.nxml.txt.nlp	24216983	SENT55	15	15	29	29	paraformaldehyde	CD31	PA450790	5175	0.788
NULL	Lab_Invest_2012_Mar_12_92(3)_420-436.nxml.txt.nlp	22157717	SENT307	19	19	5	5	carbachol	CXCR4	PA448784	7852	0.788
NULL	J_Biomed_Sci_2013_Mar_15_20(1)_17.nxml.txt.nlp	23497194	SENT158	0	0	27	27	rivaroxaban	COX	PA165958360	1351	0.788
NULL	Jpn_Clin_Med_2013_Mar_6_4_7-13.nxml.txt.nlp	23966811	SENT92	18	18	14	14	esomeprazole	ESD	PA10075	2098	0.788
NULL	Mol_Vis_2012_Apr_11_18_901-908.nxml.txt.nlp	22539869	SENT167	13	13	2	2	curcumin	p38	PA151958596	10598;1432;7965	0.788
NULL	Cancers_(Basel)_2013_May_27_5(2)_617-638.nxml.txt.nlp	24216994	SENT135	7	7	14	14	curcumin	PC3	PA151958596	57332;7832;5122	0.788
NULL	Crit_Care_2011_Mar_3_15(2)_R82.nxml.txt.nlp	21371308	SENT108	9	9	16	16	heparin	ACT	PA449855	12;11332;9457;641455	0.788
NULL	Ann_Hematol_2014_Mar_18_93(8)_1335-1344.nxml.txt.nlp	24638841	SENT92	30	30	19	19	cyclophosphamide	CHOP	PA449165	1649	0.788
NULL	Cell_Death_Dis_2014_Jul_10_5(7)_e1318.nxml.txt.nlp	25010984	SENT33	3	3	5	5	nutlin-3	RITA		55422;84934	0.788
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1063.nxml.txt.nlp	24556678	SENT49	19	19	6	6	thioridazine	c-FLIP	PA451666	8837	0.788
NULL	Pharmaceuticals_(Basel)_2013_Aug_21_6(8)_988-1038.nxml.txt.nlp	24276379	SENT2544	13	13	4	4	cetuximab	BRAF	PA10040	673	0.788
NULL	Iran_J_Neurol_2014_Apr_3_13(2)_108-109.nxml.txt.nlp	25295156	SENT15	34	34	19	19	creatine	GAMT	PA164778930	2593	0.788
NULL	J_Mol_Signal_2010_May_10_5_4.nxml.txt.nlp	20459745	SENT13	15	15	6	6	cisplatin	p53	PA449014	7157	0.788
NULL	Acta_Pharmacol_Sin_2012_Aug_23_33(8)_1095-1100.nxml.txt.nlp	22820908	SENT114	20	20	10	10	ilaprazole	CYP3A	PA165947499	1574	0.788
NULL	Front_Endocrinol_(Lausanne)_2015_Jan_9_5_235.nxml.txt.nlp	25620956	SENT137	0	0	10	10	glucosamine	HBP	PA164747613	3069;50865;7884;566	0.788
NULL	Clin_Pharmacokinet_2014_Aug_21_53(10)_931-941.nxml.txt.nlp	25141974	SENT167	31	31	29	29	midazolam	CYP3A	PA450496	1574	0.788
NULL	Cell_Cycle_2012_Dec_15_11(24)_4661-4672.nxml.txt.nlp	23187802	SENT112	28	28	24	24	doxorubicin	DREAM	PA449412	30818	0.788
NULL	Hematol_Rep_2011_Oct_28_3(3_Suppl)_e5.nxml.txt.nlp	22586513	SENT34	15	15	12	12	cyclophosphamide	CHOP	PA449165	1649	0.788
NULL	Mol_Clin_Oncol_2013_Sep_24_1(5)_918-924.nxml.txt.nlp	24649271	SENT92	9	9	22	22	cetuximab	EGFR	PA10040	1956	0.788
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT171	9	9	0	0	phenprocoumon	VKORC1	PA450921	79001	0.788
NULL	Diabetes_Metab_Syndr_Obes_2010_Sep_22_3_325-335.nxml.txt.nlp	21437102	SENT27	27	27	11	11	saxagliptin	GLP-1	PA165958362	100125288	0.788
NULL	J_Biol_Chem_2012_Apr_27_287(18)_14644-14658.nxml.txt.nlp	22375002	SENT353	16	16	9	9	forskolin	CC2D1A	PA146096022	54862	0.788
NULL	Tetrahedron_2009_Sep_26_65(39)_8154-8160.nxml.txt.nlp	19888470	SENT19	16	16	13	13	lithium	SN2	PA450243	92745	0.788
NULL	Stroke_Res_Treat_2012_Nov_30_2012_382361.nxml.txt.nlp	22195291	SENT85	8	8	13	13	aspirin	CEA	PA448497	5670;1087	0.788
NULL	Int_J_Biol_Sci_2011_May_24_7(5)_664-672.nxml.txt.nlp	21647249	SENT104	34	34	11	11	tamoxifen	EGFR	PA451581	1956	0.788
NULL	Cancers_(Basel)_2013_Jul_24_5(3)_901-918.nxml.txt.nlp	24202326	SENT7	26	26	34	34	doxorubicin	CDC7	PA449412	8317	0.788
NULL	Case_Rep_Endocrinol_2013_Dec_22_2013_675298.nxml.txt.nlp	24455332	SENT105	13	13	24	24	cisplatin	ACTH	PA449014	5443	0.788
NULL	Am_J_Trop_Med_Hyg_2014_Jul_2_91(1)_1-2.nxml.txt.nlp	24752684	SENT28	7	7	26	26	primaquine	G6PD	PA451103	2539	0.788
NULL	J_Korean_Assoc_Oral_Maxillofac_Surg_2014_Aug_26_40(4)_195-198.nxml.txt.nlp	25247150	SENT87	7	7	16	16	heparin	CST	PA449855	9514	0.788
NULL	Theranostics_2013_Nov_30_3(12)_943-952.nxml.txt.nlp	24396505	SENT132	18	18	23	23	cisplatin	PTEN	PA449014	5728	0.788
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_21-38.nxml.txt.nlp	19305786	SENT115	5	5	10	10	capsaicin	TRPV1	PA448776	7442	0.788
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT165	8	8	11	11	capsaicin	p53	PA448776	7157	0.788
NULL	Niger_Med_J_2014_Jul-Aug_55(4)_327-332.nxml.txt.nlp	25114369	SENT15	24	24	11	11	streptomycin	RIF	PA451512	54509;80196	0.788
NULL	BMJ_2011_Jul_26_343_d4366.nxml.txt.nlp	21791491	SENT272	32	32	29	29	lisinopril	ACE	PA450242	1636	0.788
NULL	Clin_Interv_Aging_2009_Dec_29_4_463-472.nxml.txt.nlp	20054411	SENT60	2	2	15	15	vardenafil	SEP2	PA10229	23176;23157	0.788
NULL	Front_Comput_Neurosci_2013_Apr_5_7_22.nxml.txt.nlp	23576979	SENT16	13	13	24	24	propofol	HCN1	PA451141	348980	0.788
NULL	J_Biomed_Biotechnol_2006_Oct_16_2006_97287.nxml.txt.nlp	17489020	SENT160	3	3	8	8	perindopril	c-fos	PA450877	2353	0.788
NULL	Eur_J_Clin_Pharmacol_2012_Jan_8_68(1)_29-37.nxml.txt.nlp	21739267	SENT135	5	5	17	17	aripiprazole	PRX	PA10026	9588;57716	0.788
NULL	Front_Immunol_2012_Feb_27_3_23.nxml.txt.nlp	22566907	SENT969	0	0	9	9	hyaluronan	CD44	PA165958431	960	0.788
NULL	Virol_J_2012_Feb_16_9_45.nxml.txt.nlp	22340040	SENT143	15	15	21	21	heparin	CD163	PA449855	9332	0.788
NULL	Front_Pharmacol_2014_Oct_31_5_231.nxml.txt.nlp	25400580	SENT2979	18	18	7	7	gemcitabine	RRM1	PA449748	6240	0.788
NULL	Braz_J_Med_Biol_Res_2014_Nov_4_48(1)_13-24.nxml.txt.nlp	25493378	SENT76	31	31	38	38	cisplatin	p53	PA449014	7157	0.788
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT103	19	19	10	10	resveratrol	DR5		8795	0.788
NULL	Front_Chem_2014_Mar_14_2_12.nxml.txt.nlp	24790981	SENT119	18	18	32	32	curcumin	MEF2C	PA151958596	4208	0.788
NULL	J_Clin_Biochem_Nutr_2011_Mar_26_48(2)_154-160.nxml.txt.nlp	21373269	SENT11	21	21	12	12	dextran	IFN	PA449261	3439	0.788
NULL	Acta_Pharmacol_Sin_2012_Oct_3_33(10)_1311-1318.nxml.txt.nlp	22941289	SENT153	22	22	29	29	sorafenib	VEGFR2	PA7000	3791	0.788
NULL	Database_(Oxford)_2014_Dec_23_2014_bau124.nxml.txt.nlp	25539768	SENT125	0	0	13	13	celecoxib	AKT	PA448871	207	0.788
NULL	Arthritis_Res_Ther_2011_Sep_21_13(5)_239.nxml.txt.nlp	21955617	SENT102	0	0	24	24	celecoxib	COX	PA448871	1351	0.788
NULL	Oncoimmunology_2013_Dec_1_2(12)_e26904.nxml.txt.nlp	24498560	SENT66	16	16	29	29	cetuximab	KRAS	PA10040	3845	0.788
NULL	Acta_Pharmacol_Sin_2010_Feb_5_31(2)_137-144.nxml.txt.nlp	20139896	SENT191	4	4	10	10	zileuton	p38	PA451955	10598;1432;7965	0.788
NULL	Br_J_Cancer_2010_Sep_7_103(6)_796-801.nxml.txt.nlp	20823888	SENT34	9	9	32	32	gefitinib	AST	PA131301952	26503	0.788
NULL	Mol_Biol_Cell_2012_Nov_1_23(21)_4212-4225.nxml.txt.nlp	22956765	SENT99	0	0	8	8	pp2	SHP2		5781	0.788
NULL	J_Neuroinflammation_2010_Sep_7_7_51.nxml.txt.nlp	20822529	SENT187	6	6	12	12	hemin	p38	PA449849	10598;1432;7965	0.788
NULL	Mol_Cancer_2011_Sep_7_10_109.nxml.txt.nlp	21899742	SENT214	22	22	11	11	doxorubicin	TRAIL-R2	PA449412	8795	0.788
NULL	Curr_Opin_Nephrol_Hypertens_2015_Jan_4_24(1)_37-46.nxml.txt.nlp	25427230	SENT179	21	21	8	8	warfarin	ANG	PA451906	283	0.788
NULL	Breast_Cancer_(Auckl)_2011_Jul_27_5_175-199.nxml.txt.nlp	21863131	SENT365	21	21	13	13	cisplatin	HER2	PA449014	2064	0.788
NULL	Arthritis_Res_Ther_2012_Jul_27_14(4)_R175.nxml.txt.nlp	22838733	SENT111	27	27	12	12	adalimumab	CD14	PA10004	929	0.788
NULL	Arthritis_Res_Ther_2009_Jun_29_11(3)_R100.nxml.txt.nlp	19563672	SENT222	16	16	19	19	infliximab	IFN	PA452639	3439	0.788
NULL	Comput_Struct_Biotechnol_J_2013_Oct_18_6_e201303014.nxml.txt.nlp	24688722	SENT128	4	4	13	13	camptothecin	ADP	PA153590860	23038	0.788
NULL	Chemother_Res_Pract_2011_Apr_7_2011_393976.nxml.txt.nlp	22312553	SENT39	20	20	12	12	lumefantrine	CYP3A4	PA165111722	1576	0.788
NULL	Ann_Rheum_Dis_2009_Jan_15_69(1)_301-304.nxml.txt.nlp	19147618	SENT74	21	21	5	5	infliximab	TWEAK	PA452639	8742	0.788
NULL	Oncotarget_2014_Oct_21_5(22)_11709-11722.nxml.txt.nlp	25365944	SENT227	35	35	27	27	metformin	Rho	PA450395	29984	0.788
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT187	6	6	11	11	tacrolimus	OPG	PA451578	690	0.788
NULL	J_Carcinog_2013_Dec_31_12_22.nxml.txt.nlp	24574860	SENT6	38	38	21	21	bevacizumab	EGFR	PA130232992	1956	0.787
NULL	Arthritis_Res_Ther_2012_Jun_12_14(3)_R141.nxml.txt.nlp	22691241	SENT211	42	42	44	44	abatacept	CTLA4	PA164747080	1493	0.787
NULL	Oncotarget_2013_Jul_26_4(8)_1317-1328.nxml.txt.nlp	23945331	SENT175	36	36	29	29	metformin	ATG12	PA450395	9140	0.787
NULL	Mol_Cancer_2014_Jan_13_13_7.nxml.txt.nlp	24418169	SENT180	16	16	3	3	sorafenib	STAT3	PA7000	6774	0.787
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT146	6	6	15	15	resveratrol	cIAP1		329	0.787
NULL	Cancers_(Basel)_2013_May_27_5(2)_617-638.nxml.txt.nlp	24216994	SENT339	2	2	12	12	curcumin	MMP9	PA151958596	4318	0.787
NULL	Psychiatr_Genet_2013_Aug_28_23(4)_153-162.nxml.txt.nlp	23811784	SENT213	27	27	22	22	clozapine	PICALM	PA449061	8301	0.787
NULL	Angiogenesis_2010_Sep_29_13(3)_259-267.nxml.txt.nlp	20803239	SENT257	8	8	16	16	everolimus	VEGFR	PA164746311	3791	0.787
NULL	Neuropsychopharmacology_2009_Jul_25_34(8)_1968-1978.nxml.txt.nlp	19322168	SENT229	2	2	5	5	clozapine	PI3K	PA449061	5290	0.787
NULL	Mol_Vis_2011_May_27_17_1397-1404.nxml.txt.nlp	21655359	SENT79	9	9	24	24	paraformaldehyde	nucleostemin	PA450790	26354	0.787
NULL	Cancer_Cell_Int_2008_Mar_18_8_3.nxml.txt.nlp	18348720	SENT104	5	5	35	35	gefitinib	PC3	PA131301952	57332;7832;5122	0.787
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Oct_31_65(Pt_11)_o2963.nxml.txt.nlp	21578534	SENT47	20	20	35	35	ethanol	mol	PA448073	90527	0.787
NULL	Front_Genet_2012_Nov_5_3_236.nxml.txt.nlp	23133441	SENT213	6	6	0	0	cyclosporine	CYP3A5	PA449167	1577	0.787
NULL	Clinics_2008_Dec_63(6)_725b-730.nxml.txt.nlp	19060991	SENT46	27	27	23	23	losartan	AT1	PA450268	9197;185	0.787
NULL	Aging_(Albany_NY)_2012_Jul_22_4(7)_480-498.nxml.txt.nlp	22837425	SENT89	38	38	1	1	metformin	LKB1	PA450395	6794	0.787
NULL	Acta_Pharmacol_Sin_2009_Jun_5_30(6)_859-867.nxml.txt.nlp	19498425	SENT22	3	3	17	17	carbachol	CA3	PA448784	761	0.787
NULL	Oxid_Med_Cell_Longev_2013_Mar_5_2013_264935.nxml.txt.nlp	23533686	SENT167	39	39	22	22	hemin	HO-1	PA449849	3162	0.787
NULL	Int_J_Mol_Imaging_2011_Oct_26_2011_874585.nxml.txt.nlp	21490735	SENT176	0	0	19	19	docetaxel	FDG	PA449383	23583	0.787
NULL	Patient_Prefer_Adherence_2009_Nov_3_3_51-59.nxml.txt.nlp	19936145	SENT226	2	2	4	4	levodopa	COMT	PA450213	1312	0.787
NULL	Breast_Cancer_Res_2007_Jul_5_9(4)_R41.nxml.txt.nlp	17612393	SENT43	24	24	27	27	celecoxib	Bcl-2	PA448871	596	0.787
NULL	Chem_Cent_J_2013_Jul_18_7_124.nxml.txt.nlp	23866043	SENT171	36	36	21	21	metformin	HPS3	PA450395	84343	0.787
NULL	Iran_J_Pharm_Res_2014_Autumn_13(4)_1393-1401.nxml.txt.nlp	25587329	SENT127	19	19	21	21	celecoxib	ABCG2	PA448871	9429	0.787
NULL	Clin_Pharmacol_2009_Sep_7_1_1-6.nxml.txt.nlp	22291481	SENT68	1	1	10	10	fluoxetine	PDE4B	PA449673	5142	0.787
NULL	Oncotarget_2014_Mar_16_5(9)_2513-2528.nxml.txt.nlp	24810336	SENT78	8	8	16	16	vemurafenib	BRAF	PA165946873	673	0.787
NULL	Mol_Vis_2011_Dec_30_17_3556-3565.nxml.txt.nlp	22219651	SENT289	12	12	4	4	latanoprost	PGF	PA164774763	5228	0.787
NULL	J_Biol_Chem_2009_Jul_24_284(30)_20011-20021.nxml.txt.nlp	19473976	SENT192	0	0	9	9	trypsin	MCT1	PA451806	6566	0.787
NULL	Oncotarget_2012_Nov_17_4(1)_18-28.nxml.txt.nlp	23248157	SENT89	8	8	35	35	pargyline	PUMA	PA450797	27113	0.787
NULL	Leukemia_2014_Jun_25_28(6)_1280-1288.nxml.txt.nlp	24270737	SENT202	22	22	7	7	vorinostat	PD-L2	PA164748224	80380	0.787
NULL	J_Int_AIDS_Soc_2012_Mar_12_15_13.nxml.txt.nlp	22410312	SENT25	5	5	39	39	stavudine	CD4	PA451494	920	0.787
NULL	Diabetes_2009_Feb_58(2)_329-336.nxml.txt.nlp	19171749	SENT159	16	16	30	30	imatinib	JNK	PA10804	5599	0.787
NULL	Aging_(Albany_NY)_2009_Sep_25_1(10)_845-854.nxml.txt.nlp	20157557	SENT146	5	5	12	12	doxorubicin	p53	PA449412	7157	0.787
NULL	Cancers_(Basel)_2013_Jun_24_5(3)_762-785.nxml.txt.nlp	24202320	SENT49	10	10	18	18	heparin	VEGF-A	PA449855	7422	0.787
NULL	Structure_2012_May_9_20-540(5-7)_841-849.nxml.txt.nlp	22579251	SENT86	5	5	16	16	formoterol	EL2	PA134687907	6708	0.787
NULL	Genet_Mol_Biol_2009_Sep_1_Jul-Sep_32(3)_516-520.nxml.txt.nlp	21637514	SENT65	0	0	19	19	estradiol	FGF2	PA449503	2247;2258	0.787
NULL	Arthritis_Res_Ther_2012_Jul_27_14(4)_R175.nxml.txt.nlp	22838733	SENT11	32	32	23	23	adalimumab	CD14	PA10004	929	0.787
NULL	Cancer_Immunol_Immunother_2015_Oct_7_64_61-73.nxml.txt.nlp	25287778	SENT261	11	11	19	19	lenalidomide	CD56	PA162363968	4684	0.787
NULL	Br_J_Cancer_2014_Mar_4_110(5)_1221-1227.nxml.txt.nlp	24496456	SENT26	22	22	15	15	cetuximab	EGFR	PA10040	1956	0.787
NULL	Semin_Immunopathol_2013_Jan_26_35(1)_39-52.nxml.txt.nlp	22829332	SENT197	16	16	18	18	melphalan	CHOP	PA450354	1649	0.787
NULL	Mucosal_Immunol_2014_Mar_24_7(2)_335-347.nxml.txt.nlp	23881354	SENT327	15	15	6	6	dextran	CD11c	PA449261	3687	0.787
NULL	J_Inflamm_(Lond)_2008_Dec_5_5_23.nxml.txt.nlp	19061493	SENT14	29	29	26	26	hemin	HO-1	PA449849	3162	0.787
NULL	Cardiovasc_Diabetol_2013_Mar_4_12_42.nxml.txt.nlp	23452502	SENT101	27	27	13	13	sevoflurane	AMPK	PA451341	5563	0.787
NULL	Curr_Hepat_Rep_2010_Aug_19_9(3)_147-154.nxml.txt.nlp	20676191	SENT262	24	24	7	7	ribavirin	EPO	PA451241	7076;8288;2056	0.787
NULL	Pharm_Pract_(Granada)_2009_Mar_15_Apr-Jun_7(2)_113-123.nxml.txt.nlp	25152787	SENT188	18	18	0	0	warfarin	Yes	PA451906	7525	0.787
NULL	Braz_J_Med_Biol_Res_2014_Sep_5_47(11)_1008-1015.nxml.txt.nlp	25296365	SENT122	34	34	44	44	paroxetine	CYP2D6	PA450801	1565	0.787
NULL	Chemother_Res_Pract_2011_Dec_1_2011_715469.nxml.txt.nlp	22312557	SENT101	6	6	18	18	cisplatin	P48	PA449014	6767	0.787
NULL	Nat_Neurosci_2013_Dec_10_16(12)_1794-1801.nxml.txt.nlp	24212673	SENT22	0	0	8	8	betaine	BGT-1	PA448603	6539	0.787
NULL	Diabetes_Care_2010_Mar_15_33(3)_608-613.nxml.txt.nlp	20009095	SENT168	10	10	13	13	rosiglitazone	adiponectin	PA451283	9370	0.787
NULL	Clin_Med_Insights_Circ_Respir_Pulm_Med_2012_Jun_12_6_27-40.nxml.txt.nlp	22745565	SENT25	22	22	35	35	omalizumab	IL-5	PA164752253	3567	0.787
NULL	Oncotarget_2014_Jun_7_5(14)_5257-5271.nxml.txt.nlp	24913448	SENT157	16	16	11	11	imatinib	CRKL	PA10804	1399	0.787
NULL	Cardiovasc_Res_2010_Jul_1_87(1)_60-72.nxml.txt.nlp	20110334	SENT156	0	0	25	25	propranolol	SCN5A	PA451145	6331	0.787
NULL	Br_J_Cancer_2010_Oct_26_103(9)_1331-1334.nxml.txt.nlp	20877352	SENT18	5	5	3	3	trastuzumab	GM-CSF	PA451743	1437	0.787
NULL	Blood_Res_2014_Sep_25_49(3)_200-203.nxml.txt.nlp	25325043	SENT27	7	7	14	14	doxorubicin	CHOP	PA449412	1649	0.787
NULL	Arthritis_Res_Ther_2011_Sep_21_13(5)_239.nxml.txt.nlp	21955617	SENT185	6	6	3	3	celecoxib	RANKL	PA448871	8600	0.787
NULL	Indian_J_Ophthalmol_2011_Jan_59(Suppl1)_S102-S113.nxml.txt.nlp	21150020	SENT174	6	6	26	26	brimonidine	Bcl-2	PA448665	596	0.787
NULL	Cell_Death_Differ_2010_Nov_13_17(11)_1672-1683.nxml.txt.nlp	20706276	SENT194	31	31	0	0	l-glutamine	HC11	PA10090	6347	0.787
NULL	Environ_Health_Perspect_2009_Feb_8_117(2)_175-180.nxml.txt.nlp	19270784	SENT145	7	7	0	0	doxorubicin	BPA	PA449412	667	0.787
NULL	Lab_Invest_2009_Dec_19_89(12)_1397-1409.nxml.txt.nlp	19841616	SENT242	4	4	8	8	curcumin	NAC	PA151958596	22861	0.787
NULL	Mol_Pain_2013_Jun_10_9_27.nxml.txt.nlp	23758830	SENT117	2	2	6	6	tetracaine	ASIC2a	PA451638	40	0.787
NULL	Arch_Med_Sci_2011_Dec_31_7(6)_977-983.nxml.txt.nlp	22328880	SENT7	14	14	4	4	heparin	PAPP-A	PA449855	5069	0.787
NULL	Breast_Cancer_Res_2009_Jan_27_11(1)_R5.nxml.txt.nlp	19173736	SENT225	3	3	21	21	tamoxifen	CD68	PA451581	968	0.787
NULL	Cardiovasc_Diabetol_2013_Jun_7_12_84.nxml.txt.nlp	23759020	SENT208	11	11	9	9	dipyridamole	LSR	PA449367	51599	0.787
NULL	Reprod_Biol_Endocrinol_2003_Oct_7_1_71.nxml.txt.nlp	14577832	SENT117	5	5	10	10	cisplatin	p38	PA449014	10598;1432;7965	0.787
NULL	EPMA_J_2010_Mar_13_1(1)_138-163.nxml.txt.nlp	23199048	SENT324	5	5	8	8	pramlintide	DPP4	PA164781394	1803	0.787
NULL	Iran_J_Pharm_Res_2015_Winter_14(1)_279-289.nxml.txt.nlp	25561934	SENT189	33	33	39	39	isoproterenol	ANOVA	PA450121	4858	0.787
NULL	Diabetes_2013_Jun_20_62(6)_2122-2129.nxml.txt.nlp	23378607	SENT244	4	4	17	17	pioglitazone	CO2	PA450970	4513	0.787
NULL	Curr_Genomics_2014_Jun_15(3)_217-230.nxml.txt.nlp	24955029	SENT59	2	2	37	37	oxygen	ROS	PA450744	6098	0.787
NULL	Biochim_Biophys_Acta_2014_Apr_1841(4)_588-594.nxml.txt.nlp	24440819	SENT26	2	2	16	16	lipase	PNPLA2	PA450239	57104	0.787
NULL	Arthritis_Res_Ther_2011_Apr_6_13(2)_403.nxml.txt.nlp	21542877	SENT0	14	14	33	33	etanercept	CB2	PA449515	1269	0.787
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Nov_30_67(Pt_12)_o3513.nxml.txt.nlp	22199982	SENT73	34	34	20	20	ethanol	mol	PA448073	90527	0.787
NULL	Mol_Cancer_2013_Nov_13_12_137.nxml.txt.nlp	24225025	SENT307	17	17	33	33	doxorubicin	HMGB1	PA449412	3146	0.787
NULL	Open_AIDS_J_2011_Jul_11_5_62-66.nxml.txt.nlp	21772932	SENT14	15	15	36	36	ritonavir	CD4	PA451260	920	0.787
NULL	Mol_Cancer_2010_Dec_20_9_316.nxml.txt.nlp	21172016	SENT163	14	14	42	42	heparin	CCL21	PA449855	6366	0.787
NULL	Cancer_Cell_Int_2010_Sep_9_10_32.nxml.txt.nlp	20828393	SENT125	24	24	16	16	cisplatin	ATF3	PA449014	467	0.787
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT151	12	12	14	14	nutlin-3	MDM2		4193	0.787
NULL	J_Hematol_Oncol_2009_Apr_22_2_18.nxml.txt.nlp	19386128	SENT160	11	11	23	23	cetuximab	KRAS	PA10040	3845	0.787
NULL	Br_J_Pharmacol_2014_Sep_28_171(18)_4255-4272.nxml.txt.nlp	24846338	SENT213	15	15	20	20	ondansetron	gamma	PA450705	9913	0.787
NULL	Core_Evid_2010_Oct_21_5_23-37.nxml.txt.nlp	21042540	SENT161	10	10	38	38	saxagliptin	CYP1A2	PA165958362	1544	0.787
NULL	Biologics_2012_Dec_17_6_429-464.nxml.txt.nlp	23269860	SENT11	1	1	18	18	etanercept	ACR	PA449515	49	0.787
NULL	Arthritis_Res_Ther_2010_Apr_9_12(2)_R65.nxml.txt.nlp	20380722	SENT85	20	20	42	42	imatinib	MMP3	PA10804	4314	0.787
NULL	Lab_Invest_2009_Nov_7_89(11)_1275-1290.nxml.txt.nlp	19736547	SENT309	17	17	24	24	curcumin	LOX-1	PA151958596	4973	0.787
NULL	Leukemia_2013_Feb_3_27(2)_315-324.nxml.txt.nlp	22751450	SENT205	5	5	2	2	sorafenib	AKT	PA7000	207	0.787
NULL	Sensors_(Basel)_2010_May_19_10(5)_5031-5053.nxml.txt.nlp	22399922	SENT164	4	4	9	9	resveratrol	FOXO1		2308	0.787
NULL	Cancer_Med_2012_Aug_31_1(1)_89-95.nxml.txt.nlp	23342258	SENT34	11	11	18	18	carboplatin	CTX	PA448803	1593	0.787
NULL	Oncol_Lett_2015_Jan_4_9(1)_91-95.nxml.txt.nlp	25435939	SENT73	19	19	8	8	cisplatin	NACT	PA449014	284111	0.787
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Oct_31_65(Pt_11)_o2935.nxml.txt.nlp	21578511	SENT58	26	26	41	41	ethanol	mol	PA448073	90527	0.787
NULL	Front_Oncol_2014_Mar_25_4_54.nxml.txt.nlp	24724051	SENT51	24	24	30	30	ponatinib	ABL1	PA165980594	25	0.787
NULL	Mol_Biol_Cell_2014_May_1_25(9)_1411-1420.nxml.txt.nlp	24623724	SENT116	21	21	42	42	doxycycline	XIAP	PA449415	331	0.787
NULL	Front_Pharmacol_2014_May_27_5_115.nxml.txt.nlp	24904418	SENT778	6	6	16	16	hemin	p38	PA449849	10598;1432;7965	0.787
NULL	Diabetes_2013_Sep_15_62(9)_3019-3021.nxml.txt.nlp	23970522	SENT32	19	19	7	7	chymotrypsin	CTRB1	PA448994	1504	0.787
NULL	Cancers_(Basel)_2011_Aug_5_3(3)_3114-3142.nxml.txt.nlp	24212948	SENT1546	24	24	5	5	dacarbazine	gp100	PA449197	6490	0.787
NULL	Acta_Oncol_2014_Oct_9_53(10)_1347-1355.nxml.txt.nlp	24909504	SENT140	16	16	5	5	doxorubicin	TP53	PA449412	7157	0.787
NULL	Nat_Med_2012_Jan_8_18(2)_281-285.nxml.txt.nlp	22231557	SENT54	20	20	12	12	ezetimibe	NPC1L1	PA10816	29881	0.787
NULL	Oncotarget_2013_Nov_24_4(12)_2430-2438.nxml.txt.nlp	24280348	SENT69	12	12	9	9	gefitinib	EGFR	PA131301952	1956	0.787
NULL	Evid_Based_Complement_Alternat_Med_2013_Nov_26_2013_156574.nxml.txt.nlp	24379885	SENT55	22	22	13	13	loratadine	NIF	PA450266	6280	0.787
NULL	Br_J_Cancer_2012_Apr_10_106(8)_1395-1405.nxml.txt.nlp	22460269	SENT116	6	6	13	13	sulindac	ABCB1	PA451565	5243	0.787
NULL	Br_J_Clin_Pharmacol_2013_Aug_23_76(2)_299-315.nxml.txt.nlp	23701319	SENT186	18	18	6	6	alemtuzumab	CD4	PA164783958	920	0.787
NULL	Braz_J_Med_Biol_Res_2012_Feb_17_45(3)_244-249.nxml.txt.nlp	22331137	SENT22	15	15	2	2	gentamicin	PAG	PA449753	55824	0.787
NULL	Iran_J_Pharm_Res_2013_Winter_12(1)_141-146.nxml.txt.nlp	24250582	SENT105	18	18	30	30	rifampin	NAC	PA451250	22861	0.787
NULL	Curr_Chem_Genomics_2008_May_23_1_54-64.nxml.txt.nlp	20161828	SENT127	7	7	18	18	staurosporine	MEK1	PA165109623	5604	0.787
NULL	Mol_Cancer_2010_May_18_9_110.nxml.txt.nlp	20482802	SENT152	5	5	20	20	bortezomib	p53	PA10252	7157	0.787
NULL	Cardiovasc_Diabetol_2006_Sep_26_5_20.nxml.txt.nlp	17002798	SENT52	11	11	32	32	aspirin	CAD	PA448497	1677;790	0.787
NULL	Biosci_Rep_2012_Aug_1_32(Pt_4)_361-374.nxml.txt.nlp	22762204	SENT209	42	42	5	5	cisplatin	p53	PA449014	7157	0.787
NULL	Cell_Regen_(Lond)_2013_Apr_30_2(1)_3.nxml.txt.nlp	25408875	SENT95	21	21	43	43	staurosporine	SNX16	PA165109623	64089	0.787
NULL	J_Vet_Med_Sci_2014_Nov_5_76(11)_1527-1529.nxml.txt.nlp	25099737	SENT24	10	10	21	21	clarithromycin	P-gp	PA449028	5243	0.787
NULL	J_Mol_Med_2011_Mar_8_89(3)_213-220.nxml.txt.nlp	21301796	SENT121	33	33	6	6	nadh	IDH1	PA164755085	3417	0.787
NULL	J_Hematol_Oncol_2014_Aug_1_7_52.nxml.txt.nlp	25085632	SENT154	10	10	18	18	sunitinib	EGFR	PA162372840	1956	0.787
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Nov_26_3(11)_e149.nxml.txt.nlp	25426564	SENT81	18	18	14	14	atorvastatin	PCSK9	PA448500	255738	0.787
NULL	EMBO_Mol_Med_2011_Nov_3(11)_623-636.nxml.txt.nlp	21953712	SENT192	14	14	9	9	trastuzumab	PTEN	PA451743	5728	0.787
NULL	Blood_Cancer_J_2013_Oct_4_3(10)_e150.nxml.txt.nlp	24096714	SENT162	8	8	3	3	bortezomib	IL2	PA10252	3558	0.787
NULL	Psychiatr_Genet_2013_Aug_28_23(4)_153-162.nxml.txt.nlp	23811784	SENT145	9	9	5	5	clozapine	PICALM	PA449061	8301	0.787
NULL	Int_J_Nanomedicine_2007_Mar_2(1)_13-18.nxml.txt.nlp	17722507	SENT103	4	4	27	27	aprepitant	CYP3A4	PA164747039	1576	0.787
NULL	Nat_Chem_Biol_2010_Apr_28_6(4)_291-299.nxml.txt.nlp	20190765	SENT10	25	25	15	15	dasatinib	FYN	PA162372878	2534	0.787
NULL	Core_Evid_2011_Feb_8_6_23-29.nxml.txt.nlp	21468240	SENT49	42	42	26	26	plerixafor	CD34	PA165958410	947	0.787
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_29_2013_590393.nxml.txt.nlp	23737838	SENT302	3	3	9	9	resveratrol	p53		7157	0.787
NULL	Acta_Pharmacol_Sin_2014_Jan_16_35(1)_41-47.nxml.txt.nlp	24335844	SENT96	4	4	26	26	capsaicin	ANOVA	PA448776	4858	0.787
NULL	Clin_Interv_Aging_2013_Jul_16_8_889-897.nxml.txt.nlp	23898224	SENT10	32	32	28	28	gemcitabine	SIRT1	PA449748	23411	0.787
NULL	Lipids_Health_Dis_2011_Jan_24_10_20.nxml.txt.nlp	21261970	SENT79	17	17	12	12	lipase	HSL	PA450239	3991	0.787
NULL	Int_J_Endocrinol_2013_Sep_5_2013_895102.nxml.txt.nlp	24089613	SENT21	13	13	24	24	vildagliptin	GLP-1	PA165958346	100125288	0.787
NULL	Curr_Pharm_Des_2012_Apr_18(11)_1519-1530.nxml.txt.nlp	22364136	SENT106	8	8	13	13	lovastatin	IL-2	PA450272	3558	0.787
NULL	Leukemia_2013_Apr_14_27(4)_803-812.nxml.txt.nlp	23238589	SENT154	19	19	15	15	nilotinib	IFN	PA165958345	3439	0.787
NULL	Curr_Cardiol_Rev_2010_Feb_6(1)_1-14.nxml.txt.nlp	21286273	SENT206	13	13	6	6	milrinone	SPAP	PA164749171	10158	0.787
NULL	Cancer_Causes_Control_2013_Aug_18_24(8)_1605-1614.nxml.txt.nlp	23775025	SENT64	33	33	8	8	doxorubicin	CYP2A6	PA449412	1548	0.787
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1542-1553.nxml.txt.nlp	21970874	SENT266	2	2	6	6	pemetrexed	EGFR	PA10810	1956	0.787
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT151	12	12	5	5	nutlin-3	p53		7157	0.787
NULL	Nat_Med_2013_Mar_10_19(3)_313-321.nxml.txt.nlp	23396211	SENT166	5	5	14	14	amlexanox	TBK1	PA164745310	29110	0.787
NULL	Cell_Death_Dis_2014_Jul_3_5(7)_e1316.nxml.txt.nlp	24991768	SENT12	4	4	22	22	pemetrexed	ATF3	PA10810	467	0.787
NULL	Oxid_Med_Cell_Longev_2013_Jun_6_2013_462361.nxml.txt.nlp	23840917	SENT258	7	7	15	15	nebivolol	p67phox	PA151958426	4688	0.787
NULL	Diabetes_Metab_J_2013_Dec_12_37(6)_415-422.nxml.txt.nlp	24404512	SENT66	11	11	29	29	rosuvastatin	adiponectin	PA134308647	9370	0.787
NULL	Oncoimmunology_2013_Jan_1_2(1)_e22890.nxml.txt.nlp	23483066	SENT84	10	10	22	22	vemurafenib	IFN	PA165946873	3439	0.787
NULL	Pharmaceuticals_(Basel)_2013_Aug_21_6(8)_988-1038.nxml.txt.nlp	24276379	SENT2679	15	15	6	6	cetuximab	NRAS	PA10040	4893	0.787
NULL	FASEB_J_2012_Dec_26(12)_4951-4965.nxml.txt.nlp	22919070	SENT236	34	34	41	41	doxycycline	10C	PA449415	64333	0.787
NULL	Mol_Cancer_2008_May_21_7_42.nxml.txt.nlp	18492291	SENT165	19	19	13	13	gefitinib	EGFR	PA131301952	1956	0.787
NULL	ScientificWorldJournal_2012_Apr_26_2012_358102.nxml.txt.nlp	22645419	SENT192	21	21	29	29	captopril	DES	PA448780	1674	0.787
NULL	Mol_Cancer_2014_Jun_5_13_143.nxml.txt.nlp	24898067	SENT104	10	10	12	12	gefitinib	HER-2	PA131301952	2064	0.787
NULL	Cell_Death_Dis_2014_Feb_13_5(2)_e1055.nxml.txt.nlp	24525731	SENT40	21	21	4	4	cisplatin	XRCC1	PA449014	7515	0.787
NULL	Mol_Cancer_2010_Mar_2_9_47.nxml.txt.nlp	20196847	SENT81	17	17	8	8	paclitaxel	SFN	PA450761	25996;2810	0.787
NULL	Lab_Invest_2014_May_10_94(5)_503-516.nxml.txt.nlp	24614199	SENT10	30	30	20	20	curcumin	RAGE	PA151958596	177	0.787
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1522-1532.nxml.txt.nlp	21997136	SENT152	15	15	25	25	lapatinib	UGT1A1	PA152241907	54658	0.787
NULL	J_Nutr_Metab_2011_Jun_1_2011_708183.nxml.txt.nlp	21773024	SENT172	8	8	3	3	liraglutide	GLP-1	PA165958364	100125288	0.787
NULL	Mol_Brain_2014_Nov_12_7(1)_81.nxml.txt.nlp	NULL	SENT129	6	6	10	10	lithium	spatial	PA450243	219793	0.787
NULL	Br_J_Cancer_2012_Jan_3_106(1)_32-38.nxml.txt.nlp	22108523	SENT166	10	10	4	4	trastuzumab	HER2	PA451743	2064	0.787
NULL	Neural_Regen_Res_2014_Nov_1_9(21)_1897-1901.nxml.txt.nlp	25558239	SENT89	7	7	18	18	diazepam	CA1	PA449283	759	0.787
NULL	Mol_Cancer_2014_Jun_5_13_143.nxml.txt.nlp	24898067	SENT180	5	5	9	9	trastuzumab	HER-2	PA451743	2064	0.787
NULL	Ann_Rheum_Dis_2014_Sep_2_73(9)_1626-1634.nxml.txt.nlp	24297381	SENT284	37	37	27	27	tocilizumab	IL-6	PA165292659	3569	0.787
NULL	Exp_Transl_Stroke_Med_2012_Oct_2_4_20.nxml.txt.nlp	23031714	SENT83	7	7	24	24	ketamine	CO2	PA450144	4513	0.787
NULL	Oncotarget_2014_Feb_7_5(3)_775-787.nxml.txt.nlp	24519956	SENT112	22	22	8	8	dasatinib	PC3	PA162372878	57332;7832;5122	0.787
NULL	J_Bras_Pneumol_2014_May-Jun_40(3)_238-243.nxml.txt.nlp	25029646	SENT91	3	3	18	18	methylprednisolone	LPO	PA450466	4025	0.787
NULL	Clinics_(Sao_Paulo)_2014_Apr_69(4)_225-233.nxml.txt.nlp	24714829	SENT128	21	21	31	31	mannitol	adiponectin	PA450320	9370	0.787
NULL	Biomed_Res_Int_2014_Jun_26_2014_161346.nxml.txt.nlp	25054130	SENT240	41	41	30	30	curcumin	STZ	PA151958596	6484	0.787
NULL	Int_J_Nanomedicine_2007_Sep_2(3)_277-288.nxml.txt.nlp	18019828	SENT46	29	29	13	13	vincristine	CHOP	PA451879	1649	0.787
NULL	Diagn_Pathol_2013_May_15_8_81.nxml.txt.nlp	23675804	SENT21	26	26	33	33	doxorubicin	CHOP	PA449412	1649	0.787
NULL	Case_Rep_Med_2014_Jun_1_2014_356379.nxml.txt.nlp	24982677	SENT101	17	17	9	9	trypsin	CK19	PA451806	3880	0.787
NULL	Indian_J_Hum_Genet_2014_Apr-Jun_20(2)_175-184.nxml.txt.nlp	25400347	SENT12	9	9	11	11	warfarin	VKORC1	PA451906	79001	0.787
NULL	Br_J_Cancer_2009_May_19_100(10)_1540-1548.nxml.txt.nlp	19384300	SENT21	9	9	7	7	trypsin	TATI	PA451806	6690	0.787
NULL	Arthritis_Res_Ther_2011_Nov_1_13(6)_R182.nxml.txt.nlp	22044682	SENT62	10	10	35	35	collagenase	CD21	PA449107	1380	0.787
NULL	Onco_Targets_Ther_2014_May_28_7_841-852.nxml.txt.nlp	24920926	SENT142	7	7	3	3	gefitinib	EGFR	PA131301952	1956	0.787
NULL	Pharmaceuticals_(Basel)_2011_Oct_13_4(10)_1328-1354.nxml.txt.nlp	23115527	SENT867	10	10	8	8	gemcitabine	p53R2	PA449748	50484	0.787
NULL	Cell_Death_Dis_2014_Apr_17_5(4)_e1182.nxml.txt.nlp	24743737	SENT36	8	8	6	6	capsaicin	TRPV1	PA448776	7442	0.787
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S244-S250.nxml.txt.nlp	21525463	SENT31	3	3	7	7	colesevelam	TYPE	PA449095	6445	0.787
NULL	Front_Neurosci_2013_Feb_13_7_13.nxml.txt.nlp	23407595	SENT136	26	26	13	13	estradiol	CORT	PA449503	1325	0.787
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT182	7	7	15	15	bevacizumab	VEGFR1	PA130232992	2321	0.787
NULL	Iran_J_Pharm_Res_2015_Winter_14(1)_279-289.nxml.txt.nlp	25561934	SENT152	33	33	39	39	isoproterenol	ANOVA	PA450121	4858	0.787
NULL	Case_Rep_Neurol_Med_2011_Jul_10_2011_975152.nxml.txt.nlp	22937348	SENT37	9	9	6	6	ribavirin	IFN	PA451241	3439	0.787
NULL	Mol_Cancer_2010_Nov_2_9_289.nxml.txt.nlp	21044322	SENT166	32	32	6	6	vincristine	RGS10	PA451879	6001	0.787
NULL	Case_Rep_Oncol_2010_May_7_3(2)_154-159.nxml.txt.nlp	20740189	SENT11	29	29	13	13	irinotecan	KRAS	PA450085	3845	0.787
NULL	J_Biol_Chem_2012_Dec_14_287(51)_43094-43107.nxml.txt.nlp	23118219	SENT358	6	6	0	0	hyaluronan	CD44	PA165958431	960	0.787
NULL	Front_Pharmacol_2014_May_9_5_103.nxml.txt.nlp	24847272	SENT167	13	13	15	15	bufuralol	CYP2D6	PA166110256	1565	0.787
NULL	Int_J_Mol_Sci_2014_Nov_13_15(11)_20753-20769.nxml.txt.nlp	25402640	SENT482	0	0	11	11	resveratrol	DEPTOR		64798	0.787
NULL	EMBO_Mol_Med_2012_Sep_7_4(9)_896-909.nxml.txt.nlp	22887866	SENT164	12	12	6	6	lovastatin	c-Myc	PA450272	4609	0.787
NULL	Cell_Biosci_2011_Oct_21_1_34.nxml.txt.nlp	22018000	SENT266	9	9	16	16	isoflurane	FDG	PA450106	23583	0.787
NULL	BMB_Rep_2013_Nov_46(11)_544-549.nxml.txt.nlp	24152910	SENT58	5	5	15	15	thrombin	PAR-1	PA451674	2011;2149	0.787
NULL	Pharmaceuticals_(Basel)_2012_Aug_10_5(8)_802-836.nxml.txt.nlp	24280676	SENT294	29	29	22	22	diclofenac	MRP2	PA449293	100130958;57626;1244	0.787
NULL	J_Neurochem_2012_Dec_11_123(5)_725-735.nxml.txt.nlp	22971236	SENT114	17	17	5	5	trypsin	P2X1	PA451806	5023	0.787
NULL	Leukemia_2014_Jun_17_28(6)_1216-1226.nxml.txt.nlp	24301524	SENT106	12	12	23	23	bortezomib	p105	PA10252	4790;4791	0.787
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_20_2012_383608.nxml.txt.nlp	22203870	SENT158	8	8	15	15	bleomycin	IL-6	PA448645	3569	0.787
NULL	Hum_Genomics_2009_Jan_1_3(2)_103-105.nxml.txt.nlp	19164087	SENT49	7	7	5	5	ethanol	ADH4	PA448073	127	0.787
NULL	Aging_(Albany_NY)_2010_Dec_20_2(12)_959-968.nxml.txt.nlp	21191146	SENT74	5	5	21	21	cisplatin	Rpn13	PA449014	11047	0.787
NULL	Cell_Cycle_2013_Nov_15_12(22)_3490-3499.nxml.txt.nlp	24240433	SENT128	28	28	36	36	metformin	FDG	PA450395	23583	0.787
NULL	Eur_J_Med_Res_2011_Oct_10_16(10)_427-436.nxml.txt.nlp	22024421	SENT165	35	35	23	23	tenofovir	CD4	PA10204	920	0.787
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Mar_21_68(Pt_4)_o1129.nxml.txt.nlp	22589984	SENT65	42	42	36	36	acetone	mol	PA448025	90527	0.787
NULL	BMB_Rep_2014_Jan_47(1)_33-38.nxml.txt.nlp	24209634	SENT61	14	14	9	9	cisplatin	CXCR4	PA449014	7852	0.787
NULL	J_Breast_Cancer_2012_Sep_28_15(3)_273-282.nxml.txt.nlp	23091539	SENT243	16	16	34	34	doxycycline	TRAIL	PA449415	8743	0.787
NULL	Tuberc_Respir_Dis_(Seoul)_2013_Nov_29_75(5)_188-198.nxml.txt.nlp	24348666	SENT175	22	22	37	37	crizotinib	EGF	PA165946122	1950	0.787
NULL	Eur_J_Med_Chem_2011_Nov_46(11)_5456-5464.nxml.txt.nlp	21940073	SENT87	8	8	21	21	cisplatin	CH1	PA449014	51430	0.787
NULL	Arthritis_Res_Ther_2007_Oct_10_9(5)_R105.nxml.txt.nlp	17927818	SENT181	23	23	34	34	pp2	RhoA		387	0.787
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT151	15	15	12	12	methotrexate	MSH2	PA450428	4436	0.787
NULL	Eur_J_Nutr_2012_Aug_15_51(5)_513-528.nxml.txt.nlp	22584415	SENT272	39	39	12	12	infliximab	adiponectin	PA452639	9370	0.787
NULL	Breast_Cancer_Res_2011_Jun_9_13(3)_R57.nxml.txt.nlp	21658222	SENT131	16	16	7	7	lamotrigine	UGT2B7	PA450164	7364	0.787
NULL	Biomed_Res_Int_2013_Aug_6_2013_602987.nxml.txt.nlp	24027759	SENT270	15	15	9	9	paclitaxel	SMF	PA450761	22993	0.787
NULL	Acta_Histochem_Cytochem_2013_Dec_28_46(6)_187-197.nxml.txt.nlp	24610966	SENT140	13	13	23	23	pilocarpine	AQP5	PA450962	362	0.787
NULL	EMBO_J_2009_Feb_18_28(4)_313-314.nxml.txt.nlp	19225445	SENT39	13	13	30	30	cisplatin	POLK	PA449014	51426;11044	0.787
NULL	Br_J_Cancer_2011_Jun_28_105(1)_1-8.nxml.txt.nlp	21654681	SENT55	14	14	9	9	gefitinib	EGFR	PA131301952	1956	0.787
NULL	Mol_Pain_2014_Aug_15_10_53.nxml.txt.nlp	25127716	SENT13	0	0	6	6	paclitaxel	P2X7	PA450761	5027	0.787
NULL	Protein_J_2012_Aug_5_31(6)_511-518.nxml.txt.nlp	22763563	SENT176	5	5	16	16	atorvastatin	MSR1	PA448500	4481	0.787
NULL	Br_J_Cancer_2009_Jul_21_101(2)_320-326.nxml.txt.nlp	19568234	SENT114	12	12	4	4	paraformaldehyde	CD133	PA450790	8842	0.787
NULL	Lab_Invest_2014_Jul_5_94(7)_716-725.nxml.txt.nlp	24791744	SENT129	14	14	25	25	aprotinin	GZMB	PA448472	3002	0.787
NULL	Cancer_Cell_Int_2005_Aug_23_5_27.nxml.txt.nlp	16117829	SENT140	23	23	16	16	doxycycline	p53	PA449415	7157	0.787
NULL	Br_J_Cancer_2010_Jan_19_102(2)_383-391.nxml.txt.nlp	20010943	SENT140	25	25	17	17	cisplatin	JNK	PA449014	5599	0.787
NULL	J_Gen_Physiol_1992_Jun_1_99(6)_985-1016.nxml.txt.nlp	1640223	SENT0	24	24	15	15	tetracaine	gamma	PA451638	9913	0.787
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT233	4	4	6	6	doxorubicin	B7-H1	PA449412	29126	0.787
NULL	Curr_Opin_Struct_Biol_2014_Oct_28_1-13.nxml.txt.nlp	25016573	SENT91	19	19	5	5	heparin	IDUA	PA449855	3425	0.787
NULL	Mol_Biol_Int_2012_May_24_2012_705948.nxml.txt.nlp	22693671	SENT36	10	10	14	14	cisplatin	RASSF2	PA449014	9770	0.787
NULL	J_Cardiovasc_Dis_Res_2010_Oct-Dec_1(4)_165-170.nxml.txt.nlp	21264179	SENT132	35	35	15	15	thrombin	EDRF	PA451674	51327	0.787
NULL	N_Am_J_Med_Sci_2009_Nov_1(6)_309-313.nxml.txt.nlp	22666713	SENT47	20	20	3	3	paraformaldehyde	DIF	PA450790	7124	0.787
NULL	Biosci_Rep_2013_Jun_5_33(3)_e00041.nxml.txt.nlp	23577625	SENT543	18	18	1	1	collagenase	p38	PA449107	10598;1432;7965	0.787
NULL	J_Basic_Clin_Pharm_2012_Dec_4(1)_14-19.nxml.txt.nlp	24808664	SENT14	13	13	1	1	paclitaxel	BCL2	PA450761	596	0.787
NULL	Blood_Cancer_J_2013_Jun_7_3(6)_e120.nxml.txt.nlp	23749045	SENT72	16	16	26	26	tocilizumab	IL6	PA165292659	3569	0.787
NULL	EMBO_Mol_Med_2012_Sep_7_4(9)_896-909.nxml.txt.nlp	22887866	SENT136	17	17	7	7	lovastatin	SREBF1	PA450272	6720	0.787
NULL	Diabetes_2009_Feb_58(2)_352-359.nxml.txt.nlp	19011168	SENT146	5	5	17	17	exenatide	GLP-1	PA164749238	100125288	0.787
NULL	Br_J_Cancer_2009_Oct_20_101(8)_1253-1260.nxml.txt.nlp	19755984	SENT192	2	2	16	16	anastrozole	LRH-1	PA448432	2494	0.787
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_7-17.nxml.txt.nlp	17912633	SENT83	7	7	12	12	letrozole	aromatase	PA450196	1588	0.787
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Feb_20_69(Pt_3)_o417-o418.nxml.txt.nlp	23476593	SENT74	5	5	11	11	ethanol	mol	PA448073	90527	0.787
NULL	Sci_Rep_2014_Nov_28_4_7237.nxml.txt.nlp	25429875	SENT107	10	10	0	0	hesperidin	p38	PA449867	10598;1432;7965	0.787
NULL	Br_J_Cancer_2012_Nov_20_107(11)_1844-1852.nxml.txt.nlp	23169337	SENT275	10	10	24	24	bortezomib	c-Myc	PA10252	4609	0.787
NULL	Evid_Based_Complement_Alternat_Med_2013_Mar_26_2013_974313.nxml.txt.nlp	23589723	SENT166	6	6	10	10	metformin	HIF1	PA450395	3091	0.787
NULL	Braz_J_Med_Biol_Res_2013_Aug_13_46(8)_650-658.nxml.txt.nlp	23969971	SENT31	8	8	19	19	cisplatin	STAT3	PA449014	6774	0.787
NULL	Diabetes_Care_2011_Jul_17_34(7)_1678-1680.nxml.txt.nlp	21709302	SENT83	25	25	7	7	rosiglitazone	DREAM	PA451283	30818	0.787
NULL	Cent_European_J_Urol_2013_Aug_13_66(2)_150-151.nxml.txt.nlp	24579015	SENT23	28	28	11	11	resveratrol	ski		55733	0.787
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Jun_8_69(Pt_7)_o1044.nxml.txt.nlp	24046620	SENT5	5	5	13	13	piperazine	mol	PA450977	90527	0.787
NULL	J_Immunol_Res_2014_Jan_19_2014_103780.nxml.txt.nlp	24741572	SENT117	5	5	23	23	salmeterol	p38	PA451300	10598;1432;7965	0.787
NULL	Lab_Invest_2009_Nov_7_89(11)_1275-1290.nxml.txt.nlp	19736547	SENT158	15	15	7	7	curcumin	LOX-1	PA151958596	4973	0.787
NULL	AAPS_J_2011_May_11_13(3)_365-377.nxml.txt.nlp	21560017	SENT180	19	19	2	2	ethanol	HMOX1	PA448073	3162	0.787
NULL	F1000Res_2012_Jul_18_1_4.nxml.txt.nlp	24358826	SENT226	7	7	12	12	etoposide	VCP	PA449552	7415	0.787
NULL	Exp_Ther_Med_2013_Dec_15_6(6)_1565-1569.nxml.txt.nlp	24255692	SENT97	7	7	9	9	atorvastatin	adiponectin	PA448500	9370	0.787
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT118	18	18	40	40	simvastatin	NAC	PA451363	22861	0.787
NULL	Antimicrob_Resist_Infect_Control_2013_Jun_20_2(Suppl_1)_P8.nxml.txt.nlp	NULL	SENT15	10	10	16	16	heparin	NAC	PA449855	22861	0.787
NULL	Chem_Rev_2014_Jun_11_114(11)_5753-5774.nxml.txt.nlp	24758331	SENT121	28	28	36	36	vinblastine	P-gp	PA451877	5243	0.787
NULL	Acta_Pharmacol_Sin_2012_Dec_30_33(12)_1459-1468.nxml.txt.nlp	22842730	SENT46	25	25	4	4	resveratrol	BACE1		23621	0.787
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Apr_29_67(Pt_5)_o1215.nxml.txt.nlp	21754513	SENT70	16	16	8	8	benzaldehyde	mol	PA448571	90527	0.787
NULL	J_Biol_Chem_2009_Oct_16_284(42)_28885-28895.nxml.txt.nlp	19687008	SENT37	12	12	16	16	fenofibrate	PCSK9	PA449594	255738	0.787
NULL	AMB_Express_2012_Jul_29_2_38.nxml.txt.nlp	22838397	SENT176	32	32	16	16	ethanol	EPG	PA448073	255324	0.787
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_29_2013_590393.nxml.txt.nlp	23737838	SENT11	10	10	7	7	resveratrol	p53		7157	0.787
NULL	Oxid_Med_Cell_Longev_2013_Jun_11_2013_870472.nxml.txt.nlp	23840921	SENT86	6	6	24	24	chloroquine	HO-1	PA448948	3162	0.787
NULL	F1000Res_2013_Apr_23_2_116.nxml.txt.nlp	25506419	SENT77	30	30	40	40	isoproterenol	VASP	PA450121	7408	0.787
NULL	Diabetes_2011_May_23_60(5)_1519-1527.nxml.txt.nlp	21430087	SENT122	4	4	0	0	lipase	HSL	PA450239	3991	0.787
NULL	Emerg_Infect_Dis_2012_Jul_18(7)_1072-1080.nxml.txt.nlp	22709685	SENT155	2	2	11	11	vancomycin	VISA	PA451850	57506	0.787
NULL	J_Korean_Med_Sci_2013_Jun_3_28(6)_939-945.nxml.txt.nlp	23772162	SENT134	17	17	34	34	resveratrol	IVD		3712	0.787
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT219	20	20	27	27	atorvastatin	CD14	PA448500	929	0.787
NULL	Physiol_Rep_2014_Aug_28_2(8)_e12124.nxml.txt.nlp	25168873	SENT65	24	24	17	17	creatine	ADP	PA164778930	23038	0.787
NULL	Cardiol_Res_Pract_2011_Apr_26_2011_874802.nxml.txt.nlp	21577272	SENT114	0	0	17	17	dronedarone	CYP3A4	PA153619853	1576	0.787
NULL	Oncotarget_2013_Nov_24_4(12)_2430-2438.nxml.txt.nlp	24280348	SENT27	5	5	15	15	gefitinib	STAT3	PA131301952	6774	0.787
NULL	Contemp_Oncol_(Pozn)_2012_Feb_29_16(1)_86-89.nxml.txt.nlp	23788860	SENT45	11	11	9	9	methotrexate	DDP	PA450428	1678	0.787
NULL	J_Cancer_Prev_2013_Sep_18(3)_227-234.nxml.txt.nlp	25337550	SENT63	36	36	18	18	cisplatin	RASSF1	PA449014	11186	0.787
NULL	Int_J_Mol_Sci_2014_Sep_29_15(10)_17411-17441.nxml.txt.nlp	25268615	SENT247	0	0	6	6	cyclosporine	CD147	PA449167	682	0.787
NULL	Crit_Care_2014_Mar_17_18(Suppl_1)_P383.nxml.txt.nlp	NULL	SENT23	4	4	1	1	resveratrol	survivin		332	0.787
NULL	Acta_Pharmacol_Sin_2009_Oct_21_30(10)_1392-1398.nxml.txt.nlp	19767766	SENT160	5	5	12	12	atorvastatin	ROS	PA448500	6098	0.787
NULL	Cancer_Manag_Res_2014_Oct_6_6_389-395.nxml.txt.nlp	25336989	SENT44	25	25	19	19	exemestane	HER2	PA449563	2064	0.787
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT104	4	4	22	22	metformin	MEK2	PA450395	5605	0.787
NULL	Oncol_Rep_2013_Sep_1_30(3)_1045-1052.nxml.txt.nlp	23817662	SENT148	31	31	24	24	gefitinib	EGFR	PA131301952	1956	0.787
NULL	Hum_Genomics_2008_Sep_1_3(1)_7-16.nxml.txt.nlp	19129086	SENT182	31	31	18	18	glucose	CYP2C8	PA449773	1558	0.787
NULL	J_Biol_Chem_2009_Jan_9_284(2)_784-791.nxml.txt.nlp	19008230	SENT213	10	10	18	18	forskolin	CO2	PA146096022	4513	0.787
NULL	Case_Rep_Infect_Dis_2013_Oct_8_2013_693480.nxml.txt.nlp	24223316	SENT147	14	14	7	7	fluconazole	gamma	PA449653	9913	0.787
NULL	Cancer_Metab_2014_Nov_3_2(1)_20.nxml.txt.nlp	NULL	SENT280	27	27	29	29	erlotinib	PDK4	PA134687924	5166	0.787
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT1443	21	21	36	36	urea	ECM	PA451831	22915	0.787
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT273	24	24	22	22	heparin	FGF1	PA449855	2246	0.787
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1522-1532.nxml.txt.nlp	21997136	SENT196	8	8	10	10	lapatinib	ABCB1	PA152241907	5243	0.787
NULL	Clin_Sci_(Lond)_2012_Oct_1_123(Pt_8)_473-486.nxml.txt.nlp	22757958	SENT146	32	32	18	18	glucosamine	p38	PA164747613	10598;1432;7965	0.787
NULL	Commun_Integr_Biol_2013_Nov_1_6(6)_e26316.nxml.txt.nlp	24567774	SENT25	19	19	30	30	etoposide	TPPP1	PA449552	11076	0.787
NULL	J_Korean_Med_Sci_2005_Oct_31_20(5)_883-885.nxml.txt.nlp	16224167	SENT15	29	29	33	33	vincristine	gamma	PA451879	9913	0.787
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT202	8	8	14	14	ranibizumab	PlGF-2	PA164746012	5228	0.787
NULL	Gynecol_Oncol_Case_Rep_2013_Dec_28_8_4-6.nxml.txt.nlp	24567884	SENT16	8	8	6	6	irinotecan	NAC	PA450085	22861	0.787
NULL	Adolesc_Health_Med_Ther_2013_Aug_27_4_79-87.nxml.txt.nlp	24600298	SENT35	25	25	13	13	raltegravir	UGT1A1		54658	0.787
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Aug_23_64(Pt_9)_o1828.nxml.txt.nlp	21201803	SENT66	17	17	9	9	ethanol	mol	PA448073	90527	0.787
NULL	F1000Prime_Rep_2014_Dec_1_6_117.nxml.txt.nlp	25580271	SENT50	8	8	22	22	erlotinib	EGFR	PA134687924	1956	0.787
NULL	Int_J_Endocrinol_2011_Nov_9_2011_724816.nxml.txt.nlp	22114592	SENT22	34	34	24	24	estradiol	adiponectin	PA449503	9370	0.787
NULL	CNS_Spectr_2014_Apr_1_19(2)_121-133.nxml.txt.nlp	23903233	SENT400	21	21	11	11	buspirone	5-HT1A	PA448689	3350	0.787
NULL	Oxid_Med_Cell_Longev_2010_Nov-Dec_3(6)_361-373.nxml.txt.nlp	21311214	SENT269	8	8	14	14	nitroprusside	NAC	PA451406	22861	0.787
NULL	Evid_Based_Complement_Alternat_Med_2013_Aug_28_2013_516017.nxml.txt.nlp	24066014	SENT141	4	4	21	21	telmisartan	p67phox	PA451605	4688	0.787
NULL	Oncotarget_2013_Nov_24_4(12)_2430-2438.nxml.txt.nlp	24280348	SENT103	7	7	14	14	gefitinib	STAT3	PA131301952	6774	0.787
NULL	Diabetes_Care_2012_Feb_16_35(2)_e7.nxml.txt.nlp	22275459	SENT23	9	9	11	11	metformin	DPP4	PA450395	1803	0.787
NULL	Br_J_Cancer_2010_Sep_7_103(6)_837-844.nxml.txt.nlp	20717115	SENT145	42	42	12	12	sorafenib	SHARP	PA7000	23013	0.787
NULL	Biomed_Res_Int_2013_May_28_2013_197398.nxml.txt.nlp	23781498	SENT5	21	21	23	23	loratadine	LOR	PA450266	4014	0.787
NULL	Cancer_Biol_Med_2013_Mar_10(1)_16-21.nxml.txt.nlp	23691440	SENT17	30	30	33	33	methotrexate	Bcl-2	PA450428	596	0.787
NULL	Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.nxml.txt.nlp	24736980	SENT252	20	20	24	24	rosuvastatin	OATP1B1	PA134308647	10599	0.787
NULL	Cancers_(Basel)_2013_Apr_15_5(2)_430-461.nxml.txt.nlp	24216985	SENT1469	1	1	21	21	decitabine	p38	PA164749631	10598;1432;7965	0.787
NULL	Brain_Res_2011_Mar_25_1382(C)_29-36.nxml.txt.nlp	21276431	SENT39	0	0	3	3	ketanserin	5-HT2A	PA131053734	3356	0.787
NULL	Indian_J_Med_Res_2014_Jul_140(1)_116-122.nxml.txt.nlp	25222786	SENT7	26	26	23	23	pyrazinamide	EMB	PA451182	133418	0.787
NULL	Support_Care_Cancer_2012_May_1_20(5)_941-949.nxml.txt.nlp	21533811	SENT30	25	25	40	40	palonosetron	HEC	PA10352	10403	0.787
NULL	Case_Rep_Endocrinol_2015_Jan_5_2015_268714.nxml.txt.nlp	25628901	SENT42	19	19	9	9	thyroglobulin	TTF-1	PA164754910	7080	0.787
NULL	Indian_J_Pharm_Sci_2011_Sep-Oct_73(5)_583-586.nxml.txt.nlp	22923875	SENT60	8	8	2	2	nitazoxanide	FOR	PA164754874	51741	0.786
NULL	Indian_J_Ophthalmol_2007_Nov-Dec_55(6)_421-425.nxml.txt.nlp	17951897	SENT53	18	18	34	34	ranibizumab	VEGFR1	PA164746012	2321	0.786
NULL	Nat_Genet_2011_Feb_26_43(2)_117-120.nxml.txt.nlp	21186350	SENT25	26	26	29	29	metformin	AMPK	PA450395	5563	0.786
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT241	19	19	24	24	perifosine	JNK	PA165291471	5599	0.786
NULL	F1000Prime_Rep_2014_Aug_1_6_68.nxml.txt.nlp	25165567	SENT113	13	13	6	6	clomipramine	CYP1A2	PA449048	1544	0.786
NULL	Chin_J_Cancer_2011_Oct_30(10)_701-711.nxml.txt.nlp	21959047	SENT165	32	32	4	4	cetuximab	TRAIL	PA10040	8743	0.786
NULL	Breast_Cancer_Res_2011_Nov_28_13(6)_R121.nxml.txt.nlp	22123186	SENT319	13	13	10	10	pertuzumab	HER2		2064	0.786
NULL	Nucleic_Acids_Res_2011_Nov_23_39(20)_8803-8819.nxml.txt.nlp	21785133	SENT447	7	7	40	40	zinc	RNR3	PA451956	6054	0.786
NULL	Mol_Cancer_2008_Jul_24_7_64.nxml.txt.nlp	18652674	SENT134	16	16	2	2	cisplatin	cIAP2	PA449014	330	0.786
NULL	ScientificWorldJournal_2013_Apr_18_2013_808460.nxml.txt.nlp	23710149	SENT133	7	7	4	4	diazepam	BOR	PA449283	55143	0.786
NULL	Iran_J_Microbiol_2013_Sep_5(3)_203-208.nxml.txt.nlp	24475324	SENT46	16	16	5	5	gentamicin	MAST	PA449753	51324	0.786
NULL	Cancer_Cell_Int_2011_Nov_2_11_39.nxml.txt.nlp	22047021	SENT139	10	10	6	6	cisplatin	REV3	PA449014	5980	0.786
NULL	Cardiovasc_Diabetol_2010_Nov_25_9_78.nxml.txt.nlp	21106105	SENT66	18	18	3	3	pentobarbital	STZ	PA450859	6484	0.786
NULL	Front_Neurosci_2012_May_30_6_77.nxml.txt.nlp	22661925	SENT173	13	13	1	1	ethanol	DCX	PA448073	1641	0.786
NULL	Br_J_Haematol_2014_Mar_13_164(1)_811-821.nxml.txt.nlp	24328678	SENT129	30	30	13	13	lenalidomide	IKZF3	PA162363968	22806	0.786
NULL	Mol_Cancer_2010_Oct_12_9_269.nxml.txt.nlp	20939893	SENT59	0	0	7	7	isoproterenol	STAT3	PA450121	6774	0.786
NULL	Oncol_Lett_2013_Apr_22_5(4)_1093-1100.nxml.txt.nlp	23599746	SENT226	6	6	13	13	docetaxel	MDR1	PA449383	5243	0.786
NULL	Front_Endocrinol_(Lausanne)_2013_Sep_3_4_118.nxml.txt.nlp	24027561	SENT141	22	22	16	16	isoproterenol	ghrelin	PA450121	51738	0.786
NULL	J_Med_Chem_2014_Jan_23_57(2)_462-476.nxml.txt.nlp	24313754	SENT116	2	2	37	37	piperazine	BRD9	PA450977	65980	0.786
NULL	Int_J_Endocrinol_2010_Aug_19_2010_320721.nxml.txt.nlp	20016682	SENT33	18	18	26	26	alendronate	PTH	PA448082	5741	0.786
NULL	J_Gynecol_Oncol_2012_Jan_9_23(1)_35-42.nxml.txt.nlp	22355465	SENT157	11	11	0	0	cisplatin	BCL2	PA449014	596	0.786
NULL	Indian_J_Endocrinol_Metab_2011_Oct-Dec_15(4)_294-297.nxml.txt.nlp	22029000	SENT3	7	7	21	21	pioglitazone	adiponectin	PA450970	9370	0.786
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1137-1144.nxml.txt.nlp	20234366	SENT171	23	23	12	12	oxaliplatin	KRAS	PA131285527	3845	0.786
NULL	Cytojournal_2014_May_22_11_11.nxml.txt.nlp	24987442	SENT60	21	21	19	19	thyroglobulin	TTF-1	PA164754910	7080	0.786
NULL	Cancer_Cell_Int_2005_Aug_24_5_28.nxml.txt.nlp	16120219	SENT168	3	3	13	13	etoposide	p53	PA449552	7157	0.786
NULL	Breast_Cancer_Res_2012_Mar_14_14(2)_R45.nxml.txt.nlp	22417809	SENT28	28	28	6	6	everolimus	EGFR	PA164746311	1956	0.786
NULL	Ann_Indian_Acad_Neurol_2009_Oct-Dec_12(4)_254-263.nxml.txt.nlp	20182573	SENT177	8	8	18	18	daclizumab	IL-2	PA164764446	3558	0.786
NULL	J_Exerc_Rehabil_2013_Jun_30_9(3)_389-393.nxml.txt.nlp	24278889	SENT45	14	14	26	26	isoniazid	EMB	PA450112	133418	0.786
NULL	Int_J_Mol_Sci_2014_Oct_6_15(10)_17886-17900.nxml.txt.nlp	25290095	SENT113	3	3	9	9	resveratrol	p38		10598;1432;7965	0.786
NULL	Cardiovasc_Diabetol_2010_Nov_16_9_76.nxml.txt.nlp	21080957	SENT24	11	11	25	25	exenatide	GLP-1	PA164749238	100125288	0.786
NULL	Curr_Opin_Oncol_2014_Jul_6_26(4)_428-433.nxml.txt.nlp	24840521	SENT155	27	27	15	15	temozolomide	ADP	PA451609	23038	0.786
NULL	Oncotarget_2012_Nov_19_3(11)_1272-1283.nxml.txt.nlp	23174755	SENT111	32	32	19	19	doxorubicin	p53	PA449412	7157	0.786
NULL	Nat_Commun_2014_Nov_19_5_5479.nxml.txt.nlp	25407222	SENT91	22	22	0	0	dextran	YTS	PA449261	8565	0.786
NULL	Diabetes_Obes_Metab_2011_Nov_13(11)_982-989.nxml.txt.nlp	21615670	SENT168	17	17	13	13	sitagliptin	GLP-1	PA164748978	100125288	0.786
NULL	J_Exp_Med_2000_Mar_6_191(5)_859-870.nxml.txt.nlp	10704466	SENT67	25	25	13	13	neomycin	p38	PA450608	10598;1432;7965	0.786
NULL	Diabetol_Metab_Syndr_2014_Mar_31_6_47.nxml.txt.nlp	24684779	SENT105	0	0	27	27	pioglitazone	IL-6	PA450970	3569	0.786
NULL	Allergy_Asthma_Immunol_Res_2014_Mar_15_6(2)_126-130.nxml.txt.nlp	24587948	SENT112	8	8	22	22	salbutamol	TTN	PA448068	7273	0.786
NULL	Acta_Pharmacol_Sin_2011_Oct_15_32(10)_1233-1238.nxml.txt.nlp	21841815	SENT78	0	0	6	6	atropine	CTX	PA448505	1593	0.786
NULL	Case_Rep_Med_2014_Jan_16_2014_389425.nxml.txt.nlp	24550989	SENT40	19	19	42	42	trypsin	CD56	PA451806	4684	0.786
NULL	Aging_(Albany_NY)_2009_Jun_3_1(6)_515-528.nxml.txt.nlp	20157535	SENT5	4	4	27	27	resveratrol	SIRT1		23411	0.786
NULL	Cases_J_2009_Jun_17_2_7246.nxml.txt.nlp	19829938	SENT58	33	33	24	24	iron	HFE	PA450087	3077	0.786
NULL	Br_J_Cancer_2013_May_28_108(10)_2039-2044.nxml.txt.nlp	23652306	SENT20	19	19	23	23	tamoxifen	aromatase	PA451581	1588	0.786
NULL	Int_J_Breast_Cancer_2014_Sep_14_2014_423059.nxml.txt.nlp	25302124	SENT83	12	12	17	17	paclitaxel	LZTS1	PA450761	11178	0.786
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT166	1	1	6	6	chloroquine	BMPR-II	PA448948	659	0.786
NULL	Front_Genet_2014_Nov_14_5_391.nxml.txt.nlp	25452763	SENT1202	15	15	0	0	cisplatin	BRCA1	PA449014	672	0.786
NULL	Neural_Dev_2013_Mar_7_8_4.nxml.txt.nlp	23497494	SENT296	14	14	31	31	sevoflurane	CO2	PA451341	4513	0.786
NULL	Int_J_Endocrinol_2013_May_2_2013_501851.nxml.txt.nlp	23737774	SENT93	15	15	4	4	estradiol	PCB	PA449503	5091	0.786
NULL	Cancer_Med_2013_Feb_3_2(1)_11-20.nxml.txt.nlp	24133623	SENT291	2	2	24	24	irinotecan	KRAS	PA450085	3845	0.786
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT233	4	4	36	36	doxorubicin	B7-H1	PA449412	29126	0.786
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT30	8	8	18	18	gefitinib	PIK3CA	PA131301952	5290	0.786
NULL	J_Invest_Dermatol_2013_Jun_14_133(6)_1541-1549.nxml.txt.nlp	23407395	SENT75	8	8	17	17	imiquimod	CXCL1	PA449972	2919	0.786
NULL	Diabetes_Care_2010_Jul_22_33(7)_1629-1634.nxml.txt.nlp	20413520	SENT129	20	20	14	14	rosiglitazone	adiponectin	PA451283	9370	0.786
NULL	Int_J_Environ_Res_Public_Health_2011_Oct_24_8(10)_4102-4117.nxml.txt.nlp	22073031	SENT129	19	19	11	11	buprenorphine	OTP	PA448685	23440	0.786
NULL	Oncoimmunology_2013_Apr_1_2(4)_e23660.nxml.txt.nlp	23734321	SENT39	16	16	7	7	maraviroc	CCR5	PA164768835	1234	0.786
NULL	J_Int_Soc_Sports_Nutr_2010_Jan_29_7_6.nxml.txt.nlp	20205834	SENT16	0	0	28	28	creatine	ADP	PA164778930	23038	0.786
NULL	Diabetes_2009_Jan_58(1)_243-249.nxml.txt.nlp	18840785	SENT15	2	2	26	26	vildagliptin	GLP-1	PA165958346	100125288	0.786
NULL	Int_J_Mol_Sci_2014_Oct_6_15(10)_17886-17900.nxml.txt.nlp	25290095	SENT108	2	2	12	12	resveratrol	p38		10598;1432;7965	0.786
NULL	Mol_Cancer_2013_Mar_5_12_17.nxml.txt.nlp	23497256	SENT193	5	5	13	13	sunitinib	p53	PA162372840	7157	0.786
NULL	Endosc_Ultrasound_2013_Oct-Dec_2(4)_181-189.nxml.txt.nlp	24949393	SENT57	9	9	14	14	gemcitabine	CD14	PA449748	929	0.786
NULL	Physiol_Rep_2014_Oct_3_2(10)_e12117.nxml.txt.nlp	25281615	SENT86	22	22	1	1	paraformaldehyde	CO2	PA450790	4513	0.786
NULL	Calcif_Tissue_Int_2010_Aug_23_87(2)_130-136.nxml.txt.nlp	20571786	SENT10	25	25	10	10	teriparatide	CSA	PA451620	1442;1161	0.786
NULL	J_Mol_Med_(Berl)_2014_May_10_92(7)_709-722.nxml.txt.nlp	24811491	SENT218	19	19	10	10	cetuximab	NRAS	PA10040	4893	0.786
NULL	Cell_Death_Dis_2012_Mar_1_3(3)_e275.nxml.txt.nlp	22378068	SENT43	5	5	9	9	metformin	AMPK	PA450395	5563	0.786
NULL	J_Cell_Mol_Med_2014_Jan_4_18(1)_38-48.nxml.txt.nlp	24188742	SENT141	34	34	21	21	cisplatin	PAX3	PA449014	5077	0.786
NULL	Oxid_Med_Cell_Longev_2011_Aug_4_2011_471590.nxml.txt.nlp	21904644	SENT65	3	3	32	32	probucol	CA1	PA451107	759	0.786
NULL	J_Biol_Chem_2012_Apr_6_287(15)_12433-12444.nxml.txt.nlp	22351758	SENT474	13	13	18	18	hyaluronan	HC2	PA165958431	360184;3053;5682	0.786
NULL	Arthritis_Res_Ther_2010_May_28_12(3)_R105.nxml.txt.nlp	20509880	SENT243	21	21	17	17	celecoxib	p38	PA448871	10598;1432;7965	0.786
NULL	Oncol_Lett_2014_May_11_7(5)_1401-1408.nxml.txt.nlp	24765145	SENT144	37	37	26	26	paclitaxel	HIF-1	PA450761	29072	0.786
NULL	Arthritis_Res_Ther_2005_Feb_17_7(Suppl_1)_P21.nxml.txt.nlp	NULL	SENT15	21	21	30	30	abatacept	gamma	PA164747080	9913	0.786
NULL	Indian_J_Anaesth_2009_Oct_53(5)_582-591.nxml.txt.nlp	20640109	SENT84	5	5	11	11	clopidogrel	ADP	PA449053	23038	0.786
NULL	Comp_Hepatol_2004_Jan_14_3(Suppl_1)_S31.nxml.txt.nlp	14960183	SENT19	26	26	3	3	ethanol	TNF-alpha	PA448073	7124	0.786
NULL	Acta_Pharmacol_Sin_2013_Jun_22_34(6)_765-776.nxml.txt.nlp	23603980	SENT146	2	2	33	33	vorinostat	Oct4	PA164748224	5460	0.786
NULL	Clin_Transl_Allergy_2014_Feb_28_4(Suppl_1)_P35.nxml.txt.nlp	25045492	SENT16	27	27	12	12	atorvastatin	IL-10	PA448500	3586	0.786
NULL	Blood_Cancer_J_2014_Jan_17_4(1)_e175.nxml.txt.nlp	24442204	SENT84	7	7	19	19	bortezomib	c-MAF	PA10252	4094	0.786
NULL	Mol_Biol_Cell_2014_May_15_25(10)_1620-1628.nxml.txt.nlp	24648493	SENT89	22	22	11	11	nystatin	CPZ	PA450666	8532	0.786
NULL	Br_J_Pharmacol_2014_Nov_5_171(21)_4820-4830.nxml.txt.nlp	24467283	SENT126	39	39	14	14	meloxicam	Bcl-2	PA450353	596	0.786
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S18-S30.nxml.txt.nlp	20680104	SENT82	21	21	1	1	panitumumab	STEPP	PA162373091	222659	0.786
NULL	Environ_Health_Perspect_2006_Sep_23_114(9)_1401-1406.nxml.txt.nlp	16966095	SENT113	2	2	5	5	tetracycline	p53	PA451640	7157	0.786
NULL	Nat_Chem_Biol_2013_Nov_22_9(11)_715-720.nxml.txt.nlp	24056400	SENT78	24	24	0	0	propofol	MS2	PA451141	101	0.786
NULL	Front_Mol_Neurosci_2012_May_14_5_63.nxml.txt.nlp	22593734	SENT119	5	5	13	13	retigabine	AMH	PA144997862	268	0.786
NULL	Front_Syst_Neurosci_2014_Apr_21_8_60.nxml.txt.nlp	24795576	SENT561	10	10	8	8	rifampin	MDR1	PA451250	5243	0.786
NULL	Ann_Saudi_Med_2011_May-Jun_31(3)_279-283.nxml.txt.nlp	21623058	SENT54	23	23	3	3	cyclosporine	IL-2	PA449167	3558	0.786
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Apr_17_6_43-57.nxml.txt.nlp	24833916	SENT146	3	3	15	15	exemestane	aromatase	PA449563	1588	0.786
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT52	14	14	9	9	nutlin-3	MDM2		4193	0.786
NULL	Indian_J_Med_Res_2012_Jul_136(1)_54-59.nxml.txt.nlp	22885264	SENT145	7	7	13	13	cisplatin	IFN	PA449014	3439	0.786
NULL	Cancer_Manag_Res_2014_Oct_4_6_397-404.nxml.txt.nlp	25328417	SENT75	45	45	37	37	erlotinib	EGFR	PA134687924	1956	0.786
NULL	Int_J_Endocrinol_2014_Jun_3_2014_435481.nxml.txt.nlp	24995016	SENT23	2	2	24	24	exenatide	GLP-1	PA164749238	100125288	0.786
NULL	J_Cell_Biol_2003_Dec_22_163(6)_1385-1395.nxml.txt.nlp	14676308	SENT50	3	3	22	22	thrombin	Rho	PA451674	29984	0.786
NULL	Ann_Oncol_2011_Aug_27_22(8)_1736-1747.nxml.txt.nlp	21709140	SENT97	37	37	30	30	cisplatin	BRCA1	PA449014	672	0.786
NULL	Biochimie_2015_Jan_108_40-47.nxml.txt.nlp	25447146	SENT194	21	21	12	12	thiamylal	CPZ	PA164746997	8532	0.786
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT159	29	29	31	31	doxorubicin	ABCB1	PA449412	5243	0.786
NULL	Breast_Cancer_Res_2008_Dec_18_10(Suppl_4)_S17.nxml.txt.nlp	19128430	SENT35	21	21	16	16	tamoxifen	CYP2D6	PA451581	1565	0.786
NULL	Acta_Pharmacol_Sin_2011_May_25_32(5)_664-672.nxml.txt.nlp	21516131	SENT165	11	11	32	32	ethanol	mol	PA448073	90527	0.786
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT129	16	16	12	12	rituximab	CD36	PA451261	948	0.786
NULL	Front_Neurosci_2014_Apr_8_8_63.nxml.txt.nlp	24782698	SENT119	0	0	23	23	rivastigmine	P200	PA451262	5035	0.786
NULL	Ecancermedicalscience_2008_Aug_15_2_91.nxml.txt.nlp	22275974	SENT227	22	22	5	5	temozolomide	CD4	PA451609	920	0.786
NULL	Oncotarget_2014_Aug_4_5(17)_7776-7787.nxml.txt.nlp	25277200	SENT123	11	11	46	46	cisplatin	ANXA4	PA449014	307	0.786
NULL	Diabetes_Obes_Metab_2011_Nov_13(11)_982-989.nxml.txt.nlp	21615670	SENT166	12	12	15	15	exenatide	GLP-1	PA164749238	100125288	0.786
NULL	Biol_Open_2014_Nov_21_3(12)_1207-1216.nxml.txt.nlp	25416063	SENT78	6	6	14	14	zinc	NANOS2	PA451956	339345	0.786
NULL	Infection_2013_Sep_14_41(Suppl_2)_91-115.nxml.txt.nlp	24037688	SENT142	7	7	28	28	atovaquone	G6PD	PA448502	2539	0.786
NULL	Cancer_Med_2013_Jun_25_2(3)_277-285.nxml.txt.nlp	23930204	SENT188	16	16	3	3	cetuximab	KRAS	PA10040	3845	0.786
NULL	Clin_Dev_Immunol_2013_Oct_8_2013_859761.nxml.txt.nlp	24222777	SENT138	5	5	32	32	eculizumab	ABO	PA164776637	28	0.786
NULL	J_Headache_Pain_2009_Oct_19_10(5)_387-388.nxml.txt.nlp	NULL	SENT52	13	13	2	2	heparin	S100A12	PA449855	6283	0.786
NULL	Front_Neurosci_2012_May_30_6_77.nxml.txt.nlp	22661925	SENT174	26	26	14	14	ethanol	DCX	PA448073	1641	0.786
NULL	Oncogene_2010_Sep_16_29(37)_5193-5203.nxml.txt.nlp	20581867	SENT125	26	26	21	21	lapatinib	AKT	PA152241907	207	0.786
NULL	Core_Evid_2010_Oct_21_5_61-76.nxml.txt.nlp	21042543	SENT253	23	23	6	6	cetuximab	PIK3CA	PA10040	5290	0.786
NULL	Br_J_Pharmacol_2010_Sep_161(2)_288-307.nxml.txt.nlp	20735416	SENT125	26	26	12	12	propofol	c-fos	PA451141	2353	0.786
NULL	J_Hematol_Oncol_2010_Sep_9_3_31.nxml.txt.nlp	20828403	SENT53	8	8	20	20	trastuzumab	HER2	PA451743	2064	0.786
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT292	12	12	24	24	metformin	HIF-1	PA450395	29072	0.786
NULL	Oncotarget_2014_Oct_21_5(22)_11252-11268.nxml.txt.nlp	25361004	SENT3	15	15	8	8	metformin	CLIC1	PA450395	1192	0.786
NULL	Chemother_Res_Pract_2012_Aug_29_2012_817297.nxml.txt.nlp	22970367	SENT155	8	8	24	24	erlotinib	EGFR	PA134687924	1956	0.786
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT71	3	3	14	14	metformin	p53	PA450395	7157	0.786
NULL	J_Korean_Med_Sci_2014_Jul_11_29(7)_965-972.nxml.txt.nlp	25045229	SENT155	21	21	12	12	metformin	B12	PA450395	7126;4709	0.786
NULL	Cancer_Cell_Int_2013_Sep_3_13_89.nxml.txt.nlp	24004445	SENT130	13	13	10	10	irinotecan	TPT	PA450085	23590;6469	0.786
NULL	Crit_Care_2006_Jan_23_10(1)_113.nxml.txt.nlp	16469122	SENT36	29	29	35	35	simvastatin	HO-1	PA451363	3162	0.786
NULL	Cell_Death_Dis_2010_Jan_21_1(1)_e16.nxml.txt.nlp	21364617	SENT66	11	11	18	18	cisplatin	p63	PA449014	8626	0.786
NULL	CNS_Drugs_2012_Jun_13_26(6)_509-535.nxml.txt.nlp	22668247	SENT77	2	2	4	4	fentanyl	CYP3A4	PA449599	1576	0.786
NULL	Int_J_Mol_Sci_2014_Nov_7_15(11)_20500-20517.nxml.txt.nlp	25387078	SENT125	23	23	7	7	vorinostat	c-FLIP	PA164748224	8837	0.786
NULL	J_Am_Heart_Assoc_2013_Dec_19_2(6)_e000376.nxml.txt.nlp	24308935	SENT37	4	4	1	1	crizotinib	Met	PA165946122	79811	0.786
NULL	Mar_Drugs_2008_Aug_21_6(3)_456-479.nxml.txt.nlp	19005579	SENT120	2	2	14	14	mannitol	CTX	PA450320	1593	0.786
NULL	Biomed_Res_Int_2014_Jun_26_2014_161346.nxml.txt.nlp	25054130	SENT144	3	3	15	15	curcumin	p47phox	PA151958596	653361	0.786
NULL	Diabetes_2009_Mar_58(3)_579-589.nxml.txt.nlp	19074989	SENT97	36	36	11	11	troglitazone	ANGPTL4	PA451799	51129	0.786
NULL	Allergy_Asthma_Clin_Immunol_2010_Mar_17_6(1)_5.nxml.txt.nlp	20236545	SENT76	0	0	8	8	cyclosporine	IL-2	PA449167	3558	0.786
NULL	Biomed_Res_Int_2013_Jan_21_2013_581631.nxml.txt.nlp	23484133	SENT79	9	9	20	20	infliximab	GM-CSF	PA452639	1437	0.786
NULL	Surg_Neurol_Int_2014_Oct_7_5_145.nxml.txt.nlp	25324974	SENT151	29	29	26	26	erlotinib	EGFR	PA134687924	1956	0.786
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT278	5	5	10	10	metformin	HIF-1	PA450395	29072	0.786
NULL	J_Am_Heart_Assoc_2013_Dec_19_2(6)_e000441.nxml.txt.nlp	24252844	SENT315	24	24	22	22	pioglitazone	PPARgamma	PA450970	5468	0.786
NULL	Diabetes_Care_2013_Aug_17_36(Suppl_2)_S245-S252.nxml.txt.nlp	23882053	SENT87	25	25	19	19	exenatide	GLP-1	PA164749238	100125288	0.786
NULL	Genet_Mol_Biol_2009_Mar_1_Jan-Mar_32(1)_144-150.nxml.txt.nlp	21637660	SENT125	19	19	21	21	etoposide	mol	PA449552	90527	0.786
NULL	Oncotarget_2013_Jan_14_4(1)_118-127.nxml.txt.nlp	23435217	SENT184	23	23	12	12	bevacizumab	EGFR	PA130232992	1956	0.786
NULL	Front_Neurol_2013_Nov_6_4_176.nxml.txt.nlp	24223570	SENT147	3	3	25	25	atropine	PPN	PA448505	64840	0.786
NULL	Breast_Cancer_Res_2011_Jun_10_13(3)_R60.nxml.txt.nlp	21663668	SENT97	25	25	2	2	tamoxifen	aromatase	PA451581	1588	0.786
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT232	12	12	15	15	metformin	HIF-1	PA450395	29072	0.786
NULL	Clin_Ophthalmol_2014_Mar_2_8_343-346.nxml.txt.nlp	24591809	SENT75	4	4	8	8	ranibizumab	PED	PA164746012	8682	0.786
NULL	Int_J_Gen_Med_2011_Jul_20_4_539-545.nxml.txt.nlp	21845063	SENT148	10	10	33	33	pitavastatin	adiponectin	PA142650384	9370	0.786
NULL	Diabetes_2013_Nov_18_62(11)_3677-3686.nxml.txt.nlp	24158999	SENT182	10	10	24	24	capsaicin	GAP43	PA448776	2596	0.786
NULL	Indian_J_Endocrinol_Metab_2012_May-Jun_16(3)_364-370.nxml.txt.nlp	22629500	SENT100	11	11	9	9	thyroglobulin	TPO	PA164754910	7066;7173	0.786
NULL	BioData_Min_2008_Jul_17_1_2.nxml.txt.nlp	18822146	SENT226	23	23	21	21	ethanol	p53	PA448073	7157	0.786
NULL	J_Invest_Dermatol_2012_Sep_19_132(9)_2198-2205.nxml.txt.nlp	22513780	SENT57	0	0	11	11	isotretinoin	IL-10	PA450128	3586	0.786
NULL	Onco_Targets_Ther_2014_Sep_9_7_1571-1582.nxml.txt.nlp	25228815	SENT173	9	9	17	17	sunitinib	VEGFR2	PA162372840	3791	0.786
NULL	Comp_Hepatol_2004_Jan_14_3(Suppl_1)_S37.nxml.txt.nlp	14960189	SENT66	2	2	6	6	ethanol	CD14	PA448073	929	0.786
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Aug_27_67(Pt_9)_o2453.nxml.txt.nlp	22059021	SENT47	23	23	38	38	ethanol	mol	PA448073	90527	0.786
NULL	Cancer_Res_Treat_2014_Jan_15_46(1)_81-92.nxml.txt.nlp	24520227	SENT226	2	2	9	9	celecoxib	ADP	PA448871	23038	0.786
NULL	Evid_Based_Complement_Alternat_Med_2013_May_13_2013_506324.nxml.txt.nlp	23818927	SENT253	2	2	6	6	doxorubicin	STAT3	PA449412	6774	0.786
NULL	Cancer_Res_Treat_2012_Sep_30_44(3)_195-201.nxml.txt.nlp	23091446	SENT108	14	14	16	16	irinotecan	MKP-1	PA450085	1843	0.786
NULL	EMBO_Mol_Med_2012_Sep_20_4(9)_980-991.nxml.txt.nlp	22903875	SENT169	25	25	8	8	paraformaldehyde	BACE2	PA450790	25825	0.786
NULL	Arthritis_Res_Ther_2010_Apr_29_12(2)_R73.nxml.txt.nlp	20429888	SENT116	0	0	3	3	bortezomib	COL1A1	PA10252	1277	0.786
NULL	Cancers_(Basel)_2011_Apr_18_3(2)_2014-2031.nxml.txt.nlp	24212794	SENT70	22	22	32	32	cetuximab	EGFR	PA10040	1956	0.786
NULL	Curr_Oncol_2009_Jul_16(Suppl_2)_S1-S13.nxml.txt.nlp	19672416	SENT57	18	18	13	13	anastrozole	TTR	PA448432	7276	0.786
NULL	J_Oncol_2009_Jul_14_2009_804108.nxml.txt.nlp	19636422	SENT184	22	22	6	6	irinotecan	EGFR	PA450085	1956	0.786
NULL	Cell_Commun_Signal_2014_May_15_12_34.nxml.txt.nlp	24885272	SENT190	16	16	11	11	heparin	FGF2	PA449855	2247;2258	0.786
NULL	Br_J_Cancer_2010_Oct_12_103(8)_1284-1291.nxml.txt.nlp	20859285	SENT165	11	11	18	18	tamoxifen	ERBB3	PA451581	2065	0.786
NULL	Int_J_Fertil_Steril_2014_Jul_8_Jul-Sep_8(2)_193-206.nxml.txt.nlp	25083185	SENT20	20	20	4	4	estradiol	PRL	PA449503	5617	0.786
NULL	Oncotarget_2011_Sep_9_2(9)_658-668.nxml.txt.nlp	21911919	SENT96	10	10	14	14	cytarabine	HO-1	PA449177	3162	0.786
NULL	Mol_Cancer_2012_Aug_23_11_60.nxml.txt.nlp	22917272	SENT128	29	29	10	10	nadh	COX	PA164755085	1351	0.786
NULL	Breast_Cancer_Res_2010_Jul_1_12(4)_R45.nxml.txt.nlp	20594311	SENT135	32	32	37	37	tamoxifen	AKT	PA451581	207	0.786
NULL	Eur_J_Nucl_Med_Mol_Imaging_2010_Feb_24_37(2)_386-398.nxml.txt.nlp	19777175	SENT107	0	0	15	15	adalimumab	IL-6	PA10004	3569	0.786
NULL	Br_J_Cancer_2013_Dec_10_109(12)_3067-3072.nxml.txt.nlp	24263065	SENT156	30	30	17	17	irinotecan	KRAS	PA450085	3845	0.786
NULL	Breast_Cancer_Res_2009_Jan_27_11(1)_R5.nxml.txt.nlp	19173736	SENT218	20	20	8	8	tamoxifen	CD68	PA451581	968	0.786
NULL	J_Inj_Violence_Res_2014_Jan_6(1)_44-49.nxml.txt.nlp	23669602	SENT31	0	0	12	12	heparin	ACT	PA449855	12;11332;9457;641455	0.786
NULL	Breast_Cancer_Res_2008_Apr_1_10(2)_R30.nxml.txt.nlp	18380893	SENT19	15	15	2	2	tamoxifen	HER2	PA451581	2064	0.786
NULL	Case_Rep_Transplant_2014_Jun_30_2014_754256.nxml.txt.nlp	25061532	SENT63	37	37	11	11	clopidogrel	B19	PA449053	59271	0.786
NULL	Mol_Vis_2011_Aug_11_17_2157-2170.nxml.txt.nlp	21850191	SENT213	28	28	16	16	tacrolimus	p50	PA451578	958;4790	0.786
NULL	J_Bras_Pneumol_2013_Jan-Feb_39(1)_5-15.nxml.txt.nlp	23503480	SENT228	0	0	20	20	doxycycline	LAM	PA449415	7249;7248	0.786
NULL	Epigenetics_2012_Nov_1_7(11)_1225-1229.nxml.txt.nlp	23069641	SENT51	21	21	14	14	cisplatin	BRCA1	PA449014	672	0.786
NULL	Acta_Neuropathol_Commun_2013_May_20_1_17.nxml.txt.nlp	24252689	SENT6	35	35	20	20	celecoxib	CRK	PA448871	1398	0.786
NULL	Arch_Med_Sci_2013_Apr_20_9(2)_361-367.nxml.txt.nlp	23671450	SENT17	3	3	11	11	budesonide	HIF-1	PA448681	29072	0.786
NULL	Mol_Cell_Biochem_2015_Oct_8_398(1-2)_165-173.nxml.txt.nlp	25292312	SENT197	20	20	27	27	bortezomib	ORP150	PA10252	10525	0.786
NULL	Oncoimmunology_2013_Jun_1_2(6)_e24677.nxml.txt.nlp	23894722	SENT145	26	26	41	41	cetuximab	CD86	PA10040	942	0.786
NULL	Harm_Reduct_J_2012_Feb_16_9_9.nxml.txt.nlp	22339847	SENT151	11	11	14	14	methamphetamine	hole	PA450403	80757	0.786
NULL	Indian_J_Endocrinol_Metab_2011_Sep_15(Suppl3)_S180-S187.nxml.txt.nlp	22029022	SENT93	34	34	21	21	vasopressin	AVP	PA451858	114548;551	0.786
NULL	Clin_Exp_Otorhinolaryngol_2011_Dec_15_4(4)_177-183.nxml.txt.nlp	22232712	SENT34	10	10	13	13	doxycycline	MUC5B	PA449415	727897	0.786
NULL	Front_Psychol_2014_Jun_27_5_658.nxml.txt.nlp	25018744	SENT321	14	14	19	19	vasopressin	spatial	PA451858	219793	0.786
NULL	Mol_Clin_Oncol_2013_Sep_24_1(5)_918-924.nxml.txt.nlp	24649271	SENT155	2	2	4	4	gemcitabine	Gem	PA449748	51053	0.786
NULL	Asian_J_Androl_2014_Jan_28_May-Jun_16(3)_437-441.nxml.txt.nlp	24480925	SENT137	15	15	7	7	cetuximab	EGFR	PA10040	1956	0.786
NULL	Breast_Cancer_Res_2004_Mar_18_6(3)_119-127.nxml.txt.nlp	15084232	SENT161	9	9	18	18	genistein	EGF	PA165109660	1950	0.786
NULL	Oncotarget_2012_Sep_28_3(10)_1169-1181.nxml.txt.nlp	23045411	SENT184	2	2	15	15	doxorubicin	p53	PA449412	7157	0.786
NULL	Int_J_Mol_Sci_2014_Oct_14_15(10)_18557-18573.nxml.txt.nlp	25318057	SENT186	4	4	9	9	troglitazone	TRAIL	PA451799	8743	0.786
NULL	Crit_Care_2010_Aug_11_14(4)_R153.nxml.txt.nlp	20701787	SENT62	5	5	12	12	exenatide	San	PA164749238	80218	0.786
NULL	Cells_2014_Nov_27_3(4)_1116-1130.nxml.txt.nlp	25437441	SENT73	5	5	32	32	ethanol	IL-22	PA448073	50616;53342	0.786
NULL	Indian_J_Dermatol_2011_Mar-Apr_56(2)_137-144.nxml.txt.nlp	21716938	SENT117	19	19	13	13	abacavir	HLA-B	PA448004	3106	0.786
NULL	Biomed_Res_Int_2014_Feb_16_2014_284836.nxml.txt.nlp	24696846	SENT54	15	15	4	4	collagenase	IL-10	PA449107	3586	0.786
NULL	Arthritis_Res_Ther_2014_Apr_3_16(2)_R86.nxml.txt.nlp	24708674	SENT246	25	25	41	41	bosentan	Fli1	PA10034	2314	0.786
NULL	Br_J_Cancer_2010_Jul_13_103(2)_265-274.nxml.txt.nlp	20551953	SENT202	4	4	24	24	cisplatin	JNK	PA449014	5599	0.786
NULL	Mol_Cancer_2009_Nov_10_8_99.nxml.txt.nlp	19903356	SENT43	6	6	22	22	imatinib	IGFBP3	PA10804	3486	0.786
NULL	Biosci_Rep_2012_Dec_13_33(1)_e00007.nxml.txt.nlp	23095119	SENT205	21	21	38	38	forskolin	AMPK	PA146096022	5563	0.786
NULL	Angiogenesis_2013_Apr_10_16(2)_373-386.nxml.txt.nlp	23143659	SENT142	33	33	15	15	vincristine	ABCC2	PA451879	1244	0.786
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Oct_3_65(Pt_11)_o2603.nxml.txt.nlp	21578222	SENT5	10	10	2	2	febuxostat	mol	PA165958521	90527	0.786
NULL	Cardiovasc_Diabetol_2013_Mar_23_12_48.nxml.txt.nlp	23522121	SENT72	12	12	2	2	exenatide	NNT	PA164749238	23530	0.786
NULL	Diabetes_Care_2010_Apr_12_33(4)_861-868.nxml.txt.nlp	20067962	SENT136	16	16	5	5	hyaluronan	TLR2	PA165958431	7097	0.786
NULL	Asian_J_Androl_2015_Aug_15_Jan-Feb_17(1)_143-148.nxml.txt.nlp	25155105	SENT28	43	43	15	15	udenafil	SEP	PA164776753	79258;5364	0.786
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Dec_16_66(Pt_1)_o157.nxml.txt.nlp	21580046	SENT72	16	16	19	19	benzaldehyde	mol	PA448571	90527	0.786
NULL	Cancer_Med_2014_Jun_27_3(3)_462-471.nxml.txt.nlp	24573979	SENT231	5	5	21	21	sunitinib	CD31	PA162372840	5175	0.786
NULL	Angiogenesis_2010_Dec_7_13(4)_305-315.nxml.txt.nlp	20927579	SENT216	3	3	32	32	resveratrol	p53		7157	0.786
NULL	J_Nat_Med_2014_Feb_19_68(2)_253-266.nxml.txt.nlp	24550097	SENT60	17	17	21	21	lipase	desnutrin	PA450239	57104	0.786
NULL	Int_J_Biol_Sci_2011_Jun_9_7(6)_753-761.nxml.txt.nlp	21698001	SENT163	15	15	8	8	doxycycline	LRRK2	PA449415	120892	0.786
NULL	Eur_Arch_Otorhinolaryngol_2013_Mar_13_270(4)_1397-1404.nxml.txt.nlp	23404469	SENT8	20	20	25	25	dasatinib	DDP	PA162372878	1678	0.786
NULL	Mol_Cancer_2009_Oct_1_8_81.nxml.txt.nlp	19796390	SENT175	10	10	16	16	celecoxib	Bcl-2	PA448871	596	0.786
NULL	J_Cell_Biol_2003_Dec_8_163(5)_1099-1109.nxml.txt.nlp	14662748	SENT122	3	3	7	7	forskolin	AQP2	PA146096022	359	0.786
NULL	Cancer_Cell_Int_2012_Feb_21_12_5.nxml.txt.nlp	22353776	SENT11	8	8	1	1	pravastatin	MAT1A	PA451089	4143	0.786
NULL	BMB_Rep_2013_Sep_46(9)_448-453.nxml.txt.nlp	24064059	SENT73	30	30	27	27	dextran	CD83	PA449261	9308	0.786
NULL	Semin_Immunopathol_2013_Jan_26_35(1)_39-52.nxml.txt.nlp	22829332	SENT197	10	10	18	18	carmustine	CHOP	PA448810	1649	0.786
NULL	Biomed_Res_Int_2013_Apr_15_2013_378380.nxml.txt.nlp	23691500	SENT220	8	8	10	10	chlorpromazine	CPZ	PA448964	8532	0.786
NULL	J_Carcinog_2012_Sep_13_11_15.nxml.txt.nlp	23230392	SENT127	15	15	40	40	panitumumab	VEGFR	PA162373091	3791	0.786
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT88	2	2	12	12	atorvastatin	survivin	PA448500	332	0.786
NULL	Angiogenesis_2010_Dec_7_13(4)_305-315.nxml.txt.nlp	20927579	SENT218	3	3	10	10	resveratrol	p53		7157	0.786
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT222	28	28	10	10	nutlin-3	MDM2		4193	0.786
NULL	Case_Rep_Obstet_Gynecol_2014_Sep_25_2014_793534.nxml.txt.nlp	25328732	SENT93	9	9	18	18	podofilox	CO2	PA450993	4513	0.786
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT30	2	2	31	31	trastuzumab	AKT	PA451743	207	0.786
NULL	BMB_Rep_2014_Mar_47(3)_167-172.nxml.txt.nlp	24499665	SENT99	23	23	30	30	nutlin-3	MDM2		4193	0.786
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_13_2012_978127.nxml.txt.nlp	23304234	SENT133	2	2	19	19	fosinopril	ACE2	PA449710	59272	0.786
NULL	Indian_J_Med_Res_2014_Feb_139(2)_216-225.nxml.txt.nlp	24718395	SENT127	25	25	7	7	amitriptyline	PMPS	PA448385	5377	0.786
NULL	Nat_Med_2012_Jun_18(6)_956-960.nxml.txt.nlp	22610278	SENT51	37	37	11	11	auranofin	AIRAP	PA448510	90637	0.786
NULL	J_Lipids_2011_Jan_13_2011_565316.nxml.txt.nlp	21490804	SENT121	6	6	13	13	etoposide	CHOP	PA449552	1649	0.786
NULL	J_Gastroenterol_2014_Apr_17_49(1)_126-137.nxml.txt.nlp	23591768	SENT312	16	16	6	6	ribavirin	IL28B	PA451241	282617	0.786
NULL	Br_J_Cancer_2009_Jun_2_100(11)_1739-1745.nxml.txt.nlp	19436299	SENT149	2	2	13	13	everolimus	MVD	PA164746311	4597	0.786
NULL	J_Biol_Chem_2012_Dec_21_287(52)_43482-43491.nxml.txt.nlp	23135270	SENT167	14	14	8	8	trypsin	PCSK9	PA451806	255738	0.786
NULL	Front_Oncol_2014_Apr_9_4_75.nxml.txt.nlp	24782986	SENT209	37	37	7	7	paclitaxel	IL-6	PA450761	3569	0.786
NULL	Endocrinol_Metab_(Seoul)_2014_Sep_25_29(3)_379-387.nxml.txt.nlp	25309798	SENT113	6	6	27	27	resveratrol	SIRT1		23411	0.786
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT303	16	16	13	13	paliperidone	PRL	PA163518919	5617	0.786
NULL	Oncoimmunology_2013_Jun_1_2(6)_e24677.nxml.txt.nlp	23894722	SENT109	5	5	16	16	cetuximab	CD83	PA10040	9308	0.786
NULL	Environ_Health_Perspect_2011_Mar_10_119(3)_357-363.nxml.txt.nlp	21362589	SENT177	15	15	8	8	picrotoxin	RDX	PA164777007	5962	0.786
NULL	J_Biol_Chem_2012_Apr_20_287(17)_13868-13876.nxml.txt.nlp	22389490	SENT92	7	7	28	28	capsaicin	TRPV1	PA448776	7442	0.786
NULL	J_Cell_Biol_2005_Nov_21_171(4)_651-661.nxml.txt.nlp	16301331	SENT93	24	24	36	36	flutamide	Cbl-b	PA449685	868	0.786
NULL	Biomed_Res_Int_2013_Sep_30_2013_694269.nxml.txt.nlp	24195077	SENT55	14	14	10	10	trypsin	CO2	PA451806	4513	0.786
NULL	J_Korean_Med_Sci_2005_Oct_31_20(5)_883-885.nxml.txt.nlp	16224167	SENT38	10	10	15	15	cyclosporine	gamma	PA449167	9913	0.786
NULL	Acta_Pharmacol_Sin_2010_Oct_13_31(10)_1350-1358.nxml.txt.nlp	20835264	SENT136	26	26	32	32	simvastatin	gamma	PA451363	9913	0.786
NULL	Nat_Commun_2013_Sep_4_4_2338.nxml.txt.nlp	24005565	SENT125	15	15	17	17	cisplatin	RAD51B	PA449014	5890	0.786
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT39	10	10	20	20	capsaicin	p53	PA448776	7157	0.786
NULL	Nat_Commun_2013_Apr_9_4_1685.nxml.txt.nlp	23575689	SENT219	14	14	23	23	fluorescein	IFN	PA164746009	3439	0.786
NULL	Int_J_Mol_Imaging_2011_Oct_26_2011_874585.nxml.txt.nlp	21490735	SENT125	24	24	43	43	docetaxel	FDG	PA449383	23583	0.786
NULL	Int_J_Mol_Sci_2012_Feb_1_13(2)_1481-1496.nxml.txt.nlp	22408403	SENT422	17	17	24	24	omeprazole	ANOVA	PA450704	4858	0.786
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT160	18	18	11	11	trastuzumab	HER2	PA451743	2064	0.786
NULL	Diabetes_2009_Jan_58(1)_250-259.nxml.txt.nlp	18840786	SENT213	0	0	12	12	rosiglitazone	aP2	PA451283	2167	0.786
NULL	Nat_Commun_2014_Dec_8_5_5736.nxml.txt.nlp	25484020	SENT114	16	16	0	0	trypsin	PAR2	PA451806	2150;55065;8856	0.786
NULL	Biotechnol_Res_Int_2014_Jun_9_2014_674286.nxml.txt.nlp	25009746	SENT250	9	9	17	17	l-histidine	X11	PA449882	320	0.786
NULL	Drug_Healthc_Patient_Saf_2013_Mar_28_5_79-99.nxml.txt.nlp	23569399	SENT35	23	23	6	6	rifampin	IFN	PA451250	3439	0.786
NULL	Indian_J_Urol_2009_Apr-Jun_25(2)_186-189.nxml.txt.nlp	19672343	SENT49	29	29	8	8	bleomycin	GTS	PA448645	2973	0.786
NULL	Diabetes_2011_Nov_17_60(11)_2691-2700.nxml.txt.nlp	21896928	SENT11	19	19	8	8	resveratrol	SIRT1		23411	0.786
NULL	Target_Oncol_2013_Mar_30_8(1)_27-33.nxml.txt.nlp	23361373	SENT76	5	5	19	19	erlotinib	EGFR	PA134687924	1956	0.786
NULL	Front_Endocrinol_(Lausanne)_2014_Feb_25_5_22.nxml.txt.nlp	24611062	SENT278	13	13	37	37	estradiol	spatial	PA449503	219793	0.786
NULL	Multidiscip_Respir_Med_2013_Feb_6_8(1)_11.nxml.txt.nlp	23388501	SENT54	32	32	34	34	carbachol	ASM	PA448784	6609;283120	0.786
NULL	Cell_Commun_Signal_2014_Jan_10_12_3.nxml.txt.nlp	24410813	SENT90	14	14	22	22	tamoxifen	THOC5	PA451581	8563	0.786
NULL	Cell_Mol_Life_Sci_2011_Nov_2_68(21)_3573-3587.nxml.txt.nlp	21365278	SENT203	17	17	32	32	iloprost	EP4	PA164746843	5734	0.786
NULL	Cancer_Biol_Med_2012_Mar_9(1)_18-22.nxml.txt.nlp	23691449	SENT89	14	14	9	9	gefitinib	PTEN	PA131301952	5728	0.786
NULL	Cancers_(Basel)_2011_May_3_3(2)_2255-2273.nxml.txt.nlp	24212808	SENT587	3	3	0	0	paclitaxel	HER2	PA450761	2064	0.786
NULL	Oncogene_2014_Jul_17_33(29)_3784-3793.nxml.txt.nlp	24013225	SENT140	17	17	3	3	heparin	HBEGF	PA449855	1839	0.786
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT122	5	5	11	11	vemurafenib	ABCC10	PA165946873	89845	0.786
NULL	J_Autoimmune_Dis_2005_Mar_11_2_1.nxml.txt.nlp	15762980	SENT412	15	15	13	13	thyroglobulin	ZFAT	PA164754910	57623	0.786
NULL	J_Parasitol_Res_2012_Mar_15_2012_930257.nxml.txt.nlp	22523644	SENT195	9	9	7	7	imiquimod	TLR8	PA449972	51311	0.786
NULL	Crit_Care_2010_Oct_21_14(5)_1004.nxml.txt.nlp	20979668	SENT23	4	4	8	8	exenatide	GLP-1	PA164749238	100125288	0.786
NULL	Clin_Drug_Investig_2013_Apr_20_33(4)_243-254.nxml.txt.nlp	23512639	SENT263	10	10	26	26	desipramine	CYP2C9	PA449233	1559	0.786
NULL	Mol_Brain_2014_May_31_7_42.nxml.txt.nlp	24886461	SENT150	2	2	13	13	suramin	GPCR	PA10292	151306;165140	0.786
NULL	Crit_Care_2005_Nov_4_9(6)_561-565.nxml.txt.nlp	16356239	SENT170	28	28	4	4	dobutamine	CO2	PA449381	4513	0.786
NULL	J_Vet_Med_Sci_2014_Aug_15_76(8)_1119-1127.nxml.txt.nlp	24829081	SENT133	25	25	21	21	trypsin	fractalkine	PA451806	6376	0.786
NULL	Indian_J_Pharm_Sci_2013_Jan-Feb_75(1)_94-98.nxml.txt.nlp	23901167	SENT87	30	30	19	19	tolbutamide	CYP2C19	PA451718	1557	0.786
NULL	Biosci_Rep_2014_Aug_6_34(4)_e00131.nxml.txt.nlp	24975826	SENT184	9	9	13	13	pp2	TRPM8		79054	0.786
NULL	Open_Neurol_J_2013_May_31_7_23-31.nxml.txt.nlp	23894259	SENT97	21	21	23	23	risperidone	FGA	PA451257	2243	0.786
NULL	Chemother_Res_Pract_2012_Dec_20_2012_743193.nxml.txt.nlp	23320171	SENT114	19	19	9	9	trastuzumab	HER2	PA451743	2064	0.786
NULL	Arthritis_Res_Ther_2009_Apr_6_11(Suppl_1)_S1.nxml.txt.nlp	19368701	SENT116	4	4	0	0	abatacept	ACR	PA164747080	49	0.786
NULL	Mol_Cancer_2012_Aug_24_11_61.nxml.txt.nlp	22917467	SENT221	28	28	5	5	hydrocortisone	B27	PA449905	56246	0.786
NULL	J_Cell_Mol_Med_2013_Dec_6_17(12)_1588-1597.nxml.txt.nlp	24199964	SENT65	4	4	1	1	dobutamine	APT	PA449381	653639	0.786
NULL	Nat_Commun_2014_Aug_6_5_4619.nxml.txt.nlp	25099074	SENT190	26	26	45	45	l-glutamine	CO2	PA10090	4513	0.786
NULL	J_Signal_Transduct_2010_Sep_1_2010_643642.nxml.txt.nlp	21637354	SENT89	15	15	5	5	pp2	ghrelin		51738	0.786
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1013.nxml.txt.nlp	24457957	SENT140	23	23	31	31	orlistat	NOXA	PA164776864	5366	0.786
NULL	Aging_(Albany_NY)_2009_Mar_31_1(4)_412-424.nxml.txt.nlp	20195491	SENT93	1	1	8	8	resveratrol	TXNIP		10628	0.786
NULL	Front_Oncol_2014_Nov_10_4_316.nxml.txt.nlp	25426448	SENT110	18	18	12	12	cisplatin	CRT	PA449014	811	0.786
NULL	Indian_J_Med_Res_2014_Jan_139(1)_27-65.nxml.txt.nlp	24604039	SENT243	29	29	0	0	tamoxifen	SULT1A1	PA451581	6817	0.786
NULL	Cancer_Manag_Res_2013_Jun_11_5_103-115.nxml.txt.nlp	23807861	SENT56	12	12	8	8	bevacizumab	VEGF-A	PA130232992	7422	0.786
NULL	Br_J_Cancer_2010_Jul_27_103(3)_340-346.nxml.txt.nlp	20606684	SENT25	17	17	8	8	bevacizumab	EGFR	PA130232992	1956	0.786
NULL	Diabetes_Care_2012_Jan_9_35(1)_131-136.nxml.txt.nlp	22040838	SENT166	8	8	20	20	metformin	NEFA	PA450395	4925	0.786
NULL	Indian_J_Med_Paediatr_Oncol_2012_Oct-Dec_33(4)_195-202.nxml.txt.nlp	23580819	SENT123	27	27	10	10	vincristine	CD99	PA451879	4267	0.786
NULL	Oncogene_2010_Sep_16_29(37)_5193-5203.nxml.txt.nlp	20581867	SENT78	11	11	14	14	lapatinib	HER3	PA152241907	2065	0.786
NULL	J_Thromb_Haemost_2014_May_22_12(5)_726-735.nxml.txt.nlp	24581425	SENT188	22	22	9	9	thrombin	ARF6	PA451674	382	0.786
NULL	Indian_J_Plast_Surg_2014_Jan-Apr_47(1)_102-108.nxml.txt.nlp	24987213	SENT70	17	17	28	28	fluorescein	FOR	PA164746009	51741	0.786
NULL	Virchows_Arch_2012_Feb_16_460(2)_141-149.nxml.txt.nlp	22173329	SENT218	9	9	28	28	leucovorin	BRAF	PA450198	673	0.786
NULL	Br_J_Cancer_2010_Jun_29_103(1)_61-72.nxml.txt.nlp	20588279	SENT18	4	4	13	13	trastuzumab	RhoB	PA451743	388	0.786
NULL	Front_Cell_Neurosci_2013_Apr_10_7_38.nxml.txt.nlp	23596393	SENT151	3	3	12	12	nadh	NPAS2	PA164755085	4862	0.786
NULL	Clin_Pract_2014_Aug_21_4(2)_656.nxml.txt.nlp	25332764	SENT29	39	39	20	20	pyrazinamide	AKT	PA451182	207	0.786
NULL	Eur_Respir_J_2012_Nov_26_40(5)_1106-1114.nxml.txt.nlp	23060624	SENT117	34	34	4	4	tiotropium	TDI	PA164769056	100038246	0.786
NULL	Mol_Cancer_2010_Apr_12_9_75.nxml.txt.nlp	20385023	SENT219	19	19	24	24	imatinib	c-ABL	PA10804	25	0.786
NULL	Nat_Genet_2013_Oct_25_45(10)_10_1038_ng_2742.nxml.txt.nlp	23974872	SENT93	15	15	29	29	isradipine	CACNA1C	PA450131	775	0.786
NULL	Clin_Genet_2014_Feb_9_86(1)_1-11.nxml.txt.nlp	24665880	SENT140	0	0	23	23	trastuzumab	HER2	PA451743	2064	0.786
NULL	F1000_Med_Rep_2012_Feb_1_4_4.nxml.txt.nlp	22312414	SENT62	32	32	8	8	vancomycin	VISA	PA451850	57506	0.786
NULL	Onco_Targets_Ther_2014_Sep_9_7_1571-1582.nxml.txt.nlp	25228815	SENT172	35	35	30	30	sunitinib	VEGFR1	PA162372840	2321	0.786
NULL	Cancer_Immunol_Immunother_2013_Aug_27_62(10)_1637-1648.nxml.txt.nlp	23982484	SENT7	21	21	6	6	lenalidomide	IL-2	PA162363968	3558	0.786
NULL	J_Med_Life_2011_Nov_14_4(4)_432-439.nxml.txt.nlp	22514580	SENT105	18	18	15	15	tipranavir	ATV	PA163522473	4683	0.786
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT117	3	3	0	0	trastuzumab	STAT3	PA451743	6774	0.786
NULL	Hum_Genomics_2013_Sep_23_7(1)_20.nxml.txt.nlp	24060470	SENT100	12	12	5	5	crizotinib	p53	PA165946122	7157	0.786
NULL	Front_Pharmacol_2014_Nov_25_5_256.nxml.txt.nlp	25505414	SENT959	2	2	8	8	isoflurane	CA1	PA450106	759	0.786
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT49	31	31	13	13	coumarin	CYP2D6	PA134521193	1565	0.786
NULL	Curr_Neuropharmacol_2014_Mar_12(2)_186-192.nxml.txt.nlp	24669211	SENT33	13	13	46	46	l-methionine	Met	PA450423	79811	0.786
NULL	J_Hematol_Oncol_2012_Sep_18_5_57.nxml.txt.nlp	22989009	SENT89	1	1	6	6	nutlin-3	HDM2		4193	0.785
NULL	Oncol_Rep_2013_Oct_24_30(4)_1587-1592.nxml.txt.nlp	23900512	SENT124	15	15	11	11	tranylcypromine	NOXA	PA451741	5366	0.785
NULL	Biochem_Res_Int_2012_Feb_12_2012_346972.nxml.txt.nlp	22400115	SENT75	17	17	9	9	doxorubicin	CD44	PA449412	960	0.785
NULL	BMJ_Open_2014_Feb_21_4(2)_e003512.nxml.txt.nlp	24561494	SENT171	12	12	2	2	pravastatin	Gen	PA451089	348654	0.785
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT218	6	6	11	11	adalimumab	CD36	PA10004	948	0.785
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jan_15_67(Pt_2)_o426.nxml.txt.nlp	21523094	SENT3	28	28	2	2	benzaldehyde	mol	PA448571	90527	0.785
NULL	Mol_Cancer_2012_Apr_26_11_26.nxml.txt.nlp	22537224	SENT123	15	15	21	21	cisplatin	FANCF	PA449014	2188	0.785
NULL	Biomed_Res_Int_2014_Aug_6_2014_967826.nxml.txt.nlp	25165721	SENT365	9	9	3	3	cisplatin	HO-1	PA449014	3162	0.785
NULL	Mol_Cancer_2013_Nov_15_12_139.nxml.txt.nlp	24238140	SENT199	15	15	5	5	paraformaldehyde	ALDH1A3	PA450790	220	0.785
NULL	Breast_Cancer_Res_2014_May_28_16(3)_R53.nxml.txt.nlp	24886537	SENT289	13	13	18	18	tamoxifen	VAV3	PA451581	10451	0.785
NULL	Cell_Commun_Signal_2013_Nov_11_11_86.nxml.txt.nlp	24215724	SENT130	10	10	36	36	thrombin	SMAD2	PA451674	4087	0.785
NULL	J_Cell_Mol_Med_2014_Sep_7_18(9)_1785-1796.nxml.txt.nlp	24909956	SENT245	1	1	12	12	cangrelor	GPR17	PA165945763	2840	0.785
NULL	Ther_Clin_Risk_Manag_2005_Jun_1(2)_107-114.nxml.txt.nlp	18360550	SENT25	8	8	44	44	paclitaxel	Yes	PA450761	7525	0.785
NULL	Emerg_Infect_Dis_2011_Apr_17(4)_702-704.nxml.txt.nlp	21470465	SENT108	21	21	16	16	oseltamivir	HIN1	PA450721	92304	0.785
NULL	Acta_Pharmacol_Sin_2011_Oct_12_32(10)_1259-1265.nxml.txt.nlp	21909126	SENT136	17	17	22	22	losartan	p38	PA450268	10598;1432;7965	0.785
NULL	Cell_Death_Dis_2014_Jul_3_5(7)_e1316.nxml.txt.nlp	24991768	SENT28	4	4	14	14	pemetrexed	ATF4	PA10810	468	0.785
NULL	Int_Neurourol_J_2013_Dec_31_17(4)_174-179.nxml.txt.nlp	24466464	SENT115	18	18	2	2	carbachol	CAV1	PA448784	857	0.785
NULL	Br_J_Pharmacol_2012_Jan_165(2)_390-400.nxml.txt.nlp	21671897	SENT212	2	2	5	5	suramin	P2X2	PA10292	22953	0.785
NULL	Cancer_Manag_Res_2014_Oct_6_6_389-395.nxml.txt.nlp	25336989	SENT34	27	27	44	44	everolimus	HER2	PA164746311	2064	0.785
NULL	J_Immunother_Cancer_2014_Jan_27_2_2.nxml.txt.nlp	24829759	SENT75	27	27	34	34	sorafenib	IL-21	PA7000	59067;50616;27189	0.785
NULL	Clin_Ophthalmol_2012_Jul_12_6_1063-1071.nxml.txt.nlp	22888204	SENT139	29	29	37	37	thyroglobulin	TPO	PA164754910	7066;7173	0.785
NULL	Cell_Death_Differ_2010_Apr_16_17(4)_666-676.nxml.txt.nlp	19834494	SENT93	27	27	11	11	oxaliplatin	p53	PA131285527	7157	0.785
NULL	Br_J_Cancer_2011_Sep_27_105(7)_1030-1038.nxml.txt.nlp	21863025	SENT135	5	5	21	21	saracatinib	COPA		1314	0.785
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT1243	6	6	2	2	doxorubicin	MDR1	PA449412	5243	0.785
NULL	Cancer_Cell_Int_2006_Aug_9_6_20.nxml.txt.nlp	16899133	SENT54	22	22	11	11	tamoxifen	p27	PA451581	5715;10534	0.785
NULL	Cancer_Cell_Int_2013_Jun_26_13_64.nxml.txt.nlp	23802572	SENT95	16	16	20	20	curcumin	Bcl-2	PA151958596	596	0.785
NULL	Cancers_(Basel)_2014_Jun_27_6(3)_1363-1381.nxml.txt.nlp	24978438	SENT220	11	11	15	15	melphalan	CD138	PA450354	6382	0.785
NULL	Proteome_Sci_2008_Nov_4_6_31.nxml.txt.nlp	18983648	SENT141	4	4	14	14	benzaldehyde	San	PA448571	80218	0.785
NULL	Breast_Cancer_Res_2011_May_26_13(3)_209.nxml.txt.nlp	21635709	SENT181	31	31	4	4	tamoxifen	CYP2D6	PA451581	1565	0.785
NULL	Br_J_Cancer_2010_Sep_7_103(6)_889-898.nxml.txt.nlp	20664599	SENT155	10	10	22	22	paclitaxel	HER-2	PA450761	2064	0.785
NULL	Oncotarget_2013_Dec_28_5(6)_1475-1490.nxml.txt.nlp	24721996	SENT165	6	6	0	0	celecoxib	PTEN	PA448871	5728	0.785
NULL	Oncol_Lett_2013_Jun_3_5(6)_1760-1764.nxml.txt.nlp	23833637	SENT111	10	10	8	8	gemcitabine	TRAIL	PA449748	8743	0.785
NULL	Oncotarget_2013_Apr_16_4(5)_677-690.nxml.txt.nlp	23633472	SENT211	8	8	29	29	doxorubicin	CD95	PA449412	355	0.785
NULL	Br_J_Cancer_2013_Jun_25_108(12)_2464-2469.nxml.txt.nlp	23695016	SENT56	11	11	3	3	cisplatin	NACT	PA449014	284111	0.785
NULL	J_Hematol_Oncol_2011_Jan_21_4_5.nxml.txt.nlp	21255411	SENT240	24	24	38	38	gemcitabine	GC-E	PA449748	390226	0.785
NULL	Acta_Pharmacol_Sin_2009_Jun_5_30(6)_859-867.nxml.txt.nlp	19498425	SENT32	5	5	9	9	carbachol	CA3	PA448784	761	0.785
NULL	J_Hematol_Oncol_2010_Sep_9_3_30.nxml.txt.nlp	20828385	SENT72	30	30	16	16	temsirolimus	VEGF-A	PA164746890	7422	0.785
NULL	Clinics_(Sao_Paulo)_2013_May_68(5)_694-701.nxml.txt.nlp	23778405	SENT136	9	9	17	17	curcumin	survivin	PA151958596	332	0.785
NULL	Mol_Cancer_2012_Jul_25_11_47.nxml.txt.nlp	22830443	SENT89	22	22	13	13	panitumumab	EGFR	PA162373091	1956	0.785
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1449-1456.nxml.txt.nlp	24077631	SENT104	14	14	3	3	tolbutamide	CYP2C9	PA451718	1559	0.785
NULL	AIDS_Res_Ther_2007_May_1_4_8.nxml.txt.nlp	17472747	SENT106	37	37	9	9	ethanol	adiponectin	PA448073	9370	0.785
NULL	Dis_Markers_2011_Sep_6_31(2)_55-65.nxml.txt.nlp	21896999	SENT6	11	11	32	32	theophylline	TSP-1	PA451647	7057	0.785
NULL	Behav_Brain_Funct_2012_Jul_10_8_20.nxml.txt.nlp	22559224	SENT159	5	5	1	1	baclofen	ANOVA	PA448533	4858	0.785
NULL	Arthritis_Res_Ther_2012_Oct_18_14(5)_R224.nxml.txt.nlp	23079134	SENT171	8	8	15	15	alendronate	PTH	PA448082	5741	0.785
NULL	Exp_Diabetes_Res_2012_Oct_15_2012_465282.nxml.txt.nlp	23118742	SENT91	6	6	19	19	metformin	AMPK	PA450395	5563	0.785
NULL	Insights_Imaging_2011_Mar_25_2(3)_235-246.nxml.txt.nlp	22347950	SENT24	11	11	1	1	oxygen	MRI	PA450744	78996	0.785
NULL	Front_Neurosci_2013_Jan_31_7_3.nxml.txt.nlp	23386808	SENT176	26	26	5	5	capsaicin	TRPV1	PA448776	7442	0.785
NULL	J_Antimicrob_Chemother_2014_Mar_13_69(3)_651-663.nxml.txt.nlp	24235095	SENT107	7	7	2	2	pentamidine	AQP2	PA450850	359	0.785
NULL	Drugs_R_D_2014_Sep_28_14(3)_159-164.nxml.txt.nlp	24973042	SENT32	21	21	19	19	atorvastatin	CYP2C9	PA448500	1559	0.785
NULL	Biosci_Rep_2012_Aug_1_32(Pt_4)_361-374.nxml.txt.nlp	22762204	SENT186	14	14	18	18	paclitaxel	TAZ	PA450761	25937;6901	0.785
NULL	Curr_Oncol_2006_Feb_13(1)_14-26.nxml.txt.nlp	17576437	SENT338	17	17	22	22	cisplatin	HER2	PA449014	2064	0.785
NULL	Clinics_(Sao_Paulo)_2013_Dec_68(12)_1528-1536.nxml.txt.nlp	24473511	SENT19	21	21	6	6	methacholine	IL-10	PA165958382	3586	0.785
NULL	Int_J_Environ_Res_Public_Health_2011_Jul_21_8(7)_3019-3031.nxml.txt.nlp	21845171	SENT135	14	14	18	18	ethanol	adiponectin	PA448073	9370	0.785
NULL	Br_J_Cancer_2009_Jul_21_101(2)_238-243.nxml.txt.nlp	19568242	SENT143	15	15	17	17	bevacizumab	IFN	PA130232992	3439	0.785
NULL	Mol_Vis_2011_Aug_4_17_2056-2064.nxml.txt.nlp	21850181	SENT58	10	10	37	37	pentobarbital	ERG	PA450859	2078	0.785
NULL	Case_Rep_Oncol_Med_2011_Dec_8_2011_805893.nxml.txt.nlp	22606447	SENT11	13	13	7	7	vincristine	CHOP	PA451879	1649	0.785
NULL	HSR_Proc_Intensive_Care_Cardiovasc_Anesth_2010_2(2)_119-127.nxml.txt.nlp	23440905	SENT40	14	14	44	44	heparin	ACT	PA449855	12;11332;9457;641455	0.785
NULL	Mol_Cancer_2008_Jun_5_7_50.nxml.txt.nlp	18534018	SENT13	19	19	24	24	bortezomib	p38	PA10252	10598;1432;7965	0.785
NULL	Anesth_Pain_Med_2012_Apr_1_Spring_1(4)_262-264.nxml.txt.nlp	24904812	SENT14	10	10	7	7	oxycodone	CYP2D6	PA450741	1565	0.785
NULL	Thorax_2012_Sep_11_67(9)_796-803.nxml.txt.nlp	22496351	SENT186	2	2	17	17	bleomycin	TRAIL	PA448645	8743	0.785
NULL	Nucleic_Acids_Res_2008_Feb_20_36(3)_998-1008.nxml.txt.nlp	18096616	SENT7	10	10	8	8	heparin	PACT	PA449855	8575;5930	0.785
NULL	Gastric_Cancer_2013_Jul_12_16(3)_345-354.nxml.txt.nlp	22968820	SENT15	6	6	8	8	oxaliplatin	FANCJ	PA131285527	83990	0.785
NULL	Ann_Clin_Microbiol_Antimicrob_2005_Apr_1_4_6.nxml.txt.nlp	15804353	SENT82	3	3	5	5	metronidazole	Met	PA450484	79811	0.785
NULL	BMB_Rep_2013_Sep_46(9)_429-438.nxml.txt.nlp	24064057	SENT1102	5	5	1	1	epirubicin	SIRT6	PA449476	51548	0.785
NULL	Oncol_Lett_2014_May_10_7(5)_1651-1656.nxml.txt.nlp	24765194	SENT27	30	30	35	35	capsaicin	TRPV1	PA448776	7442	0.785
NULL	Croat_Med_J_2012_Aug_53(4)_314-320.nxml.txt.nlp	22911523	SENT64	39	39	19	19	warfarin	VKORC1	PA451906	79001	0.785
NULL	Breast_Cancer_Res_2008_Mar_27_10(2)_R27.nxml.txt.nlp	18371219	SENT41	28	28	30	30	cyclophosphamide	TFEC	PA449165	22797	0.785
NULL	Cardiovasc_Diabetol_2013_Oct_17_12_150.nxml.txt.nlp	24134550	SENT149	9	9	28	28	metformin	activin	PA450395	83729	0.785
NULL	Adv_Hematol_2012_Jul_24_2012_513702.nxml.txt.nlp	22888354	SENT156	0	0	5	5	lenalidomide	IL-2	PA162363968	3558	0.785
NULL	Chin_J_Cancer_2011_Oct_30(10)_731-738.nxml.txt.nlp	21959050	SENT76	31	31	29	29	cyclophosphamide	CHOP	PA449165	1649	0.785
NULL	Chin_J_Cancer_2011_May_30(5)_293-302.nxml.txt.nlp	21527062	SENT77	34	34	25	25	leucovorin	IFL	PA450198	3439	0.785
NULL	Indian_J_Dermatol_2013_Mar-Apr_58(2)_159a.nxml.txt.nlp	23716826	SENT83	11	11	26	26	penicillamine	gamma	PA450840	9913	0.785
NULL	J_Korean_Med_Sci_2010_Feb_19_25(2)_304-308.nxml.txt.nlp	20119588	SENT35	41	41	46	46	levofloxacin	EMB	PA450214	133418	0.785
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT10	0	0	3	3	metformin	HIF-1	PA450395	29072	0.785
NULL	Biosci_Rep_2012_Dec_1_32(Pt_6)_559-566.nxml.txt.nlp	NULL	SENT48	14	14	10	10	vincristine	ADM	PA451879	133	0.785
NULL	Oncogene_2010_Sep_16_29(37)_5135-5145.nxml.txt.nlp	20622897	SENT97	0	0	5	5	cetuximab	HIF-1	PA10040	29072	0.785
NULL	Exp_Ther_Med_2013_Mar_8_5(3)_707-710.nxml.txt.nlp	23404433	SENT147	8	8	5	5	cisplatin	OST	PA449014	1650;23263	0.785
NULL	Front_Oncol_2011_Aug_22_1_22.nxml.txt.nlp	22666659	SENT131	0	0	3	3	erlotinib	EGFR	PA134687924	1956	0.785
NULL	Mol_Vis_2011_Aug_11_17_2157-2170.nxml.txt.nlp	21850191	SENT202	12	12	9	9	tacrolimus	p50	PA451578	958;4790	0.785
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT90	17	17	7	7	metformin	EGFR	PA450395	1956	0.785
NULL	J_Korean_Med_Sci_2014_Jul_11_29(7)_965-972.nxml.txt.nlp	25045229	SENT118	9	9	5	5	metformin	B12	PA450395	7126;4709	0.785
NULL	Viruses_2014_Apr_14_6(4)_1715-1758.nxml.txt.nlp	24736215	SENT247	23	23	12	12	disulfiram	CD4	PA449376	920	0.785
NULL	Curr_Neuropharmacol_2013_Jul_11(4)_338-378.nxml.txt.nlp	24381528	SENT328	21	21	36	36	curcumin	BACE1	PA151958596	23621	0.785
NULL	Anal_Biochem_2014_Jun_1_454(100)_17-22.nxml.txt.nlp	24637157	SENT36	39	39	33	33	temozolomide	TOP1	PA451609	7150	0.785
NULL	Exp_Ther_Med_2014_Oct_16_8(4)_1150-1158.nxml.txt.nlp	25187814	SENT53	7	7	21	21	fluorescein	CD90	PA164746009	7070	0.785
NULL	Acta_Pharmacol_Sin_2010_Jun_4_31(6)_709-717.nxml.txt.nlp	20523342	SENT10	4	4	14	14	repaglinide	PPG	PA451234	5552	0.785
NULL	Pain_2012_Apr_153(4)_775-783.nxml.txt.nlp	22325744	SENT440	9	9	13	13	naloxone	P14	PA450586	11102;;6280;56259	0.785
NULL	Ann_Rheum_Dis_2008_Oct_25_68(10)_1644-1650.nxml.txt.nlp	18957484	SENT201	23	23	6	6	methotrexate	IL-15	PA450428	3600	0.785
NULL	Front_Chem_2014_Oct_8_2_85.nxml.txt.nlp	25340049	SENT68	8	8	13	13	heparin	mol	PA449855	90527	0.785
NULL	J_Cell_Mol_Med_2013_Jun_15_17(6)_792-799.nxml.txt.nlp	23672538	SENT64	32	32	24	24	fluorescein	CD14	PA164746009	929	0.785
NULL	Nat_Prod_Bioprospect_2012_Mar_8_2(2)_59-64.nxml.txt.nlp	NULL	SENT4	0	0	3	3	verapamil	P-gp	PA451868	5243	0.785
NULL	Br_J_Cancer_2004_May_4_90(9)_1733-1739.nxml.txt.nlp	15150604	SENT109	10	10	5	5	letrozole	aromatase	PA450196	1588	0.785
NULL	Case_Rep_Hematol_2012_May_16_2012_624590.nxml.txt.nlp	22928126	SENT42	15	15	9	9	cytarabine	IFN	PA449177	3439	0.785
NULL	J_Inherit_Metab_Dis_2010_Oct_3_33(5)_625-632.nxml.txt.nlp	20814828	SENT131	4	4	9	9	simvastatin	RhoA	PA451363	387	0.785
NULL	J_Cancer_2013_Sep_27_4(8)_662-670.nxml.txt.nlp	24155778	SENT156	18	18	9	9	cisplatin	UCHL1	PA449014	7345	0.785
NULL	Clin_Med_Insights_Oncol_2011_Sep_21_5_265-314.nxml.txt.nlp	22084619	SENT411	2	2	17	17	temozolomide	CD41	PA451609	3674	0.785
NULL	Multidiscip_Respir_Med_2013_Feb_13_8(1)_13.nxml.txt.nlp	23406847	SENT8	12	12	5	5	moxifloxacin	EMB	PA450555	133418	0.785
NULL	Nat_Med_2014_Jun_11_20(6)_599-606.nxml.txt.nlp	24813251	SENT102	12	12	15	15	bortezomib	YAP1	PA10252	10413	0.785
NULL	Cancers_(Basel)_2014_Sep_5_6(3)_1769-1792.nxml.txt.nlp	25198391	SENT93	14	14	22	22	imatinib	STAT3	PA10804	6774	0.785
NULL	Nucleic_Acids_Res_2012_Jul_30_40(13)_6319-6337.nxml.txt.nlp	22467215	SENT6	0	0	3	3	trastuzumab	HER2	PA451743	2064	0.785
NULL	Iran_J_Pharm_Res_2014_Summer_13(3)_919-926.nxml.txt.nlp	25276192	SENT126	0	0	2	2	doxorubicin	Bcl-2	PA449412	596	0.785
NULL	Cancers_(Basel)_2010_Dec_30_3(1)_126-163.nxml.txt.nlp	24212610	SENT948	6	6	0	0	urokinase	EGFR	PA451836	1956	0.785
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT301	4	4	13	13	gefitinib	AKT	PA131301952	207	0.785
NULL	J_Invest_Dermatol_2012_Nov_14_132(11)_2601-2609.nxml.txt.nlp	22696056	SENT75	11	11	27	27	guanabenz	PERK	PA164774903	9451	0.785
NULL	Cell_Commun_Signal_2013_Aug_29_11_65.nxml.txt.nlp	23987506	SENT331	8	8	26	26	geldanamycin	TRAF1	PA152031327	7185	0.785
NULL	Mol_Cancer_2009_Aug_25_8_66.nxml.txt.nlp	19706164	SENT91	5	5	7	7	celecoxib	p53	PA448871	7157	0.785
NULL	Target_Oncol_2013_Jun_27_8(2)_127-136.nxml.txt.nlp	23625191	SENT46	18	18	21	21	panitumumab	KRAS	PA162373091	3845	0.785
NULL	Indian_J_Plast_Surg_2011_May-Aug_44(2)_298-307.nxml.txt.nlp	22022040	SENT171	23	23	16	16	phentolamine	SIP	PA450926	10432;128229;27101;94241	0.785
NULL	Front_Neurol_2013_Nov_4_4_172.nxml.txt.nlp	24204362	SENT185	14	14	24	24	levetiracetam	CA3	PA450206	761	0.785
NULL	ISRN_Obstet_Gynecol_2011_Dec_1_2011_350813.nxml.txt.nlp	22191044	SENT67	34	34	31	31	letrozole	aromatase	PA450196	1588	0.785
NULL	Int_J_Endocrinol_2013_Nov_14_2013_624962.nxml.txt.nlp	24348556	SENT94	3	3	9	9	mitotane	CYP3A4	PA164746157	1576	0.785
NULL	Drugs_Aging_2012_Nov_5_29(11)_863-869.nxml.txt.nlp	23038608	SENT93	16	16	13	13	amitriptyline	NNT	PA448385	23530	0.785
NULL	J_Adv_Pract_Oncol_2014_Jan_1_Jan-Feb_5(1)_57-60.nxml.txt.nlp	25032035	SENT101	10	10	23	23	tamoxifen	ATAC	PA451581	6375	0.785
NULL	Curr_Heart_Fail_Rep_2011_Dec_13_8(4)_242-251.nxml.txt.nlp	21842146	SENT139	28	28	24	24	liraglutide	GLP-1	PA165958364	100125288	0.785
NULL	Clin_Ophthalmol_2012_Jul_12_6_1063-1071.nxml.txt.nlp	22888204	SENT139	29	29	2	2	thyroglobulin	ANA	PA164754910	10950	0.785
NULL	Oncotarget_2013_Jul_21_4(8)_1253-1265.nxml.txt.nlp	23896512	SENT250	15	15	21	21	gefitinib	HRG	PA131301952	3084;3273	0.785
NULL	Eur_J_Clin_Pharmacol_2012_Jan_7_68(1)_55-64.nxml.txt.nlp	21735164	SENT41	23	23	2	2	oxycodone	CYP2D6	PA450741	1565	0.785
NULL	J_Immunother_2014_Apr_12_37(3)_180-186.nxml.txt.nlp	24598448	SENT150	47	47	28	28	sorafenib	IL-2	PA7000	3558	0.785
NULL	Breast_Cancer_Res_2007_Dec_20_9(Suppl_2)_S11.nxml.txt.nlp	NULL	SENT19	17	17	24	24	tamoxifen	ATAC	PA451581	6375	0.785
NULL	Mol_Cancer_2012_Apr_26_11_26.nxml.txt.nlp	22537224	SENT69	13	13	16	16	curcumin	FANCD2	PA151958596	2177	0.785
NULL	Oncotarget_2011_Sep_5_2(8)_646-653.nxml.txt.nlp	21896960	SENT108	29	29	27	27	melphalan	TRAIL	PA450354	8743	0.785
NULL	J_Cell_Mol_Med_2013_May_12_17(5)_636-647.nxml.txt.nlp	23577651	SENT32	30	30	27	27	thrombin	ADP	PA451674	23038	0.785
NULL	Protein_Cell_2014_Jun_22_5(11)_805-815.nxml.txt.nlp	24952721	SENT118	40	40	30	30	crizotinib	ALK	PA165946122	238	0.785
NULL	Diabetol_Metab_Syndr_2014_Mar_4_6_31.nxml.txt.nlp	24594121	SENT228	14	14	36	36	telmisartan	DM2	PA451605	28508	0.785
NULL	Mol_Cancer_2007_Aug_21_6_53.nxml.txt.nlp	17711579	SENT248	30	30	7	7	cisplatin	CAPN1	PA449014	823	0.785
NULL	Arthritis_Res_Ther_2009_Jun_23_11(3)_R95.nxml.txt.nlp	19549290	SENT216	26	26	11	11	adalimumab	ACR	PA10004	49	0.785
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT127	4	4	11	11	doxorubicin	B7-H1	PA449412	29126	0.785
NULL	Basic_Clin_Neurosci_2013_Winter_4(1)_42-49.nxml.txt.nlp	25337327	SENT106	8	8	21	21	scopolamine	ANOVA	PA451308	4858	0.785
NULL	JRSM_Cardiovasc_Dis_2012_Sep_24_1(6)_cvd_2012_012015.nxml.txt.nlp	24175073	SENT12	45	45	32	32	clopidogrel	ADP	PA449053	23038	0.785
NULL	Int_J_Surg_Case_Rep_2014_Jun_24_5(8)_540-543.nxml.txt.nlp	25024021	SENT27	25	25	30	30	tamoxifen	aromatase	PA451581	1588	0.785
NULL	Biomed_Res_Int_2014_Jan_28_2014_320801.nxml.txt.nlp	24592385	SENT140	6	6	25	25	erythromycin	L22	PA449493	6146	0.785
NULL	Diabetes_Care_2010_Feb_23_33(2)_246-251.nxml.txt.nlp	19933994	SENT185	17	17	27	27	metformin	B12	PA450395	7126;4709	0.785
NULL	Radiol_Res_Pract_2012_Jun_20_2012_268483.nxml.txt.nlp	22919485	SENT17	34	34	36	36	acetazolamide	ACZ	PA448018	27445	0.785
NULL	J_Obes_2011_Dec_22_2011_252817.nxml.txt.nlp	21318055	SENT242	16	16	6	6	metformin	AMPK	PA450395	5563	0.785
NULL	Angiogenesis_2013_Apr_10_16(2)_373-386.nxml.txt.nlp	23143659	SENT145	8	8	5	5	verapamil	P-gp	PA451868	5243	0.785
NULL	Cancer_Metab_2013_Sep_6_1_19.nxml.txt.nlp	24280423	SENT133	29	29	16	16	nadh	LDHB	PA164755085	3945	0.785
NULL	Arch_Med_Sci_2013_Oct_31_9(5)_936-943.nxml.txt.nlp	24273582	SENT103	27	27	42	42	nateglinide	GLP-1	PA450600	100125288	0.785
NULL	Curr_Cardiol_Rev_2010_Feb_6(1)_31-40.nxml.txt.nlp	21286276	SENT187	29	29	8	8	pp2	EGFR		1956	0.785
NULL	Breast_Cancer_Res_2011_Jun_21_13(3)_R66.nxml.txt.nlp	21693010	SENT272	2	2	9	9	sunitinib	c-Raf	PA162372840	5894	0.785
NULL	J_Hematol_Oncol_2012_Sep_18_5_57.nxml.txt.nlp	22989009	SENT271	17	17	9	9	berberine	HDM2	PA165860812	4193	0.785
NULL	Mol_Cancer_2014_Jan_13_13_7.nxml.txt.nlp	24418169	SENT244	5	5	9	9	sorafenib	STAT3	PA7000	6774	0.785
NULL	Onco_Targets_Ther_2014_May_28_7_841-852.nxml.txt.nlp	24920926	SENT34	9	9	17	17	gefitinib	EGFR	PA131301952	1956	0.785
NULL	Reprod_Biol_Endocrinol_2003_Oct_9_1_74.nxml.txt.nlp	14613550	SENT196	11	11	8	8	diclofenac	COX	PA449293	1351	0.785
NULL	J_Gen_Physiol_1992_Jun_1_99(6)_985-1016.nxml.txt.nlp	1640223	SENT0	24	24	1	1	tetracaine	Gen	PA451638	348654	0.785
NULL	Clin_Dev_Immunol_2011_Mar_22_2011_790460.nxml.txt.nlp	21603161	SENT416	9	9	1	1	imatinib	OED	PA10804	4961	0.785
NULL	J_Hum_Genet_2009_Sep_24_54(9)_516-524.nxml.txt.nlp	19629138	SENT305	7	7	0	0	tetracycline	POLG	PA451640	5428	0.785
NULL	J_Mol_Signal_2008_Dec_1_3_18.nxml.txt.nlp	19046439	SENT193	17	17	22	22	metformin	AMPK	PA450395	5563	0.785
NULL	Chem_Cent_J_2012_May_11_6_41.nxml.txt.nlp	22578215	SENT136	13	13	5	5	lipase	castor	PA450239	54897	0.785
NULL	Clin_Ophthalmol_2009_Dec_29_3_671-679.nxml.txt.nlp	20054415	SENT69	0	0	20	20	fluorescein	hole	PA164746009	80757	0.785
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT88	36	36	8	8	efavirenz	CYP2D6	PA449441	1565	0.785
NULL	Acta_Pharmacol_Sin_2013_May_25_34(5)_625-635.nxml.txt.nlp	23524572	SENT157	25	25	15	15	ethanol	LC3	PA448073	84557	0.785
NULL	Breast_Cancer_Res_2005_Aug_1_7(5)_R796-R807.nxml.txt.nlp	16168126	SENT280	3	3	19	19	celecoxib	HER-2	PA448871	2064	0.785
NULL	Virol_J_2012_Dec_27_9_318.nxml.txt.nlp	23270577	SENT127	19	19	1	1	betaine	LAMP	PA448603	4045;27074	0.785
NULL	Arthritis_Res_Ther_2009_Aug_3_11(4)_238.nxml.txt.nlp	19678909	SENT74	3	3	10	10	hydroquinone	IFN	PA449924	3439	0.785
NULL	Aging_Cell_2009_Apr_8(2)_113-127.nxml.txt.nlp	19239417	SENT243	4	4	6	6	resveratrol	AMPK		5563	0.785
NULL	Cerebrospinal_Fluid_Res_2005_Jun_12_2_2.nxml.txt.nlp	15953386	SENT69	27	27	7	7	pentobarbital	CO2	PA450859	4513	0.785
NULL	Exp_Neurobiol_2014_Sep_18_23(3)_224-230.nxml.txt.nlp	25258569	SENT116	33	33	6	6	duloxetine	EPM	PA10066	2054	0.785
NULL	Curr_Neuropharmacol_2007_Dec_5(4)_268-277.nxml.txt.nlp	19305743	SENT129	18	18	10	10	levodopa	CB1	PA450213	1268	0.785
NULL	Mucosal_Immunol_2014_Mar_24_7(2)_335-347.nxml.txt.nlp	23881354	SENT335	23	23	15	15	dextran	CD11c	PA449261	3687	0.785
NULL	Surg_Neurol_Int_2013_Jun_1_4_72.nxml.txt.nlp	23776758	SENT125	13	13	10	10	erlotinib	EGFR	PA134687924	1956	0.785
NULL	Br_J_Cancer_1981_Jun_43(6)_832-841.nxml.txt.nlp	6788061	SENT4	0	0	28	28	perphenazine	PRL	PA450882	5617	0.785
NULL	Clinics_(Sao_Paulo)_2014_Jan_69(1)_68-74.nxml.txt.nlp	24473562	SENT135	19	19	21	21	nutlin-3	SOCS-1		8651	0.785
NULL	Iran_Red_Crescent_Med_J_2014_Aug_5_16(8)_e6915.nxml.txt.nlp	25389496	SENT72	39	39	15	15	simvastatin	adiponectin	PA451363	9370	0.785
NULL	Breast_Cancer_Res_2010_May_10_12(3)_R26.nxml.txt.nlp	20459744	SENT110	4	4	19	19	doxorubicin	HDC	PA449412	3067;51696	0.785
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Jun_25_3(6)_e120.nxml.txt.nlp	24964282	SENT19	25	25	32	32	efavirenz	CYP3A4	PA449441	1576	0.785
NULL	Cancer_Manag_Res_2012_Nov_9_4_383-395.nxml.txt.nlp	23204869	SENT7	3	3	10	10	carmustine	PC-3	PA448810	692094	0.785
NULL	Diabetes_2013_Jun_17_62(6)_1913-1922.nxml.txt.nlp	23349495	SENT7	8	8	23	23	sildenafil	AMPK	PA451346	5563	0.785
NULL	Acta_Pharmacol_Sin_2012_May_16_33(5)_682-690.nxml.txt.nlp	22504904	SENT226	0	0	9	9	celecoxib	STAT3	PA448871	6774	0.785
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT119	9	9	7	7	curcumin	TRAIL	PA151958596	8743	0.785
NULL	Diabetes_Care_2011_Jun_20_34(6)_1265-1269.nxml.txt.nlp	21515846	SENT3	21	21	26	26	ramipril	DREAM	PA451223	30818	0.785
NULL	J_Cardiovasc_Dis_Res_2010_Oct-Dec_1(4)_171-176.nxml.txt.nlp	21264180	SENT113	8	8	0	0	resveratrol	Ray		26751	0.785
NULL	Bone_Marrow_Transplant_2011_Mar_24_46(3)_430-435.nxml.txt.nlp	20498647	SENT25	16	16	18	18	daclizumab	CD25	PA164764446	3669;3559	0.785
NULL	Oxid_Med_Cell_Longev_2013_Jun_2_2013_793525.nxml.txt.nlp	23819014	SENT250	20	20	36	36	resveratrol	AMPK		5563	0.785
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1063.nxml.txt.nlp	24556678	SENT33	26	26	5	5	thioridazine	TRAIL	PA451666	8743	0.785
NULL	Sensors_(Basel)_2013_Apr_18_13(4)_5130-5166.nxml.txt.nlp	23598501	SENT327	0	0	35	35	vancomycin	VISA	PA451850	57506	0.785
NULL	Gut_2013_Apr_14_62(4)_540-549.nxml.txt.nlp	22798500	SENT257	23	23	14	14	cetuximab	NRAS	PA10040	4893	0.785
NULL	J_Korean_Med_Sci_2010_Nov_26_25(11)_1601-1608.nxml.txt.nlp	21060749	SENT104	18	18	10	10	eptifibatide	IMPACT	PA449483	55364	0.785
NULL	Environ_Health_Perspect_2010_Jul_3_118(7)_936-942.nxml.txt.nlp	20199942	SENT202	31	31	16	16	arsenite	mot-2	PA452638	3313	0.785
NULL	Cancer_Med_2013_Apr_1_2(2)_144-154.nxml.txt.nlp	23634282	SENT179	10	10	3	3	cisplatin	EGFR	PA449014	1956	0.785
NULL	Diabetes_2011_Mar_21_60(3)_757-765.nxml.txt.nlp	21282370	SENT117	4	4	11	11	isoproterenol	PTRF	PA450121	284119	0.785
NULL	J_Cancer_Res_Clin_Oncol_2012_Mar_31_138(3)_537-544.nxml.txt.nlp	22209975	SENT34	6	6	17	17	tanespimycin	Hsp90	PA165291490	3320	0.785
NULL	J_Gastrointest_Surg_2012_Apr_13_16(4)_842-848.nxml.txt.nlp	22246855	SENT94	24	24	12	12	erlotinib	EGFR	PA134687924	1956	0.785
NULL	Acta_Pharmacol_Sin_2009_Sep_17_30(9)_1316-1322.nxml.txt.nlp	19684609	SENT105	4	4	6	6	rosiglitazone	PTEN	PA451283	5728	0.785
NULL	Front_Oncol_2014_Jun_18_4_153.nxml.txt.nlp	24995158	SENT583	19	19	4	4	paclitaxel	ERCC1	PA450761	2067	0.785
NULL	J_Hematol_Oncol_2013_Sep_5_6_66.nxml.txt.nlp	24010946	SENT301	12	12	6	6	cetuximab	CRT	PA10040	811	0.785
NULL	J_Nutr_Metab_2011_Oct_1_2011_525094.nxml.txt.nlp	21977315	SENT117	1	1	8	8	resveratrol	CO2		4513	0.785
NULL	Br_J_Cancer_2003_Mar_10_88(5)_754-759.nxml.txt.nlp	12618886	SENT77	20	20	7	7	amifostine	p53	PA448365	7157	0.785
NULL	Cardiovasc_Diabetol_2010_Nov_16_9_76.nxml.txt.nlp	21080957	SENT290	9	9	20	20	liraglutide	GLP	PA165958364	342096	0.785
NULL	Ann_Rheum_Dis_2008_Oct_25_68(10)_1644-1650.nxml.txt.nlp	18957484	SENT18	3	3	8	8	leflunomide	STAT6	PA450192	6778	0.785
NULL	J_Lipid_Res_2014_Oct_55(10)_2103-2112.nxml.txt.nlp	25139399	SENT186	14	14	16	16	atorvastatin	APOE	PA448500	348	0.785
NULL	Hum_Genomics_Proteomics_2010_Sep_13_2010_754919.nxml.txt.nlp	20981234	SENT126	0	0	14	14	warfarin	VKORC1	PA451906	79001	0.785
NULL	Toxins_(Basel)_2011_Jun_14_3(6)_566-590.nxml.txt.nlp	22069726	SENT1089	2	2	7	7	tamoxifen	Q10	PA451581	27161	0.785
NULL	Clin_Ophthalmol_2010_Apr_26_4_233-241.nxml.txt.nlp	20463789	SENT82	12	12	21	21	brinzolamide	CRA	PA164744929	51747;10903	0.785
NULL	EMBO_Mol_Med_2012_Jun_21_4(6)_500-514.nxml.txt.nlp	22438244	SENT36	18	18	6	6	cisplatin	p53	PA449014	7157	0.785
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT2300	5	5	37	37	decitabine	CYP1A1	PA164749631	1543	0.785
NULL	Hum_Genomics_2004_Nov_1_1(6)_444-455.nxml.txt.nlp	15606999	SENT136	17	17	25	25	paroxetine	CYP2D6	PA450801	1565	0.785
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_May_31_68(Pt_6)_m856.nxml.txt.nlp	22719389	SENT63	36	36	17	17	ethanol	NO3	PA448073	4681	0.785
NULL	Int_J_Biol_Sci_2014_Jun_5_10(6)_614-619.nxml.txt.nlp	24948874	SENT119	0	0	10	10	paclitaxel	FOXO1	PA450761	2308	0.785
NULL	Calcif_Tissue_Int_2011_Aug_3_89(2)_140-150.nxml.txt.nlp	21633782	SENT244	5	5	13	13	heparin	FGF23	PA449855	8074	0.785
NULL	Int_J_Environ_Res_Public_Health_2011_Jun_8_8(6)_2090-2108.nxml.txt.nlp	21776218	SENT309	11	11	17	17	arsenite	NFKBIE	PA452638	4794	0.785
NULL	Int_J_Endocrinol_2014_Feb_18_2014_232454.nxml.txt.nlp	24695544	SENT76	13	13	2	2	tazarotene	RARRES2	PA164746821	5919	0.785
NULL	J_Carcinog_2014_Nov_27_13_13.nxml.txt.nlp	25525412	SENT94	12	12	17	17	cetuximab	KRAS	PA10040	3845	0.785
NULL	Int_J_Mol_Sci_2014_Sep_26_15(10)_17204-17220.nxml.txt.nlp	25264738	SENT139	10	10	16	16	sildenafil	HO-1	PA451346	3162	0.785
NULL	Environ_Health_Perspect_2010_Dec_12_118(12)_1707-1713.nxml.txt.nlp	20705543	SENT132	15	15	3	3	bleomycin	XRCC1	PA448645	7515	0.785
NULL	Am_J_Pathol_2011_Jul_179(1)_23-29.nxml.txt.nlp	21703391	SENT37	35	35	12	12	fluorescein	CD31	PA164746009	5175	0.785
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1554-1562.nxml.txt.nlp	21970876	SENT170	34	34	19	19	lapatinib	HER-2	PA152241907	2064	0.785
NULL	J_Oncol_2012_Jul_14_2012_193436.nxml.txt.nlp	21804824	SENT107	5	5	15	15	bevacizumab	EGFR	PA130232992	1956	0.785
NULL	Eur_J_Clin_Pharmacol_2013_May_14_69(5)_1091-1101.nxml.txt.nlp	23150149	SENT7	3	3	8	8	isoniazid	NAT2	PA450112	10;81539	0.785
NULL	Cancer_Metab_2013_Dec_23_1_23.nxml.txt.nlp	24359630	SENT378	14	14	4	4	glucose	TIGAR	PA449773	57103	0.785
NULL	Evid_Based_Complement_Alternat_Med_2013_May_16_2013_857929.nxml.txt.nlp	23762164	SENT128	12	12	2	2	doxorubicin	p53	PA449412	7157	0.785
NULL	Mol_Cancer_2010_May_3_9_99.nxml.txt.nlp	20438634	SENT167	18	18	7	7	doxorubicin	IL6	PA449412	3569	0.785
NULL	Breast_Cancer_Res_2005_May_24_7(5)_R589-R597.nxml.txt.nlp	16168102	SENT67	25	25	36	36	doxorubicin	FBS	PA449412	64319;26269	0.785
NULL	Biomed_Res_Int_2014_Jun_26_2014_483501.nxml.txt.nlp	25057490	SENT30	10	10	21	21	resveratrol	p53		7157	0.785
NULL	Case_Rep_Oncol_Med_2013_Apr_11_2013_485025.nxml.txt.nlp	23878753	SENT60	18	18	30	30	thyroglobulin	CD10	PA164754910	4311	0.785
NULL	Braz_J_Med_Biol_Res_2014_May_9_47(6)_505-514.nxml.txt.nlp	24878606	SENT101	5	5	28	28	estradiol	ACT	PA449503	12;11332;9457;641455	0.785
NULL	Diabetes_Care_2008_Dec_31(12)_2398-2403.nxml.txt.nlp	19033420	SENT187	41	41	16	16	bupropion	Nix	PA448687	665	0.785
NULL	Crit_Care_2011_Mar_3_15(2)_R82.nxml.txt.nlp	21371308	SENT80	0	0	10	10	heparin	ACT	PA449855	12;11332;9457;641455	0.785
NULL	Exp_Ther_Med_2014_Sep_14_8(3)_836-840.nxml.txt.nlp	25120610	SENT7	27	27	24	24	fasudil	Rho	PA165946121	29984	0.785
NULL	Reprod_Biol_Endocrinol_2003_Oct_7_1_66.nxml.txt.nlp	14609433	SENT257	6	6	28	28	cisplatin	p53	PA449014	7157	0.785
NULL	Front_Neuroanat_2011_Jan_14_4_151.nxml.txt.nlp	21258616	SENT343	4	4	0	0	clozapine	GLT-1	PA449061	6506	0.785
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Sep_20_64(Pt_10)_o1983.nxml.txt.nlp	21201183	SENT52	20	20	3	3	ethanol	mol	PA448073	90527	0.785
NULL	Clinics_(Sao_Paulo)_2013_Feb_68(2)_253-262.nxml.txt.nlp	23525324	SENT244	15	15	24	24	genistein	Gen	PA165109660	348654	0.785
NULL	Int_J_Hypertens_2012_Feb_8_2012_189512.nxml.txt.nlp	22518281	SENT63	12	12	9	9	hemin	HO-1	PA449849	3162	0.785
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1953-1985.nxml.txt.nlp	25268164	SENT662	7	7	1	1	temozolomide	MSH6	PA451609	2956	0.785
NULL	Oncotarget_2011_Sep_9_2(9)_658-668.nxml.txt.nlp	21911919	SENT61	18	18	29	29	cytarabine	HO-1	PA449177	3162	0.785
NULL	F1000_Biol_Rep_2010_May_24_2_40.nxml.txt.nlp	20948793	SENT46	21	21	12	12	ustekinumab	IL-23	PA166048654	51561	0.785
NULL	Cancer_Cell_Int_2011_Oct_31_11_37.nxml.txt.nlp	22040460	SENT72	23	23	42	42	l-glutamine	CO2	PA10090	4513	0.785
NULL	Orphanet_J_Rare_Dis_2014_Oct_29_9(1)_162.nxml.txt.nlp	NULL	SENT162	2	2	6	6	iron	FGF23	PA450087	8074	0.785
NULL	Oxid_Med_Cell_Longev_2013_Nov_28_2013_596496.nxml.txt.nlp	24379902	SENT162	0	0	9	9	chloroquine	p53	PA448948	7157	0.785
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT115	12	12	20	20	celecoxib	IL-6	PA448871	3569	0.785
NULL	Clin_Exp_Gastroenterol_2013_Aug_30_6_153-160.nxml.txt.nlp	24039442	SENT40	16	16	10	10	adalimumab	CDAI	PA10004	146059	0.785
NULL	J_Headache_Pain_2008_Apr_7_9(2)_103-107.nxml.txt.nlp	18256782	SENT98	3	3	10	10	cabergoline	PRL	PA448708	5617	0.785
NULL	J_Aging_Res_2012_Jul_19_2012_194821.nxml.txt.nlp	22888430	SENT311	5	5	24	24	resveratrol	AMPK		5563	0.785
NULL	Exp_Ther_Med_2013_Nov_13_6(5)_1317-1321.nxml.txt.nlp	24223665	SENT110	28	28	20	20	curcumin	CD133	PA151958596	8842	0.785
NULL	Chin_J_Cancer_2012_Jun_31(6)_306-314.nxml.txt.nlp	22640627	SENT157	7	7	17	17	rituximab	Bcl-2	PA451261	596	0.785
NULL	Emerg_Infect_Dis_2014_Apr_20(4)_612-619.nxml.txt.nlp	24655615	SENT99	8	8	4	4	ciprofloxacin	GISP	PA449009	83998	0.785
NULL	Br_J_Cancer_1994_Sep_70(3)_409-414.nxml.txt.nlp	8080723	SENT11	14	14	7	7	cisplatin	CH1	PA449014	51430	0.785
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT94	37	37	29	29	l-cysteine	p27	PA449173	5715;10534	0.785
NULL	Cell_Death_Dis_2012_Jun_21_3(6)_e330.nxml.txt.nlp	22717585	SENT87	26	26	35	35	simvastatin	Bcl-2	PA451363	596	0.785
NULL	Arthritis_Res_Ther_2011_Jul_28_13(4)_235.nxml.txt.nlp	21861862	SENT136	9	9	13	13	infliximab	RANKL	PA452639	8600	0.785
NULL	J_Cell_Biol_2000_Jul_24_150(2)_321-334.nxml.txt.nlp	10908575	SENT197	4	4	10	10	staurosporine	ICAD	PA165109623	1676	0.785
NULL	Mol_Cancer_2014_Jul_5_13_165.nxml.txt.nlp	24996221	SENT184	16	16	10	10	docetaxel	HMGB1	PA449383	3146	0.785
NULL	Front_Endocrinol_(Lausanne)_2013_Oct_11_4_140.nxml.txt.nlp	24130552	SENT311	5	5	11	11	estradiol	ARC	PA449503	8996;23237	0.785
NULL	Arthritis_Res_Ther_2005_Jan_10_7(2)_R250-R255.nxml.txt.nlp	15743471	SENT23	31	31	22	22	adalimumab	p75	PA10004	7133;11168	0.785
NULL	Front_Neurol_2014_Nov_17_5_234.nxml.txt.nlp	25452743	SENT202	16	16	19	19	sevoflurane	spatial	PA451341	219793	0.785
NULL	Ann_Rheum_Dis_2008_Oct_25_68(10)_1644-1650.nxml.txt.nlp	18957484	SENT20	11	11	25	25	leflunomide	IL-17	PA450192	3605	0.785
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT284	11	11	13	13	paclitaxel	HER2	PA450761	2064	0.785
NULL	Br_J_Cancer_2011_Jan_4_104(1)_91-100.nxml.txt.nlp	21139584	SENT132	4	4	19	19	coumarin	Hsp90	PA134521193	3320	0.785
NULL	J_Cell_Biol_2005_Nov_21_171(4)_729-738.nxml.txt.nlp	16286510	SENT215	22	22	30	30	heparin	FGF2	PA449855	2247;2258	0.785
NULL	J_Headache_Pain_2013_Apr_10_14(1)_33.nxml.txt.nlp	23574808	SENT120	42	42	17	17	capsaicin	CO2	PA448776	4513	0.785
NULL	Front_Oncol_2014_Apr_15_4_79.nxml.txt.nlp	24782989	SENT68	10	10	32	32	l-glutamine	CO2	PA10090	4513	0.785
NULL	Mol_Pain_2013_Jun_10_9_27.nxml.txt.nlp	23758830	SENT79	0	0	4	4	tetracaine	ASIC3	PA451638	9311	0.785
NULL	Int_J_Cell_Biol_2014_Nov_17_2014_280638.nxml.txt.nlp	25477962	SENT587	3	3	6	6	paclitaxel	CDK1	PA450761	983	0.785
NULL	Indian_J_Pharm_Sci_2013_Jan-Feb_75(1)_94-98.nxml.txt.nlp	23901167	SENT69	10	10	35	35	tolbutamide	CYP1A2	PA451718	1544	0.785
NULL	J_Breast_Cancer_2011_Jun_18_14(2)_135-139.nxml.txt.nlp	21847409	SENT21	31	31	36	36	letrozole	aromatase	PA450196	1588	0.785
NULL	Br_J_Cancer_2013_Feb_19_108(3)_570-578.nxml.txt.nlp	23299527	SENT130	0	0	11	11	acetohexamide	MLC2	PA164777011	10398	0.785
NULL	Front_Endocrinol_(Lausanne)_2011_Mar_3_2_6.nxml.txt.nlp	21633718	SENT117	4	4	7	7	tetracycline	GPCR	PA451640	151306;165140	0.785
NULL	Br_J_Ophthalmol_2009_Mar_19_93(3)_316-321.nxml.txt.nlp	19019922	SENT162	16	16	8	8	latanoprost	PGF	PA164774763	5228	0.785
NULL	Cells_2014_May_23_3(2)_500-516.nxml.txt.nlp	24861976	SENT384	0	0	6	6	menthol	TRPM8	PA164776605	79054	0.785
NULL	Onco_Targets_Ther_2014_Sep_9_7_1571-1582.nxml.txt.nlp	25228815	SENT170	17	17	29	29	sunitinib	VEGFR2	PA162372840	3791	0.785
NULL	Arthritis_Res_Ther_2011_Feb_11_13(1)_R21.nxml.txt.nlp	21314928	SENT126	30	30	14	14	etanercept	CD4	PA449515	920	0.785
NULL	Mol_Cancer_2008_May_21_7_42.nxml.txt.nlp	18492291	SENT145	6	6	12	12	gefitinib	EGFR	PA131301952	1956	0.785
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT2405	17	17	6	6	ketoconazole	CYP3A4	PA450146	1576	0.784
NULL	Nat_Commun_2014_Nov_19_5_5479.nxml.txt.nlp	25407222	SENT534	34	34	10	10	dextran	YTS	PA449261	8565	0.784
NULL	Clin_Cosmet_Investig_Dermatol_2013_Mar_14_6_75-80.nxml.txt.nlp	23515267	SENT84	9	9	13	13	ustekinumab	IL-23	PA166048654	51561	0.784
NULL	J_Cell_Mol_Med_2014_Aug_6_18(8)_1519-1539.nxml.txt.nlp	25100284	SENT209	31	31	11	11	erlotinib	EGFR	PA134687924	1956	0.784
NULL	Curr_Neuropharmacol_2014_Jul_12(4)_365-379.nxml.txt.nlp	25342944	SENT160	15	15	8	8	fluoxetine	GluK4	PA449673	2900	0.784
NULL	Ann_Rheum_Dis_2010_Sep_1_69(9)_1629-1635.nxml.txt.nlp	20488885	SENT108	16	16	7	7	rituximab	ACR	PA451261	49	0.784
NULL	Cell_Death_Dis_2010_Oct_21_1(10)_e86.nxml.txt.nlp	21368859	SENT127	10	10	8	8	doxorubicin	TRAIL	PA449412	8743	0.784
NULL	J_Cancer_Prev_2014_Mar_19(1)_39-46.nxml.txt.nlp	25337571	SENT8	0	0	13	13	ethanol	c-Jun	PA448073	3725	0.784
NULL	J_Headache_Pain_2010_Feb_10_11(1)_5-12.nxml.txt.nlp	20012125	SENT199	8	8	2	2	sumatriptan	5-HT1B	PA451566	3351	0.784
NULL	Mol_Cancer_2010_Apr_23_9_87.nxml.txt.nlp	20416058	SENT196	23	23	19	19	doxorubicin	TRAIL	PA449412	8743	0.784
NULL	Nucl_Recept_Signal_2014_Nov_4_12_e005.nxml.txt.nlp	25422595	SENT214	13	13	22	22	geldanamycin	Hsp90	PA152031327	3320	0.784
NULL	Parasit_Vectors_2009_Sep_25_2(Suppl_2)_S5.nxml.txt.nlp	19778466	SENT71	8	8	5	5	ivermectin	MOX	PA450133	26002	0.784
NULL	Target_Oncol_2013_Jun_27_8(2)_127-136.nxml.txt.nlp	23625191	SENT22	37	37	7	7	panitumumab	KRAS	PA162373091	3845	0.784
NULL	F1000Prime_Rep_2013_Dec_3_5_56.nxml.txt.nlp	24381731	SENT51	22	22	7	7	clopidogrel	P2Y12	PA449053	64805	0.784
NULL	Clin_Med_Insights_Oncol_2012_Feb_28_6_125-135.nxml.txt.nlp	22408376	SENT172	7	7	23	23	panitumumab	KRAS	PA162373091	3845	0.784
NULL	J_Clin_Hypertens_(Greenwich)_2014_Jun_25_16(6)_442-450.nxml.txt.nlp	24766515	SENT98	5	5	10	10	olmesartan	CSBP	PA164742950	3190	0.784
NULL	Front_Neurosci_2011_Jul_26_5_92.nxml.txt.nlp	21845173	SENT36	18	18	37	37	ketorolac	NRM	PA450150	11270	0.784
NULL	Clinics_(Sao_Paulo)_2014_Jan_69(1)_68-74.nxml.txt.nlp	24473562	SENT102	6	6	11	11	nutlin-3	SOCS-1		8651	0.784
NULL	Biosci_Rep_2013_Feb_5_33(2)_e00021.nxml.txt.nlp	23216091	SENT35	10	10	6	6	leflunomide	DHODH	PA450192	1723	0.784
NULL	Diabetes_Care_2009_Aug_12_32(8)_1428-1430.nxml.txt.nlp	19435956	SENT48	18	18	6	6	glibenclamide	KCNJ11	PA449782	3767	0.784
NULL	Case_Rep_Med_2010_Dec_27_2010_201809.nxml.txt.nlp	21209810	SENT0	18	18	35	35	salbutamol	S10	PA448068	9861;6204	0.784
NULL	Bone_Joint_Res_2014_Mar_1_3(3)_51-59.nxml.txt.nlp	24615710	SENT33	9	9	13	13	resveratrol	SIRT1		23411	0.784
NULL	Evid_Based_Complement_Alternat_Med_2012_Dec_20_2012_908601.nxml.txt.nlp	23326293	SENT29	40	40	28	28	oxaliplatin	HCC	PA131285527	84668	0.784
NULL	J_Breast_Cancer_2011_Mar_31_14(1)_20-27.nxml.txt.nlp	21847390	SENT119	6	6	10	10	estradiol	CLDN6	PA449503	9074	0.784
NULL	Diabetes_Care_2008_Oct_31(10)_2062-2069.nxml.txt.nlp	18820229	SENT129	18	18	15	15	rosiglitazone	DREAM	PA451283	30818	0.784
NULL	Arthritis_Res_Ther_2011_Apr_4_13(2)_R56.nxml.txt.nlp	21463515	SENT19	17	17	26	26	adalimumab	IL-6	PA10004	3569	0.784
NULL	Diabetes_Care_2012_Feb_16_35(2)_327-333.nxml.txt.nlp	22179958	SENT47	13	13	17	17	metformin	B12	PA450395	7126;4709	0.784
NULL	Diabetes_Care_2013_Jun_15_36(6)_1454-1461.nxml.txt.nlp	23275372	SENT252	6	6	17	17	resveratrol	SIRT1		23411	0.784
NULL	Br_J_Haematol_2014_Mar_13_164(1)_811-821.nxml.txt.nlp	24328678	SENT219	2	2	12	12	lenalidomide	Aiolos	PA162363968	22806	0.784
NULL	Br_J_Pharmacol_2014_Jan_23_171(2)_523-535.nxml.txt.nlp	24372553	SENT208	7	7	13	13	metformin	p53	PA450395	7157	0.784
NULL	Aging_(Albany_NY)_2012_Jul_22_4(7)_480-498.nxml.txt.nlp	22837425	SENT166	17	17	8	8	metformin	AMPK	PA450395	5563	0.784
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT195	8	8	30	30	sitagliptin	HIP	PA164748978	6767;6159;64399;5068	0.784
NULL	Br_J_Cancer_2002_Jan_21_86(2)_179-184.nxml.txt.nlp	11870502	SENT23	19	19	40	40	cisplatin	IFN	PA449014	3439	0.784
NULL	Oncotarget_2014_Oct_18_5(22)_11641-11652.nxml.txt.nlp	25361002	SENT246	7	7	4	4	cisplatin	NAC	PA449014	22861	0.784
NULL	Bone_Marrow_Transplant_2011_Mar_24_46(3)_430-435.nxml.txt.nlp	20498647	SENT25	16	16	20	20	daclizumab	IL2	PA164764446	3558	0.784
NULL	Arthritis_Res_Ther_2012_Jun_12_14(3)_R141.nxml.txt.nlp	22691241	SENT52	16	16	18	18	abatacept	CTLA4	PA164747080	1493	0.784
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_75-89.nxml.txt.nlp	17912638	SENT580	36	36	31	31	tamoxifen	ATAC	PA451581	6375	0.784
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_29_2013_590393.nxml.txt.nlp	23737838	SENT301	0	0	8	8	resveratrol	p53		7157	0.784
NULL	J_Cell_Mol_Med_2014_Dec_9_18(12)_2499-2511.nxml.txt.nlp	24912879	SENT288	17	17	6	6	docetaxel	DACH1	PA449383	1602	0.784
NULL	BMB_Rep_2013_Nov_46(11)_544-549.nxml.txt.nlp	24152910	SENT94	2	2	21	21	thrombin	IL-6	PA451674	3569	0.784
NULL	Int_J_Breast_Cancer_2011_Feb_24_2011_967419.nxml.txt.nlp	22332018	SENT237	9	9	11	11	goserelin	MRP1	PA164747674	4437	0.784
NULL	Arthritis_Res_Ther_2005_Mar_9_7(3)_93.nxml.txt.nlp	15899057	SENT102	11	11	21	21	methotrexate	CD4	PA450428	920	0.784
NULL	Oncotarget_2014_Feb_7_5(3)_775-787.nxml.txt.nlp	24519956	SENT113	15	15	8	8	dasatinib	PC3	PA162372878	57332;7832;5122	0.784
NULL	Evid_Based_Complement_Alternat_Med_2013_May_28_2013_629750.nxml.txt.nlp	23781265	SENT28	7	7	39	39	capsaicin	GADD153	PA448776	1649	0.784
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Sep_26_68(Pt_10)_o3024.nxml.txt.nlp	23125791	SENT66	20	20	6	6	ethanol	mol	PA448073	90527	0.784
NULL	Cancer_Med_2014_Aug_7_3(4)_796-811.nxml.txt.nlp	24802970	SENT68	16	16	36	36	trypsin	San	PA451806	80218	0.784
NULL	Arthritis_Res_Ther_2009_Apr_30_11(2)_R58.nxml.txt.nlp	19405951	SENT6	9	9	21	21	alendronate	RANKL	PA448082	8600	0.784
NULL	Br_J_Cancer_2009_Jun_2_100(11)_1739-1745.nxml.txt.nlp	19436299	SENT5	0	0	25	25	everolimus	FDG	PA164746311	23583	0.784
NULL	Eur_J_Clin_Pharmacol_2008_Jul_16_64(7)_683-690.nxml.txt.nlp	18415093	SENT150	14	14	16	16	artesunate	ACT	PA165111697	12;11332;9457;641455	0.784
NULL	Oncol_Lett_2014_Sep_17_8(3)_1217-1221.nxml.txt.nlp	25120692	SENT32	34	34	2	2	l-glutamine	PC3	PA10090	57332;7832;5122	0.784
NULL	Front_Neurosci_2014_Jun_24_8_176.nxml.txt.nlp	25009459	SENT326	0	0	6	6	ivermectin	P2X4	PA450133	5025	0.784
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT271	5	5	11	11	maraviroc	CYP3A4	PA164768835	1576	0.784
NULL	Biochimie_2010_Nov_92(11)_1546-1567.nxml.txt.nlp	20615447	SENT218	21	21	6	6	heparin	KLK1	PA449855	3816	0.784
NULL	Breast_Cancer_Res_2014_May_5_16(3)_R45.nxml.txt.nlp	24887236	SENT30	2	2	8	8	lapatinib	HER2	PA152241907	2064	0.784
NULL	Indian_J_Ophthalmol_2007_Nov-Dec_55(6)_483b-486.nxml.txt.nlp	17951918	SENT6	11	11	29	29	bevacizumab	PED	PA130232992	8682	0.784
NULL	Acta_Pharmacol_Sin_2014_Aug_30_35(8)_1045-1054.nxml.txt.nlp	24976155	SENT147	7	7	22	22	resveratrol	STAT3		6774	0.784
NULL	Oncol_Lett_2014_May_26_7(5)_1345-1351.nxml.txt.nlp	24765136	SENT103	8	8	24	24	sorafenib	CHOP	PA7000	1649	0.784
NULL	Clin_Interv_Aging_2013_Jul_16_8_889-897.nxml.txt.nlp	23898224	SENT7	47	47	44	44	gemcitabine	SIRT1	PA449748	23411	0.784
NULL	Br_J_Cancer_1998_Sep_78(6)_745-751.nxml.txt.nlp	9743293	SENT4	31	31	7	7	camptothecin	p53	PA153590860	7157	0.784
NULL	Cancer_Med_2014_Oct_2_3(5)_1246-1255.nxml.txt.nlp	24890221	SENT123	12	12	36	36	fluorescein	LAT2	PA164746009	7462;23428	0.784
NULL	Nat_Med_2010_Jun_23_16(6)_671-677.nxml.txt.nlp	20495567	SENT191	13	13	24	24	sorafenib	ATF5	PA7000	22809	0.784
NULL	Breast_Cancer_Res_2012_Feb_14_14(1)_R30.nxml.txt.nlp	22333315	SENT16	22	22	2	2	indomethacin	IFN	PA449982	3439	0.784
NULL	Cardiovasc_Diabetol_2013_Jun_7_12_84.nxml.txt.nlp	23759020	SENT161	3	3	0	0	dipyridamole	LSR	PA449367	51599	0.784
NULL	BMB_Rep_2014_Jun_47(6)_318-323.nxml.txt.nlp	24286322	SENT324	9	9	6	6	etoposide	BRCA1	PA449552	672	0.784
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_25_2013_504642.nxml.txt.nlp	23878600	SENT164	6	6	2	2	captopril	TFG	PA448780	10342	0.784
NULL	J_Korean_Med_Sci_2008_Aug_25_23(4)_657-661.nxml.txt.nlp	18756053	SENT19	36	36	6	6	estradiol	AMH	PA449503	268	0.784
NULL	Cancer_Cell_Int_2011_Mar_10_11_6.nxml.txt.nlp	21392380	SENT168	11	11	14	14	imipramine	Gen	PA449969	348654	0.784
NULL	Thorax_2009_Aug_12_64(8)_671-676.nxml.txt.nlp	19213775	SENT155	10	10	15	15	cilomilast	TNF-alpha	PA165948031	7124	0.784
NULL	Lab_Invest_2013_Dec_14_93(12)_1265-1275.nxml.txt.nlp	24126890	SENT299	2	2	8	8	celecoxib	JAM-A	PA448871	50848	0.784
NULL	Ther_Clin_Risk_Manag_2005_Jun_1(2)_107-114.nxml.txt.nlp	18360550	SENT25	2	2	17	17	paclitaxel	Yes	PA450761	7525	0.784
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT254	9	9	11	11	cisplatin	MDM2	PA449014	4193	0.784
NULL	Breast_Cancer_Res_Treat_2014_Nov_24_143(1)_125-133.nxml.txt.nlp	24272078	SENT116	12	12	1	1	exemestane	aromatase	PA449563	1588	0.784
NULL	J_Hematol_Oncol_2012_Sep_18_5_57.nxml.txt.nlp	22989009	SENT177	5	5	8	8	nutlin-3	p53AIP1		63970	0.784
NULL	Indian_J_Med_Paediatr_Oncol_2013_Oct-Dec_34(4)_292-298.nxml.txt.nlp	24604960	SENT47	11	11	0	0	doxorubicin	CHOP	PA449412	1649	0.784
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Nov_22_64(Pt_12)_o2409.nxml.txt.nlp	21581378	SENT57	25	25	40	40	ethanol	mol	PA448073	90527	0.784
NULL	Curr_Neuropharmacol_2013_Dec_11(6)_652-663.nxml.txt.nlp	24396340	SENT82	1	1	24	24	paclitaxel	TRPV1	PA450761	7442	0.784
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jul_7_66(Pt_8)_o1952.nxml.txt.nlp	21588276	SENT76	29	29	22	22	benzaldehyde	mol	PA448571	90527	0.784
NULL	Clin_Mol_Hepatol_2014_Sep_25_20(3)_283-290.nxml.txt.nlp	25320732	SENT120	10	10	15	15	propranolol	EVL	PA451145	51466	0.784
NULL	Exp_Anim_2014_Jul_22_63(4)_403-413.nxml.txt.nlp	25048266	SENT75	4	4	11	11	pentobarbital	MRI	PA450859	78996	0.784
NULL	Br_J_Clin_Pharmacol_2011_Oct_72(4)_647-657.nxml.txt.nlp	21518389	SENT212	5	5	10	10	cangrelor	P2Y12	PA165945763	64805	0.784
NULL	J_Oncol_2009_May_6_2009_567486.nxml.txt.nlp	19424511	SENT76	15	15	26	26	cetuximab	KRAS	PA10040	3845	0.784
NULL	Cancers_(Basel)_2014_Apr_9_6(2)_829-859.nxml.txt.nlp	24722453	SENT1961	1	1	11	11	auranofin	STAT3	PA448510	6774	0.784
NULL	Fibrogenesis_Tissue_Repair_2012_Apr_13_5_5.nxml.txt.nlp	22502865	SENT122	17	17	7	7	troglitazone	CCN2	PA451799	1490	0.784
NULL	Clin_Pharmacokinet_2014_Jun_27_53(8)_741-751.nxml.txt.nlp	24968986	SENT250	23	23	19	19	docetaxel	OATP1B1	PA449383	10599	0.784
NULL	Front_Psychol_2014_Apr_4_5_282.nxml.txt.nlp	24772099	SENT505	5	5	2	2	resveratrol	SIRT1		23411	0.784
NULL	Oncotarget_2011_Dec_24_2(12)_896-917.nxml.txt.nlp	22203527	SENT207	20	20	10	10	doxorubicin	CD24	PA449412	100133941	0.784
NULL	J_Skin_Cancer_2012_Oct_22_2012_706452.nxml.txt.nlp	23133758	SENT179	29	29	32	32	aldesleukin	BRAF	PA448081	673	0.784
NULL	J_Med_Case_Rep_2013_Jul_26_7_200.nxml.txt.nlp	23889916	SENT33	18	18	15	15	thyroglobulin	TTF-1	PA164754910	7080	0.784
NULL	Exp_Ther_Med_2014_Aug_4_8(2)_657-661.nxml.txt.nlp	25009636	SENT9	17	17	27	27	propofol	CCL2	PA451141	6347	0.784
NULL	Arthritis_Rheumatol_2014_Jun_27_66(6)_1574-1582.nxml.txt.nlp	24577881	SENT105	11	11	18	18	hydralazine	CD4	PA449894	920	0.784
NULL	Breast_Cancer_Res_2014_Jul_24_16(4)_411.nxml.txt.nlp	25056669	SENT162	21	21	9	9	tamoxifen	CC3	PA451581	10553	0.784
NULL	Front_Neurol_2012_Apr_2_3_41.nxml.txt.nlp	22485105	SENT48	41	41	43	43	vasopressin	AVP	PA451858	114548;551	0.784
NULL	Nat_Med_2014_Jul_8_20(7)_764-768.nxml.txt.nlp	24908571	SENT259	13	13	7	7	citalopram	GRM4	PA449015	2914	0.784
NULL	J_Cell_Biol_2004_Jan_19_164(2)_169-174.nxml.txt.nlp	14718521	SENT105	10	10	0	0	dextran	MARCKS	PA449261	4082	0.784
NULL	Mol_Biol_Int_2012_May_24_2012_705948.nxml.txt.nlp	22693671	SENT9	10	10	2	2	cisplatin	RASSF2	PA449014	9770	0.784
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT126	21	21	23	23	pp2	LYN		4067	0.784
NULL	Oncol_Lett_2013_Mar_11_5(3)_1010-1016.nxml.txt.nlp	23426784	SENT21	6	6	28	28	midazolam	TRPM7	PA450496	54822	0.784
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT146	6	6	13	13	resveratrol	survivin		332	0.784
NULL	Br_J_Cancer_2013_Jul_23_109(2)_351-359.nxml.txt.nlp	23799854	SENT146	26	26	24	24	paclitaxel	P-gp	PA450761	5243	0.784
NULL	J_Gastroenterol_2014_Feb_9_49(1)_24-45.nxml.txt.nlp	23397116	SENT451	2	2	11	11	naltrexone	IL-6	PA450588	3569	0.784
NULL	Br_J_Cancer_2012_Jan_31_106(3)_562-568.nxml.txt.nlp	22223087	SENT54	8	8	5	5	thyroglobulin	ACTB	PA164754910	60	0.784
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT126	34	34	20	20	nifedipine	CYP3A	PA450631	1574	0.784
NULL	Acta_Pharmacol_Sin_2012_Jan_12_33(1)_27-33.nxml.txt.nlp	22158109	SENT154	10	10	12	12	propofol	AMPK	PA451141	5563	0.784
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT279	0	0	39	39	clozapine	FGA	PA449061	2243	0.784
NULL	Cardiovasc_Diabetol_2008_Dec_23_7_36.nxml.txt.nlp	19108709	SENT112	6	6	11	11	eptifibatide	JNK	PA449483	5599	0.784
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT116	0	0	6	6	metformin	CCL16	PA450395	6360	0.784
NULL	Breast_Cancer_Res_Treat_2014_Nov_11_148(3)_563-570.nxml.txt.nlp	25385180	SENT58	16	16	10	10	docetaxel	PTH	PA449383	5741	0.784
NULL	Cancers_(Basel)_2013_Jul_26_5(3)_959-984.nxml.txt.nlp	24202329	SENT123	13	13	25	25	trypsin	KSR	PA451806	10256	0.784
NULL	Oncologist_2011_Jan_6_16(1)_5-24.nxml.txt.nlp	21212434	SENT189	4	4	12	12	cisplatin	IFN	PA449014	3439	0.784
NULL	Breast_Cancer_Res_2007_Oct_26_9(5)_112.nxml.txt.nlp	17980056	SENT96	11	11	27	27	lapatinib	HER2	PA152241907	2064	0.784
NULL	Oncotarget_2014_Oct_15_5(21)_10763-10777.nxml.txt.nlp	25333257	SENT72	21	21	15	15	sn-38	P-gp		5243	0.784
NULL	J_Biol_Chem_2009_Jul_24_284(30)_20011-20021.nxml.txt.nlp	19473976	SENT181	3	3	15	15	trypsin	MCT1	PA451806	6566	0.784
NULL	Indian_J_Pharmacol_2014_Nov-Dec_46(6)_627-632.nxml.txt.nlp	25538335	SENT125	6	6	9	9	metformin	Q10	PA450395	27161	0.784
NULL	Acta_Pharmacol_Sin_2012_Aug_23_33(8)_1095-1100.nxml.txt.nlp	22820908	SENT31	20	20	14	14	ilaprazole	CYP2C19	PA165947499	1557	0.784
NULL	Mol_Imaging_Biol_2012_Jun_13_14(3)_261-276.nxml.txt.nlp	22160875	SENT76	0	0	2	2	cetuximab	EGFR	PA10040	1956	0.784
NULL	Clin_Mol_Allergy_2010_Feb_16_8_2.nxml.txt.nlp	20158902	SENT14	0	0	7	7	heparin	CD63	PA449855	967	0.784
NULL	Br_J_Cancer_2010_Jun_29_103(1)_52-60.nxml.txt.nlp	20531411	SENT12	1	1	23	23	gemcitabine	EGF	PA449748	1950	0.784
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R91.nxml.txt.nlp	22541814	SENT105	0	0	2	2	thrombin	HO-1	PA451674	3162	0.784
NULL	J_Cell_Mol_Med_2014_Sep_1_18(9)_1895-1907.nxml.txt.nlp	25088572	SENT46	9	9	37	37	phenol	EGF	PA450913	1950	0.784
NULL	Breast_Cancer_Res_2011_Jan_11_13(1)_R3.nxml.txt.nlp	21223569	SENT152	12	12	3	3	etoposide	p53	PA449552	7157	0.784
NULL	Oxid_Med_Cell_Longev_2013_Apr_24_2013_168039.nxml.txt.nlp	23738033	SENT200	11	11	9	9	capsaicin	NNT	PA448776	23530	0.784
NULL	Mediators_Inflamm_2011_Jun_7_2011_432080.nxml.txt.nlp	21772662	SENT108	6	6	12	12	rivaroxaban	IL-6	PA165958360	3569	0.784
NULL	Arch_Osteoporos_2013_Sep_13_8(1-2)_144.nxml.txt.nlp	24030479	SENT1004	19	19	30	30	raloxifene	PTH	PA451221	5741	0.784
NULL	J_Mol_Signal_2010_Jul_12_5_8.nxml.txt.nlp	20624308	SENT32	21	21	7	7	gefitinib	Met	PA131301952	79811	0.784
NULL	J_Cancer_2013_Jan_11_4(2)_117-132.nxml.txt.nlp	23386910	SENT64	38	38	23	23	maytansine	DM1	PA165291473	338023;1760;28509	0.784
NULL	J_Carcinog_Mutagen_2013_Suppl_6_003.nxml.txt.nlp	25379355	SENT171	7	7	37	37	cisplatin	PI3K	PA449014	5290	0.784
NULL	AMB_Express_2011_Jul_13_1_16.nxml.txt.nlp	21906371	SENT114	5	5	42	42	nitrogen	PHB	PA450643	5245	0.784
NULL	Clin_Sci_(Lond)_2012_May_1_122(Pt_9)_421-428.nxml.txt.nlp	22092038	SENT161	26	26	11	11	doxycycline	IL-8	PA449415	3576	0.784
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT157	19	19	34	34	perifosine	JNK	PA165291471	5599	0.784
NULL	J_Cell_Biol_1998_Nov_16_143(4)_901-910.nxml.txt.nlp	9817749	SENT35	0	0	5	5	geldanamycin	p23	PA152031327	10728	0.784
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S202-S209.nxml.txt.nlp	21525456	SENT155	34	34	22	22	exenatide	GLP-1	PA164749238	100125288	0.784
NULL	J_Vet_Med_Sci_2014_Jun_15_76(6)_813-817.nxml.txt.nlp	24531829	SENT96	7	7	10	10	primaquine	DPT	PA451103	1805	0.784
NULL	J_Headache_Pain_2008_Oct_31_9(5)_277-288.nxml.txt.nlp	18668199	SENT62	4	4	9	9	clonidine	Yes	PA449051	7525	0.784
NULL	Cell_Death_Dis_2013_Oct_3_4(10)_e828.nxml.txt.nlp	24091671	SENT271	28	28	9	9	cetuximab	CD44	PA10040	960	0.784
NULL	Oncotarget_2014_Nov_11_5(22)_11490-11500.nxml.txt.nlp	25359780	SENT79	9	9	2	2	docetaxel	LIMK1	PA449383	3984	0.784
NULL	Breast_Cancer_Res_2000_Mar_12_2(Suppl_1)_P7_04.nxml.txt.nlp	NULL	SENT12	29	29	5	5	vincristine	BRCA1	PA451879	672	0.784
NULL	Brain_Sci_2013_Jun_14_3(2)_941-963.nxml.txt.nlp	24961432	SENT116	2	2	18	18	ethanol	p38	PA448073	10598;1432;7965	0.784
NULL	Gut_2011_Jun_7_60(6)_837-845.nxml.txt.nlp	21139063	SENT107	8	8	5	5	ribavirin	IFN	PA451241	3439	0.784
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT38	13	13	4	4	tamoxifen	TFF3	PA451581	7033	0.784
NULL	Nat_Commun_2013_Nov_26_4_10_1038_ncomms3816.nxml.txt.nlp	24281383	SENT334	30	30	8	8	picrotoxin	MSN	PA164777007	4478	0.784
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT178	10	10	3	3	doxorubicin	SLK	PA449412	9748;2534	0.784
NULL	Cell_Mol_Life_Sci_2011_Nov_2_68(21)_3573-3587.nxml.txt.nlp	21365278	SENT172	15	15	31	31	iloprost	EP4	PA164746843	5734	0.784
NULL	Biomed_Res_Int_2013_Jul_31_2013_692071.nxml.txt.nlp	23984399	SENT182	24	24	31	31	paclitaxel	OCT1	PA450761	5451;6580	0.784
NULL	Clin_Psychopharmacol_Neurosci_2012_Apr_30_10(1)_25-33.nxml.txt.nlp	23429852	SENT13	5	5	17	17	olanzapine	alpha-synuclein	PA450688	6622	0.784
NULL	Ann_Neurosci_2013_Jan_20(1)_24-29.nxml.txt.nlp	25206006	SENT125	5	5	22	22	scopolamine	spatial	PA451308	219793	0.784
NULL	Br_J_Ophthalmol_2014_Jun_98(Suppl_1)_i11-i16.nxml.txt.nlp	24836865	SENT147	11	11	6	6	ranibizumab	VEGF-A	PA164746012	7422	0.784
NULL	J_Korean_Med_Sci_2006_Dec_31_21(6)_1037-1040.nxml.txt.nlp	17179683	SENT5	18	18	10	10	clarithromycin	BAM	PA449028	9126	0.784
NULL	Bioinform_Biol_Insights_2013_Jul_23_7_217-230.nxml.txt.nlp	23926424	SENT151	4	4	2	2	flavopiridol	CDK4	PA452627	1019	0.784
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT87	23	23	34	34	pemetrexed	UNG	PA10810	7374	0.784
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jun_16_66(Pt_7)_o1638.nxml.txt.nlp	21587867	SENT74	22	22	15	15	benzaldehyde	mol	PA448571	90527	0.784
NULL	Clin_Med_Insights_Arthritis_Musculoskelet_Disord_2012_Jan_5_5_1-14.nxml.txt.nlp	22267947	SENT102	25	25	5	5	risedronate	FACT	PA451255	11198	0.784
NULL	Diabetes_2011_Nov_17_60(11)_2691-2700.nxml.txt.nlp	21896928	SENT146	9	9	7	7	resveratrol	SIRT1		23411	0.784
NULL	Exp_Anim_2014_Jul_22_63(4)_447-457.nxml.txt.nlp	25048263	SENT10	41	41	3	3	estradiol	LEP	PA449503	3952	0.784
NULL	Ecancermedicalscience_2015_Jan_8_9_499.nxml.txt.nlp	25624880	SENT30	27	27	24	24	pioglitazone	gamma	PA450970	9913	0.784
NULL	Evid_Based_Complement_Alternat_Med_2012_Sep_25_2012_174916.nxml.txt.nlp	23049604	SENT124	9	9	0	0	curcumin	Tuba	PA151958596	23268	0.784
NULL	Oncogene_2011_Apr_21_30(16)_1901-1911.nxml.txt.nlp	21151179	SENT296	15	15	19	19	doxycycline	KLF8	PA449415	11279	0.784
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1126-1134.nxml.txt.nlp	21364592	SENT132	39	39	31	31	capecitabine	CYP2A6	PA448771	1548	0.784
NULL	Ann_Oncol_2011_Jan_13_22(1)_215-223.nxml.txt.nlp	20627875	SENT133	6	6	12	12	mesna	ETO	PA450385	862	0.784
NULL	Cancer_Cell_Int_2013_May_24_13_48.nxml.txt.nlp	23706027	SENT6	7	7	4	4	cisplatin	ADM	PA449014	133	0.784
NULL	Biologics_2014_Apr_10_8_129-139.nxml.txt.nlp	24748771	SENT90	0	0	3	3	pazopanib	VEGFR	PA165291492	3791	0.784
NULL	Br_J_Pharmacol_2008_Oct_18_155(4)_596-605.nxml.txt.nlp	18852694	SENT216	5	5	15	15	fenofibrate	SREBP2	PA449594	6721	0.784
NULL	Cardiovasc_Diabetol_2008_Aug_11_7_24.nxml.txt.nlp	18694484	SENT215	31	31	8	8	exenatide	Ray	PA164749238	26751	0.784
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT446	31	31	16	16	olanzapine	PRL	PA450688	5617	0.784
NULL	J_Oncol_2013_Feb_17_2013_872957.nxml.txt.nlp	23476648	SENT171	11	11	4	4	cisplatin	SFN	PA449014	25996;2810	0.784
NULL	Anal_Chem_Insights_2014_Mar_2_9_1-7.nxml.txt.nlp	24634579	SENT141	16	16	8	8	ethanol	TRB	PA448073	6957	0.784
NULL	Ther_Clin_Risk_Manag_2005_Jun_1(2)_107-114.nxml.txt.nlp	18360550	SENT25	2	2	39	39	paclitaxel	Yes	PA450761	7525	0.784
NULL	Drug_Des_Devel_Ther_2014_Sep_23_8_1527-1538.nxml.txt.nlp	25284985	SENT7	9	9	7	7	celecoxib	IFN	PA448871	3439	0.784
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_May_24_70(Pt_6)_o713.nxml.txt.nlp	24940283	SENT75	0	0	10	10	benzaldehyde	mol	PA448571	90527	0.784
NULL	J_Breast_Cancer_2013_Jun_28_16(2)_133-137.nxml.txt.nlp	23843843	SENT56	1	1	3	3	curcumin	p27	PA151958596	5715;10534	0.784
NULL	J_Viral_Hepat_2010_Feb_17(2)_139-147.nxml.txt.nlp	19674282	SENT177	33	33	21	21	ribavirin	RVR	PA451241	9975	0.784
NULL	Int_J_Mol_Sci_2014_Oct_29_15(11)_19700-19728.nxml.txt.nlp	25356505	SENT245	5	5	3	3	thrombin	LPA	PA451674	4018	0.784
NULL	Nucleic_Acids_Res_2007_Jan_19_35(2)_664-677.nxml.txt.nlp	17179180	SENT483	2	2	8	8	ketamine	TNF-alpha	PA450144	7124	0.784
NULL	Oxid_Med_Cell_Longev_2013_Jun_6_2013_891748.nxml.txt.nlp	23840922	SENT264	5	5	9	9	resveratrol	Bcl-2		596	0.784
NULL	Ann_Surg_Oncol_2010_Jan_20_17(1)_14-17.nxml.txt.nlp	19841980	SENT27	3	3	17	17	trastuzumab	ERBB2	PA451743	2064	0.784
NULL	Biomed_Res_Int_2014_Jan_15_2014_859871.nxml.txt.nlp	24527460	SENT126	20	20	10	10	doxorubicin	CD24	PA449412	100133941	0.784
NULL	Drugs_R_D_2014_Sep_28_14(3)_159-164.nxml.txt.nlp	24973042	SENT47	37	37	34	34	rosiglitazone	CYP2C19	PA451283	1557	0.784
NULL	Biochem_Res_Int_2012_Feb_12_2012_346972.nxml.txt.nlp	22400115	SENT211	21	21	23	23	hyaluronan	CD44	PA165958431	960	0.784
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1427-1436.nxml.txt.nlp	24096601	SENT85	4	4	13	13	erlotinib	EGFR	PA134687924	1956	0.784
NULL	Arthritis_Res_Ther_2009_Apr_6_11(Suppl_1)_S1.nxml.txt.nlp	19368701	SENT76	11	11	4	4	adalimumab	ACR	PA10004	49	0.784
NULL	Oncotarget_2013_Mar_26_4(3)_397-412.nxml.txt.nlp	23651630	SENT308	22	22	32	32	doxorubicin	CHOP	PA449412	1649	0.784
NULL	Oncotarget_2013_Aug_29_4(10)_1673-1685.nxml.txt.nlp	24127549	SENT189	25	25	6	6	resveratrol	PC-3		692094	0.784
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jul_10_68(Pt_8)_o2402-o2403.nxml.txt.nlp	22904859	SENT72	27	27	14	14	ethanol	mol	PA448073	90527	0.784
NULL	EPMA_J_2011_Dec_12_2(4)_391-402.nxml.txt.nlp	23199176	SENT324	13	13	16	16	olanzapine	Gen	PA450688	348654	0.784
NULL	Breast_Cancer_Res_2012_Mar_14_14(2)_R46.nxml.txt.nlp	22417870	SENT192	8	8	2	2	trastuzumab	HER2	PA451743	2064	0.784
NULL	Front_Immunol_2012_May_18_3_126.nxml.txt.nlp	22629256	SENT909	12	12	5	5	sirolimus	CD25	PA451365	3669;3559	0.784
NULL	Cardiovasc_Diabetol_2013_Mar_23_12_48.nxml.txt.nlp	23522121	SENT113	7	7	10	10	sitagliptin	NNT	PA164748978	23530	0.784
NULL	Biosci_Rep_2012_Dec_20_33(1)_e00011.nxml.txt.nlp	23137297	SENT261	15	15	0	0	heparin	RPSA	PA449855	3921	0.784
NULL	J_Cell_Mol_Med_2014_Jan_4_18(1)_38-48.nxml.txt.nlp	24188742	SENT143	34	34	21	21	cisplatin	PAX3	PA449014	5077	0.784
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT238	0	0	11	11	pp2	JNK		5599	0.784
NULL	Mol_Cancer_2014_Jan_13_13_7.nxml.txt.nlp	24418169	SENT234	14	14	18	18	sorafenib	STAT3	PA7000	6774	0.784
NULL	Breast_Cancer_Res_2000_Dec_17_2(1)_32-44.nxml.txt.nlp	11250691	SENT303	10	10	6	6	paclitaxel	p53	PA450761	7157	0.784
NULL	Indian_J_Med_Res_2011_Jun_133(6)_581-593.nxml.txt.nlp	21727656	SENT83	28	28	30	30	diethylstilbestrol	DES	PA449307	1674	0.784
NULL	Front_Neurosci_2014_Jun_6_8_140.nxml.txt.nlp	24936171	SENT1056	6	6	11	11	ethanol	FAST	PA448073	10922	0.784
NULL	Oncotarget_2012_Sep_28_3(10)_1169-1181.nxml.txt.nlp	23045411	SENT96	12	12	44	44	doxorubicin	JIP1	PA449412	9479	0.784
NULL	Mol_Cancer_2013_Sep_3_12_100.nxml.txt.nlp	24004603	SENT33	10	10	7	7	irinotecan	TPT	PA450085	23590;6469	0.784
NULL	Case_Rep_Oncol_Med_2012_Dec_26_2012_390702.nxml.txt.nlp	23326741	SENT103	1	1	8	8	axitinib	VEGFR	PA164924493	3791	0.784
NULL	Genome_Med_2010_Aug_11_2(8)_53.nxml.txt.nlp	20701793	SENT45	16	16	8	8	axitinib	VEGFR	PA164924493	3791	0.784
NULL	Front_Immunol_2013_Oct_7_4_325.nxml.txt.nlp	24109484	SENT79	13	13	18	18	nutlin-3	ULBP2		80328	0.784
NULL	Breast_Cancer_Res_2004_Jun_29_6(5)_R488-R498.nxml.txt.nlp	15318931	SENT10	6	6	14	14	estradiol	SULT1A1	PA449503	6817	0.784
NULL	Breast_Cancer_Res_2011_Apr_14_13(2)_R43.nxml.txt.nlp	21492444	SENT309	9	9	31	31	tamoxifen	HER-2	PA451581	2064	0.784
NULL	Iran_J_Pharm_Res_2013_Summer_12(3)_495-501.nxml.txt.nlp	24250655	SENT122	6	6	9	9	estradiol	CA1	PA449503	759	0.784
NULL	J_Biol_Chem_2009_Mar_13_284(11)_6861-6868.nxml.txt.nlp	19074143	SENT209	5	5	18	18	s-adenosylmethionine	ICMT	PA164754994	23463	0.784
NULL	Diabetes_2009_Jan_58(1)_243-249.nxml.txt.nlp	18840785	SENT5	11	11	24	24	vildagliptin	GLP-1	PA165958346	100125288	0.784
NULL	Br_J_Pharmacol_2008_Nov_11_155(6)_896-905.nxml.txt.nlp	18695641	SENT136	0	0	18	18	genistein	OPG	PA165109660	690	0.784
NULL	Oncoimmunology_2012_May_1_1(3)_372-374.nxml.txt.nlp	22737619	SENT33	10	10	12	12	lenalidomide	CD4	PA162363968	920	0.784
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_9_2013_456747.nxml.txt.nlp	23653662	SENT125	5	5	24	24	berberine	VEGFA	PA165860812	7422	0.784
NULL	Arthritis_Res_Ther_2012_Nov_11_14(6)_R244.nxml.txt.nlp	23140401	SENT160	39	39	42	42	imiquimod	PGRN	PA449972	2896	0.784
NULL	Pharmaceuticals_(Basel)_2013_Mar_21_6(3)_358-392.nxml.txt.nlp	24276023	SENT451	13	13	27	27	ethanol	gamma	PA448073	9913	0.784
NULL	Mol_Cancer_2008_Mar_6_7_24.nxml.txt.nlp	18325101	SENT134	14	14	28	28	cisplatin	BRCA1	PA449014	672	0.784
NULL	Open_Biol_2014_Jan_4(1)_130138.nxml.txt.nlp	24403013	SENT278	4	4	12	12	etoposide	PP1	PA449552	5540;5464	0.784
NULL	Mol_Cancer_2010_Nov_8_9_291.nxml.txt.nlp	21059223	SENT87	30	30	3	3	gemcitabine	ZNF217	PA449748	7764	0.784
NULL	Environ_Health_Perspect_2011_Apr_16_119(4)_534-541.nxml.txt.nlp	21081300	SENT197	12	12	16	16	genistein	COX	PA165109660	1351	0.784
NULL	Br_J_Cancer_2013_Mar_5_108(4)_983-992.nxml.txt.nlp	23361057	SENT226	14	14	22	22	cytarabine	ANOVA	PA449177	4858	0.784
NULL	Br_J_Cancer_1998_Oct_78(8)_1024-1029.nxml.txt.nlp	9792145	SENT12	6	6	24	24	amifostine	CD34	PA448365	947	0.784
NULL	Brain_Sci_2013_Jun_14_3(2)_941-963.nxml.txt.nlp	24961432	SENT117	0	0	10	10	ethanol	RhoA	PA448073	387	0.784
NULL	Cancer_Immunol_Immunother_2011_Jun_24_60(6)_771-780.nxml.txt.nlp	21347809	SENT118	21	21	7	7	rituximab	mol	PA451261	90527	0.784
NULL	Korean_Circ_J_2013_Jun_30_43(6)_400-407.nxml.txt.nlp	23882289	SENT105	12	12	16	16	doxorubicin	Bcl-2	PA449412	596	0.784
NULL	Adolesc_Health_Med_Ther_2014_Nov_27_5_211-221.nxml.txt.nlp	25473324	SENT153	25	25	7	7	aripiprazole	ERG	PA10026	2078	0.784
NULL	Crit_Care_2009_Feb_6_13(1)_R11.nxml.txt.nlp	19196475	SENT198	4	4	13	13	clonidine	IL-6	PA449051	3569	0.784
NULL	Arthritis_Res_Ther_2012_Apr_30_14(2)_R96.nxml.txt.nlp	22546471	SENT119	5	5	2	2	methotrexate	IL-6	PA450428	3569	0.784
NULL	Br_J_Cancer_2000_Jun_82(11)_1827-1834.nxml.txt.nlp	10839298	SENT10	11	11	6	6	camptothecin	JNK2	PA153590860	5601	0.784
NULL	Arch_Drug_Inf_2011_Mar_4(1)_1-9.nxml.txt.nlp	21572514	SENT13	0	0	19	19	ciprofloxacin	PK1	PA449009	84432	0.784
NULL	Front_Oncol_2013_Nov_18_3_282.nxml.txt.nlp	24303367	SENT245	5	5	24	24	glucose	GDNF	PA449773	2668	0.784
NULL	Cardiovasc_Drugs_Ther_2010_Dec_13_24(5-6)_391-399.nxml.txt.nlp	20640495	SENT42	14	14	9	9	atorvastatin	DIP	PA448500	23151;1831	0.784
NULL	Core_Evid_2010_Oct_21_5_61-76.nxml.txt.nlp	21042543	SENT252	34	34	42	42	panitumumab	PIK3CA	PA162373091	5290	0.784
NULL	Int_J_Biol_Sci_2014_Jun_5_10(6)_620-626.nxml.txt.nlp	24948875	SENT32	10	10	3	3	paclitaxel	FOXO1	PA450761	2308	0.784
NULL	Indian_J_Pharmacol_2014_Jul-Aug_46(4)_404-408.nxml.txt.nlp	25097278	SENT28	22	22	33	33	carrageenan	COX	PA448814	1351	0.784
NULL	Indian_J_Pharmacol_2014_Jan-Feb_46(1)_3-12.nxml.txt.nlp	24550577	SENT221	15	15	7	7	fluconazole	CYP3A4	PA449653	1576	0.784
NULL	Br_J_Pharmacol_2014_Oct_26_171(20)_4785-4796.nxml.txt.nlp	25074741	SENT39	10	10	15	15	guanfacine	NK1R	PA449825	6869	0.784
NULL	Breast_Cancer_Res_Treat_2014_Nov_27_143(1)_19-31.nxml.txt.nlp	24281828	SENT170	13	13	5	5	indomethacin	EP4	PA449982	5734	0.784
NULL	Hematol_Rep_2011_Oct_28_3(3_Suppl)_e5.nxml.txt.nlp	22586513	SENT34	7	7	12	12	vincristine	CHOP	PA451879	1649	0.784
NULL	Iran_J_Pharm_Res_2014_Spring_13(2)_635-639.nxml.txt.nlp	25237359	SENT18	37	37	12	12	chlorzoxazone	CYP3A	PA448971	1574	0.784
NULL	Arthritis_Res_Ther_2011_Nov_1_13(6)_R182.nxml.txt.nlp	22044682	SENT62	10	10	31	31	collagenase	CD11c	PA449107	3687	0.784
NULL	Exp_Diabetes_Res_2011_Dec_27_2011_604989.nxml.txt.nlp	21253359	SENT170	4	4	6	6	clonidine	GLP-1	PA449051	100125288	0.784
NULL	Nat_Commun_2013_Oct_1_4_2516.nxml.txt.nlp	24084631	SENT92	0	0	14	14	losartan	AK4	PA450268	205	0.784
NULL	Oncotarget_2013_Nov_26_4(12)_2502-2511.nxml.txt.nlp	24318446	SENT140	15	15	13	13	doxycycline	PHGDH	PA449415	26227	0.784
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_91-103.nxml.txt.nlp	17912639	SENT104	6	6	19	19	letrozole	HER2	PA450196	2064	0.784
NULL	Front_Physiol_2013_Jul_17_4_157.nxml.txt.nlp	23882218	SENT137	9	9	23	23	carrageenan	CD11b	PA448814	3684	0.784
NULL	J_Gastrointest_Cancer_2013_Aug_7_44(4)_385-392.nxml.txt.nlp	23921604	SENT149	4	4	14	14	imatinib	BSC	PA10804	6558	0.784
NULL	Acta_Pharmacol_Sin_2012_Jun_14_33(6)_832-838.nxml.txt.nlp	22580740	SENT13	30	30	32	32	cisplatin	DDP	PA449014	1678	0.784
NULL	J_Exp_Med_2000_Mar_20_191(6)_949-960.nxml.txt.nlp	10727457	SENT85	19	19	31	31	gentamicin	CO2	PA449753	4513	0.784
NULL	Int_J_Nanomedicine_2007_Sep_2(3)_277-288.nxml.txt.nlp	18019828	SENT46	34	34	13	13	bleomycin	CHOP	PA448645	1649	0.784
NULL	Enzyme_Res_2009_Nov_1_2010_165878.nxml.txt.nlp	21048860	SENT227	6	6	27	27	asparaginase	NAC	PA448492	22861	0.784
NULL	J_Med_Case_Reports_2011_Feb_17_5_70.nxml.txt.nlp	21329500	SENT16	12	12	20	20	raltegravir	ATV		4683	0.784
NULL	Front_Chem_2014_Mar_14_2_12.nxml.txt.nlp	24790981	SENT115	0	0	12	12	curcumin	GATA4	PA151958596	2626	0.784
NULL	Physiol_Rep_2014_Sep_11_2(9)_e12144.nxml.txt.nlp	25214522	SENT147	6	6	13	13	resveratrol	RVR		9975	0.784
NULL	Diabetes_2009_Apr_9_58(4)_965-974.nxml.txt.nlp	19136651	SENT147	5	5	12	12	nadh	AMPK	PA164755085	5563	0.784
NULL	J_Exp_Med_2003_Aug_4_198(3)_505-512.nxml.txt.nlp	12900524	SENT59	9	9	4	4	heparin	CCL21	PA449855	6366	0.784
NULL	Clinicoecon_Outcomes_Res_2014_Oct_17_6_451-461.nxml.txt.nlp	25378939	SENT8	6	6	3	3	vancomycin	HAP	PA451850	5915;10313	0.784
NULL	Front_Mol_Neurosci_2008_Apr_8_1_6.nxml.txt.nlp	18946539	SENT764	12	12	3	3	methamphetamine	gamma	PA450403	9913	0.784
NULL	Curr_Opin_Pharmacol_2013_Aug_13(4)_497-503.nxml.txt.nlp	23664091	SENT47	16	16	12	12	gefitinib	EGFR	PA131301952	1956	0.784
NULL	J_Cell_Biol_1988_Dec_1_107(6)_2541-2549.nxml.txt.nlp	2849608	SENT13	4	4	6	6	diethylstilbestrol	DES	PA449307	1674	0.784
NULL	Clin_Ophthalmol_2011_May_24_5_705-713.nxml.txt.nlp	21629578	SENT45	3	3	33	33	ranibizumab	VEGF-A	PA164746012	7422	0.784
NULL	Clinics_(Sao_Paulo)_2013_Feb_68(2)_253-262.nxml.txt.nlp	23525324	SENT244	30	30	24	24	genistein	Gen	PA165109660	348654	0.784
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT88	4	4	12	12	celecoxib	survivin	PA448871	332	0.784
NULL	Cancer_Cell_Int_2014_Jun_16_14_53.nxml.txt.nlp	24966801	SENT186	3	3	7	7	metformin	LC3	PA450395	84557	0.784
NULL	Breast_Cancer_Res_2008_Jan_25_10(1)_101.nxml.txt.nlp	18226190	SENT41	0	0	15	15	denosumab	RANK	PA166048634	8792	0.784
NULL	Oncogene_2013_Sep_5_32(36)_4252-4263.nxml.txt.nlp	23045288	SENT292	22	22	5	5	cisplatin	CD49f	PA449014	3655	0.784
NULL	Exp_Ther_Med_2014_Nov_12_8(5)_1443-1446.nxml.txt.nlp	25289037	SENT92	31	31	17	17	bleomycin	EPO	PA448645	7076;8288;2056	0.784
NULL	Oncotarget_2013_Nov_4_5(1)_161-172.nxml.txt.nlp	24389287	SENT158	0	0	11	11	propranolol	p53	PA451145	7157	0.784
NULL	Sci_Rep_2014_Nov_28_4_7237.nxml.txt.nlp	25429875	SENT81	11	11	8	8	hesperidin	IRF7	PA449867	3665	0.784
NULL	Reprod_Biol_Endocrinol_2013_Feb_25_11_14.nxml.txt.nlp	23442383	SENT14	28	28	30	30	domperidone	DOM	PA134711056	6663	0.784
NULL	Clin_Med_Insights_Cardiol_2010_Oct_31_4_99-110.nxml.txt.nlp	21079754	SENT68	0	0	3	3	ezetimibe	NPC1L1	PA10816	29881	0.784
NULL	Cell_Death_Differ_2010_Apr_16_17(4)_666-676.nxml.txt.nlp	19834494	SENT92	12	12	7	7	oxaliplatin	RAGE	PA131285527	177	0.784
NULL	Cancers_(Basel)_2010_Jan_14_2(1)_1-19.nxml.txt.nlp	24281029	SENT848	11	11	15	15	pertuzumab	HER2		2064	0.784
NULL	Mol_Vis_2014_Nov_4_20_1518-1526.nxml.txt.nlp	25489225	SENT121	7	7	12	12	fenofibrate	IL-6	PA449594	3569	0.784
NULL	Am_J_Med_Genet_B_Neuropsychiatr_Genet_2014_Jun_9_165(4)_373-380.nxml.txt.nlp	24817687	SENT171	16	16	13	13	ly686017	NK1R		6869	0.784
NULL	J_Hematol_Oncol_2013_Jan_15_6_5.nxml.txt.nlp	23320987	SENT218	31	31	0	0	heparin	PI-PLC	PA449855	2923	0.784
NULL	Cancer_Cell_Int_2010_Apr_29_10_12.nxml.txt.nlp	20429927	SENT116	5	5	0	0	bortezomib	HRI	PA10252	27102	0.784
NULL	Br_J_Cancer_2010_Nov_2_103(11)_1637-1643.nxml.txt.nlp	21045832	SENT20	0	0	17	17	sorafenib	VEGFR3	PA7000	2324	0.784
NULL	Clin_Pharmacol_2011_Jun_22_3_13-25.nxml.txt.nlp	22287853	SENT119	22	22	28	28	diltiazem	ANOVA	PA449334	4858	0.784
NULL	Lancet_2011_Jun_9_377(9784)_2181-2192.nxml.txt.nlp	21663949	SENT105	14	14	1	1	ezetimibe	SHARP	PA10816	23013	0.784
NULL	Acta_Pharmacol_Sin_2012_Jan_12_33(1)_27-33.nxml.txt.nlp	22158109	SENT136	4	4	33	33	propofol	IL-10	PA451141	3586	0.784
NULL	Cell_Res_2013_Feb_15_23(2)_201-212.nxml.txt.nlp	23318584	SENT43	27	27	19	19	l-cysteine	MSU	PA449173	593	0.784
NULL	Cancer_Cell_Int_2009_Sep_10_9_25.nxml.txt.nlp	19744341	SENT199	5	5	43	43	glucosamine	STAT3	PA164747613	6774	0.784
NULL	Br_J_Cancer_1995_Feb_71(2)_294-299.nxml.txt.nlp	7841043	SENT6	6	6	10	10	tamoxifen	P-gp	PA451581	5243	0.784
NULL	Oncotarget_2011_Nov_9_2(11)_850-861.nxml.txt.nlp	22081665	SENT177	15	15	7	7	idarubicin	DNMT3A	PA449961	1788	0.783
NULL	J_Cancer_Prev_2013_Jun_18(2)_186-191.nxml.txt.nlp	25337545	SENT80	0	0	5	5	curcumin	p53	PA151958596	7157	0.783
NULL	Viruses_2013_Nov_22_5(11)_2898-2919.nxml.txt.nlp	24284880	SENT580	24	24	7	7	temozolomide	CD34	PA451609	947	0.783
NULL	Breast_Cancer_(Auckl)_2014_May_12_8_81-88.nxml.txt.nlp	24855372	SENT138	13	13	21	21	pertuzumab	HER3		2065	0.783
NULL	Carcinogenesis_2014_Sep_1_35(9)_1983-1992.nxml.txt.nlp	24692066	SENT500	7	7	11	11	urokinase	HuR	PA451836	1994	0.783
NULL	Asia_Pac_Fam_Med_2011_Nov_24_10(1)_15.nxml.txt.nlp	22115027	SENT140	19	19	9	9	glucose	ADA	PA449773	100	0.783
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT119	25	25	17	17	heparin	FGF1	PA449855	2246	0.783
NULL	Exp_Diabetes_Res_2012_Sep_20_2012_936518.nxml.txt.nlp	23049542	SENT199	3	3	7	7	glucose	SGK1	PA449773	6446	0.783
NULL	Breast_Cancer_Res_2012_Mar_15_14(2)_R47.nxml.txt.nlp	22420423	SENT133	13	13	18	18	paclitaxel	TP53	PA450761	7157	0.783
NULL	Comp_Hepatol_2004_Jan_14_3(Suppl_1)_S37.nxml.txt.nlp	14960189	SENT111	3	3	32	32	thalidomide	TNF-alpha	PA451644	7124	0.783
NULL	Diagn_Pathol_2013_Feb_6_8_20.nxml.txt.nlp	23388086	SENT39	13	13	10	10	cyclophosphamide	CHOP	PA449165	1649	0.783
NULL	Diabetes_2013_Jun_17_62(6)_2048-2058.nxml.txt.nlp	23349496	SENT283	15	15	19	19	hyaluronan	CD44	PA165958431	960	0.783
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT281	14	14	26	26	nutlin-3	MDM2		4193	0.783
NULL	Oncotarget_2014_Jun_1_5(13)_4881-4894.nxml.txt.nlp	24952679	SENT191	17	17	9	9	bortezomib	IRE1	PA10252	2081	0.783
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_May_31_69(Pt_6)_o980.nxml.txt.nlp	23795133	SENT73	11	11	27	27	desloratadine	mol	PA164776964	90527	0.783
NULL	Cancer_Metab_2013_Mar_7_1_10.nxml.txt.nlp	24280167	SENT174	0	0	7	7	metformin	AMPK	PA450395	5563	0.783
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT133	29	29	26	26	methotrexate	MSH2	PA450428	4436	0.783
NULL	Front_Genet_2012_Nov_5_3_236.nxml.txt.nlp	23133441	SENT116	4	4	36	36	efavirenz	ABCB1	PA449441	5243	0.783
NULL	Br_J_Cancer_2012_Feb_14_106(4)_719-726.nxml.txt.nlp	22240798	SENT175	19	19	17	17	trastuzumab	PTEN	PA451743	5728	0.783
NULL	Ann_Dermatol_2011_Nov_3_23(4)_529-535.nxml.txt.nlp	22148028	SENT29	13	13	7	7	vincristine	CHOP	PA451879	1649	0.783
NULL	Arthritis_Res_Ther_2011_Mar_16_13(2)_R44.nxml.txt.nlp	21410959	SENT149	2	2	13	13	glucosamine	IL-10	PA164747613	3586	0.783
NULL	Arch_Med_Sci_2011_Dec_31_7(6)_977-983.nxml.txt.nlp	22328880	SENT22	17	17	9	9	heparin	PAPP-A	PA449855	5069	0.783
NULL	J_Hepatol_2013_Aug_59(2)_318-326.nxml.txt.nlp	23624001	SENT155	9	9	18	18	oxaliplatin	JNK	PA131285527	5599	0.783
NULL	Clin_Psychopharmacol_Neurosci_2011_Apr_30_9(1)_36-43.nxml.txt.nlp	23431025	SENT125	10	10	15	15	aripiprazole	FLI	PA10026	2314	0.783
NULL	Pharmaceutics_2011_Oct_27_3(4)_782-792.nxml.txt.nlp	24309308	SENT92	20	20	3	3	calcein	P-gp	PA132595336	5243	0.783
NULL	Mol_Cell_2014_May_8_54(3)_445-459.nxml.txt.nlp	24746700	SENT49	11	11	2	2	etoposide	BCLAF1	PA449552	9774	0.783
NULL	Breast_Cancer_Res_2011_Jun_9_13(3)_R57.nxml.txt.nlp	21658222	SENT0	21	21	13	13	epirubicin	UGT2B7	PA449476	7364	0.783
NULL	Orphanet_J_Rare_Dis_2010_Jul_14_5_21.nxml.txt.nlp	20630065	SENT60	30	30	7	7	hydroquinone	GGCX	PA449924	2677	0.783
NULL	Acta_Pharmacol_Sin_2012_Jan_3_33(1)_49-56.nxml.txt.nlp	22212430	SENT17	0	0	15	15	thrombin	AP-1	PA451674	2353;3727;2354;3725	0.783
NULL	Front_Neurosci_2011_Dec_5_5_131.nxml.txt.nlp	22164129	SENT614	0	0	19	19	ethanol	StAR	PA448073	6770	0.783
NULL	AIDS_Res_Ther_2013_May_1_10_10.nxml.txt.nlp	23634877	SENT11	7	7	28	28	lovastatin	CXCR4	PA450272	7852	0.783
NULL	Oncotarget_2014_Feb_27_5(5)_1315-1325.nxml.txt.nlp	24675476	SENT15	18	18	3	3	choline	PEMT	PA448976	10400	0.783
NULL	Mol_Cells_2014_Sep_30_37(9)_664-671.nxml.txt.nlp	25234467	SENT209	4	4	10	10	cisplatin	miR-217	PA449014	406999	0.783
NULL	Br_J_Cancer_2011_Aug_23_105(5)_658-665.nxml.txt.nlp	21829201	SENT56	33	33	39	39	docetaxel	DCX	PA449383	1641	0.783
NULL	Exp_Cell_Res_2011_Apr_15_317(7)_1028-1039.nxml.txt.nlp	21237154	SENT255	14	14	6	6	staurosporine	JNK	PA165109623	5599	0.783
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT1706	5	5	23	23	fosamprenavir	ATV	PA10084	4683	0.783
NULL	Clinics_(Sao_Paulo)_2010_Dec_65(12)_1357-1361.nxml.txt.nlp	21340227	SENT65	13	13	43	43	phenol	mol	PA450913	90527	0.783
NULL	Breast_Cancer_Res_2005_Jul_20_7(5)_205-211.nxml.txt.nlp	16168139	SENT103	18	18	8	8	tamoxifen	HER2	PA451581	2064	0.783
NULL	J_Oncol_2010_Jan_3_2010_709678.nxml.txt.nlp	21274259	SENT48	31	31	16	16	gefitinib	EGFR	PA131301952	1956	0.783
NULL	Int_J_Vasc_Med_2012_Feb_14_2012_569654.nxml.txt.nlp	22489274	SENT174	14	14	3	3	vardenafil	PKG	PA10229	5592	0.783
NULL	Breast_Cancer_Res_2014_Jul_24_16(4)_411.nxml.txt.nlp	25056669	SENT30	12	12	26	26	tamoxifen	CD49b	PA451581	3673	0.783
NULL	Oncol_Lett_2013_Dec_4_6(6)_1665-1672.nxml.txt.nlp	24273604	SENT93	7	7	12	12	chloroquine	TLR9	PA448948	54106	0.783
NULL	Pediatr_Nephrol_2009_Jul_20_24(7)_1355-1361.nxml.txt.nlp	19301038	SENT176	14	14	7	7	cinacalcet	PTH	PA164776671	5741	0.783
NULL	Front_Psychiatry_2014_Mar_6_5_20.nxml.txt.nlp	24639656	SENT502	19	19	1	1	methylphenidate	Gen	PA450464	348654	0.783
NULL	Trials_2014_Sep_10_15(1)_356.nxml.txt.nlp	NULL	SENT869	7	7	10	10	venlafaxine	Gen	PA451866	348654	0.783
NULL	Br_J_Cancer_2006_Feb_13_94(3)_363-371.nxml.txt.nlp	16465172	SENT8	18	18	33	33	cetuximab	NACT	PA10040	284111	0.783
NULL	FASEB_J_2013_Jul_27(7)_2880-2892.nxml.txt.nlp	23543682	SENT40	33	33	43	43	gentamicin	CO2	PA449753	4513	0.783
NULL	Evid_Based_Complement_Alternat_Med_2015_Jan_6_2015_736431.nxml.txt.nlp	25632290	SENT456	14	14	7	7	celiprolol	CYP3A		1574	0.783
NULL	Crit_Care_2011_Mar_11_15(Suppl_1)_P366.nxml.txt.nlp	NULL	SENT9	5	5	8	8	atropine	NAC	PA448505	22861	0.783
NULL	Neural_Regen_Res_2013_Sep_5_8(25)_2379-2388.nxml.txt.nlp	25206548	SENT122	2	2	10	10	metformin	NPY	PA450395	4852	0.783
NULL	Cancer_Cell_Int_2006_Aug_9_6_20.nxml.txt.nlp	16899133	SENT99	40	40	23	23	tamoxifen	p27	PA451581	5715;10534	0.783
NULL	Br_J_Cancer_1998_Nov_78(9)_1170-1174.nxml.txt.nlp	9820175	SENT13	40	40	9	9	bufuralol	CYP3A4	PA166110256	1576	0.783
NULL	J_Biomed_Sci_2012_May_31_19(1)_56.nxml.txt.nlp	22651102	SENT68	34	34	17	17	paraformaldehyde	PD1	PA450790	9825;6622;5133	0.783
NULL	BMJ_2011_Aug_4_343_d4588.nxml.txt.nlp	21816733	SENT452	16	16	5	5	clopidogrel	CYP2C19	PA449053	1557	0.783
NULL	Breast_Cancer_Res_2011_Jun_21_13(3)_R66.nxml.txt.nlp	21693010	SENT149	32	32	20	20	sunitinib	VEGF-D	PA162372840	2277	0.783
NULL	Oncotarget_2013_Dec_21_5(9)_2404-2417.nxml.txt.nlp	24811221	SENT150	6	6	13	13	bleomycin	FIR	PA448645	22827;9855	0.783
NULL	Biomed_Res_Int_2014_Jan_29_2014_831845.nxml.txt.nlp	24605337	SENT110	17	17	23	23	bupivacaine	S6K1	PA135057240	6198	0.783
NULL	Nat_Commun_2013_Apr_9_4_1667.nxml.txt.nlp	23575671	SENT138	10	10	0	0	fluorescein	S15	PA164746009	6209	0.783
NULL	Brain_Behav_2013_Mar_6_3(2)_114-133.nxml.txt.nlp	23533150	SENT244	24	24	6	6	ethanol	HSF1	PA448073	3297	0.783
NULL	Brain_Res_2012_Feb_3_1436(C)_111-121.nxml.txt.nlp	22200378	SENT127	22	22	32	32	indomethacin	OAT	PA449982	4942	0.783
NULL	Breast_Cancer_Res_2011_Apr_15_13(2)_R44.nxml.txt.nlp	21496232	SENT334	1	1	6	6	lapatinib	HER2	PA152241907	2064	0.783
NULL	Int_J_Mol_Sci_2012_Aug_21_13(8)_10424-10431.nxml.txt.nlp	22949871	SENT58	23	23	4	4	doxorubicin	MCH	PA449412	5367	0.783
NULL	Alzheimers_Res_Ther_2012_Nov_26_4(6)_50.nxml.txt.nlp	23181523	SENT253	5	5	7	7	quetiapine	5-HT2A	PA451201	3356	0.783
NULL	EMBO_J_2009_May_6_28(9)_1197-1207.nxml.txt.nlp	19322195	SENT181	21	21	8	8	dextran	EGF	PA449261	1950	0.783
NULL	Mol_Pain_2013_Jun_10_9_27.nxml.txt.nlp	23758830	SENT178	13	13	31	31	tetracaine	ASIC2a	PA451638	40	0.783
NULL	Inflamm_Bowel_Dis_2014_Nov_2_20(11)_2029-2037.nxml.txt.nlp	25185684	SENT43	31	31	14	14	infliximab	CDAI	PA452639	146059	0.783
NULL	Cancer_Cell_Int_2013_Jun_26_13_63.nxml.txt.nlp	23800022	SENT114	0	0	12	12	genistein	MDM2	PA165109660	4193	0.783
NULL	Cancer_Med_2014_Aug_7_3(4)_796-811.nxml.txt.nlp	24802970	SENT302	3	3	9	9	amiloride	CD49f	PA448368	3655	0.783
NULL	Asian_J_Transfus_Sci_2010_Jul_4(2)_136-137.nxml.txt.nlp	20859519	SENT14	7	7	10	10	rituximab	DAT	PA451261	6531	0.783
NULL	Leukemia_2014_Apr_14_28(4)_961-964.nxml.txt.nlp	24418991	SENT70	2	2	10	10	nilotinib	P-gp	PA165958345	5243	0.783
NULL	Breast_Cancer_Res_Treat_2013_Jun_5_139(3)_649-655.nxml.txt.nlp	23736997	SENT11	6	6	3	3	tamoxifen	CYP2C19	PA451581	1557	0.783
NULL	J_Cell_Biol_2001_Jul_9_154(1)_95-108.nxml.txt.nlp	11448993	SENT157	20	20	1	1	trypsin	OTC	PA451806	5009	0.783
NULL	Ecancermedicalscience_2015_Jan_8_9_499.nxml.txt.nlp	25624880	SENT30	35	35	24	24	rofecoxib	gamma	PA451268	9913	0.783
NULL	Korean_Circ_J_2013_Jun_30_43(6)_384-390.nxml.txt.nlp	23882287	SENT105	21	21	27	27	dobutamine	CRT	PA449381	811	0.783
NULL	Br_J_Cancer_2003_Mar_10_88(5)_754-759.nxml.txt.nlp	12618886	SENT121	26	26	6	6	amifostine	p53	PA448365	7157	0.783
NULL	Eur_J_Contracept_Reprod_Health_Care_2011_Aug_20_16(4)_258-269.nxml.txt.nlp	21774563	SENT184	6	6	11	11	naproxen	MBL	PA450595	50639	0.783
NULL	Clinics_(Sao_Paulo)_2014_Jan_69(1)_68-74.nxml.txt.nlp	24473562	SENT102	6	6	30	30	nutlin-3	SOCS-1		8651	0.783
NULL	J_Cell_Biol_1998_Aug_10_142(3)_625-633.nxml.txt.nlp	9700154	SENT106	13	13	7	7	estradiol	Raf-1	PA449503	5894	0.783
NULL	J_Cardiothorac_Surg_2012_Jun_28_7_61.nxml.txt.nlp	22741616	SENT109	29	29	16	16	amiodarone	NAC	PA448383	22861	0.783
NULL	Br_J_Cancer_2013_Feb_19_108(3)_493-502.nxml.txt.nlp	23299530	SENT157	21	21	35	35	bevacizumab	VEGFR	PA130232992	3791	0.783
NULL	Anticancer_Agents_Med_Chem_2012_Feb_12(2)_163-171.nxml.txt.nlp	22043994	SENT242	15	15	4	4	cetuximab	PTEN	PA10040	5728	0.783
NULL	Infect_Dis_Obstet_Gynecol_2012_Nov_29_2012_543916.nxml.txt.nlp	23251074	SENT37	7	7	15	15	lamivudine	CD4	PA450163	920	0.783
NULL	Mol_Biol_Cell_2014_Mar_15_25(6)_828-840.nxml.txt.nlp	24478456	SENT61	12	12	6	6	staurosporine	LIMK1	PA165109623	3984	0.783
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Nov_13_64(Pt_12)_m1532.nxml.txt.nlp	21581147	SENT3	27	27	14	14	ethanol	NO3	PA448073	4681	0.783
NULL	Diabetes_2011_Nov_17_60(11)_2928-2938.nxml.txt.nlp	21885868	SENT311	12	12	9	9	curcumin	NF-kappaB	PA151958596	4790	0.783
NULL	Lab_Invest_2009_Nov_7_89(11)_1275-1290.nxml.txt.nlp	19736547	SENT307	17	17	23	23	curcumin	LOX-1	PA151958596	4973	0.783
NULL	Diabetes_Care_2009_Apr_32(4)_531-540.nxml.txt.nlp	19336638	SENT125	19	19	23	23	clopidogrel	P2Y12	PA449053	64805	0.783
NULL	Breast_Cancer_Res_2010_Mar_5_12(2)_R16.nxml.txt.nlp	20205716	SENT332	11	11	8	8	lovastatin	PTEN	PA450272	5728	0.783
NULL	J_Hematol_Oncol_2013_Jan_17_6_8.nxml.txt.nlp	23327547	SENT6	9	9	23	23	sulindac	JNK1	PA451565	5599	0.783
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT292	12	12	20	20	metformin	AMPK	PA450395	5563	0.783
NULL	Front_Chem_2014_Mar_14_2_12.nxml.txt.nlp	24790981	SENT134	6	6	12	12	curcumin	P19	PA151958596	51561	0.783
NULL	Curr_Hematol_Malig_Rep_2012_Sep_27_7(3)_235-240.nxml.txt.nlp	22538464	SENT33	26	26	12	12	carboplatin	CHOP	PA448803	1649	0.783
NULL	Mol_Cancer_2007_Dec_21_6_81.nxml.txt.nlp	18096084	SENT57	4	4	9	9	pp2	CD44		960	0.783
NULL	Scientifica_(Cairo)_2013_Apr_2_2013_415279.nxml.txt.nlp	24278778	SENT253	25	25	8	8	fentanyl	ABCB1	PA449599	5243	0.783
NULL	Br_J_Cancer_2010_Jan_5_102(1)_80-86.nxml.txt.nlp	19920817	SENT100	15	15	17	17	bevacizumab	IFN	PA130232992	3439	0.783
NULL	Arthritis_Res_Ther_2006_Apr_12_8(Suppl_1)_S3.nxml.txt.nlp	16820042	SENT147	27	27	11	11	colchicine	NALP3	PA449092	114548	0.783
NULL	Diabetes_Metab_Syndr_Obes_2009_Jul_31_2_135-144.nxml.txt.nlp	21437127	SENT31	9	9	14	14	exenatide	solo	PA164749238	55701	0.783
NULL	Clin_Ophthalmol_2008_Jun_2(2)_355-368.nxml.txt.nlp	19668727	SENT81	11	11	18	18	amfenac	COX	PA166049186	1351	0.783
NULL	Allergy_Asthma_Clin_Immunol_2013_Oct_3_9(1)_39.nxml.txt.nlp	24219860	SENT42	16	16	25	25	rituximab	BAFF	PA451261	10673	0.783
NULL	J_Cardiovasc_Magn_Reson_2008_Nov_3_10(1)_48.nxml.txt.nlp	18980685	SENT112	28	28	4	4	dobutamine	spatial	PA449381	219793	0.783
NULL	Br_J_Cancer_2012_May_22_106(11)_1779-1789.nxml.txt.nlp	22549178	SENT219	15	15	8	8	trastuzumab	HER3	PA451743	2065	0.783
NULL	J_Oncol_2009_Mar_10_2009_831626.nxml.txt.nlp	20300583	SENT96	38	38	17	17	cetuximab	BRAF	PA10040	673	0.783
NULL	Insect_Biochem_Mol_Biol_2014_Dec_55_19-25.nxml.txt.nlp	25460510	SENT18	13	13	3	3	picrotoxin	A20	PA164777007	7128;28935	0.783
NULL	Patient_Prefer_Adherence_2011_Dec_23_6_1-9.nxml.txt.nlp	22272064	SENT68	46	46	9	9	telmisartan	ACE	PA451605	1636	0.783
NULL	Genet_Vaccines_Ther_2011_Jun_23_9_11.nxml.txt.nlp	21699699	SENT2	14	14	10	10	ribavirin	IFN	PA451241	3439	0.783
NULL	Arthritis_Res_Ther_2005_Mar_1_7(3)_R545-R551.nxml.txt.nlp	15899041	SENT112	34	34	27	27	infliximab	ACL	PA452639	47	0.783
NULL	Neurosci_Lett_2010_Oct_29_484(2-2)_108-112.nxml.txt.nlp	20709148	SENT5	38	38	36	36	ondansetron	5-HT3R	PA450705	3359	0.783
NULL	Dement_Geriatr_Cogn_Dis_Extra_2014_Nov_15_4(3)_450-456.nxml.txt.nlp	25538729	SENT84	6	6	13	13	donepezil	CYP2D6	PA449394	1565	0.783
NULL	Br_J_Cancer_2012_Oct_9_107(8)_1233-1238.nxml.txt.nlp	22955852	SENT112	6	6	3	3	docetaxel	RPN2	PA449383	6185	0.783
NULL	Endocrinol_Metab_(Seoul)_2014_Sep_25_29(3)_379-387.nxml.txt.nlp	25309798	SENT119	8	8	21	21	resveratrol	CLOCK		9575	0.783
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1676-1682.nxml.txt.nlp	19844234	SENT147	0	0	10	10	lapatinib	IGF1R	PA152241907	3480	0.783
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT194	7	7	3	3	erlotinib	CYP3A	PA134687924	1574	0.783
NULL	Br_J_Cancer_2009_Jul_7_101(1)_71-79.nxml.txt.nlp	19491901	SENT273	16	16	8	8	clodronate	IGF1R	PA10239	3480	0.783
NULL	EMBO_Mol_Med_2011_Dec_3(12)_713-725.nxml.txt.nlp	22038924	SENT278	24	24	35	35	maraviroc	CXCR4	PA164768835	7852	0.783
NULL	Nat_Biotechnol_2010_Jul_20_28(7)_727-732.nxml.txt.nlp	20562863	SENT23	20	20	2	2	indomethacin	ADP	PA449982	23038	0.783
NULL	Exp_Ther_Med_2013_May_15_5(5)_1293-1300.nxml.txt.nlp	23737867	SENT118	6	6	18	18	finasteride	Bcl-2	PA449627	596	0.783
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT1245	2	2	16	16	tenofovir	ABCC2	PA10204	1244	0.783
NULL	Br_J_Cancer_2010_Jul_13_103(2)_201-208.nxml.txt.nlp	20588272	SENT106	6	6	15	15	isoflurane	FDG	PA450106	23583	0.783
NULL	Clin_Psychopharmacol_Neurosci_2011_Apr_30_9(1)_36-43.nxml.txt.nlp	23431025	SENT36	34	34	15	15	aripiprazole	FLI	PA10026	2314	0.783
NULL	Oncotarget_2011_Sep_5_2(8)_646-653.nxml.txt.nlp	21896960	SENT108	33	33	27	27	carboplatin	TRAIL	PA448803	8743	0.783
NULL	Biomed_Res_Int_2014_Jun_26_2014_161346.nxml.txt.nlp	25054130	SENT228	41	41	30	30	curcumin	STZ	PA151958596	6484	0.783
NULL	Diagn_Pathol_2014_Jan_23_9_22.nxml.txt.nlp	24456584	SENT57	23	23	9	9	doxorubicin	ADM	PA449412	133	0.783
NULL	Front_Oncol_2014_Sep_15_4_248.nxml.txt.nlp	25309873	SENT211	17	17	25	25	erlotinib	EGFR	PA134687924	1956	0.783
NULL	EMBO_Mol_Med_2013_Dec_8_5(12)_1821-1834.nxml.txt.nlp	24293316	SENT164	6	6	9	9	doxorubicin	p53	PA449412	7157	0.783
NULL	Cancer_Cell_Int_2013_Oct_22_13_103.nxml.txt.nlp	24148306	SENT137	10	10	2	2	etoposide	PRL	PA449552	5617	0.783
NULL	Br_J_Cancer_2010_Jan_5_102(1)_134-143.nxml.txt.nlp	19920829	SENT182	2	2	27	27	pertuzumab	IL-2		3558	0.783
NULL	Breast_Cancer_(Auckl)_2012_Nov_19_6_191-207.nxml.txt.nlp	23226023	SENT192	10	10	12	12	trastuzumab	HER2	PA451743	2064	0.783
NULL	Arthritis_Res_Ther_2010_Jan_22_12(1)_R11.nxml.txt.nlp	20096109	SENT217	23	23	10	10	infliximab	IFN	PA452639	3439	0.783
NULL	Bioinformation_2012_Jan_6_8(1)_13-19.nxml.txt.nlp	22359429	SENT100	0	0	7	7	curcumin	MRP1	PA151958596	4437	0.783
NULL	J_Oncol_2009_Mar_24_2009_491985.nxml.txt.nlp	19325924	SENT98	29	29	1	1	genistein	CXCR4	PA165109660	7852	0.783
NULL	J_Occup_Med_Toxicol_2008_Feb_27_3(Suppl_1)_S6.nxml.txt.nlp	18315837	SENT71	7	7	22	22	salmeterol	IL-5	PA451300	3567	0.783
NULL	Eur_J_Haematol_2014_Feb_25_92(2)_127-136.nxml.txt.nlp	24118452	SENT89	20	20	16	16	anagrelide	CRT	PA164742986	811	0.783
NULL	Biomed_Res_Int_2013_Jan_31_2013_503047.nxml.txt.nlp	23484127	SENT103	12	12	46	46	imatinib	PDGFRB	PA10804	5159	0.783
NULL	Arch_Med_Sci_2011_Dec_31_7(6)_977-983.nxml.txt.nlp	22328880	SENT128	42	42	32	32	heparin	PAPP-A	PA449855	5069	0.783
NULL	Clin_Med_Pathol_2008_Mar_1_1_17-34.nxml.txt.nlp	21876648	SENT147	3	3	9	9	estradiol	c-fos	PA449503	2353	0.783
NULL	Cell_Death_Dis_2014_Jul_3_5(7)_e1316.nxml.txt.nlp	24991768	SENT12	4	4	14	14	pemetrexed	ATF4	PA10810	468	0.783
NULL	Int_J_Mol_Sci_2014_Sep_2_15(9)_15512-15529.nxml.txt.nlp	25184950	SENT81	15	15	6	6	resveratrol	IL-10		3586	0.783
NULL	Semin_Immunopathol_2012_Jan_4_34(1)_93-106.nxml.txt.nlp	21845431	SENT158	28	28	13	13	thrombin	PAR-1	PA451674	2011;2149	0.783
NULL	Anesthesiol_Res_Pract_2013_Sep_23_2013_297141.nxml.txt.nlp	24174934	SENT179	8	8	20	20	bupivacaine	mol	PA135057240	90527	0.783
NULL	Oncol_Lett_2014_Mar_11_7(3)_685-692.nxml.txt.nlp	24527073	SENT36	35	35	37	37	cisplatin	DDP	PA449014	1678	0.783
NULL	Mol_Biol_Rep_2012_May_20_39(5)_5253-5267.nxml.txt.nlp	22183301	SENT302	5	5	10	10	gliclazide	LOX-1	PA10892	4973	0.783
NULL	Front_Oncol_2014_Mar_3_4_35.nxml.txt.nlp	24624362	SENT124	18	18	7	7	cetuximab	BRAF	PA10040	673	0.783
NULL	Breast_Cancer_Res_2008_Mar_27_10(2)_R27.nxml.txt.nlp	18371219	SENT41	40	40	30	30	cyclophosphamide	TFEC	PA449165	22797	0.783
NULL	Breast_Cancer_Res_2011_Nov_17_13(6)_R114.nxml.txt.nlp	22087758	SENT131	29	29	18	18	tamoxifen	TMEM135	PA451581	65084	0.783
NULL	Diabetes_Metab_Syndr_Obes_2010_Sep_22_3_325-335.nxml.txt.nlp	21437102	SENT137	28	28	13	13	saxagliptin	GLP-1	PA165958362	100125288	0.783
NULL	Amino_Acids_2012_Oct_10_43(4)_1751-1759.nxml.txt.nlp	22407485	SENT33	40	40	6	6	carrageenan	ghrelin	PA448814	51738	0.783
NULL	Mol_Med_Rep_2015_Jan_16_11(1)_91-98.nxml.txt.nlp	25322694	SENT128	15	15	24	24	cisplatin	LC3	PA449014	84557	0.783
NULL	Ann_Oncol_2011_Mar_8_22(3)_503-514.nxml.txt.nlp	20616198	SENT174	15	15	12	12	tamoxifen	aromatase	PA451581	1588	0.783
NULL	Cancer_Med_2014_Jun_19_3(3)_555-564.nxml.txt.nlp	24648042	SENT188	32	32	6	6	cytarabine	NOTCH1	PA449177	4851	0.783
NULL	Arch_Med_Sci_2013_Apr_20_9(2)_361-367.nxml.txt.nlp	23671450	SENT162	7	7	12	12	budesonide	HIF-1	PA448681	29072	0.783
NULL	Vet_Res_Forum_2013_Winter_4(1)_19-24.nxml.txt.nlp	25593681	SENT104	9	9	4	4	diclofenac	B12	PA449293	7126;4709	0.783
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT166	42	42	21	21	trastuzumab	STAT3	PA451743	6774	0.783
NULL	Curr_Neuropharmacol_2008_Jun_6(2)_151-163.nxml.txt.nlp	19305794	SENT372	15	15	18	18	capsaicin	VR1	PA448776	56664	0.783
NULL	Br_J_Cancer_2012_Dec_4_107(12)_1950-1955.nxml.txt.nlp	23169295	SENT118	19	19	7	7	oxaliplatin	DPD	PA131285527	1806	0.783
NULL	Aging_(Albany_NY)_2009_Dec_31_1(12)_988-1007.nxml.txt.nlp	20157582	SENT101	6	6	10	10	nilutamide	CTX	PA450632	1593	0.783
NULL	Cell_Death_Dis_2014_Jan_30_5(1)_e1030.nxml.txt.nlp	24481444	SENT124	13	13	9	9	sorafenib	Mcl-1	PA7000	4170	0.783
NULL	Ann_Rheum_Dis_2008_Oct_25_68(10)_1644-1650.nxml.txt.nlp	18957484	SENT89	4	4	22	22	leflunomide	IL-15	PA450192	3600	0.783
NULL	Front_Neurosci_2014_Dec_5_8_398.nxml.txt.nlp	25538552	SENT199	16	16	13	13	glucose	gamma	PA449773	9913	0.783
NULL	Indian_J_Endocrinol_Metab_2013_May-Jun_17(3)_472-479.nxml.txt.nlp	23869305	SENT6	2	2	9	9	ezetimibe	ATV	PA10816	4683	0.783
NULL	Br_J_Pharmacol_2011_Aug_163(8)_1626-1638.nxml.txt.nlp	21410464	SENT46	13	13	21	21	rolipram	CA3	PA153906323	761	0.783
NULL	Cell_Microbiol_2013_Aug_14_15(8)_1385-1400.nxml.txt.nlp	23421931	SENT175	6	6	23	23	paraformaldehyde	IL-6	PA450790	3569	0.783
NULL	Blood_Res_2014_Mar_24_49(1)_36-41.nxml.txt.nlp	24724065	SENT107	39	39	46	46	vincristine	CHOP	PA451879	1649	0.783
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1063.nxml.txt.nlp	24556678	SENT33	3	3	5	5	thioridazine	TRAIL	PA451666	8743	0.783
NULL	Mol_Microbiol_2014_Mar_23_91(5)_918-934.nxml.txt.nlp	24372851	SENT58	11	11	34	34	amodiaquine	LUM	PA448404	4060	0.783
NULL	Nucl_Recept_Signal_2009_Dec_31_7_e012.nxml.txt.nlp	20087433	SENT194	7	7	18	18	ns-398	EDN2		1907	0.783
NULL	Environ_Health_Perspect_2007_Dec_8_115(Suppl_1)_69-76.nxml.txt.nlp	18174953	SENT46	8	8	13	13	estradiol	aromatase	PA449503	1588	0.783
NULL	Oncotarget_2012_Oct_20_3(10)_1236-1245.nxml.txt.nlp	23100449	SENT53	33	33	11	11	doxorubicin	NGAL	PA449412	3934	0.783
NULL	Cancers_(Basel)_2011_Aug_10_3(3)_3242-3278.nxml.txt.nlp	24212955	SENT443	9	9	19	19	bevacizumab	VEGF-A	PA130232992	7422	0.783
NULL	J_Korean_Med_Sci_2011_Dec_29_26(12)_1556-1562.nxml.txt.nlp	22147991	SENT32	25	25	32	32	daunorubicin	CHOP	PA449212	1649	0.783
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1063.nxml.txt.nlp	24556678	SENT31	13	13	15	15	thioridazine	TRAIL	PA451666	8743	0.783
NULL	Gene_Regul_Syst_Bio_2014_Mar_4_8_63-73.nxml.txt.nlp	24634581	SENT247	0	0	17	17	minocycline	NANOS1	PA450519	340719	0.783
NULL	Oncologist_2013_Oct_18(Suppl_1)_S1-S7.nxml.txt.nlp	24157419	SENT3	17	17	7	7	erlotinib	EGFR	PA134687924	1956	0.783
NULL	Oncotarget_2013_Nov_15_5(6)_1458-1474.nxml.txt.nlp	24681547	SENT114	3	3	13	13	celecoxib	CDH11	PA448871	1009	0.783
NULL	Hum_Mol_Genet_2014_Apr_15_23(8)_2055-2077.nxml.txt.nlp	24282027	SENT252	15	15	18	18	galactose	LRRK2	PA449725	120892	0.783
NULL	Biochemistry_2013_Oct_15_52(41)_7167-7169.nxml.txt.nlp	24083983	SENT28	10	10	27	27	cyclosporine	P-gp	PA449167	5243	0.783
NULL	J_Cell_Mol_Med_2013_Sep_11_17(9)_1160-1172.nxml.txt.nlp	23844832	SENT171	14	14	12	12	gefitinib	EGF	PA131301952	1950	0.783
NULL	Pharmaceuticals_(Basel)_2013_Apr_29_6(5)_650-658.nxml.txt.nlp	24276172	SENT473	24	24	11	11	methotrexate	P2X7	PA450428	5027	0.783
NULL	Drugs_Context_2012_Nov_19_2012_212242.nxml.txt.nlp	24432031	SENT232	30	30	35	35	bevacizumab	IFN	PA130232992	3439	0.783
NULL	Int_Arch_Med_2010_Nov_24_3_34.nxml.txt.nlp	21092333	SENT121	4	4	10	10	metformin	B12	PA450395	7126;4709	0.783
NULL	Biochemistry_2011_Feb_8_50(5)_715-726.nxml.txt.nlp	21182262	SENT289	6	6	22	22	glutaraldehyde	Cby	PA449777	25776	0.783
NULL	Acta_Pharmacol_Sin_2009_Aug_13_30(8)_1099-1106.nxml.txt.nlp	19597524	SENT4	32	32	18	18	isoproterenol	ERG	PA450121	2078	0.783
NULL	Nat_Commun_2013_Apr_9_4_1684.nxml.txt.nlp	23575688	SENT57	14	14	30	30	rolipram	IL-8	PA153906323	3576	0.783
NULL	Ther_Clin_Risk_Manag_2007_Dec_3(6)_1097-1104.nxml.txt.nlp	18516268	SENT175	19	19	7	7	tenofovir	CD4	PA10204	920	0.783
NULL	Br_J_Cancer_1999_Nov_81(6)_942-951.nxml.txt.nlp	10576649	SENT9	25	25	13	13	vinblastine	P-gp	PA451877	5243	0.783
NULL	Exp_Ther_Med_2013_Mar_21_5(3)_987-991.nxml.txt.nlp	23407636	SENT99	17	17	1	1	losartan	IL-8	PA450268	3576	0.783
NULL	Exp_Hematol_Oncol_2013_Oct_4_2_26.nxml.txt.nlp	24219920	SENT250	3	3	9	9	reserpine	ABCB1	PA451236	5243	0.783
NULL	Genome_Biol_2011_May_25_12(5)_R46.nxml.txt.nlp	21609475	SENT138	6	6	3	3	etoposide	CCND1	PA449552	595	0.783
NULL	Int_J_Mol_Imaging_2011_Oct_26_2011_874585.nxml.txt.nlp	21490735	SENT184	32	32	44	44	docetaxel	FDG	PA449383	23583	0.783
NULL	Front_Neural_Circuits_2014_Jun_11_8_58.nxml.txt.nlp	24966814	SENT735	17	17	2	2	scopolamine	5-HT1A	PA451308	3350	0.783
NULL	Int_J_Mol_Sci_2014_Nov_7_15(11)_20500-20517.nxml.txt.nlp	25387078	SENT123	5	5	19	19	sorafenib	Mcl-1	PA7000	4170	0.783
NULL	Cell_Res_2014_Jul_9_24(7)_820-841.nxml.txt.nlp	24810299	SENT293	23	23	14	14	doxycycline	RBP-J	PA449415	3516	0.783
NULL	Diabetes_Metab_Syndr_Obes_2010_Dec_6_3_421-429.nxml.txt.nlp	21437112	SENT115	10	10	20	20	curcumin	p65	PA151958596	5970	0.783
NULL	FASEB_J_2011_Sep_25(9)_3208-3218.nxml.txt.nlp	21593432	SENT440	13	13	7	7	acitretin	ADAM10	PA448039	102	0.783
NULL	Pharmaceuticals_(Basel)_2011_Jun_14_4(6)_804-821.nxml.txt.nlp	23997653	SENT164	29	29	11	11	ethanol	OX2R	PA448073	3062;131450	0.783
NULL	Diabetes_Metab_J_2013_Oct_17_37(5)_315-325.nxml.txt.nlp	24199159	SENT193	1	1	6	6	resveratrol	SIRT1		23411	0.783
NULL	Oncol_Lett_2014_Mar_2_7(3)_791-796.nxml.txt.nlp	24527087	SENT174	2	2	10	10	imatinib	CD34	PA10804	947	0.783
NULL	Exp_Brain_Res_2010_Jan_19_200(2)_125-140.nxml.txt.nlp	19690847	SENT236	9	9	28	28	tetracaine	CA3	PA451638	761	0.783
NULL	Genome_Biol_2007_Sep_24_8(9)_R200.nxml.txt.nlp	17892536	SENT377	29	29	18	18	rosuvastatin	APOE	PA134308647	348	0.783
NULL	Oncogene_2014_Feb_6_33(6)_734-744.nxml.txt.nlp	23376847	SENT115	0	0	15	15	tetracycline	p53	PA451640	7157	0.783
NULL	Diabetes_2009_Jul_28_58(7)_1659-1667.nxml.txt.nlp	19401417	SENT195	9	9	6	6	aspirin	ARI	PA448497	25820	0.783
NULL	Biomed_Res_Int_2014_Jun_26_2014_161346.nxml.txt.nlp	25054130	SENT225	41	41	30	30	curcumin	STZ	PA151958596	6484	0.783
NULL	Arthritis_Res_Ther_2009_Aug_24_11(4)_R127.nxml.txt.nlp	19703304	SENT182	13	13	16	16	adalimumab	OASIS	PA10004	90993	0.783
NULL	Onco_Targets_Ther_2014_Jun_11_7_969-983.nxml.txt.nlp	24959084	SENT115	27	27	20	20	carbamazepine	CYP3A4	PA448785	1576	0.783
NULL	Int_J_Biol_Sci_2013_Mar_7_9(3)_279-288.nxml.txt.nlp	23493630	SENT161	3	3	11	11	tocilizumab	IL-6	PA165292659	3569	0.783
NULL	Gut_Liver_2014_Sep_18_8(5)_471-479.nxml.txt.nlp	25228970	SENT17	26	26	23	23	telaprevir	BOC	PA165958354	91653	0.783
NULL	Oncoimmunology_2013_Jul_1_2(7)_e24964.nxml.txt.nlp	24073376	SENT26	32	32	17	17	bortezomib	IFN	PA10252	3439	0.783
NULL	BMJ_2011_Aug_4_343_d4588.nxml.txt.nlp	21816733	SENT313	12	12	6	6	clopidogrel	CYP2C19	PA449053	1557	0.783
NULL	Clin_Exp_Reprod_Med_2011_Jun_30_38(2)_98-102.nxml.txt.nlp	22384426	SENT117	8	8	16	16	pioglitazone	IL-6	PA450970	3569	0.783
NULL	Diabetes_Obes_Metab_2011_Nov_13(11)_982-989.nxml.txt.nlp	21615670	SENT175	28	28	32	32	exenatide	PPG	PA164749238	5552	0.783
NULL	Diagn_Pathol_2013_May_15_8_81.nxml.txt.nlp	23675804	SENT21	26	26	19	19	doxorubicin	CD5	PA449412	921	0.783
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT52	14	14	3	3	nutlin-3	p53		7157	0.783
NULL	Indian_Dermatol_Online_J_2014_Jul-Sep_5(3)_250-259.nxml.txt.nlp	25165639	SENT319	23	23	35	35	rituximab	CHOP	PA451261	1649	0.783
NULL	Acta_Naturae_2011_Oct-Dec_3(4)_55-65.nxml.txt.nlp	22649704	SENT97	3	3	19	19	nevirapine	gp160	PA450616	2028	0.783
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT102	4	4	15	15	cisplatin	MDM2	PA449014	4193	0.783
NULL	J_Headache_Pain_2010_Feb_10_11(1)_5-12.nxml.txt.nlp	20012125	SENT204	11	11	13	13	dihydroergotamine	c-fos	PA164743028	2353	0.783
NULL	Arthritis_Res_Ther_2013_Mar_20_15(2)_R44.nxml.txt.nlp	23514433	SENT9	21	21	27	27	methotrexate	MRI	PA450428	78996	0.783
NULL	Anal_Bioanal_Chem_2011_Mar_29_399(9)_3157-3176.nxml.txt.nlp	21046088	SENT399	16	16	29	29	tobramycin	mol	PA451704	90527	0.783
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1063.nxml.txt.nlp	24556678	SENT41	2	2	7	7	thioridazine	c-FLIP	PA451666	8837	0.783
NULL	BMB_Rep_2013_Jan_46(1)_59-64.nxml.txt.nlp	23351386	SENT5	33	33	15	15	auranofin	NAC	PA448510	22861	0.783
NULL	Cancer_Res_Treat_2014_Jan_15_46(1)_55-64.nxml.txt.nlp	24520224	SENT167	6	6	16	16	irinotecan	ERCC1	PA450085	2067	0.783
NULL	Evid_Based_Complement_Alternat_Med_2013_May_28_2013_629750.nxml.txt.nlp	23781265	SENT153	18	18	12	12	capsaicin	GADD153	PA448776	1649	0.783
NULL	Cell_J_2012_Dec_22_Winter_13(4)_281-289.nxml.txt.nlp	23507624	SENT171	20	20	7	7	isoproterenol	IL-4	PA450121	3565	0.783
NULL	J_Thromb_Haemost_2011_Oct_9(10)_2103-2105.nxml.txt.nlp	21812912	SENT32	0	0	6	6	ticagrelor	ADP	PA165374673	23038	0.783
NULL	Cell_Death_Dis_2013_Jul_4_4(7)_e702.nxml.txt.nlp	23828565	SENT67	25	25	4	4	etoposide	XIAP	PA449552	331	0.783
NULL	BMB_Rep_2014_Apr_47(4)_221-226.nxml.txt.nlp	24286312	SENT121	29	29	11	11	nutlin-3	p53		7157	0.783
NULL	Oxid_Med_Cell_Longev_2011_Aug_4_2011_471590.nxml.txt.nlp	21904644	SENT65	28	28	11	11	probucol	CA1	PA451107	759	0.783
NULL	Diabetes_2013_Jun_17_62(6)_2141-2150.nxml.txt.nlp	23378610	SENT9	23	23	27	27	betaine	SLC6A12	PA448603	6539	0.783
NULL	Cancer_Cell_Int_2005_Jul_24_5_22.nxml.txt.nlp	16042792	SENT105	23	23	21	21	vincristine	MRP1	PA451879	4437	0.783
NULL	Hematol_Rep_2011_Aug_1_3(2)_e9.nxml.txt.nlp	22184541	SENT46	21	21	10	10	etoposide	SMILE	PA449552	160418	0.783
NULL	Clin_Ophthalmol_2008_Mar_2(1)_139-145.nxml.txt.nlp	19668397	SENT35	12	12	6	6	vancomycin	IVD	PA451850	3712	0.783
NULL	Diabetes_Obes_Metab_2011_Nov_13(11)_982-989.nxml.txt.nlp	21615670	SENT176	26	26	29	29	exenatide	PPG	PA164749238	5552	0.783
NULL	Nat_Genet_2011_Feb_26_43(2)_117-120.nxml.txt.nlp	21186350	SENT78	10	10	7	7	metformin	AMPK	PA450395	5563	0.783
NULL	Ann_Rheum_Dis_2008_May_21_68(2)_175-182.nxml.txt.nlp	18495735	SENT13	27	27	3	3	infliximab	IL-6	PA452639	3569	0.783
NULL	Mol_Cancer_2010_May_20_9_115.nxml.txt.nlp	20487546	SENT121	9	9	29	29	fludarabine	p53	PA449655	7157	0.783
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Mar_6_69(Pt_4)_o485-o486.nxml.txt.nlp	23634038	SENT84	0	0	6	6	cinnarizine	mol	PA164749342	90527	0.783
NULL	EPMA_J_2011_Dec_22_3(1)_1.nxml.txt.nlp	22738081	SENT194	28	28	19	19	sunitinib	NGAL	PA162372840	3934	0.783
NULL	Nat_Commun_2014_5_3071.nxml.txt.nlp	24468981	SENT114	29	29	25	25	lipase	PPARA	PA450239	5465	0.783
NULL	J_Thromb_Haemost_2014_May_22_12(5)_748-760.nxml.txt.nlp	24612393	SENT199	7	7	20	20	thrombin	P2Y12	PA451674	64805	0.783
NULL	Front_Neurosci_2014_Jun_24_8_176.nxml.txt.nlp	25009459	SENT1033	13	13	15	15	ethanol	P2X4	PA448073	5025	0.783
NULL	Cardiovasc_Res_2014_Mar_1_101(3)_513-521.nxml.txt.nlp	24323316	SENT13	15	15	11	11	maraviroc	CCR5	PA164768835	1234	0.783
NULL	Br_J_Cancer_2009_Mar_10_100(5)_758-763.nxml.txt.nlp	19259094	SENT68	8	8	2	2	decitabine	MLH1	PA164749631	4292	0.783
NULL	J_Biol_Chem_2009_Jan_2_284(1)_77-84.nxml.txt.nlp	18854318	SENT166	35	35	24	24	forskolin	STRAD	PA146096022	92335	0.783
NULL	Antimicrob_Agents_Chemother_2014_Nov_10_59(1)_490-497.nxml.txt.nlp	25385107	SENT206	12	12	23	23	primaquine	ACT	PA451103	12;11332;9457;641455	0.783
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_4_2013_378657.nxml.txt.nlp	23662132	SENT495	27	27	34	34	saxagliptin	GLP-1	PA165958362	100125288	0.783
NULL	Br_J_Cancer_2006_Dec_4_95(11)_1483-1489.nxml.txt.nlp	17106442	SENT145	6	6	19	19	gefitinib	MST	PA131301952	55154;4357;4294	0.783
NULL	J_Hematol_Oncol_2013_Jul_18_6_53.nxml.txt.nlp	23866964	SENT7	4	4	26	26	temsirolimus	MYC	PA164746890	4609	0.783
NULL	Int_J_Biomed_Sci_2013_Sep_9(3)_112-122.nxml.txt.nlp	24170986	SENT112	2	2	16	16	benazepril	p65	PA448561	5970	0.783
NULL	Front_Oncol_2014_Sep_23_4_252.nxml.txt.nlp	25295225	SENT297	27	27	7	7	trastuzumab	PTEN	PA451743	5728	0.783
NULL	Int_J_Mol_Sci_2014_Oct_6_15(10)_17886-17900.nxml.txt.nlp	25290095	SENT109	27	27	33	33	resveratrol	p38		10598;1432;7965	0.783
NULL	Diabetes_Care_2012_Feb_16_35(2)_327-333.nxml.txt.nlp	22179958	SENT175	17	17	11	11	metformin	B12	PA450395	7126;4709	0.783
NULL	Front_Behav_Neurosci_2011_Sep_13_5_57.nxml.txt.nlp	21949506	SENT244	11	11	18	18	rimonabant	CB1	PA152407999	1268	0.783
NULL	Adv_Virol_2011_Mar_24_2011_260561.nxml.txt.nlp	22312337	SENT29	19	19	13	13	basiliximab	IL-2	PA164747126	3558	0.783
NULL	Cell_Death_Dis_2014_Apr_24_5(4)_e1197.nxml.txt.nlp	24763054	SENT63	15	15	11	11	cisplatin	ARC	PA449014	8996;23237	0.783
NULL	Br_J_Cancer_2013_Jul_23_109(2)_351-359.nxml.txt.nlp	23799854	SENT131	9	9	6	6	paclitaxel	BLT2	PA450761	56413	0.783
NULL	Oncogene_2010_May_6_29(18)_2628-2637.nxml.txt.nlp	20190820	SENT40	4	4	13	13	nutlin-3	San		80218	0.783
NULL	Breast_Cancer_Res_2007_Aug_8_9(4)_R50.nxml.txt.nlp	17686159	SENT246	19	19	28	28	gefitinib	HRG	PA131301952	3084;3273	0.783
NULL	Acta_Vet_Scand_2011_Feb_22_53(1)_12.nxml.txt.nlp	21342526	SENT273	20	20	24	24	flutamide	PD2	PA449685	54623	0.783
NULL	EJC_Suppl_2013_Sep_5_11(2)_3-22.nxml.txt.nlp	NULL	SENT1178	32	32	29	29	tamoxifen	p53	PA451581	7157	0.783
NULL	Cancer_Metastasis_Rev_2010_Dec_10_29(4)_581-594.nxml.txt.nlp	20830503	SENT298	37	37	31	31	tamoxifen	ATAC	PA451581	6375	0.783
NULL	Anal_Bioanal_Chem_2013_Jul_23_405(23)_7337-7345.nxml.txt.nlp	23877175	SENT124	20	20	31	31	creatine	CA3	PA164778930	761	0.783
NULL	Drugs_Context_2012_Nov_19_2012_212242.nxml.txt.nlp	24432031	SENT128	2	2	20	20	carmustine	IFN	PA448810	3439	0.783
NULL	J_Hematol_Oncol_2009_Feb_23_2_9.nxml.txt.nlp	19236713	SENT48	13	13	4	4	cetuximab	KRAS	PA10040	3845	0.783
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Sep_30_66(Pt_10)_o2661.nxml.txt.nlp	21587632	SENT3	21	21	1	1	benzaldehyde	mol	PA448571	90527	0.783
NULL	J_Biomed_Biotechnol_2003_Mar_19_2003(1)_35-47.nxml.txt.nlp	12686721	SENT188	14	14	24	24	thyroglobulin	FGFR4	PA164754910	2264	0.783
NULL	Acta_Pharmacol_Sin_2013_Jun_8_34(6)_830-836.nxml.txt.nlp	23564080	SENT133	7	7	14	14	simvastatin	HMGB1	PA451363	3146	0.783
NULL	Cancer_Med_2013_Feb_3_2(1)_86-98.nxml.txt.nlp	24133631	SENT174	17	17	13	13	cisplatin	HAI	PA449014	6692;6768	0.783
NULL	Cancer_Cell_Int_2013_Mar_4_13_21.nxml.txt.nlp	23497288	SENT8	2	2	8	8	doxorubicin	EWS	PA449412	2130	0.783
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Mar_27_66(Pt_4)_o923.nxml.txt.nlp	21580733	SENT54	19	19	34	34	ethanol	mol	PA448073	90527	0.783
NULL	Acta_Physiol_(Oxf)_2012_Feb_204(2)_267-276.nxml.txt.nlp	21418147	SENT198	10	10	34	34	lipase	ABHD12	PA450239	26090	0.783
NULL	Diabetes_2011_Nov_17_60(11)_2843-2852.nxml.txt.nlp	21911753	SENT274	23	23	13	13	staurosporine	JNK	PA165109623	5599	0.783
NULL	Br_J_Cancer_2009_Oct_20_101(8)_1253-1260.nxml.txt.nlp	19755984	SENT8	40	40	18	18	anastrozole	HER-2	PA448432	2064	0.783
NULL	Diabetes_Obes_Metab_2010_May_12(5)_437-441.nxml.txt.nlp	20415692	SENT33	41	41	19	19	metformin	GLA	PA450395	9027;2717	0.783
NULL	J_Neurochem_2012_Dec_11_123(5)_725-735.nxml.txt.nlp	22971236	SENT372	1	1	5	5	trypsin	P2X1	PA451806	5023	0.783
NULL	AIDS_Res_Treat_2012_Nov_8_2012_595762.nxml.txt.nlp	23193464	SENT89	21	21	1	1	raltegravir	DUET		8997	0.783
NULL	Chemother_Res_Pract_2011_Feb_6_2011_249867.nxml.txt.nlp	22312550	SENT47	4	4	9	9	amoxicillin	CAP	PA448406	23476;9200;4012;5269;10580;10487	0.783
NULL	Cancer_Med_2014_Apr_27_3(2)_245-251.nxml.txt.nlp	24464861	SENT67	14	14	6	6	metformin	HIF1	PA450395	3091	0.783
NULL	Mol_Cells_2014_Mar_31_37(3)_234-240.nxml.txt.nlp	24642709	SENT130	14	14	7	7	capsaicin	HO-1	PA448776	3162	0.783
NULL	Mol_Cancer_2009_Dec_3_8_115.nxml.txt.nlp	19958544	SENT72	6	6	18	18	nutlin-3	p53		7157	0.782
NULL	Acta_Pharmacol_Sin_2012_Jan_28_33(1)_66-74.nxml.txt.nlp	22120966	SENT184	3	3	10	10	genistein	RANKL	PA165109660	8600	0.782
NULL	Exp_Ther_Med_2014_Jun_27_7(6)_1752-1756.nxml.txt.nlp	24926379	SENT71	23	23	11	11	vildagliptin	PPG	PA165958346	5552	0.782
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Oct_13_65(Pt_11)_o2724.nxml.txt.nlp	21578321	SENT57	33	33	22	22	ethanol	mol	PA448073	90527	0.782
NULL	J_Immunother_Cancer_2014_Jan_27_2_2.nxml.txt.nlp	24829759	SENT102	17	17	3	3	sorafenib	IL-21	PA7000	59067;50616;27189	0.782
NULL	Nature_2012_Apr_25_484(7395)_524-528.nxml.txt.nlp	22538616	SENT121	31	31	23	23	ciprofloxacin	PD1	PA449009	9825;6622;5133	0.782
NULL	Ann_Oncol_2013_Aug_12_24(8)_1994-1999.nxml.txt.nlp	23670096	SENT130	9	9	14	14	tamoxifen	AIB1	PA451581	8202	0.782
NULL	Br_J_Cancer_2010_Jan_5_102(1)_162-164.nxml.txt.nlp	19953097	SENT56	23	23	5	5	cetuximab	PTEN	PA10040	5728	0.782
NULL	Cell_J_2011_Aug_24_Summer_13(2)_97-102.nxml.txt.nlp	23508230	SENT67	18	18	15	15	pyrazinamide	ETB	PA451182	1910	0.782
NULL	Cancer_Cell_Int_2005_Jul_24_5_22.nxml.txt.nlp	16042792	SENT135	11	11	7	7	vincristine	NAC	PA451879	22861	0.782
NULL	BMB_Rep_2014_Apr_47(4)_221-226.nxml.txt.nlp	24286312	SENT106	3	3	6	6	nutlin-3	p53		7157	0.782
NULL	Biomed_Res_Int_2014_Jan_20_2014_789765.nxml.txt.nlp	24575414	SENT36	0	0	3	3	piroxicam	PRX	PA450985	9588;57716	0.782
NULL	Front_Immunol_2013_Nov_20_4_385.nxml.txt.nlp	24312095	SENT353	8	8	26	26	heparin	CD4	PA449855	920	0.782
NULL	Exp_Ther_Med_2014_Oct_16_8(4)_1150-1158.nxml.txt.nlp	25187814	SENT53	7	7	17	17	fluorescein	CD29	PA164746009	3688	0.782
NULL	Scientifica_(Cairo)_2012_Nov_25_2012_473829.nxml.txt.nlp	24278698	SENT225	38	38	24	24	oxaliplatin	ATP7B	PA131285527	540	0.782
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1063.nxml.txt.nlp	24556678	SENT87	0	0	10	10	thioridazine	Mcl-1	PA451666	4170	0.782
NULL	EMBO_Mol_Med_2012_Sep_7_4(9)_896-909.nxml.txt.nlp	22887866	SENT144	0	0	14	14	lovastatin	MYC	PA450272	4609	0.782
NULL	Oncogene_2014_Sep_4_33(36)_4521-4530.nxml.txt.nlp	24662833	SENT37	20	20	17	17	bicalutamide	ARSI	PA164746255	340075	0.782
NULL	Int_Neurourol_J_2014_Sep_24_18(3)_115-125.nxml.txt.nlp	25279238	SENT140	31	31	38	38	berberine	Bcl-2	PA165860812	596	0.782
NULL	Arthritis_Res_Ther_2014_Jul_18_16(4)_R153.nxml.txt.nlp	25037855	SENT110	27	27	11	11	adalimumab	CD14	PA10004	929	0.782
NULL	Acta_Pharmacol_Sin_2012_May_4_33(5)_710-716.nxml.txt.nlp	22555373	SENT13	8	8	15	15	diazepam	DOM	PA449283	6663	0.782
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT109	17	17	26	26	l-leucine	S6K1	PA450197	6198	0.782
NULL	Br_J_Cancer_2011_Aug_23_105(5)_618-627.nxml.txt.nlp	21829197	SENT129	17	17	5	5	lapatinib	CRT	PA152241907	811	0.782
NULL	Br_J_Cancer_1988_Nov_58(5)_640-643.nxml.txt.nlp	3064798	SENT10	17	17	19	19	chlorambucil	CLB	PA448926	171425	0.782
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_45-53.nxml.txt.nlp	17912635	SENT36	32	32	11	11	estradiol	aromatase	PA449503	1588	0.782
NULL	Evid_Based_Complement_Alternat_Med_2014_Jun_16_2014_371475.nxml.txt.nlp	25024728	SENT126	23	23	20	20	atropine	AKT2	PA448505	208	0.782
NULL	Br_J_Cancer_2010_Jun_8_102(12)_1707-1716.nxml.txt.nlp	20461078	SENT13	13	13	30	30	bortezomib	TRAIL	PA10252	8743	0.782
NULL	Theranostics_2014_Jan_29_4(4)_336-365.nxml.txt.nlp	24578720	SENT286	21	21	3	3	everolimus	PI3K	PA164746311	5290	0.782
NULL	Biomed_Res_Int_2014_Aug_6_2014_967826.nxml.txt.nlp	25165721	SENT199	23	23	19	19	cisplatin	IL-18	PA449014	3606	0.782
NULL	Breast_Cancer_Res_2011_Aug_16_13(4)_312.nxml.txt.nlp	21861853	SENT30	16	16	24	24	tamoxifen	CUEDC2	PA451581	79004	0.782
NULL	Eur_J_Clin_Pharmacol_2012_Jan_7_68(1)_55-64.nxml.txt.nlp	21735164	SENT206	7	7	0	0	oxycodone	CYP2D6	PA450741	1565	0.782
NULL	Anticancer_Agents_Med_Chem_2010_Oct_10(8)_617-624.nxml.txt.nlp	21182469	SENT261	2	2	33	33	pemetrexed	ABCC11	PA10810	85320	0.782
NULL	J_Cancer_Prev_2014_Mar_19(1)_39-46.nxml.txt.nlp	25337571	SENT92	4	4	16	16	ethanol	p38	PA448073	10598;1432;7965	0.782
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT220	11	11	17	17	resveratrol	TRAIL		8743	0.782
NULL	Int_J_Impot_Res_2010_Mar_26_22(2)_120-126.nxml.txt.nlp	19940852	SENT50	29	29	33	33	nitroprusside	mol	PA451406	90527	0.782
NULL	Arthritis_Res_Ther_2003_Sep_12_5(Suppl_3)_145.nxml.txt.nlp	NULL	SENT4	6	6	14	14	forskolin	IL-16	PA146096022	3603	0.782
NULL	Breast_Cancer_Res_2007_Feb_6_9(1)_R17.nxml.txt.nlp	17280616	SENT30	9	9	22	22	tamoxifen	aromatase	PA451581	1588	0.782
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1495-1502.nxml.txt.nlp	21989186	SENT201	22	22	28	28	fluorouracil	HSI	PA128406956	57016	0.782
NULL	Angiogenesis_2013_Apr_10_16(2)_373-386.nxml.txt.nlp	23143659	SENT224	29	29	19	19	cyclophosphamide	LDM	PA449165	1595	0.782
NULL	Acta_Pharmacol_Sin_2009_Oct_21_30(10)_1392-1398.nxml.txt.nlp	19767766	SENT91	0	0	10	10	atorvastatin	ROS	PA448500	6098	0.782
NULL	Acta_Pharmacol_Sin_2012_Mar_30_33(3)_401-406.nxml.txt.nlp	22286916	SENT131	6	6	37	37	paclitaxel	DDP	PA450761	1678	0.782
NULL	Mol_Med_Rep_2015_Jan_22_11(1)_83-90.nxml.txt.nlp	25338529	SENT21	7	7	28	28	octreotide	HO-1	PA450678	3162	0.782
NULL	Case_Rep_Dermatol_2013_Jan_18_5(1)_11-14.nxml.txt.nlp	23466694	SENT57	15	15	9	9	calcipotriol	LAM	PA448714	7249;7248	0.782
NULL	Diabetes_Obes_Metab_2011_Nov_13(11)_982-989.nxml.txt.nlp	21615670	SENT22	17	17	10	10	exenatide	GLP-1	PA164749238	100125288	0.782
NULL	Cancer_Cell_Int_2010_Jul_8_10_23.nxml.txt.nlp	20615241	SENT61	7	7	24	24	erlotinib	BAR	PA134687924	154;51283	0.782
NULL	Cancer_Res_Treat_2015_Jan_25_47(1)_46-54.nxml.txt.nlp	25327492	SENT123	11	11	22	22	docetaxel	CRT	PA449383	811	0.782
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT13	31	31	18	18	ziprasidone	PRL	PA451974	5617	0.782
NULL	J_Cell_Mol_Med_2013_Dec_6_17(12)_1588-1597.nxml.txt.nlp	24199964	SENT21	6	6	18	18	doxycycline	APT	PA449415	653639	0.782
NULL	Br_J_Pharmacol_2011_Apr_162(8)_1832-1842.nxml.txt.nlp	21232033	SENT216	14	14	3	3	colchicine	ADP	PA449092	23038	0.782
NULL	Front_Zool_2009_Sep_22_6_21.nxml.txt.nlp	19772622	SENT393	18	18	8	8	pancuronium	mol	PA450771	90527	0.782
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT89	0	0	17	17	etravirine	CYP2C19	PA166014703	1557	0.782
NULL	Indian_J_Nucl_Med_2015_Jan-Mar_30(1)_21-25.nxml.txt.nlp	25589801	SENT89	29	29	21	21	gefitinib	EGFR	PA131301952	1956	0.782
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Sep_24_3(9)_e137.nxml.txt.nlp	25250527	SENT62	20	20	15	15	ketoprofen	P2Y12	PA450149	64805	0.782
NULL	Cancer_Causes_Control_2013_Aug_18_24(8)_1605-1614.nxml.txt.nlp	23775025	SENT64	33	33	39	39	doxorubicin	GSTM1	PA449412	2944	0.782
NULL	Oncotarget_2014_Jun_8_5(13)_5040-5053.nxml.txt.nlp	24970815	SENT65	32	32	35	35	cisplatin	AKT	PA449014	207	0.782
NULL	Anesth_Essays_Res_2012_Jul-Dec_6(2)_140-146.nxml.txt.nlp	NULL	SENT101	18	18	9	9	lidocaine	IL8	PA450226	3576	0.782
NULL	Br_J_Cancer_2012_Oct_9_107(8)_1277-1285.nxml.txt.nlp	22990652	SENT166	9	9	22	22	axitinib	CYP2C8	PA164924493	1558	0.782
NULL	Hum_Genomics_2008_Sep_1_3(1)_7-16.nxml.txt.nlp	19129086	SENT156	11	11	22	22	rosiglitazone	CYP2C8	PA451283	1558	0.782
NULL	Arthritis_Res_Ther_2008_Dec_15_10(6)_230.nxml.txt.nlp	19090981	SENT80	9	9	24	24	thrombin	p38	PA451674	10598;1432;7965	0.782
NULL	Exp_Ther_Med_2012_Sep_29_4(3)_375-380.nxml.txt.nlp	23181102	SENT141	5	5	1	1	lovastatin	Rho	PA450272	29984	0.782
NULL	Diabetes_Care_2008_Aug_31(8)_1585-1589.nxml.txt.nlp	18469206	SENT52	17	17	12	12	heparin	PON1	PA449855	5444	0.782
NULL	Front_Immunol_2013_Mar_1_4_52.nxml.txt.nlp	23459829	SENT449	6	6	18	18	raltegravir	CD4		920	0.782
NULL	Eur_J_Med_Res_2009_Dec_7_14(Suppl_4)_108-111.nxml.txt.nlp	20156738	SENT82	6	6	15	15	theophylline	IL-13	PA451647	3596	0.782
NULL	Br_J_Cancer_2001_Apr_84(7)_959-964.nxml.txt.nlp	11286477	SENT10	4	4	10	10	dexrazoxane	MDR1	PA449259	5243	0.782
NULL	J_Clin_Biochem_Nutr_2009_Nov_28_45(3)_285-291.nxml.txt.nlp	19902018	SENT149	7	7	17	17	hesperetin	XDH	PA164742902	7498	0.782
NULL	Clin_Ophthalmol_2012_Feb_20_6_277-282.nxml.txt.nlp	22375096	SENT2	32	32	26	26	ranibizumab	STA	PA164746012	2010;2656	0.782
NULL	Br_J_Cancer_2014_Dec_9_111(12)_2380.nxml.txt.nlp	24619079	SENT28	24	24	9	9	panitumumab	EGFR	PA162373091	1956	0.782
NULL	J_Gynecol_Oncol_2013_Jan_8_24(1)_66-82.nxml.txt.nlp	23346316	SENT249	0	0	16	16	pertuzumab	HER2		2064	0.782
NULL	HSR_Proc_Intensive_Care_Cardiovasc_Anesth_2010_2(2)_81-91.nxml.txt.nlp	23440622	SENT134	5	5	12	12	prasugrel	ADP	PA154410481	23038	0.782
NULL	Mol_Vis_2012_Apr_11_18_901-908.nxml.txt.nlp	22539869	SENT31	0	0	9	9	curcumin	HO-1	PA151958596	3162	0.782
NULL	Front_Oncol_2014_Mar_18_4_55.nxml.txt.nlp	24672775	SENT325	23	23	15	15	decitabine	DNMT3A	PA164749631	1788	0.782
NULL	Front_Neurosci_2014_Jul_23_8_213.nxml.txt.nlp	25100939	SENT85	25	25	36	36	chloramphenicol	OXT	PA448927	5020	0.782
NULL	J_Med_Case_Reports_2011_Aug_3_5_345.nxml.txt.nlp	21812958	SENT78	11	11	13	13	temsirolimus	IL-2	PA164746890	3558	0.782
NULL	Pain_2011_Aug_152(8)_1899-1908.nxml.txt.nlp	21600693	SENT538	37	37	10	10	cangrelor	ADP	PA165945763	23038	0.782
NULL	J_Immunother_2014_Apr_12_37(3)_180-186.nxml.txt.nlp	24598448	SENT28	7	7	20	20	sorafenib	IL-2	PA7000	3558	0.782
NULL	Iran_J_Basic_Med_Sci_2012_Jul-Aug_15(4)_926-936.nxml.txt.nlp	23493641	SENT160	17	17	6	6	pilocarpine	CB1	PA450962	1268	0.782
NULL	Ann_Rheum_Dis_2009_Dec_1_68(12)_1819-1826.nxml.txt.nlp	19054822	SENT73	41	41	10	10	abatacept	CDP	PA164747080	1523	0.782
NULL	Oncotarget_2012_Dec_31_3(12)_1653-1668.nxml.txt.nlp	23391506	SENT175	11	11	8	8	docetaxel	U87	PA449383	677775;641648	0.782
NULL	Cancer_Cell_Int_2005_Jul_24_5_22.nxml.txt.nlp	16042792	SENT53	11	11	3	3	vincristine	MRP1	PA451879	4437	0.782
NULL	Exp_Ther_Med_2013_Mar_8_5(3)_707-710.nxml.txt.nlp	23404433	SENT129	5	5	7	7	cisplatin	DDP	PA449014	1678	0.782
NULL	Brain_Struct_Funct_2013_Jan_14_218(1)_59-72.nxml.txt.nlp	22246100	SENT234	0	0	7	7	pilocarpine	c-fos	PA450962	2353	0.782
NULL	Ann_Surg_Oncol_2011_Mar_26_18(3)_659-669.nxml.txt.nlp	20976564	SENT143	14	14	4	4	oxaliplatin	HCN	PA131285527	378938	0.782
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_1-2.nxml.txt.nlp	17221160	SENT16	6	6	29	29	letrozole	HER2	PA450196	2064	0.782
NULL	Breast_Cancer_Res_2011_Mar_1_13(2)_R21.nxml.txt.nlp	21362200	SENT239	11	11	14	14	fulvestrant	PI3K	PA164747170	5290	0.782
NULL	Evid_Based_Complement_Alternat_Med_2011_Jan_20_2011_751671.nxml.txt.nlp	21318106	SENT147	9	9	19	19	tacrolimus	CYP3A4	PA451578	1576	0.782
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1137-1144.nxml.txt.nlp	20234366	SENT138	6	6	8	8	cetuximab	KRAS	PA10040	3845	0.782
NULL	J_Skin_Cancer_2012_Dec_13_2012_147863.nxml.txt.nlp	23316365	SENT184	29	29	17	17	curcumin	STAT3	PA151958596	6774	0.782
NULL	Br_J_Cancer_2011_Apr_12_104(8)_1256-1261.nxml.txt.nlp	21448165	SENT159	14	14	16	16	sorafenib	IL-2	PA7000	3558	0.782
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT175	6	6	12	12	atorvastatin	MARK	PA448500	4139	0.782
NULL	Cell_Biol_Int_Rep_(2010)_2012_Jun_21_19(1)_e00017.nxml.txt.nlp	23124518	SENT51	6	6	8	8	etoposide	TRAIL	PA449552	8743	0.782
NULL	Pediatr_Cardiol_2010_Jan_14_31(1)_90-95.nxml.txt.nlp	19915892	SENT98	36	36	15	15	palivizumab	Era	PA164748781	2099	0.782
NULL	EMBO_J_2010_Nov_17_29(22)_3773-3786.nxml.txt.nlp	20924358	SENT73	22	22	5	5	geldanamycin	Hsp90	PA152031327	3320	0.782
NULL	J_Korean_Med_Sci_2014_Jul_11_29(7)_965-972.nxml.txt.nlp	25045229	SENT122	14	14	7	7	metformin	B12	PA450395	7126;4709	0.782
NULL	Acta_Pharmacol_Sin_2014_Aug_30_35(8)_1045-1054.nxml.txt.nlp	24976155	SENT100	0	0	8	8	resveratrol	STAT3		6774	0.782
NULL	Int_J_Biol_Sci_2013_Jan_3_9(1)_94-107.nxml.txt.nlp	23355795	SENT35	23	23	14	14	hyaluronan	HMGB1	PA165958431	3146	0.782
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Jul_6_69(Pt_8)_o1202.nxml.txt.nlp	24109300	SENT66	20	20	13	13	ethanol	mol	PA448073	90527	0.782
NULL	Mol_Cancer_2014_Feb_20_13_32.nxml.txt.nlp	24555657	SENT186	2	2	16	16	cisplatin	SET	PA449014	6418	0.782
NULL	Front_Endocrinol_(Lausanne)_2013_Nov_11_4_166.nxml.txt.nlp	24273531	SENT60	18	18	3	3	losartan	AT2	PA450268	186	0.782
NULL	J_Gastroenterol_2013_Jan_27_48(1)_22-30.nxml.txt.nlp	23104468	SENT114	18	18	5	5	ribavirin	RVR	PA451241	9975	0.782
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT43	25	25	10	10	ritonavir	CYP3A4	PA451260	1576	0.782
NULL	Curr_Neuropharmacol_2012_Sep_10(3)_239-253.nxml.txt.nlp	23449817	SENT241	14	14	4	4	risperidone	5-HT2A	PA451257	3356	0.782
NULL	Diabetes_Care_2011_Jun_20_34(6)_1265-1269.nxml.txt.nlp	21515846	SENT149	12	12	7	7	ramipril	DREAM	PA451223	30818	0.782
NULL	Oncol_Lett_2013_Oct_24_6(4)_970-976.nxml.txt.nlp	24137447	SENT3	15	15	17	17	doxorubicin	ADM	PA449412	133	0.782
NULL	Nat_Biotechnol_2010_Mar_14_28(3)_249-255.nxml.txt.nlp	20160716	SENT72	28	28	21	21	meclizine	HIF1	PA450338	3091	0.782
NULL	Cell_Cycle_2012_Dec_15_11(24)_4661-4672.nxml.txt.nlp	23187802	SENT157	7	7	4	4	doxorubicin	E2F4	PA449412	1874	0.782
NULL	Breast_Cancer_(Auckl)_2012_Mar_7_6_67-77.nxml.txt.nlp	22438669	SENT96	12	12	7	7	gemcitabine	HER2	PA449748	2064	0.782
NULL	Gastric_Cancer_2014_Apr_7_17(1)_1-12.nxml.txt.nlp	23563986	SENT310	3	3	25	25	trastuzumab	HER2	PA451743	2064	0.782
NULL	Breast_Cancer_Res_2002_Apr_18_4(3)_95-99.nxml.txt.nlp	12052251	SENT32	2	2	11	11	doxorubicin	San	PA449412	80218	0.782
NULL	Oncotarget_2014_Oct_9_5(20)_9564-9576.nxml.txt.nlp	25333255	SENT174	7	7	22	22	flavopiridol	CDK8	PA452627	1024	0.782
NULL	Pharmaceuticals_(Basel)_2011_Jan_11_4(1)_154-168.nxml.txt.nlp	NULL	SENT42	20	20	32	32	vasopressin	AVP	PA451858	114548;551	0.782
NULL	Biomed_Res_Int_2013_Jun_18_2013_104315.nxml.txt.nlp	23853765	SENT108	5	5	11	11	pitrakinra	IL-4	PA165983754	3565	0.782
NULL	Mol_Cancer_2012_Dec_12_11_91.nxml.txt.nlp	23234355	SENT87	12	12	4	4	erlotinib	EGFR	PA134687924	1956	0.782
NULL	Mol_Cancer_2013_Mar_2_12_16.nxml.txt.nlp	23452820	SENT13	2	2	8	8	chloroquine	Mcl-1	PA448948	4170	0.782
NULL	Arthritis_Res_2002_Nov_14_4(2)_139-144.nxml.txt.nlp	11879550	SENT43	15	15	0	0	trypsin	IL-18	PA451806	3606	0.782
NULL	Breast_Cancer_Res_2007_Aug_10_9(4)_R52.nxml.txt.nlp	17692126	SENT245	17	17	15	15	exemestane	aromatase	PA449563	1588	0.782
NULL	Diabetes_2011_May_23_60(5)_1435-1445.nxml.txt.nlp	21471512	SENT192	2	2	12	12	forskolin	PPP1R3G	PA146096022	648791	0.782
NULL	Diabetes_Metab_J_2013_Oct_17_37(5)_315-325.nxml.txt.nlp	24199159	SENT192	12	12	14	14	resveratrol	SIRT1		23411	0.782
NULL	Diabetes_2011_Jun_21_60(6)_1770-1778.nxml.txt.nlp	21562078	SENT133	22	22	8	8	metformin	HL-1	PA450395	55600	0.782
NULL	Oncotarget_2010_Jun_4_1(2)_120-130.nxml.txt.nlp	20651942	SENT201	13	13	1	1	paraformaldehyde	E12	PA450790	64100	0.782
NULL	Br_J_Cancer_1999_Dec_81(8)_1285-1293.nxml.txt.nlp	10604724	SENT13	14	14	23	23	sn-38	p53		7157	0.782
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT345	6	6	2	2	lapatinib	c-src	PA152241907	6714	0.782
NULL	Br_J_Haematol_2014_Feb_16_164(4)_586-596.nxml.txt.nlp	24236640	SENT155	18	18	13	13	carboplatin	EPO	PA448803	7076;8288;2056	0.782
NULL	J_Headache_Pain_2008_Oct_8_9(5)_317-323.nxml.txt.nlp	18688693	SENT133	37	37	13	13	sumatriptan	5-HT1B	PA451566	3351	0.782
NULL	Oncotarget_2013_Dec_5_5(1)_49-66.nxml.txt.nlp	24393708	SENT94	7	7	13	13	temsirolimus	FKBP12	PA164746890	2280	0.782
NULL	Glycobiology_2012_Jan_26_22(1)_134-145.nxml.txt.nlp	21873605	SENT109	8	8	17	17	heparin	IL-8	PA449855	3576	0.782
NULL	Front_Oncol_2013_Sep_11_3_231.nxml.txt.nlp	24062984	SENT228	9	9	34	34	esomeprazole	IFN	PA10075	3439	0.782
NULL	Nat_Chem_Biol_2010_Apr_28_6(4)_291-299.nxml.txt.nlp	20190765	SENT146	7	7	14	14	dasatinib	EGFR	PA162372878	1956	0.782
NULL	Eur_J_Clin_Pharmacol_2012_Sep_15_68(9)_1267-1274.nxml.txt.nlp	22418828	SENT99	15	15	8	8	pantoprazole	CYP2C19	PA450774	1557	0.782
NULL	Anal_Chem_Insights_2014_Mar_2_9_1-7.nxml.txt.nlp	24634579	SENT4	10	10	7	7	terbutaline	SLB	PA451616	26160	0.782
NULL	Adv_Hematol_2010_May_16_2010_672137.nxml.txt.nlp	20490274	SENT14	25	25	18	18	idarubicin	AIDA	PA449961	64853	0.782
NULL	Br_J_Cancer_2013_Feb_19_108(3)_557-563.nxml.txt.nlp	23361053	SENT25	17	17	10	10	tamoxifen	PAK1	PA451581	5585;5058	0.782
NULL	Arch_Med_Sci_2012_Sep_8_8(4)_659-671.nxml.txt.nlp	23056078	SENT198	26	26	20	20	daunorubicin	P-gp	PA449212	5243	0.782
NULL	Pharmaceuticals_(Basel)_2011_Jan_26_4(2)_285-342.nxml.txt.nlp	NULL	SENT173	9	9	5	5	fluoxetine	5-HT2C	PA449673	3358	0.782
NULL	Pain_2013_Sep_154(9)_1680-1690.nxml.txt.nlp	23707289	SENT207	8	8	20	20	yohimbine	c-fos	PA451946	2353	0.782
NULL	CNS_Neurosci_Ther_2009_Spring_15(1)_32-51.nxml.txt.nlp	19228178	SENT71	10	10	13	13	ramelteon	MT3	PA164744896	4504	0.782
NULL	Aging_(Albany_NY)_2012_Mar_12_4(3)_146-158.nxml.txt.nlp	22436213	SENT10	12	12	32	32	resveratrol	SIRT1		23411	0.782
NULL	Clin_Interv_Aging_2012_Jul_12_7_235-247.nxml.txt.nlp	22866001	SENT217	27	27	19	19	denosumab	PTH	PA166048634	5741	0.782
NULL	Front_Neurosci_2011_Dec_5_5_131.nxml.txt.nlp	22164129	SENT1617	0	0	9	9	ethanol	CRF1	PA448073	1394	0.782
NULL	Indian_J_Crit_Care_Med_2015_Jan_19(1)_42-46.nxml.txt.nlp	25624650	SENT82	14	14	41	41	dobutamine	APE	PA449381	55704;328	0.782
NULL	Front_Genet_2012_Nov_5_3_236.nxml.txt.nlp	23133441	SENT116	4	4	10	10	efavirenz	ABCB1	PA449441	5243	0.782
NULL	Cell_Commun_Signal_2013_May_29_11_38.nxml.txt.nlp	23718910	SENT186	24	24	11	11	pp2	PP2		4888	0.782
NULL	Oncoscience_2014_Oct_24_1(10)_665-673.nxml.txt.nlp	25593995	SENT79	15	15	3	3	doxorubicin	NANOG	PA449412	79923	0.782
NULL	Acta_Vet_Scand_2003_Sep_30_44(3)_121-129.nxml.txt.nlp	15074625	SENT103	21	21	18	18	ampicillin	TMP	PA448419	2012	0.782
NULL	Mol_Cancer_2008_May_21_7_42.nxml.txt.nlp	18492291	SENT14	0	0	14	14	gefitinib	EGFR	PA131301952	1956	0.782
NULL	Mol_Cancer_2014_Jun_4_13_141.nxml.txt.nlp	24894453	SENT65	8	8	34	34	cetuximab	KRAS	PA10040	3845	0.782
NULL	J_Gynecol_Oncol_2013_Jul_4_24(3)_265-272.nxml.txt.nlp	23875077	SENT142	26	26	8	8	thrombin	DKK1	PA451674	22943	0.782
NULL	J_Korean_Med_Sci_2011_Feb_24_26(2)_304-307.nxml.txt.nlp	21286027	SENT45	30	30	10	10	etoposide	CHOP	PA449552	1649	0.782
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT109	2	2	13	13	curcumin	IL-8	PA151958596	3576	0.782
NULL	Br_J_Clin_Pharmacol_2014_Nov_20_78(5)_1050-1057.nxml.txt.nlp	24962564	SENT14	22	22	19	19	ketoconazole	CYP3A4	PA450146	1576	0.782
NULL	J_Biol_2003_Sep_24_2(4)_28.nxml.txt.nlp	14511394	SENT13	8	8	19	19	phenformin	LKB1	PA1000	6794	0.782
NULL	Evid_Based_Complement_Alternat_Med_2013_Dec_18_2013_459390.nxml.txt.nlp	24454495	SENT205	23	23	32	32	berberine	C10	PA165860812	113246	0.782
NULL	Clin_Epigenetics_2011_Dec_5_3(1)_8.nxml.txt.nlp	22414275	SENT87	5	5	7	7	ribavirin	ESR1	PA451241	2099	0.782
NULL	Exp_Ther_Med_2014_May_5_7(5)_1420-1426.nxml.txt.nlp	24940450	SENT26	3	3	40	40	sorafenib	FLT3	PA7000	2322	0.782
NULL	J_Hematol_Oncol_2011_Jan_21_4_5.nxml.txt.nlp	21255411	SENT240	12	12	38	38	erlotinib	GC-E	PA134687924	390226	0.782
NULL	Eur_J_Haematol_2014_Feb_25_92(2)_127-136.nxml.txt.nlp	24118452	SENT164	23	23	21	21	anagrelide	CRT	PA164742986	811	0.782
NULL	Breast_Cancer_Res_2008_Mar_7_10(2)_R22.nxml.txt.nlp	18328103	SENT50	34	34	44	44	hydrocortisone	EGF	PA449905	1950	0.782
NULL	J_Korean_Med_Sci_2006_Oct_31_21(5)_854-858.nxml.txt.nlp	17043419	SENT46	6	6	18	18	heparin	ACT	PA449855	12;11332;9457;641455	0.782
NULL	Acta_Pharmacol_Sin_2010_Feb_5_31(2)_137-144.nxml.txt.nlp	20139896	SENT26	6	6	14	14	oxygen	5-LOX	PA450744	240	0.782
NULL	J_Immunotoxicol_2013_Jan_11_10(1)_75-82.nxml.txt.nlp	22967038	SENT101	25	25	6	6	muromonab	CD4	PA164743097	920	0.782
NULL	Br_J_Cancer_2010_Jun_29_103(1)_61-72.nxml.txt.nlp	20588279	SENT17	14	14	28	28	trastuzumab	HER-2	PA451743	2064	0.782
NULL	Nat_Commun_2014_Dec_8_5_5736.nxml.txt.nlp	25484020	SENT482	0	0	9	9	oxaliplatin	TRPA1	PA131285527	8989	0.782
NULL	Cells_2014_May_23_3(2)_517-545.nxml.txt.nlp	24861977	SENT15	2	2	10	10	capsaicin	TRPV1	PA448776	7442	0.782
NULL	Chromatographia_2014_Oct_17_77(23-24)_1713-1720.nxml.txt.nlp	25477555	SENT171	9	9	11	11	saquinavir	CD4	PA451305	920	0.782
NULL	Diabetes_2011_Mar_21_60(3)_746-756.nxml.txt.nlp	21282364	SENT268	6	6	0	0	rosiglitazone	AMPK	PA451283	5563	0.782
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_11_2014_274786.nxml.txt.nlp	25505920	SENT246	9	9	36	36	curcumin	ERCC1	PA151958596	2067	0.782
NULL	Cancer_Med_2014_Jun_18_3(3)_453-461.nxml.txt.nlp	24639373	SENT59	11	11	35	35	tamoxifen	ANO1	PA451581	55107	0.782
NULL	Br_J_Cancer_2010_Nov_2_103(11)_1671-1679.nxml.txt.nlp	21045835	SENT221	11	11	0	0	gemcitabine	CXCL12	PA449748	6387	0.782
NULL	J_Exp_Clin_Cancer_Res_2009_Nov_24_28(1)_144.nxml.txt.nlp	19930704	SENT121	26	26	3	3	vinblastine	P-gp	PA451877	5243	0.782
NULL	Br_J_Cancer_2010_Jun_29_103(1)_61-72.nxml.txt.nlp	20588279	SENT274	26	26	7	7	trastuzumab	PTEN	PA451743	5728	0.782
NULL	J_Inherit_Metab_Dis_2012_Nov_24_35(6)_1137-1145.nxml.txt.nlp	22447153	SENT210	5	5	12	12	fenofibrate	ABCD2	PA449594	225	0.782
NULL	Biomed_Res_Int_2014_Jun_2_2014_946492.nxml.txt.nlp	24991574	SENT104	10	10	37	37	olmesartan	ATRAP	PA164742950	57085	0.782
NULL	Biomed_Res_Int_2014_Apr_23_2014_421415.nxml.txt.nlp	24864241	SENT136	14	14	11	11	doxorubicin	ETO	PA449412	862	0.782
NULL	J_Asthma_Allergy_2013_Feb_22_6_31-39.nxml.txt.nlp	23459334	SENT5	11	11	18	18	rupatadine	DES		1674	0.782
NULL	Ann_Indian_Acad_Neurol_2014_Mar_17(Suppl_1)_S32-S36.nxml.txt.nlp	24791086	SENT112	20	20	22	22	pentobarbital	PTB	PA450859	58155	0.782
NULL	Alzheimers_Res_Ther_2013_Apr_29_5(2)_21.nxml.txt.nlp	23634965	SENT121	5	5	9	9	clonidine	spatial	PA449051	219793	0.782
NULL	Evid_Based_Complement_Alternat_Med_2011_Mar_10_2011_561396.nxml.txt.nlp	21792360	SENT122	9	9	5	5	simvastatin	CD40	PA451363	958	0.782
NULL	Indian_J_Endocrinol_Metab_2013_Dec_17(Suppl_3)_S674-S679.nxml.txt.nlp	24910836	SENT164	4	4	26	26	acarbose	PPG	PA448010	5552	0.782
NULL	Cancer_Med_2013_Dec_31_2(6)_950-963.nxml.txt.nlp	24403269	SENT238	7	7	4	4	cisplatin	RAB25	PA449014	57111	0.782
NULL	Oncol_Lett_2014_Jul_12_8(1)_223-229.nxml.txt.nlp	24959250	SENT90	2	2	13	13	captopril	MCP-1	PA448780	6347	0.782
NULL	Acta_Pharmacol_Sin_2009_Sep_24_30(9)_1262-1275.nxml.txt.nlp	19701231	SENT201	37	37	27	27	lovastatin	LRP10	PA450272	26020	0.782
NULL	Biomed_Res_Int_2013_Jul_22_2013_408573.nxml.txt.nlp	23971034	SENT167	17	17	12	12	midazolam	CYP3A	PA450496	1574	0.782
NULL	Arch_Public_Health_2011_Dec_5_69(1)_8.nxml.txt.nlp	22958637	SENT132	11	11	21	21	warfarin	CYP2C9	PA451906	1559	0.782
NULL	Oncogenesis_2014_Dec_15_3(12)_e133.nxml.txt.nlp	25500906	SENT118	25	25	9	9	trastuzumab	PI3K	PA451743	5290	0.782
NULL	EJC_Suppl_2013_Sep_5_11(2)_307-309.nxml.txt.nlp	NULL	SENT148	8	8	23	23	docetaxel	LBA1	PA449383	9881	0.782
NULL	Oncogene_2014_Oct_16_33(42)_5028-5038.nxml.txt.nlp	24747972	SENT65	11	11	29	29	nilotinib	CD150	PA165958345	6504	0.782
NULL	Int_J_Gen_Med_2012_Nov_23_5_983-990.nxml.txt.nlp	23226071	SENT45	24	24	7	7	efavirenz	ART	PA449441	181	0.782
NULL	Br_J_Cancer_2011_Jun_7_104(12)_1848-1853.nxml.txt.nlp	21610704	SENT120	19	19	6	6	panitumumab	TOX	PA162373091	9760	0.782
NULL	AMB_Express_2014_May_22_4_37.nxml.txt.nlp	25401060	SENT357	31	31	26	26	nicotine	S16	PA450626	6217	0.782
NULL	Mar_Drugs_2008_Nov_3_6(4)_595-606.nxml.txt.nlp	19172197	SENT38	38	38	8	8	hydrocortisone	SCC4	PA449905	23383	0.782
NULL	Eur_J_Clin_Pharmacol_2011_May_8_67(5)_493-506.nxml.txt.nlp	21140139	SENT388	16	16	9	9	oxycodone	CYP3A	PA450741	1574	0.782
NULL	Psychiatry_Investig_2011_Sep_26_8(3)_234-244.nxml.txt.nlp	21994511	SENT209	35	35	18	18	quetiapine	5-HT1A	PA451201	3350	0.782
NULL	J_Biol_Chem_2013_Nov_15_288(46)_33049-33059.nxml.txt.nlp	24089524	SENT268	6	6	16	16	nicotine	GATA6	PA450626	2627	0.782
NULL	Nucleic_Acids_Res_2005_Jun_1_33(10)_3109-3124.nxml.txt.nlp	15930159	SENT47	32	32	29	29	trypsin	DTNB	PA451806	1838	0.782
NULL	Pharmaceuticals_(Basel)_2011_Nov_10_4(11)_1488-1502.nxml.txt.nlp	NULL	SENT114	3	3	10	10	geldanamycin	HER2	PA152031327	2064	0.782
NULL	Oxid_Med_Cell_Longev_2012_Jan_19_2012_390678.nxml.txt.nlp	22315655	SENT50	9	9	11	11	gliclazide	NAC	PA10892	22861	0.782
NULL	Mol_Cancer_2012_Apr_5_11_20.nxml.txt.nlp	22480225	SENT281	10	10	4	4	temozolomide	AKT3	PA451609	10000	0.782
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT108	32	32	9	9	glucose	PP2	PA449773	4888	0.782
NULL	J_Thromb_Haemost_2013_Jan_11(1)_132-141.nxml.txt.nlp	23205847	SENT188	2	2	17	17	thrombin	FVIII	PA451674	2157	0.782
NULL	Lab_Invest_2011_Jun_14_91(6)_852-858.nxml.txt.nlp	21403643	SENT15	13	13	1	1	tenofovir	OAT1	PA10204	9356	0.782
NULL	Breast_Cancer_Res_Treat_2013_Oct_8_141(3)_437-446.nxml.txt.nlp	24101324	SENT173	19	19	12	12	everolimus	PI3K	PA164746311	5290	0.782
NULL	Mol_Cancer_2010_Apr_23_9_87.nxml.txt.nlp	20416058	SENT202	20	20	22	22	doxorubicin	TRAIL	PA449412	8743	0.782
NULL	Aging_(Albany_NY)_2011_Feb_20_3(2)_108-124.nxml.txt.nlp	21386132	SENT269	12	12	18	18	l-glutamine	B27	PA10090	56246	0.782
NULL	J_Korean_Med_Sci_2008_Aug_25_23(4)_685-690.nxml.txt.nlp	18756058	SENT5	26	26	10	10	olanzapine	ghrelin	PA450688	51738	0.782
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_17_2013_308134.nxml.txt.nlp	23843872	SENT124	8	8	2	2	cyclosporine	P-gp	PA449167	5243	0.782
NULL	J_Appl_Microbiol_2014_Feb_25_116(2)_258-268.nxml.txt.nlp	24118802	SENT76	6	6	21	21	ethanol	mol	PA448073	90527	0.782
NULL	Oncoimmunology_2013_Jan_1_2(1)_e22890.nxml.txt.nlp	23483066	SENT85	20	20	28	28	temozolomide	IFN	PA451609	3439	0.782
NULL	Cancer_Manag_Res_2013_Nov_21_5_387-400.nxml.txt.nlp	24294007	SENT75	13	13	35	35	oxaliplatin	KRAS	PA131285527	3845	0.782
NULL	J_Cell_Biol_2001_Oct_1_155(1)_133-144.nxml.txt.nlp	11581290	SENT196	38	38	34	34	pp2	PP2		4888	0.782
NULL	Br_J_Cancer_2012_Jul_24_107(3)_516-526.nxml.txt.nlp	22782351	SENT299	36	36	14	14	tamoxifen	p16	PA451581	1029	0.782
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_127043.nxml.txt.nlp	23227093	SENT16	5	5	9	9	lovastatin	RYR	PA450272	6261	0.782
NULL	Case_Rep_Med_2013_Aug_5_2013_345473.nxml.txt.nlp	23983707	SENT75	4	4	21	21	cisplatin	Yes	PA449014	7525	0.782
NULL	J_Cell_Mol_Med_2014_Aug_1_18(8)_1599-1611.nxml.txt.nlp	24889822	SENT250	10	10	4	4	resveratrol	SIRT1		23411	0.782
NULL	Breast_Cancer_Res_2007_Aug_8_9(4)_R50.nxml.txt.nlp	17686159	SENT277	25	25	35	35	gefitinib	HRG	PA131301952	3084;3273	0.782
NULL	Front_Genet_2014_Aug_5_5_261.nxml.txt.nlp	25140173	SENT691	3	3	10	10	ethanol	H19	PA448073	283120	0.782
NULL	Breast_Cancer_Res_2012_Mar_20_14(2)_R53.nxml.txt.nlp	22433433	SENT110	22	22	26	26	paclitaxel	CDK1	PA450761	983	0.782
NULL	eLife_2014_May_27_3_e02200.nxml.txt.nlp	24867637	SENT670	14	14	1	1	nutlin-3	p53		7157	0.782
NULL	Mol_Cancer_2007_Oct_11_6_63.nxml.txt.nlp	17931419	SENT125	14	14	21	21	cetuximab	HIF-1	PA10040	29072	0.782
NULL	J_Young_Pharm_2010_Apr-Jun_2(2)_196-200.nxml.txt.nlp	21264125	SENT123	8	8	6	6	atorvastatin	CYP2C9	PA448500	1559	0.782
NULL	Mol_Microbiol_2012_Sep_26_85(6)_1148-1165.nxml.txt.nlp	22780904	SENT40	21	21	13	13	isoniazid	CHP	PA450112	11261	0.782
NULL	Adv_Hematol_2012_Jan_5_2012_507257.nxml.txt.nlp	22272202	SENT136	8	8	25	25	zidovudine	CYP3A	PA451954	1574	0.782
NULL	Mol_Cancer_2008_Jun_5_7_50.nxml.txt.nlp	18534018	SENT103	20	20	7	7	bortezomib	CLB	PA10252	171425	0.782
NULL	Mol_Cancer_2008_Jun_30_7_60.nxml.txt.nlp	18590557	SENT140	22	22	18	18	paclitaxel	TRAIL	PA450761	8743	0.782
NULL	Aging_(Albany_NY)_2011_Jan_18_3(1)_33-43.nxml.txt.nlp	21248371	SENT7	12	12	15	15	zinc	HIPK2	PA451956	28996	0.782
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT198	30	30	42	42	adalimumab	CD36	PA10004	948	0.782
NULL	J_Anaesthesiol_Clin_Pharmacol_2012_Jan-Mar_28(1)_92-100.nxml.txt.nlp	22345954	SENT116	22	22	15	15	enflurane	CO2	PA449461	4513	0.782
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_6_2014_270930.nxml.txt.nlp	25431606	SENT28	10	10	18	18	losartan	AT2	PA450268	186	0.782
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Oct_28_65(Pt_11)_o2898.nxml.txt.nlp	21578480	SENT59	23	23	29	29	vanillin	mol	PA451852	90527	0.782
NULL	J_Appl_Microbiol_2014_Feb_25_116(2)_258-268.nxml.txt.nlp	24118802	SENT76	6	6	32	32	ethanol	mol	PA448073	90527	0.782
NULL	J_Exp_Med_2003_Jan_20_197(2)_207-220.nxml.txt.nlp	12538660	SENT281	9	9	30	30	tetracycline	RAG2	PA451640	5897	0.782
NULL	EMBO_Rep_2012_Mar_7_13(3)_251-257.nxml.txt.nlp	22310300	SENT213	6	6	26	26	doxycycline	NRF2	PA449415	2551;4780	0.782
NULL	Semin_Immunopathol_2013_Jan_26_35(1)_39-52.nxml.txt.nlp	22829332	SENT197	3	3	18	18	bleomycin	CHOP	PA448645	1649	0.782
NULL	Mol_Pain_2013_Jun_10_9_27.nxml.txt.nlp	23758830	SENT108	2	2	6	6	tetracaine	ASIC2a	PA451638	40	0.782
NULL	eLife_2013_Nov_5_2_e00969.nxml.txt.nlp	24192036	SENT210	0	0	10	10	vemurafenib	p38	PA165946873	10598;1432;7965	0.782
NULL	Alcohol_Res_2012_34(3)_367-374.nxml.txt.nlp	23134054	SENT44	29	29	22	22	ethanol	MPDZ	PA448073	8777;84708	0.782
NULL	Clin_Drug_Investig_2013_Jan_27_33(1)_45-54.nxml.txt.nlp	23184666	SENT47	11	11	27	27	anagrelide	CYP1A2	PA164742986	1544	0.782
NULL	J_Gen_Intern_Med_2007_Feb_17_22(2)_171-176.nxml.txt.nlp	17356982	SENT49	11	11	1	1	buprenorphine	NCM	PA448685	57703	0.782
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT308	16	16	21	21	bevacizumab	VEGF-A	PA130232992	7422	0.782
NULL	J_Immunother_Cancer_2013_Nov_7_1(Suppl_1)_P191.nxml.txt.nlp	NULL	SENT15	7	7	32	32	celecoxib	p38	PA448871	10598;1432;7965	0.782
NULL	Angiogenesis_2010_Dec_7_13(4)_305-315.nxml.txt.nlp	20927579	SENT218	3	3	19	19	resveratrol	HIF-1		29072	0.782
NULL	Chin_J_Cancer_2012_Feb_31(2)_110-118.nxml.txt.nlp	22098951	SENT27	34	34	37	37	imatinib	P-gp	PA10804	5243	0.782
NULL	Int_J_Biol_Sci_2013_Apr_22_9(4)_350-360.nxml.txt.nlp	23630447	SENT173	23	23	15	15	doxorubicin	MDR1	PA449412	5243	0.782
NULL	Acta_Pharmacol_Sin_2009_Oct_21_30(10)_1392-1398.nxml.txt.nlp	19767766	SENT160	5	5	7	7	atorvastatin	DPI	PA448500	1832	0.782
NULL	Exp_Ther_Med_2013_Jan_30_5(1)_308-314.nxml.txt.nlp	23251289	SENT148	26	26	4	4	methotrexate	ABCC2	PA450428	1244	0.782
NULL	Cancer_Cell_Int_2009_Aug_18_9_23.nxml.txt.nlp	19689790	SENT247	22	22	20	20	hyperforin	TRPC6	PA165985514	7225	0.782
NULL	Acta_Pharmacol_Sin_2009_Jul_22_30(7)_956-964.nxml.txt.nlp	19543298	SENT5	7	7	29	29	atorvastatin	SLC22A1	PA448500	6580	0.782
NULL	Gut_Liver_2014_Sep_24_8(5)_480-486.nxml.txt.nlp	25228971	SENT52	5	5	3	3	pantoprazole	ESD	PA450774	2098	0.782
NULL	Mol_Neurodegener_2011_Nov_17_6_78.nxml.txt.nlp	22093090	SENT45	27	27	15	15	sr144528	p38		10598;1432;7965	0.782
NULL	Ann_Oncol_2009_Nov_23_20(11)_1803-1812.nxml.txt.nlp	19549706	SENT252	8	8	32	32	sunitinib	IFN	PA162372840	3439	0.782
NULL	Braz_J_Med_Biol_Res_2014_Jan_10_47(1)_60-69.nxml.txt.nlp	24519092	SENT3	22	22	25	25	doxorubicin	YWHAZ	PA449412	7534	0.782
NULL	Acta_Pharmacol_Sin_2009_Nov_12_30(11)_1566-1572.nxml.txt.nlp	19820718	SENT155	24	24	29	29	ketoconazole	CYP3A4	PA450146	1576	0.782
NULL	Arthritis_Res_Ther_2014_Apr_3_16(2)_R86.nxml.txt.nlp	24708674	SENT15	6	6	12	12	bosentan	Fli1	PA10034	2314	0.782
NULL	Int_J_Cell_Biol_2013_Sep_12_2013_153634.nxml.txt.nlp	24159334	SENT140	9	9	35	35	doxorubicin	YB-1	PA449412	4904	0.782
NULL	Hum_Genomics_Proteomics_2010_Sep_13_2010_754919.nxml.txt.nlp	20981234	SENT45	24	24	29	29	warfarin	VKORC1	PA451906	79001	0.782
NULL	J_Breast_Cancer_2013_Jun_28_16(2)_164-170.nxml.txt.nlp	23843848	SENT14	0	0	13	13	doxorubicin	PTEN	PA449412	5728	0.782
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Jul_23_64(Pt_8)_o1563.nxml.txt.nlp	21203266	SENT61	1	1	7	7	benzaldehyde	mol	PA448571	90527	0.782
NULL	Acta_Pharmacol_Sin_2013_Sep_5_34(9)_1192-1200.nxml.txt.nlp	23685957	SENT31	0	0	24	24	curcumin	5-LOX	PA151958596	240	0.782
NULL	Ann_Oncol_2013_Sep_4_24(9)_2206-2223.nxml.txt.nlp	23917950	SENT318	9	9	0	0	letrozole	SP3	PA450196	6670	0.782
NULL	J_Vet_Sci_2006_Dec_31_7(4)_343-348.nxml.txt.nlp	17106225	SENT39	24	24	46	46	l-glutamine	CO2	PA10090	4513	0.782
NULL	Insights_Imaging_2013_Jan_29_4(2)_163-175.nxml.txt.nlp	23359240	SENT153	11	11	0	0	carboplatin	HER2	PA448803	2064	0.782
NULL	EMBO_Mol_Med_2012_Jul_11_4(7)_577-593.nxml.txt.nlp	22496117	SENT97	11	11	7	7	clofazimine	PAP-1	PA164748759	6100	0.782
NULL	Cancer_Cell_Int_2013_Dec_23_13_123.nxml.txt.nlp	24365069	SENT27	39	39	2	2	imatinib	CD34	PA10804	947	0.782
NULL	Ann_Oncol_2011_Mar_8_22(3)_503-514.nxml.txt.nlp	20616198	SENT191	17	17	9	9	exemestane	aromatase	PA449563	1588	0.782
NULL	Exp_Ther_Med_2013_May_15_5(5)_1327-1331.nxml.txt.nlp	23737873	SENT150	10	10	36	36	imidapril	AQP2	PA452640	359	0.782
NULL	Front_Endocrinol_(Lausanne)_2014_Oct_9_5_166.nxml.txt.nlp	25346724	SENT264	33	33	30	30	resveratrol	p53		7157	0.782
NULL	Mol_Vis_2012_May_1_18_1115-1122.nxml.txt.nlp	22605923	SENT105	29	29	4	4	estradiol	IL-6	PA449503	3569	0.782
NULL	J_Clin_Biochem_Nutr_2010_Mar_27_46(2)_126-134.nxml.txt.nlp	20216945	SENT66	7	7	23	23	taurine	NAC	PA451590	22861	0.782
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT771	1	1	16	16	vemurafenib	ABCG2	PA165946873	9429	0.782
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT10	15	15	8	8	heparin	FGF1	PA449855	2246	0.782
NULL	Breast_Cancer_Res_2003_Jun_5_5(5)_R110-R113.nxml.txt.nlp	12927040	SENT96	9	9	16	16	thyroglobulin	TPO	PA164754910	7066;7173	0.781
NULL	Anesth_Essays_Res_2013_Sep-Dec_7(3)_319-325.nxml.txt.nlp	NULL	SENT32	0	0	4	4	propofol	AVP	PA451141	114548;551	0.781
NULL	J_Hematol_Oncol_2013_Jan_15_6_5.nxml.txt.nlp	23320987	SENT134	6	6	17	17	heparin	PI-PLC	PA449855	2923	0.781
NULL	Exp_Brain_Res_2014_Jun_27_232(8)_2637-2644.nxml.txt.nlp	24969614	SENT133	12	12	36	36	granisetron	NK1	PA449809	11126	0.781
NULL	J_Occup_Med_Toxicol_2006_Jun_23_1_13.nxml.txt.nlp	16796737	SENT59	46	46	17	17	ethanol	IFN	PA448073	3439	0.781
NULL	Cell_Mol_Life_Sci_2013_Aug_18_70(15)_2697-2712.nxml.txt.nlp	23076254	SENT254	5	5	2	2	metformin	AMPK	PA450395	5563	0.781
NULL	Br_J_Cancer_2009_Jul_21_101(2)_238-243.nxml.txt.nlp	19568242	SENT42	9	9	15	15	sunitinib	IFN	PA162372840	3439	0.781
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT129	34	34	36	36	trastuzumab	STAT3	PA451743	6774	0.781
NULL	Indian_J_Pharmacol_2013_Sep-Oct_45(5)_458-463.nxml.txt.nlp	24130379	SENT124	2	2	10	10	carvedilol	p50	PA448817	958;4790	0.781
NULL	Ital_J_Pediatr_2012_Sep_19_38_45.nxml.txt.nlp	22992442	SENT41	0	0	23	23	fluorescein	CD19	PA164746009	930	0.781
NULL	Cancers_(Basel)_2013_Nov_1_5(4)_1379-1412.nxml.txt.nlp	24202450	SENT1640	19	19	2	2	cyclophosphamide	CD4	PA449165	920	0.781
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Aug_11_67(Pt_9)_o2296.nxml.txt.nlp	22064675	SENT73	0	0	24	24	opipramol	mol	PA144614922	90527	0.781
NULL	J_Mol_Signal_2006_Dec_6_1_8.nxml.txt.nlp	17224083	SENT15	8	8	17	17	guanidine	Rho	PA164781028	29984	0.781
NULL	Oncotarget_2014_Feb_7_5(3)_775-787.nxml.txt.nlp	24519956	SENT111	15	15	8	8	dasatinib	PC3	PA162372878	57332;7832;5122	0.781
NULL	Clin_Sci_(Lond)_2012_May_1_122(Pt_9)_421-428.nxml.txt.nlp	22092038	SENT161	26	26	9	9	doxycycline	IL-6	PA449415	3569	0.781
NULL	Sci_Rep_2014_Dec_4_4_7310.nxml.txt.nlp	25472472	SENT207	19	19	2	2	decitabine	CD34	PA164749631	947	0.781
NULL	Pharm_Methods_2011_Jan-Mar_2(1)_42-46.nxml.txt.nlp	23781429	SENT3	31	31	33	33	lornoxicam	LOX	PA165958395	4015	0.781
NULL	Mol_Cancer_2014_Jun_26_13_158.nxml.txt.nlp	24965046	SENT116	4	4	20	20	sorafenib	TSP1	PA7000	7057	0.781
NULL	Nucleic_Acids_Res_2011_Mar_21_39(4)_1197-1207.nxml.txt.nlp	20965966	SENT95	6	6	38	38	trypsin	San	PA451806	80218	0.781
NULL	J_Invest_Dermatol_2013_Jun_14_133(6)_1541-1549.nxml.txt.nlp	23407395	SENT75	8	8	21	21	imiquimod	IL-8	PA449972	3576	0.781
NULL	Oncol_Lett_2013_Dec_4_6(6)_1665-1672.nxml.txt.nlp	24273604	SENT6	10	10	37	37	chloroquine	TLR9	PA448948	54106	0.781
NULL	Blood_Cancer_J_2014_May_30_4(5)_e215.nxml.txt.nlp	24879116	SENT55	2	2	8	8	doxycycline	BANK1	PA449415	55024	0.781
NULL	Cancer_Immunol_Immunother_2011_Jun_25_60(6)_793-808.nxml.txt.nlp	21350947	SENT268	34	34	29	29	sunitinib	IFN	PA162372840	3439	0.781
NULL	Infect_Dis_Obstet_Gynecol_2012_Nov_29_2012_543916.nxml.txt.nlp	23251074	SENT37	5	5	15	15	zidovudine	CD4	PA451954	920	0.781
NULL	Mol_Clin_Oncol_2013_Sep_24_1(5)_918-924.nxml.txt.nlp	24649271	SENT91	2	2	6	6	gemcitabine	EGFR	PA449748	1956	0.781
NULL	J_Biomed_Biotechnol_2008_Apr_29_2008_821529.nxml.txt.nlp	18483568	SENT21	26	26	7	7	cisplatin	FANCD2	PA449014	2177	0.781
NULL	Oncotarget_2014_Oct_21_5(22)_11180-11192.nxml.txt.nlp	25361003	SENT250	8	8	26	26	doxycycline	NTRK1	PA449415	4914	0.781
NULL	Cardiovasc_J_Afr_2013_Mar_24(2)_19-23.nxml.txt.nlp	23750346	SENT111	26	26	13	13	warfarin	CYP3A4	PA451906	1576	0.781
NULL	Cell_Death_Dis_2013_Jun_6_4(6)_e654.nxml.txt.nlp	23744354	SENT183	14	14	17	17	fluorescein	P-gp	PA164746009	5243	0.781
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S31-S40.nxml.txt.nlp	20680106	SENT70	29	29	34	34	panitumumab	KRAS	PA162373091	3845	0.781
NULL	Diabetes_Care_2013_Jun_15_36(6)_1779-1788.nxml.txt.nlp	23704680	SENT266	12	12	19	19	pioglitazone	adiponectin	PA450970	9370	0.781
NULL	J_Bras_Pneumol_2013_Jun-Aug_39(4)_434-439.nxml.txt.nlp	24068264	SENT179	20	20	42	42	pentobarbital	por	PA450859	64840	0.781
NULL	BMB_Rep_2013_Jan_46(1)_59-64.nxml.txt.nlp	23351386	SENT34	12	12	35	35	auranofin	STAT3	PA448510	6774	0.781
NULL	Diabetes_Care_2008_Aug_31(8)_1635-1638.nxml.txt.nlp	18458144	SENT6	22	22	27	27	ramipril	DREAM	PA451223	30818	0.781
NULL	Toxins_(Basel)_2010_Oct_26_2(11)_2490-2518.nxml.txt.nlp	22069563	SENT231	15	15	8	8	cisplatin	TLR9	PA449014	54106	0.781
NULL	Breast_Cancer_Res_2011_Nov_28_13(6)_R121.nxml.txt.nlp	22123186	SENT2	13	13	8	8	trastuzumab	HER2	PA451743	2064	0.781
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Nov_19_67(Pt_12)_o3378.nxml.txt.nlp	22199869	SENT56	20	20	3	3	ethanol	mol	PA448073	90527	0.781
NULL	Acta_Neuropathol_Commun_2014_Feb_7_2_16.nxml.txt.nlp	24507707	SENT35	23	23	13	13	ethanol	PUMA	PA448073	27113	0.781
NULL	J_Biol_Chem_2009_Jun_19_284(25)_17138-17146.nxml.txt.nlp	19383603	SENT39	21	21	3	3	thrombin	Atp12p	PA451674	91647	0.781
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT230	4	4	0	0	vinblastine	MVP	PA451877	9961	0.781
NULL	Br_J_Cancer_2009_Jan_13_100(1)_19-23.nxml.txt.nlp	19018262	SENT93	0	0	4	4	brivanib	VEGFR	PA164924492	3791	0.781
NULL	Diabetes_2008_Sep_57(9)_2296-2303.nxml.txt.nlp	18544705	SENT274	28	28	8	8	collagenase	Cc1	PA449107	9821	0.781
NULL	J_Hematol_Oncol_2014_Apr_28_7_37.nxml.txt.nlp	24775308	SENT184	30	30	22	22	imatinib	JAK2	PA10804	3717	0.781
NULL	Ann_Oncol_2011_Jan_13_22(1)_215-223.nxml.txt.nlp	20627875	SENT134	6	6	12	12	mesna	ETO	PA450385	862	0.781
NULL	Food_Nutr_Res_2008_Oct_1_52_10_3402_fnr_v52i0_1872.nxml.txt.nlp	19109651	SENT120	10	10	3	3	alendronate	Tech	PA448082	57449	0.781
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1699-1708.nxml.txt.nlp	19861960	SENT263	7	7	15	15	dasatinib	mol	PA162372878	90527	0.781
NULL	AIDS_Res_Treat_2011_Aug_28_2011_349165.nxml.txt.nlp	21904672	SENT105	11	11	1	1	etravirine	DUET	PA166014703	8997	0.781
NULL	Niger_Med_J_2011_Jul-Sep_52(3)_167-172.nxml.txt.nlp	22083028	SENT40	32	32	17	17	ganciclovir	CD4	PA449733	920	0.781
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT205	6	6	15	15	adalimumab	CD36	PA10004	948	0.781
NULL	Oncotarget_2013_Nov_24_4(12)_2430-2438.nxml.txt.nlp	24280348	SENT70	6	6	15	15	gefitinib	EGFR	PA131301952	1956	0.781
NULL	Br_J_Cancer_2011_Dec_6_105(12)_1920-1926.nxml.txt.nlp	22095222	SENT108	7	7	14	14	trastuzumab	PIK3CA	PA451743	5290	0.781
NULL	Drug_Saf_2014_Feb_19_37(4)_201-211.nxml.txt.nlp	24550106	SENT27	36	36	23	23	omeprazole	CYP3A4	PA450704	1576	0.781
NULL	Arthritis_Res_Ther_2010_Jul_6_12(4)_R129.nxml.txt.nlp	20604932	SENT213	31	31	6	6	collagenase	CCL5	PA449107	6352	0.781
NULL	Br_J_Cancer_2004_Mar_22_90(6)_1285-1292.nxml.txt.nlp	15026814	SENT143	3	3	6	6	doxorubicin	p53	PA449412	7157	0.781
NULL	Acta_Pharmacol_Sin_2014_Jun_4_35(6)_792-805.nxml.txt.nlp	24902787	SENT194	22	22	30	30	pravastatin	INS-1	PA451089	2305	0.781
NULL	J_Biomed_Biotechnol_2010_Jun_7_2010_150960.nxml.txt.nlp	20617134	SENT241	22	22	35	35	bevacizumab	KRAS	PA130232992	3845	0.781
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT165	8	8	13	13	capsaicin	MDM2	PA448776	4193	0.781
NULL	Arthritis_Res_Ther_2006_Nov_10_8(6)_220.nxml.txt.nlp	17118212	SENT231	10	10	13	13	capsaicin	TRPV1	PA448776	7442	0.781
NULL	Nat_Med_2011_May_1_17(5)_604-609.nxml.txt.nlp	21532597	SENT74	12	12	4	4	daclizumab	CD25	PA164764446	3669;3559	0.781
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1137-1144.nxml.txt.nlp	20234366	SENT170	17	17	12	12	irinotecan	MKP-1	PA450085	1843	0.781
NULL	Int_J_Nanomedicine_2007_Sep_2(3)_277-288.nxml.txt.nlp	18019828	SENT46	25	25	13	13	doxorubicin	CHOP	PA449412	1649	0.781
NULL	Cancer_Cell_Int_2012_Nov_23_12_49.nxml.txt.nlp	23176676	SENT37	8	8	1	1	vorinostat	HDAC	PA164748224	9734	0.781
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT132	0	0	7	7	metformin	CCL16	PA450395	6360	0.781
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Apr_21_68(Pt_5)_o1492.nxml.txt.nlp	22590364	SENT71	3	3	18	18	isoniazid	mol	PA450112	90527	0.781
NULL	Case_Rep_Transplant_2012_Dec_20_2012_126592.nxml.txt.nlp	23320241	SENT27	5	5	2	2	cyclophosphamide	CHOP	PA449165	1649	0.781
NULL	Pharmaceutics_2010_Jun_2_2(2)_258-274.nxml.txt.nlp	NULL	SENT173	40	40	34	34	risperidone	P-gp	PA451257	5243	0.781
NULL	Int_J_Biol_Sci_2015_Jan_1_11(1)_67-74.nxml.txt.nlp	25552931	SENT228	11	11	18	18	l-arginine	ADP	PA448478	23038	0.781
NULL	Ther_Clin_Risk_Manag_2005_Jun_1(2)_107-114.nxml.txt.nlp	18360550	SENT25	2	2	44	44	paclitaxel	Yes	PA450761	7525	0.781
NULL	Contemp_Oncol_(Pozn)_2012_Nov_20_16(5)_401-406.nxml.txt.nlp	23788917	SENT147	10	10	7	7	lapatinib	HER2	PA152241907	2064	0.781
NULL	Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.nxml.txt.nlp	24736980	SENT222	27	27	22	22	rosuvastatin	OATP1B1	PA134308647	10599	0.781
NULL	Indian_J_Med_Res_2012_May_135(5)_599-613.nxml.txt.nlp	22771588	SENT319	11	11	7	7	nadh	ND5	PA164755085	4540	0.781
NULL	Korean_J_Anesthesiol_2013_Dec_26_65(6_Suppl)_S135-S136.nxml.txt.nlp	24478846	SENT19	18	18	5	5	ropivacaine	SGB	PA451271	2719	0.781
NULL	Evid_Based_Complement_Alternat_Med_2012_May_9_2012_928234.nxml.txt.nlp	22649479	SENT133	0	0	12	12	atorvastatin	CYP7A1	PA448500	1581	0.781
NULL	Br_J_Cancer_2010_Oct_12_103(8)_1284-1291.nxml.txt.nlp	20859285	SENT134	10	10	15	15	tamoxifen	ERBB2	PA451581	2064	0.781
NULL	Chin_J_Cancer_2012_Apr_31(4)_178-184.nxml.txt.nlp	22237038	SENT78	22	22	10	10	niclosamide	S100A4	PA165958408	6275	0.781
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT127	19	19	2	2	capsaicin	p53	PA448776	7157	0.781
NULL	Indian_J_Anaesth_2014_Jul-Aug_58(4)_423-429.nxml.txt.nlp	25197110	SENT43	9	9	7	7	ondansetron	ODF	PA450705	8600	0.781
NULL	Oncotarget_2013_Nov_22_5(4)_933-943.nxml.txt.nlp	24659749	SENT112	14	14	0	0	nutlin-3	p53		7157	0.781
NULL	Mol_Cancer_2009_Nov_18_8_106.nxml.txt.nlp	19922650	SENT25	8	8	16	16	verapamil	CD19	PA451868	930	0.781
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT188	0	0	25	25	curcumin	TRAIL-R2	PA151958596	8795	0.781
NULL	Biomed_Res_Int_2013_Jul_15_2013_386074.nxml.txt.nlp	23956980	SENT3	13	13	20	20	clopidogrel	P2Y12	PA449053	64805	0.781
NULL	Acta_Pharmacol_Sin_2013_Sep_5_34(9)_1192-1200.nxml.txt.nlp	23685957	SENT209	5	5	30	30	curcumin	AP-2	PA151958596	7020	0.781
NULL	Mol_Cancer_2008_Jun_3_7_47.nxml.txt.nlp	18519000	SENT177	3	3	5	5	gefitinib	EGFR	PA131301952	1956	0.781
NULL	J_Cell_Biol_1995_Mar_2_128(6)_1185-1196.nxml.txt.nlp	7896881	SENT4	21	21	30	30	mitomycin	p53	PA450524	7157	0.781
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT258	4	4	0	0	vinblastine	MVP	PA451877	9961	0.781
NULL	Diabetes_2009_Dec_31_58(12)_2851-2862.nxml.txt.nlp	19720788	SENT107	7	7	11	11	forskolin	ATF4	PA146096022	468	0.781
NULL	Emerg_Med_Int_2014_Feb_20_2014_935474.nxml.txt.nlp	24696784	SENT212	13	13	17	17	rivaroxaban	STA	PA165958360	2010;2656	0.781
NULL	Front_Oncol_2014_Sep_15_4_244.nxml.txt.nlp	25309870	SENT28	7	7	23	23	gefitinib	EGFR	PA131301952	1956	0.781
NULL	Case_Rep_Oncol_2011_Nov_22_4(3)_534-541.nxml.txt.nlp	22187539	SENT87	6	6	20	20	paclitaxel	GEM	PA450761	2669	0.781
NULL	Mol_Vis_2012_Jul_18_18_1966-1972.nxml.txt.nlp	22876123	SENT105	22	22	4	4	curcumin	IL-4	PA151958596	3565	0.781
NULL	Diabetes_Obes_Metab_2012_Dec_19_14(12)_1097-1103.nxml.txt.nlp	22734440	SENT196	22	22	0	0	exenatide	San	PA164749238	80218	0.781
NULL	Br_J_Cancer_2011_Sep_6_105(6)_807-813.nxml.txt.nlp	21847121	SENT73	3	3	20	20	pha-665752	HER3		2065	0.781
NULL	Br_J_Cancer_2013_Dec_10_109(12)_2954-2958.nxml.txt.nlp	24231949	SENT69	5	5	2	2	nutlin-3	p53		7157	0.781
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_May_29_65(Pt_6)_o1404-o1405.nxml.txt.nlp	21583249	SENT75	7	7	23	23	benzaldehyde	mol	PA448571	90527	0.781
NULL	Biomed_Res_Int_2014_Jun_26_2014_161346.nxml.txt.nlp	25054130	SENT236	41	41	30	30	curcumin	STZ	PA151958596	6484	0.781
NULL	Int_J_Alzheimers_Dis_2010_Dec_27_2011_231595.nxml.txt.nlp	21234401	SENT111	14	14	7	7	iron	APP	PA450087	351	0.781
NULL	Int_J_Hypertens_2013_Mar_19_2013_175428.nxml.txt.nlp	23573410	SENT279	2	2	21	21	vasopressin	SON	PA451858	6651	0.781
NULL	Clin_Med_Insights_Oncol_2012_Dec_6_6_407-421.nxml.txt.nlp	23239933	SENT48	24	24	30	30	gefitinib	KRAS	PA131301952	3845	0.781
NULL	Br_J_Cancer_2009_Jul_21_101(2)_350-356.nxml.txt.nlp	19513075	SENT109	36	36	16	16	cisplatin	TP53	PA449014	7157	0.781
NULL	Ann_Rheum_Dis_2011_Apr_22_70(8)_1395-1400.nxml.txt.nlp	21515602	SENT182	15	15	8	8	warfarin	CYP2C9	PA451906	1559	0.781
NULL	AIDS_Res_Ther_2008_Mar_28_5_5.nxml.txt.nlp	18373851	SENT15	3	3	10	10	fosamprenavir	ATV	PA10084	4683	0.781
NULL	Indian_J_Ophthalmol_2007_Nov-Dec_55(6)_457-458.nxml.txt.nlp	17951904	SENT18	8	8	14	14	bevacizumab	INA	PA130232992	9118	0.781
NULL	Diabetes_Metab_J_2013_Oct_17_37(5)_315-325.nxml.txt.nlp	24199159	SENT194	44	44	17	17	resveratrol	AMPK		5563	0.781
NULL	ScientificWorldJournal_2012_Jun_18_2012_373709.nxml.txt.nlp	22761550	SENT106	29	29	17	17	sevoflurane	NALCN	PA451341	259232	0.781
NULL	Chonnam_Med_J_2014_Apr_22_50(1)_27-30.nxml.txt.nlp	24855605	SENT48	8	8	6	6	cyclophosphamide	CHOP	PA449165	1649	0.781
NULL	Nat_Commun_2014_Nov_25_5_5548.nxml.txt.nlp	25420520	SENT45	5	5	1	1	docetaxel	ERG	PA449383	2078	0.781
NULL	Aging_(Albany_NY)_2014_Mar_26_6(3)_187-206.nxml.txt.nlp	24753144	SENT202	10	10	4	4	liraglutide	GLP-1	PA165958364	100125288	0.781
NULL	J_Invest_Dermatol_2013_Mar_25_133(3)_793-802.nxml.txt.nlp	23096711	SENT10	13	13	15	15	diethylstilbestrol	DES	PA449307	1674	0.781
NULL	Int_J_Nanomedicine_2012_Sep_21_7_5091-5106.nxml.txt.nlp	23049256	SENT7	11	11	23	23	protamine	SOD1	PA10366	6647	0.781
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT2905	13	13	15	15	acetaminophen	TRAIL	PA448015	8743	0.781
NULL	Cancers_(Basel)_2012_Apr_5_4(2)_354-378.nxml.txt.nlp	24213315	SENT155	3	3	20	20	cisplatin	TRAIL-R2	PA449014	8795	0.781
NULL	Front_Endocrinol_(Lausanne)_2013_May_10_4_52.nxml.txt.nlp	23675368	SENT1612	0	0	18	18	rosiglitazone	IRS1	PA451283	3667	0.781
NULL	Case_Rep_Oncol_2012_Apr_13_5(1)_173-180.nxml.txt.nlp	22666209	SENT12	32	32	28	28	paclitaxel	OSC	PA450761	4047	0.781
NULL	Eur_Arch_Otorhinolaryngol_2013_Mar_13_270(4)_1397-1404.nxml.txt.nlp	23404469	SENT191	6	6	4	4	dasatinib	DDP	PA162372878	1678	0.781
NULL	J_Clin_Biochem_Nutr_2007_Jan_27_40(1)_13-23.nxml.txt.nlp	18437209	SENT575	37	37	32	32	trypsin	PAR2	PA451806	2150;55065;8856	0.781
NULL	Iran_J_Ped_Hematol_Oncol_2014_Jul_20_4(3)_118-126.nxml.txt.nlp	25254091	SENT112	16	16	21	21	doxorubicin	ABCA2	PA449412	20	0.781
NULL	Front_Oncol_2014_May_16_4_107.nxml.txt.nlp	24904823	SENT186	8	8	23	23	cyclophosphamide	HER-2	PA449165	2064	0.781
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT245	4	4	0	0	vinblastine	MVP	PA451877	9961	0.781
NULL	Core_Evid_2009_Jun_15_4_131-147.nxml.txt.nlp	20694070	SENT176	0	0	4	4	raltegravir	CD4		920	0.781
NULL	Adv_Hematol_2014_Nov_9_2014_369084.nxml.txt.nlp	25431593	SENT177	9	9	5	5	warfarin	GGCX	PA451906	2677	0.781
NULL	Int_J_Surg_Oncol_2012_May_17_2012_406830.nxml.txt.nlp	22675625	SENT51	10	10	28	28	panitumumab	KRAS	PA162373091	3845	0.781
NULL	Clin_Pharmacol_2012_Oct_26_4_65-70.nxml.txt.nlp	23204874	SENT25	8	8	13	13	pazopanib	VEGFR2	PA165291492	3791	0.781
NULL	Hum_Reprod_Update_2014_Jul_9_20(4)_485-500.nxml.txt.nlp	24615662	SENT204	24	24	35	35	naloxone	Casper	PA450586	8837	0.781
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT40	7	7	2	2	pemetrexed	UNG	PA10810	7374	0.781
NULL	Mol_Cancer_2012_Jul_12_11_45.nxml.txt.nlp	22788833	SENT134	34	34	10	10	cisplatin	EGFR	PA449014	1956	0.781
NULL	Aging_(Albany_NY)_2009_Mar_31_1(4)_412-424.nxml.txt.nlp	20195491	SENT131	23	23	34	34	resveratrol	G6PD		2539	0.781
NULL	Acta_Pharmacol_Sin_2014_Aug_7_35(8)_1023-1030.nxml.txt.nlp	24998255	SENT187	28	28	15	15	octreotide	E14	PA450678	4863	0.781
NULL	Clinics_(Sao_Paulo)_2010_Sep_65(9)_885-894.nxml.txt.nlp	21049217	SENT243	16	16	25	25	risperidone	spatial	PA451257	219793	0.781
NULL	Diabetes_Metab_J_2014_Aug_20_38(4)_245-251.nxml.txt.nlp	25215270	SENT66	5	5	3	3	metformin	FGF21	PA450395	26291	0.781
NULL	J_Korean_Med_Sci_2014_Jul_11_29(7)_965-972.nxml.txt.nlp	25045229	SENT120	21	21	12	12	metformin	B12	PA450395	7126;4709	0.781
NULL	Chem_Cent_J_2013_Apr_15_7_68.nxml.txt.nlp	23587363	SENT240	28	28	7	7	ethanol	mol	PA448073	90527	0.781
NULL	J_Oncol_2013_Feb_17_2013_872957.nxml.txt.nlp	23476648	SENT192	18	18	2	2	cisplatin	SFN	PA449014	25996;2810	0.781
NULL	J_Mol_Med_(Berl)_2014_Jun_1_92(8)_797-810.nxml.txt.nlp	24880953	SENT103	22	22	30	30	thrombin	C5a	PA451674	727	0.781
NULL	Nat_Commun_2011_May_24_2_326.nxml.txt.nlp	21610729	SENT80	26	26	19	19	l-tyrosine	TYR	PA451822	7299	0.781
NULL	J_Korean_Med_Sci_2009_Jun_16_24(3)_525-528.nxml.txt.nlp	19543522	SENT14	32	32	6	6	methotrexate	CHOP	PA450428	1649	0.781
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT96	4	4	26	26	etravirine	CYP3A4	PA166014703	1576	0.781
NULL	Arch_Med_Sci_2011_Dec_31_7(6)_1055-1066.nxml.txt.nlp	22328891	SENT16	13	13	9	9	simvastatin	SHARP	PA451363	23013	0.781
NULL	Acta_Pharmacol_Sin_2010_Feb_5_31(2)_184-190.nxml.txt.nlp	20139901	SENT122	3	3	6	6	metformin	OCT2	PA450395	6582;5452	0.781
NULL	J_Am_Heart_Assoc_2013_Dec_19_2(6)_e000407.nxml.txt.nlp	24166492	SENT162	21	21	19	19	doxorubicin	p53	PA449412	7157	0.781
NULL	Cardiovasc_Diabetol_2013_Jan_9_12_8.nxml.txt.nlp	23298374	SENT147	6	6	12	12	sitagliptin	adiponectin	PA164748978	9370	0.781
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT152	32	32	10	10	dasatinib	JNK	PA162372878	5599	0.781
NULL	Ann_Clin_Transl_Neurol_2014_Sep_30_1(9)_721-732.nxml.txt.nlp	25493285	SENT12	16	16	21	21	liraglutide	GLP-1	PA165958364	100125288	0.781
NULL	JAKSTAT_2013_Jan_1_2(1)_e22925.nxml.txt.nlp	24058789	SENT150	16	16	2	2	sorafenib	JAK2	PA7000	3717	0.781
NULL	J_Hematol_Oncol_2014_Aug_1_7_52.nxml.txt.nlp	25085632	SENT167	3	3	11	11	sunitinib	EGFR	PA162372840	1956	0.781
NULL	Cell_Cycle_2012_Dec_15_11(24)_4661-4672.nxml.txt.nlp	23187802	SENT145	17	17	15	15	doxorubicin	p53	PA449412	7157	0.781
NULL	Br_J_Clin_Pharmacol_2013_Aug_23_76(2)_299-315.nxml.txt.nlp	23701319	SENT94	16	16	21	21	rituximab	IFN	PA451261	3439	0.781
NULL	Braz_J_Med_Biol_Res_2013_Aug_13_46(8)_650-658.nxml.txt.nlp	23969971	SENT204	28	28	39	39	cisplatin	STAT3	PA449014	6774	0.781
NULL	Brain_Sci_2013_Jul_9_3(3)_1043-1059.nxml.txt.nlp	24961520	SENT123	8	8	29	29	rimonabant	CBR1	PA152407999	873	0.781
NULL	Cancer_Manag_Res_2011_May_10_3_157-175.nxml.txt.nlp	21625399	SENT293	10	10	18	18	itraconazole	CYP3A	PA450132	1574	0.781
NULL	J_Gen_Physiol_2003_May_121(5)_413-425.nxml.txt.nlp	12695484	SENT36	38	38	14	14	vasopressin	AQP2	PA451858	359	0.781
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_24_2012_673132.nxml.txt.nlp	23133498	SENT119	7	7	13	13	berberine	P-gp	PA165860812	5243	0.781
NULL	Cell_Death_Dis_2014_Mar_6_5(3)_e1108.nxml.txt.nlp	24603336	SENT64	16	16	5	5	etoposide	p53	PA449552	7157	0.781
NULL	Environ_Health_Perspect_2006_Apr_27_114(4)_500-506.nxml.txt.nlp	16581536	SENT46	7	7	2	2	estradiol	aromatase	PA449503	1588	0.781
NULL	Cell_Res_2014_Jul_9_24(7)_820-841.nxml.txt.nlp	24810299	SENT131	15	15	31	31	doxycycline	CD34	PA449415	947	0.781
NULL	Protein_Sci_2014_Dec_1_23(12)_1686-1697.nxml.txt.nlp	25200501	SENT185	7	7	13	13	nadh	G6PD	PA164755085	2539	0.781
NULL	Diabetes_2009_Jan_58(1)_243-249.nxml.txt.nlp	18840785	SENT100	7	7	10	10	vildagliptin	GLP-1	PA165958346	100125288	0.781
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jul_13_67(Pt_8)_o2017-o2018.nxml.txt.nlp	22091049	SENT75	0	0	25	25	flupenthixol	mol	PA10268	90527	0.781
NULL	Cancer_Cell_Int_2007_Sep_10_7_14.nxml.txt.nlp	17845729	SENT195	14	14	5	5	decitabine	PDCD5	PA164749631	9141	0.781
NULL	Int_J_Breast_Cancer_2012_Feb_26_2012_761917.nxml.txt.nlp	22482061	SENT121	37	37	43	43	lapatinib	PI3K	PA152241907	5290	0.781
NULL	Mol_Vis_2007_Jul_9_13_1083-1093.nxml.txt.nlp	17653053	SENT160	2	2	21	21	minocycline	RANTES	PA450519	6352	0.781
NULL	J_Vis_Exp_2009_Jan_16_(23)_990.nxml.txt.nlp	19229177	SENT58	24	24	8	8	papain	CO2	PA450778	4513	0.781
NULL	Int_J_Biol_Sci_2011_May_24_7(5)_673-684.nxml.txt.nlp	21647250	SENT196	4	4	10	10	berberine	AMPK	PA165860812	5563	0.781
NULL	Cardiovasc_Diabetol_2013_May_4_12_73.nxml.txt.nlp	23642288	SENT151	19	19	26	26	acarbose	GLP-1	PA448010	100125288	0.781
NULL	Mol_Pain_2013_Jun_10_9_27.nxml.txt.nlp	23758830	SENT114	10	10	13	13	tetracaine	ASIC2a	PA451638	40	0.781
NULL	Antimicrob_Agents_Chemother_2014_Oct_58(10)_5714-5718.nxml.txt.nlp	25022586	SENT41	10	10	24	24	ethanol	TGY	PA448073	343641	0.781
NULL	Nucleic_Acids_Res_2013_Nov_8_41(20)_9524-9536.nxml.txt.nlp	23935071	SENT221	6	6	36	36	potassium	L24	PA451047	6152	0.781
NULL	Cancer_Cell_Int_2005_Jul_29_5_24.nxml.txt.nlp	16053526	SENT48	20	20	38	38	chloramphenicol	p53	PA448927	7157	0.781
NULL	Asia_Pac_Allergy_2013_Oct_31_3(4)_266-280.nxml.txt.nlp	24260732	SENT104	22	22	36	36	amoxicillin	CD63	PA448406	967	0.781
NULL	J_Clin_Exp_Pathol_2012_May_17_Suppl_4_7327.nxml.txt.nlp	25379357	SENT26	16	16	13	13	resveratrol	SIRT1		23411	0.781
NULL	Pharmaceuticals_(Basel)_2011_May_17_4(5)_741-757.nxml.txt.nlp	NULL	SENT188	3	3	15	15	ethanol	RhoA	PA448073	387	0.781
NULL	Acta_Pharmacol_Sin_2011_Nov_10_32(11)_1402-1410.nxml.txt.nlp	21986579	SENT155	3	3	40	40	curcumin	p27	PA151958596	5715;10534	0.781
NULL	Eur_J_Clin_Pharmacol_2010_Nov_29_66(11)_1131-1136.nxml.txt.nlp	20669013	SENT118	7	7	9	9	erythromycin	CYP2C19	PA449493	1557	0.781
NULL	Mol_Vis_2012_Oct_5_18_2454-2467.nxml.txt.nlp	23077404	SENT175	6	6	2	2	bevacizumab	VEGF-A	PA130232992	7422	0.781
NULL	Breast_Cancer_Res_2009_Jun_23_11(Suppl_1)_P10.nxml.txt.nlp	NULL	SENT6	12	12	21	21	tamoxifen	p27	PA451581	5715;10534	0.781
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT280	19	19	28	28	clozapine	PRL	PA449061	5617	0.781
NULL	Clin_Ophthalmol_2007_Mar_1(1)_11-24.nxml.txt.nlp	19668462	SENT192	18	18	16	16	travoprost	BAK	PA164781371	578	0.781
NULL	ISRN_Neurosci_2013_Sep_5_2013_759640.nxml.txt.nlp	24959565	SENT106	14	14	38	38	etomidate	ANOVA	PA164743987	4858	0.781
NULL	Oncotarget_2012_Sep_27_3(10)_1137-1145.nxml.txt.nlp	23087155	SENT16	6	6	20	20	decitabine	DNMT1	PA164749631	1786	0.781
NULL	Diabetes_Care_2010_Nov_33(11)_2484-2485.nxml.txt.nlp	20980428	SENT36	13	13	8	8	pegaptanib	VEGF-A	PA164771236	7422	0.781
NULL	Cancer_Med_2014_Jun_16_3(3)_537-549.nxml.txt.nlp	24737780	SENT83	21	21	29	29	ethanol	SDS	PA448073	51119;10993	0.781
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT13	22	22	19	19	curcumin	TRAIL	PA151958596	8743	0.781
NULL	Breast_Cancer_Res_2011_May_26_13(3)_209.nxml.txt.nlp	21635709	SENT157	21	21	34	34	letrozole	HER2	PA450196	2064	0.781
NULL	Patient_Prefer_Adherence_2010_Sep_7_4_325-334.nxml.txt.nlp	20859459	SENT180	2	2	13	13	olanzapine	Gen	PA450688	348654	0.781
NULL	Ann_Surg_Oncol_2014_Sep_5_21(2)_553-559.nxml.txt.nlp	24006094	SENT10	7	7	4	4	doxorubicin	CO2	PA449412	4513	0.781
NULL	Cancer_Metab_2013_Feb_4_1_7.nxml.txt.nlp	24280108	SENT199	21	21	11	11	doxycycline	GOT2	PA449415	2806	0.781
NULL	Oncogene_2014_Feb_6_33(6)_713-723.nxml.txt.nlp	23435429	SENT53	16	16	7	7	camptothecin	BRCA1	PA153590860	672	0.781
NULL	J_Thromb_Haemost_2014_May_22_12(5)_726-735.nxml.txt.nlp	24581425	SENT188	22	22	4	4	thrombin	GEF	PA451674	56731	0.781
NULL	BMB_Rep_2014_Jul_47(7)_376-381.nxml.txt.nlp	24286332	SENT76	8	8	2	2	thrombin	PPG	PA451674	5552	0.781
NULL	Nat_Med_2011_Oct_2_17(10)_1304-1309.nxml.txt.nlp	21963515	SENT34	0	0	11	11	tacrolimus	TRPV5	PA451578	56302	0.781
NULL	Adv_Hematol_2009_Jun_22_2009_251915.nxml.txt.nlp	19946423	SENT149	25	25	15	15	hemin	HRI	PA449849	27102	0.781
NULL	Ann_Indian_Acad_Neurol_2010_Jul-Sep_13(3)_211-212.nxml.txt.nlp	21085535	SENT57	22	22	20	20	clonazepam	ACTH	PA449050	5443	0.781
NULL	Biosci_Rep_2012_Dec_1_32(Pt_6)_619-629.nxml.txt.nlp	NULL	SENT114	4	4	7	7	troglitazone	PPARG	PA451799	5468	0.781
NULL	Mol_Cancer_2007_Sep_24_6_59.nxml.txt.nlp	17888187	SENT168	3	3	19	19	raloxifene	p65	PA451221	5970	0.781
NULL	Ann_Surg_Oncol_2010_Apr_20_17(4)_1168-1176.nxml.txt.nlp	19936839	SENT87	3	3	10	10	cetuximab	KRAS	PA10040	3845	0.781
NULL	Arthritis_Res_Ther_2009_Aug_28_11(4)_R131.nxml.txt.nlp	19715572	SENT156	5	5	26	26	rituximab	CD69	PA451261	969	0.781
NULL	J_Biomed_Biotechnol_2010_May_20_2010_263810.nxml.txt.nlp	20508848	SENT21	8	8	2	2	ribavirin	IFN	PA451241	3439	0.781
NULL	Curr_Neuropharmacol_2011_Dec_9(4)_530-552.nxml.txt.nlp	22654714	SENT153	8	8	17	17	duloxetine	BDNF	PA10066	627	0.781
NULL	Cancer_Imaging_2011_Mar_1_11(1)_1-8.nxml.txt.nlp	21362586	SENT73	42	42	36	36	tariquidar	P-gp		5243	0.781
NULL	Cancer_Cell_Int_2010_Apr_29_10_12.nxml.txt.nlp	20429927	SENT124	13	13	2	2	bortezomib	HRI	PA10252	27102	0.781
NULL	Sci_Rep_2014_Nov_28_4_7237.nxml.txt.nlp	25429875	SENT114	15	15	40	40	hesperidin	p38	PA449867	10598;1432;7965	0.781
NULL	Indian_J_Med_Paediatr_Oncol_2013_Jul-Sep_34(3)_213-220.nxml.txt.nlp	24516315	SENT45	13	13	19	19	imatinib	LYN	PA10804	4067	0.781
NULL	Acta_Pharmacol_Sin_2011_Feb_4_32(2)_239-244.nxml.txt.nlp	21293476	SENT167	5	5	11	11	urokinase	APT	PA451836	653639	0.781
NULL	J_Hematol_Oncol_2011_Dec_1_4_49.nxml.txt.nlp	22128838	SENT33	38	38	19	19	bortezomib	Bcl-2	PA10252	596	0.781
NULL	Exp_Cell_Res_2011_Apr_15_317(7)_1028-1039.nxml.txt.nlp	21237154	SENT121	4	4	2	2	staurosporine	TRAIL	PA165109623	8743	0.781
NULL	Breast_Cancer_Res_2008_Dec_16_10(6)_R105.nxml.txt.nlp	19087274	SENT12	18	18	44	44	creatine	GSTM3	PA164778930	2947	0.781
NULL	Allergy_Asthma_Immunol_Res_2010_Jan_30_2(1)_48-54.nxml.txt.nlp	20224678	SENT24	32	32	43	43	montelukast	CYSLTR2	PA450546	57105	0.781
NULL	Oncoimmunology_2012_Nov_1_1(8)_1445-1447.nxml.txt.nlp	23243624	SENT28	40	40	13	13	bevacizumab	CD83	PA130232992	9308	0.781
NULL	Clin_Med_Insights_Oncol_2012_Nov_20_6_381-393.nxml.txt.nlp	23226079	SENT138	23	23	7	7	sunitinib	CYP3A4	PA162372840	1576	0.781
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1495-1502.nxml.txt.nlp	21989186	SENT195	9	9	23	23	fluorouracil	HSI	PA128406956	57016	0.781
NULL	Arthritis_Res_Ther_2012_Jan_23_14(1)_R17.nxml.txt.nlp	22269139	SENT222	12	12	14	14	diethylstilbestrol	DES	PA449307	1674	0.781
NULL	Open_Med_Chem_J_2011_Sep_9_5_82-92.nxml.txt.nlp	21966329	SENT74	0	0	7	7	liraglutide	GLP-1	PA165958364	100125288	0.781
NULL	Oncotarget_2013_Aug_26_4(10)_1662-1672.nxml.txt.nlp	24091566	SENT148	15	15	1	1	trastuzumab	HER2	PA451743	2064	0.781
NULL	J_Am_Heart_Assoc_2013_Aug_23_2(4)_e000263.nxml.txt.nlp	23900214	SENT52	4	4	12	12	fluorescein	SNA	PA164746009	6615	0.781
NULL	J_Clin_Biochem_Nutr_2008_Jan_28_42(1)_29-34.nxml.txt.nlp	18231627	SENT185	13	13	7	7	ethanol	spatial	PA448073	219793	0.781
NULL	Ann_Thorac_Med_2013_Apr-Jun_8(2)_109-115.nxml.txt.nlp	23741274	SENT3	19	19	13	13	docetaxel	CRT	PA449383	811	0.781
NULL	Oncoimmunology_2012_Oct_1_1(7)_1038-1047.nxml.txt.nlp	23170252	SENT147	25	25	0	0	l-glutamine	CT26	PA10090	168400	0.781
NULL	Front_Immunol_2013_Nov_18_4_382.nxml.txt.nlp	24302925	SENT97	0	0	16	16	zoledronate	IFN	PA10235	3439	0.781
NULL	Int_J_Gen_Med_2012_Nov_12_5_943-951.nxml.txt.nlp	23204858	SENT112	13	13	21	21	tolterodine	CYP2D6	PA164746757	1565	0.781
NULL	Arch_Drug_Inf_2009_Mar_2(1)_1-7.nxml.txt.nlp	19381337	SENT26	26	26	35	35	ritonavir	CYP3A4	PA451260	1576	0.781
NULL	Oncotarget_2011_Mar_27_2(3)_209-221.nxml.txt.nlp	21444945	SENT32	11	11	18	18	geldanamycin	HSF1	PA152031327	3297	0.781
NULL	Biomed_Res_Int_2014_May_12_2014_989101.nxml.txt.nlp	24901006	SENT99	27	27	8	8	indinavir	p24	PA449977	11261;140767	0.781
NULL	Nucleic_Acids_Res_2012_Jul_5_40(13)_5988-6000.nxml.txt.nlp	22492511	SENT131	21	21	8	8	flavopiridol	RGM	PA452627	56963	0.781
NULL	Brain_Res_2011_Mar_25_1382(C)_29-36.nxml.txt.nlp	21276431	SENT13	4	4	0	0	ketanserin	5-HT2A	PA131053734	3356	0.781
NULL	Biomed_Res_Int_2013_Dec_23_2013_287696.nxml.txt.nlp	23509704	SENT121	13	13	18	18	ramipril	DREAM	PA451223	30818	0.781
NULL	Exp_Ther_Med_2014_Jun_27_7(6)_1752-1756.nxml.txt.nlp	24926379	SENT9	4	4	15	15	vildagliptin	PPG	PA165958346	5552	0.781
NULL	J_Physiol_2014_Nov_15_592(22)_5093-5107.nxml.txt.nlp	25239460	SENT156	14	14	17	17	ketoprofen	PAG	PA450149	55824	0.781
NULL	Int_J_Environ_Res_Public_Health_2011_Jul_30_8(7)_2747-2757.nxml.txt.nlp	21845156	SENT134	14	14	25	25	trypsin	PRSS2	PA451806	5645	0.781
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT120	6	6	19	19	resveratrol	PARP		142	0.781
NULL	J_Biol_Chem_2012_Apr_6_287(15)_12433-12444.nxml.txt.nlp	22351758	SENT980	21	21	5	5	hyaluronan	TSG-6	PA165958431	7130	0.781
NULL	Stroke_Res_Treat_2011_Nov_10_2011_212485.nxml.txt.nlp	22135769	SENT221	7	7	2	2	ticagrelor	ABCB1	PA165374673	5243	0.781
NULL	EMBO_J_2009_Mar_18_28(6)_663-676.nxml.txt.nlp	19214186	SENT406	15	15	27	27	forskolin	U87	PA146096022	677775;641648	0.781
NULL	Exp_Diabetes_Res_2012_Apr_17_2012_635472.nxml.txt.nlp	22577369	SENT69	7	7	18	18	sitagliptin	GLP-1	PA164748978	100125288	0.781
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_408-414.nxml.txt.nlp	21372831	SENT144	35	35	4	4	doxorubicin	spatial	PA449412	219793	0.781
NULL	Front_Pharmacol_2014_Nov_25_5_256.nxml.txt.nlp	25505414	SENT111	9	9	20	20	propofol	KCC2	PA451141	57468	0.781
NULL	Brain_Sci_2013_Jun_14_3(2)_941-963.nxml.txt.nlp	24961432	SENT132	14	14	2	2	ethanol	TLR4	PA448073	7099	0.781
NULL	Indian_J_Pharm_Sci_2013_Jan-Feb_75(1)_31-35.nxml.txt.nlp	23901158	SENT75	14	14	5	5	dicloxacillin	DCX	PA164749649	1641	0.781
NULL	Clin_Ophthalmol_2014_Mar_2_8_343-346.nxml.txt.nlp	24591809	SENT42	4	4	8	8	ranibizumab	PED	PA164746012	8682	0.781
NULL	Int_J_Mol_Sci_2014_Oct_14_15(10)_18557-18573.nxml.txt.nlp	25318057	SENT176	5	5	17	17	bortezomib	c-Jun	PA10252	3725	0.781
NULL	Natl_J_Maxillofac_Surg_2011_Jul-Dec_2(2)_210-213.nxml.txt.nlp	22639517	SENT63	14	14	8	8	cyclophosphamide	CHOP	PA449165	1649	0.781
NULL	Cell_Cycle_2012_Nov_1_11(21)_3983-3996.nxml.txt.nlp	22987153	SENT123	8	8	12	12	cisplatin	DNA2	PA449014	1763	0.781
NULL	Chemother_Res_Pract_2011_Dec_1_2011_715469.nxml.txt.nlp	22312557	SENT134	18	18	21	21	cisplatin	p53	PA449014	7157	0.781
NULL	Sci_Rep_2014_Dec_16_4_7500.nxml.txt.nlp	25511254	SENT335	4	4	1	1	hyperforin	TRPC6	PA165985514	7225	0.781
NULL	Evid_Based_Complement_Alternat_Med_2012_Feb_12_2012_472897.nxml.txt.nlp	22454667	SENT128	0	0	15	15	hesperetin	IL-2	PA164742902	3558	0.781
NULL	Int_J_Mol_Sci_2014_May_8_15(5)_8106-8121.nxml.txt.nlp	24815071	SENT463	25	25	17	17	atorvastatin	LC3	PA448500	84557	0.781
NULL	Ann_Gastroenterol_2013_26(1)_29-36.nxml.txt.nlp	24714698	SENT75	12	12	7	7	fluorouracil	STZ	PA128406956	6484	0.781
NULL	Int_J_Mol_Sci_2010_May_5_11(5)_2039-2055.nxml.txt.nlp	20559500	SENT389	15	15	2	2	scopolamine	spatial	PA451308	219793	0.781
NULL	Int_J_Nanomedicine_2010_Feb_2_5_25-36.nxml.txt.nlp	20161985	SENT32	22	22	2	2	fluorescein	ITK	PA164746009	3702	0.781
NULL	Ann_Hematol_2014_Aug_17_93(3)_403-409.nxml.txt.nlp	23955074	SENT160	22	22	28	28	rituximab	CHOP	PA451261	1649	0.781
NULL	Oncoscience_2014_Apr_30_1(4)_283-286.nxml.txt.nlp	25594020	SENT6	33	33	17	17	rituximab	STAT6	PA451261	6778	0.781
NULL	Oncoimmunology_2013_Aug_1_2(8)_e25375.nxml.txt.nlp	24167764	SENT15	0	0	24	24	ethanol	TLR4	PA448073	7099	0.781
NULL	Cardiovasc_Res_2014_Nov_1_104(2)_258-269.nxml.txt.nlp	25209314	SENT251	16	16	26	26	verapamil	ANOVA	PA451868	4858	0.781
NULL	Cancer_Med_2014_Feb_16_3(1)_111-117.nxml.txt.nlp	24403010	SENT44	15	15	7	7	capecitabine	CRT	PA448771	811	0.781
NULL	Mol_Vis_2011_Aug_25_17_2297-2310.nxml.txt.nlp	21921981	SENT217	6	6	9	9	estradiol	HSD17B1	PA449503	3292	0.781
NULL	Drug_Saf_2014_Feb_19_37(4)_201-211.nxml.txt.nlp	24550106	SENT148	11	11	22	22	lansoprazole	CYP2C19	PA450180	1557	0.781
NULL	Indian_J_Med_Paediatr_Oncol_2014_Jul-Sep_35(3)_192-196.nxml.txt.nlp	25336788	SENT31	26	26	30	30	panitumumab	BRAF	PA162373091	673	0.781
NULL	Mol_Cancer_2009_Nov_24_8_109.nxml.txt.nlp	19930708	SENT154	14	14	19	19	exemestane	EGFR	PA449563	1956	0.781
NULL	Front_Psychiatry_2014_Mar_25_5_30.nxml.txt.nlp	24723894	SENT190	29	29	14	14	ketamine	spatial	PA450144	219793	0.781
NULL	J_Gastrointest_Surg_2012_Apr_13_16(4)_842-848.nxml.txt.nlp	22246855	SENT94	22	22	16	16	lapatinib	HER2	PA152241907	2064	0.781
NULL	Front_Oncol_2013_Nov_15_3_281.nxml.txt.nlp	24298448	SENT188	29	29	16	16	cetuximab	KRAS	PA10040	3845	0.781
NULL	J_Invest_Dermatol_2013_Mar_25_133(3)_793-802.nxml.txt.nlp	23096711	SENT43	8	8	10	10	diethylstilbestrol	DES	PA449307	1674	0.78
NULL	Anesth_Pain_Med_2013_Dec_27_4(1)_e11906.nxml.txt.nlp	24660144	SENT108	5	5	12	12	rituximab	VIII	PA451261	1351	0.78
NULL	Br_J_Cancer_2013_Apr_16_108(7)_1408-1414.nxml.txt.nlp	23511562	SENT120	19	19	7	7	tamoxifen	ATAC	PA451581	6375	0.78
NULL	Acta_Pharmacol_Sin_2012_Mar_30_33(3)_401-406.nxml.txt.nlp	22286916	SENT131	26	26	37	37	cisplatin	DDP	PA449014	1678	0.78
NULL	Oncol_Lett_2013_Oct_24_6(4)_985-989.nxml.txt.nlp	24137450	SENT130	21	21	28	28	vincristine	ADM	PA451879	133	0.78
NULL	J_Cell_Biol_2006_Sep_25_174(7)_1047-1058.nxml.txt.nlp	17000881	SENT242	0	0	5	5	forskolin	VEGFR1	PA146096022	2321	0.78
NULL	Crit_Care_2008_Dec_17_12(6)_R159.nxml.txt.nlp	19091080	SENT158	12	12	17	17	rolipram	PDE4B	PA153906323	5142	0.78
NULL	Case_Rep_Transplant_2011_Jan_5_2011_210178.nxml.txt.nlp	23213600	SENT39	29	29	11	11	tacrolimus	CYP3A	PA451578	1574	0.78
NULL	Cells_2014_Jan_27_3(1)_53-78.nxml.txt.nlp	24709902	SENT1739	8	8	4	4	trastuzumab	IL6	PA451743	3569	0.78
NULL	Mol_Cancer_2014_Jun_30_13_160.nxml.txt.nlp	24976026	SENT150	16	16	20	20	bortezomib	AGR2	PA10252	10551	0.78
NULL	Clin_Psychopharmacol_Neurosci_2011_Apr_30_9(1)_36-43.nxml.txt.nlp	23431025	SENT36	34	34	29	29	aripiprazole	HIP	PA10026	6767;6159;64399;5068	0.78
NULL	Open_Allergy_J_2010_3_91-101.nxml.txt.nlp	25018787	SENT271	2	2	10	10	omalizumab	IL-13	PA164752253	3596	0.78
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT122	17	17	10	10	trastuzumab	HER2	PA451743	2064	0.78
NULL	Front_Genet_2012_Oct_10_3_206.nxml.txt.nlp	23087703	SENT128	11	11	17	17	estradiol	CYP2C19	PA449503	1557	0.78
NULL	Hematol_Rep_2011_Oct_10_3(2)_e16.nxml.txt.nlp	22184537	SENT63	8	8	22	22	acenocoumarol	CD4	PA452632	920	0.78
NULL	J_Anaesthesiol_Clin_Pharmacol_2011_Oct-Dec_27(4)_435-437.nxml.txt.nlp	22096272	SENT62	14	14	4	4	desflurane	REL	PA164749136	5966	0.78
NULL	J_Mol_Signal_2010_May_10_5_4.nxml.txt.nlp	20459745	SENT57	21	21	7	7	cisplatin	p53	PA449014	7157	0.78
NULL	Front_Genet_2012_Nov_5_3_236.nxml.txt.nlp	23133441	SENT122	31	31	11	11	efavirenz	ABCB1	PA449441	5243	0.78
NULL	Brain_Behav_2011_Sep_1(1)_44-54.nxml.txt.nlp	22398980	SENT178	0	0	29	29	heroin	CO2	PA452619	4513	0.78
NULL	Environ_Health_Perspect_1998_Jan_106(1)_23-26.nxml.txt.nlp	9417770	SENT7	19	19	17	17	genistein	mol	PA165109660	90527	0.78
NULL	Gene_Regul_Syst_Bio_2014_Mar_4_8_63-73.nxml.txt.nlp	24634581	SENT247	0	0	8	8	minocycline	STAT3	PA450519	6774	0.78
NULL	Nat_Med_2010_Jun_23_16(6)_671-677.nxml.txt.nlp	20495567	SENT112	4	4	12	12	sorafenib	MCL1	PA7000	4170	0.78
NULL	Environ_Health_Perspect_2009_Feb_8_117(2)_175-180.nxml.txt.nlp	19270784	SENT136	2	2	7	7	doxorubicin	survivin	PA449412	332	0.78
NULL	Mol_Cancer_2008_Jun_4_7_49.nxml.txt.nlp	18533032	SENT107	19	19	3	3	tamoxifen	GATA3	PA451581	2625	0.78
NULL	Oncotarget_2014_Feb_2_5(3)_754-763.nxml.txt.nlp	24504508	SENT263	11	11	7	7	trastuzumab	HER2	PA451743	2064	0.78
NULL	Biosci_Rep_2013_Mar_13_33(2)_e00029.nxml.txt.nlp	23387308	SENT157	0	0	14	14	resveratrol	Bcl-2		596	0.78
NULL	Br_J_Cancer_2002_Apr_22_86(8)_1257-1261.nxml.txt.nlp	11953882	SENT112	8	8	10	10	cimetidine	IL-2	PA449001	3558	0.78
NULL	Gastric_Cancer_2014_Oct_19_17(3)_489-496.nxml.txt.nlp	24142107	SENT70	7	7	5	5	rabeprazole	ESD	PA451216	2098	0.78
NULL	Front_Endocrinol_(Lausanne)_2011_Dec_2_2_90.nxml.txt.nlp	22654832	SENT176	15	15	19	19	estradiol	STX	PA449503	8128	0.78
NULL	Nucleic_Acids_Res_2013_May_5_41(10)_5210-5222.nxml.txt.nlp	23563151	SENT12	10	10	4	4	arsenite	GADD45	PA452638	1647	0.78
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT207	7	7	12	12	tacrolimus	RANKL	PA451578	8600	0.78
NULL	Br_J_Haematol_2014_Mar_13_164(1)_811-821.nxml.txt.nlp	24328678	SENT10	11	11	22	22	lenalidomide	Aiolos	PA162363968	22806	0.78
NULL	Front_Endocrinol_(Lausanne)_2011_Apr_25_2_9.nxml.txt.nlp	22649361	SENT31	8	8	20	20	estradiol	aromatase	PA449503	1588	0.78
NULL	Clin_Pharmacol_2013_Jul_4_5_117-129.nxml.txt.nlp	23861604	SENT4	4	4	20	20	denosumab	RANKL	PA166048634	8600	0.78
NULL	J_Cell_Mol_Med_2014_May_14_18(5)_811-823.nxml.txt.nlp	24628949	SENT106	14	14	8	8	docetaxel	FOXM1	PA449383	2305	0.78
NULL	Anat_Cell_Biol_2011_Mar_31_44(1)_14-24.nxml.txt.nlp	21519545	SENT36	29	29	12	12	cyclophosphamide	CK8	PA449165	3856	0.78
NULL	Nucleic_Acids_Res_2005_Mar_1_33(4)_1352-1361.nxml.txt.nlp	15741187	SENT28	8	8	10	10	bleomycin	BLM	PA448645	641	0.78
NULL	Cancer_Cell_Int_2014_Jul_2_14_59.nxml.txt.nlp	25120382	SENT136	18	18	20	20	metformin	Met	PA450395	79811	0.78
NULL	Cancer_Inform_2010_Apr_27_9_93-103.nxml.txt.nlp	20467479	SENT205	13	13	1	1	efavirenz	CYP2B6	PA449441	1555	0.78
NULL	Front_Neural_Circuits_2013_Sep_20_7_148.nxml.txt.nlp	24065892	SENT252	2	2	23	23	scopolamine	HDB	PA451308	26512	0.78
NULL	J_Nat_Sci_Biol_Med_2012_Jul-Dec_3(2)_189-191.nxml.txt.nlp	23225984	SENT74	14	14	21	21	doxorubicin	CHOP	PA449412	1649	0.78
NULL	FEBS_Open_Bio_2014_Aug_30_4_763-776.nxml.txt.nlp	25349781	SENT213	15	15	4	4	curcumin	NAC	PA151958596	22861	0.78
NULL	Front_Oncol_2014_Sep_23_4_264.nxml.txt.nlp	25295231	SENT265	34	34	25	25	rituximab	p53	PA451261	7157	0.78
NULL	Ann_Indian_Acad_Neurol_2008_Jan-Mar_11(1)_13-19.nxml.txt.nlp	19966973	SENT55	22	22	7	7	curcumin	C21	PA151958596	79718	0.78
NULL	Aging_(Albany_NY)_2011_Dec_16_3(12)_1142-1153.nxml.txt.nlp	22184279	SENT156	4	4	13	13	resveratrol	AMPK		5563	0.78
NULL	Br_J_Cancer_2010_Sep_7_103(6)_765-771.nxml.txt.nlp	20700120	SENT149	23	23	20	20	tamoxifen	aromatase	PA451581	1588	0.78
NULL	Cancer_Immunol_Immunother_2013_Aug_27_62(10)_1637-1648.nxml.txt.nlp	23982484	SENT168	30	30	39	39	lenalidomide	DNAM-1	PA162363968	10666	0.78
NULL	Angiogenesis_2013_Apr_10_16(2)_373-386.nxml.txt.nlp	23143659	SENT28	22	22	38	38	temozolomide	MDR1	PA451609	5243	0.78
NULL	Cardiovasc_Diabetol_2010_Nov_16_9_76.nxml.txt.nlp	21080957	SENT47	9	9	26	26	ketamine	S12	PA450144	3351;6206;5713;6268	0.78
NULL	J_Hematol_Oncol_2008_Oct_23_1_19.nxml.txt.nlp	18947412	SENT122	10	10	18	18	alemtuzumab	CD34	PA164783958	947	0.78
NULL	Target_Oncol_2013_Jun_27_8(2)_127-136.nxml.txt.nlp	23625191	SENT121	27	27	38	38	panitumumab	KRAS	PA162373091	3845	0.78
NULL	EJC_Suppl_2013_Sep_5_11(2)_310-311.nxml.txt.nlp	NULL	SENT41	16	16	24	24	imatinib	aromatase	PA10804	1588	0.78
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Oct_28_65(Pt_11)_o2899.nxml.txt.nlp	21578481	SENT63	22	22	28	28	vanillin	mol	PA451852	90527	0.78
NULL	Biosci_Rep_2014_Aug_6_34(4)_e00131.nxml.txt.nlp	24975826	SENT153	11	11	28	28	pp2	TRPM8		79054	0.78
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Nov_27_66(Pt_12)_o3337.nxml.txt.nlp	21589611	SENT46	19	19	34	34	ethanol	mol	PA448073	90527	0.78
NULL	Int_J_Biol_Sci_2013_Apr_22_9(4)_350-360.nxml.txt.nlp	23630447	SENT30	37	37	29	29	doxorubicin	MDR1	PA449412	5243	0.78
NULL	BMJ_Open_2013_Feb_26_3(2)_e002149.nxml.txt.nlp	23447463	SENT258	11	11	23	23	amantadine	Gen	PA448360	348654	0.78
NULL	Arthritis_Res_Ther_2009_Jan_3_11(1)_R1.nxml.txt.nlp	19121222	SENT11	8	8	14	14	estradiol	IFN	PA449503	3439	0.78
NULL	Oncogene_2010_Jul_8_29(27)_3896-3907.nxml.txt.nlp	20453888	SENT112	12	12	32	32	trastuzumab	HER2	PA451743	2064	0.78
NULL	Int_J_Biol_Sci_2013_Mar_7_9(3)_279-288.nxml.txt.nlp	23493630	SENT17	2	2	13	13	tocilizumab	CD4	PA165292659	920	0.78
NULL	Oncol_Lett_2014_Jun_8_7(6)_1903-1910.nxml.txt.nlp	24932256	SENT101	22	22	20	20	cisplatin	CRT	PA449014	811	0.78
NULL	Int_J_Gen_Med_2010_Oct_5_3_313-320.nxml.txt.nlp	21042570	SENT117	6	6	17	17	natalizumab	CD4	PA164747191	920	0.78
NULL	J_Hum_Genet_2013_Jun_23_58(6)_339-345.nxml.txt.nlp	23697979	SENT55	29	29	34	34	clopidogrel	ADP	PA449053	23038	0.78
NULL	Chin_J_Cancer_2012_Jul_31(7)_348-353.nxml.txt.nlp	22704490	SENT6	7	7	5	5	rituximab	CHOP	PA451261	1649	0.78
NULL	Biomed_Res_Int_2014_Jun_26_2014_161346.nxml.txt.nlp	25054130	SENT3	7	7	24	24	curcumin	NOX2	PA151958596	1536	0.78
NULL	Mol_Cancer_2010_Jun_25_9_165.nxml.txt.nlp	20576164	SENT0	9	9	18	18	curcumin	STAT3	PA151958596	6774	0.78
NULL	Oncotarget_2012_May_18_3(5)_525-534.nxml.txt.nlp	22619113	SENT44	5	5	13	13	fludarabine	IL-4	PA449655	3565	0.78
NULL	Cell_Commun_Signal_2013_Oct_1_11_73.nxml.txt.nlp	24083678	SENT168	15	15	10	10	sulindac	IL-8	PA451565	3576	0.78
NULL	Br_J_Cancer_2010_Sep_7_103(6)_796-801.nxml.txt.nlp	20823888	SENT106	32	32	39	39	sirolimus	D29	PA451365	55520	0.78
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT82	0	0	9	9	curcumin	DcR1	PA151958596	8794	0.78
NULL	Mol_Biol_Int_2011_Feb_24_2011_137459.nxml.txt.nlp	22091395	SENT83	15	15	8	8	arsenite	PRMT3	PA452638	10196	0.78
NULL	Chemother_Res_Pract_2012_Dec_20_2012_743193.nxml.txt.nlp	23320171	SENT122	14	14	7	7	trastuzumab	HER2	PA451743	2064	0.78
NULL	Int_J_Gen_Med_2012_May_4_5_403-411.nxml.txt.nlp	22615536	SENT83	18	18	22	22	pioglitazone	RBP4	PA450970	5433;5950	0.78
NULL	Mol_Cancer_2009_Jul_3_8_43.nxml.txt.nlp	19575780	SENT107	8	8	2	2	colchicine	survivin	PA449092	332	0.78
NULL	Oncol_Lett_2014_Nov_12_8(5)_2203-2208.nxml.txt.nlp	25295109	SENT13	20	20	30	30	celecoxib	GLI1	PA448871	2735	0.78
NULL	Diabetes_Obes_Metab_2011_Apr_13(4)_348-356.nxml.txt.nlp	21205128	SENT93	26	26	3	3	liraglutide	PPG	PA165958364	5552	0.78
NULL	Cardiol_Res_Pract_2012_Sep_5_2012_607486.nxml.txt.nlp	22988540	SENT155	16	16	20	20	dobutamine	FDG	PA449381	23583	0.78
NULL	Front_Neurol_2014_Dec_11_5_264.nxml.txt.nlp	25566171	SENT68	22	22	19	19	olanzapine	IL-6	PA450688	3569	0.78
NULL	Front_Oncol_2012_Oct_2_2_127.nxml.txt.nlp	23061044	SENT20	7	7	11	11	imatinib	BRAF	PA10804	673	0.78
NULL	Eur_J_Clin_Pharmacol_2011_May_8_67(5)_493-506.nxml.txt.nlp	21140139	SENT157	6	6	4	4	carbamazepine	CYP3A4	PA448785	1576	0.78
NULL	Biomed_Rep_2014_May_26_2(3)_344-348.nxml.txt.nlp	24748972	SENT34	13	13	26	26	trypsin	survivin	PA451806	332	0.78
NULL	Ann_Rheum_Dis_2014_Jan_13_73(1)_95-100.nxml.txt.nlp	23765873	SENT208	8	8	28	28	tocilizumab	IL-6	PA165292659	3569	0.78
NULL	Eur_Arch_Otorhinolaryngol_2013_Mar_13_270(4)_1397-1404.nxml.txt.nlp	23404469	SENT192	6	6	11	11	dasatinib	DDP	PA162372878	1678	0.78
NULL	Br_J_Cancer_2011_Sep_6_105(6)_796-806.nxml.txt.nlp	21847123	SENT205	5	5	45	45	trastuzumab	AKT1	PA451743	207	0.78
NULL	Cell_Res_2013_Jun_21_23(6)_746-758.nxml.txt.nlp	23689277	SENT52	3	3	14	14	resveratrol	p25		11076;84516	0.78
NULL	Mol_Cancer_2014_Jan_28_13_17.nxml.txt.nlp	24472312	SENT117	28	28	30	30	ponatinib	Mcl-1	PA165980594	4170	0.78
NULL	Cancer_Cell_2007_Dec_11_12(6)_514-527.nxml.txt.nlp	18068629	SENT121	17	17	24	24	paclitaxel	ANOVA	PA450761	4858	0.78
NULL	Oncoimmunology_2013_May_1_2(5)_e23850.nxml.txt.nlp	23762785	SENT38	9	9	25	25	denosumab	RANK	PA166048634	8792	0.78
NULL	Oncotarget_2014_Feb_1_5(6)_1576-1594.nxml.txt.nlp	24742531	SENT142	24	24	6	6	doxorubicin	NGAL	PA449412	3934	0.78
NULL	Psychiatry_Investig_2009_Sep_23_6(3)_185-193.nxml.txt.nlp	20046394	SENT174	39	39	9	9	carbamazepine	TGB	PA448785	5473	0.78
NULL	Arch_Med_Sci_2012_Nov_9_8(5)_865-873.nxml.txt.nlp	23185197	SENT53	6	6	3	3	thyroglobulin	TPO	PA164754910	7066;7173	0.78
NULL	Evid_Based_Complement_Alternat_Med_2012_May_7_2012_242810.nxml.txt.nlp	22645625	SENT191	22	22	10	10	rifampin	CYP3A4	PA451250	1576	0.78
NULL	Oncotarget_2014_Mar_10_5(4)_894-900.nxml.txt.nlp	24658595	SENT153	22	22	1	1	gemcitabine	PIK3CA	PA449748	5290	0.78
NULL	Front_Physiol_2013_Jul_24_4_181.nxml.txt.nlp	23898301	SENT242	18	18	4	4	naratriptan	PAG	PA450597	55824	0.78
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jul_18_68(Pt_8)_o2486.nxml.txt.nlp	22904928	SENT69	11	11	17	17	piperazine	mol	PA450977	90527	0.78
NULL	Nature_2012_Apr_25_484(7395)_524-528.nxml.txt.nlp	22538616	SENT13	17	17	13	13	ciprofloxacin	PD1	PA449009	9825;6622;5133	0.78
NULL	Arthritis_Res_1999_Oct_26_1(1)_81-91.nxml.txt.nlp	11056663	SENT333	9	9	4	4	collagenase	IL-4	PA449107	3565	0.78
NULL	Cancers_(Basel)_2012_Oct_29_4(4)_1146-1160.nxml.txt.nlp	24213502	SENT491	0	0	12	12	letrozole	BRCA2	PA450196	675	0.78
NULL	Lab_Invest_2009_Dec_19_89(12)_1397-1409.nxml.txt.nlp	19841616	SENT214	0	0	26	26	curcumin	AKT	PA151958596	207	0.78
NULL	Int_J_Mol_Sci_2014_Nov_5_15(11)_20169-20208.nxml.txt.nlp	25380523	SENT1353	4	4	1	1	creatine	Q10	PA164778930	27161	0.78
NULL	J_Breast_Cancer_2011_Mar_31_14(1)_20-27.nxml.txt.nlp	21847390	SENT18	16	16	18	18	estradiol	CLDN6	PA449503	9074	0.78
NULL	Br_J_Dermatol_2009_Feb_160(2)_438-441.nxml.txt.nlp	19016697	SENT73	26	26	18	18	methotrexate	GGH	PA450428	8836	0.78
NULL	Ann_Indian_Acad_Neurol_2008_Oct-Dec_11(4)_245-247.nxml.txt.nlp	19893682	SENT51	23	23	45	45	zidovudine	CD4	PA451954	920	0.78
NULL	Breast_Cancer_Res_2010_Oct_14_12(5)_R84.nxml.txt.nlp	20946630	SENT238	32	32	19	19	choline	SLC22A2	PA448976	6582	0.78
NULL	Oncogene_2009_Dec_3_28(48)_4237-4248.nxml.txt.nlp	19734937	SENT86	32	32	9	9	collagenase	PAR-1	PA449107	2011;2149	0.78
NULL	Cardiol_Res_Pract_2012_Jan_5_2012_909154.nxml.txt.nlp	22347666	SENT321	17	17	10	10	cilostazol	P2Y12	PA164746334	64805	0.78
NULL	Gene_Regul_Syst_Bio_2014_Mar_4_8_63-73.nxml.txt.nlp	24634581	SENT113	3	3	11	11	minocycline	MT1-MMP	PA450519	4323	0.78
NULL	Br_J_Anaesth_2011_Oct_17_107(4)_490-502.nxml.txt.nlp	21852280	SENT85	15	15	17	17	capsaicin	TRPV1	PA448776	7442	0.78
NULL	Cancer_Med_2013_Aug_2_2(4)_571-582.nxml.txt.nlp	24156030	SENT163	14	14	24	24	curcumin	IL-6	PA151958596	3569	0.78
NULL	Cancers_(Basel)_2014_Nov_25_6(4)_2313-2329.nxml.txt.nlp	25534569	SENT136	11	11	8	8	crizotinib	Met	PA165946122	79811	0.78
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_3_2014_639856.nxml.txt.nlp	25530785	SENT488	10	10	26	26	ethanol	p53	PA448073	7157	0.78
NULL	J_Gen_Physiol_1960_Jan_1_43(3)_495-502.nxml.txt.nlp	13845142	SENT0	19	19	1	1	meprobamate	Gen	PA450377	348654	0.78
NULL	Pharmaceuticals_(Basel)_2012_Aug_10_5(8)_802-836.nxml.txt.nlp	24280676	SENT25	12	12	14	14	ribavirin	CNT2	PA451241	9153	0.78
NULL	Front_Oncol_2014_Sep_23_4_264.nxml.txt.nlp	25295231	SENT123	36	36	18	18	lenalidomide	p53	PA162363968	7157	0.78
NULL	Breast_Cancer_Res_2014_Dec_19_16(6)_499.nxml.txt.nlp	25522654	SENT206	26	26	20	20	estradiol	CYP19A1	PA449503	1588	0.78
NULL	J_Young_Pharm_2010_Jan-Mar_2(1)_54-58.nxml.txt.nlp	21331192	SENT23	15	15	17	17	thrombin	PAR-1	PA451674	2011;2149	0.78
NULL	Gut_Liver_2012_Oct_18_6(4)_464-470.nxml.txt.nlp	23170151	SENT112	5	5	23	23	propofol	ESD	PA451141	2098	0.78
NULL	Front_Psychol_2011_Jul_7_2_159.nxml.txt.nlp	21779273	SENT385	8	8	25	25	fluoxetine	ADM	PA449673	133	0.78
NULL	Exp_Ther_Med_2013_Jul_25_6(1)_109-114.nxml.txt.nlp	23935730	SENT150	15	15	13	13	cyclophosphamide	CHOP	PA449165	1649	0.78
NULL	Biologics_2009_Oct_12_3_469-474.nxml.txt.nlp	19851472	SENT14	5	5	13	13	mometasone	IL-5	PA450541	3567	0.78
NULL	Diabetes_Metab_J_2012_Aug_20_36(4)_293-299.nxml.txt.nlp	22950061	SENT23	0	0	3	3	metformin	AMPK	PA450395	5563	0.78
NULL	Osteoporos_Int_2009_Dec_13_20(12)_1999-2008.nxml.txt.nlp	19283328	SENT56	17	17	5	5	ketamine	CO2	PA450144	4513	0.78
NULL	Oncotarget_2012_Sep_3_3(9)_921-939.nxml.txt.nlp	22948112	SENT312	15	15	32	32	tamoxifen	BCAR1	PA451581	9564	0.78
NULL	Cell_Death_Dis_2014_Feb_13_5(2)_e1055.nxml.txt.nlp	24525731	SENT73	21	21	4	4	cisplatin	XRCC1	PA449014	7515	0.78
NULL	Comput_Math_Methods_Med_2013_Mar_20_2013_802512.nxml.txt.nlp	23573174	SENT79	27	27	14	14	doxycycline	MYC	PA449415	4609	0.78
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Apr_8_65(Pt_5)_o981-o982.nxml.txt.nlp	21584020	SENT87	4	4	21	21	benzaldehyde	mol	PA448571	90527	0.78
NULL	Emerg_Infect_Dis_2010_Oct_16(10)_1608-1610.nxml.txt.nlp	20875291	SENT53	15	15	24	24	artesunate	ACT	PA165111697	12;11332;9457;641455	0.78
NULL	BMB_Rep_2013_Aug_46(8)_410-415.nxml.txt.nlp	23977989	SENT33	0	0	2	2	curcumin	HO-1	PA151958596	3162	0.78
NULL	Indian_J_Pharmacol_2013_Jan-Feb_45(1)_54-60.nxml.txt.nlp	23543867	SENT172	21	21	15	15	terlipressin	NAC	PA164781020	22861	0.78
NULL	Diabetes_Care_2013_Aug_17_36(Suppl_2)_S162-S174.nxml.txt.nlp	23882042	SENT323	12	12	19	19	pioglitazone	adiponectin	PA450970	9370	0.78
NULL	Biologics_2012_Dec_17_6_429-464.nxml.txt.nlp	23269860	SENT162	1	1	19	19	etanercept	ACR	PA449515	49	0.78
NULL	Int_J_Vasc_Med_2012_Oct_5_2012_784536.nxml.txt.nlp	22007304	SENT48	8	8	16	16	ezetimibe	CD36	PA10816	948	0.78
NULL	Drugs_2009_Mar_17_69(5)_549-565.nxml.txt.nlp	19368417	SENT76	15	15	6	6	budesonide	DPI	PA448681	1832	0.78
NULL	J_Res_Med_Sci_2012_Aug_17(8)_760-763.nxml.txt.nlp	23798943	SENT109	17	17	25	25	ondansetron	NK1	PA450705	11126	0.78
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT356	26	26	6	6	acetaminophen	NK1	PA448015	11126	0.78
NULL	Diabetes_2011_Nov_17_60(11)_2691-2700.nxml.txt.nlp	21896928	SENT255	8	8	25	25	resveratrol	SIRT1		23411	0.78
NULL	Adv_Hematol_2009_Jun_22_2009_251915.nxml.txt.nlp	19946423	SENT149	25	25	27	27	hemin	HRI	PA449849	27102	0.78
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT218	9	9	20	20	sitagliptin	HIP	PA164748978	6767;6159;64399;5068	0.78
NULL	J_Mol_Med_(Berl)_2014_May_10_92(7)_709-722.nxml.txt.nlp	24811491	SENT249	3	3	10	10	cetuximab	KRAS	PA10040	3845	0.78
NULL	Front_Physiol_2012_Sep_18_3_355.nxml.txt.nlp	23060802	SENT1331	17	17	0	0	collagenase	p38	PA449107	10598;1432;7965	0.78
NULL	Int_J_Mol_Sci_2014_Sep_29_15(10)_17411-17441.nxml.txt.nlp	25268615	SENT248	0	0	20	20	cyclosporine	p65	PA449167	5970	0.78
NULL	Eur_J_Neurosci_2008_Jun_27(12)_3151-3160.nxml.txt.nlp	18598259	SENT332	6	6	21	21	capsaicin	TRPA1	PA448776	8989	0.78
NULL	Br_J_Cancer_1999_May_80(5-6)_650-656.nxml.txt.nlp	10360640	SENT8	12	12	22	22	suramin	Met	PA10292	79811	0.78
NULL	Clin_Med_Insights_Ear_Nose_Throat_2012_Apr_3_5_1-16.nxml.txt.nlp	24179404	SENT47	29	29	22	22	cetuximab	Bcl-2	PA10040	596	0.78
NULL	J_Med_Case_Reports_2011_May_3_5_168.nxml.txt.nlp	21539737	SENT54	15	15	8	8	vincristine	CHOP	PA451879	1649	0.78
NULL	Acta_Pharmacol_Sin_2011_Jul_13_32(7)_967-972.nxml.txt.nlp	21666702	SENT131	17	17	13	13	losartan	P-gp	PA450268	5243	0.78
NULL	Virol_J_2011_May_17_8_234.nxml.txt.nlp	21575275	SENT2	31	31	23	23	ribavirin	IFN	PA451241	3439	0.78
NULL	Am_J_Physiol_Cell_Physiol_2014_Jan_15_306(2)_C89-C97.nxml.txt.nlp	24133067	SENT169	4	4	22	22	hyaluronan	CD44	PA165958431	960	0.78
NULL	Cancer_Cell_Int_2014_Jan_29_14_10.nxml.txt.nlp	24472145	SENT10	27	27	5	5	paclitaxel	HER-2	PA450761	2064	0.78
NULL	J_Gen_Physiol_1985_Dec_1_86(6)_833-852.nxml.txt.nlp	2416870	SENT11	45	45	11	11	choline	gamma	PA448976	9913	0.78
NULL	Acta_Pharmacol_Sin_2010_Oct_27_31(10)_1389-1394.nxml.txt.nlp	20871620	SENT110	5	5	10	10	carbachol	cadherin	PA448784	1015	0.78
NULL	Aging_(Albany_NY)_2009_Jun_3_1(6)_515-528.nxml.txt.nlp	20157535	SENT157	7	7	12	12	resveratrol	S6K1		6198	0.78
NULL	Arch_Med_Sci_2013_Oct_31_9(5)_936-943.nxml.txt.nlp	24273582	SENT37	23	23	39	39	glibenclamide	SUR2	PA449782	10060	0.78
NULL	Oncotarget_2013_Nov_24_4(12)_2430-2438.nxml.txt.nlp	24280348	SENT27	5	5	13	13	gefitinib	EGFR	PA131301952	1956	0.78
NULL	Ann_Gen_Psychiatry_2009_Jul_27_8_16.nxml.txt.nlp	19635147	SENT80	29	29	5	5	carbamazepine	CYP2D6	PA448785	1565	0.78
NULL	Bioarchitecture_2011_Sep_1_1(5)_245-249.nxml.txt.nlp	22754617	SENT73	32	32	40	40	paraformaldehyde	FLNA	PA450790	2316	0.78
NULL	Oncoimmunology_2013_Sep_1_2(9)_e25773.nxml.txt.nlp	24319639	SENT28	22	22	5	5	rituximab	SIRP	PA451261	140885	0.78
NULL	Exp_Diabetes_Res_2012_Oct_26_2012_820989.nxml.txt.nlp	22110480	SENT87	3	3	8	8	rosiglitazone	LYRM1	PA451283	57149	0.78
NULL	Adv_Ther_2014_Dec_2_31_1228-1246.nxml.txt.nlp	25447269	SENT7	5	5	30	30	timolol	TIM	PA451690	7984;8914	0.78
NULL	Biochemistry_2012_Aug_7_51(31)_6195-6206.nxml.txt.nlp	22702953	SENT363	12	12	9	9	capsaicin	TRPV1	PA448776	7442	0.78
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT272	5	5	7	7	pemetrexed	UNG	PA10810	7374	0.78
NULL	Br_J_Cancer_2010_Nov_2_103(11)_1680-1691.nxml.txt.nlp	21045833	SENT133	29	29	4	4	vorinostat	p53	PA164748224	7157	0.78
NULL	Open_Med_2007_Dec_18_1(3)_e184-e190.nxml.txt.nlp	21673951	SENT67	46	46	36	36	letrozole	aromatase	PA450196	1588	0.78
NULL	Oncoscience_2014_Mar_12_1(2)_158-166.nxml.txt.nlp	25594008	SENT24	30	30	20	20	imatinib	HER2	PA10804	2064	0.78
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jan_8_67(Pt_2)_o258.nxml.txt.nlp	21522951	SENT57	5	5	22	22	benzaldehyde	mol	PA448571	90527	0.78
NULL	J_Incl_Phenom_Macrocycl_Chem_2014_Apr_17_78(1-4)_437-443.nxml.txt.nlp	24431983	SENT99	11	11	43	43	alendronate	HPO2	PA448082	2671	0.78
NULL	Calcif_Tissue_Int_2010_Dec_16_87(6)_485-492.nxml.txt.nlp	20953593	SENT189	7	7	29	29	teriparatide	PTH	PA451620	5741	0.78
NULL	Pharmaceutics_2011_Nov_18_3(4)_865-913.nxml.txt.nlp	24309312	SENT163	25	25	44	44	raltegravir	CYP3A4		1576	0.78
NULL	Cancer_Cell_Int_2009_Sep_10_9_25.nxml.txt.nlp	19744341	SENT15	16	16	8	8	glucosamine	STAT3	PA164747613	6774	0.78
NULL	J_Oncol_2009_Mar_24_2009_491985.nxml.txt.nlp	19325924	SENT141	8	8	3	3	genistein	CXCL12	PA165109660	6387	0.78
NULL	Environ_Health_Perspect_2000_Feb_108(2)_97-103.nxml.txt.nlp	10656848	SENT11	29	29	34	34	estradiol	RIP140	PA449503	8204	0.78
NULL	Oncogene_2013_Oct_17_32(42)_5089-5100.nxml.txt.nlp	23178492	SENT294	33	33	10	10	vorinostat	TGFBR2	PA164748224	7048	0.78
NULL	J_Asthma_Allergy_2008_Sep_19_1_19-29.nxml.txt.nlp	21436982	SENT59	17	17	1	1	fexofenadine	MDR1	PA449621	5243	0.78
NULL	CNS_Drugs_2014_Apr_11_28(6)_535-558.nxml.txt.nlp	24723124	SENT162	0	0	7	7	natalizumab	CD34	PA164747191	947	0.78
NULL	Biomed_Imaging_Interv_J_2008_Jul_1_4(3)_e47.nxml.txt.nlp	21611010	SENT60	19	19	5	5	cetuximab	EGFR	PA10040	1956	0.78
NULL	Cancer_Immunol_Immunother_2015_Oct_7_64_61-73.nxml.txt.nlp	25287778	SENT193	14	14	22	22	lenalidomide	IL-2	PA162363968	3558	0.78
NULL	Breast_Cancer_Res_2007_Dec_20_9(Suppl_2)_S23.nxml.txt.nlp	NULL	SENT4	13	13	22	22	tamoxifen	aromatase	PA451581	1588	0.78
NULL	Aging_(Albany_NY)_2014_May_17_6(5)_369-379.nxml.txt.nlp	24860943	SENT7	24	24	2	2	l-arginine	S6K1	PA448478	6198	0.78
NULL	Breast_Cancer_Res_Treat_2012_Jun_18_133(3)_937-947.nxml.txt.nlp	22094936	SENT206	30	30	12	12	tamoxifen	CDC2	PA451581	5424	0.78
NULL	Oncoimmunology_2013_Sep_1_2(9)_e25773.nxml.txt.nlp	24319639	SENT32	39	39	6	6	trastuzumab	SIRP	PA451743	140885	0.78
NULL	Oxid_Med_Cell_Longev_2013_Apr_30_2013_796891.nxml.txt.nlp	23738041	SENT114	5	5	26	26	rosuvastatin	LOX-1	PA134308647	4973	0.78
NULL	Clin_Med_Insights_Oncol_2013_Feb_28_7_53-73.nxml.txt.nlp	23492937	SENT354	5	5	20	20	bortezomib	p53	PA10252	7157	0.78
NULL	Cancer_Inform_2013_Feb_13_12_31-51.nxml.txt.nlp	23470717	SENT158	4	4	0	0	epirubicin	TOP2A	PA449476	7153	0.78
NULL	Case_Rep_Med_2011_Jul_31_2011_145856.nxml.txt.nlp	21811505	SENT17	9	9	21	21	vasopressin	AVP	PA451858	114548;551	0.78
NULL	J_Korean_Med_Sci_2010_Mar_19_25(3)_481-484.nxml.txt.nlp	20191052	SENT75	5	5	11	11	daunorubicin	CHOP	PA449212	1649	0.78
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT14	2	2	13	13	nutlin-3	p53		7157	0.78
NULL	Iran_J_Basic_Med_Sci_2012_May-Jun_15(3)_803-810.nxml.txt.nlp	23492756	SENT16	13	13	20	20	ethanol	CB1	PA448073	1268	0.78
NULL	Clin_Proteomics_2014_Jan_6_11(1)_2.nxml.txt.nlp	24393573	SENT27	4	4	0	0	hydroquinone	ENOX2	PA449924	10495	0.78
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_4_2013_378657.nxml.txt.nlp	23662132	SENT427	25	25	14	14	resveratrol	SIRT1		23411	0.78
NULL	Cell_Death_Dis_2011_Aug_11_2(8)_e191.nxml.txt.nlp	21833029	SENT280	0	0	11	11	oxaliplatin	CT26	PA131285527	168400	0.78
NULL	Oncol_Lett_2013_Feb_7_5(2)_440-446.nxml.txt.nlp	23420122	SENT247	32	32	0	0	sorafenib	Gem	PA7000	51053	0.78
NULL	Biochemistry_2012_Sep_25_51(38)_7456-7464.nxml.txt.nlp	22947085	SENT104	5	5	12	12	thyroglobulin	gamma	PA164754910	9913	0.78
NULL	Ann_Rheum_Dis_2014_Jul_1_73(7)_1405-1413.nxml.txt.nlp	23727633	SENT127	4	4	30	30	ethanol	p53	PA448073	7157	0.78
NULL	Arch_Virol_2010_Dec_15_155(12)_1977-1987.nxml.txt.nlp	20842394	SENT294	14	14	27	27	ribavirin	Gen	PA451241	348654	0.78
NULL	Cell_Death_Dis_2014_Feb_27_5(2)_e1091.nxml.txt.nlp	24577089	SENT34	14	14	25	25	cetuximab	AKT	PA10040	207	0.78
NULL	J_Cereb_Blood_Flow_Metab_2014_Oct_23_34(10)_1688-1694.nxml.txt.nlp	25052553	SENT121	32	32	47	47	losartan	AT1	PA450268	9197;185	0.78
NULL	Cancers_(Basel)_2010_Jan_14_2(1)_1-19.nxml.txt.nlp	24281029	SENT373	9	9	23	23	trastuzumab	San	PA451743	80218	0.78
NULL	Biomed_Res_Int_2013_Aug_7_2013_864012.nxml.txt.nlp	23991423	SENT75	23	23	9	9	alfacalcidol	PTH	PA164746469	5741	0.78
NULL	Crit_Care_2008_Nov_26_12(Suppl_6)_S4.nxml.txt.nlp	19105797	SENT26	14	14	24	24	thrombin	PAR-1	PA451674	2011;2149	0.78
NULL	Br_J_Cancer_1995_Aug_72(2)_418-423.nxml.txt.nlp	7640227	SENT0	16	16	23	23	verapamil	MRP	PA451868	79971	0.78
NULL	Breast_Cancer_Res_2010_Aug_9_12(4)_R62.nxml.txt.nlp	20696059	SENT158	37	37	21	21	tamoxifen	HRG	PA451581	3084;3273	0.78
NULL	Cardiovasc_Ultrasound_2011_Feb_7_9_5.nxml.txt.nlp	21299902	SENT116	3	3	21	21	simvastatin	ERK2	PA451363	5594	0.78
NULL	Mol_Cancer_2010_Apr_12_9_75.nxml.txt.nlp	20385023	SENT178	26	26	19	19	lapatinib	ERBB2	PA152241907	2064	0.78
NULL	Biologics_2014_May_29_8_199-205.nxml.txt.nlp	24920882	SENT114	3	3	24	24	nadh	ENOX	PA164755085	554203	0.78
NULL	J_Gen_Intern_Med_2009_May_21_24(5)_656-664.nxml.txt.nlp	19306050	SENT325	13	13	9	9	warfarin	VKORC1	PA451906	79001	0.78
NULL	Fibrogenesis_Tissue_Repair_2012_Jul_23_5_11.nxml.txt.nlp	22824096	SENT231	23	23	9	9	bleomycin	PTEN	PA448645	5728	0.78
NULL	Int_J_Mol_Sci_2012_Aug_13_13(8)_10091-10112.nxml.txt.nlp	22949849	SENT4	5	5	10	10	lipase	PPL	PA450239	5493	0.78
NULL	Oncogene_2009_Apr_2_28(13)_1616-1625.nxml.txt.nlp	19219073	SENT99	2	2	10	10	nutlin-3	MDM2		4193	0.78
NULL	Cancers_(Basel)_2014_Jul_8_6(3)_1487-1499.nxml.txt.nlp	25006835	SENT106	14	14	26	26	cisplatin	FAK	PA449014	5747	0.78
NULL	Br_J_Cancer_2012_Oct_9_107(8)_1233-1238.nxml.txt.nlp	22955852	SENT36	10	10	6	6	docetaxel	RPN2	PA449383	6185	0.78
NULL	Ann_Hematol_2010_Nov_25_89(11)_1115-1124.nxml.txt.nlp	20499237	SENT119	25	25	5	5	cladribine	CD5	PA449027	921	0.78
NULL	Int_J_Biol_Sci_2014_Jun_5_10(6)_614-619.nxml.txt.nlp	24948874	SENT122	0	0	9	9	paclitaxel	FOXO1	PA450761	2308	0.78
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Jan_19_69(Pt_2)_o260-o261.nxml.txt.nlp	23424537	SENT90	0	0	6	6	flunarizine	mol	PA164776636	90527	0.78
NULL	Eur_J_Clin_Pharmacol_2013_Jan_11_69(6)_1275-1283.nxml.txt.nlp	23307232	SENT247	20	20	15	15	warfarin	VKORC1	PA451906	79001	0.78
NULL	Exp_Ther_Med_2014_Sep_20_8(3)_968-972.nxml.txt.nlp	25120631	SENT124	15	15	23	23	naringin	ADP	PA151958360	23038	0.78
NULL	Br_J_Pharmacol_2012_Jan_165(2)_390-400.nxml.txt.nlp	21671897	SENT216	3	3	14	14	suramin	P2X2	PA10292	22953	0.78
NULL	Environ_Health_Perspect_2007_Dec_8_115(Suppl_1)_77-83.nxml.txt.nlp	18174954	SENT82	3	3	13	13	genistein	TPO	PA165109660	7066;7173	0.78
NULL	Curr_Chem_Genomics_2008_May_23_1_54-64.nxml.txt.nlp	20161828	SENT149	9	9	19	19	staurosporine	AKT	PA165109623	207	0.78
NULL	Iran_J_Pharm_Res_2014_Winter_13(1)_253-262.nxml.txt.nlp	24734078	SENT137	5	5	16	16	propofol	CCL4	PA451141	6351	0.78
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT84	15	15	9	9	resveratrol	IL-6		3569	0.78
NULL	J_Oncol_2009_Mar_10_2009_831626.nxml.txt.nlp	20300583	SENT50	24	24	9	9	cetuximab	BRAF	PA10040	673	0.78
NULL	Pediatr_Cardiol_2010_Jan_14_31(1)_90-95.nxml.txt.nlp	19915892	SENT98	36	36	32	32	palivizumab	AAP	PA164748781	5345	0.78
NULL	Br_J_Cancer_2010_Oct_26_103(9)_1380-1390.nxml.txt.nlp	20877355	SENT168	0	0	24	24	etoposide	p75NTR	PA449552	4804	0.78
NULL	Clinicoecon_Outcomes_Res_2014_Oct_17_6_451-461.nxml.txt.nlp	25378939	SENT121	30	30	14	14	vancomycin	HAP	PA451850	5915;10313	0.78
NULL	Biologics_2014_Feb_15_8_67-81.nxml.txt.nlp	24600203	SENT162	18	18	5	5	infliximab	IFN	PA452639	3439	0.78
NULL	J_Korean_Med_Sci_2007_Apr_30_22(2)_283-289.nxml.txt.nlp	17449938	SENT101	0	0	5	5	minoxidil	Bcl-2	PA450521	596	0.78
NULL	Curr_Health_Sci_J_2014_Dec_29_Jan-Mar_40(1)_12-17.nxml.txt.nlp	24791199	SENT58	23	23	1	1	sibutramine	5-HT2C	PA451344	3358	0.78
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT138	28	28	25	25	trastuzumab	HER2	PA451743	2064	0.78
NULL	Cancer_Cell_Int_2010_May_11_10_16.nxml.txt.nlp	20459793	SENT10	10	10	14	14	cisplatin	ABCC1	PA449014	4363	0.78
NULL	J_Cell_Biol_2008_Jul_14_182(1)_197-213.nxml.txt.nlp	18625847	SENT206	2	2	5	5	nutlin-3	BRCA1		672	0.78
NULL	Acta_Pharmacol_Sin_2010_Sep_16_31(9)_1075-1084.nxml.txt.nlp	20711221	SENT110	11	11	13	13	metformin	AMPK	PA450395	5563	0.78
NULL	Clin_Med_Insights_Cardiol_2010_Oct_11_4_89-93.nxml.txt.nlp	20981132	SENT89	9	9	20	20	fosinopril	TNF	PA449710	7124	0.78
NULL	Exp_Cell_Res_2013_Aug_1_319(13)_2037-2048.nxml.txt.nlp	23562655	SENT15	26	26	9	9	urokinase	PRKD2	PA451836	25865	0.78
NULL	Breast_Cancer_Res_2007_Jan_23_9(1)_R7.nxml.txt.nlp	17244352	SENT104	22	22	14	14	tamoxifen	SULT1A1	PA451581	6817	0.78
NULL	Mol_Cancer_2009_Jun_23_8_39.nxml.txt.nlp	19549337	SENT233	19	19	14	14	resveratrol	TRAIL		8743	0.78
NULL	J_Thromb_Haemost_2011_Oct_9(10)_2103-2105.nxml.txt.nlp	21812912	SENT15	9	9	21	21	ticagrelor	mol	PA165374673	90527	0.78
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT120	33	33	30	30	capsaicin	p53	PA448776	7157	0.78
NULL	J_Cancer_Prev_2013_Dec_18(4)_313-321.nxml.txt.nlp	25337560	SENT136	26	26	3	3	estradiol	AKT	PA449503	207	0.78
NULL	Mol_Vis_2012_Nov_29_18_2839-2846.nxml.txt.nlp	23233786	SENT188	17	17	29	29	geldanamycin	Hsp90	PA152031327	3320	0.78
NULL	Int_J_Mol_Sci_2014_Sep_29_15(10)_17411-17441.nxml.txt.nlp	25268615	SENT214	13	13	0	0	hyaluronan	CD147	PA165958431	682	0.78
NULL	J_Mol_Signal_2013_Oct_1_8_10.nxml.txt.nlp	24083380	SENT75	18	18	1	1	forskolin	ANOVA	PA146096022	4858	0.78
NULL	J_Carcinog_2011_Dec_22_10_36.nxml.txt.nlp	22279421	SENT112	3	3	9	9	doxorubicin	RANKL	PA449412	8600	0.78
NULL	Breast_Cancer_Res_Treat_2014_Dec_19_143(2)_351-358.nxml.txt.nlp	24352574	SENT215	0	0	8	8	docetaxel	HER-2	PA449383	2064	0.78
NULL	Oncotarget_2014_Jun_8_5(13)_5040-5053.nxml.txt.nlp	24970815	SENT242	23	23	15	15	cisplatin	SPRY2	PA449014	10253	0.78
NULL	Environ_Health_Perspect_2008_Sep_13_116(9)_1243-1247.nxml.txt.nlp	18795170	SENT53	13	13	20	20	estradiol	pS2	PA449503	7031	0.78
NULL	Chin_J_Cancer_2011_Oct_30(10)_690-700.nxml.txt.nlp	21959046	SENT20	16	16	7	7	cisplatin	TPT	PA449014	23590;6469	0.78
NULL	Oncotarget_2013_Oct_19_4(11)_2045-2056.nxml.txt.nlp	24185104	SENT47	5	5	2	2	cisplatin	14-3-3	PA449014	10971	0.78
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT196	7	7	13	13	sulindac	survivin	PA451565	332	0.78
NULL	Br_J_Cancer_2004_May_4_90(9)_1710-1714.nxml.txt.nlp	15150625	SENT32	19	19	45	45	oxaliplatin	GEM	PA131285527	2669	0.78
NULL	Curr_Opin_Endocrinol_Diabetes_Obes_2014_Oct_28_21(5)_394-404.nxml.txt.nlp	25122493	SENT100	17	17	1	1	thyroglobulin	RAI	PA164754910	10848;6050	0.78
NULL	Mol_Cell_Proteomics_2012_Jan_3_11(1)_M111_011445.nxml.txt.nlp	22338125	SENT153	9	9	36	36	trypsin	Met	PA451806	79811	0.78
NULL	Indian_J_Psychiatry_2010_Jan_52(Suppl1)_S317-S340.nxml.txt.nlp	21836703	SENT119	24	24	15	15	thioproperazine	TFP	PA164754875	7034	0.78
NULL	Exp_Diabetes_Res_2011_Nov_28_2011_625813.nxml.txt.nlp	22144989	SENT34	5	5	2	2	cyclophosphamide	STZ	PA449165	6484	0.78
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT45	15	15	29	29	metformin	AKT	PA450395	207	0.78
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT75	8	8	5	5	trastuzumab	STAT3	PA451743	6774	0.78
NULL	Cancer_Inform_2014_Oct_14_13(Suppl_1)_103-111.nxml.txt.nlp	25392688	SENT225	33	33	29	29	ketoconazole	CYP3A4	PA450146	1576	0.78
NULL	Mol_Cancer_2006_Sep_5_5_34.nxml.txt.nlp	16953886	SENT39	20	20	12	12	doxorubicin	XIAP	PA449412	331	0.78
NULL	Oncol_Lett_2013_Aug_17_6(2)_295-305.nxml.txt.nlp	24137320	SENT343	16	16	9	9	tamoxifen	EZH2	PA451581	2146	0.78
NULL	Br_J_Cancer_2011_Mar_15_104(6)_941-947.nxml.txt.nlp	21407223	SENT151	27	27	8	8	sorafenib	VEGFR	PA7000	3791	0.78
NULL	Int_J_Mol_Sci_2010_Oct_19_11(10)_3999-4013.nxml.txt.nlp	21152316	SENT216	9	9	12	12	celecoxib	p53	PA448871	7157	0.78
NULL	Ulster_Med_J_2008_May_77(2)_135-137.nxml.txt.nlp	NULL	SENT52	13	13	9	9	metformin	DPPIV	PA450395	2191;1803	0.78
NULL	Oncotarget_2014_Oct_21_5(22)_11252-11268.nxml.txt.nlp	25361004	SENT272	3	3	6	6	metformin	CLIC1	PA450395	1192	0.78
NULL	Mol_Cancer_2012_Apr_26_11_26.nxml.txt.nlp	22537224	SENT124	13	13	19	19	cisplatin	FANCF	PA449014	2188	0.78
NULL	Basic_Clin_Neurosci_2014_Winter_5(1)_31-41.nxml.txt.nlp	25436082	SENT234	26	26	14	14	lidocaine	c-fos	PA450226	2353	0.78
NULL	Curr_Chem_Genomics_2011_Apr_8_5_13-20.nxml.txt.nlp	21643506	SENT20	0	0	16	16	sn-38	UGT		7361;7355	0.78
NULL	J_Headache_Pain_2013_Apr_10_14(1)_33.nxml.txt.nlp	23574808	SENT9	14	14	23	23	capsaicin	TRVP1	PA448776	7242	0.779
NULL	Neuro_Oncol_2010_Apr_27_12(4)_389-400.nxml.txt.nlp	20308316	SENT176	36	36	22	22	chloroquine	p53	PA448948	7157	0.779
NULL	Neuroscience_2009_Jun_30_161(2-3)_572-577.nxml.txt.nlp	19327387	SENT9	6	6	12	12	capsaicin	NAPE-PLD	PA448776	222236	0.779
NULL	Cancers_(Basel)_2010_Jan_14_2(1)_1-19.nxml.txt.nlp	24281029	SENT41	0	0	4	4	trastuzumab	HER2	PA451743	2064	0.779
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Dec_11_67(Pt_1)_o64.nxml.txt.nlp	21522775	SENT48	20	20	35	35	ethanol	mol	PA448073	90527	0.779
NULL	Acta_Neuropathol_2013_Jan_1_125(1)_111-120.nxml.txt.nlp	22941226	SENT248	23	23	32	32	lenalidomide	CD34	PA162363968	947	0.779
NULL	Nat_Med_2010_Jun_23_16(6)_671-677.nxml.txt.nlp	20495567	SENT8	3	3	5	5	sorafenib	ATF5	PA7000	22809	0.779
NULL	Curr_Neuropharmacol_2008_Sep_6(3)_215-234.nxml.txt.nlp	19506722	SENT389	24	24	13	13	fluoxetine	5-HT1A	PA449673	3350	0.779
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S18-S30.nxml.txt.nlp	20680104	SENT194	18	18	5	5	irinotecan	IFL	PA450085	3439	0.779
NULL	Scientifica_(Cairo)_2012_Jul_8_2012_128382.nxml.txt.nlp	24278667	SENT178	34	34	19	19	ribavirin	IFN	PA451241	3439	0.779
NULL	Ann_Lab_Med_2012_Jul_20_32(4)_298-303.nxml.txt.nlp	22779073	SENT40	35	35	37	37	ethambutol	EMB	PA164784021	133418	0.779
NULL	Acta_Pharmacol_Sin_2009_Jul_22_30(7)_956-964.nxml.txt.nlp	19543298	SENT172	24	24	8	8	ezetimibe	ABCB1	PA10816	5243	0.779
NULL	Cancers_(Basel)_2011_Apr_1_3(2)_1844-1860.nxml.txt.nlp	24212785	SENT566	12	12	2	2	cetuximab	PTEN	PA10040	5728	0.779
NULL	Acta_Pharmacol_Sin_2012_Jun_14_33(6)_832-838.nxml.txt.nlp	22580740	SENT13	11	11	8	8	gemcitabine	ADM	PA449748	133	0.779
NULL	Breast_Cancer_Res_2010_Mar_5_12(2)_R16.nxml.txt.nlp	20205716	SENT234	34	34	20	20	lovastatin	MCM7	PA450272	4176	0.779
NULL	Ann_Med_2011_Nov_5_43(7)_531-544.nxml.txt.nlp	21815879	SENT39	15	15	17	17	thrombin	P2Y12	PA451674	64805	0.779
NULL	BMB_Rep_2014_Jul_47(7)_376-381.nxml.txt.nlp	24286332	SENT88	13	13	5	5	thrombin	PPG	PA451674	5552	0.779
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_7-17.nxml.txt.nlp	17912633	SENT44	2	2	27	27	aminoglutethimide	aromatase	PA448375	1588	0.779
NULL	Mol_Imaging_Radionucl_Ther_2013_Aug_1_22(2)_36-41.nxml.txt.nlp	24003395	SENT98	16	16	20	20	carbimazole	RAI	PA164742970	10848;6050	0.779
NULL	J_Gastroenterol_2014_Dec_24_49(12)_1536-1547.nxml.txt.nlp	24366288	SENT132	9	9	0	0	omeprazole	CYP2C19	PA450704	1557	0.779
NULL	Breast_Cancer_Res_2002_Jan_14_4(2)_65-69.nxml.txt.nlp	11879566	SENT77	12	12	8	8	estradiol	aromatase	PA449503	1588	0.779
NULL	J_Geriatr_Cardiol_2012_Jun_9(2)_209-210.nxml.txt.nlp	23097648	SENT21	4	4	11	11	warfarin	VKORC1	PA451906	79001	0.779
NULL	Oncotarget_2014_Mar_26_5(21)_10342-10355.nxml.txt.nlp	25431950	SENT117	31	31	29	29	doxycycline	EZH2	PA449415	2146	0.779
NULL	Br_J_Cancer_2010_Jun_29_103(1)_12-17.nxml.txt.nlp	20588278	SENT189	6	6	25	25	carboplatin	mol	PA448803	90527	0.779
NULL	J_Biol_Chem_2009_Oct_16_284(42)_28563-28570.nxml.txt.nlp	19706610	SENT26	4	4	21	21	heparin	CD36	PA449855	948	0.779
NULL	Nat_Chem_Biol_2010_Jun_2_6(6)_411-417.nxml.txt.nlp	20436487	SENT245	6	6	10	10	curcumin	COX	PA151958596	1351	0.779
NULL	Arch_Med_Sci_2013_Jun_20_9(3)_466-471.nxml.txt.nlp	23847668	SENT151	9	9	24	24	tamoxifen	HER2	PA451581	2064	0.779
NULL	Diabetes_Care_2013_May_13_36(5)_1368-1376.nxml.txt.nlp	23275363	SENT23	5	5	27	27	metformin	GLP-1	PA450395	100125288	0.779
NULL	Breast_Cancer_Res_Treat_2014_Nov_11_148(3)_563-570.nxml.txt.nlp	25385180	SENT172	3	3	5	5	pertuzumab	HER2		2064	0.779
NULL	Ann_Gastroenterol_2011_24(3)_164-172.nxml.txt.nlp	24713780	SENT136	9	9	0	0	l-carnitine	OCTN2	PA450154	6584	0.779
NULL	Br_J_Cancer_2010_Mar_2_102(5)_815-826.nxml.txt.nlp	20145614	SENT194	27	27	33	33	tamoxifen	HER2	PA451581	2064	0.779
NULL	Endocrinol_Metab_(Seoul)_2014_Sep_25_29(3)_211-216.nxml.txt.nlp	25309777	SENT83	12	12	10	10	axitinib	RET	PA164924493	5979	0.779
NULL	Exp_Diabetes_Res_2012_Oct_15_2012_465282.nxml.txt.nlp	23118742	SENT84	5	5	11	11	metformin	FGF21	PA450395	26291	0.779
NULL	Onco_Targets_Ther_2014_May_16_7_751-759.nxml.txt.nlp	24876784	SENT117	38	38	25	25	bevacizumab	MVD	PA130232992	4597	0.779
NULL	J_Cell_Mol_Med_2014_Mar_22_18(3)_422-433.nxml.txt.nlp	24450475	SENT258	26	26	21	21	hyaluronan	LYVE-1	PA165958431	10894	0.779
NULL	Arthritis_Res_Ther_2010_Apr_29_12(2)_R73.nxml.txt.nlp	20429888	SENT158	24	24	6	6	bortezomib	SP1	PA10252	6667	0.779
NULL	Breast_Cancer_Res_Treat_2013_Oct_8_141(3)_437-446.nxml.txt.nlp	24101324	SENT18	9	9	3	3	pertuzumab	HER2		2064	0.779
NULL	Psychol_Res_Behav_Manag_2010_Dec_6_3_109-118.nxml.txt.nlp	22110334	SENT114	32	32	28	28	fluoxetine	CYP2D6	PA449673	1565	0.779
NULL	Evid_Based_Complement_Alternat_Med_2013_Aug_13_2013_976342.nxml.txt.nlp	23997804	SENT190	13	13	41	41	tetracycline	IL-10	PA451640	3586	0.779
NULL	Front_Integr_Neurosci_2011_Oct_14_5_63.nxml.txt.nlp	22016725	SENT338	31	31	37	37	estradiol	NCM	PA449503	57703	0.779
NULL	Angiogenesis_2010_Dec_7_13(4)_305-315.nxml.txt.nlp	20927579	SENT216	3	3	15	15	resveratrol	HIF-1		29072	0.779
NULL	Eur_J_Immunol_2014_Jun_10_44(6)_1759-1769.nxml.txt.nlp	24595810	SENT71	23	23	4	4	fludrocortisone	CCR7	PA164743961	1236	0.779
NULL	Indian_J_Dermatol_2011_Mar-Apr_56(2)_137-144.nxml.txt.nlp	21716938	SENT123	19	19	12	12	abacavir	HCP5	PA448004	360158;10866	0.779
NULL	J_Biol_Chem_2013_Dec_6_288(49)_35387-35395.nxml.txt.nlp	24142790	SENT143	6	6	9	9	meclizine	PCYT2	PA450338	5833	0.779
NULL	Nature_2012_Feb_23_482(7386)_524-528.nxml.txt.nlp	22358842	SENT217	3	3	11	11	tamoxifen	Dicer	PA451581	23405	0.779
NULL	J_Psychopharmacol_2010_Nov_24(4_supplement)_91-118.nxml.txt.nlp	18801830	SENT621	12	12	19	19	quetiapine	ACTH	PA451201	5443	0.779
NULL	J_Korean_Med_Sci_2010_Aug_21_25(8)_1222-1227.nxml.txt.nlp	20676337	SENT54	29	29	24	24	aminophylline	LPA	PA164781029	4018	0.779
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT60	21	21	24	24	bevacizumab	VEGF-A	PA130232992	7422	0.779
NULL	J_Cell_Biol_2008_Jul_14_182(1)_197-213.nxml.txt.nlp	18625847	SENT317	9	9	28	28	nutlin-3	p53		7157	0.779
NULL	Curr_Neuropharmacol_2013_Dec_11(6)_652-663.nxml.txt.nlp	24396340	SENT191	23	23	16	16	lidocaine	TRPV1	PA450226	7442	0.779
NULL	Breast_Cancer_Res_2000_Mar_12_2(Suppl_1)_P2_02.nxml.txt.nlp	NULL	SENT2	7	7	4	4	estradiol	EGF	PA449503	1950	0.779
NULL	Acta_Otorhinolaryngol_Ital_2011_Dec_31(6)_358-365.nxml.txt.nlp	22323846	SENT150	44	44	24	24	octreotide	CEA	PA450678	5670;1087	0.779
NULL	Diabetes_Obes_Metab_2012_Apr_14(4)_304-314.nxml.txt.nlp	22051096	SENT141	18	18	25	25	exenatide	PPG	PA164749238	5552	0.779
NULL	Neuropsychopharmacology_2009_May_1_34(6)_1443-1453.nxml.txt.nlp	18830237	SENT65	7	7	22	22	ethanol	hole	PA448073	80757	0.779
NULL	Indian_J_Pharm_Sci_2011_Sep-Oct_73(5)_510-516.nxml.txt.nlp	22923863	SENT100	19	19	4	4	venlafaxine	ANOVA	PA451866	4858	0.779
NULL	Commun_Integr_Biol_2014_Feb_27_7_e28231.nxml.txt.nlp	24778765	SENT70	21	21	27	27	imatinib	AKT	PA10804	207	0.779
NULL	Cell_Cycle_2013_Feb_15_12(4)_625-634.nxml.txt.nlp	23324396	SENT185	29	29	10	10	doxycycline	p53	PA449415	7157	0.779
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1013.nxml.txt.nlp	24457957	SENT88	0	0	8	8	orlistat	NOXA	PA164776864	5366	0.779
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT304	16	16	8	8	risperidone	PRL	PA451257	5617	0.779
NULL	Ital_J_Pediatr_2010_Jul_6_36_47.nxml.txt.nlp	20604944	SENT102	6	6	2	2	salbutamol	LTA	PA448068	4049	0.779
NULL	Oncol_Lett_2014_Mar_2_7(3)_791-796.nxml.txt.nlp	24527087	SENT160	32	32	10	10	imatinib	CD34	PA10804	947	0.779
NULL	Biomed_Res_Int_2014_Feb_19_2014_162314.nxml.txt.nlp	24701564	SENT74	10	10	12	12	amiloride	NHE	PA448368	285335	0.779
NULL	Br_J_Cancer_2011_Aug_9_105(4)_523-533.nxml.txt.nlp	21792199	SENT264	8	8	11	11	erlotinib	AKT	PA134687924	207	0.779
NULL	Open_Access_J_Urol_2010_May_19_2_67-84.nxml.txt.nlp	24198616	SENT150	3	3	10	10	gemcitabine	IFN	PA449748	3439	0.779
NULL	Br_J_Cancer_1988_Nov_58(5)_640-643.nxml.txt.nlp	3064798	SENT0	12	12	14	14	carboplatin	JM8	PA448803	778	0.779
NULL	Breast_Cancer_Res_2013_Oct_31_15(5)_R102.nxml.txt.nlp	24176089	SENT329	17	17	11	11	vincristine	CDKN2A	PA451879	1029	0.779
NULL	Oncotarget_2014_Oct_18_5(22)_11604-11619.nxml.txt.nlp	25344099	SENT148	21	21	9	9	cisplatin	RYBP	PA449014	23429	0.779
NULL	Br_J_Cancer_2004_Mar_22_90(6)_1285-1292.nxml.txt.nlp	15026814	SENT87	41	41	23	23	cisplatin	p53	PA449014	7157	0.779
NULL	Biologics_2014_Mar_17_8_91-105.nxml.txt.nlp	24669185	SENT41	0	0	11	11	sorafenib	BRAF	PA7000	673	0.779
NULL	Oncotarget_2014_Feb_19_5(9)_2462-2474.nxml.txt.nlp	24770864	SENT349	3	3	16	16	docetaxel	YB-1	PA449383	4904	0.779
NULL	J_Lipid_Res_2014_Dec_55(12)_2479-2490.nxml.txt.nlp	25325755	SENT126	0	0	12	12	indomethacin	aP2	PA449982	2167	0.779
NULL	Mol_Cancer_2012_Jul_12_11_45.nxml.txt.nlp	22788833	SENT105	18	18	36	36	cisplatin	EGFR	PA449014	1956	0.779
NULL	Apoptosis_2014_Apr_23_19(7)_1055-1068.nxml.txt.nlp	24756955	SENT313	0	0	2	2	metformin	AMPK	PA450395	5563	0.779
NULL	Cell_Death_Dis_2010_Oct_21_1(10)_e86.nxml.txt.nlp	21368859	SENT242	27	27	35	35	doxorubicin	TRAIL	PA449412	8743	0.779
NULL	Ann_Nucl_Med_2014_Jul_8_28(9)_836-850.nxml.txt.nlp	25001261	SENT166	18	18	27	27	acetazolamide	spatial	PA448018	219793	0.779
NULL	Cardiovasc_Res_2011_Apr_1_90(1)_140-147.nxml.txt.nlp	21071431	SENT144	0	0	8	8	resveratrol	p38		10598;1432;7965	0.779
NULL	Breast_Cancer_Res_2004_Nov_7_6(1)_39-52.nxml.txt.nlp	14680484	SENT90	15	15	9	9	tamoxifen	DES	PA451581	1674	0.779
NULL	Tuberc_Respir_Dis_(Seoul)_2014_Apr_25_76(4)_160-162.nxml.txt.nlp	24851128	SENT33	17	17	7	7	streptokinase	MIST1	PA164754919	168620	0.779
NULL	Arthritis_Res_Ther_2013_Jan_25_15(1)_R20.nxml.txt.nlp	23351360	SENT61	5	5	29	29	rituximab	San	PA451261	80218	0.779
NULL	J_Cell_Biol_1998_Jan_26_140(2)_335-345.nxml.txt.nlp	9442109	SENT185	17	17	12	12	amiloride	NHE	PA448368	285335	0.779
NULL	Int_J_Environ_Res_Public_Health_2013_Sep_17_10(9)_4352-4389.nxml.txt.nlp	24048206	SENT268	24	24	5	5	choline	MTHFR	PA448976	4524	0.779
NULL	Ann_Hematol_2014_Sep_10_93(1)_1-11.nxml.txt.nlp	24018623	SENT143	29	29	8	8	lenalidomide	CD34	PA162363968	947	0.779
NULL	Bioinformation_2012_Jan_6_8(1)_13-19.nxml.txt.nlp	22359429	SENT97	17	17	13	13	curcumin	MRP1	PA151958596	4437	0.779
NULL	Clinics_(Sao_Paulo)_2010_Mar_65(3)_311-316.nxml.txt.nlp	20360923	SENT107	7	7	12	12	l-cysteine	NAC	PA449173	22861	0.779
NULL	Breast_Cancer_Res_2012_Mar_20_14(2)_R53.nxml.txt.nlp	22433433	SENT317	9	9	11	11	paclitaxel	CCNE1	PA450761	898	0.779
NULL	Cancer_Cell_Int_2013_Oct_11_13_97.nxml.txt.nlp	24119761	SENT52	9	9	19	19	trastuzumab	HRG	PA451743	3084;3273	0.779
NULL	J_Obes_2011_Dec_12_2011_179674.nxml.txt.nlp	21197148	SENT191	0	0	7	7	liraglutide	GLP1	PA165958364	100125288;2641	0.779
NULL	Clin_Med_Insights_Oncol_2013_Aug_21_7_221-234.nxml.txt.nlp	24179413	SENT61	23	23	27	27	gefitinib	KRAS	PA131301952	3845	0.779
NULL	Ann_Thorac_Med_2014_Jul-Sep_9(Suppl_1)_S47-S55.nxml.txt.nlp	25076997	SENT197	25	25	7	7	nitroprusside	PAWP	PA451406	164684	0.779
NULL	Arthritis_Res_Ther_2009_Feb_3_11(1)_R15.nxml.txt.nlp	19192274	SENT223	8	8	34	34	azathioprine	IL-8	PA448515	3576	0.779
NULL	Case_Rep_Dermatol_2013_Jan_18_5(1)_11-14.nxml.txt.nlp	23466694	SENT7	15	15	5	5	calcipotriol	LAM	PA448714	7249;7248	0.779
NULL	Diabetes_2013_Jul_14_62(7)_2545-2558.nxml.txt.nlp	23423573	SENT294	10	10	19	19	camptothecin	CXCR7	PA153590860	57007	0.779
NULL	Adv_Ther_2013_Oct_25_30(10)_870-884.nxml.txt.nlp	24158787	SENT99	10	10	18	18	exemestane	aromatase	PA449563	1588	0.779
NULL	Diabetes_Care_2011_Jul_17_34(7)_e115-e120.nxml.txt.nlp	21709286	SENT185	7	7	13	13	etoposide	AMPK	PA449552	5563	0.779
NULL	Emerg_Infect_Dis_2013_Mar_19(3)_449-455.nxml.txt.nlp	23622714	SENT105	7	7	1	1	cycloserine	DST	PA164764600	667	0.779
NULL	Ann_Med_2011_Nov_5_43(7)_531-544.nxml.txt.nlp	21815879	SENT36	0	0	30	30	thrombin	PAR-1	PA451674	2011;2149	0.779
NULL	Breast_Cancer_Res_2008_Dec_18_10(Suppl_4)_S18.nxml.txt.nlp	19128431	SENT60	1	1	5	5	tamoxifen	aromatase	PA451581	1588	0.779
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT120	16	16	30	30	capsaicin	p53	PA448776	7157	0.779
NULL	Breast_Cancer_2014_Feb_13_21(6)_703-714.nxml.txt.nlp	23404211	SENT53	35	35	23	23	letrozole	HER2	PA450196	2064	0.779
NULL	Br_J_Cancer_2013_Mar_19_108(5)_1052-1060.nxml.txt.nlp	23422754	SENT151	11	11	40	40	bevacizumab	VEGF-A	PA130232992	7422	0.779
NULL	Cancer_Cell_Int_2014_Jan_29_14_10.nxml.txt.nlp	24472145	SENT10	27	27	42	42	paclitaxel	HER-2	PA450761	2064	0.779
NULL	Oncotarget_2013_Apr_10_4(4)_622-635.nxml.txt.nlp	23599172	SENT76	10	10	22	22	gefitinib	PI3	PA131301952	5266	0.779
NULL	Cardiovasc_Res_2012_Feb_1_93(2)_291-301.nxml.txt.nlp	22116619	SENT43	22	22	8	8	ethanol	E14	PA448073	4863	0.779
NULL	Int_J_Biol_Sci_2014_Aug_23_10(8)_921-939.nxml.txt.nlp	25170305	SENT299	17	17	5	5	nadh	EPO	PA164755085	7076;8288;2056	0.779
NULL	Front_Physiol_2012_Sep_18_3_355.nxml.txt.nlp	23060802	SENT1331	17	17	12	12	collagenase	MEK1	PA449107	5604	0.779
NULL	Br_J_Cancer_1997_75(10)_1447-1453.nxml.txt.nlp	9166936	SENT10	12	12	9	9	melphalan	TNF-alpha	PA450354	7124	0.779
NULL	J_Headache_Pain_2013_Apr_10_14(1)_33.nxml.txt.nlp	23574808	SENT154	16	16	13	13	capsaicin	c-fos	PA448776	2353	0.779
NULL	Arthritis_Res_Ther_2010_Jul_6_12(4)_R129.nxml.txt.nlp	20604932	SENT213	31	31	14	14	collagenase	CXCL8	PA449107	3576	0.779
NULL	Int_J_Surg_Oncol_2012_Jun_12_2012_862879.nxml.txt.nlp	22778941	SENT108	29	29	16	16	cisplatin	BIN1	PA449014	274	0.779
NULL	Arch_Med_Sci_2012_May_9_8(2)_375-388.nxml.txt.nlp	22662015	SENT256	6	6	26	26	cilostazol	CYP3A4	PA164746334	1576	0.779
NULL	Front_Neurosci_2011_Jul_26_5_92.nxml.txt.nlp	21845173	SENT93	5	5	11	11	naloxone	NRM	PA450586	11270	0.779
NULL	Curr_Cardiol_Rev_2012_Aug_8(3)_239-249.nxml.txt.nlp	22935021	SENT50	33	33	31	31	omeprazole	CYP2C19	PA450704	1557	0.779
NULL	J_Cell_Biol_2001_Oct_29_155(3)_427-438.nxml.txt.nlp	11673478	SENT177	10	10	5	5	genistein	PP1	PA165109660	5540;5464	0.779
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT1736	3	3	9	9	sulfasalazine	ABCG2	PA451547	9429	0.779
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_79-96.nxml.txt.nlp	19305789	SENT130	30	30	15	15	capsaicin	TRPV1	PA448776	7442	0.779
NULL	Curr_Control_Trials_Cardiovasc_Med_2001_Feb_8_2(1)_45-53.nxml.txt.nlp	11806772	SENT219	2	2	14	14	azathioprine	IL-2	PA448515	3558	0.779
NULL	Eur_J_Clin_Pharmacol_2011_May_8_67(5)_493-506.nxml.txt.nlp	21140139	SENT42	10	10	15	15	oxymorphone	CYP3A4	PA450748	1576	0.779
NULL	Breast_Cancer_Res_2007_Jan_23_9(1)_R7.nxml.txt.nlp	17244352	SENT197	8	8	3	3	tamoxifen	CYP3A5	PA451581	1577	0.779
NULL	Cell_Death_Dis_2014_Jul_17_5(7)_e1333.nxml.txt.nlp	25032856	SENT45	8	8	24	24	candesartan	EAAC1	PA448765	6505	0.779
NULL	Exp_Ther_Med_2013_Aug_20_6(2)_310-316.nxml.txt.nlp	24137180	SENT151	2	2	6	6	fasudil	MCP-1	PA165946121	6347	0.779
NULL	J_Gastroenterol_2014_Sep_25_49(8)_1253-1263.nxml.txt.nlp	24065124	SENT277	16	16	6	6	ribavirin	IL28B	PA451241	282617	0.779
NULL	Ann_Dermatol_2011_Dec_27_23(Suppl_3)_S360-S363.nxml.txt.nlp	22346278	SENT13	17	17	21	21	imatinib	CML	PA10804	613	0.779
NULL	Arch_Med_Sci_2010_Dec_29_6(6)_964-970.nxml.txt.nlp	22427774	SENT104	3	3	8	8	methotrexate	IL-18	PA450428	3606	0.779
NULL	Arch_Med_Sci_2013_Aug_30_9(4)_622-628.nxml.txt.nlp	24049520	SENT143	6	6	16	16	atorvastatin	ADP	PA448500	23038	0.779
NULL	Biomed_Res_Int_2014_Feb_27_2014_214587.nxml.txt.nlp	24716192	SENT141	18	18	27	27	amlodipine	LPA	PA448388	4018	0.779
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S31-S40.nxml.txt.nlp	20680106	SENT69	8	8	30	30	cetuximab	KRAS	PA10040	3845	0.779
NULL	Hum_Genomics_2009_Jan_1_3(2)_128-142.nxml.txt.nlp	19164090	SENT176	18	18	1	1	carboplatin	CD44	PA448803	960	0.779
NULL	Biomed_Res_Int_2014_Feb_6_2014_323594.nxml.txt.nlp	24689036	SENT237	3	3	29	29	raloxifene	EGFR	PA451221	1956	0.779
NULL	Case_Rep_Endocrinol_2013_Mar_28_2013_192573.nxml.txt.nlp	23607000	SENT59	16	16	9	9	sorafenib	RAI	PA7000	10848;6050	0.779
NULL	J_Cell_Mol_Med_2014_Nov_12_18(11)_2198-2212.nxml.txt.nlp	25215580	SENT196	3	3	5	5	bleomycin	BLM	PA448645	641	0.779
NULL	Neural_Plast_2013_Dec_30_2013_863970.nxml.txt.nlp	24490088	SENT16	42	42	10	10	fluoxetine	NPAS4	PA449673	266743	0.779
NULL	Acta_Pharmacol_Sin_2011_Mar_31_32(3)_295-302.nxml.txt.nlp	21278785	SENT112	0	0	3	3	evodiamine	spatial	PA165860788	219793	0.779
NULL	Acta_Pharmacol_Sin_2014_Oct_15_35(10)_1302-1310.nxml.txt.nlp	25220642	SENT37	11	11	2	2	cisplatin	CTX	PA449014	1593	0.779
NULL	Breast_Cancer_Res_2007_Sep_17_9(5)_R61.nxml.txt.nlp	17875215	SENT28	22	22	16	16	trastuzumab	aromatase	PA451743	1588	0.779
NULL	ScientificWorldJournal_2012_Apr_19_2012_804730.nxml.txt.nlp	22606063	SENT116	14	14	18	18	tafluprost	BAK	PA165958432	578	0.779
NULL	Cell_Commun_Signal_2014_Nov_7_12(1)_73.nxml.txt.nlp	NULL	SENT197	7	7	9	9	tamoxifen	THOC5	PA451581	8563	0.779
NULL	Cancer_Cell_Int_2011_Aug_19_11_29.nxml.txt.nlp	21854619	SENT271	7	7	1	1	cisplatin	BRCA1	PA449014	672	0.779
NULL	Breast_Cancer_Res_Treat_2013_Jan_13_137(2)_471-482.nxml.txt.nlp	23239151	SENT195	23	23	28	28	trastuzumab	HER2	PA451743	2064	0.779
NULL	Lab_Invest_2014_May_10_94(5)_503-516.nxml.txt.nlp	24614199	SENT185	8	8	38	38	curcumin	RAGE	PA151958596	177	0.779
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT336	0	0	5	5	bevacizumab	VEGF-A	PA130232992	7422	0.779
NULL	Nat_Med_2012_Jul_18(7)_1118-1122.nxml.txt.nlp	22683780	SENT57	41	41	23	23	crizotinib	FGFR1	PA165946122	2260	0.779
NULL	Croat_Med_J_2013_Apr_54(2)_171-179.nxml.txt.nlp	23630144	SENT18	0	0	17	17	taurine	HO-1	PA451590	3162	0.779
NULL	Acta_Pharmacol_Sin_2014_Aug_21_35(8)_994-1004.nxml.txt.nlp	25042549	SENT169	5	5	15	15	pravastatin	PCSK9	PA451089	255738	0.779
NULL	Int_J_Med_Sci_2013_Mar_5_10(4)_467-474.nxml.txt.nlp	23470962	SENT47	11	11	17	17	l-lysine	mol	PA450280	90527	0.779
NULL	Br_J_Cancer_2009_Jun_2_100(11)_1704-1719.nxml.txt.nlp	19436303	SENT37	0	0	13	13	bevacizumab	IFL	PA130232992	3439	0.779
NULL	Mucosal_Immunol_2012_Mar_16_5(2)_121-128.nxml.txt.nlp	22089029	SENT100	3	3	31	31	collagenase	CD4	PA449107	920	0.779
NULL	Int_J_Biol_Sci_2012_Feb_9_8(3)_310-327.nxml.txt.nlp	22355267	SENT437	2	2	14	14	simvastatin	PCSK9	PA451363	255738	0.779
NULL	J_Clin_Biochem_Nutr_2009_Jul_30_45(1)_9-13.nxml.txt.nlp	19590701	SENT306	6	6	3	3	lansoprazole	HO-1	PA450180	3162	0.779
NULL	Exp_Ther_Med_2014_Sep_14_8(3)_836-840.nxml.txt.nlp	25120610	SENT88	4	4	23	23	fasudil	ROCK2	PA165946121	9475	0.779
NULL	Aging_(Albany_NY)_2010_Dec_31_2(12)_924-935.nxml.txt.nlp	21212465	SENT52	4	4	2	2	etoposide	p53	PA449552	7157	0.779
NULL	Crit_Care_2011_Oct_25_15(5)_233.nxml.txt.nlp	22104633	SENT230	0	0	9	9	bosentan	ETB	PA10034	1910	0.779
NULL	Case_Rep_Dermatol_2012_Sep_16_4(3)_256-260.nxml.txt.nlp	23275770	SENT16	2	2	18	18	isotretinoin	OMG	PA450128	4974	0.779
NULL	Exp_Diabetes_Res_2011_Jun_4_2011_489708.nxml.txt.nlp	21747829	SENT188	27	27	31	31	aliskiren	GLP-1	PA143487910	100125288	0.779
NULL	Mol_Cancer_2013_May_13_12_41.nxml.txt.nlp	23668310	SENT68	2	2	24	24	piroxicam	ANOVA	PA450985	4858	0.779
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2013_Dec_8_6_75-79.nxml.txt.nlp	24348081	SENT64	6	6	15	15	colesevelam	GLP-1	PA449095	100125288	0.779
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Feb_17_68(Pt_3)_o782.nxml.txt.nlp	22412655	SENT60	9	9	24	24	benzaldehyde	mol	PA448571	90527	0.779
NULL	J_Invest_Dermatol_2014_Apr_11_134(4)_1083-1090.nxml.txt.nlp	24335898	SENT56	11	11	4	4	nutlin-3	p53		7157	0.779
NULL	J_Exp_Clin_Cancer_Res_2009_Jul_10_28(1)_99.nxml.txt.nlp	19591692	SENT108	13	13	9	9	tariquidar	ABCB1		5243	0.779
NULL	Cardiovasc_Diabetol_2010_Mar_24_9_12.nxml.txt.nlp	20334663	SENT33	7	7	4	4	acarbose	solo	PA448010	55701	0.779
NULL	Oncotarget_2013_Nov_15_4(11)_1866-1867.nxml.txt.nlp	24272818	SENT3	13	13	2	2	pertuzumab	HER2		2064	0.779
NULL	EMBO_Mol_Med_2013_Jul_30_5(7)_932-948.nxml.txt.nlp	23723167	SENT78	25	25	34	34	pilocarpine	MMP13	PA450962	4322	0.779
NULL	Clin_Drug_Investig_2015_Dec_16_35_141-147.nxml.txt.nlp	25511640	SENT90	26	26	30	30	miglitol	GLP-1	PA164776726	100125288	0.779
NULL	Bioimpacts_2014_Feb_27_4(1)_21-27.nxml.txt.nlp	24790895	SENT114	20	20	26	26	isoproterenol	ANOVA	PA450121	4858	0.779
NULL	Br_J_Anaesth_2014_Jul_22_113(1)_157-167.nxml.txt.nlp	24154701	SENT246	17	17	4	4	sevoflurane	TREK-1	PA451341	3776	0.779
NULL	Biol_Direct_2007_Feb_21_2_8.nxml.txt.nlp	17313671	SENT175	14	14	21	21	doxorubicin	CHOP	PA449412	1649	0.779
NULL	Cases_J_2009_Jul_30_2_7134.nxml.txt.nlp	19829918	SENT101	9	9	17	17	entacapone	LCE	PA164748726	79071	0.779
NULL	J_Adv_Pract_Oncol_2012_Jan_1_Jan-Feb_3(1)_49-54.nxml.txt.nlp	25031928	SENT57	14	14	2	2	plerixafor	CD34	PA165958410	947	0.779
NULL	Biologics_2012_Dec_17_6_429-464.nxml.txt.nlp	23269860	SENT238	5	5	19	19	tocilizumab	ACR	PA165292659	49	0.779
NULL	Allergy_Asthma_Immunol_Res_2013_Jul_27_5(4)_224-231.nxml.txt.nlp	23814676	SENT193	34	34	30	30	forskolin	EP4	PA146096022	5734	0.779
NULL	Acta_Histochem_Cytochem_2012_Apr_26_45(2)_113-119.nxml.txt.nlp	22685353	SENT38	24	24	9	9	paraformaldehyde	E16	PA450790	8140	0.779
NULL	Eur_J_Clin_Pharmacol_2012_Jan_7_68(1)_55-64.nxml.txt.nlp	21735164	SENT300	9	9	4	4	oxycodone	CYP2D6	PA450741	1565	0.779
NULL	Br_J_Cancer_2013_Jun_25_108(12)_2485-2494.nxml.txt.nlp	23695022	SENT115	10	10	20	20	carvedilol	P-gp	PA448817	5243	0.779
NULL	Oncoscience_2014_Mar_16_1(2)_132-157.nxml.txt.nlp	25594007	SENT308	11	11	2	2	cetuximab	ERBB2	PA10040	2064	0.779
NULL	Behav_Brain_Funct_2012_Feb_13_8_9.nxml.txt.nlp	22329956	SENT102	7	7	31	31	duloxetine	PMP22	PA10066	5376;5827	0.779
NULL	Cancer_Growth_Metastasis_2014_Aug_10_7_33-42.nxml.txt.nlp	25187738	SENT189	23	23	14	14	bortezomib	OCN	PA10252	632	0.779
NULL	Arthritis_Res_Ther_2004_Jun_21_6(Suppl_2)_S3-S11.nxml.txt.nlp	15228615	SENT89	18	18	10	10	etanercept	ACR	PA449515	49	0.779
NULL	Mediators_Inflamm_1999_8(3)_147-151.nxml.txt.nlp	10704052	SENT2	26	26	5	5	trypsin	SLPI	PA451806	6590	0.779
NULL	Acta_Pharmacol_Sin_2010_May_26_31(5)_554-559.nxml.txt.nlp	20418892	SENT3	5	5	7	7	bleomycin	BLM	PA448645	641	0.779
NULL	Mol_Neurodegener_2011_Nov_25_6_81.nxml.txt.nlp	22118545	SENT187	24	24	10	10	dantrolene	SOC	PA449208	91544	0.779
NULL	Cancer_Med_2013_Aug_30_2(4)_457-467.nxml.txt.nlp	24156018	SENT112	23	23	27	27	marimastat	MMP14	PA164748329	4323	0.779
NULL	Mol_Imaging_Biol_2009_Sep_28_11(5)_334-342.nxml.txt.nlp	19330383	SENT36	11	11	21	21	bevacizumab	RAPA	PA130232992	55809	0.779
NULL	Acta_Vet_Scand_2014_May_20_56(1)_33.nxml.txt.nlp	24884817	SENT188	10	10	36	36	heparin	IL-6	PA449855	3569	0.779
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT272	4	4	0	0	vinblastine	MVP	PA451877	9961	0.779
NULL	Clinics_(Sao_Paulo)_2013_Oct_68(10)_1325-1332.nxml.txt.nlp	24212839	SENT140	13	13	16	16	ribavirin	IL28B	PA451241	282617	0.779
NULL	Iran_J_Basic_Med_Sci_2011_Sep-Oct_14(5)_436-442.nxml.txt.nlp	23493930	SENT35	29	29	20	20	glibenclamide	STZ	PA449782	6484	0.779
NULL	Cardiovasc_Diabetol_2007_Aug_15_6_20.nxml.txt.nlp	17697384	SENT70	11	11	3	3	rosiglitazone	DREAM	PA451283	30818	0.779
NULL	Clin_Mol_Allergy_2007_Jan_25_5_1.nxml.txt.nlp	17254346	SENT152	0	0	6	6	curcumin	CD80	PA151958596	941	0.779
NULL	Braz_J_Med_Biol_Res_2013_Aug_13_46(8)_659-669.nxml.txt.nlp	24036938	SENT167	8	8	6	6	resveratrol	SIRT1		23411	0.779
NULL	Environ_Health_Perspect_2007_Dec_8_115(Suppl_1)_129-136.nxml.txt.nlp	18174961	SENT166	10	10	17	17	lindane	CYP1A1	PA164754914	1543	0.779
NULL	Oncotarget_2011_Mar_23_2(3)_165-177.nxml.txt.nlp	21444946	SENT31	19	19	11	11	gefitinib	EGFR	PA131301952	1956	0.779
NULL	Diabetes_2013_Oct_17_62(10)_3547-3552.nxml.txt.nlp	23863812	SENT77	33	33	3	3	pravastatin	adiponectin	PA451089	9370	0.779
NULL	Arthritis_Res_Ther_2004_Sep_23_6(6)_R535-R543.nxml.txt.nlp	15535831	SENT215	9	9	2	2	infliximab	ACL	PA452639	47	0.779
NULL	Acta_Naturae_2013_Apr-Jun_5(2)_19-39.nxml.txt.nlp	23819034	SENT209	5	5	3	3	thrombin	FVIII	PA451674	2157	0.779
NULL	J_Headache_Pain_2013_Apr_10_14(1)_33.nxml.txt.nlp	23574808	SENT119	10	10	4	4	capsaicin	CO2	PA448776	4513	0.779
NULL	J_Headache_Pain_2009_Apr_27_10(2)_105-110.nxml.txt.nlp	19172228	SENT146	4	4	8	8	sumatriptan	c-fos	PA451566	2353	0.779
NULL	Cancer_Cell_Int_2006_May_26_6_15.nxml.txt.nlp	16729884	SENT250	21	21	12	12	doxorubicin	p53	PA449412	7157	0.779
NULL	FEBS_Open_Bio_2012_Aug_22_2_279-283.nxml.txt.nlp	23650611	SENT344	6	6	10	10	tamoxifen	IFN	PA451581	3439	0.779
NULL	Indian_J_Pharm_Sci_2013_Jan-Feb_75(1)_94-98.nxml.txt.nlp	23901167	SENT69	16	16	35	35	bupropion	CYP1A2	PA448687	1544	0.779
NULL	Hum_Genomics_2010_Apr_1_4(4)_238-249.nxml.txt.nlp	20511137	SENT76	27	27	22	22	raloxifene	UGT1A1	PA451221	54658	0.779
NULL	Front_Neural_Circuits_2013_Oct_21_7_165.nxml.txt.nlp	24155693	SENT209	22	22	37	37	protamine	CA3	PA10366	761	0.779
NULL	Oncotarget_2014_Nov_3_5(20)_10127-10139.nxml.txt.nlp	25333256	SENT148	35	35	18	18	vemurafenib	TRIM16	PA165946873	10626	0.779
NULL	Anat_Cell_Biol_2012_Jun_30_45(2)_73-78.nxml.txt.nlp	22822460	SENT85	19	19	26	26	gemcitabine	HIF-1	PA449748	29072	0.779
NULL	Genome_Announc_2013_Mar_28_1(2)_e00097-13.nxml.txt.nlp	23538904	SENT23	23	23	6	6	bacitracin	L12	PA448531	26156;6136	0.779
NULL	Exp_Ther_Med_2013_May_15_5(5)_1327-1331.nxml.txt.nlp	23737873	SENT10	5	5	13	13	vasopressin	AQP2	PA451858	359	0.779
NULL	J_Biomed_Biotechnol_2011_Dec_6_2011_856985.nxml.txt.nlp	21188173	SENT277	26	26	31	31	tamoxifen	PAK1	PA451581	5585;5058	0.779
NULL	Virol_J_2011_May_25_8_258.nxml.txt.nlp	21609495	SENT17	24	24	22	22	ribavirin	IFN	PA451241	3439	0.779
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT109	19	19	26	26	l-methionine	S6K1	PA450423	6198	0.779
NULL	Neuro_Oncol_2010_Apr_27_12(4)_389-400.nxml.txt.nlp	20308316	SENT117	29	29	20	20	chloroquine	p53	PA448948	7157	0.779
NULL	Breast_Cancer_Res_2009_Jun_23_11(Suppl_1)_P10.nxml.txt.nlp	NULL	SENT9	16	16	19	19	tamoxifen	p27	PA451581	5715;10534	0.779
NULL	Mediators_Inflamm_2010_Mar_22_2010_823486.nxml.txt.nlp	20339530	SENT137	24	24	22	22	hyaluronan	HMGB1	PA165958431	3146	0.779
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT118	9	9	15	15	doxorubicin	B7-H1	PA449412	29126	0.779
NULL	Br_J_Cancer_2011_Apr_12_104(8)_1278-1287.nxml.txt.nlp	21487429	SENT159	11	11	22	22	cisplatin	XIAP	PA449014	331	0.779
NULL	Mol_Cancer_2012_Sep_11_11_66.nxml.txt.nlp	22966907	SENT346	0	0	26	26	hyaluronan	CD44	PA165958431	960	0.779
NULL	Int_J_Mol_Sci_2014_Jun_5_15(6)_10083-10100.nxml.txt.nlp	24905407	SENT19	36	36	11	11	tetracycline	STP	PA451640	9322	0.779
NULL	Open_Virol_J_2008_Oct_16_2_69-73.nxml.txt.nlp	19440466	SENT116	18	18	5	5	nevirapine	CD4	PA450616	920	0.779
NULL	Diabetes_2011_May_23_60(5)_1561-1565.nxml.txt.nlp	21430088	SENT81	8	8	4	4	ethanol	GLP-1	PA448073	100125288	0.779
NULL	Exp_Transl_Stroke_Med_2012_Mar_13_4_5.nxml.txt.nlp	22414527	SENT125	19	19	22	22	isoflurane	ANOVA	PA450106	4858	0.779
NULL	J_Ayurveda_Integr_Med_2010_Oct-Dec_1(4)_257-265.nxml.txt.nlp	21731372	SENT183	14	14	24	24	curcumin	COX2	PA151958596	4513;5743	0.779
NULL	Arthritis_Res_2002_May_9_4(Suppl_3)_S17-S24.nxml.txt.nlp	12110119	SENT253	15	15	5	5	infliximab	IL-18	PA452639	3606	0.779
NULL	J_Hematol_Oncol_2013_Jan_4_6_1.nxml.txt.nlp	23286345	SENT13	0	0	20	20	trastuzumab	HER2	PA451743	2064	0.779
NULL	Patient_Prefer_Adherence_2013_Apr_26_7_369-377.nxml.txt.nlp	23641151	SENT73	17	17	9	9	ustekinumab	p40	PA166048654	3921;339541;10314	0.779
NULL	Pharmaceutics_2010_Oct_27_2(4)_339-350.nxml.txt.nlp	NULL	SENT179	23	23	17	17	piroxicam	BCS	PA450985	617	0.779
NULL	Case_Rep_Gastroenterol_2014_Apr_10_8(1)_134-140.nxml.txt.nlp	24847196	SENT76	14	14	11	11	cyclophosphamide	CHOP	PA449165	1649	0.779
NULL	Front_Immunol_2012_May_7_3_101.nxml.txt.nlp	22783250	SENT251	25	25	30	30	papain	IL-5	PA450778	3567	0.779
NULL	Allergy_Asthma_Immunol_Res_2010_Jul_19_2(3)_177-182.nxml.txt.nlp	20592916	SENT100	28	28	21	21	tiotropium	ADRB2	PA164769056	154	0.779
NULL	Diabetes_2011_Jul_20_60(7)_1926-1937.nxml.txt.nlp	21617180	SENT252	23	23	15	15	lipase	KLF15	PA450239	28999	0.779
NULL	Pharmaceuticals_(Basel)_2012_Aug_10_5(8)_802-836.nxml.txt.nlp	24280676	SENT1752	3	3	18	18	methotrexate	MRP1	PA450428	4437	0.779
NULL	J_Carcinog_2013_Aug_8_12_16.nxml.txt.nlp	24082825	SENT90	6	6	0	0	phenformin	AMPK	PA1000	5563	0.779
NULL	Cancer_Immunol_Immunother_2012_Jul_23_61(7)_1101-1111.nxml.txt.nlp	22193989	SENT205	10	10	20	20	oxaliplatin	STAT3	PA131285527	6774	0.779
NULL	Oncotarget_2014_Oct_21_5(22)_11709-11722.nxml.txt.nlp	25365944	SENT221	4	4	11	11	metformin	Rho	PA450395	29984	0.779
NULL	Cell_Death_Dis_2014_Apr_17_5(4)_e1182.nxml.txt.nlp	24743737	SENT31	4	4	2	2	capsaicin	TRPV1	PA448776	7442	0.779
NULL	Cell_Death_Dis_2012_Jun_7_3(6)_e319.nxml.txt.nlp	22673193	SENT83	12	12	2	2	cisplatin	Mcl-1	PA449014	4170	0.779
NULL	Nature_2012_Feb_23_482(7386)_524-528.nxml.txt.nlp	22358842	SENT106	7	7	18	18	collagenase	F10	PA449107	2159	0.779
NULL	Arthritis_Res_Ther_2014_Apr_3_16(2)_R86.nxml.txt.nlp	24708674	SENT276	9	9	15	15	imatinib	Fli1	PA10804	2314	0.779
NULL	Acta_Pharmacol_Sin_2012_Mar_30_33(3)_335-341.nxml.txt.nlp	22286918	SENT79	11	11	18	18	carvedilol	EGFR	PA448817	1956	0.779
NULL	Br_J_Cancer_2009_Mar_10_100(5)_758-763.nxml.txt.nlp	19259094	SENT80	5	5	19	19	belinostat	MLH1		4292	0.779
NULL	Clin_Ophthalmol_2007_Mar_1(1)_11-24.nxml.txt.nlp	19668462	SENT192	18	18	20	20	travoprost	BAK	PA164781371	578	0.779
NULL	J_Invest_Dermatol_2012_Nov_21_132(11)_2642-2651.nxml.txt.nlp	22718118	SENT251	8	8	20	20	collagenase	CCR2	PA449107	729230	0.779
NULL	Evid_Based_Complement_Alternat_Med_2014_Mar_26_2014_924560.nxml.txt.nlp	24795772	SENT162	44	44	20	20	calcein	AKT	PA132595336	207	0.779
NULL	Mol_Biol_Rep_2013_Sep_28_40(10)_5573-5585.nxml.txt.nlp	24078156	SENT48	22	22	11	11	iron	FPN1	PA450087	30061	0.779
NULL	Cancer_Cell_2015_Jan_12_27(1)_57-71.nxml.txt.nlp	25584894	SENT901	7	7	2	2	doxycycline	ACSS2	PA449415	55902	0.779
NULL	J_Inflamm_(Lond)_2008_Apr_27_5_5.nxml.txt.nlp	18439312	SENT165	20	20	1	1	genistein	AREG	PA165109660	374	0.779
NULL	J_Hematol_Oncol_2013_Nov_5_6_83.nxml.txt.nlp	24283248	SENT74	23	23	40	40	nutlin-3	TP53		7157	0.779
NULL	J_Cardiothorac_Surg_2013_Apr_29_8_113.nxml.txt.nlp	23628149	SENT52	7	7	27	27	heparin	ACT	PA449855	12;11332;9457;641455	0.779
NULL	Clin_Dev_Immunol_2011_Sep_14_2011_267539.nxml.txt.nlp	21922022	SENT172	2	2	14	14	gemcitabine	CD4	PA449748	920	0.779
NULL	Aging_(Albany_NY)_2013_Jan_19_5(1)_67-83.nxml.txt.nlp	23425686	SENT215	23	23	14	14	nadh	CLS	PA164755085	1210	0.779
NULL	Curr_Neuropharmacol_2008_Jun_6(2)_151-163.nxml.txt.nlp	19305794	SENT233	9	9	2	2	capsaicin	TRPV1	PA448776	7442	0.779
NULL	Am_J_Trop_Med_Hyg_2014_Oct_1_91(4)_833-843.nxml.txt.nlp	25048375	SENT145	11	11	17	17	artemether	ACT	PA165111698	12;11332;9457;641455	0.779
NULL	Oncotarget_2011_Mar_27_2(3)_209-221.nxml.txt.nlp	21444945	SENT134	3	3	17	17	bortezomib	p53	PA10252	7157	0.779
NULL	Breast_Cancer_Res_2007_Aug_8_9(4)_R50.nxml.txt.nlp	17686159	SENT243	3	3	12	12	gefitinib	EGFR	PA131301952	1956	0.779
NULL	J_Gen_Physiol_1976_Nov_1_68(5)_537-549.nxml.txt.nlp	993771	SENT0	11	11	1	1	verapamil	Gen	PA451868	348654	0.779
NULL	Br_J_Pharmacol_2014_May_171(10)_2659-2670.nxml.txt.nlp	24116661	SENT151	9	9	4	4	naringenin	TRPP2	PA151958361	5311	0.779
NULL	Breast_Cancer_Res_2010_Mar_5_12(2)_R16.nxml.txt.nlp	20205716	SENT362	0	0	22	22	lovastatin	MCM7	PA450272	4176	0.779
NULL	Anal_Chem_Insights_2008_Mar_25_3_45-60.nxml.txt.nlp	19609389	SENT21	39	39	32	32	cholestyramine	CYP7A1	PA448974	1581	0.778
NULL	Int_J_Mol_Sci_2014_Sep_22_15(9)_16848-16884.nxml.txt.nlp	25247581	SENT479	7	7	10	10	resveratrol	SIRT1		23411	0.778
NULL	Breast_Cancer_Res_2010_Jul_1_12(4)_R45.nxml.txt.nlp	20594311	SENT129	14	14	25	25	nelfinavir	AKT	PA450606	207	0.778
NULL	Cancers_(Basel)_2013_May_24_5(2)_569-590.nxml.txt.nlp	24216992	SENT241	5	5	19	19	cyclophosphamide	TRAMP	PA449165	8718;23471;9189	0.778
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Jan_15_70(Pt_2)_o140.nxml.txt.nlp	24764866	SENT75	20	20	12	12	ethanol	mol	PA448073	90527	0.778
NULL	Eur_J_Haematol_2014_Feb_25_92(2)_127-136.nxml.txt.nlp	24118452	SENT172	21	21	10	10	anagrelide	CRT	PA164742986	811	0.778
NULL	Mol_Cell_Biochem_2014_Jul_26_396(1-2)_221-228.nxml.txt.nlp	25063218	SENT102	2	2	6	6	resveratrol	EGFR		1956	0.778
NULL	Cardiovasc_Ultrasound_2012_Nov_30_10_47.nxml.txt.nlp	23199010	SENT124	14	14	28	28	dobutamine	TDI	PA449381	100038246	0.778
NULL	Breast_Cancer_Res_2004_Nov_25_6(1)_E8.nxml.txt.nlp	14680493	SENT44	0	0	30	30	tamoxifen	BRCA2	PA451581	675	0.778
NULL	Mol_Cell_Proteomics_2014_Jan_18_13(1)_145-156.nxml.txt.nlp	24142993	SENT147	20	20	23	23	trastuzumab	HER2	PA451743	2064	0.778
NULL	J_Gen_Physiol_2008_Sep_132(3)_329-338.nxml.txt.nlp	18695009	SENT29	18	18	6	6	forskolin	GLP-1	PA146096022	100125288	0.778
NULL	Oncotarget_2014_Feb_14_5(3)_841-852.nxml.txt.nlp	24553354	SENT297	5	5	20	20	bortezomib	p53	PA10252	7157	0.778
NULL	J_Med_Genet_2010_Aug_18_47(8)_507-512.nxml.txt.nlp	19542079	SENT15	5	5	20	20	s-adenosylmethionine	NDUFB3	PA164754994	4709	0.778
NULL	J_Headache_Pain_2010_Jun_6_11(3)_207-214.nxml.txt.nlp	20369271	SENT143	18	18	15	15	thyroglobulin	TPO	PA164754910	7066;7173	0.778
NULL	Clin_Ophthalmol_2014_Sep_1_8_1681-1687.nxml.txt.nlp	25214761	SENT21	19	19	28	28	brimonidine	BAK	PA448665	578	0.778
NULL	Environ_Health_Perspect_2008_Sep_116(9)_A402a.nxml.txt.nlp	NULL	SENT13	8	8	2	2	iron	HFE	PA450087	3077	0.778
NULL	EJC_Suppl_2013_Sep_5_11(2)_3-22.nxml.txt.nlp	NULL	SENT261	21	21	12	12	paclitaxel	ACT	PA450761	12;11332;9457;641455	0.778
NULL	Clin_Pharmacokinet_2014_Jun_27_53(8)_741-751.nxml.txt.nlp	24968986	SENT250	23	23	44	44	docetaxel	OATP1B3	PA449383	28234	0.778
NULL	Br_J_Cancer_2009_Mar_10_100(5)_758-763.nxml.txt.nlp	19259094	SENT76	8	8	2	2	decitabine	MLH1	PA164749631	4292	0.778
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Mar_27_66(Pt_4)_o922.nxml.txt.nlp	21580732	SENT56	19	19	34	34	ethanol	mol	PA448073	90527	0.778
NULL	Front_Oncol_2014_Mar_25_4_54.nxml.txt.nlp	24724051	SENT346	9	9	18	18	imatinib	p53	PA10804	7157	0.778
NULL	Mol_Biol_Cell_2012_Mar_1_23(5)_853-863.nxml.txt.nlp	22262458	SENT221	17	17	0	0	etoposide	JMY	PA449552	133746	0.778
NULL	Diabetes_Care_2013_Jun_15_36(6)_1765-1771.nxml.txt.nlp	23704676	SENT181	19	19	22	22	metformin	B12	PA450395	7126;4709	0.778
NULL	Cancer_Immunol_Immunother_2013_Aug_27_62(10)_1637-1648.nxml.txt.nlp	23982484	SENT231	10	10	23	23	lenalidomide	IL-6	PA162363968	3569	0.778
NULL	Neural_Regen_Res_2013_Jul_15_8(20)_1853-1862.nxml.txt.nlp	25206494	SENT121	12	12	2	2	ethanol	JNK	PA448073	5599	0.778
NULL	Clin_Dev_Immunol_2011_Mar_28_2011_370872.nxml.txt.nlp	21461372	SENT7	11	11	19	19	tetracycline	IL-1B	PA451640	3553	0.778
NULL	Braz_J_Microbiol_2012_Jun_1_Jan-Mar_43(1)_187-200.nxml.txt.nlp	24031817	SENT87	7	7	4	4	ether	TLC	PA449525	3933	0.778
NULL	Neural_Regen_Res_2013_May_5_8(13)_1180-1189.nxml.txt.nlp	25206412	SENT11	3	3	0	0	fasudil	Rho	PA165946121	29984	0.778
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1137-1144.nxml.txt.nlp	20234366	SENT34	15	15	18	18	cetuximab	KRAS	PA10040	3845	0.778
NULL	Oncol_Lett_2013_Mar_19_5(3)_923-928.nxml.txt.nlp	23426648	SENT181	14	14	0	0	celecoxib	MVD	PA448871	4597	0.778
NULL	Breast_Cancer_(Auckl)_2009_Sep_2_3_61-75.nxml.txt.nlp	19809577	SENT230	0	0	2	2	curcumin	BRCA1	PA151958596	672	0.778
NULL	Hum_Genomics_2010_Apr_1_4(4)_238-249.nxml.txt.nlp	20511137	SENT251	9	9	4	4	raloxifene	UGT1A1	PA451221	54658	0.778
NULL	J_Cell_Biol_1998_Jan_26_140(2)_335-345.nxml.txt.nlp	9442109	SENT3	29	29	12	12	chloroquine	NHE	PA448948	285335	0.778
NULL	J_Autoimmune_Dis_2005_Mar_11_2_1.nxml.txt.nlp	15762980	SENT414	10	10	13	13	thyroglobulin	ZFAT	PA164754910	57623	0.778
NULL	Neuro_Oncol_2010_Apr_27_12(4)_389-400.nxml.txt.nlp	20308316	SENT136	19	19	10	10	chloroquine	p53	PA448948	7157	0.778
NULL	J_Korean_Neurosurg_Soc_2014_Jul_31_56(1)_1-4.nxml.txt.nlp	25289117	SENT85	11	11	29	29	curcumin	p38	PA151958596	10598;1432;7965	0.778
NULL	Int_J_Environ_Res_Public_Health_2013_Sep_27_10(9)_3843-3854.nxml.txt.nlp	23985770	SENT115	23	23	34	34	l-carnitine	ACR	PA450154	49	0.778
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT264	14	14	12	12	chloroquine	BMPR-II	PA448948	659	0.778
NULL	Diabetes_2013_May_16_62(5)_1464-1477.nxml.txt.nlp	23349479	SENT24	14	14	18	18	lipase	PNPLA2	PA450239	57104	0.778
NULL	Arthritis_Res_Ther_2011_Feb_11_13(1)_R21.nxml.txt.nlp	21314928	SENT126	36	36	14	14	tocilizumab	CD4	PA165292659	920	0.778
NULL	Curr_Neuropharmacol_2008_Sep_6(3)_215-234.nxml.txt.nlp	19506722	SENT156	1	1	20	20	fluoxetine	5-HT7	PA449673	3363	0.778
NULL	Eur_J_Med_Res_2010_Jul_26_15(7)_314-318.nxml.txt.nlp	20696644	SENT143	22	22	17	17	hemin	c-Jun	PA449849	3725	0.778
NULL	J_Korean_Med_Sci_2013_Nov_31_28(11)_1609-1614.nxml.txt.nlp	24265523	SENT109	23	23	20	20	everolimus	DES	PA164746311	1674	0.778
NULL	Biomed_Res_Int_2014_Jan_29_2014_831845.nxml.txt.nlp	24605337	SENT90	0	0	2	2	bupivacaine	S6K1	PA135057240	6198	0.778
NULL	Biosci_Rep_2012_Dec_20_33(1)_e00011.nxml.txt.nlp	23137297	SENT138	8	8	2	2	heparin	RPSA	PA449855	3921	0.778
NULL	Oncotarget_2012_Aug_19_3(8)_890-903.nxml.txt.nlp	23097685	SENT139	19	19	26	26	rofecoxib	COX	PA451268	1351	0.778
NULL	Diabetes_Care_2009_Apr_32(4)_531-540.nxml.txt.nlp	19336638	SENT221	4	4	18	18	cilostazol	VASP	PA164746334	7408	0.778
NULL	Exp_Diabetes_Res_2011_Dec_27_2011_604989.nxml.txt.nlp	21253359	SENT50	9	9	21	21	clonidine	GLP-1	PA449051	100125288	0.778
NULL	Cancer_Imaging_2011_Jan_11_11(1)_259-265.nxml.txt.nlp	22245974	SENT0	25	25	12	12	sunitinib	MRI	PA162372840	78996	0.778
NULL	Mol_Cancer_2003_Apr_17_2_23.nxml.txt.nlp	12740039	SENT314	16	16	13	13	deferoxamine	p53	PA164746490	7157	0.778
NULL	Eur_J_Clin_Pharmacol_2012_Jan_8_68(1)_29-37.nxml.txt.nlp	21739267	SENT93	6	6	16	16	aripiprazole	CYP2D6	PA10026	1565	0.778
NULL	Exp_Ther_Med_2013_Sep_4_6(3)_663-670.nxml.txt.nlp	24137243	SENT139	5	5	23	23	omeprazole	IL-6	PA450704	3569	0.778
NULL	Diabetes_Care_2012_Dec_14_35(12)_2432-2437.nxml.txt.nlp	23173132	SENT162	6	6	2	2	nadh	NNT	PA164755085	23530	0.778
NULL	Diabetes_Care_2010_Oct_2_33(10)_2164-2168.nxml.txt.nlp	20519663	SENT25	9	9	14	14	ramipril	DREAM	PA451223	30818	0.778
NULL	Evid_Based_Complement_Alternat_Med_2012_Sep_4_2012_485042.nxml.txt.nlp	22988474	SENT63	0	0	9	9	evodiamine	Bcl-2	PA165860788	596	0.778
NULL	Clin_Transl_Allergy_2013_Sep_2_3_29.nxml.txt.nlp	24004581	SENT90	5	5	7	7	omalizumab	IL-6	PA164752253	3569	0.778
NULL	J_Hematol_Oncol_2009_Jul_27_2_31.nxml.txt.nlp	19635146	SENT167	24	24	33	33	vorinostat	Mcl-1	PA164748224	4170	0.778
NULL	Indian_J_Pharmacol_2013_May-Jun_45(3)_248-251.nxml.txt.nlp	23833367	SENT88	7	7	15	15	diazepam	EPM	PA449283	2054	0.778
NULL	Front_Physiol_2013_Nov_14_4_323.nxml.txt.nlp	24294204	SENT176	28	28	19	19	bucindolol	BEST	PA165945764	7439	0.778
NULL	J_Cancer_Res_Clin_Oncol_2010_May_11_136(5)_737-743.nxml.txt.nlp	19904559	SENT40	31	31	21	21	bevacizumab	IFL	PA130232992	3439	0.778
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT196	4	4	14	14	metformin	EGFR	PA450395	1956	0.778
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT171	3	3	16	16	atorvastatin	MARK	PA448500	4139	0.778
NULL	Arthritis_Res_Ther_2003_Jan_14_5(2)_54-67.nxml.txt.nlp	12718745	SENT383	15	15	0	0	hyaluronan	ACL	PA165958431	47	0.778
NULL	Oncotarget_2013_Aug_9_4(9)_1332-1333.nxml.txt.nlp	23934763	SENT1	5	5	28	28	imatinib	ABL1	PA10804	25	0.778
NULL	Endocrinol_Metab_(Seoul)_2013_Dec_12_28(4)_262-274.nxml.txt.nlp	24396690	SENT112	14	14	4	4	exenatide	GLP-1	PA164749238	100125288	0.778
NULL	Semin_Cancer_Biol_2014_Jun_26(100)_89-98.nxml.txt.nlp	24316494	SENT47	8	8	10	10	zidovudine	IFN	PA451954	3439	0.778
NULL	Cancer_Med_2013_Feb_3_2(1)_76-85.nxml.txt.nlp	24133630	SENT197	18	18	28	28	vemurafenib	P-gp	PA165946873	5243	0.778
NULL	J_Cardiothorac_Surg_2011_Mar_3_6_22.nxml.txt.nlp	21371317	SENT84	20	20	13	13	cyclophosphamide	SCAD	PA449165	35	0.778
NULL	Clin_Exp_Gastroenterol_2012_May_14_5_49-59.nxml.txt.nlp	22649281	SENT76	11	11	19	19	omeprazole	CYP2C19	PA450704	1557	0.778
NULL	Oncotarget_2014_Aug_19_5(18)_8729-8736.nxml.txt.nlp	25238266	SENT105	26	26	9	9	docetaxel	IL-6	PA449383	3569	0.778
NULL	Eur_J_Epidemiol_2009_Sep_2_24(9)_553-572.nxml.txt.nlp	19728115	SENT1531	10	10	26	26	acenocoumarol	PAGM	PA452632	5238	0.778
NULL	J_Mol_Signal_2011_Jul_20_6_7.nxml.txt.nlp	21774804	SENT34	5	5	14	14	dasatinib	EGFR	PA162372878	1956	0.778
NULL	Indian_J_Anaesth_2014_Sep-Oct_58(5)_565-572.nxml.txt.nlp	25535418	SENT128	8	8	46	46	heparin	ACT	PA449855	12;11332;9457;641455	0.778
NULL	Breast_Cancer_Res_2014_Sep_12_16(5)_436.nxml.txt.nlp	25213081	SENT244	6	6	12	12	tamoxifen	FOXM1	PA451581	2305	0.778
NULL	Trials_2014_May_15_15_171.nxml.txt.nlp	24885324	SENT57	23	23	36	36	estradiol	CEA	PA449503	5670;1087	0.778
NULL	Ann_Surg_Oncol_2012_Aug_31_19(8)_2700-2706.nxml.txt.nlp	22466664	SENT137	24	24	17	17	sorafenib	VEGFR	PA7000	3791	0.778
NULL	BMB_Rep_2013_Jan_46(1)_59-64.nxml.txt.nlp	23351386	SENT65	13	13	3	3	auranofin	NAC	PA448510	22861	0.778
NULL	J_Cell_Mol_Med_2014_Dec_9_18(12)_2499-2511.nxml.txt.nlp	24912879	SENT239	11	11	21	21	docetaxel	DACH1	PA449383	1602	0.778
NULL	Interdiscip_Toxicol_2010_Dec_3(4)_122-126.nxml.txt.nlp	21331177	SENT66	2	2	6	6	carvedilol	CA1	PA448817	759	0.778
NULL	Cancers_(Basel)_2011_Apr_13_3(2)_1957-1974.nxml.txt.nlp	24212791	SENT154	13	13	0	0	oxaliplatin	IL-4	PA131285527	3565	0.778
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jul_15_65(Pt_8)_o1857.nxml.txt.nlp	21583555	SENT49	15	15	31	31	benzaldehyde	mol	PA448571	90527	0.778
NULL	J_Infect_Dev_Ctries_2011_Jul_4_5(6)_484-488.nxml.txt.nlp	21727649	SENT51	18	18	20	20	methotrexate	TNF-alpha	PA450428	7124	0.778
NULL	Arthritis_Res_2000_Nov_15_1(Suppl_1)_S47.nxml.txt.nlp	NULL	SENT12	5	5	16	16	methotrexate	ACR	PA450428	49	0.778
NULL	Acta_Pharmacol_Sin_2013_Jun_8_34(6)_830-836.nxml.txt.nlp	23564080	SENT133	7	7	21	21	simvastatin	MCP-1	PA451363	6347	0.778
NULL	Biomed_Res_Int_2013_Nov_28_2013_791406.nxml.txt.nlp	24369536	SENT41	18	18	10	10	cisplatin	MDC	PA449014	6367	0.778
NULL	Gynecol_Oncol_Case_Rep_2013_Apr_11_5_37-39.nxml.txt.nlp	24371692	SENT12	6	6	27	27	cyclophosphamide	CA125	PA449165	4077;94025	0.778
NULL	J_Gen_Intern_Med_2009_May_21_24(5)_656-664.nxml.txt.nlp	19306050	SENT331	7	7	3	3	warfarin	GGCX	PA451906	2677	0.778
NULL	Oncotarget_2014_Jun_8_5(13)_5040-5053.nxml.txt.nlp	24970815	SENT218	28	28	4	4	cisplatin	PUMA	PA449014	27113	0.778
NULL	Mol_Vis_2011_Feb_1_17_332-340.nxml.txt.nlp	21297899	SENT214	0	0	9	9	benazepril	DPI	PA448561	1832	0.778
NULL	Hum_Genomics_Proteomics_2010_Aug_3_2010_159761.nxml.txt.nlp	20981231	SENT60	10	10	7	7	topiramate	GBP	PA451728	54972;3030;3956;8554	0.778
NULL	Front_Oncol_2014_Apr_9_4_75.nxml.txt.nlp	24782986	SENT296	24	24	8	8	paclitaxel	CA125	PA450761	4077;94025	0.778
NULL	Cancer_Manag_Res_2013_Jun_11_5_103-115.nxml.txt.nlp	23807861	SENT56	12	12	36	36	bevacizumab	VEGF-A	PA130232992	7422	0.778
NULL	Front_Microbiol_2013_Feb_11_4_16.nxml.txt.nlp	23403609	SENT56	8	8	14	14	indomethacin	IFN	PA449982	3439	0.778
NULL	Vet_Res_Forum_2013_Winter_4(1)_19-24.nxml.txt.nlp	25593681	SENT22	17	17	20	20	diclofenac	B12	PA449293	7126;4709	0.778
NULL	Core_Evid_2011_Mar_17_6_31-42.nxml.txt.nlp	21468241	SENT95	13	13	17	17	ticagrelor	IPA	PA165374673	3160	0.778
NULL	Case_Rep_Oncol_2012_May_10_5(2)_233-237.nxml.txt.nlp	22679429	SENT82	14	14	26	26	carboplatin	GEM	PA448803	2669	0.778
NULL	Eur_J_Clin_Pharmacol_2010_Nov_29_66(11)_1131-1136.nxml.txt.nlp	20669013	SENT137	13	13	24	24	erythromycin	CYP2C19	PA449493	1557	0.778
NULL	J_Biol_Chem_2013_Nov_22_288(47)_34217-34229.nxml.txt.nlp	24106270	SENT273	4	4	8	8	thrombin	RhoG	PA451674	391	0.778
NULL	Biosci_Rep_2012_Aug_1_32(Pt_4)_361-374.nxml.txt.nlp	22762204	SENT1620	15	15	4	4	paclitaxel	p16	PA450761	1029	0.778
NULL	Anat_Cell_Biol_2010_Dec_31_43(4)_325-331.nxml.txt.nlp	21267407	SENT10	30	30	21	21	minocycline	TNF-alpha	PA450519	7124	0.778
NULL	Mol_Cancer_2010_Aug_23_9_222.nxml.txt.nlp	20731837	SENT205	35	35	24	24	hydroxyurea	ATR	PA449942	390502;84168;545	0.778
NULL	Oncotarget_2013_Dec_18_5(2)_375-385.nxml.txt.nlp	24495868	SENT109	3	3	7	7	fludarabine	CD40L	PA449655	959	0.778
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jul_31_66(Pt_8)_o2157.nxml.txt.nlp	21588441	SENT47	24	24	39	39	ethanol	mol	PA448073	90527	0.778
NULL	Case_Rep_Oncol_2012_Dec_6_5(3)_651-656.nxml.txt.nlp	23275781	SENT83	10	10	7	7	sunitinib	VEGFR	PA162372840	3791	0.778
NULL	Acta_Pharmacol_Sin_2009_Jan_8_30(1)_25-30.nxml.txt.nlp	19060918	SENT58	21	21	4	4	ribavirin	IFN	PA451241	3439	0.778
NULL	Oncotarget_2014_Jun_3_5(13)_4920-4928.nxml.txt.nlp	24952482	SENT95	0	0	4	4	crizotinib	ALK	PA165946122	238	0.778
NULL	Arthritis_Res_Ther_2011_Mar_16_13(2)_R44.nxml.txt.nlp	21410959	SENT149	2	2	11	11	glucosamine	IL-6	PA164747613	3569	0.778
NULL	Indian_J_Pharm_Sci_2013_Jan-Feb_75(1)_94-98.nxml.txt.nlp	23901167	SENT69	14	14	39	39	omeprazole	CYP2B6	PA450704	1555	0.778
NULL	Ann_Oncol_2013_Nov_12_24(11)_2892-2897.nxml.txt.nlp	24030098	SENT73	9	9	7	7	cyclophosphamide	CHOP	PA449165	1649	0.778
NULL	Bioinformation_2012_Dec_19_8(25)_1249-1254.nxml.txt.nlp	23275729	SENT57	1	1	7	7	pazopanib	VEGFR	PA165291492	3791	0.778
NULL	Clin_Infect_Dis_2014_Apr_1_58(7)_928-936.nxml.txt.nlp	24399087	SENT167	28	28	25	25	ribavirin	API	PA451241	5345	0.778
NULL	Int_J_Mol_Sci_2007_Jan_29_8(1)_13-28.nxml.txt.nlp	NULL	SENT105	14	14	8	8	galactose	NAG	PA449725	51594;4669	0.778
NULL	Br_J_Cancer_2010_Sep_7_103(6)_796-801.nxml.txt.nlp	20823888	SENT106	2	2	39	39	erlotinib	D29	PA134687924	55520	0.778
NULL	J_Cardiothorac_Surg_2013_Sep_11_8(Suppl_1)_P109.nxml.txt.nlp	NULL	SENT8	23	23	15	15	protamine	ACT	PA10366	12;11332;9457;641455	0.778
NULL	J_Gen_Physiol_2012_Nov_140(5)_541-555.nxml.txt.nlp	23109716	SENT15	22	22	45	45	capsaicin	TRPV1	PA448776	7442	0.778
NULL	Case_Rep_Hematol_2012_Mar_26_2012_954201.nxml.txt.nlp	22953081	SENT36	12	12	19	19	vincristine	CHOP	PA451879	1649	0.778
NULL	Front_Aging_Neurosci_2010_Feb_3_2_2.nxml.txt.nlp	20552042	SENT130	24	24	12	12	isoproterenol	CA1	PA450121	759	0.778
NULL	Br_J_Cancer_2010_Jul_13_103(2)_186-195.nxml.txt.nlp	20588277	SENT7	13	13	31	31	nutlin-3	p53		7157	0.778
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT134	10	10	19	19	metformin	CCL16	PA450395	6360	0.778
NULL	Int_J_Biol_Sci_2014_Sep_21_10(10)_1108-1115.nxml.txt.nlp	25332685	SENT191	7	7	17	17	dexmedetomidine	JNK	PA449256	5599	0.778
NULL	Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.nxml.txt.nlp	24736980	SENT181	3	3	5	5	rosuvastatin	OATP1B1	PA134308647	10599	0.778
NULL	Philos_Trans_R_Soc_Lond_B_Biol_Sci_2010_Mar_12_365(1541)_749-763.nxml.txt.nlp	20124342	SENT269	32	32	38	38	nadh	PDH	PA164755085	54704	0.778
NULL	Cancers_(Basel)_2010_Oct_25_2(4)_1794-1812.nxml.txt.nlp	24281201	SENT134	11	11	2	2	gemcitabine	AP2	PA449748	2971	0.778
NULL	Oncol_Rep_2013_Jun_22_29(6)_2479-2485.nxml.txt.nlp	23525656	SENT117	14	14	11	11	cisplatin	MRP7	PA449014	89845;1080	0.778
NULL	Mol_Cancer_2012_Apr_26_11_24.nxml.txt.nlp	22537161	SENT222	34	34	45	45	pp2	MUC4		4585	0.778
NULL	J_Thyroid_Res_2011_Apr_10_2011_895923.nxml.txt.nlp	21603172	SENT272	4	4	26	26	thyroglobulin	IL-10	PA164754910	3586	0.778
NULL	Oncotarget_2014_Dec_4_5(22)_11365-11380.nxml.txt.nlp	25426548	SENT139	10	10	5	5	nutlin-3	p53		7157	0.778
NULL	Front_Neurol_2014_May_20_5_78.nxml.txt.nlp	24904522	SENT83	8	8	5	5	buspirone	5-HT1A	PA448689	3350	0.778
NULL	Mol_Cancer_2009_Dec_10_8_118.nxml.txt.nlp	20003259	SENT16	22	22	26	26	sorafenib	MMP2	PA7000	4313	0.778
NULL	J_Health_Popul_Nutr_2011_Feb_29(1)_20-25.nxml.txt.nlp	21528787	SENT32	22	22	24	24	ethambutol	EMB	PA164784021	133418	0.778
NULL	Cancer_Cell_Int_2013_Jun_26_13_63.nxml.txt.nlp	23800022	SENT118	23	23	9	9	genistein	BAX	PA165109660	581	0.778
NULL	Breast_Cancer_Res_2010_Oct_28_12(5)_212.nxml.txt.nlp	21067532	SENT109	17	17	29	29	cyclophosphamide	ACT	PA449165	12;11332;9457;641455	0.778
NULL	Mol_Cancer_2007_Aug_21_6_53.nxml.txt.nlp	17711579	SENT150	9	9	2	2	cisplatin	LATS2	PA449014	26524	0.778
NULL	J_Viral_Hepat_2008_Mar_15(3)_219-228.nxml.txt.nlp	18194173	SENT43	23	23	16	16	ribavirin	IFN	PA451241	3439	0.778
NULL	Am_J_Trop_Med_Hyg_2012_Mar_1_86(3)_489-495.nxml.txt.nlp	22403324	SENT177	19	19	23	23	ritonavir	P-gp	PA451260	5243	0.778
NULL	HSR_Proc_Intensive_Care_Cardiovasc_Anesth_2009_1(3)_46-53.nxml.txt.nlp	23439979	SENT52	19	19	8	8	aprotinin	BART	PA448472	7809;23568	0.778
NULL	Indian_J_Psychol_Med_2014_Apr-Jun_36(2)_129-133.nxml.txt.nlp	24860211	SENT20	14	14	22	22	l-tryptophan	CD4	PA10323	920	0.778
NULL	ASN_Neuro_2013_Dec_18_5(5)_e00129.nxml.txt.nlp	24215544	SENT28	14	14	19	19	pioglitazone	Yes	PA450970	7525	0.778
NULL	Iran_J_Pharm_Res_2014_Winter_13(1)_253-262.nxml.txt.nlp	24734078	SENT159	15	15	4	4	propofol	LPO	PA451141	4025	0.778
NULL	Int_J_Med_Chem_2012_Dec_13_2012_530392.nxml.txt.nlp	25379286	SENT301	27	27	12	12	ethanol	mol	PA448073	90527	0.778
NULL	Curr_Neuropharmacol_2013_Jul_11(4)_338-378.nxml.txt.nlp	24381528	SENT583	20	20	34	34	curcumin	JNK	PA151958596	5599	0.778
NULL	Int_J_Mol_Sci_2014_Jun_5_15(6)_10083-10100.nxml.txt.nlp	24905407	SENT220	0	0	18	18	tetracycline	STP	PA451640	9322	0.778
NULL	Clin_Epidemiol_2010_Aug_9_2_29-36.nxml.txt.nlp	20865100	SENT35	12	12	40	40	sertraline	B10	PA451333	5169	0.778
NULL	Bone_2012_Jan_50(1)_218-225.nxml.txt.nlp	22023931	SENT221	8	8	21	21	iron	FGF23	PA450087	8074	0.778
NULL	Front_Genet_2012_Nov_12_3_235.nxml.txt.nlp	23162568	SENT174	13	13	3	3	methamphetamine	CYP2D6	PA450403	1565	0.778
NULL	Int_J_Breast_Cancer_2011_Jul_12_2011_232435.nxml.txt.nlp	22295213	SENT272	36	36	8	8	tamoxifen	EGFR	PA451581	1956	0.778
NULL	Genet_Mol_Biol_2009_Sep_1_Jul-Sep_32(3)_516-520.nxml.txt.nlp	21637514	SENT109	7	7	5	5	estradiol	FGF2	PA449503	2247;2258	0.778
NULL	Br_J_Anaesth_2011_Oct_17_107(4)_490-502.nxml.txt.nlp	21852280	SENT66	9	9	14	14	capsaicin	TRPV1	PA448776	7442	0.778
NULL	Mol_Cancer_2012_Jun_26_11_43.nxml.txt.nlp	22731636	SENT118	12	12	8	8	pp2	p38		10598;1432;7965	0.778
NULL	Pharmaceuticals_(Basel)_2013_Aug_21_6(8)_988-1038.nxml.txt.nlp	24276379	SENT219	12	12	9	9	oxaliplatin	ERCC2	PA131285527	2068	0.778
NULL	Front_Immunol_2012_May_18_3_126.nxml.txt.nlp	22629256	SENT909	12	12	3	3	sirolimus	CD4	PA451365	920	0.778
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT158	9	9	14	14	trastuzumab	HER2	PA451743	2064	0.778
NULL	Biomed_Res_Int_2014_Apr_10_2014_580852.nxml.txt.nlp	24812624	SENT48	0	0	5	5	resveratrol	PTEN		5728	0.778
NULL	Curr_Neuropharmacol_2007_Dec_5(4)_278-288.nxml.txt.nlp	19305744	SENT265	10	10	5	5	phenytoin	SMF	PA450947	22993	0.778
NULL	Arthritis_Res_Ther_2010_Apr_1_12(2)_R60.nxml.txt.nlp	20359365	SENT9	15	15	19	19	bleomycin	SPARC	PA448645	6678	0.778
NULL	Int_J_Mol_Sci_2014_Mar_5_15(3)_3970-3988.nxml.txt.nlp	24603537	SENT28	2	2	0	0	curcumin	MCH	PA151958596	5367	0.778
NULL	Biofactors_2014_May_6_40(3)_277-283.nxml.txt.nlp	24353111	SENT78	14	14	17	17	choline	PEMT	PA448976	10400	0.778
NULL	Trials_2014_Aug_20_15(1)_331.nxml.txt.nlp	NULL	SENT33	15	15	26	26	memantine	spatial	PA10364	219793	0.778
NULL	Behav_Brain_Funct_2008_Aug_15_4_37.nxml.txt.nlp	18702828	SENT101	16	16	24	24	methamphetamine	FZD3	PA450403	7976;8326	0.778
NULL	Acta_Pharmacol_Sin_2012_Nov_22_33(11)_1395-1400.nxml.txt.nlp	23085738	SENT131	31	31	19	19	prasugrel	CYP2C9	PA154410481	1559	0.778
NULL	Biologics_2012_Sep_25_6_337-345.nxml.txt.nlp	23055691	SENT48	2	2	12	12	erlotinib	EGFR	PA134687924	1956	0.778
NULL	J_Biol_Chem_2013_Oct_11_288(41)_29642-29653.nxml.txt.nlp	24005673	SENT947	8	8	12	12	hyaluronan	CD44	PA165958431	960	0.778
NULL	EMBO_Mol_Med_2013_May_22_5(5)_776-794.nxml.txt.nlp	23606583	SENT175	17	17	15	15	maraviroc	CCL5	PA164768835	6352	0.778
NULL	Oncol_Lett_2013_Feb_7_5(2)_440-446.nxml.txt.nlp	23420122	SENT247	21	21	0	0	gemcitabine	Gem	PA449748	51053	0.778
NULL	Br_J_Cancer_2012_Apr_10_106(8)_1460-1463.nxml.txt.nlp	22415235	SENT87	23	23	16	16	olaparib	RAD51D		5892	0.778
NULL	Biomed_Res_Int_2014_Jan_20_2014_948427.nxml.txt.nlp	24563867	SENT188	10	10	5	5	buspirone	COB	PA448689	4519	0.778
NULL	Cancer_Res_Treat_2013_Dec_31_45(4)_251-262.nxml.txt.nlp	24453997	SENT141	7	7	10	10	cisplatin	ASS1	PA449014	445	0.778
NULL	Nat_Med_2011_Dec_11_18(1)_74-82.nxml.txt.nlp	22157681	SENT52	3	3	16	16	gefitinib	APAF-1	PA131301952	317	0.778
NULL	Open_Cardiovasc_Med_J_2010_Jul_20_4_151-156.nxml.txt.nlp	20922049	SENT55	32	32	23	23	heparin	ACT	PA449855	12;11332;9457;641455	0.778
NULL	Front_Immunol_2013_Sep_11_4_272.nxml.txt.nlp	24062740	SENT179	15	15	30	30	dextran	IFN	PA449261	3439	0.778
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT115	10	10	23	23	neratinib	HER2	PA165291472	2064	0.778
NULL	Mol_Cancer_2009_Aug_25_8_66.nxml.txt.nlp	19706164	SENT180	9	9	6	6	celecoxib	p53	PA448871	7157	0.778
NULL	J_Innate_Immun_2011_Dec_12_4(1)_69-79.nxml.txt.nlp	21997473	SENT195	13	13	23	23	heparin	ADAMTS-4	PA449855	9508	0.778
NULL	Environ_Sci_Technol_2014_May_20_48(10)_5955-5963.nxml.txt.nlp	24762061	SENT130	3	3	36	36	diclofenac	API	PA449293	5345	0.778
NULL	J_Adv_Pharm_Technol_Res_2012_Oct-Dec_3(4)_202-209.nxml.txt.nlp	23378940	SENT164	11	11	5	5	aprepitant	CYP3A4	PA164747039	1576	0.778
NULL	Iran_J_Basic_Med_Sci_2012_May-Jun_15(3)_795-802.nxml.txt.nlp	23493622	SENT7	0	0	5	5	capsaicin	TRPV1	PA448776	7442	0.778
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jun_5_66(Pt_7)_o1565.nxml.txt.nlp	21587808	SENT58	20	20	35	35	ethanol	mol	PA448073	90527	0.778
NULL	Environ_Health_Perspect_2003_Jun_111(7)_981-991.nxml.txt.nlp	12782502	SENT8	13	13	19	19	methacholine	SRM	PA165958382	6723;6725	0.778
NULL	J_Breast_Cancer_2014_Mar_28_17(1)_33-39.nxml.txt.nlp	24744795	SENT29	37	37	14	14	trastuzumab	HER2	PA451743	2064	0.778
NULL	Front_Genet_2013_Aug_29_4_163.nxml.txt.nlp	24009622	SENT14	5	5	16	16	ethanol	ABCG2	PA448073	9429	0.778
NULL	Case_Rep_Nephrol_2014_Mar_5_2014_845372.nxml.txt.nlp	24711939	SENT51	8	8	15	15	phenazopyridine	G6PD	PA164746899	2539	0.778
NULL	Oncotarget_2014_Feb_19_5(8)_2085-2095.nxml.txt.nlp	24742694	SENT296	20	20	16	16	suramin	SIRT1	PA10292	23411	0.778
NULL	Brain_Sci_2014_Mar_14_4(1)_136-149.nxml.txt.nlp	24961704	SENT326	2	2	11	11	sevoflurane	PSD-95	PA451341	1742	0.778
NULL	Oncotarget_2014_Jun_30_5(12)_3970-3982.nxml.txt.nlp	24994116	SENT94	12	12	21	21	phenol	TOX1	PA450913	9760	0.778
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1046.nxml.txt.nlp	24503538	SENT86	19	19	25	25	irinotecan	FGFR4	PA450085	2264	0.778
NULL	Orphanet_J_Rare_Dis_2010_Dec_1_5_34.nxml.txt.nlp	21122112	SENT45	18	18	6	6	l-glutamine	F10	PA10090	2159	0.778
NULL	Surg_Today_2012_Jan_6_42(1)_8-28.nxml.txt.nlp	22139128	SENT235	25	25	18	18	tegafur	PSK	PA452620	9344	0.778
NULL	Br_J_Cancer_1991_Aug_64(2)_215-220.nxml.txt.nlp	1892748	SENT8	32	32	36	36	cisplatin	CHIP	PA449014	10273	0.778
NULL	Nat_Neurosci_2012_Jul_15_15(8)_1153-1159.nxml.txt.nlp	22797694	SENT223	10	10	13	13	tetracycline	NR1	PA451640	27158	0.778
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT208	16	16	9	9	simvastatin	AKT	PA451363	207	0.778
NULL	J_Cell_Biol_2003_Dec_22_163(6)_1385-1395.nxml.txt.nlp	14676308	SENT166	33	33	24	24	thrombin	p38	PA451674	10598;1432;7965	0.778
NULL	Iran_J_Pharm_Res_2015_Winter_14(1)_279-289.nxml.txt.nlp	25561934	SENT108	15	15	21	21	isoproterenol	ANOVA	PA450121	4858	0.778
NULL	Case_Rep_Ophthalmol_2011_Dec_13_2(3)_367-375.nxml.txt.nlp	22220161	SENT88	12	12	7	7	infliximab	OCT3	PA452639	5460;6581	0.778
NULL	Springerplus_2013_Jan_12_2_12.nxml.txt.nlp	23483788	SENT43	16	16	23	23	thyroglobulin	gamma	PA164754910	9913	0.778
NULL	J_Immunother_Cancer_2014_Apr_15_2_7.nxml.txt.nlp	24855562	SENT90	13	13	5	5	cyclophosphamide	CD4	PA449165	920	0.778
NULL	J_Clin_Biochem_Nutr_2008_Mar_1_42(2)_126-132.nxml.txt.nlp	18385829	SENT87	0	0	9	9	bosentan	ETB	PA10034	1910	0.778
NULL	Acta_Pharmacol_Sin_2013_Jan_17_34(1)_157-166.nxml.txt.nlp	23247593	SENT210	0	0	8	8	berberine	IL-6	PA165860812	3569	0.778
NULL	Clinics_(Sao_Paulo)_2013_May_68(5)_592-598.nxml.txt.nlp	23778413	SENT84	31	31	17	17	docetaxel	HIF2A	PA449383	2034	0.778
NULL	J_Oncol_2013_Feb_17_2013_872957.nxml.txt.nlp	23476648	SENT6	18	18	7	7	cisplatin	SFN	PA449014	25996;2810	0.778
NULL	Oncotarget_2014_Sep_10_5(19)_8924-8936.nxml.txt.nlp	25238040	SENT113	7	7	15	15	decitabine	p53	PA164749631	7157	0.778
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Mar_26_3(3)_e107.nxml.txt.nlp	24670388	SENT402	12	12	6	6	midazolam	CYP3A4	PA450496	1576	0.778
NULL	Int_J_Biol_Sci_2012_Jul_7_8(6)_913-934.nxml.txt.nlp	22811614	SENT414	17	17	4	4	acarbose	GIT	PA448010	5034	0.778
NULL	Tumour_Biol_2013_Jun_5_34(3)_1371-1380.nxml.txt.nlp	23558965	SENT117	4	4	13	13	gefitinib	EGFR	PA131301952	1956	0.778
NULL	Br_J_Cancer_2013_Jun_25_108(12)_2485-2494.nxml.txt.nlp	23695022	SENT120	2	2	15	15	carvedilol	P-gp	PA448817	5243	0.778
NULL	Front_Neurosci_2011_Jan_14_4_207.nxml.txt.nlp	21258618	SENT372	0	0	9	9	ethanol	CRF1	PA448073	1394	0.778
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_May_14_65(Pt_6)_o1294-o1295.nxml.txt.nlp	21583154	SENT70	8	8	19	19	coumarin	C10	PA134521193	113246	0.778
NULL	Br_J_Cancer_2014_Nov_25_111(11)_2091-2102.nxml.txt.nlp	25349971	SENT15	8	8	0	0	imatinib	PTPN18	PA10804	26469	0.778
NULL	Br_J_Cancer_2010_Jan_5_102(1)_80-86.nxml.txt.nlp	19920817	SENT143	13	13	15	15	bevacizumab	IFN	PA130232992	3439	0.778
NULL	Acta_Pharmacol_Sin_2009_Apr_9_30(4)_467-477.nxml.txt.nlp	19270721	SENT25	0	0	9	9	cisplatin	DDP	PA449014	1678	0.778
NULL	Case_Rep_Oncol_2013_Jul_20_6(2)_382-386.nxml.txt.nlp	23904849	SENT37	8	8	17	17	cetuximab	KRAS	PA10040	3845	0.778
NULL	Patient_Prefer_Adherence_2013_Mar_27_7_245-258.nxml.txt.nlp	23569364	SENT26	18	18	26	26	tamoxifen	aromatase	PA451581	1588	0.778
NULL	Mol_Cancer_2010_May_20_9_115.nxml.txt.nlp	20487546	SENT240	32	32	10	10	fludarabine	CDK4	PA449655	1019	0.778
NULL	J_Invest_Dermatol_2014_Feb_10_134(2)_319-325.nxml.txt.nlp	24108405	SENT132	10	10	4	4	vemurafenib	FOXD3	PA165946873	27022	0.778
NULL	Oncol_Lett_2014_Nov_10_8(5)_2333-2339.nxml.txt.nlp	25295120	SENT143	21	21	29	29	sorafenib	ADM	PA7000	133	0.778
NULL	Indian_J_Pharm_Sci_2013_Jan-Feb_75(1)_94-98.nxml.txt.nlp	23901167	SENT69	10	10	37	37	tolbutamide	CYP2C19	PA451718	1557	0.778
NULL	Trials_2013_May_4_14_125.nxml.txt.nlp	23782591	SENT39	31	31	20	20	galantamine	CYP2D6	PA449726	1565	0.778
NULL	Orphanet_J_Rare_Dis_2011_Oct_3_6_63.nxml.txt.nlp	21967988	SENT389	7	7	34	34	octreotide	HNF4A	PA450678	3172	0.778
NULL	Front_Genet_2014_Sep_10_5_317.nxml.txt.nlp	25309576	SENT123	17	17	24	24	vorinostat	HDAC8	PA164748224	55869	0.778
NULL	J_Cell_Mol_Med_2013_May_12_17(5)_636-647.nxml.txt.nlp	23577651	SENT136	20	20	18	18	quinacrine	CD41	PA164745551	3674	0.778
NULL	Brain_Behav_2013_Mar_6_3(2)_114-133.nxml.txt.nlp	23533150	SENT246	3	3	7	7	ethanol	HSF1	PA448073	3297	0.778
NULL	Cell_Commun_Signal_2013_Oct_1_11_73.nxml.txt.nlp	24083678	SENT73	33	33	20	20	sulindac	ICAM1	PA451565	3383	0.778
NULL	Clin_Transl_Allergy_2013_Sep_2_3_29.nxml.txt.nlp	24004581	SENT140	20	20	13	13	omalizumab	IL-4	PA164752253	3565	0.778
NULL	Int_J_Tryptophan_Res_2013_Aug_19_6_35-45.nxml.txt.nlp	24023520	SENT94	9	9	24	24	hydroquinone	IDO1	PA449924	3620	0.778
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_May_30_64(Pt_6)_o1169.nxml.txt.nlp	21202676	SENT59	24	24	7	7	ethanol	mol	PA448073	90527	0.778
NULL	Eur_J_Clin_Pharmacol_2012_Sep_15_68(9)_1267-1274.nxml.txt.nlp	22418828	SENT204	29	29	6	6	amoxicillin	CYP2C19	PA448406	1557	0.778
NULL	Hum_Genomics_2009_Dec_1_4(2)_91-106.nxml.txt.nlp	20038497	SENT144	7	7	23	23	donepezil	APOE	PA449394	348	0.778
NULL	Breast_Cancer_Res_2011_Apr_14_13(2)_R43.nxml.txt.nlp	21492444	SENT253	33	33	14	14	tamoxifen	PTEN	PA451581	5728	0.778
NULL	J_Exp_Bot_2011_Oct_4_62(14)_4787-4803.nxml.txt.nlp	21821598	SENT300	22	22	0	0	mannitol	M6PR	PA450320	4074	0.778
NULL	F1000_Biol_Rep_2012_Mar_1_4_5.nxml.txt.nlp	22403588	SENT107	9	9	14	14	boceprevir	IFN	PA165948902	3439	0.778
NULL	Arthritis_Res_Ther_2011_Jun_21_13(3)_R98.nxml.txt.nlp	21693018	SENT4	18	18	20	20	tiludronate	TLN	PA451688	7087	0.778
NULL	Bull_Math_Biol_2014_Dec_14_76(2)_401-430.nxml.txt.nlp	24338592	SENT321	22	22	20	20	etoposide	CHOP	PA449552	1649	0.778
NULL	J_Cell_Biol_1990_Mar_1_110(3)_777-787.nxml.txt.nlp	2307707	SENT16	23	23	19	19	heparin	CS1	PA449855	57823	0.778
NULL	Patient_Prefer_Adherence_2011_Apr_13_5_181-185.nxml.txt.nlp	21573049	SENT176	27	27	24	24	vardenafil	CYP3A4	PA10229	1576	0.778
NULL	Oncotarget_2011_Mar_27_2(3)_209-221.nxml.txt.nlp	21444945	SENT218	15	15	7	7	bortezomib	p53	PA10252	7157	0.778
NULL	Clin_Drug_Investig_2014_Nov_9_34(2)_107-115.nxml.txt.nlp	24214232	SENT43	34	34	12	12	paricalcitol	IMPACT	PA450798	55364	0.778
NULL	J_Int_AIDS_Soc_2010_Nov_8_13(Suppl_4)_P92.nxml.txt.nlp	NULL	SENT19	8	8	5	5	stavudine	DDX	PA451494	8644	0.778
NULL	Asian-Australas_J_Anim_Sci_2014_Dec_27(12)_1783-1793.nxml.txt.nlp	25358373	SENT130	23	23	6	6	capsaicin	PPARG	PA448776	5468	0.778
NULL	Support_Care_Cancer_2011_Oct_12_19(10)_1609-1617.nxml.txt.nlp	20835873	SENT130	30	30	12	12	granisetron	FAS	PA449809	355;2194	0.778
NULL	J_Cancer_2014_Jul_4_5(7)_559-571.nxml.txt.nlp	25057307	SENT234	12	12	24	24	tamoxifen	STAT3	PA451581	6774	0.778
NULL	Curr_Oncol_2009_Aug_16(4)_25-35.nxml.txt.nlp	19672422	SENT174	8	8	0	0	lapatinib	PI3	PA152241907	5266	0.778
NULL	Cancer_Cell_2015_Jan_12_27(1)_57-71.nxml.txt.nlp	25584894	SENT157	4	4	6	6	doxycycline	ACSS2	PA449415	55902	0.778
NULL	Indian_J_Anaesth_2009_Jun_53(3)_268-269.nxml.txt.nlp	20640133	SENT4	10	10	17	17	vasopressin	VIII	PA451858	1351	0.778
NULL	Open_Neurol_J_2010_May_26_4_15-24.nxml.txt.nlp	21258574	SENT200	26	26	32	32	mitoxantrone	IFN	PA450526	3439	0.778
NULL	Indian_J_Orthop_2014_Jul-Aug_48(4)_347-353.nxml.txt.nlp	25143636	SENT46	31	31	14	14	fluorescein	CD44	PA164746009	960	0.778
NULL	Daru_2012_Dec_5_20(1)_87.nxml.txt.nlp	23351503	SENT186	25	25	31	31	isoproterenol	ANOVA	PA450121	4858	0.778
NULL	Oncol_Lett_2013_Dec_4_6(6)_1665-1672.nxml.txt.nlp	24273604	SENT6	27	27	37	37	chloroquine	TLR9	PA448948	54106	0.778
NULL	Evid_Based_Complement_Alternat_Med_2011_Feb_14_2011_429843.nxml.txt.nlp	21869897	SENT120	7	7	19	19	alprazolam	EPM	PA448333	2054	0.778
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_75-89.nxml.txt.nlp	17912638	SENT577	37	37	32	32	tamoxifen	ATAC	PA451581	6375	0.778
NULL	Indian_J_Anaesth_2011_Mar-Apr_55(2)_135-140.nxml.txt.nlp	21712869	SENT131	13	13	8	8	propofol	CO2	PA451141	4513	0.778
NULL	Alcohol_Res_2012_34(4)_468-483.nxml.txt.nlp	23584113	SENT283	25	25	10	10	acamprosate	ACTH	PA10344	5443	0.778
NULL	Clin_Med_Insights_Oncol_2012_Feb_28_6_125-135.nxml.txt.nlp	22408376	SENT64	10	10	25	25	panitumumab	KRAS	PA162373091	3845	0.778
NULL	Blood_Cancer_J_2013_Oct_18_3(10)_e153.nxml.txt.nlp	24141622	SENT90	14	14	19	19	fludarabine	XIAP	PA449655	331	0.778
NULL	Mol_Cancer_2010_Jun_24_9_164.nxml.txt.nlp	20576107	SENT142	7	7	3	3	etoposide	Mcl-1	PA449552	4170	0.778
NULL	Nucleic_Acids_Res_2013_Apr_17_41(7)_4129-4143.nxml.txt.nlp	23420868	SENT154	13	13	26	26	hemin	GATA-1	PA449849	2623	0.778
NULL	Front_Oncol_2014_Sep_22_4_258.nxml.txt.nlp	25295228	SENT112	18	18	25	25	erlotinib	EGFR	PA134687924	1956	0.778
NULL	Anesthesiol_Res_Pract_2013_Sep_23_2013_297141.nxml.txt.nlp	24174934	SENT80	29	29	21	21	lidocaine	mol	PA450226	90527	0.778
NULL	Ther_Clin_Risk_Manag_2006_Dec_2(4)_365-375.nxml.txt.nlp	18360649	SENT142	9	9	4	4	methotrexate	ACR	PA450428	49	0.778
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT8	9	9	13	13	tacrolimus	SOCS3	PA451578	9021	0.778
NULL	Environ_Health_Perspect_2006_Sep_23_114(9)_1401-1406.nxml.txt.nlp	16966095	SENT52	16	16	29	29	arsenite	ID1	PA452638	3397	0.778
NULL	Adolesc_Health_Med_Ther_2012_Jun_20_3_85-93.nxml.txt.nlp	24600289	SENT72	33	33	7	7	methotrexate	ACR	PA450428	49	0.778
NULL	Nat_Commun_2014_Nov_25_5_5582.nxml.txt.nlp	25420773	SENT108	5	5	17	17	erlotinib	PHD3	PA134687924	112399	0.778
NULL	Oncotarget_2010_May_27_1(2)_89-103.nxml.txt.nlp	20671809	SENT209	7	7	21	21	perifosine	raptor	PA165291471	57521	0.778
NULL	Acta_Naturae_2010_Oct-Dec_2(4)_31-35.nxml.txt.nlp	22649661	SENT116	21	21	16	16	cisplatin	BRCA1	PA449014	672	0.778
NULL	Am_J_Trop_Med_Hyg_2012_Nov_7_87(5)_783-784.nxml.txt.nlp	23136171	SENT15	13	13	8	8	artemisinin	ACT	PA165111696	12;11332;9457;641455	0.778
NULL	Nat_Med_2013_Oct_22_19(10)_1281-1287.nxml.txt.nlp	24056772	SENT240	14	14	4	4	chloroquine	VWF	PA448948	7450	0.778
NULL	Reprod_Biol_Endocrinol_2003_Apr_1_1_31.nxml.txt.nlp	12740033	SENT274	20	20	14	14	estradiol	StAR	PA449503	6770	0.778
NULL	Diabetes_Metab_Syndr_Obes_2014_Mar_18_7_107-120.nxml.txt.nlp	24672252	SENT35	9	9	21	21	saxagliptin	GLP-1	PA165958362	100125288	0.778
NULL	Lab_Invest_2009_Dec_19_89(12)_1397-1409.nxml.txt.nlp	19841616	SENT241	10	10	15	15	curcumin	NAC	PA151958596	22861	0.778
NULL	Indian_J_Med_Res_2014_Apr_139(4)_572-578.nxml.txt.nlp	24927344	SENT86	18	18	2	2	acenocoumarol	CYP4F2	PA452632	8529	0.778
NULL	Mol_Cell_2014_May_8_54(3)_445-459.nxml.txt.nlp	24746700	SENT169	3	3	6	6	camptothecin	MDM2	PA153590860	4193	0.778
NULL	Viruses_2013_Oct_28_5(11)_2624-2642.nxml.txt.nlp	24169630	SENT661	12	12	3	3	hydralazine	NKG2D	PA449894	22914	0.778
NULL	Cancer_Microenviron_2008_Dec_29_1(1)_37-42.nxml.txt.nlp	19308683	SENT213	19	19	13	13	paclitaxel	TLR-4	PA450761	7099	0.778
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jul_8_65(Pt_8)_o1796.nxml.txt.nlp	21583502	SENT61	0	0	6	6	benzaldehyde	mol	PA448571	90527	0.778
NULL	Indian_J_Endocrinol_Metab_2012_Dec_16(Suppl_3)_S529-S531.nxml.txt.nlp	23565485	SENT48	5	5	10	10	metformin	GLP-1	PA450395	100125288	0.778
NULL	J_Headache_Pain_2013_Aug_13_14(1)_71.nxml.txt.nlp	23941062	SENT31	8	8	0	0	capsaicin	TRPV1	PA448776	7442	0.778
NULL	J_Carcinog_2012_Feb_17_11_4.nxml.txt.nlp	22438770	SENT182	9	9	39	39	estradiol	MMP2	PA449503	4313	0.777
NULL	Curr_Neuropharmacol_2013_Jul_11(4)_338-378.nxml.txt.nlp	24381528	SENT438	13	13	26	26	curcumin	JNK	PA151958596	5599	0.777
NULL	Exp_Ther_Med_2014_Jun_27_7(6)_1752-1756.nxml.txt.nlp	24926379	SENT90	7	7	18	18	vildagliptin	PPG	PA165958346	5552	0.777
NULL	Front_Oncol_2014_Sep_23_4_263.nxml.txt.nlp	25295230	SENT218	16	16	9	9	daunorubicin	FLT3	PA449212	2322	0.777
NULL	Oncotarget_2012_Aug_19_3(8)_890-903.nxml.txt.nlp	23097685	SENT139	17	17	26	26	etodolac	COX	PA449550	1351	0.777
NULL	Clin_Med_Insights_Oncol_2011_Sep_21_5_315-323.nxml.txt.nlp	22084620	SENT139	0	0	9	9	gemcitabine	IFN	PA449748	3439	0.777
NULL	Protein_Expr_Purif_2009_Aug_66(2)_181-184.nxml.txt.nlp	19269329	SENT8	9	9	15	15	thrombin	AMPK	PA451674	5563	0.777
NULL	Arthritis_Res_Ther_2014_Apr_3_16(2)_R86.nxml.txt.nlp	24708674	SENT201	17	17	33	33	bosentan	Fli1	PA10034	2314	0.777
NULL	J_Immunother_Cancer_2013_Nov_7_1(Suppl_1)_P46.nxml.txt.nlp	NULL	SENT6	18	18	15	15	ribavirin	IFN	PA451241	3439	0.777
NULL	Cell_Death_Dis_2010_Nov_18_1(11)_e102.nxml.txt.nlp	21368867	SENT21	12	12	4	4	gentamicin	14-3-3	PA449753	10971	0.777
NULL	Clinics_(Sao_Paulo)_2013_Feb_68(2)_253-262.nxml.txt.nlp	23525324	SENT238	30	30	24	24	genistein	Gen	PA165109660	348654	0.777
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT120	33	33	25	25	capsaicin	p53	PA448776	7157	0.777
NULL	Diabetologia_2010_Dec_25_53(12)_2646-2655.nxml.txt.nlp	20865240	SENT158	12	12	35	35	sulodexide	DM2	PA164746343	28508	0.777
NULL	J_Cell_Mol_Med_2013_Oct_23_17(10)_1207-1217.nxml.txt.nlp	24106980	SENT149	13	13	23	23	paclitaxel	HIPK2	PA450761	28996	0.777
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT45	13	13	29	29	erlotinib	AKT	PA134687924	207	0.777
NULL	Environ_Toxicol_Chem_2014_Oct_25_33(10)_2363-2367.nxml.txt.nlp	25043914	SENT46	16	16	4	4	galactose	ARNT	PA449725	405	0.777
NULL	Nat_Commun_2013_Sep_20_4_2444.nxml.txt.nlp	24051492	SENT140	13	13	21	21	nutlin-3	CT9		676	0.777
NULL	Oncol_Rep_2012_Apr_30_27(4)_1163-1169.nxml.txt.nlp	22210010	SENT50	4	4	22	22	fluorescein	CD80	PA164746009	941	0.777
NULL	EMBO_Mol_Med_2013_Apr_25_5(4)_531-547.nxml.txt.nlp	23526793	SENT296	17	17	3	3	rosiglitazone	14-3-3	PA451283	10971	0.777
NULL	Ann_Oncol_2014_Oct_23_25(10)_1941-1948.nxml.txt.nlp	25057173	SENT110	21	21	28	28	docetaxel	EGFR	PA449383	1956	0.777
NULL	Brain_Sci_2013_Jun_14_3(2)_941-963.nxml.txt.nlp	24961432	SENT478	3	3	9	9	ethanol	14-3-3	PA448073	10971	0.777
NULL	Diabetes_2011_Nov_17_60(11)_2691-2700.nxml.txt.nlp	21896928	SENT311	6	6	17	17	resveratrol	SIRT1		23411	0.777
NULL	N_Am_J_Med_Sci_2011_May_3(5)_212-216.nxml.txt.nlp	22558596	SENT119	10	10	4	4	cisplatin	BTC	PA449014	685	0.777
NULL	Acta_Pharmacol_Sin_2014_Jun_5_35(6)_727-737.nxml.txt.nlp	24793312	SENT218	9	9	19	19	telmisartan	B27	PA451605	56246	0.777
NULL	Diabetes_2011_Mar_21_60(3)_757-765.nxml.txt.nlp	21282370	SENT24	24	24	1	1	lipase	HSL	PA450239	3991	0.777
NULL	Bone_Marrow_Transplant_2012_Apr_9_47(4)_581-588.nxml.txt.nlp	21552302	SENT181	16	16	4	4	sirolimus	CD4	PA451365	920	0.777
NULL	Crit_Care_2007_Sep_26_11(Suppl_4)_P19.nxml.txt.nlp	NULL	SENT2	11	11	8	8	terlipressin	AVP	PA164781020	114548;551	0.777
NULL	Br_J_Cancer_2013_Jun_25_108(12)_2464-2469.nxml.txt.nlp	23695016	SENT164	14	14	27	27	carboplatin	CRT	PA448803	811	0.777
NULL	Int_J_Biomed_Sci_2013_Sep_9(3)_112-122.nxml.txt.nlp	24170986	SENT134	3	3	11	11	sorafenib	RAF1	PA7000	5894	0.777
NULL	Cancer_Cell_2007_Dec_11_12(6)_514-527.nxml.txt.nlp	18068629	SENT661	5	5	8	8	paclitaxel	TGFBI	PA450761	7045	0.777
NULL	Cancer_Cell_Int_2010_May_11_10_16.nxml.txt.nlp	20459793	SENT10	10	10	25	25	cisplatin	CDKN1A	PA449014	1026	0.777
NULL	Mol_Biol_Cell_2013_Aug_15_24(16)_2582-2592.nxml.txt.nlp	23783032	SENT312	13	13	7	7	bortezomib	CO2	PA10252	4513	0.777
NULL	Br_J_Cancer_2010_Dec_7_103(12)_1822-1830.nxml.txt.nlp	21063405	SENT32	30	30	8	8	cisplatin	NBS1	PA449014	55655	0.777
NULL	Acta_Pharmacol_Sin_2012_Jan_28_33(1)_66-74.nxml.txt.nlp	22120966	SENT174	22	22	35	35	genistein	RANKL	PA165109660	8600	0.777
NULL	J_Mol_Med_2008_Sep_4_86(9)_1045-1056.nxml.txt.nlp	18600309	SENT34	8	8	15	15	salmeterol	IL-8	PA451300	3576	0.777
NULL	Mol_Vis_2012_Oct_5_18_2454-2467.nxml.txt.nlp	23077404	SENT154	13	13	18	18	bevacizumab	HIF-1	PA130232992	29072	0.777
NULL	Infect_Dis_Rep_2013_Jun_6_5(Suppl_1)_e5.nxml.txt.nlp	24470969	SENT93	28	28	19	19	enfuvirtide	CCR5	PA164744517	1234	0.777
NULL	Diabetes_2013_May_16_62(5)_1681-1688.nxml.txt.nlp	23250356	SENT182	35	35	26	26	sevoflurane	spatial	PA451341	219793	0.777
NULL	Brain_Sci_2013_Jun_14_3(2)_941-963.nxml.txt.nlp	24961432	SENT1161	11	11	0	0	ethanol	RhoE	PA448073	390	0.777
NULL	Hematol_Rep_2010_Nov_30_2(1)_e9.nxml.txt.nlp	22184522	SENT69	3	3	0	0	etoposide	CHOP	PA449552	1649	0.777
NULL	Cell_Cycle_2012_Oct_1_11(19)_3521-3522.nxml.txt.nlp	22935702	SENT26	10	10	18	18	metformin	spatial	PA450395	219793	0.777
NULL	Biomed_Opt_Express_2014_Jul_14_5(8)_2614-2619.nxml.txt.nlp	25136489	SENT40	6	6	22	22	fluorescein	LTA	PA164746009	4049	0.777
NULL	Int_J_Biol_Sci_2015_Jan_1_11(1)_67-74.nxml.txt.nlp	25552931	SENT87	11	11	18	18	l-arginine	ADP	PA448478	23038	0.777
NULL	Acta_Pharmacol_Sin_2011_Jul_13_32(7)_967-972.nxml.txt.nlp	21666702	SENT23	29	29	11	11	losartan	P-gp	PA450268	5243	0.777
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1150.nxml.txt.nlp	24675468	SENT103	4	4	19	19	ethanol	PARP-1	PA448073	25976	0.777
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1066.nxml.txt.nlp	24556681	SENT215	27	27	16	16	ethanol	p62	PA448073	8878;10657;23636	0.777
NULL	Int_J_Breast_Cancer_2011_Jul_12_2011_232435.nxml.txt.nlp	22295213	SENT263	9	9	7	7	gefitinib	EGFR	PA131301952	1956	0.777
NULL	ScientificWorldJournal_2013_Feb_13_2013_292687.nxml.txt.nlp	23476127	SENT206	8	8	15	15	dexmedetomidine	IL6	PA449256	3569	0.777
NULL	J_Cell_Biol_2001_Apr_2_153(1)_221-228.nxml.txt.nlp	11285287	SENT119	40	40	35	35	etoposide	TRAIL	PA449552	8743	0.777
NULL	Mol_Vis_2012_Apr_11_18_901-908.nxml.txt.nlp	22539869	SENT155	20	20	13	13	curcumin	HO-1	PA151958596	3162	0.777
NULL	Cell_Death_Dis_2014_Jul_17_5(7)_e1333.nxml.txt.nlp	25032856	SENT76	18	18	34	34	candesartan	EAAC1	PA448765	6505	0.777
NULL	Crit_Care_2007_Aug_24_11(4)_222.nxml.txt.nlp	17764585	SENT10	7	7	4	4	terlipressin	AVP	PA164781020	114548;551	0.777
NULL	Case_Rep_Dermatol_2014_Mar_7_6(1)_74-79.nxml.txt.nlp	24707255	SENT54	24	24	35	35	dacarbazine	IFN	PA449197	3439	0.777
NULL	J_Clin_Biochem_Nutr_2010_Mar_27_46(2)_126-134.nxml.txt.nlp	20216945	SENT72	15	15	13	13	s-adenosylmethionine	Met	PA164754994	79811	0.777
NULL	Cell_Res_2010_Apr_26_20(4)_434-444.nxml.txt.nlp	20101261	SENT66	15	15	23	23	rosiglitazone	UCP1	PA451283	7350	0.777
NULL	Diabetes_Care_2009_Sep_19_32(9)_1663-1668.nxml.txt.nlp	19542207	SENT130	25	25	17	17	anakinra	IL-6	PA10799	3569	0.777
NULL	Oncol_Rep_2012_Dec_5_28(6)_1968-1976.nxml.txt.nlp	22961650	SENT29	5	5	12	12	gemcitabine	GEM	PA449748	2669	0.777
NULL	Adipocyte_2012_Oct_1_1(4)_256-258.nxml.txt.nlp	23700542	SENT41	33	33	6	6	rolipram	AMPK	PA153906323	5563	0.777
NULL	J_Infect_Dis_2011_Oct_1_204(7)_1104-1114.nxml.txt.nlp	21881126	SENT163	9	9	11	11	chloroquine	MxA	PA448948	4599	0.777
NULL	J_Thromb_Haemost_2011_Oct_9(10)_2050-2056.nxml.txt.nlp	21794076	SENT140	4	4	17	17	prasugrel	ADP	PA154410481	23038	0.777
NULL	Biol_Open_2014_Nov_13_3(12)_1164-1172.nxml.txt.nlp	25395667	SENT95	17	17	15	15	capsaicin	TRPV1	PA448776	7442	0.777
NULL	J_Korean_Med_Sci_2006_Jun_21_21(3)_418-424.nxml.txt.nlp	16778382	SENT99	4	4	9	9	hemin	INS-1	PA449849	2305	0.777
NULL	Br_J_Cancer_2010_Jul_13_103(2)_186-195.nxml.txt.nlp	20588277	SENT92	5	5	13	13	nutlin-3	p53		7157	0.777
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT11	14	14	27	27	l-leucine	S6K1	PA450197	6198	0.777
NULL	Nucleic_Acids_Res_2011_Dec_2_39(22)_9549-9558.nxml.txt.nlp	21890893	SENT159	6	6	4	4	resveratrol	SIRT1		23411	0.777
NULL	Front_Oncol_2014_Mar_3_4_35.nxml.txt.nlp	24624362	SENT124	18	18	9	9	cetuximab	NRAS	PA10040	4893	0.777
NULL	Oncol_Lett_2013_Mar_11_5(3)_1010-1016.nxml.txt.nlp	23426784	SENT8	12	12	17	17	midazolam	TRPM7	PA450496	54822	0.777
NULL	Environ_Health_Perspect_1998_Sep_106(9)_597-606.nxml.txt.nlp	9721260	SENT4	14	14	16	16	colchicine	CLC	PA449092	23529;1178	0.777
NULL	Curr_HIV_Res_2011_Dec_9(8)_554-567.nxml.txt.nlp	22211660	SENT236	13	13	23	23	disulfiram	CD4	PA449376	920	0.777
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1437-1448.nxml.txt.nlp	24056706	SENT253	5	5	14	14	sn-38	C10		113246	0.777
NULL	BMB_Rep_2014_Jul_47(7)_376-381.nxml.txt.nlp	24286332	SENT69	7	7	2	2	thrombin	PPG	PA451674	5552	0.777
NULL	Mucosal_Immunol_2014_Mar_24_7(2)_335-347.nxml.txt.nlp	23881354	SENT112	5	5	22	22	atropine	GAL	PA448505	51083	0.777
NULL	Front_Oncol_2014_Jun_18_4_153.nxml.txt.nlp	24995158	SENT175	6	6	12	12	vinblastine	AP-1	PA451877	2353;3727;2354;3725	0.777
NULL	Oncotarget_2012_Oct_20_3(10)_1236-1245.nxml.txt.nlp	23100449	SENT7	18	18	9	9	doxorubicin	NGAL	PA449412	3934	0.777
NULL	J_Viral_Hepat_2009_May_16(5)_315-324.nxml.txt.nlp	19243499	SENT95	30	30	15	15	imiquimod	IFN	PA449972	3439	0.777
NULL	Cancer_Med_2012_Oct_16_1(2)_207-217.nxml.txt.nlp	23342270	SENT210	32	32	9	9	saracatinib	PI3K		5290	0.777
NULL	Int_J_Nanomedicine_2012_Sep_21_7_5091-5106.nxml.txt.nlp	23049256	SENT27	33	33	5	5	oxygen	SOD1	PA450744	6647	0.777
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1059-1066.nxml.txt.nlp	21364577	SENT180	17	17	8	8	anastrozole	ATAC	PA448432	6375	0.777
NULL	Adv_Appl_Bioinforma_Chem_2008_Oct_30_1_85-98.nxml.txt.nlp	21918608	SENT86	11	11	3	3	bortezomib	SPARC	PA10252	6678	0.777
NULL	Cell_Death_Dis_2011_Aug_11_2(8)_e191.nxml.txt.nlp	21833029	SENT78	28	28	15	15	oxaliplatin	CT26	PA131285527	168400	0.777
NULL	Evid_Based_Complement_Alternat_Med_2012_Aug_25_2012_946867.nxml.txt.nlp	21876716	SENT117	4	4	9	9	oseltamivir	TRAIL	PA450721	8743	0.777
NULL	Acta_Pharmacol_Sin_2012_Jan_28_33(1)_66-74.nxml.txt.nlp	22120966	SENT186	3	3	26	26	genistein	OPG	PA165109660	690	0.777
NULL	Orphanet_J_Rare_Dis_2010_Dec_16_5_39.nxml.txt.nlp	21162721	SENT77	23	23	10	10	carbamazepine	HLA-B	PA448785	3106	0.777
NULL	Diabetes_Care_2011_Jun_20_34(6)_1406-1411.nxml.txt.nlp	21515837	SENT154	5	5	23	23	glucose	LVM	PA449773	23209	0.777
NULL	Nucleic_Acids_Res_2011_Dec_31_39(22)_9536-9548.nxml.txt.nlp	21880590	SENT165	22	22	10	10	etoposide	BRCA1	PA449552	672	0.777
NULL	Breast_Cancer_Res_2010_Mar_5_12(2)_R16.nxml.txt.nlp	20205716	SENT348	13	13	3	3	lovastatin	NDRG1	PA450272	10397	0.777
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R91.nxml.txt.nlp	22541814	SENT221	3	3	5	5	thrombin	HO-1	PA451674	3162	0.777
NULL	Biomed_Res_Int_2013_Dec_9_2013_535049.nxml.txt.nlp	24383055	SENT173	10	10	12	12	bleomycin	APT	PA448645	653639	0.777
NULL	Oncotarget_2014_Aug_29_5(18)_8052-8082.nxml.txt.nlp	25211298	SENT406	10	10	1	1	ritonavir	AKT	PA451260	207	0.777
NULL	Aging_(Albany_NY)_2009_Dec_31_1(12)_988-1007.nxml.txt.nlp	20157582	SENT58	17	17	24	24	docetaxel	CTX	PA449383	1593	0.777
NULL	Cancer_Med_2013_Jun_24_2(3)_360-366.nxml.txt.nlp	23930213	SENT108	9	9	15	15	erlotinib	EGFR	PA134687924	1956	0.777
NULL	J_Invest_Dermatol_2013_Jul_13_133(7)_1742-1751.nxml.txt.nlp	23407402	SENT81	3	3	14	14	etanercept	TREM-1	PA449515	54210	0.777
NULL	Biologics_2012_Aug_17_6_267-276.nxml.txt.nlp	22956858	SENT82	41	41	39	39	sorafenib	STAT3	PA7000	6774	0.777
NULL	Channels_(Austin)_2010_Jan_1_4(1)_22-41.nxml.txt.nlp	19934650	SENT409	5	5	14	14	quinidine	Slo3	PA451209	157855	0.777
NULL	Brain_Behav_2013_Mar_6_3(2)_114-133.nxml.txt.nlp	23533150	SENT189	3	3	5	5	ethanol	HSF1	PA448073	3297	0.777
NULL	Front_Psychol_2013_May_14_4_254.nxml.txt.nlp	23717290	SENT162	14	14	8	8	nicotine	P50	PA450626	8874	0.777
NULL	Amyloid_2014_Sep_11_21(3)_175-184.nxml.txt.nlp	24918964	SENT129	3	3	21	21	anakinra	p65	PA10799	5970	0.777
NULL	Core_Evid_2008_Jun_3(1)_13-30.nxml.txt.nlp	20694081	SENT190	0	0	22	22	vildagliptin	GLP-1	PA165958346	100125288	0.777
NULL	Clin_Sci_(Lond)_2009_Apr_1_116(Pt_8)_607-620.nxml.txt.nlp	19275766	SENT116	2	2	7	7	cilostazol	AMPK	PA164746334	5563	0.777
NULL	Cells_2012_Dec_5_1(4)_1156-1167.nxml.txt.nlp	24710548	SENT43	22	22	34	34	staurosporine	p38	PA165109623	10598;1432;7965	0.777
NULL	Arch_Osteoporos_2013_Sep_13_8(1-2)_144.nxml.txt.nlp	24030479	SENT1004	13	13	30	30	risedronate	PTH	PA451255	5741	0.777
NULL	Acta_Pharmacol_Sin_2009_Oct_21_30(10)_1392-1398.nxml.txt.nlp	19767766	SENT162	14	14	10	10	atorvastatin	ROS	PA448500	6098	0.777
NULL	Biomed_Res_Int_2013_Jul_31_2013_692071.nxml.txt.nlp	23984399	SENT170	11	11	37	37	ondansetron	CYP2D6	PA450705	1565	0.777
NULL	Curr_Neuropharmacol_2010_Mar_8(1)_62-68.nxml.txt.nlp	20808546	SENT76	5	5	7	7	celecoxib	spatial	PA448871	219793	0.777
NULL	Leukemia_2014_Aug_4_28(8)_1573-1585.nxml.txt.nlp	24496300	SENT71	4	4	19	19	norfloxacin	CYP1A2	PA450654	1544	0.777
NULL	J_Gynecol_Oncol_2013_Jul_4_24(3)_265-272.nxml.txt.nlp	23875077	SENT100	14	14	25	25	thrombin	SMAD2	PA451674	4087	0.777
NULL	Breast_Cancer_Res_2011_Mar_11_13(2)_R29.nxml.txt.nlp	21396094	SENT242	30	30	2	2	fulvestrant	HRG	PA164747170	3084;3273	0.777
NULL	BMB_Rep_2013_Sep_46(9)_448-453.nxml.txt.nlp	24064059	SENT73	30	30	16	16	dextran	CD83	PA449261	9308	0.777
NULL	Front_Behav_Neurosci_2011_Sep_13_5_57.nxml.txt.nlp	21949506	SENT1738	2	2	6	6	rimonabant	spatial	PA152407999	219793	0.777
NULL	Breast_Cancer_Res_2014_May_28_16(3)_R53.nxml.txt.nlp	24886537	SENT334	11	11	6	6	tamoxifen	VAV3	PA451581	10451	0.777
NULL	J_Gen_Physiol_2012_May_139(5)_371-388.nxml.txt.nlp	22508847	SENT40	23	23	5	5	thrombin	GluA3	PA451674	2892	0.777
NULL	J_Exp_Med_1998_Jun_1_187(11)_1885-1892.nxml.txt.nlp	9607928	SENT108	9	9	33	33	thalidomide	CD4	PA451644	920	0.777
NULL	Onco_Targets_Ther_2014_Dec_4_7_2249-2255.nxml.txt.nlp	25587220	SENT55	22	22	14	14	verapamil	ABCG2	PA451868	9429	0.777
NULL	JRSM_Short_Rep_2011_Feb_10_2(2)_9.nxml.txt.nlp	21369527	SENT16	9	9	36	36	triamcinolone	GM-CSF	PA451749	1437	0.777
NULL	J_Asthma_Allergy_2011_Sep_26_4_93-102.nxml.txt.nlp	22034573	SENT253	11	11	17	17	fluorescein	CD11b	PA164746009	3684	0.777
NULL	Cell_Commun_Signal_2013_Oct_1_11_73.nxml.txt.nlp	24083678	SENT73	33	33	22	22	sulindac	IL-8	PA451565	3576	0.777
NULL	J_Cell_Mol_Med_2014_Aug_6_18(8)_1519-1539.nxml.txt.nlp	25100284	SENT131	13	13	22	22	erlotinib	EGFR	PA134687924	1956	0.777
NULL	Int_J_Biol_Sci_2011_Sep_8_7(8)_1077-1092.nxml.txt.nlp	21927577	SENT144	12	12	6	6	telmisartan	CHOP	PA451605	1649	0.777
NULL	Brain_Behav_2013_Mar_6_3(2)_114-133.nxml.txt.nlp	23533150	SENT176	26	26	20	20	ethanol	HSF1	PA448073	3297	0.777
NULL	Clin_Transl_Allergy_2014_Jan_15_4_3.nxml.txt.nlp	24428928	SENT174	9	9	14	14	methacholine	IL-17	PA165958382	3605	0.777
NULL	Breast_Cancer_Res_Treat_2013_Aug_20_141(1)_43-53.nxml.txt.nlp	23959396	SENT245	17	17	3	3	pertuzumab	HER3		2065	0.777
NULL	Indian_Dermatol_Online_J_2011_Jul-Dec_2(2)_111-119.nxml.txt.nlp	23130241	SENT326	12	12	22	22	cyclosporine	FAE	PA449167	2178	0.777
NULL	Br_J_Cancer_2013_Feb_19_108(3)_477-478.nxml.txt.nlp	23422787	SENT18	3	3	12	12	vatalanib	VEGFR	PA7001	3791	0.777
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Apr_17_6_43-57.nxml.txt.nlp	24833916	SENT97	14	14	29	29	everolimus	aromatase	PA164746311	1588	0.777
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jun_23_66(Pt_7)_o1753.nxml.txt.nlp	21587969	SENT74	10	10	6	6	benzaldehyde	mol	PA448571	90527	0.777
NULL	Cancer_Med_2014_Oct_2_3(5)_1256-1265.nxml.txt.nlp	24890382	SENT188	4	4	9	9	trastuzumab	HER2	PA451743	2064	0.777
NULL	Oncogene_2010_Sep_16_29(37)_5193-5203.nxml.txt.nlp	20581867	SENT122	10	10	7	7	lapatinib	HRG	PA152241907	3084;3273	0.777
NULL	J_Mol_Signal_2013_Jan_26_8_1.nxml.txt.nlp	23351368	SENT92	6	6	22	22	estradiol	TRAF6	PA449503	7189	0.777
NULL	Sci_Rep_2014_Dec_23_4_7593.nxml.txt.nlp	25534349	SENT57	4	4	30	30	atorvastatin	PC-3	PA448500	692094	0.777
NULL	Oncotarget_2014_Nov_8_5(21)_10280-10292.nxml.txt.nlp	25373733	SENT3	16	16	9	9	bevacizumab	HIF-1	PA130232992	29072	0.777
NULL	Exp_Ther_Med_2014_Sep_14_8(3)_836-840.nxml.txt.nlp	25120610	SENT88	4	4	19	19	fasudil	RhoA	PA165946121	387	0.777
NULL	Daru_2012_Dec_5_20(1)_87.nxml.txt.nlp	23351503	SENT150	33	33	39	39	isoproterenol	ANOVA	PA450121	4858	0.777
NULL	Indian_J_Psychiatry_2011_Oct-Dec_53(4)_289-299.nxml.txt.nlp	22303036	SENT91	22	22	11	11	escitalopram	5-HTT	PA10074	6532	0.777
NULL	Front_Behav_Neurosci_2012_Nov_22_6_78.nxml.txt.nlp	23189046	SENT133	28	28	19	19	ethanol	OX1R	PA448073	3061	0.777
NULL	Int_J_Mol_Sci_2013_Apr_2_14(4)_7193-7230.nxml.txt.nlp	23549262	SENT3	27	27	16	16	urokinase	FPR2	PA451836	2358	0.777
NULL	Int_J_Fertil_Steril_2014_Jul_8_Jul-Sep_8(2)_119-128.nxml.txt.nlp	25083175	SENT8	6	6	18	18	metformin	NAC	PA450395	22861	0.777
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R91.nxml.txt.nlp	22541814	SENT247	17	17	22	22	thrombin	HO-1	PA451674	3162	0.777
NULL	J_Cell_Mol_Med_2014_Mar_22_18(3)_480-491.nxml.txt.nlp	24450440	SENT72	9	9	34	34	axitinib	EDD	PA164924493	51366	0.777
NULL	J_Cell_Biol_1998_Jan_26_140(2)_335-345.nxml.txt.nlp	9442109	SENT203	19	19	13	13	chloroquine	NHE	PA448948	285335	0.777
NULL	J_Biomed_Biotechnol_2010_Mar_9_2010_525180.nxml.txt.nlp	20300455	SENT41	11	11	6	6	calcein	P-gp	PA132595336	5243	0.777
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_21-38.nxml.txt.nlp	19305786	SENT477	3	3	5	5	menthol	TRPM8	PA164776605	79054	0.777
NULL	Environ_Health_Perspect_2005_Apr_14_113(4)_431-439.nxml.txt.nlp	15811834	SENT142	26	26	8	8	nifedipine	DES	PA450631	1674	0.777
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Nov_22_64(Pt_12)_o2422.nxml.txt.nlp	21581390	SENT62	0	0	15	15	phenol	mol	PA450913	90527	0.777
NULL	Pharmacogn_Mag_2014_Jan-Feb_10(Suppl_1)_S14-S21.nxml.txt.nlp	24914294	SENT123	16	16	27	27	phenol	PLK1	PA450913	5347	0.777
NULL	Oncotarget_2014_Jun_11_5(21)_10407-10420.nxml.txt.nlp	25431951	SENT206	37	37	23	23	gefitinib	BRAF	PA131301952	673	0.777
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT112	0	0	4	4	curcumin	survivin	PA151958596	332	0.777
NULL	Eur_J_Clin_Pharmacol_2011_May_9_67(5)_477-482.nxml.txt.nlp	21305273	SENT121	31	31	35	35	atropine	DSE	PA448505	29940	0.777
NULL	Breast_Cancer_Res_2007_Mar_2_9(2)_205.nxml.txt.nlp	NULL	SENT26	18	18	29	29	ekb-569	EGFR		1956	0.777
NULL	Nat_Med_2014_Jun_11_20(6)_599-606.nxml.txt.nlp	24813251	SENT84	0	0	6	6	imatinib	YAP1	PA10804	10413	0.777
NULL	Int_J_Mol_Sci_2012_Feb_1_13(2)_1481-1496.nxml.txt.nlp	22408403	SENT433	6	6	13	13	omeprazole	ANOVA	PA450704	4858	0.777
NULL	Patient_Prefer_Adherence_2014_Apr_8_8_463-471.nxml.txt.nlp	24748775	SENT133	11	11	15	15	teriparatide	BMD	PA451620	1756;7439	0.777
NULL	Mediators_Inflamm_2011_Jul_13_2011_560194.nxml.txt.nlp	21785528	SENT40	20	20	26	26	bleomycin	IL-10	PA448645	3586	0.777
NULL	Oncol_Lett_2014_Jul_12_8(1)_223-229.nxml.txt.nlp	24959250	SENT153	2	2	11	11	captopril	IL-18	PA448780	3606	0.777
NULL	Clin_Ophthalmol_2008_Dec_2(4)_897-905.nxml.txt.nlp	19668444	SENT130	3	3	5	5	latanoprost	BAK	PA164774763	578	0.777
NULL	J_Mol_Signal_2006_Dec_6_1_8.nxml.txt.nlp	17224083	SENT30	1	1	4	4	thrombin	Rho	PA451674	29984	0.777
NULL	Diabetes_Care_2010_Feb_23_33(2)_246-251.nxml.txt.nlp	19933994	SENT186	11	11	24	24	metformin	B12	PA450395	7126;4709	0.777
NULL	Arthritis_Res_Ther_2014_Jan_27_16(1)_R24.nxml.txt.nlp	24460746	SENT150	11	11	16	16	etanercept	ACR	PA449515	49	0.777
NULL	Br_J_Anaesth_2014_Jul_22_113(1)_157-167.nxml.txt.nlp	24154701	SENT262	9	9	19	19	sevoflurane	TREK-1	PA451341	3776	0.777
NULL	Adv_Hematol_2012_Sep_14_2012_524308.nxml.txt.nlp	21941553	SENT310	7	7	27	27	fludarabine	BCL2	PA449655	596	0.777
NULL	Cent_European_J_Urol_2013_Apr_26_66(1)_39-44.nxml.txt.nlp	24578986	SENT87	38	38	13	13	carboplatin	ACT	PA448803	12;11332;9457;641455	0.777
NULL	BMJ_2010_Feb_8_340_c693.nxml.txt.nlp	20142325	SENT258	25	25	23	23	imipramine	CYP2D6	PA449969	1565	0.777
NULL	Nature_2012_Apr_25_484(7395)_510-513.nxml.txt.nlp	22538615	SENT121	39	39	21	21	mitomycin	GK1	PA450524	2710	0.777
NULL	Br_J_Cancer_2013_Jul_23_109(2)_351-359.nxml.txt.nlp	23799854	SENT164	19	19	31	31	paclitaxel	P-gp	PA450761	5243	0.777
NULL	Br_J_Cancer_2012_Jan_17_106(2)_284-289.nxml.txt.nlp	22215065	SENT168	6	6	10	10	atrasentan	IFN	PA143414738	3439	0.777
NULL	Mycobiology_2006_Dec_31_34(4)_219-229.nxml.txt.nlp	24039503	SENT160	30	30	28	28	ethanol	CO2	PA448073	4513	0.777
NULL	J_Cell_Mol_Med_2014_Feb_3_18(2)_344-354.nxml.txt.nlp	24393246	SENT186	0	0	13	13	mitomycin	IFN	PA450524	3439	0.777
NULL	Case_Rep_Oncol_Med_2012_Nov_6_2012_164082.nxml.txt.nlp	23198199	SENT64	39	39	26	26	rituximab	ACTH	PA451261	5443	0.777
NULL	Br_J_Pharmacol_2014_Jan_23_171(2)_523-535.nxml.txt.nlp	24372553	SENT38	3	3	0	0	metformin	SIRT1	PA450395	23411	0.777
NULL	Mol_Cell_Proteomics_2014_Mar_20_13(3)_701-715.nxml.txt.nlp	24361865	SENT1098	10	10	3	3	idarubicin	AKR1B10	PA449961	57016	0.777
NULL	Drug_Des_Devel_Ther_2014_Sep_9_8_1307-1314.nxml.txt.nlp	25246772	SENT5	3	3	13	13	tacrolimus	HTX	PA451578	7547	0.777
NULL	Support_Care_Cancer_2014_Oct_19_22(2)_469-477.nxml.txt.nlp	24141698	SENT142	29	29	39	39	granisetron	HEC	PA449809	10403	0.777
NULL	ScientificWorldJournal_2014_Dec_9_2014_808320.nxml.txt.nlp	25548793	SENT43	21	21	19	19	argatroban	RAC	PA164745516	207	0.777
NULL	J_Korean_Med_Sci_2005_Oct_31_20(5)_883-885.nxml.txt.nlp	16224167	SENT74	19	19	26	26	cyclophosphamide	gamma	PA449165	9913	0.777
NULL	Front_Behav_Neurosci_2014_Oct_30_8_366.nxml.txt.nlp	25400560	SENT318	2	2	11	11	ceftriaxone	xCT	PA448866	23657	0.777
NULL	Br_J_Haematol_2014_Mar_6_164(6)_759-766.nxml.txt.nlp	24387053	SENT130	21	21	11	11	rituximab	ADAMTS13	PA451261	11093	0.777
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Aug_17_69(Pt_9)_o1442.nxml.txt.nlp	24427070	SENT70	19	19	34	34	ethanol	mol	PA448073	90527	0.777
NULL	Allergy_2012_Jul_15_67(7)_858-868.nxml.txt.nlp	22583069	SENT28	28	28	25	25	cladribine	IFN	PA449027	3439	0.777
NULL	Springerplus_2014_Sep_9_3_510.nxml.txt.nlp	25279302	SENT256	5	5	10	10	s-adenosylmethionine	ADP	PA164754994	23038	0.777
NULL	Hum_Mol_Genet_2013_Nov_15_22(22)_4616-4626.nxml.txt.nlp	23814041	SENT178	5	5	10	10	simvastatin	neuroserpin	PA451363	5274	0.777
NULL	Oncotarget_2012_Jan_28_3(1)_22-30.nxml.txt.nlp	22289880	SENT90	27	27	20	20	rituximab	TH1	PA451261	51497	0.777
NULL	EMBO_Mol_Med_2012_Oct_30_4(10)_1087-1096.nxml.txt.nlp	22933245	SENT99	9	9	32	32	olaparib	BRCA2		675	0.777
NULL	J_Gen_Physiol_2010_Apr_135(4)_333-353.nxml.txt.nlp	20231374	SENT418	7	7	13	13	amitriptyline	P2X4	PA448385	5025	0.777
NULL	Cancer_Manag_Res_2014_Sep_10_6_349-356.nxml.txt.nlp	25228821	SENT77	9	9	3	3	nilotinib	KIT	PA165958345	3815	0.777
NULL	Exp_Hematol_Oncol_2013_Jul_1_2_17.nxml.txt.nlp	23815814	SENT72	25	25	8	8	doxorubicin	ABCB5	PA449412	340273	0.777
NULL	Biomed_Res_Int_2014_Jan_29_2014_831845.nxml.txt.nlp	24605337	SENT121	3	3	0	0	bupivacaine	S6K1	PA135057240	6198	0.777
NULL	Arthritis_Res_Ther_2011_Mar_30_13(2)_105.nxml.txt.nlp	21542897	SENT16	36	36	21	21	adalimumab	IL-8	PA10004	3576	0.777
NULL	Cancer_Immunol_Immunother_2015_Oct_7_64_61-73.nxml.txt.nlp	25287778	SENT216	25	25	13	13	lenalidomide	IL-2	PA162363968	3558	0.777
NULL	Acta_Pharmacol_Sin_2013_Sep_5_34(9)_1208-1216.nxml.txt.nlp	23852087	SENT216	2	2	7	7	disulfiram	HIF-1	PA449376	29072	0.777
NULL	Mol_Cancer_2009_Dec_23_8_129.nxml.txt.nlp	20030852	SENT245	13	13	5	5	curcumin	ABCA1	PA151958596	19	0.777
NULL	Anal_Bioanal_Chem_2014_Jan_23_406(15)_3667-3680.nxml.txt.nlp	24452745	SENT60	20	20	14	14	furosemide	KET	PA449719	8626	0.777
NULL	Infect_Drug_Resist_2009_Apr_24_2_13-26.nxml.txt.nlp	21694884	SENT112	14	14	19	19	emtricitabine	TDF	PA10069	6736	0.777
NULL	Comp_Hepatol_2004_Jan_14_3(Suppl_1)_S31.nxml.txt.nlp	14960183	SENT34	1	1	10	10	ethanol	TNF-alpha	PA448073	7124	0.777
NULL	Atherosclerosis_2011_Nov_219(1)_109-115.nxml.txt.nlp	21820657	SENT282	9	9	16	16	probucol	CETP	PA451107	1071	0.777
NULL	Breast_Cancer_Res_2009_Nov_11_11(6)_R82.nxml.txt.nlp	19906290	SENT45	29	29	16	16	hydrocortisone	F12	PA449905	2161	0.777
NULL	Mol_Cancer_2010_Nov_8_9_291.nxml.txt.nlp	21059223	SENT175	26	26	17	17	paclitaxel	ZNF217	PA450761	7764	0.777
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_May_5_68(Pt_6)_o1607.nxml.txt.nlp	22719413	SENT70	20	20	10	10	ethanol	mol	PA448073	90527	0.777
NULL	Acta_Pharmacol_Sin_2010_Feb_5_31(2)_137-144.nxml.txt.nlp	20139896	SENT139	20	20	6	6	zileuton	5-LOX	PA451955	240	0.777
NULL	Front_Oncol_2012_Oct_8_2_121.nxml.txt.nlp	23061040	SENT325	9	9	6	6	doxorubicin	PI3K	PA449412	5290	0.777
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_75-89.nxml.txt.nlp	17912638	SENT501	5	5	15	15	estradiol	MAF	PA449503	4094	0.777
NULL	Nucleic_Acids_Res_2011_Mar_17_39(6)_2144-2152.nxml.txt.nlp	21087997	SENT131	23	23	7	7	etoposide	CtIP	PA449552	5932	0.777
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Nov_5_67(Pt_12)_o3168.nxml.txt.nlp	22199692	SENT70	3	3	18	18	vanillin	mol	PA451852	90527	0.777
NULL	Exp_Ther_Med_2012_Sep_12_4(3)_475-480.nxml.txt.nlp	23181121	SENT163	8	8	6	6	cyclophosphamide	CHOP	PA449165	1649	0.777
NULL	Nat_Commun_2013_Aug_15_4_2130.nxml.txt.nlp	23945651	SENT129	11	11	9	9	etoposide	ATG5	PA449552	9474	0.777
NULL	Mediators_Inflamm_2010_May_25_2010_367838.nxml.txt.nlp	20508825	SENT53	9	9	16	16	capsaicin	IL-6	PA448776	3569	0.777
NULL	F1000_Biol_Rep_2012_Mar_1_4_5.nxml.txt.nlp	22403588	SENT173	1	1	14	14	boceprevir	GT1	PA165948902	4635	0.777
NULL	Front_Neurosci_2012_Apr_9_6_44.nxml.txt.nlp	22509146	SENT241	17	17	22	22	ethanol	PP1	PA448073	5540;5464	0.777
NULL	Breast_Cancer_Res_2009_May_18_11(3)_303.nxml.txt.nlp	19519950	SENT10	15	15	11	11	cyclophosphamide	ACT	PA449165	12;11332;9457;641455	0.777
NULL	J_Cell_Biol_2001_Apr_2_153(1)_207-220.nxml.txt.nlp	11285286	SENT128	5	5	19	19	carbachol	DGK	PA448784	8526;1607	0.777
NULL	Ann_Hematol_2011_May_21_90(5)_601-602.nxml.txt.nlp	20730538	SENT46	14	14	16	16	etoposide	SMILE	PA449552	160418	0.777
NULL	Open_Cardiovasc_Med_J_2012_Mar_22_6_28-32.nxml.txt.nlp	22481984	SENT90	4	4	6	6	atorvastatin	DAN	PA448500	5073;4681	0.777
NULL	Case_Rep_Transplant_2011_Jun_27_2011_251930.nxml.txt.nlp	23198254	SENT23	3	3	20	20	carmustine	CD34	PA448810	947	0.777
NULL	Diabetes_Care_2008_Oct_31(10)_2062-2069.nxml.txt.nlp	18820229	SENT238	37	37	42	42	ramipril	DREAM	PA451223	30818	0.777
NULL	Braz_J_Med_Biol_Res_2014_Mar_3_47(3)_192-205.nxml.txt.nlp	24676492	SENT190	24	24	29	29	lipase	desnutrin	PA450239	57104	0.777
NULL	Indian_J_Pharmacol_2014_Nov-Dec_46(6)_639-643.nxml.txt.nlp	25538337	SENT4	24	24	21	21	escitalopram	KET	PA10074	8626	0.777
NULL	Indian_J_Pharmacol_2009_Dec_41(6)_262-267.nxml.txt.nlp	20407557	SENT52	16	16	34	34	ezetimibe	STZ	PA10816	6484	0.777
NULL	Leukemia_2013_Jan_11_27(1)_32-40.nxml.txt.nlp	22781593	SENT108	9	9	6	6	ponatinib	FGFR1	PA165980594	2260	0.777
NULL	Clin_Endosc_2013_Jul_31_46(4)_311-312.nxml.txt.nlp	23964324	SENT28	10	10	5	5	propofol	solo	PA451141	55701	0.777
NULL	Open_Access_J_Urol_2011_May_10_3_69-82.nxml.txt.nlp	24198638	SENT60	12	12	20	20	midazolam	CYP2D6	PA450496	1565	0.777
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Jan_8_3(1)_e89.nxml.txt.nlp	24402116	SENT268	0	0	20	20	tocilizumab	IL-6	PA165292659	3569	0.777
NULL	Paediatr_Drugs_2014_Feb_27_16(3)_199-211.nxml.txt.nlp	24574047	SENT282	5	5	9	9	doxylamine	OTC	PA449419	5009	0.777
NULL	Case_Rep_Oncol_Med_2013_Nov_26_2013_862585.nxml.txt.nlp	24371535	SENT38	19	19	26	26	doxorubicin	CHOP	PA449412	1649	0.777
NULL	F1000Res_2014_Aug_19_3_198.nxml.txt.nlp	25400908	SENT398	16	16	13	13	tamoxifen	aromatase	PA451581	1588	0.777
NULL	Front_Hum_Neurosci_2013_Jul_25_7_417.nxml.txt.nlp	23898259	SENT134	18	18	0	0	pilocarpine	FAST	PA450962	10922	0.777
NULL	Oncoimmunology_2012_Oct_1_1(7)_1048-1060.nxml.txt.nlp	23170253	SENT184	11	11	5	5	pertuzumab	HER-2		2064	0.777
NULL	Cancer_Cell_Int_2012_Jun_18_12_30.nxml.txt.nlp	22709569	SENT10	14	14	4	4	doxorubicin	CALM1	PA449412	801	0.777
NULL	Crit_Care_2008_Mar_13_12(Suppl_2)_P405.nxml.txt.nlp	NULL	SENT2	13	13	10	10	terlipressin	AVP	PA164781020	114548;551	0.777
NULL	Gut_Liver_2013_Sep_14_7(5)_585-593.nxml.txt.nlp	24073317	SENT102	22	22	18	18	ribavirin	IFN	PA451241	3439	0.777
NULL	Indian_J_Anaesth_2014_Sep-Oct_58(5)_565-572.nxml.txt.nlp	25535418	SENT128	29	29	46	46	warfarin	ACT	PA451906	12;11332;9457;641455	0.777
NULL	Arthritis_Res_Ther_2005_Jan_21_7(2)_55-61.nxml.txt.nlp	15743490	SENT106	8	8	43	43	atorvastatin	CCR7	PA448500	1236	0.777
NULL	Eur_J_Med_Res_2014_Apr_9_19(1)_19.nxml.txt.nlp	24717101	SENT43	10	10	23	23	rituximab	CHOP	PA451261	1649	0.777
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT232	7	7	3	3	chloroquine	BMPR-II	PA448948	659	0.777
NULL	J_Immunother_Cancer_2014_Nov_6_2(Suppl_3)_P199.nxml.txt.nlp	NULL	SENT8	36	36	16	16	cetuximab	PD-L1	PA10040	29126	0.777
NULL	Neural_Regen_Res_2014_Mar_1_9(5)_540-548.nxml.txt.nlp	25206852	SENT189	31	31	1	1	choline	HSP27	PA448976	3315	0.777
NULL	Diabetes_Care_2011_Aug_16_34(8)_1799-1803.nxml.txt.nlp	21680718	SENT171	14	14	27	27	iodixanol	TNF-alpha	PA164783998	7124	0.777
NULL	BMJ_2011_Aug_4_343_d4588.nxml.txt.nlp	21816733	SENT385	4	4	14	14	cilostazol	CYP2C19	PA164746334	1557	0.777
NULL	ISRN_Cardiol_2012_Jun_21_2012_376071.nxml.txt.nlp	22778994	SENT65	28	28	6	6	amiodarone	STAF	PA448383	7702	0.777
NULL	Biomed_Res_Int_2013_Feb_21_2013_856754.nxml.txt.nlp	23555099	SENT93	21	21	8	8	thrombin	FIX	PA451674	2158	0.777
NULL	Cancer_Metastasis_Rev_2010_Jun_28_29(2)_317-329.nxml.txt.nlp	20422276	SENT212	2	2	9	9	anakinra	IL-6	PA10799	3569	0.777
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_2_2014_659343.nxml.txt.nlp	25530786	SENT488	7	7	10	10	bupivacaine	spatial	PA135057240	219793	0.777
NULL	Oncoimmunology_2013_Jan_1_2(1)_e22840.nxml.txt.nlp	23482926	SENT171	37	37	14	14	cetuximab	EGFR	PA10040	1956	0.777
NULL	Neuropsychopharmacology_2009_Apr_2_34(5)_1135-1148.nxml.txt.nlp	18596687	SENT28	29	29	12	12	betaxolol	CRF	PA448611	1392;10882	0.777
NULL	AAPS_J_2011_Jun_1_13(3)_405-416.nxml.txt.nlp	21630127	SENT252	43	43	33	33	tocilizumab	OATP1B1	PA165292659	10599	0.777
NULL	J_Antimicrob_Chemother_2014_Dec_20_69(12)_3329-3334.nxml.txt.nlp	25147095	SENT38	24	24	9	9	nevirapine	HLA-C	PA450616	3107	0.777
NULL	Cell_Commun_Signal_2013_Nov_11_11_86.nxml.txt.nlp	24215724	SENT501	27	27	34	34	thrombin	PAR1	PA451674	79581;2149	0.777
NULL	Drugs_R_D_2010_Sep_27_10(3)_203-210.nxml.txt.nlp	20945949	SENT109	0	0	10	10	boceprevir	IFN	PA165948902	3439	0.777
NULL	Int_J_Breast_Cancer_2012_Sep_4_2012_290854.nxml.txt.nlp	22988515	SENT42	12	12	5	5	trastuzumab	HER-2	PA451743	2064	0.777
NULL	Ther_Clin_Risk_Manag_2005_Jun_1(2)_107-114.nxml.txt.nlp	18360550	SENT25	8	8	49	49	paclitaxel	Yes	PA450761	7525	0.777
NULL	Curr_Neuropharmacol_2013_Jul_11(4)_338-378.nxml.txt.nlp	24381528	SENT698	6	6	31	31	curcumin	PTEN	PA151958596	5728	0.777
NULL	Mol_Neurobiol_2007_Oct_10_36(2)_137-151.nxml.txt.nlp	17952658	SENT388	10	10	47	47	vasopressin	CXCR4	PA451858	7852	0.777
NULL	Bioimpacts_2014_May_28_4(2)_75-81.nxml.txt.nlp	25035850	SENT6	3	3	33	33	methacholine	IFN	PA165958382	3439	0.777
NULL	Eur_J_Immunol_2014_Jun_10_44(6)_1759-1769.nxml.txt.nlp	24595810	SENT67	21	21	5	5	fludrocortisone	CD62L	PA164743961	6402	0.777
NULL	Arthritis_Res_Ther_2011_Sep_21_13(5)_239.nxml.txt.nlp	21955617	SENT159	21	21	6	6	celecoxib	RANKL	PA448871	8600	0.777
NULL	Biologics_2011_Aug_9_5_87-94.nxml.txt.nlp	21847344	SENT156	14	14	19	19	trastuzumab	HER-2	PA451743	2064	0.777
NULL	Front_Oncol_2013_Oct_29_3_269.nxml.txt.nlp	24195060	SENT251	7	7	4	4	cisplatin	p53	PA449014	7157	0.777
NULL	Int_J_Mol_Sci_2014_Sep_18_15(9)_16544-16576.nxml.txt.nlp	25238417	SENT106	24	24	22	22	hyaluronan	HAPLN3	PA165958431	145864	0.777
NULL	Indian_J_Pharmacol_2013_Sep-Oct_45(5)_458-463.nxml.txt.nlp	24130379	SENT157	33	33	22	22	carvedilol	TLR4	PA448817	7099	0.777
NULL	J_Geriatr_Cardiol_2013_Jun_10(2)_151-158.nxml.txt.nlp	23888175	SENT222	21	21	8	8	rosuvastatin	AT1	PA134308647	9197;185	0.777
NULL	J_Cell_Biol_2000_Feb_21_148(4)_801-810.nxml.txt.nlp	10684260	SENT523	14	14	12	12	heparin	perlecan	PA449855	3339	0.777
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT235	10	10	27	27	cisplatin	Bcl-2	PA449014	596	0.777
NULL	Cell_Commun_Signal_2014_Dec_24_12(1)_78.nxml.txt.nlp	NULL	SENT357	25	25	1	1	losartan	MYH7	PA450268	4625	0.777
NULL	Glycobiology_2012_Jan_26_22(1)_134-145.nxml.txt.nlp	21873605	SENT128	38	38	48	48	heparin	IL-8	PA449855	3576	0.777
NULL	ScientificWorldJournal_2014_Aug_5_2014_616432.nxml.txt.nlp	25162059	SENT141	3	3	10	10	indomethacin	EGF	PA449982	1950	0.777
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_45-53.nxml.txt.nlp	17912635	SENT36	17	17	11	11	letrozole	aromatase	PA450196	1588	0.777
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT171	16	16	6	6	doxorubicin	AKT	PA449412	207	0.777
NULL	Cancer_Immunol_Immunother_2012_Jul_23_61(7)_1101-1111.nxml.txt.nlp	22193989	SENT217	12	12	20	20	oxaliplatin	SHP-1	PA131285527	5777	0.777
NULL	Diabetes_2008_Sep_57(9)_2332-2340.nxml.txt.nlp	18567824	SENT118	15	15	35	35	atropine	ANOVA	PA448505	4858	0.776
NULL	Oncogene_2013_Sep_26_32(39)_10_1038_onc_2012_491.nxml.txt.nlp	23108394	SENT39	19	19	12	12	epirubicin	BRIP1	PA449476	64979;83990	0.776
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT148	2	2	26	26	tamoxifen	ATP5A	PA451581	498	0.776
NULL	Cell_Commun_Signal_2004_Jun_30_2_6.nxml.txt.nlp	15228623	SENT95	14	14	38	38	flunarizine	TTN	PA164776636	7273	0.776
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Mar_26_3(3)_e107.nxml.txt.nlp	24670388	SENT5	13	13	10	10	midazolam	CYP2C9	PA450496	1559	0.776
NULL	Oncogene_2010_Sep_16_29(37)_5193-5203.nxml.txt.nlp	20581867	SENT125	28	28	21	21	trastuzumab	AKT	PA451743	207	0.776
NULL	J_Cell_Sci_2014_Jul_1_127(13)_2898-2909.nxml.txt.nlp	24806960	SENT74	0	0	16	16	bortezomib	BAG6	PA10252	7917	0.776
NULL	J_Oncol_2010_May_19_2010_285191.nxml.txt.nlp	20508725	SENT24	5	5	10	10	paclitaxel	NAC1	PA450761	112939;6323	0.776
NULL	Clin_Exp_Otorhinolaryngol_2012_Sep_27_5(3)_117-121.nxml.txt.nlp	22977707	SENT12	39	39	28	28	kanamycin	KCC2	PA450137	57468	0.776
NULL	Springerplus_2014_Sep_11_3_516.nxml.txt.nlp	25279308	SENT155	17	17	27	27	ethanol	CS-2	PA448073	58529;1443	0.776
NULL	JAKSTAT_2013_Jul_1_2(3)_e24812.nxml.txt.nlp	24069562	SENT55	33	33	7	7	pp2	STAT3		6774	0.776
NULL	Oxid_Med_Cell_Longev_2012_Aug_22_2012_534705.nxml.txt.nlp	22966415	SENT220	2	2	6	6	riluzole	GLT-1	PA451251	6506	0.776
NULL	Acta_Pharmacol_Sin_2012_Dec_29_33(12)_1518-1524.nxml.txt.nlp	23103625	SENT15	0	0	10	10	telmisartan	ACE2	PA451605	59272	0.776
NULL	Oncogene_2014_Feb_6_33(6)_713-723.nxml.txt.nlp	23435429	SENT53	27	27	7	7	cisplatin	BRCA1	PA449014	672	0.776
NULL	Br_J_Cancer_2013_Jul_23_109(2)_332-341.nxml.txt.nlp	23807171	SENT57	24	24	34	34	sunitinib	IFN	PA162372840	3439	0.776
NULL	Oncotarget_2014_Oct_18_5(22)_11552-11563.nxml.txt.nlp	25344911	SENT27	20	20	22	22	cisplatin	DDP	PA449014	1678	0.776
NULL	ISRN_Neurosci_2013_Jul_17_2013_253210.nxml.txt.nlp	24967306	SENT121	3	3	11	11	naloxone	ANOVA	PA450586	4858	0.776
NULL	Pharmaceuticals_(Basel)_2013_Aug_21_6(8)_988-1038.nxml.txt.nlp	24276379	SENT483	14	14	20	20	sorafenib	EGFR	PA7000	1956	0.776
NULL	Blood_Cancer_J_2014_Mar_7_4(3)_e190.nxml.txt.nlp	24608734	SENT98	10	10	14	14	bleomycin	CHOP	PA448645	1649	0.776
NULL	Ann_Indian_Acad_Neurol_2014_Mar_17(Suppl_1)_S27-S31.nxml.txt.nlp	24791084	SENT113	19	19	21	21	lorazepam	LOR	PA450267	4014	0.776
NULL	Br_J_Ophthalmol_2008_Sep_22_92(9)_1275-1282.nxml.txt.nlp	18723745	SENT101	27	27	41	41	latanoprost	BAK	PA164774763	578	0.776
NULL	Br_J_Pharmacol_2014_Jun_15_171(11)_2705-2725.nxml.txt.nlp	24467436	SENT286	22	22	1	1	isoniazid	NAT	PA450112	6046	0.776
NULL	Cholesterol_2014_Nov_18_2014_720507.nxml.txt.nlp	25478215	SENT114	42	42	23	23	atorvastatin	AT2	PA448500	186	0.776
NULL	Clin_Pharmacokinet_2014_Sep_3_53(1)_1-16.nxml.txt.nlp	23999929	SENT279	3	3	8	8	rivaroxaban	P-gp	PA165958360	5243	0.776
NULL	Acta_Neuropathol_Commun_2014_Aug_27_2(1)_97.nxml.txt.nlp	NULL	SENT141	9	9	12	12	resveratrol	SIRT1		23411	0.776
NULL	Int_J_Inflam_2011_Aug_15_2011_580295.nxml.txt.nlp	21876832	SENT74	2	2	30	30	infliximab	CD163	PA452639	9332	0.776
NULL	Ann_Oncol_2012_Dec_2_23(12)_3007-3016.nxml.txt.nlp	22865781	SENT86	10	10	5	5	trastuzumab	HER2	PA451743	2064	0.776
NULL	Adv_Hematol_2012_Mar_8_2012_856341.nxml.txt.nlp	22496694	SENT139	19	19	26	26	rivaroxaban	CYP3A4	PA165958360	1576	0.776
NULL	Front_Chem_2014_Dec_23_2_113.nxml.txt.nlp	25566531	SENT171	0	0	6	6	curcumin	JNK	PA151958596	5599	0.776
NULL	Neuropsychologia_2011_Jul_49(9)_2755-2765.nxml.txt.nlp	21689671	SENT55	16	16	28	28	rivastigmine	LPA	PA451262	4018	0.776
NULL	J_Antimicrob_Chemother_2013_Mar_9_68(3)_697-707.nxml.txt.nlp	23143901	SENT150	21	21	23	23	zanamivir	ZAN	PA164740891	7455	0.776
NULL	Evid_Based_Complement_Alternat_Med_2013_Mar_14_2013_429706.nxml.txt.nlp	23573127	SENT268	34	34	4	4	indomethacin	DAI	PA449982	81030	0.776
NULL	Arthritis_Res_Ther_2014_Apr_3_16(2)_R86.nxml.txt.nlp	24708674	SENT220	27	27	10	10	bosentan	Fli1	PA10034	2314	0.776
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT424	12	12	5	5	docetaxel	TFF3	PA449383	7033	0.776
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Oct_13_68(Pt_11)_o3104-o3105.nxml.txt.nlp	23284431	SENT75	12	12	6	6	ethanol	mol	PA448073	90527	0.776
NULL	Arthritis_Res_Ther_2014_Jul_18_16(4)_R153.nxml.txt.nlp	25037855	SENT111	25	25	11	11	adalimumab	CD14	PA10004	929	0.776
NULL	Cancer_Cell_Int_2013_Jan_15_13_3.nxml.txt.nlp	23320839	SENT35	2	2	15	15	gemcitabine	MRP3	PA449748	8714	0.776
NULL	Clin_Dev_Immunol_2011_Nov_3_2011_320571.nxml.txt.nlp	22110523	SENT201	26	26	11	11	irinotecan	SOX2	PA450085	6657	0.776
NULL	J_Hematol_Oncol_2011_Apr_20_4_16.nxml.txt.nlp	21504625	SENT48	0	0	2	2	nutlin-3	p53		7157	0.776
NULL	J_Cell_Biol_2002_May_28_157(5)_761-770.nxml.txt.nlp	12034770	SENT10	28	28	32	32	doxycycline	TFF1	PA449415	7031	0.776
NULL	Comp_Hepatol_2004_Jan_14_3(Suppl_1)_S37.nxml.txt.nlp	14960189	SENT105	6	6	13	13	thalidomide	TNF-alpha	PA451644	7124	0.776
NULL	Breast_Cancer_Res_2004_May_7_6(4)_R352-R365.nxml.txt.nlp	15217502	SENT142	3	3	17	17	estradiol	CYP1A2	PA449503	1544	0.776
NULL	J_Exp_Med_1996_Dec_1_184(6)_2341-2352.nxml.txt.nlp	8976188	SENT150	4	4	17	17	metrizamide	MLN	PA164742936	4295	0.776
NULL	Br_J_Cancer_2011_Apr_12_104(8)_1256-1261.nxml.txt.nlp	21448165	SENT161	24	24	15	15	sorafenib	IL-2	PA7000	3558	0.776
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1063.nxml.txt.nlp	24556678	SENT31	0	0	15	15	thioridazine	TRAIL	PA451666	8743	0.776
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT148	16	16	28	28	l-leucine	SIRT3	PA450197	23410	0.776
NULL	Pain_Res_Treat_2012_Aug_13_2012_621619.nxml.txt.nlp	22937238	SENT25	6	6	8	8	capsaicin	VR1	PA448776	56664	0.776
NULL	Cancers_(Basel)_2013_Nov_11_5(4)_1522-1544.nxml.txt.nlp	24351670	SENT193	18	18	25	25	etoposide	CD9	PA449552	928	0.776
NULL	Mol_Cancer_2009_Dec_10_8_118.nxml.txt.nlp	20003259	SENT128	2	2	13	13	sorafenib	VEGF-A	PA7000	7422	0.776
NULL	Oncotarget_2011_May_16_2(5)_418-421.nxml.txt.nlp	21789791	SENT33	32	32	34	34	bortezomib	TRAIL	PA10252	8743	0.776
NULL	Curr_Oncol_2009_May_16(Suppl_1)_S52-S59.nxml.txt.nlp	19478903	SENT282	1	1	5	5	verapamil	CYP3A4	PA451868	1576	0.776
NULL	Indian_J_Anaesth_2012_Jan-Feb_56(1)_98-99.nxml.txt.nlp	22529440	SENT32	0	0	12	12	bivalirudin	ACT	PA10032	12;11332;9457;641455	0.776
NULL	Biomed_Rep_2014_May_26_2(3)_344-348.nxml.txt.nlp	24748972	SENT34	13	13	23	23	trypsin	survivin	PA451806	332	0.776
NULL	Curr_Neuropharmacol_2013_May_11(3)_276-297.nxml.txt.nlp	24179464	SENT777	26	26	32	32	oxygen	CA1	PA450744	759	0.776
NULL	Front_Oncol_2013_Oct_29_3_269.nxml.txt.nlp	24195060	SENT119	34	34	5	5	paclitaxel	THBS1	PA450761	7057	0.776
NULL	Toxins_(Basel)_2010_Mar_31_2(4)_517-551.nxml.txt.nlp	22069598	SENT392	24	24	8	8	resveratrol	SIRT1		23411	0.776
NULL	Core_Evid_2010_Jul_27_5_1-10.nxml.txt.nlp	20694135	SENT159	15	15	7	7	entacapone	CLE	PA164748726	51637	0.776
NULL	Br_J_Pharmacol_2011_Oct_164(3)_866-883.nxml.txt.nlp	21323893	SENT320	17	17	20	20	thrombin	CD44	PA451674	960	0.776
NULL	Front_Oncol_2013_Apr_23_3_86.nxml.txt.nlp	23630663	SENT1084	22	22	2	2	trastuzumab	HER-2	PA451743	2064	0.776
NULL	Braz_J_Med_Biol_Res_2013_Jun_25_46(6)_528-532.nxml.txt.nlp	23802228	SENT83	5	5	26	26	rosiglitazone	Bcl-2	PA451283	596	0.776
NULL	Biomed_Res_Int_2014_Feb_19_2014_240642.nxml.txt.nlp	24701565	SENT55	23	23	18	18	doxorubicin	IL-6	PA449412	3569	0.776
NULL	Int_J_Mol_Sci_2012_Dec_5_13(12)_16624-16635.nxml.txt.nlp	23443122	SENT281	17	17	9	9	doxorubicin	MDR1	PA449412	5243	0.776
NULL	Patient_Prefer_Adherence_2008_Feb_2_2_387-392.nxml.txt.nlp	19920986	SENT148	7	7	17	17	cyclosporine	IFN	PA449167	3439	0.776
NULL	Oncogene_2013_Sep_5_32(36)_4252-4263.nxml.txt.nlp	23045288	SENT78	15	15	7	7	doxorubicin	CD49f	PA449412	3655	0.776
NULL	Indian_J_Endocrinol_Metab_2012_Jul-Aug_16(4)_542-547.nxml.txt.nlp	22837913	SENT69	13	13	3	3	amiodarone	AIT	PA448383	160728	0.776
NULL	Aging_(Albany_NY)_2014_Mar_29_6(3)_207-214.nxml.txt.nlp	24704640	SENT87	6	6	15	15	glucosamine	GFAT	PA164747613	2673	0.776
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT868	16	16	5	5	saquinavir	MRP2	PA451305	100130958;57626;1244	0.776
NULL	Mol_Cancer_2012_Mar_21_11_13.nxml.txt.nlp	22436134	SENT241	36	36	41	41	staurosporine	HuR	PA165109623	1994	0.776
NULL	Eur_J_Clin_Pharmacol_2008_Feb_26_64(2)_133-157.nxml.txt.nlp	18224312	SENT544	45	45	6	6	trimipramine	CYP2C9	PA451791	1559	0.776
NULL	Acta_Pharmacol_Sin_2011_Jan_29_32(1)_38-44.nxml.txt.nlp	21113177	SENT10	41	41	16	16	chloroquine	LC3	PA448948	84557	0.776
NULL	Ther_Clin_Risk_Manag_2006_Jun_2(2)_129-158.nxml.txt.nlp	18360588	SENT157	0	0	6	6	erythromycin	CYP3A4	PA449493	1576	0.776
NULL	Environ_Health_Perspect_1993_Dec_101(Suppl_5)_259-264.nxml.txt.nlp	8013417	SENT5	30	30	32	32	diethylstilbestrol	DES	PA449307	1674	0.776
NULL	Int_J_Appl_Basic_Med_Res_2013_Jul-Dec_3(2)_117-121.nxml.txt.nlp	24083147	SENT128	11	11	1	1	clopidogrel	ADP	PA449053	23038	0.776
NULL	Oncol_Lett_2014_Jul_25_8(1)_62-66.nxml.txt.nlp	24959219	SENT20	9	9	15	15	doxorubicin	CHOP	PA449412	1649	0.776
NULL	J_Thromb_Haemost_2010_Mar_8(3)_577-587.nxml.txt.nlp	20040043	SENT232	19	19	22	22	rosiglitazone	mol	PA451283	90527	0.776
NULL	Oncotarget_2014_Jun_3_5(13)_4920-4928.nxml.txt.nlp	24952482	SENT22	32	32	28	28	geldanamycin	Hsp90	PA152031327	3320	0.776
NULL	Cancer_Cell_Int_2004_Aug_17_4_5.nxml.txt.nlp	15315711	SENT84	31	31	27	27	genistein	PC3	PA165109660	57332;7832;5122	0.776
NULL	Br_J_Cancer_2010_Nov_2_103(11)_1671-1679.nxml.txt.nlp	21045835	SENT121	14	14	5	5	gemcitabine	CXCL12	PA449748	6387	0.776
NULL	Mol_Cancer_2013_Sep_30_12_112.nxml.txt.nlp	24073816	SENT343	7	7	38	38	phenol	CO2	PA450913	4513	0.776
NULL	Indian_J_Dermatol_2013_Mar-Apr_58(2)_159a.nxml.txt.nlp	23716826	SENT83	18	18	26	26	calcipotriol	gamma	PA448714	9913	0.776
NULL	Pharmaceuticals_(Basel)_2013_Apr_8_6(4)_500-509.nxml.txt.nlp	24276120	SENT2	33	33	39	39	fenoldopam	GPR35	PA164784034	2859	0.776
NULL	Oncol_Lett_2013_Feb_7_5(2)_440-446.nxml.txt.nlp	23420122	SENT12	29	29	19	19	gemcitabine	EGFR	PA449748	1956	0.776
NULL	Nat_Med_2011_May_1_17(5)_604-609.nxml.txt.nlp	21532597	SENT60	7	7	11	11	daclizumab	IL-2	PA164764446	3558	0.776
NULL	Clin_Ophthalmol_2010_Oct_21_4_1165-1171.nxml.txt.nlp	21060666	SENT122	5	5	7	7	latanoprost	BAK	PA164774763	578	0.776
NULL	Int_J_Gen_Med_2012_May_4_5_403-411.nxml.txt.nlp	22615536	SENT112	17	17	2	2	metformin	RBP4	PA450395	5433;5950	0.776
NULL	Diabetes_Metab_J_2012_Jun_14_36(3)_181-189.nxml.txt.nlp	22737657	SENT75	16	16	11	11	pioglitazone	adiponectin	PA450970	9370	0.776
NULL	Cent_European_J_Urol_2013_Apr_26_66(1)_39-44.nxml.txt.nlp	24578986	SENT87	38	38	23	23	carboplatin	ADM	PA448803	133	0.776
NULL	Breast_Cancer_Res_2008_Jul_16_10(4)_R60.nxml.txt.nlp	18631394	SENT149	14	14	16	16	capecitabine	HER2	PA448771	2064	0.776
NULL	Oncoimmunology_2012_Dec_1_1(9)_1557-1576.nxml.txt.nlp	23264902	SENT150	33	33	25	25	cyclophosphamide	GM-CSF	PA449165	1437	0.776
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Feb_6_69(Pt_3)_o345.nxml.txt.nlp	23476538	SENT63	12	12	35	35	coumarin	C15	PA134521193	51316	0.776
NULL	Cancer_Sci_2012_Sep_4_103(9)_1679-1687.nxml.txt.nlp	22625227	SENT80	15	15	8	8	cyclophosphamide	BCS	PA449165	617	0.776
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Sep_30_66(Pt_10)_o2686.nxml.txt.nlp	21587654	SENT54	18	18	33	33	ethanol	mol	PA448073	90527	0.776
NULL	Breast_Cancer_Res_2010_Jun_28_12(3)_R43.nxml.txt.nlp	20579400	SENT280	20	20	27	27	fulvestrant	MAPT	PA164747170	4137	0.776
NULL	Indian_J_Plast_Surg_2014_Jan-Apr_47(1)_102-108.nxml.txt.nlp	24987213	SENT137	19	19	12	12	thrombin	ATIII	PA451674	462	0.776
NULL	J_Carcinog_2013_Dec_31_12_22.nxml.txt.nlp	24574860	SENT235	30	30	35	35	docetaxel	KRAS	PA449383	3845	0.776
NULL	Nat_Neurosci_2012_Sep_5_15(9)_1245-1254.nxml.txt.nlp	22864611	SENT36	8	8	15	15	clozapine	mGlu2	PA449061	2912	0.776
NULL	Cancer_Immunol_Immunother_2013_Jul_20_62(9)_1533-1545.nxml.txt.nlp	23873089	SENT150	2	2	14	14	gemcitabine	CD69	PA449748	969	0.776
NULL	J_Immunol_Res_2014_May_21_2014_371087.nxml.txt.nlp	24963497	SENT206	0	0	21	21	decitabine	TRAIL	PA164749631	8743	0.776
NULL	Oncotarget_2014_Oct_21_5(22)_11709-11722.nxml.txt.nlp	25365944	SENT161	20	20	22	22	metformin	JNK	PA450395	5599	0.776
NULL	ISRN_Obstet_Gynecol_2011_Nov_24_2011_436936.nxml.txt.nlp	22191045	SENT87	7	7	0	0	trypsin	SLPI	PA451806	6590	0.776
NULL	Sensors_(Basel)_2010_Jan_12_10(1)_526-543.nxml.txt.nlp	22315554	SENT120	12	12	18	18	benzphetamine	2B4	PA448586	51744	0.776
NULL	Oncol_Lett_2014_Nov_12_8(5)_2203-2208.nxml.txt.nlp	25295109	SENT133	6	6	1	1	celecoxib	GLI1	PA448871	2735	0.776
NULL	FASEB_J_2008_Nov_22(11)_4005-4010.nxml.txt.nlp	18753249	SENT156	13	13	18	18	rofecoxib	COX	PA451268	1351	0.776
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT49	23	23	7	7	phenacetin	CYP2C8	PA450897	1558	0.776
NULL	Leukemia_2013_Jan_11_27(1)_32-40.nxml.txt.nlp	22781593	SENT90	3	3	26	26	ponatinib	IL3	PA165980594	3562	0.776
NULL	Acta_Pharmacol_Sin_2011_Sep_5_32(9)_1128-1137.nxml.txt.nlp	21892192	SENT273	6	6	15	15	hydroxyzine	HERG	PA449943	3757	0.776
NULL	Br_J_Cancer_2013_Feb_5_108(2)_334-341.nxml.txt.nlp	23257893	SENT262	5	5	33	33	sorafenib	MVD	PA7000	4597	0.776
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT73	5	5	14	14	neratinib	EGFR	PA165291472	1956	0.776
NULL	J_Cell_Mol_Med_2014_May_14_18(5)_811-823.nxml.txt.nlp	24628949	SENT138	43	43	16	16	docetaxel	FOXM1	PA449383	2305	0.776
NULL	Core_Evid_2009_Jun_15_4_25-36.nxml.txt.nlp	20694062	SENT325	32	32	13	13	sulfinpyrazone	ACTH	PA451550	5443	0.776
NULL	Interdiscip_Toxicol_2011_Mar_4(1)_33-39.nxml.txt.nlp	21577282	SENT100	5	5	8	8	methotrexate	Q10	PA450428	27161	0.776
NULL	Cardiovasc_Diabetol_2013_May_4_12_73.nxml.txt.nlp	23642288	SENT126	13	13	10	10	acarbose	GLP-1	PA448010	100125288	0.776
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Dec_16_66(Pt_1)_o140.nxml.txt.nlp	21580032	SENT61	11	11	26	26	ethanol	mol	PA448073	90527	0.776
NULL	Breast_Cancer_Res_2008_Jul_28_10(4)_R65.nxml.txt.nlp	18662380	SENT193	28	28	3	3	trastuzumab	HER2	PA451743	2064	0.776
NULL	AIDS_Res_Treat_2012_Mar_21_2012_186987.nxml.txt.nlp	22536495	SENT37	13	13	5	5	etravirine	TYPE	PA166014703	6445	0.776
NULL	Genome_Med_2010_Apr_28_2(4)_27.nxml.txt.nlp	20423530	SENT93	1	1	23	23	ethanol	H19	PA448073	283120	0.776
NULL	Mol_Brain_2013_Dec_16_6_56.nxml.txt.nlp	24330819	SENT210	0	0	5	5	dantrolene	c-fos	PA449208	2353	0.776
NULL	J_Res_Med_Sci_2012_May_17(5)_487-490.nxml.txt.nlp	23626617	SENT18	12	12	20	20	cyclophosphamide	CHOP	PA449165	1649	0.776
NULL	Eur_J_Nucl_Med_Mol_Imaging_2009_Dec_8_36(12)_2002-2013.nxml.txt.nlp	19585116	SENT310	10	10	34	34	flumazenil	NAC	PA449659	22861	0.776
NULL	Arthritis_Res_Ther_2007_Oct_9_9(5)_R104.nxml.txt.nlp	17925024	SENT95	7	7	39	39	glucosamine	MMP1	PA164747613	4312	0.776
NULL	Lab_Anim_Res_2014_Mar_24_30(1)_21-27.nxml.txt.nlp	24707301	SENT17	26	26	23	23	thrombin	ADP	PA451674	23038	0.776
NULL	Oncotarget_2010_Dec_25_1(8)_741-750.nxml.txt.nlp	21321383	SENT95	5	5	20	20	geldanamycin	JNK	PA152031327	5599	0.776
NULL	Cancer_Immunol_Immunother_2011_Jun_25_60(6)_793-808.nxml.txt.nlp	21350947	SENT176	9	9	7	7	sorafenib	IFN	PA7000	3439	0.776
NULL	Oncotarget_2013_Dec_17_5(1)_67-77.nxml.txt.nlp	24393766	SENT170	32	32	24	24	lapatinib	EGFR	PA152241907	1956	0.776
NULL	Oncol_Rep_2013_Apr_23_29(4)_1268-1274.nxml.txt.nlp	23354756	SENT181	3	3	16	16	epirubicin	SLC25A43	PA449476	203427	0.776
NULL	J_Antimicrob_Chemother_2013_Mar_9_68(3)_697-707.nxml.txt.nlp	23143901	SENT146	21	21	23	23	zanamivir	ZAN	PA164740891	7455	0.776
NULL	Int_J_Mol_Sci_2014_Sep_5_15(9)_15754-15765.nxml.txt.nlp	25198898	SENT73	0	0	2	2	curcumin	JNK	PA151958596	5599	0.776
NULL	Cardiovasc_Diabetol_2013_May_4_12_73.nxml.txt.nlp	23642288	SENT173	18	18	3	3	acarbose	GLP-1	PA448010	100125288	0.776
NULL	Semin_Immunopathol_2008_Apr_28_30(2)_165-177.nxml.txt.nlp	18305941	SENT269	0	0	14	14	lovastatin	Rho	PA450272	29984	0.776
NULL	Harm_Reduct_J_2012_Jan_13_9_3.nxml.txt.nlp	22243982	SENT200	4	4	21	21	methadone	Gen	PA450401	348654	0.776
NULL	EMBO_Mol_Med_2011_Nov_3(11)_623-636.nxml.txt.nlp	21953712	SENT194	8	8	32	32	trastuzumab	PTEN	PA451743	5728	0.776
NULL	Nat_Med_2011_Oct_2_17(10)_1304-1309.nxml.txt.nlp	21963515	SENT205	8	8	26	26	tacrolimus	SPAK	PA451578	27347	0.776
NULL	J_Gen_Physiol_1993_Jun_1_101(6)_909-931.nxml.txt.nlp	8331323	SENT0	12	12	1	1	heparin	Gen	PA449855	348654	0.776
NULL	Subst_Abuse_Rehabil_2011_Mar_16_2_11-20.nxml.txt.nlp	24474851	SENT39	6	6	9	9	ketamine	CYP3A4	PA450144	1576	0.776
NULL	Oncogene_2013_Oct_17_32(42)_5058-5065.nxml.txt.nlp	23160381	SENT81	16	16	23	23	docetaxel	p53	PA449383	7157	0.776
NULL	Comp_Hepatol_2004_Jan_14_3(Suppl_1)_S31.nxml.txt.nlp	14960183	SENT90	8	8	28	28	ethanol	TNF-alpha	PA448073	7124	0.776
NULL	Biomed_Res_Int_2014_Jan_23_2014_312647.nxml.txt.nlp	24587984	SENT187	23	23	12	12	infliximab	ABCG1	PA452639	9619	0.776
NULL	Clinics_(Sao_Paulo)_2013_Feb_68(2)_253-262.nxml.txt.nlp	23525324	SENT213	29	29	23	23	genistein	Gen	PA165109660	348654	0.776
NULL	Eur_J_Clin_Pharmacol_2012_Jan_7_68(1)_55-64.nxml.txt.nlp	21735164	SENT206	10	10	0	0	oxymorphone	CYP2D6	PA450748	1565	0.776
NULL	Curr_Neuropharmacol_2008_Sep_6(3)_215-234.nxml.txt.nlp	19506722	SENT450	17	17	21	21	fluoxetine	5-HT2A	PA449673	3356	0.776
NULL	Drug_Saf_2014_Feb_19_37(4)_201-211.nxml.txt.nlp	24550106	SENT310	7	7	12	12	rabeprazole	CYP2C19	PA451216	1557	0.776
NULL	BioData_Min_2008_Jul_17_1_2.nxml.txt.nlp	18822146	SENT178	12	12	26	26	ethanol	ADAM17	PA448073	6868	0.776
NULL	Br_J_Cancer_2013_Oct_1_109(7)_1717-1724.nxml.txt.nlp	24022187	SENT102	11	11	34	34	trabectedin	PTX3	PA165958349	5806	0.776
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT254	3	3	15	15	dasatinib	AKT	PA162372878	207	0.776
NULL	J_Nutr_Metab_2012_Apr_10_2012_431574.nxml.txt.nlp	22570769	SENT198	33	33	41	41	sertraline	P14	PA451333	11102;;6280;56259	0.776
NULL	Nat_Med_2012_Sep_18(9)_1413-1417.nxml.txt.nlp	22885997	SENT70	19	19	32	32	imipramine	GATA1	PA449969	2623	0.776
NULL	Mar_Drugs_2011_May_18_9(5)_863-878.nxml.txt.nlp	21673895	SENT170	24	24	21	21	ethanol	CO2	PA448073	4513	0.776
NULL	Niger_Med_J_2014_Jul-Aug_55(4)_327-332.nxml.txt.nlp	25114369	SENT15	24	24	21	21	streptomycin	EMB	PA451512	133418	0.776
NULL	Clin_Med_Insights_Circ_Respir_Pulm_Med_2013_Nov_13_7_61-77.nxml.txt.nlp	24324354	SENT130	12	12	30	30	tobramycin	TIP	PA451704	81533;79828	0.776
NULL	Br_J_Cancer_2010_Jul_13_103(2)_265-274.nxml.txt.nlp	20551953	SENT202	22	22	6	6	cisplatin	JNK	PA449014	5599	0.776
NULL	Ann_Hematol_2014_Sep_10_93(1)_1-11.nxml.txt.nlp	24018623	SENT128	5	5	11	11	lenalidomide	p53	PA162363968	7157	0.776
NULL	Eur_J_Clin_Pharmacol_2012_Jan_8_68(1)_29-37.nxml.txt.nlp	21739267	SENT93	6	6	25	25	aripiprazole	PRX	PA10026	9588;57716	0.776
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT132	15	15	0	0	simvastatin	AKT	PA451363	207	0.776
NULL	Biomed_Res_Int_2014_May_12_2014_261745.nxml.txt.nlp	24900960	SENT365	26	26	4	4	ethanol	ANOVA	PA448073	4858	0.776
NULL	Autophagy_2013_Jan_1_9(1)_20-32.nxml.txt.nlp	23075929	SENT87	27	27	8	8	chloroquine	SQSTM1	PA448948	8878	0.776
NULL	Clin_Drug_Investig_2015_Dec_4_35_45-51.nxml.txt.nlp	25471740	SENT146	34	34	30	30	rosiglitazone	CYP2C9	PA451283	1559	0.776
NULL	Toxins_(Basel)_2010_Mar_31_2(4)_517-551.nxml.txt.nlp	22069598	SENT371	5	5	25	25	resveratrol	TRAIL		8743	0.776
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT160	8	8	2	2	trastuzumab	MUC4	PA451743	4585	0.776
NULL	J_Gastrointest_Surg_2012_Apr_13_16(4)_842-848.nxml.txt.nlp	22246855	SENT96	10	10	15	15	cetuximab	BTC	PA10040	685	0.776
NULL	J_Hematol_Oncol_2012_Sep_18_5_57.nxml.txt.nlp	22989009	SENT202	7	7	35	35	nutlin-3	p53		7157	0.776
NULL	EMBO_Mol_Med_2013_Mar_5_5(3)_384-396.nxml.txt.nlp	23495140	SENT114	14	14	28	28	tetracycline	CD24	PA451640	100133941	0.776
NULL	J_Hematol_Oncol_2009_Apr_22_2_18.nxml.txt.nlp	19386128	SENT107	45	45	23	23	irinotecan	KRAS	PA450085	3845	0.776
NULL	Case_Rep_Rheumatol_2011_Dec_15_2011_185657.nxml.txt.nlp	22937439	SENT75	11	11	23	23	etanercept	TNF-alpha	PA449515	7124	0.776
NULL	Am_J_Rhinol_Allergy_2013_Nov-Dec_27(6)_482-489.nxml.txt.nlp	24274224	SENT145	16	16	6	6	zileuton	LTA	PA451955	4049	0.776
NULL	Arch_Plast_Surg_2013_Mar_11_40(2)_141-153.nxml.txt.nlp	23529264	SENT214	15	15	24	24	abatacept	CD86	PA164747080	942	0.776
NULL	Arthritis_Res_Ther_2005_Mar_30_7(3)_111-113.nxml.txt.nlp	15899059	SENT13	33	33	41	41	infliximab	IL-6	PA452639	3569	0.776
NULL	Infect_Drug_Resist_2010_Oct_13_3_103-114.nxml.txt.nlp	21694899	SENT248	8	8	15	15	etravirine	TRIO	PA166014703	7204	0.776
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT207	11	11	4	4	perifosine	DR4	PA165291471	8797	0.776
NULL	Front_Genet_2014_Nov_14_5_391.nxml.txt.nlp	25452763	SENT1202	15	15	2	2	cisplatin	XRCC1	PA449014	7515	0.776
NULL	J_Headache_Pain_2013_Feb_21_14(Suppl_1)_P75.nxml.txt.nlp	NULL	SENT16	12	12	16	16	dihydroergotamine	CYP3A4	PA164743028	1576	0.776
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1137-1144.nxml.txt.nlp	20234366	SENT121	17	17	19	19	cetuximab	BRAF	PA10040	673	0.776
NULL	Clin_Mol_Hepatol_2014_Sep_25_20(3)_283-290.nxml.txt.nlp	25320732	SENT135	11	11	14	14	propranolol	EVL	PA451145	51466	0.776
NULL	J_Mol_Med_(Berl)_2014_May_10_92(7)_709-722.nxml.txt.nlp	24811491	SENT158	19	19	12	12	cetuximab	EGFR	PA10040	1956	0.776
NULL	EMBO_Mol_Med_2013_Aug_4_5(8)_1180-1195.nxml.txt.nlp	23828858	SENT174	27	27	20	20	rituximab	MYC	PA451261	4609	0.776
NULL	Neural_Plast_2007_Jan_1_2007_30585.nxml.txt.nlp	25148070	SENT3514	14	14	22	22	paroxetine	PAC1	PA450801	8624;1316;117	0.776
NULL	Mol_Cancer_2010_May_20_9_115.nxml.txt.nlp	20487546	SENT240	32	32	23	23	fludarabine	p27	PA449655	5715;10534	0.776
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_May_16_68(Pt_6)_o1747.nxml.txt.nlp	22719532	SENT74	0	0	6	6	cinnarizine	mol	PA164749342	90527	0.776
NULL	Oncol_Lett_2014_May_27_7(5)_1613-1617.nxml.txt.nlp	24765188	SENT108	12	12	8	8	gemcitabine	CTX	PA449748	1593	0.776
NULL	Front_Physiol_2012_Nov_26_3_443.nxml.txt.nlp	23189061	SENT381	2	2	5	5	capsaicin	VR1	PA448776	56664	0.776
NULL	Cell_Death_Dis_2013_Jul_18_4(7)_e730.nxml.txt.nlp	23868063	SENT56	6	6	0	0	bortezomib	PES	PA10252	23481	0.776
NULL	Br_J_Cancer_2012_Aug_21_107(5)_793-799.nxml.txt.nlp	22850551	SENT107	34	34	38	38	trastuzumab	p27	PA451743	5715;10534	0.776
NULL	Adv_Biomed_Res_2013_Jul_30_2_54.nxml.txt.nlp	24223369	SENT105	2	2	17	17	fenofibrate	AMPK	PA449594	5563	0.776
NULL	J_Oncol_2013_Feb_17_2013_872957.nxml.txt.nlp	23476648	SENT186	10	10	2	2	cisplatin	SFN	PA449014	25996;2810	0.776
NULL	Oncoimmunology_2012_Nov_1_1(8)_1422-1424.nxml.txt.nlp	23243615	SENT24	11	11	19	19	estradiol	aromatase	PA449503	1588	0.776
NULL	Reprod_Biol_Endocrinol_2013_Feb_26_11_15.nxml.txt.nlp	23442442	SENT193	5	5	15	15	l-arginine	BAX	PA448478	581	0.776
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT296	26	26	18	18	atorvastatin	PIK3CA	PA448500	5290	0.776
NULL	Arthritis_Res_Ther_2011_Jan_11_13(1)_R3.nxml.txt.nlp	21223583	SENT169	9	9	18	18	bleomycin	TLR3	PA448645	7098	0.776
NULL	Cell_Cycle_2013_Feb_15_12(4)_625-634.nxml.txt.nlp	23324396	SENT185	29	29	19	19	doxycycline	p53	PA449415	7157	0.776
NULL	Mol_Cancer_2012_Jul_25_11_46.nxml.txt.nlp	22830422	SENT140	5	5	2	2	rolipram	AKT	PA153906323	207	0.776
NULL	Genet_Mol_Biol_2009_Sep_1_Jul-Sep_32(3)_516-520.nxml.txt.nlp	21637514	SENT82	12	12	6	6	estradiol	EGF	PA449503	1950	0.776
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT132	41	41	34	34	cisplatin	IBP	PA449014	706;50619	0.776
NULL	Breast_Cancer_Res_2011_Jun_29_13(3)_R70.nxml.txt.nlp	21707964	SENT3	48	48	31	31	tamoxifen	14-3-3	PA451581	10971	0.776
NULL	Front_Oncol_2014_Jun_11_4_145.nxml.txt.nlp	24967214	SENT163	3	3	16	16	doxorubicin	PD-L1	PA449412	29126	0.776
NULL	Mol_Vis_2011_May_27_17_1397-1404.nxml.txt.nlp	21655359	SENT79	9	9	22	22	paraformaldehyde	p63	PA450790	8626	0.776
NULL	Mol_Pain_2014_Apr_9_10_24.nxml.txt.nlp	24716552	SENT46	2	2	11	11	capsaicin	NK1R	PA448776	6869	0.776
NULL	Oncogene_2010_Mar_11_29(10)_1509-1518.nxml.txt.nlp	19946334	SENT109	20	20	9	9	bortezomib	pS2	PA10252	7031	0.776
NULL	Int_J_Biomed_Sci_2013_Sep_9(3)_112-122.nxml.txt.nlp	24170986	SENT112	2	2	22	22	benazepril	VCAM1	PA448561	7412	0.776
NULL	J_Cell_Biol_2001_Apr_2_153(1)_207-220.nxml.txt.nlp	11285286	SENT466	0	0	2	2	carbachol	DGK	PA448784	8526;1607	0.776
NULL	Acta_Pharmacol_Sin_2010_May_5_31(5)_523-530.nxml.txt.nlp	20364156	SENT119	24	24	2	2	dexmedetomidine	ANOVA	PA449256	4858	0.776
NULL	Cell_Commun_Signal_2013_Nov_11_11_86.nxml.txt.nlp	24215724	SENT31	14	14	5	5	thrombin	PAR3	PA451674	56288;2151	0.776
NULL	J_Neurosci_Rural_Pract_2012_Jan-Apr_3(1)_105-106.nxml.txt.nlp	22346220	SENT16	0	0	17	17	curcumin	CA1	PA151958596	759	0.776
NULL	J_Thromb_Haemost_2007_May_1_5(5)_910-917.nxml.txt.nlp	17362227	SENT43	5	5	16	16	thrombin	ADP	PA451674	23038	0.776
NULL	Front_Endocrinol_(Lausanne)_2011_Nov_10_2_72.nxml.txt.nlp	22649383	SENT211	0	0	19	19	ethanol	StAR	PA448073	6770	0.776
NULL	Viruses_2014_Oct_7_6(10)_3787-3808.nxml.txt.nlp	25296112	SENT582	8	8	16	16	rifampin	p65	PA451250	5970	0.776
NULL	Genome_Biol_2008_Feb_14_9(2)_R32.nxml.txt.nlp	18275597	SENT384	15	15	20	20	phenylephrine	p42	PA450935	5706;23552	0.776
NULL	Br_J_Cancer_2012_Jul_24_107(3)_435-441.nxml.txt.nlp	22767144	SENT146	39	39	13	13	capecitabine	TEF	PA448771	7008	0.776
NULL	Adolesc_Health_Med_Ther_2012_Jun_20_3_85-93.nxml.txt.nlp	24600289	SENT72	24	24	7	7	adalimumab	ACR	PA10004	49	0.776
NULL	Biol_Open_2013_Apr_9_2(6)_535-545.nxml.txt.nlp	23789104	SENT130	19	19	29	29	arsenite	p38	PA452638	10598;1432;7965	0.776
NULL	Anticancer_Agents_Med_Chem_2012_Feb_12(2)_163-171.nxml.txt.nlp	22043994	SENT178	31	31	18	18	panitumumab	KRAS	PA162373091	3845	0.776
NULL	Exp_Brain_Res_2014_Jun_27_232(8)_2637-2644.nxml.txt.nlp	24969614	SENT152	9	9	18	18	palonosetron	NK1	PA10352	11126	0.776
NULL	Nat_Med_2012_Jul_18(7)_1118-1122.nxml.txt.nlp	22683780	SENT118	26	26	31	31	crizotinib	MET	PA165946122	4233	0.776
NULL	J_Occup_Med_Toxicol_2008_Feb_27_3(Suppl_1)_S6.nxml.txt.nlp	18315837	SENT71	7	7	24	24	salmeterol	IL-13	PA451300	3596	0.776
NULL	J_Biol_Chem_2013_Nov_15_288(46)_33049-33059.nxml.txt.nlp	24089524	SENT253	7	7	17	17	nicotine	GATA6	PA450626	2627	0.776
NULL	Eur_Arch_Otorhinolaryngol_2012_Mar_8_269(3)_939-946.nxml.txt.nlp	21739092	SENT165	27	27	25	25	cisplatin	CRT	PA449014	811	0.776
NULL	Oncol_Rep_2012_Apr_30_27(4)_923-928.nxml.txt.nlp	22209766	SENT138	14	14	9	9	erlotinib	PI3K	PA134687924	5290	0.776
NULL	Cell_Commun_Signal_2013_Nov_11_11_86.nxml.txt.nlp	24215724	SENT477	25	25	13	13	irbesartan	PAR1	PA450084	79581;2149	0.776
NULL	J_Mol_Signal_2010_Jun_11_5_6.nxml.txt.nlp	20540776	SENT131	7	7	3	3	etoposide	CRM1	PA449552	7514	0.776
NULL	Mol_Imaging_Radionucl_Ther_2011_Dec_1_20(3)_114-116.nxml.txt.nlp	23486704	SENT34	12	12	4	4	metformin	FDG	PA450395	23583	0.776
NULL	Crit_Care_2010_Jul_9_14(4)_R131.nxml.txt.nlp	20615266	SENT55	7	7	40	40	aprotinin	CXCL12	PA448472	6387	0.776
NULL	Int_J_Surg_Oncol_2012_May_17_2012_406830.nxml.txt.nlp	22675625	SENT51	8	8	28	28	cetuximab	KRAS	PA10040	3845	0.776
NULL	Sci_Rep_2014_Nov_28_4_7237.nxml.txt.nlp	25429875	SENT39	4	4	22	22	hesperidin	JNK	PA449867	5599	0.776
NULL	Br_J_Cancer_2009_Jul_21_101(2)_238-243.nxml.txt.nlp	19568242	SENT104	9	9	13	13	sunitinib	IFN	PA162372840	3439	0.776
NULL	Apoptosis_2014_Apr_23_19(7)_1055-1068.nxml.txt.nlp	24756955	SENT313	0	0	12	12	metformin	p53	PA450395	7157	0.776
NULL	Infect_Dis_Ther_2013_Dec_19_2(2)_83-93.nxml.txt.nlp	25134473	SENT204	14	14	20	20	etravirine	TRIO	PA166014703	7204	0.776
NULL	Cancer_Immunol_Immunother_2012_Nov_11_61(11)_1953-1963.nxml.txt.nlp	22491788	SENT229	28	28	10	10	imiquimod	CD4	PA449972	920	0.776
NULL	J_Breast_Cancer_2013_Jun_28_16(2)_164-170.nxml.txt.nlp	23843848	SENT55	14	14	35	35	doxorubicin	PTEN	PA449412	5728	0.776
NULL	Case_Rep_Neurol_2012_Aug_22_4(2)_131-136.nxml.txt.nlp	22949911	SENT108	35	35	6	6	heparin	VIII	PA449855	1351	0.776
NULL	Front_Neurosci_2011_Feb_2_5_12.nxml.txt.nlp	21344007	SENT215	6	6	26	26	capsaicin	NR1	PA448776	27158	0.776
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Oct_31_65(Pt_11)_o2938.nxml.txt.nlp	21578514	SENT51	25	25	40	40	ethanol	mol	PA448073	90527	0.776
NULL	J_Cell_Mol_Med_2014_Oct_11_18(10)_2031-2043.nxml.txt.nlp	25109475	SENT278	18	18	14	14	valsartan	STZ	PA451848	6484	0.776
NULL	J_Cell_Mol_Med_2014_May_7_18(5)_766-779.nxml.txt.nlp	24606538	SENT290	19	19	10	10	methylprednisolone	EGFR	PA450466	1956	0.776
NULL	Mar_Drugs_2014_Nov_20_12(11)_5576-5589.nxml.txt.nlp	25419998	SENT544	11	11	3	3	metformin	AKT	PA450395	207	0.776
NULL	Oncotarget_2014_Oct_16_5(22)_11442-11451.nxml.txt.nlp	25347345	SENT40	7	7	16	16	oxaliplatin	CT26	PA131285527	168400	0.776
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_55-78.nxml.txt.nlp	19305788	SENT488	0	0	18	18	scopolamine	EPM	PA451308	2054	0.776
NULL	Mol_Cancer_2009_Dec_3_8_115.nxml.txt.nlp	19958544	SENT3	9	9	5	5	nutlin-3	MDM2		4193	0.776
NULL	Cell_Death_Dis_2014_Apr_24_5(4)_e1197.nxml.txt.nlp	24763054	SENT72	12	12	7	7	cisplatin	ARC	PA449014	8996;23237	0.776
NULL	Sci_Rep_2014_Dec_1_4_7268.nxml.txt.nlp	25434695	SENT211	0	0	12	12	erlotinib	EGFR	PA134687924	1956	0.776
NULL	Br_J_Pharmacol_2008_Nov_11_155(6)_896-905.nxml.txt.nlp	18695641	SENT190	2	2	25	25	alendronate	CTX	PA448082	1593	0.776
NULL	Arch_Med_Sci_2013_Oct_31_9(5)_936-943.nxml.txt.nlp	24273582	SENT37	46	46	39	39	repaglinide	SUR2	PA451234	10060	0.776
NULL	Behav_Neurol_2014_Nov_16_2014_360978.nxml.txt.nlp	25477708	SENT145	5	5	8	8	nicotine	P28	PA450626	9446;7802;9527	0.776
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Nov_8_64(Pt_12)_o2286-o2287.nxml.txt.nlp	21581265	SENT83	19	19	11	11	benzaldehyde	mol	PA448571	90527	0.776
NULL	Carbon_Balance_Manag_2010_Jun_17_5_3.nxml.txt.nlp	20565736	SENT170	15	15	31	31	ethanol	CO2	PA448073	4513	0.776
NULL	Diabetes_Metab_Syndr_Obes_2009_May_5_2_11-21.nxml.txt.nlp	21437115	SENT34	15	15	42	42	colestipol	B18	PA449096	59271;4713	0.776
NULL	Oncotarget_2013_Aug_30_4(10)_1698-1711.nxml.txt.nlp	24091605	SENT183	21	21	34	34	cisplatin	POU5F1	PA449014	5460	0.776
NULL	Oxid_Med_Cell_Longev_2012_Jan_19_2012_390678.nxml.txt.nlp	22315655	SENT42	14	14	16	16	gliclazide	NAC	PA10892	22861	0.776
NULL	Breast_Cancer_Res_Treat_2012_Jul_24_134(1)_13-20.nxml.txt.nlp	22198412	SENT242	12	12	16	16	pertuzumab	HER2		2064	0.776
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2014_Jun_29_70(Pt_7)_1922-1933.nxml.txt.nlp	25004969	SENT14	16	16	14	14	cycloserine	PLP	PA164764600	25824;5744	0.776
NULL	J_Cell_Biol_2002_Nov_25_159(4)_637-648.nxml.txt.nlp	12438416	SENT140	15	15	3	3	staurosporine	p115	PA165109623	8615;393	0.776
NULL	Cancer_Cell_Int_2013_Mar_4_13_21.nxml.txt.nlp	23497288	SENT71	12	12	9	9	doxorubicin	EWS	PA449412	2130	0.776
NULL	Indian_J_Urol_2009_Apr-Jun_25(2)_186-189.nxml.txt.nlp	19672343	SENT49	21	21	8	8	cyclophosphamide	GTS	PA449165	2973	0.776
NULL	J_Cardiothorac_Surg_2013_Sep_11_8(Suppl_1)_P109.nxml.txt.nlp	NULL	SENT17	18	18	9	9	protamine	ACT	PA10366	12;11332;9457;641455	0.776
NULL	Biomed_Res_Int_2014_Jan_16_2014_821513.nxml.txt.nlp	24527458	SENT118	17	17	22	22	ketamine	NAC	PA450144	22861	0.776
NULL	Lipids_Health_Dis_2011_Feb_28_10_38.nxml.txt.nlp	21352602	SENT198	29	29	8	8	ezetimibe	PCSK9	PA10816	255738	0.776
NULL	Arthritis_Res_Ther_2010_Mar_25_12(2)_R54.nxml.txt.nlp	20338043	SENT150	4	4	18	18	rituximab	CD19	PA451261	930	0.776
NULL	J_Cell_Biol_2001_Mar_5_152(5)_971-984.nxml.txt.nlp	11238453	SENT90	6	6	28	28	paraformaldehyde	PYK2	PA450790	2185	0.775
NULL	Mol_Biol_Cell_2013_Jul_1_24(13)_2124-2133.nxml.txt.nlp	23657815	SENT282	12	12	3	3	galactose	GAL	PA449725	51083	0.775
NULL	Cancer_Cell_Int_2009_Feb_17_9_4.nxml.txt.nlp	19222856	SENT195	10	10	14	14	cisplatin	p53	PA449014	7157	0.775
NULL	Indian_J_Med_Res_2012_Dec_136(6)_926-941.nxml.txt.nlp	23391788	SENT137	13	13	19	19	cangrelor	PAR-1	PA165945763	2011;2149	0.775
NULL	Acta_Ortop_Bras_2012_20(5)_258-261.nxml.txt.nlp	24453613	SENT2	18	18	22	22	bupivacaine	ACL	PA135057240	47	0.775
NULL	Br_J_Cancer_2013_Jul_23_109(2)_351-359.nxml.txt.nlp	23799854	SENT246	7	7	4	4	paclitaxel	BLT2	PA450761	56413	0.775
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT49	34	34	5	5	diclofenac	CYP1A2	PA449293	1544	0.775
NULL	Exp_Diabetes_Res_2012_Oct_15_2012_465282.nxml.txt.nlp	23118742	SENT9	20	20	18	18	metformin	FGF21	PA450395	26291	0.775
NULL	Acta_Pharmacol_Sin_2010_Jul_28_31(7)_867-873.nxml.txt.nlp	20581857	SENT101	31	31	28	28	docetaxel	PC3	PA449383	57332;7832;5122	0.775
NULL	Exp_Ther_Med_2014_Mar_19_7(3)_669-674.nxml.txt.nlp	24520265	SENT5	21	21	23	23	bleomycin	BLM	PA448645	641	0.775
NULL	Mol_Vis_2007_Dec_17_13_2282-2288.nxml.txt.nlp	18199969	SENT34	16	16	31	31	l-glutamine	FBS	PA10090	64319;26269	0.775
NULL	Ther_Clin_Risk_Manag_2007_Jun_3(2)_333-339.nxml.txt.nlp	18360642	SENT87	12	12	22	22	ondansetron	NNT	PA450705	23530	0.775
NULL	Adv_Hematol_2012_Feb_28_2012_843085.nxml.txt.nlp	22505939	SENT103	0	0	5	5	perifosine	AKT	PA165291471	207	0.775
NULL	Cardiovasc_Psychiatry_Neurol_2009_Oct_13_2009_475108.nxml.txt.nlp	20029624	SENT76	17	17	20	20	ketanserin	5-HT2A	PA131053734	3356	0.775
NULL	Arthritis_Res_Ther_2010_Dec_21_12(6)_223.nxml.txt.nlp	21205285	SENT73	33	33	13	13	losartan	URAT1	PA450268	116085	0.775
NULL	Int_J_Mol_Sci_2014_Oct_8_15(10)_17974-17999.nxml.txt.nlp	25299695	SENT116	19	19	28	28	curcumin	HO-2	PA151958596	3163	0.775
NULL	Nat_Med_2013_Mar_10_19(3)_313-321.nxml.txt.nlp	23396211	SENT72	0	0	13	13	amlexanox	TBK1	PA164745310	29110	0.775
NULL	Oncotarget_2014_Aug_4_5(17)_7776-7787.nxml.txt.nlp	25277200	SENT181	32	32	12	12	paclitaxel	ANXA4	PA450761	307	0.775
NULL	Sci_Rep_2014_Dec_3_4_7298.nxml.txt.nlp	25466238	SENT263	0	0	9	9	chloroquine	UCHL1	PA448948	7345	0.775
NULL	Open_Biochem_J_2009_Dec_11_3_78-84.nxml.txt.nlp	20111725	SENT94	18	18	8	8	morphine	CB1	PA450550	1268	0.775
NULL	Acta_Pharmacol_Sin_2012_May_4_33(5)_644-651.nxml.txt.nlp	22555371	SENT20	2	2	11	11	irbesartan	eNOS	PA450084	4846	0.775
NULL	Pancreas_2014_Nov_24_43(8)_1223-1231.nxml.txt.nlp	25275271	SENT91	10	10	34	34	lipase	GLP-1	PA450239	100125288	0.775
NULL	Hum_Genomics_2009_Dec_1_4(2)_91-106.nxml.txt.nlp	20038497	SENT68	5	5	8	8	donepezil	CYP2D6	PA449394	1565	0.775
NULL	Aging_(Albany_NY)_2012_Mar_12_4(3)_146-158.nxml.txt.nlp	22436213	SENT52	30	30	7	7	resveratrol	SIRT1		23411	0.775
NULL	AAPS_J_2014_Jun_11_16(5)_1029-1037.nxml.txt.nlp	24917180	SENT126	19	19	36	36	tariquidar	ANOVA		4858	0.775
NULL	Cancer_Manag_Res_2014_Sep_10_6_349-356.nxml.txt.nlp	25228821	SENT77	11	11	3	3	dasatinib	KIT	PA162372878	3815	0.775
NULL	Br_J_Cancer_2010_Oct_12_103(8)_1284-1291.nxml.txt.nlp	20859285	SENT55	32	32	5	5	tamoxifen	BCAR4	PA451581	400500	0.775
NULL	Arthritis_Res_Ther_2011_Jun_16_13(3)_R90.nxml.txt.nlp	21679445	SENT59	8	8	16	16	isoflurane	San	PA450106	80218	0.775
NULL	Anal_Chem_Insights_2007_Nov_14_2_93-106.nxml.txt.nlp	19662183	SENT184	10	10	0	0	imatinib	P-gp	PA10804	5243	0.775
NULL	Interdiscip_Toxicol_2011_Mar_4(1)_40-46.nxml.txt.nlp	21577283	SENT52	18	18	34	34	sulodexide	STZ	PA164746343	6484	0.775
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Feb_20_69(Pt_3)_m162-m163.nxml.txt.nlp	23476505	SENT79	25	25	2	2	ethanol	NO3	PA448073	4681	0.775
NULL	J_Anim_Sci_Biotechnol_2013_Jun_26_4(1)_23.nxml.txt.nlp	23800120	SENT136	20	20	33	33	estradiol	IFNG	PA449503	3458	0.775
NULL	Ann_Clin_Transl_Neurol_2014_Mar_3_1(3)_190-198.nxml.txt.nlp	24839611	SENT16	19	19	27	27	memantine	GRIN2A	PA10364	2903	0.775
NULL	Am_J_Case_Rep_2012_Jun_20_13_118-121.nxml.txt.nlp	23569505	SENT77	0	0	3	3	heparin	PF4	PA449855	5196	0.775
NULL	Mol_Cancer_2009_Dec_23_8_129.nxml.txt.nlp	20030852	SENT190	11	11	15	15	curcumin	p65	PA151958596	5970	0.775
NULL	Lipids_Health_Dis_2011_Feb_28_10_38.nxml.txt.nlp	21352602	SENT94	10	10	23	23	atorvastatin	PCSK9	PA448500	255738	0.775
NULL	Acta_Histochem_Cytochem_2012_Apr_26_45(2)_139-146.nxml.txt.nlp	22685356	SENT115	14	14	0	0	forskolin	AQP2	PA146096022	359	0.775
NULL	Oncotarget_2012_Dec_18_3(12)_1615-1628.nxml.txt.nlp	23271044	SENT219	11	11	33	33	temsirolimus	4E-BP1	PA164746890	1978	0.775
NULL	BMB_Rep_2014_Oct_47(10)_569-574.nxml.txt.nlp	24499676	SENT102	9	9	12	12	hemin	HO-1	PA449849	3162	0.775
NULL	Lipids_Health_Dis_2011_Jan_18_10_8.nxml.txt.nlp	21241519	SENT116	3	3	9	9	simvastatin	ABCA1	PA451363	19	0.775
NULL	Cancer_Cell_2013_Jul_8_24(1)_15-29.nxml.txt.nlp	23845441	SENT177	18	18	12	12	gefitinib	EGFR	PA131301952	1956	0.775
NULL	Oncotarget_2014_Oct_9_5(20)_9564-9576.nxml.txt.nlp	25333255	SENT174	7	7	29	29	flavopiridol	STAT1	PA452627	6772	0.775
NULL	Ann_Med_Health_Sci_Res_2013_Oct-Dec_3(4)_498-503.nxml.txt.nlp	24379998	SENT86	8	8	16	16	cyclophosphamide	CD4	PA449165	920	0.775
NULL	Protein_Cell_2014_Jul_2_5(7)_544-551.nxml.txt.nlp	24691905	SENT65	32	32	12	12	doxorubicin	p53	PA449412	7157	0.775
NULL	Neural_Regen_Res_2013_Jul_25_8(21)_1925-1937.nxml.txt.nlp	25206501	SENT112	38	38	26	26	atorvastatin	HO-1	PA448500	3162	0.775
NULL	J_Cancer_2013_Jan_11_4(2)_117-132.nxml.txt.nlp	23386910	SENT227	24	24	39	39	trastuzumab	HER3	PA451743	2065	0.775
NULL	Breast_Cancer_Res_2007_Mar_2_9(2)_205.nxml.txt.nlp	NULL	SENT116	8	8	2	2	trastuzumab	PTEN	PA451743	5728	0.775
NULL	Nat_Med_2013_Sep_11_19(9)_1147-1152.nxml.txt.nlp	23933984	SENT116	34	34	10	10	ethanol	PEN	PA448073	9933	0.775
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT434	26	26	29	29	forskolin	IL-6	PA146096022	3569	0.775
NULL	Ther_Clin_Risk_Manag_2007_Jun_3(3)_363-379.nxml.txt.nlp	18488081	SENT97	14	14	11	11	rabeprazole	CYP2C19	PA451216	1557	0.775
NULL	Neuropsychopharmacology_2009_Sep_3_34(10)_2227-2236.nxml.txt.nlp	19494805	SENT34	41	41	17	17	bupropion	STAR	PA448687	6770;2984	0.775
NULL	Breast_Cancer_Res_2011_Apr_15_13(2)_R44.nxml.txt.nlp	21496232	SENT4	26	26	15	15	erlotinib	HER2	PA134687924	2064	0.775
NULL	Chin_J_Cancer_2011_Sep_30(9)_638-644.nxml.txt.nlp	21880185	SENT115	7	7	2	2	tamoxifen	aromatase	PA451581	1588	0.775
NULL	Acta_Pharmacol_Sin_2010_Aug_19_31(8)_963-969.nxml.txt.nlp	20644547	SENT189	2	2	7	7	fenofibrate	PDX-1	PA449594	3651	0.775
NULL	Cancer_Cell_Int_2010_Sep_9_10_32.nxml.txt.nlp	20828393	SENT157	15	15	12	12	cisplatin	ATF3	PA449014	467	0.775
NULL	Br_J_Cancer_2012_Nov_20_107(11)_1844-1852.nxml.txt.nlp	23169337	SENT219	14	14	24	24	bortezomib	SP1	PA10252	6667	0.775
NULL	Biomed_Res_Int_2014_Jun_26_2014_161346.nxml.txt.nlp	25054130	SENT216	41	41	30	30	curcumin	STZ	PA151958596	6484	0.775
NULL	Arch_Gynecol_Obstet_2012_May_30_285(5)_1447-1453.nxml.txt.nlp	22127553	SENT40	12	12	1	1	epirubicin	TEC	PA449476	7006	0.775
NULL	Genet_Mol_Biol_2009_Sep_1_Jul-Sep_32(3)_516-520.nxml.txt.nlp	21637514	SENT6	5	5	9	9	estradiol	MMP2	PA449503	4313	0.775
NULL	BMB_Rep_2013_Aug_46(8)_410-415.nxml.txt.nlp	23977989	SENT26	0	0	2	2	curcumin	HO-1	PA151958596	3162	0.775
NULL	Pediatr_Cardiol_2010_Jan_14_31(1)_90-95.nxml.txt.nlp	19915892	SENT152	12	12	26	26	palivizumab	Era	PA164748781	2099	0.775
NULL	Ther_Clin_Risk_Manag_2007_Jun_3(2)_333-339.nxml.txt.nlp	18360642	SENT87	28	28	22	22	methotrexate	NNT	PA450428	23530	0.775
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2007_Dec_6_64(Pt_1)_o198.nxml.txt.nlp	21200763	SENT59	11	11	27	27	ethanol	mol	PA448073	90527	0.775
NULL	Am_J_Trop_Med_Hyg_2010_Dec_6_83(6)_1221-1229.nxml.txt.nlp	21118925	SENT129	11	11	8	8	piperaquine	ACT	PA166104279	12;11332;9457;641455	0.775
NULL	Drug_Des_Devel_Ther_2014_Sep_23_8_1527-1538.nxml.txt.nlp	25284985	SENT11	10	10	8	8	celecoxib	IFN	PA448871	3439	0.775
NULL	Mar_Drugs_2014_Jun_27_12(7)_3818-3837.nxml.txt.nlp	24979269	SENT48	12	12	23	23	calcein	P-gp	PA132595336	5243	0.775
NULL	Acta_Pharmacol_Sin_2011_Oct_15_32(10)_1233-1238.nxml.txt.nlp	21841815	SENT83	0	0	6	6	mecamylamine	CTX	PA450334	1593	0.775
NULL	Chin_J_Cancer_2011_May_30(5)_287-292.nxml.txt.nlp	21527061	SENT65	16	16	7	7	gefitinib	EGFR	PA131301952	1956	0.775
NULL	Biologics_2012_Sep_25_6_337-345.nxml.txt.nlp	23055691	SENT52	24	24	17	17	cisplatin	EGFR	PA449014	1956	0.775
NULL	Nucleic_Acids_Res_2012_Apr_16_40(8)_3511-3523.nxml.txt.nlp	22180533	SENT224	26	26	3	3	hydroxyurea	E2F7	PA449942	144455	0.775
NULL	J_Gen_Physiol_1997_Apr_1_109(4)_477-490.nxml.txt.nlp	9101406	SENT166	43	43	22	22	staurosporine	GIRK1	PA165109623	3760	0.775
NULL	Anemia_2012_Aug_12_2012_297641.nxml.txt.nlp	22924125	SENT131	25	25	30	30	deferasirox	EOS	PA164760843	260429	0.775
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_91-103.nxml.txt.nlp	17912639	SENT101	14	14	5	5	letrozole	HER2	PA450196	2064	0.775
NULL	Viruses_2014_Sep_16_6(9)_3428-3437.nxml.txt.nlp	25256391	SENT350	23	23	10	10	nevirapine	CD4	PA450616	920	0.775
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Apr_2_65(Pt_5)_o953.nxml.txt.nlp	21583996	SENT65	23	23	31	31	oxygen	AMPH	PA450744	273	0.775
NULL	Vet_Res_2013_Dec_5_44(1)_119.nxml.txt.nlp	24308795	SENT81	28	28	7	7	formaldehyde	AQP3	PA449703	360	0.775
NULL	J_Mol_Med_(Berl)_2014_Jan_10_92(5)_497-507.nxml.txt.nlp	24408111	SENT186	23	23	11	11	pioglitazone	HIF-1	PA450970	29072	0.775
NULL	Diabetes_2008_Sep_57(9)_2470-2479.nxml.txt.nlp	18511847	SENT141	1	1	6	6	pioglitazone	adiponectin	PA450970	9370	0.775
NULL	N_Am_J_Med_Sci_2011_Oct_3(10)_441-450.nxml.txt.nlp	22363081	SENT230	21	21	12	12	gemcitabine	DPD	PA449748	1806	0.775
NULL	Br_J_Cancer_2013_Mar_19_108(5)_1052-1060.nxml.txt.nlp	23422754	SENT39	16	16	34	34	bevacizumab	VEGF-A	PA130232992	7422	0.775
NULL	Int_J_Environ_Res_Public_Health_2010_Mar_15_7(3)_1076-1092.nxml.txt.nlp	20617019	SENT197	17	17	0	0	ethanol	ADH4	PA448073	127	0.775
NULL	Oncotarget_2014_Jun_19_5(15)_6540-6551.nxml.txt.nlp	25153728	SENT105	34	34	19	19	paclitaxel	p27	PA450761	5715;10534	0.775
NULL	Int_J_Mol_Imaging_2011_Oct_26_2011_874585.nxml.txt.nlp	21490735	SENT79	21	21	7	7	doxorubicin	FDG	PA449412	23583	0.775
NULL	J_Cell_Mol_Med_2014_Jan_4_18(1)_38-48.nxml.txt.nlp	24188742	SENT152	32	32	5	5	cisplatin	PAX3	PA449014	5077	0.775
NULL	Int_J_Mol_Sci_2014_Jun_3_15(6)_9924-9944.nxml.txt.nlp	24897026	SENT186	5	5	3	3	resveratrol	AMPK		5563	0.775
NULL	J_Cell_Mol_Med_2013_Jun_15_17(6)_792-799.nxml.txt.nlp	23672538	SENT64	32	32	40	40	fluorescein	CXCR4	PA164746009	7852	0.775
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT241	32	32	15	15	nutlin-3	FasL		356	0.775
NULL	Orphanet_J_Rare_Dis_2011_Sep_8_6_60.nxml.txt.nlp	21902819	SENT560	0	0	21	21	eculizumab	C5b	PA164776637	727	0.775
NULL	Diabetes_Care_2009_Aug_26_32(8)_1411-1417.nxml.txt.nlp	19470837	SENT128	1	1	18	18	glucose	PPG	PA449773	5552	0.775
NULL	Genetics_2013_Jan_193(1)_1-50.nxml.txt.nlp	23275493	SENT363	9	9	23	23	cerulenin	DAG	PA164764551	1605	0.775
NULL	Neuropsychopharmacology_2009_Apr_2_34(5)_1135-1148.nxml.txt.nlp	18596687	SENT253	20	20	33	33	cocaine	CRF	PA449072	1392;10882	0.775
NULL	Cancer_Cell_Int_2013_Jun_26_13_63.nxml.txt.nlp	23800022	SENT228	0	0	17	17	genistein	MDM2	PA165109660	4193	0.775
NULL	Clin_Epigenetics_2011_Jun_25_2(2)_283-297.nxml.txt.nlp	22704343	SENT109	30	30	3	3	etoposide	Rvb1	PA449552	8607	0.775
NULL	J_Clin_Biochem_Nutr_2010_Jan_29_46(1)_36-42.nxml.txt.nlp	20104263	SENT121	17	17	44	44	ribavirin	IFN	PA451241	3439	0.775
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT127	29	29	34	34	trastuzumab	HER2	PA451743	2064	0.775
NULL	Acta_Pharmacol_Sin_2011_Jun_3_32(6)_845-852.nxml.txt.nlp	21642952	SENT156	2	2	4	4	prazosin	TRPV1	PA451093	7442	0.775
NULL	Viruses_2009_Aug_11_1(2)_126-143.nxml.txt.nlp	21994542	SENT240	20	20	11	11	ribavirin	PPARgamma	PA451241	5468	0.775
NULL	Mol_Brain_2014_Sep_4_7(1)_69.nxml.txt.nlp	NULL	SENT355	3	3	5	5	sevoflurane	spatial	PA451341	219793	0.775
NULL	Leukemia_2013_Jan_11_27(1)_32-40.nxml.txt.nlp	22781593	SENT173	3	3	7	7	ponatinib	FGFR1	PA165980594	2260	0.775
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT77	7	7	4	4	erlotinib	EGFR	PA134687924	1956	0.775
NULL	Blood_Res_2014_Dec_23_49(4)_253-258.nxml.txt.nlp	25548759	SENT73	25	25	33	33	doxorubicin	CHOP	PA449412	1649	0.775
NULL	J_Inherit_Metab_Dis_2013_Mar_13_36(2)_363-371.nxml.txt.nlp	22971959	SENT46	7	7	15	15	gentamicin	ARSB	PA449753	411	0.775
NULL	Indian_J_Med_Res_2013_Jan_137(1)_102-110.nxml.txt.nlp	23481058	SENT146	17	17	6	6	oxygen	HIF-1	PA450744	29072	0.775
NULL	J_Ophthalmol_2012_Nov_3_2012_852183.nxml.txt.nlp	22132316	SENT116	14	14	29	29	bevacizumab	VEGF-A	PA130232992	7422	0.775
NULL	Biomed_Res_Int_2013_Apr_9_2013_428726.nxml.txt.nlp	23653895	SENT52	12	12	45	45	collagenase	CO2	PA449107	4513	0.775
NULL	J_Carcinog_2011_Nov_30_10_28.nxml.txt.nlp	22190870	SENT115	9	9	7	7	trastuzumab	p27	PA451743	5715;10534	0.775
NULL	Oncotarget_2011_Jun_15_2(6)_518-524.nxml.txt.nlp	21680956	SENT93	12	12	1	1	pimozide	STAT3	PA450965	6774	0.775
NULL	Ther_Clin_Risk_Manag_2005_Jun_1(2)_107-114.nxml.txt.nlp	18360550	SENT25	2	2	49	49	paclitaxel	Yes	PA450761	7525	0.775
NULL	Indian_J_Pharmacol_2008_Mar-Apr_40(2)_84-86.nxml.txt.nlp	21279172	SENT85	23	23	5	5	lidocaine	CYP3A4	PA450226	1576	0.775
NULL	Front_Chem_2014_Mar_14_2_12.nxml.txt.nlp	24790981	SENT98	4	4	19	19	curcumin	MEF2C	PA151958596	4208	0.775
NULL	Bone_Joint_Res_2014_Apr_1_3(4)_108-116.nxml.txt.nlp	24740649	SENT73	8	8	29	29	fluorescein	CD40	PA164746009	958	0.775
NULL	Blood_Res_2014_Mar_24_49(1)_15-21.nxml.txt.nlp	24724062	SENT165	47	47	22	22	etoposide	CHOP	PA449552	1649	0.775
NULL	Breast_Cancer_Res_2008_Jul_24_10(4)_211.nxml.txt.nlp	18671839	SENT212	0	0	14	14	erlotinib	HER2	PA134687924	2064	0.775
NULL	Int_J_Gen_Med_2011_Apr_19_4_333-343.nxml.txt.nlp	21674026	SENT302	5	5	18	18	norfloxacin	AK1	PA450654	203	0.775
NULL	Gut_Liver_2013_Sep_14_7(5)_552-559.nxml.txt.nlp	24073313	SENT153	2	2	10	10	celecoxib	EGFR	PA448871	1956	0.775
NULL	Breast_Cancer_Res_2004_Oct_6_6(6)_262-268.nxml.txt.nlp	15535857	SENT148	22	22	43	43	tipifarnib	aromatase	PA165110778	1588	0.775
NULL	Cancer_Cell_Int_2005_Aug_24_5_28.nxml.txt.nlp	16120219	SENT69	7	7	32	32	etoposide	p53	PA449552	7157	0.775
NULL	J_Asthma_Allergy_2008_Sep_19_1_19-29.nxml.txt.nlp	21436982	SENT110	0	0	19	19	fexofenadine	RANTES	PA449621	6352	0.775
NULL	Eur_J_Immunol_2012_Mar_27_42(3)_716-725.nxml.txt.nlp	22105559	SENT142	17	17	43	43	ethanol	MSU	PA448073	593	0.775
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT372	11	11	5	5	cetuximab	KRAS	PA10040	3845	0.775
NULL	J_Adv_Pract_Oncol_2012_Nov_1_Nov-Dec_3(6)_391-394.nxml.txt.nlp	25031970	SENT64	21	21	10	10	trastuzumab	HER2	PA451743	2064	0.775
NULL	Clin_Drug_Investig_2012_Dec_13_32(8)_e1-e15.nxml.txt.nlp	22712629	SENT153	20	20	11	11	memantine	ANOVA	PA10364	4858	0.775
NULL	Cancer_Cell_Int_2014_Jan_14_14_4.nxml.txt.nlp	24423208	SENT60	24	24	8	8	gemcitabine	IL-2	PA449748	3558	0.775
NULL	Evid_Based_Complement_Alternat_Med_2013_Mar_26_2013_625892.nxml.txt.nlp	23589719	SENT254	0	0	11	11	probenecid	TAS2R31	PA451106	259290	0.775
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jul_17_66(Pt_8)_o2039.nxml.txt.nlp	21588348	SENT64	29	29	6	6	ethanol	mol	PA448073	90527	0.775
NULL	Indian_J_Med_Res_2013_Jan_137(1)_203-209.nxml.txt.nlp	23481074	SENT142	22	22	12	12	acenocoumarol	VKORC1	PA452632	79001	0.775
NULL	Arthritis_Res_Ther_2006_Jul_21_8(4)_R130.nxml.txt.nlp	16859540	SENT91	0	0	2	2	atorvastatin	CD59	PA448500	966	0.775
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jun_18_67(Pt_7)_o1733.nxml.txt.nlp	21837122	SENT68	23	23	26	26	benzaldehyde	mol	PA448571	90527	0.775
NULL	Mol_Biol_Cell_2013_Dec_15_24(24)_3939-3944.nxml.txt.nlp	24152728	SENT49	31	31	16	16	tamoxifen	CCN2	PA451581	1490	0.775
NULL	Aliment_Pharmacol_Ther_2012_Aug_19_36(4)_370-378.nxml.txt.nlp	22708649	SENT24	3	3	10	10	ribavirin	IFN	PA451241	3439	0.775
NULL	Case_Rep_Transplant_2013_Aug_1_2013_765230.nxml.txt.nlp	23984169	SENT37	6	6	13	13	doxorubicin	CHOP	PA449412	1649	0.775
NULL	Parasit_Vectors_2011_Aug_24_4_164.nxml.txt.nlp	21864384	SENT78	34	34	39	39	artesunate	LAMP	PA165111697	4045;27074	0.775
NULL	Fibrogenesis_Tissue_Repair_2010_Apr_1_3_6.nxml.txt.nlp	20359336	SENT147	25	25	11	11	trypsin	CO2	PA451806	4513	0.775
NULL	Genetics_2013_Jan_193(1)_1-50.nxml.txt.nlp	23275493	SENT410	23	23	10	10	lipase	DAG	PA450239	1605	0.775
NULL	Acta_Pharmacol_Sin_2014_Jun_4_35(6)_752-757.nxml.txt.nlp	24902786	SENT11	6	6	23	23	tamoxifen	STZ	PA451581	6484	0.775
NULL	Oncol_Lett_2014_May_11_7(5)_1401-1408.nxml.txt.nlp	24765145	SENT163	2	2	12	12	paclitaxel	HIF-1	PA450761	29072	0.775
NULL	Clin_Med_Insights_Oncol_2013_Jun_3_7_103-122.nxml.txt.nlp	23843721	SENT133	0	0	4	4	trastuzumab	PTEN	PA451743	5728	0.775
NULL	Oncogene_2010_Jun_10_29(23)_3335-3348.nxml.txt.nlp	20383197	SENT130	21	21	12	12	cetuximab	HER2	PA10040	2064	0.775
NULL	Exp_Transl_Stroke_Med_2010_Jan_21_2_2.nxml.txt.nlp	20298534	SENT253	5	5	3	3	deferoxamine	HIF-1	PA164746490	29072	0.775
NULL	Exp_Ther_Med_2014_Aug_4_8(2)_657-661.nxml.txt.nlp	25009636	SENT108	22	22	28	28	propofol	CCL2	PA451141	6347	0.775
NULL	Blood_Cancer_J_2013_Mar_1_3(3)_e103.nxml.txt.nlp	23454896	SENT89	18	18	9	9	nelfinavir	AKT	PA450606	207	0.775
NULL	Aging_(Albany_NY)_2011_Apr_6_3(4)_444-449.nxml.txt.nlp	21483037	SENT17	5	5	18	18	resveratrol	SIRT1		23411	0.775
NULL	Rare_Tumors_2009_Dec_28_1(2)_e53.nxml.txt.nlp	21139932	SENT67	0	0	8	8	temsirolimus	FKBP-12	PA164746890	2280	0.775
NULL	Oncoscience_2014_Apr_30_1(4)_262-271.nxml.txt.nlp	25594018	SENT79	28	28	8	8	paclitaxel	GAPDH	PA450761	2597	0.775
NULL	Oncotarget_2011_Mar_23_2(3)_165-177.nxml.txt.nlp	21444946	SENT201	15	15	5	5	crizotinib	EGFR	PA165946122	1956	0.775
NULL	Int_J_Ion_Mobil_Spectrom_2009_Aug_1_12(3)_91-102.nxml.txt.nlp	20835390	SENT170	0	0	6	6	famotidine	mol	PA449586	90527	0.775
NULL	Front_Genet_2014_Dec_19_5_438.nxml.txt.nlp	25566322	SENT1555	16	16	13	13	curcumin	p38	PA151958596	10598;1432;7965	0.775
NULL	eLife_2014_May_20_3_e01763.nxml.txt.nlp	24844244	SENT495	20	20	14	14	doxycycline	MELK	PA449415	9833	0.775
NULL	Acta_Myol_2011_Oct_30(2)_152a.nxml.txt.nlp	NULL	SENT13	7	7	21	21	rosiglitazone	AMPK	PA451283	5563	0.775
NULL	Breast_Cancer_Res_2011_Nov_23_13(6)_R117.nxml.txt.nlp	22112244	SENT27	9	9	31	31	docetaxel	IL-8	PA449383	3576	0.775
NULL	F1000_Med_Rep_2009_Feb_24_1_13.nxml.txt.nlp	20948769	SENT79	31	31	42	42	mitoxantrone	CHOP	PA450526	1649	0.775
NULL	Front_Neurosci_2014_Jul_17_8_200.nxml.txt.nlp	25100932	SENT77	2	2	13	13	ceftriaxone	GLT-1	PA448866	6506	0.775
NULL	Arthritis_Res_Ther_2013_Apr_17_15(2)_R51.nxml.txt.nlp	23594962	SENT218	2	2	15	15	fenofibrate	p65	PA449594	5970	0.775
NULL	Diabetes_2013_Jun_17_62(6)_2141-2150.nxml.txt.nlp	23378610	SENT9	23	23	44	44	betaine	ALDH1L1	PA448603	10840	0.775
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S272-S275.nxml.txt.nlp	21525467	SENT145	15	15	30	30	liraglutide	Met	PA165958364	79811	0.775
NULL	Endocr_Relat_Cancer_2014_Jun_21(3)_R209-R225.nxml.txt.nlp	24500760	SENT133	12	12	9	9	resveratrol	COX		1351	0.775
NULL	Breast_Cancer_Res_2014_Jul_29_16(4)_412.nxml.txt.nlp	25410383	SENT329	8	8	22	22	paclitaxel	Hsp90	PA450761	3320	0.775
NULL	Open_Biol_2014_Jan_4(1)_130138.nxml.txt.nlp	24403013	SENT347	6	6	17	17	etoposide	PP1	PA449552	5540;5464	0.775
NULL	Ther_Clin_Risk_Manag_2007_Jun_3(2)_333-339.nxml.txt.nlp	18360642	SENT86	7	7	22	22	ondansetron	NNT	PA450705	23530	0.775
NULL	Evid_Based_Complement_Alternat_Med_2014_Dec_18_2014_890842.nxml.txt.nlp	25587347	SENT155	14	14	28	28	ethanol	APT	PA448073	653639	0.775
NULL	Mol_Cancer_2009_Dec_10_8_118.nxml.txt.nlp	20003259	SENT100	3	3	14	14	sorafenib	ERM	PA7000	2119	0.775
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT102	9	9	18	18	nutlin-3	p53		7157	0.775
NULL	Arthritis_Res_Ther_2012_Jun_12_14(3)_R142.nxml.txt.nlp	22691272	SENT129	15	15	23	23	mianserin	IL-6	PA134687937	3569	0.775
NULL	Cardiol_Res_Pract_2013_Jan_31_2013_128795.nxml.txt.nlp	23431496	SENT5	16	16	5	5	clopidogrel	CYP2C19	PA449053	1557	0.775
NULL	Arthritis_Res_Ther_2012_Dec_7_14(6)_R265.nxml.txt.nlp	23217273	SENT7	16	16	21	21	lenalidomide	CLE	PA162363968	51637	0.775
NULL	Pain_Res_Treat_2011_Aug_14_2011_864605.nxml.txt.nlp	22110933	SENT115	17	17	26	26	levorphanol	PLP	PA164744368	25824;5744	0.775
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Oct_29_6_169-177.nxml.txt.nlp	25378949	SENT11	8	8	3	3	trastuzumab	HER2	PA451743	2064	0.775
NULL	Indian_J_Pharmacol_2013_Jan-Feb_45(1)_54-60.nxml.txt.nlp	23543867	SENT172	11	11	15	15	terlipressin	NAC	PA164781020	22861	0.775
NULL	Nat_Commun_2010_Nov_30_1_130.nxml.txt.nlp	21119643	SENT47	0	0	8	8	fenofibrate	PS1	PA449594	5663	0.775
NULL	Indian_J_Dermatol_2011_Mar-Apr_56(2)_165-170.nxml.txt.nlp	21716541	SENT165	6	6	1	1	methotrexate	VIII	PA450428	1351	0.775
NULL	Mol_Cancer_2007_Nov_17_6_73.nxml.txt.nlp	18021420	SENT61	15	15	2	2	bortezomib	Bcl-2	PA10252	596	0.775
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Oct_28_65(Pt_11)_m1441.nxml.txt.nlp	21578172	SENT61	10	10	3	3	ethanol	mol	PA448073	90527	0.775
NULL	Mol_Cancer_2013_Sep_11_12_104.nxml.txt.nlp	24025152	SENT209	26	26	0	0	gemcitabine	STAT3	PA449748	6774	0.775
NULL	Aging_(Albany_NY)_2013_Jul_11_5(7)_487.nxml.txt.nlp	23852312	SENT5	20	20	15	15	glucose	HIF-1	PA449773	29072	0.775
NULL	Onco_Targets_Ther_2014_May_28_7_841-852.nxml.txt.nlp	24920926	SENT67	39	39	35	35	erlotinib	DELTA	PA134687924	7528;5694	0.775
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT222	28	28	8	8	nutlin-3	p53		7157	0.775
NULL	Acta_Pharmacol_Sin_2011_Nov_10_32(11)_1402-1410.nxml.txt.nlp	21986579	SENT202	14	14	34	34	curcumin	CDK4	PA151958596	1019	0.775
NULL	Ther_Clin_Risk_Manag_2005_Jun_1(2)_107-114.nxml.txt.nlp	18360550	SENT15	13	13	21	21	paclitaxel	castor	PA450761	54897	0.775
NULL	Biomed_Res_Int_2014_Jun_4_2014_105214.nxml.txt.nlp	24991534	SENT157	2	2	43	43	carvedilol	EDN	PA448817	6036	0.775
NULL	Int_J_Environ_Res_Public_Health_2011_Dec_30_8(12)_4460-4476.nxml.txt.nlp	22408583	SENT172	11	11	7	7	erythromycin	S12	PA449493	3351;6206;5713;6268	0.775
NULL	Hum_Genomics_Proteomics_2010_Sep_13_2010_754919.nxml.txt.nlp	20981234	SENT92	9	9	0	0	phenprocoumon	CYP3A4	PA450921	1576	0.775
NULL	Biomed_Res_Int_2013_Jul_31_2013_965417.nxml.txt.nlp	23984423	SENT193	32	32	3	3	lipase	CB1	PA450239	1268	0.775
NULL	Drug_Des_Devel_Ther_2014_Sep_23_8_1527-1538.nxml.txt.nlp	25284985	SENT133	10	10	7	7	celecoxib	IFN	PA448871	3439	0.775
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Jul_9_3(7)_e124.nxml.txt.nlp	25006781	SENT20	26	26	11	11	rosuvastatin	OATP1B1	PA134308647	10599	0.775
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2009_Jun_1_65(Pt_6)_513-522.nxml.txt.nlp	19465765	SENT240	6	6	23	23	chloramphenicol	CEA	PA448927	5670;1087	0.775
NULL	FEBS_Open_Bio_2012_May_23_2_103-112.nxml.txt.nlp	23650588	SENT379	7	7	2	2	bortezomib	AP-1	PA10252	2353;3727;2354;3725	0.775
NULL	Acta_Naturae_2013_Apr-Jun_5(2)_19-39.nxml.txt.nlp	23819034	SENT247	33	33	15	15	thrombin	FVIII	PA451674	2157	0.775
NULL	Acta_Otorhinolaryngol_Ital_2012_Apr_32(2)_130-132.nxml.txt.nlp	22767976	SENT30	12	12	7	7	metronidazole	B12	PA450484	7126;4709	0.775
NULL	Cancer_Cell_Int_2014_Jan_29_14_10.nxml.txt.nlp	24472145	SENT176	9	9	6	6	doxorubicin	HER-2	PA449412	2064	0.775
NULL	Biosci_Rep_2014_Jul_29_34(4)_e00122.nxml.txt.nlp	24924257	SENT557	13	13	8	8	heparin	VEGF-A	PA449855	7422	0.775
NULL	Arthritis_Res_Ther_2010_Jan_22_12(1)_R11.nxml.txt.nlp	20096109	SENT179	21	21	12	12	infliximab	IFN	PA452639	3439	0.775
NULL	Mol_Vis_2007_Jul_9_13_1083-1093.nxml.txt.nlp	17653053	SENT160	2	2	13	13	minocycline	MCP-3	PA450519	6354	0.775
NULL	Allergy_Asthma_Immunol_Res_2014_Nov_28_6(6)_567-572.nxml.txt.nlp	25374757	SENT88	25	25	28	28	fexofenadine	IL-6	PA449621	3569	0.775
NULL	Crit_Care_2009_Mar_13_13(Suppl_1)_P310.nxml.txt.nlp	NULL	SENT4	11	11	13	13	vancomycin	VAN	PA451850	10318	0.775
NULL	J_Infect_Dis_2014_Jul_15_210(2)_200-208.nxml.txt.nlp	24511101	SENT28	40	40	11	11	l-glutamine	CO2	PA10090	4513	0.775
NULL	Indian_J_Nephrol_2014_Jul-Aug_24(4)_232-238.nxml.txt.nlp	25097336	SENT63	15	15	6	6	methylprednisolone	ACR	PA450466	49	0.775
NULL	Mol_Pain_2013_Aug_8_9_39.nxml.txt.nlp	23924059	SENT92	33	33	10	10	vasopressin	SON	PA451858	6651	0.775
NULL	Acta_Pharmacol_Sin_2011_Aug_18_32(8)_1031-1037.nxml.txt.nlp	21765446	SENT189	35	35	7	7	raloxifene	MCP-1	PA451221	6347	0.775
NULL	Br_J_Ophthalmol_2010_May_94(5)_639-642.nxml.txt.nlp	20447966	SENT67	15	15	39	39	fluorometholone	MYOC	PA164781355	4653	0.775
NULL	Colomb_Med_(Cali)_44(1)_42-45.nxml.txt.nlp	24892321	SENT66	24	24	3	3	phenytoin	B12	PA450947	7126;4709	0.775
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Mar_28_68(Pt_4)_o1219.nxml.txt.nlp	22606156	SENT59	23	23	38	38	ethanol	mol	PA448073	90527	0.775
NULL	J_Breast_Cancer_2013_Sep_30_16(3)_274-284.nxml.txt.nlp	24155756	SENT49	31	31	33	33	tamoxifen	aromatase	PA451581	1588	0.775
NULL	Jpn_Clin_Med_2014_Sep_17_5_33-41.nxml.txt.nlp	25288908	SENT3	0	0	5	5	liraglutide	GLP-1	PA165958364	100125288	0.775
NULL	Oncotarget_2010_Oct_30_1(7)_639-650.nxml.txt.nlp	21317459	SENT128	3	3	12	12	nutlin-3	p53		7157	0.775
NULL	Ann_Neurosci_2011_Apr_18(2)_76-83.nxml.txt.nlp	25205926	SENT13	24	24	6	6	rasagiline	COMT	PA164764584	1312	0.775
NULL	Breast_Cancer_Res_2012_Mar_14_14(2)_R45.nxml.txt.nlp	22417809	SENT28	15	15	6	6	gefitinib	EGFR	PA131301952	1956	0.775
NULL	Carcinogenesis_2013_Mar_7_34(3)_703-712.nxml.txt.nlp	23222814	SENT147	0	0	8	8	curcumin	RPS6	PA151958596	6194	0.775
NULL	Toxins_(Basel)_2010_Oct_28_2(11)_2584-2592.nxml.txt.nlp	22069565	SENT307	7	7	4	4	warfarin	CYP2C9	PA451906	1559	0.775
NULL	Front_Physiol_2011_Jul_19_2_40.nxml.txt.nlp	21811470	SENT141	5	5	14	14	candesartan	RVR	PA448765	9975	0.775
NULL	Breast_Cancer_Res_2002_May_15_4(4)_133-136.nxml.txt.nlp	12100736	SENT83	7	7	2	2	diethylstilbestrol	aromatase	PA449307	1588	0.775
NULL	Breast_Cancer_Res_2006_Nov_27_8(6)_R66.nxml.txt.nlp	17129383	SENT40	7	7	2	2	paclitaxel	p53	PA450761	7157	0.775
NULL	Acta_Pharmacol_Sin_2014_Jun_5_35(6)_727-737.nxml.txt.nlp	24793312	SENT139	3	3	6	6	pioglitazone	B27	PA450970	56246	0.775
NULL	Br_J_Haematol_2014_Mar_13_164(1)_811-821.nxml.txt.nlp	24328678	SENT212	15	15	10	10	lenalidomide	Aiolos	PA162363968	22806	0.775
NULL	Indian_J_Psychiatry_2014_Jan_56(Suppl_1)_S63-S96.nxml.txt.nlp	NULL	SENT814	7	7	23	23	promethazine	OGC	PA451128	8402	0.775
NULL	Cancer_Cell_Int_2012_Jun_18_12_30.nxml.txt.nlp	22709569	SENT10	14	14	2	2	doxorubicin	PLCG2	PA449412	5336	0.775
NULL	Mucosal_Immunol_2011_May_10_4(3)_304-313.nxml.txt.nlp	21068720	SENT221	8	8	21	21	dextran	Diva	PA449261	10017	0.775
NULL	Br_J_Cancer_2011_Jul_12_105(2)_255-262.nxml.txt.nlp	21694725	SENT43	8	8	4	4	cetuximab	KRAS	PA10040	3845	0.775
NULL	Blood_Press_Monit_2014_Jun_9_19(3)_164-169.nxml.txt.nlp	24710336	SENT149	11	11	19	19	olmesartan	AT1	PA164742950	9197;185	0.775
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT122	7	7	5	5	dasatinib	PP2	PA162372878	4888	0.775
NULL	Diabetes_2011_Jan_4_60(1)_119-126.nxml.txt.nlp	20921208	SENT252	17	17	21	21	glucose	TRPM2	PA449773	7226	0.775
NULL	Cancers_(Basel)_2013_Sep_10_5(3)_1163-1176.nxml.txt.nlp	24202339	SENT377	15	15	2	2	nitazoxanide	c-Myc	PA164754874	4609	0.775
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT45	15	15	25	25	metformin	EGFR	PA450395	1956	0.775
NULL	J_Oncol_2012_Feb_6_2012_737981.nxml.txt.nlp	22481932	SENT142	31	31	8	8	carboplatin	MDR1	PA448803	5243	0.775
NULL	Cancers_(Basel)_2013_Apr_11_5(2)_418-429.nxml.txt.nlp	24216984	SENT41	19	19	3	3	irinotecan	HIF-1	PA450085	29072	0.775
NULL	Clin_Psychopharmacol_Neurosci_2013_Dec_24_11(3)_144-151.nxml.txt.nlp	24465251	SENT13	21	21	25	25	quetiapine	IL-4	PA451201	3565	0.775
NULL	Colorectal_Dis_2012_Feb_14(2)_e31-e47.nxml.txt.nlp	21848897	SENT118	20	20	11	11	cetuximab	KRAS	PA10040	3845	0.775
NULL	Evid_Based_Complement_Alternat_Med_2011_Feb_14_2011_429843.nxml.txt.nlp	21869897	SENT110	10	10	17	17	ethanol	EPM	PA448073	2054	0.775
NULL	Drug_Des_Devel_Ther_2014_Sep_23_8_1527-1538.nxml.txt.nlp	25284985	SENT24	6	6	3	3	celecoxib	IFN	PA448871	3439	0.775
NULL	Evid_Based_Complement_Alternat_Med_2012_Feb_12_2012_472897.nxml.txt.nlp	22454667	SENT128	0	0	21	21	hesperetin	IFN	PA164742902	3439	0.775
NULL	Front_Behav_Neurosci_2014_May_6_8_147.nxml.txt.nlp	24834033	SENT68	0	0	29	29	agomelatine	5-HT2C	PA165958363	3358	0.775
NULL	Cell_Commun_Signal_2014_Sep_25_12(1)_61.nxml.txt.nlp	NULL	SENT49	9	9	3	3	doxycycline	INPP4B	PA449415	8821	0.775
NULL	J_Biol_Eng_2009_Oct_16_3_18.nxml.txt.nlp	19835592	SENT50	9	9	17	17	kanamycin	CPZ	PA450137	8532	0.775
NULL	Oncotarget_2014_Jun_26_5(14)_5559-5569.nxml.txt.nlp	24980819	SENT38	0	0	14	14	vemurafenib	p53	PA165946873	7157	0.775
NULL	Acta_Pharmacol_Sin_2014_Jun_4_35(6)_792-805.nxml.txt.nlp	24902787	SENT242	10	10	18	18	paroxetine	INS-1	PA450801	2305	0.775
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1522-1532.nxml.txt.nlp	21997136	SENT256	8	8	17	17	gefitinib	UGT1A1	PA131301952	54658	0.775
NULL	Cancer_Manag_Res_2014_Sep_10_6_349-356.nxml.txt.nlp	25228821	SENT77	5	5	3	3	imatinib	KIT	PA10804	3815	0.775
NULL	J_Exp_Clin_Cancer_Res_2009_Nov_24_28(1)_144.nxml.txt.nlp	19930704	SENT121	30	30	3	3	paclitaxel	P-gp	PA450761	5243	0.775
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT282	18	18	25	25	nutlin-3	DcR2		8793	0.775
NULL	Aging_(Albany_NY)_2009_Mar_31_1(4)_412-424.nxml.txt.nlp	20195491	SENT131	23	23	19	19	resveratrol	TXNIP		10628	0.775
NULL	J_Cell_Sci_2014_May_15_127(10)_2313-2325.nxml.txt.nlp	24634514	SENT181	4	4	12	12	galactose	DRP1	PA449725	8562;10059;7402	0.775
NULL	Chemother_Res_Pract_2012_Aug_29_2012_817297.nxml.txt.nlp	22970367	SENT40	18	18	23	23	erlotinib	BRCA1	PA134687924	672	0.775
NULL	J_Oncol_2012_Jun_19_2012_521215.nxml.txt.nlp	22778735	SENT254	11	11	3	3	cetuximab	ERBB2	PA10040	2064	0.775
NULL	Cancer_Med_2014_Jun_19_3(3)_555-564.nxml.txt.nlp	24648042	SENT188	27	27	6	6	rituximab	NOTCH1	PA451261	4851	0.775
NULL	Int_J_Biol_Sci_2011_Nov_5_8(1)_1-14.nxml.txt.nlp	22211100	SENT31	10	10	22	22	evodiamine	Bcl-2	PA165860788	596	0.775
NULL	Emerg_Infect_Dis_2013_Nov_19(11)_1803-1810.nxml.txt.nlp	24188126	SENT144	8	8	5	5	ceftazidime	CTX	PA448861	1593	0.775
NULL	Case_Rep_Oncol_2014_Jul_16_7(2)_491-496.nxml.txt.nlp	25202264	SENT51	22	22	15	15	erlotinib	EGFR	PA134687924	1956	0.775
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_May_5_68(Pt_6)_o1640-o1641.nxml.txt.nlp	22719441	SENT71	34	34	27	27	ethanol	mol	PA448073	90527	0.775
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT160	18	18	2	2	trastuzumab	MUC4	PA451743	4585	0.775
NULL	Cardiovasc_Diabetol_2010_Sep_23_9_57.nxml.txt.nlp	20863381	SENT162	34	34	5	5	pioglitazone	DM2	PA450970	28508	0.775
NULL	Aging_(Albany_NY)_2010_Dec_20_2(12)_959-968.nxml.txt.nlp	21191146	SENT97	4	4	12	12	cisplatin	LKB1	PA449014	6794	0.775
NULL	J_Ginseng_Res_2011_Nov_35(4)_471-478.nxml.txt.nlp	23717094	SENT202	22	22	17	17	ethanol	CaCC	PA448073	1179	0.774
NULL	Diabetes_Care_2013_Jul_12_36(7)_e92-e93.nxml.txt.nlp	23801816	SENT19	36	36	4	4	cilostazol	SMAP	PA164746334	22920;10944;10902	0.774
NULL	Gut_Liver_2011_Sep_18_5(3)_253-266.nxml.txt.nlp	21927652	SENT51	42	42	39	39	tegaserod	5-HT4	PA130413154	3360	0.774
NULL	Ann_Hematol_2014_Sep_10_93(1)_1-11.nxml.txt.nlp	24018623	SENT7	13	13	37	37	lenalidomide	RPS14	PA162363968	6208	0.774
NULL	Breast_Cancer_Res_Treat_2013_Jan_6_137(1)_167-174.nxml.txt.nlp	23129173	SENT178	23	23	16	16	letrozole	CYP19A1	PA450196	1588	0.774
NULL	Cancer_Med_2014_Apr_27_3(2)_310-321.nxml.txt.nlp	24464839	SENT225	2	2	6	6	everolimus	MVD	PA164746311	4597	0.774
NULL	Acta_Pharmacol_Sin_2013_Jul_5_34(7)_870-879.nxml.txt.nlp	23624759	SENT91	33	33	22	22	bevacizumab	VEGFA	PA130232992	7422	0.774
NULL	Environ_Health_Perspect_2010_Dec_12_118(12)_1707-1713.nxml.txt.nlp	20705543	SENT153	13	13	1	1	bleomycin	XRCC1	PA448645	7515	0.774
NULL	Aging_(Albany_NY)_2009_Mar_31_1(4)_412-424.nxml.txt.nlp	20195491	SENT130	0	0	3	3	resveratrol	AMPK		5563	0.774
NULL	Acta_Pharmacol_Sin_2010_Aug_19_31(8)_963-969.nxml.txt.nlp	20644547	SENT99	7	7	10	10	fenofibrate	PDX-1	PA449594	3651	0.774
NULL	BMB_Rep_2013_Nov_46(11)_544-549.nxml.txt.nlp	24152910	SENT20	10	10	8	8	thrombin	PAR-1	PA451674	2011;2149	0.774
NULL	Diabetologia_2010_Jan_22_53(1)_111-114.nxml.txt.nlp	19847395	SENT40	6	6	31	31	ketamine	STZ	PA450144	6484	0.774
NULL	Biomed_Res_Int_2014_Feb_6_2014_323594.nxml.txt.nlp	24689036	SENT201	7	7	1	1	raloxifene	PC3	PA451221	57332;7832;5122	0.774
NULL	EMBO_Mol_Med_2014_Oct_17_6(10)_1294-1311.nxml.txt.nlp	25231413	SENT418	20	20	28	28	l-glutamine	IL-2	PA10090	3558	0.774
NULL	Curr_Neuropharmacol_2007_Dec_5(4)_224-231.nxml.txt.nlp	19305739	SENT200	7	7	4	4	tegaserod	5-HT4	PA130413154	3360	0.774
NULL	Br_J_Cancer_2014_Nov_25_111(11)_2091-2102.nxml.txt.nlp	25349971	SENT13	7	7	24	24	imatinib	KIT	PA10804	3815	0.774
NULL	J_Korean_Med_Sci_2008_Aug_25_23(4)_685-690.nxml.txt.nlp	18756058	SENT89	14	14	9	9	olanzapine	ghrelin	PA450688	51738	0.774
NULL	J_Cancer_2013_Nov_21_4(9)_727-735.nxml.txt.nlp	24312143	SENT156	17	17	5	5	cisplatin	SRPK1	PA449014	6732	0.774
NULL	Adv_Urol_2012_Jul_31_2012_429213.nxml.txt.nlp	22899908	SENT39	21	21	8	8	heparin	FGFR1	PA449855	2260	0.774
NULL	J_Cell_Biol_2001_Aug_6_154(3)_659-666.nxml.txt.nlp	11489922	SENT312	3	3	19	19	warfarin	GLA	PA451906	9027;2717	0.774
NULL	Clin_Ophthalmol_2014_Jan_7_8_177-185.nxml.txt.nlp	24531415	SENT104	2	2	41	41	latanoprost	ANOVA	PA164774763	4858	0.774
NULL	CNS_Neurosci_Ther_2009_Spring_15(1)_32-51.nxml.txt.nlp	19228178	SENT215	16	16	19	19	ramelteon	CYP2C	PA164744896	1562	0.774
NULL	ScientificWorldJournal_2014_Mar_23_2014_183147.nxml.txt.nlp	24790551	SENT81	24	24	15	15	aprepitant	NK1	PA164747039	11126	0.774
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_May_14_3(5)_e114.nxml.txt.nlp	24827872	SENT122	20	20	4	4	sorafenib	MYC	PA7000	4609	0.774
NULL	Nat_Med_2011_Feb_9_17(2)_179-188.nxml.txt.nlp	21217695	SENT171	12	12	27	27	anakinra	IL-6	PA10799	3569	0.774
NULL	Evid_Based_Complement_Alternat_Med_2011_Jan_20_2011_713523.nxml.txt.nlp	21318104	SENT19	7	7	27	27	verapamil	P-gp	PA451868	5243	0.774
NULL	Br_J_Cancer_2010_Sep_7_103(6)_837-844.nxml.txt.nlp	20717115	SENT145	14	14	12	12	sorafenib	SHARP	PA7000	23013	0.774
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT248	4	4	6	6	aripiprazole	PRL	PA10026	5617	0.774
NULL	J_Res_Med_Sci_2010_Nov-Dec_15(6)_331-343.nxml.txt.nlp	21526106	SENT28	10	10	23	23	l-arginine	HDEL	PA448478	10945	0.774
NULL	Oncotarget_2014_Dec_4_5(22)_11365-11380.nxml.txt.nlp	25426548	SENT59	2	2	9	9	nutlin-3	p53		7157	0.774
NULL	J_Cell_Mol_Med_2013_Sep_24_17(9)_1065-1087.nxml.txt.nlp	24151975	SENT180	16	16	1	1	palifermin	IL10	PA164744014	3586	0.774
NULL	Br_J_Pharmacol_2012_Jan_165(2)_390-400.nxml.txt.nlp	21671897	SENT229	24	24	29	29	suramin	P2X1	PA10292	5023	0.774
NULL	J_Korean_Med_Sci_2008_Aug_25_23(4)_685-690.nxml.txt.nlp	18756058	SENT135	21	21	14	14	olanzapine	ghrelin	PA450688	51738	0.774
NULL	Cardiovasc_Diabetol_2013_Jun_7_12_84.nxml.txt.nlp	23759020	SENT127	2	2	26	26	dipyridamole	LSR	PA449367	51599	0.774
NULL	Cell_Cycle_2012_Dec_15_11(24)_4661-4672.nxml.txt.nlp	23187802	SENT201	17	17	11	11	doxorubicin	p130	PA449412	5934	0.774
NULL	Pharmaceuticals_(Basel)_2012_Sep_10_5(9)_944-962.nxml.txt.nlp	24280699	SENT468	1	1	7	7	novobiocin	Hsp90	PA164768819	3320	0.774
NULL	eLife_2014_May_20_3_e02523.nxml.txt.nlp	24844246	SENT212	40	40	37	37	sorafenib	PAO	PA7000	196743;54498	0.774
NULL	J_Cell_Biol_1997_Nov_3_139(3)_665-673.nxml.txt.nlp	9348283	SENT73	26	26	17	17	dextran	mol	PA449261	90527	0.774
NULL	AIDS_Res_Treat_2012_Mar_26_2012_948059.nxml.txt.nlp	22536498	SENT155	11	11	23	23	lamivudine	CD4	PA450163	920	0.774
NULL	Acta_Pharmacol_Sin_2009_Sep_24_30(9)_1323-1329.nxml.txt.nlp	19701237	SENT200	20	20	10	10	clarithromycin	CYP3A	PA449028	1574	0.774
NULL	Front_Oncol_2014_Sep_23_4_264.nxml.txt.nlp	25295231	SENT100	24	24	26	26	lenalidomide	MDM2	PA162363968	4193	0.774
NULL	Acta_Naturae_2013_Oct-Dec_5(4)_83-93.nxml.txt.nlp	24455187	SENT140	17	17	10	10	methotrexate	7SL	PA450428	6029	0.774
NULL	Evid_Based_Complement_Alternat_Med_2012_Aug_27_2012_361516.nxml.txt.nlp	22969825	SENT91	29	29	15	15	ketoconazole	P-gp	PA450146	5243	0.774
NULL	Mol_Biol_Cell_2013_Sep_15_24(18)_2849-2860.nxml.txt.nlp	23885123	SENT185	20	20	3	3	dextran	JAM-A	PA449261	50848	0.774
NULL	Cancer_2014_Apr_8_120(8)_1145-1154.nxml.txt.nlp	24501009	SENT79	9	9	5	5	gefitinib	EGFR	PA131301952	1956	0.774
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1196-1204.nxml.txt.nlp	22315058	SENT240	10	10	2	2	gefitinib	EGFR	PA131301952	1956	0.774
NULL	Front_Genet_2013_Aug_29_4_163.nxml.txt.nlp	24009622	SENT102	28	28	14	14	ethanol	DDP	PA448073	1678	0.774
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Jul_3_6_81-91.nxml.txt.nlp	25114586	SENT169	32	32	4	4	urokinase	aromatase	PA451836	1588	0.774
NULL	Oncotarget_2013_Mar_26_4(3)_397-412.nxml.txt.nlp	23651630	SENT162	8	8	14	14	trastuzumab	PI3K	PA451743	5290	0.774
NULL	Behav_Brain_Funct_2012_Jun_11_8_30.nxml.txt.nlp	22686184	SENT262	0	0	8	8	diazepam	CORT	PA449283	1325	0.774
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT129	22	22	3	3	sulindac	AKT	PA451565	207	0.774
NULL	Br_J_Clin_Pharmacol_2011_Oct_72(4)_647-657.nxml.txt.nlp	21518389	SENT30	25	25	5	5	thrombin	P2Y1	PA451674	5028	0.774
NULL	Cell_Death_Dis_2013_Jul_11_4(7)_e719.nxml.txt.nlp	23846221	SENT54	3	3	30	30	cisplatin	TRAIL	PA449014	8743	0.774
NULL	Aging_(Albany_NY)_2014_Jan_14_6(1)_70-81.nxml.txt.nlp	24429382	SENT178	17	17	6	6	etoposide	WRN	PA449552	7486	0.774
NULL	Breast_Cancer_(Auckl)_2011_Jul_27_5_175-199.nxml.txt.nlp	21863131	SENT508	10	10	1	1	cisplatin	Met	PA449014	79811	0.774
NULL	Clin_Ophthalmol_2008_Sep_2(3)_613-621.nxml.txt.nlp	19668762	SENT144	14	14	21	21	travoprost	BAK	PA164781371	578	0.774
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_May_31_70(Pt_6)_o733-o734.nxml.txt.nlp	24940299	SENT80	5	5	28	28	benzaldehyde	mol	PA448571	90527	0.774
NULL	Arch_Med_Sci_2011_Dec_31_7(6)_977-983.nxml.txt.nlp	22328880	SENT20	23	23	16	16	heparin	PAPP-A	PA449855	5069	0.774
NULL	EMBO_J_2014_Feb_18_33(4)_296-311.nxml.txt.nlp	24488179	SENT291	31	31	0	0	l-glutamine	E14	PA10090	4863	0.774
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1150.nxml.txt.nlp	24675468	SENT76	11	11	24	24	ethanol	Bcl-2	PA448073	596	0.774
NULL	Br_J_Pharmacol_2008_Oct_18_155(4)_596-605.nxml.txt.nlp	18852694	SENT137	5	5	11	11	fenofibrate	SREBP2	PA449594	6721	0.774
NULL	Oncol_Lett_2013_Mar_11_5(3)_1010-1016.nxml.txt.nlp	23426784	SENT105	24	24	17	17	midazolam	TRPM7	PA450496	54822	0.774
NULL	Cancer_Cell_Int_2010_Mar_24_10_9.nxml.txt.nlp	20334687	SENT28	8	8	40	40	collagenase	MT1-MMP	PA449107	4323	0.774
NULL	Oxid_Med_Cell_Longev_2013_Apr_21_2013_412576.nxml.txt.nlp	23710286	SENT135	8	8	13	13	curcumin	NRF2	PA151958596	2551;4780	0.774
NULL	Ann_Rheum_Dis_2014_Sep_3_73(9)_1616-1625.nxml.txt.nlp	24699939	SENT206	18	18	24	24	tocilizumab	IL-6	PA165292659	3569	0.774
NULL	J_Cell_Mol_Med_2014_May_14_18(5)_811-823.nxml.txt.nlp	24628949	SENT17	6	6	4	4	docetaxel	FOXM1	PA449383	2305	0.774
NULL	Diabetes_Obes_Metab_2010_Aug_12(8)_700-708.nxml.txt.nlp	20590747	SENT138	35	35	19	19	voglibose	PPG	PA164752433	5552	0.774
NULL	J_Asthma_Allergy_2013_Jun_6_6_69-80.nxml.txt.nlp	23776339	SENT131	14	14	36	36	ciclesonide	ACT	PA164781399	12;11332;9457;641455	0.774
NULL	Breast_Cancer_Res_2005_Jul_20_7(5)_205-211.nxml.txt.nlp	16168139	SENT123	18	18	15	15	tamoxifen	HER2	PA451581	2064	0.774
NULL	Br_J_Cancer_2012_Sep_25_107(7)_1044-1050.nxml.txt.nlp	22910317	SENT122	41	41	21	21	vatalanib	KDR	PA7001	3791	0.774
NULL	Vet_Res_Forum_2013_Winter_4(1)_19-24.nxml.txt.nlp	25593681	SENT107	14	14	12	12	diclofenac	B12	PA449293	7126;4709	0.774
NULL	Pain_2013_Sep_154(9)_1680-1690.nxml.txt.nlp	23707289	SENT516	4	4	12	12	yohimbine	ANOVA	PA451946	4858	0.774
NULL	Br_J_Cancer_2011_Mar_1_104(5)_750-755.nxml.txt.nlp	21326243	SENT154	1	1	27	27	dacarbazine	MPG	PA449197	4350	0.774
NULL	J_Cell_Biol_2004_Jul_19_166(2)_193-203.nxml.txt.nlp	15263017	SENT44	10	10	0	0	staurosporine	Bcl-2	PA165109623	596	0.774
NULL	Cancer_Res_Treat_2012_Mar_31_44(1)_37-42.nxml.txt.nlp	22500159	SENT91	37	37	13	13	vinorelbine	EGFR	PA451881	1956	0.774
NULL	Int_J_Mol_Sci_2012_Feb_1_13(2)_1481-1496.nxml.txt.nlp	22408403	SENT425	17	17	24	24	omeprazole	ANOVA	PA450704	4858	0.774
NULL	Acta_Neuropathol_2009_Sep_14_118(3)_329-347.nxml.txt.nlp	19597829	SENT417	14	14	10	10	mi-63	p53		7157	0.774
NULL	J_Agric_Food_Chem_2011_Jan_12_59(1)_289-297.nxml.txt.nlp	21128664	SENT230	0	0	11	11	resveratrol	SIRT1		23411	0.774
NULL	J_Korean_Med_Sci_2005_Jun_30_20(3)_456-460.nxml.txt.nlp	15953869	SENT103	5	5	0	0	lipase	HSL	PA450239	3991	0.774
NULL	Int_J_Breast_Cancer_2011_Sep_6_2011_352182.nxml.txt.nlp	22295219	SENT75	16	16	18	18	trastuzumab	HER2	PA451743	2064	0.774
NULL	Oncol_Rep_2015_Feb_11_33(2)_526-532.nxml.txt.nlp	25501339	SENT9	17	17	9	9	gefitinib	p53	PA131301952	7157	0.774
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1063.nxml.txt.nlp	24556678	SENT67	24	24	12	12	thioridazine	Mcl-1	PA451666	4170	0.774
NULL	Pain_Res_Treat_2011_Jun_15_2011_738645.nxml.txt.nlp	22110931	SENT198	12	12	6	6	bumetanide	NKCC1	PA448682	6558	0.774
NULL	Curr_Neuropharmacol_2013_Jul_11(4)_338-378.nxml.txt.nlp	24381528	SENT664	34	34	7	7	curcumin	p53	PA151958596	7157	0.774
NULL	Cholesterol_2010_Oct_31_2010_271504.nxml.txt.nlp	21490912	SENT179	12	12	20	20	efavirenz	CCR5	PA449441	1234	0.774
NULL	BMB_Rep_2014_Oct_47(10)_575-580.nxml.txt.nlp	24499675	SENT104	20	20	26	26	arsenite	ROS	PA452638	6098	0.774
NULL	FASEB_J_2010_Dec_24(12)_4648-4659.nxml.txt.nlp	20667978	SENT251	13	13	3	3	lipase	ANGPTL4	PA450239	51129	0.774
NULL	Nat_Med_2011_Aug_7_17(9)_1116-1120.nxml.txt.nlp	21822287	SENT175	16	16	6	6	doxycycline	c-Myc	PA449415	4609	0.774
NULL	Cancers_(Basel)_2013_Jun_5_5(2)_676-713.nxml.txt.nlp	24216997	SENT306	10	10	27	27	vorinostat	FasL	PA164748224	356	0.774
NULL	J_Mol_Med_(Berl)_2014_May_10_92(7)_709-722.nxml.txt.nlp	24811491	SENT135	32	32	9	9	pertuzumab	EGFR		1956	0.774
NULL	Curr_Chem_Genomics_2009_Mar_17_3_7-12.nxml.txt.nlp	19936037	SENT48	5	5	13	13	forskolin	NKH	PA146096022	275;2731	0.774
NULL	J_Antimicrob_Chemother_2013_Mar_9_68(3)_697-707.nxml.txt.nlp	23143901	SENT152	21	21	23	23	zanamivir	ZAN	PA164740891	7455	0.774
NULL	Cell_Death_Differ_2010_Mar_16_17(3)_499-512.nxml.txt.nlp	19834490	SENT339	4	4	12	12	bevacizumab	VEGFR2	PA130232992	3791	0.774
NULL	Breast_Cancer_Res_Treat_2013_Aug_20_141(1)_43-53.nxml.txt.nlp	23959396	SENT185	37	37	13	13	trastuzumab	HER2	PA451743	2064	0.774
NULL	Biomed_Res_Int_2014_Jan_2_2014_126586.nxml.txt.nlp	24527434	SENT124	14	14	21	21	metformin	HER2	PA450395	2064	0.774
NULL	Acta_Pharmacol_Sin_2010_Jun_4_31(6)_753-758.nxml.txt.nlp	20523346	SENT117	37	37	5	5	amiodarone	P-gp	PA448383	5243	0.774
NULL	EMBO_Mol_Med_2013_Jul_30_5(7)_932-948.nxml.txt.nlp	23723167	SENT77	23	23	38	38	pilocarpine	MMP13	PA450962	4322	0.774
NULL	Int_J_Mol_Sci_2013_Apr_2_14(4)_7193-7230.nxml.txt.nlp	23549262	SENT3	27	27	37	37	urokinase	FPR2	PA451836	2358	0.774
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_33-43.nxml.txt.nlp	17912634	SENT158	22	22	14	14	letrozole	HER2	PA450196	2064	0.774
NULL	Ann_Hematol_2011_May_12_90(5)_557-568.nxml.txt.nlp	20938660	SENT217	30	30	35	35	plerixafor	CD34	PA165958410	947	0.774
NULL	Clinics_2009_Mar_64(3)_245-252.nxml.txt.nlp	19330252	SENT152	13	13	10	10	diclofenac	COX	PA449293	1351	0.774
NULL	Viruses_2014_Oct_24_6(10)_4095-4139.nxml.txt.nlp	25341668	SENT224	22	22	37	37	efavirenz	TMC	PA449441	3703	0.774
NULL	J_Headache_Pain_2008_Oct_8_9(5)_317-323.nxml.txt.nlp	18688693	SENT182	6	6	8	8	dihydroergotamine	c-fos	PA164743028	2353	0.774
NULL	J_Clin_Biochem_Nutr_2009_Nov_28_45(3)_285-291.nxml.txt.nlp	19902018	SENT104	7	7	17	17	hesperetin	XDH	PA164742902	7498	0.774
NULL	Mol_Cancer_2012_Apr_26_11_24.nxml.txt.nlp	22537161	SENT222	21	21	28	28	pp2	MUC4		4585	0.774
NULL	Br_J_Pharmacol_2008_Oct_18_155(4)_596-605.nxml.txt.nlp	18852694	SENT177	5	5	10	10	fenofibrate	SREBP2	PA449594	6721	0.774
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT166	34	34	8	8	trastuzumab	EGF	PA451743	1950	0.774
NULL	Proteome_Sci_2010_Nov_12_8_56.nxml.txt.nlp	21073729	SENT245	17	17	37	37	thrombin	GPVI	PA451674	51206	0.774
NULL	Breast_Cancer_Res_2007_Jan_23_9(1)_R7.nxml.txt.nlp	17244352	SENT205	8	8	3	3	tamoxifen	UGT2B15	PA451581	7366	0.774
NULL	Oncoimmunology_2013_Sep_1_2(9)_e25789.nxml.txt.nlp	24244905	SENT4	6	6	30	30	cyclophosphamide	p53	PA449165	7157	0.774
NULL	Int_J_Mol_Sci_2014_Oct_8_15(10)_17974-17999.nxml.txt.nlp	25299695	SENT98	1	1	3	3	curcumin	HO-1	PA151958596	3162	0.774
NULL	Oncol_Lett_2013_Apr_4_5(4)_1165-1170.nxml.txt.nlp	23599757	SENT30	0	0	22	22	pemetrexed	DHFR	PA10810	1719	0.774
NULL	Atherosclerosis_2011_Feb_214(2)_338-344.nxml.txt.nlp	21130993	SENT136	7	7	22	22	genistein	IL-8	PA165109660	3576	0.774
NULL	Exp_Diabetes_Res_2012_Mar_4_2012_653678.nxml.txt.nlp	22474428	SENT31	35	35	23	23	repaglinide	gamma	PA451234	9913	0.774
NULL	Mol_Cancer_2007_Oct_11_6_63.nxml.txt.nlp	17931419	SENT117	18	18	12	12	gefitinib	EGFR	PA131301952	1956	0.774
NULL	Clin_Pharmacokinet_2014_Sep_3_53(1)_1-16.nxml.txt.nlp	23999929	SENT288	38	38	28	28	rivaroxaban	P-gp	PA165958360	5243	0.774
NULL	Ann_Rheum_Dis_2013_Aug_21_72(8)_1287-1294.nxml.txt.nlp	22915624	SENT226	24	24	28	28	methotrexate	MRI	PA450428	78996	0.774
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_39-54.nxml.txt.nlp	19305787	SENT184	7	7	13	13	ethanol	NR1	PA448073	27158	0.774
NULL	Arthritis_Res_Ther_2005_Feb_18_7(3)_R476-R484.nxml.txt.nlp	15899034	SENT28	4	4	9	9	thrombin	IL-6	PA451674	3569	0.774
NULL	Cancer_Cell_Int_2006_Mar_6_6_5.nxml.txt.nlp	16519802	SENT33	9	9	13	13	tamoxifen	SSTR2	PA451581	6752	0.774
NULL	Breast_Cancer_Res_2012_Feb_8_14(1)_R26.nxml.txt.nlp	22316048	SENT33	22	22	11	11	letrozole	aromatase	PA450196	1588	0.774
NULL	AIDS_Res_Ther_2014_Aug_4_11_25.nxml.txt.nlp	25120580	SENT10	3	3	7	7	atazanavir	CYP2C19	PA10251	1557	0.774
NULL	Oncologist_2011_Jan_6_16(1)_5-24.nxml.txt.nlp	21212434	SENT196	15	15	29	29	lomustine	IFN	PA164749407	3439	0.774
NULL	Br_J_Cancer_2010_May_11_102(10)_1503-1510.nxml.txt.nlp	20461093	SENT179	9	9	15	15	tamoxifen	AKT	PA451581	207	0.774
NULL	eLife_2014_May_20_3_e02523.nxml.txt.nlp	24844246	SENT625	9	9	32	32	sorafenib	survivin	PA7000	332	0.774
NULL	Avicenna_J_Phytomed_2013_Autumn_3(4)_302-312.nxml.txt.nlp	25050287	SENT90	4	4	16	16	ethanol	castor	PA448073	54897	0.774
NULL	Cancers_(Basel)_2014_Nov_25_6(4)_2313-2329.nxml.txt.nlp	25534569	SENT193	0	0	9	9	cabozantinib	Met	PA165906891	79811	0.774
NULL	J_Cell_Biol_1997_Mar_24_136(6)_1213-1226.nxml.txt.nlp	9087438	SENT61	6	6	13	13	creatine	San	PA164778930	80218	0.774
NULL	Mol_Cancer_2012_Jul_12_11_45.nxml.txt.nlp	22788833	SENT138	9	9	40	40	cisplatin	EGFR	PA449014	1956	0.774
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT190	6	6	20	20	curcumin	p53	PA151958596	7157	0.774
NULL	Int_J_Mol_Sci_2014_Oct_8_15(10)_17974-17999.nxml.txt.nlp	25299695	SENT139	4	4	11	11	curcumin	HO-1	PA151958596	3162	0.774
NULL	Reprod_Biol_Endocrinol_2013_Feb_26_11_15.nxml.txt.nlp	23442442	SENT149	18	18	6	6	l-arginine	BCL2	PA448478	596	0.774
NULL	Oxid_Med_Cell_Longev_2013_Apr_21_2013_412576.nxml.txt.nlp	23710286	SENT104	5	5	8	8	curcumin	NRF2	PA151958596	2551;4780	0.774
NULL	J_Clin_Biochem_Nutr_2009_Jul_30_45(1)_9-13.nxml.txt.nlp	19590701	SENT314	0	0	2	2	lansoprazole	HO-1	PA450180	3162	0.774
NULL	Exp_Cell_Res_2011_Apr_15_317(7)_1028-1039.nxml.txt.nlp	21237154	SENT193	7	7	5	5	staurosporine	TRAIL	PA165109623	8743	0.774
NULL	J_Gen_Physiol_1936_Jul_20_19(6)_991-1007.nxml.txt.nlp	19872978	SENT0	17	17	1	1	trypsin	Gen	PA451806	348654	0.774
NULL	Oncol_Lett_2013_Feb_7_5(2)_440-446.nxml.txt.nlp	23420122	SENT247	21	21	16	16	gemcitabine	Gem	PA449748	51053	0.774
NULL	Breast_Cancer_Res_2007_Jul_5_9(4)_R41.nxml.txt.nlp	17612393	SENT176	8	8	11	11	celecoxib	Bcl-2	PA448871	596	0.774
NULL	J_Biol_Chem_2009_Oct_16_284(42)_28885-28895.nxml.txt.nlp	19687008	SENT30	8	8	16	16	atorvastatin	PCSK9	PA448500	255738	0.774
NULL	CNS_Drugs_2013_May_27_27(5)_335-343.nxml.txt.nlp	23533009	SENT124	22	22	33	33	risperidone	FGA	PA451257	2243	0.774
NULL	Oncoscience_2014_Apr_30_1(4)_262-271.nxml.txt.nlp	25594018	SENT80	31	31	11	11	paclitaxel	GAPDH	PA450761	2597	0.774
NULL	Front_Neurosci_2014_Jul_17_8_200.nxml.txt.nlp	25100932	SENT77	2	2	11	11	ceftriaxone	xCT	PA448866	23657	0.774
NULL	Int_J_Mol_Sci_2014_Mar_20_15(3)_4946-4964.nxml.txt.nlp	24658439	SENT667	23	23	11	11	capsaicin	GBF	PA448776	1316	0.774
NULL	Mediators_Inflamm_2010_Jun_2_2010_682879.nxml.txt.nlp	20592757	SENT202	11	11	26	26	l-arginine	MCP-1	PA448478	6347	0.774
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT110	16	16	23	23	perifosine	DR5	PA165291471	8795	0.774
NULL	Exp_Ther_Med_2014_Aug_11_8(2)_671-675.nxml.txt.nlp	25009638	SENT152	6	6	16	16	scopolamine	FAE	PA451308	2178	0.774
NULL	J_Mol_Med_2011_Mar_8_89(3)_213-220.nxml.txt.nlp	21301796	SENT121	33	33	8	8	nadh	IDH2	PA164755085	3418	0.774
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT186	5	5	11	11	cisplatin	p53	PA449014	7157	0.774
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2011_Mar_14_4_13-24.nxml.txt.nlp	22879790	SENT33	26	26	8	8	liraglutide	PPG	PA165958364	5552	0.774
NULL	Mucosal_Immunol_2013_Sep_30_6(5)_1027-1037.nxml.txt.nlp	23360902	SENT136	13	13	4	4	paraformaldehyde	CCL20	PA450790	6364	0.774
NULL	Int_J_Biol_Sci_2015_Jan_1_11(1)_48-58.nxml.txt.nlp	25552929	SENT141	10	10	22	22	paclitaxel	TSP-1	PA450761	7057	0.774
NULL	J_Cell_Biol_2000_Jan_10_148(1)_59-72.nxml.txt.nlp	10629218	SENT171	14	14	3	3	staurosporine	p21Cip1/Waf1	PA165109623	1026	0.774
NULL	Open_Access_J_Urol_2010_Dec_30_3_7-17.nxml.txt.nlp	24198630	SENT99	19	19	7	7	solifenacin	CYP2D6	PA164783810	1565	0.774
NULL	Aging_(Albany_NY)_2011_Apr_6_3(4)_444-449.nxml.txt.nlp	21483037	SENT71	19	19	8	8	resveratrol	AMPK		5563	0.774
NULL	Aging_(Albany_NY)_2009_Mar_31_1(4)_412-424.nxml.txt.nlp	20195491	SENT52	2	2	11	11	resveratrol	TXNIP		10628	0.774
NULL	Oncotarget_2013_Nov_4_5(1)_161-172.nxml.txt.nlp	24389287	SENT89	25	25	10	10	propranolol	ADRB2	PA451145	154	0.774
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT113	8	8	19	19	everolimus	HER2	PA164746311	2064	0.774
NULL	Kidney_Int_Suppl_(2011)_2012_Mar_29_2(1)_69-88.nxml.txt.nlp	25018920	SENT129	16	16	14	14	theophylline	NAC	PA451647	22861	0.774
NULL	Cardiovasc_Ther_2009_27(4)_259-274.nxml.txt.nlp	19604248	SENT162	18	18	4	4	ticagrelor	IPA	PA165374673	3160	0.774
NULL	J_Biomed_Biotechnol_2003_Mar_19_2003(1)_48-70.nxml.txt.nlp	12686722	SENT254	18	18	15	15	doxorubicin	CPG2	PA449412	23345	0.774
NULL	Indian_J_Psychol_Med_2009_Jan-Jun_31(1)_24-29.nxml.txt.nlp	21938087	SENT153	13	13	3	3	fluoxetine	CRT	PA449673	811	0.774
NULL	Cancer_Manag_Res_2013_Jul_31_5_197-203.nxml.txt.nlp	23940421	SENT51	0	0	7	7	vismodegib	SMO		6608;54498	0.774
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT49	39	39	5	5	dextromethorphan	CYP1A2	PA449273	1544	0.774
NULL	Endocr_Connect_2012_Jun_21_1(1)_22-30.nxml.txt.nlp	23781300	SENT6	9	9	17	17	olmesartan	AGTR2	PA164742950	186	0.774
NULL	Mol_Biol_Int_2012_May_24_2012_705948.nxml.txt.nlp	22693671	SENT124	11	11	4	4	cisplatin	RASSF2	PA449014	9770	0.774
NULL	Channels_(Austin)_2010_Jan_1_4(1)_22-41.nxml.txt.nlp	19934650	SENT39	14	14	8	8	quinidine	Slo3	PA451209	157855	0.774
NULL	Front_Oncol_2013_Oct_1_3_259.nxml.txt.nlp	24102047	SENT105	23	23	29	29	sunitinib	VEGFR2	PA162372840	3791	0.774
NULL	Cancer_Cell_Int_2013_Feb_12_13_14.nxml.txt.nlp	23402310	SENT5	28	28	9	9	celecoxib	p65	PA448871	5970	0.774
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT133	38	38	8	8	glucose	EGFR	PA449773	1956	0.774
NULL	Org_Biomol_Chem_2014_Jul_28_12(28)_5082-5088.nxml.txt.nlp	24914735	SENT83	14	14	7	7	ethanol	mol	PA448073	90527	0.774
NULL	Mol_Vis_2011_Dec_2_17_3137-3146.nxml.txt.nlp	22171160	SENT27	13	13	0	0	capsaicin	TRPV1	PA448776	7442	0.774
NULL	Front_Physiol_2013_Nov_14_4_323.nxml.txt.nlp	24294204	SENT200	19	19	10	10	metoprolol	UGT1A1	PA450480	54658	0.774
NULL	Front_Behav_Neurosci_2010_Apr_5_4_14.nxml.txt.nlp	20407577	SENT261	0	0	13	13	doxycycline	NAC1	PA449415	112939;6323	0.774
NULL	Pharmaceutics_2011_Nov_18_3(4)_865-913.nxml.txt.nlp	24309312	SENT91	0	0	21	21	posaconazole	CYP3A4	PA151958574	1576	0.774
NULL	Scientifica_(Cairo)_2012_Dec_16_2012_402783.nxml.txt.nlp	24278688	SENT185	29	29	3	3	thrombin	PAR4	PA451674	9002;5074	0.774
NULL	Diabetes_2013_Oct_17_62(10)_3305-3306.nxml.txt.nlp	NULL	SENT56	35	35	22	22	resveratrol	SIRT1		23411	0.774
NULL	Oncol_Lett_2014_Nov_14_8(5)_2086-2092.nxml.txt.nlp	25295095	SENT188	27	27	18	18	gemcitabine	CHK2	PA449748	11200	0.774
NULL	Cancer_Manag_Res_2011_May_10_3_157-175.nxml.txt.nlp	21625399	SENT54	6	6	24	24	midazolam	CYP3A4	PA450496	1576	0.774
NULL	Environ_Health_Perspect_2006_Sep_23_114(9)_1401-1406.nxml.txt.nlp	16966095	SENT257	8	8	18	18	arsenite	ID1	PA452638	3397	0.774
NULL	Breast_Cancer_Res_2012_Mar_16_14(2)_206.nxml.txt.nlp	22423895	SENT182	8	8	0	0	estradiol	FES	PA449503	2242	0.774
NULL	AIDS_Res_Treat_2012_Mar_5_2012_703604.nxml.txt.nlp	22500218	SENT112	12	12	9	9	artemether	CYP2A6	PA165111698	1548	0.774
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT265	12	12	18	18	chloroquine	BMPR-II	PA448948	659	0.774
NULL	Pak_J_Med_Sci_2013_Jan-Mar_29(1)_140-143.nxml.txt.nlp	24353526	SENT78	7	7	14	14	captopril	adiponectin	PA448780	9370	0.774
NULL	Onco_Targets_Ther_2014_Mar_20_7_457-467.nxml.txt.nlp	24672248	SENT91	29	29	25	25	imatinib	PDGFRA	PA10804	5156	0.774
NULL	Ther_Clin_Risk_Manag_2005_Jun_1(2)_107-114.nxml.txt.nlp	18360550	SENT25	8	8	39	39	paclitaxel	Yes	PA450761	7525	0.774
NULL	Nat_Commun_2013_Aug_15_4_2130.nxml.txt.nlp	23945651	SENT137	1	1	11	11	etoposide	ATG5	PA449552	9474	0.774
NULL	Carcinogenesis_2008_Aug_28_29(8)_1483-1492.nxml.txt.nlp	18310089	SENT63	8	8	28	28	heparin	RANKL	PA449855	8600	0.774
NULL	Oncotarget_2014_Jun_11_5(21)_10407-10420.nxml.txt.nlp	25431951	SENT206	37	37	34	34	gefitinib	EGFR	PA131301952	1956	0.774
NULL	J_Gynecol_Oncol_2012_Jul_2_23(3)_139-140.nxml.txt.nlp	NULL	SENT26	28	28	19	19	cisplatin	EZH2	PA449014	2146	0.774
NULL	Mol_Cancer_2006_Oct_17_5_45.nxml.txt.nlp	17044934	SENT15	2	2	12	12	resveratrol	COX		1351	0.774
NULL	Nat_Commun_2012_3_1041.nxml.txt.nlp	22948823	SENT175	19	19	8	8	paraformaldehyde	Delta1	PA450790	8788	0.774
NULL	Open_Ophthalmol_J_2010_Jun_22_4_28-29.nxml.txt.nlp	20871754	SENT18	12	12	37	37	bevacizumab	San	PA130232992	80218	0.774
NULL	J_Cell_Biol_2003_Dec_8_163(5)_1067-1076.nxml.txt.nlp	14662747	SENT302	39	39	11	11	diltiazem	LPA	PA449334	4018	0.774
NULL	Mol_Imaging_Biol_2011_Apr_9_13(2)_199-207.nxml.txt.nlp	20617389	SENT113	12	12	14	14	trastuzumab	HER2	PA451743	2064	0.774
NULL	Breast_Cancer_Res_2010_Oct_22_12(Suppl_2)_S1.nxml.txt.nlp	21050422	SENT110	8	8	10	10	trastuzumab	DM1	PA451743	338023;1760;28509	0.774
NULL	Nat_Neurosci_2012_Sep_5_15(9)_1245-1254.nxml.txt.nlp	22864611	SENT104	3	3	16	16	clozapine	mGlu3	PA449061	2913	0.774
NULL	Br_J_Cancer_2010_Oct_12_103(8)_1284-1291.nxml.txt.nlp	20859285	SENT165	11	11	14	14	tamoxifen	EGFR	PA451581	1956	0.774
NULL	Int_J_Biol_Sci_2014_Sep_6_10(9)_990-996.nxml.txt.nlp	25210497	SENT113	19	19	0	0	evodiamine	TRPV1	PA165860788	7442	0.774
NULL	Cancer_Causes_Control_2013_Aug_18_24(8)_1605-1614.nxml.txt.nlp	23775025	SENT64	33	33	28	28	doxorubicin	DHFR	PA449412	1719	0.774
NULL	Iran_Red_Crescent_Med_J_2013_Mar_5_15(3)_249-253.nxml.txt.nlp	23984007	SENT69	15	15	26	26	carbamazepine	B12	PA448785	7126;4709	0.774
NULL	Mol_Cell_Neurosci_2014_Mar_59(100)_24-36.nxml.txt.nlp	24444792	SENT664	29	29	5	5	calcein	CA1	PA132595336	759	0.774
NULL	Ther_Clin_Risk_Manag_2005_Jun_1(2)_125-140.nxml.txt.nlp	18360552	SENT269	14	14	8	8	montelukast	ACR	PA450546	49	0.774
NULL	Asia_Pac_Allergy_2014_Jul_29_4(3)_156-163.nxml.txt.nlp	25097851	SENT34	25	25	22	22	pyrazinamide	EMB	PA451182	133418	0.774
NULL	J_Breast_Cancer_2011_Jun_18_14(2)_140-146.nxml.txt.nlp	21847410	SENT170	11	11	36	36	trastuzumab	HER2	PA451743	2064	0.774
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT1404	7	7	1	1	heparin	HGF	PA449855	3569;6654;3082	0.774
NULL	Sci_Rep_2015_Jan_19_5_7830.nxml.txt.nlp	25597938	SENT366	1	1	4	4	triamcinolone	IL-6	PA451749	3569	0.774
NULL	Oncol_Lett_2014_May_11_7(5)_1401-1408.nxml.txt.nlp	24765145	SENT156	2	2	11	11	paclitaxel	HIF-1	PA450761	29072	0.774
NULL	Br_J_Cancer_2012_Feb_14_106(4)_646-650.nxml.txt.nlp	22240794	SENT11	7	7	9	9	sunitinib	IFN	PA162372840	3439	0.774
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT117	6	6	4	4	gefitinib	KRAS	PA131301952	3845	0.774
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1563-1573.nxml.txt.nlp	22015557	SENT122	13	13	24	24	sunitinib	c-Myc	PA162372840	4609	0.774
NULL	Evid_Based_Complement_Alternat_Med_2011_Mar_14_2011_635058.nxml.txt.nlp	21437195	SENT228	15	15	12	12	roflumilast	PDE4D	PA165948052	5144	0.774
NULL	Mol_Biol_Cell_2014_May_1_25(9)_1411-1420.nxml.txt.nlp	24623724	SENT116	5	5	13	13	tetracycline	ATF6	PA451640	22926	0.774
NULL	J_Antimicrob_Chemother_2013_Mar_9_68(3)_697-707.nxml.txt.nlp	23143901	SENT148	21	21	23	23	zanamivir	ZAN	PA164740891	7455	0.774
NULL	Mol_Cancer_2012_Oct_22_11_80.nxml.txt.nlp	23088607	SENT67	14	14	29	29	fulvestrant	YC1	PA164747170	5937	0.774
NULL	Cell_Cycle_2013_Feb_15_12(4)_625-634.nxml.txt.nlp	23324396	SENT59	16	16	20	20	doxycycline	p53	PA449415	7157	0.774
NULL	Anal_Bioanal_Chem_2009_Oct_30_395(4)_893-905.nxml.txt.nlp	19484227	SENT186	16	16	8	8	neomycin	OTC	PA450608	5009	0.774
NULL	J_Biomed_Biotechnol_2011_Jul_3_2011_343791.nxml.txt.nlp	21799660	SENT119	6	6	16	16	ethanol	COD	PA448073	6628	0.774
NULL	Cases_J_2009_May_26_2_6567.nxml.txt.nlp	19829827	SENT36	17	17	13	13	capecitabine	IFN	PA448771	3439	0.774
NULL	Evid_Based_Complement_Alternat_Med_2012_Feb_12_2012_472897.nxml.txt.nlp	22454667	SENT146	0	0	15	15	hesperetin	IL-4	PA164742902	3565	0.774
NULL	Breast_Cancer_Res_2007_Sep_17_9(5)_R61.nxml.txt.nlp	17875215	SENT48	16	16	6	6	gefitinib	EGFR	PA131301952	1956	0.774
NULL	Mol_Syst_Biol_2011_Apr_26_7_486.nxml.txt.nlp	21525872	SENT501	7	7	36	36	simvastatin	COX1	PA451363	4512;5742	0.774
NULL	Int_J_Environ_Res_Public_Health_2014_Apr_3_11(4)_3728-3742.nxml.txt.nlp	24705360	SENT413	3	3	11	11	allopurinol	adiponectin	PA448320	9370	0.774
NULL	Semin_Immunopathol_2012_Jan_6_34(1)_127-132.nxml.txt.nlp	21822632	SENT41	14	14	16	16	thrombin	PAR-1	PA451674	2011;2149	0.774
NULL	Clin_Med_Oncol_2008_Jun_11_2_469-470.nxml.txt.nlp	21892319	SENT25	14	14	20	20	trastuzumab	HER2	PA451743	2064	0.774
NULL	EMBO_Mol_Med_2012_Aug_6_4(8)_705-718.nxml.txt.nlp	22674894	SENT193	0	0	9	9	tamoxifen	p53	PA451581	7157	0.774
NULL	Behav_Brain_Funct_2012_Jul_10_8_20.nxml.txt.nlp	22559224	SENT188	5	5	1	1	baclofen	ANOVA	PA448533	4858	0.774
NULL	Anesth_Essays_Res_2012_Jul-Dec_6(2)_140-146.nxml.txt.nlp	NULL	SENT101	28	28	9	9	lidocaine	IL8	PA450226	3576	0.774
NULL	Diabetes_Care_2013_Aug_11_36(8)_2233-2238.nxml.txt.nlp	23564917	SENT29	9	9	15	15	glucose	MNT	PA449773	4335	0.774
NULL	Iran_J_Pharm_Res_2013_Winter_12(Suppl)_37-46.nxml.txt.nlp	24250670	SENT201	5	5	7	7	ganciclovir	P-gp	PA449733	5243	0.774
NULL	J_Exp_Med_1996_Dec_1_184(6)_2341-2352.nxml.txt.nlp	8976188	SENT252	4	4	10	10	neomycin	PGK	PA450608	5592	0.774
NULL	J_Res_Med_Sci_2012_May_17(5)_487-490.nxml.txt.nlp	23626617	SENT18	14	14	20	20	vincristine	CHOP	PA451879	1649	0.774
NULL	Apoptosis_2014_Apr_23_19(7)_1055-1068.nxml.txt.nlp	24756955	SENT152	13	13	22	22	cisplatin	p53	PA449014	7157	0.774
NULL	J_Oncol_2009_Mar_24_2009_491985.nxml.txt.nlp	19325924	SENT168	16	16	5	5	genistein	CXCL12	PA165109660	6387	0.774
NULL	Arch_Virol_2014_Dec_24_159(6)_1365-1371.nxml.txt.nlp	24366548	SENT147	25	25	12	12	ribavirin	IL28B	PA451241	282617	0.774
NULL	J_Gen_Physiol_2000_Jun_1_115(6)_685-696.nxml.txt.nlp	10828243	SENT163	6	6	10	10	genistein	OLF	PA165109660	83857	0.774
NULL	J_Carcinog_2013_Aug_8_12_16.nxml.txt.nlp	24082825	SENT117	9	9	1	1	dasatinib	PI3K	PA162372878	5290	0.774
NULL	Braz_J_Med_Biol_Res_2014_Feb_17_47(2)_101-109.nxml.txt.nlp	24519125	SENT197	0	0	28	28	forskolin	IL-6	PA146096022	3569	0.774
NULL	J_Biol_Chem_2010_Aug_20_285(34)_26211-26222.nxml.txt.nlp	20554518	SENT58	36	36	11	11	gentamicin	CO2	PA449753	4513	0.774
NULL	Front_Immunol_2013_Sep_17_4_281.nxml.txt.nlp	24062747	SENT380	28	28	20	20	atorvastatin	IFN	PA448500	3439	0.774
NULL	Indian_J_Crit_Care_Med_2008_Oct-Dec_12(4)_181-189.nxml.txt.nlp	19742267	SENT202	5	5	21	21	anakinra	ACR	PA10799	49	0.774
NULL	Ann_Hematol_2008_Jan_16_87(1)_1-10.nxml.txt.nlp	17938925	SENT141	11	11	8	8	imatinib	PDGFRB	PA10804	5159	0.774
NULL	Biochimie_2012_Sep_94(9)_1997-2005.nxml.txt.nlp	22659570	SENT54	14	14	10	10	pp2	JNK		5599	0.774
NULL	Thorax_2011_Dec_23_66(12)_1029-1035.nxml.txt.nlp	21606476	SENT75	39	39	22	22	papaverine	EP2	PA164745550	5732;10407	0.774
NULL	Cell_Death_Dis_2014_Mar_20_5(3)_e1138.nxml.txt.nlp	24651441	SENT95	4	4	24	24	paclitaxel	P-gp	PA450761	5243	0.774
NULL	J_Headache_Pain_2011_Apr_5_12(2)_219-226.nxml.txt.nlp	20686810	SENT156	2	2	24	24	frovatriptan	5-HT1B	PA164754891	3351	0.774
NULL	Evid_Based_Complement_Alternat_Med_2013_Mar_21_2013_701956.nxml.txt.nlp	23573147	SENT241	17	17	8	8	tacrine	spatial	PA451576	219793	0.774
NULL	Clinics_(Sao_Paulo)_2013_Feb_68(2)_253-262.nxml.txt.nlp	23525324	SENT221	14	14	23	23	genistein	Gen	PA165109660	348654	0.774
NULL	J_Cell_Biol_1998_Apr_6_141(1)_5-20.nxml.txt.nlp	9531544	SENT444	1	1	4	4	dextran	mol	PA449261	90527	0.774
NULL	Cardiovasc_Diabetol_2007_Apr_3_6_12.nxml.txt.nlp	17407587	SENT195	11	11	7	7	telmisartan	AT1	PA451605	9197;185	0.774
NULL	Ann_Clin_Microbiol_Antimicrob_2007_Oct_30_6_13.nxml.txt.nlp	17967199	SENT9	27	27	19	19	vancomycin	VISA	PA451850	57506	0.774
NULL	Cell_Death_Dis_2014_Feb_13_5(2)_e1055.nxml.txt.nlp	24525731	SENT77	4	4	21	21	irinotecan	XRCC1	PA450085	7515	0.774
NULL	Cancer_Manag_Res_2014_Oct_17_6_423-430.nxml.txt.nlp	25378950	SENT66	3	3	19	19	anastrozole	aromatase	PA448432	1588	0.774
NULL	Croat_Med_J_2014_Aug_55(4)_366-376.nxml.txt.nlp	25165050	SENT301	11	11	5	5	nortriptyline	ABCB1	PA450657	5243	0.774
NULL	Mol_Vis_2007_Jul_9_13_1083-1093.nxml.txt.nlp	17653053	SENT160	2	2	19	19	minocycline	eotaxin	PA450519	6356	0.774
NULL	Mol_Cancer_2010_Aug_20_9_220.nxml.txt.nlp	20727180	SENT232	5	5	21	21	curcumin	p53	PA151958596	7157	0.774
NULL	Mol_Cancer_2012_Jun_18_11_41.nxml.txt.nlp	22709873	SENT39	9	9	28	28	lapatinib	PI3K	PA152241907	5290	0.774
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT1673	26	26	21	21	diazepam	CYP1A1	PA449283	1543	0.774
NULL	Clin_Epigenetics_2011_Dec_5_3(1)_8.nxml.txt.nlp	22414275	SENT156	5	5	11	11	ribavirin	ESR1	PA451241	2099	0.774
NULL	Cell_Cycle_2012_Dec_15_11(24)_4661-4672.nxml.txt.nlp	23187802	SENT33	15	15	13	13	doxorubicin	p53	PA449412	7157	0.774
NULL	Breast_Cancer_Res_2007_Mar_2_9(2)_205.nxml.txt.nlp	NULL	SENT26	37	37	29	29	gefitinib	EGFR	PA131301952	1956	0.774
NULL	Core_Evid_2010_Oct_21_5_61-76.nxml.txt.nlp	21042543	SENT358	20	20	7	7	cetuximab	KRAS	PA10040	3845	0.774
NULL	Oncotarget_2014_Nov_5_5(22)_11381-11398.nxml.txt.nlp	25359767	SENT231	11	11	24	24	gemcitabine	PIF1	PA449748	80119	0.774
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT199	1	1	23	23	doxorubicin	SLK	PA449412	9748;2534	0.774
NULL	Oncologist_2010_Mar_9_15(3)_236-245.nxml.txt.nlp	20215359	SENT88	7	7	9	9	bevacizumab	IFN	PA130232992	3439	0.774
NULL	Alcohol_Res_Health_2008_31(3)_196-214.nxml.txt.nlp	23584863	SENT391	7	7	1	1	rimonabant	CB1	PA152407999	1268	0.774
NULL	AAPS_J_2012_Dec_7_15(2)_308-315.nxml.txt.nlp	23224752	SENT194	0	0	18	18	ritonavir	OATP1B1	PA451260	10599	0.774
NULL	Breast_Cancer_Res_2010_Jun_28_12(3)_R43.nxml.txt.nlp	20579400	SENT274	9	9	0	0	tamoxifen	MAPT	PA451581	4137	0.773
NULL	AMB_Express_2012_Aug_1_2_39.nxml.txt.nlp	22853547	SENT142	17	17	15	15	l-leucine	mol	PA450197	90527	0.773
NULL	Mol_Cancer_2010_Aug_16_9_217.nxml.txt.nlp	20712901	SENT37	30	30	21	21	curcumin	STAT3	PA151958596	6774	0.773
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT99	10	10	18	18	celecoxib	IL-6	PA448871	3569	0.773
NULL	Target_Oncol_2013_Jun_27_8(2)_127-136.nxml.txt.nlp	23625191	SENT109	10	10	24	24	panitumumab	KRAS	PA162373091	3845	0.773
NULL	J_Invest_Dermatol_2012_Sep_19_132(9)_2198-2205.nxml.txt.nlp	22513780	SENT84	0	0	18	18	isotretinoin	IFN	PA450128	3439	0.773
NULL	J_Hematol_Oncol_2009_Jan_21_2_2.nxml.txt.nlp	19159467	SENT116	11	11	5	5	cetuximab	EGFR	PA10040	1956	0.773
NULL	Molecules_2013_Jul_26_18(8)_8945-8958.nxml.txt.nlp	23896619	SENT192	8	8	13	13	l-glutamine	FBS	PA10090	64319;26269	0.773
NULL	Drug_Des_Devel_Ther_2014_Sep_23_8_1527-1538.nxml.txt.nlp	25284985	SENT156	13	13	11	11	celecoxib	IFN	PA448871	3439	0.773
NULL	J_Oncol_2009_Jul_27_2009_305420.nxml.txt.nlp	19644558	SENT100	44	44	9	9	trastuzumab	p27	PA451743	5715;10534	0.773
NULL	Cancer_Immunol_Immunother_2013_Aug_27_62(10)_1637-1648.nxml.txt.nlp	23982484	SENT165	0	0	15	15	lenalidomide	CD16	PA162363968	2215;2214	0.773
NULL	Pharmaceuticals_(Basel)_2014_Apr_10_7(4)_433-452.nxml.txt.nlp	24727459	SENT378	15	15	20	20	saquinavir	CYP3A4	PA451305	1576	0.773
NULL	Acta_Physiol_(Oxf)_2007_Sep_191(1)_43-57.nxml.txt.nlp	17524066	SENT182	13	13	33	33	nifedipine	PES	PA450631	23481	0.773
NULL	Tumour_Biol_2012_Dec_14_33(6)_2209-2216.nxml.txt.nlp	22890830	SENT159	15	15	19	19	cetuximab	KRAS	PA10040	3845	0.773
NULL	Oncotarget_2013_Dec_7_4(12)_2532-2549.nxml.txt.nlp	24345883	SENT286	17	17	0	0	cisplatin	EZH2	PA449014	2146	0.773
NULL	J_Korean_Med_Sci_2009_Jan_29_24(Suppl_1)_S183-S188.nxml.txt.nlp	19194550	SENT107	3	3	15	15	celecoxib	COX	PA448871	1351	0.773
NULL	Oncol_Lett_2014_Sep_19_8(3)_1269-1274.nxml.txt.nlp	25120704	SENT12	19	19	7	7	cisplatin	Met	PA449014	79811	0.773
NULL	Arthritis_Res_Ther_2014_Oct_10_16(5)_454.nxml.txt.nlp	25301447	SENT37	12	12	25	25	creatine	BAFF	PA164778930	10673	0.773
NULL	Clinics_(Sao_Paulo)_2014_Jan_69(1)_68-74.nxml.txt.nlp	24473562	SENT89	36	36	7	7	nutlin-3	p53		7157	0.773
NULL	Int_J_Med_Sci_2015_Jan_1_12(1)_23-31.nxml.txt.nlp	25552915	SENT148	36	36	2	2	oxygen	CAT	PA450744	847	0.773
NULL	Nucleic_Acids_Res_2005_May_19_33(9)_2859-2867.nxml.txt.nlp	15905475	SENT118	17	17	10	10	temozolomide	MPG	PA451609	4350	0.773
NULL	Cancer_Immunol_Immunother_2011_Jun_25_60(6)_793-808.nxml.txt.nlp	21350947	SENT284	21	21	39	39	sorafenib	IFNAR2	PA7000	3455	0.773
NULL	Oncol_Lett_2013_Dec_4_6(6)_1665-1672.nxml.txt.nlp	24273604	SENT88	7	7	3	3	chloroquine	TLR9	PA448948	54106	0.773
NULL	Acta_Pharmacol_Sin_2010_Jan_5_31(1)_93-101.nxml.txt.nlp	20048748	SENT11	8	8	13	13	cisplatin	DAPK	PA449014	1612	0.773
NULL	Asian-Australas_J_Anim_Sci_2014_Aug_27(8)_1150-1156.nxml.txt.nlp	25083109	SENT199	2	2	8	8	l-proline	DAO	PA451125	26;1610	0.773
NULL	Core_Evid_2011_Mar_17_6_31-42.nxml.txt.nlp	21468241	SENT135	26	26	13	13	ticagrelor	ADP	PA165374673	23038	0.773
NULL	Arch_Med_Sci_2013_Jun_20_9(3)_466-471.nxml.txt.nlp	23847668	SENT150	23	23	13	13	tamoxifen	HER2	PA451581	2064	0.773
NULL	J_Korean_Med_Sci_2014_Jul_11_29(7)_965-972.nxml.txt.nlp	25045229	SENT11	8	8	1	1	metformin	B12	PA450395	7126;4709	0.773
NULL	Autophagy_2013_Jul_1_9(7)_996-1008.nxml.txt.nlp	23580233	SENT9	11	11	25	25	cisplatin	LC3	PA449014	84557	0.773
NULL	J_Korean_Med_Sci_2010_Apr_19_25(4)_557-563.nxml.txt.nlp	20357998	SENT116	13	13	6	6	cisplatin	IFN	PA449014	3439	0.773
NULL	Ann_Oncol_2010_Jan_21(1)_133-139.nxml.txt.nlp	20019090	SENT24	9	9	0	0	vincristine	CHOP	PA451879	1649	0.773
NULL	An_Bras_Dermatol_2014_Mar-Apr_89(2)_301-310.nxml.txt.nlp	24770508	SENT110	15	15	33	33	vinblastine	IFN	PA451877	3439	0.773
NULL	Br_J_Cancer_2011_Jan_4_104(1)_91-100.nxml.txt.nlp	21139584	SENT221	25	25	17	17	doxorubicin	BTZ	PA449412	22794	0.773
NULL	Oncol_Lett_2014_Jun_14_7(6)_2130-2134.nxml.txt.nlp	24932302	SENT21	25	25	5	5	eltrombopag	TPO	PA165981594	7066;7173	0.773
NULL	J_Med_Case_Reports_2011_Jan_17_5_13.nxml.txt.nlp	21241493	SENT50	40	40	28	28	meropenem	HCAP	PA164764445	117159;9126	0.773
NULL	Cells_2014_Nov_27_3(4)_1089-1101.nxml.txt.nlp	25437439	SENT71	1	1	32	32	spermine	TRPM7	PA164781199	54822	0.773
NULL	Oncogene_2010_Jul_8_29(27)_3896-3907.nxml.txt.nlp	20453888	SENT125	10	10	2	2	trastuzumab	HER2	PA451743	2064	0.773
NULL	Oncoimmunology_2013_Jan_1_2(1)_e23033.nxml.txt.nlp	23483678	SENT66	28	28	40	40	dacarbazine	IFN	PA449197	3439	0.773
NULL	Sci_Rep_2014_Nov_28_4_7237.nxml.txt.nlp	25429875	SENT86	34	34	22	22	hesperidin	JNK	PA449867	5599	0.773
NULL	J_Gastroenterol_2014_Dec_24_49(12)_1536-1547.nxml.txt.nlp	24366288	SENT126	9	9	0	0	omeprazole	CYP2C19	PA450704	1557	0.773
NULL	ScientificWorldJournal_2012_Jul_31_2012_475675.nxml.txt.nlp	22919323	SENT36	41	41	8	8	metformin	ghrelin	PA450395	51738	0.773
NULL	Evid_Based_Complement_Alternat_Med_2014_Jun_17_2014_931269.nxml.txt.nlp	25045392	SENT339	5	5	0	0	ethanol	ANOVA	PA448073	4858	0.773
NULL	Eur_J_Clin_Pharmacol_2012_Sep_15_68(9)_1267-1274.nxml.txt.nlp	22418828	SENT31	31	31	7	7	pantoprazole	CYP2C19	PA450774	1557	0.773
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT227	25	25	18	18	doxorubicin	B7-H1	PA449412	29126	0.773
NULL	Oncol_Lett_2013_Sep_8_6(3)_789-794.nxml.txt.nlp	24137412	SENT144	34	34	24	24	cisplatin	BCL2	PA449014	596	0.773
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT517	3	3	13	13	delavirdine	CYP2C9	PA449223	1559	0.773
NULL	Diabetol_Metab_Syndr_2014_Sep_8_6(1)_95.nxml.txt.nlp	NULL	SENT0	16	16	22	22	liraglutide	GLP-1	PA165958364	100125288	0.773
NULL	Cancer_Cell_Int_2010_Sep_9_10_32.nxml.txt.nlp	20828393	SENT52	16	16	18	18	cisplatin	ATF3	PA449014	467	0.773
NULL	Ther_Clin_Risk_Manag_2006_Jun_2(2)_129-158.nxml.txt.nlp	18360588	SENT120	0	0	12	12	voriconazole	CYP2C19	PA10233	1557	0.773
NULL	Iran_Red_Crescent_Med_J_2014_Aug_5_16(8)_e6915.nxml.txt.nlp	25389496	SENT116	8	8	16	16	simvastatin	adiponectin	PA451363	9370	0.773
NULL	Ann_Indian_Acad_Neurol_2014_Mar_17(Suppl_1)_S3-S11.nxml.txt.nlp	24791085	SENT215	25	25	27	27	lorazepam	LOR	PA450267	4014	0.773
NULL	Interdiscip_Toxicol_2012_Dec_5(4)_192-200.nxml.txt.nlp	23554563	SENT305	2	2	10	10	ceftriaxone	ALAD	PA448866	210	0.773
NULL	Br_J_Cancer_2009_Nov_3_101(9)_1620-1629.nxml.txt.nlp	19809428	SENT21	0	0	12	12	geldanamycin	Hsp90	PA152031327	3320	0.773
NULL	Br_J_Cancer_2011_Jul_12_105(2)_255-262.nxml.txt.nlp	21694725	SENT43	16	16	4	4	irinotecan	KRAS	PA450085	3845	0.773
NULL	Int_J_Chron_Obstruct_Pulmon_Dis_2007_Jun_2(2)_157-167.nxml.txt.nlp	18044688	SENT106	7	7	12	12	tiotropium	TDI	PA164769056	100038246	0.773
NULL	F1000_Med_Rep_2009_Feb_24_1_13.nxml.txt.nlp	20948769	SENT79	15	15	42	42	rituximab	CHOP	PA451261	1649	0.773
NULL	Biosci_Rep_2012_Aug_1_32(Pt_4)_361-374.nxml.txt.nlp	22762204	SENT184	19	19	33	33	etoposide	PUMA	PA449552	27113	0.773
NULL	Br_J_Cancer_2012_Feb_14_106(4)_685-692.nxml.txt.nlp	22294184	SENT198	10	10	29	29	lovastatin	JNK	PA450272	5599	0.773
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT378	34	34	10	10	resveratrol	SRC3		8202	0.773
NULL	Eur_J_Clin_Pharmacol_2012_Jan_8_68(1)_29-37.nxml.txt.nlp	21739267	SENT135	15	15	26	26	paroxetine	CYP2D6	PA450801	1565	0.773
NULL	Clin_Transl_Allergy_2013_Sep_2_3_29.nxml.txt.nlp	24004581	SENT90	5	5	9	9	omalizumab	IL-8	PA164752253	3576	0.773
NULL	Curr_HIV_Res_2014_May_12(3)_174-188.nxml.txt.nlp	24862327	SENT148	25	25	37	37	hemin	MCP-1	PA449849	6347	0.773
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT128	17	17	6	6	metformin	AMPK	PA450395	5563	0.773
NULL	Diabetes_Care_2008_Aug_31(8)_1635-1638.nxml.txt.nlp	18458144	SENT28	17	17	22	22	ramipril	DREAM	PA451223	30818	0.773
NULL	J_Biol_Chem_2009_Feb_27_284(9)_5645-5653.nxml.txt.nlp	19095655	SENT217	10	10	30	30	rolipram	AMPK	PA153906323	5563	0.773
NULL	Nat_Med_2010_Nov_17_16(11)_1328-1332.nxml.txt.nlp	20953200	SENT138	17	17	34	34	fluoxetine	AAT	PA449673	5265	0.773
NULL	J_Int_AIDS_Soc_2012_Oct_9_15(2)_17324.nxml.txt.nlp	23078767	SENT140	37	37	9	9	fluconazole	CD4	PA449653	920	0.773
NULL	Eur_J_Neurosci_2007_Sep_26(6)_1657-1669.nxml.txt.nlp	17880399	SENT272	21	21	0	0	haloperidol	DAO	PA449841	26;1610	0.773
NULL	Oncotarget_2013_Nov_22_5(4)_933-943.nxml.txt.nlp	24659749	SENT93	2	2	19	19	nutlin-3	AML2		864	0.773
NULL	Br_J_Ophthalmol_2008_Sep_22_92(9)_1275-1282.nxml.txt.nlp	18723745	SENT85	2	2	9	9	latanoprost	BAK	PA164774763	578	0.773
NULL	Vet_Res_Forum_2013_Winter_4(1)_19-24.nxml.txt.nlp	25593681	SENT84	31	31	37	37	diclofenac	B12	PA449293	7126;4709	0.773
NULL	Indian_J_Pharmacol_2014_Jan-Feb_46(1)_46-50.nxml.txt.nlp	24550584	SENT129	16	16	26	26	metformin	GLP-1	PA450395	100125288	0.773
NULL	Carcinogenesis_2010_Dec_27_31(12)_2049-2057.nxml.txt.nlp	20876285	SENT91	7	7	0	0	tamoxifen	HER2	PA451581	2064	0.773
NULL	Diabetes_2009_Jan_58(1)_243-249.nxml.txt.nlp	18840785	SENT15	2	2	9	9	vildagliptin	GLP-1	PA165958346	100125288	0.773
NULL	Br_J_Cancer_2012_Feb_14_106(4)_685-692.nxml.txt.nlp	22294184	SENT251	4	4	8	8	docetaxel	p27	PA449383	5715;10534	0.773
NULL	Ann_Surg_Oncol_2012_Dec_6_19(13)_4287-4299.nxml.txt.nlp	22766981	SENT20	15	15	25	25	capecitabine	VEGF-A	PA448771	7422	0.773
NULL	Nature_2012_Dec_13_492(7428)_285-289.nxml.txt.nlp	23103865	SENT165	14	14	19	19	doxycycline	POT1	PA449415	25913	0.773
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT120	1	1	34	34	curcumin	TRAIL	PA151958596	8743	0.773
NULL	Curr_Control_Trials_Cardiovasc_Med_2001_Jul_20_2(4)_165-170.nxml.txt.nlp	11806791	SENT63	24	24	15	15	thrombin	PAR-1	PA451674	2011;2149	0.773
NULL	Br_J_Cancer_1967_Mar_21(1)_33-39.nxml.txt.nlp	6024514	SENT0	10	10	13	13	podophyllum	SPG	PA10162	55764	0.773
NULL	Front_Oncol_2013_Nov_15_3_281.nxml.txt.nlp	24298448	SENT188	29	29	20	20	cetuximab	NRAS	PA10040	4893	0.773
NULL	J_Invest_Dermatol_2012_Mar_8_132(3)_882-886.nxml.txt.nlp	22158552	SENT111	12	12	24	24	imiquimod	TLR7	PA449972	51284	0.773
NULL	Avicenna_J_Med_Biotechnol_2009_Jul-Sep_1(2)_125-131.nxml.txt.nlp	23407681	SENT26	33	33	20	20	thyroglobulin	NT3	PA164754910	4877;6272	0.773
NULL	Breast_Cancer_Res_2005_Jul_18_7(5)_187-189.nxml.txt.nlp	16168136	SENT25	11	11	2	2	tamoxifen	HER2	PA451581	2064	0.773
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT194	7	7	5	5	erlotinib	CYP2C8	PA134687924	1558	0.773
NULL	Braz_J_Med_Biol_Res_2013_Aug_13_46(8)_650-658.nxml.txt.nlp	23969971	SENT10	1	1	22	22	oxaliplatin	STAT3	PA131285527	6774	0.773
NULL	BMJ_Open_2013_Nov_4_3(11)_e003995.nxml.txt.nlp	24189085	SENT36	22	22	19	19	liraglutide	GLP-1	PA165958364	100125288	0.773
NULL	J_Lipid_Res_2014_Feb_55(2)_190-200.nxml.txt.nlp	24273196	SENT10	12	12	23	23	lipase	HSL	PA450239	3991	0.773
NULL	Oncogene_2010_May_20_29(20)_3010-3016.nxml.txt.nlp	20208559	SENT131	18	18	10	10	heparin	San	PA449855	80218	0.773
NULL	Oncotarget_2014_Oct_18_5(22)_11641-11652.nxml.txt.nlp	25361002	SENT85	29	29	20	20	cisplatin	NAC	PA449014	22861	0.773
NULL	Cell_Death_Dis_2013_Jan_31_4(1)_e478.nxml.txt.nlp	23370278	SENT84	1	1	9	9	bleomycin	FANCD2	PA448645	2177	0.773
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Dec_8_67(Pt_1)_o50.nxml.txt.nlp	21522760	SENT48	18	18	33	33	ethanol	mol	PA448073	90527	0.773
NULL	EPMA_J_2010_Sep_20_1(3)_421-437.nxml.txt.nlp	23199086	SENT192	5	5	10	10	tamoxifen	HOXB13	PA451581	10481	0.773
NULL	Cancers_(Basel)_2011_Apr_1_3(2)_1844-1860.nxml.txt.nlp	24212785	SENT620	2	2	11	11	cetuximab	PIK3CA	PA10040	5290	0.773
NULL	Breast_Cancer_(Auckl)_2009_Sep_2_3_61-75.nxml.txt.nlp	19809577	SENT127	4	4	30	30	curcumin	survivin	PA151958596	332	0.773
NULL	J_Cancer_2013_Aug_28_4(7)_585-596.nxml.txt.nlp	24069069	SENT152	0	0	4	4	verteporfin	p62	PA451871	8878;10657;23636	0.773
NULL	J_Cell_Mol_Med_2013_Dec_6_17(12)_1588-1597.nxml.txt.nlp	24199964	SENT61	4	4	1	1	dobutamine	APT	PA449381	653639	0.773
NULL	Dev_Cell_2014_Sep_8_30(5)_541-552.nxml.txt.nlp	25175707	SENT567	20	20	9	9	dextran	VEGF-A	PA449261	7422	0.773
NULL	J_Vet_Med_Sci_2014_Sep_9_76(9)_1291-1295.nxml.txt.nlp	24909969	SENT22	22	22	20	20	proguanil	ATV	PA451124	4683	0.773
NULL	Oncotarget_2012_Dec_17_4(1)_48-63.nxml.txt.nlp	23295955	SENT182	18	18	9	9	cisplatin	MTHFD2	PA449014	10797	0.773
NULL	Indian_J_Pharm_Sci_2008_Jan-Feb_70(1)_102-105.nxml.txt.nlp	20390092	SENT40	30	30	32	32	domperidone	DOM	PA134711056	6663	0.773
NULL	Environ_Health_Perspect_2013_May_22_121(5)_551-557.nxml.txt.nlp	23434795	SENT175	6	6	29	29	hyaluronan	BAL	PA165958431	83666	0.773
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT105	2	2	9	9	neratinib	HER2	PA165291472	2064	0.773
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jan_12_67(Pt_2)_o322.nxml.txt.nlp	21523008	SENT61	0	0	6	6	benzaldehyde	mol	PA448571	90527	0.773
NULL	Carcinogenesis_2014_May_13_35(5)_1055-1066.nxml.txt.nlp	24419232	SENT301	4	4	14	14	metformin	CYP1B1	PA450395	1545	0.773
NULL	Curr_Neuropharmacol_2008_Jun_6(2)_151-163.nxml.txt.nlp	19305794	SENT111	6	6	0	0	capsaicin	TRPV1	PA448776	7442	0.773
NULL	J_Cell_Biol_2002_Jun_24_157(7)_1267-1278.nxml.txt.nlp	12082084	SENT654	4	4	11	11	thrombin	Rho	PA451674	29984	0.773
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT283	6	6	18	18	trastuzumab	HER2	PA451743	2064	0.773
NULL	J_Ophthalmol_2012_Nov_3_2012_852183.nxml.txt.nlp	22132316	SENT116	12	12	29	29	ranibizumab	VEGF-A	PA164746012	7422	0.773
NULL	Acta_Pharmacol_Sin_2014_Jan_9_35(1)_1-10.nxml.txt.nlp	24317012	SENT69	19	19	6	6	vincristine	MRP1	PA451879	4437	0.773
NULL	Biomed_Res_Int_2013_Sep_5_2013_929531.nxml.txt.nlp	24083250	SENT188	7	7	1	1	hyaluronan	CD44	PA165958431	960	0.773
NULL	Cancer_Immunol_Immunother_2012_Jul_23_61(7)_1101-1111.nxml.txt.nlp	22193989	SENT99	4	4	10	10	oxaliplatin	IL-6	PA131285527	3569	0.773
NULL	Int_J_Gen_Med_2012_Jun_18_5_535-540.nxml.txt.nlp	22807641	SENT63	23	23	19	19	pitavastatin	adiponectin	PA142650384	9370	0.773
NULL	Indian_Dermatol_Online_J_2011_Jul-Dec_2(2)_111-119.nxml.txt.nlp	23130241	SENT326	12	12	0	0	cyclosporine	FAE	PA449167	2178	0.773
NULL	Daru_2012_Dec_5_20(1)_87.nxml.txt.nlp	23351503	SENT164	25	25	31	31	isoproterenol	ANOVA	PA450121	4858	0.773
NULL	Mol_Cancer_2008_Jun_4_7_49.nxml.txt.nlp	18533032	SENT107	19	19	7	7	tamoxifen	MUC1	PA451581	4582	0.773
NULL	Pharmaceuticals_(Basel)_2014_Mar_5_7(3)_311-338.nxml.txt.nlp	24603603	SENT60	7	7	21	21	cetuximab	EGFR	PA10040	1956	0.773
NULL	Acta_Pharmacol_Sin_2013_Sep_5_34(9)_1192-1200.nxml.txt.nlp	23685957	SENT132	8	8	10	10	curcumin	AP-2	PA151958596	7020	0.773
NULL	Diabetes_2011_Mar_21_60(3)_710-719.nxml.txt.nlp	21282365	SENT67	29	29	0	0	aprotinin	ARC	PA448472	8996;23237	0.773
NULL	Br_J_Cancer_2009_Oct_20_101(8)_1253-1260.nxml.txt.nlp	19755984	SENT192	4	4	18	18	letrozole	HER-2	PA450196	2064	0.773
NULL	Cancer_Cell_Int_2011_Dec_29_11_44.nxml.txt.nlp	22206574	SENT51	28	28	32	32	sorafenib	p38	PA7000	10598;1432;7965	0.773
NULL	J_Gastroenterol_2013_Feb_22_48(2)_222-237.nxml.txt.nlp	22722906	SENT303	27	27	46	46	ethanol	p38	PA448073	10598;1432;7965	0.773
NULL	Breast_Cancer_Res_2007_May_30_9(3)_R34.nxml.txt.nlp	17537232	SENT173	16	16	34	34	tamoxifen	TP53	PA451581	7157	0.773
NULL	Mol_Cancer_2009_Aug_25_8_66.nxml.txt.nlp	19706164	SENT77	5	5	8	8	celecoxib	p53	PA448871	7157	0.773
NULL	Oxid_Med_Cell_Longev_2013_Apr_21_2013_412576.nxml.txt.nlp	23710286	SENT247	15	15	3	3	curcumin	NRF2	PA151958596	2551;4780	0.773
NULL	Diabetes_Care_2012_Feb_16_35(2)_327-333.nxml.txt.nlp	22179958	SENT93	2	2	22	22	metformin	B12	PA450395	7126;4709	0.773
NULL	Front_Oncol_2014_Sep_15_4_248.nxml.txt.nlp	25309873	SENT211	19	19	25	25	gefitinib	EGFR	PA131301952	1956	0.773
NULL	J_Antimicrob_Chemother_2014_Feb_29_69(2)_368-374.nxml.txt.nlp	24080503	SENT40	11	11	6	6	sulfamethoxazole	BSAC	PA451544	57591	0.773
NULL	Breast_Cancer_Res_2001_Mar_26_3(3)_180-182.nxml.txt.nlp	11305952	SENT19	9	9	21	21	letrozole	aromatase	PA450196	1588	0.773
NULL	Core_Evid_2012_Dec_11_7_131-143.nxml.txt.nlp	23271985	SENT112	16	16	39	39	vancomycin	hole	PA451850	80757	0.773
NULL	BioDrugs_2013_Jun_7_27(6)_591-603.nxml.txt.nlp	23743670	SENT93	12	12	27	27	cisplatin	TRAMP	PA449014	8718;23471;9189	0.773
NULL	Int_J_Surg_Oncol_2012_Jun_12_2012_862879.nxml.txt.nlp	22778941	SENT234	9	9	5	5	cisplatin	BIN1	PA449014	274	0.773
NULL	Patient_Prefer_Adherence_2008_Feb_2_2_387-392.nxml.txt.nlp	19920986	SENT20	2	2	13	13	methotrexate	IFN	PA450428	3439	0.773
NULL	Nat_Med_2012_Mar_4_18(4)_547-554.nxml.txt.nlp	22388091	SENT249	32	32	21	21	methacholine	IL-17A	PA165958382	3605	0.773
NULL	Int_J_Surg_Oncol_2012_Jun_12_2012_862879.nxml.txt.nlp	22778941	SENT124	40	40	19	19	cisplatin	PARP1	PA449014	142	0.773
NULL	Diabetologia_2010_Sep_6_53(9)_2056-2065.nxml.txt.nlp	20526760	SENT217	17	17	7	7	glucosamine	NDST1	PA164747613	3340	0.773
NULL	J_Korean_Med_Sci_2007_Dec_20_22(6)_1055-1059.nxml.txt.nlp	18162722	SENT121	19	19	13	13	pantoprazole	ESD	PA450774	2098	0.773
NULL	Cardiol_Res_Pract_2013_Feb_19_2013_195456.nxml.txt.nlp	23533940	SENT127	7	7	15	15	prasugrel	CYP2B6	PA154410481	1555	0.773
NULL	Environ_Health_Perspect_2009_Jan_22_117(1)_112-116.nxml.txt.nlp	19165396	SENT133	29	29	32	32	estradiol	PRL	PA449503	5617	0.773
NULL	Can_J_Infect_Dis_Med_Microbiol_2014_Nov-Dec_25(6)_327-343.nxml.txt.nlp	25587296	SENT304	6	6	9	9	fluconazole	CYP3A4	PA449653	1576	0.773
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Sep_14_67(Pt_10)_o2574.nxml.txt.nlp	22058740	SENT52	23	23	38	38	ethanol	mol	PA448073	90527	0.773
NULL	Int_J_Lab_Hematol_2009_Aug_31(4)_468-470.nxml.txt.nlp	18294236	SENT13	42	42	28	28	rituximab	CHOP	PA451261	1649	0.773
NULL	Arthritis_Res_Ther_2011_Sep_29_13(5)_R157.nxml.txt.nlp	21959034	SENT35	25	25	10	10	dextran	IL-21	PA449261	59067;50616;27189	0.773
NULL	Mol_Cancer_2013_Mar_5_12_17.nxml.txt.nlp	23497256	SENT8	0	0	3	3	sunitinib	p53	PA162372840	7157	0.773
NULL	Eur_J_Med_Res_2009_Nov_24_14(Suppl_3)_22-29.nxml.txt.nlp	19959413	SENT6	31	31	19	19	efavirenz	CD4	PA449441	920	0.773
NULL	Breast_Cancer_Res_2011_Jun_21_13(3)_R66.nxml.txt.nlp	21693010	SENT274	1	1	12	12	sunitinib	c-Raf	PA162372840	5894	0.773
NULL	Pharmaceuticals_(Basel)_2013_Aug_6_6(8)_929-959.nxml.txt.nlp	24276377	SENT1235	13	13	4	4	curcumin	c-Jun	PA151958596	3725	0.773
NULL	J_Cell_Biol_1998_Jan_26_140(2)_335-345.nxml.txt.nlp	9442109	SENT84	10	10	23	23	amiloride	NHE	PA448368	285335	0.773
NULL	Ann_Dermatol_2011_Dec_27_23(Suppl_3)_S290-S295.nxml.txt.nlp	22346260	SENT91	17	17	3	3	dapsone	EED	PA449211	8726	0.773
NULL	Exp_Ther_Med_2013_May_15_5(5)_1327-1331.nxml.txt.nlp	23737873	SENT22	8	8	19	19	vasopressin	AQP2	PA451858	359	0.773
NULL	J_Occup_Med_Toxicol_2008_Feb_27_3(Suppl_1)_S6.nxml.txt.nlp	18315837	SENT79	27	27	10	10	theophylline	CD4	PA451647	920	0.773
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT163	0	0	2	2	perifosine	JNK	PA165291471	5599	0.773
NULL	Hum_Genomics_2013_Apr_5_7(1)_10.nxml.txt.nlp	23561625	SENT305	19	19	12	12	flavopiridol	CDK7	PA452627	1022	0.773
NULL	Environ_Health_Perspect_2010_Nov_25_118(11)_1603-1608.nxml.txt.nlp	20797929	SENT146	46	46	15	15	estradiol	aromatase	PA449503	1588	0.773
NULL	Adv_Hematol_2010_Dec_2_2010_424786.nxml.txt.nlp	21188274	SENT22	7	7	15	15	doxorubicin	CHOP	PA449412	1649	0.773
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT164	0	0	20	20	atorvastatin	CD14	PA448500	929	0.773
NULL	Front_Genet_2014_Feb_26_5_40.nxml.txt.nlp	24616734	SENT313	18	18	29	29	docetaxel	CCL20	PA449383	6364	0.773
NULL	J_Hematol_Oncol_2011_Jun_13_4_28.nxml.txt.nlp	21668998	SENT133	8	8	10	10	cyclophosphamide	CTX	PA449165	1593	0.773
NULL	Mol_Cancer_2009_Jul_3_8_43.nxml.txt.nlp	19575780	SENT137	5	5	9	9	colchicine	survivin	PA449092	332	0.773
NULL	J_Breast_Cancer_2013_Mar_31_16(1)_66-71.nxml.txt.nlp	23593084	SENT26	0	0	5	5	exemestane	aromatase	PA449563	1588	0.773
NULL	Indian_J_Radiol_Imaging_2011_Jan-Mar_21(1)_57-59.nxml.txt.nlp	21431035	SENT19	19	19	6	6	iohexol	CT2	PA450061	85413	0.773
NULL	Diabetes_Metab_J_2013_Dec_12_37(6)_415-422.nxml.txt.nlp	24404512	SENT66	9	9	29	29	atorvastatin	adiponectin	PA448500	9370	0.773
NULL	Environ_Health_Perspect_2009_Dec_8_117(12)_1799-1802.nxml.txt.nlp	20049195	SENT48	6	6	10	10	choline	B12	PA448976	7126;4709	0.773
NULL	Cell_Biochem_Biophys_2013_May_28_67(1)_25-43.nxml.txt.nlp	23712866	SENT108	35	35	2	2	mitomycin	USP1	PA450524	7398	0.773
NULL	Braz_J_Med_Biol_Res_2013_Aug_13_46(8)_659-669.nxml.txt.nlp	24036938	SENT233	9	9	7	7	resveratrol	SIRT1		23411	0.773
NULL	Br_J_Cancer_1996_Dec_74(12)_1908-1915.nxml.txt.nlp	8980389	SENT11	13	13	11	11	melphalan	TNF-alpha	PA450354	7124	0.773
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT156	8	8	14	14	capsaicin	p53	PA448776	7157	0.773
NULL	Acta_Pharmacol_Sin_2012_Jul_18_33(7)_861-872.nxml.txt.nlp	22705730	SENT112	35	35	28	28	atorvastatin	PI3K	PA448500	5290	0.773
NULL	Breast_Cancer_Res_2010_Oct_14_12(5)_R84.nxml.txt.nlp	20946630	SENT303	7	7	13	13	choline	Hsp90	PA448976	3320	0.773
NULL	J_Inherit_Metab_Dis_2010_Oct_3_33(5)_625-632.nxml.txt.nlp	20814828	SENT104	3	3	14	14	simvastatin	RhoA	PA451363	387	0.773
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2014_Sep_27_70(Pt_10)_2740-2753.nxml.txt.nlp	25286857	SENT312	3	3	6	6	bsi-201	TNKS2		80351	0.773
NULL	Breast_Cancer_Res_2012_Jun_25_14(3)_R97.nxml.txt.nlp	22731827	SENT235	3	3	6	6	estradiol	GAPDH	PA449503	2597	0.773
NULL	Int_J_Mol_Sci_2012_Dec_7_13(12)_16751-16768.nxml.txt.nlp	23222680	SENT170	23	23	37	37	pargyline	LSD2	PA450797	221656	0.773
NULL	Adv_Hematol_2012_Nov_20_2012_861060.nxml.txt.nlp	23251161	SENT31	36	36	29	29	lenalidomide	MVD	PA162363968	4597	0.773
NULL	Biochem_Res_Int_2012_Mar_4_2012_685267.nxml.txt.nlp	22496978	SENT202	7	7	9	9	thrombin	MT1-MMP	PA451674	4323	0.773
NULL	Cancer_Res_Treat_2013_Sep_30_45(3)_178-185.nxml.txt.nlp	24155676	SENT101	19	19	2	2	gefitinib	EGFR	PA131301952	1956	0.773
NULL	Clin_Drug_Investig_2014_Nov_9_34(2)_107-115.nxml.txt.nlp	24214232	SENT37	20	20	12	12	paricalcitol	IMPACT	PA450798	55364	0.773
NULL	Indian_J_Anaesth_2011_Nov-Dec_55(6)_567-572.nxml.txt.nlp	22223899	SENT18	16	16	12	12	isoflurane	NAC	PA450106	22861	0.773
NULL	Clin_Med_Insights_Oncol_2011_Mar_16_5_35-43.nxml.txt.nlp	21499557	SENT44	7	7	13	13	trabectedin	IL-6	PA165958349	3569	0.773
NULL	Acta_Pharmacol_Sin_2011_Feb_4_32(2)_245-252.nxml.txt.nlp	21293477	SENT112	13	13	9	9	fluorescein	ALDH2	PA164746009	217	0.773
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2007_Dec_6_64(Pt_1)_o197.nxml.txt.nlp	21200762	SENT56	11	11	27	27	ethanol	mol	PA448073	90527	0.773
NULL	Front_Genet_2015_Jan_9_5_441.nxml.txt.nlp	25620975	SENT479	4	4	14	14	camptothecin	WRN	PA153590860	7486	0.773
NULL	Drug_Target_Insights_2006_Oct_23_1_5-10.nxml.txt.nlp	21901053	SENT70	3	3	6	6	aprotinin	INCA	PA448472	440068	0.773
NULL	J_Cancer_2013_Sep_27_4(8)_662-670.nxml.txt.nlp	24155778	SENT238	6	6	3	3	cisplatin	UCHL1	PA449014	7345	0.773
NULL	Indian_J_Med_Res_2014_Apr_139(4)_572-578.nxml.txt.nlp	24927344	SENT14	32	32	5	5	acenocoumarol	CYP4F2	PA452632	8529	0.773
NULL	Oncotarget_2012_Dec_31_3(12)_1653-1668.nxml.txt.nlp	23391506	SENT106	11	11	16	16	docetaxel	U87	PA449383	677775;641648	0.773
NULL	Exp_Hematol_Oncol_2014_Jan_11_3_2.nxml.txt.nlp	24410791	SENT144	7	7	28	28	erlotinib	EGFR	PA134687924	1956	0.773
NULL	Neural_Regen_Res_2014_Mar_15_9(6)_622-629.nxml.txt.nlp	25206865	SENT71	15	15	4	4	vasopressin	c-Jun	PA451858	3725	0.773
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_May_29_66(Pt_6)_o1514.nxml.txt.nlp	21579573	SENT58	36	36	19	19	ethanol	mol	PA448073	90527	0.773
NULL	Curr_Neuropharmacol_2008_Jun_6(2)_151-163.nxml.txt.nlp	19305794	SENT551	41	41	39	39	capsaicin	VR1	PA448776	56664	0.773
NULL	Acta_Pharmacol_Sin_2009_Apr_3_30(4)_478-484.nxml.txt.nlp	19343062	SENT100	35	35	4	4	simvastatin	CYP3A4	PA451363	1576	0.773
NULL	Antiviral_Res_2009_May_82(2)_A99-A109.nxml.txt.nlp	19176219	SENT615	7	7	20	20	saquinavir	P-gp	PA451305	5243	0.773
NULL	Ann_Oncol_2014_Oct_23_25(10)_1941-1948.nxml.txt.nlp	25057173	SENT110	21	21	12	12	docetaxel	EGFR	PA449383	1956	0.773
NULL	J_Hematol_Oncol_2013_Jun_3_6_38.nxml.txt.nlp	23731980	SENT183	10	10	18	18	neratinib	HER2	PA165291472	2064	0.773
NULL	Nat_Commun_2014_Dec_8_5_5736.nxml.txt.nlp	25484020	SENT160	14	14	8	8	exemestane	TRPA1	PA449563	8989	0.773
NULL	Open_Biol_2014_Jan_4(1)_130138.nxml.txt.nlp	24403013	SENT278	4	4	17	17	etoposide	PP1	PA449552	5540;5464	0.773
NULL	Mol_Cancer_2013_Mar_2_12_16.nxml.txt.nlp	23452820	SENT133	13	13	24	24	chloroquine	NOXA	PA448948	5366	0.773
NULL	Biomed_Res_Int_2014_Jan_20_2014_948427.nxml.txt.nlp	24563867	SENT200	10	10	5	5	buspirone	COB	PA448689	4519	0.773
NULL	Cancer_Metab_2014_Nov_3_2(1)_20.nxml.txt.nlp	NULL	SENT218	8	8	3	3	erlotinib	PDK4	PA134687924	5166	0.773
NULL	Virchows_Arch_2012_Feb_16_460(2)_141-149.nxml.txt.nlp	22173329	SENT228	20	20	7	7	cetuximab	KRAS	PA10040	3845	0.773
NULL	J_Immunother_Cancer_2014_Nov_6_2(Suppl_3)_P210.nxml.txt.nlp	NULL	SENT8	0	0	7	7	curcumin	IL6	PA151958596	3569	0.773
NULL	Oxid_Med_Cell_Longev_2012_Jan_19_2012_390678.nxml.txt.nlp	22315655	SENT191	15	15	17	17	gliclazide	NAC	PA10892	22861	0.773
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Sep_20_64(Pt_10)_o1972.nxml.txt.nlp	21201172	SENT62	27	27	6	6	ethanol	mol	PA448073	90527	0.773
NULL	Crit_Care_2011_Nov_23_15(6)_R278.nxml.txt.nlp	22112587	SENT174	4	4	14	14	phenylephrine	LIR	PA450935	10871	0.773
NULL	Br_J_Cancer_2012_Feb_14_106(4)_685-692.nxml.txt.nlp	22294184	SENT192	3	3	5	5	docetaxel	survivin	PA449383	332	0.773
NULL	J_Gastroenterol_2013_Jan_24_48(1)_13-21.nxml.txt.nlp	23090000	SENT146	22	22	6	6	lamivudine	IFN	PA450163	3439	0.773
NULL	Cancers_(Basel)_2011_Apr_1_3(2)_1844-1860.nxml.txt.nlp	24212785	SENT98	29	29	36	36	irinotecan	PTEN	PA450085	5728	0.773
NULL	Br_J_Cancer_2009_Sep_15_101(6)_957-966.nxml.txt.nlp	19738618	SENT193	32	32	25	25	trastuzumab	p38	PA451743	10598;1432;7965	0.773
NULL	Br_J_Cancer_1999_Dec_81(8)_1285-1293.nxml.txt.nlp	10604724	SENT11	17	17	36	36	sn-38	p53		7157	0.773
NULL	Br_J_Pharmacol_2008_Dec_25_155(7)_1056-1065.nxml.txt.nlp	18724386	SENT257	29	29	27	27	nitrendipine	GLP-1	PA146096020	100125288	0.773
NULL	Arthritis_Res_Ther_2014_Sep_18_16(5)_427.nxml.txt.nlp	25230745	SENT145	2	2	26	26	bevacizumab	ADAMTS5	PA130232992	11096	0.773
NULL	Front_Immunol_2013_Oct_28_4_346.nxml.txt.nlp	24194739	SENT70	26	26	16	16	vemurafenib	gp100	PA165946873	6490	0.773
NULL	Oncotarget_2013_Oct_19_4(11)_2045-2056.nxml.txt.nlp	24185104	SENT103	6	6	15	15	cisplatin	p38	PA449014	10598;1432;7965	0.773
NULL	Exp_Ther_Med_2014_Nov_29_8(5)_1473-1478.nxml.txt.nlp	25289044	SENT142	19	19	12	12	heparin	AZU	PA449855	566	0.773
NULL	J_Mol_Signal_2008_Dec_1_3_18.nxml.txt.nlp	19046439	SENT91	8	8	0	0	metformin	CDK2	PA450395	1017	0.773
NULL	Diabetes_Care_2010_Jun_9_33(6)_1224-1229.nxml.txt.nlp	20215447	SENT20	13	13	3	3	gliclazide	SUR1	PA10892	6833	0.773
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S258-S263.nxml.txt.nlp	21525465	SENT115	6	6	16	16	liraglutide	GLP-1	PA165958364	100125288	0.773
NULL	Acta_Pharmacol_Sin_2013_Apr_25_34(4)_455-463.nxml.txt.nlp	23524568	SENT14	1	1	28	28	pioglitazone	p65	PA450970	5970	0.773
NULL	J_Nutr_Metab_2011_Jun_1_2011_708183.nxml.txt.nlp	21773024	SENT172	6	6	3	3	exenatide	GLP-1	PA164749238	100125288	0.773
NULL	Front_Neurosci_2013_Jan_31_7_3.nxml.txt.nlp	23386808	SENT280	7	7	14	14	capsaicin	TRPV1	PA448776	7442	0.773
NULL	Thorax_2009_Sep_3_64(9)_798-805.nxml.txt.nlp	19497921	SENT61	21	21	9	9	paraformaldehyde	TLR4	PA450790	7099	0.773
NULL	J_Hum_Genet_2013_Jun_16_58(6)_353-361.nxml.txt.nlp	23677058	SENT163	10	10	29	29	cytarabine	DCK	PA449177	1633	0.773
NULL	Int_J_Environ_Res_Public_Health_2012_Jun_31_9(6)_2075-2091.nxml.txt.nlp	22829791	SENT139	4	4	6	6	etoposide	TOP2A	PA449552	7153	0.773
NULL	Arthritis_Res_Ther_2009_Aug_28_11(4)_R131.nxml.txt.nlp	19715572	SENT156	5	5	28	28	rituximab	CD154	PA451261	959	0.773
NULL	Br_J_Cancer_2013_Apr_16_108(7)_1393-1401.nxml.txt.nlp	23511559	SENT177	12	12	33	33	gemcitabine	FLT3	PA449748	2322	0.773
NULL	Hum_Genomics_2010_Aug_1_4(6)_371-374.nxml.txt.nlp	20846925	SENT20	40	40	24	24	warfarin	CYP2C9	PA451906	1559	0.773
NULL	Breast_Cancer_Res_2010_Jul_1_12(4)_R45.nxml.txt.nlp	20594311	SENT135	2	2	11	11	nelfinavir	AKT	PA450606	207	0.773
NULL	Nucleic_Acids_Res_2011_Sep_17_39(16)_e107.nxml.txt.nlp	21685448	SENT94	20	20	38	38	neomycin	PPP1R12C	PA450608	54776	0.773
NULL	Breast_Cancer_Res_2006_Nov_6_8(6)_215.nxml.txt.nlp	17096862	SENT95	27	27	12	12	pertuzumab	HER2		2064	0.773
NULL	Acta_Pharmacol_Sin_2011_Oct_12_32(10)_1259-1265.nxml.txt.nlp	21909126	SENT95	5	5	24	24	fluvastatin	MCP-1	PA449688	6347	0.773
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT154	8	8	33	33	glucose	p38	PA449773	10598;1432;7965	0.773
NULL	J_Oncol_2010_Jan_5_2010_257058.nxml.txt.nlp	20069126	SENT232	6	6	14	14	curcumin	AMPK	PA151958596	5563	0.773
NULL	Kidney_Int_Suppl_(2011)_2013_Dec_27_3(5)_451-456.nxml.txt.nlp	25019029	SENT82	5	5	25	25	cinacalcet	PTH	PA164776671	5741	0.773
NULL	Oncologist_2010_Mar_9_15(3)_236-245.nxml.txt.nlp	20215359	SENT82	9	9	25	25	bevacizumab	IFN	PA130232992	3439	0.773
NULL	Cancer_Cell_Int_2013_Feb_12_13_14.nxml.txt.nlp	23402310	SENT183	36	36	21	21	celecoxib	Bcl-2	PA448871	596	0.773
NULL	Mol_Cancer_2008_Jun_3_7_47.nxml.txt.nlp	18519000	SENT141	10	10	15	15	gefitinib	EGFR	PA131301952	1956	0.773
NULL	Clin_Ophthalmol_2009_Jun_2_3_199-210.nxml.txt.nlp	19668566	SENT185	6	6	0	0	bromfenac	Rho	PA448670	29984	0.773
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT354	17	17	7	7	ziprasidone	PRL	PA451974	5617	0.773
NULL	Ann_Gen_Psychiatry_2014_Nov_18_13(1)_34.nxml.txt.nlp	NULL	SENT16	4	4	20	20	l-histidine	HNMT	PA449882	3176	0.773
NULL	Mol_Cancer_2009_Dec_23_8_129.nxml.txt.nlp	20030852	SENT193	7	7	21	21	curcumin	survivin	PA151958596	332	0.773
NULL	Toxins_(Basel)_2010_Oct_26_2(11)_2490-2518.nxml.txt.nlp	22069563	SENT265	15	15	28	28	cisplatin	CD25	PA449014	3669;3559	0.773
NULL	Oncol_Rep_2013_Jun_22_29(6)_2479-2485.nxml.txt.nlp	23525656	SENT8	22	22	17	17	vincristine	MRP7	PA451879	89845;1080	0.773
NULL	Cent_European_J_Urol_2013_Aug_13_66(2)_144-149.nxml.txt.nlp	24579014	SENT41	31	31	34	34	methotrexate	survivin	PA450428	332	0.773
NULL	J_Oncol_2009_Mar_24_2009_491985.nxml.txt.nlp	19325924	SENT159	13	13	6	6	genistein	CXCR4	PA165109660	7852	0.773
NULL	Diabetes_2009_Jul_28_58(7)_1518-1525.nxml.txt.nlp	19401427	SENT290	25	25	12	12	candesartan	LOX-1	PA448765	4973	0.773
NULL	J_Hum_Genet_2013_Jun_23_58(6)_339-345.nxml.txt.nlp	23697979	SENT23	7	7	40	40	clopidogrel	CYP2C9	PA449053	1559	0.773
NULL	Front_Genet_2012_Nov_2_3_229.nxml.txt.nlp	23130019	SENT122	25	25	7	7	thioguanine	TPMT	PA451663	7172	0.773
NULL	Biomed_Res_Int_2014_Jan_20_2014_948427.nxml.txt.nlp	24563867	SENT216	10	10	5	5	buspirone	COB	PA448689	4519	0.773
NULL	Daru_2012_Oct_30_20(1)_69.nxml.txt.nlp	23351548	SENT154	12	12	41	41	coumarin	p38	PA134521193	10598;1432;7965	0.773
NULL	Diabetes_2013_Jun_20_62(6)_2122-2129.nxml.txt.nlp	23378607	SENT20	23	23	32	32	glucose	AMPK	PA449773	5563	0.773
NULL	J_Oncol_2012_Aug_7_2012_803294.nxml.txt.nlp	22919383	SENT81	15	15	26	26	piroxicam	COX	PA450985	1351	0.773
NULL	Diabetes_Metab_J_2012_Aug_20_36(4)_293-299.nxml.txt.nlp	22950061	SENT111	3	3	10	10	metformin	POMC	PA450395	5443	0.773
NULL	Acta_Vet_Scand_2011_Feb_22_53(1)_12.nxml.txt.nlp	21342526	SENT176	13	13	23	23	flutamide	PD2	PA449685	54623	0.773
NULL	Mol_Cancer_2010_May_17_9_108.nxml.txt.nlp	20478051	SENT276	19	19	7	7	deferoxamine	HIF-1	PA164746490	29072	0.773
NULL	Oncologist_2010_Mar_3_15(3)_216-235.nxml.txt.nlp	20200040	SENT115	16	16	4	4	trastuzumab	HER-2	PA451743	2064	0.773
NULL	Arthritis_Res_Ther_2005_Nov_16_7(1)_R93-R100.nxml.txt.nlp	15642147	SENT190	2	2	4	4	nifedipine	NIF	PA450631	6280	0.773
NULL	Neural_Plast_2007_Sep_19_2007_26496.nxml.txt.nlp	18301726	SENT99	19	19	8	8	fluoxetine	TIEG1	PA449673	7071	0.773
NULL	ACS_Nano_2013_Oct_22_7(10)_9001-9009.nxml.txt.nlp	24015809	SENT60	2	2	20	20	bivalirudin	ANOVA	PA10032	4858	0.773
NULL	Nucleic_Acids_Res_2011_Dec_2_39(22)_9549-9558.nxml.txt.nlp	21890893	SENT49	14	14	10	10	resveratrol	SIRT1		23411	0.773
NULL	Genet_Mol_Biol_2009_Sep_1_Jul-Sep_32(3)_516-520.nxml.txt.nlp	21637514	SENT82	12	12	8	8	estradiol	FGF2	PA449503	2247;2258	0.772
NULL	J_Cancer_2013_Nov_23_4(9)_736-754.nxml.txt.nlp	24312144	SENT185	32	32	27	27	gefitinib	VEGFR	PA131301952	3791	0.772
NULL	Mol_Cancer_2012_Mar_21_11_13.nxml.txt.nlp	22436134	SENT11	0	0	11	11	doxorubicin	HuR	PA449412	1994	0.772
NULL	Arch_Plast_Surg_2012_Sep_12_39(5)_540-545.nxml.txt.nlp	23094252	SENT22	11	11	9	9	propofol	TCI	PA451141	6947	0.772
NULL	Evid_Based_Complement_Alternat_Med_2013_Dec_10_2013_304290.nxml.txt.nlp	24386002	SENT222	8	8	10	10	curcumin	IFN	PA151958596	3439	0.772
NULL	Eur_J_Epidemiol_2009_Sep_2_24(9)_553-572.nxml.txt.nlp	19728115	SENT1541	8	8	32	32	lactulose	PAGM	PA164748762	5238	0.772
NULL	Oncoimmunology_2012_Oct_1_1(7)_1218-1219.nxml.txt.nlp	23170286	SENT33	14	14	7	7	bortezomib	CD91	PA10252	4035	0.772
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_33-43.nxml.txt.nlp	17912634	SENT196	22	22	15	15	tamoxifen	HER2	PA451581	2064	0.772
NULL	Curr_Neuropharmacol_2010_Dec_8(4)_409-421.nxml.txt.nlp	21629447	SENT177	13	13	30	30	diazepam	PTH	PA449283	5741	0.772
NULL	Breast_Cancer_Res_Treat_2013_Oct_4_141(3)_385-395.nxml.txt.nlp	24091769	SENT236	14	14	11	11	trastuzumab	HER2	PA451743	2064	0.772
NULL	Biosci_Rep_2014_Dec_8_34(6)_e00156.nxml.txt.nlp	25307539	SENT316	15	15	17	17	diethylstilbestrol	DES	PA449307	1674	0.772
NULL	F1000_Med_Rep_2009_Feb_24_1_13.nxml.txt.nlp	20948769	SENT79	21	21	27	27	vincristine	CHOP	PA451879	1649	0.772
NULL	J_Psychopharmacol_2010_Nov_24(4_supplement)_91-118.nxml.txt.nlp	18801830	SENT135	31	31	46	46	fenfluramine	FGA	PA449592	2243	0.772
NULL	Oxid_Med_Cell_Longev_2012_Jan_19_2012_390678.nxml.txt.nlp	22315655	SENT186	16	16	18	18	gliclazide	NAC	PA10892	22861	0.772
NULL	Cancers_(Basel)_2010_May_26_2(2)_955-969.nxml.txt.nlp	24281101	SENT59	11	11	7	7	hydroxyurea	BHD	PA449942	201163	0.772
NULL	Diabetes_Metab_Syndr_Obes_2010_Jul_9_3_227-242.nxml.txt.nlp	21437091	SENT135	0	0	3	3	liraglutide	GLP-1	PA165958364	100125288	0.772
NULL	Front_Behav_Neurosci_2012_Nov_22_6_78.nxml.txt.nlp	23189046	SENT78	19	19	11	11	ethanol	OX1R	PA448073	3061	0.772
NULL	Respir_Med_Case_Rep_2012_Jan_24_5_6-8.nxml.txt.nlp	NULL	SENT119	19	19	6	6	phenytoin	CD4	PA450947	920	0.772
NULL	Oncoscience_2014_Apr_30_1(4)_283-286.nxml.txt.nlp	25594020	SENT6	31	31	22	22	doxorubicin	BCL6	PA449412	604	0.772
NULL	Curr_Pharm_Des_2011_Feb_17(6)_578-590.nxml.txt.nlp	21391908	SENT179	6	6	9	9	nutlin-3	MDM2		4193	0.772
NULL	Med_Sci_Monit_2012_Jul_1_18(7)_CS57-CS62.nxml.txt.nlp	22739739	SENT103	28	28	12	12	sulfapyridine	CYP2E1	PA164779050	1571	0.772
NULL	Mol_Biol_Int_2014_Sep_7_2014_852748.nxml.txt.nlp	25276427	SENT133	10	10	25	25	doxorubicin	HER2	PA449412	2064	0.772
NULL	Curr_Neuropharmacol_2007_Dec_5(4)_232-243.nxml.txt.nlp	19305740	SENT124	11	11	26	26	pioglitazone	IL-6	PA450970	3569	0.772
NULL	Clin_Ophthalmol_2014_Mar_2_8_343-346.nxml.txt.nlp	24591809	SENT27	4	4	8	8	ranibizumab	PED	PA164746012	8682	0.772
NULL	Epigenetics_Chromatin_2013_Mar_18_6(Suppl_1)_P66.nxml.txt.nlp	NULL	SENT17	28	28	2	2	doxycycline	MMSET	PA449415	7468	0.772
NULL	Oncotarget_2013_Dec_18_5(2)_375-385.nxml.txt.nlp	24495868	SENT158	5	5	13	13	fludarabine	XIAP	PA449655	331	0.772
NULL	J_Clin_Biochem_Nutr_2011_Jul_30_49(1)_20-24.nxml.txt.nlp	21765602	SENT108	33	33	7	7	ethanol	IL-6	PA448073	3569	0.772
NULL	Int_J_Mol_Sci_2014_Oct_29_15(11)_19700-19728.nxml.txt.nlp	25356505	SENT261	10	10	7	7	thrombin	PAR1	PA451674	79581;2149	0.772
NULL	Nat_Med_2013_Mar_10_19(3)_313-321.nxml.txt.nlp	23396211	SENT368	5	5	30	30	amlexanox	TBK1	PA164745310	29110	0.772
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_105-115.nxml.txt.nlp	17912640	SENT41	4	4	11	11	trastuzumab	HER2	PA451743	2064	0.772
NULL	Osteoporos_Int_2013_Jan_10_24(1)_227-235.nxml.txt.nlp	22776860	SENT107	6	6	13	13	denosumab	CTX	PA166048634	1593	0.772
NULL	Br_J_Cancer_2013_Feb_19_108(3)_557-563.nxml.txt.nlp	23361053	SENT144	16	16	29	29	tamoxifen	IPA	PA451581	3160	0.772
NULL	Ther_Clin_Risk_Manag_2006_Mar_2(1)_45-57.nxml.txt.nlp	18360581	SENT49	9	9	2	2	etoricoxib	CYP3A	PA164776853	1574	0.772
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jun_25_67(Pt_7)_o1792.nxml.txt.nlp	21837165	SENT59	23	23	38	38	ethanol	mol	PA448073	90527	0.772
NULL	Endocrinol_Diabetes_Metab_Case_Rep_2014_Dec_1_2014_140083.nxml.txt.nlp	25535576	SENT93	10	10	13	13	ketoconazole	CYP3A4	PA450146	1576	0.772
NULL	Acta_Oncol_2014_Feb_19_53(2)_186-194.nxml.txt.nlp	23957715	SENT183	7	7	4	4	trastuzumab	HER2	PA451743	2064	0.772
NULL	Oncotarget_2014_Jun_22_5(13)_4581-4602.nxml.txt.nlp	25015035	SENT89	43	43	22	22	oxaliplatin	AKT	PA131285527	207	0.772
NULL	Br_J_Cancer_2009_Jun_2_100(11)_1739-1745.nxml.txt.nlp	19436299	SENT88	8	8	5	5	everolimus	FDG	PA164746311	23583	0.772
NULL	Biomed_Res_Int_2013_Aug_7_2013_864012.nxml.txt.nlp	23991423	SENT160	7	7	20	20	cinacalcet	IMPACT	PA164776671	55364	0.772
NULL	Front_Physiol_2013_Jun_4_4_128.nxml.txt.nlp	23760815	SENT79	7	7	3	3	lipase	ATGL	PA450239	57104	0.772
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT1706	0	0	4	4	atazanavir	ATV	PA10251	4683	0.772
NULL	Oncogene_2010_Nov_18_29(46)_6115-6124.nxml.txt.nlp	20729912	SENT81	13	13	18	18	doxorubicin	ABCB5	PA449412	340273	0.772
NULL	J_Med_Case_Reports_2008_May_19_2_167.nxml.txt.nlp	18489739	SENT19	25	25	31	31	doxorubicin	CHOP	PA449412	1649	0.772
NULL	Oncol_Lett_2014_Jul_25_8(1)_313-316.nxml.txt.nlp	24959268	SENT93	0	0	23	23	sulindac	PC-3	PA451565	692094	0.772
NULL	J_Gen_Physiol_2003_Jul_122(1)_45-61.nxml.txt.nlp	12835470	SENT351	5	5	9	9	capsaicin	VR1	PA448776	56664	0.772
NULL	Ther_Clin_Risk_Manag_2005_Jun_1(2)_107-114.nxml.txt.nlp	18360550	SENT25	8	8	30	30	paclitaxel	Yes	PA450761	7525	0.772
NULL	Front_Neurol_2014_Sep_11_5_173.nxml.txt.nlp	25309501	SENT238	21	21	16	16	hyaluronidase	HYAL2	PA164745713	8692	0.772
NULL	Mol_Cancer_2009_Feb_13_8_8.nxml.txt.nlp	19216791	SENT212	12	12	39	39	cisplatin	PTEN	PA449014	5728	0.772
NULL	Nucleic_Acids_Res_2013_May_12_41(9)_e101.nxml.txt.nlp	23482392	SENT381	6	6	8	8	bortezomib	AKR1C1	PA10252	1645	0.772
NULL	Cancer_Cell_Int_2002_Jul_5_2_7.nxml.txt.nlp	12234376	SENT131	27	27	41	41	etoposide	ERCC1	PA449552	2067	0.772
NULL	Alzheimers_Res_Ther_2011_Dec_20_3(6)_36.nxml.txt.nlp	22236739	SENT78	29	29	18	18	pioglitazone	APOE	PA450970	348	0.772
NULL	J_Oncol_2013_Apr_29_2013_854121.nxml.txt.nlp	23737784	SENT65	0	0	8	8	pertuzumab	HER3		2065	0.772
NULL	J_Oncol_2012_Aug_25_2012_782020.nxml.txt.nlp	21876694	SENT213	18	18	13	13	cyclophosphamide	FGFR1	PA449165	2260	0.772
NULL	Oncotarget_2013_May_1_4(5)_705-714.nxml.txt.nlp	23670029	SENT104	19	19	9	9	bevacizumab	p53	PA130232992	7157	0.772
NULL	Pharmaceuticals_(Basel)_2014_Apr_10_7(4)_433-452.nxml.txt.nlp	24727459	SENT646	5	5	3	3	ethanol	CYP3A	PA448073	1574	0.772
NULL	Aging_(Albany_NY)_2010_Dec_20_2(12)_959-968.nxml.txt.nlp	21191146	SENT97	4	4	15	15	cisplatin	Rpn13	PA449014	11047	0.772
NULL	Basic_Clin_Neurosci_2014_Summer_5(3)_182-190.nxml.txt.nlp	25337378	SENT175	5	5	2	2	bupropion	mol	PA448687	90527	0.772
NULL	Clin_Pharmacokinet_2014_Aug_3_53(1)_89-102.nxml.txt.nlp	23912563	SENT88	37	37	26	26	rivaroxaban	CYP2J2	PA165958360	1573	0.772
NULL	Support_Care_Cancer_2009_Sep_10_17(9)_1187-1193.nxml.txt.nlp	19205754	SENT84	13	13	10	10	dolasetron	CYP2D6	PA449390	1565	0.772
NULL	Lipids_Health_Dis_2011_Feb_28_10_38.nxml.txt.nlp	21352602	SENT10	24	24	27	27	ezetimibe	PCSK9	PA10816	255738	0.772
NULL	Diabetes_Care_2012_Jul_12_35(7)_1446-1454.nxml.txt.nlp	22584132	SENT234	19	19	34	34	liraglutide	Met	PA165958364	79811	0.772
NULL	J_Exp_Clin_Cancer_Res_2009_Nov_24_28(1)_144.nxml.txt.nlp	19930704	SENT121	38	38	18	18	epirubicin	P-gp	PA449476	5243	0.772
NULL	Biomed_Res_Int_2013_Jun_6_2013_626910.nxml.txt.nlp	23841079	SENT194	29	29	26	26	cyclophosphamide	CHOP	PA449165	1649	0.772
NULL	Appl_Microbiol_Biotechnol_2014_Feb_18_98(8)_3829-3840.nxml.txt.nlp	24535257	SENT35	24	24	9	9	ethanol	CAT-1	PA448073	6541	0.772
NULL	J_Bras_Pneumol_2014_Mar-Apr_40(2)_188-192.nxml.txt.nlp	24831405	SENT3	10	10	25	25	isoniazid	IFN	PA450112	3439	0.772
NULL	Cell_Regen_(Lond)_2012_Jun_28_1(1)_3.nxml.txt.nlp	25408866	SENT51	9	9	0	0	oxygen	ADP	PA450744	23038	0.772
NULL	Braz_J_Med_Biol_Res_2013_Jun_25_46(6)_507-512.nxml.txt.nlp	23802227	SENT133	8	8	37	37	propofol	IL-6	PA451141	3569	0.772
NULL	Clinics_2008_Dec_63(6)_725b-730.nxml.txt.nlp	19060991	SENT46	8	8	23	23	carvedilol	AT1	PA448817	9197;185	0.772
NULL	Gut_Liver_2011_Jun_24_5(2)_160-164.nxml.txt.nlp	21814595	SENT94	8	8	14	14	midazolam	ESD	PA450496	2098	0.772
NULL	EMBO_Mol_Med_2012_Sep_7_4(9)_896-909.nxml.txt.nlp	22887866	SENT144	0	0	9	9	lovastatin	SREBF1	PA450272	6720	0.772
NULL	Exp_Ther_Med_2013_Jan_19_5(1)_23-27.nxml.txt.nlp	23251236	SENT133	6	6	12	12	curcumin	EGR1	PA151958596	1958	0.772
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jul_31_66(Pt_8)_o2162-o2163.nxml.txt.nlp	21588446	SENT74	16	16	6	6	ethanol	mol	PA448073	90527	0.772
NULL	Anesth_Essays_Res_2012_Jul-Dec_6(2)_140-146.nxml.txt.nlp	NULL	SENT111	3	3	17	17	lidocaine	IL-8	PA450226	3576	0.772
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT81	42	42	7	7	trastuzumab	EGF	PA451743	1950	0.772
NULL	Daru_2012_Dec_5_20(1)_87.nxml.txt.nlp	23351503	SENT134	15	15	21	21	isoproterenol	ANOVA	PA450121	4858	0.772
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT239	36	36	34	34	exenatide	GLP-1	PA164749238	100125288	0.772
NULL	Arthritis_Res_Ther_2012_Jul_27_14(4)_R175.nxml.txt.nlp	22838733	SENT104	23	23	33	33	adalimumab	CD14	PA10004	929	0.772
NULL	Indian_J_Urol_2011_Apr-Jun_27(2)_252-261.nxml.txt.nlp	21814318	SENT192	17	17	13	13	valrubicin	ADM	PA164748616	133	0.772
NULL	J_Oncol_2013_Mar_16_2013_386906.nxml.txt.nlp	23577026	SENT39	6	6	3	3	cetuximab	EGFR	PA10040	1956	0.772
NULL	J_Signal_Transduct_2011_Jun_7_2011_982879.nxml.txt.nlp	21776391	SENT152	11	11	17	17	cetuximab	EGFR	PA10040	1956	0.772
NULL	Eur_J_Med_Res_2009_Nov_24_14(Suppl_3)_17-21.nxml.txt.nlp	19959412	SENT56	7	7	10	10	lamotrigine	CYP3A	PA450164	1574	0.772
NULL	Crit_Care_2008_Aug_15_12(4)_R104.nxml.txt.nlp	18702832	SENT26	10	10	24	24	thrombin	VIII	PA451674	1351	0.772
NULL	Oncoimmunology_2013_Jan_1_2(1)_e22890.nxml.txt.nlp	23483066	SENT58	6	6	12	12	vemurafenib	IFN	PA165946873	3439	0.772
NULL	BMJ_Open_2013_Nov_4_3(11)_e003556.nxml.txt.nlp	24189081	SENT265	18	18	36	36	cyclophosphamide	AGO	PA449165	55294	0.772
NULL	Clin_Dev_Immunol_2011_Dec_5_2011_894704.nxml.txt.nlp	22190975	SENT230	14	14	7	7	vincristine	CHOP	PA451879	1649	0.772
NULL	Mol_Neurobiol_2010_Jun_2_41(2-3)_392-409.nxml.txt.nlp	20437209	SENT286	4	4	23	23	curcumin	FDG	PA151958596	23583	0.772
NULL	Chem_Cent_J_2012_Nov_23_6_140.nxml.txt.nlp	23173949	SENT20	15	15	8	8	oxygen	ROS	PA450744	6098	0.772
NULL	Channels_(Austin)_2010_Jan_1_4(1)_22-41.nxml.txt.nlp	19934650	SENT14	15	15	18	18	quinidine	Slo3	PA451209	157855	0.772
NULL	Cell_Death_Dis_2012_Jun_21_3(6)_e330.nxml.txt.nlp	22717585	SENT281	9	9	14	14	simvastatin	LC3	PA451363	84557	0.772
NULL	Front_Endocrinol_(Lausanne)_2013_Jul_8_4_80.nxml.txt.nlp	23847592	SENT36	6	6	44	44	diclofenac	UGT2B17	PA449293	7367	0.772
NULL	BMJ_2009_Jul_14_339_b2538.nxml.txt.nlp	19602530	SENT9	15	15	2	2	diclofenac	COX	PA449293	1351	0.772
NULL	Int_J_Mol_Imaging_2011_Oct_26_2011_874585.nxml.txt.nlp	21490735	SENT184	32	32	9	9	docetaxel	FDG	PA449383	23583	0.772
NULL	Cardiol_Res_Pract_2010_Sep_19_2010_649164.nxml.txt.nlp	20886058	SENT165	6	6	21	21	acetylcysteine	NAC	PA448033	22861	0.772
NULL	J_Carcinog_2011_Nov_30_10_28.nxml.txt.nlp	22190870	SENT225	13	13	20	20	trastuzumab	PPM1H	PA451743	57460	0.772
NULL	Oncol_Lett_2013_Aug_20_6(2)_329-335.nxml.txt.nlp	24137325	SENT233	19	19	3	3	pp2	PP2		4888	0.772
NULL	Mol_Cancer_2010_Apr_29_9_95.nxml.txt.nlp	20429933	SENT105	29	29	10	10	cisplatin	p53	PA449014	7157	0.772
NULL	Anticancer_Agents_Med_Chem_2013_Dec_13(10)_1601-1613.nxml.txt.nlp	23796248	SENT318	5	5	24	24	resveratrol	TRAIL		8743	0.772
NULL	Indian_J_Pharmacol_2014_Sep-Oct_46(5)_549-550.nxml.txt.nlp	25298588	SENT59	22	22	17	17	warfarin	CYP2C9	PA451906	1559	0.772
NULL	Br_J_Cancer_2010_Nov_2_103(11)_1671-1679.nxml.txt.nlp	21045835	SENT117	28	28	36	36	gemcitabine	CXCL12	PA449748	6387	0.772
NULL	Br_J_Cancer_1996_Jul_74(1)_63-68.nxml.txt.nlp	8679460	SENT13	36	36	5	5	cyclophosphamide	P-gp	PA449165	5243	0.772
NULL	Leukemia_2013_Jan_11_27(1)_32-40.nxml.txt.nlp	22781593	SENT172	0	0	13	13	ponatinib	CD34	PA165980594	947	0.772
NULL	Oncol_Lett_2013_Sep_12_6(3)_860-864.nxml.txt.nlp	24137426	SENT98	28	28	30	30	ketoconazole	CYP3A4	PA450146	1576	0.772
NULL	Breast_Cancer_Res_2007_Jul_5_9(4)_R41.nxml.txt.nlp	17612393	SENT5	3	3	10	10	celecoxib	Bcl-2	PA448871	596	0.772
NULL	Acta_Pharmacol_Sin_2012_May_4_33(5)_710-716.nxml.txt.nlp	22555373	SENT13	6	6	15	15	phenylbutazone	DOM	PA450932	6663	0.772
NULL	Breast_Cancer_Res_2014_Sep_9_16(5)_433.nxml.txt.nlp	25212966	SENT377	2	2	12	12	aprotinin	ILEI	PA448472	10447	0.772
NULL	Int_J_Mol_Sci_2014_Mar_20_15(3)_4965-4976.nxml.txt.nlp	24658440	SENT24	11	11	6	6	venlafaxine	P-gp	PA451866	5243	0.772
NULL	Am_J_Trop_Med_Hyg_2012_Aug_1_87(2)_231-241.nxml.txt.nlp	22855752	SENT16	8	8	0	0	artemisinin	ACT	PA165111696	12;11332;9457;641455	0.772
NULL	Biofactors_2014_May_6_40(3)_277-283.nxml.txt.nlp	24353111	SENT79	7	7	4	4	choline	PEMT	PA448976	10400	0.772
NULL	Cancer_Cell_Int_2014_Aug_16_14_74.nxml.txt.nlp	25187756	SENT67	0	0	11	11	cytarabine	CCN1	PA449177	3491	0.772
NULL	Cancer_Cell_Int_2005_Aug_23_5_27.nxml.txt.nlp	16117829	SENT10	18	18	9	9	doxycycline	p53	PA449415	7157	0.772
NULL	Blood_Cancer_J_2013_Oct_4_3(10)_e150.nxml.txt.nlp	24096714	SENT97	6	6	3	3	bortezomib	IL2	PA10252	3558	0.772
NULL	J_Breast_Cancer_2011_Jun_18_14(2)_135-139.nxml.txt.nlp	21847409	SENT21	38	38	27	27	exemestane	aromatase	PA449563	1588	0.772
NULL	Front_Oncol_2014_Sep_22_4_258.nxml.txt.nlp	25295228	SENT211	18	18	33	33	cisplatin	EGFR	PA449014	1956	0.772
NULL	Arthritis_Res_Ther_2011_Mar_29_13(2)_R55.nxml.txt.nlp	21447156	SENT247	17	17	5	5	hyaluronan	OP-1	PA165958431	655	0.772
NULL	Mol_Cancer_2010_Aug_20_9_220.nxml.txt.nlp	20727180	SENT134	23	23	6	6	nicotine	p53	PA450626	7157	0.772
NULL	Oxid_Med_Cell_Longev_2013_Nov_28_2013_568093.nxml.txt.nlp	24379901	SENT52	44	44	10	10	resveratrol	SIRT1		23411	0.772
NULL	Clin_Pharmacokinet_2014_Aug_3_53(1)_89-102.nxml.txt.nlp	23912563	SENT88	8	8	26	26	rivaroxaban	CYP2J2	PA165958360	1573	0.772
NULL	Nat_Med_2011_Aug_28_17(9)_1094-1100.nxml.txt.nlp	21873989	SENT25	1	1	13	13	imatinib	IL-17	PA10804	3605	0.772
NULL	Anal_Bioanal_Chem_2014_Jan_23_406(15)_3667-3680.nxml.txt.nlp	24452745	SENT60	20	20	6	6	furosemide	IBP	PA449719	706;50619	0.772
NULL	Arthritis_Res_Ther_2013_Jul_9_15(4)_R73.nxml.txt.nlp	23837669	SENT304	10	10	5	5	colchicine	IL-8	PA449092	3576	0.772
NULL	Br_J_Pharmacol_2012_Jan_165(2)_390-400.nxml.txt.nlp	21671897	SENT38	3	3	10	10	suramin	P2X1	PA10292	5023	0.772
NULL	Indian_J_Pharmacol_2013_Sep-Oct_45(5)_458-463.nxml.txt.nlp	24130379	SENT135	11	11	19	19	carvedilol	TLR4	PA448817	7099	0.772
NULL	Vet_Res_2013_Oct_2_44(1)_89.nxml.txt.nlp	24088531	SENT159	1	1	8	8	hemin	IFN	PA449849	3439	0.772
NULL	Bioarchitecture_2011_Sep_1_1(5)_245-249.nxml.txt.nlp	22754617	SENT74	36	36	44	44	paraformaldehyde	FLNA	PA450790	2316	0.772
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1150.nxml.txt.nlp	24675468	SENT69	11	11	5	5	ethanol	CA1	PA448073	759	0.772
NULL	Br_J_Cancer_2010_Dec_7_103(12)_1815-1821.nxml.txt.nlp	21063408	SENT98	30	30	13	13	capecitabine	6-16	PA448771	2537	0.772
NULL	Scientifica_(Cairo)_2012_Nov_25_2012_473829.nxml.txt.nlp	24278698	SENT225	38	38	22	22	oxaliplatin	ATP7A	PA131285527	538	0.772
NULL	Breast_Cancer_Res_Treat_2013_Aug_20_141(1)_43-53.nxml.txt.nlp	23959396	SENT4	20	20	7	7	trastuzumab	HER3	PA451743	2065	0.772
NULL	Front_Oncol_2014_Nov_5_4_281.nxml.txt.nlp	25414829	SENT106	14	14	26	26	erlotinib	EGFR	PA134687924	1956	0.772
NULL	Biomed_Res_Int_2014_Jan_29_2014_831845.nxml.txt.nlp	24605337	SENT187	8	8	5	5	bupivacaine	S6K1	PA135057240	6198	0.772
NULL	Indian_J_Med_Res_2013_Nov_138(5)_632-647.nxml.txt.nlp	24434318	SENT164	41	41	0	0	l-tryptophan	IFN	PA10323	3439	0.772
NULL	Biochem_Biophys_Res_Commun_2009_Apr_17_381(4)_523-527.nxml.txt.nlp	19239903	SENT311	4	4	20	20	betaine	GNMT	PA448603	27232	0.772
NULL	Breast_Cancer_Res_2005_May_24_7(5)_R589-R597.nxml.txt.nlp	16168102	SENT97	26	26	16	16	doxorubicin	HER3	PA449412	2065	0.772
NULL	Alzheimers_Res_Ther_2013_Oct_24_5(5)_50.nxml.txt.nlp	24401551	SENT323	3	3	6	6	donepezil	spatial	PA449394	219793	0.772
NULL	Endocrinol_Metab_(Seoul)_2013_Dec_12_28(4)_262-274.nxml.txt.nlp	24396690	SENT107	0	0	9	9	exenatide	GLP-1	PA164749238	100125288	0.772
NULL	J_Gen_Physiol_1961_Jul_1_44(6)_1103-1120.nxml.txt.nlp	13691379	SENT0	17	17	1	1	trypsin	Gen	PA451806	348654	0.772
NULL	J_Cell_Mol_Med_2014_Dec_7_18(12)_2536-2552.nxml.txt.nlp	25287328	SENT326	22	22	29	29	tamoxifen	PKD1	PA451581	5310	0.772
NULL	Iran_Red_Crescent_Med_J_2014_Jul_5_16(7)_e16664.nxml.txt.nlp	25237570	SENT225	7	7	15	15	fluvastatin	AT1	PA449688	9197;185	0.772
NULL	J_Carcinog_2014_Feb_20_13_4.nxml.txt.nlp	24737952	SENT61	12	12	1	1	capecitabine	HER-2	PA448771	2064	0.772
NULL	Arthritis_Res_Ther_2014_Jan_7_16(1)_R4.nxml.txt.nlp	24398084	SENT57	10	10	34	34	fluorescein	San	PA164746009	80218	0.772
NULL	J_Cell_Biol_2000_Feb_21_148(4)_791-800.nxml.txt.nlp	10684259	SENT190	17	17	5	5	estradiol	Raf-1	PA449503	5894	0.772
NULL	Oncotarget_2011_Mar_10_2(3)_186-196.nxml.txt.nlp	21406729	SENT122	14	14	22	22	orlistat	SREBP1	PA164776864	6720	0.772
NULL	Diabetes_Care_2010_Apr_19_33(4)_914-919.nxml.txt.nlp	20086255	SENT146	6	6	10	10	valsartan	adiponectin	PA451848	9370	0.772
NULL	Breast_Cancer_Res_Treat_2014_Dec_21_143(3)_459-467.nxml.txt.nlp	24362951	SENT57	16	16	26	26	letrozole	aromatase	PA450196	1588	0.772
NULL	Acta_Pharmacol_Sin_2013_Jun_8_34(6)_830-836.nxml.txt.nlp	23564080	SENT133	7	7	16	16	simvastatin	RAGE	PA451363	177	0.772
NULL	Oncotarget_2014_Oct_11_5(20)_10070-10083.nxml.txt.nlp	25301722	SENT177	33	33	10	10	gefitinib	EGFR	PA131301952	1956	0.772
NULL	Int_J_Inflam_2010_Aug_9_2010_151097.nxml.txt.nlp	21152121	SENT95	10	10	4	4	thrombin	neuroserpin	PA451674	5274	0.772
NULL	Gastric_Cancer_2014_Feb_28_17(1)_76-86.nxml.txt.nlp	23455716	SENT33	17	17	25	25	lapatinib	HER2	PA152241907	2064	0.772
NULL	Genet_Mol_Biol_2010_Dec_1_Oct-Dec_33(4)_686-695.nxml.txt.nlp	21637578	SENT73	28	28	26	26	nadh	mol	PA164755085	90527	0.772
NULL	J_Hematol_Oncol_2010_Sep_9_3_31.nxml.txt.nlp	20828403	SENT43	21	21	14	14	cisplatin	HER2	PA449014	2064	0.772
NULL	Genome_Biol_2008_Nov_25_9(11)_R166.nxml.txt.nlp	19032775	SENT216	28	28	24	24	suramin	EGFR	PA10292	1956	0.772
NULL	Diabetes_2008_Sep_57(9)_2272-2279.nxml.txt.nlp	18519799	SENT304	0	0	3	3	rosiglitazone	PDK4	PA451283	5166	0.772
NULL	Br_J_Cancer_2009_Jun_2_100(11)_1739-1745.nxml.txt.nlp	19436299	SENT188	14	14	5	5	everolimus	FDG	PA164746311	23583	0.772
NULL	Ann_Clin_Microbiol_Antimicrob_2010_May_27_9_16.nxml.txt.nlp	20504376	SENT148	19	19	40	40	oxacillin	SP2	PA450725	6668	0.772
NULL	Arthritis_Res_Ther_2013_Dec_4_15(6)_R206.nxml.txt.nlp	24299152	SENT105	11	11	21	21	thrombin	FXI	PA451674	2160	0.772
NULL	Int_J_Endocrinol_2014_Mar_11_2014_927317.nxml.txt.nlp	24738001	SENT133	6	6	14	14	sitagliptin	GLP-1	PA164748978	100125288	0.772
NULL	Mol_Cancer_2008_Mar_26_7_27.nxml.txt.nlp	18366759	SENT143	12	12	6	6	etoposide	MEF-2	PA449552	50804	0.772
NULL	Clinics_(Sao_Paulo)_2012_Sep_67(9)_1039-1046.nxml.txt.nlp	23018301	SENT55	17	17	15	15	trypsin	IL-4	PA451806	3565	0.772
NULL	Oncologist_2010_Jan_19_15(1)_3-5.nxml.txt.nlp	20086166	SENT28	28	28	9	9	paclitaxel	EGFR	PA450761	1956	0.772
NULL	Cell_Death_Dis_2014_Jul_10_5(7)_e1318.nxml.txt.nlp	25010984	SENT41	14	14	4	4	nutlin-3	p53		7157	0.772
NULL	Clin_Ophthalmol_2010_Nov_3_4_1253-1261.nxml.txt.nlp	21151330	SENT132	7	7	13	13	travoprost	BAK	PA164781371	578	0.772
NULL	Bone_Marrow_Res_2011_Mar_2_2011_924058.nxml.txt.nlp	22046572	SENT270	40	40	9	9	cyclophosphamide	IL-6	PA449165	3569	0.772
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT181	18	18	11	11	metformin	HIF-1	PA450395	29072	0.772
NULL	Breast_Cancer_Res_Treat_2012_Jul_24_134(1)_13-20.nxml.txt.nlp	22198412	SENT232	24	24	11	11	bevacizumab	HER2	PA130232992	2064	0.772
NULL	Arthritis_Res_Ther_2008_Mar_17_10(2)_R33.nxml.txt.nlp	18346273	SENT152	16	16	10	10	infliximab	HMGB1	PA452639	3146	0.772
NULL	Trials_2014_Nov_4_15(1)_425.nxml.txt.nlp	NULL	SENT289	16	16	19	19	fluoxetine	Gen	PA449673	348654	0.772
NULL	Acta_Vet_Scand_2011_Feb_22_53(1)_12.nxml.txt.nlp	21342526	SENT6	25	25	35	35	flutamide	PD2	PA449685	54623	0.772
NULL	Mol_Cell_Biochem_2014_Oct_9_385(1-2)_265-275.nxml.txt.nlp	24104452	SENT92	0	0	15	15	bortezomib	U87	PA10252	677775;641648	0.772
NULL	Oncol_Lett_2013_Mar_11_5(3)_1010-1016.nxml.txt.nlp	23426784	SENT168	5	5	20	20	midazolam	p27	PA450496	5715;10534	0.772
NULL	Med_Sci_Monit_2012_Jun_1_18(6)_BR229-BR236.nxml.txt.nlp	22648244	SENT32	0	0	8	8	amiloride	ASIC3	PA448368	9311	0.772
NULL	Evid_Based_Complement_Alternat_Med_2013_May_26_2013_161628.nxml.txt.nlp	23781255	SENT253	4	4	10	10	sunitinib	RAF1	PA162372840	5894	0.772
NULL	Case_Rep_Hematol_2013_Aug_31_2013_687260.nxml.txt.nlp	24073345	SENT32	10	10	17	17	doxorubicin	CHOP	PA449412	1649	0.772
NULL	Exp_Diabetes_Res_2012_Mar_15_2012_146194.nxml.txt.nlp	22474415	SENT204	21	21	14	14	valsartan	MCP-1	PA451848	6347	0.772
NULL	FASEB_J_2013_Feb_27(2)_557-567.nxml.txt.nlp	23104985	SENT602	9	9	17	17	bimatoprost	EP2	PA164748867	5732;10407	0.772
NULL	Ecancermedicalscience_2009_Aug_5_3_144.nxml.txt.nlp	22276009	SENT22	9	9	15	15	doxorubicin	CHOP	PA449412	1649	0.772
NULL	Autoimmune_Dis_2013_Aug_28_2013_613086.nxml.txt.nlp	24069534	SENT22	39	39	22	22	etanercept	p40	PA449515	3921;339541;10314	0.772
NULL	J_Gen_Intern_Med_2009_May_21_24(5)_656-664.nxml.txt.nlp	19306050	SENT504	32	32	20	20	warfarin	CYP2C9	PA451906	1559	0.772
NULL	Iran_J_Pharm_Res_2015_Winter_14(1)_279-289.nxml.txt.nlp	25561934	SENT140	6	6	12	12	isoproterenol	ANOVA	PA450121	4858	0.772
NULL	J_Korean_Med_Sci_2010_Nov_26_25(11)_1683-1687.nxml.txt.nlp	21060764	SENT57	11	11	9	9	thyroglobulin	TTF-1	PA164754910	7080	0.772
NULL	Biomed_Res_Int_2014_Jan_2_2014_682010.nxml.txt.nlp	24524084	SENT87	35	35	41	41	imatinib	CD28	PA10804	1493;940	0.772
NULL	Eur_J_Clin_Pharmacol_2012_Sep_15_68(9)_1267-1274.nxml.txt.nlp	22418828	SENT160	10	10	6	6	pantoprazole	CYP2C19	PA450774	1557	0.772
NULL	Curr_Neuropharmacol_2007_Dec_5(4)_232-243.nxml.txt.nlp	19305740	SENT124	9	9	26	26	rosiglitazone	IL-6	PA451283	3569	0.772
NULL	Clinics_(Sao_Paulo)_2013_Feb_68(2)_253-262.nxml.txt.nlp	23525324	SENT213	14	14	23	23	genistein	Gen	PA165109660	348654	0.772
NULL	Int_J_Mol_Sci_2014_Jun_27_15(7)_11510-11522.nxml.txt.nlp	24979133	SENT83	7	7	11	11	genistein	TRAIL-R2	PA165109660	8795	0.772
NULL	Comput_Math_Methods_Med_2012_Jan_16_2012_792375.nxml.txt.nlp	22291855	SENT48	26	26	17	17	estradiol	E2F1	PA449503	1869	0.772
NULL	Biomed_Res_Int_2013_Jul_15_2013_386074.nxml.txt.nlp	23956980	SENT21	6	6	13	13	clopidogrel	P2Y12	PA449053	64805	0.772
NULL	Exp_Ther_Med_2013_Nov_13_6(5)_1317-1321.nxml.txt.nlp	24223665	SENT110	28	28	34	34	curcumin	CD133	PA151958596	8842	0.772
NULL	J_Cell_Mol_Med_2014_May_7_18(5)_766-779.nxml.txt.nlp	24606538	SENT334	12	12	19	19	sirolimus	LAM	PA451365	7249;7248	0.772
NULL	Curr_Clin_Pharmacol_2008_Sep_3(3)_198-203.nxml.txt.nlp	18781906	SENT5	13	13	0	0	oxcarbazepine	CYP3A4	PA450732	1576	0.772
NULL	Oncol_Lett_2013_Feb_7_5(2)_440-446.nxml.txt.nlp	23420122	SENT157	0	0	21	21	sorafenib	AKT	PA7000	207	0.772
NULL	Cancer_Cell_Int_2010_Sep_9_10_32.nxml.txt.nlp	20828393	SENT199	12	12	0	0	cisplatin	ATF3	PA449014	467	0.772
NULL	Breast_Cancer_Res_2004_Oct_24_6(1)_R8-R17.nxml.txt.nlp	14680495	SENT122	10	10	17	17	tamoxifen	BRCA1	PA451581	672	0.772
NULL	Arthritis_Res_Ther_2009_Jul_23_11(4)_236.nxml.txt.nlp	19664185	SENT69	27	27	36	36	benzbromarone	URAT1	PA134852920	116085	0.772
NULL	Cancers_(Basel)_2010_Apr_14_2(2)_523-548.nxml.txt.nlp	24281081	SENT317	8	8	33	33	erlotinib	PTEN	PA134687924	5728	0.772
NULL	Adv_Ther_2014_Feb_18_31(3)_247-263.nxml.txt.nlp	24535624	SENT41	3	3	8	8	exenatide	GLP-1	PA164749238	100125288	0.772
NULL	Clinics_(Sao_Paulo)_2013_Jun_68(6)_766-771.nxml.txt.nlp	23778483	SENT117	32	32	22	22	chloroquine	IL-6	PA448948	3569	0.772
NULL	Cell_Commun_Signal_2004_Jun_30_2_6.nxml.txt.nlp	15228623	SENT95	14	14	19	19	flunarizine	TTN	PA164776636	7273	0.772
NULL	Chin_J_Cancer_2011_May_30(5)_293-302.nxml.txt.nlp	21527062	SENT77	39	39	25	25	bevacizumab	IFL	PA130232992	3439	0.772
NULL	BMJ_2010_Feb_8_340_c693.nxml.txt.nlp	20142325	SENT258	27	27	41	41	desipramine	CYP3A4	PA449233	1576	0.772
NULL	J_Gen_Physiol_1997_Apr_1_109(4)_477-490.nxml.txt.nlp	9101406	SENT166	10	10	25	25	staurosporine	GIRK2	PA165109623	3763	0.772
NULL	Nat_Commun_2013_Aug_13_4_2316.nxml.txt.nlp	23939267	SENT38	8	8	4	4	lipase	HSL	PA450239	3991	0.772
NULL	Mol_Cancer_2009_Aug_25_8_66.nxml.txt.nlp	19706164	SENT74	0	0	2	2	celecoxib	p53	PA448871	7157	0.772
NULL	J_Cell_Mol_Med_2014_Aug_1_18(8)_1599-1611.nxml.txt.nlp	24889822	SENT37	5	5	18	18	resveratrol	STZ		6484	0.772
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Jul_23_3(7)_e126.nxml.txt.nlp	25054314	SENT60	33	33	18	18	docetaxel	OATP1B3	PA449383	28234	0.772
NULL	Front_Neural_Circuits_2009_Aug_20_3_8.nxml.txt.nlp	19738924	SENT196	29	29	16	16	ethanol	PDF	PA448073	64146;9518	0.772
NULL	J_Gynecol_Oncol_2014_Jul_3_25(3)_236-248.nxml.txt.nlp	25045437	SENT159	13	13	23	23	paclitaxel	VEGFR	PA450761	3791	0.772
NULL	Physiol_Rep_2014_Aug_28_2(8)_e12108.nxml.txt.nlp	25168868	SENT6	18	18	7	7	rimonabant	CB1	PA152407999	1268	0.772
NULL	Diabetes_Care_2011_Apr_21_34(4)_845-851.nxml.txt.nlp	21330640	SENT116	39	39	45	45	valsartan	PLB	PA451848	151056	0.772
NULL	Evid_Based_Complement_Alternat_Med_2013_Nov_27_2013_685159.nxml.txt.nlp	24379889	SENT286	0	0	23	23	curcumin	AKT	PA151958596	207	0.772
NULL	J_Hematol_Oncol_2009_Apr_22_2_18.nxml.txt.nlp	19386128	SENT123	16	16	25	25	panitumumab	KRAS	PA162373091	3845	0.772
NULL	Clin_Drug_Investig_2013_Aug_23_33(10)_727-736.nxml.txt.nlp	23975654	SENT66	0	0	2	2	omeprazole	CYP2C19	PA450704	1557	0.772
NULL	Biomed_Res_Int_2014_Feb_18_2014_487129.nxml.txt.nlp	24696852	SENT78	18	18	29	29	thiopental	Sky	PA451664	7301	0.772
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT100	19	19	26	26	l-methionine	4E-BP1	PA450423	1978	0.772
NULL	Case_Rep_Nephrol_Urol_2013_Dec_14_3(2)_139-146.nxml.txt.nlp	24570684	SENT89	5	5	22	22	thrombin	C5b	PA451674	727	0.772
NULL	Int_J_Mol_Sci_2014_Mar_24_15(3)_5140-5162.nxml.txt.nlp	24663085	SENT743	11	11	20	20	cyclophosphamide	IL-2	PA449165	3558	0.772
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Sep_30_67(Pt_10)_o2783-o2784.nxml.txt.nlp	22064768	SENT84	4	4	10	10	piperazine	mol	PA450977	90527	0.772
NULL	Biol_Open_2014_May_2_3(6)_418-430.nxml.txt.nlp	24795145	SENT128	4	4	11	11	etoposide	RanBPM	PA449552	10048	0.772
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Feb_13_66(Pt_3)_o627.nxml.txt.nlp	21580384	SENT58	19	19	34	34	ethanol	mol	PA448073	90527	0.772
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT42	3	3	16	16	chloroquine	BMPR-II	PA448948	659	0.772
NULL	Int_J_Inflam_2011_Sep_18_2011_535241.nxml.txt.nlp	21941677	SENT224	7	7	16	16	clodronate	CD4	PA10239	920	0.772
NULL	Cancer_Med_2013_Feb_3_2(1)_99-107.nxml.txt.nlp	24133632	SENT102	5	5	17	17	metformin	ANOVA	PA450395	4858	0.772
NULL	Br_J_Cancer_2013_Sep_3_109(5)_1079-1084.nxml.txt.nlp	23928659	SENT90	11	11	27	27	docetaxel	DES	PA449383	1674	0.772
NULL	J_Cell_Biol_2003_Sep_1_162(5)_877-888.nxml.txt.nlp	12952938	SENT240	35	35	8	8	etoposide	IL-3	PA449552	3562	0.772
NULL	Clin_Transl_Allergy_2013_Sep_2_3_29.nxml.txt.nlp	24004581	SENT67	27	27	18	18	omalizumab	IL-4	PA164752253	3565	0.772
NULL	Cancer_Immunol_Immunother_2013_Aug_27_62(10)_1637-1648.nxml.txt.nlp	23982484	SENT153	31	31	40	40	lenalidomide	DNAM-1	PA162363968	10666	0.772
NULL	CNS_Drugs_2012_Dec_13_26(12)_1033-1049.nxml.txt.nlp	23192413	SENT398	15	15	19	19	trazodone	Gen	PA451744	348654	0.772
NULL	Virol_J_2010_Oct_27_7_285.nxml.txt.nlp	20979618	SENT21	18	18	14	14	isoproterenol	c-fos	PA450121	2353	0.772
NULL	Biologics_2012_Feb_1_6_31-35.nxml.txt.nlp	22355257	SENT13	7	7	24	24	rituximab	IL-6	PA451261	3569	0.772
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2011_Mar_14_4_13-24.nxml.txt.nlp	22879790	SENT254	29	29	8	8	rosiglitazone	GLP-1	PA451283	100125288	0.772
NULL	Curr_Oncol_2009_Jul_16(Suppl_2)_S1-S13.nxml.txt.nlp	19672416	SENT97	31	31	3	3	anastrozole	ATAC	PA448432	6375	0.772
NULL	N_Am_J_Med_Sci_2011_Apr_3(4)_167-175.nxml.txt.nlp	22540086	SENT213	0	0	12	12	lapatinib	NEU	PA152241907	2064	0.772
NULL	Cancer_Cell_Int_2013_Jan_15_13_3.nxml.txt.nlp	23320839	SENT139	16	16	9	9	doxorubicin	MRP1	PA449412	4437	0.772
NULL	J_Cell_Biol_2001_Nov_12_155(4)_593-604.nxml.txt.nlp	11696560	SENT156	16	16	31	31	iodixanol	TGN	PA164783998	7038	0.772
NULL	Carcinogenesis_2013_Mar_7_34(3)_703-712.nxml.txt.nlp	23222814	SENT149	13	13	26	26	curcumin	ANOVA	PA151958596	4858	0.772
NULL	Cancer_Med_2013_Jun_25_2(3)_277-285.nxml.txt.nlp	23930204	SENT158	14	14	7	7	bevacizumab	PTEN	PA130232992	5728	0.772
NULL	Indian_J_Nephrol_2009_Apr_19(2)_77-79.nxml.txt.nlp	20368930	SENT69	22	22	13	13	tacrolimus	CYP3A4	PA451578	1576	0.772
NULL	Biomed_Res_Int_2014_Jan_29_2014_361020.nxml.txt.nlp	24605326	SENT147	4	4	27	27	genistein	CCND1	PA165109660	595	0.772
NULL	Case_Rep_Genet_2014_Jan_22_2014_413743.nxml.txt.nlp	24627811	SENT71	31	31	20	20	warfarin	CYP2C9	PA451906	1559	0.772
NULL	J_Cancer_2013_Nov_23_4(9)_736-754.nxml.txt.nlp	24312144	SENT310	6	6	20	20	erlotinib	OTT	PA134687924	64783	0.772
NULL	Oncol_Rep_2013_Apr_23_29(4)_1268-1274.nxml.txt.nlp	23354756	SENT10	23	23	4	4	paclitaxel	SLC25A43	PA450761	203427	0.772
NULL	Front_Neurosci_2013_Jan_31_7_3.nxml.txt.nlp	23386808	SENT209	11	11	24	24	capsaicin	TRPV1	PA448776	7442	0.772
NULL	Blood_Res_2014_Sep_25_49(3)_162-169.nxml.txt.nlp	25325035	SENT22	5	5	7	7	rituximab	CHOP	PA451261	1649	0.772
NULL	Biomed_Res_Int_2013_Aug_19_2013_129629.nxml.txt.nlp	24024180	SENT176	0	0	24	24	curcumin	PEN2	PA151958596	55851	0.772
NULL	Br_J_Cancer_2009_Jan_27_100(2)_251-258.nxml.txt.nlp	19165196	SENT20	40	40	15	15	irinotecan	ACRC	PA450085	93953	0.772
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT385	5	5	19	19	resveratrol	p300		2033	0.772
NULL	Biosci_Rep_2013_Nov_25_33(6)_e00081.nxml.txt.nlp	24070327	SENT190	4	4	11	11	imatinib	survivin	PA10804	332	0.772
NULL	Bioinformatics_2014_Jul_15_30(14)_2051-2059.nxml.txt.nlp	24665131	SENT97	12	12	17	17	methotrexate	DHFRL1	PA450428	200895	0.772
NULL	Diabetes_Metab_Syndr_Obes_2009_May_18_2_37-49.nxml.txt.nlp	20148188	SENT171	14	14	12	12	liraglutide	GLP-1	PA165958364	100125288	0.772
NULL	Br_J_Pharmacol_2014_May_11_171(9)_2385-2398.nxml.txt.nlp	24467222	SENT215	8	8	11	11	rolipram	CXCL10	PA153906323	3627	0.772
NULL	Int_J_Chron_Obstruct_Pulmon_Dis_2007_Dec_2(4)_453-462.nxml.txt.nlp	18268919	SENT94	9	9	19	19	heparin	VEGFR1	PA449855	2321	0.772
NULL	Cell_Death_Dis_2013_Oct_3_4(10)_e827.nxml.txt.nlp	24091670	SENT88	17	17	40	40	nilotinib	CD38	PA165958345	952	0.772
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_May_22_66(Pt_6)_o1429.nxml.txt.nlp	21579505	SENT57	20	20	35	35	ethanol	mol	PA448073	90527	0.772
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Sep_30_66(Pt_10)_o2685.nxml.txt.nlp	21587653	SENT57	19	19	34	34	ethanol	mol	PA448073	90527	0.772
NULL	J_Hematol_Oncol_2011_Feb_7_4_6.nxml.txt.nlp	21299849	SENT154	8	8	13	13	imatinib	RPS6	PA10804	6194	0.772
NULL	Mar_Drugs_2014_Nov_13_12(11)_5408-5424.nxml.txt.nlp	25402829	SENT112	27	27	10	10	doxorubicin	HMGN5	PA449412	79366	0.772
NULL	Front_Oncol_2013_Sep_12_3_232.nxml.txt.nlp	24062985	SENT219	13	13	7	7	daunorubicin	Raf-1	PA449212	5894	0.772
NULL	Mol_Cancer_2010_Oct_12_9_269.nxml.txt.nlp	20939893	SENT79	4	4	9	9	isoproterenol	STAT3	PA450121	6774	0.772
NULL	Exp_Hematol_Oncol_2014_Dec_17_3(1)_30.nxml.txt.nlp	NULL	SENT283	10	10	18	18	thrombin	ATIII	PA451674	462	0.772
NULL	Biol_Proced_Online_1999_Oct_4_2_1-38.nxml.txt.nlp	12734586	SENT324	4	4	9	9	galactose	GAL4	PA449725	3960	0.772
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_29_2013_590393.nxml.txt.nlp	23737838	SENT193	5	5	9	9	resveratrol	p53		7157	0.772
NULL	Cancer_Cell_Int_2009_Sep_10_9_25.nxml.txt.nlp	19744341	SENT41	3	3	14	14	glucosamine	PC-3	PA164747613	692094	0.772
NULL	Clin_Ophthalmol_2010_Oct_21_4_1165-1171.nxml.txt.nlp	21060666	SENT123	6	6	4	4	travoprost	BAK	PA164781371	578	0.772
NULL	Biomed_Res_Int_2014_Apr_10_2014_615363.nxml.txt.nlp	24818147	SENT5	29	29	12	12	thrombin	ADP	PA451674	23038	0.771
NULL	Br_J_Clin_Pharmacol_2012_Apr_7_73(4)_518-535.nxml.txt.nlp	22053916	SENT56	7	7	34	34	pitavastatin	CYP3A4	PA142650384	1576	0.771
NULL	Front_Oncol_2014_Mar_25_4_54.nxml.txt.nlp	24724051	SENT601	22	22	11	11	imatinib	PP1	PA10804	5540;5464	0.771
NULL	Indian_J_Endocrinol_Metab_2013_Jul-Aug_17(4)_611-619.nxml.txt.nlp	23961476	SENT194	4	4	14	14	saxagliptin	GLP-1	PA165958362	100125288	0.771
NULL	Addict_Sci_Clin_Pract_2010_Dec_5(2)_17-29.nxml.txt.nlp	22002450	SENT50	31	31	20	20	oxymorphone	CYP2D6	PA450748	1565	0.771
NULL	Crit_Care_2008_Dec_17_12(6)_R159.nxml.txt.nlp	19091080	SENT120	20	20	6	6	forskolin	CD14	PA146096022	929	0.771
NULL	Curr_Opin_Allergy_Clin_Immunol_2013_Dec_6_13(6)_669-676.nxml.txt.nlp	24169433	SENT79	4	4	11	11	galactose	TLR2	PA449725	7097	0.771
NULL	Br_J_Pharmacol_2008_Nov_11_155(6)_896-905.nxml.txt.nlp	18695641	SENT110	0	0	12	12	alendronate	CTX	PA448082	1593	0.771
NULL	Angiogenesis_2012_Dec_28_15(4)_623-641.nxml.txt.nlp	22843200	SENT276	17	17	10	10	sunitinib	MVD	PA162372840	4597	0.771
NULL	Breast_Cancer_Res_2010_Mar_5_12(2)_R16.nxml.txt.nlp	20205716	SENT185	0	0	7	7	lovastatin	G3BP1	PA450272	10146	0.771
NULL	Front_Neurosci_2012_May_30_6_77.nxml.txt.nlp	22661925	SENT241	27	27	0	0	ethanol	ANOVA	PA448073	4858	0.771
NULL	Evid_Based_Complement_Alternat_Med_2014_Sep_3_2014_809083.nxml.txt.nlp	25276218	SENT7	11	11	19	19	berberine	TLR4	PA165860812	7099	0.771
NULL	J_Headache_Pain_2011_Apr_5_12(2)_127-133.nxml.txt.nlp	21298314	SENT135	11	11	5	5	amitriptyline	CSMT	PA448385	1442	0.771
NULL	Case_Rep_Oncol_2010_Mar_24_3(1)_72-76.nxml.txt.nlp	20740162	SENT69	13	13	9	9	rituximab	CHOP	PA451261	1649	0.771
NULL	Int_J_Breast_Cancer_2012_May_9_2012_415170.nxml.txt.nlp	22649737	SENT76	3	3	17	17	trastuzumab	MUC4	PA451743	4585	0.771
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT240	2	2	12	12	gefitinib	KRAS	PA131301952	3845	0.771
NULL	Breast_Cancer_Res_2008_May_13_10(Suppl_2)_P13.nxml.txt.nlp	NULL	SENT22	22	22	2	2	lapatinib	XIAP	PA152241907	331	0.771
NULL	Brain_Sci_2013_Jun_19_3(2)_964-991.nxml.txt.nlp	24961433	SENT305	23	23	6	6	ethanol	spatial	PA448073	219793	0.771
NULL	Environ_Health_Perspect_1983_Apr_50_163-168.nxml.txt.nlp	6135607	SENT5	9	9	11	11	pentobarbital	PTB	PA450859	58155	0.771
NULL	Diabetes_2011_Nov_17_60(11)_2691-2700.nxml.txt.nlp	21896928	SENT3	8	8	3	3	resveratrol	SIRT1		23411	0.771
NULL	J_Invest_Dermatol_2012_Nov_21_132(11)_2642-2651.nxml.txt.nlp	22718118	SENT158	17	17	28	28	collagenase	CD11b	PA449107	3684	0.771
NULL	Br_J_Cancer_2013_Mar_19_108(5)_1021-1026.nxml.txt.nlp	23403817	SENT116	9	9	13	13	temsirolimus	PTEN	PA164746890	5728	0.771
NULL	Sci_Rep_2014_Dec_1_4_7268.nxml.txt.nlp	25434695	SENT215	4	4	19	19	gemcitabine	EGFR	PA449748	1956	0.771
NULL	Int_J_Endocrinol_Metab_2013_Dec_21_Winter_11(1)_57-61.nxml.txt.nlp	23853622	SENT122	31	31	22	22	bromocriptine	PRL	PA448671	5617	0.771
NULL	Eur_J_Neurosci_2008_Jun_27(12)_3151-3160.nxml.txt.nlp	18598259	SENT99	28	28	33	33	paraformaldehyde	TRPA1	PA450790	8989	0.771
NULL	Breast_Cancer_Res_2006_Jul_25_8(4)_R48.nxml.txt.nlp	16869955	SENT108	10	10	14	14	tamoxifen	aromatase	PA451581	1588	0.771
NULL	J_Thromb_Haemost_2007_May_5(5)_1010-1018.nxml.txt.nlp	17355572	SENT50	11	11	29	29	thrombin	VWF	PA451674	7450	0.771
NULL	Case_Rep_Hematol_2014_Dec_24_2014_460574.nxml.txt.nlp	25610674	SENT9	28	28	12	12	vincristine	PHL	PA451879	613	0.771
NULL	Breast_Cancer_Res_2014_Oct_28_16(5)_456.nxml.txt.nlp	25349073	SENT72	23	23	28	28	bevacizumab	HER2	PA130232992	2064	0.771
NULL	Int_J_Biol_Sci_2013_Apr_22_9(4)_350-360.nxml.txt.nlp	23630447	SENT28	32	32	23	23	doxorubicin	MDR1	PA449412	5243	0.771
NULL	JAKSTAT_2013_Jul_1_2(3)_e24574.nxml.txt.nlp	24069558	SENT68	22	22	16	16	doxycycline	JAK2	PA449415	3717	0.771
NULL	Int_J_Endocrinol_2011_Aug_21_2011_742719.nxml.txt.nlp	21869886	SENT128	19	19	33	33	clopidogrel	CYP2C9	PA449053	1559	0.771
NULL	Eur_J_Clin_Pharmacol_2011_May_8_67(5)_493-506.nxml.txt.nlp	21140139	SENT41	31	31	27	27	oxycodone	CYP2D6	PA450741	1565	0.771
NULL	Drugs_R_D_2014_Jun_6_14(2)_113-123.nxml.txt.nlp	24797400	SENT29	17	17	9	9	dabigatran	CES1		1066	0.771
NULL	Cancers_(Basel)_2014_Mar_26_6(2)_708-722.nxml.txt.nlp	24675568	SENT107	27	27	42	42	afatinib	STAT3	PA165981154	6774	0.771
NULL	Oxid_Med_Cell_Longev_2012_Nov_14_2012_856085.nxml.txt.nlp	23213350	SENT171	13	13	17	17	pioglitazone	p47phox	PA450970	653361	0.771
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT107	12	12	24	24	curcumin	IL-8	PA151958596	3576	0.771
NULL	Mol_Cancer_2009_Dec_10_8_118.nxml.txt.nlp	20003259	SENT135	0	0	7	7	sorafenib	VEGF-A	PA7000	7422	0.771
NULL	J_Biol_Chem_2011_Sep_16_286(37)_31984-31992.nxml.txt.nlp	21768113	SENT240	2	2	0	0	heparin	CD81	PA449855	975	0.771
NULL	Neural_Regen_Res_2013_Jul_15_8(20)_1853-1862.nxml.txt.nlp	25206494	SENT135	0	0	2	2	ethanol	p53	PA448073	7157	0.771
NULL	Appl_Plant_Sci_2015_Jan_5_3(1)_apps_1400086.nxml.txt.nlp	25606353	SENT94	3	3	28	28	vancomycin	BAM	PA451850	9126	0.771
NULL	Oncotarget_2014_Feb_7_5(3)_775-787.nxml.txt.nlp	24519956	SENT126	0	0	8	8	dasatinib	PC3	PA162372878	57332;7832;5122	0.771
NULL	Libyan_J_Med_2007_Dec_1_2(4)_176-179.nxml.txt.nlp	21503241	SENT23	11	11	33	33	vancomycin	VISA	PA451850	57506	0.771
NULL	Indian_J_Pharm_Sci_2013_Jan-Feb_75(1)_94-98.nxml.txt.nlp	23901167	SENT69	12	12	33	33	phenacetin	CYP2C9	PA450897	1559	0.771
NULL	Breast_Cancer_Res_Treat_2013_Sep_1_141(2)_243-248.nxml.txt.nlp	23996142	SENT150	13	13	5	5	tamoxifen	SULT1A1	PA451581	6817	0.771
NULL	Cancer_Cell_Int_2005_Aug_24_5_28.nxml.txt.nlp	16120219	SENT155	5	5	18	18	etoposide	p53	PA449552	7157	0.771
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT70	14	14	23	23	metformin	p53	PA450395	7157	0.771
NULL	J_Gen_Physiol_2003_Mar_121(3)_181-197.nxml.txt.nlp	12601083	SENT414	8	8	18	18	tolbutamide	ADP	PA451718	23038	0.771
NULL	Br_J_Pharmacol_2013_Apr_25_168(8)_1868-1877.nxml.txt.nlp	23194305	SENT173	5	5	11	11	bortezomib	ALDH2	PA10252	217	0.771
NULL	Curr_Neuropharmacol_2010_Sep_8(3)_287-304.nxml.txt.nlp	21358978	SENT249	23	23	15	15	agomelatine	5-HT1A	PA165958363	3350	0.771
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Dec_10_65(Pt_1)_o52.nxml.txt.nlp	21581693	SENT57	20	20	35	35	ethanol	mol	PA448073	90527	0.771
NULL	Allergy_Asthma_Immunol_Res_2010_Apr_24_2(2)_134-140.nxml.txt.nlp	20358028	SENT85	17	17	10	10	aspirin	IL-13	PA448497	3596	0.771
NULL	Biomed_Res_Int_2014_May_27_2014_782625.nxml.txt.nlp	24971350	SENT76	16	16	20	20	mannitol	GAPDH	PA450320	2597	0.771
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT248	0	0	13	13	tacrolimus	RANKL	PA451578	8600	0.771
NULL	ScientificWorldJournal_2012_Apr_26_2012_358102.nxml.txt.nlp	22645419	SENT192	6	6	29	29	losartan	DES	PA450268	1674	0.771
NULL	Mol_Cancer_2007_Jan_14_6_5.nxml.txt.nlp	17222355	SENT194	11	11	3	3	doxorubicin	HMGA2	PA449412	8091	0.771
NULL	J_Invest_Dermatol_2013_Jul_13_133(7)_1742-1751.nxml.txt.nlp	23407402	SENT82	24	24	9	9	etanercept	TREM-1	PA449515	54210	0.771
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT57	28	28	12	12	cisplatin	MVP	PA449014	9961	0.771
NULL	Cancer_2014_Apr_8_120(8)_1145-1154.nxml.txt.nlp	24501009	SENT79	3	3	5	5	erlotinib	EGFR	PA134687924	1956	0.771
NULL	Cells_2014_Apr_8_3(2)_258-287.nxml.txt.nlp	24717323	SENT265	4	4	10	10	carbachol	TRPC5	PA448784	7224	0.771
NULL	Environ_Health_Perspect_2002_Oct_110(Suppl_5)_819-822.nxml.txt.nlp	12426138	SENT10	26	26	24	24	staurosporine	NF-kappaB	PA165109623	4790	0.771
NULL	Biol_Open_2014_Dec_12_4(1)_48-61.nxml.txt.nlp	25505152	SENT504	3	3	8	8	metformin	SNRK	PA450395	54861	0.771
NULL	Int_J_Biol_Sci_2011_May_19_7(5)_645-650.nxml.txt.nlp	21647332	SENT79	35	35	31	31	metformin	AMPK	PA450395	5563	0.771
NULL	Oxid_Med_Cell_Longev_2011_Aug_15_2011_824597.nxml.txt.nlp	21904648	SENT133	2	2	0	0	cyclophosphamide	TPT	PA449165	23590;6469	0.771
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT148	5	5	10	10	metformin	HIF-1	PA450395	29072	0.771
NULL	Neuropsychopharmacology_2011_Apr_2_36(5)_1033-1046.nxml.txt.nlp	21289603	SENT361	3	3	11	11	ethanol	MSN	PA448073	4478	0.771
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Jun_25_3(6)_e120.nxml.txt.nlp	24964282	SENT25	42	42	34	34	ketoconazole	CYP3A4	PA450146	1576	0.771
NULL	J_Med_Chem_2014_Feb_13_57(3)_1063-1078.nxml.txt.nlp	24450337	SENT646	7	7	4	4	resveratrol	SIRT1		23411	0.771
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT198	9	9	32	32	curcumin	Bcl-2	PA151958596	596	0.771
NULL	Indian_J_Pharmacol_2014_Nov-Dec_46(6)_627-632.nxml.txt.nlp	25538335	SENT137	7	7	40	40	metformin	Q10	PA450395	27161	0.771
NULL	Evid_Based_Complement_Alternat_Med_2013_May_13_2013_506324.nxml.txt.nlp	23818927	SENT149	7	7	22	22	doxorubicin	p38	PA449412	10598;1432;7965	0.771
NULL	Croat_Med_J_2012_Jun_53(3)_214-223.nxml.txt.nlp	22661134	SENT62	1	1	28	28	diazepam	ACTH	PA449283	5443	0.771
NULL	Can_J_Infect_Dis_Med_Microbiol_2014_Nov-Dec_25(6)_327-343.nxml.txt.nlp	25587296	SENT74	27	27	7	7	itraconazole	CYP3A4	PA450132	1576	0.771
NULL	Diabetes_Care_2012_Feb_16_35(2)_327-333.nxml.txt.nlp	22179958	SENT116	13	13	20	20	metformin	B12	PA450395	7126;4709	0.771
NULL	Mol_Cancer_2008_May_21_7_42.nxml.txt.nlp	18492291	SENT165	19	19	25	25	gefitinib	EGFR	PA131301952	1956	0.771
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Dec_10_3(12)_e151.nxml.txt.nlp	25494035	SENT202	15	15	2	2	pravastatin	OATP-C	PA451089	10599	0.771
NULL	Case_Rep_Ophthalmol_Med_2012_Oct_4_2012_380863.nxml.txt.nlp	23091761	SENT36	2	2	5	5	risperidone	BID	PA451257	637	0.771
NULL	Breast_Cancer_Res_2010_Mar_5_12(2)_R16.nxml.txt.nlp	20205716	SENT302	3	3	14	14	lovastatin	G3BP1	PA450272	10146	0.771
NULL	Mol_Biol_Cell_2014_Jan_1_25(1)_169-183.nxml.txt.nlp	24173718	SENT191	11	11	18	18	bortezomib	ADARB2	PA10252	105	0.771
NULL	Mol_Cancer_2003_Jan_7_2_5.nxml.txt.nlp	12537586	SENT113	5	5	11	11	fluvastatin	RhoA	PA449688	387	0.771
NULL	Nucleic_Acids_Res_2005_Jun_21_33(11)_3540-3549.nxml.txt.nlp	15972796	SENT340	4	4	24	24	collagenase	AP-1	PA449107	2353;3727;2354;3725	0.771
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1224-1233.nxml.txt.nlp	22353810	SENT198	19	19	17	17	vincristine	MRP-1	PA451879	928	0.771
NULL	Br_J_Cancer_2009_Jul_21_101(2)_350-356.nxml.txt.nlp	19513075	SENT126	2	2	13	13	camptothecin	p53	PA153590860	7157	0.771
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1676-1682.nxml.txt.nlp	19844234	SENT14	17	17	6	6	lapatinib	PIK3CA	PA152241907	5290	0.771
NULL	Clinics_(Sao_Paulo)_2013_Feb_68(2)_253-262.nxml.txt.nlp	23525324	SENT217	14	14	23	23	genistein	Gen	PA165109660	348654	0.771
NULL	J_Nat_Med_2014_Feb_19_68(2)_253-266.nxml.txt.nlp	24550097	SENT195	16	16	21	21	berberine	AMPK	PA165860812	5563	0.771
NULL	Ther_Clin_Risk_Manag_2007_Jun_3(2)_333-339.nxml.txt.nlp	18360642	SENT86	14	14	22	22	carmustine	NNT	PA448810	23530	0.771
NULL	Springerplus_2014_Sep_9_3_510.nxml.txt.nlp	25279302	SENT35	31	31	21	21	creatine	SLC6A8	PA164778930	6535	0.771
NULL	Braz_J_Microbiol_2011_Dec_1_Oct-Dec_42(4)_1300-1307.nxml.txt.nlp	24031756	SENT30	23	23	43	43	clotrimazole	OTC	PA449057	5009	0.771
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1150.nxml.txt.nlp	24675468	SENT97	43	43	24	24	ethanol	AMPK	PA448073	5563	0.771
NULL	Clin_Med_Insights_Oncol_2013_Aug_21_7_221-234.nxml.txt.nlp	24179413	SENT25	46	46	32	32	bevacizumab	EGFR	PA130232992	1956	0.771
NULL	Oncotarget_2014_Oct_21_5(22)_11252-11268.nxml.txt.nlp	25361004	SENT210	14	14	11	11	metformin	CLIC1	PA450395	1192	0.771
NULL	Drug_Saf_2014_Feb_19_37(4)_201-211.nxml.txt.nlp	24550106	SENT12	5	5	24	24	omeprazole	CYP3A4	PA450704	1576	0.771
NULL	Arthritis_Res_Ther_2013_Jul_9_15(4)_R73.nxml.txt.nlp	23837669	SENT300	3	3	9	9	colchicine	MICL	PA449092	160364	0.771
NULL	Protein_Cell_2014_Jun_19_5(6)_469-479.nxml.txt.nlp	24748116	SENT134	5	5	0	0	paclitaxel	EB1	PA450761	9167;22919;10982	0.771
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT166	42	42	8	8	trastuzumab	EGF	PA451743	1950	0.771
NULL	J_Korean_Med_Sci_2010_Sep_14_25(9)_1277-1283.nxml.txt.nlp	20808669	SENT143	31	31	11	11	pamidronate	IFN	PA450767	3439	0.771
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_24_2013_482318.nxml.txt.nlp	23864891	SENT96	5	5	18	18	metoprolol	CHOP	PA450480	1649	0.771
NULL	Biomed_Res_Int_2014_Feb_19_2014_240642.nxml.txt.nlp	24701565	SENT62	8	8	19	19	doxorubicin	TNF-alpha	PA449412	7124	0.771
NULL	Breast_Cancer_Res_2010_Mar_12_12(2)_R20.nxml.txt.nlp	20226014	SENT144	28	28	19	19	trastuzumab	PTEN	PA451743	5728	0.771
NULL	Genome_Biol_2008_Mar_10_9(3)_211.nxml.txt.nlp	18341708	SENT61	14	14	1	1	imiquimod	TLR7	PA449972	51284	0.771
NULL	Orphanet_J_Rare_Dis_2014_Sep_26_9(1)_145.nxml.txt.nlp	NULL	SENT216	6	6	4	4	denosumab	RANKL	PA166048634	8600	0.771
NULL	J_Cell_Biol_1998_Jan_26_140(2)_335-345.nxml.txt.nlp	9442109	SENT149	20	20	10	10	chloroquine	NHE	PA448948	285335	0.771
NULL	Cancers_(Basel)_2011_May_18_3(2)_2444-2461.nxml.txt.nlp	24212818	SENT115	20	20	1	1	estradiol	EGFR	PA449503	1956	0.771
NULL	Oncoimmunology_2012_Nov_1_1(8)_1451-1453.nxml.txt.nlp	23243626	SENT65	26	26	35	35	sorafenib	IL-10	PA7000	3586	0.771
NULL	Ann_Gastroenterol_2014_27(4)_313-319.nxml.txt.nlp	25331779	SENT147	25	25	17	17	azathioprine	POR	PA448515	5447	0.771
NULL	Diabetologia_2011_Apr_25_54(4)_783-788.nxml.txt.nlp	21188353	SENT152	11	11	6	6	glucose	MTNR1B	PA449773	4544	0.771
NULL	Front_Cell_Neurosci_2014_Jul_29_8_213.nxml.txt.nlp	25120434	SENT248	27	27	9	9	bortezomib	XBP1	PA10252	7494	0.771
NULL	Org_Electron_2014_May_15(5)_997-1001.nxml.txt.nlp	24817837	SENT273	24	24	13	13	ether	ITO	PA449525	3160	0.771
NULL	Clinics_(Sao_Paulo)_2014_Feb_69(2)_145-149.nxml.txt.nlp	24519206	SENT148	12	12	21	21	olmesartan	gamma	PA164742950	9913	0.771
NULL	Ann_Rehabil_Med_2012_Dec_28_36(6)_857-860.nxml.txt.nlp	23342320	SENT25	13	13	6	6	warfarin	CYP2C9	PA451906	1559	0.771
NULL	Oncogene_2014_Aug_28_33(35)_4407-4417.nxml.txt.nlp	24469038	SENT51	1	1	18	18	cisplatin	p53	PA449014	7157	0.771
NULL	Viruses_2014_Jul_22_6(7)_2858-2879.nxml.txt.nlp	25054884	SENT99	28	28	30	30	atazanavir	ATV	PA10251	4683	0.771
NULL	J_Oncol_2013_Apr_29_2013_854121.nxml.txt.nlp	23737784	SENT167	38	38	23	23	bevacizumab	HER2	PA130232992	2064	0.771
NULL	Oncoimmunology_2012_Sep_1_1(6)_957-958.nxml.txt.nlp	23162770	SENT17	24	24	28	28	trastuzumab	CD137	PA451743	3604	0.771
NULL	Acta_Pharmacol_Sin_2009_Nov_12_30(11)_1566-1572.nxml.txt.nlp	19820718	SENT150	14	14	25	25	ketoconazole	CYP3A	PA450146	1574	0.771
NULL	Eur_J_Clin_Pharmacol_2012_Apr_14_68(4)_371-377.nxml.txt.nlp	21997404	SENT155	4	4	12	12	leflunomide	IL-6	PA450192	3569	0.771
NULL	Curr_Neuropharmacol_2013_Mar_11(2)_160-170.nxml.txt.nlp	23997751	SENT162	14	14	12	12	mianserin	5-HT2C	PA134687937	3358	0.771
NULL	Braz_J_Med_Biol_Res_2014_Sep_5_47(11)_929-939.nxml.txt.nlp	25296354	SENT79	0	0	6	6	gefitinib	EGFR	PA131301952	1956	0.771
NULL	Biomed_Res_Int_2013_Nov_4_2013_517237.nxml.txt.nlp	24294611	SENT87	12	12	21	21	paclitaxel	MDR1	PA450761	5243	0.771
NULL	AIDS_Res_Ther_2013_Dec_13_10_33.nxml.txt.nlp	24330617	SENT45	15	15	21	21	etravirine	CCR5	PA166014703	1234	0.771
NULL	J_Psychopharmacol_2012_Nov_26(11)_1417-1423.nxml.txt.nlp	22596208	SENT216	13	13	1	1	ketamine	Gen	PA450144	348654	0.771
NULL	Biomed_Imaging_Interv_J_2008_Jul_1_4(3)_e47.nxml.txt.nlp	21611010	SENT96	26	26	23	23	cisplatin	ERCC1	PA449014	2067	0.771
NULL	Biochemistry_2011_May_3_50(17)_3408-3410.nxml.txt.nlp	21425834	SENT44	14	14	17	17	nadh	VDAC2	PA164755085	7417	0.771
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT180	6	6	4	4	cisplatin	p53	PA449014	7157	0.771
NULL	J_Hematol_Oncol_2013_Jun_3_6_38.nxml.txt.nlp	23731980	SENT76	14	14	2	2	lapatinib	HER2	PA152241907	2064	0.771
NULL	Mediators_Inflamm_2011_Jun_7_2011_432080.nxml.txt.nlp	21772662	SENT114	14	14	23	23	rivaroxaban	IL-6	PA165958360	3569	0.771
NULL	Front_Endocrinol_(Lausanne)_2014_Apr_1_5_39.nxml.txt.nlp	24744750	SENT68	10	10	26	26	estradiol	IL-10	PA449503	3586	0.771
NULL	Cell_Rep_2012_Feb_23_1(2)_99-109.nxml.txt.nlp	22832160	SENT51	21	21	14	14	tetracycline	Oct4	PA451640	5460	0.771
NULL	Environ_Health_Perspect_2005_Aug_18_113(8)_969-977.nxml.txt.nlp	16079065	SENT114	7	7	13	13	phenol	DES	PA450913	1674	0.771
NULL	Diabetes_Care_2012_Jan_9_35(1)_4-11.nxml.txt.nlp	22040840	SENT146	23	23	21	21	liraglutide	GLP-1	PA165958364	100125288	0.771
NULL	J_Immunol_Res_2014_Jul_16_2014_696812.nxml.txt.nlp	25133198	SENT107	3	3	26	26	rifaximin	TLR4	PA164752443	7099	0.771
NULL	Mycobact_Dis_2014_May_5_4_145.nxml.txt.nlp	25525563	SENT29	10	10	7	7	rifampin	EMB	PA451250	133418	0.771
NULL	J_Immunol_Res_2014_Apr_28_2014_286170.nxml.txt.nlp	24868562	SENT67	28	28	11	11	docetaxel	CO2	PA449383	4513	0.771
NULL	Kidney_Int_Suppl_(2011)_2013_Dec_27_3(4)_392-409.nxml.txt.nlp	NULL	SENT644	9	9	4	4	curcumin	OCT2	PA151958596	6582;5452	0.771
NULL	Mol_Biol_Cell_2012_Nov_1_23(21)_4256-4272.nxml.txt.nlp	22973053	SENT439	6	6	40	40	dextran	B12	PA449261	7126;4709	0.771
NULL	eLife_2014_May_27_3_e02200.nxml.txt.nlp	24867637	SENT42	3	3	20	20	nutlin-3	p53		7157	0.771
NULL	Nat_Commun_2014_Jun_9_5_4088.nxml.txt.nlp	24909826	SENT301	39	39	29	29	doxycycline	EGF	PA449415	1950	0.771
NULL	Oncogene_2013_Sep_26_32(39)_10_1038_onc_2012_491.nxml.txt.nlp	23108394	SENT65	22	22	33	33	epirubicin	FOXM1	PA449476	2305	0.771
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jan_11_68(Pt_2)_o324-o325.nxml.txt.nlp	22346958	SENT70	18	18	12	12	ethanol	mol	PA448073	90527	0.771
NULL	Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.nxml.txt.nlp	24736980	SENT197	7	7	10	10	rosuvastatin	OATP1B1	PA134308647	10599	0.771
NULL	Blood_Res_2014_Mar_24_49(1)_36-41.nxml.txt.nlp	24724065	SENT107	35	35	33	33	cyclophosphamide	CHOP	PA449165	1649	0.771
NULL	Diabetes_Care_2012_Feb_16_35(2)_327-333.nxml.txt.nlp	22179958	SENT148	22	22	30	30	metformin	B12	PA450395	7126;4709	0.771
NULL	ScientificWorldJournal_2014_Mar_12_2014_731462.nxml.txt.nlp	24715817	SENT131	3	3	23	23	diclofenac	IL-6	PA449293	3569	0.771
NULL	Front_Oncol_2014_Sep_29_4_256.nxml.txt.nlp	25325013	SENT162	18	18	33	33	cisplatin	EGFR	PA449014	1956	0.771
NULL	Nat_Commun_2012_Jan_10_3_614.nxml.txt.nlp	22233624	SENT120	42	42	26	26	ethanol	mol	PA448073	90527	0.771
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT116	40	40	19	19	pemetrexed	UNG	PA10810	7374	0.771
NULL	Oncogene_2014_Feb_6_33(6)_713-723.nxml.txt.nlp	23435429	SENT54	13	13	2	2	camptothecin	BRCA1	PA153590860	672	0.771
NULL	AIDS_Res_Ther_2008_Mar_28_5_5.nxml.txt.nlp	18373851	SENT15	8	8	10	10	atazanavir	ATV	PA10251	4683	0.771
NULL	Br_J_Cancer_2010_Jan_5_102(1)_151-161.nxml.txt.nlp	19935791	SENT149	9	9	17	17	panitumumab	KRAS	PA162373091	3845	0.771
NULL	Int_J_Mol_Sci_2014_Mar_6_15(3)_4088-4103.nxml.txt.nlp	24663083	SENT100	14	14	28	28	l-arginine	DDAH	PA448478	23576	0.771
NULL	Br_J_Cancer_2010_Jan_5_102(1)_80-86.nxml.txt.nlp	19920817	SENT71	15	15	17	17	bevacizumab	IFN	PA130232992	3439	0.771
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT158	10	10	33	33	capsaicin	p53	PA448776	7157	0.771
NULL	Mol_Cancer_2010_Apr_21_9_83.nxml.txt.nlp	20409325	SENT214	23	23	13	13	doxycycline	MYCN	PA449415	4613	0.771
NULL	Arch_Gynecol_Obstet_2012_May_30_285(5)_1447-1453.nxml.txt.nlp	22127553	SENT29	41	41	9	9	carboplatin	TEC	PA448803	7006	0.771
NULL	Mol_Cancer_2014_Jun_27_13_159.nxml.txt.nlp	24972933	SENT94	5	5	39	39	cisplatin	BTK	PA449014	695	0.771
NULL	Neural_Plast_2014_Mar_19_2014_610343.nxml.txt.nlp	24772353	SENT93	15	15	4	4	fluoxetine	IL-6	PA449673	3569	0.771
NULL	Cancers_(Basel)_2014_Mar_6_6(1)_494-525.nxml.txt.nlp	24662938	SENT579	1	1	11	11	auranofin	STAT3	PA448510	6774	0.771
NULL	Neural_Regen_Res_2014_Jan_15_9(2)_119-128.nxml.txt.nlp	25206792	SENT233	19	19	15	15	l-glutamine	B27	PA10090	56246	0.771
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1137-1144.nxml.txt.nlp	20234366	SENT145	6	6	8	8	cetuximab	KRAS	PA10040	3845	0.771
NULL	Infect_Dis_Ther_2013_Dec_3_2(2)_111-122.nxml.txt.nlp	25134475	SENT52	9	9	28	28	desipramine	CYP2B6	PA449233	1555	0.771
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT81	42	42	12	12	trastuzumab	STAT3	PA451743	6774	0.771
NULL	Breast_Cancer_Res_2010_Aug_9_12(4)_R62.nxml.txt.nlp	20696059	SENT292	9	9	7	7	trastuzumab	HER2	PA451743	2064	0.771
NULL	Clin_Epigenetics_2011_Nov_1_3(1)_5.nxml.txt.nlp	22414227	SENT149	12	12	6	6	imipramine	HDAC5	PA449969	10014	0.771
NULL	J_Oncol_2010_Jun_6_2010_921682.nxml.txt.nlp	20628483	SENT21	19	19	11	11	thyroglobulin	TPO	PA164754910	7066;7173	0.771
NULL	BMB_Rep_2014_May_47(5)_268-273.nxml.txt.nlp	24286315	SENT102	9	9	5	5	trastuzumab	PTEN	PA451743	5728	0.771
NULL	Case_Rep_Oncol_Med_2011_Oct_11_2011_638794.nxml.txt.nlp	22606444	SENT8	11	11	15	15	imatinib	NAC	PA10804	22861	0.771
NULL	Clin_Endosc_2011_Sep_30_44(1)_22-26.nxml.txt.nlp	22741108	SENT19	11	11	1	1	midazolam	ESD	PA450496	2098	0.771
NULL	Biomed_Res_Int_2014_Jan_20_2014_948427.nxml.txt.nlp	24563867	SENT123	7	7	14	14	glucose	5-HT1A	PA449773	3350	0.771
NULL	Nat_Commun_2014_Aug_4_5_4535.nxml.txt.nlp	25088745	SENT654	7	7	12	12	paraformaldehyde	CRTC2	PA450790	200186	0.771
NULL	Br_J_Cancer_2011_Aug_23_105(5)_618-627.nxml.txt.nlp	21829197	SENT172	8	8	3	3	lapatinib	CRT	PA152241907	811	0.771
NULL	Oxid_Med_Cell_Longev_2009_Jul-Aug_2(3)_130-137.nxml.txt.nlp	20592767	SENT45	23	23	31	31	pilocarpine	ROS	PA450962	6098	0.771
NULL	J_Biol_Chem_2012_Apr_20_287(17)_14122-14135.nxml.txt.nlp	22351750	SENT658	8	8	12	12	hyaluronan	CD44	PA165958431	960	0.771
NULL	Curr_Nanosci_2014_Oct_10(5)_695-699.nxml.txt.nlp	25237290	SENT32	12	12	5	5	ethanol	NO3	PA448073	4681	0.771
NULL	Front_Hum_Neurosci_2013_Apr_9_7_136.nxml.txt.nlp	23576977	SENT232	4	4	9	9	propofol	gamma	PA451141	9913	0.771
NULL	Oncotarget_2013_Dec_28_5(6)_1475-1490.nxml.txt.nlp	24721996	SENT7	4	4	13	13	celecoxib	CD133	PA448871	8842	0.771
NULL	Exp_Mol_Med_2012_Sep_30_44(9)_536-544.nxml.txt.nlp	22771771	SENT171	3	3	10	10	celecoxib	p53	PA448871	7157	0.771
NULL	J_Carcinog_Mutagen_2013_Aug_5_Suppl_7_4.nxml.txt.nlp	25587491	SENT160	37	37	16	16	gefitinib	AKT	PA131301952	207	0.771
NULL	Front_Physiol_2011_Jul_19_2_40.nxml.txt.nlp	21811470	SENT170	5	5	9	9	candesartan	RVR	PA448765	9975	0.771
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Dec_17_3(12)_e152.nxml.txt.nlp	25518025	SENT13	5	5	0	0	oxycodone	CYP3A4	PA450741	1576	0.771
NULL	Core_Evid_2008_Jun_3(1)_13-30.nxml.txt.nlp	20694081	SENT288	0	0	26	26	vildagliptin	GLP-1	PA165958346	100125288	0.771
NULL	Br_J_Cancer_2011_Dec_6_105(12)_1920-1926.nxml.txt.nlp	22095222	SENT108	7	7	19	19	trastuzumab	PTEN	PA451743	5728	0.771
NULL	Emerg_Med_J_2014_Feb_22_31(2)_163-168.nxml.txt.nlp	23435652	SENT82	47	47	27	27	dabigatran	VIII		1351	0.771
NULL	J_Mol_Med_(Berl)_2014_May_10_92(7)_709-722.nxml.txt.nlp	24811491	SENT270	17	17	4	4	cetuximab	KRAS	PA10040	3845	0.771
NULL	Diabetes_Care_2011_Apr_21_34(4)_845-851.nxml.txt.nlp	21330640	SENT125	19	19	25	25	valsartan	PLB	PA451848	151056	0.771
NULL	Curr_Oncol_2009_May_16(Suppl_1)_S52-S59.nxml.txt.nlp	19478903	SENT281	5	5	11	11	nifedipine	CYP3A4	PA450631	1576	0.771
NULL	Blood_Res_2014_Mar_24_49(1)_15-21.nxml.txt.nlp	24724062	SENT165	24	24	22	22	cyclophosphamide	CHOP	PA449165	1649	0.771
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_650809.nxml.txt.nlp	23258995	SENT26	0	0	10	10	vasopressin	AQP3	PA451858	360	0.771
NULL	Breast_Cancer_Res_2004_Jun_29_6(5)_R488-R498.nxml.txt.nlp	15318931	SENT14	3	3	18	18	estradiol	SULT	PA449503	6816	0.771
NULL	Front_Oncol_2012_Oct_4_2_123.nxml.txt.nlp	23061041	SENT646	10	10	19	19	anastrozole	ATAC	PA448432	6375	0.771
NULL	Croat_Med_J_2013_Apr_54(2)_171-179.nxml.txt.nlp	23630144	SENT113	2	2	25	25	taurine	STZ	PA451590	6484	0.771
NULL	Front_Oncol_2013_Oct_1_3_259.nxml.txt.nlp	24102047	SENT105	33	33	29	29	brivanib	VEGFR2	PA164924492	3791	0.771
NULL	Br_J_Cancer_2012_Feb_14_106(4)_646-650.nxml.txt.nlp	22240794	SENT55	34	34	36	36	sunitinib	IFN	PA162372840	3439	0.771
NULL	Oncol_Lett_2013_Aug_17_6(2)_295-305.nxml.txt.nlp	24137320	SENT177	5	5	20	20	tamoxifen	14-3-3	PA451581	10971	0.771
NULL	J_Immunother_2014_Apr_12_37(3)_180-186.nxml.txt.nlp	24598448	SENT15	15	15	23	23	sorafenib	IL-2	PA7000	3558	0.771
NULL	Oncotarget_2014_Jun_8_5(17)_7446-7457.nxml.txt.nlp	25277184	SENT40	8	8	19	19	nutlin-3	TRIM8		81603	0.771
NULL	Front_Endocrinol_(Lausanne)_2011_Dec_27_2_104.nxml.txt.nlp	22654839	SENT123	34	34	18	18	docetaxel	PMP22	PA449383	5376;5827	0.771
NULL	Acta_Otolaryngol_2010_Nov_30_130(11)_1278-1286.nxml.txt.nlp	20586674	SENT244	24	24	19	19	methimazole	TRPV2	PA450422	51393	0.771
NULL	Cancer_Cell_Int_2011_May_15_11_13.nxml.txt.nlp	21569620	SENT94	8	8	5	5	bortezomib	PC-3	PA10252	692094	0.771
NULL	Carcinogenesis_2014_May_13_35(5)_1055-1066.nxml.txt.nlp	24419232	SENT38	10	10	6	6	metformin	AMPK	PA450395	5563	0.771
NULL	AAPS_J_2014_Jun_11_16(5)_1029-1037.nxml.txt.nlp	24917180	SENT122	10	10	8	8	quinidine	P-gp	PA451209	5243	0.771
NULL	J_Radiat_Res_2014_Nov_16_55(6)_1171-1177.nxml.txt.nlp	25129557	SENT157	8	8	12	12	bevacizumab	CRT	PA130232992	811	0.771
NULL	Anat_Cell_Biol_2010_Sep_30_43(3)_194-200.nxml.txt.nlp	21212859	SENT15	12	12	29	29	ethanol	PLP	PA448073	25824;5744	0.771
NULL	Cancer_Res_Treat_2014_Jan_15_46(1)_48-54.nxml.txt.nlp	24520223	SENT121	12	12	14	14	bevacizumab	IFL	PA130232992	3439	0.771
NULL	Evid_Based_Complement_Alternat_Med_2011_Mar_13_2011_913898.nxml.txt.nlp	21785639	SENT185	13	13	3	3	curcumin	CYP3A4	PA151958596	1576	0.771
NULL	Diabetes_Care_2011_Sep_19_34(9)_2041-2047.nxml.txt.nlp	21868779	SENT260	15	15	10	10	ramipril	DREAM	PA451223	30818	0.771
NULL	Curr_Neuropharmacol_2012_Jun_10(2)_97-123.nxml.txt.nlp	23204981	SENT857	34	34	23	23	mirtazapine	CXCR4	PA450522	7852	0.771
NULL	Emerg_Infect_Dis_2011_Mar_17(3)_510-513.nxml.txt.nlp	21392446	SENT26	25	25	20	20	ethionamide	DST	PA164768738	667	0.771
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT11	1	1	30	30	metformin	HIF-1	PA450395	29072	0.771
NULL	Anesth_Pain_Med_2014_Apr_7_4(2)_e15460.nxml.txt.nlp	24790902	SENT97	27	27	19	19	dexmedetomidine	NTG	PA449256	4976	0.771
NULL	Mol_Cell_Proteomics_2012_Feb_6_11(2)_M111_015222.nxml.txt.nlp	22147731	SENT43	14	14	9	9	gefitinib	EGF	PA131301952	1950	0.771
NULL	Clin_Kidney_J_2013_Jun_11_6(3)_287-294.nxml.txt.nlp	23717787	SENT8	16	16	3	3	cinacalcet	PTH	PA164776671	5741	0.771
NULL	Allergy_Asthma_Immunol_Res_2009_Oct_25_1(1)_30-35.nxml.txt.nlp	20224667	SENT98	18	18	33	33	aspirin	PPARG	PA448497	5468	0.771
NULL	Mol_Cancer_2010_Jun_24_9_164.nxml.txt.nlp	20576107	SENT75	5	5	11	11	etoposide	Mcl-1	PA449552	4170	0.771
NULL	Biomed_Res_Int_2014_Jun_2_2014_946492.nxml.txt.nlp	24991574	SENT72	16	16	9	9	olmesartan	adiponectin	PA164742950	9370	0.771
NULL	Blood_Cancer_J_2013_Mar_1_3(3)_e103.nxml.txt.nlp	23454896	SENT89	7	7	9	9	saquinavir	AKT	PA451305	207	0.771
NULL	Cardiovasc_Diabetol_2005_Aug_9_4_12.nxml.txt.nlp	16086844	SENT138	23	23	31	31	heparin	ANOVA	PA449855	4858	0.771
NULL	J_Gen_Physiol_2004_Jul_124(1)_1b.nxml.txt.nlp	NULL	SENT1329	16	16	8	8	thrombin	ASM	PA451674	6609;283120	0.771
NULL	Ann_Med_Health_Sci_Res_2013_Oct-Dec_3(4)_498-503.nxml.txt.nlp	24379998	SENT86	28	28	16	16	cyclophosphamide	CD4	PA449165	920	0.771
NULL	Arthritis_Res_Ther_2003_Dec_2_5(Suppl_4)_S12-S16.nxml.txt.nlp	15180892	SENT81	6	6	0	0	vincristine	CHOP	PA451879	1649	0.771
NULL	Arthritis_Res_Ther_2014_Jul_24_16(4)_R157.nxml.txt.nlp	25059342	SENT236	18	18	13	13	bleomycin	IL-6	PA448645	3569	0.771
NULL	Mol_Cancer_2012_Dec_12_11_91.nxml.txt.nlp	23234355	SENT13	14	14	24	24	trastuzumab	EGFR	PA451743	1956	0.771
NULL	Br_J_Pharmacol_2011_Feb_162(4)_989-999.nxml.txt.nlp	21054342	SENT220	10	10	22	22	ketoconazole	CYP2C8	PA450146	1558	0.771
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1563-1573.nxml.txt.nlp	22015557	SENT145	34	34	9	9	sunitinib	c-Myc	PA162372840	4609	0.771
NULL	Cancer_Causes_Control_2013_Aug_18_24(8)_1605-1614.nxml.txt.nlp	23775025	SENT55	17	17	7	7	methotrexate	UBC	PA450428	7316	0.771
NULL	Indian_J_Psychiatry_2014_Jan_56(Suppl_1)_S63-S96.nxml.txt.nlp	NULL	SENT814	3	3	23	23	trihexyphenidyl	OGC	PA164747026	8402	0.771
NULL	Mol_Neurobiol_2007_Oct_10_36(2)_137-151.nxml.txt.nlp	17952658	SENT388	39	39	47	47	vasopressin	CXCR4	PA451858	7852	0.771
NULL	Mol_Cancer_2012_Apr_5_11_20.nxml.txt.nlp	22480225	SENT222	27	27	21	21	temozolomide	SPARC	PA451609	6678	0.771
NULL	Am_J_Trop_Med_Hyg_2014_Jul_2_91(1)_1-2.nxml.txt.nlp	24752684	SENT35	10	10	34	34	primaquine	G6PD	PA451103	2539	0.771
NULL	DNA_Res_2014_Feb_13_21(1)_1-13.nxml.txt.nlp	23942912	SENT438	18	18	6	6	l-arginine	TLR4	PA448478	7099	0.771
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2675-2684.nxml.txt.nlp	24129246	SENT237	26	26	9	9	etoposide	p53	PA449552	7157	0.771
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2654-2664.nxml.txt.nlp	24136149	SENT131	14	14	5	5	doxorubicin	DNA-PKcs	PA449412	5591	0.771
NULL	Ann_Oncol_2013_Aug_12_24(8)_1994-1999.nxml.txt.nlp	23670096	SENT71	7	7	10	10	tamoxifen	AIB1	PA451581	8202	0.771
NULL	Breast_Cancer_Res_2011_Mar_1_13(2)_R21.nxml.txt.nlp	21362200	SENT11	0	0	18	18	estradiol	PI3K	PA449503	5290	0.771
NULL	Arthritis_Res_Ther_2013_Sep_25_15(5)_118.nxml.txt.nlp	24063679	SENT22	5	5	13	13	colchicine	MSU	PA449092	593	0.771
NULL	Crit_Care_2005_Nov_4_9(6)_561-565.nxml.txt.nlp	16356239	SENT117	2	2	13	13	propranolol	IL-6	PA451145	3569	0.771
NULL	Int_J_Environ_Res_Public_Health_2012_Sep_19_9(9)_3354-3364.nxml.txt.nlp	23202692	SENT104	3	3	8	8	resveratrol	CYP2E1		1571	0.771
NULL	Breast_Cancer_Res_2005_Jan_26_7(2)_R267-R273.nxml.txt.nlp	15743507	SENT28	9	9	16	16	trastuzumab	San	PA451743	80218	0.771
NULL	Ann_Hematol_2010_Oct_22_89(10)_971-978.nxml.txt.nlp	20567823	SENT94	12	12	3	3	filgrastim	CD34	PA449626	947	0.771
NULL	Cardiovasc_Diabetol_2005_Jan_10_4_2.nxml.txt.nlp	15642122	SENT94	15	15	21	21	camptothecin	p15	PA153590860	10923;10573	0.771
NULL	Cancers_(Basel)_2012_Oct_29_4(4)_1146-1160.nxml.txt.nlp	24213502	SENT602	22	22	4	4	letrozole	aromatase	PA450196	1588	0.771
NULL	Front_Endocrinol_(Lausanne)_2013_Jul_29_4_94.nxml.txt.nlp	23908645	SENT121	6	6	16	16	estradiol	UGT2B17	PA449503	7367	0.771
NULL	Gut_2012_Aug_24_61(8)_1146-1153.nxml.txt.nlp	22115910	SENT211	32	32	42	42	fluorescein	CLE	PA164746009	51637	0.771
NULL	J_Cell_Mol_Med_2013_Sep_24_17(9)_1065-1087.nxml.txt.nlp	24151975	SENT258	2	2	12	12	palifermin	CD4	PA164744014	920	0.771
NULL	Arthritis_Res_Ther_2008_May_2_10(3)_R50.nxml.txt.nlp	18454843	SENT179	15	15	6	6	etanercept	IL-6	PA449515	3569	0.771
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2735-2743.nxml.txt.nlp	24129244	SENT178	3	3	8	8	crizotinib	ROS1	PA165946122	6098	0.771
NULL	Cell_Death_Dis_2012_Jun_21_3(6)_e325.nxml.txt.nlp	22717580	SENT133	11	11	7	7	heparin	FGF2	PA449855	2247;2258	0.771
NULL	Lancet_2011_Jun_9_377(9784)_2181-2192.nxml.txt.nlp	21663949	SENT7	16	16	1	1	ezetimibe	SHARP	PA10816	23013	0.77
NULL	Ann_Hematol_2011_Oct_23_90(10)_1161-1166.nxml.txt.nlp	21698395	SENT183	2	2	6	6	lovastatin	BAX	PA450272	581	0.77
NULL	Mol_Cancer_2012_Mar_21_11_13.nxml.txt.nlp	22436134	SENT1	14	14	8	8	doxorubicin	HuR	PA449412	1994	0.77
NULL	ScientificWorldJournal_2014_Feb_4_2014_695402.nxml.txt.nlp	24672355	SENT72	9	9	3	3	sirolimus	DES	PA451365	1674	0.77
NULL	Diabetes_Care_2009_Nov_32(Suppl_2)_S184-S188.nxml.txt.nlp	19875549	SENT138	28	28	12	12	rosiglitazone	DREAM	PA451283	30818	0.77
NULL	J_Med_Chem_2014_Jan_23_57(2)_462-476.nxml.txt.nlp	24313754	SENT116	2	2	15	15	piperazine	BRD4	PA450977	23476	0.77
NULL	Breast_Cancer_Res_2012_May_23_14(3)_R84.nxml.txt.nlp	22621373	SENT12	12	12	7	7	urokinase	CD44	PA451836	960	0.77
NULL	Acta_Pharmacol_Sin_2012_Jun_6_33(6)_798-808.nxml.txt.nlp	22669117	SENT25	0	0	19	19	heparin	14-3-3	PA449855	10971	0.77
NULL	Cancer_Med_2013_Aug_10_2(4)_496-506.nxml.txt.nlp	24156022	SENT236	17	17	4	4	cetuximab	KRAS	PA10040	3845	0.77
NULL	Asian-Australas_J_Anim_Sci_2014_Jun_27(6)_855-861.nxml.txt.nlp	25050024	SENT108	11	11	20	20	galactose	GIT	PA449725	5034	0.77
NULL	Int_J_Biol_Sci_2013_Aug_27_9(8)_842-852.nxml.txt.nlp	23983617	SENT137	0	0	5	5	heparin	PPX	PA449855	5531	0.77
NULL	Allergy_Asthma_Immunol_Res_2014_Nov_28_6(6)_567-572.nxml.txt.nlp	25374757	SENT141	5	5	18	18	fexofenadine	p38	PA449621	10598;1432;7965	0.77
NULL	Int_J_Nanomedicine_2012_May_7_7_2307-2314.nxml.txt.nlp	22661887	SENT108	4	4	1	1	gemcitabine	zeta	PA449748	9907	0.77
NULL	Behav_Brain_Funct_2009_Jan_15_5_3.nxml.txt.nlp	19146665	SENT79	5	5	24	24	ethanol	P31	PA448073	529	0.77
NULL	Carcinogenesis_2013_Feb_3_34(2)_351-360.nxml.txt.nlp	23125222	SENT256	6	6	12	12	curcumin	CDC27	PA151958596	996	0.77
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Mar_7_68(Pt_4)_o968.nxml.txt.nlp	22590024	SENT74	4	4	10	10	piperazine	mol	PA450977	90527	0.77
NULL	Biomed_Res_Int_2014_Jan_29_2014_831845.nxml.txt.nlp	24605337	SENT64	15	15	11	11	bupivacaine	S6K1	PA135057240	6198	0.77
NULL	Front_Endocrinol_(Lausanne)_2013_Sep_30_4_127.nxml.txt.nlp	24137156	SENT352	22	22	26	26	estradiol	activin	PA449503	83729	0.77
NULL	Front_Oncol_2014_Apr_22_4_86.nxml.txt.nlp	24795863	SENT308	0	0	13	13	olaparib	BRCA1		672	0.77
NULL	Indian_J_Nephrol_2012_Nov-Dec_22(6)_462-465.nxml.txt.nlp	23439779	SENT55	12	12	21	21	fluconazole	API	PA449653	5345	0.77
NULL	Biologics_2012_Aug_17_6_267-276.nxml.txt.nlp	22956858	SENT83	7	7	9	9	sorafenib	Bcl-2	PA7000	596	0.77
NULL	Mol_Pain_2013_Feb_15_9_3.nxml.txt.nlp	23413875	SENT186	2	2	21	21	resveratrol	TRPA1		8989	0.77
NULL	J_Inflamm_(Lond)_2005_Oct_31_2_14.nxml.txt.nlp	16259633	SENT275	4	4	14	14	staurosporine	IFN	PA165109623	3439	0.77
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Apr_8_65(Pt_5)_o979.nxml.txt.nlp	21584018	SENT62	13	13	6	6	ethanol	mol	PA448073	90527	0.77
NULL	Case_Rep_Oncol_2014_Jul_30_7(2)_541-549.nxml.txt.nlp	25232324	SENT121	22	22	0	0	pemetrexed	Yes	PA10810	7525	0.77
NULL	Breast_Cancer_(Auckl)_2012_Mar_7_6_67-77.nxml.txt.nlp	22438669	SENT60	17	17	7	7	trastuzumab	HER2	PA451743	2064	0.77
NULL	Hematol_Rep_2011_Oct_28_3(3_Suppl)_e1.nxml.txt.nlp	22586509	SENT11	3	3	10	10	doxorubicin	CHOP	PA449412	1649	0.77
NULL	Exp_Ther_Med_2014_Mar_10_7(3)_640-648.nxml.txt.nlp	24520260	SENT138	2	2	26	26	resveratrol	IL-6		3569	0.77
NULL	EMBO_J_2009_May_20_28(10)_1479-1491.nxml.txt.nlp	19322198	SENT32	3	3	9	9	capsaicin	TRPV1	PA448776	7442	0.77
NULL	Mol_Cancer_2012_Mar_21_11_13.nxml.txt.nlp	22436134	SENT40	0	0	2	2	doxorubicin	HuR	PA449412	1994	0.77
NULL	Mol_Cell_2014_Jun_5_54(5)_858-869.nxml.txt.nlp	24905007	SENT724	16	16	10	10	hydroxyurea	FANCD2	PA449942	2177	0.77
NULL	Mol_Microbiol_2013_Nov_17_90(3)_597-611.nxml.txt.nlp	23998526	SENT320	32	32	11	11	neomycin	BBS1	PA450608	582	0.77
NULL	Subst_Abuse_Rehabil_2012_Jun_20_3_49-57.nxml.txt.nlp	22933845	SENT45	14	14	3	3	methamphetamine	HTR1B	PA450403	3351	0.77
NULL	Diabetes_Obes_Metab_2012_Apr_14(4)_304-314.nxml.txt.nlp	22051096	SENT73	43	43	31	31	exenatide	PPG	PA164749238	5552	0.77
NULL	Exp_Ther_Med_2014_Feb_4_7(2)_478-482.nxml.txt.nlp	24396429	SENT128	5	5	14	14	glucose	HO-1	PA449773	3162	0.77
NULL	Front_Oncol_2014_Sep_23_4_264.nxml.txt.nlp	25295231	SENT109	9	9	30	30	lenalidomide	MDM2	PA162363968	4193	0.77
NULL	Curr_Neuropharmacol_2010_Dec_8(4)_409-421.nxml.txt.nlp	21629447	SENT177	25	25	30	30	primidone	PTH	PA451105	5741	0.77
NULL	Front_Cell_Neurosci_2015_Jan_15_8_459.nxml.txt.nlp	25642166	SENT93	0	0	3	3	hemin	HO-1	PA449849	3162	0.77
NULL	Oncogene_2009_Feb_5_28(5)_674-685.nxml.txt.nlp	19015634	SENT220	5	5	30	30	ethanol	53BP1	PA448073	7158	0.77
NULL	Cancer_Med_2012_Oct_13_1(2)_218-229.nxml.txt.nlp	23342271	SENT207	10	10	14	14	carboplatin	p53	PA448803	7157	0.77
NULL	Chin_J_Cancer_2012_Feb_31(2)_73-99.nxml.txt.nlp	22098950	SENT223	4	4	9	9	canertinib	EGFR	PA134687925	1956	0.77
NULL	Oncol_Lett_2014_May_11_7(5)_1401-1408.nxml.txt.nlp	24765145	SENT163	2	2	8	8	paclitaxel	PI3K	PA450761	5290	0.77
NULL	Cancer_Cell_Int_2003_Jul_15_3_11.nxml.txt.nlp	12904267	SENT97	5	5	10	10	vinblastine	p53	PA451877	7157	0.77
NULL	BMB_Rep_2014_Jul_47(7)_376-381.nxml.txt.nlp	24286332	SENT85	6	6	2	2	thrombin	PPG	PA451674	5552	0.77
NULL	Int_J_Mol_Sci_2014_Nov_7_15(11)_20449-20468.nxml.txt.nlp	25387075	SENT418	0	0	11	11	resveratrol	SIRT1		23411	0.77
NULL	Nat_Med_2013_Mar_10_19(3)_313-321.nxml.txt.nlp	23396211	SENT368	5	5	47	47	amlexanox	TBK1	PA164745310	29110	0.77
NULL	Br_J_Cancer_2011_Jun_28_105(1)_118-123.nxml.txt.nlp	21654685	SENT90	5	5	13	13	dasatinib	HOXC11	PA162372878	3227	0.77
NULL	Biologics_2014_May_27_8_207-210.nxml.txt.nlp	24904202	SENT29	33	33	23	23	infliximab	ACT	PA452639	12;11332;9457;641455	0.77
NULL	Acta_Pharmacol_Sin_2012_May_4_33(5)_710-716.nxml.txt.nlp	22555373	SENT13	6	6	12	12	phenylbutazone	DOM	PA450932	6663	0.77
NULL	Oncotarget_2013_Nov_7_4(12)_2550-2566.nxml.txt.nlp	24334291	SENT142	4	4	9	9	dasatinib	AMPK	PA162372878	5563	0.77
NULL	J_Korean_Med_Sci_2011_Jul_20_26(7)_893-899.nxml.txt.nlp	21738342	SENT78	0	0	18	18	resveratrol	CD97		976	0.77
NULL	Acta_Pharmacol_Sin_2013_Jan_17_34(1)_157-166.nxml.txt.nlp	23247593	SENT29	5	5	14	14	berberine	IL-6	PA165860812	3569	0.77
NULL	Acta_Pharmacol_Sin_2011_Mar_31_32(3)_295-302.nxml.txt.nlp	21278785	SENT151	4	4	11	11	evodiamine	IL-6	PA165860788	3569	0.77
NULL	Cells_2012_Dec_5_1(4)_1156-1167.nxml.txt.nlp	24710548	SENT316	16	16	6	6	taurine	CD95	PA451590	355	0.77
NULL	Amino_Acids_2011_May_22_40(5)_1369-1383.nxml.txt.nlp	21424716	SENT114	5	5	3	3	creatine	CEE	PA164778930	51608	0.77
NULL	Evid_Based_Complement_Alternat_Med_2014_Jul_24_2014_107501.nxml.txt.nlp	25152756	SENT86	13	13	0	0	verapamil	TMP	PA451868	2012	0.77
NULL	J_Headache_Pain_2001_Jun_2(1)_3-11.nxml.txt.nlp	NULL	SENT1	16	16	25	25	frovatriptan	5-HT1B	PA164754891	3351	0.77
NULL	J_Oncol_2009_May_6_2009_567486.nxml.txt.nlp	19424511	SENT36	20	20	34	34	erlotinib	EGFR	PA134687924	1956	0.77
NULL	Biologics_2012_Dec_17_6_429-464.nxml.txt.nlp	23269860	SENT217	11	11	30	30	etanercept	ACR	PA449515	49	0.77
NULL	J_Hematol_Oncol_2012_May_17_5_24.nxml.txt.nlp	22594538	SENT183	22	22	10	10	bortezomib	CHOP	PA10252	1649	0.77
NULL	Cancers_(Basel)_2013_Dec_4_5(4)_1655-1675.nxml.txt.nlp	24305655	SENT118	16	16	4	4	doxorubicin	p53	PA449412	7157	0.77
NULL	J_Oncol_2010_Jun_13_2010_915046.nxml.txt.nlp	20628484	SENT163	14	14	32	32	cyclosporine	ABCC2	PA449167	1244	0.77
NULL	Br_J_Cancer_2006_Feb_13_94(3)_407-426.nxml.txt.nlp	16434996	SENT243	4	4	8	8	genistein	BRCA2	PA165109660	675	0.77
NULL	Cell_Cycle_2013_Feb_1_12(3)_430-441.nxml.txt.nlp	23287532	SENT32	11	11	13	13	etoposide	ETO	PA449552	862	0.77
NULL	Aging_Cell_2012_Aug_11(4)_579-587.nxml.txt.nlp	22435726	SENT157	38	38	13	13	etoposide	CD28	PA449552	1493;940	0.77
NULL	Case_Rep_Oncol_Med_2013_Nov_26_2013_862585.nxml.txt.nlp	24371535	SENT57	24	24	31	31	doxorubicin	CHOP	PA449412	1649	0.77
NULL	Brain_Sci_2014_May_6_4(2)_356-375.nxml.txt.nlp	24961766	SENT207	17	17	8	8	propofol	CA1	PA451141	759	0.77
NULL	Curr_Neuropharmacol_2009_Dec_7(4)_296-301.nxml.txt.nlp	20514209	SENT49	13	13	5	5	vasopressin	ACTH	PA451858	5443	0.77
NULL	Front_Immunol_2012_Jan_12_2_98.nxml.txt.nlp	22566887	SENT357	22	22	18	18	geldanamycin	Hsp90	PA152031327	3320	0.77
NULL	Clin_Ophthalmol_2012_Jul_13_6_1073-1082.nxml.txt.nlp	22888205	SENT168	7	7	16	16	ranibizumab	ERG	PA164746012	2078	0.77
NULL	Environ_Health_Perspect_2007_Jul_5_115(7)_1094-1100.nxml.txt.nlp	17637928	SENT203	10	10	29	29	arsenite	JNK	PA452638	5599	0.77
NULL	N_Am_J_Med_Sci_2014_Aug_6(8)_422-424.nxml.txt.nlp	25210678	SENT50	8	8	15	15	doxorubicin	CHOP	PA449412	1649	0.77
NULL	Oncotarget_2014_Oct_21_5(22)_11252-11268.nxml.txt.nlp	25361004	SENT71	19	19	13	13	metformin	CLIC1	PA450395	1192	0.77
NULL	Biosci_Rep_2014_Jun_25_34(3)_e00115.nxml.txt.nlp	24877606	SENT707	1	1	3	3	thrombin	NF-kappaB	PA451674	4790	0.77
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT142	9	9	2	2	lopinavir	SLK	PA450264	9748;2534	0.77
NULL	Pharmaceuticals_(Basel)_2013_Aug_2_6(8)_915-928.nxml.txt.nlp	24276376	SENT186	20	20	4	4	clopidogrel	PAR-1	PA449053	2011;2149	0.77
NULL	Int_J_Mol_Sci_2014_Oct_6_15(10)_17886-17900.nxml.txt.nlp	25290095	SENT11	5	5	10	10	resveratrol	OPG		690	0.77
NULL	Int_J_Emerg_Med_2010_May_12_3(2)_133-134.nxml.txt.nlp	20606823	SENT26	7	7	9	9	pralidoxime	PAM	PA164744926	5066;23077	0.77
NULL	Pharmaceuticals_(Basel)_2013_Aug_2_6(8)_915-928.nxml.txt.nlp	24276376	SENT127	43	43	24	24	clopidogrel	CAD	PA449053	1677;790	0.77
NULL	J_Gastroenterol_Hepatol_2014_Dec_18_29(12)_1996-2005.nxml.txt.nlp	24910341	SENT218	37	37	27	27	ribavirin	IL28B	PA451241	282617	0.77
NULL	Ann_Saudi_Med_2010_Jan-Feb_30(1)_15-17.nxml.txt.nlp	20103953	SENT32	7	7	13	13	zidovudine	CD4	PA451954	920	0.77
NULL	FEBS_Open_Bio_2013_Dec_30_4_96-104.nxml.txt.nlp	24490130	SENT567	2	2	8	8	cisplatin	BRCA1	PA449014	672	0.77
NULL	Drug_Des_Devel_Ther_2014_Oct_31_8_2121-2128.nxml.txt.nlp	25382970	SENT119	9	9	18	18	curcumin	TTR	PA151958596	7276	0.77
NULL	Cell_Commun_Signal_2013_Nov_11_11_86.nxml.txt.nlp	24215724	SENT254	15	15	22	22	thrombin	PAR1	PA451674	79581;2149	0.77
NULL	Patient_Prefer_Adherence_2013_Mar_27_7_245-258.nxml.txt.nlp	23569364	SENT113	6	6	3	3	tamoxifen	aromatase	PA451581	1588	0.77
NULL	Biomed_Res_Int_2014_May_4_2014_171892.nxml.txt.nlp	24883302	SENT155	21	21	9	9	fulvestrant	LYN	PA164747170	4067	0.77
NULL	Br_J_Haematol_2014_Mar_13_164(1)_811-821.nxml.txt.nlp	24328678	SENT98	0	0	7	7	lenalidomide	Aiolos	PA162363968	22806	0.77
NULL	J_Midlife_Health_2013_Jul-Sep_4(3)_147-152.nxml.txt.nlp	24672186	SENT95	10	10	15	15	teriparatide	PTH	PA451620	5741	0.77
NULL	J_Inflamm_(Lond)_2008_Jul_29_5_11.nxml.txt.nlp	18664275	SENT104	19	19	16	16	ciprofloxacin	IL-8	PA449009	3576	0.77
NULL	Cancer_Med_2013_Feb_3_2(1)_108-115.nxml.txt.nlp	24279005	SENT82	4	4	19	19	coumarin	PC-3	PA134521193	692094	0.77
NULL	Eur_J_Med_Res_2011_Jul_25_16(7)_303-314.nxml.txt.nlp	21813371	SENT59	11	11	32	32	telaprevir	SOC	PA165958354	91544	0.77
NULL	Interdiscip_Toxicol_2012_Dec_5(4)_192-200.nxml.txt.nlp	23554563	SENT174	29	29	5	5	ceftriaxone	ANOVA	PA448866	4858	0.77
NULL	Biomed_Res_Int_2014_Jan_20_2014_948427.nxml.txt.nlp	24563867	SENT230	10	10	5	5	buspirone	COB	PA448689	4519	0.77
NULL	Arch_Med_Sci_2014_Oct_27_10(5)_920-932.nxml.txt.nlp	25395943	SENT173	6	6	12	12	salmeterol	CYP3A4	PA451300	1576	0.77
NULL	Biomed_Res_Int_2013_Jul_16_2013_687658.nxml.txt.nlp	23956997	SENT111	24	24	16	16	guanidine	PH1	PA164781028	189	0.77
NULL	Mol_Cells_2014_Aug_31_37(8)_585-591.nxml.txt.nlp	25134539	SENT107	5	5	14	14	indacaterol	ADRB2	PA165958348	154	0.77
NULL	Autophagy_2013_Sep_1_9(9)_1418-1430.nxml.txt.nlp	23748697	SENT270	18	18	28	28	glucose	MTOR	PA449773	2475	0.77
NULL	Indian_J_Med_Res_2011_Sep_134(3)_295-301.nxml.txt.nlp	21985811	SENT122	27	27	23	23	carbamazepine	MRP2	PA448785	100130958;57626;1244	0.77
NULL	Oncol_Rep_2014_Apr_28_31(4)_1605-1612.nxml.txt.nlp	24481648	SENT129	39	39	29	29	ponatinib	MRP7	PA165980594	89845;1080	0.77
NULL	Oncotarget_2013_Nov_23_5(1)_196-210.nxml.txt.nlp	24344116	SENT31	17	17	7	7	doxorubicin	bcl-xL	PA449412	598	0.77
NULL	J_Korean_Med_Sci_2008_Aug_25_23(4)_657-661.nxml.txt.nlp	18756053	SENT76	9	9	4	4	estradiol	AMH	PA449503	268	0.77
NULL	Cancer_Res_Treat_2014_Jan_15_46(1)_48-54.nxml.txt.nlp	24520223	SENT120	18	18	15	15	bevacizumab	KRAS	PA130232992	3845	0.77
NULL	Eur_J_Clin_Pharmacol_2008_Feb_26_64(2)_133-157.nxml.txt.nlp	18224312	SENT133	21	21	0	0	acenocoumarol	CYP2C9	PA452632	1559	0.77
NULL	Biol_Proced_Online_2003_Dec_12_5_228-237.nxml.txt.nlp	14702098	SENT137	40	40	15	15	ampicillin	p62	PA448419	8878;10657;23636	0.77
NULL	Cell_Death_Dis_2010_May_13_1(5)_e41.nxml.txt.nlp	21364648	SENT346	5	5	7	7	etoposide	p53	PA449552	7157	0.77
NULL	Oncol_Lett_2014_Jul_12_8(1)_117-122.nxml.txt.nlp	24959230	SENT124	8	8	13	13	azacitidine	p16	PA451996	1029	0.77
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT188	9	9	21	21	curcumin	Bcl-2	PA151958596	596	0.77
NULL	Ital_J_Pediatr_2011_Aug_22_37_39.nxml.txt.nlp	21859484	SENT15	8	8	5	5	salbutamol	BDP	PA448068	10620;152926	0.77
NULL	Curr_Neuropharmacol_2013_Dec_11(6)_652-663.nxml.txt.nlp	24396340	SENT198	24	24	4	4	capsaicin	TRPV1	PA448776	7442	0.77
NULL	Nat_Commun_2013_Aug_15_4_2130.nxml.txt.nlp	23945651	SENT129	11	11	27	27	etoposide	survivin	PA449552	332	0.77
NULL	Cancer_Cell_Int_2009_Sep_10_9_25.nxml.txt.nlp	19744341	SENT138	8	8	2	2	glucosamine	survivin	PA164747613	332	0.77
NULL	Mol_Biol_Cell_2013_Jun_1_24(11)_1619-1637.nxml.txt.nlp	23576546	SENT112	13	13	4	4	trypsin	SIMPLE	PA451806	9516	0.77
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1563-1573.nxml.txt.nlp	22015557	SENT33	18	18	6	6	sunitinib	c-Myc	PA162372840	4609	0.77
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT10	15	15	35	35	celecoxib	IL-6	PA448871	3569	0.77
NULL	Breast_Cancer_Res_2014_May_23_16(3)_R50.nxml.txt.nlp	24887458	SENT193	22	22	6	6	trastuzumab	HER2	PA451743	2064	0.77
NULL	Mol_Cancer_2010_Nov_8_9_291.nxml.txt.nlp	21059223	SENT103	36	36	2	2	paclitaxel	ABCB1	PA450761	5243	0.77
NULL	Nat_Genet_2011_Feb_26_43(2)_153-158.nxml.txt.nlp	21186352	SENT81	21	21	4	4	geldanamycin	Hsp90	PA152031327	3320	0.77
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT30	9	9	14	14	atorvastatin	OPG	PA448500	690	0.77
NULL	Acta_Pharmacol_Sin_2012_May_4_33(5)_710-716.nxml.txt.nlp	22555373	SENT115	6	6	23	23	phenylbutazone	DOM	PA450932	6663	0.77
NULL	Iran_J_Pharm_Res_2015_Winter_14(1)_279-289.nxml.txt.nlp	25561934	SENT179	33	33	39	39	isoproterenol	ANOVA	PA450121	4858	0.77
NULL	Acta_Pharmacol_Sin_2013_Mar_21_34(3)_373-379.nxml.txt.nlp	23334240	SENT144	28	28	11	11	raloxifene	CYP3A4	PA451221	1576	0.77
NULL	Orphanet_J_Rare_Dis_2014_Oct_29_9(1)_162.nxml.txt.nlp	NULL	SENT186	16	16	5	5	tacrolimus	CYP3A4	PA451578	1576	0.77
NULL	Oncotarget_2013_Apr_16_4(5)_677-690.nxml.txt.nlp	23633472	SENT211	8	8	16	16	doxorubicin	CD95	PA449412	355	0.77
NULL	Eur_J_Med_Res_2010_Aug_20_15(8)_337-344.nxml.txt.nlp	20947470	SENT33	45	45	36	36	paclitaxel	BLM	PA450761	641	0.77
NULL	Arthritis_Res_Ther_2008_Sep_24_10(5)_R115.nxml.txt.nlp	18816401	SENT171	5	5	12	12	etanercept	BMP7	PA449515	655	0.77
NULL	Cancer_Cell_Int_2013_Jan_15_13_3.nxml.txt.nlp	23320839	SENT16	15	15	11	11	gemcitabine	MRP1	PA449748	4437	0.77
NULL	Clin_Drug_Investig_2013_Aug_23_33(10)_727-736.nxml.txt.nlp	23975654	SENT80	3	3	19	19	fluconazole	CYP3A	PA449653	1574	0.77
NULL	Oncotarget_2014_Aug_29_5(17)_7217-7259.nxml.txt.nlp	25277175	SENT301	21	21	13	13	axitinib	KIT	PA164924493	3815	0.77
NULL	Case_Rep_Transplant_2012_Jul_29_2012_952359.nxml.txt.nlp	23259146	SENT56	15	15	22	22	rituximab	CHOP	PA451261	1649	0.77
NULL	Basic_Clin_Neurosci_2013_Autumn_4(4)_323-328.nxml.txt.nlp	25337364	SENT133	7	7	17	17	colchicine	CA1	PA449092	759	0.77
NULL	Diabetes_Obes_Metab_2011_Nov_13(11)_982-989.nxml.txt.nlp	21615670	SENT163	7	7	11	11	sitagliptin	GLP-1	PA164748978	100125288	0.77
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1420-1426.nxml.txt.nlp	24056704	SENT129	0	0	4	4	ketoconazole	CYP3A	PA450146	1574	0.77
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jul_17_66(Pt_8)_o2061.nxml.txt.nlp	21588365	SENT47	19	19	34	34	ethanol	mol	PA448073	90527	0.77
NULL	Cell_Commun_Signal_2013_Nov_11_11_86.nxml.txt.nlp	24215724	SENT420	16	16	25	25	thrombin	TRPV1	PA451674	7442	0.77
NULL	Front_Chem_2014_Dec_23_2_113.nxml.txt.nlp	25566531	SENT254	6	6	21	21	curcumin	p65	PA151958596	5970	0.77
NULL	Oncogene_2010_Sep_16_29(37)_5193-5203.nxml.txt.nlp	20581867	SENT125	28	28	14	14	trastuzumab	HER3	PA451743	2065	0.77
NULL	Alzheimers_Res_Ther_2013_Nov_7_5(6)_54.nxml.txt.nlp	24229456	SENT46	8	8	11	11	bexarotene	spatial	PA164752250	219793	0.77
NULL	Eur_J_Med_Res_2011_Jan_27_16(1)_20-28.nxml.txt.nlp	21345766	SENT247	35	35	39	39	aprotinin	BART	PA448472	7809;23568	0.77
NULL	Breast_Cancer_Res_2005_Jan_26_7(2)_R256-R266.nxml.txt.nlp	15743506	SENT29	40	40	10	10	fluorouracil	HER-2	PA128406956	2064	0.77
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT171	3	3	10	10	atorvastatin	JNK	PA448500	5599	0.77
NULL	Europace_2011_Feb_7_13(2)_161-173.nxml.txt.nlp	21138930	SENT9	8	8	16	16	flecainide	CAST	PA449646	10849;26059;831	0.77
NULL	Biomed_Imaging_Interv_J_2011_Oct_1_7(4)_e25.nxml.txt.nlp	22279502	SENT199	3	3	6	6	oxaliplatin	CRT	PA131285527	811	0.77
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Dec_4_67(Pt_1)_o32.nxml.txt.nlp	21522744	SENT58	23	23	38	38	ethanol	mol	PA448073	90527	0.77
NULL	Behav_Brain_Funct_2013_May_3_9_17.nxml.txt.nlp	23642235	SENT139	23	23	0	0	baclofen	ANOVA	PA448533	4858	0.77
NULL	J_Biomed_Sci_2013_May_20_20(1)_30.nxml.txt.nlp	23687991	SENT175	22	22	20	20	ethanol	PGD2	PA448073	27306	0.77
NULL	Biol_Open_2014_Nov_13_3(12)_1158-1163.nxml.txt.nlp	25395668	SENT134	14	14	5	5	paraformaldehyde	CO2	PA450790	4513	0.77
NULL	Cancers_(Basel)_2011_May_18_3(2)_2444-2461.nxml.txt.nlp	24212818	SENT116	14	14	33	33	estradiol	EGFR	PA449503	1956	0.77
NULL	Int_J_Hypertens_2012_Feb_8_2012_189512.nxml.txt.nlp	22518281	SENT70	12	12	9	9	hemin	HO-1	PA449849	3162	0.77
NULL	FEBS_J_2008_Nov_275(21)_5408-5421.nxml.txt.nlp	18959765	SENT227	17	17	14	14	nadh	ADP	PA164755085	23038	0.77
NULL	Cancer_Imaging_2005_Dec_15_5(1)_150-156.nxml.txt.nlp	16361144	SENT89	14	14	11	11	imatinib	FDG	PA10804	23583	0.77
NULL	Nature_2012_Jan_25_482(7384)_232-236.nxml.txt.nlp	22278056	SENT14	12	12	16	16	suramin	AP-1	PA10292	2353;3727;2354;3725	0.77
NULL	Clin_Med_Insights_Oncol_2011_May_10_5_131-144.nxml.txt.nlp	21695100	SENT32	3	3	14	14	vinorelbine	CYP3A4	PA451881	1576	0.77
NULL	Mol_Cancer_2007_Oct_22_6_66.nxml.txt.nlp	17953743	SENT196	2	2	12	12	cisplatin	p53	PA449014	7157	0.77
NULL	Mol_Syst_Biol_2011_Apr_26_7_486.nxml.txt.nlp	21525872	SENT513	11	11	9	9	gefitinib	EGF	PA131301952	1950	0.77
NULL	Br_J_Cancer_2012_Sep_25_107(7)_1044-1050.nxml.txt.nlp	22910317	SENT190	5	5	20	20	vatalanib	CD31	PA7001	5175	0.77
NULL	N_Am_J_Med_Sci_2011_May_3(5)_212-216.nxml.txt.nlp	22558596	SENT119	14	14	4	4	gemcitabine	BTC	PA449748	685	0.77
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Mar_19_65(Pt_4)_o783.nxml.txt.nlp	21582508	SENT61	25	25	16	16	gabapentin	mol	PA449720	90527	0.77
NULL	Mol_Cancer_2006_Oct_17_5_45.nxml.txt.nlp	17044934	SENT126	9	9	23	23	resveratrol	COX		1351	0.77
NULL	Oncotarget_2011_May_16_2(5)_418-421.nxml.txt.nlp	21789791	SENT14	25	25	15	15	bortezomib	TRAIL	PA10252	8743	0.77
NULL	Oncogene_2013_Sep_26_32(39)_10_1038_onc_2012_491.nxml.txt.nlp	23108394	SENT47	10	10	17	17	epirubicin	FOXM1	PA449476	2305	0.77
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT289	4	4	26	26	paclitaxel	ABCB1	PA450761	5243	0.77
NULL	South_Asian_J_Cancer_2014_Jan-Mar_3(1)_71-73.nxml.txt.nlp	24665452	SENT52	29	29	25	25	tamoxifen	UBC	PA451581	7316	0.77
NULL	Acta_Pharmacol_Sin_2012_Oct_17_33(10)_1301-1310.nxml.txt.nlp	22983390	SENT122	17	17	5	5	cisplatin	p53	PA449014	7157	0.77
NULL	Br_J_Cancer_2010_Dec_7_103(12)_1898-1900.nxml.txt.nlp	NULL	SENT24	40	40	26	26	vorinostat	VEGFR	PA164748224	3791	0.77
NULL	J_Headache_Pain_2011_Apr_5_12(2)_127-133.nxml.txt.nlp	21298314	SENT97	37	37	20	20	amitriptyline	CSMT	PA448385	1442	0.77
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT138	8	8	13	13	resveratrol	Bcl-2		596	0.77
NULL	Int_J_Mol_Sci_2014_Oct_8_15(10)_17974-17999.nxml.txt.nlp	25299695	SENT123	3	3	15	15	curcumin	HO-2	PA151958596	3163	0.77
NULL	Oncol_Lett_2013_Mar_8_5(3)_805-812.nxml.txt.nlp	23426281	SENT9	9	9	24	24	gemcitabine	B7-H3	PA449748	80381	0.77
NULL	Bioinorg_Chem_Appl_2013_Sep_19_2013_541030.nxml.txt.nlp	24170995	SENT59	4	4	18	18	amoxicillin	SBF	PA448406	7702	0.77
NULL	Cancer_Inform_2013_Feb_13_12_31-51.nxml.txt.nlp	23470717	SENT158	4	4	7	7	epirubicin	PLK1	PA449476	5347	0.77
NULL	Br_J_Cancer_1996_Apr_73(8)_972-978.nxml.txt.nlp	8611434	SENT0	10	10	17	17	collagenase	MMP3	PA449107	4314	0.77
NULL	Diabetes_Care_2009_Sep_28_32(9)_1649-1655.nxml.txt.nlp	19478198	SENT103	20	20	7	7	saxagliptin	PPG	PA165958362	5552	0.77
NULL	J_Immunol_Res_2014_Jul_16_2014_696812.nxml.txt.nlp	25133198	SENT255	29	29	12	12	rifaximin	TLR4	PA164752443	7099	0.77
NULL	J_Inflamm_(Lond)_2006_Feb_22_3_2.nxml.txt.nlp	16504062	SENT131	22	22	24	24	bleomycin	BLM	PA448645	641	0.77
NULL	Cancer_Med_2014_Aug_14_3(4)_1010-1024.nxml.txt.nlp	24931821	SENT251	27	27	18	18	doxorubicin	IVL	PA449412	3713	0.77
NULL	Parasit_Vectors_2009_Sep_25_2(Suppl_2)_S8.nxml.txt.nlp	19778469	SENT35	15	15	22	22	ivermectin	MOX	PA450133	26002	0.77
NULL	Oncotarget_2013_Nov_24_4(12)_2430-2438.nxml.txt.nlp	24280348	SENT140	15	15	25	25	gefitinib	STAT3	PA131301952	6774	0.77
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jan_8_67(Pt_2)_o313-o314.nxml.txt.nlp	21523001	SENT73	16	16	22	22	benzaldehyde	mol	PA448571	90527	0.77
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Apr_17_6_43-57.nxml.txt.nlp	24833916	SENT146	1	1	15	15	everolimus	aromatase	PA164746311	1588	0.77
NULL	J_Gen_Physiol_2012_Nov_140(5)_541-555.nxml.txt.nlp	23109716	SENT318	6	6	13	13	capsaicin	TRPV1	PA448776	7442	0.77
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT151	0	0	7	7	metformin	AMPK	PA450395	5563	0.77
NULL	Cell_Cycle_2013_Dec_15_12(24)_3791-3803.nxml.txt.nlp	24107631	SENT59	10	10	20	20	etoposide	YB-1	PA449552	4904	0.77
NULL	Braz_J_Med_Biol_Res_2014_Sep_5_47(11)_929-939.nxml.txt.nlp	25296354	SENT84	8	8	0	0	afatinib	EGFR	PA165981154	1956	0.77
NULL	Curr_Neuropharmacol_2012_Jun_10(2)_97-123.nxml.txt.nlp	23204981	SENT268	12	12	15	15	fluoxetine	IL-2	PA449673	3558	0.77
NULL	Breast_Cancer_(Auckl)_2011_Oct_9_5_209-226.nxml.txt.nlp	22084574	SENT299	11	11	16	16	tamoxifen	aromatase	PA451581	1588	0.77
NULL	Crit_Care_2006_Dec_7_10(6)_239.nxml.txt.nlp	17169139	SENT56	21	21	7	7	thrombin	PAR1	PA451674	79581;2149	0.77
NULL	J_Korean_Med_Sci_2008_Aug_25_23(4)_609-615.nxml.txt.nlp	18756046	SENT54	7	7	2	2	nitrogen	BAL	PA450643	83666	0.77
NULL	Infect_Dis_Ther_2013_Dec_2_2(2)_123-144.nxml.txt.nlp	25134476	SENT127	38	38	3	3	ethambutol	DST	PA164784021	667	0.77
NULL	J_Neurochem_2014_Sep_16_130(5)_668-677.nxml.txt.nlp	24814819	SENT263	35	35	32	32	fasudil	Rho	PA165946121	29984	0.77
NULL	Indian_J_Endocrinol_Metab_2011_Oct_15(Suppl4)_S409.nxml.txt.nlp	22145149	SENT6	12	12	19	19	simvastatin	CYP3A4	PA451363	1576	0.77
NULL	J_Hematol_Oncol_2013_Aug_2_6_55.nxml.txt.nlp	23915913	SENT142	15	15	24	24	rituximab	FLG3	PA451261	388697	0.77
NULL	Pain_2011_Aug_152(8)_1899-1908.nxml.txt.nlp	21600693	SENT492	37	37	35	35	capsaicin	ADP	PA448776	23038	0.77
NULL	Indian_J_Sex_Transm_Dis_2013_Jul-Dec_34(2)_141-144.nxml.txt.nlp	NULL	SENT63	5	5	9	9	abacavir	HLA-B	PA448004	3106	0.77
NULL	Int_J_Mol_Imaging_2011_Oct_26_2011_874585.nxml.txt.nlp	21490735	SENT204	34	34	0	0	doxorubicin	FDG	PA449412	23583	0.77
NULL	Cancer_Med_2013_Aug_30_2(4)_457-467.nxml.txt.nlp	24156018	SENT230	15	15	33	33	temozolomide	gamma	PA451609	9913	0.77
NULL	Indian_J_Pharmacol_2014_Sep-Oct_46(5)_549-550.nxml.txt.nlp	25298588	SENT64	29	29	12	12	warfarin	Xin	PA451906	165904	0.77
NULL	Front_Neurosci_2014_Mar_26_8_47.nxml.txt.nlp	24723845	SENT206	25	25	6	6	theophylline	PARP-1	PA451647	25976	0.77
NULL	J_Oncol_2012_Dec_22_2012_682480.nxml.txt.nlp	22235203	SENT135	8	8	5	5	paclitaxel	HER2	PA450761	2064	0.77
NULL	Arthritis_Res_Ther_2014_Mar_13_16(2)_R68.nxml.txt.nlp	24620998	SENT186	15	15	12	12	pp2	p38		10598;1432;7965	0.77
NULL	J_Korean_Med_Sci_2010_May_22_25(5)_766-771.nxml.txt.nlp	20436715	SENT94	15	15	9	9	tacrolimus	IL-4	PA451578	3565	0.77
NULL	Oncotarget_2014_Aug_29_5(18)_8052-8082.nxml.txt.nlp	25211298	SENT685	6	6	15	15	itraconazole	VEGFR2	PA450132	3791	0.77
NULL	Diabetes_2009_Jan_58(1)_174-184.nxml.txt.nlp	18984736	SENT245	15	15	7	7	tranilast	TRPV2	PA131890628	51393	0.77
NULL	Front_Neurosci_2011_Dec_5_5_131.nxml.txt.nlp	22164129	SENT91	9	9	26	26	midazolam	CA1	PA450496	759	0.77
NULL	Arthritis_Res_Ther_2011_Sep_21_13(5)_239.nxml.txt.nlp	21955617	SENT73	8	8	10	10	celecoxib	CBX	PA448871	10951	0.77
NULL	Indian_J_Pharmacol_2013_Mar-Apr_45(2)_121-125.nxml.txt.nlp	23716885	SENT11	6	6	16	16	aripiprazole	CYP3A4	PA10026	1576	0.77
NULL	Biologics_2013_Apr_15_7_77-90.nxml.txt.nlp	23723688	SENT147	27	27	17	17	carboplatin	CRT	PA448803	811	0.77
NULL	Case_Rep_Oncol_2012_Aug_9_5(2)_428-433.nxml.txt.nlp	22949905	SENT94	6	6	15	15	cetuximab	KRAS	PA10040	3845	0.77
NULL	Nat_Commun_2013_Sep_20_4_2444.nxml.txt.nlp	24051492	SENT141	15	15	17	17	nutlin-3	CT9		676	0.77
NULL	Daru_2013_Jan_5_21(1)_4.nxml.txt.nlp	23351476	SENT17	21	21	2	2	imipramine	ANOVA	PA449969	4858	0.77
NULL	Evid_Based_Complement_Alternat_Med_2014_Dec_25_2014_871720.nxml.txt.nlp	25610485	SENT87	25	25	36	36	berberine	G6PD	PA165860812	2539	0.77
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Apr_30_65(Pt_5)_o1161.nxml.txt.nlp	21583964	SENT59	26	26	18	18	benzaldehyde	mol	PA448571	90527	0.77
NULL	Cancer_Cell_Int_2010_Apr_29_10_12.nxml.txt.nlp	20429927	SENT170	13	13	3	3	bortezomib	HRI	PA10252	27102	0.77
NULL	Int_J_Mol_Sci_2014_Nov_25_15(12)_21703-21722.nxml.txt.nlp	25429431	SENT147	0	0	17	17	curcumin	AKT	PA151958596	207	0.77
NULL	Int_J_Chron_Obstruct_Pulmon_Dis_2006_Jun_1(2)_137-150.nxml.txt.nlp	18046891	SENT158	13	13	7	7	gefitinib	EGFR	PA131301952	1956	0.77
NULL	Acta_Pharmacol_Sin_2014_Aug_30_35(8)_1045-1054.nxml.txt.nlp	24976155	SENT36	12	12	5	5	resveratrol	STAT3		6774	0.77
NULL	Adv_Biomed_Res_2014_Sep_8_3_189.nxml.txt.nlp	25298958	SENT92	23	23	4	4	clarithromycin	NAC	PA449028	22861	0.77
NULL	Mol_Neurobiol_2010_Jun_2_41(2-3)_392-409.nxml.txt.nlp	20437209	SENT318	7	7	13	13	curcumin	COX	PA151958596	1351	0.77
NULL	Reprod_Biol_Endocrinol_2003_Oct_7_1_66.nxml.txt.nlp	14609433	SENT81	11	11	16	16	cisplatin	FasL	PA449014	356	0.77
NULL	Evid_Based_Complement_Alternat_Med_2014_Dec_25_2014_871720.nxml.txt.nlp	25610485	SENT87	8	8	36	36	berberine	G6PD	PA165860812	2539	0.77
NULL	J_Clin_Biochem_Nutr_2009_Nov_28_45(3)_285-291.nxml.txt.nlp	19902018	SENT337	7	7	12	12	allopurinol	XDH	PA448320	7498	0.77
NULL	J_Korean_Med_Sci_2011_Jan_22_26(1)_33-41.nxml.txt.nlp	21218027	SENT146	13	13	3	3	ofloxacin	DST	PA450684	667	0.77
NULL	J_Nat_Sci_Biol_Med_2011_Jan-Jun_2(1)_26-37.nxml.txt.nlp	22470231	SENT100	10	10	22	22	tamoxifen	DCX	PA451581	1641	0.77
NULL	Adv_Virol_2011_Mar_24_2011_260561.nxml.txt.nlp	22312337	SENT29	24	24	13	13	daclizumab	IL-2	PA164764446	3558	0.77
NULL	Adv_Ther_2014_Sep_23_31(9)_986-999.nxml.txt.nlp	25245811	SENT211	10	10	25	25	liraglutide	Met	PA165958364	79811	0.77
NULL	Acta_Pharmacol_Sin_2013_Oct_7_34(10)_1317-1324.nxml.txt.nlp	23933652	SENT122	8	8	13	13	rosiglitazone	TNF	PA451283	7124	0.77
NULL	Case_Rep_Oncol_2010_Apr_22_3(2)_98-105.nxml.txt.nlp	20740181	SENT42	17	17	11	11	erlotinib	CYP3A4	PA134687924	1576	0.77
NULL	Nucleic_Acids_Res_2011_Dec_5_39(22)_9671-9680.nxml.txt.nlp	21821658	SENT134	4	4	12	12	thyroglobulin	gamma	PA164754910	9913	0.77
NULL	Clin_Sci_(Lond)_2011_Nov_1_121(Pt_10)_449-458.nxml.txt.nlp	21671887	SENT5	7	7	22	22	simvastatin	AMPK	PA451363	5563	0.77
NULL	Clin_Pharmacol_2010_Sep_6_2_155-162.nxml.txt.nlp	22291500	SENT57	8	8	13	13	clopidogrel	CYP2C19	PA449053	1557	0.77
NULL	J_Physiol_2014_Nov_1_592(21)_4715-4731.nxml.txt.nlp	25172947	SENT94	6	6	2	2	l-arginine	ADP	PA448478	23038	0.77
NULL	Diagn_Pathol_2006_Aug_15_1_19.nxml.txt.nlp	16911776	SENT17	17	17	24	24	trastuzumab	San	PA451743	80218	0.77
NULL	J_Anaesthesiol_Clin_Pharmacol_2012_Apr-Jun_28(2)_178-184.nxml.txt.nlp	22557739	SENT45	20	20	22	22	propofol	LDP	PA451141	10404	0.77
NULL	Arthritis_Res_Ther_2013_Sep_27_15(5)_R138.nxml.txt.nlp	24289726	SENT30	5	5	3	3	methotrexate	IL-10	PA450428	3586	0.77
NULL	Breast_Cancer_Res_2007_Jul_5_9(4)_R41.nxml.txt.nlp	17612393	SENT216	4	4	18	18	celecoxib	Bcl-2	PA448871	596	0.77
NULL	Breast_Cancer_Res_2010_Oct_22_12(Suppl_2)_S2.nxml.txt.nlp	21050423	SENT99	25	25	9	9	mitoxantrone	MSH2	PA450526	4436	0.77
NULL	EMBO_Mol_Med_2012_Oct_30_4(10)_1087-1096.nxml.txt.nlp	22933245	SENT161	26	26	13	13	olaparib	NAMPT		10135	0.77
NULL	J_Am_Heart_Assoc_2013_Aug_23_2(4)_e000096.nxml.txt.nlp	23832324	SENT476	19	19	7	7	resveratrol	S6K1		6198	0.77
NULL	Case_Rep_Oncol_Med_2013_Nov_30_2013_175263.nxml.txt.nlp	24363944	SENT5	22	22	16	16	leucovorin	CRT	PA450198	811	0.77
NULL	Oncol_Lett_2014_May_4_7(5)_1352-1362.nxml.txt.nlp	24765137	SENT142	34	34	29	29	cisplatin	p53	PA449014	7157	0.77
NULL	J_Mol_Med_(Berl)_2014_May_10_92(7)_709-722.nxml.txt.nlp	24811491	SENT229	4	4	26	26	irinotecan	KRAS	PA450085	3845	0.77
NULL	Oncotarget_2014_Sep_16_5(20)_10034-10047.nxml.txt.nlp	25296981	SENT183	0	0	5	5	doxorubicin	CHK1	PA449412	1111	0.77
NULL	Int_J_Med_Sci_2013_Jan_3_10(2)_141-147.nxml.txt.nlp	23329885	SENT32	28	28	20	20	creatine	AGAT	PA164778930	2628	0.77
NULL	J_Oncol_2013_Apr_29_2013_854121.nxml.txt.nlp	23737784	SENT114	33	33	41	41	trastuzumab	PI3K	PA451743	5290	0.77
NULL	Evid_Based_Complement_Alternat_Med_2012_Dec_17_2012_485262.nxml.txt.nlp	23304202	SENT172	6	6	29	29	thrombin	JNK1	PA451674	5599	0.77
NULL	J_Cell_Biol_1978_Oct_1_79(1)_121-131.nxml.txt.nlp	701368	SENT1	18	18	9	9	guanethidine	SCGN	PA449823	10590	0.77
NULL	J_Oncol_2009_Mar_10_2009_831626.nxml.txt.nlp	20300583	SENT50	24	24	7	7	cetuximab	KRAS	PA10040	3845	0.77
NULL	Arch_Gynecol_Obstet_2012_May_30_285(5)_1447-1453.nxml.txt.nlp	22127553	SENT29	32	32	9	9	paclitaxel	TEC	PA450761	7006	0.77
NULL	Int_J_Mol_Imaging_2011_Jul_14_2011_813028.nxml.txt.nlp	21785722	SENT187	2	2	0	0	glucose	FDG	PA449773	23583	0.77
NULL	Neurorehabil_Neural_Repair_2013_Feb_27(2)_118-124.nxml.txt.nlp	22961264	SENT61	12	12	37	37	creatine	GPC	PA164778930	2995	0.77
NULL	Front_Endocrinol_(Lausanne)_2014_Apr_24_5_58.nxml.txt.nlp	24795698	SENT297	1	1	5	5	lipase	LIPE	PA450239	3991	0.77
NULL	J_Korean_Med_Sci_2007_Apr_30_22(2)_242-247.nxml.txt.nlp	17449931	SENT46	5	5	19	19	paraformaldehyde	San	PA450790	80218	0.77
NULL	Exp_Ther_Med_2013_Jul_25_6(1)_109-114.nxml.txt.nlp	23935730	SENT150	15	15	27	27	cyclophosphamide	CHOP	PA449165	1649	0.77
NULL	Neural_Regen_Res_2013_Jul_15_8(20)_1853-1862.nxml.txt.nlp	25206494	SENT193	0	0	4	4	ethanol	p53	PA448073	7157	0.77
NULL	Case_Rep_Rheumatol_2011_Dec_15_2011_185657.nxml.txt.nlp	22937439	SENT65	5	5	10	10	etanercept	IL-6	PA449515	3569	0.77
NULL	Oncotarget_2013_Nov_26_4(12)_2502-2511.nxml.txt.nlp	24318446	SENT130	15	15	13	13	doxycycline	PHGDH	PA449415	26227	0.77
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT150	38	38	44	44	l-cysteine	SIRT3	PA449173	23410	0.77
NULL	Biologics_2012_Apr_11_6_83-87.nxml.txt.nlp	22532776	SENT78	22	22	18	18	rituximab	CD54	PA451261	3383	0.77
NULL	Eur_J_Med_Res_2011_Jul_25_16(7)_303-314.nxml.txt.nlp	21813371	SENT59	27	27	16	16	telaprevir	SOC	PA165958354	91544	0.77
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Jun_25_3(6)_e120.nxml.txt.nlp	24964282	SENT25	42	42	39	39	ketoconazole	CYP3A4	PA450146	1576	0.77
NULL	Cancer_Cell_Int_2014_Jun_11_14_49.nxml.txt.nlp	24991192	SENT134	12	12	9	9	berberine	AMPK	PA165860812	5563	0.769
NULL	Mol_Pain_2013_Jun_10_9_27.nxml.txt.nlp	23758830	SENT74	8	8	5	5	tetracaine	ASIC3	PA451638	9311	0.769
NULL	Mol_Cell_2014_May_8_54(3)_445-459.nxml.txt.nlp	24746700	SENT169	3	3	18	18	camptothecin	MDM2	PA153590860	4193	0.769
NULL	Emerg_Med_J_2011_Apr_26_28(4)_313-315.nxml.txt.nlp	20581384	SENT112	9	9	11	11	atropine	PAM	PA448505	5066;23077	0.769
NULL	Breast_Cancer_Res_2012_May_3_14(3)_R71.nxml.txt.nlp	22554015	SENT259	27	27	8	8	trastuzumab	EGFR	PA451743	1956	0.769
NULL	Braz_J_Med_Biol_Res_2014_Jan_10_47(1)_60-69.nxml.txt.nlp	24519092	SENT165	12	12	21	21	doxorubicin	YWHAZ	PA449412	7534	0.769
NULL	Front_Neural_Circuits_2015_Jan_12_8_150.nxml.txt.nlp	25628540	SENT283	16	16	9	9	atropine	gamma	PA448505	9913	0.769
NULL	J_Mol_Signal_2010_Feb_18_5_1.nxml.txt.nlp	20167101	SENT19	29	29	15	15	metformin	adiponectin	PA450395	9370	0.769
NULL	Front_Genet_2013_Aug_29_4_163.nxml.txt.nlp	24009622	SENT122	8	8	4	4	ethanol	DDP	PA448073	1678	0.769
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT202	8	8	20	20	ranibizumab	VEGFR2	PA164746012	3791	0.769
NULL	Oncotarget_2013_Aug_24_4(10)_1618-1631.nxml.txt.nlp	24113128	SENT194	18	18	26	26	sorafenib	p53	PA7000	7157	0.769
NULL	Oncoimmunology_2012_Oct_1_1(7)_1004-1016.nxml.txt.nlp	23170249	SENT159	22	22	8	8	trastuzumab	HER-2	PA451743	2064	0.769
NULL	Mol_Cancer_2010_Aug_20_9_220.nxml.txt.nlp	20727180	SENT232	12	12	21	21	nicotine	p53	PA450626	7157	0.769
NULL	Iran_J_Pharm_Res_2014_Autumn_13(4)_1313-1318.nxml.txt.nlp	25587320	SENT166	22	22	18	18	berberine	AMPK	PA165860812	5563	0.769
NULL	Mol_Cancer_2009_Aug_25_8_66.nxml.txt.nlp	19706164	SENT32	3	3	20	20	celecoxib	p27	PA448871	5715;10534	0.769
NULL	J_Biomed_Biotechnol_2010_Sep_21_2010_980567.nxml.txt.nlp	20936136	SENT122	39	39	11	11	glucosamine	API	PA164747613	5345	0.769
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT547	4	4	8	8	metformin	HIF1	PA450395	3091	0.769
NULL	Cancer_Med_2013_Aug_10_2(4)_496-506.nxml.txt.nlp	24156022	SENT264	27	27	3	3	cetuximab	KRAS	PA10040	3845	0.769
NULL	Stroke_Res_Treat_2009_Dec_20_2010_386389.nxml.txt.nlp	20700422	SENT291	19	19	23	23	resveratrol	NAC		22861	0.769
NULL	Acta_Pharmacol_Sin_2010_Feb_5_31(2)_137-144.nxml.txt.nlp	20139896	SENT26	6	6	17	17	oxygen	p38	PA450744	10598;1432;7965	0.769
NULL	Radiol_Res_Pract_2012_Jun_20_2012_268483.nxml.txt.nlp	22919485	SENT17	34	34	20	20	acetazolamide	CO2	PA448018	4513	0.769
NULL	Breast_Cancer_Res_2012_Mar_14_14(2)_R45.nxml.txt.nlp	22417809	SENT244	25	25	6	6	tamoxifen	CLU	PA451581	1191	0.769
NULL	Breast_Cancer_Res_2012_Jan_17_14(1)_R12.nxml.txt.nlp	22251451	SENT282	17	17	22	22	tamoxifen	GPER	PA451581	2852	0.769
NULL	Exp_Diabetes_Res_2011_Nov_28_2011_625813.nxml.txt.nlp	22144989	SENT5	5	5	2	2	cyclophosphamide	STZ	PA449165	6484	0.769
NULL	Curr_Cardiol_Rev_2009_Aug_5(3)_166-176.nxml.txt.nlp	20676275	SENT226	4	4	28	28	ketoconazole	HERG	PA450146	3757	0.769
NULL	Ann_Lab_Med_2012_Jul_20_32(4)_298-303.nxml.txt.nlp	22779073	SENT86	41	41	10	10	clarithromycin	EMB	PA449028	133418	0.769
NULL	Int_J_Biol_Sci_2013_Apr_22_9(4)_350-360.nxml.txt.nlp	23630447	SENT162	23	23	18	18	doxorubicin	ARC	PA449412	8996;23237	0.769
NULL	Cancers_(Basel)_2014_Jul_7_6(3)_1441-1463.nxml.txt.nlp	25003395	SENT196	5	5	15	15	everolimus	HER2	PA164746311	2064	0.769
NULL	Oncotarget_2011_Dec_20_2(12)_1094-1108.nxml.txt.nlp	22190353	SENT88	18	18	11	11	gemcitabine	PUMA	PA449748	27113	0.769
NULL	J_Hematol_Oncol_2011_Jan_21_4_5.nxml.txt.nlp	21255411	SENT229	9	9	24	24	paclitaxel	EGFR	PA450761	1956	0.769
NULL	Int_J_Mol_Sci_2012_Sep_26_13(10)_12268-12286.nxml.txt.nlp	23202898	SENT183	10	10	3	3	trastuzumab	AMPK	PA451743	5563	0.769
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_13_2013_468537.nxml.txt.nlp	23956772	SENT23	14	14	7	7	curcumin	IFN	PA151958596	3439	0.769
NULL	Cell_Death_Differ_2010_Sep_5_17(9)_1511-1523.nxml.txt.nlp	20203690	SENT322	11	11	3	3	ethanol	PC-3	PA448073	692094	0.769
NULL	Br_J_Cancer_2014_Aug_12_111(4)_646-650.nxml.txt.nlp	24755886	SENT49	3	3	11	11	trabectedin	CCL2	PA165958349	6347	0.769
NULL	Curr_Neuropharmacol_2013_Dec_11(6)_652-663.nxml.txt.nlp	24396340	SENT190	0	0	2	2	lidocaine	TRPV1	PA450226	7442	0.769
NULL	Diabetes_Care_2013_Aug_17_36(Suppl_2)_S245-S252.nxml.txt.nlp	23882053	SENT87	27	27	19	19	liraglutide	GLP-1	PA165958364	100125288	0.769
NULL	Cancer_Inform_2013_Feb_13_12_31-51.nxml.txt.nlp	23470717	SENT158	4	4	16	16	epirubicin	AURKA	PA449476	6790	0.769
NULL	Basic_Clin_Neurosci_2014_Summer_5(3)_182-190.nxml.txt.nlp	25337378	SENT200	14	14	11	11	bupropion	mol	PA448687	90527	0.769
NULL	Environ_Health_Perspect_2005_Jun_24_113(6)_680-687.nxml.txt.nlp	15929889	SENT45	9	9	17	17	phenol	SULT1A1	PA450913	6817	0.769
NULL	Breast_Cancer_Res_2007_Aug_8_9(4)_R50.nxml.txt.nlp	17686159	SENT16	8	8	0	0	gefitinib	HRG	PA131301952	3084;3273	0.769
NULL	Biomed_Res_Int_2013_Sep_2_2013_168512.nxml.txt.nlp	24078905	SENT26	7	7	10	10	creatine	B12	PA164778930	7126;4709	0.769
NULL	Arch_Plast_Surg_2012_Sep_12_39(5)_540-545.nxml.txt.nlp	23094252	SENT36	16	16	11	11	remifentanil	TCI	PA451232	6947	0.769
NULL	Mol_Vis_2011_Dec_15_17_3254-3261.nxml.txt.nlp	22194651	SENT31	19	19	7	7	vasopressin	AVP	PA451858	114548;551	0.769
NULL	Eur_J_Clin_Pharmacol_2010_Nov_29_66(11)_1131-1136.nxml.txt.nlp	20669013	SENT14	16	16	24	24	erythromycin	CYP2C19	PA449493	1557	0.769
NULL	Br_J_Cancer_1996_Dec_74(12)_1908-1915.nxml.txt.nlp	8980389	SENT13	21	21	17	17	melphalan	TNF-alpha	PA450354	7124	0.769
NULL	Mol_Brain_2014_Jun_16_7_47.nxml.txt.nlp	24935250	SENT146	9	9	35	35	gabapentin	ANOVA	PA449720	4858	0.769
NULL	Ayu_2014_Jan-Mar_35(1)_54-57.nxml.txt.nlp	25364201	SENT55	28	28	5	5	ether	TLC	PA449525	3933	0.769
NULL	Cell_Cycle_2013_Feb_15_12(4)_625-634.nxml.txt.nlp	23324396	SENT185	15	15	19	19	etoposide	p53	PA449552	7157	0.769
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R91.nxml.txt.nlp	22541814	SENT197	29	29	21	21	thrombin	PP2	PA451674	4888	0.769
NULL	Br_J_Cancer_2004_May_4_90(9)_1710-1714.nxml.txt.nlp	15150625	SENT8	12	12	14	14	gemcitabine	GEM	PA449748	2669	0.769
NULL	Cardiovasc_Res_2012_Dec_1_96(3)_552-560.nxml.txt.nlp	22918977	SENT19	19	19	13	13	hydralazine	JAM-A	PA449894	50848	0.769
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT43	11	11	6	6	adalimumab	CD36	PA10004	948	0.769
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Nov_13_64(Pt_12)_o2338.nxml.txt.nlp	21581313	SENT73	39	39	13	13	ethanol	mol	PA448073	90527	0.769
NULL	Mol_Neurodegener_2011_Aug_8_6_57.nxml.txt.nlp	21819629	SENT356	10	10	7	7	arsenite	JNK	PA452638	5599	0.769
NULL	J_Cardiothorac_Surg_2009_Jun_18_4_25.nxml.txt.nlp	19538741	SENT55	19	19	23	23	heparin	ACT	PA449855	12;11332;9457;641455	0.769
NULL	Mol_Cancer_2014_Jul_5_13_165.nxml.txt.nlp	24996221	SENT125	33	33	12	12	docetaxel	HMGB1	PA449383	3146	0.769
NULL	Breast_Cancer_Res_2012_Feb_8_14(1)_R26.nxml.txt.nlp	22316048	SENT294	33	33	17	17	trastuzumab	aromatase	PA451743	1588	0.769
NULL	Oncogene_2014_Mar_20_33(12)_1495-1505.nxml.txt.nlp	23604115	SENT125	23	23	27	27	nilotinib	RAD51	PA165958345	5888	0.769
NULL	Int_J_Emerg_Med_2010_May_12_3(2)_133-134.nxml.txt.nlp	20606823	SENT4	7	7	9	9	pralidoxime	PAM	PA164744926	5066;23077	0.769
NULL	Diabetes_Care_2010_Jul_11_33(7)_1625-1628.nxml.txt.nlp	20150294	SENT148	12	12	22	22	atorvastatin	APOE	PA448500	348	0.769
NULL	Cell_Cycle_2012_Nov_1_11(21)_4069-4078.nxml.txt.nlp	23095523	SENT69	6	6	9	9	imatinib	PERK	PA10804	9451	0.769
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT195	8	8	25	25	sitagliptin	HIP	PA164748978	6767;6159;64399;5068	0.769
NULL	Br_J_Cancer_2013_May_14_108(9)_1862-1869.nxml.txt.nlp	23579219	SENT78	8	8	5	5	cetuximab	ISX	PA10040	91464	0.769
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT188	24	24	14	14	heparin	FGF1	PA449855	2246	0.769
NULL	J_Carcinog_2013_Dec_31_12_22.nxml.txt.nlp	24574860	SENT377	16	16	23	23	cabozantinib	VEGFR2	PA165906891	3791	0.769
NULL	Neural_Regen_Res_2013_Mar_25_8(9)_825-832.nxml.txt.nlp	25206730	SENT179	7	7	12	12	isoflurane	P2X7	PA450106	5027	0.769
NULL	Int_J_Mol_Sci_2012_Dec_5_13(12)_16500-16513.nxml.txt.nlp	23443115	SENT101	5	5	13	13	estradiol	gamma	PA449503	9913	0.769
NULL	Int_J_Mol_Sci_2014_Sep_30_15(10)_17733-17750.nxml.txt.nlp	25272228	SENT139	3	3	7	7	oxygen	HIF-1	PA450744	29072	0.769
NULL	J_Korean_Med_Sci_2013_Feb_29_28(2)_308-314.nxml.txt.nlp	23399960	SENT164	4	4	18	18	gabapentin	IL-6	PA449720	3569	0.769
NULL	EJC_Suppl_2013_Sep_5_11(2)_45-59.nxml.txt.nlp	NULL	SENT190	32	32	35	35	oxaliplatin	CRT	PA131285527	811	0.769
NULL	Nucleic_Acids_Res_2012_Jun_10_40(11)_4804-4815.nxml.txt.nlp	22328728	SENT288	4	4	32	32	resveratrol	SIRT1		23411	0.769
NULL	Basic_Clin_Neurosci_2014_Winter_5(1)_31-41.nxml.txt.nlp	25436082	SENT110	3	3	11	11	bupropion	mol	PA448687	90527	0.769
NULL	Int_J_Mol_Sci_2012_Aug_13_13(8)_10091-10112.nxml.txt.nlp	22949849	SENT46	33	33	19	19	ethanol	PPL	PA448073	5493	0.769
NULL	Biomed_Res_Int_2014_Jan_16_2014_821513.nxml.txt.nlp	24527458	SENT115	7	7	15	15	propofol	NAC	PA451141	22861	0.769
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Sep_30_66(Pt_10)_o2696.nxml.txt.nlp	21587664	SENT56	24	24	39	39	ethanol	mol	PA448073	90527	0.769
NULL	Iran_J_Psychiatry_2012_Winter_7(1)_1-10.nxml.txt.nlp	23056111	SENT36	0	0	11	11	topiramate	BD1	PA451728	1672	0.769
NULL	Blood_Res_2014_Jun_25_49(2)_115-119.nxml.txt.nlp	25025013	SENT89	22	22	27	27	rituximab	CHOP	PA451261	1649	0.769
NULL	Cell_Biol_Int_Rep_(2010)_2012_Jun_21_19(1)_e00017.nxml.txt.nlp	23124518	SENT137	27	27	29	29	etoposide	TRAIL	PA449552	8743	0.769
NULL	Biomed_Res_Int_2014_Feb_23_2014_297808.nxml.txt.nlp	24707480	SENT154	8	8	29	29	ofloxacin	HA-3	PA450684	11214	0.769
NULL	Cardiovasc_Ther_2012_Aug_17_30(4)_e174-e182.nxml.txt.nlp	21883999	SENT105	20	20	4	4	clopidogrel	PACT	PA449053	8575;5930	0.769
NULL	Cell_Biol_Int_Rep_(2010)_2012_Jun_21_19(1)_e00017.nxml.txt.nlp	23124518	SENT168	3	3	5	5	etoposide	TRAIL	PA449552	8743	0.769
NULL	J_Appl_Oral_Sci_2010_Nov-Dec_18(6)_613-620.nxml.txt.nlp	21308293	SENT60	25	25	6	6	trypsin	C-1	PA451806	5203	0.769
NULL	Emerg_Infect_Dis_2012_Mar_18(3)_537-539.nxml.txt.nlp	22377132	SENT81	29	29	0	0	isoniazid	Bravo	PA450112	4897	0.769
NULL	Int_J_Med_Chem_2012_Dec_13_2012_530392.nxml.txt.nlp	25379286	SENT165	24	24	10	10	ethanol	mol	PA448073	90527	0.769
NULL	BMB_Rep_2013_Jan_46(1)_59-64.nxml.txt.nlp	23351386	SENT7	12	12	15	15	auranofin	NAC	PA448510	22861	0.769
NULL	Oncogene_2010_Sep_23_29(38)_5299-5310.nxml.txt.nlp	20622903	SENT49	4	4	9	9	paclitaxel	HMGB1	PA450761	3146	0.769
NULL	J_Hematol_Oncol_2010_Mar_23_3_11.nxml.txt.nlp	20331897	SENT158	16	16	19	19	capecitabine	CRT	PA448771	811	0.769
NULL	Evid_Based_Complement_Alternat_Med_2013_Mar_19_2013_184358.nxml.txt.nlp	23573117	SENT222	30	30	17	17	berberine	AMPK	PA165860812	5563	0.769
NULL	Acta_Pharmacol_Sin_2012_Oct_17_33(10)_1301-1310.nxml.txt.nlp	22983390	SENT205	30	30	23	23	cisplatin	migfilin	PA449014	54751	0.769
NULL	Orphanet_J_Rare_Dis_2014_Dec_5_9(1)_194.nxml.txt.nlp	NULL	SENT791	13	13	4	4	desogestrel	CO2	PA449238	4513	0.769
NULL	Apoptosis_2014_Apr_23_19(7)_1055-1068.nxml.txt.nlp	24756955	SENT166	16	16	5	5	nutlin-3	p53		7157	0.769
NULL	Breast_Cancer_Res_2010_Oct_22_12(Suppl_2)_S3.nxml.txt.nlp	21050424	SENT23	36	36	4	4	trastuzumab	HER2	PA451743	2064	0.769
NULL	Genetics_2014_Sep_1_198(1)_17-29.nxml.txt.nlp	25236446	SENT525	5	5	8	8	isoflurane	p65	PA450106	5970	0.769
NULL	Allergy_Asthma_Immunol_Res_2013_Jul_27_5(4)_216-223.nxml.txt.nlp	23814675	SENT36	15	15	33	33	l-glutamine	CO2	PA10090	4513	0.769
NULL	Nucleic_Acids_Res_2011_Dec_2_39(22)_9549-9558.nxml.txt.nlp	21890893	SENT31	3	3	1	1	resveratrol	SIRT1		23411	0.769
NULL	Pain_Res_Treat_2013_Jan_30_2013_217864.nxml.txt.nlp	23431433	SENT77	26	26	6	6	capsaicin	NHE	PA448776	285335	0.769
NULL	Leukemia_2013_Dec_27_27(12)_2322-2331.nxml.txt.nlp	24072044	SENT224	10	10	8	8	plerixafor	CXCL12	PA165958410	6387	0.769
NULL	Environ_Health_Perspect_2010_Sep_28_118(9)_1267-1272.nxml.txt.nlp	20427257	SENT114	30	30	5	5	estradiol	BPA	PA449503	667	0.769
NULL	Cell_Death_Dis_2013_Jun_13_4(6)_e665.nxml.txt.nlp	23764846	SENT265	18	18	9	9	sorafenib	BLM	PA7000	641	0.769
NULL	Clin_Ophthalmol_2008_Dec_2(4)_829-836.nxml.txt.nlp	19668437	SENT76	23	23	13	13	methylprednisolone	KCS	PA450466	3771	0.769
NULL	EMBO_J_2009_Jul_8_28(13)_1978-1987.nxml.txt.nlp	19494830	SENT42	3	3	10	10	zinc	CTD	PA451956	1283	0.769
NULL	Clin_Ophthalmol_2011_Apr_18_5_495-502.nxml.txt.nlp	21573098	SENT222	4	4	14	14	gatifloxacin	BAK	PA449738	578	0.769
NULL	Curr_Neuropharmacol_2013_Jan_11(1)_102-108.nxml.txt.nlp	23814542	SENT225	25	25	35	35	rivastigmine	Yes	PA451262	7525	0.769
NULL	Curr_Med_Chem_2014_Feb_21_1129-1145.nxml.txt.nlp	24304271	SENT268	11	11	13	13	diethylstilbestrol	DES	PA449307	1674	0.769
NULL	J_Asthma_Allergy_2009_Aug_31_2_73-92.nxml.txt.nlp	21437146	SENT57	6	6	8	8	azelastine	AP-1	PA448517	2353;3727;2354;3725	0.769
NULL	Int_J_Mol_Sci_2014_Mar_20_15(3)_4965-4976.nxml.txt.nlp	24658440	SENT72	0	0	14	14	etanercept	CD4	PA449515	920	0.769
NULL	Brain_Sci_2014_Apr_16_4(2)_273-294.nxml.txt.nlp	24961761	SENT358	2	2	11	11	sevoflurane	PSD-95	PA451341	1742	0.769
NULL	Mucosal_Immunol_2012_Mar_16_5(2)_121-128.nxml.txt.nlp	22089029	SENT100	3	3	14	14	collagenase	CD4	PA449107	920	0.769
NULL	Arthritis_Res_Ther_2007_Jun_29_9(Suppl_1)_S3.nxml.txt.nlp	17634142	SENT132	16	16	10	10	denosumab	BSAP	PA166048634	5079	0.769
NULL	Cell_Death_Dis_2014_Jan_16_5(1)_e1000.nxml.txt.nlp	24434508	SENT292	16	16	25	25	teniposide	p53	PA451611	7157	0.769
NULL	Cancer_Cell_Int_2007_Jun_8_7_11.nxml.txt.nlp	17559657	SENT112	18	18	8	8	estradiol	CD133	PA449503	8842	0.769
NULL	Braz_J_Med_Biol_Res_2013_Aug_13_46(8)_650-658.nxml.txt.nlp	23969971	SENT204	28	28	19	19	cisplatin	STAT3	PA449014	6774	0.769
NULL	Int_J_Gen_Med_2011_Jul_20_4_539-545.nxml.txt.nlp	21845063	SENT98	24	24	14	14	miglitol	GLP-1	PA164776726	100125288	0.769
NULL	Br_J_Haematol_2008_Mar_3_144(5)_677-685.nxml.txt.nlp	19055662	SENT87	15	15	13	13	cyclophosphamide	CHOP	PA449165	1649	0.769
NULL	Diabetes_Care_2008_Oct_31(10)_2062-2069.nxml.txt.nlp	18820229	SENT127	6	6	11	11	ramipril	DREAM	PA451223	30818	0.769
NULL	Evid_Based_Complement_Alternat_Med_2011_Jan_9_2011_619650.nxml.txt.nlp	21799685	SENT30	11	11	6	6	ketanserin	5-HT2A	PA131053734	3356	0.769
NULL	J_Gastroenterol_2013_Mar_9_48(3)_382-390.nxml.txt.nlp	22875473	SENT142	13	13	5	5	ribavirin	IL28B	PA451241	282617	0.769
NULL	Cell_Death_Dis_2014_Feb_13_5(2)_e1055.nxml.txt.nlp	24525731	SENT285	31	31	10	10	cisplatin	XRCC1	PA449014	7515	0.769
NULL	Mol_Med_Rep_2014_Oct_18_10(4)_1739-1745.nxml.txt.nlp	25051506	SENT35	8	8	28	28	ethanol	F12	PA448073	2161	0.769
NULL	Mol_Cancer_2008_Jan_25_7_14.nxml.txt.nlp	18221502	SENT138	4	4	17	17	oxaliplatin	PSAT1	PA131285527	29968	0.769
NULL	Nat_Neurosci_2012_Sep_5_15(9)_1245-1254.nxml.txt.nlp	22864611	SENT215	12	12	14	14	clozapine	HDAC2	PA449061	3066	0.769
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Jul_21_9_20.nxml.txt.nlp	20663145	SENT83	12	12	17	17	clarithromycin	LBH	PA449028	81606;221491	0.769
NULL	Iran_J_Pharm_Res_2015_Winter_14(1)_279-289.nxml.txt.nlp	25561934	SENT144	33	33	39	39	isoproterenol	ANOVA	PA450121	4858	0.769
NULL	Diabetes_2009_Jul_28_58(7)_1659-1667.nxml.txt.nlp	19401417	SENT202	4	4	27	27	aspirin	p53	PA448497	7157	0.769
NULL	EMBO_Mol_Med_2012_Jun_13_4(6)_515-527.nxml.txt.nlp	22416035	SENT238	4	4	37	37	olaparib	p53		7157	0.769
NULL	Int_J_Gen_Med_2012_Nov_23_5_983-990.nxml.txt.nlp	23226071	SENT45	13	13	7	7	stavudine	ART	PA451494	181	0.769
NULL	Mol_Imaging_Biol_2013_Apr_11_15(2)_136-147.nxml.txt.nlp	22886728	SENT87	1	1	16	16	orlistat	FDG	PA164776864	23583	0.769
NULL	Curr_Med_Chem_2012_Sep_19(26)_4399-4413.nxml.txt.nlp	22830345	SENT241	4	4	2	2	rifampin	CYP3A4	PA451250	1576	0.769
NULL	Biomed_Res_Int_2014_Apr_15_2014_182862.nxml.txt.nlp	24839598	SENT98	32	32	8	8	cyclophosphamide	COX2	PA449165	4513;5743	0.769
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT44	5	5	19	19	sitagliptin	HIP	PA164748978	6767;6159;64399;5068	0.769
NULL	Br_J_Cancer_2012_Feb_28_106(5)_883-888.nxml.txt.nlp	22315050	SENT98	13	13	19	19	panitumumab	KRAS	PA162373091	3845	0.769
NULL	Clin_Med_Insights_Oncol_2013_May_20_7_87-102.nxml.txt.nlp	23761989	SENT197	15	15	11	11	lapatinib	EGFR	PA152241907	1956	0.769
NULL	Gastric_Cancer_2014_Dec_8_17(4)_630-637.nxml.txt.nlp	24318670	SENT192	3	3	25	25	irinotecan	KRAS	PA450085	3845	0.769
NULL	Drugs_2012_Sep_6_72(9)_e1-e25.nxml.txt.nlp	22686620	SENT285	5	5	19	19	maraviroc	CXCR4	PA164768835	7852	0.769
NULL	EMBO_Mol_Med_2012_Sep_7_4(9)_896-909.nxml.txt.nlp	22887866	SENT130	9	9	13	13	lovastatin	SREBF1	PA450272	6720	0.769
NULL	Front_Genet_2014_Oct_21_5_372.nxml.txt.nlp	25374583	SENT307	27	27	15	15	oxaliplatin	FANCJ	PA131285527	83990	0.769
NULL	J_Hematol_Oncol_2008_Aug_11_1_11.nxml.txt.nlp	18694493	SENT141	13	13	11	11	sorafenib	IL-2	PA7000	3558	0.769
NULL	Infect_Agent_Cancer_2012_Apr_19_7(Suppl_1)_P32.nxml.txt.nlp	NULL	SENT7	9	9	25	25	nelfinavir	CHOP10	PA450606	1649	0.769
NULL	Biomed_Res_Int_2013_Dec_31_2013_795103.nxml.txt.nlp	23710462	SENT9	1	1	28	28	fenofibrate	ACR	PA449594	49	0.769
NULL	Allergy_Asthma_Clin_Immunol_2012_Jan_20_8(1)_1.nxml.txt.nlp	22264407	SENT63	13	13	43	43	phenol	BAT	PA450913	570	0.769
NULL	Mucosal_Immunol_2011_May_10_4(3)_304-313.nxml.txt.nlp	21068720	SENT238	8	8	21	21	dextran	Diva	PA449261	10017	0.769
NULL	Nat_Med_2010_Feb_24_16(2)_214-218.nxml.txt.nlp	20098429	SENT49	19	19	0	0	doxorubicin	LAPTM4B	PA449412	55353	0.769
NULL	Breast_Cancer_Res_Treat_2012_Aug_13_135(1)_49-58.nxml.txt.nlp	22527098	SENT207	9	9	6	6	tamoxifen	FGFR1	PA451581	2260	0.769
NULL	Case_Rep_Dent_2013_Jul_10_2013_812323.nxml.txt.nlp	23936686	SENT96	34	34	8	8	hyaluronan	CD31	PA165958431	5175	0.769
NULL	ScientificWorldJournal_2012_Apr_29_2012_718791.nxml.txt.nlp	22649316	SENT4	23	23	25	25	trimethoprim	TMP	PA451788	2012	0.769
NULL	Parasit_Vectors_2011_Aug_24_4_164.nxml.txt.nlp	21864384	SENT116	40	40	42	42	praziquantel	LAMP	PA164764583	4045;27074	0.769
NULL	Vet_Res_Forum_2013_Winter_4(1)_19-24.nxml.txt.nlp	25593681	SENT89	32	32	38	38	diclofenac	B12	PA449293	7126;4709	0.769
NULL	J_Korean_Med_Sci_2007_Dec_20_22(6)_1055-1059.nxml.txt.nlp	18162722	SENT119	14	14	33	33	pantoprazole	ESD	PA450774	2098	0.769
NULL	Front_Endocrinol_(Lausanne)_2013_Jan_25_4_1.nxml.txt.nlp	23355833	SENT87	13	13	0	0	hyaluronan	CD44	PA165958431	960	0.769
NULL	Environ_Health_Perspect_2005_Oct_14_113(10)_1330-1335.nxml.txt.nlp	16203242	SENT114	2	2	9	9	phenylephrine	MLC	PA450935	23209	0.769
NULL	J_Exp_Med_2000_Nov_20_192(10)_1479-1490.nxml.txt.nlp	11085749	SENT87	6	6	19	19	neomycin	BRL	PA450608	23774	0.769
NULL	Mol_Cancer_2008_Mar_6_7_24.nxml.txt.nlp	18325101	SENT81	8	8	5	5	cisplatin	FANCD2	PA449014	2177	0.769
NULL	Infect_Ecol_Epidemiol_2012_Mar_27_2_10_3402_iee_v2i0_7438.nxml.txt.nlp	22957135	SENT9	37	37	39	39	vancomycin	VAN	PA451850	10318	0.769
NULL	Int_J_Gen_Med_2014_Apr_11_7_193-203.nxml.txt.nlp	24748813	SENT114	11	11	39	39	ribavirin	IFN	PA451241	3439	0.769
NULL	Allergy_Asthma_Immunol_Res_2010_Jan_30_2(1)_34-40.nxml.txt.nlp	20224676	SENT148	13	13	27	27	methacholine	Eos	PA165958382	64375	0.769
NULL	Curr_Neuropharmacol_2013_Jan_11(1)_102-108.nxml.txt.nlp	23814542	SENT225	25	25	20	20	rivastigmine	Yes	PA451262	7525	0.769
NULL	Contemp_Oncol_(Pozn)_2012_Feb_29_16(1)_86-89.nxml.txt.nlp	23788860	SENT83	13	13	16	16	cetuximab	DDP	PA10040	1678	0.769
NULL	Acta_Pharmacol_Sin_2011_Oct_12_32(10)_1259-1265.nxml.txt.nlp	21909126	SENT129	31	31	15	15	losartan	MCP-1	PA450268	6347	0.769
NULL	ScientificWorldJournal_2014_Mar_3_2014_781857.nxml.txt.nlp	24729754	SENT234	6	6	9	9	rosiglitazone	CD40L	PA451283	959	0.769
NULL	Gut_Liver_2013_Jul_20_7(4)_458-461.nxml.txt.nlp	23898387	SENT16	20	20	18	18	ribavirin	IFN	PA451241	3439	0.769
NULL	Evol_Med_Public_Health_2013_Apr_9_2013(1)_46-64.nxml.txt.nlp	24481186	SENT121	17	17	9	9	infliximab	COX2	PA452639	4513;5743	0.769
NULL	Exp_Ther_Med_2013_Jul_25_6(1)_109-114.nxml.txt.nlp	23935730	SENT142	31	31	43	43	cyclophosphamide	CHOP	PA449165	1649	0.769
NULL	Sci_Rep_2014_Nov_28_4_7237.nxml.txt.nlp	25429875	SENT39	4	4	20	20	hesperidin	p38	PA449867	10598;1432;7965	0.769
NULL	Front_Aging_Neurosci_2010_May_18_2_16.nxml.txt.nlp	20559464	SENT210	5	5	22	22	indomethacin	COX	PA449982	1351	0.769
NULL	Biomed_Res_Int_2014_Feb_19_2014_240642.nxml.txt.nlp	24701565	SENT54	0	0	18	18	doxorubicin	TNF-alpha	PA449412	7124	0.769
NULL	Br_J_Cancer_2003_Mar_10_88(5)_754-759.nxml.txt.nlp	12618886	SENT120	2	2	7	7	amifostine	p53	PA448365	7157	0.769
NULL	Mol_Cancer_2012_Apr_26_11_24.nxml.txt.nlp	22537161	SENT139	36	36	21	21	pp2	MUC4		4585	0.769
NULL	Eur_J_Neurosci_2007_Mar_1_25(6)_1619-1630.nxml.txt.nlp	17408433	SENT57	15	15	9	9	fluorescein	ACPA	PA164746009	5657	0.769
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_127043.nxml.txt.nlp	23227093	SENT162	7	7	4	4	lovastatin	RYR	PA450272	6261	0.769
NULL	Anal_Chem_2009_Sep_1_81(17)_7342-7348.nxml.txt.nlp	19637924	SENT123	19	19	16	16	methamphetamine	CHAMP	PA450403	283489;54456	0.769
NULL	Case_Rep_Oncol_2011_Nov_22_4(3)_534-541.nxml.txt.nlp	22187539	SENT88	11	11	30	30	paclitaxel	GEM	PA450761	2669	0.769
NULL	Front_Neurosci_2010_Jun_17_4_35.nxml.txt.nlp	20661455	SENT580	12	12	4	4	paroxetine	5-HT1A	PA450801	3350	0.769
NULL	Front_Neurosci_2014_Jun_3_8_128.nxml.txt.nlp	24917782	SENT434	2	2	13	13	ethanol	ACTH	PA448073	5443	0.769
NULL	Evid_Based_Complement_Alternat_Med_2011_Feb_14_2011_429843.nxml.txt.nlp	21869897	SENT120	5	5	19	19	diazepam	EPM	PA449283	2054	0.769
NULL	ISRN_Otolaryngol_2012_Nov_14_2012_797619.nxml.txt.nlp	23762619	SENT80	12	12	10	10	gefitinib	EGF	PA131301952	1950	0.769
NULL	Drugs_R_D_2014_Sep_31_14(3)_177-184.nxml.txt.nlp	25079671	SENT28	11	11	38	38	voglibose	MCP-1	PA164752433	6347	0.769
NULL	Arthritis_Res_Ther_2014_Sep_24_16(5)_434.nxml.txt.nlp	25249397	SENT9	37	37	11	11	adalimumab	CXCL13	PA10004	10563	0.769
NULL	Cell_Death_Dis_2014_Feb_13_5(2)_e1055.nxml.txt.nlp	24525731	SENT302	20	20	8	8	cisplatin	XRCC1	PA449014	7515	0.769
NULL	Int_J_Endocrinol_Metab_2013_Jul_1_Summer_11(3)_184-190.nxml.txt.nlp	24348591	SENT82	22	22	0	0	glutaraldehyde	INS-1	PA449777	2305	0.769
NULL	Environ_Health_Perspect_2004_Nov_28_112(15)_1512-1518.nxml.txt.nlp	15531436	SENT41	10	10	3	3	methoxyflurane	CYP2A6	PA450434	1548	0.769
NULL	Arthritis_Res_Ther_2008_Jan_7_10(1)_R1.nxml.txt.nlp	18179697	SENT212	9	9	23	23	oxaliplatin	HMGB1	PA131285527	3146	0.769
NULL	Diabetes_2013_Sep_15_62(9)_3151-3162.nxml.txt.nlp	23649518	SENT335	24	24	21	21	resveratrol	p53		7157	0.769
NULL	Oncogene_2014_Sep_11_33(37)_4579-4588.nxml.txt.nlp	24662835	SENT13	18	18	24	24	fulvestrant	aromatase	PA164747170	1588	0.769
NULL	Int_J_Gen_Med_2012_Jun_18_5_535-540.nxml.txt.nlp	22807641	SENT95	19	19	16	16	pitavastatin	adiponectin	PA142650384	9370	0.769
NULL	Sci_Rep_2014_Dec_3_4_7294.nxml.txt.nlp	25465236	SENT502	33	33	23	23	staurosporine	TYK2	PA165109623	7297	0.769
NULL	Int_J_Biomed_Sci_2013_Sep_9(3)_112-122.nxml.txt.nlp	24170986	SENT112	2	2	20	20	benazepril	p65	PA448561	5970	0.769
NULL	Biologics_2011_Feb_14_5_21-31.nxml.txt.nlp	21383913	SENT204	29	29	13	13	pimecrolimus	CLE	PA164783790	51637	0.769
NULL	Arthritis_Res_Ther_2011_Nov_1_13(6)_R182.nxml.txt.nlp	22044682	SENT62	10	10	33	33	collagenase	CD23	PA449107	2208	0.769
NULL	Daru_2013_Jan_18_21(1)_10.nxml.txt.nlp	23351340	SENT136	2	2	9	9	tramadol	mol	PA451735	90527	0.769
NULL	Stroke_Res_Treat_2009_Dec_20_2010_386389.nxml.txt.nlp	20700422	SENT258	5	5	16	16	resveratrol	MCP-1		6347	0.769
NULL	Oncotarget_2012_Oct_20_3(10)_1068-1111.nxml.txt.nlp	23085539	SENT375	0	0	8	8	sorafenib	Bcl-2	PA7000	596	0.769
NULL	J_Mol_Med_(Berl)_2013_Aug_17_91(11)_1257-1271.nxml.txt.nlp	23955016	SENT134	23	23	9	9	thrombin	MASP2	PA451674	10747	0.769
NULL	Mol_Cancer_2008_Jan_25_7_14.nxml.txt.nlp	18221502	SENT233	28	28	18	18	thioguanine	PSAT1	PA451663	29968	0.769
NULL	Br_J_Cancer_2009_Nov_3_101(9)_1585-1595.nxml.txt.nlp	19809435	SENT175	17	17	24	24	curcumin	MDC	PA151958596	6367	0.769
NULL	Cost_Eff_Resour_Alloc_2004_Apr_15_2_2.nxml.txt.nlp	15086954	SENT126	22	22	7	7	metformin	PPG	PA450395	5552	0.769
NULL	Ann_Clin_Transl_Neurol_2014_Mar_4_1(3)_199-208.nxml.txt.nlp	25356398	SENT169	32	32	39	39	reserpine	LRRK2	PA451236	120892	0.769
NULL	J_Invest_Dermatol_2012_Nov_21_132(11)_2642-2651.nxml.txt.nlp	22718118	SENT59	19	19	11	11	collagenase	CD11b	PA449107	3684	0.769
NULL	Oncotarget_2012_Oct_27_3(10)_1052-1053.nxml.txt.nlp	23165648	SENT25	26	26	19	19	nutlin-3	STAT1		6772	0.769
NULL	Nat_Med_2014_Jun_11_20(6)_599-606.nxml.txt.nlp	24813251	SENT82	17	17	9	9	imatinib	ABL1	PA10804	25	0.769
NULL	Springerplus_2015_Jan_23_4_29.nxml.txt.nlp	25628986	SENT33	27	27	15	15	dapsone	G6PD	PA449211	2539	0.769
NULL	Adv_Urol_2012_Oct_26_2012_812398.nxml.txt.nlp	22110495	SENT116	12	12	4	4	cisplatin	ERCC1	PA449014	2067	0.769
NULL	Arthritis_Res_Ther_2012_Mar_30_14(2)_114.nxml.txt.nlp	22494450	SENT2	35	35	18	18	methotrexate	CCR5	PA450428	1234	0.769
NULL	Breast_Cancer_Res_Treat_2012_Jul_5_134(2)_693-700.nxml.txt.nlp	22562123	SENT210	22	22	13	13	tamoxifen	FMO3	PA451581	2328	0.769
NULL	Acta_Vet_Scand_2013_Mar_8_55(1)_21.nxml.txt.nlp	23497696	SENT140	7	7	25	25	doxycycline	BCS	PA449415	617	0.769
NULL	Neuropsychopharmacology_2011_Jul_30_36(8)_1575-1586.nxml.txt.nlp	21451498	SENT254	13	13	1	1	methylphenidate	ANOVA	PA450464	4858	0.769
NULL	Cancer_Med_2013_Aug_10_2(4)_496-506.nxml.txt.nlp	24156022	SENT264	27	27	9	9	cetuximab	IGF1R	PA10040	3480	0.769
NULL	Cardiovasc_Diabetol_2005_May_15_4_6.nxml.txt.nlp	15892894	SENT146	20	20	0	0	telmisartan	CIR	PA451605	3762;9541	0.769
NULL	Cancers_(Basel)_2012_Oct_29_4(4)_1146-1160.nxml.txt.nlp	24213502	SENT403	16	16	18	18	raloxifene	STAR	PA451221	6770;2984	0.769
NULL	Cardiovasc_Toxicol_2013_May_1_13(4)_307-315.nxml.txt.nlp	23632742	SENT202	20	20	48	48	rosiglitazone	SOD2	PA451283	6648	0.769
NULL	J_Hematol_Oncol_2014_Apr_21_7_35.nxml.txt.nlp	24751163	SENT200	4	4	33	33	tetracycline	CO2	PA451640	4513	0.769
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT149	7	7	43	43	panitumumab	KRAS	PA162373091	3845	0.769
NULL	Cardiovasc_Ther_2009_27(3)_151-158.nxml.txt.nlp	19604249	SENT131	17	17	13	13	losartan	AT1	PA450268	9197;185	0.769
NULL	Acta_Pharmacol_Sin_2012_Aug_23_33(8)_1095-1100.nxml.txt.nlp	22820908	SENT113	1	1	9	9	ilaprazole	CYP3A5	PA165947499	1577	0.769
NULL	Acta_Vet_Scand_2011_Feb_22_53(1)_12.nxml.txt.nlp	21342526	SENT213	13	13	23	23	flutamide	PD2	PA449685	54623	0.769
NULL	J_Cardiothorac_Surg_2012_Sep_27_7_97.nxml.txt.nlp	23013706	SENT153	10	10	22	22	warfarin	CYP4F2	PA451906	8529	0.769
NULL	Pharmaceutics_2010_Jun_2_2(2)_258-274.nxml.txt.nlp	NULL	SENT171	21	21	19	19	risperidone	P-gp	PA451257	5243	0.769
NULL	Cancer_Inform_2007_May_1_3_125-139.nxml.txt.nlp	19455240	SENT147	20	20	15	15	indomethacin	VEGF-A	PA449982	7422	0.769
NULL	Breast_Cancer_Res_Treat_2012_Jun_3_133(2)_793-798.nxml.txt.nlp	22388692	SENT124	13	13	5	5	tamoxifen	SULT1A1	PA451581	6817	0.769
NULL	Breast_Cancer_Res_2011_Mar_4_13(2)_R23.nxml.txt.nlp	21375726	SENT213	7	7	0	0	tamoxifen	AP-2	PA451581	7020	0.769
NULL	Front_Neurosci_2010_May_15_4_13.nxml.txt.nlp	20859447	SENT1066	6	6	8	8	phencyclidine	PCP	PA128406980	5547	0.769
NULL	Diabetes_Metab_Syndr_Obes_2014_Jul_17_7_313-319.nxml.txt.nlp	25092992	SENT92	25	25	10	10	glimepiride	adiponectin	PA449761	9370	0.769
NULL	FEBS_J_2012_May_279(10)_1857-1870.nxml.txt.nlp	22420714	SENT287	4	4	10	10	capsaicin	TRPV1	PA448776	7442	0.769
NULL	J_Bras_Pneumol_2013_Jun-Aug_39(4)_434-439.nxml.txt.nlp	24068264	SENT179	20	20	10	10	pentobarbital	por	PA450859	64840	0.769
NULL	J_Immunother_Cancer_2013_Nov_7_1(Suppl_1)_P25.nxml.txt.nlp	NULL	SENT12	14	14	26	26	cyclophosphamide	IL-2	PA449165	3558	0.769
NULL	Oncogene_2010_Jul_8_29(27)_3896-3907.nxml.txt.nlp	20453888	SENT93	19	19	30	30	trastuzumab	p27	PA451743	5715;10534	0.769
NULL	Front_Immunol_2012_Jul_12_3_175.nxml.txt.nlp	22807925	SENT142	14	14	24	24	heparin	CXCR2	PA449855	3579	0.769
NULL	Int_J_Biomed_Sci_2006_Jun_2(2)_114-120.nxml.txt.nlp	23674973	SENT102	9	9	20	20	hydrocortisone	IL-10	PA449905	3586	0.769
NULL	Algorithms_Mol_Biol_2010_Jul_15_5_29.nxml.txt.nlp	20633297	SENT241	15	15	21	21	sildenafil	PDE4B	PA451346	5142	0.769
NULL	Int_J_Mol_Sci_2014_Mar_18_15(3)_4747-4779.nxml.txt.nlp	24646914	SENT1976	6	6	9	9	maraviroc	CCR5	PA164768835	1234	0.769
NULL	Breast_Cancer_Res_2008_Dec_18_10(Suppl_4)_S19.nxml.txt.nlp	19128432	SENT13	33	33	22	22	tamoxifen	IMPACT	PA451581	55364	0.769
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT170	16	16	34	34	l-leucine	AMPK	PA450197	5563	0.769
NULL	Acta_Pharmacol_Sin_2011_Oct_12_32(10)_1259-1265.nxml.txt.nlp	21909126	SENT106	22	22	10	10	losartan	p38	PA450268	10598;1432;7965	0.769
NULL	Int_J_Breast_Cancer_2011_Sep_6_2011_352182.nxml.txt.nlp	22295219	SENT122	13	13	1	1	hyaluronan	CD44	PA165958431	960	0.769
NULL	Br_J_Cancer_2010_Jul_13_103(2)_186-195.nxml.txt.nlp	20588277	SENT9	29	29	19	19	nutlin-3	p53		7157	0.769
NULL	Clin_Interv_Aging_2009_May_14_4_109-113.nxml.txt.nlp	19503773	SENT87	10	10	27	27	tolcapone	COMT	PA451720	1312	0.769
NULL	Biomed_Res_Int_2014_Feb_27_2014_827415.nxml.txt.nlp	24719890	SENT47	13	13	4	4	bortezomib	HER2	PA10252	2064	0.769
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_75-89.nxml.txt.nlp	17912638	SENT479	41	41	11	11	tamoxifen	Gen	PA451581	348654	0.769
NULL	EMBO_J_2010_Nov_17_29(22)_3773-3786.nxml.txt.nlp	20924358	SENT73	22	22	11	11	geldanamycin	SENP3	PA152031327	26168	0.769
NULL	Biomed_Res_Int_2014_May_11_2014_942960.nxml.txt.nlp	24901002	SENT93	29	29	32	32	nadh	Q10	PA164755085	27161	0.769
NULL	Indian_J_Endocrinol_Metab_2012_Dec_16(Suppl_2)_S239-S241.nxml.txt.nlp	23565388	SENT34	27	27	16	16	sitagliptin	GLP-1	PA164748978	100125288	0.769
NULL	Pharmaceutics_2010_Apr_27_2(2)_136-158.nxml.txt.nlp	NULL	SENT2	1	1	18	18	diclofenac	HSM	PA449293	94030	0.769
NULL	Open_AIDS_J_2011_Apr_22_5_44-50.nxml.txt.nlp	21643422	SENT185	20	20	8	8	zidovudine	CD4	PA451954	920	0.769
NULL	Oncol_Lett_2013_Oct_26_6(4)_1063-1067.nxml.txt.nlp	24137465	SENT95	11	11	19	19	gefitinib	HER2	PA131301952	2064	0.769
NULL	Ann_Med_2011_Nov_5_43(7)_531-544.nxml.txt.nlp	21815879	SENT117	20	20	4	4	prasugrel	ADP	PA154410481	23038	0.769
NULL	Cancers_(Basel)_2013_May_27_5(2)_617-638.nxml.txt.nlp	24216994	SENT224	3	3	1	1	curcumin	MMP9	PA151958596	4318	0.769
NULL	Cell_Commun_Signal_2013_Jan_11_11_2.nxml.txt.nlp	23305203	SENT263	4	4	6	6	thrombin	RACK1	PA451674	10399	0.769
NULL	Int_J_Biol_Sci_2013_Apr_22_9(4)_350-360.nxml.txt.nlp	23630447	SENT155	2	2	10	10	verapamil	ANOVA	PA451868	4858	0.769
NULL	Oncotarget_2014_May_27_5(19)_9049-9064.nxml.txt.nlp	24979294	SENT183	15	15	34	34	dasatinib	FBS	PA162372878	64319;26269	0.769
NULL	Br_J_Clin_Pharmacol_2013_Aug_23_76(2)_299-315.nxml.txt.nlp	23701319	SENT150	3	3	18	18	rituximab	IL-10	PA451261	3586	0.769
NULL	Biomed_Res_Int_2014_Mar_4_2014_836769.nxml.txt.nlp	24724101	SENT83	3	3	9	9	fulvestrant	HER2	PA164747170	2064	0.769
NULL	eLife_2014_May_7_3_e02444.nxml.txt.nlp	24894464	SENT192	15	15	10	10	bexarotene	ABCA1	PA164752250	19	0.769
NULL	Cancer_Cell_Int_2010_Jun_22_10_18.nxml.txt.nlp	20569458	SENT204	12	12	7	7	heparin	IL-21	PA449855	59067;50616;27189	0.769
NULL	Front_Oncol_2014_Mar_18_4_55.nxml.txt.nlp	24672775	SENT99	32	32	30	30	sorafenib	CR2	PA7000	1380	0.769
NULL	Nat_Med_2011_Aug_7_17(9)_1116-1120.nxml.txt.nlp	21822287	SENT97	30	30	28	28	doxycycline	EGF	PA449415	1950	0.769
NULL	Diabetes_2013_May_16_62(5)_1697-1708.nxml.txt.nlp	23364453	SENT8	16	16	18	18	exenatide	GLP-1	PA164749238	100125288	0.769
NULL	Curr_Rheumatol_Rep_2012_Dec_18_14(6)_604-616.nxml.txt.nlp	22987043	SENT470	5	5	2	2	curcumin	NF-kappaB	PA151958596	4790	0.769
NULL	Curr_Dermatol_Rep_2014_Nov_28_3(1)_13-22.nxml.txt.nlp	24587975	SENT141	12	12	29	29	imiquimod	IL-17	PA449972	3605	0.769
NULL	Pharmaceuticals_(Basel)_2011_May_16_4(5)_726-740.nxml.txt.nlp	NULL	SENT192	4	4	11	11	estradiol	spatial	PA449503	219793	0.769
NULL	Gastric_Cancer_2013_Jul_12_16(3)_345-354.nxml.txt.nlp	22968820	SENT142	4	4	8	8	oxaliplatin	MLH1	PA131285527	4292	0.768
NULL	Allergy_Asthma_Immunol_Res_2009_Oct_25_1(1)_30-35.nxml.txt.nlp	20224667	SENT104	13	13	38	38	aspirin	PPARG	PA448497	5468	0.768
NULL	eLife_2014_May_7_3_e02536.nxml.txt.nlp	24843004	SENT371	14	14	25	25	genistein	TRPC3	PA165109660	7222	0.768
NULL	Epidemiol_Rev_2011_Jul_27_33(1)_46-62.nxml.txt.nlp	21622851	SENT298	14	14	0	0	rosiglitazone	DREAM	PA451283	30818	0.768
NULL	J_Gen_Physiol_2013_Feb_141(2)_165-178.nxml.txt.nlp	23359281	SENT37	0	0	26	26	thrombin	PP1	PA451674	5540;5464	0.768
NULL	Cell_Death_Differ_2010_Apr_16_17(4)_666-676.nxml.txt.nlp	19834494	SENT269	17	17	4	4	oxaliplatin	RAGE	PA131285527	177	0.768
NULL	J_Gynecol_Oncol_2014_Apr_9_25(2)_130-135.nxml.txt.nlp	24761217	SENT112	35	35	29	29	paclitaxel	P-gp	PA450761	5243	0.768
NULL	Infect_Dis_Obstet_Gynecol_2014_Sep_25_2014_961375.nxml.txt.nlp	25328370	SENT194	7	7	0	0	atazanavir	ATV	PA10251	4683	0.768
NULL	Cancer_Manag_Res_2014_Jun_20_6_279-289.nxml.txt.nlp	25018651	SENT82	16	16	28	28	cisplatin	IL-2	PA449014	3558	0.768
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT148	13	13	7	7	dasatinib	PP2	PA162372878	4888	0.768
NULL	Gynecol_Oncol_Case_Rep_2013_Sep_21_6_42-44.nxml.txt.nlp	24371718	SENT107	6	6	19	19	tamoxifen	ATAC	PA451581	6375	0.768
NULL	ScientificWorldJournal_2013_Oct_24_2013_726912.nxml.txt.nlp	24282387	SENT40	9	9	29	29	fluorescein	AVP	PA164746009	114548;551	0.768
NULL	Surg_Neurol_Int_2013_Mar_22_4(Suppl_2)_S94-S105.nxml.txt.nlp	23646279	SENT268	12	12	29	29	simvastatin	IVD	PA451363	3712	0.768
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Nov_26_64(Pt_12)_o2445.nxml.txt.nlp	21581413	SENT4	1	1	33	33	ethanol	mol	PA448073	90527	0.768
NULL	Cell_Death_Dis_2010_Sep_23_1(9)_e77.nxml.txt.nlp	21170291	SENT142	18	18	28	28	l-glutamine	B27	PA10090	56246	0.768
NULL	Basic_Res_Cardiol_2013_Jul_28_108(4)_367.nxml.txt.nlp	23812248	SENT219	12	12	0	0	collagenase	5-LOX	PA449107	240	0.768
NULL	Chem_Rev_2014_Jun_11_114(11)_5753-5774.nxml.txt.nlp	24758331	SENT426	30	30	3	3	verapamil	P-gp	PA451868	5243	0.768
NULL	Clin_Drug_Investig_2013_Jan_27_33(1)_45-54.nxml.txt.nlp	23184666	SENT120	5	5	30	30	anagrelide	CYP1A2	PA164742986	1544	0.768
NULL	Cancer_Res_Treat_2013_Sep_30_45(3)_178-185.nxml.txt.nlp	24155676	SENT154	3	3	7	7	gefitinib	EGFR	PA131301952	1956	0.768
NULL	Nanoscale_Res_Lett_2010_Jul_28_5(11)_1749-1754.nxml.txt.nlp	21124643	SENT39	22	22	13	13	ethanol	NO3	PA448073	4681	0.768
NULL	Int_J_Mol_Sci_2014_Sep_5_15(9)_15754-15765.nxml.txt.nlp	25198898	SENT103	6	6	11	11	curcumin	MKK4	PA151958596	6416	0.768
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT226	10	10	2	2	capsaicin	p53	PA448776	7157	0.768
NULL	Int_J_Endocrinol_Metab_2012_Sep_30_Autumn_10(4)_646-647.nxml.txt.nlp	23843842	SENT16	24	24	28	28	raloxifene	PTH	PA451221	5741	0.768
NULL	Cancer_Res_Treat_2013_Dec_31_45(4)_251-262.nxml.txt.nlp	24453997	SENT88	21	21	23	23	cytarabine	PI3K	PA449177	5290	0.768
NULL	Acta_Pharmacol_Sin_2010_Sep_16_31(9)_1075-1084.nxml.txt.nlp	20711221	SENT73	36	36	33	33	glucose	AMPK	PA449773	5563	0.768
NULL	Mol_Cancer_2010_Aug_20_9_220.nxml.txt.nlp	20727180	SENT223	26	26	8	8	nicotine	p53	PA450626	7157	0.768
NULL	Mol_Pain_2014_Aug_15_10_53.nxml.txt.nlp	25127716	SENT98	12	12	8	8	paclitaxel	SDH	PA450761	1757;10993	0.768
NULL	Nucleic_Acids_Res_2013_May_20_41(9)_e104.nxml.txt.nlp	23519618	SENT127	8	8	10	10	decitabine	DAC	PA164749631	13	0.768
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT264	3	3	9	9	resveratrol	IL-6		3569	0.768
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT97	28	28	10	10	ethanol	CO2	PA448073	4513	0.768
NULL	Trials_2013_Sep_24_14_311.nxml.txt.nlp	24063608	SENT372	23	23	29	29	sulfadoxine	IPT	PA451540	54802	0.768
NULL	EMBO_Mol_Med_2013_Jun_30_5(6)_935-948.nxml.txt.nlp	23629957	SENT123	21	21	17	17	cisplatin	COL6A3	PA449014	1293	0.768
NULL	J_Exp_Clin_Cancer_Res_2009_Feb_15_28(1)_19.nxml.txt.nlp	19216799	SENT138	24	24	7	7	doxorubicin	AEG-1	PA449412	92140	0.768
NULL	Environ_Health_Perspect_2004_Nov_28_112(15)_1512-1518.nxml.txt.nlp	15531436	SENT41	12	12	3	3	halothane	CYP2A6	PA449845	1548	0.768
NULL	Can_J_Infect_Dis_Med_Microbiol_2014_May-Jun_25(3)_155-158.nxml.txt.nlp	25285112	SENT87	11	11	17	17	doxycycline	TMP	PA449415	2012	0.768
NULL	Biochem_Res_Int_2010_Aug_4_2010_549572.nxml.txt.nlp	21188077	SENT30	15	15	2	2	l-phenylalanine	TAT	PA450931	6898	0.768
NULL	Nat_Commun_2014_Dec_9_5_5691.nxml.txt.nlp	25487737	SENT98	37	37	20	20	doxorubicin	TP53BP1	PA449412	7158	0.768
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT176	22	22	10	10	midazolam	CYP3A	PA450496	1574	0.768
NULL	J_Hematol_Oncol_2011_Jan_21_4_5.nxml.txt.nlp	21255411	SENT164	11	11	5	5	paclitaxel	EGFR	PA450761	1956	0.768
NULL	J_Biol_Chem_2008_Oct_31_283(44)_29841-29846.nxml.txt.nlp	18765669	SENT149	5	5	14	14	suramin	P2X1	PA10292	5023	0.768
NULL	Cardiovasc_Diabetol_2013_Oct_17_12_150.nxml.txt.nlp	24134550	SENT107	33	33	4	4	metformin	activin	PA450395	83729	0.768
NULL	Mol_Pain_2012_Sep_22_8_71.nxml.txt.nlp	22998838	SENT183	21	21	2	2	paclitaxel	CB2	PA450761	1269	0.768
NULL	Case_Rep_Hematol_2014_Jun_16_2014_269359.nxml.txt.nlp	25031876	SENT24	27	27	18	18	vemurafenib	BRAF	PA165946873	673	0.768
NULL	J_Cell_Biol_2001_Dec_24_155(7)_1333-1344.nxml.txt.nlp	11748248	SENT547	3	3	23	23	collagenase	AP-1	PA449107	2353;3727;2354;3725	0.768
NULL	Eur_J_Clin_Pharmacol_2012_Jan_8_68(1)_29-37.nxml.txt.nlp	21739267	SENT135	15	15	17	17	paroxetine	PRX	PA450801	9588;57716	0.768
NULL	Clin_Psychopharmacol_Neurosci_2011_Apr_30_9(1)_36-43.nxml.txt.nlp	23431025	SENT88	7	7	3	3	haloperidol	FLI	PA449841	2314	0.768
NULL	Mol_Biol_Cell_2014_Jan_15_25(2)_257-266.nxml.txt.nlp	24227885	SENT250	2	2	0	0	nadh	SIRT2	PA164755085	22933	0.768
NULL	Osteoarthritis_Cartilage_2010_Apr_18(4)_555-562.nxml.txt.nlp	20060953	SENT143	8	8	21	21	clenbuterol	MNX	PA164745640	3892	0.768
NULL	Cardiovasc_Diabetol_2010_Oct_18_9_64.nxml.txt.nlp	20955583	SENT88	18	18	6	6	telmisartan	PPARgamma	PA451605	5468	0.768
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_650809.nxml.txt.nlp	23258995	SENT170	28	28	22	22	vasopressin	AQP3	PA451858	360	0.768
NULL	Br_J_Cancer_2003_Mar_24_88(6)_879-886.nxml.txt.nlp	12644825	SENT219	9	9	4	4	cisplatin	MRP1	PA449014	4437	0.768
NULL	Oncol_Rep_2013_May_4_29(5)_1683-1688.nxml.txt.nlp	23467693	SENT149	8	8	13	13	staurosporine	PARP1	PA165109623	142	0.768
NULL	Cancer_Med_2014_Jun_19_3(3)_555-564.nxml.txt.nlp	24648042	SENT188	32	32	3	3	cytarabine	SF3B1	PA449177	23451	0.768
NULL	Cholesterol_2013_Dec_10_2013_314170.nxml.txt.nlp	24386561	SENT111	28	28	21	21	atorvastatin	adiponectin	PA448500	9370	0.768
NULL	Br_J_Cancer_2011_Jul_26_105(3)_372-381.nxml.txt.nlp	21730979	SENT154	18	18	9	9	cisplatin	p53	PA449014	7157	0.768
NULL	Br_J_Ophthalmol_2008_Sep_22_92(9)_1275-1282.nxml.txt.nlp	18723745	SENT62	31	31	10	10	latanoprost	BAK	PA164774763	578	0.768
NULL	J_Cell_Biol_2001_Jul_9_154(1)_95-108.nxml.txt.nlp	11448993	SENT177	11	11	22	22	trypsin	OTC	PA451806	5009	0.768
NULL	Chemother_Res_Pract_2011_Apr_7_2011_393976.nxml.txt.nlp	22312553	SENT39	20	20	6	6	lumefantrine	CYP3A4	PA165111722	1576	0.768
NULL	Cancer_Cell_Int_2011_Aug_19_11_29.nxml.txt.nlp	21854619	SENT220	18	18	37	37	cisplatin	HDAC	PA449014	9734	0.768
NULL	Avicenna_J_Med_Biotechnol_2014_Jan-Mar_6(1)_10-20.nxml.txt.nlp	24523953	SENT17	3	3	17	17	trypsin	CD105	PA451806	2022	0.768
NULL	Crit_Care_2003_Mar_3_7(Suppl_2)_P223.nxml.txt.nlp	NULL	SENT16	4	4	17	17	furosemide	ANOVA	PA449719	4858	0.768
NULL	Neural_Regen_Res_2013_Jul_5_8(19)_1803-1813.nxml.txt.nlp	25206477	SENT158	0	0	23	23	cilostazol	Bcl-2	PA164746334	596	0.768
NULL	Eur_J_Clin_Pharmacol_2012_Jan_8_68(1)_29-37.nxml.txt.nlp	21739267	SENT97	7	7	17	17	aripiprazole	CYP2D6	PA10026	1565	0.768
NULL	J_Cell_Biol_2001_Apr_2_153(1)_207-220.nxml.txt.nlp	11285286	SENT128	5	5	8	8	carbachol	DGK	PA448784	8526;1607	0.768
NULL	Front_Physiol_2013_Mar_13_4_45.nxml.txt.nlp	23494712	SENT314	10	10	8	8	rifampin	MDR1	PA451250	5243	0.768
NULL	Hum_Genomics_2010_Oct_1_5(1)_61-72.nxml.txt.nlp	21106490	SENT155	26	26	19	19	simvastatin	CYP3A	PA451363	1574	0.768
NULL	Exp_Neurol_2013_Oct_248(100)_530-540.nxml.txt.nlp	23933576	SENT208	1	1	9	9	acetazolamide	ClC-1	PA448018	1180	0.768
NULL	Indian_J_Pharm_Sci_2013_Jul-Aug_75(4)_435-441.nxml.txt.nlp	24302798	SENT47	6	6	11	11	carrageenan	AAP	PA448814	5345	0.768
NULL	Nucleic_Acids_Res_2005_Oct_19_33(18)_5819-5828.nxml.txt.nlp	16237123	SENT171	26	26	44	44	cisplatin	HMGB1	PA449014	3146	0.768
NULL	Hematol_Rep_2011_Oct_28_3(3_Suppl)_e3.nxml.txt.nlp	22586511	SENT10	4	4	11	11	doxorubicin	CHOP	PA449412	1649	0.768
NULL	Oxid_Med_Cell_Longev_2013_Jul_9_2013_574029.nxml.txt.nlp	23936610	SENT263	4	4	6	6	resveratrol	RAGE		177	0.768
NULL	Case_Rep_Endocrinol_2014_Feb_10_2014_479641.nxml.txt.nlp	24660072	SENT63	11	11	47	47	cinacalcet	PTH	PA164776671	5741	0.768
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Feb_24_66(Pt_3)_o682-o683.nxml.txt.nlp	21580426	SENT76	0	0	24	24	orphenadrine	mol	PA450715	90527	0.768
NULL	Int_J_Med_Sci_2015_Jan_1_12(1)_78-82.nxml.txt.nlp	25552922	SENT26	11	11	0	0	omeprazole	CYP2C19	PA450704	1557	0.768
NULL	Nano_Rev_2010_Feb_22_1_10_3402_nano_v1i0_4883.nxml.txt.nlp	22110854	SENT159	1	1	32	32	iron	MRI	PA450087	78996	0.768
NULL	Breast_Cancer_Res_2011_Jan_11_13(1)_R3.nxml.txt.nlp	21223569	SENT177	1	1	4	4	etoposide	p53	PA449552	7157	0.768
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT106	16	16	9	9	capsaicin	p53	PA448776	7157	0.768
NULL	Mol_Cancer_2010_Apr_15_9_77.nxml.txt.nlp	20398291	SENT74	9	9	16	16	geldanamycin	Hsp90	PA152031327	3320	0.768
NULL	Free_Radic_Biol_Med_2012_Nov_1_53(9)_1770-1781.nxml.txt.nlp	22982051	SENT51	13	13	11	11	hydrocortisone	F12	PA449905	2161	0.768
NULL	Oncotarget_2011_Dec_24_2(12)_896-917.nxml.txt.nlp	22203527	SENT175	2	2	33	33	metformin	survivin	PA450395	332	0.768
NULL	Ther_Clin_Risk_Manag_2007_Mar_3(1)_133-148.nxml.txt.nlp	18360621	SENT15	17	17	30	30	infliximab	p75	PA452639	7133;11168	0.768
NULL	EPMA_J_2014_Feb_11_5(Suppl_1)_A26.nxml.txt.nlp	NULL	SENT23	14	14	3	3	imatinib	KIT	PA10804	3815	0.768
NULL	Genome_Med_2010_Aug_11_2(8)_53.nxml.txt.nlp	20701793	SENT133	22	22	14	14	paclitaxel	CERT	PA450761	10087	0.768
NULL	Osteoporos_Int_2010_Oct_18_21(10)_1657-1680.nxml.txt.nlp	20480148	SENT590	26	26	28	28	raloxifene	STAR	PA451221	6770;2984	0.768
NULL	Acta_Neuropathol_2015_Oct_17_129_115-131.nxml.txt.nlp	25322816	SENT274	21	21	15	15	bevacizumab	ANOVA	PA130232992	4858	0.768
NULL	J_Mol_Med_2011_Jul_23_89(7)_667-676.nxml.txt.nlp	21431325	SENT59	25	25	14	14	resveratrol	adiponectin		9370	0.768
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_11_2014_274786.nxml.txt.nlp	25505920	SENT246	7	7	36	36	cisplatin	ERCC1	PA449014	2067	0.768
NULL	Arthritis_Res_2002_May_9_4(Suppl_3)_S17-S24.nxml.txt.nlp	12110119	SENT107	9	9	11	11	infliximab	IL-18	PA452639	3606	0.768
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_4_2013_378657.nxml.txt.nlp	23662132	SENT75	13	13	8	8	liraglutide	GLP-1	PA165958364	100125288	0.768
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT285	2	2	4	4	atorvastatin	ATV	PA448500	4683	0.768
NULL	Oncotarget_2013_Nov_22_5(4)_933-943.nxml.txt.nlp	24659749	SENT93	2	2	14	14	nutlin-3	AML3		860	0.768
NULL	Breast_Cancer_Res_2011_Jun_10_13(3)_R60.nxml.txt.nlp	21663668	SENT97	31	31	2	2	cyclophosphamide	aromatase	PA449165	1588	0.768
NULL	Bioinformation_2012_Jan_6_8(1)_13-19.nxml.txt.nlp	22359429	SENT191	6	6	4	4	curcumin	MRP1	PA151958596	4437	0.768
NULL	Neural_Regen_Res_2013_Mar_25_8(9)_825-832.nxml.txt.nlp	25206730	SENT85	2	2	4	4	isoflurane	P2X7	PA450106	5027	0.768
NULL	Breast_Cancer_Res_2010_May_18_12(Suppl_1)_O5.nxml.txt.nlp	NULL	SENT9	0	0	19	19	vorinostat	CD44	PA164748224	960	0.768
NULL	J_Thromb_Haemost_2011_Oct_9(10)_2050-2056.nxml.txt.nlp	21794076	SENT131	10	10	16	16	prasugrel	ADP	PA154410481	23038	0.768
NULL	Environ_Health_Perspect_2013_May_22_121(5)_551-557.nxml.txt.nlp	23434795	SENT175	30	30	5	5	hyaluronan	BAL	PA165958431	83666	0.768
NULL	Oncoimmunology_2012_Nov_1_1(8)_1445-1447.nxml.txt.nlp	23243624	SENT45	33	33	10	10	bevacizumab	CD83	PA130232992	9308	0.768
NULL	Front_Immunol_2014_Apr_16_5_171.nxml.txt.nlp	24795718	SENT287	9	9	7	7	imiquimod	TLR7	PA449972	51284	0.768
NULL	Gastric_Cancer_2013_Jul_12_16(3)_345-354.nxml.txt.nlp	22968820	SENT18	20	20	8	8	oxaliplatin	FANCJ	PA131285527	83990	0.768
NULL	Int_J_Breast_Cancer_2011_Sep_6_2011_352182.nxml.txt.nlp	22295219	SENT64	8	8	4	4	trastuzumab	HER2	PA451743	2064	0.768
NULL	Contemp_Oncol_(Pozn)_2012_Nov_20_16(5)_401-406.nxml.txt.nlp	23788917	SENT162	16	16	10	10	ekb-569	EGFR		1956	0.768
NULL	Breast_Cancer_Res_2004_Jun_18_6(4)_179-180.nxml.txt.nlp	NULL	SENT41	19	19	2	2	celecoxib	aromatase	PA448871	1588	0.768
NULL	Br_J_Cancer_2010_Oct_12_103(8)_1309-1310.nxml.txt.nlp	NULL	SENT29	17	17	19	19	bevacizumab	IFN	PA130232992	3439	0.768
NULL	ScientificWorldJournal_2012_May_1_2012_520524.nxml.txt.nlp	22623908	SENT134	7	7	13	13	praziquantel	IFN	PA164764583	3439	0.768
NULL	Int_J_Endocrinol_Metab_2013_Jul_1_Summer_11(3)_184-190.nxml.txt.nlp	24348591	SENT82	15	15	0	0	paraformaldehyde	INS-1	PA450790	2305	0.768
NULL	J_Korean_Assoc_Oral_Maxillofac_Surg_2014_Dec_26_40(6)_291-296.nxml.txt.nlp	25551094	SENT126	4	4	14	14	alendronate	OPG	PA448082	690	0.768
NULL	AIDS_Res_Treat_2014_Nov_9_2014_724958.nxml.txt.nlp	25431661	SENT18	22	22	19	19	lopinavir	ATV	PA450264	4683	0.768
NULL	Clin_Exp_Metastasis_2013_May_15_30(7)_867-876.nxml.txt.nlp	23673558	SENT194	8	8	15	15	vemurafenib	BRAF	PA165946873	673	0.768
NULL	Clin_Sci_(Lond)_2009_Oct_2_118(Pt_1)_79-85.nxml.txt.nlp	19456294	SENT141	8	8	22	22	lipase	PLTP	PA450239	5360	0.768
NULL	Int_Clin_Psychopharmacol_2014_Jul_26_29(4)_206-211.nxml.txt.nlp	24374906	SENT84	20	20	11	11	venlafaxine	CYP2C9	PA451866	1559	0.768
NULL	Oncoscience_2014_Apr_30_1(4)_283-286.nxml.txt.nlp	25594020	SENT6	33	33	14	14	rituximab	BCL6	PA451261	604	0.768
NULL	J_Thromb_Haemost_2011_Oct_9(10)_2050-2056.nxml.txt.nlp	21794076	SENT126	17	17	13	13	prasugrel	P2Y12	PA154410481	64805	0.768
NULL	Breast_Cancer_Res_2013_Nov_29_15(6)_R114.nxml.txt.nlp	24289103	SENT252	19	19	10	10	tamoxifen	EGFR	PA451581	1956	0.768
NULL	Nat_Commun_2013_Oct_1_4_2516.nxml.txt.nlp	24084631	SENT50	5	5	18	18	losartan	CCN2	PA450268	1490	0.768
NULL	Front_Genet_2013_Aug_30_4_166.nxml.txt.nlp	24009623	SENT124	31	31	10	10	everolimus	PBX3	PA164746311	5090	0.768
NULL	Mol_Cancer_2010_Apr_29_9_95.nxml.txt.nlp	20429933	SENT105	14	14	10	10	cisplatin	p53	PA449014	7157	0.768
NULL	Int_J_Inflam_2011_Jul_12_2011_569416.nxml.txt.nlp	21785693	SENT44	34	34	15	15	trypsin	CO2	PA451806	4513	0.768
NULL	Acta_Pharmacol_Sin_2014_Sep_4_35(9)_1157-1166.nxml.txt.nlp	25088002	SENT104	0	0	24	24	curcumin	STAT3	PA151958596	6774	0.768
NULL	Bone_Marrow_Transplant_2014_Apr_27_49(4)_532-538.nxml.txt.nlp	24464142	SENT278	32	32	11	11	cyclosporine	NOT	PA449167	4929	0.768
NULL	Nanoscale_Res_Lett_2012_Feb_13_7(1)_119.nxml.txt.nlp	22330902	SENT36	22	22	1	1	molybdenum	TEM	PA450536	64102	0.768
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Apr_16_67(Pt_5)_m597.nxml.txt.nlp	21754317	SENT66	22	22	3	3	ethanol	NO3	PA448073	4681	0.768
NULL	Cancer_Causes_Control_2012_Oct_21_23(10)_1739-1744.nxml.txt.nlp	22907422	SENT20	38	38	10	10	sulindac	CRA	PA451565	51747;10903	0.768
NULL	Oncoscience_2014_Aug_7_1(8)_540-549.nxml.txt.nlp	25594061	SENT135	23	23	12	12	bevacizumab	EGFR	PA130232992	1956	0.768
NULL	Acta_Pharmacol_Sin_2012_Oct_3_33(10)_1311-1318.nxml.txt.nlp	22941289	SENT212	3	3	8	8	sorafenib	VEGFR2	PA7000	3791	0.768
NULL	Cell_Death_Dis_2013_Jun_27_4(6)_e694.nxml.txt.nlp	23807223	SENT85	5	5	12	12	chloroquine	HMGB1	PA448948	3146	0.768
NULL	Mol_Cancer_2014_Jun_26_13_158.nxml.txt.nlp	24965046	SENT201	22	22	13	13	paraformaldehyde	NK1	PA450790	11126	0.768
NULL	Cancers_(Basel)_2011_May_18_3(2)_2444-2461.nxml.txt.nlp	24212818	SENT724	6	6	0	0	urokinase	EGFR	PA451836	1956	0.768
NULL	J_Immunol_Res_2014_Nov_30_2014_342693.nxml.txt.nlp	25762441	SENT6	10	10	7	7	valsartan	AT1	PA451848	9197;185	0.768
NULL	Front_Neuroeng_2013_Nov_19_6_10.nxml.txt.nlp	24312049	SENT13	10	10	46	46	carbamazepine	BIC	PA448785	114614	0.768
NULL	Ann_Lab_Med_2013_May_17_33(3)_229-232.nxml.txt.nlp	23667855	SENT48	21	21	11	11	hydroxyurea	MPN	PA449942	83886	0.768
NULL	Arthritis_Rheum_2013_Sep_26_65(9)_2290-2300.nxml.txt.nlp	23740547	SENT205	20	20	10	10	doxycycline	S100A9	PA449415	6280	0.768
NULL	Oncol_Lett_2013_Jun_29_5(6)_1943-1947.nxml.txt.nlp	23833672	SENT159	0	0	14	14	celecoxib	AKT	PA448871	207	0.768
NULL	Cells_2012_Aug_21_1(3)_535-557.nxml.txt.nlp	24710489	SENT233	0	0	9	9	cetuximab	KRAS	PA10040	3845	0.768
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Sep_30_64(Pt_10)_o2048.nxml.txt.nlp	21201240	SENT60	25	25	14	14	ethanol	mol	PA448073	90527	0.768
NULL	Nucleic_Acids_Res_2012_Sep_26_40(17)_8499-8518.nxml.txt.nlp	22740652	SENT73	9	9	2	2	paraformaldehyde	VRK1	PA450790	7443	0.768
NULL	Mol_Cancer_2010_Aug_27_9_226.nxml.txt.nlp	20799951	SENT191	20	20	32	32	clofarabine	PRAME	PA164754863	23532	0.768
NULL	Ann_Thorac_Med_2008_Oct-Dec_3(4)_149-151.nxml.txt.nlp	19561898	SENT56	0	0	24	24	isoniazid	gamma	PA450112	9913	0.768
NULL	Tuberc_Respir_Dis_(Seoul)_2013_Nov_29_75(5)_188-198.nxml.txt.nlp	24348666	SENT42	0	0	11	11	gefitinib	HER2	PA131301952	2064	0.768
NULL	Pain_Res_Treat_2011_Aug_14_2011_864605.nxml.txt.nlp	22110933	SENT134	2	2	12	12	pregabalin	PLP	PA164754814	25824;5744	0.768
NULL	Cells_2014_Apr_29_3(2)_331-362.nxml.txt.nlp	24785347	SENT301	5	5	20	20	capsaicin	TRPV1	PA448776	7442	0.768
NULL	Indian_J_Ophthalmol_2011_May-Jun_59(3)_197-200.nxml.txt.nlp	21586839	SENT25	26	26	38	38	tropicamide	San	PA164749389	80218	0.768
NULL	Oncotarget_2014_Jun_19_5(15)_6540-6551.nxml.txt.nlp	25153728	SENT35	19	19	22	22	gemcitabine	p53	PA449748	7157	0.768
NULL	J_Vet_Med_Sci_2014_Oct_16_76(10)_1383-1387.nxml.txt.nlp	24931645	SENT67	2	2	9	9	sitagliptin	GLP-1	PA164748978	100125288	0.768
NULL	Acta_Pharmacol_Sin_2011_Jun_3_32(6)_817-823.nxml.txt.nlp	21642950	SENT142	0	0	8	8	propofol	HCN1	PA451141	348980	0.768
NULL	Mol_Cancer_2008_Mar_6_7_24.nxml.txt.nlp	18325101	SENT99	16	16	23	23	cisplatin	BRCA1	PA449014	672	0.768
NULL	Clin_Proteomics_2014_May_5_11(1)_18.nxml.txt.nlp	24872809	SENT54	25	25	13	13	galactose	SNA	PA449725	6615	0.768
NULL	Eur_Arch_Psychiatry_Clin_Neurosci_2010_Nov_14_260(Suppl_2)_81-89.nxml.txt.nlp	20945070	SENT169	0	0	6	6	olanzapine	NPY	PA450688	4852	0.768
NULL	Mol_Vis_2007_Jul_9_13_1083-1093.nxml.txt.nlp	17653053	SENT160	2	2	24	24	minocycline	IL-10	PA450519	3586	0.768
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Mar_24_68(Pt_4)_o1165-o1166.nxml.txt.nlp	22606110	SENT78	0	0	6	6	cinnarizine	mol	PA164749342	90527	0.768
NULL	Leukemia_2014_Jun_25_28(6)_1280-1288.nxml.txt.nlp	24270737	SENT211	20	20	9	9	decitabine	PD-L1	PA164749631	29126	0.768
NULL	J_Hematol_Oncol_2011_Nov_4_4_44.nxml.txt.nlp	22053759	SENT103	16	16	5	5	thrombin	PAR1	PA451674	79581;2149	0.768
NULL	Nat_Med_2012_May_18(5)_783-790.nxml.txt.nlp	22466704	SENT78	24	24	3	3	etoposide	HDAC4	PA449552	9759	0.768
NULL	J_Cell_Biol_1990_Dec_1_111(6)_2733-2745.nxml.txt.nlp	2277084	SENT18	11	11	6	6	heparin	CS1	PA449855	57823	0.768
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT206	9	9	5	5	sitagliptin	HIP	PA164748978	6767;6159;64399;5068	0.768
NULL	Breast_Cancer_Res_2010_May_18_12(Suppl_1)_P45.nxml.txt.nlp	NULL	SENT10	23	23	27	27	estradiol	FKBPL	PA449503	63943	0.768
NULL	Cell_Death_Dis_2014_Jul_3_5(7)_e1316.nxml.txt.nlp	24991768	SENT71	14	14	12	12	pemetrexed	Mcl-1	PA10810	4170	0.768
NULL	Br_J_Cancer_2013_May_14_108(9)_1862-1869.nxml.txt.nlp	23579219	SENT83	5	5	2	2	bevacizumab	ANXA11	PA130232992	311	0.768
NULL	Semin_Immunopathol_2013_May_10_35(3)_351-373.nxml.txt.nlp	23572207	SENT368	9	9	15	15	bortezomib	IRE1	PA10252	2081	0.768
NULL	Front_Behav_Neurosci_2014_Oct_30_8_366.nxml.txt.nlp	25400560	SENT141	16	16	1	1	ethanol	ANOVA	PA448073	4858	0.768
NULL	Child_Adolesc_Psychiatry_Ment_Health_2013_Jun_19_7_19.nxml.txt.nlp	23777626	SENT135	44	44	12	12	methylphenidate	ATX	PA450464	5168;23049	0.768
NULL	Reprod_Biol_Endocrinol_2003_Aug_27_1_59.nxml.txt.nlp	12967350	SENT16	7	7	9	9	estradiol	XIAP	PA449503	331	0.768
NULL	J_Oncol_2013_Feb_17_2013_872957.nxml.txt.nlp	23476648	SENT110	34	34	8	8	cisplatin	SFN	PA449014	25996;2810	0.768
NULL	Oncol_Lett_2014_Jan_6_7(1)_255-259.nxml.txt.nlp	24348859	SENT93	16	16	27	27	capecitabine	DCX	PA448771	1641	0.768
NULL	Clin_Interv_Aging_2013_Jan_18_8_47-59.nxml.txt.nlp	23355775	SENT86	6	6	29	29	simvastatin	CYP3A4	PA451363	1576	0.768
NULL	Br_J_Pharmacol_2008_Oct_18_155(4)_596-605.nxml.txt.nlp	18852694	SENT16	2	2	10	10	fenofibrate	SREBP2	PA449594	6721	0.768
NULL	J_Gastrointest_Cancer_2010_Mar_28_41(1)_60-70.nxml.txt.nlp	19946763	SENT208	11	11	0	0	imatinib	LRG	PA10804	116844	0.768
NULL	Oncoimmunology_2014_Jan_17_3_e27574.nxml.txt.nlp	24800167	SENT18	13	13	6	6	cyclophosphamide	CD4	PA449165	920	0.768
NULL	J_Cell_Biol_2008_Jul_28_182(2)_327-340.nxml.txt.nlp	18644889	SENT51	0	0	17	17	estradiol	CRM1	PA449503	7514	0.768
NULL	Br_J_Clin_Pharmacol_2012_Apr_7_73(4)_518-535.nxml.txt.nlp	22053916	SENT64	17	17	7	7	phenytoin	CYP2C9	PA450947	1559	0.768
NULL	Ann_Oncol_2014_Oct_18_25(10)_1871-1888.nxml.txt.nlp	25234545	SENT203	10	10	33	33	tamoxifen	aromatase	PA451581	1588	0.768
NULL	Breast_Cancer_(Auckl)_2012_Nov_19_6_191-207.nxml.txt.nlp	23226023	SENT278	16	16	44	44	carboplatin	HER-2	PA448803	2064	0.768
NULL	Br_J_Cancer_2009_Mar_24_100(6)_865-869.nxml.txt.nlp	19240721	SENT96	12	12	3	3	heparin	VEGF-A	PA449855	7422	0.768
NULL	J_Korean_Med_Sci_2011_Aug_27_26(8)_1001-1006.nxml.txt.nlp	21860549	SENT88	7	7	4	4	trastuzumab	HER-2	PA451743	2064	0.768
NULL	Cancer_Causes_Control_2013_Aug_18_24(8)_1605-1614.nxml.txt.nlp	23775025	SENT64	33	33	18	18	doxorubicin	CYP3A5	PA449412	1577	0.768
NULL	J_Inflamm_(Lond)_2006_Jul_12_3_10.nxml.txt.nlp	16834783	SENT107	14	14	7	7	mometasone	CXCR4	PA450541	7852	0.768
NULL	Ann_Rheum_Dis_2013_Dec_5_72(12)_1897-1904.nxml.txt.nlp	23918035	SENT252	19	19	32	32	tocilizumab	ACT	PA165292659	12;11332;9457;641455	0.768
NULL	Iran_J_Pharm_Res_2014_Summer_13(3)_819-833.nxml.txt.nlp	25276182	SENT269	8	8	5	5	docetaxel	HER2	PA449383	2064	0.768
NULL	Mol_Cancer_2012_Sep_11_11_66.nxml.txt.nlp	22966907	SENT353	15	15	0	0	collagenase	RUNX2	PA449107	860	0.768
NULL	Mol_Cancer_2010_Dec_20_9_317.nxml.txt.nlp	21172025	SENT33	24	24	9	9	trastuzumab	HER2	PA451743	2064	0.768
NULL	Neuropsychopharmacology_2009_May_1_34(6)_1443-1453.nxml.txt.nlp	18830237	SENT320	12	12	28	28	ethanol	hole	PA448073	80757	0.768
NULL	J_Carcinog_Mutagen_2013_Aug_5_Suppl_7_4.nxml.txt.nlp	25587491	SENT160	37	37	20	20	gefitinib	STAT3	PA131301952	6774	0.768
NULL	Breast_Cancer_Res_2008_Jun_3_10(3)_R49.nxml.txt.nlp	18522728	SENT163	13	13	6	6	tamoxifen	HER-2	PA451581	2064	0.768
NULL	J_Biol_Chem_2012_Dec_14_287(51)_43094-43107.nxml.txt.nlp	23118219	SENT504	3	3	8	8	hyaluronan	CD4	PA165958431	920	0.768
NULL	J_Headache_Pain_2009_Oct_5_10(5)_317-325.nxml.txt.nlp	19499287	SENT275	9	9	18	18	sumatriptan	5-HT1B	PA451566	3351	0.768
NULL	Evid_Based_Complement_Alternat_Med_2011_Feb_14_2011_248231.nxml.txt.nlp	19233878	SENT238	5	5	7	7	rosiglitazone	DBT	PA451283	1629	0.768
NULL	Pharmaceuticals_(Basel)_2012_Dec_4_5(12)_1332-1345.nxml.txt.nlp	24281339	SENT220	24	24	3	3	trypsin	COX2	PA451806	4513;5743	0.768
NULL	Exp_Ther_Med_2014_Sep_20_8(3)_968-972.nxml.txt.nlp	25120631	SENT134	2	2	8	8	naringin	FIB	PA151958360	2091	0.768
NULL	Osteoporos_Int_2011_Jan_1_22(1)_27-35.nxml.txt.nlp	20358360	SENT66	22	22	26	26	ibandronate	PTH	PA10270	5741	0.768
NULL	Acta_Pharmacol_Sin_2011_Jan_29_32(1)_38-44.nxml.txt.nlp	21113177	SENT117	10	10	13	13	chloroquine	LC3	PA448948	84557	0.768
NULL	Breast_Cancer_(Auckl)_2009_Apr_7_3_23-34.nxml.txt.nlp	21556247	SENT103	2	2	10	10	celecoxib	AKT	PA448871	207	0.768
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R91.nxml.txt.nlp	22541814	SENT20	7	7	11	11	thrombin	HO-1	PA451674	3162	0.768
NULL	Int_J_Nanomedicine_2009_Dec_29_4_289-297.nxml.txt.nlp	20054433	SENT33	6	6	11	11	ether	mol	PA449525	90527	0.768
NULL	Neural_Plast_2012_May_20_2012_124548.nxml.txt.nlp	22685676	SENT52	12	12	15	15	minocycline	FMR1	PA450519	2332	0.768
NULL	Breast_Cancer_Res_2005_Apr_8_7(4)_R436-R443.nxml.txt.nlp	15987448	SENT65	1	1	11	11	fluorescein	NB-3	PA164746009	27255	0.768
NULL	Exp_Diabetes_Res_2011_Jun_22_2011_279530.nxml.txt.nlp	21747825	SENT107	7	7	16	16	vildagliptin	GLP-1	PA165958346	100125288	0.768
NULL	Indian_J_Dermatol_2014_Nov-Dec_59(6)_630b.nxml.txt.nlp	25484410	SENT3	1	1	9	9	isotretinoin	B12	PA450128	7126;4709	0.768
NULL	Med_Sci_Monit_2013_Sep_9_19_751-756.nxml.txt.nlp	24019010	SENT20	17	17	19	19	lamivudine	LAM	PA450163	7249;7248	0.768
NULL	Mol_Vis_2011_Feb_1_17_332-340.nxml.txt.nlp	21297899	SENT230	30	30	35	35	telmisartan	DPI	PA451605	1832	0.768
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT172	34	34	10	10	atorvastatin	TNF	PA448500	7124	0.768
NULL	Endocr_Relat_Cancer_2013_Aug_20(5)_677-689.nxml.txt.nlp	23913484	SENT194	2	2	9	9	paclitaxel	IFN	PA450761	3439	0.768
NULL	Oncotarget_2011_Sep_8_2(9)_728-736.nxml.txt.nlp	21908901	SENT78	13	13	25	25	pertuzumab	EGFR		1956	0.768
NULL	Indian_J_Pharmacol_2014_Nov-Dec_46(6)_627-632.nxml.txt.nlp	25538335	SENT112	8	8	11	11	metformin	Q10	PA450395	27161	0.768
NULL	Oxid_Med_Cell_Longev_2012_Oct_24_2012_906252.nxml.txt.nlp	23150750	SENT648	35	35	24	24	lipase	Cocoa	PA450239	57658	0.768
NULL	J_Invest_Dermatol_2014_Jun_10_134(6)_1710-1717.nxml.txt.nlp	24326454	SENT123	6	6	4	4	imiquimod	TLR7	PA449972	51284	0.768
NULL	Neural_Dev_2009_Nov_2_4_41.nxml.txt.nlp	19883499	SENT217	35	35	9	9	l-glutamine	CO2	PA10090	4513	0.768
NULL	Gut_Liver_2014_Jan_5_8(1)_49-57.nxml.txt.nlp	24516701	SENT149	11	11	5	5	diclofenac	cPLA2	PA449293	10524	0.768
NULL	Hum_Mol_Genet_2013_Jul_1_22(13)_2705-2722.nxml.txt.nlp	23492669	SENT229	8	8	19	19	spermine	SAT1	PA164781199	6303;81539	0.768
NULL	Arthritis_Res_Ther_2005_Jan_12_7(2)_R256-R267.nxml.txt.nlp	15743472	SENT100	18	18	1	1	naphthol	CCR7	PA154081779	1236	0.768
NULL	Cancers_(Basel)_2014_Oct_24_6(4)_2187-2223.nxml.txt.nlp	25347122	SENT699	12	12	35	35	methotrexate	MA5	PA450428	29944	0.768
NULL	Int_Neurourol_J_2014_Sep_24_18(3)_115-125.nxml.txt.nlp	25279238	SENT112	2	2	11	11	berberine	CA1	PA165860812	759	0.768
NULL	Acta_Pharmacol_Sin_2014_Aug_7_35(8)_1015-1022.nxml.txt.nlp	24998256	SENT121	14	14	23	23	ethanol	ALDH2	PA448073	217	0.768
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT194	30	30	42	42	adalimumab	CD36	PA10004	948	0.768
NULL	Cell_Cycle_2013_Sep_1_12(17)_2876-2887.nxml.txt.nlp	23966160	SENT130	34	34	12	12	paclitaxel	TUBGCP3	PA450761	10426	0.768
NULL	Br_J_Pharmacol_2008_Nov_11_155(6)_896-905.nxml.txt.nlp	18695641	SENT195	4	4	13	13	raloxifene	OPG	PA451221	690	0.768
NULL	Mol_Cancer_2007_Sep_26_6_61.nxml.txt.nlp	17894897	SENT109	0	0	8	8	etoposide	p53	PA449552	7157	0.768
NULL	Leukemia_2013_Feb_3_27(2)_315-324.nxml.txt.nlp	22751450	SENT191	5	5	10	10	sorafenib	Mcl-1	PA7000	4170	0.768
NULL	Cancers_(Basel)_2013_Dec_27_6(1)_67-78.nxml.txt.nlp	24378752	SENT57	32	32	17	17	etoposide	p53	PA449552	7157	0.768
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT214	12	12	8	8	curcumin	DR4	PA151958596	8797	0.768
NULL	Int_J_Mol_Imaging_2011_Oct_26_2011_874585.nxml.txt.nlp	21490735	SENT128	26	26	19	19	docetaxel	FDG	PA449383	23583	0.768
NULL	Cell_Death_Differ_2010_Apr_16_17(4)_666-676.nxml.txt.nlp	19834494	SENT269	26	26	4	4	melphalan	RAGE	PA450354	177	0.768
NULL	Ann_Rheum_Dis_2008_Nov_24_68(7)_1086-1093.nxml.txt.nlp	19033291	SENT178	23	23	10	10	methotrexate	AST	PA450428	26503	0.768
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jan_18_68(Pt_2)_o448.nxml.txt.nlp	22347059	SENT71	23	23	10	10	phenol	mol	PA450913	90527	0.768
NULL	Indian_J_Dermatol_2014_Sep-Oct_59(5)_460-464.nxml.txt.nlp	25284850	SENT81	16	16	12	12	cosyntropin	ACTH	PA164749052	5443	0.768
NULL	Br_J_Cancer_2012_Jul_24_107(3)_435-441.nxml.txt.nlp	22767144	SENT28	8	8	32	32	cisplatin	TTP	PA449014	7538;11093	0.768
NULL	J_Gen_Physiol_2000_Jun_1_115(6)_685-696.nxml.txt.nlp	10828243	SENT8	18	18	38	38	genistein	OLF	PA165109660	83857	0.768
NULL	Diabetes_2013_Jun_17_62(6)_1865-1875.nxml.txt.nlp	23423567	SENT155	22	22	4	4	doxycycline	PAK1	PA449415	5585;5058	0.768
NULL	Acta_Oncol_2014_Oct_9_53(10)_1347-1355.nxml.txt.nlp	24909504	SENT123	31	31	8	8	doxorubicin	TP53	PA449412	7157	0.768
NULL	Oncol_Lett_2014_May_11_7(5)_1401-1408.nxml.txt.nlp	24765145	SENT156	2	2	9	9	paclitaxel	PI3K	PA450761	5290	0.768
NULL	Acta_Oncol_2014_Oct_9_53(10)_1347-1355.nxml.txt.nlp	24909504	SENT123	31	31	20	20	doxorubicin	TP53	PA449412	7157	0.768
NULL	J_Hematol_Oncol_2013_Feb_17_6_17.nxml.txt.nlp	23414938	SENT173	0	0	19	19	prasugrel	VASP	PA154410481	7408	0.768
NULL	Surg_Today_2012_Jan_6_42(1)_8-28.nxml.txt.nlp	22139128	SENT230	37	37	39	39	tegafur	PSK	PA452620	9344	0.768
NULL	Blood_Cancer_J_2014_Jan_10_4(1)_e171.nxml.txt.nlp	24413065	SENT3	9	9	6	6	clofarabine	Gem	PA164754863	51053	0.768
NULL	Cancer_Manag_Res_2011_Mar_3_3_57-64.nxml.txt.nlp	21556317	SENT165	7	7	20	20	docetaxel	A30	PA449383	28937	0.768
NULL	Exp_Diabetes_Res_2012_Oct_15_2012_465282.nxml.txt.nlp	23118742	SENT133	14	14	12	12	metformin	FGF21	PA450395	26291	0.768
NULL	Oxid_Med_Cell_Longev_2013_Apr_21_2013_412576.nxml.txt.nlp	23710286	SENT247	15	15	5	5	curcumin	NRF1	PA151958596	4899;4779	0.768
NULL	Int_J_Mol_Sci_2014_Sep_25_15(9)_17065-17076.nxml.txt.nlp	25257528	SENT68	17	17	15	15	decitabine	DAC	PA164749631	13	0.768
NULL	EMBO_Mol_Med_2012_Sep_7_4(9)_896-909.nxml.txt.nlp	22887866	SENT153	1	1	19	19	lovastatin	ODC	PA450272	4953;89874	0.768
NULL	Cancer_Inform_2008_Apr_23_6_381-387.nxml.txt.nlp	19259418	SENT52	6	6	2	2	ribavirin	IFN	PA451241	3439	0.768
NULL	Oncotarget_2012_Sep_28_3(10)_1169-1181.nxml.txt.nlp	23045411	SENT130	0	0	7	7	doxorubicin	JIP1	PA449412	9479	0.767
NULL	Front_Chem_2014_Mar_14_2_12.nxml.txt.nlp	24790981	SENT152	15	15	22	22	curcumin	p300	PA151958596	2033	0.767
NULL	Semin_Immunopathol_2013_Jan_26_35(1)_39-52.nxml.txt.nlp	22829332	SENT197	33	33	18	18	rituximab	CHOP	PA451261	1649	0.767
NULL	J_Cell_Biol_1998_Jan_26_140(2)_335-345.nxml.txt.nlp	9442109	SENT80	0	0	6	6	chloroquine	NHE	PA448948	285335	0.767
NULL	Neuropsychopharmacology_2011_Apr_2_36(5)_1033-1046.nxml.txt.nlp	21289603	SENT370	11	11	27	27	ethanol	MSN	PA448073	4478	0.767
NULL	Ann_Rheum_Dis_2009_Jan_15_69(1)_301-304.nxml.txt.nlp	19147618	SENT74	21	21	16	16	infliximab	TWEAK	PA452639	8742	0.767
NULL	Cancer_Cell_Int_2003_Jul_15_3_11.nxml.txt.nlp	12904267	SENT97	25	25	10	10	vinblastine	p53	PA451877	7157	0.767
NULL	J_Hematol_Oncol_2012_Apr_25_5(Suppl_1)_A1.nxml.txt.nlp	22738713	SENT21	0	0	5	5	pertuzumab	HER2		2064	0.767
NULL	J_Cell_Biol_2004_Jun_21_165(6)_893-902.nxml.txt.nlp	15197174	SENT128	6	6	8	8	trifluoperazine	TFP	PA451771	7034	0.767
NULL	Genome_Biol_2005_Jan_31_6(2)_R11.nxml.txt.nlp	15693940	SENT143	27	27	24	24	nadh	AGGG	PA164755085	4708	0.767
NULL	J_Oncol_2009_Mar_24_2009_491985.nxml.txt.nlp	19325924	SENT94	20	20	7	7	genistein	CXCL12	PA165109660	6387	0.767
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT77	10	10	19	19	l-methionine	p27	PA450423	5715;10534	0.767
NULL	Mol_Biol_Int_2014_Sep_7_2014_852748.nxml.txt.nlp	25276427	SENT133	15	15	25	25	paclitaxel	HER2	PA450761	2064	0.767
NULL	Diabetes_2011_Mar_21_60(3)_757-765.nxml.txt.nlp	21282370	SENT118	0	0	6	6	isoproterenol	PTRF	PA450121	284119	0.767
NULL	Cancer_Inform_2007_Jun_6_2_329-343.nxml.txt.nlp	19458775	SENT182	20	20	13	13	vasopressin	ACTH	PA451858	5443	0.767
NULL	Oncol_Lett_2013_Mar_11_5(3)_1010-1016.nxml.txt.nlp	23426784	SENT147	13	13	9	9	midazolam	TRPM7	PA450496	54822	0.767
NULL	Oncologist_2010_Mar_3_15(3)_216-235.nxml.txt.nlp	20200040	SENT76	32	32	11	11	canertinib	HER-2	PA134687925	2064	0.767
NULL	Evid_Based_Complement_Alternat_Med_2011_Feb_20_2011_541209.nxml.txt.nlp	21799681	SENT102	4	4	10	10	curcumin	Bcl-2	PA151958596	596	0.767
NULL	Aging_(Albany_NY)_2009_Jun_3_1(6)_515-528.nxml.txt.nlp	20157535	SENT193	14	14	30	30	resveratrol	San		80218	0.767
NULL	Mol_Cancer_2012_Jul_12_11_45.nxml.txt.nlp	22788833	SENT12	5	5	20	20	cisplatin	EGFR	PA449014	1956	0.767
NULL	Breast_Cancer_Res_2010_Oct_22_12(Suppl_2)_S2.nxml.txt.nlp	21050423	SENT113	17	17	10	10	cyclophosphamide	ALDH3A1	PA449165	218	0.767
NULL	Int_J_Endocrinol_2013_May_2_2013_501851.nxml.txt.nlp	23737774	SENT24	7	7	9	9	diethylstilbestrol	DES	PA449307	1674	0.767
NULL	Br_J_Cancer_2012_May_8_106(10)_1587-1590.nxml.txt.nlp	22568998	SENT77	14	14	30	30	sunitinib	IFN	PA162372840	3439	0.767
NULL	J_Gen_Physiol_2008_Nov_132(5)_521-535.nxml.txt.nlp	18852303	SENT118	6	6	13	13	aprotinin	CAP2	PA448472	5271;10486	0.767
NULL	Mol_Biol_Cell_2014_Jul_1_25(13)_2116-2127.nxml.txt.nlp	24807908	SENT172	35	35	29	29	hemin	NAC	PA449849	22861	0.767
NULL	Clin_Ophthalmol_2008_Jun_2(2)_355-368.nxml.txt.nlp	19668727	SENT81	9	9	18	18	nepafenac	COX	PA165958407	1351	0.767
NULL	Korean_J_Anesthesiol_2013_May_24_64(5)_420-425.nxml.txt.nlp	23741564	SENT72	29	29	0	0	esmolol	EPI	PA449500	7035	0.767
NULL	Oncol_Lett_2013_Feb_19_5(2)_583-587.nxml.txt.nlp	23420689	SENT112	16	16	2	2	cisplatin	p53	PA449014	7157	0.767
NULL	Oncotarget_2014_Oct_23_5(21)_10816-10829.nxml.txt.nlp	25333261	SENT181	7	7	4	4	doxorubicin	p53	PA449412	7157	0.767
NULL	Exp_Diabetes_Res_2011_Jun_20_2011_601047.nxml.txt.nlp	21747830	SENT88	30	30	20	20	exenatide	GLP-1	PA164749238	100125288	0.767
NULL	Cancer_Immunol_Immunother_2011_Jan_21_60(1)_75-85.nxml.txt.nlp	20857100	SENT159	6	6	14	14	fludarabine	TH1	PA449655	51497	0.767
NULL	J_Cell_Biol_1998_Apr_6_141(1)_5-20.nxml.txt.nlp	9531544	SENT116	4	4	1	1	dextran	mol	PA449261	90527	0.767
NULL	Clin_Med_Insights_Oncol_2013_Aug_12_7_181-197.nxml.txt.nlp	23997579	SENT157	25	25	29	29	cytarabine	CR1	PA449177	1378	0.767
NULL	Front_Genet_2014_Jun_4_5_167.nxml.txt.nlp	24926315	SENT185	45	45	30	30	methotrexate	DHFR	PA450428	1719	0.767
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_29_2013_327629.nxml.txt.nlp	23737827	SENT154	12	12	8	8	berberine	TPMT	PA165860812	7172	0.767
NULL	J_Hematol_Oncol_2014_Aug_1_7_52.nxml.txt.nlp	25085632	SENT140	14	14	22	22	sunitinib	EGFR	PA162372840	1956	0.767
NULL	Acta_Pharmacol_Sin_2010_Nov_18_31(11)_1447-1453.nxml.txt.nlp	20953204	SENT146	23	23	20	20	rimonabant	IL-6	PA152407999	3569	0.767
NULL	Mol_Brain_2014_Aug_21_7_59.nxml.txt.nlp	25139109	SENT83	24	24	3	3	chloroquine	HRH1	PA448948	3269;1659	0.767
NULL	F1000Prime_Rep_2014_Dec_1_6_117.nxml.txt.nlp	25580271	SENT143	3	3	17	17	erlotinib	EGFR	PA134687924	1956	0.767
NULL	AIDS_Res_Ther_2012_Mar_12_9_7.nxml.txt.nlp	22409770	SENT163	29	29	17	17	maraviroc	CCR5	PA164768835	1234	0.767
NULL	J_Physiol_2014_Nov_15_592(22)_5093-5107.nxml.txt.nlp	25239460	SENT248	5	5	8	8	sc-560	PAG		55824	0.767
NULL	Cancer_Cell_Int_2010_Apr_29_10_12.nxml.txt.nlp	20429927	SENT95	12	12	4	4	bortezomib	HRI	PA10252	27102	0.767
NULL	Oncotarget_2014_Feb_7_5(3)_775-787.nxml.txt.nlp	24519956	SENT113	22	22	8	8	dasatinib	PC3	PA162372878	57332;7832;5122	0.767
NULL	Anticancer_Agents_Med_Chem_2012_Feb_12(2)_163-171.nxml.txt.nlp	22043994	SENT242	15	15	19	19	cetuximab	KRAS	PA10040	3845	0.767
NULL	Mol_Cancer_2007_Jun_8_6_40.nxml.txt.nlp	17559677	SENT163	27	27	8	8	paclitaxel	BPHL	PA450761	670	0.767
NULL	Iran_J_Public_Health_2012_Jan_31_41(1)_59-65.nxml.txt.nlp	23113123	SENT133	8	8	25	25	lipase	HDL2	PA450239	57338	0.767
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT216	6	6	14	14	nutlin-3	TRAIL		8743	0.767
NULL	Oncoscience_2014_Mar_31_1(3)_216-228.nxml.txt.nlp	25594014	SENT312	3	3	12	12	curcumin	STAT3	PA151958596	6774	0.767
NULL	J_Geriatr_Cardiol_2014_Mar_11(1)_63-73.nxml.txt.nlp	24748884	SENT149	16	16	13	13	fenoldopam	DR5	PA164784034	8795	0.767
NULL	J_Gerontol_A_Biol_Sci_Med_Sci_2014_Jun_8_69(Suppl_1)_S21-S27.nxml.txt.nlp	24833582	SENT254	1	1	12	12	resveratrol	SIRT1		23411	0.767
NULL	F1000_Med_Rep_2012_Mar_1_4_5.nxml.txt.nlp	22403586	SENT55	17	17	19	19	tocilizumab	IL-6	PA165292659	3569	0.767
NULL	Front_Neurosci_2011_Jan_25_5_6.nxml.txt.nlp	21283532	SENT12	16	16	2	2	choline	c-Jun	PA448976	3725	0.767
NULL	Bone_Marrow_Transplant_2013_Jul_21_48(7)_947-952.nxml.txt.nlp	23334272	SENT188	14	14	9	9	isotretinoin	GM-CSF	PA450128	1437	0.767
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT371	0	0	15	15	cisplatin	GADD45	PA449014	1647	0.767
NULL	J_Inflamm_(Lond)_2006_Jul_12_3_10.nxml.txt.nlp	16834783	SENT24	27	27	17	17	mometasone	IL-5	PA450541	3567	0.767
NULL	Mol_Vis_2011_Dec_24_17_3384-3391.nxml.txt.nlp	22219634	SENT104	3	3	16	16	mannitol	TLR2	PA450320	7097	0.767
NULL	eLife_2013_Oct_29_2_e01236.nxml.txt.nlp	24171104	SENT510	13	13	15	15	bortezomib	HSF1	PA10252	3297	0.767
NULL	Case_Rep_Endocrinol_2014_Nov_6_2014_693294.nxml.txt.nlp	25431697	SENT36	27	27	16	16	vasopressin	PRL	PA451858	5617	0.767
NULL	Acta_Pharmacol_Sin_2009_Jul_22_30(7)_956-964.nxml.txt.nlp	19543298	SENT180	9	9	11	11	atorvastatin	ABCC2	PA448500	1244	0.767
NULL	J_Hematol_Oncol_2012_Feb_14_5_3.nxml.txt.nlp	22333219	SENT149	11	11	31	31	vemurafenib	BRAF	PA165946873	673	0.767
NULL	Reprod_Biol_Endocrinol_2003_Feb_14_1_22.nxml.txt.nlp	12646054	SENT172	32	32	4	4	estradiol	aromatase	PA449503	1588	0.767
NULL	J_Hematol_Oncol_2011_Jan_21_4_5.nxml.txt.nlp	21255411	SENT152	26	26	9	9	paclitaxel	EGFR	PA450761	1956	0.767
NULL	Nat_Commun_2014_Aug_6_5_4602.nxml.txt.nlp	25098764	SENT507	18	18	7	7	rosiglitazone	IL-6	PA451283	3569	0.767
NULL	Aging_(Albany_NY)_2010_Sep_18_2(9)_535-537.nxml.txt.nlp	20876940	SENT16	6	6	17	17	doxorubicin	MTOR	PA449412	2475	0.767
NULL	Lab_Invest_2013_Dec_14_93(12)_1265-1275.nxml.txt.nlp	24126890	SENT299	2	2	10	10	celecoxib	ZO-1	PA448871	7082	0.767
NULL	Case_Rep_Neurol_2011_Oct_14_3(3)_258-262.nxml.txt.nlp	22114583	SENT66	2	2	8	8	mirtazapine	5-HT2A	PA450522	3356	0.767
NULL	Nucleic_Acids_Res_2012_Sep_8_40(16)_8059-8071.nxml.txt.nlp	22684629	SENT254	15	15	19	19	forskolin	U2AF65	PA146096022	11338	0.767
NULL	Daru_2013_Dec_20_21(1)_78.nxml.txt.nlp	24359941	SENT10	14	14	6	6	gentamicin	EPO	PA449753	7076;8288;2056	0.767
NULL	Pharmaceuticals_(Basel)_2013_Aug_21_6(8)_988-1038.nxml.txt.nlp	24276379	SENT2679	15	15	2	2	cetuximab	KRAS	PA10040	3845	0.767
NULL	Nat_Commun_2014_Nov_25_5_5548.nxml.txt.nlp	25420520	SENT46	14	14	30	30	docetaxel	ERG	PA449383	2078	0.767
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT193	31	31	12	12	perifosine	DR4	PA165291471	8797	0.767
NULL	J_Hematol_Oncol_2013_Jan_4_6_1.nxml.txt.nlp	23286345	SENT71	6	6	29	29	trastuzumab	FCGR3A	PA451743	2214	0.767
NULL	Curr_Med_Chem_2013_Jan_20(3)_438-447.nxml.txt.nlp	23157636	SENT115	13	13	4	4	risperidone	FGA	PA451257	2243	0.767
NULL	ScientificWorldJournal_2012_Sep_17_2012_637953.nxml.txt.nlp	23028251	SENT267	2	2	4	4	oxytetracycline	OTC	PA450757	5009	0.767
NULL	Breast_Cancer_Res_2014_Jul_24_16(4)_411.nxml.txt.nlp	25056669	SENT173	29	29	14	14	tamoxifen	CC3	PA451581	10553	0.767
NULL	Antibiotics_(Basel)_2014_Jul_1_3(3)_285-316.nxml.txt.nlp	25364574	SENT180	18	18	9	9	cefoxitin	IMP-1	PA448856	10642	0.767
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1063.nxml.txt.nlp	24556678	SENT44	1	1	11	11	thioridazine	Mcl-1	PA451666	4170	0.767
NULL	Nucleic_Acids_Res_2011_Dec_2_39(22)_9620-9632.nxml.txt.nlp	21890905	SENT471	23	23	8	8	cisplatin	XPA	PA449014	7507	0.767
NULL	Acta_Orthop_2010_Apr_6_81(2)_234-236.nxml.txt.nlp	20367417	SENT1	1	1	6	6	teriparatide	PTH	PA451620	5741	0.767
NULL	J_Biomed_Biotechnol_2011_Dec_6_2011_856985.nxml.txt.nlp	21188173	SENT294	29	29	32	32	tamoxifen	aromatase	PA451581	1588	0.767
NULL	Leukemia_2013_Jan_11_27(1)_32-40.nxml.txt.nlp	22781593	SENT113	19	19	5	5	ponatinib	FGFR1	PA165980594	2260	0.767
NULL	Breast_Cancer_Res_2004_Oct_6_6(6)_262-268.nxml.txt.nlp	15535857	SENT148	10	10	43	43	tipifarnib	aromatase	PA165110778	1588	0.767
NULL	Nat_Commun_2013_4_2598.nxml.txt.nlp	24121673	SENT19	7	7	16	16	cyclophosphamide	CHOP	PA449165	1649	0.767
NULL	Oncol_Lett_2014_May_11_7(5)_1401-1408.nxml.txt.nlp	24765145	SENT120	23	23	32	32	paclitaxel	HIF-1	PA450761	29072	0.767
NULL	Diabetes_2011_Nov_17_60(11)_2810-2819.nxml.txt.nlp	21911750	SENT299	0	0	10	10	metformin	IL-6	PA450395	3569	0.767
NULL	ACS_Med_Chem_Lett_2014_Mar_13_5(3)_214-220.nxml.txt.nlp	24672647	SENT22	15	15	4	4	ribavirin	IFN	PA451241	3439	0.767
NULL	Hum_Mol_Genet_2013_Jul_1_22(13)_2676-2688.nxml.txt.nlp	23474818	SENT77	28	28	34	34	doxycycline	FUS	PA449415	2521	0.767
NULL	Acta_Pharmacol_Sin_2010_Aug_5_31(8)_970-976.nxml.txt.nlp	20686521	SENT27	15	15	12	12	ifosfamide	CDP	PA449964	1523	0.767
NULL	Structure_2013_Jun_4_21(6)_1051-1058.nxml.txt.nlp	23665170	SENT129	24	24	20	20	oxygen	hole	PA450744	80757	0.767
NULL	Acta_Orthop_2011_Apr_5_82(2)_211-216.nxml.txt.nlp	21434784	SENT50	14	14	25	25	doxorubicin	CDP	PA449412	1523	0.767
NULL	Genome_Announc_2013_Nov_14_1(6)_e00953-13.nxml.txt.nlp	24233593	SENT9	25	25	23	23	arsenite	CO2	PA452638	4513	0.767
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT49	26	26	11	11	paclitaxel	CYP2C9	PA450761	1559	0.767
NULL	Evid_Based_Complement_Alternat_Med_2013_May_13_2013_506324.nxml.txt.nlp	23818927	SENT184	7	7	9	9	doxorubicin	SHP-2	PA449412	5781	0.767
NULL	Oncogene_2010_Sep_16_29(37)_5159-5170.nxml.txt.nlp	20562917	SENT26	23	23	17	17	gefitinib	EGF	PA131301952	1950	0.767
NULL	Biologics_2009_Sep_15_3_419-428.nxml.txt.nlp	19774209	SENT30	10	10	4	4	gefitinib	EGFR	PA131301952	1956	0.767
NULL	Breast_Cancer_Res_2009_Nov_18_11(6)_R85.nxml.txt.nlp	19922614	SENT187	40	40	34	34	tamoxifen	BCS	PA451581	617	0.767
NULL	J_Oncol_2010_Nov_19_2010_568938.nxml.txt.nlp	20037743	SENT313	43	43	36	36	bevacizumab	VEGFR	PA130232992	3791	0.767
NULL	Mol_Cancer_2013_Mar_2_12_16.nxml.txt.nlp	23452820	SENT13	2	2	11	11	chloroquine	NOXA	PA448948	5366	0.767
NULL	Ann_Surg_Oncol_2007_Apr_26_14(4)_1499-1506.nxml.txt.nlp	17253101	SENT41	23	23	39	39	melphalan	gamma	PA450354	9913	0.767
NULL	Acta_Pharmacol_Sin_2014_Jun_5_35(6)_716-726.nxml.txt.nlp	24793311	SENT234	7	7	16	16	atorvastatin	PSD-95	PA448500	1742	0.767
NULL	Trials_2013_Sep_23_14_307.nxml.txt.nlp	24059911	SENT451	19	19	12	12	clindamycin	ACT	PA449035	12;11332;9457;641455	0.767
NULL	Ann_Rheum_Dis_2011_Apr_22_70(8)_1395-1400.nxml.txt.nlp	21515602	SENT185	22	22	16	16	warfarin	CYP4F2	PA451906	8529	0.767
NULL	Exp_Ther_Med_2014_Mar_17_7(3)_703-708.nxml.txt.nlp	24520271	SENT169	11	11	3	3	doxorubicin	IFN	PA449412	3439	0.767
NULL	Acta_Histochem_Cytochem_2012_Apr_26_45(2)_139-146.nxml.txt.nlp	22685356	SENT16	3	3	12	12	vasopressin	AQP2	PA451858	359	0.767
NULL	Mol_Pain_2013_Feb_15_9_3.nxml.txt.nlp	23413875	SENT71	4	4	17	17	resveratrol	TRPV1		7442	0.767
NULL	Mol_Biol_Rep_2013_Apr_4_40(4)_3429-3435.nxml.txt.nlp	23283741	SENT74	1	1	5	5	fosfomycin	VIII	PA164748039	1351	0.767
NULL	Eur_J_Immunol_2014_Jun_10_44(6)_1759-1769.nxml.txt.nlp	24595810	SENT139	17	17	9	9	fludrocortisone	CXCR4	PA164743961	7852	0.767
NULL	J_Cell_Biol_2001_Apr_2_153(1)_207-220.nxml.txt.nlp	11285286	SENT123	0	0	8	8	carbachol	DGK	PA448784	8526;1607	0.767
NULL	Cancer_Cell_Int_2005_Jul_24_5_22.nxml.txt.nlp	16042792	SENT138	7	7	4	4	vincristine	NAC	PA451879	22861	0.767
NULL	Eur_J_Clin_Pharmacol_2012_Jan_7_68(1)_55-64.nxml.txt.nlp	21735164	SENT275	5	5	9	9	oxycodone	CYP2D6	PA450741	1565	0.767
NULL	Cancer_Cell_Int_2009_Feb_17_9_4.nxml.txt.nlp	19222856	SENT224	23	23	9	9	paclitaxel	p53	PA450761	7157	0.767
NULL	Cancers_(Basel)_2014_Aug_12_6(3)_1631-1669.nxml.txt.nlp	25119536	SENT1220	2	2	4	4	imatinib	CXCR4	PA10804	7852	0.767
NULL	J_Immunother_Cancer_2014_Jan_27_2_2.nxml.txt.nlp	24829759	SENT195	23	23	15	15	sorafenib	IL-21	PA7000	59067;50616;27189	0.767
NULL	Genome_Biol_2003_Feb_3_4(2)_R11.nxml.txt.nlp	12620121	SENT277	5	5	1	1	vancomycin	Gen	PA451850	348654	0.767
NULL	Aging_(Albany_NY)_2009_Jul_30_1(7)_669-673.nxml.txt.nlp	20157548	SENT78	5	5	16	16	forskolin	SIRT1	PA146096022	23411	0.767
NULL	EMBO_Mol_Med_2012_Sep_7_4(9)_896-909.nxml.txt.nlp	22887866	SENT169	17	17	10	10	lovastatin	MYC	PA450272	4609	0.767
NULL	Protein_J_2012_Aug_5_31(6)_511-518.nxml.txt.nlp	22763563	SENT9	24	24	17	17	atorvastatin	MSR1	PA448500	4481	0.767
NULL	J_Clin_Biochem_Nutr_2011_Mar_26_48(2)_126-133.nxml.txt.nlp	21373265	SENT140	6	6	20	20	hemin	IL-17	PA449849	3605	0.767
NULL	Oncotarget_2014_Feb_7_5(3)_775-787.nxml.txt.nlp	24519956	SENT112	15	15	8	8	dasatinib	PC3	PA162372878	57332;7832;5122	0.767
NULL	Oncotarget_2012_May_19_3(5)_535-545.nxml.txt.nlp	22619121	SENT83	17	17	24	24	topotecan	B-MYB	PA451729	4605	0.767
NULL	Cancers_(Basel)_2013_Nov_7_5(4)_1456-1468.nxml.txt.nlp	24213559	SENT154	0	0	6	6	cabozantinib	AXL	PA165906891	558	0.767
NULL	Br_J_Cancer_2003_Mar_10_88(5)_788-795.nxml.txt.nlp	12618891	SENT164	3	3	22	22	bosentan	FasL	PA10034	356	0.767
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT35	19	19	6	6	phenprocoumon	CYP2C9	PA450921	1559	0.767
NULL	Nucleic_Acids_Res_2005_Dec_9_33(22)_6982-6991.nxml.txt.nlp	16340008	SENT157	38	38	8	8	chymotrypsin	ADP	PA448994	23038	0.767
NULL	Hematol_Rep_2011_Oct_10_3(2)_e16.nxml.txt.nlp	22184537	SENT71	12	12	5	5	warfarin	CYP3A4	PA451906	1576	0.767
NULL	Braz_J_Med_Biol_Res_2012_Mar_23_45(4)_366-375.nxml.txt.nlp	22437485	SENT183	20	20	45	45	naloxone	ETM	PA450586	2112	0.767
NULL	Diabetes_Care_2013_Jul_12_36(7)_2020-2026.nxml.txt.nlp	23536581	SENT115	14	14	29	29	metformin	ADM	PA450395	133	0.767
NULL	Drug_Des_Devel_Ther_2014_Oct_31_8_2121-2128.nxml.txt.nlp	25382970	SENT81	25	25	10	10	curcumin	TTR	PA151958596	7276	0.767
NULL	Oncotarget_2014_Sep_5_5(17)_7216.nxml.txt.nlp	25277174	SENT11	25	25	17	17	doxorubicin	STAT6	PA449412	6778	0.767
NULL	Cancer_Cell_Int_2014_Jan_23_14_6.nxml.txt.nlp	24456610	SENT214	20	20	3	3	resveratrol	p53		7157	0.767
NULL	BMB_Rep_2014_Apr_47(4)_221-226.nxml.txt.nlp	24286312	SENT131	24	24	9	9	nutlin-3	p53		7157	0.767
NULL	Adv_Ther_2014_Feb_15_31(3)_289-317.nxml.txt.nlp	24535623	SENT355	9	9	24	24	liraglutide	Met	PA165958364	79811	0.767
NULL	J_Vis_Exp_2014_Jul_4_(89)_51847.nxml.txt.nlp	25045833	SENT7	13	13	6	6	theophylline	CARS	PA451647	833	0.767
NULL	EJC_Suppl_2013_Sep_5_11(2)_307-309.nxml.txt.nlp	NULL	SENT102	0	0	12	12	erlotinib	EGFR	PA134687924	1956	0.767
NULL	Int_J_Mol_Sci_2014_May_9_15(5)_8186-8215.nxml.txt.nlp	24821541	SENT398	16	16	5	5	ethanol	ACR1	PA448073	25824	0.767
NULL	Neuroscience_2010_Jun_2_167(4)_1192-1204.nxml.txt.nlp	20303396	SENT558	1	1	28	28	capsaicin	ANOVA	PA448776	4858	0.767
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT189	31	31	27	27	phenprocoumon	CYP2C9	PA450921	1559	0.767
NULL	Cell_Death_Dis_2014_Feb_13_5(2)_e1055.nxml.txt.nlp	24525731	SENT328	19	19	32	32	cisplatin	TXNL1	PA449014	9352	0.767
NULL	Front_Neuroendocrinol_2014_Aug_35(3)_370-384.nxml.txt.nlp	24607323	SENT1553	15	15	17	17	estradiol	GDX	PA449503	8266	0.767
NULL	Eur_J_Clin_Pharmacol_2012_Sep_15_68(9)_1267-1274.nxml.txt.nlp	22418828	SENT76	8	8	5	5	pantoprazole	CYP2C19	PA450774	1557	0.767
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Nov_13_64(Pt_12)_o2320.nxml.txt.nlp	21581296	SENT59	20	20	35	35	ethanol	mol	PA448073	90527	0.767
NULL	Mol_Cancer_2009_Dec_3_8_115.nxml.txt.nlp	19958544	SENT72	6	6	20	20	nutlin-3	MDM2		4193	0.767
NULL	Oncoscience_2014_Jul_23_1(7)_486-503.nxml.txt.nlp	25594051	SENT173	9	9	17	17	rofecoxib	COX2	PA451268	4513;5743	0.767
NULL	Acta_Naturae_2013_Oct-Dec_5(4)_71-77.nxml.txt.nlp	24455185	SENT64	26	26	32	32	fluorescein	CD123	PA164746009	3563	0.767
NULL	J_Cardiothorac_Surg_2011_Feb_8_6_14.nxml.txt.nlp	21303502	SENT24	4	4	11	11	helium	CO2	PA449848	4513	0.767
NULL	Indian_J_Endocrinol_Metab_2013_Jan-Feb_17(1)_91-94.nxml.txt.nlp	23776858	SENT31	6	6	16	16	sitagliptin	GLP-1	PA164748978	100125288	0.767
NULL	J_Antimicrob_Chemother_2014_Feb_29_69(2)_368-374.nxml.txt.nlp	24080503	SENT143	38	38	33	33	sulfamethoxazole	DHPS	PA451544	1725	0.767
NULL	Front_Behav_Neurosci_2014_Sep_30_8_340.nxml.txt.nlp	25324748	SENT429	4	4	11	11	citalopram	STAR	PA449015	6770;2984	0.767
NULL	Arthritis_Rheum_2013_Sep_26_65(9)_2290-2300.nxml.txt.nlp	23740547	SENT224	12	12	4	4	doxycycline	DIP	PA449415	23151;1831	0.767
NULL	J_Inflamm_(Lond)_2006_Feb_22_3_2.nxml.txt.nlp	16504062	SENT167	14	14	16	16	bleomycin	BLM	PA448645	641	0.767
NULL	Support_Care_Cancer_2012_May_1_20(5)_941-949.nxml.txt.nlp	21533811	SENT27	23	23	28	28	palonosetron	HEC	PA10352	10403	0.767
NULL	Case_Rep_Oncol_Med_2013_Sep_26_2013_234391.nxml.txt.nlp	24191208	SENT58	18	18	11	11	capecitabine	HER2	PA448771	2064	0.767
NULL	Indian_J_Pharmacol_2008_Oct_40(Suppl_2)_S160-S171.nxml.txt.nlp	21593969	SENT184	0	0	7	7	indomethacin	COX	PA449982	1351	0.767
NULL	J_Gen_Physiol_2009_Apr_133(4)_421-438.nxml.txt.nlp	19289574	SENT230	22	22	19	19	glibenclamide	SLC26A9	PA449782	115019	0.767
NULL	Endocrinol_Diabetes_Metab_Case_Rep_2013_Sep_30_2013_130051.nxml.txt.nlp	24616777	SENT101	11	11	7	7	thyroglobulin	WBS	PA164754910	2006	0.767
NULL	Virol_J_2008_Sep_26_5_109.nxml.txt.nlp	18822145	SENT10	20	20	28	28	zanamivir	IMP	PA164740891	8315	0.767
NULL	Diabetes_Care_2012_Feb_16_35(2)_327-333.nxml.txt.nlp	22179958	SENT168	16	16	12	12	metformin	B12	PA450395	7126;4709	0.767
NULL	Indian_J_Pharm_Sci_2013_Nov-Dec_75(6)_680-687.nxml.txt.nlp	24591743	SENT31	8	8	15	15	gemfibrozil	CYP2C8	PA449750	1558	0.767
NULL	J_Cell_Biol_2001_May_28_153(5)_1049-1060.nxml.txt.nlp	11381089	SENT69	35	35	22	22	streptomycin	FBS	PA451512	64319;26269	0.767
NULL	Diabetes_2009_Dec_15_58(12)_2766-2775.nxml.txt.nlp	19755527	SENT233	10	10	15	15	glucose	PEPCK	PA449773	5106	0.767
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT52	1	1	11	11	bevacizumab	VEGF-A	PA130232992	7422	0.767
NULL	Cancer_Cell_Int_2012_Jul_18_12_34.nxml.txt.nlp	22809533	SENT181	21	21	32	32	cisplatin	CO2	PA449014	4513	0.767
NULL	Environ_Health_Perspect_2010_Jul_3_118(7)_936-942.nxml.txt.nlp	20199942	SENT46	5	5	0	0	arsenite	p53	PA452638	7157	0.767
NULL	Case_Rep_Gastroenterol_2012_Jul_31_6(2)_518-522.nxml.txt.nlp	22949891	SENT33	22	22	5	5	gemcitabine	CRT	PA449748	811	0.767
NULL	Br_J_Cancer_2012_Jul_10_107(2)_315-324.nxml.txt.nlp	22713656	SENT69	26	26	5	5	ethanol	MLL4	PA448073	;8085	0.767
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT8	6	6	18	18	methotrexate	MSH2	PA450428	4436	0.767
NULL	Pak_J_Med_Sci_2013_May-Jun_29(3)_768-772.nxml.txt.nlp	24353625	SENT38	17	17	9	9	ceftazidime	hole	PA448861	80757	0.767
NULL	Acta_Pharmacol_Sin_2012_May_4_33(5)_710-716.nxml.txt.nlp	22555373	SENT13	8	8	12	12	diazepam	DOM	PA449283	6663	0.767
NULL	Breast_Cancer_Res_2012_May_3_14(3)_R71.nxml.txt.nlp	22554015	SENT44	22	22	27	27	trastuzumab	HER2	PA451743	2064	0.767
NULL	Int_J_Endocrinol_2013_Jun_16_2013_290734.nxml.txt.nlp	23843787	SENT74	21	21	13	13	pioglitazone	CTX	PA450970	1593	0.767
NULL	Anal_Chem_Insights_2014_Mar_2_9_1-7.nxml.txt.nlp	24634579	SENT139	16	16	8	8	ethanol	SLB	PA448073	26160	0.767
NULL	Clinics_(Sao_Paulo)_2013_Feb_68(2)_253-262.nxml.txt.nlp	23525324	SENT221	29	29	23	23	genistein	Gen	PA165109660	348654	0.767
NULL	Mol_Biol_Cell_2012_Jul_1_23(13)_2571-2582.nxml.txt.nlp	22573884	SENT288	3	3	12	12	fluorescein	San	PA164746009	80218	0.767
NULL	Pharmaceuticals_(Basel)_2013_Oct_11_6(10)_1304-1321.nxml.txt.nlp	24275851	SENT454	0	0	33	33	liraglutide	San	PA165958364	80218	0.767
NULL	Oncol_Rep_2013_Oct_24_30(4)_1587-1592.nxml.txt.nlp	23900512	SENT129	17	17	8	8	tranylcypromine	NOXA	PA451741	5366	0.767
NULL	J_Res_Med_Sci_2011_May_16(5)_611-620.nxml.txt.nlp	22091283	SENT6	21	21	18	18	desflurane	DES	PA164749136	1674	0.767
NULL	Mol_Cancer_2008_Sep_12_7_69.nxml.txt.nlp	18789131	SENT96	3	3	6	6	pp2	EGFR		1956	0.767
NULL	Diabetes_Care_2009_Apr_8_32(4)_720-725.nxml.txt.nlp	19131464	SENT121	17	17	28	28	metformin	ACR	PA450395	49	0.767
NULL	Acta_Pharmacol_Sin_2011_Jan_29_32(1)_38-44.nxml.txt.nlp	21113177	SENT147	18	18	7	7	chloroquine	LC3	PA448948	84557	0.767
NULL	Breast_Cancer_Res_2014_Jun_18_16(3)_212.nxml.txt.nlp	NULL	SENT152	24	24	16	16	estradiol	LAS	PA449503	11019	0.767
NULL	Mol_Cell_Endocrinol_2013_Jan_30_365(2)_303-308.nxml.txt.nlp	23178796	SENT152	8	8	14	14	rimonabant	ghrelin	PA152407999	51738	0.767
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_24_2012_673132.nxml.txt.nlp	23133498	SENT124	3	3	11	11	berberine	CYP3A4	PA165860812	1576	0.767
NULL	Oncotarget_2013_Nov_22_5(4)_933-943.nxml.txt.nlp	24659749	SENT56	20	20	23	23	nutlin-3	AML2		864	0.767
NULL	Orphanet_J_Rare_Dis_2014_Dec_10_9(1)_180.nxml.txt.nlp	NULL	SENT214	28	28	20	20	glucosamine	HGSNAT	PA164747613	138050	0.767
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT53	8	8	1	1	tariquidar	MRP7		89845;1080	0.767
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1542-1553.nxml.txt.nlp	21970874	SENT167	3	3	22	22	carboplatin	EGFR	PA448803	1956	0.767
NULL	J_Biol_Chem_2013_Apr_26_288(17)_11865-11876.nxml.txt.nlp	23449983	SENT292	4	4	13	13	vanillin	CXCL12	PA451852	6387	0.767
NULL	J_Med_Case_Rep_2014_Apr_3_8_113.nxml.txt.nlp	24708915	SENT55	11	11	17	17	doxorubicin	CHOP	PA449412	1649	0.767
NULL	Appl_Plant_Sci_2015_Jan_5_3(1)_apps_1400086.nxml.txt.nlp	25606353	SENT86	15	15	12	12	vancomycin	ANOVA	PA451850	4858	0.767
NULL	Biosci_Rep_2013_Aug_2_33(4)_e00055.nxml.txt.nlp	23802190	SENT29	24	24	42	42	nebivolol	p47phox	PA151958426	653361	0.767
NULL	Exp_Diabetes_Res_2012_Apr_17_2012_635472.nxml.txt.nlp	22577369	SENT74	3	3	6	6	exenatide	adiponectin	PA164749238	9370	0.767
NULL	Iran_J_Reprod_Med_2012_Jan_10(1)_33-40.nxml.txt.nlp	25242972	SENT182	7	7	4	4	letrozole	aromatase	PA450196	1588	0.767
NULL	Allergy_Asthma_Clin_Immunol_2008_Sep_15_4(3)_111-116.nxml.txt.nlp	20525132	SENT110	10	10	33	33	clarithromycin	IL-5	PA449028	3567	0.767
NULL	Front_Endocrinol_(Lausanne)_2011_Aug_29_2_24.nxml.txt.nlp	22654798	SENT186	6	6	4	4	teriparatide	PTH	PA451620	5741	0.767
NULL	BMJ_2014_Apr_15_348_g2366.nxml.txt.nlp	24736555	SENT400	0	0	5	5	liraglutide	GLP-1	PA165958364	100125288	0.767
NULL	Arthritis_Res_Ther_2009_Jun_29_11(3)_R100.nxml.txt.nlp	19563672	SENT224	24	24	30	30	infliximab	IFN	PA452639	3439	0.767
NULL	Cancers_(Basel)_2011_Mar_3_3(1)_1042-1080.nxml.txt.nlp	24212653	SENT374	9	9	36	36	genistein	GPR78	PA165109660	27201	0.767
NULL	Cancer_Cell_2007_Dec_11_12(6)_514-527.nxml.txt.nlp	18068629	SENT189	15	15	9	9	paclitaxel	Rho	PA450761	29984	0.767
NULL	Indian_J_Nucl_Med_2014_Jul-Sep_29(3)_175-176.nxml.txt.nlp	25210287	SENT29	30	30	12	12	octreotide	spatial	PA450678	219793	0.767
NULL	Cell_Death_Dis_2013_Jul_4_4(7)_e702.nxml.txt.nlp	23828565	SENT67	25	25	41	41	etoposide	TRAIL	PA449552	8743	0.767
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Sep_27_64(Pt_10)_o2032.nxml.txt.nlp	21201226	SENT61	25	25	14	14	ethanol	mol	PA448073	90527	0.767
NULL	J_Oncol_2010_May_11_2010_659231.nxml.txt.nlp	20467564	SENT54	4	4	7	7	tetracycline	Ang2	PA451640	285	0.767
NULL	Cell_Death_Dis_2010_Nov_18_1(11)_e102.nxml.txt.nlp	21368867	SENT55	6	6	3	3	gentamicin	CLIMP-63	PA449753	10970	0.767
NULL	Nucleic_Acids_Res_2013_May_3_41(10)_5413-5427.nxml.txt.nlp	23558745	SENT109	31	31	9	9	kanamycin	SOC	PA450137	91544	0.767
NULL	J_Clin_Biochem_Nutr_2009_Jul_30_45(1)_9-13.nxml.txt.nlp	19590701	SENT44	16	16	5	5	lansoprazole	HO-1	PA450180	3162	0.767
NULL	Comput_Math_Methods_Med_2013_Mar_20_2013_802512.nxml.txt.nlp	23573174	SENT79	27	27	9	9	doxycycline	MYC	PA449415	4609	0.767
NULL	J_Biol_Chem_2012_Apr_27_287(18)_14644-14658.nxml.txt.nlp	22375002	SENT421	18	18	26	26	forskolin	CC2D1A	PA146096022	54862	0.767
NULL	Physiol_Rep_2014_Sep_11_2(9)_e12133.nxml.txt.nlp	25214520	SENT288	22	22	3	3	bleomycin	CXCL12	PA448645	6387	0.767
NULL	J_Hematol_Oncol_2014_Aug_1_7_52.nxml.txt.nlp	25085632	SENT140	14	14	24	24	sunitinib	KRAS	PA162372840	3845	0.767
NULL	Exp_Anim_2014_Apr_26_63(2)_257-267.nxml.txt.nlp	24770651	SENT214	11	11	13	13	perindopril	ACE	PA450877	1636	0.767
NULL	Front_Neurol_2014_Oct_9_5_200.nxml.txt.nlp	25346720	SENT307	24	24	14	14	cyclosporine	EPO	PA449167	7076;8288;2056	0.767
NULL	Indian_J_Pharm_Sci_2013_Jan-Feb_75(1)_94-98.nxml.txt.nlp	23901167	SENT69	16	16	37	37	bupropion	CYP2C19	PA448687	1557	0.767
NULL	Cancer_Cell_Int_2003_Aug_20_3_14.nxml.txt.nlp	12952550	SENT25	9	9	4	4	chymotrypsin	SLPI	PA448994	6590	0.767
NULL	Biologics_2009_Jul_13_3_289-301.nxml.txt.nlp	19707416	SENT156	11	11	37	37	trastuzumab	HER2	PA451743	2064	0.767
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_39-54.nxml.txt.nlp	19305787	SENT302	19	19	10	10	ethanol	RACK1	PA448073	10399	0.767
NULL	Contemp_Oncol_(Pozn)_2012_Feb_29_16(1)_12-15.nxml.txt.nlp	23788849	SENT93	24	24	37	37	palifermin	KGF	PA164744014	2252	0.767
NULL	Braz_J_Microbiol_2009_Jun_1_Apr-Jun_40(2)_314-320.nxml.txt.nlp	24031364	SENT92	19	19	21	21	ethambutol	EMB	PA164784021	133418	0.767
NULL	Basic_Clin_Pharmacol_Toxicol_2013_Feb_5_112(2)_132-137.nxml.txt.nlp	22900583	SENT117	11	11	8	8	omeprazole	CYP2C19	PA450704	1557	0.767
NULL	Breast_Cancer_Res_2008_Dec_18_10(Suppl_4)_S26.nxml.txt.nlp	19128440	SENT61	28	28	11	11	tamoxifen	IMPACT	PA451581	55364	0.767
NULL	Front_Oncol_2013_Oct_9_3_261.nxml.txt.nlp	24130964	SENT370	29	29	39	39	gemcitabine	Gem	PA449748	51053	0.767
NULL	Cancer_Immunol_Immunother_2011_Jun_25_60(6)_793-808.nxml.txt.nlp	21350947	SENT192	24	24	22	22	sorafenib	IFN	PA7000	3439	0.767
NULL	Cell_Commun_Signal_2013_Aug_29_11_65.nxml.txt.nlp	23987506	SENT331	8	8	6	6	geldanamycin	Raf-1	PA152031327	5894	0.767
NULL	Endocrinol_Metab_(Seoul)_2014_Sep_25_29(3)_379-387.nxml.txt.nlp	25309798	SENT105	2	2	7	7	resveratrol	SIRT1		23411	0.767
NULL	Indian_J_Pharmacol_2013_Mar-Apr_45(2)_121-125.nxml.txt.nlp	23716885	SENT138	24	24	14	14	aripiprazole	CYP3A4	PA10026	1576	0.767
NULL	Osteoporos_Int_2014_Aug_15_25(10)_2359-2381.nxml.txt.nlp	25182228	SENT809	35	35	37	37	raloxifene	STAR	PA451221	6770;2984	0.767
NULL	Br_J_Cancer_2009_Jul_21_101(2)_238-243.nxml.txt.nlp	19568242	SENT124	26	26	28	28	bevacizumab	IFN	PA130232992	3439	0.767
NULL	Br_J_Cancer_2010_Oct_26_103(9)_1380-1390.nxml.txt.nlp	20877355	SENT227	7	7	3	3	etoposide	FasL	PA449552	356	0.767
NULL	J_Inflamm_(Lond)_2006_May_4_3_8.nxml.txt.nlp	16674821	SENT98	2	2	4	4	pp2	SKI-1		8720	0.767
NULL	Front_Oncol_2013_Aug_20_3_202.nxml.txt.nlp	23971004	SENT628	17	17	28	28	doxorubicin	CYP3A4	PA449412	1576	0.767
NULL	AIDS_Res_Ther_2013_May_1_10_10.nxml.txt.nlp	23634877	SENT187	34	34	27	27	atorvastatin	CCL4	PA448500	6351	0.767
NULL	Front_Neurol_2011_Dec_26_2_83.nxml.txt.nlp	22363312	SENT622	20	20	16	16	prasugrel	P2Y12	PA154410481	64805	0.767
NULL	J_Mol_Signal_2009_Apr_28_4_2.nxml.txt.nlp	19400946	SENT107	0	0	7	7	genistein	PRL	PA165109660	5617	0.767
NULL	Virol_J_2011_May_12_8_220.nxml.txt.nlp	21569385	SENT18	18	18	14	14	ribavirin	IFN	PA451241	3439	0.767
NULL	Cell_Commun_Signal_2011_Sep_13_9_18.nxml.txt.nlp	21914164	SENT122	15	15	13	13	pp2	PP1		5540;5464	0.767
NULL	Cancer_Cell_Int_2010_Sep_9_10_32.nxml.txt.nlp	20828393	SENT191	16	16	6	6	cisplatin	ATF3	PA449014	467	0.767
NULL	Nat_Biotechnol_2010_May_28(5)_478-485.nxml.txt.nlp	20458318	SENT338	19	19	11	11	gentamicin	NAG	PA449753	51594;4669	0.767
NULL	Oncotarget_2014_Feb_25_5(5)_1304-1314.nxml.txt.nlp	24675421	SENT33	20	20	2	2	cisplatin	JNK	PA449014	5599	0.767
NULL	Exp_Cell_Res_2011_Apr_15_317(7)_1028-1039.nxml.txt.nlp	21237154	SENT115	14	14	12	12	staurosporine	TRAIL	PA165109623	8743	0.767
NULL	Indian_J_Pharmacol_2008_Oct_40(Suppl_2)_S66-S91.nxml.txt.nlp	21593982	SENT1605	0	0	20	20	resveratrol	adiponectin		9370	0.767
NULL	Ann_Hematol_2013_Aug_24_92(11)_1521-1528.nxml.txt.nlp	23978945	SENT206	3	3	1	1	etoposide	CHOP	PA449552	1649	0.767
NULL	Br_J_Cancer_2011_Aug_23_105(5)_649-657.nxml.txt.nlp	21811251	SENT219	9	9	4	4	gefitinib	IGF1R	PA131301952	3480	0.767
NULL	Infect_Dis_Ther_2014_Jun_18_3(1)_35-43.nxml.txt.nlp	25134810	SENT3	14	14	12	12	daptomycin	VAN	PA164768820	10318	0.767
NULL	Genome_Announc_2014_Feb_6_2(1)_e00006-14.nxml.txt.nlp	24503981	SENT10	17	17	33	33	trimethoprim	CO2	PA451788	4513	0.767
NULL	Front_Neurosci_2010_Jun_17_4_35.nxml.txt.nlp	20661455	SENT96	4	4	15	15	buspirone	5-HT1A	PA448689	3350	0.767
NULL	Clin_Pediatr_Endocrinol_2006_Aug_2_15(3)_101-107.nxml.txt.nlp	24790329	SENT63	16	16	28	28	alfacalcidol	PTH	PA164746469	5741	0.767
NULL	Cell_Death_Dis_2014_Jul_17_5(7)_e1346.nxml.txt.nlp	25032869	SENT138	28	28	11	11	hydrocortisone	F12	PA449905	2161	0.767
NULL	Oncotarget_2014_Dec_4_5(22)_11365-11380.nxml.txt.nlp	25426548	SENT66	0	0	5	5	nutlin-3	p53		7157	0.767
NULL	Adv_Hematol_2012_Jul_24_2012_513702.nxml.txt.nlp	22888354	SENT94	28	28	8	8	lenalidomide	IL-2	PA162363968	3558	0.767
NULL	Mol_Vis_2012_Nov_29_18_2839-2846.nxml.txt.nlp	23233786	SENT190	30	30	27	27	sr144528	CB2		1269	0.767
NULL	Patient_Prefer_Adherence_2013_Mar_27_7_245-258.nxml.txt.nlp	23569364	SENT36	9	9	14	14	exemestane	aromatase	PA449563	1588	0.766
NULL	Iran_J_Pharm_Res_2014_Autumn_13(4)_1393-1401.nxml.txt.nlp	25587329	SENT119	8	8	14	14	celecoxib	ABCG2	PA448871	9429	0.766
NULL	Psychiatry_Investig_2008_Jun_30_5(2)_102-105.nxml.txt.nlp	20046352	SENT77	25	25	12	12	carbamazepine	DTNBP1	PA448785	84062	0.766
NULL	Cancer_Med_2013_Feb_3_2(1)_11-20.nxml.txt.nlp	24133623	SENT277	13	13	6	6	irinotecan	BRAF	PA450085	673	0.766
NULL	Cell_Logist_2014_Jan_9_4_e27732.nxml.txt.nlp	24843827	SENT58	33	33	36	36	perifosine	PI3K	PA165291471	5290	0.766
NULL	J_Biomed_Biotechnol_2010_Mar_3_2010_289360.nxml.txt.nlp	20204129	SENT161	9	9	25	25	triamcinolone	MMP13	PA451749	4322	0.766
NULL	Cancer_2012_Mar_1_118(5)_1181-1191.nxml.txt.nlp	22038681	SENT158	27	27	15	15	nilotinib	IFN	PA165958345	3439	0.766
NULL	Clin_Med_Insights_Oncol_2012_Feb_28_6_125-135.nxml.txt.nlp	22408376	SENT147	12	12	26	26	panitumumab	KRAS	PA162373091	3845	0.766
NULL	Br_J_Cancer_2012_Jan_31_106(3)_482-489.nxml.txt.nlp	22233925	SENT257	21	21	30	30	carboplatin	PEO1	PA448803	56652	0.766
NULL	Front_Synaptic_Neurosci_2010_Dec_22_2_152.nxml.txt.nlp	21423538	SENT23	15	15	18	18	forskolin	DAG	PA146096022	1605	0.766
NULL	Oncol_Lett_2013_Jun_3_5(6)_1836-1838.nxml.txt.nlp	23833651	SENT33	4	4	14	14	thyroglobulin	TTF-1	PA164754910	7080	0.766
NULL	Arthritis_Res_Ther_2013_Sep_10_15(5)_R110.nxml.txt.nlp	24020899	SENT152	19	19	25	25	pioglitazone	IL-6	PA450970	3569	0.766
NULL	Oncologist_2010_May_28_15(5)_436-446.nxml.txt.nlp	20427383	SENT69	28	28	34	34	bevacizumab	San	PA130232992	80218	0.766
NULL	Breast_Cancer_Res_2001_Aug_10_3(5)_E004.nxml.txt.nlp	NULL	SENT34	21	21	27	27	tamoxifen	EGF	PA451581	1950	0.766
NULL	Cardiovasc_Ther_2009_27(4)_259-274.nxml.txt.nlp	19604248	SENT162	32	32	8	8	clopidogrel	ADP	PA449053	23038	0.766
NULL	Korean_J_Anesthesiol_2013_Jan_21_64(1)_54-60.nxml.txt.nlp	23372887	SENT5	5	5	12	12	methylprednisolone	CRT	PA450466	811	0.766
NULL	Cell_Death_Dis_2010_Nov_18_1(11)_e101.nxml.txt.nlp	21368866	SENT31	21	21	9	9	docetaxel	PC3	PA449383	57332;7832;5122	0.766
NULL	J_Korean_Med_Sci_2010_Aug_21_25(8)_1222-1227.nxml.txt.nlp	20676337	SENT46	32	32	27	27	aminophylline	LPA	PA164781029	4018	0.766
NULL	Mol_Pain_2013_Feb_15_9_3.nxml.txt.nlp	23413875	SENT182	5	5	11	11	resveratrol	TRPA1		8989	0.766
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT115	5	5	12	12	pertuzumab	HER3		2065	0.766
NULL	Onco_Targets_Ther_2014_Nov_28_7_2183-2195.nxml.txt.nlp	25506223	SENT29	12	12	5	5	doxorubicin	MICA	PA449412	100507436	0.766
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Jul_26_64(Pt_8)_o1594-o1595.nxml.txt.nlp	21203289	SENT71	22	22	14	14	benzaldehyde	mol	PA448571	90527	0.766
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT140	24	24	5	5	atazanavir	SLK	PA10251	9748;2534	0.766
NULL	Oncotarget_2011_May_16_2(5)_418-421.nxml.txt.nlp	21789791	SENT22	29	29	35	35	bortezomib	TRAIL	PA10252	8743	0.766
NULL	Oncotarget_2013_Nov_24_4(12)_2430-2438.nxml.txt.nlp	24280348	SENT73	0	0	2	2	gefitinib	STAT3	PA131301952	6774	0.766
NULL	Mol_Vis_2012_Apr_11_18_901-908.nxml.txt.nlp	22539869	SENT155	28	28	31	31	curcumin	p38	PA151958596	10598;1432;7965	0.766
NULL	Acta_Pharmacol_Sin_2014_Oct_15_35(10)_1227-1246.nxml.txt.nlp	25220640	SENT231	18	18	5	5	paclitaxel	MKP-1	PA450761	1843	0.766
NULL	Acta_Pharmacol_Sin_2012_May_26_33(5)_578-587.nxml.txt.nlp	22447225	SENT40	20	20	13	13	trypsin	F12	PA451806	2161	0.766
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Mar_24_68(Pt_4)_o1180.nxml.txt.nlp	22606121	SENT63	18	18	27	27	ethanol	mol	PA448073	90527	0.766
NULL	Exp_Anim_2014_Apr_26_63(2)_257-267.nxml.txt.nlp	24770651	SENT6	5	5	16	16	olmesartan	APJ	PA164742950	187	0.766
NULL	Cancer_Med_2014_Feb_10_3(1)_134-142.nxml.txt.nlp	24407937	SENT182	10	10	17	17	letrozole	HER2	PA450196	2064	0.766
NULL	Oncologist_2011_Jan_6_16(1)_5-24.nxml.txt.nlp	21212434	SENT189	9	9	12	12	dacarbazine	IFN	PA449197	3439	0.766
NULL	Acta_Pharmacol_Sin_2011_Oct_15_32(10)_1303-1308.nxml.txt.nlp	21841812	SENT17	10	10	0	0	losartan	CYP2C9	PA450268	1559	0.766
NULL	Br_J_Cancer_1999_Mar_79(9-10)_1386-1391.nxml.txt.nlp	10188880	SENT5	23	23	11	11	cisplatin	SA-1	PA449014	10274	0.766
NULL	Pharm_Methods_2011_Jul-Sep_2(3)_173-177.nxml.txt.nlp	23781451	SENT142	18	18	5	5	prasugrel	MSN	PA154410481	4478	0.766
NULL	Braz_J_Med_Biol_Res_2013_Feb_1_46(2)_171-177.nxml.txt.nlp	23369979	SENT120	7	7	12	12	enalapril	IL-10	PA449456	3586	0.766
NULL	Hum_Mol_Genet_2011_Jun_15_20(12)_2422-2434.nxml.txt.nlp	21493629	SENT661	0	0	11	11	resveratrol	SIRT1		23411	0.766
NULL	J_Cardiothorac_Surg_2013_Sep_11_8(Suppl_1)_P122.nxml.txt.nlp	NULL	SENT8	15	15	10	10	clopidogrel	ADP	PA449053	23038	0.766
NULL	Acta_Pharmacol_Sin_2012_Jan_28_33(1)_66-74.nxml.txt.nlp	22120966	SENT165	6	6	20	20	genistein	RANKL	PA165109660	8600	0.766
NULL	Drugs_R_D_2014_Sep_28_14(3)_159-164.nxml.txt.nlp	24973042	SENT32	21	21	16	16	atorvastatin	CYP2C8	PA448500	1558	0.766
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S18-S30.nxml.txt.nlp	20680104	SENT82	26	26	1	1	panitumumab	STEPP	PA162373091	222659	0.766
NULL	Front_Genet_2014_Jul_25_5_241.nxml.txt.nlp	25120558	SENT194	41	41	43	43	l-tyrosine	TYR	PA451822	7299	0.766
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Feb_6_65(Pt_3)_o482.nxml.txt.nlp	21582151	SENT72	30	30	7	7	ethanol	CS2	PA448073	64084	0.766
NULL	Oncoimmunology_2012_Sep_1_1(6)_810-821.nxml.txt.nlp	23162748	SENT2	4	4	7	7	trastuzumab	HER2	PA451743	2064	0.766
NULL	Nat_Commun_2014_Nov_25_5_5548.nxml.txt.nlp	25420520	SENT557	9	9	3	3	paclitaxel	TEKT4	PA450761	150483	0.766
NULL	Mucosal_Immunol_2013_Nov_10_6(6)_1179-1190.nxml.txt.nlp	23571504	SENT95	18	18	23	23	auranofin	TRX	PA448510	7295	0.766
NULL	Clin_Pharmacokinet_2014_Sep_3_53(1)_1-16.nxml.txt.nlp	23999929	SENT288	7	7	24	24	clarithromycin	CYP3A4	PA449028	1576	0.766
NULL	Oncoimmunology_2014_May_29_3_e28925.nxml.txt.nlp	25083322	SENT68	2	2	12	12	dasatinib	CD4	PA162372878	920	0.766
NULL	J_Hematol_Oncol_2008_Aug_11_1_11.nxml.txt.nlp	18694493	SENT61	11	11	20	20	sunitinib	IFN	PA162372840	3439	0.766
NULL	Protein_Cell_2014_Jun_19_5(6)_469-479.nxml.txt.nlp	24748116	SENT128	12	12	7	7	paclitaxel	EB1	PA450761	9167;22919;10982	0.766
NULL	Oxid_Med_Cell_Longev_2011_Nov_24_2011_467180.nxml.txt.nlp	22191013	SENT89	21	21	26	26	methamphetamine	GAPDH	PA450403	2597	0.766
NULL	Clin_Ophthalmol_2010_May_14_4_437-445.nxml.txt.nlp	20505836	SENT12	14	14	19	19	bimatoprost	BAK	PA164748867	578	0.766
NULL	Cancer_Cell_Int_2010_Sep_9_10_32.nxml.txt.nlp	20828393	SENT137	18	18	2	2	cisplatin	ATF3	PA449014	467	0.766
NULL	Ann_Saudi_Med_2011_May-Jun_31(3)_279-283.nxml.txt.nlp	21623058	SENT61	23	23	3	3	cyclosporine	IL-2	PA449167	3558	0.766
NULL	EPMA_J_2012_Sep_27_3(1)_10.nxml.txt.nlp	23016735	SENT194	21	21	6	6	acenocoumarol	APOE	PA452632	348	0.766
NULL	Clin_Psychopharmacol_Neurosci_2012_Apr_30_10(1)_25-33.nxml.txt.nlp	23429852	SENT98	46	46	41	41	haloperidol	SNAP-25	PA449841	6616	0.766
NULL	Int_J_Mol_Sci_2014_Sep_19_15(9)_16698-16718.nxml.txt.nlp	25244018	SENT68	8	8	33	33	estradiol	LKB1	PA449503	6794	0.766
NULL	Multidiscip_Respir_Med_2013_Feb_6_8(1)_11.nxml.txt.nlp	23388501	SENT54	32	32	15	15	carbachol	ASM	PA448784	6609;283120	0.766
NULL	J_Biomed_Sci_2012_Nov_14_19(1)_94.nxml.txt.nlp	23148884	SENT122	0	0	23	23	bortezomib	DNMT1	PA10252	1786	0.766
NULL	Biosci_Rep_2014_Aug_6_34(4)_e00131.nxml.txt.nlp	24975826	SENT142	15	15	24	24	pp2	TRPA1		8989	0.766
NULL	Evid_Based_Complement_Alternat_Med_2013_Dec_12_2013_324618.nxml.txt.nlp	24416065	SENT112	14	14	10	10	nevirapine	CYP3A4	PA450616	1576	0.766
NULL	Ann_Oncol_2014_Apr_26_25(4)_801-807.nxml.txt.nlp	24577117	SENT107	18	18	9	9	cetuximab	p16	PA10040	1029	0.766
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT193	24	24	13	13	heparin	FGF1	PA449855	2246	0.766
NULL	Cardiol_Res_Pract_2013_Jan_31_2013_128795.nxml.txt.nlp	23431496	SENT150	12	12	20	20	clopidogrel	CYP2C19	PA449053	1557	0.766
NULL	Oncogene_2013_Sep_5_32(36)_4252-4263.nxml.txt.nlp	23045288	SENT78	15	15	9	9	doxorubicin	CD49f	PA449412	3655	0.766
NULL	Int_J_Mol_Sci_2012_Sep_25_13(10)_12153-12168.nxml.txt.nlp	23202889	SENT534	15	15	2	2	cetuximab	KRAS	PA10040	3845	0.766
NULL	Acta_Pharmacol_Sin_2010_Mar_22_31(3)_329-340.nxml.txt.nlp	20173759	SENT13	4	4	8	8	ethanol	AMPK	PA448073	5563	0.766
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT11	14	14	37	37	l-leucine	4E-BP1	PA450197	1978	0.766
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jan_27_66(Pt_2)_o445.nxml.txt.nlp	21579860	SENT57	16	16	13	13	benzaldehyde	mol	PA448571	90527	0.766
NULL	Breast_Cancer_Res_2010_Jun_22_12(3)_R39.nxml.txt.nlp	20569502	SENT236	38	38	11	11	tamoxifen	IGFBP5	PA451581	3488	0.766
NULL	Front_Genet_2012_Sep_3_3_169.nxml.txt.nlp	22969794	SENT183	13	13	24	24	estradiol	PARP1	PA449503	142	0.766
NULL	J_Cell_Biol_2001_May_28_153(5)_933-946.nxml.txt.nlp	11381080	SENT622	15	15	13	13	heparin	perlecan	PA449855	3339	0.766
NULL	Biosci_Rep_2013_Nov_25_33(6)_e00081.nxml.txt.nlp	24070327	SENT195	10	10	28	28	imatinib	survivin	PA10804	332	0.766
NULL	Oncotarget_2012_Nov_17_4(1)_18-28.nxml.txt.nlp	23248157	SENT71	0	0	12	12	pargyline	U87	PA450797	677775;641648	0.766
NULL	Br_J_Cancer_1998_Nov_78(9)_1170-1174.nxml.txt.nlp	9820175	SENT13	12	12	19	19	paclitaxel	CYP1A1	PA450761	1543	0.766
NULL	Clin_Ophthalmol_2014_Oct_31_8_2189-2193.nxml.txt.nlp	25382969	SENT108	16	16	18	18	travoprost	BAK	PA164781371	578	0.766
NULL	Breast_Cancer_Res_2006_Nov_27_8(6)_R66.nxml.txt.nlp	17129383	SENT6	12	12	34	34	paclitaxel	p53	PA450761	7157	0.766
NULL	Indian_J_Med_Paediatr_Oncol_2014_Apr-Jun_35(2)_140-142.nxml.txt.nlp	25197175	SENT61	26	26	13	13	panitumumab	KRAS	PA162373091	3845	0.766
NULL	Anal_Biochem_2014_Jun_1_454(100)_17-22.nxml.txt.nlp	24637157	SENT36	39	39	22	22	temozolomide	TDP1	PA451609	55775	0.766
NULL	Pharmaceuticals_(Basel)_2014_Jan_9_7(1)_46-57.nxml.txt.nlp	24451403	SENT81	34	34	27	27	ritonavir	Bcl-2	PA451260	596	0.766
NULL	Oncotarget_2014_Oct_21_5(22)_11709-11722.nxml.txt.nlp	25365944	SENT226	5	5	11	11	metformin	Rho	PA450395	29984	0.766
NULL	Allergy_Rhinol_(Providence)_2011_Apr-Jun_2(2)_e51-e53.nxml.txt.nlp	22852117	SENT15	3	3	16	16	curcumin	AP-1	PA151958596	2353;3727;2354;3725	0.766
NULL	Cancer_Cell_Int_2006_Nov_8_6_25.nxml.txt.nlp	17092342	SENT280	2	2	4	4	thrombin	Yes	PA451674	7525	0.766
NULL	Mol_Neurodegener_2011_Jul_21_6_52.nxml.txt.nlp	21777416	SENT274	24	24	34	34	l-glutamine	B27	PA10090	56246	0.766
NULL	J_Cell_Mol_Med_2014_May_14_18(5)_811-823.nxml.txt.nlp	24628949	SENT138	43	43	35	35	docetaxel	FOXM1	PA449383	2305	0.766
NULL	Front_Neurosci_2012_May_30_6_77.nxml.txt.nlp	22661925	SENT252	43	43	24	24	ethanol	DCX	PA448073	1641	0.766
NULL	Psychiatry_Investig_2009_Sep_3_6(3)_222-225.nxml.txt.nlp	20046399	SENT7	23	23	1	1	perospirone	DRD2	PA165291546	1813	0.766
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_May_22_66(Pt_6)_o1397.nxml.txt.nlp	21579476	SENT47	8	8	18	18	benzaldehyde	mol	PA448571	90527	0.766
NULL	Drug_Saf_2014_Oct_29_37(Suppl_1)_57-62.nxml.txt.nlp	25352328	SENT25	4	4	37	37	ribavirin	UGT1A1	PA451241	54658	0.766
NULL	Neuro_Oncol_2010_Apr_27_12(4)_389-400.nxml.txt.nlp	20308316	SENT175	6	6	13	13	chloroquine	p53	PA448948	7157	0.766
NULL	J_Cell_Biol_2001_Aug_6_154(3)_599-610.nxml.txt.nlp	11481345	SENT129	28	28	10	10	doxycycline	ARF6	PA449415	382	0.766
NULL	J_Cell_Mol_Med_2013_May_12_17(5)_636-647.nxml.txt.nlp	23577651	SENT121	26	26	22	22	quinacrine	CD62P	PA164745551	6403	0.766
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_6_2014_270930.nxml.txt.nlp	25431606	SENT184	5	5	9	9	curcumin	IL-6	PA151958596	3569	0.766
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_11_2014_274786.nxml.txt.nlp	25505920	SENT484	3	3	17	17	curcumin	ERCC1	PA151958596	2067	0.766
NULL	Cell_Res_2013_Feb_15_23(2)_201-212.nxml.txt.nlp	23318584	SENT41	44	44	36	36	l-cysteine	MSU	PA449173	593	0.766
NULL	J_Hematol_Oncol_2013_Jul_9_6_49.nxml.txt.nlp	23837843	SENT222	11	11	9	9	verapamil	P-gp	PA451868	5243	0.766
NULL	Onco_Targets_Ther_2014_Sep_9_7_1571-1582.nxml.txt.nlp	25228815	SENT197	12	12	30	30	sunitinib	VEGFR2	PA162372840	3791	0.766
NULL	J_Gynecol_Oncol_2013_Jul_4_24(3)_265-272.nxml.txt.nlp	23875077	SENT97	2	2	7	7	thrombin	SMAD2	PA451674	4087	0.766
NULL	Nat_Genet_2013_Sep_28_45(9)_1004-1012.nxml.txt.nlp	23892607	SENT171	9	9	30	30	doxycycline	P28	PA449415	9446;7802;9527	0.766
NULL	Ann_Rheum_Dis_2013_Apr_21_72(4)_482-492.nxml.txt.nlp	23172750	SENT395	30	30	20	20	tocilizumab	IL-6	PA165292659	3569	0.766
NULL	J_Cell_Mol_Med_2014_May_18_18(5)_875-884.nxml.txt.nlp	24533641	SENT28	23	23	38	38	naphthol	HIF-1	PA154081779	29072	0.766
NULL	Cancer_Cell_Int_2013_Oct_22_13_103.nxml.txt.nlp	24148306	SENT137	10	10	4	4	etoposide	PRL	PA449552	5617	0.766
NULL	J_Biol_Chem_2013_Dec_6_288(49)_35592-35603.nxml.txt.nlp	24165129	SENT248	0	0	26	26	ebselen	STAT3	PA161660841	6774	0.766
NULL	ScientificWorldJournal_2013_Oct_1_2013_523480.nxml.txt.nlp	24198723	SENT28	7	7	17	17	cisplatin	p53	PA449014	7157	0.766
NULL	Diabetes_2011_Jun_21_60(6)_1770-1778.nxml.txt.nlp	21562078	SENT291	1	1	5	5	metformin	AMPK	PA450395	5563	0.766
NULL	Oncol_Rep_2012_Apr_13_27(4)_979-986.nxml.txt.nlp	22179630	SENT51	12	12	14	14	cisplatin	DDP	PA449014	1678	0.766
NULL	Core_Evid_2008_Jun_3(1)_13-30.nxml.txt.nlp	20694081	SENT398	2	2	10	10	vildagliptin	GLP-1	PA165958346	100125288	0.766
NULL	J_Immunother_Cancer_2014_Jan_27_2_2.nxml.txt.nlp	24829759	SENT45	22	22	20	20	sorafenib	IL-21	PA7000	59067;50616;27189	0.766
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2675-2684.nxml.txt.nlp	24129246	SENT173	33	33	24	24	etoposide	KSR1	PA449552	8844	0.766
NULL	Open_Virol_J_2007_Aug_13_1_1-7.nxml.txt.nlp	19440453	SENT54	6	6	0	0	l-glutamine	U87	PA10090	677775;641648	0.766
NULL	EPMA_J_2012_Sep_27_3(1)_10.nxml.txt.nlp	23016735	SENT238	9	9	20	20	warfarin	CYP2C9	PA451906	1559	0.766
NULL	Arthritis_Res_Ther_2006_Nov_8_8(6)_R167.nxml.txt.nlp	17092341	SENT140	18	18	11	11	rituximab	BAFF	PA451261	10673	0.766
NULL	Curr_Neuropharmacol_2014_Jul_12(4)_365-379.nxml.txt.nlp	25342944	SENT192	23	23	3	3	fluoxetine	GluA2	PA449673	2891	0.766
NULL	Cell_Commun_Signal_2013_Jan_11_11_2.nxml.txt.nlp	23305203	SENT156	0	0	11	11	forskolin	TIMAP	PA146096022	26051	0.766
NULL	Indian_J_Pharm_Sci_2013_Jan-Feb_75(1)_94-98.nxml.txt.nlp	23901167	SENT87	30	30	17	17	tolbutamide	CYP1A2	PA451718	1544	0.766
NULL	Br_J_Cancer_2010_Jan_5_102(1)_80-86.nxml.txt.nlp	19920817	SENT106	9	9	17	17	bevacizumab	IFN	PA130232992	3439	0.766
NULL	Cancer_Cell_Int_2014_Apr_17_14_34.nxml.txt.nlp	24739220	SENT220	2	2	7	7	curcumin	EGFR	PA151958596	1956	0.766
NULL	Nucleic_Acids_Res_2011_Dec_31_39(22)_9536-9548.nxml.txt.nlp	21880590	SENT174	3	3	7	7	etoposide	CCL4L2	PA449552	388372	0.766
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT226	4	4	16	16	chloroquine	BMP9	PA448948	2658	0.766
NULL	Br_J_Cancer_2011_Jan_4_104(1)_91-100.nxml.txt.nlp	21139584	SENT101	5	5	8	8	geldanamycin	Hsp90	PA152031327	3320	0.766
NULL	Mol_Cancer_2012_Mar_21_11_13.nxml.txt.nlp	22436134	SENT65	26	26	2	2	doxorubicin	HuR	PA449412	1994	0.766
NULL	J_Gen_Intern_Med_2009_May_21_24(5)_656-664.nxml.txt.nlp	19306050	SENT388	9	9	2	2	warfarin	CYP2C9	PA451906	1559	0.766
NULL	J_Adv_Pharm_Technol_Res_2013_Apr-Jun_4(2)_108-117.nxml.txt.nlp	23833751	SENT114	7	7	1	1	metformin	VIII	PA450395	1351	0.766
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT146	6	6	11	11	resveratrol	XIAP		331	0.766
NULL	Basic_Clin_Neurosci_2014_Winter_5(1)_66-73.nxml.txt.nlp	25436086	SENT126	12	12	4	4	lidocaine	LHA	PA450226	1081	0.766
NULL	Neural_Regen_Res_2014_Nov_1_9(21)_1897-1901.nxml.txt.nlp	25558239	SENT122	3	3	20	20	diazepam	CA1	PA449283	759	0.766
NULL	Oncotarget_2014_Mar_16_5(12)_4087-4102.nxml.txt.nlp	24961479	SENT59	24	24	12	12	hemin	HO-1	PA449849	3162	0.766
NULL	Drug_Des_Devel_Ther_2014_Sep_23_8_1527-1538.nxml.txt.nlp	25284985	SENT11	31	31	29	29	celecoxib	IFN	PA448871	3439	0.766
NULL	Acta_Pharmacol_Sin_2011_Oct_15_32(10)_1233-1238.nxml.txt.nlp	21841815	SENT109	4	4	12	12	atropine	CTX	PA448505	1593	0.766
NULL	Front_Immunol_2014_Aug_20_5_348.nxml.txt.nlp	25191322	SENT212	24	24	37	37	forskolin	LGALS13	PA146096022	29124	0.766
NULL	Tob_Induc_Dis_2004_Mar_15_2(1)_2.nxml.txt.nlp	NULL	SENT14	11	11	13	13	thrombin	ADP	PA451674	23038	0.766
NULL	Glia_2014_Jul_25_62(7)_1066-1074.nxml.txt.nlp	24668732	SENT23	23	23	16	16	paraformaldehyde	CO2	PA450790	4513	0.766
NULL	Oncotarget_2011_May_16_2(5)_418-421.nxml.txt.nlp	21789791	SENT42	6	6	11	11	bortezomib	TRAIL	PA10252	8743	0.766
NULL	Oncotarget_2014_Aug_12_5(20)_9710-9726.nxml.txt.nlp	25339152	SENT173	5	5	9	9	pp2	DGK		8526;1607	0.766
NULL	Pharmaceuticals_(Basel)_2013_Apr_8_6(4)_500-509.nxml.txt.nlp	24276120	SENT133	13	13	43	43	benserazide	GPR35		2859	0.766
NULL	Ann_Neurol_2014_Aug_9_76(2)_305-309.nxml.txt.nlp	24977390	SENT53	9	9	6	6	tocilizumab	IL-6	PA165292659	3569	0.766
NULL	Oncogene_2013_Sep_26_32(39)_10_1038_onc_2012_491.nxml.txt.nlp	23108394	SENT39	19	19	10	10	epirubicin	FOXM1	PA449476	2305	0.766
NULL	Biologics_2009_Sep_15_3_429-441.nxml.txt.nlp	19774210	SENT304	11	11	30	30	leucovorin	IFL	PA450198	3439	0.766
NULL	Breast_Cancer_Res_2010_Jun_28_12(3)_R43.nxml.txt.nlp	20579400	SENT166	0	0	15	15	tamoxifen	MAPT	PA451581	4137	0.766
NULL	Cancer_Cell_Int_2013_Jan_15_13_3.nxml.txt.nlp	23320839	SENT139	16	16	11	11	doxorubicin	MRP3	PA449412	8714	0.766
NULL	Patient_Prefer_Adherence_2013_Mar_27_7_245-258.nxml.txt.nlp	23569364	SENT99	31	31	21	21	doxorubicin	B18	PA449412	59271;4713	0.766
NULL	Front_Microbiol_2015_Jan_12_5_776.nxml.txt.nlp	25628615	SENT246	23	23	11	11	nitrogen	DSE	PA450643	29940	0.766
NULL	ARYA_Atheroscler_2013_Jan_9(1)_112-114.nxml.txt.nlp	23690810	SENT62	14	14	1	1	argatroban	Mal	PA164745516	114609	0.766
NULL	J_Mol_Signal_2010_May_10_5_4.nxml.txt.nlp	20459745	SENT121	7	7	15	15	cisplatin	p53	PA449014	7157	0.766
NULL	Diagn_Pathol_2013_Nov_25_8_192.nxml.txt.nlp	24274261	SENT89	8	8	14	14	paclitaxel	IFN	PA450761	3439	0.766
NULL	ScientificWorldJournal_2012_Apr_1_2012_987508.nxml.txt.nlp	22566785	SENT112	0	0	7	7	montelukast	CysLT1	PA450546	10800	0.766
NULL	Lab_Invest_2009_Nov_7_89(11)_1275-1290.nxml.txt.nlp	19736547	SENT355	11	11	8	8	carrageenan	LOX-1	PA448814	4973	0.766
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT114	21	21	7	7	trastuzumab	MUC4	PA451743	4585	0.766
NULL	Int_J_Gen_Med_2013_Dec_4_6_877-895.nxml.txt.nlp	24403842	SENT57	9	9	12	12	exenatide	PPG	PA164749238	5552	0.766
NULL	J_Thromb_Haemost_2010_Mar_8(3)_577-587.nxml.txt.nlp	20040043	SENT144	25	25	30	30	rosiglitazone	mol	PA451283	90527	0.766
NULL	Chem_Cent_J_2014_Jul_1_8_43.nxml.txt.nlp	25050134	SENT122	22	22	13	13	hemin	Bcl-2	PA449849	596	0.766
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Mar_5_67(Pt_4)_o785.nxml.txt.nlp	21754076	SENT56	17	17	7	7	ethanol	mol	PA448073	90527	0.766
NULL	Curr_Neuropharmacol_2008_Jun_6(2)_151-163.nxml.txt.nlp	19305794	SENT179	2	2	6	6	capsaicin	TRPV1	PA448776	7442	0.766
NULL	Iran_Red_Crescent_Med_J_2012_Dec_6_14(12)_782-786.nxml.txt.nlp	23483042	SENT138	10	10	40	40	vancomycin	VISA	PA451850	57506	0.766
NULL	Arthritis_Res_Ther_2012_Mar_14_14(2)_R65.nxml.txt.nlp	22417743	SENT84	34	34	9	9	fluorescein	San	PA164746009	80218	0.766
NULL	Eur_Arch_Psychiatry_Clin_Neurosci_2010_Nov_14_260(Suppl_2)_81-89.nxml.txt.nlp	20945070	SENT169	2	2	6	6	clozapine	NPY	PA449061	4852	0.766
NULL	J_Biol_2006_Apr_27_5(3)_7.nxml.txt.nlp	16643674	SENT260	41	41	6	6	cyclosporine	CAST	PA449167	10849;26059;831	0.766
NULL	Cancer_Cell_Int_2013_Jun_26_13_63.nxml.txt.nlp	23800022	SENT213	12	12	17	17	genistein	p53	PA165109660	7157	0.766
NULL	Front_Mol_Neurosci_2012_Nov_26_5_100.nxml.txt.nlp	23189038	SENT222	18	18	23	23	furosemide	KCC2	PA449719	57468	0.766
NULL	Croat_Med_J_2012_Aug_53(4)_294-297.nxml.txt.nlp	22911518	SENT28	11	11	25	25	warfarin	VKORC1	PA451906	79001	0.766
NULL	Neuropsychologia_2011_Jul_49(9)_2755-2765.nxml.txt.nlp	21689671	SENT55	19	19	28	28	memantine	LPA	PA10364	4018	0.766
NULL	J_Gen_Physiol_2003_Jul_122(1)_45-61.nxml.txt.nlp	12835470	SENT262	22	22	2	2	capsaicin	VR1	PA448776	56664	0.766
NULL	Oncogene_2010_Jun_10_29(23)_3335-3348.nxml.txt.nlp	20383197	SENT130	21	21	9	9	cetuximab	HER2	PA10040	2064	0.766
NULL	Mol_Cytogenet_2013_Jul_16_6_27.nxml.txt.nlp	23866735	SENT31	35	35	22	22	imatinib	ELN	PA10804	2006	0.766
NULL	Cancer_Imaging_2013_Jul_22_13(3)_306-313.nxml.txt.nlp	23876444	SENT178	25	25	12	12	vemurafenib	BRAF	PA165946873	673	0.766
NULL	J_Obes_2011_Sep_19_2011_984245.nxml.txt.nlp	20885921	SENT130	0	0	8	8	exenatide	GLP-1	PA164749238	100125288	0.766
NULL	Leukemia_2014_Jan_12_28(1)_15-33.nxml.txt.nlp	23778311	SENT252	27	27	0	0	imatinib	SIRT1	PA10804	23411	0.766
NULL	Oncol_Rep_2014_Jan_13_31(1)_376-383.nxml.txt.nlp	24220856	SENT13	36	36	8	8	paclitaxel	PA1	PA450761	79447	0.766
NULL	J_Biomed_Biotechnol_2010_Mar_28_2010_174378.nxml.txt.nlp	20368780	SENT289	6	6	8	8	sargramostim	GM-CSF	PA164748631	1437	0.766
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_11_2014_274786.nxml.txt.nlp	25505920	SENT246	21	21	36	36	cisplatin	ERCC1	PA449014	2067	0.766
NULL	Br_J_Cancer_2013_Jan_15_108(1)_82-90.nxml.txt.nlp	23321512	SENT202	7	7	26	26	paclitaxel	TUBB3	PA450761	10381	0.766
NULL	Protein_Cell_2014_Jun_19_5(6)_469-479.nxml.txt.nlp	24748116	SENT75	8	8	0	0	paclitaxel	EB1	PA450761	9167;22919;10982	0.766
NULL	Arch_Gynecol_Obstet_2012_May_25_285(5)_1331-1338.nxml.txt.nlp	22116314	SENT12	0	0	19	19	alendronate	OCN	PA448082	632	0.766
NULL	Cell_Death_Dis_2013_Jan_31_4(1)_e478.nxml.txt.nlp	23370278	SENT78	20	20	13	13	bleomycin	KAP1	PA448645	10155	0.766
NULL	Int_J_Endocrinol_Metab_2013_Dec_21_Winter_11(1)_57-61.nxml.txt.nlp	23853622	SENT31	12	12	2	2	thioridazine	FGA	PA451666	2243	0.766
NULL	Hum_Genomics_2012_Aug_2_6(1)_9.nxml.txt.nlp	23245743	SENT164	30	30	32	32	atorvastatin	ENA-78	PA448500	6374	0.766
NULL	Mol_Cancer_2010_Aug_23_9_222.nxml.txt.nlp	20731837	SENT279	5	5	10	10	celecoxib	COX	PA448871	1351	0.766
NULL	Clin_Ophthalmol_2011_Apr_18_5_495-502.nxml.txt.nlp	21573098	SENT223	6	6	19	19	levofloxacin	BAK	PA450214	578	0.766
NULL	Cancer_Med_2013_Aug_10_2(4)_496-506.nxml.txt.nlp	24156022	SENT264	27	27	7	7	cetuximab	PTEN	PA10040	5728	0.766
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT185	8	8	11	11	tacrolimus	RANKL	PA451578	8600	0.766
NULL	Eur_J_Pharm_Sci_2012_Jul_16_46(4)_244-258.nxml.txt.nlp	22085636	SENT392	8	8	15	15	pertuzumab	PI3K		5290	0.766
NULL	Cell_Commun_Signal_2011_May_20_9_14.nxml.txt.nlp	21599982	SENT73	22	22	14	14	pp2	ERK		5594	0.766
NULL	J_Gastroenterol_2014_Mar_30_49(3)_492-501.nxml.txt.nlp	23543311	SENT242	9	9	18	18	ribavirin	IL28B	PA451241	282617	0.766
NULL	Ann_Rheum_Dis_2015_Jan_23_74(1)_252-259.nxml.txt.nlp	24152419	SENT40	1	1	11	11	isoflurane	TRPV1	PA450106	7442	0.766
NULL	J_Cell_Mol_Med_2014_Mar_26_18(3)_391-395.nxml.txt.nlp	24571258	SENT7	14	14	7	7	deferoxamine	LTF	PA164746490	4057	0.766
NULL	Oncol_Lett_2013_Apr_28_5(4)_1305-1310.nxml.txt.nlp	23599784	SENT146	2	2	7	7	tamoxifen	aromatase	PA451581	1588	0.766
NULL	J_Oncol_2011_Dec_15_2011_852970.nxml.txt.nlp	21209724	SENT225	9	9	7	7	nutlin-3	p53		7157	0.766
NULL	Neuropsychopharmacology_2009_Jul_25_34(8)_1968-1978.nxml.txt.nlp	19322168	SENT5	25	25	12	12	clozapine	PI3K	PA449061	5290	0.766
NULL	Oncogene_2010_Sep_16_29(37)_5193-5203.nxml.txt.nlp	20581867	SENT125	26	26	14	14	lapatinib	HER3	PA152241907	2065	0.766
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT117	10	10	22	22	atorvastatin	survivin	PA448500	332	0.766
NULL	Front_Neurosci_2014_Jan_31_8_6.nxml.txt.nlp	24550768	SENT221	20	20	17	17	vanillin	TRPV3	PA451852	162514	0.766
NULL	Clin_Pharmacol_2011_Jun_22_3_13-25.nxml.txt.nlp	22287853	SENT181	16	16	19	19	saxagliptin	CYP3A4	PA165958362	1576	0.766
NULL	Breast_Cancer_(Auckl)_2012_Nov_19_6_191-207.nxml.txt.nlp	23226023	SENT278	25	25	44	44	carboplatin	HER-2	PA448803	2064	0.766
NULL	Oncol_Lett_2013_Feb_5_5(2)_424-426.nxml.txt.nlp	23420786	SENT67	13	13	26	26	vemurafenib	BRAF	PA165946873	673	0.766
NULL	J_Biol_2006_Apr_27_5(3)_7.nxml.txt.nlp	16643674	SENT116	18	18	8	8	cyclosporine	GDA	PA449167	8034;9615	0.766
NULL	Gastric_Cancer_2013_Jul_12_16(3)_345-354.nxml.txt.nlp	22968820	SENT208	20	20	7	7	oxaliplatin	FANCJ	PA131285527	83990	0.766
NULL	Int_J_Endocrinol_2014_Feb_13_2014_329456.nxml.txt.nlp	24688539	SENT223	9	9	25	25	tadalafil	IL-8	PA10333	3576	0.766
NULL	Front_Oncol_2014_Jun_18_4_153.nxml.txt.nlp	24995158	SENT175	6	6	9	9	vinblastine	c-Jun	PA451877	3725	0.766
NULL	Pharmaceuticals_(Basel)_2013_Aug_21_6(8)_988-1038.nxml.txt.nlp	24276379	SENT2544	13	13	2	2	cetuximab	PTEN	PA10040	5728	0.766
NULL	Br_J_Cancer_2012_Feb_14_106(4)_685-692.nxml.txt.nlp	22294184	SENT125	32	32	9	9	docetaxel	survivin	PA449383	332	0.766
NULL	Am_J_Trop_Med_Hyg_2012_Aug_1_87(2)_231-241.nxml.txt.nlp	22855752	SENT136	7	7	19	19	primaquine	G6PD	PA451103	2539	0.766
NULL	Infect_Dis_Obstet_Gynecol_2012_Nov_29_2012_543916.nxml.txt.nlp	23251074	SENT37	30	30	38	38	ritonavir	CD4	PA451260	920	0.766
NULL	Curr_Neuropharmacol_2009_Sep_7(3)_246-256.nxml.txt.nlp	20190966	SENT181	0	0	11	11	cisplatin	NOX3	PA449014	50508	0.766
NULL	J_Anaesthesiol_Clin_Pharmacol_2011_Jan-Mar_27(1)_91-96.nxml.txt.nlp	21804715	SENT152	14	14	5	5	ketamine	DBP	PA450144	3295;1628;2638	0.766
NULL	Gastric_Cancer_2012_Jul_17_15(3)_313-322.nxml.txt.nlp	22179434	SENT23	0	0	22	22	trastuzumab	HER2	PA451743	2064	0.766
NULL	J_Cardiothorac_Surg_2011_Apr_8_6_44.nxml.txt.nlp	21477293	SENT14	1	1	12	12	heparin	PF4	PA449855	5196	0.766
NULL	Front_Oncol_2014_Sep_4_4_242.nxml.txt.nlp	25237652	SENT149	11	11	23	23	erlotinib	EGFR	PA134687924	1956	0.766
NULL	Arthritis_Res_Ther_2014_Sep_18_16(5)_427.nxml.txt.nlp	25230745	SENT148	20	20	13	13	bevacizumab	ADAMTS5	PA130232992	11096	0.766
NULL	J_Biol_Chem_2009_Sep_4_284(36)_24443-24452.nxml.txt.nlp	19561358	SENT16	17	17	7	7	mitomycin	FANCD2	PA450524	2177	0.766
NULL	Cell_Cycle_2013_Sep_15_12(18)_3013-3024.nxml.txt.nlp	23974104	SENT134	11	11	21	21	doxorubicin	CD24	PA449412	100133941	0.766
NULL	Ann_Rheum_Dis_2008_Nov_14_67(11)_1516-1523.nxml.txt.nlp	18625622	SENT5	11	11	32	32	tocilizumab	TNF	PA165292659	7124	0.766
NULL	Environ_Health_Perspect_2011_Apr_16_119(4)_534-541.nxml.txt.nlp	21081300	SENT107	26	26	28	28	diethylstilbestrol	DES	PA449307	1674	0.766
NULL	Allergy_Asthma_Immunol_Res_2014_Nov_28_6(6)_567-572.nxml.txt.nlp	25374757	SENT83	0	0	5	5	fexofenadine	IL-6	PA449621	3569	0.766
NULL	J_Gen_Physiol_2009_Apr_133(4)_421-438.nxml.txt.nlp	19289574	SENT301	10	10	23	23	forskolin	SLC26A9	PA146096022	115019	0.766
NULL	Neuropsychopharmacology_2009_Jul_25_34(8)_1968-1978.nxml.txt.nlp	19322168	SENT255	7	7	4	4	clozapine	PI3K	PA449061	5290	0.766
NULL	Aging_(Albany_NY)_2011_Apr_6_3(4)_444-449.nxml.txt.nlp	21483037	SENT64	4	4	8	8	resveratrol	SIRT1		23411	0.766
NULL	Diabetes_2013_Oct_17_62(10)_3547-3552.nxml.txt.nlp	23863812	SENT71	15	15	26	26	valsartan	ANOVA	PA451848	4858	0.766
NULL	Breast_Cancer_Res_2012_May_23_14(3)_R84.nxml.txt.nlp	22621373	SENT10	3	3	8	8	hyaluronan	CD44	PA165958431	960	0.766
NULL	Arthritis_Res_Ther_2014_Apr_3_16(2)_R86.nxml.txt.nlp	24708674	SENT223	5	5	16	16	bosentan	BLM	PA10034	641	0.766
NULL	Cancers_(Basel)_2012_Jul_16_4(3)_673-700.nxml.txt.nlp	24213461	SENT288	25	25	7	7	bezafibrate	HIF-1	PA162364313	29072	0.766
NULL	Oncotarget_2014_Aug_4_5(17)_7760-7775.nxml.txt.nlp	25226615	SENT224	16	16	27	27	etoposide	ADM	PA449552	133	0.766
NULL	Ther_Clin_Risk_Manag_2007_Jun_3(3)_401-410.nxml.txt.nlp	18488071	SENT53	6	6	20	20	tramadol	ACR	PA451735	49	0.766
NULL	Pharmaceuticals_(Basel)_2014_Mar_5_7(3)_311-338.nxml.txt.nlp	24603603	SENT44	21	21	5	5	cetuximab	EGFR	PA10040	1956	0.766
NULL	Ecancermedicalscience_2008_Feb_18_2_75.nxml.txt.nlp	22275966	SENT146	26	26	7	7	gefitinib	EGFR	PA131301952	1956	0.766
NULL	Indian_J_Dermatol_2013_Mar-Apr_58(2)_164c.nxml.txt.nlp	23716858	SENT10	33	33	41	41	bevacizumab	CEA	PA130232992	5670;1087	0.766
NULL	ScientificWorldJournal_2013_Oct_1_2013_523480.nxml.txt.nlp	24198723	SENT109	8	8	25	25	sertraline	Bcl-2	PA451333	596	0.766
NULL	Clin_Drug_Investig_2013_Aug_23_33(10)_727-736.nxml.txt.nlp	23975654	SENT170	24	24	12	12	dextromethorphan	CYP1A2	PA449273	1544	0.766
NULL	Springerplus_2014_Sep_9_3_510.nxml.txt.nlp	25279302	SENT185	15	15	17	17	creatine	GAMT	PA164778930	2593	0.766
NULL	Environ_Health_Perspect_1999_Nov_107(11)_861-866.nxml.txt.nlp	10544152	SENT6	11	11	13	13	diethylstilbestrol	DES	PA449307	1674	0.766
NULL	Breast_Cancer_Res_2005_Jul_18_7(5)_187-189.nxml.txt.nlp	16168136	SENT4	14	14	25	25	tamoxifen	EGFR	PA451581	1956	0.766
NULL	Acta_Pharmacol_Sin_2014_Oct_25_35(10)_1293-1301.nxml.txt.nlp	25152022	SENT161	35	35	22	22	enalapril	CD68	PA449456	968	0.766
NULL	Case_Rep_Med_2014_Mar_4_2014_923496.nxml.txt.nlp	24715926	SENT137	20	20	27	27	tocilizumab	IL-6	PA165292659	3569	0.766
NULL	ScientificWorldJournal_2012_Aug_2_2012_940613.nxml.txt.nlp	22919361	SENT175	35	35	12	12	naloxone	PAG	PA450586	55824	0.766
NULL	Int_J_Chron_Obstruct_Pulmon_Dis_2006_Dec_1(4)_373-379.nxml.txt.nlp	18044094	SENT109	3	3	14	14	roflumilast	PDE4D	PA165948052	5144	0.766
NULL	Mol_Biol_Cell_2012_Mar_15_23(6)_1104-1114.nxml.txt.nlp	22262456	SENT347	4	4	12	12	genistein	San	PA165109660	80218	0.766
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Jun_22_69(Pt_7)_o1137.nxml.txt.nlp	24046688	SENT69	19	19	6	6	ethanol	mol	PA448073	90527	0.766
NULL	Open_Med_Chem_J_2011_Sep_9_5_82-92.nxml.txt.nlp	21966329	SENT7	9	9	3	3	liraglutide	GLP-1	PA165958364	100125288	0.766
NULL	Breast_Cancer_Res_Treat_2013_Jan_10_137(1)_1-12.nxml.txt.nlp	23143215	SENT108	16	16	5	5	lapatinib	BCRP1	PA152241907	317687	0.766
NULL	Front_Physiol_2014_Dec_19_5_497.nxml.txt.nlp	25566093	SENT127	34	34	11	11	paraformaldehyde	MIO	PA450790	51085	0.766
NULL	Ecancermedicalscience_2009_Jun_9_3_148.nxml.txt.nlp	22276013	SENT43	23	23	4	4	anastrozole	ATAC	PA448432	6375	0.766
NULL	Biomed_Res_Int_2014_Jan_20_2014_948427.nxml.txt.nlp	24563867	SENT194	10	10	5	5	buspirone	COB	PA448689	4519	0.766
NULL	Int_J_Mol_Sci_2012_Aug_21_13(8)_10461-10477.nxml.txt.nlp	22949874	SENT790	14	14	1	1	paclitaxel	Beta3	PA450761	27319	0.766
NULL	J_Gen_Physiol_1987_Aug_1_90(2)_209-227.nxml.txt.nlp	3655717	SENT7	37	37	33	33	aminohippurate	NO3	PA134711723	4681	0.766
NULL	Oncoscience_2014_Mar_12_1(2)_167-179.nxml.txt.nlp	25126591	SENT228	35	35	5	5	everolimus	PTEN	PA164746311	5728	0.766
NULL	Oxid_Med_Cell_Longev_2012_Jan_19_2012_390678.nxml.txt.nlp	22315655	SENT8	16	16	27	27	gliclazide	NAC	PA10892	22861	0.766
NULL	J_Immunol_Res_2014_Jul_16_2014_696812.nxml.txt.nlp	25133198	SENT107	3	3	24	24	rifaximin	TLR2	PA164752443	7097	0.766
NULL	J_Korean_Med_Sci_2006_Dec_31_21(6)_1037-1040.nxml.txt.nlp	17179683	SENT71	41	41	13	13	metronidazole	BAM	PA450484	9126	0.766
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Sep_30_66(Pt_10)_o2696.nxml.txt.nlp	21587664	SENT56	8	8	18	18	benzaldehyde	mol	PA448571	90527	0.766
NULL	Ann_Oncol_2011_Mar_8_22(3)_503-514.nxml.txt.nlp	20616198	SENT220	12	12	29	29	anastrozole	aromatase	PA448432	1588	0.766
NULL	FASEB_J_2012_May_26(5)_1884-1891.nxml.txt.nlp	22253475	SENT419	4	4	14	14	ivermectin	gamma	PA450133	9913	0.766
NULL	Br_J_Ophthalmol_2010_Oct_16_94(10)_1307-1311.nxml.txt.nlp	20558428	SENT83	18	18	13	13	dorzolamide	CRA	PA164748765	51747;10903	0.766
NULL	Cough_2006_Dec_15_2_10.nxml.txt.nlp	17173683	SENT30	16	16	24	24	capsaicin	TRPV1	PA448776	7442	0.766
NULL	Oncol_Rep_2012_Apr_30_27(4)_923-928.nxml.txt.nlp	22209766	SENT90	14	14	19	19	erlotinib	EGFR	PA134687924	1956	0.765
NULL	Ther_Clin_Risk_Manag_2005_Jun_1(2)_107-114.nxml.txt.nlp	18360550	SENT25	2	2	24	24	paclitaxel	Yes	PA450761	7525	0.765
NULL	Cancer_Cell_Int_2005_Aug_24_5_28.nxml.txt.nlp	16120219	SENT168	3	3	20	20	etoposide	p53	PA449552	7157	0.765
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT230	8	8	3	3	capsaicin	p53	PA448776	7157	0.765
NULL	Cell_Death_Dis_2013_Jul_4_4(7)_e702.nxml.txt.nlp	23828565	SENT67	25	25	9	9	etoposide	TRAIL	PA449552	8743	0.765
NULL	FEBS_Open_Bio_2014_Jan_6_4_77-89.nxml.txt.nlp	24490132	SENT52	12	12	6	6	ebselen	GDH	PA161660841	51084;2746	0.765
NULL	Nat_Biotechnol_2011_Oct_23_29(11)_1028-1033.nxml.txt.nlp	22020385	SENT248	15	15	1	1	thrombin	VIII	PA451674	1351	0.765
NULL	Cancer_2014_Jun_15_120(12)_1871-1880.nxml.txt.nlp	24634003	SENT13	8	8	10	10	sunitinib	IFN	PA162372840	3439	0.765
NULL	J_Mol_Signal_2008_Mar_31_3_8.nxml.txt.nlp	18377662	SENT190	16	16	7	7	pp2	KDR		3791	0.765
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_May_22_66(Pt_6)_o1400.nxml.txt.nlp	21579479	SENT47	19	19	34	34	ethanol	mol	PA448073	90527	0.765
NULL	Br_J_Cancer_2010_Sep_7_103(6)_889-898.nxml.txt.nlp	20664599	SENT11	24	24	20	20	paclitaxel	HER-2	PA450761	2064	0.765
NULL	Int_Semin_Surg_Oncol_2007_Feb_14_4_5.nxml.txt.nlp	17394628	SENT162	27	27	38	38	cisplatin	MLH1	PA449014	4292	0.765
NULL	Biomed_Res_Int_2013_Aug_6_2013_602987.nxml.txt.nlp	24027759	SENT195	21	21	4	4	etoposide	SMF	PA449552	22993	0.765
NULL	Hum_Genomics_2013_Apr_5_7(1)_10.nxml.txt.nlp	23561625	SENT34	10	10	21	21	flavopiridol	CDK7	PA452627	1022	0.765
NULL	Mol_Brain_2014_Aug_29_7_62.nxml.txt.nlp	25167838	SENT143	7	7	24	24	resveratrol	SIRT1		23411	0.765
NULL	Mol_Cancer_2009_Jul_14_8_48.nxml.txt.nlp	19602291	SENT29	18	18	4	4	vincristine	BRCA1	PA451879	672	0.765
NULL	Cell_Cycle_2013_Jul_1_12(13)_1995.nxml.txt.nlp	23759574	SENT30	11	11	34	34	gemcitabine	NLRP3	PA449748	114548	0.765
NULL	Exp_Diabetes_Res_2011_Dec_27_2011_604989.nxml.txt.nlp	21253359	SENT175	15	15	29	29	clonidine	GLP-1	PA449051	100125288	0.765
NULL	Tuberc_Res_Treat_2014_May_20_2014_349141.nxml.txt.nlp	24967101	SENT169	10	10	14	14	ethionamide	DST	PA164768738	667	0.765
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT104	10	10	5	5	trastuzumab	MUC1	PA451743	4582	0.765
NULL	Int_J_Mol_Sci_2014_Sep_29_15(10)_17411-17441.nxml.txt.nlp	25268615	SENT247	0	0	15	15	cyclosporine	CD147	PA449167	682	0.765
NULL	Iran_J_Pharm_Res_2014_Winter_13(1)_181-189.nxml.txt.nlp	24734070	SENT189	7	7	10	10	estradiol	CA1	PA449503	759	0.765
NULL	Genome_Biol_2011_Sep_14_12(9)_228.nxml.txt.nlp	21920049	SENT135	6	6	0	0	lipase	ANGPTL3	PA450239	27329	0.765
NULL	Oncotarget_2012_Jan_28_3(1)_84-97.nxml.txt.nlp	22289741	SENT214	12	12	4	4	acetazolamide	CAIX	PA448018	768	0.765
NULL	J_Cardiothorac_Surg_2014_Jun_19_9_105.nxml.txt.nlp	24942178	SENT52	9	9	12	12	protamine	ACT	PA10366	12;11332;9457;641455	0.765
NULL	Nature_2012_Jan_25_482(7384)_232-236.nxml.txt.nlp	22278056	SENT201	19	19	9	9	suramin	ODC	PA10292	4953;89874	0.765
NULL	J_Cell_Biol_1997_Jul_28_138(2)_323-330.nxml.txt.nlp	9230074	SENT4	9	9	11	11	thrombin	ADP	PA451674	23038	0.765
NULL	Neural_Regen_Res_2014_Nov_1_9(21)_1897-1901.nxml.txt.nlp	25558239	SENT32	7	7	15	15	diazepam	CA1	PA449283	759	0.765
NULL	EMBO_Mol_Med_2014_Oct_17_6(10)_1294-1311.nxml.txt.nlp	25231413	SENT183	0	0	14	14	forskolin	S5B	PA146096022	5711	0.765
NULL	Exp_Diabetes_Res_2011_Dec_27_2011_604989.nxml.txt.nlp	21253359	SENT7	11	11	13	13	clonidine	GLP-1	PA449051	100125288	0.765
NULL	Toxins_(Basel)_2010_Jun_9_2(6)_1381-1398.nxml.txt.nlp	22069643	SENT215	0	0	12	12	probenecid	OAT4	PA451106	114571;55867	0.765
NULL	Oncotarget_2014_Jun_8_5(17)_7446-7457.nxml.txt.nlp	25277184	SENT33	19	19	5	5	nutlin-3	TRIM8		81603	0.765
NULL	Front_Neurol_2011_May_17_2_30.nxml.txt.nlp	21629765	SENT215	2	2	4	4	riluzole	GDNF	PA451251	2668	0.765
NULL	Mol_Cancer_2014_Jan_28_13_17.nxml.txt.nlp	24472312	SENT232	5	5	15	15	ponatinib	Mcl-1	PA165980594	4170	0.765
NULL	Oncologist_2010_Apr_15(4)_360-371.nxml.txt.nlp	20413641	SENT213	35	35	11	11	palifermin	KGF	PA164744014	2252	0.765
NULL	J_Mol_Signal_2014_Mar_6_9_1.nxml.txt.nlp	24597858	SENT103	0	0	5	5	alprenolol	EGFR	PA164750541	1956	0.765
NULL	J_Cardiovasc_Thorac_Res_2014_Jun_30_6(2)_79-84.nxml.txt.nlp	25031821	SENT64	6	6	11	11	hydrocortisone	IL-6	PA449905	3569	0.765
NULL	Front_Oncol_2014_May_19_4_113.nxml.txt.nlp	24904827	SENT132	23	23	2	2	cisplatin	DGCR8	PA449014	54487	0.765
NULL	J_Carcinog_Mutagen_2013_Aug_5_Suppl_7_4.nxml.txt.nlp	25587491	SENT149	23	23	20	20	cetuximab	EGFR	PA10040	1956	0.765
NULL	Acta_Pharmacol_Sin_2012_May_4_33(5)_644-651.nxml.txt.nlp	22555371	SENT179	17	17	8	8	lipase	CRF	PA450239	1392;10882	0.765
NULL	Br_J_Cancer_2009_Jul_21_101(2)_269-277.nxml.txt.nlp	19603033	SENT36	8	8	3	3	cisplatin	XIAP	PA449014	331	0.765
NULL	J_Korean_Med_Sci_2009_Jun_15_24(3)_511-512.nxml.txt.nlp	19543518	SENT37	35	35	28	28	clarithromycin	DST	PA449028	667	0.765
NULL	Ann_Rheum_Dis_2008_Sep_11_68(7)_1146-1152.nxml.txt.nlp	18794178	SENT64	10	10	32	32	sulfasalazine	ACR	PA451547	49	0.765
NULL	Ital_J_Pediatr_2010_Dec_22_36_79.nxml.txt.nlp	21176172	SENT112	12	12	17	17	dextroamphetamine	ATX	PA449269	5168;23049	0.765
NULL	Oncotarget_2014_Oct_21_5(22)_11709-11722.nxml.txt.nlp	25365944	SENT221	4	4	7	7	metformin	JNK	PA450395	5599	0.765
NULL	Onco_Targets_Ther_2014_Sep_9_7_1571-1582.nxml.txt.nlp	25228815	SENT119	10	10	8	8	sunitinib	VEGFR2	PA162372840	3791	0.765
NULL	Cell_Death_Dis_2010_Feb_4_1(2)_e23.nxml.txt.nlp	21364631	SENT100	30	30	35	35	imipramine	JNK	PA449969	5599	0.765
NULL	Biomed_Res_Int_2014_Jan_2_2014_682010.nxml.txt.nlp	24524084	SENT85	6	6	12	12	imatinib	IL-2	PA10804	3558	0.765
NULL	Exp_Ther_Med_2013_Aug_20_6(2)_310-316.nxml.txt.nlp	24137180	SENT158	5	5	2	2	fasudil	NF-kappaB	PA165946121	4790	0.765
NULL	Exp_Ther_Med_2014_Sep_20_8(3)_968-972.nxml.txt.nlp	25120631	SENT124	3	3	23	23	naringin	ADP	PA151958360	23038	0.765
NULL	Clin_Exp_Reprod_Med_2012_Dec_31_39(4)_153-160.nxml.txt.nlp	23346525	SENT55	6	6	16	16	hyaluronidase	MTF	PA164745713	4500	0.765
NULL	BMB_Rep_2014_Jan_47(1)_33-38.nxml.txt.nlp	24209634	SENT85	10	10	7	7	cisplatin	CXCR4	PA449014	7852	0.765
NULL	Curr_Neuropharmacol_2013_May_11(3)_263-275.nxml.txt.nlp	24179463	SENT111	25	25	18	18	sr144528	CB2		1269	0.765
NULL	J_Hematol_Oncol_2013_Nov_5_6_83.nxml.txt.nlp	24283248	SENT117	11	11	13	13	nutlin-3	TP53		7157	0.765
NULL	Breast_Cancer_Res_Treat_2013_Apr_12_138(2)_427-435.nxml.txt.nlp	23479422	SENT282	12	12	17	17	trastuzumab	HER2	PA451743	2064	0.765
NULL	Exp_Ther_Med_2013_Jan_30_5(1)_308-314.nxml.txt.nlp	23251289	SENT148	20	20	4	4	vinblastine	ABCC2	PA451877	1244	0.765
NULL	Drugs_R_D_2011_Jun_27_11(2)_101-111.nxml.txt.nlp	21679003	SENT114	22	22	27	27	irinotecan	IFL	PA450085	3439	0.765
NULL	Diabetes_Obes_Metab_2011_Nov_13(11)_982-989.nxml.txt.nlp	21615670	SENT168	30	30	13	13	exenatide	GLP-1	PA164749238	100125288	0.765
NULL	Breast_Cancer_(Auckl)_2012_Oct_25_6_159-171.nxml.txt.nlp	23133315	SENT78	17	17	24	24	carboplatin	HER2	PA448803	2064	0.765
NULL	Oncotarget_2011_Dec_24_2(12)_896-917.nxml.txt.nlp	22203527	SENT309	14	14	32	32	metformin	AKT	PA450395	207	0.765
NULL	Front_Mol_Neurosci_2012_Nov_12_5_99.nxml.txt.nlp	23162427	SENT259	0	0	27	27	cocaine	CPP	PA449072	340451	0.765
NULL	Mol_Vis_2011_May_4_17_1172-1181.nxml.txt.nlp	21617754	SENT208	14	14	6	6	staurosporine	FKBP51	PA165109623	2289	0.765
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jul_31_66(Pt_8)_o2178-o2179.nxml.txt.nlp	21588457	SENT73	16	16	6	6	ethanol	mol	PA448073	90527	0.765
NULL	Oncotarget_2013_Aug_26_4(10)_1662-1672.nxml.txt.nlp	24091566	SENT17	7	7	12	12	trastuzumab	EGFR	PA451743	1956	0.765
NULL	Oncol_Lett_2014_Jan_6_7(1)_255-259.nxml.txt.nlp	24348859	SENT93	25	25	27	27	capecitabine	DCX	PA448771	1641	0.765
NULL	Int_J_Mol_Sci_2013_Apr_26_14(5)_9111-9125.nxml.txt.nlp	23624604	SENT373	16	16	7	7	protamine	MRI	PA10366	78996	0.765
NULL	Chin_J_Cancer_2011_Nov_30(11)_749-756.nxml.txt.nlp	22035855	SENT110	7	7	20	20	tamoxifen	beta-catenin	PA451581	1499	0.765
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT267	20	20	14	14	warfarin	CYP4F2	PA451906	8529	0.765
NULL	Drugs_R_D_2011_Sep_25_11(3)_227-249.nxml.txt.nlp	21902286	SENT84	0	0	12	12	decitabine	CD34	PA164749631	947	0.765
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT45	15	15	27	27	metformin	AMPK	PA450395	5563	0.765
NULL	Mol_Cancer_2010_Aug_18_9_218.nxml.txt.nlp	20718987	SENT187	12	12	22	22	gefitinib	VEGFR	PA131301952	3791	0.765
NULL	Clin_Med_Insights_Womens_Health_2013_Jan_22_6_1-11.nxml.txt.nlp	24665209	SENT61	33	33	11	11	anastrozole	ATAC	PA448432	6375	0.765
NULL	Mol_Vis_2011_Aug_11_17_2157-2170.nxml.txt.nlp	21850191	SENT189	27	27	22	22	tacrolimus	Bp50	PA451578	958	0.765
NULL	Mol_Cancer_2009_Feb_13_8_8.nxml.txt.nlp	19216791	SENT212	12	12	20	20	cisplatin	PTEN	PA449014	5728	0.765
NULL	Oncoimmunology_2012_Dec_1_1(9)_1557-1576.nxml.txt.nlp	23264902	SENT81	37	37	35	35	temozolomide	GM-CSF	PA451609	1437	0.765
NULL	Evid_Based_Complement_Alternat_Med_2012_May_7_2012_242810.nxml.txt.nlp	22645625	SENT158	20	20	24	24	rifampin	CYP3A4	PA451250	1576	0.765
NULL	FEBS_Open_Bio_2011_Dec_27_2_1-5.nxml.txt.nlp	23650573	SENT293	20	20	32	32	sunitinib	MDM2	PA162372840	4193	0.765
NULL	Mol_Biol_Cell_2013_Jul_1_24(13)_2134-2145.nxml.txt.nlp	23657817	SENT80	9	9	12	12	pp2	ILK		3611	0.765
NULL	Braz_J_Microbiol_2012_Jun_1_Jan-Mar_43(1)_187-200.nxml.txt.nlp	24031817	SENT162	12	12	5	5	nitrogen	C15	PA450643	51316	0.765
NULL	Semin_Immunol_2011_Aug_23(4)_293-303.nxml.txt.nlp	21616680	SENT461	11	11	8	8	sirolimus	CD86	PA451365	942	0.765
NULL	J_Cancer_Prev_2014_Mar_19(1)_39-46.nxml.txt.nlp	25337571	SENT109	20	20	27	27	ethanol	JNK	PA448073	5599	0.765
NULL	Iran_J_Reprod_Med_2013_Jul_11(7)_565-576.nxml.txt.nlp	24639792	SENT16	9	9	20	20	nonoxynol-9	SLPI	PA450648	6590	0.765
NULL	Leukemia_2014_Mar_13_28(3)_629-641.nxml.txt.nlp	24263804	SENT201	34	34	10	10	imatinib	PAK2	PA10804	5062	0.765
NULL	J_Gen_Physiol_2004_Apr_123(4)_427-439.nxml.txt.nlp	15024039	SENT478	15	15	19	19	genistein	PP2	PA165109660	4888	0.765
NULL	Br_J_Cancer_2012_May_22_106(11)_1779-1789.nxml.txt.nlp	22549178	SENT136	0	0	9	9	pertuzumab	HER3		2065	0.765
NULL	Cell_Commun_Signal_2014_Oct_5_12(1)_54.nxml.txt.nlp	NULL	SENT237	19	19	17	17	fasudil	MRCK	PA165946121	8476	0.765
NULL	J_Mol_Signal_2006_Dec_6_1_8.nxml.txt.nlp	17224083	SENT128	31	31	46	46	thrombin	Rho	PA451674	29984	0.765
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1137-1144.nxml.txt.nlp	20234366	SENT34	13	13	18	18	panitumumab	KRAS	PA162373091	3845	0.765
NULL	Diabetes_Obes_Metab_2011_Nov_13(11)_982-989.nxml.txt.nlp	21615670	SENT19	6	6	15	15	exenatide	PPG	PA164749238	5552	0.765
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Jul_23_3(7)_e126.nxml.txt.nlp	25054314	SENT74	15	15	29	29	docetaxel	MRP2	PA449383	100130958;57626;1244	0.765
NULL	Adv_Hematol_2010_Dec_30_2010_624040.nxml.txt.nlp	21234357	SENT112	13	13	20	20	bleomycin	CHOP	PA448645	1649	0.765
NULL	eLife_2013_Nov_5_2_e00969.nxml.txt.nlp	24192036	SENT556	14	14	8	8	vemurafenib	BRAF	PA165946873	673	0.765
NULL	Oncol_Lett_2014_Jan_11_7(1)_156-158.nxml.txt.nlp	24348840	SENT4	7	7	13	13	epirubicin	CHOP	PA449476	1649	0.765
NULL	Chem_Rev_2011_Oct_12_111(10)_5899-5921.nxml.txt.nlp	21923193	SENT539	11	11	4	4	ketorolac	FAAH	PA450150	79152;2166	0.765
NULL	Target_Oncol_2013_Mar_30_8(1)_27-33.nxml.txt.nlp	23361373	SENT53	18	18	10	10	paclitaxel	EGFR	PA450761	1956	0.765
NULL	Aging_(Albany_NY)_2011_Jan_18_3(1)_33-43.nxml.txt.nlp	21248371	SENT122	2	2	16	16	zinc	p53	PA451956	7157	0.765
NULL	Iran_J_Basic_Med_Sci_2012_Mar-Apr_15(2)_709-718.nxml.txt.nlp	23493500	SENT151	32	32	29	29	indomethacin	COX	PA449982	1351	0.765
NULL	Mol_Cancer_2010_May_20_9_115.nxml.txt.nlp	20487546	SENT235	12	12	18	18	fludarabine	SULF2	PA449655	55959	0.765
NULL	J_Cardiothorac_Surg_2012_Sep_27_7_97.nxml.txt.nlp	23013706	SENT159	14	14	6	6	warfarin	CYP4F2	PA451906	8529	0.765
NULL	Exp_Mol_Med_2012_Sep_30_44(9)_536-544.nxml.txt.nlp	22771771	SENT171	3	3	12	12	celecoxib	p16	PA448871	1029	0.765
NULL	J_Carcinog_2014_Nov_27_13_13.nxml.txt.nlp	25525412	SENT86	21	21	29	29	irinotecan	EGFR	PA450085	1956	0.765
NULL	Oncol_Lett_2014_May_11_7(5)_1401-1408.nxml.txt.nlp	24765145	SENT173	2	2	7	7	paclitaxel	PI3K	PA450761	5290	0.765
NULL	Iran_J_Basic_Med_Sci_2012_Nov-Dec_15(6)_1202-1209.nxml.txt.nlp	23653852	SENT127	7	7	16	16	metformin	VEGF-A	PA450395	7422	0.765
NULL	Diabetes_Care_2010_Jan_21_33(1)_156-161.nxml.txt.nlp	19846797	SENT176	20	20	16	16	metformin	B12	PA450395	7126;4709	0.765
NULL	J_Korean_Neurosurg_Soc_2013_Oct_31_54(4)_329-335.nxml.txt.nlp	24294457	SENT185	19	19	32	32	trastuzumab	HER-2	PA451743	2064	0.765
NULL	Evid_Based_Complement_Alternat_Med_2013_May_16_2013_928280.nxml.txt.nlp	23762169	SENT157	10	10	20	20	doxorubicin	P-gp	PA449412	5243	0.765
NULL	Clin_Med_Insights_Blood_Disord_2013_Nov_14_6_23-27.nxml.txt.nlp	25512717	SENT21	23	23	30	30	doxorubicin	CHOP	PA449412	1649	0.765
NULL	Nucleic_Acids_Res_2006_Jun_6_34(10)_3128-3138.nxml.txt.nlp	16757578	SENT142	18	18	33	33	norfloxacin	CRL3	PA450654	133396	0.765
NULL	Mol_Cancer_2013_Mar_5_12_17.nxml.txt.nlp	23497256	SENT197	8	8	17	17	sunitinib	p53	PA162372840	7157	0.765
NULL	Cancers_(Basel)_2012_Oct_29_4(4)_1146-1160.nxml.txt.nlp	24213502	SENT148	39	39	10	10	lapatinib	HER2	PA152241907	2064	0.765
NULL	Clin_Sci_(Lond)_2013_Feb_1_124(Pt_3)_153-164.nxml.txt.nlp	23075334	SENT184	6	6	3	3	resveratrol	SIRT1		23411	0.765
NULL	Leukemia_2013_Jan_11_27(1)_32-40.nxml.txt.nlp	22781593	SENT110	16	16	12	12	dasatinib	FGFR1	PA162372878	2260	0.765
NULL	HSR_Proc_Intensive_Care_Cardiovasc_Anesth_2010_2(2)_81-91.nxml.txt.nlp	23440622	SENT134	3	3	12	12	clopidogrel	ADP	PA449053	23038	0.765
NULL	Cell_Commun_Signal_2014_Dec_24_12(1)_78.nxml.txt.nlp	NULL	SENT58	12	12	22	22	losartan	MYH7	PA450268	4625	0.765
NULL	Oncotarget_2014_Aug_19_5(18)_8737-8749.nxml.txt.nlp	25228590	SENT79	0	0	24	24	crizotinib	MYCN	PA165946122	4613	0.765
NULL	Diabetes_2009_Feb_58(2)_422-432.nxml.txt.nlp	19033399	SENT152	5	5	31	31	carbachol	CHOP	PA448784	1649	0.765
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jun_5_66(Pt_7)_o1550.nxml.txt.nlp	21587795	SENT58	36	36	28	28	ethanol	mol	PA448073	90527	0.765
NULL	Open_Biochem_J_2011_Sep_23_5_45-51.nxml.txt.nlp	21966325	SENT6	3	3	17	17	indomethacin	IRE1	PA449982	2081	0.765
NULL	Core_Evid_2010_Oct_21_5_61-76.nxml.txt.nlp	21042543	SENT76	9	9	11	11	panitumumab	IFL	PA162373091	3439	0.765
NULL	Mol_Cancer_2006_Sep_5_5_34.nxml.txt.nlp	16953886	SENT114	26	26	17	17	doxorubicin	XIAP	PA449412	331	0.765
NULL	Int_J_Mol_Sci_2014_Jun_26_15(7)_11416-11434.nxml.txt.nlp	24972137	SENT30	2	2	14	14	sitagliptin	GLP-1	PA164748978	100125288	0.765
NULL	Indian_J_Endocrinol_Metab_2014_Jan-Feb_18(1)_32-38.nxml.txt.nlp	24701427	SENT121	3	3	23	23	iron	IL-6	PA450087	3569	0.765
NULL	Biomed_Res_Int_2013_Nov_7_2013_946958.nxml.txt.nlp	24312914	SENT26	3	3	9	9	hyaluronan	RHAMM	PA165958431	3161	0.765
NULL	Braz_J_Med_Biol_Res_2011_Dec_9_45(1)_13-19.nxml.txt.nlp	22147192	SENT56	38	38	1	1	paraformaldehyde	P14	PA450790	11102;;6280;56259	0.765
NULL	Biomed_Res_Int_2013_Jun_18_2013_104315.nxml.txt.nlp	23853765	SENT108	5	5	33	33	pitrakinra	IL-13	PA165983754	3596	0.765
NULL	Cell_Death_Dis_2014_Mar_13_5(3)_e1118.nxml.txt.nlp	24625977	SENT43	24	24	8	8	etoposide	UBXN2A	PA449552	165324	0.765
NULL	Exp_Ther_Med_2014_Nov_29_8(5)_1473-1478.nxml.txt.nlp	25289044	SENT125	15	15	12	12	heparin	AZU	PA449855	566	0.765
NULL	Bone_Marrow_Transplant_2011_Mar_24_46(3)_430-435.nxml.txt.nlp	20498647	SENT144	7	7	1	1	infliximab	IL-2	PA452639	3558	0.765
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT238	4	4	0	0	vinblastine	MVP	PA451877	9961	0.765
NULL	Acta_Pharmacol_Sin_2013_Sep_5_34(9)_1208-1216.nxml.txt.nlp	23852087	SENT127	32	32	25	25	disulfiram	EPO	PA449376	7076;8288;2056	0.765
NULL	Case_Rep_Med_2014_Mar_24_2014_860570.nxml.txt.nlp	24782898	SENT16	17	17	24	24	choline	FDG	PA448976	23583	0.765
NULL	Clin_Ophthalmol_2014_Apr_28_8_807-812.nxml.txt.nlp	24812486	SENT6	40	40	16	16	bevacizumab	CRT	PA130232992	811	0.765
NULL	Nucleic_Acids_Res_2005_Jun_21_33(11)_3540-3549.nxml.txt.nlp	15972796	SENT187	22	22	34	34	collagenase	Fli1	PA449107	2314	0.765
NULL	Br_J_Cancer_2010_May_11_102(10)_1503-1510.nxml.txt.nlp	20461093	SENT179	9	9	11	11	tamoxifen	AIB1	PA451581	8202	0.765
NULL	ScientificWorldJournal_2012_Jun_18_2012_565047.nxml.txt.nlp	22792045	SENT12	30	30	14	14	ethanol	CO2	PA448073	4513	0.765
NULL	Lancet_2011_Aug_13_378(9791)_595-605.nxml.txt.nlp	21784508	SENT272	19	19	0	0	perindopril	P14	PA450877	11102;;6280;56259	0.765
NULL	Aging_(Albany_NY)_2014_Oct_30_6(10)_788-819.nxml.txt.nlp	25411230	SENT242	26	26	11	11	levodopa	COMT	PA450213	1312	0.765
NULL	Diabetes_2013_Jun_20_62(6)_2122-2129.nxml.txt.nlp	23378607	SENT235	10	10	12	12	troglitazone	AMPK	PA451799	5563	0.765
NULL	J_Adv_Pract_Oncol_2012_Nov_1_Nov-Dec_3(6)_391-394.nxml.txt.nlp	25031970	SENT19	1	1	9	9	pertuzumab	HER2		2064	0.765
NULL	Int_J_Breast_Cancer_2011_Aug_23_2011_420981.nxml.txt.nlp	22295222	SENT134	4	4	34	34	chloroquine	CXCL12	PA448948	6387	0.765
NULL	Nat_Neurosci_2013_Dec_10_16(12)_1794-1801.nxml.txt.nlp	24212673	SENT92	26	26	24	24	betaine	BGT-1	PA448603	6539	0.765
NULL	Curr_Clin_Pharmacol_2011_Feb_7(1)_56-65.nxml.txt.nlp	22299770	SENT29	18	18	6	6	cetuximab	KRAS	PA10040	3845	0.765
NULL	Diabetes_2009_Jan_58(1)_174-184.nxml.txt.nlp	18984736	SENT169	2	2	6	6	nifedipine	TRPV2	PA450631	51393	0.765
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT110	1	1	6	6	pp2	EGFR		1956	0.765
NULL	Mol_Cancer_2007_Sep_18_6_56.nxml.txt.nlp	17877814	SENT157	28	28	17	17	erlotinib	EGFR	PA134687924	1956	0.765
NULL	Iran_Red_Crescent_Med_J_2014_Jun_5_16(6)_e18022.nxml.txt.nlp	25068053	SENT93	3	3	8	8	alendronate	BMD	PA448082	1756;7439	0.765
NULL	ASN_Neuro_2009_Oct_21_1(4)_e00018.nxml.txt.nlp	19807694	SENT179	15	15	7	7	ganciclovir	E16	PA449733	8140	0.765
NULL	Core_Evid_2014_Jul_21_9_89-97.nxml.txt.nlp	25093016	SENT80	5	5	29	29	infliximab	IL-17	PA452639	3605	0.765
NULL	BMJ_Open_2013_Sep_3_3(9)_e003201.nxml.txt.nlp	24002982	SENT210	25	25	11	11	miglitol	GLP-1	PA164776726	100125288	0.765
NULL	Biologics_2014_Dec_4_8_281-291.nxml.txt.nlp	25506209	SENT115	20	20	25	25	vemurafenib	CRAF	PA165946873	5894	0.765
NULL	Int_J_Environ_Res_Public_Health_2010_Apr_30_7(4)_1448-1466.nxml.txt.nlp	20617039	SENT77	6	6	11	11	ethanol	NR1	PA448073	27158	0.765
NULL	Cell_Cycle_2012_Oct_15_11(20)_3718.nxml.txt.nlp	22982997	SENT18	12	12	20	20	hydroxychloroquine	ATG12	PA164777036	9140	0.765
NULL	Mol_Pain_2014_Apr_9_10_24.nxml.txt.nlp	24716552	SENT168	7	7	23	23	capsaicin	NK1R	PA448776	6869	0.765
NULL	Int_J_Endocrinol_2010_May_26_2010_906163.nxml.txt.nlp	20585352	SENT91	10	10	44	44	cinacalcet	MEN1	PA164776671	4221	0.765
NULL	Front_Microbiol_2014_Mar_14_5_99.nxml.txt.nlp	24672516	SENT95	17	17	11	11	voriconazole	NF-kappaB	PA10233	4790	0.765
NULL	Cell_Death_Dis_2012_Jun_21_3(6)_e327.nxml.txt.nlp	22717582	SENT9	12	12	27	27	vincristine	p53	PA451879	7157	0.765
NULL	Int_J_Biochem_Cell_Biol_2010_Jan_42(1)_113-119.nxml.txt.nlp	19800021	SENT117	26	26	14	14	curcumin	JNK	PA151958596	5599	0.765
NULL	Cell_Regen_(Lond)_2012_Jun_28_1(1)_3.nxml.txt.nlp	25408866	SENT138	21	21	5	5	calcein	MSC	PA132595336	9242	0.765
NULL	Bone_Marrow_Transplant_2011_Jul_11_46(7)_943-949.nxml.txt.nlp	20935680	SENT129	6	6	25	25	plerixafor	CD34	PA165958410	947	0.765
NULL	Br_J_Pharmacol_2008_Oct_18_155(4)_596-605.nxml.txt.nlp	18852694	SENT287	0	0	35	35	fenofibrate	SCAP	PA449594	22937	0.765
NULL	Indian_J_Pharmacol_2013_May-Jun_45(3)_274-277.nxml.txt.nlp	23833372	SENT126	33	33	9	9	colchicine	CA1	PA449092	759	0.765
NULL	Int_J_Mol_Sci_2014_Nov_4_15(11)_20022-20044.nxml.txt.nlp	25375187	SENT190	4	4	11	11	rosiglitazone	adiponectin	PA451283	9370	0.765
NULL	Biochem_Res_Int_2012_Mar_4_2012_685267.nxml.txt.nlp	22496978	SENT211	13	13	22	22	thrombin	Rac-1	PA451674	5879	0.765
NULL	Cells_2014_Nov_27_3(4)_1116-1130.nxml.txt.nlp	25437441	SENT73	5	5	26	26	ethanol	IL-17A	PA448073	3605	0.765
NULL	Ann_Surg_Treat_Res_2014_Feb_22_86(2)_68-75.nxml.txt.nlp	24761411	SENT123	10	10	16	16	resveratrol	survivin		332	0.765
NULL	Mol_Pain_2013_Jun_10_9_27.nxml.txt.nlp	23758830	SENT152	4	4	7	7	tetracaine	ASIC3	PA451638	9311	0.765
NULL	Breast_Cancer_Res_Treat_2012_Jul_24_134(1)_13-20.nxml.txt.nlp	22198412	SENT232	22	22	11	11	trastuzumab	HER2	PA451743	2064	0.765
NULL	Front_Microbiol_2015_Jan_12_5_776.nxml.txt.nlp	25628615	SENT246	4	4	11	11	nitrogen	DSE	PA450643	29940	0.765
NULL	Acta_Pharmacol_Sin_2013_Oct_7_34(10)_1359-1366.nxml.txt.nlp	23933653	SENT36	21	21	28	28	retigabine	KCNQ2	PA144997862	3785	0.765
NULL	Oncotarget_2011_Aug_28_2(8)_588-589.nxml.txt.nlp	21876228	SENT16	19	19	3	3	sunitinib	PTPN12	PA162372840	5782	0.765
NULL	J_Res_Med_Sci_2011_May_16(5)_611-620.nxml.txt.nlp	22091283	SENT4	24	24	26	26	desflurane	DES	PA164749136	1674	0.765
NULL	Int_J_Mol_Sci_2012_Feb_1_13(2)_1481-1496.nxml.txt.nlp	22408403	SENT429	6	6	13	13	omeprazole	ANOVA	PA450704	4858	0.765
NULL	J_Invest_Dermatol_2012_Sep_19_132(9)_2198-2205.nxml.txt.nlp	22513780	SENT84	0	0	7	7	isotretinoin	IL-4	PA450128	3565	0.765
NULL	J_Biol_Chem_2008_Nov_14_283(46)_31679-31689.nxml.txt.nlp	18755684	SENT234	16	16	37	37	iron	FTL	PA450087	2512	0.765
NULL	Oncogene_2014_Oct_9_33(41)_4941-4951.nxml.txt.nlp	24681952	SENT97	1	1	10	10	metformin	WNT5A	PA450395	7474	0.765
NULL	Int_J_Endocrinol_Metab_2013_Apr_1_Spring_11(2)_65-70.nxml.txt.nlp	23825975	SENT149	16	16	3	3	estradiol	CEE	PA449503	51608	0.765
NULL	Biomed_Res_Int_2014_May_4_2014_351252.nxml.txt.nlp	24877084	SENT68	7	7	3	3	bevacizumab	FTM	PA130232992	23322	0.765
NULL	Ann_Intensive_Care_2011_Sep_19_1_38.nxml.txt.nlp	21929821	SENT4	32	32	10	10	glucose	TGC	PA449773	7052	0.765
NULL	Front_Mol_Neurosci_2014_Nov_4_7_83.nxml.txt.nlp	25414638	SENT867	6	6	21	21	sorafenib	c-Jun	PA7000	3725	0.765
NULL	Br_J_Cancer_2003_Mar_10_88(5)_788-795.nxml.txt.nlp	12618891	SENT164	20	20	22	22	bosentan	FasL	PA10034	356	0.765
NULL	Biomed_Res_Int_2013_Dec_10_2013_565218.nxml.txt.nlp	24386638	SENT242	18	18	25	25	imipramine	DIO2	PA449969	1734	0.765
NULL	J_Oncol_2013_Feb_17_2013_872957.nxml.txt.nlp	23476648	SENT110	34	34	25	25	cisplatin	SFN	PA449014	25996;2810	0.765
NULL	Front_Immunol_2013_Nov_8_4_363.nxml.txt.nlp	24265631	SENT255	13	13	21	21	temozolomide	CCL5	PA451609	6352	0.765
NULL	J_Immunol_Res_2014_Jul_21_2014_297073.nxml.txt.nlp	25143957	SENT63	28	28	11	11	glucosamine	HLA-G	PA164747613	3135	0.765
NULL	Curr_Biol_2012_Dec_18_22(24)_2285-2293.nxml.txt.nlp	23142042	SENT183	8	8	10	10	riluzole	SNA	PA451251	6615	0.765
NULL	J_Cell_Biol_1983_Aug_1_97(2)_323-328.nxml.txt.nlp	6224800	SENT7	30	30	25	25	thrombin	EGF	PA451674	1950	0.765
NULL	Breast_Cancer_(Auckl)_2012_Mar_7_6_67-77.nxml.txt.nlp	22438669	SENT48	3	3	22	22	trastuzumab	HER2	PA451743	2064	0.765
NULL	Cell_Death_Dis_2010_Oct_21_1(10)_e86.nxml.txt.nlp	21368859	SENT35	7	7	5	5	doxorubicin	TRAIL	PA449412	8743	0.765
NULL	Breast_Cancer_(Auckl)_2012_Mar_7_6_67-77.nxml.txt.nlp	22438669	SENT96	21	21	7	7	cisplatin	HER2	PA449014	2064	0.765
NULL	Eur_J_Neurosci_2014_Feb_4_39(3)_419-434.nxml.txt.nlp	24494682	SENT313	4	4	23	23	lipase	MGL	PA450239	11343	0.765
NULL	Leukemia_2014_Aug_7_28(8)_1636-1646.nxml.txt.nlp	24418989	SENT130	7	7	20	20	chloroquine	SQSTM1	PA448948	8878	0.765
NULL	FEBS_Open_Bio_2014_Oct_22_4_905-914.nxml.txt.nlp	25383314	SENT97	4	4	11	11	atropine	L-FABP	PA448505	2168	0.765
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT175	6	6	11	11	atorvastatin	p38	PA448500	10598;1432;7965	0.765
NULL	Mol_Biol_Cell_2013_Jul_15_24(14)_2285-2298.nxml.txt.nlp	23720763	SENT116	31	31	3	3	trypsin	MD-1	PA451806	9450	0.765
NULL	Lab_Invest_2011_Apr_14_91(4)_598-608.nxml.txt.nlp	21321535	SENT135	0	0	6	6	sorafenib	CD4	PA7000	920	0.765
NULL	Diabetes_2013_Sep_15_62(9)_3232-3240.nxml.txt.nlp	23835329	SENT21	20	20	17	17	aripiprazole	AAP	PA10026	5345	0.765
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1126-1134.nxml.txt.nlp	21364592	SENT118	5	5	8	8	nicotine	CYP2A6	PA450626	1548	0.765
NULL	J_Physiol_2011_Dec_15_589(Pt_24)_5965-5986.nxml.txt.nlp	22041182	SENT329	1	1	37	37	clotrimazole	ACTH	PA449057	5443	0.765
NULL	Diabetes_Metab_J_2013_Aug_14_37(4)_240-248.nxml.txt.nlp	23991401	SENT132	0	0	2	2	ezetimibe	NPC1L1	PA10816	29881	0.765
NULL	Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.nxml.txt.nlp	24736980	SENT9	34	34	19	19	rosuvastatin	OATP1B1	PA134308647	10599	0.765
NULL	Diabetologia_2007_Mar_24_50(3)_654-665.nxml.txt.nlp	17245590	SENT180	3	3	8	8	rosiglitazone	adiponectin	PA451283	9370	0.765
NULL	Exp_Ther_Med_2013_Nov_13_6(5)_1317-1321.nxml.txt.nlp	24223665	SENT110	28	28	18	18	curcumin	ABCG2	PA151958596	9429	0.765
NULL	Amino_Acids_2014_Feb_20_46(5)_1275-1283.nxml.txt.nlp	24553827	SENT85	3	3	8	8	taurine	CDO	PA451590	50937	0.765
NULL	Nanoscale_Res_Lett_2012_Jan_5_7(1)_48.nxml.txt.nlp	22222095	SENT56	17	17	6	6	ethanol	FTO	PA448073	79068	0.765
NULL	Aging_(Albany_NY)_2009_Feb_18_1(3)_335-349.nxml.txt.nlp	20195489	SENT284	9	9	6	6	etoposide	TNF	PA449552	7124	0.765
NULL	Int_J_Endocrinol_Metab_2013_Dec_21_Winter_11(1)_57-61.nxml.txt.nlp	23853622	SENT114	8	8	3	3	risperidone	PRL	PA451257	5617	0.765
NULL	Ann_Hematol_2011_Feb_17_90(2)_173-183.nxml.txt.nlp	20714724	SENT107	36	36	25	25	resveratrol	CD5		921	0.765
NULL	Oxid_Med_Cell_Longev_2012_Nov_14_2012_856085.nxml.txt.nlp	23213350	SENT234	7	7	23	23	pioglitazone	p47phox	PA450970	653361	0.765
NULL	Int_J_Chron_Obstruct_Pulmon_Dis_2007_Dec_2(4)_453-462.nxml.txt.nlp	18268919	SENT94	9	9	4	4	heparin	VEGF-A	PA449855	7422	0.765
NULL	Clin_Med_Cardiol_2009_Feb_9_3_9-14.nxml.txt.nlp	20508762	SENT31	25	25	8	8	atropine	ACLS	PA448505	46;2737	0.765
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT51	23	23	16	16	trastuzumab	HER3	PA451743	2065	0.765
NULL	Front_Neurosci_2011_Feb_22_5_20.nxml.txt.nlp	21373362	SENT184	11	11	5	5	cyclophosphamide	GP130	PA449165	10128;3572	0.765
NULL	Int_J_Biol_Sci_2013_Mar_7_9(3)_279-288.nxml.txt.nlp	23493630	SENT213	0	0	7	7	tocilizumab	CD4	PA165292659	920	0.765
NULL	Mol_Vis_2012_Jul_18_18_1966-1972.nxml.txt.nlp	22876123	SENT106	9	9	13	13	curcumin	IL-4	PA151958596	3565	0.765
NULL	J_Hematol_Oncol_2013_Jul_18_6_53.nxml.txt.nlp	23866964	SENT66	3	3	17	17	temsirolimus	MTOR	PA164746890	2475	0.765
NULL	Toxins_(Basel)_2010_Mar_31_2(4)_517-551.nxml.txt.nlp	22069598	SENT1541	15	15	2	2	resveratrol	CD95		355	0.765
NULL	Oncologist_2010_Apr_15(4)_372-381.nxml.txt.nlp	20413642	SENT155	0	0	10	10	cetuximab	EGFR	PA10040	1956	0.765
NULL	Iran_J_Pharm_Res_2014_Spring_13(2)_659-664.nxml.txt.nlp	25237362	SENT148	34	34	27	27	pantoprazole	AP-1	PA450774	2353;3727;2354;3725	0.765
NULL	Indian_J_Pharmacol_2008_Aug_40(4)_137-143.nxml.txt.nlp	20040945	SENT157	13	13	10	10	warfarin	CYP2C9	PA451906	1559	0.765
NULL	J_Hematol_Oncol_2013_Jan_4_6_1.nxml.txt.nlp	23286345	SENT149	27	27	10	10	irinotecan	FCGR3A	PA450085	2214	0.765
NULL	Alzheimers_Res_Ther_2013_Jan_3_5(1)_2.nxml.txt.nlp	23286718	SENT145	37	37	22	22	galantamine	ADAS	PA449726	8540	0.765
NULL	Oncol_Lett_2014_Apr_22_7(4)_1191-1196.nxml.txt.nlp	24944691	SENT125	25	25	11	11	tamoxifen	CYP3A4	PA451581	1576	0.765
NULL	Front_Oncol_2014_May_27_4_125.nxml.txt.nlp	24904835	SENT338	24	24	26	26	idarubicin	AIDA	PA449961	64853	0.765
NULL	Breast_Cancer_Res_2010_Jun_18_12(3)_110.nxml.txt.nlp	20584345	SENT56	35	35	38	38	ibandronate	aromatase	PA10270	1588	0.765
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2675-2684.nxml.txt.nlp	24129246	SENT197	24	24	9	9	etoposide	DBC1	PA449552	57805;1620	0.765
NULL	Oncotarget_2014_Mar_13_5(4)_1101-1110.nxml.txt.nlp	24658355	SENT165	18	18	0	0	tamoxifen	MKP-2	PA451581	1846	0.765
NULL	Arch_Toxicol_2014_Nov_5_88(12)_2135-2190.nxml.txt.nlp	25370008	SENT932	13	13	32	32	prednicarbate	LSE	PA164749394	54414	0.765
NULL	Springerplus_2013_Feb_15_2_52.nxml.txt.nlp	23476897	SENT140	1	1	5	5	tamoxifen	aromatase	PA451581	1588	0.765
NULL	J_Clin_Biochem_Nutr_2008_May_29_42(3)_197-203.nxml.txt.nlp	18545641	SENT457	4	4	1	1	curcumin	HO-1	PA151958596	3162	0.765
NULL	Pharmaceuticals_(Basel)_2013_Nov_7_6(11)_1381-1406.nxml.txt.nlp	24287463	SENT42	15	15	12	12	vancomycin	PEN	PA451850	9933	0.765
NULL	J_Cell_Biol_1998_Jan_26_140(2)_335-345.nxml.txt.nlp	9442109	SENT94	11	11	27	27	chloroquine	NHE	PA448948	285335	0.765
NULL	Arthritis_Res_Ther_2007_Sep_23_9(5)_R96.nxml.txt.nlp	17888176	SENT5	12	12	16	16	etanercept	RANKL	PA449515	8600	0.765
NULL	Cell_Death_Differ_2010_Mar_16_17(3)_469-481.nxml.txt.nlp	19834493	SENT145	0	0	3	3	rosiglitazone	p63	PA451283	8626	0.765
NULL	BioDrugs_2014_Aug_18_28(1)_27-39.nxml.txt.nlp	23955284	SENT250	18	18	13	13	cisplatin	FasL	PA449014	356	0.765
NULL	Mol_Cancer_2008_Mar_26_7_27.nxml.txt.nlp	18366759	SENT111	18	18	8	8	etoposide	p53	PA449552	7157	0.765
NULL	Ann_Neurosci_2014_Jul_21(3)_90-96.nxml.txt.nlp	25206072	SENT13	20	20	7	7	scopolamine	spatial	PA451308	219793	0.765
NULL	Oncotarget_2014_Oct_23_5(22)_11154-11167.nxml.txt.nlp	25525888	SENT180	25	25	19	19	bevacizumab	VEGFR	PA130232992	3791	0.765
NULL	J_Cancer_2013_Aug_28_4(7)_585-596.nxml.txt.nlp	24069069	SENT152	0	0	7	7	verteporfin	LC3	PA451871	84557	0.765
NULL	Br_J_Clin_Pharmacol_2013_Aug_23_76(2)_299-315.nxml.txt.nlp	23701319	SENT240	6	6	3	3	basiliximab	IL-2	PA164747126	3558	0.765
NULL	Indian_J_Anaesth_2013_Jul-Aug_57(4)_397-400.nxml.txt.nlp	24163457	SENT71	11	11	27	27	bupivacaine	SGB	PA135057240	2719	0.765
NULL	Open_Biochem_J_2010_Jan_27_4_9-21.nxml.txt.nlp	20224684	SENT2	9	9	6	6	curcumin	VCP	PA151958596	7415	0.765
NULL	Clin_Med_Insights_Oncol_2013_Jul_4_7_159-163.nxml.txt.nlp	23885182	SENT86	18	18	27	27	cyclophosphamide	CHOP	PA449165	1649	0.765
NULL	J_Cell_Sci_2013_Aug_1_126(15)_3475-3484.nxml.txt.nlp	23704353	SENT97	28	28	35	35	dextran	spatial	PA449261	219793	0.765
NULL	Oncoimmunology_2013_Sep_1_2(9)_e25737.nxml.txt.nlp	24327935	SENT28	0	0	35	35	bleomycin	ERp57	PA448645	2923	0.765
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1063.nxml.txt.nlp	24556678	SENT29	26	26	35	35	thioridazine	TRAIL	PA451666	8743	0.765
NULL	Cancer_Cell_Int_2009_Sep_10_9_25.nxml.txt.nlp	19744341	SENT13	5	5	15	15	glucosamine	PC-3	PA164747613	692094	0.765
NULL	Case_Rep_Dermatol_2012_Mar_17_4(1)_56-60.nxml.txt.nlp	22548037	SENT57	17	17	24	24	doxorubicin	CHOP	PA449412	1649	0.765
NULL	Cancer_Cell_Int_2011_Nov_17_11_40.nxml.txt.nlp	22088142	SENT180	22	22	4	4	doxorubicin	RAF1	PA449412	5894	0.764
NULL	J_Exp_Med_2000_Nov_20_192(10)_1491-1500.nxml.txt.nlp	11085750	SENT141	2	2	12	12	trypsin	CD4	PA451806	920	0.764
NULL	Curr_Neuropharmacol_2013_Jan_11(1)_102-108.nxml.txt.nlp	23814542	SENT225	25	25	9	9	rivastigmine	Yes	PA451262	7525	0.764
NULL	Nat_Biotechnol_2010_Jul_20_28(7)_727-732.nxml.txt.nlp	20562863	SENT122	9	9	11	11	indomethacin	P2Y12	PA449982	64805	0.764
NULL	J_Gen_Physiol_2000_Dec_1_116(6)_755-768.nxml.txt.nlp	11099345	SENT148	5	5	15	15	tetracaine	DAG	PA451638	1605	0.764
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT192	10	10	20	20	lapatinib	Yes	PA152241907	7525	0.764
NULL	Oncoimmunology_2013_Jun_1_2(6)_e24677.nxml.txt.nlp	23894722	SENT109	5	5	14	14	cetuximab	CD80	PA10040	941	0.764
NULL	Eur_J_Clin_Pharmacol_2011_Dec_23_67(12)_1231-1241.nxml.txt.nlp	21698374	SENT190	19	19	2	2	tacrolimus	ABCB1	PA451578	5243	0.764
NULL	Gut_2013_Apr_14_62(4)_540-549.nxml.txt.nlp	22798500	SENT257	23	23	10	10	cetuximab	KRAS	PA10040	3845	0.764
NULL	Diabetes_Metab_Syndr_Obes_2010_Sep_22_3_325-335.nxml.txt.nlp	21437102	SENT27	2	2	39	39	saxagliptin	GLP-1	PA165958362	100125288	0.764
NULL	J_Cell_Mol_Med_2014_Mar_22_18(3)_422-433.nxml.txt.nlp	24450475	SENT409	2	2	4	4	hyaluronan	LYVE-1	PA165958431	10894	0.764
NULL	Open_Biochem_J_2008_Feb_6_2_6-15.nxml.txt.nlp	18949070	SENT36	11	11	16	16	heparin	nexin	PA449855	5270	0.764
NULL	J_Cell_Biol_2001_Oct_29_155(3)_447-458.nxml.txt.nlp	11684709	SENT319	7	7	5	5	pp2	PP1		5540;5464	0.764
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT930	9	9	4	4	doxorubicin	MDR1	PA449412	5243	0.764
NULL	BMB_Rep_2014_May_47(5)_274-279.nxml.txt.nlp	24286313	SENT21	31	31	14	14	bortezomib	TRAF3	PA10252	7187	0.764
NULL	Adv_Hematol_2012_Jan_18_2012_195484.nxml.txt.nlp	22312366	SENT22	7	7	14	14	doxorubicin	CHOP	PA449412	1649	0.764
NULL	Arthritis_Res_Ther_2007_Oct_9_9(5)_R104.nxml.txt.nlp	17925024	SENT49	29	29	6	6	glucosamine	JNK	PA164747613	5599	0.764
NULL	Cancer_Cell_Int_2009_Sep_10_9_25.nxml.txt.nlp	19744341	SENT199	5	5	36	36	glucosamine	survivin	PA164747613	332	0.764
NULL	Indian_J_Psychiatry_2012_Jul-Sep_54(3)_248-252.nxml.txt.nlp	23226849	SENT88	10	10	17	17	quetiapine	CPZ	PA451201	8532	0.764
NULL	J_Korean_Med_Sci_1999_Oct_14(5)_565-570.nxml.txt.nlp	10576154	SENT9	12	12	18	18	doxorubicin	CHOP	PA449412	1649	0.764
NULL	Anat_Cell_Biol_2010_Sep_30_43(3)_194-200.nxml.txt.nlp	21212859	SENT99	21	21	33	33	ethanol	PLP	PA448073	25824;5744	0.764
NULL	Adolesc_Health_Med_Ther_2012_Jun_20_3_85-93.nxml.txt.nlp	24600289	SENT34	0	0	6	6	adalimumab	TNF	PA10004	7124	0.764
NULL	Environ_Health_Perspect_2007_Oct_19_115(10)_1454-1459.nxml.txt.nlp	17938735	SENT122	1	1	7	7	procainamide	p16	PA451108	1029	0.764
NULL	J_Korean_Med_Sci_2010_Jan_26_25(1)_110-116.nxml.txt.nlp	20054409	SENT165	31	31	12	12	doxorubicin	BCS	PA449412	617	0.764
NULL	Subst_Abuse_Treat_Prev_Policy_2008_Jan_29_3_3.nxml.txt.nlp	18230139	SENT53	27	27	36	36	phencyclidine	gamma	PA128406980	9913	0.764
NULL	Int_J_Biol_Sci_2011_Sep_8_7(8)_1077-1092.nxml.txt.nlp	21927577	SENT129	2	2	10	10	telmisartan	ANG	PA451605	283	0.764
NULL	Cell_Death_Dis_2014_Apr_17_5(4)_e1188.nxml.txt.nlp	24743743	SENT76	25	25	19	19	dantrolene	IRE1	PA449208	2081	0.764
NULL	Osteoarthritis_Cartilage_2010_Apr_18(4)_593-600.nxml.txt.nlp	20067755	SENT149	20	20	23	23	collagenase	MMP9	PA449107	4318	0.764
NULL	Int_J_Biol_Sci_2011_Nov_5_8(1)_1-14.nxml.txt.nlp	22211100	SENT136	4	4	10	10	gemcitabine	PI3K	PA449748	5290	0.764
NULL	Curr_Neuropharmacol_2012_Jun_10(2)_134-138.nxml.txt.nlp	23204983	SENT143	18	18	29	29	minocycline	SOD1	PA450519	6647	0.764
NULL	Target_Oncol_2013_Jun_27_8(2)_127-136.nxml.txt.nlp	23625191	SENT6	8	8	15	15	panitumumab	KRAS	PA162373091	3845	0.764
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_May_31_69(Pt_6)_o980.nxml.txt.nlp	23795133	SENT73	11	11	17	17	desloratadine	mol	PA164776964	90527	0.764
NULL	Biomed_Res_Int_2013_Sep_5_2013_929531.nxml.txt.nlp	24083250	SENT202	3	3	14	14	hyaluronan	HYAL2	PA165958431	8692	0.764
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_127043.nxml.txt.nlp	23227093	SENT231	24	24	13	13	ketoconazole	CYP2C19	PA450146	1557	0.764
NULL	Arthritis_Res_Ther_2013_Dec_4_15(6)_R206.nxml.txt.nlp	24299152	SENT105	16	16	21	21	lepirudin	FXI	PA450195	2160	0.764
NULL	J_Bras_Pneumol_2014_May-Jun_40(3)_238-243.nxml.txt.nlp	25029646	SENT14	4	4	9	9	methylprednisolone	LPO	PA450466	4025	0.764
NULL	Br_J_Pharmacol_2013_Jun_27_169(4)_736-747.nxml.txt.nlp	23489111	SENT162	41	41	29	29	morphine	5-HT3A	PA450550	3359	0.764
NULL	Front_Psychol_2013_Oct_17_4_712.nxml.txt.nlp	24151474	SENT30	14	14	23	23	vasopressin	SLC6A4	PA451858	6532	0.764
NULL	Cancer_Cell_Int_2007_Sep_10_7_14.nxml.txt.nlp	17845729	SENT195	14	14	0	0	decitabine	GADD45A	PA164749631	1647	0.764
NULL	Br_J_Cancer_2009_May_5_100(9)_1379-1384.nxml.txt.nlp	19401697	SENT39	17	17	37	37	bortezomib	EGFR	PA10252	1956	0.764
NULL	J_Korean_Med_Sci_2007_Apr_30_22(2)_283-289.nxml.txt.nlp	17449938	SENT98	20	20	27	27	minoxidil	Bcl-2	PA450521	596	0.764
NULL	Br_J_Cancer_2013_Mar_19_108(5)_1079-1091.nxml.txt.nlp	23449353	SENT172	28	28	5	5	docetaxel	MIC-1	PA449383	29919;9518	0.764
NULL	Subst_Abuse_Treat_Prev_Policy_2010_Apr_29_5_7.nxml.txt.nlp	20429943	SENT74	19	19	28	28	diclofenac	UGT2B17	PA449293	7367	0.764
NULL	Breast_Cancer_(Auckl)_2012_Mar_7_6_67-77.nxml.txt.nlp	22438669	SENT54	0	0	15	15	lapatinib	HER2	PA152241907	2064	0.764
NULL	Pharm_Pract_(Granada)_2011_Mar_15_Jan-Mar_9(1)_1-10.nxml.txt.nlp	25132883	SENT155	9	9	7	7	dabigatran	SPAF		166378	0.764
NULL	Clin_Med_Insights_Arthritis_Musculoskelet_Disord_2012_Jan_5_5_1-14.nxml.txt.nlp	22267947	SENT95	21	21	14	14	risedronate	NNT	PA451255	23530	0.764
NULL	J_Int_AIDS_Soc_2010_Nov_8_13(Suppl_4)_P95.nxml.txt.nlp	NULL	SENT23	8	8	1	1	didanosine	CD4	PA449301	920	0.764
NULL	Biologics_2012_Aug_17_6_267-276.nxml.txt.nlp	22956858	SENT82	41	41	27	27	sorafenib	IL-6	PA7000	3569	0.764
NULL	J_Cell_Biol_2001_Aug_6_154(3)_599-610.nxml.txt.nlp	11481345	SENT161	20	20	7	7	doxycycline	ARNO	PA449415	9266	0.764
NULL	Exp_Ther_Med_2014_Mar_10_7(3)_640-648.nxml.txt.nlp	24520260	SENT9	5	5	23	23	resveratrol	c-Jun		3725	0.764
NULL	Adv_Urol_2012_Jul_31_2012_429213.nxml.txt.nlp	22899908	SENT39	21	21	4	4	heparin	FGFR1	PA449855	2260	0.764
NULL	Breast_Cancer_Res_2012_Feb_14_14(1)_R30.nxml.txt.nlp	22333315	SENT160	8	8	14	14	celecoxib	CXCL10	PA448871	3627	0.764
NULL	J_Hematol_Oncol_2009_Nov_22_2_49.nxml.txt.nlp	19930611	SENT50	13	13	21	21	cyclophosphamide	CHOP	PA449165	1649	0.764
NULL	Arthritis_Res_2002_May_24_4(Suppl_2)_S34-S40.nxml.txt.nlp	12110156	SENT105	9	9	11	11	infliximab	IL-18	PA452639	3606	0.764
NULL	Int_J_Hypertens_2011_May_26_2011_916310.nxml.txt.nlp	21747985	SENT103	10	10	26	26	losartan	p38	PA450268	10598;1432;7965	0.764
NULL	Front_Neurol_2012_Apr_2_3_41.nxml.txt.nlp	22485105	SENT48	41	41	35	35	vasopressin	PRL	PA451858	5617	0.764
NULL	J_Int_AIDS_Soc_2012_Mar_12_15_13.nxml.txt.nlp	22410312	SENT25	7	7	39	39	tenofovir	CD4	PA10204	920	0.764
NULL	Br_J_Cancer_2012_Feb_14_106(4)_685-692.nxml.txt.nlp	22294184	SENT197	4	4	9	9	docetaxel	JNK	PA449383	5599	0.764
NULL	Diabetologia_2010_Jun_27_53(6)_1142-1150.nxml.txt.nlp	20349036	SENT189	1	1	39	39	spermine	AMPK	PA164781199	5563	0.764
NULL	Environ_Health_Perspect_1996_May_104(5)_544-548.nxml.txt.nlp	8743443	SENT8	10	10	16	16	estradiol	DES	PA449503	1674	0.764
NULL	Chemother_Res_Pract_2012_Aug_29_2012_817297.nxml.txt.nlp	22970367	SENT190	12	12	9	9	afatinib	EGFR	PA165981154	1956	0.764
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT110	16	16	21	21	perifosine	DR4	PA165291471	8797	0.764
NULL	Oncotarget_2014_Oct_21_5(22)_11709-11722.nxml.txt.nlp	25365944	SENT226	5	5	19	19	metformin	Rho	PA450395	29984	0.764
NULL	Asian-Australas_J_Anim_Sci_2014_Dec_27(12)_1783-1793.nxml.txt.nlp	25358373	SENT204	3	3	24	24	capsaicin	CEBPA	PA448776	1050	0.764
NULL	J_Clin_Biochem_Nutr_2009_Jan_27_44(1)_79-84.nxml.txt.nlp	19177192	SENT81	21	21	26	26	curcumin	HO-1	PA151958596	3162	0.764
NULL	EMBO_Mol_Med_2013_Aug_4_5(8)_1180-1195.nxml.txt.nlp	23828858	SENT200	6	6	14	14	rituximab	MYC	PA451261	4609	0.764
NULL	Cell_Host_Microbe_2014_Jul_9_16(1)_10-18.nxml.txt.nlp	25011104	SENT66	25	25	3	3	cyclosporine	IFN	PA449167	3439	0.764
NULL	Environ_Health_Perspect_2009_Feb_8_117(2)_175-180.nxml.txt.nlp	19270784	SENT145	12	12	0	0	vinblastine	BPA	PA451877	667	0.764
NULL	Cancer_Res_Treat_2014_Jan_15_46(1)_33-40.nxml.txt.nlp	24520221	SENT66	31	31	22	22	fludarabine	CHOP	PA449655	1649	0.764
NULL	Mol_Cancer_2010_Aug_16_9_217.nxml.txt.nlp	20712901	SENT9	16	16	9	9	curcumin	JAK2	PA151958596	3717	0.764
NULL	Ann_Thorac_Med_2008_Oct-Dec_3(4)_149-151.nxml.txt.nlp	19561898	SENT3	9	9	17	17	isoniazid	EMB	PA450112	133418	0.764
NULL	Biomed_Res_Int_2013_Aug_6_2013_602987.nxml.txt.nlp	24027759	SENT262	11	11	8	8	doxorubicin	SMF	PA449412	22993	0.764
NULL	Breast_Cancer_Res_2005_May_24_7(5)_R589-R597.nxml.txt.nlp	16168102	SENT144	9	9	31	31	trastuzumab	FAK	PA451743	5747	0.764
NULL	Indian_J_Dermatol_2011_May-Jun_56(3)_306-308.nxml.txt.nlp	21772594	SENT69	32	32	21	21	cyclosporine	CHOP	PA449167	1649	0.764
NULL	BMB_Rep_2014_Jul_47(7)_376-381.nxml.txt.nlp	24286332	SENT71	19	19	9	9	thrombin	PPG	PA451674	5552	0.764
NULL	Pharmaceuticals_(Basel)_2011_May_24_4(5)_770-781.nxml.txt.nlp	NULL	SENT103	0	0	39	39	carvedilol	IL-10	PA448817	3586	0.764
NULL	BMJ_2011_Oct_31_343_d6333.nxml.txt.nlp	22042753	SENT181	21	21	25	25	warfarin	C10	PA451906	113246	0.764
NULL	Breast_Cancer_Res_2012_Jul_23_14(4)_R112.nxml.txt.nlp	22824341	SENT231	13	13	9	9	doxorubicin	RANK	PA449412	8792	0.764
NULL	Evid_Based_Complement_Alternat_Med_2011_Mar_10_2011_561396.nxml.txt.nlp	21792360	SENT62	12	12	21	21	paraformaldehyde	CD40	PA450790	958	0.764
NULL	Br_J_Pharmacol_2014_Oct_26_171(20)_4785-4796.nxml.txt.nlp	25074741	SENT240	0	0	14	14	guanfacine	NK1	PA449825	11126	0.764
NULL	Front_Genet_2012_Oct_26_3_213.nxml.txt.nlp	23112805	SENT37	7	7	14	14	lovastatin	CYP3A4	PA450272	1576	0.764
NULL	Cancer_Med_2014_Oct_25_3(5)_1099-1111.nxml.txt.nlp	24961511	SENT329	22	22	6	6	cisplatin	CXCR4	PA449014	7852	0.764
NULL	Cell_Cycle_2013_Feb_15_12(4)_625-634.nxml.txt.nlp	23324396	SENT59	16	16	22	22	doxycycline	p21CIP1	PA449415	1026	0.764
NULL	Mol_Cancer_2010_May_18_9_110.nxml.txt.nlp	20482802	SENT160	0	0	15	15	bortezomib	p53	PA10252	7157	0.764
NULL	Front_Behav_Neurosci_2015_Jan_6_8_445.nxml.txt.nlp	25610380	SENT516	17	17	2	2	paroxetine	FKBP51	PA450801	2289	0.764
NULL	Mol_Cells_2014_Sep_30_37(9)_664-671.nxml.txt.nlp	25234467	SENT6	24	24	8	8	cisplatin	miR-217	PA449014	406999	0.764
NULL	J_Biomed_Sci_2014_Apr_17_21(1)_30.nxml.txt.nlp	24742230	SENT163	5	5	10	10	lovastatin	OPG	PA450272	690	0.764
NULL	Biochim_Biophys_Acta_2014_Jul_1842(7)_959-970.nxml.txt.nlp	24594481	SENT812	38	38	32	32	lipase	HSL	PA450239	3991	0.764
NULL	Mol_Cancer_2010_Oct_12_9_269.nxml.txt.nlp	20939893	SENT7	21	21	5	5	isoproterenol	AP-1	PA450121	2353;3727;2354;3725	0.764
NULL	Diabetes_Care_2011_Jul_17_34(7)_1678-1680.nxml.txt.nlp	21709302	SENT34	9	9	14	14	ramipril	DREAM	PA451223	30818	0.764
NULL	Niger_J_Surg_2014_Jan-Jun_20(1)_9-15.nxml.txt.nlp	24665195	SENT224	0	0	7	7	denosumab	RANK	PA166048634	8792	0.764
NULL	Indian_J_Anaesth_2009_Aug_53(4)_434-441.nxml.txt.nlp	20640205	SENT154	30	30	17	17	acetazolamide	STP	PA448018	9322	0.764
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Jul_21_9_20.nxml.txt.nlp	20663145	SENT112	30	30	5	5	ciprofloxacin	LBH	PA449009	81606;221491	0.764
NULL	Int_J_Environ_Res_Public_Health_2013_Sep_17_10(9)_4352-4389.nxml.txt.nlp	24048206	SENT293	16	16	11	11	choline	B12	PA448976	7126;4709	0.764
NULL	Anemia_2011_Oct_13_2011_248527.nxml.txt.nlp	21490760	SENT207	19	19	44	44	clotrimazole	NO3	PA449057	4681	0.764
NULL	Virol_J_2010_Oct_20_7_279.nxml.txt.nlp	20961433	SENT169	4	4	2	2	trypsin	VLP	PA451806	391104	0.764
NULL	Open_Cardiovasc_Med_J_2011_Jun_20_5_136-147.nxml.txt.nlp	21760856	SENT167	17	17	3	3	atorvastatin	ghrelin	PA448500	51738	0.764
NULL	Br_J_Cancer_2001_Aug_85(4)_600-607.nxml.txt.nlp	11506502	SENT2	5	5	21	21	hyaluronan	HAS2	PA165958431	3037	0.764
NULL	Emerg_Infect_Dis_2011_Mar_17(3)_510-513.nxml.txt.nlp	21392446	SENT26	23	23	20	20	capreomycin	DST	PA164746226	667	0.764
NULL	Cell_Death_Dis_2014_Jul_3_5(7)_e1311.nxml.txt.nlp	24991763	SENT348	20	20	22	22	ketamine	PSD95	PA450144	1742	0.764
NULL	Pharmaceuticals_(Basel)_2013_Mar_21_6(3)_407-439.nxml.txt.nlp	23580870	SENT47	10	10	47	47	phenylephrine	DAG	PA450935	1605	0.764
NULL	Clin_Mol_Allergy_2007_Jan_25_5_1.nxml.txt.nlp	17254346	SENT188	0	0	17	17	curcumin	IL-13	PA151958596	3596	0.764
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Sep_6_64(Pt_10)_m1225.nxml.txt.nlp	21200986	SENT60	29	29	19	19	ethanol	mol	PA448073	90527	0.764
NULL	Endocrinol_Diabetes_Metab_Case_Rep_2013_Aug_30_2013_130026.nxml.txt.nlp	24616766	SENT92	3	3	15	15	octreotide	SSTR5	PA450678	6755	0.764
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Aug_13_64(Pt_9)_o1744.nxml.txt.nlp	21201726	SENT60	23	23	38	38	ethanol	mol	PA448073	90527	0.764
NULL	Br_J_Cancer_2009_Jul_21_101(2)_269-277.nxml.txt.nlp	19603033	SENT125	9	9	11	11	cisplatin	XIAP	PA449014	331	0.764
NULL	Nat_Biotechnol_2010_Jul_20_28(7)_727-732.nxml.txt.nlp	20562863	SENT12	11	11	20	20	thrombin	PAR4	PA451674	9002;5074	0.764
NULL	Cardiovasc_Diabetol_2011_Feb_11_10_18.nxml.txt.nlp	21314919	SENT4	9	9	16	16	pioglitazone	Met	PA450970	79811	0.764
NULL	J_Korean_Med_Sci_2011_Jul_20_26(7)_954-958.nxml.txt.nlp	21738352	SENT95	3	3	14	14	sorafenib	VEGFR	PA7000	3791	0.764
NULL	Environ_Health_Perspect_2008_Mar_116(3)_A104.nxml.txt.nlp	18335070	SENT26	13	13	3	3	choline	PEMT	PA448976	10400	0.764
NULL	Cancer_Cell_Int_2008_Mar_18_8_3.nxml.txt.nlp	18348720	SENT104	7	7	35	35	lapatinib	PC3	PA152241907	57332;7832;5122	0.764
NULL	Nucleic_Acids_Res_2011_Sep_7_39(17)_7465-7476.nxml.txt.nlp	21653549	SENT219	13	13	38	38	camptothecin	DEK	PA153590860	7913	0.764
NULL	Oncotarget_2011_Dec_30_2(12)_918-934.nxml.txt.nlp	22248740	SENT194	11	11	14	14	imatinib	CD34	PA10804	947	0.764
NULL	Int_J_Fertil_Steril_2011_Dec_22_Oct-Dec_5(3)_122-127.nxml.txt.nlp	25101154	SENT119	10	10	6	6	diethylstilbestrol	hole	PA449307	80757	0.764
NULL	Breast_Cancer_Res_2004_Aug_5_6(5)_R601-R607.nxml.txt.nlp	15318941	SENT147	42	42	18	18	docetaxel	TNFRSF1A	PA449383	7132	0.764
NULL	Br_J_Cancer_2014_Nov_25_111(11)_2091-2102.nxml.txt.nlp	25349971	SENT51	37	37	25	25	imatinib	KIT	PA10804	3815	0.764
NULL	Int_J_Mol_Sci_2012_Dec_3_13(12)_16373-16386.nxml.txt.nlp	23208375	SENT148	22	22	27	27	doxorubicin	DDB2	PA449412	1643	0.764
NULL	Fibrogenesis_Tissue_Repair_2012_Jul_23_5_11.nxml.txt.nlp	22824096	SENT90	17	17	9	9	bleomycin	CXCL12	PA448645	6387	0.764
NULL	Arthritis_Res_Ther_2009_Feb_23_11(1)_216.nxml.txt.nlp	19291269	SENT84	5	5	12	12	etanercept	ACR	PA449515	49	0.764
NULL	Br_J_Cancer_2009_Mar_10_100(5)_834-839.nxml.txt.nlp	19174821	SENT108	34	34	19	19	fosfomycin	TMP	PA164748039	2012	0.764
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Dec_16_66(Pt_1)_o165-o166.nxml.txt.nlp	21580052	SENT75	8	8	25	25	ethanol	mol	PA448073	90527	0.764
NULL	Mol_Cancer_2012_Jul_25_11_46.nxml.txt.nlp	22830422	SENT141	28	28	6	6	rolipram	AKT	PA153906323	207	0.764
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT7	9	9	6	6	pemetrexed	UNG	PA10810	7374	0.764
NULL	Mol_Imaging_Radionucl_Ther_2011_Apr_1_20(1)_1-6.nxml.txt.nlp	23486728	SENT53	16	16	2	2	amifostine	DBL	PA448365	4168	0.764
NULL	Alcohol_Res_2012_34(3)_355-361.nxml.txt.nlp	23134052	SENT96	4	4	9	9	ethanol	CYP2E1	PA448073	1571	0.764
NULL	J_Korean_Med_Sci_2007_Dec_20_22(6)_1055-1059.nxml.txt.nlp	18162722	SENT82	13	13	7	7	pantoprazole	ESD	PA450774	2098	0.764
NULL	Oncogene_2010_Sep_16_29(37)_5193-5203.nxml.txt.nlp	20581867	SENT80	2	2	12	12	lapatinib	p85	PA152241907	5296;5295;54776;23368	0.764
NULL	Breast_Cancer_Res_2005_Jun_21_7(5)_181-183.nxml.txt.nlp	16168134	SENT29	15	15	11	11	tamoxifen	ATAC	PA451581	6375	0.764
NULL	Indian_J_Nephrol_2012_Jan-Feb_22(1)_48-51.nxml.txt.nlp	22279344	SENT87	26	26	19	19	clopidogrel	ADAMTS13	PA449053	11093	0.764
NULL	Arthritis_Res_Ther_2009_Jun_29_11(3)_R100.nxml.txt.nlp	19563672	SENT168	11	11	7	7	infliximab	IFN	PA452639	3439	0.764
NULL	Curr_HIV_Res_2011_Jan_9(1)_40-53.nxml.txt.nlp	21198432	SENT351	22	22	32	32	efavirenz	ART	PA449441	181	0.764
NULL	Oncol_Lett_2014_Jul_25_8(1)_313-316.nxml.txt.nlp	24959268	SENT102	0	0	7	7	sulindac	JNK1	PA451565	5599	0.764
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1063.nxml.txt.nlp	24556678	SENT44	21	21	6	6	thioridazine	c-FLIP	PA451666	8837	0.764
NULL	Breast_Cancer_Res_2007_Jul_22_9(4)_R45.nxml.txt.nlp	17659092	SENT180	20	20	0	0	tamoxifen	FDG	PA451581	23583	0.764
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1676-1682.nxml.txt.nlp	19844234	SENT147	0	0	6	6	lapatinib	PTEN	PA152241907	5728	0.764
NULL	Int_J_Anal_Chem_2012_Feb_8_2012_546282.nxml.txt.nlp	22505920	SENT97	3	3	9	9	terazosin	PF6	PA451612	200162	0.764
NULL	Diabetes_2011_Mar_21_60(3)_757-765.nxml.txt.nlp	21282370	SENT167	11	11	0	0	isoproterenol	PTRF	PA450121	284119	0.764
NULL	J_Neuroinflammation_2010_Nov_18_7_81.nxml.txt.nlp	21087489	SENT84	20	20	10	10	pilocarpine	CA1	PA450962	759	0.764
NULL	BMB_Rep_2014_Jul_47(7)_376-381.nxml.txt.nlp	24286332	SENT70	23	23	18	18	thrombin	PPG	PA451674	5552	0.764
NULL	Mol_Syst_Biol_2009_Jul_28_5_288.nxml.txt.nlp	19638969	SENT225	3	3	21	21	resveratrol	SIRT1		23411	0.764
NULL	CNS_Drugs_2014_May_1_28(6)_497-511.nxml.txt.nlp	24788672	SENT29	9	9	24	24	methylphenidate	ATX	PA450464	5168;23049	0.764
NULL	Mol_Clin_Oncol_2013_Sep_4_1(5)_853-857.nxml.txt.nlp	24649260	SENT60	20	20	34	34	paclitaxel	CO2	PA450761	4513	0.764
NULL	Indian_J_Med_Res_2014_Apr_139(4)_572-578.nxml.txt.nlp	24927344	SENT23	24	24	1	1	warfarin	GGCX	PA451906	2677	0.764
NULL	J_Aging_Res_2012_Jul_19_2012_194821.nxml.txt.nlp	22888430	SENT311	5	5	22	22	resveratrol	SIRT1		23411	0.764
NULL	Breast_Cancer_Res_2012_Feb_21_14(1)_R35.nxml.txt.nlp	22353783	SENT172	26	26	4	4	glucose	AMPK	PA449773	5563	0.764
NULL	Int_Semin_Surg_Oncol_2006_Sep_18_3_31.nxml.txt.nlp	16981992	SENT46	17	17	2	2	letrozole	ATAC	PA450196	6375	0.764
NULL	Gynecol_Oncol_Case_Rep_2013_Dec_28_8_4-6.nxml.txt.nlp	24567884	SENT15	2	2	0	0	irinotecan	NAC	PA450085	22861	0.764
NULL	Clin_Interv_Aging_2009_May_14_4_179-186.nxml.txt.nlp	19503779	SENT135	6	6	11	11	amantadine	COMT	PA448360	1312	0.764
NULL	Cases_J_2009_Jun_17_2_7246.nxml.txt.nlp	19829938	SENT83	8	8	4	4	iron	HFE	PA450087	3077	0.764
NULL	Cancer_Inform_2007_May_1_3_125-139.nxml.txt.nlp	19455240	SENT135	13	13	15	15	indomethacin	Mcl-1	PA449982	4170	0.764
NULL	Cancers_(Basel)_2013_May_27_5(2)_617-638.nxml.txt.nlp	24216994	SENT292	7	7	17	17	curcumin	PC3	PA151958596	57332;7832;5122	0.764
NULL	Breast_Cancer_(Auckl)_2014_Mar_23_8_51-56.nxml.txt.nlp	24678242	SENT81	2	2	13	13	carboplatin	BRCA1	PA448803	672	0.764
NULL	Clin_Cosmet_Investig_Dermatol_2013_Mar_14_6_75-80.nxml.txt.nlp	23515267	SENT84	9	9	7	7	ustekinumab	TNF-alpha	PA166048654	7124	0.764
NULL	Arthritis_Res_Ther_2005_Mar_9_7(3)_93.nxml.txt.nlp	15899057	SENT72	25	25	13	13	methotrexate	CD25	PA450428	3669;3559	0.764
NULL	Curr_Pharm_Biotechnol_2011_Jan_12(1)_35-41.nxml.txt.nlp	20932261	SENT85	3	3	6	6	hyperforin	TRPC6	PA165985514	7225	0.764
NULL	Cardiovasc_Diabetol_2011_Aug_10_10_74.nxml.txt.nlp	21827713	SENT122	39	39	10	10	candesartan	AT1	PA448765	9197;185	0.764
NULL	Cancer_Cell_Int_2013_Sep_23_13_94.nxml.txt.nlp	24059699	SENT201	30	30	27	27	bevacizumab	VEGFA	PA130232992	7422	0.764
NULL	Br_J_Cancer_2010_May_11_102(10)_1495-1502.nxml.txt.nlp	20461092	SENT238	27	27	2	2	lapatinib	HER2	PA152241907	2064	0.764
NULL	Br_J_Cancer_2009_Oct_6_101(7)_1162-1167.nxml.txt.nlp	19724276	SENT6	0	0	27	27	axitinib	APC	PA164924493	324	0.764
NULL	Sci_Rep_2014_Nov_28_4_7237.nxml.txt.nlp	25429875	SENT114	21	21	40	40	hesperidin	p38	PA449867	10598;1432;7965	0.764
NULL	Front_Immunol_2013_May_15_4_116.nxml.txt.nlp	23720663	SENT509	3	3	12	12	curcumin	STAT3	PA151958596	6774	0.764
NULL	Oncologist_2010_Apr_15(4)_372-381.nxml.txt.nlp	20413642	SENT181	1	1	6	6	gemcitabine	EGFR	PA449748	1956	0.764
NULL	Korean_J_Radiol_2011_Apr_25_May-Jun_12(3)_319-326.nxml.txt.nlp	21603291	SENT17	0	0	18	18	propranolol	DBP	PA451145	3295;1628;2638	0.764
NULL	Br_J_Cancer_1982_Jan_45(1)_35-43.nxml.txt.nlp	7059463	SENT4	14	14	39	39	cimetidine	CTX	PA449001	1593	0.764
NULL	Curr_Neuropharmacol_2013_Mar_11(2)_160-170.nxml.txt.nlp	23997751	SENT102	40	40	23	23	pilocarpine	5-HT2C	PA450962	3358	0.764
NULL	Neural_Plast_2012_Jul_8_2012_710943.nxml.txt.nlp	22830052	SENT234	12	12	31	31	creatine	UBE3A	PA164778930	7337	0.764
NULL	Exp_Ther_Med_2013_Apr_18_5(4)_1219-1225.nxml.txt.nlp	23596493	SENT101	27	27	6	6	cyclophosphamide	DNMT1	PA449165	1786	0.764
NULL	J_Inherit_Metab_Dis_2013_Mar_5_36(2)_385-394.nxml.txt.nlp	22669363	SENT167	36	36	8	8	galsulfase	ERT	PA164746235	1999	0.764
NULL	Pharmaceutics_2011_Nov_18_3(4)_865-913.nxml.txt.nlp	24309312	SENT1987	2	2	12	12	clarithromycin	CYP2C19	PA449028	1557	0.764
NULL	J_Breast_Cancer_2013_Jun_28_16(2)_164-170.nxml.txt.nlp	23843848	SENT187	18	18	6	6	doxorubicin	PTEN	PA449412	5728	0.764
NULL	Mol_Biol_Cell_2014_Aug_15_25(16)_2499-2508.nxml.txt.nlp	24943844	SENT37	6	6	2	2	estradiol	GPS2	PA449503	2874	0.764
NULL	J_Clin_Exp_Pathol_2012_May_17_Suppl_4_7327.nxml.txt.nlp	25379357	SENT33	42	42	39	39	resveratrol	SIRT1		23411	0.764
NULL	Clin_Psychopharmacol_Neurosci_2012_Apr_30_10(1)_25-33.nxml.txt.nlp	23429852	SENT98	8	8	14	14	haloperidol	SNAP-25	PA449841	6616	0.764
NULL	ScientificWorldJournal_2013_Sep_19_2013_809891.nxml.txt.nlp	24170983	SENT180	8	8	2	2	ketorolac	CD80	PA450150	941	0.764
NULL	Cell_Biol_Int_Rep_(2010)_2012_Jun_21_19(1)_e00017.nxml.txt.nlp	23124518	SENT81	2	2	4	4	etoposide	TRAIL	PA449552	8743	0.764
NULL	Korean_J_Anesthesiol_2013_Dec_26_65(6_Suppl)_S62-S64.nxml.txt.nlp	24478876	SENT24	16	16	19	19	heparin	ACT	PA449855	12;11332;9457;641455	0.764
NULL	Acta_Pharmacol_Sin_2011_Nov_10_32(11)_1402-1410.nxml.txt.nlp	21986579	SENT202	14	14	39	39	curcumin	p27	PA151958596	5715;10534	0.764
NULL	Cancers_(Basel)_2014_Apr_30_6(2)_1031-1046.nxml.txt.nlp	24785146	SENT114	18	18	43	43	geldanamycin	Hsp90	PA152031327	3320	0.764
NULL	Acta_Pharmacol_Sin_2013_Sep_5_34(9)_1192-1200.nxml.txt.nlp	23685957	SENT14	0	0	9	9	curcumin	FasL	PA151958596	356	0.764
NULL	Oncotarget_2012_Dec_23_3(12)_1489-1490.nxml.txt.nlp	23455231	SENT32	13	13	20	20	thioridazine	MALT1	PA451666	10892	0.764
NULL	Indian_J_Med_Res_2014_Aug_140(2)_262-270.nxml.txt.nlp	25297360	SENT61	14	14	6	6	imipenem	MBL	PA449968	50639	0.764
NULL	Diabetes_Care_2013_Aug_11_36(8)_2233-2238.nxml.txt.nlp	23564917	SENT153	18	18	4	4	glucose	MNT	PA449773	4335	0.764
NULL	Mol_Cell_Proteomics_2014_Jan_1_13(1)_30-48.nxml.txt.nlp	24085812	SENT837	8	8	4	4	meloxicam	kallistatin	PA450353	5267	0.764
NULL	Oxid_Med_Cell_Longev_2013_Jun_2_2013_793525.nxml.txt.nlp	23819014	SENT173	2	2	32	32	resveratrol	SGBS		2719	0.764
NULL	Korean_Circ_J_2013_Dec_20_43(12)_785-792.nxml.txt.nlp	24385988	SENT123	13	13	10	10	l-carnitine	SLC22A5	PA450154	6584	0.764
NULL	Carcinogenesis_2013_Feb_3_34(2)_351-360.nxml.txt.nlp	23125222	SENT34	17	17	22	22	curcumin	CDC27	PA151958596	996	0.764
NULL	Mol_Cell_Biochem_2014_Jul_26_396(1-2)_221-228.nxml.txt.nlp	25063218	SENT2	10	10	15	15	resveratrol	EGFR		1956	0.764
NULL	Oncol_Lett_2013_Feb_7_5(2)_440-446.nxml.txt.nlp	23420122	SENT109	15	15	19	19	gemcitabine	AKT	PA449748	207	0.764
NULL	Ann_Hematol_2014_Sep_10_93(1)_1-11.nxml.txt.nlp	24018623	SENT170	20	20	43	43	lenalidomide	CXCR4	PA162363968	7852	0.764
NULL	Breast_Cancer_Res_2002_Jan_14_4(2)_65-69.nxml.txt.nlp	11879566	SENT69	13	13	15	15	estradiol	IL-6	PA449503	3569	0.764
NULL	Oncotarget_2013_Dec_28_5(6)_1475-1490.nxml.txt.nlp	24721996	SENT82	2	2	9	9	celecoxib	CD44	PA448871	960	0.764
NULL	Nucl_Recept_Signal_2009_Jan_16_7_e001.nxml.txt.nlp	19240808	SENT420	24	24	3	3	estradiol	SXR	PA449503	8856	0.764
NULL	Front_Neuroenergetics_2013_Apr_26_5_4.nxml.txt.nlp	23637659	SENT103	36	36	12	12	picrotoxin	CA1	PA164777007	759	0.764
NULL	Leukemia_2013_Apr_14_27(4)_803-812.nxml.txt.nlp	23238589	SENT168	8	8	10	10	imatinib	IFN	PA10804	3439	0.764
NULL	Vet_Res_2013_Mar_11_44(1)_16.nxml.txt.nlp	23497076	SENT289	6	6	11	11	thrombin	PAR2	PA451674	2150;55065;8856	0.764
NULL	Aging_Cell_2012_Aug_11(4)_579-587.nxml.txt.nlp	22435726	SENT125	15	15	11	11	etoposide	CD28	PA449552	1493;940	0.764
NULL	Br_J_Haematol_2007_Sep_26_138(6)_676-686.nxml.txt.nlp	17655728	SENT169	1	1	11	11	imiglucerase	EPO	PA164742934	7076;8288;2056	0.764
NULL	Front_Neurosci_2014_Nov_24_8_380.nxml.txt.nlp	25505380	SENT312	29	29	40	40	estradiol	Met	PA449503	79811	0.764
NULL	J_Geriatr_Cardiol_2014_Mar_11(1)_63-73.nxml.txt.nlp	24748884	SENT231	6	6	21	21	levodopa	PKD	PA450213	5587	0.764
NULL	Asia_Pac_Allergy_2012_Oct_31_2(4)_256-263.nxml.txt.nlp	23130331	SENT90	10	10	26	26	trypsin	EBM	PA451806	1881	0.764
NULL	Cardiovasc_Diabetol_2010_Sep_23_9_57.nxml.txt.nlp	20863381	SENT27	10	10	15	15	pioglitazone	TDI	PA450970	100038246	0.764
NULL	Basic_Clin_Neurosci_2014_Summer_5(3)_182-190.nxml.txt.nlp	25337378	SENT177	10	10	7	7	bupropion	mol	PA448687	90527	0.764
NULL	Cells_2012_Aug_23_1(3)_558-575.nxml.txt.nlp	24710490	SENT1042	8	8	12	12	celecoxib	P-gp	PA448871	5243	0.764
NULL	Biomed_Res_Int_2014_Apr_13_2014_275178.nxml.txt.nlp	24822191	SENT146	40	40	35	35	resveratrol	AMPK		5563	0.764
NULL	Comp_Hepatol_2004_Jan_14_3(Suppl_1)_S31.nxml.txt.nlp	14960183	SENT63	7	7	4	4	ethanol	TNF-alpha	PA448073	7124	0.764
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT747	15	15	23	23	glucose	AMPK	PA449773	5563	0.764
NULL	Ann_Hematol_2011_Feb_17_90(2)_173-183.nxml.txt.nlp	20714724	SENT102	16	16	3	3	resveratrol	BAX		581	0.764
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S31-S40.nxml.txt.nlp	20680106	SENT31	8	8	4	4	panitumumab	EGFR	PA162373091	1956	0.764
NULL	Front_Oncol_2013_Nov_15_3_281.nxml.txt.nlp	24298448	SENT193	21	21	38	38	leucovorin	KRAS	PA450198	3845	0.764
NULL	Biomed_Res_Int_2014_May_20_2014_418975.nxml.txt.nlp	24967364	SENT205	31	31	12	12	resveratrol	AMPK		5563	0.764
NULL	Indian_J_Pharm_Sci_2008_Jul-Aug_70(4)_494-497.nxml.txt.nlp	20046778	SENT29	7	7	5	5	clozapine	RIS	PA449061	51285	0.764
NULL	Clin_Interv_Aging_2011_Jun_21_6_151-160.nxml.txt.nlp	21753870	SENT177	24	24	26	26	raloxifene	STAR	PA451221	6770;2984	0.764
NULL	Indian_J_Pharmacol_2008_Oct_40(Suppl_2)_S112-S142.nxml.txt.nlp	21593965	SENT224	14	14	4	4	apomorphine	CA1	PA164781163	759	0.764
NULL	Indian_J_Pharmacol_2013_Jan-Feb_45(1)_98-99.nxml.txt.nlp	23543750	SENT34	17	17	44	44	bromocriptine	BPAD	PA448671	4095	0.764
NULL	Cardiol_Res_Pract_2013_Feb_19_2013_195456.nxml.txt.nlp	23533940	SENT108	6	6	8	8	clopidogrel	CYP1A2	PA449053	1544	0.764
NULL	Clin_Exp_Otorhinolaryngol_2012_Sep_27_5(3)_117-121.nxml.txt.nlp	22977707	SENT117	19	19	29	29	kanamycin	KCC2	PA450137	57468	0.764
NULL	Clin_Exp_Otorhinolaryngol_2011_Jun_31_4(2)_77-82.nxml.txt.nlp	21716954	SENT121	18	18	3	3	cisplatin	Bcl-2	PA449014	596	0.764
NULL	Front_Endocrinol_(Lausanne)_2013_Jul_12_4_88.nxml.txt.nlp	23874324	SENT140	24	24	19	19	tamoxifen	SULT1A1	PA451581	6817	0.764
NULL	Oncol_Lett_2014_May_6_7(5)_1695-1700.nxml.txt.nlp	24765203	SENT51	17	17	36	36	fluorescein	CD133	PA164746009	8842	0.764
NULL	Chem_Rev_2011_Oct_12_111(10)_5899-5921.nxml.txt.nlp	21923193	SENT549	19	19	6	6	flurbiprofen	COX	PA449683	1351	0.764
NULL	J_Cell_Biol_2008_Jul_14_182(1)_171-184.nxml.txt.nlp	18606850	SENT204	20	20	28	28	geldanamycin	TWEAK	PA152031327	8742	0.764
NULL	Arthritis_Res_Ther_2008_Jan_7_10(1)_R1.nxml.txt.nlp	18179697	SENT205	4	4	31	31	oxaliplatin	HMGB1	PA131285527	3146	0.764
NULL	J_Hum_Genet_2013_Jun_23_58(6)_339-345.nxml.txt.nlp	23697979	SENT23	7	7	38	38	clopidogrel	CYP2B6	PA449053	1555	0.764
NULL	Arch_Med_Sci_2010_Dec_29_6(6)_829-836.nxml.txt.nlp	22427753	SENT66	16	16	32	32	mitomycin	IL-2	PA450524	3558	0.764
NULL	J_Gastroenterol_2014_Dec_24_49(12)_1536-1547.nxml.txt.nlp	24366288	SENT118	9	9	0	0	omeprazole	CYP2C19	PA450704	1557	0.764
NULL	J_Oncol_2013_Feb_17_2013_872957.nxml.txt.nlp	23476648	SENT135	14	14	7	7	cisplatin	SFN	PA449014	25996;2810	0.764
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT231	5	5	19	19	nutlin-3	MDM2		4193	0.764
NULL	Nucleic_Acids_Res_2012_Jul_19_40(13)_6158-6173.nxml.txt.nlp	22434880	SENT137	10	10	7	7	ampicillin	LBA	PA448419	987	0.764
NULL	Iran_J_Pharm_Res_2014_Autumn_13(4)_1393-1401.nxml.txt.nlp	25587329	SENT129	8	8	15	15	nimesulide	ABCG2	PA137179528	9429	0.764
NULL	Biosci_Rep_2012_Aug_1_32(Pt_4)_361-374.nxml.txt.nlp	22762204	SENT164	25	25	10	10	doxorubicin	BRCA1	PA449412	672	0.764
NULL	J_Gen_Physiol_2010_Jun_135(6)_619-628.nxml.txt.nlp	20479110	SENT188	21	21	40	40	nifedipine	DHPR	PA450631	5860	0.764
NULL	J_Cancer_2014_Jan_29_5(3)_182-191.nxml.txt.nlp	24563673	SENT163	27	27	17	17	heparin	PRELP	PA449855	5549	0.764
NULL	Breast_Cancer_Res_2009_Jul_30_11(4)_R56.nxml.txt.nlp	19643025	SENT253	26	26	23	23	celecoxib	IL-17	PA448871	3605	0.764
NULL	Springerplus_2013_Feb_15_2_52.nxml.txt.nlp	23476897	SENT83	0	0	8	8	tamoxifen	CYP2D6	PA451581	1565	0.764
NULL	Target_Oncol_2013_Jun_27_8(2)_127-136.nxml.txt.nlp	23625191	SENT47	7	7	10	10	panitumumab	KRAS	PA162373091	3845	0.764
NULL	Br_J_Haematol_2014_Mar_13_164(1)_811-821.nxml.txt.nlp	24328678	SENT129	30	30	16	16	lenalidomide	IKZF3	PA162363968	22806	0.764
NULL	BMJ_Open_2014_Feb_21_4(2)_e003512.nxml.txt.nlp	24561494	SENT171	28	28	2	2	pravastatin	Gen	PA451089	348654	0.764
NULL	Cancer_Res_Treat_2014_Jan_15_46(1)_48-54.nxml.txt.nlp	24520223	SENT47	6	6	13	13	bevacizumab	KRAS	PA130232992	3845	0.764
NULL	Adv_Hematol_2011_Apr_10_2011_960137.nxml.txt.nlp	21547266	SENT88	15	15	2	2	cyclophosphamide	CHOP	PA449165	1649	0.764
NULL	Comp_Hepatol_2005_Feb_8_4_2.nxml.txt.nlp	15701172	SENT102	9	9	16	16	ketoconazole	CYP3A	PA450146	1574	0.764
NULL	Diabetes_Metab_J_2012_Oct_18_36(5)_328-335.nxml.txt.nlp	23130316	SENT77	9	9	42	42	lipase	PDK4	PA450239	5166	0.764
NULL	Mol_Brain_2014_Apr_21_7_28.nxml.txt.nlp	24751148	SENT155	5	5	25	25	minocycline	TLR4	PA450519	7099	0.763
NULL	Hum_Genomics_2015_Jan_7_9(1)_1.nxml.txt.nlp	25563503	SENT313	0	0	8	8	nicotine	COT	PA450626	54677	0.763
NULL	Braz_J_Med_Biol_Res_2012_Jul_20_45(10)_935-941.nxml.txt.nlp	22801415	SENT46	19	19	33	33	pioglitazone	ghrelin	PA450970	51738	0.763
NULL	Diabetes_Care_2011_Jun_20_34(6)_1265-1269.nxml.txt.nlp	21515846	SENT19	5	5	0	0	rosiglitazone	DREAM	PA451283	30818	0.763
NULL	Sci_Rep_2014_Dec_4_4_7310.nxml.txt.nlp	25472472	SENT128	5	5	9	9	decitabine	CD34	PA164749631	947	0.763
NULL	Infect_Dis_Ther_2014_Jun_18_3(1)_35-43.nxml.txt.nlp	25134810	SENT120	25	25	15	15	oxacillin	VAN	PA450725	10318	0.763
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Apr_30_65(Pt_5)_o1175.nxml.txt.nlp	21583977	SENT9	0	0	11	11	nitrile	mol	PA450636	90527	0.763
NULL	Hum_Genomics_2010_Oct_1_5(1)_61-72.nxml.txt.nlp	21106490	SENT64	7	7	4	4	midazolam	CYP3A	PA450496	1574	0.763
NULL	J_Korean_Med_Sci_2009_Jun_15_24(3)_511-512.nxml.txt.nlp	19543518	SENT37	33	33	28	28	azithromycin	DST	PA448519	667	0.763
NULL	Mucosal_Immunol_2014_Jan_12_7(1)_10_1038_mi_2013_36.nxml.txt.nlp	23757303	SENT312	25	25	7	7	mitomycin	CD4	PA450524	920	0.763
NULL	Br_J_Cancer_2006_Feb_13_94(3)_407-426.nxml.txt.nlp	16434996	SENT120	8	8	19	19	genistein	BRCA2	PA165109660	675	0.763
NULL	J_Hum_Genet_2013_Jun_16_58(6)_353-361.nxml.txt.nlp	23677058	SENT124	3	3	34	34	etoposide	ABCC3	PA449552	8714	0.763
NULL	Diabetes_Care_2012_Jan_13_35(Suppl_1)_S11-S63.nxml.txt.nlp	22187469	SENT1733	21	21	18	18	pramlintide	GLP1	PA164781394	100125288;2641	0.763
NULL	Breast_Cancer_(Auckl)_2011_Jul_27_5_175-199.nxml.txt.nlp	21863131	SENT8	23	23	8	8	trastuzumab	HER-2	PA451743	2064	0.763
NULL	Bone_Joint_Res_2014_Mar_1_3(3)_51-59.nxml.txt.nlp	24615710	SENT26	9	9	13	13	resveratrol	SIRT1		23411	0.763
NULL	Anticancer_Agents_Med_Chem_2012_Feb_12(2)_163-171.nxml.txt.nlp	22043994	SENT181	7	7	3	3	cetuximab	BRAF	PA10040	673	0.763
NULL	Nanoscale_Res_Lett_2014_Apr_1_9(1)_156.nxml.txt.nlp	24685243	SENT127	2	2	8	8	paclitaxel	API	PA450761	5345	0.763
NULL	Allergy_Asthma_Clin_Immunol_2011_Nov_10_7(Suppl_1)_S8.nxml.txt.nlp	22165816	SENT128	30	30	21	21	omalizumab	IL-5	PA164752253	3567	0.763
NULL	Diabetes_2013_Jun_17_62(6)_1800-1807.nxml.txt.nlp	23704521	SENT130	8	8	5	5	resveratrol	SIRT1		23411	0.763
NULL	Cell_Commun_Signal_2013_Nov_11_11_86.nxml.txt.nlp	24215724	SENT477	23	23	13	13	valsartan	PAR1	PA451848	79581;2149	0.763
NULL	Case_Rep_Rheumatol_2013_Dec_17_2013_923497.nxml.txt.nlp	24455384	SENT45	21	21	8	8	tocilizumab	IL6	PA165292659	3569	0.763
NULL	Biochim_Biophys_Acta_2013_Jul_1832(7)_905-910.nxml.txt.nlp	23032152	SENT56	11	11	39	39	fenfluramine	5-HT2B	PA449592	3357	0.763
NULL	J_Cell_Biol_2001_Oct_15_155(2)_301-310.nxml.txt.nlp	11604425	SENT520	14	14	12	12	heparin	perlecan	PA449855	3339	0.763
NULL	Part_Fibre_Toxicol_2011_Aug_2_8_23.nxml.txt.nlp	21810225	SENT193	14	14	21	21	iron	ROS	PA450087	6098	0.763
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Dec_16_66(Pt_1)_o157.nxml.txt.nlp	21580046	SENT72	25	25	19	19	ethanol	mol	PA448073	90527	0.763
NULL	Cell_Biol_Int_Rep_(2010)_2012_Jun_21_19(1)_e00017.nxml.txt.nlp	23124518	SENT85	4	4	6	6	etoposide	TRAIL	PA449552	8743	0.763
NULL	Clin_Ophthalmol_2010_Sep_7_4_993-1001.nxml.txt.nlp	20856595	SENT45	0	0	13	13	azelastine	BAK	PA448517	578	0.763
NULL	Mediators_Inflamm_2010_May_25_2010_367838.nxml.txt.nlp	20508825	SENT53	9	9	18	18	capsaicin	MCP-1	PA448776	6347	0.763
NULL	Diabetes_Obes_Metab_2011_Nov_13(11)_982-989.nxml.txt.nlp	21615670	SENT177	18	18	26	26	exenatide	GLP-1	PA164749238	100125288	0.763
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Apr_8_65(Pt_5)_o996-o997.nxml.txt.nlp	21584031	SENT71	39	39	29	29	ethanol	mol	PA448073	90527	0.763
NULL	Acta_Neuropathol_Commun_2014_Oct_21_2(1)_149.nxml.txt.nlp	NULL	SENT240	7	7	11	11	riluzole	p38	PA451251	10598;1432;7965	0.763
NULL	Oncotarget_2013_Jul_26_4(8)_1317-1328.nxml.txt.nlp	23945331	SENT42	20	20	8	8	trastuzumab	HER2	PA451743	2064	0.763
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT44	0	0	7	7	curcumin	PC-3	PA151958596	692094	0.763
NULL	J_Immunol_Res_2014_Jan_19_2014_103780.nxml.txt.nlp	24741572	SENT123	20	20	10	10	salmeterol	TAK1	PA451300	7182	0.763
NULL	Acta_Pharmacol_Sin_2010_Aug_5_31(8)_938-943.nxml.txt.nlp	20686519	SENT201	18	18	10	10	reserpine	GML	PA451236	2765	0.763
NULL	Open_Biochem_J_2008_Nov_18_2_135-142.nxml.txt.nlp	19238187	SENT64	4	4	10	10	heparin	EXTL2	PA449855	2135	0.763
NULL	Crit_Care_2007_Dec_6_11(6)_235.nxml.txt.nlp	18177512	SENT133	23	23	3	3	amiodarone	CASH	PA448383	8837	0.763
NULL	Breast_Cancer_Res_2009_Jun_29_11(3)_R41.nxml.txt.nlp	19563669	SENT224	37	37	31	31	lapatinib	TRAIL	PA152241907	8743	0.763
NULL	Chemother_Res_Pract_2012_Apr_11_2012_283181.nxml.txt.nlp	22567280	SENT301	7	7	13	13	bortezomib	HYD1	PA10252	4487	0.763
NULL	Iran_J_Reprod_Med_2013_Jul_11(7)_565-576.nxml.txt.nlp	24639792	SENT37	8	8	47	47	berberine	SP-D	PA165860812	6441	0.763
NULL	Front_Immunol_2013_Nov_20_4_385.nxml.txt.nlp	24312095	SENT178	5	5	12	12	heparin	gp160	PA449855	2028	0.763
NULL	J_Biol_Chem_2008_Nov_14_283(46)_31679-31689.nxml.txt.nlp	18755684	SENT233	27	27	5	5	iron	FTL	PA450087	2512	0.763
NULL	Biomed_Res_Int_2013_Jul_9_2013_281230.nxml.txt.nlp	23936784	SENT210	27	27	12	12	dextran	gamma	PA449261	9913	0.763
NULL	Oncotarget_2010_May_1_1(1)_6-8.nxml.txt.nlp	21293050	SENT37	8	8	4	4	bortezomib	KIT	PA10252	3815	0.763
NULL	Evid_Based_Complement_Alternat_Med_2013_May_28_2013_629750.nxml.txt.nlp	23781265	SENT186	14	14	12	12	capsaicin	GADD153	PA448776	1649	0.763
NULL	Theor_Appl_Genet_2010_Jan_15_120(2)_463-473.nxml.txt.nlp	19916003	SENT51	34	34	32	32	creatine	ADP	PA164778930	23038	0.763
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_55-78.nxml.txt.nlp	19305788	SENT330	4	4	18	18	memantine	CA3	PA10364	761	0.763
NULL	Curr_HIV_Res_2014_May_12(3)_174-188.nxml.txt.nlp	24862327	SENT147	14	14	8	8	hemin	MCP-1	PA449849	6347	0.763
NULL	Arthritis_Res_Ther_2003_Oct_17_5(1)_R9-R17.nxml.txt.nlp	12716448	SENT260	4	4	9	9	urokinase	CD87	PA451836	5329	0.763
NULL	Curr_Neuropharmacol_2013_Dec_11(6)_652-663.nxml.txt.nlp	24396340	SENT193	13	13	18	18	propofol	TRPV1	PA451141	7442	0.763
NULL	Int_J_Mol_Sci_2014_Oct_29_15(11)_19700-19728.nxml.txt.nlp	25356505	SENT160	5	5	31	31	vasopressin	IGFR	PA451858	3480	0.763
NULL	ScientificWorldJournal_2013_Dec_30_2013_565813.nxml.txt.nlp	24489506	SENT238	32	32	10	10	cisplatin	Q10	PA449014	27161	0.763
NULL	Acta_Pharmacol_Sin_2012_Jun_6_33(6)_798-808.nxml.txt.nlp	22669117	SENT238	2	2	9	9	heparin	14-3-3	PA449855	10971	0.763
NULL	Curr_Hematol_Malig_Rep_2014_Jun_27_9(3)_243-253.nxml.txt.nlp	24969265	SENT255	24	24	4	4	leucovorin	MTHFR	PA450198	4524	0.763
NULL	Oncol_Lett_2014_Nov_10_8(5)_2333-2339.nxml.txt.nlp	25295120	SENT144	5	5	13	13	sorafenib	ADM	PA7000	133	0.763
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Apr_4_68(Pt_5)_o1275.nxml.txt.nlp	22590190	SENT58	20	20	35	35	ethanol	mol	PA448073	90527	0.763
NULL	J_Neurol_2011_Jul_2_258(7)_1207-1222.nxml.txt.nlp	21461686	SENT260	25	25	12	12	clonazepam	OPT	PA449050	51430	0.763
NULL	Diabetes_Care_2010_Jun_18_33(6)_1304-1308.nxml.txt.nlp	20299480	SENT158	12	12	25	25	metformin	HER-2	PA450395	2064	0.763
NULL	Breast_Cancer_Res_2007_Dec_20_9(Suppl_2)_S13.nxml.txt.nlp	NULL	SENT50	12	12	8	8	tamoxifen	ATAC	PA451581	6375	0.763
NULL	Cardiol_Res_Pract_2013_Feb_19_2013_195456.nxml.txt.nlp	23533940	SENT127	7	7	25	25	prasugrel	CYP2C19	PA154410481	1557	0.763
NULL	Lab_Invest_2009_Nov_7_89(11)_1275-1290.nxml.txt.nlp	19736547	SENT159	14	14	7	7	curcumin	LOX-1	PA151958596	4973	0.763
NULL	N_Am_J_Med_Sci_2011_May_3(5)_212-216.nxml.txt.nlp	22558596	SENT118	17	17	24	24	gemcitabine	BTC	PA449748	685	0.763
NULL	Oncotarget_2014_Feb_25_5(5)_1304-1314.nxml.txt.nlp	24675421	SENT142	25	25	6	6	cisplatin	RIP1	PA449014	10928;7386	0.763
NULL	Int_J_Mol_Sci_2012_Sep_25_13(10)_12153-12168.nxml.txt.nlp	23202889	SENT497	2	2	24	24	irinotecan	KRAS	PA450085	3845	0.763
NULL	Alcohol_Res_Health_2008_31(4)_310-339.nxml.txt.nlp	20729980	SENT471	2	2	11	11	ethanol	CRF1	PA448073	1394	0.763
NULL	Brain_Sci_2014_Mar_14_4(1)_136-149.nxml.txt.nlp	24961704	SENT80	15	15	22	22	ketamine	NR1	PA450144	27158	0.763
NULL	J_Cell_Biol_2001_Dec_24_155(7)_1319-1332.nxml.txt.nlp	11756480	SENT335	2	2	0	0	staurosporine	LPA	PA165109623	4018	0.763
NULL	Clin_Med_Insights_Oncol_2012_Dec_6_6_407-421.nxml.txt.nlp	23239933	SENT43	19	19	26	26	gefitinib	ABCG2	PA131301952	9429	0.763
NULL	Exp_Diabetes_Res_2012_Jun_14_2012_859395.nxml.txt.nlp	22778716	SENT136	27	27	10	10	estradiol	adiponectin	PA449503	9370	0.763
NULL	J_Antimicrob_Chemother_2014_Jul_14_69(7)_1945-1953.nxml.txt.nlp	24633206	SENT46	8	8	13	13	tigecycline	RGM	PA164746412	56963	0.763
NULL	Clin_Drug_Investig_2015_Dec_4_35_45-51.nxml.txt.nlp	25471740	SENT146	37	37	30	30	warfarin	CYP2C9	PA451906	1559	0.763
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT1443	21	21	14	14	urea	ECM	PA451831	22915	0.763
NULL	Oncol_Rep_2013_Apr_23_29(4)_1268-1274.nxml.txt.nlp	23354756	SENT169	9	9	0	0	trastuzumab	SLC25A43	PA451743	203427	0.763
NULL	Biomed_Res_Int_2014_Jan_2_2014_682010.nxml.txt.nlp	24524084	SENT87	11	11	17	17	imatinib	IL-2	PA10804	3558	0.763
NULL	Virchows_Arch_2012_Feb_16_460(2)_141-149.nxml.txt.nlp	22173329	SENT228	20	20	9	9	cetuximab	BRAF	PA10040	673	0.763
NULL	Cardiovasc_Diabetol_2008_Dec_23_7_36.nxml.txt.nlp	19108709	SENT117	11	11	29	29	thrombin	AP-1	PA451674	2353;3727;2354;3725	0.763
NULL	Leukemia_2014_Jun_25_28(6)_1280-1288.nxml.txt.nlp	24270737	SENT210	19	19	5	5	cytarabine	PD-L1	PA449177	29126	0.763
NULL	Front_Endocrinol_(Lausanne)_2011_Nov_10_2_65.nxml.txt.nlp	22649380	SENT60	12	12	35	35	estradiol	ACTH	PA449503	5443	0.763
NULL	Core_Evid_2007_Nov_30_2(2)_81-88.nxml.txt.nlp	21221177	SENT227	9	9	11	11	irinotecan	IFL	PA450085	3439	0.763
NULL	Front_Oncol_2013_Oct_9_3_261.nxml.txt.nlp	24130964	SENT285	0	0	12	12	erlotinib	EGFR	PA134687924	1956	0.763
NULL	Front_Oncol_2014_May_15_4_109.nxml.txt.nlp	24860787	SENT327	2	2	14	14	doxorubicin	AKT	PA449412	207	0.763
NULL	Cell_Death_Dis_2013_Sep_19_4(9)_e810.nxml.txt.nlp	24052078	SENT64	8	8	12	12	erlotinib	EGFR	PA134687924	1956	0.763
NULL	Eur_J_Clin_Pharmacol_2013_Jan_11_69(6)_1275-1283.nxml.txt.nlp	23307232	SENT249	9	9	21	21	warfarin	VKORC1	PA451906	79001	0.763
NULL	ScientificWorldJournal_2012_Aug_2_2012_940613.nxml.txt.nlp	22919361	SENT54	13	13	7	7	naloxone	PAG	PA450586	55824	0.763
NULL	Oncol_Lett_2014_Mar_19_7(3)_674-678.nxml.txt.nlp	24527071	SENT92	10	10	4	4	cisplatin	AKR1C2	PA449014	1646	0.763
NULL	Case_Rep_Rheumatol_2011_Dec_15_2011_185657.nxml.txt.nlp	22937439	SENT95	3	3	6	6	etanercept	TNF-alpha	PA449515	7124	0.763
NULL	Oncoimmunology_2012_Nov_1_1(8)_1451-1453.nxml.txt.nlp	23243626	SENT65	26	26	13	13	sorafenib	p38	PA7000	10598;1432;7965	0.763
NULL	Front_Oncol_2014_Apr_22_4_86.nxml.txt.nlp	24795863	SENT174	17	17	28	28	irinotecan	p53	PA450085	7157	0.763
NULL	J_Med_Genet_2009_Nov_7_46(11)_730-735.nxml.txt.nlp	19429598	SENT167	41	41	11	11	thalidomide	SALL4	PA451644	57167	0.763
NULL	Front_Microbiol_2014_Mar_3_5_70.nxml.txt.nlp	24624123	SENT100	18	18	23	23	tetracycline	TOB	PA451640	10140	0.763
NULL	Pharmaceuticals_(Basel)_2013_Aug_21_6(8)_988-1038.nxml.txt.nlp	24276379	SENT448	8	8	10	10	sorafenib	EGFR	PA7000	1956	0.763
NULL	EMBO_Mol_Med_2012_Sep_7_4(9)_896-909.nxml.txt.nlp	22887866	SENT153	1	1	14	14	lovastatin	c-Myc	PA450272	4609	0.763
NULL	Esophagus_2013_Mar_19_10(1)_27-29.nxml.txt.nlp	23482402	SENT28	11	11	20	20	docetaxel	TEF	PA449383	7008	0.763
NULL	Acta_Pharmacol_Sin_2010_May_12_31(5)_578-584.nxml.txt.nlp	20383171	SENT137	3	3	39	39	berberine	ORP150	PA165860812	10525	0.763
NULL	J_Carcinog_2013_Dec_31_12_22.nxml.txt.nlp	24574860	SENT6	14	14	21	21	gefitinib	EGFR	PA131301952	1956	0.763
NULL	Exp_Ther_Med_2014_Oct_16_8(4)_1150-1158.nxml.txt.nlp	25187814	SENT53	7	7	28	28	fluorescein	San	PA164746009	80218	0.763
NULL	Cell_Death_Dis_2014_Jul_10_5(7)_e1318.nxml.txt.nlp	25010984	SENT28	3	3	7	7	nutlin-3	RITA		55422;84934	0.763
NULL	FEBS_Open_Bio_2012_Aug_22_2_279-283.nxml.txt.nlp	23650611	SENT111	11	11	23	23	raloxifene	IFN	PA451221	3439	0.763
NULL	J_Exp_Med_2003_Aug_4_198(3)_505-512.nxml.txt.nlp	12900524	SENT116	15	15	3	3	dextran	CD11c	PA449261	3687	0.763
NULL	Cancer_Metastasis_Rev_2010_Dec_10_29(4)_581-594.nxml.txt.nlp	20830503	SENT310	8	8	4	4	tamoxifen	ATAC	PA451581	6375	0.763
NULL	Aging_(Albany_NY)_2011_Jan_18_3(1)_33-43.nxml.txt.nlp	21248371	SENT216	12	12	7	7	zinc	HIPK2	PA451956	28996	0.763
NULL	Acta_Pharmacol_Sin_2010_Feb_5_31(2)_137-144.nxml.txt.nlp	20139896	SENT100	8	8	20	20	zileuton	ROS	PA451955	6098	0.763
NULL	Br_J_Cancer_2012_May_8_106(10)_1587-1590.nxml.txt.nlp	22568998	SENT26	4	4	10	10	sunitinib	IFN	PA162372840	3439	0.763
NULL	Gastric_Cancer_2014_Oct_19_17(3)_489-496.nxml.txt.nlp	24142107	SENT38	2	2	17	17	warfarin	ESD	PA451906	2098	0.763
NULL	Cancer_Immunol_Immunother_2013_Aug_27_62(10)_1637-1648.nxml.txt.nlp	23982484	SENT122	2	2	12	12	lenalidomide	IL-6	PA162363968	3569	0.763
NULL	Evid_Based_Complement_Alternat_Med_2013_Mar_26_2013_625892.nxml.txt.nlp	23589719	SENT250	0	0	12	12	probenecid	TAS2R31	PA451106	259290	0.763
NULL	Clin_Med_Insights_Oncol_2012_Mar_19_6_165-178.nxml.txt.nlp	22474408	SENT234	25	25	22	22	ofatumumab	CHOP	PA165291493	1649	0.763
NULL	Core_Evid_2013_Sep_30_8_69-78.nxml.txt.nlp	24115917	SENT4	17	17	37	37	lapatinib	HER-2	PA152241907	2064	0.763
NULL	Adv_Hematol_2010_May_16_2010_672137.nxml.txt.nlp	20490274	SENT22	21	21	17	17	mitoxantrone	AIDA	PA450526	64853	0.763
NULL	Subst_Abuse_Treat_Prev_Policy_2009_Apr_17_4_6.nxml.txt.nlp	19374740	SENT61	33	33	1	1	buprenorphine	OST	PA448685	1650;23263	0.763
NULL	Br_J_Cancer_2010_Jul_27_103(3)_347-353.nxml.txt.nlp	20628392	SENT43	17	17	9	9	l-glutamine	p53	PA10090	7157	0.763
NULL	Br_J_Cancer_2013_Nov_26_109(11)_2864-2874.nxml.txt.nlp	24201754	SENT40	18	18	31	31	cetuximab	OED	PA10040	4961	0.763
NULL	J_Inflamm_(Lond)_2008_Apr_27_5_5.nxml.txt.nlp	18439312	SENT68	17	17	15	15	genistein	AREG	PA165109660	374	0.763
NULL	Ther_Clin_Risk_Manag_2006_Jun_2(2)_129-158.nxml.txt.nlp	18360588	SENT120	0	0	14	14	voriconazole	CYP2C9	PA10233	1559	0.763
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT138	30	30	19	19	pertuzumab	HER3		2065	0.763
NULL	Front_Behav_Neurosci_2011_Sep_8_5_56.nxml.txt.nlp	21927600	SENT196	5	5	10	10	amphetamine	DARPP-32	PA448408	84152	0.763
NULL	Oncogene_2014_Sep_4_33(36)_4521-4530.nxml.txt.nlp	24662833	SENT64	36	36	44	44	bicalutamide	AMPK	PA164746255	5563	0.763
NULL	Lipids_Health_Dis_2011_Feb_28_10_38.nxml.txt.nlp	21352602	SENT89	38	38	45	45	atorvastatin	PCSK9	PA448500	255738	0.763
NULL	Arthritis_Res_Ther_2005_May_18_7(Suppl_3)_S2-S8.nxml.txt.nlp	15960819	SENT63	15	15	0	0	etanercept	ACR	PA449515	49	0.763
NULL	Br_J_Cancer_2013_Oct_15_109(8)_2131-2141.nxml.txt.nlp	24052043	SENT288	4	4	29	29	docetaxel	PC-3	PA449383	692094	0.763
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jul_3_66(Pt_8)_o1911.nxml.txt.nlp	21588243	SENT56	18	18	6	6	ethanol	mol	PA448073	90527	0.763
NULL	Sensors_(Basel)_2012_Dec_28_13(1)_500-515.nxml.txt.nlp	23275085	SENT126	8	8	25	25	isoflurane	ARC	PA450106	8996;23237	0.763
NULL	Braz_J_Med_Biol_Res_2014_Oct_14_47(12)_1062-1067.nxml.txt.nlp	25387673	SENT123	7	7	43	43	propofol	IL-6	PA451141	3569	0.763
NULL	Mol_Cancer_2007_Apr_2_6_25.nxml.txt.nlp	17407558	SENT201	0	0	6	6	bevacizumab	VEGFR1	PA130232992	2321	0.763
NULL	Front_Neurosci_2012_May_30_6_77.nxml.txt.nlp	22661925	SENT149	3	3	11	11	ethanol	HEC	PA448073	10403	0.763
NULL	Arthritis_Res_Ther_2003_Sep_3_5(6)_R317-R328.nxml.txt.nlp	14680506	SENT212	6	6	12	12	rolipram	IL-10	PA153906323	3586	0.763
NULL	Curr_Neuropharmacol_2013_Dec_11(6)_652-663.nxml.txt.nlp	24396340	SENT198	9	9	4	4	lidocaine	TRPV1	PA450226	7442	0.763
NULL	Acta_Pharmacol_Sin_2009_Aug_13_30(8)_1099-1106.nxml.txt.nlp	19597524	SENT118	5	5	24	24	propranolol	NCX	PA451145	3196	0.763
NULL	Cell_Commun_Signal_2013_Nov_11_11_86.nxml.txt.nlp	24215724	SENT267	17	17	15	15	thrombin	PAR4	PA451674	9002;5074	0.763
NULL	J_Gastrointest_Cancer_2013_Aug_7_44(4)_385-392.nxml.txt.nlp	23921604	SENT234	5	5	22	22	imatinib	KIT	PA10804	3815	0.763
NULL	Indian_J_Endocrinol_Metab_2012_Mar-Apr_16(2)_177-182.nxml.txt.nlp	22470852	SENT137	5	5	33	33	octreotide	FGF23	PA450678	8074	0.763
NULL	BMB_Rep_2013_Nov_46(11)_544-549.nxml.txt.nlp	24152910	SENT41	6	6	16	16	thrombin	PAR-1	PA451674	2011;2149	0.763
NULL	Mol_Cancer_2008_Mar_26_7_27.nxml.txt.nlp	18366759	SENT279	20	20	5	5	etoposide	AP-1	PA449552	2353;3727;2354;3725	0.763
NULL	Arthritis_Res_Ther_2014_Jul_24_16(4)_R157.nxml.txt.nlp	25059342	SENT121	11	11	31	31	bleomycin	IL-6	PA448645	3569	0.763
NULL	J_Cancer_2013_Nov_23_4(9)_736-754.nxml.txt.nlp	24312144	SENT222	19	19	12	12	erlotinib	VEGFR	PA134687924	3791	0.763
NULL	Curr_Opin_Infect_Dis_2013_Dec_6_26(6)_538-544.nxml.txt.nlp	24126716	SENT111	0	0	26	26	colistin	San	PA164760862	80218	0.763
NULL	J_Cell_Biol_1983_Jul_1_97(1)_166-172.nxml.txt.nlp	6863389	SENT4	25	25	23	23	choline	CDP	PA448976	1523	0.763
NULL	Brain_Behav_2013_Mar_6_3(2)_114-133.nxml.txt.nlp	23533150	SENT212	2	2	15	15	ethanol	HSF1	PA448073	3297	0.763
NULL	Acta_Pharmacol_Sin_2013_Mar_11_34(3)_403-413.nxml.txt.nlp	23396374	SENT194	0	0	16	16	denosumab	RANKL	PA166048634	8600	0.763
NULL	Int_J_Med_Chem_2012_Dec_13_2012_530392.nxml.txt.nlp	25379286	SENT195	21	21	10	10	ethanol	mol	PA448073	90527	0.763
NULL	ISRN_Neurosci_2013_Dec_8_2013_152567.nxml.txt.nlp	24967301	SENT61	9	9	16	16	isoflurane	CO2	PA450106	4513	0.763
NULL	J_Hematol_Oncol_2009_Aug_12_2_36.nxml.txt.nlp	19674465	SENT101	0	0	38	38	lenalidomide	EGFR	PA162363968	1956	0.763
NULL	Extremophiles_2009_Nov_23_13(6)_885-894.nxml.txt.nlp	19701714	SENT138	23	23	38	38	ethanol	mol	PA448073	90527	0.763
NULL	J_Med_Case_Reports_2011_Feb_14_5_60.nxml.txt.nlp	21320326	SENT124	15	15	11	11	doxorubicin	CHOP	PA449412	1649	0.763
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jul_17_66(Pt_8)_o2053-o2054.nxml.txt.nlp	21588360	SENT80	0	0	6	6	benzaldehyde	mol	PA448571	90527	0.763
NULL	EMBO_Mol_Med_2011_May_3(5)_266-278.nxml.txt.nlp	21438154	SENT125	36	36	28	28	oxaliplatin	TRPA1	PA131285527	8989	0.763
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT121	7	7	9	9	trastuzumab	AKT	PA451743	207	0.763
NULL	Cell_Mol_Neurobiol_2011_Jul_20_31(5)_715-727.nxml.txt.nlp	21424551	SENT59	16	16	11	11	l-glutamine	B27	PA10090	56246	0.763
NULL	Breast_Cancer_Res_2010_Jun_28_12(3)_R43.nxml.txt.nlp	20579400	SENT39	4	4	10	10	tamoxifen	MAPT	PA451581	4137	0.763
NULL	Br_J_Cancer_2013_Oct_15_109(8)_2051-2057.nxml.txt.nlp	24064969	SENT85	29	29	27	27	capecitabine	SOC	PA448771	91544	0.763
NULL	Br_J_Cancer_2011_Jul_12_105(2)_255-262.nxml.txt.nlp	21694725	SENT21	22	22	5	5	cetuximab	KRAS	PA10040	3845	0.763
NULL	Breast_Cancer_Res_2001_Oct_1_3(6)_361-364.nxml.txt.nlp	11737886	SENT27	21	21	43	43	cyclophosphamide	HER-2	PA449165	2064	0.763
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Feb_17_6_29-36.nxml.txt.nlp	24648767	SENT53	29	29	11	11	tamoxifen	BRCA2	PA451581	675	0.763
NULL	Jpn_Clin_Med_2014_Sep_17_5_33-41.nxml.txt.nlp	25288908	SENT56	8	8	25	25	glibenclamide	GLP-1	PA449782	100125288	0.763
NULL	Oncotarget_2014_Jun_29_5(12)_4567-4578.nxml.txt.nlp	24994120	SENT154	5	5	11	11	doxorubicin	CREB3L1	PA449412	90993	0.763
NULL	Basic_Clin_Neurosci_2014_Summer_5(3)_182-190.nxml.txt.nlp	25337378	SENT203	10	10	7	7	bupropion	mol	PA448687	90527	0.763
NULL	AIDS_Res_Ther_2013_May_1_10_10.nxml.txt.nlp	23634877	SENT187	34	34	7	7	atorvastatin	CCR5	PA448500	1234	0.763
NULL	Biomed_Res_Int_2014_Jun_26_2014_161346.nxml.txt.nlp	25054130	SENT170	3	3	11	11	curcumin	IL-6	PA151958596	3569	0.763
NULL	Br_J_Cancer_2013_Feb_19_108(3)_557-563.nxml.txt.nlp	23361053	SENT166	19	19	16	16	tamoxifen	PAK1	PA451581	5585;5058	0.763
NULL	Arthritis_Res_Ther_2007_Oct_19_9(Suppl_3)_P20.nxml.txt.nlp	NULL	SENT19	25	25	19	19	infliximab	p38	PA452639	10598;1432;7965	0.763
NULL	Mol_Neurodegener_2011_May_4_6_28.nxml.txt.nlp	21542899	SENT359	43	43	27	27	theophylline	ADP	PA451647	23038	0.763
NULL	Korean_J_Anesthesiol_2013_Jan_21_64(1)_54-60.nxml.txt.nlp	23372887	SENT28	5	5	12	12	methylprednisolone	CRT	PA450466	811	0.763
NULL	J_Oncol_2012_Feb_15_2012_168303.nxml.txt.nlp	22481917	SENT83	7	7	11	11	irinotecan	NET	PA450085	2004;6530	0.763
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT543	2	2	24	24	amisulpride	PRL	PA162565877	5617	0.763
NULL	Allergy_Asthma_Clin_Immunol_2012_May_20_8(1)_6.nxml.txt.nlp	22607519	SENT101	13	13	18	18	daclizumab	IL-6	PA164764446	3569	0.763
NULL	Int_J_Mol_Sci_2014_Jun_5_15(6)_10083-10100.nxml.txt.nlp	24905407	SENT68	20	20	16	16	tetracycline	STP	PA451640	9322	0.763
NULL	Oncol_Rep_2012_Apr_30_27(4)_923-928.nxml.txt.nlp	22209766	SENT128	23	23	8	8	irinotecan	EGFR	PA450085	1956	0.763
NULL	Br_J_Cancer_1996_Dec_74(12)_1908-1915.nxml.txt.nlp	8980389	SENT22	9	9	7	7	melphalan	TNF-alpha	PA450354	7124	0.763
NULL	Core_Evid_2010_Jul_27_5_1-10.nxml.txt.nlp	20694135	SENT163	21	21	13	13	entacapone	CLE	PA164748726	51637	0.763
NULL	Nucleic_Acids_Res_2013_Nov_27_41(21)_9786-9799.nxml.txt.nlp	23982513	SENT137	6	6	17	17	arsenite	TIAR	PA452638	7073	0.763
NULL	Clin_Dev_Immunol_2013_Sep_17_2013_791262.nxml.txt.nlp	24151519	SENT202	0	0	7	7	heparin	CCR2	PA449855	729230	0.763
NULL	Evid_Based_Complement_Alternat_Med_2011_Mar_1_2011_207034.nxml.txt.nlp	21423686	SENT186	5	5	29	29	clopidogrel	CYP2C19	PA449053	1557	0.763
NULL	Oncotarget_2014_Dec_4_5(22)_11365-11380.nxml.txt.nlp	25426548	SENT37	28	28	25	25	nutlin-3	p53		7157	0.763
NULL	Int_J_Appl_Basic_Med_Res_2012_Jul-Dec_2(2)_77-83.nxml.txt.nlp	23776817	SENT119	25	25	11	11	indinavir	CYP3A4	PA449977	1576	0.763
NULL	Acta_Pharmacol_Sin_2011_Oct_12_32(10)_1259-1265.nxml.txt.nlp	21909126	SENT106	31	31	10	10	losartan	p38	PA450268	10598;1432;7965	0.763
NULL	Endocrine_2012_Dec_14_42(3)_622-636.nxml.txt.nlp	22695986	SENT306	6	6	14	14	forskolin	PTH	PA146096022	5741	0.763
NULL	Basic_Res_Cardiol_2014_May_22_109(4)_416.nxml.txt.nlp	24847907	SENT7	22	22	16	16	candesartan	AT1	PA448765	9197;185	0.763
NULL	Sci_Rep_2014_Dec_17_4_7035.nxml.txt.nlp	25516351	SENT273	10	10	21	21	docetaxel	SPARC	PA449383	6678	0.763
NULL	Br_J_Cancer_2011_Jan_4_104(1)_91-100.nxml.txt.nlp	21139584	SENT107	21	21	25	25	bortezomib	c-Raf	PA10252	5894	0.763
NULL	Indian_J_Med_Paediatr_Oncol_2013_Oct-Dec_34(4)_299-304.nxml.txt.nlp	24604961	SENT85	6	6	12	12	doxorubicin	CHOP	PA449412	1649	0.763
NULL	Br_J_Cancer_2013_Dec_10_109(12)_3034-3041.nxml.txt.nlp	24178758	SENT142	37	37	7	7	tamoxifen	CHOP	PA451581	1649	0.763
NULL	Drug_Saf_2014_Feb_19_37(4)_201-211.nxml.txt.nlp	24550106	SENT302	6	6	12	12	tacrolimus	CYP2C19	PA451578	1557	0.763
NULL	Br_J_Pharmacol_2008_Sep_9_155(1)_127-137.nxml.txt.nlp	18536750	SENT196	35	35	26	26	piroxicam	IL-10	PA450985	3586	0.763
NULL	Biologics_2012_Feb_1_6_31-35.nxml.txt.nlp	22355257	SENT13	7	7	22	22	rituximab	IL-2	PA451261	3558	0.763
NULL	J_Cell_Biol_1997_Jun_30_137(7)_1555-1566.nxml.txt.nlp	9199170	SENT106	12	12	15	15	dextran	mol	PA449261	90527	0.763
NULL	Front_Genet_2013_Aug_30_4_166.nxml.txt.nlp	24009623	SENT569	9	9	3	3	sirolimus	ABCB1	PA451365	5243	0.763
NULL	Breast_Cancer_Res_2010_Mar_5_12(2)_R16.nxml.txt.nlp	20205716	SENT234	28	28	20	20	lovastatin	MCM7	PA450272	4176	0.763
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT213	15	15	43	43	l-leucine	SIRT3	PA450197	23410	0.763
NULL	Blood_Cancer_J_2013_Oct_18_3(10)_e153.nxml.txt.nlp	24141622	SENT81	5	5	9	9	fludarabine	XIAP	PA449655	331	0.763
NULL	Acta_Physiol_(Oxf)_2012_Feb_204(2)_267-276.nxml.txt.nlp	21418147	SENT10	6	6	13	13	lipase	ABHD12	PA450239	26090	0.763
NULL	Nat_Commun_2013_Sep_20_4_2444.nxml.txt.nlp	24051492	SENT46	25	25	7	7	nutlin-3	p53		7157	0.763
NULL	Emerg_Med_Int_2014_Aug_13_2014_571326.nxml.txt.nlp	25197573	SENT85	0	0	7	7	acetaminophen	COX	PA448015	1351	0.763
NULL	Cell_Biol_Int_Rep_(2010)_2012_Jun_21_19(1)_e00017.nxml.txt.nlp	23124518	SENT75	0	0	9	9	etoposide	TRAIL-R2	PA449552	8795	0.763
NULL	Clinics_(Sao_Paulo)_2013_May_68(5)_694-701.nxml.txt.nlp	23778405	SENT188	22	22	26	26	curcumin	survivin	PA151958596	332	0.763
NULL	Diabetes_2011_Jan_4_60(1)_119-126.nxml.txt.nlp	20921208	SENT149	19	19	11	11	glucose	GLP-1	PA449773	100125288	0.763
NULL	Front_Mol_Neurosci_2012_Nov_12_5_99.nxml.txt.nlp	23162427	SENT867	5	5	2	2	cocaine	BDNF	PA449072	627	0.763
NULL	J_Gastroenterol_2013_Jan_27_48(1)_22-30.nxml.txt.nlp	23104468	SENT108	10	10	3	3	ribavirin	IL28B	PA451241	282617	0.763
NULL	Oncogene_2014_Sep_18_33(38)_4697-4708.nxml.txt.nlp	24681955	SENT156	27	27	1	1	fluorescein	SOX2	PA164746009	6657	0.763
NULL	Indian_J_Pharmacol_2009_Aug_41(4)_192-196.nxml.txt.nlp	20523872	SENT95	22	22	26	26	scopolamine	ANOVA	PA451308	4858	0.763
NULL	Nucleic_Acids_Res_2006_Jul_4_34(11)_3299-3308.nxml.txt.nlp	16820530	SENT207	15	15	4	4	ethanol	APOBEC-1	PA448073	339	0.763
NULL	Ann_Rheum_Dis_2011_Nov_25_71(5)_687-693.nxml.txt.nlp	22121130	SENT144	27	27	10	10	rituximab	IL-6	PA451261	3569	0.763
NULL	Cell_Death_Dis_2010_Nov_18_1(11)_e102.nxml.txt.nlp	21368867	SENT94	6	6	0	0	gentamicin	CLIMP-63	PA449753	10970	0.763
NULL	Arthritis_Res_Ther_2014_Dec_3_16(6)_484.nxml.txt.nlp	25465897	SENT181	8	8	32	32	hyaluronan	UGDH	PA165958431	7358	0.763
NULL	Aging_(Albany_NY)_2012_Jul_22_4(7)_480-498.nxml.txt.nlp	22837425	SENT87	13	13	3	3	metformin	LKB1	PA450395	6794	0.763
NULL	Br_J_Ophthalmol_2011_Jun_22_95(6)_869-875.nxml.txt.nlp	21429894	SENT37	8	8	34	34	paraformaldehyde	ZO-1	PA450790	7082	0.763
NULL	Mol_Cancer_2014_Jan_28_13_17.nxml.txt.nlp	24472312	SENT117	28	28	18	18	ponatinib	Mcl-1	PA165980594	4170	0.763
NULL	Chin_J_Cancer_2011_Oct_30(10)_690-700.nxml.txt.nlp	21959046	SENT107	5	5	3	3	chloroquine	TPT	PA448948	23590;6469	0.763
NULL	Case_Rep_Ophthalmol_Med_2012_Oct_18_2012_102739.nxml.txt.nlp	23119208	SENT78	19	19	16	16	ribavirin	IFN	PA451241	3439	0.763
NULL	Indian_J_Ophthalmol_2014_Jan_62(1)_66-73.nxml.txt.nlp	24492504	SENT43	3	3	13	13	ranibizumab	VEGF-A	PA164746012	7422	0.763
NULL	Biomed_Imaging_Interv_J_2011_Oct_1_7(4)_e25.nxml.txt.nlp	22279502	SENT48	7	7	39	39	oxaliplatin	LARC	PA131285527	6364	0.763
NULL	Oncol_Rep_2012_Apr_30_27(4)_923-928.nxml.txt.nlp	22209766	SENT127	5	5	9	9	erlotinib	EGFR	PA134687924	1956	0.763
NULL	J_Hum_Genet_2013_Jun_16_58(6)_353-361.nxml.txt.nlp	23677058	SENT166	9	9	16	16	cytarabine	RRM1	PA449177	6240	0.763
NULL	Mol_Cancer_2007_Oct_11_6_63.nxml.txt.nlp	17931419	SENT25	10	10	21	21	cetuximab	EGFR	PA10040	1956	0.763
NULL	Epigenetics_Chromatin_2014_Jan_20_7_2.nxml.txt.nlp	24443974	SENT24	25	25	3	3	protamine	PRM1	PA10366	5619	0.763
NULL	J_Inflamm_(Lond)_2006_Jul_12_3_10.nxml.txt.nlp	16834783	SENT20	13	13	24	24	mometasone	IL-5	PA450541	3567	0.763
NULL	Brain_Res_2012_Feb_3_1436(C)_111-121.nxml.txt.nlp	22200378	SENT127	16	16	32	32	probenecid	OAT	PA451106	4942	0.763
NULL	Br_J_Cancer_2010_Jan_5_102(1)_234-235.nxml.txt.nlp	NULL	SENT8	21	21	31	31	sunitinib	IFN	PA162372840	3439	0.763
NULL	J_Cardiovasc_Dis_Res_2012_Oct-Dec_3(4)_319-322.nxml.txt.nlp	23233778	SENT13	26	26	9	9	azithromycin	CYP3A4	PA448519	1576	0.763
NULL	Ann_Clin_Transl_Neurol_2014_Dec_21_1(12)_996-1005.nxml.txt.nlp	25574474	SENT122	20	20	7	7	riluzole	P-gp	PA451251	5243	0.763
NULL	Int_J_Endocrinol_Metab_2013_Dec_21_Winter_11(1)_57-61.nxml.txt.nlp	23853622	SENT127	14	14	8	8	bromocriptine	PRL	PA448671	5617	0.763
NULL	Eur_J_Clin_Pharmacol_2011_May_2_67(Suppl_1)_87-107.nxml.txt.nlp	21287160	SENT301	6	6	1	1	doxorubicin	SLC22A16	PA449412	85413	0.763
NULL	Comp_Funct_Genomics_2012_Feb_6_2012_876893.nxml.txt.nlp	22400011	SENT209	22	22	0	0	zinc	PCF11	PA451956	51585	0.763
NULL	Clin_Mol_Allergy_2011_Apr_28_9_7.nxml.txt.nlp	21527026	SENT36	2	2	7	7	omalizumab	CD23	PA164752253	2208	0.763
NULL	Brain_2008_Nov_22_131(11)_3072-3080.nxml.txt.nlp	18945724	SENT41	8	8	5	5	thyroglobulin	TPO	PA164754910	7066;7173	0.763
NULL	Cell_Death_Dis_2010_Oct_21_1(10)_e86.nxml.txt.nlp	21368859	SENT241	2	2	0	0	doxorubicin	TRAIL	PA449412	8743	0.763
NULL	Sci_Rep_2014_Dec_3_4_7294.nxml.txt.nlp	25465236	SENT533	7	7	26	26	gefitinib	EGFR	PA131301952	1956	0.763
NULL	J_Headache_Pain_2011_Aug_29_12(4)_411-417.nxml.txt.nlp	21626018	SENT196	6	6	8	8	capsaicin	c-fos	PA448776	2353	0.763
NULL	Acta_Diabetol_2012_Feb_15_49(1)_17-24.nxml.txt.nlp	21234613	SENT0	17	17	13	13	glucose	TNF	PA449773	7124	0.763
NULL	J_Inflamm_(Lond)_2006_Jul_12_3_10.nxml.txt.nlp	16834783	SENT19	3	3	8	8	mometasone	IL-8	PA450541	3576	0.763
NULL	Int_J_Mol_Sci_2014_Sep_23_15(9)_16911-16935.nxml.txt.nlp	25250910	SENT142	0	0	6	6	paraformaldehyde	mol	PA450790	90527	0.763
NULL	Nat_Neurosci_2014_Jan_8_17(1)_114-120.nxml.txt.nlp	24316890	SENT85	26	26	3	3	vanillin	OR10G4	PA451852	390264	0.763
NULL	Front_Physiol_2011_Apr_12_2_13.nxml.txt.nlp	21559063	SENT599	6	6	20	20	resveratrol	SIRT1		23411	0.763
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT309	15	15	47	47	metformin	CCL16	PA450395	6360	0.763
NULL	Biologics_2013_Dec_16_8_13-25.nxml.txt.nlp	24368879	SENT102	16	16	6	6	ranibizumab	VEGF-A	PA164746012	7422	0.763
NULL	Mol_Cancer_2009_Jul_3_8_43.nxml.txt.nlp	19575780	SENT126	8	8	2	2	colchicine	survivin	PA449092	332	0.763
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Sep_30_66(Pt_10)_o2667.nxml.txt.nlp	21587638	SENT66	11	11	26	26	ethanol	mol	PA448073	90527	0.763
NULL	Blood_Cancer_J_2012_Mar_9_2(3)_e60.nxml.txt.nlp	22829255	SENT10	20	20	5	5	daunorubicin	FLT3	PA449212	2322	0.763
NULL	Oxid_Med_Cell_Longev_2012_Jan_19_2012_390678.nxml.txt.nlp	22315655	SENT37	35	35	39	39	gliclazide	NAC	PA10892	22861	0.763
NULL	Pain_2012_Apr_153(4)_775-783.nxml.txt.nlp	22325744	SENT442	9	9	13	13	naloxone	P28	PA450586	9446;7802;9527	0.763
NULL	Diabetes_2009_Apr_9_58(4)_803-812.nxml.txt.nlp	19136652	SENT251	4	4	6	6	estradiol	adiponectin	PA449503	9370	0.763
NULL	Front_Oncol_2014_Apr_9_4_75.nxml.txt.nlp	24782986	SENT52	22	22	10	10	paclitaxel	Oct4	PA450761	5460	0.763
NULL	Cancers_(Basel)_2013_Jan_31_5(1)_149-169.nxml.txt.nlp	24216702	SENT202	26	26	13	13	gefitinib	EGFR	PA131301952	1956	0.763
NULL	Ann_Hematol_2010_Nov_25_89(11)_1115-1124.nxml.txt.nlp	20499237	SENT118	32	32	2	2	simvastatin	CD19	PA451363	930	0.763
NULL	Brain_Tumor_Res_Treat_2013_Apr_30_1(1)_32-35.nxml.txt.nlp	24904887	SENT43	24	24	20	20	cyclophosphamide	CHOP	PA449165	1649	0.763
NULL	Diabetes_Obes_Metab_2010_May_12(5)_437-441.nxml.txt.nlp	20415692	SENT121	11	11	7	7	metformin	GLA	PA450395	9027;2717	0.763
NULL	Nature_2012_Apr_25_484(7395)_524-528.nxml.txt.nlp	22538616	SENT112	6	6	25	25	ciprofloxacin	IFN	PA449009	3439	0.763
NULL	J_Inflamm_(Lond)_2006_Feb_22_3_2.nxml.txt.nlp	16504062	SENT143	32	32	34	34	bleomycin	BLM	PA448645	641	0.763
NULL	Acta_Pharmacol_Sin_2010_Jan_7_31(1)_27-34.nxml.txt.nlp	19966836	SENT44	21	21	14	14	trypsin	CO2	PA451806	4513	0.763
NULL	Biomed_Res_Int_2013_Dec_23_2013_676192.nxml.txt.nlp	24455715	SENT281	9	9	6	6	indomethacin	COX	PA449982	1351	0.763
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_7-17.nxml.txt.nlp	17912633	SENT368	9	9	37	37	fulvestrant	aromatase	PA164747170	1588	0.763
NULL	Breast_Cancer_Res_2008_May_12_10(3)_R45.nxml.txt.nlp	18474099	SENT200	38	38	10	10	paclitaxel	IL-8	PA450761	3576	0.762
NULL	Br_J_Cancer_2013_Feb_19_108(3)_557-563.nxml.txt.nlp	23361053	SENT198	20	20	23	23	tamoxifen	IPA	PA451581	3160	0.762
NULL	Front_Oncol_2014_Mar_3_4_35.nxml.txt.nlp	24624362	SENT124	18	18	5	5	cetuximab	KRAS	PA10040	3845	0.762
NULL	J_Inherit_Metab_Dis_2012_Jan_10_35(1)_141-149.nxml.txt.nlp	21556832	SENT14	18	18	10	10	creatine	GAMT	PA164778930	2593	0.762
NULL	Cell_Death_Dis_2012_Jun_21_3(6)_e327.nxml.txt.nlp	22717582	SENT218	21	21	29	29	vincristine	p53	PA451879	7157	0.762
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT194	14	14	27	27	methotrexate	MSH2	PA450428	4436	0.762
NULL	Iran_J_Reprod_Med_2012_Jul_10(4)_363-372.nxml.txt.nlp	25246899	SENT48	2	2	16	16	metyrosine	San	PA450487	80218	0.762
NULL	CNS_Drugs_2013_May_27_27(5)_335-343.nxml.txt.nlp	23533009	SENT124	20	20	33	33	olanzapine	FGA	PA450688	2243	0.762
NULL	J_Lipid_Res_2015_Jan_56(1)_109-121.nxml.txt.nlp	25421061	SENT358	26	26	20	20	lipase	G0S2	PA450239	50486	0.762
NULL	Eur_J_Med_Res_2009_Jul_22_14(7)_309-314.nxml.txt.nlp	19661014	SENT178	4	4	12	12	azithromycin	IL-8	PA448519	3576	0.762
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Apr_13_69(Pt_5)_o718-o719.nxml.txt.nlp	23723871	SENT79	9	9	33	33	benzaldehyde	mol	PA448571	90527	0.762
NULL	Ann_Oncol_2011_May_3_22(5)_1078-1087.nxml.txt.nlp	21048039	SENT185	17	17	3	3	cetuximab	EGFR	PA10040	1956	0.762
NULL	Int_Semin_Surg_Oncol_2007_Jul_23_4_18.nxml.txt.nlp	17645796	SENT88	37	37	39	39	raloxifene	STAR	PA451221	6770;2984	0.762
NULL	Ther_Clin_Risk_Manag_2007_Jun_3(2)_259-268.nxml.txt.nlp	18360634	SENT8	5	5	20	20	natalizumab	IFN	PA164747191	3439	0.762
NULL	Exp_Ther_Med_2013_Dec_15_6(6)_1565-1569.nxml.txt.nlp	24255692	SENT128	17	17	7	7	atorvastatin	adiponectin	PA448500	9370	0.762
NULL	Indian_J_Pharmacol_2008_Oct_40(Suppl_2)_S97-S112.nxml.txt.nlp	21593984	SENT465	7	7	21	21	telmisartan	STZ	PA451605	6484	0.762
NULL	Breast_Cancer_Res_2012_Feb_8_14(1)_R26.nxml.txt.nlp	22316048	SENT33	8	8	11	11	letrozole	aromatase	PA450196	1588	0.762
NULL	Indian_J_Med_Res_2011_Apr_133(4)_434-441.nxml.txt.nlp	21537099	SENT103	30	30	26	26	lansoprazole	EGF	PA450180	1950	0.762
NULL	J_Cardiothorac_Surg_2014_Sep_17_9(1)_129.nxml.txt.nlp	NULL	SENT33	17	17	1	1	heparin	ACT	PA449855	12;11332;9457;641455	0.762
NULL	Adolesc_Health_Med_Ther_2011_Sep_14_2_85-93.nxml.txt.nlp	24600277	SENT135	24	24	27	27	enfuvirtide	DUET	PA164744517	8997	0.762
NULL	Hum_Genomics_2008_Sep_1_3(1)_7-16.nxml.txt.nlp	19129086	SENT195	6	6	12	12	rosiglitazone	CYP2C8	PA451283	1558	0.762
NULL	Indian_J_Pharmacol_2013_Sep-Oct_45(5)_458-463.nxml.txt.nlp	24130379	SENT94	2	2	16	16	carvedilol	Bcl-2	PA448817	596	0.762
NULL	Acta_Pharmacol_Sin_2010_Jul_28_31(7)_867-873.nxml.txt.nlp	20581857	SENT141	27	27	14	14	docetaxel	PC3	PA449383	57332;7832;5122	0.762
NULL	Oncotarget_2013_Aug_24_4(10)_1618-1631.nxml.txt.nlp	24113128	SENT217	5	5	15	15	sorafenib	VEGFR2	PA7000	3791	0.762
NULL	Arch_Plast_Surg_2012_Sep_12_39(5)_540-545.nxml.txt.nlp	23094252	SENT147	23	23	20	20	propofol	TCI	PA451141	6947	0.762
NULL	J_Hematol_Oncol_2009_Feb_27_2_11.nxml.txt.nlp	19250532	SENT59	6	6	0	0	vincristine	CHOP	PA451879	1649	0.762
NULL	Diabetes_2009_Dec_31_58(12)_2851-2862.nxml.txt.nlp	19720788	SENT149	8	8	13	13	forskolin	CHOP	PA146096022	1649	0.762
NULL	Oncotarget_2013_Jun_3_4(6)_875-883.nxml.txt.nlp	23900261	SENT94	17	17	5	5	bortezomib	RB1	PA10252	5925	0.762
NULL	Hematol_Rep_2011_Oct_28_3(3_Suppl)_e5.nxml.txt.nlp	22586513	SENT34	3	3	12	12	cyclophosphamide	CHOP	PA449165	1649	0.762
NULL	Cancer_Manag_Res_2014_Oct_6_6_389-395.nxml.txt.nlp	25336989	SENT44	9	9	19	19	everolimus	HER2	PA164746311	2064	0.762
NULL	Curr_Osteoporos_Rep_2011_Mar_16_9(1)_4-5.nxml.txt.nlp	21161452	SENT16	21	21	8	8	zoledronate	CTX	PA10235	1593	0.762
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT74	18	18	26	26	nutlin-3	IBP		706;50619	0.762
NULL	Virchows_Arch_2009_Nov_17_455(5)_455-459.nxml.txt.nlp	19838726	SENT26	16	16	29	29	bevacizumab	San	PA130232992	80218	0.762
NULL	J_Headache_Pain_2013_Apr_10_14(1)_33.nxml.txt.nlp	23574808	SENT185	13	13	11	11	capsaicin	CO2	PA448776	4513	0.762
NULL	Arthritis_Res_Ther_2013_Sep_23_15(5)_R130.nxml.txt.nlp	24286267	SENT94	11	11	22	22	methotrexate	IL-6	PA450428	3569	0.762
NULL	Front_Immunol_2013_Mar_8_4_50.nxml.txt.nlp	23483669	SENT496	0	0	11	11	resveratrol	SIRT1		23411	0.762
NULL	FEBS_J_2009_Oct_276(19)_5571-5578.nxml.txt.nlp	19702827	SENT39	5	5	18	18	gefitinib	EGF	PA131301952	1950	0.762
NULL	Viruses_2013_Nov_22_5(11)_2898-2919.nxml.txt.nlp	24284880	SENT181	12	12	8	8	ritonavir	CYP3A4	PA451260	1576	0.762
NULL	Oncol_Lett_2014_Nov_18_8(5)_2187-2192.nxml.txt.nlp	25295107	SENT115	1	1	22	22	glucosamine	SMAD2	PA164747613	4087	0.762
NULL	Breast_Cancer_Res_2009_Jun_23_11(Suppl_1)_S15.nxml.txt.nlp	NULL	SENT10	20	20	26	26	anastrozole	ATAC	PA448432	6375	0.762
NULL	BMB_Rep_2014_Oct_47(10)_575-580.nxml.txt.nlp	24499675	SENT91	18	18	37	37	arsenite	p53	PA452638	7157	0.762
NULL	J_Hematol_Oncol_2013_Jan_17_6_8.nxml.txt.nlp	23327547	SENT6	9	9	19	19	sulindac	p27	PA451565	5715;10534	0.762
NULL	J_Hematol_Oncol_2014_Apr_4_7_30.nxml.txt.nlp	24708874	SENT15	15	15	22	22	doxorubicin	CHOP	PA449412	1649	0.762
NULL	EPMA_J_2012_Jun_22_3(1)_9.nxml.txt.nlp	22738272	SENT16	18	18	10	10	natalizumab	IFN	PA164747191	3439	0.762
NULL	BMB_Rep_2013_Jan_46(1)_59-64.nxml.txt.nlp	23351386	SENT33	5	5	13	13	auranofin	STAT3	PA448510	6774	0.762
NULL	Niger_Med_J_2014_Jul-Aug_55(4)_327-332.nxml.txt.nlp	25114369	SENT15	4	4	21	21	isoniazid	EMB	PA450112	133418	0.762
NULL	Cells_2014_Apr_29_3(2)_331-362.nxml.txt.nlp	24785347	SENT189	11	11	8	8	capsaicin	TRPV1	PA448776	7442	0.762
NULL	J_Mol_Signal_2011_Oct_5_6_13.nxml.txt.nlp	21975218	SENT260	5	5	27	27	ethanol	E4BP4	PA448073	4783	0.762
NULL	Biomed_Res_Int_2013_Oct_27_2013_467869.nxml.txt.nlp	24282816	SENT167	28	28	24	24	ribavirin	SOC	PA451241	91544	0.762
NULL	Arch_Plast_Surg_2012_Sep_12_39(5)_540-545.nxml.txt.nlp	23094252	SENT9	16	16	11	11	remifentanil	TCI	PA451232	6947	0.762
NULL	Int_J_Mol_Imaging_2011_Apr_5_2011_796025.nxml.txt.nlp	21603240	SENT209	26	26	3	3	arcitumomab	CEA	PA164746540	5670;1087	0.762
NULL	Br_J_Cancer_2013_Feb_5_108(2)_469-476.nxml.txt.nlp	23169292	SENT7	14	14	34	34	gemcitabine	TTF2	PA449748	8458	0.762
NULL	Curr_Oncol_2007_Aug_14(4)_149-153.nxml.txt.nlp	17710207	SENT24	12	12	18	18	trastuzumab	San	PA451743	80218	0.762
NULL	J_Oncol_2012_Sep_27_2012_461562.nxml.txt.nlp	23056046	SENT129	4	4	18	18	cisplatin	4E-BP1	PA449014	1978	0.762
NULL	Int_J_Biomed_Sci_2006_Jun_2(2)_135-142.nxml.txt.nlp	23674975	SENT158	16	16	20	20	estradiol	aromatase	PA449503	1588	0.762
NULL	Case_Rep_Oncol_2012_Feb_29_5(1)_110-113.nxml.txt.nlp	22539923	SENT7	25	25	6	6	rituximab	ABO	PA451261	28	0.762
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Dec_18_67(Pt_1)_o190-o191.nxml.txt.nlp	21522693	SENT75	0	0	24	24	orphenadrine	mol	PA450715	90527	0.762
NULL	Breast_Cancer_Res_Treat_2009_Jul_22_116(2)_371-378.nxml.txt.nlp	18941892	SENT15	18	18	24	24	estradiol	aromatase	PA449503	1588	0.762
NULL	Breast_Cancer_Res_2004_Jun_29_6(5)_R488-R498.nxml.txt.nlp	15318931	SENT10	6	6	12	12	estradiol	UGT2B15	PA449503	7366	0.762
NULL	Crit_Care_2010_Jun_18_14(3)_R119.nxml.txt.nlp	20565863	SENT139	3	3	16	16	hydrocortisone	IL-6	PA449905	3569	0.762
NULL	Emerg_Microbes_Infect_2013_Sep_18_2(9)_e60.nxml.txt.nlp	NULL	SENT78	12	12	7	7	dextran	IL-17F	PA449261	112744	0.762
NULL	Breast_Cancer_Res_2011_Oct_14_13(5)_316.nxml.txt.nlp	22017807	SENT12	35	35	8	8	tamoxifen	ETS2	PA451581	2114	0.762
NULL	Mol_Biol_Rep_2013_Sep_28_40(10)_5573-5585.nxml.txt.nlp	24078156	SENT43	12	12	19	19	iron	IRP1	PA450087	48	0.762
NULL	Cell_Commun_Signal_2013_Jan_11_11_3.nxml.txt.nlp	23311350	SENT234	7	7	14	14	triciribine	San	PA165958661	80218	0.762
NULL	Cells_2014_Apr_8_3(2)_258-287.nxml.txt.nlp	24717323	SENT282	37	37	27	27	forskolin	TRPV1	PA146096022	7442	0.762
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT66	0	0	4	4	curcumin	PC-3	PA151958596	692094	0.762
NULL	Front_Oncol_2013_Apr_29_3_99.nxml.txt.nlp	23641363	SENT142	12	12	1	1	decitabine	IL-2	PA164749631	3558	0.762
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT84	12	12	8	8	curcumin	DR4	PA151958596	8797	0.762
NULL	Pak_J_Med_Sci_2014_Mar-Apr_30(2)_449-451.nxml.txt.nlp	24772161	SENT58	2	2	4	4	cyclophosphamide	CTX	PA449165	1593	0.762
NULL	J_Biomed_Sci_2014_Feb_3_21(1)_10.nxml.txt.nlp	24490900	SENT127	30	30	20	20	alendronate	RANKL	PA448082	8600	0.762
NULL	BMJ_Open_2013_Nov_4_3(11)_e003995.nxml.txt.nlp	24189085	SENT80	27	27	21	21	exenatide	GLP-1	PA164749238	100125288	0.762
NULL	Leukemia_2013_Jan_11_27(1)_32-40.nxml.txt.nlp	22781593	SENT173	3	3	17	17	ponatinib	FGFR1	PA165980594	2260	0.762
NULL	Inflamm_Res_2014_Jul_22_63(10)_803-819.nxml.txt.nlp	25048990	SENT311	0	0	14	14	olmesartan	IL-6	PA164742950	3569	0.762
NULL	Biologics_2013_Apr_15_7_77-90.nxml.txt.nlp	23723688	SENT57	14	14	25	25	cetuximab	CRT	PA10040	811	0.762
NULL	ScientificWorldJournal_2013_Jun_19_2013_174392.nxml.txt.nlp	23853530	SENT4	13	13	5	5	doxazosin	c-FLIP	PA449407	8837	0.762
NULL	Iran_J_Public_Health_2013_Feb_1_42(2)_129-133.nxml.txt.nlp	23515306	SENT23	3	3	10	10	lumefantrine	ACT	PA165111722	12;11332;9457;641455	0.762
NULL	Br_J_Clin_Pharmacol_2013_Aug_23_76(2)_299-315.nxml.txt.nlp	23701319	SENT239	18	18	5	5	rituximab	IL-8	PA451261	3576	0.762
NULL	J_Clin_Immunol_2007_May_14_27(3)_275-283.nxml.txt.nlp	17510806	SENT116	13	13	24	24	rosiglitazone	ZO-1	PA451283	7082	0.762
NULL	Ann_Oncol_2014_Apr_26_25(4)_801-807.nxml.txt.nlp	24577117	SENT22	23	23	7	7	cetuximab	p16	PA10040	1029	0.762
NULL	Clin_Pharmacol_2010_Sep_6_2_155-162.nxml.txt.nlp	22291500	SENT68	12	12	6	6	clopidogrel	VASP	PA449053	7408	0.762
NULL	Front_Mol_Neurosci_2009_May_14_2_1.nxml.txt.nlp	19506703	SENT158	3	3	11	11	candesartan	ACTH	PA448765	5443	0.762
NULL	Exp_Brain_Res_2010_Jan_19_200(2)_125-140.nxml.txt.nlp	19690847	SENT236	9	9	30	30	tetracaine	CA1	PA451638	759	0.762
NULL	Pharmacogn_Rev_2011_Jul-Dec_5(10)_120-137.nxml.txt.nlp	22279370	SENT36	29	29	15	15	valdecoxib	COX2	PA10226	4513;5743	0.762
NULL	Gut_2012_Feb_27_61(2)_248-254.nxml.txt.nlp	21708826	SENT115	5	5	8	8	celecoxib	MAF	PA448871	4094	0.762
NULL	Clin_Pharmacokinet_2014_Jun_27_53(8)_741-751.nxml.txt.nlp	24968986	SENT311	12	12	3	3	temozolomide	ABCB1	PA451609	5243	0.762
NULL	Clin_Microbiol_Infect_2014_Jun_21_20(6)_536-541.nxml.txt.nlp	24107197	SENT8	15	15	35	35	isoniazid	DST	PA450112	667	0.762
NULL	Br_J_Cancer_2011_Apr_12_104(8)_1256-1261.nxml.txt.nlp	21448165	SENT8	47	47	26	26	sorafenib	IL-2	PA7000	3558	0.762
NULL	Oxid_Med_Cell_Longev_2013_Nov_28_2013_568093.nxml.txt.nlp	24379901	SENT68	5	5	28	28	resveratrol	HO-1		3162	0.762
NULL	Hum_Genomics_2009_Dec_1_4(2)_91-106.nxml.txt.nlp	20038497	SENT120	48	48	35	35	galantamine	CYP3A4	PA449726	1576	0.762
NULL	AIDS_Res_Ther_2008_Mar_28_5_5.nxml.txt.nlp	18373851	SENT35	12	12	10	10	ritonavir	ATV	PA451260	4683	0.762
NULL	Eur_J_Endocrinol_2010_May_162(5)_987-992.nxml.txt.nlp	20164212	SENT29	0	0	11	11	diazoxide	GLUD1	PA449285	2746	0.762
NULL	Int_J_Mol_Sci_2014_Nov_7_15(11)_20500-20517.nxml.txt.nlp	25387078	SENT630	2	2	12	12	sorafenib	CD95	PA7000	355	0.762
NULL	Cell_Death_Dis_2014_Jun_26_5(6)_e1306.nxml.txt.nlp	24967968	SENT284	45	45	27	27	dextran	LAMP1	PA449261	3916	0.762
NULL	Exp_Hematol_Oncol_2012_Sep_6_1_26.nxml.txt.nlp	23210433	SENT129	10	10	23	23	eculizumab	BCS	PA164776637	617	0.762
NULL	Acta_Pharmacol_Sin_2009_Nov_12_30(11)_1566-1572.nxml.txt.nlp	19820718	SENT13	22	22	33	33	verapamil	P-gp	PA451868	5243	0.762
NULL	Croat_Med_J_2012_Jun_53(3)_214-223.nxml.txt.nlp	22661134	SENT94	5	5	13	13	clonidine	ACTH	PA449051	5443	0.762
NULL	Ann_Clin_Transl_Neurol_2014_Dec_21_1(12)_996-1005.nxml.txt.nlp	25574474	SENT122	20	20	31	31	riluzole	P-gp	PA451251	5243	0.762
NULL	Tumour_Biol_2012_Dec_14_33(6)_2209-2216.nxml.txt.nlp	22890830	SENT159	15	15	4	4	cetuximab	PTEN	PA10040	5728	0.762
NULL	Pharmaceuticals_(Basel)_2011_Mar_17_4(3)_551-566.nxml.txt.nlp	NULL	SENT584	10	10	8	8	doxorubicin	MCP-1	PA449412	6347	0.762
NULL	J_Cell_Mol_Med_2014_Sep_5_18(9)_1773-1784.nxml.txt.nlp	25091058	SENT279	12	12	14	14	bleomycin	IL-22	PA448645	50616;53342	0.762
NULL	Arthritis_Res_Ther_2009_Jun_29_11(3)_R100.nxml.txt.nlp	19563672	SENT38	33	33	24	24	infliximab	IFN	PA452639	3439	0.762
NULL	Arthritis_Res_Ther_2006_Apr_12_8(Suppl_1)_S3.nxml.txt.nlp	16820042	SENT147	27	27	9	9	colchicine	MSU	PA449092	593	0.762
NULL	Pain_Res_Treat_2012_Apr_23_2012_295926.nxml.txt.nlp	22577544	SENT139	12	12	20	20	dicyclomine	ARC	PA164744928	8996;23237	0.762
NULL	Nucleic_Acids_Res_2012_Jun_10_40(11)_4804-4815.nxml.txt.nlp	22328728	SENT283	27	27	10	10	resveratrol	SIRT1		23411	0.762
NULL	Acta_Pharmacol_Sin_2014_Jun_4_35(6)_792-805.nxml.txt.nlp	24902787	SENT79	3	3	10	10	tropisetron	INS-1	PA161925594	2305	0.762
NULL	Indian_J_Dermatol_2013_Jul-Aug_58(4)_249-254.nxml.txt.nlp	23918993	SENT75	33	33	9	9	cyclosporine	CYP3A4	PA449167	1576	0.762
NULL	Core_Evid_2010_Jul_27_5_1-10.nxml.txt.nlp	20694135	SENT27	14	14	9	9	entacapone	CLE	PA164748726	51637	0.762
NULL	Diabetes_Care_2013_Jun_15_36(6)_1654-1659.nxml.txt.nlp	23250803	SENT25	7	7	15	15	glimepiride	SUR1	PA449761	6833	0.762
NULL	Breast_Cancer_Res_2010_Oct_14_12(5)_R84.nxml.txt.nlp	20946630	SENT265	12	12	9	9	choline	Hsp90	PA448976	3320	0.762
NULL	Chemother_Res_Pract_2011_Sep_25_2011_730360.nxml.txt.nlp	22295205	SENT236	15	15	6	6	maytansine	DM1	PA165291473	338023;1760;28509	0.762
NULL	Int_J_Breast_Cancer_2012_May_9_2012_415170.nxml.txt.nlp	22649737	SENT76	38	38	41	41	trastuzumab	MUC4	PA451743	4585	0.762
NULL	Patient_Prefer_Adherence_2014_Apr_8_8_463-471.nxml.txt.nlp	24748775	SENT100	14	14	23	23	denosumab	BMD	PA166048634	1756;7439	0.762
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT38	4	4	12	12	curcumin	PC-3	PA151958596	692094	0.762
NULL	J_Invest_Dermatol_2012_Sep_19_132(9)_2198-2205.nxml.txt.nlp	22513780	SENT84	0	0	11	11	isotretinoin	IL-10	PA450128	3586	0.762
NULL	Am_J_Trop_Med_Hyg_2014_Oct_1_91(4)_854-861.nxml.txt.nlp	25071003	SENT18	23	23	29	29	primaquine	G6PD	PA451103	2539	0.762
NULL	Mol_Cancer_2010_Jun_23_9_162.nxml.txt.nlp	20573255	SENT33	29	29	21	21	paclitaxel	WIF1	PA450761	11197	0.762
NULL	Indian_J_Dermatol_2009_Jan-Mar_54(1)_7-12.nxml.txt.nlp	20049260	SENT36	3	3	31	31	alefacept	CD2	PA164748040	914	0.762
NULL	Mol_Cancer_2009_Dec_10_8_118.nxml.txt.nlp	20003259	SENT126	5	5	18	18	sorafenib	MMP2	PA7000	4313	0.762
NULL	Braz_J_Med_Biol_Res_2013_Aug_13_46(8)_650-658.nxml.txt.nlp	23969971	SENT13	29	29	19	19	oxaliplatin	STAT3	PA131285527	6774	0.762
NULL	Depress_Res_Treat_2011_Aug_4_2011_680194.nxml.txt.nlp	21826264	SENT127	34	34	6	6	paliperidone	ANOVA	PA163518919	4858	0.762
NULL	Oxid_Med_Cell_Longev_2013_Apr_18_2013_239854.nxml.txt.nlp	23710284	SENT85	14	14	5	5	zonisamide	SEL1L	PA451978	6400	0.762
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_3_2012_856029.nxml.txt.nlp	23091559	SENT105	15	15	24	24	fluorescein	San	PA164746009	80218	0.762
NULL	Aging_(Albany_NY)_2010_Oct_31_2(10)_669-677.nxml.txt.nlp	21076179	SENT96	16	16	26	26	vorinostat	HRI	PA164748224	27102	0.762
NULL	Oncotarget_2012_Nov_8_3(11)_1472-1482.nxml.txt.nlp	23178531	SENT20	4	4	12	12	oxygen	VHL	PA450744	7428	0.762
NULL	Braz_J_Med_Biol_Res_2013_Aug_13_46(8)_650-658.nxml.txt.nlp	23969971	SENT10	34	34	22	22	cisplatin	STAT3	PA449014	6774	0.762
NULL	J_Headache_Pain_2011_Aug_29_12(4)_411-417.nxml.txt.nlp	21626018	SENT86	0	0	27	27	sumatriptan	mol	PA451566	90527	0.762
NULL	Cell_Commun_Signal_2013_Oct_1_11_73.nxml.txt.nlp	24083678	SENT44	9	9	18	18	sulindac	IL-8	PA451565	3576	0.762
NULL	Biologics_2009_Sep_15_3_429-441.nxml.txt.nlp	19774210	SENT309	12	12	31	31	leucovorin	IFL	PA450198	3439	0.762
NULL	Diabetes_Care_2013_Aug_17_36(Suppl_2)_S180-S189.nxml.txt.nlp	23882044	SENT50	23	23	9	9	metformin	GLP-1	PA450395	100125288	0.762
NULL	Mol_Imaging_Biol_2011_Feb_16_13(1)_67-77.nxml.txt.nlp	20396956	SENT147	21	21	11	11	doxycycline	EGF	PA449415	1950	0.762
NULL	Curr_Hypertens_Rep_2010_Jun_22_12(3)_154-161.nxml.txt.nlp	20424954	SENT62	19	19	4	4	nadh	XDH	PA164755085	7498	0.762
NULL	Oncol_Rep_2012_Apr_6_27(4)_1213-1218.nxml.txt.nlp	22159760	SENT84	5	5	7	7	chloroquine	TRAIL	PA448948	8743	0.762
NULL	Hum_Genomics_2008_Sep_1_3(1)_7-16.nxml.txt.nlp	19129086	SENT156	15	15	22	22	rosiglitazone	CYP2C8	PA451283	1558	0.762
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Aug_18_66(Pt_9)_o2310.nxml.txt.nlp	21588659	SENT67	11	11	4	4	ethanol	mol	PA448073	90527	0.762
NULL	Br_J_Cancer_1995_May_71(5)_931-936.nxml.txt.nlp	7734315	SENT15	26	26	9	9	daunorubicin	P-gp	PA449212	5243	0.762
NULL	Carcinogenesis_2013_Mar_7_34(3)_703-712.nxml.txt.nlp	23222814	SENT101	2	2	6	6	curcumin	BAX	PA151958596	581	0.762
NULL	Cancer_Manag_Res_2013_Mar_9_6_25-30.nxml.txt.nlp	23516140	SENT70	0	0	27	27	dasatinib	EPHA2	PA162372878	1969	0.762
NULL	Cancer_Cell_Int_2005_Jun_1_5_18.nxml.txt.nlp	15929791	SENT45	0	0	6	6	bortezomib	JNK	PA10252	5599	0.762
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT799	38	38	8	8	rosuvastatin	SLC10A1	PA134308647	6554	0.762
NULL	Case_Rep_Oncol_2014_Mar_26_7(1)_204-209.nxml.txt.nlp	24803896	SENT64	38	38	36	36	trabectedin	MRCL	PA165958349	348174	0.762
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1099-1105.nxml.txt.nlp	20234364	SENT97	8	8	13	13	trastuzumab	HER2	PA451743	2064	0.762
NULL	J_Immunother_Cancer_2014_Jan_27_2_2.nxml.txt.nlp	24829759	SENT186	16	16	11	11	sorafenib	IL-21	PA7000	59067;50616;27189	0.762
NULL	Iran_J_Pharm_Res_2014_Spring_13(2)_635-639.nxml.txt.nlp	25237359	SENT20	40	40	42	42	bupropion	BUP	PA448687	23412	0.762
NULL	Cancers_(Basel)_2014_Jul_22_6(3)_1540-1552.nxml.txt.nlp	25055117	SENT450	3	3	14	14	gefitinib	Met	PA131301952	79811	0.762
NULL	J_Hematol_Oncol_2013_Apr_12_6_27.nxml.txt.nlp	23587417	SENT172	15	15	24	24	sorafenib	HCC	PA7000	84668	0.762
NULL	Contemp_Oncol_(Pozn)_2012_Feb_29_16(1)_86-89.nxml.txt.nlp	23788860	SENT45	26	26	9	9	mitomycin	DDP	PA450524	1678	0.762
NULL	Exp_Mol_Med_2012_Sep_30_44(9)_545-553.nxml.txt.nlp	22809901	SENT70	44	44	40	40	quetiapine	PRDM16	PA451201	63976	0.762
NULL	Arthritis_Res_Ther_2010_Feb_24_12(1)_R32.nxml.txt.nlp	20181277	SENT300	17	17	8	8	imatinib	M-CSF	PA10804	1435	0.762
NULL	Oncoimmunology_2012_Sep_1_1(6)_957-958.nxml.txt.nlp	23162770	SENT17	22	22	28	28	rituximab	CD137	PA451261	3604	0.762
NULL	Springerplus_2013_Jun_15_2_263.nxml.txt.nlp	23875127	SENT186	5	5	14	14	heparin	IL-24	PA449855	11009	0.762
NULL	EMBO_Mol_Med_2012_Jun_13_4(6)_515-527.nxml.txt.nlp	22416035	SENT86	2	2	12	12	olaparib	p53		7157	0.762
NULL	J_Clin_Biochem_Nutr_2010_Mar_27_46(2)_177-185.nxml.txt.nlp	20216951	SENT99	16	16	11	11	l-arginine	CEA	PA448478	5670;1087	0.762
NULL	Diabetes_2011_Nov_17_60(11)_2730-2739.nxml.txt.nlp	21926273	SENT265	7	7	18	18	resveratrol	SIRT1		23411	0.762
NULL	Clin_Med_Insights_Oncol_2014_Aug_24_8_95-100.nxml.txt.nlp	25210485	SENT71	13	13	20	20	asparaginase	ASS1	PA448492	445	0.762
NULL	J_Cell_Biol_2001_Oct_1_155(1)_89-100.nxml.txt.nlp	11581288	SENT266	11	11	1	1	paraformaldehyde	VASP	PA450790	7408	0.762
NULL	Oncotarget_2013_Oct_19_4(11)_2045-2056.nxml.txt.nlp	24185104	SENT55	5	5	2	2	cisplatin	14-3-3	PA449014	10971	0.762
NULL	Clin_Interv_Aging_2009_May_14_4_51-57.nxml.txt.nlp	19503765	SENT208	8	8	1	1	thioridazine	NOT	PA451666	4929	0.762
NULL	Indian_Dermatol_Online_J_2011_Jul-Dec_2(2)_111-119.nxml.txt.nlp	23130241	SENT326	10	10	22	22	methotrexate	FAE	PA450428	2178	0.762
NULL	Cancer_Med_2013_Aug_2_2(4)_571-582.nxml.txt.nlp	24156030	SENT182	8	8	21	21	curcumin	IFN	PA151958596	3439	0.762
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1196-1204.nxml.txt.nlp	22315058	SENT146	36	36	31	31	gefitinib	HER2	PA131301952	2064	0.762
NULL	Breast_Cancer_Res_2012_Jul_6_14(4)_R102.nxml.txt.nlp	22770227	SENT6	32	32	34	34	tamoxifen	aromatase	PA451581	1588	0.762
NULL	Fibrogenesis_Tissue_Repair_2012_Jun_6_5(Suppl_1)_S13.nxml.txt.nlp	23259677	SENT114	13	13	33	33	pentoxifylline	GAPDH	PA450864	2597	0.762
NULL	Br_J_Cancer_2013_Mar_19_108(5)_1052-1060.nxml.txt.nlp	23422754	SENT64	14	14	1	1	bevacizumab	VEGF-A	PA130232992	7422	0.762
NULL	Clin_Kidney_J_2012_Oct_5(5)_434-437.nxml.txt.nlp	23986860	SENT18	30	30	16	16	tacrolimus	SPK	PA451578	55872;8189	0.762
NULL	J_Gastrointest_Cancer_2013_Aug_7_44(4)_385-392.nxml.txt.nlp	23921604	SENT174	16	16	12	12	imatinib	PDGFRA	PA10804	5156	0.762
NULL	Ther_Clin_Risk_Manag_2006_Sep_2(3)_235-249.nxml.txt.nlp	18360599	SENT303	10	10	8	8	alendronate	PTH	PA448082	5741	0.762
NULL	J_Immunother_Cancer_2013_Jun_27_1_9.nxml.txt.nlp	NULL	SENT175	5	5	12	12	sunitinib	CD33	PA162372840	945	0.762
NULL	Infect_Drug_Resist_2010_Mar_11_3_45-51.nxml.txt.nlp	21694893	SENT111	0	0	9	9	posaconazole	CYP3A4	PA151958574	1576	0.762
NULL	Cancer_Biol_Med_2013_Mar_10(1)_36-42.nxml.txt.nlp	23691443	SENT72	18	18	9	9	rituximab	CHOP	PA451261	1649	0.762
NULL	Contemp_Clin_Dent_2013_Jan-Mar_4(1)_48-53.nxml.txt.nlp	23853452	SENT148	11	11	23	23	metronidazole	CAL	PA450484	54751;57120	0.762
NULL	Chem_Cent_J_2012_Nov_8_6_133.nxml.txt.nlp	23137100	SENT246	14	14	26	26	chymotrypsin	mol	PA448994	90527	0.762
NULL	Clin_Med_Insights_Cardiol_2010_Dec_1_4_117-128.nxml.txt.nlp	21151850	SENT267	7	7	2	2	clopidogrel	CYP2C19	PA449053	1557	0.762
NULL	J_Immunother_Cancer_2014_Nov_6_2(Suppl_3)_P210.nxml.txt.nlp	NULL	SENT13	4	4	19	19	curcumin	IL6	PA151958596	3569	0.762
NULL	FEBS_Open_Bio_2014_Sep_2_4_755-762.nxml.txt.nlp	25349780	SENT149	4	4	15	15	simvastatin	PCSK9	PA451363	255738	0.762
NULL	Cancer_Med_2013_Feb_3_2(1)_11-20.nxml.txt.nlp	24133623	SENT445	15	15	2	2	cetuximab	KRAS	PA10040	3845	0.762
NULL	Breast_Cancer_Res_Treat_2014_Nov_24_143(1)_125-133.nxml.txt.nlp	24272078	SENT116	15	15	1	1	fulvestrant	aromatase	PA164747170	1588	0.762
NULL	Oncotarget_2013_Nov_22_5(4)_933-943.nxml.txt.nlp	24659749	SENT5	4	4	16	16	nutlin-3	p53		7157	0.762
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_55-78.nxml.txt.nlp	19305788	SENT462	2	2	15	15	ethanol	NR1	PA448073	27158	0.762
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT136	13	13	2	2	adalimumab	CD36	PA10004	948	0.762
NULL	J_Biomed_Sci_2014_Jul_22_21(1)_65.nxml.txt.nlp	25047949	SENT129	3	3	8	8	docetaxel	PC-3	PA449383	692094	0.762
NULL	J_Histochem_Cytochem_2012_Dec_60(12)_908-915.nxml.txt.nlp	22899865	SENT24	25	25	2	2	hyaluronan	betaglycan	PA165958431	7049	0.762
NULL	Cancer_Immunol_Immunother_2014_Sep_4_63(12)_1297-1306.nxml.txt.nlp	25186613	SENT174	13	13	1	1	ns-398	COX		1351	0.762
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Feb_21_65(Pt_3)_o559.nxml.txt.nlp	21582217	SENT3	15	15	32	32	benzaldehyde	mol	PA448571	90527	0.762
NULL	Core_Evid_2007_Nov_30_2(2)_121-129.nxml.txt.nlp	21221180	SENT19	2	2	10	10	cyclophosphamide	EFS	PA449165	10278	0.762
NULL	J_Med_Econ_2013_Jul_24_16(7)_917-925.nxml.txt.nlp	23663091	SENT172	13	13	9	9	aripiprazole	SOC	PA10026	91544	0.762
NULL	J_Cell_Biol_2000_Jun_12_149(6)_1167-1170.nxml.txt.nlp	10851014	SENT49	12	12	8	8	collagenase	MMP2	PA449107	4313	0.762
NULL	Biomed_Res_Int_2014_Mar_9_2014_687835.nxml.txt.nlp	24734239	SENT228	26	26	21	21	lidocaine	CTB	PA450226	9468	0.762
NULL	Ann_Surg_Oncol_2010_Apr_20_17(4)_1168-1176.nxml.txt.nlp	19936839	SENT114	17	17	36	36	bevacizumab	KRAS	PA130232992	3845	0.762
NULL	Cell_Death_Dis_2013_Jun_13_4(6)_e665.nxml.txt.nlp	23764846	SENT91	15	15	31	31	sorafenib	FSP1	PA7000	6275;51062	0.762
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_May_28_67(Pt_6)_m813-m814.nxml.txt.nlp	21754686	SENT3	38	38	47	47	phenol	mol	PA450913	90527	0.762
NULL	Clin_Pharmacol_2012_Feb_20_4_13-20.nxml.txt.nlp	22427735	SENT87	38	38	18	18	clopidogrel	PON1	PA449053	5444	0.762
NULL	Case_Rep_Hematol_2014_Dec_11_2014_587912.nxml.txt.nlp	25574404	SENT22	31	31	20	20	cyclophosphamide	HLA-A	PA449165	3105	0.762
NULL	J_Int_AIDS_Soc_2010_Nov_8_13(Suppl_4)_P92.nxml.txt.nlp	NULL	SENT19	12	12	5	5	zalcitabine	DDX	PA451950	8644	0.762
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1495-1502.nxml.txt.nlp	21989186	SENT201	14	14	28	28	fluorouracil	HSI	PA128406956	57016	0.762
NULL	Leukemia_2014_Jun_17_28(6)_1216-1226.nxml.txt.nlp	24301524	SENT191	12	12	33	33	bortezomib	GAPDH	PA10252	2597	0.762
NULL	Breast_Cancer_Res_2005_Apr_4_7(4)_R422-R435.nxml.txt.nlp	15987447	SENT204	10	10	7	7	indomethacin	COX	PA449982	1351	0.762
NULL	Clin_Pharmacol_2011_Jun_22_3_13-25.nxml.txt.nlp	22287853	SENT182	12	12	42	42	saxagliptin	CYP3A4	PA165958362	1576	0.762
NULL	Blood_Press_Monit_2014_Jun_9_19(3)_164-169.nxml.txt.nlp	24710336	SENT25	39	39	18	18	valsartan	AT1	PA451848	9197;185	0.762
NULL	Basic_Res_Cardiol_2015_Jan_20_110_4.nxml.txt.nlp	25600226	SENT113	2	2	17	17	ezetimibe	PCSK9	PA10816	255738	0.762
NULL	Int_J_Biol_Sci_2011_Sep_8_7(8)_1077-1092.nxml.txt.nlp	21927577	SENT258	2	2	10	10	telmisartan	CHOP	PA451605	1649	0.762
NULL	Cancer_Cell_Int_2005_Jul_24_5_22.nxml.txt.nlp	16042792	SENT80	10	10	18	18	vincristine	NAC	PA451879	22861	0.762
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT116	5	5	12	12	trastuzumab	MUC4	PA451743	4585	0.762
NULL	Neuropsychopharmacology_2009_Jul_11_34(8)_1946-1957.nxml.txt.nlp	19279569	SENT170	11	11	38	38	heroin	DOR	PA452619	58476	0.762
NULL	Oncol_Lett_2014_Nov_14_8(5)_2086-2092.nxml.txt.nlp	25295095	SENT136	39	39	34	34	gemcitabine	LKB1	PA449748	6794	0.762
NULL	Clin_Interv_Aging_2008_Sep_3(3)_503-509.nxml.txt.nlp	18982920	SENT147	5	5	3	3	solifenacin	STAR	PA164783810	6770;2984	0.762
NULL	Ann_Gastroenterol_2014_27(4)_313-319.nxml.txt.nlp	25331779	SENT147	12	12	17	17	mesalazine	POR	PA450384	5447	0.762
NULL	Ann_Clin_Transl_Neurol_2014_Dec_21_1(12)_996-1005.nxml.txt.nlp	25574474	SENT11	10	10	14	14	elacridar	P-gp		5243	0.762
NULL	Indian_J_Endocrinol_Metab_2012_Mar_16(Suppl1)_S79-S82.nxml.txt.nlp	22701852	SENT37	31	31	26	26	phenytoin	B12	PA450947	7126;4709	0.762
NULL	Clin_Transl_Allergy_2013_Sep_2_3_29.nxml.txt.nlp	24004581	SENT197	20	20	13	13	omalizumab	IL-4	PA164752253	3565	0.762
NULL	Bone_Joint_Res_2014_Mar_1_3(3)_51-59.nxml.txt.nlp	24615710	SENT198	8	8	12	12	resveratrol	SIRT1		23411	0.762
NULL	Clin_Transl_Allergy_2014_Feb_28_4(Suppl_1)_P35.nxml.txt.nlp	25045492	SENT16	0	0	12	12	atorvastatin	IL-10	PA448500	3586	0.762
NULL	Oncotarget_2014_Dec_4_5(22)_11365-11380.nxml.txt.nlp	25426548	SENT38	21	21	5	5	nutlin-3	TP53		7157	0.762
NULL	Front_Oncol_2014_Sep_16_4_238.nxml.txt.nlp	25279350	SENT196	18	18	33	33	cisplatin	EGFR	PA449014	1956	0.762
NULL	Arthritis_Res_Ther_2003_Sep_3_5(6)_R317-R328.nxml.txt.nlp	14680506	SENT239	19	19	22	22	rolipram	IL-10	PA153906323	3586	0.762
NULL	Breast_Cancer_Res_2009_Jun_23_11(Suppl_1)_S15.nxml.txt.nlp	NULL	SENT10	22	22	26	26	tamoxifen	ATAC	PA451581	6375	0.762
NULL	Evid_Based_Complement_Alternat_Med_2013_Dec_17_2013_589169.nxml.txt.nlp	24454499	SENT210	16	16	3	3	resveratrol	AT1		9197;185	0.762
NULL	Front_Neurosci_2012_May_30_6_78.nxml.txt.nlp	22661926	SENT11	24	24	34	34	vasopressin	VR2	PA451858	56663	0.762
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_4_2013_378657.nxml.txt.nlp	23662132	SENT495	7	7	3	3	exenatide	GLP-1	PA164749238	100125288	0.762
NULL	Breast_Cancer_Res_2007_Jun_4_9(3)_207.nxml.txt.nlp	17561991	SENT182	30	30	18	18	lapatinib	HER-2	PA152241907	2064	0.762
NULL	Cell_Death_Dis_2014_Feb_13_5(2)_e1055.nxml.txt.nlp	24525731	SENT328	19	19	7	7	cisplatin	TXNL1	PA449014	9352	0.762
NULL	Br_J_Pharmacol_2011_Jul_163(6)_1263-1275.nxml.txt.nlp	21391977	SENT220	5	5	28	28	ketoconazole	CYP3A4	PA450146	1576	0.762
NULL	Front_Oncol_2013_Sep_23_3_250.nxml.txt.nlp	24069582	SENT142	4	4	11	11	trastuzumab	HER2	PA451743	2064	0.762
NULL	Oncotarget_2013_Jun_29_4(7)_1019-1036.nxml.txt.nlp	23859937	SENT320	2	2	18	18	rituximab	VEGFR	PA451261	3791	0.762
NULL	Autism_Res_Treat_2011_Jun_7_2011_307152.nxml.txt.nlp	22937244	SENT135	18	18	27	27	minocycline	NF-kappaB	PA450519	4790	0.762
NULL	Biol_Open_2014_Sep_12_3(10)_937-946.nxml.txt.nlp	25217618	SENT170	18	18	34	34	niclosamide	CUX1	PA165958408	1523	0.761
NULL	Ann_Rheum_Dis_2015_Jan_3_74(1)_19-26.nxml.txt.nlp	25367713	SENT182	22	22	28	28	tocilizumab	DREAM	PA165292659	30818	0.761
NULL	Pharmaceuticals_(Basel)_2011_Nov_11_4(11)_1503-1517.nxml.txt.nlp	NULL	SENT154	7	7	3	3	capsaicin	TRPV1	PA448776	7442	0.761
NULL	Br_J_Cancer_2011_Nov_22_105(11)_1635-1639.nxml.txt.nlp	22033275	SENT109	4	4	13	13	everolimus	VEGFR	PA164746311	3791	0.761
NULL	J_Mol_Signal_2006_Dec_6_1_8.nxml.txt.nlp	17224083	SENT7	28	28	12	12	thrombin	LARG	PA451674	23365	0.761
NULL	Oncoimmunology_2013_Jan_1_2(1)_e22890.nxml.txt.nlp	23483066	SENT102	6	6	22	22	vemurafenib	IFN	PA165946873	3439	0.761
NULL	Behav_Brain_Funct_2012_Jun_11_8_30.nxml.txt.nlp	22686184	SENT270	15	15	27	27	diazepam	CORT	PA449283	1325	0.761
NULL	Nat_Commun_2013_Aug_15_4_2130.nxml.txt.nlp	23945651	SENT137	1	1	5	5	etoposide	ATG5	PA449552	9474	0.761
NULL	Br_J_Cancer_2010_Oct_12_103(8)_1284-1291.nxml.txt.nlp	20859285	SENT208	8	8	14	14	tamoxifen	EGF	PA451581	1950	0.761
NULL	Oncotarget_2013_Nov_7_4(12)_2550-2566.nxml.txt.nlp	24334291	SENT210	14	14	27	27	dasatinib	AMPK	PA162372878	5563	0.761
NULL	Indian_J_Orthop_2010_Jul-Sep_44(3)_246-251.nxml.txt.nlp	20697475	SENT6	9	9	3	3	vancomycin	DBM	PA451850	1621	0.761
NULL	Acta_Pharmacol_Sin_2010_Jan_21_31(1)_35-42.nxml.txt.nlp	20023693	SENT14	0	0	5	5	atorvastatin	IL-6	PA448500	3569	0.761
NULL	Int_J_Genomics_2014_Jan_29_2014_894296.nxml.txt.nlp	24616891	SENT186	23	23	5	5	ethanol	PC1	PA448073	5122	0.761
NULL	Cancers_(Basel)_2014_Jul_8_6(3)_1487-1499.nxml.txt.nlp	25006835	SENT112	10	10	22	22	cisplatin	AKT	PA449014	207	0.761
NULL	Adv_Hematol_2012_Feb_26_2012_529572.nxml.txt.nlp	22474449	SENT76	13	13	20	20	doxorubicin	CHOP	PA449412	1649	0.761
NULL	Breast_Cancer_Res_2003_Jul_29_5(5)_235-238.nxml.txt.nlp	12927031	SENT26	9	9	19	19	thyroglobulin	TPO	PA164754910	7066;7173	0.761
NULL	Pharmaceutics_2011_Oct_12_3(4)_680-705.nxml.txt.nlp	24309303	SENT774	4	4	23	23	gemfibrozil	CYP2C8	PA449750	1558	0.761
NULL	Clin_Pharmacol_2012_Feb_20_4_13-20.nxml.txt.nlp	22427735	SENT12	26	26	7	7	clopidogrel	PON1	PA449053	5444	0.761
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Jun_25_3(6)_e120.nxml.txt.nlp	24964282	SENT53	20	20	22	22	carbamazepine	CYP3A4	PA448785	1576	0.761
NULL	Chemother_Res_Pract_2011_Apr_7_2011_393976.nxml.txt.nlp	22312553	SENT39	33	33	6	6	artemether	CYP3A4	PA165111698	1576	0.761
NULL	J_Gen_Physiol_1994_May_1_103(5)_787-805.nxml.txt.nlp	7913485	SENT12	16	16	14	14	neomycin	gamma	PA450608	9913	0.761
NULL	Oncoimmunology_2014_Apr_25_3_e28518.nxml.txt.nlp	25071979	SENT157	7	7	11	11	carboplatin	HMGB1	PA448803	3146	0.761
NULL	Evid_Based_Complement_Alternat_Med_2013_Mar_26_2013_974313.nxml.txt.nlp	23589723	SENT143	7	7	13	13	metformin	AMPK	PA450395	5563	0.761
NULL	Exp_Eye_Res_2013_Oct_115(100)_172-177.nxml.txt.nlp	23891863	SENT113	18	18	4	4	xanthophyll	BCMO1	PA164748318	53630	0.761
NULL	Diabetes_Obes_Metab_2011_Apr_13(4)_348-356.nxml.txt.nlp	21205128	SENT196	28	28	7	7	rosiglitazone	GLP-1	PA451283	100125288	0.761
NULL	Oncotarget_2012_Nov_17_4(1)_18-28.nxml.txt.nlp	23248157	SENT78	10	10	20	20	pargyline	U87	PA450797	677775;641648	0.761
NULL	Stroke_Res_Treat_2009_Dec_20_2010_386389.nxml.txt.nlp	20700422	SENT160	4	4	16	16	ebselen	MCP-1	PA161660841	6347	0.761
NULL	Cancers_(Basel)_2011_May_3_3(2)_2255-2273.nxml.txt.nlp	24212808	SENT106	12	12	14	14	paclitaxel	EGFR	PA450761	1956	0.761
NULL	Exp_Ther_Med_2012_Sep_12_4(3)_475-480.nxml.txt.nlp	23181121	SENT24	5	5	9	9	rituximab	CHOP	PA451261	1649	0.761
NULL	Oncoscience_2014_Mar_12_1(2)_158-166.nxml.txt.nlp	25594008	SENT47	23	23	14	14	dasatinib	IGFBP2	PA162372878	3485	0.761
NULL	Clinics_(Sao_Paulo)_2013_Oct_68(10)_1350-1357.nxml.txt.nlp	24212843	SENT118	1	1	10	10	bleomycin	COL1A1	PA448645	1277	0.761
NULL	J_Cardiovasc_Magn_Reson_2008_Feb_6_10(1)_9.nxml.txt.nlp	18275592	SENT35	38	38	3	3	creatine	GAMT	PA164778930	2593	0.761
NULL	Semin_Cancer_Biol_2014_Jun_26(100)_89-98.nxml.txt.nlp	24316494	SENT49	21	21	23	23	zidovudine	IFN	PA451954	3439	0.761
NULL	Int_J_Bipolar_Disord_2014_Dec_24_2_16.nxml.txt.nlp	25540718	SENT262	15	15	4	4	lithium	Gen	PA450243	348654	0.761
NULL	Int_J_Endocrinol_2014_Mar_12_2014_847827.nxml.txt.nlp	24744784	SENT163	2	2	8	8	pioglitazone	TLR2	PA450970	7097	0.761
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_May_22_66(Pt_6)_o1394-o1395.nxml.txt.nlp	21579474	SENT79	20	20	10	10	ethanol	mol	PA448073	90527	0.761
NULL	Oncol_Lett_2014_May_28_7(5)_1581-1585.nxml.txt.nlp	24765180	SENT21	10	10	5	5	urokinase	LPA	PA451836	4018	0.761
NULL	Exp_Ther_Med_2015_Feb_16_9(2)_289-293.nxml.txt.nlp	25574188	SENT51	30	30	16	16	oxaliplatin	CD44	PA131285527	960	0.761
NULL	Breast_Cancer_Res_2001_Oct_1_3(6)_361-364.nxml.txt.nlp	11737886	SENT77	12	12	20	20	epirubicin	Bcl-2	PA449476	596	0.761
NULL	Lab_Invest_2009_Dec_19_89(12)_1397-1409.nxml.txt.nlp	19841616	SENT218	7	7	16	16	curcumin	EGF	PA151958596	1950	0.761
NULL	Virchows_Arch_2012_Feb_16_460(2)_141-149.nxml.txt.nlp	22173329	SENT218	9	9	26	26	leucovorin	KRAS	PA450198	3845	0.761
NULL	Arthritis_Res_Ther_2008_Jan_7_10(1)_R1.nxml.txt.nlp	18179697	SENT13	3	3	11	11	oxaliplatin	HMGB1	PA131285527	3146	0.761
NULL	Oncotarget_2011_Dec_20_2(12)_1094-1108.nxml.txt.nlp	22190353	SENT180	7	7	14	14	gemcitabine	PUMA	PA449748	27113	0.761
NULL	Br_J_Cancer_2009_Jul_21_101(2)_312-319.nxml.txt.nlp	19568237	SENT110	31	31	29	29	pp2	PP1		5540;5464	0.761
NULL	Mol_Neurodegener_2011_Nov_25_6_81.nxml.txt.nlp	22118545	SENT196	6	6	41	41	dantrolene	Bcl-2	PA449208	596	0.761
NULL	Eur_J_Clin_Pharmacol_2013_Mar_11_69(3)_327-339.nxml.txt.nlp	22782539	SENT270	25	25	31	31	dabigatran	P-gp		5243	0.761
NULL	Exp_Ther_Med_2012_Sep_29_4(3)_524-532.nxml.txt.nlp	23181130	SENT25	8	8	20	20	mk-571	MRP4		10257	0.761
NULL	Diabetes_2009_Jul_28_58(7)_1659-1667.nxml.txt.nlp	19401417	SENT267	33	33	21	21	glucose	CTGF	PA449773	1490	0.761
NULL	Crit_Care_2011_Oct_26_15(5)_R257.nxml.txt.nlp	22030215	SENT261	0	0	9	9	dexmedetomidine	SAPS	PA449256	8935	0.761
NULL	Oxid_Med_Cell_Longev_2011_Oct_15_2011_703676.nxml.txt.nlp	22013498	SENT84	17	17	4	4	resveratrol	IL-6		3569	0.761
NULL	Exp_Anim_2014_Aug_22_63(3)_277-287.nxml.txt.nlp	25077757	SENT593	0	0	11	11	resveratrol	SIRT1		23411	0.761
NULL	Curr_Opin_Endocrinol_Diabetes_Obes_2014_Feb_2_21(1)_15-21.nxml.txt.nlp	24296462	SENT27	32	32	3	3	fluconazole	CLEC7A	PA449653	64581	0.761
NULL	Front_Behav_Neurosci_2012_Jun_13_6_24.nxml.txt.nlp	22707936	SENT1671	3	3	13	13	scopolamine	spatial	PA451308	219793	0.761
NULL	Blood_Res_2014_Dec_23_49(4)_253-258.nxml.txt.nlp	25548759	SENT75	24	24	26	26	rituximab	CHOP	PA451261	1649	0.761
NULL	AMB_Express_2011_Jul_13_1_16.nxml.txt.nlp	21906371	SENT107	28	28	17	17	fructose	PTS	PA449716	5805	0.761
NULL	Nucleic_Acids_Res_2011_Mar_17_39(6)_2144-2152.nxml.txt.nlp	21087997	SENT141	11	11	4	4	etoposide	CtIP	PA449552	5932	0.761
NULL	Int_J_Hypertens_2012_Feb_26_2012_957235.nxml.txt.nlp	22518298	SENT147	9	9	7	7	hemin	HO-1	PA449849	3162	0.761
NULL	Br_J_Cancer_2003_Mar_24_88(6)_803-807.nxml.txt.nlp	12644813	SENT51	7	7	23	23	sulindac	DR5	PA451565	8795	0.761
NULL	Neural_Regen_Res_2013_Jul_15_8(20)_1853-1862.nxml.txt.nlp	25206494	SENT15	8	8	24	24	ethanol	p38	PA448073	10598;1432;7965	0.761
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT156	2	2	15	15	atorvastatin	CD14	PA448500	929	0.761
NULL	Leukemia_2014_Mar_13_28(3)_629-641.nxml.txt.nlp	24263804	SENT203	24	24	13	13	imatinib	PAK2	PA10804	5062	0.761
NULL	Breast_Cancer_Res_2008_Dec_18_10(Suppl_4)_S24.nxml.txt.nlp	19128438	SENT64	21	21	12	12	tamoxifen	IMPACT	PA451581	55364	0.761
NULL	Eur_J_Clin_Pharmacol_2014_May_27_70(8)_975-981.nxml.txt.nlp	24858823	SENT33	24	24	20	20	rivaroxaban	P-gp	PA165958360	5243	0.761
NULL	Br_J_Cancer_2010_Sep_7_103(6)_796-801.nxml.txt.nlp	20823888	SENT34	11	11	32	32	sirolimus	AST	PA451365	26503	0.761
NULL	Diabetes_2009_Dec_31_58(12)_2851-2862.nxml.txt.nlp	19720788	SENT107	7	7	13	13	forskolin	CHOP	PA146096022	1649	0.761
NULL	Chem_Res_Toxicol_2010_Jul_19_23(7)_1151-1162.nxml.txt.nlp	20536192	SENT64	16	16	6	6	doxycycline	p53	PA449415	7157	0.761
NULL	Indian_J_Dermatol_2011_Mar-Apr_56(2)_165-170.nxml.txt.nlp	21716541	SENT53	13	13	8	8	methotrexate	VIII	PA450428	1351	0.761
NULL	Anticancer_Agents_Med_Chem_2010_Dec_10(10)_753-768.nxml.txt.nlp	21269250	SENT250	5	5	19	19	cilengitide	HIF-1	PA164924491	29072	0.761
NULL	Int_J_Mol_Sci_2014_Jun_26_15(7)_11416-11434.nxml.txt.nlp	24972137	SENT94	2	2	8	8	sitagliptin	AMPK	PA164748978	5563	0.761
NULL	Int_J_Mol_Sci_2014_Nov_7_15(11)_20500-20517.nxml.txt.nlp	25387078	SENT565	2	2	11	11	sorafenib	CD95	PA7000	355	0.761
NULL	Int_J_Mol_Sci_2014_Sep_29_15(10)_17411-17441.nxml.txt.nlp	25268615	SENT240	30	30	3	3	docetaxel	CD44	PA449383	960	0.761
NULL	Environ_Health_Perspect_1995_Jul-Aug_103(7-8)_708-713.nxml.txt.nlp	7588483	SENT7	5	5	3	3	genistein	DES	PA165109660	1674	0.761
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT31	3	3	13	13	cisplatin	MDM2	PA449014	4193	0.761
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT143	6	6	39	39	perifosine	DR5	PA165291471	8795	0.761
NULL	Clin_Pharmacokinet_2014_Sep_3_53(1)_1-16.nxml.txt.nlp	23999929	SENT271	3	3	9	9	rivaroxaban	CYP3A4	PA165958360	1576	0.761
NULL	Breast_Cancer_Res_2004_Nov_7_6(1)_39-52.nxml.txt.nlp	14680484	SENT174	8	8	2	2	raloxifene	STAR	PA451221	6770;2984	0.761
NULL	Curr_Chem_Genomics_2010_Mar_1_4_1-8.nxml.txt.nlp	20448812	SENT100	18	18	12	12	methotrexate	OATP1B1	PA450428	10599	0.761
NULL	Case_Rep_Dermatol_2011_Feb_5_3(1)_13-17.nxml.txt.nlp	21931572	SENT50	5	5	11	11	bexarotene	p75	PA164752250	7133;11168	0.761
NULL	J_Biol_Chem_2008_Oct_31_283(44)_29841-29846.nxml.txt.nlp	18765669	SENT1	9	9	12	12	suramin	P2X1	PA10292	5023	0.761
NULL	F1000Res_2014_Jul_1_3_149.nxml.txt.nlp	25352980	SENT114	19	19	24	24	galactose	GAL4	PA449725	3960	0.761
NULL	Indian_J_Anaesth_2009_Oct_53(5)_582-591.nxml.txt.nlp	20640109	SENT140	15	15	3	3	clopidogrel	DES	PA449053	1674	0.761
NULL	J_Adv_Pract_Oncol_2014_Mar_1_Mar-Apr_5(2)_134-139.nxml.txt.nlp	25032047	SENT40	6	6	1	1	maytansine	DM1	PA165291473	338023;1760;28509	0.761
NULL	Acta_Pharmacol_Sin_2013_Jun_25_34(6)_819-829.nxml.txt.nlp	23524566	SENT135	12	12	28	28	carbachol	gamma	PA448784	9913	0.761
NULL	Adv_Hematol_2012_Jul_24_2012_513702.nxml.txt.nlp	22888354	SENT36	5	5	14	14	lenalidomide	SOCS1	PA162363968	8651	0.761
NULL	Diabetes_Care_2013_Aug_17_36(Suppl_2)_S127-S138.nxml.txt.nlp	23882037	SENT334	14	14	21	21	pioglitazone	adiponectin	PA450970	9370	0.761
NULL	Front_Oncol_2013_Sep_11_3_228.nxml.txt.nlp	24062981	SENT191	13	13	27	27	camptothecin	PARP1	PA153590860	142	0.761
NULL	Crit_Care_2007_Dec_21_11(6)_181.nxml.txt.nlp	18190727	SENT23	13	13	11	11	terlipressin	AVP	PA164781020	114548;551	0.761
NULL	Diabetes_Metab_Syndr_Obes_2009_May_13_2_23-30.nxml.txt.nlp	21437116	SENT18	0	0	18	18	sitagliptin	GLP-1	PA164748978	100125288	0.761
NULL	Clinics_(Sao_Paulo)_2013_Feb_68(2)_253-262.nxml.txt.nlp	23525324	SENT217	29	29	23	23	genistein	Gen	PA165109660	348654	0.761
NULL	Cell_Cycle_2012_Dec_15_11(24)_4661-4672.nxml.txt.nlp	23187802	SENT170	15	15	19	19	doxorubicin	p130	PA449412	5934	0.761
NULL	FEBS_Open_Bio_2011_Dec_27_2_1-5.nxml.txt.nlp	23650573	SENT107	11	11	6	6	sunitinib	MDM2	PA162372840	4193	0.761
NULL	Evid_Based_Complement_Alternat_Med_2013_May_13_2013_506324.nxml.txt.nlp	23818927	SENT187	7	7	19	19	doxorubicin	STAT3	PA449412	6774	0.761
NULL	Brain_Res_2013_Jul_12_1521(100)_1-15.nxml.txt.nlp	22789905	SENT835	0	0	44	44	colchicine	P-gp	PA449092	5243	0.761
NULL	Breast_Cancer_Res_2006_Jul_19_8(4)_R42.nxml.txt.nlp	16859511	SENT227	10	10	26	26	pp2	p38		10598;1432;7965	0.761
NULL	Oncogene_2013_Sep_26_32(39)_10_1038_onc_2012_491.nxml.txt.nlp	23108394	SENT138	12	12	1	1	epirubicin	FOXM1	PA449476	2305	0.761
NULL	Cancer_Med_2013_Jun_25_2(3)_277-285.nxml.txt.nlp	23930204	SENT162	16	16	12	12	cetuximab	KRAS	PA10040	3845	0.761
NULL	Arthritis_Res_Ther_2010_Jun_2_12(3)_R107.nxml.txt.nlp	20525198	SENT20	8	8	2	2	infliximab	TNF	PA452639	7124	0.761
NULL	Nat_Commun_2013_Apr_9_4_1684.nxml.txt.nlp	23575688	SENT49	5	5	19	19	roflumilast	CYLD	PA165948052	1540	0.761
NULL	Bone_Joint_Res_2014_Sep_1_3(9)_280-288.nxml.txt.nlp	25237168	SENT207	14	14	24	24	celecoxib	NF-kappaB	PA448871	4790	0.761
NULL	Cancer_Cell_Int_2011_Aug_19_11_29.nxml.txt.nlp	21854619	SENT137	4	4	10	10	cisplatin	BRCA1	PA449014	672	0.761
NULL	NMR_Biomed_2013_Oct_7_26(10)_1258-1270.nxml.txt.nlp	23564602	SENT263	26	26	17	17	erythromycin	MRI	PA449493	78996	0.761
NULL	Leukemia_2014_Jun_25_28(6)_1280-1288.nxml.txt.nlp	24270737	SENT209	21	21	9	9	cytarabine	CTLA4	PA449177	1493	0.761
NULL	J_Cancer_Prev_2014_Mar_19(1)_1-6.nxml.txt.nlp	25337566	SENT53	17	17	26	26	noscapine	p53		7157	0.761
NULL	Ther_Clin_Risk_Manag_2006_Jun_2(2)_207-212.nxml.txt.nlp	18360594	SENT99	19	19	31	31	cyclophosphamide	ACR	PA449165	49	0.761
NULL	J_Invest_Dermatol_2012_Sep_10_132(9)_2255-2262.nxml.txt.nlp	22572817	SENT54	25	25	30	30	forskolin	MC1R	PA146096022	4157	0.761
NULL	Neural_Dev_2011_Feb_1_6_4.nxml.txt.nlp	21284844	SENT60	7	7	31	31	bumetanide	NKCC1	PA448682	6558	0.761
NULL	Int_J_Mol_Imaging_2011_Oct_26_2011_874585.nxml.txt.nlp	21490735	SENT184	20	20	44	44	tamoxifen	FDG	PA451581	23583	0.761
NULL	Int_J_Mol_Cell_Med_2014_Summer_3(3)_183-189.nxml.txt.nlp	25317405	SENT35	0	0	12	12	estradiol	NPY	PA449503	4852	0.761
NULL	Eur_J_Clin_Pharmacol_2012_Jan_7_68(1)_55-64.nxml.txt.nlp	21735164	SENT308	16	16	9	9	oxycodone	CYP3A	PA450741	1574	0.761
NULL	Br_J_Cancer_2011_Mar_15_104(6)_941-947.nxml.txt.nlp	21407223	SENT165	9	9	6	6	sorafenib	survivin	PA7000	332	0.761
NULL	Hum_Mol_Genet_2012_Sep_1_21(17)_3910-3917.nxml.txt.nlp	22678059	SENT331	0	0	11	11	resveratrol	SIRT1		23411	0.761
NULL	J_Exp_Med_1968_Oct_1_128(4)_699-713.nxml.txt.nlp	19867304	SENT7	6	6	25	25	galactose	NAG	PA449725	51594;4669	0.761
NULL	Emerg_Infect_Dis_2012_Jan_18(1)_113-116.nxml.txt.nlp	22260877	SENT11	29	29	42	42	ethionamide	CA4	PA164768738	762	0.761
NULL	Mol_Cancer_2010_Aug_20_9_220.nxml.txt.nlp	20727180	SENT228	7	7	17	17	cisplatin	p53	PA449014	7157	0.761
NULL	Int_J_Mol_Sci_2014_Sep_2_15(9)_15512-15529.nxml.txt.nlp	25184950	SENT96	0	0	10	10	resveratrol	IL-10		3586	0.761
NULL	Mol_Cancer_2014_Jan_28_13_17.nxml.txt.nlp	24472312	SENT139	23	23	5	5	ponatinib	Mcl-1	PA165980594	4170	0.761
NULL	Gene_Regul_Syst_Bio_2014_Mar_4_8_63-73.nxml.txt.nlp	24634581	SENT247	0	0	15	15	minocycline	MT1-MMP	PA450519	4323	0.761
NULL	Diabetes_Care_2009_Nov_32(Suppl_2)_S232-S236.nxml.txt.nlp	19875557	SENT52	15	15	20	20	glucose	TRAP	PA449773	959;54;57410	0.761
NULL	Acta_Pharmacol_Sin_2012_Jun_30_33(6)_767-774.nxml.txt.nlp	22543702	SENT31	14	14	12	12	doxorubicin	P-gp	PA449412	5243	0.761
NULL	Curr_Neuropharmacol_2014_Jul_12(4)_365-379.nxml.txt.nlp	25342944	SENT447	39	39	32	32	paroxetine	5-HT2B	PA450801	3357	0.761
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_9_2013_801374.nxml.txt.nlp	23662153	SENT9	3	3	20	20	gentamicin	HAP	PA449753	5915;10313	0.761
NULL	Anticancer_Agents_Med_Chem_2012_Feb_12(2)_163-171.nxml.txt.nlp	22043994	SENT256	20	20	4	4	cetuximab	PTEN	PA10040	5728	0.761
NULL	Diabetes_2013_Jun_17_62(6)_2141-2150.nxml.txt.nlp	23378610	SENT9	23	23	12	12	betaine	CPS1	PA448603	1373;1589	0.761
NULL	Diabetes_Metab_Syndr_Obes_2014_Jul_17_7_313-319.nxml.txt.nlp	25092992	SENT92	17	17	10	10	pioglitazone	adiponectin	PA450970	9370	0.761
NULL	Mol_Clin_Oncol_2013_Jul_17_1(4)_680-684.nxml.txt.nlp	24649228	SENT4	13	13	21	21	cyclophosphamide	CHOP	PA449165	1649	0.761
NULL	Acta_Pharmacol_Sin_2012_May_16_33(5)_682-690.nxml.txt.nlp	22504904	SENT115	21	21	19	19	celecoxib	STAT3	PA448871	6774	0.761
NULL	Nat_Biotechnol_2011_Oct_30_29(11)_1039-1045.nxml.txt.nlp	22037377	SENT147	37	37	26	26	fasudil	Rho	PA165946121	29984	0.761
NULL	J_Oncol_2010_Mar_4_2010_460859.nxml.txt.nlp	20224640	SENT45	4	4	9	9	nilotinib	CD34	PA165958345	947	0.761
NULL	Oncotarget_2010_Oct_15_1(7)_515-529.nxml.txt.nlp	21317448	SENT88	6	6	18	18	gemcitabine	EGFR	PA449748	1956	0.761
NULL	J_Cell_Biol_1997_Jun_30_137(7)_1555-1566.nxml.txt.nlp	9199170	SENT106	12	12	7	7	dextran	IQGAP1	PA449261	8826	0.761
NULL	Mol_Cell_Proteomics_2013_Aug_14_12(8)_2313-2323.nxml.txt.nlp	23674616	SENT203	5	5	20	20	levamisole	LPP1	PA450205	8611;57216	0.761
NULL	Nat_Med_2011_Aug_28_17(9)_1094-1100.nxml.txt.nlp	21873989	SENT236	33	33	7	7	imatinib	ETV4	PA10804	2118	0.761
NULL	J_Cell_Biol_2008_Jan_28_180(2)_417-426.nxml.txt.nlp	18227283	SENT246	26	26	22	22	l-glutamine	B27	PA10090	56246	0.761
NULL	Diabetes_2013_Mar_14_62(3)_953-964.nxml.txt.nlp	23223176	SENT180	16	16	28	28	glucose	PRX	PA449773	9588;57716	0.761
NULL	Int_J_Cell_Biol_2013_Sep_24_2013_898563.nxml.txt.nlp	24223594	SENT50	16	16	14	14	urea	SDS	PA451831	51119;10993	0.761
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_11_2014_274786.nxml.txt.nlp	25505920	SENT474	0	0	4	4	oxaliplatin	ERCC1	PA131285527	2067	0.761
NULL	Oncoimmunology_2013_Dec_1_2(12)_e27215.nxml.txt.nlp	24501692	SENT32	39	39	5	5	erlotinib	STAT1	PA134687924	6772	0.761
NULL	J_Breast_Cancer_2013_Jun_28_16(2)_133-137.nxml.txt.nlp	23843843	SENT95	3	3	45	45	curcumin	p27	PA151958596	5715;10534	0.761
NULL	J_Hematol_Oncol_2008_May_28_1_3.nxml.txt.nlp	18577255	SENT137	3	3	38	38	tamoxifen	CHAMP	PA451581	283489;54456	0.761
NULL	Genet_Sel_Evol_2014_Mar_4_46(1)_19.nxml.txt.nlp	24592996	SENT152	2	2	20	20	taurine	MYL12B	PA451590	103910	0.761
NULL	Biosci_Rep_2014_Dec_23_34(6)_e00165.nxml.txt.nlp	25423293	SENT295	2	2	17	17	diazepam	ACBP	PA449283	1622	0.761
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT87	23	23	7	7	pemetrexed	UNG	PA10810	7374	0.761
NULL	Oncoimmunology_2013_Sep_1_2(9)_e25789.nxml.txt.nlp	24244905	SENT22	4	4	26	26	cyclophosphamide	IL-8	PA449165	3576	0.761
NULL	Indian_J_Pharmacol_2014_May-Jun_46(3)_266-269.nxml.txt.nlp	24987171	SENT29	17	17	15	15	dextromethorphan	CYP2D6	PA449273	1565	0.761
NULL	Breast_Cancer_Res_2008_Aug_21_10(4)_R71.nxml.txt.nlp	18718015	SENT153	18	18	4	4	paraformaldehyde	RXFP1	PA450790	59350	0.761
NULL	Crit_Care_2004_Mar_15_8(Suppl_1)_P82.nxml.txt.nlp	NULL	SENT3	15	15	12	12	levosimendan	AVP	PA164749138	114548;551	0.761
NULL	Oncotarget_2014_Jun_1_5(13)_4868-4880.nxml.txt.nlp	24947902	SENT203	23	23	19	19	lapatinib	HER2	PA152241907	2064	0.761
NULL	BMJ_2014_Apr_15_348_g2366.nxml.txt.nlp	24736555	SENT474	9	9	24	24	liraglutide	Met	PA165958364	79811	0.761
NULL	BMJ_Open_2013_Nov_4_3(11)_e003995.nxml.txt.nlp	24189085	SENT382	15	15	30	30	liraglutide	Met	PA165958364	79811	0.761
NULL	Aging_Cell_2013_Jun_27_12(3)_435-445.nxml.txt.nlp	23448364	SENT272	5	5	7	7	doxorubicin	p53	PA449412	7157	0.761
NULL	Int_J_Biol_Sci_2013_Nov_16_9(10)_1070-1078.nxml.txt.nlp	24250252	SENT203	5	5	22	22	fluorescein	CD146	PA164746009	4162	0.761
NULL	Mol_Cells_2014_Sep_30_37(9)_664-671.nxml.txt.nlp	25234467	SENT268	13	13	16	16	cisplatin	miR-217	PA449014	406999	0.761
NULL	Adv_Hematol_2012_Nov_20_2012_861060.nxml.txt.nlp	23251161	SENT55	4	4	34	34	lenalidomide	IL-2	PA162363968	3558	0.761
NULL	Clin_Exp_Otorhinolaryngol_2014_Jun_21_7(2)_79-86.nxml.txt.nlp	24917902	SENT54	22	22	18	18	aztreonam	TOB	PA448523	10140	0.761
NULL	Int_J_Mol_Sci_2012_Feb_1_13(2)_1512-1523.nxml.txt.nlp	22408405	SENT28	0	0	6	6	olmesartan	LOX-1	PA164742950	4973	0.761
NULL	Braz_J_Microbiol_2014_Mar_10_44(4)_1121-1131.nxml.txt.nlp	24688501	SENT122	42	42	29	29	sugar	CO2	PA451529	4513	0.761
NULL	Open_Access_J_Urol_2010_May_19_2_67-84.nxml.txt.nlp	24198616	SENT150	5	5	10	10	valrubicin	IFN	PA164748616	3439	0.761
NULL	Nat_Neurosci_2014_Jul_25_17(7)_943-952.nxml.txt.nlp	24859199	SENT123	4	4	8	8	doxycycline	P56	PA449415	8999	0.761
NULL	Sensors_(Basel)_2012_May_18_12(5)_6520-6537.nxml.txt.nlp	22778656	SENT163	31	31	37	37	cyclophosphamide	CYP1A2	PA449165	1544	0.761
NULL	Breast_Cancer_Res_2007_Aug_8_9(4)_R50.nxml.txt.nlp	17686159	SENT246	26	26	43	43	gefitinib	AKT	PA131301952	207	0.761
NULL	J_Gen_Physiol_1985_Dec_1_86(6)_877-889.nxml.txt.nlp	4078558	SENT0	13	13	1	1	tetracaine	Gen	PA451638	348654	0.761
NULL	Cancer_Imaging_2012_May_7_12(1)_163-172.nxml.txt.nlp	22571819	SENT94	28	28	8	8	sorafenib	EGFR	PA7000	1956	0.761
NULL	Curr_Neuropharmacol_2012_Sep_10(3)_212-218.nxml.txt.nlp	23449551	SENT109	10	10	29	29	rimonabant	CB1	PA152407999	1268	0.761
NULL	Oncol_Lett_2014_Jun_28_7(6)_1747-1754.nxml.txt.nlp	24932227	SENT106	47	47	45	45	trypsin	SPINK1	PA451806	6690	0.761
NULL	J_Hematol_Oncol_2011_Nov_4_4_44.nxml.txt.nlp	22053759	SENT103	16	16	10	10	thrombin	PAR4	PA451674	9002;5074	0.761
NULL	Drug_Target_Insights_2012_Aug_6_6_19-39.nxml.txt.nlp	22915839	SENT245	38	38	6	6	doxorubicin	Hsp90	PA449412	3320	0.761
NULL	Diabetes_Care_2013_Aug_11_36(8)_2324-2330.nxml.txt.nlp	23564921	SENT196	11	11	18	18	pioglitazone	adiponectin	PA450970	9370	0.761
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1059-1066.nxml.txt.nlp	21364577	SENT180	19	19	8	8	tamoxifen	ATAC	PA451581	6375	0.761
NULL	Mol_Cancer_2012_Dec_12_11_91.nxml.txt.nlp	23234355	SENT199	13	13	23	23	trastuzumab	EGFR	PA451743	1956	0.761
NULL	Oncogene_2014_Sep_11_33(37)_4579-4588.nxml.txt.nlp	24662835	SENT79	21	21	9	9	tamoxifen	MAGEA2	PA451581	4101;266740	0.761
NULL	Environ_Health_Perspect_2006_Apr_27_114(4)_500-506.nxml.txt.nlp	16581536	SENT195	19	19	31	31	estradiol	aromatase	PA449503	1588	0.761
NULL	Biol_Open_2013_Aug_14_2(10)_1013-1021.nxml.txt.nlp	24167711	SENT60	11	11	20	20	ethanol	EVL	PA448073	51466	0.761
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Mar_13_66(Pt_4)_o830.nxml.txt.nlp	21580658	SENT59	20	20	6	6	ethanol	mol	PA448073	90527	0.761
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT119	25	25	14	14	heparin	FGF1	PA449855	2246	0.761
NULL	J_Neuroinflammation_2011_Aug_5_8_91.nxml.txt.nlp	21819568	SENT222	25	25	35	35	pioglitazone	ANOVA	PA450970	4858	0.761
NULL	J_Cancer_2012_Nov_30_4(1)_3-11.nxml.txt.nlp	23386900	SENT116	8	8	29	29	sildenafil	CCL2	PA451346	6347	0.761
NULL	Leukemia_2013_Jan_11_27(1)_32-40.nxml.txt.nlp	22781593	SENT95	16	16	10	10	ponatinib	IL3	PA165980594	3562	0.761
NULL	Diabetes_Obes_Metab_2012_Apr_14(4)_304-314.nxml.txt.nlp	22051096	SENT143	8	8	29	29	exenatide	PPG	PA164749238	5552	0.761
NULL	Patient_Prefer_Adherence_2013_Mar_27_7_245-258.nxml.txt.nlp	23569364	SENT156	1	1	3	3	tamoxifen	aromatase	PA451581	1588	0.761
NULL	J_Biol_Chem_2013_Feb_22_288(8)_5530-5538.nxml.txt.nlp	23235146	SENT135	14	14	6	6	heparin	TSG-6	PA449855	7130	0.761
NULL	Diabetologia_2009_Oct_14_52(10)_2046-2055.nxml.txt.nlp	19688338	SENT328	25	25	5	5	rosiglitazone	GLP-1	PA451283	100125288	0.761
NULL	Case_Rep_Oncol_Med_2014_Dec_14_2014_685857.nxml.txt.nlp	25580325	SENT49	12	12	10	10	octreotide	CHOP	PA450678	1649	0.761
NULL	Front_Endocrinol_(Lausanne)_2014_Oct_27_5_163.nxml.txt.nlp	25386163	SENT133	24	24	13	13	ethanol	ghrelin	PA448073	51738	0.761
NULL	J_Res_Med_Sci_2011_Oct_16(10)_1361-1365.nxml.txt.nlp	22973332	SENT38	6	6	11	11	ketamine	CO2	PA450144	4513	0.761
NULL	Case_Rep_Oncol_2014_Mar_19_7(1)_210-216.nxml.txt.nlp	24803897	SENT19	2	2	17	17	trastuzumab	HER2	PA451743	2064	0.761
NULL	Ther_Clin_Risk_Manag_2006_Sep_2(3)_297-301.nxml.txt.nlp	18360604	SENT67	7	7	13	13	paricalcitol	PTH	PA450798	5741	0.761
NULL	Sci_Rep_2014_Nov_28_4_7237.nxml.txt.nlp	25429875	SENT96	0	0	9	9	hesperidin	JNK	PA449867	5599	0.761
NULL	Arthritis_Res_Ther_2012_Jun_12_14(3)_R142.nxml.txt.nlp	22691272	SENT65	23	23	26	26	mianserin	TLR7	PA134687937	51284	0.761
NULL	Indian_J_Pharmacol_2014_Sep-Oct_46(5)_549-550.nxml.txt.nlp	25298588	SENT64	9	9	12	12	warfarin	Xin	PA451906	165904	0.761
NULL	Eur_J_Immunol_2014_Jun_10_44(6)_1759-1769.nxml.txt.nlp	24595810	SENT7	28	28	41	41	fludrocortisone	CXCR4	PA164743961	7852	0.761
NULL	Br_J_Pharmacol_2012_Apr_165(8)_2611-2619.nxml.txt.nlp	21718301	SENT207	0	0	5	5	rimonabant	CB1	PA152407999	1268	0.761
NULL	Sci_Rep_2014_Dec_3_4_7294.nxml.txt.nlp	25465236	SENT502	33	33	19	19	staurosporine	TYK2	PA165109623	7297	0.761
NULL	ACS_Nano_2014_Sep_23_8(9)_8786-8793.nxml.txt.nlp	25130648	SENT43	1	1	3	3	tobramycin	NGC	PA451704	10675	0.761
NULL	Mol_Cancer_2010_Jun_25_9_165.nxml.txt.nlp	20576164	SENT176	19	19	31	31	curcumin	IFN	PA151958596	3439	0.761
NULL	Breast_Cancer_Res_2014_Sep_12_16(5)_436.nxml.txt.nlp	25213081	SENT8	32	32	4	4	tamoxifen	FOXM1	PA451581	2305	0.761
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT35	29	29	8	8	imatinib	CML	PA10804	613	0.761
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT184	9	9	6	6	adalimumab	CD36	PA10004	948	0.761
NULL	Ann_Rehabil_Med_2012_Aug_27_36(4)_466-473.nxml.txt.nlp	22977771	SENT22	29	29	22	22	hyaluronidase	ILEI	PA164745713	10447	0.761
NULL	Oxid_Med_Cell_Longev_2013_Jul_9_2013_574029.nxml.txt.nlp	23936610	SENT8	3	3	14	14	resveratrol	RAGE		177	0.761
NULL	Int_J_Gen_Med_2009_Jul_30_2_129-140.nxml.txt.nlp	20360896	SENT58	10	10	12	12	tamoxifen	aromatase	PA451581	1588	0.761
NULL	Br_J_Cancer_2011_Jul_26_105(3)_372-381.nxml.txt.nlp	21730979	SENT11	16	16	7	7	hydroxyurea	ATR	PA449942	390502;84168;545	0.761
NULL	Am_J_Case_Rep_2014_Mar_21_15_119-122.nxml.txt.nlp	24696753	SENT87	14	14	11	11	metformin	DPP4	PA450395	1803	0.761
NULL	Nature_2012_Feb_23_482(7386)_524-528.nxml.txt.nlp	22358842	SENT85	14	14	25	25	collagenase	F10	PA449107	2159	0.761
NULL	Mol_Cancer_2012_Apr_26_11_26.nxml.txt.nlp	22537224	SENT199	14	14	18	18	cisplatin	CHK1	PA449014	1111	0.761
NULL	Indian_J_Endocrinol_Metab_2013_Dec_17(Suppl_3)_S696-S699.nxml.txt.nlp	24910842	SENT74	20	20	18	18	metoclopramide	PRL	PA450475	5617	0.761
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT122	37	37	19	19	capsaicin	p53	PA448776	7157	0.761
NULL	Curr_Hepat_Rep_2010_Nov_26_9(4)_231-238.nxml.txt.nlp	20949114	SENT78	11	11	13	13	lamivudine	LAM	PA450163	7249;7248	0.761
NULL	Breast_Cancer_Res_2011_Mar_11_13(2)_R29.nxml.txt.nlp	21396094	SENT211	29	29	18	18	fulvestrant	HRG	PA164747170	3084;3273	0.761
NULL	Indian_J_Med_Res_2014_Apr_139(4)_572-578.nxml.txt.nlp	24927344	SENT86	18	18	8	8	acenocoumarol	GGCX	PA452632	2677	0.761
NULL	Cell_Death_Differ_2010_Oct_30_17(10)_1624-1635.nxml.txt.nlp	20431602	SENT66	10	10	0	0	paclitaxel	Mcl-1	PA450761	4170	0.761
NULL	Breast_Cancer_Res_2006_Nov_6_8(6)_215.nxml.txt.nlp	17096862	SENT94	6	6	10	10	pertuzumab	HER2		2064	0.761
NULL	Acta_Histochem_Cytochem_2012_Apr_26_45(2)_83-106.nxml.txt.nlp	22685351	SENT304	11	11	18	18	arsenite	survivin	PA452638	332	0.761
NULL	Pharmaceuticals_(Basel)_2013_May_23_6(6)_689-699.nxml.txt.nlp	24276256	SENT111	9	9	14	14	salbutamol	PTB	PA448068	58155	0.761
NULL	J_Physiol_2008_Jul_1_586(Pt_13)_3087-3095.nxml.txt.nlp	18467363	SENT156	18	18	28	28	lipase	DAG	PA450239	1605	0.761
NULL	Biomed_Res_Int_2014_Apr_10_2014_615363.nxml.txt.nlp	24818147	SENT7	34	34	38	38	thrombin	ADP	PA451674	23038	0.761
NULL	Ann_Dermatol_2013_May_10_25(2)_261-263.nxml.txt.nlp	23717030	SENT36	5	5	28	28	imiquimod	p40	PA449972	3921;339541;10314	0.761
NULL	Crit_Care_2004_Sep_2_8(5)_R353-R357.nxml.txt.nlp	15469580	SENT42	5	5	18	18	midazolam	CO2	PA450496	4513	0.761
NULL	J_Cell_Biol_2003_Aug_18_162(4)_587-597.nxml.txt.nlp	12913114	SENT153	19	19	21	21	etoposide	ETO	PA449552	862	0.761
NULL	Oxid_Med_Cell_Longev_2013_Nov_28_2013_568093.nxml.txt.nlp	24379901	SENT35	0	0	2	2	resveratrol	SIRT1		23411	0.761
NULL	BMB_Rep_2013_Jan_46(1)_59-64.nxml.txt.nlp	23351386	SENT62	4	4	10	10	auranofin	STAT3	PA448510	6774	0.761
NULL	Adv_Pharmacol_Sci_2013_Dec_5_2013_387071.nxml.txt.nlp	24381587	SENT113	14	14	3	3	methotrexate	TNF	PA450428	7124	0.761
NULL	Cancer_Cell_Int_2009_Sep_10_9_25.nxml.txt.nlp	19744341	SENT112	26	26	6	6	glucosamine	STAT3	PA164747613	6774	0.761
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Jan_12_69(Pt_2)_o232-o233.nxml.txt.nlp	23424512	SENT81	0	0	6	6	olanzapine	mol	PA450688	90527	0.761
NULL	J_Mol_Med_(Berl)_2013_Apr_10_91(4)_473-483.nxml.txt.nlp	23052483	SENT7	0	0	12	12	bevacizumab	LC3	PA130232992	84557	0.761
NULL	Cancer_2012_Mar_1_118(5)_1181-1191.nxml.txt.nlp	22038681	SENT158	29	29	15	15	dasatinib	IFN	PA162372878	3439	0.761
NULL	Mol_Cancer_2006_Oct_17_5_45.nxml.txt.nlp	17044934	SENT122	6	6	20	20	resveratrol	COX		1351	0.761
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Feb_6_69(Pt_3)_o345.nxml.txt.nlp	23476538	SENT63	12	12	19	19	coumarin	C10	PA134521193	113246	0.76
NULL	Oncotarget_2014_Nov_2_5(21)_10222-10236.nxml.txt.nlp	25400118	SENT224	34	34	36	36	lapatinib	EGFR	PA152241907	1956	0.76
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Aug_29_65(Pt_9)_o2259.nxml.txt.nlp	21577655	SENT62	25	25	14	14	ethanol	mol	PA448073	90527	0.76
NULL	Nat_Commun_2013_Apr_9_4_1684.nxml.txt.nlp	23575688	SENT149	10	10	12	12	rolipram	CYLD	PA153906323	1540	0.76
NULL	J_Oncol_2009_Mar_10_2009_831626.nxml.txt.nlp	20300583	SENT97	27	27	14	14	cetuximab	KRAS	PA10040	3845	0.76
NULL	Nat_Biotechnol_2013_Jan_16_31(1)_63-70.nxml.txt.nlp	23242163	SENT147	31	31	19	19	clodronate	MMP9	PA10239	4318	0.76
NULL	Breast_Cancer_Res_2008_Dec_18_10(Suppl_4)_S25.nxml.txt.nlp	19128439	SENT15	0	0	9	9	erlotinib	EGFR	PA134687924	1956	0.76
NULL	Cancers_(Basel)_2011_Oct_14_3(4)_3894-3908.nxml.txt.nlp	24213116	SENT121	12	12	18	18	gefitinib	PTGS2	PA131301952	5743	0.76
NULL	Exp_Neurobiol_2014_Jun_13_23(2)_124-129.nxml.txt.nlp	24963276	SENT54	30	30	27	27	naringin	GDNF	PA151958360	2668	0.76
NULL	Breast_Cancer_Res_2011_Jun_29_13(3)_R70.nxml.txt.nlp	21707964	SENT230	26	26	32	32	tamoxifen	14-3-3	PA451581	10971	0.76
NULL	Acta_Pharmacol_Sin_2011_Aug_11_32(8)_999-1008.nxml.txt.nlp	21743486	SENT224	0	0	15	15	fasudil	JNK	PA165946121	5599	0.76
NULL	Arch_Med_Sci_2013_Aug_30_9(4)_724-730.nxml.txt.nlp	24049536	SENT113	36	36	23	23	genistein	PTH	PA165109660	5741	0.76
NULL	Breast_Cancer_Res_2012_Nov_5_14(6)_R143.nxml.txt.nlp	23127292	SENT169	24	24	42	42	tamoxifen	p53	PA451581	7157	0.76
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1063.nxml.txt.nlp	24556678	SENT84	7	7	23	23	thioridazine	Mcl-1	PA451666	4170	0.76
NULL	J_Oncol_2013_Feb_17_2013_872957.nxml.txt.nlp	23476648	SENT10	10	10	2	2	cisplatin	SFN	PA449014	25996;2810	0.76
NULL	J_Cell_Biol_2001_May_14_153(4)_785-794.nxml.txt.nlp	11352939	SENT636	24	24	9	9	tetracycline	LIP	PA451640	23049	0.76
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT111	11	11	6	6	trastuzumab	MUC1	PA451743	4582	0.76
NULL	J_Hum_Genet_2013_Jun_2_58(6)_306-312.nxml.txt.nlp	23635953	SENT81	4	4	9	9	estradiol	TCL1A	PA449503	8115	0.76
NULL	Curr_Hepat_Rep_2010_Nov_26_9(4)_231-238.nxml.txt.nlp	20949114	SENT15	21	21	2	2	entecavir	IFN	PA164784025	3439	0.76
NULL	Cardiovasc_Res_2010_Jul_1_87(1)_60-72.nxml.txt.nlp	20110334	SENT120	2	2	12	12	carbachol	SCN5A	PA448784	6331	0.76
NULL	Clinics_(Sao_Paulo)_2011_Apr_66(4)_673-679.nxml.txt.nlp	21655764	SENT94	6	6	11	11	estradiol	spatial	PA449503	219793	0.76
NULL	Ann_Surg_Oncol_2009_Aug_10_16(8)_2086-2088.nxml.txt.nlp	19513600	SENT72	31	31	15	15	irinotecan	KRAS	PA450085	3845	0.76
NULL	J_Cachexia_Sarcopenia_Muscle_2011_Dec_8_2(4)_209-261.nxml.txt.nlp	22476871	SENT89	12	12	10	10	resveratrol	SIRT1		23411	0.76
NULL	Arthritis_Rheumatol_2014_Jun_27_66(6)_1574-1582.nxml.txt.nlp	24577881	SENT105	11	11	15	15	hydralazine	CD28	PA449894	1493;940	0.76
NULL	FASEB_J_2009_Feb_23(2)_575-585.nxml.txt.nlp	18957574	SENT127	34	34	6	6	streptomycin	IFN	PA451512	3439	0.76
NULL	Iran_Red_Crescent_Med_J_2013_Oct_5_15(10)_e7624.nxml.txt.nlp	24693368	SENT31	15	15	26	26	allopurinol	STZ	PA448320	6484	0.76
NULL	Cell_Biochem_Biophys_2013_Jan_13_66(3)_499-512.nxml.txt.nlp	23314884	SENT380	16	16	3	3	resveratrol	CD95		355	0.76
NULL	Protein_Cell_2014_Jun_22_5(11)_805-815.nxml.txt.nlp	24952721	SENT118	40	40	26	26	crizotinib	EML4	PA165946122	27436	0.76
NULL	Breast_Cancer_Res_2011_Sep_20_13(5)_R90.nxml.txt.nlp	21542898	SENT324	19	19	10	10	epirubicin	TP53	PA449476	7157	0.76
NULL	J_Cancer_2014_Jan_21_5(2)_133-142.nxml.txt.nlp	24494031	SENT134	0	0	2	2	midazolam	CYP3A	PA450496	1574	0.76
NULL	Br_J_Cancer_2014_Dec_9_111(12)_2380.nxml.txt.nlp	24619079	SENT28	24	24	33	33	panitumumab	KRAS	PA162373091	3845	0.76
NULL	Indian_J_Anaesth_2014_Jan-Feb_58(1)_63-65.nxml.txt.nlp	24700903	SENT10	20	20	26	26	remifentanil	adrenoleukodystrophy	PA451232	215	0.76
NULL	J_Addict_Med_2014_Nov_5_8(6)_476-478.nxml.txt.nlp	25314340	SENT91	5	5	1	1	clonidine	CYP2D6	PA449051	1565	0.76
NULL	Cell_Death_Dis_2011_Aug_11_2(8)_e191.nxml.txt.nlp	21833029	SENT63	41	41	16	16	oxaliplatin	CT26	PA131285527	168400	0.76
NULL	Clin_Interv_Aging_2013_Apr_29_8_467-483.nxml.txt.nlp	23766636	SENT112	12	12	1	1	ranibizumab	CRT	PA164746012	811	0.76
NULL	Clin_Ophthalmol_2011_Feb_10_5_171-176.nxml.txt.nlp	21383945	SENT30	1	1	14	14	heparin	ACT	PA449855	12;11332;9457;641455	0.76
NULL	Front_Genet_2012_Oct_19_3_220.nxml.txt.nlp	23091481	SENT14	17	17	19	19	bleomycin	BLM	PA448645	641	0.76
NULL	Braz_J_Med_Biol_Res_2014_Jan_10_47(1)_60-69.nxml.txt.nlp	24519092	SENT216	31	31	16	16	doxorubicin	YWHAZ	PA449412	7534	0.76
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT113	3	3	13	13	doxorubicin	SLK	PA449412	9748;2534	0.76
NULL	Cancer_Cell_Int_2012_Feb_21_12_5.nxml.txt.nlp	22353776	SENT128	6	6	20	20	pravastatin	MAT1A	PA451089	4143	0.76
NULL	Aging_(Albany_NY)_2010_Mar_17_2(3)_129-132.nxml.txt.nlp	20375467	SENT37	13	13	22	22	nadh	SIRT3	PA164755085	23410	0.76
NULL	Core_Evid_2011_Mar_17_6_31-42.nxml.txt.nlp	21468241	SENT94	14	14	27	27	ticagrelor	IPA	PA165374673	3160	0.76
NULL	Cancer_Cell_Int_2013_Mar_4_13_21.nxml.txt.nlp	23497288	SENT59	20	20	3	3	vincristine	EWS	PA451879	2130	0.76
NULL	J_Lipid_Res_2014_Dec_55(12)_2562-2575.nxml.txt.nlp	25316883	SENT196	35	35	3	3	lipase	CGI-58	PA450239	51099	0.76
NULL	Lab_Invest_2011_Apr_14_91(4)_598-608.nxml.txt.nlp	21321535	SENT130	20	20	31	31	sorafenib	CD25	PA7000	3669;3559	0.76
NULL	Cell_Death_Dis_2012_Jun_21_3(6)_e327.nxml.txt.nlp	22717582	SENT218	21	21	6	6	vincristine	NOXA	PA451879	5366	0.76
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT98	6	6	29	29	neratinib	HER2	PA165291472	2064	0.76
NULL	Braz_J_Med_Biol_Res_2012_Jul_20_45(10)_935-941.nxml.txt.nlp	22801415	SENT149	10	10	16	16	pioglitazone	adiponectin	PA450970	9370	0.76
NULL	Arthritis_Res_Ther_2006_Jul_21_8(4)_R130.nxml.txt.nlp	16859540	SENT261	7	7	5	5	atorvastatin	CD59	PA448500	966	0.76
NULL	EPMA_J_2012_Sep_27_3(1)_10.nxml.txt.nlp	23016735	SENT177	16	16	13	13	warfarin	PROC	PA451906	5624	0.76
NULL	Breast_Cancer_Res_2007_Dec_20_9(Suppl_2)_S24.nxml.txt.nlp	NULL	SENT20	36	36	32	32	tamoxifen	ATAC	PA451581	6375	0.76
NULL	Cancers_(Basel)_2012_Jul_16_4(3)_673-700.nxml.txt.nlp	24213461	SENT314	4	4	13	13	bezafibrate	survivin	PA162364313	332	0.76
NULL	Diabetes_Obes_Metab_2011_Apr_13(4)_348-356.nxml.txt.nlp	21205128	SENT197	10	10	25	25	liraglutide	Met	PA165958364	79811	0.76
NULL	Diabetes_2008_Sep_57(9)_2288-2295.nxml.txt.nlp	18535187	SENT246	32	32	39	39	pioglitazone	adiponectin	PA450970	9370	0.76
NULL	Cell_Commun_Signal_2009_Aug_10_7_18.nxml.txt.nlp	19664273	SENT477	26	26	21	21	methotrexate	DHFR	PA450428	1719	0.76
NULL	Case_Rep_Oncol_2010_Apr_22_3(2)_98-105.nxml.txt.nlp	20740181	SENT61	4	4	13	13	erlotinib	CYP3A4	PA134687924	1576	0.76
NULL	Nat_Med_2013_Oct_8_19(10)_1313-1317.nxml.txt.nlp	24013700	SENT69	23	23	19	19	ribavirin	IFN	PA451241	3439	0.76
NULL	Hum_Genomics_2009_Jan_1_3(2)_128-142.nxml.txt.nlp	19164090	SENT8	11	11	27	27	carboplatin	CD44	PA448803	960	0.76
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT54	0	0	21	21	resveratrol	DR4		8797	0.76
NULL	Cent_European_J_Urol_2013_Dec_19_66(4)_394-404.nxml.txt.nlp	24757527	SENT174	3	3	6	6	temsirolimus	IFN	PA164746890	3439	0.76
NULL	Breast_Cancer_Res_2010_Oct_20_12(5)_315.nxml.txt.nlp	21062517	SENT5	17	17	11	11	tamoxifen	PI3K	PA451581	5290	0.76
NULL	Mult_Scler_Int_2013_Mar_10_2013_189624.nxml.txt.nlp	23555057	SENT191	24	24	7	7	rituximab	IFN	PA451261	3439	0.76
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT105	31	31	5	5	resveratrol	IL-6		3569	0.76
NULL	Clin_Dev_Immunol_2011_Dec_26_2011_890758.nxml.txt.nlp	22235224	SENT120	2	2	6	6	pertuzumab	HER2		2064	0.76
NULL	Cell_Cycle_2013_Jan_15_12(2)_197-198.nxml.txt.nlp	23287464	SENT26	13	13	15	15	estradiol	GLP1	PA449503	100125288;2641	0.76
NULL	Br_J_Cancer_2012_Apr_24_106(9)_1543-1550.nxml.txt.nlp	22531721	SENT89	13	13	30	30	trastuzumab	CD55	PA451743	1604	0.76
NULL	Oncotarget_2014_Mar_26_5(19)_8959-8969.nxml.txt.nlp	25344859	SENT237	19	19	14	14	simvastatin	EAF2	PA451363	55929;55840	0.76
NULL	Turk_J_Haematol_2013_Dec_5_30(4)_387-393.nxml.txt.nlp	24385829	SENT124	9	9	6	6	imatinib	DDR1	PA10804	780	0.76
NULL	J_Gastrointest_Cancer_2010_Mar_28_41(1)_60-70.nxml.txt.nlp	19946763	SENT56	12	12	17	17	imatinib	KIT	PA10804	3815	0.76
NULL	Asian_J_Androl_2015_Oct_24_Jan-Feb_17(1)_61-67.nxml.txt.nlp	25370206	SENT151	13	13	1	1	tadalafil	SEP2	PA10333	23176;23157	0.76
NULL	Oncotarget_2012_May_19_3(5)_535-545.nxml.txt.nlp	22619121	SENT108	11	11	16	16	topotecan	MYCN	PA451729	4613	0.76
NULL	Breast_Cancer_2013_Mar_1_20(4)_302-309.nxml.txt.nlp	23456736	SENT29	8	8	15	15	tegafur	CDHP	PA452620	1001	0.76
NULL	Croat_Med_J_2012_Aug_53(4)_314-320.nxml.txt.nlp	22911523	SENT209	23	23	12	12	cetuximab	BRAF	PA10040	673	0.76
NULL	Breast_Cancer_Res_2004_Oct_6_6(6)_269-274.nxml.txt.nlp	15535858	SENT100	6	6	2	2	tamoxifen	ATAC	PA451581	6375	0.76
NULL	Braz_J_Med_Biol_Res_2013_Feb_1_46(2)_171-177.nxml.txt.nlp	23369979	SENT136	0	0	3	3	enalapril	IL-6	PA449456	3569	0.76
NULL	BMJ_Open_2014_Feb_13_4(2)_e003960.nxml.txt.nlp	24525389	SENT88	19	19	5	5	warfarin	OAT	PA451906	4942	0.76
NULL	J_Cell_Mol_Med_2014_Mar_26_18(3)_391-395.nxml.txt.nlp	24571258	SENT23	14	14	7	7	deferoxamine	LTF	PA164746490	4057	0.76
NULL	Arthritis_Res_Ther_2007_Jun_29_9(Suppl_1)_S5.nxml.txt.nlp	17634144	SENT162	6	6	24	24	denosumab	RANKL	PA166048634	8600	0.76
NULL	Oncologist_2011_Jan_6_16(1)_5-24.nxml.txt.nlp	21212434	SENT195	7	7	12	12	temozolomide	IFN	PA451609	3439	0.76
NULL	J_Biomed_Biotechnol_2011_Jul_3_2011_343791.nxml.txt.nlp	21799660	SENT95	32	32	24	24	ethanol	COD	PA448073	6628	0.76
NULL	Oncotarget_2014_Feb_7_5(3)_775-787.nxml.txt.nlp	24519956	SENT111	22	22	8	8	dasatinib	PC3	PA162372878	57332;7832;5122	0.76
NULL	J_Korean_Med_Sci_2010_Feb_19_25(2)_240-244.nxml.txt.nlp	20119577	SENT23	24	24	1	1	bleomycin	NAC	PA448645	22861	0.76
NULL	J_Hematol_Oncol_2011_Feb_7_4_6.nxml.txt.nlp	21299849	SENT133	2	2	9	9	imatinib	RPS6	PA10804	6194	0.76
NULL	Oncotarget_2013_Nov_23_5(1)_196-210.nxml.txt.nlp	24344116	SENT191	20	20	16	16	doxorubicin	ICAM1	PA449412	3383	0.76
NULL	Acta_Pharmacol_Sin_2014_Jun_5_35(6)_727-737.nxml.txt.nlp	24793312	SENT13	10	10	14	14	losartan	B27	PA450268	56246	0.76
NULL	Breast_Cancer_Res_2010_Mar_5_12(2)_R16.nxml.txt.nlp	20205716	SENT234	28	28	18	18	lovastatin	MSH2	PA450272	4436	0.76
NULL	Cancer_Med_2013_Dec_27_2(6)_751-762.nxml.txt.nlp	24403249	SENT296	11	11	32	32	paclitaxel	SOX2	PA450761	6657	0.76
NULL	Breast_Cancer_Res_2011_Apr_15_13(2)_R44.nxml.txt.nlp	21496232	SENT401	10	10	29	29	erlotinib	EGF	PA134687924	1950	0.76
NULL	Pharmaceuticals_(Basel)_2013_Aug_21_6(8)_988-1038.nxml.txt.nlp	24276379	SENT2651	18	18	6	6	cetuximab	EGFR	PA10040	1956	0.76
NULL	Br_J_Cancer_2011_Nov_22_105(11)_1628-1634.nxml.txt.nlp	22009028	SENT70	25	25	0	0	flutamide	Men	PA449685	8178	0.76
NULL	Diabetes_2013_Mar_14_62(3)_743-752.nxml.txt.nlp	23238294	SENT207	3	3	9	9	betaine	adiponectin	PA448603	9370	0.76
NULL	Clinics_(Sao_Paulo)_2013_May_68(5)_592-598.nxml.txt.nlp	23778413	SENT84	31	31	26	26	docetaxel	NACT	PA449383	284111	0.76
NULL	Mol_Cancer_2012_Jul_25_11_46.nxml.txt.nlp	22830422	SENT154	9	9	46	46	rolipram	KRAS	PA153906323	3845	0.76
NULL	Int_J_Biol_Sci_2011_Sep_8_7(8)_1077-1092.nxml.txt.nlp	21927577	SENT123	2	2	5	5	telmisartan	ANG	PA451605	283	0.76
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_39-54.nxml.txt.nlp	19305787	SENT303	5	5	7	7	ethanol	RACK1	PA448073	10399	0.76
NULL	Nat_Med_2013_Mar_10_19(3)_313-321.nxml.txt.nlp	23396211	SENT154	7	7	18	18	amlexanox	TBK1	PA164745310	29110	0.76
NULL	J_Hematol_Oncol_2008_Oct_1_1_16.nxml.txt.nlp	18828924	SENT261	8	8	17	17	sunitinib	HER2	PA162372840	2064	0.76
NULL	Oncotarget_2014_Jun_30_5(14)_5637-5650.nxml.txt.nlp	25026298	SENT79	4	4	10	10	vorinostat	CHK1	PA164748224	1111	0.76
NULL	Mol_Cancer_2012_Dec_12_11_91.nxml.txt.nlp	23234355	SENT303	29	29	16	16	erlotinib	EGFR	PA134687924	1956	0.76
NULL	Cells_2014_Apr_8_3(2)_258-287.nxml.txt.nlp	24717323	SENT264	9	9	7	7	carbachol	TRPC5	PA448784	7224	0.76
NULL	Breast_Cancer_Res_Treat_2013_Aug_20_141(1)_43-53.nxml.txt.nlp	23959396	SENT30	18	18	11	11	trastuzumab	HER3	PA451743	2065	0.76
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT435	19	19	24	24	olanzapine	PRL	PA450688	5617	0.76
NULL	Int_J_Endocrinol_2014_Feb_18_2014_232454.nxml.txt.nlp	24695544	SENT76	13	13	11	11	tazarotene	TIG2	PA164746821	5919	0.76
NULL	Indian_J_Urol_2009_Apr-Jun_25(2)_186-189.nxml.txt.nlp	19672343	SENT49	44	44	8	8	cisplatin	GTS	PA449014	2973	0.76
NULL	Int_J_Biomater_2012_Oct_15_2012_181024.nxml.txt.nlp	23118752	SENT61	8	8	18	18	ethanol	Tech	PA448073	57449	0.76
NULL	Cell_Death_Dis_2014_Jan_16_5(1)_e1000.nxml.txt.nlp	24434508	SENT52	8	8	17	17	etoposide	p53	PA449552	7157	0.76
NULL	Clin_Ophthalmol_2008_Jun_2(2)_355-368.nxml.txt.nlp	19668727	SENT43	18	18	28	28	amfenac	COX2	PA166049186	4513;5743	0.76
NULL	BMB_Rep_2014_Nov_47(11)_649-654.nxml.txt.nlp	25301019	SENT61	3	3	5	5	l-serine	p38	PA451330	10598;1432;7965	0.76
NULL	Br_J_Cancer_2012_Aug_7_107(4)_604-611.nxml.txt.nlp	22805331	SENT49	16	16	5	5	pemetrexed	B12	PA10810	7126;4709	0.76
NULL	Gut_2011_Sep_8_60(9)_1284-1293.nxml.txt.nlp	21303914	SENT172	27	27	7	7	ribavirin	IFN	PA451241	3439	0.76
NULL	Mol_Cancer_2010_Apr_21_9_83.nxml.txt.nlp	20409325	SENT214	23	23	19	19	doxycycline	MYCN	PA449415	4613	0.76
NULL	Int_J_Breast_Cancer_2012_May_9_2012_415170.nxml.txt.nlp	22649737	SENT64	17	17	11	11	trastuzumab	PTEN	PA451743	5728	0.76
NULL	Oxid_Med_Cell_Longev_2011_Oct_15_2011_703676.nxml.txt.nlp	22013498	SENT78	2	2	6	6	resveratrol	IL-6		3569	0.76
NULL	Indian_J_Med_Res_2011_Sep_134(3)_295-301.nxml.txt.nlp	21985811	SENT28	19	19	28	28	phenytoin	CYP2C19	PA450947	1557	0.76
NULL	Breast_Cancer_(Auckl)_2014_Jul_29_8_109-118.nxml.txt.nlp	25125981	SENT39	3	3	10	10	pertuzumab	HER2		2064	0.76
NULL	Mol_Cancer_2010_Nov_8_9_291.nxml.txt.nlp	21059223	SENT183	35	35	9	9	gemcitabine	ZNF217	PA449748	7764	0.76
NULL	Breast_Cancer_Res_2011_Mar_14_13(2)_205.nxml.txt.nlp	21457526	SENT64	5	5	16	16	tamoxifen	CTX	PA451581	1593	0.76
NULL	Core_Evid_2011_Sep_8_6_67-79.nxml.txt.nlp	22022289	SENT176	24	24	43	43	exenatide	GLP-1	PA164749238	100125288	0.76
NULL	Oncoscience_2014_Oct_22_1(10)_614-623.nxml.txt.nlp	25593991	SENT95	38	38	9	9	panitumumab	NRAS	PA162373091	4893	0.76
NULL	Eur_J_Nutr_2009_Jun_24_48(4)_229-234.nxml.txt.nlp	19238310	SENT179	23	23	10	10	capsaicin	ghrelin	PA448776	51738	0.76
NULL	Biomed_Res_Int_2013_Sep_5_2013_929531.nxml.txt.nlp	24083250	SENT56	8	8	20	20	hyaluronan	HAS3	PA165958431	3038	0.76
NULL	J_Gen_Physiol_2012_Nov_140(5)_541-555.nxml.txt.nlp	23109716	SENT711	10	10	7	7	capsaicin	TRPV1	PA448776	7442	0.76
NULL	Evid_Based_Complement_Alternat_Med_2013_Mar_13_2013_685642.nxml.txt.nlp	23573144	SENT49	12	12	6	6	metformin	STZ	PA450395	6484	0.76
NULL	Oncotarget_2013_Nov_4_5(1)_161-172.nxml.txt.nlp	24389287	SENT106	22	22	4	4	propranolol	NOXA	PA451145	5366	0.76
NULL	J_Med_Case_Reports_2011_Jan_12_5_5.nxml.txt.nlp	21226894	SENT101	11	11	5	5	etoposide	CHOP	PA449552	1649	0.76
NULL	Lab_Invest_2014_May_10_94(5)_503-516.nxml.txt.nlp	24614199	SENT472	15	15	31	31	curcumin	RAGE	PA151958596	177	0.76
NULL	Br_J_Cancer_2013_Mar_19_108(5)_1052-1060.nxml.txt.nlp	23422754	SENT109	10	10	1	1	bevacizumab	VEGF-A	PA130232992	7422	0.76
NULL	Front_Hum_Neurosci_2014_Feb_3_8_29.nxml.txt.nlp	24550809	SENT281	2	2	17	17	fluoxetine	FDG	PA449673	23583	0.76
NULL	Nucleic_Acids_Res_2013_Dec_30_41(22)_10268-10282.nxml.txt.nlp	23997120	SENT10	24	24	3	3	camptothecin	TRF1	PA153590860	7013	0.76
NULL	Indian_J_Endocrinol_Metab_2012_Nov-Dec_16(6)_972-975.nxml.txt.nlp	23226644	SENT81	33	33	10	10	metyrapone	ACTH	PA450486	5443	0.76
NULL	Cell_Death_Dis_2014_Jul_3_5(7)_e1313.nxml.txt.nlp	24991765	SENT93	25	25	30	30	staurosporine	parkin	PA165109623	5071	0.76
NULL	Biomed_Res_Int_2014_May_4_2014_351252.nxml.txt.nlp	24877084	SENT61	4	4	6	6	bevacizumab	FTM	PA130232992	23322	0.76
NULL	Oncotarget_2011_Mar_23_2(3)_165-177.nxml.txt.nlp	21444946	SENT125	11	11	26	26	gefitinib	EGFR	PA131301952	1956	0.76
NULL	Patient_Prefer_Adherence_2011_Dec_23_6_1-9.nxml.txt.nlp	22272064	SENT66	22	22	13	13	telmisartan	ACE	PA451605	1636	0.76
NULL	Diabetes_Care_2009_Aug_12_32(8)_1428-1430.nxml.txt.nlp	19435956	SENT19	18	18	12	12	glibenclamide	KCNJ11	PA449782	3767	0.76
NULL	Cell_Death_Dis_2010_May_13_1(5)_e41.nxml.txt.nlp	21364648	SENT332	10	10	21	21	etoposide	p65	PA449552	5970	0.76
NULL	Mult_Scler_Int_2013_Mar_10_2013_189624.nxml.txt.nlp	23555057	SENT191	26	26	7	7	cyclophosphamide	IFN	PA449165	3439	0.76
NULL	Front_Pharmacol_2014_Nov_12_5_237.nxml.txt.nlp	25429268	SENT97	0	0	10	10	ethanol	p75NTR	PA448073	4804	0.76
NULL	Br_J_Cancer_1996_Apr_73(8)_972-978.nxml.txt.nlp	8611434	SENT0	10	10	26	26	collagenase	TIMP1	PA449107	7076	0.76
NULL	Int_J_Mol_Sci_2014_Sep_30_15(10)_17686-17704.nxml.txt.nlp	25272226	SENT182	8	8	17	17	phenol	San	PA450913	80218	0.76
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT102	17	17	26	26	l-methionine	4E-BP1	PA450423	1978	0.76
NULL	Cardiol_Res_Pract_2012_Apr_22_2012_181394.nxml.txt.nlp	22577589	SENT49	29	29	26	26	chloroquine	IFN	PA448948	3439	0.76
NULL	Proteome_Sci_2003_Jun_12_1_4.nxml.txt.nlp	12818002	SENT113	23	23	10	10	l-glutamine	B27	PA10090	56246	0.76
NULL	Diabetes_Care_2009_Aug_26_32(8)_1411-1417.nxml.txt.nlp	19470837	SENT129	1	1	14	14	glucose	PPG	PA449773	5552	0.76
NULL	Stroke_Res_Treat_2009_Dec_20_2010_386389.nxml.txt.nlp	20700422	SENT160	2	2	6	6	resveratrol	NAC		22861	0.76
NULL	Front_Aging_Neurosci_2014_Sep_18_6_245.nxml.txt.nlp	25278877	SENT211	13	13	26	26	doxycycline	ADAM12	PA449415	8038	0.76
NULL	Oncoimmunology_2012_May_1_1(3)_279-286.nxml.txt.nlp	22737603	SENT121	4	4	7	7	doxorubicin	CRT	PA449412	811	0.76
NULL	Case_Rep_Oncol_2014_Apr_25_7(1)_277-284.nxml.txt.nlp	24926257	SENT23	0	0	24	24	lenalidomide	p53	PA162363968	7157	0.76
NULL	J_Hematol_Oncol_2012_Oct_10_5_62.nxml.txt.nlp	23050865	SENT48	24	24	34	34	gefitinib	EGFR	PA131301952	1956	0.76
NULL	J_Breast_Cancer_2013_Jun_28_16(2)_164-170.nxml.txt.nlp	23843848	SENT116	3	3	18	18	doxorubicin	PTEN	PA449412	5728	0.76
NULL	Colorectal_Dis_2012_Feb_14(2)_e31-e47.nxml.txt.nlp	21848897	SENT121	19	19	27	27	irinotecan	KRAS	PA450085	3845	0.76
NULL	Diabetes_2013_Oct_17_62(10)_3547-3552.nxml.txt.nlp	23863812	SENT16	4	4	10	10	atorvastatin	adiponectin	PA448500	9370	0.76
NULL	Chin_J_Cancer_2012_Aug_31(8)_364-372.nxml.txt.nlp	22739265	SENT9	3	3	5	5	etoposide	p53	PA449552	7157	0.76
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jan_22_67(Pt_2)_o472-o473.nxml.txt.nlp	21523131	SENT69	31	31	24	24	ethanol	mol	PA448073	90527	0.76
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_91-103.nxml.txt.nlp	17912639	SENT71	23	23	33	33	letrozole	HER2	PA450196	2064	0.76
NULL	J_Mol_Med_(Berl)_2014_May_10_92(7)_709-722.nxml.txt.nlp	24811491	SENT218	19	19	6	6	cetuximab	KRAS	PA10040	3845	0.76
NULL	Oncotarget_2013_Nov_19_5(1)_95-102.nxml.txt.nlp	24395633	SENT67	0	0	5	5	sirolimus	FOXP3	PA451365	50943	0.76
NULL	Curr_Neuropharmacol_2013_Mar_11(2)_160-170.nxml.txt.nlp	23997751	SENT122	15	15	8	8	haloperidol	5-HT2C	PA449841	3358	0.76
NULL	J_Korean_Med_Sci_2011_Jan_22_26(1)_33-41.nxml.txt.nlp	21218027	SENT146	7	7	3	3	capreomycin	DST	PA164746226	667	0.76
NULL	J_Biol_Chem_2013_Oct_11_288(41)_29642-29653.nxml.txt.nlp	24005673	SENT947	8	8	3	3	hyaluronan	TSG-6	PA165958431	7130	0.76
NULL	Case_Rep_Ophthalmol_2011_Mar_12_2(1)_105-110.nxml.txt.nlp	22110438	SENT6	24	24	21	21	ribavirin	IFN	PA451241	3439	0.76
NULL	Breast_Cancer_Res_2012_Jul_23_14(4)_R112.nxml.txt.nlp	22824341	SENT95	12	12	10	10	doxorubicin	RANKL	PA449412	8600	0.76
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_39-54.nxml.txt.nlp	19305787	SENT377	7	7	14	14	ethanol	DARPP-32	PA448073	84152	0.76
NULL	Oncotarget_2013_Nov_23_5(1)_196-210.nxml.txt.nlp	24344116	SENT191	20	20	14	14	doxorubicin	CXCL1	PA449412	2919	0.76
NULL	N_Am_J_Med_Sci_2011_Jan_3(1)_1-12.nxml.txt.nlp	22540056	SENT82	22	22	37	37	gemcitabine	CRT	PA449748	811	0.76
NULL	Toxins_(Basel)_2010_Mar_31_2(4)_517-551.nxml.txt.nlp	22069598	SENT759	1	1	16	16	curcumin	IkappaBalpha	PA151958596	4792	0.76
NULL	Open_Biochem_J_2011_Sep_23_5_45-51.nxml.txt.nlp	21966325	SENT109	5	5	30	30	diclofenac	ATF6	PA449293	22926	0.76
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jun_22_67(Pt_7)_o1772.nxml.txt.nlp	21837149	SENT70	16	16	8	8	benzaldehyde	mol	PA448571	90527	0.76
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT309	4	4	14	14	quetiapine	PRL	PA451201	5617	0.76
NULL	Cancer_Cell_Int_2008_Apr_29_8_4.nxml.txt.nlp	18442416	SENT187	10	10	32	32	trypsin	Ku86	PA451806	7520	0.76
NULL	Indian_J_Med_Res_2012_Jun_135(6)_843-852.nxml.txt.nlp	22825604	SENT49	6	6	4	4	cyclophosphamide	NACT	PA449165	284111	0.76
NULL	J_Korean_Med_Sci_2011_Jul_20_26(7)_893-899.nxml.txt.nlp	21738342	SENT153	12	12	4	4	genistein	CD97	PA165109660	976	0.76
NULL	Oncol_Lett_2013_Aug_17_6(2)_605-611.nxml.txt.nlp	24137379	SENT27	0	0	25	25	imatinib	KIT	PA10804	3815	0.76
NULL	Breast_Cancer_Res_Treat_2014_Jan_9_143(3)_493-505.nxml.txt.nlp	24402830	SENT4	34	34	19	19	trastuzumab	HER2	PA451743	2064	0.76
NULL	Acta_Pharmacol_Sin_2012_Jul_18_33(7)_861-872.nxml.txt.nlp	22705730	SENT109	17	17	10	10	atorvastatin	PI3K	PA448500	5290	0.76
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_13_2014_849783.nxml.txt.nlp	25477998	SENT132	13	13	10	10	berberine	HMGB1	PA165860812	3146	0.76
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT288	32	32	18	18	cetuximab	KRAS	PA10040	3845	0.76
NULL	Diabetes_Metab_J_2013_Oct_17_37(5)_315-325.nxml.txt.nlp	24199159	SENT194	44	44	41	41	resveratrol	SIRT1		23411	0.76
NULL	Breast_Cancer_Res_2014_Dec_19_16(6)_499.nxml.txt.nlp	25522654	SENT206	11	11	20	20	estradiol	CYP19A1	PA449503	1588	0.76
NULL	Mol_Vis_2011_Feb_1_17_332-340.nxml.txt.nlp	21297899	SENT214	0	0	11	11	benazepril	NAC	PA448561	22861	0.76
NULL	Mol_Cancer_2012_Dec_12_11_91.nxml.txt.nlp	23234355	SENT103	0	0	19	19	gefitinib	EGFR	PA131301952	1956	0.76
NULL	Ann_Clin_Microbiol_Antimicrob_2010_May_27_9_16.nxml.txt.nlp	20504376	SENT148	23	23	40	40	vancomycin	SP2	PA451850	6668	0.76
NULL	Oncoimmunology_2012_Oct_1_1(7)_1004-1016.nxml.txt.nlp	23170249	SENT66	18	18	15	15	paclitaxel	HER-2	PA450761	2064	0.76
NULL	Mol_Cancer_2012_Aug_24_11_61.nxml.txt.nlp	22917467	SENT215	38	38	21	21	hydrocortisone	F12	PA449905	2161	0.76
NULL	Bioessays_2013_May_12_35(5)_462-471.nxml.txt.nlp	23494566	SENT160	17	17	8	8	staurosporine	CDK1	PA165109623	983	0.76
NULL	Mol_Pain_2013_Feb_15_9_3.nxml.txt.nlp	23413875	SENT93	3	3	10	10	resveratrol	TRPV1		7442	0.76
NULL	Br_J_Cancer_2004_Mar_22_90(6)_1285-1292.nxml.txt.nlp	15026814	SENT142	29	29	27	27	doxorubicin	p53	PA449412	7157	0.76
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT166	14	14	41	41	pertuzumab	HER3		2065	0.76
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Aug_4_66(Pt_9)_o2198-o2199.nxml.txt.nlp	21588573	SENT79	16	16	6	6	ethanol	mol	PA448073	90527	0.76
NULL	Int_J_Endocrinol_2010_Mar_2_2010_621687.nxml.txt.nlp	20204178	SENT9	5	5	23	23	paricalcitol	PTH	PA450798	5741	0.76
NULL	Mol_Pain_2013_Feb_15_9_3.nxml.txt.nlp	23413875	SENT100	22	22	5	5	capsaicin	TRPV1	PA448776	7442	0.76
NULL	Nat_Commun_2014_Dec_8_5_5736.nxml.txt.nlp	25484020	SENT140	5	5	14	14	nitrile	TRPA1	PA450636	8989	0.76
NULL	Mol_Microbiol_2014_Jul_23_93(2)_369-389.nxml.txt.nlp	24912400	SENT32	22	22	16	16	urea	Car1	PA451831	759	0.76
NULL	Arthritis_Res_Ther_2008_Oct_10_10(5)_224.nxml.txt.nlp	18947376	SENT95	3	3	6	6	efalizumab	LFA-1	PA164748817	3683;3689	0.76
NULL	Oncol_Lett_2014_Nov_14_8(5)_2086-2092.nxml.txt.nlp	25295095	SENT188	27	27	12	12	gemcitabine	CHK1	PA449748	1111	0.76
NULL	Nat_Commun_2013_Sep_20_4_2444.nxml.txt.nlp	24051492	SENT140	13	13	15	15	nutlin-3	p53		7157	0.76
NULL	Breast_Cancer_Res_2014_May_5_16(3)_R45.nxml.txt.nlp	24887236	SENT219	22	22	5	5	lapatinib	EGFR	PA152241907	1956	0.76
NULL	Br_J_Cancer_2013_Sep_3_109(5)_1243-1251.nxml.txt.nlp	23922111	SENT50	13	13	22	22	bevacizumab	EGFR	PA130232992	1956	0.76
NULL	J_Hematol_Oncol_2012_Jun_8_5_27.nxml.txt.nlp	22682004	SENT146	20	20	10	10	cisplatin	CHOP	PA449014	1649	0.76
NULL	Arch_Toxicol_2011_Feb_12_85(2)_79-117.nxml.txt.nlp	21225242	SENT752	20	20	27	27	phenacetin	CYP2D6	PA450897	1565	0.76
NULL	Clin_Pharmacol_2011_Jun_22_3_13-25.nxml.txt.nlp	22287853	SENT119	14	14	28	28	saxagliptin	ANOVA	PA165958362	4858	0.76
NULL	J_Physiol_2009_Feb_15_587(Pt_4)_731-744.nxml.txt.nlp	19074966	SENT252	7	7	11	11	taurine	PAT1	PA451590	10513;206358	0.76
NULL	Pharmaceuticals_(Basel)_2013_Aug_21_6(8)_988-1038.nxml.txt.nlp	24276379	SENT349	22	22	15	15	cetuximab	PIK3CA	PA10040	5290	0.76
NULL	Oncotarget_2011_Mar_23_2(3)_165-177.nxml.txt.nlp	21444946	SENT232	23	23	35	35	carboplatin	EGFR	PA448803	1956	0.76
NULL	Br_J_Cancer_2010_Jan_5_102(1)_80-86.nxml.txt.nlp	19920817	SENT38	20	20	22	22	bevacizumab	IFN	PA130232992	3439	0.76
NULL	Exp_Diabetes_Res_2012_Nov_1_2012_972679.nxml.txt.nlp	22110483	SENT76	0	0	6	6	resveratrol	fractalkine		6376	0.76
NULL	Cell_Death_Dis_2012_Mar_1_3(3)_e275.nxml.txt.nlp	22378068	SENT202	11	11	7	7	metformin	AKT	PA450395	207	0.76
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1067-1070.nxml.txt.nlp	21386841	SENT81	8	8	20	20	capecitabine	STZ	PA448771	6484	0.76
NULL	Patient_Prefer_Adherence_2008_Feb_2_2_387-392.nxml.txt.nlp	19920986	SENT8	0	0	11	11	cyclosporine	gamma	PA449167	9913	0.76
NULL	Ther_Clin_Risk_Manag_2006_Dec_2(4)_337-346.nxml.txt.nlp	18360646	SENT186	13	13	6	6	timolol	BAK	PA451690	578	0.76
NULL	Ecancermedicalscience_2009_Oct_29_3_157.nxml.txt.nlp	22276018	SENT71	6	6	2	2	tamoxifen	HER3	PA451581	2065	0.76
NULL	Pharmacogn_Rev_2011_Jul-Dec_5(10)_159-163.nxml.txt.nlp	22279373	SENT161	5	5	12	12	naloxone	CEE	PA450586	51608	0.76
NULL	Arthritis_Res_Ther_2013_Dec_19_15(6)_R218.nxml.txt.nlp	24351550	SENT22	37	37	27	27	methotrexate	AMPK	PA450428	5563	0.76
NULL	Curr_Neuropharmacol_2008_Sep_6(3)_193-202.nxml.txt.nlp	19506720	SENT172	10	10	14	14	olanzapine	ghrelin	PA450688	51738	0.76
NULL	J_Invest_Dermatol_2013_Sep_31_133(9)_2247-2254.nxml.txt.nlp	23370537	SENT73	17	17	23	23	chloroquine	PUMA	PA448948	27113	0.76
NULL	Comp_Funct_Genomics_2009_Jul_2_2009_820381.nxml.txt.nlp	19590748	SENT216	16	16	26	26	nadh	ADP	PA164755085	23038	0.76
NULL	Mol_Cancer_2007_Jun_6_6_38.nxml.txt.nlp	17553164	SENT195	8	8	3	3	doxycycline	DDC	PA449415	1644	0.76
NULL	Psychiatr_Genet_2013_Aug_28_23(4)_153-162.nxml.txt.nlp	23811784	SENT5	2	2	9	9	chlorpromazine	AP2	PA448964	2971	0.76
NULL	Br_J_Pharmacol_2008_Oct_18_155(4)_596-605.nxml.txt.nlp	18852694	SENT150	8	8	24	24	fenofibrate	SREBP2	PA449594	6721	0.76
NULL	Cell_J_2012_Dec_22_Winter_13(4)_281-289.nxml.txt.nlp	23507624	SENT171	25	25	7	7	propranolol	IL-4	PA451145	3565	0.76
NULL	J_Korean_Med_Sci_2013_Nov_31_28(11)_1609-1614.nxml.txt.nlp	24265523	SENT108	19	19	16	16	everolimus	DES	PA164746311	1674	0.76
NULL	Curr_Med_Chem_2014_May_21(14)_1595-1606.nxml.txt.nlp	23992330	SENT80	23	23	13	13	vemurafenib	EGFR	PA165946873	1956	0.76
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT218	39	39	17	17	heparin	FGF1	PA449855	2246	0.76
NULL	Breast_Cancer_Res_2007_Sep_17_9(5)_R61.nxml.txt.nlp	17875215	SENT28	14	14	16	16	tamoxifen	aromatase	PA451581	1588	0.76
NULL	Clin_Exp_Metastasis_2014_Sep_17_31(1)_135-147.nxml.txt.nlp	24043563	SENT184	23	23	7	7	paclitaxel	KLK4	PA450761	9622	0.76
NULL	Oncol_Lett_2013_Feb_9_5(2)_552-558.nxml.txt.nlp	23420128	SENT136	3	3	9	9	imatinib	KIT	PA10804	3815	0.76
NULL	Pharmaceuticals_(Basel)_2014_Mar_5_7(3)_311-338.nxml.txt.nlp	24603603	SENT42	5	5	29	29	cetuximab	EGFR	PA10040	1956	0.76
NULL	Springerplus_2014_Sep_11_3_516.nxml.txt.nlp	25279308	SENT176	12	12	22	22	ethanol	CS-2	PA448073	58529;1443	0.76
NULL	ScientificWorldJournal_2013_Sep_19_2013_809891.nxml.txt.nlp	24170983	SENT130	4	4	25	25	dexketoprofen	CD54	PA166049175	3383	0.76
NULL	Adv_Hematol_2012_Mar_8_2012_856341.nxml.txt.nlp	22496694	SENT108	16	16	13	13	enoxaparin	TKR	PA449463	8277	0.76
NULL	Arthritis_Res_Ther_2014_Apr_3_16(2)_R86.nxml.txt.nlp	24708674	SENT14	5	5	33	33	bosentan	Fli1	PA10034	2314	0.76
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_21-38.nxml.txt.nlp	19305786	SENT523	3	3	8	8	menthol	TRPM8	PA164776605	79054	0.76
NULL	Crit_Care_2010_Mar_15_14(2)_R30.nxml.txt.nlp	20226064	SENT279	11	11	2	2	midazolam	IL-2	PA450496	3558	0.76
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_8_2012_859185.nxml.txt.nlp	23304219	SENT8	27	27	16	16	docetaxel	LC3	PA449383	84557	0.76
NULL	Ann_Oncol_2011_May_3_22(5)_1078-1087.nxml.txt.nlp	21048039	SENT155	15	15	3	3	cetuximab	EGFR	PA10040	1956	0.76
NULL	Diabetes_2008_Sep_57(9)_2332-2340.nxml.txt.nlp	18567824	SENT12	4	4	9	9	atropine	ghrelin	PA448505	51738	0.76
NULL	Alcohol_Res_2013_35(1)_87-96.nxml.txt.nlp	24313168	SENT71	18	18	0	0	nadh	SIRT1	PA164755085	23411	0.76
NULL	Clin_Sci_(Lond)_2013_Feb_1_124(Pt_3)_153-164.nxml.txt.nlp	23075334	SENT772	4	4	1	1	resveratrol	SIRT1		23411	0.76
NULL	Chem_Cent_J_2014_Jul_1_8_43.nxml.txt.nlp	25050134	SENT11	4	4	12	12	hemin	Bcl-2	PA449849	596	0.76
NULL	Alcohol_Res_2013_35(1)_69-76.nxml.txt.nlp	24313166	SENT73	16	16	24	24	ethanol	PDYN	PA448073	5173	0.76
NULL	Breast_Cancer_Res_Treat_2014_Apr_6_145(1)_33-44.nxml.txt.nlp	24706169	SENT28	11	11	18	18	trastuzumab	San	PA451743	80218	0.76
NULL	Drug_Healthc_Patient_Saf_2012_Jun_6_4_39-54.nxml.txt.nlp	22792008	SENT201	10	10	13	13	diazepam	UGT	PA449283	7361;7355	0.76
NULL	BioDrugs_2013_Jun_7_27(6)_591-603.nxml.txt.nlp	23743670	SENT93	14	14	27	27	gemcitabine	TRAMP	PA449748	8718;23471;9189	0.76
NULL	J_Korean_Med_Sci_2010_Apr_19_25(4)_557-563.nxml.txt.nlp	20357998	SENT120	14	14	18	18	rosiglitazone	IFN	PA451283	3439	0.76
NULL	Emerg_Infect_Dis_2011_Oct_17(10)_1966-1968.nxml.txt.nlp	22000388	SENT9	39	39	6	6	nevirapine	CD4	PA450616	920	0.76
NULL	Nat_Med_2014_Jul_8_20(7)_764-768.nxml.txt.nlp	24908571	SENT258	13	13	7	7	citalopram	GRM4	PA449015	2914	0.76
NULL	JAKSTAT_2014_Jun_12_3_e29554.nxml.txt.nlp	25105067	SENT38	0	0	2	2	propofol	STAT3	PA451141	6774	0.76
NULL	Oncotarget_2014_Aug_27_5(19)_9227-9238.nxml.txt.nlp	25193861	SENT117	2	2	10	10	cisplatin	HN3	PA449014	5692	0.76
NULL	Diabetes_2009_Feb_58(2)_352-359.nxml.txt.nlp	19011168	SENT141	33	33	35	35	exenatide	GLP-1	PA164749238	100125288	0.76
NULL	Front_Neural_Circuits_2014_Sep_8_8_100.nxml.txt.nlp	25249941	SENT1755	20	20	8	8	dexmedetomidine	5-HT1A	PA449256	3350	0.76
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT417	12	12	17	17	cetuximab	KRAS	PA10040	3845	0.76
NULL	Int_J_Breast_Cancer_2013_Jan_28_2013_101705.nxml.txt.nlp	23431460	SENT35	4	4	23	23	rosiglitazone	San	PA451283	80218	0.76
NULL	J_Invest_Dermatol_2011_Dec_11_131(12)_2458-2466.nxml.txt.nlp	21833016	SENT162	7	7	15	15	paraformaldehyde	MITF	PA450790	4286	0.76
NULL	Cancer_Med_2014_Oct_2_3(5)_1385-1395.nxml.txt.nlp	24890702	SENT153	3	3	25	25	irinotecan	KRAS	PA450085	3845	0.76
NULL	Genome_Med_2009_Sep_29_1(9)_88.nxml.txt.nlp	19754960	SENT156	26	26	20	20	warfarin	CYP4F2	PA451906	8529	0.76
NULL	Ther_Clin_Risk_Manag_2006_Sep_2(3)_297-301.nxml.txt.nlp	18360604	SENT52	13	13	16	16	paricalcitol	PTH	PA450798	5741	0.76
NULL	Acta_Pharmacol_Sin_2014_Oct_15_35(10)_1227-1246.nxml.txt.nlp	25220640	SENT238	17	17	5	5	cisplatin	MKP-1	PA449014	1843	0.76
NULL	Diabetes_Care_2008_Oct_31(10)_2013-2017.nxml.txt.nlp	18650372	SENT129	29	29	6	6	estradiol	aromatase	PA449503	1588	0.76
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT212	8	8	6	6	erlotinib	CYP3A	PA134687924	1574	0.76
NULL	Case_Rep_Endocrinol_2014_Feb_10_2014_479641.nxml.txt.nlp	24660072	SENT100	4	4	16	16	cinacalcet	PTH	PA164776671	5741	0.76
NULL	J_Cell_Biol_2001_Aug_6_154(3)_599-610.nxml.txt.nlp	11481345	SENT161	20	20	25	25	doxycycline	ARNO	PA449415	9266	0.76
NULL	Lab_Invest_2009_Nov_7_89(11)_1275-1290.nxml.txt.nlp	19736547	SENT162	9	9	27	27	curcumin	LOX-1	PA151958596	4973	0.76
NULL	Genome_Biol_2008_Feb_14_9(2)_R32.nxml.txt.nlp	18275597	SENT384	15	15	22	22	phenylephrine	p44	PA450935	10561;2966	0.76
NULL	Nat_Commun_2013_Aug_15_4_2130.nxml.txt.nlp	23945651	SENT89	21	21	3	3	etoposide	ATG5	PA449552	9474	0.76
NULL	Biochem_Res_Int_2012_Mar_4_2012_685267.nxml.txt.nlp	22496978	SENT214	7	7	23	23	thrombin	HSPC	PA451674	5688	0.76
NULL	AIDS_Res_Ther_2013_May_1_10_10.nxml.txt.nlp	23634877	SENT210	14	14	10	10	atorvastatin	CD38	PA448500	952	0.759
NULL	Curr_Neuropharmacol_2008_Jun_6(2)_151-163.nxml.txt.nlp	19305794	SENT275	2	2	35	35	capsaicin	TRPV1	PA448776	7442	0.759
NULL	Oncogenesis_2012_Apr_2_1(4)_e5.nxml.txt.nlp	23552603	SENT235	3	3	8	8	celecoxib	cIAP2	PA448871	330	0.759
NULL	J_Inflamm_(Lond)_2008_Dec_5_5_23.nxml.txt.nlp	19061493	SENT166	16	16	30	30	hemin	HO-1	PA449849	3162	0.759
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT771	1	1	13	13	vemurafenib	ABCB1	PA165946873	5243	0.759
NULL	Core_Evid_2011_Mar_17_6_31-42.nxml.txt.nlp	21468241	SENT108	14	14	8	8	clopidogrel	IPA	PA449053	3160	0.759
NULL	Lancet_2011_Jun_18_377(9783)_2103-2114.nxml.txt.nlp	21641636	SENT191	24	24	27	27	cetuximab	KRAS	PA10040	3845	0.759
NULL	Am_J_Physiol_Endocrinol_Metab_2013_Nov_1_305(9)_E1134-E1144.nxml.txt.nlp	24022868	SENT202	13	13	7	7	rosiglitazone	FASN	PA451283	2194	0.759
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT332	30	30	14	14	resveratrol	TRAIL		8743	0.759
NULL	Case_Rep_Transplant_2011_Jan_5_2011_210178.nxml.txt.nlp	23213600	SENT110	3	3	8	8	tacrolimus	CYP2C19	PA451578	1557	0.759
NULL	Clin_Ophthalmol_2009_Jun_2_3_199-210.nxml.txt.nlp	19668566	SENT182	15	15	0	0	ketorolac	Rho	PA450150	29984	0.759
NULL	Cardiovasc_Ther_2009_27(4)_259-274.nxml.txt.nlp	19604248	SENT11	21	21	4	4	clopidogrel	IPA	PA449053	3160	0.759
NULL	Anesthesiol_Res_Pract_2012_Nov_24_2012_921405.nxml.txt.nlp	22162685	SENT136	27	27	10	10	lidocaine	NPY	PA450226	4852	0.759
NULL	Parasit_Vectors_2009_Sep_25_2(Suppl_2)_S5.nxml.txt.nlp	19778466	SENT131	29	29	27	27	praziquantel	MOX	PA164764583	26002	0.759
NULL	Br_J_Pharmacol_2010_Aug_160(8)_1997-2007.nxml.txt.nlp	20649597	SENT119	7	7	14	14	pp2	TLR4		7099	0.759
NULL	Clin_Pharmacol_2012_Feb_20_4_13-20.nxml.txt.nlp	22427735	SENT74	8	8	34	34	clopidogrel	PON1	PA449053	5444	0.759
NULL	Int_J_Endocrinol_2010_Mar_2_2010_621687.nxml.txt.nlp	20204178	SENT100	1	1	12	12	paricalcitol	PTH	PA450798	5741	0.759
NULL	Exp_Ther_Med_2013_Jul_25_6(1)_109-114.nxml.txt.nlp	23935730	SENT137	13	13	19	19	doxorubicin	CHOP	PA449412	1649	0.759
NULL	J_Gen_Physiol_1947_May_20_30(5)_375-376.nxml.txt.nlp	19873502	SENT0	11	11	1	1	papain	Gen	PA450778	348654	0.759
NULL	Curr_Colorectal_Cancer_Rep_2014_Jan_12_10(1)_45-54.nxml.txt.nlp	24659930	SENT91	0	0	29	29	curcumin	IL-6	PA151958596	3569	0.759
NULL	Case_Rep_Dermatol_2011_Feb_5_3(1)_13-17.nxml.txt.nlp	21931572	SENT55	19	19	10	10	bexarotene	CD25	PA164752250	3669;3559	0.759
NULL	Int_J_Mol_Sci_2014_Sep_25_15(9)_17065-17076.nxml.txt.nlp	25257528	SENT6	14	14	25	25	decitabine	SMG1	PA164749631	23049	0.759
NULL	AAPS_J_2011_May_11_13(3)_365-377.nxml.txt.nlp	21560017	SENT180	19	19	8	8	ethanol	AKR1B10	PA448073	57016	0.759
NULL	EMBO_Mol_Med_2013_Aug_4_5(8)_1247-1262.nxml.txt.nlp	23737459	SENT6	29	29	14	14	nilotinib	parkin	PA165958345	5071	0.759
NULL	Pharmaceuticals_(Basel)_2013_Aug_21_6(8)_988-1038.nxml.txt.nlp	24276379	SENT2679	15	15	4	4	cetuximab	BRAF	PA10040	673	0.759
NULL	Asian-Australas_J_Anim_Sci_2013_Feb_26(2)_233-240.nxml.txt.nlp	25049781	SENT113	5	5	10	10	l-carnitine	SDH	PA450154	1757;10993	0.759
NULL	Cell_Tissue_Res_2012_Sep_10_349(3)_635-647.nxml.txt.nlp	22322423	SENT277	24	24	36	36	bevacizumab	VEGF-A	PA130232992	7422	0.759
NULL	J_Biol_Chem_2010_Apr_23_285(17)_12979-12989.nxml.txt.nlp	20189985	SENT274	13	13	11	11	forskolin	PTH	PA146096022	5741	0.759
NULL	Front_Neurosci_2010_Mar_19_4_22.nxml.txt.nlp	20582262	SENT12	5	5	26	26	bethanechol	P2X3	PA448613	5024	0.759
NULL	Brain_Sci_2013_Jun_14_3(2)_941-963.nxml.txt.nlp	24961432	SENT712	19	19	9	9	ethanol	p75NTR	PA448073	4804	0.759
NULL	Br_J_Cancer_2010_Jul_13_103(2)_186-195.nxml.txt.nlp	20588277	SENT108	3	3	6	6	nutlin-3	TP53		7157	0.759
NULL	Pharmaceuticals_(Basel)_2012_Sep_12_5(9)_1008-1020.nxml.txt.nlp	24280702	SENT414	9	9	18	18	novobiocin	Hsp90	PA164768819	3320	0.759
NULL	Breast_Cancer_Res_2012_Feb_14_14(1)_R30.nxml.txt.nlp	22333315	SENT38	31	31	9	9	indomethacin	CXCL9	PA449982	4283	0.759
NULL	J_Biol_Chem_2013_Nov_22_288(47)_34217-34229.nxml.txt.nlp	24106270	SENT334	6	6	11	11	thrombin	RhoG	PA451674	391	0.759
NULL	Croat_Med_J_2012_Aug_53(4)_314-320.nxml.txt.nlp	22911523	SENT193	24	24	18	18	warfarin	CYP4F2	PA451906	8529	0.759
NULL	Cell_Death_Dis_2013_Oct_3_4(10)_e828.nxml.txt.nlp	24091671	SENT271	28	28	17	17	cetuximab	CD54	PA10040	3383	0.759
NULL	Evid_Based_Complement_Alternat_Med_2011_Jan_4_2011_392627.nxml.txt.nlp	19542183	SENT130	2	2	5	5	glibenclamide	mol	PA449782	90527	0.759
NULL	Drug_Saf_2014_Feb_19_37(4)_201-211.nxml.txt.nlp	24550106	SENT12	5	5	19	19	omeprazole	CYP2C19	PA450704	1557	0.759
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT10	27	27	21	21	gefitinib	KRAS	PA131301952	3845	0.759
NULL	JAKSTAT_2014_Jun_12_3_e29554.nxml.txt.nlp	25105067	SENT56	0	0	21	21	propofol	STAT3	PA451141	6774	0.759
NULL	Breast_Cancer_Res_2013_Oct_22_15(5)_R98.nxml.txt.nlp	24148581	SENT52	13	13	33	33	tamoxifen	aromatase	PA451581	1588	0.759
NULL	J_Vet_Med_Sci_2013_Nov_5_75(11)_1443-1448.nxml.txt.nlp	23832627	SENT90	2	2	14	14	phenylephrine	MRAP	PA450935	56246	0.759
NULL	Arthritis_Res_Ther_2006_Jul_21_8(4)_R130.nxml.txt.nlp	16859540	SENT115	27	27	20	20	atorvastatin	CD59	PA448500	966	0.759
NULL	Br_J_Cancer_2011_Mar_15_104(6)_957-967.nxml.txt.nlp	21364585	SENT93	39	39	25	25	doxorubicin	CD138	PA449412	6382	0.759
NULL	J_Occup_Med_Toxicol_2008_Feb_27_3(Suppl_1)_S6.nxml.txt.nlp	18315837	SENT329	15	15	42	42	rosiglitazone	IL-10	PA451283	3586	0.759
NULL	J_Am_Heart_Assoc_2013_Dec_19_2(6)_e000355.nxml.txt.nlp	24190878	SENT160	25	25	27	27	isoproterenol	HK2	PA450121	3796;3099;29911;3741	0.759
NULL	EMBO_Mol_Med_2012_Jul_11_4(7)_577-593.nxml.txt.nlp	22496117	SENT242	7	7	3	3	clofazimine	PAP-1	PA164748759	6100	0.759
NULL	Cancer_Cell_Int_2005_Aug_24_5_28.nxml.txt.nlp	16120219	SENT11	1	1	13	13	etoposide	p53	PA449552	7157	0.759
NULL	Front_Oncol_2013_Aug_12_3_206.nxml.txt.nlp	23964347	SENT185	27	27	14	14	cisplatin	XRCC1	PA449014	7515	0.759
NULL	Diabetes_Care_2013_Aug_17_36(Suppl_2)_S245-S252.nxml.txt.nlp	23882053	SENT34	9	9	17	17	sitagliptin	HIP	PA164748978	6767;6159;64399;5068	0.759
NULL	J_Clin_Exp_Pathol_2012_May_17_Suppl_4_7327.nxml.txt.nlp	25379357	SENT92	2	2	37	37	resveratrol	SIRT1		23411	0.759
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT218	27	27	4	4	pp2	PP2		4888	0.759
NULL	Cerebrospinal_Fluid_Res_2008_Jan_11_5_1.nxml.txt.nlp	18186943	SENT8	3	3	27	27	doxycycline	EGFR	PA449415	1956	0.759
NULL	Cell_J_2012_Dec_22_Winter_13(4)_275-280.nxml.txt.nlp	23508090	SENT129	4	4	13	13	methamphetamine	Bcl-2	PA450403	596	0.759
NULL	Mol_Pain_2013_Jun_10_9_27.nxml.txt.nlp	23758830	SENT56	8	8	5	5	tetracaine	ASIC3	PA451638	9311	0.759
NULL	Breast_Cancer_Res_2011_Feb_23_13(1)_203.nxml.txt.nlp	21392408	SENT102	14	14	16	16	tamoxifen	aromatase	PA451581	1588	0.759
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT195	2	2	30	30	metformin	HIP	PA450395	6767;6159;64399;5068	0.759
NULL	Mol_Cancer_2012_Dec_12_11_91.nxml.txt.nlp	23234355	SENT184	11	11	47	47	erlotinib	NKG2D	PA134687924	22914	0.759
NULL	Clin_Exp_Gastroenterol_2011_Sep_14_4_213-220.nxml.txt.nlp	22016582	SENT79	10	10	3	3	dexlansoprazole	CYP2C19	PA166110257	1557	0.759
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_May_14_3(5)_e114.nxml.txt.nlp	24827872	SENT122	20	20	9	9	sorafenib	RAF1	PA7000	5894	0.759
NULL	Acta_Psychiatr_Scand_2014_Sep_21_130(3)_163-180.nxml.txt.nlp	24649967	SENT260	20	20	18	18	s-adenosylmethionine	B12	PA164754994	7126;4709	0.759
NULL	Cancer_Immunol_Immunother_2012_Jul_23_61(7)_1101-1111.nxml.txt.nlp	22193989	SENT148	15	15	23	23	oxaliplatin	PD-L1	PA131285527	29126	0.759
NULL	Mol_Vis_2012_Nov_29_18_2839-2846.nxml.txt.nlp	23233786	SENT151	30	30	27	27	sr144528	CB2		1269	0.759
NULL	Neural_Regen_Res_2014_Mar_15_9(6)_622-629.nxml.txt.nlp	25206865	SENT116	0	0	9	9	vasopressin	p38	PA451858	10598;1432;7965	0.759
NULL	J_Cell_Biol_2003_Dec_22_163(6)_1385-1395.nxml.txt.nlp	14676308	SENT269	15	15	9	9	thrombin	Rho	PA451674	29984	0.759
NULL	Breast_Cancer_Res_2012_Mar_14_14(2)_R45.nxml.txt.nlp	22417809	SENT413	32	32	11	11	tamoxifen	ITGB1	PA451581	3688	0.759
NULL	Exp_Ther_Med_2014_Sep_20_8(3)_968-972.nxml.txt.nlp	25120631	SENT136	13	13	0	0	naringin	FIB	PA151958360	2091	0.759
NULL	Acta_Pharmacol_Sin_2009_Jul_22_30(7)_956-964.nxml.txt.nlp	19543298	SENT5	9	9	18	18	simvastatin	ABCG2	PA451363	9429	0.759
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_May_5_68(Pt_6)_o1640-o1641.nxml.txt.nlp	22719441	SENT71	11	11	4	4	ethanol	mol	PA448073	90527	0.759
NULL	Int_J_Biol_Sci_2011_Sep_8_7(8)_1077-1092.nxml.txt.nlp	21927577	SENT21	38	38	25	25	telmisartan	CHOP	PA451605	1649	0.759
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Jun_19_64(Pt_7)_o1302.nxml.txt.nlp	21202931	SENT61	1	1	17	17	benzaldehyde	mol	PA448571	90527	0.759
NULL	Ann_Gastroenterol_2014_27(2)_105-112.nxml.txt.nlp	24733569	SENT181	24	24	8	8	entecavir	IFN	PA164784025	3439	0.759
NULL	Genet_Mol_Biol_2009_Sep_1_Jul-Sep_32(3)_484-490.nxml.txt.nlp	21637510	SENT157	5	5	10	10	estradiol	aromatase	PA449503	1588	0.759
NULL	Biomed_Res_Int_2014_Aug_6_2014_967826.nxml.txt.nlp	25165721	SENT280	2	2	21	21	cisplatin	CD4	PA449014	920	0.759
NULL	Ann_Dermatol_2014_Apr_30_26(2)_221-230.nxml.txt.nlp	24882978	SENT129	24	24	3	3	imiquimod	IL-17A	PA449972	3605	0.759
NULL	Ann_Indian_Acad_Neurol_2009_Apr-Jun_12(2)_89-98.nxml.txt.nlp	20142853	SENT147	15	15	23	23	choline	MRP4	PA448976	10257	0.759
NULL	Emerg_Infect_Dis_2011_Jun_17(6)_1099-1102.nxml.txt.nlp	21749780	SENT102	20	20	6	6	vancomycin	San	PA451850	80218	0.759
NULL	Ther_Clin_Risk_Manag_2007_Jun_3(3)_363-379.nxml.txt.nlp	18488081	SENT360	16	16	22	22	rabeprazole	MDR1	PA451216	5243	0.759
NULL	J_Oncol_2013_Jun_5_2013_102735.nxml.txt.nlp	23840208	SENT270	8	8	16	16	resveratrol	S15		6209	0.759
NULL	Ann_Med_Health_Sci_Res_2011_Jan-Jun_1(1)_115-121.nxml.txt.nlp	23209964	SENT56	9	9	5	5	simvastatin	BHD	PA451363	201163	0.759
NULL	Cell_Death_Dis_2012_Jun_7_3(6)_e319.nxml.txt.nlp	22673193	SENT48	25	25	16	16	cisplatin	Mcl-1	PA449014	4170	0.759
NULL	Br_J_Cancer_2004_Mar_22_90(6)_1285-1292.nxml.txt.nlp	15026814	SENT142	20	20	11	11	doxorubicin	p53	PA449412	7157	0.759
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_39-54.nxml.txt.nlp	19305787	SENT414	10	10	34	34	ethanol	CA1	PA448073	759	0.759
NULL	Br_J_Cancer_2003_Mar_10_88(5)_788-795.nxml.txt.nlp	12618891	SENT163	8	8	10	10	bosentan	FasL	PA10034	356	0.759
NULL	Diabetes_2009_Apr_9_58(4)_965-974.nxml.txt.nlp	19136651	SENT125	19	19	24	24	nadh	AMPK	PA164755085	5563	0.759
NULL	Indian_J_Urol_2009_Oct-Dec_25(4)_427-436.nxml.txt.nlp	19955664	SENT106	29	29	27	27	erlotinib	EGFR	PA134687924	1956	0.759
NULL	Front_Oncol_2014_Jun_12_4_144.nxml.txt.nlp	24971229	SENT414	7	7	3	3	cisplatin	EZH2	PA449014	2146	0.759
NULL	Open_Ophthalmol_J_2010_Oct_21_4_66-69.nxml.txt.nlp	21293730	SENT4	5	5	17	17	ranibizumab	VEGF-A	PA164746012	7422	0.759
NULL	Cell_Death_Dis_2014_Apr_17_5(4)_e1182.nxml.txt.nlp	24743737	SENT91	23	23	21	21	capsaicin	TRPV1	PA448776	7442	0.759
NULL	J_Mol_Signal_2010_May_10_5_4.nxml.txt.nlp	20459745	SENT55	16	16	23	23	cisplatin	p53	PA449014	7157	0.759
NULL	J_Cachexia_Sarcopenia_Muscle_2010_Sep_26_1(1)_43-128.nxml.txt.nlp	22477519	SENT745	11	11	8	8	fenfluramine	ghrelin	PA449592	51738	0.759
NULL	Nucleic_Acids_Res_2011_Oct_30_39(18)_7908-7919.nxml.txt.nlp	21724609	SENT301	0	0	4	4	flavopiridol	AIRE	PA452627	326	0.759
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT11	0	0	13	13	pp2	EGFR		1956	0.759
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT239	0	0	6	6	dasatinib	JNK	PA162372878	5599	0.759
NULL	Int_J_Endocrinol_2010_Mar_2_2010_621687.nxml.txt.nlp	20204178	SENT102	13	13	15	15	paricalcitol	PTH	PA450798	5741	0.759
NULL	Oncotarget_2014_Aug_29_5(19)_8947-8958.nxml.txt.nlp	25333254	SENT128	10	10	16	16	cytarabine	CXCR4	PA449177	7852	0.759
NULL	J_Oncol_2013_Feb_17_2013_872957.nxml.txt.nlp	23476648	SENT165	16	16	8	8	cisplatin	SFN	PA449014	25996;2810	0.759
NULL	J_Biol_Chem_2012_Aug_24_287(35)_30000-30013.nxml.txt.nlp	22773837	SENT245	30	30	23	23	thrombin	GPVI	PA451674	51206	0.759
NULL	Front_Behav_Neurosci_2013_Dec_16_7_200.nxml.txt.nlp	24379768	SENT51	18	18	20	20	l-tyrosine	TYR	PA451822	7299	0.759
NULL	Biosci_Rep_2014_Dec_12_34(6)_e00160.nxml.txt.nlp	25495645	SENT94	23	23	47	47	fenofibrate	ANGPTL3	PA449594	27329	0.759
NULL	Int_J_Mol_Sci_2014_Sep_15_15(9)_16226-16245.nxml.txt.nlp	25226533	SENT186	1	1	11	11	staurosporine	HIF-1	PA165109623	29072	0.759
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT164	40	40	12	12	l-leucine	p27	PA450197	5715;10534	0.759
NULL	Int_J_Environ_Res_Public_Health_2010_Feb_12_7(2)_565-582.nxml.txt.nlp	20616991	SENT171	6	6	15	15	zinc	STP	PA451956	9322	0.759
NULL	Aging_(Albany_NY)_2013_Jan_26_4(12)_894-898.nxml.txt.nlp	23525940	SENT43	2	2	41	41	metformin	AMPK	PA450395	5563	0.759
NULL	Cells_2012_Jul_27_1(3)_372-395.nxml.txt.nlp	24710481	SENT898	34	34	5	5	l-leucine	p27	PA450197	5715;10534	0.759
NULL	Ital_J_Pediatr_2011_Aug_22_37_39.nxml.txt.nlp	21859484	SENT53	14	14	11	11	salbutamol	BDP	PA448068	10620;152926	0.759
NULL	Mol_Cancer_2014_Apr_29_13_96.nxml.txt.nlp	24779681	SENT222	24	24	15	15	tamoxifen	EGF	PA451581	1950	0.759
NULL	Diabetes_2011_Jul_20_60(7)_1926-1937.nxml.txt.nlp	21617180	SENT196	24	24	39	39	forskolin	UCP1	PA146096022	7350	0.759
NULL	Exp_Neurol_2012_Jun_235(2)_528-538.nxml.txt.nlp	22417924	SENT269	4	4	15	15	pioglitazone	IkappaBalpha	PA450970	4792	0.759
NULL	Exp_Ther_Med_2014_Sep_20_8(3)_968-972.nxml.txt.nlp	25120631	SENT132	9	9	0	0	naringin	PF4	PA151958360	5196	0.759
NULL	Arthritis_Res_Ther_2005_Jul_13_7(5)_R1072-R1081.nxml.txt.nlp	16207324	SENT7	16	16	11	11	propylthiouracil	ATD	PA451156	465	0.759
NULL	Environ_Health_Perspect_1985_Sep_61_111-121.nxml.txt.nlp	3905370	SENT4	4	4	6	6	diethylstilbestrol	DES	PA449307	1674	0.759
NULL	Case_Rep_Gastroenterol_2014_Jun_4_8(2)_199-205.nxml.txt.nlp	25028576	SENT24	26	26	4	4	doxorubicin	CHOP	PA449412	1649	0.759
NULL	Carcinogenesis_2010_Dec_27_31(12)_2049-2057.nxml.txt.nlp	20876285	SENT305	15	15	6	6	tamoxifen	AIB1	PA451581	8202	0.759
NULL	Eur_J_Nucl_Med_Mol_Imaging_2010_Feb_24_37(2)_386-398.nxml.txt.nlp	19777175	SENT107	0	0	17	17	adalimumab	IL-8	PA10004	3576	0.759
NULL	Oncotarget_2014_Jun_11_5(21)_10407-10420.nxml.txt.nlp	25431951	SENT206	16	16	23	23	imatinib	BRAF	PA10804	673	0.759
NULL	Clin_Psychopharmacol_Neurosci_2013_Aug_26_11(2)_60-66.nxml.txt.nlp	24023549	SENT151	6	6	2	2	aripiprazole	ANOVA	PA10026	4858	0.759
NULL	Oncogene_2009_Dec_3_28(48)_4237-4248.nxml.txt.nlp	19734937	SENT135	16	16	6	6	collagenase	PAR-1	PA449107	2011;2149	0.759
NULL	Front_Cell_Neurosci_2013_Dec_18_7_250.nxml.txt.nlp	24391538	SENT1844	11	11	18	18	suramin	P2X1	PA10292	5023	0.759
NULL	Acta_Neuropathol_Commun_2014_Jul_17_2(1)_74.nxml.txt.nlp	NULL	SENT214	6	6	8	8	estradiol	p53	PA449503	7157	0.759
NULL	Oncotarget_2012_Jan_28_3(1)_22-30.nxml.txt.nlp	22289880	SENT90	1	1	20	20	rituximab	TH1	PA451261	51497	0.759
NULL	Brain_Behav_2012_Jan_2(1)_22-31.nxml.txt.nlp	22574271	SENT89	15	15	13	13	ethanol	ANOVA	PA448073	4858	0.759
NULL	BioDrugs_2013_May_7_27(5)_479-493.nxml.txt.nlp	23649937	SENT28	11	11	6	6	trypsin	HD6	PA451806	10013	0.759
NULL	Neural_Regen_Res_2014_Apr_15_9(8)_864-871.nxml.txt.nlp	25206902	SENT85	0	0	5	5	levothyroxine	spatial	PA450221	219793	0.759
NULL	Antimicrob_Agents_Chemother_2014_Aug_58(8)_4971-4973.nxml.txt.nlp	24913169	SENT33	46	46	29	29	primaquine	G6PD	PA451103	2539	0.759
NULL	Cancer_Immunol_Immunother_2012_Jul_23_61(7)_1101-1111.nxml.txt.nlp	22193989	SENT144	17	17	2	2	oxaliplatin	PD-L2	PA131285527	80380	0.759
NULL	J_Oncol_2010_Jun_22_2010_939407.nxml.txt.nlp	20652010	SENT5	4	4	9	9	heparin	CXCR2	PA449855	3579	0.759
NULL	Indian_J_Pharmacol_2014_Jan-Feb_46(1)_3-12.nxml.txt.nlp	24550577	SENT221	38	38	5	5	vismodegib	CYP2C9		1559	0.759
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_13_2012_636848.nxml.txt.nlp	23258994	SENT152	4	4	7	7	carrageenan	TRPV1	PA448814	7442	0.759
NULL	Oncotarget_2014_Aug_31_5(19)_9239-9255.nxml.txt.nlp	25238453	SENT299	11	11	7	7	cetuximab	EGFR	PA10040	1956	0.759
NULL	Behav_Neurol_2014_Nov_16_2014_360978.nxml.txt.nlp	25477708	SENT145	5	5	10	10	nicotine	P56	PA450626	8999	0.759
NULL	J_Cell_Biol_1998_Mar_23_140(6)_1519-1534.nxml.txt.nlp	9508783	SENT87	14	14	4	4	papain	Ep-CAM	PA450778	4072	0.759
NULL	Arch_Med_Sci_2011_Jun_11_7(3)_388-396.nxml.txt.nlp	22312373	SENT26	8	8	13	13	simvastatin	CYP3A	PA451363	1574	0.759
NULL	Crit_Care_2010_Jul_9_14(4)_R131.nxml.txt.nlp	20615266	SENT55	7	7	29	29	aprotinin	AVP	PA448472	114548;551	0.759
NULL	Cell_Commun_Signal_2014_Jun_15_12_37.nxml.txt.nlp	24930026	SENT417	28	28	6	6	glutaraldehyde	RACK1	PA449777	10399	0.759
NULL	Int_J_Alzheimers_Dis_2010_Dec_27_2011_231595.nxml.txt.nlp	21234401	SENT121	3	3	6	6	iron	HFE	PA450087	3077	0.759
NULL	Am_J_Cardiovasc_Drugs_2013_Jun_20_13(5)_331-342.nxml.txt.nlp	23784266	SENT195	8	8	33	33	amiodarone	P-gp	PA448383	5243	0.759
NULL	Cell_Cycle_2012_Nov_1_11(21)_3917-3918.nxml.txt.nlp	23032263	SENT8	36	36	10	10	hydroxyurea	JNK	PA449942	5599	0.759
NULL	Front_Genet_2013_Dec_20_4_302.nxml.txt.nlp	24391665	SENT48	25	25	22	22	caspofungin	CCR4	PA164743013	25819;57472;1233	0.759
NULL	Environ_Health_Perspect_2006_Sep_23_114(9)_1401-1406.nxml.txt.nlp	16966095	SENT215	5	5	2	2	arsenite	ID1	PA452638	3397	0.759
NULL	J_Mol_Signal_2009_May_14_4_3.nxml.txt.nlp	19442290	SENT153	17	17	13	13	genistein	BRCA2	PA165109660	675	0.759
NULL	Int_J_Biol_Sci_2011_Sep_8_7(8)_1077-1092.nxml.txt.nlp	21927577	SENT137	0	0	10	10	telmisartan	ANG	PA451605	283	0.759
NULL	Oncotarget_2011_May_16_2(5)_418-421.nxml.txt.nlp	21789791	SENT38	8	8	6	6	bortezomib	TRAIL	PA10252	8743	0.759
NULL	Int_J_Cell_Biol_2013_Jan_21_2013_463637.nxml.txt.nlp	23401689	SENT67	19	19	14	14	staurosporine	CD95	PA165109623	355	0.759
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jul_10_68(Pt_8)_o2422.nxml.txt.nlp	22904873	SENT64	5	5	11	11	hydroquinone	mol	PA449924	90527	0.759
NULL	Br_J_Cancer_2010_Oct_26_103(9)_1380-1390.nxml.txt.nlp	20877355	SENT305	5	5	10	10	etoposide	TRAIL	PA449552	8743	0.759
NULL	Breast_Cancer_Res_2008_Dec_18_10(Suppl_4)_S26.nxml.txt.nlp	19128440	SENT17	29	29	20	20	tamoxifen	IMPACT	PA451581	55364	0.759
NULL	Br_J_Cancer_2012_Nov_20_107(11)_1844-1852.nxml.txt.nlp	23169337	SENT320	16	16	18	18	bortezomib	Brt	PA10252	7301	0.759
NULL	Int_J_Endocrinol_2011_Aug_21_2011_742719.nxml.txt.nlp	21869886	SENT123	27	27	40	40	clopidogrel	ADP	PA449053	23038	0.759
NULL	Int_J_Biomed_Sci_2014_Dec_10(4)_229-235.nxml.txt.nlp	25598752	SENT141	4	4	32	32	tocilizumab	IL-6	PA165292659	3569	0.759
NULL	Br_J_Pharmacol_2012_Jan_165(2)_390-400.nxml.txt.nlp	21671897	SENT183	18	18	14	14	suramin	P2X2	PA10292	22953	0.759
NULL	Clin_Med_Insights_Cardiol_2010_Oct_11_4_89-93.nxml.txt.nlp	20981132	SENT19	0	0	5	5	benazepril	TLR4	PA448561	7099	0.759
NULL	J_Headache_Pain_2010_Feb_10_11(1)_5-12.nxml.txt.nlp	20012125	SENT199	12	12	2	2	dihydroergotamine	5-HT1B	PA164743028	3351	0.759
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT280	24	24	7	7	bevacizumab	VEGF-A	PA130232992	7422	0.759
NULL	Acta_Pharmacol_Sin_2012_Jun_6_33(6)_798-808.nxml.txt.nlp	22669117	SENT135	8	8	3	3	heparin	HCS	PA449855	3141;54205	0.759
NULL	Acta_Pharmacol_Sin_2013_Sep_5_34(9)_1192-1200.nxml.txt.nlp	23685957	SENT145	6	6	4	4	curcumin	AP-2	PA151958596	7020	0.759
NULL	Arthritis_Res_Ther_2003_Aug_5_5(5)_214-222.nxml.txt.nlp	12932280	SENT71	0	0	8	8	alendronate	PTH	PA448082	5741	0.759
NULL	Patient_Prefer_Adherence_2013_May_7_7_391-400.nxml.txt.nlp	23687442	SENT33	21	21	39	39	aprepitant	HEC	PA164747039	10403	0.759
NULL	J_Cardiothorac_Surg_2010_Feb_24_5_8.nxml.txt.nlp	20181268	SENT43	10	10	17	17	heparin	ACT	PA449855	12;11332;9457;641455	0.759
NULL	Clin_Med_Insights_Oncol_2012_Dec_6_6_407-421.nxml.txt.nlp	23239933	SENT48	24	24	28	28	gefitinib	EGFR	PA131301952	1956	0.759
NULL	Cardiovasc_Ther_2012_Jun_19_30(3)_e146-e155.nxml.txt.nlp	21167014	SENT40	21	21	16	16	liraglutide	GLP-1	PA165958364	100125288	0.759
NULL	Child_Adolesc_Psychiatry_Ment_Health_2013_Jun_19_7_19.nxml.txt.nlp	23777626	SENT12	14	14	10	10	methylphenidate	ATX	PA450464	5168;23049	0.759
NULL	Environ_Health_Perspect_2008_Mar_26_116(3)_322-328.nxml.txt.nlp	18335098	SENT134	43	43	23	23	estradiol	PMI	PA449503	8834;5373	0.759
NULL	Mol_Cancer_2010_Apr_23_9_87.nxml.txt.nlp	20416058	SENT280	36	36	26	26	etoposide	TRAIL	PA449552	8743	0.759
NULL	Cases_J_2009_Mar_10_2_6464.nxml.txt.nlp	20181162	SENT52	30	30	26	26	ribavirin	IFN	PA451241	3439	0.759
NULL	Hum_Genomics_2013_Apr_5_7(1)_10.nxml.txt.nlp	23561625	SENT148	0	0	10	10	flavopiridol	CDK7	PA452627	1022	0.759
NULL	Curr_Neuropharmacol_2013_Dec_11(6)_652-663.nxml.txt.nlp	24396340	SENT82	1	1	8	8	paclitaxel	TRPV1	PA450761	7442	0.759
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT381	8	8	11	11	pp2	PP1		5540;5464	0.759
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S285-S290.nxml.txt.nlp	21525470	SENT54	9	9	28	28	sitagliptin	MCP-1	PA164748978	6347	0.759
NULL	J_Cell_Mol_Med_2014_Aug_6_18(8)_1519-1539.nxml.txt.nlp	25100284	SENT191	12	12	31	31	cisplatin	EGFR	PA449014	1956	0.759
NULL	Iran_J_Pharm_Res_2014_Winter_13(1)_279-282.nxml.txt.nlp	24734081	SENT94	4	4	12	12	tacrolimus	UGT1A9	PA451578	54600	0.759
NULL	Arthritis_Res_Ther_2005_Oct_18_7(6)_R1412-R1420.nxml.txt.nlp	16277694	SENT48	12	12	39	39	fluorescein	San	PA164746009	80218	0.759
NULL	Calcif_Tissue_Int_2014_Aug_21_94(2)_170-175.nxml.txt.nlp	23963633	SENT122	12	12	16	16	teriparatide	PTH	PA451620	5741	0.759
NULL	Cancer_Biol_Med_2012_Mar_9(1)_18-22.nxml.txt.nlp	23691449	SENT79	13	13	19	19	erlotinib	KRAS	PA134687924	3845	0.759
NULL	Exp_Ther_Med_2013_Jan_19_5(1)_23-27.nxml.txt.nlp	23251236	SENT136	31	31	13	13	curcumin	EGF	PA151958596	1950	0.759
NULL	Acta_Pharmacol_Sin_2013_Mar_21_34(3)_352-359.nxml.txt.nlp	23334241	SENT109	8	8	12	12	eplerenone	NOX4	PA164749044	50507	0.759
NULL	J_Korean_Med_Sci_2006_Oct_31_21(5)_883-890.nxml.txt.nlp	17043424	SENT20	41	41	32	32	terlipressin	EVL	PA164781020	51466	0.759
NULL	Cancers_(Basel)_2013_Apr_2_5(2)_320-333.nxml.txt.nlp	24216979	SENT152	13	13	20	20	doxorubicin	HIF1	PA449412	3091	0.759
NULL	Biologics_2014_May_29_8_199-205.nxml.txt.nlp	24920882	SENT114	6	6	24	24	nadh	ENOX	PA164755085	554203	0.759
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Aug_17_67(Pt_9)_o2351.nxml.txt.nlp	22058967	SENT78	15	15	24	24	ethanol	mol	PA448073	90527	0.759
NULL	Oncoimmunology_2013_Jan_1_2(1)_e22890.nxml.txt.nlp	23483066	SENT94	27	27	40	40	vemurafenib	IFN	PA165946873	3439	0.759
NULL	Cancer_Manag_Res_2012_Mar_29_4_105-111.nxml.txt.nlp	22570564	SENT117	9	9	4	4	anastrozole	aromatase	PA448432	1588	0.759
NULL	J_Basic_Clin_Pharm_2010_Mar_15_1(2)_115-118.nxml.txt.nlp	24825976	SENT0	25	25	45	45	lornoxicam	KSA	PA165958395	4072	0.759
NULL	Oncol_Lett_2013_Apr_6_5(4)_1253-1257.nxml.txt.nlp	23599774	SENT28	15	15	36	36	goserelin	CA125	PA164747674	4077;94025	0.759
NULL	Front_Oncol_2013_Sep_23_3_250.nxml.txt.nlp	24069582	SENT359	26	26	28	28	raloxifene	STAR	PA451221	6770;2984	0.759
NULL	Iran_J_Pharm_Res_2014_Summer_13(3)_919-926.nxml.txt.nlp	25276192	SENT124	3	3	16	16	doxorubicin	Bcl-2	PA449412	596	0.759
NULL	Biofactors_2014_May_6_40(3)_277-283.nxml.txt.nlp	24353111	SENT187	9	9	3	3	choline	MTHFR	PA448976	4524	0.759
NULL	F1000Res_2014_Apr_3_3_83.nxml.txt.nlp	24860645	SENT44	26	26	31	31	naltrexone	CMT1A	PA450588	1248	0.759
NULL	Indian_J_Pharmacol_2014_Nov-Dec_46(6)_627-632.nxml.txt.nlp	25538335	SENT114	6	6	9	9	metformin	Q10	PA450395	27161	0.759
NULL	Indian_J_Med_Res_2014_Apr_139(4)_572-578.nxml.txt.nlp	24927344	SENT23	13	13	1	1	warfarin	GGCX	PA451906	2677	0.759
NULL	J_Cell_Mol_Med_2014_May_14_18(5)_811-823.nxml.txt.nlp	24628949	SENT158	11	11	7	7	docetaxel	MCAK	PA449383	11004	0.759
NULL	Clin_Ophthalmol_2009_Jun_2_3_199-210.nxml.txt.nlp	19668566	SENT84	31	31	4	4	bromfenac	COX	PA448670	1351	0.759
NULL	J_Cell_Mol_Med_2014_Apr_20_18(4)_709-720.nxml.txt.nlp	24444314	SENT167	17	17	24	24	losartan	Met	PA450268	79811	0.759
NULL	Exp_Ther_Med_2013_Apr_11_5(4)_1147-1152.nxml.txt.nlp	23599738	SENT118	13	13	9	9	fentanyl	OPRM1	PA449599	4988	0.759
NULL	Nat_Med_2011_Oct_23_17(11)_1490-1497.nxml.txt.nlp	22019885	SENT199	11	11	14	14	thrombin	PAR-1	PA451674	2011;2149	0.759
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Nov_21_65(Pt_12)_o3140.nxml.txt.nlp	21578861	SENT60	31	31	23	23	ethanol	mol	PA448073	90527	0.759
NULL	Cardiovasc_Diabetol_2010_Nov_16_9_76.nxml.txt.nlp	21080957	SENT265	16	16	24	24	sitagliptin	GLP-1	PA164748978	100125288	0.759
NULL	Crit_Care_2008_Aug_29_12(4)_R112.nxml.txt.nlp	18759980	SENT235	12	12	24	24	pentobarbital	BTF	PA450859	9774	0.759
NULL	J_Adv_Pharm_Technol_Res_2011_Jan-Mar_2(1)_51-55.nxml.txt.nlp	22171293	SENT30	12	12	23	23	metformin	GIT	PA450395	5034	0.759
NULL	J_Korean_Med_Sci_2009_Jun_16_24(3)_525-528.nxml.txt.nlp	19543522	SENT14	34	34	6	6	bleomycin	CHOP	PA448645	1649	0.759
NULL	Breast_Cancer_Res_2004_Mar_26_6(3)_R252-R263.nxml.txt.nlp	15084249	SENT26	3	3	15	15	tamoxifen	FMO5	PA451581	2330	0.759
NULL	Parasit_Vectors_2008_Oct_21_1_40.nxml.txt.nlp	18937874	SENT294	17	17	7	7	metronidazole	IL-8	PA450484	3576	0.759
NULL	F1000Prime_Rep_2014_Apr_1_6_21.nxml.txt.nlp	24765526	SENT72	8	8	11	11	canakinumab	IL-6	PA165958358	3569	0.759
NULL	Sensors_(Basel)_2010_Oct_20_10(10)_9397-9406.nxml.txt.nlp	22163415	SENT69	11	11	5	5	ethanol	IPA	PA448073	3160	0.759
NULL	Br_J_Clin_Pharmacol_2011_Oct_72(4)_647-657.nxml.txt.nlp	21518389	SENT140	27	27	30	30	cangrelor	P2Y12	PA165945763	64805	0.759
NULL	Biomed_Res_Int_2013_Dec_17_2013_696317.nxml.txt.nlp	24455716	SENT111	10	10	6	6	l-arginine	NAC	PA448478	22861	0.759
NULL	Front_Oncol_2013_Aug_5_3_201.nxml.txt.nlp	23936765	SENT284	16	16	8	8	staurosporine	RSK1	PA165109623	6195	0.759
NULL	J_Cell_Mol_Med_2013_Dec_6_17(12)_1588-1597.nxml.txt.nlp	24199964	SENT229	6	6	12	12	doxycycline	APT	PA449415	653639	0.759
NULL	Iran_J_Pharm_Res_2013_Summer_12(3)_457-469.nxml.txt.nlp	24250652	SENT130	14	14	20	20	indomethacin	spatial	PA449982	219793	0.759
NULL	Eur_J_Clin_Microbiol_Infect_Dis_2012_Jul_26_31(7)_1647-1652.nxml.txt.nlp	22278291	SENT121	32	32	10	10	voriconazole	ARTEMIS	PA10233	64421	0.759
NULL	Toxins_(Basel)_2010_Mar_31_2(4)_517-551.nxml.txt.nlp	22069598	SENT108	5	5	15	15	curcumin	EGFR	PA151958596	1956	0.759
NULL	Cancer_Cell_Int_2013_Nov_8_13_111.nxml.txt.nlp	24209962	SENT92	15	15	11	11	fluvastatin	A20	PA449688	7128;28935	0.759
NULL	Biologics_2009_Sep_15_3_419-428.nxml.txt.nlp	19774209	SENT122	42	42	17	17	cetuximab	EGFR	PA10040	1956	0.759
NULL	Gut_2013_Apr_14_62(4)_540-549.nxml.txt.nlp	22798500	SENT257	23	23	12	12	cetuximab	BRAF	PA10040	673	0.759
NULL	J_Antimicrob_Chemother_2014_Jul_14_69(7)_1945-1953.nxml.txt.nlp	24633206	SENT41	0	0	25	25	tigecycline	RGM	PA164746412	56963	0.759
NULL	Cardiovasc_J_Afr_2013_Apr_24(3)_78-81.nxml.txt.nlp	23736131	SENT18	25	25	21	21	hemin	HO-2	PA449849	3163	0.759
NULL	Crit_Care_2002_Oct_14_6(6)_481-490.nxml.txt.nlp	12493069	SENT95	0	0	16	16	tyloxapol	IL-8	PA164743726	3576	0.759
NULL	Evid_Based_Complement_Alternat_Med_2013_Mar_26_2013_974313.nxml.txt.nlp	23589723	SENT166	6	6	16	16	metformin	AMPK	PA450395	5563	0.759
NULL	Diabetes_2013_Oct_17_62(10)_3362-3372.nxml.txt.nlp	23801581	SENT78	38	38	34	34	lipase	ND1	PA450239	4535;10625	0.759
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT253	1	1	6	6	perifosine	DR4	PA165291471	8797	0.759
NULL	Breast_Cancer_Res_2008_Mar_29_10(2)_R28.nxml.txt.nlp	18373870	SENT135	19	19	5	5	estradiol	HSPC111	PA449503	51491	0.759
NULL	Int_J_Gen_Med_2011_Jul_20_4_539-545.nxml.txt.nlp	21845063	SENT97	5	5	13	13	miglitol	adiponectin	PA164776726	9370	0.759
NULL	Breast_Cancer_Res_2011_Jun_27_13(3)_212.nxml.txt.nlp	21787441	SENT213	17	17	31	31	tamoxifen	aromatase	PA451581	1588	0.759
NULL	Ann_Oncol_2011_Mar_8_22(3)_503-514.nxml.txt.nlp	20616198	SENT220	20	20	29	29	exemestane	aromatase	PA449563	1588	0.759
NULL	Breast_Cancer_Res_2012_Jul_19_14(4)_R108.nxml.txt.nlp	22812534	SENT369	7	7	27	27	letrozole	PELP1	PA450196	27043	0.759
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT12	8	8	21	21	atorvastatin	CD14	PA448500	929	0.759
NULL	Mol_Cancer_2013_Sep_11_12_104.nxml.txt.nlp	24025152	SENT53	3	3	9	9	gemcitabine	EGFR	PA449748	1956	0.759
NULL	Front_Comput_Neurosci_2013_Oct_16_7_134.nxml.txt.nlp	24137127	SENT295	24	24	19	19	mefloquine	gamma	PA450348	9913	0.759
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_3_2012_856029.nxml.txt.nlp	23091559	SENT237	15	15	11	11	flutamide	EGF	PA449685	1950	0.759
NULL	J_Gen_Physiol_2004_Apr_123(4)_427-439.nxml.txt.nlp	15024039	SENT436	16	16	31	31	pp2	EGFR		1956	0.759
NULL	J_Adv_Pract_Oncol_2013_May_1_May-Jun_4(3)_176-181.nxml.txt.nlp	25031998	SENT146	36	36	24	24	tamoxifen	HER2	PA451581	2064	0.759
NULL	Leukemia_2014_Jun_17_28(6)_1216-1226.nxml.txt.nlp	24301524	SENT229	38	38	25	25	bortezomib	p65	PA10252	5970	0.759
NULL	Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.nxml.txt.nlp	24736980	SENT234	15	15	7	7	rosuvastatin	OATP1B1	PA134308647	10599	0.759
NULL	Ann_Oncol_2013_Aug_12_24(8)_1994-1999.nxml.txt.nlp	23670096	SENT92	10	10	14	14	tamoxifen	BCS	PA451581	617	0.759
NULL	Breast_Cancer_Res_2004_May_7_6(4)_R352-R365.nxml.txt.nlp	15217502	SENT260	25	25	18	18	estradiol	CYP1A2	PA449503	1544	0.759
NULL	Int_J_Surg_Oncol_2012_May_17_2012_406830.nxml.txt.nlp	22675625	SENT188	32	32	12	12	oxaliplatin	STAR	PA131285527	6770;2984	0.759
NULL	Clin_Pharmacol_2013_Dec_9_5_185-192.nxml.txt.nlp	24353446	SENT76	8	8	19	19	clopidogrel	CYP2C19	PA449053	1557	0.759
NULL	Aging_(Albany_NY)_2009_Sep_25_1(10)_845-854.nxml.txt.nlp	20157557	SENT159	15	15	18	18	doxorubicin	p53	PA449412	7157	0.759
NULL	Int_J_Mol_Sci_2014_Oct_8_15(10)_17974-17999.nxml.txt.nlp	25299695	SENT174	8	8	17	17	curcumin	HO-2	PA151958596	3163	0.759
NULL	J_Med_Life_2011_Feb_15_4(1)_11-20.nxml.txt.nlp	21505570	SENT196	0	0	26	26	celecoxib	CB1	PA448871	1268	0.759
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT690	10	10	17	17	estradiol	NF-kappaB	PA449503	4790	0.759
NULL	Cell_Res_2010_Apr_9_20(4)_458-469.nxml.txt.nlp	20142842	SENT214	14	14	9	9	doxycycline	BCL2	PA449415	596	0.759
NULL	Breast_Cancer_Res_Treat_2012_Jun_18_133(3)_937-947.nxml.txt.nlp	22094936	SENT165	23	23	7	7	tamoxifen	EZH2	PA451581	2146	0.759
NULL	Exp_Ther_Med_2014_Feb_19_7(2)_389-392.nxml.txt.nlp	24396411	SENT28	0	0	3	3	metformin	AMPK	PA450395	5563	0.759
NULL	Nat_Biotechnol_2011_Jul_17_29(8)_757-761.nxml.txt.nlp	21765402	SENT148	32	32	10	10	kanamycin	SOC	PA450137	91544	0.759
NULL	Bone_2012_Jan_50(1)_218-225.nxml.txt.nlp	22023931	SENT220	19	19	11	11	iron	FGF23	PA450087	8074	0.759
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT137	6	6	2	2	adalimumab	CD36	PA10004	948	0.759
NULL	Open_Biochem_J_2014_Jul_11_8_52-67.nxml.txt.nlp	25191528	SENT67	4	4	23	23	glutaraldehyde	eRF1	PA449777	2107	0.759
NULL	Asian-Australas_J_Anim_Sci_2014_Dec_27(12)_1783-1793.nxml.txt.nlp	25358373	SENT134	3	3	8	8	capsaicin	BAX	PA448776	581	0.759
NULL	Summit_on_Translat_Bioinforma_2009_Mar_1_2009_124-128.nxml.txt.nlp	21347183	SENT69	9	9	13	13	azathioprine	TPMT	PA448515	7172	0.758
NULL	Case_Rep_Ophthalmol_2011_Feb_25_2(1)_84-90.nxml.txt.nlp	21475606	SENT49	20	20	24	24	carvedilol	HIF-1	PA448817	29072	0.758
NULL	EMBO_Mol_Med_2012_Jun_13_4(6)_515-527.nxml.txt.nlp	22416035	SENT189	3	3	18	18	olaparib	p53		7157	0.758
NULL	Comp_Funct_Genomics_2011_May_18_2011_876064.nxml.txt.nlp	21687556	SENT22	9	9	14	14	lipase	SP-2	PA450239	100505741	0.758
NULL	Pharmaceuticals_(Basel)_2011_Jan_11_4(1)_169-186.nxml.txt.nlp	NULL	SENT208	11	11	7	7	fluconazole	CDR1	PA449653	1038	0.758
NULL	J_Cell_Biol_2005_Nov_21_171(4)_729-738.nxml.txt.nlp	16286510	SENT215	22	22	20	20	heparin	MMP7	PA449855	4316	0.758
NULL	Cancers_(Basel)_2014_Sep_30_6(4)_2035-2048.nxml.txt.nlp	25271833	SENT10	20	20	15	15	gefitinib	IL-2	PA131301952	3558	0.758
NULL	Br_J_Cancer_2012_Nov_6_107(10)_1714-1721.nxml.txt.nlp	23073173	SENT143	9	9	23	23	docetaxel	Bcl-2	PA449383	596	0.758
NULL	J_Cell_Biol_2005_Jun_20_169(6)_921-928.nxml.txt.nlp	15967813	SENT137	22	22	5	5	reserpine	BCRP1	PA451236	317687	0.758
NULL	Ital_J_Pediatr_2010_Feb_8_36_15.nxml.txt.nlp	20181122	SENT226	15	15	13	13	vigabatrin	ACTH	PA10231	5443	0.758
NULL	Nat_Commun_2013_4_2598.nxml.txt.nlp	24121673	SENT19	9	9	16	16	doxorubicin	CHOP	PA449412	1649	0.758
NULL	Braz_J_Med_Biol_Res_2013_Aug_13_46(8)_650-658.nxml.txt.nlp	23969971	SENT31	8	8	35	35	cisplatin	STAT3	PA449014	6774	0.758
NULL	Ann_Indian_Acad_Neurol_2010_Jan-Mar_13(1)_6-13.nxml.txt.nlp	20436740	SENT263	20	20	39	39	cangrelor	PAR-1	PA165945763	2011;2149	0.758
NULL	J_Cell_Biol_2004_Apr_26_165(2)_175-180.nxml.txt.nlp	15096524	SENT73	9	9	11	11	forskolin	VASP	PA146096022	7408	0.758
NULL	Oncotarget_2012_Nov_17_3(12)_1600-1614.nxml.txt.nlp	23307622	SENT50	18	18	5	5	trastuzumab	HER2	PA451743	2064	0.758
NULL	Int_J_Biol_Sci_2011_Sep_8_7(8)_1077-1092.nxml.txt.nlp	21927577	SENT135	2	2	9	9	telmisartan	ANG	PA451605	283	0.758
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_May_24_70(Pt_6)_o700-o701.nxml.txt.nlp	24940274	SENT85	4	4	10	10	piperazine	mol	PA450977	90527	0.758
NULL	Oncotarget_2010_Jun_7_1(2)_104-119.nxml.txt.nlp	21297223	SENT138	36	36	46	46	l-glutamine	CO2	PA10090	4513	0.758
NULL	Breast_Cancer_Res_2007_Feb_6_9(1)_R17.nxml.txt.nlp	17280616	SENT5	9	9	22	22	tamoxifen	aromatase	PA451581	1588	0.758
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2751-2762.nxml.txt.nlp	24169358	SENT156	0	0	3	3	fulvestrant	CDK6	PA164747170	1021	0.758
NULL	Front_Oncol_2013_Aug_12_3_206.nxml.txt.nlp	23964347	SENT185	27	27	12	12	cisplatin	BRCA1	PA449014	672	0.758
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT99	0	0	13	13	sitagliptin	HIP	PA164748978	6767;6159;64399;5068	0.758
NULL	Acta_Neuropathol_2015_Oct_17_129_81-96.nxml.txt.nlp	25322817	SENT255	3	3	7	7	capsaicin	TRPV1	PA448776	7442	0.758
NULL	Br_J_Cancer_2001_Mar_84(5)_670-673.nxml.txt.nlp	11237388	SENT5	22	22	9	9	curcumin	JNK	PA151958596	5599	0.758
NULL	Cell_Death_Differ_2010_Mar_16_17(3)_499-512.nxml.txt.nlp	19834490	SENT119	5	5	9	9	bevacizumab	VEGFR2	PA130232992	3791	0.758
NULL	Cancer_Cell_Int_2013_Feb_8_13_11.nxml.txt.nlp	23394616	SENT129	20	20	32	32	geldanamycin	Hsp90	PA152031327	3320	0.758
NULL	Indian_J_Pharmacol_2008_Oct_40(Suppl_2)_S112-S142.nxml.txt.nlp	21593965	SENT458	7	7	13	13	candesartan	spatial	PA448765	219793	0.758
NULL	Leukemia_2013_Apr_14_27(4)_803-812.nxml.txt.nlp	23238589	SENT183	5	5	17	17	imatinib	IFN	PA10804	3439	0.758
NULL	Nat_Commun_2013_Oct_25_4_2667.nxml.txt.nlp	24157709	SENT313	30	30	37	37	cisplatin	mol	PA449014	90527	0.758
NULL	J_Cell_Biol_2004_Apr_26_165(2)_175-180.nxml.txt.nlp	15096524	SENT110	0	0	3	3	forskolin	ZO-1	PA146096022	7082	0.758
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT87	0	0	14	14	metformin	p53	PA450395	7157	0.758
NULL	J_Immunol_Res_2014_Apr_28_2014_286170.nxml.txt.nlp	24868562	SENT167	3	3	13	13	docetaxel	IFN	PA449383	3439	0.758
NULL	Theranostics_2014_Aug_15_4(11)_1072-1084.nxml.txt.nlp	25250092	SENT172	26	26	23	23	trastuzumab	EGFR	PA451743	1956	0.758
NULL	ScientificWorldJournal_2013_Sep_21_2013_208309.nxml.txt.nlp	24170980	SENT167	25	25	15	15	lenalidomide	MRP8	PA162363968	6833;6279;85320	0.758
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1066.nxml.txt.nlp	24556681	SENT214	36	36	21	21	ethanol	p62	PA448073	8878;10657;23636	0.758
NULL	Cell_Death_Dis_2010_Oct_21_1(10)_e86.nxml.txt.nlp	21368859	SENT64	10	10	8	8	doxorubicin	TRAIL	PA449412	8743	0.758
NULL	J_Med_Chem_2014_Jan_23_57(2)_449-461.nxml.txt.nlp	24387105	SENT8	10	10	5	5	cyclophosphamide	ALDH3A1	PA449165	218	0.758
NULL	Breast_Cancer_Res_2010_Oct_14_12(5)_R84.nxml.txt.nlp	20946630	SENT269	15	15	19	19	choline	SLC44A1	PA448976	23446	0.758
NULL	J_Biomed_Sci_2012_Nov_21_19(1)_99.nxml.txt.nlp	23170833	SENT165	34	34	25	25	atorvastatin	CXCR4	PA448500	7852	0.758
NULL	Mol_Cancer_2010_Dec_20_9_317.nxml.txt.nlp	21172025	SENT25	21	21	9	9	tamoxifen	HER2	PA451581	2064	0.758
NULL	Pharmaceuticals_(Basel)_2012_Mar_16_5(3)_317-324.nxml.txt.nlp	24281381	SENT41	23	23	33	33	rimonabant	CB1	PA152407999	1268	0.758
NULL	Genetics_2012_Jul_191(3)_765-780.nxml.txt.nlp	22505622	SENT300	29	29	9	9	ethanol	TTI2	PA448073	80185	0.758
NULL	Front_Plant_Sci_2012_Mar_2_3_39.nxml.txt.nlp	22645583	SENT203	8	8	6	6	pp2	PP1		5540;5464	0.758
NULL	Cancer_Med_2013_Feb_3_2(1)_108-115.nxml.txt.nlp	24279005	SENT145	25	25	27	27	raloxifene	STAR	PA451221	6770;2984	0.758
NULL	Clin_Ophthalmol_2011_Jun_9_5_771-781.nxml.txt.nlp	21750610	SENT152	14	14	7	7	bevacizumab	VEGF-A	PA130232992	7422	0.758
NULL	Ann_Surg_Oncol_2010_Apr_20_17(4)_1168-1176.nxml.txt.nlp	19936839	SENT204	13	13	6	6	irinotecan	BRAF	PA450085	673	0.758
NULL	Front_Behav_Neurosci_2011_Sep_8_5_56.nxml.txt.nlp	21927600	SENT836	3	3	10	10	lithium	DARPP-32	PA450243	84152	0.758
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S349-S354.nxml.txt.nlp	21525481	SENT23	1	1	14	14	sibutramine	adiponectin	PA451344	9370	0.758
NULL	Clin_Microbiol_Infect_2014_Jun_21_20(6)_536-541.nxml.txt.nlp	24107197	SENT107	33	33	2	2	isoniazid	DST	PA450112	667	0.758
NULL	J_Headache_Pain_2010_Feb_10_11(1)_5-12.nxml.txt.nlp	20012125	SENT204	9	9	13	13	sumatriptan	c-fos	PA451566	2353	0.758
NULL	J_Thromb_Thrombolysis_2013_Jul_17_36(1)_31-41.nxml.txt.nlp	23073747	SENT207	17	17	27	27	abciximab	AIDA	PA448006	64853	0.758
NULL	Front_Mol_Neurosci_2012_Feb_24_5_22.nxml.txt.nlp	22375105	SENT68	38	38	18	18	spermine	GluA2	PA164781199	2891	0.758
NULL	Br_J_Pharmacol_2008_Nov_11_155(6)_896-905.nxml.txt.nlp	18695641	SENT190	4	4	25	25	raloxifene	CTX	PA451221	1593	0.758
NULL	Curr_Neuropharmacol_2013_Dec_11(6)_641-651.nxml.txt.nlp	24396339	SENT227	4	4	10	10	mefloquine	ANO1	PA450348	55107	0.758
NULL	Br_J_Clin_Pharmacol_2013_Aug_23_76(2)_299-315.nxml.txt.nlp	23701319	SENT186	18	18	12	12	alemtuzumab	CD4	PA164783958	920	0.758
NULL	Exp_Diabetes_Res_2012_Dec_26_2012_230624.nxml.txt.nlp	23365557	SENT167	10	10	6	6	exenatide	GLP-1	PA164749238	100125288	0.758
NULL	Cancers_(Basel)_2011_Sep_2_3(3)_3461-3495.nxml.txt.nlp	24212964	SENT144	1	1	31	31	imiquimod	NK1	PA449972	11126	0.758
NULL	Oncoimmunology_2014_May_29_3_e28925.nxml.txt.nlp	25083322	SENT82	6	6	17	17	imatinib	CD4	PA10804	920	0.758
NULL	Nat_Commun_2011_Jul_5_2_376.nxml.txt.nlp	21730957	SENT1473	20	20	29	29	zolpidem	GAD65	PA451976	2572	0.758
NULL	Oxid_Med_Cell_Longev_2013_Jun_2_2013_793525.nxml.txt.nlp	23819014	SENT133	35	35	22	22	resveratrol	AMPK		5563	0.758
NULL	Onco_Targets_Ther_2014_Sep_19_7_1631-1639.nxml.txt.nlp	25278770	SENT76	10	10	17	17	docetaxel	BRAF	PA449383	673	0.758
NULL	Case_Rep_Gastroenterol_2010_Oct_21_4(3)_465-468.nxml.txt.nlp	21103206	SENT36	8	8	6	6	rituximab	CHOP	PA451261	1649	0.758
NULL	Cardiovasc_Diabetol_2008_Dec_23_7_36.nxml.txt.nlp	19108709	SENT122	22	22	8	8	thrombin	JNK1	PA451674	5599	0.758
NULL	Age_(Dordr)_2010_Mar_12_32(1)_109-121.nxml.txt.nlp	19908165	SENT82	12	12	32	32	fluorescein	CD61	PA164746009	3690	0.758
NULL	Cancer_Cell_Int_2013_Jun_26_13_63.nxml.txt.nlp	23800022	SENT214	2	2	10	10	genistein	MCL1	PA165109660	4170	0.758
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT90	0	0	6	6	nevirapine	CYP2C9	PA450616	1559	0.758
NULL	Arthritis_Res_Ther_2010_Apr_29_12(2)_R73.nxml.txt.nlp	20429888	SENT161	4	4	34	34	bortezomib	COL1A1	PA10252	1277	0.758
NULL	Alzheimers_Res_Ther_2013_Oct_24_5(5)_50.nxml.txt.nlp	24401551	SENT220	2	2	22	22	donepezil	spatial	PA449394	219793	0.758
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jan_31_65(Pt_2)_o439.nxml.txt.nlp	21582024	SENT69	0	0	9	9	benzaldehyde	mol	PA448571	90527	0.758
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1563-1573.nxml.txt.nlp	22015557	SENT170	5	5	7	7	sunitinib	c-Myc	PA162372840	4609	0.758
NULL	Exp_Ther_Med_2013_May_8_5(5)_1491-1495.nxml.txt.nlp	23737905	SENT8	4	4	2	2	hemin	HO-1	PA449849	3162	0.758
NULL	Environ_Toxicol_Chem_2014_Oct_25_33(10)_2363-2367.nxml.txt.nlp	25043914	SENT56	15	15	2	2	galactose	ARNT	PA449725	405	0.758
NULL	Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.nxml.txt.nlp	24736980	SENT9	34	34	25	25	rosuvastatin	OATP1B1	PA134308647	10599	0.758
NULL	Cancer_Res_Treat_2014_Jan_15_46(1)_48-54.nxml.txt.nlp	24520223	SENT9	20	20	12	12	bevacizumab	KRAS	PA130232992	3845	0.758
NULL	Int_J_Endocrinol_2014_Jan_23_2014_108419.nxml.txt.nlp	24587801	SENT137	12	12	17	17	metformin	GLP-1	PA450395	100125288	0.758
NULL	BMB_Rep_2014_Jun_47(6)_330-335.nxml.txt.nlp	24286326	SENT298	9	9	6	6	etoposide	BRCA1	PA449552	672	0.758
NULL	J_Cell_Biol_1997_Nov_3_139(3)_665-673.nxml.txt.nlp	9348283	SENT73	26	26	29	29	dextran	mol	PA449261	90527	0.758
NULL	Ann_Neurosci_2014_Jul_21(3)_90-96.nxml.txt.nlp	25206072	SENT104	21	21	11	11	scopolamine	spatial	PA451308	219793	0.758
NULL	Pharmaceuticals_(Basel)_2014_Jan_9_7(1)_46-57.nxml.txt.nlp	24451403	SENT134	9	9	14	14	ritonavir	AKT	PA451260	207	0.758
NULL	J_Immunother_Cancer_2013_Nov_7_1(Suppl_1)_P175.nxml.txt.nlp	NULL	SENT9	13	13	10	10	cetuximab	HLA-A	PA10040	3105	0.758
NULL	Support_Care_Cancer_2009_Sep_10_17(9)_1187-1193.nxml.txt.nlp	19205754	SENT123	28	28	7	7	dolasetron	CYP2D6	PA449390	1565	0.758
NULL	Breast_Cancer_Res_2007_Dec_18_9(6)_216.nxml.txt.nlp	18190723	SENT192	2	2	15	15	sunitinib	VEGFR2	PA162372840	3791	0.758
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Dec_16_66(Pt_1)_o165-o166.nxml.txt.nlp	21580052	SENT75	8	8	11	11	ethanol	mol	PA448073	90527	0.758
NULL	F1000Res_2013_Oct_8_2_173.nxml.txt.nlp	24555085	SENT258	43	43	31	31	hydrocortisone	CYP3A5	PA449905	1577	0.758
NULL	Oncogene_2010_Sep_16_29(37)_5193-5203.nxml.txt.nlp	20581867	SENT80	2	2	21	21	lapatinib	PI3K	PA152241907	5290	0.758
NULL	Arch_Med_Sci_2013_Oct_31_9(5)_916-921.nxml.txt.nlp	24273579	SENT40	21	21	10	10	bleomycin	AQP1	PA448645	358	0.758
NULL	Oxid_Med_Cell_Longev_2011_Aug_4_2011_471590.nxml.txt.nlp	21904644	SENT37	9	9	21	21	probucol	CA1	PA451107	759	0.758
NULL	Cell_Biol_Int_Rep_(2010)_2012_Jun_21_19(1)_e00017.nxml.txt.nlp	23124518	SENT97	3	3	5	5	etoposide	TRAIL	PA449552	8743	0.758
NULL	Arch_Womens_Ment_Health_2014_Sep_12_17(6)_471-483.nxml.txt.nlp	25212663	SENT74	28	28	9	9	venlafaxine	NBAS	PA451866	51594	0.758
NULL	Int_J_Mol_Sci_2012_Sep_26_13(10)_12336-12348.nxml.txt.nlp	23202901	SENT62	6	6	15	15	phenol	P90	PA450913	821	0.758
NULL	Int_J_Mol_Cell_Med_2012_Summer_1(3)_145-152.nxml.txt.nlp	24551770	SENT6	15	15	4	4	memantine	mol	PA10364	90527	0.758
NULL	Mol_Cancer_2010_Mar_2_9_46.nxml.txt.nlp	20196838	SENT202	20	20	13	13	verapamil	CYP3A4	PA451868	1576	0.758
NULL	Front_Chem_2014_Mar_14_2_12.nxml.txt.nlp	24790981	SENT151	11	11	3	3	curcumin	p300	PA151958596	2033	0.758
NULL	Cancer_Causes_Control_2013_Aug_18_24(8)_1605-1614.nxml.txt.nlp	23775025	SENT55	15	15	7	7	cyclophosphamide	UBC	PA449165	7316	0.758
NULL	Cancer_Cell_Int_2014_Jun_11_14_49.nxml.txt.nlp	24991192	SENT25	5	5	23	23	berberine	AMPK	PA165860812	5563	0.758
NULL	Cell_Death_Dis_2010_Nov_18_1(11)_e102.nxml.txt.nlp	21368867	SENT283	11	11	4	4	gentamicin	CLIMP-63	PA449753	10970	0.758
NULL	Bone_Marrow_Transplant_2012_Apr_9_47(4)_581-588.nxml.txt.nlp	21552302	SENT172	17	17	28	28	sirolimus	NRM	PA451365	11270	0.758
NULL	J_Biomed_Sci_2013_Aug_2_20(1)_54.nxml.txt.nlp	23915271	SENT377	7	7	13	13	thyroglobulin	ERp57	PA164754910	2923	0.758
NULL	Indian_J_Urol_2007_Jan-Mar_23(1)_61-66.nxml.txt.nlp	19675766	SENT66	28	28	21	21	paclitaxel	Bcl-2	PA450761	596	0.758
NULL	Acta_Pharmacol_Sin_2012_Feb_3_33(2)_173-181.nxml.txt.nlp	22301857	SENT68	2	2	19	19	sibutramine	NEFA	PA451344	4925	0.758
NULL	J_Mol_Med_(Berl)_2014_May_10_92(7)_709-722.nxml.txt.nlp	24811491	SENT2	28	28	25	25	cetuximab	EGFR	PA10040	1956	0.758
NULL	Adv_Biomed_Res_2013_Jul_30_2_66.nxml.txt.nlp	24223381	SENT113	7	7	13	13	imipramine	TNF-alpha	PA449969	7124	0.758
NULL	Arch_Med_Sci_2012_Feb_29_8(1)_154-161.nxml.txt.nlp	22457689	SENT43	4	4	10	10	ranitidine	IL-4	PA451224	3565	0.758
NULL	J_Mol_Med_(Berl)_2014_May_10_92(7)_709-722.nxml.txt.nlp	24811491	SENT248	15	15	19	19	cetuximab	KRAS	PA10040	3845	0.758
NULL	Breast_Cancer_Res_2011_Jan_21_13(1)_R9.nxml.txt.nlp	21255398	SENT15	14	14	2	2	cyclophosphamide	RAD21	PA449165	5885	0.758
NULL	Hum_Mol_Genet_2014_Apr_15_23(8)_2055-2077.nxml.txt.nlp	24282027	SENT251	33	33	17	17	ethanol	GPD	PA448073	2532	0.758
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1059-1066.nxml.txt.nlp	21364577	SENT23	18	18	11	11	exemestane	aromatase	PA449563	1588	0.758
NULL	Oncotarget_2012_Oct_20_3(10)_1236-1245.nxml.txt.nlp	23100449	SENT10	17	17	3	3	doxorubicin	NGAL	PA449412	3934	0.758
NULL	J_Cancer_Prev_2014_Mar_19(1)_39-46.nxml.txt.nlp	25337571	SENT112	4	4	14	14	ethanol	p38	PA448073	10598;1432;7965	0.758
NULL	Mol_Cancer_2010_Aug_20_9_220.nxml.txt.nlp	20727180	SENT144	29	29	34	34	nicotine	p53	PA450626	7157	0.758
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT113	25	25	19	19	neratinib	HER2	PA165291472	2064	0.758
NULL	Oncotarget_2014_Aug_27_5(17)_7328-7341.nxml.txt.nlp	25193862	SENT200	28	28	19	19	erlotinib	EGFR	PA134687924	1956	0.758
NULL	Br_J_Cancer_1996_Dec_74(12)_1908-1915.nxml.txt.nlp	8980389	SENT24	17	17	15	15	melphalan	TNF-alpha	PA450354	7124	0.758
NULL	Cell_Death_Dis_2014_Feb_13_5(2)_e1055.nxml.txt.nlp	24525731	SENT124	10	10	4	4	cisplatin	XRCC1	PA449014	7515	0.758
NULL	Oncotarget_2011_Aug_30_2(8)_610-626.nxml.txt.nlp	21881167	SENT117	8	8	12	12	doxorubicin	Raf-1	PA449412	5894	0.758
NULL	Cancer_Metab_2013_Mar_18_1_11.nxml.txt.nlp	24280190	SENT313	6	6	31	31	nadh	HIF-1	PA164755085	29072	0.758
NULL	Oncogene_2014_Sep_11_33(37)_4613-4622.nxml.txt.nlp	24662828	SENT205	11	11	27	27	paraformaldehyde	HIF1	PA450790	3091	0.758
NULL	Arthritis_Res_2002_Nov_23_4(3)_157-164.nxml.txt.nlp	12010565	SENT198	5	5	25	25	collagenase	AP-1	PA449107	2353;3727;2354;3725	0.758
NULL	Mol_Cell_Proteomics_2013_Aug_14_12(8)_2313-2323.nxml.txt.nlp	23674616	SENT778	4	4	14	14	ketoconazole	CYP4F2	PA450146	8529	0.758
NULL	Oncotarget_2012_Nov_14_3(12)_1557-1565.nxml.txt.nlp	23238683	SENT87	2	2	4	4	imatinib	CD34	PA10804	947	0.758
NULL	Cancer_Res_Treat_2013_Dec_31_45(4)_251-262.nxml.txt.nlp	24453997	SENT88	20	20	23	23	pemetrexed	PI3K	PA10810	5290	0.758
NULL	Clin_Pharmacokinet_2014_Sep_17_53(11)_1045-1051.nxml.txt.nlp	25227283	SENT215	13	13	8	8	midazolam	CYP3A	PA450496	1574	0.758
NULL	Oncotarget_2012_May_19_3(5)_535-545.nxml.txt.nlp	22619121	SENT83	17	17	31	31	topotecan	MYCN	PA451729	4613	0.758
NULL	J_Inflamm_(Lond)_2008_Dec_5_5_23.nxml.txt.nlp	19061493	SENT164	16	16	7	7	hemin	HO-1	PA449849	3162	0.758
NULL	Breast_Cancer_Res_2006_Nov_27_8(6)_R66.nxml.txt.nlp	17129383	SENT6	12	12	28	28	paclitaxel	HER2	PA450761	2064	0.758
NULL	Clin_Ophthalmol_2008_Jun_2(2)_355-368.nxml.txt.nlp	19668727	SENT81	22	22	26	26	ketorolac	COX1	PA450150	4512;5742	0.758
NULL	Support_Care_Cancer_2009_Sep_10_17(9)_1187-1193.nxml.txt.nlp	19205754	SENT174	39	39	7	7	aprepitant	NK1	PA164747039	11126	0.758
NULL	Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.nxml.txt.nlp	24736980	SENT201	6	6	9	9	rosuvastatin	OATP1B1	PA134308647	10599	0.758
NULL	J_Biol_Chem_2012_Apr_27_287(18)_14644-14658.nxml.txt.nlp	22375002	SENT20	7	7	0	0	forskolin	CC2D1A	PA146096022	54862	0.758
NULL	J_Biomed_Sci_2014_Feb_3_21(1)_10.nxml.txt.nlp	24490900	SENT126	7	7	17	17	alendronate	RANKL	PA448082	8600	0.758
NULL	Int_J_Biol_Sci_2011_Sep_8_7(8)_1077-1092.nxml.txt.nlp	21927577	SENT250	2	2	9	9	telmisartan	ANG	PA451605	283	0.758
NULL	Int_J_Mol_Sci_2012_Feb_1_13(2)_1512-1523.nxml.txt.nlp	22408405	SENT145	6	6	15	15	olmesartan	LOX-1	PA164742950	4973	0.758
NULL	Breast_Cancer_Res_2009_Jul_15_11(4)_207.nxml.txt.nlp	19664181	SENT172	44	44	14	14	trastuzumab	PTEN	PA451743	5728	0.758
NULL	Gastric_Cancer_2014_Dec_8_17(4)_630-637.nxml.txt.nlp	24318670	SENT192	8	8	25	25	leucovorin	KRAS	PA450198	3845	0.758
NULL	Front_Oncol_2013_Oct_29_3_269.nxml.txt.nlp	24195060	SENT119	28	28	5	5	cisplatin	THBS1	PA449014	7057	0.758
NULL	Clin_Transl_Allergy_2013_Sep_2_3_29.nxml.txt.nlp	24004581	SENT141	29	29	22	22	omalizumab	CD40	PA164752253	958	0.758
NULL	Neural_Dev_2009_Nov_2_4_41.nxml.txt.nlp	19883499	SENT256	31	31	24	24	l-glutamine	B27	PA10090	56246	0.758
NULL	Interdiscip_Toxicol_2008_Sep_1(2)_155-159.nxml.txt.nlp	21218106	SENT146	3	3	7	7	haloperidol	CYP3A4	PA449841	1576	0.758
NULL	Allergy_Asthma_Immunol_Res_2014_Nov_19_6(6)_548-557.nxml.txt.nlp	25374755	SENT147	26	26	5	5	lovastatin	Rho	PA450272	29984	0.758
NULL	Cough_2005_Aug_4_1_2.nxml.txt.nlp	16270920	SENT96	4	4	6	6	capsaicin	TRPV1	PA448776	7442	0.758
NULL	Breast_Cancer_Res_2010_Jul_1_12(4)_R45.nxml.txt.nlp	20594311	SENT129	14	14	5	5	nelfinavir	AKT	PA450606	207	0.758
NULL	Br_J_Cancer_2012_Nov_20_107(11)_1853-1863.nxml.txt.nlp	23169338	SENT153	2	2	10	10	cisplatin	CCT4	PA449014	10575	0.758
NULL	Commun_Integr_Biol_2012_Jul_1_5(4)_312-315.nxml.txt.nlp	23060950	SENT38	12	12	23	23	heparin	FGF10	PA449855	2255	0.758
NULL	Aging_(Albany_NY)_2014_Oct_30_6(10)_788-819.nxml.txt.nlp	25411230	SENT245	7	7	0	0	levodopa	COMT	PA450213	1312	0.758
NULL	Cancer_Metab_2014_Nov_3_2(1)_20.nxml.txt.nlp	NULL	SENT208	31	31	3	3	erlotinib	PDK4	PA134687924	5166	0.758
NULL	ScientificWorldJournal_2012_Mar_12_2012_793823.nxml.txt.nlp	22500143	SENT332	29	29	36	36	lipase	adiponectin	PA450239	9370	0.758
NULL	Indian_J_Pharm_Sci_2014_Jul-Aug_76(4)_299-307.nxml.txt.nlp	25284927	SENT109	6	6	4	4	phenylbutazone	2-19	PA450932	60343	0.758
NULL	Basic_Res_Cardiol_2013_Jul_28_108(4)_366.nxml.txt.nlp	23812247	SENT250	12	12	16	16	bromocriptine	NIMP	PA448671	84816	0.758
NULL	Cancer_Inform_2010_Apr_27_9_93-103.nxml.txt.nlp	20467479	SENT199	12	12	5	5	desipramine	CYP2D6	PA449233	1565	0.758
NULL	Br_J_Cancer_1996_Oct_74(7)_1109-1113.nxml.txt.nlp	8855983	SENT21	3	3	6	6	levamisole	IL-2	PA450205	3558	0.758
NULL	Clin_Drug_Investig_2014_Nov_9_34(2)_107-115.nxml.txt.nlp	24214232	SENT253	3	3	26	26	cinacalcet	IMPACT	PA164776671	55364	0.758
NULL	Biomed_Res_Int_2013_Aug_18_2013_946206.nxml.txt.nlp	24024216	SENT236	27	27	11	11	nadh	PDH	PA164755085	54704	0.758
NULL	Stroke_Res_Treat_2009_Dec_20_2010_386389.nxml.txt.nlp	20700422	SENT72	22	22	26	26	resveratrol	NAC		22861	0.758
NULL	Clin_Exp_Otorhinolaryngol_2013_Dec_29_6(4)_237-242.nxml.txt.nlp	24353864	SENT116	0	0	9	9	doxycycline	p38	PA449415	10598;1432;7965	0.758
NULL	Parasit_Vectors_2009_Sep_25_2(Suppl_2)_S5.nxml.txt.nlp	19778466	SENT22	9	9	5	5	praziquantel	MOX	PA164764583	26002	0.758
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_P41.nxml.txt.nlp	NULL	SENT7	31	31	11	11	flucloxacillin	CD4	PA164781042	920	0.758
NULL	J_Hematol_Oncol_2008_Oct_17_1_18.nxml.txt.nlp	18928548	SENT49	3	3	1	1	sorafenib	SHARP	PA7000	23013	0.758
NULL	Ann_Oncol_2013_Aug_12_24(8)_1994-1999.nxml.txt.nlp	23670096	SENT104	6	6	12	12	tamoxifen	AIB1	PA451581	8202	0.758
NULL	Int_J_Biomed_Sci_2014_Mar_10(1)_1-7.nxml.txt.nlp	24711742	SENT24	18	18	10	10	thrombin	PAR-1	PA451674	2011;2149	0.758
NULL	Hum_Mol_Genet_2011_May_1_20(9)_1763-1775.nxml.txt.nlp	21317159	SENT441	14	14	12	12	heparin	perlecan	PA449855	3339	0.758
NULL	J_Res_Med_Sci_2011_May_16(5)_611-620.nxml.txt.nlp	22091283	SENT44	26	26	23	23	desflurane	DES	PA164749136	1674	0.758
NULL	Croat_Med_J_2012_Aug_53(4)_314-320.nxml.txt.nlp	22911523	SENT209	23	23	10	10	cetuximab	KRAS	PA10040	3845	0.758
NULL	Nat_Commun_2013_4_1911.nxml.txt.nlp	23715270	SENT296	24	24	26	26	tubocurarine	TBC	PA451811	23216	0.758
NULL	Breast_Cancer_Res_2012_Feb_14_14(1)_R30.nxml.txt.nlp	22333315	SENT21	11	11	21	21	indomethacin	CXCR3	PA449982	2833	0.758
NULL	Arthritis_Res_Ther_2006_Jul_21_8(4)_R130.nxml.txt.nlp	16859540	SENT5	15	15	40	40	atorvastatin	CD59	PA448500	966	0.758
NULL	Clin_Mol_Hepatol_2013_Mar_25_19(1)_17-25.nxml.txt.nlp	23593605	SENT67	40	40	38	38	ezetimibe	NPC1L1	PA10816	29881	0.758
NULL	Case_Rep_Gastroenterol_2009_Nov_21_3(3)_366-371.nxml.txt.nlp	21103255	SENT14	35	35	30	30	ribavirin	IFN	PA451241	3439	0.758
NULL	J_Thorac_Oncol_2014_Jun_30_9(6)_775-783.nxml.txt.nlp	24828661	SENT126	1	1	9	9	crizotinib	Met	PA165946122	79811	0.758
NULL	J_Carcinog_2011_Dec_22_10_35.nxml.txt.nlp	22279420	SENT125	13	13	8	8	tamoxifen	p53	PA451581	7157	0.758
NULL	ScientificWorldJournal_2013_Jun_24_2013_534807.nxml.txt.nlp	23864826	SENT193	20	20	34	34	fluoxetine	SNK	PA449673	10769	0.758
NULL	Br_J_Cancer_2009_Sep_15_101(6)_875-878.nxml.txt.nlp	19672259	SENT53	36	36	22	22	exemestane	aromatase	PA449563	1588	0.758
NULL	Int_J_Med_Sci_2014_Jul_29_11(10)_1015-1021.nxml.txt.nlp	25136257	SENT88	8	8	1	1	rosiglitazone	ANOVA	PA451283	4858	0.758
NULL	Oncotarget_2014_Aug_19_5(18)_8737-8749.nxml.txt.nlp	25228590	SENT171	8	8	6	6	crizotinib	MYCN	PA165946122	4613	0.758
NULL	Oncoscience_2014_Apr_30_1(4)_283-286.nxml.txt.nlp	25594020	SENT6	33	33	22	22	rituximab	BCL6	PA451261	604	0.758
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1063.nxml.txt.nlp	24556678	SENT47	7	7	19	19	thioridazine	Mcl-1	PA451666	4170	0.758
NULL	Int_J_Mol_Imaging_2011_Oct_12_2011_694179.nxml.txt.nlp	22013519	SENT121	11	11	23	23	zolmitriptan	5-HT1B	PA451975	3351	0.758
NULL	Mol_Vis_2012_Jul_18_18_1966-1972.nxml.txt.nlp	22876123	SENT107	9	9	24	24	ng-monomethyl-l-arginine	IL-5		3567	0.758
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT111	11	11	29	29	pertuzumab	EGFR		1956	0.758
NULL	Comput_Struct_Biotechnol_J_2013_Feb_22_3_e201210020.nxml.txt.nlp	24688680	SENT63	3	3	11	11	naringenin	CHS	PA151958361	1130	0.758
NULL	Cancer_Cell_Int_2005_Jul_24_5_22.nxml.txt.nlp	16042792	SENT72	16	16	37	37	vincristine	NAC	PA451879	22861	0.758
NULL	Mol_Imaging_Biol_2011_Dec_16_13(6)_1234-1240.nxml.txt.nlp	21161686	SENT214	3	3	9	9	imatinib	AKT	PA10804	207	0.758
NULL	Mol_Cell_Proteomics_2014_Jun_9_13(6)_1598-1610.nxml.txt.nlp	24719452	SENT226	33	33	30	30	galactose	BG1	PA449725	23205	0.758
NULL	ASN_Neuro_2014_Aug_26_6(4)_1759091414544472.nxml.txt.nlp	25289647	SENT294	23	23	12	12	arsenite	FUS	PA452638	2521	0.758
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jan_11_68(Pt_2)_o340-o341.nxml.txt.nlp	22346970	SENT72	18	18	12	12	ethanol	mol	PA448073	90527	0.758
NULL	Brain_Sci_2013_Jun_3_3(2)_877-907.nxml.txt.nlp	24961429	SENT1304	0	0	13	13	taurine	MELAS	PA451590	4219	0.758
NULL	Exp_Ther_Med_2014_Aug_4_8(2)_657-661.nxml.txt.nlp	25009636	SENT105	6	6	20	20	propofol	CCR2	PA451141	729230	0.758
NULL	Infect_Dis_Obstet_Gynecol_2013_Mar_7_2013_195637.nxml.txt.nlp	23533318	SENT61	27	27	8	8	isoniazid	IPT	PA450112	54802	0.758
NULL	Int_J_Endocrinol_2013_Oct_31_2013_865965.nxml.txt.nlp	24288531	SENT225	35	35	42	42	rimonabant	adiponectin	PA152407999	9370	0.758
NULL	Clin_Ophthalmol_2009_Dec_29_3_689-692.nxml.txt.nlp	20054418	SENT64	6	6	12	12	doxorubicin	CHOP	PA449412	1649	0.758
NULL	Breast_Cancer_Res_2014_May_30_16(3)_R55.nxml.txt.nlp	24886669	SENT298	21	21	15	15	carboplatin	survivin	PA448803	332	0.758
NULL	Exp_Ther_Med_2013_Mar_21_5(3)_761-766.nxml.txt.nlp	23404440	SENT64	28	28	37	37	ampicillin	CO2	PA448419	4513	0.758
NULL	Oncol_Lett_2013_May_19_5(5)_1643-1648.nxml.txt.nlp	23760877	SENT73	7	7	13	13	epirubicin	CHOP	PA449476	1649	0.758
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2675-2684.nxml.txt.nlp	24129246	SENT237	26	26	14	14	etoposide	KSR1	PA449552	8844	0.758
NULL	J_Am_Heart_Assoc_2013_Dec_19_2(6)_e000407.nxml.txt.nlp	24166492	SENT144	4	4	2	2	doxorubicin	p53	PA449412	7157	0.758
NULL	Br_J_Cancer_2011_Jul_26_105(3)_420-427.nxml.txt.nlp	21730982	SENT193	24	24	9	9	paclitaxel	EGFR	PA450761	1956	0.758
NULL	Mol_Vis_2011_Jun_9_17_1564-1576.nxml.txt.nlp	21738386	SENT169	4	4	6	6	ethambutol	EMB	PA164784021	133418	0.758
NULL	J_Gen_Intern_Med_2009_May_21_24(5)_656-664.nxml.txt.nlp	19306050	SENT445	8	8	12	12	warfarin	CYP2C9	PA451906	1559	0.758
NULL	Pain_Res_Treat_2012_Apr_23_2012_295926.nxml.txt.nlp	22577544	SENT53	5	5	22	22	trometamol	ARC	PA451802	8996;23237	0.758
NULL	Cardiovasc_Diabetol_2013_Oct_17_12_150.nxml.txt.nlp	24134550	SENT115	0	0	3	3	metformin	activin	PA450395	83729	0.758
NULL	BMB_Rep_2013_Nov_46(11)_544-549.nxml.txt.nlp	24152910	SENT101	10	10	16	16	thrombin	IL-6	PA451674	3569	0.758
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT5	0	0	20	20	methotrexate	MSH2	PA450428	4436	0.758
NULL	Indian_J_Pharmacol_2008_Oct_40(Suppl_2)_S91-S97.nxml.txt.nlp	21593983	SENT177	24	24	6	6	pioglitazone	CYP3A	PA450970	1574	0.758
NULL	Hum_Genomics_Proteomics_2010_Aug_3_2010_159761.nxml.txt.nlp	20981231	SENT365	15	15	10	10	lithium	NTRK2	PA450243	4915	0.758
NULL	Osteoporos_Int_2013_Oct_19_24(1)_23-57.nxml.txt.nlp	23079689	SENT973	24	24	26	26	raloxifene	STAR	PA451221	6770;2984	0.758
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_P51.nxml.txt.nlp	NULL	SENT12	24	24	2	2	nevirapine	HLA-B	PA450616	3106	0.758
NULL	Acta_Pharmacol_Sin_2010_Feb_5_31(2)_137-144.nxml.txt.nlp	20139896	SENT5	8	8	24	24	zileuton	ROS	PA451955	6098	0.758
NULL	J_Gen_Physiol_2012_Nov_140(5)_571-575.nxml.txt.nlp	23109718	SENT48	17	17	19	19	ivermectin	P2X4	PA450133	5025	0.758
NULL	Int_J_Appl_Basic_Med_Res_2012_Jul-Dec_2(2)_84-91.nxml.txt.nlp	23776818	SENT151	20	20	9	9	cefoxitin	OSSA	PA448856	23196	0.758
NULL	Br_J_Cancer_2010_Mar_2_102(5)_827-832.nxml.txt.nlp	20160731	SENT29	20	20	13	13	letrozole	HER2	PA450196	2064	0.758
NULL	Front_Oncol_2013_Sep_23_3_250.nxml.txt.nlp	24069582	SENT338	36	36	38	38	raloxifene	STAR	PA451221	6770;2984	0.758
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT256	3	3	9	9	resveratrol	IL-6		3569	0.758
NULL	J_Exp_Bot_2011_Oct_4_62(14)_4787-4803.nxml.txt.nlp	21821598	SENT249	4	4	1	1	mannitol	M6PR	PA450320	4074	0.758
NULL	Niger_Med_J_2013_Mar-Apr_54(2)_79-86.nxml.txt.nlp	23798791	SENT117	25	25	11	11	tamoxifen	PTEN	PA451581	5728	0.758
NULL	Curr_Neuropharmacol_2010_Sep_8(3)_243-253.nxml.txt.nlp	21358974	SENT110	11	11	9	9	capsaicin	TRPV1	PA448776	7442	0.758
NULL	Int_J_Gen_Med_2013_Jun_7_6_453-464.nxml.txt.nlp	23785241	SENT205	10	10	31	31	budesonide	GM-CSF	PA448681	1437	0.758
NULL	Clin_Exp_Otorhinolaryngol_2011_Dec_15_4(4)_177-183.nxml.txt.nlp	22232712	SENT9	8	8	11	11	doxycycline	MUC5B	PA449415	727897	0.758
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Feb_6_65(Pt_3)_o482.nxml.txt.nlp	21582151	SENT72	30	30	16	16	ethanol	mol	PA448073	90527	0.758
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT136	6	6	2	2	sulindac	survivin	PA451565	332	0.758
NULL	Oncol_Lett_2013_Feb_27_5(2)_483-488.nxml.txt.nlp	23420047	SENT203	21	21	25	25	cetuximab	KRAS	PA10040	3845	0.758
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_7-17.nxml.txt.nlp	17912633	SENT368	42	42	4	4	fulvestrant	aromatase	PA164747170	1588	0.758
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Sep_12_65(Pt_10)_o2429.nxml.txt.nlp	21577885	SENT59	23	23	12	12	phenol	mol	PA450913	90527	0.758
NULL	ACS_Chem_Biol_2010_Sep_17_5(9)_863-873.nxml.txt.nlp	20849068	SENT291	10	10	7	7	resveratrol	SIRT1		23411	0.758
NULL	Int_J_Mol_Sci_2014_Sep_19_15(9)_16698-16718.nxml.txt.nlp	25244018	SENT72	22	22	32	32	estradiol	LKB1	PA449503	6794	0.758
NULL	Orphanet_J_Rare_Dis_2014_May_21_9_78.nxml.txt.nlp	24885036	SENT153	1	1	7	7	resveratrol	AMPK		5563	0.758
NULL	J_Gen_Physiol_2009_Apr_133(4)_421-438.nxml.txt.nlp	19289574	SENT470	1	1	24	24	forskolin	SLC26A9	PA146096022	115019	0.758
NULL	Diabetologia_2009_Oct_4_52(10)_2182-2189.nxml.txt.nlp	19652946	SENT29	27	27	17	17	phenformin	AMPK	PA1000	5563	0.758
NULL	Acta_Pharmacol_Sin_2011_May_18_32(5)_591-600.nxml.txt.nlp	21499286	SENT205	6	6	20	20	bezafibrate	AMPK	PA162364313	5563	0.758
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Dec_17_3(12)_e152.nxml.txt.nlp	25518025	SENT177	16	16	9	9	oxycodone	CYP3A	PA450741	1574	0.758
NULL	Diabetes_2013_Nov_18_62(11)_3851-3862.nxml.txt.nlp	23884890	SENT212	18	18	20	20	metformin	Met	PA450395	79811	0.758
NULL	J_Gen_Physiol_1947_Jul_20_30(6)_465-473.nxml.txt.nlp	19873512	SENT0	12	12	1	1	streptokinase	Gen	PA164754919	348654	0.758
NULL	Int_J_Mol_Imaging_2011_Oct_26_2011_874585.nxml.txt.nlp	21490735	SENT184	20	20	9	9	tamoxifen	FDG	PA451581	23583	0.757
NULL	Cancer_Inform_2014_Oct_14_13(Suppl_1)_103-111.nxml.txt.nlp	25392688	SENT212	7	7	30	30	carboplatin	FADD	PA448803	8772	0.757
NULL	Hum_Genomics_Proteomics_2010_Apr_13_2010_164906.nxml.txt.nlp	20981232	SENT253	12	12	6	6	thrombin	MAPK3	PA451674	5595	0.757
NULL	Nat_Commun_2013_Apr_23_4_1758.nxml.txt.nlp	23612299	SENT68	14	14	9	9	isoproterenol	SOD1	PA450121	6647	0.757
NULL	Cancers_(Basel)_2011_Apr_1_3(2)_1844-1860.nxml.txt.nlp	24212785	SENT620	2	2	4	4	cetuximab	KRAS	PA10040	3845	0.757
NULL	Am_J_Cardiovasc_Drugs_2013_Jun_20_13(5)_331-342.nxml.txt.nlp	23784266	SENT183	17	17	6	6	amiodarone	P-gp	PA448383	5243	0.757
NULL	Oncol_Lett_2014_Mar_2_7(3)_791-796.nxml.txt.nlp	24527087	SENT97	14	14	17	17	imatinib	CD34	PA10804	947	0.757
NULL	Front_Neurosci_2012_May_30_6_77.nxml.txt.nlp	22661925	SENT245	14	14	0	0	ethanol	ANOVA	PA448073	4858	0.757
NULL	Case_Rep_Med_2012_Aug_8_2012_403932.nxml.txt.nlp	22924044	SENT29	7	7	20	20	estradiol	PRL	PA449503	5617	0.757
NULL	Springerplus_2014_Sep_9_3_510.nxml.txt.nlp	25279302	SENT105	11	11	6	6	creatine	CKM	PA164778930	1158	0.757
NULL	N_Am_J_Med_Sci_2010_Sep_2(9)_433-437.nxml.txt.nlp	22558593	SENT46	11	11	1	1	paraformaldehyde	DIF	PA450790	7124	0.757
NULL	Front_Oncol_2014_Aug_11_4_204.nxml.txt.nlp	25157335	SENT73	14	14	3	3	afatinib	EGFR	PA165981154	1956	0.757
NULL	Biomed_Res_Int_2014_Jan_29_2014_232870.nxml.txt.nlp	24592384	SENT130	13	13	4	4	tamoxifen	HEXIM1	PA451581	10614	0.757
NULL	Adv_Hematol_2012_Feb_26_2012_529572.nxml.txt.nlp	22474449	SENT92	4	4	10	10	crizotinib	ALK	PA165946122	238	0.757
NULL	Neuropsychopharmacology_2009_Jul_25_34(8)_1968-1978.nxml.txt.nlp	19322168	SENT258	45	45	35	35	clozapine	PI3K	PA449061	5290	0.757
NULL	Cancer_Manag_Res_2012_Nov_9_4_383-395.nxml.txt.nlp	23204869	SENT140	35	35	15	15	carmustine	PC-3	PA448810	692094	0.757
NULL	J_Psychopharmacol_2010_Jan_24(1)_27-38.nxml.txt.nlp	19204064	SENT235	20	20	9	9	cocaine	NK1R	PA449072	6869	0.757
NULL	Biomed_Res_Int_2014_Apr_10_2014_615363.nxml.txt.nlp	24818147	SENT104	18	18	14	14	thrombin	ADP	PA451674	23038	0.757
NULL	Br_J_Cancer_2012_Jan_17_106(2)_324-332.nxml.txt.nlp	22134507	SENT46	15	15	7	7	chloroquine	San	PA448948	80218	0.757
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Aug_27_67(Pt_9)_o2502.nxml.txt.nlp	22064274	SENT78	0	0	24	24	triprolidine	mol	PA451797	90527	0.757
NULL	J_Thromb_Thrombolysis_2010_Nov_23_30(4)_446-451.nxml.txt.nlp	20571920	SENT148	4	4	28	28	bivalirudin	ARNO	PA10032	9266	0.757
NULL	Biol_Proced_Online_2003_Feb_17_5_43-52.nxml.txt.nlp	12734557	SENT177	6	6	13	13	bupivacaine	IFNA6	PA135057240	3443	0.757
NULL	Hum_Genomics_2009_Dec_1_4(2)_91-106.nxml.txt.nlp	20038497	SENT145	11	11	4	4	tacrine	APOE	PA451576	348	0.757
NULL	JAKSTAT_2014_Jun_12_3_e29554.nxml.txt.nlp	25105067	SENT44	0	0	2	2	propofol	STAT3	PA451141	6774	0.757
NULL	Brain_Behav_2012_Mar_2(2)_155-177.nxml.txt.nlp	22574283	SENT460	15	15	5	5	vincristine	CB2	PA451879	1269	0.757
NULL	Int_J_Endocrinol_2011_Nov_17_2011_401258.nxml.txt.nlp	22164158	SENT67	10	10	22	22	tetracycline	GPR39	PA451640	2863	0.757
NULL	Int_J_Mol_Sci_2012_Sep_25_13(10)_12153-12168.nxml.txt.nlp	23202889	SENT497	7	7	24	24	leucovorin	KRAS	PA450198	3845	0.757
NULL	Clin_Pharmacokinet_2014_Sep_3_53(1)_1-16.nxml.txt.nlp	23999929	SENT269	15	15	9	9	rivaroxaban	CYP2J2	PA165958360	1573	0.757
NULL	J_Geriatr_Cardiol_2014_Jun_11(2)_151-157.nxml.txt.nlp	25009566	SENT119	0	0	13	13	cilostazol	CDP	PA164746334	1523	0.757
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_25_2013_504642.nxml.txt.nlp	23878600	SENT156	11	11	6	6	captopril	TFG	PA448780	10342	0.757
NULL	Neuroscience_2009_Jun_30_161(2-3)_572-577.nxml.txt.nlp	19327387	SENT491	28	28	3	3	capsaicin	NAPE-PLD	PA448776	222236	0.757
NULL	J_Vet_Med_Sci_2014_Oct_16_76(10)_1383-1387.nxml.txt.nlp	24931645	SENT68	5	5	2	2	sitagliptin	GLP-1	PA164748978	100125288	0.757
NULL	Diabetes_Care_2012_Feb_16_35(2)_327-333.nxml.txt.nlp	22179958	SENT109	6	6	18	18	metformin	B12	PA450395	7126;4709	0.757
NULL	Curr_Oncol_2009_Aug_16(4)_9-21.nxml.txt.nlp	19672420	SENT200	10	10	8	8	aprepitant	NK1	PA164747039	11126	0.757
NULL	Br_J_Pharmacol_2008_Oct_18_155(4)_596-605.nxml.txt.nlp	18852694	SENT149	2	2	21	21	fenofibrate	SREBP2	PA449594	6721	0.757
NULL	Cell_Oncol_(Dordr)_2012_Jun_12_35(3)_189-196.nxml.txt.nlp	22528563	SENT267	17	17	1	1	gefitinib	EGFR	PA131301952	1956	0.757
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1495-1502.nxml.txt.nlp	21989186	SENT171	15	15	31	31	panitumumab	KRAS	PA162373091	3845	0.757
NULL	Leukemia_2014_Jun_17_28(6)_1216-1226.nxml.txt.nlp	24301524	SENT191	12	12	31	31	bortezomib	HDAC1	PA10252	3065	0.757
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT49	23	23	9	9	phenacetin	CYP2A6	PA450897	1548	0.757
NULL	Acta_Neuropathol_Commun_2013_May_20_1_17.nxml.txt.nlp	24252689	SENT6	35	35	18	18	celecoxib	ICAM1	PA448871	3383	0.757
NULL	Carcinogenesis_2010_Dec_27_31(12)_2049-2057.nxml.txt.nlp	20876285	SENT8	24	24	3	3	fulvestrant	HER2	PA164747170	2064	0.757
NULL	Int_J_Mol_Sci_2014_Sep_30_15(10)_17686-17704.nxml.txt.nlp	25272226	SENT107	3	3	5	5	cetuximab	EGFR	PA10040	1956	0.757
NULL	Clin_Exp_Otorhinolaryngol_2012_Sep_27_5(3)_117-121.nxml.txt.nlp	22977707	SENT103	9	9	12	12	kanamycin	KCC2	PA450137	57468	0.757
NULL	Arthritis_Res_Ther_2009_Jul_23_11(4)_236.nxml.txt.nlp	19664185	SENT66	0	0	12	12	probenecid	GLUT9	PA451106	11182	0.757
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT168	10	10	34	34	methotrexate	MSH2	PA450428	4436	0.757
NULL	Cancers_(Basel)_2012_Mar_9_4(1)_295-306.nxml.txt.nlp	24213241	SENT99	5	5	20	20	imatinib	PDGFRB	PA10804	5159	0.757
NULL	Crit_Care_2008_Jun_25_12(3)_R84.nxml.txt.nlp	18578859	SENT97	8	8	18	18	heparin	PF4	PA449855	5196	0.757
NULL	Eur_J_Epidemiol_2011_Aug_30_26(8)_657-686.nxml.txt.nlp	21877163	SENT961	3	3	11	11	phenprocoumon	CYP2C9	PA450921	1559	0.757
NULL	Case_Rep_Hematol_2013_Oct_10_2013_840253.nxml.txt.nlp	24224107	SENT56	9	9	18	18	cyclophosphamide	CHOP	PA449165	1649	0.757
NULL	Oncotarget_2014_Sep_9_5(20)_9811-9822.nxml.txt.nlp	25238146	SENT194	6	6	16	16	trypsin	CD133	PA451806	8842	0.757
NULL	Crit_Care_2011_Mar_11_15(Suppl_1)_P251.nxml.txt.nlp	NULL	SENT20	10	10	28	28	thrombin	PAR-1	PA451674	2011;2149	0.757
NULL	Int_J_Mol_Sci_2014_Oct_29_15(11)_19700-19728.nxml.txt.nlp	25356505	SENT244	6	6	21	21	thrombin	RhoA	PA451674	387	0.757
NULL	Breast_Cancer_Res_2011_Mar_11_13(2)_R29.nxml.txt.nlp	21396094	SENT222	4	4	7	7	fulvestrant	HRG	PA164747170	3084;3273	0.757
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT13	0	0	17	17	chloroquine	BMPR-II	PA448948	659	0.757
NULL	Diagn_Pathol_2013_Feb_6_8_20.nxml.txt.nlp	23388086	SENT39	15	15	10	10	doxorubicin	CHOP	PA449412	1649	0.757
NULL	J_Inflamm_(Lond)_2005_Oct_31_2_14.nxml.txt.nlp	16259633	SENT296	5	5	12	12	staurosporine	IFN	PA165109623	3439	0.757
NULL	Case_Rep_Hematol_2014_Feb_10_2014_641483.nxml.txt.nlp	24660077	SENT77	12	12	19	19	doxorubicin	CHOP	PA449412	1649	0.757
NULL	Clin_Ophthalmol_2011_Jan_6_5_37-44.nxml.txt.nlp	21386919	SENT21	5	5	21	21	ranibizumab	VEGF-A	PA164746012	7422	0.757
NULL	Cough_2005_Oct_19_1_10.nxml.txt.nlp	16270907	SENT108	5	5	17	17	capsaicin	GOR	PA448776	254958	0.757
NULL	Arch_Med_Sci_2011_Dec_31_7(6)_977-983.nxml.txt.nlp	22328880	SENT22	23	23	9	9	heparin	PAPP-A	PA449855	5069	0.757
NULL	Cancer_Cell_Int_2012_Sep_20_12_41.nxml.txt.nlp	22995409	SENT257	12	12	14	14	bortezomib	BTZ	PA10252	22794	0.757
NULL	Int_J_Mol_Sci_2014_Oct_30_15(11)_19777-19790.nxml.txt.nlp	25361208	SENT138	21	21	11	11	temozolomide	B10	PA451609	5169	0.757
NULL	Part_Fibre_Toxicol_2011_Aug_2_8_23.nxml.txt.nlp	21810225	SENT192	9	9	22	22	iron	ROS	PA450087	6098	0.757
NULL	Clin_Pharmacol_2010_Sep_6_2_155-162.nxml.txt.nlp	22291500	SENT92	7	7	19	19	clopidogrel	DES	PA449053	1674	0.757
NULL	Bioinformation_2012_Jan_6_8(1)_13-19.nxml.txt.nlp	22359429	SENT192	9	9	7	7	curcumin	MRP1	PA151958596	4437	0.757
NULL	Chemother_Res_Pract_2011_Sep_25_2011_730360.nxml.txt.nlp	22295205	SENT213	30	30	14	14	trastuzumab	HER2	PA451743	2064	0.757
NULL	Adv_Appl_Bioinforma_Chem_2008_Oct_30_1_85-98.nxml.txt.nlp	21918608	SENT163	14	14	10	10	bortezomib	SPARC	PA10252	6678	0.757
NULL	Allergy_Asthma_Immunol_Res_2014_Nov_19_6(6)_548-557.nxml.txt.nlp	25374755	SENT171	2	2	7	7	lovastatin	MUC5AC	PA450272	4586	0.757
NULL	Curr_Heart_Fail_Rep_2012_Sep_19_9(3)_200-210.nxml.txt.nlp	22711313	SENT64	4	4	1	1	methotrexate	DHFR	PA450428	1719	0.757
NULL	Oncotarget_2011_Apr_20_2(4)_274-276.nxml.txt.nlp	21512204	SENT17	18	18	38	38	nutlin-3	p53		7157	0.757
NULL	Exp_Ther_Med_2014_Mar_24_7(3)_663-668.nxml.txt.nlp	24520264	SENT101	0	0	5	5	curcumin	IL-6	PA151958596	3569	0.757
NULL	Arthritis_Res_Ther_2007_Jun_29_9(Suppl_1)_S4.nxml.txt.nlp	17634143	SENT100	21	21	18	18	denosumab	RANKL	PA166048634	8600	0.757
NULL	Br_J_Haematol_2014_Mar_13_164(1)_811-821.nxml.txt.nlp	24328678	SENT137	0	0	6	6	lenalidomide	Aiolos	PA162363968	22806	0.757
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT219	23	23	34	34	etoposide	B7-H1	PA449552	29126	0.757
NULL	Iran_J_Neurol_2013_12(4)_166-168.nxml.txt.nlp	24250927	SENT47	12	12	17	17	mitoxantrone	BCS	PA450526	617	0.757
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT11	14	14	43	43	l-leucine	p27	PA450197	5715;10534	0.757
NULL	HPB_Surg_2009_Apr_27_2009_397375.nxml.txt.nlp	19421334	SENT124	2	2	26	26	trypsin	cadherin	PA451806	1015	0.757
NULL	Arthritis_Res_Ther_2014_Apr_30_16(2)_R90.nxml.txt.nlp	25167216	SENT294	32	32	4	4	adalimumab	STEPP	PA10004	222659	0.757
NULL	Biomed_Res_Int_2014_Jan_2_2014_526301.nxml.txt.nlp	24524079	SENT56	13	13	34	34	sevoflurane	GOX	PA451341	54363	0.757
NULL	Br_J_Cancer_1998_Nov_78(9)_1170-1174.nxml.txt.nlp	9820175	SENT13	40	40	19	19	bufuralol	CYP1A1	PA166110256	1543	0.757
NULL	Mol_Cancer_2008_Jun_5_7_50.nxml.txt.nlp	18534018	SENT66	27	27	6	6	bortezomib	p53	PA10252	7157	0.757
NULL	Br_J_Cancer_2010_Jul_13_103(2)_186-195.nxml.txt.nlp	20588277	SENT92	5	5	15	15	nutlin-3	MDM2		4193	0.757
NULL	Hum_Genomics_Proteomics_2010_Aug_3_2010_159761.nxml.txt.nlp	20981231	SENT259	13	13	35	35	lithium	FYN	PA450243	2534	0.757
NULL	Evid_Based_Complement_Alternat_Med_2011_Feb_24_2011_348686.nxml.txt.nlp	21423692	SENT5	17	17	7	7	candesartan	HIF-1	PA448765	29072	0.757
NULL	Br_J_Cancer_2009_Oct_6_101(7)_1162-1167.nxml.txt.nlp	19724276	SENT45	37	37	32	32	axitinib	Gem	PA164924493	51053	0.757
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT198	30	30	33	33	adalimumab	DPI	PA10004	1832	0.757
NULL	Hum_Genomics_2005_Jun_1_2(2)_138-143.nxml.txt.nlp	16004729	SENT99	22	22	1	1	ethanol	ALDH2	PA448073	217	0.757
NULL	Environ_Health_Perspect_1994_Oct_102(Suppl_6)_213-216.nxml.txt.nlp	7889851	SENT7	14	14	0	0	sulfamethazine	NAT2	PA451542	10;81539	0.757
NULL	Front_Oncol_2014_Sep_15_4_248.nxml.txt.nlp	25309873	SENT213	16	16	28	28	erlotinib	EGFR	PA134687924	1956	0.757
NULL	Biomed_Res_Int_2014_Jun_25_2014_764981.nxml.txt.nlp	25057499	SENT185	16	16	30	30	sorafenib	survivin	PA7000	332	0.757
NULL	Oncol_Rep_2012_Apr_30_27(4)_923-928.nxml.txt.nlp	22209766	SENT166	15	15	5	5	erlotinib	EGFR	PA134687924	1956	0.757
NULL	Clinics_(Sao_Paulo)_2010_Jun_65(6)_645-646.nxml.txt.nlp	20613942	SENT40	14	14	20	20	orlistat	CEA	PA164776864	5670;1087	0.757
NULL	Mol_Vis_2014_May_2_20_616-628.nxml.txt.nlp	24826069	SENT271	19	19	17	17	heparin	CCL2	PA449855	6347	0.757
NULL	Oncotarget_2014_Jun_19_5(15)_6540-6551.nxml.txt.nlp	25153728	SENT170	10	10	27	27	paclitaxel	CD31	PA450761	5175	0.757
NULL	Int_J_Endocrinol_2010_Feb_10_2010_625852.nxml.txt.nlp	20169119	SENT125	0	0	15	15	cinacalcet	PTH	PA164776671	5741	0.757
NULL	Cancers_(Basel)_2014_Mar_26_6(2)_708-722.nxml.txt.nlp	24675568	SENT59	19	19	1	1	cisplatin	STAT3	PA449014	6774	0.757
NULL	J_Clin_Biochem_Nutr_2009_Jan_27_44(1)_79-84.nxml.txt.nlp	19177192	SENT266	5	5	13	13	curcumin	HO-1	PA151958596	3162	0.757
NULL	J_Cell_Biol_2002_Mar_4_156(5)_905-919.nxml.txt.nlp	11864993	SENT340	10	10	17	17	phenylephrine	p44	PA450935	10561;2966	0.757
NULL	Cancer_Inform_2007_Apr_3_5_10-18.nxml.txt.nlp	19390665	SENT87	26	26	9	9	gefitinib	EGFR	PA131301952	1956	0.757
NULL	Mol_Brain_2013_Dec_16_6_56.nxml.txt.nlp	24330819	SENT284	0	0	10	10	dantrolene	c-fos	PA449208	2353	0.757
NULL	Clinics_(Sao_Paulo)_2011_Aug_66(8)_1457-1462.nxml.txt.nlp	21915500	SENT97	44	44	35	35	rosuvastatin	ALP	PA134308647	6590;10850;27295;80150;470;26033	0.757
NULL	J_Clin_Biochem_Nutr_2011_May_13_48(3)_214-221.nxml.txt.nlp	21562641	SENT220	29	29	21	21	ethanol	PC1	PA448073	5122	0.757
NULL	Front_Physiol_2011_Jun_30_2_33.nxml.txt.nlp	21747769	SENT228	0	0	9	9	berberine	KCNQ1	PA165860812	3784	0.757
NULL	Mol_Cancer_2008_Mar_26_7_27.nxml.txt.nlp	18366759	SENT160	11	11	13	13	etoposide	HIF-1	PA449552	29072	0.757
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT250	25	25	16	16	aripiprazole	PRL	PA10026	5617	0.757
NULL	Clin_Epigenetics_2010_Sep_18_1(3-4)_101-116.nxml.txt.nlp	21258631	SENT244	4	4	14	14	curcumin	ATF3	PA151958596	467	0.757
NULL	Cancer_Med_2013_Feb_3_2(1)_86-98.nxml.txt.nlp	24133631	SENT162	16	16	12	12	cisplatin	HAI	PA449014	6692;6768	0.757
NULL	J_Cell_Mol_Med_2014_Dec_7_18(12)_2536-2552.nxml.txt.nlp	25287328	SENT147	18	18	9	9	estradiol	PKD1	PA449503	5310	0.757
NULL	Eur_J_Epidemiol_2011_Aug_30_26(8)_657-686.nxml.txt.nlp	21877163	SENT959	11	11	6	6	metformin	OCT1	PA450395	5451;6580	0.757
NULL	Case_Rep_Obstet_Gynecol_2013_May_29_2013_906825.nxml.txt.nlp	23819082	SENT83	0	0	8	8	thrombin	VIII	PA451674	1351	0.757
NULL	Nat_Med_2010_Nov_24_16(11)_1299-1304.nxml.txt.nlp	20972434	SENT4	6	6	11	11	chloroquine	ASM	PA448948	6609;283120	0.757
NULL	Acta_Pharmacol_Sin_2011_Feb_4_32(2)_188-193.nxml.txt.nlp	21293471	SENT92	2	2	10	10	mannitol	MCP-1	PA450320	6347	0.757
NULL	J_Biol_Chem_2013_Apr_26_288(17)_11865-11876.nxml.txt.nlp	23449983	SENT292	4	4	15	15	vanillin	CXCR4	PA451852	7852	0.757
NULL	Acta_Orthop_2009_Feb_26_80(1)_46-50.nxml.txt.nlp	19234885	SENT5	3	3	18	18	celecoxib	TKR	PA448871	8277	0.757
NULL	J_Headache_Pain_2014_Sep_18_15(Suppl_1)_E6.nxml.txt.nlp	NULL	SENT19	10	10	7	7	bupivacaine	SPG	PA135057240	55764	0.757
NULL	Braz_J_Med_Biol_Res_2013_Dec_10_46(12)_1033-1039.nxml.txt.nlp	24345912	SENT17	28	28	16	16	ethanol	IL-6	PA448073	3569	0.757
NULL	Ann_Gen_Psychiatry_2010_Jun_24_9_27.nxml.txt.nlp	20573264	SENT135	17	17	2	2	tropisetron	ANOVA	PA161925594	4858	0.757
NULL	Exp_Neurobiol_2014_Mar_27_23(1)_65-76.nxml.txt.nlp	24737941	SENT9	12	12	18	18	etoposide	TRAP1	PA449552	9392;10131	0.757
NULL	Int_J_Nephrol_2011_Aug_9_2011_206835.nxml.txt.nlp	21860793	SENT30	38	38	23	23	trypsin	ACE2	PA451806	59272	0.757
NULL	J_Hematol_Oncol_2013_Jan_17_6_8.nxml.txt.nlp	23327547	SENT80	13	13	21	21	sulindac	p53	PA451565	7157	0.757
NULL	Front_Endocrinol_(Lausanne)_2013_Jul_16_4_89.nxml.txt.nlp	23882261	SENT124	17	17	32	32	vasopressin	FGF8	PA451858	2253	0.757
NULL	Arthritis_Res_Ther_2003_Feb_24_5(Suppl_1)_56.nxml.txt.nlp	NULL	SENT6	17	17	4	4	hyaluronan	IL-10	PA165958431	3586	0.757
NULL	Infect_Drug_Resist_2009_Apr_24_2_13-26.nxml.txt.nlp	21694884	SENT291	14	14	9	9	lamivudine	TDF	PA450163	6736	0.757
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_91-103.nxml.txt.nlp	17912639	SENT104	8	8	19	19	anastrozole	HER2	PA448432	2064	0.757
NULL	Cells_2014_Jan_27_3(1)_53-78.nxml.txt.nlp	24709902	SENT1462	8	8	13	13	trastuzumab	PTEN	PA451743	5728	0.757
NULL	J_Invest_Dermatol_2012_Nov_14_132(11)_2601-2609.nxml.txt.nlp	22696056	SENT74	0	0	16	16	guanabenz	PERK	PA164774903	9451	0.757
NULL	Hum_Genomics_2013_Apr_5_7(1)_10.nxml.txt.nlp	23561625	SENT144	16	16	14	14	flavopiridol	CDK7	PA452627	1022	0.757
NULL	Pancreas_2014_Nov_24_43(8)_1223-1231.nxml.txt.nlp	25275271	SENT218	15	15	38	38	lipase	GLP-1	PA450239	100125288	0.757
NULL	Cent_European_J_Urol_2011_Dec_9_64(4)_256-257.nxml.txt.nlp	24578906	SENT51	15	15	9	9	doxazosin	CD133	PA449407	8842	0.757
NULL	Indian_J_Pharm_Sci_2008_Jan-Feb_70(1)_85-88.nxml.txt.nlp	20390086	SENT62	30	30	18	18	benzaldehyde	mol	PA448571	90527	0.757
NULL	Diabetes_Care_2010_Feb_23_33(2)_246-251.nxml.txt.nlp	19933994	SENT200	17	17	13	13	metformin	B12	PA450395	7126;4709	0.757
NULL	Onco_Targets_Ther_2014_May_28_7_841-852.nxml.txt.nlp	24920926	SENT67	37	37	35	35	docetaxel	DELTA	PA449383	7528;5694	0.757
NULL	Cancer_Metastasis_Rev_2007_Dec_24_26(3-4)_489-502.nxml.txt.nlp	17717633	SENT262	6	6	23	23	tetracycline	MT1-MMP	PA451640	4323	0.757
NULL	Arthritis_Res_Ther_2013_Oct_28_15(5)_R168.nxml.txt.nlp	24289101	SENT30	22	22	4	4	bleomycin	IL-6	PA448645	3569	0.757
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT77	9	9	2	2	atorvastatin	AKT	PA448500	207	0.757
NULL	Arch_Med_Sci_2012_Nov_9_8(5)_899-906.nxml.txt.nlp	23185202	SENT143	13	13	23	23	pioglitazone	ADN	PA450970	1675	0.757
NULL	Arch_Drug_Inf_2011_Mar_4(1)_1-9.nxml.txt.nlp	21572514	SENT143	18	18	7	7	ciprofloxacin	P-gp	PA449009	5243	0.757
NULL	Br_J_Haematol_2008_Jan_7_140(1)_46-58.nxml.txt.nlp	17991300	SENT239	46	46	8	8	chlorpromazine	CD21	PA448964	1380	0.757
NULL	BMJ_Open_Diabetes_Res_Care_2014_Dec_3_2(1)_e000034.nxml.txt.nlp	25512873	SENT26	42	42	29	29	lipase	ANGPTL4	PA450239	51129	0.757
NULL	Mol_Cancer_2012_Jun_18_11_41.nxml.txt.nlp	22709873	SENT297	25	25	17	17	lapatinib	CCND1	PA152241907	595	0.757
NULL	Brain_Sci_2012_Oct_30_2(4)_553-572.nxml.txt.nlp	24961260	SENT160	7	7	17	17	amphetamine	spatial	PA448408	219793	0.757
NULL	Allergy_Asthma_Immunol_Res_2014_Nov_19_6(6)_548-557.nxml.txt.nlp	25374755	SENT87	5	5	10	10	lovastatin	MUC5AC	PA450272	4586	0.757
NULL	Br_J_Cancer_1995_Mar_71(3)_619-624.nxml.txt.nlp	7880748	SENT9	23	23	25	25	cisplatin	HOP	PA449014	84525;10963	0.757
NULL	J_Pain_Res_2014_Sep_11_7_547-554.nxml.txt.nlp	25246806	SENT118	8	8	25	25	capsaicin	TRPV1	PA448776	7442	0.757
NULL	Int_J_Mol_Sci_2014_Mar_5_15(3)_3952-3969.nxml.txt.nlp	24603536	SENT952	0	0	6	6	cisplatin	JNK	PA449014	5599	0.757
NULL	Gut_Liver_2013_Sep_14_7(5)_552-559.nxml.txt.nlp	24073313	SENT86	2	2	13	13	celecoxib	EGFR	PA448871	1956	0.757
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT219	7	7	14	14	atorvastatin	OPG	PA448500	690	0.757
NULL	Croat_Med_J_2012_Aug_53(4)_294-297.nxml.txt.nlp	22911518	SENT85	20	20	13	13	warfarin	VKORC1	PA451906	79001	0.757
NULL	Oncoimmunology_2013_Oct_1_2(10)_e27025.nxml.txt.nlp	24353914	SENT173	14	14	19	19	vinorelbine	CD4	PA451881	920	0.757
NULL	Diabetes_2013_Nov_18_62(11)_3909-3919.nxml.txt.nlp	23835339	SENT195	7	7	10	10	glibenclamide	SUR1	PA449782	6833	0.757
NULL	Pain_2011_Aug_152(8)_1899-1908.nxml.txt.nlp	21600693	SENT493	19	19	32	32	capsaicin	ADP	PA448776	23038	0.757
NULL	J_Korean_Med_Sci_2014_Jul_11_29(7)_965-972.nxml.txt.nlp	25045229	SENT99	3	3	17	17	metformin	B12	PA450395	7126;4709	0.757
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_May_17_70(Pt_6)_o681-o682.nxml.txt.nlp	24940261	SENT81	0	0	6	6	flunarizine	mol	PA164776636	90527	0.757
NULL	Cell_Commun_Signal_2006_Oct_18_4_7.nxml.txt.nlp	17049074	SENT391	33	33	21	21	cisplatin	EGFR	PA449014	1956	0.757
NULL	Leukemia_2014_Nov_15_28(11)_2148-2154.nxml.txt.nlp	24667943	SENT9	10	10	35	35	thrombin	C5a	PA451674	727	0.757
NULL	Cancer_Immunol_Immunother_2012_Jul_23_61(7)_1101-1111.nxml.txt.nlp	22193989	SENT10	2	2	16	16	oxaliplatin	PD-L1	PA131285527	29126	0.757
NULL	J_Immunol_Res_2014_Jul_21_2014_297073.nxml.txt.nlp	25143957	SENT232	21	21	24	24	hydrocortisone	HLA-G	PA449905	3135	0.757
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT49	26	26	9	9	paclitaxel	CYP2A6	PA450761	1548	0.757
NULL	Front_Behav_Neurosci_2014_Oct_30_8_366.nxml.txt.nlp	25400560	SENT158	18	18	3	3	ethanol	ANOVA	PA448073	4858	0.757
NULL	Mol_Pain_2013_Feb_22_9_6.nxml.txt.nlp	23433248	SENT148	9	9	18	18	capsaicin	PKM	PA448776	5315	0.757
NULL	Int_J_Hypertens_2012_Jun_26_2012_124758.nxml.txt.nlp	22792446	SENT251	6	6	0	0	vasopressin	AT1	PA451858	9197;185	0.757
NULL	Front_Hum_Neurosci_2008_May_15_2_3.nxml.txt.nlp	18958204	SENT268	3	3	12	12	atropine	CA1	PA448505	759	0.757
NULL	Subst_Abuse_Rehabil_2011_Mar_16_2_11-20.nxml.txt.nlp	24474851	SENT39	25	25	13	13	ketamine	CYP2B6	PA450144	1555	0.757
NULL	Arthritis_Res_Ther_2006_Apr_21_8(3)_R74.nxml.txt.nlp	16630358	SENT146	7	7	13	13	rituximab	San	PA451261	80218	0.757
NULL	Oncol_Lett_2013_Mar_8_5(3)_805-812.nxml.txt.nlp	23426281	SENT12	7	7	2	2	gemcitabine	survivin	PA449748	332	0.757
NULL	Front_Microbiol_2014_Nov_19_5_628.nxml.txt.nlp	25477871	SENT246	3	3	19	19	mannitol	GatA	PA450320	55278	0.757
NULL	Cell_Death_Dis_2013_Oct_3_4(10)_e828.nxml.txt.nlp	24091671	SENT90	2	2	19	19	cetuximab	CD44	PA10040	960	0.757
NULL	Indian_J_Pharmacol_2014_Mar-Apr_46(2)_147-151.nxml.txt.nlp	24741183	SENT127	6	6	11	11	ketamine	IL-6	PA450144	3569	0.757
NULL	J_Gen_Physiol_2009_Oct_134(4)_323-337.nxml.txt.nlp	19786585	SENT547	3	3	14	14	fenofibrate	ClC-1	PA449594	1180	0.757
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1150.nxml.txt.nlp	24675468	SENT103	4	4	6	6	ethanol	adiponectin	PA448073	9370	0.757
NULL	Int_J_Biol_Sci_2014_Jan_20_10(2)_171-180.nxml.txt.nlp	24520215	SENT145	2	2	9	9	cerulenin	L-FABP	PA164764551	2168	0.757
NULL	Cell_Cycle_2013_Nov_15_12(22)_3490-3499.nxml.txt.nlp	24240433	SENT27	34	34	3	3	metformin	FDG	PA450395	23583	0.757
NULL	Cancer_Cell_Int_2009_Sep_10_9_25.nxml.txt.nlp	19744341	SENT16	3	3	12	12	glucosamine	STAT3	PA164747613	6774	0.757
NULL	Biomed_Eng_Online_2007_Apr_20_6_14.nxml.txt.nlp	17448235	SENT328	22	22	18	18	nadh	ADP	PA164755085	23038	0.757
NULL	Neuropsychopharmacology_2009_Sep_3_34(10)_2227-2236.nxml.txt.nlp	19494805	SENT34	10	10	17	17	sertraline	STAR	PA451333	6770;2984	0.757
NULL	Cancer_Immunol_Immunother_2015_Oct_7_64_61-73.nxml.txt.nlp	25287778	SENT215	3	3	9	9	lenalidomide	IL-2	PA162363968	3558	0.757
NULL	Front_Immunol_2013_Mar_27_4_76.nxml.txt.nlp	23543707	SENT1015	8	8	3	3	isotretinoin	GM-CSF	PA450128	1437	0.757
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1495-1502.nxml.txt.nlp	21989186	SENT191	14	14	28	28	fluorouracil	HSI	PA128406956	57016	0.757
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT226	17	17	6	6	perifosine	NAC	PA165291471	22861	0.757
NULL	J_Oncol_2010_Jun_10_2010_652320.nxml.txt.nlp	20628530	SENT223	6	6	31	31	bevacizumab	VEGFR1	PA130232992	2321	0.757
NULL	Braz_J_Med_Biol_Res_2013_Aug_13_46(8)_650-658.nxml.txt.nlp	23969971	SENT13	29	29	23	23	oxaliplatin	survivin	PA131285527	332	0.757
NULL	ScientificWorldJournal_2012_Apr_1_2012_159456.nxml.txt.nlp	22547977	SENT19	22	22	13	13	doxycycline	OTC	PA449415	5009	0.757
NULL	Int_J_Mol_Sci_2012_Aug_16_13(8)_10257-10267.nxml.txt.nlp	22949859	SENT40	7	7	1	1	ethanol	TPC	PA448073	8030;60386	0.757
NULL	Nat_Chem_Biol_2013_Feb_2_9(2)_97-104.nxml.txt.nlp	23201900	SENT291	10	10	12	12	metformin	Met	PA450395	79811	0.757
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT162	9	9	16	16	trastuzumab	MUC1	PA451743	4582	0.757
NULL	Paediatr_Drugs_2013_Apr_20_15(2)_119-131.nxml.txt.nlp	23512128	SENT284	7	7	15	15	ilaprazole	CYP3A5	PA165947499	1577	0.757
NULL	Pain_2011_Aug_152(8)_1899-1908.nxml.txt.nlp	21600693	SENT422	13	13	11	11	capsaicin	VR1	PA448776	56664	0.757
NULL	Breast_Cancer_Res_2014_May_23_16(3)_R50.nxml.txt.nlp	24887458	SENT193	24	24	6	6	docetaxel	HER2	PA449383	2064	0.757
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1033-1038.nxml.txt.nlp	22374460	SENT137	7	7	12	12	gemcitabine	HER2	PA449748	2064	0.757
NULL	J_Biol_Chem_2013_Apr_26_288(17)_11865-11876.nxml.txt.nlp	23449983	SENT276	17	17	24	24	forskolin	CXCL12	PA146096022	6387	0.757
NULL	Eur_J_Clin_Pharmacol_2014_Oct_8_70(1)_37-45.nxml.txt.nlp	24100471	SENT15	11	11	28	28	rosuvastatin	CYP3A4	PA134308647	1576	0.757
NULL	Exp_Mol_Med_2012_Sep_30_44(9)_536-544.nxml.txt.nlp	22771771	SENT171	0	0	10	10	ns-398	p53		7157	0.757
NULL	Eur_J_Clin_Pharmacol_2014_Oct_8_70(12)_1433-1441.nxml.txt.nlp	25291992	SENT131	16	16	13	13	olanzapine	B12	PA450688	7126;4709	0.757
NULL	Cancers_(Basel)_2010_Feb_23_2(1)_88-113.nxml.txt.nlp	24281034	SENT56	1	1	13	13	docetaxel	VEGFR	PA449383	3791	0.757
NULL	Arthritis_Res_Ther_2007_Oct_9_9(5)_R104.nxml.txt.nlp	17925024	SENT172	8	8	13	13	glucosamine	G10	PA164747613	8896;221527	0.757
NULL	Exp_Hematol_Oncol_2014_Mar_11_3_7.nxml.txt.nlp	24618035	SENT147	27	27	15	15	imatinib	CXCL12	PA10804	6387	0.757
NULL	Cardiovasc_Diabetol_2013_Jan_9_12_8.nxml.txt.nlp	23298374	SENT127	17	17	4	4	lipase	GLP-1	PA450239	100125288	0.757
NULL	J_Cell_Mol_Med_2014_Sep_7_18(9)_1785-1796.nxml.txt.nlp	24909956	SENT238	20	20	13	13	cangrelor	GPR17	PA165945763	2840	0.757
NULL	Oncoimmunology_2014_Apr_25_3_e28518.nxml.txt.nlp	25071979	SENT143	6	6	9	9	oxaliplatin	HMGB1	PA131285527	3146	0.757
NULL	J_Korean_Med_Sci_2007_Apr_30_22(2)_209-212.nxml.txt.nlp	17449925	SENT87	8	8	18	18	pamidronate	PTH	PA450767	5741	0.757
NULL	J_Clin_Biochem_Nutr_2008_Jul_1_43(1)_6-12.nxml.txt.nlp	18648659	SENT25	20	20	31	31	oxygen	ROS	PA450744	6098	0.757
NULL	EMBO_J_2010_Aug_18_29(16)_2772-2787.nxml.txt.nlp	20664520	SENT42	25	25	4	4	forskolin	RXFP1	PA146096022	59350	0.757
NULL	J_Neurochem_2007_Dec_103(6)_2268-2280.nxml.txt.nlp	17908240	SENT261	5	5	18	18	picrotoxin	MARCKS	PA164777007	4082	0.757
NULL	Breast_Cancer_Res_2011_Aug_16_13(4)_312.nxml.txt.nlp	21861853	SENT22	20	20	12	12	tamoxifen	CUEDC2	PA451581	79004	0.757
NULL	Breast_Cancer_Res_2008_Jan_8_10(1)_R2.nxml.txt.nlp	18182100	SENT216	14	14	9	9	tamoxifen	HER3	PA451581	2065	0.757
NULL	J_Exp_Med_1998_Jun_1_187(11)_1885-1892.nxml.txt.nlp	9607928	SENT147	16	16	24	24	thalidomide	CD4	PA451644	920	0.757
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Oct_31_70(Pt_11)_o1214-o1215.nxml.txt.nlp	25484836	SENT93	26	26	8	8	ethanol	mol	PA448073	90527	0.757
NULL	J_Biomed_Biotechnol_2010_Mar_22_2010_702836.nxml.txt.nlp	20339474	SENT102	1	1	16	16	fluoxetine	5-HTT	PA449673	6532	0.757
NULL	Leukemia_2013_Jan_11_27(1)_32-40.nxml.txt.nlp	22781593	SENT96	2	2	13	13	ponatinib	FGFR1	PA165980594	2260	0.757
NULL	Endocrinol_Metab_(Seoul)_2014_Sep_25_29(3)_379-387.nxml.txt.nlp	25309798	SENT113	6	6	15	15	resveratrol	SIRT1		23411	0.757
NULL	Front_Psychol_2013_Oct_17_4_712.nxml.txt.nlp	24151474	SENT44	17	17	30	30	vasopressin	INA	PA451858	9118	0.757
NULL	J_Cancer_2014_Jul_4_5(7)_559-571.nxml.txt.nlp	25057307	SENT215	25	25	14	14	trastuzumab	PIK3CA	PA451743	5290	0.757
NULL	Contemp_Oncol_(Pozn)_2012_Jul_6_16(3)_197-200.nxml.txt.nlp	23788878	SENT79	17	17	11	11	paclitaxel	VEGFR	PA450761	3791	0.757
NULL	Breast_Cancer_Res_2014_May_30_16(3)_R55.nxml.txt.nlp	24886669	SENT15	24	24	4	4	doxorubicin	survivin	PA449412	332	0.757
NULL	Pharmaceutics_2011_Oct_27_3(4)_782-792.nxml.txt.nlp	24309308	SENT62	9	9	4	4	calcein	P-gp	PA132595336	5243	0.757
NULL	Br_J_Cancer_2010_Jun_29_103(1)_61-72.nxml.txt.nlp	20588279	SENT249	13	13	36	36	trastuzumab	RhoB	PA451743	388	0.756
NULL	Oxid_Med_Cell_Longev_2013_Jun_2_2013_793525.nxml.txt.nlp	23819014	SENT133	35	35	12	12	resveratrol	AMPK		5563	0.756
NULL	Exp_Brain_Res_2012_Apr_28_217(3-4)_389-395.nxml.txt.nlp	21952790	SENT44	17	17	36	36	heparin	APLP2	PA449855	334	0.756
NULL	N_Am_J_Med_Sci_2013_Nov_5(11)_666-668.nxml.txt.nlp	24404547	SENT69	37	37	30	30	hyaluronan	CD34	PA165958431	947	0.756
NULL	J_Gynecol_Oncol_2011_Mar_31_22(1)_9-17.nxml.txt.nlp	21607090	SENT92	10	10	12	12	paclitaxel	PCFT	PA450761	113235	0.756
NULL	Clinics_(Sao_Paulo)_2014_Jan_69(1)_68-74.nxml.txt.nlp	24473562	SENT89	14	14	7	7	nutlin-3	p53		7157	0.756
NULL	EJNMMI_Res_2011_Jun_20_1_7.nxml.txt.nlp	22214546	SENT34	9	9	36	36	rituximab	CHOP	PA451261	1649	0.756
NULL	Arthritis_Res_Ther_2003_Sep_3_5(6)_R317-R328.nxml.txt.nlp	14680506	SENT9	26	26	6	6	rolipram	IL-10	PA153906323	3586	0.756
NULL	Cent_European_J_Urol_2013_Aug_13_66(2)_144-149.nxml.txt.nlp	24579014	SENT60	32	32	21	21	resveratrol	p53		7157	0.756
NULL	Acta_Pharmacol_Sin_2010_Apr_8_31(4)_461-469.nxml.txt.nlp	20208553	SENT171	4	4	7	7	ethanol	adiponectin	PA448073	9370	0.756
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jan_8_67(Pt_2)_o258.nxml.txt.nlp	21522951	SENT57	5	5	32	32	benzaldehyde	mol	PA448571	90527	0.756
NULL	Br_J_Cancer_2011_Jun_7_104(12)_1848-1853.nxml.txt.nlp	21610704	SENT26	32	32	14	14	panitumumab	KRAS	PA162373091	3845	0.756
NULL	Front_Oncol_2013_Nov_18_3_282.nxml.txt.nlp	24303367	SENT245	5	5	9	9	glucose	GDNF	PA449773	2668	0.756
NULL	J_Headache_Pain_2011_Jun_25_12(3)_361-368.nxml.txt.nlp	21437714	SENT199	9	9	0	0	frovatriptan	Cad	PA164754891	124872	0.756
NULL	Ann_Oncol_2011_Mar_8_22(3)_503-514.nxml.txt.nlp	20616198	SENT220	14	14	29	29	letrozole	aromatase	PA450196	1588	0.756
NULL	Ann_Rheum_Dis_2010_Dec_27_70(5)_755-759.nxml.txt.nlp	21187298	SENT161	12	12	40	40	tocilizumab	IL-6	PA165292659	3569	0.756
NULL	Pharmaceuticals_(Basel)_2011_Mar_17_4(3)_551-566.nxml.txt.nlp	NULL	SENT584	10	10	6	6	doxorubicin	IL-8	PA449412	3576	0.756
NULL	J_Nutr_Metab_2011_Jul_28_2011_235389.nxml.txt.nlp	21811679	SENT6	35	35	12	12	rosiglitazone	CORT	PA451283	1325	0.756
NULL	Front_Neurol_2011_Dec_16_2_72.nxml.txt.nlp	22203815	SENT195	10	10	15	15	protamine	IL-17	PA10366	3605	0.756
NULL	Glia_2013_Mar_61(3)_349-360.nxml.txt.nlp	23108585	SENT138	6	6	10	10	paraformaldehyde	CD11b	PA450790	3684	0.756
NULL	J_Gen_Physiol_1967_Dec_1_50(11)_2513-2525.nxml.txt.nlp	4230916	SENT0	12	12	1	1	valinomycin	Gen	PA151917011	348654	0.756
NULL	EMBO_Mol_Med_2011_Dec_3(12)_713-725.nxml.txt.nlp	22038924	SENT249	12	12	25	25	heparin	CXCL9	PA449855	4283	0.756
NULL	Bioinformation_2012_Jan_6_8(1)_13-19.nxml.txt.nlp	22359429	SENT154	8	8	19	19	curcumin	MRP1	PA151958596	4437	0.756
NULL	Curr_Gerontol_Geriatr_Res_2010_Jun_20_2010_348174.nxml.txt.nlp	20672050	SENT125	29	29	13	13	erlotinib	EGFR	PA134687924	1956	0.756
NULL	J_Korean_Med_Sci_2005_Oct_31_20(5)_883-885.nxml.txt.nlp	16224167	SENT8	17	17	24	24	cyclophosphamide	gamma	PA449165	9913	0.756
NULL	Clin_Interv_Aging_2009_Jun_9_4_251-258.nxml.txt.nlp	19554096	SENT141	16	16	9	9	ketoconazole	CYP3A4	PA450146	1576	0.756
NULL	Ann_Surg_Treat_Res_2014_Feb_22_86(2)_68-75.nxml.txt.nlp	24761411	SENT146	12	12	9	9	oxaliplatin	survivin	PA131285527	332	0.756
NULL	Nucleic_Acids_Res_2008_Feb_20_36(3)_998-1008.nxml.txt.nlp	18096616	SENT19	23	23	0	0	heparin	PKR	PA449855	5610	0.756
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT322	11	11	5	5	nutlin-3	DR5		8795	0.756
NULL	J_Mol_Med_(Berl)_2014_May_10_92(7)_709-722.nxml.txt.nlp	24811491	SENT127	18	18	8	8	panitumumab	HER2	PA162373091	2064	0.756
NULL	Mol_Neurodegener_2011_Nov_25_6_81.nxml.txt.nlp	22118545	SENT187	5	5	10	10	dantrolene	SOC	PA449208	91544	0.756
NULL	J_Biol_Chem_2008_Oct_31_283(44)_29841-29846.nxml.txt.nlp	18765669	SENT149	5	5	22	22	suramin	P2X1	PA10292	5023	0.756
NULL	J_Hematol_Oncol_2012_Sep_18_5_57.nxml.txt.nlp	22989009	SENT89	1	1	8	8	nutlin-3	p53		7157	0.756
NULL	Biomed_Res_Int_2014_Jan_29_2014_196249.nxml.txt.nlp	24605321	SENT54	5	5	19	19	bortezomib	ORP150	PA10252	10525	0.756
NULL	Indian_J_Nephrol_2012_May-Jun_22(3)_184-188.nxml.txt.nlp	23087552	SENT102	6	6	4	4	methylprednisolone	ACR	PA450466	49	0.756
NULL	J_Med_Case_Reports_2008_May_23_2_174.nxml.txt.nlp	18500979	SENT30	15	15	10	10	sulfamethoxazole	TMP	PA451544	2012	0.756
NULL	Int_J_Med_Chem_2012_Dec_13_2012_530392.nxml.txt.nlp	25379286	SENT135	24	24	10	10	ethanol	mol	PA448073	90527	0.756
NULL	Acta_Pharmacol_Sin_2009_Sep_24_30(9)_1220-1226.nxml.txt.nlp	19701239	SENT138	15	15	13	13	cyclosporine	KCNQ4	PA449167	9132	0.756
NULL	Front_Immunol_2011_Aug_29_2_38.nxml.txt.nlp	22566828	SENT32	35	35	40	40	basiliximab	CD52	PA164747126	1043	0.756
NULL	Br_J_Cancer_2012_Jul_24_107(3)_516-526.nxml.txt.nlp	22782351	SENT108	37	37	26	26	tamoxifen	TIGAR	PA451581	57103	0.756
NULL	Acta_Pharmacol_Sin_2012_Dec_3_33(12)_1533-1541.nxml.txt.nlp	22941291	SENT86	14	14	31	31	paraformaldehyde	SP5	PA450790	389058	0.756
NULL	Oncotarget_2012_May_19_3(5)_535-545.nxml.txt.nlp	22619121	SENT116	11	11	23	23	topotecan	MYCN	PA451729	4613	0.756
NULL	Cancers_(Basel)_2013_Apr_2_5(2)_320-333.nxml.txt.nlp	24216979	SENT146	25	25	3	3	ridaforolimus	HIF1	PA165291475	3091	0.756
NULL	Crit_Care_2008_Nov_26_12(Suppl_6)_S3.nxml.txt.nlp	19105796	SENT155	32	32	38	38	thrombin	PAR1	PA451674	79581;2149	0.756
NULL	J_Gen_Physiol_2005_Jul_126(1)_1.nxml.txt.nlp	NULL	SENT1051	8	8	6	6	fluorescein	SERCA2	PA164746009	488	0.756
NULL	Oncol_Lett_2013_Mar_8_5(3)_805-812.nxml.txt.nlp	23426281	SENT11	2	2	16	16	gemcitabine	B7-H3	PA449748	80381	0.756
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2751-2762.nxml.txt.nlp	24169358	SENT181	0	0	6	6	fulvestrant	MYC	PA164747170	4609	0.756
NULL	Indian_J_Med_Res_2014_Jan_139(1)_117-124.nxml.txt.nlp	24604047	SENT135	2	2	9	9	fluvastatin	p38	PA449688	10598;1432;7965	0.756
NULL	Biochimie_2014_Jan_96(100)_106-112.nxml.txt.nlp	23827855	SENT29	21	21	29	29	lipase	desnutrin	PA450239	57104	0.756
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_127043.nxml.txt.nlp	23227093	SENT10	38	38	44	44	lovastatin	RYR	PA450272	6261	0.756
NULL	J_Oncol_2010_Mar_3_2010_242016.nxml.txt.nlp	20204128	SENT21	3	3	24	24	lipase	CEA	PA450239	5670;1087	0.756
NULL	Cell_Death_Dis_2013_Jul_11_4(7)_e719.nxml.txt.nlp	23846221	SENT56	7	7	36	36	cisplatin	TRAIL	PA449014	8743	0.756
NULL	Arthritis_Res_Ther_2013_Oct_2_15(5)_R141.nxml.txt.nlp	24286116	SENT184	6	6	22	22	tocilizumab	IL-6	PA165292659	3569	0.756
NULL	Oncoscience_2014_Oct_22_1(10)_614-623.nxml.txt.nlp	25593991	SENT109	34	34	13	13	dacarbazine	BRAF	PA449197	673	0.756
NULL	Acta_Pharmacol_Sin_2014_Jun_4_35(6)_752-757.nxml.txt.nlp	24902786	SENT93	12	12	3	3	letrozole	STL2	PA450196	1301	0.756
NULL	Cell_Death_Dis_2010_Nov_18_1(11)_e102.nxml.txt.nlp	21368867	SENT55	6	6	22	22	gentamicin	CLIMP-63	PA449753	10970	0.756
NULL	Int_J_Mol_Sci_2012_Aug_23_13(8)_10608-10629.nxml.txt.nlp	22949883	SENT923	1	1	3	3	bromocriptine	NQO1	PA448671	1728	0.756
NULL	BMB_Rep_2014_Jan_47(1)_33-38.nxml.txt.nlp	24209634	SENT84	27	27	19	19	cisplatin	CXCR4	PA449014	7852	0.756
NULL	J_Biol_Chem_2010_Aug_20_285(34)_25913-25927.nxml.txt.nlp	20452970	SENT183	6	6	16	16	indomethacin	CYR61	PA449982	3491	0.756
NULL	Cancer_Cell_Int_2013_Jan_31_13_4.nxml.txt.nlp	23368843	SENT35	33	33	19	19	phenol	TWIST1	PA450913	7291	0.756
NULL	J_Inflamm_(Lond)_2005_Nov_29_2_16.nxml.txt.nlp	16316467	SENT298	36	36	6	6	collagenase	TLR3	PA449107	7098	0.756
NULL	Iran_J_Psychiatry_Behav_Sci_2012_Spring-Summer_6(1)_72-74.nxml.txt.nlp	24644473	SENT39	7	7	19	19	risperidone	5-HT2C	PA451257	3358	0.756
NULL	Int_Clin_Psychopharmacol_2014_Jul_26_29(4)_197-205.nxml.txt.nlp	24667487	SENT180	22	22	29	29	citalopram	STAR	PA449015	6770;2984	0.756
NULL	Mol_Pain_2012_Sep_24_8_74.nxml.txt.nlp	23006894	SENT68	20	20	25	25	oxcarbazepine	TNP1	PA450732	7141	0.756
NULL	Front_Oncol_2013_Nov_15_3_281.nxml.txt.nlp	24298448	SENT85	31	31	22	22	fluorouracil	KRAS	PA128406956	3845	0.756
NULL	J_Mol_Signal_2010_May_10_5_4.nxml.txt.nlp	20459745	SENT88	9	9	4	4	cisplatin	p53	PA449014	7157	0.756
NULL	Cancers_(Basel)_2010_Feb_23_2(1)_88-113.nxml.txt.nlp	24281034	SENT248	17	17	38	38	cisplatin	p53	PA449014	7157	0.756
NULL	Nat_Methods_2011_Jun_24_8(6)_487-493.nxml.txt.nlp	21516115	SENT105	10	10	15	15	gefitinib	EGF	PA131301952	1950	0.756
NULL	Int_J_Biol_Sci_2012_May_10_8(5)_685-696.nxml.txt.nlp	22606049	SENT129	13	13	1	1	benazepril	MTHFR	PA448561	4524	0.756
NULL	Oncogene_2010_Sep_16_29(37)_5135-5145.nxml.txt.nlp	20622897	SENT10	19	19	25	25	cetuximab	EGFR	PA10040	1956	0.756
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT105	26	26	6	6	curcumin	IL-8	PA151958596	3576	0.756
NULL	Anesth_Essays_Res_2012_Jul-Dec_6(2)_140-146.nxml.txt.nlp	NULL	SENT19	15	15	8	8	lidocaine	C3a	PA450226	718	0.756
NULL	Oxid_Med_Cell_Longev_2013_Jul_9_2013_574029.nxml.txt.nlp	23936610	SENT184	6	6	33	33	resveratrol	RAGE		177	0.756
NULL	Clin_Interv_Aging_2012_Jul_12_7_235-247.nxml.txt.nlp	22866001	SENT131	34	34	27	27	alendronate	PTH	PA448082	5741	0.756
NULL	Cancer_Cell_Int_2007_Sep_10_7_14.nxml.txt.nlp	17845729	SENT212	3	3	5	5	decitabine	GADD45A	PA164749631	1647	0.756
NULL	J_Med_Chem_2014_Jan_23_57(2)_462-476.nxml.txt.nlp	24313754	SENT116	2	2	39	39	piperazine	CREBBP	PA450977	1387	0.756
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Dec_16_66(Pt_1)_o158.nxml.txt.nlp	21580047	SENT64	24	24	18	18	ethanol	mol	PA448073	90527	0.756
NULL	Arthritis_Res_2002_Sep_16_4(6)_R12.nxml.txt.nlp	12453315	SENT98	34	34	15	15	methotrexate	CRP	PA450428	1401;140913	0.756
NULL	Oncotarget_2013_Jun_3_4(6)_875-883.nxml.txt.nlp	23900261	SENT127	3	3	15	15	estradiol	ESR1	PA449503	2099	0.756
NULL	Cancers_(Basel)_2010_May_26_2(2)_1013-1026.nxml.txt.nlp	24281104	SENT25	30	30	11	11	lipase	FAAH	PA450239	79152;2166	0.756
NULL	Biosci_Rep_2012_Aug_1_32(Pt_4)_361-374.nxml.txt.nlp	22762204	SENT186	30	30	18	18	paclitaxel	TAZ	PA450761	25937;6901	0.756
NULL	Kidney_Int_Suppl_(2011)_2013_Dec_27_3(4)_392-409.nxml.txt.nlp	NULL	SENT498	5	5	17	17	cinacalcet	MASS	PA164776671	2200	0.756
NULL	J_Gen_Physiol_1947_Mar_20_30(4)_311-320.nxml.txt.nlp	19873497	SENT0	16	16	1	1	trypsin	Gen	PA451806	348654	0.756
NULL	J_Cell_Mol_Med_2014_Apr_20_18(4)_709-720.nxml.txt.nlp	24444314	SENT239	17	17	21	21	telmisartan	AMPK	PA451605	5563	0.756
NULL	Exp_Ther_Med_2015_Feb_16_9(2)_289-293.nxml.txt.nlp	25574188	SENT51	30	30	18	18	oxaliplatin	CD166	PA131285527	214	0.756
NULL	Breast_Cancer_Res_2010_Mar_5_12(2)_R16.nxml.txt.nlp	20205716	SENT234	34	34	18	18	lovastatin	MSH2	PA450272	4436	0.756
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jul_15_65(Pt_8)_o1860-o1861.nxml.txt.nlp	21583558	SENT52	12	12	7	7	benzaldehyde	mol	PA448571	90527	0.756
NULL	Clin_Ophthalmol_2011_Jun_9_5_771-781.nxml.txt.nlp	21750610	SENT112	11	11	5	5	ranibizumab	CRT	PA164746012	811	0.756
NULL	J_Korean_Med_Sci_2006_Dec_31_21(6)_1037-1040.nxml.txt.nlp	17179683	SENT71	39	39	13	13	clarithromycin	BAM	PA449028	9126	0.756
NULL	Arthritis_Res_2001_Jan_26_3(3)_168-177.nxml.txt.nlp	11299057	SENT178	15	15	5	5	collagenase	IL-17	PA449107	3605	0.756
NULL	Acta_Pharmacol_Sin_2009_Jul_3_30(7)_889-898.nxml.txt.nlp	19574994	SENT114	21	21	10	10	pp2	PI3K		5290	0.756
NULL	J_Hematol_Oncol_2013_Jul_9_6_49.nxml.txt.nlp	23837843	SENT232	16	16	26	26	cyclosporine	P-gp	PA449167	5243	0.756
NULL	Int_J_Gen_Med_2012_Sep_10_5_753-758.nxml.txt.nlp	23049268	SENT12	0	0	36	36	telmisartan	adiponectin	PA451605	9370	0.756
NULL	Oncoimmunology_2012_Oct_1_1(7)_1048-1060.nxml.txt.nlp	23170253	SENT66	21	21	13	13	trastuzumab	HER-2	PA451743	2064	0.756
NULL	J_Immunotoxicol_2013_Jan_11_10(1)_75-82.nxml.txt.nlp	22967038	SENT97	9	9	3	3	muromonab	CD4	PA164743097	920	0.756
NULL	Drugs_R_D_2014_Sep_31_14(3)_177-184.nxml.txt.nlp	25079671	SENT172	11	11	25	25	voglibose	MCP-1	PA164752433	6347	0.756
NULL	J_Biol_Chem_2009_Sep_4_284(36)_24553-24567.nxml.txt.nlp	19570982	SENT439	0	0	7	7	heparin	PF1	PA449855	57649	0.756
NULL	Drugs_2014_Jul_18_74(11)_1209-1231.nxml.txt.nlp	25034361	SENT177	26	26	2	2	warfarin	TTR	PA451906	7276	0.756
NULL	Open_AIDS_J_2008_Dec_18_2_89-93.nxml.txt.nlp	19274065	SENT88	31	31	23	23	nevirapine	CD4	PA450616	920	0.756
NULL	J_Psychopharmacol_2010_Nov_24(4_supplement)_91-118.nxml.txt.nlp	18801830	SENT621	10	10	19	19	olanzapine	ACTH	PA450688	5443	0.756
NULL	Diabetes_2011_Nov_17_60(11)_2928-2938.nxml.txt.nlp	21885868	SENT49	15	15	21	21	paraformaldehyde	p50	PA450790	958;4790	0.756
NULL	Front_Oncol_2014_Sep_15_4_244.nxml.txt.nlp	25309870	SENT162	18	18	33	33	cisplatin	EGFR	PA449014	1956	0.756
NULL	Acta_Pharmacol_Sin_2010_Jun_4_31(6)_709-717.nxml.txt.nlp	20523342	SENT39	21	21	13	13	repaglinide	IGF2BP2	PA451234	10644	0.756
NULL	Evid_Based_Complement_Alternat_Med_2013_Mar_26_2013_974313.nxml.txt.nlp	23589723	SENT20	2	2	13	13	metformin	AMPK	PA450395	5563	0.756
NULL	Ann_Dermatol_2011_Aug_6_23(3)_329-337.nxml.txt.nlp	21909203	SENT81	11	11	18	18	doxorubicin	CHOP	PA449412	1649	0.756
NULL	Oncotarget_2014_Jul_25_5(21)_10460-10472.nxml.txt.nlp	25361005	SENT155	27	27	10	10	everolimus	AKT	PA164746311	207	0.756
NULL	Diabetes_2013_Oct_17_62(10)_3305-3306.nxml.txt.nlp	NULL	SENT40	10	10	27	27	valsartan	adiponectin	PA451848	9370	0.756
NULL	Acta_Pharmacol_Sin_2013_Jul_5_34(7)_939-950.nxml.txt.nlp	23603982	SENT173	2	2	12	12	curcumin	NAC	PA151958596	22861	0.756
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Nov_24_66(Pt_12)_o3298.nxml.txt.nlp	21589577	SENT61	15	15	8	8	ethanol	mol	PA448073	90527	0.756
NULL	Oncotarget_2013_Dec_21_5(9)_2404-2417.nxml.txt.nlp	24811221	SENT150	6	6	8	8	bleomycin	BLM	PA448645	641	0.756
NULL	Mol_Brain_2014_May_15_7_37.nxml.txt.nlp	24886748	SENT125	30	30	12	12	vorinostat	TIMP1	PA164748224	7076	0.756
NULL	Acta_Pharmacol_Sin_2009_Sep_24_30(9)_1323-1329.nxml.txt.nlp	19701237	SENT129	25	25	3	3	clarithromycin	CYP3A	PA449028	1574	0.756
NULL	J_Exp_Clin_Cancer_Res_2009_Jul_3_28(1)_97.nxml.txt.nlp	19575783	SENT132	24	24	30	30	cisplatin	HER2	PA449014	2064	0.756
NULL	Best_Pract_Res_Clin_Endocrinol_Metab_2013_Dec_27(6)_745-762.nxml.txt.nlp	24275187	SENT124	31	31	38	38	lipase	NEFA	PA450239	4925	0.756
NULL	Diabetes_Care_2013_Jun_15_36(6)_1765-1771.nxml.txt.nlp	23704676	SENT142	8	8	16	16	metformin	B12	PA450395	7126;4709	0.756
NULL	Oncol_Lett_2014_Aug_19_8(2)_809-812.nxml.txt.nlp	25009658	SENT88	12	12	17	17	metformin	HO-1	PA450395	3162	0.756
NULL	Adv_Ther_2013_Nov_22_30(12)_1031-1032.nxml.txt.nlp	24263555	SENT12	19	19	3	3	sitagliptin	GLP-1	PA164748978	100125288	0.756
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1224-1233.nxml.txt.nlp	22353810	SENT164	15	15	11	11	etoposide	MRP-1	PA449552	928	0.756
NULL	Oncoimmunology_2013_Feb_1_2(2)_e23079.nxml.txt.nlp	23525192	SENT47	14	14	22	22	imatinib	IL-2	PA10804	3558	0.756
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT32	21	21	17	17	cisplatin	p53	PA449014	7157	0.756
NULL	J_Gynecol_Oncol_2013_Jul_4_24(3)_273-279.nxml.txt.nlp	23875078	SENT89	8	8	5	5	paclitaxel	COX	PA450761	1351	0.756
NULL	Curr_HIV_Res_2014_May_12(3)_174-188.nxml.txt.nlp	24862327	SENT155	11	11	2	2	hemin	HO-1	PA449849	3162	0.756
NULL	J_Immunother_Cancer_2014_Jan_27_2_2.nxml.txt.nlp	24829759	SENT69	17	17	15	15	sorafenib	IL-21	PA7000	59067;50616;27189	0.756
NULL	Int_J_Med_Sci_2013_Mar_19_10(5)_599-606.nxml.txt.nlp	23569422	SENT56	32	32	28	28	propofol	HO-1	PA451141	3162	0.756
NULL	J_Mol_Signal_2010_May_10_5_4.nxml.txt.nlp	20459745	SENT147	12	12	4	4	cisplatin	p53	PA449014	7157	0.756
NULL	Trials_2013_Nov_13_14_385.nxml.txt.nlp	24220602	SENT285	8	8	47	47	warfarin	Gen	PA451906	348654	0.756
NULL	J_Oncol_2012_Jun_19_2012_521215.nxml.txt.nlp	22778735	SENT76	20	20	30	30	cisplatin	p16	PA449014	1029	0.756
NULL	J_Cell_Biol_2003_Dec_8_163(5)_1045-1055.nxml.txt.nlp	14657236	SENT292	30	30	24	24	streptomycin	FBS	PA451512	64319;26269	0.756
NULL	Springerplus_2013_Jan_30_2_31.nxml.txt.nlp	23450269	SENT43	26	26	28	28	cefotaxime	CTX	PA448852	1593	0.756
NULL	ScientificWorldJournal_2013_Apr_24_2013_928197.nxml.txt.nlp	23737732	SENT59	4	4	10	10	enalapril	ACR	PA449456	49	0.756
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT49	23	23	16	16	phenacetin	CYP2E1	PA450897	1571	0.756
NULL	Oncotarget_2014_Nov_5_5(22)_11381-11398.nxml.txt.nlp	25359767	SENT231	11	11	13	13	gemcitabine	PIF1	PA449748	80119	0.756
NULL	Drug_Des_Devel_Ther_2014_Oct_31_8_2121-2128.nxml.txt.nlp	25382970	SENT77	7	7	11	11	curcumin	TTR	PA151958596	7276	0.756
NULL	Nat_Commun_2014_Dec_11_5_5732.nxml.txt.nlp	25501034	SENT185	33	33	21	21	capsaicin	TRPV1	PA448776	7442	0.756
NULL	Acta_Neuropathol_2015_Oct_17_129_81-96.nxml.txt.nlp	25322817	SENT195	27	27	33	33	capsaicin	Rho	PA448776	29984	0.756
NULL	Clin_Transl_Allergy_2014_Jan_15_4_3.nxml.txt.nlp	24428928	SENT161	18	18	4	4	methacholine	IL-17	PA165958382	3605	0.756
NULL	Mol_Cancer_2010_Aug_16_9_217.nxml.txt.nlp	20712901	SENT157	9	9	15	15	curcumin	STAT3	PA151958596	6774	0.756
NULL	Braz_J_Med_Biol_Res_2014_Feb_17_47(2)_101-109.nxml.txt.nlp	24519125	SENT197	0	0	13	13	forskolin	IL-6	PA146096022	3569	0.756
NULL	Eur_J_Clin_Pharmacol_2012_Sep_15_68(9)_1267-1274.nxml.txt.nlp	22418828	SENT174	17	17	10	10	pantoprazole	CYP2C19	PA450774	1557	0.756
NULL	Nat_Genet_2011_Feb_26_43(2)_153-158.nxml.txt.nlp	21186352	SENT287	4	4	1	1	geldanamycin	Hsp90	PA152031327	3320	0.756
NULL	Front_Oncol_2014_Mar_24_4_47.nxml.txt.nlp	24716189	SENT190	0	0	11	11	sorafenib	PDGFRB	PA7000	5159	0.756
NULL	Nucleic_Acids_Res_2012_Sep_26_40(17)_8499-8518.nxml.txt.nlp	22740652	SENT73	14	14	2	2	ethanol	VRK1	PA448073	7443	0.756
NULL	Mol_Cancer_2008_Sep_12_7_70.nxml.txt.nlp	18789133	SENT97	12	12	31	31	belinostat	TYMS		7298	0.756
NULL	Mol_Cancer_2009_Dec_3_8_115.nxml.txt.nlp	19958544	SENT31	12	12	5	5	nutlin-3	MDM2		4193	0.756
NULL	Exp_Diabetes_Res_2009_Jul_7_2009_910783.nxml.txt.nlp	19609456	SENT132	0	0	3	3	rosiglitazone	AMPK	PA451283	5563	0.756
NULL	J_Innate_Immun_2011_Dec_12_4(1)_69-79.nxml.txt.nlp	21997473	SENT195	13	13	27	27	heparin	ADAMTS-4	PA449855	9508	0.756
NULL	ASN_Neuro_2013_Dec_18_5(5)_e00129.nxml.txt.nlp	24215544	SENT223	0	0	3	3	pioglitazone	mitoNEET	PA450970	55847	0.756
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_7-17.nxml.txt.nlp	17912633	SENT43	14	14	8	8	aminoglutethimide	aromatase	PA448375	1588	0.756
NULL	Iran_J_Pharm_Res_2015_Winter_14(1)_27-34.nxml.txt.nlp	25561909	SENT64	9	9	7	7	rifampin	MSN	PA451250	4478	0.756
NULL	Nat_Chem_Biol_2010_Jun_9_6(6)_424-432.nxml.txt.nlp	20453863	SENT81	0	0	6	6	curcumin	SERCA2	PA151958596	488	0.756
NULL	J_Hematol_Oncol_2012_Sep_18_5_57.nxml.txt.nlp	22989009	SENT271	17	17	21	21	berberine	HDM2	PA165860812	4193	0.756
NULL	Oxid_Med_Cell_Longev_2013_Nov_14_2013_680545.nxml.txt.nlp	24349614	SENT159	21	21	25	25	oxygen	ROS	PA450744	6098	0.756
NULL	Arthritis_Res_Ther_2009_Jul_23_11(4)_236.nxml.txt.nlp	19664185	SENT69	25	25	36	36	probenecid	URAT1	PA451106	116085	0.756
NULL	Br_J_Cancer_2011_Jan_4_104(1)_91-100.nxml.txt.nlp	21139584	SENT193	6	6	10	10	geldanamycin	Hsp90	PA152031327	3320	0.756
NULL	Diabetes_2009_Dec_31_58(12)_2851-2862.nxml.txt.nlp	19720788	SENT48	6	6	36	36	forskolin	Bcl-2	PA146096022	596	0.756
NULL	J_Oncol_2013_Apr_29_2013_854121.nxml.txt.nlp	23737784	SENT120	24	24	36	36	capecitabine	PI3K	PA448771	5290	0.756
NULL	J_Biomed_Biotechnol_2003_Mar_19_2003(1)_35-47.nxml.txt.nlp	12686721	SENT188	14	14	23	23	thyroglobulin	HER2	PA164754910	2064	0.756
NULL	Diabetes_2013_May_16_62(5)_1697-1708.nxml.txt.nlp	23364453	SENT253	16	16	12	12	fasudil	GLP-1	PA165946121	100125288	0.756
NULL	Diabetes_Metab_Syndr_Obes_2009_Jul_30_2_127-134.nxml.txt.nlp	21437126	SENT58	23	23	10	10	vildagliptin	GLP-1	PA165958346	100125288	0.756
NULL	Int_J_Mol_Sci_2014_Sep_5_15(9)_15754-15765.nxml.txt.nlp	25198898	SENT491	1	1	6	6	curcumin	p38	PA151958596	10598;1432;7965	0.756
NULL	J_Carcinog_2011_Nov_30_10_28.nxml.txt.nlp	22190870	SENT103	23	23	5	5	trastuzumab	PIK3CA	PA451743	5290	0.756
NULL	Breast_Cancer_Res_2014_May_23_16(3)_R50.nxml.txt.nlp	24887458	SENT3	34	34	19	19	docetaxel	HER2	PA449383	2064	0.756
NULL	Breast_Cancer_Res_Treat_2012_Jul_5_134(2)_693-700.nxml.txt.nlp	22562123	SENT219	13	13	5	5	tamoxifen	SULT1A1	PA451581	6817	0.756
NULL	Mol_Cancer_2010_Mar_4_9_49.nxml.txt.nlp	20202195	SENT128	16	16	5	5	vorinostat	HDAC2	PA164748224	3066	0.756
NULL	Nature_2008_Oct_23_455(7216)_1076-1081.nxml.txt.nlp	18948948	SENT125	12	12	9	9	staurosporine	BIM	PA165109623	10018	0.756
NULL	Br_J_Cancer_2014_Jan_21_110(2)_510-519.nxml.txt.nlp	24327015	SENT214	15	15	28	28	cisplatin	PLK1	PA449014	5347	0.756
NULL	Indian_J_Pharm_Sci_2014_Mar-Apr_76(2)_125-131.nxml.txt.nlp	24843185	SENT7	9	9	13	13	resveratrol	S100B		6285	0.756
NULL	Indian_J_Endocrinol_Metab_2013_May-Jun_17(3)_509-513.nxml.txt.nlp	23869312	SENT145	16	16	13	13	estradiol	aromatase	PA449503	1588	0.756
NULL	J_Radiat_Res_2014_Nov_16_55(6)_1171-1177.nxml.txt.nlp	25129557	SENT44	13	13	18	18	bevacizumab	CRT	PA130232992	811	0.756
NULL	Mol_Biol_Rep_2013_May_11_40(8)_5013-5026.nxml.txt.nlp	23666059	SENT118	7	7	3	3	resveratrol	p53		7157	0.756
NULL	Br_J_Pharmacol_2012_Jan_165(2)_390-400.nxml.txt.nlp	21671897	SENT195	11	11	3	3	suramin	P2X1	PA10292	5023	0.756
NULL	Front_Hum_Neurosci_2010_Nov_2_4_187.nxml.txt.nlp	21103019	SENT666	13	13	10	10	carbachol	CA3	PA448784	761	0.756
NULL	Exp_Diabetes_Res_2011_Apr_6_2011_928523.nxml.txt.nlp	21603181	SENT155	22	22	28	28	bromocriptine	DRD3	PA448671	1814	0.756
NULL	Int_Neurourol_J_2014_Sep_24_18(3)_115-125.nxml.txt.nlp	25279238	SENT194	2	2	18	18	berberine	CA1	PA165860812	759	0.756
NULL	Neural_Plast_2007_Jan_1_2007_30585.nxml.txt.nlp	25148070	SENT3514	16	16	22	22	citalopram	PAC1	PA449015	8624;1316;117	0.756
NULL	Genome_Med_2010_Aug_11_2(8)_53.nxml.txt.nlp	20701793	SENT105	29	29	26	26	temsirolimus	PTEN	PA164746890	5728	0.756
NULL	Br_J_Cancer_2011_Nov_22_105(11)_1759-1767.nxml.txt.nlp	22045189	SENT32	26	26	30	30	cetuximab	ERCC1	PA10040	2067	0.756
NULL	J_Cell_Biol_2002_May_28_157(5)_761-770.nxml.txt.nlp	12034770	SENT10	28	28	17	17	doxycycline	TFF1	PA449415	7031	0.756
NULL	Cell_Death_Dis_2013_Jul_11_4(7)_e720.nxml.txt.nlp	23846222	SENT112	12	12	20	20	staurosporine	San	PA165109623	80218	0.756
NULL	J_Cell_Mol_Med_2014_Mar_22_18(3)_480-491.nxml.txt.nlp	24450440	SENT72	21	21	34	34	sunitinib	EDD	PA162372840	51366	0.756
NULL	Europace_2012_Dec_6_14(12)_1700-1707.nxml.txt.nlp	22772054	SENT128	16	16	41	41	heparin	Yes	PA449855	7525	0.756
NULL	Clin_Microbiol_Infect_2014_Jun_21_20(6)_536-541.nxml.txt.nlp	24107197	SENT8	15	15	30	30	isoniazid	DST	PA450112	667	0.756
NULL	Aging_(Albany_NY)_2010_Nov_9_2(12)_981-989.nxml.txt.nlp	21098885	SENT141	13	13	6	6	paraformaldehyde	CD36	PA450790	948	0.756
NULL	Cancer_Cell_Int_2008_Apr_29_8_4.nxml.txt.nlp	18442416	SENT224	2	2	9	9	chymotrypsin	Ku86	PA448994	7520	0.756
NULL	Oncotarget_2010_May_27_1(2)_89-103.nxml.txt.nlp	20671809	SENT213	2	2	13	13	perifosine	JNK	PA165291471	5599	0.756
NULL	Br_J_Haematol_2008_Jun_141(5)_659-671.nxml.txt.nlp	18410446	SENT35	27	27	5	5	cerulenin	JNK	PA164764551	5599	0.756
NULL	Front_Immunol_2012_Jun_13_3_154.nxml.txt.nlp	22707952	SENT82	23	23	10	10	dextran	NLRP3	PA449261	114548	0.756
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT252	4	4	0	0	vinblastine	MVP	PA451877	9961	0.756
NULL	J_Antimicrob_Chemother_2013_Jul_6_68(7)_1594-1600.nxml.txt.nlp	23467176	SENT59	27	27	20	20	imipenem	BSAC	PA449968	57591	0.756
NULL	Int_J_Environ_Res_Public_Health_2010_Apr_30_7(4)_1448-1466.nxml.txt.nlp	20617039	SENT25	26	26	5	5	ethanol	DRD2	PA448073	1813	0.756
NULL	Ther_Clin_Risk_Manag_2006_Sep_2(3)_281-295.nxml.txt.nlp	18360603	SENT251	14	14	28	28	raloxifene	NNT	PA451221	23530	0.756
NULL	Anticancer_Agents_Med_Chem_2012_Feb_12(2)_163-171.nxml.txt.nlp	22043994	SENT182	13	13	3	3	panitumumab	BRAF	PA162373091	673	0.756
NULL	J_Res_Med_Sci_2012_Nov_17(11)_1020-1026.nxml.txt.nlp	23833575	SENT163	12	12	17	17	estradiol	PON1	PA449503	5444	0.756
NULL	Diabetes_2013_Mar_14_62(3)_953-964.nxml.txt.nlp	23223176	SENT174	20	20	28	28	paroxetine	ROS	PA450801	6098	0.756
NULL	EMBO_Rep_2013_Jan_30_14(1)_49-56.nxml.txt.nlp	23196367	SENT193	22	22	38	38	granisetron	5-HT3R	PA449809	3359	0.756
NULL	Front_Endocrinol_(Lausanne)_2014_Feb_25_5_22.nxml.txt.nlp	24611062	SENT284	23	23	26	26	estradiol	RhoA	PA449503	387	0.756
NULL	Mol_Pain_2014_Apr_9_10_24.nxml.txt.nlp	24716552	SENT170	7	7	28	28	capsaicin	NK1R	PA448776	6869	0.756
NULL	Int_J_Mol_Sci_2014_Oct_23_15(10)_19265-19280.nxml.txt.nlp	25342321	SENT60	8	8	17	17	sc-560	MVD		4597	0.756
NULL	Neural_Regen_Res_2014_Nov_15_9(22)_2002-2007.nxml.txt.nlp	25598783	SENT20	0	0	5	5	remifentanil	p53	PA451232	7157	0.756
NULL	J_Cell_Biol_2005_Nov_7_171(3)_505-516.nxml.txt.nlp	16275754	SENT126	17	17	30	30	pp2	HRG		3084;3273	0.756
NULL	Diabetes_Metab_Syndr_Obes_2014_Jul_17_7_313-319.nxml.txt.nlp	25092992	SENT107	38	38	24	24	metformin	adiponectin	PA450395	9370	0.756
NULL	Mycorrhiza_2008_Jun_24_18(5)_227-239.nxml.txt.nlp	18437431	SENT88	23	23	15	15	ethanol	FAE	PA448073	2178	0.756
NULL	Br_J_Cancer_2003_Jun_16_88(12)_1963-1970.nxml.txt.nlp	12799644	SENT227	28	28	21	21	gemcitabine	MRP1	PA449748	4437	0.756
NULL	Aging_(Albany_NY)_2014_Jan_14_6(1)_70-81.nxml.txt.nlp	24429382	SENT83	11	11	20	20	bleomycin	WRN	PA448645	7486	0.756
NULL	Front_Pharmacol_2014_Nov_11_5_242.nxml.txt.nlp	25426073	SENT623	23	23	21	21	rosiglitazone	PPARgamma	PA451283	5468	0.756
NULL	Neural_Regen_Res_2013_May_5_8(13)_1180-1189.nxml.txt.nlp	25206412	SENT27	3	3	0	0	fasudil	Rho	PA165946121	29984	0.756
NULL	Arthritis_Res_Ther_2003_Sep_12_5(Suppl_3)_82.nxml.txt.nlp	NULL	SENT12	3	3	11	11	anakinra	IL-8	PA10799	3576	0.756
NULL	Curr_Chem_Genomics_2011_Aug_22_5_72-84.nxml.txt.nlp	21966347	SENT142	10	10	14	14	suramin	SIRT1	PA10292	23411	0.756
NULL	Antiviral_Res_2009_May_82(2)_A99-A109.nxml.txt.nlp	19176219	SENT615	7	7	18	18	saquinavir	MRP2	PA451305	100130958;57626;1244	0.756
NULL	Oncol_Lett_2014_Jul_25_8(1)_313-316.nxml.txt.nlp	24959268	SENT19	18	18	31	31	sulindac	JNK1	PA451565	5599	0.756
NULL	Front_Oncol_2014_Mar_3_4_34.nxml.txt.nlp	24624361	SENT234	5	5	34	34	bortezomib	BRCA1	PA10252	672	0.756
NULL	Indian_Dermatol_Online_J_2014_Dec_5(Suppl_2)_S140-S141.nxml.txt.nlp	25593810	SENT31	0	0	13	13	etretinate	CO2	PA449554	4513	0.756
NULL	J_Cell_Sci_2012_Jun_15_125(12)_2940-2953.nxml.txt.nlp	22366451	SENT278	16	16	9	9	imatinib	PP2	PA10804	4888	0.756
NULL	Psychiatry_Investig_2013_Dec_24_10(4)_417-420.nxml.txt.nlp	24474992	SENT64	10	10	23	23	fluvoxamine	BiP	PA449690	3309	0.756
NULL	Breast_Cancer_Res_2007_May_30_9(3)_R34.nxml.txt.nlp	17537232	SENT175	41	41	9	9	tamoxifen	MDM2	PA451581	4193	0.756
NULL	Vet_Res_2013_Jul_22_44(1)_61.nxml.txt.nlp	23876161	SENT192	16	16	18	18	etoposide	TRAIL	PA449552	8743	0.756
NULL	Acta_Pharmacol_Sin_2009_Feb_5_30(2)_228-234.nxml.txt.nlp	19122672	SENT153	3	3	8	8	isoflurane	HO-1	PA450106	3162	0.756
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Aug_11_67(Pt_9)_o2293.nxml.txt.nlp	22058933	SENT67	28	28	13	13	ethanol	mol	PA448073	90527	0.756
NULL	Acta_Neuropathol_Commun_2013_Jul_17_1_39.nxml.txt.nlp	24252174	SENT152	6	6	21	21	erlotinib	NRG1	PA134687924	3084	0.756
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1126-1134.nxml.txt.nlp	21364592	SENT25	12	12	17	17	tegafur	CYP2A6	PA452620	1548	0.756
NULL	Front_Oncol_2013_Aug_5_3_201.nxml.txt.nlp	23936765	SENT286	3	3	9	9	staurosporine	RSK	PA165109623	6195;6196;6197	0.756
NULL	J_Exp_Clin_Cancer_Res_2009_May_27_28(1)_68.nxml.txt.nlp	19470182	SENT172	24	24	6	6	cisplatin	ERCC1	PA449014	2067	0.756
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT35	9	9	21	21	heparin	FGF1	PA449855	2246	0.756
NULL	Crit_Care_2014_Mar_17_18(Suppl_1)_P260.nxml.txt.nlp	NULL	SENT8	23	23	28	28	amikacin	PARI	PA164744372	55010	0.756
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_79-96.nxml.txt.nlp	19305789	SENT491	35	35	46	46	capsaicin	TRPV4	PA448776	59341	0.756
NULL	Ann_Pediatr_Cardiol_2009_Jan-Jun_2(1)_65-73.nxml.txt.nlp	20300273	SENT68	0	0	9	9	vasopressin	AVPR1A	PA451858	552	0.756
NULL	Physiol_Rep_2014_Sep_28_2(9)_e12158.nxml.txt.nlp	25263207	SENT14	42	42	19	19	forskolin	TGR5	PA146096022	151306	0.756
NULL	Anal_Bioanal_Chem_2014_Jan_23_406(15)_3667-3680.nxml.txt.nlp	24452745	SENT60	12	12	6	6	ketoprofen	IBP	PA450149	706;50619	0.756
NULL	BMJ_Open_2014_Feb_27_4(2)_e004071.nxml.txt.nlp	24578536	SENT196	6	6	2	2	warfarin	TTR	PA451906	7276	0.756
NULL	Epilepsia_2014_Jun_6_55(6)_806-818.nxml.txt.nlp	24802699	SENT148	3	3	7	7	bumetanide	NKCC1	PA448682	6558	0.756
NULL	Front_Oncol_2014_Mar_17_4_51.nxml.txt.nlp	24672772	SENT100	22	22	4	4	nadh	GLS2	PA164755085	27165	0.756
NULL	Oncol_Lett_2014_Apr_6_7(4)_1260-1264.nxml.txt.nlp	24660037	SENT38	8	8	36	36	fluorescein	San	PA164746009	80218	0.756
NULL	EMBO_Mol_Med_2012_Sep_7_4(9)_896-909.nxml.txt.nlp	22887866	SENT130	9	9	26	26	lovastatin	MYC	PA450272	4609	0.756
NULL	J_Antimicrob_Chemother_2014_Mar_11_69(3)_594-597.nxml.txt.nlp	24216768	SENT43	8	8	19	19	cefoxitin	BSAC	PA448856	57591	0.756
NULL	Int_J_Nanomedicine_2010_Apr_7_5_249-259.nxml.txt.nlp	20463941	SENT76	23	23	6	6	cisplatin	mol	PA449014	90527	0.756
NULL	Cancers_(Basel)_2011_Apr_11_3(2)_1929-1946.nxml.txt.nlp	24212789	SENT545	8	8	3	3	flavopiridol	survivin	PA452627	332	0.756
NULL	Br_J_Cancer_2011_Jul_12_105(2)_255-262.nxml.txt.nlp	21694725	SENT21	22	22	12	12	cetuximab	EGFR	PA10040	1956	0.756
NULL	Cancer_2012_Mar_1_118(5)_1181-1191.nxml.txt.nlp	22038681	SENT158	6	6	15	15	imatinib	IFN	PA10804	3439	0.756
NULL	Case_Rep_Psychiatry_2012_Oct_9_2012_642752.nxml.txt.nlp	23094178	SENT66	29	29	22	22	escitalopram	CYP1A2	PA10074	1544	0.756
NULL	Clin_Sci_(Lond)_2013_Apr_1_124(Pt_8)_543-552.nxml.txt.nlp	23130652	SENT151	3	3	6	6	enalapril	STZ	PA449456	6484	0.756
NULL	Exp_Diabetes_Res_2011_Dec_27_2011_604989.nxml.txt.nlp	21253359	SENT72	22	22	35	35	clonidine	INS-1	PA449051	2305	0.756
NULL	Cell_Oncol_(Dordr)_2011_Apr_11_34(2)_89-95.nxml.txt.nlp	21394646	SENT193	26	26	38	38	paclitaxel	HER2	PA450761	2064	0.756
NULL	Arthritis_Res_Ther_2013_May_24_15(3)_213.nxml.txt.nlp	23731900	SENT18	9	9	5	5	tocilizumab	IL6	PA165292659	3569	0.756
NULL	Core_Evid_2010_Jul_27_5_1-10.nxml.txt.nlp	20694135	SENT123	16	16	11	11	levodopa	CLE	PA450213	51637	0.756
NULL	J_Gen_Physiol_1988_Nov_1_92(5)_601-612.nxml.txt.nlp	3266232	SENT0	12	12	1	1	tetracaine	Gen	PA451638	348654	0.756
NULL	J_Gen_Physiol_1968_Dec_1_52(6)_955-968.nxml.txt.nlp	4235401	SENT0	12	12	1	1	quinidine	Gen	PA451209	348654	0.756
NULL	Biologics_2009_Oct_12_3_469-474.nxml.txt.nlp	19851472	SENT16	4	4	16	16	mometasone	IL-5	PA450541	3567	0.756
NULL	Curr_Neuropharmacol_2009_Jun_7(2)_96-105.nxml.txt.nlp	19949567	SENT40	28	28	20	20	carbamazepine	SV2A	PA448785	9900	0.756
NULL	Front_Chem_2014_Mar_14_2_12.nxml.txt.nlp	24790981	SENT71	15	15	6	6	curcumin	p300	PA151958596	2033	0.756
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT71	14	14	16	16	curcumin	TRAIL	PA151958596	8743	0.755
NULL	Mol_Cancer_2012_Aug_8_11_53.nxml.txt.nlp	22871047	SENT16	7	7	4	4	paclitaxel	HIN-1	PA450761	92304	0.755
NULL	Arthritis_Res_Ther_2010_Aug_25_12(4)_R163.nxml.txt.nlp	20738860	SENT205	3	3	9	9	ns-398	COX2		4513;5743	0.755
NULL	Asian-Australas_J_Anim_Sci_2014_Dec_27(12)_1783-1793.nxml.txt.nlp	25358373	SENT130	23	23	8	8	capsaicin	CEBPA	PA448776	1050	0.755
NULL	Indian_J_Pharm_Sci_2013_Jul-Aug_75(4)_463-475.nxml.txt.nlp	24302802	SENT103	19	19	13	13	ethanol	mol	PA448073	90527	0.755
NULL	Acta_Pharmacol_Sin_2012_Oct_17_33(10)_1301-1310.nxml.txt.nlp	22983390	SENT118	22	22	41	41	cisplatin	migfilin	PA449014	54751	0.755
NULL	J_Thromb_Haemost_2013_Jan_11(1)_132-141.nxml.txt.nlp	23205847	SENT188	2	2	25	25	thrombin	FVIII	PA451674	2157	0.755
NULL	J_Inherit_Metab_Dis_2010_Oct_3_33(5)_625-632.nxml.txt.nlp	20814828	SENT93	7	7	12	12	simvastatin	RhoA	PA451363	387	0.755
NULL	Chemother_Res_Pract_2011_Dec_1_2011_715469.nxml.txt.nlp	22312557	SENT101	6	6	11	11	cisplatin	p53	PA449014	7157	0.755
NULL	Stroke_Res_Treat_2009_Dec_20_2010_386389.nxml.txt.nlp	20700422	SENT160	2	2	16	16	resveratrol	MCP-1		6347	0.755
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2014_Sep_27_70(Pt_10)_2740-2753.nxml.txt.nlp	25286857	SENT272	2	2	14	14	bsi-201	TNKS2		80351	0.755
NULL	Hum_Mol_Genet_2013_Nov_15_22(22)_4616-4626.nxml.txt.nlp	23814041	SENT75	9	9	15	15	doxycycline	neuroserpin	PA449415	5274	0.755
NULL	Exp_Ther_Med_2013_May_15_5(5)_1327-1331.nxml.txt.nlp	23737873	SENT119	7	7	17	17	imidapril	AQP2	PA452640	359	0.755
NULL	Clin_Interv_Aging_2013_Apr_29_8_467-483.nxml.txt.nlp	23766636	SENT112	20	20	1	1	bevacizumab	CRT	PA130232992	811	0.755
NULL	Pharmaceuticals_(Basel)_2013_Aug_21_6(8)_988-1038.nxml.txt.nlp	24276379	SENT2544	13	13	17	17	cetuximab	KRAS	PA10040	3845	0.755
NULL	BMJ_Open_2014_Sep_2_4(9)_e005864.nxml.txt.nlp	25183709	SENT182	13	13	6	6	warfarin	TTR	PA451906	7276	0.755
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT329	5	5	7	7	resveratrol	IL-6		3569	0.755
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT136	13	13	19	19	capsaicin	p53	PA448776	7157	0.755
NULL	Toxins_(Basel)_2010_Oct_28_2(11)_2584-2592.nxml.txt.nlp	22069565	SENT68	5	5	13	13	warfarin	CYP2C9	PA451906	1559	0.755
NULL	Acta_Pharmacol_Sin_2010_Nov_18_31(11)_1447-1453.nxml.txt.nlp	20953204	SENT13	18	18	6	6	rimonabant	PI3K	PA152407999	5290	0.755
NULL	Nat_Genet_2011_Feb_26_43(2)_117-120.nxml.txt.nlp	21186350	SENT29	5	5	11	11	metformin	AMPK	PA450395	5563	0.755
NULL	Breast_Cancer_Res_2011_Jan_17_13(1)_R5.nxml.txt.nlp	21241485	SENT211	22	22	8	8	estradiol	Brn-3b	PA449503	5458	0.755
NULL	Cancer_Microenviron_2008_Dec_19_1(1)_53-68.nxml.txt.nlp	19308685	SENT365	4	4	9	9	geldanamycin	HIF-1	PA152031327	29072	0.755
NULL	J_Cell_Mol_Med_2014_Jul_30_18(7)_1392-1406.nxml.txt.nlp	24779927	SENT256	5	5	23	23	imatinib	RhoA	PA10804	387	0.755
NULL	Behav_Neurol_2014_Mar_11_2014_304203.nxml.txt.nlp	24825955	SENT64	5	5	10	10	phenol	COMT	PA450913	1312	0.755
NULL	Crit_Care_2007_Jun_28_11(3)_145.nxml.txt.nlp	17610749	SENT38	18	18	4	4	etomidate	Ray	PA164743987	26751	0.755
NULL	Clinicoecon_Outcomes_Res_2014_Dec_15_7_9-15.nxml.txt.nlp	25548525	SENT122	10	10	28	28	gefitinib	EGFR	PA131301952	1956	0.755
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT200	21	21	42	42	l-leucine	ATP5A	PA450197	498	0.755
NULL	Brain_Sci_2014_May_6_4(2)_356-375.nxml.txt.nlp	24961766	SENT124	3	3	29	29	propofol	P28	PA451141	9446;7802;9527	0.755
NULL	Diabetes_Care_2010_Apr_12_33(4)_861-868.nxml.txt.nlp	20067962	SENT155	11	11	27	27	hyaluronan	TLR2	PA165958431	7097	0.755
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT94	8	8	37	37	imatinib	ABCG2	PA10804	9429	0.755
NULL	Ann_Hematol_2013_May_22_92(9)_1181-1188.nxml.txt.nlp	23694997	SENT197	17	17	19	19	idarubicin	AIDA	PA449961	64853	0.755
NULL	Br_J_Cancer_2009_Jan_27_100(2)_298-304.nxml.txt.nlp	19127259	SENT157	7	7	0	0	cetuximab	HER2	PA10040	2064	0.755
NULL	Mol_Cancer_2014_Jun_24_13_157.nxml.txt.nlp	24958351	SENT189	32	32	22	22	lapatinib	HER2	PA152241907	2064	0.755
NULL	Clin_Pharmacokinet_2014_Sep_3_53(1)_1-16.nxml.txt.nlp	23999929	SENT288	7	7	28	28	clarithromycin	P-gp	PA449028	5243	0.755
NULL	Int_J_Mol_Sci_2013_Apr_26_14(5)_9126-9167.nxml.txt.nlp	23624605	SENT2179	1	1	13	13	curcumin	p38	PA151958596	10598;1432;7965	0.755
NULL	Carcinogenesis_2008_Sep_9_29(9)_1734-1741.nxml.txt.nlp	18544564	SENT374	9	9	5	5	sorafenib	cIAP2	PA7000	330	0.755
NULL	Stroke_Res_Treat_2009_Dec_20_2010_386389.nxml.txt.nlp	20700422	SENT190	5	5	22	22	resveratrol	MCP-1		6347	0.755
NULL	Front_Immunol_2013_Oct_31_4_351.nxml.txt.nlp	24198817	SENT395	19	19	23	23	etanercept	PAPA	PA449515	2737;5069	0.755
NULL	Exp_Hematol_Oncol_2013_Jan_10_2_2.nxml.txt.nlp	23305345	SENT45	2	2	4	4	bortezomib	BTZ	PA10252	22794	0.755
NULL	Cent_European_J_Urol_2013_Aug_13_66(2)_144-149.nxml.txt.nlp	24579014	SENT44	0	0	15	15	resveratrol	MKP5		11221	0.755
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT74	18	18	16	16	nutlin-3	MDM2		4193	0.755
NULL	Breast_Cancer_Res_2012_Feb_14_14(1)_R30.nxml.txt.nlp	22333315	SENT227	3	3	10	10	indomethacin	CXCL10	PA449982	3627	0.755
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT139	26	26	21	21	efavirenz	CYP3A	PA449441	1574	0.755
NULL	Evid_Based_Complement_Alternat_Med_2015_Jan_6_2015_736431.nxml.txt.nlp	25632290	SENT62	7	7	13	13	ritonavir	CYP3A4	PA451260	1576	0.755
NULL	Mol_Cell_Proteomics_2013_Aug_14_12(8)_2313-2323.nxml.txt.nlp	23674616	SENT204	3	3	11	11	levamisole	ALPL	PA450205	249	0.755
NULL	Biochem_Res_Int_2012_Feb_12_2012_346972.nxml.txt.nlp	22400115	SENT194	6	6	0	0	hyaluronan	EMMPRIN	PA165958431	682	0.755
NULL	Clin_Dev_Immunol_2011_Oct_18_2011_176759.nxml.txt.nlp	22028727	SENT44	38	38	0	0	l-glutamine	TC-1	PA10090	56892	0.755
NULL	Case_Rep_Med_2014_Jan_16_2014_389425.nxml.txt.nlp	24550989	SENT40	17	17	30	30	lipase	CDX2	PA450239	1045	0.755
NULL	Br_J_Cancer_2003_Mar_10_88(5)_788-795.nxml.txt.nlp	12618891	SENT165	8	8	10	10	bosentan	FasL	PA10034	356	0.755
NULL	J_Biol_Eng_2009_Oct_16_3_18.nxml.txt.nlp	19835592	SENT140	1	1	31	31	tetracycline	CPZ	PA451640	8532	0.755
NULL	Biomed_Res_Int_2014_Jun_4_2014_253243.nxml.txt.nlp	24995279	SENT45	31	31	7	7	fludarabine	CHOP	PA449655	1649	0.755
NULL	Curr_Control_Trials_Cardiovasc_Med_2005_May_23_6(1)_9.nxml.txt.nlp	15910680	SENT106	21	21	13	13	simvastatin	SHARP	PA451363	23013	0.755
NULL	Breast_Cancer_Res_2012_Mar_19_14(2)_R52.nxml.txt.nlp	22429491	SENT351	25	25	11	11	tamoxifen	PUMA	PA451581	27113	0.755
NULL	J_Korean_Med_Sci_2007_Aug_31_22(4)_677-681.nxml.txt.nlp	17728509	SENT45	37	37	39	39	ethambutol	EMB	PA164784021	133418	0.755
NULL	J_Biol_2003_Sep_24_2(4)_28.nxml.txt.nlp	14511394	SENT348	23	23	30	30	phenformin	LKB1	PA1000	6794	0.755
NULL	Arthritis_Res_Ther_2004_Apr_26_6(3)_R264-R272.nxml.txt.nlp	15142273	SENT31	22	22	10	10	infliximab	ACR	PA452639	49	0.755
NULL	ScientificWorldJournal_2014_Feb_6_2014_328513.nxml.txt.nlp	24683330	SENT91	14	14	38	38	propofol	IL-10	PA451141	3586	0.755
NULL	Cancer_Cell_Int_2011_Aug_19_11_29.nxml.txt.nlp	21854619	SENT218	26	26	18	18	cisplatin	BRCA1	PA449014	672	0.755
NULL	J_Korean_Med_Sci_2011_Aug_27_26(8)_1007-1013.nxml.txt.nlp	21860550	SENT26	18	18	12	12	tamoxifen	CYP2D6	PA451581	1565	0.755
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_13_2014_849783.nxml.txt.nlp	25477998	SENT88	2	2	8	8	berberine	IL-6	PA165860812	3569	0.755
NULL	Anticancer_Agents_Med_Chem_2012_Feb_12(2)_163-171.nxml.txt.nlp	22043994	SENT152	40	40	23	23	cetuximab	KRAS	PA10040	3845	0.755
NULL	Case_Rep_Med_2010_Jun_10_2010_984981.nxml.txt.nlp	20592999	SENT4	11	11	6	6	amiodarone	AIT	PA448383	160728	0.755
NULL	Infect_Dis_Ther_2014_Jun_18_3(1)_35-43.nxml.txt.nlp	25134810	SENT27	28	28	19	19	daptomycin	VAN	PA164768820	10318	0.755
NULL	Core_Evid_2011_Mar_17_6_31-42.nxml.txt.nlp	21468241	SENT108	20	20	8	8	ticagrelor	IPA	PA165374673	3160	0.755
NULL	Indian_J_Pharmacol_2013_Jan-Feb_45(1)_98-99.nxml.txt.nlp	23543750	SENT34	8	8	44	44	levodopa	BPAD	PA450213	4095	0.755
NULL	Eur_J_Histochem_2010_Jun_14_54(2)_e15.nxml.txt.nlp	20558338	SENT30	6	6	14	14	flutamide	PD2	PA449685	54623	0.755
NULL	Ann_Oncol_2010_Mar_18_21(3)_655-661.nxml.txt.nlp	19767314	SENT227	3	3	13	13	erlotinib	EGFR	PA134687924	1956	0.755
NULL	J_Cell_Biol_2000_Feb_21_148(4)_791-800.nxml.txt.nlp	10684259	SENT173	40	40	28	28	estradiol	Raf-1	PA449503	5894	0.755
NULL	Crit_Care_2001_Mar_2_5(Suppl_1)_P197.nxml.txt.nlp	NULL	SENT16	18	18	0	0	propofol	PTH	PA451141	5741	0.755
NULL	Nucleic_Acids_Res_2011_Dec_2_39(22)_9549-9558.nxml.txt.nlp	21890893	SENT75	6	6	12	12	resveratrol	SIRT1		23411	0.755
NULL	Facts_Views_Vis_Obgyn_2010_2(2)_74-87.nxml.txt.nlp	25302102	SENT222	4	4	0	0	vincristine	CHOP	PA451879	1649	0.755
NULL	Environ_Health_Perspect_2006_Apr_2_114(4)_527-531.nxml.txt.nlp	16581540	SENT14	44	44	17	17	arsenite	AQP7	PA452638	364	0.755
NULL	Acta_Pharmacol_Sin_2010_Aug_5_31(8)_938-943.nxml.txt.nlp	20686519	SENT185	27	27	0	0	reserpine	GML	PA451236	2765	0.755
NULL	Cancers_(Basel)_2013_May_10_5(2)_529-549.nxml.txt.nlp	24216990	SENT218	19	19	34	34	pazopanib	KIT	PA165291492	3815	0.755
NULL	BMJ_Open_2014_Oct_31_4(10)_e005781.nxml.txt.nlp	25361837	SENT106	18	18	30	30	clopidogrel	ADP	PA449053	23038	0.755
NULL	J_Cardiothorac_Surg_2012_Sep_27_7_97.nxml.txt.nlp	23013706	SENT163	7	7	14	14	warfarin	CYP2C9	PA451906	1559	0.755
NULL	Front_Oncol_2014_Aug_11_4_204.nxml.txt.nlp	25157335	SENT304	20	20	31	31	crizotinib	ROS1	PA165946122	6098	0.755
NULL	J_Nutr_Metab_2011_Oct_1_2011_525094.nxml.txt.nlp	21977315	SENT154	20	20	22	22	resveratrol	SIRT1		23411	0.755
NULL	Aging_(Albany_NY)_2012_Nov_24_4(11)_742-754.nxml.txt.nlp	23178507	SENT218	18	18	11	11	acetone	FBS	PA448025	64319;26269	0.755
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT145	19	19	11	11	perifosine	DR5	PA165291471	8795	0.755
NULL	Anemia_2012_Aug_12_2012_297641.nxml.txt.nlp	22924125	SENT136	22	22	18	18	deferasirox	EOS	PA164760843	260429	0.755
NULL	Inflamm_Res_2010_Sep_26_59(9)_699-709.nxml.txt.nlp	20339899	SENT29	7	7	9	9	thrombin	PAR2	PA451674	2150;55065;8856	0.755
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT84	12	12	10	10	curcumin	DR5	PA151958596	8795	0.755
NULL	Hum_Genomics_2008_Sep_1_3(1)_7-16.nxml.txt.nlp	19129086	SENT170	3	3	7	7	rosiglitazone	OATP1B1	PA451283	10599	0.755
NULL	Anesthesiol_Res_Pract_2012_Jul_5_2012_709531.nxml.txt.nlp	22829813	SENT146	17	17	33	33	bupivacaine	IL-10	PA135057240	3586	0.755
NULL	Breast_Cancer_Res_2010_Jun_28_12(3)_R43.nxml.txt.nlp	20579400	SENT159	6	6	12	12	estradiol	MAPT	PA449503	4137	0.755
NULL	J_Neurosci_Methods_2009_Oct_15_183(2)_107-113.nxml.txt.nlp	19524611	SENT88	8	8	25	25	carbachol	CA3	PA448784	761	0.755
NULL	Clin_Ophthalmol_2009_Jun_2_3_291-295.nxml.txt.nlp	19668581	SENT109	7	7	31	31	latanoprost	BAK	PA164774763	578	0.755
NULL	Int_Clin_Psychopharmacol_2014_Jul_26_29(4)_229-234.nxml.txt.nlp	24419004	SENT130	20	20	1	1	risperidone	Gen	PA451257	348654	0.755
NULL	Cardiol_Res_Pract_2013_Jan_31_2013_128795.nxml.txt.nlp	23431496	SENT172	22	22	28	28	clopidogrel	CYP2C19	PA449053	1557	0.755
NULL	J_Biomed_Biotechnol_2002_2(1)_7-13.nxml.txt.nlp	12488594	SENT99	11	11	1	1	thalidomide	ANOVA	PA451644	4858	0.755
NULL	Diabetes_Care_2012_Jun_11_35(6)_1225-1231.nxml.txt.nlp	22432104	SENT202	9	9	15	15	liraglutide	GLP-1	PA165958364	100125288	0.755
NULL	Comp_Hepatol_2005_Feb_8_4_2.nxml.txt.nlp	15701172	SENT255	10	10	23	23	ketoconazole	CYP3A	PA450146	1574	0.755
NULL	Mol_Cells_2014_Mar_31_37(3)_234-240.nxml.txt.nlp	24642709	SENT128	3	3	16	16	capsaicin	HMGB1	PA448776	3146	0.755
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT107	12	12	7	7	curcumin	TRAIL	PA151958596	8743	0.755
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT49	23	23	11	11	phenacetin	CYP2C9	PA450897	1559	0.755
NULL	J_Gen_Physiol_2009_Jun_133(6)_603-622.nxml.txt.nlp	19468075	SENT419	4	4	27	27	acetazolamide	CO2	PA448018	4513	0.755
NULL	Diabetes_2013_Sep_15_62(9)_3224-3231.nxml.txt.nlp	23545707	SENT159	40	40	27	27	losartan	ACR	PA450268	49	0.755
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT315	30	30	10	10	pitavastatin	ABCG2	PA142650384	9429	0.755
NULL	Oncologist_2010_Jan_19_15(1)_3-5.nxml.txt.nlp	20086166	SENT28	11	11	9	9	cetuximab	EGFR	PA10040	1956	0.755
NULL	J_Biomed_Sci_2013_Aug_2_20(1)_54.nxml.txt.nlp	23915271	SENT52	3	3	25	25	fluorescein	San	PA164746009	80218	0.755
NULL	Aging_(Albany_NY)_2010_Dec_20_2(12)_959-968.nxml.txt.nlp	21191146	SENT126	11	11	14	14	cisplatin	LKB1	PA449014	6794	0.755
NULL	Oncotarget_2013_Nov_23_5(1)_196-210.nxml.txt.nlp	24344116	SENT308	30	30	41	41	doxorubicin	CO2	PA449412	4513	0.755
NULL	Mol_Brain_2014_May_15_7_37.nxml.txt.nlp	24886748	SENT235	1	1	23	23	vorinostat	TIMP1	PA164748224	7076	0.755
NULL	Mol_Cell_Biochem_2013_Jul_3_382(1-2)_283-291.nxml.txt.nlp	23820733	SENT47	17	17	38	38	ethanol	BMI1	PA448073	648	0.755
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Apr_21_68(Pt_5)_o1472.nxml.txt.nlp	22590345	SENT57	20	20	35	35	ethanol	mol	PA448073	90527	0.755
NULL	Curr_Pharm_Des_2008_Oct_14(28)_2983-2998.nxml.txt.nlp	18991714	SENT80	8	8	13	13	erlotinib	EGFR	PA134687924	1956	0.755
NULL	J_Invest_Dermatol_2012_Sep_10_132(9)_2255-2262.nxml.txt.nlp	22572817	SENT83	12	12	3	3	forskolin	HBD3	PA146096022	414325	0.755
NULL	Case_Rep_Oncol_Med_2014_Sep_14_2014_532924.nxml.txt.nlp	25298899	SENT83	8	8	4	4	paclitaxel	NAC	PA450761	22861	0.755
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT8	7	7	20	20	heparin	FGF1	PA449855	2246	0.755
NULL	Clin_Epigenetics_2010_Sep_18_1(3-4)_101-116.nxml.txt.nlp	21258631	SENT228	11	11	8	8	curcumin	DNMT1	PA151958596	1786	0.755
NULL	Neural_Regen_Res_2013_May_5_8(13)_1180-1189.nxml.txt.nlp	25206412	SENT51	4	4	17	17	fasudil	Rho	PA165946121	29984	0.755
NULL	Int_J_Med_Sci_2015_Jan_1_12(1)_63-71.nxml.txt.nlp	25552920	SENT111	4	4	15	15	berberine	PC-3	PA165860812	692094	0.755
NULL	Cell_Cycle_2013_May_1_12(9)_1331-1332.nxml.txt.nlp	23588071	SENT12	11	11	6	6	doxorubicin	p53	PA449412	7157	0.755
NULL	Front_Public_Health_2013_Nov_14_1_50.nxml.txt.nlp	24350219	SENT140	13	13	15	15	hydrocortisone	HYD	PA449905	51366	0.755
NULL	Biomed_Res_Int_2013_Aug_27_2013_960126.nxml.txt.nlp	24069608	SENT137	23	23	11	11	haloperidol	MAP2	PA449841	4133;10988	0.755
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_May_30_64(Pt_6)_o1169.nxml.txt.nlp	21202676	SENT59	24	24	17	17	ethanol	mol	PA448073	90527	0.755
NULL	Br_J_Cancer_2010_Jun_29_103(1)_52-60.nxml.txt.nlp	20531411	SENT12	1	1	27	27	gemcitabine	IL-8	PA449748	3576	0.755
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT118	0	0	3	3	curcumin	PC-3	PA151958596	692094	0.755
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1063.nxml.txt.nlp	24556678	SENT44	21	21	28	28	thioridazine	Mcl-1	PA451666	4170	0.755
NULL	Clin_Ophthalmol_2009_Jun_2_3_291-295.nxml.txt.nlp	19668581	SENT109	7	7	14	14	latanoprost	BAK	PA164774763	578	0.755
NULL	Oncotarget_2014_Jun_6_5(13)_4935-4944.nxml.txt.nlp	24952732	SENT5	0	0	24	24	doxazosin	PDK1	PA449407	5170;5163	0.755
NULL	Anat_Cell_Biol_2010_Sep_30_43(3)_194-200.nxml.txt.nlp	21212859	SENT10	15	15	12	12	ethanol	PLP	PA448073	25824;5744	0.755
NULL	Oncotarget_2014_Dec_1_5(22)_10965-10966.nxml.txt.nlp	25473898	SENT13	27	27	10	10	rituximab	BCL6	PA451261	604	0.755
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT253	27	27	34	34	nutlin-3	p53		7157	0.755
NULL	Diabetes_2013_May_16_62(5)_1464-1477.nxml.txt.nlp	23349479	SENT5	7	7	25	25	lipase	ATGL	PA450239	57104	0.755
NULL	Chin_J_Cancer_2011_Oct_30(10)_690-700.nxml.txt.nlp	21959046	SENT150	38	38	7	7	verapamil	TPT	PA451868	23590;6469	0.755
NULL	Mol_Cancer_2009_Aug_25_8_66.nxml.txt.nlp	19706164	SENT11	13	13	3	3	celecoxib	p53	PA448871	7157	0.755
NULL	J_Biomed_Biotechnol_2011_Jul_6_2011_783528.nxml.txt.nlp	21785566	SENT302	2	2	0	0	nifedipine	CYP3A4	PA450631	1576	0.755
NULL	Cell_Death_Dis_2010_Oct_21_1(10)_e86.nxml.txt.nlp	21368859	SENT48	7	7	9	9	doxorubicin	TRAIL	PA449412	8743	0.755
NULL	Arthritis_Res_Ther_2014_Apr_11_16(2)_R93.nxml.txt.nlp	24725461	SENT165	13	13	2	2	estradiol	aromatase	PA449503	1588	0.755
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT174	18	18	15	15	trastuzumab	HER2	PA451743	2064	0.755
NULL	Drug_Saf_2014_Feb_19_37(4)_201-211.nxml.txt.nlp	24550106	SENT302	4	4	12	12	rabeprazole	CYP2C19	PA451216	1557	0.755
NULL	Indian_J_Pharm_Sci_2008_Jul-Aug_70(4)_415-422.nxml.txt.nlp	20046764	SENT95	3	3	5	5	timolol	mol	PA451690	90527	0.755
NULL	Breast_Cancer_Res_2009_Jul_15_11(4)_207.nxml.txt.nlp	19664181	SENT172	17	17	22	22	trastuzumab	PTEN	PA451743	5728	0.755
NULL	Oncotarget_2013_Oct_19_4(11)_2045-2056.nxml.txt.nlp	24185104	SENT107	27	27	9	9	cisplatin	14-3-3	PA449014	10971	0.755
NULL	Comp_Funct_Genomics_2012_Feb_6_2012_876893.nxml.txt.nlp	22400011	SENT148	1	1	22	22	zinc	CPSF4	PA451956	10898	0.755
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jun_23_66(Pt_7)_o1766.nxml.txt.nlp	21587980	SENT58	4	4	10	10	isopropamide	mol	PA164781398	90527	0.755
NULL	Br_J_Cancer_2010_Oct_12_103(8)_1284-1291.nxml.txt.nlp	20859285	SENT165	11	11	16	16	tamoxifen	ERBB2	PA451581	2064	0.755
NULL	Cardiol_Res_Pract_2012_Aug_15_2012_713294.nxml.txt.nlp	22928146	SENT125	21	21	4	4	carvedilol	CARMEN	PA448817	8915	0.755
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT212	13	13	26	26	l-leucine	p27	PA450197	5715;10534	0.755
NULL	Br_J_Pharmacol_2012_Jan_165(2)_380-389.nxml.txt.nlp	21585347	SENT17	25	25	6	6	rosiglitazone	ATGL	PA451283	57104	0.755
NULL	Oxid_Med_Cell_Longev_2013_Jun_2_2013_793525.nxml.txt.nlp	23819014	SENT7	21	21	6	6	resveratrol	SGBS		2719	0.755
NULL	Korean_J_Anesthesiol_2013_Dec_26_65(6)_501-507.nxml.txt.nlp	24427455	SENT115	2	2	33	33	neostigmine	NMB	PA450611	10457;4828	0.755
NULL	Allergy_Asthma_Clin_Immunol_2013_Oct_3_9(1)_39.nxml.txt.nlp	24219860	SENT46	15	15	20	20	rituximab	BAFF	PA451261	10673	0.755
NULL	Eur_J_Clin_Pharmacol_2012_Jan_8_68(1)_29-37.nxml.txt.nlp	21739267	SENT12	10	10	18	18	paroxetine	CYP2D6	PA450801	1565	0.755
NULL	J_Cardiovasc_Dis_Res_2010_Oct-Dec_1(4)_171-176.nxml.txt.nlp	21264180	SENT109	8	8	28	28	resveratrol	AMPK		5563	0.755
NULL	Core_Evid_2007_Nov_30_2(2)_121-129.nxml.txt.nlp	21221180	SENT19	2	2	0	0	cyclophosphamide	CHOP	PA449165	1649	0.755
NULL	Extremophiles_2009_Nov_23_13(6)_885-894.nxml.txt.nlp	19701714	SENT138	23	23	32	32	ethanol	mol	PA448073	90527	0.755
NULL	Oncotarget_2011_Jan_25_2(1-2)_8-17.nxml.txt.nlp	21378407	SENT47	4	4	18	18	thrombin	IL-8	PA451674	3576	0.755
NULL	J_Korean_Med_Sci_2006_Jun_21_21(3)_418-424.nxml.txt.nlp	16778382	SENT131	8	8	15	15	hemin	HO-1	PA449849	3162	0.755
NULL	Mol_Cancer_2010_Nov_25_9_305.nxml.txt.nlp	21108789	SENT114	12	12	3	3	decitabine	TRAIL	PA164749631	8743	0.755
NULL	J_Cell_Biol_1977_Aug_1_74(2)_531-546.nxml.txt.nlp	407233	SENT8	12	12	17	17	trypsin	DPL	PA451806	23627	0.755
NULL	Front_Neurosci_2010_Jun_17_4_35.nxml.txt.nlp	20661455	SENT1086	4	4	11	11	citalopram	STAR	PA449015	6770;2984	0.755
NULL	Toxins_(Basel)_2010_Oct_26_2(11)_2490-2518.nxml.txt.nlp	22069563	SENT201	15	15	8	8	cisplatin	IL-10	PA449014	3586	0.755
NULL	J_Thromb_Haemost_2014_Jul_19_12(7)_1054-1065.nxml.txt.nlp	24766850	SENT207	18	18	16	16	thrombin	FVIII	PA451674	2157	0.755
NULL	Cell_Commun_Signal_2013_Nov_11_11_86.nxml.txt.nlp	24215724	SENT501	27	27	41	41	thrombin	PAR2	PA451674	2150;55065;8856	0.755
NULL	Sensors_(Basel)_2011_May_4_11(5)_4990-5004.nxml.txt.nlp	22163886	SENT261	24	24	11	11	oxygen	CFD	PA450744	1675	0.755
NULL	Mol_Vis_2012_Nov_29_18_2839-2846.nxml.txt.nlp	23233786	SENT167	6	6	15	15	geldanamycin	CB2	PA152031327	1269	0.755
NULL	J_Clin_Biochem_Nutr_2011_Mar_26_48(2)_126-133.nxml.txt.nlp	21373265	SENT116	23	23	21	21	lansoprazole	HO-1	PA450180	3162	0.755
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT117	10	10	31	31	perifosine	DR5	PA165291471	8795	0.755
NULL	Breast_Cancer_Res_2008_May_12_10(3)_R45.nxml.txt.nlp	18474099	SENT200	38	38	5	5	paclitaxel	IL-6	PA450761	3569	0.755
NULL	Mol_Cancer_2010_Aug_23_9_222.nxml.txt.nlp	20731837	SENT186	24	24	10	10	gefitinib	ATM	PA131301952	472	0.755
NULL	Oncotarget_2011_Nov_9_2(11)_850-861.nxml.txt.nlp	22081665	SENT142	2	2	10	10	idarubicin	DNMT3A	PA449961	1788	0.755
NULL	Br_J_Cancer_2012_May_8_106(10)_1587-1590.nxml.txt.nlp	22568998	SENT90	4	4	11	11	sunitinib	IFN	PA162372840	3439	0.755
NULL	J_Nutr_Metab_2012_Apr_10_2012_431574.nxml.txt.nlp	22570769	SENT157	11	11	20	20	sertraline	TPH2	PA451333	6999;121278	0.755
NULL	Vet_Res_2013_Dec_11_44(1)_121.nxml.txt.nlp	24330735	SENT138	3	3	15	15	carbachol	ATP4B	PA448784	496	0.755
NULL	J_Cell_Mol_Med_2014_Dec_6_18(12)_2331-2339.nxml.txt.nlp	25284457	SENT98	21	21	29	29	hydroxytryptamine	HMGB1	PA140222718	3146	0.755
NULL	Mediators_Inflamm_2001_Oct_10(5)_253-258.nxml.txt.nlp	11759109	SENT5	27	27	25	25	ribavirin	IFN	PA451241	3439	0.755
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT1558	15	15	6	6	paclitaxel	CYP3A5	PA450761	1577	0.755
NULL	J_Vet_Sci_2007_Dec_31_8(4)_341-351.nxml.txt.nlp	17993747	SENT156	9	9	15	15	echinacea	gamma	PA131550706	9913	0.755
NULL	J_Breast_Cancer_2014_Dec_26_17(4)_308-313.nxml.txt.nlp	25548577	SENT53	39	39	14	14	trastuzumab	HIRA	PA451743	7290	0.755
NULL	Diabetes_2011_May_23_60(5)_1458-1466.nxml.txt.nlp	21464445	SENT115	15	15	43	43	lipase	HSL	PA450239	3991	0.755
NULL	Diabetes_Care_2011_Nov_15_34(11)_2448-2453.nxml.txt.nlp	21926283	SENT142	18	18	5	5	glucose	CD4	PA449773	920	0.755
NULL	Evid_Based_Complement_Alternat_Med_2012_Dec_17_2012_485262.nxml.txt.nlp	23304202	SENT172	6	6	19	19	thrombin	ERK2	PA451674	5594	0.755
NULL	Front_Oncol_2014_Apr_17_4_78.nxml.txt.nlp	24860780	SENT659	16	16	23	23	panitumumab	KRAS	PA162373091	3845	0.755
NULL	Int_J_Mol_Sci_2014_Sep_16_15(9)_16381-16417.nxml.txt.nlp	25229821	SENT1805	5	5	7	7	tacrolimus	CD4	PA451578	920	0.755
NULL	F1000Res_2014_Sep_29_3_228.nxml.txt.nlp	25485098	SENT295	19	19	24	24	creatine	SLC6A8	PA164778930	6535	0.755
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT231	5	5	21	21	nutlin-3	DR5		8795	0.755
NULL	Case_Rep_Oncol_2009_Mar_14_2(1)_53-56.nxml.txt.nlp	20740145	SENT16	15	15	9	9	vincristine	CHOP	PA451879	1649	0.755
NULL	J_Res_Med_Sci_2010_Nov-Dec_15(6)_348-358.nxml.txt.nlp	21526108	SENT31	1	1	18	18	thrombin	Rho	PA451674	29984	0.755
NULL	Br_J_Cancer_2012_Apr_24_106(9)_1543-1550.nxml.txt.nlp	22531721	SENT89	13	13	32	32	trastuzumab	CD59	PA451743	966	0.755
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT82	16	16	8	8	cisplatin	p53	PA449014	7157	0.755
NULL	Dermatoendocrinol_2013_Apr_1_5(2)_252-263.nxml.txt.nlp	24194965	SENT159	32	32	39	39	metformin	B12	PA450395	7126;4709	0.755
NULL	Adv_Ther_2014_Feb_15_31(3)_289-317.nxml.txt.nlp	24535623	SENT208	13	13	18	18	exenatide	PPG	PA164749238	5552	0.755
NULL	Diabetes_2008_Sep_57(9)_2272-2279.nxml.txt.nlp	18519799	SENT168	3	3	8	8	rosiglitazone	NEFA	PA451283	4925	0.755
NULL	Breast_Cancer_Res_2012_Jun_7_14(3)_R89.nxml.txt.nlp	22676470	SENT340	37	37	26	26	geldanamycin	HER2	PA152031327	2064	0.755
NULL	Diagn_Pathol_2013_Nov_25_8_192.nxml.txt.nlp	24274261	SENT89	8	8	6	6	paclitaxel	IL-2	PA450761	3558	0.755
NULL	Biomed_Res_Int_2013_Aug_6_2013_602987.nxml.txt.nlp	24027759	SENT262	11	11	24	24	doxorubicin	ADM	PA449412	133	0.755
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT265	4	4	0	0	vinblastine	MVP	PA451877	9961	0.755
NULL	Oxid_Med_Cell_Longev_2011_Aug_4_2011_471590.nxml.txt.nlp	21904644	SENT59	8	8	18	18	probucol	CA1	PA451107	759	0.755
NULL	Ann_Rheum_Dis_2009_Jan_5_68(6)_1051-1058.nxml.txt.nlp	18662930	SENT220	6	6	17	17	hyaluronan	NF-kappaB	PA165958431	4790	0.755
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_30_2013_789764.nxml.txt.nlp	23737845	SENT254	26	26	15	15	tolbutamide	CYP3A	PA451718	1574	0.755
NULL	Mol_Cancer_2009_Dec_23_8_129.nxml.txt.nlp	20030852	SENT248	8	8	36	36	curcumin	ABCA1	PA151958596	19	0.755
NULL	Cancer_Immunol_Immunother_2011_Jun_25_60(6)_793-808.nxml.txt.nlp	21350947	SENT224	11	11	7	7	sorafenib	IFN	PA7000	3439	0.755
NULL	J_Korean_Neurosurg_Soc_2014_Jul_31_56(1)_1-4.nxml.txt.nlp	25289117	SENT76	37	37	4	4	curcumin	p38	PA151958596	10598;1432;7965	0.755
NULL	Biomed_Res_Int_2014_May_29_2014_645762.nxml.txt.nlp	24971341	SENT163	11	11	16	16	estradiol	A-FABP	PA449503	2167	0.755
NULL	Ann_Dermatol_2013_May_10_25(2)_252-254.nxml.txt.nlp	23717026	SENT56	0	0	8	8	tacrolimus	IL-5	PA451578	3567	0.755
NULL	Front_Neurol_2013_May_1_4_10.nxml.txt.nlp	23641231	SENT176	10	10	17	17	natalizumab	IFN	PA164747191	3439	0.755
NULL	J_Biomed_Biotechnol_2011_Jan_24_2011_250860.nxml.txt.nlp	21318107	SENT161	0	0	11	11	lenalidomide	CD40L	PA162363968	959	0.755
NULL	Leukemia_2013_Dec_27_27(12)_2322-2331.nxml.txt.nlp	24072044	SENT176	15	15	28	28	plerixafor	HSPC	PA165958410	5688	0.755
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT33	3	3	30	30	metformin	HIP	PA450395	6767;6159;64399;5068	0.755
NULL	Springerplus_2014_Sep_9_3_510.nxml.txt.nlp	25279302	SENT45	12	12	10	10	creatine	ADP	PA164778930	23038	0.755
NULL	Cancer_Metastasis_Rev_2010_Dec_9_29(4)_777-784.nxml.txt.nlp	20936327	SENT73	0	0	21	21	thrombin	PAR1	PA451674	79581;2149	0.755
NULL	Front_Immunol_2012_Jan_24_3_3.nxml.txt.nlp	22566889	SENT122	15	15	6	6	rituximab	CD55	PA451261	1604	0.755
NULL	Sci_Rep_2014_Dec_17_4_7461.nxml.txt.nlp	25514838	SENT220	5	5	13	13	cisplatin	PTEN	PA449014	5728	0.755
NULL	J_Ind_Microbiol_Biotechnol_2013_Jul_30_40(10)_1153-1160.nxml.txt.nlp	23896974	SENT90	4	4	18	18	nadh	mol	PA164755085	90527	0.755
NULL	Aging_(Albany_NY)_2010_Apr_30_2(4)_183-184.nxml.txt.nlp	20436227	SENT7	5	5	22	22	resveratrol	IL-10		3586	0.755
NULL	Cancer_Metastasis_Rev_2011_Dec_20_30(3-4)_465-480.nxml.txt.nlp	22012553	SENT251	23	23	17	17	indomethacin	EP2	PA449982	5732;10407	0.755
NULL	Mol_Cancer_2010_Nov_8_9_291.nxml.txt.nlp	21059223	SENT196	20	20	28	28	docetaxel	Bcl-2	PA449383	596	0.755
NULL	Cell_Cycle_2012_Jul_15_11(14)_2591.nxml.txt.nlp	22751433	SENT18	21	21	13	13	doxorubicin	p53	PA449412	7157	0.755
NULL	EPMA_J_2011_Sep_24_2(Suppl_1)_119-130.nxml.txt.nlp	NULL	SENT137	7	7	19	19	warfarin	CYP2C9	PA451906	1559	0.755
NULL	Adv_Pharmacol_Sci_2013_Dec_5_2013_387071.nxml.txt.nlp	24381587	SENT89	0	0	7	7	curcumin	TNF	PA151958596	7124	0.755
NULL	Int_J_Environ_Res_Public_Health_2012_Sep_19_9(9)_3354-3364.nxml.txt.nlp	23202692	SENT357	0	0	11	11	resveratrol	SIRT1		23411	0.755
NULL	Neural_Regen_Res_2013_Mar_25_8(9)_825-832.nxml.txt.nlp	25206730	SENT107	2	2	7	7	isoflurane	P2X7	PA450106	5027	0.755
NULL	Cancer_Microenviron_2009_Sep_26_2(Suppl_1)_19-204.nxml.txt.nlp	NULL	SENT2495	9	9	0	0	sorafenib	CXCR4	PA7000	7852	0.755
NULL	Nat_Biotechnol_2010_May_28(5)_478-485.nxml.txt.nlp	20458318	SENT44	3	3	32	32	cisplatin	NAG	PA449014	51594;4669	0.755
NULL	Basic_Clin_Pharmacol_Toxicol_2013_Feb_5_112(2)_132-137.nxml.txt.nlp	22900583	SENT154	25	25	5	5	ketoconazole	CYP3A	PA450146	1574	0.755
NULL	J_Mol_Med_(Berl)_2014_May_10_92(7)_709-722.nxml.txt.nlp	24811491	SENT17	12	12	7	7	panitumumab	EGFR	PA162373091	1956	0.755
NULL	Cell_Commun_Signal_2004_Jun_30_2_6.nxml.txt.nlp	15228623	SENT95	16	16	19	19	mibefradil	TTN	PA450492	7273	0.755
NULL	Diabetes_2013_Jun_17_62(6)_1843-1854.nxml.txt.nlp	23349486	SENT208	20	20	13	13	pioglitazone	CD25	PA450970	3669;3559	0.755
NULL	Mol_Cell_Biochem_2014_Oct_9_385(1-2)_265-275.nxml.txt.nlp	24104452	SENT112	0	0	8	8	bortezomib	U87	PA10252	677775;641648	0.755
NULL	Oncol_Lett_2014_Jan_6_7(1)_255-259.nxml.txt.nlp	24348859	SENT93	32	32	27	27	cisplatin	DCX	PA449014	1641	0.755
NULL	J_Cardiothorac_Surg_2010_Apr_19_5_26.nxml.txt.nlp	20403156	SENT90	3	3	13	13	etomidate	RAI	PA164743987	10848;6050	0.755
NULL	Case_Rep_Transplant_2011_Jun_27_2011_251930.nxml.txt.nlp	23198254	SENT23	7	7	20	20	cytarabine	CD34	PA449177	947	0.755
NULL	Oncogene_2014_Jun_26_33(26)_3422-3431.nxml.txt.nlp	23912457	SENT16	4	4	2	2	trastuzumab	HER2	PA451743	2064	0.755
NULL	Eur_J_Endocrinol_2009_Nov_161(5)_655-662.nxml.txt.nlp	19729432	SENT86	4	4	7	7	rimonabant	CB1	PA152407999	1268	0.755
NULL	Evid_Based_Complement_Alternat_Med_2012_Aug_30_2012_517965.nxml.txt.nlp	22969827	SENT154	13	13	0	0	ethanol	SIRT1	PA448073	23411	0.755
NULL	Br_J_Cancer_2013_Mar_19_108(5)_1052-1060.nxml.txt.nlp	23422754	SENT34	4	4	18	18	bevacizumab	VEGF-A	PA130232992	7422	0.755
NULL	Evid_Based_Complement_Alternat_Med_2013_Mar_26_2013_974313.nxml.txt.nlp	23589723	SENT172	27	27	38	38	metformin	AMPK	PA450395	5563	0.755
NULL	F1000Res_2013_Oct_8_2_173.nxml.txt.nlp	24555085	SENT38	30	30	9	9	flunisolide	BDP	PA449661	10620;152926	0.755
NULL	Int_J_Mol_Imaging_2011_Oct_26_2011_874585.nxml.txt.nlp	21490735	SENT191	3	3	17	17	glucose	FDG	PA449773	23583	0.755
NULL	Arthritis_Res_Ther_2007_Oct_9_9(5)_R104.nxml.txt.nlp	17925024	SENT193	28	28	5	5	glucosamine	JNK	PA164747613	5599	0.755
NULL	J_Clin_Biochem_Nutr_2009_Nov_28_45(3)_285-291.nxml.txt.nlp	19902018	SENT150	12	12	16	16	hesperetin	XDH	PA164742902	7498	0.755
NULL	Am_J_Physiol_Cell_Physiol_2014_Jan_15_306(2)_C89-C97.nxml.txt.nlp	24133067	SENT194	7	7	22	22	hyaluronidase	CD44	PA164745713	960	0.755
NULL	Curr_Oncol_2007_Aug_14(4)_125.nxml.txt.nlp	NULL	SENT11	12	12	18	18	trastuzumab	San	PA451743	80218	0.755
NULL	J_Neuroinflammation_2010_Sep_7_7_51.nxml.txt.nlp	20822529	SENT155	0	0	14	14	hemin	p38	PA449849	10598;1432;7965	0.755
NULL	J_Radiat_Res_2014_Nov_16_55(6)_1171-1177.nxml.txt.nlp	25129557	SENT183	22	22	25	25	bevacizumab	CRT	PA130232992	811	0.755
NULL	Cell_Death_Dis_2012_Mar_1_3(3)_e275.nxml.txt.nlp	22378068	SENT84	7	7	10	10	metformin	AMPK	PA450395	5563	0.755
NULL	Front_Endocrinol_(Lausanne)_2011_Dec_21_2_84.nxml.txt.nlp	22654830	SENT50	6	6	17	17	rosiglitazone	CPT1	PA451283	56994	0.755
NULL	Curr_Oncol_2009_Aug_16(4)_9-21.nxml.txt.nlp	19672420	SENT109	7	7	4	4	gefitinib	EGFR	PA131301952	1956	0.755
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT176	16	16	10	10	doxorubicin	B7-H1	PA449412	29126	0.755
NULL	Extremophiles_2009_Nov_23_13(6)_885-894.nxml.txt.nlp	19701714	SENT138	23	23	45	45	ethanol	mol	PA448073	90527	0.755
NULL	Arthritis_Res_Ther_2007_Sep_4_9(5)_R85.nxml.txt.nlp	17784951	SENT177	26	26	2	2	nitroprusside	IL-15	PA451406	3600	0.755
NULL	BMB_Rep_2014_Nov_47(11)_649-654.nxml.txt.nlp	25301019	SENT130	16	16	11	11	l-alanine	T1R1	PA448055	80835	0.755
NULL	Clinics_(Sao_Paulo)_2014_Jan_69(1)_68-74.nxml.txt.nlp	24473562	SENT146	7	7	5	5	nutlin-3	SOCS-1		8651	0.755
NULL	Int_J_Mol_Sci_2014_May_9_15(5)_8256-8279.nxml.txt.nlp	24821544	SENT156	21	21	10	10	choline	THP1	PA448976	2736	0.755
NULL	J_Mol_Signal_2010_May_10_5_4.nxml.txt.nlp	20459745	SENT58	14	14	5	5	cisplatin	p53	PA449014	7157	0.755
NULL	Oncotarget_2014_Aug_29_5(19)_8947-8958.nxml.txt.nlp	25333254	SENT129	15	15	29	29	plerixafor	CXCR7	PA165958410	57007	0.755
NULL	Front_Oncol_2014_Nov_25_4_329.nxml.txt.nlp	25505733	SENT34	14	14	8	8	gefitinib	EGFR	PA131301952	1956	0.755
NULL	Diabetes_2009_Jun_31_58(6)_1434-1439.nxml.txt.nlp	19336679	SENT198	17	17	9	9	metformin	OCT2	PA450395	6582;5452	0.755
NULL	Breast_Cancer_Res_2012_Jun_7_14(3)_R89.nxml.txt.nlp	22676470	SENT195	0	0	8	8	trastuzumab	HER2	PA451743	2064	0.755
NULL	Ann_Surg_Treat_Res_2014_Feb_22_86(2)_68-75.nxml.txt.nlp	24761411	SENT167	0	0	9	9	resveratrol	survivin		332	0.755
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Nov_13_64(Pt_12)_o2334.nxml.txt.nlp	21581309	SENT3	10	10	14	14	piperazine	mol	PA450977	90527	0.755
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT171	3	3	8	8	atorvastatin	ERK	PA448500	5594	0.755
NULL	Diabetes_Care_2013_Jan_10_36(Suppl_1)_S11-S66.nxml.txt.nlp	23264422	SENT1745	21	21	18	18	pramlintide	GLP-1	PA164781394	100125288	0.754
NULL	Adipocyte_2013_Jan_1_2(1)_28-32.nxml.txt.nlp	23700549	SENT70	20	20	39	39	valsartan	c-Jun	PA451848	3725	0.754
NULL	Oncogene_2014_Sep_18_33(38)_4685-4696.nxml.txt.nlp	24121268	SENT155	13	13	5	5	bortezomib	p53	PA10252	7157	0.754
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_127043.nxml.txt.nlp	23227093	SENT10	33	33	44	44	gemfibrozil	RYR	PA449750	6261	0.754
NULL	Pharmaceutics_2011_Nov_18_3(4)_865-913.nxml.txt.nlp	24309312	SENT167	0	0	33	33	tizanidine	CYP3A4	PA451701	1576	0.754
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Sep_12_65(Pt_10)_o2430.nxml.txt.nlp	21577886	SENT84	0	0	6	6	benzaldehyde	mol	PA448571	90527	0.754
NULL	Front_Oncol_2014_Sep_15_4_248.nxml.txt.nlp	25309873	SENT211	15	15	25	25	afatinib	EGFR	PA165981154	1956	0.754
NULL	Cell_Res_2012_Aug_22_22(8)_1227-1245.nxml.txt.nlp	22613949	SENT102	12	12	5	5	bortezomib	CDC6	PA10252	990	0.754
NULL	Clin_Sci_(Lond)_2012_May_1_122(Pt_9)_421-428.nxml.txt.nlp	22092038	SENT185	3	3	10	10	doxycycline	AP-1	PA449415	2353;3727;2354;3725	0.754
NULL	Oncogene_2009_Jan_15_28(2)_279-288.nxml.txt.nlp	18836480	SENT262	12	12	16	16	pp2	PP2		4888	0.754
NULL	Mol_Cancer_2010_May_18_9_110.nxml.txt.nlp	20482802	SENT121	7	7	19	19	bortezomib	CHOP	PA10252	1649	0.754
NULL	Korean_J_Anesthesiol_2013_May_24_64(5)_426-431.nxml.txt.nlp	23741565	SENT154	3	3	0	0	dexmedetomidine	DMT	PA449256	2039	0.754
NULL	J_Breast_Cancer_2013_Jun_28_16(2)_164-170.nxml.txt.nlp	23843848	SENT14	0	0	30	30	doxorubicin	p53	PA449412	7157	0.754
NULL	Int_J_Mol_Sci_2014_Mar_5_15(3)_3970-3988.nxml.txt.nlp	24603537	SENT169	2	2	0	0	curcumin	MCH	PA151958596	5367	0.754
NULL	Breast_Cancer_Res_2006_Nov_6_8(6)_215.nxml.txt.nlp	17096862	SENT104	27	27	17	17	lapatinib	EGFR	PA152241907	1956	0.754
NULL	J_Breast_Cancer_2013_Dec_31_16(4)_395-403.nxml.txt.nlp	24454461	SENT121	17	17	15	15	trastuzumab	NACT	PA451743	284111	0.754
NULL	Biomed_Imaging_Interv_J_2007_Oct_1_3(4)_e52.nxml.txt.nlp	21614300	SENT98	5	5	12	12	doxorubicin	CHOP	PA449412	1649	0.754
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT1443	21	21	30	30	urea	ECM	PA451831	22915	0.754
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT141	7	7	10	10	simvastatin	survivin	PA451363	332	0.754
NULL	Front_Endocrinol_(Lausanne)_2013_Jun_10_4_69.nxml.txt.nlp	23772224	SENT1211	4	4	13	13	rosiglitazone	NFkappaB	PA451283	4790	0.754
NULL	Anesth_Essays_Res_2014_Sep-Dec_8(3)_307-312.nxml.txt.nlp	NULL	SENT49	10	10	24	24	bupivacaine	Era	PA135057240	2099	0.754
NULL	Breast_Cancer_Res_2013_Oct_22_15(5)_R98.nxml.txt.nlp	24148581	SENT52	18	18	33	33	tamoxifen	aromatase	PA451581	1588	0.754
NULL	Mol_Cell_Proteomics_2012_Feb_6_11(2)_M111_015222.nxml.txt.nlp	22147731	SENT360	22	22	29	29	gefitinib	EGF	PA131301952	1950	0.754
NULL	CNS_Drugs_2014_May_1_28(6)_497-511.nxml.txt.nlp	24788672	SENT29	3	3	24	24	amphetamine	ATX	PA448408	5168;23049	0.754
NULL	Alcohol_Res_2012_34(4)_495-505.nxml.txt.nlp	23584115	SENT150	23	23	8	8	ethanol	RACK1	PA448073	10399	0.754
NULL	Brain_Behav_2012_Sep_10_2(5)_532-540.nxml.txt.nlp	23139899	SENT36	20	20	12	12	pilocarpine	CA1	PA450962	759	0.754
NULL	J_Gen_Physiol_1994_Oct_1_104(4)_773-800.nxml.txt.nlp	7836941	SENT9	0	0	12	12	protamine	ADP	PA10366	23038	0.754
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_127043.nxml.txt.nlp	23227093	SENT191	16	16	10	10	gemfibrozil	CYP2C8	PA449750	1558	0.754
NULL	Oncotarget_2012_Jul_10_3(6)_640-650.nxml.txt.nlp	22791660	SENT192	3	3	20	20	curcumin	MDR1	PA151958596	5243	0.754
NULL	Ann_Hematol_2012_Sep_28_91(9)_1499-1500.nxml.txt.nlp	22281990	SENT20	18	18	20	20	rituximab	CHOP	PA451261	1649	0.754
NULL	EMBO_Mol_Med_2011_May_3(5)_266-278.nxml.txt.nlp	21438154	SENT106	6	6	10	10	oxaliplatin	TRPM8	PA131285527	79054	0.754
NULL	Oncotarget_2014_Aug_29_5(18)_8052-8082.nxml.txt.nlp	25211298	SENT453	2	2	7	7	sertraline	U87	PA451333	677775;641648	0.754
NULL	Front_Behav_Neurosci_2009_Jan_27_3_1.nxml.txt.nlp	19194528	SENT126	5	5	12	12	fluoxetine	spatial	PA449673	219793	0.754
NULL	Mol_Cancer_2010_Apr_23_9_87.nxml.txt.nlp	20416058	SENT44	27	27	23	23	etoposide	TRAIL	PA449552	8743	0.754
NULL	F1000Res_2013_Jul_9_2_151.nxml.txt.nlp	24555069	SENT340	6	6	11	11	memantine	CA3	PA10364	761	0.754
NULL	Mol_Biol_Int_2012_Jun_26_2012_256982.nxml.txt.nlp	22792462	SENT163	29	29	25	25	maraviroc	CCR5	PA164768835	1234	0.754
NULL	Evid_Based_Complement_Alternat_Med_2011_Mar_14_2011_635058.nxml.txt.nlp	21437195	SENT228	6	6	12	12	cilomilast	PDE4D	PA165948031	5144	0.754
NULL	Environ_Health_Perspect_2008_Mar_3_116(3)_308-314.nxml.txt.nlp	18335096	SENT190	5	5	29	29	estradiol	aromatase	PA449503	1588	0.754
NULL	Int_J_Mol_Sci_2014_Mar_24_15(3)_5140-5162.nxml.txt.nlp	24663085	SENT234	18	18	26	26	cyclophosphamide	LP1	PA449165	6176	0.754
NULL	Clin_Med_Insights_Oncol_2012_Mar_12_6_137-147.nxml.txt.nlp	22550402	SENT81	10	10	1	1	erlotinib	EGFR	PA134687924	1956	0.754
NULL	J_Biomed_Sci_2013_Mar_15_20(1)_17.nxml.txt.nlp	23497194	SENT145	19	19	17	17	indomethacin	COX	PA449982	1351	0.754
NULL	Case_Rep_Med_2009_Aug_9_2009_378287.nxml.txt.nlp	19721707	SENT15	1	1	7	7	simvastatin	CYP3A	PA451363	1574	0.754
NULL	Breast_Cancer_Res_2010_Aug_23_12(4)_R64.nxml.txt.nlp	20731819	SENT334	1	1	5	5	tamoxifen	aromatase	PA451581	1588	0.754
NULL	Mol_Cytogenet_2010_Sep_15_3_17.nxml.txt.nlp	20840797	SENT115	35	35	10	10	mitomycin	p53	PA450524	7157	0.754
NULL	Int_J_Endocrinol_2014_Aug_11_2014_312452.nxml.txt.nlp	25183970	SENT159	11	11	7	7	liraglutide	PI3K	PA165958364	5290	0.754
NULL	Iran_J_Pharm_Res_2014_Summer_13(3)_919-926.nxml.txt.nlp	25276192	SENT161	3	3	5	5	hesperidin	p53	PA449867	7157	0.754
NULL	J_Young_Pharm_2011_Jul-Sep_3(3)_216-220.nxml.txt.nlp	21897661	SENT79	5	5	8	8	ramipril	SLN	PA451223	6588	0.754
NULL	Ther_Clin_Risk_Manag_2007_Jun_3(2)_245-258.nxml.txt.nlp	18360633	SENT57	1	1	10	10	etanercept	TNF-alpha	PA449515	7124	0.754
NULL	Brain_Res_2013_Jul_12_1521(100)_1-15.nxml.txt.nlp	22789905	SENT275	14	14	16	16	colchicine	P-gp	PA449092	5243	0.754
NULL	F1000_Biol_Rep_2012_Mar_1_4_5.nxml.txt.nlp	22403588	SENT101	13	13	10	10	ribavirin	IFN	PA451241	3439	0.754
NULL	Neuropsychopharmacology_2011_Apr_2_36(5)_1033-1046.nxml.txt.nlp	21289603	SENT367	10	10	20	20	ethanol	MSN	PA448073	4478	0.754
NULL	Case_Rep_Med_2014_Mar_24_2014_860570.nxml.txt.nlp	24782898	SENT16	17	17	8	8	choline	FDG	PA448976	23583	0.754
NULL	EMBO_Mol_Med_2013_Mar_18_5(3)_344-352.nxml.txt.nlp	23417962	SENT98	6	6	23	23	resveratrol	SIRT1		23411	0.754
NULL	Clinics_(Sao_Paulo)_2014_Jan_69(1)_68-74.nxml.txt.nlp	24473562	SENT124	5	5	3	3	nutlin-3	SOCS-1		8651	0.754
NULL	Cardiol_Res_Pract_2011_Apr_3_2011_320983.nxml.txt.nlp	21559260	SENT18	1	1	22	22	everolimus	DES	PA164746311	1674	0.754
NULL	Target_Oncol_2013_Jun_27_8(2)_127-136.nxml.txt.nlp	23625191	SENT154	24	24	13	13	cetuximab	BRAF	PA10040	673	0.754
NULL	Infect_Drug_Resist_2009_Apr_24_2_13-26.nxml.txt.nlp	21694884	SENT86	7	7	5	5	emtricitabine	TDF	PA10069	6736	0.754
NULL	Basic_Res_Cardiol_2015_Jan_20_110_4.nxml.txt.nlp	25600226	SENT293	6	6	14	14	simvastatin	PCSK9	PA451363	255738	0.754
NULL	J_Vet_Med_Sci_2014_Sep_27_76(9)_1201-1208.nxml.txt.nlp	24871549	SENT144	19	19	6	6	diethylstilbestrol	StAR	PA449307	6770	0.754
NULL	Evid_Based_Complement_Alternat_Med_2004_Jun_1(1)_83-91.nxml.txt.nlp	15257329	SENT103	18	18	8	8	sugar	SKT	PA451529	56243	0.754
NULL	Front_Oncol_2011_Jul_20_1_18.nxml.txt.nlp	22655233	SENT711	8	8	3	3	isotretinoin	GM-CSF	PA450128	1437	0.754
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1063.nxml.txt.nlp	24556678	SENT41	2	2	12	12	thioridazine	Mcl-1	PA451666	4170	0.754
NULL	Indian_J_Anaesth_2013_Sep-Oct_57(5)_446-454.nxml.txt.nlp	24249877	SENT196	4	4	18	18	desflurane	CO2	PA164749136	4513	0.754
NULL	Cancer_Cell_Int_2010_Sep_9_10_32.nxml.txt.nlp	20828393	SENT152	20	20	31	31	cisplatin	PC3	PA449014	57332;7832;5122	0.754
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT146	15	15	4	4	simvastatin	survivin	PA451363	332	0.754
NULL	Br_J_Cancer_2012_Jul_24_107(3)_549-555.nxml.txt.nlp	22713658	SENT142	2	2	4	4	tamoxifen	aromatase	PA451581	1588	0.754
NULL	ScientificWorldJournal_2013_Sep_19_2013_809891.nxml.txt.nlp	24170983	SENT180	8	8	4	4	ketorolac	CD86	PA450150	942	0.754
NULL	Clin_Drug_Investig_2013_Jun_20_33(6)_419-427.nxml.txt.nlp	23605507	SENT171	17	17	5	5	ciprofloxacin	DPI	PA449009	1832	0.754
NULL	ACS_Synth_Biol_2013_Oct_18_2(10)_547-567.nxml.txt.nlp	23905721	SENT399	19	19	21	21	trimethoprim	TMP	PA451788	2012	0.754
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT81	16	16	39	39	trastuzumab	STAT3	PA451743	6774	0.754
NULL	Crit_Care_2000_Mar_21_4(Suppl_1)_P26.nxml.txt.nlp	NULL	SENT16	19	19	2	2	staurosporine	ATIII	PA165109623	462	0.754
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT4	11	11	7	7	resveratrol	TNF		7124	0.754
NULL	Acta_Neuropathol_2015_Oct_17_129_81-96.nxml.txt.nlp	25322817	SENT143	3	3	15	15	capsaicin	TRPV1	PA448776	7442	0.754
NULL	ScientificWorldJournal_2014_Jul_23_2014_854093.nxml.txt.nlp	25147870	SENT165	44	44	36	36	chlorophyll	gamma	PA448942	9913	0.754
NULL	Environ_Health_Perspect_2001_May_109(5)_539-545.nxml.txt.nlp	11401768	SENT9	15	15	9	9	cholestyramine	PEAS	PA448974	116138	0.754
NULL	Cancer_Inform_2014_Oct_14_13(Suppl_1)_103-111.nxml.txt.nlp	25392688	SENT225	33	33	31	31	ketoconazole	CYP3A5	PA450146	1577	0.754
NULL	Int_J_Med_Sci_2015_Jan_1_12(1)_63-71.nxml.txt.nlp	25552920	SENT106	34	34	14	14	berberine	PC-3	PA165860812	692094	0.754
NULL	J_Korean_Med_Sci_2010_Dec_24_25(12)_1766-1770.nxml.txt.nlp	21165292	SENT84	13	13	26	26	sugar	GFR	PA451529	9771	0.754
NULL	Mol_Cancer_2013_Oct_7_12_116.nxml.txt.nlp	24098916	SENT155	0	0	6	6	benzaldehyde	mol	PA448571	90527	0.754
NULL	Int_J_Mol_Sci_2013_Apr_18_14(4)_8570-8584.nxml.txt.nlp	23598418	SENT116	5	5	11	11	bevacizumab	San	PA130232992	80218	0.754
NULL	Br_J_Cancer_2013_Oct_15_109(8)_2155-2166.nxml.txt.nlp	24045666	SENT43	8	8	20	20	erlotinib	CD4	PA134687924	920	0.754
NULL	Chem_Rev_2011_Oct_12_111(10)_5899-5921.nxml.txt.nlp	21923193	SENT551	38	38	24	24	indomethacin	CB1	PA449982	1268	0.754
NULL	Int_J_Hypertens_2011_Nov_13_2011_902129.nxml.txt.nlp	22164326	SENT82	17	17	27	27	l-arginine	nNOS	PA448478	4842	0.754
NULL	Oncotarget_2013_Nov_23_5(1)_196-210.nxml.txt.nlp	24344116	SENT108	11	11	30	30	doxorubicin	TNFAIP3	PA449412	7128	0.754
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_30_2013_789764.nxml.txt.nlp	23737845	SENT254	28	28	15	15	carbamazepine	CYP3A	PA448785	1574	0.754
NULL	Acta_Pharmacol_Sin_2012_Jun_30_33(6)_767-774.nxml.txt.nlp	22543702	SENT10	11	11	21	21	nitroprusside	P-gp	PA451406	5243	0.754
NULL	J_Gen_Physiol_1997_Dec_1_110(6)_643-654.nxml.txt.nlp	9382893	SENT154	10	10	16	16	diazoxide	SUR1	PA449285	6833	0.754
NULL	Orphanet_J_Rare_Dis_2014_Aug_5_9_122.nxml.txt.nlp	25091295	SENT190	8	8	19	19	rosiglitazone	ACTH	PA451283	5443	0.754
NULL	Exp_Anim_2014_Jul_22_63(4)_467-473.nxml.txt.nlp	25048262	SENT345	8	8	13	13	l-carnitine	OCTN2	PA450154	6584	0.754
NULL	Avicenna_J_Phytomed_2012_Spring_2(2)_72-78.nxml.txt.nlp	25050233	SENT4	10	10	25	25	imipramine	FST	PA449969	10468	0.754
NULL	Br_J_Cancer_2009_Mar_10_100(5)_758-763.nxml.txt.nlp	19259094	SENT73	2	2	9	9	belinostat	MLH1		4292	0.754
NULL	Pain_Res_Manag_2014_Nov-Dec_19(6)_e172-e178.nxml.txt.nlp	24992453	SENT186	4	4	17	17	fasudil	Rho	PA165946121	29984	0.754
NULL	EMBO_Mol_Med_2012_Sep_7_4(9)_896-909.nxml.txt.nlp	22887866	SENT168	13	13	10	10	lovastatin	c-Myc	PA450272	4609	0.754
NULL	Cardiol_Ther_2013_Jun_7_2(1)_57-68.nxml.txt.nlp	25135289	SENT41	8	8	0	0	ticagrelor	P2Y12	PA165374673	64805	0.754
NULL	Exp_Diabetes_Res_2011_Jun_23_2011_898913.nxml.txt.nlp	21747834	SENT32	0	0	17	17	metformin	GLP-1	PA450395	100125288	0.754
NULL	Br_J_Cancer_2012_Nov_20_107(11)_1892-1900.nxml.txt.nlp	23079573	SENT128	3	3	13	13	paclitaxel	TMSB15A	PA450761	11013	0.754
NULL	Nucleic_Acids_Res_2011_Mar_23_39(4)_e20.nxml.txt.nlp	21106497	SENT271	13	13	6	6	arsenite	c-fos	PA452638	2353	0.754
NULL	Mol_Cancer_2010_Aug_18_9_218.nxml.txt.nlp	20718987	SENT187	12	12	24	24	gefitinib	EGFR	PA131301952	1956	0.754
NULL	Case_Rep_Dermatol_2013_Apr_16_5(1)_115-119.nxml.txt.nlp	23687489	SENT100	7	7	20	20	rituximab	CD19	PA451261	930	0.754
NULL	Nat_Med_2013_Mar_10_19(3)_313-321.nxml.txt.nlp	23396211	SENT368	5	5	13	13	amlexanox	TBK1	PA164745310	29110	0.754
NULL	Clin_Interv_Aging_2008_Mar_3(1)_45-50.nxml.txt.nlp	18488877	SENT148	6	6	8	8	raloxifene	STAR	PA451221	6770;2984	0.754
NULL	Adv_Hematol_2012_Jul_24_2012_513702.nxml.txt.nlp	22888354	SENT111	5	5	36	36	lenalidomide	CD16	PA162363968	2215;2214	0.754
NULL	Clin_Ophthalmol_2014_Dec_30_9_43-49.nxml.txt.nlp	25565767	SENT107	6	6	3	3	acetazolamide	SRF	PA448018	6722	0.754
NULL	Nucl_Recept_Signal_2010_Nov_19_8_e005.nxml.txt.nlp	21383957	SENT273	27	27	14	14	taurine	BAAT	PA451590	570	0.754
NULL	Br_J_Cancer_2010_Nov_2_103(11)_1680-1691.nxml.txt.nlp	21045833	SENT154	12	12	24	24	vorinostat	BAX	PA164748224	581	0.754
NULL	Carcinogenesis_2010_Dec_27_31(12)_2049-2057.nxml.txt.nlp	20876285	SENT106	10	10	3	3	tamoxifen	HER2	PA451581	2064	0.754
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2654-2664.nxml.txt.nlp	24136149	SENT256	27	27	5	5	doxorubicin	HSF1	PA449412	3297	0.754
NULL	Mol_Cancer_2012_Jul_25_11_46.nxml.txt.nlp	22830422	SENT8	2	2	5	5	rolipram	AKT	PA153906323	207	0.754
NULL	Behav_Sci_(Basel)_2012_Jun_21_2(2)_135-171.nxml.txt.nlp	23077729	SENT396	29	29	21	21	fluoxetine	CRHR1	PA449673	1394	0.754
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT76	15	15	30	30	l-methionine	p27	PA450423	5715;10534	0.754
NULL	Cancers_(Basel)_2014_Mar_26_6(2)_708-722.nxml.txt.nlp	24675568	SENT107	27	27	17	17	afatinib	IL-6	PA165981154	3569	0.754
NULL	Subst_Abuse_Treat_Prev_Policy_2008_Oct_3_3_20.nxml.txt.nlp	18834506	SENT191	15	15	5	5	escitalopram	Gen	PA10074	348654	0.754
NULL	Sensors_(Basel)_2012_May_18_12(5)_6520-6537.nxml.txt.nlp	22778656	SENT163	31	31	29	29	cyclophosphamide	CYP3A4	PA449165	1576	0.754
NULL	Eur_J_Clin_Pharmacol_2013_Jan_11_69(6)_1275-1283.nxml.txt.nlp	23307232	SENT10	9	9	14	14	warfarin	VKORC1	PA451906	79001	0.754
NULL	J_Clin_Exp_Pathol_2012_May_17_Suppl_4_7327.nxml.txt.nlp	25379357	SENT92	2	2	35	35	resveratrol	AMPK		5563	0.754
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Sep_5_65(Pt_10)_o2357.nxml.txt.nlp	21577826	SENT61	23	23	12	12	phenol	mol	PA450913	90527	0.754
NULL	Breast_Cancer_Res_Treat_2014_Nov_24_143(1)_125-133.nxml.txt.nlp	24272078	SENT116	9	9	1	1	everolimus	aromatase	PA164746311	1588	0.754
NULL	F1000Res_2013_Oct_8_2_173.nxml.txt.nlp	24555085	SENT227	44	44	14	14	hydrocortisone	BDP	PA449905	10620;152926	0.754
NULL	J_Oncol_2012_Jun_19_2012_521215.nxml.txt.nlp	22778735	SENT254	11	11	17	17	cetuximab	ERBB2	PA10040	2064	0.754
NULL	Eur_J_Med_Res_2014_Sep_16_19(1)_50.nxml.txt.nlp	25223338	SENT246	9	9	2	2	cisplatin	ERCC1	PA449014	2067	0.754
NULL	Breast_Cancer_Res_2004_Nov_7_6(1)_39-52.nxml.txt.nlp	14680484	SENT243	11	11	5	5	raloxifene	STAR	PA451221	6770;2984	0.754
NULL	Indian_J_Med_Res_2013_Jan_137(1)_203-209.nxml.txt.nlp	23481074	SENT96	4	4	16	16	coumarin	VKORC1	PA134521193	79001	0.754
NULL	Clin_Dev_Immunol_2011_Dec_5_2011_894704.nxml.txt.nlp	22190975	SENT249	14	14	27	27	panitumumab	EGFR	PA162373091	1956	0.754
NULL	J_Antimicrob_Chemother_2009_Feb_28_63(2)_389-395.nxml.txt.nlp	19042940	SENT18	19	19	6	6	trimethoprim	UTI	PA451788	259	0.754
NULL	Br_J_Cancer_2013_Sep_3_109(5)_1157-1164.nxml.txt.nlp	23942075	SENT144	10	10	8	8	trastuzumab	HER2	PA451743	2064	0.754
NULL	Int_J_Mol_Imaging_2011_Oct_26_2011_874585.nxml.txt.nlp	21490735	SENT206	0	0	24	24	glucose	OMG	PA449773	4974	0.754
NULL	Oncotarget_2014_Sep_3_5(19)_9362-9381.nxml.txt.nlp	25313139	SENT74	20	20	33	33	orlistat	AMPK	PA164776864	5563	0.754
NULL	Br_J_Cancer_1998_May_77(10)_1645-1652.nxml.txt.nlp	9635842	SENT19	18	18	16	16	sn-38	TPT		23590;6469	0.754
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Sep_14_67(Pt_10)_o2587-o2588.nxml.txt.nlp	22064439	SENT80	4	4	10	10	piperazine	mol	PA450977	90527	0.754
NULL	J_Mol_Signal_2008_Mar_31_3_8.nxml.txt.nlp	18377662	SENT124	25	25	12	12	pp2	KDR		3791	0.754
NULL	Endocrinol_Metab_(Seoul)_2014_Sep_25_29(3)_211-216.nxml.txt.nlp	25309777	SENT81	6	6	38	38	sunitinib	MTC	PA162372840	4914	0.754
NULL	Int_J_Mol_Sci_2014_Sep_29_15(10)_17411-17441.nxml.txt.nlp	25268615	SENT217	25	25	5	5	paclitaxel	P-gp	PA450761	5243	0.754
NULL	Chin_J_Cancer_2012_Jul_31(7)_319-326.nxml.txt.nlp	22257382	SENT105	0	0	7	7	gefitinib	EGFR	PA131301952	1956	0.754
NULL	J_Cell_Biol_1998_May_4_141(3)_839-847.nxml.txt.nlp	9566981	SENT276	11	11	20	20	guanidine	osteoadherin	PA164781028	4958	0.754
NULL	Cancer_Med_2014_Jun_14_3(3)_580-591.nxml.txt.nlp	24574330	SENT43	18	18	14	14	bevacizumab	IL-6	PA130232992	3569	0.754
NULL	Infect_Dis_Ther_2014_Dec_5_3(2)_69-81.nxml.txt.nlp	25475412	SENT80	22	22	13	13	daptomycin	TEC	PA164768820	7006	0.754
NULL	Dermatoendocrinol_2013_Apr_1_5(2)_252-263.nxml.txt.nlp	24194965	SENT146	0	0	9	9	metformin	AMPK	PA450395	5563	0.754
NULL	Int_J_Med_Sci_2015_Jan_1_12(1)_63-71.nxml.txt.nlp	25552920	SENT116	3	3	15	15	berberine	NODAL	PA165860812	4838	0.754
NULL	Indian_J_Pharmacol_2012_Sep-Oct_44(5)_624-628.nxml.txt.nlp	23112426	SENT135	25	25	21	21	pravastatin	P-gp	PA451089	5243	0.754
NULL	Cancer_Microenviron_2009_Sep_26_2(Suppl_1)_19-204.nxml.txt.nlp	NULL	SENT5191	19	19	16	16	cetuximab	EGFR	PA10040	1956	0.754
NULL	Appl_Microbiol_Biotechnol_2014_Feb_18_98(8)_3829-3840.nxml.txt.nlp	24535257	SENT11	21	21	11	11	ethanol	PE-2	PA448073	2077	0.754
NULL	J_Vet_Med_Sci_2014_Jul_27_76(7)_1055-1059.nxml.txt.nlp	24670993	SENT53	31	31	18	18	gentamicin	CO2	PA449753	4513	0.754
NULL	Semin_Immunol_2014_Aug_26(4)_329-340.nxml.txt.nlp	25028340	SENT489	9	9	21	21	dextran	IL-5	PA449261	3567	0.754
NULL	Med_Sci_Monit_2013_Oct_31_19_916-926.nxml.txt.nlp	24172537	SENT108	22	22	17	17	sorafenib	VEGFR	PA7000	3791	0.754
NULL	Infect_Drug_Resist_2010_Apr_26_3_15-23.nxml.txt.nlp	21694890	SENT25	11	11	4	4	raltegravir	UGT		7361;7355	0.754
NULL	J_Immunother_Cancer_2014_Nov_6_2(Suppl_3)_P56.nxml.txt.nlp	NULL	SENT7	11	11	6	6	cisplatin	IFN	PA449014	3439	0.754
NULL	J_Mol_Med_2009_Jul_30_87(7)_713-722.nxml.txt.nlp	19404587	SENT13	14	14	8	8	ribavirin	IFN	PA451241	3439	0.754
NULL	Cancer_Growth_Metastasis_2013_Aug_8_6_35-52.nxml.txt.nlp	24665206	SENT59	0	0	9	9	curcumin	NFKBIA	PA151958596	4792	0.754
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT85	15	15	6	6	celecoxib	IL-6	PA448871	3569	0.754
NULL	Ann_Hematol_2010_Nov_25_89(11)_1115-1124.nxml.txt.nlp	20499237	SENT119	32	32	2	2	simvastatin	CD19	PA451363	930	0.754
NULL	J_Cell_Mol_Med_2014_Aug_1_18(8)_1599-1611.nxml.txt.nlp	24889822	SENT306	8	8	14	14	resveratrol	FOXO1		2308	0.754
NULL	Brain_Sci_2013_Jun_3_3(2)_877-907.nxml.txt.nlp	24961429	SENT172	4	4	16	16	taurine	IRE1	PA451590	2081	0.754
NULL	Am_J_Case_Rep_2012_Nov_19_13_271-275.nxml.txt.nlp	23569547	SENT73	6	6	21	21	diethylstilbestrol	DES	PA449307	1674	0.754
NULL	Nucl_Recept_Signal_2009_Jan_16_7_e001.nxml.txt.nlp	19240808	SENT213	17	17	10	10	paclitaxel	SXR	PA450761	8856	0.754
NULL	Oncoimmunology_2014_Apr_25_3_e28518.nxml.txt.nlp	25071979	SENT136	5	5	8	8	oxaliplatin	CRT	PA131285527	811	0.754
NULL	Cancer_Metab_2014_Nov_3_2(1)_20.nxml.txt.nlp	NULL	SENT206	28	28	16	16	erlotinib	PDK4	PA134687924	5166	0.754
NULL	J_Hematol_Oncol_2013_Feb_18_6_18.nxml.txt.nlp	23415012	SENT175	12	12	21	21	perifosine	PRAP	PA165291471	51478	0.754
NULL	J_Vet_Med_Sci_2014_Jun_15_76(6)_813-817.nxml.txt.nlp	24531829	SENT142	41	41	44	44	artesunate	DPT	PA165111697	1805	0.754
NULL	Evid_Based_Complement_Alternat_Med_2013_Aug_12_2013_982689.nxml.txt.nlp	23997806	SENT152	20	20	25	25	tolbutamide	APE	PA451718	55704;328	0.754
NULL	J_Korean_Med_Sci_2006_Oct_31_21(5)_904-910.nxml.txt.nlp	17043427	SENT140	11	11	4	4	cisplatin	PK1	PA449014	84432	0.754
NULL	Biomed_Res_Int_2013_Jul_31_2013_692071.nxml.txt.nlp	23984399	SENT4	37	37	4	4	sorafenib	SLC22A1	PA7000	6580	0.754
NULL	Int_J_Environ_Res_Public_Health_2011_Jul_6_8(7)_2816-2827.nxml.txt.nlp	21845160	SENT225	25	25	17	17	naltrexone	gamma	PA450588	9913	0.754
NULL	BMJ_2014_Apr_15_348_g2366.nxml.txt.nlp	24736555	SENT400	26	26	5	5	rosiglitazone	GLP-1	PA451283	100125288	0.754
NULL	Amino_Acids_2012_Oct_10_43(4)_1751-1759.nxml.txt.nlp	22407485	SENT186	19	19	10	10	carrageenan	ghrelin	PA448814	51738	0.754
NULL	Chemother_Res_Pract_2011_Sep_21_2011_839742.nxml.txt.nlp	22295206	SENT79	6	6	9	9	oxaliplatin	CRT	PA131285527	811	0.754
NULL	Cases_J_2009_Jul_29_2_6449.nxml.txt.nlp	19829805	SENT62	25	25	7	7	cabergoline	PRL	PA448708	5617	0.754
NULL	Oncotarget_2013_Aug_30_4(10)_1698-1711.nxml.txt.nlp	24091605	SENT183	21	21	32	32	cisplatin	SOX2	PA449014	6657	0.754
NULL	Front_Neuroeng_2014_Oct_10_7_39.nxml.txt.nlp	25346683	SENT227	22	22	10	10	papain	SLC	PA450778	6366	0.754
NULL	Can_J_Infect_Dis_Med_Microbiol_2014_Nov-Dec_25(6)_327-343.nxml.txt.nlp	25587296	SENT155	2	2	7	7	posaconazole	P-gp	PA151958574	5243	0.754
NULL	Int_J_Breast_Cancer_2012_May_9_2012_415170.nxml.txt.nlp	22649737	SENT131	32	32	21	21	trastuzumab	DM1	PA451743	338023;1760;28509	0.754
NULL	J_Mol_Signal_2012_Aug_16_7_12.nxml.txt.nlp	22898329	SENT254	13	13	8	8	gefitinib	EGFR	PA131301952	1956	0.754
NULL	Mol_Cancer_2009_Oct_1_8_81.nxml.txt.nlp	19796390	SENT73	11	11	17	17	celecoxib	Bcl-2	PA448871	596	0.754
NULL	Diabetes_2011_Jul_20_60(7)_1926-1937.nxml.txt.nlp	21617180	SENT252	23	23	17	17	lipase	aP2	PA450239	2167	0.754
NULL	Front_Neurol_2014_Jan_31_5_11.nxml.txt.nlp	24550884	SENT201	15	15	30	30	levetiracetam	CA3	PA450206	761	0.754
NULL	Comp_Hepatol_2004_Jan_14_3(Suppl_1)_S37.nxml.txt.nlp	14960189	SENT107	9	9	12	12	thalidomide	TNF-alpha	PA451644	7124	0.754
NULL	Cancer_Metab_2013_Aug_14_1_18.nxml.txt.nlp	24280377	SENT340	31	31	8	8	phenformin	LKB1	PA1000	6794	0.754
NULL	Mol_Cancer_2014_Jan_13_13_7.nxml.txt.nlp	24418169	SENT173	2	2	9	9	sorafenib	STAT3	PA7000	6774	0.754
NULL	Breast_Cancer_Res_2012_Mar_16_14(2)_206.nxml.txt.nlp	22423895	SENT158	36	36	14	14	sunitinib	FDG	PA162372840	23583	0.754
NULL	Cancer_Med_2013_Aug_30_2(4)_457-467.nxml.txt.nlp	24156018	SENT6	9	9	18	18	marimastat	U87	PA164748329	677775;641648	0.754
NULL	Breast_Cancer_Res_Treat_2014_Dec_12_143(2)_239-253.nxml.txt.nlp	24337508	SENT290	13	13	26	26	efavirenz	TERT	PA449441	7015	0.754
NULL	Core_Evid_2009_Jun_15_4_131-147.nxml.txt.nlp	20694070	SENT242	4	4	14	14	raltegravir	CD4		920	0.754
NULL	Br_J_Cancer_2010_Oct_12_103(8)_1297-1304.nxml.txt.nlp	20842126	SENT103	30	30	13	13	choline	SMO	PA448976	6608;54498	0.754
NULL	Cancers_(Basel)_2014_Sep_30_6(4)_2035-2048.nxml.txt.nlp	25271833	SENT22	8	8	27	27	gefitinib	RANTES	PA131301952	6352	0.754
NULL	Mol_Biol_Rep_2012_May_20_39(5)_5253-5267.nxml.txt.nlp	22183301	SENT66	16	16	14	14	gliclazide	NAC	PA10892	22861	0.754
NULL	Breast_Cancer_Res_2008_Mar_27_10(2)_R26.nxml.txt.nlp	18371194	SENT113	23	23	25	25	cisplatin	PARP	PA449014	142	0.754
NULL	Cell_Death_Dis_2014_Mar_13_5(3)_e1118.nxml.txt.nlp	24625977	SENT81	36	36	13	13	etoposide	mot-2	PA449552	3313	0.754
NULL	Front_Oncol_2014_Apr_22_4_86.nxml.txt.nlp	24795863	SENT308	0	0	15	15	olaparib	BRCA2		675	0.754
NULL	Curr_Med_Chem_2014_May_21(14)_1595-1606.nxml.txt.nlp	23992330	SENT163	31	31	14	14	everolimus	PI3K	PA164746311	5290	0.754
NULL	Mol_Cancer_2008_Mar_26_7_27.nxml.txt.nlp	18366759	SENT261	12	12	22	22	etoposide	p53	PA449552	7157	0.754
NULL	Breast_Cancer_Res_2011_Mar_1_13(2)_R21.nxml.txt.nlp	21362200	SENT295	3	3	29	29	fulvestrant	PI3K	PA164747170	5290	0.754
NULL	Oxid_Med_Cell_Longev_2012_Aug_8_2012_920932.nxml.txt.nlp	22919442	SENT170	0	0	9	9	creatine	IL-10	PA164778930	3586	0.754
NULL	Int_J_Cell_Biol_2014_Jan_22_2014_709828.nxml.txt.nlp	24578708	SENT108	29	29	5	5	betaine	PEMT	PA448603	10400	0.754
NULL	Cancer_Med_2013_Jun_2_2(3)_286-295.nxml.txt.nlp	23930205	SENT252	17	17	20	20	doxorubicin	ABCG2	PA449412	9429	0.754
NULL	Clin_Pharmacol_2012_Feb_20_4_13-20.nxml.txt.nlp	22427735	SENT98	37	37	32	32	clopidogrel	P2Y12	PA449053	64805	0.754
NULL	Am_J_Trop_Med_Hyg_2012_Aug_1_87(2)_231-241.nxml.txt.nlp	22855752	SENT264	10	10	13	13	artemisinin	TRAC	PA165111696	28755	0.754
NULL	Breast_Cancer_Res_2001_Oct_1_3(6)_361-364.nxml.txt.nlp	11737886	SENT77	14	14	20	20	cyclophosphamide	Bcl-2	PA449165	596	0.754
NULL	Breast_Cancer_Res_2010_Mar_5_12(2)_R16.nxml.txt.nlp	20205716	SENT33	41	41	43	43	tamoxifen	aromatase	PA451581	1588	0.754
NULL	Gut_Liver_2011_Jun_24_5(2)_160-164.nxml.txt.nlp	21814595	SENT94	10	10	14	14	meperidine	ESD	PA450369	2098	0.754
NULL	Cancer_Microenviron_2009_May_6_2(1)_59-67.nxml.txt.nlp	19418243	SENT117	8	8	18	18	tetracycline	CCL21	PA451640	6366	0.754
NULL	J_Hematol_Oncol_2010_Oct_27_3_42.nxml.txt.nlp	20979652	SENT172	19	19	12	12	carboplatin	EGFR	PA448803	1956	0.754
NULL	Clin_Med_Insights_Case_Rep_2010_Aug_12_3_31-39.nxml.txt.nlp	21769252	SENT86	15	15	7	7	estradiol	aromatase	PA449503	1588	0.754
NULL	Acta_Pharmacol_Sin_2011_Dec_7_32(12)_1466-1474.nxml.txt.nlp	22056616	SENT245	2	2	16	16	iptakalim	FFR	PA165949694	738	0.754
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT137	0	0	6	6	perifosine	DR5	PA165291471	8795	0.754
NULL	J_Hematol_Oncol_2009_Apr_22_2_18.nxml.txt.nlp	19386128	SENT45	12	12	5	5	cetuximab	EGFR	PA10040	1956	0.754
NULL	J_Mol_Med_(Berl)_2014_Jan_10_92(5)_497-507.nxml.txt.nlp	24408111	SENT186	23	23	7	7	pioglitazone	HIF-1	PA450970	29072	0.754
NULL	Front_Neurosci_2011_Jul_14_5_88.nxml.txt.nlp	21808604	SENT438	8	8	6	6	aprepitant	NK1	PA164747039	11126	0.754
NULL	Biochim_Biophys_Acta_2013_Jul_1832(7)_905-910.nxml.txt.nlp	23032152	SENT110	32	32	35	35	ketanserin	5-HT2B	PA131053734	3357	0.754
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1676-1682.nxml.txt.nlp	19844234	SENT146	36	36	24	24	lapatinib	HER2	PA152241907	2064	0.754
NULL	F1000_Med_Rep_2009_Jan_21_1_8.nxml.txt.nlp	20948699	SENT9	27	27	22	22	thrombin	ADP	PA451674	23038	0.754
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT89	0	0	4	4	etravirine	CYP2B6	PA166014703	1555	0.754
NULL	Mol_Cancer_2008_Jan_7_7_2.nxml.txt.nlp	18179710	SENT231	27	27	39	39	l-glutamine	CO2	PA10090	4513	0.754
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT209	8	8	19	19	ranibizumab	VEGFR2	PA164746012	3791	0.754
NULL	Mol_Cancer_2009_Nov_10_8_99.nxml.txt.nlp	19903356	SENT101	21	21	4	4	imatinib	IGFBP3	PA10804	3486	0.754
NULL	Environ_Health_Perspect_1990_Apr_85_89-94.nxml.txt.nlp	2384071	SENT7	1	1	4	4	oxygen	NAC	PA450744	22861	0.754
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT257	26	26	21	21	ranibizumab	VEGF-A	PA164746012	7422	0.754
NULL	Biologics_2009_Sep_15_3_429-441.nxml.txt.nlp	19774210	SENT300	16	16	35	35	leucovorin	IFL	PA450198	3439	0.754
NULL	Nat_Chem_Biol_2013_Feb_2_9(2)_97-104.nxml.txt.nlp	23201900	SENT64	16	16	24	24	metformin	AMPK	PA450395	5563	0.754
NULL	Oncotarget_2013_Aug_30_4(10)_1698-1711.nxml.txt.nlp	24091605	SENT183	21	21	7	7	cisplatin	CD44	PA449014	960	0.754
NULL	Biochem_Biophys_Res_Commun_2008_Sep_5_373(4)_584-588.nxml.txt.nlp	18586007	SENT105	11	11	18	18	curcumin	NQO1	PA151958596	1728	0.754
NULL	JAKSTAT_2014_Jun_12_3_e29554.nxml.txt.nlp	25105067	SENT56	0	0	4	4	propofol	STAT3	PA451141	6774	0.754
NULL	Oncol_Lett_2013_Feb_30_5(2)_588-592.nxml.txt.nlp	23420263	SENT29	0	0	11	11	lenalidomide	IRF4	PA162363968	3662	0.754
NULL	Arthritis_Res_Ther_2010_Dec_21_12(6)_223.nxml.txt.nlp	21205285	SENT73	29	29	13	13	benzbromarone	URAT1	PA134852920	116085	0.754
NULL	Cancer_Cell_Int_2005_Jul_29_5_24.nxml.txt.nlp	16053526	SENT47	1	1	9	9	estradiol	beta-catenin	PA449503	1499	0.754
NULL	J_Anaesthesiol_Clin_Pharmacol_2011_Oct-Dec_27(4)_489-494.nxml.txt.nlp	22096282	SENT83	19	19	7	7	dextromethorphan	ACTH	PA449273	5443	0.754
NULL	Diabetes_Care_2010_Aug_27_33(8)_1734-1737.nxml.txt.nlp	20424219	SENT12	3	3	6	6	exenatide	adiponectin	PA164749238	9370	0.754
NULL	Acta_Pharmacol_Sin_2010_Nov_18_31(11)_1447-1453.nxml.txt.nlp	20953204	SENT157	0	0	6	6	rimonabant	IL-6	PA152407999	3569	0.754
NULL	Oncotarget_2014_Oct_23_5(22)_11154-11167.nxml.txt.nlp	25525888	SENT194	13	13	28	28	bevacizumab	PLGF	PA130232992	5228	0.754
NULL	Indian_J_Endocrinol_Metab_2011_Jan-Mar_15(1)_9-17.nxml.txt.nlp	21584160	SENT6	0	0	8	8	liraglutide	GLP-1	PA165958364	100125288	0.754
NULL	Acta_Pharmacol_Sin_2011_Jun_3_32(6)_817-823.nxml.txt.nlp	21642950	SENT142	0	0	13	13	propofol	HCN4	PA451141	10021	0.754
NULL	Diabetologia_2010_Jul_2_53(7)_1270-1287.nxml.txt.nlp	20361178	SENT266	0	0	10	10	pioglitazone	adiponectin	PA450970	9370	0.754
NULL	Target_Oncol_2013_Jun_27_8(2)_127-136.nxml.txt.nlp	23625191	SENT107	10	10	24	24	panitumumab	KRAS	PA162373091	3845	0.754
NULL	Nat_Neurosci_2012_Jun_15(6)_845-852.nxml.txt.nlp	22522402	SENT108	2	2	19	19	primaquine	KAR	PA451103	51144	0.754
NULL	J_Mol_Signal_2011_Sep_1_6_11.nxml.txt.nlp	21884615	SENT55	7	7	9	9	thrombin	ADP	PA451674	23038	0.754
NULL	Pharmaceutics_2011_Oct_12_3(4)_680-705.nxml.txt.nlp	24309303	SENT101	20	20	7	7	sitagliptin	OCT1	PA164748978	5451;6580	0.754
NULL	J_Hematol_Oncol_2014_Apr_28_7_37.nxml.txt.nlp	24775308	SENT135	14	14	7	7	imatinib	JAK2	PA10804	3717	0.754
NULL	Ann_Hematol_2010_Oct_22_89(10)_971-978.nxml.txt.nlp	20567823	SENT132	8	8	2	2	filgrastim	CD34	PA449626	947	0.754
NULL	Br_J_Cancer_2013_Apr_16_108(7)_1393-1401.nxml.txt.nlp	23511559	SENT177	29	29	33	33	cytarabine	FLT3	PA449177	2322	0.754
NULL	Aging_(Albany_NY)_2011_Aug_21_3(8)_716-732.nxml.txt.nlp	21869457	SENT287	17	17	4	4	spermine	ODC	PA164781199	4953;89874	0.754
NULL	Front_Microbiol_2014_Sep_11_5_477.nxml.txt.nlp	25309517	SENT318	4	4	16	16	cyclophosphamide	PLG	PA449165	5340	0.754
NULL	Pharmaceutics_2012_Jan_31_4(1)_104-129.nxml.txt.nlp	24300183	SENT334	27	27	36	36	lidocaine	SMO	PA450226	6608;54498	0.753
NULL	Breast_Cancer_Res_2011_Jan_26_13(1)_R10.nxml.txt.nlp	21269472	SENT243	20	20	6	6	tamoxifen	PPARGC1B	PA451581	133522	0.753
NULL	Biomed_Res_Int_2013_Aug_7_2013_864012.nxml.txt.nlp	23991423	SENT116	39	39	7	7	paricalcitol	PTH	PA450798	5741	0.753
NULL	Pharmaceuticals_(Basel)_2013_Oct_11_6(10)_1304-1321.nxml.txt.nlp	24275851	SENT1044	11	11	5	5	acitretin	ADAM10	PA448039	102	0.753
NULL	Sci_Rep_2014_Dec_3_4_7294.nxml.txt.nlp	25465236	SENT532	25	25	43	43	erlotinib	EGFR	PA134687924	1956	0.753
NULL	J_Hematol_Oncol_2009_Jul_27_2_31.nxml.txt.nlp	19635146	SENT167	26	26	33	33	sorafenib	Mcl-1	PA7000	4170	0.753
NULL	Oncotarget_2010_Nov_19_1(7)_472-482.nxml.txt.nlp	21317446	SENT203	4	4	12	12	lenalidomide	IL-6	PA162363968	3569	0.753
NULL	Genet_Vaccines_Ther_2008_Feb_15_6_7.nxml.txt.nlp	18279512	SENT188	4	4	7	7	imiquimod	IL-4	PA449972	3565	0.753
NULL	Clin_Ophthalmol_2009_Jun_2_3_291-295.nxml.txt.nlp	19668581	SENT109	12	12	14	14	travoprost	BAK	PA164781371	578	0.753
NULL	Acta_Pharmacol_Sin_2012_Jun_6_33(6)_798-808.nxml.txt.nlp	22669117	SENT156	2	2	7	7	heparin	14-3-3	PA449855	10971	0.753
NULL	J_Korean_Med_Sci_1998_Dec_13(6)_685-688.nxml.txt.nlp	9886182	SENT13	8	8	27	27	cyclophosphamide	GM-CSF	PA449165	1437	0.753
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT72	43	43	10	10	vinorelbine	ASC	PA451881	29108	0.753
NULL	Bioinformation_2012_Jan_6_8(1)_13-19.nxml.txt.nlp	22359429	SENT181	20	20	10	10	curcumin	MRP1	PA151958596	4437	0.753
NULL	Autophagy_2013_Jul_1_9(7)_996-1008.nxml.txt.nlp	23580233	SENT11	26	26	16	16	chloroquine	ATG7	PA448948	10533	0.753
NULL	Exp_Ther_Med_2013_Aug_20_6(2)_310-316.nxml.txt.nlp	24137180	SENT84	2	2	9	9	fasudil	MCP-1	PA165946121	6347	0.753
NULL	Int_J_Mol_Sci_2014_Oct_20_15(10)_18840-18855.nxml.txt.nlp	25334060	SENT156	31	31	13	13	heparin	OPG	PA449855	690	0.753
NULL	Int_J_Mol_Imaging_2011_Oct_26_2011_874585.nxml.txt.nlp	21490735	SENT206	0	0	31	31	glucose	OMG	PA449773	4974	0.753
NULL	Int_J_Mol_Sci_2014_Nov_4_15(11)_20022-20044.nxml.txt.nlp	25375187	SENT189	9	9	4	4	metformin	AMPK	PA450395	5563	0.753
NULL	Aging_(Albany_NY)_2009_Dec_31_1(12)_988-1007.nxml.txt.nlp	20157582	SENT58	22	22	24	24	cyclophosphamide	CTX	PA449165	1593	0.753
NULL	Int_J_Mol_Sci_2014_Jun_25_15(7)_11234-11244.nxml.txt.nlp	24968266	SENT78	6	6	11	11	docetaxel	PC-3	PA449383	692094	0.753
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jun_22_67(Pt_7)_o1753.nxml.txt.nlp	21837136	SENT3	21	21	1	1	benzaldehyde	mol	PA448571	90527	0.753
NULL	Front_Immunol_2012_Jun_11_3_144.nxml.txt.nlp	22701453	SENT13	28	28	31	31	imiquimod	TLR9	PA449972	54106	0.753
NULL	Cancer_Med_2013_Dec_3_2(6)_774-783.nxml.txt.nlp	24403251	SENT194	22	22	24	24	tamoxifen	aromatase	PA451581	1588	0.753
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Sep_27_70(Pt_10)_256-258.nxml.txt.nlp	25484667	SENT39	23	23	12	12	ethanol	mol	PA448073	90527	0.753
NULL	Br_J_Cancer_2011_Apr_12_104(8)_1256-1261.nxml.txt.nlp	21448165	SENT154	10	10	12	12	sorafenib	IL-2	PA7000	3558	0.753
NULL	Arthritis_Res_Ther_2012_Jun_25_14(3)_215.nxml.txt.nlp	22731694	SENT143	7	7	24	24	cyclosporine	RIBA	PA449167	6014	0.753
NULL	Exp_Cell_Res_2011_Apr_15_317(7)_1028-1039.nxml.txt.nlp	21237154	SENT238	11	11	16	16	staurosporine	JIP1	PA165109623	9479	0.753
NULL	BMB_Rep_2014_Apr_47(4)_221-226.nxml.txt.nlp	24286312	SENT112	6	6	22	22	nutlin-3	p53		7157	0.753
NULL	Nat_Commun_2014_Nov_25_5_5548.nxml.txt.nlp	25420520	SENT46	12	12	30	30	cabazitaxel	ERG	PA165958401	2078	0.753
NULL	Ann_Oncol_2012_Nov_22_23(11)_2782-2790.nxml.txt.nlp	22730099	SENT122	22	22	17	17	estradiol	OPG	PA449503	690	0.753
NULL	Spermatogenesis_2012_Apr_1_2(2)_79-87.nxml.txt.nlp	22670217	SENT213	31	31	29	29	imatinib	C-Kit	PA10804	3815	0.753
NULL	Oxid_Med_Cell_Longev_2013_Nov_28_2013_568093.nxml.txt.nlp	24379901	SENT154	3	3	5	5	resveratrol	SIRT1		23411	0.753
NULL	Curr_Neuropharmacol_2013_Dec_11(6)_652-663.nxml.txt.nlp	24396340	SENT565	6	6	11	11	propofol	TRPV1	PA451141	7442	0.753
NULL	Drug_Des_Devel_Ther_2014_Sep_23_8_1527-1538.nxml.txt.nlp	25284985	SENT125	16	16	13	13	celecoxib	IFN	PA448871	3439	0.753
NULL	Oncotarget_2013_Aug_8_4(8)_1130-1142.nxml.txt.nlp	24029073	SENT155	21	21	30	30	paclitaxel	TUBB3	PA450761	10381	0.753
NULL	J_Cardiothorac_Surg_2012_Sep_27_7_97.nxml.txt.nlp	23013706	SENT15	9	9	4	4	warfarin	CYP4F2	PA451906	8529	0.753
NULL	Orphanet_J_Rare_Dis_2014_Nov_15_9(1)_161.nxml.txt.nlp	NULL	SENT205	28	28	9	9	s-adenosylmethionine	cblC	PA164754994	25974	0.753
NULL	Evid_Based_Complement_Alternat_Med_2004_Sep_1(2)_207-209.nxml.txt.nlp	15480447	SENT50	19	19	23	23	cisplatin	HER-2	PA449014	2064	0.753
NULL	Curr_Med_Chem_2012_Aug_19(22)_3763-3778.nxml.txt.nlp	22680930	SENT70	27	27	31	31	celecoxib	5-LOX	PA448871	240	0.753
NULL	Mol_Cancer_2009_Nov_24_8_109.nxml.txt.nlp	19930708	SENT101	12	12	1	1	estradiol	aromatase	PA449503	1588	0.753
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT10	2	2	12	12	metformin	HIP	PA450395	6767;6159;64399;5068	0.753
NULL	Arthritis_Res_Ther_2007_Oct_9_9(5)_R104.nxml.txt.nlp	17925024	SENT112	11	11	16	16	glucosamine	G10	PA164747613	8896;221527	0.753
NULL	Eur_J_Haematol_2008_Feb_80(2)_93-106.nxml.txt.nlp	18081719	SENT365	25	25	6	6	iron	MRI	PA450087	78996	0.753
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1522-1532.nxml.txt.nlp	21997136	SENT5	26	26	14	14	irinotecan	EGFR	PA450085	1956	0.753
NULL	Dermatoendocrinol_2013_Apr_1_5(2)_252-263.nxml.txt.nlp	24194965	SENT149	0	0	9	9	metformin	gamma	PA450395	9913	0.753
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT269	3	3	18	18	sitagliptin	HIP	PA164748978	6767;6159;64399;5068	0.753
NULL	Indian_J_Pharm_Sci_2014_Mar-Apr_76(2)_125-131.nxml.txt.nlp	24843185	SENT144	0	0	8	8	resveratrol	CA1		759	0.753
NULL	Arch_Drug_Inf_2009_Mar_2(1)_8-16.nxml.txt.nlp	19381336	SENT115	23	23	18	18	rifampin	CYP3A4	PA451250	1576	0.753
NULL	Cell_Cycle_2012_May_15_11(10)_2022-2029.nxml.txt.nlp	22580450	SENT128	28	28	17	17	doxycycline	ATG12	PA449415	9140	0.753
NULL	Mol_Cell_Biochem_2014_Jan_3_389(1-2)_177-185.nxml.txt.nlp	24385108	SENT49	5	5	20	20	bortezomib	ORP150	PA10252	10525	0.753
NULL	Virol_J_2009_Dec_1_6_213.nxml.txt.nlp	19951438	SENT142	29	29	34	34	mitomycin	TRAIL	PA450524	8743	0.753
NULL	J_Mol_Signal_2008_Mar_31_3_8.nxml.txt.nlp	18377662	SENT187	18	18	10	10	pp2	SHP-1		5777	0.753
NULL	Acta_Pharmacol_Sin_2013_Feb_12_34(2)_255-261.nxml.txt.nlp	23147557	SENT112	18	18	10	10	pioglitazone	PTPRD	PA450970	5789	0.753
NULL	Breast_Cancer_Res_2011_Mar_4_13(2)_R23.nxml.txt.nlp	21375726	SENT208	12	12	6	6	tamoxifen	AP-2	PA451581	7020	0.753
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Mar_28_69(Pt_4)_o612-o613.nxml.txt.nlp	23634137	SENT71	3	3	18	18	benzaldehyde	mol	PA448571	90527	0.753
NULL	Cancer_Metastasis_Rev_2010_Dec_10_29(4)_581-594.nxml.txt.nlp	20830503	SENT367	12	12	24	24	anastrozole	ARNO	PA448432	9266	0.753
NULL	Int_J_Biol_Sci_2012_Oct_25_8(9)_1267-1280.nxml.txt.nlp	23136555	SENT185	7	7	10	10	atenolol	CCL20	PA448499	6364	0.753
NULL	Exp_Ther_Med_2014_May_25_7(5)_1327-1331.nxml.txt.nlp	24940433	SENT6	13	13	38	38	aminophylline	HDAC2	PA164781029	3066	0.753
NULL	Mol_Cancer_2007_Sep_18_6_56.nxml.txt.nlp	17877814	SENT36	17	17	20	20	erlotinib	EGFR	PA134687924	1956	0.753
NULL	Kidney_Int_Suppl_(2011)_2012_Mar_29_2(1)_124-138.nxml.txt.nlp	25018923	SENT975	3	3	15	15	nesiritide	NAPA	PA164781045	9476;8775	0.753
NULL	Curr_Rheumatol_Rep_2011_Aug_19_13(4)_353-359.nxml.txt.nlp	21503693	SENT52	33	33	24	24	abatacept	CD86	PA164747080	942	0.753
NULL	Br_J_Pharmacol_2014_Jun_15_171(11)_2705-2725.nxml.txt.nlp	24467436	SENT5	9	9	2	2	isoniazid	NAT	PA450112	6046	0.753
NULL	J_Headache_Pain_2014_Feb_8_15(1)_7.nxml.txt.nlp	24506953	SENT194	4	4	19	19	capsaicin	TRPV1	PA448776	7442	0.753
NULL	Brain_Sci_2012_Oct_30_2(4)_553-572.nxml.txt.nlp	24961260	SENT499	6	6	11	11	methamphetamine	MRS	PA450403	8011	0.753
NULL	Acta_Pharmacol_Sin_2010_Jan_28_31(1)_102-110.nxml.txt.nlp	20037603	SENT104	10	10	25	25	salbutamol	CXCR4	PA448068	7852	0.753
NULL	J_Biol_Eng_2008_Mar_27_2_4.nxml.txt.nlp	18366808	SENT212	10	10	16	16	nadh	PHB	PA164755085	5245	0.753
NULL	Clin_Med_Insights_Oncol_2012_Dec_20_7_1-12.nxml.txt.nlp	23362372	SENT35	27	27	37	37	carbamazepine	CYP3A	PA448785	1574	0.753
NULL	Oncotarget_2013_Feb_27_4(2)_178-179.nxml.txt.nlp	23563503	SENT14	9	9	11	11	nutlin-3	Wip1		8493	0.753
NULL	Bone_Joint_Res_2014_Mar_1_3(3)_51-59.nxml.txt.nlp	24615710	SENT249	6	6	3	3	resveratrol	SIRT1		23411	0.753
NULL	Cell_Death_Dis_2013_Jul_11_4(7)_e719.nxml.txt.nlp	23846221	SENT74	6	6	2	2	cisplatin	TRAIL	PA449014	8743	0.753
NULL	J_Cardiothorac_Surg_2010_Feb_24_5_7.nxml.txt.nlp	20181257	SENT49	4	4	11	11	heparin	ACT	PA449855	12;11332;9457;641455	0.753
NULL	Int_J_Nanomedicine_2009_Dec_29_4_299-319.nxml.txt.nlp	20054434	SENT266	4	4	26	26	doxorubicin	AP-1	PA449412	2353;3727;2354;3725	0.753
NULL	Cardiovasc_Psychiatry_Neurol_2009_Jun_24_2009_861324.nxml.txt.nlp	20029634	SENT135	45	45	13	13	imipramine	P2X7	PA449969	5027	0.753
NULL	Evid_Based_Complement_Alternat_Med_2012_Feb_12_2012_472897.nxml.txt.nlp	22454667	SENT128	0	0	31	31	hesperetin	IL-5	PA164742902	3567	0.753
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_4_2013_378657.nxml.txt.nlp	23662132	SENT75	11	11	8	8	exenatide	GLP-1	PA164749238	100125288	0.753
NULL	Biosci_Rep_2014_Nov_21_34(6)_e00151.nxml.txt.nlp	25312000	SENT56	20	20	30	30	trypsin	CO2	PA451806	4513	0.753
NULL	JRSM_Cardiovasc_Dis_2012_Sep_24_1(6)_cvd_2012_012015.nxml.txt.nlp	24175073	SENT90	21	21	29	29	clopidogrel	HPR	PA449053	3250	0.753
NULL	J_Biol_Chem_2013_Dec_27_288(52)_36762-36771.nxml.txt.nlp	24217250	SENT30	13	13	0	0	galactose	Langerin	PA449725	50489	0.753
NULL	Bioessays_2010_Mar_32(3)_236-245.nxml.txt.nlp	20127700	SENT139	17	17	11	11	doxorubicin	MRP1	PA449412	4437	0.753
NULL	N_Am_J_Med_Sci_2012_Dec_4(12)_638-640.nxml.txt.nlp	23272306	SENT6	10	10	5	5	liraglutide	GLP-1	PA165958364	100125288	0.753
NULL	Eur_J_Med_Res_2014_Apr_9_19(1)_19.nxml.txt.nlp	24717101	SENT80	37	37	11	11	doxorubicin	FDG	PA449412	23583	0.753
NULL	Front_Oncol_2014_Sep_29_4_251.nxml.txt.nlp	25325012	SENT244	17	17	8	8	gefitinib	EGFR	PA131301952	1956	0.753
NULL	Crit_Care_2011_Oct_26_15(5)_R257.nxml.txt.nlp	22030215	SENT261	0	0	17	17	dexmedetomidine	SAPS	PA449256	8935	0.753
NULL	Front_Endocrinol_(Lausanne)_2014_Aug_18_5_129.nxml.txt.nlp	25183960	SENT146	16	16	14	14	cabergoline	DRD2	PA448708	1813	0.753
NULL	Front_Behav_Neurosci_2011_Sep_8_5_56.nxml.txt.nlp	21927600	SENT1883	0	0	25	25	cocaine	DARPP-32	PA449072	84152	0.753
NULL	Acta_Pharmacol_Sin_2009_Apr_9_30(4)_467-477.nxml.txt.nlp	19270721	SENT124	23	23	5	5	cisplatin	IL-24	PA449014	11009	0.753
NULL	Viruses_2014_Apr_14_6(4)_1715-1758.nxml.txt.nlp	24736215	SENT282	23	23	13	13	raltegravir	IL-7		3574	0.753
NULL	Breast_Cancer_Res_Treat_2014_Nov_11_148(3)_563-570.nxml.txt.nlp	25385180	SENT58	8	8	10	10	docetaxel	PTH	PA449383	5741	0.753
NULL	Indian_J_Pharm_Sci_2013_May-Jun_75(3)_302-309.nxml.txt.nlp	24082346	SENT150	2	2	7	7	diclofenac	SRMS	PA449293	6725	0.753
NULL	Braz_J_Med_Biol_Res_2012_Sep_21_45(12)_1240-1243.nxml.txt.nlp	22983178	SENT36	30	30	15	15	diclofenac	CB1	PA449293	1268	0.753
NULL	Iran_J_Pharm_Res_2014_Autumn_13(4)_1393-1401.nxml.txt.nlp	25587329	SENT112	2	2	7	7	celecoxib	ABCG2	PA448871	9429	0.753
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_650809.nxml.txt.nlp	23258995	SENT26	0	0	4	4	vasopressin	AQP3	PA451858	360	0.753
NULL	Cardiovasc_Ultrasound_2005_Jan_28_3_2.nxml.txt.nlp	15679889	SENT42	19	19	16	16	dobutamine	TDI	PA449381	100038246	0.753
NULL	Br_J_Cancer_2010_Aug_24_103(5)_656-662.nxml.txt.nlp	20700122	SENT121	1	1	9	9	topotecan	MRP4	PA451729	10257	0.753
NULL	Diabetes_Care_2012_Jun_11_35(6)_1364-1379.nxml.txt.nlp	22517736	SENT560	20	20	35	35	liraglutide	Met	PA165958364	79811	0.753
NULL	Breast_Cancer_Res_2011_Mar_1_13(2)_R21.nxml.txt.nlp	21362200	SENT288	12	12	16	16	estradiol	PI3K	PA449503	5290	0.753
NULL	Biomed_Res_Int_2013_Jun_17_2013_312656.nxml.txt.nlp	23844360	SENT171	8	8	20	20	plerixafor	CD34	PA165958410	947	0.753
NULL	Front_Immunol_2013_Oct_7_4_325.nxml.txt.nlp	24109484	SENT79	13	13	4	4	nutlin-3	p53		7157	0.753
NULL	Pharmacogn_Mag_2014_Jul-Sep_10(39)_374-383.nxml.txt.nlp	25210328	SENT155	28	28	2	2	evodiamine	PC2	PA165860788	5126;5311;8535	0.753
NULL	Breast_Cancer_Res_2010_Jun_4_12(3)_R32.nxml.txt.nlp	20525379	SENT17	7	7	0	0	tamoxifen	AGR2	PA451581	10551	0.753
NULL	JRSM_Cardiovasc_Dis_2012_Sep_24_1(6)_cvd_2012_012015.nxml.txt.nlp	24175073	SENT51	14	14	8	8	clopidogrel	CYP2C19	PA449053	1557	0.753
NULL	Crit_Care_2011_Jun_24_15(3)_R153.nxml.txt.nlp	21702944	SENT107	3	3	9	9	dexmedetomidine	HK2	PA449256	3796;3099;29911;3741	0.753
NULL	Clin_Kidney_J_2013_Jun_11_6(3)_287-294.nxml.txt.nlp	23717787	SENT56	14	14	4	4	cinacalcet	PTH	PA164776671	5741	0.753
NULL	Indian_J_Endocrinol_Metab_2012_Mar-Apr_16(2)_183-191.nxml.txt.nlp	22470853	SENT50	23	23	41	41	mannitol	AVP	PA450320	114548;551	0.753
NULL	Gut_Liver_2013_Sep_14_7(5)_552-559.nxml.txt.nlp	24073313	SENT116	1	1	17	17	celecoxib	EGFR	PA448871	1956	0.753
NULL	Case_Rep_Oncol_2013_Apr_6_6(1)_197-203.nxml.txt.nlp	23626561	SENT87	19	19	17	17	rituximab	CHOP	PA451261	1649	0.753
NULL	Autoimmune_Dis_2013_Sep_26_2013_827254.nxml.txt.nlp	24187614	SENT220	20	20	37	37	rituximab	IL-17	PA451261	3605	0.753
NULL	Physiol_Rep_2014_Sep_11_2(9)_e12144.nxml.txt.nlp	25214522	SENT305	4	4	1	1	resveratrol	SIRT1		23411	0.753
NULL	Lab_Invest_2009_Nov_7_89(11)_1275-1290.nxml.txt.nlp	19736547	SENT175	24	24	11	11	curcumin	LOX-1	PA151958596	4973	0.753
NULL	J_Gastroenterol_2013_Jan_27_48(1)_22-30.nxml.txt.nlp	23104468	SENT69	14	14	12	12	ribavirin	IFN	PA451241	3439	0.753
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_12_2012_160726.nxml.txt.nlp	23243430	SENT264	5	5	11	11	losartan	c-Jun	PA450268	3725	0.753
NULL	Ann_Hematol_2014_Sep_10_93(1)_1-11.nxml.txt.nlp	24018623	SENT162	16	16	35	35	lenalidomide	CD163	PA162363968	9332	0.753
NULL	Cancer_Metab_2014_May_28_2(Suppl_1)_P65.nxml.txt.nlp	NULL	SENT26	4	4	16	16	resveratrol	NAMPT		10135	0.753
NULL	Cell_Death_Dis_2014_Jul_17_5(7)_e1333.nxml.txt.nlp	25032856	SENT8	5	5	25	25	candesartan	EAAC1	PA448765	6505	0.753
NULL	J_Cardiovasc_Magn_Reson_2008_Jan_22_10(1)_5.nxml.txt.nlp	18272009	SENT4	0	0	15	15	trastuzumab	HER2	PA451743	2064	0.753
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Sep_24_64(Pt_10)_o2005.nxml.txt.nlp	21201203	SENT66	0	0	6	6	benzaldehyde	mol	PA448571	90527	0.753
NULL	J_Exp_Med_2000_Mar_6_191(5)_859-870.nxml.txt.nlp	10704466	SENT225	13	13	16	16	arsenite	p38	PA452638	10598;1432;7965	0.753
NULL	Basic_Clin_Neurosci_2014_Winter_5(1)_74-79.nxml.txt.nlp	25436087	SENT136	6	6	3	3	fluoxetine	AQP4	PA449673	361	0.753
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT111	19	19	25	25	l-cysteine	S6K1	PA449173	6198	0.753
NULL	CNS_Drugs_2012_Dec_13_26(12)_1033-1049.nxml.txt.nlp	23192413	SENT280	4	4	11	11	citalopram	STAR	PA449015	6770;2984	0.753
NULL	J_Headache_Pain_2009_Jun_11_10(3)_219-223.nxml.txt.nlp	19277837	SENT131	15	15	5	5	indomethacin	EPH	PA449982	2041	0.753
NULL	Br_J_Cancer_2010_Jan_5_102(1)_80-86.nxml.txt.nlp	19920817	SENT108	22	22	10	10	sunitinib	IFN	PA162372840	3439	0.753
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1420-1426.nxml.txt.nlp	24056704	SENT37	34	34	11	11	midazolam	CYP3A	PA450496	1574	0.753
NULL	Chemother_Res_Pract_2012_Aug_29_2012_817297.nxml.txt.nlp	22970367	SENT138	9	9	2	2	cetuximab	ERBB2	PA10040	2064	0.753
NULL	Br_J_Cancer_2010_Dec_7_103(12)_1815-1821.nxml.txt.nlp	21063408	SENT98	25	25	13	13	cisplatin	6-16	PA449014	2537	0.753
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1150.nxml.txt.nlp	24675468	SENT21	8	8	19	19	ethanol	adiponectin	PA448073	9370	0.753
NULL	Asia_Pac_Allergy_2013_Oct_31_3(4)_266-280.nxml.txt.nlp	24260732	SENT61	10	10	18	18	diclofenac	CD63	PA449293	967	0.753
NULL	J_Biol_Chem_2013_Nov_22_288(47)_34217-34229.nxml.txt.nlp	24106270	SENT42	8	8	2	2	thrombin	RhoG	PA451674	391	0.753
NULL	Oncotarget_2011_Dec_31_2(12)_1322-1328.nxml.txt.nlp	22249159	SENT7	15	15	7	7	resveratrol	AMPK		5563	0.753
NULL	Nucleic_Acids_Res_2013_Nov_8_41(20)_9524-9536.nxml.txt.nlp	23935071	SENT206	47	47	29	29	sugar	C17	PA451529	54360	0.753
NULL	J_Cell_Mol_Med_2014_Dec_7_18(12)_2536-2552.nxml.txt.nlp	25287328	SENT174	23	23	3	3	estradiol	PKD1	PA449503	5310	0.753
NULL	Eur_J_Clin_Invest_2008_Jun_38(6)_361-371.nxml.txt.nlp	18489398	SENT52	16	16	4	4	heparin	ACT	PA449855	12;11332;9457;641455	0.753
NULL	Exp_Ther_Med_2013_Dec_26_6(6)_1359-1364.nxml.txt.nlp	24255662	SENT170	11	11	25	25	dexmedetomidine	TLR4	PA449256	7099	0.753
NULL	Curr_Neuropharmacol_2012_Jun_10(2)_139-158.nxml.txt.nlp	23204984	SENT378	4	4	11	11	citalopram	STAR	PA449015	6770;2984	0.753
NULL	Proteome_Sci_2010_Nov_12_8_56.nxml.txt.nlp	21073729	SENT235	19	19	8	8	thrombin	gamma	PA451674	9913	0.753
NULL	Mol_Vis_2012_May_11_18_1260-1270.nxml.txt.nlp	22665973	SENT182	22	22	24	24	topotecan	TPT	PA451729	23590;6469	0.753
NULL	ScientificWorldJournal_2013_Dec_30_2013_645653.nxml.txt.nlp	24489509	SENT236	10	10	23	23	aztreonam	TOB	PA448523	10140	0.753
NULL	Asian-Australas_J_Anim_Sci_2014_Dec_27(12)_1783-1793.nxml.txt.nlp	25358373	SENT134	3	3	10	10	capsaicin	CASP3	PA448776	836	0.753
NULL	Front_Immunol_2012_Jun_13_3_154.nxml.txt.nlp	22707952	SENT82	23	23	7	7	dextran	NLRP3	PA449261	114548	0.753
NULL	Arthritis_Res_Ther_2003_Oct_2_5(Suppl_4)_S17-S21.nxml.txt.nlp	15180893	SENT54	11	11	17	17	methotrexate	ACR	PA450428	49	0.753
NULL	Open_Cardiovasc_Med_J_2014_Feb_7_8_12-17.nxml.txt.nlp	24653785	SENT34	12	12	5	5	simvastatin	CYP3A5	PA451363	1577	0.753
NULL	Anal_Bioanal_Chem_2011_Jul_3_400(10)_3473-3479.nxml.txt.nlp	21537911	SENT17	9	9	2	2	oseltamivir	OSC	PA450721	4047	0.753
NULL	Drugs_R_D_2014_Sep_31_14(3)_177-184.nxml.txt.nlp	25079671	SENT28	9	9	38	38	acarbose	MCP-1	PA448010	6347	0.753
NULL	Acta_Orthop_2010_Apr_6_81(2)_263-267.nxml.txt.nlp	20148646	SENT163	7	7	12	12	taurine	ATF4	PA451590	468	0.753
NULL	J_Cancer_2012_Aug_24_3_354-361.nxml.txt.nlp	22962562	SENT178	13	13	8	8	cyclophosphamide	CLB	PA449165	171425	0.753
NULL	J_Exp_Clin_Cancer_Res_2009_Jun_6_28(1)_76.nxml.txt.nlp	19500405	SENT240	19	19	15	15	gemcitabine	p53	PA449748	7157	0.753
NULL	J_Gastroenterol_2013_Jan_28_48(1)_1-12.nxml.txt.nlp	23188091	SENT232	30	30	11	11	ribavirin	RVR	PA451241	9975	0.753
NULL	J_Orthop_Traumatol_2013_Jun_1_14(2)_109-114.nxml.txt.nlp	23456483	SENT32	26	26	8	8	hyaluronan	ACP	PA165958431	4706	0.753
NULL	Clin_Epigenetics_2010_Sep_18_1(3-4)_101-116.nxml.txt.nlp	21258631	SENT207	5	5	16	16	genistein	p16INK4a	PA165109660	1029	0.753
NULL	Evol_Bioinform_Online_2014_Jun_12_10_87-96.nxml.txt.nlp	25002811	SENT49	14	14	12	12	nadh	ND6	PA164755085	4541	0.753
NULL	Chin_J_Cancer_2012_Feb_31(2)_110-118.nxml.txt.nlp	22098951	SENT201	21	21	7	7	imatinib	P-gp	PA10804	5243	0.753
NULL	Am_J_Trop_Med_Hyg_2012_Mar_1_86(3)_489-495.nxml.txt.nlp	22403324	SENT194	18	18	15	15	ritonavir	P-gp	PA451260	5243	0.753
NULL	Mol_Cancer_2012_Aug_8_11_53.nxml.txt.nlp	22871047	SENT297	20	20	14	14	paclitaxel	HIN-1	PA450761	92304	0.753
NULL	J_Cardiothorac_Surg_2012_Sep_27_7_97.nxml.txt.nlp	23013706	SENT30	9	9	3	3	warfarin	CYP4F2	PA451906	8529	0.753
NULL	Cells_2014_May_23_3(2)_517-545.nxml.txt.nlp	24861977	SENT72	12	12	0	0	capsaicin	TRPV1	PA448776	7442	0.753
NULL	Int_J_Mol_Sci_2014_Oct_17_15(10)_18762-18775.nxml.txt.nlp	25329617	SENT132	21	21	23	23	heparin	EGF	PA449855	1950	0.753
NULL	EMBO_Mol_Med_2012_Jul_11_4(7)_577-593.nxml.txt.nlp	22496117	SENT153	23	23	21	21	clofazimine	PAP-1	PA164748759	6100	0.753
NULL	Cell_Cycle_2013_Sep_15_12(18)_3013-3024.nxml.txt.nlp	23974104	SENT67	19	19	12	12	disulfiram	IQGAP1	PA449376	8826	0.753
NULL	Eur_Arch_Psychiatry_Clin_Neurosci_2011_Mar_1_261(2)_133-138.nxml.txt.nlp	20593192	SENT164	31	31	0	0	ethanol	S100B	PA448073	6285	0.753
NULL	Indian_J_Pharmacol_2008_Oct_40(Suppl_2)_S112-S142.nxml.txt.nlp	21593965	SENT864	20	20	26	26	ketanserin	5-HT2A	PA131053734	3356	0.753
NULL	Indian_J_Med_Paediatr_Oncol_2014_Apr-Jun_35(2)_140-142.nxml.txt.nlp	25197175	SENT30	9	9	11	11	bevacizumab	EGFR	PA130232992	1956	0.753
NULL	Oncoscience_2013_Dec_11_1(1)_30-38.nxml.txt.nlp	25593982	SENT3	25	25	0	0	oxygen	Met	PA450744	79811	0.753
NULL	ScientificWorldJournal_2013_Aug_18_2013_230176.nxml.txt.nlp	24023528	SENT145	21	21	11	11	creatine	CT26	PA164778930	168400	0.753
NULL	Indian_J_Med_Res_2012_Sep_136(3)_391-403.nxml.txt.nlp	23041732	SENT185	11	11	16	16	erlotinib	HCC	PA134687924	84668	0.753
NULL	Mol_Biol_Rep_2013_Sep_28_40(10)_5573-5585.nxml.txt.nlp	24078156	SENT327	17	17	9	9	iron	IREG1	PA450087	30061	0.753
NULL	Acta_Neuropathol_2010_Feb_21_119(2)_157-175.nxml.txt.nlp	19936768	SENT202	12	12	34	34	troglitazone	Bcl-2	PA451799	596	0.753
NULL	Int_J_Endocrinol_2014_Aug_11_2014_312452.nxml.txt.nlp	25183970	SENT159	25	25	16	16	liraglutide	PI3K	PA165958364	5290	0.753
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT13	2	2	8	8	atorvastatin	p38	PA448500	10598;1432;7965	0.753
NULL	Br_J_Cancer_2012_Apr_24_106(9)_1543-1550.nxml.txt.nlp	22531721	SENT172	36	36	26	26	trastuzumab	CD55	PA451743	1604	0.753
NULL	FEBS_Open_Bio_2012_Mar_5_2_32-36.nxml.txt.nlp	23650578	SENT41	10	10	24	24	isoproterenol	PDK4	PA450121	5166	0.753
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT125	2	2	5	5	metformin	HIF-1	PA450395	29072	0.753
NULL	Br_J_Cancer_2014_Jan_21_110(2)_409-420.nxml.txt.nlp	24201748	SENT45	17	17	10	10	l-glutamine	F12	PA10090	2161	0.753
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT102	20	20	34	34	l-cysteine	4E-BP1	PA449173	1978	0.753
NULL	Nat_Med_2011_Jun_26_17(7)_875-882.nxml.txt.nlp	21706030	SENT27	45	45	15	15	doxycycline	BRCA1	PA449415	672	0.753
NULL	Leukemia_2013_Jan_11_27(1)_32-40.nxml.txt.nlp	22781593	SENT168	3	3	9	9	ponatinib	CD34	PA165980594	947	0.753
NULL	Mol_Cancer_2008_Mar_26_7_27.nxml.txt.nlp	18366759	SENT83	30	30	19	19	etoposide	AKT2	PA449552	208	0.753
NULL	Mol_Cancer_2009_Feb_25_8_10.nxml.txt.nlp	19243593	SENT169	32	32	25	25	paclitaxel	NEDD1	PA450761	121441	0.753
NULL	Mol_Biol_Cell_2012_Nov_1_23(21)_4212-4225.nxml.txt.nlp	22956765	SENT90	0	0	5	5	thrombin	SHP2	PA451674	5781	0.753
NULL	Oncogene_2009_Feb_5_28(5)_674-685.nxml.txt.nlp	19015634	SENT220	5	5	36	36	ethanol	FANCD2	PA448073	2177	0.753
NULL	Oncotarget_2011_Aug_30_2(8)_610-626.nxml.txt.nlp	21881167	SENT125	22	22	5	5	tamoxifen	Raf-1	PA451581	5894	0.753
NULL	Breast_Cancer_Res_2010_Nov_16_12(6)_R96.nxml.txt.nlp	21080941	SENT94	5	5	36	36	lapatinib	HRG	PA152241907	3084;3273	0.753
NULL	Int_J_Endocrinol_2014_Aug_11_2014_312452.nxml.txt.nlp	25183970	SENT189	3	3	11	11	liraglutide	PI3K	PA165958364	5290	0.753
NULL	Int_J_Endocrinol_Metab_2013_Dec_21_Winter_11(1)_57-61.nxml.txt.nlp	23853622	SENT38	14	14	20	20	quetiapine	PRL	PA451201	5617	0.753
NULL	Target_Oncol_2013_Jun_27_8(2)_127-136.nxml.txt.nlp	23625191	SENT154	24	24	11	11	cetuximab	KRAS	PA10040	3845	0.753
NULL	Cancer_Imaging_2012_Apr_27_12(1)_100-108.nxml.txt.nlp	22542728	SENT156	9	9	18	18	imatinib	FDG	PA10804	23583	0.753
NULL	EMBO_Mol_Med_2012_Sep_8_4(9)_939-951.nxml.txt.nlp	22684844	SENT186	6	6	1	1	bleomycin	IL-6	PA448645	3569	0.753
NULL	Virol_J_2010_Oct_20_7_279.nxml.txt.nlp	20961433	SENT154	4	4	2	2	trypsin	VLP	PA451806	391104	0.753
NULL	Oncotarget_2013_Dec_4_5(2)_351-362.nxml.txt.nlp	24504051	SENT212	18	18	12	12	olaparib	ERG		2078	0.753
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT74	18	18	5	5	metformin	p53	PA450395	7157	0.753
NULL	Br_J_Cancer_2010_Nov_2_103(11)_1671-1679.nxml.txt.nlp	21045835	SENT242	25	25	23	23	gemcitabine	CXCL12	PA449748	6387	0.753
NULL	Breast_Cancer_Res_2012_Apr_4_14(2)_R57.nxml.txt.nlp	22475046	SENT22	31	31	10	10	tamoxifen	ATAC	PA451581	6375	0.753
NULL	Biochemistry_2010_Feb_16_49(6)_1268-1280.nxml.txt.nlp	20052994	SENT25	13	13	17	17	amiloride	AOC2	PA448368	314	0.753
NULL	Cancer_Cell_Int_2014_Jan_14_14_4.nxml.txt.nlp	24423208	SENT60	24	24	4	4	gemcitabine	IL-2	PA449748	3558	0.753
NULL	Indian_J_Endocrinol_Metab_2013_Jul-Aug_17(4)_636-646.nxml.txt.nlp	23961479	SENT159	10	10	24	24	warfarin	CYP2C9	PA451906	1559	0.753
NULL	Oncotarget_2013_Nov_7_4(12)_2550-2566.nxml.txt.nlp	24334291	SENT300	16	16	27	27	dasatinib	PI3K	PA162372878	5290	0.753
NULL	Cell_J_2012_Dec_22_Winter_13(4)_265-274.nxml.txt.nlp	23507995	SENT246	18	18	6	6	ethanol	spatial	PA448073	219793	0.753
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT137	2	2	7	7	resveratrol	Bcl-2		596	0.753
NULL	Cancers_(Basel)_2014_Feb_13_6(1)_396-415.nxml.txt.nlp	24531055	SENT522	3	3	10	10	collagenase	MMP3	PA449107	4314	0.753
NULL	Int_J_Endocrinol_2013_Nov_20_2013_607939.nxml.txt.nlp	24363671	SENT96	4	4	6	6	tamoxifen	TMX	PA451581	81542	0.753
NULL	Amino_Acids_2011_Feb_23_40(2)_477-485.nxml.txt.nlp	20571841	SENT216	0	0	17	17	sibutramine	mGlu5	PA451344	2915	0.753
NULL	Ann_Rheum_Dis_2008_Oct_25_68(10)_1644-1650.nxml.txt.nlp	18957484	SENT33	8	8	14	14	methotrexate	JAK3	PA450428	3718	0.753
NULL	Br_J_Cancer_2010_Sep_28_103(7)_1048-1056.nxml.txt.nlp	20736952	SENT227	18	18	28	28	fluorouracil	HER2	PA128406956	2064	0.753
NULL	Mol_Cancer_2007_Sep_24_6_59.nxml.txt.nlp	17888187	SENT161	7	7	15	15	raloxifene	c-Myc	PA451221	4609	0.753
NULL	Int_J_Mol_Sci_2012_Sep_25_13(10)_12153-12168.nxml.txt.nlp	23202889	SENT534	15	15	4	4	cetuximab	BRAF	PA10040	673	0.753
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_16_2012_395912.nxml.txt.nlp	23118789	SENT149	20	20	0	0	cyproheptadine	UGT1A4	PA164749366	54657	0.753
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Dec_14_70(Pt_1)_o59-o60.nxml.txt.nlp	24855469	SENT3	23	23	2	2	nitrile	mol	PA450636	90527	0.753
NULL	J_Oncol_2011_Dec_23_2011_591427.nxml.txt.nlp	21253528	SENT101	10	10	22	22	paclitaxel	CD24	PA450761	100133941	0.753
NULL	Nat_Commun_2012_Jan_10_3_614.nxml.txt.nlp	22233624	SENT120	42	42	17	17	ethanol	mol	PA448073	90527	0.753
NULL	Mol_Cancer_2014_Aug_4_13_161.nxml.txt.nlp	NULL	SENT16	9	9	6	6	metformin	AMPK	PA450395	5563	0.753
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_P43.nxml.txt.nlp	NULL	SENT8	11	11	34	34	abacavir	HLA-B	PA448004	3106	0.753
NULL	J_Exp_Bot_2008_Oct_59(13)_3721-3728.nxml.txt.nlp	18820260	SENT184	31	31	38	38	pp2	14-3-3		10971	0.753
NULL	Blood_Cancer_J_2013_Sep_13_3(9)_e146.nxml.txt.nlp	24036945	SENT12	11	11	14	14	ribavirin	AKT	PA451241	207	0.753
NULL	Cerebrovasc_Dis_Extra_2013_Jun_11_3(1)_85-94.nxml.txt.nlp	23885261	SENT127	9	9	15	15	alteplase	OCSP	PA164776730	83882	0.753
NULL	Case_Rep_Dermatol_2012_Sep_16_4(3)_256-260.nxml.txt.nlp	23275770	SENT103	2	2	18	18	isotretinoin	OMG	PA450128	4974	0.753
NULL	Core_Evid_2008_Jun_3(1)_13-30.nxml.txt.nlp	20694081	SENT288	18	18	26	26	vildagliptin	GLP-1	PA165958346	100125288	0.753
NULL	J_Med_Case_Reports_2011_Jun_28_5_245.nxml.txt.nlp	21711523	SENT153	8	8	11	11	rituximab	CHOP	PA451261	1649	0.753
NULL	Kidney_Int_Suppl_(2011)_2013_Dec_27_3(5)_436-441.nxml.txt.nlp	25019026	SENT7	6	6	37	37	cinacalcet	PTH	PA164776671	5741	0.753
NULL	Acta_Oncol_2013_May_13_52(4)_776-782.nxml.txt.nlp	23480638	SENT26	21	21	7	7	imatinib	KIT	PA10804	3815	0.753
NULL	Nat_Genet_2011_Jan_12_43(1)_27-33.nxml.txt.nlp	21151129	SENT158	48	48	34	34	tamoxifen	FOXA1	PA451581	3169	0.753
NULL	Core_Evid_2011_Mar_17_6_31-42.nxml.txt.nlp	21468241	SENT85	21	21	4	4	clopidogrel	IPA	PA449053	3160	0.753
NULL	Braz_J_Med_Biol_Res_2013_Mar_15_46(3)_299-305.nxml.txt.nlp	23532269	SENT11	24	24	33	33	propofol	TLR4	PA451141	7099	0.753
NULL	Clin_Pharmacokinet_2014_Aug_21_53(10)_931-941.nxml.txt.nlp	25141974	SENT257	18	18	4	4	atorvastatin	MDR1	PA448500	5243	0.753
NULL	Case_Rep_Oncol_Med_2012_Nov_3_2012_819809.nxml.txt.nlp	23198202	SENT33	24	24	15	15	thyroglobulin	CK20	PA164754910	54474	0.753
NULL	Int_J_Mol_Sci_2014_Jun_5_15(6)_10083-10100.nxml.txt.nlp	24905407	SENT19	36	36	24	24	tetracycline	TRB	PA451640	6957	0.753
NULL	Mol_Cell_Proteomics_2014_Jun_9_13(6)_1598-1610.nxml.txt.nlp	24719452	SENT237	16	16	32	32	galactose	P19	PA449725	51561	0.753
NULL	Front_Neurol_2014_Feb_28_5_21.nxml.txt.nlp	24592254	SENT46	10	10	6	6	clopidogrel	APT	PA449053	653639	0.753
NULL	Br_J_Cancer_1985_Apr_51(4)_525-532.nxml.txt.nlp	3978031	SENT11	28	28	23	23	vincristine	PCB	PA451879	5091	0.753
NULL	Front_Microbiol_2013_Aug_19_4_241.nxml.txt.nlp	23966991	SENT241	6	6	20	20	ceftriaxone	GLT-1	PA448866	6506	0.753
NULL	Arthritis_Res_Ther_2011_Feb_16_13(1)_R25.nxml.txt.nlp	21324169	SENT98	24	24	20	20	adalimumab	TNF	PA10004	7124	0.753
NULL	J_Mol_Med_(Berl)_2014_May_10_92(7)_709-722.nxml.txt.nlp	24811491	SENT256	9	9	12	12	vemurafenib	BRAF	PA165946873	673	0.753
NULL	Exp_Ther_Med_2012_Sep_12_4(3)_475-480.nxml.txt.nlp	23181121	SENT159	2	2	0	0	cyclophosphamide	CHOP	PA449165	1649	0.753
NULL	Br_J_Cancer_2012_Jan_3_106(1)_6-13.nxml.txt.nlp	22215104	SENT18	6	6	4	4	pertuzumab	HER2		2064	0.753
NULL	Nat_Genet_2011_Jan_12_43(1)_27-33.nxml.txt.nlp	21151129	SENT158	48	48	5	5	tamoxifen	FOXA1	PA451581	3169	0.753
NULL	Mol_Cancer_2009_Nov_24_8_109.nxml.txt.nlp	19930708	SENT209	19	19	30	30	exemestane	aromatase	PA449563	1588	0.753
NULL	Mol_Cancer_2010_Aug_20_9_220.nxml.txt.nlp	20727180	SENT8	8	8	17	17	nicotine	p53	PA450626	7157	0.753
NULL	J_Exp_Clin_Cancer_Res_2009_Jul_10_28(1)_99.nxml.txt.nlp	19591692	SENT122	7	7	9	9	tariquidar	ABCB1		5243	0.753
NULL	Int_J_Surg_Case_Rep_2014_Oct_23_5(12)_979-983.nxml.txt.nlp	25460452	SENT171	23	23	15	15	paclitaxel	CK7	PA450761	3855	0.753
NULL	Diabetes_2013_Oct_17_62(10)_e19-e22.nxml.txt.nlp	24065800	SENT50	19	19	25	25	exenatide	GLP-1	PA164749238	100125288	0.753
NULL	Infect_Dis_Ther_2014_Dec_5_3(2)_69-81.nxml.txt.nlp	25475412	SENT80	6	6	13	13	vancomycin	TEC	PA451850	7006	0.753
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Sep_9_65(Pt_10)_o2409.nxml.txt.nlp	21577869	SENT58	23	23	10	10	ethanol	mol	PA448073	90527	0.753
NULL	J_Mol_Med_(Berl)_2014_Jan_10_92(5)_497-507.nxml.txt.nlp	24408111	SENT184	15	15	20	20	pioglitazone	HIF-1	PA450970	29072	0.753
NULL	Pak_J_Med_Sci_2013_Apr_29(2)_663-665.nxml.txt.nlp	24353600	SENT37	9	9	11	11	bleomycin	BLM	PA448645	641	0.753
NULL	Front_Oncol_2014_Nov_18_4_334.nxml.txt.nlp	25478327	SENT20	14	14	40	40	afatinib	HER2	PA165981154	2064	0.753
NULL	Arthritis_Res_Ther_2010_Apr_29_12(2)_R73.nxml.txt.nlp	20429888	SENT271	18	18	31	31	bortezomib	COL1A1	PA10252	1277	0.753
NULL	J_Biol_2003_Sep_24_2(4)_28.nxml.txt.nlp	14511394	SENT149	20	20	3	3	phenformin	LKB1	PA1000	6794	0.752
NULL	Chem_Cent_J_2012_Nov_23_6_139.nxml.txt.nlp	23173901	SENT200	26	26	38	38	thrombin	p300	PA451674	2033	0.752
NULL	Mol_Biol_Int_2011_Feb_24_2011_137459.nxml.txt.nlp	22091395	SENT187	10	10	29	29	arsenite	FMRP	PA452638	2332	0.752
NULL	J_Biomed_Sci_2014_Feb_3_21(1)_10.nxml.txt.nlp	24490900	SENT127	30	30	24	24	alendronate	M-CSF	PA448082	1435	0.752
NULL	Exp_Hematol_Oncol_2012_Sep_11_1_27.nxml.txt.nlp	23210501	SENT59	0	0	20	20	lenalidomide	IL-2	PA162363968	3558	0.752
NULL	Br_J_Pharmacol_2011_Oct_164(3)_866-883.nxml.txt.nlp	21323893	SENT385	12	12	15	15	l-arginine	eNOS	PA448478	4846	0.752
NULL	Open_Med_2007_Dec_18_1(3)_e184-e190.nxml.txt.nlp	21673951	SENT81	6	6	8	8	tamoxifen	BRCA1	PA451581	672	0.752
NULL	Oncologist_2010_Nov_4_15(11)_1135-1146.nxml.txt.nlp	21051659	SENT122	11	11	13	13	bevacizumab	IFN	PA130232992	3439	0.752
NULL	Aging_(Albany_NY)_2009_Mar_31_1(4)_412-424.nxml.txt.nlp	20195491	SENT8	19	19	24	24	resveratrol	AMPK		5563	0.752
NULL	Gut_Liver_2011_Jun_24_5(2)_160-164.nxml.txt.nlp	21814595	SENT106	29	29	33	33	meperidine	ESD	PA450369	2098	0.752
NULL	Br_J_Cancer_2010_Oct_12_103(8)_1309-1310.nxml.txt.nlp	NULL	SENT38	24	24	26	26	bevacizumab	IFN	PA130232992	3439	0.752
NULL	Br_J_Cancer_2010_Jun_8_102(12)_1707-1716.nxml.txt.nlp	20461078	SENT136	1	1	17	17	bortezomib	TRAIL	PA10252	8743	0.752
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT267	20	20	7	7	warfarin	VKORC1	PA451906	79001	0.752
NULL	Mol_Clin_Oncol_2013_Sep_24_1(5)_918-924.nxml.txt.nlp	24649271	SENT58	40	40	22	22	gemcitabine	CO2	PA449748	4513	0.752
NULL	J_Skin_Cancer_2013_Oct_27_2013_246848.nxml.txt.nlp	24286011	SENT113	19	19	15	15	diclofenac	p53	PA449293	7157	0.752
NULL	J_Oncol_2013_Aug_20_2013_732047.nxml.txt.nlp	24027583	SENT10	7	7	2	2	pertuzumab	HER2		2064	0.752
NULL	Int_J_Endocrinol_2014_Feb_25_2014_769671.nxml.txt.nlp	24719615	SENT184	16	16	7	7	metformin	TCF7L2	PA450395	6934	0.752
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT102	17	17	34	34	l-methionine	4E-BP1	PA450423	1978	0.752
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2008_Jun_1_64(Pt_6)_611-619.nxml.txt.nlp	18560148	SENT161	0	0	14	14	heparin	PF4	PA449855	5196	0.752
NULL	Cell_Commun_Signal_2013_Oct_1_11_73.nxml.txt.nlp	24083678	SENT115	18	18	39	39	sulindac	c-Jun	PA451565	3725	0.752
NULL	J_Neurodev_Disord_2009_Jun_17_1(2)_150-157.nxml.txt.nlp	19812701	SENT200	15	15	18	18	donepezil	spatial	PA449394	219793	0.752
NULL	Int_J_Mol_Sci_2014_May_9_15(5)_8256-8279.nxml.txt.nlp	24821544	SENT67	0	0	5	5	nadh	mol	PA164755085	90527	0.752
NULL	Oncol_Lett_2014_Nov_14_8(5)_2086-2092.nxml.txt.nlp	25295095	SENT118	12	12	6	6	gemcitabine	LKB1	PA449748	6794	0.752
NULL	J_Cell_Mol_Med_2014_Oct_11_18(10)_2031-2043.nxml.txt.nlp	25109475	SENT269	28	28	24	24	valsartan	STZ	PA451848	6484	0.752
NULL	Clinics_(Sao_Paulo)_2011_Aug_66(8)_1457-1462.nxml.txt.nlp	21915500	SENT110	5	5	14	14	rosuvastatin	NOS	PA134308647	4843	0.752
NULL	Lab_Anim_Res_2013_Jun_24_29(2)_113-126.nxml.txt.nlp	23825484	SENT163	0	0	27	27	genistein	NKCC1	PA165109660	6558	0.752
NULL	Clinics_(Sao_Paulo)_2009_Apr_64(4)_313-318.nxml.txt.nlp	19488588	SENT82	9	9	19	19	budesonide	BDP	PA448681	10620;152926	0.752
NULL	J_Biomed_Biotechnol_2010_Mar_31_2010_590707.nxml.txt.nlp	20379367	SENT165	30	30	15	15	artemisinin	ACT	PA165111696	12;11332;9457;641455	0.752
NULL	Br_J_Cancer_2011_Jul_26_105(3)_372-381.nxml.txt.nlp	21730979	SENT80	0	0	14	14	camptothecin	CHK1	PA153590860	1111	0.752
NULL	J_Cell_Biol_1998_Jan_26_140(2)_335-345.nxml.txt.nlp	9442109	SENT184	10	10	16	16	chloroquine	NHE	PA448948	285335	0.752
NULL	Oxid_Med_Cell_Longev_2012_Nov_14_2012_856085.nxml.txt.nlp	23213350	SENT141	2	2	8	8	pioglitazone	p47phox	PA450970	653361	0.752
NULL	Breast_Cancer_Res_2004_Mar_11_6(3)_109-118.nxml.txt.nlp	15084231	SENT14	19	19	21	21	tamoxifen	aromatase	PA451581	1588	0.752
NULL	Mol_Biol_Cell_2012_May_15_23(10)_1928-1942.nxml.txt.nlp	22438580	SENT258	21	21	32	32	galactose	S12	PA449725	3351;6206;5713;6268	0.752
NULL	Cancer_Immunol_Immunother_2008_Mar_25_57(3)_289-302.nxml.txt.nlp	17721783	SENT382	28	28	10	10	imiquimod	CD4	PA449972	920	0.752
NULL	Mol_Neurodegener_2011_Aug_8_6_57.nxml.txt.nlp	21819629	SENT346	5	5	13	13	arsenite	JNK	PA452638	5599	0.752
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT39	22	22	26	26	metformin	EGFR	PA450395	1956	0.752
NULL	Front_Physiol_2011_Jun_30_2_33.nxml.txt.nlp	21747769	SENT21	3	3	16	16	berberine	KCNQ1	PA165860812	3784	0.752
NULL	Open_Virol_J_2014_Mar_7_8_1-8.nxml.txt.nlp	24799968	SENT145	16	16	27	27	telaprevir	PKR	PA165958354	5610	0.752
NULL	Lipids_Health_Dis_2011_Feb_28_10_38.nxml.txt.nlp	21352602	SENT110	33	33	21	21	ezetimibe	PCSK9	PA10816	255738	0.752
NULL	Biomed_Res_Int_2014_Jun_25_2014_764981.nxml.txt.nlp	25057499	SENT226	32	32	4	4	crizotinib	Met	PA165946122	79811	0.752
NULL	Mol_Cancer_2014_Jun_27_13_159.nxml.txt.nlp	24972933	SENT94	28	28	39	39	temsirolimus	BTK	PA164746890	695	0.752
NULL	JRSM_Cardiovasc_Dis_2012_Sep_24_1(6)_cvd_2012_012015.nxml.txt.nlp	24175073	SENT30	7	7	26	26	clopidogrel	CYP2C19	PA449053	1557	0.752
NULL	Oncogene_2014_Oct_9_33(41)_4941-4951.nxml.txt.nlp	24681952	SENT89	3	3	10	10	metformin	HIF1	PA450395	3091	0.752
NULL	Biomed_Res_Int_2014_Mar_4_2014_836769.nxml.txt.nlp	24724101	SENT85	5	5	31	31	fulvestrant	EGFR	PA164747170	1956	0.752
NULL	Pharmaceuticals_(Basel)_2014_Nov_25_7(12)_1028-1048.nxml.txt.nlp	25429645	SENT791	2	2	9	9	celecoxib	IL-6	PA448871	3569	0.752
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jan_26_67(Pt_2)_o500-o501.nxml.txt.nlp	21523154	SENT79	0	0	16	16	cinnarizine	mol	PA164749342	90527	0.752
NULL	Oncogene_2010_Nov_18_29(46)_6160-6171.nxml.txt.nlp	20729916	SENT226	19	19	2	2	cisplatin	YAP	PA449014	55249	0.752
NULL	Mol_Cancer_2010_Dec_20_9_317.nxml.txt.nlp	21172025	SENT139	10	10	23	23	tamoxifen	HER2	PA451581	2064	0.752
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_21-38.nxml.txt.nlp	19305786	SENT617	40	40	29	29	capsaicin	TRP	PA448776	7306	0.752
NULL	Cancers_(Basel)_2013_Apr_2_5(2)_320-333.nxml.txt.nlp	24216979	SENT152	15	15	20	20	daunorubicin	HIF1	PA449212	3091	0.752
NULL	Orphanet_J_Rare_Dis_2007_Jan_4_2_1.nxml.txt.nlp	17204147	SENT152	26	26	13	13	trypsin	PRSS1	PA451806	5644	0.752
NULL	Oncol_Lett_2014_Jun_8_7(6)_1903-1910.nxml.txt.nlp	24932256	SENT13	37	37	35	35	cisplatin	CRT	PA449014	811	0.752
NULL	Emerg_Infect_Dis_2011_Mar_17(3)_432-440.nxml.txt.nlp	21392434	SENT5	14	14	11	11	isoniazid	DST	PA450112	667	0.752
NULL	EMBO_Mol_Med_2013_Jun_30_5(6)_935-948.nxml.txt.nlp	23629957	SENT52	2	2	8	8	cisplatin	COL6A3	PA449014	1293	0.752
NULL	Front_Endocrinol_(Lausanne)_2013_Mar_28_4_22.nxml.txt.nlp	23543285	SENT250	9	9	38	38	estradiol	ARC	PA449503	8996;23237	0.752
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT189	23	23	26	26	trastuzumab	KRT5	PA451743	3852	0.752
NULL	Case_Rep_Dent_2013_Jun_13_2013_852932.nxml.txt.nlp	23840974	SENT103	18	18	8	8	vincristine	CHOP	PA451879	1649	0.752
NULL	Oncol_Lett_2014_Sep_19_8(3)_1269-1274.nxml.txt.nlp	25120704	SENT81	6	6	0	0	cisplatin	Met	PA449014	79811	0.752
NULL	Cardiovasc_Res_2009_May_1_82(2)_296-302.nxml.txt.nlp	19088082	SENT126	15	15	5	5	nifedipine	Rho	PA450631	29984	0.752
NULL	Glia_2013_Mar_61(3)_349-360.nxml.txt.nlp	23108585	SENT323	12	12	23	23	paraformaldehyde	TLR4	PA450790	7099	0.752
NULL	Onco_Targets_Ther_2014_Jun_12_7_1001-1014.nxml.txt.nlp	24959087	SENT136	9	9	18	18	cabozantinib	Men	PA165906891	8178	0.752
NULL	Clin_Dev_Immunol_2013_Nov_26_2013_875343.nxml.txt.nlp	24371449	SENT33	1	1	11	11	rituximab	B10	PA451261	5169	0.752
NULL	Cancer_Med_2014_Oct_2_3(5)_1256-1265.nxml.txt.nlp	24890382	SENT182	27	27	11	11	trastuzumab	HER2	PA451743	2064	0.752
NULL	Pediatr_Cardiol_2010_Jan_14_31(1)_90-95.nxml.txt.nlp	19915892	SENT107	31	31	18	18	palivizumab	Era	PA164748781	2099	0.752
NULL	Hum_Genomics_2008_Sep_1_3(1)_7-16.nxml.txt.nlp	19129086	SENT133	28	28	13	13	rosiglitazone	CYP2C8	PA451283	1558	0.752
NULL	Exp_Ther_Med_2013_Apr_5_5(4)_1259-1263.nxml.txt.nlp	23596498	SENT93	8	8	0	0	propofol	TRPA1	PA451141	8989	0.752
NULL	Nucleic_Acids_Res_2011_Oct_9_39(19)_8355-8365.nxml.txt.nlp	21745816	SENT164	32	32	17	17	doxycycline	UHRF1	PA449415	29128	0.752
NULL	Clin_Interv_Aging_2008_Sep_3(3)_431-444.nxml.txt.nlp	18982914	SENT119	20	20	10	10	mitomycin	NBS1	PA450524	55655	0.752
NULL	J_Biol_Chem_2008_Nov_14_283(46)_31679-31689.nxml.txt.nlp	18755684	SENT233	34	34	5	5	iron	FTL	PA450087	2512	0.752
NULL	EMBO_Mol_Med_2013_Jun_4_5(6)_802-804.nxml.txt.nlp	23737442	SENT49	11	11	0	0	glucose	PHD1	PA449773	112398	0.752
NULL	Crit_Care_2010_Mar_15_14(2)_R30.nxml.txt.nlp	20226064	SENT271	31	31	19	19	remifentanil	SOCS-3	PA451232	9021	0.752
NULL	Virchows_Arch_2012_Feb_16_460(2)_141-149.nxml.txt.nlp	22173329	SENT226	13	13	17	17	cetuximab	KRAS	PA10040	3845	0.752
NULL	Arch_Med_Sci_2013_Dec_30_9(6)_1090-1096.nxml.txt.nlp	24482655	SENT123	0	0	16	16	tacrolimus	CD4	PA451578	920	0.752
NULL	J_Immunother_Cancer_2013_Jul_15_1_10.nxml.txt.nlp	24829747	SENT194	0	0	26	26	gemcitabine	survivin	PA449748	332	0.752
NULL	Mol_Cancer_2008_Mar_6_7_24.nxml.txt.nlp	18325101	SENT74	20	20	16	16	cisplatin	FANCD2	PA449014	2177	0.752
NULL	Nucleic_Acids_Res_2012_Jun_10_40(11)_4804-4815.nxml.txt.nlp	22328728	SENT288	4	4	9	9	resveratrol	SIRT1		23411	0.752
NULL	Mol_Biol_Cell_2014_Jan_1_25(1)_145-159.nxml.txt.nlp	24196833	SENT250	18	18	22	22	valinomycin	LC3	PA151917011	84557	0.752
NULL	Br_J_Cancer_2009_Nov_3_101(9)_1585-1595.nxml.txt.nlp	19809435	SENT308	8	8	15	15	curcumin	MDC	PA151958596	6367	0.752
NULL	Breast_Cancer_Res_2007_Jul_5_9(4)_R41.nxml.txt.nlp	17612393	SENT43	24	24	10	10	celecoxib	Bcl-2	PA448871	596	0.752
NULL	Comput_Struct_Biotechnol_J_2013_May_27_4_e201301012.nxml.txt.nlp	24688693	SENT44	26	26	15	15	nadh	GAPDH	PA164755085	2597	0.752
NULL	Cancer_Cell_Int_2012_Jun_18_12_30.nxml.txt.nlp	22709569	SENT52	17	17	4	4	cisplatin	PLCG2	PA449014	5336	0.752
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT206	2	2	5	5	telatinib	ABCG2	PA165980595	9429	0.752
NULL	Br_J_Cancer_2014_Nov_25_111(11)_2091-2102.nxml.txt.nlp	25349971	SENT51	37	37	14	14	imatinib	KIT	PA10804	3815	0.752
NULL	Ann_Indian_Acad_Neurol_2010_Jul-Sep_13(3)_211-212.nxml.txt.nlp	21085535	SENT57	24	24	20	20	baclofen	ACTH	PA448533	5443	0.752
NULL	J_Immunother_Cancer_2013_Aug_27_1_14.nxml.txt.nlp	24829750	SENT161	6	6	18	18	isoflurane	FDG	PA450106	23583	0.752
NULL	Core_Evid_2010_Oct_21_5_61-76.nxml.txt.nlp	21042543	SENT352	17	17	3	3	cetuximab	EGFR	PA10040	1956	0.752
NULL	Int_J_Mol_Sci_2013_Aug_14_14(8)_16719-16731.nxml.txt.nlp	23949634	SENT167	5	5	15	15	thrombin	TPC	PA451674	8030;60386	0.752
NULL	J_Korean_Med_Sci_2007_Dec_20_22(6)_1055-1059.nxml.txt.nlp	18162722	SENT27	16	16	24	24	famotidine	ESD	PA449586	2098	0.752
NULL	Int_J_Impot_Res_2010_Mar_26_22(2)_120-126.nxml.txt.nlp	19940852	SENT50	16	16	20	20	forskolin	mol	PA146096022	90527	0.752
NULL	EMBO_Mol_Med_2012_Dec_15_4(12)_1276-1293.nxml.txt.nlp	23065753	SENT156	13	13	9	9	cisplatin	AIM2	PA449014	9447	0.752
NULL	Breast_Cancer_Res_2011_Mar_11_13(2)_R29.nxml.txt.nlp	21396094	SENT142	2	2	7	7	fulvestrant	HRG	PA164747170	3084;3273	0.752
NULL	Biosci_Rep_2014_Dec_12_34(6)_e00160.nxml.txt.nlp	25495645	SENT103	3	3	7	7	rosiglitazone	ANGPTL3	PA451283	27329	0.752
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Sep_30_67(Pt_10)_o2749.nxml.txt.nlp	22058807	SENT55	20	20	3	3	ethanol	mol	PA448073	90527	0.752
NULL	Open_Virol_J_2014_Mar_7_8_1-8.nxml.txt.nlp	24799968	SENT148	19	19	37	37	telaprevir	PKR	PA165958354	5610	0.752
NULL	Cancer_Cell_Int_2012_Jun_6_12_22.nxml.txt.nlp	22672528	SENT168	16	16	14	14	fludarabine	TRAIL	PA449655	8743	0.752
NULL	Ther_Clin_Risk_Manag_2006_Dec_2(4)_335-480.nxml.txt.nlp	18360645	SENT91	22	22	8	8	erlotinib	EGFR	PA134687924	1956	0.752
NULL	J_Gen_Physiol_2003_Jan_121(1)_3-16.nxml.txt.nlp	12508050	SENT20	6	6	15	15	nifedipine	c-fos	PA450631	2353	0.752
NULL	Nucleic_Acids_Res_2011_Dec_31_39(22)_9536-9548.nxml.txt.nlp	21880590	SENT164	18	18	34	34	etoposide	BRCA1	PA449552	672	0.752
NULL	Mol_Med_Rep_2015_Feb_27_11(2)_829-836.nxml.txt.nlp	25351707	SENT54	1	1	28	28	estradiol	San	PA449503	80218	0.752
NULL	Arch_Microbiol_2012_Apr_24_194(4)_255-268.nxml.txt.nlp	21947170	SENT63	23	23	18	18	erythromycin	BTL	PA449493	26511	0.752
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2012_Nov_7_1(11)_e13.nxml.txt.nlp	23835795	SENT308	14	14	5	5	pravastatin	OATP-C	PA451089	10599	0.752
NULL	Br_J_Cancer_2010_Jun_8_102(12)_1699-1706.nxml.txt.nlp	20485286	SENT80	41	41	14	14	ifosfamide	San	PA449964	80218	0.752
NULL	Clin_Ophthalmol_2010_Oct_21_4_1217-1222.nxml.txt.nlp	21060675	SENT14	11	11	16	16	latanoprost	BAK	PA164774763	578	0.752
NULL	Allergy_Asthma_Immunol_Res_2014_Nov_19_6(6)_548-557.nxml.txt.nlp	25374755	SENT147	26	26	33	33	lovastatin	Rho	PA450272	29984	0.752
NULL	Evid_Based_Complement_Alternat_Med_2015_Jan_6_2015_736431.nxml.txt.nlp	25632290	SENT119	0	0	5	5	curcumin	CYP1A1	PA151958596	1543	0.752
NULL	Biomed_Res_Int_2013_Dec_20_2013_162724.nxml.txt.nlp	23509685	SENT76	19	19	0	0	glibenclamide	STZ	PA449782	6484	0.752
NULL	Mol_Pain_2013_Aug_8_9_39.nxml.txt.nlp	23924059	SENT92	18	18	10	10	vasopressin	SON	PA451858	6651	0.752
NULL	Gastric_Cancer_2013_Jul_12_16(3)_345-354.nxml.txt.nlp	22968820	SENT149	25	25	8	8	oxaliplatin	FANCJ	PA131285527	83990	0.752
NULL	Cancers_(Basel)_2012_Oct_29_4(4)_1146-1160.nxml.txt.nlp	24213502	SENT53	14	14	16	16	raloxifene	STAR	PA451221	6770;2984	0.752
NULL	Oncol_Lett_2014_May_11_7(5)_1401-1408.nxml.txt.nlp	24765145	SENT119	2	2	7	7	paclitaxel	PI3K	PA450761	5290	0.752
NULL	Neural_Plast_2012_Oct_24_2012_832757.nxml.txt.nlp	23150836	SENT190	43	43	6	6	haloperidol	MMP2	PA449841	4313	0.752
NULL	Acta_Pharmacol_Sin_2014_Sep_25_35(9)_1199-1206.nxml.txt.nlp	25152024	SENT100	42	42	17	17	cisplatin	mig-2	PA449014	10979	0.752
NULL	Biologics_2012_Dec_17_6_429-464.nxml.txt.nlp	23269860	SENT238	5	5	22	22	tocilizumab	ACR	PA165292659	49	0.752
NULL	Oncol_Rep_2014_Feb_13_31(2)_581-588.nxml.txt.nlp	24337105	SENT191	20	20	14	14	capsaicin	XBP1	PA448776	7494	0.752
NULL	Br_J_Haematol_2008_Mar_3_144(5)_677-685.nxml.txt.nlp	19055662	SENT20	9	9	15	15	doxorubicin	CHOP	PA449412	1649	0.752
NULL	Front_Oncol_2014_Jun_18_4_153.nxml.txt.nlp	24995158	SENT546	34	34	22	22	vinblastine	p53	PA451877	7157	0.752
NULL	Int_J_Biol_Sci_2013_Mar_7_9(3)_279-288.nxml.txt.nlp	23493630	SENT17	2	2	9	9	tocilizumab	IL-21	PA165292659	59067;50616;27189	0.752
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT209	6	6	15	15	adalimumab	CD36	PA10004	948	0.752
NULL	Oncologist_2010_Mar_3_15(3)_216-235.nxml.txt.nlp	20200040	SENT101	15	15	21	21	pertuzumab	HER-2		2064	0.752
NULL	Arch_Drug_Inf_2008_Jul_1(1)_14-22.nxml.txt.nlp	20157364	SENT71	31	31	21	21	pravastatin	IL-6	PA451089	3569	0.752
NULL	Cells_2014_Nov_27_3(4)_1089-1101.nxml.txt.nlp	25437439	SENT13	21	21	13	13	potassium	TRPM7	PA451047	54822	0.752
NULL	Crit_Care_2003_Feb_18_7(Suppl_1)_5.nxml.txt.nlp	NULL	SENT15	4	4	17	17	hydrocortisone	IL-10	PA449905	3586	0.752
NULL	J_Gen_Physiol_2000_Jun_1_115(6)_685-696.nxml.txt.nlp	10828243	SENT195	6	6	3	3	genistein	OLF	PA165109660	83857	0.752
NULL	Oncotarget_2011_Dec_20_2(12)_1094-1108.nxml.txt.nlp	22190353	SENT127	22	22	47	47	gemcitabine	S5B	PA449748	5711	0.752
NULL	Evid_Based_Complement_Alternat_Med_2012_May_7_2012_242810.nxml.txt.nlp	22645625	SENT269	4	4	19	19	ketoconazole	HNF4	PA450146	3172	0.752
NULL	J_Hematol_Oncol_2013_Jul_18_6_53.nxml.txt.nlp	23866964	SENT91	6	6	20	20	temsirolimus	MTOR	PA164746890	2475	0.752
NULL	Contemp_Clin_Dent_2013_Jan-Mar_4(1)_48-53.nxml.txt.nlp	23853452	SENT136	5	5	21	21	minocycline	CAL	PA450519	54751;57120	0.752
NULL	Mol_Med_Rep_2014_Oct_23_10(4)_1717-1724.nxml.txt.nlp	25069516	SENT89	3	3	8	8	resveratrol	PC-3		692094	0.752
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT185	9	9	16	16	doxorubicin	ABCB1	PA449412	5243	0.752
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1495-1502.nxml.txt.nlp	21989186	SENT191	18	18	28	28	irinotecan	HSI	PA450085	57016	0.752
NULL	Eur_J_Endocrinol_2009_Nov_161(5)_655-662.nxml.txt.nlp	19729432	SENT48	15	15	24	24	lipase	adiponectin	PA450239	9370	0.752
NULL	Breast_Cancer_Res_2011_Jun_29_13(3)_R70.nxml.txt.nlp	21707964	SENT120	19	19	3	3	tamoxifen	14-3-3	PA451581	10971	0.752
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Sep_14_67(Pt_10)_o2642.nxml.txt.nlp	22058772	SENT70	5	5	8	8	phenol	mol	PA450913	90527	0.752
NULL	Eur_J_Clin_Pharmacol_2014_Oct_8_70(1)_37-45.nxml.txt.nlp	24100471	SENT198	4	4	18	18	pioglitazone	CYP2C8	PA450970	1558	0.752
NULL	Ann_Oncol_2011_Jun_25_22(6)_1392-1403.nxml.txt.nlp	21266519	SENT222	3	3	6	6	rituximab	CHOP	PA451261	1649	0.752
NULL	J_Cell_Biol_2008_Jul_14_182(1)_15-17.nxml.txt.nlp	18606854	SENT30	6	6	27	27	chloroquine	cIAP1	PA448948	329	0.752
NULL	Oncoimmunology_2012_Nov_1_1(8)_1376-1386.nxml.txt.nlp	23243601	SENT101	19	19	13	13	lenalidomide	BTK	PA162363968	695	0.752
NULL	Arthritis_Res_Ther_2008_Mar_17_10(2)_R33.nxml.txt.nlp	18346273	SENT169	6	6	20	20	infliximab	IL-15	PA452639	3600	0.752
NULL	J_Cancer_Prev_2014_Mar_19(1)_39-46.nxml.txt.nlp	25337571	SENT96	0	0	2	2	ethanol	p53	PA448073	7157	0.752
NULL	J_Vet_Med_Sci_2014_Aug_15_76(8)_1119-1127.nxml.txt.nlp	24829081	SENT129	6	6	22	22	trypsin	IL-8	PA451806	3576	0.752
NULL	Br_J_Cancer_2010_Jun_8_102(12)_1707-1716.nxml.txt.nlp	20461078	SENT105	6	6	11	11	bortezomib	TRAIL	PA10252	8743	0.752
NULL	J_Gastroenterol_2013_May_20_48(5)_574-594.nxml.txt.nlp	23512346	SENT328	21	21	13	13	cisplatin	ghrelin	PA449014	51738	0.752
NULL	Br_J_Cancer_2012_Jan_3_106(1)_6-13.nxml.txt.nlp	22215104	SENT15	19	19	27	27	trastuzumab	HER2	PA451743	2064	0.752
NULL	Aliment_Pharmacol_Ther_2012_Apr_22_35(7)_745-767.nxml.txt.nlp	22356640	SENT61	3	3	10	10	cinitapride	STIL	PA165958427	6491	0.752
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Feb_6_69(Pt_3)_o345.nxml.txt.nlp	23476538	SENT63	12	12	37	37	coumarin	C17	PA134521193	54360	0.752
NULL	Front_Behav_Neurosci_2011_Oct_5_5_63.nxml.txt.nlp	22007164	SENT1186	14	14	2	2	alprazolam	CB2	PA448333	1269	0.752
NULL	Evid_Based_Complement_Alternat_Med_2011_Mar_1_2011_207034.nxml.txt.nlp	21423686	SENT135	9	9	0	0	clopidogrel	CYP2C19	PA449053	1557	0.752
NULL	Cardiovasc_Diabetol_2010_Oct_18_9_64.nxml.txt.nlp	20955583	SENT6	35	35	14	14	telmisartan	PPARgamma	PA451605	5468	0.752
NULL	Iran_J_Pharm_Res_2013_Winter_12(Suppl)_37-46.nxml.txt.nlp	24250670	SENT145	9	9	16	16	etoposide	P-gp	PA449552	5243	0.752
NULL	J_Pain_Res_2014_Aug_30_7_531-545.nxml.txt.nlp	25210474	SENT180	6	6	18	18	atrasentan	ETB	PA143414738	1910	0.752
NULL	Asian-Australas_J_Anim_Sci_2012_Feb_1_25(2)_207-212.nxml.txt.nlp	25049553	SENT114	20	20	23	23	urea	CO2	PA451831	4513	0.752
NULL	Exp_Ther_Med_2013_Jan_10_5(1)_287-291.nxml.txt.nlp	23251285	SENT118	26	26	34	34	aspirin	APS	PA448497	10603	0.752
NULL	Breast_Cancer_Res_2010_Oct_22_12(Suppl_2)_S1.nxml.txt.nlp	21050422	SENT423	10	10	23	23	gemcitabine	TRN	PA449748	3842	0.752
NULL	Environ_Health_Perspect_2006_Sep_23_114(9)_1401-1406.nxml.txt.nlp	16966095	SENT27	12	12	0	0	arsenite	p53	PA452638	7157	0.752
NULL	Cancer_Cell_Int_2007_Jun_8_7_11.nxml.txt.nlp	17559657	SENT112	18	18	11	11	estradiol	CD34	PA449503	947	0.752
NULL	Comput_Struct_Biotechnol_J_2013_Mar_3_5_e201302008.nxml.txt.nlp	24688701	SENT94	35	35	40	40	doxorubicin	HBP	PA449412	3069;50865;7884;566	0.752
NULL	Aging_(Albany_NY)_2013_Apr_14_5(4)_288-303.nxml.txt.nlp	23596277	SENT195	42	42	12	12	pioglitazone	KSR	PA450970	10256	0.752
NULL	J_Immunotoxicol_2013_Jan_11_10(1)_75-82.nxml.txt.nlp	22967038	SENT96	21	21	6	6	rituximab	CD4	PA451261	920	0.752
NULL	Exp_Ther_Med_2014_Sep_20_8(3)_968-972.nxml.txt.nlp	25120631	SENT132	21	21	0	0	naringin	PF4	PA151958360	5196	0.752
NULL	Nat_Commun_2014_Nov_25_5_5582.nxml.txt.nlp	25420773	SENT108	5	5	34	34	erlotinib	PHD3	PA134687924	112399	0.752
NULL	Cancer_Med_2013_Apr_26_2(2)_117-129.nxml.txt.nlp	23634280	SENT68	40	40	25	25	sargramostim	GM-CSF	PA164748631	1437	0.752
NULL	Ann_Hematol_2013_May_22_92(9)_1181-1188.nxml.txt.nlp	23694997	SENT215	10	10	12	12	idarubicin	AIDA	PA449961	64853	0.752
NULL	J_Geriatr_Cardiol_2013_Mar_10(1)_21-27.nxml.txt.nlp	23610570	SENT75	12	12	19	19	fluorescein	PAC-1	PA164746009	1844	0.752
NULL	Oncotarget_2014_Jun_26_5(14)_5559-5569.nxml.txt.nlp	24980819	SENT85	20	20	5	5	vemurafenib	p53	PA165946873	7157	0.752
NULL	Oncotarget_2013_Nov_23_5(1)_196-210.nxml.txt.nlp	24344116	SENT3	11	11	28	28	doxorubicin	p53	PA449412	7157	0.752
NULL	Curr_Cardiol_Rev_2011_Aug_7(3)_163-183.nxml.txt.nlp	22758615	SENT409	25	25	35	35	simvastatin	IL-6	PA451363	3569	0.752
NULL	Aging_(Albany_NY)_2010_Dec_20_2(12)_959-968.nxml.txt.nlp	21191146	SENT69	16	16	22	22	cisplatin	LKB1	PA449014	6794	0.752
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Dec_4_66(Pt_1)_o9.nxml.txt.nlp	21580186	SENT50	21	21	16	16	ethanol	mol	PA448073	90527	0.752
NULL	Curr_Pharm_Des_2011_Feb_17(6)_578-590.nxml.txt.nlp	21391908	SENT181	2	2	19	19	nutlin-3	E2F1		1869	0.752
NULL	Eur_Radiol_2011_Jun_3_21(6)_1188-1199.nxml.txt.nlp	21127880	SENT65	13	13	21	21	cyclophosphamide	BCS	PA449165	617	0.752
NULL	Mol_Vis_2007_Apr_30_13_677-691.nxml.txt.nlp	17563718	SENT328	2	2	8	8	celecoxib	PDK1	PA448871	5170;5163	0.752
NULL	Cancers_(Basel)_2013_Jul_4_5(3)_838-856.nxml.txt.nlp	24202322	SENT207	19	19	11	11	doxorubicin	p53	PA449412	7157	0.752
NULL	J_Neurochem_2014_Feb_24_128(3)_391-402.nxml.txt.nlp	24117850	SENT103	25	25	27	27	trifluoperazine	TFP	PA451771	7034	0.752
NULL	Exp_Ther_Med_2015_Feb_3_9(2)_377-383.nxml.txt.nlp	25574201	SENT31	21	21	26	26	curcumin	TSP-1	PA151958596	7057	0.752
NULL	J_Cancer_2013_Jan_11_4(2)_117-132.nxml.txt.nlp	23386910	SENT85	27	27	31	31	trastuzumab	HER2	PA451743	2064	0.752
NULL	Br_J_Cancer_2004_May_4_90(9)_1733-1739.nxml.txt.nlp	15150604	SENT44	9	9	4	4	letrozole	aromatase	PA450196	1588	0.752
NULL	Pancreas_2014_Oct_12_43(7)_1060-1065.nxml.txt.nlp	25121413	SENT128	18	18	7	7	erlotinib	FDG	PA134687924	23583	0.752
NULL	Mol_Brain_2014_Aug_21_7_59.nxml.txt.nlp	25139109	SENT103	16	16	22	22	capsaicin	TLR4	PA448776	7099	0.752
NULL	J_Biol_Chem_2008_Apr_4_283(14)_8837-8845.nxml.txt.nlp	18250166	SENT186	32	32	24	24	methotrexate	StAR	PA450428	6770	0.752
NULL	Hematol_Rep_2011_Oct_28_3(3_Suppl)_e3.nxml.txt.nlp	22586511	SENT24	6	6	13	13	doxorubicin	CHOP	PA449412	1649	0.752
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Jun_19_64(Pt_7)_o1302.nxml.txt.nlp	21202931	SENT61	1	1	7	7	benzaldehyde	mol	PA448571	90527	0.752
NULL	Eur_J_Clin_Pharmacol_2011_May_9_67(5)_477-482.nxml.txt.nlp	21305273	SENT25	9	9	11	11	dobutamine	DSE	PA449381	29940	0.752
NULL	Oncol_Lett_2014_Jul_16_8(1)_211-217.nxml.txt.nlp	24959248	SENT7	18	18	6	6	cisplatin	ANGPTL4	PA449014	51129	0.752
NULL	Oncogene_2013_Oct_17_32(42)_5089-5100.nxml.txt.nlp	23178492	SENT74	15	15	11	11	vorinostat	LOX	PA164748224	4015	0.752
NULL	Evid_Based_Complement_Alternat_Med_2012_Feb_16_2012_430262.nxml.txt.nlp	22454664	SENT120	14	14	27	27	clopidogrel	CYP3A4	PA449053	1576	0.752
NULL	Curr_Neuropharmacol_2010_Sep_8(3)_228-242.nxml.txt.nlp	21358973	SENT357	30	30	13	13	methylprednisolone	p75	PA450466	7133;11168	0.752
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jun_16_66(Pt_7)_o1656-o1657.nxml.txt.nlp	21587884	SENT68	14	14	9	9	benzaldehyde	mol	PA448571	90527	0.752
NULL	Crit_Care_2007_Mar_22_11(Suppl_2)_P122.nxml.txt.nlp	NULL	SENT15	5	5	14	14	mannitol	IL-6	PA450320	3569	0.752
NULL	Br_J_Cancer_2009_Mar_24_100(6)_950-958.nxml.txt.nlp	19293809	SENT218	18	18	0	0	cetuximab	EGFR	PA10040	1956	0.752
NULL	Mol_Cell_Biochem_2014_Oct_9_385(1-2)_265-275.nxml.txt.nlp	24104452	SENT236	21	21	34	34	bortezomib	U87	PA10252	677775;641648	0.752
NULL	Mol_Cancer_2009_Aug_25_8_66.nxml.txt.nlp	19706164	SENT54	0	0	14	14	celecoxib	p53	PA448871	7157	0.752
NULL	Mol_Cell_Endocrinol_2013_Oct_15_379(1-2)_2-11.nxml.txt.nlp	23769710	SENT244	20	20	0	0	carbamazepine	MELAS	PA448785	4219	0.752
NULL	Behav_Brain_Funct_2010_Jul_9_6_41.nxml.txt.nlp	20615259	SENT32	3	3	6	6	methamphetamine	DTNBP1	PA450403	84062	0.752
NULL	ScientificWorldJournal_2014_Dec_9_2014_808320.nxml.txt.nlp	25548793	SENT112	3	3	17	17	heparin	RAC	PA449855	207	0.752
NULL	Leukemia_2013_Jan_11_27(1)_32-40.nxml.txt.nlp	22781593	SENT231	5	5	28	28	ponatinib	BCR	PA165980594	613	0.752
NULL	J_Clin_Biochem_Nutr_2011_Sep_3_49(2)_70-78.nxml.txt.nlp	21980221	SENT201	20	20	32	32	cisplatin	NAC	PA449014	22861	0.752
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT103	0	0	6	6	trastuzumab	HER2	PA451743	2064	0.752
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT15	25	25	11	11	simvastatin	AKT	PA451363	207	0.752
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT102	20	20	26	26	l-cysteine	4E-BP1	PA449173	1978	0.752
NULL	Ann_Oncol_2011_Mar_8_22(3)_503-514.nxml.txt.nlp	20616198	SENT67	34	34	15	15	letrozole	aromatase	PA450196	1588	0.752
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT129	9	9	3	3	simvastatin	AKT	PA451363	207	0.752
NULL	J_Headache_Pain_2011_Apr_5_12(2)_127-133.nxml.txt.nlp	21298314	SENT135	7	7	5	5	amitriptyline	CSMT	PA448385	1442	0.752
NULL	Nat_Biotechnol_2010_Jul_20_28(7)_727-732.nxml.txt.nlp	20562863	SENT67	35	35	24	24	thrombin	ADP	PA451674	23038	0.752
NULL	Cancer_Metastasis_Rev_2011_Jun_23_30(2)_185-197.nxml.txt.nlp	21340664	SENT144	21	21	4	4	topotecan	CHK1	PA451729	1111	0.752
NULL	Nat_Biotechnol_2011_May_29_29(6)_542-546.nxml.txt.nlp	21623355	SENT267	26	26	18	18	imatinib	PTPN1	PA10804	5770	0.752
NULL	Arthritis_Res_Ther_2007_Sep_23_9(5)_R96.nxml.txt.nlp	17888176	SENT128	15	15	9	9	etanercept	OPG	PA449515	690	0.752
NULL	Open_Access_J_Urol_2011_May_10_3_69-82.nxml.txt.nlp	24198638	SENT60	2	2	14	14	sorafenib	CYP3A4	PA7000	1576	0.752
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT43	17	17	26	26	pertuzumab	HER2		2064	0.752
NULL	J_Ginseng_Res_2011_Sep_35(3)_261-271.nxml.txt.nlp	23717069	SENT286	15	15	8	8	diltiazem	gamma	PA449334	9913	0.752
NULL	Breast_Cancer_Res_2011_Mar_11_13(2)_R29.nxml.txt.nlp	21396094	SENT101	2	2	4	4	fulvestrant	HRG	PA164747170	3084;3273	0.752
NULL	J_Hematol_Oncol_2013_Nov_22_6_88.nxml.txt.nlp	24261963	SENT328	6	6	14	14	paclitaxel	PI3K	PA450761	5290	0.752
NULL	Chemother_Res_Pract_2011_Feb_27_2011_175054.nxml.txt.nlp	22295203	SENT202	4	4	19	19	cisplatin	MTD	PA449014	4493	0.752
NULL	Curr_Genomics_2014_Jun_15(3)_217-230.nxml.txt.nlp	24955029	SENT189	37	37	9	9	oxygen	ROS	PA450744	6098	0.752
NULL	Ann_Lab_Med_2012_Jul_20_32(4)_264-269.nxml.txt.nlp	22779067	SENT53	12	12	9	9	isoniazid	DST	PA450112	667	0.752
NULL	Cell_Death_Dis_2010_Oct_21_1(10)_e86.nxml.txt.nlp	21368859	SENT242	27	27	8	8	doxorubicin	TRAIL	PA449412	8743	0.752
NULL	Pharmaceutics_2012_Dec_27_5(1)_81-93.nxml.txt.nlp	24300398	SENT22	29	29	23	23	ridaforolimus	FKBP-12	PA165291475	2280	0.752
NULL	Oncotarget_2013_Nov_20_5(1)_173-184.nxml.txt.nlp	24368422	SENT36	15	15	23	23	chloroquine	LC3	PA448948	84557	0.752
NULL	J_Asthma_Allergy_2012_Nov_8_5_65-70.nxml.txt.nlp	23204847	SENT16	2	2	18	18	omalizumab	ACT	PA164752253	12;11332;9457;641455	0.752
NULL	Front_Physiol_2011_Jul_19_2_40.nxml.txt.nlp	21811470	SENT253	8	8	12	12	candesartan	RVR	PA448765	9975	0.752
NULL	Nat_Med_2012_Aug_22_18(8)_10_1038_nm_2827.nxml.txt.nlp	22820645	SENT175	16	16	20	20	glutaraldehyde	TRPV1	PA449777	7442	0.752
NULL	Open_Med_Chem_J_2012_May_17_6_1-14.nxml.txt.nlp	22876271	SENT225	16	16	13	13	sr144528	CB2		1269	0.752
NULL	J_Oncol_2012_Apr_10_2012_931071.nxml.txt.nlp	22570654	SENT56	19	19	9	9	plerixafor	CD34	PA165958410	947	0.752
NULL	Exp_Diabetes_Res_2011_Dec_27_2011_604989.nxml.txt.nlp	21253359	SENT171	20	20	26	26	clonidine	GLP-1	PA449051	100125288	0.752
NULL	Cancers_(Basel)_2012_Oct_12_4(4)_989-1035.nxml.txt.nlp	24213498	SENT572	10	10	18	18	gemcitabine	CD133	PA449748	8842	0.752
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT164	40	40	47	47	l-leucine	p27	PA450197	5715;10534	0.752
NULL	Int_J_Mol_Sci_2013_Apr_12_14(4)_8093-8121.nxml.txt.nlp	23584026	SENT703	12	12	16	16	sumatriptan	5-HT1B	PA451566	3351	0.752
NULL	Gut_2012_May_7_61(5)_673-684.nxml.txt.nlp	22315472	SENT292	29	29	8	8	trastuzumab	HER-2	PA451743	2064	0.752
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT119	5	5	11	11	curcumin	TRAIL	PA151958596	8743	0.752
NULL	Front_Neuroeng_2012_Jan_12_4_20.nxml.txt.nlp	22319493	SENT21	26	26	16	16	oxygen	CO2	PA450744	4513	0.752
NULL	Mol_Biol_Rep_2012_May_20_39(5)_5253-5267.nxml.txt.nlp	22183301	SENT151	27	27	25	25	gliclazide	NAC	PA10892	22861	0.752
NULL	Exp_Diabetes_Res_2011_Nov_30_2011_162092.nxml.txt.nlp	22203828	SENT213	12	12	21	21	sitagliptin	HSL	PA164748978	3991	0.752
NULL	Cancer_Cell_Int_2010_May_11_10_16.nxml.txt.nlp	20459793	SENT87	6	6	21	21	cisplatin	ABCC1	PA449014	4363	0.752
NULL	Nat_Commun_2014_Nov_25_5_5548.nxml.txt.nlp	25420520	SENT46	14	14	25	25	docetaxel	ERG	PA449383	2078	0.752
NULL	Mol_Cancer_2009_Aug_25_8_66.nxml.txt.nlp	19706164	SENT157	13	13	7	7	celecoxib	p53	PA448871	7157	0.752
NULL	Braz_J_Med_Biol_Res_2012_Mar_2_45(3)_250-255.nxml.txt.nlp	22370705	SENT99	2	2	26	26	atropine	ADM	PA448505	133	0.752
NULL	Cancer_Microenviron_2009_May_6_2(1)_59-67.nxml.txt.nlp	19418243	SENT33	1	1	14	14	tetracycline	CCL21	PA451640	6366	0.752
NULL	Clin_Interv_Aging_2010_Dec_3_5_403-416.nxml.txt.nlp	21152242	SENT117	5	5	26	26	telmisartan	ACE	PA451605	1636	0.752
NULL	Environ_Health_Perspect_2010_Dec_12_118(12)_1707-1713.nxml.txt.nlp	20705543	SENT134	15	15	3	3	bleomycin	XRCC1	PA448645	7515	0.752
NULL	Mol_Pain_2014_Apr_12_10_25.nxml.txt.nlp	24725960	SENT121	21	21	17	17	carrageenan	SDH	PA448814	1757;10993	0.752
NULL	Pharmaceuticals_(Basel)_2013_Apr_3_6(4)_480-499.nxml.txt.nlp	24276119	SENT342	4	4	11	11	citalopram	STAR	PA449015	6770;2984	0.752
NULL	Diabetes_2013_Oct_17_62(10)_3547-3552.nxml.txt.nlp	23863812	SENT74	10	10	19	19	pravastatin	ANOVA	PA451089	4858	0.752
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT179	21	21	39	39	metformin	HIF-1	PA450395	29072	0.752
NULL	Blood_Cancer_J_2013_Mar_1_3(3)_e103.nxml.txt.nlp	23454896	SENT87	6	6	25	25	nelfinavir	CHOP	PA450606	1649	0.752
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT42	9	9	0	0	capsaicin	p53	PA448776	7157	0.751
NULL	Cardiovasc_Diabetol_2013_Oct_17_12_150.nxml.txt.nlp	24134550	SENT140	9	9	20	20	pioglitazone	activin	PA450970	83729	0.751
NULL	Cell_Res_2014_Feb_12_24(2)_143-160.nxml.txt.nlp	24217768	SENT67	29	29	46	46	heparin	FGF2	PA449855	2247;2258	0.751
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT257	28	28	8	8	bevacizumab	VEGF-A	PA130232992	7422	0.751
NULL	Nat_Commun_2014_Dec_18_5_5815.nxml.txt.nlp	25519973	SENT411	27	27	14	14	tranylcypromine	EGF	PA451741	1950	0.751
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_127043.nxml.txt.nlp	23227093	SENT202	45	45	27	27	nifedipine	P-gp	PA450631	5243	0.751
NULL	Mol_Cancer_2012_Jul_12_11_45.nxml.txt.nlp	22788833	SENT150	9	9	17	17	cisplatin	p38	PA449014	10598;1432;7965	0.751
NULL	J_Hematol_Oncol_2013_Sep_5_6_66.nxml.txt.nlp	24010946	SENT301	30	30	6	6	trastuzumab	CRT	PA451743	811	0.751
NULL	Adv_Ther_2014_Feb_15_31(3)_289-317.nxml.txt.nlp	24535623	SENT274	9	9	13	13	sitagliptin	GLP-1	PA164748978	100125288	0.751
NULL	Br_J_Cancer_2014_Aug_12_111(4)_646-650.nxml.txt.nlp	24755886	SENT49	3	3	9	9	trabectedin	IL-6	PA165958349	3569	0.751
NULL	Croat_Med_J_2012_Aug_53(4)_294-297.nxml.txt.nlp	22911518	SENT27	20	20	11	11	trastuzumab	HER2	PA451743	2064	0.751
NULL	Oncotarget_2014_Feb_16_5(3)_587-598.nxml.txt.nlp	24583822	SENT110	15	15	31	31	carboplatin	MAGEB2	PA448803	4113	0.751
NULL	Arch_Immunol_Ther_Exp_(Warsz)_2008_Apr_31_56(2)_135-140.nxml.txt.nlp	18373243	SENT34	26	26	16	16	phenol	BTL	PA450913	26511	0.751
NULL	Cancers_(Basel)_2014_Mar_6_6(1)_494-525.nxml.txt.nlp	24662938	SENT1920	13	13	2	2	cetuximab	PTEN	PA10040	5728	0.751
NULL	Acta_Pharmacol_Sin_2011_Oct_15_32(10)_1303-1308.nxml.txt.nlp	21841812	SENT162	4	4	16	16	losartan	CYP2C9	PA450268	1559	0.751
NULL	Br_J_Haematol_2008_Jun_141(5)_659-671.nxml.txt.nlp	18410446	SENT161	8	8	23	23	cerulenin	JNK	PA164764551	5599	0.751
NULL	Oncol_Lett_2014_Sep_11_8(3)_1333-1339.nxml.txt.nlp	25120719	SENT145	15	15	28	28	bevacizumab	DR5	PA130232992	8795	0.751
NULL	Cancer_Immunol_Immunother_2011_Jun_25_60(6)_793-808.nxml.txt.nlp	21350947	SENT220	9	9	15	15	sorafenib	IFN	PA7000	3439	0.751
NULL	J_Vet_Med_Sci_2014_Aug_15_76(8)_1119-1127.nxml.txt.nlp	24829081	SENT12	5	5	32	32	trypsin	fractalkine	PA451806	6376	0.751
NULL	Environ_Health_Perspect_2011_Jun_17_119(6)_778-783.nxml.txt.nlp	21169129	SENT189	14	14	42	42	fluorescein	CD40	PA164746009	958	0.751
NULL	Scientifica_(Cairo)_2012_Oct_9_2012_821549.nxml.txt.nlp	24278743	SENT286	6	6	20	20	fenfluramine	5-HTT	PA449592	6532	0.751
NULL	Mol_Cancer_2009_May_15_8_28.nxml.txt.nlp	19445670	SENT45	21	21	12	12	doxorubicin	XIAP	PA449412	331	0.751
NULL	J_Invest_Dermatol_2014_Jul_31_134(7)_1903-1911.nxml.txt.nlp	24487305	SENT145	14	14	34	34	fluorescein	San	PA164746009	80218	0.751
NULL	J_Clin_Biochem_Nutr_2010_Mar_27_46(2)_126-134.nxml.txt.nlp	20216945	SENT64	13	13	22	22	taurine	NAC	PA451590	22861	0.751
NULL	Nucleic_Acids_Res_2005_Mar_22_33(5)_1722-1736.nxml.txt.nlp	15784612	SENT13	27	27	7	7	chloramphenicol	ENO2	PA448927	2026	0.751
NULL	Clinics_(Sao_Paulo)_2014_Oct_69(10)_655-659.nxml.txt.nlp	25518015	SENT42	15	15	27	27	propofol	NGAL	PA451141	3934	0.751
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT193	31	31	14	14	perifosine	DR5	PA165291471	8795	0.751
NULL	Case_Rep_Pediatr_2012_Aug_9_2012_323681.nxml.txt.nlp	22924145	SENT87	11	11	2	2	tocilizumab	BAFF	PA165292659	10673	0.751
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1106-1112.nxml.txt.nlp	20234360	SENT128	24	24	17	17	doxorubicin	TTR	PA449412	7276	0.751
NULL	Curr_Genomics_2014_Jun_15(3)_190-202.nxml.txt.nlp	24955027	SENT77	15	15	1	1	pp2	PP1		5540;5464	0.751
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT49	39	39	11	11	dextromethorphan	CYP2C9	PA449273	1559	0.751
NULL	Hum_Genomics_2009_Dec_1_4(2)_91-106.nxml.txt.nlp	20038497	SENT120	48	48	33	33	galantamine	CYP2D6	PA449726	1565	0.751
NULL	Mol_Cancer_2008_Mar_6_7_24.nxml.txt.nlp	18325101	SENT134	14	14	10	10	cisplatin	FANCD2	PA449014	2177	0.751
NULL	Diabetes_Obes_Metab_2011_Nov_13(11)_982-989.nxml.txt.nlp	21615670	SENT99	3	3	16	16	sitagliptin	PPG	PA164748978	5552	0.751
NULL	Pharmaceuticals_(Basel)_2013_Aug_6_6(8)_929-959.nxml.txt.nlp	24276377	SENT1245	4	4	15	15	curcumin	AP-1	PA151958596	2353;3727;2354;3725	0.751
NULL	Breast_Cancer_Res_2004_Nov_7_6(1)_39-52.nxml.txt.nlp	14680484	SENT137	18	18	14	14	tamoxifen	ATAC	PA451581	6375	0.751
NULL	Indian_J_Pharmacol_2014_May-Jun_46(3)_281-285.nxml.txt.nlp	24987174	SENT102	34	34	4	4	sildenafil	SPAP	PA451346	10158	0.751
NULL	Curr_Pharm_Biotechnol_2011_Jan_12(1)_35-41.nxml.txt.nlp	20932261	SENT86	3	3	6	6	hyperforin	TRPC6	PA165985514	7225	0.751
NULL	Mol_Cancer_2009_Apr_22_8_26.nxml.txt.nlp	19386116	SENT214	14	14	10	10	trypsin	CO2	PA451806	4513	0.751
NULL	Nucleic_Acids_Res_2011_Mar_3_39(5)_1833-1842.nxml.txt.nlp	21051361	SENT179	38	38	14	14	galactose	THG1	PA449725	84528	0.751
NULL	Breast_Cancer_Res_Treat_2014_Nov_24_143(1)_125-133.nxml.txt.nlp	24272078	SENT207	8	8	13	13	exemestane	aromatase	PA449563	1588	0.751
NULL	Cell_Death_Dis_2013_Jun_27_4(6)_e694.nxml.txt.nlp	23807223	SENT43	0	0	3	3	chloroquine	HMGB1	PA448948	3146	0.751
NULL	J_Biomed_Sci_2013_Jul_2_20(1)_46.nxml.txt.nlp	23815815	SENT225	15	15	8	8	phenylephrine	EPAC	PA450935	10411	0.751
NULL	Infect_Dis_Ther_2013_Dec_3_2(2)_111-122.nxml.txt.nlp	25134475	SENT53	6	6	22	22	trimethoprim	MATE1	PA451788	55244	0.751
NULL	Ann_Gen_Psychiatry_2014_Jul_9_13_19.nxml.txt.nlp	25089150	SENT0	17	17	1	1	fluvoxamine	Gen	PA449690	348654	0.751
NULL	Pharmaceuticals_(Basel)_2011_May_17_4(5)_741-757.nxml.txt.nlp	NULL	SENT145	0	0	28	28	ethanol	TGN	PA448073	7038	0.751
NULL	FEBS_Open_Bio_2013_Dec_30_4_96-104.nxml.txt.nlp	24490130	SENT509	2	2	14	14	cisplatin	BRCA1	PA449014	672	0.751
NULL	Indian_J_Pharmacol_2014_Nov-Dec_46(6)_627-632.nxml.txt.nlp	25538335	SENT7	19	19	7	7	metformin	Q10	PA450395	27161	0.751
NULL	J_Thorac_Oncol_2015_Jan_29_10(1)_156-163.nxml.txt.nlp	25247337	SENT263	6	6	23	23	afatinib	BSC	PA165981154	6558	0.751
NULL	Clin_Pharmacokinet_2014_Sep_3_53(1)_1-16.nxml.txt.nlp	23999929	SENT275	8	8	14	14	rivaroxaban	CYP3A4	PA165958360	1576	0.751
NULL	Br_J_Cancer_2002_Jan_21_86(2)_218-221.nxml.txt.nlp	11870509	SENT80	6	6	17	17	tamoxifen	BRCA2	PA451581	675	0.751
NULL	Carcinogenesis_2013_Mar_7_34(3)_703-712.nxml.txt.nlp	23222814	SENT85	11	11	3	3	curcumin	p53	PA151958596	7157	0.751
NULL	Breast_Cancer_Res_2010_Oct_28_12(5)_212.nxml.txt.nlp	21067532	SENT109	27	27	29	29	paclitaxel	ACT	PA450761	12;11332;9457;641455	0.751
NULL	Breast_Cancer_Res_2011_Dec_16_13(6)_R131.nxml.txt.nlp	22177475	SENT12	20	20	46	46	cetuximab	AKT	PA10040	207	0.751
NULL	Case_Rep_Endocrinol_2013_Oct_22_2013_815821.nxml.txt.nlp	24251048	SENT54	18	18	15	15	lorazepam	PRN	PA450267	64428	0.751
NULL	Br_J_Clin_Pharmacol_2013_Aug_23_76(2)_299-315.nxml.txt.nlp	23701319	SENT150	3	3	16	16	rituximab	IL-5	PA451261	3567	0.751
NULL	Arthritis_Res_Ther_2010_Sep_8_12(5)_R167.nxml.txt.nlp	20825639	SENT171	27	27	35	35	resveratrol	JNK		5599	0.751
NULL	Arthritis_Res_Ther_2006_May_15_8(3)_211.nxml.txt.nlp	16719936	SENT88	12	12	25	25	methotrexate	ACR	PA450428	49	0.751
NULL	Mol_Cancer_2009_Mar_26_8_23.nxml.txt.nlp	19323829	SENT210	18	18	12	12	bortezomib	p53	PA10252	7157	0.751
NULL	Adv_Hematol_2012_Jan_5_2012_507257.nxml.txt.nlp	22272202	SENT140	6	6	18	18	atazanavir	UGT1A1	PA10251	54658	0.751
NULL	Cancer_Biol_Med_2013_Dec_10(4)_192-205.nxml.txt.nlp	24349829	SENT309	21	21	8	8	cetuximab	KRAS	PA10040	3845	0.751
NULL	Cancer_Cell_Int_2010_Sep_9_10_32.nxml.txt.nlp	20828393	SENT152	20	20	18	18	cisplatin	ATF3	PA449014	467	0.751
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_May_31_69(Pt_6)_o980.nxml.txt.nlp	23795133	SENT73	11	11	8	8	desloratadine	mol	PA164776964	90527	0.751
NULL	J_Breast_Cancer_2013_Jun_28_16(2)_138-145.nxml.txt.nlp	23843844	SENT126	10	10	20	20	tamoxifen	STAT3	PA451581	6774	0.751
NULL	Br_J_Pharmacol_2012_Apr_165(8)_2611-2619.nxml.txt.nlp	21718301	SENT215	9	9	15	15	rimonabant	GPR55	PA152407999	9290	0.751
NULL	Cancer_Cell_Int_2005_Jun_1_5_18.nxml.txt.nlp	15929791	SENT140	5	5	32	32	bortezomib	JNK	PA10252	5599	0.751
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Feb_23_69(Pt_3)_m165-m166.nxml.txt.nlp	23476507	SENT6	8	8	2	2	phenol	mol	PA450913	90527	0.751
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT294	3	3	21	21	neratinib	HRG	PA165291472	3084;3273	0.751
NULL	Acta_Pharmacol_Sin_2009_Nov_12_30(11)_1566-1572.nxml.txt.nlp	19820718	SENT150	33	33	9	9	omeprazole	CYP3A4	PA450704	1576	0.751
NULL	Bioinform_Biol_Insights_2009_Oct_5_3_109-127.nxml.txt.nlp	20140064	SENT463	7	7	17	17	didanosine	P200	PA449301	5035	0.751
NULL	Hum_Mol_Genet_2008_Jul_15_17(14)_2101-2107.nxml.txt.nlp	18413323	SENT112	16	16	7	7	ezetimibe	NPC1L1	PA10816	29881	0.751
NULL	J_Exp_Clin_Cancer_Res_2009_Aug_19_28(1)_116.nxml.txt.nlp	19689822	SENT28	6	6	8	8	rituximab	CHOP	PA451261	1649	0.751
NULL	Cell_Commun_Signal_2014_Oct_5_12(1)_54.nxml.txt.nlp	NULL	SENT194	9	9	26	26	fasudil	MRCK	PA165946121	8476	0.751
NULL	Diabetes_Obes_Metab_2011_Nov_13(11)_982-989.nxml.txt.nlp	21615670	SENT99	1	1	16	16	exenatide	PPG	PA164749238	5552	0.751
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT211	14	14	10	10	ranibizumab	VEGFR2	PA164746012	3791	0.751
NULL	Oncol_Lett_2014_Sep_11_8(3)_1333-1339.nxml.txt.nlp	25120719	SENT145	15	15	21	21	bevacizumab	TRAIL	PA130232992	8743	0.751
NULL	Nat_Med_2013_Dec_10_19(12)_10_1038_nm_3385.nxml.txt.nlp	24216752	SENT17	18	18	31	31	thrombin	PAR1	PA451674	79581;2149	0.751
NULL	Arthritis_Res_Ther_2009_Aug_17_11(4)_R123.nxml.txt.nlp	19686595	SENT168	0	0	8	8	rituximab	CD38	PA451261	952	0.751
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_May_24_70(Pt_6)_o713.nxml.txt.nlp	24940283	SENT75	22	22	10	10	ethanol	mol	PA448073	90527	0.751
NULL	Mar_Drugs_2014_Sep_1_12(9)_4713-4731.nxml.txt.nlp	25257783	SENT132	29	29	37	37	caspofungin	MAS1	PA164743013	4142	0.751
NULL	J_Brachial_Plex_Peripher_Nerve_Inj_2008_Oct_25_3_22.nxml.txt.nlp	18950516	SENT45	14	14	12	12	clonidine	SGB	PA449051	2719	0.751
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT860	22	22	13	13	aripiprazole	San	PA10026	80218	0.751
NULL	Arthritis_Res_Ther_2006_Nov_16_8(6)_R173.nxml.txt.nlp	17109745	SENT159	14	14	29	29	glucosamine	IL-6	PA164747613	3569	0.751
NULL	Front_Neurol_2014_Jul_10_5_125.nxml.txt.nlp	25071710	SENT212	7	7	0	0	warfarin	STR	PA451906	6779	0.751
NULL	Curr_Med_Chem_2013_Apr_20(10)_1241-1285.nxml.txt.nlp	23409712	SENT987	10	10	12	12	carbachol	MPP1	PA448784	4354;9585	0.751
NULL	Breast_Cancer_Res_2008_Dec_4_10(6)_R103.nxml.txt.nlp	19055788	SENT166	11	11	8	8	tamoxifen	CDH1	PA451581	51343;999	0.751
NULL	J_Adv_Pract_Oncol_2013_Jul_1_Jul-Aug_4(4)_238-250.nxml.txt.nlp	25032004	SENT237	9	9	11	11	tamoxifen	aromatase	PA451581	1588	0.751
NULL	J_Cancer_Prev_2013_Sep_18(3)_227-234.nxml.txt.nlp	25337550	SENT148	6	6	2	2	cisplatin	EZH2	PA449014	2146	0.751
NULL	Anesth_Pain_Med_2014_Sep_9_4(4)_e14221.nxml.txt.nlp	25599022	SENT155	5	5	13	13	cisplatin	NFkappaB	PA449014	4790	0.751
NULL	BMB_Rep_2014_May_47(5)_274-279.nxml.txt.nlp	24286313	SENT31	14	14	23	23	bortezomib	CD138	PA10252	6382	0.751
NULL	Breast_Cancer_Res_2011_Sep_14_13(5)_R88.nxml.txt.nlp	21914219	SENT241	5	5	24	24	perifosine	c-FLIP	PA165291471	8837	0.751
NULL	Br_J_Cancer_2012_Jan_17_106(2)_284-289.nxml.txt.nlp	22215065	SENT162	20	20	12	12	atrasentan	IFN	PA143414738	3439	0.751
NULL	J_Cell_Mol_Med_2013_Nov_23_17(11)_1422-1433.nxml.txt.nlp	24112466	SENT239	11	11	21	21	lapatinib	CD133	PA152241907	8842	0.751
NULL	J_Exp_Clin_Cancer_Res_2009_Feb_15_28(1)_19.nxml.txt.nlp	19216799	SENT81	13	13	19	19	doxorubicin	CO2	PA449412	4513	0.751
NULL	Neuro_Oncol_2010_Apr_27_12(4)_389-400.nxml.txt.nlp	20308316	SENT176	5	5	22	22	chloroquine	p53	PA448948	7157	0.751
NULL	BMJ_2010_Feb_8_340_c693.nxml.txt.nlp	20142325	SENT24	6	6	22	22	tamoxifen	CYP2D6	PA451581	1565	0.751
NULL	Breast_Cancer_Res_2014_Sep_28_16(5)_446.nxml.txt.nlp	25467785	SENT464	23	23	25	25	raloxifene	STAR	PA451221	6770;2984	0.751
NULL	J_Cancer_Prev_2014_Jun_19(2)_75-88.nxml.txt.nlp	25337575	SENT96	20	20	39	39	ritonavir	CHOP	PA451260	1649	0.751
NULL	Leukemia_2013_Apr_14_27(4)_803-812.nxml.txt.nlp	23238589	SENT159	22	22	26	26	nilotinib	IFN	PA165958345	3439	0.751
NULL	J_Vet_Sci_2007_Dec_31_8(4)_341-351.nxml.txt.nlp	17993747	SENT158	4	4	9	9	echinacea	gamma	PA131550706	9913	0.751
NULL	Biomed_Res_Int_2014_Jan_20_2014_948427.nxml.txt.nlp	24563867	SENT223	10	10	5	5	buspirone	COB	PA448689	4519	0.751
NULL	J_Infect_Dis_2011_Oct_1_204(7)_1104-1114.nxml.txt.nlp	21881126	SENT163	9	9	6	6	chloroquine	MDA5	PA448948	64135	0.751
NULL	Int_J_Mol_Sci_2014_Oct_8_15(10)_17974-17999.nxml.txt.nlp	25299695	SENT119	4	4	18	18	curcumin	HO-1	PA151958596	3162	0.751
NULL	J_Clin_Biochem_Nutr_2010_Jan_29_46(1)_87-92.nxml.txt.nlp	20104270	SENT24	13	13	26	26	hesperidin	STZ	PA449867	6484	0.751
NULL	J_Adv_Pharm_Technol_Res_2012_Oct-Dec_3(4)_202-209.nxml.txt.nlp	23378940	SENT164	26	26	5	5	cisapride	CYP3A4	PA449011	1576	0.751
NULL	Nucleic_Acids_Res_2005_Jun_8_33(10)_3283-3291.nxml.txt.nlp	15944449	SENT444	12	12	41	41	sjg-136	ERCC1		2067	0.751
NULL	Cell_Commun_Signal_2014_Oct_5_12(1)_54.nxml.txt.nlp	NULL	SENT194	9	9	31	31	fasudil	ROCK1	PA165946121	6093	0.751
NULL	J_Inflamm_(Lond)_2008_Jul_29_5_11.nxml.txt.nlp	18664275	SENT105	3	3	6	6	ciprofloxacin	IL-8	PA449009	3576	0.751
NULL	Indian_Dermatol_Online_J_2011_Jan-Jun_2(1)_43-45.nxml.txt.nlp	23130220	SENT26	25	25	29	29	etretinate	CO2	PA449554	4513	0.751
NULL	Clin_Ophthalmol_2012_Feb_20_6_277-282.nxml.txt.nlp	22375096	SENT106	32	32	19	19	ranibizumab	STA	PA164746012	2010;2656	0.751
NULL	Br_J_Cancer_2011_Jun_28_105(1)_1-8.nxml.txt.nlp	21654681	SENT40	25	25	32	32	cetuximab	EGFR	PA10040	1956	0.751
NULL	J_Biol_Chem_2008_Oct_31_283(44)_29841-29846.nxml.txt.nlp	18765669	SENT118	5	5	14	14	suramin	P2X1	PA10292	5023	0.751
NULL	Oncotarget_2013_Nov_24_4(12)_2430-2438.nxml.txt.nlp	24280348	SENT78	3	3	18	18	gefitinib	STAT3	PA131301952	6774	0.751
NULL	Curr_Neuropharmacol_2008_Sep_6(3)_215-234.nxml.txt.nlp	19506722	SENT415	22	22	28	28	paroxetine	5-HT1B	PA450801	3351	0.751
NULL	Oncol_Lett_2013_Feb_9_5(2)_495-498.nxml.txt.nlp	23420572	SENT29	10	10	14	14	amlodipine	PRN	PA448388	64428	0.751
NULL	Int_Clin_Psychopharmacol_2014_Jul_26_29(4)_185-196.nxml.txt.nlp	24424469	SENT100	0	0	5	5	sertraline	CYP2D6	PA451333	1565	0.751
NULL	J_Immunother_Cancer_2013_Nov_7_1(Suppl_1)_P29.nxml.txt.nlp	NULL	SENT5	0	0	3	3	famotidine	LAK	PA449586	10123	0.751
NULL	Front_Microbiol_2013_Aug_19_4_241.nxml.txt.nlp	23966991	SENT247	18	18	11	11	ethanol	GLT-1	PA448073	6506	0.751
NULL	Br_J_Cancer_2011_Apr_12_104(8)_1256-1261.nxml.txt.nlp	21448165	SENT82	10	10	15	15	sorafenib	IL-2	PA7000	3558	0.751
NULL	Arch_Med_Sci_2012_Nov_9_8(5)_907-917.nxml.txt.nlp	23185203	SENT160	13	13	9	9	metformin	p53	PA450395	7157	0.751
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1699-1708.nxml.txt.nlp	19861960	SENT166	2	2	6	6	dasatinib	Yes	PA162372878	7525	0.751
NULL	Ann_Med_Health_Sci_Res_2012_Jul-Dec_2(2)_191-198.nxml.txt.nlp	23439914	SENT167	7	7	1	1	elacridar	P-gp		5243	0.751
NULL	Cancer_Cell_Int_2012_Jun_18_12_30.nxml.txt.nlp	22709569	SENT69	17	17	4	4	doxorubicin	PLCG2	PA449412	5336	0.751
NULL	Med_Sci_Monit_2012_Jul_1_18(7)_BR286-BR291.nxml.txt.nlp	22739729	SENT162	21	21	3	3	staurosporine	GLP-1	PA165109623	100125288	0.751
NULL	Cell_Death_Dis_2010_Oct_21_1(10)_e86.nxml.txt.nlp	21368859	SENT76	20	20	33	33	doxorubicin	Mcl-1	PA449412	4170	0.751
NULL	Oncologist_2010_Apr_15(4)_372-381.nxml.txt.nlp	20413642	SENT181	3	3	11	11	cisplatin	EGFR	PA449014	1956	0.751
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT182	5	5	7	7	doxorubicin	B7-H1	PA449412	29126	0.751
NULL	J_Adv_Pract_Oncol_2013_Sep_1_Sep-Oct_4(5)_289-306.nxml.txt.nlp	25032009	SENT373	9	9	21	21	genistein	AMPK	PA165109660	5563	0.751
NULL	J_Geriatr_Cardiol_2012_Jun_9(2)_180-184.nxml.txt.nlp	22916066	SENT13	18	18	5	5	rosuvastatin	Rho	PA134308647	29984	0.751
NULL	Int_J_Mol_Cell_Med_2014_Summer_3(3)_183-189.nxml.txt.nlp	25317405	SENT36	7	7	17	17	estradiol	NPY	PA449503	4852	0.751
NULL	Oncotarget_2013_Dec_5_5(1)_49-66.nxml.txt.nlp	24393708	SENT94	10	10	13	13	ridaforolimus	FKBP12	PA165291475	2280	0.751
NULL	Diabetologia_2010_Oct_26_53(10)_2209-2219.nxml.txt.nlp	20582536	SENT314	13	13	9	9	dilazep	HL-1	PA152530737	55600	0.751
NULL	Asia_Pac_Allergy_2014_Apr_29_4(2)_106-112.nxml.txt.nlp	24809016	SENT54	17	17	8	8	amoxicillin	PPL	PA448406	5493	0.751
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT190	0	0	13	13	chloroquine	BMPR-II	PA448948	659	0.751
NULL	Indian_J_Med_Res_2012_Sep_136(3)_391-403.nxml.txt.nlp	23041732	SENT191	16	16	19	19	oxaliplatin	HCC	PA131285527	84668	0.751
NULL	J_Oncol_2013_Feb_17_2013_872957.nxml.txt.nlp	23476648	SENT108	23	23	16	16	cisplatin	SFN	PA449014	25996;2810	0.751
NULL	Iran_J_Pharm_Res_2014_Spring_13(2)_635-639.nxml.txt.nlp	25237359	SENT18	18	18	25	25	dextromethorphan	CYP2C19	PA449273	1557	0.751
NULL	Ther_Clin_Risk_Manag_2007_Dec_3(6)_1009-1020.nxml.txt.nlp	18516316	SENT180	19	19	22	22	palonosetron	NK-1	PA10352	27087	0.751
NULL	Breast_Cancer_Res_2011_Jan_7_13(1)_R1.nxml.txt.nlp	21214929	SENT268	9	9	24	24	doxorubicin	p53	PA449412	7157	0.751
NULL	J_Invest_Dermatol_2014_Jul_31_134(7)_1903-1911.nxml.txt.nlp	24487305	SENT10	17	17	22	22	chloroquine	IL-9	PA448948	3578	0.751
NULL	Apoptosis_2014_Apr_23_19(7)_1055-1068.nxml.txt.nlp	24756955	SENT152	13	13	15	15	cisplatin	RITA	PA449014	55422;84934	0.751
NULL	Front_Behav_Neurosci_2014_Oct_6_8_343.nxml.txt.nlp	25339876	SENT106	14	14	22	22	clozapine	ski	PA449061	55733	0.751
NULL	Arthritis_Res_Ther_2009_Jan_3_11(1)_R1.nxml.txt.nlp	19121222	SENT37	18	18	14	14	estradiol	IFN	PA449503	3439	0.751
NULL	Oncol_Lett_2013_Feb_7_5(2)_440-446.nxml.txt.nlp	23420122	SENT44	21	21	10	10	gemcitabine	EGFR	PA449748	1956	0.751
NULL	Allergy_Asthma_Immunol_Res_2010_Jan_30_2(1)_34-40.nxml.txt.nlp	20224676	SENT148	13	13	4	4	methacholine	IFN	PA165958382	3439	0.751
NULL	Indian_J_Pharmacol_2013_Jan-Feb_45(1)_9-12.nxml.txt.nlp	23543259	SENT110	28	28	16	16	salbutamol	eNOS	PA448068	4846	0.751
NULL	Mol_Cancer_2009_Oct_8_8_83.nxml.txt.nlp	19814803	SENT217	1	1	18	18	triciribine	AKT	PA165958661	207	0.751
NULL	J_Vet_Med_Sci_2014_Mar_8_76(3)_347-354.nxml.txt.nlp	24200895	SENT446	2	2	11	11	methotrexate	JNK	PA450428	5599	0.751
NULL	Breast_Cancer_(Auckl)_2012_Mar_7_6_67-77.nxml.txt.nlp	22438669	SENT85	18	18	22	22	capecitabine	HER2	PA448771	2064	0.751
NULL	Neuroscience_2012_Mar_15_205(C)_154-166.nxml.txt.nlp	22244974	SENT615	7	7	21	21	ethanol	spatial	PA448073	219793	0.751
NULL	Acta_Neuropathol_Commun_2013_Aug_9_1_49.nxml.txt.nlp	24252504	SENT101	9	9	6	6	arsenite	TDP-43	PA452638	23435	0.751
NULL	Front_Endocrinol_(Lausanne)_2013_Sep_13_4_122.nxml.txt.nlp	24062725	SENT147	4	4	15	15	forskolin	HCN	PA146096022	378938	0.751
NULL	Breast_Cancer_(Auckl)_2011_Sep_25_5_201-208.nxml.txt.nlp	22084573	SENT93	9	9	2	2	cisplatin	BRCA1	PA449014	672	0.751
NULL	Endocrinol_Metab_(Seoul)_2014_Sep_25_29(3)_211-216.nxml.txt.nlp	25309777	SENT79	24	24	10	10	sunitinib	PTC	PA162372840	5979;8030	0.751
NULL	Adv_Urol_2012_Oct_26_2012_812398.nxml.txt.nlp	22110495	SENT63	30	30	36	36	cisplatin	ERCC1	PA449014	2067	0.751
NULL	J_Radiat_Res_2014_Mar_1_55(2)_359-363.nxml.txt.nlp	24187329	SENT43	12	12	0	0	rituximab	CHOP	PA451261	1649	0.751
NULL	Blood_Res_2014_Mar_24_49(1)_3-4.nxml.txt.nlp	24724058	SENT19	20	20	28	28	mercaptopurine	TPMT	PA450379	7172	0.751
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jun_5_66(Pt_7)_o1596.nxml.txt.nlp	21587833	SENT67	0	0	18	18	sulfanilamide	mol	PA451545	90527	0.751
NULL	Onco_Targets_Ther_2014_Jun_12_7_1015-1023.nxml.txt.nlp	24959088	SENT108	8	8	20	20	doxorubicin	IL-6	PA449412	3569	0.751
NULL	Patient_Prefer_Adherence_2011_Dec_23_6_1-9.nxml.txt.nlp	22272064	SENT67	14	14	16	16	telmisartan	ACE	PA451605	1636	0.751
NULL	Mol_Cancer_2007_Sep_26_6_61.nxml.txt.nlp	17894897	SENT382	3	3	12	12	etoposide	p53	PA449552	7157	0.751
NULL	Nucleic_Acids_Res_2005_Oct_19_33(18)_5819-5828.nxml.txt.nlp	16237123	SENT98	33	33	36	36	cisplatin	HMGB1	PA449014	3146	0.751
NULL	AIDS_Res_Ther_2014_Aug_4_11_25.nxml.txt.nlp	25120580	SENT63	19	19	11	11	voriconazole	CYP2C19	PA10233	1557	0.751
NULL	J_Biol_2009_Apr_15_8(3)_30.nxml.txt.nlp	19435483	SENT36	39	39	24	24	imatinib	NQO2	PA10804	4835	0.751
NULL	Int_J_Mol_Sci_2014_Mar_5_15(3)_3970-3988.nxml.txt.nlp	24603537	SENT521	8	8	6	6	curcumin	MCH	PA151958596	5367	0.751
NULL	J_Asthma_Allergy_2008_Sep_19_1_19-29.nxml.txt.nlp	21436982	SENT110	0	0	21	21	fexofenadine	I-TAC	PA449621	6373	0.751
NULL	Leukemia_2014_Jul_21_28(7)_1501-1510.nxml.txt.nlp	24445867	SENT52	8	8	32	32	fluorescein	San	PA164746009	80218	0.751
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jun_16_66(Pt_7)_o1638.nxml.txt.nlp	21587867	SENT74	22	22	25	25	benzaldehyde	mol	PA448571	90527	0.751
NULL	Case_Rep_Gastroenterol_2011_Jun_10_5(2)_336-343.nxml.txt.nlp	21712950	SENT91	0	0	3	3	voglibose	GLP-1	PA164752433	100125288	0.751
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Jul_23_3(7)_e126.nxml.txt.nlp	25054314	SENT23	23	23	12	12	docetaxel	OATP1B3	PA449383	28234	0.751
NULL	Pediatr_Nephrol_2007_Dec_7_22(12)_1983-1990.nxml.txt.nlp	17554565	SENT71	6	6	3	3	irbesartan	AT1	PA450084	9197;185	0.751
NULL	Adv_Hematol_2012_Aug_2_2012_842945.nxml.txt.nlp	22919394	SENT160	31	31	25	25	lenalidomide	CRBN	PA162363968	51185	0.751
NULL	Br_J_Cancer_2010_Jun_29_103(1)_61-72.nxml.txt.nlp	20588279	SENT309	3	3	9	9	trastuzumab	HER-2	PA451743	2064	0.751
NULL	J_Thromb_Thrombolysis_2011_Nov_26_32(4)_459-466.nxml.txt.nlp	21706290	SENT213	15	15	5	5	clopidogrel	CYP2C19	PA449053	1557	0.751
NULL	Clin_Med_Insights_Oncol_2012_Aug_16_6_287-303.nxml.txt.nlp	22933844	SENT86	22	22	9	9	denosumab	RANKL	PA166048634	8600	0.751
NULL	Diabetes_Metab_J_2012_Aug_20_36(4)_293-299.nxml.txt.nlp	22950061	SENT109	8	8	2	2	metformin	STAT3	PA450395	6774	0.751
NULL	Mol_Biol_Int_2014_Sep_7_2014_852748.nxml.txt.nlp	25276427	SENT173	11	11	20	20	trastuzumab	HER2	PA451743	2064	0.751
NULL	Chin_J_Cancer_2012_Mar_31(3)_150-158.nxml.txt.nlp	22360854	SENT6	16	16	10	10	topotecan	ABCG2	PA451729	9429	0.751
NULL	Evid_Based_Complement_Alternat_Med_2014_Oct_29_2014_594354.nxml.txt.nlp	25530784	SENT6	3	3	1	1	4-methylumbelliferone	UGT	PA154081778	7361;7355	0.751
NULL	Ecancermedicalscience_2010_Oct_7_4_192.nxml.txt.nlp	22276040	SENT32	6	6	18	18	trastuzumab	PI3K	PA451743	5290	0.751
NULL	Int_J_Breast_Cancer_2012_Feb_26_2012_740353.nxml.txt.nlp	22500240	SENT112	11	11	13	13	diethylstilbestrol	DES	PA449307	1674	0.751
NULL	Biomed_Res_Int_2014_Jun_26_2014_161346.nxml.txt.nlp	25054130	SENT216	7	7	30	30	curcumin	STZ	PA151958596	6484	0.751
NULL	J_Korean_Med_Sci_2010_Jun_24_25(6)_829-834.nxml.txt.nlp	20514301	SENT138	6	6	13	13	papain	p38	PA450778	10598;1432;7965	0.751
NULL	J_Immunol_Res_2014_May_12_2014_897249.nxml.txt.nlp	24901013	SENT131	18	18	7	7	natalizumab	E2F1	PA164747191	1869	0.751
NULL	Front_Microbiol_2012_May_3_3_164.nxml.txt.nlp	22563326	SENT107	25	25	5	5	glucose	PEP	PA449773	5047	0.751
NULL	Ann_Rheum_Dis_2008_Nov_14_67(11)_1516-1523.nxml.txt.nlp	18625622	SENT224	9	9	19	19	adalimumab	TNF	PA10004	7124	0.751
NULL	Ther_Clin_Risk_Manag_2006_Sep_2(3)_303-308.nxml.txt.nlp	18360605	SENT40	6	6	9	9	sumatriptan	5-HT1B	PA451566	3351	0.751
NULL	Nucleic_Acids_Res_2005_Jun_8_33(10)_3283-3291.nxml.txt.nlp	15944449	SENT120	15	15	10	10	mechlorethamine	ERCC1	PA450336	2067	0.751
NULL	Clin_Sci_(Lond)_2011_Apr_1_120(Pt_8)_335-345.nxml.txt.nlp	21091432	SENT127	31	31	19	19	ramipril	ACE2	PA451223	59272	0.751
NULL	Front_Immunol_2012_Jan_24_3_3.nxml.txt.nlp	22566889	SENT148	2	2	5	5	ofatumumab	CHOP	PA165291493	1649	0.751
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_13_2013_874367.nxml.txt.nlp	23843887	SENT64	13	13	18	18	ethanol	CO2	PA448073	4513	0.751
NULL	Oncologist_2010_Apr_15(4)_372-381.nxml.txt.nlp	20413642	SENT181	1	1	11	11	gemcitabine	EGFR	PA449748	1956	0.751
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1986-2011.nxml.txt.nlp	25268165	SENT166	30	30	6	6	paclitaxel	STAT3	PA450761	6774	0.751
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT173	20	20	6	6	simvastatin	AKT	PA451363	207	0.751
NULL	Sci_Rep_2015_Jan_15_5_7817.nxml.txt.nlp	25588710	SENT56	29	29	26	26	trastuzumab	MPL	PA451743	4352	0.751
NULL	J_Cell_Biol_2003_Dec_8_163(5)_1067-1076.nxml.txt.nlp	14662747	SENT302	37	37	11	11	nitrendipine	LPA	PA146096020	4018	0.751
NULL	Respir_Med_Case_Rep_2013_Sep_7_10_34-36.nxml.txt.nlp	NULL	SENT28	5	5	12	12	bevacizumab	EGFR	PA130232992	1956	0.751
NULL	Mol_Cells_2014_Aug_31_37(8)_585-591.nxml.txt.nlp	25134539	SENT105	3	3	13	13	indacaterol	ADRB2	PA165958348	154	0.751
NULL	Gut_Liver_2013_Sep_14_7(5)_552-559.nxml.txt.nlp	24073313	SENT72	13	13	5	5	celecoxib	EGFR	PA448871	1956	0.751
NULL	Br_J_Cancer_2013_Aug_6_109(3)_714-722.nxml.txt.nlp	23799849	SENT213	12	12	6	6	methotrexate	MRP2	PA450428	100130958;57626;1244	0.751
NULL	Int_J_Cell_Biol_2013_Mar_19_2013_834684.nxml.txt.nlp	23573093	SENT216	0	0	13	13	ketoconazole	CYP17A1	PA450146	1586	0.751
NULL	Br_J_Pharmacol_2011_Mar_162(5)_1074-1082.nxml.txt.nlp	20973779	SENT24	17	17	14	14	nifedipine	BTZ	PA450631	22794	0.751
NULL	Int_J_Biol_Sci_2014_Jan_20_10(2)_171-180.nxml.txt.nlp	24520215	SENT168	0	0	24	24	cerulenin	L-FABP	PA164764551	2168	0.751
NULL	Hum_Genomics_2009_Jan_1_3(2)_128-142.nxml.txt.nlp	19164090	SENT168	31	31	12	12	carboplatin	CNTN5	PA448803	53942	0.751
NULL	Indian_J_Anaesth_2010_Jan-Feb_54(1)_24-28.nxml.txt.nlp	20532067	SENT16	7	7	21	21	l-arginine	GMP	PA448478	22978	0.751
NULL	Cancer_Cell_Int_2010_May_4_10_14.nxml.txt.nlp	20441573	SENT121	16	16	0	0	staurosporine	Bcl-2	PA165109623	596	0.751
NULL	Biosci_Rep_2012_Aug_1_32(Pt_4)_361-374.nxml.txt.nlp	22762204	SENT187	2	2	6	6	paclitaxel	TAZ	PA450761	25937;6901	0.751
NULL	Mol_Cancer_2007_May_11_6_33.nxml.txt.nlp	17498302	SENT13	0	0	11	11	daunorubicin	Mcl-1	PA449212	4170	0.751
NULL	Nucl_Recept_Signal_2009_Jan_16_7_e001.nxml.txt.nlp	19240808	SENT77	7	7	10	10	hyperforin	SXR	PA165985514	8856	0.751
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT1245	4	4	13	13	tenofovir	ABCG2	PA10204	9429	0.751
NULL	Oncol_Rep_2012_Nov_22_28(5)_1851-1858.nxml.txt.nlp	22922937	SENT23	18	18	20	20	bortezomib	BTZ	PA10252	22794	0.751
NULL	Acta_Odontol_Scand_2013_Mar_8_71(2)_312-316.nxml.txt.nlp	22564045	SENT40	20	20	27	27	benzbromarone	URAT1	PA134852920	116085	0.751
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT320	11	11	5	5	risperidone	PRL	PA451257	5617	0.751
NULL	Acta_Biomater_2013_Aug_9(8)_7865-7873.nxml.txt.nlp	23624219	SENT72	17	17	43	43	trypsin	CO2	PA451806	4513	0.751
NULL	Adv_Hematol_2012_Mar_8_2012_856341.nxml.txt.nlp	22496694	SENT111	22	22	20	20	enoxaparin	TKR	PA449463	8277	0.751
NULL	Curr_Neuropharmacol_2013_Jan_11(1)_80-94.nxml.txt.nlp	23814540	SENT405	20	20	13	13	methamphetamine	mGlu5	PA450403	2915	0.751
NULL	Aging_(Albany_NY)_2010_Jun_27_2(6)_329-330.nxml.txt.nlp	20603525	SENT8	15	15	21	21	doxorubicin	p53	PA449412	7157	0.751
NULL	Pharmaceutics_2011_Oct_12_3(4)_680-705.nxml.txt.nlp	24309303	SENT57	23	23	12	12	repaglinide	BSP	PA451234	3381	0.751
NULL	Exp_Diabetes_Res_2011_Apr_6_2011_928523.nxml.txt.nlp	21603181	SENT155	22	22	12	12	bromocriptine	DRD4	PA448671	1815	0.751
NULL	Cell_Death_Differ_2010_Oct_30_17(10)_1624-1635.nxml.txt.nlp	20431602	SENT256	24	24	22	22	paclitaxel	Bcl-2	PA450761	596	0.751
NULL	Oncoimmunology_2013_Dec_1_2(12)_e26663.nxml.txt.nlp	24498552	SENT31	25	25	12	12	lenalidomide	MICA	PA162363968	100507436	0.751
NULL	J_Immunother_Cancer_2013_Nov_7_1(Suppl_1)_O17.nxml.txt.nlp	NULL	SENT10	34	34	21	21	imiquimod	TLR4	PA449972	7099	0.751
NULL	Oncotarget_2011_Nov_9_2(11)_850-861.nxml.txt.nlp	22081665	SENT182	14	14	2	2	idarubicin	DNMT3A	PA449961	1788	0.751
NULL	J_Mol_Model_2006_Jul_29_12(5)_597-609.nxml.txt.nlp	16261297	SENT90	17	17	30	30	phosphorus	mol	PA450954	90527	0.751
NULL	Drug_Saf_2014_Feb_19_37(4)_201-211.nxml.txt.nlp	24550106	SENT163	30	30	15	15	rabeprazole	CYP2C19	PA451216	1557	0.751
NULL	EMBO_Mol_Med_2013_May_22_5(5)_776-794.nxml.txt.nlp	23606583	SENT174	42	42	25	25	maraviroc	CCR5	PA164768835	1234	0.751
NULL	Cancer_Manag_Res_2013_Mar_9_6_25-30.nxml.txt.nlp	23516140	SENT70	0	0	9	9	dasatinib	ACK1	PA162372878	10188	0.751
NULL	Pharmacogn_Rev_2011_Jul-Dec_5(10)_164-173.nxml.txt.nlp	22279374	SENT217	8	8	22	22	curcumin	ODC	PA151958596	4953;89874	0.751
NULL	Int_J_Mol_Sci_2014_Sep_23_15(9)_16911-16935.nxml.txt.nlp	25250910	SENT162	25	25	10	10	ethanol	mol	PA448073	90527	0.751
NULL	Diabetes_2013_Oct_17_62(10)_3547-3552.nxml.txt.nlp	23863812	SENT70	6	6	11	11	valsartan	adiponectin	PA451848	9370	0.751
NULL	Angew_Chem_Int_Ed_Engl_2013_Dec_23_52(52)_13991-13996.nxml.txt.nlp	24214017	SENT73	15	15	25	25	nadh	ADP	PA164755085	23038	0.751
NULL	J_Inherit_Metab_Dis_2010_Oct_3_33(5)_625-632.nxml.txt.nlp	20814828	SENT110	2	2	17	17	simvastatin	RhoA	PA451363	387	0.751
NULL	Br_J_Cancer_2003_Mar_10_88(5)_754-759.nxml.txt.nlp	12618886	SENT156	0	0	30	30	amifostine	p53	PA448365	7157	0.751
NULL	J_Cell_Biol_2001_Aug_6_154(3)_599-610.nxml.txt.nlp	11481345	SENT62	23	23	18	18	doxycycline	ARNO	PA449415	9266	0.751
NULL	J_Clin_Biochem_Nutr_2010_Jan_29_46(1)_87-92.nxml.txt.nlp	20104270	SENT3	5	5	19	19	hesperidin	adiponectin	PA449867	9370	0.751
NULL	Gut_Liver_2013_Sep_14_7(5)_585-593.nxml.txt.nlp	24073317	SENT134	14	14	25	25	ribavirin	IFN	PA451241	3439	0.751
NULL	Exp_Diabetes_Res_2011_Jun_1_2011_281674.nxml.txt.nlp	21747826	SENT80	8	8	2	2	liraglutide	GLP-1	PA165958364	100125288	0.751
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Apr_17_6_43-57.nxml.txt.nlp	24833916	SENT338	4	4	11	11	fluorouracil	HER2	PA128406956	2064	0.751
NULL	J_Biol_Chem_2013_Mar_22_288(12)_8279-8288.nxml.txt.nlp	23400816	SENT249	9	9	16	16	chloroquine	PCSK9	PA448948	255738	0.751
NULL	Cell_Death_Dis_2012_Jun_21_3(6)_e327.nxml.txt.nlp	22717582	SENT218	21	21	39	39	vincristine	NOXA	PA451879	5366	0.751
NULL	J_Hematol_Oncol_2014_Dec_19_7(1)_91.nxml.txt.nlp	NULL	SENT236	10	10	5	5	isotretinoin	GM-CSF	PA450128	1437	0.751
NULL	Neural_Plast_2007_Oct_10_2007_23250.nxml.txt.nlp	NULL	SENT4481	21	21	7	7	anastrozole	CA1	PA448432	759	0.751
NULL	Cancer_Cell_Int_2012_Jun_18_12_30.nxml.txt.nlp	22709569	SENT93	17	17	4	4	paclitaxel	PLCG2	PA450761	5336	0.751
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_May_11_67(Pt_6)_o1379.nxml.txt.nlp	21754769	SENT68	4	4	10	10	benzaldehyde	mol	PA448571	90527	0.751
NULL	Mol_Cancer_2010_Apr_23_9_87.nxml.txt.nlp	20416058	SENT259	16	16	14	14	doxorubicin	TRAIL	PA449412	8743	0.751
NULL	Front_Syst_Neurosci_2014_Jul_1_8_114.nxml.txt.nlp	25071473	SENT515	8	8	1	1	ketamine	HCN1	PA450144	348980	0.751
NULL	Oncogene_2014_Feb_6_33(6)_713-723.nxml.txt.nlp	23435429	SENT112	27	27	17	17	etoposide	BRCA1	PA449552	672	0.751
NULL	AIDS_Res_Ther_2007_Mar_13_4_6.nxml.txt.nlp	17352834	SENT142	23	23	30	30	nevirapine	CD4	PA450616	920	0.751
NULL	Pharmaceutics_2011_Nov_18_3(4)_865-913.nxml.txt.nlp	24309312	SENT500	9	9	16	16	thrombin	P-gp	PA451674	5243	0.75
NULL	J_Hematol_Oncol_2011_Jan_21_4_5.nxml.txt.nlp	21255411	SENT164	1	1	5	5	paclitaxel	EGFR	PA450761	1956	0.75
NULL	J_Biomed_Biotechnol_2011_Jul_3_2011_343791.nxml.txt.nlp	21799660	SENT96	21	21	12	12	ethanol	mol	PA448073	90527	0.75
NULL	An_Bras_Dermatol_2014_Jan-Feb_89(1)_59-66.nxml.txt.nlp	24626649	SENT140	9	9	5	5	hydroxyurea	ASM	PA449942	6609;283120	0.75
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT1702	18	18	2	2	famotidine	ATV	PA449586	4683	0.75
NULL	Int_J_Nanomedicine_2008_Mar_3(1)_1-19.nxml.txt.nlp	18488412	SENT377	20	20	6	6	nedocromil	BDP	PA450601	10620;152926	0.75
NULL	Cell_Div_2014_Sep_25_9_3.nxml.txt.nlp	25278993	SENT168	18	18	22	22	decitabine	SFRP1	PA164749631	6422	0.75
NULL	Case_Rep_Oncol_Med_2013_Nov_30_2013_175263.nxml.txt.nlp	24363944	SENT15	5	5	1	1	leucovorin	CRT	PA450198	811	0.75
NULL	EMBO_Mol_Med_2012_Jul_11_4(7)_577-593.nxml.txt.nlp	22496117	SENT266	34	34	30	30	clofazimine	PAP-1	PA164748759	6100	0.75
NULL	Exp_Ther_Med_2013_Aug_20_6(2)_355-360.nxml.txt.nlp	24137188	SENT10	20	20	30	30	docetaxel	EGFR	PA449383	1956	0.75
NULL	Endocrinol_Metab_(Seoul)_2013_Dec_12_28(4)_262-274.nxml.txt.nlp	24396690	SENT76	5	5	8	8	exenatide	GLP-1	PA164749238	100125288	0.75
NULL	Mucosal_Immunol_2013_Nov_10_6(6)_1179-1190.nxml.txt.nlp	23571504	SENT111	32	32	11	11	dextran	TRX	PA449261	7295	0.75
NULL	Br_J_Cancer_2010_Jan_5_102(1)_151-161.nxml.txt.nlp	19935791	SENT9	21	21	24	24	panitumumab	KRAS	PA162373091	3845	0.75
NULL	Ann_Hematol_2013_Jan_23_92(1)_41-52.nxml.txt.nlp	23090499	SENT244	10	10	12	12	idarubicin	AIDA	PA449961	64853	0.75
NULL	Fibrogenesis_Tissue_Repair_2012_Jul_23_5_11.nxml.txt.nlp	22824096	SENT180	17	17	13	13	bleomycin	FasL	PA448645	356	0.75
NULL	J_Carcinog_2012_Sep_13_11_15.nxml.txt.nlp	23230392	SENT127	24	24	40	40	erlotinib	VEGFR	PA134687924	3791	0.75
NULL	J_Oncol_2009_Mar_21_2009_963037.nxml.txt.nlp	20339520	SENT33	24	24	48	48	l-glutamine	CO2	PA10090	4513	0.75
NULL	Calcif_Tissue_Int_2011_Aug_3_89(2)_91-104.nxml.txt.nlp	21637997	SENT181	16	16	18	18	raloxifene	STAR	PA451221	6770;2984	0.75
NULL	Hum_Genomics_2004_Jan_1_1(2)_111-125.nxml.txt.nlp	15601539	SENT226	19	19	0	0	lipase	ATV	PA450239	4683	0.75
NULL	Curr_Neuropharmacol_2010_Dec_8(4)_409-421.nxml.txt.nlp	21629447	SENT177	25	25	18	18	primidone	LZP	PA451105	170392	0.75
NULL	J_Thromb_Thrombolysis_2011_Nov_26_32(4)_459-466.nxml.txt.nlp	21706290	SENT217	7	7	2	2	clopidogrel	CYP2C19	PA449053	1557	0.75
NULL	Nucleic_Acids_Res_2005_May_19_33(9)_2859-2867.nxml.txt.nlp	15905475	SENT26	21	21	11	11	temozolomide	MPG	PA451609	4350	0.75
NULL	Arthritis_Res_Ther_2012_Aug_15_14(4)_R186.nxml.txt.nlp	22894827	SENT59	46	46	16	16	etanercept	ACTH	PA449515	5443	0.75
NULL	Cancer_Res_Treat_2012_Jun_30_44(2)_133-141.nxml.txt.nlp	22802752	SENT190	3	3	13	13	gemcitabine	GM-CSF	PA449748	1437	0.75
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT140	9	9	6	6	heparin	FGF1	PA449855	2246	0.75
NULL	Indian_J_Anaesth_2010_Jul-Aug_54(4)_296-301.nxml.txt.nlp	20882170	SENT109	0	0	33	33	propofol	sit	PA451141	55733	0.75
NULL	Cancer_Cell_Int_2003_Aug_20_3_14.nxml.txt.nlp	12952550	SENT25	11	11	4	4	trypsin	SLPI	PA451806	6590	0.75
NULL	Breast_Cancer_Res_2012_Jul_23_14(4)_R112.nxml.txt.nlp	22824341	SENT242	3	3	5	5	doxorubicin	RANKL	PA449412	8600	0.75
NULL	Oncol_Lett_2013_Apr_25_5(4)_1261-1265.nxml.txt.nlp	23599776	SENT29	14	14	10	10	cisplatin	CO2	PA449014	4513	0.75
NULL	Indian_J_Anaesth_2014_Jul-Aug_58(4)_423-429.nxml.txt.nlp	25197110	SENT44	12	12	10	10	ondansetron	ODF	PA450705	8600	0.75
NULL	Front_Immunol_2013_Sep_30_4_305.nxml.txt.nlp	24137161	SENT271	24	24	30	30	doxycycline	CD4	PA449415	920	0.75
NULL	J_Breast_Cancer_2014_Dec_26_17(4)_308-313.nxml.txt.nlp	25548577	SENT53	39	39	6	6	trastuzumab	HIRA	PA451743	7290	0.75
NULL	J_Exp_Med_1998_May_18_187(10)_1583-1598.nxml.txt.nlp	9584137	SENT47	17	17	33	33	l-glutamine	CO2	PA10090	4513	0.75
NULL	Gene_Regul_Syst_Bio_2014_Mar_4_8_63-73.nxml.txt.nlp	24634581	SENT96	24	24	0	0	minocycline	STAT3	PA450519	6774	0.75
NULL	Arthritis_Res_Ther_2009_Dec_11_11(6)_R187.nxml.txt.nlp	20003323	SENT232	16	16	13	13	denosumab	RANKL	PA166048634	8600	0.75
NULL	Arthritis_Res_Ther_2013_Dec_19_15(6)_R218.nxml.txt.nlp	24351550	SENT47	2	2	18	18	methotrexate	AMPK	PA450428	5563	0.75
NULL	Biomed_Res_Int_2013_Jan_21_2013_581631.nxml.txt.nlp	23484133	SENT78	7	7	10	10	infliximab	GM-CSF	PA452639	1437	0.75
NULL	Lab_Invest_2010_Jan_9_90(1)_128-139.nxml.txt.nlp	19901912	SENT53	13	13	33	33	heparin	ACT	PA449855	12;11332;9457;641455	0.75
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT9	0	0	17	17	neratinib	HER2	PA165291472	2064	0.75
NULL	J_Biomed_Sci_2014_Nov_18_21(1)_99.nxml.txt.nlp	25407417	SENT312	6	6	13	13	oseltamivir	CCR2	PA450721	729230	0.75
NULL	Drugs_R_D_2014_Sep_25_14(3)_165-176.nxml.txt.nlp	24962635	SENT350	2	2	8	8	glimepiride	CYP2C9	PA449761	1559	0.75
NULL	Psychiatry_Investig_2010_Dec_30_7(4)_236-242.nxml.txt.nlp	21253406	SENT78	27	27	7	7	desipramine	BDNF	PA449233	627	0.75
NULL	J_Orthop_Traumatol_2013_Jun_23_14(2)_143-145.nxml.txt.nlp	22358780	SENT27	31	31	33	33	ethambutol	ETB	PA164784021	1910	0.75
NULL	J_Breast_Cancer_2013_Jun_28_16(2)_220-228.nxml.txt.nlp	23843857	SENT214	8	8	10	10	tamoxifen	aromatase	PA451581	1588	0.75
NULL	Front_Neurosci_2011_Jan_14_4_207.nxml.txt.nlp	21258618	SENT111	8	8	18	18	ethanol	HET	PA448073	6294	0.75
NULL	J_Cancer_Prev_2013_Sep_18(3)_227-234.nxml.txt.nlp	25337550	SENT68	9	9	29	29	cisplatin	HDAC4	PA449014	9759	0.75
NULL	Arthritis_Res_Ther_2009_Aug_24_11(4)_R127.nxml.txt.nlp	19703304	SENT92	0	0	14	14	adalimumab	OASIS	PA10004	90993	0.75
NULL	Adv_Pharmacol_Sci_2014_Jan_15_2014_132034.nxml.txt.nlp	24527029	SENT112	10	10	15	15	clomipramine	CYP1A2	PA449048	1544	0.75
NULL	Anal_Chem_Insights_2007_Nov_14_2_93-106.nxml.txt.nlp	19662183	SENT186	24	24	9	9	imatinib	P-gp	PA10804	5243	0.75
NULL	Eur_J_Endocrinol_2011_Jan_164(1)_69-74.nxml.txt.nlp	20961967	SENT33	21	21	26	26	pioglitazone	OPG	PA450970	690	0.75
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT285	10	10	21	21	gefitinib	PIK3CA	PA131301952	5290	0.75
NULL	Diabetes_Obes_Metab_2011_Apr_13(4)_348-356.nxml.txt.nlp	21205128	SENT93	16	16	3	3	liraglutide	PPG	PA165958364	5552	0.75
NULL	Int_J_Biol_Sci_2013_Nov_20_9(10)_1079-1088.nxml.txt.nlp	24339729	SENT55	12	12	31	31	papain	CO2	PA450778	4513	0.75
NULL	Int_J_Mol_Sci_2014_Mar_12_15(3)_4356-4392.nxml.txt.nlp	24625663	SENT1893	5	5	11	11	etoposide	Bcl-2	PA449552	596	0.75
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT244	12	12	28	28	tamoxifen	p27	PA451581	5715;10534	0.75
NULL	Adv_Urol_2012_Jul_31_2012_429213.nxml.txt.nlp	22899908	SENT39	21	21	24	24	heparin	FGFR1	PA449855	2260	0.75
NULL	Oncoimmunology_2012_May_1_1(3)_383-384.nxml.txt.nlp	22737623	SENT26	4	4	17	17	dacarbazine	CXCL10	PA449197	3627	0.75
NULL	Structure_2012_May_9_20-540(5-7)_841-849.nxml.txt.nlp	22579251	SENT86	43	43	40	40	dobutamine	EL2	PA449381	6708	0.75
NULL	Oncoscience_2014_Mar_12_1(2)_158-166.nxml.txt.nlp	25594008	SENT64	20	20	10	10	dasatinib	IGFBP2	PA162372878	3485	0.75
NULL	Evid_Based_Complement_Alternat_Med_2011_Jan_20_2011_751671.nxml.txt.nlp	21318106	SENT122	21	21	27	27	cyclosporine	P-gp	PA449167	5243	0.75
NULL	Exp_Ther_Med_2013_Apr_5_5(4)_1259-1263.nxml.txt.nlp	23596498	SENT80	0	0	5	5	propofol	TRPV1	PA451141	7442	0.75
NULL	Ann_Oncol_2012_Jan_29_23(1)_127-134.nxml.txt.nlp	21447618	SENT196	10	10	3	3	imatinib	KIT	PA10804	3815	0.75
NULL	Eur_J_Clin_Pharmacol_2012_Jan_7_68(1)_55-64.nxml.txt.nlp	21735164	SENT216	11	11	6	6	oxycodone	CYP2D6	PA450741	1565	0.75
NULL	Cell_Death_Dis_2013_Jun_27_4(6)_e694.nxml.txt.nlp	23807223	SENT212	0	0	3	3	chloroquine	HMGB1	PA448948	3146	0.75
NULL	Exp_Ther_Med_2013_Aug_21_6(2)_347-354.nxml.txt.nlp	24137187	SENT66	8	8	38	38	trypsin	CO2	PA451806	4513	0.75
NULL	Cancer_Causes_Control_2009_Nov_4_20(9)_1617-1622.nxml.txt.nlp	19653109	SENT109	14	14	9	9	metformin	PC-3	PA450395	692094	0.75
NULL	J_Cell_Mol_Med_2013_Oct_16_17(10)_1261-1270.nxml.txt.nlp	23855452	SENT12	21	21	23	23	gemcitabine	GEM	PA449748	2669	0.75
NULL	Acta_Pharmacol_Sin_2011_Jul_20_32(7)_956-966.nxml.txt.nlp	21685928	SENT26	8	8	10	10	streptozocin	STZ	PA451514	6484	0.75
NULL	Front_Mol_Neurosci_2012_Nov_12_5_99.nxml.txt.nlp	23162427	SENT1245	11	11	2	2	cocaine	CREB1	PA449072	1385	0.75
NULL	Reprod_Biol_Endocrinol_2003_Oct_7_1_66.nxml.txt.nlp	14609433	SENT97	29	29	11	11	cisplatin	p53	PA449014	7157	0.75
NULL	Comp_Hepatol_2004_Jan_14_3(Suppl_1)_S31.nxml.txt.nlp	14960183	SENT98	6	6	2	2	ethanol	p38	PA448073	10598;1432;7965	0.75
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Nov_6_66(Pt_12)_m1521.nxml.txt.nlp	21589223	SENT61	41	41	22	22	ethanol	NO3	PA448073	4681	0.75
NULL	Cancer_Med_2013_Jun_25_2(3)_277-285.nxml.txt.nlp	23930204	SENT139	40	40	19	19	bevacizumab	MAX	PA130232992	4149	0.75
NULL	Arthritis_Res_Ther_2009_Apr_30_11(2)_R58.nxml.txt.nlp	19405951	SENT10	9	9	0	0	alendronate	RANKL	PA448082	8600	0.75
NULL	Open_Allergy_J_2010_3_91-101.nxml.txt.nlp	25018787	SENT184	33	33	18	18	omalizumab	IL-4	PA164752253	3565	0.75
NULL	Eur_J_Endocrinol_2011_Jan_164(1)_69-74.nxml.txt.nlp	20961967	SENT106	3	3	20	20	pioglitazone	adiponectin	PA450970	9370	0.75
NULL	Cell_Cycle_2012_Nov_1_11(21)_3917-3918.nxml.txt.nlp	23032263	SENT8	40	40	8	8	camptothecin	p38	PA153590860	10598;1432;7965	0.75
NULL	Sci_Rep_2014_Nov_28_4_7237.nxml.txt.nlp	25429875	SENT96	0	0	25	25	hesperidin	JNK	PA449867	5599	0.75
NULL	Cancer_Res_Treat_2014_Jan_15_46(1)_48-54.nxml.txt.nlp	24520223	SENT89	25	25	20	20	oxaliplatin	KRAS	PA131285527	3845	0.75
NULL	Scientifica_(Cairo)_2013_Feb_21_2013_405876.nxml.txt.nlp	24278777	SENT153	6	6	11	11	clodronate	CCL11	PA10239	6356	0.75
NULL	J_Young_Pharm_2010_Jul-Sep_2(3)_255-260.nxml.txt.nlp	21042481	SENT5	19	19	8	8	ethanol	STZ	PA448073	6484	0.75
NULL	Mol_Neurobiol_2010_Jun_2_41(2-3)_392-409.nxml.txt.nlp	20437209	SENT299	26	26	16	16	curcumin	5-LOX	PA151958596	240	0.75
NULL	AIDS_Res_Treat_2012_Feb_20_2012_105980.nxml.txt.nlp	22454762	SENT135	21	21	17	17	efavirenz	CYP2B6	PA449441	1555	0.75
NULL	Ann_Oncol_2013_Sep_30_24(9)_2371-2376.nxml.txt.nlp	23723294	SENT120	17	17	35	35	erlotinib	PTEN	PA134687924	5728	0.75
NULL	J_Skin_Cancer_2013_Oct_27_2013_246848.nxml.txt.nlp	24286011	SENT189	2	2	10	10	diclofenac	p53	PA449293	7157	0.75
NULL	Diabetes_2013_Jun_17_62(6)_1843-1854.nxml.txt.nlp	23349486	SENT160	25	25	21	21	pioglitazone	CCR2	PA450970	729230	0.75
NULL	Acta_Pharmacol_Sin_2014_Jun_4_35(6)_792-805.nxml.txt.nlp	24902787	SENT346	2	2	12	12	tropisetron	INS-1	PA161925594	2305	0.75
NULL	Brain_Sci_2013_Jun_3_3(2)_877-907.nxml.txt.nlp	24961429	SENT187	0	0	5	5	taurine	ATF6	PA451590	22926	0.75
NULL	Oncotarget_2013_Nov_24_4(12)_2186-2207.nxml.txt.nlp	24327604	SENT119	8	8	18	18	bortezomib	P-gp	PA10252	5243	0.75
NULL	Clinics_(Sao_Paulo)_2014_Jan_69(1)_68-74.nxml.txt.nlp	24473562	SENT102	27	27	30	30	nutlin-3	SOCS-1		8651	0.75
NULL	Sleep_Breath_2013_Jan_23_17(3)_1063-1069.nxml.txt.nlp	23340852	SENT128	40	40	26	26	creatine	EPO	PA164778930	7076;8288;2056	0.75
NULL	Curr_Pharm_Biotechnol_2011_Jan_12(1)_35-41.nxml.txt.nlp	20932261	SENT136	6	6	18	18	hyperforin	TRPC6	PA165985514	7225	0.75
NULL	Acta_Histochem_Cytochem_2012_Apr_26_45(2)_139-146.nxml.txt.nlp	22685356	SENT314	1	1	4	4	forskolin	AQP2	PA146096022	359	0.75
NULL	Eur_J_Clin_Pharmacol_2013_Mar_11_69(3)_327-339.nxml.txt.nlp	22782539	SENT270	20	20	31	31	dabigatran	P-gp		5243	0.75
NULL	Oncotarget_2012_Dec_18_3(12)_1615-1628.nxml.txt.nlp	23271044	SENT219	6	6	33	33	clofarabine	4E-BP1	PA164754863	1978	0.75
NULL	Arthritis_Res_Ther_2007_Oct_9_9(5)_R104.nxml.txt.nlp	17925024	SENT137	11	11	16	16	glucosamine	G10	PA164747613	8896;221527	0.75
NULL	J_Immunol_Res_2014_Jul_16_2014_696812.nxml.txt.nlp	25133198	SENT248	16	16	5	5	rifaximin	TLR2	PA164752443	7097	0.75
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_13_2014_478653.nxml.txt.nlp	25477992	SENT573	0	0	9	9	curcumin	p38	PA151958596	10598;1432;7965	0.75
NULL	Indian_J_Med_Res_2013_Dec_138(6)_969-976.nxml.txt.nlp	24521644	SENT155	35	35	30	30	ethanol	CK1	PA448073	1452	0.75
NULL	Breast_Cancer_Res_2010_Oct_22_12(Suppl_2)_S2.nxml.txt.nlp	21050423	SENT266	5	5	8	8	olaparib	BRCA1		672	0.75
NULL	Leukemia_2014_Jun_25_28(6)_1280-1288.nxml.txt.nlp	24270737	SENT121	7	7	27	27	decitabine	THP1	PA164749631	2736	0.75
NULL	Asia_Pac_Allergy_2013_Apr_26_3(2)_127-135.nxml.txt.nlp	23667837	SENT81	17	17	27	27	capsaicin	TRPV1	PA448776	7442	0.75
NULL	Case_Rep_Gastroenterol_2014_Jun_4_8(2)_199-205.nxml.txt.nlp	25028576	SENT24	35	35	4	4	vincristine	CHOP	PA451879	1649	0.75
NULL	Clin_Psychopharmacol_Neurosci_2011_Apr_30_9(1)_36-43.nxml.txt.nlp	23431025	SENT108	10	10	15	15	aripiprazole	FLI	PA10026	2314	0.75
NULL	Cancer_Microenviron_2009_Sep_26_2(Suppl_1)_19-204.nxml.txt.nlp	NULL	SENT2052	3	3	23	23	fluorescein	maspin	PA164746009	5268	0.75
NULL	Mol_Cancer_2014_Aug_22_13(1)_195.nxml.txt.nlp	NULL	SENT10	8	8	2	2	cisplatin	TBL1XR1	PA449014	79718	0.75
NULL	Acta_Pharmacol_Sin_2012_Jan_28_33(1)_66-74.nxml.txt.nlp	22120966	SENT122	6	6	8	8	genistein	OPG	PA165109660	690	0.75
NULL	Pharmaceutics_2011_Oct_12_3(4)_680-705.nxml.txt.nlp	24309303	SENT60	1	1	21	21	repaglinide	OATP1B1	PA451234	10599	0.75
NULL	Clin_Dev_Immunol_2013_Oct_10_2013_746068.nxml.txt.nlp	24223607	SENT252	0	0	11	11	minocycline	MMP12	PA450519	4321	0.75
NULL	J_Cancer_Prev_2014_Mar_19(1)_39-46.nxml.txt.nlp	25337571	SENT89	18	18	3	3	ethanol	JNK	PA448073	5599	0.75
NULL	Exp_Cell_Res_2012_Aug_1_318(13-16)_1528-1541.nxml.txt.nlp	22426197	SENT46	29	29	25	25	heparin	EGF	PA449855	1950	0.75
NULL	Exp_Ther_Med_2014_Aug_4_8(2)_657-661.nxml.txt.nlp	25009636	SENT105	6	6	18	18	propofol	CCL2	PA451141	6347	0.75
NULL	Biosci_Rep_2014_Oct_22_34(5)_e00146.nxml.txt.nlp	25188723	SENT219	18	18	11	11	heparin	C3b	PA449855	718	0.75
NULL	Breast_Cancer_Res_2014_May_28_16(3)_R53.nxml.txt.nlp	24886537	SENT320	32	32	11	11	erlotinib	VAV3	PA134687924	10451	0.75
NULL	F1000_Biol_Rep_2010_Sep_8_2_65.nxml.txt.nlp	21173868	SENT23	24	24	18	18	ethanol	CO2	PA448073	4513	0.75
NULL	Breast_Cancer_Res_2008_Mar_27_10(2)_R27.nxml.txt.nlp	18371219	SENT41	7	7	30	30	cyclophosphamide	TFEC	PA449165	22797	0.75
NULL	Front_Oncol_2013_Apr_29_3_99.nxml.txt.nlp	23641363	SENT184	11	11	2	2	hydralazine	NKG2D	PA449894	22914	0.75
NULL	Int_J_Gen_Med_2009_Dec_29_2_209-217.nxml.txt.nlp	20360906	SENT142	8	8	11	11	cabergoline	ACTH	PA448708	5443	0.75
NULL	Cell_Death_Dis_2014_Jan_9_5(1)_e986.nxml.txt.nlp	24407239	SENT339	3	3	8	8	fludarabine	STAT1	PA449655	6772	0.75
NULL	Osteoporos_Int_2014_Dec_18_25(3)_1163-1172.nxml.txt.nlp	24345886	SENT259	17	17	15	15	alendronate	PTH	PA448082	5741	0.75
NULL	Endocrine_2012_Dec_14_42(3)_622-636.nxml.txt.nlp	22695986	SENT314	8	8	6	6	forskolin	PTH	PA146096022	5741	0.75
NULL	Hum_Mol_Genet_2013_Nov_15_22(22)_4602-4615.nxml.txt.nlp	23814040	SENT215	4	4	16	16	l-cysteine	TRMU	PA449173	55687	0.75
NULL	Pharmaceuticals_(Basel)_2011_Oct_25_4(11)_1400-1422.nxml.txt.nlp	NULL	SENT220	16	16	19	19	irinotecan	TRAP1	PA450085	9392;10131	0.75
NULL	Oncogene_2014_Jan_16_33(3)_300-307.nxml.txt.nlp	23318441	SENT89	15	15	6	6	etoposide	p53	PA449552	7157	0.75
NULL	Orphanet_J_Rare_Dis_2010_Oct_14_5_28.nxml.txt.nlp	20946626	SENT213	3	3	33	33	hydrochlorothiazide	ClC-5	PA449899	1184	0.75
NULL	Clin_Pharmacol_2011_Jun_22_3_13-25.nxml.txt.nlp	22287853	SENT198	5	5	11	11	saxagliptin	CYP3A4	PA165958362	1576	0.75
NULL	Clin_Ophthalmol_2014_Mar_2_8_343-346.nxml.txt.nlp	24591809	SENT112	15	15	7	7	ranibizumab	PED	PA164746012	8682	0.75
NULL	Mucosal_Immunol_2012_May_22_5(3)_320-331.nxml.txt.nlp	22354319	SENT263	33	33	5	5	heparin	CEACAM1	PA449855	634	0.75
NULL	J_Neurochem_2007_Dec_103(6)_2268-2280.nxml.txt.nlp	17908240	SENT258	5	5	16	16	picrotoxin	MARCKS	PA164777007	4082	0.75
NULL	Br_J_Cancer_2011_Sep_6_105(6)_807-813.nxml.txt.nlp	21847121	SENT73	3	3	16	16	pha-665752	EGFR		1956	0.75
NULL	Brain_Behav_2014_Jan_27_4(1)_51-59.nxml.txt.nlp	24653954	SENT8	1	1	10	10	estradiol	EPM	PA449503	2054	0.75
NULL	Indian_J_Crit_Care_Med_2013_Nov-Dec_17(6)_378-381.nxml.txt.nlp	24501492	SENT80	18	18	15	15	desmopressin	FVIII	PA449237	2157	0.75
NULL	Clin_Med_Insights_Oncol_2011_Sep_21_5_315-323.nxml.txt.nlp	22084620	SENT18	3	3	5	5	gemcitabine	IFN	PA449748	3439	0.75
NULL	J_Cell_Biol_2003_Dec_8_163(5)_1157-1165.nxml.txt.nlp	14662753	SENT34	33	33	21	21	neomycin	PLIC-1	PA450608	29979	0.75
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT135	4	4	12	12	resveratrol	Bcl-2		596	0.75
NULL	Oncotarget_2013_Nov_23_5(1)_196-210.nxml.txt.nlp	24344116	SENT10	19	19	8	8	doxorubicin	p53	PA449412	7157	0.75
NULL	Front_Microbiol_2014_Mar_14_5_99.nxml.txt.nlp	24672516	SENT77	12	12	26	26	caspofungin	TLR9	PA164743013	54106	0.75
NULL	Case_Rep_Oncol_Med_2013_Nov_26_2013_862585.nxml.txt.nlp	24371535	SENT9	9	9	16	16	doxorubicin	CHOP	PA449412	1649	0.75
NULL	N_Am_J_Med_Sci_2011_May_3(5)_212-216.nxml.txt.nlp	22558596	SENT119	32	32	4	4	gemcitabine	BTC	PA449748	685	0.75
NULL	Int_J_Biochem_Cell_Biol_2010_Jan_42(1)_113-119.nxml.txt.nlp	19800021	SENT117	3	3	14	14	curcumin	JNK	PA151958596	5599	0.75
NULL	Biomed_Res_Int_2013_Dec_30_2013_396839.nxml.txt.nlp	24490159	SENT77	21	21	7	7	urokinase	CXCL12	PA451836	6387	0.75
NULL	Oncotarget_2013_Nov_22_5(4)_933-943.nxml.txt.nlp	24659749	SENT170	4	4	17	17	nutlin-3	p53		7157	0.75
NULL	Evid_Based_Complement_Alternat_Med_2013_May_28_2013_464508.nxml.txt.nlp	23781262	SENT211	4	4	26	26	amiodarone	FKBP12	PA448383	2280	0.75
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT116	5	5	18	18	cisplatin	PMS2	PA449014	5395	0.75
NULL	Biomed_Res_Int_2014_Aug_7_2014_191967.nxml.txt.nlp	25165691	SENT237	30	30	34	34	pioglitazone	IL-8	PA450970	3576	0.75
NULL	J_Invest_Dermatol_2012_Sep_19_132(9)_2198-2205.nxml.txt.nlp	22513780	SENT84	0	0	13	13	isotretinoin	IL-17A	PA450128	3605	0.75
NULL	Appl_Microbiol_Biotechnol_2014_Feb_18_98(8)_3829-3840.nxml.txt.nlp	24535257	SENT11	19	19	9	9	ethanol	CAT-1	PA448073	6541	0.75
NULL	Int_J_Appl_Basic_Med_Res_2012_Jul-Dec_2(2)_77-83.nxml.txt.nlp	23776817	SENT119	18	18	11	11	itraconazole	CYP3A4	PA450132	1576	0.75
NULL	Mol_Cancer_2010_Apr_29_9_95.nxml.txt.nlp	20429933	SENT105	29	29	18	18	cisplatin	p63	PA449014	8626	0.75
NULL	Int_J_Mol_Sci_2012_Sep_26_13(10)_12336-12348.nxml.txt.nlp	23202901	SENT97	26	26	13	13	phenol	P90	PA450913	821	0.75
NULL	Pharmaceuticals_(Basel)_2012_Aug_17_5(8)_837-852.nxml.txt.nlp	24280677	SENT94	3	3	1	1	capsaicin	TRPV1	PA448776	7442	0.75
NULL	Int_J_Biomed_Sci_2014_Sep_10(3)_146-157.nxml.txt.nlp	25324695	SENT123	0	0	12	12	lovastatin	RANTES	PA450272	6352	0.75
NULL	N_Am_J_Med_Sci_2013_Dec_5(12)_721-723.nxml.txt.nlp	24404557	SENT62	20	20	7	7	cyclophosphamide	CHOP	PA449165	1649	0.75
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT193	0	0	17	17	sitagliptin	HIP	PA164748978	6767;6159;64399;5068	0.75
NULL	Cancers_(Basel)_2010_May_28_2(2)_1040-1065.nxml.txt.nlp	24281106	SENT39	15	15	17	17	tamoxifen	aromatase	PA451581	1588	0.75
NULL	Int_J_Inflam_2010_Aug_9_2010_151097.nxml.txt.nlp	21152121	SENT15	14	14	7	7	thrombin	C3a	PA451674	718	0.75
NULL	Indian_J_Dermatol_2012_May-Jun_57(3)_219-221.nxml.txt.nlp	22707777	SENT27	26	26	19	19	vincristine	CHOP	PA451879	1649	0.75
NULL	Br_J_Cancer_2004_Mar_22_90(6)_1285-1292.nxml.txt.nlp	15026814	SENT87	41	41	12	12	cisplatin	p53	PA449014	7157	0.75
NULL	Front_Comput_Neurosci_2012_Apr_3_6_17.nxml.txt.nlp	22514532	SENT696	13	13	10	10	carbachol	CA3	PA448784	761	0.75
NULL	Biomed_Res_Int_2014_Jan_20_2014_948427.nxml.txt.nlp	24563867	SENT209	10	10	5	5	buspirone	COB	PA448689	4519	0.75
NULL	ScientificWorldJournal_2013_Oct_24_2013_726912.nxml.txt.nlp	24282387	SENT40	22	22	6	6	fluorescein	AVP	PA164746009	114548;551	0.75
NULL	Eur_J_Nutr_2012_Aug_15_51(5)_513-528.nxml.txt.nlp	22584415	SENT137	13	13	20	20	adalimumab	IL-6	PA10004	3569	0.75
NULL	Iran_J_Pharm_Res_2014_Autumn_13(4)_1227-1233.nxml.txt.nlp	25587311	SENT144	11	11	4	4	tolbutamide	CYP2C9	PA451718	1559	0.75
NULL	Cardiol_Res_Pract_2011_Apr_26_2011_837841.nxml.txt.nlp	21577267	SENT41	11	11	29	29	heparin	ACT	PA449855	12;11332;9457;641455	0.75
NULL	Inflamm_Res_2014_Jul_22_63(10)_803-819.nxml.txt.nlp	25048990	SENT311	0	0	16	16	olmesartan	MCP-1	PA164742950	6347	0.75
NULL	Exp_Ther_Med_2013_Apr_5_5(4)_1259-1263.nxml.txt.nlp	23596498	SENT25	0	0	27	27	propofol	TRPV1	PA451141	7442	0.75
NULL	Clin_Dev_Immunol_2011_Sep_14_2011_267539.nxml.txt.nlp	21922022	SENT201	10	10	8	8	gemcitabine	VEGFR2	PA449748	3791	0.75
NULL	Front_Neurosci_2014_Dec_5_8_398.nxml.txt.nlp	25538552	SENT917	13	13	10	10	carbachol	CA3	PA448784	761	0.75
NULL	Int_Semin_Surg_Oncol_2007_Feb_14_4_5.nxml.txt.nlp	17394628	SENT162	25	25	38	38	doxorubicin	MLH1	PA449412	4292	0.75
NULL	Exp_Hematol_Oncol_2012_Sep_6_1_26.nxml.txt.nlp	23210433	SENT128	3	3	10	10	eculizumab	BCS	PA164776637	617	0.75
NULL	Mol_Cancer_2010_Apr_23_9_87.nxml.txt.nlp	20416058	SENT222	17	17	15	15	doxorubicin	TRAIL	PA449412	8743	0.75
NULL	Br_J_Cancer_2006_Feb_13_94(3)_407-426.nxml.txt.nlp	16434996	SENT321	21	21	34	34	genistein	BRCA1	PA165109660	672	0.75
NULL	Aging_(Albany_NY)_2011_Apr_6_3(4)_444-449.nxml.txt.nlp	21483037	SENT26	3	3	1	1	resveratrol	SIRT1		23411	0.75
NULL	Breast_Cancer_Res_2010_Oct_14_12(5)_R84.nxml.txt.nlp	20946630	SENT276	3	3	5	5	choline	SLC44A1	PA448976	23446	0.75
NULL	BMB_Rep_2013_Nov_46(11)_544-549.nxml.txt.nlp	24152910	SENT28	2	2	7	7	thrombin	HMGB1	PA451674	3146	0.75
NULL	Cancer_Cell_Int_2013_Sep_23_13_94.nxml.txt.nlp	24059699	SENT158	17	17	1	1	bevacizumab	VEGFA	PA130232992	7422	0.75
NULL	Contemp_Oncol_(Pozn)_2012_Jul_6_16(3)_197-200.nxml.txt.nlp	23788878	SENT156	2	2	19	19	cabozantinib	RDT	PA165906891	6598	0.75
NULL	Multidiscip_Respir_Med_2013_Feb_6_8(1)_11.nxml.txt.nlp	23388501	SENT61	16	16	3	3	thrombin	ASM	PA451674	6609;283120	0.75
NULL	Open_Ophthalmol_J_2014_May_16_8_3-6.nxml.txt.nlp	24949110	SENT4	18	18	14	14	ranibizumab	CRT	PA164746012	811	0.75
NULL	Mol_Pain_2013_Jun_10_9_27.nxml.txt.nlp	23758830	SENT82	7	7	33	33	tetracaine	ASIC3	PA451638	9311	0.75
NULL	Acta_Pharmacol_Sin_2009_Nov_5_30(11)_1522-1528.nxml.txt.nlp	19890360	SENT68	0	0	3	3	fenoterol	IL-8	PA10079	3576	0.75
NULL	EPMA_J_2010_Sep_20_1(3)_421-437.nxml.txt.nlp	23199086	SENT159	23	23	12	12	tamoxifen	HER2	PA451581	2064	0.75
NULL	Infect_Dis_Obstet_Gynecol_2012_May_20_2012_727248.nxml.txt.nlp	22675243	SENT43	28	28	9	9	fluconazole	API	PA449653	5345	0.75
NULL	Viruses_2014_Sep_17_6(9)_3438-3449.nxml.txt.nlp	25256392	SENT141	8	8	19	19	oseltamivir	N10	PA450721	3164	0.75
NULL	Clin_Psychopharmacol_Neurosci_2011_Apr_30_9(1)_36-43.nxml.txt.nlp	23431025	SENT85	15	15	6	6	aripiprazole	CA3	PA10026	761	0.75
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT148	13	13	5	5	dasatinib	PP1	PA162372878	5540;5464	0.75
NULL	Braz_J_Med_Biol_Res_2014_Mar_21_47(4)_273-278.nxml.txt.nlp	24676475	SENT154	14	14	20	20	doxorubicin	CIAPIN1	PA449412	57019	0.75
NULL	J_Adv_Pharm_Technol_Res_2012_Oct-Dec_3(4)_202-209.nxml.txt.nlp	23378940	SENT165	22	22	16	16	sirolimus	CYP3A4	PA451365	1576	0.75
NULL	Appl_Microbiol_Biotechnol_2012_Feb_11_93(4)_1377-1387.nxml.txt.nlp	22234536	SENT158	3	3	20	20	nadh	mol	PA164755085	90527	0.75
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jul_10_68(Pt_8)_o2402-o2403.nxml.txt.nlp	22904859	SENT72	8	8	14	14	benzaldehyde	mol	PA448571	90527	0.75
NULL	Cell_Cycle_2012_Nov_1_11(21)_3983-3996.nxml.txt.nlp	22987153	SENT129	7	7	0	0	cisplatin	DNA2	PA449014	1763	0.75
NULL	Eur_J_Pediatr_2012_Feb_17_171(2)_207-214.nxml.txt.nlp	21922352	SENT38	5	5	3	3	thrombin	VIII	PA451674	1351	0.75
NULL	Arthritis_Res_Ther_2011_Jun_24_13(3)_R102.nxml.txt.nlp	21702928	SENT89	27	27	7	7	rituximab	IMPACT	PA451261	55364	0.75
NULL	Br_J_Cancer_2012_Feb_28_106(5)_858-866.nxml.txt.nlp	22343622	SENT160	2	2	15	15	paclitaxel	PI3K	PA450761	5290	0.75
NULL	Exp_Ther_Med_2013_Nov_13_6(5)_1317-1321.nxml.txt.nlp	24223665	SENT24	24	24	36	36	cisplatin	ABCG2	PA449014	9429	0.75
NULL	Cardiovasc_Diabetol_2013_Oct_17_12_150.nxml.txt.nlp	24134550	SENT115	8	8	3	3	pioglitazone	activin	PA450970	83729	0.75
NULL	Nucleic_Acids_Res_2011_Oct_9_39(19)_8430-8444.nxml.txt.nlp	21745813	SENT51	21	21	32	32	gentamicin	CO2	PA449753	4513	0.75
NULL	Anat_Cell_Biol_2010_Sep_30_43(3)_194-200.nxml.txt.nlp	21212859	SENT99	15	15	33	33	ethanol	PLP	PA448073	25824;5744	0.75
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT118	13	13	2	2	celecoxib	IL-6	PA448871	3569	0.75
NULL	J_Hematol_Oncol_2012_Oct_11_5_63.nxml.txt.nlp	23057939	SENT109	15	15	21	21	bevacizumab	VEGFR1	PA130232992	2321	0.75
NULL	Cell_Commun_Signal_2013_Oct_1_11_73.nxml.txt.nlp	24083678	SENT129	20	20	5	5	sulindac	ICAM1	PA451565	3383	0.75
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1021.nxml.txt.nlp	24457965	SENT273	42	42	32	32	cisplatin	NAC	PA449014	22861	0.75
NULL	Arthritis_Res_Ther_2009_Nov_13_11(6)_R172.nxml.txt.nlp	19912653	SENT2	8	8	32	32	simvastatin	IVD	PA451363	3712	0.75
NULL	Br_J_Anaesth_2014_Jul_22_113(1)_157-167.nxml.txt.nlp	24154701	SENT162	11	11	5	5	sevoflurane	TREK-1	PA451341	3776	0.75
NULL	Bioinformation_2012_Jan_6_8(1)_13-19.nxml.txt.nlp	22359429	SENT7	2	2	9	9	curcumin	MRP1	PA151958596	4437	0.75
NULL	Gut_2012_Jan_21_61(1)_78-85.nxml.txt.nlp	21940721	SENT179	31	31	22	22	indomethacin	MLN	PA449982	4295	0.75
NULL	Case_Rep_Hematol_2013_Feb_6_2013_541783.nxml.txt.nlp	23476834	SENT36	11	11	18	18	doxorubicin	CHOP	PA449412	1649	0.75
NULL	Crit_Care_2013_Mar_19_17(Suppl_2)_P289.nxml.txt.nlp	NULL	SENT13	16	16	2	2	estradiol	IL-6	PA449503	3569	0.75
NULL	Arthritis_Res_Ther_2003_Dec_2_5(Suppl_4)_S12-S16.nxml.txt.nlp	15180892	SENT81	2	2	0	0	cyclophosphamide	CHOP	PA449165	1649	0.75
NULL	Sensors_(Basel)_2010_Oct_12_10(10)_9155-9162.nxml.txt.nlp	22163401	SENT31	29	29	22	22	pp2	MP2		5375	0.75
NULL	Int_J_Mol_Sci_2012_Feb_1_13(2)_1512-1523.nxml.txt.nlp	22408405	SENT62	20	20	6	6	olmesartan	LOX-1	PA164742950	4973	0.75
NULL	Br_J_Cancer_2014_Oct_14_111(8)_1552-1561.nxml.txt.nlp	25117814	SENT283	0	0	2	2	doxorubicin	XIAP	PA449412	331	0.75
NULL	Cases_J_2009_May_26_2_6567.nxml.txt.nlp	19829827	SENT20	38	38	34	34	capecitabine	IFN	PA448771	3439	0.75
NULL	Br_J_Cancer_2011_Sep_27_105(7)_1012-1022.nxml.txt.nlp	21863032	SENT133	1	1	23	23	nutlin-3	TRAIL		8743	0.75
NULL	Surg_Today_2012_Jan_6_42(1)_8-28.nxml.txt.nlp	22139128	SENT508	6	6	19	19	docetaxel	survivin	PA449383	332	0.75
NULL	Mol_Cancer_2009_Nov_10_8_99.nxml.txt.nlp	19903356	SENT97	21	21	19	19	imatinib	IGFBP3	PA10804	3486	0.75
NULL	Mult_Scler_Int_2013_Jun_25_2013_627870.nxml.txt.nlp	23878736	SENT350	21	21	10	10	natalizumab	IFN	PA164747191	3439	0.75
NULL	J_Inherit_Metab_Dis_2013_Jan_23_36(1)_29-34.nxml.txt.nlp	22729817	SENT118	17	17	9	9	estradiol	GALT	PA449503	2592	0.75
NULL	Breast_Cancer_(Auckl)_2014_Mar_23_8_51-56.nxml.txt.nlp	24678242	SENT5	13	13	6	6	carboplatin	BRCA1	PA448803	672	0.75
NULL	Cancers_(Basel)_2013_Jun_5_5(2)_676-713.nxml.txt.nlp	24216997	SENT2715	21	21	5	5	raltitrexed	p53	PA131625240	7157	0.75
NULL	Eur_J_Dent_2014_Oct-Dec_8(4)_521-527.nxml.txt.nlp	25512735	SENT43	16	16	24	24	ciprofloxacin	San	PA449009	80218	0.75
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_P64.nxml.txt.nlp	NULL	SENT15	20	20	10	10	cefuroxime	PPL	PA448868	5493	0.75
NULL	Arthritis_Res_Ther_2010_Apr_1_12(2)_R60.nxml.txt.nlp	20359365	SENT190	16	16	2	2	bleomycin	SPARC	PA448645	6678	0.75
NULL	Onco_Targets_Ther_2014_Jun_13_7_1033-1042.nxml.txt.nlp	24966685	SENT118	7	7	2	2	gemcitabine	AKT	PA449748	207	0.75
NULL	J_Cardiothorac_Surg_2013_Sep_29_8_194.nxml.txt.nlp	24074263	SENT200	31	31	0	0	potassium	KCNH2	PA451047	3757	0.75
NULL	Clin_Exp_Reprod_Med_2011_Jun_30_38(2)_98-102.nxml.txt.nlp	22384426	SENT83	7	7	27	27	pioglitazone	IL-6	PA450970	3569	0.75
NULL	Evid_Based_Complement_Alternat_Med_2014_Oct_19_2014_628712.nxml.txt.nlp	25389442	SENT10	7	7	13	13	erlotinib	PTEN	PA134687924	5728	0.749
NULL	Epilepsia_2012_Jun_21_53(Suppl_1)_18-25.nxml.txt.nlp	22612805	SENT7	17	17	43	43	furosemide	NKCC1	PA449719	6558	0.749
NULL	Diabetes_Care_2013_Aug_17_36(Suppl_2)_S245-S252.nxml.txt.nlp	23882053	SENT28	35	35	22	22	sitagliptin	HIP	PA164748978	6767;6159;64399;5068	0.749
NULL	Ann_Hematol_2014_Aug_17_93(3)_403-409.nxml.txt.nlp	23955074	SENT216	22	22	20	20	rituximab	CHOP	PA451261	1649	0.749
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_17_2013_514719.nxml.txt.nlp	23843876	SENT219	21	21	6	6	doxorubicin	LC3	PA449412	84557	0.749
NULL	Front_Chem_2014_Mar_14_2_12.nxml.txt.nlp	24790981	SENT195	0	0	8	8	curcumin	p300	PA151958596	2033	0.749
NULL	Oncotarget_2014_Sep_29_5(20)_10084-10099.nxml.txt.nlp	25275296	SENT70	6	6	26	26	bortezomib	HAX1	PA10252	10456	0.749
NULL	Iran_J_Basic_Med_Sci_2012_Sep-Oct_15(5)_1102-1105.nxml.txt.nlp	23492757	SENT8	18	18	7	7	celecoxib	IL-10	PA448871	3586	0.749
NULL	Oncotarget_2013_Nov_24_4(12)_2430-2438.nxml.txt.nlp	24280348	SENT95	14	14	6	6	gefitinib	STAT3	PA131301952	6774	0.749
NULL	Ann_Rheum_Dis_2008_Jul_26_67(7)_917-925.nxml.txt.nlp	17965121	SENT231	23	23	10	10	rituximab	BAFF	PA451261	10673	0.749
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_13_2014_849783.nxml.txt.nlp	25477998	SENT10	0	0	24	24	berberine	IL-6	PA165860812	3569	0.749
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT253	8	8	6	6	resveratrol	ROS		6098	0.749
NULL	Oncotarget_2014_Sep_10_5(20)_9877-9888.nxml.txt.nlp	25245676	SENT139	11	11	6	6	cetuximab	EGFR	PA10040	1956	0.749
NULL	Int_J_Mol_Sci_2014_Oct_20_15(10)_18985-18999.nxml.txt.nlp	25334066	SENT177	34	34	41	41	doxorubicin	HOTAIR	PA449412	100124700	0.749
NULL	Biomed_Res_Int_2013_Oct_10_2013_541947.nxml.txt.nlp	24224169	SENT126	4	4	11	11	thyroglobulin	gamma	PA164754910	9913	0.749
NULL	Clin_Med_Insights_Cardiol_2010_Oct_11_4_89-93.nxml.txt.nlp	20981132	SENT93	0	0	5	5	benazepril	TLR4	PA448561	7099	0.749
NULL	Summit_on_Translat_Bioinforma_2009_Mar_1_2009_124-128.nxml.txt.nlp	21347183	SENT69	22	22	13	13	azathioprine	TPMT	PA448515	7172	0.749
NULL	Open_Access_J_Urol_2011_May_10_3_69-82.nxml.txt.nlp	24198638	SENT60	12	12	14	14	midazolam	CYP3A4	PA450496	1576	0.749
NULL	Open_Biochem_J_2011_Sep_23_5_45-51.nxml.txt.nlp	21966325	SENT30	3	3	17	17	indomethacin	IRE1	PA449982	2081	0.749
NULL	J_Clin_Biochem_Nutr_2010_Mar_27_46(2)_177-185.nxml.txt.nlp	20216951	SENT102	4	4	40	40	l-arginine	DDAH	PA448478	23576	0.749
NULL	Curr_Pharm_Biotechnol_2011_Jan_12(1)_35-41.nxml.txt.nlp	20932261	SENT145	7	7	12	12	hyperforin	TRPC6	PA165985514	7225	0.749
NULL	Diabetes_Care_2009_Aug_32(8)_e94-e98.nxml.txt.nlp	19638520	SENT113	0	0	38	38	resveratrol	SIRT1		23411	0.749
NULL	Am_J_Trop_Med_Hyg_2014_Oct_1_91(4)_854-861.nxml.txt.nlp	25071003	SENT244	17	17	8	8	primaquine	G6PD	PA451103	2539	0.749
NULL	Mol_Biol_Cell_2013_Sep_1_24(17)_2678-2688.nxml.txt.nlp	23864716	SENT135	14	14	7	7	thrombin	PAK1	PA451674	5585;5058	0.749
NULL	Breast_Cancer_Res_Treat_2013_May_12_139(1)_107-113.nxml.txt.nlp	23580070	SENT5	38	38	32	32	trastuzumab	Hsp90	PA451743	3320	0.749
NULL	J_Vis_Exp_2014_Mar_28_(85)_51300.nxml.txt.nlp	24747269	SENT382	13	13	11	11	thrombin	RhoA	PA451674	387	0.749
NULL	Mol_Cancer_2012_Apr_26_11_24.nxml.txt.nlp	22537161	SENT139	36	36	46	46	pp2	MUC4		4585	0.749
NULL	Front_Microbiol_2015_Jan_12_5_776.nxml.txt.nlp	25628615	SENT246	23	23	27	27	nitrogen	DSE	PA450643	29940	0.749
NULL	J_Virol_2014_Jan_88(1)_710-716.nxml.txt.nlp	24173230	SENT30	14	14	23	23	cyclosporine	CD4	PA449167	920	0.749
NULL	Brain_Sci_2013_Sep_23_3(3)_1395-1414.nxml.txt.nlp	24961534	SENT918	2	2	0	0	choline	CDP	PA448976	1523	0.749
NULL	Cancers_(Basel)_2012_Sep_6_4(3)_873-903.nxml.txt.nlp	24213471	SENT1635	2	2	20	20	hyaluronan	HYAL1	PA165958431	3373	0.749
NULL	Cancer_Med_2013_Oct_19_2(5)_646-653.nxml.txt.nlp	24403230	SENT129	2	2	13	13	trastuzumab	GADD45	PA451743	1647	0.749
NULL	J_Hematol_Oncol_2014_Aug_1_7_52.nxml.txt.nlp	25085632	SENT140	14	14	19	19	sunitinib	PTEN	PA162372840	5728	0.749
NULL	Indian_J_Pharmacol_2013_Mar-Apr_45(2)_121-125.nxml.txt.nlp	23716885	SENT9	14	14	21	21	aripiprazole	CYP3A4	PA10026	1576	0.749
NULL	Cell_Death_Differ_2010_Apr_16_17(4)_666-676.nxml.txt.nlp	19834494	SENT220	22	22	26	26	paraformaldehyde	LC3	PA450790	84557	0.749
NULL	Gut_Liver_2013_Sep_14_7(5)_585-593.nxml.txt.nlp	24073317	SENT50	25	25	23	23	ribavirin	IFN	PA451241	3439	0.749
NULL	Arthritis_Res_Ther_2004_Jun_21_6(Suppl_2)_S12-S18.nxml.txt.nlp	15228616	SENT52	5	5	10	10	adalimumab	SOC	PA10004	91544	0.749
NULL	Br_J_Cancer_1996_Jan_73(2)_183-188.nxml.txt.nlp	8546904	SENT8	17	17	12	12	vincristine	P-gp	PA451879	5243	0.749
NULL	Clin_Dev_Immunol_2013_Nov_26_2013_875343.nxml.txt.nlp	24371449	SENT54	1	1	20	20	rituximab	CD4	PA451261	920	0.749
NULL	Infect_Drug_Resist_2009_Apr_24_2_13-26.nxml.txt.nlp	21694884	SENT291	5	5	9	9	tenofovir	TDF	PA10204	6736	0.749
NULL	J_Breast_Cancer_2013_Jun_28_16(2)_133-137.nxml.txt.nlp	23843843	SENT95	3	3	32	32	curcumin	CDK2	PA151958596	1017	0.749
NULL	Bone_Joint_Res_2014_Mar_1_3(3)_51-59.nxml.txt.nlp	24615710	SENT185	8	8	17	17	resveratrol	RUNX2		860	0.749
NULL	Med_Sci_Monit_2013_Jun_12_19_451-457.nxml.txt.nlp	23756824	SENT127	5	5	12	12	aliskiren	IL-6	PA143487910	3569	0.749
NULL	Case_Rep_Pathol_2014_Sep_9_2014_301780.nxml.txt.nlp	25295208	SENT27	27	27	19	19	thyroglobulin	p53	PA164754910	7157	0.749
NULL	Oncotarget_2014_Mar_16_5(12)_4087-4102.nxml.txt.nlp	24961479	SENT168	13	13	9	9	hemin	PC3	PA449849	57332;7832;5122	0.749
NULL	Breast_Cancer_Res_2008_Dec_18_10(Suppl_4)_S22.nxml.txt.nlp	19128436	SENT132	1	1	5	5	tamoxifen	aromatase	PA451581	1588	0.749
NULL	Protein_Eng_Des_Sel_2014_Apr_28_27(4)_97-109.nxml.txt.nlp	24586053	SENT114	2	2	15	15	trastuzumab	CEA	PA451743	5670;1087	0.749
NULL	Clin_J_Gastroenterol_2014_Jun_6_7(4)_355-360.nxml.txt.nlp	25132867	SENT2	10	10	33	33	ribavirin	IFN	PA451241	3439	0.749
NULL	Cell_Commun_Signal_2014_Mar_10_12_13.nxml.txt.nlp	24606867	SENT151	27	27	10	10	lipase	TCPTP	PA450239	5771	0.749
NULL	Br_J_Cancer_2013_Mar_19_108(5)_1071-1078.nxml.txt.nlp	23412102	SENT141	7	7	10	10	fentanyl	CYP3A4	PA449599	1576	0.749
NULL	CNS_Neurosci_Ther_2010_Oct_16(5)_e138-e156.nxml.txt.nlp	20626426	SENT175	4	4	21	21	vasopressin	SON	PA451858	6651	0.749
NULL	Crit_Care_2008_Mar_13_12(Suppl_2)_P29.nxml.txt.nlp	NULL	SENT3	11	11	13	13	vancomycin	VAN	PA451850	10318	0.749
NULL	Blood_Res_2014_Mar_24_49(1)_3-4.nxml.txt.nlp	24724058	SENT19	6	6	28	28	mercaptopurine	TPMT	PA450379	7172	0.749
NULL	Cancer_Med_2013_Jun_21_2(3)_316-324.nxml.txt.nlp	23930208	SENT193	29	29	18	18	bevacizumab	TSP1	PA130232992	7057	0.749
NULL	Cell_Cycle_2013_Jun_1_12(11)_1679-1687.nxml.txt.nlp	23656790	SENT165	26	26	7	7	hydrocortisone	F12	PA449905	2161	0.749
NULL	Int_J_Nanomedicine_2012_May_7_7_2307-2314.nxml.txt.nlp	22661887	SENT158	5	5	2	2	gemcitabine	F10	PA449748	2159	0.749
NULL	Oncogene_2014_Feb_6_33(6)_713-723.nxml.txt.nlp	23435429	SENT112	29	29	17	17	camptothecin	BRCA1	PA153590860	672	0.749
NULL	Arthritis_Res_Ther_2010_Jun_2_12(3)_R107.nxml.txt.nlp	20525198	SENT130	20	20	35	35	rolipram	IL-6	PA153906323	3569	0.749
NULL	Int_J_Breast_Cancer_2013_Jan_16_2013_872743.nxml.txt.nlp	23401782	SENT288	13	13	20	20	trastuzumab	DM1	PA451743	338023;1760;28509	0.749
NULL	Case_Rep_Dermatol_2011_Oct_11_3(3)_223-227.nxml.txt.nlp	22135629	SENT18	0	0	8	8	trastuzumab	San	PA451743	80218	0.749
NULL	Cell_Commun_Signal_2003_Nov_24_1_5.nxml.txt.nlp	14636425	SENT85	21	21	12	12	heparin	CCN5	PA449855	8839	0.749
NULL	FEBS_Open_Bio_2014_Jan_21_4_153-161.nxml.txt.nlp	24490140	SENT245	27	27	37	37	doxorubicin	WT1	PA449412	7490	0.749
NULL	Ann_Saudi_Med_2010_Jan-Feb_30(1)_33-37.nxml.txt.nlp	20103956	SENT15	8	8	21	21	l-arginine	NOS2	PA448478	339345;4843	0.749
NULL	Nat_Med_2013_Apr_17_19(4)_429-436.nxml.txt.nlp	23502962	SENT121	25	25	7	7	clodronate	BMP4	PA10239	652	0.749
NULL	Oncol_Lett_2013_Apr_22_5(4)_1093-1100.nxml.txt.nlp	23599746	SENT226	2	2	13	13	paclitaxel	MDR1	PA450761	5243	0.749
NULL	Acta_Pharmacol_Sin_2011_Nov_10_32(11)_1402-1410.nxml.txt.nlp	21986579	SENT202	14	14	32	32	curcumin	CDK2	PA151958596	1017	0.749
NULL	Br_J_Cancer_2010_Jun_29_103(1)_61-72.nxml.txt.nlp	20588279	SENT11	2	2	7	7	trastuzumab	RhoB	PA451743	388	0.749
NULL	Physiol_Rep_2014_Sep_11_2(9)_e12144.nxml.txt.nlp	25214522	SENT240	2	2	14	14	resveratrol	AMPK		5563	0.749
NULL	Nat_Chem_Biol_2010_Apr_28_6(4)_291-299.nxml.txt.nlp	20190765	SENT114	15	15	20	20	dasatinib	FYN	PA162372878	2534	0.749
NULL	Front_Oncol_2014_Apr_9_4_75.nxml.txt.nlp	24782986	SENT50	8	8	21	21	paclitaxel	CD117	PA450761	3815	0.749
NULL	EJC_Suppl_2013_Sep_5_11(2)_310-311.nxml.txt.nlp	NULL	SENT41	20	20	24	24	tamoxifen	aromatase	PA451581	1588	0.749
NULL	Adv_Hematol_2012_Aug_2_2012_842945.nxml.txt.nlp	22919394	SENT112	6	6	15	15	lenalidomide	AP-1	PA162363968	2353;3727;2354;3725	0.749
NULL	Contemp_Oncol_(Pozn)_2012_Jan_4_16(6)_461-466.nxml.txt.nlp	23788931	SENT76	33	33	31	31	cyclophosphamide	CHOP	PA449165	1649	0.749
NULL	Onco_Targets_Ther_2014_Sep_9_7_1571-1582.nxml.txt.nlp	25228815	SENT191	4	4	11	11	sunitinib	VEGFR2	PA162372840	3791	0.749
NULL	EMBO_Mol_Med_2012_Apr_4(4)_298-312.nxml.txt.nlp	22331558	SENT167	7	7	36	36	etoposide	SIRT1	PA449552	23411	0.749
NULL	Int_J_Endocrinol_2010_Mar_2_2010_621687.nxml.txt.nlp	20204178	SENT124	29	29	26	26	paricalcitol	PTH	PA450798	5741	0.749
NULL	Acta_Pharmacol_Sin_2014_Jun_5_35(6)_727-737.nxml.txt.nlp	24793312	SENT212	6	6	20	20	telmisartan	B27	PA451605	56246	0.749
NULL	J_Hematol_Oncol_2013_Jan_4_6_1.nxml.txt.nlp	23286345	SENT149	17	17	10	10	cetuximab	FCGR3A	PA10040	2214	0.749
NULL	Front_Physiol_2013_Jun_4_4_128.nxml.txt.nlp	23760815	SENT75	18	18	10	10	lipase	CGI-58	PA450239	51099	0.749
NULL	J_Cell_Mol_Med_2014_Apr_20_18(4)_709-720.nxml.txt.nlp	24444314	SENT267	3	3	21	21	metformin	AMPK	PA450395	5563	0.749
NULL	Exp_Mol_Med_2012_Aug_31_44(8)_473-482.nxml.txt.nlp	22627808	SENT113	8	8	15	15	lapatinib	HER3	PA152241907	2065	0.749
NULL	Cardiol_Ther_2013_Jun_7_2(1)_57-68.nxml.txt.nlp	25135289	SENT177	18	18	7	7	ticagrelor	PAR-1	PA165374673	2011;2149	0.749
NULL	Genome_Announc_2013_Jan_24_1(1)_e00114-12.nxml.txt.nlp	23405336	SENT21	6	6	20	20	arsenite	ArsB	PA452638	57152	0.749
NULL	J_Cell_Biol_2001_May_14_153(4)_785-794.nxml.txt.nlp	11352939	SENT36	10	10	15	15	tetracycline	LIP	PA451640	23049	0.749
NULL	Case_Rep_Med_2014_Dec_23_2014_381480.nxml.txt.nlp	25587282	SENT40	7	7	3	3	maraviroc	CCR5	PA164768835	1234	0.749
NULL	Indian_J_Urol_2010_Jul-Sep_26(3)_441-443.nxml.txt.nlp	21116372	SENT72	3	3	7	7	rituximab	CHOP	PA451261	1649	0.749
NULL	J_Oncol_2010_May_11_2010_659231.nxml.txt.nlp	20467564	SENT54	15	15	24	24	doxycycline	Ang2	PA449415	285	0.749
NULL	Amino_Acids_2012_Oct_10_43(4)_1751-1759.nxml.txt.nlp	22407485	SENT132	16	16	5	5	carrageenan	DAG	PA448814	1605	0.749
NULL	Front_Chem_2013_Jul_12_1_10.nxml.txt.nlp	24790939	SENT61	25	25	30	30	hydroquinone	mol	PA449924	90527	0.749
NULL	Clin_Sci_(Lond)_2009_Feb_1_116(Pt_3)_265-272.nxml.txt.nlp	18826376	SENT259	10	10	22	22	bevacizumab	VEGF-A	PA130232992	7422	0.749
NULL	Cardiovasc_Ther_2009_27(4)_259-274.nxml.txt.nlp	19604248	SENT219	41	41	3	3	clopidogrel	IPA	PA449053	3160	0.749
NULL	Exp_Ther_Med_2014_Aug_4_8(2)_657-661.nxml.txt.nlp	25009636	SENT108	22	22	30	30	propofol	CCR2	PA451141	729230	0.749
NULL	J_Indian_Soc_Periodontol_2014_May-Jun_18(3)_282-288.nxml.txt.nlp	25024538	SENT69	4	4	1	1	tocilizumab	IL-6	PA165292659	3569	0.749
NULL	Ann_Gastroenterol_2014_27(4)_429a.nxml.txt.nlp	25330914	SENT4	15	15	18	18	capsaicin	TRPV1	PA448776	7442	0.749
NULL	Am_J_Transplant_2012_Jul_12(7)_1784-1792.nxml.txt.nlp	22420490	SENT58	22	22	6	6	alemtuzumab	CD19	PA164783958	930	0.749
NULL	Int_J_Genomics_2014_Jan_29_2014_894296.nxml.txt.nlp	24616891	SENT228	17	17	7	7	ethanol	PC1	PA448073	5122	0.749
NULL	Arthritis_Res_Ther_2006_Jul_21_8(4)_R130.nxml.txt.nlp	16859540	SENT179	27	27	25	25	atorvastatin	CD59	PA448500	966	0.749
NULL	J_Int_Soc_Sports_Nutr_2010_Mar_11_7_12.nxml.txt.nlp	20222976	SENT110	21	21	12	12	creatine	PRX	PA164778930	9588;57716	0.749
NULL	Nat_Commun_2013_Apr_23_4_1758.nxml.txt.nlp	23612299	SENT534	10	10	5	5	isoproterenol	SOD1	PA450121	6647	0.749
NULL	J_Cell_Mol_Med_2014_Jul_30_18(7)_1392-1406.nxml.txt.nlp	24779927	SENT257	0	0	7	7	curcumin	RhoA	PA151958596	387	0.749
NULL	J_Gen_Physiol_2003_Mar_121(3)_181-197.nxml.txt.nlp	12601083	SENT394	27	27	18	18	forskolin	SUR1	PA146096022	6833	0.749
NULL	Nat_Med_2013_Jun_26_19(6)_713-721.nxml.txt.nlp	23708291	SENT119	20	20	22	22	indomethacin	COX1	PA449982	4512;5742	0.749
NULL	Arthritis_Res_Ther_2010_May_28_12(3)_R105.nxml.txt.nlp	20509880	SENT117	36	36	3	3	celecoxib	p38	PA448871	10598;1432;7965	0.749
NULL	Curr_HIV_Res_2011_Jan_9(1)_40-53.nxml.txt.nlp	21198432	SENT135	23	23	13	13	raltegravir	AST		26503	0.749
NULL	Cardiol_Res_Pract_2010_Jun_29_2010_824938.nxml.txt.nlp	20671994	SENT180	31	31	27	27	l-arginine	Q10	PA448478	27161	0.749
NULL	Onco_Targets_Ther_2014_May_28_7_841-852.nxml.txt.nlp	24920926	SENT67	39	39	17	17	erlotinib	EGFR	PA134687924	1956	0.749
NULL	Diabetes_Care_2012_Jan_9_35(1)_131-136.nxml.txt.nlp	22040838	SENT22	3	3	19	19	metformin	AMPK	PA450395	5563	0.749
NULL	Chem_Res_Toxicol_2011_Aug_15_24(8)_1275-1282.nxml.txt.nlp	21749116	SENT94	5	5	21	21	geldanamycin	San	PA152031327	80218	0.749
NULL	Glycobiology_2013_Apr_12_23(4)_398-411.nxml.txt.nlp	23315448	SENT269	9	9	0	0	heparin	HARE	PA449855	55576	0.749
NULL	Free_Radic_Biol_Med_2013_Jun_59(100)_45-55.nxml.txt.nlp	22940496	SENT322	39	39	30	30	ethanol	COX	PA448073	1351	0.749
NULL	Diabetes_2008_Sep_57(9)_2272-2279.nxml.txt.nlp	18519799	SENT183	13	13	7	7	rosiglitazone	PEPCK-C	PA451283	5105	0.749
NULL	J_Res_Med_Sci_2011_Jun_16(6)_814-820.nxml.txt.nlp	22091312	SENT66	12	12	19	19	doxorubicin	CHOP	PA449412	1649	0.749
NULL	Cancers_(Basel)_2014_Oct_24_6(4)_2187-2223.nxml.txt.nlp	25347122	SENT185	14	14	4	4	cetuximab	EGFR	PA10040	1956	0.749
NULL	Lipids_Health_Dis_2011_Jul_21_10_121.nxml.txt.nlp	21777432	SENT80	6	6	22	22	chymotrypsin	DTNB	PA448994	1838	0.749
NULL	Biomed_Res_Int_2014_Aug_6_2014_967826.nxml.txt.nlp	25165721	SENT259	19	19	11	11	cisplatin	PARP-1	PA449014	25976	0.749
NULL	Nucleic_Acids_Res_2011_Dec_10_39(22)_9498-9507.nxml.txt.nlp	21835778	SENT179	9	9	18	18	nutlin-3	PUMA		27113	0.749
NULL	Acta_Pharmacol_Sin_2010_Dec_22_31(12)_1643-1648.nxml.txt.nlp	21102481	SENT40	0	0	7	7	sorafenib	Raf-1	PA7000	5894	0.749
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT374	9	9	0	0	resveratrol	TNF		7124	0.749
NULL	Chin_J_Cancer_2012_Mar_31(3)_126-133.nxml.txt.nlp	22237041	SENT34	0	0	18	18	lapatinib	EGFR	PA152241907	1956	0.749
NULL	Acta_Pharmacol_Sin_2011_Oct_12_32(10)_1259-1265.nxml.txt.nlp	21909126	SENT106	29	29	10	10	fluvastatin	p38	PA449688	10598;1432;7965	0.749
NULL	Cardiovasc_Diabetol_2011_Feb_11_10_18.nxml.txt.nlp	21314919	SENT31	20	20	27	27	metformin	Met	PA450395	79811	0.749
NULL	EMBO_Mol_Med_2010_Jul_2(7)_247-257.nxml.txt.nlp	20597104	SENT122	26	26	17	17	lisinopril	MCP-1	PA450242	6347	0.749
NULL	Biomed_Res_Int_2014_Jun_3_2014_656370.nxml.txt.nlp	24995318	SENT87	31	31	43	43	chlorpromazine	FGA	PA448964	2243	0.749
NULL	Mol_Cancer_2009_Nov_10_8_99.nxml.txt.nlp	19903356	SENT101	1	1	9	9	imatinib	ANOVA	PA10804	4858	0.749
NULL	Cardiol_Res_Pract_2013_Jan_31_2013_128795.nxml.txt.nlp	23431496	SENT28	28	28	25	25	clopidogrel	CYP2C19	PA449053	1557	0.749
NULL	Breast_Cancer_Res_2012_Feb_14_14(1)_R30.nxml.txt.nlp	22333315	SENT16	22	22	7	7	indomethacin	CXCL10	PA449982	3627	0.749
NULL	Br_J_Cancer_2003_Mar_10_88(5)_788-795.nxml.txt.nlp	12618891	SENT172	22	22	25	25	bosentan	FasL	PA10034	356	0.749
NULL	Eur_J_Clin_Pharmacol_2010_Aug_21_66(8)_811-812.nxml.txt.nlp	20407763	SENT34	17	17	7	7	proguanil	CYP2C19	PA451124	1557	0.749
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2010_Aug_3_3_43-51.nxml.txt.nlp	22879786	SENT172	29	29	14	14	pioglitazone	gamma	PA450970	9913	0.749
NULL	Oncol_Lett_2013_Oct_26_6(4)_1063-1067.nxml.txt.nlp	24137465	SENT9	22	22	15	15	afatinib	EGFR	PA165981154	1956	0.749
NULL	J_Gen_Physiol_1997_Dec_1_110(6)_643-654.nxml.txt.nlp	9382893	SENT228	0	0	3	3	trypsin	ADP	PA451806	23038	0.749
NULL	Oncogene_2014_Sep_18_33(38)_4685-4696.nxml.txt.nlp	24121268	SENT116	6	6	15	15	bortezomib	p53	PA10252	7157	0.749
NULL	Support_Care_Cancer_2009_Sep_10_17(9)_1187-1193.nxml.txt.nlp	19205754	SENT73	11	11	17	17	dolasetron	CYP2D6	PA449390	1565	0.749
NULL	Surg_Today_2014_Oct_19_44(10)_1841-1846.nxml.txt.nlp	24142101	SENT162	6	6	8	8	tamoxifen	aromatase	PA451581	1588	0.749
NULL	J_Vet_Med_Sci_2013_Nov_12_75(11)_1539-1542.nxml.txt.nlp	23856759	SENT43	15	15	22	22	kanamycin	OTC	PA450137	5009	0.749
NULL	Case_Rep_Oncol_2013_Jan_29_6(1)_72-77.nxml.txt.nlp	23466899	SENT107	14	14	24	24	gemcitabine	SPARC	PA449748	6678	0.749
NULL	Br_J_Pharmacol_2008_Nov_11_155(6)_896-905.nxml.txt.nlp	18695641	SENT16	2	2	24	24	genistein	CTX	PA165109660	1593	0.749
NULL	Pharmaceuticals_(Basel)_2013_Aug_21_6(8)_988-1038.nxml.txt.nlp	24276379	SENT1887	17	17	1	1	fluorouracil	ERCC1	PA128406956	2067	0.749
NULL	Breast_Cancer_(Auckl)_2009_Sep_2_3_61-75.nxml.txt.nlp	19809577	SENT96	11	11	15	15	curcumin	BRCA1	PA151958596	672	0.749
NULL	Oncotarget_2013_Nov_7_4(12)_2550-2566.nxml.txt.nlp	24334291	SENT274	31	31	20	20	dasatinib	NAC	PA162372878	22861	0.749
NULL	Exp_Ther_Med_2014_Nov_17_8(5)_1484-1488.nxml.txt.nlp	25289046	SENT53	10	10	5	5	cisplatin	DDP	PA449014	1678	0.749
NULL	Case_Rep_Hematol_2013_Jun_11_2013_680459.nxml.txt.nlp	23840983	SENT12	19	19	40	40	hydroxocobalamin	B12	PA164768689	7126;4709	0.749
NULL	Int_J_Environ_Res_Public_Health_2006_Mar_31_3(1)_31-37.nxml.txt.nlp	16823074	SENT206	14	14	22	22	calcein	NIR	PA132595336	26155	0.749
NULL	BMB_Rep_2014_Mar_47(3)_167-172.nxml.txt.nlp	24499665	SENT104	4	4	15	15	nutlin-3	MDM2		4193	0.749
NULL	Br_J_Cancer_2009_Jun_2_100(11)_1739-1745.nxml.txt.nlp	19436299	SENT105	0	0	9	9	everolimus	FDG	PA164746311	23583	0.749
NULL	Diabetes_Metab_J_2013_Dec_12_37(6)_429-432.nxml.txt.nlp	24404514	SENT15	11	11	35	35	metformin	GLP-1	PA450395	100125288	0.749
NULL	Cancers_(Basel)_2011_Sep_13_3(3)_3506-3524.nxml.txt.nlp	24212966	SENT95	7	7	21	21	erlotinib	EGFR	PA134687924	1956	0.749
NULL	Bull_Math_Biol_2014_Dec_14_76(2)_401-430.nxml.txt.nlp	24338592	SENT26	32	32	39	39	doxorubicin	CHOP	PA449412	1649	0.749
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_17_2013_514719.nxml.txt.nlp	23843876	SENT219	24	24	6	6	docetaxel	LC3	PA449383	84557	0.749
NULL	Cancer_Cell_Int_2013_Sep_3_13_89.nxml.txt.nlp	24004445	SENT194	6	6	9	9	capsaicin	TRPV1	PA448776	7442	0.749
NULL	Drug_Des_Devel_Ther_2014_Sep_23_8_1527-1538.nxml.txt.nlp	25284985	SENT105	0	0	14	14	celecoxib	IFN	PA448871	3439	0.749
NULL	J_Invest_Dermatol_2013_Sep_31_133(9)_2247-2254.nxml.txt.nlp	23370537	SENT114	1	1	8	8	chloroquine	p53	PA448948	7157	0.749
NULL	Front_Oncol_2013_Apr_16_3_87.nxml.txt.nlp	23596570	SENT1103	0	0	10	10	tamoxifen	TGFbeta	PA451581	7040	0.749
NULL	Cardiol_Res_Pract_2011_May_10_2011_816897.nxml.txt.nlp	21629798	SENT206	40	40	34	34	sorafenib	CYP3A4	PA7000	1576	0.749
NULL	Oncotarget_2012_May_18_3(5)_525-534.nxml.txt.nlp	22619113	SENT121	22	22	10	10	fludarabine	IL-4	PA449655	3565	0.749
NULL	Mol_Med_Rep_2015_Jan_16_11(1)_189-195.nxml.txt.nlp	25323748	SENT120	22	22	20	20	cisplatin	CHOP	PA449014	1649	0.749
NULL	Environ_Health_Perspect_2006_Sep_23_114(9)_1401-1406.nxml.txt.nlp	16966095	SENT49	7	7	26	26	arsenite	p53	PA452638	7157	0.749
NULL	Exp_Ther_Med_2013_Apr_5_5(4)_1259-1263.nxml.txt.nlp	23596498	SENT52	11	11	8	8	capsaicin	TRPV1	PA448776	7442	0.749
NULL	Drugs_R_D_2010_Jul_27_10(2)_111-122.nxml.txt.nlp	20698720	SENT191	7	7	18	18	axitinib	IL-3	PA164924493	3562	0.749
NULL	Eur_J_Epidemiol_2011_Aug_30_26(8)_657-686.nxml.txt.nlp	21877163	SENT961	3	3	9	9	phenprocoumon	VKORC1	PA450921	79001	0.749
NULL	Carcinogenesis_2011_Nov_1_32(11)_1724-1733.nxml.txt.nlp	21890461	SENT412	17	17	31	31	perifosine	AKT	PA165291471	207	0.749
NULL	Mol_Cancer_2008_Jun_30_7_60.nxml.txt.nlp	18590557	SENT4	32	32	39	39	etoposide	TRAIL	PA449552	8743	0.749
NULL	Viruses_2013_Oct_7_5(10)_2483-2511.nxml.txt.nlp	24103892	SENT234	17	17	25	25	cyclosporine	NUP358	PA449167	5903	0.749
NULL	Ann_Hematol_2010_Sep_13_89(9)_861-871.nxml.txt.nlp	20387067	SENT215	2	2	16	16	dasatinib	CD34	PA162372878	947	0.749
NULL	Physiol_Rep_2014_Sep_11_2(9)_e12144.nxml.txt.nlp	25214522	SENT305	4	4	13	13	resveratrol	p53		7157	0.749
NULL	Breast_Cancer_Res_Treat_2014_Dec_21_143(3)_459-467.nxml.txt.nlp	24362951	SENT57	10	10	26	26	everolimus	aromatase	PA164746311	1588	0.749
NULL	Cancers_(Basel)_2010_Apr_21_2(2)_653-669.nxml.txt.nlp	24281087	SENT86	32	32	13	13	doxorubicin	HMGA2	PA449412	8091	0.749
NULL	Int_J_Environ_Res_Public_Health_2013_Sep_17_10(9)_4352-4389.nxml.txt.nlp	24048206	SENT5	6	6	1	1	choline	B12	PA448976	7126;4709	0.749
NULL	Br_J_Ophthalmol_2014_Aug_2_98(8)_1023-1027.nxml.txt.nlp	24695688	SENT122	9	9	32	32	tacrolimus	SPK	PA451578	55872;8189	0.749
NULL	Environ_Health_Perspect_2005_Jun_24_113(6)_675-679.nxml.txt.nlp	15929888	SENT31	20	20	30	30	estradiol	CA1	PA449503	759	0.749
NULL	J_Biol_Chem_2010_Apr_23_285(17)_12979-12989.nxml.txt.nlp	20189985	SENT251	7	7	17	17	forskolin	AC6	PA146096022	112	0.749
NULL	Diabetes_2008_Sep_57(9)_2470-2479.nxml.txt.nlp	18511847	SENT112	8	8	5	5	pioglitazone	adiponectin	PA450970	9370	0.749
NULL	Springerplus_2013_Dec_6_2_658.nxml.txt.nlp	24349960	SENT88	29	29	19	19	heparin	OPG	PA449855	690	0.749
NULL	Mol_Cancer_2004_Jul_12_3_19.nxml.txt.nlp	15248896	SENT142	12	12	30	30	oxygen	HIF-1	PA450744	29072	0.749
NULL	J_Cardiothorac_Surg_2014_Sep_17_9(1)_129.nxml.txt.nlp	NULL	SENT10	23	23	15	15	protamine	ACT	PA10366	12;11332;9457;641455	0.749
NULL	Mol_Biol_Int_2011_Jun_8_2011_571242.nxml.txt.nlp	22091408	SENT325	30	30	28	28	vinblastine	P-gp	PA451877	5243	0.749
NULL	Br_J_Cancer_2013_Mar_5_108(4)_983-992.nxml.txt.nlp	23361057	SENT118	31	31	24	24	cytarabine	MLH1	PA449177	4292	0.749
NULL	Environ_Health_Perspect_2007_Dec_8_115(Suppl_1)_77-83.nxml.txt.nlp	18174954	SENT125	9	9	15	15	genistein	TPO	PA165109660	7066;7173	0.749
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT256	5	5	16	16	aripiprazole	PRL	PA10026	5617	0.749
NULL	Breast_Cancer_Res_2010_Mar_5_12(2)_R16.nxml.txt.nlp	20205716	SENT234	34	34	13	13	lovastatin	E2F1	PA450272	1869	0.749
NULL	Diabetes_2014_Jan_13_63(1)_188-202.nxml.txt.nlp	24089508	SENT254	7	7	4	4	maraviroc	IL-2	PA164768835	3558	0.749
NULL	Hum_Genomics_2009_Jan_1_3(2)_128-142.nxml.txt.nlp	19164090	SENT248	3	3	8	8	hyaluronan	CD44	PA165958431	960	0.749
NULL	Breast_Cancer_Res_2012_May_23_14(3)_R83.nxml.txt.nlp	22621334	SENT184	13	13	44	44	trastuzumab	HER2	PA451743	2064	0.749
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT349	15	15	4	4	heparin	FGF1	PA449855	2246	0.749
NULL	Front_Pharmacol_2014_May_9_5_103.nxml.txt.nlp	24847272	SENT230	5	5	28	28	tacrolimus	POR	PA451578	5447	0.749
NULL	FEBS_Open_Bio_2014_Aug_30_4_763-776.nxml.txt.nlp	25349781	SENT467	11	11	26	26	curcumin	AMPK	PA151958596	5563	0.749
NULL	J_Carcinog_2013_Aug_8_12_16.nxml.txt.nlp	24082825	SENT87	9	9	31	31	phenformin	AMPK	PA1000	5563	0.749
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT169	20	20	31	31	metformin	HIF-1	PA450395	29072	0.749
NULL	Int_J_Mol_Sci_2014_Oct_29_15(11)_19700-19728.nxml.txt.nlp	25356505	SENT108	24	24	14	14	thrombin	EGFR	PA451674	1956	0.749
NULL	Exp_Ther_Med_2013_Dec_26_6(6)_1359-1364.nxml.txt.nlp	24255662	SENT136	18	18	11	11	dexmedetomidine	IL-6	PA449256	3569	0.749
NULL	Oncol_Lett_2014_May_27_7(5)_1327-1332.nxml.txt.nlp	24765133	SENT69	14	14	21	21	cisplatin	c-FLIP	PA449014	8837	0.749
NULL	Cardiol_Res_Pract_2014_Nov_20_2014_784018.nxml.txt.nlp	25506463	SENT146	25	25	17	17	bivalirudin	ACT	PA10032	12;11332;9457;641455	0.749
NULL	Mol_Cancer_2010_Jun_25_9_165.nxml.txt.nlp	20576164	SENT51	24	24	7	7	curcumin	STAT3	PA151958596	6774	0.749
NULL	Cancer_Cell_Int_2012_Jun_18_12_30.nxml.txt.nlp	22709569	SENT59	17	17	4	4	cisplatin	PLCG2	PA449014	5336	0.749
NULL	Osteoporos_Int_2011_Jan_1_22(1)_27-35.nxml.txt.nlp	20358360	SENT66	14	14	26	26	alendronate	PTH	PA448082	5741	0.749
NULL	Nat_Commun_2014_Dec_9_5_5691.nxml.txt.nlp	25487737	SENT50	24	24	12	12	doxorubicin	SUV39H2	PA449412	79723	0.749
NULL	Pharmaceuticals_(Basel)_2014_Jan_9_7(1)_46-57.nxml.txt.nlp	24451403	SENT115	10	10	8	8	ritonavir	AKT	PA451260	207	0.749
NULL	Oxid_Med_Cell_Longev_2013_Apr_21_2013_412576.nxml.txt.nlp	23710286	SENT31	20	20	11	11	curcumin	NRF2	PA151958596	2551;4780	0.749
NULL	Cancer_Imaging_2008_Nov_25_8(1)_199-205.nxml.txt.nlp	19028612	SENT84	18	18	15	15	cetuximab	EGFR	PA10040	1956	0.749
NULL	ASN_Neuro_2010_Aug_11_2(4)_e00040.nxml.txt.nlp	20711301	SENT111	12	12	4	4	coumarin	Hsp90	PA134521193	3320	0.749
NULL	Br_J_Cancer_2011_Jul_12_105(2)_189-193.nxml.txt.nlp	21694726	SENT99	14	14	11	11	tamoxifen	aromatase	PA451581	1588	0.749
NULL	Crit_Care_2008_Jan_24_12(1)_R27.nxml.txt.nlp	18304335	SENT234	27	27	35	35	thrombin	Rho	PA451674	29984	0.749
NULL	Ann_Coloproctol_2014_Aug_26_30(4)_165-174.nxml.txt.nlp	25210685	SENT142	16	16	33	33	panitumumab	KRAS	PA162373091	3845	0.749
NULL	Br_J_Cancer_1998_May_77(10)_1645-1652.nxml.txt.nlp	9635842	SENT14	15	15	13	13	sn-38	TPT		23590;6469	0.749
NULL	Exp_Mol_Med_2012_Sep_30_44(9)_536-544.nxml.txt.nlp	22771771	SENT8	13	13	8	8	celecoxib	p53	PA448871	7157	0.749
NULL	Br_J_Cancer_2010_Jul_13_103(2)_196-200.nxml.txt.nlp	20571495	SENT133	41	41	28	28	sunitinib	KRAS	PA162372840	3845	0.749
NULL	Front_Pharmacol_2014_Oct_31_5_231.nxml.txt.nlp	25400580	SENT4811	16	16	11	11	nateglinide	OATP1B3	PA450600	28234	0.749
NULL	Open_Biochem_J_2008_Nov_18_2_143-149.nxml.txt.nlp	19238188	SENT244	9	9	6	6	thrombin	ATIII	PA451674	462	0.749
NULL	Front_Microbiol_2014_Mar_14_5_99.nxml.txt.nlp	24672516	SENT89	13	13	16	16	voriconazole	TLR2	PA10233	7097	0.749
NULL	Breast_Cancer_Res_2003_Jul_28_5(5)_276-279.nxml.txt.nlp	12927039	SENT74	4	4	6	6	tamoxifen	aromatase	PA451581	1588	0.749
NULL	Front_Neuroanat_2011_Jul_12_5_38.nxml.txt.nlp	21808606	SENT100	17	17	7	7	haloperidol	DARPP-32	PA449841	84152	0.749
NULL	Bone_Joint_Res_2014_Mar_1_3(3)_51-59.nxml.txt.nlp	24615710	SENT35	0	0	4	4	resveratrol	SIRT1		23411	0.749
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jul_17_66(Pt_8)_o2039.nxml.txt.nlp	21588348	SENT64	29	29	23	23	ethanol	mol	PA448073	90527	0.749
NULL	Indian_J_Med_Res_2013_Jan_137(1)_125-129.nxml.txt.nlp	23481061	SENT22	1	1	19	19	cisplatin	GSTM1	PA449014	2944	0.749
NULL	Acta_Neuropathol_Commun_2013_Oct_8_1_64.nxml.txt.nlp	24252413	SENT24	9	9	42	42	ketamine	p53	PA450144	7157	0.749
NULL	Br_J_Cancer_2004_Mar_22_90(6)_1285-1292.nxml.txt.nlp	15026814	SENT42	25	25	18	18	cisplatin	p53	PA449014	7157	0.749
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Jan_12_69(Pt_2)_o226.nxml.txt.nlp	23424507	SENT76	21	21	7	7	hydroquinone	mol	PA449924	90527	0.749
NULL	N_Am_J_Med_Sci_2014_Aug_6(8)_422-424.nxml.txt.nlp	25210678	SENT50	6	6	15	15	cyclophosphamide	CHOP	PA449165	1649	0.749
NULL	Indian_J_Anaesth_2012_Mar-Apr_56(2)_202-203.nxml.txt.nlp	22701222	SENT22	21	21	17	17	isoflurane	NAC	PA450106	22861	0.749
NULL	Arthritis_Res_Ther_2005_Feb_18_7(3)_R476-R484.nxml.txt.nlp	15899034	SENT28	4	4	17	17	thrombin	Rho	PA451674	29984	0.749
NULL	ASN_Neuro_2009_Oct_21_1(4)_e00018.nxml.txt.nlp	19807694	SENT166	27	27	31	31	ganciclovir	E12	PA449733	64100	0.749
NULL	Ther_Clin_Risk_Manag_2007_Aug_3(4)_533-542.nxml.txt.nlp	18472974	SENT181	6	6	31	31	posaconazole	CYP1A2	PA151958574	1544	0.749
NULL	Chem_Commun_(Camb)_2013_Jun_21_49(76)_8441-8443.nxml.txt.nlp	23770604	SENT22	22	22	28	28	geldanamycin	Hsp90	PA152031327	3320	0.749
NULL	J_Immunother_Cancer_2014_Nov_6_2(Suppl_3)_P13.nxml.txt.nlp	NULL	SENT10	18	18	12	12	cetuximab	IL-2	PA10040	3558	0.748
NULL	Br_J_Pharmacol_2008_Dec_25_155(7)_1056-1065.nxml.txt.nlp	18724386	SENT139	19	19	11	11	nitrendipine	GPR119	PA146096020	139760	0.748
NULL	Diabetes_2009_Feb_58(2)_352-359.nxml.txt.nlp	19011168	SENT175	20	20	5	5	exenatide	GLP-1	PA164749238	100125288	0.748
NULL	ScientificWorldJournal_2012_Dec_17_2012_916381.nxml.txt.nlp	23319889	SENT27	18	18	20	20	ceftriaxone	CTX	PA448866	1593	0.748
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1063.nxml.txt.nlp	24556678	SENT221	5	5	7	7	thioridazine	TRAIL	PA451666	8743	0.748
NULL	Cancer_Cell_Int_2013_Mar_4_13_21.nxml.txt.nlp	23497288	SENT15	26	26	8	8	vincristine	EWS	PA451879	2130	0.748
NULL	J_Oncol_2009_Mar_24_2009_491985.nxml.txt.nlp	19325924	SENT113	4	4	6	6	genistein	CXCR4	PA165109660	7852	0.748
NULL	Oncoscience_2014_Jun_1_1(5)_383-391.nxml.txt.nlp	25594033	SENT85	28	28	21	21	cisplatin	BRCA1	PA449014	672	0.748
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT732	25	25	27	27	aripiprazole	STAR	PA10026	6770;2984	0.748
NULL	J_Skin_Cancer_2012_Dec_13_2012_147863.nxml.txt.nlp	23316365	SENT198	19	19	11	11	curcumin	IL-6	PA151958596	3569	0.748
NULL	J_Inflamm_(Lond)_2006_Jul_12_3_10.nxml.txt.nlp	16834783	SENT128	15	15	5	5	mometasone	MCP-1	PA450541	6347	0.748
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT257	28	28	21	21	bevacizumab	VEGF-A	PA130232992	7422	0.748
NULL	Front_Chem_2014_Mar_14_2_12.nxml.txt.nlp	24790981	SENT97	1	1	5	5	curcumin	GATA4	PA151958596	2626	0.748
NULL	Cell_Commun_Signal_2009_Oct_27_7_25.nxml.txt.nlp	19860902	SENT237	0	0	6	6	tropisetron	NFATc	PA161925594	4772	0.748
NULL	Reprod_Biol_Endocrinol_2013_May_8_11_34.nxml.txt.nlp	23656912	SENT90	11	11	3	3	omeprazole	CYP2C	PA450704	1562	0.748
NULL	Mol_Cells_2014_Mar_31_37(3)_234-240.nxml.txt.nlp	24642709	SENT98	0	0	19	19	cisplatin	IL-6	PA449014	3569	0.748
NULL	Cancer_Immunol_Immunother_2011_Jun_25_60(6)_793-808.nxml.txt.nlp	21350947	SENT176	9	9	24	24	sorafenib	IFN	PA7000	3439	0.748
NULL	Acta_Pharmacol_Sin_2009_Nov_12_30(11)_1566-1572.nxml.txt.nlp	19820718	SENT150	14	14	9	9	ketoconazole	CYP3A4	PA450146	1576	0.748
NULL	Front_Genet_2012_Nov_5_3_236.nxml.txt.nlp	23133441	SENT77	1	1	9	9	efavirenz	ABCB1	PA449441	5243	0.748
NULL	Patient_Prefer_Adherence_2009_Nov_3_3_51-59.nxml.txt.nlp	19936145	SENT148	28	28	23	23	tolcapone	COMT	PA451720	1312	0.748
NULL	Endocrinol_Diabetes_Metab_Case_Rep_2013_Aug_30_2013_130026.nxml.txt.nlp	24616766	SENT97	15	15	12	12	octreotide	IGF1	PA450678	3479	0.748
NULL	BMB_Rep_2013_Nov_46(11)_544-549.nxml.txt.nlp	24152910	SENT95	18	18	6	6	thrombin	HMGB1	PA451674	3146	0.748
NULL	J_Am_Heart_Assoc_2013_Aug_23_2(4)_e000249.nxml.txt.nlp	23817469	SENT293	3	3	20	20	creatine	APLN	PA164778930	8862	0.748
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT132	25	25	29	29	cisplatin	GSTP1	PA449014	2950	0.748
NULL	Br_J_Cancer_2012_Feb_14_106(4)_646-650.nxml.txt.nlp	22240794	SENT82	24	24	26	26	sunitinib	IFN	PA162372840	3439	0.748
NULL	J_Epilepsy_Res_2011_Dec_30_1(2)_52-56.nxml.txt.nlp	24649446	SENT20	33	33	16	16	phenytoin	LZP	PA450947	170392	0.748
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT190	35	35	28	28	heparin	FGFR1	PA449855	2260	0.748
NULL	Mol_Biol_Evol_2014_Jul_14_31(7)_1793-1802.nxml.txt.nlp	24732957	SENT82	15	15	9	9	propiconazole	PC2	PA165107991	5126;5311;8535	0.748
NULL	Diabetes_Care_2011_Jul_17_34(7)_1634-1638.nxml.txt.nlp	21617098	SENT128	0	0	21	21	salsalate	adiponectin	PA164745462	9370	0.748
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2675-2684.nxml.txt.nlp	24129246	SENT197	24	24	21	21	etoposide	DBC1	PA449552	57805;1620	0.748
NULL	Clin_Sci_(Lond)_2012_Oct_1_123(Pt_8)_473-486.nxml.txt.nlp	22757958	SENT71	7	7	1	1	glucosamine	HBP	PA164747613	3069;50865;7884;566	0.748
NULL	J_Obes_2012_Apr_17_2012_104706.nxml.txt.nlp	22577523	SENT57	28	28	35	35	diclofenac	IL-10	PA449293	3586	0.748
NULL	Breast_Cancer_(Auckl)_2009_Aug_17_3_47-60.nxml.txt.nlp	21556249	SENT75	16	16	24	24	erlotinib	EGFR	PA134687924	1956	0.748
NULL	Acta_Pharmacol_Sin_2010_Dec_1_31(12)_1625-1634.nxml.txt.nlp	21042284	SENT43	0	0	18	18	bevacizumab	San	PA130232992	80218	0.748
NULL	J_Hematol_Oncol_2009_Feb_27_2_11.nxml.txt.nlp	19250532	SENT59	2	2	0	0	cyclophosphamide	CHOP	PA449165	1649	0.748
NULL	Diabetes_Metab_Syndr_Obes_2014_Jun_24_7_229-239.nxml.txt.nlp	25018644	SENT104	11	11	8	8	exenatide	GLP-1	PA164749238	100125288	0.748
NULL	Angiogenesis_2010_Dec_7_13(4)_305-315.nxml.txt.nlp	20927579	SENT145	21	21	18	18	resveratrol	p53		7157	0.748
NULL	J_Gen_Physiol_1992_Jun_1_99(6)_985-1016.nxml.txt.nlp	1640223	SENT3	2	2	16	16	tetracaine	gamma	PA451638	9913	0.748
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Dec_10_65(Pt_1)_o73.nxml.txt.nlp	21581712	SENT63	8	8	1	1	benzaldehyde	mol	PA448571	90527	0.748
NULL	Breast_Cancer_Res_2005_May_3_7(4)_R487-R494.nxml.txt.nlp	15987454	SENT37	0	0	29	29	fluorescein	San	PA164746009	80218	0.748
NULL	Ann_Dermatol_2012_Feb_2_24(1)_103-106.nxml.txt.nlp	22363169	SENT71	11	11	2	2	isotretinoin	CO2	PA450128	4513	0.748
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Jun_7_70(Pt_7)_m247-m248.nxml.txt.nlp	25161516	SENT7	12	12	14	14	ethanol	mol	PA448073	90527	0.748
NULL	J_Neuroinflammation_2011_Feb_7_8_11.nxml.txt.nlp	21299846	SENT210	22	22	28	28	forskolin	ANOVA	PA146096022	4858	0.748
NULL	Acta_Pharmacol_Sin_2013_Apr_25_34(4)_455-463.nxml.txt.nlp	23524568	SENT14	1	1	23	23	pioglitazone	RAGE	PA450970	177	0.748
NULL	Protein_Cell_2014_Jun_19_5(6)_469-479.nxml.txt.nlp	24748116	SENT126	8	8	2	2	paclitaxel	EB1	PA450761	9167;22919;10982	0.748
NULL	Cell_Death_Dis_2010_Feb_4_1(2)_e21.nxml.txt.nlp	21364629	SENT119	15	15	5	5	nadh	PRELI	PA164755085	27166	0.748
NULL	Arthritis_Res_Ther_2011_Jan_27_13(1)_R7.nxml.txt.nlp	21272347	SENT113	18	18	36	36	etanercept	FVIII	PA449515	2157	0.748
NULL	Breast_Cancer_Res_2006_Oct_16_8(5)_111.nxml.txt.nlp	17049068	SENT57	25	25	27	27	raloxifene	STAR	PA451221	6770;2984	0.748
NULL	Breast_Cancer_Res_2004_Nov_7_6(1)_39-52.nxml.txt.nlp	14680484	SENT157	25	25	30	30	tamoxifen	SMRT	PA451581	9612	0.748
NULL	Br_J_Cancer_2013_Jul_23_109(2)_351-359.nxml.txt.nlp	23799854	SENT134	15	15	12	12	paclitaxel	BLT2	PA450761	56413	0.748
NULL	Clin_Kidney_J_2014_Apr_14_7(2)_151-155.nxml.txt.nlp	24944783	SENT104	13	13	4	4	tacrolimus	ANOVA	PA451578	4858	0.748
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT31	31	31	15	15	celecoxib	survivin	PA448871	332	0.748
NULL	Reprod_Biol_Endocrinol_2003_Aug_6_1_54.nxml.txt.nlp	12932297	SENT23	34	34	15	15	hyaluronidase	SPAM1	PA164745713	6677	0.748
NULL	Vet_Res_Forum_2013_Winter_4(1)_19-24.nxml.txt.nlp	25593681	SENT89	40	40	38	38	diclofenac	B12	PA449293	7126;4709	0.748
NULL	Diagn_Pathol_2013_Jan_21_8_10.nxml.txt.nlp	23337059	SENT152	19	19	34	34	leucovorin	beta-catenin	PA450198	1499	0.748
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT202	10	10	12	12	bevacizumab	VEGF-A	PA130232992	7422	0.748
NULL	Eur_J_Med_Res_2011_Jul_25_16(7)_303-314.nxml.txt.nlp	21813371	SENT62	23	23	36	36	telaprevir	SOC	PA165958354	91544	0.748
NULL	Am_J_Rhinol_Allergy_2013_Nov-Dec_27(6)_482-489.nxml.txt.nlp	24274224	SENT89	5	5	22	22	montelukast	LTA	PA450546	4049	0.748
NULL	Onco_Targets_Ther_2014_Dec_4_7_2249-2255.nxml.txt.nlp	25587220	SENT95	19	19	29	29	doxorubicin	P-gp	PA449412	5243	0.748
NULL	Hum_Reprod_2014_Apr_12_29(4)_652-660.nxml.txt.nlp	24522839	SENT73	23	23	6	6	l-glutamine	F10	PA10090	2159	0.748
NULL	Case_Rep_Oncol_Med_2013_Nov_26_2013_862585.nxml.txt.nlp	24371535	SENT38	17	17	26	26	cyclophosphamide	CHOP	PA449165	1649	0.748
NULL	Pediatr_Nephrol_2009_Jul_20_24(7)_1355-1361.nxml.txt.nlp	19301038	SENT7	4	4	19	19	sevelamer	San	PA164781197	80218	0.748
NULL	Diabetes_Care_2009_Feb_32(2)_e13-e19.nxml.txt.nlp	19171729	SENT67	5	5	10	10	ramipril	DREAM	PA451223	30818	0.748
NULL	Cardiovasc_Diabetol_2005_Oct_5_4_16.nxml.txt.nlp	16207378	SENT8	5	5	16	16	glucosamine	perlecan	PA164747613	3339	0.748
NULL	Mol_Cancer_2010_Dec_20_9_316.nxml.txt.nlp	21172016	SENT163	14	14	20	20	heparin	CCL21	PA449855	6366	0.748
NULL	Int_J_Biol_Sci_2014_Aug_23_10(8)_921-939.nxml.txt.nlp	25170305	SENT307	18	18	4	4	nadh	EPO	PA164755085	7076;8288;2056	0.748
NULL	Oncoimmunology_2012_Nov_1_1(8)_1445-1447.nxml.txt.nlp	23243624	SENT28	40	40	22	22	bevacizumab	CD83	PA130232992	9308	0.748
NULL	AIDS_2013_Nov_28_27(18)_F21-F28.nxml.txt.nlp	24051706	SENT196	11	11	9	9	maraviroc	CCR5	PA164768835	1234	0.748
NULL	J_Cell_Biol_2008_Jul_14_182(1)_197-213.nxml.txt.nlp	18625847	SENT226	35	35	33	33	nutlin-3	p53		7157	0.748
NULL	Mol_Cancer_2009_Aug_25_8_66.nxml.txt.nlp	19706164	SENT201	8	8	25	25	celecoxib	p53	PA448871	7157	0.748
NULL	Front_Oncol_2014_Apr_9_4_75.nxml.txt.nlp	24782986	SENT265	31	31	9	9	paclitaxel	IL-6	PA450761	3569	0.748
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_79-85.nxml.txt.nlp	23864840	SENT26	11	11	23	23	gemcitabine	EGFR	PA449748	1956	0.748
NULL	Med_Sci_Monit_2014_Aug_1_20_1345-1352.nxml.txt.nlp	25080850	SENT109	35	35	8	8	rosiglitazone	AQP7	PA451283	364	0.748
NULL	J_Cardiovasc_Dis_Res_2012_Jan-Mar_3(1)_5-11.nxml.txt.nlp	22346138	SENT68	2	2	10	10	repaglinide	IL-6	PA451234	3569	0.748
NULL	Cardiovasc_Ther_2009_27(4)_259-274.nxml.txt.nlp	19604248	SENT126	11	11	0	0	ticagrelor	IPA	PA165374673	3160	0.748
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT84	14	14	22	22	celecoxib	IL-6	PA448871	3569	0.748
NULL	Eur_J_Clin_Pharmacol_2012_Jan_8_68(1)_29-37.nxml.txt.nlp	21739267	SENT135	5	5	26	26	aripiprazole	CYP2D6	PA10026	1565	0.748
NULL	AIDS_Res_Ther_2009_Apr_9_6_3.nxml.txt.nlp	19358725	SENT7	38	38	40	40	atazanavir	ATV	PA10251	4683	0.748
NULL	Arch_Immunol_Ther_Exp_(Warsz)_2014_Feb_20_62(5)_411-422.nxml.txt.nlp	24554032	SENT27	22	22	13	13	galactose	EC2	PA449725	6939	0.748
NULL	Indian_J_Med_Res_2012_Aug_136(2)_249-259.nxml.txt.nlp	22960892	SENT127	26	26	13	13	sn-38	UGT1A1		54658	0.748
NULL	Cancer_Immunol_Immunother_2012_Oct_8_61(10)_1713-1720.nxml.txt.nlp	22399057	SENT127	24	24	12	12	plerixafor	CXCR4	PA165958410	7852	0.748
NULL	Front_Immunol_2013_Nov_18_4_382.nxml.txt.nlp	24302925	SENT176	9	9	14	14	imatinib	CD25	PA10804	3669;3559	0.748
NULL	Mol_Cancer_2010_May_20_9_115.nxml.txt.nlp	20487546	SENT235	12	12	16	16	fludarabine	MYC	PA449655	4609	0.748
NULL	Oncogene_2010_Sep_16_29(37)_5193-5203.nxml.txt.nlp	20581867	SENT167	18	18	13	13	lapatinib	EGFR	PA152241907	1956	0.748
NULL	J_Cancer_2013_Sep_27_4(8)_662-670.nxml.txt.nlp	24155778	SENT186	17	17	15	15	cisplatin	UCHL1	PA449014	7345	0.748
NULL	J_Asthma_Allergy_2009_May_8_2_49-62.nxml.txt.nlp	21437144	SENT103	41	41	11	11	omalizumab	CD4	PA164752253	920	0.748
NULL	Acta_Pharmacol_Sin_2014_Aug_21_35(8)_1082-1092.nxml.txt.nlp	25047514	SENT28	14	14	33	33	exemestane	aromatase	PA449563	1588	0.748
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_4_2013_378657.nxml.txt.nlp	23662132	SENT495	9	9	3	3	liraglutide	GLP-1	PA165958364	100125288	0.748
NULL	J_Biol_Chem_2013_Aug_23_288(34)_24848-24856.nxml.txt.nlp	23843457	SENT155	12	12	39	39	baclofen	KCTD12	PA448533	115207	0.748
NULL	Oncol_Lett_2014_May_11_7(5)_1401-1408.nxml.txt.nlp	24765145	SENT110	2	2	7	7	paclitaxel	PI3K	PA450761	5290	0.748
NULL	Lab_Invest_2014_May_10_94(5)_503-516.nxml.txt.nlp	24614199	SENT177	29	29	23	23	curcumin	RAGE	PA151958596	177	0.748
NULL	Curr_Hematol_Malig_Rep_2014_Jun_27_9(3)_243-253.nxml.txt.nlp	24969265	SENT255	24	24	6	6	leucovorin	RFC1	PA450198	5981	0.748
NULL	Clin_Med_Insights_Womens_Health_2013_Jan_22_6_1-11.nxml.txt.nlp	24665209	SENT61	35	35	11	11	tamoxifen	ATAC	PA451581	6375	0.748
NULL	Front_Genet_2012_Oct_26_3_213.nxml.txt.nlp	23112805	SENT478	6	6	4	4	oltipraz	CYP3A4		1576	0.748
NULL	Curr_Med_Chem_2011_Jun_18(18)_2686-2714.nxml.txt.nlp	21649578	SENT286	19	19	35	35	erlotinib	PI3K	PA134687924	5290	0.748
NULL	Ann_Saudi_Med_2010_May-Jun_30(3)_193-197.nxml.txt.nlp	20427934	SENT64	6	6	1	1	caspofungin	IPA	PA164743013	3160	0.748
NULL	J_Biol_Eng_2009_Oct_16_3_18.nxml.txt.nlp	19835592	SENT48	19	19	25	25	erythromycin	CPZ	PA449493	8532	0.748
NULL	Curr_Oncol_2007_Aug_14(4)_154-161.nxml.txt.nlp	17710208	SENT144	22	22	13	13	ketoconazole	CYP3A4	PA450146	1576	0.748
NULL	Mol_Cancer_2007_Jan_14_6_5.nxml.txt.nlp	17222355	SENT204	26	26	4	4	doxorubicin	HMGA2	PA449412	8091	0.748
NULL	Environ_Health_Perspect_2013_May_22_121(5)_551-557.nxml.txt.nlp	23434795	SENT167	15	15	0	0	hyaluronan	BAL	PA165958431	83666	0.748
NULL	Diabetol_Metab_Syndr_2014_Sep_23_6(1)_102.nxml.txt.nlp	NULL	SENT190	15	15	20	20	atorvastatin	RAGE	PA448500	177	0.748
NULL	Eur_J_Appl_Physiol_2011_Feb_24_111(2)_275-283.nxml.txt.nlp	20865425	SENT57	0	0	22	22	glucose	MRS	PA449773	8011	0.748
NULL	Cancer_Med_2013_Aug_2_2(4)_571-582.nxml.txt.nlp	24156030	SENT184	8	8	22	22	curcumin	IFN	PA151958596	3439	0.748
NULL	Onco_Targets_Ther_2014_May_28_7_841-852.nxml.txt.nlp	24920926	SENT67	37	37	17	17	docetaxel	EGFR	PA449383	1956	0.748
NULL	Br_J_Pharmacol_2014_Sep_28_171(18)_4255-4272.nxml.txt.nlp	24846338	SENT22	23	23	18	18	duloxetine	5-HT7	PA10066	3363	0.748
NULL	Anat_Cell_Biol_2012_Jun_30_45(2)_73-78.nxml.txt.nlp	22822460	SENT77	19	19	31	31	doxorubicin	HIF-1	PA449412	29072	0.748
NULL	Oncol_Lett_2013_Feb_27_5(2)_483-488.nxml.txt.nlp	23420047	SENT204	16	16	3	3	cetuximab	KRAS	PA10040	3845	0.748
NULL	Ann_Clin_Microbiol_Antimicrob_2007_Oct_30_6_13.nxml.txt.nlp	17967199	SENT9	27	27	25	25	vancomycin	VISA	PA451850	57506	0.748
NULL	Blood_Res_2014_Jun_25_49(2)_107-114.nxml.txt.nlp	25025012	SENT22	22	22	24	24	rituximab	CHOP	PA451261	1649	0.748
NULL	Oncotarget_2014_Jun_6_5(13)_4935-4944.nxml.txt.nlp	24952732	SENT74	15	15	9	9	doxazosin	PI3K	PA449407	5290	0.748
NULL	Mol_Cancer_2010_Aug_20_9_220.nxml.txt.nlp	20727180	SENT144	16	16	34	34	nicotine	p53	PA450626	7157	0.748
NULL	Nucleic_Acids_Res_2013_Nov_8_41(20)_9524-9536.nxml.txt.nlp	23935071	SENT206	47	47	25	25	sugar	G11	PA451529	8859	0.748
NULL	Biomed_Res_Int_2013_Dec_23_2013_931028.nxml.txt.nlp	24455740	SENT186	34	34	12	12	capecitabine	DPYD	PA448771	1806	0.748
NULL	Ther_Clin_Risk_Manag_2006_Sep_2(3)_235-249.nxml.txt.nlp	18360599	SENT321	16	16	14	14	alendronate	PTH	PA448082	5741	0.748
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Oct_17_65(Pt_11)_o2776.nxml.txt.nlp	21578369	SENT56	44	44	21	21	ethanol	mol	PA448073	90527	0.748
NULL	Front_Synaptic_Neurosci_2014_Sep_5_6_18.nxml.txt.nlp	25249974	SENT229	32	32	9	9	mecamylamine	DSI	PA450334	5034	0.748
NULL	Chem_Rev_2013_Oct_9_113(10)_7769-7792.nxml.txt.nlp	23808632	SENT394	8	8	20	20	arsenite	hole	PA452638	80757	0.748
NULL	Cardiovasc_Diabetol_2010_Jul_27_9_31.nxml.txt.nlp	20663195	SENT107	3	3	12	12	irbesartan	CD31	PA450084	5175	0.748
NULL	J_Hematol_Oncol_2012_Mar_18_5_11.nxml.txt.nlp	22424240	SENT69	21	21	5	5	napqi	HSP60		3329	0.748
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT49	39	39	9	9	dextromethorphan	CYP2A6	PA449273	1548	0.748
NULL	Evid_Based_Complement_Alternat_Med_2013_May_13_2013_506324.nxml.txt.nlp	23818927	SENT200	12	12	24	24	doxorubicin	STAT3	PA449412	6774	0.748
NULL	J_Cell_Biol_2008_Jul_14_182(1)_197-213.nxml.txt.nlp	18625847	SENT27	0	0	11	11	nutlin-3	p53		7157	0.748
NULL	Diabetes_2009_Jun_16_58(6)_1382-1390.nxml.txt.nlp	19289456	SENT276	25	25	30	30	losartan	Bcl-2	PA450268	596	0.748
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Nov_8_64(Pt_12)_o2274-o2275.nxml.txt.nlp	21581255	SENT73	1	1	10	10	benzaldehyde	mol	PA448571	90527	0.748
NULL	Gut_2015_Jan_19_64(1)_111-120.nxml.txt.nlp	24647007	SENT139	10	10	5	5	capecitabine	TYMS	PA448771	7298	0.748
NULL	Cancer_Med_2012_Oct_1_1(2)_114-127.nxml.txt.nlp	23342262	SENT171	2	2	11	11	sirolimus	EGFR	PA451365	1956	0.748
NULL	J_Gen_Physiol_1992_Jun_1_99(6)_985-1016.nxml.txt.nlp	1640223	SENT4	3	3	7	7	tetracaine	gamma	PA451638	9913	0.748
NULL	Breast_Cancer_Res_2010_Oct_14_12(5)_R84.nxml.txt.nlp	20946630	SENT238	12	12	19	19	choline	SLC22A2	PA448976	6582	0.748
NULL	Oxid_Med_Cell_Longev_2009_Nov-Dec_2(5)_259-269.nxml.txt.nlp	20716913	SENT127	9	9	15	15	carvedilol	AT1	PA448817	9197;185	0.748
NULL	Mar_Drugs_2014_May_13_12(5)_2922-2936.nxml.txt.nlp	24828295	SENT473	2	2	12	12	nitroprusside	c-Jun	PA451406	3725	0.748
NULL	Biologics_2013_Apr_26_7_91-101.nxml.txt.nlp	23671386	SENT127	18	18	16	16	erlotinib	EGFR	PA134687924	1956	0.748
NULL	J_Biomed_Biotechnol_2011_Jul_13_2011_692846.nxml.txt.nlp	21785564	SENT21	5	5	13	13	genistein	c-fos	PA165109660	2353	0.748
NULL	Mar_Drugs_2014_Jun_27_12(7)_3818-3837.nxml.txt.nlp	24979269	SENT209	30	30	18	18	calcein	P-gp	PA132595336	5243	0.748
NULL	Indian_Dermatol_Online_J_2013_Jul-Sep_4(3)_246-249.nxml.txt.nlp	23984250	SENT38	40	40	35	35	panitumumab	EGFR	PA162373091	1956	0.748
NULL	Hum_Genomics_2009_Dec_1_4(2)_119-130.nxml.txt.nlp	20038499	SENT161	20	20	8	8	ethanol	AOX1	PA448073	316	0.748
NULL	Neural_Regen_Res_2013_Mar_25_8(9)_825-832.nxml.txt.nlp	25206730	SENT88	7	7	15	15	isoflurane	P2X7	PA450106	5027	0.748
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_13_2012_636848.nxml.txt.nlp	23258994	SENT144	17	17	12	12	capsaicin	TRPV1	PA448776	7442	0.748
NULL	Neural_Regen_Res_2013_May_5_8(13)_1180-1189.nxml.txt.nlp	25206412	SENT50	17	17	13	13	fasudil	Rho	PA165946121	29984	0.748
NULL	Acta_Pharmacol_Sin_2010_Nov_18_31(11)_1447-1453.nxml.txt.nlp	20953204	SENT104	18	18	11	11	rimonabant	IL-6	PA152407999	3569	0.748
NULL	BMB_Rep_2014_Aug_47(8)_424-432.nxml.txt.nlp	24874851	SENT92	19	19	39	39	dacarbazine	PARP1	PA449197	142	0.748
NULL	Evid_Based_Complement_Alternat_Med_2012_Aug_25_2012_946867.nxml.txt.nlp	21876716	SENT118	23	23	33	33	oseltamivir	TRAIL	PA450721	8743	0.748
NULL	Clin_Pharmacokinet_2014_Jul_24_53(1)_73-87.nxml.txt.nlp	23881596	SENT147	22	22	15	15	rosuvastatin	OATP1B1	PA134308647	10599	0.748
NULL	J_Hematol_Oncol_2012_Mar_7_5_5.nxml.txt.nlp	22397365	SENT32	38	38	0	0	nadh	IDH1	PA164755085	3417	0.748
NULL	Clin_Ophthalmol_2014_Apr_28_8_807-812.nxml.txt.nlp	24812486	SENT19	23	23	9	9	ranibizumab	CRT	PA164746012	811	0.748
NULL	Oncologist_2010_Jul_24_15(7)_665-672.nxml.txt.nlp	20576644	SENT30	9	9	15	15	trastuzumab	HER-2	PA451743	2064	0.748
NULL	ASN_Neuro_2012_Apr_5_4(3)_e00082.nxml.txt.nlp	22339481	SENT580	4	4	7	7	glucose	HIF-1	PA449773	29072	0.748
NULL	Br_J_Cancer_2009_May_19_100(10)_1540-1548.nxml.txt.nlp	19384300	SENT23	9	9	7	7	trypsin	TATI	PA451806	6690	0.748
NULL	J_Am_Heart_Assoc_2013_Aug_23_2(4)_e000392.nxml.txt.nlp	23938287	SENT60	19	19	7	7	resveratrol	S6K1		6198	0.748
NULL	Arthritis_Rheumatol_2014_Aug_28_66(8)_2297-2307.nxml.txt.nlp	24756912	SENT119	14	14	12	12	cyclophosphamide	CHOP	PA449165	1649	0.748
NULL	Arthritis_Res_Ther_2014_Sep_18_16(5)_427.nxml.txt.nlp	25230745	SENT148	20	20	8	8	bevacizumab	MMP3	PA130232992	4314	0.748
NULL	Ann_Hematol_2014_Apr_1_93(8)_1371-1380.nxml.txt.nlp	24687382	SENT187	18	18	35	35	lenalidomide	MYC	PA162363968	4609	0.748
NULL	Chin_J_Cancer_2012_Feb_31(2)_51-57.nxml.txt.nlp	22257384	SENT67	4	4	11	11	genistein	P-gp	PA165109660	5243	0.748
NULL	Front_Behav_Neurosci_2014_Dec_11_8_396.nxml.txt.nlp	25565996	SENT1084	4	4	11	11	citalopram	STAR	PA449015	6770;2984	0.748
NULL	Cell_Mol_Life_Sci_2011_May_26_68(10)_1785-1798.nxml.txt.nlp	20976523	SENT220	2	2	24	24	collagenase	c-Jun	PA449107	3725	0.748
NULL	Acta_Pharmacol_Sin_2011_May_18_32(5)_601-610.nxml.txt.nlp	21499285	SENT3	27	27	29	29	bleomycin	BLM	PA448645	641	0.748
NULL	Oncol_Lett_2014_Mar_2_7(3)_791-796.nxml.txt.nlp	24527087	SENT92	0	0	7	7	imatinib	CD34	PA10804	947	0.748
NULL	J_Biol_Chem_2013_Nov_15_288(46)_33049-33059.nxml.txt.nlp	24089524	SENT312	8	8	19	19	nicotine	GATA4	PA450626	2626	0.748
NULL	Contemp_Oncol_(Pozn)_2012_Nov_20_16(5)_401-406.nxml.txt.nlp	23788917	SENT147	10	10	5	5	lapatinib	EGFR	PA152241907	1956	0.748
NULL	J_Geriatr_Cardiol_2014_Mar_11(1)_63-73.nxml.txt.nlp	24748884	SENT183	13	13	24	24	levodopa	PKD	PA450213	5587	0.748
NULL	J_Physiol_2009_Feb_15_587(Pt_4)_731-744.nxml.txt.nlp	19074966	SENT260	19	19	16	16	taurine	PAT1	PA451590	10513;206358	0.748
NULL	J_Cancer_Res_Clin_Oncol_2013_Feb_10_139(2)_269-280.nxml.txt.nlp	23052698	SENT44	20	20	10	10	tamoxifen	aromatase	PA451581	1588	0.748
NULL	Acta_Pharmacol_Sin_2010_Feb_5_31(2)_137-144.nxml.txt.nlp	20139896	SENT138	3	3	10	10	zileuton	5-LOX	PA451955	240	0.748
NULL	Br_J_Cancer_2010_Oct_12_103(8)_1201-1208.nxml.txt.nlp	20877360	SENT206	14	14	23	23	cyclophosphamide	IL-6	PA449165	3569	0.748
NULL	Cell_Res_2013_Jul_21_23(7)_915-930.nxml.txt.nlp	23689279	SENT110	29	29	27	27	ethanol	ALDH2	PA448073	217	0.748
NULL	Cardiovasc_Diabetol_2011_Feb_1_10_14.nxml.txt.nlp	21284833	SENT174	29	29	21	21	glucose	CAD	PA449773	1677;790	0.748
NULL	Acta_Pharmacol_Sin_2012_Feb_3_33(2)_194-200.nxml.txt.nlp	22301859	SENT10	7	7	19	19	sibutramine	GLP-1	PA451344	100125288	0.748
NULL	Diabetes_2013_Jun_20_62(6)_2122-2129.nxml.txt.nlp	23378607	SENT254	2	2	17	17	metformin	AMPK	PA450395	5563	0.748
NULL	Exp_Mol_Med_2012_Sep_30_44(9)_545-553.nxml.txt.nlp	22809901	SENT9	0	0	16	16	clozapine	aP2	PA449061	2167	0.748
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT233	12	12	22	22	lapatinib	HRG	PA152241907	3084;3273	0.748
NULL	Biochimie_2010_Nov_92(11)_1546-1567.nxml.txt.nlp	20615447	SENT2395	25	25	14	14	chymotrypsin	KLK1	PA448994	3816	0.748
NULL	Indian_J_Pharm_Sci_2014_Mar-Apr_76(2)_125-131.nxml.txt.nlp	24843185	SENT9	5	5	16	16	resveratrol	CA3		761	0.748
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Jul_23_64(Pt_8)_o1563.nxml.txt.nlp	21203266	SENT61	1	1	17	17	benzaldehyde	mol	PA448571	90527	0.748
NULL	Anal_Bioanal_Chem_2009_Oct_30_395(4)_893-905.nxml.txt.nlp	19484227	SENT142	23	23	18	18	gentamicin	OTC	PA449753	5009	0.748
NULL	EMBO_Mol_Med_2012_Jul_11_4(7)_577-593.nxml.txt.nlp	22496117	SENT174	38	38	36	36	clofazimine	PAP-1	PA164748759	6100	0.748
NULL	Nature_2012_Apr_25_484(7395)_524-528.nxml.txt.nlp	22538616	SENT112	6	6	17	17	ciprofloxacin	IL-6	PA449009	3569	0.748
NULL	Br_J_Ophthalmol_2008_Sep_22_92(9)_1275-1282.nxml.txt.nlp	18723745	SENT128	16	16	5	5	tafluprost	BAK	PA165958432	578	0.748
NULL	Comput_Struct_Biotechnol_J_2012_Oct_31_3_e201210005.nxml.txt.nlp	24688665	SENT145	26	26	12	12	ethanol	PDH	PA448073	54704	0.748
NULL	Cell_Death_Dis_2013_Jul_4_4(7)_e702.nxml.txt.nlp	23828565	SENT67	23	23	9	9	doxorubicin	TRAIL	PA449412	8743	0.748
NULL	J_Gen_Physiol_1967_Dec_1_50(11)_2527-2545.nxml.txt.nlp	5584619	SENT0	12	12	1	1	valinomycin	Gen	PA151917011	348654	0.748
NULL	Int_J_Environ_Res_Public_Health_2011_Jan_14_8(1)_136-147.nxml.txt.nlp	21318020	SENT75	22	22	20	20	ketanserin	5-HT2A	PA131053734	3356	0.748
NULL	Breast_Cancer_(Auckl)_2014_Oct_12_8_135-144.nxml.txt.nlp	25368520	SENT130	24	24	8	8	bleomycin	RAD51B	PA448645	5890	0.748
NULL	Endocr_Relat_Cancer_2014_Apr_21(2)_311-326.nxml.txt.nlp	24478054	SENT290	17	17	15	15	denosumab	OPG	PA166048634	690	0.748
NULL	Angiogenesis_2010_Dec_7_13(4)_305-315.nxml.txt.nlp	20927579	SENT218	3	3	12	12	resveratrol	TSP1		7057	0.748
NULL	Oxid_Med_Cell_Longev_2013_Nov_28_2013_568093.nxml.txt.nlp	24379901	SENT49	0	0	3	3	resveratrol	SIRT1		23411	0.748
NULL	Mol_Cancer_2007_Oct_22_6_66.nxml.txt.nlp	17953743	SENT144	0	0	30	30	cisplatin	TRAIL	PA449014	8743	0.748
NULL	Acta_Pharmacol_Sin_2009_May_5_30(5)_530-536.nxml.txt.nlp	19417732	SENT63	34	34	24	24	fluorescein	CD44	PA164746009	960	0.748
NULL	J_Korean_Med_Sci_2007_Dec_20_22(6)_1055-1059.nxml.txt.nlp	18162722	SENT109	18	18	12	12	pantoprazole	ESD	PA450774	2098	0.748
NULL	Arthritis_Res_Ther_2008_Jan_18_10(1)_R8.nxml.txt.nlp	18205921	SENT185	24	24	44	44	tadalafil	MRP5	PA10333	10057	0.748
NULL	ACS_Appl_Mater_Interfaces_2013_Sep_11_5(17)_8537-8545.nxml.txt.nlp	23961698	SENT60	12	12	4	4	hydroquinone	TRIM	PA449924	50852	0.748
NULL	Blood_Cancer_J_2013_Oct_18_3(10)_e153.nxml.txt.nlp	24141622	SENT91	0	0	9	9	bortezomib	Mcl-1	PA10252	4170	0.748
NULL	Br_J_Cancer_2012_Apr_24_106(9)_1543-1550.nxml.txt.nlp	22531721	SENT81	34	34	24	24	trastuzumab	CD55	PA451743	1604	0.748
NULL	Am_J_Physiol_Cell_Physiol_2014_Jan_15_306(2)_C89-C97.nxml.txt.nlp	24133067	SENT194	7	7	13	13	hyaluronidase	CD44	PA164745713	960	0.748
NULL	ScientificWorldJournal_2014_Dec_9_2014_808320.nxml.txt.nlp	25548793	SENT73	15	15	20	20	heparin	RAC	PA449855	207	0.748
NULL	Biomed_Res_Int_2013_Jun_19_2013_230805.nxml.txt.nlp	23862137	SENT227	33	33	15	15	bortezomib	IL-6	PA10252	3569	0.748
NULL	Curr_Neuropharmacol_2014_Jul_12(4)_365-379.nxml.txt.nlp	25342944	SENT484	15	15	5	5	fluoxetine	5-HT2B	PA449673	3357	0.748
NULL	Oncol_Rep_2014_Apr_28_31(4)_1605-1612.nxml.txt.nlp	24481648	SENT101	7	7	12	12	ponatinib	MRP7	PA165980594	89845;1080	0.748
NULL	Acta_Pharmacol_Sin_2010_Nov_18_31(11)_1447-1453.nxml.txt.nlp	20953204	SENT75	0	0	9	9	rimonabant	IL-6	PA152407999	3569	0.748
NULL	Eur_J_Neurosci_2012_Sep_36(5)_2597-2608.nxml.txt.nlp	22697179	SENT44	15	15	7	7	neomycin	SREB2	PA450608	54329	0.748
NULL	J_Mol_Signal_2008_Dec_1_3_18.nxml.txt.nlp	19046439	SENT92	15	15	10	10	metformin	CDK2	PA450395	1017	0.748
NULL	Br_J_Cancer_2011_Jan_4_104(1)_91-100.nxml.txt.nlp	21139584	SENT162	15	15	22	22	coumarin	Hsp90	PA134521193	3320	0.748
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jun_25_67(Pt_7)_o1796.nxml.txt.nlp	21837169	SENT56	23	23	38	38	ethanol	mol	PA448073	90527	0.748
NULL	Biomed_Res_Int_2014_Feb_10_2014_708593.nxml.txt.nlp	24689050	SENT172	3	3	10	10	etoposide	zeta	PA449552	9907	0.748
NULL	Biol_Open_2013_Apr_9_2(6)_535-545.nxml.txt.nlp	23789104	SENT117	8	8	20	20	arsenite	p38	PA452638	10598;1432;7965	0.748
NULL	Oncotarget_2014_Feb_25_5(5)_1304-1314.nxml.txt.nlp	24675421	SENT257	7	7	2	2	cisplatin	MKP-1	PA449014	1843	0.748
NULL	Ann_Thorac_Med_2014_Jul-Sep_9(Suppl_1)_S79-S91.nxml.txt.nlp	25077002	SENT304	24	24	12	12	bosentan	CYP3A4	PA10034	1576	0.748
NULL	Nat_Chem_Biol_2010_Apr_28_6(4)_291-299.nxml.txt.nlp	20190765	SENT186	7	7	2	2	dasatinib	EGFR	PA162372878	1956	0.748
NULL	J_Physiol_2009_Feb_15_587(Pt_4)_731-744.nxml.txt.nlp	19074966	SENT189	14	14	6	6	taurine	PAT1	PA451590	10513;206358	0.748
NULL	J_Biol_Chem_2012_Aug_24_287(35)_30000-30013.nxml.txt.nlp	22773837	SENT358	5	5	16	16	thrombin	GPVI	PA451674	51206	0.748
NULL	Indian_J_Anaesth_2012_Mar-Apr_56(2)_129-134.nxml.txt.nlp	22701202	SENT3	29	29	14	14	ropivacaine	CEA	PA451271	5670;1087	0.748
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_28_2012_937605.nxml.txt.nlp	23304227	SENT165	14	14	30	30	resveratrol	GDNF		2668	0.748
NULL	Arthritis_Res_Ther_2009_Jun_5_11(3)_R84.nxml.txt.nlp	19500335	SENT219	4	4	35	35	infliximab	IL8	PA452639	3576	0.748
NULL	Chem_Cent_J_2013_Sep_4_7_147.nxml.txt.nlp	24006941	SENT191	2	2	6	6	lipase	LOX	PA450239	4015	0.748
NULL	EMBO_J_2009_May_6_28(9)_1197-1207.nxml.txt.nlp	19322195	SENT181	30	30	8	8	dextran	EGF	PA449261	1950	0.748
NULL	Diabetes_Obes_Metab_2011_Apr_13(4)_348-356.nxml.txt.nlp	21205128	SENT93	30	30	3	3	glimepiride	PPG	PA449761	5552	0.748
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_4_2013_378657.nxml.txt.nlp	23662132	SENT495	23	23	34	34	sitagliptin	GLP-1	PA164748978	100125288	0.748
NULL	Contemp_Oncol_(Pozn)_2012_Nov_20_16(5)_401-406.nxml.txt.nlp	23788917	SENT64	11	11	4	4	afatinib	EGFR	PA165981154	1956	0.748
NULL	Environ_Health_Perspect_2010_Jul_118(7)_A292-A297.nxml.txt.nlp	NULL	SENT42	4	4	30	30	nadh	ADP	PA164755085	23038	0.748
NULL	J_Cell_Biol_2002_Sep_16_158(6)_1133-1144.nxml.txt.nlp	12235127	SENT420	8	8	4	4	hyaluronan	CD44	PA165958431	960	0.748
NULL	Environ_Health_Perspect_2005_Jun_24_113(6)_680-687.nxml.txt.nlp	15929889	SENT45	9	9	5	5	phenol	SULT1E1	PA450913	6783	0.748
NULL	Open_Cardiovasc_Med_J_2011_Feb_24_5_49-63.nxml.txt.nlp	21643501	SENT223	14	14	20	20	raltegravir	CCR5		1234	0.748
NULL	Oncogenesis_2014_Oct_20_3(10)_e122.nxml.txt.nlp	25329721	SENT66	22	22	8	8	doxycycline	IL-3	PA449415	3562	0.748
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S258-S263.nxml.txt.nlp	21525465	SENT202	36	36	15	15	rosiglitazone	GLP-1	PA451283	100125288	0.748
NULL	Breast_Cancer_Res_2010_May_12_12(3)_R27.nxml.txt.nlp	20462431	SENT266	31	31	25	25	trastuzumab	HER2	PA451743	2064	0.748
NULL	J_Biol_Eng_2009_Aug_24_3_13.nxml.txt.nlp	19703305	SENT285	39	39	31	31	ethanol	PES	PA448073	23481	0.748
NULL	J_Immunol_Res_2014_Jul_13_2014_964069.nxml.txt.nlp	25126586	SENT139	14	14	23	23	anakinra	IL36RN	PA10799	26525	0.748
NULL	Front_Behav_Neurosci_2014_Oct_30_8_366.nxml.txt.nlp	25400560	SENT318	2	2	13	13	ceftriaxone	GLT-1	PA448866	6506	0.748
NULL	EMBO_Mol_Med_2012_Jun_13_4(6)_515-527.nxml.txt.nlp	22416035	SENT238	4	4	25	25	olaparib	GADD45		1647	0.748
NULL	Breast_Cancer_Res_Treat_2009_Jul_22_116(2)_371-378.nxml.txt.nlp	18941892	SENT147	21	21	13	13	tamoxifen	aromatase	PA451581	1588	0.748
NULL	BMB_Rep_2013_Nov_46(11)_544-549.nxml.txt.nlp	24152910	SENT103	16	16	14	14	thrombin	PAR-1	PA451674	2011;2149	0.748
NULL	Acta_Pharmacol_Sin_2009_Jun_5_30(6)_859-867.nxml.txt.nlp	19498425	SENT75	13	13	3	3	carbachol	CA1	PA448784	759	0.748
NULL	Br_J_Cancer_1985_Jul_52(1)_7-13.nxml.txt.nlp	3893507	SENT0	15	15	17	17	carboplatin	JM8	PA448803	778	0.748
NULL	Int_J_Mol_Sci_2014_Oct_23_15(10)_19265-19280.nxml.txt.nlp	25342321	SENT132	19	19	4	4	sc-560	MVD		4597	0.748
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Jun_7_64(Pt_7)_o1181.nxml.txt.nlp	21202824	SENT70	33	33	7	7	ethanol	mol	PA448073	90527	0.748
NULL	Biomed_Res_Int_2014_Jan_2_2014_126586.nxml.txt.nlp	24527434	SENT124	1	1	21	21	metformin	HER2	PA450395	2064	0.748
NULL	Eur_J_Clin_Pharmacol_2014_Oct_8_70(12)_1433-1441.nxml.txt.nlp	25291992	SENT165	29	29	12	12	risperidone	B12	PA451257	7126;4709	0.748
NULL	Nat_Med_2011_Jun_26_17(7)_875-882.nxml.txt.nlp	21706030	SENT226	28	28	5	5	doxycycline	BRCA1	PA449415	672	0.748
NULL	Breast_Cancer_Res_2011_Mar_11_13(2)_R29.nxml.txt.nlp	21396094	SENT156	35	35	8	8	fulvestrant	HRG	PA164747170	3084;3273	0.748
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT106	3	3	38	38	methotrexate	MSH2	PA450428	4436	0.748
NULL	Stroke_Res_Treat_2009_Dec_20_2010_386389.nxml.txt.nlp	20700422	SENT157	7	7	11	11	resveratrol	NAC		22861	0.748
NULL	Biomed_Res_Int_2013_Jul_31_2013_692071.nxml.txt.nlp	23984399	SENT170	13	13	37	37	tropisetron	CYP2D6	PA161925594	1565	0.748
NULL	Indian_J_Pharm_Sci_2009_Nov-Dec_71(6)_622-629.nxml.txt.nlp	20376214	SENT76	0	0	20	20	captopril	B10	PA448780	5169	0.748
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2675-2684.nxml.txt.nlp	24129246	SENT197	24	24	16	16	etoposide	KSR1	PA449552	8844	0.748
NULL	Biologics_2014_Dec_4_8_281-291.nxml.txt.nlp	25506209	SENT115	20	20	23	23	vemurafenib	BRAF	PA165946873	673	0.748
NULL	Acta_Pharmacol_Sin_2011_Oct_12_32(10)_1259-1265.nxml.txt.nlp	21909126	SENT133	7	7	12	12	losartan	p38	PA450268	10598;1432;7965	0.747
NULL	Cancer_Cell_Int_2011_Aug_19_11_29.nxml.txt.nlp	21854619	SENT8	25	25	18	18	cisplatin	BRCA1	PA449014	672	0.747
NULL	EPMA_J_2011_Jun_1_2(2)_231-239.nxml.txt.nlp	23199151	SENT31	11	11	25	25	trifluoperazine	UGT	PA451771	7361;7355	0.747
NULL	J_Gen_Physiol_2010_Jul_136(1)_117.nxml.txt.nlp	NULL	SENT228	15	15	17	17	trimethoprim	TMP	PA451788	2012	0.747
NULL	Cancer_Cell_Int_2009_Sep_10_9_25.nxml.txt.nlp	19744341	SENT163	4	4	7	7	glucosamine	STAT3	PA164747613	6774	0.747
NULL	Br_J_Pharmacol_2014_Sep_28_171(18)_4255-4272.nxml.txt.nlp	24846338	SENT22	21	21	12	12	escitalopram	5-HT1D	PA10074	3352	0.747
NULL	Br_J_Pharmacol_2010_Feb_159(4)_772-786.nxml.txt.nlp	20105183	SENT42	24	24	11	11	l-glutamine	F12	PA10090	2161	0.747
NULL	Br_J_Cancer_2013_Aug_6_109(3)_686-693.nxml.txt.nlp	23839492	SENT143	16	16	28	28	everolimus	HIF-1	PA164746311	29072	0.747
NULL	Diabetologia_2010_Jul_2_53(7)_1270-1287.nxml.txt.nlp	20361178	SENT244	26	26	40	40	rosiglitazone	NEFA	PA451283	4925	0.747
NULL	J_Exp_Clin_Cancer_Res_2009_Nov_24_28(1)_144.nxml.txt.nlp	19930704	SENT121	47	47	18	18	melphalan	P-gp	PA450354	5243	0.747
NULL	Psychol_Res_Behav_Manag_2010_Oct_19_3_91-108.nxml.txt.nlp	22110333	SENT246	3	3	6	6	cyproheptadine	Gen	PA164749366	348654	0.747
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1137-1144.nxml.txt.nlp	20234366	SENT35	23	23	16	16	panitumumab	KRAS	PA162373091	3845	0.747
NULL	Mol_Cancer_2012_Apr_26_11_24.nxml.txt.nlp	22537161	SENT222	34	34	8	8	pp2	IFN		3439	0.747
NULL	Mediators_Inflamm_2011_Jun_7_2011_432080.nxml.txt.nlp	21772662	SENT110	14	14	24	24	rivaroxaban	IFN	PA165958360	3439	0.747
NULL	EPMA_J_2013_Jan_28_4(1)_3.nxml.txt.nlp	23356214	SENT360	7	7	19	19	cetuximab	KRAS	PA10040	3845	0.747
NULL	Mol_Cancer_2009_Dec_3_8_115.nxml.txt.nlp	19958544	SENT37	18	18	6	6	nutlin-3	MDM2		4193	0.747
NULL	Int_J_Mol_Sci_2014_Sep_5_15(9)_15754-15765.nxml.txt.nlp	25198898	SENT103	6	6	13	13	curcumin	JNK	PA151958596	5599	0.747
NULL	Nucleic_Acids_Res_2013_Dec_4_41(22)_10124-10134.nxml.txt.nlp	24005039	SENT120	42	42	23	23	ethanol	CYC1	PA448073	1537	0.747
NULL	Mucosal_Immunol_2014_Jan_22_7(1)_10_1038_mi_2013_32.nxml.txt.nlp	23695512	SENT12	2	2	22	22	dextran	CD100	PA449261	10507	0.747
NULL	Pain_Res_Treat_2011_Dec_12_2011_507029.nxml.txt.nlp	22220274	SENT178	15	15	17	17	ceftriaxone	CTX	PA448866	1593	0.747
NULL	J_Mol_Signal_2009_May_14_4_3.nxml.txt.nlp	19442290	SENT177	16	16	13	13	genistein	BRCA2	PA165109660	675	0.747
NULL	Cancers_(Basel)_2014_Nov_14_6(4)_2275-2295.nxml.txt.nlp	25405526	SENT201	19	19	25	25	doxorubicin	CHOP	PA449412	1649	0.747
NULL	Breast_Cancer_Res_2008_Mar_27_10(2)_R27.nxml.txt.nlp	18371219	SENT41	37	37	30	30	epirubicin	TFEC	PA449476	22797	0.747
NULL	Br_J_Cancer_2010_Jan_5_102(1)_115-123.nxml.txt.nlp	19997099	SENT215	17	17	19	19	gemcitabine	GEM	PA449748	2669	0.747
NULL	Nat_Genet_2013_May_31_45(5)_531-536.nxml.txt.nlp	23542698	SENT79	15	15	8	8	eculizumab	HUS	PA164776637	3075	0.747
NULL	Mol_Pain_2014_Aug_15_10_53.nxml.txt.nlp	25127716	SENT145	21	21	7	7	paclitaxel	CCL3	PA450761	6348	0.747
NULL	Adv_Biomed_Res_2014_Aug_19_3_173.nxml.txt.nlp	25250287	SENT107	5	5	11	11	glucose	STZ	PA449773	6484	0.747
NULL	Acta_Pharmacol_Sin_2014_Aug_7_35(8)_1023-1030.nxml.txt.nlp	24998255	SENT170	29	29	6	6	octreotide	E14	PA450678	4863	0.747
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT116	0	0	17	17	cisplatin	p53	PA449014	7157	0.747
NULL	Curr_Med_Chem_2014_Feb_21_1129-1145.nxml.txt.nlp	24304271	SENT501	7	7	9	9	raloxifene	STAR	PA451221	6770;2984	0.747
NULL	J_Biol_Chem_2013_Jun_28_288(26)_18789-18802.nxml.txt.nlp	23625922	SENT329	23	23	10	10	thrombin	C5a	PA451674	727	0.747
NULL	J_Hematol_Oncol_2013_Jul_9_6_49.nxml.txt.nlp	23837843	SENT226	4	4	17	17	verapamil	Rho	PA451868	29984	0.747
NULL	Eur_J_Clin_Pharmacol_2012_Jan_8_68(1)_29-37.nxml.txt.nlp	21739267	SENT197	3	3	6	6	itraconazole	CYP2D6	PA450132	1565	0.747
NULL	Acta_Pharmacol_Sin_2009_Jul_22_30(7)_956-964.nxml.txt.nlp	19543298	SENT172	24	24	6	6	ezetimibe	ABCC2	PA10816	1244	0.747
NULL	Core_Evid_2007_Nov_30_2(2)_121-129.nxml.txt.nlp	21221180	SENT146	8	8	6	6	rituximab	CHOP	PA451261	1649	0.747
NULL	Int_J_Vasc_Med_2012_Feb_14_2012_569654.nxml.txt.nlp	22489274	SENT221	20	20	23	23	glucosamine	GFAT	PA164747613	2673	0.747
NULL	Br_J_Cancer_2011_Jul_26_105(3)_372-381.nxml.txt.nlp	21730979	SENT240	20	20	6	6	hydroxyurea	ATR	PA449942	390502;84168;545	0.747
NULL	Cell_Tissue_Res_2012_Sep_10_349(3)_635-647.nxml.txt.nlp	22322423	SENT200	3	3	10	10	diethylstilbestrol	P21	PA449307	1026;9338	0.747
NULL	Curr_Clin_Pharmacol_2011_Feb_7(1)_56-65.nxml.txt.nlp	22299770	SENT29	20	20	6	6	panitumumab	KRAS	PA162373091	3845	0.747
NULL	J_Cardiothorac_Surg_2013_Apr_4_8_64.nxml.txt.nlp	23557242	SENT29	0	0	8	8	montelukast	CysLT1	PA450546	10800	0.747
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT121	24	24	0	0	resveratrol	IL-6		3569	0.747
NULL	J_Biol_Chem_2008_Nov_7_283(45)_31005-31011.nxml.txt.nlp	18765663	SENT211	12	12	24	24	baclofen	CA1	PA448533	759	0.747
NULL	J_Neurophysiol_2013_May_1_109(9)_2393-2403.nxml.txt.nlp	23427303	SENT232	17	17	22	22	capsaicin	TRPV1	PA448776	7442	0.747
NULL	Allergy_Asthma_Clin_Immunol_2005_Sep_15_1(3)_101-116.nxml.txt.nlp	20529221	SENT413	0	0	17	17	l-arginine	IFN	PA448478	3439	0.747
NULL	Cell_Death_Dis_2014_Jul_17_5(7)_e1324.nxml.txt.nlp	25032847	SENT87	18	18	3	3	doxycycline	HAND1	PA449415	9421	0.747
NULL	AIDS_Res_Ther_2011_Oct_6_8_36.nxml.txt.nlp	21978457	SENT11	23	23	13	13	zinc	ZIP1	PA451956	27173	0.747
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S31-S40.nxml.txt.nlp	20680106	SENT191	14	14	5	5	irinotecan	EGFR	PA450085	1956	0.747
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT203	24	24	13	13	dasatinib	LYN	PA162372878	4067	0.747
NULL	J_Cell_Mol_Med_2014_Sep_3_18(9)_1840-1850.nxml.txt.nlp	24894955	SENT244	5	5	12	12	ethanol	TFR1	PA448073	7037	0.747
NULL	Int_J_Alzheimers_Dis_2012_Dec_3_2012_509529.nxml.txt.nlp	23251824	SENT82	6	6	22	22	resveratrol	SIRT1		23411	0.747
NULL	Indian_J_Pharmacol_2013_Nov-Dec_45(6)_597-602.nxml.txt.nlp	24347768	SENT130	21	21	26	26	doxorubicin	P-gp	PA449412	5243	0.747
NULL	Aging_(Albany_NY)_2014_Jan_14_6(1)_70-81.nxml.txt.nlp	24429382	SENT102	0	0	2	2	bleomycin	WRN	PA448645	7486	0.747
NULL	Colorectal_Dis_2012_Feb_14(2)_e31-e47.nxml.txt.nlp	21848897	SENT121	13	13	27	27	panitumumab	KRAS	PA162373091	3845	0.747
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT1545	2	2	16	16	paclitaxel	MDR1	PA450761	5243	0.747
NULL	Ecancermedicalscience_2008_Feb_18_2_75.nxml.txt.nlp	22275966	SENT152	17	17	29	29	oxaliplatin	ERCC1	PA131285527	2067	0.747
NULL	Cancer_Res_Treat_2013_Sep_30_45(3)_172-177.nxml.txt.nlp	24155675	SENT34	18	18	20	20	aprepitant	NK-1	PA164747039	27087	0.747
NULL	Hum_Genomics_2010_Apr_1_4(4)_238-249.nxml.txt.nlp	20511137	SENT37	11	11	6	6	sn-38	UGT1A1		54658	0.747
NULL	Acta_Pharmacol_Sin_2012_May_4_33(5)_710-716.nxml.txt.nlp	22555373	SENT13	8	8	18	18	diazepam	DOM	PA449283	6663	0.747
NULL	J_Res_Pharm_Pract_2013_Oct-Dec_2(4)_156-161.nxml.txt.nlp	24991625	SENT126	29	29	24	24	imatinib	IFN	PA10804	3439	0.747
NULL	Oncoimmunology_2012_Oct_1_1(7)_1004-1016.nxml.txt.nlp	23170249	SENT233	25	25	17	17	paclitaxel	HER-2	PA450761	2064	0.747
NULL	Curr_HIV_Res_2014_May_12(3)_174-188.nxml.txt.nlp	24862327	SENT148	25	25	18	18	hemin	HO-1	PA449849	3162	0.747
NULL	Cent_European_J_Urol_2012_Dec_11_65(4)_227-229.nxml.txt.nlp	24578969	SENT31	32	32	34	34	gemcitabine	IFN	PA449748	3439	0.747
NULL	Int_J_Environ_Res_Public_Health_2010_Dec_21_7(12)_4281-4304.nxml.txt.nlp	21318009	SENT158	1	1	13	13	ethanol	spatial	PA448073	219793	0.747
NULL	Breast_Cancer_Res_2007_Jul_5_9(4)_R41.nxml.txt.nlp	17612393	SENT136	16	16	37	37	celecoxib	PARP	PA448871	142	0.747
NULL	J_Cell_Mol_Med_2014_Mar_22_18(3)_480-491.nxml.txt.nlp	24450440	SENT62	41	41	9	9	bevacizumab	EDD	PA130232992	51366	0.747
NULL	Nat_Methods_2011_Jun_24_8(6)_487-493.nxml.txt.nlp	21516115	SENT70	17	17	6	6	gefitinib	EGF	PA131301952	1950	0.747
NULL	Br_J_Cancer_2006_Dec_4_95(11)_1483-1489.nxml.txt.nlp	17106442	SENT81	8	8	20	20	gefitinib	EGFR	PA131301952	1956	0.747
NULL	Case_Rep_Dermatol_2012_Mar_17_4(1)_56-60.nxml.txt.nlp	22548037	SENT67	29	29	27	27	methotrexate	CHOP	PA450428	1649	0.747
NULL	Cancers_(Basel)_2010_May_26_2(2)_955-969.nxml.txt.nlp	24281101	SENT1100	6	6	20	20	imatinib	KIT	PA10804	3815	0.747
NULL	Oncotarget_2014_Sep_2_5(19)_9308-9321.nxml.txt.nlp	25301721	SENT73	7	7	2	2	rolipram	MRP4	PA153906323	10257	0.747
NULL	Br_J_Cancer_2009_Nov_3_101(9)_1620-1629.nxml.txt.nlp	19809428	SENT9	0	0	4	4	geldanamycin	PC3	PA152031327	57332;7832;5122	0.747
NULL	EMBO_Mol_Med_2013_Apr_25_5(4)_531-547.nxml.txt.nlp	23526793	SENT304	29	29	18	18	rosiglitazone	EZH2	PA451283	2146	0.747
NULL	Cancer_Res_Treat_2011_Mar_31_43(1)_19-23.nxml.txt.nlp	21509159	SENT41	27	27	30	30	paclitaxel	castor	PA450761	54897	0.747
NULL	Daru_2012_Dec_26_20(1)_100.nxml.txt.nlp	23351304	SENT20	12	12	25	25	staurosporine	PP1	PA165109623	5540;5464	0.747
NULL	Indian_J_Pharmacol_2008_Feb_40(Suppl1)_S1-S2.nxml.txt.nlp	21369404	SENT27	31	31	17	17	aprotinin	BART	PA448472	7809;23568	0.747
NULL	Breast_Cancer_Res_2011_Apr_14_13(2)_R43.nxml.txt.nlp	21492444	SENT152	6	6	18	18	tamoxifen	HER2	PA451581	2064	0.747
NULL	Thorax_2011_Dec_23_66(12)_1029-1035.nxml.txt.nlp	21606476	SENT97	32	32	14	14	papaverine	EP4	PA164745550	5734	0.747
NULL	Bone_Marrow_Res_2011_Mar_2_2011_924058.nxml.txt.nlp	22046572	SENT44	9	9	31	31	rituximab	CD16	PA451261	2215;2214	0.747
NULL	Cancer_Cell_Int_2013_Jun_26_13_63.nxml.txt.nlp	23800022	SENT114	0	0	10	10	genistein	XIAP	PA165109660	331	0.747
NULL	Breast_Cancer_Res_2001_Oct_11_3(6)_380-384.nxml.txt.nlp	11737889	SENT142	8	8	21	21	trastuzumab	HER2	PA451743	2064	0.747
NULL	Int_J_Nanomedicine_2012_Oct_25_7_5565-5575.nxml.txt.nlp	23118538	SENT138	28	28	31	31	fenofibrate	CO2	PA449594	4513	0.747
NULL	J_Mol_Signal_2010_Jul_1_5_7.nxml.txt.nlp	20594350	SENT21	23	23	2	2	etoposide	CCAR1	PA449552	55749	0.747
NULL	Cell_Death_Dis_2012_Jun_21_3(6)_e327.nxml.txt.nlp	22717582	SENT75	7	7	18	18	etoposide	p53	PA449552	7157	0.747
NULL	Acta_Physiol_(Oxf)_2008_Apr_192(4)_505-517.nxml.txt.nlp	17973950	SENT248	13	13	27	27	propranolol	LQT3	PA451145	6331	0.747
NULL	Community_Ment_Health_J_2011_Apr_25_47(2)_123-135.nxml.txt.nlp	20658320	SENT366	20	20	3	3	olanzapine	CAGE	PA450688	168400	0.747
NULL	Oncoimmunology_2013_Dec_1_2(12)_e26689.nxml.txt.nlp	24527364	SENT22	13	13	2	2	lapatinib	STAT1	PA152241907	6772	0.747
NULL	Front_Pharmacol_2014_May_8_5_85.nxml.txt.nlp	24847263	SENT153	12	12	19	19	resveratrol	STEP		84867	0.747
NULL	Breast_Cancer_Res_2005_May_27_7(Suppl_1)_P13.nxml.txt.nlp	NULL	SENT14	13	13	6	6	vinorelbine	Raf-1	PA451881	5894	0.747
NULL	Clinics_(Sao_Paulo)_2014_Jan_69(1)_68-74.nxml.txt.nlp	24473562	SENT99	38	38	30	30	nutlin-3	SOCS-1		8651	0.747
NULL	CNS_Drugs_2013_Aug_20_27(12)_1081-1092.nxml.txt.nlp	23959815	SENT30	9	9	11	11	atomoxetine	ATX	PA134688071	5168;23049	0.747
NULL	Endocrinology_2014_Oct_22_155(10)_3732-3738.nxml.txt.nlp	25051442	SENT71	11	11	2	2	sibutramine	POMC	PA451344	5443	0.747
NULL	Daru_2011_19(5)_322-325.nxml.txt.nlp	22615676	SENT7	13	13	24	24	telmisartan	STZ	PA451605	6484	0.747
NULL	Biologics_2010_May_25_4_131-138.nxml.txt.nlp	20531965	SENT181	8	8	19	19	anakinra	NALP3	PA10799	114548	0.747
NULL	Br_J_Cancer_2011_Aug_23_105(5)_658-665.nxml.txt.nlp	21829201	SENT7	14	14	16	16	capecitabine	DCX	PA448771	1641	0.747
NULL	Br_J_Cancer_2010_Jan_5_102(1)_80-86.nxml.txt.nlp	19920817	SENT69	9	9	13	13	sunitinib	IFN	PA162372840	3439	0.747
NULL	Drugs_R_D_2014_Sep_28_14(3)_159-164.nxml.txt.nlp	24973042	SENT47	37	37	39	39	rosiglitazone	CYP2C8	PA451283	1558	0.747
NULL	Indian_J_Endocrinol_Metab_2013_Jan-Feb_17(1)_91-94.nxml.txt.nlp	23776858	SENT31	10	10	16	16	saxagliptin	GLP-1	PA165958362	100125288	0.747
NULL	J_Korean_Med_Sci_2009_Oct_23_24(5)_941-944.nxml.txt.nlp	19794996	SENT74	5	5	7	7	ethanol	CYP2E1	PA448073	1571	0.747
NULL	Protein_Cell_2014_Jun_19_5(6)_469-479.nxml.txt.nlp	24748116	SENT83	5	5	0	0	paclitaxel	EB1	PA450761	9167;22919;10982	0.747
NULL	Indian_J_Pharmacol_2014_Jan-Feb_46(1)_3-12.nxml.txt.nlp	24550577	SENT222	28	28	16	16	clarithromycin	P-gp	PA449028	5243	0.747
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Jun_7_64(Pt_7)_o1181.nxml.txt.nlp	21202824	SENT70	33	33	26	26	ethanol	mol	PA448073	90527	0.747
NULL	Vet_Res_2013_Jan_11_44(1)_2.nxml.txt.nlp	23311865	SENT71	16	16	34	34	vancomycin	CO2	PA451850	4513	0.747
NULL	Oncol_Rep_2013_Jun_22_29(6)_2479-2485.nxml.txt.nlp	23525656	SENT8	20	20	17	17	paclitaxel	MRP7	PA450761	89845;1080	0.747
NULL	Hum_Mol_Genet_2013_Jul_1_22(13)_2676-2688.nxml.txt.nlp	23474818	SENT110	38	38	21	21	arsenite	FUS	PA452638	2521	0.747
NULL	Front_Behav_Neurosci_2009_Jun_29_3_10.nxml.txt.nlp	19587848	SENT157	21	21	23	23	estradiol	DES	PA449503	1674	0.747
NULL	Cell_Death_Dis_2010_Nov_18_1(11)_e102.nxml.txt.nlp	21368867	SENT117	1	1	7	7	gentamicin	14-3-3	PA449753	10971	0.747
NULL	J_Gen_Physiol_1996_Jun_1_107(6)_743-754.nxml.txt.nlp	8783074	SENT0	15	15	1	1	lidocaine	Gen	PA450226	348654	0.747
NULL	Curr_Osteoporos_Rep_2010_Dec_1_8(4)_178-184.nxml.txt.nlp	20809203	SENT221	9	9	24	24	liraglutide	Met	PA165958364	79811	0.747
NULL	Clin_Exp_Gastroenterol_2012_Jul_19_5_139-150.nxml.txt.nlp	22888267	SENT188	10	10	4	4	indomethacin	I-FABP	PA449982	2169	0.747
NULL	Cell_Death_Dis_2010_Jan_21_1(1)_e16.nxml.txt.nlp	21364617	SENT66	11	11	5	5	cisplatin	p63	PA449014	8626	0.747
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT289	11	11	8	8	chloroquine	BMPR-II	PA448948	659	0.747
NULL	Mol_Biol_Rep_2012_May_20_39(5)_5253-5267.nxml.txt.nlp	22183301	SENT154	20	20	18	18	gliclazide	NAC	PA10892	22861	0.747
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R91.nxml.txt.nlp	22541814	SENT168	5	5	24	24	thrombin	HO-1	PA451674	3162	0.747
NULL	Cancers_(Basel)_2011_Aug_5_3(3)_3114-3142.nxml.txt.nlp	24212948	SENT746	25	25	4	4	cyclophosphamide	CD25	PA449165	3669;3559	0.747
NULL	Aging_(Albany_NY)_2009_Jun_3_1(6)_515-528.nxml.txt.nlp	20157535	SENT123	0	0	9	9	resveratrol	S6K1		6198	0.747
NULL	Pharmaceuticals_(Basel)_2012_Aug_17_5(8)_837-852.nxml.txt.nlp	24280677	SENT610	5	5	3	3	capsaicin	TRPV1	PA448776	7442	0.747
NULL	J_Gen_Physiol_1976_Jul_1_68(1)_43-63.nxml.txt.nlp	7635	SENT0	11	11	1	1	amiloride	Gen	PA448368	348654	0.747
NULL	Clin_Ophthalmol_2008_Dec_2(4)_897-905.nxml.txt.nlp	19668444	SENT130	3	3	12	12	latanoprost	BAK	PA164774763	578	0.747
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_13_2014_849783.nxml.txt.nlp	25477998	SENT132	7	7	16	16	isoproterenol	HMGB1	PA450121	3146	0.747
NULL	Drug_Des_Devel_Ther_2014_Sep_30_8_1695-1708.nxml.txt.nlp	25328384	SENT168	26	26	31	31	tacrolimus	H-FABP	PA451578	2170	0.747
NULL	Korean_J_Radiol_2011_Apr_25_May-Jun_12(3)_319-326.nxml.txt.nlp	21603291	SENT13	16	16	9	9	propranolol	DBP	PA451145	3295;1628;2638	0.747
NULL	Comp_Hepatol_2004_Jan_14_3(Suppl_1)_S37.nxml.txt.nlp	14960189	SENT81	2	2	9	9	thalidomide	TNF-alpha	PA451644	7124	0.747
NULL	Mol_Biol_Cell_2012_Mar_15_23(6)_996-1009.nxml.txt.nlp	22278744	SENT114	5	5	10	10	forskolin	14-3-3	PA146096022	10971	0.747
NULL	J_Anaesthesiol_Clin_Pharmacol_2011_Oct-Dec_27(4)_516-521.nxml.txt.nlp	22096287	SENT109	14	14	7	7	papaverine	SGB	PA164745550	2719	0.747
NULL	J_Ophthalmol_2010_Jun_22_2010_170393.nxml.txt.nlp	20652047	SENT138	0	0	5	5	telmisartan	RAGE	PA451605	177	0.747
NULL	Oncotarget_2012_Aug_10_3(8)_744-758.nxml.txt.nlp	22889873	SENT237	34	34	32	32	cetuximab	EGFR	PA10040	1956	0.747
NULL	Diabetes_Care_2010_Apr_19_33(4)_914-919.nxml.txt.nlp	20086255	SENT118	8	8	13	13	ramipril	DREAM	PA451223	30818	0.747
NULL	Nat_Med_2010_Jun_23_16(6)_671-677.nxml.txt.nlp	20495567	SENT65	21	21	6	6	sorafenib	ATF5	PA7000	22809	0.747
NULL	Cancer_Cell_Int_2011_Nov_17_11_40.nxml.txt.nlp	22088142	SENT88	0	0	9	9	gemcitabine	MRP2	PA449748	100130958;57626;1244	0.747
NULL	Environ_Health_Perspect_2009_Feb_8_117(2)_175-180.nxml.txt.nlp	19270784	SENT114	23	23	13	13	doxorubicin	BPA	PA449412	667	0.747
NULL	Breast_Cancer_(Auckl)_2009_Sep_2_3_61-75.nxml.txt.nlp	19809577	SENT245	3	3	13	13	curcumin	BRCA1	PA151958596	672	0.747
NULL	Exp_Ther_Med_2015_Feb_16_9(2)_405-410.nxml.txt.nlp	25574206	SENT126	5	5	14	14	l-carnitine	LPO	PA450154	4025	0.747
NULL	Case_Rep_Gastroenterol_2007_Dec_31_1(1)_174-177.nxml.txt.nlp	21487565	SENT31	11	11	22	22	sn-38	UGT1A1		54658	0.747
NULL	Onco_Targets_Ther_2014_Sep_9_7_1571-1582.nxml.txt.nlp	25228815	SENT157	10	10	8	8	sunitinib	VEGFR2	PA162372840	3791	0.747
NULL	Evid_Based_Complement_Alternat_Med_2013_Mar_14_2013_247145.nxml.txt.nlp	23573120	SENT136	9	9	5	5	celecoxib	COX	PA448871	1351	0.747
NULL	Behav_Brain_Funct_2005_Jul_15_1_9.nxml.txt.nlp	16022733	SENT254	22	22	15	15	methylphenidate	spatial	PA450464	219793	0.747
NULL	Hum_Genomics_2008_Sep_1_3(1)_7-16.nxml.txt.nlp	19129086	SENT3	26	26	11	11	rosiglitazone	SLCO1B1	PA451283	10599	0.747
NULL	Eur_J_Nucl_Med_Mol_Imaging_2008_Jul_19_35(7)_1350-1356.nxml.txt.nlp	18283451	SENT127	10	10	4	4	alpha-methyl-para-tyrosine	PRL	PA147358765	5617	0.747
NULL	J_Biol_Chem_2009_Apr_24_284(17)_11572-11578.nxml.txt.nlp	19244244	SENT105	20	20	9	9	lipase	CGI-58	PA450239	51099	0.747
NULL	Clin_Ophthalmol_2007_Sep_1(3)_273-284.nxml.txt.nlp	19668481	SENT196	16	16	5	5	bevacizumab	CRT	PA130232992	811	0.747
NULL	Acta_Pharmacol_Sin_2013_Jan_17_34(1)_157-166.nxml.txt.nlp	23247593	SENT105	2	2	8	8	berberine	IL-6	PA165860812	3569	0.747
NULL	Diabetes_Care_2008_Oct_31(10)_1939-1944.nxml.txt.nlp	18599530	SENT175	41	41	31	31	metformin	OCT1	PA450395	5451;6580	0.747
NULL	Clin_Interv_Aging_2014_Aug_28_9_1437-1452.nxml.txt.nlp	25210448	SENT60	6	6	0	0	tamoxifen	SRC1	PA451581	8648	0.747
NULL	Gut_2011_Sep_8_60(9)_1284-1293.nxml.txt.nlp	21303914	SENT233	21	21	10	10	ribavirin	IL28B	PA451241	282617	0.747
NULL	Nat_Med_2011_Aug_28_17(9)_1094-1100.nxml.txt.nlp	21873989	SENT25	1	1	11	11	imatinib	IL-4	PA10804	3565	0.747
NULL	Diabetes_Care_2013_Jul_12_36(7)_2126-2132.nxml.txt.nlp	23645884	SENT175	39	39	37	37	liraglutide	GLP-1	PA165958364	100125288	0.747
NULL	Br_J_Cancer_1981_Mar_43(3)_384-391.nxml.txt.nlp	6164381	SENT4	16	16	23	23	bleomycin	ADM	PA448645	133	0.747
NULL	J_Adv_Pract_Oncol_2014_May_1_May-Jun_5(3)_205-210.nxml.txt.nlp	25089219	SENT118	11	11	20	20	capecitabine	DPD	PA448771	1806	0.747
NULL	CNS_Drugs_2014_Apr_11_28(6)_535-558.nxml.txt.nlp	24723124	SENT195	6	6	8	8	alemtuzumab	IFN	PA164783958	3439	0.747
NULL	Oncoscience_2014_Oct_22_1(10)_614-623.nxml.txt.nlp	25593991	SENT132	13	13	16	16	carboplatin	p53	PA448803	7157	0.747
NULL	J_Thromb_Haemost_2007_May_1_5(5)_910-917.nxml.txt.nlp	17362227	SENT124	24	24	29	29	thrombin	P2X1	PA451674	5023	0.747
NULL	Oncol_Lett_2013_Feb_7_5(2)_440-446.nxml.txt.nlp	23420122	SENT136	46	46	9	9	gemcitabine	EGFR	PA449748	1956	0.747
NULL	Oncotarget_2013_Nov_23_5(1)_196-210.nxml.txt.nlp	24344116	SENT12	10	10	4	4	doxorubicin	p53	PA449412	7157	0.747
NULL	Ther_Clin_Risk_Manag_2006_Mar_2(1)_87-98.nxml.txt.nlp	18360584	SENT212	5	5	9	9	sorafenib	IFN	PA7000	3439	0.747
NULL	Biomed_Res_Int_2014_Jun_25_2014_764981.nxml.txt.nlp	25057499	SENT159	12	12	23	23	crizotinib	Met	PA165946122	79811	0.747
NULL	Oncotarget_2014_Mar_16_5(12)_4087-4102.nxml.txt.nlp	24961479	SENT69	5	5	3	3	hemin	HO-1	PA449849	3162	0.747
NULL	Core_Evid_2009_Jun_15_4_67-82.nxml.txt.nlp	20694066	SENT433	4	4	11	11	citalopram	STAR	PA449015	6770;2984	0.747
NULL	F1000Res_2013_Jul_9_2_150.nxml.txt.nlp	24627787	SENT61	4	4	11	11	olanzapine	DIP	PA450688	23151;1831	0.747
NULL	Clin_Interv_Aging_2009_May_14_4_121-136.nxml.txt.nlp	19503775	SENT375	24	24	26	26	raloxifene	STAR	PA451221	6770;2984	0.747
NULL	Asia_Pac_Allergy_2014_Jan_31_4(1)_14-18.nxml.txt.nlp	24527405	SENT57	0	0	27	27	iloprost	IP-10	PA164746843	3627	0.747
NULL	J_Radiat_Res_2012_Jul_5_53(4)_620-627.nxml.txt.nlp	22843629	SENT51	14	14	6	6	hydrocortisone	F12	PA449905	2161	0.747
NULL	Carcinogenesis_2010_Dec_27_31(12)_2049-2057.nxml.txt.nlp	20876285	SENT235	8	8	30	30	tamoxifen	HER2	PA451581	2064	0.747
NULL	Oncogene_2009_Feb_5_28(5)_625-637.nxml.txt.nlp	19015636	SENT49	14	14	18	18	methotrexate	GLI2	PA450428	2736	0.747
NULL	Ann_N_Y_Acad_Sci_2012_Aug_17_1264(1)_87-102.nxml.txt.nlp	22804097	SENT327	20	20	29	29	metformin	HSD1	PA450395	26871	0.747
NULL	Biologics_2013_Apr_15_7_77-90.nxml.txt.nlp	23723688	SENT107	5	5	8	8	cetuximab	CRT	PA10040	811	0.747
NULL	Front_Neurosci_2011_Jan_20_5_3.nxml.txt.nlp	21270945	SENT123	7	7	31	31	ethanol	ANOVA	PA448073	4858	0.747
NULL	EMBO_Mol_Med_2012_Jul_11_4(7)_577-593.nxml.txt.nlp	22496117	SENT67	27	27	25	25	clofazimine	PAP-1	PA164748759	6100	0.747
NULL	Breast_Cancer_(Auckl)_2009_Aug_17_3_47-60.nxml.txt.nlp	21556249	SENT281	24	24	26	26	raloxifene	STAR	PA451221	6770;2984	0.747
NULL	Leukemia_2014_Jun_25_28(6)_1280-1288.nxml.txt.nlp	24270737	SENT202	22	22	5	5	vorinostat	PD-L1	PA164748224	29126	0.747
NULL	Osteoporos_Int_2012_Feb_4_23(Suppl_1)_S1-S23.nxml.txt.nlp	22311111	SENT732	14	14	16	16	raloxifene	STAR	PA451221	6770;2984	0.747
NULL	Cancer_Res_Treat_2014_Jan_15_46(1)_48-54.nxml.txt.nlp	24520223	SENT29	14	14	7	7	cetuximab	EGFR	PA10040	1956	0.747
NULL	Br_J_Haematol_2014_Mar_13_164(1)_811-821.nxml.txt.nlp	24328678	SENT10	11	11	2	2	lenalidomide	Aiolos	PA162363968	22806	0.747
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT85	37	37	32	32	trastuzumab	EGF	PA451743	1950	0.747
NULL	Evid_Based_Complement_Alternat_Med_2012_Feb_12_2012_472897.nxml.txt.nlp	22454667	SENT184	0	0	6	6	cilomilast	PDE4D	PA165948031	5144	0.747
NULL	Br_J_Cancer_2010_Feb_2_102(3)_457-461.nxml.txt.nlp	20010942	SENT60	8	8	14	14	trastuzumab	ERBB2	PA451743	2064	0.747
NULL	Osteoporos_Int_2008_Apr_12_19(4)_399-428.nxml.txt.nlp	18266020	SENT879	25	25	27	27	raloxifene	STAR	PA451221	6770;2984	0.747
NULL	Asian_J_Androl_2014_Jan_17_Mar-Apr_16(2)_274-279.nxml.txt.nlp	24457841	SENT89	35	35	5	5	dutasteride	ARIA	PA164749300	641700	0.747
NULL	Cancer_Cell_Int_2005_Jun_1_5_18.nxml.txt.nlp	15929791	SENT140	5	5	15	15	bortezomib	p27	PA10252	5715;10534	0.747
NULL	Oncogenesis_2014_Dec_15_3(12)_e133.nxml.txt.nlp	25500906	SENT109	20	20	7	7	trastuzumab	HER3	PA451743	2065	0.747
NULL	Mol_Biol_Cell_2012_May_15_23(10)_1812-1825.nxml.txt.nlp	22438585	SENT245	10	10	24	24	dextran	VIII	PA449261	1351	0.747
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1013.nxml.txt.nlp	24457957	SENT92	7	7	19	19	orlistat	NOXA	PA164776864	5366	0.747
NULL	Environ_Health_Perspect_2010_Feb_16_118(2)_265-272.nxml.txt.nlp	20123619	SENT334	4	4	13	13	miconazole	StAR	PA450494	6770	0.747
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_May_14_64(Pt_6)_o1081.nxml.txt.nlp	21202597	SENT57	5	5	21	21	benzaldehyde	mol	PA448571	90527	0.747
NULL	Br_J_Cancer_2012_Jan_3_106(1)_32-38.nxml.txt.nlp	22108523	SENT147	27	27	31	31	trastuzumab	HER2	PA451743	2064	0.747
NULL	Alzheimers_Dement_2014_Nov_10(6)_799-807_e2.nxml.txt.nlp	25012867	SENT330	2	2	6	6	levodopa	RANTES	PA450213	6352	0.747
NULL	Oncotarget_2011_Aug_30_2(8)_610-626.nxml.txt.nlp	21881167	SENT181	26	26	10	10	doxorubicin	PTEN	PA449412	5728	0.747
NULL	Oncogene_2014_Sep_18_33(38)_4685-4696.nxml.txt.nlp	24121268	SENT113	0	0	3	3	bortezomib	p53	PA10252	7157	0.747
NULL	J_Antimicrob_Chemother_2008_Nov_13_62(5)_1086-1093.nxml.txt.nlp	18703526	SENT86	12	12	17	17	cefotaxime	CTX	PA448852	1593	0.747
NULL	Mol_Cancer_2013_May_24_12_47.nxml.txt.nlp	23705854	SENT16	19	19	15	15	celecoxib	P-gp	PA448871	5243	0.747
NULL	Neural_Regen_Res_2014_Mar_15_9(6)_622-629.nxml.txt.nlp	25206865	SENT188	10	10	34	34	vasopressin	c-Jun	PA451858	3725	0.747
NULL	F1000_Med_Rep_2009_Feb_24_1_13.nxml.txt.nlp	20948769	SENT79	19	19	27	27	cyclophosphamide	CHOP	PA449165	1649	0.747
NULL	Mol_Biol_Cell_2013_Jul_15_24(14)_2186-2200.nxml.txt.nlp	23699397	SENT206	9	9	11	11	gefitinib	TRAIL	PA131301952	8743	0.747
NULL	Curr_Clin_Pharmacol_2008_Sep_3(3)_198-203.nxml.txt.nlp	18781906	SENT35	15	15	12	12	oxcarbazepine	CYP3A4	PA450732	1576	0.747
NULL	Arthritis_Rheumatol_2014_Jun_27_66(6)_1574-1582.nxml.txt.nlp	24577881	SENT110	14	14	18	18	hydralazine	CD70	PA449894	970	0.747
NULL	Acta_Pharmacol_Sin_2010_Jul_28_31(7)_867-873.nxml.txt.nlp	20581857	SENT123	11	11	6	6	docetaxel	PDCD4	PA449383	27250	0.747
NULL	Biosci_Rep_2014_Dec_12_34(6)_e00160.nxml.txt.nlp	25495645	SENT95	5	5	25	25	rosiglitazone	ANGPTL3	PA451283	27329	0.747
NULL	Br_J_Cancer_2013_Sep_3_109(5)_1214-1222.nxml.txt.nlp	23922104	SENT17	29	29	35	35	doxorubicin	TP53	PA449412	7157	0.747
NULL	Curr_Clin_Pharmacol_2013_May_8(2)_135-155.nxml.txt.nlp	23062036	SENT361	14	14	12	12	medroxyprogesterone	CEE	PA450344	51608	0.747
NULL	Acta_Pharmacol_Sin_2010_Nov_18_31(11)_1447-1453.nxml.txt.nlp	20953204	SENT110	32	32	16	16	rimonabant	MCP-1	PA152407999	6347	0.747
NULL	Int_J_Biomed_Sci_2006_Dec_2(4)_375-394.nxml.txt.nlp	23675006	SENT55	14	14	23	23	estradiol	PRG	PA449503	5544	0.747
NULL	Core_Evid_2010_Jul_27_5_1-10.nxml.txt.nlp	20694135	SENT123	16	16	4	4	levodopa	CLE	PA450213	51637	0.747
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2011_Sep_13_4_47-62.nxml.txt.nlp	22879794	SENT235	10	10	5	5	liraglutide	PPG	PA165958364	5552	0.747
NULL	J_Biol_Chem_2013_Oct_11_288(41)_29642-29653.nxml.txt.nlp	24005673	SENT935	20	20	11	11	hyaluronan	CD44	PA165958431	960	0.747
NULL	Front_Neurosci_2012_May_30_6_77.nxml.txt.nlp	22661925	SENT313	7	7	4	4	ethanol	HEC	PA448073	10403	0.747
NULL	Breast_Cancer_Res_2010_Jul_19_12(4)_R51.nxml.txt.nlp	20642837	SENT330	5	5	37	37	etoposide	Bcl-2	PA449552	596	0.747
NULL	J_Cell_Mol_Med_2013_Oct_23_17(10)_1207-1217.nxml.txt.nlp	24106980	SENT146	23	23	2	2	paclitaxel	P-gp	PA450761	5243	0.747
NULL	J_Hematol_Oncol_2013_Jul_9_6_49.nxml.txt.nlp	23837843	SENT281	32	32	24	24	cyclosporine	P-gp	PA449167	5243	0.747
NULL	Case_Rep_Ophthalmol_2010_Dec_8_1(2)_110-113.nxml.txt.nlp	21373383	SENT46	15	15	25	25	ranibizumab	PED	PA164746012	8682	0.747
NULL	Biomed_Res_Int_2014_Apr_27_2014_180428.nxml.txt.nlp	24877063	SENT257	2	2	9	9	oxaliplatin	TRPA1	PA131285527	8989	0.747
NULL	Aging_Cell_2009_Apr_8(2)_113-127.nxml.txt.nlp	19239417	SENT234	0	0	12	12	metformin	HER-2	PA450395	2064	0.747
NULL	Diabetes_2008_Sep_57(9)_2272-2279.nxml.txt.nlp	18519799	SENT156	16	16	10	10	rosiglitazone	PDK4	PA451283	5166	0.747
NULL	EMBO_Mol_Med_2012_Jun_21_4(6)_500-514.nxml.txt.nlp	22438244	SENT36	18	18	24	24	cisplatin	TP53	PA449014	7157	0.747
NULL	Diabetes_Care_2009_Oct_32(10)_1941-1943.nxml.txt.nlp	19794006	SENT75	12	12	19	19	pravastatin	adiponectin	PA451089	9370	0.747
NULL	Pain_Res_Treat_2012_Apr_23_2012_295926.nxml.txt.nlp	22577544	SENT26	20	20	25	25	diclofenac	DLD	PA449293	1738	0.747
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Mar_19_67(Pt_4)_o902.nxml.txt.nlp	21754176	SENT68	27	27	12	12	ethanol	mol	PA448073	90527	0.747
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1427-1436.nxml.txt.nlp	24096601	SENT171	1	1	19	19	erlotinib	EGFR	PA134687924	1956	0.747
NULL	Endocrinol_Metab_(Seoul)_2014_Sep_25_29(3)_379-387.nxml.txt.nlp	25309798	SENT119	8	8	24	24	resveratrol	BMAL1		406	0.747
NULL	Oncol_Lett_2014_Nov_14_8(5)_2086-2092.nxml.txt.nlp	25295095	SENT114	18	18	16	16	gemcitabine	LKB1	PA449748	6794	0.747
NULL	Arch_Med_Sci_2013_Jun_20_9(3)_569-575.nxml.txt.nlp	23847684	SENT145	7	7	16	16	etoposide	BCL2L1	PA449552	598	0.747
NULL	Biol_Open_2014_Sep_19_3(10)_958-965.nxml.txt.nlp	25238758	SENT465	13	13	8	8	zinc	SOCS-3	PA451956	9021	0.747
NULL	Oncotarget_2014_Jun_7_5(13)_5017-5028.nxml.txt.nlp	24970809	SENT196	19	19	7	7	docetaxel	GCIP	PA449383	23582	0.747
NULL	Core_Evid_2010_Oct_21_5_61-76.nxml.txt.nlp	21042543	SENT378	16	16	3	3	cetuximab	KRAS	PA10040	3845	0.747
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT375	5	5	9	9	cisplatin	PTEN	PA449014	5728	0.747
NULL	Arch_Med_Sci_2014_Feb_24_10(1)_1-9.nxml.txt.nlp	24701207	SENT20	22	22	15	15	cetuximab	EGFR	PA10040	1956	0.747
NULL	Clinics_(Sao_Paulo)_2011_Aug_66(8)_1457-1462.nxml.txt.nlp	21915500	SENT97	44	44	33	33	rosuvastatin	AST	PA134308647	26503	0.747
NULL	Breast_Cancer_Res_2011_Jun_9_13(3)_R57.nxml.txt.nlp	21658222	SENT105	11	11	22	22	epirubicin	UGT	PA449476	7361;7355	0.747
NULL	Clin_Med_Insights_Oncol_2012_Feb_28_6_125-135.nxml.txt.nlp	22408376	SENT161	15	15	9	9	panitumumab	KRAS	PA162373091	3845	0.747
NULL	Acta_Pharmacol_Sin_2010_Oct_27_31(10)_1389-1394.nxml.txt.nlp	20871620	SENT144	4	4	11	11	carbachol	JNK	PA448784	5599	0.747
NULL	Br_J_Cancer_2010_Oct_12_103(8)_1284-1291.nxml.txt.nlp	20859285	SENT134	10	10	17	17	tamoxifen	ERBB3	PA451581	2065	0.747
NULL	Oncotarget_2012_May_18_3(5)_525-534.nxml.txt.nlp	22619113	SENT167	5	5	25	25	fludarabine	IL-4	PA449655	3565	0.747
NULL	Diabetes_2013_May_16_62(5)_1697-1708.nxml.txt.nlp	23364453	SENT27	13	13	15	15	vildagliptin	GLP-1	PA165958346	100125288	0.746
NULL	Breast_Cancer_(Auckl)_2009_Sep_2_3_61-75.nxml.txt.nlp	19809577	SENT131	3	3	11	11	curcumin	survivin	PA151958596	332	0.746
NULL	Int_J_Mol_Sci_2014_Mar_20_15(3)_4977-4993.nxml.txt.nlp	24658441	SENT704	5	5	8	8	resveratrol	STAT3		6774	0.746
NULL	ScientificWorldJournal_2013_Dec_9_2013_434151.nxml.txt.nlp	24385881	SENT251	13	13	6	6	carrageenan	IL-6	PA448814	3569	0.746
NULL	J_Exp_Med_1968_Oct_1_128(4)_699-713.nxml.txt.nlp	19867304	SENT7	22	22	9	9	galactose	NAG	PA449725	51594;4669	0.746
NULL	Diabetes_2013_Nov_18_62(11)_3909-3919.nxml.txt.nlp	23835339	SENT227	39	39	42	42	gliclazide	SUR1	PA10892	6833	0.746
NULL	J_Oncol_2012_Mar_26_2012_198412.nxml.txt.nlp	22536237	SENT11	0	0	17	17	trastuzumab	HER2	PA451743	2064	0.746
NULL	Breast_Cancer_Res_2012_Mar_20_14(2)_R53.nxml.txt.nlp	22433433	SENT110	22	22	28	28	paclitaxel	CDK2	PA450761	1017	0.746
NULL	Front_Microbiol_2012_Mar_22_3_106.nxml.txt.nlp	22461783	SENT102	19	19	8	8	clarithromycin	EMB	PA449028	133418	0.746
NULL	J_Hepatol_2012_Nov_57(5)_1061-1068.nxml.txt.nlp	22750465	SENT354	9	9	1	1	choline	GATA4	PA448976	2626	0.746
NULL	Cell_Biol_Int_Rep_(2010)_2012_Jun_21_19(1)_e00017.nxml.txt.nlp	23124518	SENT101	3	3	5	5	etoposide	TRAIL	PA449552	8743	0.746
NULL	Eur_J_Clin_Pharmacol_2011_Nov_1_67(11)_1109-1117.nxml.txt.nlp	21630032	SENT50	14	14	26	26	bezafibrate	IL-2	PA162364313	3558	0.746
NULL	Nat_Biotechnol_2011_Oct_30_29(11)_1039-1045.nxml.txt.nlp	22037377	SENT149	2	2	8	8	fasudil	PRKX	PA165946121	5613	0.746
NULL	J_Cardiothorac_Surg_2012_Sep_27_7_97.nxml.txt.nlp	23013706	SENT5	18	18	9	9	warfarin	CYP4F2	PA451906	8529	0.746
NULL	Oncoscience_2014_Mar_12_1(2)_167-179.nxml.txt.nlp	25126591	SENT201	7	7	11	11	paclitaxel	TLE3	PA450761	7090	0.746
NULL	Arthritis_Res_Ther_2009_Feb_3_11(1)_R15.nxml.txt.nlp	19192274	SENT223	20	20	34	34	methylprednisolone	IL-8	PA450466	3576	0.746
NULL	Br_J_Cancer_2006_Dec_4_95(11)_1504-1513.nxml.txt.nlp	17088902	SENT193	21	21	32	32	gefitinib	HER2	PA131301952	2064	0.746
NULL	Eur_J_Clin_Pharmacol_2011_May_8_67(5)_493-506.nxml.txt.nlp	21140139	SENT251	4	4	17	17	oxycodone	CYP3A4	PA450741	1576	0.746
NULL	BMJ_Open_2013_Nov_4_3(11)_e003995.nxml.txt.nlp	24189085	SENT379	32	32	11	11	rosiglitazone	GLP-1	PA451283	100125288	0.746
NULL	Indian_J_Pharmacol_2014_Nov-Dec_46(6)_627-632.nxml.txt.nlp	25538335	SENT126	5	5	8	8	metformin	Q10	PA450395	27161	0.746
NULL	Chem_Res_Toxicol_2013_Oct_21_26(10)_1570-1578.nxml.txt.nlp	24047243	SENT522	19	19	13	13	sparteine	CYP1A2	PA452610	1544	0.746
NULL	Int_J_Biol_Sci_2013_Apr_22_9(4)_350-360.nxml.txt.nlp	23630447	SENT155	35	35	10	10	verapamil	ANOVA	PA451868	4858	0.746
NULL	Br_J_Pharmacol_2011_Oct_164(3)_866-883.nxml.txt.nlp	21323893	SENT320	17	17	22	22	thrombin	HAS2	PA451674	3037	0.746
NULL	J_Neuroinflammation_2011_Feb_4_8_10.nxml.txt.nlp	21294877	SENT155	34	34	38	38	capsaicin	TAC1	PA448776	6863	0.746
NULL	BMB_Rep_2014_Oct_47(10)_575-580.nxml.txt.nlp	24499675	SENT58	7	7	16	16	arsenite	p53	PA452638	7157	0.746
NULL	Biochem_Res_Int_2012_Jun_25_2012_518437.nxml.txt.nlp	22792465	SENT111	9	9	38	38	doxycycline	RGS5	PA449415	8490	0.746
NULL	Ann_Oncol_2009_Aug_17_20(8)_1319-1329.nxml.txt.nlp	19535820	SENT349	23	23	43	43	docetaxel	San	PA449383	80218	0.746
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1495-1502.nxml.txt.nlp	21989186	SENT195	17	17	23	23	fluorouracil	HSI	PA128406956	57016	0.746
NULL	Acta_Pharmacol_Sin_2009_Sep_17_30(9)_1316-1322.nxml.txt.nlp	19684609	SENT16	20	20	18	18	rosiglitazone	PTEN	PA451283	5728	0.746
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jul_3_66(Pt_8)_o1910.nxml.txt.nlp	21588242	SENT71	1	1	7	7	benzaldehyde	mol	PA448571	90527	0.746
NULL	Int_J_Surg_Oncol_2012_May_17_2012_347385.nxml.txt.nlp	22675624	SENT231	11	11	18	18	tamoxifen	BCS	PA451581	617	0.746
NULL	Br_J_Cancer_2013_Feb_5_108(2)_334-341.nxml.txt.nlp	23257893	SENT185	0	0	18	18	sorafenib	CD31	PA7000	5175	0.746
NULL	Clinics_(Sao_Paulo)_2013_May_68(5)_592-598.nxml.txt.nlp	23778413	SENT84	33	33	14	14	epirubicin	HIF1A	PA449476	3091	0.746
NULL	Indian_J_Pharm_Sci_2014_Mar-Apr_76(2)_125-131.nxml.txt.nlp	24843185	SENT144	0	0	10	10	resveratrol	CA3		761	0.746
NULL	Diabetes_Metab_Syndr_Obes_2010_Aug_24_3_297-299.nxml.txt.nlp	21437098	SENT35	24	24	19	19	liraglutide	GLP-1	PA165958364	100125288	0.746
NULL	Clin_Dev_Immunol_2013_Sep_17_2013_791262.nxml.txt.nlp	24151519	SENT10	0	0	16	16	heparin	TLR7	PA449855	51284	0.746
NULL	Diabetes_2011_Nov_17_60(11)_2691-2700.nxml.txt.nlp	21896928	SENT122	19	19	7	7	resveratrol	p53		7157	0.746
NULL	Drugs_R_D_2010_Nov_25_10(4)_271-284.nxml.txt.nlp	21171673	SENT301	19	19	8	8	methotrexate	JAK3	PA450428	3718	0.746
NULL	Case_Rep_Oncol_2014_Jun_18_7(2)_393-400.nxml.txt.nlp	25076890	SENT45	34	34	31	31	erlotinib	EGFR	PA134687924	1956	0.746
NULL	Nat_Commun_2014_Jul_17_5_4421.nxml.txt.nlp	25030704	SENT23	0	0	14	14	heparin	LIM	PA449855	10611	0.746
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT143	12	12	10	10	doxorubicin	AKT	PA449412	207	0.746
NULL	Oncogene_2010_Sep_16_29(37)_5193-5203.nxml.txt.nlp	20581867	SENT127	8	8	14	14	lapatinib	PI3K	PA152241907	5290	0.746
NULL	J_Oncol_2012_Sep_5_2012_141236.nxml.txt.nlp	21904550	SENT157	16	16	14	14	bevacizumab	VEGF-A	PA130232992	7422	0.746
NULL	Breast_Cancer_Res_Treat_2014_Apr_6_145(1)_33-44.nxml.txt.nlp	24706169	SENT43	26	26	12	12	trastuzumab	HER2	PA451743	2064	0.746
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_May_7_65(Pt_6)_o1188-o1189.nxml.txt.nlp	21583061	SENT72	4	4	20	20	benzaldehyde	mol	PA448571	90527	0.746
NULL	Lipids_Health_Dis_2011_Feb_28_10_38.nxml.txt.nlp	21352602	SENT113	10	10	14	14	ezetimibe	PCSK9	PA10816	255738	0.746
NULL	Oncotarget_2014_Nov_8_5(21)_10280-10292.nxml.txt.nlp	25373733	SENT168	16	16	26	26	bortezomib	HIF-1	PA10252	29072	0.746
NULL	Hematol_Rep_2011_Jan_21_3(1)_e2.nxml.txt.nlp	22184524	SENT15	29	29	31	31	ethambutol	ETB	PA164784021	1910	0.746
NULL	Int_Clin_Psychopharmacol_2014_Mar_31_29(2)_86-92.nxml.txt.nlp	24247740	SENT188	9	9	16	16	citalopram	STAR	PA449015	6770;2984	0.746
NULL	Nucleic_Acids_Res_2011_Sep_24_39(16)_7223-7233.nxml.txt.nlp	21609964	SENT29	18	18	27	27	l-glutamine	CO2	PA10090	4513	0.746
NULL	Br_J_Pharmacol_2014_Feb_24_171(1)_1019-1032.nxml.txt.nlp	24251620	SENT48	24	24	13	13	nicardipine	TRPM3	PA450620	80036	0.746
NULL	Dermatoendocrinol_2013_Apr_1_5(2)_252-263.nxml.txt.nlp	24194965	SENT12	0	0	10	10	metformin	B12	PA450395	7126;4709	0.746
NULL	Korean_J_Anesthesiol_2013_Jan_21_64(1)_47-53.nxml.txt.nlp	23372886	SENT4	18	18	12	12	bupivacaine	IGK	PA135057240	50802	0.746
NULL	Br_J_Ophthalmol_2014_Aug_10_98(8)_1036-1041.nxml.txt.nlp	24723616	SENT18	25	25	22	22	bevacizumab	CRT	PA130232992	811	0.746
NULL	Scientifica_(Cairo)_2012_Dec_16_2012_402783.nxml.txt.nlp	24278688	SENT134	8	8	24	24	thrombin	C3b	PA451674	718	0.746
NULL	Cancer_Immunol_Immunother_2015_Oct_7_64_61-73.nxml.txt.nlp	25287778	SENT216	7	7	13	13	lenalidomide	IL-2	PA162363968	3558	0.746
NULL	Iran_J_Neurol_2012_11(2)_70-73.nxml.txt.nlp	24250865	SENT48	11	11	7	7	doxycycline	IFN	PA449415	3439	0.746
NULL	Diabetes_2009_Dec_31_58(12)_2851-2862.nxml.txt.nlp	19720788	SENT149	10	10	13	13	forskolin	CHOP	PA146096022	1649	0.746
NULL	Neuroscience_2009_Jun_30_161(2-3)_572-577.nxml.txt.nlp	19327387	SENT163	8	8	2	2	capsaicin	CB2	PA448776	1269	0.746
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT228	34	34	26	26	methotrexate	MSH2	PA450428	4436	0.746
NULL	Br_J_Cancer_2013_Feb_5_108(2)_395-401.nxml.txt.nlp	23322208	SENT197	33	33	12	12	cisplatin	CEA	PA449014	5670;1087	0.746
NULL	Arch_Med_Sci_2014_Aug_29_10(4)_717-724.nxml.txt.nlp	25276156	SENT147	21	21	6	6	paclitaxel	VEGFR	PA450761	3791	0.746
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT235	6	6	16	16	bevacizumab	PlGF-2	PA130232992	5228	0.746
NULL	Br_J_Pharmacol_2014_Sep_28_171(18)_4255-4272.nxml.txt.nlp	24846338	SENT22	24	24	18	18	ondansetron	5-HT7	PA450705	3363	0.746
NULL	Clin_Med_Insights_Oncol_2011_Nov_7_5_349-364.nxml.txt.nlp	22174596	SENT174	15	15	9	9	axitinib	VEGFR	PA164924493	3791	0.746
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Oct_30_66(Pt_11)_o2981.nxml.txt.nlp	21589147	SENT60	18	18	12	12	ethanol	mol	PA448073	90527	0.746
NULL	Front_Behav_Neurosci_2012_Jun_13_6_24.nxml.txt.nlp	22707936	SENT390	15	15	5	5	scopolamine	spatial	PA451308	219793	0.746
NULL	Br_J_Cancer_2009_Sep_15_101(6)_957-966.nxml.txt.nlp	19738618	SENT170	10	10	13	13	dexrazoxane	THBS-1	PA449259	7057	0.746
NULL	J_Hematol_Oncol_2013_Mar_27_6_23.nxml.txt.nlp	23531342	SENT97	5	5	3	3	mi-63	RITA		55422;84934	0.746
NULL	Diabetes_Obes_Metab_2011_Nov_13(11)_982-989.nxml.txt.nlp	21615670	SENT175	12	12	32	32	exenatide	PPG	PA164749238	5552	0.746
NULL	Biosci_Rep_2013_Sep_4_33(5)_e00064.nxml.txt.nlp	23889169	SENT61	15	15	18	18	thrombin	PAR2	PA451674	2150;55065;8856	0.746
NULL	Carcinogenesis_2010_Dec_27_31(12)_2049-2057.nxml.txt.nlp	20876285	SENT175	10	10	7	7	tamoxifen	HER2	PA451581	2064	0.746
NULL	Mol_Pain_2013_Jun_10_9_27.nxml.txt.nlp	23758830	SENT118	28	28	13	13	tetracaine	ASIC1	PA451638	41	0.746
NULL	Arthritis_Res_Ther_2006_Jan_3_8(1)_R23.nxml.txt.nlp	16507127	SENT158	11	11	3	3	urokinase	DPPIV	PA451836	2191;1803	0.746
NULL	J_Carcinog_2011_Nov_30_10_28.nxml.txt.nlp	22190870	SENT114	5	5	10	10	trastuzumab	PI3K	PA451743	5290	0.746
NULL	J_Cell_Mol_Med_2014_Dec_7_18(12)_2536-2552.nxml.txt.nlp	25287328	SENT202	13	13	0	0	estradiol	PKD1	PA449503	5310	0.746
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT115	0	0	4	4	perifosine	DR5	PA165291471	8795	0.746
NULL	Oncotarget_2011_Dec_31_2(12)_935-947.nxml.txt.nlp	22249213	SENT237	6	6	18	18	paclitaxel	MCAK	PA450761	11004	0.746
NULL	Breast_Cancer_Res_2009_Jul_15_11(4)_207.nxml.txt.nlp	19664181	SENT172	34	34	22	22	triciribine	PTEN	PA165958661	5728	0.746
NULL	Oxid_Med_Cell_Longev_2013_Jun_2_2013_793525.nxml.txt.nlp	23819014	SENT136	10	10	19	19	resveratrol	PI3K		5290	0.746
NULL	J_Equine_Sci_2014_Apr_22_25(1)_23-27.nxml.txt.nlp	24834010	SENT31	15	15	8	8	buserelin	DES	PA10253	1674	0.746
NULL	Oncotarget_2014_Jun_8_5(13)_5040-5053.nxml.txt.nlp	24970815	SENT242	23	23	4	4	cisplatin	SPRY2	PA449014	10253	0.746
NULL	Drugs_Context_2012_Nov_19_2012_212242.nxml.txt.nlp	24432031	SENT128	10	10	20	20	vinblastine	IFN	PA451877	3439	0.746
NULL	Arthritis_Res_Ther_2007_May_30_9(3)_212.nxml.txt.nlp	17561993	SENT116	27	27	14	14	capsaicin	CCL2	PA448776	6347	0.746
NULL	Front_Physiol_2011_Jul_19_2_40.nxml.txt.nlp	21811470	SENT187	5	5	12	12	candesartan	RVR	PA448765	9975	0.746
NULL	Evid_Based_Complement_Alternat_Med_2013_May_23_2013_632121.nxml.txt.nlp	23762150	SENT122	3	3	11	11	resveratrol	MITF		4286	0.746
NULL	Anesthesiol_Res_Pract_2011_Oct_27_2011_317410.nxml.txt.nlp	22110498	SENT10	14	14	5	5	isoflurane	IL-8	PA450106	3576	0.746
NULL	Reprod_Biol_Endocrinol_2003_Jul_9_1_52.nxml.txt.nlp	12904263	SENT38	15	15	8	8	estradiol	aromatase	PA449503	1588	0.746
NULL	Arthritis_Res_Ther_2014_Aug_19_16(4)_413.nxml.txt.nlp	25135077	SENT91	4	4	17	17	infliximab	IL-6	PA452639	3569	0.746
NULL	Exp_Neurobiol_2013_Mar_31_22(1)_51-57.nxml.txt.nlp	23585723	SENT130	0	0	20	20	capsaicin	p38	PA448776	10598;1432;7965	0.746
NULL	Evid_Based_Complement_Alternat_Med_2011_Mar_10_2011_561396.nxml.txt.nlp	21792360	SENT122	11	11	5	5	losartan	CD40	PA450268	958	0.746
NULL	J_Cancer_Epidemiol_2012_Aug_27_2012_978391.nxml.txt.nlp	22969803	SENT131	21	21	3	3	rituximab	IPW	PA451261	3653	0.746
NULL	Iran_Red_Crescent_Med_J_2014_Aug_5_16(8)_e6915.nxml.txt.nlp	25389496	SENT163	23	23	8	8	pravastatin	adiponectin	PA451089	9370	0.746
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Jun_25_3(6)_e120.nxml.txt.nlp	24964282	SENT19	23	23	32	32	rifampin	CYP3A4	PA451250	1576	0.746
NULL	Arch_Med_Sci_2013_Oct_31_9(5)_936-943.nxml.txt.nlp	24273582	SENT37	23	23	37	37	glibenclamide	SUR1	PA449782	6833	0.746
NULL	Allergy_Asthma_Immunol_Res_2009_Oct_25_1(1)_30-35.nxml.txt.nlp	20224667	SENT88	6	6	4	4	rosiglitazone	PPARG	PA451283	5468	0.746
NULL	Apoptosis_2014_Aug_26_19(11)_1603-1615.nxml.txt.nlp	25156145	SENT157	10	10	0	0	mitomycin	TRAIL	PA450524	8743	0.746
NULL	Oncol_Rep_2013_Apr_23_29(4)_1268-1274.nxml.txt.nlp	23354756	SENT98	7	7	9	9	paclitaxel	SLC25A43	PA450761	203427	0.746
NULL	J_Biomed_Biotechnol_2004_Sep_30_2004(4)_203-210.nxml.txt.nlp	15467160	SENT80	15	15	5	5	glutaraldehyde	TEM	PA449777	64102	0.746
NULL	J_Cancer_2013_Nov_23_4(9)_736-754.nxml.txt.nlp	24312144	SENT82	20	20	11	11	carboplatin	EGFR	PA448803	1956	0.746
NULL	Indian_J_Med_Res_2011_Apr_133(4)_434-441.nxml.txt.nlp	21537099	SENT12	18	18	16	16	ampicillin	EGF	PA448419	1950	0.746
NULL	Exp_Ther_Med_2013_Jul_29_6(1)_33-36.nxml.txt.nlp	23935714	SENT95	3	3	9	9	doxorubicin	CHOP	PA449412	1649	0.746
NULL	Blood_Cancer_J_2013_Jun_7_3(6)_e120.nxml.txt.nlp	23749045	SENT229	8	8	24	24	imatinib	JAG2	PA10804	3714	0.746
NULL	J_Mol_Signal_2008_Dec_1_3_18.nxml.txt.nlp	19046439	SENT32	2	2	24	24	metformin	LKB1	PA450395	6794	0.746
NULL	J_Cell_Biol_2002_Jun_24_157(7)_1267-1278.nxml.txt.nlp	12082084	SENT155	2	2	14	14	rolipram	AC6	PA153906323	112	0.746
NULL	Nat_Med_2013_Mar_10_19(3)_313-321.nxml.txt.nlp	23396211	SENT67	0	0	19	19	amlexanox	adiponectin	PA164745310	9370	0.746
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S279-S284.nxml.txt.nlp	21525469	SENT184	30	30	9	9	rosiglitazone	GLP-1	PA451283	100125288	0.746
NULL	J_Hematol_Oncol_2013_Aug_2_6_55.nxml.txt.nlp	23915913	SENT142	13	13	24	24	lenalidomide	FLG3	PA162363968	388697	0.746
NULL	Br_J_Cancer_2002_Jan_21_86(2)_179-184.nxml.txt.nlp	11870502	SENT59	14	14	19	19	tamoxifen	IL-2	PA451581	3558	0.746
NULL	Drug_Target_Insights_2011_Jun_7_5_11-32.nxml.txt.nlp	22087060	SENT155	11	11	2	2	paclitaxel	Hsp90	PA450761	3320	0.746
NULL	Oncotarget_2014_Jun_19_5(15)_6540-6551.nxml.txt.nlp	25153728	SENT106	6	6	15	15	paclitaxel	p16	PA450761	1029	0.746
NULL	Br_J_Cancer_2012_Nov_20_107(11)_1844-1852.nxml.txt.nlp	23169337	SENT178	18	18	2	2	bortezomib	AKT	PA10252	207	0.746
NULL	Evid_Based_Complement_Alternat_Med_2013_Nov_26_2013_731370.nxml.txt.nlp	24376467	SENT210	3	3	6	6	resveratrol	EGFR		1956	0.746
NULL	Diabetes_Care_2013_Mar_13_36(3)_498-504.nxml.txt.nlp	23139373	SENT203	27	27	19	19	metformin	GLP-1	PA450395	100125288	0.746
NULL	Int_J_Biol_Sci_2013_Apr_22_9(4)_350-360.nxml.txt.nlp	23630447	SENT165	13	13	42	42	doxorubicin	AXIN1	PA449412	8312	0.746
NULL	Arthritis_Res_Ther_2006_Jul_20_8(4)_R129.nxml.txt.nlp	16859536	SENT79	27	27	33	33	fluorescein	CD19	PA164746009	930	0.746
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT280	15	15	28	28	fluphenazine	PRL	PA449676	5617	0.746
NULL	Nucleic_Acids_Res_2012_Jul_19_40(13)_5910-5925.nxml.txt.nlp	22434882	SENT301	26	26	21	21	curcumin	HBZ	PA151958596	3050	0.746
NULL	Oncol_Lett_2013_Mar_7_5(3)_857-861.nxml.txt.nlp	23426781	SENT89	11	11	23	23	cisplatin	PI3K	PA449014	5290	0.746
NULL	J_Psychopharmacol_2011_Aug_25(8)_1030-1042.nxml.txt.nlp	21693554	SENT374	12	12	15	15	donepezil	spatial	PA449394	219793	0.746
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2012_Feb_20_5_13-30.nxml.txt.nlp	22879796	SENT166	14	14	19	19	pravastatin	adiponectin	PA451089	9370	0.746
NULL	Diabetes_2009_Jan_58(1)_243-249.nxml.txt.nlp	18840785	SENT27	7	7	5	5	glucose	GLP-1	PA449773	100125288	0.746
NULL	Croat_Med_J_2012_Jun_53(3)_214-223.nxml.txt.nlp	22661134	SENT10	4	4	12	12	yohimbine	ACTH	PA451946	5443	0.746
NULL	Oncoimmunology_2013_Jul_1_2(7)_e24882.nxml.txt.nlp	24073370	SENT7	22	22	33	33	gemcitabine	BTC	PA449748	685	0.746
NULL	Core_Evid_2009_Jun_15_4_131-147.nxml.txt.nlp	20694070	SENT176	9	9	4	4	efavirenz	CD4	PA449441	920	0.746
NULL	BMB_Rep_2013_Oct_46(10)_507-512.nxml.txt.nlp	24148772	SENT314	10	10	16	16	heparin	PP13	PA449855	29124	0.746
NULL	Mol_Cancer_2010_Nov_8_9_291.nxml.txt.nlp	21059223	SENT124	13	13	18	18	paclitaxel	PARP	PA450761	142	0.746
NULL	Breast_Cancer_Res_2003_Feb_5_5(2)_113-116.nxml.txt.nlp	12631392	SENT103	19	19	23	23	carboplatin	HER-2	PA448803	2064	0.746
NULL	Front_Oncol_2014_May_23_4_114.nxml.txt.nlp	24904828	SENT512	23	23	18	18	isotretinoin	GM-CSF	PA450128	1437	0.746
NULL	Arthritis_Res_Ther_2009_Jun_29_11(3)_R100.nxml.txt.nlp	19563672	SENT144	12	12	4	4	infliximab	IFN	PA452639	3439	0.746
NULL	J_Cell_Mol_Med_2014_Jan_4_18(1)_38-48.nxml.txt.nlp	24188742	SENT227	4	4	7	7	hyaluronan	HMMR	PA165958431	3161	0.746
NULL	J_Korean_Assoc_Oral_Maxillofac_Surg_2014_Dec_26_40(6)_291-296.nxml.txt.nlp	25551094	SENT125	7	7	21	21	alendronate	RANKL	PA448082	8600	0.746
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jun_5_66(Pt_7)_o1559-o1560.nxml.txt.nlp	21587803	SENT74	0	0	6	6	sulfanilamide	mol	PA451545	90527	0.746
NULL	Arthritis_Res_2002_Aug_6_4(5)_307-321.nxml.txt.nlp	12223105	SENT355	15	15	34	34	infliximab	IL-2	PA452639	3558	0.746
NULL	Cancer_Cell_Int_2013_May_15_13_42.nxml.txt.nlp	23672670	SENT201	2	2	8	8	paclitaxel	PIDD	PA450761	55367	0.746
NULL	Eur_J_Nucl_Med_Mol_Imaging_2008_May_22_35(5)_1008-1018.nxml.txt.nlp	18157531	SENT163	39	39	17	17	trastuzumab	HER2	PA451743	2064	0.746
NULL	J_Adv_Pharm_Technol_Res_2011_Jan-Mar_2(1)_39-42.nxml.txt.nlp	22171290	SENT53	0	0	5	5	loperamide	castor	PA450262	54897	0.746
NULL	Oncotarget_2014_Jun_26_5(14)_5510-5522.nxml.txt.nlp	24980816	SENT42	6	6	13	13	doxycycline	BSP	PA449415	3381	0.746
NULL	Arthritis_Res_Ther_2012_Apr_16_14(2)_R76.nxml.txt.nlp	22507741	SENT172	21	21	11	11	estradiol	IL-10	PA449503	3586	0.746
NULL	Front_Immunol_2012_Jul_18_3_198.nxml.txt.nlp	22826708	SENT2268	9	9	0	0	rituximab	BAFF	PA451261	10673	0.746
NULL	Hum_Genomics_2008_Sep_1_3(1)_7-16.nxml.txt.nlp	19129086	SENT177	25	25	22	22	rosiglitazone	CYP2C8	PA451283	1558	0.746
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jun_5_66(Pt_7)_o1596.nxml.txt.nlp	21587833	SENT67	0	0	6	6	sulfanilamide	mol	PA451545	90527	0.746
NULL	Cancer_Cell_Int_2010_Aug_13_10_26.nxml.txt.nlp	20707917	SENT102	20	20	37	37	doxorubicin	RhoA	PA449412	387	0.746
NULL	Alcohol_Res_2012_34(3)_306-317.nxml.txt.nlp	23134046	SENT71	22	22	32	32	ethanol	HAP	PA448073	5915;10313	0.746
NULL	J_Antimicrob_Chemother_2014_Dec_20_69(12)_3329-3334.nxml.txt.nlp	25147095	SENT136	17	17	26	26	nevirapine	CD4	PA450616	920	0.746
NULL	Oxid_Med_Cell_Longev_2012_Aug_22_2012_534705.nxml.txt.nlp	22966415	SENT318	21	21	3	3	riluzole	GLAST	PA451251	6507	0.746
NULL	Biochem_Res_Int_2012_Mar_4_2012_685267.nxml.txt.nlp	22496978	SENT211	13	13	8	8	thrombin	HSPC	PA451674	5688	0.746
NULL	Behav_Genet_2012_Jul_17_42(4)_509-527.nxml.txt.nlp	22426781	SENT384	12	12	16	16	phenol	B27	PA450913	56246	0.746
NULL	Mol_Cell_Proteomics_2014_Jun_9_13(6)_1598-1610.nxml.txt.nlp	24719452	SENT226	21	21	18	18	galactose	BG1	PA449725	23205	0.746
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1012.nxml.txt.nlp	24457956	SENT163	27	27	10	10	paraformaldehyde	MDC	PA450790	6367	0.746
NULL	Ann_Hematol_2014_Sep_10_93(1)_1-11.nxml.txt.nlp	24018623	SENT137	11	11	24	24	lenalidomide	p53	PA162363968	7157	0.746
NULL	Cancers_(Basel)_2014_Apr_9_6(2)_829-859.nxml.txt.nlp	24722453	SENT256	3	3	9	9	auranofin	STAT3	PA448510	6774	0.746
NULL	Biomed_Imaging_Interv_J_2008_Jul_1_4(3)_e47.nxml.txt.nlp	21611010	SENT96	32	32	23	23	cetuximab	ERCC1	PA10040	2067	0.746
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Mar_13_66(Pt_4)_o830.nxml.txt.nlp	21580658	SENT59	20	20	13	13	ethanol	mol	PA448073	90527	0.746
NULL	Arthritis_Res_Ther_2012_Nov_2_14(Suppl_4)_S2.nxml.txt.nlp	23281926	SENT134	5	5	3	3	cyclophosphamide	BAFF	PA449165	10673	0.746
NULL	Cancers_(Basel)_2014_Aug_29_6(3)_1753-1768.nxml.txt.nlp	25256831	SENT179	16	16	2	2	oxaliplatin	CEA	PA131285527	5670;1087	0.746
NULL	BMB_Rep_2014_Mar_47(3)_167-172.nxml.txt.nlp	24499665	SENT101	20	20	22	22	nutlin-3	MDM2		4193	0.746
NULL	Int_J_Gen_Med_2011_Apr_8_4_277-287.nxml.txt.nlp	21556314	SENT270	14	14	16	16	raloxifene	STAR	PA451221	6770;2984	0.746
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT426	16	16	3	3	cetuximab	KRAS	PA10040	3845	0.746
NULL	Chin_J_Cancer_2011_Oct_30(10)_655-668.nxml.txt.nlp	21959043	SENT196	35	35	33	33	thalidomide	PTEN	PA451644	5728	0.746
NULL	Neuro_Oncol_2010_Apr_27_12(4)_389-400.nxml.txt.nlp	20308316	SENT8	6	6	9	9	chloroquine	p53	PA448948	7157	0.746
NULL	Tuberc_Respir_Dis_(Seoul)_2013_Nov_29_75(5)_188-198.nxml.txt.nlp	24348666	SENT186	39	39	33	33	crizotinib	EGFR	PA165946122	1956	0.746
NULL	Chin_J_Cancer_2011_Sep_30(9)_645-654.nxml.txt.nlp	21880186	SENT199	32	32	19	19	cisplatin	NACT	PA449014	284111	0.746
NULL	Oncotarget_2012_Dec_17_4(1)_48-63.nxml.txt.nlp	23295955	SENT310	10	10	14	14	paraformaldehyde	CD44	PA450790	960	0.746
NULL	J_Cell_Mol_Med_2014_Jul_30_18(7)_1392-1406.nxml.txt.nlp	24779927	SENT256	5	5	11	11	imatinib	RhoA	PA10804	387	0.746
NULL	Oncotarget_2014_May_27_5(19)_9049-9064.nxml.txt.nlp	24979294	SENT236	15	15	9	9	dasatinib	EGFR	PA162372878	1956	0.746
NULL	Mol_Pain_2012_Sep_27_8_75.nxml.txt.nlp	23013719	SENT266	12	12	17	17	capsaicin	TRPA1	PA448776	8989	0.746
NULL	Br_J_Cancer_1995_Sep_72(3)_543-549.nxml.txt.nlp	7669559	SENT10	24	24	40	40	calcein	P-gp	PA132595336	5243	0.746
NULL	J_Radiat_Res_2014_Nov_16_55(6)_1171-1177.nxml.txt.nlp	25129557	SENT9	24	24	20	20	bevacizumab	CRT	PA130232992	811	0.746
NULL	Br_J_Cancer_2013_Mar_19_108(5)_1079-1091.nxml.txt.nlp	23449353	SENT27	20	20	32	32	docetaxel	CD133	PA449383	8842	0.746
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT123	15	15	10	10	mitoxantrone	ABCC10	PA450526	89845	0.746
NULL	Patient_Prefer_Adherence_2013_Mar_27_7_245-258.nxml.txt.nlp	23569364	SENT99	33	33	21	21	cyclophosphamide	B18	PA449165	59271;4713	0.746
NULL	Allergy_Asthma_Clin_Immunol_2013_Oct_3_9(1)_39.nxml.txt.nlp	24219860	SENT24	11	11	15	15	rituximab	BAFF	PA451261	10673	0.746
NULL	J_Invest_Dermatol_2013_Sep_31_133(9)_2247-2254.nxml.txt.nlp	23370537	SENT114	1	1	19	19	chloroquine	PUMA	PA448948	27113	0.746
NULL	J_Am_Heart_Assoc_2013_Apr_24_2(2)_e000131.nxml.txt.nlp	23537811	SENT22	10	10	1	1	clopidogrel	CYP2C19	PA449053	1557	0.746
NULL	J_Orthop_Surg_2007_May_21_2_9.nxml.txt.nlp	17511887	SENT101	20	20	12	12	alendronate	DPD	PA448082	1806	0.746
NULL	Arch_Med_Sci_2012_Sep_8_8(4)_659-671.nxml.txt.nlp	23056078	SENT198	30	30	14	14	mitoxantrone	MDR1	PA450526	5243	0.746
NULL	Acta_Pharmacol_Sin_2009_Jul_22_30(7)_956-964.nxml.txt.nlp	19543298	SENT169	9	9	5	5	simvastatin	ABCB1	PA451363	5243	0.746
NULL	Lipids_Health_Dis_2011_Feb_28_10_38.nxml.txt.nlp	21352602	SENT94	10	10	14	14	atorvastatin	PCSK9	PA448500	255738	0.746
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_30_2013_789764.nxml.txt.nlp	23737845	SENT254	26	26	10	10	tolbutamide	CYP2C9	PA451718	1559	0.746
NULL	J_Hematol_Oncol_2013_Jun_3_6_38.nxml.txt.nlp	23731980	SENT70	21	21	1	1	lapatinib	San	PA152241907	80218	0.746
NULL	Virol_J_2010_Dec_3_7_354.nxml.txt.nlp	21129188	SENT74	7	7	27	27	raltegravir	CD4		920	0.746
NULL	Acta_Pharmacol_Sin_2013_Sep_5_34(9)_1192-1200.nxml.txt.nlp	23685957	SENT139	6	6	12	12	curcumin	AP-2	PA151958596	7020	0.746
NULL	Indian_J_Endocrinol_Metab_2013_May-Jun_17(3)_472-479.nxml.txt.nlp	23869305	SENT44	2	2	9	9	ezetimibe	ATV	PA10816	4683	0.746
NULL	Cell_Res_2012_Aug_22_22(8)_1227-1245.nxml.txt.nlp	22613949	SENT397	9	9	33	33	bortezomib	KRAS	PA10252	3845	0.746
NULL	Breast_Cancer_Res_2008_Mar_26_10(2)_203.nxml.txt.nlp	18373886	SENT52	16	16	7	7	hyaluronan	CD44	PA165958431	960	0.746
NULL	Cell_Cycle_2012_Nov_1_11(21)_3983-3996.nxml.txt.nlp	22987153	SENT182	13	13	0	0	cisplatin	DNA2	PA449014	1763	0.746
NULL	Crit_Care_2006_Mar_21_10(Suppl_1)_P160.nxml.txt.nlp	NULL	SENT24	8	8	11	11	heparin	ACT	PA449855	12;11332;9457;641455	0.746
NULL	Clin_Endosc_2011_Sep_30_44(1)_22-26.nxml.txt.nlp	22741108	SENT116	7	7	36	36	propofol	ESD	PA451141	2098	0.746
NULL	Br_J_Cancer_2012_Jul_10_107(2)_221-223.nxml.txt.nlp	22735901	SENT41	13	13	10	10	tamoxifen	UBC	PA451581	7316	0.746
NULL	Open_Biol_2014_May_4(5)_140065.nxml.txt.nlp	24850914	SENT160	27	27	11	11	bortezomib	USP15	PA10252	9958	0.746
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT417	14	14	5	5	irinotecan	EGFR	PA450085	1956	0.746
NULL	Nat_Genet_2013_Mar_20_45(3)_279-284.nxml.txt.nlp	23334666	SENT274	9	9	4	4	isotretinoin	GM-CSF	PA450128	1437	0.746
NULL	J_Exp_Bot_2012_Mar_15_63(5)_1969-1983.nxml.txt.nlp	22174442	SENT80	43	43	24	24	nitroprusside	NO3	PA451406	4681	0.746
NULL	Br_J_Cancer_2009_Jul_21_101(2)_238-243.nxml.txt.nlp	19568242	SENT118	36	36	12	12	sunitinib	IFN	PA162372840	3439	0.746
NULL	J_Biol_Chem_2008_Oct_31_283(44)_29841-29846.nxml.txt.nlp	18765669	SENT118	5	5	21	21	suramin	P2X1	PA10292	5023	0.746
NULL	Arthritis_Res_2001_Jan_26_3(Suppl_A)_P094.nxml.txt.nlp	NULL	SENT5	13	13	5	5	pamidronate	OPG	PA450767	690	0.746
NULL	Oncotarget_2014_Jun_6_5(13)_4935-4944.nxml.txt.nlp	24952732	SENT33	0	0	24	24	doxazosin	PDK1	PA449407	5170;5163	0.746
NULL	Br_J_Cancer_1999_Mar_79(7-8)_1104-1110.nxml.txt.nlp	10098743	SENT5	33	33	40	40	cisplatin	JNK	PA449014	5599	0.746
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT276	12	12	10	10	resveratrol	ROS		6098	0.746
NULL	Diabetes_Care_2009_Dec_6_32(12)_2251-2257.nxml.txt.nlp	19808924	SENT24	4	4	10	10	exenatide	GLP	PA164749238	342096	0.746
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jan_31_65(Pt_2)_o439.nxml.txt.nlp	21582024	SENT69	0	0	16	16	benzaldehyde	mol	PA448571	90527	0.746
NULL	Asia_Pac_Allergy_2014_Jul_29_4(3)_156-163.nxml.txt.nlp	25097851	SENT34	10	10	22	22	isoniazid	EMB	PA450112	133418	0.745
NULL	Biochem_Biophys_Res_Commun_2013_Aug_23_438(2)_249-256.nxml.txt.nlp	23850620	SENT159	32	32	10	10	indomethacin	IFN	PA449982	3439	0.745
NULL	Front_Oncol_2013_Apr_2_3_68.nxml.txt.nlp	23565504	SENT286	3	3	6	6	rituximab	CHOP	PA451261	1649	0.745
NULL	Emerg_Infect_Dis_2011_Mar_17(3)_432-440.nxml.txt.nlp	21392434	SENT130	31	31	12	12	isoniazid	DST	PA450112	667	0.745
NULL	Inflammation_2014_Sep_5_37(1)_1-9.nxml.txt.nlp	24005897	SENT14	0	0	9	9	diclofenac	COX	PA449293	1351	0.745
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_24_2012_673132.nxml.txt.nlp	23133498	SENT124	3	3	6	6	berberine	CYP2D6	PA165860812	1565	0.745
NULL	Chem_Rev_2012_May_9_112(5)_2593-2603.nxml.txt.nlp	22335786	SENT41	12	12	6	6	choline	ATX	PA448976	5168;23049	0.745
NULL	Eur_J_Haematol_2014_Feb_25_92(2)_127-136.nxml.txt.nlp	24118452	SENT163	33	33	8	8	anagrelide	ELN	PA164742986	2006	0.745
NULL	Oncotarget_2011_Dec_20_2(12)_1094-1108.nxml.txt.nlp	22190353	SENT205	9	9	24	24	doxorubicin	PUMA	PA449412	27113	0.745
NULL	Braz_J_Microbiol_2013_Apr_9_44(1)_245-252.nxml.txt.nlp	24159311	SENT95	11	11	23	23	lipase	castor	PA450239	54897	0.745
NULL	Cancer_Metastasis_Rev_2012_Jun_20_31(1-2)_143-162.nxml.txt.nlp	22101807	SENT434	12	12	8	8	cisplatin	gamma	PA449014	9913	0.745
NULL	Open_Biochem_J_2013_Feb_22_7_19-23.nxml.txt.nlp	23526382	SENT38	24	24	18	18	repaglinide	DM2	PA451234	28508	0.745
NULL	J_Med_Case_Reports_2011_Mar_19_5_112.nxml.txt.nlp	21418592	SENT110	7	7	4	4	risperidone	5-HT2A	PA451257	3356	0.745
NULL	Int_J_Cell_Biol_2013_Nov_13_2013_674751.nxml.txt.nlp	24324498	SENT154	10	10	24	24	bacitracin	PDIA1	PA448531	5034	0.745
NULL	Oncologist_2011_Jan_6_16(1)_5-24.nxml.txt.nlp	21212434	SENT189	6	6	14	14	vinblastine	IL-2	PA451877	3558	0.745
NULL	Indian_J_Pharm_Sci_2013_Jan-Feb_75(1)_94-98.nxml.txt.nlp	23901167	SENT69	10	10	39	39	tolbutamide	CYP2B6	PA451718	1555	0.745
NULL	Support_Care_Cancer_2014_Oct_19_22(2)_469-477.nxml.txt.nlp	24141698	SENT155	16	16	25	25	doxorubicin	NK1	PA449412	11126	0.745
NULL	Chem_Cent_J_2013_Sep_4_7_147.nxml.txt.nlp	24006941	SENT132	8	8	20	20	lipase	WBS	PA450239	2006	0.745
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT154	15	15	6	6	metformin	AMPK	PA450395	5563	0.745
NULL	Inflammation_2014_Sep_5_37(1)_1-9.nxml.txt.nlp	24005897	SENT151	16	16	21	21	diclofenac	COX	PA449293	1351	0.745
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1129-1136.nxml.txt.nlp	20234368	SENT182	25	25	30	30	imiquimod	IFN	PA449972	3439	0.745
NULL	J_Oncol_2010_Nov_19_2010_568938.nxml.txt.nlp	20037743	SENT35	11	11	15	15	heparin	EGFR	PA449855	1956	0.745
NULL	Int_J_Biol_Sci_2014_Jun_21_10(7)_702-714.nxml.txt.nlp	25013379	SENT37	13	13	25	25	cetuximab	HER3	PA10040	2065	0.745
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT49	34	34	9	9	diclofenac	CYP2A6	PA449293	1548	0.745
NULL	Cancer_Med_2013_Dec_31_2(6)_950-963.nxml.txt.nlp	24403269	SENT314	35	35	38	38	cisplatin	RAB25	PA449014	57111	0.745
NULL	Pharmaceutics_2011_Oct_12_3(4)_680-705.nxml.txt.nlp	24309303	SENT79	15	15	37	37	gemfibrozil	CYP2C8	PA449750	1558	0.745
NULL	J_Asthma_Allergy_2008_Sep_19_1_19-29.nxml.txt.nlp	21436982	SENT112	2	2	17	17	fexofenadine	IFN	PA449621	3439	0.745
NULL	Clin_Sci_(Lond)_2011_Nov_1_121(Pt_10)_449-458.nxml.txt.nlp	21671887	SENT0	22	22	46	46	simvastatin	eNOS	PA451363	4846	0.745
NULL	Drugs_Aging_2012_Nov_5_29(11)_863-869.nxml.txt.nlp	23038608	SENT120	20	20	7	7	oxycodone	NNT	PA450741	23530	0.745
NULL	Adv_Hematol_2011_Oct_23_2011_829525.nxml.txt.nlp	22110506	SENT208	37	37	12	12	etoposide	p53	PA449552	7157	0.745
NULL	Core_Evid_2010_Jul_27_5_1-10.nxml.txt.nlp	20694135	SENT35	13	13	9	9	entacapone	CLE	PA164748726	51637	0.745
NULL	Mol_Cancer_2009_Dec_3_8_115.nxml.txt.nlp	19958544	SENT7	18	18	6	6	nutlin-3	MDM2		4193	0.745
NULL	Cancer_Cell_Int_2011_Aug_19_11_29.nxml.txt.nlp	21854619	SENT3	17	17	7	7	platinum	BRCA1	PA150595617	672	0.745
NULL	Arthritis_Res_Ther_2010_Jan_8_12(1)_R4.nxml.txt.nlp	20064200	SENT9	17	17	24	24	infliximab	COX2	PA452639	4513;5743	0.745
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_105-115.nxml.txt.nlp	17912640	SENT4	0	0	7	7	letrozole	aromatase	PA450196	1588	0.745
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT97	10	10	5	5	trastuzumab	MUC1	PA451743	4582	0.745
NULL	Open_Microbiol_J_2008_May_23_2_66-73.nxml.txt.nlp	19088913	SENT247	1	1	9	9	ketoconazole	Yes	PA450146	7525	0.745
NULL	Cancer_Cell_2007_Dec_11_12(6)_514-527.nxml.txt.nlp	18068629	SENT130	14	14	36	36	paclitaxel	ANOVA	PA450761	4858	0.745
NULL	Hum_Genomics_2010_Oct_1_5(1)_61-72.nxml.txt.nlp	21106490	SENT152	18	18	25	25	verapamil	CYP3A	PA451868	1574	0.745
NULL	Cell_Cycle_2013_Feb_15_12(4)_625-634.nxml.txt.nlp	23324396	SENT185	15	15	10	10	etoposide	p53	PA449552	7157	0.745
NULL	Cancer_Med_2013_Jun_25_2(3)_277-285.nxml.txt.nlp	23930204	SENT121	12	12	19	19	capecitabine	PTEN	PA448771	5728	0.745
NULL	Tuberc_Respir_Dis_(Seoul)_2014_Mar_29_76(3)_99-104.nxml.txt.nlp	24734096	SENT88	21	21	13	13	oxygen	CO2	PA450744	4513	0.745
NULL	Exp_Ther_Med_2012_Oct_23_4(4)_562-568.nxml.txt.nlp	23170106	SENT119	8	8	21	21	tegafur	CDHP	PA452620	1001	0.745
NULL	J_Mol_Signal_2010_May_10_5_4.nxml.txt.nlp	20459745	SENT147	12	12	23	23	cisplatin	p53	PA449014	7157	0.745
NULL	Leukemia_2013_Jan_11_27(1)_32-40.nxml.txt.nlp	22781593	SENT172	0	0	22	22	ponatinib	CD34	PA165980594	947	0.745
NULL	Front_Oncol_2013_Aug_12_3_206.nxml.txt.nlp	23964347	SENT180	35	35	14	14	paclitaxel	ERCC1	PA450761	2067	0.745
NULL	Carcinogenesis_2012_Nov_4_33(11)_2220-2227.nxml.txt.nlp	22798379	SENT547	10	10	3	3	cisplatin	EGFR	PA449014	1956	0.745
NULL	J_Vis_Exp_2009_Jun_8_(28)_1355.nxml.txt.nlp	19506547	SENT23	19	19	12	12	l-glutamine	L15	PA10090	6138;91057	0.745
NULL	Oncotarget_2010_Oct_22_1(7)_530-543.nxml.txt.nlp	21317449	SENT98	10	10	13	13	erlotinib	HER2	PA134687924	2064	0.745
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT12	12	12	25	25	l-leucine	ATP5A	PA450197	498	0.745
NULL	J_Occup_Med_Toxicol_2008_Feb_27_3(Suppl_1)_S6.nxml.txt.nlp	18315837	SENT67	6	6	15	15	salbutamol	IL-10	PA448068	3586	0.745
NULL	J_Immunol_Res_2014_May_8_2014_565320.nxml.txt.nlp	24901010	SENT84	28	28	8	8	allopurinol	HLA-B	PA448320	3106	0.745
NULL	Oncol_Rep_2012_Apr_30_27(4)_923-928.nxml.txt.nlp	22209766	SENT128	19	19	8	8	docetaxel	EGFR	PA449383	1956	0.745
NULL	Int_J_Alzheimers_Dis_2012_Jul_15_2012_489428.nxml.txt.nlp	22844635	SENT63	9	9	6	6	bexarotene	ABCA1	PA164752250	19	0.745
NULL	ScientificWorldJournal_2013_Dec_30_2013_645653.nxml.txt.nlp	24489509	SENT236	15	15	23	23	colistin	TOB	PA164760862	10140	0.745
NULL	Ann_Rheum_Dis_2009_Dec_4_68(12)_1870-1877.nxml.txt.nlp	19124524	SENT160	5	5	16	16	abatacept	ACR	PA164747080	49	0.745
NULL	J_Korean_Med_Sci_2006_Feb_20_21(1)_52-57.nxml.txt.nlp	16479065	SENT7	6	6	28	28	capecitabine	LARC	PA448771	6364	0.745
NULL	Mol_Cell_2014_May_8_54(3)_445-459.nxml.txt.nlp	24746700	SENT36	30	30	3	3	etoposide	BCLAF1	PA449552	9774	0.745
NULL	Indian_J_Ophthalmol_2007_Nov-Dec_55(6)_421-425.nxml.txt.nlp	17951897	SENT53	18	18	36	36	ranibizumab	VEGFR2	PA164746012	3791	0.745
NULL	Inflammation_2013_Apr_26_36(2)_387-404.nxml.txt.nlp	23100032	SENT116	23	23	4	4	carrageenan	HGB	PA448814	114757	0.745
NULL	Cancer_Cell_Int_2013_Sep_23_13_94.nxml.txt.nlp	24059699	SENT191	19	19	17	17	bevacizumab	VEGFA	PA130232992	7422	0.745
NULL	J_Hematol_Oncol_2010_Oct_27_3_42.nxml.txt.nlp	20979652	SENT172	24	24	12	12	cetuximab	EGFR	PA10040	1956	0.745
NULL	Oncotarget_2014_Aug_29_5(19)_8947-8958.nxml.txt.nlp	25333254	SENT215	5	5	44	44	plerixafor	CXCR4	PA165958410	7852	0.745
NULL	Oncotarget_2014_Feb_27_5(5)_1315-1325.nxml.txt.nlp	24675476	SENT158	7	7	14	14	choline	BRCA1	PA448976	672	0.745
NULL	Hematol_Rep_2011_Oct_10_3(2)_e16.nxml.txt.nlp	22184537	SENT71	10	10	7	7	acenocoumarol	CYP2C9	PA452632	1559	0.745
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Sep_5_65(Pt_10)_o2316.nxml.txt.nlp	21577787	SENT61	25	25	14	14	ethanol	mol	PA448073	90527	0.745
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT166	42	42	30	30	trastuzumab	MUC1	PA451743	4582	0.745
NULL	J_Adv_Pract_Oncol_2012_Nov_1_Nov-Dec_3(6)_355-356.nxml.txt.nlp	25031966	SENT30	18	18	20	20	diethylstilbestrol	DES	PA449307	1674	0.745
NULL	Front_Oncol_2013_Sep_6_3_218.nxml.txt.nlp	24032106	SENT122	17	17	37	37	daunorubicin	NPM1	PA449212	4869	0.745
NULL	Acta_Pharmacol_Sin_2011_Oct_5_32(10)_1276-1284.nxml.txt.nlp	21970838	SENT35	19	19	2	2	tranylcypromine	KET	PA451741	8626	0.745
NULL	Antimicrob_Agents_Chemother_2014_Aug_58(8)_4971-4973.nxml.txt.nlp	24913169	SENT13	30	30	13	13	primaquine	G6PD	PA451103	2539	0.745
NULL	J_Headache_Pain_2007_Dec_10_8(6)_340-341.nxml.txt.nlp	18071630	SENT1	19	19	8	8	naratriptan	B12	PA450597	7126;4709	0.745
NULL	Adv_Hematol_2012_Jul_24_2012_513702.nxml.txt.nlp	22888354	SENT69	3	3	6	6	lenalidomide	IL-2	PA162363968	3558	0.745
NULL	Eur_J_Appl_Physiol_2013_Jul_9_113(7)_1719-1729.nxml.txt.nlp	23397151	SENT222	17	17	10	10	lipase	LIPE	PA450239	3991	0.745
NULL	Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.nxml.txt.nlp	24736980	SENT5	30	30	5	5	rosuvastatin	OATP1B1	PA134308647	10599	0.745
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jan_22_67(Pt_2)_m236-m237.nxml.txt.nlp	21522892	SENT4	8	8	36	36	zinc	mol	PA451956	90527	0.745
NULL	J_Headache_Pain_2011_Feb_23_12(1)_81-88.nxml.txt.nlp	20862509	SENT144	0	0	8	8	rizatriptan	5-HT1B	PA451264	3351	0.745
NULL	Mol_Biol_Cell_2012_Oct_15_23(20)_4097-4108.nxml.txt.nlp	22918955	SENT148	11	11	30	30	lovastatin	MMP3	PA450272	4314	0.745
NULL	Clin_Pharmacokinet_2014_Sep_3_53(1)_1-16.nxml.txt.nlp	23999929	SENT268	4	4	14	14	rivaroxaban	P-gp	PA165958360	5243	0.745
NULL	Oxid_Med_Cell_Longev_2012_Jan_19_2012_390678.nxml.txt.nlp	22315655	SENT8	2	2	13	13	gliclazide	NAC	PA10892	22861	0.745
NULL	Indian_J_Pharmacol_2008_Oct_40(5)_221-226.nxml.txt.nlp	20040961	SENT58	9	9	36	36	metoclopramide	VHP	PA450475	285193	0.745
NULL	Acta_Pharmacol_Sin_2012_May_2_33(5)_615-624.nxml.txt.nlp	22465948	SENT193	30	30	15	15	glibenclamide	PRG	PA449782	5544	0.745
NULL	Mol_Cancer_2009_Feb_28_8_11.nxml.txt.nlp	19250552	SENT120	32	32	29	29	hydroxyurea	RRM2	PA449942	6241	0.745
NULL	ChemistryOpen_2014_Apr_13_3(2)_65-75.nxml.txt.nlp	24808993	SENT211	11	11	24	24	losartan	AT2	PA450268	186	0.745
NULL	Clin_Psychopharmacol_Neurosci_2011_Apr_30_9(1)_36-43.nxml.txt.nlp	23431025	SENT88	9	9	3	3	aripiprazole	FLI	PA10026	2314	0.745
NULL	Clin_Dev_Immunol_2007_Dec_13_2007_17315.nxml.txt.nlp	18320010	SENT118	11	11	31	31	gefitinib	VEGFR	PA131301952	3791	0.745
NULL	Biomed_Res_Int_2013_May_22_2013_430791.nxml.txt.nlp	23762845	SENT150	13	13	27	27	fasudil	STZ	PA165946121	6484	0.745
NULL	Support_Care_Cancer_2010_May_27_18(5)_529-541.nxml.txt.nlp	20191292	SENT62	5	5	0	0	vincristine	CHOP	PA451879	1649	0.745
NULL	Neuroscience_2010_Feb_17_165(4)_1412-1419.nxml.txt.nlp	19961905	SENT146	0	0	8	8	capsaicin	TRPV1	PA448776	7442	0.745
NULL	Mol_Cell_Biochem_2015_Oct_8_398(1-2)_165-173.nxml.txt.nlp	25292312	SENT111	19	19	27	27	bortezomib	HIF-1	PA10252	29072	0.745
NULL	Cardiovasc_J_Afr_2013_Mar_24(2)_19-23.nxml.txt.nlp	23750346	SENT156	11	11	3	3	warfarin	VKORC1	PA451906	79001	0.745
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Jul_9_3(7)_e124.nxml.txt.nlp	25006781	SENT8	30	30	24	24	rosuvastatin	OATP1B1	PA134308647	10599	0.745
NULL	Indian_J_Pharm_Sci_2008_Mar-Apr_70(2)_145-153.nxml.txt.nlp	20046703	SENT26	21	21	0	0	cyclosporine	P-gp	PA449167	5243	0.745
NULL	Oncotarget_2013_Nov_19_5(1)_95-102.nxml.txt.nlp	24395633	SENT34	7	7	9	9	etoposide	ICE	PA449552	834	0.745
NULL	J_Vis_Exp_2014_Mar_28_(85)_51300.nxml.txt.nlp	24747269	SENT285	11	11	4	4	thrombin	Rho	PA451674	29984	0.745
NULL	eLife_2014_May_6_3_e02482.nxml.txt.nlp	24843002	SENT180	16	16	5	5	etoposide	SETD2	PA449552	29072	0.745
NULL	J_Viral_Hepat_2010_Feb_17(2)_139-147.nxml.txt.nlp	19674282	SENT31	42	42	33	33	ribavirin	RVR	PA451241	9975	0.745
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Sep_20_64(Pt_10)_o1972.nxml.txt.nlp	21201172	SENT62	0	0	6	6	benzaldehyde	mol	PA448571	90527	0.745
NULL	Biomed_Res_Int_2014_Feb_27_2014_802539.nxml.txt.nlp	24719888	SENT26	4	4	8	8	isoflurane	NR1	PA450106	27158	0.745
NULL	Cerebrum_2012_May_30_2012_6.nxml.txt.nlp	23447792	SENT149	4	4	11	11	citalopram	STAR	PA449015	6770;2984	0.745
NULL	Diabetes_2009_Apr_16_58(4)_975-983.nxml.txt.nlp	19151200	SENT264	10	10	15	15	liraglutide	GLP-1	PA165958364	100125288	0.745
NULL	Indian_J_Pharmacol_2013_Sep-Oct_45(5)_458-463.nxml.txt.nlp	24130379	SENT109	2	2	7	7	carvedilol	TLR4	PA448817	7099	0.745
NULL	Arch_Drug_Inf_2008_Jul_1(1)_14-22.nxml.txt.nlp	20157364	SENT82	0	0	4	4	pravastatin	IL-6	PA451089	3569	0.745
NULL	Indian_J_Pharm_Sci_2012_Nov-Dec_74(6)_505-511.nxml.txt.nlp	23798775	SENT81	22	22	4	4	indomethacin	IL20	PA449982	50604	0.745
NULL	J_Korean_Med_Sci_2014_Jul_11_29(7)_965-972.nxml.txt.nlp	25045229	SENT154	30	30	6	6	metformin	B12	PA450395	7126;4709	0.745
NULL	Environ_Health_Perspect_2006_Sep_23_114(9)_1401-1406.nxml.txt.nlp	16966095	SENT24	23	23	30	30	arsenite	ID1	PA452638	3397	0.745
NULL	Exp_Ther_Med_2013_Aug_6_6(2)_427-434.nxml.txt.nlp	24137203	SENT124	29	29	4	4	fosinopril	MCP-1	PA449710	6347	0.745
NULL	Arthritis_Res_2000_Nov_15_1(Suppl_1)_S47.nxml.txt.nlp	NULL	SENT12	28	28	16	16	methotrexate	ACR	PA450428	49	0.745
NULL	Front_Aging_Neurosci_2010_May_18_2_16.nxml.txt.nlp	20559464	SENT210	5	5	14	14	indomethacin	COX	PA449982	1351	0.745
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Oct_29_67(Pt_11)_o3069-o3070.nxml.txt.nlp	22220078	SENT65	15	15	24	24	benzaldehyde	mol	PA448571	90527	0.745
NULL	Arthritis_Res_Ther_2005_Jun_21_7(4)_160-169.nxml.txt.nlp	15987500	SENT42	38	38	36	36	heparin	ADAMTS-4	PA449855	9508	0.745
NULL	Clin_Med_Insights_Oncol_2012_Mar_12_6_137-147.nxml.txt.nlp	22550402	SENT102	30	30	37	37	erlotinib	EGFR	PA134687924	1956	0.745
NULL	Carcinogenesis_2014_Sep_1_35(9)_2142-2153.nxml.txt.nlp	24986896	SENT208	7	7	24	24	everolimus	PTEN	PA164746311	5728	0.745
NULL	Br_J_Cancer_1998_Nov_78(10)_1361-1367.nxml.txt.nlp	9823980	SENT15	22	22	14	14	dextromethorphan	CYP3A	PA449273	1574	0.745
NULL	Cancers_(Basel)_2010_Apr_21_2(2)_653-669.nxml.txt.nlp	24281087	SENT77	25	25	17	17	cisplatin	HMGA2	PA449014	8091	0.745
NULL	Exp_Diabetes_Res_2012_Nov_1_2012_892706.nxml.txt.nlp	23197976	SENT272	19	19	3	3	vildagliptin	HIF-1	PA165958346	29072	0.745
NULL	Angiogenesis_2010_Dec_7_13(4)_305-315.nxml.txt.nlp	20927579	SENT143	4	4	8	8	resveratrol	p53		7157	0.745
NULL	Mar_Drugs_2014_Jun_27_12(7)_3818-3837.nxml.txt.nlp	24979269	SENT225	34	34	6	6	verapamil	P-gp	PA451868	5243	0.745
NULL	Breast_Cancer_Res_Treat_2012_Jul_31_134(1)_199-205.nxml.txt.nlp	22290080	SENT191	2	2	17	17	estradiol	EGF	PA449503	1950	0.745
NULL	Clin_Dev_Immunol_2011_Mar_28_2011_370872.nxml.txt.nlp	21461372	SENT7	11	11	17	17	tetracycline	IL-6	PA451640	3569	0.745
NULL	Acta_Pharmacol_Sin_2013_Feb_12_34(2)_255-261.nxml.txt.nlp	23147557	SENT163	29	29	25	25	pioglitazone	PTPRD	PA450970	5789	0.745
NULL	Drugs_Context_2012_Nov_19_2012_212242.nxml.txt.nlp	24432031	SENT175	12	12	5	5	sorafenib	VEGFR	PA7000	3791	0.745
NULL	Front_Neuroanat_2011_Jul_12_5_38.nxml.txt.nlp	21808606	SENT96	6	6	14	14	haloperidol	DARPP-32	PA449841	84152	0.745
NULL	Gynecol_Oncol_Case_Rep_2013_Dec_28_8_4-6.nxml.txt.nlp	24567884	SENT81	11	11	7	7	cisplatin	NAC	PA449014	22861	0.745
NULL	Indian_J_Dermatol_2009_Apr-Jun_54(2)_100-109.nxml.txt.nlp	20101303	SENT147	0	0	11	11	tocilizumab	IL-6	PA165292659	3569	0.745
NULL	Front_Neurol_2014_Jun_2_5_83.nxml.txt.nlp	24917847	SENT40	15	15	20	20	metformin	RANKL	PA450395	8600	0.745
NULL	Acta_Pharmacol_Sin_2009_Oct_21_30(10)_1392-1398.nxml.txt.nlp	19767766	SENT3	5	5	17	17	atorvastatin	ROS	PA448500	6098	0.745
NULL	Ann_Surg_Oncol_2010_Apr_22_17(4)_947-949.nxml.txt.nlp	20094919	SENT56	4	4	0	0	fluorouracil	IMPACT	PA128406956	55364	0.745
NULL	Oncoscience_2014_Aug_21_1(8)_513-521.nxml.txt.nlp	25594058	SENT27	29	29	31	31	docetaxel	EGFR	PA449383	1956	0.745
NULL	Neural_Regen_Res_2014_Nov_1_9(21)_1897-1901.nxml.txt.nlp	25558239	SENT131	5	5	17	17	diazepam	CA1	PA449283	759	0.745
NULL	Pharmaceutics_2012_Feb_16_4(1)_179-196.nxml.txt.nlp	24300187	SENT46	3	3	5	5	trimethoprim	TMP	PA451788	2012	0.745
NULL	Semin_Immunopathol_2012_Jan_6_34(1)_127-132.nxml.txt.nlp	21822632	SENT41	14	14	2	2	thrombin	PAR-1	PA451674	2011;2149	0.745
NULL	Protein_Cell_2014_Jun_19_5(6)_469-479.nxml.txt.nlp	24748116	SENT107	5	5	0	0	paclitaxel	EB1	PA450761	9167;22919;10982	0.745
NULL	Nucleic_Acids_Res_2013_Nov_13_41(20)_9471-9483.nxml.txt.nlp	23945945	SENT98	38	38	18	18	chlorhexidine	p16	PA164776863	1029	0.745
NULL	Front_Behav_Neurosci_2010_Apr_5_4_14.nxml.txt.nlp	20407577	SENT311	13	13	21	21	doxycycline	NAC1	PA449415	112939;6323	0.745
NULL	J_Cell_Biol_2001_Apr_2_153(1)_207-220.nxml.txt.nlp	11285286	SENT118	12	12	9	9	carbachol	CD69	PA448784	969	0.745
NULL	Br_J_Pharmacol_2014_Feb_24_171(1)_1019-1032.nxml.txt.nlp	24251620	SENT126	5	5	14	14	nifedipine	TRPM3	PA450631	80036	0.745
NULL	ScientificWorldJournal_2012_Apr_26_2012_358102.nxml.txt.nlp	22645419	SENT182	6	6	30	30	losartan	DES	PA450268	1674	0.745
NULL	AAPS_J_2012_Jan_4_14(1)_87-96.nxml.txt.nlp	22215264	SENT245	27	27	38	38	quinidine	P-gp	PA451209	5243	0.745
NULL	Indian_J_Pharmacol_2014_Nov-Dec_46(6)_627-632.nxml.txt.nlp	25538335	SENT146	6	6	4	4	metformin	Q10	PA450395	27161	0.745
NULL	Apoptosis_2014_Aug_26_19(11)_1603-1615.nxml.txt.nlp	25156145	SENT252	4	4	6	6	mitomycin	JNK	PA450524	5599	0.745
NULL	Eur_J_Clin_Pharmacol_2014_Oct_8_70(1)_37-45.nxml.txt.nlp	24100471	SENT200	4	4	12	12	pioglitazone	CYP3A4	PA450970	1576	0.745
NULL	Cardiovasc_Diabetol_2013_Mar_18_12_46.nxml.txt.nlp	23497197	SENT221	3	3	5	5	metformin	adiponectin	PA450395	9370	0.745
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jul_7_66(Pt_8)_o1952.nxml.txt.nlp	21588276	SENT76	29	29	32	32	benzaldehyde	mol	PA448571	90527	0.745
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT443	3	3	14	14	risperidone	PRL	PA451257	5617	0.745
NULL	Br_J_Cancer_2009_Sep_15_101(6)_924-934.nxml.txt.nlp	19690550	SENT257	27	27	7	7	irinotecan	CRT	PA450085	811	0.745
NULL	Open_Neurol_J_2008_May_7_2_20-24.nxml.txt.nlp	19018303	SENT96	7	7	17	17	roxithromycin	IL-8	PA164750505	3576	0.745
NULL	Exp_Ther_Med_2013_Nov_13_6(5)_1317-1321.nxml.txt.nlp	24223665	SENT111	30	30	17	17	cisplatin	CD133	PA449014	8842	0.745
NULL	Drug_Des_Devel_Ther_2014_Sep_23_8_1527-1538.nxml.txt.nlp	25284985	SENT129	30	30	13	13	celecoxib	IFN	PA448871	3439	0.745
NULL	Mol_Pain_2013_Feb_15_9_3.nxml.txt.nlp	23413875	SENT191	8	8	4	4	capsaicin	TRPV1	PA448776	7442	0.745
NULL	Ann_Biomed_Eng_2011_Apr_1_39(4)_1174-1185.nxml.txt.nlp	21120695	SENT112	14	14	6	6	calcein	DM1	PA132595336	338023;1760;28509	0.745
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jul_14_66(Pt_8)_o1996.nxml.txt.nlp	21588310	SENT73	31	31	24	24	benzaldehyde	mol	PA448571	90527	0.745
NULL	Cell_Death_Dis_2010_Nov_18_1(11)_e102.nxml.txt.nlp	21368867	SENT21	12	12	14	14	gentamicin	14-3-3	PA449753	10971	0.745
NULL	Neural_Plast_2012_Nov_2_2012_309494.nxml.txt.nlp	22164341	SENT102	24	24	7	7	tamoxifen	CA1	PA451581	759	0.745
NULL	Emerg_Infect_Dis_2012_Jun_18(6)_1010-1012.nxml.txt.nlp	22608114	SENT20	11	11	33	33	ethanol	NAK	PA448073	29110	0.745
NULL	Trials_2013_Apr_23_14_105.nxml.txt.nlp	23782520	SENT260	23	23	30	30	citalopram	STAR	PA449015	6770;2984	0.745
NULL	Br_J_Cancer_2009_May_5_100(9)_1415-1424.nxml.txt.nlp	19352384	SENT187	25	25	2	2	cisplatin	JNK1	PA449014	5599	0.745
NULL	Breast_Cancer_Res_2012_Feb_14_14(1)_R30.nxml.txt.nlp	22333315	SENT227	3	3	8	8	indomethacin	CXCL9	PA449982	4283	0.745
NULL	Brain_Sci_2013_Jun_19_3(2)_964-991.nxml.txt.nlp	24961433	SENT369	0	0	18	18	ethanol	DAG	PA448073	1605	0.745
NULL	Psychiatr_Genet_2013_Aug_28_23(4)_153-162.nxml.txt.nlp	23811784	SENT184	13	13	7	7	clozapine	HTR2A	PA449061	3356	0.745
NULL	Carcinogenesis_2010_Dec_27_31(12)_2049-2057.nxml.txt.nlp	20876285	SENT127	35	35	11	11	tamoxifen	HER2	PA451581	2064	0.745
NULL	Leukemia_2014_Mar_13_28(3)_600-608.nxml.txt.nlp	24240203	SENT194	4	4	2	2	nutlin-3	p53		7157	0.745
NULL	J_Cell_Mol_Med_2013_Sep_11_17(9)_1160-1172.nxml.txt.nlp	23844832	SENT264	15	15	13	13	pp2	PP1		5540;5464	0.745
NULL	Acta_Naturae_2013_Jul-Sep_5(3)_92-98.nxml.txt.nlp	24303205	SENT147	29	29	23	23	l-methionine	MGL	PA450423	11343	0.745
NULL	Carcinogenesis_2010_Dec_27_31(12)_2049-2057.nxml.txt.nlp	20876285	SENT336	19	19	31	31	letrozole	c-Myc	PA450196	4609	0.745
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Aug_11_67(Pt_9)_o2293.nxml.txt.nlp	22058933	SENT67	3	3	13	13	ethanol	mol	PA448073	90527	0.745
NULL	Endocr_Connect_2012_Jun_8_1(1)_1-12.nxml.txt.nlp	23781298	SENT192	18	18	7	7	fenofibrate	adiponectin	PA449594	9370	0.745
NULL	Blood_Cancer_J_2014_Oct_10_4(10)_eXX.nxml.txt.nlp	25303370	SENT58	9	9	14	14	fluorescein	San	PA164746009	80218	0.745
NULL	J_Exp_Med_1980_Dec_1_152(6)_1699-1708.nxml.txt.nlp	7452150	SENT3	1	1	16	16	trypsin	mol	PA451806	90527	0.745
NULL	J_Korean_Med_Sci_2005_Oct_31_20(5)_883-885.nxml.txt.nlp	16224167	SENT15	21	21	33	33	cyclophosphamide	gamma	PA449165	9913	0.745
NULL	Br_J_Cancer_2003_Mar_10_88(5)_788-795.nxml.txt.nlp	12618891	SENT172	22	22	17	17	bosentan	FasL	PA10034	356	0.745
NULL	J_Gen_Physiol_2008_Nov_132(5)_521-535.nxml.txt.nlp	18852303	SENT66	15	15	13	13	trypsin	CAP2	PA451806	5271;10486	0.745
NULL	Alzheimers_Res_Ther_2010_Oct_29_2(5)_31.nxml.txt.nlp	21062519	SENT65	7	7	13	13	atorvastatin	PSEN1	PA448500	5663	0.745
NULL	Clin_Epigenetics_2010_Sep_18_1(3-4)_101-116.nxml.txt.nlp	21258631	SENT240	5	5	25	25	curcumin	GCN5	PA151958596	2648;8850	0.745
NULL	Ann_Oncol_2010_Jul_23_21(7)_1436-1441.nxml.txt.nlp	20032126	SENT207	2	2	9	9	docetaxel	HER2	PA449383	2064	0.745
NULL	Curr_Gerontol_Geriatr_Res_2011_May_11_2011_624156.nxml.txt.nlp	21765826	SENT73	7	7	20	20	erythromycin	CYP3A	PA449493	1574	0.745
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT193	31	31	22	22	perifosine	DR4	PA165291471	8797	0.745
NULL	J_Mol_Signal_2008_Dec_1_3_18.nxml.txt.nlp	19046439	SENT79	15	15	20	20	metformin	Met	PA450395	79811	0.745
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT224	12	12	17	17	adalimumab	CD36	PA10004	948	0.745
NULL	Br_J_Cancer_2003_Mar_10_88(5)_788-795.nxml.txt.nlp	12618891	SENT120	9	9	18	18	bosentan	ETB	PA10034	1910	0.745
NULL	Indian_J_Endocrinol_Metab_2012_Dec_16(Suppl_2)_S252-S255.nxml.txt.nlp	23565392	SENT60	13	13	10	10	metformin	GLP-1	PA450395	100125288	0.745
NULL	Br_J_Clin_Pharmacol_2010_Jan_69(1)_23-26.nxml.txt.nlp	20078609	SENT86	2	2	17	17	sitaxentan	CYP3A4	PA165958361	1576	0.745
NULL	Aging_(Albany_NY)_2011_Apr_4_3(4)_348-362.nxml.txt.nlp	21483040	SENT109	7	7	16	16	metformin	BRCA1	PA450395	672	0.745
NULL	Diabetologia_2007_Mar_24_50(3)_654-665.nxml.txt.nlp	17245590	SENT12	13	13	24	24	rosiglitazone	adiponectin	PA451283	9370	0.745
NULL	Brain_Sci_2014_May_6_4(2)_356-375.nxml.txt.nlp	24961766	SENT208	6	6	23	23	propofol	CA1	PA451141	759	0.745
NULL	Curr_Osteoporos_Rep_2010_Dec_1_8(4)_178-184.nxml.txt.nlp	20809203	SENT199	16	16	12	12	rosiglitazone	PPARgamma	PA451283	5468	0.745
NULL	Ther_Clin_Risk_Manag_2007_Aug_3(4)_533-542.nxml.txt.nlp	18472974	SENT101	0	0	14	14	itraconazole	CYP3A4	PA450132	1576	0.745
NULL	Stroke_Res_Treat_2011_Nov_10_2011_212485.nxml.txt.nlp	22135769	SENT111	24	24	14	14	warfarin	CYP1A1	PA451906	1543	0.745
NULL	Br_J_Cancer_2014_Jan_21_110(2)_421-429.nxml.txt.nlp	24300973	SENT205	28	28	7	7	oxaliplatin	DAP3	PA131285527	58512;7818	0.745
NULL	Breast_Cancer_Res_2004_Mar_26_6(3)_R252-R263.nxml.txt.nlp	15084249	SENT110	40	40	16	16	tamoxifen	GSTM3	PA451581	2947	0.745
NULL	Drugs_R_D_2014_Sep_31_14(3)_177-184.nxml.txt.nlp	25079671	SENT124	6	6	24	24	miglitol	MCP-1	PA164776726	6347	0.745
NULL	Sensors_(Basel)_2012_Apr_20_12(4)_5170-5194.nxml.txt.nlp	22666081	SENT113	4	4	9	9	ethanol	IPA	PA448073	3160	0.745
NULL	J_Exerc_Nutrition_Biochem_2014_Sep_17_18(3)_267-275.nxml.txt.nlp	25566463	SENT29	0	0	13	13	creatine	ADP	PA164778930	23038	0.745
NULL	Ecotoxicology_2012_Oct_5_21(7)_1828-1840.nxml.txt.nlp	22562719	SENT209	4	4	7	7	propiconazole	BAF	PA165107991	8815	0.745
NULL	J_Cell_Biol_1998_Aug_24_142(4)_923-936.nxml.txt.nlp	9722606	SENT292	21	21	11	11	fluorescein	TGN	PA164746009	7038	0.745
NULL	Curr_Genomics_2014_Jun_15(3)_217-230.nxml.txt.nlp	24955029	SENT129	18	18	8	8	oxygen	ROS	PA450744	6098	0.745
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT112	5	5	17	17	neratinib	HER2	PA165291472	2064	0.745
NULL	Contemp_Oncol_(Pozn)_2012_Sep_29_16(4)_279-284.nxml.txt.nlp	23788895	SENT119	21	21	3	3	doxorubicin	FasL	PA449412	356	0.745
NULL	Mol_Cancer_2012_Apr_26_11_26.nxml.txt.nlp	22537224	SENT125	0	0	3	3	geldanamycin	CHK1	PA152031327	1111	0.745
NULL	J_Neuroinflammation_2011_Apr_16_8_35.nxml.txt.nlp	21496301	SENT75	16	16	28	28	collagenase	San	PA449107	80218	0.745
NULL	Acta_Pharmacol_Sin_2012_Aug_23_33(8)_1023-1029.nxml.txt.nlp	22820911	SENT60	15	15	8	8	glibenclamide	PAG	PA449782	55824	0.745
NULL	Diabetes_Metab_Syndr_Obes_2014_Aug_1_7_381-389.nxml.txt.nlp	25120374	SENT144	23	23	26	26	salsalate	AMPK	PA164745462	5563	0.745
NULL	J_Hematol_Oncol_2013_Dec_17_6_93.nxml.txt.nlp	24341609	SENT113	35	35	26	26	gefitinib	EGF	PA131301952	1950	0.745
NULL	Arthritis_Res_Ther_2008_Jun_2_10(3)_111.nxml.txt.nlp	18557992	SENT37	24	24	11	11	infliximab	HMGB1	PA452639	3146	0.745
NULL	Aging_(Albany_NY)_2012_Apr_18_4(4)_279-289.nxml.txt.nlp	22529334	SENT127	5	5	0	0	zinc	SOD1	PA451956	6647	0.745
NULL	Clin_Dev_Immunol_2013_Nov_26_2013_325481.nxml.txt.nlp	24371447	SENT147	8	8	14	14	propofol	IL-6	PA451141	3569	0.745
NULL	Diabetes_2011_Jun_21_60(6)_1770-1778.nxml.txt.nlp	21562078	SENT198	0	0	13	13	metformin	STZ	PA450395	6484	0.745
NULL	Eur_J_Clin_Pharmacol_2012_Jan_8_68(1)_29-37.nxml.txt.nlp	21739267	SENT12	34	34	18	18	fluvoxamine	CYP2D6	PA449690	1565	0.745
NULL	Ann_Dermatol_2014_Jun_12_26(3)_363-373.nxml.txt.nlp	24966637	SENT220	22	22	8	8	imiquimod	MT1-MMP	PA449972	4323	0.745
NULL	Br_J_Cancer_2012_Sep_25_107(7)_1059-1068.nxml.txt.nlp	22935581	SENT27	20	20	12	12	pazopanib	IFN	PA165291492	3439	0.745
NULL	Arthritis_Res_Ther_2013_Sep_10_15(5)_R110.nxml.txt.nlp	24020899	SENT161	32	32	19	19	pioglitazone	IL-6	PA450970	3569	0.745
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT192	12	12	20	20	trastuzumab	Yes	PA451743	7525	0.745
NULL	Braz_J_Med_Biol_Res_2012_Feb_17_45(3)_244-249.nxml.txt.nlp	22331137	SENT129	32	32	2	2	gentamicin	PAG	PA449753	55824	0.745
NULL	Clin_Med_Oncol_2008_Jun_11_2_469-470.nxml.txt.nlp	21892319	SENT5	17	17	25	25	doxorubicin	HER-2	PA449412	2064	0.745
NULL	Mol_Cancer_2010_Nov_8_9_291.nxml.txt.nlp	21059223	SENT86	3	3	0	0	paclitaxel	ZNF217	PA450761	7764	0.745
NULL	Diabetes_2011_Nov_17_60(11)_2691-2700.nxml.txt.nlp	21896928	SENT157	8	8	6	6	resveratrol	SIRT1		23411	0.745
NULL	Int_J_Endocrinol_2014_Jul_1_2014_685396.nxml.txt.nlp	25097549	SENT49	6	6	2	2	vemurafenib	BRAF	PA165946873	673	0.745
NULL	Eur_Arch_Psychiatry_Clin_Neurosci_2010_Mar_12_260(2)_101-111.nxml.txt.nlp	19856012	SENT168	30	30	18	18	clozapine	NR2D	PA449061	2906	0.745
NULL	Clinics_(Sao_Paulo)_2013_May_68(5)_694-701.nxml.txt.nlp	23778405	SENT225	24	24	13	13	curcumin	survivin	PA151958596	332	0.745
NULL	Cancer_Metastasis_Rev_2010_Dec_10_29(4)_581-594.nxml.txt.nlp	20830503	SENT278	22	22	11	11	exemestane	ARNO	PA449563	9266	0.745
NULL	Cancer_Immunol_Immunother_2014_Feb_11_63(5)_419-435.nxml.txt.nlp	24514955	SENT57	31	31	25	25	sorafenib	VEGFR	PA7000	3791	0.745
NULL	Mol_Cancer_2010_Apr_29_9_95.nxml.txt.nlp	20429933	SENT105	14	14	18	18	cisplatin	p63	PA449014	8626	0.745
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1821-1889.nxml.txt.nlp	25268160	SENT305	3	3	28	28	imatinib	FDG	PA10804	23583	0.745
NULL	Cancers_(Basel)_2014_Mar_25_6(2)_684-707.nxml.txt.nlp	24670368	SENT189	8	8	19	19	trastuzumab	HER2	PA451743	2064	0.745
NULL	Gut_Liver_2015_Jan_15_9(1)_103-108.nxml.txt.nlp	NULL	SENT4	27	27	29	29	lamivudine	LAM	PA450163	7249;7248	0.745
NULL	Int_J_Vasc_Med_2013_Mar_31_2013_543141.nxml.txt.nlp	23606968	SENT11	5	5	21	21	etanercept	IL-13	PA449515	3596	0.745
NULL	Oncol_Lett_2013_Mar_11_5(3)_1010-1016.nxml.txt.nlp	23426784	SENT104	23	23	32	32	midazolam	TRPM7	PA450496	54822	0.745
NULL	Front_Physiol_2011_Jul_19_2_40.nxml.txt.nlp	21811470	SENT136	1	1	12	12	candesartan	RVR	PA448765	9975	0.745
NULL	Cancer_Med_2014_Dec_11_3(6)_1502-1511.nxml.txt.nlp	25111859	SENT25	13	13	6	6	cisplatin	BTC	PA449014	685	0.745
NULL	Iran_J_Basic_Med_Sci_2012_Jul-Aug_15(4)_916-925.nxml.txt.nlp	23493150	SENT158	8	8	1	1	milrinone	INS-1	PA164749171	2305	0.745
NULL	J_Adv_Pract_Oncol_2012_May_1_May-Jun_3(3)_184-190.nxml.txt.nlp	25031945	SENT10	19	19	6	6	doxorubicin	ALK1	PA449412	6590;94	0.744
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT190	6	6	26	26	curcumin	PUMA	PA151958596	27113	0.744
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Jan_12_69(Pt_2)_o232-o233.nxml.txt.nlp	23424512	SENT81	0	0	16	16	olanzapine	mol	PA450688	90527	0.744
NULL	Indian_J_Nucl_Med_2010_Jul-Sep_25(3)_78-87.nxml.txt.nlp	NULL	SENT291	10	10	16	16	budesonide	gamma	PA448681	9913	0.744
NULL	Braz_J_Med_Biol_Res_2013_Jan_11_46(1)_91-97.nxml.txt.nlp	23314338	SENT104	20	20	24	24	dinoprostone	ANOVA	PA449345	4858	0.744
NULL	Pharmaceutics_2012_Jan_31_4(1)_93-103.nxml.txt.nlp	24300182	SENT24	20	20	41	41	amlodipine	PDF	PA448388	64146;9518	0.744
NULL	Cancer_Manag_Res_2013_Nov_21_5_387-400.nxml.txt.nlp	24294007	SENT72	1	1	15	15	panitumumab	KRAS	PA162373091	3845	0.744
NULL	Front_Endocrinol_(Lausanne)_2014_Oct_9_5_161.nxml.txt.nlp	25346723	SENT418	1	1	15	15	metformin	GLP-1	PA450395	100125288	0.744
NULL	Infect_Dis_Ther_2014_Jun_18_3(1)_35-43.nxml.txt.nlp	25134810	SENT118	20	20	12	12	oxacillin	VAN	PA450725	10318	0.744
NULL	Oncotarget_2010_Nov_22_1(7)_606-619.nxml.txt.nlp	21317456	SENT159	10	10	2	2	doxorubicin	BRCA2	PA449412	675	0.744
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Oct_26_69(Pt_11)_o1706.nxml.txt.nlp	24454132	SENT77	33	33	39	39	piperazine	mol	PA450977	90527	0.744
NULL	Alcohol_Alcohol_2009_Sep_19_Nov-Dec_44(6)_547-554.nxml.txt.nlp	19767625	SENT121	13	13	1	1	ethanol	ANOVA	PA448073	4858	0.744
NULL	Cancer_Res_Treat_2014_Apr_22_46(2)_194-199.nxml.txt.nlp	24851112	SENT45	13	13	5	5	capecitabine	HER2	PA448771	2064	0.744
NULL	Arthritis_Res_Ther_2014_Jan_15_16(1)_R10.nxml.txt.nlp	24423138	SENT287	3	3	12	12	collagenase	TRPV1	PA449107	7442	0.744
NULL	Drugs_Aging_2014_May_6_31(6)_413-424.nxml.txt.nlp	24797286	SENT49	22	22	10	10	denosumab	CTX	PA166048634	1593	0.744
NULL	Mol_Pain_2013_Jun_10_9_27.nxml.txt.nlp	23758830	SENT109	17	17	21	21	tetracaine	ASIC2a	PA451638	40	0.744
NULL	Adv_Biomed_Res_2014_Sep_4_3_184.nxml.txt.nlp	25250298	SENT115	22	22	7	7	tretinoin	CO2	PA451746	4513	0.744
NULL	AAPS_J_2012_Dec_7_15(2)_308-315.nxml.txt.nlp	23224752	SENT240	17	17	14	14	atazanavir	CYP3A5	PA10251	1577	0.744
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Jan_12_69(Pt_2)_o226.nxml.txt.nlp	23424507	SENT76	21	21	16	16	hydroquinone	mol	PA449924	90527	0.744
NULL	Eur_J_Med_Res_2014_Apr_9_19(1)_19.nxml.txt.nlp	24717101	SENT43	16	16	23	23	vincristine	CHOP	PA451879	1649	0.744
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT83	13	13	21	21	celecoxib	IL-6	PA448871	3569	0.744
NULL	Cancer_Microenviron_2008_Dec_20_1(1)_103-111.nxml.txt.nlp	19308689	SENT55	0	0	21	21	thrombin	PAR-1	PA451674	2011;2149	0.744
NULL	J_Korean_Med_Sci_2014_Jul_11_29(7)_965-972.nxml.txt.nlp	25045229	SENT78	12	12	5	5	metformin	B12	PA450395	7126;4709	0.744
NULL	Gastric_Cancer_2013_Jul_12_16(3)_345-354.nxml.txt.nlp	22968820	SENT159	6	6	18	18	oxaliplatin	FANCJ	PA131285527	83990	0.744
NULL	J_Gynecol_Oncol_2013_Jul_4_24(3)_265-272.nxml.txt.nlp	23875077	SENT177	18	18	32	32	thrombin	GAPDH	PA451674	2597	0.744
NULL	Br_J_Pharmacol_2014_May_171(10)_2659-2670.nxml.txt.nlp	24116661	SENT153	35	35	39	39	naringenin	TRPP2	PA151958361	5311	0.744
NULL	Case_Rep_Crit_Care_2014_Aug_19_2014_242703.nxml.txt.nlp	25215245	SENT24	24	24	7	7	nicardipine	APE	PA450620	55704;328	0.744
NULL	Bioinformation_2012_Mar_31_8(6)_276-280.nxml.txt.nlp	22493536	SENT111	6	6	0	0	lipase	BCHE	PA450239	590	0.744
NULL	J_Gynecol_Oncol_2012_Jan_9_23(1)_53-64.nxml.txt.nlp	22355468	SENT74	24	24	17	17	olaparib	BRCA2		675	0.744
NULL	Oncotarget_2013_Oct_19_4(11)_2045-2056.nxml.txt.nlp	24185104	SENT109	11	11	1	1	cisplatin	RhoGDI2	PA449014	397	0.744
NULL	Biomed_Res_Int_2014_May_13_2014_348647.nxml.txt.nlp	24949436	SENT122	3	3	15	15	chlorhexidine	PV1	PA164776863	83483	0.744
NULL	Ann_N_Y_Acad_Sci_2012_Aug_30_1264(1)_49-63.nxml.txt.nlp	22548651	SENT42	16	16	2	2	glucose	BDNF	PA449773	627	0.744
NULL	Avicenna_J_Med_2013_Apr-Jun_3(2)_37-47.nxml.txt.nlp	23930241	SENT202	27	27	5	5	methotrexate	CD4	PA450428	920	0.744
NULL	FEBS_Open_Bio_2014_Jan_21_4_153-161.nxml.txt.nlp	24490140	SENT334	14	14	0	0	cisplatin	WT1	PA449014	7490	0.744
NULL	Case_Rep_Dermatol_2013_Jan_18_5(1)_11-14.nxml.txt.nlp	23466694	SENT29	8	8	18	18	calcipotriol	LAM	PA448714	7249;7248	0.744
NULL	Ann_Surg_Treat_Res_2014_Feb_22_86(2)_68-75.nxml.txt.nlp	24761411	SENT18	18	18	12	12	oxaliplatin	Bcl-2	PA131285527	596	0.744
NULL	Clinics_(Sao_Paulo)_2011_Dec_66(12)_2179-2181.nxml.txt.nlp	22189748	SENT13	10	10	15	15	didanosine	CD4	PA449301	920	0.744
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT51	23	23	12	12	trastuzumab	HER2	PA451743	2064	0.744
NULL	Diagn_Pathol_2013_Feb_4_8_16.nxml.txt.nlp	23379953	SENT61	11	11	18	18	doxorubicin	CHOP	PA449412	1649	0.744
NULL	Braz_J_Med_Biol_Res_2013_Oct_2_46(10)_815-908.nxml.txt.nlp	24141608	SENT113	28	28	11	11	desvenlafaxine	CYP2D6	PA165958374	1565	0.744
NULL	Hum_Genomics_2009_Jan_1_3(2)_128-142.nxml.txt.nlp	19164090	SENT174	24	24	29	29	carboplatin	CD44	PA448803	960	0.744
NULL	Int_J_Mol_Sci_2012_Dec_3_13(12)_16373-16386.nxml.txt.nlp	23208375	SENT148	20	20	27	27	cisplatin	DDB2	PA449014	1643	0.744
NULL	Curr_Neuropharmacol_2013_Jan_11(1)_80-94.nxml.txt.nlp	23814540	SENT387	6	6	17	17	methamphetamine	c-fos	PA450403	2353	0.744
NULL	An_Bras_Dermatol_2014_Mar-Apr_89(2)_365-367.nxml.txt.nlp	24770527	SENT20	26	26	13	13	etanercept	IL-23	PA449515	51561	0.744
NULL	Diabetes_Care_2012_Feb_16_35(2)_327-333.nxml.txt.nlp	22179958	SENT181	18	18	13	13	metformin	B12	PA450395	7126;4709	0.744
NULL	Front_Neurosci_2012_May_30_6_77.nxml.txt.nlp	22661925	SENT262	21	21	24	24	ethanol	DCX	PA448073	1641	0.744
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT59	21	21	11	11	ranibizumab	VEGF-A	PA164746012	7422	0.744
NULL	Clin_Ophthalmol_2009_Jun_2_3_199-210.nxml.txt.nlp	19668566	SENT84	19	19	4	4	bromfenac	COX	PA448670	1351	0.744
NULL	Cancer_Metastasis_Rev_2009_Dec_16_28(3-4)_305-316.nxml.txt.nlp	20013032	SENT255	3	3	15	15	trastuzumab	ERBB2	PA451743	2064	0.744
NULL	Environ_Sci_Technol_2014_May_20_48(10)_5955-5963.nxml.txt.nlp	24762061	SENT139	17	17	11	11	diclofenac	API	PA449293	5345	0.744
NULL	Oncol_Rep_2014_Jul_15_32(1)_45-49.nxml.txt.nlp	24841138	SENT40	30	30	8	8	pp2	CO2		4513	0.744
NULL	Cancer_Cell_Int_2003_Jul_15_3_11.nxml.txt.nlp	12904267	SENT96	8	8	21	21	vinblastine	p53	PA451877	7157	0.744
NULL	Front_Neurosci_2014_May_27_8_129.nxml.txt.nlp	24904269	SENT474	15	15	7	7	ethanol	AC5	PA448073	111	0.744
NULL	Diabetes_Care_2012_Feb_16_35(2)_327-333.nxml.txt.nlp	22179958	SENT3	21	21	6	6	metformin	B12	PA450395	7126;4709	0.744
NULL	Breast_Cancer_Res_Treat_2014_Nov_24_143(1)_125-133.nxml.txt.nlp	24272078	SENT207	6	6	13	13	anastrozole	aromatase	PA448432	1588	0.744
NULL	Oncoscience_2014_Mar_12_1(2)_167-179.nxml.txt.nlp	25126591	SENT226	9	9	5	5	trastuzumab	PTEN	PA451743	5728	0.744
NULL	J_Asthma_Allergy_2008_Sep_19_1_19-29.nxml.txt.nlp	21436982	SENT112	2	2	13	13	fexofenadine	IL-4	PA449621	3565	0.744
NULL	Clin_Mol_Hepatol_2014_Sep_25_20(3)_283-290.nxml.txt.nlp	25320732	SENT21	2	2	0	0	propranolol	EVL	PA451145	51466	0.744
NULL	Gut_2011_May_29_60(5)_638-647.nxml.txt.nlp	21115544	SENT311	12	12	10	10	cisapride	5-HT4	PA449011	3360	0.744
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT146	2	2	9	9	atorvastatin	survivin	PA448500	332	0.744
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jun_27_68(Pt_7)_o2237.nxml.txt.nlp	22798893	SENT75	4	4	10	10	piperazine	mol	PA450977	90527	0.744
NULL	Diabetes_Care_2008_Oct_31(10)_2062-2069.nxml.txt.nlp	18820229	SENT238	11	11	42	42	ramipril	DREAM	PA451223	30818	0.744
NULL	Arthritis_Res_Ther_2008_Jun_2_10(3)_111.nxml.txt.nlp	18557992	SENT35	6	6	0	0	infliximab	HMGB1	PA452639	3146	0.744
NULL	Indian_J_Pharmacol_2009_Dec_41(6)_262-267.nxml.txt.nlp	20407557	SENT153	6	6	1	1	ezetimibe	VIII	PA10816	1351	0.744
NULL	Arthritis_Rheumatol_2014_Jun_27_66(6)_1574-1582.nxml.txt.nlp	24577881	SENT111	0	0	8	8	hydralazine	KIR	PA449894	2669	0.744
NULL	J_Neurovirol_2013_Jun_4_19(4)_351-358.nxml.txt.nlp	23733308	SENT6	6	6	3	3	mefloquine	SOC	PA450348	91544	0.744
NULL	J_Biol_Chem_2008_Nov_14_283(46)_31679-31689.nxml.txt.nlp	18755684	SENT30	6	6	3	3	iron	FTL	PA450087	2512	0.744
NULL	Cancer_Cell_Int_2014_Jun_11_14_49.nxml.txt.nlp	24991192	SENT128	26	26	16	16	berberine	AMPK	PA165860812	5563	0.744
NULL	J_Hematol_Oncol_2012_Apr_25_5(Suppl_1)_A1.nxml.txt.nlp	22738713	SENT7	0	0	12	12	trastuzumab	HER2	PA451743	2064	0.744
NULL	Indian_J_Med_Res_2011_Jun_133(6)_633-640.nxml.txt.nlp	21727662	SENT26	41	41	15	15	genistein	TPO	PA165109660	7066;7173	0.744
NULL	J_Hematol_Oncol_2012_Apr_25_5(Suppl_1)_A8.nxml.txt.nlp	NULL	SENT19	8	8	16	16	rituximab	BII	PA451261	777	0.744
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Nov_14_65(Pt_12)_o3083.nxml.txt.nlp	21578813	SENT69	32	32	19	19	ethanol	mol	PA448073	90527	0.744
NULL	J_Hematol_Oncol_2010_Mar_13_3_10.nxml.txt.nlp	20226083	SENT115	19	19	14	14	gemcitabine	RRM1	PA449748	6240	0.744
NULL	J_Immunother_Cancer_2014_Jan_27_2_2.nxml.txt.nlp	24829759	SENT112	13	13	9	9	sorafenib	IL-21	PA7000	59067;50616;27189	0.744
NULL	Open_Neurol_J_2013_May_31_7_23-31.nxml.txt.nlp	23894259	SENT70	0	0	11	11	risperidone	5-HT2C	PA451257	3358	0.744
NULL	Indian_Dermatol_Online_J_2014_Oct-Dec_5(4)_539-540.nxml.txt.nlp	25396160	SENT33	11	11	5	5	azathioprine	gamma	PA448515	9913	0.744
NULL	Evid_Based_Complement_Alternat_Med_2013_Aug_12_2013_301549.nxml.txt.nlp	23997792	SENT177	8	8	4	4	tamoxifen	CAM	PA451581	889	0.744
NULL	Breast_Cancer_Res_2011_Jun_29_13(3)_R70.nxml.txt.nlp	21707964	SENT237	32	32	25	25	tamoxifen	14-3-3	PA451581	10971	0.744
NULL	Ann_Lab_Med_2012_Jul_20_32(4)_264-269.nxml.txt.nlp	22779067	SENT15	10	10	7	7	isoniazid	DST	PA450112	667	0.744
NULL	Mol_Cancer_2010_Dec_20_9_316.nxml.txt.nlp	21172016	SENT163	31	31	20	20	heparin	CCL21	PA449855	6366	0.744
NULL	J_Gen_Physiol_1997_Dec_1_110(6)_643-654.nxml.txt.nlp	9382893	SENT182	24	24	26	26	diazoxide	ADP	PA449285	23038	0.744
NULL	Case_Rep_Gastroenterol_2014_Jul_5_8(2)_240-244.nxml.txt.nlp	25120415	SENT44	10	10	7	7	ganciclovir	gamma	PA449733	9913	0.744
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Apr_13_69(Pt_5)_m257-m258.nxml.txt.nlp	23723769	SENT79	37	37	15	15	ethanol	NO3	PA448073	4681	0.744
NULL	Oncotarget_2014_Sep_10_5(19)_8924-8936.nxml.txt.nlp	25238040	SENT113	7	7	28	28	decitabine	p53	PA164749631	7157	0.744
NULL	Cell_Death_Dis_2014_Jan_30_5(1)_e1038.nxml.txt.nlp	24481452	SENT232	11	11	9	9	raloxifene	CYP1A1	PA451221	1543	0.744
NULL	Diabetes_2009_Jan_58(1)_87-94.nxml.txt.nlp	18984739	SENT245	28	28	40	40	cerulenin	POMC	PA164764551	5443	0.744
NULL	Cancer_Med_2013_Feb_3_2(1)_11-20.nxml.txt.nlp	24133623	SENT291	7	7	24	24	leucovorin	KRAS	PA450198	3845	0.744
NULL	Br_J_Anaesth_2014_Jul_22_113(1)_157-167.nxml.txt.nlp	24154701	SENT16	26	26	5	5	sevoflurane	TREK-1	PA451341	3776	0.744
NULL	Scientifica_(Cairo)_2012_Dec_25_2012_561761.nxml.txt.nlp	24278716	SENT447	11	11	20	20	remifentanil	PAG	PA451232	55824	0.744
NULL	Cancers_(Basel)_2014_Jun_27_6(3)_1298-1327.nxml.txt.nlp	24978435	SENT149	11	11	5	5	collagenase	IL-8	PA449107	3576	0.744
NULL	Aging_(Albany_NY)_2011_Dec_12_3(11)_1063-1077.nxml.txt.nlp	22170748	SENT160	8	8	20	20	metformin	HER2	PA450395	2064	0.744
NULL	Mol_Cancer_2008_Mar_6_7_24.nxml.txt.nlp	18325101	SENT38	22	22	18	18	cisplatin	FANCD2	PA449014	2177	0.744
NULL	Neuropsychopharmacology_2011_Apr_2_36(5)_1033-1046.nxml.txt.nlp	21289603	SENT251	12	12	20	20	ethanol	MSN	PA448073	4478	0.744
NULL	Breast_Cancer_Res_Treat_2013_Aug_20_141(1)_43-53.nxml.txt.nlp	23959396	SENT185	37	37	15	15	trastuzumab	HER3	PA451743	2065	0.744
NULL	Nat_Med_2011_Oct_2_17(10)_1304-1309.nxml.txt.nlp	21963515	SENT203	8	8	25	25	tacrolimus	NKCC2	PA451578	6557	0.744
NULL	Pharmacogn_Rev_2011_Jul-Dec_5(10)_120-137.nxml.txt.nlp	22279370	SENT301	18	18	15	15	evodiamine	COX2	PA165860788	4513;5743	0.744
NULL	Ecancermedicalscience_2009_Oct_12_3_161.nxml.txt.nlp	22276022	SENT91	10	10	2	2	trastuzumab	HER-2	PA451743	2064	0.744
NULL	Breast_Cancer_Res_2012_Jul_19_14(4)_R109.nxml.txt.nlp	22812567	SENT296	31	31	6	6	gemcitabine	CHK1	PA449748	1111	0.744
NULL	Diabetes_Obes_Metab_2011_Nov_13(11)_982-989.nxml.txt.nlp	21615670	SENT175	14	14	32	32	sitagliptin	PPG	PA164748978	5552	0.744
NULL	Dermatol_Pract_Concept_2012_Apr_30_2(2)_0202a03.nxml.txt.nlp	23785591	SENT54	9	9	15	15	doxorubicin	CHOP	PA449412	1649	0.744
NULL	Oncol_Lett_2014_Jul_10_8(1)_387-393.nxml.txt.nlp	24959282	SENT41	0	0	6	6	etoposide	E2F1	PA449552	1869	0.744
NULL	Nat_Commun_2014_Jun_30_5_4209.nxml.txt.nlp	24979243	SENT192	27	27	25	25	heparin	FGF4	PA449855	2249	0.744
NULL	Ann_Clin_Microbiol_Antimicrob_2005_Sep_13_4_13.nxml.txt.nlp	16159399	SENT266	8	8	4	4	lamivudine	IFN	PA450163	3439	0.744
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1137-1144.nxml.txt.nlp	20234366	SENT165	38	38	42	42	cetuximab	KRAS	PA10040	3845	0.744
NULL	J_Mol_Signal_2010_May_10_5_4.nxml.txt.nlp	20459745	SENT115	8	8	15	15	cisplatin	p53	PA449014	7157	0.744
NULL	Aging_(Albany_NY)_2009_Feb_18_1(3)_335-349.nxml.txt.nlp	20195489	SENT111	16	16	20	20	etoposide	p65	PA449552	5970	0.744
NULL	Oncol_Lett_2014_Jan_11_7(1)_82-86.nxml.txt.nlp	24348826	SENT51	44	44	6	6	hydrocortisone	San	PA449905	80218	0.744
NULL	J_Cancer_2013_Sep_27_4(8)_662-670.nxml.txt.nlp	24155778	SENT149	8	8	2	2	cisplatin	UCHL1	PA449014	7345	0.744
NULL	Mol_Biol_Cell_2013_Sep_1_24(17)_2678-2688.nxml.txt.nlp	23864716	SENT252	9	9	3	3	thrombin	RhoA	PA451674	387	0.744
NULL	Front_Cell_Neurosci_2015_Jan_15_8_459.nxml.txt.nlp	25642166	SENT88	0	0	3	3	hemin	HO-1	PA449849	3162	0.744
NULL	Adv_Hematol_2010_Dec_5_2010_595934.nxml.txt.nlp	21151515	SENT16	2	2	28	28	clopidogrel	ADP	PA449053	23038	0.744
NULL	Br_J_Cancer_1996_Aug_74(3)_418-422.nxml.txt.nlp	8695358	SENT8	15	15	4	4	collagenase	PC-3	PA449107	692094	0.744
NULL	Brain_Behav_2013_Mar_6_3(2)_114-133.nxml.txt.nlp	23533150	SENT250	21	21	6	6	ethanol	HSF1	PA448073	3297	0.744
NULL	Evid_Based_Complement_Alternat_Med_2013_Mar_13_2013_685642.nxml.txt.nlp	23573144	SENT49	14	14	6	6	glimepiride	STZ	PA449761	6484	0.744
NULL	J_Oncol_2012_Sep_5_2012_128608.nxml.txt.nlp	21904549	SENT125	13	13	22	22	bevacizumab	VEGFR2	PA130232992	3791	0.744
NULL	Ann_N_Y_Acad_Sci_2012_Oct_10_1271(1)_10-19.nxml.txt.nlp	23050959	SENT203	11	11	7	7	doxorubicin	SIRT1	PA449412	23411	0.744
NULL	J_Exp_Clin_Cancer_Res_2009_Jul_10_28(1)_99.nxml.txt.nlp	19591692	SENT122	7	7	11	11	tariquidar	ABCG2		9429	0.744
NULL	Diabetes_2009_Jul_28_58(7)_1659-1667.nxml.txt.nlp	19401417	SENT259	6	6	2	2	aspirin	ARI	PA448497	25820	0.744
NULL	Virol_J_2009_Dec_1_6_213.nxml.txt.nlp	19951438	SENT8	17	17	22	22	mitomycin	TRAIL	PA450524	8743	0.744
NULL	Breast_Cancer_Res_2004_Oct_6_6(6)_269-274.nxml.txt.nlp	15535858	SENT17	9	9	14	14	letrozole	aromatase	PA450196	1588	0.744
NULL	Front_Immunol_2013_Nov_8_4_363.nxml.txt.nlp	24265631	SENT255	11	11	21	21	dacarbazine	CCL5	PA449197	6352	0.744
NULL	Br_J_Pharmacol_2012_Jan_165(2)_390-400.nxml.txt.nlp	21671897	SENT199	17	17	37	37	suramin	P2X1	PA10292	5023	0.744
NULL	Diabetes_Care_2009_Aug_32(8)_e94-e98.nxml.txt.nlp	19638520	SENT114	12	12	23	23	resveratrol	SIRT1		23411	0.744
NULL	Endocrinol_Metab_(Seoul)_2014_Sep_25_29(3)_379-387.nxml.txt.nlp	25309798	SENT42	20	20	17	17	resveratrol	SIRT1		23411	0.744
NULL	Breast_Cancer_Res_2014_May_28_16(3)_R53.nxml.txt.nlp	24886537	SENT315	12	12	3	3	erlotinib	VAV3	PA134687924	10451	0.744
NULL	Oncol_Lett_2014_May_11_7(5)_1401-1408.nxml.txt.nlp	24765145	SENT121	0	0	9	9	paclitaxel	HIF-1	PA450761	29072	0.744
NULL	Biomed_Res_Int_2014_May_14_2014_278956.nxml.txt.nlp	24949431	SENT100	20	20	11	11	resveratrol	CAV1		857	0.744
NULL	Clin_Ophthalmol_2009_Jun_2_3_291-295.nxml.txt.nlp	19668581	SENT109	24	24	14	14	latanoprost	BAK	PA164774763	578	0.744
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Mar_7_68(Pt_4)_o968.nxml.txt.nlp	22590024	SENT74	4	4	20	20	piperazine	mol	PA450977	90527	0.744
NULL	Mol_Cells_2014_Mar_31_37(3)_234-240.nxml.txt.nlp	24642709	SENT157	6	6	11	11	capsaicin	HO-1	PA448776	3162	0.744
NULL	Br_J_Anaesth_2014_Jul_22_113(1)_157-167.nxml.txt.nlp	24154701	SENT48	8	8	2	2	sevoflurane	TREK-1	PA451341	3776	0.744
NULL	Clin_Med_Insights_Oncol_2012_Feb_28_6_125-135.nxml.txt.nlp	22408376	SENT192	15	15	23	23	panitumumab	KRAS	PA162373091	3845	0.744
NULL	Front_Chem_2014_Mar_14_2_12.nxml.txt.nlp	24790981	SENT151	11	11	17	17	curcumin	p300	PA151958596	2033	0.744
NULL	Chin_J_Cancer_2012_Feb_31(2)_73-99.nxml.txt.nlp	22098950	SENT261	12	12	19	19	axitinib	ATP7A	PA164924493	538	0.744
NULL	Clin_Mol_Hepatol_2014_Sep_25_20(3)_283-290.nxml.txt.nlp	25320732	SENT123	5	5	3	3	propranolol	EVL	PA451145	51466	0.744
NULL	Exp_Ther_Med_2014_Mar_17_7(3)_703-708.nxml.txt.nlp	24520271	SENT10	23	23	28	28	doxorubicin	CD11b	PA449412	3684	0.744
NULL	Oxid_Med_Cell_Longev_2011_Oct_9_2011_756938.nxml.txt.nlp	22007271	SENT167	26	26	16	16	forskolin	PNMT	PA146096022	5409	0.744
NULL	Oncologist_2010_Feb_15_15(2)_122-129.nxml.txt.nlp	20156908	SENT36	18	18	10	10	letrozole	HER-2	PA450196	2064	0.744
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT49	31	31	7	7	coumarin	CYP2C8	PA134521193	1558	0.744
NULL	J_Headache_Pain_2010_Feb_10_11(1)_5-12.nxml.txt.nlp	20012125	SENT52	20	20	25	25	sumatriptan	c-fos	PA451566	2353	0.744
NULL	Exp_Cell_Res_2013_Aug_1_319(13)_2037-2048.nxml.txt.nlp	23562655	SENT15	26	26	44	44	urokinase	MMP1	PA451836	4312	0.744
NULL	Nat_Neurosci_2012_Sep_5_15(9)_1245-1254.nxml.txt.nlp	22864611	SENT503	25	25	6	6	clozapine	HDAC2	PA449061	3066	0.744
NULL	Adv_Ther_2013_Oct_25_30(10)_870-884.nxml.txt.nlp	24158787	SENT99	7	7	18	18	everolimus	aromatase	PA164746311	1588	0.744
NULL	Cancers_(Basel)_2013_Jul_4_5(3)_838-856.nxml.txt.nlp	24202322	SENT207	17	17	28	28	flavopiridol	p53	PA452627	7157	0.744
NULL	Br_J_Cancer_2010_Jan_5_102(1)_80-86.nxml.txt.nlp	19920817	SENT123	17	17	29	29	sunitinib	IFN	PA162372840	3439	0.744
NULL	Endocrinol_Metab_(Seoul)_2014_Sep_25_29(3)_379-387.nxml.txt.nlp	25309798	SENT105	2	2	11	11	resveratrol	BMAL1		406	0.744
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_13_2014_849783.nxml.txt.nlp	25477998	SENT305	2	2	12	12	berberine	IL-6	PA165860812	3569	0.744
NULL	Environ_Sci_Technol_2014_May_6_48(9)_5211-5219.nxml.txt.nlp	24422420	SENT267	20	20	18	18	estradiol	gamma	PA449503	9913	0.744
NULL	Breast_Cancer_Res_2011_Mar_11_13(2)_R29.nxml.txt.nlp	21396094	SENT168	8	8	2	2	fulvestrant	HRG	PA164747170	3084;3273	0.744
NULL	Eur_J_Neurosci_2007_Aug_26(4)_935-942.nxml.txt.nlp	17714187	SENT26	14	14	29	29	capsaicin	TRPV1	PA448776	7442	0.744
NULL	J_Korean_Med_Sci_2012_Sep_22_27(9)_1037-1043.nxml.txt.nlp	22969249	SENT93	22	22	40	40	paricalcitol	CDK2	PA450798	1017	0.744
NULL	Med_Sci_Monit_2012_Jun_1_18(6)_BR247-BR252.nxml.txt.nlp	22648246	SENT22	10	10	17	17	celecoxib	IBP	PA448871	706;50619	0.744
NULL	J_Biomed_Biotechnol_2010_May_23_2010_798467.nxml.txt.nlp	20508851	SENT52	0	0	3	3	cyclophosphamide	CTX	PA449165	1593	0.744
NULL	Cell_Cycle_2012_Nov_1_11(21)_4069-4078.nxml.txt.nlp	23095523	SENT70	23	23	19	19	imatinib	PERK	PA10804	9451	0.744
NULL	Oncotarget_2014_Jun_6_5(13)_4935-4944.nxml.txt.nlp	24952732	SENT82	11	11	23	23	doxazosin	PI3K	PA449407	5290	0.744
NULL	Reprod_Biol_Endocrinol_2003_Jul_9_1_52.nxml.txt.nlp	12904263	SENT20	19	19	21	21	diethylstilbestrol	DES	PA449307	1674	0.744
NULL	Curr_Cardiol_Rev_2013_Aug_9(3)_230-240.nxml.txt.nlp	23909633	SENT50	24	24	28	28	eplerenone	EGFR	PA164749044	1956	0.744
NULL	Exp_Cell_Res_2013_Apr_1_319(6)_800-809.nxml.txt.nlp	23247073	SENT205	3	3	8	8	curcumin	AKT	PA151958596	207	0.744
NULL	Scientifica_(Cairo)_2012_Nov_25_2012_473829.nxml.txt.nlp	24278698	SENT343	33	33	14	14	cisplatin	OCT1	PA449014	5451;6580	0.744
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT115	0	0	2	2	perifosine	DR4	PA165291471	8797	0.744
NULL	Cancer_Res_Treat_2014_Jul_15_46(3)_209-222.nxml.txt.nlp	25038756	SENT169	27	27	4	4	cisplatin	EZH2	PA449014	2146	0.744
NULL	J_Clin_Immunol_2007_May_14_27(3)_275-283.nxml.txt.nlp	17510806	SENT148	8	8	3	3	rosiglitazone	ZO-1	PA451283	7082	0.744
NULL	Mucosal_Immunol_2011_May_10_4(3)_304-313.nxml.txt.nlp	21068720	SENT230	8	8	21	21	dextran	Diva	PA449261	10017	0.744
NULL	Curr_Respir_Med_Rev_2013_Aug_9(4)_238-247.nxml.txt.nlp	24634642	SENT24	15	15	11	11	ibritumomab	CHOP	PA164781375	1649	0.744
NULL	Oxid_Med_Cell_Longev_2013_May_7_2013_984546.nxml.txt.nlp	23738048	SENT28	23	23	17	17	arsenite	HO-1	PA452638	3162	0.744
NULL	Angiogenesis_2010_Dec_7_13(4)_305-315.nxml.txt.nlp	20927579	SENT214	8	8	13	13	resveratrol	THBS1		7057	0.744
NULL	Cell_Death_Dis_2014_Jan_16_5(1)_e1000.nxml.txt.nlp	24434508	SENT179	34	34	46	46	collagenase	CO2	PA449107	4513	0.744
NULL	Eur_J_Appl_Physiol_2011_Feb_24_111(2)_275-283.nxml.txt.nlp	20865425	SENT105	14	14	5	5	glucose	APE	PA449773	55704;328	0.744
NULL	J_Immunol_Res_2014_Jul_16_2014_696812.nxml.txt.nlp	25133198	SENT247	17	17	5	5	rifaximin	TLR2	PA164752443	7097	0.744
NULL	J_Ginseng_Res_2011_Nov_35(4)_436-441.nxml.txt.nlp	23717089	SENT107	21	21	32	32	ginseng	CAGC	PA164781150	6283	0.744
NULL	Diagn_Pathol_2013_Jul_2_8_108.nxml.txt.nlp	23819507	SENT130	17	17	15	15	thyroglobulin	TTF-1	PA164754910	7080	0.744
NULL	Clin_Interv_Aging_2012_Dec_30_7_1-13.nxml.txt.nlp	22291468	SENT268	20	20	11	11	phenytoin	CYP3A4	PA450947	1576	0.744
NULL	Breast_Cancer_Res_Treat_2009_Jul_22_116(2)_371-378.nxml.txt.nlp	18941892	SENT147	19	19	13	13	letrozole	aromatase	PA450196	1588	0.744
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1554-1562.nxml.txt.nlp	21970876	SENT145	11	11	3	3	afatinib	EGFR	PA165981154	1956	0.744
NULL	Nature_2012_Jan_11_481(7381)_329-334.nxml.txt.nlp	22237022	SENT131	12	12	8	8	carboplatin	TPT	PA448803	23590;6469	0.744
NULL	Cough_2009_Nov_20_5_9.nxml.txt.nlp	19930579	SENT24	5	5	0	0	capsaicin	TRPV1	PA448776	7442	0.744
NULL	Mol_Vis_2011_Sep_27_17_2495-2506.nxml.txt.nlp	21976960	SENT217	8	8	15	15	sirolimus	PDEF	PA451365	25803	0.744
NULL	Mol_Pain_2012_Sep_24_8_74.nxml.txt.nlp	23006894	SENT68	13	13	25	25	carbamazepine	TNP1	PA448785	7141	0.744
NULL	Front_Oncol_2013_Aug_5_3_195.nxml.txt.nlp	23936763	SENT209	11	11	21	21	erlotinib	EGFR	PA134687924	1956	0.744
NULL	J_Hematol_Oncol_2011_Jan_21_4_5.nxml.txt.nlp	21255411	SENT240	36	36	38	38	erlotinib	GC-E	PA134687924	390226	0.744
NULL	Virchows_Arch_2012_Feb_16_460(2)_141-149.nxml.txt.nlp	22173329	SENT226	15	15	8	8	irinotecan	BRAF	PA450085	673	0.744
NULL	Anal_Chem_Insights_2007_Sep_17_2_61-67.nxml.txt.nlp	19662178	SENT86	34	34	40	40	calcein	LIP	PA132595336	23049	0.744
NULL	Mol_Vis_2011_Dec_24_17_3384-3391.nxml.txt.nlp	22219634	SENT151	27	27	12	12	mannitol	TLR2	PA450320	7097	0.744
NULL	Case_Rep_Oncol_2010_Apr_22_3(2)_98-105.nxml.txt.nlp	20740181	SENT61	20	20	13	13	erlotinib	CYP3A4	PA134687924	1576	0.744
NULL	Arthritis_Res_Ther_2003_Feb_28_5(3)_105-115.nxml.txt.nlp	12723975	SENT300	4	4	7	7	hyaluronan	CD44	PA165958431	960	0.744
NULL	Behav_Brain_Funct_2014_Feb_13_10_5.nxml.txt.nlp	24524628	SENT124	24	24	3	3	capsaicin	TRPV1	PA448776	7442	0.744
NULL	Arthritis_Res_Ther_2012_Sep_24_14(5)_R200.nxml.txt.nlp	23006144	SENT164	9	9	13	13	alefacept	IL-20	PA164748040	27190;50604	0.744
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT18	6	6	11	11	pp2	PP2		4888	0.744
NULL	Diabetes_2013_Jun_17_62(6)_2141-2150.nxml.txt.nlp	23378610	SENT213	4	4	12	12	betaine	BHMT	PA448603	635	0.744
NULL	Stroke_Res_Treat_2009_Dec_20_2010_386389.nxml.txt.nlp	20700422	SENT200	8	8	6	6	ebselen	JNK	PA161660841	5599	0.744
NULL	Gut_Liver_2011_Jun_24_5(2)_160-164.nxml.txt.nlp	21814595	SENT83	10	10	7	7	midazolam	ESD	PA450496	2098	0.744
NULL	J_Invest_Dermatol_2013_Sep_31_133(9)_2247-2254.nxml.txt.nlp	23370537	SENT68	8	8	11	11	etoposide	p53	PA449552	7157	0.744
NULL	Hum_Genomics_Proteomics_2010_Aug_3_2010_159761.nxml.txt.nlp	20981231	SENT271	32	32	9	9	lithium	BDNF	PA450243	627	0.744
NULL	Acta_Pharmacol_Sin_2013_Jan_23_34(1)_33-38.nxml.txt.nlp	22820909	SENT73	8	8	13	13	amiloride	ASIC3	PA448368	9311	0.744
NULL	Br_J_Cancer_2010_Sep_7_103(6)_796-801.nxml.txt.nlp	20823888	SENT34	13	13	32	32	temsirolimus	AST	PA164746890	26503	0.744
NULL	Cancers_(Basel)_2010_Apr_26_2(2)_693-712.nxml.txt.nlp	24281089	SENT186	27	27	14	14	meloxicam	U87	PA450353	677775;641648	0.744
NULL	Eur_J_Clin_Pharmacol_2007_Apr_21_63(4)_335-343.nxml.txt.nlp	17318526	SENT234	35	35	7	7	trimethoprim	CYP2C8	PA451788	1558	0.744
NULL	Autoimmune_Dis_2012_Oct_31_2012_874680.nxml.txt.nlp	23193443	SENT316	0	0	16	16	cyclosporine	CD4	PA449167	920	0.744
NULL	Cancer_Metastasis_Rev_2013_Jun_6_32(1-2)_179-188.nxml.txt.nlp	23129208	SENT216	15	15	8	8	bevacizumab	VEGF-A	PA130232992	7422	0.744
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT151	9	9	7	7	perifosine	DR4	PA165291471	8797	0.744
NULL	Breast_Cancer_Res_2011_Nov_7_13(6)_R112.nxml.txt.nlp	22060274	SENT345	17	17	22	22	vincristine	TWIST1	PA451879	7291	0.744
NULL	Br_J_Pharmacol_2014_Sep_28_171(18)_4255-4272.nxml.txt.nlp	24846338	SENT22	23	23	12	12	duloxetine	5-HT1D	PA10066	3352	0.744
NULL	Cell_Biol_Int_Rep_(2010)_2012_Jun_21_19(1)_e00017.nxml.txt.nlp	23124518	SENT164	2	2	10	10	etoposide	Mcl-1	PA449552	4170	0.744
NULL	Cancer_Med_2014_Oct_3_3(5)_1416-1429.nxml.txt.nlp	24890561	SENT185	27	27	0	0	epirubicin	San	PA449476	80218	0.744
NULL	Mol_Cancer_2014_Aug_29_13(1)_201.nxml.txt.nlp	NULL	SENT404	10	10	14	14	bortezomib	NF-kappaB	PA10252	4790	0.744
NULL	Int_J_Environ_Res_Public_Health_2011_Jul_21_8(7)_3019-3031.nxml.txt.nlp	21845171	SENT136	14	14	7	7	ethanol	adiponectin	PA448073	9370	0.744
NULL	Breast_Cancer_Res_2014_Dec_19_16(6)_499.nxml.txt.nlp	25522654	SENT206	26	26	33	33	estradiol	aromatase	PA449503	1588	0.744
NULL	Cell_Cycle_2013_May_15_12(10)_1510-1520.nxml.txt.nlp	23598719	SENT106	13	13	9	9	temozolomide	CO2	PA451609	4513	0.744
NULL	Oncogene_2010_Jul_22_29(29)_4170-4182.nxml.txt.nlp	20498638	SENT11	41	41	26	26	cetuximab	EGFR	PA10040	1956	0.744
NULL	Nat_Commun_2013_Nov_29_4_10_1038_ncomms3812.nxml.txt.nlp	24287487	SENT47	25	25	15	15	tetracycline	Dicer	PA451640	23405	0.744
NULL	Asian-Australas_J_Anim_Sci_2014_Dec_27(12)_1783-1793.nxml.txt.nlp	25358373	SENT50	0	0	12	12	capsaicin	CASP3	PA448776	836	0.744
NULL	EJC_Suppl_2013_Sep_5_11(2)_248-253.nxml.txt.nlp	NULL	SENT46	23	23	18	18	gefitinib	EGFR	PA131301952	1956	0.744
NULL	Curr_Pharm_Biotechnol_2011_Jan_12(1)_35-41.nxml.txt.nlp	20932261	SENT136	6	6	24	24	hyperforin	TRPC3	PA165985514	7222	0.744
NULL	J_Biol_Eng_2009_Oct_16_3_18.nxml.txt.nlp	19835592	SENT56	14	14	12	12	kanamycin	CPZ	PA450137	8532	0.744
NULL	Chin_J_Cancer_2012_Feb_31(2)_73-99.nxml.txt.nlp	22098950	SENT268	4	4	11	11	flavopiridol	P-gp	PA452627	5243	0.744
NULL	Oncotarget_2014_Jun_3_5(13)_4920-4928.nxml.txt.nlp	24952482	SENT131	18	18	8	8	crizotinib	EGFR	PA165946122	1956	0.744
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT282	30	30	26	26	pemetrexed	UNG	PA10810	7374	0.744
NULL	Drug_Healthc_Patient_Saf_2012_Nov_29_4_173-180.nxml.txt.nlp	23236256	SENT66	40	40	22	22	olanzapine	FGA	PA450688	2243	0.744
NULL	Oxid_Med_Cell_Longev_2012_Oct_24_2012_906252.nxml.txt.nlp	23150750	SENT191	14	14	0	0	l-arginine	Cocoa	PA448478	57658	0.744
NULL	J_Biomed_Biotechnol_2011_Dec_6_2011_856985.nxml.txt.nlp	21188173	SENT277	26	26	36	36	tamoxifen	AKT	PA451581	207	0.744
NULL	Cancer_Manag_Res_2014_May_23_6_225-252.nxml.txt.nlp	24904222	SENT487	17	17	5	5	fulvestrant	DES	PA164747170	1674	0.744
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_May_17_70(Pt_6)_o681-o682.nxml.txt.nlp	24940261	SENT81	0	0	16	16	flunarizine	mol	PA164776636	90527	0.744
NULL	Ann_Gastroenterol_2013_26(1)_71.nxml.txt.nlp	24714639	SENT16	13	13	16	16	lipase	CEA	PA450239	5670;1087	0.744
NULL	Breast_Cancer_Res_2008_Jul_24_10(4)_211.nxml.txt.nlp	18671839	SENT52	8	8	11	11	verapamil	survivin	PA451868	332	0.744
NULL	Comput_Struct_Biotechnol_J_2013_Mar_12_4_e201301008.nxml.txt.nlp	24688689	SENT167	26	26	19	19	ethanol	NAT	PA448073	6046	0.744
NULL	Reprod_Biol_Endocrinol_2004_Jul_7_2_54.nxml.txt.nlp	15239838	SENT149	11	11	0	0	spermine	SSAT	PA164781199	6303	0.743
NULL	Br_J_Cancer_1981_Mar_43(3)_384-391.nxml.txt.nlp	6164381	SENT4	16	16	18	18	bleomycin	BLM	PA448645	641	0.743
NULL	J_Cell_Mol_Med_2013_Jan_11_17(1)_134-146.nxml.txt.nlp	23305490	SENT298	26	26	22	22	bupivacaine	TWIK-2	PA135057240	9424	0.743
NULL	Biologics_2011_Aug_9_5_87-94.nxml.txt.nlp	21847344	SENT176	1	1	29	29	pertuzumab	San		80218	0.743
NULL	J_Skin_Cancer_2012_Sep_13_2012_907543.nxml.txt.nlp	23024864	SENT205	37	37	28	28	tamoxifen	PR1	PA451581	140738	0.743
NULL	Cells_2014_May_23_3(2)_517-545.nxml.txt.nlp	24861977	SENT303	9	9	5	5	capsaicin	TRPV1	PA448776	7442	0.743
NULL	Iran_Red_Crescent_Med_J_2013_Mar_5_15(3)_249-253.nxml.txt.nlp	23984007	SENT135	7	7	15	15	carbamazepine	B12	PA448785	7126;4709	0.743
NULL	Acta_Pharmacol_Sin_2011_Oct_12_32(10)_1259-1265.nxml.txt.nlp	21909126	SENT95	7	7	24	24	losartan	MCP-1	PA450268	6347	0.743
NULL	Clin_Ophthalmol_2014_Dec_30_9_43-49.nxml.txt.nlp	25565767	SENT88	12	12	15	15	acetazolamide	RPE	PA448018	6120	0.743
NULL	J_Oncol_2011_Oct_28_2011_963614.nxml.txt.nlp	21052543	SENT130	11	11	3	3	etoposide	p33ING1b	PA449552	3621	0.743
NULL	J_Korean_Med_Sci_2011_Jul_20_26(7)_893-899.nxml.txt.nlp	21738342	SENT10	14	14	27	27	resveratrol	CD97		976	0.743
NULL	Clin_Psychopharmacol_Neurosci_2011_Apr_30_9(1)_36-43.nxml.txt.nlp	23431025	SENT115	13	13	26	26	olanzapine	FLI	PA450688	2314	0.743
NULL	Cells_2014_Apr_29_3(2)_331-362.nxml.txt.nlp	24785347	SENT273	0	0	33	33	lidocaine	TRPV1	PA450226	7442	0.743
NULL	Braz_J_Med_Biol_Res_2012_Feb_17_45(3)_244-249.nxml.txt.nlp	22331137	SENT118	10	10	2	2	gentamicin	PAG	PA449753	55824	0.743
NULL	Indian_J_Pharmacol_2008_Oct_40(Suppl_2)_S211-S221.nxml.txt.nlp	21593975	SENT564	15	15	40	40	curcumin	CLE	PA151958596	51637	0.743
NULL	Oncotarget_2011_Dec_31_2(12)_1352-1367.nxml.txt.nlp	22267462	SENT125	13	13	10	10	cisplatin	p53	PA449014	7157	0.743
NULL	Virol_J_2009_Jul_31_6_119.nxml.txt.nlp	19646266	SENT138	25	25	14	14	cefazolin	TEM1	PA448839	57124	0.743
NULL	J_Cell_Biol_2001_Oct_29_155(3)_427-438.nxml.txt.nlp	11673478	SENT11	8	8	17	17	genistein	PP1	PA165109660	5540;5464	0.743
NULL	Open_Biochem_J_2008_Nov_18_2_135-142.nxml.txt.nlp	19238187	SENT64	4	4	12	12	heparin	EXT1	PA449855	2131	0.743
NULL	Indian_J_Pharm_Sci_2013_Nov-Dec_75(6)_680-687.nxml.txt.nlp	24591743	SENT42	4	4	7	7	gemfibrozil	CYP2C8	PA449750	1558	0.743
NULL	Osteoporos_Int_2013_Jan_24_24(1)_219-226.nxml.txt.nlp	23093347	SENT24	5	5	3	3	teriparatide	PTH	PA451620	5741	0.743
NULL	Ann_Hematol_2014_Sep_10_93(1)_1-11.nxml.txt.nlp	24018623	SENT162	16	16	12	12	lenalidomide	CD34	PA162363968	947	0.743
NULL	Mol_Vis_2012_Jul_18_18_1966-1972.nxml.txt.nlp	22876123	SENT106	9	9	15	15	curcumin	IL-5	PA151958596	3567	0.743
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT182	7	7	11	11	bevacizumab	PlGF-2	PA130232992	5228	0.743
NULL	Oncol_Rep_2013_Jun_22_29(6)_2479-2485.nxml.txt.nlp	23525656	SENT117	26	26	11	11	cisplatin	MRP7	PA449014	89845;1080	0.743
NULL	Endocr_Relat_Cancer_2014_Feb_21(1)_85-99.nxml.txt.nlp	24189182	SENT158	35	35	24	24	amiloride	FGFR1	PA448368	2260	0.743
NULL	Oncotarget_2013_Dec_19_5(3)_649-658.nxml.txt.nlp	24378360	SENT210	10	10	12	12	idarubicin	AIDA	PA449961	64853	0.743
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT141	35	35	28	28	gefitinib	AKT	PA131301952	207	0.743
NULL	Curr_Pharm_Des_2011_Apr_17(10)_985-989.nxml.txt.nlp	21524255	SENT84	37	37	27	27	imipramine	PAC1	PA449969	8624;1316;117	0.743
NULL	J_Biomed_Biotechnol_2010_Jun_7_2010_150960.nxml.txt.nlp	20617134	SENT241	22	22	13	13	bevacizumab	KRAS	PA130232992	3845	0.743
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Sep_30_64(Pt_10)_o2033.nxml.txt.nlp	21201227	SENT61	25	25	14	14	ethanol	mol	PA448073	90527	0.743
NULL	Curr_Neuropharmacol_2012_Jun_10(2)_139-158.nxml.txt.nlp	23204984	SENT246	5	5	9	9	fluoxetine	p11	PA449673	118460	0.743
NULL	Front_Genet_2014_Nov_14_5_391.nxml.txt.nlp	25452763	SENT1214	16	16	0	0	fluorouracil	ERCC1	PA128406956	2067	0.743
NULL	Nat_Commun_2013_Sep_20_4_2444.nxml.txt.nlp	24051492	SENT10	15	15	13	13	nutlin-3	p53		7157	0.743
NULL	Oncol_Rep_2012_Oct_13_28(4)_1146-1152.nxml.txt.nlp	22797812	SENT52	28	28	42	42	camptothecin	WRN	PA153590860	7486	0.743
NULL	Mol_Cell_2014_May_8_54(3)_445-459.nxml.txt.nlp	24746700	SENT49	11	11	17	17	etoposide	BRCA1	PA449552	672	0.743
NULL	Environ_Health_Perspect_2005_Oct_14_113(10)_1330-1335.nxml.txt.nlp	16203242	SENT115	13	13	28	28	arsenite	MLC	PA452638	23209	0.743
NULL	Front_Immunol_2012_May_4_3_98.nxml.txt.nlp	22566974	SENT29	11	11	16	16	vincristine	CHOP	PA451879	1649	0.743
NULL	Mol_Cell_Biochem_2014_Oct_9_385(1-2)_265-275.nxml.txt.nlp	24104452	SENT228	20	20	40	40	bortezomib	LC3	PA10252	84557	0.743
NULL	Calcif_Tissue_Int_2010_Aug_23_87(2)_130-136.nxml.txt.nlp	20571786	SENT94	8	8	17	17	teriparatide	CSA	PA451620	1442;1161	0.743
NULL	Oncotarget_2011_Aug_30_2(8)_610-626.nxml.txt.nlp	21881167	SENT83	22	22	5	5	doxorubicin	Raf-1	PA449412	5894	0.743
NULL	Oncotarget_2014_Dec_1_5(22)_10965-10966.nxml.txt.nlp	25473898	SENT13	30	30	10	10	vincristine	BCL6	PA451879	604	0.743
NULL	Acta_Histochem_Cytochem_2013_Dec_28_46(6)_187-197.nxml.txt.nlp	24610966	SENT140	17	17	23	23	pilocarpine	AQP5	PA450962	362	0.743
NULL	Viruses_2014_Oct_24_6(10)_4095-4139.nxml.txt.nlp	25341668	SENT224	17	17	37	37	delavirdine	TMC	PA449223	3703	0.743
NULL	J_Clin_Biochem_Nutr_2007_Sep_29_41(2)_115-123.nxml.txt.nlp	18193105	SENT46	5	5	14	14	fluorescein	CD14	PA164746009	929	0.743
NULL	Oncotarget_2012_Nov_17_4(1)_18-28.nxml.txt.nlp	23248157	SENT74	8	8	20	20	pargyline	U87	PA450797	677775;641648	0.743
NULL	J_Hematol_Oncol_2013_Jun_3_6_38.nxml.txt.nlp	23731980	SENT111	23	23	30	30	pertuzumab	HER2		2064	0.743
NULL	Front_Mol_Neurosci_2012_Nov_12_5_99.nxml.txt.nlp	23162427	SENT230	24	24	3	3	cocaine	CPP	PA449072	340451	0.743
NULL	BMB_Rep_2014_Apr_47(4)_221-226.nxml.txt.nlp	24286312	SENT75	12	12	14	14	nutlin-3	p53		7157	0.743
NULL	Ann_Hematol_2010_Mar_2_89(3)_283-289.nxml.txt.nlp	19727725	SENT122	4	4	7	7	rituximab	CHOP	PA451261	1649	0.743
NULL	G3_(Bethesda)_2014_Nov_6_5(1)_21-33.nxml.txt.nlp	25380729	SENT71	12	12	30	30	galactose	GAL	PA449725	51083	0.743
NULL	J_Cell_Mol_Med_2013_May_20_17(5)_648-656.nxml.txt.nlp	23601074	SENT109	5	5	25	25	gefitinib	AKT	PA131301952	207	0.743
NULL	AIDS_Res_Ther_2008_Mar_28_5_5.nxml.txt.nlp	18373851	SENT131	1	1	5	5	ritonavir	ATV	PA451260	4683	0.743
NULL	J_Biol_2009_Apr_15_8(3)_30.nxml.txt.nlp	19435483	SENT32	13	13	17	17	imatinib	NQO2	PA10804	4835	0.743
NULL	Br_J_Cancer_2012_Sep_4_107(6)_947-955.nxml.txt.nlp	22892392	SENT143	12	12	27	27	paclitaxel	BCAR4	PA450761	400500	0.743
NULL	Breast_Cancer_Res_2009_Jun_23_11(Suppl_1)_P10.nxml.txt.nlp	NULL	SENT12	12	12	17	17	tamoxifen	p27	PA451581	5715;10534	0.743
NULL	Oncologist_2010_Mar_3_15(3)_216-235.nxml.txt.nlp	20200040	SENT165	13	13	5	5	neratinib	HER-2	PA165291472	2064	0.743
NULL	ScientificWorldJournal_2013_Apr_24_2013_928197.nxml.txt.nlp	23737732	SENT134	3	3	8	8	pitavastatin	ACR	PA142650384	49	0.743
NULL	Viruses_2014_Oct_24_6(10)_4095-4139.nxml.txt.nlp	25341668	SENT224	27	27	37	37	etravirine	TMC	PA166014703	3703	0.743
NULL	Cancer_Cell_Int_2012_Jun_6_12_22.nxml.txt.nlp	22672528	SENT44	6	6	23	23	perifosine	DR5	PA165291471	8795	0.743
NULL	Ann_Rheum_Dis_2014_Sep_19_73(9)_1689-1694.nxml.txt.nlp	24748630	SENT151	16	16	35	35	infliximab	IMPACT	PA452639	55364	0.743
NULL	Mol_Cytogenet_2013_Jul_16_6_27.nxml.txt.nlp	23866735	SENT33	14	14	17	17	imatinib	ELN	PA10804	2006	0.743
NULL	J_Gynecol_Oncol_2013_Jul_4_24(3)_287-290.nxml.txt.nlp	23875080	SENT84	2	2	0	0	cisplatin	NACT	PA449014	284111	0.743
NULL	Crit_Care_2008_Oct_13_12(5)_R125.nxml.txt.nlp	18847498	SENT42	13	13	18	18	pentostatin	ADA2	PA450863	6871	0.743
NULL	J_Cell_Biol_2003_Dec_22_163(6)_1219-1230.nxml.txt.nlp	14676306	SENT82	16	16	7	7	lipase	cPLA2	PA450239	10524	0.743
NULL	Br_J_Cancer_2010_Oct_26_103(9)_1415-1421.nxml.txt.nlp	20924373	SENT27	5	5	17	17	oxaliplatin	HMGB1	PA131285527	3146	0.743
NULL	Arthritis_Res_Ther_2006_Nov_8_8(6)_R167.nxml.txt.nlp	17092341	SENT135	4	4	9	9	rituximab	BAFF	PA451261	10673	0.743
NULL	BMJ_Open_2014_Apr_1_4(4)_e004666.nxml.txt.nlp	24694626	SENT60	24	24	4	4	buprenorphine	OST	PA448685	1650;23263	0.743
NULL	Orphanet_J_Rare_Dis_2013_Sep_13_8_142.nxml.txt.nlp	24034279	SENT171	4	4	11	11	vasopressin	AVPR1B	PA451858	553	0.743
NULL	Breast_Cancer_Res_2011_Apr_15_13(2)_R44.nxml.txt.nlp	21496232	SENT53	15	15	22	22	erlotinib	HER2	PA134687924	2064	0.743
NULL	Open_Med_Chem_J_2012_May_17_6_1-14.nxml.txt.nlp	22876271	SENT46	31	31	29	29	sr144528	CB2		1269	0.743
NULL	An_Bras_Dermatol_2014_Mar-Apr_89(2)_301-310.nxml.txt.nlp	24770508	SENT110	13	13	33	33	cisplatin	IFN	PA449014	3439	0.743
NULL	Endocrinology_2014_Oct_22_155(10)_3732-3738.nxml.txt.nlp	25051442	SENT71	11	11	1	1	sibutramine	ARC	PA451344	8996;23237	0.743
NULL	Int_J_Endocrinol_2014_Mar_12_2014_847827.nxml.txt.nlp	24744784	SENT163	2	2	10	10	pioglitazone	TLR4	PA450970	7099	0.743
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2675-2684.nxml.txt.nlp	24129246	SENT197	24	24	6	6	etoposide	p53	PA449552	7157	0.743
NULL	Open_AIDS_J_2010_May_14_4_116-122.nxml.txt.nlp	20657827	SENT1	11	11	0	0	methamphetamine	Men	PA450403	8178	0.743
NULL	Cell_Commun_Signal_2013_Oct_1_11_73.nxml.txt.nlp	24083678	SENT126	22	22	28	28	sulindac	IL-8	PA451565	3576	0.743
NULL	BMJ_2013_Nov_6_347_f6530.nxml.txt.nlp	24196498	SENT344	2	2	14	14	paclitaxel	OUT	PA450761	150921	0.743
NULL	Epilepsia_2012_Jun_21_53(Suppl_1)_18-25.nxml.txt.nlp	22612805	SENT81	0	0	24	24	furosemide	NKCC1	PA449719	6558	0.743
NULL	Breast_Cancer_Res_2012_Feb_14_14(1)_R30.nxml.txt.nlp	22333315	SENT144	17	17	22	22	indomethacin	IFN	PA449982	3439	0.743
NULL	Nat_Neurosci_2014_Jul_25_17(7)_943-952.nxml.txt.nlp	24859199	SENT474	21	21	5	5	doxycycline	c-fos	PA449415	2353	0.743
NULL	Cancers_(Basel)_2012_Sep_6_4(3)_873-903.nxml.txt.nlp	24213471	SENT1019	1	1	6	6	hyaluronan	RHAMM	PA165958431	3161	0.743
NULL	FASEB_J_2011_Dec_25(12)_4486-4497.nxml.txt.nlp	21865315	SENT45	25	25	14	14	l-glutamine	F12	PA10090	2161	0.743
NULL	Oncotarget_2011_Mar_27_2(3)_209-221.nxml.txt.nlp	21444945	SENT6	19	19	24	24	bortezomib	Hsp90	PA10252	3320	0.743
NULL	Br_J_Cancer_2012_Jan_31_106(3)_482-489.nxml.txt.nlp	22233925	SENT257	21	21	7	7	carboplatin	PEO1	PA448803	56652	0.743
NULL	Br_J_Cancer_2014_Jan_21_110(2)_409-420.nxml.txt.nlp	24201748	SENT45	17	17	42	42	l-glutamine	CO2	PA10090	4513	0.743
NULL	Leukemia_2014_Sep_30_28(9)_1918-1922.nxml.txt.nlp	24791858	SENT28	8	8	12	12	imatinib	JAK2	PA10804	3717	0.743
NULL	Epigenetics_Chromatin_2013_Mar_18_6(Suppl_1)_P66.nxml.txt.nlp	NULL	SENT17	28	28	21	21	doxycycline	MMSET	PA449415	7468	0.743
NULL	Oncol_Lett_2014_Nov_10_8(5)_2333-2339.nxml.txt.nlp	25295120	SENT143	2	2	29	29	sorafenib	ADM	PA7000	133	0.743
NULL	Ann_Surg_Treat_Res_2014_Feb_22_86(2)_68-75.nxml.txt.nlp	24761411	SENT51	13	13	8	8	oxaliplatin	survivin	PA131285527	332	0.743
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Dec_3_65(Pt_1)_o7.nxml.txt.nlp	21581708	SENT50	0	0	6	6	phenol	mol	PA450913	90527	0.743
NULL	Acta_Pharmacol_Sin_2014_Oct_25_35(10)_1293-1301.nxml.txt.nlp	25152022	SENT179	2	2	14	14	enalapril	IL-18	PA449456	3606	0.743
NULL	Front_Endocrinol_(Lausanne)_2011_Nov_10_2_65.nxml.txt.nlp	22649380	SENT52	3	3	8	8	vasopressin	ACTH	PA451858	5443	0.743
NULL	Mol_Cancer_2007_Sep_24_6_59.nxml.txt.nlp	17888187	SENT163	10	10	18	18	tamoxifen	c-Myc	PA451581	4609	0.743
NULL	Front_Pharmacol_2014_Oct_31_5_231.nxml.txt.nlp	25400580	SENT4923	5	5	11	11	gemcitabine	CNT1	PA449748	9154	0.743
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT144	7	7	2	2	capsaicin	p53	PA448776	7157	0.743
NULL	Cancer_Res_Treat_2014_Jan_15_46(1)_48-54.nxml.txt.nlp	24520223	SENT125	20	20	5	5	bevacizumab	MAX	PA130232992	4149	0.743
NULL	Arch_Med_Sci_2014_Aug_29_10(4)_643-650.nxml.txt.nlp	25276146	SENT8	27	27	9	9	sirolimus	DES	PA451365	1674	0.743
NULL	Behav_Brain_Funct_2013_Jan_10_9_4.nxml.txt.nlp	23305134	SENT252	10	10	13	13	biperiden	spatial	PA448626	219793	0.743
NULL	Evid_Based_Complement_Alternat_Med_2012_Aug_27_2012_361516.nxml.txt.nlp	22969825	SENT94	5	5	2	2	verapamil	P-gp	PA451868	5243	0.743
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT166	34	34	30	30	trastuzumab	MUC1	PA451743	4582	0.743
NULL	Mol_Cancer_2014_Jun_30_13_160.nxml.txt.nlp	24976026	SENT13	21	21	3	3	bortezomib	AGR2	PA10252	10551	0.743
NULL	Breast_Cancer_Res_2010_Mar_12_12(2)_R20.nxml.txt.nlp	20226014	SENT144	28	28	25	25	trastuzumab	PI3K	PA451743	5290	0.743
NULL	Pharmaceutics_2011_Jun_22_3(2)_326-337.nxml.txt.nlp	24310499	SENT350	8	8	21	21	saquinavir	P-gp	PA451305	5243	0.743
NULL	Ann_Hematol_2014_Sep_10_93(1)_1-11.nxml.txt.nlp	24018623	SENT170	0	0	15	15	lenalidomide	CD48	PA162363968	962	0.743
NULL	Br_J_Cancer_1988_Nov_58(5)_640-643.nxml.txt.nlp	3064798	SENT10	10	10	12	12	carboplatin	JM8	PA448803	778	0.743
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Apr_22_67(Pt_5)_o1177-o1178.nxml.txt.nlp	21754481	SENT76	30	30	12	12	ethanol	mol	PA448073	90527	0.743
NULL	Oncoimmunology_2013_Aug_1_2(8)_e25123.nxml.txt.nlp	24083076	SENT18	3	3	8	8	everolimus	AKT1	PA164746311	207	0.743
NULL	Acta_Pharmacol_Sin_2009_Sep_17_30(9)_1316-1322.nxml.txt.nlp	19684609	SENT173	28	28	8	8	rosiglitazone	PTEN	PA451283	5728	0.743
NULL	Mol_Cancer_2010_Mar_2_9_47.nxml.txt.nlp	20196847	SENT47	14	14	10	10	trypsin	CO2	PA451806	4513	0.743
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_31_2012_656150.nxml.txt.nlp	23304209	SENT73	7	7	9	9	streptozocin	STZ	PA451514	6484	0.743
NULL	Cancer_Med_2013_Dec_31_2(6)_950-963.nxml.txt.nlp	24403269	SENT265	4	4	17	17	cisplatin	RAB25	PA449014	57111	0.743
NULL	Basic_Res_Cardiol_2013_Jul_6_108(4)_356.nxml.txt.nlp	23740214	SENT320	6	6	8	8	enalapril	IL-6	PA449456	3569	0.743
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT0	15	15	18	18	adalimumab	CD36	PA10004	948	0.743
NULL	Breast_Cancer_Res_2007_Jan_23_9(1)_R7.nxml.txt.nlp	17244352	SENT15	6	6	9	9	tamoxifen	CYP3A5	PA451581	1577	0.743
NULL	Br_J_Clin_Pharmacol_2011_Oct_72(4)_647-657.nxml.txt.nlp	21518389	SENT110	3	3	6	6	ticagrelor	P2Y12	PA165374673	64805	0.743
NULL	Nat_Med_2011_Oct_2_17(10)_1304-1309.nxml.txt.nlp	21963515	SENT36	0	0	6	6	tacrolimus	WNK3	PA451578	65267	0.743
NULL	Oxid_Med_Cell_Longev_2012_May_28_2012_386527.nxml.txt.nlp	22690271	SENT179	2	2	4	4	curcumin	HO-1	PA151958596	3162	0.743
NULL	Genome_Med_2010_Feb_22_2(2)_13.nxml.txt.nlp	20236491	SENT51	20	20	10	10	abacavir	HLA-B	PA448004	3106	0.743
NULL	Cancer_Cell_Int_2014_Jan_23_14_6.nxml.txt.nlp	24456610	SENT80	22	22	35	35	metformin	PI3K	PA450395	5290	0.743
NULL	Acta_Pharmacol_Sin_2011_Oct_15_32(10)_1253-1258.nxml.txt.nlp	21970837	SENT17	29	29	11	11	darapladib	MCP-1	PA165884699	6347	0.743
NULL	Target_Oncol_2013_Jun_27_8(2)_127-136.nxml.txt.nlp	23625191	SENT36	23	23	28	28	panitumumab	KRAS	PA162373091	3845	0.743
NULL	Clin_Med_Case_Rep_2009_Jul_31_2_43-49.nxml.txt.nlp	24179373	SENT94	26	26	9	9	daunorubicin	CD33	PA449212	945	0.743
NULL	Acta_Pharmacol_Sin_2009_Sep_17_30(9)_1316-1322.nxml.txt.nlp	19684609	SENT112	16	16	26	26	rosiglitazone	PTEN	PA451283	5728	0.743
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_75-89.nxml.txt.nlp	17912638	SENT577	37	37	7	7	tamoxifen	ATAC	PA451581	6375	0.743
NULL	Neuropsychopharmacology_2012_Feb_2_37(3)_641-650.nxml.txt.nlp	22048466	SENT153	7	7	4	4	ondansetron	HTR3	PA450705	908	0.743
NULL	Arthritis_Res_Ther_2004_Feb_19_6(3)_R181-R189.nxml.txt.nlp	15142263	SENT143	7	7	17	17	genistein	PP1	PA165109660	5540;5464	0.743
NULL	Br_J_Cancer_2006_Feb_13_94(3)_407-426.nxml.txt.nlp	16434996	SENT298	32	32	41	41	genistein	BRCA2	PA165109660	675	0.743
NULL	Nat_Genet_2013_Sep_28_45(9)_1004-1012.nxml.txt.nlp	23892607	SENT75	5	5	13	13	doxycycline	PC2	PA449415	5126;5311;8535	0.743
NULL	Osteoarthritis_Cartilage_2010_Apr_18(4)_555-562.nxml.txt.nlp	20060953	SENT140	3	3	6	6	clenbuterol	MNX	PA164745640	3892	0.743
NULL	Cardiovasc_Diabetol_2005_May_15_4_6.nxml.txt.nlp	15892894	SENT60	4	4	24	24	losartan	ANOVA	PA450268	4858	0.743
NULL	F1000_Biol_Rep_2012_Mar_1_4_5.nxml.txt.nlp	22403588	SENT45	38	38	35	35	ribavirin	IFN	PA451241	3439	0.743
NULL	Curr_Neuropharmacol_2012_Jun_10(2)_139-158.nxml.txt.nlp	23204984	SENT246	3	3	9	9	citalopram	p11	PA449015	118460	0.743
NULL	Case_Rep_Oncol_2013_Jan_29_6(1)_72-77.nxml.txt.nlp	23466899	SENT98	3	3	9	9	gemcitabine	GTX	PA449748	84504	0.743
NULL	Crit_Care_2007_Aug_14_11(4)_R87.nxml.txt.nlp	17697359	SENT175	20	20	16	16	dextran	IL-8	PA449261	3576	0.743
NULL	Amino_Acids_2011_May_22_40(5)_1369-1383.nxml.txt.nlp	21424716	SENT217	19	19	14	14	creatine	CEE	PA164778930	51608	0.743
NULL	Drug_Des_Devel_Ther_2014_Oct_13_8_1851-1867.nxml.txt.nlp	25378905	SENT103	2	2	26	26	cabazitaxel	BCA-1	PA165958401	10563	0.743
NULL	Contemp_Oncol_(Pozn)_2012_Nov_20_16(5)_401-406.nxml.txt.nlp	23788917	SENT64	20	20	4	4	gefitinib	EGFR	PA131301952	1956	0.743
NULL	Mol_Biol_Rep_2012_May_20_39(5)_5253-5267.nxml.txt.nlp	22183301	SENT164	31	31	29	29	gliclazide	NAC	PA10892	22861	0.743
NULL	Mol_Cancer_2010_Apr_15_9_77.nxml.txt.nlp	20398291	SENT74	9	9	5	5	geldanamycin	Hsp90	PA152031327	3320	0.743
NULL	JAKSTAT_2012_Jul_1_1(3)_197-199.nxml.txt.nlp	24058771	SENT33	12	12	30	30	fulvestrant	STAT1	PA164747170	6772	0.743
NULL	Eur_J_Med_Res_2010_Feb_26_15(2)_81-83.nxml.txt.nlp	20452889	SENT61	5	5	14	14	raltegravir	CD4		920	0.743
NULL	Clin_Pharmacol_2010_Sep_6_2_155-162.nxml.txt.nlp	22291500	SENT175	14	14	34	34	clopidogrel	CYP2C19	PA449053	1557	0.743
NULL	Int_J_Endocrinol_Metab_2013_Dec_21_Winter_11(1)_57-61.nxml.txt.nlp	23853622	SENT38	17	17	20	20	risperidone	PRL	PA451257	5617	0.743
NULL	J_Psychopharmacol_2010_Jan_24(1)_27-38.nxml.txt.nlp	19204064	SENT208	12	12	3	3	methylphenidate	NK1R	PA450464	6869	0.743
NULL	Cerebellum_2009_Jun_10_8(2)_80-88.nxml.txt.nlp	19137382	SENT95	1	1	11	11	dextran	PTPBR7	PA449261	5801	0.743
NULL	Neuropsychopharmacology_2009_Oct_15_34(11)_2376-2389.nxml.txt.nlp	19606083	SENT238	19	19	10	10	desipramine	CA1	PA449233	759	0.743
NULL	Arthritis_Res_Ther_2012_May_1_14(3)_R99.nxml.txt.nlp	22546542	SENT105	27	27	21	21	infliximab	CD28	PA452639	1493;940	0.743
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2012_Feb_20_5_13-30.nxml.txt.nlp	22879796	SENT170	21	21	7	7	rosuvastatin	adiponectin	PA134308647	9370	0.743
NULL	Diabetes_2009_Apr_9_58(4)_855-866.nxml.txt.nlp	19136649	SENT10	11	11	5	5	lipase	desnutrin	PA450239	57104	0.743
NULL	Br_J_Pharmacol_2014_Sep_28_171(18)_4255-4272.nxml.txt.nlp	24846338	SENT22	24	24	12	12	ondansetron	5-HT1D	PA450705	3352	0.743
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT103	2	2	7	7	curcumin	Bcl-2	PA151958596	596	0.743
NULL	Eur_J_Clin_Pharmacol_2012_Sep_15_68(9)_1267-1274.nxml.txt.nlp	22418828	SENT200	12	12	18	18	pantoprazole	CYP2C19	PA450774	1557	0.743
NULL	Nucleic_Acids_Res_2011_Oct_9_39(19)_8355-8365.nxml.txt.nlp	21745816	SENT164	32	32	24	24	doxycycline	USP7	PA449415	7874	0.743
NULL	J_Clin_Gastroenterol_2014_Sep_24_48(8)_679-686.nxml.txt.nlp	24921215	SENT136	11	11	13	13	boceprevir	BOC	PA165948902	91653	0.743
NULL	J_Korean_Med_Sci_2013_Feb_29_28(2)_308-314.nxml.txt.nlp	23399960	SENT129	12	12	5	5	gabapentin	IL-10	PA449720	3586	0.743
NULL	Oncogene_2010_Jul_8_29(27)_3896-3907.nxml.txt.nlp	20453888	SENT22	11	11	13	13	trastuzumab	HER2	PA451743	2064	0.743
NULL	Breast_Cancer_Res_2011_Jan_17_13(1)_R5.nxml.txt.nlp	21241485	SENT199	6	6	22	22	estradiol	Brn-3b	PA449503	5458	0.743
NULL	Acta_Pharmacol_Sin_2010_Mar_22_31(3)_329-340.nxml.txt.nlp	20173759	SENT13	4	4	12	12	ethanol	MEF2D	PA448073	4209	0.743
NULL	Psychiatr_Genet_2013_Aug_28_23(4)_153-162.nxml.txt.nlp	23811784	SENT212	5	5	9	9	clozapine	ARRB2	PA449061	409	0.743
NULL	J_Asthma_Allergy_2008_Sep_19_1_19-29.nxml.txt.nlp	21436982	SENT110	15	15	23	23	fexofenadine	MDC	PA449621	6367	0.743
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT53	33	33	24	24	trastuzumab	HER3	PA451743	2065	0.743
NULL	Acta_Pharmacol_Sin_2012_Jan_28_33(1)_66-74.nxml.txt.nlp	22120966	SENT14	11	11	28	28	genistein	RANKL	PA165109660	8600	0.743
NULL	Curr_Hematol_Malig_Rep_2012_Sep_27_7(3)_235-240.nxml.txt.nlp	22538464	SENT149	3	3	6	6	rituximab	CHOP	PA451261	1649	0.743
NULL	J_Anaesthesiol_Clin_Pharmacol_2012_Jan-Mar_28(1)_92-100.nxml.txt.nlp	22345954	SENT116	29	29	15	15	isoflurane	CO2	PA450106	4513	0.743
NULL	G3_(Bethesda)_2014_Nov_6_5(1)_21-33.nxml.txt.nlp	25380729	SENT71	25	25	30	30	galactose	GAL	PA449725	51083	0.743
NULL	Neuropsychopharmacology_2011_Apr_2_36(5)_1033-1046.nxml.txt.nlp	21289603	SENT199	2	2	5	5	ethanol	MSN	PA448073	4478	0.743
NULL	Clin_Pharmacol_2011_Jun_22_3_13-25.nxml.txt.nlp	22287853	SENT127	14	14	27	27	saxagliptin	ANOVA	PA165958362	4858	0.743
NULL	Int_J_Med_Sci_2012_Aug_10_9(6)_472-479.nxml.txt.nlp	22927772	SENT115	30	30	25	25	warfarin	VKORC1	PA451906	79001	0.743
NULL	Arthritis_Res_Ther_2012_Jul_12_14(4)_R163.nxml.txt.nlp	22784880	SENT30	6	6	14	14	leflunomide	CYP1A2	PA450192	1544	0.743
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT194	0	0	10	10	metformin	HIF-1	PA450395	29072	0.743
NULL	Cell_Commun_Signal_2013_Jan_11_11_2.nxml.txt.nlp	23305203	SENT108	0	0	6	6	forskolin	TIMAP	PA146096022	26051	0.743
NULL	Br_J_Cancer_2013_Jul_9_109(1)_1-7.nxml.txt.nlp	23736035	SENT98	29	29	31	31	raloxifene	STAR	PA451221	6770;2984	0.743
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT198	2	2	28	28	metformin	10C	PA450395	64333	0.743
NULL	Oncotarget_2014_Jun_19_5(15)_6540-6551.nxml.txt.nlp	25153728	SENT106	6	6	17	17	paclitaxel	p27	PA450761	5715;10534	0.743
NULL	Oncogenesis_2012_Apr_2_1(4)_e5.nxml.txt.nlp	23552603	SENT570	5	5	12	12	celecoxib	BAX	PA448871	581	0.743
NULL	Ann_Oncol_2011_Jul_6_22(7)_1561-1570.nxml.txt.nlp	21135055	SENT197	36	36	23	23	cisplatin	BRCA1	PA449014	672	0.743
NULL	Environ_Health_Perspect_2009_Feb_8_117(2)_175-180.nxml.txt.nlp	19270784	SENT111	10	10	0	0	vinblastine	BPA	PA451877	667	0.743
NULL	Mol_Cancer_2008_Jun_5_7_50.nxml.txt.nlp	18534018	SENT134	9	9	13	13	bortezomib	HSP	PA10252	7190	0.743
NULL	Int_J_Womens_Health_2014_Aug_13_6_759-769.nxml.txt.nlp	25152632	SENT148	12	12	9	9	denosumab	RANK	PA166048634	8792	0.743
NULL	Br_J_Cancer_1998_77(3)_434-439.nxml.txt.nlp	9472640	SENT8	14	14	43	43	cisplatin	p53	PA449014	7157	0.743
NULL	Endocr_Connect_2012_Jun_8_1(1)_1-12.nxml.txt.nlp	23781298	SENT125	0	0	9	9	fenofibrate	adiponectin	PA449594	9370	0.743
NULL	Chem_Commun_(Camb)_2013_Jun_21_49(76)_8441-8443.nxml.txt.nlp	23770604	SENT22	15	15	28	28	geldanamycin	Hsp90	PA152031327	3320	0.743
NULL	Indian_J_Pharm_Sci_2008_Jan-Feb_70(1)_111-113.nxml.txt.nlp	20390095	SENT34	9	9	14	14	indomethacin	IF2	PA449982	9669	0.743
NULL	Diabetes_2013_Jun_17_62(6)_1913-1922.nxml.txt.nlp	23349495	SENT196	11	11	14	14	sildenafil	AMPK	PA451346	5563	0.743
NULL	Crit_Care_2006_Jan_11_10(1)_R12.nxml.txt.nlp	16420663	SENT100	9	9	21	21	dobutamine	IL-6	PA449381	3569	0.743
NULL	Tob_Induc_Dis_2004_Mar_15_2(1)_27-33.nxml.txt.nlp	19570268	SENT14	11	11	13	13	thrombin	ADP	PA451674	23038	0.743
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Mar_27_66(Pt_4)_o942-o943.nxml.txt.nlp	21580748	SENT78	11	11	7	7	benzaldehyde	mol	PA448571	90527	0.743
NULL	Lab_Invest_2014_May_10_94(5)_503-516.nxml.txt.nlp	24614199	SENT194	4	4	16	16	curcumin	RAGE	PA151958596	177	0.743
NULL	Crit_Care_2008_Oct_13_12(5)_R125.nxml.txt.nlp	18847498	SENT197	9	9	2	2	pentostatin	ADA2	PA450863	6871	0.743
NULL	Clin_Ophthalmol_2009_Jun_2_3_167-174.nxml.txt.nlp	19668561	SENT65	11	11	6	6	vatalanib	VEGFR	PA7001	3791	0.743
NULL	J_Vet_Med_Sci_2014_May_13_76(5)_629-636.nxml.txt.nlp	24419976	SENT154	26	26	30	30	meloxicam	EP2	PA450353	5732;10407	0.743
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Feb_4_68(Pt_3)_o600.nxml.txt.nlp	22412513	SENT79	0	0	24	24	tramadol	mol	PA451735	90527	0.743
NULL	Iran_Red_Crescent_Med_J_2013_Mar_5_15(3)_249-253.nxml.txt.nlp	23984007	SENT92	6	6	10	10	carbamazepine	B12	PA448785	7126;4709	0.743
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT128	9	9	2	2	phenprocoumon	VKORC1	PA450921	79001	0.743
NULL	Emerg_Infect_Dis_2015_Jan_21(1)_164-166.nxml.txt.nlp	25531800	SENT7	12	12	28	28	artesunate	GMP	PA165111697	22978	0.743
NULL	JAKSTAT_2012_Jul_1_1(3)_197-199.nxml.txt.nlp	24058771	SENT33	12	12	41	41	fulvestrant	STAT1	PA164747170	6772	0.743
NULL	J_Biol_Chem_2008_Aug_8_283(32)_21873-21880.nxml.txt.nlp	18539602	SENT190	26	26	17	17	s-adenosylmethionine	CTCF	PA164754994	10664	0.743
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1153-1159.nxml.txt.nlp	22353811	SENT50	30	30	19	19	thalidomide	IL-8	PA451644	3576	0.743
NULL	Oncotarget_2014_Jun_26_5(14)_5559-5569.nxml.txt.nlp	24980819	SENT2	14	14	11	11	vemurafenib	BRAF	PA165946873	673	0.743
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT253	29	29	8	8	atorvastatin	THP1	PA448500	2736	0.743
NULL	Cardiovasc_Diabetol_2011_Dec_22_10_115.nxml.txt.nlp	22189184	SENT131	10	10	19	19	miglitol	GLP-1	PA164776726	100125288	0.743
NULL	Diabetes_Care_2010_Jul_33(7)_1674-1685.nxml.txt.nlp	20587728	SENT444	11	11	24	24	metformin	HER-2	PA450395	2064	0.743
NULL	Cancer_Med_2013_Jun_24_2(3)_360-366.nxml.txt.nlp	23930213	SENT121	30	30	24	24	thalidomide	FGFR1	PA451644	2260	0.743
NULL	Br_J_Cancer_2012_Feb_14_106(4)_685-692.nxml.txt.nlp	22294184	SENT185	1	1	7	7	docetaxel	Mcl-1	PA449383	4170	0.743
NULL	J_Cell_Biol_2001_Mar_19_152(6)_1169-1182.nxml.txt.nlp	11257118	SENT247	20	20	6	6	heparin	TSP-1	PA449855	7057	0.743
NULL	Cardiovasc_Diabetol_2013_Mar_25_12_49.nxml.txt.nlp	23530768	SENT395	18	18	13	13	indomethacin	COX	PA449982	1351	0.743
NULL	Br_J_Cancer_2010_Dec_7_103(12)_1822-1830.nxml.txt.nlp	21063405	SENT35	3	3	6	6	cisplatin	RAD50	PA449014	10111	0.743
NULL	Biochem_Res_Int_2012_Mar_4_2012_685267.nxml.txt.nlp	22496978	SENT208	10	10	4	4	thrombin	HSPC	PA451674	5688	0.743
NULL	Front_Genet_2013_Dec_16_4_281.nxml.txt.nlp	24379827	SENT319	35	35	16	16	l-proline	CACNA1F	PA451125	778	0.743
NULL	Arthritis_Res_Ther_2004_Jun_21_6(4)_R384-R392.nxml.txt.nlp	15225374	SENT54	6	6	41	41	gentamicin	CO2	PA449753	4513	0.743
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_9_2013_456747.nxml.txt.nlp	23653662	SENT125	5	5	22	22	berberine	IL1B	PA165860812	3553	0.743
NULL	Indian_J_Pharm_Sci_2013_Jan-Feb_75(1)_94-98.nxml.txt.nlp	23901167	SENT69	14	14	33	33	omeprazole	CYP2C9	PA450704	1559	0.743
NULL	J_Hematol_Oncol_2008_Aug_11_1_11.nxml.txt.nlp	18694493	SENT60	9	9	19	19	sunitinib	IFN	PA162372840	3439	0.743
NULL	BMB_Rep_2014_Apr_47(4)_221-226.nxml.txt.nlp	24286312	SENT107	4	4	7	7	nutlin-3	p53		7157	0.743
NULL	Breast_Cancer_Res_2012_May_14_14(3)_R77.nxml.txt.nlp	22583478	SENT52	15	15	25	25	estradiol	c-Myc	PA449503	4609	0.743
NULL	Cardiovasc_J_Afr_2009_Apr_20(2)_122-125.nxml.txt.nlp	19421648	SENT31	0	0	23	23	linezolid	DBL	PA450233	4168	0.743
NULL	Acta_Pharmacol_Sin_2012_May_2_33(5)_615-624.nxml.txt.nlp	22465948	SENT97	16	16	11	11	ethanol	PRG	PA448073	5544	0.743
NULL	J_Inflamm_(Lond)_2006_May_4_3_8.nxml.txt.nlp	16674821	SENT194	3	3	16	16	pp2	p38		10598;1432;7965	0.743
NULL	F1000Res_2013_Oct_8_2_173.nxml.txt.nlp	24555085	SENT227	29	29	14	14	hydrocortisone	BDP	PA449905	10620;152926	0.743
NULL	Acta_Pharmacol_Sin_2009_Nov_12_30(11)_1566-1572.nxml.txt.nlp	19820718	SENT7	26	26	21	21	ketoconazole	CYP3A4	PA450146	1576	0.743
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT166	34	34	10	10	trastuzumab	IL-6	PA451743	3569	0.743
NULL	J_Hematol_Oncol_2013_Jun_3_6_38.nxml.txt.nlp	23731980	SENT100	28	28	10	10	docetaxel	HER2	PA449383	2064	0.742
NULL	Case_Rep_Hematol_2012_Mar_14_2012_343742.nxml.txt.nlp	22937325	SENT78	18	18	15	15	vincristine	CYP3A5	PA451879	1577	0.742
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT523	15	15	5	5	amisulpride	PRL	PA162565877	5617	0.742
NULL	Endocrinol_Diabetes_Metab_Case_Rep_2013_Sep_30_2013_130051.nxml.txt.nlp	24616777	SENT31	16	16	11	11	levothyroxine	WBS	PA450221	2006	0.742
NULL	BMB_Rep_2014_Apr_47(4)_221-226.nxml.txt.nlp	24286312	SENT112	6	6	14	14	nutlin-3	p53		7157	0.742
NULL	J_Korean_Med_Sci_2011_Dec_29_26(12)_1563-1568.nxml.txt.nlp	22147992	SENT129	11	11	30	30	ekb-569	CDK4		1019	0.742
NULL	Front_Syst_Neurosci_2014_Jun_23_8_115.nxml.txt.nlp	25002838	SENT622	8	8	1	1	ketamine	HCN1	PA450144	348980	0.742
NULL	Oncotarget_2014_Aug_4_5(17)_7760-7775.nxml.txt.nlp	25226615	SENT224	16	16	9	9	etoposide	DDP	PA449552	1678	0.742
NULL	Cancer_Med_2013_Dec_31_2(6)_950-963.nxml.txt.nlp	24403269	SENT240	4	4	17	17	cisplatin	RAB25	PA449014	57111	0.742
NULL	Arthritis_Res_Ther_2003_Feb_24_5(Suppl_1)_47.nxml.txt.nlp	NULL	SENT20	11	11	7	7	leflunomide	IFN	PA450192	3439	0.742
NULL	Br_J_Cancer_2013_Jun_25_108(12)_2464-2469.nxml.txt.nlp	23695016	SENT4	12	12	9	9	paclitaxel	NACT	PA450761	284111	0.742
NULL	Hum_Genomics_2008_Sep_1_3(1)_7-16.nxml.txt.nlp	19129086	SENT117	0	0	5	5	rosiglitazone	CYP2C8	PA451283	1558	0.742
NULL	Osteoporos_Int_2014_Aug_15_25(10)_2359-2381.nxml.txt.nlp	25182228	SENT521	5	5	0	0	teriparatide	PTH	PA451620	5741	0.742
NULL	Allergy_Asthma_Immunol_Res_2014_Nov_19_6(6)_548-557.nxml.txt.nlp	25374755	SENT127	21	21	18	18	lovastatin	IL-6	PA450272	3569	0.742
NULL	J_Gen_Physiol_2004_Apr_123(4)_427-439.nxml.txt.nlp	15024039	SENT21	3	3	8	8	genistein	EGFR	PA165109660	1956	0.742
NULL	Surg_Neurol_Int_2013_Mar_22_4(Suppl_2)_S94-S105.nxml.txt.nlp	23646279	SENT269	9	9	16	16	simvastatin	IVD	PA451363	3712	0.742
NULL	Indian_J_Pharmacol_2013_Mar-Apr_45(2)_121-125.nxml.txt.nlp	23716885	SENT29	1	1	17	17	aripiprazole	5-HT1A	PA10026	3350	0.742
NULL	Mol_Cancer_2009_Aug_25_8_66.nxml.txt.nlp	19706164	SENT201	8	8	13	13	celecoxib	p53	PA448871	7157	0.742
NULL	Acta_Pharmacol_Sin_2010_Sep_16_31(9)_1075-1084.nxml.txt.nlp	20711221	SENT110	20	20	13	13	nitrogen	AMPK	PA450643	5563	0.742
NULL	Indian_J_Med_Res_2012_Apr_135(4)_456-458.nxml.txt.nlp	22664491	SENT30	27	27	24	24	mefloquine	ACT	PA450348	12;11332;9457;641455	0.742
NULL	Saudi_J_Anaesth_2013_Apr-Jun_7(2)_151-154.nxml.txt.nlp	23956714	SENT56	25	25	19	19	theophylline	NAC	PA451647	22861	0.742
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT189	5	5	2	2	cisplatin	p53	PA449014	7157	0.742
NULL	Ann_Indian_Acad_Neurol_2011_Jul_14(Suppl1)_S11-S13.nxml.txt.nlp	21847317	SENT8	14	14	39	39	pergolide	COMT	PA450873	1312	0.742
NULL	Indian_J_Psychiatry_2010_Jan_52(Suppl1)_S317-S340.nxml.txt.nlp	21836703	SENT119	26	26	33	33	triflupromazine	CPZ	PA451773	8532	0.742
NULL	Cancer_Cell_Int_2010_Sep_9_10_32.nxml.txt.nlp	20828393	SENT187	11	11	19	19	cisplatin	ATF3	PA449014	467	0.742
NULL	J_Occup_Med_Toxicol_2008_Feb_27_3(Suppl_1)_S6.nxml.txt.nlp	18315837	SENT67	2	2	15	15	salmeterol	IL-10	PA451300	3586	0.742
NULL	Front_Neurosci_2012_Feb_21_6_26.nxml.txt.nlp	22363256	SENT88	0	0	10	10	estradiol	NR1	PA449503	27158	0.742
NULL	Indian_J_Endocrinol_Metab_2012_Jul-Aug_16(4)_604-608.nxml.txt.nlp	22837924	SENT111	9	9	15	15	metformin	PPG	PA450395	5552	0.742
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Apr_8_65(Pt_5)_o963.nxml.txt.nlp	21584006	SENT60	13	13	6	6	ethanol	mol	PA448073	90527	0.742
NULL	Eur_J_Appl_Physiol_2011_Feb_24_111(2)_275-283.nxml.txt.nlp	20865425	SENT178	19	19	29	29	glucose	MRS	PA449773	8011	0.742
NULL	Evid_Based_Complement_Alternat_Med_2013_Aug_12_2013_982689.nxml.txt.nlp	23997806	SENT6	8	8	0	0	tolbutamide	APE	PA451718	55704;328	0.742
NULL	Int_J_Nanomedicine_2012_Oct_25_7_5565-5575.nxml.txt.nlp	23118538	SENT4	11	11	19	19	fenofibrate	CO2	PA449594	4513	0.742
NULL	Acta_Pharmacol_Sin_2012_Jan_3_33(1)_49-56.nxml.txt.nlp	22212430	SENT14	0	0	10	10	thrombin	AP-1	PA451674	2353;3727;2354;3725	0.742
NULL	Ann_Clin_Transl_Neurol_2014_Dec_21_1(12)_996-1005.nxml.txt.nlp	25574474	SENT119	6	6	20	20	riluzole	P-gp	PA451251	5243	0.742
NULL	Ann_Dermatol_2014_Jun_12_26(3)_363-373.nxml.txt.nlp	24966637	SENT184	5	5	15	15	imiquimod	MT1-MMP	PA449972	4323	0.742
NULL	Core_Evid_2010_Oct_22_5_91-105.nxml.txt.nlp	21468365	SENT110	8	8	14	14	atorvastatin	CYP2C9	PA448500	1559	0.742
NULL	Core_Evid_2010_Jul_27_5_1-10.nxml.txt.nlp	20694135	SENT186	24	24	26	26	entacapone	CLE	PA164748726	51637	0.742
NULL	Biomed_Res_Int_2014_Feb_6_2014_323594.nxml.txt.nlp	24689036	SENT242	4	4	8	8	raloxifene	EGFR	PA451221	1956	0.742
NULL	Indian_J_Med_Paediatr_Oncol_2014_Jan-Mar_35(1)_17-20.nxml.txt.nlp	25006278	SENT19	11	11	8	8	paclitaxel	NACT	PA450761	284111	0.742
NULL	ISRN_Allergy_2013_Feb_7_2013_971036.nxml.txt.nlp	23738146	SENT246	33	33	18	18	papain	CCL22	PA450778	6367	0.742
NULL	Breast_Cancer_Res_2010_Jun_28_12(3)_R43.nxml.txt.nlp	20579400	SENT166	22	22	15	15	fulvestrant	MAPT	PA164747170	4137	0.742
NULL	Cancer_Cell_Int_2009_Sep_10_9_25.nxml.txt.nlp	19744341	SENT179	12	12	3	3	glucosamine	survivin	PA164747613	332	0.742
NULL	Nat_Commun_2013_Oct_25_4_2667.nxml.txt.nlp	24157709	SENT690	16	16	19	19	nutlin-3	mol		90527	0.742
NULL	Curr_Neuropharmacol_2012_Jun_10(2)_139-158.nxml.txt.nlp	23204984	SENT248	3	3	7	7	desipramine	p11	PA449233	118460	0.742
NULL	Curr_Neuropharmacol_2014_Jul_12(4)_365-379.nxml.txt.nlp	25342944	SENT485	24	24	9	9	fluoxetine	5-HT2B	PA449673	3357	0.742
NULL	Oxid_Med_Cell_Longev_2013_Jul_9_2013_574029.nxml.txt.nlp	23936610	SENT253	4	4	25	25	resveratrol	CD80		941	0.742
NULL	Acta_Crystallogr_Sect_F_Struct_Biol_Cryst_Commun_2011_Aug_16_67(Pt_9)_1154-1158.nxml.txt.nlp	21904066	SENT100	8	8	28	28	l-cysteine	PLP	PA449173	25824;5744	0.742
NULL	Nat_Commun_2013_Sep_20_4_2443.nxml.txt.nlp	24051437	SENT13	23	23	16	16	tamoxifen	BIG3	PA451581	57221	0.742
NULL	Dermatoendocrinol_2013_Apr_1_5(2)_239-251.nxml.txt.nlp	24194964	SENT116	12	12	2	2	l-tyrosine	TYR	PA451822	7299	0.742
NULL	Arthritis_Res_Ther_2012_Sep_20_14(5)_R199.nxml.txt.nlp	22995428	SENT102	21	21	5	5	collagenase	GM-CSF	PA449107	1437	0.742
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Sep_30_66(Pt_10)_o2656.nxml.txt.nlp	21587627	SENT4	8	8	2	2	betaine	mol	PA448603	90527	0.742
NULL	Case_Rep_Ophthalmol_Med_2014_Feb_4_2014_289107.nxml.txt.nlp	24716059	SENT25	1	1	16	16	fluorescein	PED	PA164746009	8682	0.742
NULL	Mol_Cancer_2013_May_24_12_45.nxml.txt.nlp	23705792	SENT148	4	4	6	6	thyroglobulin	DUOX1	PA164754910	53905	0.742
NULL	J_Cell_Biol_1998_Jan_26_140(2)_335-345.nxml.txt.nlp	9442109	SENT334	2	2	10	10	chloroquine	NHE	PA448948	285335	0.742
NULL	Arthritis_Res_Ther_2013_Jul_9_15(4)_R73.nxml.txt.nlp	23837669	SENT251	18	18	16	16	colchicine	MICL	PA449092	160364	0.742
NULL	Acta_Pharmacol_Sin_2012_Jan_28_33(1)_75-81.nxml.txt.nlp	22120969	SENT89	34	34	25	25	exenatide	GLP-1	PA164749238	100125288	0.742
NULL	ScientificWorldJournal_2014_May_14_2014_191847.nxml.txt.nlp	24963500	SENT70	0	0	23	23	ranibizumab	VEGF-A	PA164746012	7422	0.742
NULL	Cancer_Immunol_Immunother_2011_Jan_21_60(1)_75-85.nxml.txt.nlp	20857100	SENT166	29	29	22	22	fludarabine	IFN	PA449655	3439	0.742
NULL	Cough_2010_Aug_9_6_7.nxml.txt.nlp	20696045	SENT26	19	19	6	6	capsaicin	COX	PA448776	1351	0.742
NULL	J_Gen_Physiol_1997_Dec_1_110(6)_643-654.nxml.txt.nlp	9382893	SENT0	15	15	1	1	diazoxide	Gen	PA449285	348654	0.742
NULL	Breast_Cancer_Res_2009_Jun_29_11(3)_R41.nxml.txt.nlp	19563669	SENT184	21	21	11	11	lapatinib	XIAP	PA152241907	331	0.742
NULL	J_Biomed_Sci_2014_Feb_3_21(1)_10.nxml.txt.nlp	24490900	SENT126	28	28	21	21	alendronate	M-CSF	PA448082	1435	0.742
NULL	Breast_Cancer_Res_2005_Jan_28_7(3)_R284-R290.nxml.txt.nlp	15987423	SENT36	37	37	12	12	tamoxifen	CYP2D6	PA451581	1565	0.742
NULL	Front_Neurosci_2014_Jul_17_8_200.nxml.txt.nlp	25100932	SENT57	5	5	7	7	ceftriaxone	xCT	PA448866	23657	0.742
NULL	Biol_Proced_Online_2003_Feb_17_5_43-52.nxml.txt.nlp	12734557	SENT176	8	8	5	5	bupivacaine	IFNA6	PA135057240	3443	0.742
NULL	Indian_J_Palliat_Care_2010_Sep-Dec_16(3)_129-137.nxml.txt.nlp	21218002	SENT190	0	0	15	15	thalidomide	IL-6	PA451644	3569	0.742
NULL	Nat_Commun_2013_Apr_23_4_1758.nxml.txt.nlp	23612299	SENT550	11	11	6	6	isoproterenol	SOD1	PA450121	6647	0.742
NULL	J_Hepatobiliary_Pancreat_Surg_2008_Jan_16_15(1)_55-62.nxml.txt.nlp	18274844	SENT73	19	19	33	33	tegafur	CDHP	PA452620	1001	0.742
NULL	Case_Rep_Oncol_2014_Mar_26_7(1)_204-209.nxml.txt.nlp	24803896	SENT59	8	8	24	24	trabectedin	MRCL	PA165958349	348174	0.742
NULL	Springerplus_2014_Sep_9_3_510.nxml.txt.nlp	25279302	SENT44	7	7	14	14	creatine	CKM	PA164778930	1158	0.742
NULL	J_Exp_Clin_Cancer_Res_2009_Jun_16_28(1)_83.nxml.txt.nlp	19531250	SENT5	12	12	14	14	gemcitabine	GEM	PA449748	2669	0.742
NULL	Avicenna_J_Phytomed_2014_Nov-Dec_4(6)_377-384.nxml.txt.nlp	25386401	SENT31	9	9	12	12	piroxicam	BHD	PA450985	201163	0.742
NULL	Br_J_Pharmacol_2014_Aug_17_171(15)_3651-3665.nxml.txt.nlp	24712679	SENT271	11	11	29	29	exenatide	GLP-1	PA164749238	100125288	0.742
NULL	Mol_Cancer_2010_Aug_25_9_225.nxml.txt.nlp	20738848	SENT105	26	26	7	7	staurosporine	RhoH	PA165109623	399	0.742
NULL	Cell_Commun_Signal_2013_Oct_1_11_73.nxml.txt.nlp	24083678	SENT145	10	10	24	24	sulindac	AP-1	PA451565	2353;3727;2354;3725	0.742
NULL	Crit_Care_2008_Jan_24_12(1)_R27.nxml.txt.nlp	18304335	SENT189	12	12	6	6	thrombin	Rho	PA451674	29984	0.742
NULL	Acta_Pharmacol_Sin_2011_Oct_12_32(10)_1259-1265.nxml.txt.nlp	21909126	SENT122	8	8	14	14	candesartan	LOX-1	PA448765	4973	0.742
NULL	Ann_Indian_Acad_Neurol_2011_Jul_14(Suppl1)_S11-S13.nxml.txt.nlp	21847317	SENT8	20	20	39	39	cabergoline	COMT	PA448708	1312	0.742
NULL	Cancer_Cell_Int_2013_Oct_11_13_97.nxml.txt.nlp	24119761	SENT21	19	19	4	4	heparin	EGF	PA449855	1950	0.742
NULL	Brain_2013_Jul_24_136(7)_2279-2297.nxml.txt.nlp	23801741	SENT315	8	8	13	13	tamoxifen	NRG1	PA451581	3084	0.742
NULL	Br_J_Cancer_2010_Mar_2_102(5)_815-826.nxml.txt.nlp	20145614	SENT24	17	17	12	12	lapatinib	EGFR	PA152241907	1956	0.742
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Jul_9_3(7)_e124.nxml.txt.nlp	25006781	SENT101	26	26	31	31	rosuvastatin	OATP1B1	PA134308647	10599	0.742
NULL	Core_Evid_2010_Oct_21_5_77-90.nxml.txt.nlp	21042544	SENT21	21	21	17	17	aprepitant	NK1	PA164747039	11126	0.742
NULL	Mol_Cancer_2009_Aug_25_8_66.nxml.txt.nlp	19706164	SENT17	0	0	17	17	celecoxib	p53	PA448871	7157	0.742
NULL	AIDS_Res_Ther_2013_Sep_3_10_22.nxml.txt.nlp	24004690	SENT42	12	12	17	17	atazanavir	CD4	PA10251	920	0.742
NULL	Oncogene_2014_Oct_16_33(42)_5028-5038.nxml.txt.nlp	24747972	SENT65	11	11	31	31	nilotinib	CD48	PA165958345	962	0.742
NULL	J_Immunother_Cancer_2013_Nov_7_1(Suppl_1)_P175.nxml.txt.nlp	NULL	SENT9	13	13	15	15	cetuximab	EGFR	PA10040	1956	0.742
NULL	Hum_Genomics_2009_Dec_1_4(2)_91-106.nxml.txt.nlp	20038497	SENT120	18	18	20	20	rivastigmine	CHRNA7	PA451262	1139	0.742
NULL	J_Clin_Biochem_Nutr_2007_Nov_30_41(3)_160-168.nxml.txt.nlp	18299710	SENT105	21	21	4	4	ecabet	IL-8	PA165958350	3576	0.742
NULL	Breast_Cancer_Res_2014_May_28_16(3)_R53.nxml.txt.nlp	24886537	SENT257	11	11	21	21	tamoxifen	VAV3	PA451581	10451	0.742
NULL	Int_J_Mol_Sci_2010_Oct_19_11(10)_3999-4013.nxml.txt.nlp	21152316	SENT103	0	0	19	19	celecoxib	p53	PA448871	7157	0.742
NULL	J_Oncol_2012_Feb_6_2012_737981.nxml.txt.nlp	22481932	SENT83	26	26	11	11	doxorubicin	MUC16	PA449412	94025	0.742
NULL	Mol_Biol_Cell_2014_Jan_1_25(1)_76-86.nxml.txt.nlp	24173717	SENT294	5	5	9	9	paclitaxel	TUBB6	PA450761	84617	0.742
NULL	Pain_2013_Sep_154(9)_1680-1690.nxml.txt.nlp	23707289	SENT544	0	0	12	12	yohimbine	c-fos	PA451946	2353	0.742
NULL	Diabetologia_2010_Jul_2_53(7)_1270-1287.nxml.txt.nlp	20361178	SENT277	6	6	11	11	pioglitazone	adiponectin	PA450970	9370	0.742
NULL	J_Immunother_2014_Feb_21_37(2)_105-114.nxml.txt.nlp	24509173	SENT15	29	29	31	31	gemcitabine	WT1	PA449748	7490	0.742
NULL	J_Lipid_Res_2014_Oct_55(10)_2103-2112.nxml.txt.nlp	25139399	SENT18	21	21	23	23	atorvastatin	APOE	PA448500	348	0.742
NULL	Environ_Health_Perspect_2005_Oct_14_113(10)_1330-1335.nxml.txt.nlp	16203242	SENT164	28	28	25	25	arsenite	MLC	PA452638	23209	0.742
NULL	Ann_Oncol_2010_Mar_18_21(3)_655-661.nxml.txt.nlp	19767314	SENT223	14	14	6	6	trastuzumab	HER-2	PA451743	2064	0.742
NULL	Nat_Genet_2011_Jan_12_43(1)_27-33.nxml.txt.nlp	21151129	SENT271	0	0	11	11	tamoxifen	FOXA1	PA451581	3169	0.742
NULL	Ann_Lab_Med_2015_Jan_8_35(1)_15-21.nxml.txt.nlp	25553275	SENT160	11	11	0	0	thrombin	Lag	PA451674	3925	0.742
NULL	Front_Microbiol_2013_Dec_4_4_369.nxml.txt.nlp	24363653	SENT238	10	10	14	14	nadh	NO3	PA164755085	4681	0.742
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT115	34	34	42	42	adalimumab	CD36	PA10004	948	0.742
NULL	J_Hepatol_2010_Dec_53(6)_1101-1107.nxml.txt.nlp	20801540	SENT377	22	22	17	17	deferasirox	mol	PA164760843	90527	0.742
NULL	Ecancermedicalscience_2011_Feb_14_5_204.nxml.txt.nlp	22276051	SENT185	3	3	6	6	rituximab	CHOP	PA451261	1649	0.742
NULL	Oncol_Lett_2014_Nov_12_8(5)_2203-2208.nxml.txt.nlp	25295109	SENT133	23	23	11	11	celecoxib	GLI1	PA448871	2735	0.742
NULL	Acta_Pharmacol_Sin_2010_Apr_8_31(4)_461-469.nxml.txt.nlp	20208553	SENT187	5	5	19	19	ethanol	adiponectin	PA448073	9370	0.742
NULL	Cancers_(Basel)_2014_Feb_26_6(1)_436-458.nxml.txt.nlp	24577242	SENT986	37	37	7	7	cisplatin	PKG	PA449014	5592	0.742
NULL	Clinics_(Sao_Paulo)_2013_May_68(5)_694-701.nxml.txt.nlp	23778405	SENT140	6	6	22	22	curcumin	P-gp	PA151958596	5243	0.742
NULL	Bone_Joint_Res_2014_Mar_1_3(3)_51-59.nxml.txt.nlp	24615710	SENT197	22	22	4	4	resveratrol	SIRT1		23411	0.742
NULL	J_Biol_Chem_2013_Nov_15_288(46)_33049-33059.nxml.txt.nlp	24089524	SENT354	7	7	14	14	nicotine	GATA6	PA450626	2627	0.742
NULL	Protein_Cell_2014_Jun_19_5(6)_469-479.nxml.txt.nlp	24748116	SENT134	11	11	0	0	paclitaxel	EB1	PA450761	9167;22919;10982	0.742
NULL	Br_J_Cancer_1978_Feb_37(2)_254-260.nxml.txt.nlp	75740	SENT5	11	11	13	13	bleomycin	BLM	PA448645	641	0.742
NULL	Int_J_Womens_Health_2012_Apr_12_4_167-174.nxml.txt.nlp	22532780	SENT161	38	38	8	8	alendronate	Tech	PA448082	57449	0.742
NULL	J_Neurol_Sci_2012_Nov_15_322(1-2)_92-95.nxml.txt.nlp	22819352	SENT124	3	3	13	13	ethanol	spatial	PA448073	219793	0.742
NULL	Curr_Neuropharmacol_2012_Jun_10(2)_97-123.nxml.txt.nlp	23204981	SENT119	24	24	30	30	levodopa	IL-2	PA450213	3558	0.742
NULL	Curr_Clin_Pharmacol_2008_Sep_3(3)_198-203.nxml.txt.nlp	18781906	SENT5	26	26	0	0	lamotrigine	CYP3A4	PA450164	1576	0.742
NULL	Ann_Neurosci_2011_Apr_18(2)_48-55.nxml.txt.nlp	25205921	SENT156	14	14	8	8	reserpine	SOD1	PA451236	6647	0.742
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Apr_7_9_12.nxml.txt.nlp	20374640	SENT48	24	24	41	41	trimethoprim	BSAC	PA451788	57591	0.742
NULL	Clinics_(Sao_Paulo)_2013_May_68(5)_694-701.nxml.txt.nlp	23778405	SENT225	24	24	16	16	curcumin	MDR1	PA151958596	5243	0.742
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT9	8	8	17	17	bevacizumab	VEGF-A	PA130232992	7422	0.742
NULL	Oncotarget_2013_Nov_24_4(12)_2430-2438.nxml.txt.nlp	24280348	SENT143	8	8	16	16	gefitinib	STAT3	PA131301952	6774	0.742
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT313	19	19	39	39	quetiapine	PRL	PA451201	5617	0.742
NULL	Front_Behav_Neurosci_2014_Nov_5_8_388.nxml.txt.nlp	25414651	SENT99	19	19	10	10	ketamine	NAC	PA450144	22861	0.742
NULL	Cancer_2012_Mar_15_118(6)_1486-1497.nxml.txt.nlp	21837674	SENT44	7	7	14	14	temsirolimus	4E-BP1	PA164746890	1978	0.742
NULL	Adv_Biomed_Res_2014_Oct_21_3_219.nxml.txt.nlp	25371876	SENT211	10	10	28	28	estradiol	CA1	PA449503	759	0.742
NULL	Acta_Pharmacol_Sin_2009_Apr_3_30(4)_478-484.nxml.txt.nlp	19343062	SENT99	0	0	8	8	ketoconazole	CYP3A4	PA450146	1576	0.742
NULL	J_Oncol_2010_Nov_19_2010_568938.nxml.txt.nlp	20037743	SENT126	9	9	21	21	gefitinib	EGFR	PA131301952	1956	0.742
NULL	Cases_J_2009_Jul_30_2_7134.nxml.txt.nlp	19829918	SENT52	5	5	15	15	levodopa	LCE	PA450213	79071	0.742
NULL	Br_J_Cancer_2012_Apr_10_106(8)_1460-1463.nxml.txt.nlp	22415235	SENT87	23	23	33	33	olaparib	BRCA2		675	0.742
NULL	Mediators_Inflamm_2010_Nov_29_2010_143026.nxml.txt.nlp	21127728	SENT95	4	4	42	42	lamivudine	CD4	PA450163	920	0.742
NULL	Drugs_R_D_2011_Sep_25_11(3)_259-275.nxml.txt.nlp	21902287	SENT360	3	3	20	20	tramadol	CYP2D6	PA451735	1565	0.742
NULL	Cell_Death_Dis_2013_Jul_11_4(7)_e719.nxml.txt.nlp	23846221	SENT56	38	38	36	36	cisplatin	TRAIL	PA449014	8743	0.742
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1495-1502.nxml.txt.nlp	21989186	SENT18	6	6	11	11	panitumumab	KRAS	PA162373091	3845	0.742
NULL	Cancer_Manag_Res_2014_Feb_19_6_77-92.nxml.txt.nlp	24600246	SENT270	10	10	2	2	olaparib	GAJ		84057	0.742
NULL	Front_Oncol_2014_Jun_18_4_153.nxml.txt.nlp	24995158	SENT713	1	1	16	16	vinblastine	Rho	PA451877	29984	0.742
NULL	Int_J_Endocrinol_2014_Aug_11_2014_312452.nxml.txt.nlp	25183970	SENT227	16	16	5	5	liraglutide	PI3K	PA165958364	5290	0.742
NULL	Oncotarget_2014_Oct_18_5(21)_10206-10221.nxml.txt.nlp	25344914	SENT40	1	1	26	26	vemurafenib	ARAF	PA165946873	369	0.742
NULL	Clin_Med_Insights_Cardiol_2010_Dec_1_4_117-128.nxml.txt.nlp	21151850	SENT278	14	14	5	5	prasugrel	CYP2C19	PA154410481	1557	0.742
NULL	J_Hematol_Oncol_2010_Mar_23_3_11.nxml.txt.nlp	20331897	SENT163	15	15	10	10	capecitabine	CRT	PA448771	811	0.742
NULL	Diabetes_Metab_Syndr_Obes_2014_Jun_24_7_229-239.nxml.txt.nlp	25018644	SENT214	35	35	27	27	metformin	GLP-1	PA450395	100125288	0.742
NULL	Oncogene_2014_Oct_9_33(41)_4941-4951.nxml.txt.nlp	24681952	SENT180	14	14	6	6	metformin	San	PA450395	80218	0.742
NULL	Arthritis_Res_Ther_2012_Aug_3_14(4)_R179.nxml.txt.nlp	22863285	SENT287	9	9	11	11	anakinra	INOS	PA10799	51477	0.742
NULL	Indian_J_Endocrinol_Metab_2012_May-Jun_16(3)_406-408.nxml.txt.nlp	22629508	SENT41	8	8	3	3	octreotide	IGF1	PA450678	3479	0.742
NULL	Clin_Interv_Aging_2008_Mar_3(1)_45-50.nxml.txt.nlp	18488877	SENT79	0	0	18	18	alendronate	BMD	PA448082	1756;7439	0.742
NULL	Oncoimmunology_2012_Oct_1_1(7)_1048-1060.nxml.txt.nlp	23170253	SENT3	14	14	5	5	bevacizumab	HER-2	PA130232992	2064	0.742
NULL	Acta_Pharmacol_Sin_2014_Aug_7_35(8)_1015-1022.nxml.txt.nlp	24998256	SENT81	3	3	9	9	ethanol	ALDH2	PA448073	217	0.742
NULL	Kidney_Int_Suppl_(2011)_2012_Mar_29_2(1)_69-88.nxml.txt.nlp	25018920	SENT129	18	18	14	14	fenoldopam	NAC	PA164784034	22861	0.742
NULL	Oncotarget_2013_Aug_30_4(10)_1698-1711.nxml.txt.nlp	24091605	SENT183	21	21	30	30	cisplatin	NANOG	PA449014	79923	0.742
NULL	Front_Physiol_2015_Jan_5_5_507.nxml.txt.nlp	25601839	SENT15	9	9	18	18	tamoxifen	NFAT5	PA451581	10725	0.742
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT42	5	5	12	12	pertuzumab	HER2		2064	0.742
NULL	Int_J_Mol_Sci_2010_May_5_11(5)_2039-2055.nxml.txt.nlp	20559500	SENT82	5	5	10	10	fluoxetine	c-FLIP	PA449673	8837	0.742
NULL	J_Cell_Biol_2002_Jun_24_157(7)_1267-1278.nxml.txt.nlp	12082084	SENT666	6	6	14	14	thrombin	Rho	PA451674	29984	0.742
NULL	Endocrinol_Metab_(Seoul)_2014_Sep_25_29(3)_379-387.nxml.txt.nlp	25309798	SENT140	3	3	10	10	resveratrol	SIRT1		23411	0.742
NULL	Oncotarget_2011_May_16_2(5)_418-421.nxml.txt.nlp	21789791	SENT42	19	19	11	11	bortezomib	TRAIL	PA10252	8743	0.742
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Feb_12_70(Pt_3)_o270-o271.nxml.txt.nlp	24764985	SENT13	4	4	11	11	piperazine	mol	PA450977	90527	0.742
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT95	6	6	3	3	imatinib	ABCG2	PA10804	9429	0.742
NULL	Diabetes_2011_May_23_60(5)_1458-1466.nxml.txt.nlp	21464445	SENT39	3	3	0	0	lipase	ATGL	PA450239	57104	0.742
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT349	23	23	16	16	acetaminophen	IFN	PA448015	3439	0.742
NULL	Dev_Dyn_2008_Feb_16_237(2)_504-512.nxml.txt.nlp	18213590	SENT149	2	2	18	18	tamoxifen	E12	PA451581	64100	0.742
NULL	Int_J_Nanomedicine_2009_Apr_20_4_99-105.nxml.txt.nlp	19516888	SENT174	11	11	30	30	paclitaxel	San	PA450761	80218	0.742
NULL	Oncol_Lett_2013_Dec_4_6(6)_1665-1672.nxml.txt.nlp	24273604	SENT147	12	12	21	21	chloroquine	TLR9	PA448948	54106	0.742
NULL	Int_J_Surg_Oncol_2012_Jun_12_2012_862879.nxml.txt.nlp	22778941	SENT7	13	13	22	22	cisplatin	BIN1	PA449014	274	0.742
NULL	J_Hematol_Oncol_2011_Jun_14_4_29.nxml.txt.nlp	21672194	SENT132	10	10	16	16	sunitinib	VEGFR	PA162372840	3791	0.742
NULL	J_Cell_Mol_Med_2014_Oct_11_18(10)_2031-2043.nxml.txt.nlp	25109475	SENT314	19	19	10	10	valsartan	AMPK	PA451848	5563	0.742
NULL	Eur_J_Clin_Pharmacol_2011_May_8_67(5)_493-506.nxml.txt.nlp	21140139	SENT271	20	20	13	13	oxycodone	CYP3A4	PA450741	1576	0.742
NULL	Clin_Dev_Immunol_2013_May_29_2013_296031.nxml.txt.nlp	23818913	SENT103	2	2	20	20	hydrocortisone	CD4	PA449905	920	0.742
NULL	J_Oncol_2012_Apr_10_2012_931071.nxml.txt.nlp	22570654	SENT20	23	23	12	12	plerixafor	CD34	PA165958410	947	0.742
NULL	Mol_Cancer_2013_Oct_8_12_119.nxml.txt.nlp	24103454	SENT216	5	5	7	7	etoposide	TOP1	PA449552	7150	0.742
NULL	Hum_Genomics_2009_Dec_1_4(2)_91-106.nxml.txt.nlp	20038497	SENT200	22	22	37	37	tacrine	IL-6	PA451576	3569	0.742
NULL	Environ_Health_Perspect_2011_Aug_22_119(8)_1053-1061.nxml.txt.nlp	21697028	SENT432	17	17	19	19	raloxifene	STAR	PA451221	6770;2984	0.742
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT6	3	3	26	26	erlotinib	AKT	PA134687924	207	0.742
NULL	Diabetes_2011_Nov_17_60(11)_2691-2700.nxml.txt.nlp	21896928	SENT141	20	20	23	23	resveratrol	SIRT1		23411	0.742
NULL	Carcinogenesis_2014_May_13_35(5)_1055-1066.nxml.txt.nlp	24419232	SENT301	4	4	6	6	metformin	ADAMTS1	PA450395	9510	0.742
NULL	Cardiovasc_Ther_2012_Jun_19_30(3)_e146-e155.nxml.txt.nlp	21167014	SENT6	11	11	6	6	liraglutide	GLP-1	PA165958364	100125288	0.742
NULL	Mol_Brain_2013_Dec_16_6_56.nxml.txt.nlp	24330819	SENT284	0	0	6	6	dantrolene	c-fos	PA449208	2353	0.742
NULL	Aging_(Albany_NY)_2009_Feb_18_1(3)_335-349.nxml.txt.nlp	20195489	SENT211	19	19	13	13	etoposide	p65	PA449552	5970	0.742
NULL	Int_J_Med_Sci_2015_Jan_1_12(1)_63-71.nxml.txt.nlp	25552920	SENT104	28	28	11	11	berberine	PC-3	PA165860812	692094	0.742
NULL	J_Cancer_Prev_2014_Mar_19(1)_14-22.nxml.txt.nlp	25337568	SENT162	2	2	6	6	tamoxifen	Bcl-2	PA451581	596	0.742
NULL	Chin_J_Cancer_2011_Oct_30(10)_690-700.nxml.txt.nlp	21959046	SENT20	20	20	7	7	gemcitabine	TPT	PA449748	23590;6469	0.742
NULL	Br_J_Clin_Pharmacol_2011_Oct_72(4)_647-657.nxml.txt.nlp	21518389	SENT149	9	9	12	12	cangrelor	P2Y12	PA165945763	64805	0.742
NULL	J_Cell_Mol_Med_2014_May_14_18(5)_811-823.nxml.txt.nlp	24628949	SENT197	15	15	25	25	docetaxel	FOXM1	PA449383	2305	0.742
NULL	Front_Neurosci_2014_Jun_24_8_176.nxml.txt.nlp	25009459	SENT869	0	0	14	14	ivermectin	P2X4	PA450133	5025	0.742
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_May_3_64(Pt_6)_o960.nxml.txt.nlp	21202690	SENT4	11	11	37	37	ethanol	mol	PA448073	90527	0.742
NULL	Diabetes_2009_Dec_31_58(12)_2851-2862.nxml.txt.nlp	19720788	SENT290	5	5	3	3	forskolin	BiP	PA146096022	3309	0.742
NULL	Oncoimmunology_2013_Sep_1_2(9)_e25737.nxml.txt.nlp	24327935	SENT13	9	9	11	11	bleomycin	BLM	PA448645	641	0.742
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S272-S275.nxml.txt.nlp	21525467	SENT144	27	27	6	6	rosiglitazone	GLP-1	PA451283	100125288	0.742
NULL	Neural_Plast_2007_Jan_1_2007_30585.nxml.txt.nlp	25148070	SENT3514	14	14	24	24	paroxetine	VPAC2	PA450801	7434	0.742
NULL	Cell_Death_Dis_2010_May_13_1(5)_e41.nxml.txt.nlp	21364648	SENT30	0	0	4	4	etoposide	p65	PA449552	5970	0.742
NULL	J_Korean_Med_Sci_2010_Mar_18_25(3)_496-500.nxml.txt.nlp	20191056	SENT43	13	13	20	20	doxorubicin	CHOP	PA449412	1649	0.742
NULL	J_Vis_Exp_2010_Aug_1_(42)_2036.nxml.txt.nlp	20729802	SENT20	3	3	9	9	collagenase	CO2	PA449107	4513	0.742
NULL	Hum_Genomics_2008_Sep_1_3(1)_7-16.nxml.txt.nlp	19129086	SENT195	15	15	3	3	fluvoxamine	CYP2C8	PA449690	1558	0.742
NULL	Oncotarget_2012_May_19_3(5)_535-545.nxml.txt.nlp	22619121	SENT100	9	9	3	3	topotecan	B-MYB	PA451729	4605	0.742
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_11_2014_274786.nxml.txt.nlp	25505920	SENT244	16	16	10	10	oxaliplatin	ERCC1	PA131285527	2067	0.742
NULL	ASN_Neuro_2009_Oct_21_1(4)_e00018.nxml.txt.nlp	19807694	SENT175	37	37	40	40	ganciclovir	E12	PA449733	64100	0.742
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Jul_23_3(7)_e126.nxml.txt.nlp	25054314	SENT154	10	10	40	40	telmisartan	SLCO1B3	PA451605	28234	0.742
NULL	J_Immunother_2014_Apr_12_37(3)_180-186.nxml.txt.nlp	24598448	SENT104	8	8	4	4	sorafenib	IL-2	PA7000	3558	0.742
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT367	7	7	5	5	pp2	PP1		5540;5464	0.742
NULL	Evid_Based_Complement_Alternat_Med_2013_May_28_2013_629750.nxml.txt.nlp	23781265	SENT146	5	5	18	18	capsaicin	GADD153	PA448776	1649	0.742
NULL	Acta_Pharmacol_Sin_2014_Aug_21_35(8)_1082-1092.nxml.txt.nlp	25047514	SENT195	12	12	6	6	letrozole	aromatase	PA450196	1588	0.742
NULL	Oncol_Lett_2014_Jul_25_8(1)_367-373.nxml.txt.nlp	24959278	SENT4	29	29	38	38	cisplatin	DDP	PA449014	1678	0.742
NULL	Acta_Neuropathol_Commun_2013_Sep_6_1_57.nxml.txt.nlp	24252176	SENT96	36	36	24	24	creatine	AMPK	PA164778930	5563	0.742
NULL	J_Cardiothorac_Surg_2012_Jan_11_7_5.nxml.txt.nlp	22236692	SENT63	11	11	15	15	heparin	ACT	PA449855	12;11332;9457;641455	0.742
NULL	Clinics_(Sao_Paulo)_2014_Jun_69(6)_438-446.nxml.txt.nlp	24964310	SENT50	14	14	44	44	risedronate	OCN	PA451255	632	0.742
NULL	Mol_Vis_2012_Nov_29_18_2839-2846.nxml.txt.nlp	23233786	SENT119	0	0	13	13	geldanamycin	Hsp90	PA152031327	3320	0.742
NULL	Parasit_Vectors_2008_Oct_21_1_40.nxml.txt.nlp	18937874	SENT294	17	17	20	20	metronidazole	IL-8	PA450484	3576	0.742
NULL	Aging_(Albany_NY)_2011_Dec_12_3(11)_1063-1077.nxml.txt.nlp	22170748	SENT112	14	14	21	21	doxorubicin	p53	PA449412	7157	0.742
NULL	Exp_Ther_Med_2013_Jul_25_6(1)_109-114.nxml.txt.nlp	23935730	SENT27	3	3	10	10	doxorubicin	CHOP	PA449412	1649	0.742
NULL	FEBS_Open_Bio_2014_Jan_21_4_153-161.nxml.txt.nlp	24490140	SENT245	29	29	37	37	cisplatin	WT1	PA449014	7490	0.742
NULL	Mol_Brain_2014_Apr_21_7_28.nxml.txt.nlp	24751148	SENT146	3	3	26	26	minocycline	p65	PA450519	5970	0.742
NULL	Front_Genet_2012_Nov_2_3_234.nxml.txt.nlp	23130020	SENT273	31	31	20	20	cisplatin	HER2	PA449014	2064	0.742
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT120	6	6	8	8	resveratrol	TRAIL		8743	0.742
NULL	Breast_Cancer_Res_Treat_2014_Sep_25_148(1)_81-90.nxml.txt.nlp	25253174	SENT131	28	28	33	33	metformin	HER2	PA450395	2064	0.742
NULL	Breast_Cancer_Res_2011_Jun_9_13(3)_R57.nxml.txt.nlp	21658222	SENT105	30	30	27	27	epirubicin	UGT2B7	PA449476	7364	0.742
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT138	30	30	11	11	pertuzumab	HER2		2064	0.742
NULL	Acta_Neuropathol_Commun_2014_Jan_2_2_3.nxml.txt.nlp	24383546	SENT270	27	27	8	8	resveratrol	SIRT1		23411	0.742
NULL	Neurobiol_Aging_2013_Nov_34(11)_2585-2603.nxml.txt.nlp	23810450	SENT287	2	2	13	13	cyproterone	p62	PA10049	8878;10657;23636	0.742
NULL	J_Neurovirol_2013_Jun_4_19(4)_351-358.nxml.txt.nlp	23733308	SENT92	15	15	13	13	mefloquine	SOC	PA450348	91544	0.742
NULL	Mol_Cancer_2007_Jan_12_6_4.nxml.txt.nlp	17222350	SENT185	13	13	15	15	diethylstilbestrol	DES	PA449307	1674	0.742
NULL	Oncogene_2014_Feb_6_33(6)_713-723.nxml.txt.nlp	23435429	SENT64	31	31	20	20	camptothecin	XIAP	PA153590860	331	0.742
NULL	Korean_Circ_J_2013_Mar_31_43(3)_204-206.nxml.txt.nlp	23613701	SENT62	12	12	15	15	l-arginine	Q10	PA448478	27161	0.742
NULL	J_Korean_Med_Sci_1994_Dec_9(6)_482-489.nxml.txt.nlp	7786445	SENT15	8	8	14	14	theophylline	CYP1A2	PA451647	1544	0.742
NULL	Arthritis_Res_Ther_2005_Feb_17_7(Suppl_1)_P74.nxml.txt.nlp	NULL	SENT20	3	3	22	22	losartan	ANOVA	PA450268	4858	0.742
NULL	Infect_Agent_Cancer_2009_Jun_17_4(Suppl_2)_P14.nxml.txt.nlp	NULL	SENT8	25	25	8	8	rituximab	CD4	PA451261	920	0.742
NULL	Diabetes_Care_2013_Aug_17_36(Suppl_2)_S226-S232.nxml.txt.nlp	23882050	SENT129	9	9	14	14	metformin	GLP	PA450395	342096	0.742
NULL	Emerg_Infect_Dis_2012_Jan_18(1)_29-37.nxml.txt.nlp	22260950	SENT55	8	8	0	0	rifampin	DST	PA451250	667	0.742
NULL	Case_Rep_Neurol_2011_Sep_7_3(3)_203-209.nxml.txt.nlp	22114580	SENT62	8	8	2	2	thrombin	VIII	PA451674	1351	0.742
NULL	Nat_Med_2013_Sep_11_19(9)_1153-1156.nxml.txt.nlp	23933983	SENT162	36	36	38	38	vasopressin	AVP	PA451858	114548;551	0.742
NULL	Clin_Med_Insights_Oncol_2011_Mar_16_5_35-43.nxml.txt.nlp	21499557	SENT46	19	19	3	3	trabectedin	p53	PA165958349	7157	0.742
NULL	J_Cell_Biol_2002_Oct_28_159(2)_303-312.nxml.txt.nlp	12403815	SENT223	12	12	9	9	trypsin	CK19	PA451806	3880	0.742
NULL	Eur_J_Med_Res_2009_Nov_24_14(Suppl_3)_17-21.nxml.txt.nlp	19959412	SENT79	40	40	31	31	abacavir	UGT	PA448004	7361;7355	0.742
NULL	Chemother_Res_Pract_2011_Sep_25_2011_730360.nxml.txt.nlp	22295205	SENT236	32	32	6	6	trastuzumab	DM1	PA451743	338023;1760;28509	0.742
NULL	J_Mammary_Gland_Biol_Neoplasia_2010_Mar_27_15(1)_5-17.nxml.txt.nlp	20101446	SENT179	4	4	0	0	tamoxifen	HuR	PA451581	1994	0.742
NULL	Eur_J_Clin_Pharmacol_2012_Jan_7_68(1)_55-64.nxml.txt.nlp	21735164	SENT308	16	16	7	7	oxycodone	CYP2D6	PA450741	1565	0.742
NULL	Biotechnol_Res_Int_2013_Dec_1_2013_253286.nxml.txt.nlp	24363937	SENT61	34	34	36	36	urea	ADP	PA451831	23038	0.742
NULL	Cancer_Biol_Med_2013_Dec_10(4)_192-205.nxml.txt.nlp	24349829	SENT309	21	21	10	10	cetuximab	BRAF	PA10040	673	0.742
NULL	Sci_Rep_2014_Dec_4_4_7310.nxml.txt.nlp	25472472	SENT381	38	38	22	22	decitabine	CD34	PA164749631	947	0.742
NULL	Biologics_2014_Feb_15_8_67-81.nxml.txt.nlp	24600203	SENT183	3	3	15	15	tocilizumab	IL-6	PA165292659	3569	0.742
NULL	J_Gen_Physiol_2009_Jun_133(6)_623-625.nxml.txt.nlp	19468076	SENT190	12	12	16	16	menthol	TRPA1	PA164776605	8989	0.742
NULL	J_Cancer_2012_Nov_30_4(1)_3-11.nxml.txt.nlp	23386900	SENT116	8	8	27	27	sildenafil	GM-CSF	PA451346	1437	0.742
NULL	Biomed_Res_Int_2014_Jun_4_2014_253243.nxml.txt.nlp	24995279	SENT45	33	33	7	7	cyclophosphamide	CHOP	PA449165	1649	0.742
NULL	Exp_Cell_Res_2011_Apr_15_317(7)_1028-1039.nxml.txt.nlp	21237154	SENT128	25	25	23	23	staurosporine	TRAIL	PA165109623	8743	0.742
NULL	Front_Neurol_2014_Sep_11_5_173.nxml.txt.nlp	25309501	SENT255	14	14	12	12	choline	CDP	PA448976	1523	0.742
NULL	Arthritis_Res_Ther_2006_Jul_21_8(4)_R130.nxml.txt.nlp	16859540	SENT169	32	32	20	20	atorvastatin	CD59	PA448500	966	0.742
NULL	J_Cell_Biol_2003_Dec_22_163(6)_1385-1395.nxml.txt.nlp	14676308	SENT264	0	0	5	5	thrombin	p38	PA451674	10598;1432;7965	0.742
NULL	Glycobiology_2009_Nov_14_19(11)_1155-1162.nxml.txt.nlp	19528664	SENT104	26	26	12	12	galactose	LSECtin	PA449725	339390	0.742
NULL	Evid_Based_Complement_Alternat_Med_2013_May_22_2013_921012.nxml.txt.nlp	23762167	SENT7	6	6	2	2	glucose	AMPK	PA449773	5563	0.742
NULL	Arthritis_Res_Ther_2008_Oct_15_10(Suppl_1)_S5.nxml.txt.nlp	19007425	SENT65	11	11	14	14	infliximab	ACR	PA452639	49	0.742
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT73	3	3	8	8	curcumin	PC-3	PA151958596	692094	0.742
NULL	Cancers_(Basel)_2011_Mar_29_3(2)_1708-1731.nxml.txt.nlp	24212779	SENT1591	0	0	9	9	gemcitabine	GM-CSF	PA449748	1437	0.742
NULL	J_Gen_Physiol_2000_Jun_1_115(6)_685-696.nxml.txt.nlp	10828243	SENT195	6	6	11	11	genistein	OLF	PA165109660	83857	0.742
NULL	Anticancer_Drugs_2015_Jan_28_26(1)_46-55.nxml.txt.nlp	25099621	SENT234	17	17	10	10	etoposide	p38	PA449552	10598;1432;7965	0.742
NULL	Mol_Biol_Cell_2014_Jan_1_25(1)_145-159.nxml.txt.nlp	24196833	SENT204	3	3	11	11	valinomycin	Fis1	PA151917011	51024	0.742
NULL	Br_J_Dermatol_2013_Jul_8_169(1)_137-145.nxml.txt.nlp	23387374	SENT61	12	12	6	6	amiodarone	CYP3A4	PA448383	1576	0.742
NULL	Int_J_Biomed_Sci_2007_Mar_3(1)_1-8.nxml.txt.nlp	23675014	SENT151	3	3	9	9	thrombin	ILK	PA451674	3611	0.742
NULL	Evid_Based_Complement_Alternat_Med_2012_Dec_27_2012_827278.nxml.txt.nlp	22253647	SENT175	0	0	3	3	fenofibrate	mol	PA449594	90527	0.742
NULL	Front_Neural_Circuits_2014_Apr_3_8_32.nxml.txt.nlp	24772068	SENT1171	13	13	10	10	carbachol	CA3	PA448784	761	0.741
NULL	Emerg_Infect_Dis_2012_Nov_18(11)_e2.nxml.txt.nlp	23092736	SENT64	7	7	3	3	pyrazinamide	DST	PA451182	667	0.741
NULL	Mol_Cancer_2012_Dec_12_11_91.nxml.txt.nlp	23234355	SENT51	0	0	2	2	erlotinib	EGFR	PA134687924	1956	0.741
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_25_2013_504642.nxml.txt.nlp	23878600	SENT168	9	9	4	4	captopril	TFG	PA448780	10342	0.741
NULL	Onco_Targets_Ther_2014_May_27_7_829-834.nxml.txt.nlp	24920924	SENT23	35	35	14	14	sorafenib	SHARP	PA7000	23013	0.741
NULL	Breast_Cancer_Res_2008_Dec_4_10(6)_R103.nxml.txt.nlp	19055788	SENT120	26	26	15	15	tamoxifen	CDH1	PA451581	51343;999	0.741
NULL	Cell_Death_Dis_2013_Jul_4_4(7)_e702.nxml.txt.nlp	23828565	SENT67	23	23	4	4	doxorubicin	XIAP	PA449412	331	0.741
NULL	Arch_Med_Sci_2011_Aug_2_7(4)_713-719.nxml.txt.nlp	22291810	SENT104	3	3	7	7	methotrexate	IL-18	PA450428	3606	0.741
NULL	Oncotarget_2013_Nov_23_5(1)_196-210.nxml.txt.nlp	24344116	SENT117	24	24	7	7	doxorubicin	p53	PA449412	7157	0.741
NULL	Mol_Biol_Cell_2014_Mar_15_25(6)_811-827.nxml.txt.nlp	24430873	SENT316	15	15	30	30	paraformaldehyde	FMNL2	PA450790	114793	0.741
NULL	Front_Endocrinol_(Lausanne)_2011_Dec_2_2_90.nxml.txt.nlp	22654832	SENT852	8	8	11	11	tamoxifen	SF-1	PA451581	2516	0.741
NULL	Acta_Pharmacol_Sin_2011_Jan_6_32(1)_133-138.nxml.txt.nlp	21131997	SENT105	6	6	1	1	heparin	ACT	PA449855	12;11332;9457;641455	0.741
NULL	J_Neuroinflammation_2011_Aug_5_8_91.nxml.txt.nlp	21819568	SENT226	10	10	32	32	pioglitazone	ANOVA	PA450970	4858	0.741
NULL	Mol_Cancer_2009_Dec_31_8_131.nxml.txt.nlp	20042122	SENT258	7	7	0	0	choline	ARM	PA448976	80210	0.741
NULL	BMB_Rep_2013_Jan_46(1)_59-64.nxml.txt.nlp	23351386	SENT62	4	4	20	20	auranofin	STAT3	PA448510	6774	0.741
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1437-1448.nxml.txt.nlp	24056706	SENT111	27	27	16	16	ketoconazole	CYP2C9	PA450146	1559	0.741
NULL	Clin_Psychopharmacol_Neurosci_2012_Dec_20_10(3)_168-179.nxml.txt.nlp	23430396	SENT154	37	37	4	4	iptakalim	ANOVA	PA165949694	4858	0.741
NULL	Int_J_Mol_Sci_2014_Jun_5_15(6)_10116-10135.nxml.txt.nlp	24905409	SENT200	5	5	22	22	resveratrol	IFN		3439	0.741
NULL	Front_Microbiol_2014_Mar_18_5_102.nxml.txt.nlp	24672518	SENT590	10	10	6	6	doxorubicin	p53	PA449412	7157	0.741
NULL	EMBO_J_2010_May_19_29(10)_1652-1658.nxml.txt.nlp	20389283	SENT77	23	23	5	5	choline	PC3	PA448976	57332;7832;5122	0.741
NULL	J_Cell_Biol_2003_Dec_22_163(6)_1385-1395.nxml.txt.nlp	14676308	SENT570	6	6	14	14	thrombin	Rho	PA451674	29984	0.741
NULL	Arch_Med_Sci_2012_Nov_9_8(5)_865-873.nxml.txt.nlp	23185197	SENT174	0	0	11	11	methimazole	IFN	PA450422	3439	0.741
NULL	Biochim_Biophys_Acta_2014_Jun_1841(6)_827-835.nxml.txt.nlp	24603323	SENT36	34	34	25	25	lipase	ABCG1	PA450239	9619	0.741
NULL	J_Korean_Med_Sci_2010_Nov_26_25(11)_1683-1687.nxml.txt.nlp	21060764	SENT43	9	9	6	6	thyroglobulin	CEA	PA164754910	5670;1087	0.741
NULL	Br_J_Cancer_2009_Nov_3_101(9)_1585-1595.nxml.txt.nlp	19809435	SENT172	10	10	16	16	curcumin	MDC	PA151958596	6367	0.741
NULL	J_Exp_Bot_2012_May_15_63(8)_3157-3171.nxml.txt.nlp	22345641	SENT338	18	18	7	7	benzaldehyde	MYB	PA448571	4602	0.741
NULL	Onco_Targets_Ther_2014_Dec_4_7_2249-2255.nxml.txt.nlp	25587220	SENT106	11	11	28	28	vinblastine	MRP1	PA451877	4437	0.741
NULL	Mol_Biol_Cell_2012_Nov_1_23(21)_4212-4225.nxml.txt.nlp	22956765	SENT172	14	14	12	12	thrombin	TER	PA451674	9524	0.741
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT53	8	8	0	0	tariquidar	ABCC10		89845	0.741
NULL	Front_Physiol_2011_Jun_30_2_33.nxml.txt.nlp	21747769	SENT206	19	19	6	6	berberine	p38	PA165860812	10598;1432;7965	0.741
NULL	Oncotarget_2012_May_4_3(4)_371-394.nxml.txt.nlp	22564882	SENT298	10	10	13	13	nutlin-3	p53		7157	0.741
NULL	Braz_J_Med_Biol_Res_2014_May_9_47(6)_478-482.nxml.txt.nlp	24770568	SENT94	6	6	17	17	cisplatin	CD133	PA449014	8842	0.741
NULL	J_Cell_Biol_1998_Jan_26_140(2)_335-345.nxml.txt.nlp	9442109	SENT230	20	20	15	15	chloroquine	NHE	PA448948	285335	0.741
NULL	Br_J_Cancer_2009_Jul_21_101(2)_312-319.nxml.txt.nlp	19568237	SENT109	27	27	25	25	pp2	PP1		5540;5464	0.741
NULL	Avicenna_J_Med_Biotechnol_2013_Oct-Dec_5(4)_241-250.nxml.txt.nlp	24285999	SENT86	24	24	11	11	nitrogen	SDS	PA450643	51119;10993	0.741
NULL	Biologics_2012_Dec_17_6_429-464.nxml.txt.nlp	23269860	SENT173	17	17	14	14	etanercept	NMA	PA449515	25805	0.741
NULL	Genet_Mol_Biol_2009_Mar_1_Jan-Mar_32(1)_75-82.nxml.txt.nlp	21637649	SENT6	26	26	34	34	thyroglobulin	DGAT1	PA164754910	8694	0.741
NULL	Exp_Ther_Med_2015_Jan_10_9(1)_267-271.nxml.txt.nlp	25452814	SENT27	25	25	13	13	clopidogrel	ABCB1	PA449053	5243	0.741
NULL	Crit_Care_2011_Mar_11_15(Suppl_1)_P364.nxml.txt.nlp	NULL	SENT10	7	7	21	21	metformin	ANOVA	PA450395	4858	0.741
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT215	2	2	4	4	capsaicin	p53	PA448776	7157	0.741
NULL	Acta_Pharmacol_Sin_2010_Oct_27_31(10)_1389-1394.nxml.txt.nlp	20871620	SENT113	6	6	13	13	carbachol	cadherin	PA448784	1015	0.741
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Apr_8_65(Pt_5)_o981-o982.nxml.txt.nlp	21584020	SENT87	4	4	14	14	benzaldehyde	mol	PA448571	90527	0.741
NULL	Br_J_Pharmacol_2010_Aug_160(8)_1997-2007.nxml.txt.nlp	20649597	SENT119	7	7	16	16	pp2	NOD1		10392	0.741
NULL	Drug_Des_Devel_Ther_2014_Oct_31_8_2121-2128.nxml.txt.nlp	25382970	SENT119	9	9	15	15	curcumin	TTR	PA151958596	7276	0.741
NULL	Comp_Hepatol_2005_Feb_8_4_2.nxml.txt.nlp	15701172	SENT184	10	10	20	20	ketoconazole	CYP3A	PA450146	1574	0.741
NULL	Front_Cell_Neurosci_2014_Dec_19_8_423.nxml.txt.nlp	25565958	SENT167	8	8	15	15	vanillin	spatial	PA451852	219793	0.741
NULL	Indian_J_Pharm_Sci_2013_Mar-Apr_75(2)_230-233.nxml.txt.nlp	24019575	SENT85	2	2	32	32	tadalafil	API	PA10333	5345	0.741
NULL	Int_J_Appl_Basic_Med_Res_2012_Jul-Dec_2(2)_84-91.nxml.txt.nlp	23776818	SENT151	11	11	9	9	oxacillin	OSSA	PA450725	23196	0.741
NULL	Neurorehabil_Neural_Repair_2013_Feb_27(2)_118-124.nxml.txt.nlp	22961264	SENT61	33	33	37	37	choline	GPC	PA448976	2995	0.741
NULL	Acta_Pharmacol_Sin_2009_Oct_21_30(10)_1392-1398.nxml.txt.nlp	19767766	SENT16	0	0	4	4	atorvastatin	ROS	PA448500	6098	0.741
NULL	J_Sens_Technol_2013_Sep_3(3)_10_4236_jst_2013_33015.nxml.txt.nlp	24409399	SENT140	9	9	18	18	ketamine	DC2	PA450144	58505	0.741
NULL	Diabetes_Metab_J_2013_Feb_15_37(1)_36-39.nxml.txt.nlp	23441298	SENT45	17	17	25	25	vildagliptin	PPG	PA165958346	5552	0.741
NULL	Oncol_Lett_2013_Feb_7_5(2)_440-446.nxml.txt.nlp	23420122	SENT109	10	10	19	19	sorafenib	AKT	PA7000	207	0.741
NULL	Cell_Cycle_2013_May_15_12(10)_1492-1500.nxml.txt.nlp	23598717	SENT143	28	28	5	5	doxorubicin	ROCK1	PA449412	6093	0.741
NULL	Br_J_Cancer_2009_Jul_21_101(2)_238-243.nxml.txt.nlp	19568242	SENT105	29	29	27	27	sunitinib	IFN	PA162372840	3439	0.741
NULL	Environ_Health_Perspect_2001_Mar_109(3)_257-264.nxml.txt.nlp	11333187	SENT0	20	20	9	9	estradiol	aromatase	PA449503	1588	0.741
NULL	J_Exp_Clin_Cancer_Res_2009_Jul_10_28(1)_99.nxml.txt.nlp	19591692	SENT122	22	22	11	11	imatinib	ABCG2	PA10804	9429	0.741
NULL	Bioinformation_2011_Oct_14_7(4)_199-206.nxml.txt.nlp	22102777	SENT67	16	16	18	18	indomethacin	OAP	PA449982	4937	0.741
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT165	2	2	4	4	resveratrol	TRAIL		8743	0.741
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_21-38.nxml.txt.nlp	19305786	SENT498	28	28	13	13	menthol	TRPV3	PA164776605	162514	0.741
NULL	Biomed_Res_Int_2014_Jun_24_2014_132702.nxml.txt.nlp	25050322	SENT164	4	4	21	21	metformin	LKB1	PA450395	6794	0.741
NULL	Pharmaceutics_2011_Jul_13_3(3)_425-439.nxml.txt.nlp	24310588	SENT355	16	16	0	0	methylphenidate	SERS	PA450464	6301;54938	0.741
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1063.nxml.txt.nlp	24556678	SENT14	6	6	26	26	thioridazine	Mcl-1	PA451666	4170	0.741
NULL	Br_J_Cancer_2010_Jan_5_102(1)_134-143.nxml.txt.nlp	19920829	SENT18	2	2	20	20	pertuzumab	HER-2		2064	0.741
NULL	Int_J_Biol_Sci_2014_Jun_10_10(6)_627-642.nxml.txt.nlp	24948876	SENT17	34	34	13	13	bicalutamide	c-Myc	PA164746255	4609	0.741
NULL	Breast_Cancer_Res_2012_Jul_19_14(4)_R109.nxml.txt.nlp	22812567	SENT210	0	0	4	4	gemcitabine	RRM2	PA449748	6241	0.741
NULL	Cancer_Causes_Control_2013_Aug_18_24(8)_1605-1614.nxml.txt.nlp	23775025	SENT243	31	31	9	9	cyclophosphamide	CYP2B6	PA449165	1555	0.741
NULL	Adv_Ther_2014_Sep_23_31(9)_986-999.nxml.txt.nlp	25245811	SENT206	27	27	6	6	rosiglitazone	GLP-1	PA451283	100125288	0.741
NULL	Front_Endocrinol_(Lausanne)_2014_Sep_5_5_143.nxml.txt.nlp	25250014	SENT92	8	8	11	11	metformin	AMPK	PA450395	5563	0.741
NULL	J_Mol_Med_(Berl)_2014_May_10_92(7)_709-722.nxml.txt.nlp	24811491	SENT218	19	19	8	8	cetuximab	BRAF	PA10040	673	0.741
NULL	Exp_Diabetes_Res_2011_Jun_23_2011_898913.nxml.txt.nlp	21747834	SENT196	26	26	5	5	rosiglitazone	GLP-1	PA451283	100125288	0.741
NULL	J_Exp_Med_1967_Jul_1_126(1)_171-188.nxml.txt.nlp	4165501	SENT6	2	2	14	14	phenylbutazone	gamma	PA450932	9913	0.741
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT39	7	7	23	23	resveratrol	SIRT1		23411	0.741
NULL	Front_Neurol_2014_Feb_18_5_17.nxml.txt.nlp	24600432	SENT34	4	4	16	16	levetiracetam	CA3	PA450206	761	0.741
NULL	Front_Neurol_2013_May_15_4_53.nxml.txt.nlp	23720649	SENT272	5	5	12	12	geldanamycin	Hsp90	PA152031327	3320	0.741
NULL	Crit_Care_2011_Aug_11_15(4)_226.nxml.txt.nlp	21892977	SENT269	10	10	20	20	vasopressin	ACTH	PA451858	5443	0.741
NULL	Mol_Cancer_2008_Jul_24_7_64.nxml.txt.nlp	18652674	SENT134	20	20	2	2	paclitaxel	cIAP2	PA450761	330	0.741
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT148	18	18	28	28	l-methionine	SIRT3	PA450423	23410	0.741
NULL	Nucleic_Acids_Res_2005_Aug_26_33(15)_4838-4848.nxml.txt.nlp	16126848	SENT348	4	4	8	8	norfloxacin	DNAJ	PA450654	85406;10294	0.741
NULL	Environ_Health_Perspect_2004_Nov_28_112(15)_1481-1487.nxml.txt.nlp	15531431	SENT114	11	11	23	23	pp2	EGFR		1956	0.741
NULL	Oncotarget_2014_Aug_19_5(18)_8703-8715.nxml.txt.nlp	25237928	SENT52	13	13	21	21	glucose	CD44	PA449773	960	0.741
NULL	Breast_Cancer_Res_2007_Oct_26_9(5)_112.nxml.txt.nlp	17980056	SENT190	18	18	15	15	tamoxifen	aromatase	PA451581	1588	0.741
NULL	Oncotarget_2014_Aug_29_5(17)_7217-7259.nxml.txt.nlp	25277175	SENT288	16	16	14	14	dutasteride	HER2	PA164749300	2064	0.741
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Nov_14_65(Pt_12)_o3083.nxml.txt.nlp	21578813	SENT69	13	13	28	28	benzaldehyde	mol	PA448571	90527	0.741
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT52	3	3	11	11	ranibizumab	VEGF-A	PA164746012	7422	0.741
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT370	14	14	7	7	resveratrol	SIRT1		23411	0.741
NULL	Cell_Death_Dis_2014_Jan_9_5(1)_e991.nxml.txt.nlp	24407244	SENT80	12	12	20	20	cisplatin	Bcl-2	PA449014	596	0.741
NULL	Clin_Med_Insights_Circ_Respir_Pulm_Med_2012_Jun_12_6_27-40.nxml.txt.nlp	22745565	SENT53	7	7	12	12	omalizumab	ACT	PA164752253	12;11332;9457;641455	0.741
NULL	Breast_Cancer_Res_2011_Mar_1_13(2)_R21.nxml.txt.nlp	21362200	SENT297	29	29	18	18	fulvestrant	PIK3CA	PA164747170	5290	0.741
NULL	Biomed_Res_Int_2014_Jan_20_2014_948427.nxml.txt.nlp	24563867	SENT93	3	3	19	19	buspirone	STZ	PA448689	6484	0.741
NULL	Case_Rep_Ophthalmol_Med_2013_Feb_12_2013_906920.nxml.txt.nlp	23476848	SENT86	25	25	17	17	fluorescein	FAF	PA164746009	8239;2188	0.741
NULL	Cases_J_2008_Jun_5_1_15.nxml.txt.nlp	18577260	SENT78	22	22	20	20	cyclophosphamide	CHOP	PA449165	1649	0.741
NULL	Front_Pharmacol_2014_May_16_5_80.nxml.txt.nlp	24904415	SENT129	17	17	36	36	doxycycline	CD25	PA449415	3669;3559	0.741
NULL	Pharmaceutics_2011_Nov_18_3(4)_865-913.nxml.txt.nlp	24309312	SENT376	36	36	28	28	ivermectin	P-gp	PA450133	5243	0.741
NULL	BMB_Rep_2013_Nov_46(11)_544-549.nxml.txt.nlp	24152910	SENT97	2	2	11	11	thrombin	HMGB1	PA451674	3146	0.741
NULL	Oncotarget_2012_Nov_17_3(12)_1600-1614.nxml.txt.nlp	23307622	SENT101	11	11	6	6	trastuzumab	ATG12	PA451743	9140	0.741
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Feb_15_5_3.nxml.txt.nlp	16480505	SENT159	28	28	7	7	hydrocortisone	CYP3A4	PA449905	1576	0.741
NULL	Ann_Pediatr_Cardiol_2008_Jan-Jun_1(1)_18-26.nxml.txt.nlp	20300233	SENT118	6	6	26	26	isoproterenol	LQT3	PA450121	6331	0.741
NULL	Front_Oncol_2013_Sep_9_3_235.nxml.txt.nlp	24058902	SENT67	6	6	12	12	gefitinib	BIM	PA131301952	10018	0.741
NULL	Proteome_Sci_2010_Mar_26_8_18.nxml.txt.nlp	20346146	SENT113	21	21	4	4	hyaluronan	CD105	PA165958431	2022	0.741
NULL	Clin_Mol_Allergy_2009_Mar_12_7_5.nxml.txt.nlp	19284628	SENT152	17	17	25	25	salmeterol	IL-10	PA451300	3586	0.741
NULL	Front_Mol_Neurosci_2012_Sep_6_5_91.nxml.txt.nlp	22973190	SENT722	3	3	17	17	yohimbine	CRF1	PA451946	1394	0.741
NULL	Pharmaceuticals_(Basel)_2012_Feb_24_5(3)_279-296.nxml.txt.nlp	24281379	SENT183	12	12	21	21	rivaroxaban	ADP	PA165958360	23038	0.741
NULL	J_Hum_Genet_2013_Jun_23_58(6)_339-345.nxml.txt.nlp	23697979	SENT86	39	39	33	33	clopidogrel	P2RY12	PA449053	64805	0.741
NULL	Eur_J_Clin_Pharmacol_2012_Jan_8_68(1)_29-37.nxml.txt.nlp	21739267	SENT97	25	25	17	17	fluvoxamine	CYP2D6	PA449690	1565	0.741
NULL	Br_J_Cancer_2012_Apr_10_106(8)_1460-1463.nxml.txt.nlp	22415235	SENT87	23	23	31	31	olaparib	BRCA1		672	0.741
NULL	Int_J_Endocrinol_2014_Feb_13_2014_329456.nxml.txt.nlp	24688539	SENT223	11	11	32	32	vardenafil	MCP-1	PA10229	6347	0.741
NULL	Arthritis_Res_Ther_2007_Oct_9_9(5)_R104.nxml.txt.nlp	17925024	SENT100	11	11	16	16	glucosamine	G10	PA164747613	8896;221527	0.741
NULL	Acta_Neuropathol_Commun_2014_May_30_2_57.nxml.txt.nlp	24887326	SENT185	42	42	18	18	vardenafil	ABCB1	PA10229	5243	0.741
NULL	Br_J_Cancer_2012_Oct_9_107(8)_1257-1267.nxml.txt.nlp	23047592	SENT205	22	22	2	2	methotrexate	BCS	PA450428	617	0.741
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_23_2013_941093.nxml.txt.nlp	23864901	SENT240	12	12	15	15	fluvoxamine	CYP1A2	PA449690	1544	0.741
NULL	Cancer_Cell_Int_2011_Aug_19_11_29.nxml.txt.nlp	21854619	SENT144	14	14	3	3	cisplatin	BRCA1	PA449014	672	0.741
NULL	Multidiscip_Respir_Med_2013_Feb_27_8(1)_16.nxml.txt.nlp	23442499	SENT92	32	32	23	23	warfarin	VKORC1	PA451906	79001	0.741
NULL	Eur_J_Histochem_2010_Jun_14_54(2)_e15.nxml.txt.nlp	20558338	SENT121	11	11	13	13	flutamide	PD2	PA449685	54623	0.741
NULL	Br_J_Cancer_2011_Apr_12_104(8)_1256-1261.nxml.txt.nlp	21448165	SENT161	24	24	29	29	sorafenib	IL-2	PA7000	3558	0.741
NULL	Exp_Ther_Med_2013_Jan_10_5(1)_287-291.nxml.txt.nlp	23251285	SENT115	24	24	29	29	aspirin	APS	PA448497	10603	0.741
NULL	Tuberc_Respir_Dis_(Seoul)_2014_Sep_30_77(3)_105-110.nxml.txt.nlp	25309604	SENT47	19	19	8	8	warfarin	TTR	PA451906	7276	0.741
NULL	Curr_Oncol_2009_May_16(Suppl_1)_S52-S59.nxml.txt.nlp	19478903	SENT281	1	1	11	11	enalapril	CYP3A4	PA449456	1576	0.741
NULL	Mol_Cancer_2014_Apr_17_13_85.nxml.txt.nlp	24741998	SENT287	13	13	23	23	rituximab	CD40L	PA451261	959	0.741
NULL	J_Vet_Med_Sci_2013_Nov_5_75(11)_1443-1448.nxml.txt.nlp	23832627	SENT84	2	2	14	14	dobutamine	MRAP	PA449381	56246	0.741
NULL	Mol_Cancer_2009_Nov_10_8_99.nxml.txt.nlp	19903356	SENT31	20	20	2	2	imatinib	IGFBP3	PA10804	3486	0.741
NULL	Amyloid_2014_Sep_11_21(3)_175-184.nxml.txt.nlp	24918964	SENT90	10	10	14	14	anakinra	TTR	PA10799	7276	0.741
NULL	Neural_Develop_2008_Oct_22_3_27.nxml.txt.nlp	18945340	SENT300	21	21	27	27	mimosine	p27	PA164752445	5715;10534	0.741
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT236	30	30	15	15	olanzapine	PRL	PA450688	5617	0.741
NULL	Nature_2012_Feb_15_483(7390)_484-488.nxml.txt.nlp	22343896	SENT76	31	31	26	26	heparin	EGF	PA449855	1950	0.741
NULL	Arthritis_Res_Ther_2011_Sep_21_13(5)_239.nxml.txt.nlp	21955617	SENT100	6	6	15	15	celecoxib	IL-6	PA448871	3569	0.741
NULL	J_Mol_Signal_2009_Apr_28_4_2.nxml.txt.nlp	19400946	SENT12	14	14	4	4	genistein	PRL	PA165109660	5617	0.741
NULL	Br_J_Pharmacol_2014_Sep_28_171(18)_4255-4272.nxml.txt.nlp	24846338	SENT213	15	15	4	4	ondansetron	gamma	PA450705	9913	0.741
NULL	Int_J_Biol_Sci_2013_Apr_22_9(4)_350-360.nxml.txt.nlp	23630447	SENT155	8	8	10	10	doxorubicin	ANOVA	PA449412	4858	0.741
NULL	Oncoimmunology_2012_Oct_1_1(7)_1048-1060.nxml.txt.nlp	23170253	SENT184	18	18	5	5	bevacizumab	HER-2	PA130232992	2064	0.741
NULL	J_Infect_Dis_2013_Sep_1_208(5)_801-812.nxml.txt.nlp	23766527	SENT40	1	1	36	36	primaquine	G6PD	PA451103	2539	0.741
NULL	Front_Physiol_2011_Jun_30_2_33.nxml.txt.nlp	21747769	SENT262	0	0	2	2	berberine	p38	PA165860812	10598;1432;7965	0.741
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT295	5	5	14	14	panitumumab	EGFR	PA162373091	1956	0.741
NULL	Org_Med_Chem_Lett_2014_Feb_28_4_1.nxml.txt.nlp	24576663	SENT65	3	3	6	6	sulfamethoxazole	mol	PA451544	90527	0.741
NULL	Breast_Cancer_Res_2011_Nov_1_13(6)_R109.nxml.txt.nlp	22044691	SENT374	10	10	42	42	docetaxel	S12	PA449383	3351;6206;5713;6268	0.741
NULL	Osteoporos_Int_2011_Jan_1_22(1)_27-35.nxml.txt.nlp	20358360	SENT66	43	43	26	26	zoledronate	PTH	PA10235	5741	0.741
NULL	Oxid_Med_Cell_Longev_2013_Jun_11_2013_870472.nxml.txt.nlp	23840921	SENT9	10	10	7	7	chloroquine	SRM	PA448948	6723;6725	0.741
NULL	Curr_Neuropharmacol_2008_Sep_6(3)_215-234.nxml.txt.nlp	19506722	SENT628	15	15	7	7	fluoxetine	5-HT1A	PA449673	3350	0.741
NULL	Biomed_Res_Int_2013_Aug_7_2013_864012.nxml.txt.nlp	23991423	SENT116	37	37	7	7	alfacalcidol	PTH	PA164746469	5741	0.741
NULL	Mol_Biol_Cell_2013_Sep_1_24(17)_2620-2632.nxml.txt.nlp	23864708	SENT14	14	14	10	10	gemcitabine	CD24	PA449748	100133941	0.741
NULL	Biomed_Res_Int_2014_Jun_24_2014_132702.nxml.txt.nlp	25050322	SENT164	4	4	19	19	metformin	p53	PA450395	7157	0.741
NULL	Thorax_2012_Oct_12_67(10)_891-900.nxml.txt.nlp	22693178	SENT162	6	6	8	8	capsaicin	TRPV1	PA448776	7442	0.741
NULL	ASN_Neuro_2012_Jun_20_4(4)_e00091.nxml.txt.nlp	22591512	SENT36	8	8	12	12	l-glutamine	B27	PA10090	56246	0.741
NULL	Pharmaceutics_2011_Jun_22_3(2)_326-337.nxml.txt.nlp	24310499	SENT350	8	8	19	19	saquinavir	MRP2	PA451305	100130958;57626;1244	0.741
NULL	Respir_Med_Case_Rep_2012_Nov_7_7_8-11.nxml.txt.nlp	NULL	SENT163	0	0	7	7	sirolimus	CD4	PA451365	920	0.741
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1724-1730.nxml.txt.nlp	19861964	SENT208	23	23	9	9	temozolomide	NRAS	PA451609	4893	0.741
NULL	Exp_Diabetes_Res_2012_Apr_17_2012_635472.nxml.txt.nlp	22577369	SENT69	9	9	18	18	vildagliptin	GLP-1	PA165958346	100125288	0.741
NULL	Protein_J_2012_Aug_5_31(6)_511-518.nxml.txt.nlp	22763563	SENT176	5	5	14	14	atorvastatin	CD36	PA448500	948	0.741
NULL	Bioinformation_2008_Dec_6_3(4)_180-188.nxml.txt.nlp	19238244	SENT83	25	25	8	8	methotrexate	DHFR	PA450428	1719	0.741
NULL	Support_Care_Cancer_2014_Dec_14_22(3)_837-846.nxml.txt.nlp	24337717	SENT19	27	27	5	5	itraconazole	CYP3A4	PA450132	1576	0.741
NULL	Curr_Opin_Oncol_2014_Jul_6_26(4)_428-433.nxml.txt.nlp	24840521	SENT152	27	27	10	10	temozolomide	GPI	PA451609	10007;2821	0.741
NULL	Virulence_2013_May_15_4(4)_335-343.nxml.txt.nlp	NULL	SENT127	22	22	6	6	melarsoprol	AQP2	PA10136	359	0.741
NULL	Aging_(Albany_NY)_2013_Feb_21_5(2)_94-95.nxml.txt.nlp	23518473	SENT25	6	6	15	15	resveratrol	SIRT1		23411	0.741
NULL	Front_Chem_2014_Dec_23_2_113.nxml.txt.nlp	25566531	SENT260	18	18	12	12	curcumin	STAT3	PA151958596	6774	0.741
NULL	Cancer_Immunol_Immunother_2011_Jun_25_60(6)_793-808.nxml.txt.nlp	21350947	SENT161	21	21	9	9	sorafenib	IFN	PA7000	3439	0.741
NULL	Br_J_Cancer_1998_Jun_77(11)_1966-1970.nxml.txt.nlp	9667676	SENT0	16	16	12	12	vinblastine	MVP	PA451877	9961	0.741
NULL	Onco_Targets_Ther_2014_Nov_21_7_2143-2146.nxml.txt.nlp	25473295	SENT49	38	38	17	17	irinotecan	UGT	PA450085	7361;7355	0.741
NULL	J_Exp_Clin_Cancer_Res_2009_Oct_7_28(1)_134.nxml.txt.nlp	19811659	SENT98	2	2	12	12	imatinib	NQO2	PA10804	4835	0.741
NULL	Int_J_Endocrinol_2014_Mar_11_2014_927317.nxml.txt.nlp	24738001	SENT21	11	11	4	4	exenatide	GLP-1	PA164749238	100125288	0.741
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S31-S40.nxml.txt.nlp	20680106	SENT191	12	12	17	17	cetuximab	KRAS	PA10040	3845	0.741
NULL	J_Res_Med_Sci_2010_Nov-Dec_15(6)_331-343.nxml.txt.nlp	21526106	SENT165	3	3	18	18	l-arginine	HDEL	PA448478	10945	0.741
NULL	Cell_Death_Dis_2014_Jan_16_5(1)_e994.nxml.txt.nlp	24434517	SENT82	25	25	33	33	chloroquine	DD2	PA448948	1646	0.741
NULL	Curr_Gerontol_Geriatr_Res_2010_Jun_8_2010_915296.nxml.txt.nlp	20631897	SENT92	43	43	11	11	pravastatin	SAGE	PA451089	55511	0.741
NULL	Eur_J_Clin_Pharmacol_2012_Jan_8_68(1)_29-37.nxml.txt.nlp	21739267	SENT135	21	21	26	26	fluvoxamine	CYP2D6	PA449690	1565	0.741
NULL	Indian_J_Pharmacol_2008_Oct_40(Suppl_2)_S66-S91.nxml.txt.nlp	21593982	SENT815	5	5	12	12	proguanil	CYP2C19	PA451124	1557	0.741
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT212	13	13	7	7	daunorubicin	B7-H1	PA449212	29126	0.741
NULL	Diagn_Pathol_2013_Nov_25_8_192.nxml.txt.nlp	24274261	SENT89	4	4	6	6	temozolomide	IL-2	PA451609	3558	0.741
NULL	Drugs_2014_Jul_18_74(11)_1209-1231.nxml.txt.nlp	25034361	SENT416	2	2	11	11	enoxaparin	STARS	PA449463	137735	0.741
NULL	N_Am_J_Med_Sci_2012_Dec_4(12)_638-640.nxml.txt.nlp	23272306	SENT73	9	9	24	24	liraglutide	Met	PA165958364	79811	0.741
NULL	Int_J_Cell_Biol_2013_Sep_12_2013_153634.nxml.txt.nlp	24159334	SENT140	12	12	35	35	cisplatin	YB-1	PA449014	4904	0.741
NULL	Hum_Genomics_2008_Sep_1_3(1)_53-70.nxml.txt.nlp	19129090	SENT143	14	14	7	7	perifosine	EXOC4	PA165291471	60412	0.741
NULL	Br_J_Pharmacol_2014_Jan_23_171(2)_523-535.nxml.txt.nlp	24372553	SENT209	7	7	20	20	metformin	p53	PA450395	7157	0.741
NULL	J_Biol_2008_Jul_31_7(6)_20.nxml.txt.nlp	18710588	SENT25	42	42	36	36	procaine	B12	PA451110	7126;4709	0.741
NULL	Crit_Care_2008_Jan_24_12(1)_R27.nxml.txt.nlp	18304335	SENT199	16	16	6	6	thrombin	Rho	PA451674	29984	0.741
NULL	ChemistryOpen_2014_Apr_13_3(2)_65-75.nxml.txt.nlp	24808993	SENT211	11	11	15	15	losartan	AT2	PA450268	186	0.741
NULL	Int_J_Nanomedicine_2009_Apr_20_4_107-114.nxml.txt.nlp	19516889	SENT2	13	13	20	20	cisplatin	DDP	PA449014	1678	0.741
NULL	Diabetes_2011_Jul_20_60(7)_1990-1999.nxml.txt.nlp	21617181	SENT269	26	26	15	15	rosiglitazone	IL-6	PA451283	3569	0.741
NULL	Br_J_Cancer_1985_Oct_52(4)_599-605.nxml.txt.nlp	4063135	SENT12	13	13	3	3	vincristine	PMI	PA451879	8834;5373	0.741
NULL	Biologics_2012_Jan_5_6_13-20.nxml.txt.nlp	22291463	SENT116	9	9	13	13	trastuzumab	DM1	PA451743	338023;1760;28509	0.741
NULL	Curr_Neuropharmacol_2014_Jan_12(1)_2-36.nxml.txt.nlp	24533013	SENT208	10	10	20	20	memantine	CB1	PA10364	1268	0.741
NULL	Chin_J_Cancer_2012_Apr_31(4)_178-184.nxml.txt.nlp	22237038	SENT58	0	0	11	11	niclosamide	p65	PA165958408	5970	0.741
NULL	Int_J_Breast_Cancer_2013_Jun_24_2013_137414.nxml.txt.nlp	23864953	SENT88	14	14	21	21	trastuzumab	HER2	PA451743	2064	0.741
NULL	Int_J_Environ_Res_Public_Health_2014_Aug_6_11(8)_7918-7930.nxml.txt.nlp	25101772	SENT286	0	0	3	3	lidocaine	CA3	PA450226	761	0.741
NULL	BMJ_Open_2013_Dec_21_3(12)_e004065.nxml.txt.nlp	24366580	SENT227	10	10	1	1	isoniazid	Gen	PA450112	348654	0.741
NULL	Br_J_Cancer_2011_Jan_4_104(1)_91-100.nxml.txt.nlp	21139584	SENT133	5	5	8	8	geldanamycin	Hsp90	PA152031327	3320	0.741
NULL	Mol_Vis_2012_Nov_29_18_2839-2846.nxml.txt.nlp	23233786	SENT181	0	0	13	13	geldanamycin	Hsp90	PA152031327	3320	0.741
NULL	Int_J_Nanomedicine_2007_Mar_2(1)_13-18.nxml.txt.nlp	17722507	SENT2	0	0	12	12	aprepitant	NK1	PA164747039	11126	0.741
NULL	Biomed_Res_Int_2013_Sep_8_2013_534817.nxml.txt.nlp	24089683	SENT94	9	9	5	5	candesartan	ANOVA	PA448765	4858	0.741
NULL	Cancer_Cell_Int_2009_Sep_10_9_25.nxml.txt.nlp	19744341	SENT171	2	2	9	9	glucosamine	PC-3	PA164747613	692094	0.741
NULL	Behav_Brain_Funct_2010_Aug_30_6_50.nxml.txt.nlp	20799992	SENT59	11	11	15	15	morphine	LSD	PA450550	1776	0.741
NULL	Asian_Spine_J_2013_Jun_22_7(2)_91-95.nxml.txt.nlp	23741545	SENT74	5	5	25	25	lidocaine	hole	PA450226	80757	0.741
NULL	Biochem_Biophys_Res_Commun_2009_Nov_6_389(1)_198-203.nxml.txt.nlp	19716803	SENT91	11	11	31	31	thrombin	GPVI	PA451674	51206	0.741
NULL	Cancers_(Basel)_2014_Apr_9_6(2)_829-859.nxml.txt.nlp	24722453	SENT203	3	3	8	8	capsaicin	STAT3	PA448776	6774	0.741
NULL	Mol_Cancer_2007_Sep_26_6_61.nxml.txt.nlp	17894897	SENT192	7	7	14	14	etoposide	MCL1	PA449552	4170	0.741
NULL	Oncotarget_2012_May_19_3(5)_535-545.nxml.txt.nlp	22619121	SENT100	9	9	12	12	topotecan	MYCN	PA451729	4613	0.741
NULL	Int_J_Mol_Sci_2012_Aug_24_13(9)_10697-10721.nxml.txt.nlp	23109817	SENT1105	16	16	6	6	vasopressin	AT1	PA451858	9197;185	0.741
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1224-1233.nxml.txt.nlp	22353810	SENT193	7	7	10	10	etoposide	MRP-1	PA449552	928	0.741
NULL	Mol_Cancer_2010_Jun_25_9_166.nxml.txt.nlp	20579378	SENT13	27	27	25	25	gefitinib	EGF	PA131301952	1950	0.741
NULL	Front_Neurosci_2014_Jun_24_8_176.nxml.txt.nlp	25009459	SENT337	7	7	15	15	ethanol	P2X3	PA448073	5024	0.741
NULL	Nat_Methods_2011_Jun_24_8(6)_487-493.nxml.txt.nlp	21516115	SENT74	16	16	27	27	gefitinib	EGF	PA131301952	1950	0.741
NULL	Adv_Ther_2014_Dec_12_31_1287-1305.nxml.txt.nlp	25504156	SENT215	22	22	32	32	saxagliptin	GLP	PA165958362	342096	0.741
NULL	Multidiscip_Respir_Med_2012_Nov_23_7(1)_48.nxml.txt.nlp	23174134	SENT78	4	4	2	2	imatinib	DLST	PA10804	1743	0.741
NULL	Amino_Acids_2012_Oct_10_43(4)_1751-1759.nxml.txt.nlp	22407485	SENT157	22	22	14	14	carrageenan	ghrelin	PA448814	51738	0.741
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT111	11	11	35	35	pertuzumab	HER3		2065	0.741
NULL	J_Gynecol_Oncol_2014_Jul_3_25(3)_236-248.nxml.txt.nlp	25045437	SENT159	11	11	23	23	carboplatin	VEGFR	PA448803	3791	0.741
NULL	J_Thromb_Haemost_2013_Jan_11(1)_132-141.nxml.txt.nlp	23205847	SENT172	24	24	15	15	thrombin	FVIII	PA451674	2157	0.741
NULL	J_Cardiovasc_Dis_Res_2012_Oct-Dec_3(4)_319-322.nxml.txt.nlp	23233778	SENT28	26	26	28	28	simvastatin	CYP3A4	PA451363	1576	0.741
NULL	Physiol_Rep_2014_Sep_11_2(9)_e12133.nxml.txt.nlp	25214520	SENT181	16	16	43	43	bleomycin	CXCR4	PA448645	7852	0.741
NULL	Oncotarget_2012_Jul_13_3(6)_601-607.nxml.txt.nlp	22802145	SENT18	11	11	6	6	doxorubicin	p53	PA449412	7157	0.741
NULL	Eur_J_Clin_Pharmacol_2014_Oct_8_70(12)_1433-1441.nxml.txt.nlp	25291992	SENT56	14	14	16	16	chlorpromazine	CPZ	PA448964	8532	0.741
NULL	Breast_Cancer_Res_2005_Nov_11_7(1)_R71-R81.nxml.txt.nlp	15642171	SENT23	27	27	5	5	estradiol	aromatase	PA449503	1588	0.741
NULL	J_Biol_Chem_2012_Apr_20_287(17)_14122-14135.nxml.txt.nlp	22351750	SENT658	8	8	3	3	hyaluronan	TSG-6	PA165958431	7130	0.741
NULL	Evid_Based_Complement_Alternat_Med_2011_Mar_13_2011_913898.nxml.txt.nlp	21785639	SENT200	11	11	25	25	curcumin	UGT	PA151958596	7361;7355	0.741
NULL	Biologics_2010_Aug_9_4_173-185.nxml.txt.nlp	20714355	SENT266	5	5	20	20	cetuximab	EGFR	PA10040	1956	0.741
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT181	0	0	14	14	doxorubicin	B7-H1	PA449412	29126	0.741
NULL	J_Neurovirol_2013_Jun_4_19(4)_351-358.nxml.txt.nlp	23733308	SENT109	30	30	16	16	mefloquine	SOC	PA450348	91544	0.741
NULL	Arthritis_Res_Ther_2013_Oct_30_15(5)_R171.nxml.txt.nlp	24286269	SENT77	33	33	8	8	abatacept	GML	PA164747080	2765	0.741
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_21-38.nxml.txt.nlp	19305786	SENT617	40	40	20	20	capsaicin	FAAH	PA448776	79152;2166	0.741
NULL	BMB_Rep_2014_Nov_47(11)_649-654.nxml.txt.nlp	25301019	SENT130	16	16	13	13	l-alanine	T1R3	PA448055	83756	0.741
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Nov_14_65(Pt_12)_o3070.nxml.txt.nlp	21578800	SENT7	9	9	12	12	l-proline	mol	PA451125	90527	0.741
NULL	Pharmaceutics_2011_Nov_18_3(4)_865-913.nxml.txt.nlp	24309312	SENT353	11	11	15	15	clopidogrel	CYP3A4	PA449053	1576	0.741
NULL	Br_J_Cancer_2011_Jul_12_105(2)_255-262.nxml.txt.nlp	21694725	SENT43	10	10	4	4	panitumumab	KRAS	PA162373091	3845	0.741
NULL	Front_Neurosci_2008_Dec_15_2(2)_135-136.nxml.txt.nlp	19225584	SENT25	10	10	24	24	choline	CA1	PA448976	759	0.741
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1145.nxml.txt.nlp	24675463	SENT187	37	37	33	33	heparin	EGF	PA449855	1950	0.741
NULL	Lipids_Health_Dis_2011_Feb_12_10_31.nxml.txt.nlp	21314960	SENT190	9	9	7	7	hemin	HO-1	PA449849	3162	0.741
NULL	Cerebrospinal_Fluid_Res_2008_Jan_11_5_1.nxml.txt.nlp	18186943	SENT79	7	7	19	19	doxycycline	EGFR	PA449415	1956	0.741
NULL	Biosci_Rep_2012_Dec_20_33(1)_e00011.nxml.txt.nlp	23137297	SENT266	32	32	24	24	heparin	RPSA	PA449855	3921	0.741
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT124	0	0	6	6	phenformin	CCL16	PA1000	6360	0.741
NULL	Exp_Ther_Med_2014_Nov_22_8(5)_1559-1564.nxml.txt.nlp	25289059	SENT3	22	22	17	17	geldanamycin	Hsp90	PA152031327	3320	0.741
NULL	Clin_Exp_Otorhinolaryngol_2011_Dec_15_4(4)_177-183.nxml.txt.nlp	22232712	SENT177	3	3	9	9	doxycycline	p38	PA449415	10598;1432;7965	0.741
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1150.nxml.txt.nlp	24675468	SENT105	3	3	12	12	ethanol	PARP-1	PA448073	25976	0.741
NULL	J_Immunol_Methods_2009_Jan_1_340(1)_11-24.nxml.txt.nlp	18929568	SENT183	6	6	32	32	dasatinib	IFN	PA162372878	3439	0.741
NULL	Br_J_Clin_Pharmacol_2011_Oct_72(4)_647-657.nxml.txt.nlp	21518389	SENT192	10	10	18	18	cangrelor	PGD2	PA165945763	27306	0.741
NULL	Front_Endocrinol_(Lausanne)_2015_Jan_12_5_240.nxml.txt.nlp	25628605	SENT134	9	9	30	30	doxorubicin	P-gp	PA449412	5243	0.741
NULL	Clin_Epidemiol_2014_Nov_20_6_423-432.nxml.txt.nlp	25429239	SENT84	25	25	12	12	crizotinib	EGFR	PA165946122	1956	0.741
NULL	Front_Chem_2014_Mar_14_2_12.nxml.txt.nlp	24790981	SENT93	3	3	6	6	curcumin	P19	PA151958596	51561	0.741
NULL	J_Cancer_Res_Clin_Oncol_2010_May_11_136(5)_737-743.nxml.txt.nlp	19904559	SENT40	9	9	21	21	bevacizumab	IFL	PA130232992	3439	0.741
NULL	Hum_Genomics_2010_Oct_1_5(1)_61-72.nxml.txt.nlp	21106490	SENT59	41	41	45	45	midazolam	CYP3A	PA450496	1574	0.741
NULL	Oncoimmunology_2013_Jun_1_2(6)_e24462.nxml.txt.nlp	23894707	SENT55	2	2	26	26	vemurafenib	BRAF	PA165946873	673	0.741
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT124	11	11	15	15	imatinib	CML	PA10804	613	0.741
NULL	Exp_Mol_Med_2012_Apr_30_44(4)_281-292.nxml.txt.nlp	22228119	SENT61	15	15	11	11	genistein	activin	PA165109660	83729	0.741
NULL	Mol_Cell_Proteomics_2012_Feb_6_11(2)_M111_015222.nxml.txt.nlp	22147731	SENT176	38	38	18	18	cetuximab	EGFR	PA10040	1956	0.741
NULL	Br_J_Cancer_2010_Sep_7_103(6)_889-898.nxml.txt.nlp	20664599	SENT145	24	24	16	16	paclitaxel	HER-2	PA450761	2064	0.741
NULL	Int_Clin_Psychopharmacol_2014_Jul_26_29(4)_206-211.nxml.txt.nlp	24374906	SENT84	20	20	9	9	venlafaxine	CYP2C19	PA451866	1557	0.741
NULL	Aging_(Albany_NY)_2014_Jan_14_6(1)_70-81.nxml.txt.nlp	24429382	SENT198	20	20	10	10	etoposide	WRN	PA449552	7486	0.74
NULL	Pharmaceuticals_(Basel)_2012_Aug_10_5(8)_802-836.nxml.txt.nlp	24280676	SENT1761	3	3	16	16	methotrexate	MRP4	PA450428	10257	0.74
NULL	Exp_Ther_Med_2013_Apr_5_5(4)_1259-1263.nxml.txt.nlp	23596498	SENT105	0	0	26	26	propofol	TRPV1	PA451141	7442	0.74
NULL	Cardiol_Ther_2013_Jun_27_2(1)_1-16.nxml.txt.nlp	25135285	SENT151	3	3	10	10	pioglitazone	adiponectin	PA450970	9370	0.74
NULL	ISRN_Neurosci_2014_Jan_16_2014_258040.nxml.txt.nlp	24967314	SENT44	0	0	3	3	cyanocobalamin	B12	PA451892	7126;4709	0.74
NULL	Sensors_(Basel)_2013_Apr_2_13(4)_4367-4377.nxml.txt.nlp	23549362	SENT1	35	35	15	15	ether	NHS	PA449525	4810	0.74
NULL	Oxid_Med_Cell_Longev_2013_Apr_28_2013_702120.nxml.txt.nlp	23738040	SENT108	24	24	28	28	hydroquinone	MC1R	PA449924	4157	0.74
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jan_12_67(Pt_2)_o322.nxml.txt.nlp	21523008	SENT61	0	0	15	15	benzaldehyde	mol	PA448571	90527	0.74
NULL	Anat_Cell_Biol_2010_Sep_30_43(3)_194-200.nxml.txt.nlp	21212859	SENT85	10	10	8	8	ethanol	PLP	PA448073	25824;5744	0.74
NULL	Exp_Hematol_Oncol_2014_Mar_11_3_7.nxml.txt.nlp	24618035	SENT147	17	17	15	15	imatinib	CXCL12	PA10804	6387	0.74
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT541	8	8	31	31	risperidone	PRL	PA451257	5617	0.74
NULL	Int_J_Nephrol_2011_Apr_18_2011_732746.nxml.txt.nlp	21603106	SENT26	18	18	20	20	vasopressin	AVP	PA451858	114548;551	0.74
NULL	Biomed_Res_Int_2014_Jan_20_2014_948427.nxml.txt.nlp	24563867	SENT141	5	5	12	12	buspirone	CRP	PA448689	1401;140913	0.74
NULL	Mol_Cancer_2014_Jun_3_13_139.nxml.txt.nlp	24894297	SENT123	15	15	11	11	cisplatin	HES1	PA449014	3280;8209	0.74
NULL	Biomed_Res_Int_2014_Apr_22_2014_960803.nxml.txt.nlp	24860831	SENT166	0	0	6	6	resveratrol	AMPK		5563	0.74
NULL	Cell_Death_Dis_2014_Jul_17_5(7)_e1333.nxml.txt.nlp	25032856	SENT50	15	15	10	10	candesartan	EAAC1	PA448765	6505	0.74
NULL	J_Cancer_2012_Nov_30_4(1)_3-11.nxml.txt.nlp	23386900	SENT116	8	8	33	33	sildenafil	S100A9	PA451346	6280	0.74
NULL	J_Geriatr_Cardiol_2014_Jun_11(2)_151-157.nxml.txt.nlp	25009566	SENT112	4	4	8	8	cilostazol	CDP	PA164746334	1523	0.74
NULL	Mol_Cell_Biochem_2014_Oct_9_385(1-2)_265-275.nxml.txt.nlp	24104452	SENT161	22	22	6	6	bortezomib	LC3	PA10252	84557	0.74
NULL	Acta_Pharmacol_Sin_2011_Jan_29_32(1)_38-44.nxml.txt.nlp	21113177	SENT146	20	20	9	9	chloroquine	LC3	PA448948	84557	0.74
NULL	Br_J_Cancer_2010_Dec_7_103(12)_1765-1772.nxml.txt.nlp	21139621	SENT13	30	30	22	22	panitumumab	EGFR	PA162373091	1956	0.74
NULL	J_Adv_Pharm_Technol_Res_2012_Jan-Mar_3(1)_57-61.nxml.txt.nlp	22470895	SENT77	10	10	22	22	ethanol	mol	PA448073	90527	0.74
NULL	Acta_Pharmacol_Sin_2013_Apr_11_34(4)_473-479.nxml.txt.nlp	23474709	SENT161	0	0	7	7	probenecid	MRP2	PA451106	100130958;57626;1244	0.74
NULL	Oncol_Rep_2013_Apr_23_29(4)_1268-1274.nxml.txt.nlp	23354756	SENT181	1	1	16	16	paclitaxel	SLC25A43	PA450761	203427	0.74
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT105	26	26	28	28	curcumin	TRAIL	PA151958596	8743	0.74
NULL	Open_Microbiol_J_2008_Mar_18_2_18-28.nxml.txt.nlp	19088907	SENT87	23	23	31	31	kanamycin	HC8	PA450137	5684;121916	0.74
NULL	Genetics_2014_Jan_11_196(1)_321-347.nxml.txt.nlp	24240528	SENT766	23	23	14	14	debrisoquine	CYP2D	PA452616	1565	0.74
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Aug_17_67(Pt_9)_o2351.nxml.txt.nlp	22058967	SENT78	0	0	24	24	tramadol	mol	PA451735	90527	0.74
NULL	Acta_Pharmacol_Sin_2014_Aug_7_35(8)_1023-1030.nxml.txt.nlp	24998255	SENT83	21	21	5	5	octreotide	SSTR2	PA450678	6752	0.74
NULL	Ther_Clin_Risk_Manag_2007_Dec_3(6)_1009-1020.nxml.txt.nlp	18516316	SENT94	7	7	4	4	cisplatin	HEC	PA449014	10403	0.74
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT212	20	20	15	15	sn-38	ABCG2		9429	0.74
NULL	J_Invest_Dermatol_2014_Jul_31_134(7)_1903-1911.nxml.txt.nlp	24487305	SENT221	21	21	11	11	chloroquine	IL-9	PA448948	3578	0.74
NULL	Clinics_(Sao_Paulo)_2014_Jan_69(1)_68-74.nxml.txt.nlp	24473562	SENT22	5	5	7	7	nutlin-3	MDM2		4193	0.74
NULL	Eur_J_Immunol_2014_Jun_10_44(6)_1759-1769.nxml.txt.nlp	24595810	SENT41	5	5	14	14	fludrocortisone	CD4	PA164743961	920	0.74
NULL	Breast_Cancer_Res_2012_Aug_8_14(4)_R116.nxml.txt.nlp	22873525	SENT300	31	31	6	6	trastuzumab	PIK3CA	PA451743	5290	0.74
NULL	Cell_Death_Dis_2013_Jul_11_4(7)_e719.nxml.txt.nlp	23846221	SENT56	7	7	28	28	cisplatin	XIAP	PA449014	331	0.74
NULL	Indian_J_Psychiatry_2011_Oct-Dec_53(4)_362-366.nxml.txt.nlp	22303047	SENT124	4	4	11	11	citalopram	STAR	PA449015	6770;2984	0.74
NULL	Clin_Exp_Otorhinolaryngol_2012_Sep_27_5(3)_117-121.nxml.txt.nlp	22977707	SENT12	21	21	9	9	kanamycin	NKCC1	PA450137	6558	0.74
NULL	Br_J_Cancer_2004_Mar_22_90(6)_1285-1292.nxml.txt.nlp	15026814	SENT200	16	16	14	14	doxorubicin	p53	PA449412	7157	0.74
NULL	Cancer_Cell_Int_2013_Mar_4_13_21.nxml.txt.nlp	23497288	SENT8	2	2	22	22	doxorubicin	EWS	PA449412	2130	0.74
NULL	BioData_Min_2008_Jul_17_1_2.nxml.txt.nlp	18822146	SENT178	5	5	26	26	ethanol	ADAM17	PA448073	6868	0.74
NULL	Acta_Pharmacol_Sin_2014_Aug_7_35(8)_1015-1022.nxml.txt.nlp	24998256	SENT122	2	2	9	9	ethanol	ALDH2	PA448073	217	0.74
NULL	Br_J_Cancer_2013_Jan_15_108(1)_82-90.nxml.txt.nlp	23321512	SENT277	5	5	14	14	paclitaxel	TUBB	PA450761	203068	0.74
NULL	Braz_J_Microbiol_2010_Jun_1_Apr-Jun_41(2)_452-460.nxml.txt.nlp	24031516	SENT121	15	15	27	27	ciprofloxacin	STX	PA449009	8128	0.74
NULL	Open_Dent_J_2014_May_30_8_109-124.nxml.txt.nlp	24976875	SENT189	10	10	26	26	doxycycline	IL-6	PA449415	3569	0.74
NULL	Cell_Commun_Signal_2014_Nov_15_12(1)_69.nxml.txt.nlp	NULL	SENT208	7	7	13	13	cisplatin	IQGAP1	PA449014	8826	0.74
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Nov_14_65(Pt_12)_o3083.nxml.txt.nlp	21578813	SENT69	13	13	10	10	benzaldehyde	mol	PA448571	90527	0.74
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S279-S284.nxml.txt.nlp	21525469	SENT187	15	15	30	30	liraglutide	Met	PA165958364	79811	0.74
NULL	Onco_Targets_Ther_2014_Nov_28_7_2183-2195.nxml.txt.nlp	25506223	SENT182	8	8	18	18	doxorubicin	MICA	PA449412	100507436	0.74
NULL	J_Int_Soc_Sports_Nutr_2012_Nov_19_9(Suppl_1)_P21.nxml.txt.nlp	NULL	SENT4	0	0	38	38	echinacea	EPO	PA131550706	7076;8288;2056	0.74
NULL	Genome_Biol_2011_Feb_22_12(2)_216.nxml.txt.nlp	21338479	SENT85	19	19	23	23	hyaluronan	HAS2	PA165958431	3037	0.74
NULL	Indian_J_Endocrinol_Metab_2013_May-Jun_17(3)_413-421.nxml.txt.nlp	23869296	SENT166	9	9	6	6	exenatide	GLP-1	PA164749238	100125288	0.74
NULL	Cancer_Res_Treat_2013_Mar_31_45(1)_55-62.nxml.txt.nlp	23613671	SENT76	3	3	13	13	oxaliplatin	KRAS	PA131285527	3845	0.74
NULL	Nucleic_Acids_Res_2012_Jun_22_40(11)_4861-4878.nxml.txt.nlp	22362753	SENT247	21	21	25	25	trypsin	NPM1	PA451806	4869	0.74
NULL	Eur_J_Clin_Pharmacol_2011_Dec_23_67(12)_1231-1241.nxml.txt.nlp	21698374	SENT242	20	20	3	3	tacrolimus	CYP3A5	PA451578	1577	0.74
NULL	J_Thorac_Oncol_2015_Jan_29_10(1)_156-163.nxml.txt.nlp	25247337	SENT263	39	39	28	28	erlotinib	BSC	PA134687924	6558	0.74
NULL	Open_Virol_J_2014_Mar_7_8_1-8.nxml.txt.nlp	24799968	SENT148	21	21	37	37	boceprevir	PKR	PA165948902	5610	0.74
NULL	Cell_Mol_Life_Sci_2011_Aug_11_68(16)_2667-2688.nxml.txt.nlp	21560073	SENT366	13	13	15	15	thrombin	ADP	PA451674	23038	0.74
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT257	26	26	8	8	ranibizumab	VEGF-A	PA164746012	7422	0.74
NULL	Evid_Based_Complement_Alternat_Med_2004_Jun_1(1)_83-91.nxml.txt.nlp	15257329	SENT103	18	18	5	5	sugar	SKT	PA451529	56243	0.74
NULL	Clin_Endocrinol_(Oxf)_2014_Jan_1_81(2)_289-293.nxml.txt.nlp	24735400	SENT79	26	26	7	7	hydrocortisone	ACTH	PA449905	5443	0.74
NULL	Case_Rep_Ophthalmol_Med_2011_Jan_31_2011_679751.nxml.txt.nlp	22606470	SENT47	10	10	20	20	bevacizumab	hole	PA130232992	80757	0.74
NULL	J_Exp_Bot_2009_Apr_2_60(6)_1691-1702.nxml.txt.nlp	19342428	SENT46	28	28	14	14	chloramphenicol	TAP	PA448927	8615;2317;10482;23541	0.74
NULL	Acta_Pharmacol_Sin_2013_Jun_8_34(6)_830-836.nxml.txt.nlp	23564080	SENT109	17	17	22	22	simvastatin	HMGB1	PA451363	3146	0.74
NULL	Breast_Cancer_(Auckl)_2012_Mar_7_6_67-77.nxml.txt.nlp	22438669	SENT123	13	13	7	7	trastuzumab	HER2	PA451743	2064	0.74
NULL	Oncotarget_2012_May_4_3(4)_371-394.nxml.txt.nlp	22564882	SENT311	6	6	18	18	etoposide	CD123	PA449552	3563	0.74
NULL	Mol_Cancer_2008_Jul_24_7_64.nxml.txt.nlp	18652674	SENT198	10	10	15	15	gemcitabine	AKT	PA449748	207	0.74
NULL	Acta_Pharmacol_Sin_2009_Apr_9_30(4)_467-477.nxml.txt.nlp	19270721	SENT200	11	11	25	25	cisplatin	IL-24	PA449014	11009	0.74
NULL	J_Biol_Chem_2008_Jun_20_283(25)_17194-17204.nxml.txt.nlp	18442977	SENT289	4	4	12	12	fluoxetine	NR1	PA449673	27158	0.74
NULL	Clin_Exp_Otorhinolaryngol_2011_Dec_15_4(4)_177-183.nxml.txt.nlp	22232712	SENT164	0	0	4	4	doxycycline	MUC5B	PA449415	727897	0.74
NULL	Clin_Med_Insights_Oncol_2011_Nov_7_5_349-364.nxml.txt.nlp	22174596	SENT22	7	7	4	4	pazopanib	IFN	PA165291492	3439	0.74
NULL	J_Korean_Med_Sci_2009_Jan_29_24(Suppl_1)_S170-S175.nxml.txt.nlp	19194548	SENT84	29	29	43	43	cisplatin	EPO	PA449014	7076;8288;2056	0.74
NULL	Mol_Cancer_2008_May_21_7_42.nxml.txt.nlp	18492291	SENT170	31	31	7	7	gefitinib	SNX1	PA131301952	6642	0.74
NULL	Oncotarget_2012_May_4_3(4)_371-394.nxml.txt.nlp	22564882	SENT304	10	10	16	16	nutlin-3	p53		7157	0.74
NULL	Cerebrospinal_Fluid_Res_2009_Dec_11_6_16.nxml.txt.nlp	20003330	SENT113	31	31	3	3	dextran	MRI	PA449261	78996	0.74
NULL	Case_Rep_Med_2009_Aug_9_2009_378287.nxml.txt.nlp	19721707	SENT44	9	9	15	15	tadalafil	CYP3A	PA10333	1574	0.74
NULL	Exp_Ther_Med_2012_Sep_12_4(3)_475-480.nxml.txt.nlp	23181121	SENT22	9	9	15	15	doxorubicin	CHOP	PA449412	1649	0.74
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Aug_11_66(Pt_9)_o2228.nxml.txt.nlp	21588598	SENT70	20	20	6	6	ethanol	mol	PA448073	90527	0.74
NULL	Mol_Cancer_2010_Mar_10_9_56.nxml.txt.nlp	20219102	SENT81	5	5	24	24	bortezomib	CCL2	PA10252	6347	0.74
NULL	Breast_Cancer_Res_2004_Mar_18_6(3)_119-127.nxml.txt.nlp	15084232	SENT110	12	12	17	17	genistein	pS2	PA165109660	7031	0.74
NULL	Eur_Arch_Psychiatry_Clin_Neurosci_2010_Mar_12_260(2)_101-111.nxml.txt.nlp	19856012	SENT168	30	30	10	10	clozapine	NR1	PA449061	27158	0.74
NULL	Clin_Med_Insights_Blood_Disord_2013_Nov_14_6_23-27.nxml.txt.nlp	25512717	SENT112	36	36	28	28	bleomycin	CHOP	PA448645	1649	0.74
NULL	Case_Rep_Oncol_Med_2012_Nov_3_2012_819809.nxml.txt.nlp	23198202	SENT33	24	24	17	17	thyroglobulin	CD56	PA164754910	4684	0.74
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT125	2	2	9	9	dasatinib	LYN	PA162372878	4067	0.74
NULL	J_Exp_Clin_Cancer_Res_2009_May_27_28(1)_68.nxml.txt.nlp	19470182	SENT172	11	11	6	6	cisplatin	ERCC1	PA449014	2067	0.74
NULL	Breast_Cancer_Res_2009_Jun_29_11(3)_R41.nxml.txt.nlp	19563669	SENT12	12	12	5	5	gefitinib	TRAIL	PA131301952	8743	0.74
NULL	Arch_Drug_Inf_2008_Dec_1(3)_97-106.nxml.txt.nlp	19639031	SENT142	12	12	5	5	sn-38	UGT1A1		54658	0.74
NULL	BioDrugs_2014_Aug_18_28(1)_27-39.nxml.txt.nlp	23955284	SENT250	15	15	4	4	doxorubicin	TRAIL	PA449412	8743	0.74
NULL	Breast_Cancer_(Auckl)_2009_Mar_20_3_9-21.nxml.txt.nlp	21556246	SENT187	4	4	14	14	estradiol	aromatase	PA449503	1588	0.74
NULL	JAKSTAT_2012_Apr_1_1(2)_83-89.nxml.txt.nlp	24058756	SENT44	4	4	10	10	losartan	JAK2	PA450268	3717	0.74
NULL	Nat_Commun_2011_May_24_2_326.nxml.txt.nlp	21610729	SENT113	6	6	1	1	l-tyrosine	TYR	PA451822	7299	0.74
NULL	Alcohol_Res_Health_2007_30(1)_5-13.nxml.txt.nlp	17718394	SENT52	9	9	0	0	ethanol	ADH7	PA448073	131	0.74
NULL	J_Cell_Mol_Med_2014_Aug_1_18(8)_1599-1611.nxml.txt.nlp	24889822	SENT250	10	10	15	15	resveratrol	p62		8878;10657;23636	0.74
NULL	J_Invest_Dermatol_2014_Apr_19_134(4)_965-974.nxml.txt.nlp	24352044	SENT33	28	28	14	14	hyaluronan	CD31	PA165958431	5175	0.74
NULL	Oncotarget_2012_May_4_3(4)_371-394.nxml.txt.nlp	22564882	SENT304	10	10	6	6	nutlin-3	4E-BP1		1978	0.74
NULL	Oncol_Lett_2014_Jun_8_7(6)_1761-1766.nxml.txt.nlp	24932229	SENT101	16	16	28	28	pazopanib	PIK3CA	PA165291492	5290	0.74
NULL	J_Korean_Med_Sci_2011_Jan_22_26(1)_33-41.nxml.txt.nlp	21218027	SENT36	24	24	19	19	clarithromycin	DST	PA449028	667	0.74
NULL	EMBO_Mol_Med_2011_Jul_3(7)_367-369.nxml.txt.nlp	21591260	SENT63	1	1	18	18	thrombin	MMP1	PA451674	4312	0.74
NULL	Exp_Hematol_Oncol_2013_Aug_8_2_22.nxml.txt.nlp	23927433	SENT65	6	6	10	10	tacrolimus	BRAF	PA451578	673	0.74
NULL	J_Biomed_Sci_2013_Jun_20_20(1)_38.nxml.txt.nlp	23786217	SENT137	5	5	22	22	streptozocin	IPL	PA451514	7262	0.74
NULL	Biomed_Res_Int_2014_Jan_15_2014_859871.nxml.txt.nlp	24527460	SENT57	25	25	29	29	oxaliplatin	BMP4	PA131285527	652	0.74
NULL	Arthritis_Res_2002_May_24_4(Suppl_2)_S34-S40.nxml.txt.nlp	12110156	SENT224	15	15	5	5	infliximab	IL-18	PA452639	3606	0.74
NULL	J_Mol_Signal_2006_Dec_6_1_8.nxml.txt.nlp	17224083	SENT30	1	1	35	35	thrombin	LARG	PA451674	23365	0.74
NULL	Oncotarget_2014_Aug_29_5(19)_8947-8958.nxml.txt.nlp	25333254	SENT32	21	21	38	38	plerixafor	CXCR4	PA165958410	7852	0.74
NULL	Eur_J_Clin_Pharmacol_2011_Dec_23_67(12)_1231-1241.nxml.txt.nlp	21698374	SENT245	26	26	8	8	tacrolimus	CYP3A5	PA451578	1577	0.74
NULL	Biomed_Res_Int_2014_Jan_29_2014_196249.nxml.txt.nlp	24605321	SENT168	27	27	6	6	bortezomib	ORP150	PA10252	10525	0.74
NULL	Ecancermedicalscience_2010_Oct_7_4_192.nxml.txt.nlp	22276040	SENT61	7	7	12	12	trastuzumab	PTEN	PA451743	5728	0.74
NULL	Lab_Invest_2011_Jun_14_91(6)_852-858.nxml.txt.nlp	21403643	SENT15	13	13	3	3	tenofovir	MRP4	PA10204	10257	0.74
NULL	Sci_Rep_2014_Dec_10_4_7403.nxml.txt.nlp	25492703	SENT527	12	12	19	19	ganciclovir	FIX	PA449733	2158	0.74
NULL	Pharmaceuticals_(Basel)_2013_Aug_21_6(8)_988-1038.nxml.txt.nlp	24276379	SENT2132	30	30	6	6	irinotecan	UGT1A7	PA450085	54577	0.74
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Dec_16_66(Pt_1)_o174.nxml.txt.nlp	21580060	SENT65	39	39	31	31	benzaldehyde	mol	PA448571	90527	0.74
NULL	eLife_2013_Nov_5_2_e00969.nxml.txt.nlp	24192036	SENT110	0	0	6	6	vemurafenib	JNK	PA165946873	5599	0.74
NULL	J_Gen_Physiol_2008_Nov_132(5)_521-535.nxml.txt.nlp	18852303	SENT219	16	16	8	8	trypsin	CAP2	PA451806	5271;10486	0.74
NULL	Eur_J_Clin_Pharmacol_2011_May_2_67(Suppl_1)_87-107.nxml.txt.nlp	21287160	SENT338	24	24	5	5	flavopiridol	UGT1A7	PA452627	54577	0.74
NULL	Nat_Med_2013_Mar_10_19(3)_313-321.nxml.txt.nlp	23396211	SENT368	24	24	13	13	amlexanox	TBK1	PA164745310	29110	0.74
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT87	40	40	14	14	pemetrexed	UNG	PA10810	7374	0.74
NULL	Arthritis_Res_Ther_2005_Apr_4_7(4)_R756-R768.nxml.txt.nlp	15987477	SENT184	14	14	27	27	hyaluronidase	PH-20	PA164745713	6677	0.74
NULL	Diabetes_Care_2010_Feb_33(2)_453-455.nxml.txt.nlp	20103562	SENT60	2	2	6	6	metformin	HIP	PA450395	6767;6159;64399;5068	0.74
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1563-1573.nxml.txt.nlp	22015557	SENT9	4	4	10	10	sunitinib	c-Myc	PA162372840	4609	0.74
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1063.nxml.txt.nlp	24556678	SENT141	21	21	14	14	thioridazine	TRAIL	PA451666	8743	0.74
NULL	J_Cell_Mol_Med_2014_Mar_22_18(3)_480-491.nxml.txt.nlp	24450440	SENT72	15	15	34	34	sorafenib	EDD	PA7000	51366	0.74
NULL	Oncotarget_2013_Nov_24_4(12)_2186-2207.nxml.txt.nlp	24327604	SENT137	10	10	12	12	nutlin-3	RITA		55422;84934	0.74
NULL	Lancet_2008_Jul_12_372(9633)_127-138.nxml.txt.nlp	18620950	SENT45	18	18	5	5	amodiaquine	IPT	PA448404	54802	0.74
NULL	Protein_Eng_Des_Sel_2011_Apr_14_24(4)_351-360.nxml.txt.nlp	21159620	SENT73	24	24	6	6	tetracycline	SOC	PA451640	91544	0.74
NULL	Clin_Interv_Aging_2010_Nov_19_5_345-354.nxml.txt.nlp	21228900	SENT125	4	4	19	19	denosumab	RANKL	PA166048634	8600	0.74
NULL	J_Invest_Dermatol_2012_May_16_132(5)_1435-1442.nxml.txt.nlp	22336948	SENT98	28	28	41	41	doxycycline	TLSP	PA449415	11012	0.74
NULL	J_Clin_Biochem_Nutr_2009_Jan_27_44(1)_79-84.nxml.txt.nlp	19177192	SENT4	32	32	36	36	curcumin	HO-1	PA151958596	3162	0.74
NULL	Front_Oncol_2012_Sep_12_2_114.nxml.txt.nlp	22988546	SENT229	8	8	6	6	bexarotene	DEC2	PA164752250	79365	0.74
NULL	Diabetes_2008_Sep_57(9)_2288-2295.nxml.txt.nlp	18535187	SENT169	0	0	11	11	pioglitazone	adiponectin	PA450970	9370	0.74
NULL	Mol_Cell_Biochem_2014_Oct_9_385(1-2)_265-275.nxml.txt.nlp	24104452	SENT232	2	2	27	27	bortezomib	U87	PA10252	677775;641648	0.74
NULL	Case_Rep_Oncol_2011_Jul_9_4(2)_350-357.nxml.txt.nlp	21769294	SENT63	5	5	8	8	bevacizumab	CRT	PA130232992	811	0.74
NULL	J_Hematol_Oncol_2009_Feb_23_2_10.nxml.txt.nlp	19236716	SENT108	7	7	4	4	dasatinib	CYP3A4	PA162372878	1576	0.74
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jul_10_68(Pt_8)_o2416-o2417.nxml.txt.nlp	22904868	SENT72	17	17	26	26	ethanol	mol	PA448073	90527	0.74
NULL	Int_J_Chron_Obstruct_Pulmon_Dis_2007_Jun_2(2)_157-167.nxml.txt.nlp	18044688	SENT104	3	3	11	11	salmeterol	TDI	PA451300	100038246	0.74
NULL	Diabetes_Care_2010_Mar_33(3)_692a.nxml.txt.nlp	NULL	SENT2	9	9	24	24	liraglutide	Met	PA165958364	79811	0.74
NULL	Breast_Cancer_Res_2011_Aug_12_13(4)_311.nxml.txt.nlp	21884644	SENT4	38	38	32	32	tamoxifen	HSPB8	PA451581	26353	0.74
NULL	Acta_Pharmacol_Sin_2009_Oct_21_30(10)_1392-1398.nxml.txt.nlp	19767766	SENT184	5	5	17	17	atorvastatin	p38	PA448500	10598;1432;7965	0.74
NULL	Diabetes_Care_2009_Sep_32(9)_e104-e111.nxml.txt.nlp	19717816	SENT129	5	5	1	1	liraglutide	GLP-1	PA165958364	100125288	0.74
NULL	Environ_Health_Perspect_2006_Sep_23_114(9)_1401-1406.nxml.txt.nlp	16966095	SENT125	12	12	27	27	tetracycline	p53	PA451640	7157	0.74
NULL	J_Cell_Mol_Med_2014_Jan_31_18(1)_27-37.nxml.txt.nlp	24373581	SENT189	0	0	29	29	alendronate	RANKL	PA448082	8600	0.74
NULL	Reprod_Biol_Endocrinol_2013_Feb_26_11_15.nxml.txt.nlp	23442442	SENT149	1	1	8	8	l-arginine	BAX	PA448478	581	0.74
NULL	Acta_Vet_Scand_2003_Sep_30_44(3)_121-129.nxml.txt.nlp	15074625	SENT106	14	14	12	12	gentamicin	TMP	PA449753	2012	0.74
NULL	Oncol_Lett_2014_Jul_25_8(1)_313-316.nxml.txt.nlp	24959268	SENT65	0	0	7	7	sulindac	JNK1	PA451565	5599	0.74
NULL	Br_J_Cancer_2011_Aug_23_105(5)_649-657.nxml.txt.nlp	21811251	SENT155	7	7	19	19	gefitinib	IGF1R	PA131301952	3480	0.74
NULL	Oncoimmunology_2014_Jan_1_3_e27359.nxml.txt.nlp	24653963	SENT25	18	18	42	42	doxorubicin	IDO1	PA449412	3620	0.74
NULL	Front_Chem_2014_Dec_23_2_113.nxml.txt.nlp	25566531	SENT170	2	2	16	16	curcumin	CTNND1	PA151958596	1500	0.74
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT106	0	0	22	22	erlotinib	CYP2E1	PA134687924	1571	0.74
NULL	Breast_Cancer_Res_2008_Dec_18_10(Suppl_4)_S22.nxml.txt.nlp	19128436	SENT72	30	30	19	19	trastuzumab	HER-2	PA451743	2064	0.74
NULL	Oxid_Med_Cell_Longev_2010_Nov-Dec_3(6)_361-373.nxml.txt.nlp	21311214	SENT202	28	28	22	22	ebselen	PP1	PA161660841	5540;5464	0.74
NULL	Int_J_Biol_Sci_2012_Sep_6_8(8)_1109-1120.nxml.txt.nlp	22991499	SENT212	12	12	4	4	l-arginine	IFN	PA448478	3439	0.74
NULL	Nat_Methods_2011_Nov_27_9(1)_78-80.nxml.txt.nlp	22120468	SENT84	17	17	28	28	streptomycin	CO2	PA451512	4513	0.74
NULL	Tumour_Biol_2012_Dec_14_33(6)_2209-2216.nxml.txt.nlp	22890830	SENT193	8	8	1	1	cisplatin	ERCC1	PA449014	2067	0.74
NULL	Apoptosis_2014_Aug_26_19(11)_1603-1615.nxml.txt.nlp	25156145	SENT175	4	4	0	0	mitomycin	TRAIL	PA450524	8743	0.74
NULL	Clin_Mol_Allergy_2010_Feb_16_8_2.nxml.txt.nlp	20158902	SENT14	0	0	9	9	heparin	CD203c	PA449855	5169	0.74
NULL	Core_Evid_2009_Jun_15_4_131-147.nxml.txt.nlp	20694070	SENT449	4	4	17	17	ritonavir	San	PA451260	80218	0.74
NULL	Br_J_Pharmacol_2008_Oct_18_155(4)_596-605.nxml.txt.nlp	18852694	SENT149	2	2	11	11	fenofibrate	SREBP2	PA449594	6721	0.74
NULL	Cancer_Immunol_Immunother_2013_Aug_27_62(10)_1637-1648.nxml.txt.nlp	23982484	SENT262	10	10	5	5	isotretinoin	GM-CSF	PA450128	1437	0.74
NULL	Br_J_Cancer_2013_Feb_5_108(2)_319-326.nxml.txt.nlp	23322198	SENT157	29	29	41	41	celecoxib	VEGFR	PA448871	3791	0.74
NULL	Exp_Lung_Res_2013_Oct_1_39(8)_336-348.nxml.txt.nlp	23919450	SENT91	0	0	4	4	thrombin	PAR-1	PA451674	2011;2149	0.74
NULL	Pharm_Pract_(Granada)_2011_Mar_15_Jan-Mar_9(1)_1-10.nxml.txt.nlp	25132883	SENT156	8	8	15	15	enoxaparin	SPAF	PA449463	166378	0.74
NULL	Clin_Med_Insights_Case_Rep_2014_Oct_1_7_117-121.nxml.txt.nlp	25336995	SENT33	27	27	37	37	melphalan	CD34	PA450354	947	0.74
NULL	J_Ophthalmic_Inflamm_Infect_2013_Jun_1_3_49.nxml.txt.nlp	23724856	SENT152	0	0	12	12	fluorescein	RPE	PA164746009	6120	0.74
NULL	Anc_Sci_Life_2012_Oct-Dec_32(2)_93-98.nxml.txt.nlp	24167334	SENT11	23	23	10	10	cyclophosphamide	AR7	PA449165	7067	0.74
NULL	J_Cell_Biol_2005_Jul_4_170(1)_49-59.nxml.txt.nlp	15983061	SENT157	9	9	18	18	forskolin	MITF	PA146096022	4286	0.74
NULL	Talanta_2015_Jan_131_728-735.nxml.txt.nlp	25281165	SENT52	5	5	2	2	finasteride	2H9	PA449627	3189	0.74
NULL	Anesth_Essays_Res_2014_Sep-Dec_8(3)_319-323.nxml.txt.nlp	NULL	SENT51	29	29	24	24	sevoflurane	RGM	PA451341	56963	0.74
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Apr_17_6_43-57.nxml.txt.nlp	24833916	SENT325	7	7	33	33	exemestane	aromatase	PA449563	1588	0.74
NULL	Cancer_Immunol_Immunother_2012_Jul_23_61(7)_1101-1111.nxml.txt.nlp	22193989	SENT206	7	7	9	9	oxaliplatin	STAT1	PA131285527	6772	0.74
NULL	J_Cancer_Prev_2014_Mar_19(1)_39-46.nxml.txt.nlp	25337571	SENT86	4	4	14	14	ethanol	JNK	PA448073	5599	0.74
NULL	Acta_Pharmacol_Sin_2012_Mar_30_33(3)_335-341.nxml.txt.nlp	22286918	SENT79	9	9	18	18	atenolol	EGFR	PA448499	1956	0.74
NULL	Int_J_Mol_Sci_2014_Oct_23_15(10)_19265-19280.nxml.txt.nlp	25342321	SENT58	30	30	13	13	sc-560	CD34		947	0.74
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT365	9	9	7	7	pp2	PP1		5540;5464	0.74
NULL	ISRN_Otolaryngol_2012_Oct_18_2012_953089.nxml.txt.nlp	23762622	SENT102	0	0	33	33	temsirolimus	S6K1	PA164746890	6198	0.74
NULL	Braz_J_Med_Biol_Res_2012_Mar_9_45(4)_357-365.nxml.txt.nlp	22392189	SENT65	31	31	23	23	ethanol	EPM	PA448073	2054	0.74
NULL	Eur_J_Haematol_2014_Feb_25_92(2)_127-136.nxml.txt.nlp	24118452	SENT172	21	21	37	37	anagrelide	CRT	PA164742986	811	0.74
NULL	Ther_Clin_Risk_Manag_2007_Aug_3(4)_533-542.nxml.txt.nlp	18472974	SENT181	6	6	17	17	posaconazole	CYP3A4	PA151958574	1576	0.74
NULL	Oncol_Lett_2015_Jan_4_9(1)_91-95.nxml.txt.nlp	25435939	SENT73	12	12	33	33	bleomycin	IB2	PA448645	23542	0.74
NULL	J_Cell_Biol_2008_Jul_14_182(1)_197-213.nxml.txt.nlp	18625847	SENT340	21	21	24	24	nutlin-3	BRCA1		672	0.74
NULL	J_Korean_Med_Sci_2008_Aug_25_23(4)_657-661.nxml.txt.nlp	18756053	SENT105	16	16	26	26	estradiol	AMH	PA449503	268	0.74
NULL	Cancer_Cell_Int_2011_Aug_12_11_27.nxml.txt.nlp	21838899	SENT297	25	25	45	45	chlorpromazine	CO2	PA448964	4513	0.74
NULL	Cell_Cycle_2012_Nov_1_11(21)_3983-3996.nxml.txt.nlp	22987153	SENT126	16	16	27	27	hydroxyurea	RAD51	PA449942	5888	0.74
NULL	Clin_Med_Pathol_2008_Jul_28_1_83-91.nxml.txt.nlp	21876656	SENT170	8	8	0	0	liraglutide	GLP-1	PA165958364	100125288	0.74
NULL	Arthritis_Res_Ther_2012_Apr_26_14(2)_R90.nxml.txt.nlp	22537858	SENT184	11	11	13	13	pravastatin	IFN	PA451089	3439	0.74
NULL	J_Cell_Biol_1998_Apr_20_141(2)_493-501.nxml.txt.nlp	9548726	SENT77	13	13	18	18	forskolin	San	PA146096022	80218	0.74
NULL	Leukemia_2013_Feb_3_27(2)_315-324.nxml.txt.nlp	22751450	SENT92	10	10	12	12	sorafenib	Mcl-1	PA7000	4170	0.74
NULL	Oncogene_2013_Oct_17_32(42)_5089-5100.nxml.txt.nlp	23178492	SENT291	19	19	6	6	vorinostat	LOX	PA164748224	4015	0.74
NULL	Acta_Pharmacol_Sin_2012_Jan_3_33(1)_82-90.nxml.txt.nlp	22212431	SENT138	5	5	10	10	lipase	PDK4	PA450239	5166	0.74
NULL	J_Cell_Mol_Med_2014_May_14_18(5)_811-823.nxml.txt.nlp	24628949	SENT17	22	22	14	14	docetaxel	FOXM1	PA449383	2305	0.74
NULL	Oncol_Rep_2013_Apr_5_29(4)_1671-1677.nxml.txt.nlp	23404329	SENT6	11	11	23	23	aspirin	SFN	PA448497	25996;2810	0.74
NULL	Acta_Pharmacol_Sin_2013_Jun_8_34(6)_830-836.nxml.txt.nlp	23564080	SENT180	36	36	38	38	simvastatin	HMGB1	PA451363	3146	0.74
NULL	Br_J_Cancer_2014_Nov_25_111(11)_2091-2102.nxml.txt.nlp	25349971	SENT181	20	20	8	8	imatinib	PTPN18	PA10804	26469	0.74
NULL	J_Cell_Mol_Med_2014_Dec_6_18(12)_2404-2416.nxml.txt.nlp	25284615	SENT47	19	19	21	21	bleomycin	BLM	PA448645	641	0.74
NULL	Mol_Cancer_2008_Oct_23_7_82.nxml.txt.nlp	18947424	SENT271	9	9	27	27	doxazosin	PC-3	PA449407	692094	0.74
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Feb_15_5_3.nxml.txt.nlp	16480505	SENT197	10	10	5	5	bupropion	CYP2B6	PA448687	1555	0.74
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT460	25	25	2	2	risperidone	PRL	PA451257	5617	0.74
NULL	Biomed_Res_Int_2014_Jan_20_2014_789765.nxml.txt.nlp	24575414	SENT179	9	9	11	11	piroxicam	PRX	PA450985	9588;57716	0.74
NULL	Diabetes_Care_2010_Mar_23_33(3)_485-489.nxml.txt.nlp	20032276	SENT165	15	15	22	22	citalopram	STAR	PA449015	6770;2984	0.74
NULL	Diabetes_Care_2012_Feb_16_35(2)_327-333.nxml.txt.nlp	22179958	SENT20	13	13	16	16	metformin	B12	PA450395	7126;4709	0.74
NULL	Int_J_Med_Sci_2015_Jan_1_12(1)_23-31.nxml.txt.nlp	25552915	SENT148	21	21	26	26	oxygen	CAT	PA450744	847	0.74
NULL	Br_J_Cancer_1995_Aug_72(2)_418-423.nxml.txt.nlp	7640227	SENT21	2	2	8	8	verapamil	MRP	PA451868	79971	0.74
NULL	Drug_Target_Insights_2013_Aug_19_7_27-34.nxml.txt.nlp	24023511	SENT84	16	16	4	4	roxithromycin	P-gp	PA164750505	5243	0.74
NULL	Oncotarget_2014_Nov_11_5(19)_8818-8852.nxml.txt.nlp	25344858	SENT342	5	5	10	10	erlotinib	EGFR	PA134687924	1956	0.74
NULL	J_Biol_Eng_2009_Oct_16_3_18.nxml.txt.nlp	19835592	SENT48	17	17	25	25	chloramphenicol	CPZ	PA448927	8532	0.74
NULL	J_Res_Med_Sci_2010_Nov-Dec_15(6)_348-358.nxml.txt.nlp	21526108	SENT163	3	3	14	14	thrombin	RhoA	PA451674	387	0.74
NULL	J_Immunotoxicol_2013_Jan_11_10(1)_75-82.nxml.txt.nlp	22967038	SENT102	12	12	2	2	rituximab	IFN	PA451261	3439	0.74
NULL	J_Cell_Mol_Med_2013_Nov_23_17(11)_1422-1433.nxml.txt.nlp	24112466	SENT239	11	11	25	25	lapatinib	CD44	PA152241907	960	0.74
NULL	Protein_Cell_2014_Jun_19_5(6)_469-479.nxml.txt.nlp	24748116	SENT4	9	9	7	7	paclitaxel	EB1	PA450761	9167;22919;10982	0.74
NULL	Clin_Interv_Aging_2015_Jan_6_10_157-174.nxml.txt.nlp	25609933	SENT160	28	28	42	42	everolimus	aromatase	PA164746311	1588	0.74
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jul_15_65(Pt_8)_o1860-o1861.nxml.txt.nlp	21583558	SENT52	12	12	18	18	benzaldehyde	mol	PA448571	90527	0.74
NULL	Breast_Cancer_Res_2009_Mar_19_11(2)_204.nxml.txt.nlp	19344489	SENT144	11	11	16	16	docetaxel	HER2	PA449383	2064	0.74
NULL	Case_Rep_Dent_2012_Feb_12_2012_643436.nxml.txt.nlp	22567457	SENT55	29	29	36	36	duloxetine	CD4	PA10066	920	0.74
NULL	Drugs_2014_Jul_18_74(11)_1209-1231.nxml.txt.nlp	25034361	SENT434	10	10	19	19	enoxaparin	STARS	PA449463	137735	0.74
NULL	Br_J_Cancer_2012_Jul_24_107(3)_516-526.nxml.txt.nlp	22782351	SENT299	36	36	26	26	tamoxifen	p53	PA451581	7157	0.74
NULL	JAKSTAT_2013_Jul_1_2(3)_e24812.nxml.txt.nlp	24069562	SENT55	33	33	14	14	pp2	STAT3		6774	0.74
NULL	Breast_Cancer_Res_Treat_2012_Jul_5_134(2)_693-700.nxml.txt.nlp	22562123	SENT201	10	10	4	4	raloxifene	CYP2D6	PA451221	1565	0.74
NULL	J_Exp_Clin_Cancer_Res_2009_Jul_10_28(1)_99.nxml.txt.nlp	19591692	SENT122	22	22	9	9	imatinib	ABCB1	PA10804	5243	0.74
NULL	Mol_Brain_2013_Nov_13_6_46.nxml.txt.nlp	24225225	SENT58	11	11	2	2	pentobarbital	AMPH	PA450859	273	0.74
NULL	J_Invest_Surg_2013_Jun_20_26(3)_141-148.nxml.txt.nlp	23514063	SENT89	7	7	15	15	heparin	ACT	PA449855	12;11332;9457;641455	0.74
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT120	32	32	27	27	curcumin	TRAIL	PA151958596	8743	0.74
NULL	Front_Oncol_2014_Jun_16_4_148.nxml.txt.nlp	24982848	SENT94	9	9	18	18	cisplatin	p53	PA449014	7157	0.74
NULL	Breast_Cancer_Res_2010_Oct_22_12(Suppl_2)_S1.nxml.txt.nlp	21050422	SENT10	23	23	9	9	bevacizumab	HER2	PA130232992	2064	0.74
NULL	Arthritis_Res_Ther_2014_Apr_3_16(2)_R86.nxml.txt.nlp	24708674	SENT227	24	24	26	26	bleomycin	BLM	PA448645	641	0.74
NULL	Mult_Scler_Int_2013_Jun_25_2013_627870.nxml.txt.nlp	23878736	SENT350	21	21	6	6	natalizumab	IFN	PA164747191	3439	0.74
NULL	Front_Oncol_2013_Oct_1_3_237.nxml.txt.nlp	24098868	SENT107	37	37	35	35	olaparib	CA125		4077;94025	0.74
NULL	Br_J_Cancer_2009_Mar_10_100(5)_758-763.nxml.txt.nlp	19259094	SENT6	6	6	17	17	belinostat	MLH1		4292	0.74
NULL	J_Biol_Chem_2013_Apr_5_288(14)_9767-9778.nxml.txt.nlp	23439651	SENT207	21	21	18	18	nutlin-3	p53		7157	0.74
NULL	Cases_J_2008_Jun_5_1_15.nxml.txt.nlp	18577260	SENT78	16	16	20	20	doxorubicin	CHOP	PA449412	1649	0.74
NULL	Ann_Rheum_Dis_2008_Sep_11_68(7)_1146-1152.nxml.txt.nlp	18794178	SENT160	6	6	13	13	etanercept	ACR	PA449515	49	0.74
NULL	Gut_Liver_2013_Sep_14_7(5)_585-593.nxml.txt.nlp	24073317	SENT153	13	13	31	31	ribavirin	IFN	PA451241	3439	0.74
NULL	Acta_Pharmacol_Sin_2012_May_4_33(5)_644-651.nxml.txt.nlp	22555371	SENT37	7	7	10	10	sulodexide	CRF	PA164746343	1392;10882	0.74
NULL	J_Int_AIDS_Soc_2011_Mar_26_14_14.nxml.txt.nlp	21439074	SENT114	28	28	30	30	atazanavir	ATV	PA10251	4683	0.74
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_127043.nxml.txt.nlp	23227093	SENT10	33	33	7	7	gemfibrozil	RYR	PA449750	6261	0.74
NULL	Genome_Biol_2003_Nov_28_4(12)_R79.nxml.txt.nlp	14659016	SENT57	14	14	31	31	spermine	Spink3	PA164781199	6690	0.74
NULL	Front_Neurol_2014_Sep_11_5_173.nxml.txt.nlp	25309501	SENT160	5	5	11	11	hyaluronan	HYAL2	PA165958431	8692	0.74
NULL	Open_Cardiovasc_Med_J_2010_Apr_28_4_120-126.nxml.txt.nlp	20556204	SENT111	2	2	20	20	fenofibrate	RANTES	PA449594	6352	0.74
NULL	Diabetes_2013_Jul_14_62(7)_2569-2578.nxml.txt.nlp	23474487	SENT79	37	37	30	30	isoflurane	ERG	PA450106	2078	0.739
NULL	Breast_Cancer_Res_2007_Mar_2_9(2)_205.nxml.txt.nlp	NULL	SENT26	18	18	20	20	ekb-569	EGFR		1956	0.739
NULL	Clin_Pharmacol_2010_Jun_22_2_105-110.nxml.txt.nlp	22291493	SENT58	13	13	17	17	sibutramine	ADIPOQ	PA451344	9370	0.739
NULL	Cardiovasc_Res_2012_Dec_1_96(3)_552-560.nxml.txt.nlp	22918977	SENT64	20	20	8	8	losartan	JAM-A	PA450268	50848	0.739
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_127043.nxml.txt.nlp	23227093	SENT10	38	38	30	30	lovastatin	P-gp	PA450272	5243	0.739
NULL	Cancer_Manag_Res_2013_Jan_17_5_15-20.nxml.txt.nlp	23378782	SENT40	11	11	22	22	erlotinib	Met	PA134687924	79811	0.739
NULL	Cancer_Cell_Int_2005_Jul_24_5_22.nxml.txt.nlp	16042792	SENT109	9	9	11	11	vincristine	NAC	PA451879	22861	0.739
NULL	Cancer_Res_Treat_2011_Sep_30_43(3)_148-153.nxml.txt.nlp	22022291	SENT119	12	12	35	35	irinotecan	UGT1A1	PA450085	54658	0.739
NULL	Oncotarget_2012_Nov_17_3(12)_1600-1614.nxml.txt.nlp	23307622	SENT107	24	24	26	26	trastuzumab	HER2	PA451743	2064	0.739
NULL	Br_J_Cancer_2013_Feb_19_108(3)_557-563.nxml.txt.nlp	23361053	SENT13	14	14	23	23	tamoxifen	PAK1	PA451581	5585;5058	0.739
NULL	J_Cancer_2013_Nov_23_4(9)_736-754.nxml.txt.nlp	24312144	SENT101	5	5	15	15	neratinib	EGFR	PA165291472	1956	0.739
NULL	Indian_J_Endocrinol_Metab_2013_May-Jun_17(3)_413-421.nxml.txt.nlp	23869296	SENT113	0	0	7	7	liraglutide	GLP-1	PA165958364	100125288	0.739
NULL	Biomed_Res_Int_2014_Jun_2_2014_946492.nxml.txt.nlp	24991574	SENT73	7	7	20	20	olmesartan	ATRAP	PA164742950	57085	0.739
NULL	Clin_Pharmacokinet_2014_Sep_3_53(1)_1-16.nxml.txt.nlp	23999929	SENT271	14	14	9	9	ketoconazole	CYP3A4	PA450146	1576	0.739
NULL	Biosci_Rep_2014_Dec_12_34(6)_e00160.nxml.txt.nlp	25495645	SENT277	8	8	3	3	lipase	ANGPTL3	PA450239	27329	0.739
NULL	Int_J_Mol_Imaging_2011_Oct_26_2011_874585.nxml.txt.nlp	21490735	SENT78	14	14	19	19	glucose	OMG	PA449773	4974	0.739
NULL	Nature_2012_Apr_25_484(7395)_524-528.nxml.txt.nlp	22538616	SENT136	2	2	9	9	vancomycin	IL-6	PA451850	3569	0.739
NULL	Endocrine_2014_Feb_18_47(1)_315-321.nxml.txt.nlp	24535466	SENT25	12	12	14	14	vasopressin	AVP	PA451858	114548;551	0.739
NULL	Arthritis_Res_Ther_2010_Apr_29_12(2)_R73.nxml.txt.nlp	20429888	SENT186	2	2	11	11	bortezomib	p300	PA10252	2033	0.739
NULL	Mucosal_Immunol_2013_Sep_16_6(5)_960-971.nxml.txt.nlp	23321985	SENT60	26	26	39	39	paraformaldehyde	San	PA450790	80218	0.739
NULL	JAKSTAT_2014_Jun_12_3_e29554.nxml.txt.nlp	25105067	SENT64	8	8	13	13	propofol	AKT	PA451141	207	0.739
NULL	Crit_Care_2006_Aug_1_10(4)_R114.nxml.txt.nlp	16882337	SENT128	13	13	25	25	aztreonam	HAP	PA448523	5915;10313	0.739
NULL	EMBO_Mol_Med_2012_Dec_15_4(12)_1276-1293.nxml.txt.nlp	23065753	SENT364	4	4	13	13	cisplatin	NLRP3	PA449014	114548	0.739
NULL	Front_Oncol_2012_Sep_14_2_108.nxml.txt.nlp	23050240	SENT16	28	28	20	20	thrombin	spatial	PA451674	219793	0.739
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT189	13	13	26	26	pertuzumab	KRT5		3852	0.739
NULL	Curr_Hypertens_Rep_2013_Oct_25_15(6)_559-574.nxml.txt.nlp	24158454	SENT288	31	31	10	10	hydralazine	ACE	PA449894	1636	0.739
NULL	J_Cereb_Blood_Flow_Metab_2011_Oct_20_31(10)_2030-2040.nxml.txt.nlp	21505475	SENT11	0	0	20	20	cilostazol	Bcl-2	PA164746334	596	0.739
NULL	Case_Rep_Ophthalmol_2011_Mar_12_2(1)_105-110.nxml.txt.nlp	22110438	SENT8	4	4	2	2	ribavirin	IFN	PA451241	3439	0.739
NULL	Nat_Commun_2011_May_24_2_326.nxml.txt.nlp	21610729	SENT113	6	6	10	10	l-tyrosine	TYR	PA451822	7299	0.739
NULL	Cancer_Immunol_Immunother_2011_Jun_25_60(6)_793-808.nxml.txt.nlp	21350947	SENT176	9	9	4	4	sorafenib	IFNAR2	PA7000	3455	0.739
NULL	Br_J_Cancer_2013_Feb_19_108(3)_570-578.nxml.txt.nlp	23299527	SENT143	24	24	38	38	acetohexamide	MLC2	PA164777011	10398	0.739
NULL	Environ_Health_2013_Apr_16_12_33.nxml.txt.nlp	23590724	SENT29	21	21	25	25	betaine	B12	PA448603	7126;4709	0.739
NULL	Cancers_(Basel)_2011_Mar_7_3(1)_1158-1181.nxml.txt.nlp	24212658	SENT246	24	24	10	10	cisplatin	HSF1	PA449014	3297	0.739
NULL	Br_J_Cancer_2009_Mar_24_100(6)_870-873.nxml.txt.nlp	19293806	SENT21	6	6	3	3	gemcitabine	CDA	PA449748	978	0.739
NULL	J_Membr_Biol_2010_Apr_12_234(2)_113-123.nxml.txt.nlp	20224886	SENT184	12	12	22	22	cisplatin	CTR	PA449014	799	0.739
NULL	Cancer_Immunol_Immunother_2011_Jun_25_60(6)_793-808.nxml.txt.nlp	21350947	SENT204	20	20	29	29	sorafenib	IFNAR2	PA7000	3455	0.739
NULL	Cell_Res_2012_Aug_22_22(8)_1227-1245.nxml.txt.nlp	22613949	SENT115	31	31	17	17	doxorubicin	KRAS	PA449412	3845	0.739
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT88	6	6	10	10	pp2	PP2		4888	0.739
NULL	Emerg_Infect_Dis_2011_Mar_17(3)_432-440.nxml.txt.nlp	21392434	SENT45	14	14	4	4	rifampin	DST	PA451250	667	0.739
NULL	Cell_Death_Dis_2014_Jul_3_5(7)_e1316.nxml.txt.nlp	24991768	SENT217	7	7	4	4	pemetrexed	Mcl-1	PA10810	4170	0.739
NULL	Acta_Pharmacol_Sin_2014_Jul_9_35(7)_889-898.nxml.txt.nlp	24909515	SENT159	18	18	9	9	phenol	DRD1	PA450913	1812	0.739
NULL	Oncotarget_2014_Nov_2_5(21)_10222-10236.nxml.txt.nlp	25400118	SENT224	34	34	24	24	lapatinib	HER2	PA152241907	2064	0.739
NULL	Front_Neurosci_2010_May_15_4_13.nxml.txt.nlp	20859447	SENT477	7	7	12	12	methamphetamine	spatial	PA450403	219793	0.739
NULL	Biochem_Res_Int_2012_Aug_23_2012_135723.nxml.txt.nlp	21904679	SENT198	18	18	14	14	lipase	DAG	PA450239	1605	0.739
NULL	Front_Aging_Neurosci_2014_Sep_11_6_218.nxml.txt.nlp	25309423	SENT171	0	0	28	28	resveratrol	COX1		4512;5742	0.739
NULL	J_Cancer_2011_May_19_2_292-301.nxml.txt.nlp	21611110	SENT60	19	19	37	37	cytarabine	CRT	PA449177	811	0.739
NULL	Cancer_Med_2014_Apr_7_3(2)_362-375.nxml.txt.nlp	24515916	SENT182	10	10	19	19	zoledronate	IL-2	PA10235	3558	0.739
NULL	J_Invest_Dermatol_2012_Nov_14_132(11)_2601-2609.nxml.txt.nlp	22696056	SENT74	0	0	12	12	guanabenz	EIF2	PA164774903	1968	0.739
NULL	ScientificWorldJournal_2013_Dec_25_2013_134656.nxml.txt.nlp	24453789	SENT58	5	5	1	1	ethanol	TPC	PA448073	8030;60386	0.739
NULL	Clin_Ophthalmol_2014_Jun_3_8_1057-1064.nxml.txt.nlp	24940042	SENT40	23	23	14	14	bevacizumab	CST	PA130232992	9514	0.739
NULL	Int_J_Environ_Res_Public_Health_2011_Dec_30_8(12)_4460-4476.nxml.txt.nlp	22408583	SENT173	14	14	3	3	ampicillin	ST5	PA448419	6764	0.739
NULL	Mol_Vis_2012_Oct_5_18_2454-2467.nxml.txt.nlp	23077404	SENT230	31	31	24	24	bevacizumab	VEGF-A	PA130232992	7422	0.739
NULL	Curr_Oncol_2009_Jul_16(Suppl_2)_S1-S13.nxml.txt.nlp	19672416	SENT251	7	7	21	21	tamoxifen	ARNO	PA451581	9266	0.739
NULL	Oncogene_2013_Oct_17_32(42)_5101-5110.nxml.txt.nlp	23208508	SENT33	45	45	22	22	metformin	PC-3	PA450395	692094	0.739
NULL	Virol_J_2009_Dec_1_6_213.nxml.txt.nlp	19951438	SENT162	27	27	30	30	mitomycin	TRAIL	PA450524	8743	0.739
NULL	Int_J_Mol_Sci_2014_Sep_30_15(10)_17733-17750.nxml.txt.nlp	25272228	SENT157	8	8	30	30	oxygen	cadherin	PA450744	1015	0.739
NULL	Int_J_Mol_Sci_2012_Feb_10_13(2)_1886-1918.nxml.txt.nlp	22408430	SENT250	21	21	29	29	sorafenib	Mcl-1	PA7000	4170	0.739
NULL	Pharmaceuticals_(Basel)_2013_Feb_6_6(2)_251-268.nxml.txt.nlp	24275950	SENT554	1	1	16	16	acamprosate	CA1	PA10344	759	0.739
NULL	J_Biol_Chem_2012_Aug_10_287(33)_28169-28179.nxml.txt.nlp	22584573	SENT170	4	4	11	11	rosiglitazone	JNK	PA451283	5599	0.739
NULL	Acta_Naturae_2013_Apr-Jun_5(2)_19-39.nxml.txt.nlp	23819034	SENT46	12	12	9	9	thrombin	VIII	PA451674	1351	0.739
NULL	Int_J_Mol_Sci_2014_Oct_20_15(10)_18985-18999.nxml.txt.nlp	25334066	SENT177	32	32	5	5	cisplatin	HOTAIR	PA449014	100124700	0.739
NULL	Diabetes_Care_2013_Aug_17_36(Suppl_2)_S162-S174.nxml.txt.nlp	23882042	SENT29	0	0	27	27	troglitazone	adiponectin	PA451799	9370	0.739
NULL	Cancer_Med_2014_Jun_10_3(3)_660-666.nxml.txt.nlp	24610705	SENT136	5	5	8	8	temozolomide	gamma	PA451609	9913	0.739
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT226	17	17	24	24	perifosine	DR5	PA165291471	8795	0.739
NULL	Ann_Clin_Microbiol_Antimicrob_2005_Sep_13_4_13.nxml.txt.nlp	16159399	SENT221	8	8	10	10	lamivudine	IFN	PA450163	3439	0.739
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT103	0	0	11	11	trastuzumab	HER3	PA451743	2065	0.739
NULL	Biosci_Rep_2012_Dec_1_32(Pt_6)_511-519.nxml.txt.nlp	NULL	SENT106	22	22	6	6	lovastatin	ERK2	PA450272	5594	0.739
NULL	J_Geriatr_Cardiol_2012_Jun_9(2)_172-179.nxml.txt.nlp	22916065	SENT236	8	8	21	21	acetylcysteine	PI3	PA448033	5266	0.739
NULL	Carcinogenesis_2008_Sep_9_29(9)_1734-1741.nxml.txt.nlp	18544564	SENT374	9	9	7	7	sorafenib	c-Myc	PA7000	4609	0.739
NULL	Breast_Cancer_Res_2007_Jan_23_9(1)_R7.nxml.txt.nlp	17244352	SENT104	22	22	16	16	tamoxifen	UGT2B15	PA451581	7366	0.739
NULL	Int_J_Mol_Sci_2014_Nov_10_15(11)_20607-20637.nxml.txt.nlp	25391045	SENT40	20	20	24	24	simvastatin	CYP3A4	PA451363	1576	0.739
NULL	Arthritis_Res_Ther_2013_Nov_1_15(6)_R176.nxml.txt.nlp	24456929	SENT274	8	8	21	21	pp2	PP2		4888	0.739
NULL	J_Cell_Biol_2001_May_28_153(5)_1049-1060.nxml.txt.nlp	11381089	SENT69	35	35	38	38	streptomycin	BRL	PA451512	23774	0.739
NULL	Nat_Methods_2011_Jun_24_8(6)_487-493.nxml.txt.nlp	21516115	SENT163	27	27	33	33	gefitinib	EGF	PA131301952	1950	0.739
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT200	21	21	44	44	l-leucine	SIRT3	PA450197	23410	0.739
NULL	Indian_J_Pharmacol_2013_Sep-Oct_45(5)_458-463.nxml.txt.nlp	24130379	SENT161	8	8	26	26	carvedilol	TLR4	PA448817	7099	0.739
NULL	Cent_European_J_Urol_2013_Aug_13_66(2)_150-151.nxml.txt.nlp	24579015	SENT21	23	23	5	5	resveratrol	ski		55733	0.739
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_13_2012_636848.nxml.txt.nlp	23258994	SENT144	17	17	6	6	capsaicin	TRPV1	PA448776	7442	0.739
NULL	Eur_J_Med_Res_2010_Apr_8_15(4)_145-151.nxml.txt.nlp	20554495	SENT122	19	19	25	25	abacavir	HLA-B	PA448004	3106	0.739
NULL	Cell_Death_Dis_2014_Jan_9_5(1)_e982.nxml.txt.nlp	24407235	SENT143	23	23	15	15	l-glutamine	B27	PA10090	56246	0.739
NULL	Neuroscience_2010_May_5_167(2)_456-474.nxml.txt.nlp	20167261	SENT53	31	31	22	22	ketamine	CO2	PA450144	4513	0.739
NULL	Cancer_Med_2013_Dec_3_2(6)_774-783.nxml.txt.nlp	24403251	SENT147	10	10	12	12	tamoxifen	aromatase	PA451581	1588	0.739
NULL	Evid_Based_Complement_Alternat_Med_2014_Sep_3_2014_809083.nxml.txt.nlp	25276218	SENT135	19	19	7	7	berberine	IRAK1	PA165860812	3654	0.739
NULL	Breast_Cancer_Res_2010_Oct_14_12(5)_R84.nxml.txt.nlp	20946630	SENT276	16	16	5	5	choline	SLC44A1	PA448976	23446	0.739
NULL	Interdiscip_Toxicol_2008_Sep_1(2)_155-159.nxml.txt.nlp	21218106	SENT146	1	1	7	7	quinidine	CYP3A4	PA451209	1576	0.739
NULL	Trials_2013_Sep_24_14_311.nxml.txt.nlp	24063608	SENT372	25	25	29	29	pyrimethamine	IPT	PA451193	54802	0.739
NULL	Cancers_(Basel)_2012_Apr_5_4(2)_354-378.nxml.txt.nlp	24213315	SENT163	4	4	39	39	sorafenib	TRAIL	PA7000	8743	0.739
NULL	Front_Neuroanat_2014_Sep_10_8_90.nxml.txt.nlp	25309337	SENT50	20	20	4	4	pentobarbital	E14	PA450859	4863	0.739
NULL	Drugs_R_D_2013_Sep_28_13(3)_191-197.nxml.txt.nlp	23982688	SENT235	5	5	15	15	acenocoumarol	CYP2C9	PA452632	1559	0.739
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT29	12	12	28	28	lapatinib	EGFR	PA152241907	1956	0.739
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_P43.nxml.txt.nlp	NULL	SENT12	26	26	19	19	abacavir	HLA-B	PA448004	3106	0.739
NULL	Stroke_Res_Treat_2009_Dec_20_2010_386389.nxml.txt.nlp	20700422	SENT160	9	9	16	16	pioglitazone	MCP-1	PA450970	6347	0.739
NULL	Int_J_Nanomedicine_2012_Nov_29_7_5915-5927.nxml.txt.nlp	23226697	SENT126	22	22	4	4	trypsin	FGF1	PA451806	2246	0.739
NULL	Case_Rep_Hematol_2013_Aug_27_2013_258028.nxml.txt.nlp	24066245	SENT6	15	15	22	22	daunorubicin	DAC	PA449212	13	0.739
NULL	Arthritis_Res_Ther_2003_Sep_23_5(6)_251-265.nxml.txt.nlp	14680500	SENT29	1	1	13	13	vasopressin	ACTH	PA451858	5443	0.739
NULL	Br_J_Cancer_2012_Oct_9_107(8)_1277-1285.nxml.txt.nlp	22990652	SENT166	18	18	22	22	axitinib	CYP2C8	PA164924493	1558	0.739
NULL	J_Am_Heart_Assoc_2013_Aug_23_2(4)_e000271.nxml.txt.nlp	23842280	SENT384	12	12	17	17	estradiol	aromatase	PA449503	1588	0.739
NULL	Br_J_Cancer_2012_Sep_25_107(7)_1059-1068.nxml.txt.nlp	22935581	SENT27	18	18	12	12	lapatinib	IFN	PA152241907	3439	0.739
NULL	Front_Endocrinol_(Lausanne)_2014_Dec_18_5_218.nxml.txt.nlp	25566190	SENT36	18	18	2	2	glucose	GHR	PA449773	2690	0.739
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT769	18	18	14	14	trastuzumab	PTEN	PA451743	5728	0.739
NULL	J_Med_Case_Rep_2014_Apr_3_8_113.nxml.txt.nlp	24708915	SENT55	9	9	17	17	cyclophosphamide	CHOP	PA449165	1649	0.739
NULL	J_Oncol_2012_Sep_27_2012_461562.nxml.txt.nlp	23056046	SENT129	9	9	18	18	genistein	4E-BP1	PA165109660	1978	0.739
NULL	Clin_Pharmacol_2012_Feb_20_4_13-20.nxml.txt.nlp	22427735	SENT90	28	28	39	39	clopidogrel	PON1	PA449053	5444	0.739
NULL	Breast_Cancer_Res_Treat_2014_Nov_11_148(3)_563-570.nxml.txt.nlp	25385180	SENT58	27	27	10	10	pertuzumab	PTH		5741	0.739
NULL	Acta_Pharmacol_Sin_2010_Feb_5_31(2)_137-144.nxml.txt.nlp	20139896	SENT122	5	5	12	12	zileuton	5-LOX	PA451955	240	0.739
NULL	Breast_Cancer_(Auckl)_2012_Mar_7_6_67-77.nxml.txt.nlp	22438669	SENT112	25	25	14	14	trastuzumab	HER2	PA451743	2064	0.739
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT192	12	12	30	30	trastuzumab	Yes	PA451743	7525	0.739
NULL	Acta_Pharmacol_Sin_2011_Oct_12_32(10)_1259-1265.nxml.txt.nlp	21909126	SENT129	9	9	15	15	losartan	MCP-1	PA450268	6347	0.739
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT119	25	25	41	41	heparin	FGF1	PA449855	2246	0.739
NULL	J_Hematol_Oncol_2009_Apr_22_2_18.nxml.txt.nlp	19386128	SENT107	45	45	14	14	irinotecan	KRAS	PA450085	3845	0.739
NULL	Diabetes_Care_2012_Dec_14_35(12)_e84.nxml.txt.nlp	23173145	SENT33	11	11	7	7	metformin	B12	PA450395	7126;4709	0.739
NULL	Cell_Commun_Signal_2013_Oct_1_11_73.nxml.txt.nlp	24083678	SENT115	18	18	37	37	sulindac	A20	PA451565	7128;28935	0.739
NULL	Exp_Diabetes_Res_2010_Feb_17_2010_686734.nxml.txt.nlp	21403818	SENT167	20	20	7	7	pimozide	5-HT1A	PA450965	3350	0.739
NULL	Diabetes_Care_2013_Jul_12_36(7)_2126-2132.nxml.txt.nlp	23645884	SENT53	28	28	20	20	lipase	GLP-1	PA450239	100125288	0.739
NULL	Mol_Cells_2014_Dec_31_37(12)_899a-906.nxml.txt.nlp	25431425	SENT14	2	2	22	22	curcumin	p65	PA151958596	5970	0.739
NULL	Int_J_Mol_Cell_Med_2012_Winter_1(1)_30-38.nxml.txt.nlp	24551756	SENT153	9	9	20	20	copper	14-3-3	PA449114	10971	0.739
NULL	Arch_Drug_Inf_2008_Jul_1(1)_14-22.nxml.txt.nlp	20157364	SENT14	3	3	13	13	pravastatin	IL-6	PA451089	3569	0.739
NULL	Mar_Drugs_2014_Mar_18_12(3)_1580-1622.nxml.txt.nlp	24646945	SENT69	21	21	25	25	l-leucine	C10	PA450197	113246	0.739
NULL	J_Brachial_Plex_Peripher_Nerve_Inj_2008_Mar_19_3_8.nxml.txt.nlp	18353188	SENT205	30	30	12	12	capsaicin	SSeCKS	PA448776	9590	0.739
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2011_Mar_14_4_13-24.nxml.txt.nlp	22879790	SENT238	11	11	26	26	liraglutide	Met	PA165958364	79811	0.739
NULL	Oncogenesis_2014_May_12_3(5)_e102.nxml.txt.nlp	24819061	SENT204	17	17	4	4	nadh	NQO1	PA164755085	1728	0.739
NULL	Breast_Cancer_Res_2013_Oct_22_15(5)_R98.nxml.txt.nlp	24148581	SENT52	23	23	33	33	tamoxifen	aromatase	PA451581	1588	0.739
NULL	Ann_Rheum_Dis_2011_Jun_27_70(9)_1631-1640.nxml.txt.nlp	21708910	SENT220	31	31	10	10	etanercept	ACR	PA449515	49	0.739
NULL	Oncogene_2011_Apr_21_30(16)_1855-1867.nxml.txt.nlp	21151168	SENT132	0	0	15	15	chloroquine	IL3	PA448948	3562	0.739
NULL	BMB_Rep_2014_Jan_47(1)_33-38.nxml.txt.nlp	24209634	SENT77	14	14	5	5	cisplatin	CXCR4	PA449014	7852	0.739
NULL	Mol_Brain_2014_Apr_3_7_25.nxml.txt.nlp	24708812	SENT243	3	3	16	16	chlorpheniramine	ERK	PA448960	5594	0.739
NULL	Front_Endocrinol_(Lausanne)_2013_Jul_16_4_87.nxml.txt.nlp	23882260	SENT25	28	28	19	19	l-cysteine	PLP	PA449173	25824;5744	0.739
NULL	Ann_Nucl_Med_2013_May_12_27(4)_400-405.nxml.txt.nlp	23400394	SENT48	2	2	13	13	glucose	FDG	PA449773	23583	0.739
NULL	Arthritis_Res_Ther_2009_Jun_25_11(3)_R97.nxml.txt.nlp	19555469	SENT49	22	22	7	7	estradiol	aromatase	PA449503	1588	0.739
NULL	Curr_Neuropharmacol_2014_Jan_12(1)_57-70.nxml.txt.nlp	24533016	SENT147	2	2	24	24	ketamine	5-HT2A	PA450144	3356	0.739
NULL	Hum_Genomics_2010_Aug_1_4(6)_402-405.nxml.txt.nlp	20846929	SENT68	48	48	12	12	debrisoquine	CYP2C19	PA452616	1557	0.739
NULL	Front_Physiol_2012_Oct_2_3_389.nxml.txt.nlp	23060813	SENT251	30	30	23	23	gemcitabine	Bcl-2	PA449748	596	0.739
NULL	Gut_Liver_2011_Jun_24_5(2)_160-164.nxml.txt.nlp	21814595	SENT108	17	17	21	21	meperidine	ESD	PA450369	2098	0.739
NULL	Indian_Dermatol_Online_J_2013_Jul-Sep_4(3)_177-179.nxml.txt.nlp	23984227	SENT34	9	9	5	5	etanercept	TNF-alpha	PA449515	7124	0.739
NULL	Biomed_Res_Int_2014_Apr_10_2014_615363.nxml.txt.nlp	24818147	SENT135	11	11	16	16	thrombin	ADP	PA451674	23038	0.739
NULL	Genet_Mol_Biol_2009_Sep_1_Jul-Sep_32(3)_516-520.nxml.txt.nlp	21637514	SENT6	5	5	11	11	estradiol	MMP9	PA449503	4318	0.739
NULL	Allergy_Asthma_Immunol_Res_2011_Jul_17_3(3)_205-211.nxml.txt.nlp	21738887	SENT150	15	15	21	21	methacholine	TDI	PA165958382	100038246	0.739
NULL	Sensors_(Basel)_2010_Mar_23_10(3)_2438-2449.nxml.txt.nlp	22294934	SENT148	26	26	3	3	choline	NIR	PA448976	26155	0.739
NULL	BMB_Rep_2013_Nov_46(11)_544-549.nxml.txt.nlp	24152910	SENT5	4	4	14	14	thrombin	IL-6	PA451674	3569	0.739
NULL	Cell_Commun_Signal_2013_Jan_11_11_2.nxml.txt.nlp	23305203	SENT134	6	6	13	13	forskolin	TIMAP	PA146096022	26051	0.739
NULL	Breast_Cancer_Res_2010_Nov_16_12(6)_R96.nxml.txt.nlp	21080941	SENT191	16	16	3	3	lapatinib	HRG	PA152241907	3084;3273	0.739
NULL	Front_Mol_Neurosci_2013_Mar_21_6_5.nxml.txt.nlp	23518818	SENT355	3	3	5	5	capsaicin	TRPV1	PA448776	7442	0.739
NULL	Hum_Genomics_2009_Jan_1_3(2)_121-127.nxml.txt.nlp	19164089	SENT98	15	15	3	3	ethanol	ALDH2	PA448073	217	0.739
NULL	Clin_Ophthalmol_2014_Jun_26_8_1213-1219.nxml.txt.nlp	25061267	SENT29	17	17	26	26	tetracaine	PRK	PA451638	1263	0.739
NULL	Br_J_Cancer_2010_Jun_8_102(12)_1791-1792.nxml.txt.nlp	20531418	SENT23	15	15	9	9	cetuximab	FCGR3A	PA10040	2214	0.739
NULL	J_Korean_Med_Sci_2014_Jul_11_29(7)_965-972.nxml.txt.nlp	25045229	SENT111	9	9	22	22	metformin	B12	PA450395	7126;4709	0.739
NULL	Cell_Biol_Int_Rep_(2010)_2012_Jun_21_19(1)_e00017.nxml.txt.nlp	23124518	SENT83	6	6	11	11	etoposide	TRAIL	PA449552	8743	0.739
NULL	Curr_Neuropharmacol_2008_Jun_6(2)_151-163.nxml.txt.nlp	19305794	SENT131	8	8	3	3	capsaicin	TRPV1	PA448776	7442	0.739
NULL	Exp_Diabetes_Res_2011_Jun_20_2011_601047.nxml.txt.nlp	21747830	SENT88	8	8	24	24	sitagliptin	GLP-1	PA164748978	100125288	0.739
NULL	Calcif_Tissue_Int_2010_Dec_16_87(6)_485-492.nxml.txt.nlp	20953593	SENT49	19	19	32	32	teriparatide	PTH	PA451620	5741	0.739
NULL	Clin_Pharmacokinet_2014_Sep_3_53(1)_1-16.nxml.txt.nlp	23999929	SENT271	16	16	9	9	ritonavir	CYP3A4	PA451260	1576	0.739
NULL	Cancer_Metab_2013_Feb_4_1_7.nxml.txt.nlp	24280108	SENT158	7	7	33	33	glucose	ROS	PA449773	6098	0.739
NULL	Breast_Cancer_(Auckl)_2012_Mar_7_6_67-77.nxml.txt.nlp	22438669	SENT85	26	26	22	22	lapatinib	HER2	PA152241907	2064	0.739
NULL	Breast_Cancer_Res_Treat_2013_Aug_20_141(1)_43-53.nxml.txt.nlp	23959396	SENT187	4	4	14	14	pertuzumab	HER2		2064	0.739
NULL	Br_J_Cancer_2010_Sep_28_103(7)_1048-1056.nxml.txt.nlp	20736952	SENT227	26	26	28	28	fluorouracil	HER2	PA128406956	2064	0.739
NULL	Exp_Cell_Res_2011_Apr_15_317(7)_1028-1039.nxml.txt.nlp	21237154	SENT210	4	4	9	9	staurosporine	JNK	PA165109623	5599	0.739
NULL	Biosci_Rep_2012_Dec_6_33(1)_e00006.nxml.txt.nlp	23050906	SENT297	13	13	29	29	lovastatin	DHCR24	PA450272	1718	0.739
NULL	Mol_Clin_Oncol_2013_Jul_17_1(4)_680-684.nxml.txt.nlp	24649228	SENT29	14	14	22	22	cyclophosphamide	CHOP	PA449165	1649	0.739
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT173	12	12	30	30	cisplatin	p53	PA449014	7157	0.739
NULL	Breast_Cancer_Res_2004_Aug_9_6(5)_211-212.nxml.txt.nlp	15318927	SENT5	7	7	14	14	diclofenac	COX	PA449293	1351	0.739
NULL	Cancer_Immunol_Immunother_2015_Oct_7_64_61-73.nxml.txt.nlp	25287778	SENT194	19	19	15	15	lenalidomide	IL-2	PA162363968	3558	0.739
NULL	Eur_J_Pediatr_2012_Feb_17_171(2)_207-214.nxml.txt.nlp	21922352	SENT38	5	5	10	10	thrombin	FVIII	PA451674	2157	0.739
NULL	Br_J_Cancer_2009_Oct_6_101(7)_1155-1161.nxml.txt.nlp	19738614	SENT199	4	4	13	13	gemcitabine	MUC4	PA449748	4585	0.739
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1437-1448.nxml.txt.nlp	24056706	SENT111	27	27	12	12	ketoconazole	CYP1A2	PA450146	1544	0.739
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT319	20	20	29	29	cisplatin	DR5	PA449014	8795	0.739
NULL	Cancers_(Basel)_2014_Apr_9_6(2)_829-859.nxml.txt.nlp	24722453	SENT275	3	3	10	10	tocilizumab	IL-6	PA165292659	3569	0.739
NULL	J_Immunol_Res_2014_May_8_2014_565320.nxml.txt.nlp	24901010	SENT143	31	31	23	23	allopurinol	HLA-B	PA448320	3106	0.739
NULL	Amyloid_2014_Sep_11_21(3)_175-184.nxml.txt.nlp	24918964	SENT99	0	0	12	12	anakinra	TTR	PA10799	7276	0.739
NULL	Crit_Care_2012_Mar_20_16(Suppl_1)_P516.nxml.txt.nlp	NULL	SENT11	18	18	11	11	ranitidine	SUP	PA451224	9709	0.739
NULL	J_Cancer_Prev_2014_Dec_19(4)_279-287.nxml.txt.nlp	25574463	SENT221	26	26	8	8	fluorescein	p65	PA164746009	5970	0.739
NULL	Eur_J_Med_Res_2010_Feb_26_15(2)_47-53.nxml.txt.nlp	20452883	SENT126	13	13	3	3	etomidate	ESG	PA164743987	7089;7088;7090;7091	0.739
NULL	Leukemia_2014_Mar_13_28(3)_600-608.nxml.txt.nlp	24240203	SENT224	10	10	22	22	nutlin-3	PUMA		27113	0.739
NULL	Acta_Pharmacol_Sin_2012_May_4_33(5)_710-716.nxml.txt.nlp	22555373	SENT13	6	6	18	18	phenylbutazone	DOM	PA450932	6663	0.739
NULL	Front_Microbiol_2014_Mar_18_5_102.nxml.txt.nlp	24672518	SENT76	20	20	22	22	diethylstilbestrol	DES	PA449307	1674	0.739
NULL	EPMA_J_2014_Feb_11_5(Suppl_1)_A42.nxml.txt.nlp	NULL	SENT8	42	42	4	4	cetuximab	KRAS	PA10040	3845	0.739
NULL	Diabetes_2009_Apr_9_58(4)_965-974.nxml.txt.nlp	19136651	SENT257	6	6	19	19	nadh	AMPK	PA164755085	5563	0.739
NULL	Int_J_Med_Sci_2012_Aug_10_9(6)_472-479.nxml.txt.nlp	22927772	SENT26	14	14	21	21	warfarin	CYP2C9	PA451906	1559	0.739
NULL	Pharmaceutics_2011_Nov_18_3(4)_865-913.nxml.txt.nlp	24309312	SENT163	25	25	40	40	raltegravir	UGT1A1		54658	0.739
NULL	Pharm_Pract_(Granada)_2011_Mar_15_Jan-Mar_9(1)_1-10.nxml.txt.nlp	25132883	SENT153	5	5	18	18	warfarin	SPAF	PA451906	166378	0.739
NULL	Evid_Based_Complement_Alternat_Med_2013_Mar_26_2013_625892.nxml.txt.nlp	23589719	SENT254	0	0	5	5	probenecid	TAS2R38	PA451106	5726	0.739
NULL	Biol_Open_2013_Aug_14_2(10)_1013-1021.nxml.txt.nlp	24167711	SENT171	18	18	9	9	ethanol	EVL	PA448073	51466	0.739
NULL	Cancer_Med_2014_Oct_2_3(5)_1246-1255.nxml.txt.nlp	24890221	SENT123	12	12	34	34	fluorescein	LAT1	PA164746009	8140;27040	0.739
NULL	J_Biol_Eng_2009_Oct_16_3_18.nxml.txt.nlp	19835592	SENT48	13	13	25	25	ciprofloxacin	CPZ	PA449009	8532	0.739
NULL	Cell_Death_Dis_2012_Jun_21_3(6)_e327.nxml.txt.nlp	22717582	SENT81	32	32	7	7	vincristine	NOXA	PA451879	5366	0.739
NULL	Neuropsychopharmacology_2009_Dec_12_34(13)_2675-2690.nxml.txt.nlp	19675535	SENT208	9	9	26	26	haloperidol	A10	PA449841	28870	0.739
NULL	J_Mol_Med_(Berl)_2012_Dec_23_90(12)_1361-1389.nxml.txt.nlp	23090008	SENT562	6	6	14	14	cetuximab	HIF-1alpha	PA10040	3091	0.739
NULL	Clin_Med_Insights_Oncol_2012_Feb_28_6_125-135.nxml.txt.nlp	22408376	SENT94	18	18	22	22	panitumumab	KRAS	PA162373091	3845	0.739
NULL	Int_J_Mol_Sci_2012_Dec_5_13(12)_16514-16543.nxml.txt.nlp	23443116	SENT258	44	44	3	3	l-carnitine	HK4	PA450154	3737;2645	0.739
NULL	Clin_Mol_Hepatol_2014_Sep_25_20(3)_283-290.nxml.txt.nlp	25320732	SENT133	12	12	15	15	propranolol	EVL	PA451145	51466	0.739
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT97	3	3	10	10	curcumin	p27	PA151958596	5715;10534	0.739
NULL	Orphanet_J_Rare_Dis_2006_Apr_6_1_10.nxml.txt.nlp	16722529	SENT41	17	17	15	15	thrombin	ADP	PA451674	23038	0.739
NULL	Oncoimmunology_2012_Oct_1_1(7)_1004-1016.nxml.txt.nlp	23170249	SENT9	24	24	9	9	paclitaxel	HER-2	PA450761	2064	0.739
NULL	Nucleic_Acids_Res_2005_Mar_8_33(5)_1423-1434.nxml.txt.nlp	15755745	SENT201	38	38	30	30	urokinase	p15	PA451836	10923;10573	0.739
NULL	Clin_Med_Insights_Oncol_2012_Feb_28_6_125-135.nxml.txt.nlp	22408376	SENT190	11	11	19	19	panitumumab	KRAS	PA162373091	3845	0.739
NULL	J_Neuroinflammation_2010_Sep_7_7_51.nxml.txt.nlp	20822529	SENT155	0	0	17	17	hemin	p42	PA449849	5706;23552	0.739
NULL	Int_J_Gen_Med_2013_Jun_7_6_453-464.nxml.txt.nlp	23785241	SENT205	10	10	17	17	budesonide	IL-8	PA448681	3576	0.739
NULL	Clinics_(Sao_Paulo)_2013_May_68(5)_694-701.nxml.txt.nlp	23778405	SENT137	5	5	10	10	curcumin	MDR1	PA151958596	5243	0.739
NULL	Eur_J_Med_Res_2010_Nov_30_15(12)_533-543.nxml.txt.nlp	21163728	SENT139	23	23	18	18	rifampin	ABCB1	PA451250	5243	0.739
NULL	Oncotarget_2010_Oct_22_1(7)_530-543.nxml.txt.nlp	21317449	SENT98	15	15	20	20	lapatinib	EGFR	PA152241907	1956	0.739
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT226	20	20	33	33	ranibizumab	VEGFR2	PA164746012	3791	0.739
NULL	Cell_Death_Dis_2013_Jun_6_4(6)_e654.nxml.txt.nlp	23744354	SENT38	12	12	3	3	paclitaxel	B4GALT5	PA450761	9334	0.739
NULL	Arthritis_Res_Ther_2009_Jun_29_11(3)_R100.nxml.txt.nlp	19563672	SENT15	5	5	10	10	infliximab	IFN	PA452639	3439	0.739
NULL	Environ_Health_Perspect_2005_Jun_14_113(6)_749-755.nxml.txt.nlp	15929899	SENT123	26	26	12	12	l-glutamine	M-CSF	PA10090	1435	0.739
NULL	Mol_Vis_2012_May_11_18_1260-1270.nxml.txt.nlp	22665973	SENT14	3	3	5	5	topotecan	TPT	PA451729	23590;6469	0.739
NULL	Biomed_Imaging_Interv_J_2007_Jan_1_3(1)_e6.nxml.txt.nlp	21614267	SENT43	28	28	13	13	sunitinib	IL2	PA162372840	3558	0.739
NULL	Breast_Cancer_Res_2005_Jan_28_7(3)_R284-R290.nxml.txt.nlp	15987423	SENT100	24	24	16	16	tamoxifen	CYP2D6	PA451581	1565	0.739
NULL	J_Ophthalmic_Inflamm_Infect_2010_Dec_7_1(1)_29-34.nxml.txt.nlp	21475659	SENT121	13	13	2	2	sirolimus	solo	PA451365	55701	0.739
NULL	Oncoimmunology_2013_Jun_1_2(6)_e24677.nxml.txt.nlp	23894722	SENT95	2	2	12	12	cetuximab	CD107a	PA10040	3916	0.739
NULL	Oxid_Med_Cell_Longev_2013_Sep_11_2013_639541.nxml.txt.nlp	24101950	SENT171	16	16	13	13	hemin	HO-1	PA449849	3162	0.739
NULL	Acta_Pharmacol_Sin_2010_Aug_5_31(8)_970-976.nxml.txt.nlp	20686521	SENT44	16	16	12	12	methotrexate	CO2	PA450428	4513	0.739
NULL	Nat_Commun_2010_Sep_1(6)_1-8.nxml.txt.nlp	20842194	SENT449	15	15	25	25	vasopressin	AVP	PA451858	114548;551	0.739
NULL	J_Exp_Clin_Cancer_Res_2009_Nov_24_28(1)_144.nxml.txt.nlp	19930704	SENT121	26	26	18	18	vinblastine	P-gp	PA451877	5243	0.739
NULL	Front_Neurosci_2013_Jan_11_6_182.nxml.txt.nlp	23335873	SENT71	20	20	6	6	vasopressin	OXT	PA451858	5020	0.739
NULL	Breast_Cancer_Res_2012_May_23_14(3)_R82.nxml.txt.nlp	22621306	SENT12	11	11	1	1	trastuzumab	HER-2	PA451743	2064	0.739
NULL	Clin_Med_Insights_Case_Rep_2012_Nov_26_5_155-162.nxml.txt.nlp	23236259	SENT11	5	5	11	11	thyroglobulin	CEA	PA164754910	5670;1087	0.739
NULL	Neuro_Oncol_2010_Apr_27_12(4)_389-400.nxml.txt.nlp	20308316	SENT107	0	0	10	10	chloroquine	p53	PA448948	7157	0.739
NULL	Acta_Orthop_2010_Apr_6_81(2)_263-267.nxml.txt.nlp	20148646	SENT158	31	31	29	29	taurine	CHOP	PA451590	1649	0.739
NULL	Cancer_Cell_2007_Dec_11_12(6)_514-527.nxml.txt.nlp	18068629	SENT40	10	10	7	7	paclitaxel	TGFBI	PA450761	7045	0.739
NULL	Int_J_Mol_Sci_2013_Apr_17_14(4)_8456-8466.nxml.txt.nlp	23594996	SENT243	6	6	12	12	tazarotene	TIG3	PA164746821	5920	0.739
NULL	Mol_Cancer_2008_Jun_5_7_50.nxml.txt.nlp	18534018	SENT11	21	21	15	15	bortezomib	p38	PA10252	10598;1432;7965	0.739
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT186	9	9	13	13	curcumin	TRAIL	PA151958596	8743	0.739
NULL	Br_J_Ophthalmol_2008_Sep_22_92(9)_1275-1282.nxml.txt.nlp	18723745	SENT151	4	4	12	12	latanoprost	BAK	PA164774763	578	0.739
NULL	J_Invest_Dermatol_2014_Jul_31_134(7)_1903-1911.nxml.txt.nlp	24487305	SENT10	17	17	10	10	chloroquine	HLA-A	PA448948	3105	0.739
NULL	J_Biol_Eng_2009_Oct_16_3_18.nxml.txt.nlp	19835592	SENT48	23	23	25	25	chlorpromazine	CPZ	PA448964	8532	0.739
NULL	Exp_Diabetes_Res_2012_Nov_14_2012_386524.nxml.txt.nlp	23213322	SENT101	15	15	28	28	troglitazone	adiponectin	PA451799	9370	0.739
NULL	J_Cell_Biol_2000_Feb_21_148(4)_755-768.nxml.txt.nlp	10684256	SENT585	14	14	17	17	dextran	mol	PA449261	90527	0.739
NULL	Evid_Based_Complement_Alternat_Med_2013_Mar_26_2013_625892.nxml.txt.nlp	23589719	SENT179	0	0	4	4	probenecid	TAS2R16	PA451106	50833	0.739
NULL	Crit_Care_2011_Mar_11_15(Suppl_1)_P366.nxml.txt.nlp	NULL	SENT9	5	5	13	13	atropine	NAC	PA448505	22861	0.739
NULL	Arthritis_Res_2001_Jan_26_3(Suppl_A)_P094.nxml.txt.nlp	NULL	SENT11	28	28	26	26	pamidronate	OPG	PA450767	690	0.739
NULL	Environ_Health_Perspect_2009_Feb_28_117(2)_223-230.nxml.txt.nlp	19270792	SENT167	0	0	8	8	estradiol	CYP3A	PA449503	1574	0.739
NULL	Bone_Joint_Res_2014_Mar_1_3(3)_51-59.nxml.txt.nlp	24615710	SENT181	10	10	22	22	resveratrol	RUNX2		860	0.739
NULL	Leukemia_2014_Apr_14_28(4)_961-964.nxml.txt.nlp	24418991	SENT60	7	7	14	14	nilotinib	P-gp	PA165958345	5243	0.739
NULL	Physiol_Rep_2014_Sep_11_2(9)_e12133.nxml.txt.nlp	25214520	SENT172	26	26	11	11	bleomycin	CD68	PA448645	968	0.739
NULL	J_Ind_Microbiol_Biotechnol_2013_Jul_30_40(10)_1153-1160.nxml.txt.nlp	23896974	SENT31	3	3	23	23	nadh	CO2	PA164755085	4513	0.739
NULL	Mol_Cancer_2009_May_15_8_28.nxml.txt.nlp	19445670	SENT186	24	24	5	5	doxorubicin	Bcl-2	PA449412	596	0.739
NULL	J_Oncol_2009_Mar_24_2009_491985.nxml.txt.nlp	19325924	SENT98	29	29	3	3	genistein	CXCL12	PA165109660	6387	0.739
NULL	Oxid_Med_Cell_Longev_2013_Jun_6_2013_462361.nxml.txt.nlp	23840917	SENT278	8	8	13	13	taurine	p47phox	PA451590	653361	0.739
NULL	Drug_Target_Insights_2014_Mar_5_8_11-21.nxml.txt.nlp	24634580	SENT10	1	1	16	16	agomelatine	spatial	PA165958363	219793	0.739
NULL	Arthritis_Res_2000_Jun_8_2(5)_348-355.nxml.txt.nlp	11094447	SENT83	8	8	5	5	hyaluronan	CD44	PA165958431	960	0.739
NULL	Open_Virol_J_2010_Jun_23_4_157-162.nxml.txt.nlp	20835359	SENT85	22	22	4	4	pp2	CD4		920	0.738
NULL	Hum_Genomics_2004_Jan_1_1(2)_111-125.nxml.txt.nlp	15601539	SENT226	10	10	27	27	lipase	HDL2	PA450239	57338	0.738
NULL	Cell_Commun_Signal_2013_Jul_31_11_52.nxml.txt.nlp	23902637	SENT309	32	32	22	22	trypsin	ISG15	PA451806	9636	0.738
NULL	Biochem_Biophys_Res_Commun_2008_Sep_5_373(4)_584-588.nxml.txt.nlp	18586007	SENT106	15	15	12	12	resveratrol	gamma		9913	0.738
NULL	J_Immunother_Cancer_2013_Nov_7_1(Suppl_1)_P123.nxml.txt.nlp	NULL	SENT23	4	4	12	12	chloroquine	HMGB1	PA448948	3146	0.738
NULL	J_Int_Soc_Sports_Nutr_2009_Feb_19_6_6.nxml.txt.nlp	19228401	SENT158	13	13	29	29	creatine	CEE	PA164778930	51608	0.738
NULL	Mol_Cancer_2010_Nov_2_9_289.nxml.txt.nlp	21044322	SENT166	29	29	6	6	docetaxel	RGS10	PA449383	6001	0.738
NULL	Patient_Prefer_Adherence_2010_Mar_24_4_61-68.nxml.txt.nlp	20361006	SENT155	9	9	24	24	liraglutide	Met	PA165958364	79811	0.738
NULL	Anticancer_Drugs_2015_Jan_28_26(1)_46-55.nxml.txt.nlp	25099621	SENT234	22	22	10	10	doxorubicin	p38	PA449412	10598;1432;7965	0.738
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT97	10	10	0	0	trastuzumab	STAT3	PA451743	6774	0.738
NULL	J_Signal_Transduct_2011_Jun_7_2011_982879.nxml.txt.nlp	21776391	SENT182	23	23	21	21	erlotinib	EGFR	PA134687924	1956	0.738
NULL	Clin_Exp_Otorhinolaryngol_2011_Dec_15_4(4)_177-183.nxml.txt.nlp	22232712	SENT174	3	3	10	10	doxycycline	p38	PA449415	10598;1432;7965	0.738
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1542-1553.nxml.txt.nlp	21970874	SENT167	1	1	22	22	pemetrexed	EGFR	PA10810	1956	0.738
NULL	Core_Evid_2009_Jun_15_4_93-111.nxml.txt.nlp	20694068	SENT433	10	10	12	12	procarbazine	PCB	PA451112	5091	0.738
NULL	Trials_2012_Aug_25_13_148.nxml.txt.nlp	22920307	SENT127	47	47	37	37	clopidogrel	ADP	PA449053	23038	0.738
NULL	Eur_J_Clin_Pharmacol_2011_May_8_67(5)_493-506.nxml.txt.nlp	21140139	SENT204	15	15	10	10	oxycodone	CYP3A4	PA450741	1576	0.738
NULL	Indian_J_Psychiatry_2010_Jan_52(Suppl1)_S317-S340.nxml.txt.nlp	21836703	SENT117	18	18	27	27	thiothixene	CPZ	PA451669	8532	0.738
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT154	4	4	20	20	neratinib	HER3	PA165291472	2065	0.738
NULL	Curr_Cardiol_Rev_2012_Aug_8(3)_181-191.nxml.txt.nlp	22920489	SENT109	0	0	5	5	cangrelor	P2Y12	PA165945763	64805	0.738
NULL	Breast_Cancer_Res_2012_May_2_14(3)_R70.nxml.txt.nlp	22551440	SENT212	10	10	2	2	docetaxel	p53	PA449383	7157	0.738
NULL	J_Med_Case_Rep_2013_May_31_7_144.nxml.txt.nlp	23724918	SENT51	8	8	6	6	l-carnitine	NAC	PA450154	22861	0.738
NULL	Clin_Med_Insights_Oncol_2012_Feb_28_6_125-135.nxml.txt.nlp	22408376	SENT285	5	5	23	23	panitumumab	KRAS	PA162373091	3845	0.738
NULL	Ann_Rheum_Dis_2011_Nov_29_71(6)_891-898.nxml.txt.nlp	22128078	SENT11	10	10	4	4	adalimumab	HOA	PA10004	4148	0.738
NULL	Endocr_Connect_2012_Jul_21_1(1)_37-47.nxml.txt.nlp	23781302	SENT126	4	4	2	2	mitotane	CYP3A4	PA164746157	1576	0.738
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT160	8	8	11	11	trastuzumab	HER2	PA451743	2064	0.738
NULL	Biomed_Res_Int_2013_Jul_9_2013_281230.nxml.txt.nlp	23936784	SENT274	8	8	23	23	gemcitabine	MGLL	PA449748	11343	0.738
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_May_20_65(Pt_6)_o1324.nxml.txt.nlp	21583179	SENT4	39	39	2	2	ethanol	mol	PA448073	90527	0.738
NULL	Braz_J_Med_Biol_Res_2012_Feb_17_45(3)_244-249.nxml.txt.nlp	22331137	SENT88	19	19	2	2	gentamicin	PAG	PA449753	55824	0.738
NULL	Cancers_(Basel)_2013_Jul_4_5(3)_838-856.nxml.txt.nlp	24202322	SENT204	1	1	20	20	doxorubicin	p53	PA449412	7157	0.738
NULL	Exp_Diabetes_Res_2012_Nov_1_2012_892706.nxml.txt.nlp	23197976	SENT271	20	20	4	4	vildagliptin	HIF-1	PA165958346	29072	0.738
NULL	Eur_J_Clin_Pharmacol_2008_Feb_26_64(2)_133-157.nxml.txt.nlp	18224312	SENT59	20	20	10	10	encainide	CYP2D6	PA449459	1565	0.738
NULL	Cancers_(Basel)_2010_Dec_22_2(4)_2153-2170.nxml.txt.nlp	21390244	SENT604	17	17	28	28	erlotinib	EGFR	PA134687924	1956	0.738
NULL	Ann_Gastroenterol_2014_27(3)_200-206.nxml.txt.nlp	24976114	SENT83	8	8	12	12	thrombin	PAR2	PA451674	2150;55065;8856	0.738
NULL	Br_J_Pharmacol_2012_Jan_165(2)_390-400.nxml.txt.nlp	21671897	SENT191	0	0	38	38	suramin	P2X1	PA10292	5023	0.738
NULL	Acta_Pharmacol_Sin_2011_Dec_10_32(12)_1543-1548.nxml.txt.nlp	21986572	SENT44	23	23	40	40	l-glutamine	CO2	PA10090	4513	0.738
NULL	Case_Rep_Neurol_Med_2013_Jul_1_2013_451206.nxml.txt.nlp	23936696	SENT48	25	25	6	6	ranolazine	CYP3A4	PA164746007	1576	0.738
NULL	Front_Neurol_2014_Feb_18_5_17.nxml.txt.nlp	24600432	SENT105	21	21	14	14	levetiracetam	FasL	PA450206	356	0.738
NULL	Eur_J_Clin_Pharmacol_2012_Jan_8_68(1)_29-37.nxml.txt.nlp	21739267	SENT135	21	21	17	17	fluvoxamine	PRX	PA449690	9588;57716	0.738
NULL	Nat_Methods_2011_Jun_24_8(6)_487-493.nxml.txt.nlp	21516115	SENT158	20	20	36	36	gefitinib	EGF	PA131301952	1950	0.738
NULL	BMJ_Open_2014_Nov_7_4(11)_e006140.nxml.txt.nlp	25380812	SENT227	27	27	12	12	methotrexate	TNF-alpha	PA450428	7124	0.738
NULL	Front_Endocrinol_(Lausanne)_2013_May_16_4_57.nxml.txt.nlp	23730297	SENT169	19	19	33	33	clomipramine	OX2R	PA449048	3062;131450	0.738
NULL	J_Cell_Biol_2002_Jun_24_157(7)_1151-1160.nxml.txt.nlp	12082077	SENT170	21	21	18	18	trypsin	COX	PA451806	1351	0.738
NULL	Arthritis_Res_Ther_2012_May_1_14(3)_R99.nxml.txt.nlp	22546542	SENT8	7	7	15	15	infliximab	IL-17	PA452639	3605	0.738
NULL	Core_Evid_2010_Jul_27_5_1-10.nxml.txt.nlp	20694135	SENT6	5	5	31	31	levodopa	COMT	PA450213	1312	0.738
NULL	Ann_Dermatol_2014_Aug_31_26(4)_517-520.nxml.txt.nlp	25143685	SENT38	19	19	22	22	tazarotene	p53	PA164746821	7157	0.738
NULL	Gene_Regul_Syst_Bio_2014_Mar_10_8_75-87.nxml.txt.nlp	24653645	SENT19	8	8	10	10	methylprednisolone	MPL	PA450466	4352	0.738
NULL	Int_J_Vasc_Med_2012_Feb_14_2012_569654.nxml.txt.nlp	22489274	SENT174	14	14	16	16	vardenafil	RAGE	PA10229	177	0.738
NULL	Oncol_Lett_2014_Apr_4_7(4)_1011-1014.nxml.txt.nlp	24944660	SENT56	25	25	32	32	thyroglobulin	CD31	PA164754910	5175	0.738
NULL	Breast_Cancer_Res_2007_Oct_10_9(5)_R69.nxml.txt.nlp	17925034	SENT215	20	20	9	9	pp2	TPC		8030;60386	0.738
NULL	Int_J_Surg_Oncol_2011_Aug_8_2011_374012.nxml.txt.nlp	22312502	SENT158	4	4	10	10	tamoxifen	BRCA2	PA451581	675	0.738
NULL	Front_Neurol_2011_Dec_16_2_72.nxml.txt.nlp	22203815	SENT190	5	5	17	17	protamine	IL-17	PA10366	3605	0.738
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT240	18	18	16	16	ritonavir	UGT1A1	PA451260	54658	0.738
NULL	Cancers_(Basel)_2014_Nov_14_6(4)_2275-2295.nxml.txt.nlp	25405526	SENT201	21	21	28	28	vincristine	CHOP	PA451879	1649	0.738
NULL	Br_J_Cancer_2013_Sep_3_109(5)_1214-1222.nxml.txt.nlp	23922104	SENT168	3	3	14	14	dasatinib	TP53	PA162372878	7157	0.738
NULL	Front_Chem_2014_Jul_22_2_50.nxml.txt.nlp	25101260	SENT1014	0	0	14	14	pamidronate	PC-3	PA450767	692094	0.738
NULL	Case_Rep_Orthop_2014_Dec_2_2014_197061.nxml.txt.nlp	25544922	SENT28	22	22	12	12	isoniazid	hole	PA450112	80757	0.738
NULL	Curr_Neuropharmacol_2010_Mar_8(1)_62-68.nxml.txt.nlp	20808546	SENT135	12	12	6	6	celecoxib	P-gp	PA448871	5243	0.738
NULL	Neural_Dev_2012_Jul_4_7_17.nxml.txt.nlp	22559903	SENT278	28	28	23	23	paraformaldehyde	PLP	PA450790	25824;5744	0.738
NULL	Crit_Care_2011_Oct_26_15(5)_R257.nxml.txt.nlp	22030215	SENT134	0	0	20	20	midazolam	SAPS	PA450496	8935	0.738
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT222	15	15	7	7	lapatinib	ADAM17	PA152241907	6868	0.738
NULL	Arthritis_Res_Ther_2006_May_11_8(3)_209.nxml.txt.nlp	16712713	SENT123	14	14	6	6	indomethacin	AAP	PA449982	5345	0.738
NULL	ScientificWorldJournal_2012_Apr_19_2012_978913.nxml.txt.nlp	22593717	SENT135	0	0	12	12	naringin	CYP1A2	PA151958360	1544	0.738
NULL	Breast_Cancer_Res_2008_Dec_4_10(6)_R103.nxml.txt.nlp	19055788	SENT257	31	31	17	17	tamoxifen	CDH1	PA451581	51343;999	0.738
NULL	Drugs_R_D_2011_Sep_25_11(3)_227-249.nxml.txt.nlp	21902286	SENT84	0	0	15	15	decitabine	CD64	PA164749631	2209	0.738
NULL	Oncogene_2010_Sep_23_29(38)_5299-5310.nxml.txt.nlp	20622903	SENT174	45	45	12	12	trypsin	HMGB1	PA451806	3146	0.738
NULL	Br_J_Cancer_2013_Mar_19_108(5)_1079-1091.nxml.txt.nlp	23449353	SENT128	19	19	30	30	docetaxel	MIC-1	PA449383	29919;9518	0.738
NULL	Nat_Commun_2011_Jul_5_2_376.nxml.txt.nlp	21730957	SENT1475	19	19	28	28	zolpidem	GAD65	PA451976	2572	0.738
NULL	Front_Oncol_2013_Aug_20_3_202.nxml.txt.nlp	23971004	SENT449	4	4	14	14	vanillin	NF-kappaB	PA451852	4790	0.738
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT73	6	6	8	8	resveratrol	TRAIL		8743	0.738
NULL	Br_J_Anaesth_2014_Jul_22_113(1)_157-167.nxml.txt.nlp	24154701	SENT241	17	17	3	3	sevoflurane	TREK-1	PA451341	3776	0.738
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT39	22	22	5	5	metformin	AMPK	PA450395	5563	0.738
NULL	Environ_Health_Perspect_2008_Oct_116(10)_A426-A434.nxml.txt.nlp	18941560	SENT166	19	19	23	23	choline	S100B	PA448976	6285	0.738
NULL	Br_J_Cancer_2013_Mar_19_108(5)_1079-1091.nxml.txt.nlp	23449353	SENT115	19	19	24	24	docetaxel	PC3	PA449383	57332;7832;5122	0.738
NULL	Arthritis_Res_Ther_2006_Nov_9_8(1)_R2.nxml.txt.nlp	16356188	SENT5	19	19	34	34	naproxen	COX	PA450595	1351	0.738
NULL	Oncotarget_2013_Apr_10_4(4)_622-635.nxml.txt.nlp	23599172	SENT229	29	29	20	20	lapatinib	BRAF	PA152241907	673	0.738
NULL	Oncotarget_2013_Nov_23_5(1)_196-210.nxml.txt.nlp	24344116	SENT102	10	10	16	16	doxorubicin	p50	PA449412	958;4790	0.738
NULL	Curr_Neuropharmacol_2008_Jun_6(2)_151-163.nxml.txt.nlp	19305794	SENT218	17	17	14	14	capsaicin	TRPV1	PA448776	7442	0.738
NULL	Libyan_J_Med_2007_Dec_1_2(4)_169-175.nxml.txt.nlp	21503240	SENT239	11	11	33	33	alprazolam	CA1	PA448333	759	0.738
NULL	Breast_Cancer_Res_2007_Nov_6_9(6)_R77.nxml.txt.nlp	17986353	SENT209	11	11	34	34	estradiol	c-Myc	PA449503	4609	0.738
NULL	Eur_J_Haematol_2008_Feb_80(2)_93-106.nxml.txt.nlp	18081719	SENT48	27	27	8	8	iron	MRI	PA450087	78996	0.738
NULL	Arthritis_Res_Ther_2007_Jun_29_9(Suppl_1)_S5.nxml.txt.nlp	17634144	SENT162	6	6	13	13	denosumab	RANKL	PA166048634	8600	0.738
NULL	Cancers_(Basel)_2011_May_3_3(2)_2255-2273.nxml.txt.nlp	24212808	SENT158	8	8	11	11	cetuximab	EGFR	PA10040	1956	0.738
NULL	J_Neuroinflammation_2010_Nov_8_7_75.nxml.txt.nlp	21059245	SENT127	6	6	9	9	pp2	PI3		5266	0.738
NULL	Mol_Cancer_2010_Aug_20_9_220.nxml.txt.nlp	20727180	SENT218	15	15	6	6	nicotine	p53	PA450626	7157	0.738
NULL	Front_Oncol_2014_Mar_3_4_34.nxml.txt.nlp	24624361	SENT252	24	24	14	14	pertuzumab	ERBB2		2064	0.738
NULL	Breast_Cancer_Res_2004_Jul_29_6(5)_204-210.nxml.txt.nlp	15318926	SENT101	23	23	30	30	tamoxifen	PI3K	PA451581	5290	0.738
NULL	Carcinogenesis_2010_Dec_27_31(12)_2049-2057.nxml.txt.nlp	20876285	SENT235	8	8	4	4	tamoxifen	HER2	PA451581	2064	0.738
NULL	Cancer_Med_2013_Jun_25_2(3)_277-285.nxml.txt.nlp	23930204	SENT188	18	18	3	3	irinotecan	KRAS	PA450085	3845	0.738
NULL	Aging_Cell_2012_Aug_11(4)_579-587.nxml.txt.nlp	22435726	SENT157	38	38	34	34	etoposide	CD28	PA449552	1493;940	0.738
NULL	Cell_Mol_Life_Sci_2011_Aug_13_68(15)_2499-2512.nxml.txt.nlp	21318261	SENT314	12	12	19	19	modafinil	c-fos	PA450530	2353	0.738
NULL	Eur_J_Immunol_2014_Jun_10_44(6)_1759-1769.nxml.txt.nlp	24595810	SENT76	0	0	11	11	fludrocortisone	CD4	PA164743961	920	0.738
NULL	Clin_Infect_Dis_2013_Feb_1_56(3)_430-446.nxml.txt.nlp	23204035	SENT15	12	12	39	39	nevirapine	CD4	PA450616	920	0.738
NULL	Gut_Pathog_2010_Dec_7_2_17.nxml.txt.nlp	21138594	SENT39	28	28	32	32	kanamycin	OTC	PA450137	5009	0.738
NULL	Acta_Biomater_2014_May_10(5)_2065-2075.nxml.txt.nlp	24370641	SENT65	36	36	22	22	aluminium	PCL	PA164760864	9033;2324	0.738
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Nov_13_64(Pt_12)_o2319.nxml.txt.nlp	21581295	SENT58	8	8	11	11	benzaldehyde	mol	PA448571	90527	0.738
NULL	Hum_Genomics_2005_Jun_1_2(2)_138-143.nxml.txt.nlp	16004729	SENT99	22	22	18	18	ethanol	ALDH2	PA448073	217	0.738
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Sep_19_65(Pt_10)_o2502.nxml.txt.nlp	21577951	SENT63	12	12	6	6	benzaldehyde	mol	PA448571	90527	0.738
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT12	12	12	27	27	l-leucine	SIRT3	PA450197	23410	0.738
NULL	Bioinform_Biol_Insights_2009_Oct_5_3_109-127.nxml.txt.nlp	20140064	SENT389	6	6	16	16	abacavir	P65	PA448004	64689;6857	0.738
NULL	J_Biol_Chem_2009_Sep_18_284(38)_26106-26116.nxml.txt.nlp	19586903	SENT219	1	1	9	9	paraformaldehyde	SPEN	PA450790	23013	0.738
NULL	Front_Aging_Neurosci_2014_Sep_11_6_218.nxml.txt.nlp	25309423	SENT225	0	0	2	2	resveratrol	AMPK		5563	0.738
NULL	Case_Rep_Dent_2013_Jun_13_2013_852932.nxml.txt.nlp	23840974	SENT103	14	14	8	8	doxorubicin	CHOP	PA449412	1649	0.738
NULL	J_Immunother_Cancer_2013_Jun_27_1_9.nxml.txt.nlp	NULL	SENT172	6	6	16	16	sunitinib	IFN	PA162372840	3439	0.738
NULL	Biomed_Res_Int_2014_Jun_3_2014_932340.nxml.txt.nlp	24995336	SENT174	22	22	24	24	bleomycin	BLM	PA448645	641	0.738
NULL	Ann_Oncol_2011_Aug_27_22(8)_1736-1747.nxml.txt.nlp	21709140	SENT316	34	34	44	44	paclitaxel	San	PA450761	80218	0.738
NULL	J_Exp_Clin_Cancer_Res_2009_Oct_7_28(1)_134.nxml.txt.nlp	19811659	SENT98	2	2	10	10	imatinib	PDGFRA	PA10804	5156	0.738
NULL	Indian_J_Pharmacol_2014_Nov-Dec_46(6)_627-632.nxml.txt.nlp	25538335	SENT106	11	11	9	9	metformin	Q10	PA450395	27161	0.738
NULL	Iran_J_Pharm_Res_2014_Autumn_13(4)_1327-1334.nxml.txt.nlp	25587322	SENT151	3	3	18	18	miconazole	JNK	PA450494	5599	0.738
NULL	Drugs_2014_Nov_12_74(18)_2129-2139.nxml.txt.nlp	25389048	SENT190	8	8	14	14	tocilizumab	DREAM	PA165292659	30818	0.738
NULL	Gut_2013_Dec_21_62(12)_1714-1723.nxml.txt.nlp	23172891	SENT113	36	36	19	19	dextran	IL-6	PA449261	3569	0.738
NULL	Pharmaceutics_2011_Jul_13_3(3)_425-439.nxml.txt.nlp	24310588	SENT355	8	8	0	0	diazepam	SERS	PA449283	6301;54938	0.738
NULL	Br_J_Cancer_2011_Jun_7_104(12)_1828-1835.nxml.txt.nlp	21559012	SENT167	8	8	10	10	tamoxifen	EGFR	PA451581	1956	0.738
NULL	J_Oncol_2010_Jun_24_2010_412985.nxml.txt.nlp	20628489	SENT103	5	5	3	3	gefitinib	EGFR	PA131301952	1956	0.738
NULL	Oxid_Med_Cell_Longev_2013_Nov_28_2013_568093.nxml.txt.nlp	24379901	SENT52	44	44	41	41	resveratrol	SIRT1		23411	0.738
NULL	Front_Neural_Circuits_2013_Oct_2_7_155.nxml.txt.nlp	24106462	SENT171	8	8	20	20	apomorphine	ANOVA	PA164781163	4858	0.738
NULL	Endocrine_2012_Dec_14_42(3)_622-636.nxml.txt.nlp	22695986	SENT305	2	2	0	0	forskolin	PTH	PA146096022	5741	0.738
NULL	Cancer_Imaging_2013_Jul_22_13(3)_306-313.nxml.txt.nlp	23876444	SENT11	24	24	21	21	vemurafenib	BRAF	PA165946873	673	0.738
NULL	Braz_J_Med_Biol_Res_2013_Oct_2_46(10)_815-908.nxml.txt.nlp	24141608	SENT113	26	26	11	11	venlafaxine	CYP2D6	PA451866	1565	0.738
NULL	Oncol_Lett_2014_Mar_2_7(3)_791-796.nxml.txt.nlp	24527087	SENT174	36	36	10	10	imatinib	CD34	PA10804	947	0.738
NULL	Nat_Genet_2011_Feb_26_43(2)_117-120.nxml.txt.nlp	21186350	SENT90	4	4	10	10	metformin	LKB1	PA450395	6794	0.738
NULL	Open_Microbiol_J_2008_May_23_2_66-73.nxml.txt.nlp	19088913	SENT247	1	1	12	12	ketoconazole	Yes	PA450146	7525	0.738
NULL	Mol_Cancer_2014_Feb_5_13_24.nxml.txt.nlp	24495306	SENT292	16	16	11	11	collagenase	ADAM17	PA449107	6868	0.738
NULL	J_Breast_Cancer_2011_Mar_31_14(1)_20-27.nxml.txt.nlp	21847390	SENT18	16	16	6	6	estradiol	CLDN6	PA449503	9074	0.738
NULL	J_Korean_Med_Sci_2007_Apr_30_22(2)_283-289.nxml.txt.nlp	17449938	SENT9	32	32	16	16	minoxidil	Bcl-2	PA450521	596	0.738
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_127043.nxml.txt.nlp	23227093	SENT17	18	18	36	36	lovastatin	RYR	PA450272	6261	0.738
NULL	Arthritis_Res_Ther_2012_Mar_14_14(2)_R62.nxml.txt.nlp	22417670	SENT212	14	14	19	19	chloroquine	LC3	PA448948	84557	0.738
NULL	Indian_J_Pharmacol_2008_Oct_40(Suppl_2)_S211-S221.nxml.txt.nlp	21593975	SENT564	15	15	10	10	curcumin	CLE	PA151958596	51637	0.738
NULL	J_Immunother_2014_Feb_21_37(2)_105-114.nxml.txt.nlp	24509173	SENT202	7	7	0	0	gemcitabine	WT1	PA449748	7490	0.738
NULL	Biologics_2013_Feb_28_7_39-46.nxml.txt.nlp	23467578	SENT115	9	9	3	3	everolimus	VEGFR	PA164746311	3791	0.738
NULL	Acta_Orthop_2011_Apr_5_82(2)_211-216.nxml.txt.nlp	21434784	SENT50	14	14	16	16	doxorubicin	ADM	PA449412	133	0.738
NULL	Breast_Cancer_Res_2001_Jan_17_3(2)_99-103.nxml.txt.nlp	11250754	SENT53	13	13	15	15	raloxifene	STAR	PA451221	6770;2984	0.738
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT151	15	15	5	5	glucose	p38	PA449773	10598;1432;7965	0.738
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_408-414.nxml.txt.nlp	21372831	SENT29	5	5	12	12	doxorubicin	CHOP	PA449412	1649	0.738
NULL	Oncogene_2014_Sep_4_33(36)_4521-4530.nxml.txt.nlp	24662833	SENT115	5	5	3	3	bicalutamide	ARSI	PA164746255	340075	0.738
NULL	Diabetes_2013_May_16_62(5)_1697-1708.nxml.txt.nlp	23364453	SENT259	6	6	15	15	fasudil	p47phox	PA165946121	653361	0.738
NULL	Cancer_Cell_Int_2005_Jul_24_5_22.nxml.txt.nlp	16042792	SENT131	33	33	4	4	mitoxantrone	MRP1	PA450526	4437	0.738
NULL	Breast_Cancer_Res_2010_Mar_5_12(2)_R16.nxml.txt.nlp	20205716	SENT313	12	12	28	28	lovastatin	E2F1	PA450272	1869	0.738
NULL	J_Biol_Chem_2010_Aug_20_285(34)_26406-26416.nxml.txt.nlp	20530490	SENT352	28	28	31	31	artemisinin	SERCA1	PA165111696	487	0.738
NULL	Infect_Dis_Ther_2013_Dec_29_2(2)_187-200.nxml.txt.nlp	25134481	SENT74	19	19	36	36	daptomycin	WASP	PA164768820	7454	0.738
NULL	Br_J_Pharmacol_2014_Aug_17_171(15)_3651-3665.nxml.txt.nlp	24712679	SENT274	15	15	24	24	liraglutide	GLP-1	PA165958364	100125288	0.738
NULL	Vet_Res_Forum_2013_Winter_4(1)_19-24.nxml.txt.nlp	25593681	SENT7	6	6	4	4	diclofenac	B12	PA449293	7126;4709	0.738
NULL	eLife_2013_Oct_29_2_e01222.nxml.txt.nlp	24171103	SENT482	6	6	16	16	doxycycline	LBH	PA449415	81606;221491	0.738
NULL	Arthritis_Res_Ther_2009_Jun_29_11(3)_R100.nxml.txt.nlp	19563672	SENT155	22	22	15	15	infliximab	IFN	PA452639	3439	0.738
NULL	Curr_Neuropharmacol_2013_Jul_11(4)_338-378.nxml.txt.nlp	24381528	SENT668	7	7	3	3	curcumin	Bcl-2	PA151958596	596	0.738
NULL	J_Exp_Med_1980_Dec_1_152(6)_1699-1708.nxml.txt.nlp	7452150	SENT2	1	1	19	19	trypsin	mol	PA451806	90527	0.738
NULL	Cancer_Microenviron_2009_Sep_26_2(Suppl_1)_19-204.nxml.txt.nlp	NULL	SENT2559	22	22	16	16	estradiol	ENL	PA449503	4298	0.738
NULL	Oncol_Rep_2012_Apr_30_27(4)_923-928.nxml.txt.nlp	22209766	SENT139	31	31	25	25	erlotinib	PI3K	PA134687924	5290	0.738
NULL	Nat_Commun_2013_Aug_13_4_2300.nxml.txt.nlp	23939249	SENT266	0	0	11	11	resveratrol	SIRT1		23411	0.738
NULL	Biosci_Rep_2012_Dec_20_33(1)_e00011.nxml.txt.nlp	23137297	SENT134	5	5	9	9	heparin	RPSA	PA449855	3921	0.738
NULL	F1000_Med_Rep_2009_Feb_24_1_13.nxml.txt.nlp	20948769	SENT79	19	19	42	42	cyclophosphamide	CHOP	PA449165	1649	0.738
NULL	Cell_Commun_Signal_2013_Nov_11_11_86.nxml.txt.nlp	24215724	SENT274	9	9	28	28	thrombin	PAR4	PA451674	9002;5074	0.738
NULL	Breast_Cancer_Res_2012_Mar_14_14(2)_R45.nxml.txt.nlp	22417809	SENT28	17	17	6	6	erlotinib	EGFR	PA134687924	1956	0.738
NULL	Curr_Cardiol_Rev_2011_Nov_7(4)_245-249.nxml.txt.nlp	22758625	SENT32	3	3	17	17	trastuzumab	HER2	PA451743	2064	0.738
NULL	Iran_J_Reprod_Med_2012_Mar_10(2)_77-82.nxml.txt.nlp	25242977	SENT72	22	22	18	18	pentoxifylline	F10	PA450864	2159	0.738
NULL	Cancers_(Basel)_2014_Mar_26_6(2)_708-722.nxml.txt.nlp	24675568	SENT880	5	5	9	9	erlotinib	STAT3	PA134687924	6774	0.738
NULL	Indian_J_Endocrinol_Metab_2011_Jul_15(Suppl2)_S78-S81.nxml.txt.nlp	21966658	SENT61	24	24	15	15	thyroglobulin	TPO	PA164754910	7066;7173	0.738
NULL	Nat_Med_2014_Jul_1_20(7)_715-724.nxml.txt.nlp	24880616	SENT224	26	26	33	33	l-glutamine	CO2	PA10090	4513	0.738
NULL	Nat_Neurosci_2012_Sep_5_15(9)_1245-1254.nxml.txt.nlp	22864611	SENT497	26	26	6	6	clozapine	HDAC2	PA449061	3066	0.738
NULL	J_Cell_Mol_Med_2013_Nov_23_17(11)_1410-1414.nxml.txt.nlp	24373502	SENT51	9	9	36	36	everolimus	MPN	PA164746311	83886	0.738
NULL	J_Inflamm_(Lond)_2006_Jul_12_3_10.nxml.txt.nlp	16834783	SENT232	8	8	16	16	mometasone	GM-CSF	PA450541	1437	0.738
NULL	Crit_Care_2012_Mar_20_16(Suppl_1)_P45.nxml.txt.nlp	NULL	SENT9	29	29	36	36	tigecycline	RAB	PA164746412	3267	0.738
NULL	Hematol_Rep_2013_Jul_3_5(2)_26-27.nxml.txt.nlp	23888243	SENT36	14	14	22	22	dasatinib	SMO	PA162372878	6608;54498	0.738
NULL	Patient_Prefer_Adherence_2010_Sep_7_4_313-324.nxml.txt.nlp	20859458	SENT76	0	0	11	11	exenatide	PPG	PA164749238	5552	0.738
NULL	Clin_Drug_Investig_2015_Dec_16_35_141-147.nxml.txt.nlp	25511640	SENT75	0	0	35	35	miglitol	GLP-1	PA164776726	100125288	0.738
NULL	Breast_Cancer_Res_2007_Dec_17_9(6)_115.nxml.txt.nlp	18190722	SENT66	32	32	19	19	tamoxifen	CYP2D6	PA451581	1565	0.738
NULL	Cancers_(Basel)_2011_Mar_29_3(2)_1708-1731.nxml.txt.nlp	24212779	SENT1591	0	0	11	11	gemcitabine	IL-2	PA449748	3558	0.738
NULL	Cardiovasc_Diabetol_2010_Sep_23_9_57.nxml.txt.nlp	20863381	SENT35	25	25	10	10	pioglitazone	DM2	PA450970	28508	0.738
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT153	0	0	4	4	atorvastatin	OPG	PA448500	690	0.738
NULL	Endocrinol_Diabetes_Metab_Case_Rep_2014_Mar_1_2014_130077.nxml.txt.nlp	24688761	SENT133	31	31	46	46	hydroxyprogesterone	PRA	PA449932	6277	0.738
NULL	Toxins_(Basel)_2010_Nov_10_2(11)_2699-2737.nxml.txt.nlp	22069572	SENT1577	15	15	12	12	urokinase	IL-13R	PA451836	3598	0.738
NULL	Ann_Gastroenterol_2014_27(3)_200-206.nxml.txt.nlp	24976114	SENT83	8	8	10	10	thrombin	PAR4	PA451674	9002;5074	0.738
NULL	Oncologist_2010_Oct_7_15(10)_1026-1033.nxml.txt.nlp	20930101	SENT111	8	8	23	23	paclitaxel	P-gp	PA450761	5243	0.738
NULL	Drugs_R_D_2014_Jun_6_14(2)_113-123.nxml.txt.nlp	24797400	SENT153	13	13	4	4	dabigatran	CES1		1066	0.738
NULL	J_Hematol_Oncol_2014_Aug_12_7_57.nxml.txt.nlp	25112836	SENT168	9	9	5	5	rituximab	TLR9	PA451261	54106	0.738
NULL	Cytotechnology_2014_Dec_8_66(6)_979-986.nxml.txt.nlp	24101443	SENT44	41	41	11	11	trypsin	F12	PA451806	2161	0.738
NULL	Mar_Drugs_2009_Jul_17_7(3)_331-340.nxml.txt.nlp	19841717	SENT122	14	14	8	8	trabectedin	FDG	PA165958349	23583	0.738
NULL	Front_Oncol_2013_Nov_15_3_281.nxml.txt.nlp	24298448	SENT82	15	15	23	23	cetuximab	BRAF	PA10040	673	0.738
NULL	J_Neuroinflammation_2011_Feb_7_8_11.nxml.txt.nlp	21299846	SENT257	23	23	30	30	forskolin	ANOVA	PA146096022	4858	0.738
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT249	13	13	9	9	resveratrol	NAC		22861	0.738
NULL	Ann_Indian_Acad_Neurol_2008_Jan-Mar_11(1)_13-19.nxml.txt.nlp	19966973	SENT117	0	0	5	5	curcumin	AP-1	PA151958596	2353;3727;2354;3725	0.738
NULL	Arthritis_Res_2002_May_9_4(Suppl_3)_S91-S97.nxml.txt.nlp	12110127	SENT28	13	13	39	39	thrombin	IL-8	PA451674	3576	0.738
NULL	J_Hematol_Oncol_2008_Jul_21_1_9.nxml.txt.nlp	18644156	SENT218	17	17	29	29	fluorescein	San	PA164746009	80218	0.738
NULL	Cancer_Res_Treat_2011_Dec_27_43(4)_255-259.nxml.txt.nlp	22247712	SENT20	5	5	11	11	doxorubicin	CHOP	PA449412	1649	0.738
NULL	Clin_Pharmacol_2013_Dec_10_5_193-199.nxml.txt.nlp	24353447	SENT29	27	27	41	41	dextromethorphan	CYP3A4	PA449273	1576	0.738
NULL	Mol_Cancer_2010_Aug_20_9_220.nxml.txt.nlp	20727180	SENT40	0	0	9	9	nicotine	p53	PA450626	7157	0.738
NULL	Br_J_Cancer_1996_Sep_74(5)_704-710.nxml.txt.nlp	8795571	SENT11	6	6	24	24	paclitaxel	PA1	PA450761	79447	0.738
NULL	ScientificWorldJournal_2012_Oct_31_2012_615068.nxml.txt.nlp	23213291	SENT72	18	18	11	11	estradiol	aromatase	PA449503	1588	0.738
NULL	Front_Immunol_2011_Aug_29_2_38.nxml.txt.nlp	22566828	SENT32	33	33	40	40	daclizumab	CD52	PA164764446	1043	0.738
NULL	Mol_Cancer_2010_Apr_12_9_75.nxml.txt.nlp	20385023	SENT309	27	27	32	32	trastuzumab	PTEN	PA451743	5728	0.738
NULL	Front_Behav_Neurosci_2014_Oct_30_8_366.nxml.txt.nlp	25400560	SENT248	6	6	23	23	ceftriaxone	GLAST	PA448866	6507	0.738
NULL	Front_Oncol_2014_Sep_22_4_258.nxml.txt.nlp	25295228	SENT208	3	3	13	13	erlotinib	EGFR	PA134687924	1956	0.738
NULL	Cancers_(Basel)_2010_Sep_17_2(3)_1717-1730.nxml.txt.nlp	24281184	SENT160	18	18	4	4	capecitabine	DPD	PA448771	1806	0.738
NULL	Environ_Health_Perspect_2008_Mar_26_116(3)_322-328.nxml.txt.nlp	18335098	SENT176	17	17	2	2	estradiol	PMI	PA449503	8834;5373	0.738
NULL	Hum_Genomics_Proteomics_2010_Aug_3_2010_159761.nxml.txt.nlp	20981231	SENT365	15	15	7	7	lithium	BDNF	PA450243	627	0.738
NULL	Br_J_Cancer_2011_Nov_22_105(11)_1759-1767.nxml.txt.nlp	22045189	SENT32	19	19	30	30	oxaliplatin	ERCC1	PA131285527	2067	0.738
NULL	Virchows_Arch_2010_Sep_28_457(3)_299-307.nxml.txt.nlp	20665045	SENT4	5	5	19	19	trastuzumab	HER2	PA451743	2064	0.738
NULL	Cardiol_Res_Pract_2010_Jun_29_2010_824938.nxml.txt.nlp	20671994	SENT180	29	29	27	27	l-carnitine	Q10	PA450154	27161	0.738
NULL	Cell_Commun_Signal_2013_Nov_11_11_86.nxml.txt.nlp	24215724	SENT254	15	15	29	29	thrombin	PAR2	PA451674	2150;55065;8856	0.738
NULL	Virol_J_2011_Nov_28_8_523.nxml.txt.nlp	22122911	SENT133	24	24	33	33	heparin	RANTES	PA449855	6352	0.738
NULL	Mol_Vis_2011_Aug_4_17_2056-2064.nxml.txt.nlp	21850181	SENT58	18	18	37	37	ketamine	ERG	PA450144	2078	0.738
NULL	Arthritis_Res_Ther_2010_Feb_9_12(1)_R21.nxml.txt.nlp	20144213	SENT14	3	3	11	11	naproxen	5-LOX	PA450595	240	0.738
NULL	Asia_Pac_Allergy_2014_Apr_29_4(2)_106-112.nxml.txt.nlp	24809016	SENT55	15	15	8	8	ampicillin	PPL	PA448419	5493	0.738
NULL	Mol_Biol_Cell_2012_Oct_1_23(19)_3851-3862.nxml.txt.nlp	22875990	SENT22	31	31	13	13	nadh	GLUD1	PA164755085	2746	0.738
NULL	Drug_Des_Devel_Ther_2014_Sep_23_8_1527-1538.nxml.txt.nlp	25284985	SENT156	34	34	32	32	celecoxib	IFN	PA448871	3439	0.738
NULL	Ann_Gen_Psychiatry_2011_Mar_24_10_8.nxml.txt.nlp	21435226	SENT192	22	22	18	18	imipramine	Gen	PA449969	348654	0.738
NULL	FEBS_Open_Bio_2014_Aug_30_4_763-776.nxml.txt.nlp	25349781	SENT467	11	11	22	22	curcumin	LKB1	PA151958596	6794	0.738
NULL	Breast_Cancer_Res_2014_Sep_11_16(5)_430.nxml.txt.nlp	25212826	SENT24	29	29	17	17	tamoxifen	SRC3	PA451581	8202	0.738
NULL	Acta_Pharmacol_Sin_2013_Apr_25_34(4)_455-463.nxml.txt.nlp	23524568	SENT143	5	5	9	9	pioglitazone	RAGE	PA450970	177	0.738
NULL	Br_J_Cancer_2004_Mar_22_90(6)_1285-1292.nxml.txt.nlp	15026814	SENT91	9	9	7	7	doxorubicin	p53	PA449412	7157	0.738
NULL	Oncol_Lett_2013_Jun_29_5(6)_1943-1947.nxml.txt.nlp	23833672	SENT198	0	0	27	27	celecoxib	AKT	PA448871	207	0.738
NULL	Curr_Neuropharmacol_2014_Mar_12(2)_186-192.nxml.txt.nlp	24669211	SENT220	15	15	31	31	metformin	Met	PA450395	79811	0.738
NULL	Diabetes_2011_Mar_21_60(3)_1008-1018.nxml.txt.nlp	21282362	SENT200	21	21	4	4	glucose	GCKR	PA449773	11183;2646	0.738
NULL	Br_J_Cancer_2010_Dec_7_103(12)_1822-1830.nxml.txt.nlp	21063405	SENT270	18	18	4	4	cisplatin	CD31	PA449014	5175	0.738
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1542-1553.nxml.txt.nlp	21970874	SENT134	23	23	30	30	pemetrexed	FPGS	PA10810	2356	0.738
NULL	Biomed_Res_Int_2013_Dec_17_2013_865197.nxml.txt.nlp	24455734	SENT47	25	25	21	21	rifampin	EMB	PA451250	133418	0.738
NULL	Oncotarget_2014_Jun_6_5(13)_4929-4934.nxml.txt.nlp	24952635	SENT115	0	0	13	13	thioridazine	PDK1	PA451666	5170;5163	0.738
NULL	Breast_Cancer_(Auckl)_2014_Oct_8_8_125-133.nxml.txt.nlp	25336961	SENT122	10	10	20	20	pertuzumab	HER2		2064	0.738
NULL	Nat_Commun_2013_Apr_9_4_1684.nxml.txt.nlp	23575688	SENT145	11	11	18	18	roflumilast	CYLD	PA165948052	1540	0.738
NULL	J_Infect_Dis_2014_Jan_1_209(1)_120-129.nxml.txt.nlp	23943850	SENT164	13	13	3	3	levamisole	PRR12	PA450205	57479	0.738
NULL	Acta_Pharmacol_Sin_2013_Apr_25_34(4)_455-463.nxml.txt.nlp	23524568	SENT14	1	1	21	21	pioglitazone	BACE1	PA450970	23621	0.738
NULL	Genetics_2012_Feb_190(2)_317-349.nxml.txt.nlp	22345606	SENT209	32	32	27	27	choline	DAG	PA448976	1605	0.738
NULL	Br_J_Cancer_2013_Mar_19_108(5)_1079-1091.nxml.txt.nlp	23449353	SENT124	7	7	18	18	docetaxel	MIC-1	PA449383	29919;9518	0.738
NULL	Diabetes_2009_Feb_58(2)_352-359.nxml.txt.nlp	19011168	SENT167	8	8	6	6	erythromycin	GLP-1	PA449493	100125288	0.738
NULL	Mol_Cancer_2009_Aug_25_8_66.nxml.txt.nlp	19706164	SENT36	11	11	2	2	nimesulide	COX	PA137179528	1351	0.738
NULL	Mol_Cell_Biochem_2014_Oct_9_385(1-2)_265-275.nxml.txt.nlp	24104452	SENT94	11	11	15	15	bortezomib	U87	PA10252	677775;641648	0.738
NULL	BMB_Rep_2013_Nov_46(11)_544-549.nxml.txt.nlp	24152910	SENT299	1	1	7	7	thrombin	RhoA	PA451674	387	0.738
NULL	Chem_Rev_2011_Oct_12_111(10)_5899-5921.nxml.txt.nlp	21923193	SENT563	20	20	25	25	meloxicam	FAAH	PA450353	79152;2166	0.738
NULL	Cell_Death_Dis_2010_May_13_1(5)_e41.nxml.txt.nlp	21364648	SENT45	1	1	4	4	etoposide	p65	PA449552	5970	0.738
NULL	Br_J_Cancer_1998_Nov_78(9)_1170-1174.nxml.txt.nlp	9820175	SENT13	24	24	19	19	coumarin	CYP1A1	PA134521193	1543	0.738
NULL	Arch_Med_Sci_2012_Jul_4_8(3)_533-541.nxml.txt.nlp	22852012	SENT214	5	5	2	2	cladribine	IFN	PA449027	3439	0.738
NULL	Clin_Med_Insights_Oncol_2012_Nov_20_6_381-393.nxml.txt.nlp	23226079	SENT138	3	3	7	7	sunitinib	CYP3A4	PA162372840	1576	0.738
NULL	Nat_Commun_2014_Nov_6_5_5367.nxml.txt.nlp	25373620	SENT723	21	21	14	14	fluorescein	spatial	PA164746009	219793	0.738
NULL	Oncotarget_2011_May_16_2(5)_418-421.nxml.txt.nlp	21789791	SENT37	23	23	28	28	bortezomib	TRAIL	PA10252	8743	0.738
NULL	J_Cell_Biol_2007_Apr_23_177(2)_265-275.nxml.txt.nlp	17452530	SENT223	34	34	18	18	imiquimod	A20	PA449972	7128;28935	0.738
NULL	Blood_Res_2014_Jun_25_49(2)_85-94.nxml.txt.nlp	25025009	SENT104	20	20	2	2	heparin	VIII	PA449855	1351	0.738
NULL	J_Cell_Biol_1999_Jan_25_144(2)_255-266.nxml.txt.nlp	9922452	SENT299	36	36	15	15	fluorescein	PMP70	PA164746009	5825	0.738
NULL	J_Cancer_Prev_2013_Jun_18(2)_186-191.nxml.txt.nlp	25337545	SENT5	6	6	15	15	curcumin	STAT3	PA151958596	6774	0.738
NULL	Curr_Neuropharmacol_2014_Jan_12(1)_57-70.nxml.txt.nlp	24533016	SENT644	15	15	0	0	ketamine	Tech	PA450144	57449	0.738
NULL	J_Korean_Med_Sci_2007_Apr_30_22(2)_235-241.nxml.txt.nlp	17449930	SENT23	6	6	25	25	fenofibrate	CD36	PA449594	948	0.738
NULL	Acta_Pharmacol_Sin_2014_Aug_7_35(8)_1023-1030.nxml.txt.nlp	24998255	SENT192	25	25	12	12	octreotide	E14	PA450678	4863	0.738
NULL	J_Gen_Physiol_2003_Jun_121(6)_583-598.nxml.txt.nlp	12771193	SENT569	9	9	2	2	quinidine	HERG	PA451209	3757	0.737
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Oct_4_70(Pt_11)_269-271.nxml.txt.nlp	25484720	SENT6	26	26	36	36	benzaldehyde	mol	PA448571	90527	0.737
NULL	Br_J_Cancer_2011_May_24_104(11)_1786-1790.nxml.txt.nlp	21559018	SENT30	30	30	13	13	cetuximab	EGFR	PA10040	1956	0.737
NULL	Br_J_Cancer_2003_Mar_10_88(5)_754-759.nxml.txt.nlp	12618886	SENT121	26	26	31	31	amifostine	p53	PA448365	7157	0.737
NULL	Breast_Cancer_Res_2014_Dec_5_16(6)_489.nxml.txt.nlp	25475897	SENT77	34	34	19	19	estradiol	gamma	PA449503	9913	0.737
NULL	J_Physiol_2009_Feb_15_587(Pt_4)_731-744.nxml.txt.nlp	19074966	SENT285	11	11	14	14	taurine	PAT1	PA451590	10513;206358	0.737
NULL	J_Inherit_Metab_Dis_2010_Oct_3_33(5)_625-632.nxml.txt.nlp	20814828	SENT111	35	35	26	26	simvastatin	RhoA	PA451363	387	0.737
NULL	J_Cell_Biol_2003_Dec_8_163(5)_1067-1076.nxml.txt.nlp	14662747	SENT316	23	23	38	38	l-glutamine	CO2	PA10090	4513	0.737
NULL	Curr_Opin_Struct_Biol_2014_Oct_28_1-13.nxml.txt.nlp	25016573	SENT91	19	19	41	41	heparin	LSD	PA449855	1776	0.737
NULL	EURASIP_J_Bioinform_Syst_Biol_2012_May_10_2012(1)_2.nxml.txt.nlp	22574917	SENT46	7	7	30	30	staurosporine	HSD17B1	PA165109623	3292	0.737
NULL	Mol_Cancer_2009_Nov_10_8_99.nxml.txt.nlp	19903356	SENT9	16	16	13	13	imatinib	IGFBP3	PA10804	3486	0.737
NULL	Mol_Neurodegener_2011_Aug_8_6_57.nxml.txt.nlp	21819629	SENT379	5	5	11	11	arsenite	TDP-43	PA452638	23435	0.737
NULL	Cell_Res_2014_Jul_9_24(7)_820-841.nxml.txt.nlp	24810299	SENT131	41	41	33	33	doxycycline	CD14	PA449415	929	0.737
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jul_24_66(Pt_8)_o2099.nxml.txt.nlp	21588392	SENT62	16	16	12	12	benzaldehyde	mol	PA448571	90527	0.737
NULL	Evid_Based_Complement_Alternat_Med_2013_May_13_2013_506324.nxml.txt.nlp	23818927	SENT146	24	24	32	32	doxorubicin	STAT3	PA449412	6774	0.737
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT59	6	6	8	8	resveratrol	TRAIL		8743	0.737
NULL	Br_J_Haematol_2009_Nov_2_147(3)_396-410.nxml.txt.nlp	19758122	SENT20	19	19	21	21	chlorambucil	CLB	PA448926	171425	0.737
NULL	Croat_Med_J_2012_Jun_53(3)_214-223.nxml.txt.nlp	22661134	SENT93	6	6	11	11	clonidine	ACTH	PA449051	5443	0.737
NULL	Curr_Biol_2012_Mar_6_22(5)_397-402.nxml.txt.nlp	22305751	SENT31	32	32	39	39	physostigmine	gamma	PA450957	9913	0.737
NULL	Adv_Urol_2010_Jul_20_2010_687043.nxml.txt.nlp	20721275	SENT111	47	47	25	25	sunitinib	IFN	PA162372840	3439	0.737
NULL	J_Korean_Med_Sci_2011_Jul_20_26(7)_945-950.nxml.txt.nlp	21738350	SENT77	23	23	29	29	heparin	ACT	PA449855	12;11332;9457;641455	0.737
NULL	Crit_Care_2011_Nov_30_15(6)_R289.nxml.txt.nlp	22129171	SENT188	6	6	20	20	dipyridamole	IL-10	PA449367	3586	0.737
NULL	JRSM_Cardiovasc_Dis_2012_Sep_24_1(6)_cvd_2012_012015.nxml.txt.nlp	24175073	SENT171	30	30	17	17	clopidogrel	CYP2C19	PA449053	1557	0.737
NULL	Front_Microbiol_2012_May_3_3_164.nxml.txt.nlp	22563326	SENT107	25	25	12	12	glucose	PEP	PA449773	5047	0.737
NULL	Pain_Med_2013_Aug_24_14(8)_1202-1211.nxml.txt.nlp	23710678	SENT33	0	0	19	19	capsaicin	TRPV1	PA448776	7442	0.737
NULL	Evid_Based_Complement_Alternat_Med_2012_May_7_2012_242810.nxml.txt.nlp	22645625	SENT276	4	4	8	8	paclitaxel	CYP3A4	PA450761	1576	0.737
NULL	Mol_Cancer_2010_May_18_9_110.nxml.txt.nlp	20482802	SENT184	25	25	11	11	bortezomib	CHOP	PA10252	1649	0.737
NULL	Semin_Immunopathol_2014_Nov_27_36(1)_3-12.nxml.txt.nlp	24281248	SENT52	15	15	29	29	lipase	ATGL	PA450239	57104	0.737
NULL	FEBS_Open_Bio_2014_Jun_24_4_627-636.nxml.txt.nlp	25161871	SENT469	4	4	1	1	genistein	MEK4	PA165109660	6416	0.737
NULL	Ann_Rheum_Dis_2014_Jun_6_73(6)_1052-1059.nxml.txt.nlp	23831963	SENT20	4	4	7	7	hydroxychloroquine	MxA	PA164777036	4599	0.737
NULL	Front_Bioeng_Biotechnol_2014_Jun_12_2_20.nxml.txt.nlp	25152893	SENT251	26	26	18	18	fluorescein	spatial	PA164746009	219793	0.737
NULL	J_Vet_Med_Sci_2014_Aug_1_76(8)_1105-1110.nxml.txt.nlp	24784441	SENT64	2	2	11	11	estradiol	GDN	PA449503	5270;55534	0.737
NULL	Acta_Orthop_2010_Apr_6_81(2)_263-267.nxml.txt.nlp	20148646	SENT163	7	7	17	17	taurine	CHOP	PA451590	1649	0.737
NULL	J_Gen_Physiol_1923_Jan_20_5(3)_353-358.nxml.txt.nlp	19872001	SENT0	16	16	11	11	trypsin	FOR	PA451806	51741	0.737
NULL	Diabetes_Care_2013_Apr_14_36(4)_943-949.nxml.txt.nlp	23111057	SENT77	24	24	14	14	filgrastim	CD34	PA449626	947	0.737
NULL	Acta_Pharmacol_Sin_2009_Jul_3_30(7)_889-898.nxml.txt.nlp	19574994	SENT279	25	25	8	8	pp2	EGFR		1956	0.737
NULL	J_Korean_Med_Sci_2005_Oct_31_20(5)_883-885.nxml.txt.nlp	16224167	SENT23	17	17	24	24	cyclophosphamide	gamma	PA449165	9913	0.737
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT154	45	45	6	6	vinorelbine	ASC	PA451881	29108	0.737
NULL	Mol_Cancer_2014_Aug_22_13(1)_195.nxml.txt.nlp	NULL	SENT94	16	16	10	10	cisplatin	TBL1XR1	PA449014	79718	0.737
NULL	Cancers_(Basel)_2013_Jul_4_5(3)_838-856.nxml.txt.nlp	24202322	SENT207	19	19	2	2	doxorubicin	HEXIM1	PA449412	10614	0.737
NULL	J_Int_AIDS_Soc_2010_Nov_8_13(Suppl_4)_P82.nxml.txt.nlp	NULL	SENT5	35	35	20	20	tenofovir	CD4	PA10204	920	0.737
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_May_7_65(Pt_6)_o1188-o1189.nxml.txt.nlp	21583061	SENT72	4	4	14	14	benzaldehyde	mol	PA448571	90527	0.737
NULL	BMJ_2013_Jun_5_346_f2570.nxml.txt.nlp	23738992	SENT248	4	4	11	11	citalopram	STAR	PA449015	6770;2984	0.737
NULL	Front_Pharmacol_2014_Oct_28_5_235.nxml.txt.nlp	25389405	SENT42	38	38	6	6	cyclophosphamide	CD19	PA449165	930	0.737
NULL	Ann_Hematol_2010_Sep_13_89(9)_861-871.nxml.txt.nlp	20387067	SENT108	26	26	16	16	dasatinib	CD34	PA162372878	947	0.737
NULL	J_Oncol_2010_May_19_2010_285191.nxml.txt.nlp	20508725	SENT204	14	14	17	17	cerulenin	AKT	PA164764551	207	0.737
NULL	Oncotarget_2011_Jan_25_2(1-2)_8-17.nxml.txt.nlp	21378407	SENT34	3	3	0	0	thrombin	PAR-1	PA451674	2011;2149	0.737
NULL	Ann_Gastroenterol_2014_27(4)_380-386.nxml.txt.nlp	25331321	SENT27	27	27	10	10	tenofovir	IFN	PA10204	3439	0.737
NULL	Chin_J_Cancer_2012_Feb_31(2)_110-118.nxml.txt.nlp	22098951	SENT33	17	17	21	21	doxorubicin	MDR1	PA449412	5243	0.737
NULL	Oncoscience_2014_Aug_21_1(8)_513-521.nxml.txt.nlp	25594058	SENT27	29	29	21	21	docetaxel	EGFR	PA449383	1956	0.737
NULL	J_Cardiothorac_Surg_2012_Jun_28_7_61.nxml.txt.nlp	22741616	SENT36	29	29	22	22	amiodarone	NAC	PA448383	22861	0.737
NULL	Ann_Gen_Psychiatry_2010_Mar_6_9_11.nxml.txt.nlp	20205742	SENT25	4	4	6	6	aripiprazole	STAR	PA10026	6770;2984	0.737
NULL	Eur_J_Haematol_2014_Feb_25_92(2)_127-136.nxml.txt.nlp	24118452	SENT191	33	33	14	14	anagrelide	CRT	PA164742986	811	0.737
NULL	Mol_Cancer_2010_Oct_12_9_269.nxml.txt.nlp	20939893	SENT80	3	3	16	16	isoproterenol	AP-1	PA450121	2353;3727;2354;3725	0.737
NULL	Biotechnol_Res_Int_2013_Dec_1_2013_253286.nxml.txt.nlp	24363937	SENT60	2	2	4	4	urea	ADP	PA451831	23038	0.737
NULL	J_Immunol_Res_2014_Nov_30_2014_342693.nxml.txt.nlp	25762441	SENT139	22	22	19	19	valsartan	AT1	PA451848	9197;185	0.737
NULL	Oncotarget_2014_Jun_1_5(13)_4868-4880.nxml.txt.nlp	24947902	SENT36	24	24	11	11	afatinib	HER2	PA165981154	2064	0.737
NULL	Oncogene_2013_Sep_12_32(37)_4355-4365.nxml.txt.nlp	23108409	SENT37	34	34	9	9	hyaluronan	HAS2	PA165958431	3037	0.737
NULL	Comput_Struct_Biotechnol_J_2013_Feb_22_3_e201210020.nxml.txt.nlp	24688680	SENT160	30	30	25	25	naringenin	PDH	PA151958361	54704	0.737
NULL	J_Immunother_Cancer_2014_Nov_6_2(Suppl_3)_P77.nxml.txt.nlp	NULL	SENT18	11	11	6	6	vemurafenib	IL-2	PA165946873	3558	0.737
NULL	Arthritis_Res_Ther_2007_Jun_29_9(Suppl_1)_S3.nxml.txt.nlp	17634142	SENT132	20	20	10	10	alendronate	BSAP	PA448082	5079	0.737
NULL	Curr_Neuropharmacol_2008_Jun_6(2)_102-116.nxml.txt.nlp	19305791	SENT312	23	23	28	28	diazoxide	Bcl-2	PA449285	596	0.737
NULL	Front_Oncol_2014_Mar_18_4_53.nxml.txt.nlp	24672774	SENT394	24	24	18	18	cisplatin	ANKRD1	PA449014	27063	0.737
NULL	Exp_Anim_2014_Apr_26_63(2)_155-167.nxml.txt.nlp	24770641	SENT59	6	6	20	20	fluorescein	San	PA164746009	80218	0.737
NULL	Br_J_Cancer_2013_Jul_23_109(2)_342-350.nxml.txt.nlp	23807172	SENT181	24	24	30	30	sorafenib	p38	PA7000	10598;1432;7965	0.737
NULL	Int_J_Hypertens_2012_Feb_1_2012_859235.nxml.txt.nlp	22518295	SENT293	25	25	1	1	cisplatin	HO-1	PA449014	3162	0.737
NULL	BMB_Rep_2014_Jul_47(7)_376-381.nxml.txt.nlp	24286332	SENT112	23	23	30	30	thrombin	PPG	PA451674	5552	0.737
NULL	Biomed_Res_Int_2013_Aug_6_2013_602987.nxml.txt.nlp	24027759	SENT274	12	12	10	10	paclitaxel	SMF	PA450761	22993	0.737
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Mar_24_68(Pt_4)_o1165-o1166.nxml.txt.nlp	22606110	SENT78	0	0	16	16	cinnarizine	mol	PA164749342	90527	0.737
NULL	Reprod_Biol_Endocrinol_2003_Oct_7_1_71.nxml.txt.nlp	14577832	SENT115	3	3	6	6	cisplatin	JNK1	PA449014	5599	0.737
NULL	J_Infect_Dis_2011_May_1_203(9)_1204-1214.nxml.txt.nlp	21459813	SENT266	13	13	20	20	raltegravir	CO3		4514	0.737
NULL	Lipids_Health_Dis_2011_Feb_12_10_31.nxml.txt.nlp	21314960	SENT190	9	9	23	23	hemin	HO-1	PA449849	3162	0.737
NULL	Ann_Surg_Oncol_2012_Feb_23_19(2)_620-626.nxml.txt.nlp	21861214	SENT61	10	10	5	5	bevacizumab	FDG	PA130232992	23583	0.737
NULL	Pain_2013_Sep_154(9)_1680-1690.nxml.txt.nlp	23707289	SENT557	6	6	25	25	yohimbine	ANOVA	PA451946	4858	0.737
NULL	Exp_Diabetes_Res_2011_Dec_27_2011_604989.nxml.txt.nlp	21253359	SENT178	15	15	9	9	clonidine	GLP-1	PA449051	100125288	0.737
NULL	Biomed_Res_Int_2014_Jan_20_2014_948427.nxml.txt.nlp	24563867	SENT103	3	3	22	22	buspirone	STZ	PA448689	6484	0.737
NULL	Toxins_(Basel)_2010_May_28_2(6)_1207-1224.nxml.txt.nlp	22069634	SENT126	8	8	16	16	curcumin	PC-3	PA151958596	692094	0.737
NULL	Oncogene_2010_Sep_16_29(37)_5159-5170.nxml.txt.nlp	20562917	SENT217	9	9	5	5	gefitinib	CXCL14	PA131301952	9547	0.737
NULL	Breast_Cancer_Res_2008_Mar_26_10(2)_203.nxml.txt.nlp	18373886	SENT25	41	41	32	32	hyaluronan	CD44	PA165958431	960	0.737
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_P125.nxml.txt.nlp	NULL	SENT13	20	20	11	11	nevirapine	HLA-C	PA450616	3107	0.737
NULL	Front_Neurol_2014_Feb_18_5_17.nxml.txt.nlp	24600432	SENT166	10	10	17	17	levetiracetam	C17	PA450206	54360	0.737
NULL	Ther_Clin_Risk_Manag_2006_Dec_2(4)_337-346.nxml.txt.nlp	18360646	SENT186	11	11	6	6	brimonidine	BAK	PA448665	578	0.737
NULL	Indian_J_Dermatol_2011_May-Jun_56(3)_306-308.nxml.txt.nlp	21772594	SENT69	23	23	21	21	cyclophosphamide	CHOP	PA449165	1649	0.737
NULL	Toxins_(Basel)_2010_Oct_28_2(11)_2584-2592.nxml.txt.nlp	22069565	SENT251	8	8	2	2	warfarin	CYP2C9	PA451906	1559	0.737
NULL	Exp_Ther_Med_2013_Aug_6_6(2)_427-434.nxml.txt.nlp	24137203	SENT130	31	31	2	2	fosinopril	MCP-1	PA449710	6347	0.737
NULL	Acta_Pharmacol_Sin_2009_Apr_3_30(4)_478-484.nxml.txt.nlp	19343062	SENT13	10	10	13	13	cyclosporine	CYP3A4	PA449167	1576	0.737
NULL	Artif_Organs_2014_Nov_9_38(11)_945-953.nxml.txt.nlp	24712758	SENT226	31	31	37	37	heparin	IL-4	PA449855	3565	0.737
NULL	Cell_Biosci_2011_Apr_19_1_16.nxml.txt.nlp	21711917	SENT269	23	23	29	29	l-glutamine	GDH	PA10090	51084;2746	0.737
NULL	Mol_Cancer_2009_Nov_10_8_99.nxml.txt.nlp	19903356	SENT122	17	17	29	29	imatinib	IGFBP3	PA10804	3486	0.737
NULL	Endocr_Connect_2012_Jun_8_1(1)_1-12.nxml.txt.nlp	23781298	SENT13	26	26	7	7	fenofibrate	adiponectin	PA449594	9370	0.737
NULL	Biosci_Rep_2014_Aug_6_34(4)_e00131.nxml.txt.nlp	24975826	SENT523	5	5	1	1	probenecid	TRPA1	PA451106	8989	0.737
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT374	5	5	11	11	pp2	CDH1		51343;999	0.737
NULL	Breast_Cancer_Res_2007_Mar_2_9(2)_205.nxml.txt.nlp	NULL	SENT26	11	11	22	22	canertinib	HER-2	PA134687925	2064	0.737
NULL	Oncol_Lett_2014_May_11_7(5)_1401-1408.nxml.txt.nlp	24765145	SENT110	2	2	11	11	paclitaxel	HIF-1	PA450761	29072	0.737
NULL	J_Korean_Med_Sci_2010_May_22_25(5)_766-771.nxml.txt.nlp	20436715	SENT117	21	21	14	14	tacrolimus	IL-8	PA451578	3576	0.737
NULL	Arthritis_Res_Ther_2010_Apr_9_12(2)_R65.nxml.txt.nlp	20380722	SENT85	20	20	39	39	imatinib	MIP1	PA10804	79109;3842	0.737
NULL	Oncol_Rep_2013_Apr_23_29(4)_1268-1274.nxml.txt.nlp	23354756	SENT180	26	26	37	37	paclitaxel	SLC25A43	PA450761	203427	0.737
NULL	Breast_Cancer_Res_2010_Jun_22_12(3)_R39.nxml.txt.nlp	20569502	SENT236	14	14	5	5	tamoxifen	TFF3	PA451581	7033	0.737
NULL	Acta_Pharmacol_Sin_2010_Aug_5_31(8)_938-943.nxml.txt.nlp	20686519	SENT41	18	18	6	6	reserpine	GML	PA451236	2765	0.737
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT161	11	11	21	21	metformin	p53	PA450395	7157	0.737
NULL	Braz_J_Med_Biol_Res_2011_Dec_9_45(1)_13-19.nxml.txt.nlp	22147192	SENT56	25	25	1	1	isoflurane	P14	PA450106	11102;;6280;56259	0.737
NULL	J_Med_Case_Reports_2011_Mar_19_5_112.nxml.txt.nlp	21418592	SENT94	3	3	17	17	venlafaxine	IFN	PA451866	3439	0.737
NULL	J_Gen_Physiol_2003_Mar_121(3)_181-197.nxml.txt.nlp	12601083	SENT231	23	23	5	5	tolbutamide	cAMP-GEFII	PA451718	11069	0.737
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT106	9	9	11	11	perifosine	TRAIL	PA165291471	8743	0.737
NULL	Clin_Ophthalmol_2011_May_24_5_697-704.nxml.txt.nlp	21629577	SENT134	6	6	13	13	ranibizumab	San	PA164746012	80218	0.737
NULL	Front_Neurosci_2012_May_30_6_77.nxml.txt.nlp	22661925	SENT258	18	18	29	29	ethanol	DCX	PA448073	1641	0.737
NULL	J_Mol_Psychiatry_2013_Nov_4_1(1)_19.nxml.txt.nlp	25408910	SENT73	31	31	13	13	olanzapine	SLC18A2	PA450688	6571	0.737
NULL	Pharmaceuticals_(Basel)_2013_Aug_21_6(8)_988-1038.nxml.txt.nlp	24276379	SENT2834	14	14	16	16	cetuximab	KRAS	PA10040	3845	0.737
NULL	Oxid_Med_Cell_Longev_2013_Jun_2_2013_793525.nxml.txt.nlp	23819014	SENT165	6	6	22	22	resveratrol	SGBS		2719	0.737
NULL	Arthritis_Res_Ther_2009_Jan_13_11(1)_R5.nxml.txt.nlp	19134200	SENT191	14	14	6	6	chloroquine	TLR9	PA448948	54106	0.737
NULL	Cancer_Cell_Int_2013_Jun_26_13_63.nxml.txt.nlp	23800022	SENT114	0	0	8	8	genistein	ATF3	PA165109660	467	0.737
NULL	Acta_Histochem_Cytochem_2006_Apr_22_39(2)_35-45.nxml.txt.nlp	17375208	SENT29	20	20	26	26	dextran	ZO-1	PA449261	7082	0.737
NULL	Nucl_Recept_Signal_2009_Jan_16_7_e001.nxml.txt.nlp	19240808	SENT224	7	7	2	2	hyperforin	SXR	PA165985514	8856	0.737
NULL	J_Invest_Dermatol_2012_Sep_19_132(9)_2198-2205.nxml.txt.nlp	22513780	SENT84	0	0	9	9	isotretinoin	IL-5	PA450128	3567	0.737
NULL	Diabetes_Care_2010_Jul_33(7)_1674-1685.nxml.txt.nlp	20587728	SENT443	16	16	14	14	metformin	AMPK	PA450395	5563	0.737
NULL	Cancer_Cell_Int_2009_Sep_10_9_25.nxml.txt.nlp	19744341	SENT195	23	23	9	9	glucosamine	HC11	PA164747613	6347	0.737
NULL	Cancer_Cell_Int_2011_Jun_1_11_15.nxml.txt.nlp	21631944	SENT191	26	26	16	16	etoposide	MICB	PA449552	4277	0.737
NULL	J_Hematol_Oncol_2012_Sep_18_5_57.nxml.txt.nlp	22989009	SENT133	25	25	31	31	nutlin-3	p53		7157	0.737
NULL	Front_Immunol_2012_Jan_24_3_3.nxml.txt.nlp	22566889	SENT1346	19	19	10	10	rituximab	CD59	PA451261	966	0.737
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Mar_29_70(Pt_4)_o500.nxml.txt.nlp	24826188	SENT78	25	25	31	31	piperazine	mol	PA450977	90527	0.737
NULL	J_Mol_Med_(Berl)_2012_Dec_23_90(12)_1361-1389.nxml.txt.nlp	23090008	SENT562	6	6	16	16	cetuximab	Bcl-2	PA10040	596	0.737
NULL	FASEB_J_2014_Feb_28(2)_923-934.nxml.txt.nlp	24249636	SENT483	3	3	14	14	urokinase	p38	PA451836	10598;1432;7965	0.737
NULL	Mol_Cancer_2010_Oct_12_9_269.nxml.txt.nlp	20939893	SENT84	21	21	36	36	isoproterenol	STAT3	PA450121	6774	0.737
NULL	Pharmaceuticals_(Basel)_2011_Jun_15_4(6)_822-847.nxml.txt.nlp	NULL	SENT705	15	15	11	11	methamphetamine	NF68	PA450403	4747	0.737
NULL	Breast_Cancer_Res_Treat_2014_Nov_11_148(3)_563-570.nxml.txt.nlp	25385180	SENT58	24	24	10	10	trastuzumab	PTH	PA451743	5741	0.737
NULL	Br_J_Cancer_2012_Sep_25_107(7)_1009-1016.nxml.txt.nlp	22948724	SENT46	15	15	18	18	sorafenib	CAIX	PA7000	768	0.737
NULL	Int_J_Biol_Sci_2012_Feb_9_8(3)_310-327.nxml.txt.nlp	22355267	SENT173	33	33	18	18	simvastatin	PCSK9	PA451363	255738	0.737
NULL	Oxid_Med_Cell_Longev_2010_Nov-Dec_3(6)_361-373.nxml.txt.nlp	21311214	SENT298	29	29	18	18	pravastatin	AMPK	PA451089	5563	0.737
NULL	Arch_Drug_Inf_2008_Jul_1(1)_14-22.nxml.txt.nlp	20157364	SENT114	12	12	26	26	pravastatin	IL-6	PA451089	3569	0.737
NULL	Cancer_Cell_Int_2004_Aug_17_4_5.nxml.txt.nlp	15315711	SENT122	23	23	12	12	genistein	PC3	PA165109660	57332;7832;5122	0.737
NULL	Mar_Drugs_2014_Jun_27_12(7)_3818-3837.nxml.txt.nlp	24979269	SENT66	38	38	36	36	doxorubicin	P-gp	PA449412	5243	0.737
NULL	Cancer_Med_2013_Feb_3_2(1)_11-20.nxml.txt.nlp	24133623	SENT445	15	15	4	4	cetuximab	BRAF	PA10040	673	0.737
NULL	Oncoimmunology_2013_Oct_1_2(10)_e27025.nxml.txt.nlp	24353914	SENT180	22	22	12	12	docetaxel	CD25	PA449383	3669;3559	0.737
NULL	Inflammation_2014_Feb_25_37(4)_1202-1212.nxml.txt.nlp	24566874	SENT246	2	2	5	5	resveratrol	FasL		356	0.737
NULL	Environ_Health_Perspect_2008_Mar_26_116(3)_322-328.nxml.txt.nlp	18335098	SENT20	20	20	39	39	estradiol	FES	PA449503	2242	0.737
NULL	J_Antimicrob_Chemother_2008_Nov_13_62(5)_1086-1093.nxml.txt.nlp	18703526	SENT86	28	28	17	17	ceftazidime	CTX	PA448861	1593	0.737
NULL	Case_Rep_Dermatol_2014_Feb_12_6(1)_37-42.nxml.txt.nlp	24707248	SENT25	9	9	5	5	vincristine	CHOP	PA451879	1649	0.737
NULL	Bioinform_Biol_Insights_2013_Sep_18_7_289-306.nxml.txt.nlp	24092970	SENT209	19	19	10	10	vincristine	PRAME	PA451879	23532	0.737
NULL	Front_Genet_2014_Nov_14_5_391.nxml.txt.nlp	25452763	SENT1139	14	14	3	3	cisplatin	TPMT	PA449014	7172	0.737
NULL	Sci_Rep_2014_Nov_28_4_7237.nxml.txt.nlp	25429875	SENT126	16	16	8	8	hesperidin	p38	PA449867	10598;1432;7965	0.737
NULL	Neuropsychologia_2012_Nov_50(13)_3156-3168.nxml.txt.nlp	22884957	SENT162	36	36	5	5	physostigmine	spatial	PA450957	219793	0.737
NULL	Iran_J_Neurol_2012_11(2)_70-73.nxml.txt.nlp	24250865	SENT52	14	14	9	9	doxycycline	IFN	PA449415	3439	0.737
NULL	J_Korean_Med_Sci_2006_Jun_21_21(3)_418-424.nxml.txt.nlp	16778382	SENT45	20	20	3	3	trypsin	INS-1	PA451806	2305	0.737
NULL	Br_J_Cancer_2014_Aug_12_111(4)_646-650.nxml.txt.nlp	24755886	SENT49	3	3	13	13	trabectedin	CXCL8	PA165958349	3576	0.737
NULL	Indian_J_Anaesth_2011_Nov-Dec_55(6)_567-572.nxml.txt.nlp	22223899	SENT156	23	23	14	14	isoflurane	NAC	PA450106	22861	0.737
NULL	Oncol_Lett_2014_Jun_21_7(6)_2073-2078.nxml.txt.nlp	24932291	SENT96	27	27	10	10	gemcitabine	RRM1	PA449748	6240	0.737
NULL	Acta_Neuropathol_Commun_2014_May_30_2_57.nxml.txt.nlp	24887326	SENT34	18	18	34	34	etoposide	ABCB1	PA449552	5243	0.737
NULL	Scientifica_(Cairo)_2013_Dec_12_2013_635203.nxml.txt.nlp	24416617	SENT460	38	38	13	13	dacarbazine	gp100	PA449197	6490	0.737
NULL	Iran_J_Pharm_Res_2014_Autumn_13(4)_1393-1401.nxml.txt.nlp	25587329	SENT99	6	6	10	10	celecoxib	ABCG2	PA448871	9429	0.737
NULL	Diabetes_2013_Oct_17_62(10)_3547-3552.nxml.txt.nlp	23863812	SENT16	2	2	10	10	simvastatin	adiponectin	PA451363	9370	0.737
NULL	Diabetes_2013_Oct_17_62(10)_3547-3552.nxml.txt.nlp	23863812	SENT156	11	11	18	18	pravastatin	adiponectin	PA451089	9370	0.737
NULL	Br_J_Cancer_1998_Nov_78(9)_1170-1174.nxml.txt.nlp	9820175	SENT13	40	40	26	26	bufuralol	CYP2A6	PA166110256	1548	0.737
NULL	Mol_Cell_Biochem_2014_Oct_9_385(1-2)_265-275.nxml.txt.nlp	24104452	SENT9	17	17	27	27	bortezomib	U87	PA10252	677775;641648	0.737
NULL	J_Neuroinflammation_2010_Nov_18_7_81.nxml.txt.nlp	21087489	SENT70	20	20	10	10	pilocarpine	CA1	PA450962	759	0.737
NULL	Breast_Cancer_Res_Treat_2014_Nov_11_148(3)_563-570.nxml.txt.nlp	25385180	SENT58	29	29	10	10	trastuzumab	PTH	PA451743	5741	0.737
NULL	Cancer_Cell_Int_2004_May_17_4_4.nxml.txt.nlp	15147581	SENT138	5	5	17	17	sulindac	COX	PA451565	1351	0.737
NULL	Int_J_Endocrinol_2011_Nov_17_2011_401258.nxml.txt.nlp	22164158	SENT29	2	2	9	9	doxycycline	GPR39	PA449415	2863	0.737
NULL	Br_J_Cancer_2012_Feb_14_106(4)_685-692.nxml.txt.nlp	22294184	SENT190	4	4	6	6	docetaxel	survivin	PA449383	332	0.737
NULL	Int_Neurourol_J_2014_Sep_24_18(3)_115-125.nxml.txt.nlp	25279238	SENT202	2	2	22	22	berberine	CA1	PA165860812	759	0.737
NULL	Oncotarget_2013_Jan_14_4(1)_118-127.nxml.txt.nlp	23435217	SENT185	34	34	40	40	bevacizumab	EGFR	PA130232992	1956	0.737
NULL	Front_Behav_Neurosci_2014_Sep_15_8_322.nxml.txt.nlp	25309372	SENT19	6	6	8	8	desipramine	DES	PA449233	1674	0.737
NULL	Biosci_Rep_2012_Apr_1_32(Pt_2)_105-112.nxml.txt.nlp	22115362	SENT557	3	3	15	15	collagenase	p38	PA449107	10598;1432;7965	0.737
NULL	Colomb_Med_(Cali)_43(3)_221-225.nxml.txt.nlp	24893196	SENT135	14	14	9	9	resveratrol	ACTH		5443	0.737
NULL	Acta_Pharmacol_Sin_2013_Jan_17_34(1)_157-166.nxml.txt.nlp	23247593	SENT165	19	19	22	22	berberine	IL-6	PA165860812	3569	0.737
NULL	Brain_Sci_2013_Jul_9_3(3)_1043-1059.nxml.txt.nlp	24961520	SENT123	10	10	29	29	sr144528	CBR1		873	0.737
NULL	Oxid_Med_Cell_Longev_2013_Apr_21_2013_412576.nxml.txt.nlp	23710286	SENT9	15	15	3	3	curcumin	NRF2	PA151958596	2551;4780	0.737
NULL	Crit_Care_2009_Feb_6_13(1)_R11.nxml.txt.nlp	19196475	SENT171	21	21	7	7	clonidine	IL-6	PA449051	3569	0.737
NULL	Clinics_(Sao_Paulo)_2013_May_68(5)_694-701.nxml.txt.nlp	23778405	SENT40	10	10	22	22	curcumin	DDP	PA151958596	1678	0.737
NULL	Clin_Ophthalmol_2011_Jul_26_5_1043-1049.nxml.txt.nlp	21845032	SENT10	4	4	12	12	ranibizumab	San	PA164746012	80218	0.737
NULL	Eur_J_Endocrinol_2011_Jan_164(1)_69-74.nxml.txt.nlp	20961967	SENT17	6	6	24	24	pioglitazone	adiponectin	PA450970	9370	0.737
NULL	Open_Access_J_Urol_2010_Dec_30_3_7-17.nxml.txt.nlp	24198630	SENT99	19	19	9	9	solifenacin	CYP3A4	PA164783810	1576	0.737
NULL	Br_J_Cancer_2013_Feb_19_108(3)_493-502.nxml.txt.nlp	23299530	SENT24	19	19	14	14	oxaliplatin	VEGF-A	PA131285527	7422	0.737
NULL	Br_J_Clin_Pharmacol_2013_Aug_23_76(2)_299-315.nxml.txt.nlp	23701319	SENT94	0	0	21	21	natalizumab	IFN	PA164747191	3439	0.737
NULL	Eur_J_Med_Res_2009_Nov_24_14(Suppl_3)_30-35.nxml.txt.nlp	19959414	SENT70	8	8	0	0	raltegravir	CD4		920	0.737
NULL	Oncotarget_2013_Nov_24_4(12)_2186-2207.nxml.txt.nlp	24327604	SENT130	32	32	22	22	doxorubicin	MDM2	PA449412	4193	0.737
NULL	J_Invest_Dermatol_2013_Jun_14_133(6)_1541-1549.nxml.txt.nlp	23407395	SENT41	11	11	18	18	imiquimod	CXCL2	PA449972	2920	0.737
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT97	10	10	7	7	trastuzumab	MUC4	PA451743	4585	0.737
NULL	Am_J_Case_Rep_2012_Jun_5_13_96-98.nxml.txt.nlp	23569499	SENT41	7	7	4	4	cyclophosphamide	CHOP	PA449165	1649	0.737
NULL	Eur_J_Clin_Pharmacol_2011_May_2_67(Suppl_1)_87-107.nxml.txt.nlp	21287160	SENT327	10	10	20	20	irinotecan	UGT1A1	PA450085	54658	0.737
NULL	Nucleic_Acids_Res_2011_Dec_31_39(22)_9536-9548.nxml.txt.nlp	21880590	SENT175	27	27	25	25	etoposide	PDE4DIP	PA449552	9659	0.737
NULL	Bioinformation_2012_Jan_6_8(1)_13-19.nxml.txt.nlp	22359429	SENT142	33	33	40	40	curcumin	MRP1	PA151958596	4437	0.737
NULL	Cancer_Cell_Int_2013_Feb_12_13_14.nxml.txt.nlp	23402310	SENT37	14	14	21	21	celecoxib	p65	PA448871	5970	0.737
NULL	Br_J_Cancer_2012_Sep_4_107(6)_947-955.nxml.txt.nlp	22892392	SENT123	6	6	10	10	lapatinib	ERBB3	PA152241907	2065	0.737
NULL	Mol_Syst_Biol_2010_Jul_27_6_391.nxml.txt.nlp	20664637	SENT57	8	8	18	18	choline	PPEF2	PA448976	5470	0.737
NULL	Exp_Ther_Med_2014_Sep_20_8(3)_968-972.nxml.txt.nlp	25120631	SENT136	19	19	0	0	naringin	FIB	PA151958360	2091	0.737
NULL	Aging_(Albany_NY)_2011_Aug_21_3(8)_716-732.nxml.txt.nlp	21869457	SENT50	0	0	11	11	spermine	SMO	PA164781199	6608;54498	0.737
NULL	Open_Biomed_Eng_J_2011_Jan_19_5_1-7.nxml.txt.nlp	21625374	SENT65	5	5	19	19	metformin	EGI	PA450395	1957	0.737
NULL	Curr_Neuropharmacol_2012_Mar_10(1)_53-63.nxml.txt.nlp	22942878	SENT33	25	25	21	21	vasopressin	OXT	PA451858	5020	0.737
NULL	Cancers_(Basel)_2012_Jun_18_4(2)_581-600.nxml.txt.nlp	24213326	SENT442	0	0	16	16	paclitaxel	TLR9	PA450761	54106	0.737
NULL	Chonnam_Med_J_2014_Aug_20_50(2)_37-44.nxml.txt.nlp	25229014	SENT78	37	37	29	29	meropenem	VIM	PA164764445	7431	0.737
NULL	Eur_J_Med_Res_2011_Jul_25_16(7)_303-314.nxml.txt.nlp	21813371	SENT59	27	27	32	32	telaprevir	SOC	PA165958354	91544	0.737
NULL	Acta_Vet_Scand_2011_Feb_22_53(1)_12.nxml.txt.nlp	21342526	SENT223	16	16	31	31	flutamide	PD2	PA449685	54623	0.737
NULL	J_Cell_Mol_Med_2013_May_20_17(5)_648-656.nxml.txt.nlp	23601074	SENT109	5	5	14	14	gefitinib	PI3K	PA131301952	5290	0.737
NULL	Braz_J_Med_Biol_Res_2013_Feb_1_46(2)_121-127.nxml.txt.nlp	23369972	SENT60	16	16	25	25	ciprofloxacin	CO2	PA449009	4513	0.737
NULL	J_Biomed_Biotechnol_2007_Mar_20_2007_85208.nxml.txt.nlp	17515947	SENT95	18	18	14	14	urokinase	EGF	PA451836	1950	0.737
NULL	J_Cell_Biol_2008_Jul_14_182(1)_197-213.nxml.txt.nlp	18625847	SENT119	9	9	6	6	nutlin-3	p53		7157	0.737
NULL	Int_J_Mol_Sci_2012_Sep_20_13(9)_12000-12016.nxml.txt.nlp	23109896	SENT542	3	3	0	0	cetuximab	EGFR	PA10040	1956	0.737
NULL	Oncotarget_2013_Dec_18_5(2)_375-385.nxml.txt.nlp	24495868	SENT117	7	7	15	15	fludarabine	BCL2	PA449655	596	0.737
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Oct_4_70(Pt_11)_269-271.nxml.txt.nlp	25484720	SENT6	26	26	43	43	benzaldehyde	mol	PA448571	90527	0.737
NULL	Front_Immunol_2012_Feb_27_3_23.nxml.txt.nlp	22566907	SENT475	18	18	10	10	hyaluronan	CD44	PA165958431	960	0.737
NULL	Clin_Dev_Immunol_2013_Nov_26_2013_325481.nxml.txt.nlp	24371447	SENT95	10	10	8	8	propofol	IL-6	PA451141	3569	0.737
NULL	AIDS_Res_Treat_2014_Nov_9_2014_724958.nxml.txt.nlp	25431661	SENT18	37	37	19	19	efavirenz	ATV	PA449441	4683	0.737
NULL	Br_J_Cancer_1998_Nov_78(9)_1170-1174.nxml.txt.nlp	9820175	SENT13	24	24	42	42	coumarin	CYP2D6	PA134521193	1565	0.737
NULL	Front_Oncol_2013_Nov_15_3_281.nxml.txt.nlp	24298448	SENT188	29	29	18	18	cetuximab	BRAF	PA10040	673	0.737
NULL	Case_Rep_Oncol_Med_2011_Nov_22_2011_326815.nxml.txt.nlp	22606443	SENT45	34	34	12	12	thyroglobulin	TTF-1	PA164754910	7080	0.736
NULL	Pediatr_Cardiol_2010_Jan_14_31(1)_90-95.nxml.txt.nlp	19915892	SENT152	12	12	33	33	palivizumab	Era	PA164748781	2099	0.736
NULL	BMB_Rep_2014_Oct_47(10)_575-580.nxml.txt.nlp	24499675	SENT49	11	11	5	5	arsenite	p53	PA452638	7157	0.736
NULL	Apoptosis_2014_Aug_26_19(11)_1603-1615.nxml.txt.nlp	25156145	SENT167	4	4	0	0	mitomycin	TRAIL	PA450524	8743	0.736
NULL	Ann_Rheum_Dis_2008_Oct_25_68(10)_1644-1650.nxml.txt.nlp	18957484	SENT192	17	17	8	8	leflunomide	JAK3	PA450192	3718	0.736
NULL	Cancers_(Basel)_2014_Oct_24_6(4)_2187-2223.nxml.txt.nlp	25347122	SENT699	3	3	35	35	cyclophosphamide	MA5	PA449165	29944	0.736
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_39-54.nxml.txt.nlp	19305787	SENT239	23	23	35	35	ethanol	DARPP-32	PA448073	84152	0.736
NULL	Breast_Cancer_Res_2008_Aug_21_10(4)_R71.nxml.txt.nlp	18718015	SENT89	4	4	11	11	forskolin	San	PA146096022	80218	0.736
NULL	Biomed_Imaging_Interv_J_2011_Oct_1_7(4)_e25.nxml.txt.nlp	22279502	SENT208	10	10	13	13	oxaliplatin	CRT	PA131285527	811	0.736
NULL	Multidiscip_Respir_Med_2013_Feb_6_8(1)_11.nxml.txt.nlp	23388501	SENT54	28	28	34	34	thrombin	ASM	PA451674	6609;283120	0.736
NULL	Oncoimmunology_2012_Mar_1_1(2)_234-236.nxml.txt.nlp	22720254	SENT39	25	25	40	40	cisplatin	STAT6	PA449014	6778	0.736
NULL	Hum_Genomics_2009_Jan_1_3(2)_128-142.nxml.txt.nlp	19164090	SENT188	9	9	5	5	carboplatin	CD44	PA448803	960	0.736
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT93	16	16	36	36	atorvastatin	PTEN	PA448500	5728	0.736
NULL	J_Clin_Biochem_Nutr_2007_Nov_30_41(3)_202-210.nxml.txt.nlp	18299717	SENT252	4	4	15	15	indomethacin	p53	PA449982	7157	0.736
NULL	Breast_Cancer_Res_2005_Nov_14_7(6)_R1122-R1131.nxml.txt.nlp	16457692	SENT36	32	32	34	34	raloxifene	STAR	PA451221	6770;2984	0.736
NULL	Emerg_Infect_Dis_2011_Mar_17(3)_432-440.nxml.txt.nlp	21392434	SENT5	16	16	11	11	rifampin	DST	PA451250	667	0.736
NULL	Br_J_Cancer_2014_Oct_14_111(8)_1552-1561.nxml.txt.nlp	25117814	SENT272	0	0	3	3	doxorubicin	AKT	PA449412	207	0.736
NULL	J_Hematol_Oncol_2013_Jul_9_6_49.nxml.txt.nlp	23837843	SENT216	37	37	22	22	verapamil	Rho	PA451868	29984	0.736
NULL	Arch_Virol_2014_Dec_24_159(6)_1365-1371.nxml.txt.nlp	24366548	SENT29	30	30	27	27	ribavirin	IFN	PA451241	3439	0.736
NULL	Core_Evid_2010_Oct_21_5_61-76.nxml.txt.nlp	21042543	SENT324	9	9	11	11	irinotecan	IFL	PA450085	3439	0.736
NULL	J_Exerc_Rehabil_2013_Jun_30_9(3)_389-393.nxml.txt.nlp	24278889	SENT45	30	30	26	26	pyrazinamide	EMB	PA451182	133418	0.736
NULL	Libyan_J_Med_2007_Dec_1_2(4)_169-175.nxml.txt.nlp	21503240	SENT239	4	4	33	33	flumazenil	CA1	PA449659	759	0.736
NULL	Cell_Death_Dis_2010_Oct_21_1(10)_e86.nxml.txt.nlp	21368859	SENT60	4	4	14	14	doxorubicin	TRAIL	PA449412	8743	0.736
NULL	Front_Neurosci_2011_Jan_14_4_207.nxml.txt.nlp	21258618	SENT97	0	0	11	11	ethanol	HET	PA448073	6294	0.736
NULL	J_Hematol_Oncol_2012_Jun_8_5_27.nxml.txt.nlp	22682004	SENT146	17	17	10	10	ifosfamide	CHOP	PA449964	1649	0.736
NULL	Biomed_Res_Int_2014_Apr_13_2014_738625.nxml.txt.nlp	24822215	SENT133	6	6	15	15	montelukast	IL-13	PA450546	3596	0.736
NULL	Mol_Cell_Biochem_2009_Sep_28_329(1-2)_107-114.nxml.txt.nlp	19399589	SENT102	12	12	17	17	metformin	AMPK	PA450395	5563	0.736
NULL	Br_J_Cancer_2013_Jan_15_108(1)_82-90.nxml.txt.nlp	23321512	SENT185	25	25	12	12	ixabepilone	TUBB		203068	0.736
NULL	Evid_Based_Complement_Alternat_Med_2006_Sep_20_3(3)_365-372.nxml.txt.nlp	16951721	SENT104	16	16	22	22	ginseng	Bcl-2	PA164781150	596	0.736
NULL	Case_Rep_Hematol_2013_Aug_27_2013_258028.nxml.txt.nlp	24066245	SENT6	20	20	22	22	cladribine	DAC	PA449027	13	0.736
NULL	Cancer_Manag_Res_2014_Oct_17_6_423-430.nxml.txt.nlp	25378950	SENT66	8	8	19	19	exemestane	aromatase	PA449563	1588	0.736
NULL	Adipocyte_2014_Jul_1_3(3)_190-196.nxml.txt.nlp	25068085	SENT10	11	11	6	6	estradiol	ADIPOR2	PA449503	79602	0.736
NULL	Cell_Death_Differ_2009_Dec_14_16(12)_1681-1693.nxml.txt.nlp	19680266	SENT237	7	7	19	19	fluorescein	San	PA164746009	80218	0.736
NULL	Acta_Pharmacol_Sin_2014_Aug_30_35(8)_1045-1054.nxml.txt.nlp	24976155	SENT130	2	2	6	6	resveratrol	STAT3		6774	0.736
NULL	J_Exp_Med_2003_Aug_4_198(3)_379-389.nxml.txt.nlp	12885873	SENT94	15	15	23	23	paraformaldehyde	LSR	PA450790	51599	0.736
NULL	Exp_Cell_Res_2013_Aug_1_319(13)_2037-2048.nxml.txt.nlp	23562655	SENT15	26	26	19	19	urokinase	ITGA2	PA451836	3673	0.736
NULL	Emerg_Infect_Dis_2013_Jul_19(7)_1151-1152.nxml.txt.nlp	23763791	SENT19	37	37	19	19	ethionamide	DST	PA164768738	667	0.736
NULL	Iran_J_Ped_Hematol_Oncol_2014_Jul_20_4(3)_118-126.nxml.txt.nlp	25254091	SENT112	14	14	30	30	vinblastine	ABCA3	PA451877	21	0.736
NULL	J_Thorac_Oncol_2014_Feb_23_9(2)_189-194.nxml.txt.nlp	24419415	SENT16	8	8	14	14	gefitinib	EGFR	PA131301952	1956	0.736
NULL	Br_J_Cancer_2013_May_14_108(9)_1807-1809.nxml.txt.nlp	23612454	SENT45	18	18	12	12	trastuzumab	PIK3CA	PA451743	5290	0.736
NULL	Curr_Chem_Genomics_Transl_Med_2014_Mar_7_8_36-46.nxml.txt.nlp	24772387	SENT141	8	8	10	10	fluorouracil	p53	PA128406956	7157	0.736
NULL	J_Mol_Med_(Berl)_2014_May_10_92(7)_709-722.nxml.txt.nlp	24811491	SENT69	24	24	16	16	cetuximab	KRAS	PA10040	3845	0.736
NULL	Front_Oncol_2013_Aug_12_3_206.nxml.txt.nlp	23964347	SENT180	33	33	14	14	cisplatin	ERCC1	PA449014	2067	0.736
NULL	Curr_Control_Trials_Cardiovasc_Med_2001_Feb_8_2(1)_45-53.nxml.txt.nlp	11806772	SENT219	0	0	14	14	tacrolimus	IL-2	PA451578	3558	0.736
NULL	J_Immune_Based_Ther_Vaccines_2008_Oct_28_6_6.nxml.txt.nlp	18957084	SENT103	19	19	34	34	paraformaldehyde	San	PA450790	80218	0.736
NULL	Bioinformation_2012_Jan_6_8(1)_13-19.nxml.txt.nlp	22359429	SENT145	12	12	19	19	curcumin	MRP1	PA151958596	4437	0.736
NULL	HSR_Proc_Intensive_Care_Cardiovasc_Anesth_2011_3(1)_9-19.nxml.txt.nlp	23439940	SENT130	7	7	19	19	nesiritide	NAPA	PA164781045	9476;8775	0.736
NULL	Patient_Prefer_Adherence_2010_Mar_24_4_61-68.nxml.txt.nlp	20361006	SENT152	26	26	5	5	rosiglitazone	GLP-1	PA451283	100125288	0.736
NULL	J_Cardiothorac_Surg_2014_Dec_18_9(1)_196.nxml.txt.nlp	NULL	SENT145	22	22	11	11	protamine	ACT	PA10366	12;11332;9457;641455	0.736
NULL	EMBO_Mol_Med_2012_Jul_11_4(7)_577-593.nxml.txt.nlp	22496117	SENT228	13	13	9	9	clofazimine	PAP-1	PA164748759	6100	0.736
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Dec_17_65(Pt_1)_m96.nxml.txt.nlp	21581559	SENT68	10	10	29	29	ethanol	PF6	PA448073	200162	0.736
NULL	Case_Rep_Oncol_2014_Sep_27_7(3)_681-684.nxml.txt.nlp	25408663	SENT3	0	0	8	8	crizotinib	ALK	PA165946122	238	0.736
NULL	Eur_J_Immunol_2014_Jun_10_44(6)_1759-1769.nxml.txt.nlp	24595810	SENT7	28	28	39	39	fludrocortisone	CD62L	PA164743961	6402	0.736
NULL	Nat_Med_2013_Mar_3_19(3)_295-304.nxml.txt.nlp	23377280	SENT244	34	34	32	32	erlotinib	EGF	PA134687924	1950	0.736
NULL	Cancer_Metastasis_Rev_2010_Jun_28_29(2)_317-329.nxml.txt.nlp	20422276	SENT427	30	30	13	13	thalidomide	JCH	PA451644	3512	0.736
NULL	Breast_Cancer_(Auckl)_2009_Apr_7_3_23-34.nxml.txt.nlp	21556247	SENT105	18	18	11	11	celecoxib	AKT	PA448871	207	0.736
NULL	Int_J_Pediatr_2010_Dec_23_2010_376287.nxml.txt.nlp	21234103	SENT141	13	13	5	5	methylprednisolone	CYP3A4	PA450466	1576	0.736
NULL	Acta_Pharmacol_Sin_2009_May_6_30(5)_513-521.nxml.txt.nlp	19349966	SENT237	8	8	14	14	buprenorphine	Gen	PA448685	348654	0.736
NULL	Front_Pharmacol_2014_May_9_5_103.nxml.txt.nlp	24847272	SENT231	23	23	19	19	tacrolimus	POR	PA451578	5447	0.736
NULL	Braz_J_Med_Biol_Res_2014_Mar_3_47(3)_245-251.nxml.txt.nlp	24554037	SENT19	17	17	2	2	atorvastatin	IFN	PA448500	3439	0.736
NULL	Curr_Pain_Headache_Rep_2010_Feb_16_14(1)_8-16.nxml.txt.nlp	20425209	SENT113	6	6	3	3	ketorolac	COX	PA450150	1351	0.736
NULL	Arch_Med_Sci_2012_Nov_9_8(5)_907-917.nxml.txt.nlp	23185203	SENT75	11	11	6	6	liraglutide	GLP-1	PA165958364	100125288	0.736
NULL	J_Bras_Pneumol_2013_Jan-Feb_39(1)_5-15.nxml.txt.nlp	23503480	SENT202	6	6	1	1	doxycycline	VEGF-D	PA449415	2277	0.736
NULL	Appl_Microbiol_Biotechnol_2012_Feb_11_93(4)_1377-1387.nxml.txt.nlp	22234536	SENT158	3	3	25	25	nadh	mol	PA164755085	90527	0.736
NULL	Iran_J_Pharm_Res_2014_Winter_13(1)_29-37.nxml.txt.nlp	24734054	SENT2	8	8	10	10	streptozocin	STZ	PA451514	6484	0.736
NULL	Oncotarget_2014_Mar_13_5(4)_1101-1110.nxml.txt.nlp	24658355	SENT2	29	29	24	24	tamoxifen	MKP-1	PA451581	1843	0.736
NULL	Breast_Cancer_Res_2011_Jan_17_13(1)_R5.nxml.txt.nlp	21241485	SENT332	15	15	1	1	estradiol	Brn-3b	PA449503	5458	0.736
NULL	Exp_Ther_Med_2014_Aug_4_8(2)_657-661.nxml.txt.nlp	25009636	SENT9	17	17	29	29	propofol	CCR2	PA451141	729230	0.736
NULL	Virchows_Arch_2011_Nov_14_459(5)_465-475.nxml.txt.nlp	21997759	SENT14	35	35	37	37	heparin	periostin	PA449855	10631	0.736
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT153	20	20	22	22	perifosine	DR5	PA165291471	8795	0.736
NULL	Nat_Med_2013_Mar_10_19(3)_313-321.nxml.txt.nlp	23396211	SENT140	0	0	5	5	amlexanox	TBK1	PA164745310	29110	0.736
NULL	J_Indian_Assoc_Pediatr_Surg_2013_Apr-Jun_18(2)_74-78.nxml.txt.nlp	23798811	SENT36	16	16	13	13	enalapril	ACE	PA449456	1636	0.736
NULL	Biochemistry_2009_Aug_4_48(30)_7261-7270.nxml.txt.nlp	19527073	SENT67	19	19	13	13	trypsin	Met	PA451806	79811	0.736
NULL	J_Biol_Chem_2013_Nov_22_288(47)_34217-34229.nxml.txt.nlp	24106270	SENT227	9	9	16	16	thrombin	RhoG	PA451674	391	0.736
NULL	AoB_Plants_2013_Feb_20_5_plt003.nxml.txt.nlp	23429357	SENT185	9	9	28	28	ethanol	CO2	PA448073	4513	0.736
NULL	Eur_J_Med_Res_2010_Nov_30_15(12)_571-576.nxml.txt.nlp	21163732	SENT18	19	19	15	15	imipenem	HAP	PA449968	5915;10313	0.736
NULL	J_Headache_Pain_2012_Nov_16_13(8)_677-684.nxml.txt.nlp	23070400	SENT170	26	26	5	5	nabilone	DAI	PA164746998	81030	0.736
NULL	J_Korean_Med_Sci_2006_Jun_21_21(3)_418-424.nxml.txt.nlp	16778382	SENT99	4	4	0	0	hemin	HO-1	PA449849	3162	0.736
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT254	17	17	14	14	adalimumab	CD36	PA10004	948	0.736
NULL	Cell_Cycle_2013_Jun_15_12(12)_1811-1812.nxml.txt.nlp	23708513	SENT5	18	18	24	24	doxorubicin	CHOP	PA449412	1649	0.736
NULL	Acta_Pharmacol_Sin_2009_May_13_30(5)_628-636.nxml.txt.nlp	19363519	SENT34	9	9	2	2	camptothecin	TPT	PA153590860	23590;6469	0.736
NULL	Oncotarget_2013_Apr_13_4(4)_502-530.nxml.txt.nlp	23594434	SENT298	12	12	4	4	sertraline	U87	PA451333	677775;641648	0.736
NULL	Oncol_Lett_2013_Jun_3_5(6)_1760-1764.nxml.txt.nlp	23833637	SENT8	11	11	9	9	gemcitabine	TRAIL	PA449748	8743	0.736
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Mar_7_68(Pt_4)_o968.nxml.txt.nlp	22590024	SENT74	26	26	20	20	ethanol	mol	PA448073	90527	0.736
NULL	Mol_Pain_2014_Feb_6_10_10.nxml.txt.nlp	24499354	SENT7	21	21	23	23	cyclophosphamide	CTX	PA449165	1593	0.736
NULL	Cell_Microbiol_2013_Aug_14_15(8)_1385-1400.nxml.txt.nlp	23421931	SENT302	24	24	9	9	fluorescein	CD11c	PA164746009	3687	0.736
NULL	Mol_Cancer_2007_Feb_2_6_11.nxml.txt.nlp	17274815	SENT194	19	19	4	4	bevacizumab	p53	PA130232992	7157	0.736
NULL	Ann_Hematol_2010_Nov_25_89(11)_1115-1124.nxml.txt.nlp	20499237	SENT108	34	34	23	23	simvastatin	CD19	PA451363	930	0.736
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT24	13	13	23	23	trastuzumab	STAT3	PA451743	6774	0.736
NULL	Interdiscip_Toxicol_2011_Jun_4(2)_78-84.nxml.txt.nlp	21753903	SENT4	30	30	14	14	estradiol	CYP2E1	PA449503	1571	0.736
NULL	Nucleic_Acids_Res_2005_Apr_22_33(7)_2310-2317.nxml.txt.nlp	15849317	SENT371	27	27	13	13	geldanamycin	Hsp90	PA152031327	3320	0.736
NULL	Oncotarget_2014_Oct_21_5(22)_11252-11268.nxml.txt.nlp	25361004	SENT119	0	0	17	17	metformin	U87	PA450395	677775;641648	0.736
NULL	Oncotarget_2014_Aug_19_5(18)_8737-8749.nxml.txt.nlp	25228590	SENT79	29	29	10	10	doxycycline	MYCN	PA449415	4613	0.736
NULL	Case_Rep_Oncol_2013_Jul_20_6(2)_382-386.nxml.txt.nlp	23904849	SENT15	5	5	14	14	panitumumab	EGFR	PA162373091	1956	0.736
NULL	J_Exp_Bot_2011_Oct_4_62(14)_4787-4803.nxml.txt.nlp	21821598	SENT20	34	34	20	20	mannitol	M6PR	PA450320	4074	0.736
NULL	J_Gen_Physiol_1995_Oct_1_106(4)_745-779.nxml.txt.nlp	8576705	SENT0	16	16	1	1	verapamil	Gen	PA451868	348654	0.736
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT218	7	7	20	20	metformin	HIP	PA450395	6767;6159;64399;5068	0.736
NULL	Oncotarget_2013_Dec_18_5(2)_375-385.nxml.txt.nlp	24495868	SENT117	7	7	19	19	fludarabine	CCND1	PA449655	595	0.736
NULL	J_Hematol_Oncol_2013_Oct_1_6_75.nxml.txt.nlp	24279871	SENT153	24	24	26	26	cyclophosphamide	CTX	PA449165	1593	0.736
NULL	Drugs_R_D_2014_Sep_31_14(3)_177-184.nxml.txt.nlp	25079671	SENT13	6	6	22	22	acarbose	MCP-1	PA448010	6347	0.736
NULL	Biomed_Res_Int_2013_Dec_31_2013_273498.nxml.txt.nlp	23484100	SENT172	2	2	9	9	genistein	OTC	PA165109660	5009	0.736
NULL	Allergy_Asthma_Immunol_Res_2013_Mar_20_5(2)_106-109.nxml.txt.nlp	23449963	SENT67	19	19	10	10	methacholine	IL-5	PA165958382	3567	0.736
NULL	Nat_Genet_2011_Feb_26_43(2)_117-120.nxml.txt.nlp	21186350	SENT91	38	38	41	41	metformin	AMPK	PA450395	5563	0.736
NULL	Clin_Exp_Gastroenterol_2012_May_14_5_49-59.nxml.txt.nlp	22649281	SENT89	12	12	22	22	pantoprazole	CYP3A4	PA450774	1576	0.736
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT17	13	13	35	35	l-leucine	SIRT3	PA450197	23410	0.736
NULL	Acta_Pharmacol_Sin_2012_May_4_33(5)_644-651.nxml.txt.nlp	22555371	SENT168	8	8	11	11	irbesartan	eNOS	PA450084	4846	0.736
NULL	Biol_Direct_2007_Feb_21_2_8.nxml.txt.nlp	17313671	SENT175	12	12	21	21	cyclophosphamide	CHOP	PA449165	1649	0.736
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT111	8	8	36	36	gefitinib	PIK3CA	PA131301952	5290	0.736
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1013.nxml.txt.nlp	24457957	SENT318	3	3	7	7	orlistat	NOXA	PA164776864	5366	0.736
NULL	AIDS_Res_Treat_2011_Feb_9_2011_463704.nxml.txt.nlp	21490779	SENT65	29	29	31	31	atazanavir	ATV	PA10251	4683	0.736
NULL	Onco_Targets_Ther_2014_Oct_4_7_1817-1828.nxml.txt.nlp	25336973	SENT125	3	3	0	0	cetuximab	EGFR	PA10040	1956	0.736
NULL	J_Inflamm_(Lond)_2005_Oct_31_2_14.nxml.txt.nlp	16259633	SENT308	0	0	11	11	staurosporine	CCR1	PA165109623	1230	0.736
NULL	Surg_Endosc_2010_Feb_2_24(2)_304-334.nxml.txt.nlp	19572178	SENT921	2	2	6	6	sargramostim	GM-CSF	PA164748631	1437	0.736
NULL	Exp_Ther_Med_2012_Sep_12_4(3)_475-480.nxml.txt.nlp	23181121	SENT156	2	2	0	0	cyclophosphamide	CHOP	PA449165	1649	0.736
NULL	Leukemia_2014_Jun_25_28(6)_1280-1288.nxml.txt.nlp	24270737	SENT210	19	19	7	7	cytarabine	PD-L2	PA449177	80380	0.736
NULL	Aging_(Albany_NY)_2014_Mar_26_6(3)_187-206.nxml.txt.nlp	24753144	SENT202	8	8	4	4	exenatide	GLP-1	PA164749238	100125288	0.736
NULL	Front_Pharmacol_2014_Oct_31_5_231.nxml.txt.nlp	25400580	SENT2979	20	20	5	5	paclitaxel	SLC29A1	PA450761	2030	0.736
NULL	Int_J_Nephrol_2010_Oct_20_2011_425923.nxml.txt.nlp	21151536	SENT122	6	6	11	11	dipyridamole	NGAL	PA449367	3934	0.736
NULL	Cancer_Med_2013_Aug_10_2(4)_496-506.nxml.txt.nlp	24156022	SENT264	27	27	5	5	cetuximab	BRAF	PA10040	673	0.736
NULL	Cancer_Immunol_Immunother_2011_Jan_22_60(1)_37-47.nxml.txt.nlp	20859626	SENT66	24	24	39	39	streptomycin	CO2	PA451512	4513	0.736
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT93	8	8	13	13	curcumin	Bcl-2	PA151958596	596	0.736
NULL	Eur_J_Med_Res_2010_Feb_26_15(2)_47-53.nxml.txt.nlp	20452883	SENT94	18	18	9	9	fentanyl	ESG	PA449599	7089;7088;7090;7091	0.736
NULL	J_Oncol_2013_Feb_17_2013_872957.nxml.txt.nlp	23476648	SENT118	6	6	19	19	cisplatin	SFN	PA449014	25996;2810	0.736
NULL	J_Oncol_2013_Feb_17_2013_872957.nxml.txt.nlp	23476648	SENT107	4	4	2	2	cisplatin	SFN	PA449014	25996;2810	0.736
NULL	Int_J_Gen_Med_2012_Jun_18_5_535-540.nxml.txt.nlp	22807641	SENT97	8	8	13	13	pitavastatin	ANOVA	PA142650384	4858	0.736
NULL	Oncotarget_2012_Dec_18_3(12)_1615-1628.nxml.txt.nlp	23271044	SENT153	22	22	24	24	temsirolimus	TOR	PA164746890	6097	0.736
NULL	Psychol_Med_2007_Feb_18_37(2)_163-180.nxml.txt.nlp	16978446	SENT931	10	10	7	7	pindolol	5-HT1A	PA450966	3350	0.736
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Aug_11_68(Pt_9)_o2695-o2696.nxml.txt.nlp	22969587	SENT72	11	11	17	17	piperazine	mol	PA450977	90527	0.736
NULL	Stroke_Res_Treat_2009_Dec_20_2010_386389.nxml.txt.nlp	20700422	SENT217	4	4	11	11	resveratrol	NAC		22861	0.736
NULL	Oncol_Rep_2013_Apr_23_29(4)_1268-1274.nxml.txt.nlp	23354756	SENT149	4	4	16	16	paclitaxel	SLC25A43	PA450761	203427	0.736
NULL	Int_J_Environ_Res_Public_Health_2010_May_28_7(5)_1996-2007.nxml.txt.nlp	20632473	SENT130	9	9	17	17	arsenite	c-Jun	PA452638	3725	0.736
NULL	J_Gen_Intern_Med_2009_May_21_24(5)_656-664.nxml.txt.nlp	19306050	SENT416	18	18	10	10	warfarin	CYP2C9	PA451906	1559	0.736
NULL	Mol_Cell_2014_May_8_54(3)_445-459.nxml.txt.nlp	24746700	SENT90	22	22	13	13	etoposide	BACH1	PA449552	571;83990	0.736
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT167	28	28	38	38	trastuzumab	AKT	PA451743	207	0.736
NULL	Int_J_Nanomedicine_2012_May_7_7_2307-2314.nxml.txt.nlp	22661887	SENT165	5	5	2	2	gemcitabine	F10	PA449748	2159	0.736
NULL	Cases_J_2009_Jul_30_2_7134.nxml.txt.nlp	19829918	SENT66	4	4	23	23	levodopa	LCE	PA450213	79071	0.736
NULL	Osteoporos_Int_2010_Dec_6_21(Suppl_4)_605-614.nxml.txt.nlp	21058000	SENT144	0	0	20	20	denosumab	RANKL	PA166048634	8600	0.736
NULL	Arthritis_Res_Ther_2011_May_25_13(Suppl_1)_S5.nxml.txt.nlp	21624184	SENT240	15	15	1	1	tocilizumab	IL-6	PA165292659	3569	0.736
NULL	Clin_Pharmacol_2009_Sep_7_1_1-6.nxml.txt.nlp	22291481	SENT68	1	1	28	28	fluoxetine	PDE8B	PA449673	8622	0.736
NULL	Oncotarget_2012_Aug_10_3(8)_744-758.nxml.txt.nlp	22889873	SENT85	11	11	9	9	metformin	IGF1R	PA450395	3480	0.736
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_13_2014_849783.nxml.txt.nlp	25477998	SENT84	2	2	12	12	berberine	IL-6	PA165860812	3569	0.736
NULL	Clin_Mol_Hepatol_2014_Sep_25_20(3)_283-290.nxml.txt.nlp	25320732	SENT32	25	25	21	21	propranolol	EVL	PA451145	51466	0.736
NULL	Indian_J_Psychiatry_2010_Apr-Jun_52(2)_187-190.nxml.txt.nlp	20838509	SENT136	3	3	21	21	clozapine	B12	PA449061	7126;4709	0.736
NULL	EMBO_Mol_Med_2010_May_2(5)_172-187.nxml.txt.nlp	20432503	SENT125	30	30	27	27	indomethacin	COX	PA449982	1351	0.736
NULL	Indian_J_Nephrol_2011_Oct-Dec_21(4)_258-263.nxml.txt.nlp	22022086	SENT162	14	14	3	3	cyclosporine	IL-2	PA449167	3558	0.736
NULL	Breast_Cancer_Res_2012_Feb_7_14(1)_R23.nxml.txt.nlp	22314082	SENT25	0	0	7	7	trastuzumab	San	PA451743	80218	0.736
NULL	Int_J_Mol_Sci_2014_Mar_20_15(3)_4977-4993.nxml.txt.nlp	24658441	SENT434	0	0	7	7	resveratrol	STAT3		6774	0.736
NULL	Case_Rep_Neurol_Med_2014_Mar_5_2014_164826.nxml.txt.nlp	24716014	SENT68	2	2	21	21	fluconazole	MRI	PA449653	78996	0.736
NULL	J_Viral_Hepat_2007_Nov_14(11)_788-796.nxml.txt.nlp	17927615	SENT30	19	19	17	17	ribavirin	IFN	PA451241	3439	0.736
NULL	Biochem_Res_Int_2012_Feb_12_2012_346972.nxml.txt.nlp	22400115	SENT272	3	3	0	0	hyaluronan	PI3K	PA165958431	5290	0.736
NULL	Int_J_Biol_Sci_2011_May_19_7(5)_645-650.nxml.txt.nlp	21647332	SENT87	6	6	10	10	metformin	SREBP-1c	PA450395	6720	0.736
NULL	Int_J_Biol_Sci_2015_Jan_1_11(1)_48-58.nxml.txt.nlp	25552929	SENT35	5	5	12	12	paclitaxel	TSP-1	PA450761	7057	0.736
NULL	Mol_Cancer_2012_Dec_12_11_91.nxml.txt.nlp	23234355	SENT41	14	14	26	26	trastuzumab	EGFR	PA451743	1956	0.736
NULL	Diabetes_Metab_Syndr_Obes_2010_Apr_26_3_95-112.nxml.txt.nlp	21437080	SENT177	5	5	12	12	orlistat	OTC	PA164776864	5009	0.736
NULL	Clin_Ophthalmol_2011_Apr_18_5_495-502.nxml.txt.nlp	21573098	SENT119	30	30	32	32	gatifloxacin	BAK	PA449738	578	0.736
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Mar_24_68(Pt_4)_o1180.nxml.txt.nlp	22606121	SENT63	4	4	10	10	piperazine	mol	PA450977	90527	0.736
NULL	Diabetes_2013_Mar_14_62(3)_811-824.nxml.txt.nlp	23209186	SENT328	33	33	6	6	bortezomib	BiP	PA10252	3309	0.736
NULL	Comp_Hepatol_2003_Jan_31_2_3.nxml.txt.nlp	12622871	SENT108	6	6	22	22	clofibrate	NUP475	PA449045	7538	0.736
NULL	Oncotarget_2014_Mar_16_5(12)_4087-4102.nxml.txt.nlp	24961479	SENT48	17	17	12	12	hemin	HO-1	PA449849	3162	0.736
NULL	Oncol_Lett_2014_May_11_7(5)_1401-1408.nxml.txt.nlp	24765145	SENT120	23	23	28	28	paclitaxel	PI3K	PA450761	5290	0.736
NULL	Br_J_Pharmacol_2011_Jul_163(6)_1263-1275.nxml.txt.nlp	21391977	SENT227	29	29	9	9	ketoconazole	CYP2C9	PA450146	1559	0.736
NULL	Clin_Ophthalmol_2012_Feb_20_6_277-282.nxml.txt.nlp	22375096	SENT95	13	13	26	26	ranibizumab	STA	PA164746012	2010;2656	0.736
NULL	Cancer_Cell_Int_2012_Nov_14_12_46.nxml.txt.nlp	23151005	SENT49	29	29	3	3	l-glutamine	PC-3	PA10090	692094	0.736
NULL	Breast_Cancer_Res_2007_Jul_5_9(4)_R41.nxml.txt.nlp	17612393	SENT216	25	25	18	18	celecoxib	Bcl-2	PA448871	596	0.736
NULL	Br_J_Cancer_2011_Jul_26_105(3)_407-412.nxml.txt.nlp	21730976	SENT67	19	19	30	30	pha-665752	STAT3		6774	0.736
NULL	Nat_Commun_2013_Apr_9_4_1684.nxml.txt.nlp	23575688	SENT75	5	5	22	22	roflumilast	CYLD	PA165948052	1540	0.736
NULL	J_Carcinog_2011_Jul_19_10_17.nxml.txt.nlp	21799661	SENT244	5	5	20	20	metformin	Met	PA450395	79811	0.736
NULL	Mol_Cancer_2007_Oct_22_6_66.nxml.txt.nlp	17953743	SENT136	0	0	2	2	cisplatin	TRAIL	PA449014	8743	0.736
NULL	Ann_Gastroenterol_2011_24(3)_164-172.nxml.txt.nlp	24713780	SENT86	26	26	21	21	dextran	IL-18	PA449261	3606	0.736
NULL	Front_Oncol_2014_Sep_23_4_264.nxml.txt.nlp	25295231	SENT101	11	11	4	4	lenalidomide	MDM2	PA162363968	4193	0.736
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Feb_17_68(Pt_3)_o700-o701.nxml.txt.nlp	22412590	SENT65	6	6	19	19	erythromycin	API	PA449493	5345	0.736
NULL	Ann_Gen_Psychiatry_2014_Mar_19_13_8.nxml.txt.nlp	24645830	SENT169	22	22	29	29	citalopram	STAR	PA449015	6770;2984	0.736
NULL	Br_J_Cancer_2009_Oct_20_101(8)_1253-1260.nxml.txt.nlp	19755984	SENT192	4	4	8	8	letrozole	SRC-3	PA450196	8202	0.736
NULL	Int_J_Mol_Sci_2012_Feb_1_13(2)_1512-1523.nxml.txt.nlp	22408405	SENT58	0	0	5	5	olmesartan	LOX-1	PA164742950	4973	0.736
NULL	Nat_Methods_2013_Dec_3_10(12)_10_1038_nmeth_2724.nxml.txt.nlp	24185838	SENT103	31	31	5	5	nadh	ADP	PA164755085	23038	0.736
NULL	Cell_Death_Dis_2012_Jul_19_3(7)_e353.nxml.txt.nlp	22825471	SENT124	22	22	27	27	camptothecin	DR5	PA153590860	8795	0.736
NULL	Breast_Cancer_Res_2009_Jan_16_11(1)_201.nxml.txt.nlp	19216727	SENT152	41	41	9	9	capecitabine	HER2	PA448771	2064	0.736
NULL	Front_Neurosci_2011_Jan_14_4_207.nxml.txt.nlp	21258618	SENT115	16	16	25	25	ethanol	HET	PA448073	6294	0.736
NULL	J_Korean_Med_Sci_2008_Aug_25_23(4)_598-603.nxml.txt.nlp	18756044	SENT111	32	32	28	28	paclitaxel	CRT	PA450761	811	0.736
NULL	Oncoimmunology_2012_Aug_1_1(5)_618-629.nxml.txt.nlp	22934254	SENT196	38	38	7	7	nilotinib	JNK	PA165958345	5599	0.736
NULL	J_Skin_Cancer_2013_Oct_27_2013_246848.nxml.txt.nlp	24286011	SENT100	2	2	10	10	diclofenac	p53	PA449293	7157	0.736
NULL	CNS_Neurosci_Ther_2009_Spring_15(1)_32-51.nxml.txt.nlp	19228178	SENT79	3	3	17	17	ramelteon	MT3	PA164744896	4504	0.736
NULL	Evid_Based_Complement_Alternat_Med_2011_Feb_13_2011_248481.nxml.txt.nlp	19861508	SENT154	24	24	21	21	cisplatin	ghrelin	PA449014	51738	0.736
NULL	Case_Rep_Oncol_2012_Apr_18_5(1)_181-186.nxml.txt.nlp	22666210	SENT19	4	4	32	32	lenalidomide	PC-3	PA162363968	692094	0.736
NULL	Cell_Commun_Signal_2013_Dec_23_11_100.nxml.txt.nlp	24364863	SENT173	16	16	13	13	erlotinib	EGF	PA134687924	1950	0.736
NULL	J_Anaesthesiol_Clin_Pharmacol_2012_Jan-Mar_28(1)_106-110.nxml.txt.nlp	22345956	SENT80	4	4	28	28	argatroban	ACT	PA164745516	12;11332;9457;641455	0.736
NULL	Front_Neurosci_2012_May_30_6_77.nxml.txt.nlp	22661925	SENT252	43	43	16	16	ethanol	DCX	PA448073	1641	0.736
NULL	Ann_Hematol_2012_Sep_28_91(9)_1499-1500.nxml.txt.nlp	22281990	SENT22	20	20	11	11	rituximab	CHOP	PA451261	1649	0.736
NULL	Ann_Gen_Psychiatry_2009_May_15_8_12.nxml.txt.nlp	19445674	SENT95	16	16	9	9	l-proline	PRODH	PA451125	5625	0.736
NULL	J_Radiat_Res_2014_Nov_16_55(6)_1171-1177.nxml.txt.nlp	25129557	SENT156	9	9	34	34	bevacizumab	CRT	PA130232992	811	0.736
NULL	Diabetes_2013_Sep_15_62(9)_3261-3267.nxml.txt.nlp	23775764	SENT181	15	15	6	6	rimonabant	GLP-1	PA152407999	100125288	0.736
NULL	Front_Mol_Neurosci_2012_Nov_12_5_99.nxml.txt.nlp	23162427	SENT258	20	20	11	11	cocaine	HDAC	PA449072	9734	0.736
NULL	Mol_Pain_2013_Jun_10_9_27.nxml.txt.nlp	23758830	SENT149	4	4	9	9	tetracaine	ASIC3	PA451638	9311	0.736
NULL	Arch_Med_Sci_2013_Oct_31_9(5)_936-943.nxml.txt.nlp	24273582	SENT104	21	21	8	8	nateglinide	GLP-1	PA450600	100125288	0.736
NULL	Environ_Health_Perspect_2009_Feb_8_117(2)_175-180.nxml.txt.nlp	19270784	SENT108	11	11	0	0	doxorubicin	BPA	PA449412	667	0.736
NULL	Cancers_(Basel)_2014_Sep_5_6(3)_1769-1792.nxml.txt.nlp	25198391	SENT519	0	0	8	8	irinotecan	UGT1A1	PA450085	54658	0.736
NULL	Breast_Cancer_Res_Treat_2013_Apr_12_138(2)_427-435.nxml.txt.nlp	23479422	SENT6	28	28	11	11	trastuzumab	HER2	PA451743	2064	0.736
NULL	Diabetes_Care_2010_Apr_12_33(4)_861-868.nxml.txt.nlp	20067962	SENT160	9	9	25	25	hyaluronan	TLR4	PA165958431	7099	0.736
NULL	Alcohol_Res_2012_34(3)_282-292.nxml.txt.nlp	23134044	SENT60	6	6	19	19	ethanol	adiponectin	PA448073	9370	0.736
NULL	Breast_Cancer_Res_2007_Mar_2_9(2)_205.nxml.txt.nlp	NULL	SENT88	19	19	21	21	trastuzumab	aromatase	PA451743	1588	0.736
NULL	Cell_Res_2014_Feb_12_24(2)_143-160.nxml.txt.nlp	24217768	SENT67	7	7	4	4	heparin	FGF2	PA449855	2247;2258	0.736
NULL	Clin_Genet_2011_Jun_79(6)_582-587.nxml.txt.nlp	20573158	SENT34	9	9	13	13	diazoxide	SUR1	PA449285	6833	0.736
NULL	Mol_Cancer_2010_Aug_16_9_217.nxml.txt.nlp	20712901	SENT39	3	3	7	7	curcumin	STAT3	PA151958596	6774	0.736
NULL	Int_J_Mol_Sci_2013_Apr_16_14(4)_8381-8392.nxml.txt.nlp	23591849	SENT214	23	23	13	13	efavirenz	CYP2B6	PA449441	1555	0.735
NULL	Cancer_Cell_Int_2013_Jan_15_13_3.nxml.txt.nlp	23320839	SENT16	15	15	21	21	gemcitabine	MRP3	PA449748	8714	0.735
NULL	Clin_Pharmacol_2013_Nov_19_5_167-174.nxml.txt.nlp	24277991	SENT102	10	10	29	29	berberine	P-gp	PA165860812	5243	0.735
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT49	31	31	9	9	coumarin	CYP2A6	PA134521193	1548	0.735
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_39-54.nxml.txt.nlp	19305787	SENT142	8	8	18	18	ethanol	NRSF	PA448073	5978	0.735
NULL	Front_Genet_2014_Nov_14_5_391.nxml.txt.nlp	25452763	SENT812	8	8	1	1	cisplatin	REV1	PA449014	51455	0.735
NULL	Crit_Care_2010_Mar_1_14(Suppl_1)_P83.nxml.txt.nlp	NULL	SENT3	21	21	23	23	chlorhexidine	ODC	PA164776863	4953;89874	0.735
NULL	Trials_2013_Nov_26_14_404.nxml.txt.nlp	24279904	SENT79	19	19	31	31	choline	spatial	PA448976	219793	0.735
NULL	Front_Neuroendocrinol_2012_Jan_33(1)_45-66.nxml.txt.nlp	21802439	SENT2483	1	1	10	10	vasopressin	CA2	PA451858	760	0.735
NULL	Extremophiles_2009_Nov_23_13(6)_885-894.nxml.txt.nlp	19701714	SENT138	23	23	26	26	ethanol	mol	PA448073	90527	0.735
NULL	Emerg_Infect_Dis_2014_Jul_20(7)_1140-1148.nxml.txt.nlp	24960247	SENT15	22	22	16	16	amodiaquine	IPT	PA448404	54802	0.735
NULL	Oncotarget_2013_Nov_22_5(4)_933-943.nxml.txt.nlp	24659749	SENT170	4	4	10	10	nutlin-3	p53		7157	0.735
NULL	Mol_Cell_Proteomics_2012_Feb_6_11(2)_M111_015222.nxml.txt.nlp	22147731	SENT40	22	22	14	14	gefitinib	EGF	PA131301952	1950	0.735
NULL	Oncol_Lett_2013_Mar_28_5(3)_743-748.nxml.txt.nlp	23426389	SENT86	3	3	17	17	thyroglobulin	RAI	PA164754910	10848;6050	0.735
NULL	Exp_Diabetes_Res_2011_Dec_27_2011_604989.nxml.txt.nlp	21253359	SENT98	15	15	28	28	clonidine	GLP-1	PA449051	100125288	0.735
NULL	Clin_Transl_Allergy_2013_Sep_2_3_29.nxml.txt.nlp	24004581	SENT159	17	17	8	8	omalizumab	IL-4	PA164752253	3565	0.735
NULL	Cancer_Med_2013_Aug_30_2(4)_457-467.nxml.txt.nlp	24156018	SENT148	0	0	4	4	temozolomide	MMP14	PA451609	4323	0.735
NULL	Acta_Pharmacol_Sin_2013_Mar_21_34(3)_373-379.nxml.txt.nlp	23334240	SENT144	28	28	26	26	raloxifene	CYP3A4	PA451221	1576	0.735
NULL	J_Phys_Ther_Sci_2014_May_29_26(5)_789-792.nxml.txt.nlp	24926154	SENT84	21	21	28	28	phenylephrine	p44	PA450935	10561;2966	0.735
NULL	Nat_Med_2011_Sep_11_17(10)_1235-1241.nxml.txt.nlp	21909103	SENT320	30	30	10	10	doxycycline	IL6	PA449415	3569	0.735
NULL	Exp_Hematol_Oncol_2014_Dec_17_3(1)_30.nxml.txt.nlp	NULL	SENT163	0	0	11	11	rivaroxaban	IL-10	PA165958360	3586	0.735
NULL	Biomed_Res_Int_2013_Aug_6_2013_602987.nxml.txt.nlp	24027759	SENT274	20	20	18	18	paclitaxel	SMF	PA450761	22993	0.735
NULL	Ann_Oncol_2009_Aug_20(Suppl_6)_vi35-vi40.nxml.txt.nlp	19617296	SENT112	0	0	6	6	sorafenib	Mcl-1	PA7000	4170	0.735
NULL	Gastric_Cancer_2014_Feb_28_17(1)_76-86.nxml.txt.nlp	23455716	SENT217	21	21	29	29	cisplatin	EGFR	PA449014	1956	0.735
NULL	Nat_Med_2011_Jun_26_17(7)_875-882.nxml.txt.nlp	21706030	SENT150	7	7	11	11	doxycycline	PARP-1	PA449415	25976	0.735
NULL	Gut_Liver_2013_Sep_14_7(5)_585-593.nxml.txt.nlp	24073317	SENT165	22	22	18	18	ribavirin	IFN	PA451241	3439	0.735
NULL	Br_J_Cancer_2012_Sep_4_107(6)_947-955.nxml.txt.nlp	22892392	SENT95	6	6	14	14	lapatinib	EGFR	PA152241907	1956	0.735
NULL	Br_J_Cancer_2003_Mar_24_88(6)_910-917.nxml.txt.nlp	12644829	SENT85	24	24	17	17	doxycycline	TRAIL	PA449415	8743	0.735
NULL	Int_J_Mol_Sci_2014_Oct_14_15(10)_18557-18573.nxml.txt.nlp	25318057	SENT696	0	0	14	14	doxorubicin	TRAIL	PA449412	8743	0.735
NULL	Mol_Cancer_2008_Jun_30_7_60.nxml.txt.nlp	18590557	SENT4	30	30	39	39	doxorubicin	TRAIL	PA449412	8743	0.735
NULL	Support_Care_Cancer_2009_Sep_10_17(9)_1187-1193.nxml.txt.nlp	19205754	SENT7	6	6	12	12	dolasetron	CYP2D6	PA449390	1565	0.735
NULL	Biomed_Res_Int_2013_Apr_11_2013_469363.nxml.txt.nlp	23691504	SENT52	38	38	27	27	zinc	FFR	PA451956	738	0.735
NULL	Acta_Pharmacol_Sin_2011_Jun_3_32(6)_845-852.nxml.txt.nlp	21642952	SENT90	11	11	0	0	capsaicin	TRPV1	PA448776	7442	0.735
NULL	Br_J_Cancer_2003_Mar_10_88(5)_754-759.nxml.txt.nlp	12618886	SENT16	3	3	18	18	amifostine	p53	PA448365	7157	0.735
NULL	Adv_Urol_2014_Jan_9_2014_327917.nxml.txt.nlp	24511310	SENT177	8	8	5	5	cyclophosphamide	CHOP	PA449165	1649	0.735
NULL	Ther_Clin_Risk_Manag_2006_Jun_2(2)_129-158.nxml.txt.nlp	18360588	SENT189	5	5	2	2	voriconazole	CYP3A4	PA10233	1576	0.735
NULL	Biol_Open_2014_Sep_12_3(10)_937-946.nxml.txt.nlp	25217618	SENT172	10	10	6	6	niclosamide	SOST	PA165958408	50964	0.735
NULL	Indian_J_Ophthalmol_2011_Mar-Apr_59(2)_137-141.nxml.txt.nlp	21350283	SENT204	8	8	11	11	cyanocobalamin	B12	PA451892	7126;4709	0.735
NULL	Evid_Based_Complement_Alternat_Med_2013_May_23_2013_413906.nxml.txt.nlp	23762131	SENT19	16	16	27	27	lipase	aP2	PA450239	2167	0.735
NULL	Clinics_(Sao_Paulo)_2012_Dec_67(12)_1443-1446.nxml.txt.nlp	23295599	SENT41	10	10	30	30	curcumin	p53	PA151958596	7157	0.735
NULL	Indian_J_Pharmacol_2014_Nov-Dec_46(6)_627-632.nxml.txt.nlp	25538335	SENT133	24	24	4	4	metformin	Q10	PA450395	27161	0.735
NULL	Case_Rep_Urol_2013_Feb_28_2013_387931.nxml.txt.nlp	23533928	SENT44	11	11	6	6	creatine	CD56	PA164778930	4684	0.735
NULL	Clin_Mol_Hepatol_2014_Sep_25_20(3)_283-290.nxml.txt.nlp	25320732	SENT15	22	22	24	24	propranolol	EVL	PA451145	51466	0.735
NULL	Front_Physiol_2011_Jun_30_2_33.nxml.txt.nlp	21747769	SENT292	0	0	2	2	berberine	p38	PA165860812	10598;1432;7965	0.735
NULL	Oncotarget_2012_May_19_3(5)_535-545.nxml.txt.nlp	22619121	SENT83	15	15	24	24	camptothecin	B-MYB	PA153590860	4605	0.735
NULL	Mol_Brain_2014_Apr_3_7_25.nxml.txt.nlp	24708812	SENT149	16	16	1	1	chloroquine	ERK	PA448948	5594	0.735
NULL	Front_Cell_Neurosci_2013_Dec_19_7_269.nxml.txt.nlp	24391546	SENT787	4	4	7	7	donepezil	spatial	PA449394	219793	0.735
NULL	J_Biol_Chem_2009_Apr_3_284(14)_9558-9565.nxml.txt.nlp	19202191	SENT78	3	3	9	9	camptothecin	CtIP	PA153590860	5932	0.735
NULL	Front_Syst_Neurosci_2014_Dec_22_8_238.nxml.txt.nlp	25565991	SENT322	9	9	7	7	rimonabant	CB1	PA152407999	1268	0.735
NULL	Nat_Med_2010_Sep_22_16(9)_998-1000.nxml.txt.nlp	20729864	SENT30	16	16	11	11	sorafenib	LRRK1	PA7000	79705	0.735
NULL	Biomed_Eng_Online_2012_Nov_14_11_84.nxml.txt.nlp	23151049	SENT182	23	23	26	26	ibandronate	PTH	PA10270	5741	0.735
NULL	Tumour_Biol_2014_Mar_19_35(3)_2211-2218.nxml.txt.nlp	24142530	SENT77	17	17	29	29	heparin	CD235a	PA449855	2993	0.735
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Dec_22_69(Pt_1)_o139.nxml.txt.nlp	23476395	SENT3	19	19	1	1	phenol	mol	PA450913	90527	0.735
NULL	Onco_Targets_Ther_2014_Sep_23_7_1653-1661.nxml.txt.nlp	25285015	SENT135	23	23	37	37	sn-38	UGT1A1		54658	0.735
NULL	Ann_Oncol_2013_Aug_12_24(8)_1994-1999.nxml.txt.nlp	23670096	SENT109	12	12	17	17	tamoxifen	AIB1	PA451581	8202	0.735
NULL	BMB_Rep_2014_Apr_47(4)_221-226.nxml.txt.nlp	24286312	SENT7	7	7	17	17	nutlin-3	TP53		7157	0.735
NULL	Oncol_Lett_2013_Jun_29_5(6)_1943-1947.nxml.txt.nlp	23833672	SENT150	8	8	0	0	celecoxib	PI3K	PA448871	5290	0.735
NULL	Neural_Develop_2008_May_28_3_13.nxml.txt.nlp	18507846	SENT252	19	19	32	32	papain	BIT	PA450778	140885	0.735
NULL	Genome_Biol_2011_Nov_21_12(11)_R114.nxml.txt.nlp	22104744	SENT162	27	27	44	44	nadh	S18	PA164755085	6222	0.735
NULL	Curr_Control_Trials_Cardiovasc_Med_2001_Feb_2_2(1)_20-23.nxml.txt.nlp	11806769	SENT103	10	10	28	28	dobutamine	BEST	PA449381	7439	0.735
NULL	Clinics_(Sao_Paulo)_2014_Jan_69(1)_68-74.nxml.txt.nlp	24473562	SENT115	9	9	2	2	nutlin-3	SOCS-1		8651	0.735
NULL	Cancer_Cell_Int_2004_Aug_17_4_5.nxml.txt.nlp	15315711	SENT116	24	24	13	13	genistein	PC3	PA165109660	57332;7832;5122	0.735
NULL	Diabetes_Care_2011_Jun_20_34(6)_1265-1269.nxml.txt.nlp	21515846	SENT19	7	7	0	0	ramipril	DREAM	PA451223	30818	0.735
NULL	Diabetes_Obes_Metab_2011_Nov_13(11)_982-989.nxml.txt.nlp	21615670	SENT140	16	16	19	19	exenatide	PPG	PA164749238	5552	0.735
NULL	Mol_Pain_2013_Jan_2_9_1.nxml.txt.nlp	23279936	SENT47	41	41	11	11	capsaicin	TRPV1	PA448776	7442	0.735
NULL	Oncotarget_2013_Nov_24_4(12)_2430-2438.nxml.txt.nlp	24280348	SENT128	11	11	23	23	gefitinib	EGFR	PA131301952	1956	0.735
NULL	Mol_Cancer_2010_Nov_22_9_298.nxml.txt.nlp	21092190	SENT110	16	16	11	11	gemcitabine	SRM	PA449748	6723;6725	0.735
NULL	Mol_Cancer_2010_Aug_20_9_220.nxml.txt.nlp	20727180	SENT178	14	14	17	17	nicotine	p53	PA450626	7157	0.735
NULL	Evid_Based_Complement_Alternat_Med_2012_Dec_9_2012_329171.nxml.txt.nlp	23304197	SENT41	0	0	3	3	simvastatin	MSD	PA451363	4434	0.735
NULL	J_Korean_Med_Sci_2010_Apr_19_25(4)_557-563.nxml.txt.nlp	20357998	SENT11	9	9	21	21	cisplatin	IL-10	PA449014	3586	0.735
NULL	Nat_Med_2013_Nov_27_19(11)_10_1038_nm_3352.nxml.txt.nlp	24162815	SENT134	5	5	3	3	thyroglobulin	TTF-1	PA164754910	7080	0.735
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_67-74.nxml.txt.nlp	17912637	SENT22	6	6	1	1	anastrozole	ATAC	PA448432	6375	0.735
NULL	Breast_Cancer_Res_2000_Mar_25_2(3)_176-183.nxml.txt.nlp	11250707	SENT256	14	14	6	6	cisplatin	HER-2	PA449014	2064	0.735
NULL	J_Carcinog_2011_Dec_22_10_35.nxml.txt.nlp	22279420	SENT125	13	13	20	20	tamoxifen	p53	PA451581	7157	0.735
NULL	Evid_Based_Complement_Alternat_Med_2011_Jan_9_2011_612150.nxml.txt.nlp	21274401	SENT87	33	33	15	15	warfarin	CYP3A4	PA451906	1576	0.735
NULL	Mol_Cancer_2012_Mar_21_11_13.nxml.txt.nlp	22436134	SENT253	0	0	8	8	doxorubicin	HuR	PA449412	1994	0.735
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1717-1723.nxml.txt.nlp	19844230	SENT132	5	5	23	23	sunitinib	GM-CSF	PA162372840	1437	0.735
NULL	Cancer_Cell_Int_2011_Nov_17_11_40.nxml.txt.nlp	22088142	SENT154	5	5	8	8	gefitinib	MRP1	PA131301952	4437	0.735
NULL	Autophagy_2012_May_1_8(5)_853-855.nxml.txt.nlp	22617440	SENT51	19	19	0	0	dasatinib	MIR30A	PA162372878	407029	0.735
NULL	Diabetes_2009_Jun_31_58(6)_1434-1439.nxml.txt.nlp	19336679	SENT154	9	9	15	15	metformin	SLC22A2	PA450395	6582	0.735
NULL	Oncogene_2013_Sep_12_32(37)_4355-4365.nxml.txt.nlp	23108409	SENT31	20	20	11	11	hyaluronan	p38	PA165958431	10598;1432;7965	0.735
NULL	Anal_Chem_Insights_2014_Mar_10_9_9-16.nxml.txt.nlp	24653644	SENT2	10	10	12	12	buprenorphine	BUP	PA448685	23412	0.735
NULL	Clinics_(Sao_Paulo)_2011_Apr_66(4)_673-679.nxml.txt.nlp	21655764	SENT79	9	9	31	31	estradiol	spatial	PA449503	219793	0.735
NULL	J_Korean_Neurosurg_Soc_2014_Jul_31_56(1)_1-4.nxml.txt.nlp	25289117	SENT85	11	11	32	32	curcumin	JNK	PA151958596	5599	0.735
NULL	Biochemistry_2011_May_3_50(17)_3408-3410.nxml.txt.nlp	21425834	SENT47	18	18	36	36	nadh	VDAC2	PA164755085	7417	0.735
NULL	Clin_Psychopharmacol_Neurosci_2011_Apr_30_9(1)_1-8.nxml.txt.nlp	23430384	SENT63	5	5	7	7	aripiprazole	5-HT1A	PA10026	3350	0.735
NULL	Clin_Psychopharmacol_Neurosci_2011_Apr_30_9(1)_36-43.nxml.txt.nlp	23431025	SENT85	15	15	4	4	aripiprazole	CA1	PA10026	759	0.735
NULL	J_Mol_Signal_2008_Sep_26_3_16.nxml.txt.nlp	18822127	SENT152	30	30	18	18	l-glutamine	CO2	PA10090	4513	0.735
NULL	J_Cell_Mol_Med_2014_Apr_20_18(4)_709-720.nxml.txt.nlp	24444314	SENT219	10	10	15	15	losartan	AMPK	PA450268	5563	0.735
NULL	Mol_Cancer_2010_Aug_20_9_220.nxml.txt.nlp	20727180	SENT134	23	23	16	16	nicotine	p53	PA450626	7157	0.735
NULL	Biomed_Res_Int_2014_Jan_27_2014_696107.nxml.txt.nlp	24587987	SENT41	20	20	30	30	ebselen	CO2	PA161660841	4513	0.735
NULL	BMJ_Open_2014_Feb_27_4(2)_e004071.nxml.txt.nlp	24578536	SENT163	30	30	14	14	warfarin	TTR	PA451906	7276	0.735
NULL	Pharmaceuticals_(Basel)_2013_Aug_21_6(8)_988-1038.nxml.txt.nlp	24276379	SENT1887	15	15	1	1	oxaliplatin	ERCC1	PA131285527	2067	0.735
NULL	Biosci_Rep_2014_Aug_6_34(4)_e00131.nxml.txt.nlp	24975826	SENT164	6	6	12	12	probenecid	TRPA1	PA451106	8989	0.735
NULL	Scientifica_(Cairo)_2013_Dec_12_2013_635203.nxml.txt.nlp	24416617	SENT460	18	18	27	27	dacarbazine	gp100	PA449197	6490	0.735
NULL	Mol_Cancer_2012_Dec_10_11_88.nxml.txt.nlp	23227827	SENT172	5	5	45	45	trypsin	MIA	PA451806	8190	0.735
NULL	Int_J_Chron_Obstruct_Pulmon_Dis_2007_Dec_2(4)_517-533.nxml.txt.nlp	18268925	SENT206	8	8	25	25	roflumilast	CD4	PA165948052	920	0.735
NULL	Cough_2005_Aug_4_1_2.nxml.txt.nlp	16270920	SENT83	16	16	28	28	capsaicin	TRPV1	PA448776	7442	0.735
NULL	Carcinogenesis_2010_Dec_27_31(12)_2049-2057.nxml.txt.nlp	20876285	SENT126	28	28	15	15	tamoxifen	HER2	PA451581	2064	0.735
NULL	Environ_Health_Perspect_2007_Dec_8_115(Suppl_1)_98-105.nxml.txt.nlp	18174957	SENT89	12	12	14	14	diethylstilbestrol	DES	PA449307	1674	0.735
NULL	Chin_J_Cancer_2011_Oct_30(10)_690-700.nxml.txt.nlp	21959046	SENT20	14	14	7	7	cyclophosphamide	TPT	PA449165	23590;6469	0.735
NULL	Arthritis_Res_2002_Jun_11_4(4)_R3.nxml.txt.nlp	12106502	SENT42	15	15	22	22	staurosporine	San	PA165109623	80218	0.735
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_28_2012_937605.nxml.txt.nlp	23304227	SENT117	4	4	18	18	resveratrol	GDNF		2668	0.735
NULL	Front_Immunol_2013_Nov_8_4_363.nxml.txt.nlp	24265631	SENT255	16	16	23	23	cisplatin	CXCL9	PA449014	4283	0.735
NULL	Oncol_Rep_2014_Apr_28_31(4)_1605-1612.nxml.txt.nlp	24481648	SENT129	39	39	34	34	ponatinib	MRP7	PA165980594	89845;1080	0.735
NULL	Endocrinol_Metab_(Seoul)_2014_Sep_25_29(3)_379-387.nxml.txt.nlp	25309798	SENT186	10	10	26	26	resveratrol	SIRT1		23411	0.735
NULL	Oxid_Med_Cell_Longev_2012_Jan_19_2012_390678.nxml.txt.nlp	22315655	SENT141	12	12	24	24	gliclazide	NAC	PA10892	22861	0.735
NULL	Arthritis_Res_Ther_2010_Jul_6_12(4)_R129.nxml.txt.nlp	20604932	SENT213	31	31	22	22	collagenase	CXCL10	PA449107	3627	0.735
NULL	Exp_Transl_Stroke_Med_2010_Jan_5_2_1.nxml.txt.nlp	20150990	SENT44	12	12	5	5	paraformaldehyde	CO2	PA450790	4513	0.735
NULL	Nat_Commun_2014_Apr_11_5_3687.nxml.txt.nlp	24722317	SENT165	29	29	22	22	doxycycline	P19	PA449415	51561	0.735
NULL	Mol_Cancer_2009_Aug_25_8_66.nxml.txt.nlp	19706164	SENT72	41	41	17	17	celecoxib	p53	PA448871	7157	0.735
NULL	J_Hematop_2009_Feb_28_2(2)_113-119.nxml.txt.nlp	19669197	SENT168	9	9	4	4	camptothecin	Bcl-2	PA153590860	596	0.735
NULL	J_Neurovirol_2013_Jun_4_19(4)_351-358.nxml.txt.nlp	23733308	SENT5	31	31	29	29	mefloquine	SOC	PA450348	91544	0.735
NULL	Int_J_Environ_Res_Public_Health_2013_Sep_12_10(9)_4274-4305.nxml.txt.nlp	24036486	SENT71	21	21	11	11	imipenem	HCAP	PA449968	117159;9126	0.735
NULL	Oncotarget_2014_Mar_16_5(12)_4087-4102.nxml.txt.nlp	24961479	SENT48	17	17	32	32	hemin	HO-1	PA449849	3162	0.735
NULL	Breast_Cancer_Res_Treat_2014_Feb_23_144(2)_233-239.nxml.txt.nlp	24562824	SENT218	28	28	32	32	paclitaxel	HER2	PA450761	2064	0.735
NULL	Nat_Genet_2010_Mar_14_42(3)_229-233.nxml.txt.nlp	20154675	SENT219	16	16	1	1	ethanol	TMEM127	PA448073	55654	0.735
NULL	Diabetes_Metab_Syndr_Obes_2009_May_18_2_37-49.nxml.txt.nlp	20148188	SENT89	5	5	1	1	liraglutide	GLP-1	PA165958364	100125288	0.735
NULL	J_Oncol_2009_Mar_24_2009_491985.nxml.txt.nlp	19325924	SENT173	16	16	2	2	genistein	CXCR4	PA165109660	7852	0.735
NULL	Cell_Cycle_2012_Nov_1_11(21)_3983-3996.nxml.txt.nlp	22987153	SENT7	6	6	0	0	cisplatin	DNA2	PA449014	1763	0.735
NULL	J_Clin_Biochem_Nutr_2008_May_29_42(3)_197-203.nxml.txt.nlp	18545641	SENT46	0	0	7	7	paclitaxel	JNK	PA450761	5599	0.735
NULL	Mol_Cancer_2010_Aug_20_9_220.nxml.txt.nlp	20727180	SENT200	0	0	3	3	nicotine	p53	PA450626	7157	0.735
NULL	Mol_Cancer_2013_Oct_8_12_119.nxml.txt.nlp	24103454	SENT169	30	30	28	28	irinotecan	TOP1	PA450085	7150	0.735
NULL	Int_J_Mol_Sci_2014_Mar_19_15(3)_4878-4902.nxml.txt.nlp	24651460	SENT619	11	11	13	13	staurosporine	ADP	PA165109623	23038	0.735
NULL	J_Thorac_Oncol_2015_Jan_29_10(1)_156-163.nxml.txt.nlp	25247337	SENT174	0	0	6	6	afatinib	EGFR	PA165981154	1956	0.735
NULL	J_Cell_Mol_Med_2014_Mar_22_18(3)_480-491.nxml.txt.nlp	24450440	SENT109	15	15	20	20	axitinib	EDD	PA164924493	51366	0.735
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Jul_23_6_103-113.nxml.txt.nlp	25114588	SENT5	0	0	10	10	trastuzumab	HER2	PA451743	2064	0.735
NULL	BMJ_2011_Aug_4_343_d4588.nxml.txt.nlp	21816733	SENT385	4	4	12	12	cilostazol	CYP3A5	PA164746334	1577	0.735
NULL	J_Immunol_Res_2014_Jul_16_2014_696812.nxml.txt.nlp	25133198	SENT45	18	18	5	5	rifaximin	TLR4	PA164752443	7099	0.735
NULL	Front_Neurosci_2014_Jun_3_8_128.nxml.txt.nlp	24917782	SENT17	14	14	26	26	ethanol	MC3R	PA448073	4159	0.735
NULL	Tumour_Biol_2014_Mar_20_35(3)_2191-2197.nxml.txt.nlp	24142546	SENT174	16	16	5	5	imatinib	MDR1	PA10804	5243	0.735
NULL	J_Physiol_2009_Feb_15_587(Pt_4)_731-744.nxml.txt.nlp	19074966	SENT98	8	8	14	14	taurine	PAT1	PA451590	10513;206358	0.735
NULL	Arthritis_Res_Ther_2013_Jul_9_15(4)_R73.nxml.txt.nlp	23837669	SENT305	6	6	16	16	colchicine	MSU	PA449092	593	0.735
NULL	Eur_J_Immunol_2014_Jun_10_44(6)_1759-1769.nxml.txt.nlp	24595810	SENT117	20	20	9	9	fludrocortisone	CCR7	PA164743961	1236	0.735
NULL	JAKSTAT_2012_Oct_1_1(4)_292-299.nxml.txt.nlp	24058786	SENT116	15	15	8	8	pimozide	JAK2	PA450965	3717	0.735
NULL	Anal_Bioanal_Chem_2011_Sep_14_401(4)_1109-1125.nxml.txt.nlp	21755271	SENT146	11	11	3	3	morphine	PEBP	PA450550	5037	0.735
NULL	Cerebrospinal_Fluid_Res_2006_Dec_21_3(Suppl_1)_S41.nxml.txt.nlp	NULL	SENT12	11	11	6	6	hyaluronan	OTS	PA165958431	5012	0.735
NULL	J_Korean_Med_Sci_2005_Dec_31_20(6)_1062-1065.nxml.txt.nlp	16361823	SENT89	15	15	6	6	vincristine	CHOP	PA451879	1649	0.735
NULL	Chemother_Res_Pract_2011_Sep_25_2011_730360.nxml.txt.nlp	22295205	SENT57	22	22	16	16	anastrozole	ATAC	PA448432	6375	0.735
NULL	Nat_Commun_2014_Nov_25_5_5548.nxml.txt.nlp	25420520	SENT15	10	10	1	1	docetaxel	ERG	PA449383	2078	0.735
NULL	Int_J_Environ_Res_Public_Health_2011_Jul_21_8(7)_3019-3031.nxml.txt.nlp	21845171	SENT137	18	18	21	21	ethanol	adiponectin	PA448073	9370	0.735
NULL	Breast_Cancer_Res_2014_Jul_29_16(4)_412.nxml.txt.nlp	25410383	SENT329	6	6	22	22	vorinostat	Hsp90	PA164748224	3320	0.735
NULL	Diabetologia_2010_Jun_27_53(6)_1142-1150.nxml.txt.nlp	20349036	SENT10	25	25	32	32	spermine	GMP	PA164781199	22978	0.735
NULL	Ann_Gastroenterol_2012_25(3)_207-217.nxml.txt.nlp	24713803	SENT236	5	5	8	8	exenatide	GLP-1	PA164749238	100125288	0.735
NULL	Cancer_Med_2014_Apr_7_3(2)_362-375.nxml.txt.nlp	24515916	SENT348	10	10	19	19	zoledronate	IL-2	PA10235	3558	0.735
NULL	J_Korean_Med_Sci_2013_Aug_31_28(8)_1213-1219.nxml.txt.nlp	23960450	SENT8	24	24	15	15	ribavirin	ITPA	PA451241	3704	0.735
NULL	Br_J_Cancer_1998_Nov_78(9)_1170-1174.nxml.txt.nlp	9820175	SENT13	24	24	21	21	coumarin	CYP1A2	PA134521193	1544	0.735
NULL	Clinics_(Sao_Paulo)_2010_Aug_65(8)_803b-807.nxml.txt.nlp	20835559	SENT73	11	11	30	30	estradiol	spatial	PA449503	219793	0.735
NULL	Aging_(Albany_NY)_2012_Mar_4_4(3)_144-145.nxml.txt.nlp	22388573	SENT9	8	8	15	15	resveratrol	AMPK		5563	0.735
NULL	Paediatr_Drugs_2014_Feb_27_16(3)_199-211.nxml.txt.nlp	24574047	SENT235	37	37	34	34	doxylamine	OTC	PA449419	5009	0.735
NULL	ScientificWorldJournal_2012_Dec_17_2012_916381.nxml.txt.nlp	23319889	SENT188	14	14	25	25	ceftriaxone	CTX	PA448866	1593	0.735
NULL	J_Med_Case_Reports_2011_Jul_7_5_292.nxml.txt.nlp	21733193	SENT83	36	36	29	29	vancomycin	VISA	PA451850	57506	0.735
NULL	Br_J_Clin_Pharmacol_2011_Oct_72(4)_647-657.nxml.txt.nlp	21518389	SENT213	14	14	18	18	cangrelor	P2Y12	PA165945763	64805	0.735
NULL	J_Adv_Pharm_Technol_Res_2011_Jan-Mar_2(1)_51-55.nxml.txt.nlp	22171293	SENT98	3	3	9	9	metformin	mol	PA450395	90527	0.735
NULL	Oncogene_2014_Oct_23_33(43)_5109-5120.nxml.txt.nlp	24858043	SENT82	25	25	13	13	pp2	MCT-1		28985	0.735
NULL	Mol_Neurobiol_2009_Aug_19_40(1)_55-72.nxml.txt.nlp	19452287	SENT352	30	30	4	4	lovastatin	adrenoleukodystrophy	PA450272	215	0.735
NULL	J_Breast_Cancer_2012_Mar_28_15(1)_71-78.nxml.txt.nlp	22493631	SENT125	0	0	13	13	trastuzumab	HER2	PA451743	2064	0.735
NULL	F1000Res_2013_Feb_28_2_65.nxml.txt.nlp	24358861	SENT58	12	12	26	26	naloxone	TLR4	PA450586	7099	0.735
NULL	Ann_Oncol_2011_Mar_8_22(3)_503-514.nxml.txt.nlp	20616198	SENT55	7	7	20	20	anastrozole	aromatase	PA448432	1588	0.735
NULL	Orphanet_J_Rare_Dis_2013_Sep_13_8_142.nxml.txt.nlp	24034279	SENT141	19	19	11	11	metoclopramide	ACTH	PA450475	5443	0.735
NULL	Eur_J_Clin_Pharmacol_2011_Dec_23_67(12)_1231-1241.nxml.txt.nlp	21698374	SENT185	8	8	14	14	tacrolimus	ABCB1	PA451578	5243	0.735
NULL	Exp_Ther_Med_2013_Nov_13_6(5)_1194-1198.nxml.txt.nlp	24223643	SENT146	10	10	5	5	tocilizumab	IL-6	PA165292659	3569	0.735
NULL	Cell_Commun_Signal_2013_Oct_1_11_73.nxml.txt.nlp	24083678	SENT212	8	8	14	14	sulindac	AP-1	PA451565	2353;3727;2354;3725	0.735
NULL	Breast_Cancer_Res_2011_Jun_7_13(3)_R62.nxml.txt.nlp	21672245	SENT22	6	6	15	15	trastuzumab	HER2	PA451743	2064	0.735
NULL	Exp_Hematol_Oncol_2013_Aug_8_2_22.nxml.txt.nlp	23927433	SENT65	6	6	24	24	tacrolimus	BRAF	PA451578	673	0.735
NULL	J_Korean_Med_Sci_2010_Jun_24_25(6)_829-834.nxml.txt.nlp	20514301	SENT107	4	4	8	8	papain	JNK	PA450778	5599	0.735
NULL	Mol_Med_Rep_2015_Feb_29_11(2)_924-930.nxml.txt.nlp	25351620	SENT47	17	17	33	33	streptomycin	CO2	PA451512	4513	0.735
NULL	Int_J_Inflam_2010_Aug_9_2010_151097.nxml.txt.nlp	21152121	SENT373	36	36	21	21	thrombin	C3a	PA451674	718	0.735
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jul_31_66(Pt_8)_o2157.nxml.txt.nlp	21588441	SENT47	8	8	18	18	benzaldehyde	mol	PA448571	90527	0.735
NULL	Br_J_Cancer_2011_Apr_12_104(8)_1278-1287.nxml.txt.nlp	21487429	SENT35	9	9	31	31	cisplatin	p53	PA449014	7157	0.735
NULL	J_Mol_Signal_2010_May_10_5_4.nxml.txt.nlp	20459745	SENT33	5	5	12	12	cisplatin	p53	PA449014	7157	0.735
NULL	Drugs_Context_2012_Nov_19_2012_212242.nxml.txt.nlp	24432031	SENT128	10	10	15	15	vinblastine	IL-2	PA451877	3558	0.735
NULL	Clin_Epidemiol_2010_Aug_9_2_145-151.nxml.txt.nlp	20865112	SENT68	6	6	13	13	raltegravir	CD4		920	0.735
NULL	Biologics_2009_Oct_12_3_469-474.nxml.txt.nlp	19851472	SENT83	19	19	10	10	montelukast	IL-4	PA450546	3565	0.735
NULL	Eur_J_Med_Res_2009_Dec_7_14(Suppl_4)_71-77.nxml.txt.nlp	20156730	SENT150	21	21	1	1	tobramycin	gamma	PA451704	9913	0.735
NULL	Arthritis_Res_Ther_2011_Feb_16_13(1)_R25.nxml.txt.nlp	21324169	SENT140	46	46	26	26	abatacept	TNF	PA164747080	7124	0.735
NULL	Iran_J_Pharm_Res_2014_Spring_13(2)_583-590.nxml.txt.nlp	25237354	SENT28	11	11	19	19	enoxaparin	IL-6	PA449463	3569	0.735
NULL	J_Gen_Physiol_1997_Feb_1_109(2)_229-243.nxml.txt.nlp	9041451	SENT16	13	13	6	6	spermine	IRK1	PA164781199	3759	0.735
NULL	Diabetes_2009_Apr_9_58(4)_965-974.nxml.txt.nlp	19136651	SENT38	1	1	5	5	nadh	AMPK	PA164755085	5563	0.735
NULL	Environ_Health_Perspect_1983_Apr_50_227-232.nxml.txt.nlp	6873015	SENT2	3	3	5	5	diethylstilbestrol	DES	PA449307	1674	0.735
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT371	0	0	18	18	cisplatin	PUMA	PA449014	27113	0.735
NULL	Drugs_Context_2013_Aug_21_2013_212256.nxml.txt.nlp	24432043	SENT37	0	0	19	19	metformin	GLP-1	PA450395	100125288	0.735
NULL	Diabetes_Care_2013_Aug_17_36(Suppl_2)_S127-S138.nxml.txt.nlp	23882037	SENT387	8	8	14	14	metformin	GLP-1	PA450395	100125288	0.735
NULL	J_Cell_Biol_2001_Apr_2_153(1)_207-220.nxml.txt.nlp	11285286	SENT123	0	0	13	13	carbachol	DAG	PA448784	1605	0.735
NULL	Environ_Health_Perspect_2006_Sep_23_114(9)_1401-1406.nxml.txt.nlp	16966095	SENT247	0	0	7	7	arsenite	p53	PA452638	7157	0.735
NULL	J_Cardiovasc_Dis_Res_2012_Oct-Dec_3(4)_319-322.nxml.txt.nlp	23233778	SENT64	27	27	2	2	simvastatin	SHARP	PA451363	23013	0.735
NULL	Breast_Cancer_Res_2008_Dec_16_10(6)_R105.nxml.txt.nlp	19087274	SENT40	22	22	4	4	fulvestrant	MEK5	PA164747170	5607	0.735
NULL	Diabetes_Care_2010_May_15_33(5)_1134-1139.nxml.txt.nlp	20185740	SENT178	35	35	18	18	ezetimibe	IL-6	PA10816	3569	0.735
NULL	Clin_Ophthalmol_2012_Feb_20_6_277-282.nxml.txt.nlp	22375096	SENT17	16	16	8	8	triamcinolone	STA	PA451749	2010;2656	0.735
NULL	Gene_Ther_2010_Aug_1_17(8)_1042-1051.nxml.txt.nlp	20596059	SENT19	0	0	9	9	bevacizumab	VEGF-A	PA130232992	7422	0.735
NULL	Breast_Cancer_Res_2010_Oct_14_12(5)_R84.nxml.txt.nlp	20946630	SENT269	15	15	12	12	choline	SLC5A7	PA448976	60482	0.735
NULL	Oncol_Lett_2014_Jun_8_7(6)_1903-1910.nxml.txt.nlp	24932256	SENT153	10	10	37	37	cisplatin	DRAM1	PA449014	55332	0.735
NULL	BMJ_Open_2012_Sep_15_2(5)_e001260.nxml.txt.nlp	22983874	SENT206	17	17	32	32	propiomazine	OTC	PA164778685	5009	0.735
NULL	Open_Allergy_J_2010_3_91-101.nxml.txt.nlp	25018787	SENT184	33	33	20	20	omalizumab	IL-13	PA164752253	3596	0.735
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_21-38.nxml.txt.nlp	19305786	SENT348	2	2	19	19	menthol	TRPV3	PA164776605	162514	0.735
NULL	Pharmaceuticals_(Basel)_2011_Nov_10_4(11)_1488-1502.nxml.txt.nlp	NULL	SENT347	5	5	3	3	geldanamycin	Raf-1	PA152031327	5894	0.734
NULL	Clin_Exp_Otorhinolaryngol_2012_Sep_27_5(3)_117-121.nxml.txt.nlp	22977707	SENT28	22	22	12	12	kanamycin	KCC2	PA450137	57468	0.734
NULL	Mol_Cancer_2010_Jun_27_9_168.nxml.txt.nlp	20579391	SENT70	10	10	22	22	dasatinib	TEC	PA162372878	7006	0.734
NULL	Anal_Bioanal_Chem_2014_Jan_23_406(15)_3667-3680.nxml.txt.nlp	24452745	SENT189	4	4	9	9	ketoprofen	KET	PA450149	8626	0.734
NULL	Cases_J_2009_Apr_28_2_7081.nxml.txt.nlp	19829905	SENT116	7	7	27	27	azathioprine	CHOP	PA448515	1649	0.734
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Nov_13_64(Pt_12)_o2365.nxml.txt.nlp	21581337	SENT3	38	38	9	9	ethanol	PF6	PA448073	200162	0.734
NULL	Springerplus_2015_Jan_23_4_29.nxml.txt.nlp	25628986	SENT3	5	5	22	22	dapsone	G6PD	PA449211	2539	0.734
NULL	J_Cell_Mol_Med_2014_Mar_10_18(3)_514-529.nxml.txt.nlp	24410795	SENT198	28	28	31	31	resveratrol	SIRT1		23411	0.734
NULL	Br_J_Cancer_2009_Mar_24_100(6)_950-958.nxml.txt.nlp	19293809	SENT3	8	8	19	19	cetuximab	EGFR	PA10040	1956	0.734
NULL	Diabetologia_2009_Oct_14_52(10)_2046-2055.nxml.txt.nlp	19688338	SENT201	18	18	16	16	exenatide	GLP-1	PA164749238	100125288	0.734
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT110	17	17	15	15	capsaicin	p53	PA448776	7157	0.734
NULL	Front_Oncol_2014_Apr_9_4_75.nxml.txt.nlp	24782986	SENT50	14	14	19	19	paclitaxel	Oct4	PA450761	5460	0.734
NULL	Oncogene_2010_Oct_21_29(42)_5700-5711.nxml.txt.nlp	20676140	SENT110	13	13	18	18	doxorubicin	p53	PA449412	7157	0.734
NULL	J_Gynecol_Oncol_2013_Apr_5_24(2)_177-185.nxml.txt.nlp	23653836	SENT192	13	13	40	40	mesna	AMH	PA450385	268	0.734
NULL	Biomed_Res_Int_2014_Jan_20_2014_948427.nxml.txt.nlp	24563867	SENT163	17	17	21	21	urea	STZ	PA451831	6484	0.734
NULL	Biochem_Biophys_Res_Commun_2009_Apr_17_381(4)_523-527.nxml.txt.nlp	19239903	SENT313	33	33	14	14	betaine	B12	PA448603	7126;4709	0.734
NULL	J_Sens_Technol_2013_Sep_3(3)_10_4236_jst_2013_33015.nxml.txt.nlp	24409399	SENT140	9	9	41	41	ketamine	DC2	PA450144	58505	0.734
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_May_14_65(Pt_6)_o1257.nxml.txt.nlp	21583122	SENT58	18	18	21	21	isoniazid	mol	PA450112	90527	0.734
NULL	Curr_Oncol_2006_Feb_13(1)_14-26.nxml.txt.nlp	17576437	SENT385	37	37	18	18	paclitaxel	HER-2	PA450761	2064	0.734
NULL	Acta_Pharmacol_Sin_2012_Jan_28_33(1)_75-81.nxml.txt.nlp	22120969	SENT96	9	9	29	29	sitagliptin	GLP-1	PA164748978	100125288	0.734
NULL	Indian_J_Endocrinol_Metab_2012_Dec_16(Suppl_2)_S252-S255.nxml.txt.nlp	23565392	SENT17	13	13	10	10	bromocriptine	GLP-1	PA448671	100125288	0.734
NULL	Cancer_Cell_Int_2014_Jun_16_14_53.nxml.txt.nlp	24966801	SENT231	6	6	24	24	metformin	p62	PA450395	8878;10657;23636	0.734
NULL	Oncoscience_2014_Mar_16_1(2)_132-157.nxml.txt.nlp	25594007	SENT413	23	23	7	7	cetuximab	EGFR	PA10040	1956	0.734
NULL	J_Biol_Eng_2010_Nov_29_4_15.nxml.txt.nlp	21114841	SENT211	24	24	16	16	indomethacin	CLB	PA449982	171425	0.734
NULL	Oncotarget_2012_Oct_3_3(10)_1182-1193.nxml.txt.nlp	23045412	SENT158	19	19	22	22	imatinib	p53	PA10804	7157	0.734
NULL	J_Hum_Genet_2013_Jun_16_58(6)_353-361.nxml.txt.nlp	23677058	SENT166	9	9	18	18	cytarabine	RRM2	PA449177	6241	0.734
NULL	Adv_Ther_2014_Feb_15_31(3)_289-317.nxml.txt.nlp	24535623	SENT346	27	27	6	6	rosiglitazone	GLP-1	PA451283	100125288	0.734
NULL	Hum_Genomics_2013_Apr_5_7(1)_10.nxml.txt.nlp	23561625	SENT144	16	16	6	6	flavopiridol	CDK7	PA452627	1022	0.734
NULL	Open_Cardiovasc_Med_J_2010_Feb_23_4_71-77.nxml.txt.nlp	20360979	SENT144	10	10	5	5	warfarin	TAFI	PA451906	1361	0.734
NULL	ScientificWorldJournal_2013_Oct_1_2013_654829.nxml.txt.nlp	24198725	SENT279	26	26	17	17	naproxen	NF2	PA450595	4771	0.734
NULL	Breast_Cancer_Res_2000_Mar_12_2(Suppl_1)_P4_03.nxml.txt.nlp	NULL	SENT3	33	33	15	15	neomycin	BRCA1	PA450608	672	0.734
NULL	Neuropsychopharmacology_2011_Apr_2_36(5)_1033-1046.nxml.txt.nlp	21289603	SENT190	8	8	14	14	ethanol	MSN	PA448073	4478	0.734
NULL	Diabetes_Metab_J_2012_Aug_20_36(4)_293-299.nxml.txt.nlp	22950061	SENT111	3	3	12	12	metformin	NPY	PA450395	4852	0.734
NULL	Curr_Oncol_2009_Jan_16(1)_27-48.nxml.txt.nlp	19229369	SENT264	13	13	28	28	erlotinib	KRAS	PA134687924	3845	0.734
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT303	3	3	19	19	pertuzumab	HER3		2065	0.734
NULL	Virol_J_2010_Oct_22_7_280.nxml.txt.nlp	20969781	SENT133	29	29	34	34	l-glutamine	IL-2	PA10090	3558	0.734
NULL	Brain_Sci_2013_Jun_3_3(2)_877-907.nxml.txt.nlp	24961429	SENT174	0	0	22	22	taurine	CHOP	PA451590	1649	0.734
NULL	Proteome_Sci_2009_Jan_7_7_1.nxml.txt.nlp	19126242	SENT38	4	4	12	12	trypsin	San	PA451806	80218	0.734
NULL	J_Biomed_Sci_2014_Feb_3_21(1)_10.nxml.txt.nlp	24490900	SENT95	10	10	15	15	alendronate	CTR	PA448082	799	0.734
NULL	Eur_J_Clin_Pharmacol_2011_Dec_23_67(12)_1231-1241.nxml.txt.nlp	21698374	SENT43	25	25	18	18	tacrolimus	ABCB1	PA451578	5243	0.734
NULL	J_Clin_Biochem_Nutr_2007_Jul_27_41(1)_58-67.nxml.txt.nlp	18392099	SENT4	36	36	38	38	streptozocin	STZ	PA451514	6484	0.734
NULL	Breast_Cancer_Res_2011_Nov_28_13(6)_R121.nxml.txt.nlp	22123186	SENT208	21	21	7	7	lapatinib	HER2	PA152241907	2064	0.734
NULL	Appl_Microbiol_Biotechnol_2013_Aug_16_97(15)_6919-6930.nxml.txt.nlp	23677441	SENT127	40	40	18	18	ethanol	FAN	PA448073	8439	0.734
NULL	Pediatr_Nephrol_2008_Mar_19_23(3)_413-419.nxml.txt.nlp	18097688	SENT130	15	15	6	6	cyclophosphamide	gamma	PA449165	9913	0.734
NULL	Oncol_Lett_2013_Apr_22_5(4)_1093-1100.nxml.txt.nlp	23599746	SENT221	39	39	26	26	tamoxifen	MDR1	PA451581	5243	0.734
NULL	J_Lipid_Res_2014_Aug_55(8)_1657-1667.nxml.txt.nlp	24879802	SENT36	19	19	31	31	rosiglitazone	CYP2C	PA451283	1562	0.734
NULL	Crit_Care_2007_Mar_22_11(Suppl_2)_P101.nxml.txt.nlp	NULL	SENT10	4	4	21	21	gentamicin	TBC	PA449753	23216	0.734
NULL	Eur_J_Clin_Pharmacol_2010_Nov_29_66(11)_1131-1136.nxml.txt.nlp	20669013	SENT137	10	10	16	16	voriconazole	CYP3A4	PA10233	1576	0.734
NULL	Cancer_Cell_Int_2005_Aug_23_5_27.nxml.txt.nlp	16117829	SENT135	10	10	15	15	neomycin	p53	PA450608	7157	0.734
NULL	J_Thromb_Thrombolysis_2013_Jul_17_36(1)_31-41.nxml.txt.nlp	23073747	SENT207	35	35	27	27	bivalirudin	AIDA	PA10032	64853	0.734
NULL	Nature_2012_Aug_16_488(7411)_394-398.nxml.txt.nlp	22810587	SENT186	21	21	19	19	candesartan	AT-1	PA448765	9197	0.734
NULL	Oncol_Lett_2013_Apr_25_5(4)_1261-1265.nxml.txt.nlp	23599776	SENT47	30	30	8	8	paraformaldehyde	MDC	PA450790	6367	0.734
NULL	Oncotarget_2011_Aug_28_2(8)_588-589.nxml.txt.nlp	21876228	SENT16	19	19	6	6	sunitinib	HER2	PA162372840	2064	0.734
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Jun_8_69(Pt_7)_o1056.nxml.txt.nlp	24046630	SENT69	8	8	18	18	phenol	mol	PA450913	90527	0.734
NULL	Mol_Biol_Int_2014_Sep_7_2014_852748.nxml.txt.nlp	25276427	SENT173	7	7	18	18	trastuzumab	DM1	PA451743	338023;1760;28509	0.734
NULL	Iran_J_Pharm_Res_2014_Summer_13(3)_919-926.nxml.txt.nlp	25276192	SENT123	13	13	30	30	doxorubicin	p53	PA449412	7157	0.734
NULL	Sensors_(Basel)_2012_Feb_1_12(2)_1383-1397.nxml.txt.nlp	22438715	SENT32	31	31	35	35	l-glutamine	EGF	PA10090	1950	0.734
NULL	Breast_Cancer_(Auckl)_2014_Mar_23_8_51-56.nxml.txt.nlp	24678242	SENT21	5	5	3	3	carboplatin	BRCA1	PA448803	672	0.734
NULL	Cell_Tissue_Res_2014_Apr_18_357(1)_279-299.nxml.txt.nlp	24744264	SENT171	23	23	34	34	cyclophosphamide	ANOVA	PA449165	4858	0.734
NULL	Asian_J_Androl_2015_Aug_29_Jan-Feb_17(1)_32-39.nxml.txt.nlp	25219908	SENT157	17	17	0	0	vardenafil	Men	PA10229	8178	0.734
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_3_2014_473213.nxml.txt.nlp	25538791	SENT129	5	5	13	13	ethanol	P-gp	PA448073	5243	0.734
NULL	Endocrinol_Metab_(Seoul)_2013_Dec_12_28(4)_262-274.nxml.txt.nlp	24396690	SENT164	9	9	31	31	exenatide	GLP-1	PA164749238	100125288	0.734
NULL	Oxid_Med_Cell_Longev_2012_Aug_22_2012_534705.nxml.txt.nlp	22966415	SENT321	21	21	3	3	riluzole	GLAST	PA451251	6507	0.734
NULL	Evid_Based_Complement_Alternat_Med_2013_Aug_6_2013_560274.nxml.txt.nlp	23986783	SENT14	8	8	24	24	resveratrol	p53		7157	0.734
NULL	Cases_J_2008_Sep_30_1_195.nxml.txt.nlp	18826630	SENT25	25	25	15	15	olanzapine	hang	PA450688	374879	0.734
NULL	Curr_Neuropharmacol_2010_Dec_8(4)_409-421.nxml.txt.nlp	21629447	SENT177	13	13	9	9	diazepam	CLB	PA449283	171425	0.734
NULL	Environ_Health_Perspect_2005_Oct_14_113(10)_1330-1335.nxml.txt.nlp	16203242	SENT112	22	22	12	12	arsenite	MLC	PA452638	23209	0.734
NULL	Genome_Med_2010_Jun_14_2(6)_37.nxml.txt.nlp	20546595	SENT242	41	41	37	37	tamoxifen	ERBB2	PA451581	2064	0.734
NULL	Am_J_Trop_Med_Hyg_2012_Aug_1_87(2)_231-241.nxml.txt.nlp	22855752	SENT42	9	9	12	12	artemisinin	ACT	PA165111696	12;11332;9457;641455	0.734
NULL	J_Breast_Cancer_2011_Jun_18_14(2)_129-134.nxml.txt.nlp	21847408	SENT128	6	6	18	18	docetaxel	B27	PA449383	56246	0.734
NULL	Cancer_Cell_Int_2004_May_17_4_4.nxml.txt.nlp	15147581	SENT184	6	6	29	29	sulindac	EGF	PA451565	1950	0.734
NULL	Diabetes_Metab_Syndr_Obes_2010_Jul_9_3_227-242.nxml.txt.nlp	21437091	SENT190	10	10	4	4	exenatide	GLP-1	PA164749238	100125288	0.734
NULL	Nat_Med_2013_Feb_6_19(2)_217-226.nxml.txt.nlp	23291629	SENT358	17	17	19	19	forskolin	HSL	PA146096022	3991	0.734
NULL	Biomed_Res_Int_2013_Sep_5_2013_731516.nxml.txt.nlp	24083239	SENT81	32	32	24	24	ribavirin	IFN	PA451241	3439	0.734
NULL	Int_J_Mol_Sci_2014_Nov_25_15(12)_21703-21722.nxml.txt.nlp	25429431	SENT148	8	8	25	25	curcumin	IL-6	PA151958596	3569	0.734
NULL	Br_J_Clin_Pharmacol_2014_Nov_20_78(5)_1050-1057.nxml.txt.nlp	24962564	SENT37	21	21	18	18	ketoconazole	CYP3A4	PA450146	1576	0.734
NULL	Mol_Brain_2013_Dec_16_6_56.nxml.txt.nlp	24330819	SENT205	6	6	17	17	dantrolene	c-fos	PA449208	2353	0.734
NULL	J_Korean_Med_Sci_2005_Oct_31_20(5)_883-885.nxml.txt.nlp	16224167	SENT15	27	27	33	33	dapsone	gamma	PA449211	9913	0.734
NULL	J_Gen_Physiol_2004_Apr_123(4)_427-439.nxml.txt.nlp	15024039	SENT490	12	12	14	14	genistein	PP2	PA165109660	4888	0.734
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_P8.nxml.txt.nlp	NULL	SENT14	19	19	17	17	triamcinolone	DPT	PA451749	1805	0.734
NULL	Acta_Pharmacol_Sin_2012_Jul_18_33(7)_861-872.nxml.txt.nlp	22705730	SENT126	13	13	16	16	atorvastatin	PDK1	PA448500	5170;5163	0.734
NULL	Allergy_Asthma_Immunol_Res_2010_Jul_19_2(3)_177-182.nxml.txt.nlp	20592916	SENT93	12	12	3	3	montelukast	IL-13	PA450546	3596	0.734
NULL	Parasit_Vectors_2011_Aug_24_4_164.nxml.txt.nlp	21864384	SENT77	14	14	3	3	artesunate	LAMP	PA165111697	4045;27074	0.734
NULL	Diagn_Pathol_2006_Aug_15_1_19.nxml.txt.nlp	16911776	SENT186	46	46	26	26	erlotinib	EGFR	PA134687924	1956	0.734
NULL	Contemp_Oncol_(Pozn)_2012_Nov_20_16(5)_401-406.nxml.txt.nlp	23788917	SENT59	22	22	12	12	afatinib	EGFR	PA165981154	1956	0.734
NULL	Cell_Commun_Signal_2013_May_29_11_38.nxml.txt.nlp	23718910	SENT186	11	11	24	24	pp2	PP2		4888	0.734
NULL	J_Asthma_Allergy_2013_Jun_6_6_69-80.nxml.txt.nlp	23776339	SENT131	4	4	36	36	ciclesonide	ACT	PA164781399	12;11332;9457;641455	0.734
NULL	Clin_Pharmacokinet_2014_Jul_24_53(1)_73-87.nxml.txt.nlp	23881596	SENT240	11	11	27	27	rosuvastatin	OATP1B3	PA134308647	28234	0.734
NULL	Cell_Death_Dis_2010_Oct_21_1(10)_e86.nxml.txt.nlp	21368859	SENT49	11	11	9	9	doxorubicin	TRAIL	PA449412	8743	0.734
NULL	Front_Oncol_2014_Sep_11_4_245.nxml.txt.nlp	25309871	SENT43	0	0	22	22	thrombin	PAR1	PA451674	79581;2149	0.734
NULL	J_Epilepsy_Res_2014_Jun_30_4(1)_7-13.nxml.txt.nlp	24977124	SENT72	22	22	14	14	pilocarpine	CA1	PA450962	759	0.734
NULL	Curr_Cardiol_Rev_2012_May_8(2)_158-165.nxml.txt.nlp	22708914	SENT134	17	17	22	22	enoxaparin	TKR	PA449463	8277	0.734
NULL	J_Cell_Biol_1994_Dec_2_127(6)_1717-1727.nxml.txt.nlp	7798322	SENT4	19	19	8	8	collagenase	c-myb	PA449107	4602	0.734
NULL	Leukemia_2014_Jun_17_28(6)_1216-1226.nxml.txt.nlp	24301524	SENT87	3	3	10	10	bortezomib	HDAC1	PA10252	3065	0.734
NULL	Ann_Clin_Transl_Neurol_2014_Dec_21_1(12)_996-1005.nxml.txt.nlp	25574474	SENT122	9	9	31	31	riluzole	P-gp	PA451251	5243	0.734
NULL	Diabetes_Care_2009_Apr_8_32(4)_720-725.nxml.txt.nlp	19131464	SENT56	25	25	1	1	metformin	ACR	PA450395	49	0.734
NULL	Int_J_Mol_Sci_2014_Oct_20_15(10)_18856-18891.nxml.txt.nlp	25334061	SENT768	1	1	3	3	arsenite	HIF-1	PA452638	29072	0.734
NULL	Lab_Invest_2012_Dec_8_92(12)_1749-1759.nxml.txt.nlp	23044923	SENT7	27	27	11	11	dextran	MMP10	PA449261	4319	0.734
NULL	Cells_2014_May_23_3(2)_517-545.nxml.txt.nlp	24861977	SENT302	8	8	5	5	capsaicin	TRPV1	PA448776	7442	0.734
NULL	Int_J_Nanomedicine_2012_May_7_7_2307-2314.nxml.txt.nlp	22661887	SENT171	5	5	2	2	gemcitabine	F10	PA449748	2159	0.734
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT118	12	12	8	8	trastuzumab	STAT3	PA451743	6774	0.734
NULL	Nat_Med_2013_Mar_10_19(3)_313-321.nxml.txt.nlp	23396211	SENT433	17	17	6	6	amlexanox	UCP1	PA164745310	7350	0.734
NULL	Protein_Cell_2014_Jun_19_5(6)_469-479.nxml.txt.nlp	24748116	SENT145	20	20	9	9	paclitaxel	EB1	PA450761	9167;22919;10982	0.734
NULL	J_Radiat_Res_2014_Nov_16_55(6)_1171-1177.nxml.txt.nlp	25129557	SENT42	6	6	9	9	bevacizumab	CRT	PA130232992	811	0.734
NULL	Hum_Genomics_2013_Oct_30_7(1)_22.nxml.txt.nlp	24172014	SENT207	13	13	0	0	thrombin	SERPINE1	PA451674	5054	0.734
NULL	Hum_Mol_Genet_2013_Nov_15_22(22)_4616-4626.nxml.txt.nlp	23814041	SENT89	9	9	15	15	doxycycline	gp78	PA449415	267	0.734
NULL	Cancers_(Basel)_2014_Jul_7_6(3)_1441-1463.nxml.txt.nlp	25003395	SENT1161	7	7	5	5	cisplatin	FOXO1	PA449014	2308	0.734
NULL	Clin_Microbiol_Infect_2014_Jun_21_20(6)_536-541.nxml.txt.nlp	24107197	SENT41	24	24	11	11	isoniazid	DST	PA450112	667	0.734
NULL	Cancer_Med_2013_Aug_10_2(4)_496-506.nxml.txt.nlp	24156022	SENT260	15	15	19	19	cetuximab	KRAS	PA10040	3845	0.734
NULL	Cancer_Metab_2014_May_28_2(Suppl_1)_P65.nxml.txt.nlp	NULL	SENT27	11	11	19	19	resveratrol	SIRT1		23411	0.734
NULL	Cell_Death_Dis_2013_Oct_3_4(10)_e828.nxml.txt.nlp	24091671	SENT75	42	42	27	27	oxaliplatin	CD44	PA131285527	960	0.734
NULL	Braz_J_Med_Biol_Res_2011_Nov_18_45(1)_86-92.nxml.txt.nlp	22086466	SENT45	24	24	32	32	cisplatin	ADM	PA449014	133	0.734
NULL	Mol_Biol_Cell_2012_Sep_1_23(17)_3473-3484.nxml.txt.nlp	22787275	SENT192	13	13	24	24	doxorubicin	ABCC1	PA449412	4363	0.734
NULL	Eur_J_Clin_Pharmacol_2012_Jan_8_68(1)_29-37.nxml.txt.nlp	21739267	SENT109	17	17	9	9	fluvoxamine	CYP2D6	PA449690	1565	0.734
NULL	Indian_J_Endocrinol_Metab_2012_Dec_16(Suppl_2)_S245-S247.nxml.txt.nlp	23565390	SENT47	14	14	33	33	glipizide	DPP4	PA449762	1803	0.734
NULL	Patient_Prefer_Adherence_2014_Apr_8_8_463-471.nxml.txt.nlp	24748775	SENT93	30	30	0	0	denosumab	BMD	PA166048634	1756;7439	0.734
NULL	Cancer_Imaging_2005_Nov_23_5(Spec_No_A)_S27-S32.nxml.txt.nlp	16361133	SENT162	5	5	9	9	trastuzumab	HER2	PA451743	2064	0.734
NULL	Case_Rep_Transplant_2011_Jan_5_2011_210178.nxml.txt.nlp	23213600	SENT110	14	14	8	8	lansoprazole	CYP2C19	PA450180	1557	0.734
NULL	Curr_Neuropharmacol_2012_Jun_10(2)_97-123.nxml.txt.nlp	23204981	SENT857	37	37	23	23	clotrimazole	CXCR4	PA449057	7852	0.734
NULL	Exp_Diabetes_Res_2011_Dec_27_2011_604989.nxml.txt.nlp	21253359	SENT50	9	9	13	13	clonidine	GLP-1	PA449051	100125288	0.734
NULL	Nucleic_Acids_Res_2013_Nov_27_41(21)_9786-9799.nxml.txt.nlp	23982513	SENT198	4	4	7	7	arsenite	TIAR	PA452638	7073	0.734
NULL	J_Exp_Bot_2008_Jun_20_59(9)_2555-2564.nxml.txt.nlp	18495640	SENT122	9	9	14	14	nadh	ADP	PA164755085	23038	0.734
NULL	Oncotarget_2012_May_18_3(5)_525-534.nxml.txt.nlp	22619113	SENT10	44	44	8	8	fludarabine	MCL1	PA449655	4170	0.734
NULL	BMB_Rep_2014_Apr_47(4)_221-226.nxml.txt.nlp	24286312	SENT32	10	10	23	23	nutlin-3	TP53		7157	0.734
NULL	Arthritis_Res_Ther_2007_Oct_9_9(5)_R104.nxml.txt.nlp	17925024	SENT49	29	29	8	8	glucosamine	p38	PA164747613	10598;1432;7965	0.734
NULL	Cancer_Res_Treat_2014_Jan_15_46(1)_33-40.nxml.txt.nlp	24520221	SENT66	15	15	22	22	doxorubicin	CHOP	PA449412	1649	0.734
NULL	Oncoscience_2014_Mar_12_1(2)_158-166.nxml.txt.nlp	25594008	SENT64	20	20	6	6	dasatinib	ANXA1	PA162372878	301	0.734
NULL	Breast_Cancer_Res_2012_Jan_17_14(1)_R12.nxml.txt.nlp	22251451	SENT281	6	6	15	15	tamoxifen	GPER	PA451581	2852	0.734
NULL	Int_J_Biol_Sci_2015_Jan_1_11(1)_48-58.nxml.txt.nlp	25552929	SENT152	6	6	21	21	paclitaxel	LDM	PA450761	1595	0.734
NULL	Adv_Hematol_2012_Jul_24_2012_513702.nxml.txt.nlp	22888354	SENT69	3	3	8	8	lenalidomide	IFN	PA162363968	3439	0.734
NULL	Cancer_Imaging_2013_Jul_22_13(3)_306-313.nxml.txt.nlp	23876444	SENT219	7	7	20	20	vemurafenib	FDG	PA165946873	23583	0.734
NULL	Oncotarget_2014_Nov_3_5(20)_10100-10113.nxml.txt.nlp	25338019	SENT266	17	17	24	24	fluorescein	CD107a	PA164746009	3916	0.734
NULL	Breast_Cancer_Res_2013_Nov_6_15(6)_R105.nxml.txt.nlp	24192331	SENT36	6	6	8	8	tamoxifen	aromatase	PA451581	1588	0.734
NULL	Evid_Based_Complement_Alternat_Med_2014_Jul_15_2014_562467.nxml.txt.nlp	25132860	SENT150	27	27	22	22	forskolin	AP-1	PA146096022	2353;3727;2354;3725	0.734
NULL	Biol_Open_2014_May_8_3(6)_463-474.nxml.txt.nlp	24812354	SENT427	8	8	0	0	forskolin	PRIP	PA146096022	23054;5334	0.734
NULL	Indian_J_Pharmacol_2014_Mar-Apr_46(2)_161-165.nxml.txt.nlp	24741186	SENT41	4	4	6	6	carvedilol	STZ	PA448817	6484	0.734
NULL	Oncoscience_2014_Nov_15_1(11)_674-705.nxml.txt.nlp	25593996	SENT357	24	24	31	31	cisplatin	EGFR	PA449014	1956	0.734
NULL	Oncotarget_2012_May_24_3(5)_559-567.nxml.txt.nlp	22643847	SENT148	18	18	20	20	idarubicin	AIDA	PA449961	64853	0.734
NULL	Neuroscience_2009_Jun_30_161(2-3)_572-577.nxml.txt.nlp	19327387	SENT81	1	1	4	4	capsaicin	TRPV1	PA448776	7442	0.734
NULL	N_Am_J_Med_Sci_2011_Jan_3(1)_1-12.nxml.txt.nlp	22540056	SENT132	4	4	23	23	gemcitabine	MRP5	PA449748	10057	0.734
NULL	Arch_Med_Sci_2011_Jun_11_7(3)_388-396.nxml.txt.nlp	22312373	SENT141	16	16	25	25	simvastatin	CYP3A	PA451363	1574	0.734
NULL	Front_Neurosci_2011_Jul_26_5_92.nxml.txt.nlp	21845173	SENT91	14	14	7	7	naloxone	NRM	PA450586	11270	0.734
NULL	Cancer_Cell_Int_2011_Dec_29_11_44.nxml.txt.nlp	22206574	SENT51	28	28	17	17	sorafenib	VEGFR2	PA7000	3791	0.734
NULL	Mol_Vis_2011_Feb_1_17_341-354.nxml.txt.nlp	21297898	SENT34	26	26	14	14	hydrocortisone	F12	PA449905	2161	0.734
NULL	J_Inflamm_(Lond)_2008_Dec_5_5_23.nxml.txt.nlp	19061493	SENT30	0	0	15	15	hemin	HO-1	PA449849	3162	0.734
NULL	Oxid_Med_Cell_Longev_2012_May_27_2012_609421.nxml.txt.nlp	22693652	SENT96	13	13	28	28	venlafaxine	Bcl-2	PA451866	596	0.734
NULL	Cell_Death_Dis_2010_Jun_3_1(6)_e48.nxml.txt.nlp	21364654	SENT212	21	21	30	30	cyclophosphamide	CD4	PA449165	920	0.734
NULL	Acta_Pharmacol_Sin_2010_Aug_19_31(8)_963-969.nxml.txt.nlp	20644547	SENT12	6	6	10	10	fenofibrate	PDX-1	PA449594	3651	0.734
NULL	J_Gen_Physiol_2003_Nov_122(5)_485-500.nxml.txt.nlp	14581581	SENT12	30	30	33	33	spermine	IRK1	PA164781199	3759	0.734
NULL	Arthritis_Res_Ther_2006_Feb_13_8(2)_R42.nxml.txt.nlp	16507146	SENT111	9	9	27	27	chloroquine	IL-6	PA448948	3569	0.734
NULL	Front_Aging_Neurosci_2015_Jan_6_6_342.nxml.txt.nlp	25610395	SENT171	4	4	16	16	imatinib	GSAP	PA10804	54103	0.734
NULL	Drug_Des_Devel_Ther_2014_Sep_23_8_1527-1538.nxml.txt.nlp	25284985	SENT97	4	4	1	1	celecoxib	IFN	PA448871	3439	0.734
NULL	Cardiol_Ther_2013_Jun_28_2(1)_47-56.nxml.txt.nlp	25135288	SENT99	0	0	8	8	thrombin	PAR-1	PA451674	2011;2149	0.734
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1196-1204.nxml.txt.nlp	22315058	SENT146	20	20	6	6	trastuzumab	HER2	PA451743	2064	0.734
NULL	Ann_Oncol_2011_Jan_13_22(1)_215-223.nxml.txt.nlp	20627875	SENT132	12	12	18	18	mesna	DAC	PA450385	13	0.734
NULL	Biol_Proced_Online_2002_Apr_8_3_70-78.nxml.txt.nlp	12734577	SENT82	14	14	23	23	nystatin	FRG	PA450666	9855	0.734
NULL	Drug_Des_Devel_Ther_2014_Sep_23_8_1527-1538.nxml.txt.nlp	25284985	SENT124	9	9	6	6	celecoxib	IFN	PA448871	3439	0.734
NULL	Br_J_Cancer_1997_75(6)_810-815.nxml.txt.nlp	9062400	SENT10	3	3	19	19	indomethacin	P-gp	PA449982	5243	0.734
NULL	Orphanet_J_Rare_Dis_2013_Sep_22_8_147.nxml.txt.nlp	24053568	SENT26	7	7	4	4	laronidase	IDUA	PA164776670	3425	0.734
NULL	Chin_J_Cancer_2011_Oct_30(10)_690-700.nxml.txt.nlp	21959046	SENT20	12	12	7	7	etoposide	TPT	PA449552	23590;6469	0.734
NULL	Cell_Cycle_2012_Nov_1_11(21)_3919-3925.nxml.txt.nlp	22983094	SENT112	22	22	25	25	metformin	AMPK	PA450395	5563	0.734
NULL	Ann_Surg_Treat_Res_2014_Apr_25_86(4)_220-225.nxml.txt.nlp	24783183	SENT20	1	1	19	19	imatinib	PDGFRA	PA10804	5156	0.734
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT248	4	4	15	15	gefitinib	KRAS	PA131301952	3845	0.734
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Oct_15_64(Pt_11)_m1392-m1393.nxml.txt.nlp	21580844	SENT72	17	17	8	8	ethanol	NO3	PA448073	4681	0.734
NULL	Breast_Cancer_Res_2011_Nov_30_13(6)_221.nxml.txt.nlp	22217398	SENT191	12	12	6	6	estradiol	ZNF703	PA449503	80139	0.734
NULL	Case_Rep_Gastroenterol_2014_Apr_10_8(1)_134-140.nxml.txt.nlp	24847196	SENT78	6	6	9	9	rituximab	CHOP	PA451261	1649	0.734
NULL	Front_Neurol_2011_Dec_16_2_72.nxml.txt.nlp	22203815	SENT225	7	7	25	25	protamine	VSOP	PA10366	84329	0.734
NULL	Daru_2012_Sep_10_20(1)_30.nxml.txt.nlp	23351387	SENT41	12	12	3	3	l-cysteine	NAC	PA449173	22861	0.734
NULL	Oncoimmunology_2013_Oct_1_2(10)_e27025.nxml.txt.nlp	24353914	SENT78	5	5	24	24	docetaxel	CD4	PA449383	920	0.734
NULL	Biochem_Res_Int_2012_Mar_4_2012_685267.nxml.txt.nlp	22496978	SENT201	12	12	18	18	thrombin	MT1-MMP	PA451674	4323	0.734
NULL	Protein_J_2012_Aug_5_31(6)_511-518.nxml.txt.nlp	22763563	SENT179	40	40	30	30	atorvastatin	CD36	PA448500	948	0.734
NULL	Acta_Pharmacol_Sin_2012_Oct_3_33(10)_1311-1318.nxml.txt.nlp	22941289	SENT163	5	5	10	10	sorafenib	VEGFR2	PA7000	3791	0.734
NULL	Br_J_Cancer_2001_Sep_85(6)_902-908.nxml.txt.nlp	11556844	SENT3	15	15	18	18	paclitaxel	MN1	PA450761	4330	0.734
NULL	Breast_Cancer_Res_2002_Apr_4_4(3)_85-89.nxml.txt.nlp	12052249	SENT42	14	14	7	7	tamoxifen	SULT1A1	PA451581	6817	0.734
NULL	Apoptosis_2014_Aug_26_19(11)_1603-1615.nxml.txt.nlp	25156145	SENT154	4	4	0	0	mitomycin	TRAIL	PA450524	8743	0.734
NULL	Nucleic_Acids_Res_2005_Jun_16_33(11)_e97.nxml.txt.nlp	15961728	SENT197	17	17	13	13	camptothecin	gamma	PA153590860	9913	0.734
NULL	J_Neuroinflammation_2010_Nov_18_7_81.nxml.txt.nlp	21087489	SENT56	20	20	10	10	pilocarpine	CA1	PA450962	759	0.734
NULL	Arq_Bras_Cardiol_2014_Nov_103(5)_403-409.nxml.txt.nlp	25229355	SENT125	33	33	27	27	diltiazem	PZP	PA449334	5858	0.734
NULL	J_Gen_Physiol_2009_May_133(5)_525-546.nxml.txt.nlp	19398778	SENT974	10	10	7	7	capsaicin	TRPV1	PA448776	7442	0.734
NULL	Acta_Neuropathol_Commun_2014_May_30_2_57.nxml.txt.nlp	24887326	SENT267	3	3	13	13	etoposide	MED1	PA449552	5469;8930	0.734
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R91.nxml.txt.nlp	22541814	SENT140	2	2	26	26	thrombin	HO-1	PA451674	3162	0.734
NULL	Pharmaceutics_2011_Oct_12_3(4)_680-705.nxml.txt.nlp	24309303	SENT80	8	8	13	13	repaglinide	SLCO1B1	PA451234	10599	0.734
NULL	Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.nxml.txt.nlp	24736980	SENT47	23	23	13	13	rosuvastatin	OATP1B1	PA134308647	10599	0.734
NULL	Br_J_Cancer_2009_Jun_2_100(11)_1697-1703.nxml.txt.nlp	19384299	SENT88	25	25	30	30	fludarabine	CD4	PA449655	920	0.734
NULL	J_Cell_Mol_Med_2013_Nov_23_17(11)_1422-1433.nxml.txt.nlp	24112466	SENT239	11	11	23	23	lapatinib	CD49f	PA152241907	3655	0.734
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT80	20	20	6	6	atorvastatin	IL-6	PA448500	3569	0.734
NULL	Cardiovasc_Diabetol_2013_Mar_4_12_42.nxml.txt.nlp	23452502	SENT228	29	29	13	13	isoflurane	DPP4	PA450106	1803	0.734
NULL	Biomed_Res_Int_2013_Dec_19_2013_817279.nxml.txt.nlp	24455727	SENT125	6	6	11	11	panitumumab	EGFR	PA162373091	1956	0.734
NULL	Eur_J_Neurosci_2007_Sep_26(6)_1657-1669.nxml.txt.nlp	17880399	SENT27	8	8	33	33	l-serine	DAO	PA451330	26;1610	0.734
NULL	Br_J_Cancer_2013_May_28_108(10)_2063-2069.nxml.txt.nlp	23591198	SENT73	25	25	1	1	axitinib	GEM	PA164924493	2669	0.734
NULL	Tuberc_Respir_Dis_(Seoul)_2013_Mar_29_74(3)_129-133.nxml.txt.nlp	23579627	SENT72	11	11	21	21	gefitinib	EGFR	PA131301952	1956	0.734
NULL	Psychiatry_Investig_2009_Sep_3_6(3)_222-225.nxml.txt.nlp	20046399	SENT86	14	14	6	6	perospirone	DRD2	PA165291546	1813	0.734
NULL	Apoptosis_2014_Aug_26_19(11)_1603-1615.nxml.txt.nlp	25156145	SENT236	4	4	0	0	mitomycin	TRAIL	PA450524	8743	0.734
NULL	Exp_Ther_Med_2015_Jan_10_9(1)_267-271.nxml.txt.nlp	25452814	SENT3	9	9	36	36	clopidogrel	ABCB1	PA449053	5243	0.734
NULL	J_Cell_Mol_Med_2014_May_7_18(5)_766-779.nxml.txt.nlp	24606538	SENT334	12	12	26	26	sirolimus	LAM	PA451365	7249;7248	0.734
NULL	Exp_Ther_Med_2013_May_15_5(5)_1327-1331.nxml.txt.nlp	23737873	SENT22	8	8	10	10	vasopressin	AVP	PA451858	114548;551	0.734
NULL	J_Oncol_2012_Oct_9_2012_261750.nxml.txt.nlp	22007214	SENT111	12	12	14	14	bevacizumab	NRP1	PA130232992	8829	0.734
NULL	Int_J_Mol_Sci_2012_Sep_26_13(10)_12336-12348.nxml.txt.nlp	23202901	SENT63	15	15	1	1	phenol	P90	PA450913	821	0.734
NULL	Exp_Ther_Med_2012_Sep_12_4(3)_475-480.nxml.txt.nlp	23181121	SENT8	13	13	19	19	doxorubicin	CHOP	PA449412	1649	0.734
NULL	Scientifica_(Cairo)_2012_Dec_25_2012_561761.nxml.txt.nlp	24278716	SENT448	0	0	24	24	naloxone	PAG	PA450586	55824	0.734
NULL	Endocrinology_2014_Oct_22_155(10)_3732-3738.nxml.txt.nlp	25051442	SENT69	12	12	22	22	sibutramine	ARC	PA451344	8996;23237	0.734
NULL	J_Korean_Med_Sci_2010_Aug_21_25(8)_1222-1227.nxml.txt.nlp	20676337	SENT92	5	5	8	8	propofol	LPA	PA451141	4018	0.734
NULL	Autophagy_2012_May_1_8(5)_853-855.nxml.txt.nlp	22617440	SENT34	2	2	19	19	imatinib	ULK1	PA10804	8408	0.734
NULL	Chin_J_Cancer_2011_Sep_30(9)_645-654.nxml.txt.nlp	21880186	SENT151	15	15	7	7	carboplatin	NACT	PA448803	284111	0.734
NULL	Arthritis_Res_Ther_2005_Feb_18_7(3)_R476-R484.nxml.txt.nlp	15899034	SENT115	4	4	10	10	thrombin	IL-6	PA451674	3569	0.734
NULL	Br_J_Cancer_2013_Feb_5_108(2)_334-341.nxml.txt.nlp	23257893	SENT200	2	2	11	11	cisplatin	NOXA	PA449014	5366	0.734
NULL	Exp_Diabetes_Res_2012_Jan_16_2012_230342.nxml.txt.nlp	22291696	SENT57	38	38	33	33	gliclazide	STZ	PA10892	6484	0.734
NULL	Int_J_Mol_Sci_2014_Sep_5_15(9)_15754-15765.nxml.txt.nlp	25198898	SENT469	1	1	3	3	curcumin	c-Jun	PA151958596	3725	0.734
NULL	Sci_Rep_2014_Dec_1_4_7268.nxml.txt.nlp	25434695	SENT215	2	2	19	19	cisplatin	EGFR	PA449014	1956	0.734
NULL	Breast_Cancer_Res_2003_Jul_28_5(5)_276-279.nxml.txt.nlp	12927039	SENT18	5	5	7	7	raloxifene	STAR	PA451221	6770;2984	0.734
NULL	Arch_Plast_Surg_2012_Sep_12_39(5)_540-545.nxml.txt.nlp	23094252	SENT12	7	7	22	22	propofol	TCI	PA451141	6947	0.734
NULL	Br_J_Cancer_2010_Mar_2_102(5)_837-843.nxml.txt.nlp	20125158	SENT114	4	4	22	22	nadroparin	MVD	PA10815	4597	0.734
NULL	Arthritis_Res_Ther_2012_Jun_25_14(3)_215.nxml.txt.nlp	22731694	SENT142	6	6	4	4	ribavirin	IFN	PA451241	3439	0.734
NULL	Exp_Neurobiol_2013_Jun_27_22(2)_116-123.nxml.txt.nlp	23833560	SENT123	8	8	15	15	tamoxifen	CA1	PA451581	759	0.734
NULL	Front_Physiol_2010_Oct_14_1_135.nxml.txt.nlp	21423376	SENT1435	5	5	10	10	verapamil	CD44	PA451868	960	0.734
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Mar_26_3(3)_e107.nxml.txt.nlp	24670388	SENT5	13	13	15	15	midazolam	CYP3A	PA450496	1574	0.734
NULL	J_Thromb_Haemost_2014_Jul_19_12(7)_1054-1065.nxml.txt.nlp	24766850	SENT207	18	18	11	11	thrombin	FXI	PA451674	2160	0.734
NULL	Indian_J_Pharm_Sci_2008_Jul-Aug_70(4)_431-439.nxml.txt.nlp	20046766	SENT98	22	22	31	31	propranolol	P-gp	PA451145	5243	0.734
NULL	Acta_Histochem_Cytochem_2008_Dec_27_41(6)_149-155.nxml.txt.nlp	19180199	SENT70	33	33	5	5	colchicine	TGN	PA449092	7038	0.734
NULL	Br_J_Cancer_2011_Mar_15_104(6)_957-967.nxml.txt.nlp	21364585	SENT169	7	7	18	18	doxorubicin	p53	PA449412	7157	0.734
NULL	Apoptosis_2013_Oct_6_18(12)_1513-1525.nxml.txt.nlp	24096434	SENT28	19	19	9	9	staurosporine	PHB	PA165109623	5245	0.733
NULL	Semin_Immunol_2014_Aug_26(4)_329-340.nxml.txt.nlp	25028340	SENT489	9	9	19	19	dextran	IL-4	PA449261	3565	0.733
NULL	Oncoimmunology_2013_Jan_1_2(1)_e22890.nxml.txt.nlp	23483066	SENT78	10	10	25	25	vemurafenib	B2M	PA165946873	567	0.733
NULL	Mol_Cancer_2007_Oct_11_6_63.nxml.txt.nlp	17931419	SENT117	18	18	2	2	gefitinib	HIF-1	PA131301952	29072	0.733
NULL	Biomed_Res_Int_2014_Jan_20_2014_948427.nxml.txt.nlp	24563867	SENT83	2	2	23	23	buspirone	STZ	PA448689	6484	0.733
NULL	Front_Genet_2014_Nov_14_5_391.nxml.txt.nlp	25452763	SENT746	24	24	2	2	paclitaxel	ERCC1	PA450761	2067	0.733
NULL	Acta_Naturae_2013_Jul-Sep_5(3)_92-98.nxml.txt.nlp	24303205	SENT122	32	32	5	5	l-methionine	MGL	PA450423	11343	0.733
NULL	Asian-Australas_J_Anim_Sci_2012_Aug_25(8)_1145-1152.nxml.txt.nlp	25049674	SENT37	4	4	7	7	choline	B12	PA448976	7126;4709	0.733
NULL	Biomed_Res_Int_2013_Aug_27_2013_960126.nxml.txt.nlp	24069608	SENT128	5	5	11	11	fluoxetine	CA2	PA449673	760	0.733
NULL	J_Cereb_Blood_Flow_Metab_2012_Jan_12_32(1)_17-22.nxml.txt.nlp	21989481	SENT104	4	4	14	14	glucose	UBC9	PA449773	7329	0.733
NULL	Cancer_Immunol_Immunother_2015_Oct_7_64_61-73.nxml.txt.nlp	25287778	SENT153	7	7	15	15	lenalidomide	LFA-1	PA162363968	3683;3689	0.733
NULL	Int_J_Mol_Sci_2014_Sep_2_15(9)_15512-15529.nxml.txt.nlp	25184950	SENT36	24	24	9	9	resveratrol	IL-10		3586	0.733
NULL	Biomed_Res_Int_2013_Nov_28_2013_789184.nxml.txt.nlp	24369535	SENT115	11	11	4	4	pimozide	CYP3A4	PA450965	1576	0.733
NULL	Front_Mol_Neurosci_2012_Sep_6_5_91.nxml.txt.nlp	22973190	SENT1337	3	3	10	10	ethanol	CRF1	PA448073	1394	0.733
NULL	Aging_(Albany_NY)_2010_Dec_14_2(12)_945-958.nxml.txt.nlp	21164223	SENT241	3	3	41	41	phenformin	LKB1	PA1000	6794	0.733
NULL	Cancers_(Basel)_2013_Dec_27_6(1)_67-78.nxml.txt.nlp	24378752	SENT57	2	2	17	17	etoposide	p53	PA449552	7157	0.733
NULL	J_Antimicrob_Chemother_2009_Feb_28_63(2)_389-395.nxml.txt.nlp	19042940	SENT89	19	19	6	6	trimethoprim	UTI	PA451788	259	0.733
NULL	Oncoimmunology_2013_Jan_1_2(1)_e22890.nxml.txt.nlp	23483066	SENT108	9	9	13	13	vemurafenib	IFN	PA165946873	3439	0.733
NULL	Arthritis_Res_Ther_2013_Aug_30_15(4)_R100.nxml.txt.nlp	24000795	SENT140	19	19	9	9	methotrexate	TREM1	PA450428	54210	0.733
NULL	Apoptosis_2014_Apr_23_19(7)_1055-1068.nxml.txt.nlp	24756955	SENT166	16	16	9	9	nutlin-3	MDM2		4193	0.733
NULL	Int_J_Mol_Sci_2014_Oct_23_15(10)_19265-19280.nxml.txt.nlp	25342321	SENT61	1	1	9	9	sc-560	MVD		4597	0.733
NULL	Curr_Neuropharmacol_2013_May_11(3)_250-262.nxml.txt.nlp	24179462	SENT225	3	3	10	10	tamoxifen	GluN1	PA451581	2902	0.733
NULL	Oncoscience_2014_Mar_16_1(2)_132-157.nxml.txt.nlp	25594007	SENT413	13	13	26	26	cetuximab	EGFR	PA10040	1956	0.733
NULL	J_Exp_Bot_2009_Apr_2_60(6)_1691-1702.nxml.txt.nlp	19342428	SENT46	26	26	14	14	ampicillin	TAP	PA448419	8615;2317;10482;23541	0.733
NULL	J_Asthma_Allergy_2008_Sep_19_1_19-29.nxml.txt.nlp	21436982	SENT110	0	0	10	10	fexofenadine	IL-8	PA449621	3576	0.733
NULL	Cancer_Cell_Int_2005_Aug_24_5_28.nxml.txt.nlp	16120219	SENT11	1	1	8	8	etoposide	p53	PA449552	7157	0.733
NULL	Exp_Neurobiol_2014_Jun_13_23(2)_124-129.nxml.txt.nlp	24963276	SENT54	30	30	10	10	naringin	GDNF	PA151958360	2668	0.733
NULL	Arthritis_Res_Ther_2005_Feb_17_7(Suppl_1)_P140.nxml.txt.nlp	NULL	SENT6	23	23	14	14	staurosporine	FasL	PA165109623	356	0.733
NULL	F1000Res_2013_Oct_8_2_173.nxml.txt.nlp	24555085	SENT258	14	14	25	25	hydrocortisone	BDP	PA449905	10620;152926	0.733
NULL	Hum_Genomics_2009_Jan_1_3(2)_169-190.nxml.txt.nlp	19164093	SENT29	6	6	0	0	proguanil	CYP2C19	PA451124	1557	0.733
NULL	Mol_Cancer_2009_Dec_23_8_129.nxml.txt.nlp	20030852	SENT180	11	11	6	6	curcumin	ABCA1	PA151958596	19	0.733
NULL	Nucleic_Acids_Res_2012_Jun_10_40(11)_4804-4815.nxml.txt.nlp	22328728	SENT285	20	20	13	13	hemin	SATB1	PA449849	6304	0.733
NULL	Biomed_Res_Int_2013_Jul_31_2013_692071.nxml.txt.nlp	23984399	SENT160	11	11	27	27	tramadol	CYP2D6	PA451735	1565	0.733
NULL	J_Adv_Pharm_Technol_Res_2012_Oct-Dec_3(4)_202-209.nxml.txt.nlp	23378940	SENT170	13	13	1	1	ketoconazole	CYP3A4	PA450146	1576	0.733
NULL	Amino_Acids_2012_May_25_42(5)_1529-1539.nxml.txt.nlp	21437784	SENT102	2	2	30	30	taurine	STAT3	PA451590	6774	0.733
NULL	Int_J_Inflam_2014_Dec_24_2014_690596.nxml.txt.nlp	25610704	SENT167	0	0	29	29	diclofenac	CAT	PA449293	847	0.733
NULL	J_Korean_Med_Sci_2010_Jun_24_25(6)_829-834.nxml.txt.nlp	20514301	SENT69	15	15	9	9	papain	IL-17	PA450778	3605	0.733
NULL	J_Korean_Med_Sci_2007_Dec_20_22(6)_1055-1059.nxml.txt.nlp	18162722	SENT82	18	18	7	7	famotidine	ESD	PA449586	2098	0.733
NULL	FEBS_Open_Bio_2012_Aug_22_2_279-283.nxml.txt.nlp	23650611	SENT310	14	14	16	16	raloxifene	STAR	PA451221	6770;2984	0.733
NULL	Mol_Cancer_2009_Nov_10_8_99.nxml.txt.nlp	19903356	SENT43	6	6	13	13	imatinib	IGFBP3	PA10804	3486	0.733
NULL	J_Biomed_Biotechnol_2011_Jun_13_2011_861920.nxml.txt.nlp	21716670	SENT80	2	2	18	18	methylprednisolone	IL-2	PA450466	3558	0.733
NULL	Cardiovasc_Drugs_Ther_2014_Aug_28_28(5)_477-488.nxml.txt.nlp	25163464	SENT85	19	19	12	12	vasopressin	ACTH	PA451858	5443	0.733
NULL	J_Biomed_Biotechnol_2011_Dec_6_2011_856985.nxml.txt.nlp	21188173	SENT22	24	24	16	16	tamoxifen	CYP2D6	PA451581	1565	0.733
NULL	Oncotarget_2014_Jun_30_5(14)_5624-5636.nxml.txt.nlp	25015549	SENT157	20	20	26	26	l-glutamine	CO2	PA10090	4513	0.733
NULL	Scientifica_(Cairo)_2013_Dec_10_2013_691251.nxml.txt.nlp	24386592	SENT194	7	7	5	5	paclitaxel	SIRT6	PA450761	51548	0.733
NULL	Oncotarget_2010_May_27_1(2)_89-103.nxml.txt.nlp	20671809	SENT209	7	7	28	28	perifosine	4E-BP1	PA165291471	1978	0.733
NULL	Diabetes_2013_Oct_17_62(10)_3547-3552.nxml.txt.nlp	23863812	SENT71	15	15	9	9	valsartan	adiponectin	PA451848	9370	0.733
NULL	Daru_2012_Sep_3_20(1)_24.nxml.txt.nlp	23351176	SENT40	6	6	26	26	mannitol	ITM	PA450320	5002	0.733
NULL	J_Adv_Pharm_Technol_Res_2014_Apr-Jun_5(2)_96-103.nxml.txt.nlp	24959419	SENT199	4	4	1	1	carvedilol	DSC	PA448817	1825	0.733
NULL	J_Am_Heart_Assoc_2013_Dec_19_2(6)_e000439.nxml.txt.nlp	24334905	SENT365	9	9	7	7	doxorubicin	GATA4	PA449412	2626	0.733
NULL	F1000_Biol_Rep_2009_Mar_24_1_23.nxml.txt.nlp	20948663	SENT71	29	29	36	36	citalopram	STAR	PA449015	6770;2984	0.733
NULL	Cancer_Cell_Int_2012_Jul_4_12_19.nxml.txt.nlp	22631225	SENT186	3	3	10	10	heparin	PPIA	PA449855	5478	0.733
NULL	Int_J_Mol_Imaging_2012_Sep_13_2012_870301.nxml.txt.nlp	23008768	SENT121	33	33	15	15	ifosfamide	FDG	PA449964	23583	0.733
NULL	Int_J_Mol_Sci_2014_Jun_5_15(6)_10083-10100.nxml.txt.nlp	24905407	SENT19	21	21	11	11	tetracycline	STP	PA451640	9322	0.733
NULL	Clin_Mol_Allergy_2009_Mar_12_7_5.nxml.txt.nlp	19284628	SENT152	17	17	37	37	salmeterol	IL-13	PA451300	3596	0.733
NULL	Ann_Gastroenterol_2014_27(4)_313-319.nxml.txt.nlp	25331779	SENT76	8	8	16	16	adalimumab	POR	PA10004	5447	0.733
NULL	Am_J_Physiol_Endocrinol_Metab_2013_Nov_1_305(9)_E1134-E1144.nxml.txt.nlp	24022868	SENT40	18	18	11	11	rosiglitazone	BAT	PA451283	570	0.733
NULL	Br_J_Pharmacol_2013_Jun_27_169(4)_933-948.nxml.txt.nlp	23517055	SENT10	23	23	20	20	bepridil	NCX	PA164754755	3196	0.733
NULL	Oncotarget_2014_Aug_25_5(17)_7945-7959.nxml.txt.nlp	25277206	SENT27	10	10	6	6	pazopanib	Raf-1	PA165291492	5894	0.733
NULL	CNS_Drugs_2013_Aug_23_27(11)_943-953.nxml.txt.nlp	23975660	SENT3	15	15	17	17	atomoxetine	ATX	PA134688071	5168;23049	0.733
NULL	Behav_Brain_Funct_2006_Mar_28_2_12.nxml.txt.nlp	16569246	SENT76	1	1	4	4	methamphetamine	ANOVA	PA450403	4858	0.733
NULL	Mol_Cancer_2010_Apr_12_9_75.nxml.txt.nlp	20385023	SENT189	32	32	22	22	dasatinib	LYN	PA162372878	4067	0.733
NULL	Cells_2014_May_8_3(2)_418-437.nxml.txt.nlp	24814761	SENT563	7	7	2	2	fludarabine	BIM	PA449655	10018	0.733
NULL	Acta_Pharmacol_Sin_2014_Jun_4_35(6)_752-757.nxml.txt.nlp	24902786	SENT94	14	14	5	5	letrozole	STL2	PA450196	1301	0.733
NULL	Front_Pharmacol_2014_Nov_21_5_257.nxml.txt.nlp	25484865	SENT111	35	35	40	40	verapamil	P-gp	PA451868	5243	0.733
NULL	Indian_Dermatol_Online_J_2011_Jul-Dec_2(2)_111-119.nxml.txt.nlp	23130241	SENT211	13	13	11	11	methotrexate	FAE	PA450428	2178	0.733
NULL	Clin_Med_Insights_Blood_Disord_2013_Nov_14_6_23-27.nxml.txt.nlp	25512717	SENT21	21	21	30	30	cyclophosphamide	CHOP	PA449165	1649	0.733
NULL	Int_J_Vasc_Med_2011_Aug_11_2011_867964.nxml.txt.nlp	21860799	SENT13	0	0	19	19	clopidogrel	P2Y12	PA449053	64805	0.733
NULL	Curr_Pharm_Des_2008_Oct_14(28)_2983-2998.nxml.txt.nlp	18991714	SENT80	6	6	13	13	gefitinib	EGFR	PA131301952	1956	0.733
NULL	eLife_2013_Nov_5_2_e00969.nxml.txt.nlp	24192036	SENT414	6	6	4	4	vemurafenib	ASK1	PA165946873	4217	0.733
NULL	Mol_Cell_Biochem_2014_Oct_9_385(1-2)_265-275.nxml.txt.nlp	24104452	SENT236	15	15	34	34	bortezomib	U87	PA10252	677775;641648	0.733
NULL	Oxid_Med_Cell_Longev_2013_Nov_28_2013_568093.nxml.txt.nlp	24379901	SENT52	44	44	15	15	resveratrol	AMPK		5563	0.733
NULL	Br_J_Cancer_2012_Jan_17_106(2)_284-289.nxml.txt.nlp	22215065	SENT181	13	13	10	10	sunitinib	IFN	PA162372840	3439	0.733
NULL	Sleep_Disord_2014_Jul_10_2014_767181.nxml.txt.nlp	25126427	SENT114	13	13	25	25	bromocriptine	LDE	PA448671	7957	0.733
NULL	BMJ_2009_Jul_14_339_b2538.nxml.txt.nlp	19602530	SENT9	20	20	2	2	naproxen	COX	PA450595	1351	0.733
NULL	Virol_J_2010_Oct_20_7_279.nxml.txt.nlp	20961433	SENT271	14	14	12	12	trypsin	GP2	PA451806	2813	0.733
NULL	Oncol_Lett_2013_Sep_28_6(3)_795-800.nxml.txt.nlp	24137413	SENT30	29	29	19	19	paclitaxel	HIF-1	PA450761	29072	0.733
NULL	Oncologist_2010_Nov_4_15(11)_1135-1146.nxml.txt.nlp	21051659	SENT156	2	2	15	15	sunitinib	IFN	PA162372840	3439	0.733
NULL	F1000Res_2013_Aug_20_2_147.nxml.txt.nlp	24555068	SENT300	17	17	14	14	curcumin	NF-kappaB	PA151958596	4790	0.733
NULL	Biomed_Imaging_Interv_J_2008_Jul_1_4(3)_e40.nxml.txt.nlp	21611006	SENT139	11	11	18	18	capecitabine	HER2	PA448771	2064	0.733
NULL	Cancer_Metab_2013_Feb_4_1_7.nxml.txt.nlp	24280108	SENT153	11	11	26	26	glucose	ROS	PA449773	6098	0.733
NULL	Aging_(Albany_NY)_2009_Jul_30_1(7)_669-673.nxml.txt.nlp	20157548	SENT61	0	0	10	10	resveratrol	SIRT1		23411	0.733
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jul_10_68(Pt_8)_o2421.nxml.txt.nlp	22904872	SENT65	16	16	36	36	ethanol	mol	PA448073	90527	0.733
NULL	Chem_Rev_2011_Oct_12_111(10)_5899-5921.nxml.txt.nlp	21923193	SENT563	18	18	25	25	nimesulide	FAAH	PA137179528	79152;2166	0.733
NULL	Cancers_(Basel)_2014_Apr_3_6(2)_771-795.nxml.txt.nlp	24704793	SENT159	14	14	0	0	estradiol	BRCA1	PA449503	672	0.733
NULL	Breast_Cancer_Res_2014_Oct_28_16(5)_456.nxml.txt.nlp	25349073	SENT32	7	7	2	2	pertuzumab	HER2		2064	0.733
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Jan_4_69(Pt_2)_o167-o168.nxml.txt.nlp	23424455	SENT86	27	27	21	21	ethanol	mol	PA448073	90527	0.733
NULL	Front_Endocrinol_(Lausanne)_2014_Jan_16_5_1.nxml.txt.nlp	24474947	SENT62	32	32	23	23	estradiol	GPER	PA449503	2852	0.733
NULL	Acta_Pharmacol_Sin_2010_May_12_31(5)_578-584.nxml.txt.nlp	20383171	SENT201	6	6	24	24	berberine	ORP150	PA165860812	10525	0.733
NULL	Free_Radic_Biol_Med_2013_Aug_61(100)_438-452.nxml.txt.nlp	23608463	SENT107	10	10	14	14	apomorphine	NQO1	PA164781163	1728	0.733
NULL	J_Mol_Med_(Berl)_2014_May_10_92(7)_709-722.nxml.txt.nlp	24811491	SENT229	9	9	26	26	leucovorin	KRAS	PA450198	3845	0.733
NULL	Clin_Psychopharmacol_Neurosci_2011_Aug_31_9(2)_73-77.nxml.txt.nlp	23431108	SENT69	16	16	8	8	mirtazapine	ANOVA	PA450522	4858	0.733
NULL	AIDS_Res_Ther_2011_Oct_6_8_36.nxml.txt.nlp	21978457	SENT135	21	21	7	7	zinc	ZIP4	PA451956	55630	0.733
NULL	Endocrinology_2012_Jan_15_153(1)_200-211.nxml.txt.nlp	22087024	SENT97	15	15	9	9	methylprednisolone	CORT	PA450466	1325	0.733
NULL	J_Gastrointest_Cancer_2013_Aug_7_44(4)_385-392.nxml.txt.nlp	23921604	SENT22	16	16	9	9	imatinib	CML	PA10804	613	0.733
NULL	Int_J_Biol_Sci_2013_Dec_22_10(1)_90-102.nxml.txt.nlp	24391455	SENT197	28	28	14	14	doxorubicin	JNK	PA449412	5599	0.733
NULL	N_Am_J_Med_Sci_2011_Jan_3(1)_1-12.nxml.txt.nlp	22540056	SENT135	25	25	28	28	gemcitabine	MRP5	PA449748	10057	0.733
NULL	Evid_Based_Complement_Alternat_Med_2014_Jul_13_2014_478290.nxml.txt.nlp	25126099	SENT73	10	10	22	22	pentamidine	CO2	PA450850	4513	0.733
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT124	9	9	22	22	sitagliptin	HIP	PA164748978	6767;6159;64399;5068	0.733
NULL	Aging_(Albany_NY)_2014_Jan_14_6(1)_70-81.nxml.txt.nlp	24429382	SENT21	8	8	6	6	bleomycin	WRN	PA448645	7486	0.733
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT110	11	11	21	21	cisplatin	MLH1	PA449014	4292	0.733
NULL	J_Biomed_Sci_2014_Feb_3_21(1)_10.nxml.txt.nlp	24490900	SENT126	7	7	21	21	alendronate	M-CSF	PA448082	1435	0.733
NULL	J_Asthma_Allergy_2010_Dec_30_4_1-12.nxml.txt.nlp	21701574	SENT240	2	2	8	8	formoterol	IL-8	PA134687907	3576	0.733
NULL	J_Korean_Med_Sci_2014_Jul_11_29(7)_965-972.nxml.txt.nlp	25045229	SENT154	21	21	6	6	metformin	B12	PA450395	7126;4709	0.733
NULL	Br_J_Cancer_2011_Nov_22_105(11)_1628-1634.nxml.txt.nlp	22009028	SENT30	21	21	0	0	flutamide	Men	PA449685	8178	0.733
NULL	J_Int_Soc_Sports_Nutr_2009_Feb_19_6_6.nxml.txt.nlp	19228401	SENT9	2	2	8	8	creatine	CRT	PA164778930	811	0.733
NULL	Breast_Cancer_Res_2008_Jul_28_10(4)_R65.nxml.txt.nlp	18662380	SENT193	28	28	24	24	trastuzumab	HER2	PA451743	2064	0.733
NULL	Oncoimmunology_2014_Jan_1_3_e27359.nxml.txt.nlp	24653963	SENT30	8	8	15	15	doxorubicin	TH1	PA449412	51497	0.733
NULL	Cell_Death_Dis_2014_Feb_27_5(2)_e1088.nxml.txt.nlp	24577086	SENT124	8	8	6	6	metformin	Bcl-2	PA450395	596	0.733
NULL	Curr_Neuropharmacol_2014_Jul_12(4)_365-379.nxml.txt.nlp	25342944	SENT206	30	30	15	15	fenfluramine	5-HT2B	PA449592	3357	0.733
NULL	Int_J_Mol_Sci_2014_Oct_20_15(10)_18985-18999.nxml.txt.nlp	25334066	SENT177	34	34	5	5	doxorubicin	HOTAIR	PA449412	100124700	0.733
NULL	Case_Rep_Oncol_Med_2012_Nov_3_2012_819809.nxml.txt.nlp	23198202	SENT33	24	24	19	19	thyroglobulin	TTF1	PA164754910	7080;7270	0.733
NULL	Toxins_(Basel)_2010_Oct_26_2(11)_2490-2518.nxml.txt.nlp	22069563	SENT60	12	12	7	7	cisplatin	OCT2	PA449014	6582;5452	0.733
NULL	Aging_(Albany_NY)_2009_Feb_18_1(3)_335-349.nxml.txt.nlp	20195489	SENT199	2	2	5	5	etoposide	p65	PA449552	5970	0.733
NULL	Oncotarget_2014_Dec_4_5(22)_11365-11380.nxml.txt.nlp	25426548	SENT3	9	9	33	33	nutlin-3	TP53		7157	0.733
NULL	Orphanet_J_Rare_Dis_2014_Jun_5_9_79.nxml.txt.nlp	24898617	SENT283	23	23	14	14	bezafibrate	CPT2	PA162364313	1376	0.733
NULL	Br_J_Cancer_2009_Oct_6_101(7)_1155-1161.nxml.txt.nlp	19738614	SENT118	9	9	3	3	gemcitabine	MUC4	PA449748	4585	0.733
NULL	Biomed_Res_Int_2013_Sep_2_2013_264306.nxml.txt.nlp	24078909	SENT25	17	17	26	26	trastuzumab	HER-2	PA451743	2064	0.733
NULL	J_Gen_Intern_Med_2007_Feb_17_22(2)_171-176.nxml.txt.nlp	17356982	SENT124	24	24	8	8	buprenorphine	NCM	PA448685	57703	0.733
NULL	Biosci_Rep_2012_Dec_20_33(1)_e00011.nxml.txt.nlp	23137297	SENT263	20	20	13	13	heparin	RPSA	PA449855	3921	0.733
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT123	31	31	5	5	perifosine	DR4	PA165291471	8797	0.733
NULL	J_Hematol_Oncol_2012_Jun_8_5_29.nxml.txt.nlp	22682059	SENT29	4	4	25	25	imatinib	CR1	PA10804	1378	0.733
NULL	Br_J_Pharmacol_2014_Sep_28_171(18)_4255-4272.nxml.txt.nlp	24846338	SENT22	21	21	9	9	escitalopram	5-HT1B	PA10074	3351	0.733
NULL	Iran_J_Basic_Med_Sci_2012_Jan-Feb_15(1)_678-682.nxml.txt.nlp	23493931	SENT41	10	10	35	35	ceftazidime	MAST	PA448861	51324	0.733
NULL	Acta_Physiol_(Oxf)_2008_Apr_192(4)_505-517.nxml.txt.nlp	17973950	SENT91	9	9	38	38	propranolol	LQT3	PA451145	6331	0.733
NULL	Libyan_J_Med_2006_Jul_28_1(1)_42-59.nxml.txt.nlp	21526020	SENT214	16	16	14	14	bevacizumab	IFL	PA130232992	3439	0.733
NULL	AIDS_2013_Oct_23_27(16)_2587-2592.nxml.txt.nlp	23921616	SENT114	20	20	5	5	abacavir	HLA-B	PA448004	3106	0.733
NULL	Crit_Care_2007_Mar_22_11(Suppl_2)_P94.nxml.txt.nlp	NULL	SENT18	6	6	17	17	meropenem	BII	PA164764445	777	0.733
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT1700	15	15	2	2	famotidine	ATV	PA449586	4683	0.733
NULL	Breast_Cancer_(Auckl)_2014_Oct_8_8_125-133.nxml.txt.nlp	25336961	SENT92	14	14	9	9	paclitaxel	HER2	PA450761	2064	0.733
NULL	Int_J_Med_Sci_2014_Jul_29_11(10)_1015-1021.nxml.txt.nlp	25136257	SENT16	8	8	1	1	rosiglitazone	ANOVA	PA451283	4858	0.733
NULL	JAKSTAT_2012_Apr_1_1(2)_83-89.nxml.txt.nlp	24058756	SENT69	4	4	10	10	losartan	STAT3	PA450268	6774	0.733
NULL	Nat_Commun_2013_4_2598.nxml.txt.nlp	24121673	SENT19	25	25	16	16	rituximab	CHOP	PA451261	1649	0.733
NULL	J_Carcinog_2011_Nov_30_10_28.nxml.txt.nlp	22190870	SENT200	22	22	11	11	bevacizumab	VEGF-A	PA130232992	7422	0.733
NULL	Crit_Care_2014_Mar_17_18(Suppl_1)_P339.nxml.txt.nlp	NULL	SENT18	6	6	11	11	losartan	IL-6	PA450268	3569	0.733
NULL	Hematol_Rep_2011_Oct_10_3(2)_e16.nxml.txt.nlp	22184537	SENT71	12	12	7	7	warfarin	CYP2C9	PA451906	1559	0.733
NULL	Cancer_Res_Treat_2012_Jun_30_44(2)_133-141.nxml.txt.nlp	22802752	SENT190	3	3	18	18	gemcitabine	IL-2	PA449748	3558	0.733
NULL	Gut_Liver_2013_Jan_5_7(1)_106-111.nxml.txt.nlp	23423146	SENT45	14	14	4	4	gemcitabine	CRT	PA449748	811	0.733
NULL	Cell_Death_Dis_2010_Oct_21_1(10)_e86.nxml.txt.nlp	21368859	SENT223	23	23	10	10	doxorubicin	Mcl-1	PA449412	4170	0.733
NULL	Int_J_Biol_Sci_2015_Jan_1_11(1)_48-58.nxml.txt.nlp	25552929	SENT298	16	16	5	5	paclitaxel	THBS1	PA450761	7057	0.733
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT126	21	21	14	14	pp2	LYN		4067	0.733
NULL	Mol_Cancer_2009_Nov_24_8_109.nxml.txt.nlp	19930708	SENT204	8	8	31	31	estradiol	JNK	PA449503	5599	0.733
NULL	Int_J_Breast_Cancer_2011_Sep_6_2011_352182.nxml.txt.nlp	22295219	SENT7	8	8	14	14	trastuzumab	HER2	PA451743	2064	0.733
NULL	Curr_Pharm_Des_2011_Dec_17(35)_3846-3853.nxml.txt.nlp	21933140	SENT146	34	34	29	29	exenatide	GLP-1	PA164749238	100125288	0.733
NULL	Br_J_Cancer_2003_Mar_10_88(5)_754-759.nxml.txt.nlp	12618886	SENT122	2	2	7	7	amifostine	p53	PA448365	7157	0.733
NULL	Diabetes_Care_2009_Apr_32(4)_531-540.nxml.txt.nlp	19336638	SENT239	8	8	15	15	clopidogrel	ADP	PA449053	23038	0.733
NULL	J_Immunother_Cancer_2013_Jul_15_1_10.nxml.txt.nlp	24829747	SENT197	0	0	6	6	cisplatin	TC-1	PA449014	56892	0.733
NULL	Cancer_Cell_Int_2006_Nov_8_6_25.nxml.txt.nlp	17092342	SENT280	2	2	5	5	thrombin	Yes	PA451674	7525	0.733
NULL	Mol_Cancer_2010_May_18_9_110.nxml.txt.nlp	20482802	SENT147	6	6	0	0	bortezomib	Bcl-2	PA10252	596	0.733
NULL	Indian_J_Pharmacol_2014_Nov-Dec_46(6)_639-643.nxml.txt.nlp	25538337	SENT4	19	19	21	21	ketanserin	KET	PA131053734	8626	0.733
NULL	Aging_(Albany_NY)_2012_Feb_21_4(2)_133-143.nxml.txt.nlp	22361433	SENT163	12	12	31	31	glucose	MEF2C	PA449773	4208	0.733
NULL	J_Mol_Med_(Berl)_2013_Apr_10_91(4)_473-483.nxml.txt.nlp	23052483	SENT86	12	12	6	6	bevacizumab	HIF-1	PA130232992	29072	0.733
NULL	Oncotarget_2012_Dec_31_3(12)_1700-1710.nxml.txt.nlp	23482333	SENT12	31	31	37	37	doxorubicin	CHOP	PA449412	1649	0.733
NULL	Breast_Cancer_(Dove_Med_Press)_2014_May_2_6_59-71.nxml.txt.nlp	24833917	SENT83	5	5	7	7	raloxifene	STAR	PA451221	6770;2984	0.733
NULL	Mol_Vis_2012_Apr_11_18_901-908.nxml.txt.nlp	22539869	SENT236	15	15	19	19	curcumin	NF-kappaB	PA151958596	4790	0.733
NULL	Int_J_Mol_Sci_2014_Oct_23_15(10)_19265-19280.nxml.txt.nlp	25342321	SENT65	12	12	0	0	sc-560	MVD		4597	0.733
NULL	Biomed_Imaging_Interv_J_2006_Oct_1_2(4)_e56.nxml.txt.nlp	21614336	SENT25	9	9	6	6	thyroglobulin	WBS	PA164754910	2006	0.733
NULL	Braz_J_Microbiol_2014_Aug_29_45(2)_447-456.nxml.txt.nlp	25242927	SENT37	2	2	10	10	ethanol	CTX	PA448073	1593	0.733
NULL	J_Cell_Mol_Med_2014_Jan_4_18(1)_38-48.nxml.txt.nlp	24188742	SENT137	16	16	0	0	cisplatin	PAX3	PA449014	5077	0.733
NULL	Leukemia_2014_Jun_17_28(6)_1216-1226.nxml.txt.nlp	24301524	SENT6	3	3	15	15	bortezomib	GATA3	PA10252	2625	0.733
NULL	Braz_J_Med_Biol_Res_2014_Jan_10_47(1)_60-69.nxml.txt.nlp	24519092	SENT162	33	33	5	5	doxorubicin	YWHAZ	PA449412	7534	0.733
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_105-115.nxml.txt.nlp	17912640	SENT35	8	8	30	30	tamoxifen	HER2	PA451581	2064	0.733
NULL	J_Ayurveda_Integr_Med_2013_Apr-Jun_4(2)_99-106.nxml.txt.nlp	23930042	SENT135	5	5	31	31	glipizide	PPG	PA449762	5552	0.733
NULL	Core_Evid_2007_Nov_30_2(2)_121-129.nxml.txt.nlp	21221180	SENT97	6	6	12	12	rituximab	NHL	PA451261	51750	0.733
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_16_2014_926087.nxml.txt.nlp	25478000	SENT102	15	15	21	21	atorvastatin	PCSK9	PA448500	255738	0.733
NULL	J_Cheminform_2012_Mar_8_4_6.nxml.txt.nlp	22401035	SENT250	8	8	10	10	troglitazone	PPARG	PA451799	5468	0.733
NULL	J_Mol_Med_(Berl)_2014_May_10_92(7)_709-722.nxml.txt.nlp	24811491	SENT109	34	34	19	19	cetuximab	KRAS	PA10040	3845	0.733
NULL	Br_J_Pharmacol_2014_Feb_24_171(1)_1019-1032.nxml.txt.nlp	24251620	SENT348	16	16	18	18	nifedipine	TRPM3	PA450631	80036	0.733
NULL	Cancers_(Basel)_2010_Mar_22_2(1)_190-208.nxml.txt.nlp	24281040	SENT50	7	7	24	24	gefitinib	EGFR	PA131301952	1956	0.733
NULL	Br_J_Cancer_2014_Oct_14_111(8)_1552-1561.nxml.txt.nlp	25117814	SENT272	0	0	6	6	doxorubicin	PTEN	PA449412	5728	0.733
NULL	EMBO_Mol_Med_2012_Jun_13_4(6)_515-527.nxml.txt.nlp	22416035	SENT100	12	12	31	31	olaparib	p53		7157	0.733
NULL	Eur_Heart_J_2013_Dec_1_34(45)_3515-3524.nxml.txt.nlp	23594590	SENT16	12	12	23	23	eplerenone	p40phox	PA164749044	4689	0.733
NULL	J_Exp_Clin_Cancer_Res_2008_Sep_25_27(1)_46.nxml.txt.nlp	18816410	SENT265	24	24	30	30	cisplatin	survivin	PA449014	332	0.733
NULL	Br_J_Cancer_2009_Jul_21_101(2)_327-334.nxml.txt.nlp	19568240	SENT13	7	7	17	17	pp2	PI3K		5290	0.733
NULL	J_Gen_Physiol_2008_Nov_132(5)_521-535.nxml.txt.nlp	18852303	SENT119	7	7	19	19	aprotinin	CAP2	PA448472	5271;10486	0.733
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT88	34	34	21	21	perifosine	TRAIL	PA165291471	8743	0.733
NULL	Biomed_Res_Int_2013_Aug_7_2013_864012.nxml.txt.nlp	23991423	SENT70	0	0	6	6	paricalcitol	PTH	PA450798	5741	0.733
NULL	J_Obes_2011_Aug_16_2011_686952.nxml.txt.nlp	20847891	SENT229	9	9	26	26	candoxatril	adiponectin	PA164764517	9370	0.733
NULL	Breast_Cancer_Res_2014_Sep_9_16(5)_433.nxml.txt.nlp	25212966	SENT305	19	19	8	8	aprotinin	ILEI	PA448472	10447	0.733
NULL	Mol_Cancer_2014_Feb_5_13_24.nxml.txt.nlp	24495306	SENT248	3	3	0	0	collagenase	ADAM17	PA449107	6868	0.733
NULL	J_Epilepsy_Res_2014_Jun_30_4(1)_7-13.nxml.txt.nlp	24977124	SENT122	2	2	16	16	pilocarpine	CA1	PA450962	759	0.733
NULL	Indian_J_Endocrinol_Metab_2013_May-Jun_17(3)_472-479.nxml.txt.nlp	23869305	SENT6	7	7	9	9	atorvastatin	ATV	PA448500	4683	0.733
NULL	J_Parasitol_Res_2012_Aug_18_2012_737324.nxml.txt.nlp	21869919	SENT166	15	15	28	28	l-proline	ODC	PA451125	4953;89874	0.733
NULL	Front_Neurosci_2013_Dec_20_7_256.nxml.txt.nlp	24391536	SENT162	3	3	5	5	rimonabant	c-fos	PA152407999	2353	0.733
NULL	Oncoimmunology_2014_Apr_25_3_e28518.nxml.txt.nlp	25071979	SENT156	12	12	21	21	carboplatin	HMGB1	PA448803	3146	0.733
NULL	J_Korean_Med_Sci_2014_Jan_26_29(1)_110-116.nxml.txt.nlp	24431914	SENT111	12	12	15	15	plerixafor	CD34	PA165958410	947	0.733
NULL	Curr_Oncol_2009_May_16(Suppl_1)_S52-S59.nxml.txt.nlp	19478903	SENT145	11	11	6	6	enalapril	CYP3A4	PA449456	1576	0.733
NULL	Case_Rep_Oncol_2012_Mar_17_5(1)_125-133.nxml.txt.nlp	22666200	SENT74	45	45	26	26	trastuzumab	ACTH	PA451743	5443	0.733
NULL	Curr_Neuropharmacol_2014_Jan_12(1)_57-70.nxml.txt.nlp	24533016	SENT644	13	13	0	0	ketamine	Tech	PA450144	57449	0.733
NULL	Oncotarget_2011_Mar_23_2(3)_165-177.nxml.txt.nlp	21444946	SENT110	11	11	0	0	erlotinib	EGFR	PA134687924	1956	0.733
NULL	J_Korean_Med_Sci_2009_Jan_29_24(Suppl_1)_S170-S175.nxml.txt.nlp	19194548	SENT132	12	12	20	20	cisplatin	EPO	PA449014	7076;8288;2056	0.733
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_May_11_69(Pt_6)_o863-o864.nxml.txt.nlp	23795045	SENT73	17	17	28	28	ethanol	mol	PA448073	90527	0.733
NULL	J_Thromb_Haemost_2007_May_5(5)_1010-1018.nxml.txt.nlp	17355572	SENT159	3	3	5	5	thrombin	VWF	PA451674	7450	0.733
NULL	J_Hum_Genet_2013_Jun_16_58(6)_353-361.nxml.txt.nlp	23677058	SENT175	25	25	9	9	cytarabine	SLC28A3	PA449177	64078	0.733
NULL	J_Immunother_Cancer_2013_Nov_7_1(Suppl_1)_P88.nxml.txt.nlp	NULL	SENT13	27	27	23	23	bortezomib	DLL1	PA10252	28514	0.733
NULL	Breast_Cancer_(Auckl)_2011_Oct_9_5_209-226.nxml.txt.nlp	22084574	SENT198	11	11	23	23	anastrozole	ARNO	PA448432	9266	0.733
NULL	Front_Behav_Neurosci_2014_Oct_1_8_306.nxml.txt.nlp	25324743	SENT143	10	10	27	27	risperidone	5-HT7	PA451257	3363	0.733
NULL	BMJ_2013_Nov_5_347_f6320.nxml.txt.nlp	24192967	SENT6	18	18	1	1	tamsulosin	Men	PA451583	8178	0.733
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT321	21	21	7	7	leucovorin	ABCC1	PA450198	4363	0.733
NULL	Biomed_Res_Int_2013_Dec_10_2013_962695.nxml.txt.nlp	24386641	SENT88	12	12	9	9	thrombin	PAR4	PA451674	9002;5074	0.733
NULL	Int_J_Mol_Sci_2014_Oct_17_15(10)_18762-18775.nxml.txt.nlp	25329617	SENT520	17	17	1	1	daunorubicin	Bcl-2	PA449212	596	0.733
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT129	5	5	12	12	adalimumab	CD36	PA10004	948	0.733
NULL	Int_J_Breast_Cancer_2011_Jul_12_2011_232435.nxml.txt.nlp	22295213	SENT145	8	8	10	10	tamoxifen	PAK1	PA451581	5585;5058	0.732
NULL	Crit_Care_2008_Nov_12_12(6)_235.nxml.txt.nlp	19040780	SENT177	30	30	13	13	tacrolimus	CYP3A4	PA451578	1576	0.732
NULL	J_Immunol_Res_2014_May_8_2014_565320.nxml.txt.nlp	24901010	SENT143	31	31	28	28	allopurinol	HLA-B	PA448320	3106	0.732
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT208	0	0	7	7	pp2	EGFR		1956	0.732
NULL	Behav_Brain_Funct_2013_Jan_10_9_4.nxml.txt.nlp	23305134	SENT145	31	31	20	20	biperiden	ANOVA	PA448626	4858	0.732
NULL	AIDS_Res_Ther_2008_Aug_14_5_18.nxml.txt.nlp	18700986	SENT35	20	20	11	11	emtricitabine	ATV	PA10069	4683	0.732
NULL	Exp_Ther_Med_2013_Apr_5_5(4)_1259-1263.nxml.txt.nlp	23596498	SENT25	10	10	19	19	capsaicin	TRPA1	PA448776	8989	0.732
NULL	Int_J_Med_Sci_2015_Jan_1_12(1)_78-82.nxml.txt.nlp	25552922	SENT106	1	1	31	31	lansoprazole	CYP2C19	PA450180	1557	0.732
NULL	Epigenetics_2012_Nov_1_7(11)_1225-1229.nxml.txt.nlp	23069641	SENT46	32	32	23	23	carboplatin	BRCA1	PA448803	672	0.732
NULL	Br_J_Cancer_2013_Dec_10_109(12)_3067-3072.nxml.txt.nlp	24263065	SENT43	0	0	14	14	irinotecan	KRAS	PA450085	3845	0.732
NULL	Breast_Cancer_Res_2010_Aug_23_12(4)_208.nxml.txt.nlp	20804567	SENT153	9	9	12	12	gefitinib	EGFR	PA131301952	1956	0.732
NULL	Clin_Ophthalmol_2014_Aug_26_8_1611-1621.nxml.txt.nlp	25210429	SENT22	4	4	10	10	ranibizumab	San	PA164746012	80218	0.732
NULL	J_Anaesthesiol_Clin_Pharmacol_2012_Jul-Sep_28(3)_339-343.nxml.txt.nlp	22869941	SENT72	11	11	6	6	fentanyl	STA	PA449599	2010;2656	0.732
NULL	Mol_Biol_Cell_2012_Mar_15_23(6)_966.nxml.txt.nlp	NULL	SENT33	8	8	26	26	paclitaxel	Mcl-1	PA450761	4170	0.732
NULL	Curr_Cardiovasc_Imaging_Rep_2010_Oct_4_3(5)_317-323.nxml.txt.nlp	20835382	SENT124	6	6	2	2	sirolimus	DES	PA451365	1674	0.732
NULL	Int_J_Mol_Imaging_2011_Oct_26_2011_874585.nxml.txt.nlp	21490735	SENT15	20	20	11	11	doxorubicin	FDG	PA449412	23583	0.732
NULL	Mol_Biol_Cell_2012_Nov_1_23(21)_4212-4225.nxml.txt.nlp	22956765	SENT246	24	24	10	10	thrombin	SHP2	PA451674	5781	0.732
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT10	7	7	3	3	perifosine	DR5	PA165291471	8795	0.732
NULL	Infect_Dis_Obstet_Gynecol_2014_Sep_25_2014_961375.nxml.txt.nlp	25328370	SENT194	17	17	0	0	atazanavir	ATV	PA10251	4683	0.732
NULL	Behav_Brain_Funct_2009_Jan_15_5_3.nxml.txt.nlp	19146665	SENT13	10	10	20	20	ethanol	P90	PA448073	821	0.732
NULL	Int_Semin_Surg_Oncol_2008_Apr_28_5_9.nxml.txt.nlp	18442393	SENT122	11	11	16	16	tamoxifen	HER-2	PA451581	2064	0.732
NULL	Aging_(Albany_NY)_2013_Feb_21_5(2)_94-95.nxml.txt.nlp	23518473	SENT22	14	14	19	19	resveratrol	SIRT1		23411	0.732
NULL	Nature_2012_Aug_16_488(7411)_394-398.nxml.txt.nlp	22810587	SENT80	20	20	16	16	candesartan	AT-1	PA448765	9197	0.732
NULL	Basic_Clin_Neurosci_2014_Winter_5(1)_74-79.nxml.txt.nlp	25436087	SENT39	5	5	7	7	fluoxetine	AQP4	PA449673	361	0.732
NULL	Chin_J_Cancer_2011_May_30(5)_327-335.nxml.txt.nlp	21527065	SENT35	46	46	37	37	capecitabine	PIK3CA	PA448771	5290	0.732
NULL	CNS_Spectr_2014_Apr_1_19(2)_121-133.nxml.txt.nlp	23903233	SENT596	1	1	8	8	vilazodone	5-HT1A	PA165958365	3350	0.732
NULL	Case_Rep_Psychiatry_2012_Oct_9_2012_642752.nxml.txt.nlp	23094178	SENT66	29	29	36	36	escitalopram	CYP2D6	PA10074	1565	0.732
NULL	F1000Res_2013_Mar_5_2_74.nxml.txt.nlp	24358880	SENT264	1	1	33	33	benzaldehyde	TRPA1	PA448571	8989	0.732
NULL	Cancers_(Basel)_2011_Aug_9_3(3)_3189-3205.nxml.txt.nlp	24212952	SENT108	30	30	9	9	hyaluronidase	HAS2	PA164745713	3037	0.732
NULL	Ann_Hematol_2014_Sep_10_93(1)_1-11.nxml.txt.nlp	24018623	SENT177	0	0	26	26	lenalidomide	IL-10	PA162363968	3586	0.732
NULL	Physiol_Rep_2014_Sep_28_2(9)_e12158.nxml.txt.nlp	25263207	SENT14	2	2	19	19	forskolin	TGR5	PA146096022	151306	0.732
NULL	Child_Adolesc_Psychiatry_Ment_Health_2009_Mar_12_3_9.nxml.txt.nlp	19284622	SENT128	23	23	2	2	ziprasidone	BARS	PA451974	1487	0.732
NULL	J_Cell_Biol_2008_Jul_14_182(1)_197-213.nxml.txt.nlp	18625847	SENT184	25	25	16	16	nutlin-3	JNK		5599	0.732
NULL	Drug_Saf_2014_Apr_29_37(5)_343-350.nxml.txt.nlp	24777653	SENT124	30	30	16	16	oxycodone	OTC	PA450741	5009	0.732
NULL	J_Hematol_Oncol_2011_Feb_7_4_6.nxml.txt.nlp	21299849	SENT126	22	22	14	14	imatinib	RPS6	PA10804	6194	0.732
NULL	J_Gen_Physiol_2008_Nov_132(5)_521-535.nxml.txt.nlp	18852303	SENT325	2	2	19	19	trypsin	CAP2	PA451806	5271;10486	0.732
NULL	Diabetes_Care_2013_Aug_17_36(Suppl_2)_S245-S252.nxml.txt.nlp	23882053	SENT3	17	17	26	26	liraglutide	GLP	PA165958364	342096	0.732
NULL	Acta_Pharmacol_Sin_2011_Mar_31_32(3)_295-302.nxml.txt.nlp	21278785	SENT13	5	5	13	13	evodiamine	IL-6	PA165860788	3569	0.732
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT2404	7	7	3	3	amiodarone	CYP3A4	PA448383	1576	0.732
NULL	Cancer_Cell_2007_Dec_11_12(6)_514-527.nxml.txt.nlp	18068629	SENT593	17	17	5	5	paclitaxel	TGFBI	PA450761	7045	0.732
NULL	Cancer_Imaging_2011_Oct_3_11(1A)_S129-S145.nxml.txt.nlp	22185786	SENT26	16	16	4	4	denosumab	HER-2	PA166048634	2064	0.732
NULL	Hum_Mol_Genet_2013_Nov_15_22(22)_4616-4626.nxml.txt.nlp	23814041	SENT58	20	20	25	25	doxycycline	neuroserpin	PA449415	5274	0.732
NULL	Br_J_Cancer_1998_Nov_78(9)_1170-1174.nxml.txt.nlp	9820175	SENT13	40	40	31	31	bufuralol	CYP2E1	PA166110256	1571	0.732
NULL	Arch_Drug_Inf_2008_Jul_1(1)_14-22.nxml.txt.nlp	20157364	SENT84	0	0	8	8	pravastatin	MCP-1	PA451089	6347	0.732
NULL	Emerg_Infect_Dis_2007_Jul_13(7)_1024-1030.nxml.txt.nlp	18214174	SENT26	18	18	34	34	linezolid	LSE	PA450233	54414	0.732
NULL	Clin_Mol_Allergy_2011_May_31_9_10.nxml.txt.nlp	21624140	SENT291	19	19	9	9	itraconazole	gamma	PA450132	9913	0.732
NULL	Case_Rep_Oncol_2013_Jan_29_6(1)_72-77.nxml.txt.nlp	23466899	SENT106	7	7	19	19	paclitaxel	SPARC	PA450761	6678	0.732
NULL	Front_Oncol_2013_Nov_27_3_290.nxml.txt.nlp	24350055	SENT121	24	24	9	9	docetaxel	PARP-1	PA449383	25976	0.732
NULL	Acta_Pharmacol_Sin_2012_Oct_3_33(10)_1311-1318.nxml.txt.nlp	22941289	SENT130	0	0	5	5	sorafenib	VEGFR2	PA7000	3791	0.732
NULL	Evid_Based_Complement_Alternat_Med_2013_May_13_2013_506324.nxml.txt.nlp	23818927	SENT124	29	29	35	35	doxorubicin	MM1	PA449412	23654	0.732
NULL	Interdiscip_Perspect_Infect_Dis_2012_Oct_14_2012_976273.nxml.txt.nlp	23097666	SENT367	5	5	19	19	ciprofloxacin	HAP	PA449009	5915;10313	0.732
NULL	Front_Oncol_2014_Oct_21_4_285.nxml.txt.nlp	25374842	SENT680	19	19	26	26	nutlin-3	p53		7157	0.732
NULL	J_Oncol_2013_Feb_17_2013_872957.nxml.txt.nlp	23476648	SENT142	11	11	4	4	cisplatin	SFN	PA449014	25996;2810	0.732
NULL	Pain_2014_Nov_155(11)_2243-2252.nxml.txt.nlp	24978826	SENT321	0	0	2	2	capsaicin	TRPV1	PA448776	7442	0.732
NULL	J_Sens_Technol_2013_Sep_3(3)_10_4236_jst_2013_33015.nxml.txt.nlp	24409399	SENT140	20	20	41	41	ketamine	DC2	PA450144	58505	0.732
NULL	Libyan_J_Med_2007_Dec_1_2(4)_169-175.nxml.txt.nlp	21503240	SENT239	25	25	33	33	diazepam	CA1	PA449283	759	0.732
NULL	Appl_Microbiol_Biotechnol_2012_Feb_11_93(4)_1377-1387.nxml.txt.nlp	22234536	SENT158	3	3	17	17	nadh	mol	PA164755085	90527	0.732
NULL	Br_J_Ophthalmol_2008_Sep_22_92(9)_1275-1282.nxml.txt.nlp	18723745	SENT101	18	18	41	41	tafluprost	BAK	PA165958432	578	0.732
NULL	Br_J_Cancer_2010_Feb_16_102(4)_658-664.nxml.txt.nlp	20104222	SENT104	2	2	10	10	sunitinib	IFN	PA162372840	3439	0.732
NULL	Biol_Open_2013_Aug_6_2(10)_1022-1031.nxml.txt.nlp	24167712	SENT268	13	13	8	8	doxycycline	PLK1	PA449415	5347	0.732
NULL	Ann_Indian_Acad_Neurol_2014_Mar_17(Suppl_1)_S32-S36.nxml.txt.nlp	24791086	SENT112	27	27	22	22	midazolam	PTB	PA450496	58155	0.732
NULL	J_Biomed_Biotechnol_2011_Jul_3_2011_343791.nxml.txt.nlp	21799660	SENT95	32	32	18	18	ethanol	COD	PA448073	6628	0.732
NULL	Comp_Hepatol_2003_Jan_31_2_3.nxml.txt.nlp	12622871	SENT108	6	6	14	14	clofibrate	c-fos	PA449045	2353	0.732
NULL	Oncotarget_2014_Sep_2_5(19)_9308-9321.nxml.txt.nlp	25301721	SENT207	31	31	41	41	forskolin	CD11b	PA146096022	3684	0.732
NULL	Br_J_Cancer_2010_Feb_2_102(3)_520-529.nxml.txt.nlp	20029417	SENT146	22	22	3	3	cetuximab	IL-21	PA10040	59067;50616;27189	0.732
NULL	Ann_Hematol_2014_Mar_18_93(8)_1335-1344.nxml.txt.nlp	24638841	SENT153	5	5	7	7	rituximab	CLB	PA451261	171425	0.732
NULL	Arthritis_Res_Ther_2012_Jul_27_14(4)_R175.nxml.txt.nlp	22838733	SENT104	23	23	28	28	adalimumab	CD14	PA10004	929	0.732
NULL	Aging_(Albany_NY)_2011_Dec_16_3(12)_1142-1153.nxml.txt.nlp	22184279	SENT159	2	2	9	9	resveratrol	SIRT1		23411	0.732
NULL	J_Exerc_Nutrition_Biochem_2014_Sep_11_18(3)_259-266.nxml.txt.nlp	25566462	SENT186	7	7	2	2	nadh	NAMPT	PA164755085	10135	0.732
NULL	Cell_Death_Dis_2014_Feb_27_5(2)_e1088.nxml.txt.nlp	24577086	SENT43	34	34	16	16	metformin	Bcl-2	PA450395	596	0.732
NULL	Endocrinology_2015_Jan_6_156(1)_24-31.nxml.txt.nlp	25375036	SENT41	24	24	17	17	ethanol	DES	PA448073	1674	0.732
NULL	J_Immunol_Res_2014_May_21_2014_371087.nxml.txt.nlp	24963497	SENT327	21	21	7	7	decitabine	DAC	PA164749631	13	0.732
NULL	Lipids_Health_Dis_2011_Feb_28_10_38.nxml.txt.nlp	21352602	SENT89	6	6	10	10	atorvastatin	PCSK9	PA448500	255738	0.732
NULL	Br_J_Cancer_2010_Jun_8_102(12)_1707-1716.nxml.txt.nlp	20461078	SENT99	7	7	5	5	bortezomib	TRAIL	PA10252	8743	0.732
NULL	Evid_Based_Complement_Alternat_Med_2012_Aug_27_2012_361516.nxml.txt.nlp	22969825	SENT65	39	39	32	32	vinblastine	P-gp	PA451877	5243	0.732
NULL	Mol_Brain_2014_Nov_18_7(1)_82.nxml.txt.nlp	NULL	SENT38	7	7	13	13	tamoxifen	p35	PA451581	3592;80761	0.732
NULL	CNS_Spectr_2014_Dec_18_19(6)_528-534.nxml.txt.nlp	24642260	SENT48	7	7	20	20	aripiprazole	5-HT1A	PA10026	3350	0.732
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT279	19	19	3	3	gemcitabine	ABCC4	PA449748	10257	0.732
NULL	Diabetes_Care_2009_Nov_32(Suppl_2)_S223-S231.nxml.txt.nlp	19875556	SENT249	14	14	19	19	liraglutide	GLP-1	PA165958364	100125288	0.732
NULL	Mol_Vis_2007_Mar_14_13_374-387.nxml.txt.nlp	17392688	SENT71	19	19	25	25	gentamicin	CO2	PA449753	4513	0.732
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT481	4	4	8	8	iloperidone	PRL	PA161199368	5617	0.732
NULL	Basic_Clin_Neurosci_2014_Winter_5(1)_31-41.nxml.txt.nlp	25436082	SENT11	30	30	25	25	bupropion	mol	PA448687	90527	0.732
NULL	Cardiovasc_Res_2010_Mar_1_85(4)_719-728.nxml.txt.nlp	19861308	SENT97	22	22	26	26	estradiol	GAPDH	PA449503	2597	0.732
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT102	3	3	6	6	tenofovir	ABCB1	PA10204	5243	0.732
NULL	Int_J_Fertil_Steril_2014_Jul_8_Jul-Sep_8(2)_193-206.nxml.txt.nlp	25083185	SENT42	11	11	7	7	estradiol	PRL	PA449503	5617	0.732
NULL	Gastric_Cancer_2014_Apr_7_17(1)_1-12.nxml.txt.nlp	23563986	SENT299	9	9	24	24	lapatinib	HER2	PA152241907	2064	0.732
NULL	F1000Res_2013_Mar_5_2_74.nxml.txt.nlp	24358880	SENT230	12	12	6	6	capsaicin	TRPV1	PA448776	7442	0.732
NULL	Nat_Med_2011_Jun_26_17(7)_875-882.nxml.txt.nlp	21706030	SENT253	24	24	16	16	doxycycline	BRCA1	PA449415	672	0.732
NULL	Cell_Death_Dis_2013_Jun_13_4(6)_e665.nxml.txt.nlp	23764846	SENT91	15	15	21	21	sorafenib	BLM	PA7000	641	0.732
NULL	Br_J_Cancer_2006_Feb_13_94(3)_407-426.nxml.txt.nlp	16434996	SENT243	4	4	6	6	genistein	BRCA1	PA165109660	672	0.732
NULL	Acta_Pharmacol_Sin_2011_Jun_3_32(6)_749-757.nxml.txt.nlp	21642946	SENT124	12	12	22	22	dantrolene	FKBP12	PA449208	2280	0.732
NULL	EMBO_Mol_Med_2012_Sep_7_4(9)_896-909.nxml.txt.nlp	22887866	SENT138	0	0	10	10	lovastatin	MYC	PA450272	4609	0.732
NULL	Scientifica_(Cairo)_2012_Dec_25_2012_561761.nxml.txt.nlp	24278716	SENT408	22	22	12	12	yohimbine	NK1	PA451946	11126	0.732
NULL	Mol_Cancer_2009_Aug_25_8_66.nxml.txt.nlp	19706164	SENT196	24	24	30	30	celecoxib	p53	PA448871	7157	0.732
NULL	J_Med_Life_2011_May_15_4(2)_172-177.nxml.txt.nlp	21776301	SENT45	23	23	34	34	neomycin	CO2	PA450608	4513	0.732
NULL	BMB_Rep_2013_Jan_46(1)_59-64.nxml.txt.nlp	23351386	SENT41	8	8	11	11	auranofin	STAT3	PA448510	6774	0.732
NULL	Oncotarget_2014_Aug_4_5(17)_7843-7857.nxml.txt.nlp	25151659	SENT198	24	24	19	19	nadh	Q10	PA164755085	27161	0.732
NULL	Biosci_Rep_2013_Jun_5_33(3)_e00041.nxml.txt.nlp	23577625	SENT543	18	18	15	15	collagenase	MEK2	PA449107	5605	0.732
NULL	Emerg_Infect_Dis_2011_Jul_17(7)_1280-1282.nxml.txt.nlp	21762587	SENT125	22	22	30	30	primaquine	Mal	PA451103	114609	0.732
NULL	J_Cell_Biol_2000_Dec_11_151(6)_1257-1268.nxml.txt.nlp	11121440	SENT136	0	0	12	12	arsenite	A30	PA452638	28937	0.732
NULL	Diabetes_Metab_Syndr_Obes_2009_May_18_2_37-49.nxml.txt.nlp	20148188	SENT170	8	8	3	3	liraglutide	GLP-1	PA165958364	100125288	0.732
NULL	Croat_Med_J_2012_Jun_53(3)_224-233.nxml.txt.nlp	22661135	SENT64	35	35	9	9	estradiol	ACTH	PA449503	5443	0.732
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT150	4	4	17	17	curcumin	TRAIL	PA151958596	8743	0.732
NULL	Breast_Cancer_Res_2011_Apr_14_13(2)_R43.nxml.txt.nlp	21492444	SENT35	28	28	24	24	tamoxifen	HER2	PA451581	2064	0.732
NULL	Onco_Targets_Ther_2014_May_12_7_719-728.nxml.txt.nlp	24872713	SENT53	8	8	16	16	sunitinib	PUMA	PA162372840	27113	0.732
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT192	21	21	30	30	cetuximab	Yes	PA10040	7525	0.732
NULL	J_Korean_Med_Sci_2009_Jan_29_24(Suppl_1)_S170-S175.nxml.txt.nlp	19194548	SENT117	17	17	31	31	cisplatin	EPO	PA449014	7076;8288;2056	0.732
NULL	J_Invest_Dermatol_2012_Nov_21_132(11)_2642-2651.nxml.txt.nlp	22718118	SENT169	13	13	9	9	collagenase	CD11b	PA449107	3684	0.732
NULL	Cell_Commun_Signal_2013_Feb_20_11_13.nxml.txt.nlp	23425659	SENT35	22	22	8	8	diazepam	MCAD	PA449283	34	0.732
NULL	Indian_J_Pharmacol_2008_Nov-Dec_40(6)_248-250.nxml.txt.nlp	21279179	SENT91	11	11	2	2	estradiol	aromatase	PA449503	1588	0.732
NULL	Diabetes_2013_May_16_62(5)_1697-1708.nxml.txt.nlp	23364453	SENT347	12	12	8	8	fasudil	Rho	PA165946121	29984	0.732
NULL	Onco_Targets_Ther_2014_Sep_9_7_1571-1582.nxml.txt.nlp	25228815	SENT141	0	0	8	8	sunitinib	CD31	PA162372840	5175	0.732
NULL	Orphanet_J_Rare_Dis_2014_Dec_5_9(1)_194.nxml.txt.nlp	NULL	SENT383	31	31	37	37	desogestrel	CO2	PA449238	4513	0.732
NULL	J_Cheminform_2012_May_1_4(Suppl_1)_P46.nxml.txt.nlp	NULL	SENT13	11	11	3	3	physostigmine	BRAF	PA450957	673	0.732
NULL	Breast_Cancer_Res_2011_Apr_1_13(2)_R35.nxml.txt.nlp	21457545	SENT175	16	16	19	19	erlotinib	EGFR	PA134687924	1956	0.732
NULL	J_Biol_Chem_2009_Aug_21_284(34)_22926-22937.nxml.txt.nlp	19520847	SENT237	15	15	5	5	papain	ADP	PA450778	23038	0.732
NULL	Eur_J_Clin_Pharmacol_2014_Aug_23_70(10)_1173-1179.nxml.txt.nlp	25146692	SENT28	18	18	15	15	etravirine	CYP3A4	PA166014703	1576	0.732
NULL	J_Neuroinflammation_2011_Feb_4_8_10.nxml.txt.nlp	21294877	SENT82	12	12	10	10	capsaicin	TRPV1	PA448776	7442	0.732
NULL	J_Psychopharmacol_2010_Jan_24(1)_27-38.nxml.txt.nlp	19204064	SENT363	17	17	32	32	amphetamine	NK1	PA448408	11126	0.732
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT89	24	24	10	10	nutlin-3	IBP		706;50619	0.732
NULL	Indian_J_Pharmacol_2014_May-Jun_46(3)_281-285.nxml.txt.nlp	24987174	SENT82	10	10	0	0	sildenafil	SPAP	PA451346	10158	0.732
NULL	AIDS_Res_Ther_2008_Sep_17_5_21.nxml.txt.nlp	18799008	SENT3	5	5	20	20	lopinavir	SGC	PA450264	6443	0.732
NULL	J_Hematol_Oncol_2013_Jan_17_6_8.nxml.txt.nlp	23327547	SENT6	9	9	21	21	sulindac	p53	PA451565	7157	0.732
NULL	Tuberc_Respir_Dis_(Seoul)_2013_May_31_74(5)_235-239.nxml.txt.nlp	23750173	SENT0	40	40	38	38	etoposide	CHOP	PA449552	1649	0.732
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT219	7	7	27	27	atorvastatin	CD14	PA448500	929	0.732
NULL	Chemother_Res_Pract_2011_Dec_1_2011_715469.nxml.txt.nlp	22312557	SENT11	17	17	3	3	cisplatin	p53	PA449014	7157	0.732
NULL	Front_Neurol_2014_Sep_11_5_173.nxml.txt.nlp	25309501	SENT160	2	2	23	23	hyaluronidase	CD44	PA164745713	960	0.732
NULL	Biologics_2013_Apr_15_7_77-90.nxml.txt.nlp	23723688	SENT57	12	12	25	25	cisplatin	CRT	PA449014	811	0.732
NULL	J_Cell_Biol_1998_Jan_26_140(2)_335-345.nxml.txt.nlp	9442109	SENT204	7	7	28	28	chloroquine	NHE	PA448948	285335	0.732
NULL	ScientificWorldJournal_2012_Jul_31_2012_475675.nxml.txt.nlp	22919323	SENT36	41	41	17	17	metformin	adiponectin	PA450395	9370	0.732
NULL	Reprod_Biol_Endocrinol_2004_Jun_16_2_31.nxml.txt.nlp	15200680	SENT85	12	12	3	3	estradiol	aromatase	PA449503	1588	0.732
NULL	Eur_J_Haematol_2009_Apr_82(4)_277-287.nxml.txt.nlp	19187270	SENT187	8	8	6	6	pha-665752	IL-6		3569	0.732
NULL	Front_Chem_2014_Mar_14_2_12.nxml.txt.nlp	24790981	SENT100	2	2	7	7	curcumin	P19	PA151958596	51561	0.732
NULL	Oncotarget_2014_Aug_19_5(18)_8703-8715.nxml.txt.nlp	25237928	SENT52	30	30	21	21	glucose	CD44	PA449773	960	0.732
NULL	Braz_J_Med_Biol_Res_2013_Aug_13_46(8)_650-658.nxml.txt.nlp	23969971	SENT13	29	29	44	44	oxaliplatin	STAT3	PA131285527	6774	0.732
NULL	Breast_Cancer_Res_2008_Dec_18_10(Suppl_4)_S19.nxml.txt.nlp	19128432	SENT13	30	30	22	22	anastrozole	IMPACT	PA448432	55364	0.732
NULL	Clin_Ophthalmol_2014_Apr_28_8_807-812.nxml.txt.nlp	24812486	SENT21	12	12	18	18	bevacizumab	CRT	PA130232992	811	0.732
NULL	EMBO_Mol_Med_2012_Oct_30_4(10)_1087-1096.nxml.txt.nlp	22933245	SENT151	7	7	36	36	olaparib	ANOVA		4858	0.732
NULL	J_Antimicrob_Chemother_2011_Apr_25_66(4)_912-919.nxml.txt.nlp	21393205	SENT167	18	18	7	7	daptomycin	CLCR	PA164768820	11330	0.732
NULL	Arthritis_Res_Ther_2009_Feb_3_11(1)_R15.nxml.txt.nlp	19192274	SENT224	2	2	12	12	chloroquine	IL-8	PA448948	3576	0.732
NULL	Evid_Based_Complement_Alternat_Med_2013_Aug_12_2013_982689.nxml.txt.nlp	23997806	SENT67	10	10	22	22	tolbutamide	castor	PA451718	54897	0.732
NULL	Indian_J_Ophthalmol_2012_Nov-Dec_60(6)_531-534.nxml.txt.nlp	23202392	SENT120	48	48	3	3	triamcinolone	hole	PA451749	80757	0.732
NULL	Breast_Cancer_Res_2005_Nov_21_7(6)_R1153-R1158.nxml.txt.nlp	16457695	SENT73	11	11	21	21	tamoxifen	BRCA1	PA451581	672	0.732
NULL	Cancer_Immunol_Immunother_2011_Jun_25_60(6)_793-808.nxml.txt.nlp	21350947	SENT176	9	9	12	12	sorafenib	IFN	PA7000	3439	0.732
NULL	Front_Neurosci_2014_Jan_10_7_270.nxml.txt.nlp	24454277	SENT20	7	7	9	9	resveratrol	SIRT1		23411	0.732
NULL	Acta_Pharmacol_Sin_2009_Jul_22_30(7)_956-964.nxml.txt.nlp	19543298	SENT226	13	13	18	18	simvastatin	ANOVA	PA451363	4858	0.732
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1724-1730.nxml.txt.nlp	19861964	SENT208	23	23	12	12	temozolomide	NRAS	PA451609	4893	0.732
NULL	J_Thromb_Thrombolysis_2011_Nov_26_32(4)_459-466.nxml.txt.nlp	21706290	SENT229	14	14	5	5	prasugrel	CYP2C19	PA154410481	1557	0.732
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_29_2013_590393.nxml.txt.nlp	23737838	SENT180	20	20	12	12	resveratrol	c-Myc		4609	0.732
NULL	Biosci_Rep_2012_Dec_13_33(1)_e00007.nxml.txt.nlp	23095119	SENT28	18	18	14	14	lipase	AMPK	PA450239	5563	0.732
NULL	Exp_Ther_Med_2014_Jun_28_7(6)_1539-1544.nxml.txt.nlp	24926340	SENT24	8	8	18	18	geldanamycin	Hsp90	PA152031327	3320	0.732
NULL	J_Biomed_Biotechnol_2007_Jul_26_2007_41705.nxml.txt.nlp	17710242	SENT44	19	19	13	13	cyclosporine	IL-2	PA449167	3558	0.732
NULL	Nat_Med_2013_Mar_10_19(3)_313-321.nxml.txt.nlp	23396211	SENT301	3	3	6	6	amlexanox	TBK1	PA164745310	29110	0.732
NULL	J_Hematol_Oncol_2010_Mar_23_3_11.nxml.txt.nlp	20331897	SENT158	12	12	32	32	oxaliplatin	LARC	PA131285527	6364	0.732
NULL	Summit_on_Translat_Bioinforma_2009_Mar_1_2009_124-128.nxml.txt.nlp	21347183	SENT69	38	38	26	26	thioguanine	TPMT	PA451663	7172	0.732
NULL	J_Cell_Biol_2007_Apr_23_177(2)_265-275.nxml.txt.nlp	17452530	SENT348	37	37	46	46	imiquimod	TLR9	PA449972	54106	0.732
NULL	Breast_Cancer_Res_2011_Nov_1_13(6)_224.nxml.txt.nlp	22114931	SENT112	22	22	10	10	lapatinib	PI3K	PA152241907	5290	0.732
NULL	Indian_J_Med_Res_2011_Sep_134(3)_295-301.nxml.txt.nlp	21985811	SENT111	6	6	26	26	phenytoin	CYP2C19	PA450947	1557	0.732
NULL	Virol_J_2011_May_17_8_234.nxml.txt.nlp	21575275	SENT39	38	38	35	35	ribavirin	IFN	PA451241	3439	0.732
NULL	Aging_Cell_2012_Aug_11(4)_579-587.nxml.txt.nlp	22435726	SENT89	18	18	14	14	etoposide	CD28	PA449552	1493;940	0.732
NULL	J_Thyroid_Res_2011_Apr_10_2011_895923.nxml.txt.nlp	21603172	SENT272	4	4	19	19	thyroglobulin	IL-2	PA164754910	3558	0.732
NULL	Acta_Pharmacol_Sin_2010_Apr_15_31(4)_493-500.nxml.txt.nlp	20228829	SENT148	19	19	9	9	bupivacaine	c-Jun	PA135057240	3725	0.732
NULL	Crit_Care_2008_Jan_24_12(1)_R27.nxml.txt.nlp	18304335	SENT209	5	5	22	22	thrombin	Rho	PA451674	29984	0.732
NULL	Exp_Mol_Med_2012_Sep_30_44(9)_536-544.nxml.txt.nlp	22771771	SENT56	23	23	13	13	celecoxib	p16	PA448871	1029	0.732
NULL	Acta_Naturae_2013_Jul-Sep_5(3)_99-106.nxml.txt.nlp	24303206	SENT14	17	17	22	22	ethanol	ADH1B	PA448073	125	0.732
NULL	Oncol_Rep_2012_Nov_22_28(5)_1851-1858.nxml.txt.nlp	22922937	SENT5	20	20	22	22	bortezomib	BTZ	PA10252	22794	0.732
NULL	Biomed_Res_Int_2014_Jun_2_2014_946492.nxml.txt.nlp	24991574	SENT11	17	17	11	11	olmesartan	ATRAP	PA164742950	57085	0.732
NULL	Virol_J_2011_May_17_8_234.nxml.txt.nlp	21575275	SENT117	5	5	2	2	ribavirin	IFN	PA451241	3439	0.732
NULL	Br_J_Cancer_2013_Sep_3_109(5)_1137-1146.nxml.txt.nlp	23942078	SENT202	13	13	10	10	sunitinib	RSK4	PA162372840	27330	0.732
NULL	Environ_Health_Perspect_2006_Apr_21_114(Suppl_1)_9-12.nxml.txt.nlp	16818240	SENT32	9	9	11	11	diethylstilbestrol	DES	PA449307	1674	0.732
NULL	Curr_Opin_Endocrinol_Diabetes_Obes_2014_Oct_28_21(5)_394-404.nxml.txt.nlp	25122493	SENT25	9	9	43	43	thyroglobulin	RAI	PA164754910	10848;6050	0.732
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT1602	16	16	4	4	nelfinavir	ABCC1	PA450606	4363	0.732
NULL	Diabetes_2013_Oct_17_62(10)_3547-3552.nxml.txt.nlp	23863812	SENT71	13	13	9	9	pravastatin	adiponectin	PA451089	9370	0.732
NULL	Br_J_Cancer_2009_Jul_21_101(2)_269-277.nxml.txt.nlp	19603033	SENT43	26	26	23	23	cisplatin	mol	PA449014	90527	0.732
NULL	Leukemia_2014_Mar_13_28(3)_600-608.nxml.txt.nlp	24240203	SENT115	6	6	20	20	nutlin-3	p53		7157	0.732
NULL	J_Exp_Med_1968_Oct_31_128(5)_877-894.nxml.txt.nlp	4176225	SENT1	26	26	20	20	thrombin	gamma	PA451674	9913	0.732
NULL	Int_J_Nanomedicine_2009_Apr_1_4_27-35.nxml.txt.nlp	19421368	SENT130	20	20	25	25	genistein	IL-2	PA165109660	3558	0.732
NULL	Int_J_Biol_Sci_2014_Jan_11_10(2)_142-148.nxml.txt.nlp	24520212	SENT107	14	14	4	4	tamoxifen	WWOX	PA451581	51741	0.732
NULL	Oncotarget_2014_Sep_10_5(19)_8924-8936.nxml.txt.nlp	25238040	SENT88	5	5	15	15	decitabine	p53	PA164749631	7157	0.732
NULL	Oncotarget_2011_Jun_30_2(7)_562-568.nxml.txt.nlp	21725138	SENT126	20	20	26	26	collagenase	MMP2	PA449107	4313	0.732
NULL	Eur_J_Neurosci_2009_Jan_29(2)_307-318.nxml.txt.nlp	19200236	SENT363	13	13	16	16	clonidine	gamma	PA449051	9913	0.732
NULL	Bioinform_Biol_Insights_2009_Oct_5_3_109-127.nxml.txt.nlp	20140064	SENT361	16	16	24	24	abacavir	P65	PA448004	64689;6857	0.732
NULL	eLife_2014_May_20_3_e01763.nxml.txt.nlp	24844244	SENT349	40	40	7	7	doxycycline	MELK	PA449415	9833	0.732
NULL	Biomed_Res_Int_2014_Jan_16_2014_821513.nxml.txt.nlp	24527458	SENT145	7	7	12	12	propofol	NAC	PA451141	22861	0.732
NULL	Appl_Clin_Genet_2010_Oct_29_3_85-101.nxml.txt.nlp	23776354	SENT146	15	15	4	4	sunitinib	PDGFRA	PA162372840	5156	0.732
NULL	Comp_Hepatol_2005_May_4_4_4.nxml.txt.nlp	15871734	SENT114	7	7	19	19	nadh	DTD	PA164755085	1728	0.732
NULL	Oncotarget_2013_Aug_21_4(9)_1484-1495.nxml.txt.nlp	23986086	SENT106	0	0	10	10	metformin	PIK3CA	PA450395	5290	0.732
NULL	J_Thromb_Haemost_2007_May_5(5)_1010-1018.nxml.txt.nlp	17355572	SENT281	27	27	12	12	thrombin	VWF	PA451674	7450	0.732
NULL	Mol_Clin_Oncol_2013_Jul_17_1(4)_680-684.nxml.txt.nlp	24649228	SENT18	20	20	6	6	etoposide	CRT	PA449552	811	0.732
NULL	Pharmaceutics_2011_Nov_18_3(4)_865-913.nxml.txt.nlp	24309312	SENT167	19	19	33	33	tizanidine	CYP3A4	PA451701	1576	0.732
NULL	Mol_Biol_Int_2012_Apr_9_2012_196715.nxml.txt.nlp	22577552	SENT164	7	7	11	11	staurosporine	MST1	PA165109623	6789;4485	0.732
NULL	Pharmaceuticals_(Basel)_2012_Aug_17_5(8)_837-852.nxml.txt.nlp	24280677	SENT535	9	9	6	6	capsaicin	TRPV1	PA448776	7442	0.732
NULL	Anal_Bioanal_Chem_2012_Feb_16_402(4)_1611-1623.nxml.txt.nlp	22173207	SENT209	17	17	0	0	rimantadine	SRM	PA164748038	6723;6725	0.732
NULL	Cancer_Med_2014_Apr_27_3(2)_310-321.nxml.txt.nlp	24464839	SENT224	17	17	8	8	everolimus	MVD	PA164746311	4597	0.732
NULL	AMB_Express_2011_May_18_1_6.nxml.txt.nlp	21906338	SENT91	2	2	12	12	l-leucine	mol	PA450197	90527	0.732
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT135	2	2	7	7	metformin	HIF-1	PA450395	29072	0.732
NULL	Cancers_(Basel)_2013_Apr_11_5(2)_418-429.nxml.txt.nlp	24216984	SENT41	21	21	3	3	temsirolimus	HIF-1	PA164746890	29072	0.732
NULL	Endocrinol_Metab_(Seoul)_2013_Dec_12_28(4)_262-274.nxml.txt.nlp	24396690	SENT49	23	23	4	4	liraglutide	GLP-1	PA165958364	100125288	0.732
NULL	Cell_Commun_Signal_2013_Oct_1_11_73.nxml.txt.nlp	24083678	SENT221	15	15	23	23	sulindac	AP-1	PA451565	2353;3727;2354;3725	0.732
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT252	10	10	4	4	doxorubicin	B7-H1	PA449412	29126	0.732
NULL	Nat_Genet_2013_Sep_28_45(9)_1004-1012.nxml.txt.nlp	23892607	SENT314	17	17	9	9	doxycycline	PC2	PA449415	5126;5311;8535	0.732
NULL	Genome_Biol_2008_May_9_9(5)_221.nxml.txt.nlp	18492217	SENT30	10	10	19	19	cisplatin	p53	PA449014	7157	0.732
NULL	Exp_Lung_Res_2013_Oct_1_39(8)_336-348.nxml.txt.nlp	23919450	SENT149	23	23	18	18	argatroban	PAR-1	PA164745516	2011;2149	0.732
NULL	Child_Adolesc_Psychiatry_Ment_Health_2009_Mar_12_3_9.nxml.txt.nlp	19284622	SENT42	26	26	22	22	ziprasidone	PES	PA451974	23481	0.732
NULL	Mol_Cancer_2008_Jun_30_7_60.nxml.txt.nlp	18590557	SENT148	13	13	17	17	paclitaxel	TRAIL	PA450761	8743	0.732
NULL	Nat_Neurosci_2012_Sep_5_15(9)_1245-1254.nxml.txt.nlp	22864611	SENT103	7	7	13	13	clozapine	mGlu2	PA449061	2912	0.732
NULL	Clin_Med_Insights_Oncol_2011_Sep_21_5_315-323.nxml.txt.nlp	22084620	SENT16	4	4	6	6	gemcitabine	IFN	PA449748	3439	0.732
NULL	Int_J_Inflam_2010_Aug_9_2010_151097.nxml.txt.nlp	21152121	SENT373	36	36	43	43	thrombin	C5a	PA451674	727	0.732
NULL	Leukemia_2014_Apr_14_28(4)_961-964.nxml.txt.nlp	24418991	SENT59	2	2	9	9	nilotinib	P-gp	PA165958345	5243	0.732
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT49	31	31	11	11	coumarin	CYP2C9	PA134521193	1559	0.732
NULL	Adv_Prev_Med_2013_Jun_12_2013_346372.nxml.txt.nlp	23840957	SENT132	16	16	14	14	methadone	OST	PA450401	1650;23263	0.732
NULL	Ann_Gen_Psychiatry_2010_Sep_17_9_35.nxml.txt.nlp	20849577	SENT163	13	13	15	15	aripiprazole	STAR	PA10026	6770;2984	0.732
NULL	Indian_J_Pharm_Sci_2013_May-Jun_75(3)_302-309.nxml.txt.nlp	24082346	SENT152	10	10	23	23	diclofenac	SRMS	PA449293	6725	0.732
NULL	Breast_Cancer_Res_Treat_2012_Jun_18_133(3)_937-947.nxml.txt.nlp	22094936	SENT186	41	41	26	26	tamoxifen	E2F1	PA451581	1869	0.732
NULL	Oncogene_2010_Jul_8_29(27)_3953-3963.nxml.txt.nlp	20440263	SENT21	15	15	27	27	oxygen	ROS	PA450744	6098	0.732
NULL	Indian_J_Anaesth_2010_Jul-Aug_54(4)_327-330.nxml.txt.nlp	20882176	SENT106	17	17	24	24	halothane	CO2	PA449845	4513	0.732
NULL	Chin_J_Cancer_2012_Apr_31(4)_197-206.nxml.txt.nlp	22237040	SENT39	3	3	5	5	cisplatin	DDP	PA449014	1678	0.732
NULL	Croat_Med_J_2013_Apr_54(2)_171-179.nxml.txt.nlp	23630144	SENT172	0	0	7	7	taurine	HO-1	PA451590	3162	0.732
NULL	Eur_J_Med_Res_2009_Nov_24_14(Suppl_3)_17-21.nxml.txt.nlp	19959412	SENT71	19	19	25	25	ritonavir	UGT1A1	PA451260	54658	0.732
NULL	Pharmaceutics_2010_Jun_2_2(2)_258-274.nxml.txt.nlp	NULL	SENT410	10	10	1	1	risperidone	ABCB1	PA451257	5243	0.732
NULL	Int_J_Mol_Sci_2014_Mar_5_15(3)_3970-3988.nxml.txt.nlp	24603537	SENT147	27	27	6	6	ethanol	mol	PA448073	90527	0.732
NULL	Arthritis_Res_Ther_2013_Oct_2_15(5)_R141.nxml.txt.nlp	24286116	SENT169	0	0	7	7	tocilizumab	IL-6	PA165292659	3569	0.732
NULL	Cancer_Med_2013_Aug_30_2(4)_457-467.nxml.txt.nlp	24156018	SENT257	31	31	19	19	marimastat	EGFR	PA164748329	1956	0.732
NULL	Acta_Pharmacol_Sin_2014_Sep_25_35(9)_1199-1206.nxml.txt.nlp	25152024	SENT187	14	14	33	33	cisplatin	JNK	PA449014	5599	0.732
NULL	Mol_Cancer_2014_Jun_5_13_143.nxml.txt.nlp	24898067	SENT54	12	12	0	0	vinorelbine	HER-2	PA451881	2064	0.732
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Dec_12_66(Pt_1)_o123.nxml.txt.nlp	21580013	SENT71	0	0	15	15	benzaldehyde	mol	PA448571	90527	0.732
NULL	Biosci_Rep_2014_Aug_6_34(4)_e00131.nxml.txt.nlp	24975826	SENT150	2	2	7	7	pp2	TRPM8		79054	0.731
NULL	Br_J_Cancer_1998_Nov_78(9)_1170-1174.nxml.txt.nlp	9820175	SENT13	24	24	14	14	coumarin	CYP2C8	PA134521193	1558	0.731
NULL	J_Invest_Dermatol_2014_Jan_25_134(1)_268-271.nxml.txt.nlp	23812303	SENT47	9	9	18	18	ustekinumab	IL-23	PA166048654	51561	0.731
NULL	BMJ_Open_2012_Oct_18_2(5)_e001007.nxml.txt.nlp	23087012	SENT75	3	3	9	9	metformin	DPP4	PA450395	1803	0.731
NULL	Br_J_Cancer_2010_Jan_5_102(1)_80-86.nxml.txt.nlp	19920817	SENT123	12	12	29	29	bevacizumab	IFN	PA130232992	3439	0.731
NULL	Exp_Ther_Med_2012_Sep_8_4(3)_519-523.nxml.txt.nlp	23181129	SENT84	24	24	14	14	iodine	PTC	PA450049	5979;8030	0.731
NULL	Front_Pharmacol_2014_May_30_5_132.nxml.txt.nlp	24910615	SENT54	31	31	27	27	estradiol	NMI	PA449503	9111	0.731
NULL	Cell_Death_Dis_2010_Oct_21_1(10)_e86.nxml.txt.nlp	21368859	SENT44	17	17	22	22	doxorubicin	TRAIL	PA449412	8743	0.731
NULL	Indian_J_Med_Res_2013_Apr_137(4)_759-766.nxml.txt.nlp	23703345	SENT42	17	17	43	43	ethanol	San	PA448073	80218	0.731
NULL	J_Cell_Mol_Med_2014_Dec_7_18(12)_2536-2552.nxml.txt.nlp	25287328	SENT174	23	23	27	27	estradiol	PKD1	PA449503	5310	0.731
NULL	Ther_Clin_Risk_Manag_2006_Jun_2(2)_129-158.nxml.txt.nlp	18360588	SENT179	6	6	9	9	voriconazole	CYP2C19	PA10233	1557	0.731
NULL	Biomed_Res_Int_2014_Jan_15_2014_859871.nxml.txt.nlp	24527460	SENT97	21	21	14	14	bevacizumab	EGFR	PA130232992	1956	0.731
NULL	Breast_Cancer_Res_2011_Dec_1_13(6)_R124.nxml.txt.nlp	22132731	SENT70	26	26	38	38	fluorescein	San	PA164746009	80218	0.731
NULL	J_Biol_Eng_2009_Oct_16_3_18.nxml.txt.nlp	19835592	SENT48	15	15	25	25	ofloxacin	CPZ	PA450684	8532	0.731
NULL	J_Cancer_Prev_2014_Mar_19(1)_39-46.nxml.txt.nlp	25337571	SENT98	6	6	18	18	ethanol	p53	PA448073	7157	0.731
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2011_Sep_13_4_47-62.nxml.txt.nlp	22879794	SENT48	14	14	6	6	liraglutide	PPG	PA165958364	5552	0.731
NULL	Br_J_Cancer_1990_Oct_62(4)_692-694.nxml.txt.nlp	2223592	SENT7	39	39	18	18	spermine	UPA	PA164781199	118471;5328	0.731
NULL	Osteoporos_Int_2013_Oct_19_24(1)_23-57.nxml.txt.nlp	23079689	SENT513	20	20	18	18	teriparatide	PTH	PA451620	5741	0.731
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT103	0	0	9	9	trastuzumab	EGFR	PA451743	1956	0.731
NULL	J_Int_AIDS_Soc_2012_Oct_22_15(Suppl_3)_10_7448_IAS_15_5_18440.nxml.txt.nlp	NULL	SENT2545	20	20	14	14	saquinavir	LSR	PA451305	51599	0.731
NULL	Int_J_Endocrinol_2013_Nov_27_2013_592576.nxml.txt.nlp	24369464	SENT121	2	2	15	15	atorvastatin	SCAP	PA448500	22937	0.731
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT117	0	0	8	8	atorvastatin	RANKL	PA448500	8600	0.731
NULL	Cancer_Cell_Int_2014_Jul_2_14_59.nxml.txt.nlp	25120382	SENT157	28	28	30	30	metformin	Met	PA450395	79811	0.731
NULL	Nat_Genet_2010_Jul_6_42(7)_608-613.nxml.txt.nlp	20526338	SENT11	16	16	9	9	thrombin	ADP	PA451674	23038	0.731
NULL	JAKSTAT_2013_Jul_1_2(3)_e25025.nxml.txt.nlp	24069563	SENT178	5	5	8	8	hydroxyurea	IFN	PA449942	3439	0.731
NULL	Nucleic_Acids_Res_2005_Aug_12_33(14)_4584-4592.nxml.txt.nlp	16100380	SENT106	8	8	1	1	paromomycin	GCN2	PA164784023	440275	0.731
NULL	Front_Endocrinol_(Lausanne)_2013_May_8_4_53.nxml.txt.nlp	23658553	SENT856	17	17	10	10	imatinib	FIP1L1	PA10804	81608	0.731
NULL	Arthritis_Res_Ther_2009_Jan_3_11(1)_R1.nxml.txt.nlp	19121222	SENT11	8	8	5	5	estradiol	IFN	PA449503	3439	0.731
NULL	Cell_Death_Dis_2013_Jun_27_4(6)_e694.nxml.txt.nlp	23807223	SENT82	10	10	16	16	chloroquine	IL-6	PA448948	3569	0.731
NULL	Cell_Death_Dis_2010_Oct_21_1(10)_e86.nxml.txt.nlp	21368859	SENT100	17	17	15	15	doxorubicin	TRAIL	PA449412	8743	0.731
NULL	J_Cell_Biol_2004_Jul_5_166(1)_97-109.nxml.txt.nlp	15240572	SENT542	14	14	12	12	heparin	perlecan	PA449855	3339	0.731
NULL	Aging_(Albany_NY)_2011_Feb_20_3(2)_85-93.nxml.txt.nlp	21386133	SENT148	6	6	3	3	metformin	AMPK	PA450395	5563	0.731
NULL	J_Cell_Mol_Med_2013_Oct_23_17(10)_1207-1217.nxml.txt.nlp	24106980	SENT117	9	9	6	6	paclitaxel	miR-17-92	PA450761	407975	0.731
NULL	J_Asthma_Allergy_2012_Nov_8_5_65-70.nxml.txt.nlp	23204847	SENT72	23	23	19	19	omalizumab	ACT	PA164752253	12;11332;9457;641455	0.731
NULL	Clin_Cosmet_Investig_Dermatol_2011_Jul_1_4_93-99.nxml.txt.nlp	21760744	SENT100	19	19	5	5	etanercept	CCR6	PA449515	1235	0.731
NULL	Biol_Proced_Online_2003_Feb_17_5_43-52.nxml.txt.nlp	12734557	SENT138	4	4	0	0	bupivacaine	IFN	PA135057240	3439	0.731
NULL	Cardiovasc_Diabetol_2011_Feb_11_10_18.nxml.txt.nlp	21314919	SENT90	27	27	5	5	gliclazide	Met	PA10892	79811	0.731
NULL	Pharmaceutics_2011_Nov_18_3(4)_865-913.nxml.txt.nlp	24309312	SENT336	28	28	25	25	midazolam	CYP3A	PA450496	1574	0.731
NULL	Breast_Cancer_Res_2010_Jul_22_12(4)_R53.nxml.txt.nlp	20649975	SENT131	16	16	20	20	tamoxifen	HOXB13	PA451581	10481	0.731
NULL	Int_J_Chron_Obstruct_Pulmon_Dis_2007_Jun_2(2)_141-150.nxml.txt.nlp	18044686	SENT197	12	12	36	36	ipratropium	Mal	PA450082	114609	0.731
NULL	J_Biol_Chem_2012_Apr_27_287(18)_14644-14658.nxml.txt.nlp	22375002	SENT365	24	24	19	19	forskolin	CC2D1A	PA146096022	54862	0.731
NULL	Br_J_Cancer_2009_Jun_2_100(11)_1739-1745.nxml.txt.nlp	19436299	SENT178	25	25	6	6	everolimus	FDG	PA164746311	23583	0.731
NULL	Chin_J_Cancer_2012_Nov_31(11)_507-518.nxml.txt.nlp	22640626	SENT173	43	43	22	22	nilotinib	NQO2	PA165958345	4835	0.731
NULL	Front_Pharmacol_2014_Nov_21_5_257.nxml.txt.nlp	25484865	SENT247	15	15	6	6	dasatinib	ABCB1	PA162372878	5243	0.731
NULL	Virchows_Arch_2012_Feb_16_460(2)_141-149.nxml.txt.nlp	22173329	SENT218	4	4	26	26	irinotecan	KRAS	PA450085	3845	0.731
NULL	Indian_J_Med_Res_2013_Jan_137(1)_125-129.nxml.txt.nlp	23481061	SENT22	1	1	15	15	cisplatin	GSTP1	PA449014	2950	0.731
NULL	J_Hematol_Oncol_2009_Apr_22_2_18.nxml.txt.nlp	19386128	SENT60	16	16	9	9	cetuximab	EGFR	PA10040	1956	0.731
NULL	Mol_Cell_Biochem_2015_Oct_8_398(1-2)_165-173.nxml.txt.nlp	25292312	SENT141	3	3	8	8	bortezomib	ORP150	PA10252	10525	0.731
NULL	Breast_Cancer_Res_2008_May_12_10(3)_R43.nxml.txt.nlp	18471300	SENT209	2	2	21	21	estradiol	p53	PA449503	7157	0.731
NULL	Breast_Cancer_Res_2009_Sep_29_11(5)_209.nxml.txt.nlp	19818165	SENT168	3	3	15	15	tamoxifen	EGFR	PA451581	1956	0.731
NULL	Front_Immunol_2012_Jan_31_3_4.nxml.txt.nlp	22566890	SENT29	20	20	13	13	galactose	IL-10	PA449725	3586	0.731
NULL	Cancer_Imaging_2011_Aug_24_11(1)_123-139.nxml.txt.nlp	21865109	SENT151	13	13	18	18	estradiol	FES	PA449503	2242	0.731
NULL	Anticancer_Drugs_2015_Feb_22_26(2)_139-147.nxml.txt.nlp	25203626	SENT212	23	23	25	25	sorafenib	EZH2	PA7000	2146	0.731
NULL	Environ_Health_Perspect_2013_Sep_14_121(9)_1002-1010.nxml.txt.nlp	23771518	SENT111	21	21	17	17	picrotoxin	RDX	PA164777007	5962	0.731
NULL	Reprod_Biol_Endocrinol_2013_Feb_26_11_15.nxml.txt.nlp	23442442	SENT138	2	2	6	6	l-arginine	BCL2	PA448478	596	0.731
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Dec_3_65(Pt_1)_o9.nxml.txt.nlp	21581727	SENT57	33	33	19	19	ethanol	mol	PA448073	90527	0.731
NULL	Oncol_Lett_2014_May_11_7(5)_1474-1478.nxml.txt.nlp	24765159	SENT39	8	8	13	13	paraformaldehyde	B7-H4	PA450790	79679	0.731
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT121	24	24	19	19	resveratrol	TNF		7124	0.731
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT117	10	10	29	29	perifosine	DR4	PA165291471	8797	0.731
NULL	J_Midlife_Health_2014_Jan-Mar_5(1)_6-9.nxml.txt.nlp	24672199	SENT16	34	34	30	30	estradiol	aromatase	PA449503	1588	0.731
NULL	Oncotarget_2013_Aug_24_4(10)_1618-1631.nxml.txt.nlp	24113128	SENT103	11	11	25	25	sorafenib	p53	PA7000	7157	0.731
NULL	Biochem_Res_Int_2012_May_9_2012_290971.nxml.txt.nlp	22649731	SENT95	11	11	4	4	staurosporine	ANOVA	PA165109623	4858	0.731
NULL	Clin_Pharmacol_2010_Apr_27_2_77-82.nxml.txt.nlp	22291489	SENT48	7	7	24	24	cosyntropin	ACTH	PA164749052	5443	0.731
NULL	Brain_Sci_2013_Apr_26_3(2)_670-703.nxml.txt.nlp	24961420	SENT123	1	1	29	29	ethanol	JNK	PA448073	5599	0.731
NULL	Arthritis_Res_Ther_2006_Feb_28_8(2)_R49.nxml.txt.nlp	16507174	SENT39	18	18	15	15	fluorescein	CD54	PA164746009	3383	0.731
NULL	Br_J_Cancer_2013_Oct_15_109(8)_2155-2166.nxml.txt.nlp	24045666	SENT43	10	10	20	20	cetuximab	CD4	PA10040	920	0.731
NULL	J_Clin_Biochem_Nutr_2009_Nov_28_45(3)_285-291.nxml.txt.nlp	19902018	SENT103	9	9	14	14	hesperetin	XDH	PA164742902	7498	0.731
NULL	Exp_Ther_Med_2014_Sep_20_8(3)_968-972.nxml.txt.nlp	25120631	SENT132	15	15	0	0	naringin	PF4	PA151958360	5196	0.731
NULL	Diabetes_2013_Oct_17_62(10)_3547-3552.nxml.txt.nlp	23863812	SENT74	12	12	19	19	valsartan	ANOVA	PA451848	4858	0.731
NULL	Int_J_Mol_Sci_2014_Oct_8_15(10)_17974-17999.nxml.txt.nlp	25299695	SENT123	3	3	10	10	curcumin	HO-1	PA151958596	3162	0.731
NULL	Acta_Naturae_2013_Jul-Sep_5(3)_99-106.nxml.txt.nlp	24303206	SENT112	10	10	24	24	ethanol	ADH1B	PA448073	125	0.731
NULL	ScientificWorldJournal_2013_Dec_19_2013_313492.nxml.txt.nlp	24453831	SENT95	14	14	0	0	clopidogrel	VWF	PA449053	7450	0.731
NULL	Mol_Cell_Proteomics_2012_Feb_6_11(2)_M111_015222.nxml.txt.nlp	22147731	SENT40	24	24	14	14	cetuximab	EGF	PA10040	1950	0.731
NULL	J_Hematol_Oncol_2009_Mar_24_2_14.nxml.txt.nlp	19309523	SENT20	3	3	9	9	doxorubicin	CHOP	PA449412	1649	0.731
NULL	Arthritis_Res_Ther_2009_Apr_30_11(2)_R58.nxml.txt.nlp	19405951	SENT6	7	7	21	21	clodronate	RANKL	PA10239	8600	0.731
NULL	Acta_Pharmacol_Sin_2010_Dec_3_31(12)_1635-1642.nxml.txt.nlp	21127497	SENT131	13	13	6	6	phenylbutazone	UGT	PA450932	7361;7355	0.731
NULL	Acta_Pharmacol_Sin_2011_Oct_12_32(10)_1259-1265.nxml.txt.nlp	21909126	SENT106	7	7	10	10	losartan	p38	PA450268	10598;1432;7965	0.731
NULL	Evid_Based_Complement_Alternat_Med_2012_Aug_27_2012_361516.nxml.txt.nlp	22969825	SENT65	42	42	32	32	ketoconazole	P-gp	PA450146	5243	0.731
NULL	Br_J_Pharmacol_2014_Sep_28_171(18)_4255-4272.nxml.txt.nlp	24846338	SENT22	24	24	6	6	ondansetron	5-HT1A	PA450705	3350	0.731
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Sep_6_64(Pt_10)_m1225.nxml.txt.nlp	21200986	SENT60	29	29	8	8	ethanol	mol	PA448073	90527	0.731
NULL	Crit_Care_2000_Mar_21_4(Suppl_1)_P90.nxml.txt.nlp	NULL	SENT3	17	17	19	19	vancomycin	VAN	PA451850	10318	0.731
NULL	Dermatoendocrinol_2013_Apr_1_5(2)_235-238.nxml.txt.nlp	24194963	SENT26	0	0	10	10	metformin	B12	PA450395	7126;4709	0.731
NULL	Pharmaceuticals_(Basel)_2013_Nov_7_6(11)_1381-1406.nxml.txt.nlp	24287463	SENT42	15	15	17	17	vancomycin	VAN	PA451850	10318	0.731
NULL	Mol_Cancer_2012_Apr_26_11_24.nxml.txt.nlp	22537161	SENT222	34	34	21	21	pp2	PP2		4888	0.731
NULL	Iran_J_Public_Health_2010_Dec_31_39(4)_1-14.nxml.txt.nlp	23113033	SENT47	33	33	27	27	galactose	LPH	PA449725	5443	0.731
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Oct_10_65(Pt_11)_o2696-o2697.nxml.txt.nlp	21578300	SENT71	16	16	19	19	phenol	mol	PA450913	90527	0.731
NULL	Neuroscience_2008_Aug_13_155(2)_556-564.nxml.txt.nlp	18619738	SENT132	2	2	0	0	choline	CDP	PA448976	1523	0.731
NULL	Int_J_Biol_Sci_2012_Sep_6_8(8)_1109-1120.nxml.txt.nlp	22991499	SENT156	19	19	3	3	l-arginine	IFN	PA448478	3439	0.731
NULL	Adv_Biomed_Res_2014_Nov_29_3_232.nxml.txt.nlp	25538918	SENT156	17	17	34	34	ropivacaine	ACL	PA451271	47	0.731
NULL	Diabetes_Metab_Syndr_Obes_2013_Sep_2_6_317-325.nxml.txt.nlp	24039439	SENT50	7	7	5	5	mitiglinide	GLP-1	PA164748124	100125288	0.731
NULL	Gastric_Cancer_2014_Apr_7_17(1)_1-12.nxml.txt.nlp	23563986	SENT310	5	5	25	25	docetaxel	HER2	PA449383	2064	0.731
NULL	J_Thorac_Oncol_2014_Jun_30_9(6)_805-811.nxml.txt.nlp	24787964	SENT176	14	14	21	21	gefitinib	EGFR	PA131301952	1956	0.731
NULL	J_Korean_Med_Sci_2010_Dec_24_25(12)_1766-1770.nxml.txt.nlp	21165292	SENT103	10	10	19	19	allopurinol	GFR	PA448320	9771	0.731
NULL	Case_Rep_Oncol_Med_2014_Aug_27_2014_165670.nxml.txt.nlp	25247100	SENT173	27	27	24	24	ribavirin	IFN	PA451241	3439	0.731
NULL	Cancer_Biol_Med_2012_Jun_9(2)_141-143.nxml.txt.nlp	23691471	SENT32	10	10	12	12	doxorubicin	ADM	PA449412	133	0.731
NULL	Brain_2008_Dec_3_131(12)_3335-3347.nxml.txt.nlp	18835867	SENT163	16	16	14	14	choline	CHAT	PA448976	1103	0.731
NULL	Mol_Cancer_2014_Apr_29_13_96.nxml.txt.nlp	24779681	SENT217	1	1	38	38	tamoxifen	EGFR	PA451581	1956	0.731
NULL	Cancer_Cell_Int_2013_Nov_1_13_108.nxml.txt.nlp	24176221	SENT163	4	4	20	20	perifosine	Bcl-2	PA165291471	596	0.731
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1013.nxml.txt.nlp	24457957	SENT15	20	20	25	25	orlistat	NOXA	PA164776864	5366	0.731
NULL	Mol_Vis_2012_Nov_29_18_2839-2846.nxml.txt.nlp	23233786	SENT123	1	1	7	7	geldanamycin	Hsp90	PA152031327	3320	0.731
NULL	Cent_European_J_Urol_2011_Dec_9_64(4)_256-257.nxml.txt.nlp	24578906	SENT15	15	15	9	9	doxazosin	CD133	PA449407	8842	0.731
NULL	Indian_J_Endocrinol_Metab_2013_Nov-Dec_17(6)_996-1004.nxml.txt.nlp	24381874	SENT114	13	13	10	10	bromocriptine	PRL	PA448671	5617	0.731
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1050.nxml.txt.nlp	24503542	SENT182	30	30	39	39	l-glutamine	CO2	PA10090	4513	0.731
NULL	Brain_Sci_2014_May_6_4(2)_356-375.nxml.txt.nlp	24961766	SENT208	6	6	16	16	propofol	CA3	PA451141	761	0.731
NULL	BioDrugs_2014_Aug_18_28(1)_27-39.nxml.txt.nlp	23955284	SENT418	2	2	12	12	cisplatin	survivin	PA449014	332	0.731
NULL	J_Cardiothorac_Surg_2010_Nov_3_5_101.nxml.txt.nlp	21047408	SENT181	26	26	13	13	heparin	ACT	PA449855	12;11332;9457;641455	0.731
NULL	Int_J_Vasc_Med_2013_Mar_31_2013_543141.nxml.txt.nlp	23606968	SENT242	0	0	21	21	etanercept	IL-17	PA449515	3605	0.731
NULL	Diabetes_2011_Nov_17_60(11)_2691-2700.nxml.txt.nlp	21896928	SENT145	9	9	16	16	resveratrol	SIRT1		23411	0.731
NULL	Diabetes_2008_Oct_57(10)_2784-2793.nxml.txt.nlp	18599521	SENT130	19	19	6	6	simvastatin	Rho	PA451363	29984	0.731
NULL	J_Med_Chem_2014_Feb_13_57(3)_1079-1089.nxml.txt.nlp	24456116	SENT968	14	14	5	5	taurine	FAAH	PA451590	79152;2166	0.731
NULL	Arthritis_Res_Ther_2009_Apr_30_11(2)_R58.nxml.txt.nlp	19405951	SENT10	7	7	0	0	clodronate	RANKL	PA10239	8600	0.731
NULL	J_Hematol_Oncol_2013_Jan_15_6_5.nxml.txt.nlp	23320987	SENT118	33	33	36	36	heparin	PI-PLC	PA449855	2923	0.731
NULL	Int_J_Appl_Basic_Med_Res_2012_Jul-Dec_2(2)_77-83.nxml.txt.nlp	23776817	SENT119	20	20	11	11	clarithromycin	CYP3A4	PA449028	1576	0.731
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT321	23	23	7	7	oxaliplatin	ABCC1	PA131285527	4363	0.731
NULL	Cases_J_2009_Jan_7_2_18.nxml.txt.nlp	19128460	SENT14	45	45	30	30	ribavirin	IFN	PA451241	3439	0.731
NULL	Breast_Cancer_Res_2007_Mar_2_9(2)_205.nxml.txt.nlp	NULL	SENT13	0	0	7	7	trastuzumab	San	PA451743	80218	0.731
NULL	Br_J_Cancer_2012_Nov_20_107(11)_1844-1852.nxml.txt.nlp	23169337	SENT275	10	10	22	22	bortezomib	SP1	PA10252	6667	0.731
NULL	Pain_Res_Treat_2012_Aug_13_2012_621619.nxml.txt.nlp	22937238	SENT23	12	12	30	30	capsaicin	TRPV1	PA448776	7442	0.731
NULL	Mol_Cancer_2007_Jun_8_6_40.nxml.txt.nlp	17559677	SENT163	27	27	22	22	paclitaxel	LIMK1	PA450761	3984	0.731
NULL	Pan_Afr_Med_J_2012_Jul_9_12_67.nxml.txt.nlp	23024826	SENT35	14	14	5	5	doxorubicin	CHOP	PA449412	1649	0.731
NULL	Cell_Commun_Signal_2013_Jul_31_11_52.nxml.txt.nlp	23902637	SENT309	32	32	20	20	trypsin	NEDD8	PA451806	4738	0.731
NULL	Br_J_Cancer_2013_Feb_19_108(3)_557-563.nxml.txt.nlp	23361053	SENT171	20	20	16	16	tamoxifen	PAK1	PA451581	5585;5058	0.731
NULL	Diabetes_2011_Nov_17_60(11)_2939-2946.nxml.txt.nlp	21896931	SENT233	9	9	26	26	losartan	ANG	PA450268	283	0.731
NULL	Front_Cell_Neurosci_2013_Apr_4_7_33.nxml.txt.nlp	23576951	SENT42	30	30	42	42	l-glutamine	CO2	PA10090	4513	0.731
NULL	J_Hematol_Oncol_2008_Oct_1_1_16.nxml.txt.nlp	18828924	SENT246	16	16	30	30	lapatinib	HER2	PA152241907	2064	0.731
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT79	4	4	13	13	celecoxib	IL-6	PA448871	3569	0.731
NULL	J_Gen_Intern_Med_2009_May_26_24(5)_690-691.nxml.txt.nlp	19322614	SENT82	8	8	2	2	warfarin	VKORC1	PA451906	79001	0.731
NULL	Nat_Commun_2011_Feb_8_2_190.nxml.txt.nlp	21304519	SENT508	19	19	21	21	indomethacin	PTGER4	PA449982	5734	0.731
NULL	Diabetol_Metab_Syndr_2014_Sep_23_6(1)_102.nxml.txt.nlp	NULL	SENT34	8	8	15	15	atorvastatin	RAGE	PA448500	177	0.731
NULL	Arthritis_Res_Ther_2012_Dec_7_14(6)_R265.nxml.txt.nlp	23217273	SENT49	21	21	24	24	lenalidomide	CLE	PA162363968	51637	0.731
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT71	6	6	8	8	resveratrol	TRAIL		8743	0.731
NULL	Cell_Death_Dis_2014_Feb_13_5(2)_e1055.nxml.txt.nlp	24525731	SENT93	16	16	10	10	cisplatin	TXNL1	PA449014	9352	0.731
NULL	Thorax_2012_Oct_12_67(10)_891-900.nxml.txt.nlp	22693178	SENT162	6	6	16	16	capsaicin	TRPA1	PA448776	8989	0.731
NULL	Braz_J_Med_Biol_Res_2014_Sep_5_47(11)_929-939.nxml.txt.nlp	25296354	SENT156	12	12	4	4	afatinib	EGFR	PA165981154	1956	0.731
NULL	J_Cardiothorac_Surg_2012_Sep_27_7_97.nxml.txt.nlp	23013706	SENT194	17	17	8	8	warfarin	CYP2C9	PA451906	1559	0.731
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Nov_13_66(Pt_12)_o3183.nxml.txt.nlp	21589478	SENT57	1	1	43	43	coumarin	C17	PA134521193	54360	0.731
NULL	Clin_Exp_Reprod_Med_2013_Jun_30_40(2)_67-75.nxml.txt.nlp	23875162	SENT137	4	4	14	14	rosiglitazone	aromatase	PA451283	1588	0.731
NULL	Oncogene_2014_Aug_28_33(35)_4407-4417.nxml.txt.nlp	24469038	SENT44	26	26	6	6	cisplatin	14-3-3	PA449014	10971	0.731
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT6	17	17	19	19	curcumin	TRAIL	PA151958596	8743	0.731
NULL	Iran_Red_Crescent_Med_J_2013_Mar_5_15(3)_249-253.nxml.txt.nlp	23984007	SENT134	6	6	12	12	oxcarbazepine	B12	PA450732	7126;4709	0.731
NULL	J_Invest_Dermatol_2014_Feb_10_134(2)_319-325.nxml.txt.nlp	24108405	SENT55	19	19	32	32	vemurafenib	gp100	PA165946873	6490	0.731
NULL	Diabetes_2011_Nov_17_60(11)_2691-2700.nxml.txt.nlp	21896928	SENT243	15	15	19	19	resveratrol	SIRT1		23411	0.731
NULL	Arch_Drug_Inf_2011_Mar_4(1)_1-9.nxml.txt.nlp	21572514	SENT23	17	17	9	9	ciprofloxacin	P-gp	PA449009	5243	0.731
NULL	Exp_Hematol_Oncol_2013_Aug_28_2_23.nxml.txt.nlp	24499526	SENT266	21	21	4	4	ethanol	OPTC	PA448073	26254	0.731
NULL	BMB_Rep_2013_Feb_46(2)_92-96.nxml.txt.nlp	23433111	SENT30	9	9	3	3	etoposide	BRCA1	PA449552	672	0.731
NULL	Arthritis_Res_Ther_2009_Jun_29_11(3)_R100.nxml.txt.nlp	19563672	SENT150	18	18	6	6	infliximab	IFN	PA452639	3439	0.731
NULL	Arthritis_Res_Ther_2014_Jul_18_16(4)_R153.nxml.txt.nlp	25037855	SENT217	0	0	9	9	adalimumab	CD14	PA10004	929	0.731
NULL	Blood_Res_2013_Mar_25_48(1)_35-39.nxml.txt.nlp	23589793	SENT89	6	6	9	9	cyclophosphamide	CD4	PA449165	920	0.731
NULL	J_Biol_2003_Oct_22_2(4)_26.nxml.txt.nlp	14575531	SENT61	18	18	8	8	phenformin	LKB1	PA1000	6794	0.731
NULL	Drug_Saf_2014_Apr_29_37(5)_343-350.nxml.txt.nlp	24777653	SENT124	32	32	16	16	naproxen	OTC	PA450595	5009	0.731
NULL	Int_J_Med_Sci_2013_Mar_19_10(5)_599-606.nxml.txt.nlp	23569422	SENT36	6	6	10	10	propofol	HO-1	PA451141	3162	0.731
NULL	Cardiol_Ther_2013_Jun_28_2(1)_47-56.nxml.txt.nlp	25135288	SENT158	15	15	6	6	prasugrel	CYP2C19	PA154410481	1557	0.731
NULL	Neuroscience_2013_Oct_10_250(100)_493-506.nxml.txt.nlp	23892006	SENT380	11	11	0	0	ethanol	RhoE	PA448073	390	0.731
NULL	Breast_Cancer_Res_Treat_2014_Dec_21_143(3)_459-467.nxml.txt.nlp	24362951	SENT57	1	1	26	26	anastrozole	aromatase	PA448432	1588	0.731
NULL	Oncol_Lett_2013_Mar_28_5(3)_935-942.nxml.txt.nlp	23426424	SENT13	31	31	22	22	oxaliplatin	ERCC1	PA131285527	2067	0.731
NULL	J_Biol_Chem_2010_Aug_20_285(34)_25928-25940.nxml.txt.nlp	20547488	SENT300	11	11	19	19	cisplatin	p38	PA449014	10598;1432;7965	0.731
NULL	Amino_Acids_2012_Jun_3_42(6)_2111-2119.nxml.txt.nlp	21638020	SENT0	11	11	32	32	l-arginine	eNOS	PA448478	4846	0.731
NULL	J_Exp_Clin_Cancer_Res_2009_Jul_10_28(1)_99.nxml.txt.nlp	19591692	SENT115	25	25	29	29	elacridar	ABCB1		5243	0.731
NULL	ScientificWorldJournal_2013_Oct_1_2013_265234.nxml.txt.nlp	24235880	SENT43	20	20	5	5	doxazosin	PC3	PA449407	57332;7832;5122	0.731
NULL	Cancer_Med_2013_Dec_27_2(6)_751-762.nxml.txt.nlp	24403249	SENT296	11	11	27	27	paclitaxel	NANOG	PA450761	79923	0.731
NULL	Arthritis_Res_Ther_2006_Feb_8_8(2)_R44.nxml.txt.nlp	16507143	SENT57	16	16	36	36	fluorescein	San	PA164746009	80218	0.731
NULL	Crit_Care_2008_Jan_24_12(1)_R27.nxml.txt.nlp	18304335	SENT152	15	15	6	6	thrombin	Rho	PA451674	29984	0.731
NULL	Cell_Commun_Signal_2014_Mar_28_12_23.nxml.txt.nlp	24679124	SENT120	4	4	18	18	curcumin	BAG2	PA151958596	9532	0.731
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT31	7	7	13	13	celecoxib	IL-6	PA448871	3569	0.731
NULL	Alcohol_Res_Health_2011_34(1)_4-14.nxml.txt.nlp	23580035	SENT189	26	26	37	37	choline	L1CAM	PA448976	3897	0.731
NULL	Oncotarget_2013_Nov_7_4(12)_2550-2566.nxml.txt.nlp	24334291	SENT209	17	17	21	21	dasatinib	AMPK	PA162372878	5563	0.731
NULL	Clinics_(Sao_Paulo)_2014_Jan_69(1)_68-74.nxml.txt.nlp	24473562	SENT89	36	36	20	20	nutlin-3	p53		7157	0.731
NULL	Evid_Based_Complement_Alternat_Med_2013_May_28_2013_629750.nxml.txt.nlp	23781265	SENT185	4	4	15	15	capsaicin	ATF4	PA448776	468	0.731
NULL	Breast_Cancer_Res_Treat_2008_Jul_19_110(2)_297-307.nxml.txt.nlp	17879159	SENT87	10	10	18	18	l-methionine	mol	PA450423	90527	0.731
NULL	Cancer_Cell_2015_Jan_12_27(1)_138-148.nxml.txt.nlp	25500122	SENT486	6	6	0	0	cetuximab	Yama	PA10040	836	0.731
NULL	Front_Oncol_2013_Nov_15_3_281.nxml.txt.nlp	24298448	SENT118	8	8	17	17	vemurafenib	p53	PA165946873	7157	0.731
NULL	Breast_Cancer_(Auckl)_2009_Sep_2_3_61-75.nxml.txt.nlp	19809577	SENT79	0	0	2	2	curcumin	BRCA1	PA151958596	672	0.731
NULL	Oncotarget_2014_Jun_19_5(15)_6540-6551.nxml.txt.nlp	25153728	SENT7	5	5	22	22	paclitaxel	HIF-1	PA450761	29072	0.731
NULL	Braz_J_Med_Biol_Res_2014_Mar_3_47(3)_245-251.nxml.txt.nlp	24554037	SENT103	4	4	18	18	atorvastatin	LCX	PA448500	80312	0.731
NULL	Korean_J_Anesthesiol_2013_Dec_26_65(6)_501-507.nxml.txt.nlp	24427455	SENT34	21	21	29	29	neostigmine	NMB	PA450611	10457;4828	0.731
NULL	Nucleic_Acids_Res_2005_Dec_9_33(22)_6982-6991.nxml.txt.nlp	16340008	SENT157	36	36	8	8	trypsin	ADP	PA451806	23038	0.731
NULL	Open_Biochem_J_2008_Nov_18_2_135-142.nxml.txt.nlp	19238187	SENT64	4	4	14	14	heparin	EXT2	PA449855	2132;2133	0.731
NULL	Int_J_Gen_Med_2012_Jun_18_5_535-540.nxml.txt.nlp	22807641	SENT117	16	16	12	12	pitavastatin	adiponectin	PA142650384	9370	0.731
NULL	BMB_Rep_2014_Oct_47(10)_575-580.nxml.txt.nlp	24499675	SENT104	20	20	32	32	arsenite	SSB	PA452638	6741	0.731
NULL	Pharmacogn_Rev_2010_Jul-Dec_4(8)_172-178.nxml.txt.nlp	22228958	SENT274	22	22	7	7	ethanol	flower	PA448073	11094	0.731
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT144	9	9	21	21	gefitinib	PIK3CA	PA131301952	5290	0.731
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT94	29	29	38	38	trastuzumab	PI3K	PA451743	5290	0.731
NULL	J_Inherit_Metab_Dis_2011_Apr_27_34(2)_357-366.nxml.txt.nlp	20978943	SENT60	4	4	12	12	galactose	GALT	PA449725	2592	0.731
NULL	Autoimmune_Dis_2014_Jan_16_2014_731806.nxml.txt.nlp	24527208	SENT15	33	33	21	21	azathioprine	gamma	PA448515	9913	0.731
NULL	Front_Oncol_2013_Nov_15_3_281.nxml.txt.nlp	24298448	SENT193	16	16	38	38	irinotecan	KRAS	PA450085	3845	0.731
NULL	Adv_Hematol_2010_Jun_27_2010_343089.nxml.txt.nlp	20671999	SENT103	13	13	7	7	denosumab	RANKL	PA166048634	8600	0.731
NULL	Oncotarget_2012_May_29_3(5)_581-585.nxml.txt.nlp	22653910	SENT50	10	10	18	18	genistein	P-gp	PA165109660	5243	0.731
NULL	Aging_Cell_2013_Jun_27_12(3)_435-445.nxml.txt.nlp	23448364	SENT272	5	5	19	19	doxorubicin	p53	PA449412	7157	0.731
NULL	Mol_Vis_2012_Nov_29_18_2839-2846.nxml.txt.nlp	23233786	SENT121	6	6	18	18	geldanamycin	Hsp90	PA152031327	3320	0.731
NULL	Oncotarget_2014_Mar_16_5(12)_4087-4102.nxml.txt.nlp	24961479	SENT240	3	3	0	0	hemin	PC3	PA449849	57332;7832;5122	0.731
NULL	Br_J_Cancer_2006_Feb_13_94(3)_407-426.nxml.txt.nlp	16434996	SENT124	27	27	21	21	genistein	BRCA2	PA165109660	675	0.731
NULL	J_Invest_Dermatol_2013_Jun_14_133(6)_1541-1549.nxml.txt.nlp	23407395	SENT41	11	11	16	16	imiquimod	CXCL1	PA449972	2919	0.731
NULL	Behav_Brain_Funct_2013_Jan_10_9_4.nxml.txt.nlp	23305134	SENT145	8	8	20	20	biperiden	ANOVA	PA448626	4858	0.731
NULL	Clin_Exp_Metastasis_2014_Aug_22_31(1)_33-45.nxml.txt.nlp	23975155	SENT185	25	25	17	17	dextran	CK19	PA449261	3880	0.731
NULL	Br_J_Pharmacol_2014_Sep_28_171(18)_4255-4272.nxml.txt.nlp	24846338	SENT275	4	4	8	8	ondansetron	gamma	PA450705	9913	0.731
NULL	Environ_Health_Perspect_2011_Apr_16_119(4)_534-541.nxml.txt.nlp	21081300	SENT107	32	32	28	28	flutamide	DES	PA449685	1674	0.731
NULL	J_Gynecol_Oncol_2013_Jul_4_24(3)_265-272.nxml.txt.nlp	23875077	SENT169	15	15	29	29	thrombin	GAPDH	PA451674	2597	0.731
NULL	Br_J_Cancer_2010_Feb_16_102(4)_658-664.nxml.txt.nlp	20104222	SENT97	13	13	17	17	sunitinib	IFN	PA162372840	3439	0.731
NULL	Nat_Med_2013_Feb_6_19(2)_217-226.nxml.txt.nlp	23291629	SENT92	24	24	9	9	forskolin	HSL	PA146096022	3991	0.731
NULL	Proteome_Sci_2003_Jun_12_1_4.nxml.txt.nlp	12818002	SENT113	48	48	10	10	heparin	B27	PA449855	56246	0.731
NULL	Oncoimmunology_2012_Oct_1_1(7)_1004-1016.nxml.txt.nlp	23170249	SENT65	11	11	3	3	paclitaxel	HER-2	PA450761	2064	0.731
NULL	Mol_Biol_Cell_2014_Nov_15_25(23)_3726-3739.nxml.txt.nlp	25232004	SENT75	3	3	10	10	doxycycline	PRC1	PA449415	9055	0.731
NULL	Cancers_(Basel)_2014_Mar_6_6(1)_494-525.nxml.txt.nlp	24662938	SENT1920	13	13	17	17	cetuximab	KRAS	PA10040	3845	0.731
NULL	J_Int_Soc_Sports_Nutr_2010_Aug_22_7_28.nxml.txt.nlp	20727213	SENT157	7	7	11	11	l-glutamine	IL-6	PA10090	3569	0.731
NULL	BMB_Rep_2013_Jan_46(1)_59-64.nxml.txt.nlp	23351386	SENT62	34	34	29	29	auranofin	NAC	PA448510	22861	0.731
NULL	EMBO_J_2010_Apr_21_29(8)_1401-1411.nxml.txt.nlp	20300060	SENT180	13	13	24	24	fluorescein	DDX5	PA164746009	1655	0.731
NULL	Arthritis_Res_Ther_2012_Apr_26_14(2)_R90.nxml.txt.nlp	22537858	SENT184	9	9	13	13	atorvastatin	IFN	PA448500	3439	0.731
NULL	Cell_Death_Dis_2014_Jan_16_5(1)_e1000.nxml.txt.nlp	24434508	SENT94	24	24	22	22	etoposide	p53	PA449552	7157	0.731
NULL	Cell_Cycle_2013_Dec_15_12(24)_3791-3803.nxml.txt.nlp	24107631	SENT103	7	7	2	2	doxorubicin	YB-1	PA449412	4904	0.731
NULL	Eur_J_Med_Res_2010_Apr_8_15(4)_145-151.nxml.txt.nlp	20554495	SENT121	10	10	4	4	abacavir	HLA-B	PA448004	3106	0.731
NULL	Int_J_Biol_Sci_2014_Jun_10_10(7)_654-663.nxml.txt.nlp	25013375	SENT166	3	3	11	11	nitroxoline	p53	PA164754993	7157	0.731
NULL	Cancers_(Basel)_2014_Apr_16_6(2)_926-957.nxml.txt.nlp	24743778	SENT337	0	0	26	26	curcumin	STAT3	PA151958596	6774	0.731
NULL	J_Oncol_2011_Oct_28_2011_963614.nxml.txt.nlp	21052543	SENT130	16	16	3	3	doxorubicin	p33ING1b	PA449412	3621	0.731
NULL	Indian_J_Pharmacol_2013_Jan-Feb_45(1)_9-12.nxml.txt.nlp	23543259	SENT108	8	8	5	5	salbutamol	eNOS	PA448068	4846	0.731
NULL	J_Korean_Neurosurg_Soc_2014_Jan_31_55(1)_5-11.nxml.txt.nlp	24570811	SENT191	8	8	6	6	bevacizumab	CRT	PA130232992	811	0.731
NULL	Biologics_2012_Dec_17_6_429-464.nxml.txt.nlp	23269860	SENT253	17	17	14	14	etanercept	NMA	PA449515	25805	0.731
NULL	Case_Rep_Transplant_2012_Dec_20_2012_126592.nxml.txt.nlp	23320241	SENT27	7	7	2	2	vincristine	CHOP	PA451879	1649	0.73
NULL	Exp_Ther_Med_2014_Aug_4_8(2)_657-661.nxml.txt.nlp	25009636	SENT91	25	25	17	17	propofol	CCR2	PA451141	729230	0.73
NULL	FEBS_Open_Bio_2014_Oct_22_4_905-914.nxml.txt.nlp	25383314	SENT14	4	4	24	24	atropine	L-FABP	PA448505	2168	0.73
NULL	Clin_Ophthalmol_2012_Jul_5_6_1029-1034.nxml.txt.nlp	22848143	SENT70	0	0	7	7	bevacizumab	San	PA130232992	80218	0.73
NULL	Nat_Neurosci_2012_Jun_15(6)_845-852.nxml.txt.nlp	22522402	SENT306	6	6	21	21	primaquine	KAR	PA451103	51144	0.73
NULL	Int_J_Chron_Obstruct_Pulmon_Dis_2007_Jun_2(2)_157-167.nxml.txt.nlp	18044688	SENT103	8	8	17	17	tiotropium	TDI	PA164769056	100038246	0.73
NULL	Curr_Genomics_2014_Feb_15(1)_11-17.nxml.txt.nlp	24653659	SENT149	7	7	18	18	carbidopa	COMT	PA448794	1312	0.73
NULL	Ann_Indian_Acad_Neurol_2010_Jan-Mar_13(1)_6-13.nxml.txt.nlp	20436740	SENT263	20	20	13	13	cangrelor	P2Y12	PA165945763	64805	0.73
NULL	Curr_Neuropharmacol_2014_Mar_12(2)_186-192.nxml.txt.nlp	24669211	SENT33	33	33	35	35	metformin	Met	PA450395	79811	0.73
NULL	J_Clin_Biochem_Nutr_2009_Jan_27_44(1)_28-40.nxml.txt.nlp	19177185	SENT105	3	3	5	5	dobutamine	HO-1	PA449381	3162	0.73
NULL	Front_Neurosci_2012_Apr_9_6_44.nxml.txt.nlp	22509146	SENT452	15	15	7	7	ethanol	AC5	PA448073	111	0.73
NULL	Braz_J_Med_Biol_Res_2014_Mar_3_47(3)_245-251.nxml.txt.nlp	24554037	SENT162	5	5	11	11	atorvastatin	IL-6	PA448500	3569	0.73
NULL	Interdiscip_Perspect_Infect_Dis_2014_May_7_2014_849432.nxml.txt.nlp	24895495	SENT125	14	14	12	12	ritonavir	CYP3A4	PA451260	1576	0.73
NULL	Breast_Cancer_Res_2007_Dec_17_9(6)_R87.nxml.txt.nlp	18086299	SENT185	8	8	13	13	trastuzumab	PTEN	PA451743	5728	0.73
NULL	Int_J_Breast_Cancer_2011_Sep_6_2011_352182.nxml.txt.nlp	22295219	SENT133	22	22	18	18	trastuzumab	PIK3CA	PA451743	5290	0.73
NULL	Reprod_Biol_Endocrinol_2003_Oct_3_1_62.nxml.txt.nlp	14567758	SENT113	40	40	25	25	lindane	ANOVA	PA164754914	4858	0.73
NULL	J_Adv_Pract_Oncol_2012_Nov_1_Nov-Dec_3(6)_391-394.nxml.txt.nlp	25031970	SENT64	21	21	29	29	trastuzumab	HER2	PA451743	2064	0.73
NULL	Clin_Dev_Immunol_2013_Sep_17_2013_791262.nxml.txt.nlp	24151519	SENT10	0	0	11	11	heparin	CCR2	PA449855	729230	0.73
NULL	Mol_Cancer_2009_Apr_22_8_26.nxml.txt.nlp	19386116	SENT139	18	18	15	15	ritonavir	AKT	PA451260	207	0.73
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT42	5	5	14	14	pertuzumab	HER3		2065	0.73
NULL	Oxid_Med_Cell_Longev_2011_Aug_15_2011_824597.nxml.txt.nlp	21904648	SENT215	18	18	15	15	cyclophosphamide	TPT	PA449165	23590;6469	0.73
NULL	Mol_Cancer_2014_Jun_27_13_159.nxml.txt.nlp	24972933	SENT164	14	14	24	24	fludarabine	Gem	PA449655	51053	0.73
NULL	Exp_Cell_Res_2011_Apr_15_317(7)_1028-1039.nxml.txt.nlp	21237154	SENT238	11	11	9	9	staurosporine	TRAIL	PA165109623	8743	0.73
NULL	J_Korean_Med_Sci_2010_Jun_24_25(6)_829-834.nxml.txt.nlp	20514301	SENT89	17	17	29	29	papain	TRIF	PA450778	148022	0.73
NULL	Arthritis_Res_Ther_2003_Sep_3_5(6)_R317-R328.nxml.txt.nlp	14680506	SENT199	13	13	16	16	forskolin	IFN	PA146096022	3439	0.73
NULL	Breast_Cancer_Res_2011_Mar_11_13(2)_R29.nxml.txt.nlp	21396094	SENT130	2	2	7	7	fulvestrant	HRG	PA164747170	3084;3273	0.73
NULL	Subst_Abuse_Treat_Prev_Policy_2008_Jan_29_3_3.nxml.txt.nlp	18230139	SENT53	42	42	36	36	methamphetamine	gamma	PA450403	9913	0.73
NULL	Cancers_(Basel)_2014_Feb_26_6(1)_436-458.nxml.txt.nlp	24577242	SENT718	1	1	22	22	sulindac	GMP	PA451565	22978	0.73
NULL	J_Cardiothorac_Surg_2012_Sep_27_7_97.nxml.txt.nlp	23013706	SENT181	16	16	13	13	warfarin	CYP4F2	PA451906	8529	0.73
NULL	Oxid_Med_Cell_Longev_2012_Jul_1_2012_324256.nxml.txt.nlp	22811764	SENT148	3	3	37	37	resveratrol	AP-1		2353;3727;2354;3725	0.73
NULL	Viruses_2013_Oct_7_5(10)_2483-2511.nxml.txt.nlp	24103892	SENT234	17	17	23	23	cyclosporine	NUP153	PA449167	9972	0.73
NULL	Cell_Res_2013_Jul_21_23(7)_915-930.nxml.txt.nlp	23689279	SENT100	17	17	11	11	ethanol	ALDH2	PA448073	217	0.73
NULL	Pharmaceutics_2011_Oct_12_3(4)_680-705.nxml.txt.nlp	24309303	SENT102	13	13	9	9	metformin	OCT1	PA450395	5451;6580	0.73
NULL	Breast_Cancer_Res_2007_Aug_8_9(4)_R50.nxml.txt.nlp	17686159	SENT251	21	21	9	9	gefitinib	HRG	PA131301952	3084;3273	0.73
NULL	Oncotarget_2014_Oct_18_5(22)_11588-11603.nxml.txt.nlp	25473890	SENT158	5	5	34	34	imatinib	KIT	PA10804	3815	0.73
NULL	Nucleic_Acids_Res_2011_Mar_20_39(4)_1565-1575.nxml.txt.nlp	20961956	SENT51	16	16	19	19	ether	MME	PA449525	4311	0.73
NULL	Cardiol_Res_Pract_2012_Aug_15_2012_713294.nxml.txt.nlp	22928146	SENT50	10	10	19	19	acetylcysteine	Q10	PA448033	27161	0.73
NULL	Cancer_Med_2013_Jun_25_2(3)_277-285.nxml.txt.nlp	23930204	SENT121	8	8	19	19	bevacizumab	PTEN	PA130232992	5728	0.73
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT49	31	31	16	16	coumarin	CYP2E1	PA134521193	1571	0.73
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT174	4	4	17	17	doxorubicin	SLK	PA449412	9748;2534	0.73
NULL	Cancers_(Basel)_2012_Feb_8_4(1)_113-129.nxml.txt.nlp	24213230	SENT106	19	19	8	8	octreotide	IFN	PA450678	3439	0.73
NULL	Mol_Biol_Cell_2012_May_15_23(10)_1812-1825.nxml.txt.nlp	22438585	SENT245	10	10	15	15	dextran	EGF	PA449261	1950	0.73
NULL	J_Hematol_Oncol_2013_Jun_3_6_38.nxml.txt.nlp	23731980	SENT76	16	16	2	2	trastuzumab	HER2	PA451743	2064	0.73
NULL	Clin_Epigenetics_2010_Sep_18_1(3-4)_101-116.nxml.txt.nlp	21258631	SENT240	5	5	11	11	curcumin	p300	PA151958596	2033	0.73
NULL	Orphanet_J_Rare_Dis_2008_Sep_16_3_25.nxml.txt.nlp	18796155	SENT303	17	17	19	19	cyclophosphamide	CPX	PA449165	1371;10682;1377	0.73
NULL	Apoptosis_2013_Aug_23_18(11)_1306-1318.nxml.txt.nlp	23975731	SENT103	26	26	20	20	hydrocortisone	EPO	PA449905	7076;8288;2056	0.73
NULL	Diabetes_2009_Apr_16_58(4)_975-983.nxml.txt.nlp	19151200	SENT185	12	12	16	16	liraglutide	LIR	PA165958364	10871	0.73
NULL	Indian_J_Dermatol_2014_Sep-Oct_59(5)_425-441.nxml.txt.nlp	25284845	SENT428	9	9	11	11	bleomycin	BLM	PA448645	641	0.73
NULL	Clin_Ophthalmol_2011_Feb_28_5_269-274.nxml.txt.nlp	21468332	SENT2	0	0	17	17	ketorolac	BAK	PA450150	578	0.73
NULL	Int_J_Cell_Biol_2014_Jan_22_2014_709828.nxml.txt.nlp	24578708	SENT112	18	18	28	28	l-serine	PSS1	PA451330	9791	0.73
NULL	Brain_Behav_2012_Jan_2(1)_68-73.nxml.txt.nlp	22574275	SENT6	22	22	10	10	oxaliplatin	TRPM8	PA131285527	79054	0.73
NULL	Nucleic_Acids_Res_2005_Jun_8_33(10)_3283-3291.nxml.txt.nlp	15944449	SENT114	24	24	15	15	sjg-136	XRCC2		7516	0.73
NULL	Oncotarget_2014_Oct_21_5(22)_11180-11192.nxml.txt.nlp	25361003	SENT113	12	12	37	37	tetracycline	NTRK1	PA451640	4914	0.73
NULL	Cardiovasc_Diabetol_2007_Apr_3_6_12.nxml.txt.nlp	17407587	SENT121	0	0	20	20	irbesartan	Met	PA450084	79811	0.73
NULL	Int_J_Biol_Sci_2006_Mar_1_2(1)_1-9.nxml.txt.nlp	16585947	SENT53	6	6	4	4	pp2	PP1		5540;5464	0.73
NULL	Braz_J_Med_Biol_Res_2012_Mar_16_45(6)_488-496.nxml.txt.nlp	22415117	SENT140	0	0	45	45	creatine	UST	PA164778930	10090	0.73
NULL	Br_J_Haematol_2009_Nov_2_147(3)_396-410.nxml.txt.nlp	19758122	SENT49	37	37	10	10	dasatinib	p53	PA162372878	7157	0.73
NULL	Nat_Med_2013_Oct_8_19(10)_1313-1317.nxml.txt.nlp	24013700	SENT146	7	7	2	2	ribavirin	IFN	PA451241	3439	0.73
NULL	Summit_on_Translat_Bioinforma_2009_Mar_1_2009_124-128.nxml.txt.nlp	21347183	SENT69	36	36	26	26	mercaptopurine	TPMT	PA450379	7172	0.73
NULL	Front_Endocrinol_(Lausanne)_2014_Dec_1_5_205.nxml.txt.nlp	25520703	SENT131	3	3	15	15	metformin	B12	PA450395	7126;4709	0.73
NULL	Asia_Pac_Allergy_2013_Oct_31_3(4)_231-240.nxml.txt.nlp	24260728	SENT30	22	22	9	9	theophylline	CYP2E1	PA451647	1571	0.73
NULL	Oncogene_2014_Sep_18_33(38)_4685-4696.nxml.txt.nlp	24121268	SENT258	0	0	13	13	nutlin-3	p53		7157	0.73
NULL	Cell_Death_Dis_2011_Aug_11_2(8)_e191.nxml.txt.nlp	21833029	SENT61	11	11	2	2	oxaliplatin	CT26	PA131285527	168400	0.73
NULL	Eur_J_Clin_Pharmacol_2011_May_8_67(5)_493-506.nxml.txt.nlp	21140139	SENT230	4	4	11	11	oxycodone	CYP3A4	PA450741	1576	0.73
NULL	Cell_Commun_Signal_2014_Mar_10_12_13.nxml.txt.nlp	24606867	SENT81	19	19	13	13	lipase	TCPTP	PA450239	5771	0.73
NULL	Int_J_Biol_Sci_2013_Apr_22_9(4)_350-360.nxml.txt.nlp	23630447	SENT155	39	39	10	10	doxorubicin	ANOVA	PA449412	4858	0.73
NULL	Front_Oncol_2014_Apr_21_4_82.nxml.txt.nlp	24795859	SENT306	16	16	19	19	rituximab	CHOP	PA451261	1649	0.73
NULL	Exp_Ther_Med_2013_Apr_5_5(4)_1259-1263.nxml.txt.nlp	23596498	SENT96	12	12	10	10	propofol	TRPV1	PA451141	7442	0.73
NULL	Trials_2014_Dec_5_15(1)_477.nxml.txt.nlp	NULL	SENT322	12	12	10	10	mitomycin	PRK	PA450524	1263	0.73
NULL	J_Pain_Res_2014_May_8_7_255-263.nxml.txt.nlp	24855388	SENT67	30	30	33	33	collagenase	GMP	PA449107	22978	0.73
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jul_18_68(Pt_8)_o2486.nxml.txt.nlp	22904928	SENT69	11	11	27	27	piperazine	mol	PA450977	90527	0.73
NULL	Front_Pharmacol_2014_Oct_20_5_230.nxml.txt.nlp	25368579	SENT108	8	8	23	23	berberine	IL-6	PA165860812	3569	0.73
NULL	Hum_Genomics_2009_Jan_1_3(2)_169-190.nxml.txt.nlp	19164093	SENT29	2	2	0	0	omeprazole	CYP2C19	PA450704	1557	0.73
NULL	Cogn_Neurodyn_2012_Apr_13_6(2)_169-183.nxml.txt.nlp	22511913	SENT354	11	11	19	19	tropicamide	CRT	PA164749389	811	0.73
NULL	An_Bras_Dermatol_2014_Sep-Oct_89(5)_792-795.nxml.txt.nlp	25184919	SENT27	8	8	15	15	lamivudine	CD4	PA450163	920	0.73
NULL	Braz_J_Med_Biol_Res_2014_Feb_17_47(2)_128-134.nxml.txt.nlp	24519128	SENT32	28	28	4	4	dextran	ENL	PA449261	4298	0.73
NULL	EMBO_Mol_Med_2013_Dec_8_5(12)_1821-1834.nxml.txt.nlp	24293316	SENT173	22	22	6	6	doxorubicin	p53	PA449412	7157	0.73
NULL	Viruses_2014_Feb_18_6(2)_875-892.nxml.txt.nlp	24553110	SENT189	33	33	31	31	ribavirin	IFN	PA451241	3439	0.73
NULL	Indian_J_Radiol_Imaging_2008_Aug_18(3)_256-263.nxml.txt.nlp	19774171	SENT30	5	5	13	13	heparin	ACT	PA449855	12;11332;9457;641455	0.73
NULL	Diabetes_2009_Dec_31_58(12)_2851-2862.nxml.txt.nlp	19720788	SENT48	6	6	34	34	forskolin	BiP	PA146096022	3309	0.73
NULL	Curr_Cardiol_Rev_2008_Nov_4(4)_293-299.nxml.txt.nlp	20066137	SENT34	5	5	14	14	heparin	ACT	PA449855	12;11332;9457;641455	0.73
NULL	Oncoimmunology_2012_Mar_1_1(2)_237-239.nxml.txt.nlp	22720255	SENT73	28	28	6	6	rituximab	gamma	PA451261	9913	0.73
NULL	Summit_on_Translat_Bioinforma_2009_Mar_1_2009_124-128.nxml.txt.nlp	21347183	SENT69	36	36	40	40	mercaptopurine	TPMT	PA450379	7172	0.73
NULL	Onco_Targets_Ther_2014_Sep_9_7_1571-1582.nxml.txt.nlp	25228815	SENT119	10	10	0	0	sunitinib	VEGFA	PA162372840	7422	0.73
NULL	Mol_Clin_Oncol_2013_Jul_17_1(4)_680-684.nxml.txt.nlp	24649228	SENT89	20	20	6	6	etoposide	CRT	PA449552	811	0.73
NULL	Drugs_Context_2012_Nov_19_2012_212242.nxml.txt.nlp	24432031	SENT128	10	10	17	17	vinblastine	IL-2	PA451877	3558	0.73
NULL	J_Cancer_2013_Sep_27_4(8)_662-670.nxml.txt.nlp	24155778	SENT203	19	19	17	17	cisplatin	UCHL1	PA449014	7345	0.73
NULL	Exp_Hematol_Oncol_2014_Jan_11_3_2.nxml.txt.nlp	24410791	SENT105	2	2	6	6	everolimus	EGFR	PA164746311	1956	0.73
NULL	Osteoporos_Int_2012_Jan_28_23(1)_213-221.nxml.txt.nlp	21953472	SENT31	25	25	39	39	raloxifene	PTH	PA451221	5741	0.73
NULL	J_Ophthalmol_2012_Feb_28_2012_786870.nxml.txt.nlp	22523653	SENT27	0	0	7	7	bevacizumab	San	PA130232992	80218	0.73
NULL	J_Hematol_Oncol_2008_Oct_23_1_19.nxml.txt.nlp	18947412	SENT111	24	24	32	32	alemtuzumab	CD34	PA164783958	947	0.73
NULL	Vet_Res_2013_Oct_2_44(1)_89.nxml.txt.nlp	24088531	SENT106	8	8	13	13	hemin	HO-1	PA449849	3162	0.73
NULL	Biomed_Res_Int_2014_Feb_19_2014_240642.nxml.txt.nlp	24701565	SENT54	0	0	20	20	doxorubicin	IL-6	PA449412	3569	0.73
NULL	Neural_Regen_Res_2013_Jul_15_8(20)_1853-1862.nxml.txt.nlp	25206494	SENT137	0	0	5	5	ethanol	p53	PA448073	7157	0.73
NULL	Mol_Vis_2007_Jun_11_13_833-839.nxml.txt.nlp	17615544	SENT19	8	8	18	18	carteolol	B27	PA164768736	56246	0.73
NULL	Eur_J_Clin_Pharmacol_2013_Jan_11_69(6)_1275-1283.nxml.txt.nlp	23307232	SENT247	20	20	12	12	warfarin	CYP2C9	PA451906	1559	0.73
NULL	J_Gen_Physiol_1967_May_1_50(5)_1413-1428.nxml.txt.nlp	6033593	SENT0	13	13	1	1	procaine	Gen	PA451110	348654	0.73
NULL	Acta_Pharmacol_Sin_2011_Nov_10_32(11)_1402-1410.nxml.txt.nlp	21986579	SENT249	13	13	38	38	curcumin	p27	PA151958596	5715;10534	0.73
NULL	Acta_Pharmacol_Sin_2013_Apr_25_34(4)_455-463.nxml.txt.nlp	23524568	SENT141	0	0	7	7	pioglitazone	p65	PA450970	5970	0.73
NULL	Acta_Pharmacol_Sin_2012_Aug_30_33(8)_1013-1022.nxml.txt.nlp	22842733	SENT25	12	12	2	2	liraglutide	GLP-1	PA165958364	100125288	0.73
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Mar_9_67(Pt_4)_o820.nxml.txt.nlp	21754104	SENT68	31	31	7	7	ethanol	mol	PA448073	90527	0.73
NULL	Pharm_Pract_(Granada)_2011_Mar_15_Jan-Mar_9(1)_1-10.nxml.txt.nlp	25132883	SENT167	35	35	45	45	enoxaparin	SPAF	PA449463	166378	0.73
NULL	J_Physiol_2011_Mar_1_589(Pt_5)_1081-1093.nxml.txt.nlp	21224236	SENT139	13	13	16	16	diazoxide	mol	PA449285	90527	0.73
NULL	Surg_Today_2012_Jan_6_42(1)_8-28.nxml.txt.nlp	22139128	SENT529	4	4	9	9	mitomycin	PSK	PA450524	9344	0.73
NULL	Nat_Commun_2013_Oct_1_4_2516.nxml.txt.nlp	24084631	SENT55	2	2	18	18	losartan	CCN2	PA450268	1490	0.73
NULL	J_Cancer_2013_Sep_26_4(8)_653-661.nxml.txt.nlp	24155777	SENT104	20	20	31	31	tamoxifen	KISS1	PA451581	3814	0.73
NULL	Tuberc_Respir_Dis_(Seoul)_2014_Feb_27_76(2)_66-74.nxml.txt.nlp	24624215	SENT36	27	27	11	11	linezolid	HAP	PA450233	5915;10313	0.73
NULL	eLife_2014_May_20_3_e01763.nxml.txt.nlp	24844244	SENT452	3	3	0	0	doxycycline	MELK	PA449415	9833	0.73
NULL	Br_J_Cancer_2009_Oct_6_101(7)_1183-1193.nxml.txt.nlp	19707198	SENT212	17	17	3	3	heparin	VEGF-A	PA449855	7422	0.73
NULL	Theranostics_2013_Jan_15_3(1)_47-75.nxml.txt.nlp	23382786	SENT308	4	4	8	8	plerixafor	CXCR4	PA165958410	7852	0.73
NULL	Acta_Orthop_2009_Jun_5_80(3)_325-329.nxml.txt.nlp	19626470	SENT137	20	20	6	6	talinolol	MDR1	PA146123005	5243	0.73
NULL	Breast_Cancer_Res_2010_Sep_29_12(5)_209.nxml.txt.nlp	21067536	SENT246	0	0	7	7	trastuzumab	San	PA451743	80218	0.73
NULL	Indian_J_Pharm_Sci_2013_Nov-Dec_75(6)_680-687.nxml.txt.nlp	24591743	SENT143	11	11	9	9	gemfibrozil	CYP2C8	PA449750	1558	0.73
NULL	Br_J_Cancer_2013_Feb_19_108(3)_557-563.nxml.txt.nlp	23361053	SENT107	20	20	16	16	tamoxifen	PAK1	PA451581	5585;5058	0.73
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jul_14_66(Pt_8)_o1996.nxml.txt.nlp	21588310	SENT73	31	31	34	34	benzaldehyde	mol	PA448571	90527	0.73
NULL	Biomed_Res_Int_2014_May_18_2014_291280.nxml.txt.nlp	24949432	SENT162	40	40	5	5	trastuzumab	MYB	PA451743	4602	0.73
NULL	Case_Rep_Oncol_Med_2013_Jan_16_2013_292301.nxml.txt.nlp	23401819	SENT112	12	12	14	14	rituximab	CHOP	PA451261	1649	0.73
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT229	3	3	0	0	cisplatin	IBP	PA449014	706;50619	0.73
NULL	J_Gen_Physiol_1997_Jun_1_109(6)_681-692.nxml.txt.nlp	9222895	SENT173	28	28	4	4	amiloride	CH1	PA448368	51430	0.73
NULL	Breast_Cancer_Res_2011_Mar_14_13(2)_205.nxml.txt.nlp	21457526	SENT27	37	37	15	15	anastrozole	ATAC	PA448432	6375	0.73
NULL	J_Cell_Mol_Med_2013_Jun_15_17(6)_792-799.nxml.txt.nlp	23672538	SENT64	32	32	12	12	fluorescein	CD56	PA164746009	4684	0.73
NULL	Clin_Transl_Allergy_2013_Sep_2_3_29.nxml.txt.nlp	24004581	SENT209	14	14	27	27	omalizumab	CD23	PA164752253	2208	0.73
NULL	J_Exp_Med_1998_Jun_1_187(11)_1885-1892.nxml.txt.nlp	9607928	SENT144	0	0	17	17	thalidomide	CD4	PA451644	920	0.73
NULL	Clin_Interv_Aging_2013_Apr_29_8_467-483.nxml.txt.nlp	23766636	SENT85	27	27	10	10	ranibizumab	CRT	PA164746012	811	0.73
NULL	Mol_Cell_Proteomics_2013_Dec_9_12(12)_3704-3718.nxml.txt.nlp	24023389	SENT62	30	30	14	14	gentamicin	CO2	PA449753	4513	0.73
NULL	Indian_J_Pharmacol_2008_Oct_40(Suppl_2)_S97-S112.nxml.txt.nlp	21593984	SENT465	12	12	21	21	telmisartan	STZ	PA451605	6484	0.73
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT171	3	3	15	15	atorvastatin	p38	PA448500	10598;1432;7965	0.73
NULL	Adv_Ther_2014_Feb_18_31(3)_247-263.nxml.txt.nlp	24535624	SENT125	14	14	9	9	exenatide	GLP	PA164749238	342096	0.73
NULL	Core_Evid_2010_Oct_22_5_91-105.nxml.txt.nlp	21468365	SENT110	6	6	14	14	simvastatin	CYP2C9	PA451363	1559	0.73
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Feb_20_69(Pt_3)_o398-o399.nxml.txt.nlp	23476581	SENT79	29	29	6	6	ethanol	mol	PA448073	90527	0.73
NULL	Diabetes_2009_Jan_58(1)_243-249.nxml.txt.nlp	18840785	SENT140	26	26	33	33	glucose	GLP-1	PA449773	100125288	0.73
NULL	Nucleic_Acids_Res_2013_Feb_21_41(4)_e54.nxml.txt.nlp	23262224	SENT30	13	13	8	8	estradiol	mol	PA449503	90527	0.73
NULL	Nat_Med_2010_Feb_24_16(2)_214-218.nxml.txt.nlp	20098429	SENT165	22	22	6	6	doxorubicin	LAPTM4B	PA449412	55353	0.73
NULL	Eur_J_Clin_Pharmacol_2014_May_21_70(8)_915-920.nxml.txt.nlp	24839948	SENT146	13	13	7	7	midazolam	CYP3A	PA450496	1574	0.73
NULL	Curr_Neuropharmacol_2011_Dec_9(4)_530-552.nxml.txt.nlp	22654714	SENT407	19	19	28	28	fluoxetine	BDNF	PA449673	627	0.73
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1148-1152.nxml.txt.nlp	22343623	SENT24	22	22	13	13	gefitinib	EGFR	PA131301952	1956	0.73
NULL	An_Bras_Dermatol_2014_Mar-Apr_89(2)_301-310.nxml.txt.nlp	24770508	SENT109	30	30	34	34	cisplatin	IFN	PA449014	3439	0.73
NULL	Br_J_Cancer_2010_Nov_9_103(10)_1542-1547.nxml.txt.nlp	20959822	SENT68	6	6	3	3	cetuximab	KRAS	PA10040	3845	0.73
NULL	Eur_J_Appl_Physiol_2011_Feb_24_111(2)_275-283.nxml.txt.nlp	20865425	SENT195	29	29	17	17	glucose	AMPK	PA449773	5563	0.73
NULL	Nat_Methods_2012_Oct_16_9(10)_981-984.nxml.txt.nlp	22983458	SENT103	27	27	15	15	chloramphenicol	AG1	PA448927	100132406	0.73
NULL	Oncotarget_2013_Oct_19_4(11)_2045-2056.nxml.txt.nlp	24185104	SENT103	6	6	3	3	cisplatin	14-3-3	PA449014	10971	0.73
NULL	Neuropsychopharmacology_2009_Apr_2_34(5)_1135-1148.nxml.txt.nlp	18596687	SENT9	11	11	37	37	cocaine	CRF	PA449072	1392;10882	0.73
NULL	Breast_Cancer_Res_2008_Jul_24_10(4)_211.nxml.txt.nlp	18671839	SENT139	5	5	15	15	flavopiridol	survivin	PA452627	332	0.73
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jan_21_68(Pt_2)_o469.nxml.txt.nlp	22347077	SENT70	13	13	6	6	acetone	mol	PA448025	90527	0.73
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1063.nxml.txt.nlp	24556678	SENT52	19	19	6	6	thioridazine	TRAIL	PA451666	8743	0.73
NULL	Diabetes_Care_2013_Feb_17_36(2)_273-275.nxml.txt.nlp	23043164	SENT83	11	11	3	3	hyaluronidase	Tech	PA164745713	57449	0.73
NULL	J_Korean_Med_Sci_2013_Aug_31_28(8)_1145-1153.nxml.txt.nlp	23960440	SENT101	2	2	6	6	colchicine	ST2	PA449092	9173;6761	0.73
NULL	Cardiovasc_Res_2009_May_1_82(2)_296-302.nxml.txt.nlp	19088082	SENT83	16	16	13	13	desipramine	nSMase	PA449233	6610	0.73
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT220	17	17	10	10	erlotinib	AKT	PA134687924	207	0.73
NULL	ISRN_Nutr_2014_Jan_16_2014_149549.nxml.txt.nlp	24967264	SENT142	7	7	10	10	echinacea	EPO	PA131550706	7076;8288;2056	0.73
NULL	Front_Oncol_2012_Sep_12_2_114.nxml.txt.nlp	22988546	SENT711	2	2	10	10	bexarotene	DEC2	PA164752250	79365	0.73
NULL	J_Gen_Physiol_2000_Dec_1_116(6)_769-780.nxml.txt.nlp	11099346	SENT148	26	26	24	24	tetracaine	DAG	PA451638	1605	0.73
NULL	Arthritis_Res_Ther_2012_Jul_12_14(4)_R163.nxml.txt.nlp	22784880	SENT159	1	1	6	6	methotrexate	DHODH	PA450428	1723	0.73
NULL	Chonnam_Med_J_2011_Aug_31_47(2)_124-126.nxml.txt.nlp	22111073	SENT49	29	29	17	17	clopidogrel	DES	PA449053	1674	0.73
NULL	J_Lipids_2011_Jan_13_2011_565316.nxml.txt.nlp	21490804	SENT199	13	13	17	17	doxorubicin	TRAIL	PA449412	8743	0.73
NULL	Br_J_Haematol_2011_Jun_153(5)_634-643.nxml.txt.nlp	21477209	SENT165	17	17	14	14	etoposide	TP53	PA449552	7157	0.73
NULL	Anal_Chem_Insights_2008_Mar_25_3_45-60.nxml.txt.nlp	19609389	SENT144	27	27	22	22	cholestyramine	CYP7A1	PA448974	1581	0.73
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT369	14	14	9	9	resveratrol	p300		2033	0.73
NULL	Diabetes_2013_Jun_17_62(6)_2141-2150.nxml.txt.nlp	23378610	SENT9	23	23	31	31	betaine	BHMT	PA448603	635	0.73
NULL	Int_J_Breast_Cancer_2011_Jul_12_2011_232435.nxml.txt.nlp	22295213	SENT242	40	40	32	32	tamoxifen	SIAH2	PA451581	6478	0.73
NULL	Hum_Genomics_2010_Apr_1_4(4)_238-249.nxml.txt.nlp	20511137	SENT174	4	4	12	12	sn-38	UGT1A1		54658	0.73
NULL	Indian_J_Dermatol_2013_Jan-Feb_58(1)_61-64.nxml.txt.nlp	23372216	SENT99	8	8	6	6	fluvoxamine	CYP2D6	PA449690	1565	0.73
NULL	J_Immunother_Cancer_2013_Jun_27_1_9.nxml.txt.nlp	NULL	SENT175	5	5	24	24	sunitinib	IFN	PA162372840	3439	0.73
NULL	Ann_Rheum_Dis_2011_Aug_17_70(12)_2148-2151.nxml.txt.nlp	21852254	SENT120	5	5	33	33	tocilizumab	IL-6	PA165292659	3569	0.73
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT162	9	9	6	6	trastuzumab	STAT3	PA451743	6774	0.73
NULL	Oncotarget_2012_May_4_3(4)_395-398.nxml.txt.nlp	22565037	SENT9	31	31	43	43	trastuzumab	HER2	PA451743	2064	0.73
NULL	Antiviral_Res_2009_May_82(2)_A99-A109.nxml.txt.nlp	19176219	SENT1122	33	33	2	2	nelfinavir	OAT3	PA450606	9376	0.73
NULL	Oncoimmunology_2014_Apr_25_3_e28518.nxml.txt.nlp	25071979	SENT152	12	12	16	16	carboplatin	HMGB1	PA448803	3146	0.73
NULL	Mol_Cancer_2010_Apr_23_9_87.nxml.txt.nlp	20416058	SENT259	12	12	14	14	doxorubicin	TRAIL	PA449412	8743	0.73
NULL	Indian_J_Ophthalmol_2007_Nov-Dec_55(6)_445-450.nxml.txt.nlp	17951902	SENT34	0	0	37	37	pegaptanib	VEGF-A	PA164771236	7422	0.73
NULL	Cancer_Cell_2013_Nov_11_24(5)_617-630.nxml.txt.nlp	24229709	SENT81	16	16	2	2	tamoxifen	p110	PA451581	9733	0.73
NULL	Oncoscience_2014_Jun_4_1(6)_446-456.nxml.txt.nlp	25594043	SENT215	9	9	13	13	doxorubicin	PTEN	PA449412	5728	0.73
NULL	J_Headache_Pain_2012_Mar_14_13(2)_159-166.nxml.txt.nlp	22246026	SENT135	20	20	0	0	sumatriptan	ANOVA	PA451566	4858	0.73
NULL	J_Cell_Biol_2001_Mar_19_152(6)_1135-1144.nxml.txt.nlp	11257115	SENT224	21	21	25	25	lipase	DAG	PA450239	1605	0.73
NULL	Evid_Based_Complement_Alternat_Med_2012_May_7_2012_242810.nxml.txt.nlp	22645625	SENT339	17	17	3	3	rifampin	CYP3A4	PA451250	1576	0.73
NULL	Oncol_Lett_2014_Nov_12_8(5)_2203-2208.nxml.txt.nlp	25295109	SENT84	4	4	11	11	celecoxib	SMO	PA448871	6608;54498	0.73
NULL	Carcinogenesis_2013_Mar_7_34(3)_703-712.nxml.txt.nlp	23222814	SENT12	10	10	32	32	curcumin	RPS6	PA151958596	6194	0.73
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT216	23	23	21	21	cisplatin	MDM2	PA449014	4193	0.73
NULL	Mol_Microbiol_2014_May_28_92(3)_453-470.nxml.txt.nlp	24533860	SENT109	4	4	6	6	tetracycline	HMI	PA451640	3160	0.73
NULL	Breast_Cancer_Res_2010_Feb_16_12(1)_R13.nxml.txt.nlp	20158881	SENT63	7	7	3	3	heparin	EGF	PA449855	1950	0.73
NULL	Acta_Pharmacol_Sin_2013_Apr_25_34(4)_455-463.nxml.txt.nlp	23524568	SENT205	0	0	6	6	pioglitazone	BACE1	PA450970	23621	0.73
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT218	0	0	9	9	resveratrol	TRAIL		8743	0.73
NULL	Arthritis_2011_May_26_2011_765624.nxml.txt.nlp	22046525	SENT3	15	15	11	11	tocilizumab	IL-6	PA165292659	3569	0.73
NULL	J_Korean_Med_Sci_2010_Jun_24_25(6)_829-834.nxml.txt.nlp	20514301	SENT107	20	20	34	34	papain	p38	PA450778	10598;1432;7965	0.73
NULL	Exp_Ther_Med_2013_Jan_10_5(1)_287-291.nxml.txt.nlp	23251285	SENT27	24	24	32	32	aspirin	APS	PA448497	10603	0.73
NULL	Carcinogenesis_2013_Mar_7_34(3)_703-712.nxml.txt.nlp	23222814	SENT120	0	0	14	14	curcumin	CDK2	PA151958596	1017	0.73
NULL	Ann_Rheum_Dis_2014_Sep_18_73(9)_1607-1615.nxml.txt.nlp	24641941	SENT235	12	12	40	40	tocilizumab	IL-6	PA165292659	3569	0.73
NULL	Breast_Cancer_Res_2012_Jul_20_14(4)_R111.nxml.txt.nlp	22817771	SENT177	7	7	5	5	flutamide	PIP	PA449685	5304	0.73
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1149.nxml.txt.nlp	24675467	SENT103	9	9	19	19	trastuzumab	DM1	PA451743	338023;1760;28509	0.73
NULL	Diabetes_2009_Dec_31_58(12)_2920-2929.nxml.txt.nlp	19720797	SENT202	16	16	3	3	pravastatin	S28	PA451089	6234	0.73
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jul_31_66(Pt_8)_o2189.nxml.txt.nlp	21588466	SENT83	14	14	20	20	ethanol	mol	PA448073	90527	0.73
NULL	Oncogene_2014_Jul_17_33(29)_3784-3793.nxml.txt.nlp	24013225	SENT140	8	8	29	29	heparin	EGFR	PA449855	1956	0.73
NULL	Front_Physiol_2013_Dec_24_4_386.nxml.txt.nlp	24399968	SENT195	13	13	23	23	repaglinide	SUR2	PA451234	10060	0.73
NULL	Mol_Cancer_2010_Apr_23_9_87.nxml.txt.nlp	20416058	SENT196	21	21	19	19	doxorubicin	TRAIL	PA449412	8743	0.73
NULL	Protein_Cell_2014_Jun_19_5(6)_469-479.nxml.txt.nlp	24748116	SENT114	5	5	0	0	paclitaxel	EB1	PA450761	9167;22919;10982	0.73
NULL	Exp_Cell_Res_2011_Apr_15_317(7)_1028-1039.nxml.txt.nlp	21237154	SENT210	4	4	29	29	staurosporine	JIP1	PA165109623	9479	0.73
NULL	J_Hematol_Oncol_2013_Nov_5_6_83.nxml.txt.nlp	24283248	SENT121	10	10	7	7	etoposide	TP53	PA449552	7157	0.73
NULL	J_Korean_Med_Sci_2008_Aug_25_23(4)_685-690.nxml.txt.nlp	18756058	SENT88	46	46	14	14	olanzapine	ghrelin	PA450688	51738	0.73
NULL	Acta_Pharmacol_Sin_2009_Sep_24_30(9)_1262-1275.nxml.txt.nlp	19701231	SENT201	37	37	14	14	lovastatin	FADS3	PA450272	3995	0.73
NULL	Front_Pharmacol_2014_Oct_20_5_230.nxml.txt.nlp	25368579	SENT88	0	0	12	12	berberine	IL-6	PA165860812	3569	0.73
NULL	Br_J_Cancer_2013_Mar_19_108(5)_1052-1060.nxml.txt.nlp	23422754	SENT109	20	20	1	1	bevacizumab	VEGF-A	PA130232992	7422	0.73
NULL	J_Oncol_2012_Jun_19_2012_521215.nxml.txt.nlp	22778735	SENT24	13	13	36	36	gefitinib	San	PA131301952	80218	0.73
NULL	Breast_Cancer_Res_2007_Aug_8_9(4)_R50.nxml.txt.nlp	17686159	SENT246	26	26	28	28	gefitinib	HRG	PA131301952	3084;3273	0.73
NULL	Exp_Ther_Med_2014_Nov_29_8(5)_1473-1478.nxml.txt.nlp	25289044	SENT111	19	19	3	3	heparin	AZU	PA449855	566	0.73
NULL	Ann_Rheum_Dis_2008_Apr_20_67(4)_511-517.nxml.txt.nlp	17644552	SENT67	18	18	2	2	infliximab	IL-6	PA452639	3569	0.73
NULL	Oncogenesis_2014_Oct_20_3(10)_e123.nxml.txt.nlp	25329722	SENT61	15	15	3	3	etoposide	p53	PA449552	7157	0.73
NULL	Exp_Mol_Med_2012_Jun_30_44(6)_403-411.nxml.txt.nlp	22510730	SENT81	0	0	8	8	anastrozole	PSD-95	PA448432	1742	0.73
NULL	J_Cell_Biol_2001_Oct_29_155(3)_447-458.nxml.txt.nlp	11684709	SENT314	6	6	16	16	pp2	BRL		23774	0.73
NULL	Ann_Clin_Microbiol_Antimicrob_2005_Sep_13_4_13.nxml.txt.nlp	16159399	SENT266	10	10	4	4	ribavirin	IFN	PA451241	3439	0.73
NULL	Clin_Epigenetics_2011_Jun_14_2(2)_425-432.nxml.txt.nlp	22704355	SENT83	25	25	22	22	galactose	FUT8	PA449725	2530	0.73
NULL	Iran_J_Pharm_Res_2013_Winter_12(1)_141-146.nxml.txt.nlp	24250582	SENT108	14	14	16	16	rifampin	NAC	PA451250	22861	0.73
NULL	J_Mol_Signal_2011_Oct_5_6_13.nxml.txt.nlp	21975218	SENT143	31	31	18	18	ethanol	E4BP4	PA448073	4783	0.73
NULL	J_Mol_Signal_2012_Aug_16_7_12.nxml.txt.nlp	22898329	SENT416	8	8	21	21	oxaliplatin	BIM	PA131285527	10018	0.73
NULL	Oncotarget_2014_Sep_16_5(20)_9980-9991.nxml.txt.nlp	25296971	SENT125	11	11	34	34	oxaliplatin	E2F1	PA131285527	1869	0.73
NULL	Int_J_Mol_Sci_2014_Oct_22_15(10)_19183-19202.nxml.txt.nlp	25340982	SENT153	8	8	14	14	resveratrol	p53		7157	0.73
NULL	Front_Neurol_2010_Jul_12_1_11.nxml.txt.nlp	21206763	SENT129	2	2	4	4	riluzole	GDNF	PA451251	2668	0.73
NULL	Mol_Neurodegener_2011_Aug_8_6_57.nxml.txt.nlp	21819629	SENT13	13	13	27	27	arsenite	TDP-43	PA452638	23435	0.73
NULL	Mol_Cell_Biochem_2014_Oct_9_385(1-2)_265-275.nxml.txt.nlp	24104452	SENT235	7	7	20	20	bortezomib	U87	PA10252	677775;641648	0.73
NULL	Curr_Neuropharmacol_2007_Dec_5(4)_232-243.nxml.txt.nlp	19305740	SENT124	9	9	28	28	rosiglitazone	MCP-1	PA451283	6347	0.73
NULL	Structure_2013_Sep_3_21(9)_1648-1658.nxml.txt.nlp	23932590	SENT131	18	18	26	26	mitomycin	FANCM	PA450524	57697	0.73
NULL	Adolesc_Health_Med_Ther_2010_May_27_1_21-30.nxml.txt.nlp	24600258	SENT224	15	15	8	8	butalbital	OTC	PA448695	5009	0.73
NULL	J_Clin_Biochem_Nutr_2009_Jan_27_44(1)_79-84.nxml.txt.nlp	19177192	SENT4	25	25	36	36	curcumin	HO-1	PA151958596	3162	0.73
NULL	Clin_Mol_Hepatol_2014_Sep_25_20(3)_283-290.nxml.txt.nlp	25320732	SENT133	17	17	15	15	propranolol	EVL	PA451145	51466	0.73
NULL	J_Korean_Neurosurg_Soc_2014_Sep_30_56(3)_175-187.nxml.txt.nlp	25368758	SENT163	36	36	8	8	oxygen	CPP	PA450744	340451	0.73
NULL	Anal_Bioanal_Chem_2013_Jul_23_405(23)_7337-7345.nxml.txt.nlp	23877175	SENT16	28	28	9	9	pilocarpine	CA3	PA450962	761	0.73
NULL	J_Clin_Biochem_Nutr_2009_Jan_27_44(1)_79-84.nxml.txt.nlp	19177192	SENT84	11	11	13	13	curcumin	HO-1	PA151958596	3162	0.73
NULL	Breast_Cancer_Res_2013_Sep_23_15(5)_R86.nxml.txt.nlp	24060333	SENT61	24	24	26	26	tamoxifen	aromatase	PA451581	1588	0.73
NULL	Environ_Health_Perspect_2007_Mar_19_115(3)_346-353.nxml.txt.nlp	17431482	SENT96	39	39	24	24	trypsin	CO2	PA451806	4513	0.73
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT7	34	34	14	14	bevacizumab	VEGFR2	PA130232992	3791	0.73
NULL	Pharmaceutics_2010_Sep_9_2(3)_291-299.nxml.txt.nlp	NULL	SENT87	16	16	13	13	tacrolimus	CYP3A5	PA451578	1577	0.73
NULL	Mol_Cancer_2010_May_18_9_110.nxml.txt.nlp	20482802	SENT165	24	24	21	21	bortezomib	PSMB5	PA10252	5693	0.73
NULL	Int_J_Environ_Res_Public_Health_2010_Apr_4_7(4)_1540-1557.nxml.txt.nlp	20617045	SENT140	10	10	15	15	ethanol	APOE	PA448073	348	0.729
NULL	Exp_Mol_Med_2012_Sep_30_44(9)_545-553.nxml.txt.nlp	22809901	SENT77	0	0	10	10	clozapine	adiponectin	PA449061	9370	0.729
NULL	J_Gen_Physiol_1960_Mar_1_43(4)_753-758.nxml.txt.nlp	14433991	SENT1	3	3	8	8	dextran	gamma	PA449261	9913	0.729
NULL	Amino_Acids_2012_Oct_10_43(4)_1751-1759.nxml.txt.nlp	22407485	SENT73	42	42	31	31	carrageenan	ghrelin	PA448814	51738	0.729
NULL	Adipocyte_2014_Jul_1_3(3)_224-229.nxml.txt.nlp	25068091	SENT32	11	11	26	26	glucose	GSTA4	PA449773	2941	0.729
NULL	Int_J_Environ_Res_Public_Health_2011_Feb_15_8(2)_480-497.nxml.txt.nlp	21556198	SENT84	14	14	2	2	tetracycline	DOM	PA451640	6663	0.729
NULL	J_Oncol_2009_May_6_2009_567486.nxml.txt.nlp	19424511	SENT113	7	7	11	11	panitumumab	EGFR	PA162373091	1956	0.729
NULL	Front_Endocrinol_(Lausanne)_2013_Jun_26_4_75.nxml.txt.nlp	23805127	SENT135	10	10	14	14	gemfibrozil	UGT	PA449750	7361;7355	0.729
NULL	Indian_J_Ophthalmol_2013_May_61(5)_213-217.nxml.txt.nlp	23314254	SENT77	38	38	16	16	ranibizumab	San	PA164746012	80218	0.729
NULL	Br_J_Cancer_2010_Nov_9_103(10)_1580-1587.nxml.txt.nlp	20959823	SENT75	1	1	4	4	bortezomib	PMP22	PA10252	5376;5827	0.729
NULL	Acta_Pharmacol_Sin_2012_Feb_3_33(2)_173-181.nxml.txt.nlp	22301857	SENT66	0	0	24	24	sibutramine	NEFA	PA451344	4925	0.729
NULL	Pharmaceutics_2011_Nov_18_3(4)_865-913.nxml.txt.nlp	24309312	SENT204	3	3	16	16	bupropion	CYP2B6	PA448687	1555	0.729
NULL	Arthritis_Res_Ther_2004_Feb_24_6(Suppl_1)_66.nxml.txt.nlp	NULL	SENT19	24	24	2	2	infliximab	CD163	PA452639	9332	0.729
NULL	Nanoscale_Res_Lett_2012_Jul_20_7(1)_408.nxml.txt.nlp	22818179	SENT32	4	4	14	14	ethanol	IPA	PA448073	3160	0.729
NULL	Clin_Pharmacol_2013_Dec_9_5_185-192.nxml.txt.nlp	24353446	SENT75	43	43	46	46	clopidogrel	CYP3A4	PA449053	1576	0.729
NULL	Int_J_Mol_Sci_2014_Oct_17_15(10)_18762-18775.nxml.txt.nlp	25329617	SENT132	21	21	5	5	heparin	EGF	PA449855	1950	0.729
NULL	Acta_Pharmacol_Sin_2012_Jan_12_33(1)_27-33.nxml.txt.nlp	22158109	SENT124	17	17	7	7	propofol	AMPK	PA451141	5563	0.729
NULL	Aging_(Albany_NY)_2010_Dec_20_2(12)_959-968.nxml.txt.nlp	21191146	SENT87	5	5	17	17	cisplatin	LKB1	PA449014	6794	0.729
NULL	Arthritis_Res_Ther_2011_Feb_4_13(1)_R14.nxml.txt.nlp	21294864	SENT54	23	23	21	21	indomethacin	IL-17	PA449982	3605	0.729
NULL	Infect_Dis_Rep_2011_Jun_24_3(1)_e6.nxml.txt.nlp	23745166	SENT172	16	16	13	13	maraviroc	CCR5	PA164768835	1234	0.729
NULL	J_Antimicrob_Chemother_2011_Jun_25_66(6)_1332-1339.nxml.txt.nlp	21441248	SENT205	24	24	3	3	nevirapine	CYP2B6	PA450616	1555	0.729
NULL	Int_J_Endocrinol_2014_Aug_11_2014_312452.nxml.txt.nlp	25183970	SENT133	8	8	3	3	liraglutide	PI3K	PA165958364	5290	0.729
NULL	Acta_Pharmacol_Sin_2009_Feb_26_30(2)_219-227.nxml.txt.nlp	19169271	SENT172	5	5	11	11	atropine	CTX	PA448505	1593	0.729
NULL	Evid_Based_Complement_Alternat_Med_2013_Aug_12_2013_982689.nxml.txt.nlp	23997806	SENT8	11	11	3	3	tolbutamide	APE	PA451718	55704;328	0.729
NULL	Antimicrob_Agents_Chemother_2014_Nov_10_59(1)_490-497.nxml.txt.nlp	25385107	SENT80	10	10	0	0	artemether	ATV	PA165111698	4683	0.729
NULL	Br_J_Haematol_2014_Feb_16_164(4)_586-596.nxml.txt.nlp	24236640	SENT161	16	16	18	18	carboplatin	CARB	PA448803	9482	0.729
NULL	Br_J_Cancer_2010_Feb_2_102(3)_520-529.nxml.txt.nlp	20029417	SENT175	0	0	15	15	cetuximab	IL-21	PA10040	59067;50616;27189	0.729
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT247	6	6	9	9	resveratrol	ROS		6098	0.729
NULL	Arthritis_Res_Ther_2010_Sep_8_12(5)_R167.nxml.txt.nlp	20825639	SENT169	23	23	29	29	resveratrol	AP-1		2353;3727;2354;3725	0.729
NULL	Br_J_Pharmacol_2011_Aug_163(8)_1679-1690.nxml.txt.nlp	21371008	SENT127	24	24	26	26	forskolin	CD16	PA146096022	2215;2214	0.729
NULL	Ital_J_Pediatr_2011_Dec_19_37_58.nxml.txt.nlp	22182677	SENT169	16	16	9	9	allopurinol	LGS	PA448320	51557	0.729
NULL	Hum_Genomics_2009_Apr_1_3(3)_213-220.nxml.txt.nlp	19403456	SENT29	8	8	16	16	ethanol	ALDH2	PA448073	217	0.729
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S18-S30.nxml.txt.nlp	20680104	SENT30	15	15	18	18	bevacizumab	EGFR	PA130232992	1956	0.729
NULL	Bone_Marrow_Res_2011_Jul_13_2011_303487.nxml.txt.nlp	22046559	SENT281	10	10	23	23	cyclophosphamide	CD34	PA449165	947	0.729
NULL	Oncotarget_2013_Dec_18_5(2)_375-385.nxml.txt.nlp	24495868	SENT117	7	7	17	17	fludarabine	XIAP	PA449655	331	0.729
NULL	Case_Rep_Med_2013_Mar_30_2013_240607.nxml.txt.nlp	23606850	SENT41	14	14	27	27	fluorescein	ERG	PA164746009	2078	0.729
NULL	Exp_Ther_Med_2013_Dec_15_6(6)_1565-1569.nxml.txt.nlp	24255692	SENT95	10	10	15	15	simvastatin	adiponectin	PA451363	9370	0.729
NULL	Br_J_Cancer_2012_Sep_4_107(6)_977-987.nxml.txt.nlp	22892389	SENT121	1	1	33	33	orlistat	p53	PA164776864	7157	0.729
NULL	Int_J_Mol_Sci_2014_Nov_10_15(11)_20607-20637.nxml.txt.nlp	25391045	SENT1786	0	0	17	17	simvastatin	GDNF	PA451363	2668	0.729
NULL	J_Hematol_Oncol_2013_Aug_2_6_55.nxml.txt.nlp	23915913	SENT104	21	21	33	33	lenalidomide	FLG3	PA162363968	388697	0.729
NULL	Oncotarget_2013_Nov_7_4(12)_2550-2566.nxml.txt.nlp	24334291	SENT10	15	15	30	30	dasatinib	AMPK	PA162372878	5563	0.729
NULL	Cancers_(Basel)_2014_Jul_8_6(3)_1487-1499.nxml.txt.nlp	25006835	SENT308	8	8	3	3	cisplatin	MKP-1	PA449014	1843	0.729
NULL	Indian_J_Med_Res_2013_Jan_137(1)_203-209.nxml.txt.nlp	23481074	SENT81	7	7	12	12	acenocoumarol	CYP2C9	PA452632	1559	0.729
NULL	DNA_Res_2011_Dec_6_18(6)_423-434.nxml.txt.nlp	21900213	SENT218	20	20	35	35	galactose	GAL	PA449725	51083	0.729
NULL	Diabetes_Metab_J_2012_Oct_18_36(5)_328-335.nxml.txt.nlp	23130316	SENT66	15	15	21	21	lipase	PDK4	PA450239	5166	0.729
NULL	Br_J_Cancer_2012_Sep_25_107(7)_1059-1068.nxml.txt.nlp	22935581	SENT27	26	26	12	12	bevacizumab	IFN	PA130232992	3439	0.729
NULL	J_Int_Soc_Sports_Nutr_2013_Aug_22_10_39.nxml.txt.nlp	23967897	SENT42	26	26	21	21	betaine	Met	PA448603	79811	0.729
NULL	Toxins_(Basel)_2010_Jun_9_2(6)_1381-1398.nxml.txt.nlp	22069643	SENT169	15	15	0	0	daunorubicin	P-gp	PA449212	5243	0.729
NULL	Breast_Cancer_Res_2005_Jul_20_7(5)_205-211.nxml.txt.nlp	16168139	SENT172	31	31	1	1	tamoxifen	EGFR	PA451581	1956	0.729
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R91.nxml.txt.nlp	22541814	SENT142	32	32	6	6	thrombin	PAR3	PA451674	56288;2151	0.729
NULL	Clin_Ophthalmol_2007_Dec_1(4)_367-371.nxml.txt.nlp	19668513	SENT59	32	32	36	36	ketorolac	PRK	PA450150	1263	0.729
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT116	6	6	8	8	resveratrol	TRAIL		8743	0.729
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_May_24_70(Pt_6)_o700-o701.nxml.txt.nlp	24940274	SENT85	4	4	22	22	piperazine	mol	PA450977	90527	0.729
NULL	Mol_Cancer_2012_Sep_25_11_73.nxml.txt.nlp	23009336	SENT143	5	5	30	30	gefitinib	Oct4	PA131301952	5460	0.729
NULL	Springerplus_2014_Sep_17_3_535.nxml.txt.nlp	25279326	SENT85	25	25	22	22	denosumab	RANK	PA166048634	8792	0.729
NULL	J_Cardiothorac_Surg_2012_Jul_18_7_70.nxml.txt.nlp	22808929	SENT33	12	12	8	8	rituximab	CHOP	PA451261	1649	0.729
NULL	J_Med_Case_Reports_2011_Aug_16_5_386.nxml.txt.nlp	21846347	SENT85	10	10	13	13	octreotide	SSTR2	PA450678	6752	0.729
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1059-1066.nxml.txt.nlp	21364577	SENT59	29	29	9	9	letrozole	aromatase	PA450196	1588	0.729
NULL	Oncol_Rep_2012_Sep_26_28(3)_777-784.nxml.txt.nlp	22751903	SENT141	23	23	10	10	celecoxib	MVD	PA448871	4597	0.729
NULL	Indian_J_Pharmacol_2012_Nov-Dec_44(6)_744-748.nxml.txt.nlp	23248405	SENT107	2	2	9	9	clopidogrel	DAI	PA449053	81030	0.729
NULL	Br_J_Cancer_2013_Oct_1_109(7)_1717-1724.nxml.txt.nlp	24022187	SENT102	11	11	26	26	trabectedin	IL-6	PA165958349	3569	0.729
NULL	Br_J_Cancer_2009_Mar_24_100(6)_941-949.nxml.txt.nlp	19240716	SENT147	17	17	44	44	gefitinib	EGFR	PA131301952	1956	0.729
NULL	Bioinformation_2011_Sep_6_7(2)_59-63.nxml.txt.nlp	21938206	SENT4	23	23	25	25	cefazolin	PON1	PA448839	5444	0.729
NULL	Cancer_Immunol_Immunother_2013_Aug_27_62(10)_1637-1648.nxml.txt.nlp	23982484	SENT231	10	10	36	36	lenalidomide	IFN	PA162363968	3439	0.729
NULL	Chin_J_Cancer_2012_Feb_31(2)_51-57.nxml.txt.nlp	22257384	SENT40	8	8	3	3	cyclosporine	P-gp	PA449167	5243	0.729
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1063.nxml.txt.nlp	24556678	SENT44	21	21	11	11	thioridazine	Mcl-1	PA451666	4170	0.729
NULL	Food_Nutr_Res_2011_Jan_14_55_10_3402_fnr_v55i0_5455.nxml.txt.nlp	21249160	SENT108	15	15	25	25	spermine	mol	PA164781199	90527	0.729
NULL	J_Gastroenterol_2013_Jan_27_48(1)_22-30.nxml.txt.nlp	23104468	SENT37	5	5	15	15	ribavirin	IFN	PA451241	3439	0.729
NULL	Exp_Ther_Med_2013_Apr_5_5(4)_1259-1263.nxml.txt.nlp	23596498	SENT4	10	10	18	18	capsaicin	TRPA1	PA448776	8989	0.729
NULL	Asian_J_Transfus_Sci_2014_8(Suppl1)_S26-S87.nxml.txt.nlp	NULL	SENT2734	9	9	6	6	rituximab	ABO	PA451261	28	0.729
NULL	Tumour_Biol_2014_Mar_8_35(3)_2607-2617.nxml.txt.nlp	24318988	SENT145	9	9	34	34	nadh	EGLN3	PA164755085	112399	0.729
NULL	Oncol_Lett_2014_Jun_4_7(6)_2175-2179.nxml.txt.nlp	24932311	SENT93	17	17	2	2	choline	PEMT	PA448976	10400	0.729
NULL	Oncotarget_2013_Nov_22_5(4)_933-943.nxml.txt.nlp	24659749	SENT51	29	29	23	23	nutlin-3	p53		7157	0.729
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT110	23	23	31	31	tamoxifen	S6K1	PA451581	6198	0.729
NULL	J_Exp_Med_1995_Jul_1_182(1)_147-154.nxml.txt.nlp	7790814	SENT6	12	12	29	29	estradiol	Raf-1	PA449503	5894	0.729
NULL	J_Mol_Signal_2008_Dec_2_3_19.nxml.txt.nlp	19055733	SENT57	22	22	11	11	isoproterenol	AKAP12	PA450121	9590	0.729
NULL	Emerg_Med_J_2014_Feb_22_31(2)_163-168.nxml.txt.nlp	23435652	SENT82	39	39	27	27	thrombin	VIII	PA451674	1351	0.729
NULL	Environ_Health_Perspect_2005_Jun_24_113(6)_680-687.nxml.txt.nlp	15929889	SENT187	18	18	9	9	phenol	SULT1A1	PA450913	6817	0.729
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT227	2	2	27	27	docetaxel	B7-H1	PA449383	29126	0.729
NULL	Int_J_Biol_Sci_2011_May_19_7(5)_645-650.nxml.txt.nlp	21647332	SENT97	11	11	17	17	metformin	SREBP-1c	PA450395	6720	0.729
NULL	Cancer_Cell_Int_2013_May_1_13_39.nxml.txt.nlp	23631621	SENT209	24	24	33	33	fluorescein	CD44	PA164746009	960	0.729
NULL	J_Hematol_Oncol_2012_May_17_5_24.nxml.txt.nlp	22594538	SENT162	32	32	42	42	methotrexate	DHFR	PA450428	1719	0.729
NULL	Front_Oncol_2014_Jun_16_4_148.nxml.txt.nlp	24982848	SENT158	23	23	12	12	etoposide	p53	PA449552	7157	0.729
NULL	Eur_J_Med_Res_2011_Jul_25_16(7)_303-314.nxml.txt.nlp	21813371	SENT59	11	11	16	16	telaprevir	SOC	PA165958354	91544	0.729
NULL	Mol_Cancer_2008_Mar_26_7_27.nxml.txt.nlp	18366759	SENT262	18	18	20	20	etoposide	MCL1	PA449552	4170	0.729
NULL	Philos_Trans_R_Soc_Lond_B_Biol_Sci_2012_Sep_19_367(1602)_2529-2539.nxml.txt.nlp	22889905	SENT26	23	23	31	31	choline	CAK	PA448976	1022	0.729
NULL	F1000_Med_Rep_2010_Jun_23_2_45.nxml.txt.nlp	20948839	SENT30	14	14	16	16	zoledronate	IL-2	PA10235	3558	0.729
NULL	Diabetes_Care_2010_Jan_21_33(1)_9-16.nxml.txt.nlp	19846793	SENT130	16	16	40	40	metformin	LGA	PA450395	27165	0.729
NULL	Mol_Cancer_2014_Jul_2_13_163.nxml.txt.nlp	24990559	SENT227	0	0	2	2	tamoxifen	aromatase	PA451581	1588	0.729
NULL	Arch_Med_Sci_2011_Dec_31_7(6)_977-983.nxml.txt.nlp	22328880	SENT8	6	6	13	13	heparin	ACT	PA449855	12;11332;9457;641455	0.729
NULL	Chin_J_Cancer_2012_Feb_31(2)_58-72.nxml.txt.nlp	22098952	SENT66	18	18	3	3	arsenite	MRP1	PA452638	4437	0.729
NULL	Aging_(Albany_NY)_2009_Jun_3_1(6)_515-528.nxml.txt.nlp	20157535	SENT112	5	5	22	22	resveratrol	S6K1		6198	0.729
NULL	Acta_Pharmacol_Sin_2011_Dec_7_32(12)_1433-1445.nxml.txt.nlp	22056617	SENT253	0	0	15	15	lamotrigine	CA1	PA450164	759	0.729
NULL	Clinics_2008_Aug_63(4)_479-482.nxml.txt.nlp	18719758	SENT49	8	8	20	20	carvedilol	AT1	PA448817	9197;185	0.729
NULL	Lancet_2008_May_3_371(9623)_1505-1512.nxml.txt.nlp	18455228	SENT128	24	24	21	21	denosumab	RANKL	PA166048634	8600	0.729
NULL	ScientificWorldJournal_2013_Feb_21_2013_675898.nxml.txt.nlp	23533355	SENT176	11	11	19	19	glucose	MBL	PA449773	50639	0.729
NULL	Cancer_Manag_Res_2011_May_9_3_117-141.nxml.txt.nlp	21625397	SENT541	4	4	30	30	hydralazine	DPK	PA449894	3775;51347	0.729
NULL	ScientificWorldJournal_2013_Apr_18_2013_978394.nxml.txt.nlp	23710154	SENT108	23	23	30	30	irinotecan	IFL	PA450085	3439	0.729
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT134	2	2	10	10	perifosine	DR4	PA165291471	8797	0.729
NULL	Oncol_Lett_2014_Apr_4_7(4)_1011-1014.nxml.txt.nlp	24944660	SENT56	25	25	35	35	thyroglobulin	VIII	PA164754910	1351	0.729
NULL	Clin_Med_Insights_Case_Rep_2012_Nov_26_5_155-162.nxml.txt.nlp	23236259	SENT11	5	5	18	18	thyroglobulin	CK19	PA164754910	3880	0.729
NULL	Iran_J_Pharm_Res_2014_Spring_13(2)_635-639.nxml.txt.nlp	25237359	SENT18	5	5	25	25	chlorzoxazone	CYP2C19	PA448971	1557	0.729
NULL	Nucleic_Acids_Res_2012_Jun_22_40(11)_4861-4878.nxml.txt.nlp	22362753	SENT251	0	0	3	3	trypsin	NPM3	PA451806	10360	0.729
NULL	Br_J_Cancer_1998_Sep_78(6)_745-751.nxml.txt.nlp	9743293	SENT9	9	9	6	6	camptothecin	p53	PA153590860	7157	0.729
NULL	Oncotarget_2012_Nov_8_3(11)_1472-1482.nxml.txt.nlp	23178531	SENT127	26	26	21	21	iron	HIF1	PA450087	3091	0.729
NULL	Ann_Clin_Transl_Neurol_2014_Jan_19_1(1)_2-14.nxml.txt.nlp	24466563	SENT109	11	11	2	2	fasudil	ROCK2	PA165946121	9475	0.729
NULL	J_Biol_Chem_2012_Dec_14_287(51)_43094-43107.nxml.txt.nlp	23118219	SENT504	3	3	10	10	hyaluronan	CD25	PA165958431	3669;3559	0.729
NULL	Lipids_Health_Dis_2011_Feb_28_10_38.nxml.txt.nlp	21352602	SENT75	3	3	6	6	atorvastatin	PCSK9	PA448500	255738	0.729
NULL	Br_J_Cancer_2013_Mar_5_108(4)_983-992.nxml.txt.nlp	23361057	SENT261	15	15	11	11	cytarabine	NAC	PA449177	22861	0.729
NULL	Diabetes_2013_Nov_18_62(11)_3851-3862.nxml.txt.nlp	23884890	SENT8	14	14	3	3	metformin	AMPK	PA450395	5563	0.729
NULL	Cell_Death_Dis_2013_Jul_11_4(7)_e719.nxml.txt.nlp	23846221	SENT82	9	9	7	7	cisplatin	TRAIL	PA449014	8743	0.729
NULL	Br_J_Haematol_2011_Apr_153(1)_83-91.nxml.txt.nlp	21332705	SENT11	3	3	22	22	cangrelor	P2Y1	PA165945763	5028	0.729
NULL	Cancer_Immunol_Immunother_2011_Jan_21_60(1)_75-85.nxml.txt.nlp	20857100	SENT166	29	29	5	5	fludarabine	TH1	PA449655	51497	0.729
NULL	Arthritis_Res_Ther_2006_Apr_12_8(Suppl_1)_S4.nxml.txt.nlp	16820043	SENT62	2	2	18	18	benzbromarone	URAT1	PA134852920	116085	0.729
NULL	Braz_J_Med_Biol_Res_2013_Aug_13_46(8)_659-669.nxml.txt.nlp	24036938	SENT8	21	21	3	3	resveratrol	SIRT1		23411	0.729
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT295	4	4	23	23	gefitinib	PTEN	PA131301952	5728	0.729
NULL	Diabetes_2009_Jan_58(1)_243-249.nxml.txt.nlp	18840785	SENT147	15	15	18	18	vildagliptin	GLP-1	PA165958346	100125288	0.729
NULL	Environ_Health_Perspect_2004_Nov_28_112(15)_1512-1518.nxml.txt.nlp	15531436	SENT41	23	23	3	3	disulfiram	CYP2A6	PA449376	1548	0.729
NULL	Cancer_Immunol_Immunother_2015_Oct_7_64_61-73.nxml.txt.nlp	25287778	SENT261	11	11	13	13	lenalidomide	IL-2	PA162363968	3558	0.729
NULL	Epilepsia_2012_Jun_21_53(Suppl_1)_18-25.nxml.txt.nlp	22612805	SENT124	1	1	16	16	furosemide	NKCC1	PA449719	6558	0.729
NULL	Drug_Target_Insights_2012_Aug_6_6_19-39.nxml.txt.nlp	22915839	SENT96	23	23	34	34	doxorubicin	Hsp90	PA449412	3320	0.729
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_May_22_66(Pt_6)_m684-m685.nxml.txt.nlp	21579324	SENT3	34	34	44	44	sulfadiazine	mol	PA451539	90527	0.729
NULL	Arthritis_Res_Ther_2014_Dec_3_16(6)_484.nxml.txt.nlp	25465897	SENT181	38	38	6	6	hyaluronan	UGDH	PA165958431	7358	0.729
NULL	Cases_J_2008_Oct_29_1_283.nxml.txt.nlp	18959805	SENT32	12	12	27	27	zidovudine	CD4	PA451954	920	0.729
NULL	Virol_J_2009_Dec_1_6_213.nxml.txt.nlp	19951438	SENT118	9	9	16	16	mitomycin	TRAIL	PA450524	8743	0.729
NULL	EMBO_Mol_Med_2013_Feb_9_5(2)_309-325.nxml.txt.nlp	23300147	SENT185	1	1	10	10	geldanamycin	HER2	PA152031327	2064	0.729
NULL	Breast_Cancer_Res_2010_Oct_14_12(5)_R84.nxml.txt.nlp	20946630	SENT309	30	30	20	20	choline	Hsp90	PA448976	3320	0.729
NULL	Biochem_Res_Int_2012_Jun_25_2012_518437.nxml.txt.nlp	22792465	SENT110	15	15	20	20	tetracycline	RGS5	PA451640	8490	0.729
NULL	Acta_Pharmacol_Sin_2014_Aug_21_35(8)_994-1004.nxml.txt.nlp	25042549	SENT205	3	3	17	17	berberine	PCSK9	PA165860812	255738	0.729
NULL	Br_J_Cancer_1991_Aug_64(2)_281-287.nxml.txt.nlp	1892756	SENT8	20	20	13	13	vinblastine	CEA	PA451877	5670;1087	0.729
NULL	Biomed_Res_Int_2014_Jan_20_2014_948427.nxml.txt.nlp	24563867	SENT95	3	3	19	19	buspirone	STZ	PA448689	6484	0.729
NULL	FEBS_Open_Bio_2012_Mar_5_2_32-36.nxml.txt.nlp	23650578	SENT47	27	27	10	10	isoproterenol	PDK4	PA450121	5166	0.729
NULL	J_Young_Pharm_2012_Apr-Jun_4(2)_82-87.nxml.txt.nlp	22754259	SENT45	13	13	22	22	ethanol	mol	PA448073	90527	0.729
NULL	Br_J_Med_Med_Res_2013_Jul_18_3(4)_2157-2172.nxml.txt.nlp	24900951	SENT117	26	26	4	4	valsartan	CYP2C8	PA451848	1558	0.729
NULL	Open_Access_J_Urol_2011_May_10_3_69-82.nxml.txt.nlp	24198638	SENT40	0	0	8	8	sorafenib	EGFR	PA7000	1956	0.729
NULL	Br_J_Cancer_2012_May_22_106(11)_1742-1752.nxml.txt.nlp	22538973	SENT125	37	37	9	9	imatinib	IFN	PA10804	3439	0.729
NULL	J_Korean_Med_Sci_2007_Dec_20_22(6)_1055-1059.nxml.txt.nlp	18162722	SENT121	24	24	13	13	famotidine	ESD	PA449586	2098	0.729
NULL	Clin_Psychopharmacol_Neurosci_2012_Aug_31_10(2)_71-77.nxml.txt.nlp	23431082	SENT75	15	15	10	10	risperidone	PRKAR2B	PA451257	5577	0.729
NULL	Ann_Clin_Microbiol_Antimicrob_2008_Jan_28_7_3.nxml.txt.nlp	18226256	SENT80	8	8	13	13	rifabutin	SXR	PA451249	8856	0.729
NULL	Bioinformation_2006_Dec_23_1(8)_314-320.nxml.txt.nlp	17597912	SENT156	21	21	9	9	diclofenac	ACE	PA449293	1636	0.729
NULL	Inflammation_2012_Feb_24_35(1)_206-213.nxml.txt.nlp	21347606	SENT13	0	0	11	11	dobutamine	IL-6	PA449381	3569	0.729
NULL	Breast_Cancer_Res_Treat_2013_Aug_13_141(1)_101-110.nxml.txt.nlp	23942848	SENT199	14	14	24	24	lapatinib	HER2	PA152241907	2064	0.729
NULL	Oncol_Lett_2014_Sep_11_8(3)_1222-1228.nxml.txt.nlp	25120693	SENT41	22	22	24	24	cisplatin	DDP	PA449014	1678	0.729
NULL	Angiogenesis_2010_Dec_7_13(4)_305-315.nxml.txt.nlp	20927579	SENT204	8	8	14	14	resveratrol	HIF-1		29072	0.729
NULL	Bioconjug_Chem_2013_Apr_17_24(4)_712-723.nxml.txt.nlp	23488616	SENT105	4	4	19	19	indomethacin	COX	PA449982	1351	0.729
NULL	Mol_Biol_Int_2012_Jul_10_2012_401965.nxml.txt.nlp	22848825	SENT57	13	13	10	10	maraviroc	CCR5	PA164768835	1234	0.729
NULL	Front_Oncol_2013_Sep_9_3_235.nxml.txt.nlp	24058902	SENT58	0	0	7	7	vorinostat	BIM	PA164748224	10018	0.729
NULL	Ann_Rheum_Dis_2013_Apr_11_72(4)_583-589.nxml.txt.nlp	23144446	SENT137	11	11	39	39	tocilizumab	IL-6	PA165292659	3569	0.729
NULL	J_Circadian_Rhythms_2013_Feb_1_11_2.nxml.txt.nlp	23369611	SENT46	8	8	25	25	ketamine	CT15	PA450144	2515	0.729
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT1748	9	9	2	2	topotecan	ABCG2	PA451729	9429	0.729
NULL	Br_J_Cancer_2013_Nov_26_109(11)_2819-2828.nxml.txt.nlp	24201752	SENT43	17	17	39	39	l-glutamine	CO2	PA10090	4513	0.729
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT253	29	29	31	31	atorvastatin	CD36	PA448500	948	0.729
NULL	Breast_Cancer_Res_2009_Jul_15_11(4)_207.nxml.txt.nlp	19664181	SENT112	29	29	19	19	paclitaxel	HER2	PA450761	2064	0.729
NULL	Br_J_Cancer_2011_Aug_23_105(5)_649-657.nxml.txt.nlp	21811251	SENT185	18	18	15	15	gefitinib	EGFR	PA131301952	1956	0.729
NULL	Diabetes_2013_Nov_18_62(11)_3909-3919.nxml.txt.nlp	23835339	SENT219	13	13	10	10	gliclazide	SUR1	PA10892	6833	0.729
NULL	Eur_J_Med_Res_2011_Jul_25_16(7)_303-314.nxml.txt.nlp	21813371	SENT88	4	4	17	17	boceprevir	SOC	PA165948902	91544	0.729
NULL	Br_J_Cancer_2009_Jun_2_100(11)_1697-1703.nxml.txt.nlp	19384299	SENT66	16	16	35	35	cyclophosphamide	FOXP3	PA449165	50943	0.729
NULL	Oxid_Med_Cell_Longev_2012_Apr_5_2012_983427.nxml.txt.nlp	22550557	SENT29	0	0	26	26	ethanol	MOF	PA448073	84148	0.729
NULL	Acta_Pharmacol_Sin_2014_Sep_25_35(9)_1199-1206.nxml.txt.nlp	25152024	SENT133	31	31	19	19	cisplatin	mig-2	PA449014	10979	0.729
NULL	Oncotarget_2014_Aug_19_5(18)_8737-8749.nxml.txt.nlp	25228590	SENT166	8	8	26	26	crizotinib	MYCN	PA165946122	4613	0.729
NULL	Apoptosis_2014_Aug_26_19(11)_1603-1615.nxml.txt.nlp	25156145	SENT183	4	4	0	0	mitomycin	TRAIL	PA450524	8743	0.729
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT143	34	34	41	41	perifosine	DR4	PA165291471	8797	0.729
NULL	Pharmaceutics_2010_Oct_14_2(4)_321-338.nxml.txt.nlp	NULL	SENT583	8	8	13	13	l-carnitine	OCTN2	PA450154	6584	0.729
NULL	BMB_Rep_2014_Jan_47(1)_33-38.nxml.txt.nlp	24209634	SENT112	6	6	21	21	cisplatin	CXCR4	PA449014	7852	0.729
NULL	Ann_Surg_Treat_Res_2014_Feb_22_86(2)_68-75.nxml.txt.nlp	24761411	SENT173	6	6	16	16	resveratrol	survivin		332	0.729
NULL	Cent_European_J_Urol_2013_Dec_19_66(4)_394-404.nxml.txt.nlp	24757527	SENT260	8	8	6	6	sunitinib	IFN	PA162372840	3439	0.729
NULL	EMBO_Mol_Med_2012_Jun_13_4(6)_515-527.nxml.txt.nlp	22416035	SENT172	23	23	1	1	olaparib	p53		7157	0.729
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jul_7_68(Pt_8)_o2392-o2393.nxml.txt.nlp	22904850	SENT72	36	36	39	39	benzaldehyde	mol	PA448571	90527	0.729
NULL	Diabetes_Care_2012_Jan_9_35(1)_131-136.nxml.txt.nlp	22040838	SENT159	0	0	19	19	metformin	FFM	PA450395	24	0.729
NULL	Cancers_(Basel)_2010_Dec_23_3(1)_17-42.nxml.txt.nlp	24212604	SENT167	36	36	25	25	gemcitabine	PPX	PA449748	5531	0.729
NULL	Diabetes_Care_2010_Apr_12_33(4)_861-868.nxml.txt.nlp	20067962	SENT133	34	34	21	21	hyaluronan	TLR2	PA165958431	7097	0.729
NULL	Front_Physiol_2011_Jul_19_2_40.nxml.txt.nlp	21811470	SENT181	1	1	19	19	candesartan	RVR	PA448765	9975	0.729
NULL	J_Exp_Med_2003_Aug_4_198(3)_433-442.nxml.txt.nlp	12900519	SENT16	34	34	16	16	methylcholanthrene	IFN	PA165816878	3439	0.729
NULL	Acta_Pharmacol_Sin_2011_Oct_12_32(10)_1259-1265.nxml.txt.nlp	21909126	SENT105	1	1	7	7	fluvastatin	p38	PA449688	10598;1432;7965	0.729
NULL	Ann_Rheum_Dis_2013_Apr_21_72(4)_482-492.nxml.txt.nlp	23172750	SENT341	16	16	44	44	tocilizumab	IL-6	PA165292659	3569	0.729
NULL	Br_J_Cancer_2013_Jun_25_108(12)_2549-2556.nxml.txt.nlp	23703247	SENT120	3	3	12	12	bevacizumab	TRG	PA130232992	6965	0.729
NULL	Br_J_Cancer_2010_Jul_13_103(2)_186-195.nxml.txt.nlp	20588277	SENT13	6	6	17	17	nutlin-3	p53		7157	0.729
NULL	Ann_Rheum_Dis_2009_Nov_29_69(5)_862-867.nxml.txt.nlp	19948521	SENT209	12	12	31	31	infliximab	IMPACT	PA452639	55364	0.729
NULL	ASN_Neuro_2013_Dec_18_5(5)_e00129.nxml.txt.nlp	24215544	SENT145	6	6	27	27	gemfibrozil	PLP	PA449750	25824;5744	0.729
NULL	Diabetes_Metab_J_2013_Oct_17_37(5)_315-325.nxml.txt.nlp	24199159	SENT195	23	23	17	17	resveratrol	SIRT1		23411	0.729
NULL	Exp_Neurobiol_2014_Jun_13_23(2)_124-129.nxml.txt.nlp	24963276	SENT71	8	8	11	11	naringin	GDNF	PA151958360	2668	0.729
NULL	J_Adv_Pract_Oncol_2013_Jul_1_Jul-Aug_4(4)_238-250.nxml.txt.nlp	25032004	SENT294	24	24	10	10	imatinib	CML	PA10804	613	0.729
NULL	BMB_Rep_2014_Apr_47(4)_221-226.nxml.txt.nlp	24286312	SENT131	6	6	9	9	nutlin-3	p53		7157	0.729
NULL	Case_Rep_Dermatol_2014_Feb_12_6(1)_37-42.nxml.txt.nlp	24707248	SENT25	15	15	5	5	methylprednisolone	CHOP	PA450466	1649	0.729
NULL	Breast_Cancer_Res_2008_Mar_27_10(2)_R27.nxml.txt.nlp	18371219	SENT41	4	4	30	30	doxorubicin	TFEC	PA449412	22797	0.729
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT120	32	32	6	6	curcumin	p65	PA151958596	5970	0.729
NULL	Front_Physiol_2013_Jul_29_4_198.nxml.txt.nlp	23908634	SENT231	20	20	7	7	estradiol	TASK-2	PA449503	8645	0.729
NULL	BMJ_2011_May_19_342_d2901.nxml.txt.nlp	21596735	SENT130	1	1	25	25	l-arginine	NNT	PA448478	23530	0.729
NULL	Cancer_Immunol_Immunother_2012_Jul_23_61(7)_1101-1111.nxml.txt.nlp	22193989	SENT122	2	2	15	15	oxaliplatin	CD83	PA131285527	9308	0.729
NULL	Iran_Red_Crescent_Med_J_2012_Jul_30_14(7)_422-429.nxml.txt.nlp	22997558	SENT87	22	22	37	37	glutaraldehyde	VIII	PA449777	1351	0.729
NULL	Mol_Cancer_2007_Mar_7_6_18.nxml.txt.nlp	17343740	SENT185	4	4	9	9	pamidronate	PC3	PA450767	57332;7832;5122	0.729
NULL	Crit_Care_2011_Jan_21_15(1)_R35.nxml.txt.nlp	21255422	SENT26	8	8	5	5	exenatide	GLP-1	PA164749238	100125288	0.729
NULL	Genome_Biol_2007_Sep_25_8(9)_R201.nxml.txt.nlp	17894889	SENT187	21	21	0	0	heparin	SULF1	PA449855	23213	0.729
NULL	Int_J_Mol_Sci_2014_Sep_2_15(9)_15512-15529.nxml.txt.nlp	25184950	SENT674	1	1	6	6	resveratrol	TNF-alpha		7124	0.729
NULL	Endocr_Relat_Cancer_2014_Jun_21(3)_R209-R225.nxml.txt.nlp	24500760	SENT62	30	30	19	19	resveratrol	IGFBP3		3486	0.729
NULL	Cancer_Med_2014_Oct_3_3(5)_1416-1429.nxml.txt.nlp	24890561	SENT185	29	29	0	0	cyclophosphamide	San	PA449165	80218	0.729
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jul_8_65(Pt_8)_o1796.nxml.txt.nlp	21583502	SENT61	0	0	15	15	benzaldehyde	mol	PA448571	90527	0.729
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT205	5	5	19	19	curcumin	p53	PA151958596	7157	0.729
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT46	12	12	17	17	lapatinib	HER2	PA152241907	2064	0.729
NULL	FEBS_Open_Bio_2014_Oct_22_4_905-914.nxml.txt.nlp	25383314	SENT595	4	4	11	11	atropine	L-FABP	PA448505	2168	0.729
NULL	J_Immune_Based_Ther_Vaccines_2008_Jun_9_6_3.nxml.txt.nlp	18541039	SENT134	0	0	6	6	ribavirin	IP-10	PA451241	3627	0.729
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_33-43.nxml.txt.nlp	17912634	SENT164	15	15	29	29	letrozole	aromatase	PA450196	1588	0.729
NULL	JRSM_Cardiovasc_Dis_2012_Apr_5_1(1)_cvd_2012_012001.nxml.txt.nlp	24175062	SENT265	21	21	18	18	clopidogrel	CYP2C19	PA449053	1557	0.729
NULL	Cardiovasc_Diabetol_2013_May_4_12_73.nxml.txt.nlp	23642288	SENT138	15	15	13	13	acarbose	GLP-1	PA448010	100125288	0.729
NULL	Breast_Cancer_Res_2010_May_6_12(3)_R25.nxml.txt.nlp	20459607	SENT24	24	24	5	5	lapatinib	HER2	PA152241907	2064	0.729
NULL	Curr_Opin_Chem_Biol_2011_Apr_15(2)_249-256.nxml.txt.nlp	21130024	SENT81	16	16	5	5	nadh	GDH	PA164755085	51084;2746	0.729
NULL	Neural_Regen_Res_2014_May_15_9(10)_1055-1062.nxml.txt.nlp	25206759	SENT229	22	22	7	7	bumetanide	KCC2	PA448682	57468	0.728
NULL	Arthritis_Res_Ther_2010_Jun_2_12(3)_R107.nxml.txt.nlp	20525198	SENT130	20	20	30	30	rolipram	TNF	PA153906323	7124	0.728
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT534	9	9	24	24	risperidone	PRL	PA451257	5617	0.728
NULL	Br_J_Cancer_2010_Mar_16_102(6)_1003-1009.nxml.txt.nlp	20179710	SENT124	30	30	21	21	cyclophosphamide	CYP2B6	PA449165	1555	0.728
NULL	Nat_Chem_Biol_2010_Apr_28_6(4)_291-299.nxml.txt.nlp	20190765	SENT128	19	19	9	9	dasatinib	EGFR	PA162372878	1956	0.728
NULL	Int_J_Nanomedicine_2012_May_4_7_2293-2306.nxml.txt.nlp	22619562	SENT53	20	20	14	14	streptomycin	FBS	PA451512	64319;26269	0.728
NULL	Nucleic_Acids_Res_2011_Jun_9_39(11)_4640-4652.nxml.txt.nlp	21310710	SENT316	35	35	22	22	camptothecin	SATB1	PA153590860	6304	0.728
NULL	Oncotarget_2014_Mar_16_5(12)_4087-4102.nxml.txt.nlp	24961479	SENT59	24	24	33	33	hemin	PC3	PA449849	57332;7832;5122	0.728
NULL	J_Neurochem_2008_Jan_104(1)_74-88.nxml.txt.nlp	17995938	SENT12	2	2	22	22	forskolin	p38	PA146096022	10598;1432;7965	0.728
NULL	Infect_Dis_Rep_2010_Feb_2_2(1)_e1.nxml.txt.nlp	24470884	SENT29	7	7	11	11	tigecycline	HAP	PA164746412	5915;10313	0.728
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT80	5	5	18	18	mitoxantrone	ABCG2	PA450526	9429	0.728
NULL	Clin_Exp_Reprod_Med_2011_Mar_31_38(1)_18-23.nxml.txt.nlp	22384413	SENT150	8	8	10	10	diethylstilbestrol	DES	PA449307	1674	0.728
NULL	Cell_Death_Dis_2013_Sep_5_4(9)_e791.nxml.txt.nlp	24008735	SENT7	0	0	17	17	gemcitabine	PUMA	PA449748	27113	0.728
NULL	Acta_Pharmacol_Sin_2011_May_18_32(5)_591-600.nxml.txt.nlp	21499286	SENT135	3	3	8	8	bezafibrate	AMPK	PA162364313	5563	0.728
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_105-115.nxml.txt.nlp	17912640	SENT106	0	0	16	16	letrozole	HER2	PA450196	2064	0.728
NULL	Br_J_Clin_Pharmacol_2013_Aug_23_76(2)_299-315.nxml.txt.nlp	23701319	SENT150	3	3	14	14	rituximab	IL-2	PA451261	3558	0.728
NULL	Ther_Clin_Risk_Manag_2006_Mar_2(1)_3-18.nxml.txt.nlp	18360577	SENT152	37	37	11	11	ibandronate	CTX	PA10270	1593	0.728
NULL	Iran_J_Basic_Med_Sci_2012_Sep-Oct_15(5)_1083-1090.nxml.txt.nlp	23493977	SENT44	14	14	40	40	pentoxifylline	spatial	PA450864	219793	0.728
NULL	Eur_J_Immunol_2014_Mar_16_44(3)_905-914.nxml.txt.nlp	24285214	SENT226	8	8	33	33	heparin	CO2	PA449855	4513	0.728
NULL	Int_J_Mol_Sci_2014_Nov_7_15(11)_20500-20517.nxml.txt.nlp	25387078	SENT565	0	0	11	11	vorinostat	CD95	PA164748224	355	0.728
NULL	Oncogene_2010_Sep_16_29(37)_5193-5203.nxml.txt.nlp	20581867	SENT274	10	10	15	15	trastuzumab	PTEN	PA451743	5728	0.728
NULL	EMBO_Mol_Med_2012_Jun_13_4(6)_515-527.nxml.txt.nlp	22416035	SENT147	0	0	4	4	olaparib	p53		7157	0.728
NULL	Arch_Med_Sci_2011_Dec_31_7(6)_977-983.nxml.txt.nlp	22328880	SENT122	8	8	23	23	heparin	PAPP-A	PA449855	5069	0.728
NULL	Arch_Med_Sci_2012_Nov_9_8(5)_899-906.nxml.txt.nlp	23185202	SENT124	10	10	24	24	acarbose	ADN	PA448010	1675	0.728
NULL	Cancer_Manag_Res_2013_Nov_21_5_387-400.nxml.txt.nlp	24294007	SENT75	17	17	35	35	cetuximab	KRAS	PA10040	3845	0.728
NULL	J_Int_AIDS_Soc_2012_Oct_22_15(Suppl_3)_10_7448_IAS_15_5_18440.nxml.txt.nlp	NULL	SENT2567	19	19	13	13	raltegravir	LSR		51599	0.728
NULL	Indian_J_Psychol_Med_2014_Jan-Mar_36(1)_66-70.nxml.txt.nlp	24701014	SENT66	9	9	4	4	risperidone	CARS	PA451257	833	0.728
NULL	Diabetol_Metab_Syndr_2014_Dec_2_6(1)_132.nxml.txt.nlp	NULL	SENT78	10	10	3	3	heparin	adiponectin	PA449855	9370	0.728
NULL	Carcinogenesis_2008_Sep_9_29(9)_1751-1757.nxml.txt.nlp	18544568	SENT270	8	8	3	3	estradiol	CYP1B1	PA449503	1545	0.728
NULL	Front_Chem_2013_Jul_12_1_10.nxml.txt.nlp	24790939	SENT132	17	17	37	37	hydroquinone	mol	PA449924	90527	0.728
NULL	Int_J_Mol_Sci_2014_Sep_29_15(10)_17411-17441.nxml.txt.nlp	25268615	SENT254	14	14	3	3	estradiol	CD147	PA449503	682	0.728
NULL	Aging_(Albany_NY)_2009_Jun_3_1(6)_515-528.nxml.txt.nlp	20157535	SENT90	8	8	22	22	resveratrol	S6K1		6198	0.728
NULL	CNS_Drugs_2013_May_27_27(5)_335-343.nxml.txt.nlp	23533009	SENT124	31	31	33	33	perphenazine	FGA	PA450882	2243	0.728
NULL	Alcohol_Res_Health_2011_34(1)_106-120.nxml.txt.nlp	23580048	SENT144	10	10	19	19	ethanol	CA1	PA448073	759	0.728
NULL	J_Biomed_Biotechnol_2002_2(3)_151-157.nxml.txt.nlp	12488580	SENT10	22	22	28	28	betaine	TRG	PA448603	6965	0.728
NULL	Pharm_Pract_(Granada)_2006_Oct_26_Jul-Sep_4(3)_129-133.nxml.txt.nlp	25214899	SENT51	11	11	5	5	exenatide	CEA	PA164749238	5670;1087	0.728
NULL	Mol_Cancer_2014_Jun_9_13_146.nxml.txt.nlp	24913494	SENT144	18	18	7	7	bicalutamide	GAPDH	PA164746255	2597	0.728
NULL	Extremophiles_2009_Nov_23_13(6)_885-894.nxml.txt.nlp	19701714	SENT138	23	23	20	20	ethanol	mol	PA448073	90527	0.728
NULL	Neural_Plast_2012_Nov_2_2012_309494.nxml.txt.nlp	22164341	SENT108	27	27	13	13	tamoxifen	CA1	PA451581	759	0.728
NULL	J_Cell_Biol_2008_Jul_28_182(2)_367-379.nxml.txt.nlp	18644892	SENT74	4	4	19	19	pp2	spatial		219793	0.728
NULL	Cell_Death_Dis_2014_Feb_13_5(2)_e1055.nxml.txt.nlp	24525731	SENT45	33	33	21	21	cisplatin	XRCC1	PA449014	7515	0.728
NULL	Nat_Commun_2014_Dec_12_5_5775.nxml.txt.nlp	25503391	SENT119	10	10	15	15	paclitaxel	CLU	PA450761	1191	0.728
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Aug_8_65(Pt_9)_o2077-o2078.nxml.txt.nlp	21577497	SENT73	32	32	38	38	ethanol	mol	PA448073	90527	0.728
NULL	Breast_Cancer_Res_2011_Nov_1_13(6)_224.nxml.txt.nlp	22114931	SENT68	30	30	38	38	fulvestrant	aromatase	PA164747170	1588	0.728
NULL	Exp_Ther_Med_2012_Sep_12_4(3)_475-480.nxml.txt.nlp	23181121	SENT152	5	5	3	3	etoposide	CHOP	PA449552	1649	0.728
NULL	ScientificWorldJournal_2013_Oct_27_2013_939830.nxml.txt.nlp	24288514	SENT162	9	9	16	16	carrageenan	ANOVA	PA448814	4858	0.728
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_91-103.nxml.txt.nlp	17912639	SENT70	33	33	41	41	anastrozole	HER2	PA448432	2064	0.728
NULL	Br_J_Cancer_2010_Jul_27_103(3)_347-353.nxml.txt.nlp	20628392	SENT39	34	34	28	28	gefitinib	EGFR	PA131301952	1956	0.728
NULL	Mol_Cell_Biochem_2014_Jul_26_396(1-2)_221-228.nxml.txt.nlp	25063218	SENT53	10	10	15	15	resveratrol	EGFR		1956	0.728
NULL	Apoptosis_2014_Aug_26_19(11)_1603-1615.nxml.txt.nlp	25156145	SENT156	4	4	0	0	mitomycin	TRAIL	PA450524	8743	0.728
NULL	Int_J_Surg_Oncol_2012_Jun_12_2012_862879.nxml.txt.nlp	22778941	SENT6	46	46	21	21	cisplatin	BIN1	PA449014	274	0.728
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT233	4	4	21	21	doxorubicin	B7-H1	PA449412	29126	0.728
NULL	Cancers_(Basel)_2014_Jul_7_6(3)_1441-1463.nxml.txt.nlp	25003395	SENT1127	2	2	10	10	cisplatin	PTEN	PA449014	5728	0.728
NULL	Bioinformation_2012_Jan_20_8(2)_81-86.nxml.txt.nlp	22359440	SENT24	0	0	15	15	bosentan	ETB	PA10034	1910	0.728
NULL	Anesth_Essays_Res_2014_Sep-Dec_8(3)_393-396.nxml.txt.nlp	NULL	SENT45	8	8	40	40	fentanyl	CO2	PA449599	4513	0.728
NULL	Indian_J_Med_Res_2012_May_135(5)_745-755.nxml.txt.nlp	22771608	SENT72	29	29	41	41	l-glutamine	CO2	PA10090	4513	0.728
NULL	J_Hematol_Oncol_2011_Nov_4_4_44.nxml.txt.nlp	22053759	SENT112	9	9	24	24	thrombin	PAR1	PA451674	79581;2149	0.728
NULL	Braz_J_Med_Biol_Res_2014_Sep_5_47(11)_929-939.nxml.txt.nlp	25296354	SENT151	18	18	27	27	afatinib	EGFR	PA165981154	1956	0.728
NULL	Br_J_Cancer_2006_Feb_13_94(3)_407-426.nxml.txt.nlp	16434996	SENT313	16	16	14	14	genistein	BRCA2	PA165109660	675	0.728
NULL	Arch_Med_Sci_2013_Aug_30_9(4)_724-730.nxml.txt.nlp	24049536	SENT50	4	4	10	10	genistein	PTH	PA165109660	5741	0.728
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT281	2	2	0	0	mitomycin	MVP	PA450524	9961	0.728
NULL	Diabetes_2013_Mar_14_62(3)_811-824.nxml.txt.nlp	23209186	SENT328	33	33	8	8	bortezomib	CHOP	PA10252	1649	0.728
NULL	Case_Rep_Urol_2013_Sep_17_2013_363072.nxml.txt.nlp	24159413	SENT47	8	8	10	10	rituximab	CHOP	PA451261	1649	0.728
NULL	Orphanet_J_Rare_Dis_2014_Aug_5_9_122.nxml.txt.nlp	25091295	SENT190	8	8	30	30	rosiglitazone	POMC	PA451283	5443	0.728
NULL	Br_J_Cancer_2012_Apr_10_106(8)_1395-1405.nxml.txt.nlp	22460269	SENT162	6	6	4	4	sulindac	ABCB1	PA451565	5243	0.728
NULL	Pharmaceuticals_(Basel)_2013_Aug_21_6(8)_988-1038.nxml.txt.nlp	24276379	SENT499	8	8	13	13	oxaliplatin	CD44	PA131285527	960	0.728
NULL	Case_Rep_Ophthalmol_2011_Mar_12_2(1)_105-110.nxml.txt.nlp	22110438	SENT62	4	4	2	2	ribavirin	IFN	PA451241	3439	0.728
NULL	Front_Immunol_2012_Jun_11_3_144.nxml.txt.nlp	22701453	SENT2245	15	15	2	2	imiquimod	TH1	PA449972	51497	0.728
NULL	Breast_Cancer_Res_2013_Sep_25_15(5)_R88.nxml.txt.nlp	24063698	SENT30	22	22	10	10	olaparib	BRCA1		672	0.728
NULL	BMB_Rep_2014_Jul_47(7)_388-392.nxml.txt.nlp	24286329	SENT56	26	26	11	11	berberine	c-Jun	PA165860812	3725	0.728
NULL	Indian_J_Psychiatry_2010_Jan_52(Suppl1)_S317-S340.nxml.txt.nlp	21836703	SENT119	22	22	33	33	thiothixene	CPZ	PA451669	8532	0.728
NULL	Case_Rep_Oncol_2010_May_7_3(2)_154-159.nxml.txt.nlp	20740189	SENT11	34	34	13	13	bevacizumab	KRAS	PA130232992	3845	0.728
NULL	Ann_Lab_Med_2012_Jul_20_32(4)_264-269.nxml.txt.nlp	22779067	SENT53	14	14	9	9	rifampin	DST	PA451250	667	0.728
NULL	J_Biomed_Sci_2013_Aug_19_20(1)_61.nxml.txt.nlp	23957306	SENT354	20	20	13	13	tenofovir	MRP4	PA10204	10257	0.728
NULL	Mol_Cancer_2010_Jun_27_9_168.nxml.txt.nlp	20579391	SENT121	4	4	18	18	dasatinib	FOXM1	PA162372878	2305	0.728
NULL	N_Am_J_Med_Sci_2011_Jan_3(1)_1-12.nxml.txt.nlp	22540056	SENT398	0	0	13	13	curcumin	Bcl-X	PA151958596	598	0.728
NULL	BioDrugs_2014_Aug_18_28(1)_27-39.nxml.txt.nlp	23955284	SENT443	3	3	5	5	belinostat	survivin		332	0.728
NULL	Environ_Health_Perspect_2007_Dec_8_115(Suppl_1)_62-68.nxml.txt.nlp	18174952	SENT210	15	15	20	20	estradiol	BRCA1	PA449503	672	0.728
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT109	7	7	17	17	celecoxib	IL-6	PA448871	3569	0.728
NULL	F1000Res_2014_Sep_29_3_228.nxml.txt.nlp	25485098	SENT323	8	8	11	11	creatine	GAMT	PA164778930	2593	0.728
NULL	Oncotarget_2014_Nov_2_5(21)_10222-10236.nxml.txt.nlp	25400118	SENT224	34	34	38	38	lapatinib	HER2	PA152241907	2064	0.728
NULL	Oncoimmunology_2013_Mar_1_2(3)_e23205.nxml.txt.nlp	23802072	SENT39	7	7	10	10	rituximab	IL-2	PA451261	3558	0.728
NULL	Ann_Thorac_Med_2013_Oct-Dec_8(4)_204-208.nxml.txt.nlp	24250733	SENT38	19	19	6	6	erlotinib	EGFR	PA134687924	1956	0.728
NULL	Crit_Care_2010_Mar_1_14(Suppl_1)_P584.nxml.txt.nlp	NULL	SENT13	7	7	21	21	estradiol	IL-6	PA449503	3569	0.728
NULL	J_Cell_Biol_1980_Feb_1_84(2)_294-297.nxml.txt.nlp	7380884	SENT5	21	21	7	7	creatine	CMIP	PA164778930	80790	0.728
NULL	Diabetes_2013_Mar_14_62(3)_789-800.nxml.txt.nlp	22966074	SENT269	41	41	23	23	forskolin	AMPK	PA146096022	5563	0.728
NULL	Chemother_Res_Pract_2011_Dec_18_2011_965826.nxml.txt.nlp	22295208	SENT204	24	24	14	14	azacitidine	ACT	PA451996	12;11332;9457;641455	0.728
NULL	Br_J_Cancer_2012_Apr_24_106(9)_1543-1550.nxml.txt.nlp	22531721	SENT135	15	15	23	23	trastuzumab	CD59	PA451743	966	0.728
NULL	Hum_Genomics_Proteomics_2009_Jun_24_2009_453634.nxml.txt.nlp	20981323	SENT200	0	0	14	14	thalidomide	CCL5	PA451644	6352	0.728
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1495-1502.nxml.txt.nlp	21989186	SENT201	18	18	28	28	irinotecan	HSI	PA450085	57016	0.728
NULL	Mol_Cancer_2012_Sep_25_11_73.nxml.txt.nlp	23009336	SENT143	20	20	30	30	dasatinib	Oct4	PA162372878	5460	0.728
NULL	J_Adv_Pharm_Technol_Res_2014_Apr-Jun_5(2)_96-103.nxml.txt.nlp	24959419	SENT196	9	9	2	2	carvedilol	DSC	PA448817	1825	0.728
NULL	Int_J_Emerg_Med_2010_May_26_3(2)_81-84.nxml.txt.nlp	20606815	SENT93	0	0	3	3	quetiapine	CYP3A4	PA451201	1576	0.728
NULL	Multidiscip_Respir_Med_2013_Feb_6_8(1)_11.nxml.txt.nlp	23388501	SENT54	28	28	15	15	thrombin	ASM	PA451674	6609;283120	0.728
NULL	Mol_Cancer_2010_Mar_25_9_68.nxml.txt.nlp	20338046	SENT178	24	24	4	4	doxorubicin	GSTP1	PA449412	2950	0.728
NULL	Diabetes_2011_Nov_17_60(11)_2691-2700.nxml.txt.nlp	21896928	SENT226	0	0	8	8	resveratrol	SIRT1		23411	0.728
NULL	Leukemia_2014_Jun_25_28(6)_1280-1288.nxml.txt.nlp	24270737	SENT205	22	22	8	8	vorinostat	PD-L2	PA164748224	80380	0.728
NULL	J_Oncol_2010_May_19_2010_285191.nxml.txt.nlp	20508725	SENT24	5	5	3	3	paclitaxel	NAC1	PA450761	112939;6323	0.728
NULL	Scientifica_(Cairo)_2012_Nov_25_2012_473829.nxml.txt.nlp	24278698	SENT335	30	30	26	26	cisplatin	OCT3	PA449014	5460;6581	0.728
NULL	Cancer_Med_2013_Jun_25_2(3)_277-285.nxml.txt.nlp	23930204	SENT195	27	27	16	16	mitomycin	MAX	PA450524	4149	0.728
NULL	Neural_Plast_2007_Jun_19_2007_52908.nxml.txt.nlp	17641734	SENT202	5	5	16	16	rimonabant	CB1	PA152407999	1268	0.728
NULL	Aging_(Albany_NY)_2009_Sep_25_1(10)_845-854.nxml.txt.nlp	20157557	SENT200	14	14	5	5	doxorubicin	p53	PA449412	7157	0.728
NULL	Cancers_(Basel)_2011_May_24_3(2)_2478-2500.nxml.txt.nlp	24212820	SENT1177	7	7	15	15	temsirolimus	survivin	PA164746890	332	0.728
NULL	Br_J_Cancer_2013_Mar_5_108(4)_887-900.nxml.txt.nlp	23462807	SENT108	39	39	13	13	sunitinib	ABCB1	PA162372840	5243	0.728
NULL	Chem_Res_Toxicol_2008_Jul_21_21(7)_1359-1367.nxml.txt.nlp	18549251	SENT117	3	3	17	17	hydroquinone	PCB	PA449924	5091	0.728
NULL	Mol_Pain_2014_Apr_18_10_27.nxml.txt.nlp	24742127	SENT39	26	26	4	4	cisplatin	CB2	PA449014	1269	0.728
NULL	Cardiovasc_Diabetol_2013_Jul_19_12_108.nxml.txt.nlp	23866091	SENT27	18	18	9	9	telmisartan	gamma	PA451605	9913	0.728
NULL	Breast_Cancer_Res_2001_Dec_22_3(2)_118-121.nxml.txt.nlp	11250758	SENT34	31	31	44	44	tamoxifen	SMRT	PA451581	9612	0.728
NULL	Iran_J_Neurol_2012_11(2)_70-73.nxml.txt.nlp	24250865	SENT93	35	35	37	37	doxycycline	IFN	PA449415	3439	0.728
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1554-1562.nxml.txt.nlp	21970876	SENT143	14	14	12	12	erlotinib	EGFR	PA134687924	1956	0.728
NULL	Iran_J_Pharm_Res_2014_Spring_13(2)_635-639.nxml.txt.nlp	25237359	SENT18	5	5	20	20	chlorzoxazone	CYP2D6	PA448971	1565	0.728
NULL	Pharmaceuticals_(Basel)_2012_Jun_28_5(7)_674-689.nxml.txt.nlp	24281706	SENT571	6	6	18	18	geldanamycin	AKT	PA152031327	207	0.728
NULL	Asia_Pac_Allergy_2013_Oct_31_3(4)_231-240.nxml.txt.nlp	24260728	SENT148	9	9	31	31	theophylline	CYP1A2	PA451647	1544	0.728
NULL	Oncotarget_2014_Aug_16_5(18)_8637-8650.nxml.txt.nlp	25226617	SENT30	37	37	43	43	dasatinib	CD34	PA162372878	947	0.728
NULL	Indian_J_Anaesth_2013_Jan-Feb_57(1)_91-92.nxml.txt.nlp	23716783	SENT20	3	3	19	19	rocuronium	PORC	PA164754992	64840;5448	0.728
NULL	J_Headache_Pain_2009_Apr_27_10(2)_105-110.nxml.txt.nlp	19172228	SENT28	36	36	14	14	capsaicin	c-fos	PA448776	2353	0.728
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT89	0	0	2	2	etravirine	CYP3A4	PA166014703	1576	0.728
NULL	Front_Cell_Neurosci_2014_Jul_8_8_188.nxml.txt.nlp	25071448	SENT316	34	34	19	19	estradiol	E16	PA449503	8140	0.728
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R91.nxml.txt.nlp	22541814	SENT248	10	10	13	13	pp2	HO-1		3162	0.728
NULL	Eur_J_Clin_Pharmacol_2013_Jan_11_69(6)_1275-1283.nxml.txt.nlp	23307232	SENT239	16	16	3	3	warfarin	CYP2C9	PA451906	1559	0.728
NULL	J_Biomed_Biotechnol_2011_Feb_10_2011_207504.nxml.txt.nlp	21331367	SENT166	5	5	19	19	cyclophosphamide	IL-6	PA449165	3569	0.728
NULL	Crit_Care_2012_Oct_14_16(5)_R191.nxml.txt.nlp	23062276	SENT8	6	6	41	41	creatine	POD1	PA164778930	6943	0.728
NULL	Oncoimmunology_2013_Jun_1_2(6)_e24677.nxml.txt.nlp	23894722	SENT109	5	5	18	18	cetuximab	CD86	PA10040	942	0.728
NULL	Clin_Interv_Aging_2015_Jan_6_10_157-174.nxml.txt.nlp	25609933	SENT251	28	28	24	24	anastrozole	IMPACT	PA448432	55364	0.728
NULL	J_Oncol_2010_May_19_2010_285191.nxml.txt.nlp	20508725	SENT24	5	5	14	14	paclitaxel	NAC1	PA450761	112939;6323	0.728
NULL	Oncotarget_2013_Apr_16_4(5)_677-690.nxml.txt.nlp	23633472	SENT206	8	8	18	18	doxorubicin	XIAP	PA449412	331	0.728
NULL	Front_Neurosci_2014_Nov_28_8_387.nxml.txt.nlp	25506316	SENT84	3	3	12	12	bumetanide	NKCC1	PA448682	6558	0.728
NULL	J_Immunother_Cancer_2013_Nov_7_1(Suppl_1)_P219.nxml.txt.nlp	NULL	SENT5	21	21	31	31	protamine	TLR7	PA10366	51284	0.728
NULL	Clin_Pediatr_Endocrinol_2007_Nov_17_16(4)_81-84.nxml.txt.nlp	24790350	SENT44	1	1	11	11	levodopa	PRL	PA450213	5617	0.728
NULL	Biomed_Res_Int_2014_Apr_13_2014_738625.nxml.txt.nlp	24822215	SENT132	0	0	8	8	montelukast	ST2L	PA450546	9173;11018	0.728
NULL	J_Biomed_Biotechnol_2010_Mar_30_2010_307231.nxml.txt.nlp	20369072	SENT255	18	18	23	23	staurosporine	HMGB1	PA165109623	3146	0.728
NULL	J_Exp_Clin_Cancer_Res_2009_Jun_22_28(1)_87.nxml.txt.nlp	19545438	SENT25	5	5	11	11	doxorubicin	CHOP	PA449412	1649	0.728
NULL	Biomed_Res_Int_2014_Jun_26_2014_161346.nxml.txt.nlp	25054130	SENT232	7	7	30	30	curcumin	STZ	PA151958596	6484	0.728
NULL	Front_Genet_2014_Jun_2_5_154.nxml.txt.nlp	24917878	SENT220	15	15	20	20	ethanol	POMC	PA448073	5443	0.728
NULL	Biomed_Res_Int_2013_Sep_4_2013_906912.nxml.txt.nlp	24093107	SENT166	5	5	0	0	ciprofloxacin	MICA	PA449009	100507436	0.728
NULL	Braz_J_Med_Biol_Res_2014_Mar_3_47(3)_245-251.nxml.txt.nlp	24554037	SENT18	9	9	3	3	atorvastatin	IL-6	PA448500	3569	0.728
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_17_2013_549174.nxml.txt.nlp	23843879	SENT185	0	0	17	17	resveratrol	CHOP		1649	0.728
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT200	21	21	40	40	l-leucine	AMPK	PA450197	5563	0.728
NULL	EJNMMI_Res_2011_Jun_7_1_3.nxml.txt.nlp	22214528	SENT147	25	25	21	21	fluorescein	FVIII	PA164746009	2157	0.728
NULL	J_Adv_Pract_Oncol_2012_Jul_1_Jul-Aug_3(4)_267-272.nxml.txt.nlp	25031955	SENT41	12	12	10	10	crizotinib	CYP3A	PA165946122	1574	0.728
NULL	Basic_Res_Cardiol_2015_Jan_20_110_4.nxml.txt.nlp	25600226	SENT117	0	0	14	14	berberine	HNF1	PA165860812	6927	0.728
NULL	Mol_Cancer_2014_Feb_20_13_32.nxml.txt.nlp	24555657	SENT185	11	11	17	17	cisplatin	p53	PA449014	7157	0.728
NULL	Diabetes_2013_Oct_17_62(10)_3500-3513.nxml.txt.nlp	23884882	SENT207	0	0	18	18	resveratrol	FOXO1		2308	0.728
NULL	Brain_Sci_2013_Apr_29_3(2)_704-727.nxml.txt.nlp	24027632	SENT247	11	11	4	4	ethanol	spatial	PA448073	219793	0.728
NULL	Breast_Cancer_Res_2011_Jun_29_13(3)_R70.nxml.txt.nlp	21707964	SENT120	19	19	7	7	tamoxifen	14-3-3	PA451581	10971	0.728
NULL	Evid_Based_Complement_Alternat_Med_2014_Dec_18_2014_890842.nxml.txt.nlp	25587347	SENT244	3	3	19	19	ethanol	APT	PA448073	653639	0.728
NULL	Tuberc_Respir_Dis_(Seoul)_2014_Feb_27_76(2)_66-74.nxml.txt.nlp	24624215	SENT36	29	29	11	11	vancomycin	HAP	PA451850	5915;10313	0.728
NULL	BMB_Rep_2014_Mar_47(3)_167-172.nxml.txt.nlp	24499665	SENT95	10	10	2	2	nutlin-3	MDM2		4193	0.728
NULL	J_Exp_Med_1998_Jun_1_187(11)_1885-1892.nxml.txt.nlp	9607928	SENT102	10	10	26	26	thalidomide	CD4	PA451644	920	0.728
NULL	Breast_Cancer_Res_Treat_2014_Dec_21_143(3)_459-467.nxml.txt.nlp	24362951	SENT57	13	13	26	26	exemestane	aromatase	PA449563	1588	0.728
NULL	Onco_Targets_Ther_2014_May_23_7_799-805.nxml.txt.nlp	24920920	SENT115	22	22	18	18	pemetrexed	EGFR	PA10810	1956	0.728
NULL	Neural_Plast_2012_May_20_2012_124548.nxml.txt.nlp	22685676	SENT48	15	15	18	18	minocycline	FMR1	PA450519	2332	0.728
NULL	Breast_Cancer_Res_2012_May_18_14(3)_R78.nxml.txt.nlp	22608253	SENT183	4	4	9	9	nilotinib	AKT	PA165958345	207	0.728
NULL	Nat_Med_2013_Mar_10_19(3)_313-321.nxml.txt.nlp	23396211	SENT368	24	24	47	47	amlexanox	TBK1	PA164745310	29110	0.728
NULL	Arthritis_Res_Ther_2005_Apr_25_7(4)_R817-R824.nxml.txt.nlp	15987483	SENT211	27	27	11	11	methotrexate	RAGE	PA450428	177	0.728
NULL	Arch_Med_Sci_2013_Dec_30_9(6)_1138-1151.nxml.txt.nlp	24482663	SENT5	15	15	10	10	levodopa	CD34	PA450213	947	0.728
NULL	Aging_(Albany_NY)_2010_Nov_11_2(11)_760-774.nxml.txt.nlp	21084729	SENT154	3	3	24	24	phenformin	NMU	PA1000	10874	0.728
NULL	F1000Res_2013_Jul_9_2_150.nxml.txt.nlp	24627787	SENT40	0	0	9	9	quetiapine	DIP	PA451201	23151;1831	0.728
NULL	Biomed_Res_Int_2013_Jun_19_2013_230805.nxml.txt.nlp	23862137	SENT227	33	33	19	19	bortezomib	MCP-1	PA10252	6347	0.728
NULL	Mol_Cancer_2014_Apr_29_13_96.nxml.txt.nlp	24779681	SENT228	46	46	34	34	trastuzumab	EGF	PA451743	1950	0.728
NULL	J_Korean_Med_Sci_2010_Jan_26_25(1)_110-116.nxml.txt.nlp	20054409	SENT149	19	19	0	0	doxorubicin	BCS	PA449412	617	0.728
NULL	Sci_Rep_2014_Dec_23_4_7564.nxml.txt.nlp	25532911	SENT308	7	7	12	12	estradiol	aromatase	PA449503	1588	0.728
NULL	Mol_Med_Rep_2014_Oct_23_10(4)_1717-1724.nxml.txt.nlp	25069516	SENT92	9	9	19	19	resveratrol	PC-3		692094	0.728
NULL	Chem_Res_Toxicol_2010_Mar_15_23(3)_568-577.nxml.txt.nlp	20112989	SENT446	7	7	4	4	cisplatin	AKT2	PA449014	208	0.728
NULL	Brain_Sci_2013_Jun_14_3(2)_941-963.nxml.txt.nlp	24961432	SENT235	1	1	15	15	ethanol	CDK2	PA448073	1017	0.728
NULL	Indian_J_Pharm_Sci_2013_May-Jun_75(3)_302-309.nxml.txt.nlp	24082346	SENT119	34	34	12	12	diclofenac	SRMS	PA449293	6725	0.728
NULL	Mucosal_Immunol_2014_Mar_25_7(2)_428-439.nxml.txt.nlp	24064667	SENT142	29	29	40	40	l-glutamine	CO2	PA10090	4513	0.728
NULL	Case_Rep_Oncol_Med_2014_Dec_23_2014_597291.nxml.txt.nlp	25587475	SENT125	11	11	26	26	doxorubicin	TNF-alpha	PA449412	7124	0.728
NULL	Anticancer_Agents_Med_Chem_2012_Feb_12(2)_163-171.nxml.txt.nlp	22043994	SENT256	22	22	7	7	irinotecan	KRAS	PA450085	3845	0.728
NULL	Environ_Health_Perspect_2005_Aug_15_113(8)_1009-1014.nxml.txt.nlp	16079071	SENT102	16	16	27	27	losartan	p38	PA450268	10598;1432;7965	0.728
NULL	Endocrinol_Metab_(Seoul)_2013_Dec_12_28(4)_262-274.nxml.txt.nlp	24396690	SENT51	19	19	14	14	liraglutide	GLP-1	PA165958364	100125288	0.728
NULL	Br_J_Cancer_2012_May_22_106(11)_1742-1752.nxml.txt.nlp	22538973	SENT145	9	9	11	11	imatinib	IFN	PA10804	3439	0.728
NULL	Oncotarget_2011_Jun_16_2(6)_428-429.nxml.txt.nlp	21680955	SENT3	30	30	23	23	neratinib	HER2	PA165291472	2064	0.728
NULL	Biomed_Res_Int_2014_Jan_29_2014_831845.nxml.txt.nlp	24605337	SENT142	0	0	4	4	bupivacaine	S6K1	PA135057240	6198	0.728
NULL	Oncotarget_2012_Dec_17_4(1)_48-63.nxml.txt.nlp	23295955	SENT182	16	16	9	9	methotrexate	MTHFD2	PA450428	10797	0.728
NULL	Clin_Ophthalmol_2012_Feb_20_6_277-282.nxml.txt.nlp	22375096	SENT113	33	33	20	20	ranibizumab	STA	PA164746012	2010;2656	0.728
NULL	Clin_Drug_Investig_2015_Dec_4_35_45-51.nxml.txt.nlp	25471740	SENT146	37	37	28	28	warfarin	CYP2C8	PA451906	1558	0.728
NULL	Semin_Immunopathol_2009_Sep_26_31(3)_383-397.nxml.txt.nlp	19468733	SENT75	9	9	31	31	l-tyrosine	CD4	PA451822	920	0.728
NULL	Oncotarget_2014_Jun_8_5(13)_5040-5053.nxml.txt.nlp	24970815	SENT68	15	15	18	18	cisplatin	AKT	PA449014	207	0.728
NULL	EMBO_Mol_Med_2012_Jul_11_4(7)_577-593.nxml.txt.nlp	22496117	SENT238	16	16	12	12	clofazimine	PAP-1	PA164748759	6100	0.728
NULL	J_Med_Case_Rep_2014_Apr_3_8_113.nxml.txt.nlp	24708915	SENT85	6	6	0	0	vincristine	CHOP	PA451879	1649	0.728
NULL	Diabetes_2009_Aug_28_58(8)_1816-1825.nxml.txt.nlp	19401425	SENT161	43	43	22	22	diazoxide	GLP-1	PA449285	100125288	0.728
NULL	J_Neurol_2011_Jul_2_258(7)_1207-1222.nxml.txt.nlp	21461686	SENT260	17	17	12	12	memantine	OPT	PA10364	51430	0.728
NULL	Front_Neurosci_2014_Dec_5_8_398.nxml.txt.nlp	25538552	SENT215	26	26	4	4	glucose	gamma	PA449773	9913	0.728
NULL	BMB_Rep_2013_Jan_46(1)_59-64.nxml.txt.nlp	23351386	SENT32	11	11	24	24	auranofin	STAT3	PA448510	6774	0.728
NULL	Cancer_Cell_Int_2010_Sep_6_10_31.nxml.txt.nlp	20819205	SENT85	17	17	9	9	doxycycline	CIS	PA449415	1154	0.728
NULL	Lipids_Health_Dis_2011_Jan_24_10_20.nxml.txt.nlp	21261970	SENT79	9	9	12	12	lipase	HSL	PA450239	3991	0.728
NULL	Nat_Med_2013_Apr_17_19(4)_429-436.nxml.txt.nlp	23502962	SENT138	4	4	8	8	clodronate	BMP4	PA10239	652	0.728
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT207	16	16	23	23	tacrolimus	SOCS3	PA451578	9021	0.728
NULL	J_Cachexia_Sarcopenia_Muscle_2010_Sep_26_1(1)_43-128.nxml.txt.nlp	22477519	SENT747	17	17	3	3	fenfluramine	ghrelin	PA449592	51738	0.728
NULL	Indian_J_Nucl_Med_2010_Jul-Sep_25(3)_103-108.nxml.txt.nlp	NULL	SENT193	11	11	18	18	doxorubicin	FDG	PA449412	23583	0.728
NULL	Indian_J_Dermatol_2009_Jul-Sep_54(3)_211-220.nxml.txt.nlp	20161849	SENT185	0	0	6	6	ustekinumab	IL-23	PA166048654	51561	0.728
NULL	J_Thyroid_Res_2010_Nov_10_2011_634170.nxml.txt.nlp	21113383	SENT17	19	19	37	37	thyroglobulin	RAI	PA164754910	10848;6050	0.728
NULL	Nucleic_Acids_Res_2011_Dec_10_39(22)_9498-9507.nxml.txt.nlp	21835778	SENT183	15	15	10	10	nutlin-3	p53		7157	0.728
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT169	20	20	15	15	metformin	HIF-1	PA450395	29072	0.728
NULL	Oncotarget_2013_Nov_24_4(12)_2430-2438.nxml.txt.nlp	24280348	SENT33	28	28	9	9	gefitinib	STAT3	PA131301952	6774	0.728
NULL	Diabetes_2013_Oct_17_62(10)_3500-3513.nxml.txt.nlp	23884882	SENT207	0	0	16	16	resveratrol	NKX6-1		4825	0.728
NULL	Int_J_Mol_Sci_2014_Oct_23_15(10)_19239-19252.nxml.txt.nlp	25342319	SENT137	19	19	4	4	heparin	SERS	PA449855	6301;54938	0.728
NULL	Nucleic_Acids_Res_2013_May_5_41(10)_5210-5222.nxml.txt.nlp	23563151	SENT257	27	27	19	19	arsenite	GADD45	PA452638	1647	0.728
NULL	Br_J_Cancer_2010_Oct_26_103(9)_1380-1390.nxml.txt.nlp	20877355	SENT168	32	32	17	17	vincristine	DR5	PA451879	8795	0.728
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Jul_27_69(Pt_8)_o1344.nxml.txt.nlp	24109411	SENT73	0	0	16	16	flunarizine	mol	PA164776636	90527	0.728
NULL	Mol_Biol_Cell_2013_Jul_1_24(13)_2134-2145.nxml.txt.nlp	23657817	SENT182	23	23	37	37	pp2	PI3K		5290	0.728
NULL	Evid_Based_Complement_Alternat_Med_2011_Feb_14_2011_429843.nxml.txt.nlp	21869897	SENT134	21	21	47	47	ethanol	EPM	PA448073	2054	0.728
NULL	Breast_Cancer_Res_Treat_2013_Jun_5_139(3)_649-655.nxml.txt.nlp	23736997	SENT213	11	11	4	4	tamoxifen	CYP3A5	PA451581	1577	0.728
NULL	J_Breast_Cancer_2013_Mar_31_16(1)_23-31.nxml.txt.nlp	23593078	SENT115	8	8	21	21	resveratrol	HDAC1		3065	0.728
NULL	Mar_Drugs_2011_Dec_13_9(12)_2622-2642.nxml.txt.nlp	22363243	SENT209	10	10	13	13	mitomycin	IGFBP7	PA450524	3490	0.728
NULL	Drugs_R_D_2013_Dec_30_13(4)_281-288.nxml.txt.nlp	24170256	SENT15	40	40	33	33	risperidone	FAST	PA451257	10922	0.728
NULL	Environ_Health_Perspect_2008_Oct_116(10)_A426-A434.nxml.txt.nlp	18941560	SENT166	21	21	23	23	taurine	S100B	PA451590	6285	0.728
NULL	Breast_Cancer_Res_1999_Oct_27_1(1)_41-47.nxml.txt.nlp	11250682	SENT106	18	18	8	8	colchicine	BRCA1	PA449092	672	0.728
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT88	15	15	4	4	methotrexate	MSH2	PA450428	4436	0.728
NULL	J_Exp_Clin_Cancer_Res_2009_Aug_19_28(1)_116.nxml.txt.nlp	19689822	SENT113	3	3	5	5	rituximab	CHOP	PA451261	1649	0.728
NULL	Curr_Control_Trials_Cardiovasc_Med_2001_May_31_2(3)_129-140.nxml.txt.nlp	11806786	SENT282	34	34	8	8	heparin	STARS	PA449855	137735	0.728
NULL	Ann_Surg_Oncol_2010_Apr_20_17(4)_1168-1176.nxml.txt.nlp	19936839	SENT73	0	0	24	24	cetuximab	KRAS	PA10040	3845	0.728
NULL	Braz_J_Med_Biol_Res_2012_Jul_20_45(10)_935-941.nxml.txt.nlp	22801415	SENT46	19	19	37	37	pioglitazone	ghrelin	PA450970	51738	0.728
NULL	Cancer_Immunol_Immunother_2015_Oct_7_64_61-73.nxml.txt.nlp	25287778	SENT196	17	17	7	7	lenalidomide	CD25	PA162363968	3669;3559	0.728
NULL	Diabetes_Metab_Syndr_Obes_2010_Mar_29_3_31-41.nxml.txt.nlp	21437074	SENT157	10	10	6	6	exenatide	GLP-1	PA164749238	100125288	0.728
NULL	Iran_J_Pharm_Res_2014_Spring_13(2)_635-639.nxml.txt.nlp	25237359	SENT18	18	18	34	34	dextromethorphan	CYP1A2	PA449273	1544	0.728
NULL	Int_J_Breast_Cancer_2011_Sep_6_2011_352182.nxml.txt.nlp	22295219	SENT170	18	18	11	11	trastuzumab	PI3K	PA451743	5290	0.728
NULL	Br_J_Haematol_2014_Feb_16_164(4)_586-596.nxml.txt.nlp	24236640	SENT167	27	27	25	25	carboplatin	EPO	PA448803	7076;8288;2056	0.728
NULL	Exp_Ther_Med_2013_Jan_10_5(1)_287-291.nxml.txt.nlp	23251285	SENT101	19	19	9	9	aspirin	APS	PA448497	10603	0.728
NULL	Arthritis_Res_Ther_2011_Jun_24_13(3)_R102.nxml.txt.nlp	21702928	SENT89	32	32	7	7	methotrexate	IMPACT	PA450428	55364	0.728
NULL	Oxid_Med_Cell_Longev_2012_Aug_22_2012_534705.nxml.txt.nlp	22966415	SENT34	6	6	11	11	riluzole	GLAST	PA451251	6507	0.728
NULL	Iran_J_Pharm_Res_2013_Summer_12(3)_411-421.nxml.txt.nlp	24250648	SENT113	10	10	7	7	vanillin	ANOVA	PA451852	4858	0.728
NULL	J_Biol_Chem_2012_Apr_13_287(16)_12952-12965.nxml.txt.nlp	22371491	SENT63	16	16	5	5	vasopressin	CXCL8	PA451858	3576	0.728
NULL	Acta_Pharmacol_Sin_2012_Jan_3_33(1)_49-56.nxml.txt.nlp	22212430	SENT9	0	0	20	20	thrombin	A10	PA451674	28870	0.728
NULL	Chem_Cent_J_2012_Feb_14_6_13.nxml.txt.nlp	22333299	SENT1	20	20	28	28	sulpiride	MEB	PA164745485	4203	0.728
NULL	Exp_Diabetes_Res_2011_Apr_6_2011_928523.nxml.txt.nlp	21603181	SENT155	22	22	32	32	bromocriptine	5-HT1A	PA448671	3350	0.728
NULL	Oncotarget_2013_Jun_3_4(6)_875-883.nxml.txt.nlp	23900261	SENT46	18	18	9	9	estradiol	ESR1	PA449503	2099	0.728
NULL	J_Gen_Physiol_1923_Sep_20_6(1)_73-76.nxml.txt.nlp	19872052	SENT8	12	12	22	22	phenol	PDF	PA450913	64146;9518	0.728
NULL	eLife_2013_Nov_5_2_e00969.nxml.txt.nlp	24192036	SENT239	0	0	6	6	vemurafenib	JNK	PA165946873	5599	0.727
NULL	Arthritis_Res_Ther_2009_Jan_30_11(1)_205.nxml.txt.nlp	19232061	SENT45	42	42	0	0	methotrexate	ACR	PA450428	49	0.727
NULL	Evid_Based_Complement_Alternat_Med_2013_May_23_2013_632121.nxml.txt.nlp	23762150	SENT172	24	24	5	5	resveratrol	MITF		4286	0.727
NULL	Oncotarget_2013_May_11_4(6)_830-843.nxml.txt.nlp	23919981	SENT58	7	7	10	10	temsirolimus	PI3K	PA164746890	5290	0.727
NULL	Nucleic_Acids_Res_2013_May_3_41(10)_e107.nxml.txt.nlp	23558748	SENT313	17	17	6	6	doxycycline	CENP-A	PA449415	1058	0.727
NULL	Sci_Rep_2014_Dec_19_4_7571.nxml.txt.nlp	25524368	SENT9	37	37	14	14	estradiol	mer	PA449503	10461	0.727
NULL	Virol_J_2010_Oct_20_7_279.nxml.txt.nlp	20961433	SENT167	0	0	4	4	trypsin	VLP	PA451806	391104	0.727
NULL	Core_Evid_2009_Jun_15_4_25-36.nxml.txt.nlp	20694062	SENT156	33	33	19	19	febuxostat	FACT	PA165958521	11198	0.727
NULL	J_Immunother_Cancer_2014_Aug_19_2_27.nxml.txt.nlp	25324973	SENT58	11	11	20	20	melphalan	IFN	PA450354	3439	0.727
NULL	J_Hematol_Oncol_2008_Oct_23_1_19.nxml.txt.nlp	18947412	SENT129	29	29	5	5	alemtuzumab	CD52	PA164783958	1043	0.727
NULL	Cancer_Cell_Int_2013_Jun_26_13_64.nxml.txt.nlp	23802572	SENT91	2	2	10	10	curcumin	Bcl-2	PA151958596	596	0.727
NULL	Arthritis_Res_Ther_2005_Mar_16_7(Suppl_2)_S4-S14.nxml.txt.nlp	15833146	SENT224	0	0	23	23	methotrexate	IL-4	PA450428	3565	0.727
NULL	F1000_Biol_Rep_2012_Mar_1_4_5.nxml.txt.nlp	22403588	SENT127	28	28	21	21	telaprevir	IFN	PA165958354	3439	0.727
NULL	Ther_Clin_Risk_Manag_2006_Mar_2(1)_87-98.nxml.txt.nlp	18360584	SENT212	12	12	9	9	erlotinib	IFN	PA134687924	3439	0.727
NULL	JRSM_Short_Rep_2010_Jun_30_1(1)_5.nxml.txt.nlp	21103097	SENT145	10	10	0	0	phenol	Tech	PA450913	57449	0.727
NULL	Antibiotics_(Basel)_2014_Jul_1_3(3)_285-316.nxml.txt.nlp	25364574	SENT180	13	13	9	9	cefotaxime	IMP-1	PA448852	10642	0.727
NULL	J_Biol_Chem_2009_Aug_21_284(34)_22926-22937.nxml.txt.nlp	19520847	SENT394	21	21	8	8	amrinone	ADP	PA164746803	23038	0.727
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1563-1573.nxml.txt.nlp	22015557	SENT292	5	5	8	8	sunitinib	c-Myc	PA162372840	4609	0.727
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R91.nxml.txt.nlp	22541814	SENT140	2	2	11	11	thrombin	HO-1	PA451674	3162	0.727
NULL	Environ_Health_Perspect_2006_Jun_9_114(6)_835-841.nxml.txt.nlp	16759981	SENT211	7	7	12	12	arsenite	AP-1	PA452638	2353;3727;2354;3725	0.727
NULL	Evid_Based_Complement_Alternat_Med_2011_Feb_10_2011_109164.nxml.txt.nlp	21331373	SENT113	5	5	3	3	pentobarbital	GAD65	PA450859	2572	0.727
NULL	Clin_Dev_Immunol_2013_Nov_26_2013_875343.nxml.txt.nlp	24371449	SENT55	15	15	0	0	rituximab	CD4	PA451261	920	0.727
NULL	Ecancermedicalscience_2008_Feb_18_2_75.nxml.txt.nlp	22275966	SENT156	26	26	15	15	erlotinib	ERCC1	PA134687924	2067	0.727
NULL	Br_J_Cancer_2009_May_19_100(10)_1540-1548.nxml.txt.nlp	19384300	SENT138	31	31	19	19	trypsin	survivin	PA451806	332	0.727
NULL	Oncotarget_2012_May_18_3(5)_525-534.nxml.txt.nlp	22619113	SENT94	7	7	13	13	fludarabine	MCL1	PA449655	4170	0.727
NULL	Brain_Sci_2013_Jun_3_3(2)_877-907.nxml.txt.nlp	24961429	SENT174	0	0	28	28	taurine	ATF6	PA451590	22926	0.727
NULL	J_Virol_2014_Apr_88(7)_3664-3677.nxml.txt.nlp	24429366	SENT563	16	16	7	7	bortezomib	CT7	PA10252	9947	0.727
NULL	Oncotarget_2010_May_27_1(2)_89-103.nxml.txt.nlp	20671809	SENT212	2	2	13	13	perifosine	TRAIL	PA165291471	8743	0.727
NULL	J_Exp_Med_1994_Mar_1_179(3)_931-942.nxml.txt.nlp	8113685	SENT7	7	7	42	42	forskolin	AP-1	PA146096022	2353;3727;2354;3725	0.727
NULL	Apoptosis_2012_Sep_30_17(9)_989-997.nxml.txt.nlp	22460505	SENT6	5	5	14	14	thioridazine	4E-BP1	PA451666	1978	0.727
NULL	Front_Oncol_2014_Oct_21_4_285.nxml.txt.nlp	25374842	SENT667	2	2	0	0	nutlin-3	HDM2		4193	0.727
NULL	Acta_Pharmacol_Sin_2012_Jun_14_33(6)_832-838.nxml.txt.nlp	22580740	SENT23	5	5	12	12	doxorubicin	DDP	PA449412	1678	0.727
NULL	Semin_Immunopathol_2013_Jan_26_35(1)_39-52.nxml.txt.nlp	22829332	SENT197	37	37	18	18	mitoxantrone	CHOP	PA450526	1649	0.727
NULL	Curr_Neuropharmacol_2013_Jul_11(4)_338-378.nxml.txt.nlp	24381528	SENT307	4	4	22	22	curcumin	FDG	PA151958596	23583	0.727
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_29_2013_590393.nxml.txt.nlp	23737838	SENT181	1	1	4	4	resveratrol	ABCG2		9429	0.727
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT12	14	14	16	16	metformin	HIF-1	PA450395	29072	0.727
NULL	Cardiol_Ther_2013_Jun_7_2(1)_57-68.nxml.txt.nlp	25135289	SENT177	16	16	7	7	prasugrel	PAR-1	PA154410481	2011;2149	0.727
NULL	Apoptosis_2014_Apr_23_19(7)_1055-1068.nxml.txt.nlp	24756955	SENT166	16	16	21	21	nutlin-3	MDMX		4194	0.727
NULL	J_Korean_Med_Sci_2010_Jan_26_25(1)_110-116.nxml.txt.nlp	20054409	SENT165	33	33	12	12	cyclophosphamide	BCS	PA449165	617	0.727
NULL	Chin_J_Cancer_2012_Feb_31(2)_51-57.nxml.txt.nlp	22257384	SENT67	7	7	11	11	cyclosporine	P-gp	PA449167	5243	0.727
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1013.nxml.txt.nlp	24457957	SENT72	7	7	10	10	orlistat	NOXA	PA164776864	5366	0.727
NULL	Open_Cardiovasc_Med_J_2010_Apr_28_4_120-126.nxml.txt.nlp	20556204	SENT111	0	0	20	20	bezafibrate	RANTES	PA162364313	6352	0.727
NULL	Endocrinology_2014_Jun_31_155(6)_2144-2154.nxml.txt.nlp	24684305	SENT367	34	34	28	28	estradiol	LHA	PA449503	1081	0.727
NULL	Clin_Exp_Gastroenterol_2011_Dec_12_4_291-296.nxml.txt.nlp	22235173	SENT65	18	18	11	11	cisplatin	ghrelin	PA449014	51738	0.727
NULL	Acta_Pharmacol_Sin_2009_Nov_12_30(11)_1566-1572.nxml.txt.nlp	19820718	SENT7	28	28	21	21	verapamil	CYP3A4	PA451868	1576	0.727
NULL	Cell_Cycle_2012_Nov_1_11(21)_3917-3918.nxml.txt.nlp	23032263	SENT8	42	42	10	10	etoposide	JNK	PA449552	5599	0.727
NULL	Mol_Cancer_2010_Aug_23_9_222.nxml.txt.nlp	20731837	SENT186	2	2	10	10	cetuximab	ATM	PA10040	472	0.727
NULL	Pharmaceuticals_(Basel)_2011_Jun_17_4(6)_880-914.nxml.txt.nlp	21904468	SENT228	13	13	6	6	haloperidol	DUP	PA449841	81620;4437	0.727
NULL	Acta_Pharmacol_Sin_2011_Mar_31_32(3)_295-302.nxml.txt.nlp	21278785	SENT145	4	4	7	7	evodiamine	spatial	PA165860788	219793	0.727
NULL	Oncoscience_2014_Jul_23_1(7)_486-503.nxml.txt.nlp	25594051	SENT173	7	7	17	17	naproxen	COX2	PA450595	4513;5743	0.727
NULL	Indian_J_Radiol_Imaging_2010_Aug_20(3)_188-191.nxml.txt.nlp	21042441	SENT11	16	16	1	1	iron	PKAN	PA450087	80025	0.727
NULL	Int_J_Mol_Sci_2012_Feb_1_13(2)_1512-1523.nxml.txt.nlp	22408405	SENT141	9	9	6	6	olmesartan	LOX-1	PA164742950	4973	0.727
NULL	J_Clin_Biochem_Nutr_2007_Jul_27_41(1)_32-42.nxml.txt.nlp	18392098	SENT602	42	42	33	33	curcumin	ROS	PA151958596	6098	0.727
NULL	Cardiovasc_Diabetol_2005_May_15_4_6.nxml.txt.nlp	15892894	SENT127	4	4	22	22	telmisartan	DBP	PA451605	3295;1628;2638	0.727
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Feb_17_6_29-36.nxml.txt.nlp	24648767	SENT116	6	6	11	11	tamoxifen	BRCA1	PA451581	672	0.727
NULL	Mol_Biol_Cell_2013_Sep_1_24(17)_2620-2632.nxml.txt.nlp	23864708	SENT14	14	14	8	8	gemcitabine	CD44	PA449748	960	0.727
NULL	J_Hematol_Oncol_2010_May_2_3_18.nxml.txt.nlp	20433767	SENT172	9	9	14	14	gefitinib	EGFR	PA131301952	1956	0.727
NULL	Protein_Cell_2014_Jul_2_5(7)_544-551.nxml.txt.nlp	24691905	SENT122	15	15	6	6	doxorubicin	p53	PA449412	7157	0.727
NULL	Front_Synaptic_Neurosci_2014_May_30_6_12.nxml.txt.nlp	24910611	SENT144	4	4	2	2	l-glutamine	ASCT2	PA10090	6510	0.727
NULL	Eur_J_Med_Res_2014_Jun_24_19(1)_34.nxml.txt.nlp	24961604	SENT111	5	5	0	0	nutlin-3	MDM2		4193	0.727
NULL	Front_Immunol_2012_May_29_3_128.nxml.txt.nlp	22661975	SENT51	33	33	9	9	l-arginine	IFN	PA448478	3439	0.727
NULL	Oncogenesis_2014_May_12_3(5)_e102.nxml.txt.nlp	24819061	SENT98	45	45	37	37	nadh	SIRT1	PA164755085	23411	0.727
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1063.nxml.txt.nlp	24556678	SENT51	19	19	12	12	thioridazine	TRAIL	PA451666	8743	0.727
NULL	Oxid_Med_Cell_Longev_2013_Jun_6_2013_462361.nxml.txt.nlp	23840917	SENT294	15	15	45	45	probucol	NOX2	PA451107	1536	0.727
NULL	Cancer_Cell_Int_2013_Sep_23_13_94.nxml.txt.nlp	24059699	SENT100	13	13	21	21	bevacizumab	VEGFR1	PA130232992	2321	0.727
NULL	J_Vet_Med_Sci_2014_Oct_16_76(10)_1383-1387.nxml.txt.nlp	24931645	SENT150	11	11	7	7	glimepiride	GLP-1	PA449761	100125288	0.727
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT87	27	27	14	14	celecoxib	survivin	PA448871	332	0.727
NULL	Cancer_Immunol_Immunother_2015_Oct_7_64_61-73.nxml.txt.nlp	25287778	SENT157	17	17	4	4	lenalidomide	LFA-1	PA162363968	3683;3689	0.727
NULL	Eur_J_Pharm_Sci_2012_Jul_16_46(4)_244-258.nxml.txt.nlp	22085636	SENT50	15	15	10	10	pertuzumab	PI3K		5290	0.727
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT36	3	3	8	8	resveratrol	SIRT1		23411	0.727
NULL	Asian-Australas_J_Anim_Sci_2012_Jun_25(6)_794-799.nxml.txt.nlp	25049628	SENT40	11	11	19	19	estradiol	HSI	PA449503	57016	0.727
NULL	Front_Neuroendocrinol_2014_Aug_35(3)_370-384.nxml.txt.nlp	24607323	SENT1565	0	0	3	3	estradiol	GDX	PA449503	8266	0.727
NULL	Diabetes_2011_Nov_17_60(11)_2691-2700.nxml.txt.nlp	21896928	SENT7	19	19	22	22	resveratrol	SIRT1		23411	0.727
NULL	Acta_Naturae_2013_Oct-Dec_5(4)_83-93.nxml.txt.nlp	24455187	SENT13	13	13	26	26	tamoxifen	7SL	PA451581	6029	0.727
NULL	Front_Neural_Circuits_2015_Jan_12_8_150.nxml.txt.nlp	25628540	SENT940	13	13	10	10	carbachol	CA3	PA448784	761	0.727
NULL	Korean_Circ_J_2013_Aug_31_43(8)_541-549.nxml.txt.nlp	24044013	SENT80	23	23	26	26	ticagrelor	CYP2C19	PA165374673	1557	0.727
NULL	J_Hematol_Oncol_2013_Jan_15_6_5.nxml.txt.nlp	23320987	SENT137	2	2	0	0	heparin	PI-PLC	PA449855	2923	0.727
NULL	J_Cancer_2013_Jan_11_4(2)_117-132.nxml.txt.nlp	23386910	SENT157	20	20	7	7	olaparib	BRCA1		672	0.727
NULL	Br_J_Cancer_2011_Apr_12_104(8)_1278-1287.nxml.txt.nlp	21487429	SENT7	4	4	14	14	cisplatin	TRAIL	PA449014	8743	0.727
NULL	J_Lipid_Res_2013_May_54(5)_1410-1420.nxml.txt.nlp	23419260	SENT167	13	13	3	3	tetracycline	IDOL	PA451640	29116	0.727
NULL	Springerplus_2015_Jan_14_4_19.nxml.txt.nlp	25625039	SENT79	23	23	9	9	pha-665752	JNK		5599	0.727
NULL	Clin_Interv_Aging_2012_Sep_13_7_351-361.nxml.txt.nlp	23049247	SENT28	10	10	2	2	estradiol	aromatase	PA449503	1588	0.727
NULL	Int_J_Endocrinol_Metab_2013_Oct_1_11(4)_e10927.nxml.txt.nlp	24719626	SENT143	26	26	13	13	gliclazide	adiponectin	PA10892	9370	0.727
NULL	Indian_J_Dermatol_2009_Oct-Dec_54(4)_388-389.nxml.txt.nlp	20101349	SENT35	15	15	27	27	warfarin	gamma	PA451906	9913	0.727
NULL	Mol_Cancer_2012_Apr_16_11_21.nxml.txt.nlp	22507190	SENT76	20	20	6	6	doxorubicin	IRF5	PA449412	3663	0.727
NULL	Front_Neurosci_2012_May_30_6_77.nxml.txt.nlp	22661925	SENT224	15	15	23	23	ethanol	NALP3	PA448073	114548	0.727
NULL	Cancer_Res_Treat_2013_Mar_31_45(1)_55-62.nxml.txt.nlp	23613671	SENT35	13	13	6	6	oxaliplatin	KRAS	PA131285527	3845	0.727
NULL	Saudi_J_Anaesth_2013_Apr-Jun_7(2)_151-154.nxml.txt.nlp	23956714	SENT56	21	21	23	23	theophylline	NAC	PA451647	22861	0.727
NULL	Cancers_(Basel)_2013_May_27_5(2)_617-638.nxml.txt.nlp	24216994	SENT321	16	16	9	9	curcumin	PC3	PA151958596	57332;7832;5122	0.727
NULL	Br_J_Cancer_2013_Dec_10_109(12)_3092-3104.nxml.txt.nlp	24169343	SENT48	19	19	32	32	l-glutamine	CO2	PA10090	4513	0.727
NULL	Indian_J_Endocrinol_Metab_2012_Mar_16(Suppl1)_S79-S82.nxml.txt.nlp	22701852	SENT37	17	17	26	26	metformin	B12	PA450395	7126;4709	0.727
NULL	J_Adv_Pract_Oncol_2012_Nov_1_Nov-Dec_3(6)_391-394.nxml.txt.nlp	25031970	SENT64	14	14	10	10	trastuzumab	HER2	PA451743	2064	0.727
NULL	Asian_J_Transfus_Sci_2014_Jan-Jun_8(1)_19-25.nxml.txt.nlp	24678168	SENT100	16	16	13	13	ribavirin	IFN	PA451241	3439	0.727
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT221	18	18	24	24	cisplatin	DR5	PA449014	8795	0.727
NULL	Indian_J_Endocrinol_Metab_2015_Jan-Feb_19(1)_30-38.nxml.txt.nlp	25593823	SENT102	16	16	24	24	metformin	adiponectin	PA450395	9370	0.727
NULL	Case_Rep_Crit_Care_2013_May_20_2013_138959.nxml.txt.nlp	24829814	SENT63	17	17	6	6	diltiazem	MARS	PA449334	4141	0.727
NULL	Front_Pharmacol_2014_Nov_25_5_256.nxml.txt.nlp	25505414	SENT111	7	7	20	20	midazolam	KCC2	PA450496	57468	0.727
NULL	Indian_J_Ophthalmol_2012_Jan-Feb_60(1)_60-63.nxml.txt.nlp	22218251	SENT35	18	18	25	25	bevacizumab	San	PA130232992	80218	0.727
NULL	Front_Behav_Neurosci_2014_Dec_23_8_440.nxml.txt.nlp	25566007	SENT1055	4	4	11	11	citalopram	STAR	PA449015	6770;2984	0.727
NULL	Int_J_Mol_Sci_2014_May_8_15(5)_8106-8121.nxml.txt.nlp	24815071	SENT460	24	24	8	8	atorvastatin	LC3	PA448500	84557	0.727
NULL	Front_Oncol_2014_Jun_16_4_146.nxml.txt.nlp	24982847	SENT290	17	17	35	35	cabozantinib	RDT	PA165906891	6598	0.727
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT170	16	16	40	40	l-leucine	ATP5A	PA450197	498	0.727
NULL	Diabetes_2013_Nov_18_62(11)_3674-3676.nxml.txt.nlp	24158998	SENT35	18	18	8	8	baclofen	STZ	PA448533	6484	0.727
NULL	Adv_Hematol_2012_Jun_27_2012_498342.nxml.txt.nlp	22792112	SENT4	3	3	8	8	rituximab	CHOP	PA451261	1649	0.727
NULL	JAKSTAT_2012_Apr_1_1(2)_83-89.nxml.txt.nlp	24058756	SENT33	7	7	17	17	losartan	JAK2	PA450268	3717	0.727
NULL	Breast_Cancer_Res_2012_Apr_26_14(2)_R68.nxml.txt.nlp	22537901	SENT153	13	13	23	23	bortezomib	TRAIL	PA10252	8743	0.727
NULL	Br_J_Pharmacol_2011_Jul_163(6)_1263-1275.nxml.txt.nlp	21391977	SENT100	14	14	2	2	fluconazole	CYP2C8	PA449653	1558	0.727
NULL	Ann_Pediatr_Cardiol_2011_Jan-Jun_4(1)_45-46.nxml.txt.nlp	21677805	SENT15	15	15	13	13	oxygen	PVR	PA450744	5817	0.727
NULL	Indian_J_Anaesth_2012_Mar-Apr_56(2)_129-134.nxml.txt.nlp	22701202	SENT30	21	21	30	30	ropivacaine	CEA	PA451271	5670;1087	0.727
NULL	J_Gastroenterol_2013_Jan_27_48(1)_22-30.nxml.txt.nlp	23104468	SENT33	4	4	2	2	ribavirin	IFN	PA451241	3439	0.727
NULL	Genome_Med_2010_Aug_11_2(8)_53.nxml.txt.nlp	20701793	SENT141	9	9	6	6	cisplatin	BRCA1	PA449014	672	0.727
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT94	19	19	9	9	chloroquine	BMPR-II	PA448948	659	0.727
NULL	Hum_Genomics_2008_Sep_1_3(1)_7-16.nxml.txt.nlp	19129086	SENT35	23	23	19	19	pravastatin	OATP1B1	PA451089	10599	0.727
NULL	Biomed_Res_Int_2013_Jul_15_2013_458571.nxml.txt.nlp	23956983	SENT14	28	28	17	17	l-serine	PLP	PA451330	25824;5744	0.727
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT139	3	3	11	11	trastuzumab	HER2	PA451743	2064	0.727
NULL	Br_J_Cancer_2006_Feb_13_94(3)_407-426.nxml.txt.nlp	16434996	SENT354	14	14	4	4	genistein	BRCA1	PA165109660	672	0.727
NULL	Cancers_(Basel)_2014_May_16_6(2)_1180-1194.nxml.txt.nlp	24840048	SENT128	0	0	9	9	cabozantinib	San	PA165906891	80218	0.727
NULL	Breast_Cancer_Res_2010_Jun_28_12(3)_R43.nxml.txt.nlp	20579400	SENT0	28	28	30	30	fulvestrant	MAPT	PA164747170	4137	0.727
NULL	ScientificWorldJournal_2012_Dec_27_2012_740308.nxml.txt.nlp	23346021	SENT182	23	23	27	27	ethanol	NAC	PA448073	22861	0.727
NULL	Front_Physiol_2012_Sep_18_3_355.nxml.txt.nlp	23060802	SENT1331	17	17	14	14	collagenase	MEK2	PA449107	5605	0.727
NULL	Acta_Pharmacol_Sin_2009_Oct_21_30(10)_1392-1398.nxml.txt.nlp	19767766	SENT184	5	5	7	7	atorvastatin	DPI	PA448500	1832	0.727
NULL	Free_Radic_Biol_Med_2013_Aug_61(100)_438-452.nxml.txt.nlp	23608463	SENT856	19	19	28	28	apomorphine	ANOVA	PA164781163	4858	0.727
NULL	Open_Microbiol_J_2008_Mar_18_2_18-28.nxml.txt.nlp	19088907	SENT87	23	23	18	18	kanamycin	HC7	PA450137	360185	0.727
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT105	31	31	26	26	resveratrol	TNF		7124	0.727
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT151	9	9	5	5	perifosine	DR5	PA165291471	8795	0.727
NULL	J_Biol_Chem_2009_Jul_10_284(28)_18904-18912.nxml.txt.nlp	19473990	SENT217	9	9	18	18	forskolin	MEIS1	PA146096022	4211	0.727
NULL	Biomed_Res_Int_2014_Jun_25_2014_764981.nxml.txt.nlp	25057499	SENT126	26	26	18	18	sorafenib	AKT	PA7000	207	0.727
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT167	22	22	6	6	rosiglitazone	CD36	PA451283	948	0.727
NULL	Behav_Brain_Funct_2014_Oct_2_10(1)_35.nxml.txt.nlp	NULL	SENT34	30	30	11	11	risperidone	FTO	PA451257	79068	0.727
NULL	Clin_Transl_Allergy_2013_Sep_2_3_29.nxml.txt.nlp	24004581	SENT91	5	5	10	10	omalizumab	IL-6	PA164752253	3569	0.727
NULL	Sensors_(Basel)_2013_Mar_15_13(3)_3675-3710.nxml.txt.nlp	23503295	SENT339	4	4	13	13	ethanol	IPA	PA448073	3160	0.727
NULL	Cardiol_Res_Pract_2011_Apr_26_2011_837841.nxml.txt.nlp	21577267	SENT46	12	12	24	24	heparin	ACT	PA449855	12;11332;9457;641455	0.727
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1495-1502.nxml.txt.nlp	21989186	SENT201	26	26	28	28	oxaliplatin	HSI	PA131285527	57016	0.727
NULL	Arthritis_Res_Ther_2006_May_11_8(3)_209.nxml.txt.nlp	16712713	SENT510	16	16	34	34	leflunomide	AID	PA450192	57379	0.727
NULL	Clin_Interv_Aging_2010_Feb_2_5_7-18.nxml.txt.nlp	20169038	SENT295	24	24	19	19	creatine	ASAT	PA164778930	22	0.727
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT120	13	13	11	11	tenofovir	SLC22A11	PA10204	55867	0.727
NULL	Nanoscale_Res_Lett_2012_Jul_12_7(1)_386.nxml.txt.nlp	22784858	SENT47	26	26	42	42	neomycin	CO2	PA450608	4513	0.727
NULL	Chemother_Res_Pract_2011_Apr_7_2011_393976.nxml.txt.nlp	22312553	SENT30	19	19	34	34	ritonavir	CYP3A4	PA451260	1576	0.727
NULL	Oncol_Lett_2014_Aug_19_8(2)_809-812.nxml.txt.nlp	25009658	SENT77	1	1	5	5	metformin	AMPK	PA450395	5563	0.727
NULL	Croat_Med_J_2012_Jun_53(3)_224-233.nxml.txt.nlp	22661135	SENT64	35	35	7	7	estradiol	PRL	PA449503	5617	0.727
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT166	16	16	26	26	trastuzumab	HRG	PA451743	3084;3273	0.727
NULL	J_Histochem_Cytochem_2014_Nov_62(11)_802-812.nxml.txt.nlp	25124006	SENT38	0	0	6	6	l-leucine	ADP	PA450197	23038	0.727
NULL	Br_J_Cancer_2012_May_8_106(10)_1587-1590.nxml.txt.nlp	22568998	SENT32	19	19	21	21	sunitinib	IFN	PA162372840	3439	0.727
NULL	Evid_Based_Complement_Alternat_Med_2013_May_28_2013_629750.nxml.txt.nlp	23781265	SENT8	2	2	42	42	capsaicin	ATF4	PA448776	468	0.727
NULL	Cardiovasc_Diabetol_2011_Dec_22_10_115.nxml.txt.nlp	22189184	SENT161	6	6	9	9	voglibose	GLP-1	PA164752433	100125288	0.727
NULL	Basic_Clin_Neurosci_2014_Winter_5(1)_66-73.nxml.txt.nlp	25436086	SENT126	12	12	15	15	lidocaine	LHA	PA450226	1081	0.727
NULL	Cancer_Cell_Int_2006_Mar_6_6_5.nxml.txt.nlp	16519802	SENT33	7	7	11	11	estradiol	SSTR1	PA449503	6751	0.727
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1542-1553.nxml.txt.nlp	21970874	SENT189	0	0	15	15	carboplatin	ERCC1	PA448803	2067	0.727
NULL	Niger_Med_J_2013_Sep-Oct_54(5)_289-294.nxml.txt.nlp	24403703	SENT131	7	7	12	12	thrombin	VIII	PA451674	1351	0.727
NULL	F1000_Med_Rep_2011_May_3_3_9.nxml.txt.nlp	21654924	SENT42	27	27	4	4	ribavirin	KIR2DL3	PA451241	3804	0.727
NULL	Ther_Clin_Risk_Manag_2006_Dec_2(4)_335-480.nxml.txt.nlp	18360645	SENT66	3	3	11	11	infliximab	IMPACT	PA452639	55364	0.727
NULL	Ann_Dermatol_2011_Nov_3_23(4)_526-528.nxml.txt.nlp	22148027	SENT48	7	7	21	21	erlotinib	EGF	PA134687924	1950	0.727
NULL	Exp_Diabetes_Res_2011_Jun_4_2011_489708.nxml.txt.nlp	21747829	SENT185	1	1	19	19	aliskiren	GLP-1	PA143487910	100125288	0.727
NULL	Eur_J_Pharm_Sci_2012_Jul_16_46(4)_244-258.nxml.txt.nlp	22085636	SENT556	13	13	7	7	tamoxifen	PDK1	PA451581	5170;5163	0.727
NULL	Cancer_Cell_Int_2010_Sep_9_10_32.nxml.txt.nlp	20828393	SENT121	11	11	5	5	cisplatin	ATF3	PA449014	467	0.727
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Mar_26_3(3)_e107.nxml.txt.nlp	24670388	SENT96	17	17	14	14	midazolam	CYP3A	PA450496	1574	0.727
NULL	Int_J_Biomater_2012_Oct_15_2012_181024.nxml.txt.nlp	23118752	SENT98	8	8	18	18	ethanol	Tech	PA448073	57449	0.727
NULL	Int_J_Mol_Sci_2014_Mar_18_15(3)_4671-4713.nxml.txt.nlp	24646911	SENT1672	3	3	12	12	isoproterenol	spatial	PA450121	219793	0.727
NULL	Indian_J_Pharmacol_2013_May-Jun_45(3)_286-288.nxml.txt.nlp	23833375	SENT74	4	4	10	10	montelukast	NMU	PA450546	10874	0.727
NULL	J_Breast_Cancer_2013_Mar_31_16(1)_23-31.nxml.txt.nlp	23593078	SENT115	4	4	26	26	genistein	MBD2	PA165109660	8932	0.727
NULL	J_Korean_Med_Sci_2010_Oct_17_25(10)_1427-1430.nxml.txt.nlp	20890421	SENT57	9	9	2	2	atazanavir	CD4	PA10251	920	0.727
NULL	Acta_Pharmacol_Sin_2010_Mar_22_31(3)_329-340.nxml.txt.nlp	20173759	SENT5	26	26	7	7	ethanol	AMPK	PA448073	5563	0.727
NULL	F1000Res_2014_Aug_19_3_198.nxml.txt.nlp	25400908	SENT293	16	16	7	7	docetaxel	HER2	PA449383	2064	0.727
NULL	ASN_Neuro_2010_Mar_15_2(2)_e00030.nxml.txt.nlp	20396375	SENT211	20	20	11	11	ethanol	STZ	PA448073	6484	0.727
NULL	F1000Res_2012_Nov_9_1_47.nxml.txt.nlp	24627764	SENT11	31	31	23	23	l-alanine	SOD1	PA448055	6647	0.727
NULL	Front_Neuroeng_2013_Feb_25_6_1.nxml.txt.nlp	23443302	SENT66	7	7	16	16	propofol	gamma	PA451141	9913	0.727
NULL	Iran_Red_Crescent_Med_J_2012_Jul_30_14(7)_422-429.nxml.txt.nlp	22997558	SENT79	22	22	37	37	glutaraldehyde	VIII	PA449777	1351	0.727
NULL	Bioinorg_Chem_Appl_2012_Nov_26_2012_984291.nxml.txt.nlp	23226992	SENT35	5	5	21	21	piperazine	NO3	PA450977	4681	0.727
NULL	Front_Immunol_2013_Mar_27_4_76.nxml.txt.nlp	23543707	SENT218	31	31	15	15	irinotecan	KRAS	PA450085	3845	0.727
NULL	Hum_Genomics_2008_Sep_1_3(1)_7-16.nxml.txt.nlp	19129086	SENT177	25	25	20	20	rosiglitazone	SLCO1B1	PA451283	10599	0.727
NULL	Basic_Clin_Neurosci_2014_Summer_5(3)_191-198.nxml.txt.nlp	25337379	SENT113	7	7	28	28	naloxone	ANOVA	PA450586	4858	0.727
NULL	J_Exp_Med_1998_Jun_1_187(11)_1799-1811.nxml.txt.nlp	9607921	SENT193	25	25	17	17	staurosporine	IFN	PA165109623	3439	0.727
NULL	Curr_Neuropharmacol_2007_Dec_5(4)_232-243.nxml.txt.nlp	19305740	SENT124	11	11	28	28	pioglitazone	MCP-1	PA450970	6347	0.727
NULL	Patient_Prefer_Adherence_2011_Dec_23_6_1-9.nxml.txt.nlp	22272064	SENT26	9	9	11	11	telmisartan	ACE	PA451605	1636	0.727
NULL	J_Mol_Signal_2011_Oct_5_6_13.nxml.txt.nlp	21975218	SENT139	24	24	38	38	ethanol	ID1	PA448073	3397	0.727
NULL	Br_J_Cancer_2009_Mar_24_100(6)_870-873.nxml.txt.nlp	19293806	SENT64	13	13	10	10	gemcitabine	CDA	PA449748	978	0.727
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT244	9	9	18	18	cisplatin	PC3	PA449014	57332;7832;5122	0.727
NULL	Br_J_Cancer_2011_Apr_12_104(8)_1256-1261.nxml.txt.nlp	21448165	SENT74	25	25	20	20	sorafenib	IL-2	PA7000	3558	0.727
NULL	Multidiscip_Respir_Med_2012_Nov_23_7(1)_48.nxml.txt.nlp	23174134	SENT67	6	6	4	4	imatinib	DLST	PA10804	1743	0.727
NULL	Arch_Med_Sci_2014_Oct_27_10(5)_1007-1018.nxml.txt.nlp	25395954	SENT93	31	31	4	4	trastuzumab	TIC	PA451743	23550	0.727
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Nov_4_9_31.nxml.txt.nlp	21050425	SENT126	0	0	11	11	chloramphenicol	Gen	PA448927	348654	0.727
NULL	Biomed_Res_Int_2013_Aug_19_2013_235194.nxml.txt.nlp	24024185	SENT228	43	43	39	39	dobutamine	DIP	PA449381	23151;1831	0.727
NULL	Cancers_(Basel)_2013_Jul_4_5(3)_838-856.nxml.txt.nlp	24202322	SENT207	17	17	11	11	flavopiridol	p53	PA452627	7157	0.727
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jan_15_67(Pt_2)_o390-o391.nxml.txt.nlp	21523064	SENT75	1	1	7	7	piperazine	mol	PA450977	90527	0.727
NULL	Cancers_(Basel)_2014_Feb_13_6(1)_396-415.nxml.txt.nlp	24531055	SENT522	3	3	19	19	collagenase	TIMP1	PA449107	7076	0.727
NULL	J_Vet_Med_Sci_2014_Jun_15_76(6)_813-817.nxml.txt.nlp	24531829	SENT115	5	5	8	8	doxycycline	DPT	PA449415	1805	0.727
NULL	Oxid_Med_Cell_Longev_2013_Mar_5_2013_264935.nxml.txt.nlp	23533686	SENT180	27	27	34	34	hemin	HO-1	PA449849	3162	0.727
NULL	EMBO_J_2013_Feb_20_32(4)_511-523.nxml.txt.nlp	23241948	SENT129	24	24	22	22	kanamycin	FRP	PA450137	11167;6422	0.727
NULL	Oncotarget_2013_Apr_13_4(4)_502-530.nxml.txt.nlp	23594434	SENT426	6	6	16	16	nelfinavir	HIF-1	PA450606	29072	0.727
NULL	Front_Oncol_2014_Apr_9_4_75.nxml.txt.nlp	24782986	SENT272	40	40	13	13	paclitaxel	IL-6	PA450761	3569	0.727
NULL	Oncogene_2014_May_8_33(19)_2478-2486.nxml.txt.nlp	23752180	SENT13	41	41	35	35	trastuzumab	HER2	PA451743	2064	0.727
NULL	Exp_Cell_Res_2011_Apr_15_317(7)_1028-1039.nxml.txt.nlp	21237154	SENT134	16	16	8	8	staurosporine	JIP1	PA165109623	9479	0.727
NULL	Core_Evid_2010_Jul_27_5_1-10.nxml.txt.nlp	20694135	SENT202	15	15	33	33	levodopa	CLE	PA450213	51637	0.727
NULL	Arch_Drug_Inf_2011_Mar_4(1)_1-9.nxml.txt.nlp	21572514	SENT191	40	40	24	24	ciprofloxacin	P-gp	PA449009	5243	0.727
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT156	12	12	15	15	nutlin-3	p53		7157	0.727
NULL	Theranostics_2014_Aug_15_4(11)_1072-1084.nxml.txt.nlp	25250092	SENT172	26	26	28	28	trastuzumab	HER2	PA451743	2064	0.727
NULL	Pharmaceuticals_(Basel)_2013_Oct_11_6(10)_1304-1321.nxml.txt.nlp	24275851	SENT222	22	22	29	29	losartan	GLP-1	PA450268	100125288	0.727
NULL	Front_Neurosci_2014_Jun_3_8_128.nxml.txt.nlp	24917782	SENT133	26	26	6	6	ethanol	MC3R	PA448073	4159	0.727
NULL	J_Carcinog_2012_Nov_28_11_17.nxml.txt.nlp	23233821	SENT32	48	48	36	36	spermine	ODC	PA164781199	4953;89874	0.727
NULL	Acta_Pharmacol_Sin_2009_Sep_4_30(9)_1337-1343.nxml.txt.nlp	19730429	SENT21	0	0	9	9	gemcitabine	GEM	PA449748	2669	0.727
NULL	Diabetes_Care_2012_Feb_16_35(2)_327-333.nxml.txt.nlp	22179958	SENT119	5	5	8	8	metformin	B12	PA450395	7126;4709	0.727
NULL	Nat_Med_2011_Dec_11_18(1)_74-82.nxml.txt.nlp	22157681	SENT100	9	9	4	4	gefitinib	Dicer	PA131301952	23405	0.727
NULL	Allergy_Asthma_Clin_Immunol_2010_Nov_4_6(Suppl_2)_P27.nxml.txt.nlp	NULL	SENT12	16	16	12	12	hydrocortisone	ACTH	PA449905	5443	0.727
NULL	Gastric_Cancer_2013_Dec_14_16(4)_513-520.nxml.txt.nlp	23238856	SENT36	14	14	9	9	hyaluronan	LYVE-1	PA165958431	10894	0.727
NULL	Br_J_Cancer_1988_Nov_58(5)_640-643.nxml.txt.nlp	3064798	SENT10	10	10	19	19	carboplatin	CLB	PA448803	171425	0.727
NULL	Osteoporos_Int_2011_Jan_1_22(1)_27-35.nxml.txt.nlp	20358360	SENT66	31	31	26	26	raloxifene	PTH	PA451221	5741	0.727
NULL	CNS_Spectr_2014_Dec_18_19(6)_528-534.nxml.txt.nlp	24642260	SENT40	15	15	38	38	aripiprazole	5-HT2A	PA10026	3356	0.727
NULL	Breast_Cancer_Res_2010_Oct_22_12(Suppl_2)_S2.nxml.txt.nlp	21050423	SENT99	25	25	11	11	mitoxantrone	MLH1	PA450526	4292	0.727
NULL	J_Headache_Pain_2013_Apr_10_14(1)_33.nxml.txt.nlp	23574808	SENT35	21	21	10	10	capsaicin	CO2	PA448776	4513	0.727
NULL	Breast_Cancer_(Auckl)_2011_Sep_25_5_201-208.nxml.txt.nlp	22084573	SENT135	18	18	6	6	cisplatin	BRCA1	PA449014	672	0.727
NULL	Breast_Cancer_Res_2007_Aug_8_9(4)_R50.nxml.txt.nlp	17686159	SENT174	3	3	6	6	gefitinib	HRG	PA131301952	3084;3273	0.727
NULL	Cancers_(Basel)_2014_Apr_16_6(2)_926-957.nxml.txt.nlp	24743778	SENT327	4	4	12	12	pp2	STAT3		6774	0.727
NULL	FEBS_Open_Bio_2012_Aug_22_2_279-283.nxml.txt.nlp	23650611	SENT110	4	4	14	14	raloxifene	IFN	PA451221	3439	0.727
NULL	Hum_Genomics_2013_Apr_5_7(1)_10.nxml.txt.nlp	23561625	SENT143	4	4	9	9	flavopiridol	CDK7	PA452627	1022	0.727
NULL	J_Int_Soc_Sports_Nutr_2010_Jul_19_7_27.nxml.txt.nlp	20642826	SENT80	14	14	7	7	betaine	ANOVA	PA448603	4858	0.727
NULL	Front_Pharmacol_2014_May_27_5_115.nxml.txt.nlp	24904418	SENT2338	2	2	21	21	hyaluronan	MD-2	PA165958431	23643	0.727
NULL	Cancer_Microenviron_2009_Sep_26_2(Suppl_1)_19-204.nxml.txt.nlp	NULL	SENT2495	6	6	22	22	busulfan	AKT	PA448691	207	0.727
NULL	Theranostics_2014_Jan_29_4(4)_336-365.nxml.txt.nlp	24578720	SENT581	8	8	24	24	bortezomib	p38	PA10252	10598;1432;7965	0.727
NULL	Cancers_(Basel)_2011_Apr_26_3(2)_2176-2194.nxml.txt.nlp	24212803	SENT107	14	14	11	11	cetuximab	TRG	PA10040	6965	0.727
NULL	Arthritis_Res_Ther_2013_Sep_10_15(5)_R110.nxml.txt.nlp	24020899	SENT152	13	13	25	25	pioglitazone	IL-6	PA450970	3569	0.727
NULL	J_Cell_Biol_2000_Feb_21_148(4)_811-824.nxml.txt.nlp	10684261	SENT163	10	10	13	13	thrombin	EGF	PA451674	1950	0.727
NULL	Case_Rep_Gastroenterol_2012_Jul_24_6(2)_496-501.nxml.txt.nlp	22855667	SENT39	4	4	20	20	hydralazine	B12	PA449894	7126;4709	0.727
NULL	Front_Endocrinol_(Lausanne)_2014_Feb_25_5_22.nxml.txt.nlp	24611062	SENT282	12	12	14	14	estradiol	RhoA	PA449503	387	0.727
NULL	Mol_Cancer_2008_May_21_7_42.nxml.txt.nlp	18492291	SENT170	31	31	9	9	gefitinib	EGFR	PA131301952	1956	0.727
NULL	Braz_J_Med_Biol_Res_2013_Jun_12_46(6)_546-554.nxml.txt.nlp	23780424	SENT37	24	24	26	26	cisplatin	DDP	PA449014	1678	0.727
NULL	Diabetes_2011_Mar_21_60(3)_757-765.nxml.txt.nlp	21282370	SENT173	1	1	27	27	isoproterenol	PTRF	PA450121	284119	0.727
NULL	Chemother_Res_Pract_2011_Dec_1_2011_715469.nxml.txt.nlp	22312557	SENT156	17	17	3	3	cisplatin	p53	PA449014	7157	0.727
NULL	J_Cell_Biol_1998_Jan_12_140(1)_197-210.nxml.txt.nlp	9425167	SENT58	33	33	44	44	l-glutamine	CO2	PA10090	4513	0.727
NULL	Biomed_Res_Int_2014_Aug_6_2014_967826.nxml.txt.nlp	25165721	SENT365	9	9	5	5	cisplatin	NQO1	PA449014	1728	0.726
NULL	Breast_Cancer_Res_2010_Jul_22_12(4)_R53.nxml.txt.nlp	20649975	SENT10	18	18	12	12	tamoxifen	HOXB13	PA451581	10481	0.726
NULL	Infect_Drug_Resist_2010_Nov_23_3_133-145.nxml.txt.nlp	21694902	SENT221	30	30	11	11	ribavirin	gamma	PA451241	9913	0.726
NULL	Indian_J_Pharmacol_2014_Jan-Feb_46(1)_3-12.nxml.txt.nlp	24550577	SENT221	32	32	5	5	vismodegib	CYP2C9		1559	0.726
NULL	Front_Neurosci_2012_May_30_6_77.nxml.txt.nlp	22661925	SENT185	0	0	2	2	ethanol	DCX	PA448073	1641	0.726
NULL	Biomed_Res_Int_2013_Jan_16_2013_290575.nxml.txt.nlp	23484104	SENT58	2	2	16	16	tamoxifen	survivin	PA451581	332	0.726
NULL	Front_Endocrinol_(Lausanne)_2014_Oct_27_5_183.nxml.txt.nlp	25386167	SENT126	10	10	6	6	hyaluronidase	MGEA5	PA164745713	10724	0.726
NULL	J_Gastroenterol_2014_Dec_24_49(12)_1536-1547.nxml.txt.nlp	24366288	SENT153	19	19	41	41	omeprazole	CYP2C19	PA450704	1557	0.726
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT43	6	6	2	2	pertuzumab	HER-2		2064	0.726
NULL	Front_Cell_Neurosci_2014_Dec_11_8_422.nxml.txt.nlp	25565957	SENT249	0	0	13	13	pravastatin	RhoA	PA451089	387	0.726
NULL	Hum_Genomics_2011_Oct_1_5(6)_577-622.nxml.txt.nlp	22155605	SENT625	23	23	12	12	gefitinib	EGFR	PA131301952	1956	0.726
NULL	Cell_Mol_Life_Sci_2012_Mar_2_69(6)_963-979.nxml.txt.nlp	21964925	SENT398	24	24	19	19	imiquimod	TRIF	PA449972	148022	0.726
NULL	J_Oncol_2012_Feb_6_2012_737981.nxml.txt.nlp	22481932	SENT101	18	18	5	5	paclitaxel	IL-6	PA450761	3569	0.726
NULL	Crit_Care_2014_Mar_17_18(Suppl_1)_P339.nxml.txt.nlp	NULL	SENT24	6	6	11	11	losartan	IL-4	PA450268	3565	0.726
NULL	Breast_Cancer_(Auckl)_2010_Feb_16_4_1-3.nxml.txt.nlp	20697527	SENT3	33	33	21	21	curcumin	BRCA1	PA151958596	672	0.726
NULL	Oncotarget_2013_Nov_17_4(12)_2383-2396.nxml.txt.nlp	24280371	SENT4	5	5	9	9	etoposide	EI24	PA449552	9538	0.726
NULL	Endocrine_2012_Dec_14_42(3)_622-636.nxml.txt.nlp	22695986	SENT313	8	8	6	6	forskolin	PTH	PA146096022	5741	0.726
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2675-2684.nxml.txt.nlp	24129246	SENT305	16	16	5	5	etoposide	p53	PA449552	7157	0.726
NULL	J_Mol_Signal_2009_Apr_28_4_2.nxml.txt.nlp	19400946	SENT72	14	14	28	28	ethanol	JNK	PA448073	5599	0.726
NULL	Cancer_Med_2014_Oct_2_3(5)_1256-1265.nxml.txt.nlp	24890382	SENT19	20	20	8	8	trastuzumab	San	PA451743	80218	0.726
NULL	J_Antimicrob_Chemother_2011_Jun_25_66(6)_1332-1339.nxml.txt.nlp	21441248	SENT141	17	17	7	7	nevirapine	CYP2B6	PA450616	1555	0.726
NULL	Int_J_Mol_Sci_2007_Mar_13_8(3)_229-240.nxml.txt.nlp	NULL	SENT133	0	0	6	6	acetazolamide	AQP1	PA448018	358	0.726
NULL	Front_Neurosci_2013_Jul_31_7_132.nxml.txt.nlp	23914152	SENT191	7	7	16	16	paroxetine	NAT	PA450801	6046	0.726
NULL	Angiogenesis_2010_Dec_7_13(4)_305-315.nxml.txt.nlp	20927579	SENT166	3	3	8	8	resveratrol	HIF-1		29072	0.726
NULL	Arthritis_Res_Ther_2010_Jul_6_12(4)_R129.nxml.txt.nlp	20604932	SENT213	31	31	26	26	collagenase	CXCL9	PA449107	4283	0.726
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT107	13	13	5	5	celecoxib	IL-6	PA448871	3569	0.726
NULL	Adv_Hematol_2012_Mar_8_2012_856341.nxml.txt.nlp	22496694	SENT206	18	18	30	30	enoxaparin	TKR	PA449463	8277	0.726
NULL	Arthritis_Res_Ther_2012_Apr_18_14(2)_R80.nxml.txt.nlp	22513098	SENT45	6	6	13	13	hydroxychloroquine	TLR9	PA164777036	54106	0.726
NULL	Brain_Res_2012_Feb_3_1436(C)_111-121.nxml.txt.nlp	22200378	SENT595	12	12	8	8	indomethacin	MRP1	PA449982	4437	0.726
NULL	Br_J_Cancer_1996_Dec_74(11)_1719-1729.nxml.txt.nlp	8956784	SENT10	19	19	8	8	doxorubicin	ACL	PA449412	47	0.726
NULL	Eur_J_Clin_Pharmacol_2009_Dec_8_65(12)_1245-1251.nxml.txt.nlp	19669131	SENT17	6	6	18	18	levodopa	DRD2	PA450213	1813	0.726
NULL	Pain_Ther_2014_Jun_13_3(1)_59-69.nxml.txt.nlp	25135388	SENT17	0	0	20	20	curcumin	HSD1	PA151958596	26871	0.726
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1495-1502.nxml.txt.nlp	21989186	SENT195	13	13	23	23	irinotecan	HSI	PA450085	57016	0.726
NULL	Diabetes_2011_Nov_17_60(11)_2691-2700.nxml.txt.nlp	21896928	SENT122	19	19	2	2	resveratrol	SIRT1		23411	0.726
NULL	Front_Neurol_2013_May_15_4_53.nxml.txt.nlp	23720649	SENT271	7	7	25	25	geldanamycin	Hsp40	PA152031327	3337	0.726
NULL	Hematol_Rep_2011_Oct_28_3(3_Suppl)_e3.nxml.txt.nlp	22586511	SENT24	4	4	13	13	cyclophosphamide	CHOP	PA449165	1649	0.726
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT94	24	24	29	29	l-leucine	p27	PA450197	5715;10534	0.726
NULL	Arthritis_Res_Ther_2013_Oct_22_15(5)_R157.nxml.txt.nlp	24432366	SENT64	2	2	8	8	methotrexate	LEP	PA450428	3952	0.726
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT280	20	20	18	18	dasatinib	PP2	PA162372878	4888	0.726
NULL	Clin_Pharmacokinet_2014_Sep_3_53(1)_1-16.nxml.txt.nlp	23999929	SENT287	40	40	28	28	rivaroxaban	CYP3A4	PA165958360	1576	0.726
NULL	Front_Physiol_2011_Jul_19_2_40.nxml.txt.nlp	21811470	SENT536	7	7	1	1	vasopressin	ANG	PA451858	283	0.726
NULL	Clin_Med_Insights_Cardiol_2012_Feb_1_6_17-33.nxml.txt.nlp	22442638	SENT66	14	14	12	12	rosuvastatin	CYP2C19	PA134308647	1557	0.726
NULL	Neural_Dev_2009_Nov_2_4_41.nxml.txt.nlp	19883499	SENT217	35	35	28	28	l-glutamine	B27	PA10090	56246	0.726
NULL	Leukemia_2013_Dec_27_27(12)_2322-2331.nxml.txt.nlp	24072044	SENT49	29	29	22	22	plerixafor	CXCL12	PA165958410	6387	0.726
NULL	J_Mol_Med_(Berl)_2014_May_10_92(7)_709-722.nxml.txt.nlp	24811491	SENT256	7	7	12	12	cetuximab	BRAF	PA10040	673	0.726
NULL	J_Cell_Biol_2001_Aug_6_154(3)_599-610.nxml.txt.nlp	11481345	SENT63	13	13	17	17	doxycycline	ARNO	PA449415	9266	0.726
NULL	Acta_Pharmacol_Sin_2010_May_12_31(5)_578-584.nxml.txt.nlp	20383171	SENT137	3	3	34	34	berberine	PERK	PA165860812	9451	0.726
NULL	Mol_Vis_2011_Apr_27_17_1044-1055.nxml.txt.nlp	21552499	SENT51	0	0	6	6	bevacizumab	San	PA130232992	80218	0.726
NULL	Cardiol_Ther_2013_Jun_7_2(1)_57-68.nxml.txt.nlp	25135289	SENT58	0	0	6	6	thrombin	PAR-1	PA451674	2011;2149	0.726
NULL	Anesth_Essays_Res_2012_Jul-Dec_6(2)_140-146.nxml.txt.nlp	NULL	SENT101	18	18	11	11	lidocaine	C3a	PA450226	718	0.726
NULL	Front_Endocrinol_(Lausanne)_2014_Oct_2_5_158.nxml.txt.nlp	25324831	SENT145	7	7	26	26	carrageenan	NPFF	PA448814	8620	0.726
NULL	Br_J_Cancer_2010_Mar_2_102(5)_815-826.nxml.txt.nlp	20145614	SENT14	13	13	29	29	trastuzumab	AKT	PA451743	207	0.726
NULL	Mol_Biol_Cell_2012_Sep_1_23(17)_3473-3484.nxml.txt.nlp	22787275	SENT226	11	11	17	17	doxorubicin	ABCC1	PA449412	4363	0.726
NULL	J_Korean_Med_Sci_2007_Dec_20_22(6)_1055-1059.nxml.txt.nlp	18162722	SENT109	23	23	12	12	famotidine	ESD	PA449586	2098	0.726
NULL	Front_Immunol_2012_Feb_27_3_23.nxml.txt.nlp	22566907	SENT405	2	2	9	9	hyaluronan	CD44	PA165958431	960	0.726
NULL	Oxid_Med_Cell_Longev_2013_Nov_10_2013_680414.nxml.txt.nlp	24319532	SENT8	13	13	7	7	minocycline	PARP-1	PA450519	25976	0.726
NULL	Nat_Genet_2014_Feb_12_46(2)_166-170.nxml.txt.nlp	24413734	SENT56	2	2	33	33	dasatinib	FYN	PA162372878	2534	0.726
NULL	Anesth_Pain_Med_2014_Sep_9_4(4)_e14221.nxml.txt.nlp	25599022	SENT127	6	6	25	25	cisplatin	LPO	PA449014	4025	0.726
NULL	Front_Oncol_2013_Nov_18_3_282.nxml.txt.nlp	24303367	SENT245	5	5	26	26	glucose	RET	PA449773	5979	0.726
NULL	Oncotarget_2012_May_18_3(5)_525-534.nxml.txt.nlp	22619113	SENT78	4	4	12	12	fludarabine	AKT	PA449655	207	0.726
NULL	Harm_Reduct_J_2012_Jan_20_9_6.nxml.txt.nlp	22264343	SENT141	11	11	4	4	methadone	OST	PA450401	1650;23263	0.726
NULL	AIDS_Res_Ther_2014_Aug_4_11_25.nxml.txt.nlp	25120580	SENT10	12	12	0	0	voriconazole	CYP3A4	PA10233	1576	0.726
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT67	6	6	8	8	resveratrol	TRAIL		8743	0.726
NULL	Front_Neurosci_2011_May_2_5_64.nxml.txt.nlp	21562606	SENT155	8	8	15	15	tamoxifen	STOP	PA451581	4135	0.726
NULL	Neural_Regen_Res_2014_Nov_1_9(21)_1897-1901.nxml.txt.nlp	25558239	SENT95	4	4	24	24	diazepam	CA1	PA449283	759	0.726
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT170	16	16	42	42	l-leucine	SIRT3	PA450197	23410	0.726
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_127043.nxml.txt.nlp	23227093	SENT231	24	24	17	17	ketoconazole	CYP2C9	PA450146	1559	0.726
NULL	Mol_Cancer_2010_Nov_2_9_289.nxml.txt.nlp	21044322	SENT131	0	0	6	6	cisplatin	RGS10	PA449014	6001	0.726
NULL	J_Hematol_Oncol_2014_Apr_4_7_30.nxml.txt.nlp	24708874	SENT15	13	13	22	22	cyclophosphamide	CHOP	PA449165	1649	0.726
NULL	Nucl_Recept_Signal_2009_Jan_16_7_e001.nxml.txt.nlp	19240808	SENT412	25	25	10	10	paclitaxel	MDR1	PA450761	5243	0.726
NULL	Braz_J_Med_Biol_Res_2014_Oct_14_47(12)_1068-1074.nxml.txt.nlp	25387674	SENT83	17	17	32	32	taurine	HCS	PA451590	3141;54205	0.726
NULL	Mol_Vis_2011_Oct_31_17_2824-2834.nxml.txt.nlp	22128230	SENT33	6	6	21	21	sulpiride	APO	PA164745485	84909	0.726
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT207	17	17	34	34	erlotinib	PTEN	PA134687924	5728	0.726
NULL	J_Breast_Cancer_2013_Mar_31_16(1)_23-31.nxml.txt.nlp	23593078	SENT115	8	8	19	19	resveratrol	DNMT1		1786	0.726
NULL	Crit_Care_2011_Oct_26_15(5)_R257.nxml.txt.nlp	22030215	SENT223	2	2	22	22	dexmedetomidine	SAPS	PA449256	8935	0.726
NULL	EJC_Suppl_2013_Sep_5_11(2)_45-59.nxml.txt.nlp	NULL	SENT242	29	29	34	34	capecitabine	CRT	PA448771	811	0.726
NULL	Br_J_Cancer_2011_Aug_23_105(5)_649-657.nxml.txt.nlp	21811251	SENT135	6	6	12	12	gefitinib	IGF1R	PA131301952	3480	0.726
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Jun_21_64(Pt_7)_o1311.nxml.txt.nlp	21202939	SENT66	12	12	7	7	ethanol	mol	PA448073	90527	0.726
NULL	Diabetes_2008_Sep_57(9)_2272-2279.nxml.txt.nlp	18519799	SENT260	0	0	2	2	rosiglitazone	PDK4	PA451283	5166	0.726
NULL	J_Gynecol_Oncol_2013_Jan_8_24(1)_66-82.nxml.txt.nlp	23346316	SENT249	0	0	9	9	pertuzumab	HER2		2064	0.726
NULL	Evid_Based_Complement_Alternat_Med_2012_Feb_12_2012_743075.nxml.txt.nlp	22454682	SENT154	7	7	12	12	forskolin	TARC	PA146096022	6361	0.726
NULL	Adv_Ther_2014_Feb_18_31(3)_247-263.nxml.txt.nlp	24535624	SENT99	20	20	10	10	exenatide	PPG	PA164749238	5552	0.726
NULL	Biomed_Res_Int_2014_Apr_29_2014_186864.nxml.txt.nlp	24877064	SENT187	0	0	23	23	curcumin	AP-1	PA151958596	2353;3727;2354;3725	0.726
NULL	Springerplus_2015_Jan_14_4_19.nxml.txt.nlp	25625039	SENT232	30	30	11	11	pha-665752	JIP-1		9479	0.726
NULL	Cell_Death_Dis_2010_Nov_18_1(11)_e102.nxml.txt.nlp	21368867	SENT283	11	11	8	8	gentamicin	CLIMP-63	PA449753	10970	0.726
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1224-1233.nxml.txt.nlp	22353810	SENT198	9	9	31	31	etoposide	MRP-1	PA449552	928	0.726
NULL	Diabetol_Metab_Syndr_2014_Sep_23_6(1)_102.nxml.txt.nlp	NULL	SENT171	37	37	43	43	atorvastatin	RAGE	PA448500	177	0.726
NULL	Open_AIDS_J_2014_Dec_29_8_66-78.nxml.txt.nlp	25624956	SENT417	6	6	15	15	chloroquine	CD4	PA448948	920	0.726
NULL	Stroke_Res_Treat_2010_Mar_14_2010_864724.nxml.txt.nlp	20798894	SENT50	9	9	17	17	heparin	ACT	PA449855	12;11332;9457;641455	0.726
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT301	4	4	20	20	gefitinib	PIK3CA	PA131301952	5290	0.726
NULL	Mol_Cancer_2010_Mar_9_9_54.nxml.txt.nlp	20214788	SENT171	33	33	8	8	doxycycline	JDP2	PA449415	122953	0.726
NULL	Biomed_Res_Int_2013_Jul_1_2013_964743.nxml.txt.nlp	23936861	SENT116	10	10	35	35	topotecan	ABCG2	PA451729	9429	0.726
NULL	Arthritis_Res_Ther_2009_Jun_29_11(3)_R100.nxml.txt.nlp	19563672	SENT18	20	20	33	33	infliximab	IFN	PA452639	3439	0.726
NULL	Clin_Epidemiol_2010_Aug_9_2_29-36.nxml.txt.nlp	20865100	SENT35	6	6	40	40	citalopram	B10	PA449015	5169	0.726
NULL	Neural_Regen_Res_2013_May_25_8(15)_1368-1375.nxml.txt.nlp	25206431	SENT98	4	4	11	11	nimodipine	Bcl-2	PA450633	596	0.726
NULL	Cancer_Metastasis_Rev_2010_Dec_13_29(4)_723-735.nxml.txt.nlp	20941528	SENT417	11	11	4	4	paclitaxel	CYP2C8	PA450761	1558	0.726
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1067-1070.nxml.txt.nlp	21386841	SENT81	22	22	20	20	capecitabine	STZ	PA448771	6484	0.726
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1137-1144.nxml.txt.nlp	20234366	SENT151	30	30	3	3	cetuximab	MKP-1	PA10040	1843	0.726
NULL	Reprod_Biol_Endocrinol_2003_Oct_7_1_66.nxml.txt.nlp	14609433	SENT293	11	11	13	13	cisplatin	p53	PA449014	7157	0.726
NULL	Iran_J_Reprod_Med_2014_Jun_12(6)_395-400.nxml.txt.nlp	25071847	SENT40	17	17	11	11	estradiol	ESR1	PA449503	2099	0.726
NULL	Nat_Chem_Biol_2013_Feb_9_9(2)_112-118.nxml.txt.nlp	23222885	SENT162	0	0	18	18	geldanamycin	Hsp25	PA152031327	3315	0.726
NULL	Arthritis_Res_Ther_2009_Apr_30_11(2)_R58.nxml.txt.nlp	19405951	SENT23	19	19	10	10	alendronate	RANKL	PA448082	8600	0.726
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Jul_9_3(7)_e124.nxml.txt.nlp	25006781	SENT76	18	18	8	8	rosuvastatin	OATP1B1	PA134308647	10599	0.726
NULL	Exp_Ther_Med_2013_Feb_13_5(2)_581-585.nxml.txt.nlp	23403473	SENT93	5	5	19	19	etanercept	HMGB1	PA449515	3146	0.726
NULL	Br_J_Cancer_1998_Jun_77(12)_2286-2290.nxml.txt.nlp	9649147	SENT13	3	3	0	0	cyclophosphamide	CHOP	PA449165	1649	0.726
NULL	eLife_2013_Nov_5_2_e00969.nxml.txt.nlp	24192036	SENT234	4	4	9	9	vemurafenib	JNK	PA165946873	5599	0.726
NULL	Mol_Cancer_2014_Jun_26_13_158.nxml.txt.nlp	24965046	SENT117	0	0	13	13	sorafenib	NK1	PA7000	11126	0.726
NULL	Biomed_Res_Int_2013_Sep_8_2013_808713.nxml.txt.nlp	24083242	SENT164	22	22	9	9	isoflurane	FDG	PA450106	23583	0.726
NULL	J_Gastrointest_Surg_2012_Apr_13_16(4)_842-848.nxml.txt.nlp	22246855	SENT94	27	27	16	16	bevacizumab	HER2	PA130232992	2064	0.726
NULL	Mol_Vis_2012_Jul_18_18_1966-1972.nxml.txt.nlp	22876123	SENT107	9	9	22	22	ng-monomethyl-l-arginine	IL-4		3565	0.726
NULL	Front_Immunol_2012_Jan_24_3_3.nxml.txt.nlp	22566889	SENT122	15	15	8	8	rituximab	CD59	PA451261	966	0.726
NULL	Evid_Based_Complement_Alternat_Med_2014_Jul_7_2014_902516.nxml.txt.nlp	25097660	SENT166	2	2	20	20	fluoxetine	UCN2	PA449673	90226;10911	0.726
NULL	Niger_Med_J_2013_Mar-Apr_54(2)_100-106.nxml.txt.nlp	23798795	SENT142	21	21	7	7	indomethacin	PTEN	PA449982	5728	0.726
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_29_2013_590393.nxml.txt.nlp	23737838	SENT198	3	3	19	19	resveratrol	p53		7157	0.726
NULL	Appl_Clin_Genet_2012_Aug_29_5_81-91.nxml.txt.nlp	23776383	SENT52	20	20	24	24	resveratrol	SIRT1		23411	0.726
NULL	Biologics_2014_Dec_4_8_281-291.nxml.txt.nlp	25506209	SENT58	34	34	27	27	sorafenib	BRAF	PA7000	673	0.726
NULL	Blood_Res_2014_Mar_24_49(1)_36-41.nxml.txt.nlp	24724065	SENT107	35	35	46	46	cyclophosphamide	CHOP	PA449165	1649	0.726
NULL	Acta_Pharmacol_Sin_2011_Dec_7_32(12)_1433-1445.nxml.txt.nlp	22056617	SENT237	0	0	13	13	lamotrigine	CA1	PA450164	759	0.726
NULL	Acta_Pharmacol_Sin_2012_Nov_23_33(11)_1409-1416.nxml.txt.nlp	22820910	SENT148	38	38	34	34	clozapine	CYP1A2	PA449061	1544	0.726
NULL	Nat_Chem_Biol_2008_Nov_12_4(11)_691-699.nxml.txt.nlp	18849971	SENT135	12	12	27	27	sorafenib	VEGFR2	PA7000	3791	0.726
NULL	Exp_Diabetes_Res_2012_Mar_4_2012_653678.nxml.txt.nlp	22474428	SENT3	27	27	32	32	pioglitazone	gamma	PA450970	9913	0.726
NULL	Braz_J_Med_Biol_Res_2014_Mar_3_47(3)_192-205.nxml.txt.nlp	24676492	SENT190	24	24	31	31	lipase	adiponutrin	PA450239	80339	0.726
NULL	Mol_Vis_2012_May_10_18_1215-1225.nxml.txt.nlp	22665968	SENT62	8	8	32	32	fluorescein	CD4	PA164746009	920	0.726
NULL	Trials_2012_Aug_25_13_148.nxml.txt.nlp	22920307	SENT35	12	12	16	16	clopidogrel	P2Y12	PA449053	64805	0.726
NULL	Oncoscience_2013_Dec_11_1(1)_21-29.nxml.txt.nlp	25593981	SENT120	13	13	26	26	disulfiram	HSP27	PA449376	3315	0.726
NULL	Cancer_Manag_Res_2013_Nov_21_5_387-400.nxml.txt.nlp	24294007	SENT124	18	18	4	4	cetuximab	HER2	PA10040	2064	0.726
NULL	Open_Biochem_J_2014_Nov_1_8_74-82.nxml.txt.nlp	25400709	SENT168	18	18	24	24	resveratrol	PTEN		5728	0.726
NULL	Cardiol_Res_Pract_2011_Feb_20_2011_747861.nxml.txt.nlp	21403897	SENT209	22	22	11	11	acarbose	STOP	PA448010	4135	0.726
NULL	Br_J_Cancer_2013_Feb_19_108(3)_557-563.nxml.txt.nlp	23361053	SENT14	20	20	7	7	tamoxifen	PAK1	PA451581	5585;5058	0.726
NULL	Anal_Chem_Insights_2008_Aug_27_3_103-109.nxml.txt.nlp	19609394	SENT120	3	3	5	5	griseofulvin	C17	PA449814	54360	0.726
NULL	Oncol_Lett_2013_Oct_26_6(4)_1063-1067.nxml.txt.nlp	24137465	SENT95	13	13	19	19	erlotinib	HER2	PA134687924	2064	0.726
NULL	Indian_J_Psychol_Med_2013_Jul-Sep_35(3)_311-313.nxml.txt.nlp	24249938	SENT76	36	36	25	25	warfarin	CYP2C9	PA451906	1559	0.726
NULL	Mar_Drugs_2008_May_28_6(2)_180-219.nxml.txt.nlp	18728725	SENT334	20	20	14	14	terfenadine	NT3	PA451619	4877;6272	0.726
NULL	Exp_Diabetes_Res_2012_Oct_15_2012_465282.nxml.txt.nlp	23118742	SENT121	5	5	7	7	metformin	FGF21	PA450395	26291	0.726
NULL	Cancers_(Basel)_2011_Apr_13_3(2)_1957-1974.nxml.txt.nlp	24212791	SENT148	7	7	25	25	cetuximab	EGFR	PA10040	1956	0.726
NULL	J_Korean_Med_Sci_2014_Jul_11_29(7)_965-972.nxml.txt.nlp	25045229	SENT11	18	18	1	1	metformin	B12	PA450395	7126;4709	0.726
NULL	J_Hematol_Oncol_2009_Apr_22_2_18.nxml.txt.nlp	19386128	SENT173	11	11	16	16	panitumumab	KRAS	PA162373091	3845	0.726
NULL	Infect_Ecol_Epidemiol_2011_Aug_31_1_10_3402_iee_v1i0_7030.nxml.txt.nlp	22957123	SENT33	17	17	22	22	cefpodoxime	MAST	PA164746385	51324	0.726
NULL	Int_J_Mol_Sci_2014_Jun_3_15(6)_9924-9944.nxml.txt.nlp	24897026	SENT192	10	10	2	2	lipase	SREBP-1c	PA450239	6720	0.726
NULL	Arthritis_Res_Ther_2009_Aug_19_11(4)_240.nxml.txt.nlp	19725932	SENT86	0	0	13	13	allopurinol	IL-6	PA448320	3569	0.726
NULL	Oxid_Med_Cell_Longev_2013_Apr_21_2013_412576.nxml.txt.nlp	23710286	SENT30	5	5	8	8	curcumin	NRF2	PA151958596	2551;4780	0.726
NULL	Mol_Imaging_Biol_2013_Apr_11_15(2)_136-147.nxml.txt.nlp	22886728	SENT272	6	6	12	12	orlistat	AMPK	PA164776864	5563	0.726
NULL	Mol_Cancer_2007_Sep_26_6_61.nxml.txt.nlp	17894897	SENT151	13	13	17	17	etoposide	p53	PA449552	7157	0.726
NULL	Breast_Cancer_Res_2003_Oct_31_5(Suppl_1)_62.nxml.txt.nlp	NULL	SENT10	9	9	21	21	anastrozole	ATAC	PA448432	6375	0.726
NULL	Front_Neurosci_2014_Jun_24_8_176.nxml.txt.nlp	25009459	SENT287	24	24	12	12	ivermectin	gamma	PA450133	9913	0.726
NULL	Iran_Red_Crescent_Med_J_2014_Mar_5_16(3)_e15344.nxml.txt.nlp	24829782	SENT10	17	17	22	22	phenytoin	slim	PA450947	23008	0.726
NULL	Front_Neurosci_2012_May_30_6_77.nxml.txt.nlp	22661925	SENT156	11	11	19	19	ethanol	DCX	PA448073	1641	0.726
NULL	Drug_Des_Devel_Ther_2014_Oct_31_8_2121-2128.nxml.txt.nlp	25382970	SENT79	16	16	12	12	curcumin	TTR	PA151958596	7276	0.726
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT231	19	19	17	17	pp2	PP1		5540;5464	0.726
NULL	Oxid_Med_Cell_Longev_2013_Jun_2_2013_793525.nxml.txt.nlp	23819014	SENT204	8	8	13	13	resveratrol	AMPK		5563	0.726
NULL	ScientificWorldJournal_2013_Feb_3_2013_593267.nxml.txt.nlp	23431256	SENT149	2	2	20	20	chloramphenicol	p43	PA448927	9255	0.726
NULL	Exp_Ther_Med_2013_May_15_5(5)_1327-1331.nxml.txt.nlp	23737873	SENT14	4	4	10	10	imidapril	AQP2	PA452640	359	0.726
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT90	17	17	11	11	metformin	AKT	PA450395	207	0.726
NULL	Iran_Red_Crescent_Med_J_2014_Feb_8_16(2)_e15809.nxml.txt.nlp	24719749	SENT133	17	17	11	11	propofol	IL-10	PA451141	3586	0.726
NULL	Child_Adolesc_Psychiatry_Ment_Health_2012_May_29_6_21.nxml.txt.nlp	22643087	SENT306	17	17	22	22	fluvoxamine	Gen	PA449690	348654	0.726
NULL	Oxid_Med_Cell_Longev_2010_Jan-Feb_3(1)_23-34.nxml.txt.nlp	20716925	SENT87	8	8	1	1	cisplatin	EGFR	PA449014	1956	0.726
NULL	Oncotarget_2012_Dec_18_3(12)_1615-1628.nxml.txt.nlp	23271044	SENT218	2	2	11	11	clofarabine	Mcl-1	PA164754863	4170	0.726
NULL	Braz_J_Med_Biol_Res_2013_Aug_16_46(8)_700-707.nxml.txt.nlp	23969977	SENT25	4	4	18	18	estradiol	CYP11A1	PA449503	1583	0.726
NULL	Acta_Neuropathol_Commun_2014_Feb_7_2_16.nxml.txt.nlp	24507707	SENT53	20	20	10	10	paraformaldehyde	E14	PA450790	4863	0.726
NULL	Br_J_Cancer_2002_Jan_21_86(2)_179-184.nxml.txt.nlp	11870502	SENT23	26	26	37	37	tamoxifen	IL-2	PA451581	3558	0.726
NULL	J_Vet_Med_Sci_2014_Aug_15_76(8)_1119-1127.nxml.txt.nlp	24829081	SENT12	5	5	23	23	trypsin	IL-8	PA451806	3576	0.726
NULL	J_Cardiothorac_Surg_2012_Sep_27_7_97.nxml.txt.nlp	23013706	SENT163	7	7	21	21	warfarin	CYP4F2	PA451906	8529	0.726
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1059-1066.nxml.txt.nlp	21364577	SENT3	13	13	25	25	anastrozole	aromatase	PA448432	1588	0.726
NULL	Mol_Cancer_2010_Dec_20_9_317.nxml.txt.nlp	21172025	SENT283	26	26	2	2	tamoxifen	HER2	PA451581	2064	0.726
NULL	Alcohol_Res_Health_2008_31(4)_310-339.nxml.txt.nlp	20729980	SENT496	25	25	18	18	ethanol	CRF1	PA448073	1394	0.726
NULL	Arch_Plast_Surg_2012_Sep_12_39(5)_540-545.nxml.txt.nlp	23094252	SENT38	17	17	15	15	propofol	TCI	PA451141	6947	0.726
NULL	Int_J_Alzheimers_Dis_2011_Oct_19_2011_864753.nxml.txt.nlp	22028985	SENT188	8	8	11	11	picrotoxin	CA3	PA164777007	761	0.726
NULL	J_Asthma_Allergy_2013_Feb_22_6_31-39.nxml.txt.nlp	23459334	SENT117	12	12	29	29	rupatadine	ANOVA		4858	0.726
NULL	Hum_Genomics_Proteomics_2010_Sep_13_2010_754919.nxml.txt.nlp	20981234	SENT92	9	9	2	2	phenprocoumon	CYP2C9	PA450921	1559	0.726
NULL	Br_J_Cancer_2010_Oct_26_103(9)_1422-1431.nxml.txt.nlp	20859288	SENT150	18	18	23	23	aprotinin	kallistatin	PA448472	5267	0.726
NULL	Case_Rep_Endocrinol_2013_Feb_20_2013_719304.nxml.txt.nlp	23509641	SENT13	18	18	16	16	thyroglobulin	TTF1	PA164754910	7080;7270	0.726
NULL	Exp_Ther_Med_2012_Nov_6_4(5)_949-953.nxml.txt.nlp	23226754	SENT61	29	29	31	31	ethambutol	EMB	PA164784021	133418	0.726
NULL	Cardiovasc_Toxicol_2014_Oct_9_14(1)_64-73.nxml.txt.nlp	24104944	SENT48	23	23	37	37	doxycycline	CO2	PA449415	4513	0.726
NULL	Diabetes_Care_2011_Feb_20_34(2)_375-380.nxml.txt.nlp	20980414	SENT145	16	16	9	9	metformin	AMPK	PA450395	5563	0.726
NULL	Cancers_(Basel)_2011_Aug_12_3(3)_3279-3330.nxml.txt.nlp	24212956	SENT1198	8	8	19	19	tocilizumab	IL-6	PA165292659	3569	0.726
NULL	Evid_Based_Complement_Alternat_Med_2011_Mar_13_2011_913898.nxml.txt.nlp	21785639	SENT184	6	6	14	14	curcumin	CYP3A4	PA151958596	1576	0.726
NULL	Br_J_Cancer_2012_May_22_106(11)_1742-1752.nxml.txt.nlp	22538973	SENT61	13	13	21	21	imatinib	IFN	PA10804	3439	0.726
NULL	Acta_Pharmacol_Sin_2012_Oct_3_33(10)_1311-1318.nxml.txt.nlp	22941289	SENT167	2	2	10	10	sorafenib	VEGFR2	PA7000	3791	0.726
NULL	Contemp_Oncol_(Pozn)_2012_Feb_29_16(1)_86-89.nxml.txt.nlp	23788860	SENT81	13	13	18	18	bevacizumab	DDP	PA130232992	1678	0.726
NULL	Infect_Drug_Resist_2013_Dec_18_7_1-7.nxml.txt.nlp	24379684	SENT19	15	15	4	4	linezolid	HAP	PA450233	5915;10313	0.726
NULL	Indian_J_Pharm_Sci_2013_Nov-Dec_75(6)_680-687.nxml.txt.nlp	24591743	SENT35	32	32	17	17	gemfibrozil	CYP2C9	PA449750	1559	0.726
NULL	Case_Rep_Oncol_Med_2013_Nov_30_2013_175263.nxml.txt.nlp	24363944	SENT9	26	26	21	21	leucovorin	CRT	PA450198	811	0.726
NULL	Diabetes_Care_2012_Feb_16_35(2)_446-454.nxml.txt.nlp	22275444	SENT168	7	7	24	24	miglitol	B12	PA164776726	7126;4709	0.726
NULL	Pain_2013_Sep_154(9)_1680-1690.nxml.txt.nlp	23707289	SENT12	0	0	15	15	yohimbine	c-fos	PA451946	2353	0.726
NULL	J_Geriatr_Cardiol_2012_Jun_9(2)_209-210.nxml.txt.nlp	23097648	SENT21	4	4	18	18	warfarin	CYP4F2	PA451906	8529	0.726
NULL	Reprod_Biol_Endocrinol_2013_Feb_26_11_15.nxml.txt.nlp	23442442	SENT194	5	5	14	14	l-arginine	BAX	PA448478	581	0.726
NULL	Nat_Med_2014_Jun_17_20(6)_633-641.nxml.txt.nlp	24743305	SENT137	4	4	13	13	heparin	CD19	PA449855	930	0.726
NULL	Cell_Death_Dis_2010_Nov_4_1(11)_e92.nxml.txt.nlp	21368868	SENT7	37	37	15	15	nadh	HP1	PA164755085	23468	0.725
NULL	Exp_Ther_Med_2013_Dec_26_6(6)_1359-1364.nxml.txt.nlp	24255662	SENT162	17	17	11	11	clonidine	IL-6	PA449051	3569	0.725
NULL	Environ_Health_Perspect_2005_Aug_20_113(8)_1022-1026.nxml.txt.nlp	16079073	SENT189	5	5	7	7	diethylstilbestrol	DES	PA449307	1674	0.725
NULL	Oncotarget_2012_May_19_3(5)_535-545.nxml.txt.nlp	22619121	SENT9	19	19	13	13	topotecan	MYCN	PA451729	4613	0.725
NULL	Exp_Diabetes_Res_2012_May_28_2012_924168.nxml.txt.nlp	22693487	SENT37	11	11	6	6	liraglutide	GLP-1	PA165958364	100125288	0.725
NULL	Front_Oncol_2014_Jun_18_4_153.nxml.txt.nlp	24995158	SENT492	20	20	28	28	vinorelbine	AP-1	PA451881	2353;3727;2354;3725	0.725
NULL	Infect_Dis_Obstet_Gynecol_2014_Sep_25_2014_961375.nxml.txt.nlp	25328370	SENT197	17	17	0	0	atazanavir	ATV	PA10251	4683	0.725
NULL	Indian_J_Dermatol_2011_Jan-Feb_56(1)_48-51.nxml.txt.nlp	21572792	SENT24	39	39	24	24	hydroquinone	IPL	PA449924	7262	0.725
NULL	Br_J_Cancer_2012_Sep_4_107(6)_947-955.nxml.txt.nlp	22892392	SENT156	13	13	7	7	tamoxifen	BCAR4	PA451581	400500	0.725
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Dec_16_66(Pt_1)_o174.nxml.txt.nlp	21580060	SENT65	39	39	42	42	benzaldehyde	mol	PA448571	90527	0.725
NULL	Theranostics_2014_Aug_15_4(11)_1072-1084.nxml.txt.nlp	25250092	SENT129	34	34	5	5	sulfur	SLN	PA451558	6588	0.725
NULL	Cell_Commun_Signal_2009_Feb_26_7(Suppl_1)_A99.nxml.txt.nlp	NULL	SENT8	8	8	11	11	thrombin	PAR2	PA451674	2150;55065;8856	0.725
NULL	Diabetes_2009_Dec_58(12)_2718-2725.nxml.txt.nlp	19940235	SENT78	23	23	18	18	betaine	B12	PA448603	7126;4709	0.725
NULL	Mol_Biol_Cell_2012_Nov_1_23(21)_4212-4225.nxml.txt.nlp	22956765	SENT45	12	12	21	21	thrombin	TER	PA451674	9524	0.725
NULL	Front_Genet_2015_Jan_14_5_469.nxml.txt.nlp	25642242	SENT164	19	19	12	12	paromomycin	SDHA	PA164784023	6389	0.725
NULL	Mol_Vis_2012_Nov_29_18_2839-2846.nxml.txt.nlp	23233786	SENT123	1	1	23	23	geldanamycin	Hsp90	PA152031327	3320	0.725
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Apr_17_6_43-57.nxml.txt.nlp	24833916	SENT325	5	5	33	33	everolimus	aromatase	PA164746311	1588	0.725
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Mar_13_66(Pt_4)_o830.nxml.txt.nlp	21580658	SENT59	10	10	13	13	benzaldehyde	mol	PA448571	90527	0.725
NULL	Reprod_Biol_Endocrinol_2013_Feb_26_11_15.nxml.txt.nlp	23442442	SENT198	17	17	10	10	l-arginine	BCL2	PA448478	596	0.725
NULL	Front_Hum_Neurosci_2009_Oct_20_3_33.nxml.txt.nlp	19876408	SENT840	13	13	10	10	carbachol	CA3	PA448784	761	0.725
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT94	31	31	8	8	pertuzumab	HER2		2064	0.725
NULL	Mol_Cancer_2008_Jun_3_7_47.nxml.txt.nlp	18519000	SENT63	12	12	7	7	gefitinib	EGF	PA131301952	1950	0.725
NULL	Cancer_Manag_Res_2013_Jun_11_5_103-115.nxml.txt.nlp	23807861	SENT56	23	23	36	36	bevacizumab	VEGF-A	PA130232992	7422	0.725
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_May_14_64(Pt_6)_o1081.nxml.txt.nlp	21202597	SENT57	5	5	11	11	benzaldehyde	mol	PA448571	90527	0.725
NULL	Nat_Commun_2013_Aug_15_4_2130.nxml.txt.nlp	23945651	SENT87	6	6	4	4	etoposide	ATG5	PA449552	9474	0.725
NULL	Cancers_(Basel)_2010_Dec_23_3(1)_17-42.nxml.txt.nlp	24212604	SENT914	17	17	2	2	paclitaxel	HER-2	PA450761	2064	0.725
NULL	Breast_Cancer_Res_2009_Oct_12_11(5)_R74.nxml.txt.nlp	19821999	SENT251	16	16	4	4	bortezomib	p27	PA10252	5715;10534	0.725
NULL	Onco_Targets_Ther_2014_Dec_3_7_2227-2236.nxml.txt.nlp	25506226	SENT105	25	25	43	43	paclitaxel	ADC	PA450761	113451	0.725
NULL	Bioinformation_2012_Jan_6_8(1)_13-19.nxml.txt.nlp	22359429	SENT118	14	14	12	12	curcumin	MRP1	PA151958596	4437	0.725
NULL	Cancers_(Basel)_2014_Sep_30_6(4)_2035-2048.nxml.txt.nlp	25271833	SENT221	0	0	9	9	gefitinib	EGFR	PA131301952	1956	0.725
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Dec_18_67(Pt_1)_o193.nxml.txt.nlp	21522695	SENT62	4	4	7	7	nitrile	mol	PA450636	90527	0.725
NULL	Ann_Surg_Treat_Res_2014_Feb_22_86(2)_68-75.nxml.txt.nlp	24761411	SENT15	1	1	19	19	oxaliplatin	survivin	PA131285527	332	0.725
NULL	Cancer_Manag_Res_2012_Jul_31_4_207-214.nxml.txt.nlp	22904642	SENT90	17	17	19	19	octreotide	SSTR1	PA450678	6751	0.725
NULL	J_Mol_Med_(Berl)_2014_May_10_92(7)_709-722.nxml.txt.nlp	24811491	SENT136	33	33	28	28	cetuximab	KRAS	PA10040	3845	0.725
NULL	Chemother_Res_Pract_2011_Jun_21_2011_696208.nxml.txt.nlp	22312556	SENT80	15	15	8	8	fluorouracil	MA5	PA128406956	29944	0.725
NULL	Adipocyte_2013_Jan_1_2(1)_17-27.nxml.txt.nlp	23599907	SENT176	6	6	20	20	glucose	AMPK	PA449773	5563	0.725
NULL	Diabetes_Metab_Syndr_Obes_2014_Mar_18_7_107-120.nxml.txt.nlp	24672252	SENT39	22	22	12	12	exenatide	GLP-1	PA164749238	100125288	0.725
NULL	Breast_Cancer_Res_2011_Jan_7_13(1)_R1.nxml.txt.nlp	21214929	SENT268	17	17	24	24	cisplatin	p53	PA449014	7157	0.725
NULL	Nat_Commun_2014_Nov_25_5_5548.nxml.txt.nlp	25420520	SENT67	14	14	37	37	cabazitaxel	P-gp	PA165958401	5243	0.725
NULL	J_Inflamm_(Lond)_2005_Oct_31_2_14.nxml.txt.nlp	16259633	SENT330	6	6	11	11	staurosporine	M-CSF	PA165109623	1435	0.725
NULL	Crit_Care_2010_Jun_18_14(3)_R119.nxml.txt.nlp	20565863	SENT130	3	3	16	16	hydrocortisone	IL-6	PA449905	3569	0.725
NULL	Curr_Pharm_Des_2008_Oct_14(28)_2983-2998.nxml.txt.nlp	18991714	SENT79	11	11	8	8	lapatinib	EGFR	PA152241907	1956	0.725
NULL	J_Cell_Mol_Med_2013_Oct_2_17(10)_1218-1235.nxml.txt.nlp	23998913	SENT312	0	0	21	21	imatinib	KIT	PA10804	3815	0.725
NULL	J_Biol_Chem_2012_Apr_13_287(16)_13382-13395.nxml.txt.nlp	22367194	SENT91	19	19	12	12	marimastat	TIMP1	PA164748329	7076	0.725
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Oct_31_68(Pt_11)_m1423.nxml.txt.nlp	23284385	SENT60	24	24	18	18	ethanol	NO3	PA448073	4681	0.725
NULL	Ther_Clin_Risk_Manag_2007_Jun_3(2)_245-258.nxml.txt.nlp	18360633	SENT58	10	10	12	12	etanercept	p55	PA449515	6624;2078;8503;5718	0.725
NULL	Int_J_Environ_Res_Public_Health_2006_Mar_31_3(1)_31-37.nxml.txt.nlp	16823074	SENT214	14	14	22	22	calcein	NIR	PA132595336	26155	0.725
NULL	Clin_Ophthalmol_2014_Apr_28_8_807-812.nxml.txt.nlp	24812486	SENT6	40	40	32	32	bevacizumab	CRT	PA130232992	811	0.725
NULL	Oncotarget_2014_Jun_30_5(14)_5637-5650.nxml.txt.nlp	25026298	SENT3	42	42	34	34	cisplatin	BRCA1	PA449014	672	0.725
NULL	Int_J_Endocrinol_2010_Feb_10_2010_625852.nxml.txt.nlp	20169119	SENT119	0	0	13	13	enalapril	PTH	PA449456	5741	0.725
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT226	20	20	31	31	ranibizumab	VEGFR1	PA164746012	2321	0.725
NULL	Oncotarget_2014_Oct_21_5(22)_11709-11722.nxml.txt.nlp	25365944	SENT224	4	4	10	10	metformin	AKT	PA450395	207	0.725
NULL	Sci_Rep_2015_Jan_6_5_7641.nxml.txt.nlp	25560734	SENT127	9	9	27	27	tamoxifen	CLTC	PA451581	1213	0.725
NULL	Lab_Invest_2013_Feb_19_93(2)_181-193.nxml.txt.nlp	23212100	SENT215	9	9	11	11	cyclophosphamide	CTX	PA449165	1593	0.725
NULL	Oncotarget_2012_Dec_31_3(12)_1700-1710.nxml.txt.nlp	23482333	SENT12	29	29	37	37	cyclophosphamide	CHOP	PA449165	1649	0.725
NULL	Ann_Rheum_Dis_2013_Dec_5_72(12)_1897-1904.nxml.txt.nlp	23918035	SENT247	12	12	40	40	tocilizumab	IL-6	PA165292659	3569	0.725
NULL	J_Inflamm_(Lond)_2004_Sep_27_1_1.nxml.txt.nlp	15813979	SENT46	33	33	20	20	celecoxib	COX1	PA448871	4512;5742	0.725
NULL	Indian_J_Pharmacol_2012_Nov-Dec_44(6)_744-748.nxml.txt.nlp	23248405	SENT116	3	3	17	17	clopidogrel	DAI	PA449053	81030	0.725
NULL	Front_Endocrinol_(Lausanne)_2013_Jun_12_4_71.nxml.txt.nlp	23781214	SENT286	3	3	20	20	amlexanox	TBK1	PA164745310	29110	0.725
NULL	Mol_Vis_2012_Nov_29_18_2839-2846.nxml.txt.nlp	23233786	SENT167	6	6	13	13	geldanamycin	Hsp90	PA152031327	3320	0.725
NULL	J_Korean_Med_Sci_2014_Jul_11_29(7)_965-972.nxml.txt.nlp	25045229	SENT91	12	12	2	2	metformin	B12	PA450395	7126;4709	0.725
NULL	Drug_Des_Devel_Ther_2014_Sep_23_8_1527-1538.nxml.txt.nlp	25284985	SENT129	30	30	27	27	celecoxib	IFN	PA448871	3439	0.725
NULL	Front_Neurosci_2014_Feb_7_8_14.nxml.txt.nlp	24570653	SENT225	8	8	13	13	clonidine	SNA	PA449051	6615	0.725
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT153	20	20	24	24	perifosine	DR4	PA165291471	8797	0.725
NULL	Exp_Ther_Med_2014_Aug_11_8(2)_671-675.nxml.txt.nlp	25009638	SENT66	2	2	0	0	scopolamine	FAE	PA451308	2178	0.725
NULL	J_Gen_Physiol_2010_Apr_135(4)_379-392.nxml.txt.nlp	20351062	SENT39	31	31	5	5	halothane	TASK3	PA449845	51305	0.725
NULL	Arthritis_Res_Ther_2008_Mar_17_10(2)_R33.nxml.txt.nlp	18346273	SENT136	17	17	11	11	infliximab	HMGB1	PA452639	3146	0.725
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1063.nxml.txt.nlp	24556678	SENT49	19	19	11	11	thioridazine	Mcl-1	PA451666	4170	0.725
NULL	Nucleic_Acids_Res_2013_Nov_8_41(20)_9524-9536.nxml.txt.nlp	23935071	SENT206	47	47	23	23	sugar	G10	PA451529	8896;221527	0.725
NULL	Exp_Ther_Med_2014_Nov_29_8(5)_1473-1478.nxml.txt.nlp	25289044	SENT141	13	13	19	19	heparin	AZU	PA449855	566	0.725
NULL	Mol_Brain_2014_Aug_1_7_54.nxml.txt.nlp	25085554	SENT149	5	5	12	12	chloroquine	LAMP1	PA448948	3916	0.725
NULL	EMBO_Mol_Med_2012_Jun_13_4(6)_515-527.nxml.txt.nlp	22416035	SENT238	4	4	16	16	olaparib	p53		7157	0.725
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT270	15	15	3	3	atorvastatin	CD36	PA448500	948	0.725
NULL	J_Oncol_2009_Jul_27_2009_305420.nxml.txt.nlp	19644558	SENT100	44	44	30	30	trastuzumab	p27	PA451743	5715;10534	0.725
NULL	Core_Evid_2010_Oct_21_5_61-76.nxml.txt.nlp	21042543	SENT382	9	9	2	2	cetuximab	HER2	PA10040	2064	0.725
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT11	0	0	5	5	atorvastatin	RANKL	PA448500	8600	0.725
NULL	Acta_Pharmacol_Sin_2010_Dec_3_31(12)_1635-1642.nxml.txt.nlp	21127497	SENT131	9	9	6	6	fluconazole	UGT	PA449653	7361;7355	0.725
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Sep_8_68(Pt_10)_o2873.nxml.txt.nlp	23125672	SENT66	5	5	20	20	benzaldehyde	mol	PA448571	90527	0.725
NULL	Arthritis_Res_Ther_2009_Jul_23_11(4)_236.nxml.txt.nlp	19664185	SENT69	27	27	4	4	benzbromarone	GLUT9	PA134852920	11182	0.725
NULL	Breast_Cancer_Res_2010_Mar_5_12(2)_R16.nxml.txt.nlp	20205716	SENT234	34	34	22	22	lovastatin	HMGB1	PA450272	3146	0.725
NULL	Breast_Cancer_Res_2005_Nov_21_7(6)_R1153-R1158.nxml.txt.nlp	16457695	SENT119	38	38	7	7	raloxifene	EGFR	PA451221	1956	0.725
NULL	Cell_Cycle_2012_Nov_1_11(21)_4069-4078.nxml.txt.nlp	23095523	SENT144	18	18	25	25	imatinib	PERK	PA10804	9451	0.725
NULL	Clin_Dev_Immunol_2007_Dec_13_2007_17315.nxml.txt.nlp	18320010	SENT118	11	11	33	33	gefitinib	EGFR	PA131301952	1956	0.725
NULL	Neurobiol_Aging_2012_Nov_33(11)_2692-2703.nxml.txt.nlp	22405041	SENT481	11	11	2	2	sevoflurane	gamma	PA451341	9913	0.725
NULL	Eur_J_Neurosci_2013_Nov_29_38(10)_3408-3423.nxml.txt.nlp	24102973	SENT65	24	24	10	10	zolpidem	BIC	PA451976	114614	0.725
NULL	Br_J_Cancer_2010_Jul_27_103(3)_315-323.nxml.txt.nlp	20661248	SENT31	18	18	7	7	irinotecan	UGT1A1	PA450085	54658	0.725
NULL	Clin_Ophthalmol_2012_Sep_7_6_1471-1476.nxml.txt.nlp	23055666	SENT110	14	14	17	17	propofol	NAC	PA451141	22861	0.725
NULL	Oncotarget_2014_May_27_5(19)_9049-9064.nxml.txt.nlp	24979294	SENT255	0	0	10	10	dasatinib	RYK	PA162372878	6259	0.725
NULL	Oncotarget_2014_Feb_16_5(3)_587-598.nxml.txt.nlp	24583822	SENT110	15	15	28	28	carboplatin	IL15	PA448803	3600	0.725
NULL	J_Cell_Mol_Med_2014_Aug_6_18(8)_1519-1539.nxml.txt.nlp	25100284	SENT209	37	37	16	16	gefitinib	EGFR	PA131301952	1956	0.725
NULL	AIDS_Behav_2013_Feb_13_17(7)_2293-2300.nxml.txt.nlp	23404097	SENT167	6	6	20	20	naltrexone	Gen	PA450588	348654	0.725
NULL	Mol_Cancer_2010_Apr_23_9_87.nxml.txt.nlp	20416058	SENT6	5	5	16	16	etoposide	TRAIL	PA449552	8743	0.725
NULL	Nat_Commun_2014_Dec_8_5_5736.nxml.txt.nlp	25484020	SENT146	1	1	10	10	exemestane	TRPA1	PA449563	8989	0.725
NULL	Breast_Cancer_Res_2011_Oct_21_13(5)_R99.nxml.txt.nlp	22017816	SENT49	2	2	20	20	estradiol	San	PA449503	80218	0.725
NULL	Oncotarget_2012_May_18_3(5)_525-534.nxml.txt.nlp	22619113	SENT102	0	0	9	9	fludarabine	MCL1	PA449655	4170	0.725
NULL	Core_Evid_2009_Jun_15_4_181-189.nxml.txt.nlp	20694074	SENT204	4	4	32	32	tocilizumab	IL-6	PA165292659	3569	0.725
NULL	Cancers_(Basel)_2013_Nov_1_5(4)_1379-1412.nxml.txt.nlp	24202450	SENT238	12	12	9	9	daclizumab	IFN	PA164764446	3439	0.725
NULL	J_Radiat_Res_2014_Mar_1_55(2)_359-363.nxml.txt.nlp	24187329	SENT14	16	16	22	22	doxorubicin	CHOP	PA449412	1649	0.725
NULL	Nucleic_Acids_Res_2011_Sep_19_39(16)_7124-7133.nxml.txt.nlp	21596776	SENT40	18	18	34	34	l-glutamine	CO2	PA10090	4513	0.725
NULL	J_Biol_2009_Apr_15_8(3)_30.nxml.txt.nlp	19435483	SENT49	14	14	7	7	imatinib	SYK	PA10804	6850	0.725
NULL	BMB_Rep_2013_Jan_46(1)_59-64.nxml.txt.nlp	23351386	SENT89	14	14	9	9	auranofin	NAC	PA448510	22861	0.725
NULL	Acta_Pharmacol_Sin_2009_Jul_22_30(7)_956-964.nxml.txt.nlp	19543298	SENT139	14	14	7	7	atorvastatin	SLC22A1	PA448500	6580	0.725
NULL	Mol_Vis_2010_Oct_15_16_2109-2120.nxml.txt.nlp	21139686	SENT252	8	8	14	14	hyaluronan	CD44	PA165958431	960	0.725
NULL	J_Gen_Physiol_1997_Dec_1_110(6)_643-654.nxml.txt.nlp	9382893	SENT123	12	12	14	14	diazoxide	ADP	PA449285	23038	0.725
NULL	Comp_Hepatol_2005_Feb_8_4_2.nxml.txt.nlp	15701172	SENT11	0	0	11	11	ketoconazole	CYP3A	PA450146	1574	0.725
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_4_2013_378657.nxml.txt.nlp	23662132	SENT495	7	7	34	34	exenatide	GLP-1	PA164749238	100125288	0.725
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT128	17	17	24	24	metformin	HIF-1	PA450395	29072	0.725
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_13_2014_478653.nxml.txt.nlp	25477992	SENT573	0	0	2	2	curcumin	EGFR	PA151958596	1956	0.725
NULL	ScientificWorldJournal_2012_Apr_1_2012_620189.nxml.txt.nlp	22566774	SENT23	42	42	15	15	l-alanine	NO3	PA448055	4681	0.725
NULL	BioDrugs_2013_Jun_7_27(6)_591-603.nxml.txt.nlp	23743670	SENT93	17	17	27	27	paclitaxel	TRAMP	PA450761	8718;23471;9189	0.725
NULL	Int_J_Endocrinol_Metab_2012_Sep_30_Autumn_10(4)_646-647.nxml.txt.nlp	23843842	SENT16	24	24	13	13	raloxifene	PTH	PA451221	5741	0.725
NULL	Open_Access_J_Urol_2010_Aug_4_2_125-141.nxml.txt.nlp	24198621	SENT117	6	6	16	16	sunitinib	CXCL9	PA162372840	4283	0.725
NULL	Br_J_Cancer_2004_Mar_22_90(6)_1285-1292.nxml.txt.nlp	15026814	SENT37	0	0	7	7	doxorubicin	San	PA449412	80218	0.725
NULL	Clin_Dev_Immunol_2013_Nov_26_2013_325481.nxml.txt.nlp	24371447	SENT39	6	6	21	21	propofol	IL-6	PA451141	3569	0.725
NULL	Biomed_Res_Int_2014_Apr_13_2014_275178.nxml.txt.nlp	24822191	SENT146	5	5	35	35	rosiglitazone	AMPK	PA451283	5563	0.725
NULL	Curr_Oncol_2006_Feb_13(1)_14-26.nxml.txt.nlp	17576437	SENT385	5	5	18	18	cisplatin	HER-2	PA449014	2064	0.725
NULL	Oncogene_2013_Oct_17_32(42)_5101-5110.nxml.txt.nlp	23208508	SENT36	7	7	17	17	metformin	AMPK	PA450395	5563	0.725
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT7	32	32	14	14	ranibizumab	VEGFR2	PA164746012	3791	0.725
NULL	Curr_Chem_Genomics_2008_Feb_25_1_43-53.nxml.txt.nlp	20161827	SENT157	18	18	25	25	fluorescein	MEK1	PA164746009	5604	0.725
NULL	J_Korean_Med_Sci_2008_Aug_25_23(4)_657-661.nxml.txt.nlp	18756053	SENT71	22	22	17	17	estradiol	AMH	PA449503	268	0.725
NULL	Breast_Cancer_Res_2012_Mar_14_14(2)_R45.nxml.txt.nlp	22417809	SENT28	30	30	6	6	temsirolimus	EGFR	PA164746890	1956	0.725
NULL	J_Cell_Mol_Med_2014_Aug_17_18(8)_1491-1508.nxml.txt.nlp	24237862	SENT286	3	3	8	8	bevacizumab	San	PA130232992	80218	0.725
NULL	Cancer_Med_2014_Oct_2_3(5)_1385-1395.nxml.txt.nlp	24890702	SENT153	8	8	25	25	leucovorin	KRAS	PA450198	3845	0.725
NULL	Breast_Cancer_Res_2007_Jan_23_9(1)_R7.nxml.txt.nlp	17244352	SENT104	22	22	12	12	tamoxifen	CYP2D6	PA451581	1565	0.725
NULL	Autophagy_2012_May_1_8(5)_853-855.nxml.txt.nlp	22617440	SENT66	6	6	9	9	imatinib	CD34	PA10804	947	0.725
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2013_Dec_8_6_75-79.nxml.txt.nlp	24348081	SENT9	4	4	7	7	colesevelam	TGR5	PA449095	151306	0.725
NULL	Appl_Microbiol_Biotechnol_2014_Mar_21_98(10)_4331-4345.nxml.txt.nlp	24652063	SENT111	5	5	8	8	galactose	LTA	PA449725	4049	0.725
NULL	J_Immunol_Res_2014_May_8_2014_565320.nxml.txt.nlp	24901010	SENT68	31	31	9	9	phenytoin	HLA-B	PA450947	3106	0.725
NULL	Breast_Cancer_Res_2005_Aug_1_7(5)_R796-R807.nxml.txt.nlp	16168126	SENT95	11	11	25	25	celecoxib	HER-2	PA448871	2064	0.725
NULL	Int_J_Mol_Imaging_2012_Sep_13_2012_870301.nxml.txt.nlp	23008768	SENT121	31	31	15	15	carboplatin	FDG	PA448803	23583	0.725
NULL	Allergy_Asthma_Immunol_Res_2013_Jul_27_5(4)_224-231.nxml.txt.nlp	23814676	SENT193	34	34	24	24	forskolin	EP4	PA146096022	5734	0.725
NULL	Acta_Pharmacol_Sin_2010_Mar_22_31(3)_329-340.nxml.txt.nlp	20173759	SENT5	26	26	16	16	ethanol	MEF2A	PA448073	4205	0.725
NULL	Breast_Cancer_Res_2014_Jul_24_16(4)_411.nxml.txt.nlp	25056669	SENT115	32	32	13	13	tamoxifen	CD49f	PA451581	3655	0.725
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_13_2012_636848.nxml.txt.nlp	23258994	SENT199	5	5	11	11	carrageenan	TRPV1	PA448814	7442	0.725
NULL	Biomed_Res_Int_2014_Jan_8_2014_595286.nxml.txt.nlp	24511539	SENT217	11	11	15	15	fluorouracil	CO2	PA128406956	4513	0.725
NULL	Mol_Cancer_2010_Aug_20_9_220.nxml.txt.nlp	20727180	SENT150	16	16	30	30	nicotine	p53	PA450626	7157	0.725
NULL	Clin_Kidney_J_2012_Apr_5(2)_124-129.nxml.txt.nlp	24744849	SENT138	15	15	21	21	fenofibrate	adiponectin	PA449594	9370	0.725
NULL	J_Thyroid_Res_2011_Aug_2_2011_102636.nxml.txt.nlp	21826256	SENT206	10	10	7	7	pazopanib	VEGFR	PA165291492	3791	0.725
NULL	Diabetes_Care_2010_Oct_13_33(10)_2250-2253.nxml.txt.nlp	20628086	SENT23	21	21	14	14	rosiglitazone	DREAM	PA451283	30818	0.725
NULL	Ann_Gen_Psychiatry_2008_Aug_18_7_11.nxml.txt.nlp	18706108	SENT64	29	29	19	19	bupropion	CD50	PA448687	3385	0.725
NULL	Genome_Biol_2011_May_25_12(5)_R46.nxml.txt.nlp	21609475	SENT252	24	24	15	15	debrisoquine	CYP2D	PA452616	1565	0.725
NULL	Int_J_Mol_Sci_2014_Jun_5_15(6)_10083-10100.nxml.txt.nlp	24905407	SENT19	21	21	24	24	tetracycline	TRB	PA451640	6957	0.725
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT148	6	6	3	3	cisplatin	IBP	PA449014	706;50619	0.725
NULL	Anal_Chem_Insights_2014_Mar_2_9_1-7.nxml.txt.nlp	24634579	SENT4	10	10	12	12	terbutaline	TRB	PA451616	6957	0.725
NULL	Pharmaceuticals_(Basel)_2012_May_2_5(5)_447-459.nxml.txt.nlp	24281556	SENT141	7	7	17	17	isoflurane	MFG-E8	PA450106	4240	0.725
NULL	J_Biomed_Sci_2014_Feb_3_21(1)_10.nxml.txt.nlp	24490900	SENT119	10	10	15	15	alendronate	CTR	PA448082	799	0.725
NULL	Diabetes_2013_Mar_14_62(3)_953-964.nxml.txt.nlp	23223176	SENT169	32	32	12	12	paroxetine	ROS	PA450801	6098	0.725
NULL	F1000_Biol_Rep_2012_Mar_1_4_5.nxml.txt.nlp	22403588	SENT127	30	30	21	21	boceprevir	IFN	PA165948902	3439	0.725
NULL	Biomed_Res_Int_2013_Aug_4_2013_152909.nxml.txt.nlp	23984319	SENT39	16	16	31	31	l-glutamine	CO2	PA10090	4513	0.725
NULL	Cancers_(Basel)_2011_May_18_3(2)_2444-2461.nxml.txt.nlp	24212818	SENT116	14	14	23	23	estradiol	EGFR	PA449503	1956	0.725
NULL	Gastric_Cancer_2014_Oct_19_17(3)_489-496.nxml.txt.nlp	24142107	SENT38	12	12	17	17	heparin	ESD	PA449855	2098	0.725
NULL	Clin_Med_Insights_Oncol_2012_Mar_19_6_165-178.nxml.txt.nlp	22474408	SENT234	16	16	22	22	ofatumumab	CHOP	PA165291493	1649	0.725
NULL	J_Immunotoxicol_2013_Jan_11_10(1)_75-82.nxml.txt.nlp	22967038	SENT101	10	10	6	6	rituximab	CD4	PA451261	920	0.725
NULL	Mol_Cells_2014_Sep_30_37(9)_664-671.nxml.txt.nlp	25234467	SENT15	6	6	10	10	cisplatin	miR-217	PA449014	406999	0.725
NULL	Cell_Death_Dis_2010_May_13_1(5)_e41.nxml.txt.nlp	21364648	SENT268	0	0	4	4	etoposide	p65	PA449552	5970	0.725
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT16	4	4	19	19	tacrolimus	RANKL	PA451578	8600	0.725
NULL	Ann_Med_2011_Nov_5_43(7)_531-544.nxml.txt.nlp	21815879	SENT49	23	23	2	2	thrombin	COX	PA451674	1351	0.725
NULL	Cell_Death_Dis_2012_May_3_3(5)_e303.nxml.txt.nlp	22552280	SENT55	35	35	39	39	metformin	AMPK	PA450395	5563	0.725
NULL	Cancer_Cell_Int_2012_Jun_18_12_30.nxml.txt.nlp	22709569	SENT57	18	18	21	21	cisplatin	PLCG2	PA449014	5336	0.725
NULL	Oxid_Med_Cell_Longev_2013_Jun_2_2013_793525.nxml.txt.nlp	23819014	SENT138	15	15	21	21	resveratrol	SGBS		2719	0.725
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT50	0	0	18	18	midazolam	CYP3A	PA450496	1574	0.725
NULL	Mol_Cancer_2013_May_24_12_47.nxml.txt.nlp	23705854	SENT249	9	9	19	19	indomethacin	P-gp	PA449982	5243	0.725
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT136	15	15	7	7	cisplatin	IBP	PA449014	706;50619	0.725
NULL	Indian_J_Anaesth_2012_Mar-Apr_56(2)_129-134.nxml.txt.nlp	22701202	SENT116	23	23	14	14	ropivacaine	CEA	PA451271	5670;1087	0.725
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jun_5_66(Pt_7)_o1559-o1560.nxml.txt.nlp	21587803	SENT74	0	0	18	18	sulfanilamide	mol	PA451545	90527	0.725
NULL	BMB_Rep_2014_Nov_47(11)_649-654.nxml.txt.nlp	25301019	SENT61	1	1	5	5	l-alanine	p38	PA448055	10598;1432;7965	0.725
NULL	Mol_Cancer_2007_Sep_26_6_61.nxml.txt.nlp	17894897	SENT94	0	0	4	4	etoposide	HIF-1	PA449552	29072	0.725
NULL	Biologics_2013_Dec_16_8_13-25.nxml.txt.nlp	24368879	SENT179	29	29	15	15	oxaliplatin	IFL	PA131285527	3439	0.725
NULL	Breast_Cancer_Res_2010_Oct_26_12(5)_210.nxml.txt.nlp	21067538	SENT76	16	16	18	18	hyaluronan	CD44	PA165958431	960	0.725
NULL	Cancer_Inform_2007_Apr_27_3_159-181.nxml.txt.nlp	19455242	SENT197	3	3	12	12	paclitaxel	C10	PA450761	113246	0.725
NULL	Crit_Care_1999_Dec_23_4(Suppl_A)_4.nxml.txt.nlp	NULL	SENT18	19	19	12	12	heparin	ACT	PA449855	12;11332;9457;641455	0.725
NULL	Biomed_Res_Int_2014_Jan_29_2014_458592.nxml.txt.nlp	24592391	SENT44	22	22	9	9	curcumin	HO-1	PA151958596	3162	0.725
NULL	Autoimmune_Dis_2013_Sep_26_2013_827254.nxml.txt.nlp	24187614	SENT221	14	14	20	20	rituximab	IL-6	PA451261	3569	0.725
NULL	Nat_Commun_2013_Oct_25_4_2667.nxml.txt.nlp	24157709	SENT72	6	6	8	8	etoposide	ETO	PA449552	862	0.725
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1224-1233.nxml.txt.nlp	22353810	SENT164	13	13	11	11	doxorubicin	MRP-1	PA449412	928	0.725
NULL	Eur_J_Med_Res_2012_Aug_23_17(1)_25.nxml.txt.nlp	22913802	SENT27	10	10	16	16	bevacizumab	San	PA130232992	80218	0.725
NULL	Arthritis_Res_Ther_2010_Mar_19_12(2)_R48.nxml.txt.nlp	20302641	SENT45	8	8	19	19	fluorescein	CD4	PA164746009	920	0.725
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Nov_13_64(Pt_12)_o2338.nxml.txt.nlp	21581313	SENT73	22	22	13	13	ethanol	mol	PA448073	90527	0.725
NULL	Pain_Ther_2014_Jun_13_3(1)_59-69.nxml.txt.nlp	25135388	SENT29	8	8	22	22	curcumin	HSD1	PA151958596	26871	0.725
NULL	Drugs_Context_2012_Nov_26_2012_212243.nxml.txt.nlp	24432032	SENT134	8	8	18	18	theophylline	HDAC2	PA451647	3066	0.725
NULL	Gastric_Cancer_2014_Apr_7_17(1)_1-12.nxml.txt.nlp	23563986	SENT7	20	20	10	10	pertuzumab	HER2		2064	0.725
NULL	Br_J_Cancer_2012_Feb_14_106(4)_685-692.nxml.txt.nlp	22294184	SENT198	10	10	33	33	lovastatin	p38	PA450272	10598;1432;7965	0.725
NULL	Support_Care_Cancer_2012_Apr_25_20(4)_705-714.nxml.txt.nlp	21437780	SENT187	6	6	8	8	tamoxifen	aromatase	PA451581	1588	0.725
NULL	Eur_J_Clin_Pharmacol_2011_Dec_23_67(12)_1231-1241.nxml.txt.nlp	21698374	SENT190	8	8	2	2	tacrolimus	ABCB1	PA451578	5243	0.725
NULL	Acta_Pharmacol_Sin_2010_Feb_5_31(2)_137-144.nxml.txt.nlp	20139896	SENT136	8	8	4	4	iron	5-LOX	PA450087	240	0.725
NULL	Front_Bioeng_Biotechnol_2015_Jan_5_2_76.nxml.txt.nlp	25601910	SENT108	2	2	6	6	l-serine	FBA	PA451330	26273	0.725
NULL	Infect_Dis_Rep_2012_Jan_2_4(1)_e9.nxml.txt.nlp	24470939	SENT222	17	17	7	7	metronidazole	CD4	PA450484	920	0.725
NULL	Arch_Osteoporos_2009_Dec_18_4(1-2)_1-8.nxml.txt.nlp	20234790	SENT76	18	18	28	28	risedronate	PTH	PA451255	5741	0.725
NULL	Breast_Cancer_Res_2011_Apr_15_13(2)_R44.nxml.txt.nlp	21496232	SENT324	3	3	14	14	erlotinib	HER2	PA134687924	2064	0.725
NULL	Oncol_Rep_2013_Mar_24_29(3)_903-910.nxml.txt.nlp	23292002	SENT76	22	22	9	9	fluorescein	CO2	PA164746009	4513	0.725
NULL	Interdiscip_Toxicol_2011_Dec_4(4)_173-183.nxml.txt.nlp	22319251	SENT125	13	13	18	18	genistein	DES	PA165109660	1674	0.725
NULL	Cell_Death_Dis_2013_Jun_13_4(6)_e665.nxml.txt.nlp	23764846	SENT63	9	9	4	4	sorafenib	ZO-1	PA7000	7082	0.725
NULL	Pak_J_Med_Sci_2013_Apr_29(2)_545-548.nxml.txt.nlp	24353574	SENT29	32	32	12	12	atorvastatin	Xin	PA448500	165904	0.725
NULL	Mol_Vis_2012_Jan_1_18_1-9.nxml.txt.nlp	22232563	SENT126	3	3	17	17	bevacizumab	HIF-1	PA130232992	29072	0.725
NULL	Front_Neurol_2013_Mar_4_4_18.nxml.txt.nlp	23459929	SENT2265	0	0	3	3	methylprednisolone	TNF-alpha	PA450466	7124	0.725
NULL	Carcinogenesis_2010_Dec_27_31(12)_2049-2057.nxml.txt.nlp	20876285	SENT127	30	30	11	11	tamoxifen	HER2	PA451581	2064	0.725
NULL	Cell_Death_Dis_2014_Jul_31_5(7)_e1358.nxml.txt.nlp	25077544	SENT264	8	8	12	12	etoposide	PC-3	PA449552	692094	0.725
NULL	Breast_Cancer_Res_Treat_2012_Jun_18_133(3)_937-947.nxml.txt.nlp	22094936	SENT186	41	41	15	15	tamoxifen	CDC2	PA451581	5424	0.725
NULL	Adv_Hematol_2012_Sep_14_2012_524308.nxml.txt.nlp	21941553	SENT310	11	11	27	27	rituximab	BCL2	PA451261	596	0.725
NULL	Arthritis_Res_Ther_2011_Jul_6_13(4)_227.nxml.txt.nlp	21745420	SENT173	15	15	7	7	heparin	BAFF	PA449855	10673	0.725
NULL	Environ_Health_Perspect_2009_Feb_8_117(2)_175-180.nxml.txt.nlp	19270784	SENT18	23	23	9	9	vinblastine	BPA	PA451877	667	0.725
NULL	Part_Fibre_Toxicol_2011_Jun_9_8_19.nxml.txt.nlp	21658250	SENT209	37	37	14	14	dextran	IL-6	PA449261	3569	0.725
NULL	Arthritis_Res_Ther_2006_Apr_12_8(Suppl_1)_S4.nxml.txt.nlp	16820043	SENT58	10	10	19	19	furosemide	URAT1	PA449719	116085	0.725
NULL	Acta_Pharmacol_Sin_2012_Jun_14_33(6)_832-838.nxml.txt.nlp	22580740	SENT13	11	11	13	13	gemcitabine	GEM	PA449748	2669	0.725
NULL	Environ_Health_Perspect_2006_Sep_23_114(9)_1401-1406.nxml.txt.nlp	16966095	SENT155	31	31	8	8	arsenite	p53	PA452638	7157	0.725
NULL	J_Biol_Chem_2013_Feb_8_288(6)_3918-3928.nxml.txt.nlp	23239877	SENT180	17	17	19	19	thrombin	ADP	PA451674	23038	0.725
NULL	F1000Prime_Rep_2014_Dec_1_6_112.nxml.txt.nlp	25580266	SENT65	20	20	16	16	ustekinumab	IL-23	PA166048654	51561	0.725
NULL	J_Korean_Med_Sci_2010_Aug_21_25(8)_1222-1227.nxml.txt.nlp	20676337	SENT128	3	3	10	10	propofol	LPA	PA451141	4018	0.725
NULL	Exp_Ther_Med_2014_Oct_24_8(4)_1092-1096.nxml.txt.nlp	25187802	SENT118	2	2	12	12	carvedilol	Bcl-2	PA448817	596	0.725
NULL	Biologics_2010_Aug_9_4_187-197.nxml.txt.nlp	20714356	SENT70	4	4	8	8	bevacizumab	IFN	PA130232992	3439	0.725
NULL	Br_J_Cancer_2009_Sep_15_101(6)_924-934.nxml.txt.nlp	19690550	SENT200	11	11	21	21	irinotecan	CRT	PA450085	811	0.725
NULL	Br_J_Cancer_2013_Feb_19_108(3)_557-563.nxml.txt.nlp	23361053	SENT27	4	4	2	2	tamoxifen	PAK1	PA451581	5585;5058	0.725
NULL	Cell_Res_2012_Aug_22_22(8)_1227-1245.nxml.txt.nlp	22613949	SENT398	15	15	27	27	bortezomib	KRAS	PA10252	3845	0.725
NULL	Clin_Sci_(Lond)_2011_Nov_1_121(Pt_10)_449-458.nxml.txt.nlp	21671887	SENT193	8	8	15	15	simvastatin	AMPK	PA451363	5563	0.725
NULL	Br_J_Pharmacol_2014_Sep_28_171(18)_4255-4272.nxml.txt.nlp	24846338	SENT22	21	21	18	18	escitalopram	5-HT7	PA10074	3363	0.725
NULL	Stroke_Res_Treat_2009_Dec_20_2010_386389.nxml.txt.nlp	20700422	SENT191	9	9	15	15	pioglitazone	MCP-1	PA450970	6347	0.725
NULL	J_Carcinog_2011_Dec_22_10_36.nxml.txt.nlp	22279421	SENT111	29	29	37	37	doxorubicin	RANKL	PA449412	8600	0.725
NULL	Cancer_Manag_Res_2014_Sep_10_6_349-356.nxml.txt.nlp	25228821	SENT141	16	16	7	7	vemurafenib	BRAF	PA165946873	673	0.725
NULL	Br_J_Cancer_2010_Oct_26_103(9)_1335-1342.nxml.txt.nlp	20978512	SENT125	14	14	8	8	trastuzumab	HER-2	PA451743	2064	0.725
NULL	Nat_Neurosci_2012_Sep_5_15(9)_1245-1254.nxml.txt.nlp	22864611	SENT522	3	3	9	9	clozapine	mGlu2	PA449061	2912	0.725
NULL	Exp_Hematol_Oncol_2012_Jun_18_1_14.nxml.txt.nlp	23210689	SENT107	36	36	28	28	imatinib	KIT	PA10804	3815	0.725
NULL	Acta_Neuropathol_Commun_2013_Aug_9_1_49.nxml.txt.nlp	24252504	SENT111	13	13	39	39	arsenite	ANOVA	PA452638	4858	0.725
NULL	Cell_Death_Differ_2010_Oct_30_17(10)_1624-1635.nxml.txt.nlp	20431602	SENT90	30	30	28	28	paclitaxel	Bcl-2	PA450761	596	0.725
NULL	J_Gen_Physiol_1924_Jan_20_6(3)_337-347.nxml.txt.nlp	19872075	SENT0	19	19	11	11	trypsin	FOR	PA451806	51741	0.725
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT140	31	31	38	38	perifosine	DR4	PA165291471	8797	0.725
NULL	Br_J_Cancer_2010_Jun_29_103(1)_61-72.nxml.txt.nlp	20588279	SENT207	11	11	16	16	trastuzumab	PTEN	PA451743	5728	0.725
NULL	BMJ_2010_Feb_8_340_c693.nxml.txt.nlp	20142325	SENT55	10	10	7	7	tamoxifen	CYP2D6	PA451581	1565	0.725
NULL	Breast_Cancer_Res_2004_Jul_29_6(5)_204-210.nxml.txt.nlp	15318926	SENT101	23	23	20	20	tamoxifen	HER2	PA451581	2064	0.725
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT127	23	23	30	30	tamoxifen	HIF1	PA451581	3091	0.725
NULL	Cell_Cycle_2013_Jul_1_12(13)_1995.nxml.txt.nlp	23759574	SENT30	11	11	17	17	gemcitabine	NLRP3	PA449748	114548	0.725
NULL	Case_Rep_Hematol_2013_Sep_30_2013_628513.nxml.txt.nlp	24198984	SENT76	41	41	22	22	heparin	VIII	PA449855	1351	0.725
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT104	27	27	20	20	erlotinib	MEK1	PA134687924	5604	0.725
NULL	Br_J_Cancer_2009_Mar_24_100(6)_870-873.nxml.txt.nlp	19293806	SENT54	24	24	11	11	gemcitabine	CDA	PA449748	978	0.725
NULL	Pharmacogn_Mag_2014_Jan-Feb_10(Suppl_1)_S14-S21.nxml.txt.nlp	24914294	SENT122	13	13	20	20	phenol	PLK1	PA450913	5347	0.724
NULL	Biomed_Res_Int_2013_Jul_15_2013_458571.nxml.txt.nlp	23956983	SENT151	13	13	8	8	l-serine	SHMT	PA451330	6470	0.724
NULL	Br_J_Cancer_2010_May_11_102(10)_1511-1518.nxml.txt.nlp	20461094	SENT62	17	17	23	23	gentamicin	CO2	PA449753	4513	0.724
NULL	J_Med_Case_Reports_2008_May_19_2_167.nxml.txt.nlp	18489739	SENT19	23	23	31	31	cyclophosphamide	CHOP	PA449165	1649	0.724
NULL	Breast_Cancer_Res_Treat_2013_Sep_1_141(2)_243-248.nxml.txt.nlp	23996142	SENT150	13	13	3	3	tamoxifen	CYP2D6	PA451581	1565	0.724
NULL	Pharmaceuticals_(Basel)_2013_Oct_11_6(10)_1304-1321.nxml.txt.nlp	24275851	SENT222	24	24	29	29	minocycline	GLP-1	PA450519	100125288	0.724
NULL	Hum_Genomics_2009_Dec_1_4(2)_91-106.nxml.txt.nlp	20038497	SENT145	17	17	4	4	galantamine	APOE	PA449726	348	0.724
NULL	Lancet_2011_May_21_377(9779)_1749-1759.nxml.txt.nlp	21570111	SENT186	31	31	7	7	bevacizumab	MAX	PA130232992	4149	0.724
NULL	Mol_Cancer_2009_Oct_8_8_83.nxml.txt.nlp	19814803	SENT173	17	17	10	10	triciribine	CTRL	PA165958661	1506	0.724
NULL	EMBO_J_2009_Mar_18_28(6)_663-676.nxml.txt.nlp	19214186	SENT373	14	14	19	19	oxaliplatin	GLI1	PA131285527	2735	0.724
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT109	11	11	5	5	doxorubicin	p53	PA449412	7157	0.724
NULL	Indian_J_Med_Paediatr_Oncol_2013_Oct-Dec_34(4)_299-304.nxml.txt.nlp	24604961	SENT85	4	4	12	12	cyclophosphamide	CHOP	PA449165	1649	0.724
NULL	Nucleic_Acids_Res_2013_Nov_27_41(21)_9786-9799.nxml.txt.nlp	23982513	SENT107	1	1	7	7	arsenite	TIAR	PA452638	7073	0.724
NULL	Protein_Cell_2014_Jun_19_5(6)_469-479.nxml.txt.nlp	24748116	SENT164	23	23	18	18	paclitaxel	EB1	PA450761	9167;22919;10982	0.724
NULL	Br_J_Cancer_2010_Jun_29_103(1)_61-72.nxml.txt.nlp	20588279	SENT270	8	8	18	18	trastuzumab	PTEN	PA451743	5728	0.724
NULL	Cilia_2013_Jan_3_2_1.nxml.txt.nlp	23351214	SENT53	24	24	15	15	forskolin	ERK	PA146096022	5594	0.724
NULL	Ann_Rheum_Dis_2008_Aug_5_68(5)_702-709.nxml.txt.nlp	18684743	SENT249	13	13	31	31	infliximab	IMPACT	PA452639	55364	0.724
NULL	Int_J_Endocrinol_2009_Aug_31_2009_241786.nxml.txt.nlp	19946425	SENT12	5	5	14	14	ribavirin	IFN	PA451241	3439	0.724
NULL	J_Cell_Mol_Med_2013_Nov_17_17(11)_1385-1396.nxml.txt.nlp	24237791	SENT23	14	14	3	3	anagrelide	MPN	PA164742986	83886	0.724
NULL	Biologics_2012_Feb_1_6_31-35.nxml.txt.nlp	22355257	SENT13	7	7	29	29	rituximab	IL-10	PA451261	3586	0.724
NULL	Hum_Mol_Genet_2014_Apr_15_23(8)_2055-2077.nxml.txt.nlp	24282027	SENT251	29	29	17	17	galactose	GPD	PA449725	2532	0.724
NULL	Neural_Regen_Res_2013_May_5_8(13)_1180-1189.nxml.txt.nlp	25206412	SENT128	0	0	4	4	fasudil	RhoA	PA165946121	387	0.724
NULL	Front_Immunol_2012_Jun_4_3_134.nxml.txt.nlp	22675325	SENT120	8	8	19	19	theophylline	IL-8	PA451647	3576	0.724
NULL	Cell_Death_Dis_2014_Mar_13_5(3)_e1126.nxml.txt.nlp	24625985	SENT96	13	13	6	6	bortezomib	URI	PA10252	8725	0.724
NULL	Int_J_Nanomedicine_2012_May_7_7_2307-2314.nxml.txt.nlp	22661887	SENT174	5	5	2	2	gemcitabine	F10	PA449748	2159	0.724
NULL	Cancer_Metab_2014_May_28_2(Suppl_1)_P61.nxml.txt.nlp	NULL	SENT17	2	2	19	19	troglitazone	c-Myc	PA451799	4609	0.724
NULL	Alcohol_Res_2013_35(1)_25-35.nxml.txt.nlp	24313162	SENT52	13	13	0	0	choline	BHMT	PA448976	635	0.724
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Jul_23_3(7)_e126.nxml.txt.nlp	25054314	SENT88	30	30	15	15	docetaxel	OATP1B3	PA449383	28234	0.724
NULL	J_Cell_Biol_2008_Jul_14_182(1)_197-213.nxml.txt.nlp	18625847	SENT160	6	6	4	4	nutlin-3	p53		7157	0.724
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT192	10	10	33	33	lapatinib	Yes	PA152241907	7525	0.724
NULL	Br_J_Haematol_2014_Mar_6_164(6)_759-766.nxml.txt.nlp	24387053	SENT125	11	11	22	22	rituximab	ADAMTS13	PA451261	11093	0.724
NULL	Acta_Pharmacol_Sin_2009_Jul_3_30(7)_879-888.nxml.txt.nlp	19574993	SENT130	15	15	31	31	donepezil	IL-4	PA449394	3565	0.724
NULL	Arthritis_Res_Ther_2008_Dec_1_10(6)_R139.nxml.txt.nlp	19046432	SENT243	31	31	28	28	rosiglitazone	AP-1	PA451283	2353;3727;2354;3725	0.724
NULL	Hum_Mol_Genet_2014_Apr_15_23(8)_2055-2077.nxml.txt.nlp	24282027	SENT254	20	20	5	5	galactose	DNM1	PA449725	1759	0.724
NULL	Iran_Red_Crescent_Med_J_2014_Aug_5_16(8)_e6915.nxml.txt.nlp	25389496	SENT130	26	26	28	28	simvastatin	adiponectin	PA451363	9370	0.724
NULL	Environ_Health_Perspect_2009_Apr_14_117(4)_645-652.nxml.txt.nlp	19440506	SENT88	7	7	4	4	diclofenac	UGT	PA449293	7361;7355	0.724
NULL	Blood_Res_2013_Sep_25_48(3)_171-177.nxml.txt.nlp	24086936	SENT132	5	5	26	26	bortezomib	CHOP	PA10252	1649	0.724
NULL	Ann_Hematol_2014_Dec_14_93(2)_181-192.nxml.txt.nlp	24337485	SENT336	5	5	16	16	trastuzumab	PTEN	PA451743	5728	0.724
NULL	Physiol_Rep_2014_Aug_28_2(8)_e12143.nxml.txt.nlp	25168879	SENT97	0	0	7	7	staurosporine	COX	PA165109623	1351	0.724
NULL	Infect_Dis_Rep_2012_Mar_5_4(1)_e22.nxml.txt.nlp	24470929	SENT5	28	28	15	15	starch	HSS	PA451492	9043;2671;6448;80025	0.724
NULL	Front_Behav_Neurosci_2010_Apr_5_4_14.nxml.txt.nlp	20407577	SENT291	9	9	0	0	cocaine	HDAC	PA449072	9734	0.724
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT152	32	32	8	8	dasatinib	LYN	PA162372878	4067	0.724
NULL	Front_Microbiol_2012_Mar_22_3_106.nxml.txt.nlp	22461783	SENT368	21	21	12	12	sulfamethoxazole	STEP	PA451544	84867	0.724
NULL	J_Gen_Physiol_1997_Apr_1_109(4)_477-490.nxml.txt.nlp	9101406	SENT166	43	43	25	25	staurosporine	GIRK2	PA165109623	3763	0.724
NULL	Viruses_2014_Sep_16_6(9)_3428-3437.nxml.txt.nlp	25256391	SENT285	13	13	1	1	raltegravir	Spartan		83932	0.724
NULL	Clin_J_Gastroenterol_2014_Jun_6_7(4)_355-360.nxml.txt.nlp	25132867	SENT2	10	10	36	36	ribavirin	IFN	PA451241	3439	0.724
NULL	Br_J_Cancer_2009_Sep_15_101(6)_957-966.nxml.txt.nlp	19738618	SENT193	32	32	39	39	trastuzumab	THBS-1	PA451743	7057	0.724
NULL	Breast_Cancer_Res_Treat_2013_Aug_20_141(1)_43-53.nxml.txt.nlp	23959396	SENT189	10	10	17	17	trastuzumab	HER2	PA451743	2064	0.724
NULL	Nat_Neurosci_2012_Sep_5_15(9)_1245-1254.nxml.txt.nlp	22864611	SENT53	5	5	30	30	fluoxetine	mGlu2	PA449673	2912	0.724
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT301	4	4	22	22	gefitinib	PTEN	PA131301952	5728	0.724
NULL	Reprod_Biol_Endocrinol_2004_Jul_5_2_49.nxml.txt.nlp	15236653	SENT244	24	24	29	29	estradiol	PGF	PA449503	5228	0.724
NULL	Diabetes_Care_2012_Feb_16_35(2)_196-197.nxml.txt.nlp	22228743	SENT29	19	19	5	5	fluorescein	ADP	PA164746009	23038	0.724
NULL	Biomed_Res_Int_2014_Jun_24_2014_132702.nxml.txt.nlp	25050322	SENT157	4	4	6	6	metformin	AMPK	PA450395	5563	0.724
NULL	Breast_Cancer_Res_2009_Jun_23_11(Suppl_1)_S15.nxml.txt.nlp	NULL	SENT9	11	11	20	20	tamoxifen	HER2	PA451581	2064	0.724
NULL	Contemp_Oncol_(Pozn)_2012_Jan_4_16(6)_461-466.nxml.txt.nlp	23788931	SENT76	33	33	22	22	cyclophosphamide	CTX	PA449165	1593	0.724
NULL	Cancer_Med_2013_Jun_25_2(3)_277-285.nxml.txt.nlp	23930204	SENT121	17	17	19	19	mitomycin	PTEN	PA450524	5728	0.724
NULL	Lipids_Health_Dis_2011_Feb_12_10_31.nxml.txt.nlp	21314960	SENT123	4	4	2	2	hemin	HO-1	PA449849	3162	0.724
NULL	Mol_Biol_Int_2011_Feb_24_2011_137459.nxml.txt.nlp	22091395	SENT201	8	8	26	26	arsenite	TIA1	PA452638	7072	0.724
NULL	Br_J_Cancer_2010_Nov_9_103(10)_1588-1596.nxml.txt.nlp	20978505	SENT169	22	22	25	25	temozolomide	TGD	PA451609	19	0.724
NULL	Prostate_Int_2014_Sep_21_2(3)_105-113.nxml.txt.nlp	25325021	SENT220	1	1	23	23	indomethacin	3alpha-HSD	PA449982	10170	0.724
NULL	Br_J_Cancer_2014_Nov_25_111(11)_2091-2102.nxml.txt.nlp	25349971	SENT163	8	8	16	16	imatinib	KIT	PA10804	3815	0.724
NULL	Exp_Ther_Med_2013_Jan_1_5(1)_338-342.nxml.txt.nlp	23251295	SENT114	5	5	12	12	everolimus	HK2	PA164746311	3796;3099;29911;3741	0.724
NULL	Neuroscience_2008_Aug_13_155(2)_556-564.nxml.txt.nlp	18619738	SENT398	2	2	0	0	choline	CDP	PA448976	1523	0.724
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Feb_24_68(Pt_3)_o792-o793.nxml.txt.nlp	22412664	SENT11	10	10	4	4	deferasirox	mol	PA164760843	90527	0.724
NULL	Case_Rep_Gastroenterol_2011_May_3_5(2)_262-266.nxml.txt.nlp	21887126	SENT46	12	12	0	0	vincristine	CHOP	PA451879	1649	0.724
NULL	Exp_Ther_Med_2014_Nov_17_8(5)_1484-1488.nxml.txt.nlp	25289046	SENT138	31	31	33	33	cisplatin	DDP	PA449014	1678	0.724
NULL	Arthritis_Res_Ther_2009_Jan_13_11(1)_R5.nxml.txt.nlp	19134200	SENT191	16	16	22	22	quinacrine	TLR9	PA164745551	54106	0.724
NULL	Mol_Pain_2014_Aug_15_10_53.nxml.txt.nlp	25127716	SENT98	12	12	4	4	paclitaxel	CCR5	PA450761	1234	0.724
NULL	Cancers_(Basel)_2011_Nov_10_3(4)_4139-4150.nxml.txt.nlp	24213130	SENT74	11	11	26	26	fludarabine	NY-ESO-1	PA449655	1485	0.724
NULL	J_Oncol_2012_Nov_8_2012_705036.nxml.txt.nlp	23209466	SENT299	16	16	25	25	cinacalcet	PTH	PA164776671	5741	0.724
NULL	Crit_Care_2011_Aug_11_15(4)_226.nxml.txt.nlp	21892977	SENT57	41	41	17	17	vasopressin	P2X3	PA451858	5024	0.724
NULL	Exp_Mol_Med_2012_Sep_30_44(9)_545-553.nxml.txt.nlp	22809901	SENT9	0	0	31	31	clozapine	adiponectin	PA449061	9370	0.724
NULL	Breast_Cancer_Res_Treat_2013_Aug_20_141(1)_43-53.nxml.txt.nlp	23959396	SENT192	32	32	39	39	trastuzumab	HER3	PA451743	2065	0.724
NULL	Neural_Regen_Res_2013_Oct_25_8(30)_2820-2826.nxml.txt.nlp	25206603	SENT56	17	17	0	0	selegiline	FasL	PA451316	356	0.724
NULL	Oncotarget_2014_Aug_29_5(17)_7217-7259.nxml.txt.nlp	25277175	SENT288	6	6	14	14	lapatinib	HER2	PA152241907	2064	0.724
NULL	J_Cell_Biol_1998_May_4_141(3)_715-726.nxml.txt.nlp	9566971	SENT286	9	9	25	25	creatine	HER2	PA164778930	2064	0.724
NULL	J_Cell_Mol_Med_2013_May_14_17(5)_579-596.nxml.txt.nlp	23490277	SENT52	36	36	34	34	thrombin	ADP	PA451674	23038	0.724
NULL	Diabetes_2013_Jun_17_62(6)_2048-2058.nxml.txt.nlp	23349496	SENT283	15	15	10	10	hyaluronan	TSG-6	PA165958431	7130	0.724
NULL	Mucosal_Immunol_2014_May_13_7(3)_718-729.nxml.txt.nlp	24220297	SENT83	0	0	8	8	doxycycline	IL-13	PA449415	3596	0.724
NULL	J_Thorac_Oncol_2014_Oct_23_9(10)_1443-1448.nxml.txt.nlp	25521397	SENT103	21	21	9	9	crizotinib	EGFR	PA165946122	1956	0.724
NULL	Mol_Cancer_2009_Apr_22_8_26.nxml.txt.nlp	19386116	SENT129	8	8	11	11	ritonavir	AKT	PA451260	207	0.724
NULL	Int_J_Surg_Oncol_2012_Jun_12_2012_862879.nxml.txt.nlp	22778941	SENT128	3	3	0	0	cisplatin	c-Myc	PA449014	4609	0.724
NULL	Acta_Pharmacol_Sin_2011_Oct_12_32(10)_1259-1265.nxml.txt.nlp	21909126	SENT129	29	29	15	15	fluvastatin	MCP-1	PA449688	6347	0.724
NULL	J_Biol_Chem_2013_Feb_1_288(5)_3312-3321.nxml.txt.nlp	23255604	SENT20	20	20	0	0	hydroxyurea	IP6K1	PA449942	9807	0.724
NULL	Cancer_Cell_Int_2005_Aug_23_5_27.nxml.txt.nlp	16117829	SENT189	27	27	6	6	doxycycline	p53	PA449415	7157	0.724
NULL	J_Epilepsy_Res_2014_Jun_30_4(1)_7-13.nxml.txt.nlp	24977124	SENT122	2	2	26	26	pilocarpine	CA3	PA450962	761	0.724
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Apr_17_6_43-57.nxml.txt.nlp	24833916	SENT338	9	9	11	11	cyclophosphamide	HER2	PA449165	2064	0.724
NULL	Br_J_Haematol_2009_Nov_2_147(3)_396-410.nxml.txt.nlp	19758122	SENT15	4	4	25	25	dasatinib	TP53	PA162372878	7157	0.724
NULL	Front_Genet_2012_Oct_10_3_206.nxml.txt.nlp	23087703	SENT252	12	12	2	2	clopidogrel	CYP2C19	PA449053	1557	0.724
NULL	J_Breast_Cancer_2011_Sep_29_14(3)_185-190.nxml.txt.nlp	22031799	SENT105	26	26	15	15	fulvestrant	GPER	PA164747170	2852	0.724
NULL	eLife_2014_May_29_3_e02811.nxml.txt.nlp	24876128	SENT141	26	26	6	6	neomycin	TAF7L	PA450608	54457	0.724
NULL	FEBS_Open_Bio_2014_Oct_22_4_905-914.nxml.txt.nlp	25383314	SENT100	8	8	19	19	atropine	L-FABP	PA448505	2168	0.724
NULL	Breast_Cancer_Res_2011_Mar_11_13(2)_R29.nxml.txt.nlp	21396094	SENT207	3	3	6	6	fulvestrant	HRG	PA164747170	3084;3273	0.724
NULL	Alcohol_Res_Health_2008_31(4)_310-339.nxml.txt.nlp	20729980	SENT299	8	8	14	14	ethanol	POMC	PA448073	5443	0.724
NULL	J_Oncol_2009_Mar_24_2009_491985.nxml.txt.nlp	19325924	SENT25	11	11	17	17	genistein	CXCR4	PA165109660	7852	0.724
NULL	Cardiovasc_Res_2011_Mar_1_89(4)_794-804.nxml.txt.nlp	20621925	SENT161	16	16	10	10	isoproterenol	PES	PA450121	23481	0.724
NULL	Arch_Med_Sci_2013_Dec_30_9(6)_1090-1096.nxml.txt.nlp	24482655	SENT119	0	0	21	21	tacrolimus	CD4	PA451578	920	0.724
NULL	Cell_Oncol_(Dordr)_2011_Apr_11_34(2)_89-95.nxml.txt.nlp	21394646	SENT145	32	32	25	25	trastuzumab	HER2	PA451743	2064	0.724
NULL	Mol_Cancer_2012_Mar_21_11_13.nxml.txt.nlp	22436134	SENT229	12	12	35	35	doxorubicin	HuR	PA449412	1994	0.724
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT480	11	11	0	0	ziprasidone	PRL	PA451974	5617	0.724
NULL	J_Venom_Anim_Toxins_Incl_Trop_Dis_2014_Nov_3_20(1)_48.nxml.txt.nlp	NULL	SENT78	31	31	43	43	l-glutamine	CO2	PA10090	4513	0.724
NULL	Breast_Cancer_Res_2000_Dec_17_2(1)_10-12.nxml.txt.nlp	11250686	SENT49	14	14	16	16	raloxifene	STAR	PA451221	6770;2984	0.724
NULL	Drugs_Context_2013_May_22_2013_212255.nxml.txt.nlp	24432042	SENT137	21	21	26	26	metformin	GLP-1	PA450395	100125288	0.724
NULL	Arthritis_Res_Ther_2006_Mar_6_8(2)_R53.nxml.txt.nlp	16519795	SENT105	2	2	26	26	methotrexate	IL-10	PA450428	3586	0.724
NULL	Mol_Cells_2014_Sep_30_37(9)_699-704.nxml.txt.nlp	25245523	SENT118	24	24	26	26	cyclophosphamide	CTX	PA449165	1593	0.724
NULL	J_Biomed_Biotechnol_2011_Jul_3_2011_343791.nxml.txt.nlp	21799660	SENT96	21	21	15	15	ethanol	COD	PA448073	6628	0.724
NULL	Oncotarget_2014_Jun_5_5(21)_10382-10392.nxml.txt.nlp	25071015	SENT164	14	14	19	19	trastuzumab	p53	PA451743	7157	0.724
NULL	Int_J_Mol_Sci_2014_Sep_30_15(10)_17686-17704.nxml.txt.nlp	25272226	SENT107	3	3	11	11	cetuximab	EGF	PA10040	1950	0.724
NULL	Curr_Neuropharmacol_2010_Dec_8(4)_409-421.nxml.txt.nlp	21629447	SENT177	25	25	4	4	primidone	LGS	PA451105	51557	0.724
NULL	Case_Rep_Oncol_2010_Apr_8_3(1)_93-97.nxml.txt.nlp	20740166	SENT80	0	0	29	29	dasatinib	EPHA2	PA162372878	1969	0.724
NULL	Cancer_Cell_Int_2010_Sep_9_10_32.nxml.txt.nlp	20828393	SENT164	24	24	41	41	cisplatin	ATF3	PA449014	467	0.724
NULL	Environ_Health_Perspect_2013_May_22_121(5)_551-557.nxml.txt.nlp	23434795	SENT176	3	3	22	22	hyaluronan	BAL	PA165958431	83666	0.724
NULL	Cancer_Manag_Res_2011_May_10_3_157-175.nxml.txt.nlp	21625399	SENT54	6	6	26	26	midazolam	CYP2D6	PA450496	1565	0.724
NULL	Br_J_Clin_Pharmacol_2011_Oct_72(4)_647-657.nxml.txt.nlp	21518389	SENT185	19	19	33	33	ticagrelor	P2Y12	PA165374673	64805	0.724
NULL	Cell_Death_Dis_2014_Apr_17_5(4)_e1185.nxml.txt.nlp	24743740	SENT49	1	1	19	19	pha-665752	Met		79811	0.724
NULL	Acta_Pharmacol_Sin_2009_Feb_5_30(2)_228-234.nxml.txt.nlp	19122672	SENT125	21	21	27	27	isoflurane	HO-1	PA450106	3162	0.724
NULL	Cancer_Metab_2014_Jan_23_2_2.nxml.txt.nlp	24451478	SENT208	0	0	14	14	chloroquine	PFKFB3	PA448948	5209	0.724
NULL	J_Mol_Med_2008_Jul_15_86(7)_815-824.nxml.txt.nlp	18414821	SENT185	23	23	9	9	lipase	EARS	PA450239	2058	0.724
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Dec_19_66(Pt_1)_o194-o195.nxml.txt.nlp	21580078	SENT82	46	46	34	34	ethanol	mol	PA448073	90527	0.724
NULL	Front_Oncol_2014_May_14_4_106.nxml.txt.nlp	24860786	SENT212	2	2	7	7	estradiol	p53	PA449503	7157	0.724
NULL	Int_J_Med_Sci_2013_Feb_11_10(3)_320-330.nxml.txt.nlp	23423768	SENT242	10	10	7	7	gefitinib	EGFR	PA131301952	1956	0.724
NULL	J_Int_Soc_Sports_Nutr_2009_Feb_19_6_6.nxml.txt.nlp	19228401	SENT253	8	8	22	22	creatine	CEE	PA164778930	51608	0.724
NULL	J_Immunother_Cancer_2014_Jan_27_2_2.nxml.txt.nlp	24829759	SENT198	27	27	25	25	sorafenib	IL-21	PA7000	59067;50616;27189	0.724
NULL	Proteome_Sci_2010_Jul_9_8_38.nxml.txt.nlp	20618950	SENT62	21	21	12	12	creatine	GAPDH	PA164778930	2597	0.724
NULL	J_Exp_Clin_Cancer_Res_2009_Jun_6_28(1)_76.nxml.txt.nlp	19500405	SENT269	28	28	18	18	gemcitabine	RRM1	PA449748	6240	0.724
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jun_20_68(Pt_7)_o2146-o2147.nxml.txt.nlp	22798820	SENT73	39	39	14	14	ethanol	mol	PA448073	90527	0.724
NULL	Asian_J_Androl_2014_Apr_25_Sep-Oct_16(5)_761-766.nxml.txt.nlp	24799635	SENT116	43	43	25	25	fructose	DAN	PA449716	5073;4681	0.724
NULL	Emerg_Med_J_2011_Apr_26_28(4)_313-315.nxml.txt.nlp	20581384	SENT112	9	9	7	7	atropine	PON1	PA448505	5444	0.724
NULL	Biol_Open_2013_Aug_14_2(10)_1013-1021.nxml.txt.nlp	24167711	SENT176	9	9	14	14	ethanol	EVL	PA448073	51466	0.724
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT77	13	13	15	15	curcumin	TRAIL	PA151958596	8743	0.724
NULL	Infect_Drug_Resist_2012_Jan_19_5_23-35.nxml.txt.nlp	22294860	SENT50	21	21	28	28	vancomycin	VISA	PA451850	57506	0.724
NULL	Breast_Cancer_Res_2012_Feb_14_14(1)_R30.nxml.txt.nlp	22333315	SENT160	8	8	12	12	celecoxib	CXCL9	PA448871	4283	0.724
NULL	Breast_Cancer_Res_2008_Dec_4_10(6)_R103.nxml.txt.nlp	19055788	SENT185	39	39	22	22	tamoxifen	aromatase	PA451581	1588	0.724
NULL	Protein_Cell_2014_Jul_2_5(7)_544-551.nxml.txt.nlp	24691905	SENT94	17	17	7	7	doxorubicin	p53	PA449412	7157	0.724
NULL	Core_Evid_2013_Sep_30_8_69-78.nxml.txt.nlp	24115917	SENT27	21	21	30	30	letrozole	HER-2	PA450196	2064	0.724
NULL	Cell_Commun_Signal_2004_Jun_25_2_5.nxml.txt.nlp	15219238	SENT169	2	2	8	8	lovastatin	PC3	PA450272	57332;7832;5122	0.724
NULL	Clin_Pharmacol_2013_Dec_10_5_193-199.nxml.txt.nlp	24353447	SENT29	25	25	41	41	midazolam	CYP3A4	PA450496	1576	0.724
NULL	Arthritis_Res_Ther_2013_Feb_22_15(1)_206.nxml.txt.nlp	23433179	SENT209	24	24	40	40	rofecoxib	CD40	PA451268	958	0.724
NULL	J_Vet_Med_Sci_2014_Feb_8_76(2)_173-182.nxml.txt.nlp	24107430	SENT186	8	8	16	16	yohimbine	AVP	PA451946	114548;551	0.724
NULL	Front_Behav_Neurosci_2013_Dec_18_7_203.nxml.txt.nlp	24385956	SENT282	8	8	19	19	memantine	spatial	PA10364	219793	0.724
NULL	Nucleic_Acids_Res_2006_Jul_5_34(11)_3399-3407.nxml.txt.nlp	16822860	SENT131	20	20	18	18	doxycycline	TFIIIC90	PA449415	9329	0.724
NULL	Cancer_Microenviron_2009_Sep_26_2(Suppl_1)_19-204.nxml.txt.nlp	NULL	SENT2495	9	9	22	22	sorafenib	AKT	PA7000	207	0.724
NULL	Nat_Commun_2014_Nov_19_5_5479.nxml.txt.nlp	25407222	SENT39	8	8	37	37	dextran	YTS	PA449261	8565	0.724
NULL	Chonnam_Med_J_2012_Dec_21_48(3)_141-149.nxml.txt.nlp	23323218	SENT77	8	8	2	2	sirolimus	DES	PA451365	1674	0.724
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT17	2	2	13	13	gefitinib	PTEN	PA131301952	5728	0.724
NULL	Oncotarget_2014_Aug_4_5(17)_7776-7787.nxml.txt.nlp	25277200	SENT28	25	25	0	0	etoposide	ANXA4	PA449552	307	0.724
NULL	J_Radiat_Res_2014_Mar_1_55(2)_359-363.nxml.txt.nlp	24187329	SENT43	6	6	0	0	vincristine	CHOP	PA451879	1649	0.724
NULL	Biomed_Res_Int_2014_Apr_29_2014_186864.nxml.txt.nlp	24877064	SENT109	13	13	11	11	ciprofloxacin	IFN	PA449009	3439	0.724
NULL	Biologics_2014_Apr_23_8_183-192.nxml.txt.nlp	24790411	SENT177	0	0	5	5	afatinib	EGFR	PA165981154	1956	0.724
NULL	Acta_Pharmacol_Sin_2014_Aug_7_35(8)_1023-1030.nxml.txt.nlp	24998255	SENT109	9	9	15	15	octreotide	STAT3	PA450678	6774	0.724
NULL	Front_Neurosci_2014_Aug_1_8_230.nxml.txt.nlp	25136291	SENT407	15	15	9	9	picrotoxin	c-fos	PA164777007	2353	0.724
NULL	EMBO_Mol_Med_2012_Jun_13_4(6)_515-527.nxml.txt.nlp	22416035	SENT187	11	11	18	18	olaparib	p53		7157	0.724
NULL	Int_J_Mol_Sci_2012_Feb_10_13(2)_1886-1918.nxml.txt.nlp	22408430	SENT1725	4	4	8	8	doxorubicin	PTEN	PA449412	5728	0.724
NULL	Diabetes_Care_2011_Oct_15_34(10)_2323-2328.nxml.txt.nlp	21949223	SENT111	6	6	14	14	metformin	p53	PA450395	7157	0.724
NULL	J_Cell_Biol_1981_Feb_1_88(2)_422-429.nxml.txt.nlp	6259180	SENT7	10	10	31	31	trypsin	EGF	PA451806	1950	0.724
NULL	Arthritis_Res_Ther_2008_Mar_17_10(2)_R33.nxml.txt.nlp	18346273	SENT17	3	3	8	8	infliximab	HMGB1	PA452639	3146	0.724
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT192	12	12	47	47	trastuzumab	Yes	PA451743	7525	0.724
NULL	Arthritis_Res_Ther_2013_Apr_17_15(2)_R51.nxml.txt.nlp	23594962	SENT282	6	6	15	15	muraglitazar	IRF1	PA162356187	3659	0.724
NULL	Br_J_Cancer_2004_Mar_8_90(5)_1059-1068.nxml.txt.nlp	14997208	SENT155	27	27	6	6	remikiren	AT1	PA164774779	9197;185	0.724
NULL	Oncogene_2010_Jun_10_29(23)_3335-3348.nxml.txt.nlp	20383197	SENT154	14	14	1	1	lapatinib	HER2	PA152241907	2064	0.724
NULL	Int_J_Med_Sci_2012_Dec_28_10(2)_110-118.nxml.txt.nlp	23329881	SENT55	13	13	3	3	docetaxel	NACT	PA449383	284111	0.724
NULL	Cancer_Metab_2014_May_28_2(Suppl_1)_P65.nxml.txt.nlp	NULL	SENT15	4	4	13	13	resveratrol	p53		7157	0.724
NULL	Indian_J_Pharmacol_2014_Nov-Dec_46(6)_627-632.nxml.txt.nlp	25538335	SENT120	5	5	3	3	metformin	Q10	PA450395	27161	0.724
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Sep_18_69(Pt_10)_o1545.nxml.txt.nlp	24098230	SENT70	10	10	28	28	benzaldehyde	mol	PA448571	90527	0.724
NULL	J_Invest_Dermatol_2012_Jan_1_132(1)_105-113.nxml.txt.nlp	21881590	SENT79	24	24	10	10	etanercept	CCL20	PA449515	6364	0.724
NULL	Exp_Ther_Med_2014_Sep_20_8(3)_968-972.nxml.txt.nlp	25120631	SENT136	7	7	0	0	naringin	FIB	PA151958360	2091	0.724
NULL	Nat_Commun_2013_Sep_3_4_2394.nxml.txt.nlp	23999152	SENT75	6	6	22	22	dextran	BDNF	PA449261	627	0.724
NULL	Acta_Pharmacol_Sin_2009_Jun_5_30(6)_859-867.nxml.txt.nlp	19498425	SENT26	5	5	26	26	carbachol	CA3	PA448784	761	0.724
NULL	J_Res_Med_Sci_2010_Nov-Dec_15(6)_331-343.nxml.txt.nlp	21526106	SENT4	10	10	30	30	l-arginine	HDEL	PA448478	10945	0.724
NULL	J_Virol_2014_Sep_88(18)_10377-10391.nxml.txt.nlp	25008923	SENT260	26	26	34	34	galactose	VLP	PA449725	391104	0.724
NULL	Cancers_(Basel)_2011_Apr_26_3(2)_2176-2194.nxml.txt.nlp	24212803	SENT108	8	8	19	19	cetuximab	KRAS	PA10040	3845	0.724
NULL	Braz_J_Med_Biol_Res_2012_Apr_27_45(6)_510-516.nxml.txt.nlp	22527124	SENT34	0	0	4	4	doxorubicin	ADM	PA449412	133	0.724
NULL	Environ_Health_2009_Dec_21_8(Suppl_1)_S2.nxml.txt.nlp	20102587	SENT45	20	20	31	31	l-glutamine	CO2	PA10090	4513	0.724
NULL	Breast_Cancer_Res_2014_Dec_19_16(6)_499.nxml.txt.nlp	25522654	SENT148	14	14	3	3	estradiol	CYP19A1	PA449503	1588	0.724
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT179	37	37	39	39	metformin	HIF-1	PA450395	29072	0.724
NULL	Oncol_Rep_2013_Apr_23_29(4)_1268-1274.nxml.txt.nlp	23354756	SENT88	27	27	5	5	epirubicin	SLC25A43	PA449476	203427	0.724
NULL	Adolesc_Health_Med_Ther_2012_Jun_20_3_85-93.nxml.txt.nlp	24600289	SENT36	1	1	9	9	etanercept	TNF	PA449515	7124	0.724
NULL	Int_J_Surg_Case_Rep_2014_Oct_30_5(12)_1014-1017.nxml.txt.nlp	25460461	SENT170	6	6	8	8	imiquimod	CO2	PA449972	4513	0.724
NULL	Front_Genet_2012_Nov_22_3_249.nxml.txt.nlp	23189085	SENT116	16	16	25	25	etoposide	ABCB1	PA449552	5243	0.724
NULL	Evid_Based_Complement_Alternat_Med_2014_Oct_30_2014_365258.nxml.txt.nlp	25530780	SENT251	3	3	13	13	resveratrol	IFN		3439	0.724
NULL	J_Cell_Biol_2002_Jun_24_157(7)_1267-1278.nxml.txt.nlp	12082084	SENT155	0	0	14	14	forskolin	AC6	PA146096022	112	0.724
NULL	Cell_Oncol_(Dordr)_2014_Nov_20_37(6)_421-428.nxml.txt.nlp	25410120	SENT145	0	0	15	15	vinblastine	P-gp	PA451877	5243	0.724
NULL	Mol_Biol_Cell_2012_May_15_23(10)_1928-1942.nxml.txt.nlp	22438580	SENT180	19	19	28	28	galactose	GAL	PA449725	51083	0.724
NULL	J_Geriatr_Cardiol_2014_Jun_11(2)_151-157.nxml.txt.nlp	25009566	SENT138	2	2	7	7	cilostazol	CDP	PA164746334	1523	0.724
NULL	Arthritis_Res_Ther_2003_Sep_3_5(6)_R317-R328.nxml.txt.nlp	14680506	SENT199	7	7	16	16	rolipram	IFN	PA153906323	3439	0.724
NULL	Croat_Med_J_2014_Aug_55(4)_377-387.nxml.txt.nlp	25165051	SENT136	10	10	21	21	bumetanide	AQP4	PA448682	361	0.724
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Sep_15_68(Pt_10)_o2941.nxml.txt.nlp	23125726	SENT66	30	30	6	6	ethanol	mol	PA448073	90527	0.724
NULL	Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.nxml.txt.nlp	24736980	SENT174	11	11	13	13	rosuvastatin	OATP1B1	PA134308647	10599	0.724
NULL	J_Cell_Biol_2001_Apr_2_153(1)_207-220.nxml.txt.nlp	11285286	SENT487	5	5	13	13	carbachol	DGK	PA448784	8526;1607	0.724
NULL	Drug_Healthc_Patient_Saf_2013_Mar_28_5_79-99.nxml.txt.nlp	23569399	SENT35	15	15	6	6	isoniazid	IFN	PA450112	3439	0.724
NULL	J_Clin_Biochem_Nutr_2010_Jul_17_47(1)_53-58.nxml.txt.nlp	20664731	SENT350	13	13	4	4	rabeprazole	CYP2C19	PA451216	1557	0.724
NULL	Allergy_Asthma_Immunol_Res_2010_Oct_6_2(4)_260-266.nxml.txt.nlp	20885911	SENT40	4	4	6	6	methacholine	TDI	PA165958382	100038246	0.724
NULL	Protein_Cell_2014_Jul_2_5(7)_544-551.nxml.txt.nlp	24691905	SENT120	16	16	7	7	doxorubicin	p53	PA449412	7157	0.724
NULL	Oxid_Med_Cell_Longev_2014_Apr_30_2014_463815.nxml.txt.nlp	24876912	SENT39	3	3	0	0	guanidine	STZ	PA164781028	6484	0.724
NULL	J_Korean_Med_Sci_2010_Apr_19_25(4)_557-563.nxml.txt.nlp	20357998	SENT119	10	10	19	19	cisplatin	IFN	PA449014	3439	0.724
NULL	Exp_Mol_Med_2012_Sep_30_44(9)_545-553.nxml.txt.nlp	22809901	SENT9	0	0	19	19	clozapine	CD36	PA449061	948	0.724
NULL	Curr_Oncol_2009_Jan_16(1)_27-48.nxml.txt.nlp	19229369	SENT264	13	13	15	15	erlotinib	KRAS	PA134687924	3845	0.724
NULL	Behav_Brain_Funct_2012_Feb_28_8_11.nxml.txt.nlp	22369141	SENT38	19	19	9	9	olanzapine	GHRL	PA450688	51738	0.724
NULL	Evid_Based_Complement_Alternat_Med_2011_Jan_3_2011_274858.nxml.txt.nlp	19001481	SENT36	20	20	7	7	fluorescein	CD80	PA164746009	941	0.724
NULL	Cell_Death_Dis_2014_Jan_30_5(1)_e1030.nxml.txt.nlp	24481444	SENT103	13	13	19	19	sorafenib	PUMA	PA7000	27113	0.724
NULL	J_Lipid_Res_2013_May_54(5)_1410-1420.nxml.txt.nlp	23419260	SENT143	9	9	20	20	tetracycline	IDOL	PA451640	29116	0.724
NULL	Mol_Cancer_2012_Jul_12_11_45.nxml.txt.nlp	22788833	SENT111	5	5	12	12	cisplatin	EGFR	PA449014	1956	0.724
NULL	Emerg_Infect_Dis_2012_Jan_18(1)_176-178.nxml.txt.nlp	22261434	SENT15	24	24	20	20	pyrazinamide	EMB	PA451182	133418	0.724
NULL	Pain_2013_Sep_154(9)_1680-1690.nxml.txt.nlp	23707289	SENT164	3	3	12	12	yohimbine	c-fos	PA451946	2353	0.724
NULL	Crit_Care_2011_Mar_11_15(Suppl_1)_P122.nxml.txt.nlp	NULL	SENT2	24	24	15	15	heparin	ACT	PA449855	12;11332;9457;641455	0.724
NULL	Pharmaceuticals_(Basel)_2014_Jan_9_7(1)_46-57.nxml.txt.nlp	24451403	SENT97	20	20	8	8	ritonavir	CDK4	PA451260	1019	0.724
NULL	Oncol_Rep_2014_Apr_28_31(4)_1605-1612.nxml.txt.nlp	24481648	SENT173	2	2	9	9	ponatinib	MRP7	PA165980594	89845;1080	0.724
NULL	Exp_Ther_Med_2013_Sep_8_6(3)_791-795.nxml.txt.nlp	24137267	SENT69	23	23	16	16	thyroglobulin	TTF-1	PA164754910	7080	0.724
NULL	Drug_Target_Insights_2013_Aug_19_7_27-34.nxml.txt.nlp	24023511	SENT98	10	10	16	16	verapamil	P-gp	PA451868	5243	0.724
NULL	Core_Evid_2007_Nov_30_2(2)_121-129.nxml.txt.nlp	21221180	SENT19	4	4	10	10	vincristine	EFS	PA451879	10278	0.724
NULL	Oxid_Med_Cell_Longev_2012_Nov_14_2012_856085.nxml.txt.nlp	23213350	SENT141	0	0	8	8	losartan	p47phox	PA450268	653361	0.724
NULL	Drug_Des_Devel_Ther_2014_Oct_31_8_2121-2128.nxml.txt.nlp	25382970	SENT118	0	0	3	3	curcumin	TTR	PA151958596	7276	0.724
NULL	Acta_Pharmacol_Sin_2010_Nov_18_31(11)_1447-1453.nxml.txt.nlp	20953204	SENT10	20	20	8	8	rimonabant	CB1	PA152407999	1268	0.724
NULL	Breast_Cancer_Res_2014_Sep_28_16(5)_449.nxml.txt.nlp	25260534	SENT481	18	18	5	5	cetuximab	KRAS	PA10040	3845	0.724
NULL	Korean_J_Radiol_2011_Apr_25_May-Jun_12(3)_319-326.nxml.txt.nlp	21603291	SENT82	14	14	4	4	propranolol	DBP	PA451145	3295;1628;2638	0.724
NULL	Protein_Cell_2014_Jun_19_5(6)_469-479.nxml.txt.nlp	24748116	SENT7	10	10	4	4	paclitaxel	EB1	PA450761	9167;22919;10982	0.724
NULL	Eur_J_Clin_Pharmacol_2010_Nov_29_66(11)_1131-1136.nxml.txt.nlp	20669013	SENT121	12	12	16	16	voriconazole	CYP2C19	PA10233	1557	0.724
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT212	6	6	11	11	tacrolimus	SOCS3	PA451578	9021	0.724
NULL	Avicenna_J_Med_2013_Apr-Jun_3(2)_37-47.nxml.txt.nlp	23930241	SENT201	8	8	16	16	cyclophosphamide	CD4	PA449165	920	0.724
NULL	Curr_Neuropharmacol_2014_Mar_12(2)_186-192.nxml.txt.nlp	24669211	SENT33	13	13	35	35	l-methionine	Met	PA450423	79811	0.724
NULL	Reprod_Biol_Endocrinol_2003_Aug_27_1_59.nxml.txt.nlp	12967350	SENT145	17	17	11	11	estradiol	XIAP	PA449503	331	0.724
NULL	Front_Neurosci_2011_Jan_14_4_207.nxml.txt.nlp	21258618	SENT160	15	15	7	7	ethanol	AC7	PA448073	113	0.724
NULL	Br_J_Cancer_2013_Jan_15_108(1)_82-90.nxml.txt.nlp	23321512	SENT174	12	12	2	2	ixabepilone	TUBB		203068	0.724
NULL	Arch_Med_Sci_2014_Aug_29_10(4)_643-650.nxml.txt.nlp	25276146	SENT8	11	11	25	25	everolimus	DES	PA164746311	1674	0.724
NULL	Ann_Rheum_Dis_2011_Apr_22_70(8)_1395-1400.nxml.txt.nlp	21515602	SENT183	14	14	8	8	warfarin	CYP2C9	PA451906	1559	0.723
NULL	Breast_Cancer_Res_2010_Dec_16_12(6)_215.nxml.txt.nlp	21176175	SENT196	18	18	24	24	ns-398	MMP1		4312	0.723
NULL	Diabetes_Obes_Metab_2012_Apr_14(4)_304-314.nxml.txt.nlp	22051096	SENT185	22	22	0	0	metformin	San	PA450395	80218	0.723
NULL	Mol_Biol_Cell_2013_Sep_1_24(17)_2678-2688.nxml.txt.nlp	23864716	SENT135	23	23	7	7	thrombin	PAK1	PA451674	5585;5058	0.723
NULL	Asian-Australas_J_Anim_Sci_2014_Mar_27(3)_414-421.nxml.txt.nlp	25049969	SENT39	12	12	23	23	collagenase	CO2	PA449107	4513	0.723
NULL	ScientificWorldJournal_2013_Apr_24_2013_928197.nxml.txt.nlp	23737732	SENT132	3	3	9	9	pitavastatin	ACR	PA142650384	49	0.723
NULL	Cancer_Med_2013_Jun_21_2(3)_316-324.nxml.txt.nlp	23930208	SENT193	29	29	12	12	bevacizumab	VEGFR2	PA130232992	3791	0.723
NULL	Breast_Cancer_Res_Treat_2013_Sep_1_141(2)_243-248.nxml.txt.nlp	23996142	SENT165	10	10	4	4	raloxifene	CYP2D6	PA451221	1565	0.723
NULL	Br_J_Haematol_2014_Mar_13_164(1)_811-821.nxml.txt.nlp	24328678	SENT230	3	3	7	7	lenalidomide	Aiolos	PA162363968	22806	0.723
NULL	Chemother_Res_Pract_2011_Dec_1_2011_715469.nxml.txt.nlp	22312557	SENT106	13	13	4	4	cisplatin	p53	PA449014	7157	0.723
NULL	Mar_Drugs_2014_Nov_20_12(11)_5576-5589.nxml.txt.nlp	25419998	SENT120	18	18	15	15	metformin	AMPK	PA450395	5563	0.723
NULL	Oncotarget_2013_Nov_24_4(12)_2430-2438.nxml.txt.nlp	24280348	SENT145	31	31	40	40	gefitinib	EGFR	PA131301952	1956	0.723
NULL	Cancer_Cell_2014_Mar_17_25(3)_304-317.nxml.txt.nlp	24651012	SENT291	7	7	5	5	cisplatin	p53	PA449014	7157	0.723
NULL	Iran_J_Neurol_2013_12(4)_157-165.nxml.txt.nlp	24250926	SENT103	0	0	7	7	cimetidine	TGB	PA449001	5473	0.723
NULL	Front_Neurosci_2014_Jan_10_7_270.nxml.txt.nlp	24454277	SENT220	4	4	20	20	resveratrol	SIRT1		23411	0.723
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT106	0	0	15	15	erlotinib	CYP2A6	PA134687924	1548	0.723
NULL	Cancer_Microenviron_2009_May_6_2(1)_59-67.nxml.txt.nlp	19418243	SENT111	26	26	18	18	tetracycline	CCL21	PA451640	6366	0.723
NULL	Diabetes_Care_2012_Jan_9_35(1)_181-188.nxml.txt.nlp	22187441	SENT245	31	31	17	17	tacrolimus	TCF7L2	PA451578	6934	0.723
NULL	Cell_Death_Differ_2010_Sep_5_17(9)_1511-1523.nxml.txt.nlp	20203690	SENT319	8	8	3	3	ethanol	NF-YA	PA448073	4800	0.723
NULL	Breast_Cancer_Res_2014_May_30_16(3)_R55.nxml.txt.nlp	24886669	SENT11	0	0	23	23	doxorubicin	p53	PA449412	7157	0.723
NULL	Cancers_(Basel)_2014_Jul_22_6(3)_1540-1552.nxml.txt.nlp	25055117	SENT431	19	19	0	0	erlotinib	Met	PA134687924	79811	0.723
NULL	Exp_Ther_Med_2014_Apr_29_7(4)_849-854.nxml.txt.nlp	24669239	SENT96	7	7	11	11	rituximab	San	PA451261	80218	0.723
NULL	J_Hematol_Oncol_2010_Nov_24_3_46.nxml.txt.nlp	21106054	SENT31	25	25	27	27	gemcitabine	GEM	PA449748	2669	0.723
NULL	Blood_Cancer_J_2013_Dec_6_3(12)_e167.nxml.txt.nlp	24317089	SENT104	8	8	22	22	lovastatin	IBP	PA450272	706;50619	0.723
NULL	Acta_Pharmacol_Sin_2012_Jun_14_33(6)_832-838.nxml.txt.nlp	22580740	SENT23	16	16	12	12	methotrexate	DDP	PA450428	1678	0.723
NULL	Biosci_Rep_2014_Dec_12_34(6)_e00160.nxml.txt.nlp	25495645	SENT168	6	6	2	2	rosiglitazone	ANGPTL3	PA451283	27329	0.723
NULL	J_Invest_Dermatol_2011_Dec_22_131(12)_2467-2476.nxml.txt.nlp	21938011	SENT129	22	22	2	2	urokinase	VEGF-A	PA451836	7422	0.723
NULL	Oncotarget_2011_Mar_11_2(3)_135-164.nxml.txt.nlp	21411864	SENT194	20	20	12	12	celecoxib	PDK1	PA448871	5170;5163	0.723
NULL	Int_J_Biomed_Sci_2007_Jun_3(2)_123-130.nxml.txt.nlp	23675034	SENT17	18	18	20	20	ranitidine	RAN	PA451224	5901	0.723
NULL	Oncoimmunology_2014_Apr_25_3_e28518.nxml.txt.nlp	25071979	SENT183	26	26	6	6	paclitaxel	CRT	PA450761	811	0.723
NULL	Mol_Cancer_2012_Jul_29_11_48.nxml.txt.nlp	22839996	SENT244	21	21	31	31	l-glutamine	CO2	PA10090	4513	0.723
NULL	J_Occup_Med_Toxicol_2008_Feb_27_3(Suppl_1)_S6.nxml.txt.nlp	18315837	SENT85	6	6	18	18	theophylline	IL-5	PA451647	3567	0.723
NULL	Drug_Target_Insights_2013_Aug_19_7_27-34.nxml.txt.nlp	24023511	SENT40	29	29	9	9	valspodar	P-gp		5243	0.723
NULL	Front_Neurosci_2011_Jul_26_5_92.nxml.txt.nlp	21845173	SENT96	19	19	22	22	naloxone	NRM	PA450586	11270	0.723
NULL	Clin_Ophthalmol_2011_Jun_9_5_771-781.nxml.txt.nlp	21750610	SENT152	16	16	7	7	ranibizumab	VEGF-A	PA164746012	7422	0.723
NULL	Acta_Pharmacol_Sin_2011_Jun_3_32(6)_845-852.nxml.txt.nlp	21642952	SENT156	30	30	4	4	prazosin	TRPV1	PA451093	7442	0.723
NULL	Biomed_Res_Int_2014_Feb_6_2014_323594.nxml.txt.nlp	24689036	SENT87	44	44	30	30	raloxifene	CO2	PA451221	4513	0.723
NULL	Br_J_Pharmacol_2014_Sep_28_171(18)_4255-4272.nxml.txt.nlp	24846338	SENT196	15	15	10	10	duloxetine	gamma	PA10066	9913	0.723
NULL	Nature_2012_Aug_16_488(7411)_384-388.nxml.txt.nlp	22820255	SENT286	8	8	11	11	doxycycline	IL-2	PA449415	3558	0.723
NULL	Breast_Cancer_Res_2010_Aug_23_12(4)_R64.nxml.txt.nlp	20731819	SENT310	11	11	6	6	tamoxifen	CYP2D6	PA451581	1565	0.723
NULL	Breast_Cancer_Res_Treat_2013_Apr_12_138(2)_427-435.nxml.txt.nlp	23479422	SENT27	6	6	20	20	lapatinib	HER2	PA152241907	2064	0.723
NULL	Arthritis_Res_Ther_2010_Sep_8_12(5)_R167.nxml.txt.nlp	20825639	SENT171	27	27	14	14	resveratrol	JNK		5599	0.723
NULL	Lipids_Health_Dis_2011_Feb_28_10_38.nxml.txt.nlp	21352602	SENT101	2	2	7	7	atorvastatin	PCSK9	PA448500	255738	0.723
NULL	Pak_J_Med_Sci_2013_Jan-Mar_29(1)_97-102.nxml.txt.nlp	24353516	SENT9	32	32	15	15	clopidogrel	ADP	PA449053	23038	0.723
NULL	Indian_J_Ophthalmol_2007_Nov-Dec_55(6)_421-425.nxml.txt.nlp	17951897	SENT4	0	0	7	7	ranibizumab	San	PA164746012	80218	0.723
NULL	Cells_2013_Jul_18_2(3)_545-573.nxml.txt.nlp	24709797	SENT293	26	26	14	14	decitabine	FasL	PA164749631	356	0.723
NULL	Cancer_Inform_2013_Feb_13_12_31-51.nxml.txt.nlp	23470717	SENT335	26	26	18	18	tamoxifen	E2F1	PA451581	1869	0.723
NULL	Anesth_Pain_Med_2014_Sep_9_4(4)_e14221.nxml.txt.nlp	25599022	SENT139	3	3	5	5	propofol	LPO	PA451141	4025	0.723
NULL	Neural_Regen_Res_2013_Jul_15_8(20)_1853-1862.nxml.txt.nlp	25206494	SENT137	0	0	12	12	ethanol	p53	PA448073	7157	0.723
NULL	Mol_Cancer_2010_Aug_23_9_222.nxml.txt.nlp	20731837	SENT81	0	0	5	5	gefitinib	ATM	PA131301952	472	0.723
NULL	Orphanet_J_Rare_Dis_2007_Jan_4_2_1.nxml.txt.nlp	17204147	SENT89	21	21	8	8	trypsin	SPINK1	PA451806	6690	0.723
NULL	Diabetes_Metab_J_2013_Oct_17_37(5)_315-325.nxml.txt.nlp	24199159	SENT82	6	6	4	4	resveratrol	SIRT1		23411	0.723
NULL	Pain_Res_Treat_2011_Dec_12_2011_507029.nxml.txt.nlp	22220274	SENT29	14	14	8	8	ceftriaxone	GLT-1	PA448866	6506	0.723
NULL	Br_J_Cancer_2004_Mar_8_90(5)_1003-1010.nxml.txt.nlp	14997197	SENT200	16	16	10	10	fluorouracil	PSK	PA128406956	9344	0.723
NULL	Diabetes_Care_2010_Jun_23_33(6)_1300-1303.nxml.txt.nlp	20332351	SENT111	20	20	36	36	liraglutide	Met	PA165958364	79811	0.723
NULL	Diabetes_Care_2009_Nov_32(Suppl_2)_S384-S391.nxml.txt.nlp	19875586	SENT161	15	15	3	3	simvastatin	S12	PA451363	3351;6206;5713;6268	0.723
NULL	Cell_Death_Differ_2010_May_13_17(5)_774-786.nxml.txt.nlp	19911006	SENT313	18	18	13	13	doxycycline	AATF	PA449415	26574	0.723
NULL	Nucleic_Acids_Res_2005_Jun_8_33(10)_3283-3291.nxml.txt.nlp	15944449	SENT129	21	21	26	26	melphalan	ERCC1	PA450354	2067	0.723
NULL	Cancer_Med_2013_Feb_3_2(1)_11-20.nxml.txt.nlp	24133623	SENT277	11	11	15	15	cetuximab	KRAS	PA10040	3845	0.723
NULL	Eur_J_Pharm_Sci_2012_Jul_16_46(4)_244-258.nxml.txt.nlp	22085636	SENT359	12	12	3	3	pertuzumab	PDK1		5170;5163	0.723
NULL	Oncotarget_2010_Oct_22_1(7)_530-543.nxml.txt.nlp	21317449	SENT98	15	15	13	13	lapatinib	HER2	PA152241907	2064	0.723
NULL	Clin_Epidemiol_2010_Oct_22_2_241-246.nxml.txt.nlp	21152250	SENT7	15	15	24	24	tamoxifen	UGT2B15	PA451581	7366	0.723
NULL	Diabetes_2009_Jul_28_58(7)_1526-1531.nxml.txt.nlp	19401428	SENT189	18	18	4	4	propranolol	FDG	PA451145	23583	0.723
NULL	J_Hematol_Oncol_2010_Mar_23_3_11.nxml.txt.nlp	20331897	SENT143	28	28	24	24	cisplatin	CRT	PA449014	811	0.723
NULL	Iran_Red_Crescent_Med_J_2014_Aug_5_16(8)_e12106.nxml.txt.nlp	25389471	SENT17	17	17	12	12	glucose	CAD	PA449773	1677;790	0.723
NULL	Exp_Gerontol_2010_Aug_45(7-8)_573-579.nxml.txt.nlp	20096767	SENT110	25	25	31	31	nadh	MT-ND4	PA164755085	4538	0.723
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT509	15	15	0	0	olanzapine	PRL	PA450688	5617	0.723
NULL	Breast_Cancer_Res_2013_Nov_29_15(6)_R114.nxml.txt.nlp	24289103	SENT323	28	28	24	24	tamoxifen	EGFR	PA451581	1956	0.723
NULL	Croat_Med_J_2014_Aug_55(4)_377-387.nxml.txt.nlp	25165051	SENT132	12	12	20	20	acetazolamide	CO2	PA448018	4513	0.723
NULL	Evid_Based_Complement_Alternat_Med_2013_May_28_2013_629750.nxml.txt.nlp	23781265	SENT8	2	2	45	45	capsaicin	GADD153	PA448776	1649	0.723
NULL	Pharmaceuticals_(Basel)_2011_May_24_4(5)_770-781.nxml.txt.nlp	NULL	SENT113	5	5	14	14	carvedilol	IL-15	PA448817	3600	0.723
NULL	Int_J_Surg_Oncol_2011_Aug_8_2011_374012.nxml.txt.nlp	22312502	SENT176	13	13	7	7	tamoxifen	STAR	PA451581	6770;2984	0.723
NULL	Br_J_Cancer_2013_Jun_25_108(12)_2464-2469.nxml.txt.nlp	23695016	SENT141	17	17	22	22	paclitaxel	CRT	PA450761	811	0.723
NULL	Clin_Interv_Aging_2009_May_14_4_197-205.nxml.txt.nlp	19503782	SENT291	15	15	29	29	cytarabine	MDR1	PA449177	5243	0.723
NULL	Cancers_(Basel)_2013_Feb_22_5(1)_218-233.nxml.txt.nlp	24216705	SENT239	14	14	19	19	doxorubicin	PI3K	PA449412	5290	0.723
NULL	Curr_Neuropharmacol_2013_Jul_11(4)_338-378.nxml.txt.nlp	24381528	SENT373	15	15	3	3	curcumin	HO-1	PA151958596	3162	0.723
NULL	Chin_J_Cancer_2011_Jul_30(7)_490-496.nxml.txt.nlp	21718595	SENT51	17	17	32	32	gentamicin	CO2	PA449753	4513	0.723
NULL	Arthritis_Res_Ther_2007_Jul_5_9(4)_R64.nxml.txt.nlp	17612394	SENT205	12	12	22	22	indomethacin	PGD2	PA449982	27306	0.723
NULL	Ann_Lab_Med_2013_May_17_33(3)_229-232.nxml.txt.nlp	23667855	SENT60	22	22	8	8	hydroxyurea	MPN	PA449942	83886	0.723
NULL	J_Korean_Med_Sci_2011_Jul_20_26(7)_893-899.nxml.txt.nlp	21738342	SENT77	8	8	5	5	genistein	CD97	PA165109660	976	0.723
NULL	Oncoimmunology_2012_Nov_1_1(8)_1422-1424.nxml.txt.nlp	23243615	SENT34	39	39	37	37	daclizumab	CD25	PA164764446	3669;3559	0.723
NULL	Oncotarget_2013_Apr_10_4(4)_622-635.nxml.txt.nlp	23599172	SENT107	20	20	7	7	lapatinib	EGF	PA152241907	1950	0.723
NULL	Ann_Lab_Med_2012_Jul_20_32(4)_264-269.nxml.txt.nlp	22779067	SENT15	12	12	7	7	rifampin	DST	PA451250	667	0.723
NULL	Cell_Death_Dis_2012_May_3_3(5)_e303.nxml.txt.nlp	22552280	SENT55	11	11	39	39	metformin	AMPK	PA450395	5563	0.723
NULL	J_Immunol_Res_2014_May_21_2014_371087.nxml.txt.nlp	24963497	SENT283	8	8	10	10	decitabine	DAC	PA164749631	13	0.723
NULL	Biomed_Res_Int_2014_Apr_28_2014_549742.nxml.txt.nlp	24877113	SENT137	20	20	22	22	bevacizumab	BMP4	PA130232992	652	0.723
NULL	NDT_Plus_2009_Jan_2(Suppl_1)_i27-i36.nxml.txt.nlp	19461855	SENT47	30	30	22	22	filgrastim	EPO	PA449626	7076;8288;2056	0.723
NULL	J_Gen_Physiol_1964_Sep_1_48(1)_43-60.nxml.txt.nlp	14212149	SENT0	18	18	1	1	glucose	Gen	PA449773	348654	0.723
NULL	Leukemia_2014_Jun_25_28(6)_1280-1288.nxml.txt.nlp	24270737	SENT209	21	21	5	5	cytarabine	PD-L1	PA449177	29126	0.723
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT303	0	0	9	9	resveratrol	AMPK		5563	0.723
NULL	BMB_Rep_2013_Nov_46(11)_544-549.nxml.txt.nlp	24152910	SENT51	19	19	7	7	thrombin	HMGB1	PA451674	3146	0.723
NULL	Eur_J_Med_Res_2014_Jun_24_19(1)_34.nxml.txt.nlp	24961604	SENT100	12	12	9	9	vincristine	BCL11A	PA451879	53335	0.723
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2011_Sep_13_4_47-62.nxml.txt.nlp	22879794	SENT235	23	23	5	5	glimepiride	PPG	PA449761	5552	0.723
NULL	Case_Rep_Surg_2012_Sep_17_2012_230538.nxml.txt.nlp	23024879	SENT30	19	19	25	25	doxorubicin	CHOP	PA449412	1649	0.723
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT153	20	20	28	28	perifosine	JNK	PA165291471	5599	0.723
NULL	Mol_Cancer_2012_Dec_12_11_91.nxml.txt.nlp	23234355	SENT175	26	26	19	19	cetuximab	EGFR	PA10040	1956	0.723
NULL	Diabetes_2013_May_16_62(5)_1697-1708.nxml.txt.nlp	23364453	SENT27	17	17	15	15	exenatide	GLP-1	PA164749238	100125288	0.723
NULL	J_Oncol_2013_Feb_17_2013_872957.nxml.txt.nlp	23476648	SENT129	25	25	7	7	cisplatin	SFN	PA449014	25996;2810	0.723
NULL	Iran_J_Pharm_Res_2014_Autumn_13(4)_1327-1334.nxml.txt.nlp	25587322	SENT156	8	8	12	12	econazole	PLG	PA164746010	5340	0.723
NULL	ScientificWorldJournal_2013_Jun_19_2013_174392.nxml.txt.nlp	23853530	SENT9	21	21	3	3	doxazosin	c-FLIP	PA449407	8837	0.723
NULL	Ann_Lab_Med_2012_Jul_20_32(4)_298-303.nxml.txt.nlp	22779073	SENT40	29	29	37	37	pyrazinamide	EMB	PA451182	133418	0.723
NULL	Environ_Health_Perspect_2009_Nov_26_117(11)_1737-1744.nxml.txt.nlp	20049126	SENT182	17	17	8	8	arsenite	KU70	PA452638	2547	0.723
NULL	Free_Radic_Biol_Med_2013_Aug_61(100)_438-452.nxml.txt.nlp	23608463	SENT117	7	7	9	9	apomorphine	HO-1	PA164781163	3162	0.723
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT74	37	37	10	10	heparin	FGF1	PA449855	2246	0.723
NULL	Arthritis_Res_Ther_2010_Apr_29_12(2)_R73.nxml.txt.nlp	20429888	SENT116	0	0	8	8	bortezomib	COL1A2	PA10252	1278	0.723
NULL	Acta_Pharmacol_Sin_2010_Jan_28_31(1)_102-110.nxml.txt.nlp	20037603	SENT104	12	12	25	25	isoproterenol	CXCR4	PA450121	7852	0.723
NULL	Br_J_Cancer_2012_Jan_3_106(1)_18-24.nxml.txt.nlp	22108516	SENT77	15	15	24	24	irinotecan	TDP1	PA450085	55775	0.723
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jul_16_67(Pt_8)_o2069.nxml.txt.nlp	22091093	SENT52	15	15	6	6	benzaldehyde	mol	PA448571	90527	0.723
NULL	Cancer_Res_Treat_2012_Sep_30_44(3)_195-201.nxml.txt.nlp	23091446	SENT107	14	14	17	17	etoposide	MKP-1	PA449552	1843	0.723
NULL	Breast_Cancer_Res_2004_Aug_5_6(5)_R601-R607.nxml.txt.nlp	15318941	SENT122	19	19	8	8	tamoxifen	p27	PA451581	5715;10534	0.723
NULL	Cancer_Imaging_2011_Oct_3_11(1A)_S129-S145.nxml.txt.nlp	22185786	SENT57	7	7	0	0	tamoxifen	FDG	PA451581	23583	0.723
NULL	Cells_2014_Sep_12_3(3)_914-938.nxml.txt.nlp	25222270	SENT3	16	16	6	6	capsaicin	TRPV1	PA448776	7442	0.723
NULL	BMJ_2011_Aug_4_343_d4588.nxml.txt.nlp	21816733	SENT438	15	15	6	6	clopidogrel	CYP2C9	PA449053	1559	0.723
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R91.nxml.txt.nlp	22541814	SENT162	26	26	29	29	thrombin	HO-1	PA451674	3162	0.723
NULL	Front_Oncol_2012_Oct_2_2_127.nxml.txt.nlp	23061044	SENT20	7	7	16	16	imatinib	EGFR	PA10804	1956	0.723
NULL	Nat_Med_2011_Dec_18_18(1)_120-127.nxml.txt.nlp	22179318	SENT91	4	4	10	10	hemin	HO-1	PA449849	3162	0.723
NULL	J_Biomed_Sci_2013_Jan_25_20(1)_5.nxml.txt.nlp	23350714	SENT79	21	21	14	14	pemetrexed	B12	PA10810	7126;4709	0.723
NULL	Breast_Cancer_Res_2014_May_28_16(3)_R53.nxml.txt.nlp	24886537	SENT320	32	32	17	17	erlotinib	VAV3	PA134687924	10451	0.723
NULL	Exp_Ther_Med_2013_Mar_21_5(3)_987-991.nxml.txt.nlp	23407636	SENT83	21	21	10	10	losartan	IL-8	PA450268	3576	0.723
NULL	Acta_Neuropathol_2012_Mar_16_123(3)_369-380.nxml.txt.nlp	22083253	SENT82	6	6	2	2	vincristine	NF1	PA451879	4763	0.723
NULL	Open_Biochem_J_2011_Sep_23_5_45-51.nxml.txt.nlp	21966325	SENT109	5	5	20	20	diclofenac	ATF6	PA449293	22926	0.723
NULL	Breast_Cancer_Res_2012_Feb_9_14(1)_R27.nxml.txt.nlp	22321971	SENT69	24	24	33	33	phenol	FBS	PA450913	64319;26269	0.723
NULL	Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.nxml.txt.nlp	24736980	SENT181	26	26	40	40	rosuvastatin	OATP1B1	PA134308647	10599	0.723
NULL	Indian_Dermatol_Online_J_2013_Oct-Dec_4(4)_365-368.nxml.txt.nlp	24350028	SENT76	25	25	11	11	clarithromycin	P-gp	PA449028	5243	0.723
NULL	Environ_Sci_Technol_2014_Oct_21_48(20)_12454-12463.nxml.txt.nlp	25232892	SENT61	39	39	8	8	ether	SN2	PA449525	92745	0.723
NULL	Am_J_Physiol_Cell_Physiol_2010_Nov_18_299(5)_C1180-C1194.nxml.txt.nlp	20720182	SENT27	4	4	11	11	hyaluronan	HAS2	PA165958431	3037	0.723
NULL	Front_Neurosci_2014_Jan_10_7_270.nxml.txt.nlp	24454277	SENT196	37	37	41	41	resveratrol	SUR1		6833	0.723
NULL	Indian_J_Endocrinol_Metab_2013_Jul-Aug_17(4)_636-646.nxml.txt.nlp	23961479	SENT138	24	24	9	9	pitavastatin	CYP3A4	PA142650384	1576	0.723
NULL	Breast_Cancer_(Auckl)_2011_Oct_9_5_209-226.nxml.txt.nlp	22084574	SENT29	12	12	6	6	exemestane	aromatase	PA449563	1588	0.723
NULL	Curr_Neuropharmacol_2009_Jun_7(2)_83-95.nxml.txt.nlp	19949566	SENT171	0	0	4	4	levetiracetam	SV2A	PA450206	9900	0.723
NULL	Biologics_2009_Jul_13_3_289-301.nxml.txt.nlp	19707416	SENT187	18	18	29	29	docetaxel	HER2	PA449383	2064	0.723
NULL	Neural_Dev_2014_Nov_7_9(1)_25.nxml.txt.nlp	NULL	SENT351	3	3	16	16	choline	NeuN	PA448976	146713	0.723
NULL	Clin_Interv_Aging_2013_Jul_16_8_889-897.nxml.txt.nlp	23898224	SENT142	3	3	9	9	gemcitabine	SIRT1	PA449748	23411	0.723
NULL	Biomed_Res_Int_2013_Jun_19_2013_230805.nxml.txt.nlp	23862137	SENT227	33	33	17	17	bortezomib	IL-10	PA10252	3586	0.723
NULL	Eur_J_Med_Res_2010_Feb_26_15(2)_81-83.nxml.txt.nlp	20452889	SENT9	7	7	26	26	raltegravir	CD4		920	0.723
NULL	Int_J_Nanomedicine_2007_Sep_2(3)_277-288.nxml.txt.nlp	18019828	SENT46	36	36	13	13	vincristine	CHOP	PA451879	1649	0.723
NULL	Indian_J_Palliat_Care_2009_Jul-Dec_15(2)_132-136.nxml.txt.nlp	20668592	SENT33	13	13	15	15	gabapentin	NNT	PA449720	23530	0.723
NULL	Mol_Cancer_2008_May_19_7_40.nxml.txt.nlp	18489772	SENT131	15	15	6	6	bortezomib	PIR	PA10252	8544	0.723
NULL	Breast_Cancer_Res_2010_May_18_12(Suppl_1)_P20.nxml.txt.nlp	NULL	SENT15	8	8	15	15	vinblastine	CDKN1A	PA451877	1026	0.723
NULL	Front_Oncol_2014_May_1_4_80.nxml.txt.nlp	24822169	SENT307	12	12	4	4	curcumin	DNMT1	PA151958596	1786	0.723
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT210	0	0	13	13	doxorubicin	B7-H1	PA449412	29126	0.723
NULL	Br_J_Pharmacol_2014_May_171(10)_2659-2670.nxml.txt.nlp	24116661	SENT314	11	11	8	8	naringenin	TRPP2	PA151958361	5311	0.723
NULL	Diabetes_Care_2009_Nov_32(Suppl_2)_S217-S222.nxml.txt.nlp	19875555	SENT118	9	9	6	6	metformin	GLP-1	PA450395	100125288	0.723
NULL	Oncol_Rep_2013_Apr_23_29(4)_1268-1274.nxml.txt.nlp	23354756	SENT183	15	15	32	32	trastuzumab	SLC25A43	PA451743	203427	0.723
NULL	Mol_Biol_Cell_2014_May_15_25(10)_1653-1665.nxml.txt.nlp	24648496	SENT262	16	16	19	19	choline	CHO2	PA448976	10682	0.723
NULL	Cells_2014_Jun_26_3(3)_662-673.nxml.txt.nlp	24971848	SENT97	37	37	32	32	capsaicin	TRPV1	PA448776	7442	0.723
NULL	Arthritis_Res_Ther_2005_Dec_1_7(1)_R149-R155.nxml.txt.nlp	15642135	SENT67	7	7	3	3	infliximab	IL-6	PA452639	3569	0.723
NULL	Neural_Plast_2013_Jul_18_2013_438072.nxml.txt.nlp	23970977	SENT73	14	14	8	8	estradiol	ARC	PA449503	8996;23237	0.723
NULL	Scientifica_(Cairo)_2012_Dec_17_2012_502378.nxml.txt.nlp	24278706	SENT132	24	24	17	17	ritonavir	CYP3A4	PA451260	1576	0.723
NULL	Mol_Immunol_2009_Mar_46(6)_1149-1162.nxml.txt.nlp	19100624	SENT212	20	20	15	15	amantadine	C5L2	PA448360	27202	0.723
NULL	Oncotarget_2012_Nov_17_4(1)_18-28.nxml.txt.nlp	23248157	SENT144	21	21	33	33	pargyline	p53	PA450797	7157	0.723
NULL	Cancer_Metab_2013_Sep_6_1_19.nxml.txt.nlp	24280423	SENT50	13	13	30	30	hydrocortisone	EGF	PA449905	1950	0.723
NULL	J_Cell_Biol_2003_Sep_29_162(7)_1197-1209.nxml.txt.nlp	14517203	SENT374	17	17	4	4	mimosine	BRCA1	PA164752445	672	0.723
NULL	Arch_Plast_Surg_2012_Mar_14_39(2)_173-174.nxml.txt.nlp	22783520	SENT12	26	26	34	34	tazarotene	CO2	PA164746821	4513	0.723
NULL	Mol_Cancer_2012_Jul_12_11_45.nxml.txt.nlp	22788833	SENT143	15	15	21	21	cisplatin	EGFR	PA449014	1956	0.723
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Nov_23_69(Pt_12)_o1804-o1805.nxml.txt.nlp	24860293	SENT75	14	14	32	32	nitrile	TLC	PA450636	3933	0.723
NULL	Leukemia_2014_Mar_13_28(3)_600-608.nxml.txt.nlp	24240203	SENT115	6	6	8	8	nutlin-3	p53		7157	0.723
NULL	Diabetes_2013_Mar_14_62(3)_953-964.nxml.txt.nlp	23223176	SENT2	13	13	32	32	glucose	ROS	PA449773	6098	0.723
NULL	J_Immunother_Cancer_2013_Nov_7_1(Suppl_1)_P71.nxml.txt.nlp	NULL	SENT5	5	5	7	7	decitabine	DAC	PA164749631	13	0.723
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT23	17	17	9	9	trastuzumab	STAT3	PA451743	6774	0.723
NULL	Oncoimmunology_2014_Apr_25_3_e28518.nxml.txt.nlp	25071979	SENT186	19	19	25	25	paclitaxel	HMGB1	PA450761	3146	0.723
NULL	J_Mol_Med_(Berl)_2014_May_10_92(7)_709-722.nxml.txt.nlp	24811491	SENT135	32	32	7	7	pertuzumab	HER2		2064	0.723
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Nov_7_65(Pt_12)_o3012.nxml.txt.nlp	21578749	SENT62	13	13	30	30	ethanol	C11	PA448073	1109	0.723
NULL	Acta_Pharmacol_Sin_2012_Dec_17_33(12)_1441-1458.nxml.txt.nlp	22983389	SENT368	4	4	24	24	paclitaxel	AMPK	PA450761	5563	0.723
NULL	Front_Genet_2014_Nov_28_5_386.nxml.txt.nlp	25506353	SENT270	28	28	40	40	hyaluronidase	F12	PA164745713	2161	0.723
NULL	Clin_Ophthalmol_2011_Oct_13_5_1479-1491.nxml.txt.nlp	22069350	SENT94	12	12	7	7	ivermectin	C23	PA450133	4691	0.723
NULL	Can_J_Infect_Dis_Med_Microbiol_2014_Nov-Dec_25(6)_327-343.nxml.txt.nlp	25587296	SENT92	3	3	8	8	itraconazole	P-gp	PA450132	5243	0.723
NULL	Biomed_Res_Int_2014_Apr_10_2014_615363.nxml.txt.nlp	24818147	SENT150	39	39	19	19	thrombin	ADP	PA451674	23038	0.723
NULL	J_Cancer_Res_Clin_Oncol_2011_Feb_11_137(2)_183-192.nxml.txt.nlp	21069385	SENT31	24	24	42	42	trastuzumab	ERBB2	PA451743	2064	0.723
NULL	Clin_Exp_Otorhinolaryngol_2011_Jun_31_4(2)_77-82.nxml.txt.nlp	21716954	SENT117	2	2	8	8	minocycline	Bcl-2	PA450519	596	0.723
NULL	Biosci_Rep_2012_Dec_20_33(1)_e00011.nxml.txt.nlp	23137297	SENT148	30	30	11	11	heparin	RPSA	PA449855	3921	0.723
NULL	Acta_Pharmacol_Sin_2011_Feb_4_32(2)_259-269.nxml.txt.nlp	21293479	SENT177	13	13	6	6	sn-38	UGT1A6		54578	0.723
NULL	Apoptosis_2011_Jul_23_16(7)_708-721.nxml.txt.nlp	21516346	SENT407	35	35	30	30	etoposide	CD95	PA449552	355	0.723
NULL	Cancer_Cell_Int_2005_Jul_24_5_22.nxml.txt.nlp	16042792	SENT7	16	16	11	11	vincristine	NAC	PA451879	22861	0.723
NULL	J_Biol_Chem_2009_Oct_16_284(42)_28885-28895.nxml.txt.nlp	19687008	SENT136	18	18	8	8	fluvastatin	PCSK9	PA449688	255738	0.723
NULL	J_Cell_Biol_1999_Jan_11_144(1)_99-112.nxml.txt.nlp	9885247	SENT404	26	26	16	16	paclitaxel	MAP2C	PA450761	4133	0.723
NULL	Front_Neurol_2013_Sep_3_4_122.nxml.txt.nlp	24027553	SENT28	14	14	27	27	thrombin	HTRA1	PA451674	5654	0.723
NULL	Br_J_Pharmacol_2011_Nov_164(5)_1522-1533.nxml.txt.nlp	21557728	SENT146	17	17	12	12	cangrelor	ADP	PA165945763	23038	0.723
NULL	Arthritis_Res_Ther_2006_Mar_6_8(2)_R53.nxml.txt.nlp	16519795	SENT105	2	2	8	8	methotrexate	IL-10	PA450428	3586	0.723
NULL	Iran_J_Pharm_Res_2014_Autumn_13(4)_1393-1401.nxml.txt.nlp	25587329	SENT9	3	3	8	8	celecoxib	ABCG2	PA448871	9429	0.723
NULL	Crit_Care_2013_Mar_19_17(Suppl_2)_P435.nxml.txt.nlp	NULL	SENT12	2	2	28	28	ranitidine	mol	PA451224	90527	0.723
NULL	Int_J_Surg_Case_Rep_2014_Oct_23_5(12)_979-983.nxml.txt.nlp	25460452	SENT171	25	25	15	15	carboplatin	CK7	PA448803	3855	0.723
NULL	Croat_Med_J_2011_Feb_52(1)_41-47.nxml.txt.nlp	21328719	SENT145	27	27	1	1	risperidone	Gen	PA451257	348654	0.723
NULL	Front_Neurosci_2014_Nov_10_8_364.nxml.txt.nlp	25426018	SENT261	8	8	2	2	dextran	ANOVA	PA449261	4858	0.723
NULL	J_Gen_Physiol_2013_Aug_142(2)_137-155.nxml.txt.nlp	23858003	SENT378	26	26	31	31	mibefradil	ACTH	PA450492	5443	0.723
NULL	Neurosci_Lett_2008_Apr_25_435(3)_190-193.nxml.txt.nlp	18343032	SENT17	9	9	30	30	trypsin	B27	PA451806	56246	0.723
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT374	9	9	4	4	resveratrol	SRC3		8202	0.723
NULL	Cancer_Med_2014_Apr_7_3(2)_362-375.nxml.txt.nlp	24515916	SENT247	15	15	17	17	zoledronate	IL-2	PA10235	3558	0.723
NULL	Cogn_Neurodyn_2012_Apr_13_6(2)_169-183.nxml.txt.nlp	22511913	SENT354	13	13	19	19	phenylephrine	CRT	PA450935	811	0.723
NULL	Clin_Epidemiol_2010_Oct_22_2_241-246.nxml.txt.nlp	21152250	SENT7	15	15	29	29	tamoxifen	UGT1A8	PA451581	54576	0.723
NULL	Arthritis_Res_Ther_2006_Jul_21_8(4)_R130.nxml.txt.nlp	16859540	SENT116	2	2	14	14	atorvastatin	CD59	PA448500	966	0.723
NULL	Acta_Pharmacol_Sin_2013_Feb_12_34(2)_255-261.nxml.txt.nlp	23147557	SENT126	29	29	26	26	pioglitazone	CYP2C8	PA450970	1558	0.723
NULL	Cell_Commun_Signal_2013_Apr_17_11_27.nxml.txt.nlp	23594441	SENT88	15	15	21	21	doxorubicin	p53	PA449412	7157	0.723
NULL	Breast_Cancer_Res_2014_May_23_16(3)_R50.nxml.txt.nlp	24887458	SENT193	16	16	6	6	trastuzumab	HER2	PA451743	2064	0.723
NULL	Onco_Targets_Ther_2014_Sep_9_7_1571-1582.nxml.txt.nlp	25228815	SENT155	8	8	6	6	sunitinib	VEGFR2	PA162372840	3791	0.723
NULL	Pharm_Methods_2011_Jan-Mar_2(1)_3-8.nxml.txt.nlp	23781422	SENT142	6	6	10	10	heroin	TLC	PA452619	3933	0.723
NULL	Front_Pharmacol_2014_Sep_2_5_204.nxml.txt.nlp	25228881	SENT97	5	5	26	26	methamphetamine	IL-6	PA450403	3569	0.723
NULL	Cell_Commun_Signal_2014_May_15_12_34.nxml.txt.nlp	24885272	SENT173	17	17	15	15	heparin	FGF2	PA449855	2247;2258	0.723
NULL	Sci_Rep_2015_Jan_19_5_7856.nxml.txt.nlp	25598223	SENT382	4	4	9	9	docetaxel	JNK	PA449383	5599	0.723
NULL	Am_J_Physiol_Cell_Physiol_2014_Jan_15_306(2)_C89-C97.nxml.txt.nlp	24133067	SENT488	9	9	14	14	hyaluronan	CD44	PA165958431	960	0.723
NULL	Mol_Cancer_2008_Jun_5_7_50.nxml.txt.nlp	18534018	SENT157	3	3	6	6	bortezomib	p38	PA10252	10598;1432;7965	0.723
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Oct_29_67(Pt_11)_o3069-o3070.nxml.txt.nlp	22220078	SENT65	15	15	7	7	benzaldehyde	mol	PA448571	90527	0.723
NULL	BMB_Rep_2013_Nov_46(11)_544-549.nxml.txt.nlp	24152910	SENT101	10	10	24	24	thrombin	HMGB1	PA451674	3146	0.723
NULL	Neural_Regen_Res_2014_Mar_15_9(6)_622-629.nxml.txt.nlp	25206865	SENT15	4	4	20	20	vasopressin	c-Jun	PA451858	3725	0.723
NULL	J_Cell_Mol_Med_2014_Apr_20_18(4)_709-720.nxml.txt.nlp	24444314	SENT262	6	6	25	25	metformin	p53	PA450395	7157	0.723
NULL	Br_J_Cancer_2012_Sep_4_107(6)_947-955.nxml.txt.nlp	22892392	SENT156	13	13	9	9	tamoxifen	ERBB2	PA451581	2064	0.723
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT292	26	26	4	4	resveratrol	Bcl-2		596	0.723
NULL	Oncologist_2011_Jan_6_16(1)_5-24.nxml.txt.nlp	21212434	SENT194	14	14	11	11	temozolomide	IFN	PA451609	3439	0.723
NULL	Oncotarget_2012_May_18_3(5)_525-534.nxml.txt.nlp	22619113	SENT93	31	31	12	12	fludarabine	MCL1	PA449655	4170	0.723
NULL	Int_J_Mol_Sci_2014_Nov_5_15(11)_20240-20253.nxml.txt.nlp	25380525	SENT436	2	2	8	8	l-arginine	CAT-1	PA448478	6541	0.723
NULL	Breast_Cancer_Res_2014_May_28_16(3)_R53.nxml.txt.nlp	24886537	SENT340	41	41	36	36	tamoxifen	VAV3	PA451581	10451	0.723
NULL	Front_Neuroanat_2014_Sep_9_8_96.nxml.txt.nlp	25249946	SENT105	17	17	32	32	paraformaldehyde	San	PA450790	80218	0.723
NULL	Biol_Open_2014_Aug_29_3(9)_850-860.nxml.txt.nlp	25171888	SENT271	16	16	23	23	l-glutamine	CO2	PA10090	4513	0.723
NULL	Diabetes_2013_May_16_62(5)_1537-1546.nxml.txt.nlp	23321073	SENT92	37	37	43	43	fluorescein	San	PA164746009	80218	0.723
NULL	Subst_Abuse_Rehabil_2011_Mar_16_2_11-20.nxml.txt.nlp	24474851	SENT39	30	30	15	15	ketamine	CYP2C9	PA450144	1559	0.723
NULL	Environ_Health_Perspect_2008_Mar_11_116(3)_297-302.nxml.txt.nlp	18335094	SENT174	12	12	9	9	permethrin	OTC	PA164743137	5009	0.723
NULL	Mol_Cancer_2012_Apr_26_11_26.nxml.txt.nlp	22537224	SENT141	16	16	42	42	bortezomib	FANCF	PA10252	2188	0.723
NULL	Mol_Pain_2014_Aug_15_10_53.nxml.txt.nlp	25127716	SENT98	12	12	2	2	paclitaxel	CCL3	PA450761	6348	0.723
NULL	Curr_Med_Chem_2014_May_21(14)_1595-1606.nxml.txt.nlp	23992330	SENT260	15	15	20	20	trastuzumab	PTEN	PA451743	5728	0.723
NULL	Clin_Ophthalmol_2007_Mar_1(1)_61-64.nxml.txt.nlp	19668467	SENT30	13	13	10	10	ethanol	castor	PA448073	54897	0.723
NULL	Semin_Immunopathol_2014_Nov_27_36(1)_3-12.nxml.txt.nlp	24281248	SENT52	27	27	17	17	lipase	HSL	PA450239	3991	0.723
NULL	Arch_Med_Sci_2013_Apr_20_9(2)_332-339.nxml.txt.nlp	23671446	SENT157	9	9	17	17	midazolam	p38	PA450496	10598;1432;7965	0.723
NULL	Int_J_Breast_Cancer_2011_Sep_6_2011_352182.nxml.txt.nlp	22295219	SENT40	0	0	7	7	trastuzumab	San	PA451743	80218	0.723
NULL	Acta_Pharmacol_Sin_2012_Jul_4_33(7)_897-908.nxml.txt.nlp	22659625	SENT205	33	33	21	21	bleomycin	PI3K	PA448645	5290	0.723
NULL	Exp_Ther_Med_2013_Jun_2_5(6)_1701-1709.nxml.txt.nlp	23837058	SENT258	29	29	3	3	cisplatin	HK1	PA449014	3098;51361;3739	0.723
NULL	BMB_Rep_2014_Oct_47(10)_575-580.nxml.txt.nlp	24499675	SENT50	43	43	48	48	arsenite	p53	PA452638	7157	0.723
NULL	Oncotarget_2012_May_19_3(5)_535-545.nxml.txt.nlp	22619121	SENT83	15	15	31	31	camptothecin	MYCN	PA153590860	4613	0.723
NULL	Cells_2012_Aug_24_1(3)_576-596.nxml.txt.nlp	24710491	SENT304	17	17	5	5	l-glutamine	HL-1	PA10090	55600	0.723
NULL	Oncotarget_2014_Mar_13_5(4)_1101-1110.nxml.txt.nlp	24658355	SENT257	7	7	2	2	cisplatin	MKP-1	PA449014	1843	0.722
NULL	Br_J_Cancer_1997_76(4)_474-479.nxml.txt.nlp	9275024	SENT12	26	26	28	28	cisplatin	DDP	PA449014	1678	0.722
NULL	Clin_Pharmacol_2013_Apr_19_5_67-83.nxml.txt.nlp	23650452	SENT28	30	30	8	8	ticagrelor	CYP3A4	PA165374673	1576	0.722
NULL	Cancer_Cell_Int_2004_Mar_19_4_3.nxml.txt.nlp	15035672	SENT103	1	1	7	7	etoposide	PC3	PA449552	57332;7832;5122	0.722
NULL	Eur_J_Clin_Pharmacol_2009_Sep_3_65(9)_957.nxml.txt.nlp	19415250	SENT18	17	17	21	21	entacapone	PRX	PA164748726	9588;57716	0.722
NULL	Hum_Genomics_2013_Apr_5_7(1)_10.nxml.txt.nlp	23561625	SENT160	18	18	10	10	flavopiridol	CDK7	PA452627	1022	0.722
NULL	Acta_Vet_Scand_2009_May_7_51(1)_22.nxml.txt.nlp	19422714	SENT201	2	2	14	14	dexmedetomidine	CO2	PA449256	4513	0.722
NULL	Exp_Ther_Med_2013_Oct_2_6(4)_1062-1066.nxml.txt.nlp	24137317	SENT92	26	26	8	8	erlotinib	SF2	PA134687924	6426	0.722
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT214	39	39	41	41	metformin	HIF-1	PA450395	29072	0.722
NULL	Curr_Hypertens_Rep_2013_Oct_23_15(6)_547-558.nxml.txt.nlp	24146223	SENT188	9	9	28	28	eprosartan	OSCAR	PA449481	126014	0.722
NULL	Emerg_Infect_Dis_2007_Jul_13(7)_1024-1030.nxml.txt.nlp	18214174	SENT26	29	29	34	34	linezolid	LSE	PA450233	54414	0.722
NULL	Onco_Targets_Ther_2014_Sep_9_7_1571-1582.nxml.txt.nlp	25228815	SENT189	8	8	15	15	sunitinib	VEGFA	PA162372840	7422	0.722
NULL	Oxid_Med_Cell_Longev_2009_Sep-Oct_2(4)_214-221.nxml.txt.nlp	20716907	SENT279	6	6	9	9	pilocarpine	ANOVA	PA450962	4858	0.722
NULL	Iran_J_Basic_Med_Sci_2012_Jan-Feb_15(1)_678-682.nxml.txt.nlp	23493931	SENT41	10	10	14	14	ceftazidime	CTX	PA448861	1593	0.722
NULL	Cancer_Metastasis_Rev_2010_Sep_18_29(3)_529-542.nxml.txt.nlp	20717705	SENT334	2	2	33	33	urokinase	PC-3	PA451836	692094	0.722
NULL	Cancer_Res_Treat_2014_Jan_15_46(1)_48-54.nxml.txt.nlp	24520223	SENT15	26	26	32	32	bevacizumab	KRAS	PA130232992	3845	0.722
NULL	Br_J_Cancer_2009_Mar_24_100(6)_870-873.nxml.txt.nlp	19293806	SENT64	18	18	2	2	gemcitabine	CDA	PA449748	978	0.722
NULL	Acta_Pharmacol_Sin_2010_Feb_5_31(2)_137-144.nxml.txt.nlp	20139896	SENT117	26	26	4	4	zileuton	5-LOX	PA451955	240	0.722
NULL	Health_Econ_Rev_2013_Aug_6_3_18.nxml.txt.nlp	23919494	SENT258	28	28	8	8	palivizumab	IMPACT	PA164748781	55364	0.722
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT138	16	16	11	11	etravirine	CYP3A	PA166014703	1574	0.722
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT148	0	0	9	9	ritonavir	ABCC4	PA451260	10257	0.722
NULL	J_Cardiothorac_Surg_2013_May_13_8_127.nxml.txt.nlp	23668669	SENT5	28	28	36	36	ropivacaine	EDA	PA451271	1896	0.722
NULL	Syst_Synth_Biol_2011_Jun_26_5(1-2)_21-31.nxml.txt.nlp	21949673	SENT83	31	31	3	3	fluorescein	FDG	PA164746009	23583	0.722
NULL	J_Cell_Biol_2005_Jul_4_170(1)_61-72.nxml.txt.nlp	15998799	SENT644	6	6	18	18	geldanamycin	AKT	PA152031327	207	0.722
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Dec_12_66(Pt_1)_o123.nxml.txt.nlp	21580013	SENT71	0	0	5	5	benzaldehyde	mol	PA448571	90527	0.722
NULL	Braz_J_Med_Biol_Res_2014_Feb_17_47(2)_101-109.nxml.txt.nlp	24519125	SENT194	26	26	18	18	phentolamine	IL-6	PA450926	3569	0.722
NULL	Cell_Cycle_2013_Feb_1_12(3)_409-416.nxml.txt.nlp	23324337	SENT63	13	13	10	10	nutlin-3	p53		7157	0.722
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT95	20	20	17	17	imatinib	ABCG2	PA10804	9429	0.722
NULL	Orphanet_J_Rare_Dis_2014_Aug_8_9(1)_126.nxml.txt.nlp	NULL	SENT142	40	40	12	12	ixabepilone	p53		7157	0.722
NULL	CNS_Neurosci_Ther_2009_Spring_15(1)_32-51.nxml.txt.nlp	19228178	SENT215	16	16	22	22	ramelteon	CYP3A4	PA164744896	1576	0.722
NULL	Front_Neurosci_2013_Dec_17_7_245.nxml.txt.nlp	24381538	SENT69	19	19	7	7	memantine	FMR1	PA10364	2332	0.722
NULL	Cancer_Cell_Int_2012_Jun_18_12_30.nxml.txt.nlp	22709569	SENT75	17	17	4	4	doxorubicin	PLCG2	PA449412	5336	0.722
NULL	Breast_Cancer_Res_2007_Dec_17_9(6)_115.nxml.txt.nlp	18190722	SENT70	25	25	34	34	trastuzumab	HER-2	PA451743	2064	0.722
NULL	Oxid_Med_Cell_Longev_2012_Jul_8_2012_624925.nxml.txt.nlp	22829959	SENT69	28	28	10	10	levodopa	DJ-1	PA450213	11315	0.722
NULL	Acta_Pharmacol_Sin_2011_Apr_28_32(4)_495-502.nxml.txt.nlp	21441945	SENT223	19	19	7	7	diclofenac	SDH	PA449293	1757;10993	0.722
NULL	Clin_Ophthalmol_2010_Oct_21_4_1229-1236.nxml.txt.nlp	21060677	SENT88	42	42	40	40	latanoprost	BAK	PA164774763	578	0.722
NULL	Trials_2014_Sep_7_15(1)_352.nxml.txt.nlp	NULL	SENT213	4	4	12	12	atorvastatin	PMI	PA448500	8834;5373	0.722
NULL	Front_Oncol_2014_Apr_9_4_75.nxml.txt.nlp	24782986	SENT240	22	22	6	6	paclitaxel	CD117	PA450761	3815	0.722
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT242	17	17	19	19	trastuzumab	HER2	PA451743	2064	0.722
NULL	J_Hematol_Oncol_2013_Sep_5_6_66.nxml.txt.nlp	24010946	SENT301	38	38	6	6	bevacizumab	CRT	PA130232992	811	0.722
NULL	Arthritis_Res_Ther_2008_Apr_16_10(2)_R43.nxml.txt.nlp	18416822	SENT240	8	8	5	5	sr144528	CB2		1269	0.722
NULL	Clin_Ophthalmol_2008_Dec_2(4)_829-836.nxml.txt.nlp	19668437	SENT123	21	21	13	13	cyclosporine	KCS	PA449167	3771	0.722
NULL	EMBO_Mol_Med_2012_Jun_13_4(6)_515-527.nxml.txt.nlp	22416035	SENT179	10	10	18	18	olaparib	GADD45		1647	0.722
NULL	Neuropsychopharmacology_2009_Sep_3_34(10)_2296-2304.nxml.txt.nlp	19494804	SENT236	29	29	31	31	dantrolene	DAN	PA449208	5073;4681	0.722
NULL	Int_J_Health_Geogr_2012_Dec_14_11_53.nxml.txt.nlp	23241450	SENT162	14	14	8	8	oseltamivir	spatial	PA450721	219793	0.722
NULL	Cancer_Metab_2014_May_28_2(Suppl_1)_O23.nxml.txt.nlp	NULL	SENT18	0	0	6	6	metformin	PRAS40	PA450395	84335	0.722
NULL	Arthritis_Res_Ther_2005_Feb_17_7(Suppl_1)_P88.nxml.txt.nlp	NULL	SENT31	0	0	13	13	etanercept	p38	PA449515	10598;1432;7965	0.722
NULL	J_Clin_Biochem_Nutr_2007_May_25_40(3)_194-202.nxml.txt.nlp	18398496	SENT450	14	14	4	4	simvastatin	Q10	PA451363	27161	0.722
NULL	Ther_Clin_Risk_Manag_2006_Sep_2(3)_281-295.nxml.txt.nlp	18360603	SENT80	10	10	25	25	heparin	NOF	PA449855	740	0.722
NULL	J_Biol_Chem_2009_Oct_16_284(42)_28885-28895.nxml.txt.nlp	19687008	SENT36	2	2	12	12	fenofibrate	PCSK9	PA449594	255738	0.722
NULL	Cardiol_Res_Pract_2012_Apr_22_2012_181394.nxml.txt.nlp	22577589	SENT218	6	6	11	11	simvastatin	TLR4	PA451363	7099	0.722
NULL	Bioinformation_2010_Mar_31_4(9)_417-420.nxml.txt.nlp	20975892	SENT8	17	17	11	11	lamivudine	IFN	PA450163	3439	0.722
NULL	Clin_Pharmacokinet_2014_Jun_27_53(8)_741-751.nxml.txt.nlp	24968986	SENT295	7	7	4	4	doxorubicin	ABCG2	PA449412	9429	0.722
NULL	Biochem_Res_Int_2010_Aug_4_2010_549572.nxml.txt.nlp	21188077	SENT30	27	27	2	2	l-phenylalanine	TAT	PA450931	6898	0.722
NULL	Exp_Ther_Med_2014_Nov_17_8(5)_1484-1488.nxml.txt.nlp	25289046	SENT138	31	31	14	14	cisplatin	ECRG2	PA449014	84651	0.722
NULL	Breast_Cancer_Res_2012_Aug_8_14(4)_R116.nxml.txt.nlp	22873525	SENT314	10	10	15	15	trastuzumab	PTEN	PA451743	5728	0.722
NULL	Oncol_Lett_2013_Aug_17_6(2)_295-305.nxml.txt.nlp	24137320	SENT343	16	16	4	4	tamoxifen	CDC2	PA451581	5424	0.722
NULL	Arthritis_Res_Ther_2014_Oct_30_16(5)_467.nxml.txt.nlp	25359150	SENT14	8	8	0	0	adalimumab	CXCL13	PA10004	10563	0.722
NULL	Curr_Gerontol_Geriatr_Res_2011_May_11_2011_624156.nxml.txt.nlp	21765826	SENT212	8	8	26	26	cimetidine	NAC	PA449001	22861	0.722
NULL	Oncotarget_2014_Aug_29_5(17)_7217-7259.nxml.txt.nlp	25277175	SENT301	21	21	15	15	axitinib	CSF1R	PA164924493	1436	0.722
NULL	Acta_Pharmacol_Sin_2012_Jan_28_33(1)_75-81.nxml.txt.nlp	22120969	SENT89	34	34	36	36	exenatide	GLP-1	PA164749238	100125288	0.722
NULL	Front_Chem_2014_Aug_25_2_69.nxml.txt.nlp	25202689	SENT43	0	0	14	14	trastuzumab	HER2	PA451743	2064	0.722
NULL	J_Vet_Med_Sci_2014_Mar_22_76(3)_415-421.nxml.txt.nlp	24270802	SENT211	18	18	11	11	fasudil	Rho	PA165946121	29984	0.722
NULL	Cent_European_J_Urol_2013_Dec_19_66(4)_394-404.nxml.txt.nlp	24757527	SENT262	8	8	6	6	sunitinib	IFN	PA162372840	3439	0.722
NULL	Indian_J_Psychiatry_2011_Apr-Jun_53(2)_128-133.nxml.txt.nlp	21772644	SENT108	19	19	5	5	olanzapine	5-HT2C	PA450688	3358	0.722
NULL	Cardiol_Res_Pract_2012_Jan_5_2012_909154.nxml.txt.nlp	22347666	SENT386	5	5	1	1	heparin	RISC	PA449855	59342	0.722
NULL	J_Thyroid_Res_2010_Apr_13_2010_279468.nxml.txt.nlp	21048836	SENT392	8	8	29	29	sorafenib	BRAF	PA7000	673	0.722
NULL	Front_Immunol_2012_Jun_7_3_131.nxml.txt.nlp	22701116	SENT178	15	15	5	5	dextran	SP-A	PA449261	653509	0.722
NULL	Eur_J_Med_Res_2010_Nov_25_15(11)_483-492.nxml.txt.nlp	21159573	SENT52	29	29	47	47	l-glutamine	CO2	PA10090	4513	0.722
NULL	Eur_Radiol_2011_Jun_3_21(6)_1188-1199.nxml.txt.nlp	21127880	SENT65	11	11	21	21	epirubicin	BCS	PA449476	617	0.722
NULL	Oncoimmunology_2013_Jun_1_2(6)_e24677.nxml.txt.nlp	23894722	SENT113	23	23	19	19	cetuximab	CD83	PA10040	9308	0.722
NULL	Neuroimage_Clin_2013_Sep_6_3_290-300.nxml.txt.nlp	24273714	SENT156	0	0	10	10	pioglitazone	spatial	PA450970	219793	0.722
NULL	Front_Oncol_2014_Nov_10_4_318.nxml.txt.nlp	25426449	SENT113	17	17	4	4	topotecan	PI3K	PA451729	5290	0.722
NULL	Nat_Commun_2014_Dec_11_5_5732.nxml.txt.nlp	25501034	SENT185	33	33	31	31	capsaicin	TRPV1	PA448776	7442	0.722
NULL	Nat_Commun_2013_Apr_23_4_1758.nxml.txt.nlp	23612299	SENT560	3	3	8	8	isoproterenol	SOD1	PA450121	6647	0.722
NULL	Oxid_Med_Cell_Longev_2013_Jul_9_2013_574029.nxml.txt.nlp	23936610	SENT181	4	4	12	12	resveratrol	p65		5970	0.722
NULL	Ther_Clin_Risk_Manag_2006_Sep_2(3)_297-301.nxml.txt.nlp	18360604	SENT49	7	7	10	10	paricalcitol	PTH	PA450798	5741	0.722
NULL	Acta_Pharmacol_Sin_2009_Oct_21_30(10)_1392-1398.nxml.txt.nlp	19767766	SENT112	13	13	3	3	oxygen	eNOS	PA450744	4846	0.722
NULL	Cell_Cycle_2013_Nov_15_12(22)_3490-3499.nxml.txt.nlp	24240433	SENT131	19	19	26	26	metformin	FDG	PA450395	23583	0.722
NULL	Oncoscience_2014_Jun_1_1(5)_383-391.nxml.txt.nlp	25594033	SENT85	30	30	21	21	paclitaxel	BRCA1	PA450761	672	0.722
NULL	J_Headache_Pain_2013_Apr_10_14(1)_33.nxml.txt.nlp	23574808	SENT114	47	47	15	15	capsaicin	CO2	PA448776	4513	0.722
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jun_23_66(Pt_7)_o1756.nxml.txt.nlp	21587972	SENT4	12	12	37	37	piperazine	mol	PA450977	90527	0.722
NULL	Cancer_Cell_Int_2009_Jan_8_9_3.nxml.txt.nlp	19128511	SENT6	0	0	8	8	oxaliplatin	PI3K	PA131285527	5290	0.722
NULL	Diabetes_Care_2013_Jul_12_36(7)_2020-2026.nxml.txt.nlp	23536581	SENT115	14	14	18	18	metformin	ADM	PA450395	133	0.722
NULL	J_Nat_Med_2014_Feb_19_68(2)_253-266.nxml.txt.nlp	24550097	SENT60	17	17	19	19	lipase	ATGL	PA450239	57104	0.722
NULL	Acta_Pharmacol_Sin_2013_Feb_31_34(2)_231-238.nxml.txt.nlp	23274414	SENT136	5	5	12	12	amiloride	Bcl-2	PA448368	596	0.722
NULL	Oncol_Rep_2014_Apr_28_31(4)_1605-1612.nxml.txt.nlp	24481648	SENT10	33	33	23	23	vinblastine	MRP7	PA451877	89845;1080	0.722
NULL	Mol_Cancer_2009_Dec_23_8_129.nxml.txt.nlp	20030852	SENT178	6	6	9	9	curcumin	p65	PA151958596	5970	0.722
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT134	21	21	8	8	imatinib	ABCG2	PA10804	9429	0.722
NULL	Int_J_Nanomedicine_2012_May_7_7_2307-2314.nxml.txt.nlp	22661887	SENT109	6	6	1	1	gemcitabine	zeta	PA449748	9907	0.722
NULL	J_Cell_Biol_1984_Feb_1_98(2)_550-557.nxml.txt.nlp	6363424	SENT8	12	12	14	14	trifluoperazine	TFP	PA451771	7034	0.722
NULL	F1000_Med_Rep_2012_Feb_1_4_4.nxml.txt.nlp	22312414	SENT171	24	24	22	22	daptomycin	VISA	PA164768820	57506	0.722
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT82	0	0	11	11	curcumin	DcR2	PA151958596	8793	0.722
NULL	Br_J_Cancer_2012_Sep_25_107(7)_1059-1068.nxml.txt.nlp	22935581	SENT27	22	22	12	12	sunitinib	IFN	PA162372840	3439	0.722
NULL	Arthritis_Res_Ther_2014_Apr_8_16(2)_R89.nxml.txt.nlp	24713464	SENT277	30	30	27	27	infliximab	TNF-alpha	PA452639	7124	0.722
NULL	Int_J_Mol_Imaging_2012_Oct_2_2012_379807.nxml.txt.nlp	23091717	SENT230	4	4	9	9	bevacizumab	VEGF-A	PA130232992	7422	0.722
NULL	Oncotarget_2013_Apr_16_4(5)_677-690.nxml.txt.nlp	23633472	SENT108	9	9	23	23	doxorubicin	XIAP	PA449412	331	0.722
NULL	Case_Rep_Obstet_Gynecol_2013_May_2_2013_492754.nxml.txt.nlp	23738169	SENT12	12	12	21	21	methotrexate	EMA	PA450428	2108	0.722
NULL	Acta_Neuropathol_Commun_2013_May_20_1_17.nxml.txt.nlp	24252689	SENT6	33	33	22	22	fluvastatin	CD36	PA449688	948	0.722
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2675-2684.nxml.txt.nlp	24129246	SENT205	7	7	15	15	etoposide	DBC1	PA449552	57805;1620	0.722
NULL	J_Mol_Signal_2012_May_31_7_5.nxml.txt.nlp	22651821	SENT68	23	23	32	32	neomycin	CO2	PA450608	4513	0.722
NULL	Exp_Ther_Med_2012_Oct_16_4(4)_705-710.nxml.txt.nlp	23170130	SENT94	4	4	15	15	cyclophosphamide	P-gp	PA449165	5243	0.722
NULL	Cancer_Med_2013_Oct_19_2(5)_646-653.nxml.txt.nlp	24403230	SENT109	15	15	19	19	trastuzumab	BTG2	PA451743	7832	0.722
NULL	Iran_Red_Crescent_Med_J_2012_Jul_30_14(7)_422-429.nxml.txt.nlp	22997558	SENT75	27	27	34	34	glutaraldehyde	VIII	PA449777	1351	0.722
NULL	Front_Oncol_2013_Aug_13_3_208.nxml.txt.nlp	23986880	SENT207	18	18	27	27	erlotinib	EGF	PA134687924	1950	0.722
NULL	Acta_Pharmacol_Sin_2010_Aug_5_31(8)_970-976.nxml.txt.nlp	20686521	SENT27	5	5	12	12	methotrexate	CDP	PA450428	1523	0.722
NULL	Cancers_(Basel)_2013_Jun_5_5(2)_676-713.nxml.txt.nlp	24216997	SENT2372	2	2	12	12	sorafenib	CD95	PA7000	355	0.722
NULL	Clin_Interv_Aging_2013_Jul_16_8_889-897.nxml.txt.nlp	23898224	SENT131	3	3	9	9	gemcitabine	SIRT1	PA449748	23411	0.722
NULL	Antiviral_Res_2009_May_82(2)_A99-A109.nxml.txt.nlp	19176219	SENT604	13	13	16	16	lopinavir	CD4	PA450264	920	0.722
NULL	AMIA_Jt_Summits_Transl_Sci_Proc_2012_Mar_19_2012_25-34.nxml.txt.nlp	22779044	SENT160	12	12	16	16	ethanol	BRCA1	PA448073	672	0.722
NULL	Acta_Pharmacol_Sin_2011_Oct_12_32(10)_1259-1265.nxml.txt.nlp	21909126	SENT119	7	7	27	27	losartan	LOX-1	PA450268	4973	0.722
NULL	Cancer_Immunol_Immunother_2012_Jul_23_61(7)_1101-1111.nxml.txt.nlp	22193989	SENT125	2	2	19	19	oxaliplatin	CD80	PA131285527	941	0.722
NULL	Arthritis_Res_Ther_2013_Aug_21_15(4)_R93.nxml.txt.nlp	23965253	SENT19	19	19	2	2	collagenase	MMP1	PA449107	4312	0.722
NULL	Org_Med_Chem_Lett_2012_Mar_2_2_10.nxml.txt.nlp	22381142	SENT11	31	31	16	16	vasopressin	5-HT5A	PA451858	3361	0.722
NULL	Parasit_Vectors_2011_Jan_25_4_7.nxml.txt.nlp	21266069	SENT99	37	37	8	8	gentamicin	CO2	PA449753	4513	0.722
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1224-1233.nxml.txt.nlp	22353810	SENT96	4	4	13	13	doxorubicin	MRP-1	PA449412	928	0.722
NULL	Br_J_Cancer_2012_Apr_24_106(9)_1486-1494.nxml.txt.nlp	22472882	SENT118	11	11	16	16	rosiglitazone	TIMP3	PA451283	7078	0.722
NULL	Oncogene_2010_Sep_16_29(37)_5193-5203.nxml.txt.nlp	20581867	SENT80	2	2	14	14	lapatinib	HER3	PA152241907	2065	0.722
NULL	Cancers_(Basel)_2013_Aug_22_5(3)_1103-1119.nxml.txt.nlp	24202336	SENT129	13	13	22	22	bevacizumab	San	PA130232992	80218	0.722
NULL	Drug_Des_Devel_Ther_2014_Sep_23_8_1527-1538.nxml.txt.nlp	25284985	SENT123	2	2	0	0	celecoxib	IFN	PA448871	3439	0.722
NULL	Mol_Cancer_2007_Jan_14_6_5.nxml.txt.nlp	17222355	SENT9	18	18	11	11	cisplatin	HMGA2	PA449014	8091	0.722
NULL	Ecancermedicalscience_2008_Feb_18_2_75.nxml.txt.nlp	22275966	SENT152	32	32	29	29	cisplatin	ERCC1	PA449014	2067	0.722
NULL	Diabetologia_2007_Jun_6_50(6)_1288-1293.nxml.txt.nlp	17415544	SENT89	14	14	4	4	hyaluronan	ASAT	PA165958431	22	0.722
NULL	Eur_J_Clin_Pharmacol_2014_Oct_8_70(1)_37-45.nxml.txt.nlp	24100471	SENT199	17	17	8	8	pioglitazone	CYP2C8	PA450970	1558	0.722
NULL	Brain_Res_2012_Jun_12_1459(3)_35-42.nxml.txt.nlp	22560095	SENT512	3	3	12	12	isoproterenol	spatial	PA450121	219793	0.722
NULL	Chonnam_Med_J_2013_Apr_25_49(1)_31-37.nxml.txt.nlp	23678475	SENT138	7	7	1	1	rosuvastatin	adiponectin	PA134308647	9370	0.722
NULL	J_Neurosci_Rural_Pract_2012_Sep-Dec_3(3)_429-430.nxml.txt.nlp	23189026	SENT54	23	23	12	12	thalidomide	IFN	PA451644	3439	0.722
NULL	Oncotarget_2014_Jun_3_5(13)_4920-4928.nxml.txt.nlp	24952482	SENT130	32	32	16	16	crizotinib	ALK	PA165946122	238	0.722
NULL	Curr_Genomics_2014_Jun_15(3)_217-230.nxml.txt.nlp	24955029	SENT59	19	19	37	37	oxygen	ROS	PA450744	6098	0.722
NULL	Biomed_Res_Int_2014_May_20_2014_418975.nxml.txt.nlp	24967364	SENT205	14	14	26	26	resveratrol	AMPK		5563	0.722
NULL	EMBO_J_2009_Apr_22_28(8)_1043-1054.nxml.txt.nlp	19300439	SENT119	27	27	29	29	genistein	PP2	PA165109660	4888	0.722
NULL	Br_J_Cancer_1995_Feb_71(2)_294-299.nxml.txt.nlp	7841043	SENT11	2	2	11	11	tamoxifen	P-gp	PA451581	5243	0.722
NULL	Acta_Pharmacol_Sin_2014_Sep_25_35(9)_1199-1206.nxml.txt.nlp	25152024	SENT187	14	14	35	35	cisplatin	p38	PA449014	10598;1432;7965	0.722
NULL	Br_J_Cancer_2013_Jun_11_108(11)_2241-2249.nxml.txt.nlp	23674086	SENT125	30	30	10	10	tamoxifen	BRCA2	PA451581	675	0.722
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_7-17.nxml.txt.nlp	17912633	SENT368	42	42	29	29	fulvestrant	AMH	PA164747170	268	0.722
NULL	J_Antimicrob_Chemother_2015_Jan_3_70(1)_182-189.nxml.txt.nlp	25190720	SENT73	14	14	16	16	vancomycin	VAN	PA451850	10318	0.722
NULL	Multidiscip_Respir_Med_2013_Jun_21_8(1)_40.nxml.txt.nlp	23800154	SENT174	23	23	20	20	creatine	Q10	PA164778930	27161	0.722
NULL	Asian_Spine_J_2014_Jun_9_8(3)_361-364.nxml.txt.nlp	24967052	SENT66	15	15	13	13	thrombin	ADP	PA451674	23038	0.722
NULL	Arthritis_Res_Ther_2005_May_18_7(Suppl_3)_S19-S25.nxml.txt.nlp	15960818	SENT166	15	15	13	13	rituximab	CHOP	PA451261	1649	0.722
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT93	17	17	25	25	erlotinib	CYP3A	PA134687924	1574	0.722
NULL	Asian_J_Androl_2014_Mar_7_Jul-Aug_16(4)_647-649.nxml.txt.nlp	24625882	SENT57	10	10	1	1	cyclosporine	WT1	PA449167	7490	0.722
NULL	Biomed_Res_Int_2013_Jul_7_2013_692751.nxml.txt.nlp	23936834	SENT169	4	4	11	11	pilocarpine	TNF	PA450962	7124	0.722
NULL	Clin_Pharmacol_2013_Apr_19_5_67-83.nxml.txt.nlp	23650452	SENT49	19	19	8	8	ticagrelor	LTA	PA165374673	4049	0.722
NULL	Mol_Vis_2012_May_1_18_1115-1122.nxml.txt.nlp	22605923	SENT167	13	13	24	24	estradiol	IL-6	PA449503	3569	0.722
NULL	Pancreas_2015_Jan_11_44(1)_134-143.nxml.txt.nlp	25243385	SENT341	16	16	25	25	paclitaxel	CD24	PA450761	100133941	0.722
NULL	Ann_N_Y_Acad_Sci_2012_Oct_10_1271(1)_10-19.nxml.txt.nlp	23050959	SENT148	34	34	10	10	dextran	SIRT1	PA449261	23411	0.722
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT49	26	26	16	16	paclitaxel	CYP2E1	PA450761	1571	0.722
NULL	Inflammation_2012_Feb_24_35(1)_206-213.nxml.txt.nlp	21347606	SENT142	40	40	9	9	dobutamine	IL-8	PA449381	3576	0.722
NULL	Cancers_(Basel)_2011_Apr_26_3(2)_2160-2168.nxml.txt.nlp	24212801	SENT38	9	9	5	5	hyaluronan	CD44	PA165958431	960	0.722
NULL	Cancers_(Basel)_2014_Jul_17_6(3)_1500-1521.nxml.txt.nlp	25037020	SENT263	2	2	23	23	montelukast	IL-8	PA450546	3576	0.722
NULL	Mol_Cell_Biochem_2014_Oct_9_385(1-2)_265-275.nxml.txt.nlp	24104452	SENT96	14	14	3	3	bortezomib	U87	PA10252	677775;641648	0.722
NULL	J_Geriatr_Cardiol_2014_Jun_11(2)_151-157.nxml.txt.nlp	25009566	SENT117	2	2	7	7	cilostazol	CDP	PA164746334	1523	0.722
NULL	Comp_Hepatol_2004_Jan_14_3(Suppl_1)_S37.nxml.txt.nlp	14960189	SENT69	0	0	7	7	thalidomide	CD14	PA451644	929	0.722
NULL	Arthritis_Res_Ther_2009_Nov_13_11(6)_R172.nxml.txt.nlp	19912653	SENT178	5	5	14	14	simvastatin	IVD	PA451363	3712	0.722
NULL	Adv_Bioinformatics_2012_Oct_13_2012_159423.nxml.txt.nlp	23097667	SENT322	43	43	5	5	nadh	FBA	PA164755085	26273	0.722
NULL	Mol_Cytogenet_2014_Jan_21_7(Suppl_1)_P85.nxml.txt.nlp	NULL	SENT20	19	19	13	13	sildenafil	p53	PA451346	7157	0.722
NULL	Evid_Based_Complement_Alternat_Med_2014_Sep_2_2014_627181.nxml.txt.nlp	25258643	SENT146	4	4	2	2	losartan	TMP	PA450268	2012	0.722
NULL	Clin_Exp_Otorhinolaryngol_2011_Dec_15_4(4)_177-183.nxml.txt.nlp	22232712	SENT111	0	0	6	6	doxycycline	p38	PA449415	10598;1432;7965	0.722
NULL	Front_Genet_2014_Jun_2_5_162.nxml.txt.nlp	24917882	SENT997	13	13	6	6	irinotecan	BRAF	PA450085	673	0.722
NULL	Hum_Genomics_2009_Dec_1_4(2)_91-106.nxml.txt.nlp	20038497	SENT314	5	5	7	7	rivastigmine	APOE	PA451262	348	0.722
NULL	Arthritis_Res_Ther_2003_Sep_3_5(6)_R317-R328.nxml.txt.nlp	14680506	SENT93	9	9	21	21	rolipram	IL-10	PA153906323	3586	0.722
NULL	Oncotarget_2011_Dec_31_2(12)_1314-1321.nxml.txt.nlp	22248929	SENT136	17	17	15	15	lapatinib	HER2	PA152241907	2064	0.722
NULL	J_Biomed_Biotechnol_2010_Jun_7_2010_150960.nxml.txt.nlp	20617134	SENT242	0	0	10	10	bevacizumab	KRAS	PA130232992	3845	0.722
NULL	Mol_Cancer_2008_Mar_6_7_24.nxml.txt.nlp	18325101	SENT143	15	15	11	11	cisplatin	FANCD2	PA449014	2177	0.722
NULL	Neural_Regen_Res_2013_May_25_8(15)_1368-1375.nxml.txt.nlp	25206431	SENT100	2	2	12	12	curcumin	Bcl-2	PA151958596	596	0.722
NULL	Exp_Diabetes_Res_2012_Oct_15_2012_465282.nxml.txt.nlp	23118742	SENT92	9	9	11	11	metformin	FGF21	PA450395	26291	0.722
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Feb_21_65(Pt_3)_o559.nxml.txt.nlp	21582217	SENT3	18	18	32	32	ethanol	mol	PA448073	90527	0.722
NULL	Cancer_Causes_Control_2013_Aug_18_24(8)_1605-1614.nxml.txt.nlp	23775025	SENT221	17	17	5	5	ifosfamide	CYP2C19	PA449964	1557	0.722
NULL	Front_Oncol_2014_Apr_8_4_71.nxml.txt.nlp	24782983	SENT466	23	23	29	29	levetiracetam	HDAC2	PA450206	3066	0.722
NULL	Ann_Clin_Microbiol_Antimicrob_2005_Sep_13_4_13.nxml.txt.nlp	16159399	SENT218	29	29	19	19	lamivudine	IFN	PA450163	3439	0.722
NULL	J_Infect_Dis_2012_Oct_1_206(7)_1020-1029.nxml.txt.nlp	22829650	SENT58	24	24	34	34	gentamicin	CO2	PA449753	4513	0.722
NULL	Biomed_Res_Int_2013_Oct_28_2013_161396.nxml.txt.nlp	24288663	SENT78	0	0	9	9	losartan	CYP11B2	PA450268	1585	0.722
NULL	Arthritis_Res_Ther_2008_Oct_15_10(Suppl_1)_S5.nxml.txt.nlp	19007425	SENT247	42	42	17	17	methotrexate	p75	PA450428	7133;11168	0.722
NULL	Cancers_(Basel)_2012_Oct_29_4(4)_1146-1160.nxml.txt.nlp	24213502	SENT53	5	5	16	16	tamoxifen	STAR	PA451581	6770;2984	0.722
NULL	Ann_Rheum_Dis_2011_Mar_6_70(6)_909-920.nxml.txt.nlp	21378402	SENT336	19	19	4	4	rituximab	ASM	PA451261	6609;283120	0.722
NULL	Indian_J_Anaesth_2011_Nov-Dec_55(6)_567-572.nxml.txt.nlp	22223899	SENT5	9	9	13	13	isoflurane	NAC	PA450106	22861	0.722
NULL	Daru_2012_Sep_3_20(1)_24.nxml.txt.nlp	23351176	SENT85	8	8	20	20	itopride	EPO	PA152432599	7076;8288;2056	0.722
NULL	Int_J_Biol_Sci_2014_Jun_21_10(7)_702-714.nxml.txt.nlp	25013379	SENT37	13	13	16	16	cetuximab	EGFR	PA10040	1956	0.722
NULL	Pharmaceutics_2011_Nov_18_3(4)_865-913.nxml.txt.nlp	24309312	SENT168	15	15	22	22	zidovudine	UGT1A1	PA451954	54658	0.722
NULL	Acta_Pharmacol_Sin_2009_Sep_24_30(9)_1262-1275.nxml.txt.nlp	19701231	SENT226	20	20	12	12	lovastatin	LMNB2	PA450272	84823	0.722
NULL	J_Cell_Mol_Med_2014_Jan_31_18(1)_27-37.nxml.txt.nlp	24373581	SENT213	0	0	16	16	alendronate	CD31	PA448082	5175	0.722
NULL	Carcinogenesis_2014_May_13_35(5)_1055-1066.nxml.txt.nlp	24419232	SENT341	6	6	14	14	metformin	CD34	PA450395	947	0.722
NULL	Breast_Cancer_Res_2005_Jan_28_7(3)_R284-R290.nxml.txt.nlp	15987423	SENT8	20	20	8	8	tamoxifen	SULT1A1	PA451581	6817	0.722
NULL	Cancer_Res_Treat_2014_Jan_15_46(1)_48-54.nxml.txt.nlp	24520223	SENT120	24	24	28	28	irinotecan	IFL	PA450085	3439	0.722
NULL	Front_Immunol_2012_Mar_12_3_44.nxml.txt.nlp	22566926	SENT74	13	13	5	5	imiquimod	TLR7	PA449972	51284	0.722
NULL	Cancer_Cell_Int_2009_Sep_10_9_25.nxml.txt.nlp	19744341	SENT128	4	4	10	10	glucosamine	STAT3	PA164747613	6774	0.722
NULL	Br_J_Pharmacol_2010_Sep_161(2)_288-307.nxml.txt.nlp	20735416	SENT245	25	25	28	28	isoflurane	TASK	PA450106	3777	0.722
NULL	Front_Mol_Neurosci_2012_May_7_5_60.nxml.txt.nlp	22586367	SENT269	24	24	12	12	ivermectin	gamma	PA450133	9913	0.722
NULL	Infect_Drug_Resist_2012_Aug_8_5_121-127.nxml.txt.nlp	22893749	SENT48	10	10	25	25	amantadine	URI	PA448360	8725	0.722
NULL	Clin_Pharmacol_2010_Sep_6_2_155-162.nxml.txt.nlp	22291500	SENT175	27	27	34	34	pantoprazole	CYP2C19	PA450774	1557	0.722
NULL	Breast_Cancer_Res_2013_Oct_18_15(5)_R97.nxml.txt.nlp	24135425	SENT20	32	32	34	34	trastuzumab	DM1	PA451743	338023;1760;28509	0.722
NULL	Nucleic_Acids_Res_2007_Jan_7_35(1)_223-233.nxml.txt.nlp	17158160	SENT149	17	17	8	8	neomycin	p16	PA450608	1029	0.722
NULL	Breast_Cancer_Res_2012_May_4_14(3)_R72.nxml.txt.nlp	22559056	SENT10	11	11	16	16	tamoxifen	CENP-A	PA451581	1058	0.722
NULL	Carcinogenesis_2014_May_13_35(5)_1055-1066.nxml.txt.nlp	24419232	SENT148	8	8	13	13	metformin	CDK4	PA450395	1019	0.722
NULL	Head_Face_Med_2010_Jun_4_6_7.nxml.txt.nlp	20525327	SENT89	29	29	17	17	isotretinoin	CO2	PA450128	4513	0.722
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Oct_23_69(Pt_11)_o1687-o1688.nxml.txt.nlp	24454117	SENT80	25	25	10	10	piperazine	mol	PA450977	90527	0.722
NULL	Oncotarget_2012_May_4_3(4)_395-398.nxml.txt.nlp	22565037	SENT6	0	0	24	24	metformin	CD24	PA450395	100133941	0.722
NULL	Front_Plant_Sci_2012_Mar_21_3_57.nxml.txt.nlp	22645592	SENT27	17	17	20	20	naringenin	CHS	PA151958361	1130	0.722
NULL	Chemother_Res_Pract_2012_Aug_29_2012_817297.nxml.txt.nlp	22970367	SENT190	12	12	26	26	afatinib	EGFR	PA165981154	1956	0.722
NULL	Cancers_(Basel)_2014_Apr_16_6(2)_926-957.nxml.txt.nlp	24743778	SENT165	4	4	19	19	tamoxifen	STAT3	PA451581	6774	0.722
NULL	Front_Oncol_2014_Nov_10_4_316.nxml.txt.nlp	25426448	SENT21	23	23	14	14	cetuximab	CRT	PA10040	811	0.722
NULL	Oncotarget_2011_Aug_30_2(8)_610-626.nxml.txt.nlp	21881167	SENT147	6	6	8	8	doxorubicin	p53	PA449412	7157	0.722
NULL	Cell_Death_Dis_2012_Jun_21_3(6)_e327.nxml.txt.nlp	22717582	SENT81	32	32	9	9	vincristine	p53	PA451879	7157	0.722
NULL	Int_J_Tryptophan_Res_2010_Jun_10_3_51-59.nxml.txt.nlp	22084587	SENT118	25	25	5	5	l-tryptophan	PDK1	PA10323	5170;5163	0.722
NULL	Front_Neurosci_2010_Mar_19_4_22.nxml.txt.nlp	20582262	SENT197	21	21	12	12	mecamylamine	P2X3	PA450334	5024	0.722
NULL	Cancer_Metab_2013_Jan_23_1_3.nxml.txt.nlp	24280005	SENT226	37	37	14	14	ethanol	SREBP2	PA448073	6721	0.722
NULL	Reprod_Biol_Endocrinol_2003_Oct_3_1_62.nxml.txt.nlp	14567758	SENT113	40	40	15	15	lindane	ANOVA	PA164754914	4858	0.722
NULL	Oncotarget_2013_Nov_7_4(12)_2550-2566.nxml.txt.nlp	24334291	SENT207	31	31	17	17	chloroquine	p53	PA448948	7157	0.722
NULL	Biosci_Rep_2012_Aug_1_32(Pt_4)_361-374.nxml.txt.nlp	22762204	SENT1100	8	8	13	13	trastuzumab	PTEN	PA451743	5728	0.722
NULL	Cancer_Manag_Res_2013_Nov_21_5_387-400.nxml.txt.nlp	24294007	SENT124	18	18	33	33	cetuximab	HER3	PA10040	2065	0.722
NULL	Acta_Pharmacol_Sin_2009_Jul_3_30(7)_1025-1032.nxml.txt.nlp	19575006	SENT56	6	6	2	2	vincristine	ADM	PA451879	133	0.722
NULL	Oncoscience_2014_Jan_30_1(1)_57-68.nxml.txt.nlp	25593988	SENT215	19	19	1	1	ponatinib	TNFSF10	PA165980594	8743	0.722
NULL	Int_J_Endocrinol_2010_Aug_29_2010_481326.nxml.txt.nlp	20871656	SENT32	30	30	18	18	glucose	MPG	PA449773	4350	0.722
NULL	Br_J_Cancer_2013_Jul_23_109(2)_342-350.nxml.txt.nlp	23807172	SENT22	6	6	32	32	sorafenib	Mcl-1	PA7000	4170	0.722
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1437-1448.nxml.txt.nlp	24056706	SENT111	27	27	20	20	ketoconazole	CYP2C19	PA450146	1557	0.722
NULL	Cancer_Immunol_Immunother_2012_Jul_23_61(7)_1101-1111.nxml.txt.nlp	22193989	SENT120	0	0	7	7	oxaliplatin	CD40	PA131285527	958	0.722
NULL	Oncol_Lett_2014_Mar_14_7(3)_663-668.nxml.txt.nlp	24527070	SENT20	15	15	6	6	paclitaxel	NAC	PA450761	22861	0.722
NULL	Emerg_Infect_Dis_2012_Nov_18(11)_1802-1810.nxml.txt.nlp	23092584	SENT39	16	16	2	2	pyrazinamide	DST	PA451182	667	0.722
NULL	Br_J_Cancer_2013_Jul_23_109(2)_342-350.nxml.txt.nlp	23807172	SENT184	11	11	19	19	sorafenib	Bcl-2	PA7000	596	0.722
NULL	Crit_Care_1997_Mar_1_1(Suppl_1)_P051.nxml.txt.nlp	NULL	SENT5	8	8	37	37	halothane	MMD	PA449845	23531	0.722
NULL	Leukemia_2014_Jun_17_28(6)_1216-1226.nxml.txt.nlp	24301524	SENT229	38	38	27	27	bortezomib	GAPDH	PA10252	2597	0.722
NULL	Br_J_Cancer_2012_Jan_3_106(1)_148-156.nxml.txt.nlp	22045191	SENT130	6	6	0	0	erlotinib	ZEB1	PA134687924	6935	0.722
NULL	Clin_Interv_Aging_2008_Mar_3(1)_45-50.nxml.txt.nlp	18488877	SENT5	22	22	16	16	alendronate	BMD	PA448082	1756;7439	0.722
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1224-1233.nxml.txt.nlp	22353810	SENT292	13	13	3	3	doxorubicin	MRP-1	PA449412	928	0.722
NULL	Antiviral_Res_2009_May_82(2)_A99-A109.nxml.txt.nlp	19176219	SENT120	7	7	12	12	ritonavir	MRP-1	PA451260	928	0.722
NULL	Biomed_Imaging_Interv_J_2011_Oct_1_7(4)_e25.nxml.txt.nlp	22279502	SENT203	10	10	15	15	oxaliplatin	CRT	PA131285527	811	0.722
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1495-1502.nxml.txt.nlp	21989186	SENT195	21	21	23	23	oxaliplatin	HSI	PA131285527	57016	0.721
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT192	12	12	46	46	trastuzumab	Yes	PA451743	7525	0.721
NULL	Acta_Histochem_Cytochem_2011_Apr_28_44(2)_51-60.nxml.txt.nlp	21614166	SENT170	7	7	23	23	thalidomide	TNF	PA451644	7124	0.721
NULL	Front_Genet_2013_Aug_29_4_163.nxml.txt.nlp	24009622	SENT137	15	15	8	8	ethanol	DDP	PA448073	1678	0.721
NULL	Apoptosis_2014_Aug_26_19(11)_1603-1615.nxml.txt.nlp	25156145	SENT199	4	4	0	0	mitomycin	TRAIL	PA450524	8743	0.721
NULL	Diabetes_Obes_Metab_2010_Aug_12(8)_700-708.nxml.txt.nlp	20590747	SENT138	26	26	19	19	vildagliptin	PPG	PA165958346	5552	0.721
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT76	3	3	6	6	curcumin	TRAIL	PA151958596	8743	0.721
NULL	Lipids_Health_Dis_2011_Feb_28_10_38.nxml.txt.nlp	21352602	SENT141	18	18	8	8	fenofibrate	PCSK9	PA449594	255738	0.721
NULL	Curr_Oncol_2006_Feb_13(1)_2-7.nxml.txt.nlp	17576435	SENT48	4	4	6	6	tamoxifen	aromatase	PA451581	1588	0.721
NULL	Aging_(Albany_NY)_2009_Sep_25_1(10)_845-854.nxml.txt.nlp	20157557	SENT138	7	7	18	18	doxorubicin	p53	PA449412	7157	0.721
NULL	Protein_Cell_2014_Jun_19_5(6)_469-479.nxml.txt.nlp	24748116	SENT169	16	16	10	10	paclitaxel	EB1	PA450761	9167;22919;10982	0.721
NULL	Crit_Care_2006_Mar_21_10(Suppl_1)_P88.nxml.txt.nlp	NULL	SENT18	8	8	21	21	guanidine	TLR-4	PA164781028	7099	0.721
NULL	Mol_Cancer_2014_Feb_20_13_32.nxml.txt.nlp	24555657	SENT197	28	28	37	37	cisplatin	SET	PA449014	6418	0.721
NULL	Acta_Pharmacol_Sin_2014_Sep_25_35(9)_1199-1206.nxml.txt.nlp	25152024	SENT100	42	42	37	37	cisplatin	mig-2	PA449014	10979	0.721
NULL	Int_J_Endocrinol_Metab_2013_Oct_1_11(4)_e10927.nxml.txt.nlp	24719626	SENT46	13	13	31	31	gliclazide	STZ	PA10892	6484	0.721
NULL	Diabetes_Care_2013_Jun_15_36(6)_e80.nxml.txt.nlp	23704688	SENT10	23	23	12	12	sitagliptin	GLP-1	PA164748978	100125288	0.721
NULL	Support_Care_Cancer_2012_Jul_27_20(7)_1353-1360.nxml.txt.nlp	22539050	SENT215	7	7	5	5	denosumab	NNT	PA166048634	23530	0.721
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Apr_21_68(Pt_5)_m633-m634.nxml.txt.nlp	22590128	SENT71	14	14	2	2	l-lysine	NO3	PA450280	4681	0.721
NULL	Ann_Clin_Transl_Neurol_2014_Dec_21_1(12)_996-1005.nxml.txt.nlp	25574474	SENT134	7	7	3	3	riluzole	P-gp	PA451251	5243	0.721
NULL	Oncoimmunology_2012_Oct_1_1(7)_1004-1016.nxml.txt.nlp	23170249	SENT185	1	1	5	5	paclitaxel	HER-2	PA450761	2064	0.721
NULL	J_Hematol_Oncol_2009_Jul_27_2_31.nxml.txt.nlp	19635146	SENT167	26	26	35	35	sorafenib	p21CIP1	PA7000	1026	0.721
NULL	Oncotarget_2011_Jan_25_2(1-2)_8-17.nxml.txt.nlp	21378407	SENT49	0	0	22	22	thrombin	PAR-1	PA451674	2011;2149	0.721
NULL	J_Immunother_Cancer_2013_Nov_7_1(Suppl_1)_P35.nxml.txt.nlp	NULL	SENT23	3	3	5	5	cisplatin	IFN	PA449014	3439	0.721
NULL	J_Thromb_Haemost_2008_Dec_6(12)_2152-2159.nxml.txt.nlp	18826392	SENT66	11	11	38	38	indomethacin	ADP	PA449982	23038	0.721
NULL	Chonnam_Med_J_2013_Apr_25_49(1)_31-37.nxml.txt.nlp	23678475	SENT87	6	6	8	8	simvastatin	adiponectin	PA451363	9370	0.721
NULL	Cancer_Med_2013_Aug_30_2(4)_457-467.nxml.txt.nlp	24156018	SENT119	3	3	8	8	marimastat	U87	PA164748329	677775;641648	0.721
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT166	45	45	26	26	glucose	EGFR	PA449773	1956	0.721
NULL	Adv_Hematol_2012_Mar_8_2012_856341.nxml.txt.nlp	22496694	SENT22	14	14	25	25	thrombin	VIII	PA451674	1351	0.721
NULL	Amino_Acids_2011_May_22_40(5)_1369-1383.nxml.txt.nlp	21424716	SENT274	4	4	36	36	creatine	CLC	PA164778930	23529;1178	0.721
NULL	Mol_Biol_Cell_2012_May_15_23(10)_1812-1825.nxml.txt.nlp	22438585	SENT51	7	7	12	12	amiloride	PI3K	PA448368	5290	0.721
NULL	Biomed_Res_Int_2013_Mar_17_2013_315980.nxml.txt.nlp	23586031	SENT22	10	10	14	14	coumarin	VKORC1	PA134521193	79001	0.721
NULL	Int_J_Endocrinol_2010_Feb_10_2010_625852.nxml.txt.nlp	20169119	SENT123	8	8	4	4	paricalcitol	PTH	PA450798	5741	0.721
NULL	Breast_Cancer_Res_Treat_2012_Jun_18_133(3)_937-947.nxml.txt.nlp	22094936	SENT1	27	27	15	15	tamoxifen	CDC2	PA451581	5424	0.721
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT185	32	32	20	20	heparin	FGF1	PA449855	2246	0.721
NULL	Cell_Commun_Signal_2013_Jul_4_11_47.nxml.txt.nlp	23826796	SENT92	16	16	7	7	rolipram	CC2D1A	PA153906323	54862	0.721
NULL	Front_Genet_2014_Sep_15_5_323.nxml.txt.nlp	25309579	SENT14	17	17	21	21	methotrexate	SLCO1B1	PA450428	10599	0.721
NULL	Emerg_Infect_Dis_2011_Mar_17(3)_432-440.nxml.txt.nlp	21392434	SENT112	26	26	17	17	rifampin	DST	PA451250	667	0.721
NULL	J_Cancer_2013_Jan_11_4(2)_117-132.nxml.txt.nlp	23386910	SENT153	9	9	14	14	olaparib	BRCA2		675	0.721
NULL	Mol_Cancer_2012_Apr_26_11_24.nxml.txt.nlp	22537161	SENT138	28	28	13	13	pp2	IFN		3439	0.721
NULL	Neural_Plast_2007_Oct_10_2007_23250.nxml.txt.nlp	NULL	SENT4355	0	0	17	17	rimonabant	CA3	PA152407999	761	0.721
NULL	Br_J_Cancer_2011_Jul_12_105(2)_246-254.nxml.txt.nlp	21712828	SENT10	13	13	6	6	cetuximab	PIK3CA	PA10040	5290	0.721
NULL	Exp_Neurobiol_2014_Jun_13_23(2)_124-129.nxml.txt.nlp	24963276	SENT66	3	3	11	11	naringin	GDNF	PA151958360	2668	0.721
NULL	J_Biomed_Biotechnol_2010_May_24_2010_686457.nxml.txt.nlp	20508815	SENT151	26	26	2	2	creatine	MED	PA164778930	1298;1299;1311	0.721
NULL	Front_Oncol_2013_Sep_23_3_250.nxml.txt.nlp	24069582	SENT420	13	13	30	30	celecoxib	HER-2	PA448871	2064	0.721
NULL	Br_J_Cancer_2004_Mar_22_90(6)_1285-1292.nxml.txt.nlp	15026814	SENT205	0	0	3	3	doxorubicin	p53	PA449412	7157	0.721
NULL	Oxid_Med_Cell_Longev_2012_May_28_2012_386527.nxml.txt.nlp	22690271	SENT152	3	3	0	0	resveratrol	SIRT1		23411	0.721
NULL	Bioinformation_2012_Jan_6_8(1)_13-19.nxml.txt.nlp	22359429	SENT99	8	8	6	6	curcumin	MRP1	PA151958596	4437	0.721
NULL	Biologics_2012_Dec_17_6_429-464.nxml.txt.nlp	23269860	SENT10	24	24	34	34	rituximab	ACR	PA451261	49	0.721
NULL	EMBO_Mol_Med_2012_Jun_13_4(6)_515-527.nxml.txt.nlp	22416035	SENT244	31	31	9	9	olaparib	p53		7157	0.721
NULL	Cancer_Cell_Int_2013_Oct_11_13_97.nxml.txt.nlp	24119761	SENT153	22	22	27	27	trastuzumab	EGF	PA451743	1950	0.721
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT211	10	10	17	17	perifosine	DR5	PA165291471	8795	0.721
NULL	Neuropsychopharmacology_2009_Jul_11_34(8)_1946-1957.nxml.txt.nlp	19279569	SENT145	15	15	30	30	cocaine	DOR	PA449072	58476	0.721
NULL	Clin_Drug_Investig_2014_Nov_9_34(2)_107-115.nxml.txt.nlp	24214232	SENT249	3	3	23	23	cinacalcet	IMPACT	PA164776671	55364	0.721
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_55-78.nxml.txt.nlp	19305788	SENT176	4	4	7	7	memantine	spatial	PA10364	219793	0.721
NULL	Cancer_Cell_Int_2012_Jun_18_12_30.nxml.txt.nlp	22709569	SENT57	18	18	11	11	cisplatin	CALM1	PA449014	801	0.721
NULL	Breast_Cancer_Res_2011_Aug_16_13(4)_312.nxml.txt.nlp	21861853	SENT25	13	13	19	19	tamoxifen	CUEDC2	PA451581	79004	0.721
NULL	Cancer_Immunol_Immunother_2013_Aug_27_62(10)_1637-1648.nxml.txt.nlp	23982484	SENT165	0	0	8	8	lenalidomide	NKG2D	PA162363968	22914	0.721
NULL	Ann_Hematol_2010_Oct_22_89(10)_971-978.nxml.txt.nlp	20567823	SENT99	14	14	1	1	filgrastim	CD34	PA449626	947	0.721
NULL	Open_Virol_J_2010_Jun_18_4_123-156.nxml.txt.nlp	20835362	SENT716	9	9	11	11	paclitaxel	TRAIL	PA450761	8743	0.721
NULL	Br_J_Cancer_2012_Jan_17_106(2)_284-289.nxml.txt.nlp	22215065	SENT96	9	9	13	13	atrasentan	IFN	PA143414738	3439	0.721
NULL	Int_J_Mol_Sci_2014_Sep_29_15(10)_17411-17441.nxml.txt.nlp	25268615	SENT240	30	30	5	5	docetaxel	CD147	PA449383	682	0.721
NULL	J_Invest_Dermatol_2012_Sep_19_132(9)_2198-2205.nxml.txt.nlp	22513780	SENT78	2	2	15	15	isotretinoin	IL-10	PA450128	3586	0.721
NULL	J_Immunol_Res_2014_May_12_2014_897249.nxml.txt.nlp	24901013	SENT122	7	7	12	12	natalizumab	CD4	PA164747191	920	0.721
NULL	Br_J_Cancer_1997_75(6)_810-815.nxml.txt.nlp	9062400	SENT10	7	7	19	19	vincristine	P-gp	PA451879	5243	0.721
NULL	Nat_Med_2011_Dec_4_18(1)_111-119.nxml.txt.nlp	22138751	SENT95	21	21	16	16	doxycycline	WT1	PA449415	7490	0.721
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT88	34	34	36	36	perifosine	TRAIL	PA165291471	8743	0.721
NULL	Ital_J_Pediatr_2011_Dec_19_37_58.nxml.txt.nlp	22182677	SENT162	24	24	8	8	primidone	CLB	PA451105	171425	0.721
NULL	Sci_Rep_2014_Dec_16_4_7500.nxml.txt.nlp	25511254	SENT41	2	2	10	10	hyperforin	TRPC6	PA165985514	7225	0.721
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Sep_12_65(Pt_10)_o2430.nxml.txt.nlp	21577886	SENT84	0	0	15	15	benzaldehyde	mol	PA448571	90527	0.721
NULL	J_Korean_Med_Sci_2007_Jun_30_22(3)_470-475.nxml.txt.nlp	17596656	SENT69	16	16	3	3	hydrocortisone	RAI	PA449905	10848;6050	0.721
NULL	Cancer_Immunol_Immunother_2015_Oct_7_64_61-73.nxml.txt.nlp	25287778	SENT176	37	37	7	7	lenalidomide	IFN	PA162363968	3439	0.721
NULL	Oncol_Rep_2013_Apr_5_29(4)_1671-1677.nxml.txt.nlp	23404329	SENT165	19	19	26	26	curcumin	SFN	PA151958596	25996;2810	0.721
NULL	Eur_J_Clin_Pharmacol_2010_Nov_29_66(11)_1131-1136.nxml.txt.nlp	20669013	SENT141	28	28	21	21	voriconazole	CYP2C19	PA10233	1557	0.721
NULL	Breast_Cancer_Res_2007_Mar_2_9(2)_205.nxml.txt.nlp	NULL	SENT29	2	2	14	14	canertinib	HER-2	PA134687925	2064	0.721
NULL	Br_J_Cancer_2012_Feb_14_106(4)_685-692.nxml.txt.nlp	22294184	SENT246	4	4	14	14	docetaxel	Mcl-1	PA449383	4170	0.721
NULL	Lab_Invest_2011_Jan_9_91(1)_138-146.nxml.txt.nlp	20697379	SENT156	0	0	13	13	thyroglobulin	p63	PA164754910	8626	0.721
NULL	Cell_Commun_Signal_2013_Nov_11_11_86.nxml.txt.nlp	24215724	SENT477	38	38	13	13	palonosetron	PAR1	PA10352	79581;2149	0.721
NULL	Oncotarget_2014_Mar_26_5(21)_10342-10355.nxml.txt.nlp	25431950	SENT84	4	4	7	7	doxorubicin	EZH2	PA449412	2146	0.721
NULL	Acta_Physiol_(Oxf)_2007_Sep_191(1)_43-57.nxml.txt.nlp	17524066	SENT231	15	15	2	2	nifedipine	PES	PA450631	23481	0.721
NULL	Case_Rep_Med_2010_Jun_10_2010_984981.nxml.txt.nlp	20592999	SENT3	12	12	3	3	amiodarone	AIT	PA448383	160728	0.721
NULL	Ann_Rheum_Dis_2008_May_21_68(2)_175-182.nxml.txt.nlp	18495735	SENT154	5	5	13	13	infliximab	IL-6	PA452639	3569	0.721
NULL	Br_J_Cancer_2013_Jul_23_109(2)_351-359.nxml.txt.nlp	23799854	SENT163	17	17	1	1	paclitaxel	BLT2	PA450761	56413	0.721
NULL	J_Physiol_2011_Dec_15_589(Pt_24)_5965-5986.nxml.txt.nlp	22041182	SENT329	1	1	27	27	clotrimazole	ACTH	PA449057	5443	0.721
NULL	Br_J_Cancer_2014_Jan_21_110(2)_304-312.nxml.txt.nlp	24300978	SENT242	17	17	21	21	gemcitabine	CLCR	PA449748	11330	0.721
NULL	Br_J_Cancer_2012_May_22_106(11)_1718-1721.nxml.txt.nlp	22531628	SENT98	6	6	2	2	fluorouracil	IFL	PA128406956	3439	0.721
NULL	Curr_Pharm_Biotechnol_2011_Feb_12(2)_268-274.nxml.txt.nlp	21050165	SENT38	1	1	4	4	aldesleukin	IL-2	PA448081	3558	0.721
NULL	EMBO_J_2009_Apr_22_28(8)_1043-1054.nxml.txt.nlp	19300439	SENT121	16	16	31	31	genistein	p38	PA165109660	10598;1432;7965	0.721
NULL	Curr_Neuropharmacol_2014_Jul_12(4)_365-379.nxml.txt.nlp	25342944	SENT62	0	0	9	9	fluoxetine	AKT	PA449673	207	0.721
NULL	Mol_Pain_2014_Feb_6_10_10.nxml.txt.nlp	24499354	SENT291	21	21	8	8	capsaicin	TLR4	PA448776	7099	0.721
NULL	Mol_Cell_Proteomics_2012_Jan_3_11(1)_M111_011445.nxml.txt.nlp	22338125	SENT153	14	14	36	36	chymotrypsin	Met	PA448994	79811	0.721
NULL	J_Thyroid_Res_2011_Dec_29_2011_432890.nxml.txt.nlp	22254147	SENT5	25	25	16	16	thyroglobulin	PTPN22	PA164754910	26191	0.721
NULL	J_Adv_Pract_Oncol_2013_Jul_1_Jul-Aug_4(4)_238-250.nxml.txt.nlp	25032004	SENT161	9	9	6	6	imatinib	CYP3A5	PA10804	1577	0.721
NULL	J_Headache_Pain_2012_Jun_20_13(4)_271-275.nxml.txt.nlp	22430431	SENT99	15	15	23	23	sumatriptan	5-HT1F	PA451566	3355	0.721
NULL	Nucleic_Acids_Res_2005_Jun_7_33(10)_e92.nxml.txt.nlp	15942024	SENT60	20	20	33	33	l-glutamine	CO2	PA10090	4513	0.721
NULL	Drug_Target_Insights_2006_Oct_23_1_5-10.nxml.txt.nlp	21901053	SENT68	2	2	15	15	heparin	INCA	PA449855	440068	0.721
NULL	J_Exp_Bot_2012_Jan_6_63(1)_121-130.nxml.txt.nlp	21984651	SENT243	7	7	5	5	starch	PDI	PA451492	5034;64714;29943	0.721
NULL	Pharmaceutics_2010_Jun_2_2(2)_258-274.nxml.txt.nlp	NULL	SENT425	16	16	8	8	risperidone	CYP3A	PA451257	1574	0.721
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jan_31_68(Pt_2)_o541.nxml.txt.nlp	22347135	SENT66	30	30	6	6	ethanol	mol	PA448073	90527	0.721
NULL	Nanoscale_Res_Lett_2013_Nov_5_8(1)_462.nxml.txt.nlp	24191909	SENT37	17	17	8	8	ethanol	FTO	PA448073	79068	0.721
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT67	11	11	3	3	methotrexate	MSH2	PA450428	4436	0.721
NULL	Cancers_(Basel)_2013_Jul_4_5(3)_838-856.nxml.txt.nlp	24202322	SENT207	17	17	2	2	flavopiridol	HEXIM1	PA452627	10614	0.721
NULL	Sensors_(Basel)_2013_Dec_3_13(12)_16591-16610.nxml.txt.nlp	24300599	SENT73	14	14	1	1	fluorescein	PLIF	PA164746009	2495	0.721
NULL	EJNMMI_Res_2011_Nov_10_1_25.nxml.txt.nlp	22214344	SENT102	13	13	26	26	entacapone	DDC	PA164748726	1644	0.721
NULL	Arthritis_Res_Ther_2012_Jul_12_14(4)_R163.nxml.txt.nlp	22784880	SENT118	17	17	24	24	leflunomide	CYP2C19	PA450192	1557	0.721
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT325	6	6	10	10	nutlin-3	IBP		706;50619	0.721
NULL	Brief_Bioinform_2013_Jul_9_14(4)_491-505.nxml.txt.nlp	22877768	SENT51	7	7	18	18	cyclophosphamide	CHOP	PA449165	1649	0.721
NULL	Oncotarget_2014_May_27_5(19)_9049-9064.nxml.txt.nlp	24979294	SENT236	15	15	11	11	dasatinib	HER2	PA162372878	2064	0.721
NULL	Epilepsia_2012_Jun_21_53(Suppl_1)_18-25.nxml.txt.nlp	22612805	SENT162	9	9	5	5	bumetanide	NKCC1	PA448682	6558	0.721
NULL	Braz_J_Microbiol_2008_Mar_1_Jan-Mar_39(1)_5-9.nxml.txt.nlp	24031167	SENT37	27	27	37	37	gentamicin	CO2	PA449753	4513	0.721
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT256	17	17	8	8	warfarin	CYP2C9	PA451906	1559	0.721
NULL	Open_Biol_2014_Jun_4(6)_140027.nxml.txt.nlp	24898141	SENT241	22	22	8	8	paclitaxel	DIRAS3	PA450761	9077	0.721
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT118	6	6	8	8	resveratrol	TRAIL		8743	0.721
NULL	Adv_Hematol_2012_Jan_5_2012_507257.nxml.txt.nlp	22272202	SENT140	8	8	18	18	indinavir	UGT1A1	PA449977	54658	0.721
NULL	Oncoimmunology_2012_Dec_1_1(9)_1557-1576.nxml.txt.nlp	23264902	SENT96	28	28	30	30	cyclophosphamide	GM-CSF	PA449165	1437	0.721
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT1602	16	16	2	2	nelfinavir	ABCB1	PA450606	5243	0.721
NULL	Oncotarget_2014_Jun_6_5(12)_4516-4528.nxml.txt.nlp	24980831	SENT41	3	3	19	19	temozolomide	BRAF	PA451609	673	0.721
NULL	Ann_Dermatol_2012_Feb_2_24(1)_39-44.nxml.txt.nlp	22363154	SENT115	17	17	20	20	capsaicin	AMPK	PA448776	5563	0.721
NULL	Breast_Cancer_Res_2007_Aug_8_9(4)_R50.nxml.txt.nlp	17686159	SENT183	5	5	9	9	trastuzumab	HRG	PA451743	3084;3273	0.721
NULL	Cancer_Cell_Int_2011_Nov_17_11_40.nxml.txt.nlp	22088142	SENT147	29	29	22	22	gemcitabine	EGFR	PA449748	1956	0.721
NULL	Iran_J_Psychiatry_2010_Winter_5(1)_11-17.nxml.txt.nlp	22952484	SENT142	7	7	15	15	ranitidine	OAT	PA451224	4942	0.721
NULL	Core_Evid_2009_Jun_15_4_215-245.nxml.txt.nlp	20694078	SENT531	5	5	0	0	melphalan	San	PA450354	80218	0.721
NULL	Arthritis_Res_Ther_2008_Jan_7_10(1)_R1.nxml.txt.nlp	18179697	SENT183	13	13	7	7	oxaliplatin	HMGB1	PA131285527	3146	0.721
NULL	J_Gen_Physiol_1923_Jan_20_5(3)_353-358.nxml.txt.nlp	19872001	SENT0	16	16	1	1	trypsin	Gen	PA451806	348654	0.721
NULL	Int_J_Endocrinol_2010_Mar_2_2010_621687.nxml.txt.nlp	20204178	SENT101	6	6	10	10	paricalcitol	PTH	PA450798	5741	0.721
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R91.nxml.txt.nlp	22541814	SENT210	7	7	25	25	pp2	HO-1		3162	0.721
NULL	Breast_Cancer_Res_2002_Sep_10_4(6)_218-221.nxml.txt.nlp	12473166	SENT84	22	22	39	39	tamoxifen	ATAC	PA451581	6375	0.721
NULL	Nucleic_Acids_Res_2012_Jul_5_40(13)_5988-6000.nxml.txt.nlp	22492511	SENT265	13	13	29	29	fulvestrant	MYB	PA164747170	4602	0.721
NULL	Mol_Vis_2012_Nov_29_18_2839-2846.nxml.txt.nlp	23233786	SENT167	39	39	15	15	geldanamycin	CB2	PA152031327	1269	0.721
NULL	Blood_Cancer_J_2013_Jun_7_3(6)_e120.nxml.txt.nlp	23749045	SENT155	21	21	11	11	bortezomib	IGF1R	PA10252	3480	0.721
NULL	Korean_J_Anesthesiol_2013_Feb_15_64(2)_105-111.nxml.txt.nlp	23459312	SENT81	30	30	36	36	protamine	ACT	PA10366	12;11332;9457;641455	0.721
NULL	Breast_Cancer_Res_2003_Feb_3_5(2)_96-100.nxml.txt.nlp	12631388	SENT16	13	13	26	26	trastuzumab	HER2	PA451743	2064	0.721
NULL	Neural_Plast_2007_Apr_15_2007_90163.nxml.txt.nlp	17710249	SENT239	27	27	29	29	vasopressin	AVP	PA451858	114548;551	0.721
NULL	Patient_Prefer_Adherence_2011_Dec_23_6_1-9.nxml.txt.nlp	22272064	SENT66	22	22	36	36	telmisartan	ACE	PA451605	1636	0.721
NULL	Arthritis_Res_Ther_2014_Jan_24_16(1)_R23.nxml.txt.nlp	24460726	SENT1	28	28	34	34	hydroxychloroquine	STAT1	PA164777036	6772	0.721
NULL	Br_J_Cancer_2012_Jan_17_106(2)_284-289.nxml.txt.nlp	22215065	SENT117	3	3	26	26	atrasentan	IFN	PA143414738	3439	0.721
NULL	Arthritis_Res_Ther_2005_May_18_7(Suppl_3)_S19-S25.nxml.txt.nlp	15960818	SENT226	7	7	5	5	cyclophosphamide	CHOP	PA449165	1649	0.721
NULL	Vet_Res_2013_Jul_22_44(1)_61.nxml.txt.nlp	23876161	SENT72	28	28	39	39	l-glutamine	CO2	PA10090	4513	0.721
NULL	Asian-Australas_J_Anim_Sci_2013_Feb_26(2)_233-240.nxml.txt.nlp	25049781	SENT110	8	8	25	25	l-carnitine	PDH	PA450154	54704	0.721
NULL	Autoimmune_Dis_2010_May_18_2010_757432.nxml.txt.nlp	21188238	SENT64	14	14	7	7	carrageenan	San	PA448814	80218	0.721
NULL	Crit_Care_2011_Oct_26_15(5)_R257.nxml.txt.nlp	22030215	SENT134	2	2	20	20	propofol	SAPS	PA451141	8935	0.721
NULL	Mol_Vis_2007_Jul_9_13_1083-1093.nxml.txt.nlp	17653053	SENT160	2	2	11	11	minocycline	MCP-1	PA450519	6347	0.721
NULL	Arthritis_Res_Ther_2005_Sep_22_7(6)_R1325-R1337.nxml.txt.nlp	16277686	SENT46	9	9	37	37	collagenase	CO2	PA449107	4513	0.721
NULL	Front_Neurosci_2012_May_30_6_77.nxml.txt.nlp	22661925	SENT258	34	34	37	37	ethanol	DCX	PA448073	1641	0.721
NULL	Breast_Cancer_Res_2011_Jan_17_13(1)_R5.nxml.txt.nlp	21241485	SENT216	9	9	14	14	tamoxifen	Brn-3b	PA451581	5458	0.721
NULL	Stroke_Res_Treat_2009_Dec_20_2010_386389.nxml.txt.nlp	20700422	SENT291	21	21	23	23	ebselen	NAC	PA161660841	22861	0.721
NULL	Cancer_Microenviron_2009_Sep_26_2(Suppl_1)_19-204.nxml.txt.nlp	NULL	SENT2495	6	6	0	0	busulfan	CXCR4	PA448691	7852	0.721
NULL	Mol_Cancer_2014_Jun_27_13_159.nxml.txt.nlp	24972933	SENT132	9	9	22	22	bortezomib	CTRL	PA10252	1506	0.721
NULL	Breast_Cancer_(Auckl)_2014_Mar_23_8_51-56.nxml.txt.nlp	24678242	SENT19	10	10	13	13	carboplatin	BRCA1	PA448803	672	0.721
NULL	Oncogene_2014_Aug_28_33(35)_4407-4417.nxml.txt.nlp	24469038	SENT107	3	3	10	10	arsenite	CNOT6	PA452638	57472	0.721
NULL	Int_J_Biol_Sci_2014_Jan_20_10(2)_171-180.nxml.txt.nlp	24520215	SENT143	27	27	17	17	cerulenin	L-FABP	PA164764551	2168	0.721
NULL	Hum_Genomics_Proteomics_2010_Aug_3_2010_159761.nxml.txt.nlp	20981231	SENT141	10	10	27	27	lithium	TPH2	PA450243	6999;121278	0.721
NULL	Subst_Abuse_Rehabil_2011_Mar_16_2_11-20.nxml.txt.nlp	24474851	SENT39	30	30	9	9	ketamine	CYP3A4	PA450144	1576	0.721
NULL	Nat_Neurosci_2012_Sep_5_15(9)_1245-1254.nxml.txt.nlp	22864611	SENT585	19	19	15	15	clozapine	mGlu2	PA449061	2912	0.721
NULL	Curr_Cardiol_Rev_2012_Aug_8(3)_239-249.nxml.txt.nlp	22935021	SENT9	40	40	34	34	bivalirudin	PAR-1	PA10032	2011;2149	0.721
NULL	Br_J_Haematol_2014_Mar_13_164(1)_811-821.nxml.txt.nlp	24328678	SENT215	6	6	11	11	lenalidomide	CRBN	PA162363968	51185	0.721
NULL	Infect_Dis_Rep_2013_Jun_6_5(Suppl_1)_e5.nxml.txt.nlp	24470969	SENT93	22	22	19	19	maraviroc	CCR5	PA164768835	1234	0.721
NULL	Oncoimmunology_2013_May_1_2(5)_e24436.nxml.txt.nlp	23762809	SENT76	6	6	16	16	bevacizumab	IL-6	PA130232992	3569	0.721
NULL	Breast_Cancer_Res_2004_Jun_29_6(5)_R488-R498.nxml.txt.nlp	15318931	SENT169	17	17	23	23	estradiol	UGT2B15	PA449503	7366	0.721
NULL	J_Cancer_2013_Sep_10_4(8)_614-625.nxml.txt.nlp	24155773	SENT191	9	9	11	11	bortezomib	CRM1	PA10252	7514	0.721
NULL	J_Headache_Pain_2011_Apr_5_12(2)_219-226.nxml.txt.nlp	20686810	SENT216	9	9	0	0	frovatriptan	Cad	PA164754891	124872	0.721
NULL	Biomed_Res_Int_2013_Jul_8_2013_507103.nxml.txt.nlp	23936812	SENT209	9	9	1	1	curcumin	zeta	PA151958596	9907	0.721
NULL	J_Inflamm_(Lond)_2006_Jul_12_3_10.nxml.txt.nlp	16834783	SENT19	3	3	10	10	mometasone	MCP-1	PA450541	6347	0.721
NULL	Semin_Immunopathol_2013_May_10_35(3)_351-373.nxml.txt.nlp	23572207	SENT368	9	9	5	5	bortezomib	XBP1	PA10252	7494	0.721
NULL	Clin_Med_Insights_Oncol_2011_May_18_5_145-156.nxml.txt.nlp	21695099	SENT42	30	30	6	6	mechlorethamine	gamma	PA450336	9913	0.721
NULL	Ann_Dermatol_2014_Jun_12_26(3)_343-348.nxml.txt.nlp	24966634	SENT96	25	25	9	9	warfarin	CYP2C9	PA451906	1559	0.721
NULL	F1000_Med_Rep_2009_Feb_24_1_13.nxml.txt.nlp	20948769	SENT79	15	15	27	27	rituximab	CHOP	PA451261	1649	0.721
NULL	Breast_Cancer_Res_2004_Jun_29_6(5)_R488-R498.nxml.txt.nlp	15318931	SENT14	3	3	16	16	estradiol	UGT	PA449503	7361;7355	0.721
NULL	Adv_Hematol_2012_Jun_19_2012_851674.nxml.txt.nlp	22778745	SENT240	7	7	4	4	indomethacin	COX	PA449982	1351	0.721
NULL	Oncol_Lett_2014_Jun_8_7(6)_1761-1766.nxml.txt.nlp	24932229	SENT101	12	12	28	28	palifermin	PIK3CA	PA164744014	5290	0.721
NULL	J_Oncol_2012_Oct_22_2012_391629.nxml.txt.nlp	23133451	SENT273	11	11	16	16	thyroglobulin	CEA	PA164754910	5670;1087	0.721
NULL	Nat_Med_2014_Jul_1_20(7)_715-724.nxml.txt.nlp	24880616	SENT280	22	22	29	29	l-glutamine	CO2	PA10090	4513	0.721
NULL	Carcinogenesis_2008_Sep_9_29(9)_1734-1741.nxml.txt.nlp	18544564	SENT374	9	9	3	3	sorafenib	Mcl-1	PA7000	4170	0.721
NULL	Biosci_Rep_2012_Apr_1_32(Pt_2)_105-112.nxml.txt.nlp	22115362	SENT129	2	2	7	7	infliximab	c-Rel	PA452639	5966	0.721
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Jul_21_9_20.nxml.txt.nlp	20663145	SENT108	35	35	12	12	ciprofloxacin	LBH	PA449009	81606;221491	0.721
NULL	Int_J_Med_Sci_2013_Jun_14_10(8)_995-1002.nxml.txt.nlp	23801886	SENT111	9	9	21	21	doxycycline	ILK	PA449415	3611	0.721
NULL	Oncotarget_2014_Oct_21_5(22)_11709-11722.nxml.txt.nlp	25365944	SENT215	4	4	16	16	metformin	p38	PA450395	10598;1432;7965	0.721
NULL	Avicenna_J_Phytomed_2012_Spring_2(2)_72-78.nxml.txt.nlp	25050233	SENT4	10	10	38	38	imipramine	HIC	PA449969	29969	0.721
NULL	Cancer_Med_2013_Oct_19_2(5)_646-653.nxml.txt.nlp	24403230	SENT42	0	0	7	7	trastuzumab	San	PA451743	80218	0.721
NULL	J_Exp_Bot_2008_Nov_13_59(15)_4183-4194.nxml.txt.nlp	19008411	SENT257	10	10	0	0	l-methionine	SAMS	PA450423	4143	0.721
NULL	Biol_Open_2014_Sep_12_3(10)_937-946.nxml.txt.nlp	25217618	SENT170	18	18	10	10	niclosamide	DKK1	PA165958408	22943	0.721
NULL	Oncol_Lett_2014_Nov_14_8(5)_2086-2092.nxml.txt.nlp	25295095	SENT116	10	10	13	13	gemcitabine	LKB1	PA449748	6794	0.721
NULL	J_Clin_Biochem_Nutr_2009_Sep_28_45(2)_125-130.nxml.txt.nlp	19794918	SENT13	7	7	23	23	indomethacin	COX	PA449982	1351	0.721
NULL	Pain_2013_Sep_154(9)_1680-1690.nxml.txt.nlp	23707289	SENT541	4	4	17	17	yohimbine	ANOVA	PA451946	4858	0.721
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Dec_4_66(Pt_1)_o48-o49.nxml.txt.nlp	21580151	SENT78	44	44	32	32	ethanol	mol	PA448073	90527	0.721
NULL	Genome_Biol_2008_Mar_10_9(3)_211.nxml.txt.nlp	18341708	SENT61	14	14	4	4	imiquimod	TLR8	PA449972	51311	0.721
NULL	Br_J_Pharmacol_2008_Oct_18_155(4)_596-605.nxml.txt.nlp	18852694	SENT139	0	0	12	12	fenofibrate	SREBP2	PA449594	6721	0.721
NULL	Nature_2012_Dec_13_492(7428)_285-289.nxml.txt.nlp	23103865	SENT165	14	14	17	17	doxycycline	TPP1	PA449415	1200	0.721
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_28_2012_937605.nxml.txt.nlp	23304227	SENT105	14	14	24	24	resveratrol	GDNF		2668	0.721
NULL	Front_Cell_Neurosci_2014_Jul_28_8_209.nxml.txt.nlp	25120433	SENT38	6	6	1	1	potassium	KCNT1	PA451047	57582	0.721
NULL	Indian_J_Nephrol_2011_Oct-Dec_21(4)_258-263.nxml.txt.nlp	22022086	SENT62	44	44	38	38	azathioprine	IL-2	PA448515	3558	0.721
NULL	Cardiovasc_Ther_2009_27(4)_259-274.nxml.txt.nlp	19604248	SENT48	48	48	14	14	ticagrelor	ADP	PA165374673	23038	0.721
NULL	Reprod_Biol_Endocrinol_2004_Aug_4_2_59.nxml.txt.nlp	15294019	SENT6	16	16	22	22	forskolin	EGF	PA146096022	1950	0.721
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_127043.nxml.txt.nlp	23227093	SENT217	14	14	16	16	lovastatin	RYR	PA450272	6261	0.721
NULL	Aging_(Albany_NY)_2010_Dec_20_2(12)_959-968.nxml.txt.nlp	21191146	SENT101	0	0	7	7	cisplatin	LKB1	PA449014	6794	0.721
NULL	Br_J_Cancer_1999_Mar_79(9-10)_1356-1365.nxml.txt.nlp	10188876	SENT8	24	24	5	5	vinblastine	KAR	PA451877	51144	0.721
NULL	Mol_Cancer_2008_Jan_25_7_14.nxml.txt.nlp	18221502	SENT139	3	3	0	0	oxaliplatin	PSAT1	PA131285527	29968	0.721
NULL	J_Cancer_Prev_2013_Jun_18(2)_186-191.nxml.txt.nlp	25337545	SENT97	17	17	10	10	curcumin	CDK4	PA151958596	1019	0.721
NULL	J_Oncol_2012_Oct_22_2012_391629.nxml.txt.nlp	23133451	SENT147	22	22	34	34	sorafenib	RAI	PA7000	10848;6050	0.721
NULL	Front_Genet_2014_Nov_14_5_391.nxml.txt.nlp	25452763	SENT746	22	22	2	2	cisplatin	ERCC1	PA449014	2067	0.721
NULL	Cell_Death_Dis_2013_Jun_6_4(6)_e654.nxml.txt.nlp	23744354	SENT38	12	12	1	1	paclitaxel	B4GALT1	PA450761	2683	0.721
NULL	Indian_J_Pharm_Sci_2013_Jan-Feb_75(1)_94-98.nxml.txt.nlp	23901167	SENT87	36	36	19	19	bupropion	CYP2C19	PA448687	1557	0.721
NULL	J_Cell_Biol_1998_Jan_26_140(2)_335-345.nxml.txt.nlp	9442109	SENT206	27	27	30	30	chloroquine	NHE	PA448948	285335	0.721
NULL	Onco_Targets_Ther_2014_Oct_21_7_1945-1954.nxml.txt.nlp	25364265	SENT4	43	43	17	17	ginseng	HCC	PA164781150	84668	0.721
NULL	Cancers_(Basel)_2014_Nov_25_6(4)_2313-2329.nxml.txt.nlp	25534569	SENT176	12	12	8	8	cabozantinib	HGF	PA165906891	3569;6654;3082	0.721
NULL	Cancer_Immunol_Immunother_2011_Jun_25_60(6)_793-808.nxml.txt.nlp	21350947	SENT193	37	37	34	34	sorafenib	IFN	PA7000	3439	0.721
NULL	Int_J_Nanomedicine_2012_Oct_25_7_5565-5575.nxml.txt.nlp	23118538	SENT135	14	14	17	17	fenofibrate	CO2	PA449594	4513	0.721
NULL	EMBO_J_2009_Mar_18_28(6)_663-676.nxml.txt.nlp	19214186	SENT373	14	14	11	11	oxaliplatin	p53	PA131285527	7157	0.721
NULL	Nat_Commun_2013_Sep_3_4_2394.nxml.txt.nlp	23999152	SENT67	10	10	4	4	dextran	BDNF	PA449261	627	0.72
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT149	5	5	16	16	doxorubicin	ABCB1	PA449412	5243	0.72
NULL	Eur_J_Med_Res_2009_Nov_24_14(Suppl_3)_17-21.nxml.txt.nlp	19959412	SENT94	22	22	10	10	raltegravir	UGT		7361;7355	0.72
NULL	Diabetes_Metab_Syndr_Obes_2014_Jun_24_7_229-239.nxml.txt.nlp	25018644	SENT103	15	15	10	10	exenatide	GLP-1	PA164749238	100125288	0.72
NULL	Biomed_Res_Int_2014_Jun_26_2014_161346.nxml.txt.nlp	25054130	SENT225	7	7	30	30	curcumin	STZ	PA151958596	6484	0.72
NULL	Neuropsychopharmacology_2009_Jul_11_34(8)_1946-1957.nxml.txt.nlp	19279569	SENT107	15	15	23	23	cocaine	DOR	PA449072	58476	0.72
NULL	Curr_HIV_Res_2014_May_12(3)_174-188.nxml.txt.nlp	24862327	SENT63	3	3	6	6	hemin	HO-1	PA449849	3162	0.72
NULL	Onco_Targets_Ther_2014_Sep_9_7_1571-1582.nxml.txt.nlp	25228815	SENT190	12	12	17	17	sunitinib	VEGFA	PA162372840	7422	0.72
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_127043.nxml.txt.nlp	23227093	SENT231	24	24	7	7	ketoconazole	CYP1A2	PA450146	1544	0.72
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT246	16	16	11	11	heparin	FGF1	PA449855	2246	0.72
NULL	Mar_Drugs_2012_Aug_22_10(8)_1852-1872.nxml.txt.nlp	23015777	SENT18	7	7	9	9	melphalan	TNF	PA450354	7124	0.72
NULL	Mol_Biol_Cell_2012_Nov_15_23(22)_4444-4455.nxml.txt.nlp	22993210	SENT226	19	19	12	12	forskolin	MyRIP	PA146096022	25924	0.72
NULL	Br_J_Cancer_2004_Mar_22_90(6)_1285-1292.nxml.txt.nlp	15026814	SENT104	10	10	8	8	doxorubicin	p53	PA449412	7157	0.72
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT101	6	6	11	11	afatinib	HER2	PA165981154	2064	0.72
NULL	Cases_J_2008_Jun_5_1_15.nxml.txt.nlp	18577260	SENT78	24	24	20	20	vincristine	CHOP	PA451879	1649	0.72
NULL	eLife_2014_May_20_3_e01763.nxml.txt.nlp	24844244	SENT366	17	17	6	6	doxycycline	MELK	PA449415	9833	0.72
NULL	Exp_Ther_Med_2013_Mar_8_5(3)_707-710.nxml.txt.nlp	23404433	SENT147	8	8	10	10	cisplatin	DDP	PA449014	1678	0.72
NULL	Diabetes_2009_Dec_31_58(12)_2851-2862.nxml.txt.nlp	19720788	SENT112	2	2	7	7	forskolin	PERK	PA146096022	9451	0.72
NULL	Aging_(Albany_NY)_2009_Mar_31_1(4)_412-424.nxml.txt.nlp	20195491	SENT131	23	23	36	36	resveratrol	AMPK		5563	0.72
NULL	Br_J_Cancer_2009_Mar_24_100(6)_870-873.nxml.txt.nlp	19293806	SENT39	3	3	9	9	gemcitabine	CDA	PA449748	978	0.72
NULL	Exp_Ther_Med_2013_Dec_15_6(6)_1565-1569.nxml.txt.nlp	24255692	SENT75	5	5	12	12	atorvastatin	adiponectin	PA448500	9370	0.72
NULL	Br_J_Cancer_2012_Oct_23_107(9)_1488-1497.nxml.txt.nlp	23033007	SENT172	0	0	2	2	disulfiram	JNK	PA449376	5599	0.72
NULL	Oncotarget_2012_Aug_7_3(8)_783-797.nxml.txt.nlp	22878175	SENT217	19	19	12	12	neomycin	S100A4	PA450608	6275	0.72
NULL	J_Exp_Clin_Cancer_Res_2009_Oct_7_28(1)_134.nxml.txt.nlp	19811659	SENT95	3	3	13	13	dasatinib	DDR1	PA162372878	780	0.72
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jan_8_67(Pt_2)_o258.nxml.txt.nlp	21522951	SENT57	5	5	11	11	benzaldehyde	mol	PA448571	90527	0.72
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_May_22_66(Pt_6)_o1406.nxml.txt.nlp	21579485	SENT64	0	0	6	6	benzaldehyde	mol	PA448571	90527	0.72
NULL	Breast_Cancer_Res_2011_Nov_30_13(6)_R123.nxml.txt.nlp	22129105	SENT180	11	11	3	3	trastuzumab	HER2	PA451743	2064	0.72
NULL	Acta_Pharmacol_Sin_2013_Sep_5_34(9)_1208-1216.nxml.txt.nlp	23852087	SENT101	8	8	17	17	disulfiram	HIF-1	PA449376	29072	0.72
NULL	Cancers_(Basel)_2010_Dec_22_2(4)_2153-2170.nxml.txt.nlp	21390244	SENT80	13	13	4	4	gefitinib	AREG	PA131301952	374	0.72
NULL	Acta_Pharmacol_Sin_2011_Jun_23_32(6)_711-715.nxml.txt.nlp	21602841	SENT25	7	7	2	2	capsaicin	AQP1	PA448776	358	0.72
NULL	Indian_J_Ophthalmol_2011_Jan_59(Suppl1)_S102-S113.nxml.txt.nlp	21150020	SENT279	26	26	14	14	resveratrol	Q10		27161	0.72
NULL	Biomed_Res_Int_2013_Feb_28_2013_215283.nxml.txt.nlp	23555077	SENT209	28	28	13	13	galactose	IL-6	PA449725	3569	0.72
NULL	J_Oncol_2009_Mar_10_2009_831626.nxml.txt.nlp	20300583	SENT68	21	21	30	30	cetuximab	BRAF	PA10040	673	0.72
NULL	Mol_Cancer_2003_Jan_6_2_4.nxml.txt.nlp	12556242	SENT91	2	2	11	11	metformin	BOP	PA450395	611;150572	0.72
NULL	Indian_J_Pharmacol_2008_Jan-Feb_40(1)_10-14.nxml.txt.nlp	21264154	SENT9	22	22	33	33	vildagliptin	GLP-1	PA165958346	100125288	0.72
NULL	Viruses_2009_Aug_12_1(2)_144-165.nxml.txt.nlp	21994543	SENT134	28	28	25	25	ribavirin	IFN	PA451241	3439	0.72
NULL	Front_Microbiol_2012_Mar_22_3_106.nxml.txt.nlp	22461783	SENT368	27	27	12	12	ciprofloxacin	STEP	PA449009	84867	0.72
NULL	J_Cell_Mol_Med_2014_Feb_5_18(2)_263-273.nxml.txt.nlp	24304472	SENT139	2	2	13	13	prazosin	p65	PA451093	5970	0.72
NULL	J_Geriatr_Cardiol_2013_Sep_10(3)_211-212.nxml.txt.nlp	24133505	SENT6	29	29	25	25	paclitaxel	DES	PA450761	1674	0.72
NULL	Eur_J_Clin_Pharmacol_2014_Oct_8_70(1)_37-45.nxml.txt.nlp	24100471	SENT54	25	25	18	18	rosuvastatin	CYP2C8	PA134308647	1558	0.72
NULL	Cardiovasc_Diabetol_2010_Nov_16_9_76.nxml.txt.nlp	21080957	SENT290	9	9	11	11	liraglutide	AKT	PA165958364	207	0.72
NULL	Cell_Commun_Signal_2014_Aug_1_12_50.nxml.txt.nlp	25081034	SENT119	7	7	27	27	oxygen	CD28	PA450744	1493;940	0.72
NULL	Breast_Cancer_Res_2004_Nov_25_6(1)_E8.nxml.txt.nlp	14680493	SENT44	0	0	28	28	tamoxifen	BRCA1	PA451581	672	0.72
NULL	Int_J_Biomed_Sci_2006_Dec_2(4)_375-394.nxml.txt.nlp	23675006	SENT287	0	0	13	13	fluoxetine	ACTH	PA449673	5443	0.72
NULL	Clin_Pharmacokinet_2014_Sep_3_53(1)_1-16.nxml.txt.nlp	23999929	SENT287	12	12	30	30	erythromycin	P-gp	PA449493	5243	0.72
NULL	Front_Genet_2013_Aug_30_4_166.nxml.txt.nlp	24009623	SENT579	2	2	16	16	tacrolimus	MDR1	PA451578	5243	0.72
NULL	Oncotarget_2014_Jun_7_5(14)_5257-5271.nxml.txt.nlp	24913448	SENT82	37	37	12	12	nilotinib	LASP1	PA165958345	3927	0.72
NULL	Breast_Cancer_Res_2010_Nov_16_12(6)_R96.nxml.txt.nlp	21080941	SENT159	23	23	27	27	lapatinib	HRG	PA152241907	3084;3273	0.72
NULL	J_Hematol_Oncol_2009_Mar_24_2_14.nxml.txt.nlp	19309523	SENT23	15	15	17	17	rituximab	CHOP	PA451261	1649	0.72
NULL	Br_J_Pharmacol_2014_Feb_24_171(1)_1019-1032.nxml.txt.nlp	24251620	SENT169	5	5	8	8	nifedipine	TRPM3	PA450631	80036	0.72
NULL	J_Cell_Mol_Med_2014_Oct_11_18(10)_2031-2043.nxml.txt.nlp	25109475	SENT145	0	0	2	2	valsartan	AMPK	PA451848	5563	0.72
NULL	Acta_Neuropathol_Commun_2014_Jul_16_2(1)_81.nxml.txt.nlp	NULL	SENT191	8	8	14	14	fluoxetine	CA4	PA449673	762	0.72
NULL	Mol_Microbiol_2014_Mar_23_91(5)_918-934.nxml.txt.nlp	24372851	SENT58	38	38	34	34	artemisinin	LUM	PA165111696	4060	0.72
NULL	Eur_J_Haematol_2009_Apr_82(4)_277-287.nxml.txt.nlp	19187270	SENT203	21	21	41	41	pha-665752	IL-6		3569	0.72
NULL	Calcif_Tissue_Int_2014_Aug_21_94(2)_170-175.nxml.txt.nlp	23963633	SENT122	1	1	16	16	teriparatide	PTH	PA451620	5741	0.72
NULL	Scientifica_(Cairo)_2012_Nov_25_2012_473829.nxml.txt.nlp	24278698	SENT315	12	12	2	2	cisplatin	OCT1	PA449014	5451;6580	0.72
NULL	J_Cell_Biol_1998_May_4_141(3)_727-739.nxml.txt.nlp	9566972	SENT293	22	22	31	31	neomycin	GAPDH	PA450608	2597	0.72
NULL	Indian_J_Med_Res_2012_Sep_136(3)_391-403.nxml.txt.nlp	23041732	SENT191	10	10	19	19	bevacizumab	HCC	PA130232992	84668	0.72
NULL	J_Cell_Mol_Med_2014_Sep_5_18(9)_1773-1784.nxml.txt.nlp	25091058	SENT10	14	14	33	33	anakinra	IL-17	PA10799	3605	0.72
NULL	Br_J_Cancer_2009_Jun_16_100(12)_1889-1895.nxml.txt.nlp	19513079	SENT46	20	20	42	42	l-glutamine	CO2	PA10090	4513	0.72
NULL	Front_Genet_2014_Nov_14_5_391.nxml.txt.nlp	25452763	SENT1214	14	14	0	0	oxaliplatin	ERCC1	PA131285527	2067	0.72
NULL	Crit_Care_2000_Mar_21_4(Suppl_1)_P28.nxml.txt.nlp	NULL	SENT10	7	7	48	48	thrombin	IL-6	PA451674	3569	0.72
NULL	Oncotarget_2012_Aug_9_3(8)_774-782.nxml.txt.nlp	22885298	SENT32	9	9	21	21	tetracycline	IDH1	PA451640	3417	0.72
NULL	Saudi_J_Anaesth_2013_Apr-Jun_7(2)_151-154.nxml.txt.nlp	23956714	SENT102	5	5	8	8	theophylline	NAC	PA451647	22861	0.72
NULL	Breast_Cancer_Res_2011_Nov_1_13(6)_224.nxml.txt.nlp	22114931	SENT113	14	14	22	22	trastuzumab	PI3K	PA451743	5290	0.72
NULL	J_Hematol_Oncol_2010_Oct_27_3_42.nxml.txt.nlp	20979652	SENT141	30	30	25	25	bsi-201	PARP1		142	0.72
NULL	Pharmaceuticals_(Basel)_2012_Sep_10_5(9)_944-962.nxml.txt.nlp	24280699	SENT411	16	16	7	7	geldanamycin	Hsp90	PA152031327	3320	0.72
NULL	BMJ_2010_Feb_8_340_c693.nxml.txt.nlp	20142325	SENT258	25	25	43	43	imipramine	CYP2C9	PA449969	1559	0.72
NULL	Eur_J_Clin_Pharmacol_2014_Oct_8_70(1)_37-45.nxml.txt.nlp	24100471	SENT54	25	25	14	14	rosuvastatin	CYP3A4	PA134308647	1576	0.72
NULL	Front_Oncol_2014_Jun_18_4_159.nxml.txt.nlp	24995161	SENT154	2	2	10	10	estradiol	AKR1C3	PA449503	8644	0.72
NULL	Diabetes_2011_Nov_17_60(11)_2691-2700.nxml.txt.nlp	21896928	SENT246	14	14	16	16	resveratrol	SIRT1		23411	0.72
NULL	Ann_Clin_Transl_Neurol_2014_Jan_19_1(1)_2-14.nxml.txt.nlp	24466563	SENT109	11	11	0	0	fasudil	ROCK1	PA165946121	6093	0.72
NULL	J_Thorac_Oncol_2014_Jun_30_9(6)_775-783.nxml.txt.nlp	24828661	SENT296	12	12	7	7	erlotinib	Met	PA134687924	79811	0.72
NULL	J_Mol_Med_(Berl)_2014_May_10_92(7)_709-722.nxml.txt.nlp	24811491	SENT105	15	15	31	31	panitumumab	KRAS	PA162373091	3845	0.72
NULL	J_Nutr_Biochem_2012_Apr_23(4-2)_332-340.nxml.txt.nlp	21543215	SENT155	20	20	12	12	lipase	ATGL	PA450239	57104	0.72
NULL	Diabetes_Care_2010_Dec_30_33(12)_2549-2551.nxml.txt.nlp	20805256	SENT46	9	9	15	15	metformin	ADM	PA450395	133	0.72
NULL	Ann_N_Y_Acad_Sci_2012_Aug_30_1264(1)_49-63.nxml.txt.nlp	22548651	SENT87	36	36	26	26	glucose	BDNF	PA449773	627	0.72
NULL	Mol_Cancer_2009_Aug_25_8_66.nxml.txt.nlp	19706164	SENT55	19	19	11	11	celecoxib	p53	PA448871	7157	0.72
NULL	Br_J_Anaesth_2011_Oct_17_107(4)_490-502.nxml.txt.nlp	21852280	SENT62	12	12	10	10	capsaicin	TRPV1	PA448776	7442	0.72
NULL	Clin_Drug_Investig_2013_Sep_3_33(10)_761-771.nxml.txt.nlp	23999912	SENT39	17	17	13	13	ketoconazole	CYP3A4	PA450146	1576	0.72
NULL	Cell_Death_Dis_2011_Aug_18_2(8)_e193.nxml.txt.nlp	21850047	SENT61	4	4	17	17	doxazosin	p38	PA449407	10598;1432;7965	0.72
NULL	Acta_Pharmacol_Sin_2010_Mar_22_31(3)_329-340.nxml.txt.nlp	20173759	SENT207	6	6	39	39	ethanol	AMPK	PA448073	5563	0.72
NULL	Clin_Sci_(Lond)_2009_Nov_16_118(Pt_4)_269-279.nxml.txt.nlp	19698082	SENT12	0	0	6	6	ramipril	ACE2	PA451223	59272	0.72
NULL	Curr_Cardiovasc_Imaging_Rep_2010_Oct_4_3(5)_317-323.nxml.txt.nlp	20835382	SENT124	8	8	2	2	paclitaxel	DES	PA450761	1674	0.72
NULL	Crit_Care_2011_Aug_11_15(4)_226.nxml.txt.nlp	21892977	SENT18	0	0	28	28	vasopressin	AVPR2	PA451858	554	0.72
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT349	23	23	14	14	acetaminophen	FasL	PA448015	356	0.72
NULL	J_Biol_Chem_2013_Nov_22_288(47)_34217-34229.nxml.txt.nlp	24106270	SENT179	16	16	35	35	thrombin	RhoG	PA451674	391	0.72
NULL	J_Cell_Biol_1998_May_18_141(4)_929-942.nxml.txt.nlp	9585412	SENT149	4	4	14	14	paraformaldehyde	PLAP	PA450790	4012;9373	0.72
NULL	Mol_Pain_2013_Jun_10_9_27.nxml.txt.nlp	23758830	SENT219	7	7	4	4	tetracaine	ASIC3	PA451638	9311	0.72
NULL	Breast_Cancer_Res_2011_Mar_11_13(2)_R29.nxml.txt.nlp	21396094	SENT152	2	2	5	5	fulvestrant	HRG	PA164747170	3084;3273	0.72
NULL	Crit_Care_2011_Sep_14_15(5)_R213.nxml.txt.nlp	21917139	SENT171	27	27	11	11	furosemide	SAPS	PA449719	8935	0.72
NULL	J_Cancer_Prev_2013_Jun_18(2)_186-191.nxml.txt.nlp	25337545	SENT78	2	2	7	7	curcumin	CDK4	PA151958596	1019	0.72
NULL	Front_Endocrinol_(Lausanne)_2013_Oct_8_4_141.nxml.txt.nlp	24115945	SENT33	6	6	10	10	tamoxifen	GPER	PA451581	2852	0.72
NULL	Case_Rep_Ophthalmol_2010_Aug_18_1(1)_36-41.nxml.txt.nlp	21369348	SENT21	22	22	16	16	bevacizumab	hole	PA130232992	80757	0.72
NULL	Acta_Pharmacol_Sin_2012_Mar_23_33(3)_407-417.nxml.txt.nlp	22266726	SENT176	1	1	19	19	coumarin	PC-3	PA134521193	692094	0.72
NULL	Clin_Ophthalmol_2012_Aug_10_6_1287-1291.nxml.txt.nlp	22927741	SENT38	8	8	15	15	ranibizumab	San	PA164746012	80218	0.72
NULL	Pharmaceutics_2011_Nov_18_3(4)_865-913.nxml.txt.nlp	24309312	SENT180	3	3	28	28	posaconazole	UGT	PA151958574	7361;7355	0.72
NULL	Mol_Cancer_2007_Oct_22_6_66.nxml.txt.nlp	17953743	SENT260	12	12	9	9	cisplatin	TRAIL	PA449014	8743	0.72
NULL	J_Biomed_Sci_2012_Nov_14_19(1)_94.nxml.txt.nlp	23148884	SENT122	0	0	12	12	bortezomib	NF-kappaB	PA10252	4790	0.72
NULL	Breast_Cancer_Res_2011_Mar_11_13(2)_R30.nxml.txt.nlp	21396117	SENT272	0	0	11	11	erlotinib	p53	PA134687924	7157	0.72
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT332	3	3	14	14	resveratrol	TRAIL		8743	0.72
NULL	AMIA_Jt_Summits_Transl_Sci_Proc_2012_Mar_19_2012_25-34.nxml.txt.nlp	22779044	SENT161	7	7	9	9	ethanol	PPARD	PA448073	5467	0.72
NULL	J_Oncol_2012_Aug_7_2012_803294.nxml.txt.nlp	22919383	SENT81	18	18	26	26	sulindac	COX	PA451565	1351	0.72
NULL	Open_Biol_2013_Nov_3(11)_130130.nxml.txt.nlp	24258275	SENT155	9	9	5	5	etoposide	p53	PA449552	7157	0.72
NULL	Cerebrospinal_Fluid_Res_2006_Dec_21_3_13.nxml.txt.nlp	17184532	SENT163	12	12	20	20	verapamil	FRG	PA451868	9855	0.72
NULL	Indian_J_Med_Res_2011_Sep_134(3)_295-301.nxml.txt.nlp	21985811	SENT111	11	11	26	26	phenobarbital	CYP2C19	PA450911	1557	0.72
NULL	J_Invest_Dermatol_2012_May_16_132(5)_1435-1442.nxml.txt.nlp	22336948	SENT238	0	0	4	4	doxycycline	TLSP	PA449415	11012	0.72
NULL	CNS_Drugs_2014_May_27_28(8)_679-697.nxml.txt.nlp	24861337	SENT429	28	28	0	0	thrombin	Hua	PA451674	1994	0.72
NULL	Evid_Based_Complement_Alternat_Med_2013_May_13_2013_506324.nxml.txt.nlp	23818927	SENT261	9	9	24	24	doxorubicin	MM1	PA449412	23654	0.72
NULL	Neural_Regen_Res_2013_Mar_15_8(8)_686-692.nxml.txt.nlp	25206714	SENT188	42	42	25	25	glutaraldehyde	San	PA449777	80218	0.72
NULL	Clin_Med_Insights_Cardiol_2012_Feb_1_6_17-33.nxml.txt.nlp	22442638	SENT185	20	20	18	18	rosuvastatin	CYP2C19	PA134308647	1557	0.72
NULL	J_Biomed_Sci_2014_Feb_3_21(1)_10.nxml.txt.nlp	24490900	SENT126	28	28	17	17	alendronate	RANKL	PA448082	8600	0.72
NULL	Braz_J_Med_Biol_Res_2014_Sep_5_47(11)_929-939.nxml.txt.nlp	25296354	SENT156	7	7	4	4	gefitinib	EGFR	PA131301952	1956	0.72
NULL	Cell_Death_Dis_2013_Jun_27_4(6)_e694.nxml.txt.nlp	23807223	SENT97	15	15	8	8	chloroquine	p62	PA448948	8878;10657;23636	0.72
NULL	J_Gynecol_Oncol_2013_Jan_8_24(1)_83-91.nxml.txt.nlp	23346317	SENT73	27	27	18	18	carboplatin	AGO	PA448803	55294	0.72
NULL	J_Cell_Mol_Med_2013_Dec_6_17(12)_1588-1597.nxml.txt.nlp	24199964	SENT231	11	11	20	20	doxycycline	APT	PA449415	653639	0.72
NULL	Clin_Mol_Hepatol_2014_Sep_25_20(3)_267-273.nxml.txt.nlp	25320730	SENT5	5	5	7	7	lamivudine	LAM	PA450163	7249;7248	0.72
NULL	J_Biomed_Biotechnol_2011_Jun_13_2011_861920.nxml.txt.nlp	21716670	SENT296	28	28	8	8	rituximab	IL-21	PA451261	59067;50616;27189	0.72
NULL	Eur_J_Clin_Pharmacol_2014_Oct_8_70(1)_37-45.nxml.txt.nlp	24100471	SENT54	25	25	29	29	rosuvastatin	OATP1B1	PA134308647	10599	0.72
NULL	J_Res_Med_Sci_2012_Mar_17(3)_313.nxml.txt.nlp	23267388	SENT12	17	17	12	12	aprotinin	BART	PA448472	7809;23568	0.72
NULL	Cell_Commun_Signal_2011_May_14_9_12.nxml.txt.nlp	21569606	SENT94	5	5	1	1	troglitazone	FGF2	PA451799	2247;2258	0.72
NULL	Nucleic_Acids_Res_2011_Mar_20_39(6)_2234-2248.nxml.txt.nlp	21097889	SENT102	27	27	20	20	fluorouracil	PAK1IP1	PA128406956	55003	0.72
NULL	J_Adv_Pract_Oncol_2013_Jul_1_Jul-Aug_4(4)_238-250.nxml.txt.nlp	25032004	SENT242	38	38	8	8	dasatinib	CML	PA162372878	613	0.72
NULL	Indian_J_Pharmacol_2008_Oct_40(Suppl_2)_S178-S211.nxml.txt.nlp	21593974	SENT160	5	5	2	2	azithromycin	OTC	PA448519	5009	0.72
NULL	J_Cell_Mol_Med_2014_Apr_20_18(4)_709-720.nxml.txt.nlp	24444314	SENT246	5	5	33	33	metformin	SIRT1	PA450395	23411	0.72
NULL	Acta_Pharmacol_Sin_2013_Feb_12_34(2)_255-261.nxml.txt.nlp	23147557	SENT82	13	13	6	6	pioglitazone	PTPRD	PA450970	5789	0.72
NULL	FEBS_Open_Bio_2014_Oct_22_4_905-914.nxml.txt.nlp	25383314	SENT582	4	4	10	10	physostigmine	L-FABP	PA450957	2168	0.72
NULL	Br_J_Cancer_1996_Feb_73(3)_316-322.nxml.txt.nlp	8562336	SENT9	10	10	6	6	chloramphenicol	CYP1A1	PA448927	1543	0.72
NULL	Oncotarget_2014_Oct_16_5(20)_9546-9563.nxml.txt.nlp	25337673	SENT108	44	44	21	21	lapatinib	AXL	PA152241907	558	0.72
NULL	Nat_Commun_2013_Apr_9_4_1684.nxml.txt.nlp	23575688	SENT97	2	2	9	9	rolipram	CYLD	PA153906323	1540	0.72
NULL	JAKSTAT_2013_Jul_1_2(3)_e24812.nxml.txt.nlp	24069562	SENT62	35	35	13	13	pp2	STAT3		6774	0.72
NULL	Biomed_Res_Int_2014_Apr_29_2014_186864.nxml.txt.nlp	24877064	SENT135	0	0	7	7	curcumin	p300	PA151958596	2033	0.72
NULL	Breast_Cancer_Res_2009_Mar_19_11(2)_204.nxml.txt.nlp	19344489	SENT214	15	15	30	30	trastuzumab	HER2	PA451743	2064	0.72
NULL	J_Oncol_2012_Sep_18_2012_125278.nxml.txt.nlp	21941547	SENT397	11	11	21	21	cilengitide	VEGFR2	PA164924491	3791	0.72
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT397	5	5	11	11	metformin	GLP-1	PA450395	100125288	0.72
NULL	Clin_Exp_Otorhinolaryngol_2013_Mar_1_6(1)_48-51.nxml.txt.nlp	23526700	SENT81	11	11	7	7	thyroglobulin	CK7	PA164754910	3855	0.72
NULL	Oncotarget_2011_Dec_24_2(12)_896-917.nxml.txt.nlp	22203527	SENT115	28	28	35	35	metformin	LKB1	PA450395	6794	0.72
NULL	AIDS_Res_Ther_2012_Mar_9_9_6.nxml.txt.nlp	22405335	SENT90	25	25	9	9	fluconazole	CD4	PA449653	920	0.72
NULL	Cancer_Res_Treat_2014_Jan_15_46(1)_2-18.nxml.txt.nlp	24520218	SENT167	26	26	11	11	curcumin	TMC	PA151958596	3703	0.72
NULL	Biosci_Rep_2012_Apr_1_32(Pt_2)_105-112.nxml.txt.nlp	22115362	SENT134	4	4	33	33	collagenase	c-Jun	PA449107	3725	0.72
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT33	9	9	21	21	gefitinib	KRAS	PA131301952	3845	0.72
NULL	Mol_Cancer_2014_Apr_30_13_98.nxml.txt.nlp	24779770	SENT196	12	12	34	34	oxygen	JNK	PA450744	5599	0.72
NULL	Cell_Cycle_2013_Feb_15_12(4)_625-634.nxml.txt.nlp	23324396	SENT188	10	10	21	21	doxycycline	p53	PA449415	7157	0.72
NULL	Adv_Appl_Bioinforma_Chem_2008_Oct_30_1_85-98.nxml.txt.nlp	21918608	SENT176	15	15	3	3	bortezomib	SPARC	PA10252	6678	0.72
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Apr_28_68(Pt_5)_m681.nxml.txt.nlp	22590163	SENT64	13	13	6	6	ethanol	mol	PA448073	90527	0.72
NULL	Int_J_Med_Sci_2013_Jun_15_10(8)_1015-1021.nxml.txt.nlp	23801888	SENT124	14	14	8	8	ribavirin	IL28B	PA451241	282617	0.72
NULL	Support_Care_Cancer_2012_Jul_27_20(7)_1353-1360.nxml.txt.nlp	22539050	SENT211	11	11	8	8	denosumab	NNT	PA166048634	23530	0.72
NULL	Blood_Res_2014_Dec_23_49(4)_253-258.nxml.txt.nlp	25548759	SENT73	27	27	33	33	vincristine	CHOP	PA451879	1649	0.72
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT39	37	37	25	25	nutlin-3	p53		7157	0.72
NULL	Environ_Health_Perspect_2005_Aug_15_113(8)_1009-1014.nxml.txt.nlp	16079071	SENT100	6	6	11	11	losartan	p38	PA450268	10598;1432;7965	0.72
NULL	Saline_Systems_2005_Aug_4_1_5.nxml.txt.nlp	16176595	SENT112	17	17	29	29	betaine	mol	PA448603	90527	0.72
NULL	Ann_Gen_Psychiatry_2010_Mar_6_9_11.nxml.txt.nlp	20205742	SENT25	26	26	6	6	olanzapine	STAR	PA450688	6770;2984	0.72
NULL	Cell_Death_Dis_2014_Jul_3_5(7)_e1316.nxml.txt.nlp	24991768	SENT89	7	7	14	14	pemetrexed	ATF3	PA10810	467	0.72
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT249	4	4	9	9	pp2	AKT		207	0.72
NULL	Behav_Brain_Funct_2013_Jan_10_9_4.nxml.txt.nlp	23305134	SENT220	6	6	10	10	biperiden	spatial	PA448626	219793	0.72
NULL	Braz_J_Med_Biol_Res_2013_May_10_46(5)_433-439.nxml.txt.nlp	23681290	SENT82	17	17	8	8	bezafibrate	BAFF	PA162364313	10673	0.72
NULL	Br_J_Cancer_1999_Feb_79(3-4)_509-514.nxml.txt.nlp	10027321	SENT12	35	35	8	8	marimastat	CEA	PA164748329	5670;1087	0.72
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT53	22	22	30	30	ritonavir	ATV	PA451260	4683	0.72
NULL	Breast_Cancer_(Auckl)_2011_Sep_25_5_201-208.nxml.txt.nlp	22084573	SENT5	17	17	24	24	cisplatin	BRCA1	PA449014	672	0.72
NULL	Biomed_Res_Int_2014_Jan_20_2014_948427.nxml.txt.nlp	24563867	SENT81	3	3	21	21	buspirone	STZ	PA448689	6484	0.72
NULL	Acta_Pharmacol_Sin_2014_Jul_16_35(7)_957-966.nxml.txt.nlp	24930486	SENT50	0	0	18	18	forskolin	San	PA146096022	80218	0.72
NULL	Cell_Commun_Signal_2013_Nov_11_11_86.nxml.txt.nlp	24215724	SENT265	10	10	29	29	thrombin	PAR1	PA451674	79581;2149	0.72
NULL	Drugs_R_D_2010_Jul_27_10(2)_111-122.nxml.txt.nlp	20698720	SENT191	0	0	18	18	sorafenib	IL-3	PA7000	3562	0.72
NULL	Br_J_Clin_Pharmacol_2012_Apr_7_73(4)_518-535.nxml.txt.nlp	22053916	SENT179	0	0	10	10	pitavastatin	Rho	PA142650384	29984	0.72
NULL	Diabetes_2009_Jan_58(1)_250-259.nxml.txt.nlp	18840786	SENT213	0	0	14	14	rosiglitazone	CD36	PA451283	948	0.72
NULL	Virol_J_2011_May_25_8_258.nxml.txt.nlp	21609495	SENT25	34	34	31	31	ribavirin	IFN	PA451241	3439	0.72
NULL	J_Breast_Cancer_2013_Mar_31_16(1)_23-31.nxml.txt.nlp	23593078	SENT111	4	4	20	20	genistein	DNMT1	PA165109660	1786	0.72
NULL	Mol_Cancer_2009_Dec_23_8_129.nxml.txt.nlp	20030852	SENT238	24	24	30	30	curcumin	ABCA1	PA151958596	19	0.72
NULL	Breast_Cancer_Res_2007_Jul_5_9(4)_R41.nxml.txt.nlp	17612393	SENT40	2	2	8	8	celecoxib	Bcl-2	PA448871	596	0.72
NULL	J_Clin_Biochem_Nutr_2007_Nov_30_41(3)_160-168.nxml.txt.nlp	18299710	SENT105	36	36	4	4	ecabet	IL-8	PA165958350	3576	0.72
NULL	Acta_Pharmacol_Sin_2009_Jul_22_30(7)_956-964.nxml.txt.nlp	19543298	SENT226	11	11	18	18	atorvastatin	ANOVA	PA448500	4858	0.72
NULL	Mol_Cancer_2012_Dec_12_11_91.nxml.txt.nlp	23234355	SENT90	0	0	2	2	erlotinib	EGFR	PA134687924	1956	0.72
NULL	J_Cancer_Prev_2013_Jun_18(2)_186-191.nxml.txt.nlp	25337545	SENT69	0	0	6	6	curcumin	STAT3	PA151958596	6774	0.72
NULL	Blood_Res_2013_Sep_25_48(3)_171-177.nxml.txt.nlp	24086936	SENT131	8	8	10	10	bortezomib	CHOP	PA10252	1649	0.72
NULL	Br_J_Cancer_2013_Jun_25_108(12)_2464-2469.nxml.txt.nlp	23695016	SENT36	18	18	26	26	paclitaxel	CRT	PA450761	811	0.72
NULL	Mol_Cancer_2009_Jul_3_8_43.nxml.txt.nlp	19575780	SENT250	26	26	8	8	paclitaxel	survivin	PA450761	332	0.72
NULL	Pharmaceuticals_(Basel)_2014_Jan_27_7(2)_169-191.nxml.txt.nlp	24473270	SENT704	6	6	24	24	metoprolol	BCS	PA450480	617	0.72
NULL	Exp_Ther_Med_2012_Sep_12_4(3)_475-480.nxml.txt.nlp	23181121	SENT163	8	8	22	22	cyclophosphamide	CHOP	PA449165	1649	0.72
NULL	Open_Access_J_Urol_2010_Feb_10_2_25-30.nxml.txt.nlp	24198610	SENT114	12	12	6	6	ifosfamide	ETO	PA449964	862	0.72
NULL	Epilepsy_Res_Treat_2010_Jun_22_2010_654265.nxml.txt.nlp	22937226	SENT181	32	32	11	11	etomidate	NKCC1	PA164743987	6558	0.72
NULL	Expert_Rev_Mol_Med_2009_May_11_e16.nxml.txt.nlp	19467172	SENT431	22	22	13	13	levamisole	CD36	PA450205	948	0.72
NULL	Arthritis_Res_Ther_2003_Dec_2_5(Suppl_4)_S12-S16.nxml.txt.nlp	15180892	SENT99	6	6	0	0	vincristine	CHOP	PA451879	1649	0.72
NULL	Mol_Cancer_2010_Apr_23_9_87.nxml.txt.nlp	20416058	SENT262	27	27	23	23	etoposide	TRAIL	PA449552	8743	0.72
NULL	Br_J_Cancer_2013_Feb_19_108(3)_493-502.nxml.txt.nlp	23299530	SENT24	23	23	14	14	fluorouracil	VEGF-A	PA128406956	7422	0.72
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Apr_28_68(Pt_5)_m681.nxml.txt.nlp	22590163	SENT65	14	14	7	7	ethanol	mol	PA448073	90527	0.72
NULL	Mol_Cancer_2007_Jan_14_6_5.nxml.txt.nlp	17222355	SENT38	18	18	11	11	cisplatin	HMGA2	PA449014	8091	0.72
NULL	Genet_Sel_Evol_2012_Apr_17_44(1)_13.nxml.txt.nlp	22510482	SENT43	8	8	5	5	lipase	LIPE	PA450239	3991	0.72
NULL	Endocrinol_Metab_(Seoul)_2014_Sep_25_29(3)_379-387.nxml.txt.nlp	25309798	SENT186	41	41	32	32	resveratrol	CLOCK		9575	0.72
NULL	Cancer_Cell_Int_2011_Aug_19_11_29.nxml.txt.nlp	21854619	SENT96	6	6	17	17	formaldehyde	CAN	PA449703	8021	0.72
NULL	Front_Neurol_2011_Dec_26_2_83.nxml.txt.nlp	22363312	SENT729	13	13	3	3	ticlopidine	CYP2C19	PA451686	1557	0.72
NULL	J_Invest_Dermatol_2013_Aug_133(8)_1928-1929.nxml.txt.nlp	23856932	SENT37	19	19	15	15	vemurafenib	PAX3	PA165946873	5077	0.72
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT107	30	30	2	2	methotrexate	MSH2	PA450428	4436	0.72
NULL	Bone_Marrow_Res_2011_Sep_21_2011_976793.nxml.txt.nlp	22046574	SENT57	7	7	23	23	abatacept	IL-17	PA164747080	3605	0.72
NULL	Open_Dent_J_2014_May_30_8_109-124.nxml.txt.nlp	24976875	SENT183	0	0	3	3	minocycline	PARP-1	PA450519	25976	0.72
NULL	J_Cell_Biol_1977_May_1_73(2)_366-381.nxml.txt.nlp	858741	SENT7	16	16	8	8	vasopressin	mol	PA451858	90527	0.72
NULL	Adolesc_Health_Med_Ther_2010_May_27_1_21-30.nxml.txt.nlp	24600258	SENT224	17	17	8	8	isometheptene	OTC	PA165958379	5009	0.72
NULL	Exp_Diabetes_Res_2011_Nov_28_2011_625813.nxml.txt.nlp	22144989	SENT105	17	17	14	14	cyclophosphamide	STZ	PA449165	6484	0.72
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT49	34	34	16	16	diclofenac	CYP2E1	PA449293	1571	0.72
NULL	EPMA_J_2010_Sep_20_1(3)_421-437.nxml.txt.nlp	23199086	SENT194	4	4	15	15	tamoxifen	HOXB13	PA451581	10481	0.72
NULL	Breast_Cancer_Res_2006_Nov_6_8(6)_215.nxml.txt.nlp	17096862	SENT93	0	0	7	7	pertuzumab	EGFR		1956	0.72
NULL	Clin_Mol_Hepatol_2014_Sep_25_20(3)_283-290.nxml.txt.nlp	25320732	SENT77	26	26	24	24	propranolol	EVL	PA451145	51466	0.72
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT135	5	5	12	12	perifosine	DR5	PA165291471	8795	0.72
NULL	Eur_J_Haematol_2009_Apr_82(4)_277-287.nxml.txt.nlp	19187270	SENT62	27	27	40	40	l-glutamine	IL-6	PA10090	3569	0.72
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT166	42	42	10	10	trastuzumab	IL-6	PA451743	3569	0.72
NULL	Cancer_Cell_Int_2010_Sep_6_10_31.nxml.txt.nlp	20819205	SENT85	25	25	9	9	oxaliplatin	CIS	PA131285527	1154	0.719
NULL	J_Breast_Cancer_2013_Mar_31_16(1)_23-31.nxml.txt.nlp	23593078	SENT149	14	14	35	35	genistein	DNMT1	PA165109660	1786	0.719
NULL	Channels_(Austin)_2010_Jan_1_4(1)_22-41.nxml.txt.nlp	19934650	SENT40	8	8	16	16	quinidine	Slo3	PA451209	157855	0.719
NULL	Nucleic_Acids_Res_2012_Jun_22_40(11)_5078-5087.nxml.txt.nlp	22362747	SENT41	9	9	23	23	telithromycin	spatial	PA10202	219793	0.719
NULL	Clin_Endosc_2011_Sep_30_44(1)_22-26.nxml.txt.nlp	22741108	SENT27	12	12	25	25	midazolam	ESD	PA450496	2098	0.719
NULL	Arch_Med_Sci_2012_Sep_8_8(4)_659-671.nxml.txt.nlp	23056078	SENT198	30	30	20	20	mitoxantrone	P-gp	PA450526	5243	0.719
NULL	Physiol_Rep_2014_Oct_10_2(10)_e12177.nxml.txt.nlp	25303952	SENT71	1	1	19	19	estradiol	San	PA449503	80218	0.719
NULL	J_Exp_Clin_Cancer_Res_2008_Sep_12_27(1)_37.nxml.txt.nlp	18789152	SENT45	24	24	38	38	l-glutamine	CO2	PA10090	4513	0.719
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_May_31_70(Pt_6)_o717-o718.nxml.txt.nlp	24940287	SENT80	15	15	21	21	piperazine	mol	PA450977	90527	0.719
NULL	Biochem_Res_Int_2012_Feb_12_2012_346972.nxml.txt.nlp	22400115	SENT231	14	14	26	26	hyaluronan	CD31	PA165958431	5175	0.719
NULL	Biomed_Imaging_Interv_J_2008_Jul_1_4(3)_e40.nxml.txt.nlp	21611006	SENT127	3	3	8	8	trastuzumab	HER-2	PA451743	2064	0.719
NULL	Acta_Pharmacol_Sin_2013_Apr_11_34(4)_570-580.nxml.txt.nlp	23396375	SENT178	5	5	11	11	tegafur	CDHP	PA452620	1001	0.719
NULL	Int_Clin_Psychopharmacol_2014_Mar_31_29(2)_86-92.nxml.txt.nlp	24247740	SENT123	26	26	35	35	vilazodone	NNT	PA165958365	23530	0.719
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT151	38	38	9	9	glucose	EGFR	PA449773	1956	0.719
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT297	3	3	16	16	heparin	FGF1	PA449855	2246	0.719
NULL	Br_J_Haematol_2009_Feb_144(3)_367-375.nxml.txt.nlp	19036078	SENT69	27	27	19	19	vincristine	CHOP	PA451879	1649	0.719
NULL	Crit_Care_2004_May_25_8(4)_243-252.nxml.txt.nlp	15312206	SENT66	3	3	11	11	diazepam	ACTH	PA449283	5443	0.719
NULL	Br_J_Cancer_2012_May_22_106(11)_1779-1789.nxml.txt.nlp	22549178	SENT31	1	1	11	11	trastuzumab	HER2	PA451743	2064	0.719
NULL	Indian_J_Pharmacol_2014_Nov-Dec_46(6)_627-632.nxml.txt.nlp	25538335	SENT16	10	10	8	8	metformin	Q10	PA450395	27161	0.719
NULL	Mol_Cancer_2013_Oct_8_12_119.nxml.txt.nlp	24103454	SENT197	7	7	5	5	nutlin-3	p53		7157	0.719
NULL	Nucleic_Acids_Res_2012_Jul_5_40(13)_5988-6000.nxml.txt.nlp	22492511	SENT36	12	12	38	38	estradiol	MYB	PA449503	4602	0.719
NULL	Allergy_Asthma_Clin_Immunol_2007_Mar_15_3(1)_1-9.nxml.txt.nlp	20525147	SENT127	10	10	0	0	chymotrypsin	IFN	PA448994	3439	0.719
NULL	J_Vet_Med_Sci_2014_Jun_21_76(6)_905-908.nxml.txt.nlp	24561315	SENT151	18	18	11	11	fasudil	Rho	PA165946121	29984	0.719
NULL	Clin_Psychopharmacol_Neurosci_2011_Apr_30_9(1)_36-43.nxml.txt.nlp	23431025	SENT19	15	15	6	6	haloperidol	FLI	PA449841	2314	0.719
NULL	Int_J_Mol_Sci_2013_Aug_14_14(8)_16719-16731.nxml.txt.nlp	23949634	SENT98	24	24	17	17	thrombin	PAR-1	PA451674	2011;2149	0.719
NULL	Indian_J_Anaesth_2010_Nov-Dec_54(6)_489-495.nxml.txt.nlp	21224964	SENT69	22	22	25	25	thrombin	PAR1	PA451674	79581;2149	0.719
NULL	Chin_J_Cancer_2012_Apr_31(4)_178-184.nxml.txt.nlp	22237038	SENT86	0	0	18	18	niclosamide	p65	PA165958408	5970	0.719
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S177-S183.nxml.txt.nlp	21525452	SENT230	10	10	16	16	liraglutide	GLP-1	PA165958364	100125288	0.719
NULL	Mol_Brain_2014_Apr_3_7_25.nxml.txt.nlp	24708812	SENT11	9	9	15	15	chlorpheniramine	ERK	PA448960	5594	0.719
NULL	Oxid_Med_Cell_Longev_2011_Aug_4_2011_471590.nxml.txt.nlp	21904644	SENT65	3	3	11	11	probucol	CA1	PA451107	759	0.719
NULL	Mol_Cancer_2010_Jun_25_9_166.nxml.txt.nlp	20579378	SENT178	7	7	5	5	gefitinib	EGF	PA131301952	1950	0.719
NULL	Arthritis_Res_Ther_2011_Feb_16_13(1)_R25.nxml.txt.nlp	21324169	SENT150	22	22	18	18	adalimumab	TNF	PA10004	7124	0.719
NULL	JRSM_Cardiovasc_Dis_2012_Sep_24_1(6)_cvd_2012_012015.nxml.txt.nlp	24175073	SENT37	20	20	28	28	clopidogrel	ADP	PA449053	23038	0.719
NULL	Infect_Dis_Obstet_Gynecol_2012_Feb_25_2012_157159.nxml.txt.nlp	22505797	SENT176	21	21	24	24	metronidazole	PTB	PA450484	58155	0.719
NULL	Oncotarget_2014_Oct_16_5(20)_9546-9563.nxml.txt.nlp	25337673	SENT184	17	17	25	25	lapatinib	AXL	PA152241907	558	0.719
NULL	J_Gen_Physiol_2009_Apr_133(4)_421-438.nxml.txt.nlp	19289574	SENT298	37	37	11	11	glibenclamide	SLC26A9	PA449782	115019	0.719
NULL	Oncoimmunology_2013_Jun_1_2(6)_e24677.nxml.txt.nlp	23894722	SENT109	22	22	14	14	cetuximab	CD80	PA10040	941	0.719
NULL	Exp_Ther_Med_2014_Mar_10_7(3)_640-648.nxml.txt.nlp	24520260	SENT206	0	0	12	12	resveratrol	p38		10598;1432;7965	0.719
NULL	Front_Pharmacol_2014_Oct_31_5_231.nxml.txt.nlp	25400580	SENT4923	5	5	13	13	gemcitabine	CNT3	PA449748	64078	0.719
NULL	Cancer_Med_2014_Oct_3_3(5)_1416-1429.nxml.txt.nlp	24890561	SENT185	32	32	0	0	paclitaxel	San	PA450761	80218	0.719
NULL	Orphanet_J_Rare_Dis_2015_Jan_21_10(1)_1.nxml.txt.nlp	NULL	SENT221	14	14	30	30	estradiol	TRPC6	PA449503	7225	0.719
NULL	Mar_Drugs_2008_Oct_7_6(4)_514-527.nxml.txt.nlp	19172192	SENT85	15	15	1	1	bortezomib	Mcl-1	PA10252	4170	0.719
NULL	Oncotarget_2014_Jun_6_5(13)_4945-4958.nxml.txt.nlp	24970814	SENT116	5	5	14	14	cisplatin	PTB	PA449014	58155	0.719
NULL	Diabetes_Metab_Syndr_Obes_2014_Aug_1_7_381-389.nxml.txt.nlp	25120374	SENT9	3	3	26	26	salsalate	adiponectin	PA164745462	9370	0.719
NULL	Open_Dent_J_2014_May_30_8_109-124.nxml.txt.nlp	24976875	SENT189	10	10	28	28	doxycycline	MCP-1	PA449415	6347	0.719
NULL	Korean_J_Anesthesiol_2013_Feb_15_64(2)_105-111.nxml.txt.nlp	23459312	SENT81	30	30	11	11	protamine	ACT	PA10366	12;11332;9457;641455	0.719
NULL	J_Gen_Physiol_2003_Mar_121(3)_181-197.nxml.txt.nlp	12601083	SENT266	2	2	7	7	forskolin	SUR1	PA146096022	6833	0.719
NULL	J_Immunother_Cancer_2014_Jan_27_2_2.nxml.txt.nlp	24829759	SENT179	39	39	18	18	sorafenib	IL-21	PA7000	59067;50616;27189	0.719
NULL	Trials_2012_May_6_13_55.nxml.txt.nlp	22559260	SENT223	24	24	34	34	fluorescein	KDR	PA164746009	3791	0.719
NULL	J_Cell_Biol_2005_May_23_169(4)_647-656.nxml.txt.nlp	15911879	SENT196	8	8	10	10	staurosporine	p35	PA165109623	3592;80761	0.719
NULL	Int_J_Mol_Sci_2014_Nov_21_15(11)_21433-21454.nxml.txt.nlp	25421240	SENT240	13	13	1	1	tropicamide	EGF	PA164749389	1950	0.719
NULL	Exp_Neurobiol_2013_Sep_30_22(3)_214-223.nxml.txt.nlp	24167416	SENT89	25	25	20	20	arsenite	DTNB	PA452638	1838	0.719
NULL	J_Res_Med_Sci_2010_Nov-Dec_15(6)_348-358.nxml.txt.nlp	21526108	SENT142	11	11	4	4	thrombin	PAR-1	PA451674	2011;2149	0.719
NULL	Anesth_Pain_Med_2014_Apr_7_4(2)_e15460.nxml.txt.nlp	24790902	SENT97	21	21	19	19	phentolamine	NTG	PA450926	4976	0.719
NULL	Biomed_Res_Int_2014_Feb_10_2014_708593.nxml.txt.nlp	24689050	SENT118	9	9	20	20	etoposide	CO2	PA449552	4513	0.719
NULL	Br_J_Cancer_1998_Aug_78(3)_375-381.nxml.txt.nlp	9703286	SENT0	14	14	28	28	paclitaxel	TP53	PA450761	7157	0.719
NULL	Front_Neuroenergetics_2010_May_21_2_5.nxml.txt.nlp	20725515	SENT214	1	1	27	27	oxygen	SHP-1	PA450744	5777	0.719
NULL	Cancer_Cell_Int_2005_Jul_29_5_24.nxml.txt.nlp	16053526	SENT127	6	6	17	17	estradiol	beta-catenin	PA449503	1499	0.719
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1563-1573.nxml.txt.nlp	22015557	SENT253	10	10	2	2	sunitinib	c-Myc	PA162372840	4609	0.719
NULL	Hum_Mol_Genet_2014_Aug_1_23(15)_4077-4085.nxml.txt.nlp	24670599	SENT161	18	18	7	7	lipase	PNPLA3	PA450239	80339	0.719
NULL	Cell_Res_2013_Aug_9_23(8)_1007-1024.nxml.txt.nlp	23835473	SENT227	7	7	22	22	ethanol	ACAT1	PA448073	38	0.719
NULL	Eukaryot_Cell_2014_Aug_13(8)_1077-1084.nxml.txt.nlp	24951438	SENT251	8	8	16	16	doxycycline	RSP5	PA449415	23327	0.719
NULL	Oncotarget_2011_Jun_15_2(6)_518-524.nxml.txt.nlp	21680956	SENT34	0	0	15	15	pyrimethamine	STAT3	PA451193	6774	0.719
NULL	Aging_(Albany_NY)_2013_Feb_21_5(2)_94-95.nxml.txt.nlp	23518473	SENT28	9	9	24	24	resveratrol	SIRT1		23411	0.719
NULL	Indian_J_Anaesth_2014_Sep-Oct_58(5)_515-523.nxml.txt.nlp	25535411	SENT204	3	3	17	17	vasopressin	VIII	PA451858	1351	0.719
NULL	Exp_Ther_Med_2014_Nov_17_8(5)_1484-1488.nxml.txt.nlp	25289046	SENT133	16	16	8	8	cisplatin	ECRG2	PA449014	84651	0.719
NULL	Diabetes_Care_2011_Sep_19_34(9)_2072-2077.nxml.txt.nlp	21788633	SENT109	0	0	23	23	vildagliptin	ANOVA	PA165958346	4858	0.719
NULL	Mol_Cancer_2014_Jun_20_13_155.nxml.txt.nlp	24950741	SENT119	0	0	6	6	bortezomib	p53	PA10252	7157	0.719
NULL	J_Ophthalmic_Inflamm_Infect_2012_May_14_2(4)_231-233.nxml.txt.nlp	22581347	SENT4	18	18	13	13	infliximab	TNF	PA452639	7124	0.719
NULL	Front_Oncol_2014_Jun_18_4_153.nxml.txt.nlp	24995158	SENT539	6	6	11	11	paclitaxel	c-Jun	PA450761	3725	0.719
NULL	Cancer_Cell_Int_2011_Nov_17_11_40.nxml.txt.nlp	22088142	SENT147	29	29	7	7	gemcitabine	EGFR	PA449748	1956	0.719
NULL	Exp_Ther_Med_2014_Aug_6_8(2)_585-590.nxml.txt.nlp	25009624	SENT128	42	42	27	27	glucose	ROS	PA449773	6098	0.719
NULL	Br_J_Pharmacol_2012_Jan_165(2)_390-400.nxml.txt.nlp	21671897	SENT216	3	3	7	7	suramin	P2X2	PA10292	22953	0.719
NULL	J_Signal_Transduct_2011_Apr_7_2011_768512.nxml.txt.nlp	21776388	SENT47	18	18	39	39	cyclosporine	JNK	PA449167	5599	0.719
NULL	Acta_Pharmacol_Sin_2010_Oct_13_31(10)_1243-1257.nxml.txt.nlp	20835267	SENT236	20	20	16	16	lipase	CYP27A1	PA450239	1593	0.719
NULL	Clin_Sci_(Lond)_2013_Apr_1_124(Pt_8)_543-552.nxml.txt.nlp	23130652	SENT38	19	19	4	4	enalapril	STZ	PA449456	6484	0.719
NULL	Cell_Commun_Signal_2014_Jan_11_12_5.nxml.txt.nlp	24410844	SENT61	18	18	23	23	paraformaldehyde	DUOXA1	PA450790	90527	0.719
NULL	Indian_J_Med_Res_2014_Jan_139(1)_76-82.nxml.txt.nlp	24604041	SENT117	18	18	21	21	albendazole	STH	PA164746058	246744	0.719
NULL	Oncogene_2010_Jan_7_29(1)_81-92.nxml.txt.nlp	19784067	SENT18	19	19	4	4	cisplatin	BRG1	PA449014	6597	0.719
NULL	Brain_Sci_2012_Dec_21_3(1)_1-38.nxml.txt.nlp	24961305	SENT882	4	4	12	12	ethanol	CA1	PA448073	759	0.719
NULL	Pharmaceuticals_(Basel)_2014_Sep_4_7(9)_913-942.nxml.txt.nlp	25192192	SENT156	6	6	30	30	resveratrol	IL-6		3569	0.719
NULL	Br_J_Haematol_2014_Feb_16_164(4)_469-480.nxml.txt.nlp	24372186	SENT268	4	4	12	12	primaquine	G6PD	PA451103	2539	0.719
NULL	J_Exp_Med_1967_Jul_1_126(1)_171-188.nxml.txt.nlp	4165501	SENT7	10	10	8	8	thrombin	ADP	PA451674	23038	0.719
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT53	34	34	30	30	lopinavir	ATV	PA450264	4683	0.719
NULL	Exp_Ther_Med_2014_Oct_24_8(4)_1032-1038.nxml.txt.nlp	25187793	SENT130	13	13	15	15	cyanocobalamin	B12	PA451892	7126;4709	0.719
NULL	Breast_Cancer_Res_2001_Mar_28_3(3)_150-153.nxml.txt.nlp	11305949	SENT56	0	0	12	12	paclitaxel	JNK	PA450761	5599	0.719
NULL	Oncoimmunology_2014_Jan_1_3_e27048.nxml.txt.nlp	24605265	SENT100	4	4	22	22	trastuzumab	HER2	PA451743	2064	0.719
NULL	Curr_Oncol_2006_Feb_13(1)_2-7.nxml.txt.nlp	17576435	SENT146	0	0	2	2	tamoxifen	aromatase	PA451581	1588	0.719
NULL	Eur_J_Clin_Pharmacol_2012_Sep_15_68(9)_1267-1274.nxml.txt.nlp	22418828	SENT159	18	18	24	24	pantoprazole	CYP2C19	PA450774	1557	0.719
NULL	N_Am_J_Med_Sci_2013_Dec_5(12)_721-723.nxml.txt.nlp	24404557	SENT62	22	22	7	7	vincristine	CHOP	PA451879	1649	0.719
NULL	Cell_Commun_Signal_2013_Dec_23_11_100.nxml.txt.nlp	24364863	SENT183	28	28	35	35	pp2	EGFR		1956	0.719
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Jul_23_3(7)_e126.nxml.txt.nlp	25054314	SENT307	19	19	5	5	docetaxel	MRP2	PA449383	100130958;57626;1244	0.719
NULL	Breast_Cancer_Res_2011_Mar_1_13(2)_R21.nxml.txt.nlp	21362200	SENT310	14	14	17	17	fulvestrant	PI3K	PA164747170	5290	0.719
NULL	Oncotarget_2014_Aug_4_5(17)_7776-7787.nxml.txt.nlp	25277200	SENT181	5	5	12	12	paclitaxel	ANXA4	PA450761	307	0.719
NULL	Acta_Pharmacol_Sin_2009_Feb_5_30(2)_228-234.nxml.txt.nlp	19122672	SENT30	16	16	19	19	isoflurane	HO-1	PA450106	3162	0.719
NULL	Iran_J_Pharm_Res_2014_Spring_13(2)_635-639.nxml.txt.nlp	25237359	SENT18	5	5	34	34	chlorzoxazone	CYP1A2	PA448971	1544	0.719
NULL	Exp_Diabetes_Res_2012_Dec_12_2012_716404.nxml.txt.nlp	22194737	SENT118	6	6	2	2	metformin	adiponectin	PA450395	9370	0.719
NULL	Hum_Genomics_2009_Jan_1_3(2)_128-142.nxml.txt.nlp	19164090	SENT178	6	6	4	4	carboplatin	CD44	PA448803	960	0.719
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT109	11	11	20	20	doxorubicin	p53	PA449412	7157	0.719
NULL	Osteoporos_Int_2012_Jan_28_23(1)_213-221.nxml.txt.nlp	21953472	SENT31	7	7	39	39	ibandronate	PTH	PA10270	5741	0.719
NULL	Oncol_Lett_2014_Mar_16_7(3)_827-833.nxml.txt.nlp	24527090	SENT80	30	30	27	27	cisplatin	IFN	PA449014	3439	0.719
NULL	Oncotarget_2014_Aug_25_5(17)_7945-7959.nxml.txt.nlp	25277206	SENT28	19	19	13	13	cabozantinib	VEGFR	PA165906891	3791	0.719
NULL	Oncoimmunology_2012_Oct_1_1(7)_1038-1047.nxml.txt.nlp	23170252	SENT102	10	10	12	12	mitomycin	CT26	PA450524	168400	0.719
NULL	Sci_Rep_2015_Jan_21_5_7916.nxml.txt.nlp	25604905	SENT138	11	11	28	28	neomycin	MMP9	PA450608	4318	0.719
NULL	Brain_Sci_2014_Mar_14_4(1)_136-149.nxml.txt.nlp	24961704	SENT26	6	6	14	14	isoflurane	spatial	PA450106	219793	0.719
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT134	2	2	6	6	atorvastatin	IL-6	PA448500	3569	0.719
NULL	J_Korean_Neurosurg_Soc_2014_Jul_31_56(1)_1-4.nxml.txt.nlp	25289117	SENT74	2	2	18	18	curcumin	JNK	PA151958596	5599	0.719
NULL	Eur_J_Med_Res_2009_Nov_24_14(Suppl_3)_36-42.nxml.txt.nlp	19959415	SENT34	3	3	14	14	zalcitabine	gamma	PA451950	9913	0.719
NULL	Diabetes_Care_2013_Feb_17_36(2)_276-282.nxml.txt.nlp	22961572	SENT214	10	10	20	20	acarbose	STOP	PA448010	4135	0.719
NULL	Clin_Ophthalmol_2014_Sep_22_8_1891-1911.nxml.txt.nlp	25284976	SENT137	0	0	9	9	rituximab	San	PA451261	80218	0.719
NULL	Neural_Dev_2010_Oct_1_5_25.nxml.txt.nlp	20920300	SENT141	11	11	33	33	cocaine	BDNF	PA449072	627	0.719
NULL	Front_Oncol_2014_Apr_9_4_75.nxml.txt.nlp	24782986	SENT19	8	8	10	10	paclitaxel	Oct4	PA450761	5460	0.719
NULL	Am_J_Case_Rep_2014_Apr_14_15_152-154.nxml.txt.nlp	24753783	SENT61	18	18	28	28	metformin	DPP4	PA450395	1803	0.719
NULL	Br_J_Cancer_2013_Mar_19_108(5)_1079-1091.nxml.txt.nlp	23449353	SENT172	30	30	5	5	mitoxantrone	MIC-1	PA450526	29919;9518	0.719
NULL	Int_J_Med_Sci_2012_Jan_11_9(2)_148-156.nxml.txt.nlp	22253562	SENT56	19	19	21	21	ethambutol	EMB	PA164784021	133418	0.719
NULL	Curr_Oncol_2009_Aug_16(4)_9-21.nxml.txt.nlp	19672420	SENT226	22	22	14	14	erlotinib	KRAS	PA134687924	3845	0.719
NULL	BMJ_2011_Aug_4_343_d4588.nxml.txt.nlp	21816733	SENT293	9	9	4	4	clopidogrel	CYP2C19	PA449053	1557	0.719
NULL	J_Cell_Biol_2003_Sep_29_162(7)_1197-1209.nxml.txt.nlp	14517203	SENT168	1	1	18	18	bleomycin	BLM	PA448645	641	0.719
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_P64.nxml.txt.nlp	NULL	SENT15	22	22	10	10	ceftriaxone	PPL	PA448866	5493	0.719
NULL	Reprod_Biol_Endocrinol_2003_Oct_7_1_66.nxml.txt.nlp	14609433	SENT252	26	26	14	14	cisplatin	p53	PA449014	7157	0.719
NULL	Diabetologia_2010_Jan_6_53(1)_1-6.nxml.txt.nlp	19894028	SENT99	28	28	19	19	metformin	HIP	PA450395	6767;6159;64399;5068	0.719
NULL	Semin_Immunopathol_2013_Jan_26_35(1)_39-52.nxml.txt.nlp	22829332	SENT197	3	3	30	30	bleomycin	CHOP	PA448645	1649	0.719
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Oct_29_6_169-177.nxml.txt.nlp	25378949	SENT31	20	20	8	8	trastuzumab	HER2	PA451743	2064	0.719
NULL	J_Korean_Med_Sci_2008_Aug_25_23(4)_737-739.nxml.txt.nlp	18756069	SENT4	3	3	5	5	atazanavir	ATV	PA10251	4683	0.719
NULL	Int_J_Biol_Sci_2011_Nov_5_8(1)_1-14.nxml.txt.nlp	22211100	SENT156	0	0	12	12	evodiamine	PTEN	PA165860788	5728	0.719
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT106	0	0	13	13	erlotinib	CYP2C9	PA134687924	1559	0.719
NULL	Front_Neurosci_2014_Jan_10_7_270.nxml.txt.nlp	24454277	SENT196	8	8	18	18	resveratrol	SUR1		6833	0.719
NULL	Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.nxml.txt.nlp	24736980	SENT181	3	3	40	40	rosuvastatin	OATP1B1	PA134308647	10599	0.719
NULL	Target_Oncol_2013_Jun_27_8(2)_127-136.nxml.txt.nlp	23625191	SENT21	16	16	5	5	panitumumab	KRAS	PA162373091	3845	0.719
NULL	Nat_Commun_2014_Jul_1_5_4241.nxml.txt.nlp	24980141	SENT20	8	8	6	6	guanidine	GEF	PA164781028	56731	0.719
NULL	Nat_Genet_2014_Feb_15_46(2)_152-160.nxml.txt.nlp	24336168	SENT37	14	14	30	30	galactose	TDP-43	PA449725	23435	0.719
NULL	J_Inflamm_(Lond)_2007_Nov_24_4_23.nxml.txt.nlp	18036230	SENT41	23	23	47	47	l-glutamine	CO2	PA10090	4513	0.719
NULL	ScientificWorldJournal_2014_Dec_21_2014_586270.nxml.txt.nlp	25587567	SENT776	6	6	21	21	estradiol	RhoA	PA449503	387	0.719
NULL	Acta_Pharmacol_Sin_2011_Nov_10_32(11)_1402-1410.nxml.txt.nlp	21986579	SENT235	8	8	45	45	curcumin	p27	PA151958596	5715;10534	0.719
NULL	Clin_Pharmacol_2010_Sep_6_2_155-162.nxml.txt.nlp	22291500	SENT68	12	12	3	3	clopidogrel	IPA	PA449053	3160	0.719
NULL	Eur_J_Epidemiol_2009_Sep_2_24(9)_553-572.nxml.txt.nlp	19728115	SENT1536	19	19	37	37	acenocoumarol	PAGM	PA452632	5238	0.719
NULL	Carcinogenesis_2010_Dec_27_31(12)_2049-2057.nxml.txt.nlp	20876285	SENT33	7	7	4	4	tamoxifen	HER2	PA451581	2064	0.719
NULL	J_Cancer_2014_Aug_15_5(8)_633-645.nxml.txt.nlp	25157274	SENT36	7	7	18	18	bevacizumab	San	PA130232992	80218	0.719
NULL	Cancer_Manag_Res_2011_May_10_3_157-175.nxml.txt.nlp	21625399	SENT54	15	15	26	26	tolbutamide	CYP2D6	PA451718	1565	0.719
NULL	Ann_Surg_Oncol_2013_Jun_19_20(Suppl_3)_348-359.nxml.txt.nlp	22711178	SENT188	5	5	0	0	fluorouracil	IMPACT	PA128406956	55364	0.719
NULL	J_Hematol_Oncol_2009_Feb_23_2_9.nxml.txt.nlp	19236713	SENT69	13	13	4	4	bevacizumab	KRAS	PA130232992	3845	0.719
NULL	Cardiovasc_Diabetol_2011_Feb_11_10_18.nxml.txt.nlp	21314919	SENT90	22	22	5	5	glimepiride	Met	PA449761	79811	0.719
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT104	10	10	7	7	trastuzumab	MUC4	PA451743	4585	0.719
NULL	EPMA_J_2013_Feb_19_4(1)_6.nxml.txt.nlp	23418957	SENT244	23	23	40	40	pertuzumab	HER2		2064	0.719
NULL	F1000Res_2014_Aug_19_3_198.nxml.txt.nlp	25400908	SENT542	13	13	34	34	trastuzumab	AGO	PA451743	55294	0.719
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_321-328.nxml.txt.nlp	21372824	SENT178	33	33	16	16	fluvastatin	STZ	PA449688	6484	0.719
NULL	Int_J_Hypertens_2012_Feb_22_2012_127910.nxml.txt.nlp	22518279	SENT117	9	9	37	37	ns-398	PGD2		27306	0.719
NULL	Mol_Cancer_2013_May_24_12_46.nxml.txt.nlp	23705826	SENT114	26	26	11	11	sunitinib	ABL1	PA162372840	25	0.719
NULL	Cancers_(Basel)_2014_Apr_29_6(2)_1020-1030.nxml.txt.nlp	24784954	SENT25	6	6	11	11	guanethidine	NET	PA449823	2004;6530	0.719
NULL	Biomed_Res_Int_2013_Sep_4_2013_906912.nxml.txt.nlp	24093107	SENT159	5	5	0	0	ciprofloxacin	MICA	PA449009	100507436	0.719
NULL	Int_J_Mol_Sci_2014_Nov_25_15(12)_21703-21722.nxml.txt.nlp	25429431	SENT689	15	15	4	4	curcumin	STAT3	PA151958596	6774	0.719
NULL	Oncol_Lett_2014_Nov_14_8(5)_2086-2092.nxml.txt.nlp	25295095	SENT88	18	18	11	11	gemcitabine	LKB1	PA449748	6794	0.719
NULL	EPMA_J_2010_Sep_20_1(3)_421-437.nxml.txt.nlp	23199086	SENT159	23	23	14	14	tamoxifen	EGFR	PA451581	1956	0.719
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1224-1233.nxml.txt.nlp	22353810	SENT193	5	5	10	10	doxorubicin	MRP-1	PA449412	928	0.719
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT243	16	16	13	13	cisplatin	IBP	PA449014	706;50619	0.719
NULL	Int_J_Endocrinol_2010_Jun_27_2010_206801.nxml.txt.nlp	20652073	SENT16	0	0	8	8	cinacalcet	PTH	PA164776671	5741	0.719
NULL	Int_J_Biol_Sci_2015_Jan_1_11(1)_48-58.nxml.txt.nlp	25552929	SENT164	0	0	7	7	paclitaxel	TSP-1	PA450761	7057	0.719
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT927	7	7	22	22	raltegravir	TRIO		7204	0.719
NULL	Biol_Proced_Online_2004_Jul_1_6_144-148.nxml.txt.nlp	15243647	SENT152	17	17	8	8	hydroxyurea	IFN	PA449942	3439	0.719
NULL	Mol_Cancer_2014_Jun_5_13_143.nxml.txt.nlp	24898067	SENT78	8	8	15	15	trastuzumab	AKT	PA451743	207	0.719
NULL	Curr_Neuropharmacol_2014_Jan_12(1)_2-36.nxml.txt.nlp	24533013	SENT208	15	15	20	20	donepezil	CB1	PA449394	1268	0.719
NULL	Exp_Cell_Res_2011_Apr_15_317(7)_1028-1039.nxml.txt.nlp	21237154	SENT138	13	13	11	11	staurosporine	TRAIL	PA165109623	8743	0.719
NULL	Acta_Pharmacol_Sin_2013_Sep_5_34(9)_1229-1236.nxml.txt.nlp	23892269	SENT136	10	10	17	17	ketoconazole	CYP3A	PA450146	1574	0.719
NULL	Arthritis_Res_Ther_2013_Aug_30_15(4)_R100.nxml.txt.nlp	24000795	SENT206	6	6	17	17	paraformaldehyde	CD66b	PA450790	1088	0.719
NULL	Oncol_Lett_2013_Sep_8_6(3)_789-794.nxml.txt.nlp	24137412	SENT28	16	16	30	30	l-glutamine	CO2	PA10090	4513	0.719
NULL	Cancer_Cell_Int_2010_Jan_21_10_2.nxml.txt.nlp	20142997	SENT199	26	26	33	33	cetuximab	TGM2	PA10040	7052	0.719
NULL	Indian_J_Endocrinol_Metab_2013_May-Jun_17(3)_413-421.nxml.txt.nlp	23869296	SENT166	15	15	6	6	liraglutide	GLP-1	PA165958364	100125288	0.719
NULL	Genome_Med_2010_Nov_30_2(11)_85.nxml.txt.nlp	21122163	SENT172	18	18	7	7	imatinib	MDR1	PA10804	5243	0.719
NULL	J_Oncol_2013_Feb_17_2013_872957.nxml.txt.nlp	23476648	SENT194	14	14	12	12	cisplatin	SFN	PA449014	25996;2810	0.719
NULL	Cells_2012_Jun_29_1(3)_248-262.nxml.txt.nlp	24710475	SENT171	32	32	3	3	zinc	p62	PA451956	8878;10657;23636	0.719
NULL	Breast_Cancer_Res_2012_Nov_12_14(6)_R145.nxml.txt.nlp	23146280	SENT264	28	28	20	20	bevacizumab	VEGF-A	PA130232992	7422	0.719
NULL	Osteoarthritis_Cartilage_2013_Sep_21(9)_1336-1345.nxml.txt.nlp	23973148	SENT183	1	1	13	13	triamcinolone	MNX	PA451749	3892	0.719
NULL	J_Epilepsy_Res_2014_Jun_30_4(1)_7-13.nxml.txt.nlp	24977124	SENT70	22	22	14	14	pilocarpine	CA1	PA450962	759	0.719
NULL	Eur_J_Neurosci_2014_Feb_4_39(3)_419-434.nxml.txt.nlp	24494682	SENT313	4	4	17	17	lipase	MGL	PA450239	11343	0.719
NULL	Cell_Commun_Signal_2014_Jan_10_12_3.nxml.txt.nlp	24410813	SENT88	4	4	16	16	tamoxifen	THOC5	PA451581	8563	0.719
NULL	J_Exp_Clin_Cancer_Res_2009_Sep_7_28(1)_124.nxml.txt.nlp	19735546	SENT215	41	41	14	14	genistein	beta-catenin	PA165109660	1499	0.719
NULL	Environ_Health_Perspect_2012_Jul_11_120(7)_1029-1035.nxml.txt.nlp	22494775	SENT284	25	25	15	15	tamoxifen	AF-1	PA451581	3460;5710	0.719
NULL	Mol_Cancer_2013_Mar_5_12_17.nxml.txt.nlp	23497256	SENT94	13	13	8	8	sunitinib	HDM2	PA162372840	4193	0.719
NULL	Niger_Med_J_2012_Jul-Sep_53(3)_109-115.nxml.txt.nlp	23293407	SENT179	9	9	6	6	demeclocycline	AQP2	PA164745513	359	0.719
NULL	Blood_Res_2013_Dec_24_48(4)_274-281.nxml.txt.nlp	24466552	SENT46	24	24	33	33	doxorubicin	CHOP	PA449412	1649	0.719
NULL	Nat_Commun_2014_Jun_19_5_4037.nxml.txt.nlp	24941968	SENT34	2	2	11	11	vanillin	UGT	PA451852	7361;7355	0.719
NULL	Indian_J_Radiol_Imaging_2008_Aug_18(3)_256-263.nxml.txt.nlp	19774171	SENT22	11	11	5	5	heparin	ACT	PA449855	12;11332;9457;641455	0.719
NULL	Aging_(Albany_NY)_2010_Jan_11_2(1)_7-27.nxml.txt.nlp	20228939	SENT113	21	21	7	7	nadh	BMAL1	PA164755085	406	0.719
NULL	Cancers_(Basel)_2010_Dec_23_3(1)_17-42.nxml.txt.nlp	24212604	SENT167	34	34	25	25	vinorelbine	PPX	PA451881	5531	0.719
NULL	Viruses_2013_May_22_5(5)_1292-1324.nxml.txt.nlp	23698400	SENT104	15	15	8	8	ribavirin	IFN	PA451241	3439	0.719
NULL	Hum_Mol_Genet_2013_Nov_15_22(22)_4616-4626.nxml.txt.nlp	23814041	SENT175	11	11	18	18	simvastatin	neuroserpin	PA451363	5274	0.719
NULL	Oncotarget_2014_Sep_10_5(19)_8924-8936.nxml.txt.nlp	25238040	SENT130	14	14	6	6	decitabine	p53	PA164749631	7157	0.719
NULL	Oncoimmunology_2013_Sep_1_2(9)_e25737.nxml.txt.nlp	24327935	SENT28	0	0	32	32	bleomycin	CRT	PA448645	811	0.719
NULL	Appl_Microbiol_Biotechnol_2014_Feb_18_98(8)_3829-3840.nxml.txt.nlp	24535257	SENT11	19	19	11	11	ethanol	PE-2	PA448073	2077	0.719
NULL	Iran_J_Basic_Med_Sci_2013_Aug_16(8)_928-935.nxml.txt.nlp	24106598	SENT26	19	19	16	16	phenylephrine	ARC	PA450935	8996;23237	0.719
NULL	Aging_(Albany_NY)_2010_Dec_14_2(12)_945-958.nxml.txt.nlp	21164223	SENT241	3	3	39	39	phenformin	AMPK	PA1000	5563	0.719
NULL	Exp_Mol_Med_2012_Sep_30_44(9)_536-544.nxml.txt.nlp	22771771	SENT171	0	0	12	12	ns-398	p16		1029	0.719
NULL	Breast_Cancer_Res_Treat_2013_Feb_4_137(3)_721-731.nxml.txt.nlp	23288344	SENT208	16	16	7	7	tamoxifen	AIB1	PA451581	8202	0.719
NULL	Br_J_Pharmacol_2008_Oct_18_155(4)_596-605.nxml.txt.nlp	18852694	SENT215	2	2	9	9	fenofibrate	SREBP2	PA449594	6721	0.719
NULL	Indian_J_Endocrinol_Metab_2013_Jul-Aug_17(4)_636-646.nxml.txt.nlp	23961479	SENT157	29	29	24	24	cyclosporine	CYP3A4	PA449167	1576	0.719
NULL	Int_J_Med_Sci_2015_Jan_1_12(1)_78-82.nxml.txt.nlp	25552922	SENT26	14	14	0	0	phenytoin	CYP2C19	PA450947	1557	0.719
NULL	Contemp_Oncol_(Pozn)_2012_Feb_29_16(1)_86-89.nxml.txt.nlp	23788860	SENT81	16	16	18	18	capecitabine	DDP	PA448771	1678	0.719
NULL	Pharmaceutics_2011_Jul_13_3(3)_425-439.nxml.txt.nlp	24310588	SENT355	24	24	0	0	meperidine	SERS	PA450369	6301;54938	0.719
NULL	Am_J_Physiol_Endocrinol_Metab_2013_Nov_1_305(9)_E1134-E1144.nxml.txt.nlp	24022868	SENT91	9	9	31	31	lipase	HSD11B1	PA450239	3290	0.719
NULL	Cancers_(Basel)_2013_Jun_5_5(2)_676-713.nxml.txt.nlp	24216997	SENT2372	2	2	14	14	sorafenib	PERK	PA7000	9451	0.719
NULL	Oncogene_2013_Nov_28_32(48)_5439-5448.nxml.txt.nlp	23563182	SENT146	4	4	7	7	etoposide	Mcl-1	PA449552	4170	0.719
NULL	J_Gen_Physiol_2000_Jun_1_115(6)_685-696.nxml.txt.nlp	10828243	SENT6	16	16	24	24	genistein	OLF	PA165109660	83857	0.719
NULL	Indian_J_Med_Res_2013_Nov_138(5)_766-778.nxml.txt.nlp	24434330	SENT50	9	9	27	27	ribavirin	IL28B	PA451241	282617	0.719
NULL	Mol_Brain_2014_Aug_12_7_58.nxml.txt.nlp	25112718	SENT229	28	28	16	16	chlorpheniramine	E14	PA448960	4863	0.719
NULL	Arthritis_Res_Ther_2008_Jan_7_10(1)_R1.nxml.txt.nlp	18179697	SENT172	4	4	23	23	oxaliplatin	HMGB1	PA131285527	3146	0.719
NULL	Evid_Based_Complement_Alternat_Med_2013_May_13_2013_506324.nxml.txt.nlp	23818927	SENT148	14	14	35	35	doxorubicin	PI3	PA449412	5266	0.719
NULL	Oncotarget_2014_Oct_18_5(22)_11641-11652.nxml.txt.nlp	25361002	SENT195	7	7	24	24	cisplatin	NAC	PA449014	22861	0.719
NULL	Br_J_Cancer_2011_Apr_12_104(8)_1256-1261.nxml.txt.nlp	21448165	SENT161	10	10	21	21	sorafenib	IL2	PA7000	3558	0.719
NULL	Eur_J_Med_Res_2011_Jul_25_16(7)_303-314.nxml.txt.nlp	21813371	SENT59	11	11	40	40	telaprevir	SOC	PA165958354	91544	0.719
NULL	Arthritis_Res_Ther_2013_Jan_25_15(1)_R20.nxml.txt.nlp	23351360	SENT206	0	0	13	13	rituximab	CD19	PA451261	930	0.719
NULL	Front_Oncol_2013_Sep_12_3_232.nxml.txt.nlp	24062985	SENT221	23	23	15	15	rituximab	zeta	PA451261	9907	0.719
NULL	Open_Cardiovasc_Med_J_2012_Mar_22_6_28-32.nxml.txt.nlp	22481984	SENT91	26	26	8	8	atorvastatin	DAN	PA448500	5073;4681	0.719
NULL	J_Cancer_Prev_2014_Mar_19(1)_39-46.nxml.txt.nlp	25337571	SENT98	24	24	3	3	ethanol	JNK	PA448073	5599	0.719
NULL	J_Biol_Chem_2013_Mar_22_288(12)_8279-8288.nxml.txt.nlp	23400816	SENT228	17	17	24	24	chloroquine	PCSK9	PA448948	255738	0.719
NULL	Indian_J_Pharm_Sci_2013_Nov-Dec_75(6)_680-687.nxml.txt.nlp	24591743	SENT35	32	32	30	30	gemfibrozil	CYP2C8	PA449750	1558	0.718
NULL	Eur_J_Clin_Pharmacol_2014_Oct_8_70(12)_1433-1441.nxml.txt.nlp	25291992	SENT7	45	45	6	6	risperidone	FES	PA451257	2242	0.718
NULL	eLife_2014_Aug_1_3_e02725.nxml.txt.nlp	25085081	SENT388	15	15	9	9	olaparib	BRCA2		675	0.718
NULL	Front_Hum_Neurosci_2014_Dec_2_8_917.nxml.txt.nlp	25520636	SENT135	28	28	43	43	zolpidem	FDG	PA451976	23583	0.718
NULL	Br_J_Cancer_2009_Mar_10_100(5)_772-781.nxml.txt.nlp	19223895	SENT196	14	14	2	2	urokinase	HIF-1	PA451836	29072	0.718
NULL	Oncotarget_2014_Nov_11_5(22)_10963-10964.nxml.txt.nlp	25460503	SENT10	9	9	11	11	trastuzumab	ADAM10	PA451743	102	0.718
NULL	Indian_J_Endocrinol_Metab_2011_Sep_15(Suppl3)_S180-S187.nxml.txt.nlp	22029022	SENT93	19	19	21	21	vasopressin	AVP	PA451858	114548;551	0.718
NULL	Biomed_Res_Int_2014_Mar_9_2014_687835.nxml.txt.nlp	24734239	SENT26	22	22	18	18	lidocaine	CTB	PA450226	9468	0.718
NULL	Oxid_Med_Cell_Longev_2013_Apr_24_2013_168039.nxml.txt.nlp	23738033	SENT195	12	12	4	4	tramadol	NNT	PA451735	23530	0.718
NULL	Hematol_Rep_2010_Apr_13_2(1)_e2.nxml.txt.nlp	22184515	SENT269	0	0	7	7	thrombin	VIII	PA451674	1351	0.718
NULL	ISRN_Allergy_2013_Feb_7_2013_971036.nxml.txt.nlp	23738146	SENT246	33	33	24	24	papain	CCL24	PA450778	6369	0.718
NULL	Int_J_Pediatr_2010_Dec_23_2010_376287.nxml.txt.nlp	21234103	SENT92	21	21	28	28	amikacin	gamma	PA164744372	9913	0.718
NULL	Arthritis_2010_Nov_24_2010_687547.nxml.txt.nlp	22046510	SENT133	13	13	17	17	dapsone	ACTH	PA449211	5443	0.718
NULL	Indian_J_Pharmacol_2013_Jan-Feb_45(1)_54-60.nxml.txt.nlp	23543867	SENT145	12	12	8	8	terlipressin	NAC	PA164781020	22861	0.718
NULL	J_Cancer_2013_Nov_23_4(9)_736-754.nxml.txt.nlp	24312144	SENT165	20	20	17	17	docetaxel	EGFR	PA449383	1956	0.718
NULL	Crit_Care_2011_Mar_22_15(2)_211.nxml.txt.nlp	21457505	SENT41	18	18	26	26	heparin	PF4	PA449855	5196	0.718
NULL	J_Neurovirol_2013_Jun_4_19(4)_351-358.nxml.txt.nlp	23733308	SENT5	31	31	23	23	mefloquine	SOC	PA450348	91544	0.718
NULL	J_Cancer_2013_Nov_23_4(9)_736-754.nxml.txt.nlp	24312144	SENT82	20	20	7	7	carboplatin	EGFR	PA448803	1956	0.718
NULL	Blood_Res_2013_Sep_25_48(3)_171-177.nxml.txt.nlp	24086936	SENT141	3	3	5	5	bortezomib	CHOP	PA10252	1649	0.718
NULL	Ann_Dermatol_2014_Apr_30_26(2)_195-202.nxml.txt.nlp	24882974	SENT153	31	31	27	27	sorafenib	BRAF	PA7000	673	0.718
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT256	37	37	30	30	lapatinib	HER2	PA152241907	2064	0.718
NULL	Front_Mol_Neurosci_2012_May_7_5_60.nxml.txt.nlp	22586367	SENT137	0	0	4	4	ivermectin	P2X4	PA450133	5025	0.718
NULL	Ethiop_J_Health_Sci_2010_Nov_20(3)_179-183.nxml.txt.nlp	22434977	SENT45	15	15	26	26	amodiaquine	RDT	PA448404	6598	0.718
NULL	Br_J_Cancer_2010_Nov_2_103(11)_1671-1679.nxml.txt.nlp	21045835	SENT139	8	8	21	21	gemcitabine	CXCR4	PA449748	7852	0.718
NULL	Mol_Cancer_2013_Nov_22_12_147.nxml.txt.nlp	24261856	SENT212	18	18	37	37	sunitinib	CO2	PA162372840	4513	0.718
NULL	J_Korean_Med_Sci_2011_Jan_22_26(1)_33-41.nxml.txt.nlp	21218027	SENT146	5	5	3	3	amikacin	DST	PA164744372	667	0.718
NULL	Oncol_Lett_2013_Apr_22_5(4)_1093-1100.nxml.txt.nlp	23599746	SENT220	37	37	29	29	paclitaxel	MDR1	PA450761	5243	0.718
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT54	0	0	15	15	resveratrol	Bcl-2		596	0.718
NULL	Breast_Cancer_Res_Treat_2013_Aug_13_141(1)_101-110.nxml.txt.nlp	23942848	SENT199	19	19	24	24	capecitabine	HER2	PA448771	2064	0.718
NULL	J_Neurovirol_2013_Jun_4_19(4)_351-358.nxml.txt.nlp	23733308	SENT115	9	9	3	3	mefloquine	SOC	PA450348	91544	0.718
NULL	Pharmaceuticals_(Basel)_2011_Jan_11_4(1)_154-168.nxml.txt.nlp	NULL	SENT48	11	11	15	15	vasopressin	SON	PA451858	6651	0.718
NULL	Int_J_Endocrinol_2014_Mar_11_2014_927317.nxml.txt.nlp	24738001	SENT5	15	15	18	18	sitagliptin	GLP-1	PA164748978	100125288	0.718
NULL	Int_J_Mol_Sci_2014_Mar_5_15(3)_3970-3988.nxml.txt.nlp	24603537	SENT245	13	13	22	22	curcumin	MCH	PA151958596	5367	0.718
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_11_2014_274786.nxml.txt.nlp	25505920	SENT212	19	19	26	26	oxaliplatin	DR3	PA131285527	8718	0.718
NULL	Acta_Pharmacol_Sin_2013_Jan_5_34(1)_24-32.nxml.txt.nlp	23123646	SENT83	5	5	30	30	glibenclamide	SUR1	PA449782	6833	0.718
NULL	Arch_Toxicol_2014_Nov_5_88(12)_2135-2190.nxml.txt.nlp	25370008	SENT1106	18	18	15	15	procainamide	NAT	PA451108	6046	0.718
NULL	Amino_Acids_2012_Jun_27_42(6)_2089-2094.nxml.txt.nlp	21617969	SENT161	41	41	23	23	amiloride	Hua	PA448368	1994	0.718
NULL	Cell_Mol_Life_Sci_2012_Oct_24_69(20)_3419-3428.nxml.txt.nlp	22527724	SENT95	31	31	29	29	thrombin	ADP	PA451674	23038	0.718
NULL	Breast_Cancer_Res_2005_Jan_28_7(3)_R284-R290.nxml.txt.nlp	15987423	SENT31	10	10	3	3	phenol	SULT1A1	PA450913	6817	0.718
NULL	Br_J_Cancer_2010_Sep_28_103(7)_1048-1056.nxml.txt.nlp	20736952	SENT227	16	16	28	28	methotrexate	HER2	PA450428	2064	0.718
NULL	Int_J_Mol_Sci_2014_Sep_26_15(10)_17204-17220.nxml.txt.nlp	25264738	SENT235	3	3	17	17	sildenafil	MPG	PA451346	4350	0.718
NULL	Indian_J_Palliat_Care_2010_Sep-Dec_16(3)_129-137.nxml.txt.nlp	21218002	SENT89	0	0	15	15	thalidomide	IL-6	PA451644	3569	0.718
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1009.nxml.txt.nlp	24457953	SENT273	37	37	30	30	methylprednisolone	CD28	PA450466	1493;940	0.718
NULL	Cancer_Med_2013_Aug_2_2(4)_571-582.nxml.txt.nlp	24156030	SENT233	5	5	11	11	curcumin	IL-6	PA151958596	3569	0.718
NULL	Breast_Cancer_Res_2012_Jul_19_14(4)_R109.nxml.txt.nlp	22812567	SENT316	0	0	2	2	gemcitabine	CHK1	PA449748	1111	0.718
NULL	Oncotarget_2014_Aug_27_5(17)_7328-7341.nxml.txt.nlp	25193862	SENT27	30	30	28	28	erlotinib	EGFR	PA134687924	1956	0.718
NULL	J_Clin_Biochem_Nutr_2010_Mar_27_46(2)_177-185.nxml.txt.nlp	20216951	SENT103	2	2	14	14	l-lysine	DDAH	PA450280	23576	0.718
NULL	Clin_Epigenetics_2011_Jul_9_2(2)_197-212.nxml.txt.nlp	22704337	SENT329	30	30	40	40	busulfan	EZH2	PA448691	2146	0.718
NULL	Cancer_Metab_2014_May_28_2(Suppl_1)_P65.nxml.txt.nlp	NULL	SENT5	8	8	24	24	resveratrol	NAMPT		10135	0.718
NULL	Int_J_Biol_Sci_2014_Sep_10_10(9)_1024-1038.nxml.txt.nlp	25285035	SENT179	25	25	13	13	ethanol	REST	PA448073	5978	0.718
NULL	eLife_2013_Oct_8_2_e01009.nxml.txt.nlp	24137539	SENT514	22	22	14	14	quinidine	CTX	PA451209	1593	0.718
NULL	Arthritis_Res_Ther_2012_May_1_14(3)_R99.nxml.txt.nlp	22546542	SENT12	24	24	15	15	infliximab	IL-17	PA452639	3605	0.718
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT107	10	10	17	17	pertuzumab	HER2		2064	0.718
NULL	J_Gen_Intern_Med_2009_May_26_24(5)_690-691.nxml.txt.nlp	19322614	SENT0	23	23	1	1	warfarin	Gen	PA451906	348654	0.718
NULL	FEBS_Open_Bio_2014_Oct_22_4_905-914.nxml.txt.nlp	25383314	SENT220	20	20	5	5	physostigmine	ANOVA	PA450957	4858	0.718
NULL	Br_J_Pharmacol_2008_Sep_9_155(1)_127-137.nxml.txt.nlp	18536750	SENT179	17	17	12	12	piroxicam	IL-10	PA450985	3586	0.718
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Jul_13_69(Pt_8)_o1246.nxml.txt.nlp	24109335	SENT66	1	1	25	25	benzaldehyde	C10	PA448571	113246	0.718
NULL	Oncotarget_2013_Mar_26_4(3)_397-412.nxml.txt.nlp	23651630	SENT308	24	24	32	32	vincristine	CHOP	PA451879	1649	0.718
NULL	Biol_Proced_Online_2004_Oct_25_6_250-256.nxml.txt.nlp	15514699	SENT45	6	6	4	4	neomycin	survivin	PA450608	332	0.718
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT302	23	23	13	13	pemetrexed	UNG	PA10810	7374	0.718
NULL	Oncotarget_2012_May_19_3(5)_535-545.nxml.txt.nlp	22619121	SENT77	14	14	16	16	topotecan	TPT	PA451729	23590;6469	0.718
NULL	J_Gen_Physiol_2003_Jan_121(1)_37-47.nxml.txt.nlp	12508052	SENT28	15	15	21	21	tetracaine	CNGA1	PA451638	1259	0.718
NULL	Community_Ment_Health_J_2011_Apr_25_47(2)_123-135.nxml.txt.nlp	20658320	SENT366	25	25	3	3	risperidone	CAGE	PA451257	168400	0.718
NULL	Behav_Brain_Funct_2013_Jan_10_9_4.nxml.txt.nlp	23305134	SENT181	8	8	34	34	biperiden	hole	PA448626	80757	0.718
NULL	J_Biomed_Biotechnol_2010_Sep_21_2010_980567.nxml.txt.nlp	20936136	SENT122	39	39	34	34	glucosamine	API	PA164747613	5345	0.718
NULL	Adv_Hematol_2012_Aug_2_2012_842945.nxml.txt.nlp	22919394	SENT146	28	28	8	8	lenalidomide	CRBN	PA162363968	51185	0.718
NULL	J_Cereb_Blood_Flow_Metab_2012_Sep_20_32(9)_1699-1717.nxml.txt.nlp	22714048	SENT378	18	18	15	15	glibenclamide	CTR	PA449782	799	0.718
NULL	Mol_Cancer_2008_Apr_7_7_29.nxml.txt.nlp	18394172	SENT35	9	9	1	1	cisplatin	BRCA1	PA449014	672	0.718
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT285	0	0	11	11	resveratrol	PUMA		27113	0.718
NULL	Br_J_Cancer_2011_Jul_12_105(2)_255-262.nxml.txt.nlp	21694725	SENT190	15	15	6	6	irinotecan	EGFR	PA450085	1956	0.718
NULL	Apoptosis_2013_Aug_23_18(11)_1306-1318.nxml.txt.nlp	23975731	SENT103	26	26	22	22	hydrocortisone	IL-3	PA449905	3562	0.718
NULL	J_Biol_Chem_2012_Apr_13_287(16)_13382-13395.nxml.txt.nlp	22367194	SENT91	19	19	14	14	marimastat	TIMP2	PA164748329	7077	0.718
NULL	Lancet_2011_Aug_13_378(9791)_595-605.nxml.txt.nlp	21784508	SENT272	19	19	6	6	perindopril	Yes	PA450877	7525	0.718
NULL	Anticancer_Agents_Med_Chem_2012_Feb_12(2)_163-171.nxml.txt.nlp	22043994	SENT256	22	22	4	4	irinotecan	PTEN	PA450085	5728	0.718
NULL	J_Clin_Biochem_Nutr_2010_Jan_29_46(1)_87-92.nxml.txt.nlp	20104270	SENT123	6	6	39	39	hesperidin	STZ	PA449867	6484	0.718
NULL	J_Thromb_Haemost_2011_Oct_9(10)_2103-2105.nxml.txt.nlp	21812912	SENT15	9	9	31	31	ticagrelor	mol	PA165374673	90527	0.718
NULL	Mol_Cancer_2014_Jan_28_13_17.nxml.txt.nlp	24472312	SENT137	11	11	1	1	ponatinib	Mcl-1	PA165980594	4170	0.718
NULL	Endocrinol_Metab_(Seoul)_2013_Dec_12_28(4)_262-274.nxml.txt.nlp	24396690	SENT156	16	16	2	2	exenatide	GLP-1	PA164749238	100125288	0.718
NULL	Biomed_Res_Int_2014_Jan_20_2014_948427.nxml.txt.nlp	24563867	SENT89	3	3	14	14	buspirone	CRP	PA448689	1401;140913	0.718
NULL	Oncol_Lett_2014_Nov_10_8(5)_2333-2339.nxml.txt.nlp	25295120	SENT82	2	2	12	12	sorafenib	ADM	PA7000	133	0.718
NULL	Thorax_2013_Sep_24_68(9)_835-845.nxml.txt.nlp	23709760	SENT204	33	33	14	14	metformin	AMPK	PA450395	5563	0.718
NULL	J_Cell_Biol_1998_Aug_10_142(3)_625-633.nxml.txt.nlp	9700154	SENT44	16	16	4	4	phenol	Raf-1	PA450913	5894	0.718
NULL	Cancers_(Basel)_2011_Aug_9_3(3)_3189-3205.nxml.txt.nlp	24212952	SENT608	0	0	8	8	hyaluronan	CD44	PA165958431	960	0.718
NULL	J_Cell_Biol_2001_Feb_19_152(4)_717-728.nxml.txt.nlp	11266463	SENT126	18	18	14	14	dextran	PI3K	PA449261	5290	0.718
NULL	Mediators_Inflamm_2011_Jun_7_2011_432080.nxml.txt.nlp	21772662	SENT119	11	11	5	5	thrombin	PAR-1	PA451674	2011;2149	0.718
NULL	Breast_Cancer_Res_2014_May_23_16(3)_R50.nxml.txt.nlp	24887458	SENT22	19	19	8	8	pertuzumab	HER2		2064	0.718
NULL	J_Med_Case_Reports_2011_Jan_12_5_5.nxml.txt.nlp	21226894	SENT65	12	12	9	9	cyclophosphamide	CHOP	PA449165	1649	0.718
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Feb_27_66(Pt_3)_o714-o715.nxml.txt.nlp	21580452	SENT82	3	3	9	9	pefloxacin	mol	PA164742856	90527	0.718
NULL	Clin_Infect_Dis_2012_Jul_15_55(2)_180-188.nxml.txt.nlp	22523268	SENT57	30	30	40	40	gentamicin	CO2	PA449753	4513	0.718
NULL	Cancer_Res_Treat_2013_Sep_30_45(3)_234-238.nxml.txt.nlp	24155683	SENT21	23	23	29	29	doxorubicin	CHOP	PA449412	1649	0.718
NULL	Int_J_Biol_Sci_2012_Jul_12_8(7)_964-978.nxml.txt.nlp	22811618	SENT247	21	21	8	8	sorafenib	EGFR	PA7000	1956	0.718
NULL	Cell_Death_Dis_2010_Nov_18_1(11)_e102.nxml.txt.nlp	21368867	SENT21	12	12	17	17	gentamicin	CLIMP-63	PA449753	10970	0.718
NULL	Cancer_Metastasis_Rev_2010_Dec_10_29(4)_581-594.nxml.txt.nlp	20830503	SENT100	8	8	10	10	tamoxifen	aromatase	PA451581	1588	0.718
NULL	Breast_Cancer_Res_2010_Nov_16_12(6)_R96.nxml.txt.nlp	21080941	SENT149	35	35	29	29	lapatinib	HRG	PA152241907	3084;3273	0.718
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT140	9	9	16	16	atazanavir	ABCB1	PA10251	5243	0.718
NULL	Curr_Neuropharmacol_2014_Jul_12(4)_308-323.nxml.txt.nlp	25342939	SENT495	15	15	29	29	vasopressin	AVP	PA451858	114548;551	0.718
NULL	Breast_Cancer_Res_Treat_2013_Apr_12_138(2)_427-435.nxml.txt.nlp	23479422	SENT152	9	9	25	25	lapatinib	HER2	PA152241907	2064	0.718
NULL	Cancer_Metab_2015_Jan_25_3(1)_1.nxml.txt.nlp	NULL	SENT150	0	0	22	22	doxorubicin	TRAIL	PA449412	8743	0.718
NULL	Br_J_Cancer_2011_Jan_4_104(1)_91-100.nxml.txt.nlp	21139584	SENT221	15	15	17	17	bortezomib	BTZ	PA10252	22794	0.718
NULL	Adv_Hematol_2012_Nov_14_2012_735392.nxml.txt.nlp	22190945	SENT207	21	21	7	7	rituximab	CD4	PA451261	920	0.718
NULL	J_Cell_Sci_2013_Jun_15_126(12)_2595-2606.nxml.txt.nlp	23606741	SENT505	3	3	0	0	docetaxel	RPN2	PA449383	6185	0.718
NULL	Reprod_Biol_Endocrinol_2013_Feb_26_11_15.nxml.txt.nlp	23442442	SENT198	17	17	12	12	l-arginine	BAX	PA448478	581	0.718
NULL	Front_Oncol_2014_Nov_10_4_318.nxml.txt.nlp	25426449	SENT113	14	14	4	4	cisplatin	PI3K	PA449014	5290	0.718
NULL	Nutr_J_2014_Jan_24_13_11.nxml.txt.nlp	24461029	SENT12	3	3	31	31	curcumin	CTR	PA151958596	799	0.718
NULL	Arthritis_Res_Ther_2007_Oct_9_9(5)_R104.nxml.txt.nlp	17925024	SENT160	11	11	16	16	glucosamine	G10	PA164747613	8896;221527	0.718
NULL	Oxid_Med_Cell_Longev_2013_May_7_2013_984546.nxml.txt.nlp	23738048	SENT164	16	16	31	31	arsenite	HO-1	PA452638	3162	0.718
NULL	J_Hematol_Oncol_2013_Mar_27_6_23.nxml.txt.nlp	23531342	SENT102	35	35	40	40	melphalan	RITA	PA450354	55422;84934	0.718
NULL	ScientificWorldJournal_2012_Mar_12_2012_793823.nxml.txt.nlp	22500143	SENT174	19	19	27	27	lipase	adiponectin	PA450239	9370	0.718
NULL	Case_Rep_Hematol_2012_Mar_26_2012_954201.nxml.txt.nlp	22953081	SENT36	10	10	19	19	cyclophosphamide	CHOP	PA449165	1649	0.718
NULL	Evid_Based_Complement_Alternat_Med_2012_Aug_27_2012_361516.nxml.txt.nlp	22969825	SENT148	27	27	33	33	vinblastine	P-gp	PA451877	5243	0.718
NULL	Front_Cell_Neurosci_2015_Jan_15_8_459.nxml.txt.nlp	25642166	SENT74	7	7	13	13	hemin	HO-1	PA449849	3162	0.718
NULL	Cell_Death_Dis_2013_Jul_11_4(7)_e718.nxml.txt.nlp	23846220	SENT153	28	28	19	19	auranofin	p53	PA448510	7157	0.718
NULL	Arthritis_Res_Ther_2007_Oct_9_9(5)_R104.nxml.txt.nlp	17925024	SENT28	3	3	28	28	glucosamine	JNK	PA164747613	5599	0.718
NULL	J_Interv_Card_Electrophysiol_2013_Apr_14_37(3)_223-231.nxml.txt.nlp	23585240	SENT76	26	26	12	12	heparin	ACT	PA449855	12;11332;9457;641455	0.718
NULL	Curr_Genomics_2014_Jun_15(3)_217-230.nxml.txt.nlp	24955029	SENT3	18	18	20	20	oxygen	ROS	PA450744	6098	0.718
NULL	Indian_J_Ophthalmol_2014_Jul_62(7)_761-767.nxml.txt.nlp	25116765	SENT121	11	11	35	35	bevacizumab	CRT	PA130232992	811	0.718
NULL	Cancer_Cell_Int_2013_Jan_15_13_3.nxml.txt.nlp	23320839	SENT142	14	14	9	9	gemcitabine	ABCC3	PA449748	8714	0.718
NULL	Ther_Clin_Risk_Manag_2007_Jun_3(3)_363-379.nxml.txt.nlp	18488081	SENT291	10	10	19	19	rabeprazole	CYP2C19	PA451216	1557	0.718
NULL	ISRN_Allergy_2013_Feb_7_2013_971036.nxml.txt.nlp	23738146	SENT246	33	33	8	8	papain	CCL11	PA450778	6356	0.718
NULL	AMIA_Jt_Summits_Transl_Sci_Proc_2012_Mar_19_2012_25-34.nxml.txt.nlp	22779044	SENT161	7	7	17	17	ethanol	PPARG	PA448073	5468	0.718
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2007_Jan_1_63(Pt_1)_1-8.nxml.txt.nlp	17164520	SENT45	18	18	24	24	thrombin	PTI	PA451674	5269	0.718
NULL	Mol_Cell_Endocrinol_2011_Apr_10_336(1-2)_198-205.nxml.txt.nlp	21078366	SENT394	9	9	12	12	tamoxifen	SF-1	PA451581	2516	0.718
NULL	Alzheimers_Res_Ther_2011_Jun_29_3(3)_21.nxml.txt.nlp	21722346	SENT120	19	19	1	1	creatine	Q10	PA164778930	27161	0.718
NULL	Indian_J_Pharm_Sci_2011_Nov-Dec_73(6)_615-620.nxml.txt.nlp	23112394	SENT121	44	44	13	13	azithromycin	CP2	PA448519	7024	0.718
NULL	Cancers_(Basel)_2013_Jul_4_5(3)_838-856.nxml.txt.nlp	24202322	SENT191	20	20	30	30	nutlin-3	p53		7157	0.718
NULL	Case_Rep_Med_2014_Nov_12_2014_231651.nxml.txt.nlp	25477968	SENT47	14	14	10	10	amiodarone	AIT	PA448383	160728	0.718
NULL	Oncotarget_2012_Dec_18_3(12)_1615-1628.nxml.txt.nlp	23271044	SENT76	23	23	25	25	temsirolimus	TOR	PA164746890	6097	0.718
NULL	Korean_J_Anesthesiol_2013_Dec_26_65(6)_501-507.nxml.txt.nlp	24427455	SENT129	43	43	28	28	neostigmine	NMB	PA450611	10457;4828	0.718
NULL	Carcinogenesis_2011_Nov_1_32(11)_1724-1733.nxml.txt.nlp	21890461	SENT217	4	4	13	13	tamoxifen	BPA	PA451581	667	0.718
NULL	Front_Physiol_2013_Nov_14_4_323.nxml.txt.nlp	24294204	SENT256	17	17	4	4	carvedilol	CYP2D6	PA448817	1565	0.718
NULL	Clin_Med_Insights_Oncol_2012_Aug_16_6_287-303.nxml.txt.nlp	22933844	SENT87	10	10	17	17	denosumab	RANK	PA166048634	8792	0.718
NULL	Curr_Neuropharmacol_2014_Jul_12(4)_365-379.nxml.txt.nlp	25342944	SENT64	30	30	0	0	fluoxetine	AKT	PA449673	207	0.718
NULL	Clin_Transl_Allergy_2013_Sep_2_3_29.nxml.txt.nlp	24004581	SENT157	1	1	17	17	omalizumab	IL-4	PA164752253	3565	0.718
NULL	J_Cell_Mol_Med_2013_Jun_4_17(6)_713-722.nxml.txt.nlp	23551576	SENT135	9	9	13	13	imiquimod	TLR7	PA449972	51284	0.718
NULL	Korean_J_Anesthesiol_2013_Jan_21_64(1)_47-53.nxml.txt.nlp	23372886	SENT96	23	23	25	25	bupivacaine	IGK	PA135057240	50802	0.718
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1126-1134.nxml.txt.nlp	21364592	SENT23	13	13	33	33	potassium	CYP2A6	PA451047	1548	0.718
NULL	J_Anaesthesiol_Clin_Pharmacol_2012_Oct-Dec_28(4)_548-549.nxml.txt.nlp	23225959	SENT31	33	33	11	11	clozapine	Gen	PA449061	348654	0.718
NULL	Nature_2008_Nov_13_456(7219)_269-273.nxml.txt.nlp	18849969	SENT236	13	13	11	11	resveratrol	SIRT1		23411	0.718
NULL	Cardiovasc_Diabetol_2011_Dec_22_10_115.nxml.txt.nlp	22189184	SENT15	23	23	6	6	miglitol	GLP-1	PA164776726	100125288	0.718
NULL	Appl_Microbiol_Biotechnol_2012_Feb_11_93(4)_1377-1387.nxml.txt.nlp	22234536	SENT158	26	26	20	20	nadh	mol	PA164755085	90527	0.718
NULL	Mol_Cancer_2009_Nov_19_8_108.nxml.txt.nlp	19925669	SENT111	14	14	5	5	doxorubicin	MRP3	PA449412	8714	0.718
NULL	BMJ_2011_Aug_4_343_d4588.nxml.txt.nlp	21816733	SENT385	4	4	17	17	cilostazol	ABCB1	PA164746334	5243	0.718
NULL	Cell_J_2014_May_25_Summer_16(2)_163-170.nxml.txt.nlp	24567946	SENT106	13	13	16	16	naloxone	OAT	PA450586	4942	0.718
NULL	Mol_Cancer_2008_Jun_4_7_49.nxml.txt.nlp	18533032	SENT113	25	25	5	5	tamoxifen	pS2	PA451581	7031	0.718
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT37	33	33	40	40	mitomycin	MVP	PA450524	9961	0.718
NULL	AIDS_2013_Sep_24_27(15)_2413-2423.nxml.txt.nlp	24037210	SENT298	13	13	7	7	efavirenz	ABCB1	PA449441	5243	0.718
NULL	Adv_Hematol_2012_Mar_25_2012_302570.nxml.txt.nlp	22536253	SENT104	9	9	28	28	rituximab	CD40	PA451261	958	0.718
NULL	J_Geriatr_Cardiol_2013_Mar_10(1)_52-58.nxml.txt.nlp	23610574	SENT155	2	2	11	11	tirofiban	cadherin	PA451698	1015	0.718
NULL	J_Cell_Biol_2003_Dec_8_163(5)_1157-1165.nxml.txt.nlp	14662753	SENT34	33	33	26	26	neomycin	PLIC-2	PA450608	29978	0.718
NULL	J_Clin_Biochem_Nutr_2007_Jan_27_40(1)_13-23.nxml.txt.nlp	18437209	SENT142	16	16	18	18	thrombin	PAR2	PA451674	2150;55065;8856	0.718
NULL	Front_Immunol_2013_Sep_17_4_280.nxml.txt.nlp	24062746	SENT362	14	14	27	27	estradiol	JAM-A	PA449503	50848	0.718
NULL	Cancer_Cell_Int_2002_Jul_5_2_7.nxml.txt.nlp	12234376	SENT10	11	11	14	14	staurosporine	BRCA1	PA165109623	672	0.718
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT192	21	21	37	37	cetuximab	Yes	PA10040	7525	0.718
NULL	Diabetes_Care_2013_Jul_12_36(7)_2126-2132.nxml.txt.nlp	23645884	SENT175	14	14	37	37	lipase	GLP-1	PA450239	100125288	0.718
NULL	Br_J_Cancer_2013_Jul_9_109(1)_164-171.nxml.txt.nlp	23799852	SENT164	23	23	14	14	chloroquine	ATG7	PA448948	10533	0.718
NULL	Cancers_(Basel)_2010_May_26_2(2)_955-969.nxml.txt.nlp	24281101	SENT686	3	3	6	6	dasatinib	KIT	PA162372878	3815	0.718
NULL	J_Biol_Chem_2009_Mar_6_284(10)_6260-6269.nxml.txt.nlp	19131328	SENT163	13	13	23	23	heparin	TBCA	PA449855	6902	0.718
NULL	Int_J_Mol_Sci_2014_Mar_6_15(3)_4049-4059.nxml.txt.nlp	24663080	SENT301	8	8	10	10	dexmedetomidine	IL-6	PA449256	3569	0.718
NULL	Oncol_Lett_2013_Jun_29_5(6)_1943-1947.nxml.txt.nlp	23833672	SENT156	4	4	9	9	celecoxib	AKT	PA448871	207	0.718
NULL	J_Exp_Clin_Cancer_Res_2009_Oct_7_28(1)_134.nxml.txt.nlp	19811659	SENT95	3	3	11	11	dasatinib	PDGFRA	PA162372878	5156	0.718
NULL	Ann_Surg_Oncol_2010_Apr_20_17(4)_1168-1176.nxml.txt.nlp	19936839	SENT204	11	11	15	15	cetuximab	KRAS	PA10040	3845	0.718
NULL	Hum_Mol_Genet_2014_Aug_1_23(15)_4077-4085.nxml.txt.nlp	24670599	SENT119	9	9	5	5	lipase	PNPLA3	PA450239	80339	0.718
NULL	Oncotarget_2013_Apr_13_4(4)_502-530.nxml.txt.nlp	23594434	SENT243	23	23	11	11	disulfiram	AKT	PA449376	207	0.718
NULL	Front_Neurosci_2010_Jun_17_4_35.nxml.txt.nlp	20661455	SENT585	20	20	2	2	raloxifene	5-HT1A	PA451221	3350	0.718
NULL	Arthritis_Res_Ther_2005_Feb_18_7(3)_R476-R484.nxml.txt.nlp	15899034	SENT104	6	6	13	13	thrombin	Rho	PA451674	29984	0.718
NULL	J_Anaesthesiol_Clin_Pharmacol_2011_Oct-Dec_27(4)_537-540.nxml.txt.nlp	22096292	SENT33	22	22	12	12	clopidogrel	DES	PA449053	1674	0.718
NULL	Int_J_Mol_Sci_2014_Nov_21_15(11)_21433-21454.nxml.txt.nlp	25421240	SENT240	7	7	15	15	atropine	PP2	PA448505	4888	0.718
NULL	Clinics_(Sao_Paulo)_2013_May_68(5)_694-701.nxml.txt.nlp	23778405	SENT137	5	5	27	27	curcumin	survivin	PA151958596	332	0.718
NULL	Eur_J_Dent_2012_Oct_6(4)_349-360.nxml.txt.nlp	23077413	SENT226	5	5	7	7	ethanol	HEMA	PA448073	2157	0.718
NULL	Int_J_Endocrinol_2010_Nov_14_2010_515136.nxml.txt.nlp	21113299	SENT143	18	18	8	8	lipase	PDX-1	PA450239	3651	0.718
NULL	Epigenetics_Chromatin_2014_Jan_20_7_2.nxml.txt.nlp	24443974	SENT64	12	12	17	17	protamine	PRM2	PA10366	5620	0.718
NULL	Diabetes_2009_Apr_58(4)_773-795.nxml.txt.nlp	19336687	SENT403	3	3	17	17	exenatide	GLP-1	PA164749238	100125288	0.718
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT246	41	41	38	38	bevacizumab	RAN	PA130232992	5901	0.718
NULL	Emerg_Infect_Dis_2011_Oct_17(10)_1917-1920.nxml.txt.nlp	22000371	SENT68	13	13	9	9	neomycin	B10	PA450608	5169	0.718
NULL	Br_J_Cancer_2010_Sep_28_103(7)_1048-1056.nxml.txt.nlp	20736952	SENT227	24	24	28	28	methotrexate	HER2	PA450428	2064	0.718
NULL	Neuropsychopharmacology_2009_Jul_11_34(8)_1946-1957.nxml.txt.nlp	19279569	SENT173	31	31	27	27	cocaine	DOR	PA449072	58476	0.718
NULL	Lab_Invest_2009_Nov_7_89(11)_1275-1290.nxml.txt.nlp	19736547	SENT40	21	21	27	27	curcumin	LOX-1	PA151958596	4973	0.718
NULL	Breast_Cancer_Res_2012_May_4_14(3)_R72.nxml.txt.nlp	22559056	SENT209	8	8	29	29	tamoxifen	CENP-A	PA451581	1058	0.718
NULL	Neural_Plast_2012_May_20_2012_124548.nxml.txt.nlp	22685676	SENT145	16	16	21	21	minocycline	p53	PA450519	7157	0.718
NULL	Breast_Cancer_Res_Treat_2012_Aug_29_135(1)_241-252.nxml.txt.nlp	22872523	SENT161	27	27	9	9	docetaxel	PLGF	PA449383	5228	0.718
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Mar_6_69(Pt_4)_o485-o486.nxml.txt.nlp	23634038	SENT84	0	0	17	17	cinnarizine	mol	PA164749342	90527	0.718
NULL	Korean_J_Radiol_2010_Feb_22_Mar-Apr_11(2)_234-238.nxml.txt.nlp	20191072	SENT62	20	20	33	33	doxorubicin	CHOP	PA449412	1649	0.718
NULL	Clin_Ophthalmol_2010_Apr_26_4_227-231.nxml.txt.nlp	20463788	SENT17	0	0	8	8	ranibizumab	San	PA164746012	80218	0.718
NULL	J_Adv_Pharm_Technol_Res_2012_Oct-Dec_3(4)_202-209.nxml.txt.nlp	23378940	SENT170	17	17	1	1	aprepitant	CYP3A4	PA164747039	1576	0.718
NULL	Oncotarget_2013_Dec_24_5(9)_2418-2427.nxml.txt.nlp	24810714	SENT49	19	19	5	5	etoposide	NAC	PA449552	22861	0.718
NULL	Can_J_Infect_Dis_Med_Microbiol_2014_Nov-Dec_25(6)_327-343.nxml.txt.nlp	25587296	SENT348	6	6	8	8	voriconazole	CYP2C19	PA10233	1557	0.718
NULL	Mol_Cancer_2009_Dec_23_8_129.nxml.txt.nlp	20030852	SENT195	11	11	6	6	curcumin	ABCA1	PA151958596	19	0.718
NULL	Oxid_Med_Cell_Longev_2012_May_27_2012_609421.nxml.txt.nlp	22693652	SENT126	10	10	19	19	imipramine	NO3	PA449969	4681	0.718
NULL	EMBO_Mol_Med_2012_Dec_15_4(12)_1276-1293.nxml.txt.nlp	23065753	SENT435	8	8	14	14	cisplatin	NLRP3	PA449014	114548	0.718
NULL	Cancer_Immunol_Immunother_2010_Feb_5_59(2)_203-213.nxml.txt.nlp	19655140	SENT290	2	2	9	9	methylcholanthrene	gamma	PA165816878	9913	0.718
NULL	Clin_Ophthalmol_2007_Mar_1(1)_61-64.nxml.txt.nlp	19668467	SENT39	28	28	24	24	ethanol	castor	PA448073	54897	0.718
NULL	Curr_Neuropharmacol_2010_Sep_8(3)_254-267.nxml.txt.nlp	21358975	SENT345	24	24	18	18	lamotrigine	VIII	PA450164	1351	0.718
NULL	EJC_Suppl_2013_Sep_5_11(2)_45-59.nxml.txt.nlp	NULL	SENT242	31	31	34	34	oxaliplatin	CRT	PA131285527	811	0.718
NULL	J_Skin_Cancer_2013_Apr_21_2013_423829.nxml.txt.nlp	23738073	SENT34	14	14	31	31	vemurafenib	BRAF	PA165946873	673	0.718
NULL	Curr_Rheumatol_Rep_2012_Dec_18_14(6)_604-616.nxml.txt.nlp	22987043	SENT253	18	18	10	10	diclofenac	SKI	PA449293	6497	0.718
NULL	J_Cell_Biol_2003_Dec_22_163(6)_1385-1395.nxml.txt.nlp	14676308	SENT11	11	11	2	2	thrombin	RhoA	PA451674	387	0.718
NULL	Exp_Ther_Med_2014_Nov_29_8(5)_1473-1478.nxml.txt.nlp	25289044	SENT8	14	14	8	8	heparin	AZU	PA449855	566	0.718
NULL	Nat_Commun_2013_Apr_9_4_1684.nxml.txt.nlp	23575688	SENT96	2	2	23	23	rolipram	PDE4B	PA153906323	5142	0.718
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1046.nxml.txt.nlp	24503538	SENT8	15	15	7	7	oxaliplatin	FGFR4	PA131285527	2264	0.718
NULL	Cancer_Cell_Int_2013_Feb_12_13_14.nxml.txt.nlp	23402310	SENT189	17	17	20	20	celecoxib	p65	PA448871	5970	0.718
NULL	Crit_Care_2011_Oct_26_15(5)_R257.nxml.txt.nlp	22030215	SENT176	1	1	15	15	dexmedetomidine	SAPS	PA449256	8935	0.718
NULL	Bioconjug_Chem_2013_Apr_17_24(4)_712-723.nxml.txt.nlp	23488616	SENT96	10	10	20	20	perphenazine	COX	PA450882	1351	0.718
NULL	Clin_Mol_Allergy_2011_Apr_28_9_7.nxml.txt.nlp	21527026	SENT37	17	17	9	9	omalizumab	CD23	PA164752253	2208	0.718
NULL	Cancer_Immunol_Immunother_2011_Jun_25_60(6)_793-808.nxml.txt.nlp	21350947	SENT220	43	43	15	15	sorafenib	IFN	PA7000	3439	0.718
NULL	FEBS_J_2009_Oct_276(19)_5571-5578.nxml.txt.nlp	19702827	SENT175	11	11	35	35	fluorescein	San	PA164746009	80218	0.718
NULL	Pharmaceuticals_(Basel)_2011_Mar_17_4(3)_551-566.nxml.txt.nlp	NULL	SENT584	10	10	2	2	doxorubicin	TNF-alpha	PA449412	7124	0.718
NULL	Curr_Clin_Pharmacol_2013_May_8(2)_135-155.nxml.txt.nlp	23062036	SENT361	4	4	12	12	tamoxifen	CEE	PA451581	51608	0.718
NULL	Protein_Cell_2014_Feb_11_5(2)_124-140.nxml.txt.nlp	24515614	SENT52	11	11	0	0	bortezomib	DSS1	PA10252	7979	0.718
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT258	7	7	0	0	cisplatin	MVP	PA449014	9961	0.718
NULL	Front_Behav_Neurosci_2012_Nov_22_6_78.nxml.txt.nlp	23189046	SENT133	28	28	21	21	ethanol	OX2R	PA448073	3062;131450	0.718
NULL	Br_J_Cancer_2009_Jul_21_101(2)_312-319.nxml.txt.nlp	19568237	SENT106	25	25	22	22	pp2	PP1		5540;5464	0.718
NULL	Br_J_Pharmacol_2014_Apr_28_171(8)_1798-1817.nxml.txt.nlp	24116962	SENT243	0	0	4	4	resveratrol	SIRT1		23411	0.718
NULL	J_Burns_Wounds_2007_Oct_30_7_e7.nxml.txt.nlp	18091984	SENT133	9	9	4	4	resveratrol	NAC		22861	0.718
NULL	Brain_Sci_2014_May_6_4(2)_356-375.nxml.txt.nlp	24961766	SENT227	0	0	13	13	propofol	CA3	PA451141	761	0.718
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT192	21	21	33	33	cetuximab	Yes	PA10040	7525	0.718
NULL	Mol_Cells_2014_Aug_31_37(8)_585-591.nxml.txt.nlp	25134539	SENT111	11	11	9	9	indacaterol	ADRB2	PA165958348	154	0.718
NULL	Br_J_Cancer_2009_Oct_6_101(7)_1162-1167.nxml.txt.nlp	19724276	SENT8	19	19	23	23	gemcitabine	Gem	PA449748	51053	0.718
NULL	J_Gen_Physiol_1994_Mar_1_103(3)_501-518.nxml.txt.nlp	8195785	SENT0	11	11	1	1	benzocaine	Gen	PA448576	348654	0.718
NULL	Breast_Cancer_(Auckl)_2010_Feb_16_4_1-3.nxml.txt.nlp	20697527	SENT8	36	36	27	27	curcumin	BRCA1	PA151958596	672	0.718
NULL	Nat_Commun_2013_Apr_9_4_1684.nxml.txt.nlp	23575688	SENT611	15	15	31	31	forskolin	CYLD	PA146096022	1540	0.718
NULL	Mol_Cancer_2014_Apr_30_13_98.nxml.txt.nlp	24779770	SENT196	12	12	32	32	oxygen	ERK	PA450744	5594	0.718
NULL	Amino_Acids_2014_Feb_20_46(5)_1275-1283.nxml.txt.nlp	24553827	SENT87	27	27	21	21	taurine	CDO	PA451590	50937	0.718
NULL	Breast_Cancer_Res_2005_May_24_7(5)_R589-R597.nxml.txt.nlp	16168102	SENT190	10	10	29	29	doxorubicin	FBS	PA449412	64319;26269	0.718
NULL	Cell_J_2013_Aug_24_Autumn_15(3)_206-211.nxml.txt.nlp	24027660	SENT130	7	7	0	0	estradiol	CYP1A2	PA449503	1544	0.718
NULL	Br_J_Cancer_2001_Aug_85(3)_317-324.nxml.txt.nlp	11487258	SENT6	7	7	13	13	anastrozole	DMT	PA448432	2039	0.718
NULL	Int_J_Nanomedicine_2012_Oct_25_7_5565-5575.nxml.txt.nlp	23118538	SENT136	6	6	9	9	fenofibrate	CO2	PA449594	4513	0.718
NULL	Exp_Ther_Med_2014_Nov_29_8(5)_1473-1478.nxml.txt.nlp	25289044	SENT156	6	6	11	11	heparin	AZU	PA449855	566	0.718
NULL	Avicenna_J_Med_2013_Apr-Jun_3(2)_37-47.nxml.txt.nlp	23930241	SENT202	25	25	5	5	azathioprine	CD4	PA448515	920	0.718
NULL	Evid_Based_Complement_Alternat_Med_2013_Mar_26_2013_625892.nxml.txt.nlp	23589719	SENT250	0	0	6	6	probenecid	TAS2R38	PA451106	5726	0.718
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S18-S30.nxml.txt.nlp	20680104	SENT194	3	3	5	5	panitumumab	IFL	PA162373091	3439	0.718
NULL	Breast_Cancer_Res_2011_Mar_11_13(2)_R29.nxml.txt.nlp	21396094	SENT132	23	23	32	32	fulvestrant	HRG	PA164747170	3084;3273	0.718
NULL	Ther_Clin_Risk_Manag_2006_Dec_2(4)_389-400.nxml.txt.nlp	18360651	SENT133	13	13	6	6	infliximab	IMPACT	PA452639	55364	0.718
NULL	Clin_Pract_2014_Jul_9_4(2)_651.nxml.txt.nlp	25332762	SENT30	8	8	39	39	estradiol	ACTH	PA449503	5443	0.718
NULL	Breast_Cancer_Res_2011_Mar_11_13(2)_R29.nxml.txt.nlp	21396094	SENT12	2	2	15	15	fulvestrant	HRG	PA164747170	3084;3273	0.718
NULL	Mol_Cancer_2010_Aug_25_9_225.nxml.txt.nlp	20738848	SENT263	28	28	15	15	doxorubicin	IL3	PA449412	3562	0.718
NULL	Nat_Genet_2014_Feb_15_46(2)_152-160.nxml.txt.nlp	24336168	SENT37	14	14	9	9	galactose	TDP-43	PA449725	23435	0.718
NULL	Nucleic_Acids_Res_2011_Dec_31_39(22)_9536-9548.nxml.txt.nlp	21880590	SENT228	11	11	8	8	etoposide	BRCA1	PA449552	672	0.718
NULL	Am_J_Trop_Med_Hyg_2014_Mar_5_90(3)_530-534.nxml.txt.nlp	24420779	SENT79	25	25	30	30	nevirapine	CYP3A4	PA450616	1576	0.717
NULL	Environ_Health_Perspect_2009_Dec_8_117(12)_1799-1802.nxml.txt.nlp	20049195	SENT48	4	4	10	10	betaine	B12	PA448603	7126;4709	0.717
NULL	Acta_Neuropathol_2007_Nov_6_114(5)_443-458.nxml.txt.nlp	17805551	SENT178	3	3	0	0	hyaluronan	CD44	PA165958431	960	0.717
NULL	Int_J_Gen_Med_2011_Jun_24_4_493-499.nxml.txt.nlp	21760751	SENT121	6	6	12	12	l-arginine	STZ	PA448478	6484	0.717
NULL	Curr_Opin_Cell_Biol_2014_Dec_31_1-7.nxml.txt.nlp	25014650	SENT60	4	4	24	24	s-adenosylmethionine	NOP2	PA164754994	4839	0.717
NULL	Indian_J_Med_Res_2011_Sep_134(3)_295-301.nxml.txt.nlp	21985811	SENT111	9	9	26	26	carbamazepine	CYP2C19	PA448785	1557	0.717
NULL	Arthritis_Res_Ther_2005_Feb_18_7(3)_R476-R484.nxml.txt.nlp	15899034	SENT7	2	2	7	7	thrombin	IL-6	PA451674	3569	0.717
NULL	J_Headache_Pain_2008_Oct_31_9(5)_277-288.nxml.txt.nlp	18668199	SENT63	5	5	44	44	propranolol	Yes	PA451145	7525	0.717
NULL	J_Cancer_2014_Apr_25_5(6)_398-405.nxml.txt.nlp	24847380	SENT137	41	41	35	35	trastuzumab	HER2	PA451743	2064	0.717
NULL	Oncotarget_2010_Dec_25_1(8)_741-750.nxml.txt.nlp	21321383	SENT95	5	5	22	22	geldanamycin	ASK1	PA152031327	4217	0.717
NULL	Curr_Pain_Headache_Rep_2012_Oct_27_16(5)_439-444.nxml.txt.nlp	22836591	SENT80	14	14	12	12	creatine	ADP	PA164778930	23038	0.717
NULL	Acta_Pharmacol_Sin_2009_Jul_22_30(7)_956-964.nxml.txt.nlp	19543298	SENT220	14	14	19	19	simvastatin	ANOVA	PA451363	4858	0.717
NULL	Ann_Rheum_Dis_2008_Apr_20_67(4)_511-517.nxml.txt.nlp	17644552	SENT139	3	3	11	11	infliximab	IL-6	PA452639	3569	0.717
NULL	Open_Orthop_J_2008_Jul_14_2_115-120.nxml.txt.nlp	19478935	SENT7	14	14	16	16	amifostine	AMF	PA448365	2821	0.717
NULL	Lipids_Health_Dis_2011_Jan_27_10_24.nxml.txt.nlp	21272342	SENT36	8	8	19	19	lipase	PPL	PA450239	5493	0.717
NULL	Antimicrob_Agents_Chemother_2014_Nov_10_59(1)_490-497.nxml.txt.nlp	25385107	SENT38	19	19	17	17	lumefantrine	ACT	PA165111722	12;11332;9457;641455	0.717
NULL	ACS_Nano_2014_Sep_23_8(9)_8786-8793.nxml.txt.nlp	25130648	SENT33	2	2	7	7	tobramycin	NGC	PA451704	10675	0.717
NULL	Front_Hum_Neurosci_2014_Oct_7_8_762.nxml.txt.nlp	25339881	SENT246	0	0	12	12	eszopiclone	TRN	PA162630444	3842	0.717
NULL	Biologics_2014_Apr_23_8_183-192.nxml.txt.nlp	24790411	SENT108	24	24	33	33	afatinib	EGFR	PA165981154	1956	0.717
NULL	Open_Virol_J_2014_Mar_7_8_1-8.nxml.txt.nlp	24799968	SENT101	12	12	28	28	boceprevir	PKR	PA165948902	5610	0.717
NULL	Br_J_Cancer_2013_Jun_25_108(12)_2464-2469.nxml.txt.nlp	23695016	SENT16	13	13	17	17	paclitaxel	CRT	PA450761	811	0.717
NULL	Acta_Pharmacol_Sin_2012_May_4_33(5)_710-716.nxml.txt.nlp	22555373	SENT118	11	11	16	16	phenylbutazone	DOM	PA450932	6663	0.717
NULL	Breast_Cancer_Res_Treat_2013_Aug_20_141(1)_43-53.nxml.txt.nlp	23959396	SENT188	24	24	8	8	trastuzumab	HER3	PA451743	2065	0.717
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT129	25	25	11	11	lapatinib	PDK1	PA152241907	5170;5163	0.717
NULL	Indian_J_Pharm_Sci_2008_Mar-Apr_70(2)_159-164.nxml.txt.nlp	20046705	SENT98	40	40	32	32	nimesulide	B10	PA137179528	5169	0.717
NULL	Eur_J_Epidemiol_2009_Sep_2_24(9)_553-572.nxml.txt.nlp	19728115	SENT1546	20	20	39	39	acenocoumarol	PAGM	PA452632	5238	0.717
NULL	Brain_Sci_2013_Jun_19_3(2)_964-991.nxml.txt.nlp	24961433	SENT82	5	5	26	26	ethanol	ngn1	PA448073	4762	0.717
NULL	J_Indian_Soc_Periodontol_2014_May-Jun_18(3)_282-288.nxml.txt.nlp	25024538	SENT71	6	6	3	3	ustekinumab	IL-23	PA166048654	51561	0.717
NULL	Eur_J_Med_Res_2015_Jan_7_20(1)_1.nxml.txt.nlp	25563300	SENT81	18	18	16	16	l-glutamine	F12	PA10090	2161	0.717
NULL	An_Bras_Dermatol_2014_Mar-Apr_89(2)_266-273.nxml.txt.nlp	24770503	SENT153	23	23	10	10	thalidomide	ENL	PA451644	4298	0.717
NULL	Cancer_Res_Treat_2014_Jan_15_46(1)_48-54.nxml.txt.nlp	24520223	SENT158	12	12	5	5	bevacizumab	KRAS	PA130232992	3845	0.717
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_12_2014_342506.nxml.txt.nlp	25477990	SENT52	19	19	6	6	gentamicin	hole	PA449753	80757	0.717
NULL	Iran_J_Pharm_Res_2013_Winter_12(Suppl)_169-174.nxml.txt.nlp	24250685	SENT29	4	4	10	10	clopidogrel	P2Y12	PA449053	64805	0.717
NULL	Braz_J_Microbiol_2013_Apr_9_44(1)_245-252.nxml.txt.nlp	24159311	SENT131	14	14	7	7	lipase	castor	PA450239	54897	0.717
NULL	Acta_Pharmacol_Sin_2011_Oct_12_32(10)_1259-1265.nxml.txt.nlp	21909126	SENT133	5	5	12	12	fluvastatin	p38	PA449688	10598;1432;7965	0.717
NULL	BMJ_2011_Aug_4_343_d4588.nxml.txt.nlp	21816733	SENT438	15	15	4	4	clopidogrel	CYP3A5	PA449053	1577	0.717
NULL	Breast_Cancer_Res_2010_Jul_1_12(4)_R45.nxml.txt.nlp	20594311	SENT120	4	4	2	2	nelfinavir	BiP	PA450606	3309	0.717
NULL	FEBS_Open_Bio_2011_Dec_27_2_1-5.nxml.txt.nlp	23650573	SENT104	20	20	40	40	sunitinib	MDM2	PA162372840	4193	0.717
NULL	Case_Rep_Endocrinol_2014_Jul_9_2014_749576.nxml.txt.nlp	25114812	SENT68	20	20	3	3	thyroglobulin	TPO	PA164754910	7066;7173	0.717
NULL	Eur_J_Clin_Pharmacol_2014_Oct_8_70(12)_1433-1441.nxml.txt.nlp	25291992	SENT7	43	43	6	6	olanzapine	FES	PA450688	2242	0.717
NULL	Mol_Neurodegener_2011_Aug_8_6_57.nxml.txt.nlp	21819629	SENT242	15	15	25	25	arsenite	HuR	PA452638	1994	0.717
NULL	J_Biol_2009_Apr_15_8(3)_30.nxml.txt.nlp	19435483	SENT22	12	12	14	14	imatinib	NQO2	PA10804	4835	0.717
NULL	J_Viral_Hepat_2010_Feb_17(2)_139-147.nxml.txt.nlp	19674282	SENT11	18	18	11	11	ribavirin	RVR	PA451241	9975	0.717
NULL	Br_J_Clin_Pharmacol_2013_Aug_23_76(2)_299-315.nxml.txt.nlp	23701319	SENT94	2	2	21	21	adalimumab	IFN	PA10004	3439	0.717
NULL	J_Gen_Physiol_2004_Apr_123(4)_427-439.nxml.txt.nlp	15024039	SENT307	11	11	13	13	genistein	PP2	PA165109660	4888	0.717
NULL	Indian_J_Ophthalmol_2012_May-Jun_60(3)_207-209.nxml.txt.nlp	22569382	SENT30	8	8	24	24	ranibizumab	San	PA164746012	80218	0.717
NULL	Infect_Dis_Rep_2011_Jun_24_3(1)_e6.nxml.txt.nlp	23745166	SENT172	10	10	13	13	raltegravir	CCR5		1234	0.717
NULL	Br_J_Clin_Pharmacol_2012_Apr_7_73(4)_518-535.nxml.txt.nlp	22053916	SENT183	0	0	16	16	pitavastatin	PI3K	PA142650384	5290	0.717
NULL	Clin_Toxicol_(Phila)_2007_Jun_20_Jun-Aug_45(5)_565-570.nxml.txt.nlp	17558630	SENT181	8	8	15	15	methacholine	Rho	PA165958382	29984	0.717
NULL	Ann_Gastroenterol_2012_25(1)_21-26.nxml.txt.nlp	24713996	SENT210	7	7	3	3	methotrexate	IFN	PA450428	3439	0.717
NULL	Breast_Cancer_Res_2011_Apr_15_13(2)_R44.nxml.txt.nlp	21496232	SENT444	30	30	18	18	lapatinib	HER-2	PA152241907	2064	0.717
NULL	Bioinformation_2006_Dec_6_1(8)_281-284.nxml.txt.nlp	17597908	SENT101	17	17	13	13	thyroglobulin	neurotactin	PA164754910	6376	0.717
NULL	Int_J_Environ_Res_Public_Health_2010_Feb_11_7(2)_473-493.nxml.txt.nlp	20616986	SENT343	5	5	13	13	ethanol	5-HT1A	PA448073	3350	0.717
NULL	Gut_Pathog_2011_Dec_9_3_19.nxml.txt.nlp	22151930	SENT98	31	31	20	20	ciprofloxacin	MAX	PA449009	4149	0.717
NULL	J_Mol_Med_2011_Jul_23_89(7)_667-676.nxml.txt.nlp	21431325	SENT192	21	21	16	16	resveratrol	SIRT1		23411	0.717
NULL	Curr_Med_Chem_2008_Jun_15(13)_1274-1287.nxml.txt.nlp	18537607	SENT400	18	18	8	8	azacitidine	p15	PA451996	10923;10573	0.717
NULL	Front_Immunol_2011_Aug_29_2_38.nxml.txt.nlp	22566828	SENT32	42	42	31	31	alemtuzumab	alpha-chain	PA164783958	2217	0.717
NULL	Biomed_Res_Int_2014_Apr_29_2014_186864.nxml.txt.nlp	24877064	SENT217	10	10	20	20	curcumin	TUP1	PA151958596	7290	0.717
NULL	Braz_J_Microbiol_2010_Jun_1_Apr-Jun_41(2)_452-460.nxml.txt.nlp	24031516	SENT121	5	5	27	27	nitrofurantoin	STX	PA450640	8128	0.717
NULL	Breast_Cancer_Res_Treat_2014_Apr_9_145(1)_73-82.nxml.txt.nlp	24715380	SENT2	37	37	8	8	tamoxifen	CXCR3	PA451581	2833	0.717
NULL	Indian_J_Pharm_Sci_2013_May-Jun_75(3)_251-261.nxml.txt.nlp	24082340	SENT59	6	6	16	16	trastuzumab	HER2	PA451743	2064	0.717
NULL	J_Exp_Med_2000_Nov_20_192(10)_1501-1508.nxml.txt.nlp	11085751	SENT133	4	4	7	7	trypsin	HCC-1	PA451806	6358	0.717
NULL	J_Cell_Biol_1998_Jan_26_140(2)_335-345.nxml.txt.nlp	9442109	SENT23	22	22	13	13	chloroquine	NHE	PA448948	285335	0.717
NULL	Biomed_Res_Int_2013_May_8_2013_703130.nxml.txt.nlp	23738330	SENT132	14	14	32	32	lipase	SP75	PA450239	6674	0.717
NULL	Cardiovasc_Diabetol_2013_Nov_4_12_159.nxml.txt.nlp	24180232	SENT132	0	0	17	17	candesartan	URAT1	PA448765	116085	0.717
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT149	9	9	7	7	dasatinib	PP2	PA162372878	4888	0.717
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT486	1	1	6	6	paclitaxel	ABCB1	PA450761	5243	0.717
NULL	Mol_Cells_2014_Nov_30_37(11)_804-811.nxml.txt.nlp	25410909	SENT264	12	12	15	15	thrombin	PAR-1	PA451674	2011;2149	0.717
NULL	Eur_J_Med_Res_2010_Apr_8_15(4)_145-151.nxml.txt.nlp	20554495	SENT35	22	22	28	28	abacavir	HLA-B	PA448004	3106	0.717
NULL	J_Appl_Oral_Sci_2010_Sep-Oct_18(5)_503-508.nxml.txt.nlp	21085807	SENT102	13	13	9	9	ethanol	HEMA	PA448073	2157	0.717
NULL	Cancer_Causes_Control_2012_Oct_21_23(10)_1739-1744.nxml.txt.nlp	22907422	SENT86	18	18	10	10	sulindac	CRA	PA451565	51747;10903	0.717
NULL	Ann_Hematol_2010_Nov_25_89(11)_1115-1124.nxml.txt.nlp	20499237	SENT150	15	15	17	17	simvastatin	CD38	PA451363	952	0.717
NULL	Diabetes_Care_2010_Mar_15_33(3)_608-613.nxml.txt.nlp	20009095	SENT133	37	37	29	29	ramipril	DREAM	PA451223	30818	0.717
NULL	Indian_J_Anaesth_2011_May-Jun_55(3)_318-320.nxml.txt.nlp	21808420	SENT45	26	26	5	5	tramadol	CO2	PA451735	4513	0.717
NULL	Acta_Neuropathol_Commun_2014_Oct_21_2(1)_149.nxml.txt.nlp	NULL	SENT344	2	2	9	9	riluzole	gamma	PA451251	9913	0.717
NULL	Anemia_2012_Nov_8_2012_607436.nxml.txt.nlp	23198140	SENT163	16	16	19	19	capsaicin	TRPV1	PA448776	7442	0.717
NULL	Curr_Oncol_2009_Jul_16(Suppl_2)_S14-S23.nxml.txt.nlp	19672417	SENT205	38	38	9	9	tamoxifen	ATAC	PA451581	6375	0.717
NULL	Front_Endocrinol_(Lausanne)_2013_Jun_10_4_69.nxml.txt.nlp	23772224	SENT953	2	2	7	7	rosiglitazone	apelin	PA451283	8862	0.717
NULL	Clin_Interv_Aging_2014_Apr_8_9_593-601.nxml.txt.nlp	24748777	SENT137	4	4	6	6	denosumab	RANKL	PA166048634	8600	0.717
NULL	J_Cell_Biol_2008_Jul_28_182(2)_367-379.nxml.txt.nlp	18644892	SENT205	14	14	29	29	pp2	PP2		4888	0.717
NULL	Sensors_(Basel)_2012_Dec_3_12(12)_16614-16627.nxml.txt.nlp	23208557	SENT159	18	18	15	15	cetuximab	EGFR	PA10040	1956	0.717
NULL	Cancer_Med_2014_Feb_7_3(1)_124-133.nxml.txt.nlp	24403130	SENT206	5	5	44	44	bevacizumab	KRAS	PA130232992	3845	0.717
NULL	Acta_Neuropathol_Commun_2013_May_20_1_17.nxml.txt.nlp	24252689	SENT6	35	35	25	25	celecoxib	IQGAP1	PA448871	8826	0.717
NULL	Front_Oncol_2014_Apr_14_4_64.nxml.txt.nlp	24782981	SENT244	21	21	13	13	hydroxychloroquine	ATG3	PA164777036	64422	0.717
NULL	Neuropsychopharmacology_2009_May_22_34(6)_1482-1493.nxml.txt.nlp	18946467	SENT116	17	17	15	15	ethanol	ANOVA	PA448073	4858	0.717
NULL	Bioinformation_2012_Jan_6_8(1)_13-19.nxml.txt.nlp	22359429	SENT7	25	25	34	34	curcumin	MRP1	PA151958596	4437	0.717
NULL	Ann_Surg_Treat_Res_2015_Jan_26_88(1)_15-20.nxml.txt.nlp	25553320	SENT10	8	8	27	27	leucovorin	CRT	PA450198	811	0.717
NULL	J_Mammary_Gland_Biol_Neoplasia_2010_Mar_27_15(1)_5-17.nxml.txt.nlp	20101446	SENT200	15	15	23	23	cisplatin	DNMT3B	PA449014	1789	0.717
NULL	Sci_Rep_2015_Jan_15_5_7817.nxml.txt.nlp	25588710	SENT53	11	11	17	17	trastuzumab	HER2	PA451743	2064	0.717
NULL	Oncotarget_2013_Dec_28_5(6)_1475-1490.nxml.txt.nlp	24721996	SENT74	10	10	15	15	celecoxib	CD44	PA448871	960	0.717
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Sep_19_65(Pt_10)_o2506-o2507.nxml.txt.nlp	21577955	SENT79	15	15	11	11	benzaldehyde	mol	PA448571	90527	0.717
NULL	Biogerontology_2014_Nov_16_15(1)_47-64.nxml.txt.nlp	24243065	SENT282	4	4	11	11	doxorubicin	DNMT1	PA449412	1786	0.717
NULL	Acta_Pharmacol_Sin_2013_Jun_8_34(6)_830-836.nxml.txt.nlp	23564080	SENT109	6	6	24	24	simvastatin	RAGE	PA451363	177	0.717
NULL	J_Breast_Cancer_2011_Sep_29_14(3)_223-228.nxml.txt.nlp	22031805	SENT130	10	10	34	34	cyclophosphamide	gamma	PA449165	9913	0.717
NULL	Ther_Clin_Risk_Manag_2006_Jun_2(2)_129-158.nxml.txt.nlp	18360588	SENT189	0	0	2	2	phenytoin	CYP3A4	PA450947	1576	0.717
NULL	Indian_J_Med_Res_2014_Apr_139(4)_572-578.nxml.txt.nlp	24927344	SENT120	31	31	8	8	acenocoumarol	CYP4F2	PA452632	8529	0.717
NULL	Oncotarget_2012_May_19_3(5)_535-545.nxml.txt.nlp	22619121	SENT96	7	7	9	9	topotecan	TPT	PA451729	23590;6469	0.717
NULL	ScientificWorldJournal_2014_May_13_2014_701329.nxml.txt.nlp	24959618	SENT45	0	0	24	24	rocuronium	NMT	PA164754992	4836	0.717
NULL	Front_Oncol_2014_Sep_23_4_264.nxml.txt.nlp	25295231	SENT89	15	15	25	25	lenalidomide	CDC25C	PA162363968	995	0.717
NULL	Arthritis_Res_Ther_2005_Jan_7_7(2)_R241-R249.nxml.txt.nlp	15743470	SENT48	21	21	28	28	kanamycin	IL-2	PA450137	3558	0.717
NULL	Nat_Commun_2014_Mar_17_5_3479.nxml.txt.nlp	24632940	SENT120	26	26	41	41	streptomycin	CO2	PA451512	4513	0.717
NULL	Biomed_Res_Int_2014_Aug_6_2014_967826.nxml.txt.nlp	25165721	SENT333	15	15	11	11	cisplatin	p53	PA449014	7157	0.717
NULL	Braz_J_Med_Biol_Res_2012_Feb_17_45(3)_244-249.nxml.txt.nlp	22331137	SENT38	14	14	7	7	gentamicin	PAG	PA449753	55824	0.717
NULL	Oncotarget_2014_Nov_3_5(20)_10127-10139.nxml.txt.nlp	25333256	SENT158	27	27	14	14	vemurafenib	TRIM16	PA165946873	10626	0.717
NULL	Oncogene_2010_Nov_18_29(46)_6160-6171.nxml.txt.nlp	20729916	SENT11	13	13	2	2	cisplatin	YAP	PA449014	55249	0.717
NULL	Cell_Death_Dis_2013_Jan_31_4(1)_e480.nxml.txt.nlp	23370280	SENT112	6	6	4	4	cisplatin	WWOX	PA449014	51741	0.717
NULL	Neuropsychopharmacology_2009_Nov_5_34(12)_2560-2573.nxml.txt.nlp	19657330	SENT191	19	19	22	22	naloxone	CB1	PA450586	1268	0.717
NULL	Crit_Care_2005_Aug_25_9(Suppl_4)_S38-S45.nxml.txt.nlp	16168074	SENT150	18	18	10	10	thrombin	PAR-1	PA451674	2011;2149	0.717
NULL	Croat_Med_J_2013_Apr_54(2)_171-179.nxml.txt.nlp	23630144	SENT126	22	22	14	14	taurine	STZ	PA451590	6484	0.717
NULL	Mol_Vis_2012_Oct_5_18_2454-2467.nxml.txt.nlp	23077404	SENT135	2	2	4	4	bevacizumab	VEGF-A	PA130232992	7422	0.717
NULL	Acta_Neuropathol_Commun_2013_May_29_1_19.nxml.txt.nlp	24252778	SENT150	6	6	1	1	tranylcypromine	KDM1A	PA451741	23028	0.717
NULL	Adv_Hematol_2009_Apr_14_2009_704928.nxml.txt.nlp	19960052	SENT30	22	22	17	17	mannitol	BTZ	PA450320	22794	0.717
NULL	Front_Mol_Neurosci_2009_Aug_4_2_10.nxml.txt.nlp	19680469	SENT1070	6	6	0	0	retigabine	KCNQ4	PA144997862	9132	0.717
NULL	Breast_Cancer_Res_2007_Sep_17_9(5)_R61.nxml.txt.nlp	17875215	SENT28	14	14	20	20	tamoxifen	HER2	PA451581	2064	0.717
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT398	4	4	8	8	olanzapine	PRL	PA450688	5617	0.717
NULL	Diabetes_Care_2013_Jul_12_36(7)_2126-2132.nxml.txt.nlp	23645884	SENT67	21	21	14	14	liraglutide	GLP-1	PA165958364	100125288	0.717
NULL	Anal_Chem_Insights_2009_Apr_7_4_1-9.nxml.txt.nlp	19652757	SENT99	11	11	14	14	escitalopram	mol	PA10074	90527	0.717
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2013_Jul_31_6_15-24.nxml.txt.nlp	23966808	SENT28	8	8	1	1	liraglutide	GLP-1	PA165958364	100125288	0.717
NULL	Int_J_Biol_Sci_2013_Mar_7_9(3)_279-288.nxml.txt.nlp	23493630	SENT165	18	18	9	9	tocilizumab	IL-17	PA165292659	3605	0.717
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2011_Sep_13_4_47-62.nxml.txt.nlp	22879794	SENT235	16	16	5	5	liraglutide	PPG	PA165958364	5552	0.717
NULL	J_Oncol_2009_Mar_24_2009_491985.nxml.txt.nlp	19325924	SENT157	9	9	11	11	genistein	CXCR4	PA165109660	7852	0.717
NULL	Cancer_Cell_Int_2013_May_24_13_48.nxml.txt.nlp	23706027	SENT6	7	7	9	9	cisplatin	DDP	PA449014	1678	0.717
NULL	Cancer_Inform_2013_Feb_13_12_31-51.nxml.txt.nlp	23470717	SENT335	26	26	8	8	tamoxifen	FOXM1	PA451581	2305	0.717
NULL	Br_J_Cancer_2010_Sep_28_103(7)_1008-1018.nxml.txt.nlp	20736947	SENT240	38	38	6	6	docetaxel	MDR1	PA449383	5243	0.717
NULL	Cancer_Cell_Int_2014_Jan_14_14_4.nxml.txt.nlp	24423208	SENT60	14	14	4	4	bevacizumab	IL-2	PA130232992	3558	0.717
NULL	Br_J_Ophthalmol_2008_Sep_22_92(9)_1275-1282.nxml.txt.nlp	18723745	SENT8	12	12	14	14	latanoprost	BAK	PA164774763	578	0.717
NULL	Br_J_Pharmacol_2012_Apr_165(8)_2611-2619.nxml.txt.nlp	21718301	SENT203	17	17	24	24	rimonabant	GPR55	PA152407999	9290	0.717
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jun_13_68(Pt_7)_m889.nxml.txt.nlp	22807732	SENT69	28	28	12	12	ethanol	mol	PA448073	90527	0.717
NULL	Breast_Cancer_Res_Treat_2014_Nov_11_148(3)_563-570.nxml.txt.nlp	25385180	SENT24	9	9	11	11	docetaxel	PTH	PA449383	5741	0.717
NULL	Int_J_Mol_Sci_2007_Jun_8_8(6)_492-504.nxml.txt.nlp	NULL	SENT63	4	4	11	11	fluorescein	CD69	PA164746009	969	0.717
NULL	Breast_Cancer_Res_2011_Jan_7_13(1)_R1.nxml.txt.nlp	21214929	SENT93	3	3	9	9	doxorubicin	p53	PA449412	7157	0.717
NULL	Breast_Cancer_Res_2011_Apr_21_13(2)_R46.nxml.txt.nlp	21510863	SENT225	5	5	2	2	trastuzumab	HER2	PA451743	2064	0.717
NULL	Acta_Histochem_Cytochem_2012_Oct_31_45(5)_251-259.nxml.txt.nlp	23209334	SENT337	4	4	11	11	cevimeline	AQP5	PA164754754	362	0.717
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT231	22	22	19	19	perifosine	DR5	PA165291471	8795	0.717
NULL	J_Breast_Cancer_2012_Jun_28_15(2)_203-210.nxml.txt.nlp	22807938	SENT116	40	40	45	45	trastuzumab	NACT	PA451743	284111	0.717
NULL	Braz_J_Microbiol_2012_Jun_1_Oct-Dec_43(4)_1490-1498.nxml.txt.nlp	24031980	SENT142	4	4	1	1	lipase	ANOVA	PA450239	4858	0.717
NULL	Br_J_Cancer_2010_Oct_12_103(8)_1309-1310.nxml.txt.nlp	NULL	SENT16	12	12	14	14	bevacizumab	IFN	PA130232992	3439	0.717
NULL	Exp_Diabetes_Res_2011_Dec_27_2011_604989.nxml.txt.nlp	21253359	SENT121	30	30	43	43	clonidine	GLP-1	PA449051	100125288	0.717
NULL	J_Breast_Cancer_2011_Mar_31_14(1)_20-27.nxml.txt.nlp	21847390	SENT106	10	10	12	12	estradiol	CLDN6	PA449503	9074	0.717
NULL	Oncotarget_2013_Aug_21_4(9)_1484-1495.nxml.txt.nlp	23986086	SENT166	31	31	41	41	cetuximab	PIK3CA	PA10040	5290	0.717
NULL	Arthritis_Res_Ther_2005_Feb_17_7(Suppl_1)_P3.nxml.txt.nlp	NULL	SENT18	9	9	15	15	oxygen	HIF-1	PA450744	29072	0.717
NULL	Trials_2014_Sep_7_15(1)_352.nxml.txt.nlp	NULL	SENT214	12	12	23	23	atorvastatin	PMI	PA448500	8834;5373	0.717
NULL	Cancer_Metab_2013_Feb_4_1_7.nxml.txt.nlp	24280108	SENT98	7	7	16	16	oxygen	F1Fo-ATPase	PA450744	9551	0.717
NULL	Front_Neurosci_2015_Jan_6_8_437.nxml.txt.nlp	25610366	SENT154	3	3	5	5	pramipexole	PPX	PA164742949	5531	0.717
NULL	Carcinogenesis_2014_May_13_35(5)_1055-1066.nxml.txt.nlp	24419232	SENT42	3	3	15	15	metformin	MVD	PA450395	4597	0.717
NULL	Br_J_Cancer_2010_Jan_19_102(2)_342-350.nxml.txt.nlp	20010939	SENT21	5	5	22	22	tamoxifen	CDK2	PA451581	1017	0.717
NULL	Amino_Acids_2012_Oct_10_43(4)_1751-1759.nxml.txt.nlp	22407485	SENT29	20	20	5	5	carrageenan	ghrelin	PA448814	51738	0.717
NULL	Cholesterol_2010_Oct_31_2010_271504.nxml.txt.nlp	21490912	SENT111	23	23	9	9	pravastatin	adiponectin	PA451089	9370	0.717
NULL	Front_Oncol_2014_Apr_10_4_76.nxml.txt.nlp	24782987	SENT43	7	7	16	16	olaparib	ADP		23038	0.717
NULL	Infect_Dis_Ther_2014_Dec_5_3(2)_69-81.nxml.txt.nlp	25475412	SENT80	6	6	8	8	vancomycin	VAN	PA451850	10318	0.717
NULL	Curr_Neuropharmacol_2008_Sep_6(3)_193-202.nxml.txt.nlp	19506720	SENT298	21	21	27	27	olanzapine	ghrelin	PA450688	51738	0.717
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Dec_9_6_191-203.nxml.txt.nlp	25525387	SENT196	30	30	0	0	tamoxifen	EGF	PA451581	1950	0.717
NULL	J_Am_Heart_Assoc_2013_Aug_23_2(4)_e000264.nxml.txt.nlp	23896681	SENT162	15	15	3	3	thrombin	FVIII	PA451674	2157	0.717
NULL	J_Biomed_Sci_2014_Feb_3_21(1)_10.nxml.txt.nlp	24490900	SENT135	28	28	21	21	alendronate	RANKL	PA448082	8600	0.717
NULL	J_Obes_2010_Oct_31_2010_892081.nxml.txt.nlp	21052532	SENT123	13	13	17	17	glucose	adiponectin	PA449773	9370	0.717
NULL	Breast_Cancer_Res_2011_Jun_29_13(3)_R70.nxml.txt.nlp	21707964	SENT175	19	19	0	0	raloxifene	14-3-3	PA451221	10971	0.717
NULL	J_Clin_Biochem_Nutr_2009_Jan_27_44(1)_28-40.nxml.txt.nlp	19177185	SENT109	11	11	8	8	dobutamine	HO-1	PA449381	3162	0.717
NULL	Mol_Cancer_2010_Nov_2_9_289.nxml.txt.nlp	21044322	SENT166	32	32	8	8	vincristine	RGS17	PA451879	26575	0.717
NULL	Cancer_Cell_Int_2011_Jun_1_11_15.nxml.txt.nlp	21631944	SENT149	19	19	8	8	etoposide	MICA	PA449552	100507436	0.717
NULL	Cancer_Cell_2007_Dec_11_12(6)_514-527.nxml.txt.nlp	18068629	SENT148	3	3	9	9	paclitaxel	CA125	PA450761	4077;94025	0.717
NULL	Ann_Clin_Transl_Neurol_2014_Dec_21_1(12)_996-1005.nxml.txt.nlp	25574474	SENT24	27	27	16	16	riluzole	P-gp	PA451251	5243	0.717
NULL	Oncotarget_2013_Dec_18_5(2)_375-385.nxml.txt.nlp	24495868	SENT122	2	2	4	4	fludarabine	MCL1	PA449655	4170	0.717
NULL	Indian_J_Pharmacol_2013_Sep-Oct_45(5)_447-452.nxml.txt.nlp	24130377	SENT103	4	4	8	8	nevirapine	AKT	PA450616	207	0.717
NULL	Oncol_Lett_2014_Jul_25_8(1)_313-316.nxml.txt.nlp	24959268	SENT8	4	4	11	11	sulindac	JNK	PA451565	5599	0.717
NULL	Eur_J_Med_Res_2011_Jul_25_16(7)_303-314.nxml.txt.nlp	21813371	SENT87	12	12	6	6	boceprevir	SOC	PA165948902	91544	0.717
NULL	J_Biol_Inorg_Chem_2009_Aug_6_14(6)_979-991.nxml.txt.nlp	19504132	SENT51	21	21	35	35	l-glutamine	CO2	PA10090	4513	0.717
NULL	Cell_Commun_Signal_2003_Nov_24_1_5.nxml.txt.nlp	14636425	SENT198	24	24	10	10	heparin	CCN5	PA449855	8839	0.717
NULL	Mol_Cancer_2006_Sep_5_5_34.nxml.txt.nlp	16953886	SENT62	15	15	6	6	doxorubicin	XIAP	PA449412	331	0.717
NULL	Cancer_Imaging_2005_Nov_23_5(Spec_No_A)_S27-S32.nxml.txt.nlp	16361133	SENT164	17	17	20	20	paclitaxel	gamma	PA450761	9913	0.717
NULL	Indian_J_Pharmacol_2013_Mar-Apr_45(2)_121-125.nxml.txt.nlp	23716885	SENT9	3	3	21	21	aripiprazole	CYP3A4	PA10026	1576	0.717
NULL	Oncotarget_2011_May_16_2(5)_418-421.nxml.txt.nlp	21789791	SENT45	9	9	0	0	bortezomib	TRAIL	PA10252	8743	0.717
NULL	Front_Genet_2012_Sep_3_3_169.nxml.txt.nlp	22969794	SENT335	23	23	2	2	protamine	PARP1	PA10366	142	0.717
NULL	Clin_Drug_Investig_2013_Jun_20_33(6)_419-427.nxml.txt.nlp	23605507	SENT6	27	27	30	30	ciprofloxacin	DPI	PA449009	1832	0.717
NULL	Mol_Biol_Rep_2013_May_11_40(8)_5013-5026.nxml.txt.nlp	23666059	SENT295	27	27	22	22	paclitaxel	p53	PA450761	7157	0.717
NULL	Acta_Neuropathol_Commun_2014_Jul_16_2(1)_81.nxml.txt.nlp	NULL	SENT182	8	8	14	14	haloperidol	CA4	PA449841	762	0.717
NULL	Br_J_Cancer_2014_Nov_25_111(11)_2091-2102.nxml.txt.nlp	25349971	SENT245	34	34	18	18	imatinib	PTPN18	PA10804	26469	0.717
NULL	J_Cancer_Prev_2013_Jun_18(2)_186-191.nxml.txt.nlp	25337545	SENT93	3	3	32	32	curcumin	IFN	PA151958596	3439	0.717
NULL	Indian_J_Pharm_Sci_2014_Jan-Feb_76(1)_72-77.nxml.txt.nlp	24799741	SENT33	23	23	17	17	phenytoin	CYP2C9	PA450947	1559	0.717
NULL	Br_J_Pharmacol_2011_May_163(1)_141-172.nxml.txt.nlp	21265830	SENT338	8	8	4	4	azathioprine	NAC	PA448515	22861	0.717
NULL	Front_Neurosci_2010_Jun_17_4_35.nxml.txt.nlp	20661455	SENT11	5	5	1	1	buspirone	5-HT1A	PA448689	3350	0.717
NULL	Oncotarget_2014_Jun_1_5(13)_4868-4880.nxml.txt.nlp	24947902	SENT336	10	10	24	24	leucovorin	ERBB2	PA450198	2064	0.717
NULL	Curr_Gerontol_Geriatr_Res_2012_Mar_4_2012_361218.nxml.txt.nlp	22474448	SENT20	30	30	20	20	estradiol	HSD1	PA449503	26871	0.717
NULL	Antiviral_Res_2009_May_82(2)_A99-A109.nxml.txt.nlp	19176219	SENT78	11	11	1	1	efavirenz	P-gp	PA449441	5243	0.717
NULL	Cell_Death_Dis_2010_Nov_18_1(11)_e101.nxml.txt.nlp	21368866	SENT23	16	16	20	20	cisplatin	PC3	PA449014	57332;7832;5122	0.717
NULL	Basic_Clin_Neurosci_2014_Summer_5(3)_191-198.nxml.txt.nlp	25337379	SENT191	5	5	19	19	nimodipine	Ray	PA450633	26751	0.717
NULL	J_Exp_Bot_2012_Jun_28_63(11)_4133-4142.nxml.txt.nlp	22451724	SENT119	14	14	3	3	potassium	APX	PA451047	328	0.717
NULL	Nat_Neurosci_2012_Sep_5_15(9)_1245-1254.nxml.txt.nlp	22864611	SENT173	33	33	29	29	clozapine	mGlu2	PA449061	2912	0.717
NULL	Diabetes_Care_2010_Jan_6_33(1)_49-54.nxml.txt.nlp	19808929	SENT143	19	19	11	11	rosiglitazone	DREAM	PA451283	30818	0.717
NULL	Breast_Cancer_Res_2008_Aug_5_10(4)_R68.nxml.txt.nlp	18681966	SENT133	28	28	2	2	doxorubicin	PRL	PA449412	5617	0.717
NULL	AIDS_Res_Treat_2012_May_14_2012_246280.nxml.txt.nlp	22675613	SENT17	6	6	8	8	atazanavir	ATV	PA10251	4683	0.717
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT139	0	0	4	4	perifosine	DR5	PA165291471	8795	0.717
NULL	Sci_Rep_2014_Dec_3_4_7294.nxml.txt.nlp	25465236	SENT533	7	7	14	14	gefitinib	EGFR	PA131301952	1956	0.717
NULL	Chemother_Res_Pract_2011_Sep_21_2011_839742.nxml.txt.nlp	22295206	SENT93	14	14	18	18	gefitinib	CRT	PA131301952	811	0.717
NULL	Clin_Ophthalmol_2008_Mar_2(1)_1-14.nxml.txt.nlp	19668384	SENT36	19	19	21	21	ranibizumab	VEGF-A	PA164746012	7422	0.717
NULL	FASEB_J_2010_May_24(5)_1541-1551.nxml.txt.nlp	20026682	SENT200	20	20	37	37	cisplatin	JNK	PA449014	5599	0.717
NULL	Clin_Psychopharmacol_Neurosci_2011_Apr_30_9(1)_36-43.nxml.txt.nlp	23431025	SENT49	11	11	29	29	haloperidol	FLI	PA449841	2314	0.717
NULL	Clin_J_Gastroenterol_2014_Jun_6_7(4)_355-360.nxml.txt.nlp	25132867	SENT1	19	19	33	33	ribavirin	IFN	PA451241	3439	0.717
NULL	Chin_J_Cancer_2012_Feb_31(2)_58-72.nxml.txt.nlp	22098952	SENT66	18	18	9	9	arsenite	MRP1	PA452638	4437	0.717
NULL	Mol_Cancer_2014_Feb_20_13_32.nxml.txt.nlp	24555657	SENT197	28	28	15	15	cisplatin	SET	PA449014	6418	0.717
NULL	Breast_Cancer_Res_2010_Mar_5_12(2)_R16.nxml.txt.nlp	20205716	SENT302	3	3	27	27	lovastatin	CDC42	PA450272	998	0.717
NULL	Cancer_Med_2014_Aug_18_3(4)_1025-1034.nxml.txt.nlp	24944108	SENT173	3	3	5	5	metformin	HER2	PA450395	2064	0.717
NULL	Breast_Cancer_Res_2010_Oct_22_12(Suppl_2)_S3.nxml.txt.nlp	21050424	SENT80	7	7	26	26	cyclophosphamide	HER2	PA449165	2064	0.717
NULL	Breast_Cancer_Res_2014_May_27_16(3)_R52.nxml.txt.nlp	24887554	SENT89	7	7	5	5	phenol	B27	PA450913	56246	0.717
NULL	J_Signal_Transduct_2010_Sep_1_2010_643642.nxml.txt.nlp	21637354	SENT112	38	38	32	32	pp2	ghrelin		51738	0.717
NULL	J_Breast_Cancer_2013_Mar_31_16(1)_23-31.nxml.txt.nlp	23593078	SENT115	4	4	19	19	genistein	DNMT1	PA165109660	1786	0.717
NULL	J_Biol_Chem_2009_Mar_6_284(10)_6260-6269.nxml.txt.nlp	19131328	SENT163	0	0	23	23	staurosporine	TBCA	PA165109623	6902	0.717
NULL	Core_Evid_2009_Jun_15_4_1-11.nxml.txt.nlp	20694060	SENT108	9	9	6	6	amlodipine	CYP3A	PA448388	1574	0.717
NULL	Mol_Cancer_2007_Aug_21_6_53.nxml.txt.nlp	17711579	SENT411	20	20	27	27	etoposide	Bcl-2	PA449552	596	0.717
NULL	J_Exp_Med_2000_Nov_20_192(10)_1403-1414.nxml.txt.nlp	11085743	SENT520	17	17	5	5	staurosporine	Bcl-2	PA165109623	596	0.717
NULL	Front_Oncol_2014_Jun_3_4_132.nxml.txt.nlp	24918087	SENT376	25	25	21	21	cisplatin	TP53	PA449014	7157	0.717
NULL	Exp_Hematol_Oncol_2013_Nov_8_2_30.nxml.txt.nlp	24499550	SENT101	7	7	11	11	cisplatin	IL-2	PA449014	3558	0.717
NULL	Psychiatry_Investig_2012_Jun_30_9(2)_187-190.nxml.txt.nlp	22707971	SENT11	0	0	7	7	capsaicin	POMC	PA448776	5443	0.717
NULL	Neuroscience_2009_Jun_30_161(2-3)_572-577.nxml.txt.nlp	19327387	SENT491	28	28	9	9	capsaicin	GAPDH	PA448776	2597	0.717
NULL	Mol_Cancer_2010_Jun_27_9_168.nxml.txt.nlp	20579391	SENT121	4	4	11	11	dasatinib	MMP1	PA162372878	4312	0.717
NULL	Curr_Biol_2009_Feb_24_19(4)_297-304.nxml.txt.nlp	19217292	SENT72	29	29	24	24	vasopressin	BMAL1	PA451858	406	0.717
NULL	Breast_Cancer_Res_2011_Mar_11_13(2)_R29.nxml.txt.nlp	21396094	SENT144	23	23	32	32	fulvestrant	HRG	PA164747170	3084;3273	0.717
NULL	Cancers_(Basel)_2012_Sep_6_4(3)_873-903.nxml.txt.nlp	24213471	SENT1105	2	2	13	13	hyaluronan	ERK1	PA165958431	5595	0.717
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R91.nxml.txt.nlp	22541814	SENT210	7	7	9	9	pp2	PAR1		79581;2149	0.717
NULL	Oncotarget_2014_Jun_19_5(15)_6540-6551.nxml.txt.nlp	25153728	SENT170	15	15	27	27	paclitaxel	CD31	PA450761	5175	0.717
NULL	Breast_Cancer_Res_2009_Jul_15_11(4)_207.nxml.txt.nlp	19664181	SENT226	33	33	37	37	trastuzumab	PTEN	PA451743	5728	0.717
NULL	Autophagy_2012_May_1_8(5)_853-855.nxml.txt.nlp	22617440	SENT34	2	2	9	9	imatinib	BECN1	PA10804	8678	0.717
NULL	Diabetes_2009_Dec_31_58(12)_2851-2862.nxml.txt.nlp	19720788	SENT12	2	2	15	15	forskolin	BiP	PA146096022	3309	0.717
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_May_29_65(Pt_6)_o1404-o1405.nxml.txt.nlp	21583249	SENT75	7	7	17	17	benzaldehyde	mol	PA448571	90527	0.717
NULL	Int_J_Hypertens_2012_Feb_8_2012_414128.nxml.txt.nlp	22518283	SENT40	10	10	6	6	estradiol	ACE2	PA449503	59272	0.717
NULL	Clin_Exp_Gastroenterol_2011_Jul_15_4_163-172.nxml.txt.nlp	21904462	SENT26	0	0	14	14	adalimumab	p75	PA10004	7133;11168	0.717
NULL	J_Adv_Pract_Oncol_2012_Jul_1_Jul-Aug_3(4)_249-257.nxml.txt.nlp	25031953	SENT341	22	22	8	8	anastrozole	aromatase	PA448432	1588	0.717
NULL	Nat_Commun_2013_4_10_1038_ncomms3834.nxml.txt.nlp	24280772	SENT312	22	22	15	15	troglitazone	IL-4	PA451799	3565	0.717
NULL	Alcohol_Res_2012_34(4)_459-467.nxml.txt.nlp	23584112	SENT100	19	19	29	29	vasopressin	ACTH	PA451858	5443	0.717
NULL	Acta_Neuropathol_2010_Feb_21_119(2)_157-175.nxml.txt.nlp	19936768	SENT474	7	7	3	3	geldanamycin	p53	PA152031327	7157	0.717
NULL	Curr_Neuropharmacol_2014_Jul_12(4)_365-379.nxml.txt.nlp	25342944	SENT462	13	13	10	10	fluoxetine	AKT	PA449673	207	0.716
NULL	Neuroimage_Clin_2013_Sep_6_3_290-300.nxml.txt.nlp	24273714	SENT160	8	8	11	11	pioglitazone	spatial	PA450970	219793	0.716
NULL	Oxid_Med_Cell_Longev_2012_Jun_3_2012_914273.nxml.txt.nlp	22701758	SENT208	6	6	4	4	resveratrol	SIRT1		23411	0.716
NULL	Oxid_Med_Cell_Longev_2012_May_15_2012_890826.nxml.txt.nlp	22666522	SENT201	16	16	22	22	nadh	NOS	PA164755085	4843	0.716
NULL	Int_J_Gen_Med_2013_Dec_4_6_877-895.nxml.txt.nlp	24403842	SENT77	15	15	35	35	metformin	PPG	PA450395	5552	0.716
NULL	Indian_J_Dermatol_2008_53(4)_163-166.nxml.txt.nlp	19882025	SENT29	10	10	4	4	choline	B12	PA448976	7126;4709	0.716
NULL	Neural_Plast_2012_Nov_2_2012_309494.nxml.txt.nlp	22164341	SENT21	23	23	35	35	tamoxifen	CA1	PA451581	759	0.716
NULL	Diabetes_Care_2009_Jan_32(Suppl_1)_S13-S61.nxml.txt.nlp	19118286	SENT2163	14	14	23	23	rosiglitazone	STOP	PA451283	4135	0.716
NULL	Trials_2014_Oct_7_15(1)_391.nxml.txt.nlp	NULL	SENT194	22	22	36	36	varenicline	ANOVA	PA164781343	4858	0.716
NULL	Clin_Pharmacokinet_2014_Jul_24_53(1)_73-87.nxml.txt.nlp	23881596	SENT150	20	20	24	24	rosuvastatin	OATP1B3	PA134308647	28234	0.716
NULL	Oncotarget_2012_Sep_20_3(9)_954-987.nxml.txt.nlp	23006971	SENT184	11	11	2	2	geldanamycin	KRAS	PA152031327	3845	0.716
NULL	Front_Genet_2012_Nov_12_3_235.nxml.txt.nlp	23162568	SENT179	13	13	18	18	methamphetamine	CYP2D6	PA450403	1565	0.716
NULL	Cancers_(Basel)_2014_Aug_12_6(3)_1631-1669.nxml.txt.nlp	25119536	SENT438	28	28	18	18	cisplatin	NK4	PA449014	9235	0.716
NULL	Saudi_J_Anaesth_2013_Apr-Jun_7(2)_151-154.nxml.txt.nlp	23956714	SENT56	25	25	23	23	theophylline	NAC	PA451647	22861	0.716
NULL	Biosci_Rep_2012_Dec_20_33(1)_e00011.nxml.txt.nlp	23137297	SENT257	13	13	6	6	heparin	RPSA	PA449855	3921	0.716
NULL	Acta_Pharmacol_Sin_2011_May_18_32(5)_591-600.nxml.txt.nlp	21499286	SENT33	0	0	21	21	fenofibrate	AMPK	PA449594	5563	0.716
NULL	Ann_Hematol_2014_Oct_19_93(4)_635-644.nxml.txt.nlp	24141333	SENT163	23	23	8	8	thalidomide	MVD	PA451644	4597	0.716
NULL	Exp_Transl_Stroke_Med_2011_Oct_3_3_11.nxml.txt.nlp	21967730	SENT86	12	12	9	9	collagenase	IL-6	PA449107	3569	0.716
NULL	JRSM_Cardiovasc_Dis_2012_Sep_24_1(6)_cvd_2012_012015.nxml.txt.nlp	24175073	SENT12	17	17	35	35	clopidogrel	P2Y12	PA449053	64805	0.716
NULL	Biomed_Res_Int_2013_Jul_18_2013_603782.nxml.txt.nlp	23971041	SENT138	10	10	13	13	travoprost	BAK	PA164781371	578	0.716
NULL	Nucleic_Acids_Res_2013_Nov_22_41(21)_9825-9838.nxml.txt.nlp	23969415	SENT70	10	10	22	22	l-isoleucine	Met	PA164750430	79811	0.716
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jul_22_65(Pt_8)_o1937.nxml.txt.nlp	21583619	SENT61	8	8	6	6	abacavir	C11	PA448004	1109	0.716
NULL	Br_J_Cancer_2012_May_22_106(11)_1779-1789.nxml.txt.nlp	22549178	SENT8	2	2	12	12	pertuzumab	HER2		2064	0.716
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S31-S40.nxml.txt.nlp	20680106	SENT10	20	20	17	17	cetuximab	EGFR	PA10040	1956	0.716
NULL	Indian_J_Psychiatry_2010_Jan_52(Suppl1)_S317-S340.nxml.txt.nlp	21836703	SENT120	28	28	19	19	thiothixene	CPZ	PA451669	8532	0.716
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT53	12	12	0	0	nevirapine	ABCC10	PA450616	89845	0.716
NULL	Cancer_2011_Apr_15_117(8)_1670-1678.nxml.txt.nlp	21472714	SENT125	43	43	30	30	cisplatin	SIRT3	PA449014	23410	0.716
NULL	Daru_2013_Apr_10_21(1)_29.nxml.txt.nlp	23575006	SENT18	13	13	7	7	clindamycin	USP35	PA449035	57558	0.716
NULL	Acta_Pharmacol_Sin_2012_May_4_33(5)_710-716.nxml.txt.nlp	22555373	SENT126	3	3	5	5	ketoprofen	DOM	PA450149	6663	0.716
NULL	Iran_Red_Crescent_Med_J_2013_Mar_5_15(3)_207-211.nxml.txt.nlp	23983999	SENT53	33	33	16	16	nystatin	MTM	PA450666	326343	0.716
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Nov_22_64(Pt_12)_o2422.nxml.txt.nlp	21581390	SENT62	0	0	6	6	phenol	mol	PA450913	90527	0.716
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT82	0	0	13	13	curcumin	PC-3	PA151958596	692094	0.716
NULL	Hum_Mol_Genet_2013_Nov_15_22(22)_4602-4615.nxml.txt.nlp	23814040	SENT206	42	42	10	10	l-cysteine	TRMU	PA449173	55687	0.716
NULL	Clinics_(Sao_Paulo)_2012_Aug_67(8)_911-916.nxml.txt.nlp	22948459	SENT36	4	4	11	11	estradiol	aromatase	PA449503	1588	0.716
NULL	Cell_Cycle_2012_Nov_1_11(21)_3983-3996.nxml.txt.nlp	22987153	SENT182	13	13	5	5	cisplatin	FANCD2	PA449014	2177	0.716
NULL	Acta_Pharmacol_Sin_2012_Jun_14_33(6)_823-831.nxml.txt.nlp	22580738	SENT26	24	24	2	2	vincristine	P-gp	PA451879	5243	0.716
NULL	FEBS_Open_Bio_2014_Oct_14_4_886-891.nxml.txt.nlp	25379386	SENT80	21	21	33	33	l-glutamine	CO2	PA10090	4513	0.716
NULL	Br_J_Cancer_2011_Jan_4_104(1)_91-100.nxml.txt.nlp	21139584	SENT33	7	7	14	14	doxorubicin	p53	PA449412	7157	0.716
NULL	Int_J_Mol_Sci_2014_Mar_20_15(3)_4977-4993.nxml.txt.nlp	24658441	SENT526	13	13	7	7	resveratrol	NKG2D		22914	0.716
NULL	Braz_J_Microbiol_2013_Apr_9_44(1)_245-252.nxml.txt.nlp	24159311	SENT95	11	11	5	5	lipase	castor	PA450239	54897	0.716
NULL	Braz_J_Med_Biol_Res_2014_Nov_4_48(1)_13-24.nxml.txt.nlp	25493378	SENT97	8	8	10	10	nutlin-3	MDM2		4193	0.716
NULL	J_Adv_Pharm_Technol_Res_2014_Apr-Jun_5(2)_96-103.nxml.txt.nlp	24959419	SENT44	23	23	1	1	nitrogen	DSC	PA450643	1825	0.716
NULL	Biol_Open_2014_May_2_3(6)_444-452.nxml.txt.nlp	24795146	SENT410	10	10	5	5	protamine	CAF1	PA10366	9337;10036;8208	0.716
NULL	Cancer_Imaging_2005_Nov_23_5(Spec_No_A)_S27-S32.nxml.txt.nlp	16361133	SENT164	15	15	20	20	trastuzumab	gamma	PA451743	9913	0.716
NULL	Exp_Ther_Med_2013_Apr_11_5(4)_1147-1152.nxml.txt.nlp	23599738	SENT123	34	34	16	16	fentanyl	OPRM1	PA449599	4988	0.716
NULL	J_Gen_Physiol_2008_Nov_132(5)_521-535.nxml.txt.nlp	18852303	SENT86	15	15	24	24	trypsin	CAP2	PA451806	5271;10486	0.716
NULL	Mediators_Inflamm_2010_Mar_22_2010_823486.nxml.txt.nlp	20339530	SENT137	24	24	11	11	hyaluronan	TLR4	PA165958431	7099	0.716
NULL	Mol_Biol_Rep_2014_Jan_18_41(4)_2419-2425.nxml.txt.nlp	24443228	SENT266	5	5	17	17	liothyronine	Gen	PA164778866	348654	0.716
NULL	Environ_Health_Perspect_1994_Mar_102(3)_290-297.nxml.txt.nlp	8033869	SENT9	36	36	26	26	estradiol	PCB	PA449503	5091	0.716
NULL	Mucosal_Immunol_2014_Mar_24_7(2)_335-347.nxml.txt.nlp	23881354	SENT329	7	7	9	9	galantamine	GAL	PA449726	51083	0.716
NULL	EMBO_Mol_Med_2009_Jul_1(4)_211-222.nxml.txt.nlp	20049723	SENT296	22	22	8	8	fluorescein	CD11c	PA164746009	3687	0.716
NULL	Pharm_Pract_(Granada)_2011_Mar_15_Jan-Mar_9(1)_1-10.nxml.txt.nlp	25132883	SENT146	13	13	19	19	rivaroxaban	SPAF	PA165958360	166378	0.716
NULL	Oncotarget_2014_Oct_18_5(21)_10206-10221.nxml.txt.nlp	25344914	SENT40	1	1	21	21	vemurafenib	CRAF	PA165946873	5894	0.716
NULL	Oncotarget_2012_Oct_20_3(10)_1236-1245.nxml.txt.nlp	23100449	SENT105	3	3	13	13	doxorubicin	NGAL	PA449412	3934	0.716
NULL	Biosci_Rep_2014_Dec_12_34(6)_e00162.nxml.txt.nlp	25385088	SENT172	33	33	30	30	chymotrypsin	XPA	PA448994	7507	0.716
NULL	J_Antimicrob_Chemother_2015_Jan_24_70(1)_116-123.nxml.txt.nlp	25253286	SENT27	27	27	6	6	chloroquine	ACT	PA448948	12;11332;9457;641455	0.716
NULL	Gut_Liver_2013_Sep_14_7(5)_585-593.nxml.txt.nlp	24073317	SENT134	31	31	25	25	ribavirin	IFN	PA451241	3439	0.716
NULL	Biomed_Res_Int_2014_Feb_19_2014_240642.nxml.txt.nlp	24701565	SENT122	5	5	14	14	sunitinib	AMPK	PA162372840	5563	0.716
NULL	Br_J_Cancer_2009_Mar_24_100(6)_941-949.nxml.txt.nlp	19240716	SENT74	5	5	22	22	lapatinib	EGFR	PA152241907	1956	0.716
NULL	J_Gen_Physiol_1990_Dec_1_96(6)_1247-1269.nxml.txt.nlp	1962815	SENT10	14	14	8	8	amiloride	CO2	PA448368	4513	0.716
NULL	Oncol_Lett_2013_Feb_7_5(2)_440-446.nxml.txt.nlp	23420122	SENT109	10	10	27	27	sorafenib	Bcl-2	PA7000	596	0.716
NULL	Drug_Target_Insights_2013_Aug_19_7_27-34.nxml.txt.nlp	24023511	SENT64	15	15	21	21	elacridar	P-gp		5243	0.716
NULL	J_Biomed_Sci_2014_Feb_3_21(1)_10.nxml.txt.nlp	24490900	SENT203	10	10	20	20	alendronate	RANKL	PA448082	8600	0.716
NULL	Endocrinology_2014_Nov_21_155(11)_4380-4390.nxml.txt.nlp	25144923	SENT4	25	25	4	4	vasopressin	SON	PA451858	6651	0.716
NULL	Iran_J_Pharm_Res_2014_Spring_13(2)_635-639.nxml.txt.nlp	25237359	SENT18	5	5	12	12	chlorzoxazone	CYP3A	PA448971	1574	0.716
NULL	Indian_J_Psychiatry_2011_Apr-Jun_53(2)_111-120.nxml.txt.nlp	21772642	SENT209	32	32	16	16	diazepam	CYP2C19	PA449283	1557	0.716
NULL	Arthritis_Res_Ther_2012_Jan_17_14(1)_R11.nxml.txt.nlp	22251436	SENT5	9	9	18	18	maraviroc	CCR5	PA164768835	1234	0.716
NULL	Autoimmune_Dis_2012_Dec_5_2012_815753.nxml.txt.nlp	23251792	SENT15	14	14	21	21	hyaluronan	CD44	PA165958431	960	0.716
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT40	7	7	9	9	glucose	PP2	PA449773	4888	0.716
NULL	Ann_Rheum_Dis_2008_Nov_14_67(11)_1516-1523.nxml.txt.nlp	18625622	SENT146	11	11	19	19	methotrexate	TNF	PA450428	7124	0.716
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT244	17	17	19	19	metformin	HIF-1	PA450395	29072	0.716
NULL	Br_J_Cancer_2009_May_19_100(10)_1638-1646.nxml.txt.nlp	19401689	SENT33	18	18	11	11	l-glutamine	FBS	PA10090	64319;26269	0.716
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT230	7	7	0	0	cisplatin	MVP	PA449014	9961	0.716
NULL	Mol_Cells_2014_Mar_31_37(3)_241-247.nxml.txt.nlp	24642708	SENT286	16	16	26	26	metformin	AMPK	PA450395	5563	0.716
NULL	J_Cell_Biol_1998_Mar_23_140(6)_1485-1495.nxml.txt.nlp	9508780	SENT18	14	14	22	22	staurosporine	p53	PA165109623	7157	0.716
NULL	Oncotarget_2014_Jun_6_5(13)_4935-4944.nxml.txt.nlp	24952732	SENT74	37	37	40	40	doxazosin	PI3K	PA449407	5290	0.716
NULL	Int_J_Cell_Biol_2013_May_16_2013_639401.nxml.txt.nlp	23762063	SENT279	6	6	27	27	resveratrol	Bcl-2		596	0.716
NULL	Appl_Microbiol_Biotechnol_2012_Feb_11_93(4)_1377-1387.nxml.txt.nlp	22234536	SENT158	3	3	31	31	nadh	mol	PA164755085	90527	0.716
NULL	Breast_Cancer_Res_2012_Feb_21_14(1)_R35.nxml.txt.nlp	22353783	SENT372	20	20	25	25	metformin	adiponectin	PA450395	9370	0.716
NULL	Acta_Pharmacol_Sin_2009_Jul_22_30(7)_956-964.nxml.txt.nlp	19543298	SENT171	10	10	6	6	rifampin	ABCB1	PA451250	5243	0.716
NULL	Cancers_(Basel)_2014_Mar_26_6(2)_708-722.nxml.txt.nlp	24675568	SENT554	4	4	2	2	niclosamide	STAT3	PA165958408	6774	0.716
NULL	Int_J_Med_Sci_2012_Jan_11_9(2)_148-156.nxml.txt.nlp	22253562	SENT145	20	20	30	30	pyrazinamide	DST	PA451182	667	0.716
NULL	Int_J_Med_Sci_2015_Jan_5_12(2)_135-140.nxml.txt.nlp	25589889	SENT35	3	3	1	1	haloperidol	FGA	PA449841	2243	0.716
NULL	Oncol_Lett_2013_Feb_7_5(2)_440-446.nxml.txt.nlp	23420122	SENT121	14	14	25	25	sorafenib	Bcl-2	PA7000	596	0.716
NULL	NDT_Plus_2011_Jun_2_4(3)_158-163.nxml.txt.nlp	21629670	SENT12	4	4	0	0	vasopressin	AVP	PA451858	114548;551	0.716
NULL	J_Adv_Pract_Oncol_2014_May_1_May-Jun_5(3)_205-210.nxml.txt.nlp	25089219	SENT94	11	11	14	14	capecitabine	DPD	PA448771	1806	0.716
NULL	Breast_Cancer_Res_2000_Mar_12_2(Suppl_1)_P7_04.nxml.txt.nlp	NULL	SENT12	16	16	5	5	etoposide	BRCA1	PA449552	672	0.716
NULL	Indian_J_Med_Res_2014_Jan_139(1)_27-65.nxml.txt.nlp	24604039	SENT227	27	27	7	7	azathioprine	TPMT	PA448515	7172	0.716
NULL	Epilepsy_Res_Treat_2010_Jun_22_2010_654265.nxml.txt.nlp	22937226	SENT181	32	32	19	19	etomidate	KCC2	PA164743987	57468	0.716
NULL	Nat_Chem_Biol_2010_Apr_28_6(4)_291-299.nxml.txt.nlp	20190765	SENT141	12	12	16	16	dasatinib	EGFR	PA162372878	1956	0.716
NULL	Int_J_Endocrinol_2014_Aug_11_2014_312452.nxml.txt.nlp	25183970	SENT223	16	16	8	8	liraglutide	PI3K	PA165958364	5290	0.716
NULL	Arthritis_Rheum_2013_Sep_26_65(9)_2290-2300.nxml.txt.nlp	23740547	SENT57	17	17	26	26	doxycycline	DIP	PA449415	23151;1831	0.716
NULL	Br_J_Cancer_2013_May_28_108(10)_2013-2020.nxml.txt.nlp	23632482	SENT46	0	0	7	7	trastuzumab	San	PA451743	80218	0.716
NULL	Neuropsychopharmacology_2009_Nov_5_34(12)_2560-2573.nxml.txt.nlp	19657330	SENT9	14	14	17	17	naloxone	CB1	PA450586	1268	0.716
NULL	Adv_Urol_2012_Oct_26_2012_812398.nxml.txt.nlp	22110495	SENT111	40	40	38	38	cisplatin	ERCC1	PA449014	2067	0.716
NULL	Br_J_Cancer_2012_Jul_24_107(3)_516-526.nxml.txt.nlp	22782351	SENT105	7	7	13	13	tamoxifen	TIGAR	PA451581	57103	0.716
NULL	Lab_Invest_2009_Nov_7_89(11)_1275-1290.nxml.txt.nlp	19736547	SENT166	21	21	27	27	curcumin	LOX-1	PA151958596	4973	0.716
NULL	Diabetes_2008_Oct_57(10)_2784-2793.nxml.txt.nlp	18599521	SENT129	13	13	3	3	simvastatin	Rho	PA451363	29984	0.716
NULL	Leukemia_2013_May_1_27(5)_1072-1079.nxml.txt.nlp	23257782	SENT180	28	28	23	23	lenalidomide	p53	PA162363968	7157	0.716
NULL	Int_J_Environ_Res_Public_Health_2006_Mar_31_3(1)_31-37.nxml.txt.nlp	16823074	SENT214	12	12	22	22	fluorescein	NIR	PA164746009	26155	0.716
NULL	Case_Rep_Ophthalmol_2011_Mar_12_2(1)_105-110.nxml.txt.nlp	22110438	SENT58	24	24	22	22	ribavirin	IFN	PA451241	3439	0.716
NULL	J_Antimicrob_Chemother_2009_Feb_28_63(2)_389-395.nxml.txt.nlp	19042940	SENT140	14	14	17	17	trimethoprim	UTI	PA451788	259	0.716
NULL	Protein_Cell_2014_Apr_14_5(4)_265-296.nxml.txt.nlp	24622842	SENT200	14	14	16	16	decitabine	DAC	PA164749631	13	0.716
NULL	J_Invest_Dermatol_2012_Sep_19_132(9)_2198-2205.nxml.txt.nlp	22513780	SENT193	27	27	21	21	isotretinoin	TLR-4	PA450128	7099	0.716
NULL	Vet_Res_Forum_2013_Winter_4(1)_19-24.nxml.txt.nlp	25593681	SENT84	39	39	37	37	diclofenac	B12	PA449293	7126;4709	0.716
NULL	Mol_Biol_Cell_2012_Nov_1_23(21)_4212-4225.nxml.txt.nlp	22956765	SENT52	0	0	7	7	thrombin	TER	PA451674	9524	0.716
NULL	Biomed_Res_Int_2014_Jun_4_2014_105214.nxml.txt.nlp	24991534	SENT107	8	8	17	17	carvedilol	STZ	PA448817	6484	0.716
NULL	Parasit_Vectors_2009_Sep_25_2(Suppl_2)_S4.nxml.txt.nlp	19778465	SENT41	29	29	36	36	ivermectin	MOX	PA450133	26002	0.716
NULL	J_Mol_Signal_2010_Feb_18_5_1.nxml.txt.nlp	20167101	SENT123	8	8	2	2	metformin	AMPK	PA450395	5563	0.716
NULL	Front_Endocrinol_(Lausanne)_2011_Dec_28_2_85.nxml.txt.nlp	22649389	SENT362	12	12	5	5	isoproterenol	UCP1	PA450121	7350	0.716
NULL	Environ_Health_Perspect_2010_Jul_3_118(7)_936-942.nxml.txt.nlp	20199942	SENT158	26	26	32	32	arsenite	p53	PA452638	7157	0.716
NULL	Front_Pharmacol_2014_Oct_31_5_231.nxml.txt.nlp	25400580	SENT2284	5	5	23	23	metoprolol	BCS	PA450480	617	0.716
NULL	Mol_Cancer_2012_Jul_12_11_45.nxml.txt.nlp	22788833	SENT138	31	31	40	40	cisplatin	EGFR	PA449014	1956	0.716
NULL	Cell_Death_Dis_2010_Feb_4_1(2)_e21.nxml.txt.nlp	21364629	SENT50	8	8	3	3	nadh	PRELI	PA164755085	27166	0.716
NULL	Int_J_Biol_Sci_2015_Jan_1_11(2)_144-155.nxml.txt.nlp	25561897	SENT24	21	21	27	27	epirubicin	POLB	PA449476	5423	0.716
NULL	Alcohol_Res_Health_2011_34(1)_4-14.nxml.txt.nlp	23580035	SENT204	5	5	11	11	choline	spatial	PA448976	219793	0.716
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Sep_11_66(Pt_10)_o2555.nxml.txt.nlp	21587542	SENT56	23	23	12	12	benzaldehyde	C10	PA448571	113246	0.716
NULL	J_Cardiothorac_Surg_2011_Apr_8_6_44.nxml.txt.nlp	21477293	SENT83	6	6	8	8	heparin	PF4	PA449855	5196	0.716
NULL	Clin_Psychopharmacol_Neurosci_2013_Dec_24_11(3)_144-151.nxml.txt.nlp	24465251	SENT101	28	28	23	23	clozapine	IL-10	PA449061	3586	0.716
NULL	Acta_Pharmacol_Sin_2014_Jun_4_35(6)_752-757.nxml.txt.nlp	24902786	SENT98	18	18	5	5	flutamide	STL2	PA449685	1301	0.716
NULL	Nat_Chem_Biol_2013_Feb_2_9(2)_97-104.nxml.txt.nlp	23201900	SENT309	17	17	6	6	clonazepam	TSPO	PA449050	706	0.716
NULL	Arch_Trauma_Res_2013_Aug_1_2(2)_63-70.nxml.txt.nlp	24396796	SENT65	25	25	19	19	allopurinol	XDH	PA448320	7498	0.716
NULL	Ann_Surg_Oncol_2012_Aug_31_19(8)_2700-2706.nxml.txt.nlp	22466664	SENT137	27	27	17	17	bevacizumab	VEGFR	PA130232992	3791	0.716
NULL	Anticancer_Agents_Med_Chem_2012_Feb_12(2)_163-171.nxml.txt.nlp	22043994	SENT152	40	40	17	17	cetuximab	KRAS	PA10040	3845	0.716
NULL	Mol_Cancer_2010_Nov_25_9_305.nxml.txt.nlp	21108789	SENT121	16	16	14	14	etoposide	TRAIL	PA449552	8743	0.716
NULL	J_Mol_Signal_2006_Dec_6_1_8.nxml.txt.nlp	17224083	SENT127	18	18	30	30	thrombin	Rho	PA451674	29984	0.716
NULL	Curr_Med_Chem_2012_Aug_19(22)_3763-3778.nxml.txt.nlp	22680930	SENT59	11	11	13	13	celecoxib	5-LOX	PA448871	240	0.716
NULL	J_Biomed_Sci_2013_Oct_21_20(1)_77.nxml.txt.nlp	24143922	SENT6	18	18	15	15	mefloquine	CBX	PA450348	10951	0.716
NULL	J_Oncol_2010_Jan_14_2010_740472.nxml.txt.nlp	20130818	SENT199	40	40	32	32	olaparib	BRCA1		672	0.716
NULL	Int_J_Biol_Sci_2011_May_9_7(5)_575-587.nxml.txt.nlp	21614150	SENT118	7	7	31	31	resveratrol	SIRT1		23411	0.716
NULL	BMJ_2013_Nov_8_347_f6625.nxml.txt.nlp	24212107	SENT111	2	2	18	18	everolimus	NNT	PA164746311	23530	0.716
NULL	Biomed_Res_Int_2014_Jan_19_2014_215872.nxml.txt.nlp	24575401	SENT85	26	26	47	47	artemisinin	TC1	PA165111696	6947	0.716
NULL	Breast_Cancer_Res_2012_Jul_19_14(4)_R108.nxml.txt.nlp	22812534	SENT289	22	22	1	1	pargyline	PELP1	PA450797	27043	0.716
NULL	J_Vis_Exp_2010_Dec_19_(46)_2483.nxml.txt.nlp	21258319	SENT24	16	16	9	9	l-glutamine	F12	PA10090	2161	0.716
NULL	Indian_J_Endocrinol_Metab_2012_Sep-Oct_16(5)_722-727.nxml.txt.nlp	23087855	SENT178	6	6	1	1	cosyntropin	ACTH	PA164749052	5443	0.716
NULL	Am_J_Pathol_2011_Mar_178(3)_1245-1256.nxml.txt.nlp	21356375	SENT159	2	2	6	6	indomethacin	IL-8	PA449982	3576	0.716
NULL	Acta_Pharmacol_Sin_2010_Sep_2_31(9)_1172-1180.nxml.txt.nlp	20676117	SENT179	9	9	19	19	bsi-201	PARP1		142	0.716
NULL	BMB_Rep_2013_Aug_46(8)_410-415.nxml.txt.nlp	23977989	SENT109	7	7	10	10	curcumin	HO-1	PA151958596	3162	0.716
NULL	Cardiovasc_Ther_2009_27(4)_259-274.nxml.txt.nlp	19604248	SENT19	4	4	10	10	clopidogrel	P2Y12	PA449053	64805	0.716
NULL	Oncol_Lett_2014_May_26_7(5)_1345-1351.nxml.txt.nlp	24765136	SENT108	8	8	22	22	sorafenib	Mcl-1	PA7000	4170	0.716
NULL	Cancer_Cell_Int_2010_Sep_1_10_30.nxml.txt.nlp	20809984	SENT7	10	10	20	20	hydrocortisone	EGF	PA449905	1950	0.716
NULL	Int_J_Impot_Res_2010_Mar_26_22(2)_120-126.nxml.txt.nlp	19940852	SENT7	6	6	17	17	phenylephrine	mol	PA450935	90527	0.716
NULL	Cardiovasc_Ther_2009_27(4)_259-274.nxml.txt.nlp	19604248	SENT132	26	26	1	1	clopidogrel	IPA	PA449053	3160	0.716
NULL	Int_J_Mol_Sci_2013_Apr_10_14(4)_7742-7756.nxml.txt.nlp	23574936	SENT167	29	29	5	5	carboplatin	ATX	PA448803	5168;23049	0.716
NULL	Int_J_Mol_Sci_2014_Sep_4_15(9)_15622-15637.nxml.txt.nlp	25192287	SENT128	10	10	27	27	cisplatin	ERCC1	PA449014	2067	0.716
NULL	J_Infect_Dis_2014_May_1_209(9)_1469-1478.nxml.txt.nlp	24286983	SENT108	30	30	26	26	daptomycin	VAN	PA164768820	10318	0.716
NULL	Int_J_Biol_Sci_2013_Aug_14_9(8)_766-777.nxml.txt.nlp	23983610	SENT182	12	12	5	5	curcumin	B19	PA151958596	59271	0.716
NULL	Chin_J_Cancer_2011_May_30(5)_327-335.nxml.txt.nlp	21527065	SENT180	33	33	28	28	trastuzumab	PIK3CA	PA451743	5290	0.716
NULL	Front_Mol_Neurosci_2012_May_3_5_58.nxml.txt.nlp	22563308	SENT179	20	20	11	11	paraformaldehyde	P15	PA450790	1030;29107	0.716
NULL	Cases_J_2009_Jul_29_2_6449.nxml.txt.nlp	19829805	SENT98	27	27	25	25	cabergoline	PRL	PA448708	5617	0.716
NULL	Exp_Anim_2014_Feb_7_63(1)_11-19.nxml.txt.nlp	24521859	SENT34	14	14	6	6	ethanol	CO2	PA448073	4513	0.716
NULL	Breast_Cancer_Res_Treat_2014_Apr_6_145(1)_33-44.nxml.txt.nlp	24706169	SENT49	3	3	0	0	trastuzumab	HER2	PA451743	2064	0.716
NULL	Arthritis_Res_Ther_2011_Apr_4_13(2)_R56.nxml.txt.nlp	21463515	SENT20	21	21	6	6	abatacept	IL-23	PA164747080	51561	0.716
NULL	Front_Neurosci_2013_Jun_12_7_100.nxml.txt.nlp	23781169	SENT835	5	5	11	11	hyaluronidase	TLR2	PA164745713	7097	0.716
NULL	Curr_Med_Chem_2014_Oct_21(32)_3673-3686.nxml.txt.nlp	25174918	SENT309	17	17	23	23	nitroprusside	GMP	PA451406	22978	0.716
NULL	Ann_Oncol_2013_Aug_12_24(8)_1994-1999.nxml.txt.nlp	23670096	SENT13	37	37	11	11	tamoxifen	AIB1	PA451581	8202	0.716
NULL	Arthritis_Res_Ther_2006_Dec_28_8(1)_R18.nxml.txt.nlp	16507118	SENT128	32	32	9	9	rituximab	IL-15	PA451261	3600	0.716
NULL	Breast_Cancer_Res_2011_Apr_15_13(2)_R44.nxml.txt.nlp	21496232	SENT240	1	1	6	6	lapatinib	HER2	PA152241907	2064	0.716
NULL	Nat_Commun_2010_Nov_23_1_127.nxml.txt.nlp	21119640	SENT120	11	11	5	5	doxycycline	INS-1	PA449415	2305	0.716
NULL	Br_J_Cancer_2006_Feb_13_94(3)_407-426.nxml.txt.nlp	16434996	SENT313	16	16	5	5	genistein	BRCA1	PA165109660	672	0.716
NULL	Iran_J_Basic_Med_Sci_2012_Jan-Feb_15(1)_678-682.nxml.txt.nlp	23493931	SENT41	12	12	14	14	cefotaxime	CTX	PA448852	1593	0.716
NULL	Mol_Cancer_2009_Nov_19_8_108.nxml.txt.nlp	19925669	SENT83	22	22	13	13	doxorubicin	CTRL	PA449412	1506	0.716
NULL	J_Hum_Genet_2013_Jun_16_58(6)_353-361.nxml.txt.nlp	23677058	SENT120	18	18	9	9	etoposide	MRP3	PA449552	8714	0.716
NULL	Nat_Biotechnol_2011_Oct_30_29(11)_1039-1045.nxml.txt.nlp	22037377	SENT147	37	37	17	17	fasudil	Rho	PA165946121	29984	0.716
NULL	Nat_Commun_2014_Mar_25_5_3496.nxml.txt.nlp	24667209	SENT142	19	19	17	17	curcumin	SFN	PA151958596	25996;2810	0.716
NULL	Breast_Cancer_Res_2011_Sep_22_13(5)_R93.nxml.txt.nlp	21939528	SENT195	31	31	9	9	tamoxifen	EGFR	PA451581	1956	0.716
NULL	Bone_Marrow_Res_2012_Oct_18_2012_180391.nxml.txt.nlp	23119165	SENT229	22	22	4	4	alemtuzumab	NOD2	PA164783958	64127	0.716
NULL	J_Cell_Biol_1998_Apr_6_141(1)_135-142.nxml.txt.nlp	9531553	SENT123	21	21	4	4	carbachol	spatial	PA448784	219793	0.716
NULL	Clin_Mol_Hepatol_2014_Sep_25_20(3)_283-290.nxml.txt.nlp	25320732	SENT135	16	16	14	14	propranolol	EVL	PA451145	51466	0.716
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Jul_21_9_20.nxml.txt.nlp	20663145	SENT83	14	14	17	17	gentamicin	LBH	PA449753	81606;221491	0.716
NULL	Nat_Commun_2013_Sep_20_4_2444.nxml.txt.nlp	24051492	SENT10	15	15	8	8	nutlin-3	p53		7157	0.716
NULL	Alcohol_Res_2013_35(1)_6-16.nxml.txt.nlp	24313160	SENT259	9	9	4	4	nadh	CYP2E1	PA164755085	1571	0.716
NULL	Nat_Commun_2012_3_1000.nxml.txt.nlp	22893124	SENT162	16	16	11	11	l-glutamine	CO2	PA10090	4513	0.716
NULL	Reprod_Biol_Endocrinol_2004_Aug_4_2_59.nxml.txt.nlp	15294019	SENT256	3	3	5	5	forskolin	EGF	PA146096022	1950	0.716
NULL	J_Cell_Mol_Med_2013_Oct_16_17(10)_1261-1270.nxml.txt.nlp	23855452	SENT126	10	10	12	12	gemcitabine	GEM	PA449748	2669	0.716
NULL	ISRN_Neurosci_2014_Apr_24_2014_103213.nxml.txt.nlp	24967312	SENT24	38	38	28	28	spermine	NR1	PA164781199	27158	0.716
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT131	30	30	18	18	neratinib	HER2	PA165291472	2064	0.716
NULL	J_Immunol_Res_2014_May_21_2014_371087.nxml.txt.nlp	24963497	SENT309	11	11	17	17	decitabine	DAC	PA164749631	13	0.716
NULL	Exp_Ther_Med_2015_Jan_5_9(1)_84-88.nxml.txt.nlp	25452780	SENT71	22	22	3	3	voglibose	GLP-1	PA164752433	100125288	0.716
NULL	Oncogene_2014_May_8_33(19)_2478-2486.nxml.txt.nlp	23752180	SENT13	41	41	18	18	trastuzumab	ERBB2	PA451743	2064	0.716
NULL	Basic_Res_Cardiol_2015_Jan_20_110_4.nxml.txt.nlp	25600226	SENT112	0	0	4	4	ezetimibe	PCSK9	PA10816	255738	0.716
NULL	J_Thorac_Oncol_2014_Sep_22_9(9)_1345-1353.nxml.txt.nlp	25122430	SENT221	1	1	4	4	gefitinib	EGFR	PA131301952	1956	0.716
NULL	Evid_Based_Complement_Alternat_Med_2011_Jan_3_2011_274858.nxml.txt.nlp	19001481	SENT36	20	20	28	28	fluorescein	CD86	PA164746009	942	0.716
NULL	Adv_Appl_Bioinforma_Chem_2008_Oct_30_1_85-98.nxml.txt.nlp	21918608	SENT80	21	21	27	27	bortezomib	SPARC	PA10252	6678	0.716
NULL	Cancer_Cell_Int_2005_Aug_23_5_27.nxml.txt.nlp	16117829	SENT189	12	12	6	6	doxycycline	p53	PA449415	7157	0.716
NULL	Breast_Cancer_Res_2008_Mar_27_10(2)_R27.nxml.txt.nlp	18371219	SENT41	25	25	30	30	doxorubicin	TFEC	PA449412	22797	0.716
NULL	J_Oncol_2011_Jun_12_2011_542358.nxml.txt.nlp	21772843	SENT368	10	10	0	0	cetuximab	EGFR	PA10040	1956	0.716
NULL	Br_J_Cancer_1996_Oct_74(7)_1120-1125.nxml.txt.nlp	8855985	SENT12	44	44	15	15	tamoxifen	pS2	PA451581	7031	0.716
NULL	Infect_Drug_Resist_2011_Mar_2_4_77-86.nxml.txt.nlp	21694911	SENT197	4	4	7	7	tigecycline	CABP	PA164746412	6277	0.716
NULL	Br_J_Cancer_2009_Oct_20_101(8)_1253-1260.nxml.txt.nlp	19755984	SENT192	4	4	16	16	letrozole	LRH-1	PA450196	2494	0.716
NULL	Mol_Biol_Cell_2012_Nov_1_23(21)_4212-4225.nxml.txt.nlp	22956765	SENT208	0	0	10	10	thrombin	RhoA	PA451674	387	0.716
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2011_Mar_14_4_13-24.nxml.txt.nlp	22879790	SENT33	4	4	8	8	liraglutide	PPG	PA165958364	5552	0.716
NULL	Breast_Cancer_Res_Treat_2012_Jul_24_134(1)_13-20.nxml.txt.nlp	22198412	SENT217	11	11	16	16	lapatinib	HER2	PA152241907	2064	0.716
NULL	Front_Neurol_2011_Dec_26_2_83.nxml.txt.nlp	22363312	SENT775	0	0	20	20	clopidogrel	P2Y12	PA449053	64805	0.716
NULL	Mol_Cell_Biochem_2014_Jan_3_389(1-2)_177-185.nxml.txt.nlp	24385108	SENT167	28	28	6	6	bortezomib	ORP150	PA10252	10525	0.716
NULL	Mol_Brain_2014_May_15_7_37.nxml.txt.nlp	24886748	SENT125	18	18	8	8	vorinostat	NFKB1	PA164748224	4790	0.716
NULL	Iran_J_Pharm_Res_2014_Autumn_13(4)_1393-1401.nxml.txt.nlp	25587329	SENT6	12	12	20	20	celecoxib	ABCG2	PA448871	9429	0.716
NULL	Acta_Pharmacol_Sin_2012_Oct_17_33(10)_1301-1310.nxml.txt.nlp	22983390	SENT92	22	22	20	20	cisplatin	migfilin	PA449014	54751	0.716
NULL	Oncotarget_2011_Mar_27_2(3)_209-221.nxml.txt.nlp	21444945	SENT6	26	26	24	24	geldanamycin	Hsp90	PA152031327	3320	0.716
NULL	Cancer_Cell_Int_2009_Sep_10_9_25.nxml.txt.nlp	19744341	SENT150	6	6	9	9	glucosamine	STAT3	PA164747613	6774	0.716
NULL	Br_J_Cancer_2006_Dec_4_95(11)_1504-1513.nxml.txt.nlp	17088902	SENT193	21	21	34	34	gefitinib	HER3	PA131301952	2065	0.716
NULL	Clin_Drug_Investig_2013_Aug_23_33(10)_727-736.nxml.txt.nlp	23975654	SENT43	14	14	16	16	bupropion	CYP2B6	PA448687	1555	0.716
NULL	Cancer_Immunol_Immunother_2013_Aug_27_62(10)_1637-1648.nxml.txt.nlp	23982484	SENT165	0	0	27	27	lenalidomide	CD107a	PA162363968	3916	0.716
NULL	Ther_Clin_Risk_Manag_2007_Dec_3(6)_1009-1020.nxml.txt.nlp	18516316	SENT94	11	11	4	4	cyclophosphamide	HEC	PA449165	10403	0.716
NULL	Oncol_Rep_2014_Feb_13_31(2)_581-588.nxml.txt.nlp	24337105	SENT117	19	19	11	11	capsaicin	CHOP	PA448776	1649	0.716
NULL	Chin_J_Cancer_2011_Nov_30(11)_749-756.nxml.txt.nlp	22035855	SENT22	40	40	43	43	fulvestrant	aromatase	PA164747170	1588	0.716
NULL	Biomed_Opt_Express_2012_Aug_1_3(9)_1978-1992.nxml.txt.nlp	23024894	SENT213	11	11	9	9	isoflurane	PCL	PA450106	9033;2324	0.716
NULL	Oxid_Med_Cell_Longev_2011_Aug_15_2011_824597.nxml.txt.nlp	21904648	SENT201	8	8	10	10	topotecan	TPT	PA451729	23590;6469	0.716
NULL	Cell_Death_Dis_2014_Feb_13_5(2)_e1055.nxml.txt.nlp	24525731	SENT132	26	26	9	9	cisplatin	XRCC1	PA449014	7515	0.716
NULL	Ecancermedicalscience_2008_Aug_15_2_91.nxml.txt.nlp	22275974	SENT223	19	19	5	5	temozolomide	CD4	PA451609	920	0.716
NULL	Mol_Cell_Biochem_2014_Jul_26_396(1-2)_221-228.nxml.txt.nlp	25063218	SENT127	6	6	10	10	resveratrol	c-Myc		4609	0.716
NULL	Breast_Cancer_Res_2014_May_28_16(3)_R53.nxml.txt.nlp	24886537	SENT340	16	16	36	36	tamoxifen	VAV3	PA451581	10451	0.716
NULL	J_Cardiothorac_Surg_2010_Aug_21_5_66.nxml.txt.nlp	20727201	SENT55	11	11	13	13	collagenase	MMP1	PA449107	4312	0.716
NULL	Curr_Chem_Genomics_2008_Feb_25_1_34-42.nxml.txt.nlp	20161826	SENT31	23	23	15	15	coumarin	AMPK	PA134521193	5563	0.716
NULL	Int_J_Biol_Sci_2011_May_24_7(5)_673-684.nxml.txt.nlp	21647250	SENT174	5	5	11	11	metformin	AMPK	PA450395	5563	0.716
NULL	Oncoimmunology_2013_Jun_1_2(6)_e24677.nxml.txt.nlp	23894722	SENT12	2	2	11	11	cetuximab	CD83	PA10040	9308	0.716
NULL	Indian_J_Urol_2009_Jul-Sep_25(3)_296-301.nxml.txt.nlp	19881119	SENT113	30	30	32	32	clopidogrel	GOR	PA449053	254958	0.716
NULL	Curr_Biol_2012_Mar_6_22(5)_397-402.nxml.txt.nlp	22305751	SENT166	13	13	10	10	carbachol	CA3	PA448784	761	0.716
NULL	F1000Res_2012_Nov_9_1_47.nxml.txt.nlp	24627764	SENT1	14	14	7	7	l-alanine	SOD1	PA448055	6647	0.716
NULL	J_Cell_Biol_2000_Dec_25_151(7)_1449-1458.nxml.txt.nlp	11134074	SENT481	0	0	10	10	thrombin	c-src	PA451674	6714	0.716
NULL	Diabetes_Care_2009_Nov_32(Suppl_2)_S184-S188.nxml.txt.nlp	19875549	SENT138	20	20	12	12	rosiglitazone	DREAM	PA451283	30818	0.716
NULL	Physiol_Rep_2014_Aug_5_2(8)_e12090.nxml.txt.nlp	25096552	SENT12	10	10	2	2	dextran	CD137	PA449261	3604	0.716
NULL	Front_Neurosci_2011_Jul_26_5_92.nxml.txt.nlp	21845173	SENT36	18	18	24	24	ketorolac	NRM	PA450150	11270	0.716
NULL	Mol_Biol_Cell_2012_Sep_1_23(17)_3473-3484.nxml.txt.nlp	22787275	SENT111	4	4	13	13	doxorubicin	ABCC1	PA449412	4363	0.715
NULL	J_Med_Life_2011_Nov_14_4(4)_432-439.nxml.txt.nlp	22514580	SENT105	8	8	15	15	saquinavir	ATV	PA451305	4683	0.715
NULL	Core_Evid_2009_Jun_15_4_149-158.nxml.txt.nlp	20694071	SENT57	23	23	19	19	ritonavir	CYP3A4	PA451260	1576	0.715
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT129	9	9	6	6	nutlin-3	DR5		8795	0.715
NULL	Clin_Mol_Hepatol_2014_Sep_25_20(3)_283-290.nxml.txt.nlp	25320732	SENT73	3	3	5	5	propranolol	EVL	PA451145	51466	0.715
NULL	Breast_Cancer_Res_2011_Aug_31_13(4)_R84.nxml.txt.nlp	21884573	SENT208	30	30	36	36	trastuzumab	PI3K	PA451743	5290	0.715
NULL	Oncoimmunology_2013_Jun_1_2(6)_e24677.nxml.txt.nlp	23894722	SENT99	5	5	10	10	cetuximab	CD107a	PA10040	3916	0.715
NULL	Pharmaceutics_2011_Oct_12_3(4)_680-705.nxml.txt.nlp	24309303	SENT56	14	14	19	19	rosiglitazone	OATP1B3	PA451283	28234	0.715
NULL	Front_Endocrinol_(Lausanne)_2011_Dec_21_2_84.nxml.txt.nlp	22654830	SENT62	7	7	2	2	rosiglitazone	GPAT	PA451283	5471	0.715
NULL	J_Immunol_Res_2014_Jul_16_2014_696812.nxml.txt.nlp	25133198	SENT262	23	23	12	12	rifaximin	TLR2	PA164752443	7097	0.715
NULL	Int_J_Biol_Sci_2015_Jan_1_11(1)_1-10.nxml.txt.nlp	25552924	SENT34	0	0	19	19	cisplatin	CD133	PA449014	8842	0.715
NULL	J_Mol_Psychiatry_2014_Jan_24_2(1)_1.nxml.txt.nlp	25408912	SENT249	7	7	13	13	fluvoxamine	Gen	PA449690	348654	0.715
NULL	Arthritis_Res_Ther_2012_Jul_12_14(4)_R163.nxml.txt.nlp	22784880	SENT112	13	13	8	8	leflunomide	CYP2C19	PA450192	1557	0.715
NULL	Cancers_(Basel)_2014_Apr_16_6(2)_897-925.nxml.txt.nlp	24743777	SENT116	4	4	11	11	thrombin	Hsp90	PA451674	3320	0.715
NULL	Anc_Sci_Life_2012_Oct-Dec_32(2)_93-98.nxml.txt.nlp	24167334	SENT87	18	18	4	4	cyclophosphamide	AR7	PA449165	7067	0.715
NULL	Cancer_Cell_Int_2013_Sep_23_13_94.nxml.txt.nlp	24059699	SENT208	26	26	23	23	bevacizumab	VEGFA	PA130232992	7422	0.715
NULL	Oncol_Lett_2014_Mar_19_7(3)_674-678.nxml.txt.nlp	24527071	SENT16	17	17	6	6	cisplatin	AKR1C2	PA449014	1646	0.715
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT265	7	7	0	0	cisplatin	MVP	PA449014	9961	0.715
NULL	Breast_Cancer_Res_2011_Mar_11_13(2)_R29.nxml.txt.nlp	21396094	SENT168	13	13	2	2	gefitinib	HRG	PA131301952	3084;3273	0.715
NULL	J_Korean_Neurosurg_Soc_2014_Jun_30_55(6)_313-320.nxml.txt.nlp	25237426	SENT67	40	40	11	11	urokinase	Penumbra	PA451836	340348	0.715
NULL	Mol_Vis_2011_Apr_27_17_1044-1055.nxml.txt.nlp	21552499	SENT212	3	3	8	8	bevacizumab	apelin	PA130232992	8862	0.715
NULL	Breast_Cancer_Res_2010_May_18_12(Suppl_1)_P45.nxml.txt.nlp	NULL	SENT10	25	25	27	27	tamoxifen	FKBPL	PA451581	63943	0.715
NULL	Rare_Tumors_2010_Dec_31_2(4)_e63.nxml.txt.nlp	21234255	SENT33	29	29	6	6	cyclophosphamide	CHOP	PA449165	1649	0.715
NULL	Breast_Cancer_(Auckl)_2012_Mar_7_6_67-77.nxml.txt.nlp	22438669	SENT22	3	3	5	5	trastuzumab	HER2	PA451743	2064	0.715
NULL	Case_Rep_Pediatr_2012_Aug_9_2012_323681.nxml.txt.nlp	22924145	SENT92	1	1	4	4	tocilizumab	IL-6	PA165292659	3569	0.715
NULL	Oxid_Med_Cell_Longev_2011_Sep_20_2011_143269.nxml.txt.nlp	21941604	SENT60	22	22	16	16	suramin	HDAC6	PA10292	10013	0.715
NULL	Ann_Oncol_2011_Jun_25_22(6)_1392-1403.nxml.txt.nlp	21266519	SENT236	4	4	12	12	methotrexate	CHOP	PA450428	1649	0.715
NULL	Mol_Vis_2012_Nov_29_18_2839-2846.nxml.txt.nlp	23233786	SENT167	39	39	31	31	geldanamycin	CB2	PA152031327	1269	0.715
NULL	Int_J_Surg_Oncol_2012_May_17_2012_406830.nxml.txt.nlp	22675625	SENT91	0	0	22	22	cetuximab	CGREF1	PA10040	10669	0.715
NULL	Am_J_Case_Rep_2014_Feb_24_15_85-89.nxml.txt.nlp	24587856	SENT96	2	2	14	14	exemestane	aromatase	PA449563	1588	0.715
NULL	Biomed_Res_Int_2013_Dec_10_2013_783698.nxml.txt.nlp	24386640	SENT137	14	14	17	17	rifampin	DST	PA451250	667	0.715
NULL	Mol_Cancer_2009_Dec_23_8_129.nxml.txt.nlp	20030852	SENT189	6	6	9	9	curcumin	p65	PA151958596	5970	0.715
NULL	Bioinformation_2012_Apr_13_8(7)_301-308.nxml.txt.nlp	22553386	SENT140	7	7	12	12	collagenase	spatial	PA449107	219793	0.715
NULL	Gene_Ther_2010_Aug_1_17(8)_1042-1051.nxml.txt.nlp	20596059	SENT6	34	34	27	27	bevacizumab	VEGF-A	PA130232992	7422	0.715
NULL	Br_J_Cancer_2004_Mar_8_90(5)_1003-1010.nxml.txt.nlp	14997197	SENT200	18	18	10	10	leucovorin	PSK	PA450198	9344	0.715
NULL	J_Med_Case_Reports_2011_Jan_12_5_5.nxml.txt.nlp	21226894	SENT101	19	19	5	5	vincristine	CHOP	PA451879	1649	0.715
NULL	Br_J_Cancer_2011_Jul_12_105(2)_221-230.nxml.txt.nlp	21750559	SENT44	9	9	14	14	rituximab	Mcl-1	PA451261	4170	0.715
NULL	Int_J_Nanomedicine_2007_Jun_2(2)_129-141.nxml.txt.nlp	17722542	SENT129	15	15	27	27	ethanol	castor	PA448073	54897	0.715
NULL	Clin_Mol_Hepatol_2013_Sep_30_19(3)_300-304.nxml.txt.nlp	24133668	SENT83	44	44	26	26	entecavir	NUC	PA164784025	4924	0.715
NULL	Exp_Hematol_Oncol_2012_Sep_11_1_27.nxml.txt.nlp	23210501	SENT67	5	5	17	17	lenalidomide	HIF-1	PA162363968	29072	0.715
NULL	Braz_J_Med_Biol_Res_2013_Feb_1_46(2)_171-177.nxml.txt.nlp	23369979	SENT188	0	0	6	6	enalapril	IL-10	PA449456	3586	0.715
NULL	Curr_Neuropharmacol_2013_Dec_11(6)_652-663.nxml.txt.nlp	24396340	SENT77	20	20	5	5	oxaliplatin	TRPA1	PA131285527	8989	0.715
NULL	Int_J_Endocrinol_Metab_2013_Dec_21_Winter_11(1)_57-61.nxml.txt.nlp	23853622	SENT39	16	16	22	22	risperidone	FGA	PA451257	2243	0.715
NULL	Br_J_Cancer_2010_Oct_12_103(8)_1309-1310.nxml.txt.nlp	NULL	SENT14	17	17	19	19	bevacizumab	IFN	PA130232992	3439	0.715
NULL	Oncotarget_2012_Nov_17_3(12)_1600-1614.nxml.txt.nlp	23307622	SENT25	27	27	8	8	trastuzumab	HER2	PA451743	2064	0.715
NULL	Mol_Cancer_2014_Jun_27_13_159.nxml.txt.nlp	24972933	SENT132	5	5	22	22	temsirolimus	CTRL	PA164746890	1506	0.715
NULL	Cell_Biol_Int_Rep_(2010)_2012_Jun_21_19(1)_e00017.nxml.txt.nlp	23124518	SENT150	25	25	13	13	etoposide	DR5	PA449552	8795	0.715
NULL	BMJ_Open_2014_Oct_16_4(10)_e005859.nxml.txt.nlp	25324322	SENT116	15	15	21	21	glibenclamide	A10	PA449782	28870	0.715
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT251	29	29	18	18	pemetrexed	UNG	PA10810	7374	0.715
NULL	Gut_Liver_2011_Sep_18_5(3)_293-297.nxml.txt.nlp	21927656	SENT33	21	21	4	4	omeprazole	ESD	PA450704	2098	0.715
NULL	J_Adv_Pract_Oncol_2012_Jul_1_Jul-Aug_3(4)_267-272.nxml.txt.nlp	25031955	SENT98	0	0	9	9	crizotinib	CYP3A4	PA165946122	1576	0.715
NULL	Stroke_Res_Treat_2009_Dec_20_2010_386389.nxml.txt.nlp	20700422	SENT159	24	24	26	26	pioglitazone	NAC	PA450970	22861	0.715
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT292	26	26	43	43	resveratrol	TRAIL		8743	0.715
NULL	Nucleic_Acids_Res_2011_Mar_17_39(6)_2144-2152.nxml.txt.nlp	21087997	SENT131	23	23	12	12	etoposide	CtIP	PA449552	5932	0.715
NULL	Mol_Syst_Biol_2010_Apr_13_6_359.nxml.txt.nlp	20393579	SENT183	22	22	37	37	cyclosporine	IL-4	PA449167	3565	0.715
NULL	Acta_Pharmacol_Sin_2010_Dec_29_31(12)_1583-1592.nxml.txt.nlp	21113175	SENT172	25	25	33	33	dextran	IFN	PA449261	3439	0.715
NULL	Br_J_Cancer_2013_Feb_19_108(3)_557-563.nxml.txt.nlp	23361053	SENT45	14	14	11	11	tamoxifen	PAK1	PA451581	5585;5058	0.715
NULL	Indian_J_Endocrinol_Metab_2015_Jan-Feb_19(1)_30-38.nxml.txt.nlp	25593823	SENT103	21	21	34	34	metformin	adiponectin	PA450395	9370	0.715
NULL	Breast_Cancer_Res_2006_Nov_6_8(6)_215.nxml.txt.nlp	17096862	SENT48	11	11	7	7	trastuzumab	MUC4	PA451743	4585	0.715
NULL	Br_J_Cancer_2012_Jul_24_107(3)_516-526.nxml.txt.nlp	22782351	SENT276	17	17	35	35	tamoxifen	TIGAR	PA451581	57103	0.715
NULL	J_Invest_Dermatol_2012_May_16_132(5)_1435-1442.nxml.txt.nlp	22336948	SENT71	11	11	8	8	doxycycline	TLSP	PA449415	11012	0.715
NULL	Lab_Invest_2012_May_16_92(5)_662-675.nxml.txt.nlp	22249312	SENT26	15	15	20	20	thrombin	LPA	PA451674	4018	0.715
NULL	BMJ_2011_Aug_4_343_d4588.nxml.txt.nlp	21816733	SENT383	11	11	15	15	voriconazole	CYP2C19	PA10233	1557	0.715
NULL	Pharmaceuticals_(Basel)_2011_Nov_10_4(11)_1488-1502.nxml.txt.nlp	NULL	SENT114	3	3	30	30	geldanamycin	HER2	PA152031327	2064	0.715
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT7	7	7	9	9	nutlin-3	MDM2		4193	0.715
NULL	Front_Genet_2013_Aug_30_4_166.nxml.txt.nlp	24009623	SENT514	4	4	0	0	sirolimus	CYP3A5	PA451365	1577	0.715
NULL	Endocr_Relat_Cancer_2014_Jun_21(3)_R209-R225.nxml.txt.nlp	24500760	SENT227	19	19	39	39	resveratrol	IL6		3569	0.715
NULL	Front_Genet_2013_Aug_29_4_163.nxml.txt.nlp	24009622	SENT35	9	9	3	3	ethanol	DDP	PA448073	1678	0.715
NULL	Cell_Death_Dis_2010_May_13_1(5)_e41.nxml.txt.nlp	21364648	SENT97	16	16	14	14	etoposide	p53	PA449552	7157	0.715
NULL	Cancer_Med_2013_Jun_21_2(3)_316-324.nxml.txt.nlp	23930208	SENT193	29	29	20	20	bevacizumab	TSP2	PA130232992	7058	0.715
NULL	Appl_Microbiol_Biotechnol_2013_Aug_16_97(15)_6919-6930.nxml.txt.nlp	23677441	SENT127	40	40	24	24	ethanol	FAN	PA448073	8439	0.715
NULL	Exp_Neurobiol_2013_Mar_31_22(1)_45-50.nxml.txt.nlp	23585722	SENT107	7	7	9	9	fluoxetine	EPO	PA449673	7076;8288;2056	0.715
NULL	Mol_Cancer_2014_Jun_26_13_158.nxml.txt.nlp	24965046	SENT159	2	2	24	24	doxorubicin	TSP1	PA449412	7057	0.715
NULL	Ann_Nucl_Med_2013_Apr_5_27(7)_592-599.nxml.txt.nlp	23558450	SENT3	18	18	20	20	bleomycin	BLM	PA448645	641	0.715
NULL	Braz_J_Med_Biol_Res_2012_Mar_16_45(6)_488-496.nxml.txt.nlp	22415117	SENT18	12	12	2	2	creatine	UST	PA164778930	10090	0.715
NULL	Chin_J_Cancer_2011_Oct_30(10)_690-700.nxml.txt.nlp	21959046	SENT4	16	16	18	18	topotecan	TPT	PA451729	23590;6469	0.715
NULL	J_Cancer_2014_Jan_5_5(1)_69-78.nxml.txt.nlp	24396499	SENT127	16	16	13	13	trastuzumab	DM1	PA451743	338023;1760;28509	0.715
NULL	Exp_Cell_Res_2011_May_1_317(8)_1093-1107.nxml.txt.nlp	21320486	SENT117	31	31	20	20	bortezomib	APPL1	PA10252	26060	0.715
NULL	Pharmaceuticals_(Basel)_2014_May_7_7(5)_530-544.nxml.txt.nlp	24810947	SENT325	3	3	6	6	rituximab	CHOP	PA451261	1649	0.715
NULL	Arch_Drug_Inf_2011_Mar_4(1)_1-9.nxml.txt.nlp	21572514	SENT191	40	40	14	14	ciprofloxacin	P-gp	PA449009	5243	0.715
NULL	Iran_J_Reprod_Med_2013_Jul_11(7)_565-576.nxml.txt.nlp	24639792	SENT37	8	8	35	35	berberine	SLPI	PA165860812	6590	0.715
NULL	Front_Behav_Neurosci_2014_Sep_3_8_291.nxml.txt.nlp	25232308	SENT663	4	4	10	10	haloperidol	gamma	PA449841	9913	0.715
NULL	Med_Sci_Monit_2013_Sep_9_19_751-756.nxml.txt.nlp	24019010	SENT18	23	23	14	14	entecavir	LAM	PA164784025	7249;7248	0.715
NULL	Cancer_Cell_Int_2005_Jul_29_5_24.nxml.txt.nlp	16053526	SENT120	7	7	23	23	estradiol	beta-catenin	PA449503	1499	0.715
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Sep_30_67(Pt_10)_o2720.nxml.txt.nlp	22065500	SENT68	28	28	9	9	ethanol	mol	PA448073	90527	0.715
NULL	Cancer_Manag_Res_2011_Jul_13_3_257-266.nxml.txt.nlp	21792334	SENT145	35	35	30	30	cisplatin	HER2	PA449014	2064	0.715
NULL	Mol_Pain_2013_Jan_2_9_1.nxml.txt.nlp	23279936	SENT119	17	17	6	6	capsaicin	TRPV1	PA448776	7442	0.715
NULL	J_Vet_Med_Sci_2014_Jan_4_76(1)_113-117.nxml.txt.nlp	24004933	SENT56	22	22	32	32	heparin	CO2	PA449855	4513	0.715
NULL	Bone_2014_Sep_66(100)_240-250.nxml.txt.nlp	24971713	SENT397	0	0	28	28	zoledronate	MSX1	PA10235	4487	0.715
NULL	Ther_Clin_Risk_Manag_2006_Sep_2(3)_235-249.nxml.txt.nlp	18360599	SENT340	36	36	30	30	alendronate	PTH	PA448082	5741	0.715
NULL	Front_Neurosci_2010_Jun_17_4_35.nxml.txt.nlp	20661455	SENT94	5	5	9	9	buspirone	5-HT1A	PA448689	3350	0.715
NULL	Biomed_Res_Int_2013_Dec_30_2013_916218.nxml.txt.nlp	23509801	SENT75	19	19	11	11	glucose	MHA	PA449773	4627	0.715
NULL	Oncotarget_2012_Jul_22_3(7)_678-685.nxml.txt.nlp	22824673	SENT83	0	0	6	6	trypsin	rTS	PA451806	55556	0.715
NULL	J_Gen_Physiol_2013_Aug_142(2)_137-155.nxml.txt.nlp	23858003	SENT378	17	17	31	31	mibefradil	ACTH	PA450492	5443	0.715
NULL	J_Exp_Clin_Cancer_Res_2010_Apr_27_29(1)_38.nxml.txt.nlp	20423465	SENT147	24	24	7	7	pemetrexed	B12	PA10810	7126;4709	0.715
NULL	Neural_Regen_Res_2013_Jul_15_8(20)_1853-1862.nxml.txt.nlp	25206494	SENT193	0	0	9	9	ethanol	JNK	PA448073	5599	0.715
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT94	31	31	17	17	pertuzumab	HER3		2065	0.715
NULL	J_Cancer_2012_Dec_25_4(1)_57-65.nxml.txt.nlp	23386905	SENT103	3	3	0	0	bleomycin	IL-22	PA448645	50616;53342	0.715
NULL	Exp_Diabetes_Res_2012_Dec_26_2012_230624.nxml.txt.nlp	23365557	SENT167	12	12	6	6	liraglutide	GLP-1	PA165958364	100125288	0.715
NULL	Oncotarget_2011_Aug_30_2(8)_610-626.nxml.txt.nlp	21881167	SENT115	5	5	9	9	doxorubicin	Raf-1	PA449412	5894	0.715
NULL	Int_J_Nephrol_2011_Feb_24_2011_701603.nxml.txt.nlp	21423552	SENT68	13	13	6	6	cinacalcet	PTH	PA164776671	5741	0.715
NULL	Oncol_Lett_2013_Feb_7_5(2)_440-446.nxml.txt.nlp	23420122	SENT157	0	0	5	5	sorafenib	Bcl-2	PA7000	596	0.715
NULL	Case_Rep_Med_2012_Sep_27_2012_234515.nxml.txt.nlp	23056053	SENT142	6	6	3	3	rituximab	CRT	PA451261	811	0.715
NULL	Clin_Sarcoma_Res_2014_Aug_10_4_10.nxml.txt.nlp	25132955	SENT194	3	3	8	8	sunitinib	MVD	PA162372840	4597	0.715
NULL	Acta_Pharmacol_Sin_2010_Oct_30_31(10)_1359-1366.nxml.txt.nlp	20802507	SENT157	16	16	24	24	forskolin	ADM	PA146096022	133	0.715
NULL	Oncotarget_2014_Jun_19_5(15)_6540-6551.nxml.txt.nlp	25153728	SENT96	9	9	21	21	paclitaxel	p16	PA450761	1029	0.715
NULL	Leukemia_2013_Feb_3_27(2)_315-324.nxml.txt.nlp	22751450	SENT215	5	5	28	28	sorafenib	Mcl-1	PA7000	4170	0.715
NULL	Br_J_Cancer_2013_Oct_15_109(8)_2096-2105.nxml.txt.nlp	24064970	SENT46	24	24	9	9	erlotinib	ERCC1	PA134687924	2067	0.715
NULL	Free_Radic_Biol_Med_2014_Mar_68(100)_134-147.nxml.txt.nlp	24291398	SENT589	4	4	0	0	fasudil	Rho	PA165946121	29984	0.715
NULL	Int_J_Mol_Sci_2014_Mar_5_15(3)_3970-3988.nxml.txt.nlp	24603537	SENT560	19	19	17	17	curcumin	MCH	PA151958596	5367	0.715
NULL	Cancer_Cell_Int_2008_Apr_29_8_4.nxml.txt.nlp	18442416	SENT90	0	0	5	5	trypsin	Ku86	PA451806	7520	0.715
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT370	18	18	16	16	pp2	PP1		5540;5464	0.715
NULL	Clin_Med_Insights_Oncol_2013_Jul_4_7_159-163.nxml.txt.nlp	23885182	SENT86	20	20	27	27	doxorubicin	CHOP	PA449412	1649	0.715
NULL	Exp_Ther_Med_2012_Oct_6_4(4)_655-660.nxml.txt.nlp	23170121	SENT67	14	14	8	8	fluorescein	CD83	PA164746009	9308	0.715
NULL	Neuroscience_2009_Dec_15_164(3-3)_998-1008.nxml.txt.nlp	19751803	SENT687	16	16	3	3	l-serine	ASCT1	PA451330	6509	0.715
NULL	Lab_Invest_2014_May_10_94(5)_503-516.nxml.txt.nlp	24614199	SENT221	18	18	24	24	curcumin	RAGE	PA151958596	177	0.715
NULL	Arthritis_Res_Ther_2006_Apr_12_8(Suppl_1)_S3.nxml.txt.nlp	16820042	SENT120	7	7	10	10	colchicine	ACTH	PA449092	5443	0.715
NULL	EMBO_Mol_Med_2012_Jun_13_4(6)_515-527.nxml.txt.nlp	22416035	SENT151	0	0	14	14	olaparib	p53		7157	0.715
NULL	J_Gynecol_Oncol_2013_Jul_4_24(3)_273-279.nxml.txt.nlp	23875078	SENT147	15	15	10	10	paclitaxel	COX	PA450761	1351	0.715
NULL	ScientificWorldJournal_2013_Jun_19_2013_174392.nxml.txt.nlp	23853530	SENT116	5	5	9	9	doxazosin	c-FLIP	PA449407	8837	0.715
NULL	J_Invest_Dermatol_2012_Jan_18_132(1)_135-143.nxml.txt.nlp	21850017	SENT116	14	14	21	21	etanercept	TLR9	PA449515	54106	0.715
NULL	Mol_Cancer_2013_Sep_11_12_104.nxml.txt.nlp	24025152	SENT219	16	16	7	7	gemcitabine	STAT3	PA449748	6774	0.715
NULL	Mol_Cancer_2003_Jan_7_2_6.nxml.txt.nlp	12605713	SENT100	15	15	2	2	gemcitabine	Bcl-2	PA449748	596	0.715
NULL	Arthritis_Res_2001_Aug_2_3(5)_311-318.nxml.txt.nlp	11549373	SENT5	27	27	21	21	chloramphenicol	COL1A2	PA448927	1278	0.715
NULL	Int_J_Breast_Cancer_2012_Feb_26_2012_761917.nxml.txt.nlp	22482061	SENT55	13	13	2	2	tamoxifen	HER2	PA451581	2064	0.715
NULL	Biomed_Res_Int_2014_Apr_15_2014_175721.nxml.txt.nlp	24822180	SENT168	7	7	18	18	nutlin-3	MDM2		4193	0.715
NULL	J_Oncol_2012_Nov_20_2012_236530.nxml.txt.nlp	23213333	SENT126	21	21	27	27	resveratrol	PTEN		5728	0.715
NULL	Int_J_Mol_Sci_2013_Apr_16_14(4)_8381-8392.nxml.txt.nlp	23591849	SENT245	7	7	3	3	efavirenz	CYP2B6	PA449441	1555	0.715
NULL	Front_Genet_2014_Jun_2_5_162.nxml.txt.nlp	24917882	SENT997	11	11	15	15	cetuximab	KRAS	PA10040	3845	0.715
NULL	Amyloid_2014_Sep_11_21(3)_175-184.nxml.txt.nlp	24918964	SENT154	24	24	10	10	anakinra	BiP	PA10799	3309	0.715
NULL	Ann_Gen_Psychiatry_2010_Mar_6_9_11.nxml.txt.nlp	20205742	SENT25	17	17	6	6	aripiprazole	STAR	PA10026	6770;2984	0.715
NULL	Nucleic_Acids_Res_2012_Jul_1_40(12)_5775-5786.nxml.txt.nlp	22383579	SENT233	24	24	26	26	theophylline	MS2	PA451647	101	0.715
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT140	13	13	3	3	celecoxib	IL-6	PA448871	3569	0.715
NULL	Curr_Gerontol_Geriatr_Res_2011_Aug_18_2011_316386.nxml.txt.nlp	21869884	SENT133	2	2	12	12	estradiol	CA1	PA449503	759	0.715
NULL	Nucleic_Acids_Res_2011_Sep_7_39(17)_7465-7476.nxml.txt.nlp	21653549	SENT188	10	10	17	17	etoposide	DEK	PA449552	7913	0.715
NULL	Iran_Red_Crescent_Med_J_2013_Dec_5_15(12)_e16698.nxml.txt.nlp	24693404	SENT168	32	32	34	34	raloxifene	STAR	PA451221	6770;2984	0.715
NULL	BMB_Rep_2014_Mar_47(3)_167-172.nxml.txt.nlp	24499665	SENT105	19	19	21	21	nutlin-3	MDM2		4193	0.715
NULL	Exp_Mol_Med_2012_Sep_30_44(9)_536-544.nxml.txt.nlp	22771771	SENT56	23	23	30	30	celecoxib	p53	PA448871	7157	0.715
NULL	J_Cardiothorac_Surg_2009_Sep_17_4_50.nxml.txt.nlp	19758462	SENT201	2	2	11	11	amifostine	p53	PA448365	7157	0.715
NULL	Br_J_Cancer_2010_Jan_5_102(1)_8-18.nxml.txt.nlp	20010945	SENT120	15	15	19	19	bevacizumab	FDG	PA130232992	23583	0.715
NULL	J_Autom_Methods_Manag_Chem_2011_Mar_30_2011_143416.nxml.txt.nlp	21584273	SENT98	10	10	26	26	chloramphenicol	CAP	PA448927	23476;9200;4012;5269;10580;10487	0.715
NULL	Biol_Proced_Online_2003_Feb_17_5_43-52.nxml.txt.nlp	12734557	SENT135	12	12	2	2	bupivacaine	IFNA6	PA135057240	3443	0.715
NULL	Environ_Health_Perspect_2013_May_22_121(5)_551-557.nxml.txt.nlp	23434795	SENT66	8	8	2	2	hyaluronan	BAL	PA165958431	83666	0.715
NULL	Eur_J_Clin_Pharmacol_2011_May_8_67(5)_493-506.nxml.txt.nlp	21140139	SENT230	32	32	11	11	oxycodone	CYP3A4	PA450741	1576	0.715
NULL	Arthritis_Res_Ther_2006_Jul_21_8(4)_R130.nxml.txt.nlp	16859540	SENT182	3	3	0	0	atorvastatin	CD59	PA448500	966	0.715
NULL	Breast_Cancer_Res_2012_May_14_14(3)_R77.nxml.txt.nlp	22583478	SENT425	41	41	32	32	tamoxifen	Bcl-2	PA451581	596	0.715
NULL	Breast_Cancer_Res_2005_Jan_28_7(3)_R284-R290.nxml.txt.nlp	15987423	SENT86	22	22	8	8	tamoxifen	SULT1A1	PA451581	6817	0.715
NULL	J_Gastroenterol_2013_Feb_22_48(2)_222-237.nxml.txt.nlp	22722906	SENT216	4	4	18	18	ethanol	ANOVA	PA448073	4858	0.715
NULL	Cancer_Cell_2015_Jan_12_27(1)_57-71.nxml.txt.nlp	25584894	SENT880	16	16	20	20	doxycycline	ACSS2	PA449415	55902	0.715
NULL	Leukemia_2013_Jan_11_27(1)_32-40.nxml.txt.nlp	22781593	SENT254	0	0	17	17	ponatinib	FGFR1	PA165980594	2260	0.715
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Sep_5_65(Pt_10)_o2357.nxml.txt.nlp	21577826	SENT61	23	23	29	29	phenol	mol	PA450913	90527	0.715
NULL	Oncotarget_2013_Feb_25_4(2)_269-276.nxml.txt.nlp	23563166	SENT5	9	9	6	6	cisplatin	GEM	PA449014	2669	0.715
NULL	Stroke_Res_Treat_2012_Sep_15_2012_809417.nxml.txt.nlp	21941688	SENT116	19	19	23	23	tacrolimus	CA1	PA451578	759	0.715
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT147	0	0	5	5	perifosine	DR5	PA165291471	8795	0.715
NULL	Breast_Cancer_Res_2014_Sep_28_16(5)_449.nxml.txt.nlp	25260534	SENT481	20	20	5	5	irinotecan	KRAS	PA450085	3845	0.715
NULL	Acta_Histochem_Cytochem_2013_Dec_28_46(6)_187-197.nxml.txt.nlp	24610966	SENT171	20	20	46	46	pilocarpine	AQP5	PA450962	362	0.715
NULL	Anal_Bioanal_Chem_2012_Apr_3_402(10)_3177-3204.nxml.txt.nlp	22302165	SENT494	15	15	17	17	oxytetracycline	OTC	PA450757	5009	0.715
NULL	Mol_Imaging_Biol_2013_Apr_11_15(2)_136-147.nxml.txt.nlp	22886728	SENT87	1	1	26	26	orlistat	FDG	PA164776864	23583	0.715
NULL	Nucleic_Acids_Res_2005_Oct_6_33(18)_e154.nxml.txt.nlp	16214805	SENT150	25	25	11	11	ampicillin	SOC	PA448419	91544	0.715
NULL	Core_Evid_2010_Oct_21_5_61-76.nxml.txt.nlp	21042543	SENT378	18	18	3	3	irinotecan	KRAS	PA450085	3845	0.715
NULL	Br_J_Haematol_2014_Apr_30_165(2)_204-216.nxml.txt.nlp	24588354	SENT181	17	17	8	8	thrombin	GPVI	PA451674	51206	0.715
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT99	5	5	7	7	tenofovir	ABCC2	PA10204	1244	0.715
NULL	Oncotarget_2014_Feb_3_5(9)_2436-2449.nxml.txt.nlp	24810959	SENT69	14	14	33	33	paraformaldehyde	NG2	PA450790	1464;6048	0.715
NULL	J_Biol_Chem_2013_Jan_25_288(4)_2721-2733.nxml.txt.nlp	23209292	SENT124	4	4	33	33	heparin	FGF1	PA449855	2246	0.715
NULL	Protein_Cell_2014_May_26_5(5)_343-347.nxml.txt.nlp	24668462	SENT85	0	0	3	3	heparin	FGF1	PA449855	2246	0.715
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Aug_28_66(Pt_9)_o2417.nxml.txt.nlp	21588743	SENT58	8	8	11	11	benzaldehyde	mol	PA448571	90527	0.715
NULL	Front_Endocrinol_(Lausanne)_2014_Sep_26_5_155.nxml.txt.nlp	25309514	SENT41	33	33	12	12	glucosamine	GFAT	PA164747613	2673	0.715
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT192	12	12	9	9	trastuzumab	Yes	PA451743	7525	0.715
NULL	Cells_2014_May_8_3(2)_418-437.nxml.txt.nlp	24814761	SENT563	7	7	0	0	fludarabine	BECN1	PA449655	8678	0.715
NULL	ScientificWorldJournal_2013_Oct_27_2013_607285.nxml.txt.nlp	24288495	SENT38	15	15	12	12	dextran	NAC	PA449261	22861	0.715
NULL	J_Biol_Chem_2012_Dec_14_287(51)_43094-43107.nxml.txt.nlp	23118219	SENT643	3	3	5	5	hyaluronan	CD44	PA165958431	960	0.715
NULL	Lipids_Health_Dis_2011_Jan_18_10_8.nxml.txt.nlp	21241519	SENT103	7	7	17	17	simvastatin	ABCA1	PA451363	19	0.715
NULL	Clin_Infect_Dis_2013_Mar_1_56(5)_694-696.nxml.txt.nlp	23175557	SENT48	22	22	35	35	primaquine	G6PD	PA451103	2539	0.715
NULL	J_Antimicrob_Chemother_2015_Jan_24_70(1)_116-123.nxml.txt.nlp	25253286	SENT27	29	29	6	6	amodiaquine	ACT	PA448404	12;11332;9457;641455	0.715
NULL	Cancer_Cell_Int_2014_Jul_2_14_59.nxml.txt.nlp	25120382	SENT162	29	29	31	31	metformin	Met	PA450395	79811	0.715
NULL	Mar_Drugs_2014_Mar_13_12(3)_1512-1529.nxml.txt.nlp	24633252	SENT119	31	31	12	12	metformin	IL-6	PA450395	3569	0.715
NULL	Croat_Med_J_2013_Apr_54(2)_171-179.nxml.txt.nlp	23630144	SENT33	9	9	11	11	taurine	HO-1	PA451590	3162	0.715
NULL	Exp_Lung_Res_2013_Oct_1_39(8)_336-348.nxml.txt.nlp	23919450	SENT199	11	11	4	4	argatroban	PAR-1	PA164745516	2011;2149	0.715
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1224-1233.nxml.txt.nlp	22353810	SENT199	12	12	6	6	etoposide	MRP-1	PA449552	928	0.715
NULL	Br_J_Clin_Pharmacol_2013_Aug_23_76(2)_299-315.nxml.txt.nlp	23701319	SENT150	3	3	12	12	rituximab	IFN	PA451261	3439	0.715
NULL	J_Cell_Mol_Med_2014_Jan_4_18(1)_38-48.nxml.txt.nlp	24188742	SENT9	11	11	0	0	etoposide	PAX3	PA449552	5077	0.715
NULL	Acta_Pharmacol_Sin_2013_Feb_12_34(2)_255-261.nxml.txt.nlp	23147557	SENT138	38	38	16	16	pioglitazone	PPG	PA450970	5552	0.715
NULL	Br_J_Cancer_2011_Jul_26_105(3)_372-381.nxml.txt.nlp	21730979	SENT12	30	30	9	9	paclitaxel	RAD51	PA450761	5888	0.715
NULL	Drugs_R_D_2014_Sep_31_14(3)_177-184.nxml.txt.nlp	25079671	SENT142	25	25	31	31	miglitol	MCP-1	PA164776726	6347	0.715
NULL	Front_Oncol_2014_Sep_23_4_264.nxml.txt.nlp	25295231	SENT101	11	11	8	8	lenalidomide	p53	PA162363968	7157	0.715
NULL	J_Vet_Med_Sci_2014_Mar_1_76(3)_323-330.nxml.txt.nlp	24189582	SENT140	13	13	19	19	atovaquone	A-2	PA448502	27239	0.715
NULL	Cancers_(Basel)_2012_Jun_18_4(2)_581-600.nxml.txt.nlp	24213326	SENT48	24	24	7	7	carboplatin	CD4	PA448803	920	0.715
NULL	Oncoimmunology_2014_Jun_25_3_e29080.nxml.txt.nlp	25101222	SENT24	22	22	3	3	hyaluronan	CD11b	PA165958431	3684	0.715
NULL	J_Exp_Med_1960_Oct_31_112(5)_821-839.nxml.txt.nlp	13715281	SENT5	0	0	24	24	phenol	S20	PA450913	6224	0.715
NULL	Oncotarget_2012_Nov_17_3(12)_1600-1614.nxml.txt.nlp	23307622	SENT37	24	24	26	26	trastuzumab	HER2	PA451743	2064	0.715
NULL	Front_Aging_Neurosci_2014_Sep_11_6_218.nxml.txt.nlp	25309423	SENT171	0	0	10	10	resveratrol	SIRT1		23411	0.715
NULL	Environ_Health_Perspect_1987_Dec_76_211-219.nxml.txt.nlp	3447901	SENT8	23	23	2	2	formaldehyde	PERP	PA449703	64065	0.715
NULL	Lancet_2011_Aug_13_378(9791)_595-605.nxml.txt.nlp	21784508	SENT272	21	21	6	6	bisoprolol	Yes	PA448641	7525	0.715
NULL	Diabetes_2013_Mar_14_62(3)_953-964.nxml.txt.nlp	23223176	SENT141	13	13	15	15	paroxetine	PRX	PA450801	9588;57716	0.715
NULL	Case_Rep_Med_2013_Nov_28_2013_284323.nxml.txt.nlp	24369471	SENT22	33	33	14	14	indomethacin	EGFR	PA449982	1956	0.715
NULL	Cell_Death_Dis_2013_Oct_3_4(10)_e828.nxml.txt.nlp	24091671	SENT75	45	45	27	27	cetuximab	CD44	PA10040	960	0.715
NULL	Oncogene_2010_Sep_16_29(37)_5193-5203.nxml.txt.nlp	20581867	SENT171	28	28	3	3	lapatinib	p110	PA152241907	9733	0.715
NULL	Crit_Care_2003_Jun_25_7(Suppl_3)_P121.nxml.txt.nlp	NULL	SENT2	35	35	37	37	etoricoxib	ETO	PA164776853	862	0.715
NULL	Front_Oncol_2014_Oct_27_4_291.nxml.txt.nlp	25386408	SENT513	4	4	20	20	celecoxib	PC3	PA448871	57332;7832;5122	0.715
NULL	Nucleic_Acids_Res_2005_Dec_9_33(22)_6972-6981.nxml.txt.nlp	16340007	SENT416	3	3	10	10	bleomycin	DNA-PKcs	PA448645	5591	0.715
NULL	Braz_J_Med_Biol_Res_2013_Aug_13_46(8)_650-658.nxml.txt.nlp	23969971	SENT137	0	0	2	2	oxaliplatin	survivin	PA131285527	332	0.715
NULL	Basic_Res_Cardiol_2014_May_22_109(4)_416.nxml.txt.nlp	24847907	SENT7	20	20	16	16	olmesartan	AT1	PA164742950	9197;185	0.715
NULL	Front_Chem_2014_Dec_23_2_113.nxml.txt.nlp	25566531	SENT533	0	0	15	15	curcumin	CCL2	PA151958596	6347	0.715
NULL	ScientificWorldJournal_2014_Mar_12_2014_731462.nxml.txt.nlp	24715817	SENT134	4	4	23	23	diclofenac	IL-6	PA449293	3569	0.715
NULL	Oncotarget_2014_Mar_16_5(12)_4087-4102.nxml.txt.nlp	24961479	SENT245	41	41	29	29	hemin	HO-1	PA449849	3162	0.715
NULL	J_Ophthalmic_Inflamm_Infect_2012_May_14_2(4)_231-233.nxml.txt.nlp	22581347	SENT4	23	23	13	13	etanercept	TNF	PA449515	7124	0.715
NULL	Allergy_Asthma_Immunol_Res_2013_Nov_2_5(6)_415-417.nxml.txt.nlp	24179690	SENT18	0	0	7	7	sulfasalazine	IFN	PA451547	3439	0.715
NULL	Mol_Cancer_2008_Jun_30_7_60.nxml.txt.nlp	18590557	SENT168	17	17	22	22	doxorubicin	TRAIL	PA449412	8743	0.715
NULL	Arthritis_Res_Ther_2008_Jan_25_10(1)_R11.nxml.txt.nlp	18221522	SENT81	17	17	33	33	fluorescein	San	PA164746009	80218	0.715
NULL	Org_Med_Chem_Lett_2012_Mar_1_2_8.nxml.txt.nlp	22380426	SENT129	23	23	19	19	ethanol	mol	PA448073	90527	0.715
NULL	Biomed_Res_Int_2014_May_18_2014_453707.nxml.txt.nlp	24955358	SENT289	1	1	7	7	colchicine	BAP	PA449092	64374	0.715
NULL	Virol_J_2012_Feb_22_9_52.nxml.txt.nlp	22356831	SENT224	25	25	8	8	heparin	VLP	PA449855	391104	0.715
NULL	Mol_Biol_Rep_2013_Sep_28_40(10)_5573-5585.nxml.txt.nlp	24078156	SENT38	15	15	10	10	iron	FPN1	PA450087	30061	0.715
NULL	Eur_J_Clin_Pharmacol_2012_Sep_15_68(9)_1267-1274.nxml.txt.nlp	22418828	SENT159	18	18	15	15	pantoprazole	CYP2C19	PA450774	1557	0.715
NULL	EMBO_Mol_Med_2013_Jun_30_5(6)_935-948.nxml.txt.nlp	23629957	SENT123	21	21	7	7	cisplatin	COL6A3	PA449014	1293	0.715
NULL	Oncol_Lett_2014_Jan_11_7(1)_156-158.nxml.txt.nlp	24348840	SENT4	9	9	13	13	vindesine	CHOP	PA10232	1649	0.715
NULL	Adv_Hematol_2012_Feb_6_2012_485943.nxml.txt.nlp	22400030	SENT181	10	10	20	20	dapsone	CD4	PA449211	920	0.715
NULL	Indian_J_Anaesth_2014_Jul-Aug_58(4)_423-429.nxml.txt.nlp	25197110	SENT43	27	27	19	19	ondansetron	ODF	PA450705	8600	0.715
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_127043.nxml.txt.nlp	23227093	SENT218	18	18	24	24	lovastatin	RYR	PA450272	6261	0.715
NULL	Biomed_Res_Int_2014_May_14_2014_808302.nxml.txt.nlp	24949473	SENT320	33	33	24	24	simvastatin	CYP3A4	PA451363	1576	0.715
NULL	Chin_J_Cancer_2012_Jul_31(7)_319-326.nxml.txt.nlp	22257382	SENT93	2	2	5	5	cetuximab	EGFR	PA10040	1956	0.715
NULL	Clin_Med_Insights_Oncol_2011_Nov_7_5_349-364.nxml.txt.nlp	22174596	SENT155	10	10	17	17	pazopanib	IFN	PA165291492	3439	0.715
NULL	Mol_Cancer_2010_Nov_2_9_289.nxml.txt.nlp	21044322	SENT60	40	40	14	14	docetaxel	FBS	PA449383	64319;26269	0.715
NULL	Front_Neurol_2014_Jul_10_5_125.nxml.txt.nlp	25071710	SENT212	9	9	0	0	aspirin	STR	PA448497	6779	0.715
NULL	Oncotarget_2013_Nov_24_4(12)_2186-2207.nxml.txt.nlp	24327604	SENT119	8	8	14	14	bortezomib	P-gp	PA10252	5243	0.715
NULL	J_Oncol_2013_Feb_17_2013_872957.nxml.txt.nlp	23476648	SENT184	9	9	4	4	cisplatin	SFN	PA449014	25996;2810	0.715
NULL	EMBO_Mol_Med_2012_Sep_7_4(9)_896-909.nxml.txt.nlp	22887866	SENT149	9	9	5	5	lovastatin	SREBF1	PA450272	6720	0.715
NULL	Biologics_2009_Jul_13_3_289-301.nxml.txt.nlp	19707416	SENT220	13	13	8	8	trastuzumab	HER2	PA451743	2064	0.715
NULL	Mol_Biol_Cell_2013_Jul_15_24(14)_2186-2200.nxml.txt.nlp	23699397	SENT206	9	9	7	7	gefitinib	TRAIL	PA131301952	8743	0.715
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Jan_19_69(Pt_2)_o260-o261.nxml.txt.nlp	23424537	SENT90	0	0	16	16	flunarizine	mol	PA164776636	90527	0.714
NULL	Oncotarget_2012_Jan_28_3(1)_78-83.nxml.txt.nlp	22289679	SENT3	30	30	19	19	paclitaxel	PLK2	PA450761	10769	0.714
NULL	Carcinogenesis_2014_May_13_35(5)_1055-1066.nxml.txt.nlp	24419232	SENT269	3	3	10	10	metformin	CD31	PA450395	5175	0.714
NULL	F1000Res_2013_Jul_9_2_150.nxml.txt.nlp	24627787	SENT123	28	28	33	33	olanzapine	DIP	PA450688	23151;1831	0.714
NULL	J_Cell_Biol_1998_Jun_29_141(7)_1685-1695.nxml.txt.nlp	9647659	SENT22	5	5	7	7	thrombin	ADP	PA451674	23038	0.714
NULL	Oncol_Lett_2013_Mar_28_5(3)_935-942.nxml.txt.nlp	23426424	SENT10	32	32	22	22	oxaliplatin	ERCC1	PA131285527	2067	0.714
NULL	Oncoimmunology_2012_Aug_1_1(5)_699-716.nxml.txt.nlp	22934262	SENT272	6	6	18	18	gemcitabine	TLR9	PA449748	54106	0.714
NULL	Aging_(Albany_NY)_2010_Nov_11_2(11)_760-774.nxml.txt.nlp	21084729	SENT222	8	8	28	28	metformin	AMPK	PA450395	5563	0.714
NULL	Curr_Chem_Genomics_2010_Mar_1_4_1-8.nxml.txt.nlp	20448812	SENT142	3	3	37	37	methotrexate	OATP1B3	PA450428	28234	0.714
NULL	Curr_Pharm_Des_2012_Apr_18(11)_1519-1530.nxml.txt.nlp	22364136	SENT83	7	7	22	22	atorvastatin	RhoA	PA448500	387	0.714
NULL	Cells_2012_Sep_28_1(4)_699-710.nxml.txt.nlp	24710526	SENT41	20	20	25	25	heparin	HMGB1	PA449855	3146	0.714
NULL	Korean_J_Anesthesiol_2013_Dec_26_65(6)_583-584.nxml.txt.nlp	24427469	SENT39	14	14	7	7	remifentanil	CO2	PA451232	4513	0.714
NULL	J_Korean_Med_Sci_2013_Apr_27_28(4)_527-533.nxml.txt.nlp	23580227	SENT111	6	6	9	9	genistein	TRAIL	PA165109660	8743	0.714
NULL	Br_J_Cancer_2003_Mar_10_88(5)_754-759.nxml.txt.nlp	12618886	SENT137	14	14	7	7	amifostine	p53	PA448365	7157	0.714
NULL	Oncotarget_2012_May_4_3(4)_395-398.nxml.txt.nlp	22565037	SENT6	0	0	14	14	metformin	CD24	PA450395	100133941	0.714
NULL	Arthritis_Res_Ther_2009_Apr_6_11(Suppl_1)_S1.nxml.txt.nlp	19368701	SENT103	12	12	0	0	rituximab	ACR	PA451261	49	0.714
NULL	Curr_Cardiol_Rev_2010_Nov_6(4)_309-324.nxml.txt.nlp	22043207	SENT203	2	2	15	15	hemin	HO-1	PA449849	3162	0.714
NULL	ScientificWorldJournal_2013_Oct_27_2013_939830.nxml.txt.nlp	24288514	SENT151	6	6	15	15	carrageenan	ANOVA	PA448814	4858	0.714
NULL	EMBO_Mol_Med_2013_Aug_4_5(8)_1247-1262.nxml.txt.nlp	23737459	SENT149	38	38	40	40	nilotinib	parkin	PA165958345	5071	0.714
NULL	Avicenna_J_Phytomed_2012_Spring_2(2)_72-78.nxml.txt.nlp	25050233	SENT5	6	6	23	23	imipramine	HIC	PA449969	29969	0.714
NULL	Front_Neuroanat_2011_Jul_12_5_38.nxml.txt.nlp	21808606	SENT114	3	3	24	24	haloperidol	DARPP-32	PA449841	84152	0.714
NULL	Lab_Invest_2009_Nov_7_89(11)_1275-1290.nxml.txt.nlp	19736547	SENT269	4	4	17	17	curcumin	LOX-1	PA151958596	4973	0.714
NULL	Indian_J_Pharmacol_2008_Oct_40(Suppl_2)_S112-S142.nxml.txt.nlp	21593965	SENT761	9	9	28	28	fenofibrate	STZ	PA449594	6484	0.714
NULL	Breast_Cancer_Res_Treat_2014_Dec_19_143(2)_351-358.nxml.txt.nlp	24352574	SENT6	12	12	28	28	vinorelbine	2-21	PA451881	54097	0.714
NULL	Acta_Pharmacol_Sin_2009_Feb_5_30(2)_228-234.nxml.txt.nlp	19122672	SENT94	0	0	5	5	isoflurane	HO-1	PA450106	3162	0.714
NULL	Br_J_Pharmacol_2014_May_171(10)_2659-2670.nxml.txt.nlp	24116661	SENT45	21	21	16	16	naringenin	TRPP2	PA151958361	5311	0.714
NULL	Cell_Death_Dis_2014_Feb_13_5(2)_e1055.nxml.txt.nlp	24525731	SENT329	19	19	31	31	cisplatin	TXNL1	PA449014	9352	0.714
NULL	Diabetes_Care_2009_Dec_6_32(12)_2251-2257.nxml.txt.nlp	19808924	SENT58	0	0	6	6	exenatide	San	PA164749238	80218	0.714
NULL	Curr_Med_Chem_2011_Dec_18(35)_5424-5429.nxml.txt.nlp	22087835	SENT101	31	31	9	9	atorvastatin	FKBP51	PA448500	2289	0.714
NULL	Biomed_Res_Int_2013_May_27_2013_526367.nxml.txt.nlp	23762850	SENT63	15	15	22	22	fluorescein	CD44	PA164746009	960	0.714
NULL	Ann_R_Coll_Surg_Engl_2012_May_94(4)_227-231.nxml.txt.nlp	22613298	SENT93	14	14	38	38	gentamicin	SWI	PA449753	6594	0.714
NULL	Acta_Pharmacol_Sin_2010_Jul_28_31(7)_867-873.nxml.txt.nlp	20581857	SENT14	8	8	10	10	docetaxel	PC3	PA449383	57332;7832;5122	0.714
NULL	Int_J_Anal_Chem_2012_Mar_22_2012_592650.nxml.txt.nlp	22536244	SENT118	10	10	12	12	cyanocobalamin	B12	PA451892	7126;4709	0.714
NULL	Pharmaceutics_2011_Aug_31_3(3)_582-600.nxml.txt.nlp	24310598	SENT253	10	10	17	17	theophylline	TC1	PA451647	6947	0.714
NULL	Arthritis_Res_Ther_2014_Jul_24_16(4)_R157.nxml.txt.nlp	25059342	SENT233	28	28	16	16	bleomycin	IL-6	PA448645	3569	0.714
NULL	Int_J_Mol_Sci_2014_Nov_17_15(11)_21270-21285.nxml.txt.nlp	25407530	SENT353	4	4	16	16	collagenase	p38	PA449107	10598;1432;7965	0.714
NULL	Nature_2012_Aug_23_488(7412)_499-503.nxml.txt.nlp	22801503	SENT192	14	14	25	25	l-glutamine	CO2	PA10090	4513	0.714
NULL	Curr_Oncol_2009_Jul_16(Suppl_2)_S1-S13.nxml.txt.nlp	19672416	SENT251	37	37	21	21	tamoxifen	ARNO	PA451581	9266	0.714
NULL	Nat_Med_2012_Jul_18(7)_1118-1122.nxml.txt.nlp	22683780	SENT76	36	36	28	28	crizotinib	HGF	PA165946122	3569;6654;3082	0.714
NULL	Clin_Pharmacol_2011_Jun_22_3_13-25.nxml.txt.nlp	22287853	SENT188	22	22	10	10	simvastatin	OATP1B1	PA451363	10599	0.714
NULL	Br_J_Cancer_2012_Sep_25_107(7)_1059-1068.nxml.txt.nlp	22935581	SENT27	24	24	12	12	sorafenib	IFN	PA7000	3439	0.714
NULL	Biomed_Res_Int_2014_Apr_28_2014_549742.nxml.txt.nlp	24877113	SENT87	20	20	17	17	vincristine	U87	PA451879	677775;641648	0.714
NULL	BMB_Rep_2013_Jan_46(1)_59-64.nxml.txt.nlp	23351386	SENT89	14	14	27	27	auranofin	STAT3	PA448510	6774	0.714
NULL	Gut_Liver_2012_Oct_18_6(4)_464-470.nxml.txt.nlp	23170151	SENT29	32	32	21	21	propofol	ESD	PA451141	2098	0.714
NULL	Biochem_Biophys_Res_Commun_2007_Mar_23_354(4)_1084-1088.nxml.txt.nlp	17276402	SENT246	0	0	12	12	thrombin	AMPK	PA451674	5563	0.714
NULL	Pharmaceutics_2011_Nov_18_3(4)_865-913.nxml.txt.nlp	24309312	SENT376	10	10	28	28	ivermectin	P-gp	PA450133	5243	0.714
NULL	Int_J_Mol_Sci_2014_Nov_5_15(11)_20169-20208.nxml.txt.nlp	25380523	SENT2450	4	4	17	17	l-carnitine	Xin	PA450154	165904	0.714
NULL	Eur_J_Pediatr_2011_Mar_17_170(3)_389-391.nxml.txt.nlp	20848129	SENT118	3	3	13	13	cyclosporine	NPHS2	PA449167	7827	0.714
NULL	Mol_Cell_Endocrinol_2011_Jan_15_331(2)_194-204.nxml.txt.nlp	20688134	SENT889	19	19	29	29	buserelin	Yes	PA10253	7525	0.714
NULL	Acta_Pharmacol_Sin_2009_Jul_22_30(7)_956-964.nxml.txt.nlp	19543298	SENT5	9	9	27	27	simvastatin	SLCO2B1	PA451363	11309	0.714
NULL	J_Obes_2011_Sep_22_2011_528401.nxml.txt.nlp	21949903	SENT133	26	26	14	14	exenatide	GLP-1	PA164749238	100125288	0.714
NULL	Arthritis_Res_Ther_2003_Sep_12_5(Suppl_3)_55.nxml.txt.nlp	NULL	SENT8	17	17	21	21	rosiglitazone	AP-1	PA451283	2353;3727;2354;3725	0.714
NULL	Environ_Health_Perspect_2007_Dec_8_115(Suppl_1)_62-68.nxml.txt.nlp	18174952	SENT210	17	17	20	20	genistein	BRCA1	PA165109660	672	0.714
NULL	Ital_J_Pediatr_2011_Dec_19_37_58.nxml.txt.nlp	22182677	SENT162	24	24	17	17	primidone	LZP	PA451105	170392	0.714
NULL	J_Immunother_Cancer_2013_Nov_7_1(Suppl_1)_O17.nxml.txt.nlp	NULL	SENT10	34	34	16	16	imiquimod	TLR3	PA449972	7098	0.714
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT3	5	5	15	15	trastuzumab	EGF	PA451743	1950	0.714
NULL	J_Gen_Intern_Med_2007_Feb_17_22(2)_171-176.nxml.txt.nlp	17356982	SENT191	4	4	11	11	buprenorphine	Gen	PA448685	348654	0.714
NULL	Biologics_2009_Jul_13_3_289-301.nxml.txt.nlp	19707416	SENT147	25	25	11	11	lapatinib	HER2	PA152241907	2064	0.714
NULL	Genet_Mol_Biol_2009_Sep_1_Jul-Sep_32(3)_516-520.nxml.txt.nlp	21637514	SENT7	8	8	3	3	estradiol	EGF	PA449503	1950	0.714
NULL	Mol_Cancer_2012_Aug_8_11_53.nxml.txt.nlp	22871047	SENT305	14	14	6	6	cisplatin	HIN-1	PA449014	92304	0.714
NULL	Exp_Ther_Med_2014_Oct_24_8(4)_1092-1096.nxml.txt.nlp	25187802	SENT76	4	4	10	10	carvedilol	TLR4	PA448817	7099	0.714
NULL	Diabetes_2011_Jun_21_60(6)_1770-1778.nxml.txt.nlp	21562078	SENT198	0	0	7	7	metformin	STZ	PA450395	6484	0.714
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT265	2	2	0	0	mitomycin	MVP	PA450524	9961	0.714
NULL	Exp_Hematol_2014_Dec_42(12)_1053-1058_e1.nxml.txt.nlp	25127743	SENT7	15	15	9	9	potassium	KCNE2	PA451047	9992	0.714
NULL	Nat_Med_2013_Mar_10_19(3)_313-321.nxml.txt.nlp	23396211	SENT50	0	0	40	40	amlexanox	TBK1	PA164745310	29110	0.714
NULL	Oncol_Lett_2013_Feb_27_5(2)_435-439.nxml.txt.nlp	23420613	SENT22	13	13	7	7	paclitaxel	EGFR	PA450761	1956	0.714
NULL	Ann_Hematol_2014_Oct_27_93(1)_71-80.nxml.txt.nlp	24162333	SENT68	3	3	19	19	imatinib	IFN	PA10804	3439	0.714
NULL	Front_Neurol_2013_May_1_4_10.nxml.txt.nlp	23641231	SENT176	33	33	17	17	natalizumab	IFN	PA164747191	3439	0.714
NULL	Protein_Cell_2014_Jun_19_5(6)_469-479.nxml.txt.nlp	24748116	SENT90	5	5	0	0	paclitaxel	EB1	PA450761	9167;22919;10982	0.714
NULL	Clin_Dev_Immunol_2013_May_29_2013_289458.nxml.txt.nlp	23818912	SENT221	6	6	17	17	denosumab	CCR1	PA166048634	1230	0.714
NULL	Open_Microbiol_J_2008_Apr_29_2_38-48.nxml.txt.nlp	19088910	SENT164	42	42	37	37	ethanol	CO2	PA448073	4513	0.714
NULL	Amyloid_2014_Sep_11_21(3)_175-184.nxml.txt.nlp	24918964	SENT11	5	5	9	9	anakinra	TTR	PA10799	7276	0.714
NULL	J_Clin_Biochem_Nutr_2011_Jan_28_48(1)_96-100.nxml.txt.nlp	21297920	SENT117	15	15	38	38	hemin	HO-1	PA449849	3162	0.714
NULL	Braz_J_Med_Biol_Res_2012_Jul_20_45(10)_935-941.nxml.txt.nlp	22801415	SENT147	7	7	29	29	pioglitazone	adiponectin	PA450970	9370	0.714
NULL	Indian_J_Med_Res_2014_Jul_140(1)_130-137.nxml.txt.nlp	25222788	SENT8	28	28	13	13	gentamicin	CTX	PA449753	1593	0.714
NULL	Oxid_Med_Cell_Longev_2011_May_23_2011_213286.nxml.txt.nlp	NULL	SENT123	10	10	24	24	ethanol	ALDH2	PA448073	217	0.714
NULL	J_Cardiovasc_Dis_Res_2010_Jan-Mar_1(1)_19-22.nxml.txt.nlp	21188085	SENT27	13	13	3	3	paclitaxel	DES	PA450761	1674	0.714
NULL	Sci_Rep_2014_Dec_8_4_7355.nxml.txt.nlp	25483453	SENT12	31	31	35	35	fulvestrant	aromatase	PA164747170	1588	0.714
NULL	J_Clin_Biochem_Nutr_2010_Jan_29_46(1)_87-92.nxml.txt.nlp	20104270	SENT288	11	11	21	21	naringenin	ACAT2	PA151958361	39;8435	0.714
NULL	J_Adv_Pharm_Technol_Res_2011_Apr-Jun_2(2)_81-87.nxml.txt.nlp	22171298	SENT184	20	20	24	24	itraconazole	p53	PA450132	7157	0.714
NULL	Oncoimmunology_2014_Jan_17_3_e27574.nxml.txt.nlp	24800167	SENT20	3	3	40	40	cyclophosphamide	MYD88	PA449165	4615	0.714
NULL	Diabetes_Care_2013_Jan_10_36(Suppl_1)_S11-S66.nxml.txt.nlp	23264422	SENT1959	13	13	6	6	ramipril	DREAM	PA451223	30818	0.714
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT47	25	25	21	21	nutlin-3	TRAIL		8743	0.714
NULL	Mol_Pain_2013_Jun_10_9_27.nxml.txt.nlp	23758830	SENT11	5	5	10	10	tetracaine	ASIC1	PA451638	41	0.714
NULL	Multidiscip_Respir_Med_2013_Feb_6_8(1)_11.nxml.txt.nlp	23388501	SENT54	32	32	21	21	carbachol	ASM	PA448784	6609;283120	0.714
NULL	Behav_Brain_Funct_2009_Jan_15_5_3.nxml.txt.nlp	19146665	SENT79	5	5	29	29	ethanol	P35	PA448073	2220	0.714
NULL	Diabetes_Care_2011_Nov_15_34(11)_2381-2386.nxml.txt.nlp	21926282	SENT176	7	7	18	18	metformin	AMPK	PA450395	5563	0.714
NULL	Oncogene_2014_Sep_4_33(36)_4521-4530.nxml.txt.nlp	24662833	SENT64	36	36	46	46	bicalutamide	AKT	PA164746255	207	0.714
NULL	Breast_Cancer_Res_Treat_2013_Aug_20_141(1)_43-53.nxml.txt.nlp	23959396	SENT187	4	4	16	16	pertuzumab	HER3		2065	0.714
NULL	Front_Behav_Neurosci_2009_Sep_30_3_31.nxml.txt.nlp	19862348	SENT147	19	19	26	26	naloxone	PAG	PA450586	55824	0.714
NULL	Br_J_Cancer_1990_Dec_62(6)_891-896.nxml.txt.nlp	2124136	SENT11	10	10	13	13	mitomycin	HAI	PA450524	6692;6768	0.714
NULL	BMB_Rep_2014_Jan_47(1)_33-38.nxml.txt.nlp	24209634	SENT78	22	22	8	8	cisplatin	CXCR4	PA449014	7852	0.714
NULL	Br_J_Cancer_2010_Feb_16_102(4)_658-664.nxml.txt.nlp	20104222	SENT89	2	2	10	10	sunitinib	IFN	PA162372840	3439	0.714
NULL	Gastric_Cancer_2013_Jul_12_16(3)_345-354.nxml.txt.nlp	22968820	SENT210	21	21	14	14	oxaliplatin	FANCJ	PA131285527	83990	0.714
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT207	6	6	4	4	erlotinib	CYP3A	PA134687924	1574	0.714
NULL	Mol_Cancer_2010_Apr_23_9_87.nxml.txt.nlp	20416058	SENT197	28	28	34	34	doxorubicin	FADD	PA449412	8772	0.714
NULL	Cardiovasc_Diabetol_2005_May_15_4_6.nxml.txt.nlp	15892894	SENT127	6	6	22	22	losartan	DBP	PA450268	3295;1628;2638	0.714
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1013.nxml.txt.nlp	24457957	SENT305	9	9	3	3	orlistat	NOXA	PA164776864	5366	0.714
NULL	J_Clin_Biochem_Nutr_2009_Jan_27_44(1)_79-84.nxml.txt.nlp	19177192	SENT81	21	21	9	9	curcumin	HO-1	PA151958596	3162	0.714
NULL	Acta_Pharmacol_Sin_2009_Sep_4_30(9)_1283-1288.nxml.txt.nlp	19730428	SENT128	11	11	0	0	indomethacin	NAC	PA449982	22861	0.714
NULL	Cancers_(Basel)_2010_Dec_22_2(4)_2153-2170.nxml.txt.nlp	21390244	SENT95	40	40	5	5	gefitinib	EGFR	PA131301952	1956	0.714
NULL	J_Cell_Biol_2001_Oct_29_155(3)_427-438.nxml.txt.nlp	11673478	SENT239	4	4	2	2	pp2	PP1		5540;5464	0.714
NULL	Indian_J_Urol_2007_Jan-Mar_23(1)_67-69.nxml.txt.nlp	19675767	SENT22	13	13	5	5	dutasteride	DES	PA164749300	1674	0.714
NULL	Asian-Australas_J_Anim_Sci_2013_Feb_26(2)_233-240.nxml.txt.nlp	25049781	SENT80	0	0	6	6	l-carnitine	HGB	PA450154	114757	0.714
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT115	13	13	18	18	simvastatin	survivin	PA451363	332	0.714
NULL	Br_J_Cancer_2012_Sep_4_107(6)_947-955.nxml.txt.nlp	22892392	SENT107	19	19	24	24	lapatinib	EGF	PA152241907	1950	0.714
NULL	Br_J_Cancer_2011_Apr_12_104(8)_1270-1277.nxml.txt.nlp	21407219	SENT41	0	0	6	6	bevacizumab	San	PA130232992	80218	0.714
NULL	Int_J_Gen_Med_2012_Nov_9_5_935-942.nxml.txt.nlp	23204857	SENT119	17	17	12	12	isoflurane	CA3	PA450106	761	0.714
NULL	Cell_Death_Dis_2014_Jul_10_5(7)_e1321.nxml.txt.nlp	25010987	SENT129	8	8	13	13	doxorubicin	GAPDH	PA449412	2597	0.714
NULL	NMR_Biomed_2014_Jul_5_27(7)_760-773.nxml.txt.nlp	24798066	SENT105	4	4	1	1	trastuzumab	NACT	PA451743	284111	0.714
NULL	Clin_Med_Insights_Oncol_2011_Mar_16_5_35-43.nxml.txt.nlp	21499557	SENT44	7	7	15	15	trabectedin	CCL2	PA165958349	6347	0.714
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT7	0	0	33	33	curcumin	DR4	PA151958596	8797	0.714
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2014_Apr_30_70(Pt_5)_1321-1335.nxml.txt.nlp	24816101	SENT27	20	20	0	0	heparin	SGSH	PA449855	6448	0.714
NULL	J_Vet_Med_Sci_2013_Oct_30_75(10)_1287-1295.nxml.txt.nlp	23719751	SENT77	6	6	15	15	fluorescein	CD4	PA164746009	920	0.714
NULL	Anat_Cell_Biol_2011_Sep_29_44(3)_186-193.nxml.txt.nlp	22025970	SENT48	32	32	24	24	l-lysine	PLP	PA450280	25824;5744	0.714
NULL	Drug_Des_Devel_Ther_2014_Oct_31_8_2121-2128.nxml.txt.nlp	25382970	SENT73	0	0	3	3	curcumin	TTR	PA151958596	7276	0.714
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1013.nxml.txt.nlp	24457957	SENT15	6	6	25	25	bortezomib	NOXA	PA10252	5366	0.714
NULL	Arthritis_Res_Ther_2005_Dec_1_7(1)_R149-R155.nxml.txt.nlp	15642135	SENT27	22	22	13	13	infliximab	IL-6	PA452639	3569	0.714
NULL	Exp_Ther_Med_2013_Nov_18_6(5)_1177-1183.nxml.txt.nlp	24223641	SENT12	0	0	8	8	propofol	BMP2	PA451141	650	0.714
NULL	Cancer_Cell_Int_2003_Jul_15_3_11.nxml.txt.nlp	12904267	SENT96	12	12	21	21	vinblastine	p53	PA451877	7157	0.714
NULL	Oncotarget_2013_Nov_22_5(4)_933-943.nxml.txt.nlp	24659749	SENT123	10	10	2	2	nutlin-3	AML2		864	0.714
NULL	Anesth_Pain_Med_2014_Sep_9_4(4)_e14221.nxml.txt.nlp	25599022	SENT155	5	5	15	15	cisplatin	TNF-alpha	PA449014	7124	0.714
NULL	J_Adv_Pharm_Technol_Res_2012_Oct-Dec_3(4)_202-209.nxml.txt.nlp	23378940	SENT166	18	18	9	9	tolbutamide	CYP2C9	PA451718	1559	0.714
NULL	Mol_Neurobiol_2009_Aug_19_40(1)_55-72.nxml.txt.nlp	19452287	SENT352	30	30	25	25	lovastatin	adrenoleukodystrophy	PA450272	215	0.714
NULL	Cardiovasc_Diabetol_2006_Sep_26_5_20.nxml.txt.nlp	17002798	SENT34	22	22	27	27	gemfibrozil	CAD	PA449750	1677;790	0.714
NULL	Diagn_Pathol_2014_Jul_10_9_143.nxml.txt.nlp	25012722	SENT103	9	9	13	13	cisplatin	PDCD4	PA449014	27250	0.714
NULL	Chemother_Res_Pract_2012_Dec_20_2012_743193.nxml.txt.nlp	23320171	SENT122	26	26	7	7	docetaxel	HER2	PA449383	2064	0.714
NULL	J_Inflamm_(Lond)_2008_Dec_5_5_23.nxml.txt.nlp	19061493	SENT135	9	9	15	15	hemin	HO-1	PA449849	3162	0.714
NULL	Biochem_Res_Int_2012_Mar_4_2012_685267.nxml.txt.nlp	22496978	SENT208	10	10	0	0	thrombin	MT1-MMP	PA451674	4323	0.714
NULL	Acta_Pharmacol_Sin_2011_Jun_30_32(6)_853-860.nxml.txt.nlp	21623392	SENT31	17	17	7	7	capsaicin	TRPV1	PA448776	7442	0.714
NULL	Cancers_(Basel)_2011_May_24_3(2)_2478-2500.nxml.txt.nlp	24212820	SENT126	5	5	10	10	metformin	AMPK	PA450395	5563	0.714
NULL	Indian_J_Nephrol_2011_Oct-Dec_21(4)_258-263.nxml.txt.nlp	22022086	SENT62	44	44	36	36	azathioprine	IL-2	PA448515	3558	0.714
NULL	Arthritis_Res_Ther_2007_Oct_9_9(5)_R104.nxml.txt.nlp	17925024	SENT128	11	11	16	16	glucosamine	G10	PA164747613	8896;221527	0.714
NULL	Curr_Neuropharmacol_2007_Dec_5(4)_253-267.nxml.txt.nlp	19305742	SENT410	9	9	1	1	heparin	HBP	PA449855	3069;50865;7884;566	0.714
NULL	Breast_Cancer_Res_2010_Nov_16_12(6)_R96.nxml.txt.nlp	21080941	SENT149	35	35	41	41	lapatinib	HRG	PA152241907	3084;3273	0.714
NULL	Diagn_Pathol_2013_Nov_25_8_192.nxml.txt.nlp	24274261	SENT89	4	4	14	14	temozolomide	IFN	PA451609	3439	0.714
NULL	Clin_Pharmacokinet_2014_Sep_3_53(1)_1-16.nxml.txt.nlp	23999929	SENT343	19	19	6	6	rivaroxaban	P-gp	PA165958360	5243	0.714
NULL	Case_Rep_Med_2013_Dec_19_2013_189796.nxml.txt.nlp	24454390	SENT29	10	10	8	8	desmopressin	VIII	PA449237	1351	0.714
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT123	5	5	15	15	nutlin-3	p53		7157	0.714
NULL	Trials_2013_Sep_23_14_307.nxml.txt.nlp	24059911	SENT451	19	19	24	24	clindamycin	ACT	PA449035	12;11332;9457;641455	0.714
NULL	Breast_Cancer_Res_Treat_2012_Jul_31_134(1)_199-205.nxml.txt.nlp	22290080	SENT172	6	6	8	8	estradiol	c-fos	PA449503	2353	0.714
NULL	Clin_Ophthalmol_2012_Feb_20_6_277-282.nxml.txt.nlp	22375096	SENT106	24	24	19	19	triamcinolone	STA	PA451749	2010;2656	0.714
NULL	Arthritis_Res_2002_Sep_16_4(6)_R12.nxml.txt.nlp	12453315	SENT100	26	26	37	37	chloroquine	CRP	PA448948	1401;140913	0.714
NULL	EMBO_Mol_Med_2013_Feb_9_5(2)_309-325.nxml.txt.nlp	23300147	SENT181	15	15	12	12	geldanamycin	Hsp90	PA152031327	3320	0.714
NULL	Mol_Cancer_2008_Jun_3_7_47.nxml.txt.nlp	18519000	SENT194	7	7	10	10	gefitinib	EGFR	PA131301952	1956	0.714
NULL	Int_J_Anal_Chem_2014_Nov_18_2014_536823.nxml.txt.nlp	25484901	SENT169	23	23	16	16	glutaraldehyde	DTNB	PA449777	1838	0.714
NULL	Indian_J_Pharmacol_2014_Nov-Dec_46(6)_627-632.nxml.txt.nlp	25538335	SENT114	6	6	4	4	metformin	Q10	PA450395	27161	0.714
NULL	Front_Immunol_2012_Jun_7_3_131.nxml.txt.nlp	22701116	SENT178	15	15	23	23	dextran	RANTES	PA449261	6352	0.714
NULL	Acta_Pharmacol_Sin_2009_Jul_3_30(7)_879-888.nxml.txt.nlp	19574993	SENT154	6	6	14	14	galantamine	CA1	PA449726	759	0.714
NULL	J_Hematol_Oncol_2012_Aug_13_5_49.nxml.txt.nlp	22889180	SENT25	23	23	10	10	rituximab	CHOP	PA451261	1649	0.714
NULL	Arch_Med_Sci_2012_Jul_4_8(3)_533-541.nxml.txt.nlp	22852012	SENT221	20	20	14	14	dasatinib	KIT	PA162372878	3815	0.714
NULL	J_Korean_Med_Sci_2014_Jan_26_29(1)_53-60.nxml.txt.nlp	24431906	SENT9	11	11	18	18	doxorubicin	CHOP	PA449412	1649	0.714
NULL	Breast_Cancer_Res_2011_Apr_21_13(2)_R46.nxml.txt.nlp	21510863	SENT237	12	12	16	16	trastuzumab	HER2	PA451743	2064	0.714
NULL	Front_Chem_2014_Dec_23_2_113.nxml.txt.nlp	25566531	SENT246	0	0	24	24	curcumin	CCL2	PA151958596	6347	0.714
NULL	Mol_Cancer_2010_Nov_23_9_300.nxml.txt.nlp	21092249	SENT160	18	18	28	28	tamoxifen	CD133	PA451581	8842	0.714
NULL	Mol_Cancer_2012_Mar_21_11_13.nxml.txt.nlp	22436134	SENT226	12	12	39	39	doxorubicin	HuR	PA449412	1994	0.714
NULL	Mol_Cancer_2009_Nov_24_8_109.nxml.txt.nlp	19930708	SENT63	3	3	8	8	exemestane	aromatase	PA449563	1588	0.714
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Nov_9_67(Pt_12)_o3253.nxml.txt.nlp	22199762	SENT59	1	1	42	42	coumarin	C17	PA134521193	54360	0.714
NULL	J_Oncol_2012_Feb_6_2012_737981.nxml.txt.nlp	22481932	SENT83	28	28	37	37	etoposide	MUC16	PA449552	94025	0.714
NULL	J_Gastroenterol_2014_Dec_24_49(12)_1536-1547.nxml.txt.nlp	24366288	SENT209	12	12	3	3	rabeprazole	CYP2C19	PA451216	1557	0.714
NULL	Breast_Cancer_Res_2011_Jun_9_13(3)_R57.nxml.txt.nlp	21658222	SENT105	3	3	22	22	epirubicin	UGT	PA449476	7361;7355	0.714
NULL	Nat_Chem_Biol_2009_Sep_26_5(9)_640-646.nxml.txt.nlp	19633659	SENT54	30	30	10	10	hexachlorophene	DD2	PA449871	1646	0.714
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1013.nxml.txt.nlp	24457957	SENT315	0	0	9	9	orlistat	NOXA	PA164776864	5366	0.714
NULL	Oncotarget_2014_Mar_13_5(4)_1101-1110.nxml.txt.nlp	24658355	SENT11	9	9	7	7	tamoxifen	MKP-1	PA451581	1843	0.714
NULL	Bioinformation_2012_Jul_21_8(14)_658-663.nxml.txt.nlp	23055606	SENT3	4	4	13	13	imatinib	CML	PA10804	613	0.714
NULL	Oncogenesis_2012_Apr_2_1(4)_e5.nxml.txt.nlp	23552603	SENT149	4	4	11	11	celecoxib	RhoA	PA448871	387	0.714
NULL	Croat_Med_J_2013_Apr_54(2)_171-179.nxml.txt.nlp	23630144	SENT103	23	23	15	15	taurine	STZ	PA451590	6484	0.714
NULL	Int_J_Mol_Imaging_2011_Oct_26_2011_874585.nxml.txt.nlp	21490735	SENT124	16	16	30	30	docetaxel	FDG	PA449383	23583	0.714
NULL	J_Cancer_2013_Sep_10_4(8)_614-625.nxml.txt.nlp	24155773	SENT246	10	10	12	12	bortezomib	CRM1	PA10252	7514	0.714
NULL	Breast_Cancer_Res_2006_Nov_6_8(6)_215.nxml.txt.nlp	17096862	SENT80	15	15	5	5	docetaxel	HER2	PA449383	2064	0.714
NULL	Virol_J_2010_Nov_27_7_349.nxml.txt.nlp	21110887	SENT131	48	48	4	4	streptomycin	DEF	PA451512	27042	0.714
NULL	Curr_Neuropharmacol_2014_Jul_12(4)_365-379.nxml.txt.nlp	25342944	SENT110	6	6	20	20	fluoxetine	cPLA2	PA449673	10524	0.714
NULL	Arthritis_Res_Ther_2003_Dec_2_5(Suppl_4)_S12-S16.nxml.txt.nlp	15180892	SENT78	11	11	15	15	rituximab	CHOP	PA451261	1649	0.714
NULL	Arthritis_Res_Ther_2009_Jun_29_11(3)_R100.nxml.txt.nlp	19563672	SENT150	18	18	25	25	infliximab	IFN	PA452639	3439	0.714
NULL	Case_Rep_Pathol_2014_Sep_9_2014_301780.nxml.txt.nlp	25295208	SENT33	25	25	6	6	thyroglobulin	p53	PA164754910	7157	0.714
NULL	Acta_Pharmacol_Sin_2013_Apr_25_34(4)_455-463.nxml.txt.nlp	23524568	SENT132	0	0	6	6	pioglitazone	BACE1	PA450970	23621	0.714
NULL	ScientificWorldJournal_2014_Dec_9_2014_808320.nxml.txt.nlp	25548793	SENT142	23	23	7	7	heparin	RAC	PA449855	207	0.714
NULL	Indian_Dermatol_Online_J_2011_Jan-Jun_2(1)_43-45.nxml.txt.nlp	23130220	SENT26	21	21	29	29	dapsone	CO2	PA449211	4513	0.714
NULL	Case_Rep_Rheumatol_2012_Dec_24_2012_270315.nxml.txt.nlp	23424706	SENT4	0	0	7	7	tocilizumab	IL-6	PA165292659	3569	0.714
NULL	Tuberc_Respir_Dis_(Seoul)_2014_Mar_29_76(3)_114-119.nxml.txt.nlp	24734098	SENT126	10	10	19	19	paclitaxel	EGFR	PA450761	1956	0.714
NULL	Curr_Neuropharmacol_2007_Dec_5(4)_232-243.nxml.txt.nlp	19305740	SENT369	7	7	9	9	flurbiprofen	gamma	PA449683	9913	0.714
NULL	Int_J_Mol_Sci_2014_Sep_15_15(9)_16284-16301.nxml.txt.nlp	25226537	SENT489	4	4	21	21	mitomycin	BRCA2	PA450524	675	0.714
NULL	Breast_Cancer_Res_2005_Jul_20_7(5)_205-211.nxml.txt.nlp	16168139	SENT123	31	31	15	15	tamoxifen	HER2	PA451581	2064	0.714
NULL	Arthritis_Res_Ther_2008_Mar_17_10(2)_R33.nxml.txt.nlp	18346273	SENT154	9	9	2	2	infliximab	HMGB1	PA452639	3146	0.714
NULL	Oncotarget_2012_Aug_9_3(8)_774-782.nxml.txt.nlp	22885298	SENT52	38	38	27	27	tetracycline	IDH1	PA451640	3417	0.714
NULL	Mol_Cancer_2011_Sep_7_10_110.nxml.txt.nlp	21899728	SENT30	10	10	18	18	everolimus	HER2	PA164746311	2064	0.714
NULL	J_Vet_Med_Sci_2014_Oct_16_76(10)_1383-1387.nxml.txt.nlp	24931645	SENT228	2	2	9	9	sitagliptin	GLP-1	PA164748978	100125288	0.714
NULL	Brain_Sci_2014_May_6_4(2)_356-375.nxml.txt.nlp	24961766	SENT345	18	18	11	11	propofol	P28	PA451141	9446;7802;9527	0.714
NULL	Drug_Target_Insights_2012_Aug_6_6_19-39.nxml.txt.nlp	22915839	SENT34	16	16	23	23	doxorubicin	Hsp90	PA449412	3320	0.714
NULL	Int_J_Mol_Sci_2014_Sep_18_15(9)_16522-16543.nxml.txt.nlp	25238416	SENT812	0	0	19	19	metformin	LKB1	PA450395	6794	0.714
NULL	Neural_Regen_Res_2014_Nov_1_9(21)_1897-1901.nxml.txt.nlp	25558239	SENT0	20	20	28	28	diazepam	CA1	PA449283	759	0.714
NULL	Oncol_Rep_2013_Oct_24_30(4)_1587-1592.nxml.txt.nlp	23900512	SENT120	36	36	26	26	tranylcypromine	NOXA	PA451741	5366	0.714
NULL	J_Headache_Pain_2013_Apr_10_14(1)_33.nxml.txt.nlp	23574808	SENT113	9	9	3	3	capsaicin	CO2	PA448776	4513	0.714
NULL	J_Adv_Pract_Oncol_2014_Jan_1_Jan-Feb_5(1)_24-29.nxml.txt.nlp	25032030	SENT104	5	5	2	2	olanzapine	CYP1A2	PA450688	1544	0.714
NULL	Springerplus_2013_Jan_11_2_5.nxml.txt.nlp	23520572	SENT127	26	26	15	15	tamoxifen	ATAC	PA451581	6375	0.714
NULL	J_Hematol_Oncol_2012_Jun_8_5_27.nxml.txt.nlp	22682004	SENT146	15	15	10	10	etoposide	CHOP	PA449552	1649	0.714
NULL	J_Immunol_Res_2014_May_21_2014_371087.nxml.txt.nlp	24963497	SENT317	21	21	7	7	decitabine	DAC	PA164749631	13	0.714
NULL	Clin_Infect_Dis_2011_Mar_15_52(6)_695-706.nxml.txt.nlp	21367722	SENT179	0	0	3	3	oseltamivir	HD1	PA450721	3065	0.714
NULL	Glycobiology_2009_Jun_24_19(6)_576-582.nxml.txt.nlp	19240275	SENT168	42	42	34	34	desipramine	FB1	PA449233	29844	0.714
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT202	9	9	39	39	curcumin	CD31	PA151958596	5175	0.714
NULL	Nat_Commun_2013_Apr_9_4_1684.nxml.txt.nlp	23575688	SENT207	33	33	16	16	hemin	CO2	PA449849	4513	0.714
NULL	Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.nxml.txt.nlp	24736980	SENT267	6	6	8	8	rosuvastatin	OATP1B1	PA134308647	10599	0.714
NULL	Acta_Pharmacol_Sin_2012_Jul_18_33(7)_918-923.nxml.txt.nlp	22705728	SENT27	25	25	17	17	genistein	COX	PA165109660	1351	0.714
NULL	Indian_J_Dermatol_2010_Jan-Mar_55(1)_3-7.nxml.txt.nlp	20418968	SENT66	0	0	3	3	cosyntropin	ACTH	PA164749052	5443	0.714
NULL	Cancers_(Basel)_2011_Oct_11_3(4)_3824-3837.nxml.txt.nlp	24213113	SENT111	32	32	41	41	l-glutamine	CO2	PA10090	4513	0.714
NULL	Mol_Cells_2014_May_16_37(5)_418-425.nxml.txt.nlp	24850147	SENT319	2	2	9	9	methamphetamine	IL-8	PA450403	3576	0.714
NULL	Clin_Pharmacol_2010_Sep_6_2_155-162.nxml.txt.nlp	22291500	SENT55	16	16	8	8	clopidogrel	CYP2C19	PA449053	1557	0.714
NULL	Drugs_R_D_2014_Sep_31_14(3)_177-184.nxml.txt.nlp	25079671	SENT142	25	25	14	14	miglitol	MCP-1	PA164776726	6347	0.714
NULL	Cell_Microbiol_2013_Aug_14_15(8)_1385-1400.nxml.txt.nlp	23421931	SENT300	18	18	26	26	l-glutamine	GM-CSF	PA10090	1437	0.714
NULL	Neural_Plast_2012_Oct_24_2012_832757.nxml.txt.nlp	23150836	SENT148	35	35	32	32	haloperidol	hole	PA449841	80757	0.714
NULL	Tuberc_Res_Treat_2013_Mar_28_2013_108401.nxml.txt.nlp	23606961	SENT112	10	10	4	4	capreomycin	DST	PA164746226	667	0.714
NULL	Oncol_Rep_2014_Jul_13_32(1)_419-424.nxml.txt.nlp	24841903	SENT30	10	10	34	34	irinotecan	NDRG1	PA450085	10397	0.714
NULL	Nucl_Recept_Signal_2009_Dec_31_7_e012.nxml.txt.nlp	20087433	SENT194	0	0	18	18	indomethacin	EDN2	PA449982	1907	0.714
NULL	Oncoimmunology_2014_May_29_3_e28925.nxml.txt.nlp	25083322	SENT84	0	0	14	14	dasatinib	CD4	PA162372878	920	0.714
NULL	Eur_J_Immunol_2014_Jun_10_44(6)_1759-1769.nxml.txt.nlp	24595810	SENT76	0	0	2	2	fludrocortisone	CXCR4	PA164743961	7852	0.714
NULL	Front_Genet_2012_May_30_3_94.nxml.txt.nlp	22666228	SENT1121	5	5	13	13	temsirolimus	survivin	PA164746890	332	0.714
NULL	Biomed_Res_Int_2013_Nov_28_2013_676803.nxml.txt.nlp	24369534	SENT160	16	16	9	9	fluorescein	LHON	PA164746009	3974	0.714
NULL	Cancer_Cell_Int_2009_Sep_10_9_25.nxml.txt.nlp	19744341	SENT171	2	2	16	16	glucosamine	STAT3	PA164747613	6774	0.714
NULL	Nat_Commun_2013_Apr_9_4_1684.nxml.txt.nlp	23575688	SENT148	9	9	11	11	rolipram	CYLD	PA153906323	1540	0.713
NULL	Cell_Death_Dis_2013_Jun_27_4(6)_e696.nxml.txt.nlp	23807225	SENT176	13	13	11	11	doxycycline	AKT2	PA449415	208	0.713
NULL	Front_Immunol_2012_Jul_23_3_206.nxml.txt.nlp	22837759	SENT13	11	11	14	14	rituximab	CD4	PA451261	920	0.713
NULL	Front_Endocrinol_(Lausanne)_2014_Feb_25_5_22.nxml.txt.nlp	24611062	SENT17	0	0	4	4	estradiol	RhoA	PA449503	387	0.713
NULL	J_Cell_Mol_Med_2014_Oct_11_18(10)_2031-2043.nxml.txt.nlp	25109475	SENT351	0	0	8	8	valsartan	LKB1	PA451848	6794	0.713
NULL	Gut_Liver_2012_Apr_17_6(2)_139-148.nxml.txt.nlp	22570744	SENT149	23	23	8	8	sorafenib	SHARP	PA7000	23013	0.713
NULL	J_Inherit_Metab_Dis_2011_Dec_9_34(6)_1183-1197.nxml.txt.nlp	21744090	SENT136	4	4	13	13	dobutamine	MRI	PA449381	78996	0.713
NULL	Br_J_Pharmacol_2011_Mar_162(5)_1029-1044.nxml.txt.nlp	20958290	SENT204	33	33	37	37	carbachol	NMS	PA448784	129521	0.713
NULL	Oncotarget_2013_Nov_23_5(1)_196-210.nxml.txt.nlp	24344116	SENT185	2	2	21	21	doxorubicin	Bcl-2	PA449412	596	0.713
NULL	J_Hematol_Oncol_2008_Oct_1_1_16.nxml.txt.nlp	18828924	SENT123	6	6	11	11	tanespimycin	HER2	PA165291490	2064	0.713
NULL	J_Hum_Genet_2013_Jun_16_58(6)_353-361.nxml.txt.nlp	23677058	SENT120	21	21	9	9	etoposide	MRP3	PA449552	8714	0.713
NULL	Int_J_Biomed_Sci_2014_Sep_10(3)_146-157.nxml.txt.nlp	25324695	SENT7	17	17	13	13	bleomycin	LFA-1	PA448645	3683;3689	0.713
NULL	Br_J_Cancer_2009_Oct_20_101(8)_1290-1297.nxml.txt.nlp	19755992	SENT122	21	21	7	7	oxaliplatin	HIF-1	PA131285527	29072	0.713
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT192	21	21	16	16	curcumin	TRAIL	PA151958596	8743	0.713
NULL	Nat_Commun_2013_4_10_1038_ncomms3550.nxml.txt.nlp	24096541	SENT346	4	4	16	16	creatine	ADP	PA164778930	23038	0.713
NULL	Cancer_Cell_Int_2013_Sep_23_13_94.nxml.txt.nlp	24059699	SENT148	18	18	31	31	bevacizumab	VEGFR2	PA130232992	3791	0.713
NULL	Front_Aging_Neurosci_2014_Sep_11_6_218.nxml.txt.nlp	25309423	SENT216	5	5	12	12	resveratrol	spatial		219793	0.713
NULL	Cancer_Cell_Int_2011_Aug_19_11_29.nxml.txt.nlp	21854619	SENT210	18	18	26	26	cisplatin	BRCA1	PA449014	672	0.713
NULL	J_Immunol_Res_2014_Jul_16_2014_696812.nxml.txt.nlp	25133198	SENT271	10	10	6	6	rifaximin	CD103	PA164752443	3682	0.713
NULL	Ann_Surg_Treat_Res_2014_Feb_22_86(2)_68-75.nxml.txt.nlp	24761411	SENT39	0	0	19	19	resveratrol	survivin		332	0.713
NULL	Int_J_Inflam_2010_Aug_9_2010_151097.nxml.txt.nlp	21152121	SENT373	36	36	41	41	thrombin	C3a	PA451674	718	0.713
NULL	Asian_Spine_J_2013_Sep_4_7(3)_196-203.nxml.txt.nlp	24066215	SENT43	24	24	22	22	cefazolin	I-1	PA448839	11188	0.713
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Dec_22_69(Pt_1)_o142-o143.nxml.txt.nlp	23476398	SENT79	0	0	16	16	cinnarizine	mol	PA164749342	90527	0.713
NULL	Ann_Dermatol_2013_Nov_30_25(4)_500-502.nxml.txt.nlp	24371403	SENT26	5	5	3	3	imatinib	LDE	PA10804	7957	0.713
NULL	Exp_Ther_Med_2013_Mar_8_5(3)_707-710.nxml.txt.nlp	23404433	SENT137	8	8	10	10	cisplatin	DDP	PA449014	1678	0.713
NULL	Gut_Liver_2011_Jun_24_5(2)_160-164.nxml.txt.nlp	21814595	SENT26	10	10	15	15	propofol	ESD	PA451141	2098	0.713
NULL	JAKSTAT_2013_Jan_1_2(1)_e23576.nxml.txt.nlp	24058797	SENT62	29	29	18	18	staurosporine	IFN	PA165109623	3439	0.713
NULL	Int_J_Biol_Sci_2013_Aug_14_9(8)_766-777.nxml.txt.nlp	23983610	SENT52	25	25	18	18	curcumin	B19	PA151958596	59271	0.713
NULL	Front_Oncol_2013_Oct_29_3_269.nxml.txt.nlp	24195060	SENT92	35	35	12	12	paclitaxel	THBS1	PA450761	7057	0.713
NULL	Curr_Cardiol_Rev_2011_May_7(2)_110-122.nxml.txt.nlp	22548034	SENT243	2	2	4	4	sirolimus	RAPA	PA451365	55809	0.713
NULL	Exp_Diabetes_Res_2011_Jun_27_2011_947138.nxml.txt.nlp	21754922	SENT160	2	2	19	19	atropine	STZ	PA448505	6484	0.713
NULL	Clin_Epigenetics_2010_Sep_18_1(3-4)_101-116.nxml.txt.nlp	21258631	SENT212	7	7	15	15	genistein	p16INK4a	PA165109660	1029	0.713
NULL	Clin_Psychopharmacol_Neurosci_2012_Dec_20_10(3)_185-189.nxml.txt.nlp	23431037	SENT92	6	6	20	20	risperidone	HPD	PA451257	3242	0.713
NULL	Arthritis_Res_Ther_2005_Jul_13_7(5)_R1072-R1081.nxml.txt.nlp	16207324	SENT7	20	20	11	11	methimazole	ATD	PA450422	465	0.713
NULL	Diabetes_Care_2009_Apr_8_32(4)_720-725.nxml.txt.nlp	19131464	SENT17	23	23	31	31	metformin	ACR	PA450395	49	0.713
NULL	Exp_Ther_Med_2013_Feb_28_5(2)_555-560.nxml.txt.nlp	23403509	SENT170	13	13	18	18	sorafenib	SHARP	PA7000	23013	0.713
NULL	Case_Rep_Dermatol_2012_Jul_12_4(2)_158-162.nxml.txt.nlp	22807901	SENT45	11	11	17	17	tacrolimus	IL-10	PA451578	3586	0.713
NULL	Cancer_Metastasis_Rev_2010_Sep_24_29(3)_465-482.nxml.txt.nlp	20730632	SENT317	2	2	19	19	genistein	MEK4	PA165109660	6416	0.713
NULL	Cancers_(Basel)_2011_Apr_1_3(2)_1844-1860.nxml.txt.nlp	24212785	SENT76	16	16	25	25	cetuximab	ACRC	PA10040	93953	0.713
NULL	J_Inflamm_(Lond)_2005_Oct_31_2_14.nxml.txt.nlp	16259633	SENT308	0	0	9	9	staurosporine	CCR2	PA165109623	729230	0.713
NULL	Arthritis_Res_Ther_2010_Jun_28_12(3)_210.nxml.txt.nlp	20609263	SENT46	21	21	10	10	l-arginine	IFN	PA448478	3439	0.713
NULL	Nucleic_Acids_Res_2011_Mar_8_39(5)_1855-1867.nxml.txt.nlp	21059683	SENT69	29	29	23	23	ethanol	CO2	PA448073	4513	0.713
NULL	Ann_Surg_Treat_Res_2014_Feb_22_86(2)_68-75.nxml.txt.nlp	24761411	SENT155	3	3	11	11	oxaliplatin	Bcl-2	PA131285527	596	0.713
NULL	Curr_Med_Chem_2011_Jun_18(18)_2686-2714.nxml.txt.nlp	21649578	SENT340	19	19	32	32	erlotinib	PI3K	PA134687924	5290	0.713
NULL	Front_Endocrinol_(Lausanne)_2014_Sep_26_5_155.nxml.txt.nlp	25309514	SENT41	33	33	5	5	glucosamine	HBP	PA164747613	3069;50865;7884;566	0.713
NULL	Mol_Cancer_2009_Jun_5_8_32.nxml.txt.nlp	19497135	SENT289	10	10	8	8	resveratrol	NAC		22861	0.713
NULL	Jpn_Clin_Med_2013_Mar_6_4_7-13.nxml.txt.nlp	23966811	SENT32	11	11	17	17	esomeprazole	ESD	PA10075	2098	0.713
NULL	Nat_Methods_2013_Dec_3_10(12)_10_1038_nmeth_2724.nxml.txt.nlp	24185838	SENT111	28	28	3	3	nadh	ADP	PA164755085	23038	0.713
NULL	Oncotarget_2014_Jun_8_5(13)_5040-5053.nxml.txt.nlp	24970815	SENT175	14	14	9	9	cisplatin	AKT	PA449014	207	0.713
NULL	eLife_2013_Nov_5_2_e00969.nxml.txt.nlp	24192036	SENT71	20	20	11	11	doxorubicin	JNK	PA449412	5599	0.713
NULL	Fibrogenesis_Tissue_Repair_2012_Jul_9_5_10.nxml.txt.nlp	22776437	SENT141	18	18	10	10	s-adenosylmethionine	c-Myc	PA164754994	4609	0.713
NULL	Biomed_Res_Int_2014_Apr_14_2014_830374.nxml.txt.nlp	24829920	SENT141	10	10	4	4	suramin	ADP	PA10292	23038	0.713
NULL	Med_Sci_Monit_2012_Jul_1_18(7)_CS57-CS62.nxml.txt.nlp	22739739	SENT103	28	28	10	10	sulfapyridine	CYP2C9	PA164779050	1559	0.713
NULL	Acta_Pharmacol_Sin_2010_Dec_22_31(12)_1576-1582.nxml.txt.nlp	21102485	SENT13	3	3	17	17	ethanol	p85	PA448073	5296;5295;54776;23368	0.713
NULL	Open_Cardiovasc_Med_J_2012_Mar_22_6_28-32.nxml.txt.nlp	22481984	SENT91	0	0	8	8	fluvastatin	DAN	PA449688	5073;4681	0.713
NULL	Acta_Pharmacol_Sin_2011_Oct_5_32(10)_1285-1293.nxml.txt.nlp	21892200	SENT17	8	8	19	19	theophylline	CYP1A2	PA451647	1544	0.713
NULL	Cell_Oncol_(Dordr)_2011_Apr_11_34(2)_89-95.nxml.txt.nlp	21394646	SENT193	26	26	35	35	paclitaxel	HER2	PA450761	2064	0.713
NULL	Indian_J_Med_Res_2014_Apr_139(4)_572-578.nxml.txt.nlp	24927344	SENT88	9	9	2	2	acenocoumarol	CYP4F2	PA452632	8529	0.713
NULL	Front_Mol_Neurosci_2013_Jan_10_5_102.nxml.txt.nlp	23335879	SENT279	33	33	26	26	l-glutamine	B27	PA10090	56246	0.713
NULL	Environ_Health_Perspect_2006_Aug_10_114(8)_1154-1157.nxml.txt.nlp	16882518	SENT105	4	4	12	12	trypsin	Gen	PA451806	348654	0.713
NULL	Breast_Cancer_Res_2011_Mar_10_13(2)_R28.nxml.txt.nlp	21392397	SENT234	0	0	5	5	erlotinib	YB-1	PA134687924	4904	0.713
NULL	J_Biol_Chem_2011_Oct_7_286(40)_34998-35006.nxml.txt.nlp	21757733	SENT40	7	7	4	4	lipase	HSL	PA450239	3991	0.713
NULL	Cancers_(Basel)_2011_Oct_14_3(4)_3894-3908.nxml.txt.nlp	24213116	SENT121	12	12	5	5	gefitinib	EGFR	PA131301952	1956	0.713
NULL	Drug_Saf_2014_Feb_19_37(4)_201-211.nxml.txt.nlp	24550106	SENT27	4	4	18	18	omeprazole	CYP2C19	PA450704	1557	0.713
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT189	9	9	7	7	doxorubicin	B7-H1	PA449412	29126	0.713
NULL	Endocrinol_Diabetes_Metab_Case_Rep_2013_Sep_30_2013_130051.nxml.txt.nlp	24616777	SENT36	16	16	21	21	levothyroxine	WBS	PA450221	2006	0.713
NULL	J_Adv_Pract_Oncol_2013_Jul_1_Jul-Aug_4(4)_263-268.nxml.txt.nlp	25032007	SENT58	21	21	14	14	tamoxifen	CYP2D6	PA451581	1565	0.713
NULL	Front_Hum_Neurosci_2013_Mar_26_7_97.nxml.txt.nlp	23532379	SENT9	29	29	24	24	choline	B12	PA448976	7126;4709	0.713
NULL	Theranostics_2014_Jan_2_4(2)_119-133.nxml.txt.nlp	24465270	SENT133	0	0	22	22	estradiol	EGF	PA449503	1950	0.713
NULL	Oncogene_2010_Nov_11_29(45)_6040-6050.nxml.txt.nlp	20697357	SENT60	25	25	11	11	neomycin	Rho	PA450608	29984	0.713
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT162	2	2	6	6	atorvastatin	CD14	PA448500	929	0.713
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT127	27	27	34	34	paclitaxel	HER2	PA450761	2064	0.713
NULL	Cancer_Cell_Int_2005_Jul_24_5_22.nxml.txt.nlp	16042792	SENT75	23	23	4	4	vincristine	NAC	PA451879	22861	0.713
NULL	F1000Prime_Rep_2014_Dec_1_6_112.nxml.txt.nlp	25580266	SENT185	18	18	26	26	ustekinumab	IL-23	PA166048654	51561	0.713
NULL	Evid_Based_Complement_Alternat_Med_2014_Dec_24_2014_975450.nxml.txt.nlp	25610488	SENT8	20	20	5	5	aluminium	TPC	PA164760864	8030;60386	0.713
NULL	J_Radiat_Res_2014_Mar_1_55(2)_359-363.nxml.txt.nlp	24187329	SENT43	34	34	0	0	methotrexate	CHOP	PA450428	1649	0.713
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT248	24	24	14	14	metformin	HIF-1	PA450395	29072	0.713
NULL	Arthritis_Res_Ther_2005_Jun_3_7(4)_142-144.nxml.txt.nlp	15987496	SENT30	9	9	17	17	methotrexate	RAGE	PA450428	177	0.713
NULL	J_Oncol_2013_Feb_28_2013_897025.nxml.txt.nlp	23533410	SENT101	17	17	4	4	temsirolimus	CD34	PA164746890	947	0.713
NULL	Drugs_Context_2012_Nov_19_2012_212242.nxml.txt.nlp	24432031	SENT391	14	14	32	32	dacarbazine	IL-2	PA449197	3558	0.713
NULL	Acta_Pharmacol_Sin_2014_Jun_5_35(6)_727-737.nxml.txt.nlp	24793312	SENT135	6	6	10	10	losartan	B27	PA450268	56246	0.713
NULL	Environ_Health_Perspect_2002_Oct_110(Suppl_5)_757-759.nxml.txt.nlp	12426127	SENT7	0	0	12	12	arsenite	c-Jun	PA452638	3725	0.713
NULL	Cancers_(Basel)_2011_Aug_19_3(3)_3370-3393.nxml.txt.nlp	24212958	SENT47	0	0	12	12	trastuzumab	DM1	PA451743	338023;1760;28509	0.713
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT140	6	6	23	23	lovastatin	AKT	PA450272	207	0.713
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT146	6	6	18	18	dasatinib	JNK	PA162372878	5599	0.713
NULL	J_Med_Case_Rep_2013_May_31_7_144.nxml.txt.nlp	23724918	SENT92	18	18	16	16	l-carnitine	NAC	PA450154	22861	0.713
NULL	J_Exp_Clin_Cancer_Res_2009_Sep_23_28(1)_131.nxml.txt.nlp	19775450	SENT3	12	12	40	40	olanzapine	HEC	PA450688	10403	0.713
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT192	12	12	19	19	trastuzumab	Yes	PA451743	7525	0.713
NULL	Oncol_Lett_2014_Jul_25_8(1)_62-66.nxml.txt.nlp	24959219	SENT20	7	7	15	15	cyclophosphamide	CHOP	PA449165	1649	0.713
NULL	Tuberc_Respir_Dis_(Seoul)_2013_May_31_74(5)_235-239.nxml.txt.nlp	23750173	SENT38	22	22	20	20	etoposide	CHOP	PA449552	1649	0.713
NULL	Drugs_R_D_2014_Sep_31_14(3)_177-184.nxml.txt.nlp	25079671	SENT151	24	24	21	21	acarbose	IL-6	PA448010	3569	0.713
NULL	Cardiovasc_Diabetol_2010_Sep_23_9_57.nxml.txt.nlp	20863381	SENT27	10	10	23	23	pioglitazone	DM2	PA450970	28508	0.713
NULL	Blood_Cancer_J_2013_Oct_18_3(10)_e153.nxml.txt.nlp	24141622	SENT92	19	19	17	17	fludarabine	Mcl-1	PA449655	4170	0.713
NULL	Oncotarget_2014_Jun_8_5(17)_7446-7457.nxml.txt.nlp	25277184	SENT43	16	16	11	11	cisplatin	MDM2	PA449014	4193	0.713
NULL	Reprod_Biol_Endocrinol_2004_Mar_24_2_13.nxml.txt.nlp	15040802	SENT185	10	10	17	17	baclofen	PCNA	PA448533	5111	0.713
NULL	Clin_Dev_Immunol_2013_Nov_25_2013_271246.nxml.txt.nlp	24371445	SENT340	17	17	3	3	irinotecan	CT26	PA450085	168400	0.713
NULL	ISRN_Cardiol_2011_Jun_16_2011_397136.nxml.txt.nlp	22347642	SENT152	6	6	35	35	resveratrol	KDR		3791	0.713
NULL	Onco_Targets_Ther_2014_Mar_20_7_447-456.nxml.txt.nlp	24672247	SENT151	3	3	15	15	paclitaxel	CLU	PA450761	1191	0.713
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT272	7	7	0	0	cisplatin	MVP	PA449014	9961	0.713
NULL	Oncotarget_2014_Aug_4_5(17)_7760-7775.nxml.txt.nlp	25226615	SENT224	7	7	27	27	cisplatin	ADM	PA449014	133	0.713
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1676-1682.nxml.txt.nlp	19844234	SENT149	14	14	5	5	lapatinib	PTEN	PA152241907	5728	0.713
NULL	Cancer_Med_2014_Jun_19_3(3)_555-564.nxml.txt.nlp	24648042	SENT107	46	46	12	12	chlorambucil	PI3K	PA448926	5290	0.713
NULL	Front_Neural_Circuits_2015_Jan_12_8_150.nxml.txt.nlp	25628540	SENT39	28	28	20	20	midazolam	spatial	PA450496	219793	0.713
NULL	J_Int_Soc_Sports_Nutr_2010_Aug_22_7_28.nxml.txt.nlp	20727213	SENT151	3	3	13	13	l-glutamine	IL-6	PA10090	3569	0.713
NULL	Core_Evid_2010_Jul_27_5_1-10.nxml.txt.nlp	20694135	SENT123	29	29	4	4	levodopa	CLE	PA450213	51637	0.713
NULL	Allergy_Asthma_Immunol_Res_2014_Nov_24_6(6)_558-566.nxml.txt.nlp	25374756	SENT69	13	13	30	30	fluorescein	San	PA164746009	80218	0.713
NULL	Ann_Rheum_Dis_2014_Jan_13_73(1)_95-100.nxml.txt.nlp	23765873	SENT34	26	26	2	2	infliximab	IL-6	PA452639	3569	0.713
NULL	Oncoscience_2014_Oct_5_1(10)_624-633.nxml.txt.nlp	25593992	SENT52	25	25	18	18	doxycycline	PCTAIRE1	PA449415	5127	0.713
NULL	Front_Neurosci_2014_Jun_24_8_176.nxml.txt.nlp	25009459	SENT1043	8	8	11	11	ivermectin	P2X4	PA450133	5025	0.713
NULL	Lancet_2011_Aug_13_378(9791)_595-605.nxml.txt.nlp	21784508	SENT272	21	21	0	0	bisoprolol	P14	PA448641	11102;;6280;56259	0.713
NULL	Br_J_Pharmacol_2011_Jul_163(6)_1263-1275.nxml.txt.nlp	21391977	SENT100	26	26	2	2	ketoconazole	CYP2C8	PA450146	1558	0.713
NULL	Oncol_Rep_2013_Oct_24_30(4)_1587-1592.nxml.txt.nlp	23900512	SENT120	31	31	26	26	pargyline	NOXA	PA450797	5366	0.713
NULL	J_Int_Soc_Sports_Nutr_2008_Jan_10_5_2.nxml.txt.nlp	18186936	SENT106	37	37	35	35	glucosamine	Q10	PA164747613	27161	0.713
NULL	Dermatoendocrinol_2013_Apr_1_5(2)_252-263.nxml.txt.nlp	24194965	SENT180	2	2	4	4	metformin	AMPK	PA450395	5563	0.713
NULL	Nat_Med_2011_Nov_13_17(12)_1641-1645.nxml.txt.nlp	22081024	SENT40	23	23	12	12	paclitaxel	CRAF	PA450761	5894	0.713
NULL	Viruses_2013_Oct_28_5(11)_2624-2642.nxml.txt.nlp	24169630	SENT125	3	3	9	9	hydralazine	MICA	PA449894	100507436	0.713
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT103	17	17	19	19	trastuzumab	HER2	PA451743	2064	0.713
NULL	Epigenetics_2012_Nov_1_7(11)_1225-1229.nxml.txt.nlp	23069641	SENT38	10	10	20	20	carboplatin	BRCA1	PA448803	672	0.713
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1046.nxml.txt.nlp	24503538	SENT83	20	20	26	26	doxorubicin	FGFR4	PA449412	2264	0.713
NULL	Acta_Pharmacol_Sin_2012_Mar_27_33(3)_342-350.nxml.txt.nlp	22367283	SENT132	4	4	12	12	thrombin	p115	PA451674	8615;393	0.713
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT93	24	24	21	21	perifosine	TRAIL	PA165291471	8743	0.713
NULL	Bioinformatics_2013_Jul_1_29(13)_i126-i134.nxml.txt.nlp	23812976	SENT287	29	29	40	40	mesalazine	LTA4H	PA450384	4048	0.713
NULL	Br_J_Cancer_2013_May_28_108(10)_2021-2032.nxml.txt.nlp	23632475	SENT184	0	0	5	5	metformin	p53	PA450395	7157	0.713
NULL	Exp_Ther_Med_2014_Nov_17_8(5)_1484-1488.nxml.txt.nlp	25289046	SENT138	31	31	24	24	cisplatin	ECRG2	PA449014	84651	0.713
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT111	8	8	39	39	gefitinib	PTEN	PA131301952	5728	0.713
NULL	Oxid_Med_Cell_Longev_2013_Apr_17_2013_737591.nxml.txt.nlp	23710289	SENT165	10	10	1	1	ethanol	STAT3	PA448073	6774	0.713
NULL	J_Gynecol_Oncol_2014_Jan_8_25(1)_22-29.nxml.txt.nlp	24459577	SENT21	14	14	10	10	cisplatin	NACT	PA449014	284111	0.713
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Jul_23_3(7)_e126.nxml.txt.nlp	25054314	SENT24	8	8	2	2	docetaxel	OATP1B3	PA449383	28234	0.713
NULL	Clin_Endosc_2011_Sep_30_44(1)_22-26.nxml.txt.nlp	22741108	SENT116	5	5	36	36	midazolam	ESD	PA450496	2098	0.713
NULL	Acta_Pharmacol_Sin_2010_Apr_22_31(4)_476-484.nxml.txt.nlp	20305681	SENT63	32	32	40	40	fluorescein	CD34	PA164746009	947	0.713
NULL	Biochem_Res_Int_2011_Nov_30_2011_850924.nxml.txt.nlp	21151514	SENT163	3	3	6	6	l-cysteine	IscS	PA449173	9054	0.713
NULL	Exp_Lung_Res_2013_Oct_1_39(8)_336-348.nxml.txt.nlp	23919450	SENT90	6	6	13	13	thrombin	PAR-1	PA451674	2011;2149	0.713
NULL	Br_J_Cancer_2009_Mar_10_100(5)_758-763.nxml.txt.nlp	19259094	SENT114	6	6	11	11	decitabine	MLH1	PA164749631	4292	0.713
NULL	Reprod_Biol_Endocrinol_2003_Feb_14_1_22.nxml.txt.nlp	12646054	SENT180	17	17	13	13	estradiol	aromatase	PA449503	1588	0.713
NULL	Biologics_2012_Jul_13_6_221-231.nxml.txt.nlp	22904614	SENT54	15	15	10	10	cetuximab	PTEN	PA10040	5728	0.713
NULL	Bone_Joint_Res_2014_Apr_1_3(4)_108-116.nxml.txt.nlp	24740649	SENT73	8	8	24	24	fluorescein	CD42a	PA164746009	2815	0.713
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R91.nxml.txt.nlp	22541814	SENT210	7	7	11	11	pp2	PAR3		56288;2151	0.713
NULL	Blood_Res_2014_Mar_24_49(1)_3-4.nxml.txt.nlp	24724058	SENT21	7	7	0	0	thioguanine	TPMT	PA451663	7172	0.713
NULL	Nat_Med_2012_Aug_22_18(8)_10_1038_nm_2827.nxml.txt.nlp	22820645	SENT175	12	12	20	20	paraformaldehyde	TRPV1	PA450790	7442	0.713
NULL	Indian_J_Pharmacol_2008_Oct_40(Suppl_2)_S66-S91.nxml.txt.nlp	21593982	SENT1470	33	33	18	18	furosemide	HARC	PA449719	55664	0.713
NULL	J_Med_Case_Reports_2012_Feb_10_6_55.nxml.txt.nlp	22325469	SENT54	18	18	11	11	creatine	Q10	PA164778930	27161	0.713
NULL	Acta_Pharmacol_Sin_2011_Jun_32(6)_758-764.nxml.txt.nlp	21642947	SENT102	16	16	21	21	fluphenazine	TREK-1	PA449676	3776	0.713
NULL	Biologics_2009_Sep_15_3_429-441.nxml.txt.nlp	19774210	SENT304	11	11	42	42	leucovorin	IFL	PA450198	3439	0.713
NULL	Int_J_Biol_Sci_2012_Mar_7_8(4)_470-485.nxml.txt.nlp	22419892	SENT220	16	16	18	18	tamoxifen	aromatase	PA451581	1588	0.713
NULL	Cancers_(Basel)_2014_Jun_27_6(3)_1298-1327.nxml.txt.nlp	24978435	SENT914	1	1	11	11	finasteride	MMP9	PA449627	4318	0.713
NULL	Front_Oncol_2014_Nov_10_4_316.nxml.txt.nlp	25426448	SENT110	21	21	12	12	cetuximab	CRT	PA10040	811	0.713
NULL	F1000Res_2013_Oct_8_2_173.nxml.txt.nlp	24555085	SENT182	2	2	11	11	hydrocortisone	CYP3A5	PA449905	1577	0.713
NULL	Biomed_Res_Int_2014_Jan_20_2014_948427.nxml.txt.nlp	24563867	SENT113	2	2	13	13	buspirone	STZ	PA448689	6484	0.713
NULL	Breast_Cancer_Res_2005_Aug_5_7(5)_212-214.nxml.txt.nlp	16168140	SENT71	7	7	12	12	trastuzumab	PTEN	PA451743	5728	0.713
NULL	Diabetes_2009_Jun_31_58(6)_1434-1439.nxml.txt.nlp	19336679	SENT154	33	33	35	35	metformin	SLC22A1	PA450395	6580	0.713
NULL	J_Cell_Biol_2008_Jul_28_182(2)_327-340.nxml.txt.nlp	18644889	SENT354	4	4	7	7	estradiol	AKT	PA449503	207	0.713
NULL	Int_J_Endocrinol_Metab_2013_Oct_21_11(4)_e10266.nxml.txt.nlp	24719624	SENT5	20	20	27	27	glibenclamide	STZ	PA449782	6484	0.713
NULL	J_Carcinog_2012_Oct_27_11_16.nxml.txt.nlp	23230393	SENT59	15	15	3	3	tanespimycin	HER-2	PA165291490	2064	0.713
NULL	J_Nat_Prod_2011_Apr_25_74(4)_567-573.nxml.txt.nlp	21348461	SENT48	11	11	6	6	vinblastine	MDR1	PA451877	5243	0.713
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1137-1144.nxml.txt.nlp	20234366	SENT61	15	15	22	22	cetuximab	KRAS	PA10040	3845	0.713
NULL	Front_Neurosci_2015_Jan_9_8_441.nxml.txt.nlp	25620908	SENT229	5	5	22	22	nadh	PARK2	PA164755085	5071	0.713
NULL	Neuropsychopharmacology_2011_May_23_36(6)_1237-1247.nxml.txt.nlp	21346736	SENT225	24	24	26	26	atomoxetine	ATX	PA134688071	5168;23049	0.713
NULL	Cancer_Causes_Control_2013_Aug_18_24(8)_1605-1614.nxml.txt.nlp	23775025	SENT64	33	33	30	30	doxorubicin	MTHFR	PA449412	4524	0.713
NULL	Oncotarget_2014_Jun_6_5(13)_4935-4944.nxml.txt.nlp	24952732	SENT107	6	6	19	19	doxazosin	PDK1	PA449407	5170;5163	0.713
NULL	J_Gastrointest_Cancer_2010_Mar_28_41(1)_60-70.nxml.txt.nlp	19946763	SENT316	3	3	19	19	imatinib	MDR1	PA10804	5243	0.713
NULL	Eur_J_Clin_Pharmacol_2012_Sep_15_68(9)_1267-1274.nxml.txt.nlp	22418828	SENT5	10	10	3	3	pantoprazole	CYP2C19	PA450774	1557	0.713
NULL	Int_J_Mol_Sci_2012_Apr_24_13(4)_5242-5253.nxml.txt.nlp	22606041	SENT144	34	34	47	47	l-glutamine	CO2	PA10090	4513	0.713
NULL	Int_J_Mol_Sci_2014_Mar_20_15(3)_4946-4964.nxml.txt.nlp	24658439	SENT100	33	33	17	17	capsaicin	GBF	PA448776	1316	0.713
NULL	EJNMMI_Res_2011_Jun_7_1_1.nxml.txt.nlp	21845232	SENT134	3	3	16	16	panitumumab	EGFR	PA162373091	1956	0.713
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R91.nxml.txt.nlp	22541814	SENT209	4	4	12	12	thrombin	HO-1	PA451674	3162	0.713
NULL	FEBS_Open_Bio_2011_Dec_27_2_1-5.nxml.txt.nlp	23650573	SENT84	3	3	21	21	sunitinib	PI3K	PA162372840	5290	0.713
NULL	Oxid_Med_Cell_Longev_2012_May_28_2012_632959.nxml.txt.nlp	22690272	SENT118	13	13	21	21	genistein	PC-3	PA165109660	692094	0.713
NULL	Curr_Genomics_2014_Jun_15(3)_217-230.nxml.txt.nlp	24955029	SENT289	8	8	25	25	oxygen	ROS	PA450744	6098	0.713
NULL	Br_J_Cancer_2001_Aug_85(4)_600-607.nxml.txt.nlp	11506502	SENT4	25	25	27	27	hyaluronan	CD44	PA165958431	960	0.713
NULL	Br_J_Cancer_2009_Jul_21_101(2)_269-277.nxml.txt.nlp	19603033	SENT3	31	31	7	7	cisplatin	XIAP	PA449014	331	0.713
NULL	Mol_Vis_2012_Apr_11_18_901-908.nxml.txt.nlp	22539869	SENT154	7	7	4	4	curcumin	HO-1	PA151958596	3162	0.713
NULL	Mol_Cell_Proteomics_2012_Feb_6_11(2)_M111_015222.nxml.txt.nlp	22147731	SENT635	21	21	4	4	cetuximab	PIK3CA	PA10040	5290	0.713
NULL	Breast_Cancer_Res_2009_May_29_11(3)_206.nxml.txt.nlp	19519952	SENT48	15	15	34	34	tamoxifen	DES	PA451581	1674	0.713
NULL	Mol_Biol_Int_2011_Jun_8_2011_571242.nxml.txt.nlp	22091408	SENT379	12	12	10	10	lovastatin	P-gp	PA450272	5243	0.713
NULL	Oncotarget_2013_Nov_22_5(4)_933-943.nxml.txt.nlp	24659749	SENT51	29	29	3	3	nutlin-3	p53		7157	0.713
NULL	Blood_Cancer_J_2014_Aug_1_4(8)_e232.nxml.txt.nlp	25083816	SENT218	43	43	13	13	daunorubicin	HMGCR	PA449212	3156	0.713
NULL	Br_J_Cancer_2013_Jun_25_108(12)_2464-2469.nxml.txt.nlp	23695016	SENT36	20	20	26	26	carboplatin	CRT	PA448803	811	0.713
NULL	Arthritis_Res_Ther_2008_Mar_17_10(2)_R33.nxml.txt.nlp	18346273	SENT129	7	7	0	0	infliximab	HMGB1	PA452639	3146	0.713
NULL	Br_J_Cancer_2000_Oct_83(8)_980-985.nxml.txt.nlp	10993642	SENT1	20	20	10	10	fluorouracil	IFN	PA128406956	3439	0.713
NULL	Oxid_Med_Cell_Longev_2011_Nov_24_2011_467180.nxml.txt.nlp	22191013	SENT198	0	0	2	2	riluzole	GDNF	PA451251	2668	0.713
NULL	Cell_Commun_Signal_2010_Jun_12_8_11.nxml.txt.nlp	20540792	SENT333	20	20	14	14	thalidomide	DDB1	PA451644	1642	0.713
NULL	Trials_2012_Sep_8_13_160.nxml.txt.nlp	22958580	SENT44	28	28	17	17	vecuronium	MVD	PA164748865	4597	0.713
NULL	Patient_Prefer_Adherence_2013_May_20_7_435-446.nxml.txt.nlp	23717037	SENT212	7	7	17	17	teriparatide	ACR	PA451620	49	0.713
NULL	Oncotarget_2013_May_1_4(5)_705-714.nxml.txt.nlp	23670029	SENT114	18	18	14	14	bevacizumab	p53	PA130232992	7157	0.713
NULL	Curr_Pharm_Biotechnol_2011_Jan_12(1)_35-41.nxml.txt.nlp	20932261	SENT145	7	7	4	4	hyperforin	TRPC3	PA165985514	7222	0.713
NULL	Cell_Death_Dis_2012_Nov_15_3(11)_e422.nxml.txt.nlp	23152058	SENT130	26	26	37	37	doxycycline	ZNF143	PA449415	7702	0.713
NULL	Cell_Death_Differ_2010_Mar_16_17(3)_499-512.nxml.txt.nlp	19834490	SENT235	16	16	22	22	bevacizumab	San	PA130232992	80218	0.713
NULL	Int_J_Mol_Med_2015_Jan_29_35(1)_59-71.nxml.txt.nlp	25355277	SENT82	5	5	21	21	mannitol	DEC1	PA450320	8553;50514	0.713
NULL	Breast_Cancer_(Auckl)_2011_Oct_9_5_209-226.nxml.txt.nlp	22084574	SENT258	6	6	8	8	tamoxifen	aromatase	PA451581	1588	0.713
NULL	Cancer_Imaging_2010_Jul_6_10(1)_144-152.nxml.txt.nlp	20605761	SENT78	6	6	14	14	lapatinib	HER2	PA152241907	2064	0.713
NULL	Mol_Cancer_2010_Nov_25_9_305.nxml.txt.nlp	21108789	SENT77	29	29	33	33	doxorubicin	PI3K	PA449412	5290	0.713
NULL	J_Exp_Med_1994_May_1_179(5)_1737-1741.nxml.txt.nlp	8163952	SENT9	4	4	13	13	thrombin	MCP-1	PA451674	6347	0.713
NULL	J_Hematol_Oncol_2014_Aug_1_7_52.nxml.txt.nlp	25085632	SENT169	16	16	22	22	sunitinib	AKT	PA162372840	207	0.713
NULL	J_Immunol_Res_2014_May_12_2014_897249.nxml.txt.nlp	24901013	SENT125	29	29	35	35	natalizumab	CD4	PA164747191	920	0.713
NULL	J_Neuroinflammation_2010_Nov_18_7_81.nxml.txt.nlp	21087489	SENT84	34	34	10	10	pilocarpine	CA1	PA450962	759	0.713
NULL	Int_J_Vasc_Med_2012_Jul_24_2012_508416.nxml.txt.nlp	22888436	SENT45	3	3	17	17	troglitazone	MCP-1	PA451799	6347	0.713
NULL	Nat_Med_2012_Feb_5_18(3)_396-404.nxml.txt.nlp	22306733	SENT202	10	10	8	8	captopril	BMP7	PA448780	655	0.713
NULL	J_Cell_Biol_1999_Feb_22_144(4)_631-643.nxml.txt.nlp	10037786	SENT47	11	11	22	22	paraformaldehyde	SP260	PA450790	29956	0.713
NULL	Indian_J_Psychiatry_2009_Oct-Dec_51(4)_254-260.nxml.txt.nlp	20048449	SENT56	13	13	16	16	clozapine	FGA	PA449061	2243	0.713
NULL	Ann_Clin_Microbiol_Antimicrob_2005_Sep_13_4_13.nxml.txt.nlp	16159399	SENT217	3	3	8	8	lamivudine	IFN	PA450163	3439	0.713
NULL	Br_J_Cancer_2012_Jan_3_106(1)_107-115.nxml.txt.nlp	22116303	SENT122	7	7	29	29	vorinostat	AKT	PA164748224	207	0.713
NULL	Biomed_Res_Int_2014_Apr_27_2014_180428.nxml.txt.nlp	24877063	SENT257	0	0	7	7	cisplatin	TRPV1	PA449014	7442	0.713
NULL	HSR_Proc_Intensive_Care_Cardiovasc_Anesth_2009_1(3)_33-45.nxml.txt.nlp	23439998	SENT75	11	11	4	4	heparin	ACT	PA449855	12;11332;9457;641455	0.713
NULL	BMB_Rep_2014_Mar_47(3)_167-172.nxml.txt.nlp	24499665	SENT268	5	5	8	8	nutlin-3	Bcl-2		596	0.712
NULL	Diabetes_2009_Aug_2_58(8)_1902-1913.nxml.txt.nlp	19491211	SENT357	10	10	22	22	triamcinolone	VEGF-A	PA451749	7422	0.712
NULL	Cancer_Cell_Int_2010_Apr_29_10_12.nxml.txt.nlp	20429927	SENT99	20	20	23	23	bortezomib	GCN2	PA10252	440275	0.712
NULL	Case_Rep_Hematol_2012_Dec_12_2012_180204.nxml.txt.nlp	23304578	SENT38	12	12	3	3	vincristine	CHOP	PA451879	1649	0.712
NULL	Chin_J_Cancer_2011_Oct_30(10)_701-711.nxml.txt.nlp	21959047	SENT29	28	28	10	10	cetuximab	EGFR	PA10040	1956	0.712
NULL	Curr_Oncol_2009_Sep_16(5)_32-47.nxml.txt.nlp	19862360	SENT31	33	33	8	8	tositumomab	San	PA164748364	80218	0.712
NULL	Br_J_Cancer_2013_Mar_19_108(5)_1079-1091.nxml.txt.nlp	23449353	SENT137	20	20	18	18	docetaxel	MIC-1	PA449383	29919;9518	0.712
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2006_Dec_13_63(Pt_1)_80-93.nxml.txt.nlp	17164530	SENT156	2	2	11	11	imatinib	KDR	PA10804	3791	0.712
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Jan_9_69(Pt_2)_o211.nxml.txt.nlp	23424493	SENT64	2	2	24	24	ethanol	mol	PA448073	90527	0.712
NULL	J_Biomed_Biotechnol_2010_Mar_30_2010_307231.nxml.txt.nlp	20369072	SENT149	12	12	18	18	staurosporine	HMGB1	PA165109623	3146	0.712
NULL	Oncotarget_2014_Oct_21_5(22)_11252-11268.nxml.txt.nlp	25361004	SENT44	0	0	6	6	metformin	CLIC1	PA450395	1192	0.712
NULL	Int_J_Biol_Sci_2012_Feb_9_8(3)_310-327.nxml.txt.nlp	22355267	SENT47	23	23	16	16	simvastatin	PCSK9	PA451363	255738	0.712
NULL	Curr_Gerontol_Geriatr_Res_2012_Mar_4_2012_361218.nxml.txt.nlp	22474448	SENT137	21	21	8	8	estradiol	HSD17B1	PA449503	3292	0.712
NULL	J_Korean_Med_Sci_2013_Feb_29_28(2)_308-314.nxml.txt.nlp	23399960	SENT111	4	4	11	11	gabapentin	IL-10	PA449720	3586	0.712
NULL	Diabetologia_2007_Mar_24_50(3)_654-665.nxml.txt.nlp	17245590	SENT197	5	5	2	2	rosiglitazone	PPARG	PA451283	5468	0.712
NULL	Nat_Med_2011_Oct_2_17(10)_1304-1309.nxml.txt.nlp	21963515	SENT7	6	6	25	25	tacrolimus	WNK4	PA451578	65266	0.712
NULL	J_Korean_Med_Sci_2011_Dec_29_26(12)_1563-1568.nxml.txt.nlp	22147992	SENT30	8	8	4	4	ekb-569	EGFR		1956	0.712
NULL	Nat_Med_2013_Mar_24_19(3)_351-357.nxml.txt.nlp	23435171	SENT23	25	25	2	2	glucose	hamartin	PA449773	7248	0.712
NULL	Aging_(Albany_NY)_2009_Jun_3_1(6)_515-528.nxml.txt.nlp	20157535	SENT66	20	20	6	6	resveratrol	SIRT1		23411	0.712
NULL	Trials_2012_Dec_13_13_239.nxml.txt.nlp	23237631	SENT269	32	32	38	38	acenocoumarol	VKORC1	PA452632	79001	0.712
NULL	Indian_J_Pharmacol_2014_May-Jun_46(3)_328-333.nxml.txt.nlp	24987182	SENT157	7	7	34	34	clopidogrel	EPO	PA449053	7076;8288;2056	0.712
NULL	J_Hum_Genet_2013_Jun_23_58(6)_339-345.nxml.txt.nlp	23697979	SENT6	18	18	13	13	clopidogrel	CYP2C19	PA449053	1557	0.712
NULL	Br_J_Cancer_2004_May_17_90(10)_2032-2041.nxml.txt.nlp	15138490	SENT150	12	12	23	23	trastuzumab	HER-2	PA451743	2064	0.712
NULL	Neural_Regen_Res_2014_Mar_1_9(5)_540-548.nxml.txt.nlp	25206852	SENT38	40	40	43	43	choline	HSP27	PA448976	3315	0.712
NULL	J_Biol_Chem_2008_Nov_14_283(46)_31679-31689.nxml.txt.nlp	18755684	SENT321	0	0	5	5	iron	FTH1	PA450087	2495	0.712
NULL	Mol_Med_Rep_2015_Jan_22_11(1)_83-90.nxml.txt.nlp	25338529	SENT21	7	7	11	11	octreotide	HO-1	PA450678	3162	0.712
NULL	Clin_Med_Insights_Oncol_2011_Feb_14_5_15-21.nxml.txt.nlp	21499558	SENT89	22	22	6	6	irinotecan	OST	PA450085	1650;23263	0.712
NULL	Chonnam_Med_J_2012_Dec_21_48(3)_141-149.nxml.txt.nlp	23323218	SENT77	10	10	2	2	probucol	DES	PA451107	1674	0.712
NULL	Exp_Diabetes_Res_2011_Dec_27_2011_604989.nxml.txt.nlp	21253359	SENT176	23	23	11	11	clonidine	GLP-1	PA449051	100125288	0.712
NULL	Diabetol_Metab_Syndr_2014_Mar_31_6_48.nxml.txt.nlp	24684803	SENT116	17	17	9	9	mitiglinide	STEP	PA164748124	84867	0.712
NULL	Ther_Clin_Risk_Manag_2007_Jun_3(3)_449-459.nxml.txt.nlp	18488069	SENT196	2	2	14	14	naratriptan	RIZ	PA450597	7799	0.712
NULL	Indian_J_Urol_2009_Oct-Dec_25(4)_427-436.nxml.txt.nlp	19955664	SENT82	21	21	23	23	sunitinib	IFN	PA162372840	3439	0.712
NULL	ScientificWorldJournal_2013_Apr_18_2013_808460.nxml.txt.nlp	23710149	SENT46	11	11	21	21	indomethacin	BOR	PA449982	55143	0.712
NULL	Core_Evid_2010_Jul_27_5_1-10.nxml.txt.nlp	20694135	SENT168	16	16	28	28	entacapone	CLE	PA164748726	51637	0.712
NULL	Drug_Target_Insights_2012_Aug_6_6_19-39.nxml.txt.nlp	22915839	SENT258	11	11	9	9	curcumin	EGF	PA151958596	1950	0.712
NULL	Cancer_Med_2013_Dec_31_2(6)_950-963.nxml.txt.nlp	24403269	SENT46	24	24	4	4	cisplatin	RAB25	PA449014	57111	0.712
NULL	J_Biol_2009_Apr_15_8(3)_30.nxml.txt.nlp	19435483	SENT34	3	3	23	23	imatinib	NQO2	PA10804	4835	0.712
NULL	Arthritis_Res_Ther_2008_Sep_24_10(5)_R115.nxml.txt.nlp	18816401	SENT16	2	2	20	20	etanercept	BMP7	PA449515	655	0.712
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Mar_14_65(Pt_4)_o756.nxml.txt.nlp	21582487	SENT61	32	32	42	42	ethanol	mol	PA448073	90527	0.712
NULL	Cell_Commun_Signal_2010_Jun_12_8_11.nxml.txt.nlp	20540792	SENT334	28	28	9	9	thalidomide	CRBN	PA451644	51185	0.712
NULL	Cancer_Med_2014_Oct_10_3(5)_1368-1376.nxml.txt.nlp	25045041	SENT42	17	17	10	10	cisplatin	CRT	PA449014	811	0.712
NULL	J_Cardiothorac_Surg_2010_Aug_21_5_66.nxml.txt.nlp	20727201	SENT41	11	11	13	13	collagenase	MMP1	PA449107	4312	0.712
NULL	J_Oncol_2010_Jun_10_2010_652320.nxml.txt.nlp	20628530	SENT57	7	7	27	27	heparin	VEGFR2	PA449855	3791	0.712
NULL	Arch_Med_Sci_2013_Aug_30_9(4)_724-730.nxml.txt.nlp	24049536	SENT113	36	36	39	39	genistein	PTH	PA165109660	5741	0.712
NULL	Eur_J_Cancer_2014_Sep_50(14)_2367-2374.nxml.txt.nlp	25027307	SENT125	24	24	16	16	estradiol	AMH	PA449503	268	0.712
NULL	Diabetes_2008_Sep_57(9)_2341-2347.nxml.txt.nlp	18559659	SENT36	25	25	32	32	cyclosporine	CD4	PA449167	920	0.712
NULL	Front_Mol_Neurosci_2013_Dec_2_6_44.nxml.txt.nlp	24348325	SENT1537	17	17	9	9	clozapine	c-fos	PA449061	2353	0.712
NULL	Pharmacogn_Mag_2014_Oct-Dec_10(40)_522-528.nxml.txt.nlp	25422556	SENT138	25	25	28	28	allopurinol	Q10	PA448320	27161	0.712
NULL	Arthritis_Res_Ther_2007_Oct_19_9(Suppl_3)_P33.nxml.txt.nlp	NULL	SENT29	5	5	10	10	infliximab	IFN	PA452639	3439	0.712
NULL	Biomed_Res_Int_2014_Jan_15_2014_859871.nxml.txt.nlp	24527460	SENT57	25	25	5	5	oxaliplatin	BMP4	PA131285527	652	0.712
NULL	Ann_Nucl_Med_2014_Jul_8_28(9)_836-850.nxml.txt.nlp	25001261	SENT131	19	19	8	8	acetazolamide	spatial	PA448018	219793	0.712
NULL	Diabetol_Metab_Syndr_2014_Dec_2_6(1)_132.nxml.txt.nlp	NULL	SENT76	15	15	4	4	heparin	adiponectin	PA449855	9370	0.712
NULL	Behav_Brain_Funct_2013_Oct_28_9_41.nxml.txt.nlp	24165294	SENT154	34	34	23	23	capsaicin	c-fos	PA448776	2353	0.712
NULL	Ther_Clin_Risk_Manag_2006_Dec_2(4)_389-400.nxml.txt.nlp	18360651	SENT121	13	13	6	6	infliximab	IMPACT	PA452639	55364	0.712
NULL	Endocrinol_Metab_(Seoul)_2013_Dec_12_28(4)_262-274.nxml.txt.nlp	24396690	SENT50	26	26	5	5	exenatide	GLP-1	PA164749238	100125288	0.712
NULL	Aging_(Albany_NY)_2011_Dec_12_3(11)_1063-1077.nxml.txt.nlp	22170748	SENT116	17	17	10	10	metformin	p53	PA450395	7157	0.712
NULL	Int_J_Med_Sci_2013_Jun_14_10(8)_995-1002.nxml.txt.nlp	23801886	SENT143	8	8	19	19	doxycycline	ILK	PA449415	3611	0.712
NULL	Environ_Health_Perspect_2008_Jan_116(1)_A36a.nxml.txt.nlp	18197288	SENT16	8	8	0	0	l-cysteine	NAC	PA449173	22861	0.712
NULL	Indian_J_Med_Res_2014_Apr_139(4)_572-578.nxml.txt.nlp	24927344	SENT14	32	32	11	11	acenocoumarol	GGCX	PA452632	2677	0.712
NULL	J_Ophthalmic_Inflamm_Infect_2013_Jan_28_3_22.nxml.txt.nlp	23514095	SENT92	5	5	10	10	timolol	BAK	PA451690	578	0.712
NULL	Gene_Regul_Syst_Bio_2014_Mar_4_8_63-73.nxml.txt.nlp	24634581	SENT116	10	10	7	7	minocycline	MT1-MMP	PA450519	4323	0.712
NULL	Eur_J_Med_Res_2011_Jul_25_16(7)_303-314.nxml.txt.nlp	21813371	SENT59	27	27	13	13	telaprevir	SOC	PA165958354	91544	0.712
NULL	Breast_Cancer_Res_2014_Jul_24_16(4)_411.nxml.txt.nlp	25056669	SENT164	1	1	7	7	tamoxifen	CC3	PA451581	10553	0.712
NULL	Sci_Rep_2014_Dec_3_4_7201.nxml.txt.nlp	25467193	SENT105	48	48	2	2	doxorubicin	HER2	PA449412	2064	0.712
NULL	J_Thyroid_Res_2011_Dec_29_2011_432890.nxml.txt.nlp	22254147	SENT5	25	25	11	11	thyroglobulin	CD40	PA164754910	958	0.712
NULL	J_Cell_Biol_2001_Apr_2_153(1)_207-220.nxml.txt.nlp	11285286	SENT127	23	23	12	12	carbachol	DAG	PA448784	1605	0.712
NULL	Oxid_Med_Cell_Longev_2012_Jan_19_2012_390678.nxml.txt.nlp	22315655	SENT61	0	0	2	2	gliclazide	NAC	PA10892	22861	0.712
NULL	Biomed_Res_Int_2013_Jul_22_2013_408573.nxml.txt.nlp	23971034	SENT167	17	17	7	7	midazolam	CYP3A	PA450496	1574	0.712
NULL	Interdiscip_Perspect_Infect_Dis_2014_May_7_2014_849432.nxml.txt.nlp	24895495	SENT114	15	15	18	18	elvitegravir	CYP3A	PA165291498	1574	0.712
NULL	Protein_Eng_Des_Sel_2013_Jul_24_26(7)_463-470.nxml.txt.nlp	23708321	SENT63	25	25	43	43	trimethoprim	DHFR	PA451788	1719	0.712
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT112	6	6	16	16	docetaxel	B7-H1	PA449383	29126	0.712
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT256	17	17	6	6	warfarin	VKORC1	PA451906	79001	0.712
NULL	Osteoarthritis_Cartilage_2013_Sep_21(9)_1336-1345.nxml.txt.nlp	23973148	SENT472	1	1	13	13	triamcinolone	MIA	PA451749	8190	0.712
NULL	Cell_Death_Dis_2010_Oct_21_1(10)_e86.nxml.txt.nlp	21368859	SENT43	23	23	12	12	doxorubicin	TRAIL	PA449412	8743	0.712
NULL	Indian_J_Pharmacol_2014_Nov-Dec_46(6)_627-632.nxml.txt.nlp	25538335	SENT125	6	6	4	4	metformin	Q10	PA450395	27161	0.712
NULL	Case_Rep_Dermatol_2011_Jun_30_3(2)_130-136.nxml.txt.nlp	21743808	SENT66	15	15	20	20	adapalene	EGFR	PA448047	1956	0.712
NULL	J_Gen_Physiol_1997_Jun_1_109(6)_681-692.nxml.txt.nlp	9222895	SENT146	3	3	20	20	amiloride	CH1	PA448368	51430	0.712
NULL	Clin_Psychopharmacol_Neurosci_2011_Apr_30_9(1)_36-43.nxml.txt.nlp	23431025	SENT85	15	15	20	20	aripiprazole	FLI	PA10026	2314	0.712
NULL	Channels_(Austin)_2012_Mar_1_6(2)_124-132.nxml.txt.nlp	22627148	SENT7	10	10	19	19	capsaicin	TRPV1	PA448776	7442	0.712
NULL	Br_J_Pharmacol_2011_Jul_163(6)_1263-1275.nxml.txt.nlp	21391977	SENT227	16	16	9	9	ketoconazole	CYP2C9	PA450146	1559	0.712
NULL	Int_J_Endocrinol_2014_Jun_25_2014_534904.nxml.txt.nlp	25053942	SENT105	11	11	17	17	amiodarone	AIT	PA448383	160728	0.712
NULL	An_Bras_Dermatol_2013_Nov-Dec_88(6_Suppl_1)_120-123.nxml.txt.nlp	24346897	SENT25	5	5	16	16	methotrexate	CO2	PA450428	4513	0.712
NULL	Nucleic_Acids_Res_2013_Dec_30_41(22)_10268-10282.nxml.txt.nlp	23997120	SENT29	37	37	19	19	etoposide	TRF1	PA449552	7013	0.712
NULL	Indian_J_Endocrinol_Metab_2013_Mar-Apr_17(2)_344-348.nxml.txt.nlp	23776919	SENT75	17	17	28	28	levothyroxine	TSHR	PA450221	7253	0.712
NULL	J_Cardiothorac_Surg_2012_Sep_26_7_92.nxml.txt.nlp	23013526	SENT216	7	7	5	5	aprotinin	NAC	PA448472	22861	0.712
NULL	Oncologist_2011_Jan_6_16(1)_5-24.nxml.txt.nlp	21212434	SENT189	4	4	14	14	cisplatin	IL-2	PA449014	3558	0.712
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT180	9	9	13	13	capsaicin	p53	PA448776	7157	0.712
NULL	Ann_Rheum_Dis_2015_Jan_28_74(1)_35-43.nxml.txt.nlp	25169728	SENT205	14	14	42	42	tocilizumab	IL-6	PA165292659	3569	0.712
NULL	Breast_Cancer_Res_2008_Dec_5_10(6)_R104.nxml.txt.nlp	19061505	SENT297	7	7	20	20	estradiol	JNK	PA449503	5599	0.712
NULL	Blood_Cancer_J_2013_Oct_18_3(10)_e153.nxml.txt.nlp	24141622	SENT89	3	3	15	15	chloroquine	Mcl-1	PA448948	4170	0.712
NULL	Acta_Orthop_2009_Feb_26_80(1)_46-50.nxml.txt.nlp	19234885	SENT118	7	7	16	16	celecoxib	TKR	PA448871	8277	0.712
NULL	Mol_Vis_2014_May_13_20_649-660.nxml.txt.nlp	24868139	SENT227	11	11	20	20	bevacizumab	VEGF-A	PA130232992	7422	0.712
NULL	Front_Genet_2012_Nov_22_3_249.nxml.txt.nlp	23189085	SENT533	0	0	3	3	imatinib	ABCB1	PA10804	5243	0.712
NULL	Front_Oncol_2013_Apr_2_3_64.nxml.txt.nlp	23565502	SENT619	4	4	7	7	nutlin-3	Bcl-2		596	0.712
NULL	J_Immunol_Res_2014_May_12_2014_897249.nxml.txt.nlp	24901013	SENT182	28	28	7	7	natalizumab	IL-2	PA164747191	3558	0.712
NULL	Protein_Expr_Purif_2009_Aug_66(2)_181-184.nxml.txt.nlp	19269329	SENT53	24	24	28	28	thrombin	AMPK	PA451674	5563	0.712
NULL	Acta_Pharmacol_Sin_2009_Nov_5_30(11)_1522-1528.nxml.txt.nlp	19890360	SENT147	16	16	4	4	fenoterol	TLR4	PA10079	7099	0.712
NULL	Cancer_Cell_Int_2010_Oct_25_10_40.nxml.txt.nlp	20974006	SENT161	19	19	30	30	paraformaldehyde	FADD	PA450790	8772	0.712
NULL	Blood_Cancer_J_2013_Oct_18_3(10)_e153.nxml.txt.nlp	24141622	SENT5	11	11	23	23	fludarabine	XIAP	PA449655	331	0.712
NULL	J_Biomed_Sci_2013_Jun_20_20(1)_38.nxml.txt.nlp	23786217	SENT233	5	5	18	18	fluorescein	CD31	PA164746009	5175	0.712
NULL	Front_Mol_Neurosci_2009_May_14_2_1.nxml.txt.nlp	19506703	SENT158	3	3	1	1	candesartan	ACTH	PA448765	5443	0.712
NULL	Nat_Med_2013_Mar_10_19(3)_313-321.nxml.txt.nlp	23396211	SENT365	6	6	11	11	amlexanox	TBK1	PA164745310	29110	0.712
NULL	Br_J_Cancer_2011_Nov_22_105(11)_1628-1634.nxml.txt.nlp	22009028	SENT30	19	19	0	0	goserelin	Men	PA164747674	8178	0.712
NULL	Front_Endocrinol_(Lausanne)_2014_Oct_30_5_187.nxml.txt.nlp	25400620	SENT319	13	13	0	0	estradiol	CYP1B1	PA449503	1545	0.712
NULL	Mol_Cancer_2009_Nov_10_8_99.nxml.txt.nlp	19903356	SENT46	19	19	15	15	imatinib	IGFBP3	PA10804	3486	0.712
NULL	Front_Neurosci_2012_May_30_6_77.nxml.txt.nlp	22661925	SENT225	6	6	10	10	ethanol	NALP3	PA448073	114548	0.712
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT16	2	2	10	10	metformin	HIF-1	PA450395	29072	0.712
NULL	J_Cell_Biol_1999_Jan_25_144(2)_241-254.nxml.txt.nlp	9922451	SENT181	16	16	22	22	forskolin	ADP	PA146096022	23038	0.712
NULL	Cell_Mol_Life_Sci_2012_Jan_11_69(1)_149-163.nxml.txt.nlp	21667063	SENT193	4	4	23	23	curcumin	ATP8B1	PA151958596	5205	0.712
NULL	Ann_Oncol_2013_Aug_12_24(8)_1994-1999.nxml.txt.nlp	23670096	SENT109	12	12	14	14	tamoxifen	AIB1	PA451581	8202	0.712
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT1906	5	5	10	10	phenacetin	CYP3A4	PA450897	1576	0.712
NULL	J_Asthma_Allergy_2008_Sep_19_1_19-29.nxml.txt.nlp	21436982	SENT249	26	26	23	23	fexofenadine	MDR1	PA449621	5243	0.712
NULL	Mol_Cells_2014_Dec_31_37(12)_899a-906.nxml.txt.nlp	25431425	SENT14	2	2	20	20	curcumin	p50	PA151958596	958;4790	0.712
NULL	Front_Immunol_2013_Mar_27_4_76.nxml.txt.nlp	23543707	SENT667	10	10	12	12	rituximab	CHOP	PA451261	1649	0.712
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT148	20	20	26	26	l-cysteine	ATP5A	PA449173	498	0.712
NULL	Mol_Cell_Biochem_2014_Jul_26_396(1-2)_221-228.nxml.txt.nlp	25063218	SENT35	13	13	22	22	resveratrol	EGFR		1956	0.712
NULL	Nucleic_Acids_Res_2013_Nov_27_41(21)_9786-9799.nxml.txt.nlp	23982513	SENT307	1	1	12	12	arsenite	TIAR	PA452638	7073	0.712
NULL	Int_J_Mol_Sci_2014_Jun_25_15(7)_11234-11244.nxml.txt.nlp	24968266	SENT64	8	8	21	21	docetaxel	PC-3	PA449383	692094	0.712
NULL	Mol_Biol_Cell_2014_Jun_1_25(11)_1782-1792.nxml.txt.nlp	24719457	SENT99	22	22	25	25	nicotine	ASCL1	PA450626	429	0.712
NULL	Arthritis_Res_Ther_2010_Apr_29_12(2)_R73.nxml.txt.nlp	20429888	SENT160	2	2	8	8	bortezomib	AP2	PA10252	2971	0.712
NULL	Anal_Chem_Insights_2007_Nov_14_2_93-106.nxml.txt.nlp	19662183	SENT188	2	2	6	6	cyclosporine	P-gp	PA449167	5243	0.712
NULL	Cancers_(Basel)_2012_Jul_16_4(3)_673-700.nxml.txt.nlp	24213461	SENT691	15	15	23	23	dextran	beta-catenin	PA449261	1499	0.712
NULL	Diabetes_Care_2013_Jul_12_36(7)_2126-2132.nxml.txt.nlp	23645884	SENT79	15	15	10	10	liraglutide	GLP-1	PA165958364	100125288	0.712
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT193	10	10	23	23	l-leucine	SIRT3	PA450197	23410	0.712
NULL	Mediators_Inflamm_2011_Mar_29_2011_525691.nxml.txt.nlp	21547257	SENT20	36	36	21	21	thrombin	RANTES	PA451674	6352	0.712
NULL	J_Adv_Pharm_Technol_Res_2012_Oct-Dec_3(4)_202-209.nxml.txt.nlp	23378940	SENT128	7	7	5	5	aprepitant	CYP3A4	PA164747039	1576	0.712
NULL	Int_J_Gen_Med_2012_Nov_9_5_935-942.nxml.txt.nlp	23204857	SENT152	16	16	13	13	isoflurane	CA3	PA450106	761	0.712
NULL	Med_Sci_Monit_2013_Oct_31_19_916-926.nxml.txt.nlp	24172537	SENT108	24	24	17	17	sunitinib	VEGFR	PA162372840	3791	0.712
NULL	Indian_J_Sex_Transm_Dis_2013_Jul-Dec_34(2)_148-149.nxml.txt.nlp	24339470	SENT18	21	21	28	28	efavirenz	AKT	PA449441	207	0.712
NULL	Mol_Brain_2013_May_4_6_22.nxml.txt.nlp	23641686	SENT31	6	6	22	22	memantine	GLAST	PA10364	6507	0.712
NULL	Clin_Med_Insights_Cardiol_2010_Dec_1_4_117-128.nxml.txt.nlp	21151850	SENT261	17	17	3	3	clopidogrel	CYP2C19	PA449053	1557	0.712
NULL	Br_J_Cancer_1998_Sep_78(5)_625-630.nxml.txt.nlp	9744503	SENT10	11	11	22	22	tegafur	mol	PA452620	90527	0.712
NULL	Indian_J_Nephrol_2012_Mar-Apr_22(2)_139-142.nxml.txt.nlp	22787319	SENT34	5	5	7	7	basiliximab	IL-2	PA164747126	3558	0.712
NULL	Breast_Cancer_Res_2009_Sep_16_11(5)_R69.nxml.txt.nlp	19758440	SENT200	32	32	34	34	lapatinib	HER2	PA152241907	2064	0.712
NULL	Summit_on_Translat_Bioinforma_2009_Mar_1_2009_124-128.nxml.txt.nlp	21347183	SENT69	11	11	26	26	thioguanine	TPMT	PA451663	7172	0.712
NULL	Ther_Clin_Risk_Manag_2006_Jun_2(2)_129-158.nxml.txt.nlp	18360588	SENT120	0	0	17	17	voriconazole	CYP3A4	PA10233	1576	0.712
NULL	Oxid_Med_Cell_Longev_2013_Nov_28_2013_367040.nxml.txt.nlp	24381715	SENT61	22	22	14	14	glucose	TNF	PA449773	7124	0.712
NULL	Cell_Death_Dis_2010_Oct_21_1(10)_e86.nxml.txt.nlp	21368859	SENT62	22	22	20	20	doxorubicin	TRAIL	PA449412	8743	0.712
NULL	Pharmaceutics_2010_Oct_27_2(4)_339-350.nxml.txt.nlp	NULL	SENT175	35	35	37	37	piroxicam	BCS	PA450985	617	0.712
NULL	Cancer_Med_2013_Oct_19_2(5)_646-653.nxml.txt.nlp	24403230	SENT109	15	15	11	11	trastuzumab	BTG2	PA451743	7832	0.712
NULL	Environ_Health_Perspect_2013_Sep_14_121(9)_1002-1010.nxml.txt.nlp	23771518	SENT111	21	21	8	8	picrotoxin	RDX	PA164777007	5962	0.712
NULL	Mol_Cancer_2008_Jun_30_7_60.nxml.txt.nlp	18590557	SENT140	20	20	18	18	tamoxifen	TRAIL	PA451581	8743	0.712
NULL	BMB_Rep_2014_May_47(5)_274-279.nxml.txt.nlp	24286313	SENT66	3	3	6	6	bortezomib	CD138	PA10252	6382	0.712
NULL	J_Gen_Physiol_2009_Jun_133(6)_623-625.nxml.txt.nlp	19468076	SENT150	1	1	9	9	caffeine	TRPA1	PA448710	8989	0.712
NULL	Apoptosis_2014_Aug_26_19(11)_1603-1615.nxml.txt.nlp	25156145	SENT203	4	4	0	0	mitomycin	TRAIL	PA450524	8743	0.712
NULL	Cholesterol_2010_Oct_31_2010_271504.nxml.txt.nlp	21490912	SENT111	25	25	9	9	fenofibrate	adiponectin	PA449594	9370	0.712
NULL	Biosci_Rep_2009_Sep_2_29(Pt_6)_397-404.nxml.txt.nlp	19527224	SENT74	28	28	24	24	vasopressin	AVP	PA451858	114548;551	0.712
NULL	Scientifica_(Cairo)_2012_Dec_16_2012_402783.nxml.txt.nlp	24278688	SENT153	29	29	4	4	thrombin	MASP2	PA451674	10747	0.712
NULL	Front_Neurosci_2013_Jun_12_7_100.nxml.txt.nlp	23781169	SENT835	0	0	11	11	hyaluronan	TLR2	PA165958431	7097	0.712
NULL	Front_Neurol_2012_Aug_1_3_120.nxml.txt.nlp	23015798	SENT47	4	4	29	29	ethanol	FAE	PA448073	2178	0.712
NULL	AoB_Plants_2010_Jun_29_2010_plq010.nxml.txt.nlp	22476068	SENT101	27	27	14	14	nadh	TES	PA164755085	26136	0.712
NULL	J_Med_Internet_Res_2013_Jul_12_15(7)_e138.nxml.txt.nlp	23853350	SENT186	29	29	17	17	warfarin	TTR	PA451906	7276	0.712
NULL	Ann_Med_Health_Sci_Res_2014_Mar-Apr_4(Suppl_1)_S43-S44.nxml.txt.nlp	25031906	SENT49	12	12	33	33	metronidazole	B12	PA450484	7126;4709	0.712
NULL	Breast_Cancer_Res_2012_Aug_8_14(4)_R116.nxml.txt.nlp	22873525	SENT184	2	2	11	11	trastuzumab	HER2	PA451743	2064	0.712
NULL	Arthritis_Res_Ther_2014_Oct_29_16(5)_469.nxml.txt.nlp	25606596	SENT50	3	3	8	8	rituximab	San	PA451261	80218	0.712
NULL	Mol_Cancer_2014_Jul_5_13_165.nxml.txt.nlp	24996221	SENT124	23	23	21	21	docetaxel	p62	PA449383	8878;10657;23636	0.712
NULL	Neural_Plast_2014_Mar_20_2014_675128.nxml.txt.nlp	24778885	SENT44	33	33	18	18	pilocarpine	CA1	PA450962	759	0.712
NULL	Cancers_(Basel)_2013_Jul_4_5(3)_838-856.nxml.txt.nlp	24202322	SENT206	28	28	22	22	camptothecin	HEXIM1	PA153590860	10614	0.712
NULL	Prz_Gastroenterol_2014_Sep_16_9(4)_214-219.nxml.txt.nlp	25276252	SENT7	17	17	11	11	cisplatin	TRAIL	PA449014	8743	0.712
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT192	12	12	8	8	trastuzumab	Yes	PA451743	7525	0.712
NULL	Oncotarget_2013_Dec_28_5(6)_1475-1490.nxml.txt.nlp	24721996	SENT174	2	2	14	14	celecoxib	CD133	PA448871	8842	0.712
NULL	Ann_Hematol_2014_Apr_1_93(8)_1371-1380.nxml.txt.nlp	24687382	SENT243	3	3	0	0	melphalan	San	PA450354	80218	0.712
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT19	13	13	10	10	pemetrexed	UNG	PA10810	7374	0.712
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1563-1573.nxml.txt.nlp	22015557	SENT254	8	8	17	17	sunitinib	c-Myc	PA162372840	4609	0.712
NULL	J_Clin_Biochem_Nutr_2010_Jan_29_46(1)_87-92.nxml.txt.nlp	20104270	SENT102	7	7	12	12	hesperetin	adiponectin	PA164742902	9370	0.712
NULL	Br_J_Cancer_2014_May_27_110(11)_2716-2727.nxml.txt.nlp	24800946	SENT158	38	38	20	20	panitumumab	KRAS	PA162373091	3845	0.712
NULL	Br_J_Cancer_2013_Mar_19_108(5)_1052-1060.nxml.txt.nlp	23422754	SENT35	29	29	18	18	bevacizumab	VEGF-A	PA130232992	7422	0.712
NULL	Breast_Cancer_Res_2003_Jan_13_5(2)_R30-R36.nxml.txt.nlp	12631396	SENT140	25	25	9	9	tamoxifen	EGFR	PA451581	1956	0.712
NULL	Diabetes_2013_Sep_15_62(9)_3151-3162.nxml.txt.nlp	23649518	SENT335	24	24	16	16	resveratrol	p38		10598;1432;7965	0.712
NULL	Mol_Syst_Biol_2010_Oct_19_6_420.nxml.txt.nlp	20959818	SENT94	20	20	7	7	galactose	GAL4	PA449725	3960	0.712
NULL	Diabetes_2009_Apr_2_58(4)_954-964.nxml.txt.nlp	19188429	SENT185	12	12	28	28	perindopril	NAC	PA450877	22861	0.712
NULL	Cancers_(Basel)_2014_Feb_28_6(1)_472-490.nxml.txt.nlp	24589997	SENT192	5	5	10	10	sunitinib	IL-10	PA162372840	3586	0.712
NULL	Br_J_Haematol_2011_Apr_153(1)_83-91.nxml.txt.nlp	21332705	SENT148	11	11	18	18	thrombin	ADP	PA451674	23038	0.712
NULL	Front_Neurosci_2008_Dec_15_2(2)_135-136.nxml.txt.nlp	19225584	SENT21	18	18	11	11	choline	spatial	PA448976	219793	0.712
NULL	Br_J_Cancer_2010_Oct_12_103(8)_1309-1310.nxml.txt.nlp	NULL	SENT17	29	29	31	31	bevacizumab	IFN	PA130232992	3439	0.712
NULL	J_Cell_Biol_2001_Oct_1_155(1)_133-144.nxml.txt.nlp	11581290	SENT196	16	16	38	38	pp2	PP2		4888	0.712
NULL	Indian_J_Dermatol_2014_Nov-Dec_59(6)_632a.nxml.txt.nlp	25484418	SENT21	12	12	26	26	bevacizumab	IFN	PA130232992	3439	0.712
NULL	Adv_Hematol_2012_Nov_20_2012_861060.nxml.txt.nlp	23251161	SENT13	14	14	16	16	rituximab	CHOP	PA451261	1649	0.712
NULL	Adv_Hematol_2012_Mar_25_2012_302570.nxml.txt.nlp	22536253	SENT189	14	14	17	17	bortezomib	CHOP	PA10252	1649	0.712
NULL	Int_J_Mol_Imaging_2011_Oct_26_2011_874585.nxml.txt.nlp	21490735	SENT14	24	24	3	3	docetaxel	FDG	PA449383	23583	0.712
NULL	Nucleic_Acids_Res_2013_Apr_1_41(6)_3734-3747.nxml.txt.nlp	23376929	SENT72	30	30	14	14	streptomycin	FBS	PA451512	64319;26269	0.712
NULL	Evid_Based_Complement_Alternat_Med_2013_May_16_2013_857929.nxml.txt.nlp	23762164	SENT95	11	11	13	13	doxorubicin	JNK	PA449412	5599	0.712
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT99	2	2	10	10	curcumin	PUMA	PA151958596	27113	0.712
NULL	Cancer_Immunol_Immunother_2011_Jun_25_60(6)_793-808.nxml.txt.nlp	21350947	SENT161	21	21	4	4	sorafenib	IFNAR2	PA7000	3455	0.712
NULL	Front_Behav_Neurosci_2009_Dec_9_3_54.nxml.txt.nlp	20057937	SENT828	7	7	15	15	colchicine	CA1	PA449092	759	0.712
NULL	Iran_Red_Crescent_Med_J_2014_Aug_5_16(8)_e6915.nxml.txt.nlp	25389496	SENT116	10	10	16	16	pravastatin	adiponectin	PA451089	9370	0.712
NULL	Diabetes_Care_2009_Apr_29_32(4)_541-546.nxml.txt.nlp	19114614	SENT100	17	17	0	0	estradiol	Men	PA449503	8178	0.712
NULL	Front_Oncol_2014_May_26_4_123.nxml.txt.nlp	24904834	SENT371	22	22	2	2	resveratrol	AMPK		5563	0.712
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_May_29_65(Pt_6)_m691-m692.nxml.txt.nlp	21583048	SENT79	31	31	38	38	copper	mol	PA449114	90527	0.712
NULL	J_Thromb_Haemost_2014_May_22_12(5)_748-760.nxml.txt.nlp	24612393	SENT112	0	0	19	19	thrombin	PRAS40	PA451674	84335	0.712
NULL	Oncoimmunology_2014_Jan_17_3_e27574.nxml.txt.nlp	24800167	SENT22	48	48	24	24	vancomycin	IL-6	PA451850	3569	0.712
NULL	Leukemia_2014_Jan_12_28(1)_15-33.nxml.txt.nlp	23778311	SENT252	27	27	14	14	imatinib	p53	PA10804	7157	0.712
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Aug_27_67(Pt_9)_o2505-o2506.nxml.txt.nlp	22059051	SENT8	22	22	6	6	phenol	mol	PA450913	90527	0.712
NULL	Diabetes_2009_Dec_31_58(12)_2851-2862.nxml.txt.nlp	19720788	SENT170	5	5	0	0	forskolin	BiP	PA146096022	3309	0.712
NULL	Clin_Epigenetics_2011_Dec_5_3(1)_8.nxml.txt.nlp	22414275	SENT213	3	3	9	9	ribavirin	ESR1	PA451241	2099	0.712
NULL	Front_Public_Health_2014_Dec_5_2_246.nxml.txt.nlp	25538933	SENT74	7	7	12	12	estradiol	AMH	PA449503	268	0.712
NULL	Mol_Biol_Cell_2013_Sep_1_24(17)_2678-2688.nxml.txt.nlp	23864716	SENT134	0	0	21	21	thrombin	PAK1	PA451674	5585;5058	0.712
NULL	Biomed_Res_Int_2013_Dec_17_2013_312709.nxml.txt.nlp	24455685	SENT116	28	28	14	14	ethanol	HIC	PA448073	29969	0.712
NULL	J_Vet_Med_Sci_2014_Jun_15_76(6)_813-817.nxml.txt.nlp	24531829	SENT115	15	15	8	8	artesunate	DPT	PA165111697	1805	0.712
NULL	Clin_Transl_Allergy_2013_Sep_2_3_29.nxml.txt.nlp	24004581	SENT95	2	2	6	6	omalizumab	IL-6	PA164752253	3569	0.712
NULL	Open_Neurol_J_2013_May_31_7_23-31.nxml.txt.nlp	23894259	SENT33	37	37	15	15	haloperidol	FGA	PA449841	2243	0.712
NULL	J_Biol_Chem_2008_Jul_25_283(30)_21170-21178.nxml.txt.nlp	18492664	SENT165	14	14	9	9	geldanamycin	Hsp90	PA152031327	3320	0.712
NULL	J_Oncol_2012_Oct_22_2012_391629.nxml.txt.nlp	23133451	SENT137	4	4	10	10	sorafenib	TPC1	PA7000	53373	0.712
NULL	Pharm_Pract_(Granada)_2006_Dec_12_Oct-Dec_4(4)_168-178.nxml.txt.nlp	25214906	SENT164	31	31	36	36	gefitinib	HRG	PA131301952	3084;3273	0.712
NULL	J_Int_Soc_Sports_Nutr_2009_Feb_19_6_6.nxml.txt.nlp	19228401	SENT163	4	4	18	18	creatine	CEE	PA164778930	51608	0.712
NULL	Oncogene_2014_Jan_9_33(2)_212-224.nxml.txt.nlp	23246965	SENT195	10	10	26	26	l-glutamine	CO2	PA10090	4513	0.712
NULL	ISRN_Allergy_2013_Feb_7_2013_971036.nxml.txt.nlp	23738146	SENT246	33	33	13	13	papain	CCL17	PA450778	6361	0.712
NULL	Diabetes_Metab_Syndr_Obes_2014_Mar_6_7_85-94.nxml.txt.nlp	24623984	SENT106	0	0	4	4	metformin	GLP-1	PA450395	100125288	0.712
NULL	Int_J_Environ_Res_Public_Health_2006_Mar_31_3(1)_31-37.nxml.txt.nlp	16823074	SENT206	12	12	22	22	fluorescein	NIR	PA164746009	26155	0.712
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT212	6	6	13	13	tacrolimus	IL-6	PA451578	3569	0.712
NULL	Cell_Death_Dis_2012_Jun_21_3(6)_e330.nxml.txt.nlp	22717585	SENT48	21	21	16	16	simvastatin	LC3	PA451363	84557	0.712
NULL	Arthritis_Res_Ther_2014_Apr_3_16(2)_R86.nxml.txt.nlp	24708674	SENT227	0	0	17	17	bosentan	Fli1	PA10034	2314	0.711
NULL	Front_Neurosci_2012_May_30_6_77.nxml.txt.nlp	22661925	SENT156	25	25	0	0	ethanol	DCX	PA448073	1641	0.711
NULL	Biomed_Res_Int_2013_Jul_14_2013_434561.nxml.txt.nlp	23936798	SENT37	32	32	44	44	l-glutamine	CO2	PA10090	4513	0.711
NULL	J_Antimicrob_Chemother_2013_Mar_9_68(3)_697-707.nxml.txt.nlp	23143901	SENT148	11	11	23	23	oseltamivir	ZAN	PA450721	7455	0.711
NULL	Oncotarget_2014_Oct_21_5(22)_11252-11268.nxml.txt.nlp	25361004	SENT121	34	34	17	17	metformin	CLIC1	PA450395	1192	0.711
NULL	Diabetol_Metab_Syndr_2014_Mar_31_6_48.nxml.txt.nlp	24684803	SENT121	13	13	8	8	mitiglinide	STEP	PA164748124	84867	0.711
NULL	Front_Neurol_2011_Dec_26_2_83.nxml.txt.nlp	22363312	SENT123	14	14	29	29	clopidogrel	ADP	PA449053	23038	0.711
NULL	Front_Integr_Neurosci_2012_Aug_28_6_66.nxml.txt.nlp	22973203	SENT85	17	17	19	19	hydrocortisone	CORT	PA449905	1325	0.711
NULL	J_Cell_Biol_2000_Feb_21_148(4)_811-824.nxml.txt.nlp	10684261	SENT169	24	24	26	26	thrombin	EGF	PA451674	1950	0.711
NULL	Br_J_Cancer_2011_Aug_23_105(5)_649-657.nxml.txt.nlp	21811251	SENT155	7	7	21	21	gefitinib	IGF1R	PA131301952	3480	0.711
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_May_24_70(Pt_6)_o713.nxml.txt.nlp	24940283	SENT75	22	22	3	3	ethanol	mol	PA448073	90527	0.711
NULL	Environ_Health_Perspect_2007_Dec_8_115(Suppl_1)_129-136.nxml.txt.nlp	18174961	SENT17	13	13	5	5	estradiol	Bcl-2	PA449503	596	0.711
NULL	Oncotarget_2014_Oct_18_5(22)_11576-11587.nxml.txt.nlp	25344912	SENT78	30	30	32	32	cisplatin	DDP	PA449014	1678	0.711
NULL	ARYA_Atheroscler_2013_May_9(3)_172-178.nxml.txt.nlp	23766773	SENT80	8	8	17	17	lipase	gamma	PA450239	9913	0.711
NULL	Br_J_Cancer_1999_Dec_81(8)_1294-1303.nxml.txt.nlp	10604725	SENT2	17	17	29	29	cisplatin	CH1	PA449014	51430	0.711
NULL	Lab_Anim_Res_2014_Dec_24_30(4)_143-150.nxml.txt.nlp	25628724	SENT96	11	11	21	21	genistein	PC-3	PA165109660	692094	0.711
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT53	8	8	13	13	tariquidar	ABCG2		9429	0.711
NULL	Cancer_Metastasis_Rev_2010_Dec_10_29(4)_581-594.nxml.txt.nlp	20830503	SENT278	20	20	11	11	anastrozole	ARNO	PA448432	9266	0.711
NULL	Cancer_Immunol_Immunother_2012_Oct_8_61(10)_1713-1720.nxml.txt.nlp	22399057	SENT8	4	4	0	0	plerixafor	CXCR4	PA165958410	7852	0.711
NULL	Biologics_2011_Aug_9_5_87-94.nxml.txt.nlp	21847344	SENT24	17	17	2	2	docetaxel	B27	PA449383	56246	0.711
NULL	Diabetes_2011_Jul_20_60(7)_1907-1916.nxml.txt.nlp	21593200	SENT247	27	27	35	35	glucose	RAGE	PA449773	177	0.711
NULL	Evid_Based_Complement_Alternat_Med_2013_May_28_2013_464508.nxml.txt.nlp	23781262	SENT211	4	4	12	12	amiodarone	FKBP12	PA448383	2280	0.711
NULL	Biochim_Biophys_Acta_2013_Jul_1832(7)_905-910.nxml.txt.nlp	23032152	SENT110	32	32	29	29	ketanserin	5-HT2A	PA131053734	3356	0.711
NULL	Structure_2013_Sep_3_21(9)_1648-1658.nxml.txt.nlp	23932590	SENT131	18	18	9	9	mitomycin	FANCD2	PA450524	2177	0.711
NULL	Core_Evid_2010_Jul_27_5_1-10.nxml.txt.nlp	20694135	SENT123	29	29	11	11	levodopa	CLE	PA450213	51637	0.711
NULL	Infect_Drug_Resist_2008_Sep_9_1_27-44.nxml.txt.nlp	21694878	SENT201	11	11	16	16	linezolid	HAP	PA450233	5915;10313	0.711
NULL	Environ_Health_Perspect_2012_Aug_18_120(8)_1170-1176.nxml.txt.nlp	22514210	SENT235	3	3	8	8	estradiol	BRCA1	PA449503	672	0.711
NULL	Clin_Interv_Aging_2014_Nov_18_9_1963-1980.nxml.txt.nlp	25429208	SENT124	0	0	2	2	metformin	DPP4	PA450395	1803	0.711
NULL	Cell_Commun_Signal_2004_Jun_30_2_6.nxml.txt.nlp	15228623	SENT148	29	29	14	14	mibefradil	TTN	PA450492	7273	0.711
NULL	Gastric_Cancer_2013_Jul_12_16(3)_345-354.nxml.txt.nlp	22968820	SENT142	4	4	10	10	oxaliplatin	PMS2	PA131285527	5395	0.711
NULL	Environ_Health_Perspect_2013_Oct_1_121(10)_1142-1147.nxml.txt.nlp	23906969	SENT15	6	6	22	22	salbutamol	LHA	PA448068	1081	0.711
NULL	Oncol_Lett_2015_Jan_4_9(1)_91-95.nxml.txt.nlp	25435939	SENT73	19	19	33	33	cisplatin	IB2	PA449014	23542	0.711
NULL	Cell_Death_Dis_2013_Jun_6_4(6)_e654.nxml.txt.nlp	23744354	SENT253	24	24	12	12	vincristine	B4GALT1	PA451879	2683	0.711
NULL	J_Biol_Chem_2013_Dec_27_288(52)_36762-36771.nxml.txt.nlp	24217250	SENT11	22	22	0	0	galactose	Langerin	PA449725	50489	0.711
NULL	Exp_Mol_Med_2012_Sep_30_44(9)_554-561.nxml.txt.nlp	22809871	SENT82	0	0	20	20	palivizumab	San	PA164748781	80218	0.711
NULL	Biochem_Res_Int_2012_Feb_12_2012_346972.nxml.txt.nlp	22400115	SENT98	4	4	11	11	hyaluronan	RHAMM	PA165958431	3161	0.711
NULL	Acta_Pharmacol_Sin_2012_Aug_23_33(8)_1095-1100.nxml.txt.nlp	22820908	SENT115	13	13	4	4	clarithromycin	CYP3A	PA449028	1574	0.711
NULL	Pharmaceutics_2011_Jul_13_3(3)_425-439.nxml.txt.nlp	24310588	SENT355	32	32	0	0	hydrocodone	SERS	PA449900	6301;54938	0.711
NULL	J_Gen_Physiol_2004_Jul_124(1)_1b.nxml.txt.nlp	NULL	SENT1042	0	0	11	11	carbachol	DD1	PA448784	1645	0.711
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jun_23_68(Pt_7)_o2163.nxml.txt.nlp	22798835	SENT74	38	38	13	13	ethanol	mol	PA448073	90527	0.711
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT195	8	8	19	19	rifampin	CYP3A4	PA451250	1576	0.711
NULL	Acta_Pharmacol_Sin_2010_Dec_3_31(12)_1635-1642.nxml.txt.nlp	21127497	SENT84	0	0	8	8	phenylbutazone	UGT	PA450932	7361;7355	0.711
NULL	Oncol_Lett_2013_Feb_7_5(2)_440-446.nxml.txt.nlp	23420122	SENT166	16	16	8	8	gemcitabine	EGFR	PA449748	1956	0.711
NULL	Endocrinol_Metab_(Seoul)_2013_Dec_12_28(4)_262-274.nxml.txt.nlp	24396690	SENT51	17	17	14	14	exenatide	GLP-1	PA164749238	100125288	0.711
NULL	Mol_Cancer_2009_Aug_25_8_66.nxml.txt.nlp	19706164	SENT198	27	27	33	33	celecoxib	p53	PA448871	7157	0.711
NULL	Eur_J_Clin_Pharmacol_2011_Dec_23_67(12)_1231-1241.nxml.txt.nlp	21698374	SENT120	7	7	4	4	tacrolimus	ABCB1	PA451578	5243	0.711
NULL	Neural_Regen_Res_2012_Oct_5_7(28)_2227-2239.nxml.txt.nlp	25538744	SENT191	24	24	8	8	estradiol	spatial	PA449503	219793	0.711
NULL	Psychiatry_Investig_2009_Sep_3_6(3)_222-225.nxml.txt.nlp	20046399	SENT86	14	14	8	8	perospirone	DRD4	PA165291546	1815	0.711
NULL	Blood_Res_2014_Jun_25_49(2)_85-94.nxml.txt.nlp	25025009	SENT209	23	23	9	9	thrombin	VIII	PA451674	1351	0.711
NULL	J_Geriatr_Cardiol_2014_Jun_11(2)_151-157.nxml.txt.nlp	25009566	SENT111	2	2	7	7	cilostazol	CDP	PA164746334	1523	0.711
NULL	Mol_Cancer_2008_Sep_12_7_69.nxml.txt.nlp	18789131	SENT103	12	12	3	3	pp2	EGFR		1956	0.711
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT154	0	0	12	12	chloroquine	BMPR-II	PA448948	659	0.711
NULL	Acta_Pharmacol_Sin_2009_Oct_21_30(10)_1392-1398.nxml.txt.nlp	19767766	SENT28	5	5	25	25	oxygen	p47	PA450744	3621;55968	0.711
NULL	Fibrogenesis_Tissue_Repair_2011_Dec_13_4_27.nxml.txt.nlp	22166123	SENT142	9	9	25	25	ethanol	HO-1	PA448073	3162	0.711
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1063.nxml.txt.nlp	24556678	SENT102	5	5	16	16	thioridazine	PSMA5	PA451666	5686	0.711
NULL	Cancer_Cell_Int_2013_May_15_13_42.nxml.txt.nlp	23672670	SENT169	11	11	8	8	paclitaxel	p53	PA450761	7157	0.711
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1699-1708.nxml.txt.nlp	19861960	SENT142	14	14	18	18	dasatinib	mol	PA162372878	90527	0.711
NULL	J_Prev_Med_Public_Health_2014_Jan_29_47(1)_57-63.nxml.txt.nlp	24570807	SENT53	30	30	6	6	pentobarbital	TDI	PA450859	100038246	0.711
NULL	Protein_Cell_2014_Jun_22_5(11)_805-815.nxml.txt.nlp	24952721	SENT118	40	40	36	36	crizotinib	ALK	PA165946122	238	0.711
NULL	J_Immunother_Cancer_2013_Nov_7_1(Suppl_1)_O17.nxml.txt.nlp	NULL	SENT10	34	34	36	36	imiquimod	TLR7	PA449972	51284	0.711
NULL	Br_J_Cancer_2014_Mar_4_110(5)_1221-1227.nxml.txt.nlp	24496456	SENT28	7	7	5	5	cetuximab	EGFR	PA10040	1956	0.711
NULL	J_Thromb_Thrombolysis_2013_Oct_14_36(3)_240-246.nxml.txt.nlp	23065325	SENT110	15	15	1	1	clopidogrel	P2Y12	PA449053	64805	0.711
NULL	Cancer_Med_2013_Jun_25_2(3)_277-285.nxml.txt.nlp	23930204	SENT195	27	27	3	3	mitomycin	KRAS	PA450524	3845	0.711
NULL	Biomed_Res_Int_2014_Jun_26_2014_249780.nxml.txt.nlp	25054134	SENT212	20	20	7	7	ethanol	mol	PA448073	90527	0.711
NULL	J_Gen_Intern_Med_2009_May_21_24(5)_656-664.nxml.txt.nlp	19306050	SENT336	24	24	30	30	warfarin	CYP2C9	PA451906	1559	0.711
NULL	Diabetes_2011_May_23_60(5)_1493-1503.nxml.txt.nlp	21478464	SENT55	4	4	15	15	metformin	San	PA450395	80218	0.711
NULL	Oncol_Rep_2013_Mar_8_29(3)_917-924.nxml.txt.nlp	23314174	SENT32	0	0	2	2	sorafenib	HIF-1	PA7000	29072	0.711
NULL	Curr_HIV_Res_2011_Sep_9(6)_429-445.nxml.txt.nlp	21999778	SENT197	7	7	20	20	nevirapine	CD4	PA450616	920	0.711
NULL	EPMA_J_2010_Jun_10_1(2)_229-235.nxml.txt.nlp	23199061	SENT90	13	13	32	32	dorzolamide	OBF	PA164748765	284359	0.711
NULL	Front_Neurol_2014_Dec_11_5_264.nxml.txt.nlp	25566171	SENT114	11	11	23	23	pemoline	IL-6	PA450836	3569	0.711
NULL	Arthritis_Res_Ther_2014_Apr_30_16(2)_R90.nxml.txt.nlp	25167216	SENT294	34	34	4	4	tocilizumab	STEPP	PA165292659	222659	0.711
NULL	J_Exp_Clin_Cancer_Res_2009_Oct_7_28(1)_134.nxml.txt.nlp	19811659	SENT98	0	0	12	12	nilotinib	NQO2	PA165958345	4835	0.711
NULL	Crit_Care_2010_Mar_15_14(2)_R30.nxml.txt.nlp	20226064	SENT271	36	36	19	19	fentanyl	SOCS-3	PA449599	9021	0.711
NULL	Breast_Cancer_Res_2007_Dec_20_9(Suppl_2)_S22.nxml.txt.nlp	NULL	SENT86	26	26	28	28	raloxifene	STAR	PA451221	6770;2984	0.711
NULL	FEBS_Open_Bio_2012_Aug_22_2_279-283.nxml.txt.nlp	23650611	SENT103	6	6	15	15	raloxifene	IFN	PA451221	3439	0.711
NULL	J_Inflamm_(Lond)_2005_Oct_31_2_14.nxml.txt.nlp	16259633	SENT227	2	2	15	15	staurosporine	CCR2	PA165109623	729230	0.711
NULL	Nucleic_Acids_Res_2007_Jan_7_35(1)_214-222.nxml.txt.nlp	17158161	SENT110	44	44	32	32	kanamycin	ORF	PA450137	537	0.711
NULL	Cancer_Med_2013_Aug_10_2(4)_488-495.nxml.txt.nlp	24156021	SENT117	18	18	13	13	sn-38	GEM		2669	0.711
NULL	Oncol_Lett_2013_May_20_5(5)_1659-1663.nxml.txt.nlp	23761830	SENT33	0	0	3	3	estradiol	TLR9	PA449503	54106	0.711
NULL	Clin_Exp_Otorhinolaryngol_2010_Jun_30_3(2)_96-101.nxml.txt.nlp	20607079	SENT114	26	26	17	17	trastuzumab	HER-2	PA451743	2064	0.711
NULL	Oncotarget_2012_Aug_9_3(8)_774-782.nxml.txt.nlp	22885298	SENT35	23	23	20	20	tetracycline	IDH1	PA451640	3417	0.711
NULL	Exp_Diabetes_Res_2012_Oct_15_2012_465282.nxml.txt.nlp	23118742	SENT159	6	6	8	8	metformin	FGF21	PA450395	26291	0.711
NULL	Front_Neuroengineering_2009_Nov_16_2_16.nxml.txt.nlp	19949459	SENT130	26	26	15	15	l-glutamine	B27	PA10090	56246	0.711
NULL	Drug_Des_Devel_Ther_2014_Dec_1_8_2391-2400.nxml.txt.nlp	25489237	SENT118	22	22	29	29	liraglutide	GLP-1	PA165958364	100125288	0.711
NULL	Core_Evid_2007_Nov_30_2(2)_81-88.nxml.txt.nlp	21221177	SENT75	14	14	23	23	bevacizumab	IFL	PA130232992	3439	0.711
NULL	Core_Evid_2007_Nov_30_2(2)_121-129.nxml.txt.nlp	21221180	SENT19	4	4	0	0	vincristine	CHOP	PA451879	1649	0.711
NULL	Oncotarget_2011_Sep_9_2(9)_658-668.nxml.txt.nlp	21911919	SENT137	18	18	6	6	daunorubicin	HO-1	PA449212	3162	0.711
NULL	Environ_Health_Perspect_2008_Apr_16_116(4)_426-433.nxml.txt.nlp	18414622	SENT173	0	0	26	26	genistein	MEK1	PA165109660	5604	0.711
NULL	Int_J_Biol_Sci_2015_Jan_1_11(1)_48-58.nxml.txt.nlp	25552929	SENT301	16	16	5	5	paclitaxel	TSP-1	PA450761	7057	0.711
NULL	Blood_Cancer_J_2014_Aug_1_4(8)_e232.nxml.txt.nlp	25083816	SENT218	43	43	25	25	daunorubicin	PI3K	PA449212	5290	0.711
NULL	Oncol_Lett_2013_Jul_29_6(1)_23-27.nxml.txt.nlp	23946772	SENT34	30	30	32	32	cisplatin	DDP	PA449014	1678	0.711
NULL	Oncoimmunology_2013_Mar_1_2(3)_e23304.nxml.txt.nlp	23802074	SENT95	18	18	39	39	rituximab	HER-2	PA451261	2064	0.711
NULL	Arthritis_Res_Ther_2014_Apr_30_16(2)_R90.nxml.txt.nlp	25167216	SENT294	32	32	21	21	adalimumab	CXCL13	PA10004	10563	0.711
NULL	Oncotarget_2013_Dec_28_5(6)_1475-1490.nxml.txt.nlp	24721996	SENT9	0	0	13	13	celecoxib	PTEN	PA448871	5728	0.711
NULL	J_Headache_Pain_2013_Feb_21_14(Suppl_1)_P67.nxml.txt.nlp	NULL	SENT16	11	11	21	21	baclofen	NRM	PA448533	11270	0.711
NULL	J_Oncol_2009_Mar_24_2009_491985.nxml.txt.nlp	19325924	SENT76	16	16	36	36	genistein	CXCR4	PA165109660	7852	0.711
NULL	Asian-Australas_J_Anim_Sci_2013_Apr_26(4)_573-578.nxml.txt.nlp	25049825	SENT39	22	22	30	30	bacitracin	BP1	PA448531	1748	0.711
NULL	FEBS_J_2009_Oct_276(19)_5571-5578.nxml.txt.nlp	19702827	SENT51	39	39	28	28	gefitinib	EGFR	PA131301952	1956	0.711
NULL	Hum_Genomics_2010_Apr_1_4(4)_238-249.nxml.txt.nlp	20511137	SENT234	20	20	10	10	irinotecan	UGT1A1	PA450085	54658	0.711
NULL	Front_Behav_Neurosci_2014_Nov_27_8_407.nxml.txt.nlp	25505876	SENT127	39	39	11	11	tamoxifen	NAC	PA451581	22861	0.711
NULL	Arch_Drug_Inf_2008_Dec_1(3)_97-106.nxml.txt.nlp	19639031	SENT34	17	17	1	1	sn-38	UGT1A1		54658	0.711
NULL	Iran_J_Pharm_Res_2013_Summer_12(3)_457-469.nxml.txt.nlp	24250652	SENT12	11	11	14	14	indomethacin	spatial	PA449982	219793	0.711
NULL	J_Oncol_2009_Mar_24_2009_491985.nxml.txt.nlp	19325924	SENT7	2	2	13	13	genistein	CXCR4	PA165109660	7852	0.711
NULL	Chemother_Res_Pract_2012_Aug_29_2012_817297.nxml.txt.nlp	22970367	SENT190	12	12	16	16	afatinib	EGFR	PA165981154	1956	0.711
NULL	Virulence_2012_Oct_1_3(6)_515-517.nxml.txt.nlp	23076283	SENT54	30	30	12	12	amiloride	PAO	PA448368	196743;54498	0.711
NULL	EJC_Suppl_2013_Sep_5_11(2)_299-300.nxml.txt.nlp	NULL	SENT26	0	0	2	2	tamoxifen	aromatase	PA451581	1588	0.711
NULL	Eur_J_Clin_Pharmacol_2011_May_8_67(5)_493-506.nxml.txt.nlp	21140139	SENT27	23	23	25	25	oxymorphone	CYP3A4	PA450748	1576	0.711
NULL	Cardiovasc_Diabetol_2013_Jan_31_12_28.nxml.txt.nlp	23368770	SENT264	21	21	7	7	glucose	AMPK	PA449773	5563	0.711
NULL	Exp_Ther_Med_2013_May_15_5(5)_1327-1331.nxml.txt.nlp	23737873	SENT192	15	15	5	5	imidapril	AQP2	PA452640	359	0.711
NULL	Br_J_Cancer_2013_Jun_25_108(12)_2464-2469.nxml.txt.nlp	23695016	SENT7	29	29	21	21	cisplatin	CRT	PA449014	811	0.711
NULL	Evid_Based_Complement_Alternat_Med_2013_Mar_26_2013_974313.nxml.txt.nlp	23589723	SENT172	27	27	8	8	metformin	AMPK	PA450395	5563	0.711
NULL	Pharmaceuticals_(Basel)_2014_Apr_14_7(4)_453-463.nxml.txt.nlp	24736104	SENT160	20	20	17	17	diclofenac	GIT	PA449293	5034	0.711
NULL	Mol_Cancer_2014_Jun_30_13_160.nxml.txt.nlp	24976026	SENT160	17	17	8	8	bortezomib	AGR2	PA10252	10551	0.711
NULL	Colomb_Med_(Cali)_43(3)_235-243.nxml.txt.nlp	24893199	SENT178	7	7	27	27	doxycycline	AKT	PA449415	207	0.711
NULL	J_Cell_Physiol_2014_Dec_27_229(12)_1999-2014.nxml.txt.nlp	24777663	SENT193	33	33	31	31	collagenase	CO2	PA449107	4513	0.711
NULL	Cell_Death_Dis_2010_Nov_18_1(11)_e102.nxml.txt.nlp	21368867	SENT118	15	15	25	25	gentamicin	14-3-3	PA449753	10971	0.711
NULL	Br_J_Cancer_2010_Feb_16_102(4)_774-782.nxml.txt.nlp	20087350	SENT225	10	10	7	7	tetracycline	CLCN4	PA451640	1183	0.711
NULL	Ann_Saudi_Med_2010_Mar-Apr_30(2)_162-164.nxml.txt.nlp	20220270	SENT13	28	28	19	19	glibenclamide	KCNJ11	PA449782	3767	0.711
NULL	Cancer_Cell_Int_2011_Aug_19_11_29.nxml.txt.nlp	21854619	SENT124	0	0	3	3	cisplatin	BRCA1	PA449014	672	0.711
NULL	J_Inflamm_(Lond)_2006_Jul_12_3_10.nxml.txt.nlp	16834783	SENT231	13	13	18	18	mometasone	IL-5	PA450541	3567	0.711
NULL	Clin_Dev_Immunol_2013_Nov_26_2013_325481.nxml.txt.nlp	24371447	SENT90	4	4	19	19	propofol	IL-6	PA451141	3569	0.711
NULL	Anat_Cell_Biol_2010_Mar_31_43(1)_25-35.nxml.txt.nlp	21190002	SENT188	11	11	21	21	allopurinol	CD40	PA448320	958	0.711
NULL	Drug_Saf_2014_Feb_19_37(4)_201-211.nxml.txt.nlp	24550106	SENT91	21	21	24	24	clopidogrel	CYP2C19	PA449053	1557	0.711
NULL	Breast_Cancer_Res_2010_Mar_5_12(2)_R16.nxml.txt.nlp	20205716	SENT234	28	28	22	22	lovastatin	HMGB1	PA450272	3146	0.711
NULL	F1000_Med_Rep_2010_Apr_12_2_28.nxml.txt.nlp	20436921	SENT71	23	23	15	15	azathioprine	NAC	PA448515	22861	0.711
NULL	J_Obes_2012_Apr_17_2012_104706.nxml.txt.nlp	22577523	SENT57	10	10	35	35	diclofenac	IL-10	PA449293	3586	0.711
NULL	Mol_Cancer_2012_Jul_25_11_46.nxml.txt.nlp	22830422	SENT154	9	9	3	3	rolipram	AKT	PA153906323	207	0.711
NULL	Cancer_Immunol_Immunother_2013_Aug_27_62(10)_1637-1648.nxml.txt.nlp	23982484	SENT165	0	0	10	10	lenalidomide	DNAM-1	PA162363968	10666	0.711
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT103	11	11	9	9	curcumin	IL-8	PA151958596	3576	0.711
NULL	Indian_J_Endocrinol_Metab_2012_May-Jun_16(3)_343-348.nxml.txt.nlp	22629497	SENT28	15	15	31	31	preotact	PTH	PA165958355	5741	0.711
NULL	Breast_Cancer_Res_2011_May_25_13(3)_107.nxml.txt.nlp	21635706	SENT20	29	29	27	27	denosumab	RANKL	PA166048634	8600	0.711
NULL	Int_J_Pediatr_2010_Dec_23_2010_376287.nxml.txt.nlp	21234103	SENT92	25	25	28	28	levofloxacin	gamma	PA450214	9913	0.711
NULL	Bioinform_Biol_Insights_2009_Oct_5_3_109-127.nxml.txt.nlp	20140064	SENT431	6	6	23	23	abacavir	P62	PA448004	2965	0.711
NULL	Clin_Sci_(Lond)_2013_Apr_1_124(Pt_8)_543-552.nxml.txt.nlp	23130652	SENT12	0	0	12	12	enalapril	ACO2	PA449456	50	0.711
NULL	Int_J_Gen_Med_2009_Jul_30_2_129-140.nxml.txt.nlp	20360896	SENT5	11	11	13	13	tamoxifen	aromatase	PA451581	1588	0.711
NULL	Exp_Transl_Stroke_Med_2011_Jul_14_3_7.nxml.txt.nlp	21756314	SENT182	4	4	2	2	losartan	AT1	PA450268	9197;185	0.711
NULL	Biomed_Res_Int_2013_Apr_18_2013_351031.nxml.txt.nlp	23691498	SENT168	0	0	6	6	celecoxib	COX	PA448871	1351	0.711
NULL	Oncotarget_2014_Dec_4_5(22)_11365-11380.nxml.txt.nlp	25426548	SENT5	10	10	2	2	nutlin-3	p53		7157	0.711
NULL	EMBO_Mol_Med_2013_Aug_5_5(8)_1213-1226.nxml.txt.nlp	23918228	SENT179	13	13	16	16	cetuximab	EGFR	PA10040	1956	0.711
NULL	Cancer_Metastasis_Rev_2014_Dec_28_33(1)_161-171.nxml.txt.nlp	24375389	SENT19	39	39	24	24	lapatinib	HER2	PA152241907	2064	0.711
NULL	Oncol_Lett_2014_Oct_22_8(4)_1603-1607.nxml.txt.nlp	25202376	SENT130	11	11	37	37	cisplatin	ERCC1	PA449014	2067	0.711
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT139	28	28	21	21	etravirine	CYP3A	PA166014703	1574	0.711
NULL	Comput_Struct_Biotechnol_J_2013_Dec_7_6_e201303019.nxml.txt.nlp	24688727	SENT340	40	40	23	23	bortezomib	TRAIL	PA10252	8743	0.711
NULL	Basic_Clin_Neurosci_2014_Winter_5(1)_74-79.nxml.txt.nlp	25436087	SENT84	5	5	9	9	fluoxetine	EPAC	PA449673	10411	0.711
NULL	Aging_(Albany_NY)_2010_Dec_20_2(12)_959-968.nxml.txt.nlp	21191146	SENT24	6	6	30	30	cisplatin	LKB1	PA449014	6794	0.711
NULL	Br_J_Cancer_2011_Jul_12_105(2)_212-220.nxml.txt.nlp	21694723	SENT40	2	2	22	22	curcumin	STAT3	PA151958596	6774	0.711
NULL	Arch_Med_Sci_2013_Dec_30_9(6)_1090-1096.nxml.txt.nlp	24482655	SENT149	6	6	27	27	tacrolimus	IFN	PA451578	3439	0.711
NULL	J_Cell_Biol_2006_Sep_25_174(7)_1097-1106.nxml.txt.nlp	16982797	SENT203	33	33	17	17	heparin	SDC1	PA449855	6382	0.711
NULL	Evid_Based_Complement_Alternat_Med_2013_May_13_2013_506324.nxml.txt.nlp	23818927	SENT147	34	34	16	16	doxorubicin	STAT3	PA449412	6774	0.711
NULL	Clin_Mol_Hepatol_2014_Dec_24_20(4)_338-344.nxml.txt.nlp	25548738	SENT50	32	32	29	29	telaprevir	BOC	PA165958354	91653	0.711
NULL	J_Invest_Dermatol_2013_Sep_31_133(9)_2247-2254.nxml.txt.nlp	23370537	SENT69	2	2	17	17	chloroquine	p53	PA448948	7157	0.711
NULL	Diabetes_2013_Jun_17_62(6)_1843-1854.nxml.txt.nlp	23349486	SENT235	22	22	20	20	hyaluronan	MCP-1	PA165958431	6347	0.711
NULL	Gut_Liver_2011_Sep_18_5(3)_293-297.nxml.txt.nlp	21927656	SENT33	27	27	4	4	lansoprazole	ESD	PA450180	2098	0.711
NULL	Br_J_Pharmacol_2008_Sep_9_155(1)_127-137.nxml.txt.nlp	18536750	SENT304	10	10	5	5	piroxicam	IL-10	PA450985	3586	0.711
NULL	Arthritis_Res_Ther_2010_Sep_8_12(5)_R167.nxml.txt.nlp	20825639	SENT169	23	23	9	9	resveratrol	JNK		5599	0.711
NULL	Biochem_Res_Int_2012_Feb_12_2012_346972.nxml.txt.nlp	22400115	SENT98	4	4	13	13	hyaluronan	CD44	PA165958431	960	0.711
NULL	Brain_Sci_2013_Jun_3_3(2)_877-907.nxml.txt.nlp	24961429	SENT243	9	9	15	15	taurine	MELAS	PA451590	4219	0.711
NULL	Leukemia_2014_Jun_17_28(6)_1216-1226.nxml.txt.nlp	24301524	SENT101	2	2	29	29	bortezomib	HES1	PA10252	3280;8209	0.711
NULL	Exp_Ther_Med_2014_Nov_17_8(5)_1484-1488.nxml.txt.nlp	25289046	SENT133	16	16	18	18	cisplatin	DDP	PA449014	1678	0.711
NULL	J_Clin_Biochem_Nutr_2007_Jul_27_41(1)_32-42.nxml.txt.nlp	18392098	SENT602	42	42	11	11	curcumin	ROS	PA151958596	6098	0.711
NULL	Oncoimmunology_2013_Oct_1_2(10)_e27025.nxml.txt.nlp	24353914	SENT180	20	20	12	12	vinorelbine	CD25	PA451881	3669;3559	0.711
NULL	Ann_Gen_Psychiatry_2010_Mar_6_9_11.nxml.txt.nlp	20205742	SENT25	28	28	6	6	quetiapine	STAR	PA451201	6770;2984	0.711
NULL	J_Cell_Biol_2008_Jun_16_181(6)_1013-1026.nxml.txt.nlp	18541700	SENT277	31	31	36	36	l-glutamine	IFN	PA10090	3439	0.711
NULL	Curr_Neuropharmacol_2010_Dec_8(4)_409-421.nxml.txt.nlp	21629447	SENT177	13	13	4	4	diazepam	LGS	PA449283	51557	0.711
NULL	Biochem_Res_Int_2012_Mar_4_2012_685267.nxml.txt.nlp	22496978	SENT202	7	7	13	13	thrombin	HSPC	PA451674	5688	0.711
NULL	Nat_Chem_Biol_2010_Apr_28_6(4)_291-299.nxml.txt.nlp	20190765	SENT128	19	19	28	28	dasatinib	EGFR	PA162372878	1956	0.711
NULL	Front_Behav_Neurosci_2011_Sep_8_5_56.nxml.txt.nlp	21927600	SENT1883	0	0	21	21	cocaine	CK1	PA449072	1452	0.711
NULL	Braz_J_Med_Biol_Res_2014_Mar_3_47(3)_245-251.nxml.txt.nlp	24554037	SENT39	26	26	35	35	atorvastatin	gamma	PA448500	9913	0.711
NULL	Orphanet_J_Rare_Dis_2007_Jan_8_2_3.nxml.txt.nlp	17210076	SENT321	3	3	5	5	anagrelide	IFN	PA164742986	3439	0.711
NULL	Open_Biol_2014_Feb_4(2)_130217.nxml.txt.nlp	24522884	SENT613	29	29	21	21	trabectedin	CUL4A	PA165958349	8451	0.711
NULL	Sci_Rep_2015_Jan_19_5_7856.nxml.txt.nlp	25598223	SENT201	7	7	33	33	paraformaldehyde	San	PA450790	80218	0.711
NULL	Clin_Drug_Investig_2013_Aug_23_33(10)_727-736.nxml.txt.nlp	23975654	SENT80	3	3	10	10	fluconazole	CYP2C9	PA449653	1559	0.711
NULL	J_Med_Case_Reports_2011_Oct_5_5_504.nxml.txt.nlp	21975443	SENT18	0	0	8	8	imatinib	KIT	PA10804	3815	0.711
NULL	Cell_Death_Dis_2013_Jan_24_4(1)_e469.nxml.txt.nlp	23348583	SENT232	6	6	13	13	mitomycin	CT26	PA450524	168400	0.711
NULL	Iran_Red_Crescent_Med_J_2013_Dec_5_15(12)_e7788.nxml.txt.nlp	24693412	SENT5	38	38	35	35	telbivudine	LAM	PA164760861	7249;7248	0.711
NULL	Int_J_Alzheimers_Dis_2012_Apr_4_2012_258454.nxml.txt.nlp	22548198	SENT66	16	16	8	8	estradiol	CEE	PA449503	51608	0.711
NULL	Endosc_Ultrasound_2013_Jan-Mar_2(1)_43-60.nxml.txt.nlp	NULL	SENT197	15	15	22	22	lipase	CEA	PA450239	5670;1087	0.711
NULL	Int_J_Mol_Sci_2014_Nov_10_15(11)_20607-20637.nxml.txt.nlp	25391045	SENT40	20	20	31	31	simvastatin	CYP2C9	PA451363	1559	0.711
NULL	Hum_Genomics_2004_May_1_1(4)_300-306.nxml.txt.nlp	15588489	SENT99	12	12	10	10	debrisoquine	CYP2D6	PA452616	1565	0.711
NULL	Arthritis_Res_Ther_2006_May_11_8(3)_209.nxml.txt.nlp	16712713	SENT510	8	8	34	34	leflunomide	AID	PA450192	57379	0.711
NULL	Nat_Chem_Biol_2010_Apr_28_6(4)_291-299.nxml.txt.nlp	20190765	SENT179	24	24	4	4	dasatinib	EGFR	PA162372878	1956	0.711
NULL	Psychiatry_Investig_2008_Jun_30_5(2)_102-105.nxml.txt.nlp	20046352	SENT66	31	31	17	17	carbamazepine	DTNBP1	PA448785	84062	0.711
NULL	Infect_Dis_Rep_2011_Nov_22_3(2)_e14.nxml.txt.nlp	24470911	SENT39	31	31	6	6	ritonavir	CD4	PA451260	920	0.711
NULL	Chemother_Res_Pract_2011_Sep_21_2011_839742.nxml.txt.nlp	22295206	SENT101	5	5	8	8	bevacizumab	CRT	PA130232992	811	0.711
NULL	Case_Rep_Endocrinol_2013_Sep_8_2013_415810.nxml.txt.nlp	24083038	SENT62	11	11	9	9	sulfamethoxazole	CYP2C8	PA451544	1558	0.711
NULL	Diabetes_Care_2013_Jul_12_36(7)_1913-1918.nxml.txt.nlp	23359361	SENT87	11	11	34	34	sitagliptin	GLP-1	PA164748978	100125288	0.711
NULL	Arthritis_Res_Ther_2008_Mar_31_10(2)_205.nxml.txt.nlp	18394179	SENT154	13	13	6	6	collagenase	MMP3	PA449107	4314	0.711
NULL	Br_J_Cancer_2012_Aug_21_107(5)_800-807.nxml.txt.nlp	22850554	SENT146	26	26	16	16	trastuzumab	HER2	PA451743	2064	0.711
NULL	J_Cell_Biol_2006_Sep_25_174(7)_1047-1058.nxml.txt.nlp	17000881	SENT242	0	0	7	7	forskolin	VEGFR2	PA146096022	3791	0.711
NULL	Cancer_Inform_2007_Jun_6_2_329-343.nxml.txt.nlp	19458775	SENT182	20	20	17	17	vasopressin	PTH	PA451858	5741	0.711
NULL	Indian_J_Med_Res_2014_Jan_139(1)_7-9.nxml.txt.nlp	24604036	SENT30	20	20	3	3	mebendazole	STH	PA164776669	246744	0.711
NULL	Clin_Dev_Immunol_2011_Nov_30_2011_842849.nxml.txt.nlp	22190973	SENT151	22	22	11	11	trastuzumab	HER2	PA451743	2064	0.711
NULL	Diabetes_2013_Oct_17_62(10)_3305-3306.nxml.txt.nlp	NULL	SENT40	8	8	27	27	pravastatin	adiponectin	PA451089	9370	0.711
NULL	Indian_J_Dermatol_2014_Nov-Dec_59(6)_632a.nxml.txt.nlp	25484418	SENT37	3	3	6	6	bevacizumab	VEGF-A	PA130232992	7422	0.711
NULL	Biomed_Res_Int_2014_May_14_2014_642798.nxml.txt.nlp	24955366	SENT51	13	13	11	11	hyaluronan	ACAN	PA165958431	176	0.711
NULL	Environ_Health_Perspect_2006_Sep_23_114(9)_1401-1406.nxml.txt.nlp	16966095	SENT114	0	0	8	8	tetracycline	p53	PA451640	7157	0.711
NULL	Oncogene_2009_Feb_5_28(5)_625-637.nxml.txt.nlp	19015636	SENT194	41	41	16	16	doxycycline	GLI2	PA449415	2736	0.711
NULL	Bioinformation_2012_Jan_6_8(1)_13-19.nxml.txt.nlp	22359429	SENT8	26	26	33	33	curcumin	MRP1	PA151958596	4437	0.711
NULL	Front_Neural_Circuits_2015_Jan_12_8_150.nxml.txt.nlp	25628540	SENT326	2	2	9	9	atropine	CA1	PA448505	759	0.711
NULL	Cancer_Immunol_Immunother_2011_Jan_22_60(1)_37-47.nxml.txt.nlp	20859626	SENT66	24	24	32	32	streptomycin	IL-4	PA451512	3565	0.711
NULL	J_Cell_Biol_1998_Jul_13_142(1)_101-115.nxml.txt.nlp	9660866	SENT137	38	38	30	30	dextran	mol	PA449261	90527	0.711
NULL	Int_J_Vasc_Med_2014_Jul_22_2014_659617.nxml.txt.nlp	25140254	SENT153	7	7	19	19	isoflurane	AVP	PA450106	114548;551	0.711
NULL	Br_J_Cancer_2010_Jul_13_103(2)_196-200.nxml.txt.nlp	20571495	SENT133	41	41	30	30	sunitinib	BRAF	PA162372840	673	0.711
NULL	Hum_Genomics_2008_Sep_1_3(1)_7-16.nxml.txt.nlp	19129086	SENT10	34	34	40	40	rosiglitazone	CYP2C8	PA451283	1558	0.711
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Apr_13_69(Pt_5)_o727.nxml.txt.nlp	23723879	SENT78	21	21	12	12	ethanol	mol	PA448073	90527	0.711
NULL	Environ_Health_Perspect_2012_Aug_18_120(8)_1170-1176.nxml.txt.nlp	22514210	SENT235	5	5	8	8	genistein	BRCA1	PA165109660	672	0.711
NULL	Front_Endocrinol_(Lausanne)_2014_Feb_4_5_10.nxml.txt.nlp	24550888	SENT495	18	18	39	39	resveratrol	p53		7157	0.711
NULL	Front_Genet_2014_Oct_31_5_379.nxml.txt.nlp	25400658	SENT321	8	8	15	15	estradiol	H19	PA449503	283120	0.711
NULL	EMBO_J_2010_Jan_6_29(1)_68-79.nxml.txt.nlp	19927124	SENT45	13	13	3	3	tetracycline	NO66	PA451640	79697	0.711
NULL	EMBO_Mol_Med_2012_Mar_4(3)_180-191.nxml.txt.nlp	22174035	SENT141	14	14	37	37	dantrolene	RYR2	PA449208	6262	0.711
NULL	Oxid_Med_Cell_Longev_2012_May_30_2012_452902.nxml.txt.nlp	22701146	SENT246	7	7	26	26	ifosfamide	OCTN2	PA449964	6584	0.711
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT272	2	2	0	0	mitomycin	MVP	PA450524	9961	0.711
NULL	J_Physiol_2014_Apr_15_592(8)_1731-1744.nxml.txt.nlp	24535442	SENT233	6	6	17	17	amiloride	HSD2	PA448368	6060	0.711
NULL	Mol_Vis_2012_Oct_5_18_2454-2467.nxml.txt.nlp	23077404	SENT86	2	2	4	4	bevacizumab	VEGF-A	PA130232992	7422	0.711
NULL	J_Cell_Biol_1986_Apr_1_102(4)_1334-1343.nxml.txt.nlp	3958048	SENT11	3	3	10	10	forskolin	MP26	PA146096022	4284	0.711
NULL	Cell_Res_2012_Aug_22_22(8)_1227-1245.nxml.txt.nlp	22613949	SENT115	31	31	21	21	doxorubicin	KRAS	PA449412	3845	0.711
NULL	EMBO_Mol_Med_2013_Dec_8_5(12)_1821-1834.nxml.txt.nlp	24293316	SENT166	11	11	14	14	doxorubicin	p53	PA449412	7157	0.711
NULL	Cancer_Cell_Int_2013_Jun_26_13_63.nxml.txt.nlp	23800022	SENT114	0	0	14	14	genistein	MCL1	PA165109660	4170	0.711
NULL	Braz_J_Med_Biol_Res_2014_Sep_5_47(11)_929-939.nxml.txt.nlp	25296354	SENT84	8	8	21	21	afatinib	EGFR	PA165981154	1956	0.711
NULL	Acta_Pharmacol_Sin_2010_Apr_22_31(4)_450-454.nxml.txt.nlp	20305679	SENT112	16	16	3	3	glucose	nNOS	PA449773	4842	0.711
NULL	Oncotarget_2012_Jan_28_3(1)_22-30.nxml.txt.nlp	22289880	SENT116	18	18	24	24	rituximab	TH1	PA451261	51497	0.711
NULL	Clin_Interv_Aging_2012_Sep_17_7_363-372.nxml.txt.nlp	23049248	SENT57	0	0	9	9	denosumab	RANKL	PA166048634	8600	0.71
NULL	Cancer_Manag_Res_2014_Oct_4_6_397-404.nxml.txt.nlp	25328417	SENT78	16	16	23	23	erlotinib	KRAS	PA134687924	3845	0.71
NULL	Endocrinology_2014_Jun_31_155(6)_2144-2154.nxml.txt.nlp	24684305	SENT367	34	34	16	16	estradiol	GCK	PA449503	5871;2645	0.71
NULL	Br_J_Cancer_2010_Jan_5_102(1)_115-123.nxml.txt.nlp	19997099	SENT227	22	22	24	24	gemcitabine	GEM	PA449748	2669	0.71
NULL	Biomed_Res_Int_2014_Jun_26_2014_161346.nxml.txt.nlp	25054130	SENT228	7	7	30	30	curcumin	STZ	PA151958596	6484	0.71
NULL	Diabetes_Care_2009_Aug_32(8)_1556-1562.nxml.txt.nlp	19638526	SENT226	11	11	13	13	fenofibrate	AMPK	PA449594	5563	0.71
NULL	Pharmaceuticals_(Basel)_2011_Nov_10_4(11)_1488-1502.nxml.txt.nlp	NULL	SENT105	13	13	33	33	cisplatin	GRP94	PA449014	7184	0.71
NULL	Breast_Cancer_Res_2004_May_7_6(4)_R352-R365.nxml.txt.nlp	15217502	SENT23	29	29	7	7	estradiol	CYP1A2	PA449503	1544	0.71
NULL	J_Hematol_Oncol_2009_Jul_27_2_31.nxml.txt.nlp	19635146	SENT167	24	24	35	35	vorinostat	p21CIP1	PA164748224	1026	0.71
NULL	Int_J_Gen_Med_2011_May_3_4_345-357.nxml.txt.nlp	21674027	SENT107	17	17	33	33	l-glutamine	CO2	PA10090	4513	0.71
NULL	Ethiop_J_Health_Sci_2010_Nov_20(3)_179-183.nxml.txt.nlp	22434977	SENT45	13	13	26	26	artesunate	RDT	PA165111697	6598	0.71
NULL	Mol_Biol_Rep_2013_Sep_28_40(10)_5573-5585.nxml.txt.nlp	24078156	SENT43	12	12	21	21	iron	IRP2	PA450087	3658	0.71
NULL	J_Adv_Pharm_Technol_Res_2011_Apr-Jun_2(2)_81-87.nxml.txt.nlp	22171298	SENT184	29	29	24	24	doxorubicin	p53	PA449412	7157	0.71
NULL	Cell_Death_Dis_2013_Oct_3_4(10)_e828.nxml.txt.nlp	24091671	SENT90	2	2	21	21	cetuximab	CD54	PA10040	3383	0.71
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1150.nxml.txt.nlp	24675468	SENT100	27	27	34	34	metformin	adiponectin	PA450395	9370	0.71
NULL	Mol_Cancer_2009_Nov_10_8_99.nxml.txt.nlp	19903356	SENT102	8	8	2	2	imatinib	IGFBP3	PA10804	3486	0.71
NULL	Br_J_Ophthalmol_2014_Sep_98(9)_1144-1167.nxml.txt.nlp	25136079	SENT533	15	15	3	3	ranibizumab	EMB	PA164746012	133418	0.71
NULL	Infect_Drug_Resist_2010_Apr_26_3_15-23.nxml.txt.nlp	21694890	SENT206	8	8	25	25	etravirine	TRIO	PA166014703	7204	0.71
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT281	7	7	0	0	cisplatin	MVP	PA449014	9961	0.71
NULL	Mol_Cancer_2007_Oct_22_6_66.nxml.txt.nlp	17953743	SENT121	11	11	7	7	cisplatin	TRAIL	PA449014	8743	0.71
NULL	Arthritis_Res_Ther_2010_Apr_29_12(2)_R73.nxml.txt.nlp	20429888	SENT300	1	1	8	8	bortezomib	COL1A2	PA10252	1278	0.71
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Sep_12_65(Pt_10)_o2429.nxml.txt.nlp	21577885	SENT59	23	23	29	29	phenol	mol	PA450913	90527	0.71
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT229	4	4	10	10	curcumin	TRAIL	PA151958596	8743	0.71
NULL	ARYA_Atheroscler_2012_Winter_7(4)_133-137.nxml.txt.nlp	23205044	SENT114	12	12	4	4	pentoxifylline	p50	PA450864	958;4790	0.71
NULL	Clin_Med_Insights_Cardiol_2010_Oct_11_4_89-93.nxml.txt.nlp	20981132	SENT89	34	34	20	20	benazepril	TNF	PA448561	7124	0.71
NULL	EJC_Suppl_2013_Sep_5_11(2)_45-59.nxml.txt.nlp	NULL	SENT391	2	2	23	23	bevacizumab	LARC	PA130232992	6364	0.71
NULL	Pharmaceuticals_(Basel)_2011_Nov_10_4(11)_1488-1502.nxml.txt.nlp	NULL	SENT198	8	8	13	13	trastuzumab	PTEN	PA451743	5728	0.71
NULL	Acta_Pharmacol_Sin_2011_Jun_3_32(6)_817-823.nxml.txt.nlp	21642950	SENT146	4	4	7	7	propofol	HCN	PA451141	378938	0.71
NULL	Front_Chem_2014_Dec_23_2_113.nxml.txt.nlp	25566531	SENT254	6	6	32	32	curcumin	MKK7	PA151958596	5609	0.71
NULL	ScientificWorldJournal_2013_Oct_27_2013_939830.nxml.txt.nlp	24288514	SENT146	6	6	13	13	carrageenan	ANOVA	PA448814	4858	0.71
NULL	Clin_Ophthalmol_2014_Jun_26_8_1213-1219.nxml.txt.nlp	25061267	SENT148	5	5	11	11	ketorolac	PRK	PA450150	1263	0.71
NULL	Nat_Genet_2011_Jan_12_43(1)_27-33.nxml.txt.nlp	21151129	SENT30	28	28	31	31	tamoxifen	FOXA1	PA451581	3169	0.71
NULL	Oncoimmunology_2013_Dec_1_2(12)_e26663.nxml.txt.nlp	24498552	SENT15	13	13	30	30	melphalan	NKG2D	PA450354	22914	0.71
NULL	Curr_Neuropharmacol_2008_Jun_6(2)_151-163.nxml.txt.nlp	19305794	SENT342	2	2	20	20	capsaicin	EP4	PA448776	5734	0.71
NULL	J_Clin_Biochem_Nutr_2009_Jul_30_45(1)_9-13.nxml.txt.nlp	19590701	SENT52	9	9	7	7	lansoprazole	HO-1	PA450180	3162	0.71
NULL	Int_J_Biol_Sci_2012_Feb_9_8(3)_310-327.nxml.txt.nlp	22355267	SENT156	18	18	13	13	simvastatin	PCSK9	PA451363	255738	0.71
NULL	Oncotarget_2013_Jun_4_4(5)_772-784.nxml.txt.nlp	23800712	SENT6	17	17	12	12	erlotinib	EGFR	PA134687924	1956	0.71
NULL	Bioinformation_2012_Jan_6_8(1)_13-19.nxml.txt.nlp	22359429	SENT142	11	11	14	14	curcumin	MRP1	PA151958596	4437	0.71
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Jun_25_3(6)_e120.nxml.txt.nlp	24964282	SENT189	8	8	5	5	efavirenz	CYP3A	PA449441	1574	0.71
NULL	J_Vet_Med_Sci_2014_Nov_22_76(11)_1443-1450.nxml.txt.nlp	25452258	SENT55	6	6	14	14	fluorescein	CD11b	PA164746009	3684	0.71
NULL	Environ_Health_Perspect_2005_Jun_24_113(6)_680-687.nxml.txt.nlp	15929889	SENT182	27	27	29	29	estradiol	SULT1E1	PA449503	6783	0.71
NULL	J_Vet_Med_Sci_2014_Mar_1_76(3)_323-330.nxml.txt.nlp	24189582	SENT140	13	13	15	15	atovaquone	ATV	PA448502	4683	0.71
NULL	ScientificWorldJournal_2014_Mar_17_2014_709801.nxml.txt.nlp	24778598	SENT42	0	0	21	21	rocuronium	NMT	PA164754992	4836	0.71
NULL	Eur_J_Clin_Pharmacol_2013_Mar_11_69(3)_327-339.nxml.txt.nlp	22782539	SENT189	4	4	21	21	clopidogrel	IPA	PA449053	3160	0.71
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT68	3	3	12	12	resveratrol	GREB1		9687	0.71
NULL	Oncoimmunology_2013_Sep_1_2(9)_e25789.nxml.txt.nlp	24244905	SENT22	4	4	18	18	cyclophosphamide	TNFSF13B	PA449165	10673	0.71
NULL	Crit_Care_2008_Jul_25_12(4)_R93.nxml.txt.nlp	18657277	SENT47	8	8	26	26	heparin	ACT	PA449855	12;11332;9457;641455	0.71
NULL	Virol_J_2009_Jan_12_6_5.nxml.txt.nlp	19138419	SENT143	3	3	6	6	stavudine	CD4	PA451494	920	0.71
NULL	J_Anaesthesiol_Clin_Pharmacol_2012_Oct-Dec_28(4)_548-549.nxml.txt.nlp	23225959	SENT32	34	34	5	5	metoclopramide	Gen	PA450475	348654	0.71
NULL	Br_J_Cancer_2009_Jul_21_101(2)_238-243.nxml.txt.nlp	19568242	SENT4	15	15	25	25	sunitinib	IFN	PA162372840	3439	0.71
NULL	Oxid_Med_Cell_Longev_2013_Sep_17_2013_521563.nxml.txt.nlp	24163720	SENT67	6	6	8	8	vasopressin	AVP	PA451858	114548;551	0.71
NULL	Arthritis_Res_Ther_2013_Apr_4_15(Suppl_1)_S4.nxml.txt.nlp	23566679	SENT153	7	7	22	22	rituximab	CD19	PA451261	930	0.71
NULL	Br_J_Cancer_2012_Feb_14_106(4)_646-650.nxml.txt.nlp	22240794	SENT32	13	13	15	15	sunitinib	IFN	PA162372840	3439	0.71
NULL	Mol_Cell_Neurosci_2013_Sep_56(100)_115-127.nxml.txt.nlp	23639831	SENT275	15	15	20	20	doxycycline	San	PA449415	80218	0.71
NULL	Arthritis_Res_Ther_2012_May_1_14(3)_R99.nxml.txt.nlp	22546542	SENT110	4	4	6	6	infliximab	CD4	PA452639	920	0.71
NULL	Biomed_Imaging_Interv_J_2007_Oct_1_3(4)_e52.nxml.txt.nlp	21614300	SENT98	3	3	12	12	cyclophosphamide	CHOP	PA449165	1649	0.71
NULL	Oncotarget_2011_Mar_7_2(3)_122-134.nxml.txt.nlp	21399234	SENT66	7	7	13	13	trastuzumab	HER-2	PA451743	2064	0.71
NULL	Breast_Cancer_Res_2011_Nov_7_13(6)_R112.nxml.txt.nlp	22060274	SENT36	9	9	6	6	tamoxifen	ARTN	PA451581	9048	0.71
NULL	Acta_Pharmacol_Sin_2013_May_8_34(5)_699-709.nxml.txt.nlp	23564084	SENT55	15	15	34	34	l-glutamine	CO2	PA10090	4513	0.71
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT110	26	26	6	6	glucose	EGFR	PA449773	1956	0.71
NULL	Small_GTPases_2012_Apr_1_3(2)_73-79.nxml.txt.nlp	22790193	SENT115	23	23	27	27	l-glutamine	IFN	PA10090	3439	0.71
NULL	Case_Rep_Hematol_2013_Jun_11_2013_680459.nxml.txt.nlp	23840983	SENT12	19	19	16	16	hydroxocobalamin	B12	PA164768689	7126;4709	0.71
NULL	Reprod_Biol_Endocrinol_2003_Apr_1_1_31.nxml.txt.nlp	12740033	SENT17	15	15	5	5	estradiol	StAR	PA449503	6770	0.71
NULL	Cells_2014_Apr_29_3(2)_363-385.nxml.txt.nlp	24785348	SENT5	13	13	2	2	chloroquine	VEGFR2	PA448948	3791	0.71
NULL	Biologics_2013_Dec_16_8_13-25.nxml.txt.nlp	24368879	SENT102	14	14	6	6	bevacizumab	VEGF-A	PA130232992	7422	0.71
NULL	Exp_Hematol_Oncol_2014_Mar_11_3_7.nxml.txt.nlp	24618035	SENT149	5	5	2	2	imatinib	ABL1	PA10804	25	0.71
NULL	Cardiovasc_Diabetol_2005_May_15_4_6.nxml.txt.nlp	15892894	SENT128	10	10	8	8	telmisartan	DBP	PA451605	3295;1628;2638	0.71
NULL	Breast_Cancer_Res_Treat_2014_Dec_12_143(2)_239-253.nxml.txt.nlp	24337508	SENT53	35	35	46	46	l-glutamine	CO2	PA10090	4513	0.71
NULL	Br_J_Haematol_2008_Mar_3_144(5)_677-685.nxml.txt.nlp	19055662	SENT96	2	2	0	0	cyclophosphamide	CHOP	PA449165	1649	0.71
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT60	21	21	30	30	bevacizumab	VEGFR2	PA130232992	3791	0.71
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R91.nxml.txt.nlp	22541814	SENT152	5	5	20	20	thrombin	HO-1	PA451674	3162	0.71
NULL	Nat_Commun_2012_Dec_27_3_1316.nxml.txt.nlp	23271650	SENT531	34	34	41	41	tamoxifen	CA1	PA451581	759	0.71
NULL	J_Nat_Prod_2011_Aug_26_74(8)_1779-1786.nxml.txt.nlp	21800856	SENT202	17	17	13	13	phenol	CO2	PA450913	4513	0.71
NULL	Cancer_Cell_Int_2013_May_1_13_39.nxml.txt.nlp	23631621	SENT33	24	24	19	19	paclitaxel	FXN	PA450761	2395	0.71
NULL	Exp_Lung_Res_2013_Oct_1_39(8)_336-348.nxml.txt.nlp	23919450	SENT243	12	12	3	3	trypsin	PAR-1	PA451806	2011;2149	0.71
NULL	Drug_Healthc_Patient_Saf_2013_Jun_10_5_133-141.nxml.txt.nlp	23788840	SENT150	8	8	10	10	heparin	PF4	PA449855	5196	0.71
NULL	Crit_Care_2011_Aug_11_15(4)_226.nxml.txt.nlp	21892977	SENT57	41	41	22	22	vasopressin	P2Y1	PA451858	5028	0.71
NULL	J_Invest_Dermatol_2012_May_16_132(5)_1435-1442.nxml.txt.nlp	22336948	SENT98	28	28	9	9	doxycycline	KLK5	PA449415	25818	0.71
NULL	Front_Neural_Circuits_2013_Oct_2_7_155.nxml.txt.nlp	24106462	SENT171	16	16	20	20	haloperidol	ANOVA	PA449841	4858	0.71
NULL	Indian_J_Med_Res_2014_Jan_139(1)_27-65.nxml.txt.nlp	24604039	SENT243	29	29	6	6	tamoxifen	SULT1A1	PA451581	6817	0.71
NULL	Arthritis_Res_Ther_2010_May_28_12(3)_R105.nxml.txt.nlp	20509880	SENT135	15	15	17	17	celecoxib	p38	PA448871	10598;1432;7965	0.71
NULL	Mol_Biol_Cell_2014_May_15_25(10)_1641-1652.nxml.txt.nlp	24648491	SENT134	5	5	19	19	daunorubicin	NPM1	PA449212	4869	0.71
NULL	J_Int_Soc_Sports_Nutr_2013_Aug_6_10_36.nxml.txt.nlp	23919405	SENT204	7	7	22	22	creatine	FFM	PA164778930	24	0.71
NULL	Indian_J_Pharmacol_2014_Jan-Feb_46(1)_3-12.nxml.txt.nlp	24550577	SENT221	32	32	7	7	vismodegib	CYP3A4		1576	0.71
NULL	Breast_Cancer_Res_2010_Jun_28_12(3)_R43.nxml.txt.nlp	20579400	SENT166	22	22	26	26	fulvestrant	MAPT	PA164747170	4137	0.71
NULL	Brain_2014_Apr_27_137(4)_1145-1155.nxml.txt.nlp	24578545	SENT52	19	19	17	17	citalopram	MRI	PA449015	78996	0.71
NULL	Oncol_Lett_2013_Apr_22_5(4)_1093-1100.nxml.txt.nlp	23599746	SENT221	39	39	28	28	tamoxifen	CYP3A4	PA451581	1576	0.71
NULL	Mol_Cancer_2009_Dec_23_8_129.nxml.txt.nlp	20030852	SENT205	12	12	6	6	curcumin	ABCA1	PA151958596	19	0.71
NULL	Oncotarget_2013_Nov_23_5(1)_196-210.nxml.txt.nlp	24344116	SENT16	6	6	14	14	doxorubicin	p53	PA449412	7157	0.71
NULL	Cancer_Med_2014_Apr_7_3(2)_362-375.nxml.txt.nlp	24515916	SENT92	6	6	29	29	zoledronate	IL-2	PA10235	3558	0.71
NULL	Oncotarget_2012_May_4_3(4)_371-394.nxml.txt.nlp	22564882	SENT311	6	6	16	16	etoposide	CD38	PA449552	952	0.71
NULL	Hematol_Rep_2011_Oct_10_3(2)_e16.nxml.txt.nlp	22184537	SENT71	10	10	5	5	acenocoumarol	CYP3A4	PA452632	1576	0.71
NULL	Clin_Ophthalmol_2011_Jun_7_5_759-765.nxml.txt.nlp	21691584	SENT74	11	11	20	20	bimatoprost	hole	PA164748867	80757	0.71
NULL	Case_Rep_Transplant_2014_Aug_11_2014_262953.nxml.txt.nlp	25177510	SENT76	6	6	16	16	alemtuzumab	CD4	PA164783958	920	0.71
NULL	Bone_Marrow_Transplant_2013_Feb_24_48(2)_278-283.nxml.txt.nlp	23000644	SENT19	6	6	17	17	sirolimus	TRM3	PA451365	6894	0.71
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_321-328.nxml.txt.nlp	21372824	SENT30	39	39	28	28	fluvastatin	STZ	PA449688	6484	0.71
NULL	Int_J_Mol_Sci_2013_Apr_16_14(4)_8381-8392.nxml.txt.nlp	23591849	SENT214	23	23	27	27	efavirenz	CYP2B6	PA449441	1555	0.71
NULL	Crit_Care_2008_Jan_24_12(1)_R27.nxml.txt.nlp	18304335	SENT13	6	6	15	15	thrombin	Rho	PA451674	29984	0.71
NULL	Biochemistry_2009_Aug_11_48(31)_7353-7355.nxml.txt.nlp	19603831	SENT67	6	6	9	9	indomethacin	COX	PA449982	1351	0.71
NULL	Br_J_Cancer_2010_Oct_26_103(9)_1325-1330.nxml.txt.nlp	20940720	SENT156	10	10	13	13	cisplatin	CRT	PA449014	811	0.71
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT1602	16	16	9	9	nelfinavir	ABCG2	PA450606	9429	0.71
NULL	Cancer_Med_2013_Dec_27_2(6)_751-762.nxml.txt.nlp	24403249	SENT255	13	13	20	20	paclitaxel	KLF4	PA450761	9314	0.71
NULL	J_Biomed_Sci_2013_May_20_20(1)_30.nxml.txt.nlp	23687991	SENT283	19	19	17	17	ethanol	PGD2	PA448073	27306	0.71
NULL	Allergy_Asthma_Immunol_Res_2009_Oct_25_1(1)_30-35.nxml.txt.nlp	20224667	SENT94	38	38	9	9	aspirin	PPARG	PA448497	5468	0.71
NULL	Ann_Oncol_2012_Dec_2_23(12)_3007-3016.nxml.txt.nlp	22865781	SENT104	30	30	27	27	lapatinib	PTEN	PA152241907	5728	0.71
NULL	Nat_Med_2011_Aug_28_17(9)_1094-1100.nxml.txt.nlp	21873989	SENT236	33	33	5	5	imatinib	KIT	PA10804	3815	0.71
NULL	J_Radiat_Res_2014_Mar_1_55(2)_359-363.nxml.txt.nlp	24187329	SENT43	2	2	0	0	cyclophosphamide	CHOP	PA449165	1649	0.71
NULL	J_Cancer_2012_Dec_25_4(1)_57-65.nxml.txt.nlp	23386905	SENT103	3	3	23	23	bleomycin	IL-22	PA448645	50616;53342	0.71
NULL	J_Cell_Mol_Med_2014_Jul_10_18(7)_1290-1299.nxml.txt.nlp	24720832	SENT8	17	17	32	32	dextran	UNC5B	PA449261	219699	0.71
NULL	Cancers_(Basel)_2011_Aug_5_3(3)_3114-3142.nxml.txt.nlp	24212948	SENT163	21	21	19	19	epirubicin	GEM	PA449476	2669	0.71
NULL	Pharmaceuticals_(Basel)_2012_Feb_23_5(3)_249-278.nxml.txt.nlp	24281378	SENT357	2	2	22	22	capsaicin	TRPV1	PA448776	7442	0.71
NULL	J_Oncol_2010_Jun_3_2010_732680.nxml.txt.nlp	20613952	SENT61	0	0	13	13	lenalidomide	FLICE	PA162363968	841	0.71
NULL	Clin_Mol_Allergy_2007_Jan_25_5_1.nxml.txt.nlp	17254346	SENT212	19	19	23	23	curcumin	IFN	PA151958596	3439	0.71
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_13_2014_849783.nxml.txt.nlp	25477998	SENT145	13	13	7	7	berberine	Bcl-2	PA165860812	596	0.71
NULL	Carcinogenesis_2010_Dec_27_31(12)_2049-2057.nxml.txt.nlp	20876285	SENT126	28	28	9	9	tamoxifen	HER2	PA451581	2064	0.71
NULL	Indian_J_Med_Res_2011_Apr_133(4)_434-441.nxml.txt.nlp	21537099	SENT33	27	27	22	22	ampicillin	EGF	PA448419	1950	0.71
NULL	Eur_J_Immunol_2014_Jun_10_44(6)_1759-1769.nxml.txt.nlp	24595810	SENT8	0	0	11	11	fludrocortisone	CD4	PA164743961	920	0.71
NULL	Breast_Cancer_Res_2010_Nov_16_12(6)_R96.nxml.txt.nlp	21080941	SENT94	5	5	43	43	lapatinib	HRG	PA152241907	3084;3273	0.71
NULL	Hum_Reprod_2008_Oct_16_23(10)_2273-2281.nxml.txt.nlp	18635530	SENT154	2	2	4	4	etoposide	p53	PA449552	7157	0.71
NULL	J_Cancer_2013_Mar_15_4(3)_262-269.nxml.txt.nlp	23459716	SENT37	8	8	12	12	irinotecan	IFL	PA450085	3439	0.71
NULL	Oncol_Lett_2013_Mar_11_5(3)_1010-1016.nxml.txt.nlp	23426784	SENT23	25	25	35	35	midazolam	TRPM7	PA450496	54822	0.71
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Apr_21_68(Pt_5)_o1447.nxml.txt.nlp	22590326	SENT70	21	21	6	6	ethanol	mol	PA448073	90527	0.71
NULL	Cancer_Med_2014_Aug_7_3(4)_796-811.nxml.txt.nlp	24802970	SENT239	0	0	2	2	amiloride	CD49f	PA448368	3655	0.71
NULL	Curr_Pharm_Des_2011_Dec_17(35)_3846-3853.nxml.txt.nlp	21933140	SENT55	29	29	41	41	nadh	PDH	PA164755085	54704	0.71
NULL	Adv_Hematol_2011_Apr_10_2011_960137.nxml.txt.nlp	21547266	SENT71	8	8	27	27	rituximab	NHL	PA451261	51750	0.71
NULL	Indian_J_Psychiatry_2011_Apr-Jun_53(2)_111-120.nxml.txt.nlp	21772642	SENT209	32	32	14	14	diazepam	CYP2D6	PA449283	1565	0.71
NULL	J_Gen_Physiol_2000_Dec_1_116(6)_769-780.nxml.txt.nlp	11099346	SENT33	30	30	36	36	tetracaine	DAG	PA451638	1605	0.71
NULL	Int_J_Mol_Sci_2014_Oct_22_15(10)_19183-19202.nxml.txt.nlp	25340982	SENT153	6	6	14	14	curcumin	p53	PA151958596	7157	0.71
NULL	J_Neurol_Sci_2012_Nov_15_322(1-2)_92-95.nxml.txt.nlp	22819352	SENT22	3	3	13	13	ethanol	spatial	PA448073	219793	0.71
NULL	Int_J_Gen_Med_2012_Nov_12_5_943-951.nxml.txt.nlp	23204858	SENT112	40	40	21	21	tolterodine	CYP2D6	PA164746757	1565	0.71
NULL	Breast_Cancer_Res_2012_Feb_21_14(1)_R35.nxml.txt.nlp	22353783	SENT372	20	20	28	28	metformin	LKB1	PA450395	6794	0.71
NULL	Breast_Cancer_Res_2010_Oct_20_12(5)_315.nxml.txt.nlp	21062517	SENT17	9	9	2	2	tamoxifen	PI3K	PA451581	5290	0.71
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT182	5	5	11	11	ranibizumab	PlGF-2	PA164746012	5228	0.71
NULL	Mol_Cancer_2010_Nov_23_9_301.nxml.txt.nlp	21092273	SENT281	25	25	11	11	pentazocine	TRAIL	PA164744326	8743	0.71
NULL	Genome_Biol_2011_Jun_22_12(6)_R57.nxml.txt.nlp	21696594	SENT148	10	10	5	5	aripiprazole	PRL	PA10026	5617	0.71
NULL	Br_J_Cancer_2010_Sep_7_103(6)_796-801.nxml.txt.nlp	20823888	SENT151	29	29	4	4	sirolimus	EGFR	PA451365	1956	0.71
NULL	Hum_Genomics_2009_Jan_1_3(2)_128-142.nxml.txt.nlp	19164090	SENT29	25	25	16	16	carboplatin	XRCC3	PA448803	7517	0.71
NULL	Biomed_Res_Int_2013_Jul_1_2013_964743.nxml.txt.nlp	23936861	SENT116	3	3	35	35	axitinib	ABCG2	PA164924493	9429	0.71
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Oct_28_65(Pt_11)_o2859.nxml.txt.nlp	21578446	SENT69	15	15	11	11	benzaldehyde	mol	PA448571	90527	0.71
NULL	Evid_Based_Complement_Alternat_Med_2013_Aug_12_2013_982689.nxml.txt.nlp	23997806	SENT178	9	9	3	3	tolbutamide	APE	PA451718	55704;328	0.71
NULL	Oncogene_2013_Sep_12_32(37)_4355-4365.nxml.txt.nlp	23108409	SENT37	19	19	27	27	hyaluronan	HAS2	PA165958431	3037	0.71
NULL	Cancer_Microenviron_2009_Sep_26_2(Suppl_1)_19-204.nxml.txt.nlp	NULL	SENT2423	11	11	18	18	urokinase	CD44	PA451836	960	0.71
NULL	Biochemistry_2015_Jan_20_54(2)_184-193.nxml.txt.nlp	25454580	SENT146	4	4	15	15	nadh	NAMPT	PA164755085	10135	0.71
NULL	Front_Oncol_2013_Apr_29_3_92.nxml.txt.nlp	23641361	SENT924	6	6	9	9	heparin	VEGF-A	PA449855	7422	0.71
NULL	Br_J_Sports_Med_2010_May_10_44(11)_827-832.nxml.txt.nlp	20460257	SENT6	20	20	25	25	mannitol	ski	PA450320	55733	0.71
NULL	J_Carcinog_2012_Oct_27_11_16.nxml.txt.nlp	23230393	SENT59	7	7	3	3	ertumaxomab	HER-2	PA165291442	2064	0.71
NULL	ASN_Neuro_2009_Oct_21_1(4)_e00018.nxml.txt.nlp	19807694	SENT193	25	25	18	18	ganciclovir	E12	PA449733	64100	0.71
NULL	Hum_Genomics_2013_Apr_5_7(1)_10.nxml.txt.nlp	23561625	SENT146	8	8	15	15	flavopiridol	CDK7	PA452627	1022	0.71
NULL	J_Infect_Dis_2012_Apr_15_205(8)_1278-1286.nxml.txt.nlp	22396598	SENT177	2	2	13	13	proguanil	DHODH	PA451124	1723	0.71
NULL	Breast_Cancer_Res_2002_May_15_4(4)_133-136.nxml.txt.nlp	12100736	SENT9	37	37	39	39	diethylstilbestrol	DES	PA449307	1674	0.71
NULL	Biomed_Res_Int_2014_Jun_3_2014_459823.nxml.txt.nlp	25025052	SENT114	9	9	7	7	ezetimibe	NPC1L1	PA10816	29881	0.71
NULL	Asian-Australas_J_Anim_Sci_2013_Apr_26(4)_573-578.nxml.txt.nlp	25049825	SENT12	22	22	30	30	bacitracin	BP1	PA448531	1748	0.71
NULL	Nat_Methods_2013_Dec_3_10(12)_10_1038_nmeth_2724.nxml.txt.nlp	24185838	SENT103	31	31	14	14	nadh	ADP	PA164755085	23038	0.71
NULL	Int_J_Endocrinol_2011_Aug_21_2011_742719.nxml.txt.nlp	21869886	SENT136	12	12	4	4	cilostazol	P2Y12	PA164746334	64805	0.71
NULL	Diabetes_Care_2009_Jan_32(Suppl_1)_S13-S61.nxml.txt.nlp	19118286	SENT2163	14	14	6	6	rosiglitazone	DREAM	PA451283	30818	0.71
NULL	Oncol_Lett_2014_Jun_21_7(6)_2073-2078.nxml.txt.nlp	24932291	SENT96	27	27	12	12	gemcitabine	CHFR	PA449748	55743	0.71
NULL	Br_J_Cancer_2012_Feb_14_106(4)_685-692.nxml.txt.nlp	22294184	SENT185	3	3	7	7	lovastatin	Mcl-1	PA450272	4170	0.71
NULL	Cancer_Cell_Int_2013_Feb_12_13_14.nxml.txt.nlp	23402310	SENT162	0	0	9	9	celecoxib	p65	PA448871	5970	0.71
NULL	Biomed_Res_Int_2014_Feb_26_2014_236930.nxml.txt.nlp	24719848	SENT236	10	10	14	14	theophylline	NAC	PA451647	22861	0.71
NULL	J_Headache_Pain_2007_Jun_11_8(3)_167-174.nxml.txt.nlp	17563842	SENT2	28	28	13	13	capsaicin	CO2	PA448776	4513	0.71
NULL	Can_J_Infect_Dis_Med_Microbiol_2014_Nov-Dec_25(6)_327-343.nxml.txt.nlp	25587296	SENT587	2	2	7	7	itraconazole	CYP3A4	PA450132	1576	0.71
NULL	Cell_Commun_Signal_2013_Nov_11_11_86.nxml.txt.nlp	24215724	SENT240	20	20	13	13	thrombin	PAR3	PA451674	56288;2151	0.71
NULL	Adv_Hematol_2011_Apr_10_2011_960137.nxml.txt.nlp	21547266	SENT88	17	17	2	2	vincristine	CHOP	PA451879	1649	0.71
NULL	Biomed_Res_Int_2014_Feb_4_2014_975927.nxml.txt.nlp	24689066	SENT162	16	16	3	3	denosumab	BIM	PA166048634	10018	0.71
NULL	Acta_Pharmacol_Sin_2009_Feb_5_30(2)_228-234.nxml.txt.nlp	19122672	SENT10	6	6	8	8	isoflurane	HO-1	PA450106	3162	0.71
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Aug_27_67(Pt_9)_o2403.nxml.txt.nlp	22058995	SENT66	17	17	3	3	ethanol	mol	PA448073	90527	0.71
NULL	Crit_Care_2011_Aug_11_15(4)_226.nxml.txt.nlp	21892977	SENT285	4	4	1	1	terlipressin	AVPR1A	PA164781020	552	0.71
NULL	Ther_Clin_Risk_Manag_2006_Sep_2(3)_235-249.nxml.txt.nlp	18360599	SENT299	25	25	9	9	alendronate	PTH	PA448082	5741	0.71
NULL	J_Hematol_Oncol_2012_Feb_14_5_3.nxml.txt.nlp	22333219	SENT8	13	13	20	20	vemurafenib	BRAF	PA165946873	673	0.71
NULL	Br_J_Cancer_1998_Aug_78(3)_375-381.nxml.txt.nlp	9703286	SENT0	16	16	28	28	cyclophosphamide	TP53	PA449165	7157	0.71
NULL	Biosci_Rep_2012_Aug_1_32(Pt_4)_361-374.nxml.txt.nlp	22762204	SENT209	42	42	16	16	cisplatin	p16INK4a	PA449014	1029	0.71
NULL	Cancer_Res_Treat_2014_Jan_15_46(1)_48-54.nxml.txt.nlp	24520223	SENT30	0	0	25	25	cetuximab	KRAS	PA10040	3845	0.71
NULL	J_Thromb_Haemost_2014_May_22_12(5)_726-735.nxml.txt.nlp	24581425	SENT156	9	9	20	20	thrombin	ARF6	PA451674	382	0.71
NULL	J_Mol_Signal_2014_Aug_8_9_8.nxml.txt.nlp	25237386	SENT84	7	7	5	5	sc-560	PTGS1		5742	0.71
NULL	Pan_Afr_Med_J_2012_Jul_9_12_67.nxml.txt.nlp	23024826	SENT7	6	6	4	4	cyclophosphamide	CHOP	PA449165	1649	0.71
NULL	Oncotarget_2012_Oct_20_3(10)_1236-1245.nxml.txt.nlp	23100449	SENT105	3	3	22	22	doxorubicin	NGAL	PA449412	3934	0.71
NULL	J_Biol_Chem_2013_Jun_28_288(26)_18789-18802.nxml.txt.nlp	23625922	SENT345	17	17	12	12	thrombin	C5a	PA451674	727	0.71
NULL	Ann_Oncol_2011_May_3_22(5)_1078-1087.nxml.txt.nlp	21048039	SENT25	21	21	8	8	cetuximab	EGFR	PA10040	1956	0.71
NULL	Exp_Diabetes_Res_2011_Nov_30_2011_162092.nxml.txt.nlp	22203828	SENT116	35	35	7	7	sitagliptin	ANOVA	PA164748978	4858	0.71
NULL	EMBO_Mol_Med_2013_Mar_21_5(3)_332-343.nxml.txt.nlp	23427196	SENT188	3	3	7	7	mupirocin	IARS	PA164764568	3376	0.71
NULL	Mol_Cancer_2010_Jun_25_9_166.nxml.txt.nlp	20579378	SENT214	4	4	18	18	gefitinib	MDM2	PA131301952	4193	0.71
NULL	Acta_Pharmacol_Sin_2012_Jan_3_33(1)_49-56.nxml.txt.nlp	22212430	SENT12	0	0	13	13	thrombin	JNK	PA451674	5599	0.71
NULL	Neuropsychopharmacology_2009_May_1_34(6)_1443-1453.nxml.txt.nlp	18830237	SENT194	9	9	2	2	ethanol	AP-5	PA448073	91056	0.71
NULL	Adv_Hematol_2010_Dec_30_2010_627401.nxml.txt.nlp	21234094	SENT126	12	12	2	2	ifosfamide	SMILE	PA449964	160418	0.71
NULL	Oncotarget_2014_Feb_23_5(3)_802-814.nxml.txt.nlp	24583651	SENT13	4	4	22	22	cblb502	TLR5		7100	0.71
NULL	Clin_Exp_Otorhinolaryngol_2012_Sep_27_5(3)_132-138.nxml.txt.nlp	22977709	SENT191	16	16	24	24	fluorescein	P14	PA164746009	11102;;6280;56259	0.71
NULL	Nanoscale_Res_Lett_2014_Jun_20_9(1)_311.nxml.txt.nlp	25024678	SENT44	17	17	42	42	fluorescein	San	PA164746009	80218	0.71
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Nov_4_9_31.nxml.txt.nlp	21050425	SENT126	21	21	11	11	tetracycline	Gen	PA451640	348654	0.71
NULL	Cell_J_2012_Dec_22_Winter_13(4)_265-274.nxml.txt.nlp	23507995	SENT246	3	3	22	22	ethanol	spatial	PA448073	219793	0.71
NULL	Br_J_Cancer_2011_Jul_26_105(3)_372-381.nxml.txt.nlp	21730979	SENT240	18	18	6	6	cisplatin	ATR	PA449014	390502;84168;545	0.71
NULL	Int_J_Mol_Sci_2014_Oct_23_15(10)_19265-19280.nxml.txt.nlp	25342321	SENT64	5	5	12	12	cisplatin	MVD	PA449014	4597	0.71
NULL	Nat_Med_2013_Apr_17_19(4)_437-445.nxml.txt.nlp	23502961	SENT318	22	22	9	9	clodronate	MCH	PA10239	5367	0.71
NULL	J_Gynecol_Oncol_2014_Oct_7_25(4)_328-333.nxml.txt.nlp	25142624	SENT93	18	18	15	15	cisplatin	AMH	PA449014	268	0.71
NULL	Arthritis_Res_Ther_2009_Jan_26_11(1)_R12.nxml.txt.nlp	19171052	SENT323	10	10	15	15	dipyridamole	ACTH	PA449367	5443	0.71
NULL	Int_J_Biol_Sci_2015_Jan_1_11(1)_48-58.nxml.txt.nlp	25552929	SENT144	31	31	24	24	paclitaxel	LDM	PA450761	1595	0.71
NULL	EMBO_Mol_Med_2012_Jun_13_4(6)_515-527.nxml.txt.nlp	22416035	SENT83	20	20	28	28	olaparib	p53		7157	0.71
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT48	32	32	9	9	pemetrexed	UNG	PA10810	7374	0.71
NULL	J_Occup_Med_Toxicol_2008_Feb_27_3(Suppl_1)_S6.nxml.txt.nlp	18315837	SENT67	2	2	12	12	salmeterol	IL-13	PA451300	3596	0.71
NULL	Oncol_Rep_2013_Apr_5_29(4)_1671-1677.nxml.txt.nlp	23404329	SENT35	19	19	26	26	curcumin	SFN	PA151958596	25996;2810	0.71
NULL	J_Cheminform_2011_May_13_3_14.nxml.txt.nlp	21569515	SENT122	27	27	21	21	thrombin	F10	PA451674	2159	0.71
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT295	5	5	16	16	resveratrol	AIF		9131	0.71
NULL	Evid_Based_Complement_Alternat_Med_2014_Sep_3_2014_809083.nxml.txt.nlp	25276218	SENT132	16	16	21	21	berberine	IRAK	PA165860812	3654	0.71
NULL	J_Med_Case_Reports_2011_Jul_2_5_273.nxml.txt.nlp	21722390	SENT102	2	2	4	4	dacarbazine	IFN	PA449197	3439	0.71
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT20	9	9	12	12	vinorelbine	ASC	PA451881	29108	0.71
NULL	Diabetes_2011_Jan_7_60(1)_157-167.nxml.txt.nlp	20929977	SENT357	9	9	20	20	resveratrol	SIRT1		23411	0.71
NULL	Hum_Genomics_2009_Dec_1_4(2)_91-106.nxml.txt.nlp	20038497	SENT149	3	3	15	15	donepezil	APOE	PA449394	348	0.71
NULL	Indian_J_Med_Res_2012_Sep_136(3)_391-403.nxml.txt.nlp	23041732	SENT189	17	17	21	21	capecitabine	HCC	PA448771	84668	0.71
NULL	Front_Neurosci_2014_May_23_8_122.nxml.txt.nlp	24904264	SENT41	8	8	15	15	tamoxifen	NG2	PA451581	1464;6048	0.71
NULL	Br_J_Cancer_2010_Feb_2_102(3)_500-505.nxml.txt.nlp	20068568	SENT28	0	0	7	7	cetuximab	EGFR	PA10040	1956	0.71
NULL	Oncotarget_2014_Aug_26_5(17)_7272-7284.nxml.txt.nlp	25261375	SENT201	5	5	30	30	geldanamycin	MUC1	PA152031327	4582	0.71
NULL	Arthritis_Res_Ther_2013_Dec_30_15(6)_R223.nxml.txt.nlp	24373218	SENT144	0	0	9	9	carprofen	TSP-1	PA164781361	7057	0.71
NULL	Cell_Biosci_2015_Jan_5_5(1)_1.nxml.txt.nlp	NULL	SENT35	15	15	12	12	ribavirin	IFN	PA451241	3439	0.71
NULL	Br_J_Cancer_2010_Oct_26_103(9)_1380-1390.nxml.txt.nlp	20877355	SENT223	17	17	25	25	etoposide	FasL	PA449552	356	0.71
NULL	Oncotarget_2013_Jan_27_4(1)_3-4.nxml.txt.nlp	23448808	SENT26	25	25	18	18	bevacizumab	PYGL	PA130232992	5836	0.71
NULL	EPMA_J_2012_Sep_27_3(1)_10.nxml.txt.nlp	23016735	SENT251	30	30	42	42	amiodarone	VKORC1	PA448383	79001	0.71
NULL	Diabetes_2009_Dec_18_58(12)_2880-2892.nxml.txt.nlp	19690065	SENT320	11	11	22	22	resveratrol	SIRT1		23411	0.71
NULL	J_Immunother_Cancer_2014_Jan_27_2_2.nxml.txt.nlp	24829759	SENT6	14	14	21	21	sorafenib	IL-21	PA7000	59067;50616;27189	0.71
NULL	Cancers_(Basel)_2010_Oct_25_2(4)_1794-1812.nxml.txt.nlp	24281201	SENT1005	6	6	11	11	gemcitabine	MUC4	PA449748	4585	0.71
NULL	Evid_Based_Complement_Alternat_Med_2006_Sep_20_3(3)_365-372.nxml.txt.nlp	16951721	SENT104	10	10	22	22	ginseng	Bcl-2	PA164781150	596	0.71
NULL	ISRN_Neurosci_2013_Jul_17_2013_253210.nxml.txt.nlp	24967306	SENT182	3	3	11	11	sc-560	ANOVA		4858	0.709
NULL	Oncotarget_2014_Aug_29_5(17)_7217-7259.nxml.txt.nlp	25277175	SENT321	10	10	21	21	bicalutamide	PTEN	PA164746255	5728	0.709
NULL	Acta_Pharmacol_Sin_2014_Sep_25_35(9)_1199-1206.nxml.txt.nlp	25152024	SENT187	14	14	37	37	cisplatin	ERK5	PA449014	5598	0.709
NULL	Evid_Based_Complement_Alternat_Med_2013_May_13_2013_506324.nxml.txt.nlp	23818927	SENT182	9	9	14	14	doxorubicin	JAK2	PA449412	3717	0.709
NULL	Environ_Health_Perspect_2005_Jun_24_113(6)_675-679.nxml.txt.nlp	15929888	SENT33	12	12	22	22	estradiol	CA1	PA449503	759	0.709
NULL	Acta_Pharmacol_Sin_2014_Jun_4_35(6)_846-852.nxml.txt.nlp	24902791	SENT145	13	13	21	21	lapatinib	EGFR	PA152241907	1956	0.709
NULL	AMIA_Jt_Summits_Transl_Sci_Proc_2013_Mar_18_2013_109.nxml.txt.nlp	24303315	SENT30	31	31	17	17	clopidogrel	PSM	PA449053	2346	0.709
NULL	Front_Genet_2012_Nov_5_3_236.nxml.txt.nlp	23133441	SENT213	6	6	2	2	cyclosporine	MDR1	PA449167	5243	0.709
NULL	J_Mol_Med_(Berl)_2014_May_10_92(7)_709-722.nxml.txt.nlp	24811491	SENT270	19	19	4	4	irinotecan	KRAS	PA450085	3845	0.709
NULL	Scientifica_(Cairo)_2012_Dec_16_2012_402783.nxml.txt.nlp	24278688	SENT153	10	10	4	4	thrombin	MASP2	PA451674	10747	0.709
NULL	Arthritis_Res_Ther_2006_Nov_8_8(6)_R167.nxml.txt.nlp	17092341	SENT154	17	17	15	15	rituximab	BAFF	PA451261	10673	0.709
NULL	J_Clin_Exp_Pathol_2012_May_17_Suppl_4_7327.nxml.txt.nlp	25379357	SENT30	21	21	13	13	resveratrol	LKB1		6794	0.709
NULL	Cardiovasc_Diabetol_2011_Feb_11_10_18.nxml.txt.nlp	21314919	SENT4	14	14	16	16	metformin	Met	PA450395	79811	0.709
NULL	Mediators_Inflamm_2011_Jun_7_2011_432080.nxml.txt.nlp	21772662	SENT177	19	19	29	29	rivaroxaban	IFN	PA165958360	3439	0.709
NULL	Curr_Cardiol_Rev_2010_Nov_6(4)_363-372.nxml.txt.nlp	22043213	SENT367	9	9	1	1	iron	B12	PA450087	7126;4709	0.709
NULL	Crit_Care_2008_Aug_9_12(4)_R103.nxml.txt.nlp	18691424	SENT234	7	7	48	48	bleomycin	IP-10	PA448645	3627	0.709
NULL	Exp_Ther_Med_2013_Sep_17_6(3)_649-656.nxml.txt.nlp	24137241	SENT194	37	37	24	24	valsartan	CD68	PA451848	968	0.709
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT95	17	17	0	0	pemetrexed	UNG	PA10810	7374	0.709
NULL	Arthritis_Res_Ther_2014_Apr_3_16(2)_R86.nxml.txt.nlp	24708674	SENT190	0	0	21	21	bosentan	Fli1	PA10034	2314	0.709
NULL	ACS_Nano_2014_Jan_28_8(1)_104-112.nxml.txt.nlp	24377302	SENT254	35	35	14	14	creatine	gamma	PA164778930	9913	0.709
NULL	Cell_Death_Dis_2014_Feb_27_5(2)_e1093.nxml.txt.nlp	24577091	SENT293	7	7	9	9	curcumin	ALDH1A1	PA151958596	216	0.709
NULL	Front_Psychol_2013_May_14_4_254.nxml.txt.nlp	23717290	SENT801	1	1	6	6	tropisetron	p50	PA161925594	958;4790	0.709
NULL	Breast_Cancer_Res_2010_Mar_5_12(2)_R16.nxml.txt.nlp	20205716	SENT234	28	28	13	13	lovastatin	E2F1	PA450272	1869	0.709
NULL	FEBS_Open_Bio_2012_Jul_20_2_179-186.nxml.txt.nlp	23650597	SENT271	37	37	26	26	imiquimod	IFN	PA449972	3439	0.709
NULL	Mol_Cancer_2009_Jun_9_8_37.nxml.txt.nlp	19508729	SENT120	27	27	18	18	gemcitabine	HO-1	PA449748	3162	0.709
NULL	Mol_Cancer_2014_Jun_26_13_158.nxml.txt.nlp	24965046	SENT8	2	2	15	15	cyclophosphamide	CD11b	PA449165	3684	0.709
NULL	Acta_Pharmacol_Sin_2011_Apr_28_32(4)_495-502.nxml.txt.nlp	21441945	SENT137	31	31	24	24	diclofenac	SDH	PA449293	1757;10993	0.709
NULL	Br_J_Cancer_2013_Mar_19_108(5)_1079-1091.nxml.txt.nlp	23449353	SENT130	15	15	26	26	docetaxel	MIC-1	PA449383	29919;9518	0.709
NULL	Int_J_Nanomedicine_2012_Oct_25_7_5565-5575.nxml.txt.nlp	23118538	SENT265	11	11	14	14	fenofibrate	CO2	PA449594	4513	0.709
NULL	Cancers_(Basel)_2014_Jul_22_6(3)_1540-1552.nxml.txt.nlp	25055117	SENT335	19	19	3	3	pha-665752	Met		79811	0.709
NULL	J_Cancer_Prev_2014_Mar_19(1)_39-46.nxml.txt.nlp	25337571	SENT10	9	9	3	3	ethanol	JNK	PA448073	5599	0.709
NULL	Clin_Exp_Metastasis_2014_Aug_21_31(1)_57-65.nxml.txt.nlp	23963762	SENT9	10	10	24	24	estradiol	RXFP1	PA449503	59350	0.709
NULL	Acta_Histochem_Cytochem_2006_Dec_28_39(6)_163-172.nxml.txt.nlp	17327903	SENT338	10	10	7	7	sevoflurane	ERK	PA451341	5594	0.709
NULL	Breast_Cancer_Res_2005_May_27_7(Suppl_1)_S16.nxml.txt.nlp	NULL	SENT5	19	19	12	12	tamoxifen	IMPACT	PA451581	55364	0.709
NULL	Front_Pharmacol_2014_Oct_20_5_230.nxml.txt.nlp	25368579	SENT68	0	0	13	13	berberine	IL-6	PA165860812	3569	0.709
NULL	Oncol_Lett_2014_Jun_4_7(6)_2175-2179.nxml.txt.nlp	24932311	SENT111	12	12	7	7	choline	PEMT	PA448976	10400	0.709
NULL	Mol_Cancer_2010_Apr_12_9_75.nxml.txt.nlp	20385023	SENT189	38	38	22	22	nilotinib	LYN	PA165958345	4067	0.709
NULL	J_Gen_Physiol_2010_Aug_136(2)_135-142.nxml.txt.nlp	20660656	SENT221	2	2	5	5	nifedipine	spatial	PA450631	219793	0.709
NULL	J_Cell_Mol_Med_2013_Oct_16_17(10)_1261-1270.nxml.txt.nlp	23855452	SENT213	4	4	2	2	gemcitabine	CHK2	PA449748	11200	0.709
NULL	J_Autom_Methods_Manag_Chem_2008_Apr_5_2008_502953.nxml.txt.nlp	19365566	SENT2765	14	14	8	8	clarithromycin	FOR	PA449028	51741	0.709
NULL	Alcohol_Res_Health_2010_33(1-2)_76-86.nxml.txt.nlp	23579938	SENT80	0	0	27	27	resveratrol	SIRT1		23411	0.709
NULL	Br_J_Cancer_2010_Jan_5_102(1)_115-123.nxml.txt.nlp	19997099	SENT221	22	22	24	24	gemcitabine	GEM	PA449748	2669	0.709
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Mar_27_66(Pt_4)_o942-o943.nxml.txt.nlp	21580748	SENT78	17	17	7	7	ethanol	mol	PA448073	90527	0.709
NULL	Curr_Infect_Dis_Rep_2013_Feb_5_15(1)_4-9.nxml.txt.nlp	23212721	SENT116	6	6	4	4	eculizumab	C5a	PA164776637	727	0.709
NULL	Oncotarget_2010_May_27_1(2)_89-103.nxml.txt.nlp	20671809	SENT214	11	11	15	15	staurosporine	PDK1	PA165109623	5170;5163	0.709
NULL	Acta_Pharmacol_Sin_2013_Sep_5_34(9)_1229-1236.nxml.txt.nlp	23892269	SENT108	5	5	3	3	sulfaphenazole	CYP2C	PA130231310	1562	0.709
NULL	Oncogene_2010_Sep_16_29(37)_5193-5203.nxml.txt.nlp	20581867	SENT365	28	28	19	19	lapatinib	HRG	PA152241907	3084;3273	0.709
NULL	Eur_J_Epidemiol_2007_Nov_23_22(11)_819-829.nxml.txt.nlp	17955331	SENT726	11	11	21	21	coumarin	PAGM	PA134521193	5238	0.709
NULL	J_Cell_Biol_2002_Oct_28_159(2)_373-382.nxml.txt.nlp	12391027	SENT104	27	27	17	17	sugar	TSR2	PA451529	90121	0.709
NULL	Mol_Brain_2014_Sep_16_7(1)_63.nxml.txt.nlp	NULL	SENT240	15	15	11	11	forskolin	GDNF	PA146096022	2668	0.709
NULL	JAKSTAT_2014_Jun_12_3_e29554.nxml.txt.nlp	25105067	SENT115	26	26	28	28	propofol	Bcl-2	PA451141	596	0.709
NULL	Tumour_Biol_2012_Dec_14_33(6)_2209-2216.nxml.txt.nlp	22890830	SENT193	10	10	1	1	gemcitabine	ERCC1	PA449748	2067	0.709
NULL	Environ_Health_Perspect_2009_Feb_8_117(2)_175-180.nxml.txt.nlp	19270784	SENT101	7	7	0	0	cisplatin	BPA	PA449014	667	0.709
NULL	J_Int_Soc_Sports_Nutr_2015_Jan_21_12(1)_5.nxml.txt.nlp	NULL	SENT145	24	24	1	1	curcumin	IL-6	PA151958596	3569	0.709
NULL	Ann_Oncol_2012_Dec_2_23(12)_3007-3016.nxml.txt.nlp	22865781	SENT71	8	8	11	11	trastuzumab	DM1	PA451743	338023;1760;28509	0.709
NULL	AMB_Express_2011_May_18_1_6.nxml.txt.nlp	21906338	SENT87	8	8	15	15	l-isoleucine	mol	PA164750430	90527	0.709
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Nov_5_67(Pt_12)_o3168.nxml.txt.nlp	22199692	SENT5	15	15	27	27	vanillin	mol	PA451852	90527	0.709
NULL	J_Gen_Physiol_2003_Jul_122(1)_1a-46a.nxml.txt.nlp	NULL	SENT1649	1	1	3	3	vasopressin	AVP	PA451858	114548;551	0.709
NULL	Mol_Cell_Biochem_2014_Oct_9_385(1-2)_265-275.nxml.txt.nlp	24104452	SENT107	19	19	11	11	bortezomib	Bcl-2	PA10252	596	0.709
NULL	Ann_Oncol_2011_Jan_13_22(1)_215-223.nxml.txt.nlp	20627875	SENT306	5	5	11	11	doxorubicin	CHOP	PA449412	1649	0.709
NULL	Environ_Health_Perspect_2005_Dec_8_113(12)_1698-1704.nxml.txt.nlp	16330350	SENT118	10	10	22	22	estradiol	DES	PA449503	1674	0.709
NULL	Eur_J_Clin_Pharmacol_2013_Mar_11_69(3)_327-339.nxml.txt.nlp	22782539	SENT188	2	2	11	11	dabigatran	ADP		23038	0.709
NULL	Crit_Care_2012_Oct_14_16(5)_R191.nxml.txt.nlp	23062276	SENT8	3	3	41	41	creatine	POD1	PA164778930	6943	0.709
NULL	Bioinformation_2011_Sep_6_7(2)_59-63.nxml.txt.nlp	21938206	SENT36	5	5	15	15	cefazolin	PON1	PA448839	5444	0.709
NULL	Carcinogenesis_2014_May_13_35(5)_1055-1066.nxml.txt.nlp	24419232	SENT341	6	6	16	16	metformin	CD31	PA450395	5175	0.709
NULL	Indian_J_Anaesth_2011_Nov-Dec_55(6)_567-572.nxml.txt.nlp	22223899	SENT134	18	18	27	27	isoflurane	NAC	PA450106	22861	0.709
NULL	Diagn_Pathol_2013_May_15_8_81.nxml.txt.nlp	23675804	SENT21	28	28	19	19	vincristine	CD5	PA451879	921	0.709
NULL	Core_Evid_2010_Jul_27_5_1-10.nxml.txt.nlp	20694135	SENT195	3	3	7	7	levodopa	CLE	PA450213	51637	0.709
NULL	J_Cell_Mol_Med_2013_Oct_15_17(10)_1325-1334.nxml.txt.nlp	23947778	SENT126	4	4	13	13	estradiol	ADAMTS-4	PA449503	9508	0.709
NULL	Breast_Cancer_(Auckl)_2011_Apr_13_5_53-65.nxml.txt.nlp	21603258	SENT93	7	7	4	4	trastuzumab	HER2	PA451743	2064	0.709
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jun_16_68(Pt_7)_o2121.nxml.txt.nlp	22798797	SENT68	38	38	13	13	ethanol	mol	PA448073	90527	0.709
NULL	Ann_Gastroenterol_2014_27(4)_313-319.nxml.txt.nlp	25331779	SENT76	6	6	16	16	infliximab	POR	PA452639	5447	0.709
NULL	Brain_Sci_2013_Jun_14_3(2)_941-963.nxml.txt.nlp	24961432	SENT192	34	34	32	32	ethanol	RhoE	PA448073	390	0.709
NULL	Br_J_Cancer_2012_Jul_24_107(3)_516-526.nxml.txt.nlp	22782351	SENT332	15	15	10	10	tamoxifen	TIGAR	PA451581	57103	0.709
NULL	Int_J_Vasc_Med_2012_Jul_24_2012_508416.nxml.txt.nlp	22888436	SENT45	5	5	17	17	rosiglitazone	MCP-1	PA451283	6347	0.709
NULL	Pharmaceuticals_(Basel)_2013_Aug_21_6(8)_988-1038.nxml.txt.nlp	24276379	SENT1222	24	24	2	2	oxaliplatin	p53	PA131285527	7157	0.709
NULL	Cell_Commun_Signal_2010_Jun_12_8_11.nxml.txt.nlp	20540792	SENT67	0	0	2	2	thalidomide	CRBN	PA451644	51185	0.709
NULL	Oncol_Lett_2013_Sep_12_6(3)_667-672.nxml.txt.nlp	24137387	SENT163	24	24	4	4	sorafenib	ARG	PA7000	473;27	0.709
NULL	Breast_Cancer_Res_Treat_2013_Jan_6_137(1)_167-174.nxml.txt.nlp	23129173	SENT19	28	28	22	22	letrozole	CYP19A1	PA450196	1588	0.709
NULL	Cancers_(Basel)_2011_Aug_12_3(3)_3279-3330.nxml.txt.nlp	24212956	SENT1243	31	31	18	18	natalizumab	5T4	PA164747191	7162	0.709
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Dec_4_66(Pt_1)_o48-o49.nxml.txt.nlp	21580151	SENT78	44	44	22	22	ethanol	mol	PA448073	90527	0.709
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_3_2014_473213.nxml.txt.nlp	25538791	SENT129	5	5	15	15	ethanol	CYP3A4	PA448073	1576	0.709
NULL	Acta_Neuropathol_Commun_2014_May_3_2(1)_50.nxml.txt.nlp	NULL	SENT175	19	19	21	21	bortezomib	BTZ	PA10252	22794	0.709
NULL	Diabetes_2011_Nov_17_60(11)_2691-2700.nxml.txt.nlp	21896928	SENT266	18	18	6	6	resveratrol	AMPK		5563	0.709
NULL	Arch_Med_Sci_2012_Nov_9_8(5)_899-906.nxml.txt.nlp	23185202	SENT97	3	3	8	8	voglibose	PPG	PA164752433	5552	0.709
NULL	Breast_Cancer_Res_2001_Oct_11_3(6)_380-384.nxml.txt.nlp	11737889	SENT140	24	24	16	16	trastuzumab	HER2	PA451743	2064	0.709
NULL	Mol_Pain_2014_Aug_15_10_53.nxml.txt.nlp	25127716	SENT94	20	20	12	12	paclitaxel	CCL3	PA450761	6348	0.709
NULL	Diabetes_Metab_Syndr_Obes_2009_Jul_30_2_127-134.nxml.txt.nlp	21437126	SENT58	21	21	10	10	sitagliptin	GLP-1	PA164748978	100125288	0.709
NULL	Oncotarget_2011_Sep_9_2(9)_658-668.nxml.txt.nlp	21911919	SENT122	29	29	3	3	daunorubicin	HO-1	PA449212	3162	0.709
NULL	Front_Genet_2013_Aug_26_4_162.nxml.txt.nlp	23986774	SENT380	0	0	4	4	paclitaxel	p53	PA450761	7157	0.709
NULL	J_Biol_Eng_2013_Mar_21_7_7.nxml.txt.nlp	23517522	SENT145	22	22	11	11	l-glutamine	KSR	PA10090	10256	0.709
NULL	Surg_Today_2012_Jan_6_42(1)_8-28.nxml.txt.nlp	22139128	SENT271	20	20	16	16	tegafur	PSK	PA452620	9344	0.709
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT13	2	2	16	16	atorvastatin	TRAP	PA448500	959;54;57410	0.709
NULL	Br_J_Cancer_2013_Jun_25_108(12)_2464-2469.nxml.txt.nlp	23695016	SENT169	30	30	37	37	paclitaxel	CRT	PA450761	811	0.709
NULL	Br_J_Cancer_2009_Nov_3_101(9)_1549-1554.nxml.txt.nlp	19809436	SENT31	8	8	15	15	vincristine	ADM	PA451879	133	0.709
NULL	Front_Immunol_2012_Jun_11_3_144.nxml.txt.nlp	22701453	SENT64	21	21	24	24	imiquimod	TLR9	PA449972	54106	0.709
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Sep_26_68(Pt_10)_o3024.nxml.txt.nlp	23125791	SENT66	20	20	15	15	ethanol	mol	PA448073	90527	0.709
NULL	Biomed_Res_Int_2014_Jan_20_2014_948427.nxml.txt.nlp	24563867	SENT97	3	3	20	20	buspirone	STZ	PA448689	6484	0.709
NULL	Curr_Opin_Endocrinol_Diabetes_Obes_2014_Oct_28_21(5)_394-404.nxml.txt.nlp	25122493	SENT132	21	21	3	3	thyroglobulin	RAI	PA164754910	10848;6050	0.709
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_11_2014_274786.nxml.txt.nlp	25505920	SENT164	13	13	9	9	oxaliplatin	ERCC1	PA131285527	2067	0.709
NULL	Scientifica_(Cairo)_2014_Apr_9_2014_825463.nxml.txt.nlp	24818040	SENT113	17	17	12	12	imiquimod	TLR7	PA449972	51284	0.709
NULL	Oxid_Med_Cell_Longev_2011_Oct_9_2011_756938.nxml.txt.nlp	22007271	SENT200	18	18	37	37	forskolin	PNMT	PA146096022	5409	0.709
NULL	EPMA_J_2010_Jun_29_1(2)_343-361.nxml.txt.nlp	23199069	SENT422	33	33	4	4	rasagiline	Bcl-2	PA164764584	596	0.709
NULL	Mar_Drugs_2014_Dec_1_12(12)_5764-5787.nxml.txt.nlp	25470180	SENT353	17	17	26	26	ethanol	IL-6	PA448073	3569	0.709
NULL	Indian_J_Endocrinol_Metab_2013_Jan-Feb_17(1)_91-94.nxml.txt.nlp	23776858	SENT94	5	5	11	11	exenatide	GLP-1	PA164749238	100125288	0.709
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT17	2	2	11	11	gefitinib	PIK3CA	PA131301952	5290	0.709
NULL	Oncol_Lett_2013_Jul_15_6(1)_13-18.nxml.txt.nlp	23946770	SENT148	11	11	8	8	trastuzumab	HER2	PA451743	2064	0.709
NULL	J_Headache_Pain_2009_Apr_27_10(2)_105-110.nxml.txt.nlp	19172228	SENT1	33	33	9	9	capsaicin	c-fos	PA448776	2353	0.709
NULL	Evid_Based_Complement_Alternat_Med_2013_Aug_12_2013_982689.nxml.txt.nlp	23997806	SENT161	9	9	0	0	dextromethorphan	APE	PA449273	55704;328	0.709
NULL	Pharmaceutics_2012_Dec_27_5(1)_81-93.nxml.txt.nlp	24300398	SENT36	5	5	8	8	ridaforolimus	PPL	PA165291475	5493	0.709
NULL	J_Immunother_Cancer_2013_May_29_1_4.nxml.txt.nlp	NULL	SENT279	28	28	13	13	imatinib	IFN	PA10804	3439	0.709
NULL	Br_J_Cancer_2013_Jun_25_108(12)_2464-2469.nxml.txt.nlp	23695016	SENT119	24	24	17	17	cisplatin	NACT	PA449014	284111	0.709
NULL	Crit_Care_2005_Oct_7_9(Suppl_5)_S15-S24.nxml.txt.nlp	16221315	SENT49	6	6	15	15	thrombin	FVIII	PA451674	2157	0.709
NULL	Br_J_Cancer_1998_Nov_78(9)_1170-1174.nxml.txt.nlp	9820175	SENT13	12	12	26	26	paclitaxel	CYP2A6	PA450761	1548	0.709
NULL	Ann_Oncol_2009_Aug_20(Suppl_6)_vi41-vi50.nxml.txt.nlp	19617297	SENT268	14	14	32	32	dacarbazine	IL-2	PA449197	3558	0.709
NULL	Aging_(Albany_NY)_2009_Mar_31_1(4)_412-424.nxml.txt.nlp	20195491	SENT121	0	0	5	5	resveratrol	G6PD		2539	0.709
NULL	J_Immunol_Res_2014_Jul_16_2014_696812.nxml.txt.nlp	25133198	SENT45	18	18	3	3	rifaximin	TLR2	PA164752443	7097	0.709
NULL	Front_Oncol_2014_Jun_16_4_148.nxml.txt.nlp	24982848	SENT158	21	21	12	12	doxorubicin	p53	PA449412	7157	0.709
NULL	Turk_J_Haematol_2012_Jun_15_29(2)_197-198.nxml.txt.nlp	24744658	SENT25	10	10	25	25	cyclophosphamide	VIII	PA449165	1351	0.709
NULL	Int_Semin_Surg_Oncol_2008_Apr_28_5_9.nxml.txt.nlp	18442393	SENT80	11	11	8	8	tamoxifen	HER2	PA451581	2064	0.709
NULL	Oncotarget_2014_Oct_16_5(20)_9546-9563.nxml.txt.nlp	25337673	SENT108	44	44	4	4	lapatinib	AXL	PA152241907	558	0.709
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Mar_13_66(Pt_4)_o830.nxml.txt.nlp	21580658	SENT59	10	10	6	6	benzaldehyde	mol	PA448571	90527	0.709
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2010_Aug_3_3_43-51.nxml.txt.nlp	22879786	SENT169	6	6	1	1	pioglitazone	gamma	PA450970	9913	0.709
NULL	Summit_on_Translat_Bioinforma_2009_Mar_1_2009_124-128.nxml.txt.nlp	21347183	SENT69	24	24	40	40	mercaptopurine	TPMT	PA450379	7172	0.709
NULL	J_Biomed_Sci_2013_Mar_15_20(1)_17.nxml.txt.nlp	23497194	SENT130	0	0	8	8	rivaroxaban	PAR1	PA165958360	79581;2149	0.709
NULL	Neural_Plast_2012_May_20_2012_569149.nxml.txt.nlp	22685677	SENT37	35	35	27	27	lipase	iPLA2	PA450239	8398	0.709
NULL	Arthritis_Res_Ther_2009_Aug_24_11(4)_R127.nxml.txt.nlp	19703304	SENT104	21	21	7	7	adalimumab	OASIS	PA10004	90993	0.709
NULL	Int_J_Biol_Sci_2012_Oct_24_8(9)_1237-1247.nxml.txt.nlp	23136552	SENT168	4	4	8	8	tocilizumab	IL-6	PA165292659	3569	0.709
NULL	Acta_Pharmacol_Sin_2011_Oct_12_32(10)_1259-1265.nxml.txt.nlp	21909126	SENT105	3	3	7	7	losartan	p38	PA450268	10598;1432;7965	0.709
NULL	Case_Rep_Med_2014_Mar_4_2014_923496.nxml.txt.nlp	24715926	SENT51	10	10	6	6	tocilizumab	IL-6	PA165292659	3569	0.709
NULL	Croat_Med_J_2012_Jun_53(3)_214-223.nxml.txt.nlp	22661134	SENT95	9	9	14	14	diazepam	ACTH	PA449283	5443	0.709
NULL	Biol_Open_2014_Sep_12_3(10)_937-946.nxml.txt.nlp	25217618	SENT170	18	18	8	8	niclosamide	SOST	PA165958408	50964	0.709
NULL	Ann_Pediatr_Cardiol_2008_Jan-Jun_1(1)_18-26.nxml.txt.nlp	20300233	SENT118	6	6	16	16	isoproterenol	LQT1	PA450121	3784	0.709
NULL	Br_J_Cancer_2010_Jan_5_102(1)_80-86.nxml.txt.nlp	19920817	SENT106	9	9	4	4	bevacizumab	IFN	PA130232992	3439	0.709
NULL	Cancer_Immunol_Immunother_2010_Feb_5_59(2)_203-213.nxml.txt.nlp	19655140	SENT290	2	2	41	41	methylcholanthrene	gamma	PA165816878	9913	0.709
NULL	Br_J_Cancer_1978_Feb_37(2)_183-189.nxml.txt.nlp	629857	SENT8	16	16	4	4	guanidine	CEA	PA164781028	5670;1087	0.709
NULL	J_Hematol_Oncol_2013_Nov_5_6_83.nxml.txt.nlp	24283248	SENT88	29	29	21	21	nutlin-3	TP53		7157	0.709
NULL	Indian_J_Med_Res_2010_Dec_132(6)_676-682.nxml.txt.nlp	21245614	SENT98	4	4	13	13	zinc	p53	PA451956	7157	0.709
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT1906	5	5	13	13	phenacetin	CYP1A2	PA450897	1544	0.709
NULL	Cancer_Cell_Int_2012_Jun_18_12_30.nxml.txt.nlp	22709569	SENT57	18	18	2	2	cisplatin	PLCG2	PA449014	5336	0.709
NULL	Br_J_Cancer_2013_May_28_108(10)_2021-2032.nxml.txt.nlp	23632475	SENT253	0	0	18	18	metformin	AMPK	PA450395	5563	0.709
NULL	J_Cell_Mol_Med_2013_Jan_10_17(1)_30-54.nxml.txt.nlp	23301832	SENT223	19	19	12	12	daunorubicin	PC3	PA449212	57332;7832;5122	0.709
NULL	Biomed_Res_Int_2013_Aug_6_2013_909613.nxml.txt.nlp	24027765	SENT8	19	19	22	22	hydrocortisone	EEN	PA449905	6455	0.709
NULL	Mol_Pain_2013_Mar_20_9_12.nxml.txt.nlp	23510079	SENT41	3	3	19	19	staurosporine	PKM	PA165109623	5315	0.709
NULL	Saudi_J_Anaesth_2014_Apr-Jun_8(2)_209-214.nxml.txt.nlp	24843334	SENT38	26	26	14	14	clonidine	C15	PA449051	51316	0.709
NULL	Arch_Med_Sci_2013_Aug_30_9(4)_724-730.nxml.txt.nlp	24049536	SENT81	24	24	30	30	genistein	PTH	PA165109660	5741	0.709
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT3	34	34	12	12	curcumin	TRAIL	PA151958596	8743	0.709
NULL	J_Cardiovasc_Magn_Reson_2009_Jul_27_11(1)_24.nxml.txt.nlp	19635160	SENT168	28	28	0	0	simvastatin	ATV	PA451363	4683	0.709
NULL	Korean_Circ_J_2013_Oct_30_43(10)_699-701.nxml.txt.nlp	24255655	SENT50	15	15	6	6	amiodarone	APT	PA448383	653639	0.709
NULL	Pharmaceuticals_(Basel)_2013_Aug_21_6(8)_988-1038.nxml.txt.nlp	24276379	SENT476	18	18	9	9	vemurafenib	PIK3CA	PA165946873	5290	0.709
NULL	Adv_Pharmacol_Sci_2013_May_12_2013_313858.nxml.txt.nlp	23737767	SENT101	23	23	14	14	abatacept	ACR	PA164747080	49	0.709
NULL	Clin_Ophthalmol_2009_Dec_29_3_689-692.nxml.txt.nlp	20054418	SENT64	8	8	12	12	vincristine	CHOP	PA451879	1649	0.709
NULL	Case_Rep_Dermatol_2012_Jul_12_4(2)_158-162.nxml.txt.nlp	22807901	SENT44	0	0	19	19	tacrolimus	IL-2	PA451578	3558	0.709
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT148	0	0	13	13	nutlin-3	MDM2		4193	0.709
NULL	Ann_Clin_Microbiol_Antimicrob_2005_Jan_20_4_3.nxml.txt.nlp	15659247	SENT18	9	9	30	30	efavirenz	CD4	PA449441	920	0.709
NULL	Bioinform_Biol_Insights_2010_Oct_11_4_99-111.nxml.txt.nlp	20981267	SENT102	15	15	21	21	arsenite	KLK7	PA452638	5650	0.709
NULL	Case_Rep_Oncol_2012_Jul_3_5(2)_339-346.nxml.txt.nlp	22807902	SENT53	26	26	22	22	methotrexate	CHOP	PA450428	1649	0.709
NULL	Virol_J_2011_May_24_8_255.nxml.txt.nlp	21609431	SENT90	19	19	12	12	l-glutamine	F12	PA10090	2161	0.709
NULL	Oncol_Lett_2014_Nov_14_8(5)_2086-2092.nxml.txt.nlp	25295095	SENT7	13	13	1	1	gemcitabine	LKB1	PA449748	6794	0.709
NULL	Biomed_Res_Int_2014_Apr_29_2014_186864.nxml.txt.nlp	24877064	SENT180	4	4	15	15	curcumin	AP-1	PA151958596	2353;3727;2354;3725	0.709
NULL	Oncol_Rep_2013_Apr_23_29(4)_1268-1274.nxml.txt.nlp	23354756	SENT111	28	28	17	17	epirubicin	SLC25A43	PA449476	203427	0.709
NULL	Diabetes_2011_Nov_17_60(11)_2691-2700.nxml.txt.nlp	21896928	SENT229	7	7	24	24	resveratrol	SIRT1		23411	0.709
NULL	eLife_2014_Apr_30_3_e02445.nxml.txt.nlp	24843000	SENT236	7	7	9	9	mimosine	BRCA1	PA164752445	672	0.709
NULL	J_Headache_Pain_2013_Apr_10_14(1)_33.nxml.txt.nlp	23574808	SENT7	25	25	12	12	capsaicin	CO2	PA448776	4513	0.709
NULL	Pain_Ther_2014_Jun_13_3(1)_59-69.nxml.txt.nlp	25135388	SENT136	2	2	10	10	curcumin	HSD1	PA151958596	26871	0.709
NULL	Kidney_Int_Suppl_(2011)_2013_Dec_27_3(5)_436-441.nxml.txt.nlp	25019026	SENT9	8	8	25	25	cinacalcet	PTH	PA164776671	5741	0.709
NULL	Hum_Mol_Genet_2013_Nov_15_22(22)_4616-4626.nxml.txt.nlp	23814041	SENT142	4	4	9	9	doxycycline	neuroserpin	PA449415	5274	0.709
NULL	Breast_Cancer_Res_2005_Jul_20_7(5)_205-211.nxml.txt.nlp	16168139	SENT123	18	18	26	26	tamoxifen	AIB1	PA451581	8202	0.709
NULL	Indian_J_Anaesth_2010_Jan-Feb_54(1)_8-17.nxml.txt.nlp	20532065	SENT200	14	14	1	1	warfarin	TKR	PA451906	8277	0.709
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT133	3	3	7	7	tenofovir	ABCC10	PA10204	89845	0.709
NULL	Arthritis_Res_Ther_2009_Jun_29_11(3)_R100.nxml.txt.nlp	19563672	SENT228	3	3	9	9	infliximab	IFN	PA452639	3439	0.709
NULL	Anal_Bioanal_Chem_2013_Jul_23_405(23)_7337-7345.nxml.txt.nlp	23877175	SENT131	18	18	15	15	creatine	spatial	PA164778930	219793	0.709
NULL	Ther_Clin_Risk_Manag_2006_Sep_2(3)_235-249.nxml.txt.nlp	18360599	SENT333	12	12	26	26	alendronate	PTH	PA448082	5741	0.709
NULL	Oncotarget_2013_Dec_18_5(3)_634-648.nxml.txt.nlp	24504138	SENT189	2	2	8	8	bortezomib	IL-6	PA10252	3569	0.709
NULL	Environ_Health_Perspect_2007_Dec_8_115(Suppl_1)_77-83.nxml.txt.nlp	18174954	SENT78	26	26	11	11	resveratrol	TPO		7066;7173	0.709
NULL	Mol_Biol_Rep_2013_May_11_40(8)_5013-5026.nxml.txt.nlp	23666059	SENT118	7	7	16	16	resveratrol	p53		7157	0.709
NULL	Arch_Trauma_Res_2013_Aug_1_2(2)_97-98.nxml.txt.nlp	24396803	SENT16	27	27	22	22	meperidine	P-gp	PA450369	5243	0.709
NULL	Int_J_Inflam_2010_Aug_9_2010_151097.nxml.txt.nlp	21152121	SENT373	36	36	23	23	thrombin	C5a	PA451674	727	0.709
NULL	Cancer_Res_Treat_2012_Mar_31_44(1)_50-56.nxml.txt.nlp	22500161	SENT32	8	8	10	10	heparin	EGF	PA449855	1950	0.709
NULL	Front_Synaptic_Neurosci_2014_Apr_21_6_9.nxml.txt.nlp	24795622	SENT116	0	0	3	3	l-serine	PLP	PA451330	25824;5744	0.709
NULL	J_Biol_Chem_2009_Jul_10_284(28)_18904-18912.nxml.txt.nlp	19473990	SENT217	9	9	20	20	forskolin	PBX1	PA146096022	5087	0.709
NULL	CNS_Spectr_2014_Oct_3_19(5)_391-402.nxml.txt.nlp	24698103	SENT100	15	15	25	25	promethazine	hang	PA451128	374879	0.709
NULL	Ann_Saudi_Med_2010_Jan-Feb_30(1)_38-49.nxml.txt.nlp	20103957	SENT165	2	2	7	7	pyrazinamide	NOT	PA451182	4929	0.709
NULL	Acta_Pharmacol_Sin_2012_Aug_23_33(8)_1095-1100.nxml.txt.nlp	22820908	SENT113	1	1	11	11	ilaprazole	CYP2C19	PA165947499	1557	0.709
NULL	N_Am_J_Med_Sci_2014_Aug_6(8)_408-412.nxml.txt.nlp	25210675	SENT128	34	34	11	11	felbamate	gamma	PA449590	9913	0.709
NULL	Aging_(Albany_NY)_2014_May_17_6(5)_369-379.nxml.txt.nlp	24860943	SENT135	29	29	1	1	l-arginine	S6K1	PA448478	6198	0.709
NULL	Oncogene_2013_Sep_12_32(37)_4355-4365.nxml.txt.nlp	23108409	SENT13	13	13	7	7	hyaluronan	HAS2	PA165958431	3037	0.709
NULL	Child_Adolesc_Psychiatry_Ment_Health_2013_Oct_11_7_34.nxml.txt.nlp	24119376	SENT211	19	19	4	4	atomoxetine	NHS	PA134688071	4810	0.709
NULL	Diabetes_2011_Nov_17_60(11)_2691-2700.nxml.txt.nlp	21896928	SENT246	9	9	16	16	resveratrol	SIRT1		23411	0.709
NULL	Biol_Open_2014_May_2_3(6)_418-430.nxml.txt.nlp	24795145	SENT128	4	4	13	13	etoposide	HDAC6	PA449552	10013	0.709
NULL	Curr_Oncol_2007_Aug_14(4)_154-161.nxml.txt.nlp	17710208	SENT144	8	8	13	13	rifampin	CYP3A4	PA451250	1576	0.709
NULL	Adv_Hematol_2011_Apr_10_2011_960137.nxml.txt.nlp	21547266	SENT68	8	8	23	23	rituximab	CAD	PA451261	1677;790	0.709
NULL	Arthritis_Res_Ther_2003_Oct_2_5(Suppl_4)_S17-S21.nxml.txt.nlp	15180893	SENT54	34	34	37	37	rituximab	ACR	PA451261	49	0.709
NULL	Br_J_Cancer_2013_Mar_5_108(4)_859-865.nxml.txt.nlp	23385729	SENT110	33	33	14	14	cetuximab	EGFR	PA10040	1956	0.709
NULL	Diabetes_Metab_Syndr_Obes_2009_May_18_2_37-49.nxml.txt.nlp	20148188	SENT89	3	3	1	1	exenatide	GLP-1	PA164749238	100125288	0.709
NULL	Cancers_(Basel)_2011_Mar_29_3(2)_1708-1731.nxml.txt.nlp	24212779	SENT1591	2	2	9	9	oxaliplatin	GM-CSF	PA131285527	1437	0.709
NULL	Arthritis_Res_Ther_2012_Jun_25_14(3)_215.nxml.txt.nlp	22731694	SENT99	2	2	10	10	cyclophosphamide	RIBA	PA449165	6014	0.709
NULL	Psychiatry_Investig_2013_Dec_16_10(4)_425-427.nxml.txt.nlp	24474994	SENT41	11	11	7	7	quetiapine	CYP3A4	PA451201	1576	0.709
NULL	Indian_J_Crit_Care_Med_2014_Sep_18(9)_575-584.nxml.txt.nlp	25249742	SENT206	20	20	14	14	vecuronium	NMB	PA164748865	10457;4828	0.709
NULL	Curr_Neuropharmacol_2009_Sep_7(3)_217-227.nxml.txt.nlp	20190963	SENT97	10	10	29	29	theophylline	CA1	PA451647	759	0.709
NULL	Diabetes_2013_Jun_17_62(6)_2141-2150.nxml.txt.nlp	23378610	SENT9	23	23	19	19	betaine	PHGDH	PA448603	26227	0.709
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT541	15	15	31	31	quetiapine	PRL	PA451201	5617	0.709
NULL	Br_J_Cancer_1991_Aug_64(2)_215-220.nxml.txt.nlp	1892748	SENT19	17	17	19	19	cisplatin	CHIP	PA449014	10273	0.709
NULL	J_Cancer_2013_Jan_11_4(2)_117-132.nxml.txt.nlp	23386910	SENT64	18	18	23	23	trastuzumab	DM1	PA451743	338023;1760;28509	0.709
NULL	Int_J_Hypertens_2011_Nov_13_2011_902129.nxml.txt.nlp	22164326	SENT82	17	17	37	37	l-arginine	iNOS	PA448478	4843	0.709
NULL	Clin_Med_Insights_Oncol_2011_May_10_5_131-144.nxml.txt.nlp	21695100	SENT187	0	0	9	9	vinorelbine	EGFR	PA451881	1956	0.709
NULL	Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.nxml.txt.nlp	24736980	SENT5	30	30	20	20	rosuvastatin	OATP1B1	PA134308647	10599	0.709
NULL	Int_J_Mol_Sci_2014_Nov_21_15(11)_21433-21454.nxml.txt.nlp	25421240	SENT240	13	13	15	15	tropicamide	PP2	PA164749389	4888	0.709
NULL	Mol_Biol_Rep_2012_May_20_39(5)_5253-5267.nxml.txt.nlp	22183301	SENT29	3	3	5	5	gliclazide	SUR1	PA10892	6833	0.709
NULL	Oncotarget_2014_Oct_21_5(22)_11709-11722.nxml.txt.nlp	25365944	SENT10	4	4	6	6	metformin	Rho	PA450395	29984	0.709
NULL	FASEB_J_2011_Oct_25(10)_3465-3476.nxml.txt.nlp	21715680	SENT82	31	31	15	15	l-glutamine	F12	PA10090	2161	0.709
NULL	Cancers_(Basel)_2010_Nov_24_2(4)_1929-1951.nxml.txt.nlp	24281210	SENT185	3	3	20	20	estradiol	IFN	PA449503	3439	0.709
NULL	J_Cell_Biol_1997_Jul_14_138(1)_55-64.nxml.txt.nlp	9214381	SENT39	22	22	24	24	coumarin	BTC	PA134521193	685	0.709
NULL	Brain_Sci_2014_May_6_4(2)_356-375.nxml.txt.nlp	24961766	SENT240	31	31	27	27	propofol	P28	PA451141	9446;7802;9527	0.709
NULL	Diabetes_Care_2010_Apr_19_33(4)_914-919.nxml.txt.nlp	20086255	SENT118	23	23	13	13	ramipril	DREAM	PA451223	30818	0.709
NULL	Hum_Genomics_Proteomics_2010_Aug_3_2010_159761.nxml.txt.nlp	20981231	SENT196	3	3	21	21	lithium	BDNF	PA450243	627	0.709
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT295	4	4	21	21	gefitinib	PIK3CA	PA131301952	5290	0.709
NULL	Mol_Cancer_2009_Nov_10_8_99.nxml.txt.nlp	19903356	SENT122	17	17	12	12	imatinib	IGFBP3	PA10804	3486	0.709
NULL	Mol_Cancer_2012_Dec_12_11_91.nxml.txt.nlp	23234355	SENT46	6	6	18	18	erlotinib	HER2	PA134687924	2064	0.709
NULL	Oncoimmunology_2014_May_29_3_e28925.nxml.txt.nlp	25083322	SENT81	0	0	10	10	dasatinib	CD4	PA162372878	920	0.709
NULL	Ann_Intensive_Care_2011_Mar_21_1_3.nxml.txt.nlp	21906325	SENT111	27	27	21	21	cisplatin	EPO	PA449014	7076;8288;2056	0.709
NULL	Br_J_Pharmacol_2012_Apr_165(8)_2611-2619.nxml.txt.nlp	21718301	SENT14	38	38	10	10	rimonabant	GPR55	PA152407999	9290	0.708
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jun_22_67(Pt_7)_o1772.nxml.txt.nlp	21837149	SENT70	16	16	19	19	benzaldehyde	mol	PA448571	90527	0.708
NULL	Br_J_Cancer_2003_Mar_10_88(5)_754-759.nxml.txt.nlp	12618886	SENT107	10	10	3	3	amifostine	p53	PA448365	7157	0.708
NULL	Mol_Cancer_2009_Jul_31_8_57.nxml.txt.nlp	19646263	SENT18	5	5	21	21	docetaxel	IL-8	PA449383	3576	0.708
NULL	Chemother_Res_Pract_2012_Aug_29_2012_817297.nxml.txt.nlp	22970367	SENT79	38	38	18	18	imatinib	EGFR	PA10804	1956	0.708
NULL	Breast_Cancer_Res_Treat_2014_Apr_9_145(1)_73-82.nxml.txt.nlp	24715380	SENT2	18	18	8	8	tamoxifen	CXCR3	PA451581	2833	0.708
NULL	Cell_Commun_Signal_2014_Nov_15_12(1)_69.nxml.txt.nlp	NULL	SENT208	7	7	11	11	cisplatin	ILK	PA449014	3611	0.708
NULL	Cancer_Cell_Int_2013_Mar_4_13_21.nxml.txt.nlp	23497288	SENT27	14	14	20	20	doxorubicin	EWS	PA449412	2130	0.708
NULL	Oncotarget_2011_Jun_15_2(6)_518-524.nxml.txt.nlp	21680956	SENT37	24	24	14	14	methotrexate	STAT3	PA450428	6774	0.708
NULL	Iran_J_Pharm_Res_2013_Winter_12(1)_47-56.nxml.txt.nlp	24250571	SENT216	35	35	29	29	curcumin	AP-1	PA151958596	2353;3727;2354;3725	0.708
NULL	Bioinform_Biol_Insights_2013_Sep_18_7_289-306.nxml.txt.nlp	24092970	SENT209	21	21	10	10	etoposide	PRAME	PA449552	23532	0.708
NULL	J_Hematol_Oncol_2011_Feb_23_4_8.nxml.txt.nlp	21345215	SENT143	6	6	16	16	bortezomib	PERK	PA10252	9451	0.708
NULL	Cancer_Res_Treat_2014_Jan_15_46(1)_2-18.nxml.txt.nlp	24520218	SENT203	7	7	13	13	curcumin	DR4	PA151958596	8797	0.708
NULL	Oncotarget_2013_Nov_24_4(12)_2430-2438.nxml.txt.nlp	24280348	SENT28	3	3	5	5	gefitinib	SOCS3	PA131301952	9021	0.708
NULL	Arthritis_Res_Ther_2008_Jan_7_10(1)_R1.nxml.txt.nlp	18179697	SENT180	0	0	10	10	oxaliplatin	HMGB1	PA131285527	3146	0.708
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT212	20	20	9	9	sn-38	ABCG2		9429	0.708
NULL	Int_J_Mol_Med_2014_Sep_27_34(3)_651-660.nxml.txt.nlp	24993179	SENT10	24	24	14	14	dextran	IL-6	PA449261	3569	0.708
NULL	Front_Pharmacol_2014_May_9_5_103.nxml.txt.nlp	24847272	SENT234	2	2	14	14	tacrolimus	CYP3A5	PA451578	1577	0.708
NULL	Br_J_Cancer_2011_Jul_12_105(2)_212-220.nxml.txt.nlp	21694723	SENT154	5	5	15	15	curcumin	CD133	PA151958596	8842	0.708
NULL	Biomed_Res_Int_2013_Sep_5_2013_929531.nxml.txt.nlp	24083250	SENT56	8	8	31	31	hyaluronan	HAS2	PA165958431	3037	0.708
NULL	Acta_Neuropathol_Commun_2014_Sep_4_2(1)_93.nxml.txt.nlp	NULL	SENT340	39	39	19	19	tamoxifen	IKZF1	PA451581	10320	0.708
NULL	Br_J_Cancer_2009_Oct_6_101(7)_1175-1182.nxml.txt.nlp	19789534	SENT114	22	22	10	10	sunitinib	IFN	PA162372840	3439	0.708
NULL	J_Korean_Med_Sci_2013_Apr_27_28(4)_527-533.nxml.txt.nlp	23580227	SENT37	12	12	16	16	genistein	TRAIL	PA165109660	8743	0.708
NULL	J_Immunother_2014_Apr_12_37(3)_180-186.nxml.txt.nlp	24598448	SENT35	5	5	12	12	sorafenib	IL-2	PA7000	3558	0.708
NULL	Ann_Hematol_2007_Dec_14_86(12)_871-877.nxml.txt.nlp	17874322	SENT26	14	14	25	25	dapsone	CHOP	PA449211	1649	0.708
NULL	Br_J_Cancer_1998_Nov_78(9)_1170-1174.nxml.txt.nlp	9820175	SENT13	12	12	31	31	paclitaxel	CYP2E1	PA450761	1571	0.708
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT254	37	37	30	30	resveratrol	NAC		22861	0.708
NULL	Biomed_Res_Int_2013_May_27_2013_526367.nxml.txt.nlp	23762850	SENT63	15	15	20	20	fluorescein	CD34	PA164746009	947	0.708
NULL	Ann_Rheum_Dis_2011_Apr_22_70(8)_1395-1400.nxml.txt.nlp	21515602	SENT183	14	14	10	10	warfarin	CYP2C19	PA451906	1557	0.708
NULL	Aging_(Albany_NY)_2010_Dec_20_2(12)_959-968.nxml.txt.nlp	21191146	SENT118	11	11	4	4	cisplatin	Rpn13	PA449014	11047	0.708
NULL	J_Cell_Biol_1997_Jun_30_137(7)_1639-1649.nxml.txt.nlp	9199177	SENT156	6	6	15	15	paraformaldehyde	ZAP-70	PA450790	7535	0.708
NULL	Physiol_Rep_2014_Sep_11_2(9)_e12144.nxml.txt.nlp	25214522	SENT103	16	16	4	4	resveratrol	RVR		9975	0.708
NULL	Mol_Brain_2014_Apr_5_7_27.nxml.txt.nlp	24708859	SENT12	36	36	8	8	capsaicin	TRPV1	PA448776	7442	0.708
NULL	Tumour_Biol_2012_Jun_21_33(3)_607-615.nxml.txt.nlp	22270450	SENT125	30	30	26	26	trastuzumab	HER2	PA451743	2064	0.708
NULL	F1000Prime_Rep_2014_Dec_1_6_117.nxml.txt.nlp	25580271	SENT15	7	7	21	21	gemcitabine	EGFR	PA449748	1956	0.708
NULL	Front_Endocrinol_(Lausanne)_2014_Apr_24_5_58.nxml.txt.nlp	24795698	SENT297	1	1	3	3	lipase	HSL	PA450239	3991	0.708
NULL	Nat_Neurosci_2013_Apr_3_16(4)_394-406.nxml.txt.nlp	23455607	SENT464	32	32	27	27	tetracycline	LRRK2	PA451640	120892	0.708
NULL	Cell_Death_Dis_2012_Jun_21_3(6)_e327.nxml.txt.nlp	22717582	SENT218	21	21	31	31	vincristine	NOXA	PA451879	5366	0.708
NULL	Cell_Death_Dis_2014_Mar_13_5(3)_e1118.nxml.txt.nlp	24625977	SENT81	36	36	9	9	etoposide	UBXN2A	PA449552	165324	0.708
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT49	8	8	12	12	chloroquine	BMPR-II	PA448948	659	0.708
NULL	J_Cell_Biol_2001_Apr_30_153(3)_613-620.nxml.txt.nlp	11331310	SENT63	7	7	36	36	camptothecin	53BP1	PA153590860	7158	0.708
NULL	Korean_J_Radiol_2011_Apr_25_May-Jun_12(3)_319-326.nxml.txt.nlp	21603291	SENT61	43	43	38	38	propranolol	DBP	PA451145	3295;1628;2638	0.708
NULL	Front_Endocrinol_(Lausanne)_2013_Nov_11_4_166.nxml.txt.nlp	24273531	SENT244	9	9	14	14	losartan	ANG	PA450268	283	0.708
NULL	Int_J_Med_Sci_2013_Mar_19_10(5)_599-606.nxml.txt.nlp	23569422	SENT58	14	14	11	11	propofol	HO-1	PA451141	3162	0.708
NULL	Indian_J_Endocrinol_Metab_2013_Jul-Aug_17(4)_636-646.nxml.txt.nlp	23961479	SENT138	24	24	16	16	pitavastatin	CYP2C9	PA142650384	1559	0.708
NULL	Front_Genet_2015_Jan_14_5_469.nxml.txt.nlp	25642242	SENT662	13	13	8	8	paromomycin	S12	PA164784023	3351;6206;5713;6268	0.708
NULL	Oncoimmunology_2012_Sep_1_1(6)_951-953.nxml.txt.nlp	23162768	SENT16	26	26	3	3	irinotecan	L1CAM	PA450085	3897	0.708
NULL	Biochimie_2010_Nov_92(11)_1546-1567.nxml.txt.nlp	20615447	SENT28	29	29	20	20	trypsin	KLK1	PA451806	3816	0.708
NULL	Clin_Med_Insights_Oncol_2012_Mar_19_6_165-178.nxml.txt.nlp	22474408	SENT216	19	19	17	17	platinum	CHOP	PA150595617	1649	0.708
NULL	Biomed_Res_Int_2013_Dec_30_2013_783690.nxml.txt.nlp	23509778	SENT86	0	0	21	21	kanamycin	ACTB	PA450137	60	0.708
NULL	J_Cell_Biol_1998_Jan_26_140(2)_335-345.nxml.txt.nlp	9442109	SENT173	6	6	9	9	chloroquine	NHE	PA448948	285335	0.708
NULL	Arch_Med_Sci_2013_Jun_20_9(3)_569-575.nxml.txt.nlp	23847684	SENT126	8	8	2	2	methotrexate	MYC	PA450428	4609	0.708
NULL	Oncogene_2010_Sep_16_29(37)_5135-5145.nxml.txt.nlp	20622897	SENT77	10	10	3	3	cetuximab	STAT3	PA10040	6774	0.708
NULL	Braz_J_Med_Biol_Res_2014_Oct_24_48(1)_65-76.nxml.txt.nlp	25493385	SENT165	33	33	6	6	l-arginine	AT1	PA448478	9197;185	0.708
NULL	Neuropsychopharmacology_2009_Jul_11_34(8)_1946-1957.nxml.txt.nlp	19279569	SENT162	15	15	0	0	cocaine	DOR	PA449072	58476	0.708
NULL	J_Pain_Res_2014_Jun_23_7_353-357.nxml.txt.nlp	25018649	SENT25	14	14	6	6	lidocaine	LNP	PA450226	80856;51203	0.708
NULL	Cough_2006_Dec_15_2_10.nxml.txt.nlp	17173683	SENT7	7	7	13	13	capsaicin	TRPV1	PA448776	7442	0.708
NULL	Aging_(Albany_NY)_2009_Jun_3_1(6)_515-528.nxml.txt.nlp	20157535	SENT112	5	5	2	2	resveratrol	S6K1		6198	0.708
NULL	Breast_Cancer_Res_2011_Apr_6_13(2)_207.nxml.txt.nlp	21586099	SENT59	2	2	37	37	denosumab	RANKL	PA166048634	8600	0.708
NULL	Trials_2012_May_6_13_55.nxml.txt.nlp	22559260	SENT223	24	24	18	18	fluorescein	CD34	PA164746009	947	0.708
NULL	Biomed_Res_Int_2013_Sep_9_2013_239354.nxml.txt.nlp	24089667	SENT32	15	15	24	24	curcumin	EGFR	PA151958596	1956	0.708
NULL	EMBO_Mol_Med_2012_Dec_15_4(12)_1276-1293.nxml.txt.nlp	23065753	SENT155	14	14	3	3	cisplatin	AIM2	PA449014	9447	0.708
NULL	Cardiovasc_Res_2009_May_1_82(2)_229-239.nxml.txt.nlp	19168855	SENT60	19	19	27	27	phenylephrine	ET1	PA450935	1906	0.708
NULL	Mol_Neurodegener_2011_Aug_8_6_57.nxml.txt.nlp	21819629	SENT237	16	16	5	5	arsenite	JNK	PA452638	5599	0.708
NULL	Niger_Med_J_2014_Jul-Aug_55(4)_327-332.nxml.txt.nlp	25114369	SENT15	19	19	11	11	ethambutol	RIF	PA164784021	54509;80196	0.708
NULL	Can_J_Infect_Dis_Med_Microbiol_2014_Sep-Oct_25(5)_271-276.nxml.txt.nlp	25371690	SENT159	30	30	15	15	voriconazole	gamma	PA10233	9913	0.708
NULL	Ann_Surg_Treat_Res_2014_Feb_22_86(2)_68-75.nxml.txt.nlp	24761411	SENT144	16	16	7	7	oxaliplatin	survivin	PA131285527	332	0.708
NULL	Arthritis_Res_Ther_2013_Jul_9_15(4)_R73.nxml.txt.nlp	23837669	SENT254	0	0	6	6	colchicine	MICL	PA449092	160364	0.708
NULL	J_Korean_Med_Sci_2009_Jan_29_24(Suppl_1)_S183-S188.nxml.txt.nlp	19194550	SENT142	17	17	3	3	celecoxib	CD2AP	PA448871	23607	0.708
NULL	Front_Neurosci_2014_May_22_8_113.nxml.txt.nlp	24904259	SENT218	7	7	1	1	mirtazapine	5-HT1A	PA450522	3350	0.708
NULL	Clin_Mol_Hepatol_2014_Sep_25_20(3)_283-290.nxml.txt.nlp	25320732	SENT29	11	11	5	5	propranolol	EVL	PA451145	51466	0.708
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT110	23	23	39	39	tamoxifen	S6K1	PA451581	6198	0.708
NULL	Br_J_Cancer_2010_Mar_2_102(5)_815-826.nxml.txt.nlp	20145614	SENT195	13	13	9	9	tamoxifen	HER2	PA451581	2064	0.708
NULL	Diabetes_2009_Dec_31_58(12)_2731-2740.nxml.txt.nlp	19720798	SENT124	17	17	15	15	troglitazone	adiponectin	PA451799	9370	0.708
NULL	Nat_Genet_2014_Feb_15_46(2)_152-160.nxml.txt.nlp	24336168	SENT244	6	6	39	39	galactose	TDP-43	PA449725	23435	0.708
NULL	Emerg_Infect_Dis_2012_Aug_18(8)_1235-1241.nxml.txt.nlp	22840969	SENT43	25	25	21	21	colistin	TOB	PA164760862	10140	0.708
NULL	Ayu_2013_Oct-Dec_34(4)_421-429.nxml.txt.nlp	24696581	SENT186	42	42	33	33	scopolamine	IL-10	PA451308	3586	0.708
NULL	Emerg_Infect_Dis_2003_Jul_9(7)_864-867.nxml.txt.nlp	12890330	SENT7	9	9	14	14	sulfamethoxazole	DHPS	PA451544	1725	0.708
NULL	J_Korean_Med_Sci_2013_Feb_29_28(2)_308-314.nxml.txt.nlp	23399960	SENT6	22	22	26	26	gabapentin	IL-10	PA449720	3586	0.708
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1066.nxml.txt.nlp	24556681	SENT44	8	8	17	17	ethanol	IFN	PA448073	3439	0.708
NULL	Arthritis_Res_Ther_2009_Aug_28_11(4)_R131.nxml.txt.nlp	19715572	SENT125	0	0	3	3	rituximab	CD19	PA451261	930	0.708
NULL	Genome_Biol_2000_Dec_4_1(6)_research0014_1-14_17.nxml.txt.nlp	11178268	SENT198	11	11	7	7	betaine	bet	PA448603	92737	0.708
NULL	Acta_Vet_Scand_2009_Mar_24_51(1)_12.nxml.txt.nlp	19317903	SENT74	5	5	1	1	fluorescein	CD34	PA164746009	947	0.708
NULL	Brain_Sci_2012_Nov_7_2(4)_589-604.nxml.txt.nlp	24349762	SENT442	2	2	31	31	vasopressin	San	PA451858	80218	0.708
NULL	Biol_Open_2012_Oct_4_1(12)_1215-1225.nxml.txt.nlp	23259056	SENT201	11	11	7	7	l-glutamine	SLC1A5	PA10090	6510	0.708
NULL	Mol_Vis_2011_Feb_1_17_332-340.nxml.txt.nlp	21297899	SENT135	2	2	4	4	benazepril	NAC	PA448561	22861	0.708
NULL	Br_J_Cancer_2010_Jan_5_102(1)_115-123.nxml.txt.nlp	19997099	SENT215	12	12	19	19	oxaliplatin	GEM	PA131285527	2669	0.708
NULL	Breast_Cancer_Res_Treat_2014_Nov_11_148(3)_563-570.nxml.txt.nlp	25385180	SENT58	21	21	10	10	pertuzumab	PTH		5741	0.708
NULL	J_Cell_Mol_Med_2013_Sep_11_17(9)_1160-1172.nxml.txt.nlp	23844832	SENT175	17	17	7	7	gefitinib	EGF	PA131301952	1950	0.708
NULL	Ann_Rheum_Dis_2013_Aug_21_72(8)_1287-1294.nxml.txt.nlp	22915624	SENT218	25	25	15	15	methotrexate	MRI	PA450428	78996	0.708
NULL	Breast_Cancer_Res_2008_Mar_27_10(2)_R26.nxml.txt.nlp	18371194	SENT113	23	23	38	38	cisplatin	BRCA1	PA449014	672	0.708
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT192	10	10	19	19	lapatinib	Yes	PA152241907	7525	0.708
NULL	Breast_Cancer_Res_2010_Oct_14_12(5)_R84.nxml.txt.nlp	20946630	SENT238	12	12	14	14	choline	SLC5A7	PA448976	60482	0.708
NULL	Mol_Pain_2013_Sep_8_9_46.nxml.txt.nlp	24010880	SENT130	19	19	12	12	capsaicin	GluN2B	PA448776	2904	0.708
NULL	Biol_Open_2012_Oct_4_1(12)_1215-1225.nxml.txt.nlp	23259056	SENT190	8	8	14	14	l-leucine	S6K1	PA450197	6198	0.708
NULL	Gut_Pathog_2010_Dec_7_2_17.nxml.txt.nlp	21138594	SENT39	14	14	32	32	colistin	OTC	PA164760862	5009	0.708
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT152	32	32	12	12	dasatinib	EGR1	PA162372878	1958	0.708
NULL	Core_Evid_2010_Jul_27_5_1-10.nxml.txt.nlp	20694135	SENT202	30	30	20	20	levodopa	CLE	PA450213	51637	0.708
NULL	Nucleic_Acids_Res_2011_Dec_31_39(22)_9536-9548.nxml.txt.nlp	21880590	SENT211	20	20	2	2	paclitaxel	FOXM1	PA450761	2305	0.708
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S251-S257.nxml.txt.nlp	21525464	SENT50	18	18	11	11	metformin	GLP-1	PA450395	100125288	0.708
NULL	Toxins_(Basel)_2010_Oct_26_2(11)_2490-2518.nxml.txt.nlp	22069563	SENT94	0	0	7	7	cisplatin	OCT2	PA449014	6582;5452	0.708
NULL	Oncol_Lett_2013_Feb_27_5(2)_483-488.nxml.txt.nlp	23420047	SENT204	18	18	3	3	irinotecan	KRAS	PA450085	3845	0.708
NULL	Oncoimmunology_2014_Jun_3_3_e29030.nxml.txt.nlp	25083328	SENT80	5	5	30	30	paclitaxel	GM-CSF	PA450761	1437	0.708
NULL	Br_J_Cancer_2010_Sep_7_103(6)_796-801.nxml.txt.nlp	20823888	SENT39	0	0	8	8	erlotinib	San	PA134687924	80218	0.708
NULL	Front_Neuroanat_2010_Oct_7_4_136.nxml.txt.nlp	20953289	SENT326	6	6	1	1	apomorphine	c-fos	PA164781163	2353	0.708
NULL	Ann_Nucl_Med_2014_Jul_8_28(9)_836-850.nxml.txt.nlp	25001261	SENT163	16	16	8	8	acetazolamide	spatial	PA448018	219793	0.708
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2007_Dec_6_64(Pt_1)_o1-o2.nxml.txt.nlp	21200665	SENT69	26	26	14	14	ethanol	mol	PA448073	90527	0.708
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT408	5	5	1	1	heparin	FGF1	PA449855	2246	0.708
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT197	14	14	6	6	perifosine	DR4	PA165291471	8797	0.708
NULL	Autophagy_2013_Jul_1_9(7)_996-1008.nxml.txt.nlp	23580233	SENT11	26	26	14	14	chloroquine	BECN1	PA448948	8678	0.708
NULL	Arthritis_Res_Ther_2011_Feb_4_13(1)_R14.nxml.txt.nlp	21294864	SENT115	4	4	12	12	indomethacin	M-CSF	PA449982	1435	0.708
NULL	Eur_J_Immunol_2014_Jun_10_44(6)_1759-1769.nxml.txt.nlp	24595810	SENT8	0	0	6	6	fludrocortisone	CD4	PA164743961	920	0.708
NULL	Front_Neurol_2014_Feb_18_5_17.nxml.txt.nlp	24600432	SENT119	25	25	10	10	levetiracetam	CLIP	PA450206	5443;6249;7461	0.708
NULL	Int_J_Mol_Sci_2014_Nov_25_15(12)_21703-21722.nxml.txt.nlp	25429431	SENT835	7	7	0	0	curcumin	B19	PA151958596	59271	0.708
NULL	AIDS_2013_Sep_24_27(15)_2413-2423.nxml.txt.nlp	24037210	SENT298	13	13	10	10	efavirenz	CYP3A5	PA449441	1577	0.708
NULL	Scientifica_(Cairo)_2013_Nov_26_2013_849186.nxml.txt.nlp	24379984	SENT227	4	4	8	8	temsirolimus	TSC1	PA164746890	7248	0.708
NULL	Clin_Psychopharmacol_Neurosci_2012_Dec_20_10(3)_168-179.nxml.txt.nlp	23430396	SENT97	16	16	14	14	iptakalim	ANOVA	PA165949694	4858	0.708
NULL	J_Korean_Med_Sci_2005_Oct_31_20(5)_883-885.nxml.txt.nlp	16224167	SENT15	23	23	33	33	cyclosporine	gamma	PA449167	9913	0.708
NULL	Cells_2014_Sep_12_3(3)_914-938.nxml.txt.nlp	25222270	SENT85	18	18	9	9	capsaicin	TRPM1	PA448776	4308	0.708
NULL	Int_J_Med_Sci_2015_Jan_1_12(1)_63-71.nxml.txt.nlp	25552920	SENT101	6	6	17	17	berberine	PC-3	PA165860812	692094	0.708
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT192	10	10	30	30	lapatinib	Yes	PA152241907	7525	0.708
NULL	Cent_European_J_Urol_2011_Dec_9_64(4)_256-257.nxml.txt.nlp	24578906	SENT16	6	6	9	9	doxazosin	CD133	PA449407	8842	0.708
NULL	Mol_Cancer_2010_Nov_2_9_289.nxml.txt.nlp	21044322	SENT216	4	4	0	0	cisplatin	RGS10	PA449014	6001	0.708
NULL	Br_J_Haematol_2014_Mar_13_164(1)_811-821.nxml.txt.nlp	24328678	SENT120	0	0	4	4	lenalidomide	Aiolos	PA162363968	22806	0.708
NULL	Front_Immunol_2012_Mar_1_3_36.nxml.txt.nlp	22566919	SENT255	35	35	15	15	alefacept	CD28	PA164748040	1493;940	0.708
NULL	Acta_Pharmacol_Sin_2014_Aug_21_35(8)_994-1004.nxml.txt.nlp	25042549	SENT169	18	18	15	15	pravastatin	PCSK9	PA451089	255738	0.708
NULL	Oncotarget_2013_Dec_18_5(3)_634-648.nxml.txt.nlp	24504138	SENT149	26	26	19	19	bortezomib	p65	PA10252	5970	0.708
NULL	Bioinformation_2012_Jan_6_8(1)_13-19.nxml.txt.nlp	22359429	SENT85	2	2	4	4	curcumin	MRP1	PA151958596	4437	0.708
NULL	Cancers_(Basel)_2014_Jul_8_6(3)_1487-1499.nxml.txt.nlp	25006835	SENT332	4	4	1	1	cisplatin	AKT1	PA449014	207	0.708
NULL	Epigenomics_2014_Feb_6(1)_89-120.nxml.txt.nlp	24579949	SENT628	8	8	6	6	temozolomide	ALKBH2	PA451609	121642	0.708
NULL	J_Gen_Physiol_2010_Feb_135(2)_135-147.nxml.txt.nlp	20100893	SENT52	21	21	10	10	streptomycin	FBS	PA451512	64319;26269	0.708
NULL	ScientificWorldJournal_2013_Apr_18_2013_808460.nxml.txt.nlp	23710149	SENT113	4	4	31	31	carrageenan	IL-6	PA448814	3569	0.708
NULL	Breast_Cancer_Res_Treat_2015_Dec_30_149_171-179.nxml.txt.nlp	25547219	SENT184	5	5	8	8	rituximab	CHOP	PA451261	1649	0.708
NULL	Angiogenesis_2012_Sep_27_15(3)_361-376.nxml.txt.nlp	22451299	SENT59	27	27	40	40	hydrocortisone	FBS	PA449905	64319;26269	0.708
NULL	Biologics_2012_Apr_11_6_83-87.nxml.txt.nlp	22532776	SENT41	10	10	20	20	fluorescein	CD54	PA164746009	3383	0.708
NULL	Breast_Cancer_Res_Treat_2013_Apr_12_138(2)_427-435.nxml.txt.nlp	23479422	SENT176	15	15	25	25	lapatinib	HER2	PA152241907	2064	0.708
NULL	J_Carcinog_2012_Aug_30_11_12.nxml.txt.nlp	23233819	SENT239	9	9	25	25	gemcitabine	TP53	PA449748	7157	0.708
NULL	Evid_Based_Complement_Alternat_Med_2014_May_4_2014_620974.nxml.txt.nlp	24876872	SENT92	5	5	12	12	colchicine	San	PA449092	80218	0.708
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_4_2012_127373.nxml.txt.nlp	23227094	SENT95	3	3	1	1	vincristine	CD50	PA451879	3385	0.708
NULL	J_Int_Soc_Sports_Nutr_2010_Mar_11_7_12.nxml.txt.nlp	20222976	SENT123	36	36	2	2	creatine	PRX	PA164778930	9588;57716	0.708
NULL	Drug_Target_Insights_2012_Aug_6_6_19-39.nxml.txt.nlp	22915839	SENT22	16	16	13	13	doxorubicin	Hsp90	PA449412	3320	0.708
NULL	Int_J_Biomed_Sci_2007_Jun_3(2)_123-130.nxml.txt.nlp	23675034	SENT17	12	12	20	20	nizatidine	RAN	PA164752234	5901	0.708
NULL	Indian_J_Endocrinol_Metab_2013_Sep-Oct_17(5)_899-905.nxml.txt.nlp	24083174	SENT130	13	13	16	16	oxygen	p53	PA450744	7157	0.708
NULL	Front_Cell_Neurosci_2013_Dec_18_7_250.nxml.txt.nlp	24391538	SENT1506	0	0	14	14	ivermectin	P2X4	PA450133	5025	0.708
NULL	Diabetes_2011_Jan_4_60(1)_119-126.nxml.txt.nlp	20921208	SENT31	13	13	5	5	glucose	TRPM2	PA449773	7226	0.708
NULL	J_Hematol_Oncol_2009_Mar_24_2_14.nxml.txt.nlp	19309523	SENT160	11	11	2	2	rituximab	PRIMA	PA451261	145270	0.708
NULL	Front_Immunol_2012_Jun_11_3_144.nxml.txt.nlp	22701453	SENT64	21	21	9	9	imiquimod	TLR4	PA449972	7099	0.708
NULL	Brain_Sci_2013_Apr_29_3(2)_704-727.nxml.txt.nlp	24027632	SENT788	4	4	12	12	ethanol	CA1	PA448073	759	0.708
NULL	Br_J_Cancer_2012_Apr_24_106(9)_1543-1550.nxml.txt.nlp	22531721	SENT36	0	0	6	6	trastuzumab	San	PA451743	80218	0.708
NULL	Indian_J_Med_Paediatr_Oncol_2013_Oct-Dec_34(4)_292-298.nxml.txt.nlp	24604960	SENT20	8	8	14	14	doxorubicin	CHOP	PA449412	1649	0.708
NULL	Environ_Health_Perspect_2004_Nov_28_112(15)_1481-1487.nxml.txt.nlp	15531431	SENT52	15	15	33	33	pp2	San		80218	0.708
NULL	Br_J_Cancer_2010_Jul_13_103(2)_265-274.nxml.txt.nlp	20551953	SENT215	10	10	14	14	cisplatin	JNK	PA449014	5599	0.708
NULL	Cancers_(Basel)_2011_Apr_1_3(2)_1844-1860.nxml.txt.nlp	24212785	SENT89	22	22	33	33	cetuximab	BRAF	PA10040	673	0.708
NULL	J_Vet_Med_Sci_2014_Sep_9_76(9)_1291-1295.nxml.txt.nlp	24909969	SENT98	6	6	4	4	azithromycin	ATV	PA448519	4683	0.708
NULL	Cell_Death_Dis_2011_Aug_11_2(8)_e191.nxml.txt.nlp	21833029	SENT78	19	19	15	15	oxaliplatin	CT26	PA131285527	168400	0.708
NULL	Mol_Pain_2013_Jul_31_9_38.nxml.txt.nlp	23898828	SENT11	27	27	33	33	losartan	JNK	PA450268	5599	0.708
NULL	J_Int_AIDS_Soc_2011_Feb_9_14_7.nxml.txt.nlp	21306608	SENT74	13	13	23	23	abacavir	ATV	PA448004	4683	0.708
NULL	Cancer_Cell_Int_2014_Jul_2_14_59.nxml.txt.nlp	25120382	SENT136	18	18	15	15	metformin	CTR	PA450395	799	0.708
NULL	Braz_J_Med_Biol_Res_2014_Sep_5_47(11)_929-939.nxml.txt.nlp	25296354	SENT78	12	12	3	3	gefitinib	EGFR	PA131301952	1956	0.708
NULL	Sci_Rep_2014_Dec_17_4_7461.nxml.txt.nlp	25514838	SENT31	44	44	34	34	vincristine	XIAP	PA451879	331	0.708
NULL	Indian_J_Endocrinol_Metab_2012_Mar_16(Suppl1)_S110-S113.nxml.txt.nlp	22701828	SENT32	0	0	4	4	vildagliptin	GLP-1	PA165958346	100125288	0.708
NULL	Oncogenesis_2012_Apr_2_1(4)_e5.nxml.txt.nlp	23552603	SENT568	33	33	19	19	celecoxib	BIM	PA448871	10018	0.708
NULL	Case_Rep_Rheumatol_2013_Jul_24_2013_249471.nxml.txt.nlp	23984159	SENT46	17	17	0	0	methotrexate	IL-2	PA450428	3558	0.708
NULL	Curr_Genomics_2014_Jun_15(3)_217-230.nxml.txt.nlp	24955029	SENT41	22	22	24	24	oxygen	ROS	PA450744	6098	0.708
NULL	Nat_Chem_Biol_2010_Jun_9_6(6)_424-432.nxml.txt.nlp	20453863	SENT104	29	29	9	9	dantrolene	Hsp40	PA449208	3337	0.708
NULL	Daru_2012_Nov_28_20(1)_81.nxml.txt.nlp	23351280	SENT12	17	17	23	23	atropine	MARK	PA448505	4139	0.708
NULL	Ann_Gen_Psychiatry_2013_Aug_13_12_26.nxml.txt.nlp	23941527	SENT146	30	30	23	23	venlafaxine	NMA	PA451866	25805	0.708
NULL	Gut_2012_May_3_61(5)_695-705.nxml.txt.nlp	21813473	SENT350	17	17	12	12	dextran	CXCR2	PA449261	3579	0.708
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT306	23	23	26	26	neratinib	EGFR	PA165291472	1956	0.708
NULL	Exp_Ther_Med_2014_Nov_29_8(5)_1473-1478.nxml.txt.nlp	25289044	SENT14	23	23	28	28	heparin	AZU	PA449855	566	0.708
NULL	J_Cardiothorac_Surg_2011_Oct_14_6_138.nxml.txt.nlp	21999189	SENT132	21	21	3	3	creatine	IL-6	PA164778930	3569	0.708
NULL	Brain_Behav_2013_Mar_17_3(2)_145-158.nxml.txt.nlp	23531559	SENT342	6	6	1	1	choline	SOD1	PA448976	6647	0.708
NULL	Breast_Cancer_Res_2014_May_5_16(3)_R45.nxml.txt.nlp	24887236	SENT293	35	35	30	30	lapatinib	EGFR	PA152241907	1956	0.708
NULL	Am_J_Trop_Med_Hyg_2012_Nov_7_87(5_Suppl)_137-143.nxml.txt.nlp	23136289	SENT120	8	8	10	10	amoxicillin	PKR	PA448406	5610	0.708
NULL	Ann_Oncol_2009_Nov_23_20(11)_1803-1812.nxml.txt.nlp	19549706	SENT62	6	6	8	8	sunitinib	IFN	PA162372840	3439	0.708
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Aug_6_64(Pt_9)_o1707.nxml.txt.nlp	21201695	SENT74	15	15	11	11	benzaldehyde	mol	PA448571	90527	0.708
NULL	Br_J_Cancer_2010_Jan_19_102(2)_361-368.nxml.txt.nlp	20010949	SENT237	7	7	5	5	doxorubicin	PSMB7	PA449412	5695	0.708
NULL	Front_Cell_Neurosci_2014_Feb_6_8_27.nxml.txt.nlp	24567703	SENT319	16	16	25	25	taurine	KCC2	PA451590	57468	0.708
NULL	J_Skin_Cancer_2012_Dec_13_2012_147863.nxml.txt.nlp	23316365	SENT189	4	4	12	12	curcumin	IL-6	PA151958596	3569	0.708
NULL	Hum_Mol_Genet_2014_Apr_15_23(8)_2055-2077.nxml.txt.nlp	24282027	SENT252	15	15	2	2	galactose	MGM1	PA449725	4976	0.708
NULL	Curr_Cardiol_Rev_2012_Aug_8(3)_181-191.nxml.txt.nlp	22920489	SENT64	17	17	15	15	thrombin	ADP	PA451674	23038	0.708
NULL	Mol_Biol_Cell_2012_Nov_1_23(21)_4212-4225.nxml.txt.nlp	22956765	SENT81	4	4	16	16	thrombin	PTP	PA451674	5967;10076	0.708
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT6	17	17	8	8	cisplatin	p53	PA449014	7157	0.708
NULL	Mol_Cancer_2010_Nov_2_9_289.nxml.txt.nlp	21044322	SENT149	11	11	8	8	cisplatin	RGS5	PA449014	8490	0.708
NULL	J_Korean_Med_Sci_2006_Dec_31_21(6)_1037-1040.nxml.txt.nlp	17179683	SENT5	8	8	10	10	metronidazole	BAM	PA450484	9126	0.708
NULL	Front_Physiol_2013_May_15_4_103.nxml.txt.nlp	23720630	SENT114	17	17	24	24	simvastatin	ADP	PA451363	23038	0.708
NULL	Cell_Death_Dis_2014_Jan_30_5(1)_e1030.nxml.txt.nlp	24481444	SENT56	24	24	32	32	sorafenib	EGF	PA7000	1950	0.708
NULL	Breast_Cancer_Res_2014_Sep_11_16(5)_434.nxml.txt.nlp	25209360	SENT296	25	25	13	13	tamoxifen	HER2	PA451581	2064	0.708
NULL	Ann_Hematol_2010_Oct_29_89(10)_1019-1027.nxml.txt.nlp	20428873	SENT199	8	8	0	0	melphalan	San	PA450354	80218	0.708
NULL	Diabetes_Care_2009_Oct_8_32(10)_1873-1879.nxml.txt.nlp	19587362	SENT106	26	26	5	5	irbesartan	ANG	PA450084	283	0.708
NULL	J_Immunother_Cancer_2014_Jul_15_2_24.nxml.txt.nlp	25089198	SENT84	0	0	9	9	sunitinib	KIT	PA162372840	3815	0.708
NULL	J_Immunol_Res_2014_Jan_19_2014_103780.nxml.txt.nlp	24741572	SENT117	5	5	26	26	salmeterol	JNK	PA451300	5599	0.708
NULL	F1000Res_2013_Jul_9_2_150.nxml.txt.nlp	24627787	SENT18	3	3	28	28	olanzapine	DIP	PA450688	23151;1831	0.708
NULL	J_Korean_Med_Sci_2006_Jun_21_21(3)_418-424.nxml.txt.nlp	16778382	SENT13	6	6	2	2	hemin	HO-1	PA449849	3162	0.708
NULL	Ann_Surg_Oncol_2007_Apr_26_14(4)_1499-1506.nxml.txt.nlp	17253101	SENT240	31	31	24	24	melphalan	TNF-alpha	PA450354	7124	0.708
NULL	Front_Immunol_2012_Jan_24_3_2.nxml.txt.nlp	22566888	SENT717	15	15	25	25	rituximab	BAFF	PA451261	10673	0.708
NULL	Cancer_Med_2014_Apr_7_3(2)_362-375.nxml.txt.nlp	24515916	SENT33	19	19	21	21	zoledronate	IL-2	PA10235	3558	0.708
NULL	Mol_Cancer_2012_Aug_24_11_61.nxml.txt.nlp	22917467	SENT221	34	34	23	23	paclitaxel	EGF	PA450761	1950	0.708
NULL	Br_J_Clin_Pharmacol_2011_Oct_72(4)_647-657.nxml.txt.nlp	21518389	SENT204	7	7	9	9	prasugrel	P2Y12	PA154410481	64805	0.708
NULL	AIDS_Res_Ther_2013_Dec_13_10_29.nxml.txt.nlp	24330529	SENT194	8	8	10	10	maraviroc	CCR5	PA164768835	1234	0.708
NULL	Clin_Psychopharmacol_Neurosci_2011_Apr_30_9(1)_29-35.nxml.txt.nlp	23430964	SENT173	28	28	42	42	methylphenidate	Gen	PA450464	348654	0.708
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT447	31	31	24	24	olanzapine	PRL	PA450688	5617	0.708
NULL	Iran_J_Neurol_2012_11(2)_70-73.nxml.txt.nlp	24250865	SENT92	11	11	14	14	doxycycline	IFN	PA449415	3439	0.708
NULL	Br_J_Pharmacol_2010_Sep_161(2)_241-270.nxml.txt.nlp	20735414	SENT406	17	17	5	5	bleomycin	LPA	PA448645	4018	0.708
NULL	Ital_J_Pediatr_2011_Dec_19_37_58.nxml.txt.nlp	22182677	SENT162	12	12	3	3	diazepam	LGS	PA449283	51557	0.708
NULL	Oncotarget_2014_Jun_7_5(14)_5257-5271.nxml.txt.nlp	24913448	SENT48	34	34	10	10	nilotinib	LASP1	PA165958345	3927	0.708
NULL	Adipocyte_2014_Jul_1_3(3)_190-196.nxml.txt.nlp	25068085	SENT74	9	9	2	2	estradiol	ADIPOR2	PA449503	79602	0.708
NULL	Front_Genet_2014_Dec_19_5_438.nxml.txt.nlp	25566322	SENT1666	3	3	5	5	decitabine	AQP5	PA164749631	362	0.708
NULL	J_Korean_Med_Sci_2006_Oct_31_21(5)_781-789.nxml.txt.nlp	17043406	SENT195	13	13	10	10	didanosine	CD4	PA449301	920	0.708
NULL	Breast_Cancer_Res_2011_Aug_16_13(4)_312.nxml.txt.nlp	21861853	SENT30	16	16	12	12	tamoxifen	CUEDC2	PA451581	79004	0.708
NULL	Biomed_Res_Int_2014_Apr_13_2014_738625.nxml.txt.nlp	24822215	SENT131	22	22	19	19	montelukast	CysLT1	PA450546	10800	0.708
NULL	Oncotarget_2013_Nov_24_4(12)_2430-2438.nxml.txt.nlp	24280348	SENT4	2	2	8	8	gefitinib	STAT3	PA131301952	6774	0.708
NULL	Br_J_Cancer_2013_Jul_23_109(2)_351-359.nxml.txt.nlp	23799854	SENT116	14	14	2	2	paclitaxel	BLT2	PA450761	56413	0.708
NULL	Diabetes_Obes_Metab_2012_Apr_14(4)_304-314.nxml.txt.nlp	22051096	SENT70	29	29	13	13	metformin	GLP-1	PA450395	100125288	0.708
NULL	J_Korean_Med_Sci_2007_Jun_30_22(3)_557-559.nxml.txt.nlp	17596671	SENT18	26	26	9	9	warfarin	CYP2C9	PA451906	1559	0.707
NULL	J_Headache_Pain_2014_Sep_18_15(Suppl_1)_E6.nxml.txt.nlp	NULL	SENT8	20	20	15	15	bupivacaine	SPG	PA135057240	55764	0.707
NULL	Clin_Drug_Investig_2013_Apr_20_33(4)_243-254.nxml.txt.nlp	23512639	SENT263	8	8	26	26	imipramine	CYP2C9	PA449969	1559	0.707
NULL	Pharmaceutics_2010_Sep_9_2(3)_300-312.nxml.txt.nlp	NULL	SENT434	11	11	5	5	carboplatin	ATP7B	PA448803	540	0.707
NULL	J_Nutr_Metab_2011_Oct_1_2011_525094.nxml.txt.nlp	21977315	SENT31	8	8	22	22	resveratrol	SIRT1		23411	0.707
NULL	Indian_J_Pharm_Sci_2013_May-Jun_75(3)_302-309.nxml.txt.nlp	24082346	SENT124	23	23	29	29	diclofenac	API	PA449293	5345	0.707
NULL	Arthritis_Res_Ther_2007_Oct_9_9(5)_R104.nxml.txt.nlp	17925024	SENT49	29	29	12	12	glucosamine	AP-1	PA164747613	2353;3727;2354;3725	0.707
NULL	Cancer_Cell_2007_Dec_11_12(6)_514-527.nxml.txt.nlp	18068629	SENT159	8	8	17	17	paclitaxel	TGFBI	PA450761	7045	0.707
NULL	Arthritis_Res_Ther_2013_Feb_11_15(Suppl_1)_S2.nxml.txt.nlp	23566295	SENT314	12	12	4	4	rituximab	gamma	PA451261	9913	0.707
NULL	Adv_Hematol_2012_Jul_24_2012_513702.nxml.txt.nlp	22888354	SENT97	3	3	8	8	lenalidomide	CD56	PA162363968	4684	0.707
NULL	Cell_Res_2013_Sep_25_23(9)_1075-1090.nxml.txt.nlp	23797856	SENT116	15	15	20	20	tamoxifen	E12	PA451581	64100	0.707
NULL	J_Korean_Med_Sci_2013_Aug_31_28(8)_1213-1219.nxml.txt.nlp	23960450	SENT9	19	19	6	6	ribavirin	ITPA	PA451241	3704	0.707
NULL	Biosci_Rep_2012_Dec_20_33(1)_e00011.nxml.txt.nlp	23137297	SENT266	32	32	39	39	heparin	RPSA	PA449855	3921	0.707
NULL	Oncotarget_2013_Oct_19_4(11)_2045-2056.nxml.txt.nlp	24185104	SENT94	6	6	15	15	cisplatin	p38	PA449014	10598;1432;7965	0.707
NULL	J_Hematol_Oncol_2010_Apr_7_3_13.nxml.txt.nlp	20374647	SENT174	27	27	19	19	fludarabine	CDK2	PA449655	1017	0.707
NULL	Cell_Cycle_2012_Nov_1_11(21)_4069-4078.nxml.txt.nlp	23095523	SENT78	34	34	11	11	imatinib	PERK	PA10804	9451	0.707
NULL	J_Cancer_Prev_2014_Mar_19(1)_39-46.nxml.txt.nlp	25337571	SENT98	6	6	11	11	ethanol	p53	PA448073	7157	0.707
NULL	Sensors_(Basel)_2012_May_18_12(5)_6520-6537.nxml.txt.nlp	22778656	SENT318	13	13	8	8	cyclophosphamide	CYP2B6	PA449165	1555	0.707
NULL	Environ_Health_Perspect_2013_May_22_121(5)_551-557.nxml.txt.nlp	23434795	SENT176	23	23	13	13	hyaluronan	AHR	PA165958431	196	0.707
NULL	Reprod_Biol_Endocrinol_2003_Aug_6_1_54.nxml.txt.nlp	12932297	SENT4	13	13	6	6	hyaluronidase	SPAM1	PA164745713	6677	0.707
NULL	Breast_Cancer_Res_2006_Oct_24_8(5)_R59.nxml.txt.nlp	17062128	SENT15	13	13	31	31	urokinase	CD24	PA451836	100133941	0.707
NULL	Front_Neurol_2011_Oct_24_2_66.nxml.txt.nlp	22028699	SENT41	14	14	16	16	vasopressin	AVP	PA451858	114548;551	0.707
NULL	Exp_Diabetes_Res_2012_Dec_12_2012_716404.nxml.txt.nlp	22194737	SENT118	6	6	10	10	metformin	AMPK	PA450395	5563	0.707
NULL	Clin_Dev_Immunol_2013_Nov_26_2013_325481.nxml.txt.nlp	24371447	SENT152	2	2	8	8	propofol	IL-6	PA451141	3569	0.707
NULL	J_Cell_Biol_1995_Mar_2_128(6)_1185-1196.nxml.txt.nlp	7896881	SENT5	11	11	13	13	mitomycin	HC11	PA450524	6347	0.707
NULL	Int_J_Hypertens_2012_Nov_3_2012_320648.nxml.txt.nlp	22121477	SENT137	17	17	34	34	telmisartan	spatial	PA451605	219793	0.707
NULL	Protein_Cell_2014_Jul_2_5(7)_544-551.nxml.txt.nlp	24691905	SENT106	16	16	7	7	doxorubicin	p53	PA449412	7157	0.707
NULL	J_Biol_Chem_2009_Jan_9_284(2)_751-758.nxml.txt.nlp	19010784	SENT211	16	16	39	39	thrombin	ADP	PA451674	23038	0.707
NULL	Clin_Pharmacol_2011_Jun_22_3_13-25.nxml.txt.nlp	22287853	SENT181	42	42	28	28	ketoconazole	CYP3A4	PA450146	1576	0.707
NULL	Ann_Hematol_2011_Dec_8_90(12)_1399-1407.nxml.txt.nlp	21476016	SENT89	2	2	13	13	chlorambucil	CHOP	PA448926	1649	0.707
NULL	Eur_J_Clin_Pharmacol_2014_Mar_22_70(6)_685-693.nxml.txt.nlp	24658827	SENT117	0	0	18	18	tacrolimus	CYP3A4	PA451578	1576	0.707
NULL	Med_Sci_Monit_2013_Nov_29_19_1080-1088.nxml.txt.nlp	24287619	SENT136	16	16	9	9	estradiol	ANOVA	PA449503	4858	0.707
NULL	Breast_Cancer_Res_2008_Mar_27_10(2)_R27.nxml.txt.nlp	18371219	SENT41	13	13	30	30	epirubicin	TFEC	PA449476	22797	0.707
NULL	Cancers_(Basel)_2014_Oct_24_6(4)_2187-2223.nxml.txt.nlp	25347122	SENT699	15	15	35	35	fluorouracil	MA5	PA128406956	29944	0.707
NULL	Crit_Care_2007_Feb_19_11(1)_407.nxml.txt.nlp	17328792	SENT14	8	8	16	16	thrombin	PAR-1	PA451674	2011;2149	0.707
NULL	Int_J_Nanomedicine_2009_Dec_29_4_299-319.nxml.txt.nlp	20054434	SENT273	17	17	41	41	tacrolimus	HLA-A	PA451578	3105	0.707
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S258-S263.nxml.txt.nlp	21525465	SENT205	14	14	30	30	liraglutide	Met	PA165958364	79811	0.707
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT305	6	6	4	4	gefitinib	EGFR	PA131301952	1956	0.707
NULL	Clin_Med_Insights_Arthritis_Musculoskelet_Disord_2012_Jan_5_5_1-14.nxml.txt.nlp	22267947	SENT122	7	7	13	13	risedronate	NNT	PA451255	23530	0.707
NULL	Cerebrospinal_Fluid_Res_2010_Sep_22_7_15.nxml.txt.nlp	20860832	SENT235	8	8	19	19	vasopressin	AQP4	PA451858	361	0.707
NULL	Exp_Ther_Med_2013_Mar_8_5(3)_707-710.nxml.txt.nlp	23404433	SENT133	8	8	10	10	cisplatin	DDP	PA449014	1678	0.707
NULL	J_Breast_Cancer_2011_Sep_29_14(3)_223-228.nxml.txt.nlp	22031805	SENT130	12	12	34	34	vinorelbine	gamma	PA451881	9913	0.707
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Nov_30_67(Pt_12)_o3471-o3472.nxml.txt.nlp	22199946	SENT72	29	29	24	24	ethanol	mol	PA448073	90527	0.707
NULL	Front_Oncol_2013_Nov_15_3_281.nxml.txt.nlp	24298448	SENT84	23	23	25	25	cetuximab	KRAS	PA10040	3845	0.707
NULL	ScientificWorldJournal_2013_Oct_27_2013_939830.nxml.txt.nlp	24288514	SENT148	6	6	13	13	carrageenan	ANOVA	PA448814	4858	0.707
NULL	Oncol_Lett_2014_Jan_11_7(1)_156-158.nxml.txt.nlp	24348840	SENT38	18	18	7	7	epirubicin	CHOP	PA449476	1649	0.707
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT1	14	14	20	20	tacrolimus	RANKL	PA451578	8600	0.707
NULL	Diabetes_2013_Mar_14_62(3)_789-800.nxml.txt.nlp	22966074	SENT201	2	2	17	17	forskolin	c-Myc	PA146096022	4609	0.707
NULL	Indian_J_Nephrol_2011_Jan-Mar_21(1)_44-47.nxml.txt.nlp	21655170	SENT58	13	13	11	11	cyclophosphamide	CHOP	PA449165	1649	0.707
NULL	Nucleic_Acids_Res_2005_Jun_9_33(10)_3323-3330.nxml.txt.nlp	15947132	SENT87	6	6	3	3	cisplatin	MSH2	PA449014	4436	0.707
NULL	eLife_2014_May_20_3_e02523.nxml.txt.nlp	24844246	SENT358	14	14	39	39	sorafenib	CHAC1	PA7000	79094	0.707
NULL	J_Biomed_Biotechnol_2010_Sep_19_2010_518743.nxml.txt.nlp	20886007	SENT203	10	10	2	2	nadh	ADP	PA164755085	23038	0.707
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT252	2	2	0	0	mitomycin	MVP	PA450524	9961	0.707
NULL	Oncoimmunology_2013_Sep_1_2(9)_e25773.nxml.txt.nlp	24319639	SENT30	11	11	8	8	rituximab	SIRP	PA451261	140885	0.707
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT119	8	8	6	6	doxorubicin	B7-H1	PA449412	29126	0.707
NULL	J_Invest_Dermatol_2013_Jun_14_133(6)_1541-1549.nxml.txt.nlp	23407395	SENT75	8	8	19	19	imiquimod	CXCL2	PA449972	2920	0.707
NULL	J_Breast_Cancer_2011_Mar_31_14(1)_20-27.nxml.txt.nlp	21847390	SENT148	33	33	13	13	estradiol	CLDN6	PA449503	9074	0.707
NULL	Nucl_Recept_Signal_2009_Dec_31_7_e012.nxml.txt.nlp	20087433	SENT194	7	7	22	22	ns-398	IL-6		3569	0.707
NULL	Biomed_Res_Int_2014_Jun_26_2014_249780.nxml.txt.nlp	25054134	SENT195	31	31	18	18	ethanol	mol	PA448073	90527	0.707
NULL	J_Cell_Mol_Med_2014_Dec_9_18(12)_2499-2511.nxml.txt.nlp	24912879	SENT290	6	6	3	3	docetaxel	DACH1	PA449383	1602	0.707
NULL	Indian_J_Nucl_Med_2010_Jul-Sep_25(3)_78-87.nxml.txt.nlp	NULL	SENT218	5	5	7	7	piperazine	5-HT1A	PA450977	3350	0.707
NULL	J_Hematol_Oncol_2008_Aug_11_1_11.nxml.txt.nlp	18694493	SENT141	20	20	11	11	erlotinib	IL-2	PA134687924	3558	0.707
NULL	Oncotarget_2014_Aug_19_5(18)_8703-8715.nxml.txt.nlp	25237928	SENT54	9	9	0	0	glucose	CD44	PA449773	960	0.707
NULL	Br_J_Cancer_2013_May_14_108(9)_1807-1809.nxml.txt.nlp	23612454	SENT62	14	14	7	7	trastuzumab	PIK3CA	PA451743	5290	0.707
NULL	Arch_Med_Sci_2012_Nov_9_8(5)_899-906.nxml.txt.nlp	23185202	SENT97	11	11	14	14	miglitol	PPG	PA164776726	5552	0.707
NULL	Front_Synaptic_Neurosci_2014_May_30_6_12.nxml.txt.nlp	24910611	SENT987	16	16	3	3	l-serine	ASCT1	PA451330	6509	0.707
NULL	J_Autom_Methods_Manag_Chem_2011_Mar_30_2011_143416.nxml.txt.nlp	21584273	SENT98	10	10	35	35	chloramphenicol	CAP	PA448927	23476;9200;4012;5269;10580;10487	0.707
NULL	Ann_Hematol_2010_Nov_25_89(11)_1115-1124.nxml.txt.nlp	20499237	SENT108	34	34	26	26	simvastatin	CD5	PA451363	921	0.707
NULL	Mult_Scler_Int_2014_Jul_22_2014_436764.nxml.txt.nlp	25152817	SENT23	36	36	15	15	mitoxantrone	IFN	PA450526	3439	0.707
NULL	Oncotarget_2013_Aug_24_4(10)_1618-1631.nxml.txt.nlp	24113128	SENT101	5	5	19	19	sorafenib	p53	PA7000	7157	0.707
NULL	Acta_Histochem_Cytochem_2012_Apr_26_45(2)_139-146.nxml.txt.nlp	22685356	SENT82	9	9	6	6	forskolin	AQP2	PA146096022	359	0.707
NULL	J_Gen_Physiol_1993_Apr_1_101(4)_469-485.nxml.txt.nlp	7685047	SENT0	22	22	1	1	taurine	Gen	PA451590	348654	0.707
NULL	Chin_J_Cancer_2012_Aug_31(8)_373-380.nxml.txt.nlp	22739266	SENT104	13	13	2	2	gemcitabine	XRCC3	PA449748	7517	0.707
NULL	Ann_Pediatr_Cardiol_2008_Jan-Jun_1(1)_18-26.nxml.txt.nlp	20300233	SENT196	11	11	9	9	verapamil	LQT3	PA451868	6331	0.707
NULL	Endocrinol_Diabetes_Metab_Case_Rep_2013_Sep_30_2013_130051.nxml.txt.nlp	24616777	SENT31	41	41	11	11	thyroglobulin	WBS	PA164754910	2006	0.707
NULL	Cancer_Cell_Int_2011_Dec_2_11_42.nxml.txt.nlp	22136382	SENT82	13	13	24	24	bicalutamide	DcR2	PA164746255	8793	0.707
NULL	Br_J_Cancer_2006_Feb_13_94(3)_407-426.nxml.txt.nlp	16434996	SENT227	7	7	12	12	genistein	BRCA1	PA165109660	672	0.707
NULL	J_Cereb_Blood_Flow_Metab_2014_Oct_23_34(10)_1688-1694.nxml.txt.nlp	25052553	SENT121	17	17	47	47	losartan	AT1	PA450268	9197;185	0.707
NULL	Biosci_Rep_2012_Apr_1_32(Pt_2)_105-112.nxml.txt.nlp	22115362	SENT134	4	4	28	28	collagenase	JNK	PA449107	5599	0.707
NULL	Acta_Pharmacol_Sin_2012_Dec_29_33(12)_1518-1524.nxml.txt.nlp	23103625	SENT136	10	10	12	12	telmisartan	ACE2	PA451605	59272	0.707
NULL	Brain_Topogr_2015_Jun_1_28_113-126.nxml.txt.nlp	24881003	SENT20	25	25	19	19	amobarbital	MRI	PA448401	78996	0.707
NULL	Curr_Control_Trials_Cardiovasc_Med_2005_Oct_24_6(1)_16.nxml.txt.nlp	16242049	SENT157	34	34	0	0	captopril	EDA	PA448780	1896	0.707
NULL	Asia_Pac_Allergy_2013_Oct_31_3(4)_231-240.nxml.txt.nlp	24260728	SENT159	6	6	30	30	theophylline	CYP1A2	PA451647	1544	0.707
NULL	Iran_J_Pharm_Res_2014_Winter_13(1)_279-282.nxml.txt.nlp	24734081	SENT100	37	37	8	8	tacrolimus	MDR1	PA451578	5243	0.707
NULL	J_Thromb_Haemost_2007_May_1_5(5)_910-917.nxml.txt.nlp	17362227	SENT43	5	5	14	14	thrombin	PAR1	PA451674	79581;2149	0.707
NULL	Oncotarget_2013_Apr_13_4(4)_502-530.nxml.txt.nlp	23594434	SENT271	39	39	17	17	nelfinavir	AKT	PA450606	207	0.707
NULL	J_Cell_Biol_2002_Oct_14_159(1)_169-179.nxml.txt.nlp	12370243	SENT314	34	34	22	22	hydrocortisone	EGF	PA449905	1950	0.707
NULL	Oncol_Rep_2013_Oct_24_30(4)_1587-1592.nxml.txt.nlp	23900512	SENT124	2	2	11	11	pargyline	NOXA	PA450797	5366	0.707
NULL	J_Headache_Pain_2013_Dec_11_14(1)_96.nxml.txt.nlp	24330707	SENT139	13	13	1	1	rizatriptan	COX	PA451264	1351	0.707
NULL	Onco_Targets_Ther_2014_Mar_21_7_469-476.nxml.txt.nlp	24711703	SENT25	0	0	9	9	bevacizumab	San	PA130232992	80218	0.707
NULL	J_Exp_Bot_2008_Jun_20_59(9)_2555-2564.nxml.txt.nlp	18495640	SENT122	9	9	4	4	nadh	SSADH	PA164755085	7915	0.707
NULL	Virulence_2013_May_15_4(4)_335-343.nxml.txt.nlp	NULL	SENT127	24	24	6	6	pentamidine	AQP2	PA450850	359	0.707
NULL	Clin_Sci_(Lond)_2009_Nov_16_118(Pt_4)_269-279.nxml.txt.nlp	19698082	SENT165	3	3	19	19	ramipril	ACE2	PA451223	59272	0.707
NULL	Ann_Dermatol_2013_Nov_30_25(4)_500-502.nxml.txt.nlp	24371403	SENT22	18	18	27	27	imatinib	LDE	PA10804	7957	0.707
NULL	Acta_Physiol_(Oxf)_2008_May_1_193(1)_25-36.nxml.txt.nlp	18005217	SENT174	4	4	29	29	nifedipine	KCNE1	PA450631	3753	0.707
NULL	Nucleic_Acids_Res_2012_Apr_16_40(8)_3511-3523.nxml.txt.nlp	22180533	SENT224	21	21	12	12	doxycycline	E2F7	PA449415	144455	0.707
NULL	Curr_Med_Chem_2014_May_21(14)_1595-1606.nxml.txt.nlp	23992330	SENT142	14	14	9	9	lapatinib	PTEN	PA152241907	5728	0.707
NULL	J_Invest_Dermatol_2013_Sep_31_133(9)_2247-2254.nxml.txt.nlp	23370537	SENT136	26	26	6	6	chloroquine	PUMA	PA448948	27113	0.707
NULL	Br_J_Cancer_2010_May_11_102(10)_1495-1502.nxml.txt.nlp	20461092	SENT238	27	27	44	44	lapatinib	CEK	PA152241907	2260	0.707
NULL	Indian_J_Endocrinol_Metab_2013_Oct_17(Suppl1)_S301-S303.nxml.txt.nlp	24251194	SENT31	4	4	38	38	liraglutide	PPG	PA165958364	5552	0.707
NULL	Front_Physiol_2011_Jul_19_2_40.nxml.txt.nlp	21811470	SENT187	32	32	12	12	candesartan	RVR	PA448765	9975	0.707
NULL	Cardiovasc_Drugs_Ther_2011_Jun_12_25(3)_223-232.nxml.txt.nlp	21562974	SENT82	7	7	3	3	milrinone	ANOVA	PA164749171	4858	0.707
NULL	Clin_Pharmacokinet_2014_Sep_3_53(1)_1-16.nxml.txt.nlp	23999929	SENT271	23	23	9	9	rivaroxaban	CYP3A4	PA165958360	1576	0.707
NULL	Diabetes_2013_Oct_17_62(10)_3373-3383.nxml.txt.nlp	23835335	SENT213	16	16	9	9	glucose	POMC	PA449773	5443	0.707
NULL	Pharmaceuticals_(Basel)_2013_Aug_21_6(8)_988-1038.nxml.txt.nlp	24276379	SENT475	24	24	10	10	vemurafenib	PIK3CA	PA165946873	5290	0.707
NULL	Indian_J_Pharmacol_2014_Mar-Apr_46(2)_161-165.nxml.txt.nlp	24741186	SENT4	11	11	15	15	carvedilol	STZ	PA448817	6484	0.707
NULL	Cancer_Immunol_Immunother_2012_Jul_23_61(7)_1101-1111.nxml.txt.nlp	22193989	SENT11	2	2	7	7	oxaliplatin	STAT3	PA131285527	6774	0.707
NULL	Mol_Cancer_2010_Dec_20_9_317.nxml.txt.nlp	21172025	SENT91	16	16	8	8	tamoxifen	HER2	PA451581	2064	0.707
NULL	Breast_Cancer_Res_2007_Jul_5_9(4)_R41.nxml.txt.nlp	17612393	SENT149	15	15	6	6	celecoxib	Bcl-2	PA448871	596	0.707
NULL	Clin_Ophthalmol_2011_Feb_28_5_269-274.nxml.txt.nlp	21468332	SENT59	20	20	34	34	ketorolac	BAK	PA450150	578	0.707
NULL	J_Biol_Chem_2013_Mar_1_288(9)_6248-6258.nxml.txt.nlp	23344959	SENT741	23	23	14	14	quinidine	CTX	PA451209	1593	0.707
NULL	Breast_Cancer_Res_2000_Feb_18_2(2)_E005.nxml.txt.nlp	NULL	SENT41	35	35	24	24	paclitaxel	HER2	PA450761	2064	0.707
NULL	Ann_Neurosci_2014_Jul_21(3)_90-96.nxml.txt.nlp	25206072	SENT101	17	17	5	5	scopolamine	spatial	PA451308	219793	0.707
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT43	3	3	9	9	pertuzumab	HER2		2064	0.707
NULL	Clin_Pharmacokinet_2014_Jul_24_53(1)_73-87.nxml.txt.nlp	23881596	SENT256	36	36	30	30	cyclosporine	OATP2B1	PA449167	11309	0.707
NULL	Bioinform_Biol_Insights_2009_Oct_5_3_109-127.nxml.txt.nlp	20140064	SENT523	7	7	27	27	abacavir	P200	PA448004	5035	0.707
NULL	J_Mol_Signal_2006_Dec_6_1_8.nxml.txt.nlp	17224083	SENT30	1	1	31	31	thrombin	GEF	PA451674	56731	0.707
NULL	Mol_Pain_2013_Jul_29_9_37.nxml.txt.nlp	23889761	SENT187	19	19	17	17	capsaicin	TRPV1	PA448776	7442	0.707
NULL	Endocrinology_2014_Oct_22_155(10)_3732-3738.nxml.txt.nlp	25051442	SENT68	2	2	17	17	sibutramine	POMC	PA451344	5443	0.707
NULL	Mol_Cancer_2010_Dec_20_9_317.nxml.txt.nlp	21172025	SENT102	27	27	18	18	tamoxifen	HER2	PA451581	2064	0.707
NULL	J_Cardiothorac_Surg_2011_Apr_8_6_44.nxml.txt.nlp	21477293	SENT82	3	3	5	5	heparin	PF4	PA449855	5196	0.707
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT166	6	6	30	30	atorvastatin	ERK	PA448500	5594	0.707
NULL	J_Radiat_Res_2014_Mar_1_55(2)_359-363.nxml.txt.nlp	24187329	SENT43	40	40	0	0	vincristine	CHOP	PA451879	1649	0.707
NULL	Oncol_Rep_2014_Jul_15_32(1)_45-49.nxml.txt.nlp	24841138	SENT124	12	12	29	29	pp2	MT1-MMP		4323	0.707
NULL	Breast_Cancer_Res_2011_May_20_13(3)_106.nxml.txt.nlp	21639949	SENT29	6	6	16	16	fulvestrant	HRG	PA164747170	3084;3273	0.707
NULL	Trials_2014_Oct_7_15(1)_391.nxml.txt.nlp	NULL	SENT200	34	34	39	39	varenicline	ANOVA	PA164781343	4858	0.707
NULL	Adolesc_Health_Med_Ther_2011_Sep_14_2_85-93.nxml.txt.nlp	24600277	SENT135	22	22	27	27	etravirine	DUET	PA166014703	8997	0.707
NULL	Br_J_Cancer_2006_Feb_13_94(3)_407-426.nxml.txt.nlp	16434996	SENT313	16	16	12	12	genistein	BRCA1	PA165109660	672	0.707
NULL	Int_J_Impot_Res_2010_Mar_26_22(2)_120-126.nxml.txt.nlp	19940852	SENT37	6	6	3	3	phenylephrine	mol	PA450935	90527	0.707
NULL	Arthritis_Res_Ther_2014_Jan_15_16(1)_R10.nxml.txt.nlp	24423138	SENT19	8	8	0	0	collagenase	TRPV1	PA449107	7442	0.707
NULL	Cancers_(Basel)_2010_Jan_14_2(1)_1-19.nxml.txt.nlp	24281029	SENT1081	16	16	32	32	paclitaxel	San	PA450761	80218	0.707
NULL	Environ_Health_Perspect_2006_Sep_23_114(9)_1401-1406.nxml.txt.nlp	16966095	SENT193	35	35	15	15	arsenite	p53	PA452638	7157	0.707
NULL	Indian_J_Endocrinol_Metab_2011_Jan-Mar_15(1)_9-17.nxml.txt.nlp	21584160	SENT59	3	3	1	1	liraglutide	GLP-1	PA165958364	100125288	0.707
NULL	J_Hematol_Oncol_2011_Jan_21_4_5.nxml.txt.nlp	21255411	SENT229	15	15	12	12	paclitaxel	EGFR	PA450761	1956	0.707
NULL	Clin_Ophthalmol_2009_Jun_2_3_199-210.nxml.txt.nlp	19668566	SENT83	3	3	0	0	bromfenac	COX	PA448670	1351	0.707
NULL	J_Int_Soc_Sports_Nutr_2013_Aug_22_10_39.nxml.txt.nlp	23967897	SENT42	10	10	21	21	betaine	Met	PA448603	79811	0.707
NULL	Arthritis_Res_Ther_2008_Oct_15_10(Suppl_1)_S4.nxml.txt.nlp	19007424	SENT34	36	36	33	33	abatacept	ACR	PA164747080	49	0.707
NULL	Arthritis_Res_Ther_2003_Sep_3_5(6)_R317-R328.nxml.txt.nlp	14680506	SENT152	0	0	4	4	rolipram	IL-10	PA153906323	3586	0.707
NULL	Curr_Med_Chem_2012_Aug_19(22)_3763-3778.nxml.txt.nlp	22680930	SENT70	27	27	11	11	celecoxib	5-LOX	PA448871	240	0.707
NULL	Oncotarget_2013_Feb_26_4(2)_298-309.nxml.txt.nlp	23593653	SENT151	15	15	20	20	mitomycin	DNMT1	PA450524	1786	0.707
NULL	Clin_Pharmacokinet_2014_Jul_24_53(1)_73-87.nxml.txt.nlp	23881596	SENT31	8	8	12	12	rosuvastatin	OATP1B3	PA134308647	28234	0.707
NULL	J_Immunother_Cancer_2014_Jan_27_2_2.nxml.txt.nlp	24829759	SENT164	18	18	16	16	sunitinib	IL-21	PA162372840	59067;50616;27189	0.707
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_55-78.nxml.txt.nlp	19305788	SENT199	9	9	17	17	memantine	TNF-alpha	PA10364	7124	0.707
NULL	Aging_(Albany_NY)_2009_Mar_28_1(3)_281-288.nxml.txt.nlp	20157517	SENT143	0	0	5	5	resveratrol	SIRT1		23411	0.707
NULL	Acta_Pharmacol_Sin_2009_Oct_21_30(10)_1392-1398.nxml.txt.nlp	19767766	SENT148	5	5	10	10	atorvastatin	ROS	PA448500	6098	0.707
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT379	16	16	12	12	olanzapine	PRL	PA450688	5617	0.707
NULL	Ann_Hematol_2011_Dec_9_90(12)_1391-1398.nxml.txt.nlp	21479535	SENT161	29	29	24	24	vincristine	CHOP	PA451879	1649	0.707
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Apr_30_65(Pt_5)_o1161.nxml.txt.nlp	21583964	SENT59	26	26	32	32	benzaldehyde	mol	PA448571	90527	0.707
NULL	J_Korean_Med_Sci_2006_Dec_31_21(6)_1037-1040.nxml.txt.nlp	17179683	SENT5	16	16	10	10	amoxicillin	BAM	PA448406	9126	0.707
NULL	Ther_Clin_Risk_Manag_2007_Jun_3(3)_449-459.nxml.txt.nlp	18488069	SENT196	7	7	14	14	zolmitriptan	RIZ	PA451975	7799	0.707
NULL	Arthritis_Res_Ther_2009_May_19_11(3)_225.nxml.txt.nlp	19490600	SENT239	32	32	34	34	alemtuzumab	CD52	PA164783958	1043	0.707
NULL	Breast_Cancer_Res_2007_Aug_8_9(4)_R50.nxml.txt.nlp	17686159	SENT256	33	33	17	17	gefitinib	HRG	PA131301952	3084;3273	0.707
NULL	Nat_Neurosci_2012_Sep_5_15(9)_1245-1254.nxml.txt.nlp	22864611	SENT500	3	3	25	25	clozapine	ANOVA	PA449061	4858	0.707
NULL	Oncoimmunology_2012_Nov_1_1(8)_1445-1447.nxml.txt.nlp	23243624	SENT45	33	33	17	17	bevacizumab	CD83	PA130232992	9308	0.707
NULL	Indian_J_Pharmacol_2008_Oct_40(Suppl_2)_S211-S221.nxml.txt.nlp	21593975	SENT564	15	15	33	33	curcumin	VIII	PA151958596	1351	0.707
NULL	Indian_J_Pharmacol_2014_Nov-Dec_46(6)_627-632.nxml.txt.nlp	25538335	SENT172	10	10	8	8	metformin	Q10	PA450395	27161	0.707
NULL	EMBO_Mol_Med_2014_Oct_17_6(10)_1294-1311.nxml.txt.nlp	25231413	SENT379	5	5	12	12	imiquimod	TLR9	PA449972	54106	0.707
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Feb_27_64(Pt_3)_o630.nxml.txt.nlp	21201961	SENT55	22	22	13	13	ethanol	mol	PA448073	90527	0.707
NULL	Front_Neurosci_2014_Jun_3_8_128.nxml.txt.nlp	24917782	SENT134	11	11	15	15	ethanol	MC3R	PA448073	4159	0.707
NULL	Int_J_Mol_Sci_2014_Mar_5_15(3)_3970-3988.nxml.txt.nlp	24603537	SENT30	15	15	2	2	curcumin	MCH	PA151958596	5367	0.707
NULL	Br_J_Cancer_2011_Sep_6_105(6)_778-786.nxml.txt.nlp	21847128	SENT203	14	14	16	16	zoledronate	IL-2	PA10235	3558	0.707
NULL	J_Cell_Mol_Med_2014_Apr_20_18(4)_709-720.nxml.txt.nlp	24444314	SENT11	2	2	8	8	losartan	AMPK	PA450268	5563	0.707
NULL	J_Adv_Pract_Oncol_2014_Mar_1_Mar-Apr_5(2)_134-139.nxml.txt.nlp	25032047	SENT42	5	5	20	20	trastuzumab	DM1	PA451743	338023;1760;28509	0.707
NULL	Environ_Health_Perspect_2013_Apr_5_121(4)_459-466.nxml.txt.nlp	23384675	SENT70	28	28	2	2	phenol	Gen	PA450913	348654	0.707
NULL	Int_J_Mol_Sci_2013_Aug_14_14(8)_16732-16801.nxml.txt.nlp	23949635	SENT1873	12	12	31	31	estradiol	StAR	PA449503	6770	0.707
NULL	Case_Rep_Oncol_Med_2012_Nov_6_2012_164082.nxml.txt.nlp	23198199	SENT79	14	14	7	7	rituximab	BAFF	PA451261	10673	0.707
NULL	Environ_Health_Perspect_2006_Sep_23_114(9)_1401-1406.nxml.txt.nlp	16966095	SENT27	12	12	9	9	arsenite	ID1	PA452638	3397	0.707
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Apr_8_65(Pt_5)_o963.nxml.txt.nlp	21584006	SENT60	13	13	22	22	ethanol	mol	PA448073	90527	0.707
NULL	Clin_Ophthalmol_2014_Mar_2_8_343-346.nxml.txt.nlp	24591809	SENT34	4	4	13	13	ranibizumab	PED	PA164746012	8682	0.707
NULL	Oncologist_2010_Apr_15(4)_372-381.nxml.txt.nlp	20413642	SENT181	3	3	6	6	cisplatin	EGFR	PA449014	1956	0.707
NULL	Front_Neurosci_2012_May_30_6_77.nxml.txt.nlp	22661925	SENT172	0	0	7	7	ethanol	DCX	PA448073	1641	0.707
NULL	Rare_Tumors_2009_Dec_28_1(2)_e53.nxml.txt.nlp	21139932	SENT10	15	15	21	21	temsirolimus	TFE3	PA164746890	7030	0.707
NULL	Oncotarget_2014_Jun_7_5(14)_5257-5271.nxml.txt.nlp	24913448	SENT48	36	36	10	10	ponatinib	LASP1	PA165980594	3927	0.707
NULL	Br_J_Cancer_2013_Jul_23_109(2)_351-359.nxml.txt.nlp	23799854	SENT108	7	7	13	13	paclitaxel	BLT2	PA450761	56413	0.707
NULL	Br_J_Cancer_2010_Jan_5_102(1)_80-86.nxml.txt.nlp	19920817	SENT108	14	14	10	10	bevacizumab	IFN	PA130232992	3439	0.707
NULL	J_Cell_Mol_Med_2014_Dec_7_18(12)_2536-2552.nxml.txt.nlp	25287328	SENT279	45	45	28	28	tamoxifen	PKD1	PA451581	5310	0.707
NULL	Arch_Drug_Inf_2009_Sep_2(3)_41-50.nxml.txt.nlp	19915711	SENT72	17	17	12	12	atenolol	FGFBP2	PA448499	83888	0.707
NULL	Biochem_Res_Int_2012_Mar_4_2012_685267.nxml.txt.nlp	22496978	SENT7	21	21	29	29	thrombin	HSPC	PA451674	5688	0.707
NULL	Br_J_Cancer_2010_Oct_26_103(9)_1380-1390.nxml.txt.nlp	20877355	SENT223	17	17	23	23	etoposide	TRAIL	PA449552	8743	0.707
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Nov_4_9_31.nxml.txt.nlp	21050425	SENT90	43	43	32	32	chloramphenicol	Gen	PA448927	348654	0.707
NULL	J_Cancer_Prev_2013_Jun_18(2)_186-191.nxml.txt.nlp	25337545	SENT139	3	3	11	11	curcumin	STAT3	PA151958596	6774	0.707
NULL	Biologics_2009_Sep_15_3_419-428.nxml.txt.nlp	19774209	SENT145	9	9	6	6	gefitinib	IGF1R	PA131301952	3480	0.707
NULL	Br_J_Cancer_2013_Jan_15_108(1)_82-90.nxml.txt.nlp	23321512	SENT167	24	24	0	0	paclitaxel	TUBB	PA450761	203068	0.707
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT192	10	10	46	46	lapatinib	Yes	PA152241907	7525	0.707
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Jul_26_64(Pt_8)_o1594-o1595.nxml.txt.nlp	21203289	SENT71	28	28	14	14	ethanol	mol	PA448073	90527	0.707
NULL	Evid_Based_Complement_Alternat_Med_2013_Aug_12_2013_982689.nxml.txt.nlp	23997806	SENT247	11	11	22	22	tolbutamide	APE	PA451718	55704;328	0.707
NULL	Cell_Commun_Signal_2011_May_15_9_13.nxml.txt.nlp	21569639	SENT233	7	7	9	9	quinacrine	P-gp	PA164745551	5243	0.707
NULL	J_Asthma_Allergy_2013_Feb_22_6_31-39.nxml.txt.nlp	23459334	SENT117	14	14	29	29	desloratadine	ANOVA	PA164776964	4858	0.707
NULL	Int_J_Mol_Sci_2014_Sep_22_15(9)_16848-16884.nxml.txt.nlp	25247581	SENT301	4	4	7	7	resveratrol	SIRT1		23411	0.707
NULL	Br_J_Cancer_2009_Jan_27_100(2)_251-258.nxml.txt.nlp	19165196	SENT20	46	46	15	15	cetuximab	ACRC	PA10040	93953	0.707
NULL	Curr_Genomics_2014_Jun_15(3)_217-230.nxml.txt.nlp	24955029	SENT188	28	28	6	6	oxygen	ROS	PA450744	6098	0.707
NULL	CNS_Drugs_2013_May_27_27(5)_335-343.nxml.txt.nlp	23533009	SENT26	4	4	6	6	vasopressin	AVP	PA451858	114548;551	0.707
NULL	Adv_Hematol_2011_Apr_10_2011_960137.nxml.txt.nlp	21547266	SENT88	4	4	22	22	cyclophosphamide	NHL	PA449165	51750	0.707
NULL	Br_J_Cancer_2003_Mar_24_88(6)_863-870.nxml.txt.nlp	12644823	SENT167	39	39	8	8	tamoxifen	maspin	PA451581	5268	0.707
NULL	Br_J_Cancer_2012_Apr_24_106(9)_1543-1550.nxml.txt.nlp	22531721	SENT89	13	13	28	28	trastuzumab	CD46	PA451743	4179	0.707
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT100	6	6	34	34	pertuzumab	p85		5296;5295;54776;23368	0.707
NULL	Br_J_Cancer_2009_Mar_10_100(5)_758-763.nxml.txt.nlp	19259094	SENT102	1	1	9	9	belinostat	MLH1		4292	0.707
NULL	Diabetes_Metab_J_2014_Apr_18_38(2)_100-106.nxml.txt.nlp	24851203	SENT115	4	4	0	0	acetone	MET	PA448025	4233	0.707
NULL	AIDS_Res_Ther_2008_Mar_28_5_5.nxml.txt.nlp	18373851	SENT15	30	30	10	10	ritonavir	ATV	PA451260	4683	0.707
NULL	Environ_Health_Perspect_2012_Aug_27_120(8)_1088-1093.nxml.txt.nlp	22543081	SENT103	1	1	12	12	dobutamine	ANOVA	PA449381	4858	0.707
NULL	J_Geriatr_Cardiol_2013_Mar_10(1)_21-27.nxml.txt.nlp	23610570	SENT75	12	12	30	30	fluorescein	CD61	PA164746009	3690	0.707
NULL	Carcinogenesis_2008_Sep_9_29(9)_1734-1741.nxml.txt.nlp	18544564	SENT15	4	4	23	23	bortezomib	c-Myc	PA10252	4609	0.707
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jan_31_68(Pt_2)_o541.nxml.txt.nlp	22347135	SENT66	12	12	6	6	ethanol	mol	PA448073	90527	0.707
NULL	Oncogene_2010_Nov_18_29(46)_6160-6171.nxml.txt.nlp	20729916	SENT234	19	19	12	12	cisplatin	YAP	PA449014	55249	0.707
NULL	Patient_Prefer_Adherence_2011_Dec_23_6_1-9.nxml.txt.nlp	22272064	SENT1	39	39	24	24	ramipril	ACE	PA451223	1636	0.707
NULL	Int_J_Health_Geogr_2012_Dec_14_11_53.nxml.txt.nlp	23241450	SENT158	26	26	5	5	oseltamivir	spatial	PA450721	219793	0.707
NULL	Neural_Regen_Res_2013_Jul_15_8(20)_1853-1862.nxml.txt.nlp	25206494	SENT15	8	8	14	14	ethanol	c-Jun	PA448073	3725	0.707
NULL	Front_Oncol_2013_Apr_2_3_68.nxml.txt.nlp	23565504	SENT316	2	2	15	15	rituximab	CD19	PA451261	930	0.707
NULL	Cancer_Immunol_Immunother_2011_Jun_25_60(6)_793-808.nxml.txt.nlp	21350947	SENT206	10	10	7	7	sorafenib	IFN	PA7000	3439	0.707
NULL	Diabetes_Care_2013_May_13_36(5)_1074-1082.nxml.txt.nlp	23275352	SENT37	15	15	18	18	liraglutide	ZAG	PA165958364	563	0.707
NULL	Evid_Based_Complement_Alternat_Med_2015_Jan_6_2015_736431.nxml.txt.nlp	25632290	SENT62	7	7	35	35	ritonavir	CYP3A4	PA451260	1576	0.707
NULL	Crit_Care_2000_Mar_21_4(Suppl_1)_P28.nxml.txt.nlp	NULL	SENT10	32	32	48	48	thrombin	IL-6	PA451674	3569	0.707
NULL	Biomed_Res_Int_2014_May_20_2014_658753.nxml.txt.nlp	24967390	SENT99	2	2	4	4	riluzole	GDNF	PA451251	2668	0.707
NULL	Osteoporos_Int_2012_Feb_4_23(Suppl_1)_S1-S23.nxml.txt.nlp	22311111	SENT469	6	6	2	2	teriparatide	PTH	PA451620	5741	0.707
NULL	Int_J_Biol_Sci_2012_Oct_24_8(9)_1227-1236.nxml.txt.nlp	23136551	SENT90	6	6	8	8	tocilizumab	IL-6	PA165292659	3569	0.707
NULL	Oncotarget_2011_Aug_23_2(8)_599-609.nxml.txt.nlp	21865609	SENT73	4	4	10	10	cetuximab	EGFR	PA10040	1956	0.707
NULL	Indian_J_Anaesth_2011_Jul-Aug_55(4)_340-346.nxml.txt.nlp	22013248	SENT150	19	19	8	8	dexmedetomidine	CO2	PA449256	4513	0.707
NULL	Arthritis_Res_Ther_2012_May_1_14(3)_R99.nxml.txt.nlp	22546542	SENT68	13	13	10	10	fluorescein	IL-17	PA164746009	3605	0.707
NULL	Cell_Death_Dis_2014_Apr_17_5(4)_e1180.nxml.txt.nlp	24743735	SENT225	8	8	26	26	paraformaldehyde	San	PA450790	80218	0.707
NULL	Clin_Sci_(Lond)_2009_Nov_23_118(Pt_5)_315-332.nxml.txt.nlp	19922415	SENT962	4	4	6	6	metformin	HER2	PA450395	2064	0.707
NULL	Curr_Neuropharmacol_2014_Jul_12(4)_365-379.nxml.txt.nlp	25342944	SENT265	6	6	12	12	fluoxetine	5-HT1A	PA449673	3350	0.707
NULL	Eur_J_Neurosci_2014_Feb_4_39(3)_363-374.nxml.txt.nlp	24494677	SENT379	16	16	8	8	capsaicin	GDNF	PA448776	2668	0.707
NULL	Br_J_Cancer_2011_Jan_4_104(1)_91-100.nxml.txt.nlp	21139584	SENT133	35	35	17	17	geldanamycin	Hsp90	PA152031327	3320	0.707
NULL	Nat_Med_2011_Oct_2_17(10)_1304-1309.nxml.txt.nlp	21963515	SENT205	8	8	10	10	tacrolimus	WNK3	PA451578	65267	0.707
NULL	F1000_Med_Rep_2011_Mar_1_3_6.nxml.txt.nlp	21654927	SENT115	20	20	22	22	vancomycin	VAN	PA451850	10318	0.706
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT167	10	10	13	13	perifosine	DR5	PA165291471	8795	0.706
NULL	Autophagy_2012_May_1_8(5)_853-855.nxml.txt.nlp	22617440	SENT67	16	16	10	10	imatinib	CD34	PA10804	947	0.706
NULL	Crit_Care_2011_Oct_26_15(5)_R257.nxml.txt.nlp	22030215	SENT134	11	11	20	20	dexmedetomidine	SAPS	PA449256	8935	0.706
NULL	Braz_J_Med_Biol_Res_2012_Jul_20_45(10)_935-941.nxml.txt.nlp	22801415	SENT3	25	25	33	33	pioglitazone	adiponectin	PA450970	9370	0.706
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_6_2012_570948.nxml.txt.nlp	23193424	SENT154	12	12	23	23	fenofibrate	ACC1	PA449594	31	0.706
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT116	5	5	2	2	trastuzumab	STAT3	PA451743	6774	0.706
NULL	Exp_Ther_Med_2014_Apr_21_7(4)_855-859.nxml.txt.nlp	24669240	SENT82	8	8	12	12	pemetrexed	EGFR	PA10810	1956	0.706
NULL	Mediators_Inflamm_1999_8(6)_277-286.nxml.txt.nlp	10815616	SENT0	22	22	12	12	cladribine	IL-6	PA449027	3569	0.706
NULL	J_Cancer_2013_Aug_28_4(7)_585-596.nxml.txt.nlp	24069069	SENT156	20	20	6	6	verteporfin	p62	PA451871	8878;10657;23636	0.706
NULL	Indian_J_Pharmacol_2014_Nov-Dec_46(6)_627-632.nxml.txt.nlp	25538335	SENT7	19	19	17	17	metformin	Q10	PA450395	27161	0.706
NULL	Br_J_Cancer_2010_Jun_29_103(1)_61-72.nxml.txt.nlp	20588279	SENT194	2	2	14	14	trastuzumab	RhoB	PA451743	388	0.706
NULL	Biomed_Eng_Online_2012_Nov_14_11_84.nxml.txt.nlp	23151049	SENT182	21	21	26	26	alendronate	PTH	PA448082	5741	0.706
NULL	Br_J_Cancer_1998_Sep_78(6)_745-751.nxml.txt.nlp	9743293	SENT6	28	28	15	15	camptothecin	p53	PA153590860	7157	0.706
NULL	Crit_Care_2011_Jun_24_15(3)_R153.nxml.txt.nlp	21702944	SENT250	0	0	14	14	dexmedetomidine	HMGB1	PA449256	3146	0.706
NULL	Mycopathologia_2013_Apr_2_175(3-4)_249-254.nxml.txt.nlp	23546772	SENT14	7	7	16	16	sertaconazole	DDC	PA164748328	1644	0.706
NULL	Acta_Naturae_2013_Oct-Dec_5(4)_83-93.nxml.txt.nlp	24455187	SENT143	8	8	21	21	tamoxifen	7SL	PA451581	6029	0.706
NULL	Indian_J_Nephrol_2008_Jan_18(1)_26-27.nxml.txt.nlp	20368918	SENT55	24	24	30	30	potassium	CO2	PA451047	4513	0.706
NULL	Front_Neurosci_2012_May_30_6_77.nxml.txt.nlp	22661925	SENT197	4	4	12	12	ethanol	HEC	PA448073	10403	0.706
NULL	Clin_Med_Insights_Oncol_2012_Jul_30_6_275-286.nxml.txt.nlp	22904648	SENT209	4	4	9	9	dacarbazine	IL-2	PA449197	3558	0.706
NULL	Acta_Pharmacol_Sin_2009_Feb_5_30(2)_228-234.nxml.txt.nlp	19122672	SENT96	20	20	11	11	isoflurane	HO-1	PA450106	3162	0.706
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT110	26	26	1	1	glucose	PP2	PA449773	4888	0.706
NULL	Oncogene_2014_Aug_28_33(35)_4396-4406.nxml.txt.nlp	24531714	SENT58	29	29	19	19	nutlin-3	p53		7157	0.706
NULL	Oncol_Lett_2014_Mar_16_7(3)_827-833.nxml.txt.nlp	24527090	SENT33	24	24	21	21	cisplatin	IFN	PA449014	3439	0.706
NULL	Comput_Struct_Biotechnol_J_2012_Oct_30_3_e201210004.nxml.txt.nlp	24688664	SENT213	21	21	8	8	l-valine	AHAS	PA451843	10994	0.706
NULL	J_Korean_Med_Sci_2010_Feb_19_25(2)_304-308.nxml.txt.nlp	20119588	SENT39	23	23	17	17	moxifloxacin	EMB	PA450555	133418	0.706
NULL	Oncotarget_2012_May_19_3(5)_535-545.nxml.txt.nlp	22619121	SENT92	7	7	9	9	topotecan	TPT	PA451729	23590;6469	0.706
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1150.nxml.txt.nlp	24675468	SENT103	8	8	31	31	ethanol	adiponectin	PA448073	9370	0.706
NULL	Breast_Cancer_Res_2007_Dec_18_9(6)_216.nxml.txt.nlp	18190723	SENT6	6	6	13	13	bevacizumab	San	PA130232992	80218	0.706
NULL	Acta_Pharmacol_Sin_2011_Oct_15_32(10)_1233-1238.nxml.txt.nlp	21841815	SENT24	2	2	20	20	naloxone	CTX	PA450586	1593	0.706
NULL	Br_J_Cancer_1998_Nov_78(9)_1170-1174.nxml.txt.nlp	9820175	SENT13	24	24	31	31	coumarin	CYP2E1	PA134521193	1571	0.706
NULL	AIDS_Res_Ther_2013_May_1_10_10.nxml.txt.nlp	23634877	SENT149	23	23	27	27	lovastatin	ANOVA	PA450272	4858	0.706
NULL	Front_Behav_Neurosci_2012_Jun_13_6_24.nxml.txt.nlp	22707936	SENT326	8	8	28	28	scopolamine	spatial	PA451308	219793	0.706
NULL	Int_J_Mol_Sci_2014_Mar_24_15(3)_5128-5139.nxml.txt.nlp	24663084	SENT454	2	2	7	7	coumarin	BACE1	PA134521193	23621	0.706
NULL	Nat_Commun_2012_Jan_10_3_614.nxml.txt.nlp	22233624	SENT120	42	42	8	8	ethanol	mol	PA448073	90527	0.706
NULL	FEBS_Open_Bio_2012_Jul_20_2_179-186.nxml.txt.nlp	23650597	SENT46	13	13	29	29	imiquimod	IFN	PA449972	3439	0.706
NULL	Trials_2012_Dec_13_13_239.nxml.txt.nlp	23237631	SENT34	26	26	32	32	amiodarone	CYP2C9	PA448383	1559	0.706
NULL	J_Vet_Med_Sci_2014_Feb_8_76(2)_173-182.nxml.txt.nlp	24107430	SENT214	13	13	5	5	yohimbine	AVP	PA451946	114548;551	0.706
NULL	J_Cell_Mol_Med_2015_Jan_9_19(1)_165-174.nxml.txt.nlp	25297851	SENT63	41	41	17	17	collagenase	CO2	PA449107	4513	0.706
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT95	9	9	14	14	etravirine	CYP3A4	PA166014703	1576	0.706
NULL	J_Cell_Biol_1999_Feb_8_144(3)_459-471.nxml.txt.nlp	9971741	SENT123	14	14	35	35	tetracycline	PAM-1	PA451640	50848	0.706
NULL	J_Cardiothorac_Surg_2014_Sep_17_9(1)_129.nxml.txt.nlp	NULL	SENT79	9	9	2	2	protamine	ACT	PA10366	12;11332;9457;641455	0.706
NULL	Pharmaceutics_2011_Jul_13_3(3)_425-439.nxml.txt.nlp	24310588	SENT122	5	5	8	8	diazepam	SERS	PA449283	6301;54938	0.706
NULL	Ann_Surg_Treat_Res_2014_Feb_22_86(2)_68-75.nxml.txt.nlp	24761411	SENT173	9	9	20	20	oxaliplatin	survivin	PA131285527	332	0.706
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT15	5	5	11	11	cisplatin	p53	PA449014	7157	0.706
NULL	Mar_Drugs_2009_Jul_17_7(3)_331-340.nxml.txt.nlp	19841717	SENT62	20	20	4	4	trabectedin	FDG	PA165958349	23583	0.706
NULL	Indian_J_Endocrinol_Metab_2012_Dec_16(Suppl_2)_S242-S244.nxml.txt.nlp	23565389	SENT63	21	21	34	34	vildagliptin	RAGE	PA165958346	177	0.706
NULL	Acta_Pharmacol_Sin_2013_Jan_17_34(1)_157-166.nxml.txt.nlp	23247593	SENT142	36	36	41	41	berberine	Set9	PA165860812	80854	0.706
NULL	J_Mol_Med_2009_Jul_30_87(7)_713-722.nxml.txt.nlp	19404587	SENT35	6	6	10	10	ribavirin	IFN	PA451241	3439	0.706
NULL	Structure_2012_May_9_20-540(5-7)_841-849.nxml.txt.nlp	22579251	SENT232	5	5	10	10	carvedilol	EGFR	PA448817	1956	0.706
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT320	11	11	13	13	risperidone	PRL	PA451257	5617	0.706
NULL	Blood_Cancer_J_2013_Mar_1_3(3)_e103.nxml.txt.nlp	23454896	SENT88	10	10	20	20	nelfinavir	p27	PA450606	5715;10534	0.706
NULL	Cancer_Microenviron_2009_Sep_26_2(Suppl_1)_19-204.nxml.txt.nlp	NULL	SENT2559	12	12	16	16	tamoxifen	ENL	PA451581	4298	0.706
NULL	Biochem_Res_Int_2012_Aug_23_2012_135723.nxml.txt.nlp	21904679	SENT245	24	24	33	33	lipase	DAG	PA450239	1605	0.706
NULL	Front_Neurol_2013_Nov_6_4_176.nxml.txt.nlp	24223570	SENT11	11	11	27	27	carbachol	PPN	PA448784	64840	0.706
NULL	Case_Rep_Med_2010_Dec_26_2010_403237.nxml.txt.nlp	21209804	SENT56	21	21	26	26	bortezomib	CHOP	PA10252	1649	0.706
NULL	J_Cell_Biol_1998_Jun_15_141(6)_1323-1333.nxml.txt.nlp	9628889	SENT67	19	19	16	16	pyrimethamine	DHFR	PA451193	1719	0.706
NULL	J_Korean_Med_Sci_2013_Apr_27_28(4)_527-533.nxml.txt.nlp	23580227	SENT167	4	4	7	7	genistein	TRAIL	PA165109660	8743	0.706
NULL	Front_Oncol_2014_Sep_29_4_262.nxml.txt.nlp	25325014	SENT531	18	18	21	21	metformin	FOXO3	PA450395	2309	0.706
NULL	Clin_Transl_Allergy_2013_Sep_2_3_29.nxml.txt.nlp	24004581	SENT95	2	2	10	10	omalizumab	IL-4	PA164752253	3565	0.706
NULL	Cancer_Metab_2014_Nov_3_2(1)_20.nxml.txt.nlp	NULL	SENT210	6	6	2	2	erlotinib	PDK4	PA134687924	5166	0.706
NULL	Cancer_Med_2014_Aug_16_3(4)_927-938.nxml.txt.nlp	24740968	SENT255	5	5	8	8	rituximab	CHOP	PA451261	1649	0.706
NULL	J_Gastroenterol_2013_Jan_28_48(1)_1-12.nxml.txt.nlp	23188091	SENT232	30	30	14	14	ribavirin	RVR	PA451241	9975	0.706
NULL	Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.nxml.txt.nlp	24736980	SENT234	15	15	11	11	rosuvastatin	OATP1B1	PA134308647	10599	0.706
NULL	Int_J_Lab_Hematol_2014_Aug_14_36(4)_431-438.nxml.txt.nlp	24237750	SENT81	4	4	15	15	clopidogrel	ADP	PA449053	23038	0.706
NULL	Br_J_Cancer_2010_Jan_19_102(2)_383-391.nxml.txt.nlp	20010943	SENT182	29	29	16	16	cisplatin	mol	PA449014	90527	0.706
NULL	J_Biol_Eng_2014_Nov_19_8(1)_26.nxml.txt.nlp	NULL	SENT47	35	35	0	0	tetracycline	p27	PA451640	5715;10534	0.706
NULL	Curr_Gerontol_Geriatr_Res_2012_Mar_4_2012_361218.nxml.txt.nlp	22474448	SENT20	30	30	3	3	estradiol	HSD17B1	PA449503	3292	0.706
NULL	Arthritis_Res_Ther_2006_Dec_28_8(1)_R18.nxml.txt.nlp	16507118	SENT9	1	1	7	7	infliximab	IL-15	PA452639	3600	0.706
NULL	J_Invest_Dermatol_2015_Feb_9_135(2)_389-399.nxml.txt.nlp	25184961	SENT269	2	2	17	17	rosiglitazone	SOCS3	PA451283	9021	0.706
NULL	Reprod_Biol_Endocrinol_2003_Aug_27_1_59.nxml.txt.nlp	12967350	SENT143	20	20	10	10	estradiol	XIAP	PA449503	331	0.706
NULL	Hum_Genomics_2010_Oct_1_5(1)_61-72.nxml.txt.nlp	21106490	SENT155	22	22	19	19	atorvastatin	CYP3A	PA448500	1574	0.706
NULL	Reprod_Biol_Endocrinol_2003_Aug_27_1_59.nxml.txt.nlp	12967350	SENT140	10	10	13	13	estradiol	XIAP	PA449503	331	0.706
NULL	J_Mol_Signal_2013_Jan_26_8_1.nxml.txt.nlp	23351368	SENT87	0	0	11	11	estradiol	TRAF6	PA449503	7189	0.706
NULL	J_Exp_Clin_Cancer_Res_2010_Apr_27_29(1)_38.nxml.txt.nlp	20423465	SENT5	24	24	44	44	carboplatin	B12	PA448803	7126;4709	0.706
NULL	J_Biol_Chem_2013_Dec_6_288(49)_35592-35603.nxml.txt.nlp	24165129	SENT609	4	4	13	13	resveratrol	EGF		1950	0.706
NULL	Breast_Cancer_Res_2005_Mar_4_7(3)_R345-R352.nxml.txt.nlp	15987429	SENT221	31	31	17	17	indomethacin	CARB	PA449982	9482	0.706
NULL	Arthritis_Res_Ther_2010_Apr_9_12(2)_R65.nxml.txt.nlp	20380722	SENT85	20	20	37	37	imatinib	IL8	PA10804	3576	0.706
NULL	Mol_Clin_Oncol_2013_Sep_18_1(5)_839-844.nxml.txt.nlp	24649257	SENT134	16	16	25	25	cyclophosphamide	NAC	PA449165	22861	0.706
NULL	J_Lipid_Res_2015_Jan_56(1)_109-121.nxml.txt.nlp	25421061	SENT358	26	26	23	23	lipase	CGI-58	PA450239	51099	0.706
NULL	BMB_Rep_2014_Apr_47(4)_221-226.nxml.txt.nlp	24286312	SENT121	7	7	11	11	nutlin-3	p53		7157	0.706
NULL	Br_J_Cancer_2013_Dec_10_109(12)_2954-2958.nxml.txt.nlp	24231949	SENT73	14	14	7	7	nutlin-3	p53		7157	0.706
NULL	Oncotarget_2012_May_18_3(5)_525-534.nxml.txt.nlp	22619113	SENT44	5	5	18	18	fludarabine	CD40L	PA449655	959	0.706
NULL	Antimicrob_Resist_Infect_Control_2012_May_30_1_21.nxml.txt.nlp	22958440	SENT192	15	15	0	0	ciprofloxacin	TC1	PA449009	6947	0.706
NULL	Exp_Mol_Med_2012_Sep_30_44(9)_562-570.nxml.txt.nlp	22809900	SENT56	19	19	21	21	rosiglitazone	adiponectin	PA451283	9370	0.706
NULL	J_Cell_Biol_2002_Jun_24_157(7)_1151-1160.nxml.txt.nlp	12082077	SENT161	26	26	19	19	trypsin	COX	PA451806	1351	0.706
NULL	Pharmaceuticals_(Basel)_2011_Oct_25_4(11)_1400-1422.nxml.txt.nlp	NULL	SENT220	14	14	19	19	oxaliplatin	TRAP1	PA131285527	9392;10131	0.706
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT110	17	17	24	24	curcumin	XIAP	PA151958596	331	0.706
NULL	J_Gastrointest_Cancer_2013_Aug_7_44(4)_385-392.nxml.txt.nlp	23921604	SENT103	8	8	4	4	imatinib	CML	PA10804	613	0.706
NULL	Ann_Hematol_2010_Mar_2_89(3)_283-289.nxml.txt.nlp	19727725	SENT123	19	19	3	3	rituximab	CHOP	PA451261	1649	0.706
NULL	Curr_Heart_Fail_Rep_2012_Sep_6_9(3)_183-191.nxml.txt.nlp	22767404	SENT73	2	2	6	6	ranolazine	NCX	PA164746007	3196	0.706
NULL	J_Exp_Med_2003_Aug_4_198(3)_379-389.nxml.txt.nlp	12885873	SENT333	17	17	2	2	l-arginine	gamma	PA448478	9913	0.706
NULL	Aging_(Albany_NY)_2014_May_17_6(5)_369-379.nxml.txt.nlp	24860943	SENT8	17	17	4	4	l-arginine	S6K1	PA448478	6198	0.706
NULL	J_Bras_Pneumol_2014_May-Jun_40(3)_238-243.nxml.txt.nlp	25029646	SENT66	9	9	16	16	methylprednisolone	LPO	PA450466	4025	0.706
NULL	N_Am_J_Med_Sci_2013_Nov_5(11)_666-668.nxml.txt.nlp	24404547	SENT69	37	37	32	32	hyaluronan	CD31	PA165958431	5175	0.706
NULL	Indian_J_Dermatol_2011_Mar-Apr_56(2)_137-144.nxml.txt.nlp	21716938	SENT113	21	21	24	24	abacavir	HLA-B	PA448004	3106	0.706
NULL	Int_J_Surg_Oncol_2012_Jun_12_2012_862879.nxml.txt.nlp	22778941	SENT100	18	18	12	12	cisplatin	c-Myc	PA449014	4609	0.706
NULL	Indian_J_Pharm_Sci_2008_Nov-Dec_70(6)_745-753.nxml.txt.nlp	21369435	SENT179	14	14	16	16	ketoprofen	F10	PA450149	2159	0.706
NULL	Virchows_Arch_2006_Sep_25_449(3)_281-287.nxml.txt.nlp	16865406	SENT2	15	15	25	25	cetuximab	EGFR	PA10040	1956	0.706
NULL	Clin_Exp_Metastasis_2013_Jul_27_30(8)_1063-1071.nxml.txt.nlp	23892415	SENT211	10	10	15	15	erlotinib	EGFR	PA134687924	1956	0.706
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT192	10	10	37	37	lapatinib	Yes	PA152241907	7525	0.706
NULL	FEBS_J_2012_May_279(10)_1857-1870.nxml.txt.nlp	22420714	SENT9	22	22	10	10	capsaicin	TRPV1	PA448776	7442	0.706
NULL	Diabetes_Care_2009_Sep_32(9)_1748-1750.nxml.txt.nlp	19717820	SENT71	24	24	31	31	metformin	AMPK	PA450395	5563	0.706
NULL	Br_J_Cancer_2004_Mar_22_90(6)_1285-1292.nxml.txt.nlp	15026814	SENT144	14	14	21	21	doxorubicin	p53	PA449412	7157	0.706
NULL	Diagn_Pathol_2013_Jul_31_8_123.nxml.txt.nlp	23902646	SENT206	30	30	12	12	cyanocobalamin	B12	PA451892	7126;4709	0.706
NULL	Environ_Health_2013_Jan_28_12_11.nxml.txt.nlp	23356966	SENT147	3	3	13	13	salbutamol	LHA	PA448068	1081	0.706
NULL	Drugs_R_D_2014_Sep_31_14(3)_177-184.nxml.txt.nlp	25079671	SENT172	9	9	25	25	acarbose	MCP-1	PA448010	6347	0.706
NULL	Diabetes_Metab_Syndr_Obes_2013_Sep_2_6_317-325.nxml.txt.nlp	24039439	SENT50	7	7	18	18	mitiglinide	GLP-1	PA164748124	100125288	0.706
NULL	Osteoarthritis_Cartilage_2010_Apr_18(4)_555-562.nxml.txt.nlp	20060953	SENT142	7	7	13	13	clenbuterol	MNX	PA164745640	3892	0.706
NULL	Korean_Circ_J_2013_Jun_30_43(6)_400-407.nxml.txt.nlp	23882289	SENT151	2	2	7	7	doxorubicin	survivin	PA449412	332	0.706
NULL	Croat_Med_J_2014_Jun_55(3)_206-217.nxml.txt.nlp	24891279	SENT82	11	11	34	34	doxorubicin	p53	PA449412	7157	0.706
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT144	6	6	12	12	atorvastatin	KRAS	PA448500	3845	0.706
NULL	J_Bras_Pneumol_2014_Mar-Apr_40(2)_188-192.nxml.txt.nlp	24831405	SENT3	20	20	25	25	ethambutol	IFN	PA164784021	3439	0.706
NULL	Int_Semin_Surg_Oncol_2008_Apr_28_5_9.nxml.txt.nlp	18442393	SENT86	17	17	13	13	tamoxifen	HER2	PA451581	2064	0.706
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Sep_19_65(Pt_10)_o2502.nxml.txt.nlp	21577951	SENT63	12	12	15	15	benzaldehyde	mol	PA448571	90527	0.706
NULL	Br_J_Cancer_2000_Sep_17_83(6)_707-714.nxml.txt.nlp	10952772	SENT1	13	13	15	15	vinorelbine	Gem	PA451881	51053	0.706
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_May_5_68(Pt_6)_m731.nxml.txt.nlp	22719295	SENT5	11	11	2	2	ethanol	mol	PA448073	90527	0.706
NULL	Ann_Rheum_Dis_2008_Nov_14_67(11)_1516-1523.nxml.txt.nlp	18625622	SENT160	28	28	14	14	tocilizumab	TNF	PA165292659	7124	0.706
NULL	J_Biol_Chem_2010_Aug_20_285(34)_25928-25940.nxml.txt.nlp	20547488	SENT145	20	20	10	10	cisplatin	JNK	PA449014	5599	0.706
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT277	6	6	20	20	atorvastatin	PTEN	PA448500	5728	0.706
NULL	Curr_Neuropharmacol_2013_Dec_11(6)_641-651.nxml.txt.nlp	24396339	SENT185	17	17	3	3	capsaicin	TRPV1	PA448776	7442	0.706
NULL	J_Cell_Mol_Med_2013_Sep_11_17(9)_1160-1172.nxml.txt.nlp	23844832	SENT177	19	19	17	17	gefitinib	EGF	PA131301952	1950	0.706
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT276	12	12	18	18	resveratrol	TRAIL		8743	0.706
NULL	Diabetes_Care_2013_Aug_17_36(Suppl_2)_S127-S138.nxml.txt.nlp	23882037	SENT476	18	18	34	34	liraglutide	Met	PA165958364	79811	0.706
NULL	Front_Plant_Sci_2012_Jun_6_3_107.nxml.txt.nlp	22685446	SENT424	9	9	1	1	sugar	spatial	PA451529	219793	0.706
NULL	Br_J_Haematol_2014_Mar_13_164(1)_811-821.nxml.txt.nlp	24328678	SENT128	0	0	4	4	lenalidomide	Aiolos	PA162363968	22806	0.706
NULL	Br_J_Cancer_2011_Aug_23_105(5)_618-627.nxml.txt.nlp	21829197	SENT175	4	4	7	7	lapatinib	CRT	PA152241907	811	0.706
NULL	EMBO_Mol_Med_2013_Apr_21_5(4)_488-508.nxml.txt.nlp	23436775	SENT451	9	9	4	4	doxycycline	GLI1	PA449415	2735	0.706
NULL	Ann_Hematol_2010_Nov_25_89(11)_1115-1124.nxml.txt.nlp	20499237	SENT258	8	8	25	25	atorvastatin	Rho	PA448500	29984	0.706
NULL	Br_J_Cancer_2013_Jul_23_109(2)_351-359.nxml.txt.nlp	23799854	SENT122	6	6	3	3	paclitaxel	BLT2	PA450761	56413	0.706
NULL	Gut_Pathog_2014_May_28_6_17.nxml.txt.nlp	24883113	SENT163	17	17	11	11	pentamidine	TMP	PA450850	2012	0.706
NULL	Front_Physiol_2011_Jun_30_2_33.nxml.txt.nlp	21747769	SENT610	11	11	4	4	estradiol	KCNQ1	PA449503	3784	0.706
NULL	J_Lipid_Res_2014_Feb_55(2)_266-275.nxml.txt.nlp	24296664	SENT520	29	29	7	7	ezetimibe	PCSK9	PA10816	255738	0.706
NULL	Evid_Based_Complement_Alternat_Med_2014_May_12_2014_804746.nxml.txt.nlp	24899911	SENT157	28	28	15	15	metoclopramide	PC6	PA450475	5125	0.706
NULL	Br_J_Anaesth_2011_Oct_17_107(4)_490-502.nxml.txt.nlp	21852280	SENT75	23	23	38	38	capsaicin	TRPV1	PA448776	7442	0.706
NULL	Ann_Med_Surg_(Lond)_2014_Jun_19_3(3)_60-64.nxml.txt.nlp	25568788	SENT57	0	0	35	35	neostigmine	NNT	PA450611	23530	0.706
NULL	J_Korean_Med_Sci_2009_Jan_29_24(Suppl_1)_S170-S175.nxml.txt.nlp	19194548	SENT132	18	18	20	20	cisplatin	EPO	PA449014	7076;8288;2056	0.706
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Feb_10_68(Pt_3)_o644.nxml.txt.nlp	22412547	SENT65	25	25	16	16	ethanol	mol	PA448073	90527	0.706
NULL	Br_J_Cancer_2012_Jan_3_106(1)_6-13.nxml.txt.nlp	22215104	SENT18	8	8	4	4	trastuzumab	HER2	PA451743	2064	0.706
NULL	Pain_2011_Aug_152(8)_1899-1908.nxml.txt.nlp	21600693	SENT156	17	17	23	23	capsaicin	ADP	PA448776	23038	0.706
NULL	Br_J_Pharmacol_2011_Apr_162(8)_1832-1842.nxml.txt.nlp	21232033	SENT163	21	21	7	7	resveratrol	SAP97		1739	0.706
NULL	Ther_Clin_Risk_Manag_2007_Jun_3(2)_259-268.nxml.txt.nlp	18360634	SENT154	23	23	28	28	natalizumab	IFN	PA164747191	3439	0.706
NULL	Mol_Syst_Biol_2010_Apr_13_6_356.nxml.txt.nlp	20393576	SENT382	33	33	18	18	ethanol	GCR2	PA448073	11319	0.706
NULL	Eur_J_Dent_2012_Apr_6(2)_169-177.nxml.txt.nlp	22509120	SENT188	5	5	7	7	ethanol	HEMA	PA448073	2157	0.706
NULL	J_Cell_Mol_Med_2014_May_14_18(5)_811-823.nxml.txt.nlp	24628949	SENT158	11	11	3	3	docetaxel	FOXM1	PA449383	2305	0.706
NULL	Nucleic_Acids_Res_2008_Feb_20_36(3)_998-1008.nxml.txt.nlp	18096616	SENT410	19	19	28	28	heparin	p27	PA449855	5715;10534	0.706
NULL	Mol_Cancer_2014_Jan_13_13_7.nxml.txt.nlp	24418169	SENT282	0	0	4	4	sorafenib	STAT3	PA7000	6774	0.706
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_4_2013_378657.nxml.txt.nlp	23662132	SENT495	7	7	15	15	exenatide	GLP-1	PA164749238	100125288	0.706
NULL	Diabetes_Care_2010_Oct_13_33(10)_2250-2253.nxml.txt.nlp	20628086	SENT116	33	33	31	31	farglitazar	gamma		9913	0.706
NULL	J_Carcinog_2014_Nov_27_13_13.nxml.txt.nlp	25525412	SENT92	18	18	10	10	oxaliplatin	KRAS	PA131285527	3845	0.706
NULL	Biosci_Rep_2013_Sep_17_33(5)_e00070.nxml.txt.nlp	23883094	SENT176	14	14	21	21	ethanol	GNMT	PA448073	27232	0.706
NULL	Mol_Cancer_2014_Feb_20_13_32.nxml.txt.nlp	24555657	SENT24	17	17	4	4	cisplatin	SET	PA449014	6418	0.706
NULL	Contemp_Clin_Dent_2011_Oct-Dec_2(4)_278-282.nxml.txt.nlp	22346152	SENT89	26	26	3	3	potassium	GCF	PA451047	6936	0.706
NULL	Drugs_Context_2012_Nov_19_2012_212242.nxml.txt.nlp	24432031	SENT437	21	21	5	5	vemurafenib	BRAF	PA165946873	673	0.706
NULL	Br_J_Pharmacol_2012_Apr_165(8)_2611-2619.nxml.txt.nlp	21718301	SENT196	23	23	16	16	rimonabant	GPR55	PA152407999	9290	0.706
NULL	Int_Arch_Med_2008_Jun_23_1_9.nxml.txt.nlp	18573217	SENT172	2	2	21	21	desmopressin	VIII	PA449237	1351	0.706
NULL	Cells_2012_May_10_1(2)_100-110.nxml.txt.nlp	24710417	SENT79	36	36	34	34	alemtuzumab	CD52	PA164783958	1043	0.706
NULL	Sci_Rep_2014_Nov_28_4_7237.nxml.txt.nlp	25429875	SENT167	8	8	16	16	hesperidin	JNK	PA449867	5599	0.706
NULL	J_Hematol_Oncol_2010_Apr_7_3_13.nxml.txt.nlp	20374647	SENT174	27	27	14	14	fludarabine	PSMB5	PA449655	5693	0.706
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1522-1532.nxml.txt.nlp	21997136	SENT250	5	5	9	9	lapatinib	p53	PA152241907	7157	0.706
NULL	Mol_Cancer_2010_Jun_24_9_164.nxml.txt.nlp	20576107	SENT88	5	5	22	22	etoposide	Mcl-1	PA449552	4170	0.706
NULL	Orphanet_J_Rare_Dis_2013_Apr_19_8_60.nxml.txt.nlp	23601510	SENT168	11	11	29	29	glucosamine	DM1	PA164747613	338023;1760;28509	0.706
NULL	J_Immunol_Res_2014_Jul_16_2014_696812.nxml.txt.nlp	25133198	SENT261	19	19	7	7	rifaximin	TLR2	PA164752443	7097	0.706
NULL	Clin_Ophthalmol_2012_Feb_20_6_277-282.nxml.txt.nlp	22375096	SENT88	14	14	27	27	ranibizumab	STA	PA164746012	2010;2656	0.706
NULL	Indian_J_Psychol_Med_2013_Apr-Jun_35(2)_135-140.nxml.txt.nlp	24049223	SENT157	21	21	9	9	chlorpromazine	Gen	PA448964	348654	0.706
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT20	12	12	24	24	nutlin-3	p53		7157	0.706
NULL	J_Exp_Clin_Cancer_Res_2009_Oct_7_28(1)_134.nxml.txt.nlp	19811659	SENT98	2	2	14	14	imatinib	DDR1	PA10804	780	0.706
NULL	Diabetes_2009_Dec_9_58(12)_2828-2834.nxml.txt.nlp	19741164	SENT249	9	9	20	20	resveratrol	SIRT1		23411	0.706
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT74	5	5	10	10	heparin	FGF1	PA449855	2246	0.706
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Nov_14_65(Pt_12)_o3083.nxml.txt.nlp	21578813	SENT69	32	32	10	10	ethanol	mol	PA448073	90527	0.706
NULL	Arthritis_Res_Ther_2014_May_22_16(3)_R115.nxml.txt.nlp	24886976	SENT52	12	12	10	10	aldesleukin	IL-2	PA448081	3558	0.706
NULL	J_Anim_Sci_Biotechnol_2013_Jul_30_4(1)_27.nxml.txt.nlp	23899038	SENT191	5	5	16	16	taurine	IL-6	PA451590	3569	0.706
NULL	Mol_Biol_Evol_2013_Feb_27_30(2)_448-456.nxml.txt.nlp	23104081	SENT57	5	5	8	8	doxycycline	LCB2	PA449415	9517	0.706
NULL	Case_Rep_Hematol_2013_Jul_7_2013_896394.nxml.txt.nlp	23936694	SENT36	14	14	37	37	idarubicin	AIDA	PA449961	64853	0.706
NULL	Endocrinol_Metab_(Seoul)_2014_Sep_25_29(3)_211-216.nxml.txt.nlp	25309777	SENT45	19	19	12	12	iodine	NIS	PA450049	6528	0.706
NULL	J_Invest_Dermatol_2013_Jun_14_133(6)_1541-1549.nxml.txt.nlp	23407395	SENT169	8	8	12	12	imiquimod	San	PA449972	80218	0.706
NULL	Clinicoecon_Outcomes_Res_2014_Sep_23_6_409-414.nxml.txt.nlp	25285019	SENT139	16	16	6	6	lopinavir	ATV	PA450264	4683	0.706
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT158	2	2	4	4	resveratrol	TRAIL		8743	0.706
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Oct_3_65(Pt_11)_o2641-o2642.nxml.txt.nlp	21578256	SENT76	24	24	12	12	ethanol	mol	PA448073	90527	0.706
NULL	New_Microbes_New_Infect_2014_May_4_2(3)_58-63.nxml.txt.nlp	25356345	SENT100	10	10	20	20	cefotaxime	GEM	PA448852	2669	0.706
NULL	Indian_J_Med_Res_2014_Jul_140(1)_130-137.nxml.txt.nlp	25222788	SENT56	19	19	21	21	ceftriaxone	CTX	PA448866	1593	0.706
NULL	Korean_J_Radiol_2010_Feb_22_Mar-Apr_11(2)_234-238.nxml.txt.nlp	20191072	SENT62	18	18	13	13	cyclophosphamide	CHOP	PA449165	1649	0.706
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT229	17	17	15	15	perifosine	DR5	PA165291471	8795	0.706
NULL	Oncogenesis_2012_Apr_2_1(4)_e5.nxml.txt.nlp	23552603	SENT573	5	5	12	12	celecoxib	DR4	PA448871	8797	0.706
NULL	Nat_Commun_2010_Nov_23_1_127.nxml.txt.nlp	21119640	SENT599	6	6	15	15	doxycycline	INS-1	PA449415	2305	0.706
NULL	Patient_Prefer_Adherence_2014_Apr_8_8_463-471.nxml.txt.nlp	24748775	SENT133	13	13	15	15	denosumab	BMD	PA166048634	1756;7439	0.706
NULL	Cell_Cycle_2013_Sep_15_12(18)_3013-3024.nxml.txt.nlp	23974104	SENT8	21	21	13	13	disulfiram	IQGAP1	PA449376	8826	0.706
NULL	Oncotarget_2011_Mar_28_2(3)_222-233.nxml.txt.nlp	21447859	SENT47	8	8	46	46	metformin	p53	PA450395	7157	0.706
NULL	Int_J_Breast_Cancer_2012_Feb_26_2012_761917.nxml.txt.nlp	22482061	SENT125	0	0	18	18	trastuzumab	CDK2	PA451743	1017	0.706
NULL	J_Cell_Mol_Med_2014_Dec_7_18(12)_2536-2552.nxml.txt.nlp	25287328	SENT212	31	31	7	7	estradiol	PKD1	PA449503	5310	0.706
NULL	Endocrine_2014_Apr_3_47(3)_962-964.nxml.txt.nlp	24696097	SENT9	0	0	8	8	liraglutide	GLP	PA165958364	342096	0.706
NULL	Oncotarget_2011_Dec_31_2(12)_1314-1321.nxml.txt.nlp	22248929	SENT36	9	9	2	2	everolimus	TORC1	PA164746311	23373	0.706
NULL	Clinicoecon_Outcomes_Res_2014_Oct_17_6_451-461.nxml.txt.nlp	25378939	SENT28	32	32	21	21	linezolid	HAP	PA450233	5915;10313	0.706
NULL	Case_Rep_Ophthalmol_2011_Mar_12_2(1)_105-110.nxml.txt.nlp	22110438	SENT24	14	14	12	12	ribavirin	IFN	PA451241	3439	0.706
NULL	Oncotarget_2014_Sep_16_5(20)_10034-10047.nxml.txt.nlp	25296981	SENT194	15	15	7	7	doxorubicin	CHK2	PA449412	11200	0.706
NULL	Open_Neurol_J_2008_May_7_2_20-24.nxml.txt.nlp	19018303	SENT96	9	9	17	17	azithromycin	IL-8	PA448519	3576	0.706
NULL	Breast_Cancer_Res_2011_May_26_13(3)_209.nxml.txt.nlp	21635709	SENT168	36	36	10	10	tamoxifen	HER2	PA451581	2064	0.706
NULL	J_Korean_Med_Sci_2006_Oct_31_21(5)_904-910.nxml.txt.nlp	17043427	SENT55	19	19	11	11	4-methylumbelliferone	NAG	PA154081778	51594;4669	0.706
NULL	Clinics_(Sao_Paulo)_2014_Jan_69(1)_68-74.nxml.txt.nlp	24473562	SENT108	23	23	26	26	nutlin-3	SOCS-1		8651	0.706
NULL	Eur_J_Clin_Pharmacol_2008_Feb_26_64(2)_133-157.nxml.txt.nlp	18224312	SENT544	45	45	40	40	trimipramine	CYP2C9	PA451791	1559	0.706
NULL	Pharmaceutics_2011_Oct_12_3(4)_680-705.nxml.txt.nlp	24309303	SENT146	5	5	15	15	cimetidine	MATE1	PA449001	55244	0.706
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT359	18	18	1	1	heparin	FGF1	PA449855	2246	0.706
NULL	Int_J_Environ_Res_Public_Health_2011_Jun_8_8(6)_2090-2108.nxml.txt.nlp	21776218	SENT309	11	11	15	15	arsenite	GGT1	PA452638	2678	0.706
NULL	Breast_Cancer_Res_2010_Jul_22_12(4)_R53.nxml.txt.nlp	20649975	SENT166	12	12	8	8	estradiol	HOXB13	PA449503	10481	0.706
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_9_2013_456747.nxml.txt.nlp	23653662	SENT127	2	2	10	10	berberine	KDR	PA165860812	3791	0.706
NULL	Front_Psychiatry_2014_May_19_5_47.nxml.txt.nlp	24904434	SENT410	26	26	37	37	piperazine	5-HT1A	PA450977	3350	0.706
NULL	Biomed_Res_Int_2014_Aug_4_2014_459452.nxml.txt.nlp	25162013	SENT238	0	0	26	26	isoniazid	mol	PA450112	90527	0.706
NULL	J_Immunol_Res_2014_Jul_16_2014_696812.nxml.txt.nlp	25133198	SENT252	19	19	3	3	rifaximin	CTR	PA164752443	799	0.706
NULL	J_Carcinog_2011_Nov_30_10_28.nxml.txt.nlp	22190870	SENT3	0	0	7	7	trastuzumab	San	PA451743	80218	0.706
NULL	Chemother_Res_Pract_2012_Dec_20_2012_743193.nxml.txt.nlp	23320171	SENT125	12	12	27	27	trastuzumab	DM1	PA451743	338023;1760;28509	0.706
NULL	Indian_J_Pharm_Sci_2011_Nov-Dec_73(6)_601-607.nxml.txt.nlp	23112392	SENT117	2	2	37	37	rosiglitazone	LPO	PA451283	4025	0.705
NULL	Br_J_Cancer_2009_Nov_3_101(9)_1549-1554.nxml.txt.nlp	19809436	SENT31	3	3	15	15	cisplatin	ADM	PA449014	133	0.705
NULL	Arch_Med_Sci_2013_Apr_20_9(2)_332-339.nxml.txt.nlp	23671446	SENT129	5	5	13	13	midazolam	JNK	PA450496	5599	0.705
NULL	Cases_J_2009_Jan_7_2_18.nxml.txt.nlp	19128460	SENT13	23	23	16	16	ribavirin	IFN	PA451241	3439	0.705
NULL	J_Immunol_Res_2014_May_21_2014_371087.nxml.txt.nlp	24963497	SENT322	21	21	7	7	decitabine	DAC	PA164749631	13	0.705
NULL	Diabetes_2011_Nov_17_60(11)_2701-2709.nxml.txt.nlp	21885869	SENT206	6	6	14	14	yohimbine	PPG	PA451946	5552	0.705
NULL	Cancers_(Basel)_2013_Dec_19_6(1)_1-27.nxml.txt.nlp	24378750	SENT117	11	11	5	5	cetuximab	EGFR	PA10040	1956	0.705
NULL	Biomed_Res_Int_2014_Feb_6_2014_323594.nxml.txt.nlp	24689036	SENT310	5	5	13	13	raloxifene	EGFR	PA451221	1956	0.705
NULL	Infect_Drug_Resist_2011_Mar_2_4_77-86.nxml.txt.nlp	21694911	SENT6	28	28	16	16	tigecycline	CABP	PA164746412	6277	0.705
NULL	Basic_Res_Cardiol_2010_Jul_25_105(4)_523-533.nxml.txt.nlp	20336304	SENT221	8	8	6	6	candesartan	AT-1	PA448765	9197	0.705
NULL	Theranostics_2013_Sep_4_3(9)_719-728.nxml.txt.nlp	24019856	SENT167	36	36	32	32	hyaluronan	CD44	PA165958431	960	0.705
NULL	Mol_Vis_2011_Oct_31_17_2824-2834.nxml.txt.nlp	22128230	SENT44	0	0	12	12	atropine	APO	PA448505	84909	0.705
NULL	Cell_Death_Dis_2010_May_13_1(5)_e41.nxml.txt.nlp	21364648	SENT302	9	9	14	14	etoposide	p53	PA449552	7157	0.705
NULL	J_Invest_Dermatol_2013_Aug_133(8)_1928-1929.nxml.txt.nlp	23856932	SENT31	8	8	21	21	vemurafenib	STAT3	PA165946873	6774	0.705
NULL	Braz_J_Med_Biol_Res_2013_Oct_2_46(10)_815-908.nxml.txt.nlp	24141608	SENT112	21	21	8	8	tamoxifen	CYP2D6	PA451581	1565	0.705
NULL	Front_Pharmacol_2014_Oct_31_5_231.nxml.txt.nlp	25400580	SENT2284	7	7	23	23	labetalol	BCS	PA164743150	617	0.705
NULL	J_Hematol_Oncol_2010_Apr_9_3_14.nxml.txt.nlp	20377918	SENT102	22	22	19	19	imatinib	IFN	PA10804	3439	0.705
NULL	Curr_Neuropharmacol_2008_Jun_6(2)_151-163.nxml.txt.nlp	19305794	SENT119	19	19	21	21	indomethacin	COX	PA449982	1351	0.705
NULL	J_Am_Heart_Assoc_2013_Apr_24_2(2)_e000131.nxml.txt.nlp	23537811	SENT74	9	9	14	14	clopidogrel	CYP2C19	PA449053	1557	0.705
NULL	F1000Res_2013_Jul_29_2_142.nxml.txt.nlp	24627785	SENT186	43	43	27	27	paromomycin	mol	PA164784023	90527	0.705
NULL	EMBO_Mol_Med_2012_Jun_13_4(6)_515-527.nxml.txt.nlp	22416035	SENT84	13	13	8	8	olaparib	p53		7157	0.705
NULL	Infect_Dis_Rep_2012_Mar_5_4(1)_e22.nxml.txt.nlp	24470929	SENT220	23	23	12	12	starch	HSS	PA451492	9043;2671;6448;80025	0.705
NULL	Biomed_Res_Int_2014_Jun_24_2014_783895.nxml.txt.nlp	25050371	SENT100	31	31	41	41	l-glutamine	CO2	PA10090	4513	0.705
NULL	Cell_Death_Dis_2013_Sep_19_4(9)_e810.nxml.txt.nlp	24052078	SENT93	19	19	27	27	erlotinib	EGFR	PA134687924	1956	0.705
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_650809.nxml.txt.nlp	23258995	SENT128	1	1	3	3	vasopressin	AVP	PA451858	114548;551	0.705
NULL	Bioinformation_2012_Jan_6_8(1)_13-19.nxml.txt.nlp	22359429	SENT181	20	20	2	2	curcumin	MRP1	PA151958596	4437	0.705
NULL	Korean_J_Anesthesiol_2013_Feb_15_64(2)_105-111.nxml.txt.nlp	23459312	SENT81	30	30	23	23	protamine	ACT	PA10366	12;11332;9457;641455	0.705
NULL	Oxid_Med_Cell_Longev_2012_Aug_23_2012_139327.nxml.txt.nlp	22966413	SENT44	11	11	2	2	methimazole	METL	PA450422	55798	0.705
NULL	Indian_J_Pharmacol_2013_Mar-Apr_45(2)_121-125.nxml.txt.nlp	23716885	SENT30	2	2	24	24	aripiprazole	5-HT2A	PA10026	3356	0.705
NULL	Exp_Diabetes_Res_2012_Nov_1_2012_892706.nxml.txt.nlp	23197976	SENT160	16	16	27	27	vildagliptin	GLP-1	PA165958346	100125288	0.705
NULL	Int_J_Chron_Obstruct_Pulmon_Dis_2006_Dec_1(4)_409-423.nxml.txt.nlp	18044097	SENT242	0	0	13	13	cilomilast	CD4	PA165948031	920	0.705
NULL	Ecancermedicalscience_2011_Apr_28_5_211.nxml.txt.nlp	22276054	SENT34	28	28	8	8	palonosetron	NK-1	PA10352	27087	0.705
NULL	Indian_J_Nucl_Med_2014_Apr-Jun_29(2)_65-73.nxml.txt.nlp	24761056	SENT87	20	20	10	10	erlotinib	FDG	PA134687924	23583	0.705
NULL	Biosci_Rep_2013_Mar_28_33(2)_e00031.nxml.txt.nlp	23402389	SENT162	10	10	25	25	ebselen	APO	PA161660841	84909	0.705
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_21-38.nxml.txt.nlp	19305786	SENT309	11	11	6	6	menthol	TRPM8	PA164776605	79054	0.705
NULL	Front_Oncol_2014_Apr_8_4_71.nxml.txt.nlp	24782983	SENT208	1	1	19	19	decitabine	HOXA10	PA164749631	3206	0.705
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1106-1112.nxml.txt.nlp	20234360	SENT128	22	22	17	17	fluorouracil	TTR	PA128406956	7276	0.705
NULL	Mol_Cancer_2012_Dec_12_11_91.nxml.txt.nlp	23234355	SENT81	0	0	2	2	erlotinib	EGFR	PA134687924	1956	0.705
NULL	J_Cell_Sci_2014_Nov_1_127(21)_4728-4739.nxml.txt.nlp	25179605	SENT98	6	6	9	9	bortezomib	SGTA	PA10252	6449	0.705
NULL	Br_J_Cancer_2011_Jan_4_104(1)_91-100.nxml.txt.nlp	21139584	SENT65	11	11	7	7	fluorescein	Hsp90	PA164746009	3320	0.705
NULL	Biochem_Res_Int_2012_Feb_12_2012_346972.nxml.txt.nlp	22400115	SENT231	14	14	24	24	hyaluronan	KDR	PA165958431	3791	0.705
NULL	Breast_Cancer_Res_Treat_2013_Oct_8_141(3)_437-446.nxml.txt.nlp	24101324	SENT275	9	9	13	13	trastuzumab	PTEN	PA451743	5728	0.705
NULL	Mol_Biol_Cell_2013_Jul_15_24(14)_2186-2200.nxml.txt.nlp	23699397	SENT86	18	18	13	13	staurosporine	TRAIL	PA165109623	8743	0.705
NULL	Biol_Direct_2007_Feb_21_2_8.nxml.txt.nlp	17313671	SENT175	16	16	21	21	vincristine	CHOP	PA451879	1649	0.705
NULL	Cancer_Cell_Int_2012_Jun_18_12_30.nxml.txt.nlp	22709569	SENT86	17	17	4	4	paclitaxel	PLCG2	PA450761	5336	0.705
NULL	Indian_J_Pharm_Sci_2013_Jan-Feb_75(1)_94-98.nxml.txt.nlp	23901167	SENT87	32	32	15	15	phenacetin	CYP2C9	PA450897	1559	0.705
NULL	Breast_Cancer_Res_2012_Feb_21_14(1)_R35.nxml.txt.nlp	22353783	SENT372	20	20	13	13	metformin	LKB1	PA450395	6794	0.705
NULL	Cell_Death_Dis_2010_Nov_18_1(11)_e101.nxml.txt.nlp	21368866	SENT89	13	13	11	11	cisplatin	Bcl-2	PA449014	596	0.705
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT76	13	13	30	30	l-leucine	p27	PA450197	5715;10534	0.705
NULL	Oncotarget_2014_Nov_3_5(20)_10127-10139.nxml.txt.nlp	25333256	SENT145	25	25	7	7	vemurafenib	TRIM16	PA165946873	10626	0.705
NULL	Alzheimers_Res_Ther_2011_Jun_29_3(3)_21.nxml.txt.nlp	21722346	SENT120	3	3	14	14	creatine	Q10	PA164778930	27161	0.705
NULL	Aging_(Albany_NY)_2014_May_5_6(4)_320-334.nxml.txt.nlp	24827396	SENT232	8	8	31	31	nitrogen	ATM	PA450643	472	0.705
NULL	F1000_Biol_Rep_2009_Feb_24_1_14.nxml.txt.nlp	20948672	SENT100	2	2	19	19	arsenite	A20	PA452638	7128;28935	0.705
NULL	Brain_Behav_2014_Jul_14_4(4)_468-483.nxml.txt.nlp	25161814	SENT200	7	7	5	5	duloxetine	ANOVA	PA10066	4858	0.705
NULL	FEBS_Open_Bio_2014_Oct_22_4_905-914.nxml.txt.nlp	25383314	SENT89	5	5	11	11	physostigmine	L-FABP	PA450957	2168	0.705
NULL	Arch_Med_Sci_2010_Mar_1_6(1)_19-23.nxml.txt.nlp	22371715	SENT112	0	0	3	3	etanercept	TNF	PA449515	7124	0.705
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT315	35	35	40	40	heparin	FGF1	PA449855	2246	0.705
NULL	Acta_Pharmacol_Sin_2014_Aug_7_35(8)_1015-1022.nxml.txt.nlp	24998256	SENT77	8	8	0	0	ethanol	ALDH2	PA448073	217	0.705
NULL	Int_J_Mol_Imaging_2011_Oct_26_2011_874585.nxml.txt.nlp	21490735	SENT124	16	16	3	3	docetaxel	FDG	PA449383	23583	0.705
NULL	Cancers_(Basel)_2014_Sep_30_6(4)_2035-2048.nxml.txt.nlp	25271833	SENT140	23	23	36	36	gefitinib	IL-2	PA131301952	3558	0.705
NULL	Oncotarget_2013_Aug_14_4(9)_1334-1335.nxml.txt.nlp	23963079	SENT16	28	28	6	6	crizotinib	PAK5	PA165946122	57144;56924	0.705
NULL	Mol_Syst_Biol_2010_Jul_27_6_391.nxml.txt.nlp	20664637	SENT57	8	8	20	20	choline	SMPD1	PA448976	6609	0.705
NULL	Clin_Ophthalmol_2007_Sep_1(3)_273-284.nxml.txt.nlp	19668481	SENT135	0	0	7	7	ranibizumab	San	PA164746012	80218	0.705
NULL	Cancer_Med_2013_Apr_6_2(2)_234-242.nxml.txt.nlp	23634291	SENT162	33	33	15	15	bevacizumab	VEGF-D	PA130232992	2277	0.705
NULL	Mol_Cancer_2008_Mar_6_7_24.nxml.txt.nlp	18325101	SENT92	13	13	26	26	cisplatin	FANCD2	PA449014	2177	0.705
NULL	Endocrinol_Metab_(Seoul)_2014_Sep_25_29(3)_211-216.nxml.txt.nlp	25309777	SENT79	24	24	15	15	sunitinib	MTC	PA162372840	4914	0.705
NULL	Biologics_2009_Jul_13_3_225-232.nxml.txt.nlp	19707411	SENT114	30	30	18	18	rituximab	CTX	PA451261	1593	0.705
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT39	0	0	13	13	metformin	AKT	PA450395	207	0.705
NULL	Diabetes_2013_Jun_17_62(6)_2141-2150.nxml.txt.nlp	23378610	SENT115	11	11	8	8	betaine	SLC6A12	PA448603	6539	0.705
NULL	Mol_Cancer_2010_Mar_9_9_54.nxml.txt.nlp	20214788	SENT52	15	15	5	5	tetracycline	JDP2	PA451640	122953	0.705
NULL	Mol_Cell_Biochem_2014_Oct_9_385(1-2)_265-275.nxml.txt.nlp	24104452	SENT179	17	17	13	13	bortezomib	U87	PA10252	677775;641648	0.705
NULL	Breast_Cancer_Res_2002_Sep_10_4(6)_218-221.nxml.txt.nlp	12473166	SENT78	2	2	0	0	anastrozole	ATAC	PA448432	6375	0.705
NULL	Evid_Based_Complement_Alternat_Med_2014_Mar_26_2014_967462.nxml.txt.nlp	24790636	SENT291	0	0	30	30	curcumin	LRRK2	PA151958596	120892	0.705
NULL	Cancer_Cell_Int_2007_Mar_2_7_1.nxml.txt.nlp	17331262	SENT110	0	0	4	4	bromocriptine	p38	PA448671	10598;1432;7965	0.705
NULL	Acta_Pharmacol_Sin_2014_Sep_25_35(9)_1199-1206.nxml.txt.nlp	25152024	SENT187	14	14	39	39	cisplatin	AKT	PA449014	207	0.705
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT165	13	13	18	18	cisplatin	p53	PA449014	7157	0.705
NULL	J_Gastroenterol_2013_Jan_24_48(1)_13-21.nxml.txt.nlp	23090000	SENT146	26	26	6	6	entecavir	IFN	PA164784025	3439	0.705
NULL	Oncogene_2013_Sep_26_32(39)_10_1038_onc_2012_491.nxml.txt.nlp	23108394	SENT99	24	24	16	16	epirubicin	BRIP1	PA449476	64979;83990	0.705
NULL	Acta_Pharmacol_Sin_2013_Jan_15_34(1)_78-90.nxml.txt.nlp	23064725	SENT117	2	2	13	13	heparin	EGFR	PA449855	1956	0.705
NULL	Mucosal_Immunol_2013_May_19_6(3)_498-510.nxml.txt.nlp	22990622	SENT396	12	12	30	30	dextran	CD11b	PA449261	3684	0.705
NULL	Nat_Med_2010_Jun_23_16(6)_671-677.nxml.txt.nlp	20495567	SENT192	16	16	2	2	sorafenib	ANOVA	PA7000	4858	0.705
NULL	ScientificWorldJournal_2014_May_19_2014_567148.nxml.txt.nlp	24971383	SENT179	9	9	3	3	epirubicin	MRP-1	PA449476	928	0.705
NULL	Eur_J_Clin_Pharmacol_2010_Nov_29_66(11)_1131-1136.nxml.txt.nlp	20669013	SENT133	44	44	17	17	voriconazole	CYP2C19	PA10233	1557	0.705
NULL	Front_Oncol_2012_Sep_12_2_114.nxml.txt.nlp	22988546	SENT59	2	2	9	9	cisplatin	CTX	PA449014	1593	0.705
NULL	Nat_Neurosci_2012_Sep_5_15(9)_1245-1254.nxml.txt.nlp	22864611	SENT166	14	14	19	19	clozapine	mGlu2	PA449061	2912	0.705
NULL	Oncogenesis_2012_Apr_2_1(4)_e5.nxml.txt.nlp	23552603	SENT568	35	35	19	19	ns-398	BIM		10018	0.705
NULL	Open_Access_J_Urol_2011_May_10_3_69-82.nxml.txt.nlp	24198638	SENT66	24	24	27	27	repaglinide	CYP2C9	PA451234	1559	0.705
NULL	Neuroscience_2012_Mar_15_205(C)_154-166.nxml.txt.nlp	22244974	SENT574	3	3	12	12	isoproterenol	spatial	PA450121	219793	0.705
NULL	ACS_Med_Chem_Lett_2012_Jan_30_3(3)_232-237.nxml.txt.nlp	22408714	SENT8	13	13	8	8	thrombin	PAR1	PA451674	79581;2149	0.705
NULL	N_Am_J_Med_Sci_2011_May_3(5)_212-216.nxml.txt.nlp	22558596	SENT117	7	7	20	20	cisplatin	BTC	PA449014	685	0.705
NULL	Front_Immunol_2014_Aug_22_5_406.nxml.txt.nlp	25202312	SENT215	27	27	23	23	eculizumab	C1-INH	PA164776637	710	0.705
NULL	Breast_Cancer_(Auckl)_2014_Oct_12_8_135-144.nxml.txt.nlp	25368520	SENT5	33	33	8	8	hydroxyurea	RAD51B	PA449942	5890	0.705
NULL	Theranostics_2014_Feb_22_4(5)_514-533.nxml.txt.nlp	24672583	SENT206	13	13	7	7	paclitaxel	DES	PA450761	1674	0.705
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Dec_10_3(12)_e151.nxml.txt.nlp	25494035	SENT80	25	25	41	41	rosuvastatin	OATP1B1	PA134308647	10599	0.705
NULL	Cell_Death_Dis_2013_Sep_19_4(9)_e804.nxml.txt.nlp	24052072	SENT148	6	6	14	14	paclitaxel	IL6	PA450761	3569	0.705
NULL	Clin_Sci_(Lond)_2013_May_1_124(Pt_9)_567-578.nxml.txt.nlp	23113760	SENT301	20	20	17	17	oxygen	ROS	PA450744	6098	0.705
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT53	17	17	30	30	nelfinavir	ATV	PA450606	4683	0.705
NULL	Exp_Cell_Res_2013_Apr_1_319(6)_800-809.nxml.txt.nlp	23247073	SENT205	31	31	34	34	curcumin	AKT	PA151958596	207	0.705
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_127043.nxml.txt.nlp	23227093	SENT130	6	6	9	9	lovastatin	RYR	PA450272	6261	0.705
NULL	Sensors_(Basel)_2014_Jul_11_14(7)_12533-12559.nxml.txt.nlp	25019637	SENT31	25	25	12	12	ethanol	MOX	PA448073	26002	0.705
NULL	Exp_Neurol_2012_Oct_237(2)_396-406.nxml.txt.nlp	22771762	SENT262	34	34	17	17	l-leucine	HPD	PA450197	3242	0.705
NULL	Int_J_Biol_Sci_2011_May_24_7(5)_673-684.nxml.txt.nlp	21647250	SENT38	23	23	13	13	metformin	AMPK	PA450395	5563	0.705
NULL	Oncotarget_2011_Mar_27_2(3)_209-221.nxml.txt.nlp	21444945	SENT226	26	26	30	30	bortezomib	p53	PA10252	7157	0.705
NULL	Acta_Pharmacol_Sin_2011_Jun_3_32(6)_805-816.nxml.txt.nlp	21642949	SENT308	0	0	16	16	curcumin	Raf-1	PA151958596	5894	0.705
NULL	Front_Neurosci_2010_Mar_19_4_22.nxml.txt.nlp	20582262	SENT130	30	30	37	37	mecamylamine	P2X3	PA450334	5024	0.705
NULL	Breast_Cancer_(Auckl)_2012_Mar_7_6_67-77.nxml.txt.nlp	22438669	SENT23	12	12	4	4	trastuzumab	HER2	PA451743	2064	0.705
NULL	Nat_Commun_2014_Mar_24_5_3516.nxml.txt.nlp	24662724	SENT521	16	16	40	40	dextran	ADAM10	PA449261	102	0.705
NULL	Nucleic_Acids_Res_2011_Sep_7_39(17)_7465-7476.nxml.txt.nlp	21653549	SENT164	17	17	31	31	etoposide	DNA-PKcs	PA449552	5591	0.705
NULL	Lab_Anim_Res_2012_Jun_26_28(2)_123-129.nxml.txt.nlp	22787486	SENT19	23	23	40	40	sibutramine	CB1	PA451344	1268	0.705
NULL	J_Int_Soc_Sports_Nutr_2009_Feb_19_6_6.nxml.txt.nlp	19228401	SENT239	17	17	21	21	creatine	CEE	PA164778930	51608	0.705
NULL	Oncotarget_2014_Mar_15_5(10)_3055-3065.nxml.txt.nlp	24931391	SENT207	23	23	17	17	hydrocortisone	EGF	PA449905	1950	0.705
NULL	Int_J_Cardiovasc_Imaging_2012_Apr_21_28(4)_843-853.nxml.txt.nlp	21509430	SENT166	9	9	4	4	iron	spatial	PA450087	219793	0.705
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R91.nxml.txt.nlp	22541814	SENT136	0	0	14	14	thrombin	PAR4	PA451674	9002;5074	0.705
NULL	J_Biomed_Biotechnol_2011_Jan_17_2011_416931.nxml.txt.nlp	21318120	SENT44	5	5	11	11	ethanol	CO2	PA448073	4513	0.705
NULL	Subst_Abuse_Rehabil_2011_Mar_16_2_11-20.nxml.txt.nlp	24474851	SENT39	25	25	15	15	ketamine	CYP2C9	PA450144	1559	0.705
NULL	Acta_Pharmacol_Sin_2012_May_16_33(5)_682-690.nxml.txt.nlp	22504904	SENT229	0	0	7	7	celecoxib	STAT3	PA448871	6774	0.705
NULL	Mol_Cancer_2010_Apr_23_9_87.nxml.txt.nlp	20416058	SENT221	7	7	5	5	doxorubicin	TRAIL	PA449412	8743	0.705
NULL	Pain_Res_Treat_2013_Jan_27_2013_960270.nxml.txt.nlp	NULL	SENT4	19	19	8	8	duloxetine	NNT	PA10066	23530	0.705
NULL	Trials_2012_Aug_31_13_156.nxml.txt.nlp	22937736	SENT170	29	29	9	9	azithromycin	IL-10	PA448519	3586	0.705
NULL	Cancer_Med_2012_Oct_1_1(2)_114-127.nxml.txt.nlp	23342262	SENT232	2	2	11	11	sirolimus	EGFR	PA451365	1956	0.705
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT85	3	3	12	12	curcumin	DR4	PA151958596	8797	0.705
NULL	Diabetes_Care_2011_Jul_17_34(7)_e115-e120.nxml.txt.nlp	21709286	SENT204	16	16	30	30	metformin	HER2	PA450395	2064	0.705
NULL	Cell_Commun_Signal_2013_Nov_11_11_86.nxml.txt.nlp	24215724	SENT31	14	14	25	25	thrombin	PAR3	PA451674	56288;2151	0.705
NULL	Front_Immunol_2012_Mar_19_3_47.nxml.txt.nlp	22566929	SENT58	3	3	19	19	abatacept	CD28	PA164747080	1493;940	0.705
NULL	Br_J_Cancer_2013_Sep_3_109(5)_1157-1164.nxml.txt.nlp	23942075	SENT8	8	8	3	3	epirubicin	NAT	PA449476	6046	0.705
NULL	Acta_Naturae_2011_Jul-Sep_3(3)_12-28.nxml.txt.nlp	22649690	SENT34	21	21	18	18	enfuvirtide	CCR5	PA164744517	1234	0.705
NULL	Clin_Ophthalmol_2007_Sep_1(3)_273-284.nxml.txt.nlp	19668481	SENT141	0	0	7	7	bevacizumab	San	PA130232992	80218	0.705
NULL	J_Viral_Hepat_2012_Aug_19(8)_537-546.nxml.txt.nlp	22762137	SENT19	18	18	8	8	ribavirin	SOC	PA451241	91544	0.705
NULL	Ann_Hematol_2011_Dec_9_90(12)_1391-1398.nxml.txt.nlp	21479535	SENT161	27	27	24	24	doxorubicin	CHOP	PA449412	1649	0.705
NULL	Oncotarget_2014_Nov_11_5(22)_11490-11500.nxml.txt.nlp	25359780	SENT45	9	9	12	12	docetaxel	CXCL12	PA449383	6387	0.705
NULL	Cell_Death_Dis_2013_Jul_11_4(7)_e719.nxml.txt.nlp	23846221	SENT68	14	14	10	10	cisplatin	TRAIL	PA449014	8743	0.705
NULL	Mol_Cancer_2012_Jul_25_11_46.nxml.txt.nlp	22830422	SENT131	6	6	3	3	rolipram	AKT	PA153906323	207	0.705
NULL	Anal_Bioanal_Chem_2012_May_13_403(3)_785-796.nxml.txt.nlp	22411537	SENT171	5	5	8	8	linezolid	NIP	PA450233	90527;10755	0.705
NULL	J_Med_Life_2011_Nov_14_4(4)_432-439.nxml.txt.nlp	22514580	SENT105	3	3	15	15	nelfinavir	ATV	PA450606	4683	0.705
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT94	29	29	15	15	trastuzumab	HER2	PA451743	2064	0.705
NULL	Cancer_Immunol_Immunother_2012_Jul_23_61(7)_1101-1111.nxml.txt.nlp	22193989	SENT205	10	10	14	14	oxaliplatin	IL-4	PA131285527	3565	0.705
NULL	Front_Pharmacol_2014_Oct_31_5_231.nxml.txt.nlp	25400580	SENT5510	12	12	2	2	labetalol	BCS	PA164743150	617	0.705
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT13	28	28	18	18	iloperidone	PRL	PA161199368	5617	0.705
NULL	Biomed_Res_Int_2014_Jan_20_2014_948427.nxml.txt.nlp	24563867	SENT109	3	3	20	20	buspirone	STZ	PA448689	6484	0.705
NULL	Oncoimmunology_2013_Mar_1_2(3)_e23304.nxml.txt.nlp	23802074	SENT95	37	37	39	39	trastuzumab	HER-2	PA451743	2064	0.705
NULL	F1000Res_2013_Oct_8_2_173.nxml.txt.nlp	24555085	SENT66	18	18	3	3	flunisolide	BDP	PA449661	10620;152926	0.705
NULL	Cancers_(Basel)_2014_Apr_9_6(2)_829-859.nxml.txt.nlp	24722453	SENT262	6	6	13	13	curcumin	STAT3	PA151958596	6774	0.705
NULL	Biomed_Res_Int_2014_Aug_4_2014_459452.nxml.txt.nlp	25162013	SENT238	0	0	11	11	isoniazid	mol	PA450112	90527	0.705
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT341	20	20	10	10	bevacizumab	VEGF-A	PA130232992	7422	0.705
NULL	Anat_Cell_Biol_2011_Sep_29_44(3)_169-175.nxml.txt.nlp	22025968	SENT112	16	16	4	4	ethanol	CLU	PA448073	1191	0.705
NULL	Front_Oncol_2013_Sep_6_3_218.nxml.txt.nlp	24032106	SENT11	28	28	38	38	cytarabine	NPM1	PA449177	4869	0.705
NULL	Mol_Biol_Cell_2012_Nov_1_23(21)_4212-4225.nxml.txt.nlp	22956765	SENT81	4	4	10	10	thrombin	SHP2	PA451674	5781	0.705
NULL	Br_J_Cancer_2010_Jan_5_102(1)_134-143.nxml.txt.nlp	19920829	SENT182	2	2	6	6	pertuzumab	IL-2		3558	0.705
NULL	Clin_Interv_Aging_2014_Apr_8_9_593-601.nxml.txt.nlp	24748777	SENT81	4	4	18	18	denosumab	CTX	PA166048634	1593	0.705
NULL	Int_J_Nanomedicine_2008_Sep_3(3)_359-372.nxml.txt.nlp	18990945	SENT14	1	1	13	13	methylprednisolone	CDP	PA450466	1523	0.705
NULL	Oncotarget_2014_Jun_19_5(15)_6540-6551.nxml.txt.nlp	25153728	SENT120	4	4	16	16	paclitaxel	p53	PA450761	7157	0.705
NULL	J_Antimicrob_Chemother_2014_Mar_13_69(3)_651-663.nxml.txt.nlp	24235095	SENT201	16	16	6	6	pentamidine	AQP3	PA450850	360	0.705
NULL	Iran_J_Pharm_Res_2014_Autumn_13(4)_1431-1436.nxml.txt.nlp	25587334	SENT79	12	12	41	41	lidocaine	ANOVA	PA450226	4858	0.705
NULL	Oxid_Med_Cell_Longev_2012_Aug_22_2012_534705.nxml.txt.nlp	22966415	SENT34	6	6	13	13	riluzole	GLT-1	PA451251	6506	0.705
NULL	Ann_Saudi_Med_2010_May-Jun_30(3)_193-197.nxml.txt.nlp	20427934	SENT64	4	4	1	1	voriconazole	IPA	PA10233	3160	0.705
NULL	J_Mol_Med_2008_Sep_4_86(9)_1045-1056.nxml.txt.nlp	18600309	SENT128	0	0	11	11	salmeterol	IL-8	PA451300	3576	0.705
NULL	Mol_Vis_2011_Apr_27_17_1044-1055.nxml.txt.nlp	21552499	SENT32	47	47	35	35	bevacizumab	apelin	PA130232992	8862	0.705
NULL	Mol_Cancer_2014_Jan_13_13_7.nxml.txt.nlp	24418169	SENT296	13	13	10	10	sorafenib	STAT3	PA7000	6774	0.705
NULL	Oncotarget_2012_Aug_9_3(8)_774-782.nxml.txt.nlp	22885298	SENT52	38	38	32	32	tetracycline	IDH1	PA451640	3417	0.705
NULL	Breast_Cancer_Res_2009_Nov_18_11(6)_R85.nxml.txt.nlp	19922614	SENT190	12	12	18	18	tamoxifen	BCS	PA451581	617	0.705
NULL	Mucosal_Immunol_2013_Nov_10_6(6)_1179-1190.nxml.txt.nlp	23571504	SENT52	19	19	7	7	auranofin	TRX	PA448510	7295	0.705
NULL	Evid_Based_Complement_Alternat_Med_2013_Mar_26_2013_625892.nxml.txt.nlp	23589719	SENT254	0	0	7	7	probenecid	TAS2R43	PA451106	259289	0.705
NULL	Iran_J_Pharm_Res_2013_Summer_12(3)_457-469.nxml.txt.nlp	24250652	SENT197	10	10	23	23	indomethacin	spatial	PA449982	219793	0.705
NULL	Mol_Vis_2012_Feb_16_18_471-478.nxml.txt.nlp	22393273	SENT190	29	29	12	12	atropine	FGF2	PA448505	2247;2258	0.705
NULL	Mar_Drugs_2011_Aug_10_9(8)_1346-1358.nxml.txt.nlp	21892349	SENT112	41	41	37	37	thrombin	ADP	PA451674	23038	0.705
NULL	Arthritis_Res_Ther_2014_Mar_11_16(2)_R65.nxml.txt.nlp	24612997	SENT304	8	8	21	21	valsartan	CCL18	PA451848	6362	0.705
NULL	Reprod_Biol_Endocrinol_2013_Jul_16_11_65.nxml.txt.nlp	23855623	SENT216	20	20	1	1	estradiol	activin	PA449503	83729	0.705
NULL	Nucleic_Acids_Res_2013_May_5_41(10)_5210-5222.nxml.txt.nlp	23563151	SENT78	20	20	9	9	arsenite	GADD45	PA452638	1647	0.705
NULL	Oncotarget_2013_Dec_28_5(6)_1475-1490.nxml.txt.nlp	24721996	SENT81	5	5	13	13	celecoxib	CD133	PA448871	8842	0.705
NULL	Indian_J_Med_Res_2014_Apr_139(4)_572-578.nxml.txt.nlp	24927344	SENT90	9	9	2	2	acenocoumarol	GGCX	PA452632	2677	0.705
NULL	Exp_Diabetes_Res_2012_Dec_26_2012_230624.nxml.txt.nlp	23365557	SENT118	5	5	33	33	liraglutide	LIR1	PA165958364	10859	0.705
NULL	Diabetes_2013_Jun_17_62(6)_1843-1854.nxml.txt.nlp	23349486	SENT208	20	20	11	11	pioglitazone	FOXP3	PA450970	50943	0.705
NULL	Indian_J_Pharmacol_2014_Nov-Dec_46(6)_627-632.nxml.txt.nlp	25538335	SENT17	15	15	13	13	metformin	Q10	PA450395	27161	0.705
NULL	Acta_Naturae_2013_Apr-Jun_5(2)_19-39.nxml.txt.nlp	23819034	SENT384	26	26	37	37	thrombin	FVIII	PA451674	2157	0.705
NULL	Lab_Invest_2011_Sep_23_91(9)_1396-1409.nxml.txt.nlp	21606925	SENT141	0	0	2	2	genistein	PP2	PA165109660	4888	0.705
NULL	Drugs_(Abingdon_Engl)_2014_Dec_19_21(6)_470-475.nxml.txt.nlp	25552821	SENT59	16	16	3	3	buprenorphine	OST	PA448685	1650;23263	0.705
NULL	J_Gen_Physiol_2003_Mar_121(3)_181-197.nxml.txt.nlp	12601083	SENT268	13	13	15	15	forskolin	GLP-1	PA146096022	100125288	0.705
NULL	Arch_Med_Sci_2012_Nov_9_8(5)_899-906.nxml.txt.nlp	23185202	SENT120	3	3	20	20	acarbose	PPG	PA448010	5552	0.705
NULL	Evid_Based_Complement_Alternat_Med_2013_Mar_10_2013_203845.nxml.txt.nlp	23554826	SENT197	13	13	8	8	azithromycin	San	PA448519	80218	0.705
NULL	Int_J_Med_Sci_2012_Aug_10_9(6)_472-479.nxml.txt.nlp	22927772	SENT26	31	31	19	19	warfarin	VKORC1	PA451906	79001	0.705
NULL	Indian_J_Pharmacol_2014_Nov-Dec_46(6)_627-632.nxml.txt.nlp	25538335	SENT126	5	5	3	3	metformin	Q10	PA450395	27161	0.705
NULL	J_Int_Soc_Sports_Nutr_2009_Feb_19_6_6.nxml.txt.nlp	19228401	SENT7	5	5	15	15	creatine	CRT	PA164778930	811	0.705
NULL	Iran_J_Pediatr_2012_Dec_22(4)_524-530.nxml.txt.nlp	23430764	SENT43	13	13	26	26	gentamicin	CO2	PA449753	4513	0.705
NULL	Cancer_Immunol_Immunother_2011_Jun_25_60(6)_793-808.nxml.txt.nlp	21350947	SENT268	32	32	29	29	sorafenib	IFN	PA7000	3439	0.705
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT120	18	18	11	11	metformin	HIF-1	PA450395	29072	0.705
NULL	Acta_Neuropathol_Commun_2014_May_30_2_57.nxml.txt.nlp	24887326	SENT34	24	24	15	15	irinotecan	ABCB1	PA450085	5243	0.705
NULL	Mol_Biol_Int_2011_Feb_24_2011_137459.nxml.txt.nlp	22091395	SENT222	14	14	27	27	arsenite	TIA1	PA452638	7072	0.704
NULL	J_Cell_Biol_2005_Jul_18_170(2)_249-260.nxml.txt.nlp	16027221	SENT172	16	16	38	38	calcein	SNAP-25	PA132595336	6616	0.704
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT238	2	2	0	0	mitomycin	MVP	PA450524	9961	0.704
NULL	Oncol_Rep_2012_Apr_30_27(4)_954-958.nxml.txt.nlp	22209887	SENT81	5	5	10	10	collagenase	HSC3	PA449107	150353	0.704
NULL	Cell_Death_Dis_2012_Jun_21_3(6)_e327.nxml.txt.nlp	22717582	SENT101	0	0	14	14	acetylcysteine	San	PA448033	80218	0.704
NULL	J_Neurol_2012_Mar_13_259(3)_448-456.nxml.txt.nlp	21842303	SENT1	9	9	22	22	lipase	HCAP	PA450239	117159;9126	0.704
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT53	12	12	1	1	nevirapine	MRP7	PA450616	89845;1080	0.704
NULL	Int_J_Hypertens_2012_Mar_7_2012_842632.nxml.txt.nlp	22506100	SENT155	5	5	13	13	hemin	HO-1	PA449849	3162	0.704
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Mar_2_69(Pt_4)_m182-m183.nxml.txt.nlp	23633987	SENT77	25	25	2	2	ethanol	NO3	PA448073	4681	0.704
NULL	J_Cell_Biol_1998_Mar_9_140(5)_1199-1209.nxml.txt.nlp	9490732	SENT39	5	5	0	0	thrombin	LPA	PA451674	4018	0.704
NULL	Indian_J_Ophthalmol_2014_Apr_62(4)_424-428.nxml.txt.nlp	24145571	SENT39	18	18	29	29	l-cysteine	PRK	PA449173	1263	0.704
NULL	J_Oncol_2013_Feb_17_2013_872957.nxml.txt.nlp	23476648	SENT204	16	16	14	14	cisplatin	SFN	PA449014	25996;2810	0.704
NULL	Br_J_Cancer_2011_Aug_23_105(5)_649-657.nxml.txt.nlp	21811251	SENT185	18	18	20	20	gefitinib	EGFR	PA131301952	1956	0.704
NULL	Cardiovasc_Ultrasound_2009_Aug_20_7_39.nxml.txt.nlp	19695099	SENT42	23	23	33	33	dobutamine	CRT	PA449381	811	0.704
NULL	Front_Oncol_2012_Oct_4_2_123.nxml.txt.nlp	23061041	SENT646	8	8	19	19	tamoxifen	ATAC	PA451581	6375	0.704
NULL	Crit_Care_2011_Mar_22_15(2)_211.nxml.txt.nlp	21457505	SENT18	0	0	3	3	heparin	PF4	PA449855	5196	0.704
NULL	Front_Neurosci_2012_May_30_6_77.nxml.txt.nlp	22661925	SENT303	13	13	8	8	ethanol	HEC	PA448073	10403	0.704
NULL	Diabetes_2009_Jan_58(1)_243-249.nxml.txt.nlp	18840785	SENT142	7	7	16	16	glucose	GLP-1	PA449773	100125288	0.704
NULL	Int_J_Mol_Imaging_2011_Oct_26_2011_874585.nxml.txt.nlp	21490735	SENT17	19	19	5	5	docetaxel	FDG	PA449383	23583	0.704
NULL	J_Young_Pharm_2011_Oct-Dec_3(4)_310-314.nxml.txt.nlp	22224038	SENT32	21	21	8	8	ethanol	mol	PA448073	90527	0.704
NULL	Breast_Cancer_Res_Treat_2012_Nov_11_136(2)_457-467.nxml.txt.nlp	23053664	SENT185	35	35	32	32	bevacizumab	VEGF-A	PA130232992	7422	0.704
NULL	Endocrinology_2014_Oct_22_155(10)_3732-3738.nxml.txt.nlp	25051442	SENT117	19	19	22	22	sibutramine	POMC	PA451344	5443	0.704
NULL	Mol_Biol_Cell_2014_Jun_1_25(11)_1782-1792.nxml.txt.nlp	24719457	SENT80	31	31	19	19	nicotine	FBS	PA450626	64319;26269	0.704
NULL	Oncotarget_2011_Dec_20_2(12)_1094-1108.nxml.txt.nlp	22190353	SENT241	11	11	16	16	gemcitabine	p53	PA449748	7157	0.704
NULL	Arthritis_Res_Ther_2004_Jun_21_6(4)_R384-R392.nxml.txt.nlp	15225374	SENT27	22	22	30	30	collagenase	MMP9	PA449107	4318	0.704
NULL	Biomed_Res_Int_2013_Dec_5_2013_642848.nxml.txt.nlp	24381940	SENT166	0	0	7	7	telmisartan	IL-6	PA451605	3569	0.704
NULL	Cell_Commun_Signal_2014_Sep_25_12(1)_61.nxml.txt.nlp	NULL	SENT166	15	15	33	33	doxycycline	IL-8	PA449415	3576	0.704
NULL	Indian_J_Pharmacol_2012_Nov-Dec_44(6)_744-748.nxml.txt.nlp	23248405	SENT105	2	2	9	9	clopidogrel	DAI	PA449053	81030	0.704
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1033-1038.nxml.txt.nlp	22374460	SENT137	7	7	21	21	gemcitabine	HER2	PA449748	2064	0.704
NULL	Oncotarget_2011_May_13_2(5)_401-406.nxml.txt.nlp	21576761	SENT78	17	17	36	36	lapatinib	RSK	PA152241907	6195;6196;6197	0.704
NULL	J_Cereb_Blood_Flow_Metab_2011_Nov_24_31(11)_2152-2159.nxml.txt.nlp	21863037	SENT133	4	4	21	21	paraformaldehyde	MAP2	PA450790	4133;10988	0.704
NULL	Clin_Med_Oncol_2008_Jun_11_2_469-470.nxml.txt.nlp	21892319	SENT32	19	19	34	34	trastuzumab	HER-2	PA451743	2064	0.704
NULL	Nucleic_Acids_Res_2012_Apr_19_40(8)_e60.nxml.txt.nlp	22262732	SENT131	24	24	20	20	lipase	FAAH	PA450239	79152;2166	0.704
NULL	Case_Rep_Oncol_2012_Aug_9_5(2)_428-433.nxml.txt.nlp	22949905	SENT68	16	16	34	34	irinotecan	KRAS	PA450085	3845	0.704
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Nov_27_66(Pt_12)_m1669.nxml.txt.nlp	21589329	SENT56	22	22	25	25	ethanol	mol	PA448073	90527	0.704
NULL	Br_J_Cancer_2010_Jun_29_103(1)_52-60.nxml.txt.nlp	20531411	SENT116	3	3	22	22	gemcitabine	MTD	PA449748	4493	0.704
NULL	Br_J_Cancer_1997_76(10)_1328-1332.nxml.txt.nlp	9374379	SENT10	35	35	43	43	cisplatin	IFN	PA449014	3439	0.704
NULL	Cancer_Metab_2014_Nov_3_2(1)_20.nxml.txt.nlp	NULL	SENT350	39	39	3	3	erlotinib	PDK4	PA134687924	5166	0.704
NULL	J_Korean_Med_Sci_2010_May_16_25(5)_738-745.nxml.txt.nlp	20436711	SENT12	24	24	10	10	telbivudine	NUC	PA164760861	4924	0.704
NULL	Br_J_Cancer_2011_Sep_27_105(7)_1030-1038.nxml.txt.nlp	21863025	SENT210	18	18	25	25	saracatinib	COPA		1314	0.704
NULL	Clin_Dev_Immunol_2011_Nov_3_2011_609579.nxml.txt.nlp	22110526	SENT124	10	10	5	5	doxorubicin	HMGB1	PA449412	3146	0.704
NULL	Diabetes_2013_Sep_15_62(9)_3241-3250.nxml.txt.nlp	23630304	SENT337	7	7	30	30	irbesartan	RAGE	PA450084	177	0.704
NULL	Oncoimmunology_2013_Oct_1_2(10)_e25997.nxml.txt.nlp	24404422	SENT55	16	16	14	14	imiquimod	TLR7	PA449972	51284	0.704
NULL	Cancer_Cell_Int_2006_Aug_9_6_20.nxml.txt.nlp	16899133	SENT187	8	8	16	16	l-methionine	p27	PA450423	5715;10534	0.704
NULL	Ann_Thorac_Med_2012_Jan-Mar_7(1)_44-47.nxml.txt.nlp	22347351	SENT90	19	19	15	15	vincristine	CO2	PA451879	4513	0.704
NULL	Arthritis_Res_Ther_2011_Feb_4_13(1)_R14.nxml.txt.nlp	21294864	SENT110	16	16	9	9	indomethacin	IL-6	PA449982	3569	0.704
NULL	Front_Behav_Neurosci_2011_Sep_8_5_56.nxml.txt.nlp	21927600	SENT855	0	0	2	2	nicotine	DARPP-32	PA450626	84152	0.704
NULL	Hum_Genomics_2013_Apr_5_7(1)_10.nxml.txt.nlp	23561625	SENT166	2	2	9	9	flavopiridol	CDK7	PA452627	1022	0.704
NULL	J_Exp_Clin_Cancer_Res_2009_Jun_22_28(1)_87.nxml.txt.nlp	19545438	SENT25	3	3	11	11	cyclophosphamide	CHOP	PA449165	1649	0.704
NULL	Expert_Rev_Mol_Med_2011_Nov_13_e35.nxml.txt.nlp	22088887	SENT467	3	3	1	1	nutlin-3	MDM2		4193	0.704
NULL	J_Biol_Chem_2008_Oct_31_283(44)_29841-29846.nxml.txt.nlp	18765669	SENT52	41	41	16	16	l-glutamine	CO2	PA10090	4513	0.704
NULL	J_Cancer_2013_Nov_23_4(9)_736-754.nxml.txt.nlp	24312144	SENT222	15	15	12	12	erlotinib	VEGFR	PA134687924	3791	0.704
NULL	Int_J_Vasc_Med_2012_Sep_11_2012_524235.nxml.txt.nlp	21915378	SENT135	26	26	9	9	thrombin	IL-6	PA451674	3569	0.704
NULL	Curr_Neuropharmacol_2009_Jun_7(2)_83-95.nxml.txt.nlp	19949566	SENT515	38	38	32	32	topiramate	TGB	PA451728	5473	0.704
NULL	Ann_Clin_Microbiol_Antimicrob_2005_Sep_13_4_13.nxml.txt.nlp	16159399	SENT257	10	10	8	8	ribavirin	IFN	PA451241	3439	0.704
NULL	Acta_Pharmacol_Sin_2010_Jan_5_31(1)_93-101.nxml.txt.nlp	20048748	SENT208	3	3	5	5	cisplatin	DAPK	PA449014	1612	0.704
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT336	29	29	19	19	resveratrol	p53		7157	0.704
NULL	Mol_Cancer_2009_Aug_25_8_66.nxml.txt.nlp	19706164	SENT53	0	0	17	17	celecoxib	p53	PA448871	7157	0.704
NULL	Bioconjug_Chem_2010_Oct_20_21(10)_1811-1819.nxml.txt.nlp	20873712	SENT120	4	4	7	7	isoflurane	CO2	PA450106	4513	0.704
NULL	J_Gastroenterol_2014_Dec_24_49(12)_1536-1547.nxml.txt.nlp	24366288	SENT125	29	29	38	38	rabeprazole	CYP2C19	PA451216	1557	0.704
NULL	Virulence_2013_Oct_1_4(7)_646-653.nxml.txt.nlp	24045422	SENT105	7	7	11	11	l-lysine	CD4	PA450280	920	0.704
NULL	J_Neurosci_Methods_2009_Oct_15_183(2)_107-113.nxml.txt.nlp	19524611	SENT95	14	14	16	16	carbachol	DSI	PA448784	5034	0.704
NULL	J_Invest_Dermatol_2012_Sep_10_132(9)_2255-2262.nxml.txt.nlp	22572817	SENT51	0	0	4	4	forskolin	MC1R	PA146096022	4157	0.704
NULL	Evid_Based_Complement_Alternat_Med_2013_Mar_10_2013_203845.nxml.txt.nlp	23554826	SENT187	13	13	8	8	azithromycin	San	PA448519	80218	0.704
NULL	Am_J_Cardiovasc_Drugs_2013_Jun_20_13(5)_331-342.nxml.txt.nlp	23784266	SENT223	30	30	16	16	erythromycin	P-gp	PA449493	5243	0.704
NULL	Int_J_Environ_Res_Public_Health_2013_Apr_12_10(4)_1527-1546.nxml.txt.nlp	23583964	SENT104	27	27	35	35	arsenite	XRCC1	PA452638	7515	0.704
NULL	Int_J_Mol_Sci_2014_May_12_15(5)_8335-8351.nxml.txt.nlp	24823879	SENT845	5	5	7	7	curcumin	CD133	PA151958596	8842	0.704
NULL	Curr_Neuropharmacol_2013_May_11(3)_276-297.nxml.txt.nlp	24179464	SENT787	9	9	14	14	mibefradil	CA1	PA450492	759	0.704
NULL	J_Gen_Physiol_1978_Feb_1_71(2)_223-225.nxml.txt.nlp	641522	SENT0	18	18	1	1	lidocaine	Gen	PA450226	348654	0.704
NULL	Br_J_Cancer_2012_Feb_14_106(4)_646-650.nxml.txt.nlp	22240794	SENT63	15	15	20	20	sunitinib	IFN	PA162372840	3439	0.704
NULL	Oncologist_2010_Mar_9_15(3)_236-245.nxml.txt.nlp	20215359	SENT78	0	0	8	8	bevacizumab	San	PA130232992	80218	0.704
NULL	Biomed_Res_Int_2014_Jan_20_2014_948427.nxml.txt.nlp	24563867	SENT145	21	21	15	15	buspirone	STZ	PA448689	6484	0.704
NULL	Cancers_(Basel)_2014_Jul_7_6(3)_1441-1463.nxml.txt.nlp	25003395	SENT1149	2	2	0	0	cisplatin	PAK4	PA449014	10298	0.704
NULL	Curr_Pharm_Des_2011_Feb_17(6)_578-590.nxml.txt.nlp	21391908	SENT224	4	4	8	8	lenalidomide	CD154	PA162363968	959	0.704
NULL	J_Hematol_Oncol_2013_Jul_18_6_53.nxml.txt.nlp	23866964	SENT79	22	22	18	18	temsirolimus	CDKN1B	PA164746890	1027	0.704
NULL	J_Med_Econ_2013_Jul_24_16(7)_917-925.nxml.txt.nlp	23663091	SENT6	34	34	27	27	aripiprazole	SOC	PA10026	91544	0.704
NULL	Croat_Med_J_2013_Apr_54(2)_171-179.nxml.txt.nlp	23630144	SENT7	18	18	28	28	taurine	STZ	PA451590	6484	0.704
NULL	Diabetes_Care_2011_Jul_17_34(7)_e115-e120.nxml.txt.nlp	21709286	SENT108	41	41	26	26	metformin	IGF1	PA450395	3479	0.704
NULL	Br_J_Cancer_2012_May_8_106(10)_1587-1590.nxml.txt.nlp	22568998	SENT51	25	25	30	30	sunitinib	IFN	PA162372840	3439	0.704
NULL	J_Hematol_Oncol_2013_Jan_15_6_5.nxml.txt.nlp	23320987	SENT249	2	2	0	0	heparin	PI-PLC	PA449855	2923	0.704
NULL	Nat_Chem_Biol_2009_Jan_23_5(1)_37-44.nxml.txt.nlp	19029917	SENT55	4	4	37	37	piperazine	ABHD6	PA450977	57406	0.704
NULL	Diabetes_Metab_Syndr_Obes_2009_May_5_2_11-21.nxml.txt.nlp	21437115	SENT34	24	24	42	42	lovastatin	B18	PA450272	59271;4713	0.704
NULL	Crit_Care_2011_Nov_30_15(6)_R289.nxml.txt.nlp	22129171	SENT172	15	15	9	9	dipyridamole	IL-10	PA449367	3586	0.704
NULL	Nucleic_Acids_Res_2005_Aug_12_33(14)_4584-4592.nxml.txt.nlp	16100380	SENT387	12	12	3	3	paromomycin	GCN2	PA164784023	440275	0.704
NULL	Front_Pharmacol_2014_Mar_3_5_28.nxml.txt.nlp	24624084	SENT311	7	7	11	11	lipase	CB1	PA450239	1268	0.704
NULL	J_Breast_Cancer_2013_Mar_31_16(1)_23-31.nxml.txt.nlp	23593078	SENT111	8	8	20	20	resveratrol	DNMT1		1786	0.704
NULL	Clinics_(Sao_Paulo)_2014_Jan_69(1)_68-74.nxml.txt.nlp	24473562	SENT105	17	17	14	14	nutlin-3	p53		7157	0.704
NULL	EMBO_Mol_Med_2012_Sep_8_4(9)_939-951.nxml.txt.nlp	22684844	SENT68	35	35	4	4	bleomycin	IL-6	PA448645	3569	0.704
NULL	Br_J_Cancer_1999_Dec_81(8)_1294-1303.nxml.txt.nlp	10604725	SENT7	23	23	5	5	cisplatin	CH1	PA449014	51430	0.704
NULL	Int_J_Mol_Sci_2014_Sep_19_15(9)_16698-16718.nxml.txt.nlp	25244018	SENT72	22	22	17	17	estradiol	LKB1	PA449503	6794	0.704
NULL	Neural_Dev_2010_Nov_2_5_30.nxml.txt.nlp	21044296	SENT161	28	28	19	19	forskolin	B27	PA146096022	56246	0.704
NULL	Breast_Cancer_Res_2005_Apr_8_7(4)_R436-R443.nxml.txt.nlp	15987448	SENT30	0	0	7	7	trastuzumab	San	PA451743	80218	0.704
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT284	12	12	7	7	perifosine	TRAIL	PA165291471	8743	0.704
NULL	Br_J_Cancer_2009_May_5_100(9)_1379-1384.nxml.txt.nlp	19401697	SENT30	3	3	5	5	cetuximab	EGFR	PA10040	1956	0.704
NULL	Int_J_Mol_Sci_2014_Nov_7_15(11)_20500-20517.nxml.txt.nlp	25387078	SENT99	16	16	23	23	sorafenib	AKT	PA7000	207	0.704
NULL	Indian_J_Med_Res_2012_Apr_135(4)_500-505.nxml.txt.nlp	22664497	SENT95	17	17	27	27	estradiol	aromatase	PA449503	1588	0.704
NULL	Pharm_Pract_(Granada)_2010_Mar_15_Oct-Dec_8(4)_243-249.nxml.txt.nlp	25126148	SENT113	22	22	12	12	artesunate	ACT	PA165111697	12;11332;9457;641455	0.704
NULL	Arthritis_Res_Ther_2005_Apr_4_7(3)_R666-R676.nxml.txt.nlp	15899052	SENT19	9	9	16	16	infliximab	p75	PA452639	7133;11168	0.704
NULL	Nat_Chem_Biol_2010_Apr_28_6(4)_291-299.nxml.txt.nlp	20190765	SENT128	32	32	37	37	dasatinib	EGFR	PA162372878	1956	0.704
NULL	J_Vis_Exp_2011_Jan_15_(47)_2383.nxml.txt.nlp	21304454	SENT90	11	11	18	18	ethanol	hole	PA448073	80757	0.704
NULL	Curr_Pharm_Des_2012_Apr_18(10)_1434-1445.nxml.txt.nlp	22300258	SENT217	9	9	14	14	acarbose	GLP-1	PA448010	100125288	0.704
NULL	J_Immunother_Cancer_2013_Jun_27_1_9.nxml.txt.nlp	NULL	SENT173	5	5	18	18	sunitinib	IFN	PA162372840	3439	0.704
NULL	Drug_Target_Insights_2012_Aug_6_6_19-39.nxml.txt.nlp	22915839	SENT119	0	0	17	17	doxorubicin	Hsp90	PA449412	3320	0.704
NULL	Exp_Ther_Med_2014_Jun_28_7(6)_1539-1544.nxml.txt.nlp	24926340	SENT24	8	8	22	22	geldanamycin	Hsp90	PA152031327	3320	0.704
NULL	Nucleic_Acids_Res_2013_Nov_27_41(21)_9786-9799.nxml.txt.nlp	23982513	SENT291	4	4	13	13	arsenite	TIAR	PA452638	7073	0.704
NULL	Acta_Physiol_(Oxf)_2008_Apr_192(4)_505-517.nxml.txt.nlp	17973950	SENT238	2	2	10	10	isoproterenol	LQT3	PA450121	6331	0.704
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Aug_20_64(Pt_9)_o1785.nxml.txt.nlp	21201765	SENT69	18	18	7	7	ethanol	mol	PA448073	90527	0.704
NULL	Mol_Cancer_2014_Jun_9_13_146.nxml.txt.nlp	24913494	SENT144	18	18	4	4	bicalutamide	MID1	PA164746255	4281	0.704
NULL	J_Clin_Biochem_Nutr_2011_Jul_17_49(1)_50-56.nxml.txt.nlp	21765607	SENT170	27	27	15	15	arsenite	p38	PA452638	10598;1432;7965	0.704
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT317	0	0	6	6	risperidone	PRL	PA451257	5617	0.704
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_28_2012_937605.nxml.txt.nlp	23304227	SENT103	9	9	13	13	resveratrol	GDNF		2668	0.704
NULL	Pak_J_Med_Sci_2013_Apr_29(2)_590-592.nxml.txt.nlp	24353583	SENT4	3	3	10	10	bevacizumab	San	PA130232992	80218	0.704
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Jun_27_5_15.nxml.txt.nlp	16803618	SENT244	9	9	3	3	erythromycin	LTA	PA449493	4049	0.704
NULL	Cancers_(Basel)_2014_Sep_5_6(3)_1769-1792.nxml.txt.nlp	25198391	SENT99	18	18	14	14	tamoxifen	HER2	PA451581	2064	0.704
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT121	23	23	30	30	nutlin-3	MDM2		4193	0.704
NULL	Arthritis_Res_Ther_2012_Feb_27_14(1)_R40.nxml.txt.nlp	22369699	SENT35	0	0	14	14	abatacept	CD28	PA164747080	1493;940	0.704
NULL	Oncotarget_2012_Sep_28_3(10)_1169-1181.nxml.txt.nlp	23045411	SENT6	15	15	7	7	doxorubicin	JIP1	PA449412	9479	0.704
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT49	20	20	36	36	l-glutamine	CO2	PA10090	4513	0.704
NULL	Mol_Brain_2014_Sep_4_7(1)_69.nxml.txt.nlp	NULL	SENT169	0	0	32	32	sevoflurane	CXCL10	PA451341	3627	0.704
NULL	Front_Endocrinol_(Lausanne)_2013_Sep_4_4_116.nxml.txt.nlp	24027559	SENT183	22	22	32	32	estradiol	aromatase	PA449503	1588	0.704
NULL	J_Neuroinflammation_2011_Feb_4_8_10.nxml.txt.nlp	21294877	SENT87	23	23	30	30	capsaicin	TAC1	PA448776	6863	0.704
NULL	Arthritis_Res_Ther_2007_Oct_19_9(Suppl_3)_P20.nxml.txt.nlp	NULL	SENT19	25	25	21	21	infliximab	p38	PA452639	10598;1432;7965	0.704
NULL	Curr_Neuropharmacol_2012_Jun_10(2)_97-123.nxml.txt.nlp	23204981	SENT187	5	5	9	9	paroxetine	COX	PA450801	1351	0.704
NULL	Clin_Interv_Aging_2013_May_30_8_597-603.nxml.txt.nlp	23761968	SENT138	6	6	21	21	risedronate	PTH	PA451255	5741	0.704
NULL	Mol_Cell_Biochem_2015_Oct_8_398(1-2)_165-173.nxml.txt.nlp	25292312	SENT110	4	4	12	12	bortezomib	HIF-1	PA10252	29072	0.704
NULL	Nucleic_Acids_Res_2011_Sep_11_39(17)_7750-7763.nxml.txt.nlp	21666256	SENT265	9	9	7	7	galactose	PDE12	PA449725	201626	0.704
NULL	Br_J_Pharmacol_2012_Apr_165(8)_2611-2619.nxml.txt.nlp	21718301	SENT198	6	6	10	10	rimonabant	GPR55	PA152407999	9290	0.704
NULL	Iran_J_Psychiatry_2010_Spring_5(2)_60-65.nxml.txt.nlp	22952493	SENT46	13	13	24	24	naltrexone	DBT	PA450588	1629	0.704
NULL	J_Oncol_2009_Mar_24_2009_491985.nxml.txt.nlp	19325924	SENT159	13	13	8	8	genistein	CXCL12	PA165109660	6387	0.704
NULL	Cell_Commun_Signal_2014_Mar_11_12_16.nxml.txt.nlp	24618498	SENT240	34	34	41	41	fludarabine	STAT3	PA449655	6774	0.704
NULL	Drug_Des_Devel_Ther_2014_Sep_23_8_1527-1538.nxml.txt.nlp	25284985	SENT214	41	41	39	39	celecoxib	IFN	PA448871	3439	0.704
NULL	J_Inflamm_(Lond)_2008_Jul_29_5_11.nxml.txt.nlp	18664275	SENT66	15	15	7	7	erythromycin	IL-8	PA449493	3576	0.704
NULL	Acta_Pharmacol_Sin_2011_Oct_12_32(10)_1259-1265.nxml.txt.nlp	21909126	SENT114	7	7	26	26	rosuvastatin	LOX-1	PA134308647	4973	0.704
NULL	Front_Oncol_2014_May_26_4_123.nxml.txt.nlp	24904834	SENT374	12	12	7	7	resveratrol	AMPK		5563	0.704
NULL	J_Biol_Chem_2008_Oct_31_283(44)_29841-29846.nxml.txt.nlp	18765669	SENT152	9	9	14	14	suramin	P2X1	PA10292	5023	0.704
NULL	Breast_Cancer_Res_2007_Mar_2_9(2)_205.nxml.txt.nlp	NULL	SENT26	11	11	31	31	canertinib	HER-2	PA134687925	2064	0.704
NULL	Ther_Clin_Risk_Manag_2006_Sep_2(3)_235-249.nxml.txt.nlp	18360599	SENT325	26	26	24	24	alendronate	PTH	PA448082	5741	0.704
NULL	Acta_Pharmacol_Sin_2010_Jul_28_31(7)_867-873.nxml.txt.nlp	20581857	SENT155	1	1	21	21	docetaxel	PDCD4	PA449383	27250	0.704
NULL	Korean_Circ_J_2013_Jul_31_43(7)_443-452.nxml.txt.nlp	23964290	SENT161	8	8	1	1	paclitaxel	DES	PA450761	1674	0.704
NULL	Virol_J_2008_Sep_26_5_109.nxml.txt.nlp	18822145	SENT10	25	25	28	28	ribavirin	IMP	PA451241	8315	0.704
NULL	Mol_Brain_2014_Nov_26_7(1)_85.nxml.txt.nlp	NULL	SENT309	3	3	12	12	atorvastatin	IL-10	PA448500	3586	0.704
NULL	Breast_Cancer_Res_2008_Apr_22_10(2)_R33.nxml.txt.nlp	18430202	SENT330	24	24	4	4	paclitaxel	CHIP	PA450761	10273	0.704
NULL	Breast_Cancer_Res_2000_Mar_12_2(Suppl_1)_P7_04.nxml.txt.nlp	NULL	SENT12	14	14	5	5	cisplatin	BRCA1	PA449014	672	0.704
NULL	Acta_Pharmacol_Sin_2010_Dec_3_31(12)_1635-1642.nxml.txt.nlp	21127497	SENT137	2	2	15	15	phenylbutazone	UGT	PA450932	7361;7355	0.704
NULL	Emerg_Infect_Dis_2013_Mar_19(3)_449-455.nxml.txt.nlp	23622714	SENT105	3	3	1	1	pyrazinamide	DST	PA451182	667	0.704
NULL	Multidiscip_Respir_Med_2013_Feb_13_8(1)_13.nxml.txt.nlp	23406847	SENT5	14	14	10	10	pyrazinamide	EMB	PA451182	133418	0.704
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_321-328.nxml.txt.nlp	21372824	SENT182	28	28	9	9	phenylephrine	STZ	PA450935	6484	0.704
NULL	Oncotarget_2014_Oct_16_5(20)_9546-9563.nxml.txt.nlp	25337673	SENT109	13	13	22	22	lapatinib	AXL	PA152241907	558	0.704
NULL	Brain_Sci_2014_Mar_14_4(1)_136-149.nxml.txt.nlp	24961704	SENT26	4	4	14	14	sevoflurane	spatial	PA451341	219793	0.704
NULL	Int_J_Alzheimers_Dis_2012_Feb_1_2012_109324.nxml.txt.nlp	22506129	SENT159	33	33	30	30	simvastatin	ZO-1	PA451363	7082	0.704
NULL	Cell_Commun_Signal_2013_Nov_11_11_86.nxml.txt.nlp	24215724	SENT60	26	26	28	28	thrombin	PAR1	PA451674	79581;2149	0.704
NULL	Eur_J_Haematol_2014_Feb_25_92(2)_127-136.nxml.txt.nlp	24118452	SENT89	6	6	16	16	anagrelide	CRT	PA164742986	811	0.704
NULL	Br_J_Cancer_2010_Sep_28_103(7)_1008-1018.nxml.txt.nlp	20736947	SENT59	20	20	15	15	docetaxel	PC-3	PA449383	692094	0.704
NULL	Acta_Pharmacol_Sin_2009_Jun_5_30(6)_859-867.nxml.txt.nlp	19498425	SENT75	13	13	20	20	carbachol	CA1	PA448784	759	0.704
NULL	J_Cell_Mol_Med_2013_Nov_9_17(11)_1484-1493.nxml.txt.nlp	24015932	SENT122	26	26	21	21	berberine	PAO	PA165860812	196743;54498	0.704
NULL	Case_Rep_Oncol_2012_Dec_6_5(3)_644-650.nxml.txt.nlp	23275780	SENT78	9	9	11	11	gefitinib	EGFR	PA131301952	1956	0.704
NULL	Emerg_Infect_Dis_2012_Jan_18(1)_86-90.nxml.txt.nlp	22257484	SENT76	4	4	15	15	caspofungin	HS1	PA164743013	10971;1917;3059	0.704
NULL	Br_J_Cancer_2009_Mar_10_100(5)_758-763.nxml.txt.nlp	19259094	SENT103	19	19	17	17	decitabine	p16	PA164749631	1029	0.704
NULL	J_Cell_Mol_Med_2014_Apr_20_18(4)_709-720.nxml.txt.nlp	24444314	SENT162	1	1	5	5	metformin	p53	PA450395	7157	0.704
NULL	Biochem_Biophys_Res_Commun_2009_Apr_17_381(4)_523-527.nxml.txt.nlp	19239903	SENT313	33	33	30	30	betaine	BHMT	PA448603	635	0.704
NULL	Mol_Neurobiol_2007_Oct_10_36(2)_137-151.nxml.txt.nlp	17952658	SENT82	27	27	16	16	vasopressin	CXCL12	PA451858	6387	0.704
NULL	Gastric_Cancer_2013_Dec_14_16(4)_513-520.nxml.txt.nlp	23238856	SENT223	3	3	14	14	hyaluronan	LYVE-1	PA165958431	10894	0.704
NULL	Diabetes_2009_Feb_58(2)_344-351.nxml.txt.nlp	19008341	SENT13	7	7	12	12	resveratrol	SIRT1		23411	0.704
NULL	Oncoimmunology_2013_Dec_1_2(12)_e26937.nxml.txt.nlp	24498561	SENT55	7	7	17	17	docetaxel	CEA	PA449383	5670;1087	0.704
NULL	Arthritis_Res_Ther_2011_Feb_4_13(1)_R14.nxml.txt.nlp	21294864	SENT115	4	4	29	29	indomethacin	IL-6	PA449982	3569	0.704
NULL	Br_J_Pharmacol_2011_May_163(2)_261-271.nxml.txt.nlp	21054345	SENT192	18	18	23	23	rolipram	GLP-1	PA153906323	100125288	0.704
NULL	Biochem_Res_Int_2011_Oct_28_2011_191670.nxml.txt.nlp	21152183	SENT176	35	35	0	0	urokinase	MMP-25	PA451836	79148	0.704
NULL	Nucleic_Acids_Res_2012_Jul_5_40(13)_5988-6000.nxml.txt.nlp	22492511	SENT286	10	10	26	26	flavopiridol	MYB	PA452627	4602	0.704
NULL	J_Cell_Mol_Med_2013_Nov_1_17(11)_1475-1483.nxml.txt.nlp	24118735	SENT40	26	26	36	36	heparin	San	PA449855	80218	0.704
NULL	Breast_Cancer_Res_2013_Oct_1_15(5)_R92.nxml.txt.nlp	24286369	SENT390	27	27	17	17	everolimus	HER2	PA164746311	2064	0.704
NULL	Br_J_Cancer_2009_Oct_6_101(7)_1155-1161.nxml.txt.nlp	19738614	SENT1	8	8	13	13	gemcitabine	MUC4	PA449748	4585	0.704
NULL	Oncotarget_2014_Feb_7_5(3)_775-787.nxml.txt.nlp	24519956	SENT7	8	8	2	2	dasatinib	PC3	PA162372878	57332;7832;5122	0.704
NULL	Br_J_Cancer_2013_Mar_19_108(5)_1079-1091.nxml.txt.nlp	23449353	SENT186	43	43	15	15	docetaxel	MIC-1	PA449383	29919;9518	0.704
NULL	Ther_Clin_Risk_Manag_2006_Jun_2(2)_129-158.nxml.txt.nlp	18360588	SENT88	32	32	21	21	voriconazole	Yes	PA10233	7525	0.704
NULL	Breast_Cancer_Res_2005_Jul_18_7(5)_187-189.nxml.txt.nlp	16168136	SENT23	14	14	5	5	tamoxifen	HER2	PA451581	2064	0.704
NULL	J_Cell_Biol_1983_Jul_1_97(1)_92-98.nxml.txt.nlp	6306015	SENT11	4	4	12	12	amiloride	EGF	PA448368	1950	0.704
NULL	Front_Genet_2014_Jul_25_5_241.nxml.txt.nlp	25120558	SENT194	25	25	43	43	l-histidine	TYR	PA449882	7299	0.704
NULL	Front_Cell_Neurosci_2013_Dec_3_7_224.nxml.txt.nlp	24348327	SENT1884	7	7	9	9	rosiglitazone	spatial	PA451283	219793	0.704
NULL	J_Physiol_2007_Nov_15_585(Pt_1)_263-277.nxml.txt.nlp	17916609	SENT37	6	6	8	8	dextran	mol	PA449261	90527	0.704
NULL	J_Biol_2005_Feb_15_4(1)_3.nxml.txt.nlp	15720724	SENT158	45	45	7	7	gentamicin	HEK	PA449753	2042	0.704
NULL	Leukemia_2014_Apr_14_28(4)_961-964.nxml.txt.nlp	24418991	SENT13	13	13	19	19	nilotinib	P-gp	PA165958345	5243	0.704
NULL	J_Cell_Biol_2000_Feb_21_148(4)_755-768.nxml.txt.nlp	10684256	SENT36	11	11	13	13	dextran	mol	PA449261	90527	0.704
NULL	J_Biol_Chem_2013_Feb_8_288(6)_3918-3928.nxml.txt.nlp	23239877	SENT135	7	7	27	27	thrombin	PAR4	PA451674	9002;5074	0.704
NULL	Arch_Med_Sci_2012_Nov_9_8(5)_899-906.nxml.txt.nlp	23185202	SENT122	0	0	3	3	acarbose	adiponectin	PA448010	9370	0.704
NULL	Oncotarget_2014_Oct_21_5(22)_11709-11722.nxml.txt.nlp	25365944	SENT93	5	5	20	20	metformin	AMPK	PA450395	5563	0.704
NULL	Clin_Ophthalmol_2014_Jun_13_8_1105-1118.nxml.txt.nlp	24966664	SENT193	0	0	8	8	bevacizumab	San	PA130232992	80218	0.704
NULL	Scientifica_(Cairo)_2012_Nov_25_2012_473829.nxml.txt.nlp	24278698	SENT343	33	33	16	16	cisplatin	OCT2	PA449014	6582;5452	0.704
NULL	Genome_Biol_2008_Nov_25_9(11)_R166.nxml.txt.nlp	19032775	SENT283	0	0	2	2	suramin	EGFR	PA10292	1956	0.704
NULL	Exp_Hematol_Oncol_2013_Dec_6_2_32.nxml.txt.nlp	24314093	SENT107	5	5	22	22	everolimus	NNT	PA164746311	23530	0.704
NULL	Breast_Cancer_Res_2012_Jul_23_14(4)_R112.nxml.txt.nlp	22824341	SENT237	21	21	15	15	doxorubicin	RANKL	PA449412	8600	0.704
NULL	Acta_Pharmacol_Sin_2011_Dec_7_32(12)_1433-1445.nxml.txt.nlp	22056617	SENT237	0	0	5	5	lamotrigine	CA3	PA450164	761	0.704
NULL	Mol_Cancer_2010_May_18_9_110.nxml.txt.nlp	20482802	SENT184	21	21	11	11	bortezomib	CHOP	PA10252	1649	0.704
NULL	Curr_Gerontol_Geriatr_Res_2012_Mar_4_2012_361218.nxml.txt.nlp	22474448	SENT6	19	19	9	9	estradiol	HSD1	PA449503	26871	0.704
NULL	J_Adv_Pract_Oncol_2013_Jul_1_Jul-Aug_4(4)_238-250.nxml.txt.nlp	25032004	SENT123	31	31	25	25	imatinib	CML	PA10804	613	0.704
NULL	Oncol_Lett_2013_Jul_8_6(1)_75-80.nxml.txt.nlp	23946780	SENT173	4	4	20	20	sulindac	AP-1	PA451565	2353;3727;2354;3725	0.704
NULL	Diagn_Pathol_2006_Aug_15_1_19.nxml.txt.nlp	16911776	SENT54	31	31	33	33	gefitinib	EGFR	PA131301952	1956	0.704
NULL	Br_J_Cancer_2011_Jul_12_105(2)_272-280.nxml.txt.nlp	21712826	SENT14	29	29	22	22	tamoxifen	aromatase	PA451581	1588	0.704
NULL	Ecancermedicalscience_2010_Feb_3_4_164.nxml.txt.nlp	22276026	SENT805	8	8	10	10	bevacizumab	EGFR	PA130232992	1956	0.704
NULL	J_Korean_Med_Sci_2009_Jan_29_24(Suppl_1)_S170-S175.nxml.txt.nlp	19194548	SENT117	10	10	31	31	cisplatin	EPO	PA449014	7076;8288;2056	0.704
NULL	Korean_Circ_J_2013_May_31_43(5)_343-346.nxml.txt.nlp	23755082	SENT52	16	16	8	8	prasugrel	DES	PA154410481	1674	0.704
NULL	EMBO_J_2009_Apr_22_28(8)_1043-1054.nxml.txt.nlp	19300439	SENT121	14	14	31	31	pp2	p38		10598;1432;7965	0.704
NULL	J_Young_Pharm_2010_Apr-Jun_2(2)_169-172.nxml.txt.nlp	21264121	SENT29	10	10	7	7	ethanol	mol	PA448073	90527	0.704
NULL	Exp_Ther_Med_2014_Aug_4_8(2)_657-661.nxml.txt.nlp	25009636	SENT24	10	10	16	16	propofol	CCL2	PA451141	6347	0.704
NULL	Cancer_Cell_Int_2010_Aug_13_10_26.nxml.txt.nlp	20707917	SENT135	30	30	15	15	doxorubicin	RhoA	PA449412	387	0.704
NULL	Mol_Cancer_2010_Apr_23_9_87.nxml.txt.nlp	20416058	SENT204	27	27	11	11	doxorubicin	TRAIL	PA449412	8743	0.704
NULL	Mol_Med_Rep_2014_Oct_23_10(4)_1717-1724.nxml.txt.nlp	25069516	SENT97	30	30	14	14	resveratrol	PC-3		692094	0.704
NULL	Oncotarget_2011_Mar_27_2(3)_209-221.nxml.txt.nlp	21444945	SENT221	5	5	17	17	bortezomib	p53	PA10252	7157	0.704
NULL	Environ_Health_Perspect_2006_Apr_26_114(4)_620-626.nxml.txt.nlp	16581556	SENT194	43	43	40	40	capsaicin	TRPV1	PA448776	7442	0.704
NULL	Iran_J_Basic_Med_Sci_2011_Sep-Oct_14(5)_436-442.nxml.txt.nlp	23493930	SENT104	33	33	3	3	glibenclamide	ANOVA	PA449782	4858	0.704
NULL	J_Biomed_Sci_2013_Mar_15_20(1)_17.nxml.txt.nlp	23497194	SENT27	14	14	24	24	rivaroxaban	COX	PA165958360	1351	0.703
NULL	Crit_Care_2003_Jul_16_7(5)_374-384.nxml.txt.nlp	12974970	SENT242	0	0	3	3	cyanocobalamin	B12	PA451892	7126;4709	0.703
NULL	Int_J_Mol_Sci_2012_Apr_16_13(4)_4831-4838.nxml.txt.nlp	22606012	SENT24	7	7	25	25	curcumin	Bcl-2	PA151958596	596	0.703
NULL	Biomed_Res_Int_2013_Nov_5_2013_703626.nxml.txt.nlp	24298554	SENT118	14	14	22	22	ethanol	BAX	PA448073	581	0.703
NULL	Mol_Cancer_2012_Dec_12_11_91.nxml.txt.nlp	23234355	SENT51	0	0	4	4	erlotinib	HER2	PA134687924	2064	0.703
NULL	J_Gen_Physiol_2003_Jan_121(1)_37-47.nxml.txt.nlp	12508052	SENT28	15	15	23	23	tetracaine	CNGA2	PA451638	1260	0.703
NULL	Oncoimmunology_2013_Dec_1_2(12)_e27186.nxml.txt.nlp	24498569	SENT27	5	5	10	10	etanercept	IL-2	PA449515	3558	0.703
NULL	Cancer_Cell_Int_2013_Jun_26_13_63.nxml.txt.nlp	23800022	SENT115	24	24	16	16	genistein	MDM2	PA165109660	4193	0.703
NULL	Clin_Med_Insights_Oncol_2011_Sep_21_5_315-323.nxml.txt.nlp	22084620	SENT74	3	3	23	23	gemcitabine	IFN	PA449748	3439	0.703
NULL	Arthritis_Res_Ther_2012_May_1_14(3)_R99.nxml.txt.nlp	22546542	SENT68	13	13	21	21	fluorescein	CD4	PA164746009	920	0.703
NULL	Breast_Cancer_Res_Treat_2013_Jan_6_137(1)_167-174.nxml.txt.nlp	23129173	SENT210	39	39	24	24	letrozole	aromatase	PA450196	1588	0.703
NULL	Hum_Genomics_2010_Oct_1_5(1)_61-72.nxml.txt.nlp	21106490	SENT64	7	7	17	17	midazolam	CYP3A	PA450496	1574	0.703
NULL	Oncotarget_2014_Oct_16_5(22)_11442-11451.nxml.txt.nlp	25347345	SENT77	7	7	17	17	oxaliplatin	IL8	PA131285527	3576	0.703
NULL	J_Gynecol_Oncol_2014_Apr_9_25(2)_130-135.nxml.txt.nlp	24761217	SENT119	1	1	10	10	paclitaxel	CYP3A4	PA450761	1576	0.703
NULL	Trials_2012_Nov_29_13_228.nxml.txt.nlp	23190503	SENT48	26	26	22	22	gemcitabine	Gem	PA449748	51053	0.703
NULL	Exp_Diabetes_Res_2011_Dec_27_2011_604989.nxml.txt.nlp	21253359	SENT100	8	8	22	22	clonidine	GLP-1	PA449051	100125288	0.703
NULL	Arthritis_Res_Ther_2006_Jul_27_8(4)_R135.nxml.txt.nlp	16872525	SENT159	14	14	37	37	ethanol	cPGES	PA448073	10728	0.703
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1021.nxml.txt.nlp	24457965	SENT66	11	11	34	34	cisplatin	NAC	PA449014	22861	0.703
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT96	2	2	10	10	pertuzumab	HER2		2064	0.703
NULL	Alcohol_Res_2012_34(4)_484-494.nxml.txt.nlp	23584114	SENT129	11	11	23	23	naltrexone	Ray	PA450588	26751	0.703
NULL	Asian-Australas_J_Anim_Sci_2014_Dec_27(12)_1783-1793.nxml.txt.nlp	25358373	SENT130	30	30	6	6	capsaicin	PPARG	PA448776	5468	0.703
NULL	Acta_Pharmacol_Sin_2013_Mar_21_34(3)_373-379.nxml.txt.nlp	23334240	SENT37	6	6	9	9	raloxifene	NQO1	PA451221	1728	0.703
NULL	J_Int_Soc_Sports_Nutr_2010_Jul_7_7_26.nxml.txt.nlp	20609257	SENT108	8	8	23	23	creatine	ANOVA	PA164778930	4858	0.703
NULL	Int_J_Surg_Oncol_2012_Aug_27_2012_180574.nxml.txt.nlp	22970358	SENT27	19	19	7	7	letrozole	IMPACT	PA450196	55364	0.703
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT39	0	0	11	11	metformin	EGFR	PA450395	1956	0.703
NULL	Subst_Abuse_Rehabil_2011_Mar_16_2_11-20.nxml.txt.nlp	24474851	SENT39	25	25	9	9	ketamine	CYP3A4	PA450144	1576	0.703
NULL	Biomed_Res_Int_2013_Mar_17_2013_315980.nxml.txt.nlp	23586031	SENT25	32	32	38	38	warfarin	VKORC1	PA451906	79001	0.703
NULL	Oncol_Lett_2013_Dec_4_6(6)_1665-1672.nxml.txt.nlp	24273604	SENT138	22	22	36	36	chloroquine	p53	PA448948	7157	0.703
NULL	Oncotarget_2012_Dec_30_3(12)_1505-1521.nxml.txt.nlp	23455493	SENT254	2	2	19	19	metformin	CD34	PA450395	947	0.703
NULL	Health_Policy_Plan_2013_Sep_17_28(6)_616-625.nxml.txt.nlp	23161588	SENT119	18	18	23	23	artesunate	IPT	PA165111697	54802	0.703
NULL	Cancer_2012_Mar_15_118(6)_1474-1485.nxml.txt.nlp	21837668	SENT61	12	12	31	31	ifosfamide	GM-CSF	PA449964	1437	0.703
NULL	Biosci_Rep_2014_Jan_14_34(1)_e00089.nxml.txt.nlp	24299025	SENT127	2	2	6	6	allopurinol	DPI	PA448320	1832	0.703
NULL	Arthritis_Res_Ther_2011_Mar_24_13(2)_R51.nxml.txt.nlp	21435232	SENT222	32	32	41	41	infliximab	TWEAK	PA452639	8742	0.703
NULL	Cardiovasc_Diabetol_2013_May_4_12_73.nxml.txt.nlp	23642288	SENT95	4	4	10	10	acarbose	GLP-1	PA448010	100125288	0.703
NULL	Acta_Pharmacol_Sin_2009_Jul_22_30(7)_956-964.nxml.txt.nlp	19543298	SENT220	12	12	19	19	atorvastatin	ANOVA	PA448500	4858	0.703
NULL	Cancer_Imaging_2012_Mar_7_12(1)_72-78.nxml.txt.nlp	22418445	SENT40	4	4	16	16	zinc	HCC	PA451956	84668	0.703
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Oct_23_69(Pt_11)_o1687-o1688.nxml.txt.nlp	24454117	SENT80	25	25	31	31	piperazine	mol	PA450977	90527	0.703
NULL	Front_Neural_Circuits_2013_Sep_20_7_148.nxml.txt.nlp	24065892	SENT184	13	13	8	8	scopolamine	MOB	PA451308	259230	0.703
NULL	J_Mol_Signal_2012_Aug_16_7_12.nxml.txt.nlp	22898329	SENT314	8	8	15	15	cisplatin	TRAIL	PA449014	8743	0.703
NULL	Fibrogenesis_Tissue_Repair_2012_Jul_23_5_11.nxml.txt.nlp	22824096	SENT335	13	13	23	23	azathioprine	NAC	PA448515	22861	0.703
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT300	27	27	32	32	bevacizumab	VEGFR2	PA130232992	3791	0.703
NULL	J_Vis_Exp_2011_Jul_17_(53)_2858.nxml.txt.nlp	21788935	SENT43	9	9	25	25	choline	TES	PA448976	26136	0.703
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT258	2	2	0	0	mitomycin	MVP	PA450524	9961	0.703
NULL	Eur_J_Clin_Pharmacol_2013_Jan_11_69(6)_1275-1283.nxml.txt.nlp	23307232	SENT10	9	9	12	12	warfarin	CYP2C9	PA451906	1559	0.703
NULL	Cancer_Med_2013_Aug_2_2(4)_571-582.nxml.txt.nlp	24156030	SENT182	8	8	14	14	curcumin	CD4	PA151958596	920	0.703
NULL	BMJ_2010_Feb_8_340_c693.nxml.txt.nlp	20142325	SENT258	25	25	41	41	imipramine	CYP3A4	PA449969	1576	0.703
NULL	Open_Dent_J_2014_May_30_8_109-124.nxml.txt.nlp	24976875	SENT374	1	1	14	14	doxycycline	RANKL	PA449415	8600	0.703
NULL	Br_J_Cancer_2011_Apr_26_104(9)_1459-1471.nxml.txt.nlp	21522149	SENT74	30	30	12	12	hydrocortisone	F12	PA449905	2161	0.703
NULL	Int_J_Mol_Sci_2014_May_12_15(5)_8335-8351.nxml.txt.nlp	24823879	SENT1165	10	10	5	5	perifosine	TRAIL	PA165291471	8743	0.703
NULL	Br_J_Cancer_2013_Feb_19_108(3)_570-578.nxml.txt.nlp	23299527	SENT211	2	2	10	10	acetohexamide	ALOX12	PA164777011	239	0.703
NULL	Front_Oncol_2014_Oct_22_4_288.nxml.txt.nlp	25374843	SENT207	18	18	21	21	letrozole	TH1	PA450196	51497	0.703
NULL	Drug_Saf_2014_Feb_19_37(4)_201-211.nxml.txt.nlp	24550106	SENT163	9	9	15	15	rabeprazole	CYP2C19	PA451216	1557	0.703
NULL	Hum_Mol_Genet_2013_Nov_15_22(22)_4602-4615.nxml.txt.nlp	23814040	SENT144	31	31	18	18	l-cysteine	COX	PA449173	1351	0.703
NULL	Nucleic_Acids_Res_2005_Mar_1_33(4)_1280-1289.nxml.txt.nlp	15741181	SENT97	6	6	1	1	cisplatin	REV1	PA449014	51455	0.703
NULL	Int_J_Mol_Sci_2014_Oct_6_15(10)_17886-17900.nxml.txt.nlp	25290095	SENT160	13	13	27	27	resveratrol	SIRT1		23411	0.703
NULL	Pharmaceuticals_(Basel)_2012_Sep_17_5(9)_1021-1031.nxml.txt.nlp	24280703	SENT38	2	2	4	4	chlorpromazine	CPZ	PA448964	8532	0.703
NULL	Cardiovasc_Diabetol_2013_Nov_12_12_169.nxml.txt.nlp	24215514	SENT291	10	10	20	20	aliskiren	ANG	PA143487910	283	0.703
NULL	Front_Microbiol_2013_Dec_2_4_362.nxml.txt.nlp	24348471	SENT302	18	18	26	26	ethanol	FISH	PA448073	9644	0.703
NULL	Mol_Cancer_2009_Nov_24_8_109.nxml.txt.nlp	19930708	SENT13	18	18	7	7	exemestane	EGFR	PA449563	1956	0.703
NULL	Mol_Cancer_2010_Nov_8_9_291.nxml.txt.nlp	21059223	SENT22	4	4	29	29	zinc	ZNF217	PA451956	7764	0.703
NULL	Br_J_Pharmacol_2014_Dec_24_171(23)_5431-5445.nxml.txt.nlp	25052258	SENT41	36	36	18	18	l-glutamine	F12	PA10090	2161	0.703
NULL	Oncotarget_2013_Dec_18_5(2)_375-385.nxml.txt.nlp	24495868	SENT19	10	10	20	20	flavopiridol	MCL1	PA452627	4170	0.703
NULL	Oncotarget_2012_Sep_28_3(10)_1169-1181.nxml.txt.nlp	23045411	SENT254	7	7	4	4	doxorubicin	JNK	PA449412	5599	0.703
NULL	Ann_N_Y_Acad_Sci_2012_Aug_30_1264(1)_49-63.nxml.txt.nlp	22548651	SENT48	8	8	23	23	glucose	BDNF	PA449773	627	0.703
NULL	Front_Behav_Neurosci_2013_Dec_23_7_211.nxml.txt.nlp	24391566	SENT185	25	25	43	43	propranolol	Sara	PA451145	56681	0.703
NULL	Cancer_Manag_Res_2014_Jan_28_6_39-51.nxml.txt.nlp	24501545	SENT137	11	11	8	8	ketoconazole	CYP3A4	PA450146	1576	0.703
NULL	J_Psychosom_Res_2011_Aug_71(2)_61-68.nxml.txt.nlp	21767684	SENT136	3	3	13	13	paroxetine	IFN	PA450801	3439	0.703
NULL	J_Exp_Clin_Cancer_Res_2008_Sep_26_27(1)_48.nxml.txt.nlp	18822137	SENT45	20	20	18	18	etoposide	TRAIL	PA449552	8743	0.703
NULL	Oncotarget_2012_Nov_17_3(12)_1600-1614.nxml.txt.nlp	23307622	SENT41	0	0	28	28	trastuzumab	ATG12	PA451743	9140	0.703
NULL	J_Clin_Exp_Pathol_2012_May_17_Suppl_4_7327.nxml.txt.nlp	25379357	SENT30	21	21	26	26	resveratrol	SIRT1		23411	0.703
NULL	Emerg_Infect_Dis_2013_Jan_19(1)_133-136.nxml.txt.nlp	23260464	SENT37	19	19	29	29	cefepime	TOB	PA164754876	10140	0.703
NULL	Curr_Neuropharmacol_2008_Sep_6(3)_215-234.nxml.txt.nlp	19506722	SENT59	11	11	13	13	buspirone	5-HT1A	PA448689	3350	0.703
NULL	Indian_Dermatol_Online_J_2014_Dec_5(Suppl_2)_S76-S86.nxml.txt.nlp	25593813	SENT285	23	23	17	17	carbamazepine	HLA-A	PA448785	3105	0.703
NULL	Biologics_2012_Dec_17_6_429-464.nxml.txt.nlp	23269860	SENT162	16	16	19	19	infliximab	ACR	PA452639	49	0.703
NULL	Semin_Immunopathol_2013_Jan_26_35(1)_39-52.nxml.txt.nlp	22829332	SENT197	10	10	30	30	carmustine	CHOP	PA448810	1649	0.703
NULL	J_Immunol_Res_2014_May_21_2014_371087.nxml.txt.nlp	24963497	SENT309	21	21	7	7	decitabine	DAC	PA164749631	13	0.703
NULL	Cell_Mol_Life_Sci_2011_Jan_17_68(2)_289-301.nxml.txt.nlp	20640477	SENT339	12	12	14	14	staurosporine	ADP	PA165109623	23038	0.703
NULL	Oncogene_2010_Sep_23_29(38)_5299-5310.nxml.txt.nlp	20622903	SENT174	45	45	6	6	trypsin	HMGB1	PA451806	3146	0.703
NULL	Eur_J_Clin_Pharmacol_2014_Oct_8_70(12)_1433-1441.nxml.txt.nlp	25291992	SENT165	29	29	6	6	risperidone	FES	PA451257	2242	0.703
NULL	Front_Physiol_2013_Nov_14_4_323.nxml.txt.nlp	24294204	SENT256	17	17	7	7	carvedilol	UGT1A1	PA448817	54658	0.703
NULL	Int_J_Biol_Sci_2014_May_14_10(5)_566-575.nxml.txt.nlp	24910535	SENT71	15	15	22	22	tamoxifen	BRCA1	PA451581	672	0.703
NULL	J_Innate_Immun_2011_Dec_12_4(1)_69-79.nxml.txt.nlp	21997473	SENT208	20	20	9	9	hyaluronan	TLR4	PA165958431	7099	0.703
NULL	Mol_Brain_2014_May_15_7_37.nxml.txt.nlp	24886748	SENT125	18	18	10	10	vorinostat	RHEB	PA164748224	6008;6009	0.703
NULL	Iran_Red_Crescent_Med_J_2013_Mar_5_15(3)_249-253.nxml.txt.nlp	23984007	SENT142	5	5	12	12	carbamazepine	B12	PA448785	7126;4709	0.703
NULL	Arthritis_Res_Ther_2008_Sep_9_10(5)_R107.nxml.txt.nlp	18782442	SENT213	30	30	4	4	glucose	HNE	PA449773	1991	0.703
NULL	Front_Immunol_2013_May_16_4_114.nxml.txt.nlp	23720661	SENT1028	15	15	2	2	imiquimod	TH1	PA449972	51497	0.703
NULL	Hum_Genomics_2008_Sep_1_3(1)_7-16.nxml.txt.nlp	19129086	SENT12	21	21	14	14	rosiglitazone	SLCO1B1	PA451283	10599	0.703
NULL	J_Biol_Chem_2009_Jun_19_284(25)_17138-17146.nxml.txt.nlp	19383603	SENT85	9	9	3	3	thrombin	Atp12p	PA451674	91647	0.703
NULL	Mol_Biol_Cell_2012_Nov_1_23(21)_4212-4225.nxml.txt.nlp	22956765	SENT274	11	11	25	25	thrombin	cadherin	PA451674	1015	0.703
NULL	Clin_Med_Insights_Oncol_2011_Sep_21_5_315-323.nxml.txt.nlp	22084620	SENT122	10	10	12	12	gemcitabine	IFN	PA449748	3439	0.703
NULL	Arthritis_Res_Ther_2010_Apr_29_12(2)_R73.nxml.txt.nlp	20429888	SENT161	4	4	14	14	bortezomib	COL1A2	PA10252	1278	0.703
NULL	Diabetes_Care_2009_Sep_32(9)_e104-e111.nxml.txt.nlp	19717816	SENT235	23	23	10	10	glimepiride	GLP-1	PA449761	100125288	0.703
NULL	J_Biol_Chem_2008_Nov_7_283(45)_30735-30744.nxml.txt.nlp	18786921	SENT96	23	23	12	12	nadh	ALDH2	PA164755085	217	0.703
NULL	Iran_J_Ped_Hematol_Oncol_2014_Apr_20_4(2)_53-56.nxml.txt.nlp	25002925	SENT29	21	21	4	4	divicine	G6PD	PA166110254	2539	0.703
NULL	Clin_Infect_Dis_2011_Mar_1_52(5)_621-623.nxml.txt.nlp	21292667	SENT69	9	9	2	2	primaquine	RDT	PA451103	6598	0.703
NULL	Br_J_Cancer_2012_Feb_14_106(4)_685-692.nxml.txt.nlp	22294184	SENT247	6	6	8	8	lovastatin	L12	PA450272	26156;6136	0.703
NULL	Pharmaceuticals_(Basel)_2013_Aug_6_6(8)_929-959.nxml.txt.nlp	24276377	SENT1231	12	12	16	16	curcumin	NF-kappaB	PA151958596	4790	0.703
NULL	Ann_Oncol_2011_Aug_27_22(8)_1736-1747.nxml.txt.nlp	21709140	SENT360	2	2	7	7	letrozole	HER-2	PA450196	2064	0.703
NULL	Mol_Cancer_2008_Mar_26_7_27.nxml.txt.nlp	18366759	SENT83	12	12	19	19	etoposide	AKT2	PA449552	208	0.703
NULL	J_Biol_Chem_2010_Aug_20_285(34)_25928-25940.nxml.txt.nlp	20547488	SENT145	20	20	8	8	cisplatin	p38	PA449014	10598;1432;7965	0.703
NULL	Int_J_Womens_Health_2010_Aug_9_1_11-20.nxml.txt.nlp	21072271	SENT147	31	31	25	25	raloxifene	STAR	PA451221	6770;2984	0.703
NULL	Am_J_Case_Rep_2014_Dec_9_15_550-553.nxml.txt.nlp	25488633	SENT90	15	15	4	4	sulfasalazine	B12	PA451547	7126;4709	0.703
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_11_2013_910451.nxml.txt.nlp	23840269	SENT22	11	11	14	14	gefitinib	EGFR	PA131301952	1956	0.703
NULL	Contemp_Oncol_(Pozn)_2013_Apr_29_17(2)_113-119.nxml.txt.nlp	23788975	SENT88	0	0	29	29	thrombin	IL-6	PA451674	3569	0.703
NULL	J_Cancer_2013_Nov_23_4(9)_736-754.nxml.txt.nlp	24312144	SENT188	17	17	6	6	pemetrexed	EGFR	PA10810	1956	0.703
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT365	37	37	33	33	resveratrol	TNF		7124	0.703
NULL	Brain_Res_2012_Feb_3_1436(C)_111-121.nxml.txt.nlp	22200378	SENT60	5	5	1	1	haloperidol	P-gp	PA449841	5243	0.703
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT31	10	10	7	7	midazolam	CYP3A	PA450496	1574	0.703
NULL	Oncotarget_2013_May_11_4(6)_830-843.nxml.txt.nlp	23919981	SENT50	5	5	17	17	temsirolimus	CXCL10	PA164746890	3627	0.703
NULL	Surg_Today_2012_Jan_6_42(1)_8-28.nxml.txt.nlp	22139128	SENT271	20	20	10	10	tegafur	PSK	PA452620	9344	0.703
NULL	Br_J_Cancer_1998_Nov_78(9)_1170-1174.nxml.txt.nlp	9820175	SENT13	40	40	42	42	bufuralol	CYP2D6	PA166110256	1565	0.703
NULL	Nucleic_Acids_Res_2010_Oct_27_38(18)_6247-6264.nxml.txt.nlp	20507916	SENT207	3	3	1	1	pp2	PP1		5540;5464	0.703
NULL	Indian_J_Endocrinol_Metab_2012_Dec_16(Suppl_2)_S498-S500.nxml.txt.nlp	23565478	SENT50	23	23	27	27	rosuvastatin	Q10	PA134308647	27161	0.703
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1986-2011.nxml.txt.nlp	25268165	SENT474	4	4	2	2	niclosamide	STAT3	PA165958408	6774	0.703
NULL	Int_Neurourol_J_2012_Mar_31_16(1)_2-12.nxml.txt.nlp	22500248	SENT134	10	10	5	5	staurosporine	TXNIP	PA165109623	10628	0.703
NULL	Theranostics_2013_Jan_15_3(1)_47-75.nxml.txt.nlp	23382786	SENT16	7	7	4	4	plerixafor	CXCR4	PA165958410	7852	0.703
NULL	Exp_Lung_Res_2013_Oct_1_39(8)_336-348.nxml.txt.nlp	23919450	SENT90	6	6	0	0	thrombin	PAR-1	PA451674	2011;2149	0.703
NULL	J_Vet_Med_Sci_2014_Nov_22_76(11)_1443-1450.nxml.txt.nlp	25452258	SENT164	24	24	12	12	papain	IL-6	PA450778	3569	0.703
NULL	Evid_Based_Complement_Alternat_Med_2014_Sep_3_2014_809083.nxml.txt.nlp	25276218	SENT215	12	12	17	17	berberine	IRAK1	PA165860812	3654	0.703
NULL	EJNMMI_Res_2011_Jun_7_1_1.nxml.txt.nlp	21845232	SENT34	0	0	11	11	panitumumab	EGFR	PA162373091	1956	0.703
NULL	Acta_Myol_2010_Oct_29(2)_343-350.nxml.txt.nlp	21314017	SENT200	7	7	4	4	edrophonium	DOK7	PA449437	285489	0.703
NULL	Iran_Red_Crescent_Med_J_2014_Aug_5_16(8)_e6915.nxml.txt.nlp	25389496	SENT32	17	17	22	22	simvastatin	adiponectin	PA451363	9370	0.703
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S31-S40.nxml.txt.nlp	20680106	SENT49	33	33	24	24	cetuximab	KRAS	PA10040	3845	0.703
NULL	Acta_Pharmacol_Sin_2009_Apr_3_30(4)_478-484.nxml.txt.nlp	19343062	SENT123	13	13	18	18	cyclosporine	CYP3A4	PA449167	1576	0.703
NULL	J_Hematol_Oncol_2014_Aug_20_7_62.nxml.txt.nlp	25139395	SENT287	6	6	4	4	oxaliplatin	survivin	PA131285527	332	0.703
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1150.nxml.txt.nlp	24675468	SENT103	34	34	6	6	ethanol	adiponectin	PA448073	9370	0.703
NULL	Eur_J_Clin_Pharmacol_2011_May_8_67(5)_493-506.nxml.txt.nlp	21140139	SENT206	8	8	0	0	oxycodone	CYP3A4	PA450741	1576	0.703
NULL	BioDrugs_2013_May_9_27(5)_469-478.nxml.txt.nlp	23658121	SENT315	12	12	28	28	trastuzumab	HER2	PA451743	2064	0.703
NULL	Br_J_Cancer_2010_Mar_16_102(6)_1003-1009.nxml.txt.nlp	20179710	SENT108	12	12	7	7	trastuzumab	ERBB2	PA451743	2064	0.703
NULL	Pharmaceuticals_(Basel)_2011_Nov_11_4(11)_1503-1517.nxml.txt.nlp	NULL	SENT154	7	7	16	16	capsaicin	TRPV1	PA448776	7442	0.703
NULL	Case_Rep_Dermatol_2012_Jul_12_4(2)_158-162.nxml.txt.nlp	22807901	SENT44	0	0	25	25	tacrolimus	IFN	PA451578	3439	0.703
NULL	Breast_Cancer_Res_2010_Aug_23_12(4)_R64.nxml.txt.nlp	20731819	SENT312	13	13	7	7	tamoxifen	CYP2D6	PA451581	1565	0.703
NULL	Clin_Pharmacol_2012_Feb_20_4_13-20.nxml.txt.nlp	22427735	SENT70	16	16	11	11	clopidogrel	ADP	PA449053	23038	0.703
NULL	Breast_Cancer_Res_2010_Jul_1_12(4)_R45.nxml.txt.nlp	20594311	SENT179	30	30	39	39	nelfinavir	BTZ	PA450606	22794	0.703
NULL	Crit_Care_2011_Apr_20_15(2)_221.nxml.txt.nlp	21586104	SENT181	17	17	10	10	niacin	adiponectin	PA450617	9370	0.703
NULL	Front_Neurol_2013_Nov_6_4_176.nxml.txt.nlp	24223570	SENT195	8	8	10	10	pirenzepine	PIR	PA10159	8544	0.703
NULL	J_Biomed_Sci_2014_Nov_18_21(1)_99.nxml.txt.nlp	25407417	SENT16	10	10	16	16	oseltamivir	CCR2	PA450721	729230	0.703
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT927	5	5	22	22	etravirine	TRIO	PA166014703	7204	0.703
NULL	J_Cancer_2014_Jul_4_5(7)_559-571.nxml.txt.nlp	25057307	SENT402	13	13	4	4	tamoxifen	CYP2D6	PA451581	1565	0.703
NULL	Cell_Cycle_2013_May_15_12(10)_1492-1500.nxml.txt.nlp	23598717	SENT54	0	0	16	16	doxorubicin	ROCK1	PA449412	6093	0.703
NULL	Br_J_Cancer_1998_Nov_78(9)_1170-1174.nxml.txt.nlp	9820175	SENT13	40	40	14	14	bufuralol	CYP2C8	PA166110256	1558	0.703
NULL	Oxid_Med_Cell_Longev_2012_Jan_19_2012_390678.nxml.txt.nlp	22315655	SENT21	11	11	19	19	gliclazide	NAC	PA10892	22861	0.703
NULL	Orphanet_J_Rare_Dis_2014_Dec_5_9(1)_194.nxml.txt.nlp	NULL	SENT400	14	14	26	26	desogestrel	CO2	PA449238	4513	0.703
NULL	Cell_Commun_Signal_2010_Jun_12_8_11.nxml.txt.nlp	20540792	SENT333	20	20	6	6	thalidomide	CRBN	PA451644	51185	0.703
NULL	Biotechnol_Res_Int_2013_Dec_1_2013_253286.nxml.txt.nlp	24363937	SENT136	34	34	36	36	urea	DAP	PA451831	23549;3375;1611	0.703
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT297	24	24	16	16	heparin	FGF1	PA449855	2246	0.703
NULL	Contemp_Clin_Dent_2013_Jan-Mar_4(1)_48-53.nxml.txt.nlp	23853452	SENT15	6	6	14	14	minocycline	CAL	PA450519	54751;57120	0.703
NULL	CNS_Drugs_2014_Jul_20_28(11)_1059-1069.nxml.txt.nlp	25038977	SENT2	14	14	16	16	atomoxetine	ATX	PA134688071	5168;23049	0.703
NULL	Breast_Cancer_Res_2010_Apr_9_12(2)_202.nxml.txt.nlp	20398329	SENT149	19	19	3	3	tamoxifen	PTEN	PA451581	5728	0.703
NULL	Br_J_Cancer_2013_Jul_23_109(2)_502-511.nxml.txt.nlp	23799850	SENT192	17	17	15	15	gemcitabine	SMARCC1	PA449748	6599	0.703
NULL	Bone_Marrow_Transplant_2012_Jun_17_47(6)_770-790.nxml.txt.nlp	22002489	SENT310	24	24	26	26	rituximab	TPO	PA451261	7066;7173	0.703
NULL	Cell_Cycle_2012_Nov_1_11(21)_3983-3996.nxml.txt.nlp	22987153	SENT204	18	18	9	9	mitomycin	FANCD2	PA450524	2177	0.703
NULL	Biochem_Res_Int_2012_Mar_4_2012_685267.nxml.txt.nlp	22496978	SENT214	7	7	14	14	thrombin	CXCR4	PA451674	7852	0.703
NULL	Indian_J_Psychiatry_2004_Jul-Sep_46(3)_273-274.nxml.txt.nlp	21224912	SENT6	6	6	11	11	risperidone	BPAD	PA451257	4095	0.703
NULL	Cancer_Cell_Int_2009_Sep_10_9_25.nxml.txt.nlp	19744341	SENT40	0	0	26	26	glucosamine	survivin	PA164747613	332	0.703
NULL	Iran_J_Pharm_Res_2013_Summer_12(3)_411-421.nxml.txt.nlp	24250648	SENT103	8	8	17	17	vanillin	ANOVA	PA451852	4858	0.703
NULL	F1000Res_2014_May_1_2_182.nxml.txt.nlp	25132958	SENT121	24	24	9	9	scopolamine	ANOVA	PA451308	4858	0.703
NULL	Diabetes_Care_2009_Sep_28_32(9)_1649-1655.nxml.txt.nlp	19478198	SENT165	30	30	15	15	metformin	PPG	PA450395	5552	0.703
NULL	Indian_J_Pharmacol_2008_Oct_40(Suppl_2)_S97-S112.nxml.txt.nlp	21593984	SENT733	3	3	16	16	thrombin	PAR-1	PA451674	2011;2149	0.703
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1495-1502.nxml.txt.nlp	21989186	SENT191	26	26	28	28	oxaliplatin	HSI	PA131285527	57016	0.703
NULL	J_Immunol_Res_2014_Jul_16_2014_696812.nxml.txt.nlp	25133198	SENT266	19	19	3	3	rifaximin	CTR	PA164752443	799	0.703
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1046.nxml.txt.nlp	24503538	SENT83	22	22	26	26	cyclophosphamide	FGFR4	PA449165	2264	0.703
NULL	Genetics_2013_Jan_193(1)_1-50.nxml.txt.nlp	23275493	SENT190	14	14	32	32	lipase	DAG	PA450239	1605	0.703
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_315-322.nxml.txt.nlp	20049735	SENT46	24	24	6	6	cisplatin	PTEN	PA449014	5728	0.703
NULL	Br_J_Cancer_2010_Jul_13_103(2)_265-274.nxml.txt.nlp	20551953	SENT339	19	19	43	43	cisplatin	JNK	PA449014	5599	0.703
NULL	Chin_J_Cancer_2011_Oct_30(10)_690-700.nxml.txt.nlp	21959046	SENT20	18	18	7	7	temozolomide	TPT	PA451609	23590;6469	0.703
NULL	Int_J_Biol_Sci_2014_Aug_23_10(8)_921-939.nxml.txt.nlp	25170305	SENT311	24	24	0	0	nadh	EPO	PA164755085	7076;8288;2056	0.703
NULL	J_Biol_Chem_2013_Mar_22_288(12)_8279-8288.nxml.txt.nlp	23400816	SENT228	17	17	6	6	chloroquine	PCSK9	PA448948	255738	0.703
NULL	Int_J_Breast_Cancer_2012_Feb_12_2012_124704.nxml.txt.nlp	22482058	SENT48	17	17	14	14	collagenase	MMP1	PA449107	4312	0.703
NULL	J_Exp_Clin_Cancer_Res_2009_Jul_3_28(1)_97.nxml.txt.nlp	19575783	SENT149	22	22	19	19	cisplatin	HER2	PA449014	2064	0.703
NULL	Pharmaceutics_2011_Oct_12_3(4)_680-705.nxml.txt.nlp	24309303	SENT60	1	1	23	23	repaglinide	OATP1B3	PA451234	28234	0.703
NULL	Crit_Care_1999_Dec_23_4(Suppl_A)_4.nxml.txt.nlp	NULL	SENT11	3	3	7	7	heparin	ACT	PA449855	12;11332;9457;641455	0.703
NULL	Mol_Med_Rep_2014_Oct_18_10(4)_1786-1792.nxml.txt.nlp	25050483	SENT156	13	13	2	2	fluorescein	C5a	PA164746009	727	0.703
NULL	Arch_Med_Sci_2011_Dec_31_7(6)_977-983.nxml.txt.nlp	22328880	SENT137	25	25	27	27	heparin	PAPP-A	PA449855	5069	0.703
NULL	Biol_Open_2012_Nov_23_2(2)_183-190.nxml.txt.nlp	23429853	SENT8	17	17	36	36	oxygen	ROS	PA450744	6098	0.703
NULL	J_Lipids_2011_Aug_1_2011_702853.nxml.txt.nlp	21837278	SENT126	8	8	6	6	choline	CDP	PA448976	1523	0.703
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_29_2013_327629.nxml.txt.nlp	23737827	SENT145	15	15	0	0	thioguanine	TPMT	PA451663	7172	0.703
NULL	Oncoimmunology_2012_Sep_1_1(6)_810-821.nxml.txt.nlp	23162748	SENT213	0	0	5	5	trastuzumab	San	PA451743	80218	0.703
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT9	11	11	8	8	atorvastatin	survivin	PA448500	332	0.703
NULL	Brain_Behav_2012_Jan_2(1)_68-73.nxml.txt.nlp	22574275	SENT28	24	24	13	13	oxaliplatin	TRPM8	PA131285527	79054	0.703
NULL	Oncotarget_2014_Feb_7_5(3)_775-787.nxml.txt.nlp	24519956	SENT8	0	0	11	11	dasatinib	PC3	PA162372878	57332;7832;5122	0.703
NULL	Oncol_Lett_2013_Mar_28_5(3)_983-991.nxml.txt.nlp	23426861	SENT159	14	14	4	4	docetaxel	DDP	PA449383	1678	0.703
NULL	Adv_Prev_Med_2012_Dec_6_2012_103728.nxml.txt.nlp	23304534	SENT6	19	19	38	38	ezetimibe	STAT2	PA10816	6773	0.703
NULL	Br_J_Cancer_2009_Mar_10_100(5)_834-839.nxml.txt.nlp	19174821	SENT108	17	17	19	19	trimethoprim	TMP	PA451788	2012	0.703
NULL	Exp_Diabetes_Res_2012_Apr_11_2012_728325.nxml.txt.nlp	22566995	SENT62	0	0	9	9	ranibizumab	San	PA164746012	80218	0.703
NULL	Onco_Targets_Ther_2014_May_16_7_751-759.nxml.txt.nlp	24876784	SENT13	16	16	29	29	bevacizumab	VEGF-A	PA130232992	7422	0.703
NULL	Arthritis_Res_Ther_2005_Jan_21_7(2)_55-61.nxml.txt.nlp	15743490	SENT84	2	2	22	22	atorvastatin	MCP-1	PA448500	6347	0.703
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Aug_28_66(Pt_9)_o2421.nxml.txt.nlp	21588746	SENT63	22	22	13	13	ethanol	mol	PA448073	90527	0.703
NULL	Biomed_Res_Int_2014_Apr_15_2014_175721.nxml.txt.nlp	24822180	SENT176	26	26	3	3	nutlin-3	p63		8626	0.703
NULL	Br_J_Cancer_2010_Jan_5_102(1)_134-143.nxml.txt.nlp	19920829	SENT38	0	0	7	7	pertuzumab	San		80218	0.703
NULL	Stroke_Res_Treat_2009_Dec_20_2010_386389.nxml.txt.nlp	20700422	SENT157	9	9	11	11	ebselen	NAC	PA161660841	22861	0.703
NULL	J_Oncol_2013_Feb_17_2013_872957.nxml.txt.nlp	23476648	SENT207	11	11	2	2	cisplatin	SFN	PA449014	25996;2810	0.703
NULL	J_Int_Soc_Sports_Nutr_2011_Nov_7_8(Suppl_1)_P25.nxml.txt.nlp	NULL	SENT19	18	18	20	20	creatine	GAA	PA164778930	2548	0.703
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1021.nxml.txt.nlp	24457965	SENT47	48	48	42	42	cisplatin	JNK	PA449014	5599	0.703
NULL	EMBO_Mol_Med_2012_Jul_11_4(7)_577-593.nxml.txt.nlp	22496117	SENT239	8	8	3	3	clofazimine	PAP-1	PA164748759	6100	0.703
NULL	AIDS_2014_Mar_13_28(5)_717-725.nxml.txt.nlp	24983542	SENT3	0	0	8	8	maraviroc	CCR5	PA164768835	1234	0.703
NULL	J_Cell_Biol_2005_May_23_169(4)_681-691.nxml.txt.nlp	15911882	SENT48	3	3	7	7	heparin	MMP3	PA449855	4314	0.703
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT245	2	2	0	0	mitomycin	MVP	PA450524	9961	0.703
NULL	Cell_Death_Differ_2010_Oct_19_17(10)_1566-1576.nxml.txt.nlp	20300112	SENT156	0	0	14	14	etoposide	DPI	PA449552	1832	0.703
NULL	Oncoimmunology_2013_Oct_1_2(10)_e27025.nxml.txt.nlp	24353914	SENT180	18	18	12	12	cisplatin	CD25	PA449014	3669;3559	0.703
NULL	Mol_Cancer_2013_Mar_5_12_17.nxml.txt.nlp	23497256	SENT279	41	41	44	44	tetracycline	p53	PA451640	7157	0.703
NULL	Mol_Cancer_2012_Dec_12_11_91.nxml.txt.nlp	23234355	SENT41	12	12	26	26	cetuximab	EGFR	PA10040	1956	0.703
NULL	Breast_Cancer_Res_Treat_2013_Jan_8_137(2)_457-464.nxml.txt.nlp	23224144	SENT214	2	2	7	7	letrozole	HER-2	PA450196	2064	0.703
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_9_2013_456747.nxml.txt.nlp	23653662	SENT127	2	2	8	8	berberine	NFKB1	PA165860812	4790	0.703
NULL	Anesthesiol_Res_Pract_2008_Mar_27_2008_581948.nxml.txt.nlp	21197458	SENT81	13	13	24	24	sevoflurane	RGM	PA451341	56963	0.703
NULL	Nat_Commun_2014_Nov_25_5_5548.nxml.txt.nlp	25420520	SENT118	18	18	23	23	cabazitaxel	DTE	PA165958401	199699	0.703
NULL	Acta_Pharmacol_Sin_2010_Aug_19_31(8)_963-969.nxml.txt.nlp	20644547	SENT114	2	2	9	9	fenofibrate	PDX-1	PA449594	3651	0.703
NULL	Food_Environ_Virol_2012_Mar_9_4(1)_6-13.nxml.txt.nlp	22408689	SENT49	6	6	17	17	glutaraldehyde	MS2	PA449777	101	0.703
NULL	Brain_Sci_2014_May_6_4(2)_356-375.nxml.txt.nlp	24961766	SENT138	25	25	30	30	propofol	P28	PA451141	9446;7802;9527	0.703
NULL	Evid_Based_Complement_Alternat_Med_2011_Jan_12_2011_690518.nxml.txt.nlp	19687188	SENT178	5	5	7	7	ampicillin	APCL	PA448419	10297	0.703
NULL	JAKSTAT_2013_Jul_1_2(3)_e24812.nxml.txt.nlp	24069562	SENT62	35	35	17	17	pp2	STAT3		6774	0.703
NULL	Arthritis_Res_Ther_2007_Oct_19_9(Suppl_3)_P20.nxml.txt.nlp	NULL	SENT11	23	23	8	8	infliximab	p38	PA452639	10598;1432;7965	0.703
NULL	Ann_Rheum_Dis_2013_Aug_23_72(8)_1362-1366.nxml.txt.nlp	23345600	SENT26	0	0	13	13	tocilizumab	IL-6	PA165292659	3569	0.703
NULL	Nano_Rev_2011_Feb_16_2_10_3402_nano_v2i0_5883.nxml.txt.nlp	22110867	SENT1053	22	22	9	9	ethanol	MHA	PA448073	4627	0.702
NULL	J_Korean_Med_Sci_2011_Jul_20_26(7)_893-899.nxml.txt.nlp	21738342	SENT10	4	4	9	9	genistein	CD97	PA165109660	976	0.702
NULL	J_Am_Heart_Assoc_2013_Aug_23_2(4)_e000249.nxml.txt.nlp	23817469	SENT307	2	2	17	17	creatine	APLN	PA164778930	8862	0.702
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT258	3	3	18	18	aripiprazole	PRL	PA10026	5617	0.702
NULL	Pharm_Methods_2011_Jan-Mar_2(1)_3-8.nxml.txt.nlp	23781422	SENT119	16	16	23	23	codeine	TLC	PA449088	3933	0.702
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT164	3	3	6	6	tacrolimus	SOCS3	PA451578	9021	0.702
NULL	J_Gen_Physiol_2008_Nov_132(5)_547-562.nxml.txt.nlp	18955595	SENT96	18	18	5	5	capsaicin	TRPV1	PA448776	7442	0.702
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R91.nxml.txt.nlp	22541814	SENT114	11	11	13	13	thrombin	HO-1	PA451674	3162	0.702
NULL	Adv_Ther_2014_May_13_31(5)_473-493.nxml.txt.nlp	24821599	SENT142	30	30	2	2	warfarin	TTR	PA451906	7276	0.702
NULL	Arthritis_Res_Ther_2011_Jul_6_13(4)_228.nxml.txt.nlp	21745419	SENT54	6	6	9	9	tocilizumab	IL-6	PA165292659	3569	0.702
NULL	Int_J_Cell_Biol_2012_May_20_2012_273947.nxml.txt.nlp	22675360	SENT64	19	19	9	9	nadh	ADP	PA164755085	23038	0.702
NULL	Cancers_(Basel)_2012_Sep_6_4(3)_873-903.nxml.txt.nlp	24213471	SENT1105	2	2	4	4	hyaluronan	CD44	PA165958431	960	0.702
NULL	Comp_Hepatol_2004_Jan_14_3(Suppl_1)_S31.nxml.txt.nlp	14960183	SENT11	13	13	25	25	ethanol	TNF-alpha	PA448073	7124	0.702
NULL	J_Carcinog_2011_Jun_17_10_15.nxml.txt.nlp	NULL	SENT1076	39	39	13	13	cyclophosphamide	CYP2C9	PA449165	1559	0.702
NULL	Arthritis_Res_Ther_2009_Nov_9_11(6)_R167.nxml.txt.nlp	19900268	SENT76	8	8	0	0	mitomycin	CD11c	PA450524	3687	0.702
NULL	J_Carcinog_2013_Dec_31_12_22.nxml.txt.nlp	24574860	SENT6	24	24	21	21	crizotinib	EGFR	PA165946122	1956	0.702
NULL	J_Gen_Physiol_1970_Nov_1_56(5)_583-620.nxml.txt.nlp	5475997	SENT4	9	9	18	18	creatine	ADP	PA164778930	23038	0.702
NULL	J_Biol_Chem_2013_Dec_6_288(49)_35387-35395.nxml.txt.nlp	24142790	SENT260	12	12	5	5	meclizine	PCYT2	PA450338	5833	0.702
NULL	Arch_Drug_Inf_2009_Mar_2(1)_1-7.nxml.txt.nlp	19381337	SENT94	28	28	34	34	rifampin	CYP3A4	PA451250	1576	0.702
NULL	Cancer_Immunol_Immunother_2011_Jun_25_60(6)_793-808.nxml.txt.nlp	21350947	SENT214	10	10	12	12	sorafenib	IFN	PA7000	3439	0.702
NULL	Biologics_2013_Apr_15_7_77-90.nxml.txt.nlp	23723688	SENT24	2	2	7	7	cetuximab	EGFR	PA10040	1956	0.702
NULL	J_Gen_Physiol_2003_Jul_122(1)_45-61.nxml.txt.nlp	12835470	SENT366	7	7	10	10	capsaicin	VR1	PA448776	56664	0.702
NULL	J_Cell_Biol_1998_Jul_13_142(1)_101-115.nxml.txt.nlp	9660866	SENT137	38	38	40	40	dextran	mol	PA449261	90527	0.702
NULL	Arthritis_Res_Ther_2009_Nov_13_11(6)_R172.nxml.txt.nlp	19912653	SENT194	22	22	19	19	simvastatin	IVD	PA451363	3712	0.702
NULL	J_Adv_Pharm_Technol_Res_2014_Oct-Dec_5(4)_171-178.nxml.txt.nlp	25364695	SENT9	22	22	7	7	curcumin	ARG	PA151958596	473;27	0.702
NULL	Oncotarget_2014_Aug_14_5(16)_6552-6553.nxml.txt.nlp	25138048	SENT24	30	30	2	2	rituximab	STAT6	PA451261	6778	0.702
NULL	Pharmaceutics_2011_Jul_13_3(3)_425-439.nxml.txt.nlp	24310588	SENT15	15	15	32	32	oxycodone	OTC	PA450741	5009	0.702
NULL	Indian_J_Urol_2007_Jan-Mar_23(1)_67-69.nxml.txt.nlp	19675767	SENT22	11	11	5	5	finasteride	DES	PA449627	1674	0.702
NULL	Mar_Drugs_2008_May_28_6(2)_180-219.nxml.txt.nlp	18728725	SENT331	29	29	10	10	terfenadine	DOM	PA451619	6663	0.702
NULL	J_Nutr_Metab_2011_Oct_1_2011_525094.nxml.txt.nlp	21977315	SENT31	8	8	26	26	resveratrol	SIRT3		23410	0.702
NULL	J_Clin_Biochem_Nutr_2010_Jan_29_46(1)_36-42.nxml.txt.nlp	20104263	SENT218	17	17	5	5	ribavirin	gamma	PA451241	9913	0.702
NULL	Evid_Based_Complement_Alternat_Med_2013_May_16_2013_857929.nxml.txt.nlp	23762164	SENT95	11	11	16	16	doxorubicin	p38	PA449412	10598;1432;7965	0.702
NULL	Clin_Ophthalmol_2014_Jan_7_8_177-185.nxml.txt.nlp	24531415	SENT104	2	2	21	21	latanoprost	ANOVA	PA164774763	4858	0.702
NULL	Acta_Pharmacol_Sin_2012_Jan_28_33(1)_75-81.nxml.txt.nlp	22120969	SENT142	6	6	4	4	exenatide	GLP-1	PA164749238	100125288	0.702
NULL	Mol_Cancer_2009_Jun_23_8_39.nxml.txt.nlp	19549337	SENT146	25	25	36	36	etoposide	TRAIL	PA449552	8743	0.702
NULL	Virol_J_2010_Oct_20_7_279.nxml.txt.nlp	20961433	SENT156	0	0	5	5	trypsin	VLP	PA451806	391104	0.702
NULL	Drugs_Context_2012_Nov_19_2012_212242.nxml.txt.nlp	24432031	SENT312	9	9	11	11	famotidine	IL-2	PA449586	3558	0.702
NULL	Case_Rep_Hematol_2013_Jul_10_2013_709164.nxml.txt.nlp	23936692	SENT122	14	14	8	8	imatinib	PDGFRB	PA10804	5159	0.702
NULL	Biomed_Res_Int_2013_Nov_28_2013_789184.nxml.txt.nlp	24369535	SENT116	0	0	11	11	imatinib	CYP2C9	PA10804	1559	0.702
NULL	Allergy_Asthma_Immunol_Res_2014_Mar_15_6(2)_126-130.nxml.txt.nlp	24587948	SENT29	13	13	26	26	salbutamol	TTN	PA448068	7273	0.702
NULL	Cells_2014_May_23_3(2)_517-545.nxml.txt.nlp	24861977	SENT95	22	22	13	13	capsaicin	TRPV1	PA448776	7442	0.702
NULL	Drug_Des_Devel_Ther_2014_Sep_23_8_1527-1538.nxml.txt.nlp	25284985	SENT9	5	5	3	3	celecoxib	IFN	PA448871	3439	0.702
NULL	Exp_Ther_Med_2014_Nov_17_8(5)_1535-1538.nxml.txt.nlp	25289055	SENT59	21	21	30	30	bevacizumab	San	PA130232992	80218	0.702
NULL	Acta_Pharmacol_Sin_2014_Jun_4_35(6)_752-757.nxml.txt.nlp	24902786	SENT88	5	5	16	16	flutamide	STL2	PA449685	1301	0.702
NULL	Chemother_Res_Pract_2011_Sep_25_2011_730360.nxml.txt.nlp	22295205	SENT236	15	15	30	30	maytansine	DM1	PA165291473	338023;1760;28509	0.702
NULL	Infect_Dis_Ther_2013_Dec_8_2(2)_95-110.nxml.txt.nlp	25134474	SENT158	28	28	22	22	linezolid	VISA	PA450233	57506	0.702
NULL	Front_Oncol_2014_Sep_29_4_251.nxml.txt.nlp	25325012	SENT301	9	9	24	24	etoposide	NKX2-2	PA449552	4821	0.702
NULL	Neuropsychopharmacology_2011_Apr_2_36(5)_1033-1046.nxml.txt.nlp	21289603	SENT372	12	12	17	17	ethanol	MSN	PA448073	4478	0.702
NULL	Biomed_Res_Int_2014_Feb_10_2014_305610.nxml.txt.nlp	24683545	SENT127	12	12	14	14	chlorpromazine	CPZ	PA448964	8532	0.702
NULL	J_Adv_Pract_Oncol_2013_Jul_1_Jul-Aug_4(4)_263-268.nxml.txt.nlp	25032007	SENT42	7	7	13	13	temsirolimus	CYP3A4	PA164746890	1576	0.702
NULL	Clin_Transl_Allergy_2014_Feb_28_4(Suppl_1)_P35.nxml.txt.nlp	25045492	SENT16	27	27	20	20	atorvastatin	IL-4	PA448500	3565	0.702
NULL	Appl_Microbiol_Biotechnol_2012_Sep_31_95(6)_1427-1436.nxml.txt.nlp	22846902	SENT134	6	6	0	0	nitrogen	FAD	PA450643	5663;675;2177	0.702
NULL	Eur_J_Med_Res_2010_Apr_8_15(4)_145-151.nxml.txt.nlp	20554495	SENT65	7	7	13	13	abacavir	HLA-B	PA448004	3106	0.702
NULL	Stroke_Res_Treat_2009_Dec_20_2010_386389.nxml.txt.nlp	20700422	SENT289	28	28	30	30	ebselen	NAC	PA161660841	22861	0.702
NULL	Breast_Cancer_2014_Aug_28_21(3)_350-357.nxml.txt.nlp	22926504	SENT179	5	5	11	11	curcumin	NF-kappaB	PA151958596	4790	0.702
NULL	Iran_J_Pharm_Res_2014_Spring_13(2)_635-639.nxml.txt.nlp	25237359	SENT18	18	18	12	12	dextromethorphan	CYP3A	PA449273	1574	0.702
NULL	Int_J_Mol_Sci_2014_Nov_25_15(12)_21703-21722.nxml.txt.nlp	25429431	SENT61	8	8	17	17	curcumin	mol	PA151958596	90527	0.702
NULL	Cardiovasc_Diabetol_2013_Nov_12_12_169.nxml.txt.nlp	24215514	SENT290	10	10	14	14	candesartan	ANG	PA448765	283	0.702
NULL	J_Clin_Biochem_Nutr_2007_Nov_30_41(3)_202-210.nxml.txt.nlp	18299717	SENT84	35	35	27	27	indomethacin	MGST1	PA449982	4257	0.702
NULL	Evid_Based_Complement_Alternat_Med_2013_Jul_9_2013_783860.nxml.txt.nlp	23935682	SENT116	7	7	0	0	theobromine	Cocoa	PA451646	57658	0.702
NULL	Breast_Cancer_Res_2008_Dec_18_10(Suppl_4)_S26.nxml.txt.nlp	19128440	SENT14	13	13	2	2	tamoxifen	IMPACT	PA451581	55364	0.702
NULL	Br_J_Cancer_2011_Jun_7_104(12)_1848-1853.nxml.txt.nlp	21610704	SENT156	13	13	10	10	panitumumab	KRAS	PA162373091	3845	0.702
NULL	Br_J_Pharmacol_2014_Sep_28_171(18)_4255-4272.nxml.txt.nlp	24846338	SENT22	21	21	6	6	escitalopram	5-HT1A	PA10074	3350	0.702
NULL	J_Mol_Signal_2006_Dec_6_1_8.nxml.txt.nlp	17224083	SENT112	16	16	19	19	thrombin	Rho	PA451674	29984	0.702
NULL	Br_J_Cancer_2011_Aug_23_105(5)_649-657.nxml.txt.nlp	21811251	SENT155	7	7	9	9	gefitinib	IGF1R	PA131301952	3480	0.702
NULL	Cardiovasc_Res_2011_Apr_1_90(1)_140-147.nxml.txt.nlp	21071431	SENT94	0	0	10	10	resveratrol	ROS		6098	0.702
NULL	Environ_Health_Perspect_2009_Feb_19_117(2)_155-158.nxml.txt.nlp	19270781	SENT89	16	16	6	6	scopolamine	CO2	PA451308	4513	0.702
NULL	Case_Rep_Oncol_Med_2013_Nov_30_2013_175263.nxml.txt.nlp	24363944	SENT60	8	8	4	4	leucovorin	CRT	PA450198	811	0.702
NULL	Exp_Mol_Med_2012_Sep_30_44(9)_536-544.nxml.txt.nlp	22771771	SENT8	13	13	10	10	celecoxib	p16	PA448871	1029	0.702
NULL	Mol_Vis_2012_Mar_9_18_624-633.nxml.txt.nlp	22509094	SENT279	0	0	7	7	cyclosporine	IL-2	PA449167	3558	0.702
NULL	Clinics_(Sao_Paulo)_2014_Apr_69(4)_225-233.nxml.txt.nlp	24714829	SENT128	19	19	31	31	lactulose	adiponectin	PA164748762	9370	0.702
NULL	Arthritis_Res_Ther_2014_Apr_3_16(2)_R86.nxml.txt.nlp	24708674	SENT221	8	8	25	25	bosentan	Fli1	PA10034	2314	0.702
NULL	Indian_J_Pharmacol_2014_Sep-Oct_46(5)_549-550.nxml.txt.nlp	25298588	SENT64	21	21	5	5	warfarin	VKORC1	PA451906	79001	0.702
NULL	Br_J_Cancer_2010_Oct_12_103(8)_1297-1304.nxml.txt.nlp	20842126	SENT103	44	44	13	13	creatine	SMO	PA164778930	6608;54498	0.702
NULL	Acta_Pharmacol_Sin_2014_Sep_4_35(9)_1157-1166.nxml.txt.nlp	25088002	SENT101	0	0	16	16	curcumin	STAT3	PA151958596	6774	0.702
NULL	Oncotarget_2014_Oct_21_5(22)_11252-11268.nxml.txt.nlp	25361004	SENT249	12	12	15	15	metformin	CLIC1	PA450395	1192	0.702
NULL	Arthritis_Res_Ther_2011_Dec_12_13(6)_R204.nxml.txt.nlp	22151924	SENT32	12	12	27	27	abatacept	CFB	PA164747080	629	0.702
NULL	Cancers_(Basel)_2013_May_27_5(2)_617-638.nxml.txt.nlp	24216994	SENT319	0	0	2	2	curcumin	MMP9	PA151958596	4318	0.702
NULL	Arthritis_Res_2002_Nov_23_4(3)_157-164.nxml.txt.nlp	12010565	SENT147	6	6	18	18	collagenase	p38	PA449107	10598;1432;7965	0.702
NULL	Springerplus_2015_Jan_23_4_29.nxml.txt.nlp	25628986	SENT4	5	5	18	18	dapsone	G6PD	PA449211	2539	0.702
NULL	Sci_Rep_2014_Dec_9_4_7375.nxml.txt.nlp	25487878	SENT55	34	34	15	15	lipase	aP2	PA450239	2167	0.702
NULL	J_Breast_Cancer_2011_Sep_29_14(3)_223-228.nxml.txt.nlp	22031805	SENT130	2	2	34	34	cyclophosphamide	gamma	PA449165	9913	0.702
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT106	16	16	18	18	capsaicin	p53	PA448776	7157	0.702
NULL	Case_Rep_Oncol_2014_May_24_7(2)_343-348.nxml.txt.nlp	24987354	SENT74	5	5	21	21	vemurafenib	BRAF	PA165946873	673	0.702
NULL	Front_Endocrinol_(Lausanne)_2014_Oct_27_5_163.nxml.txt.nlp	25386163	SENT461	13	13	24	24	maprotiline	ghrelin	PA450322	51738	0.702
NULL	J_Young_Pharm_2012_Jan-Mar_4(1)_42-48.nxml.txt.nlp	22523460	SENT1	15	15	17	17	tropicamide	TPC	PA164749389	8030;60386	0.702
NULL	Exp_Ther_Med_2013_Apr_5_5(4)_1259-1263.nxml.txt.nlp	23596498	SENT8	16	16	11	11	propofol	TRPV1	PA451141	7442	0.702
NULL	Int_J_Mol_Sci_2014_Oct_23_15(10)_19265-19280.nxml.txt.nlp	25342321	SENT132	19	19	27	27	sc-560	MVD		4597	0.702
NULL	Evid_Based_Complement_Alternat_Med_2012_May_7_2012_242810.nxml.txt.nlp	22645625	SENT131	6	6	17	17	rifampin	CYP3A4	PA451250	1576	0.702
NULL	Curr_Chem_Genomics_2010_Mar_1_4_1-8.nxml.txt.nlp	20448812	SENT120	9	9	18	18	bosentan	OATP1B1	PA10034	10599	0.702
NULL	Br_J_Cancer_2004_Mar_5_90(Suppl_1)_S15-S18.nxml.txt.nlp	15094760	SENT106	19	19	6	6	fulvestrant	FACT	PA164747170	11198	0.702
NULL	Aging_(Albany_NY)_2012_Mar_4_4(3)_144-145.nxml.txt.nlp	22388573	SENT11	15	15	6	6	resveratrol	AMPK		5563	0.702
NULL	Acta_Pharmacol_Sin_2009_Nov_12_30(11)_1566-1572.nxml.txt.nlp	19820718	SENT155	26	26	33	33	verapamil	P-gp	PA451868	5243	0.702
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_May_16_68(Pt_6)_o1747.nxml.txt.nlp	22719532	SENT74	0	0	16	16	cinnarizine	mol	PA164749342	90527	0.702
NULL	Trials_2012_Jan_13_13_9.nxml.txt.nlp	22243649	SENT161	7	7	23	23	memantine	sit	PA10364	55733	0.702
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT1673	26	26	23	23	diazepam	CYP1A2	PA449283	1544	0.702
NULL	Ann_Thorac_Med_2013_Apr-Jun_8(2)_109-115.nxml.txt.nlp	23741274	SENT169	8	8	4	4	cisplatin	CRT	PA449014	811	0.702
NULL	Core_Evid_2011_Mar_17_6_31-42.nxml.txt.nlp	21468241	SENT94	18	18	27	27	clopidogrel	IPA	PA449053	3160	0.702
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT35	27	27	21	21	heparin	FGF1	PA449855	2246	0.702
NULL	Curr_Pharm_Biotechnol_2011_Jan_12(1)_35-41.nxml.txt.nlp	20932261	SENT281	10	10	12	12	hyperforin	TRPC6	PA165985514	7225	0.702
NULL	J_Cell_Biol_2002_Jun_24_157(7)_1151-1160.nxml.txt.nlp	12082077	SENT180	28	28	21	21	trypsin	COX	PA451806	1351	0.702
NULL	J_Neuroinflammation_2010_Nov_18_7_81.nxml.txt.nlp	21087489	SENT56	34	34	10	10	pilocarpine	CA1	PA450962	759	0.702
NULL	Osteoporos_Int_2008_Apr_12_19(4)_399-428.nxml.txt.nlp	18266020	SENT252	21	21	19	19	teriparatide	PTH	PA451620	5741	0.702
NULL	Chem_Res_Toxicol_2012_Nov_19_25(11)_2567-2576.nxml.txt.nlp	23016703	SENT391	23	23	8	8	isoniazid	NAT2	PA450112	10;81539	0.702
NULL	Nat_Med_2013_Mar_10_19(3)_313-321.nxml.txt.nlp	23396211	SENT368	24	24	30	30	amlexanox	TBK1	PA164745310	29110	0.702
NULL	Biochem_Res_Int_2012_Mar_4_2012_685267.nxml.txt.nlp	22496978	SENT7	21	21	24	24	thrombin	MT1-MMP	PA451674	4323	0.702
NULL	Front_Pharmacol_2014_Sep_2_5_203.nxml.txt.nlp	25228880	SENT669	12	12	2	2	desmethylastemizole	HERG	PA165817936	3757	0.702
NULL	Cancer_Metab_2014_Nov_3_2(1)_20.nxml.txt.nlp	NULL	SENT298	12	12	8	8	erlotinib	PDK4	PA134687924	5166	0.702
NULL	Br_J_Cancer_2011_Sep_6_105(6)_807-813.nxml.txt.nlp	21847121	SENT73	3	3	18	18	pha-665752	HER2		2064	0.702
NULL	Mol_Cancer_2012_Mar_21_11_13.nxml.txt.nlp	22436134	SENT326	10	10	2	2	doxorubicin	HuR	PA449412	1994	0.702
NULL	Cancers_(Basel)_2013_Jul_24_5(3)_901-918.nxml.txt.nlp	24202326	SENT7	24	24	36	36	bortezomib	CDK9	PA10252	1025	0.702
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT148	17	17	10	10	atorvastatin	TNF	PA448500	7124	0.702
NULL	J_Adv_Pract_Oncol_2013_Jul_1_Jul-Aug_4(4)_263-268.nxml.txt.nlp	25032007	SENT45	19	19	13	13	tacrolimus	CYP3A4	PA451578	1576	0.702
NULL	J_Mol_Med_(Berl)_2014_Jan_10_92(5)_497-507.nxml.txt.nlp	24408111	SENT5	3	3	12	12	pioglitazone	HIF-1	PA450970	29072	0.702
NULL	J_Invest_Dermatol_2013_Jun_14_133(6)_1541-1549.nxml.txt.nlp	23407395	SENT121	30	30	23	23	imiquimod	CXCL1	PA449972	2919	0.702
NULL	Nucleic_Acids_Res_2011_Aug_29_39(15)_6620-6632.nxml.txt.nlp	21531700	SENT224	27	27	4	4	doxycycline	MYC	PA449415	4609	0.702
NULL	Allergy_Asthma_Immunol_Res_2009_Oct_25_1(1)_30-35.nxml.txt.nlp	20224667	SENT96	18	18	14	14	aspirin	PPARG	PA448497	5468	0.702
NULL	Adv_Virol_2012_Aug_13_2012_815465.nxml.txt.nlp	22924042	SENT182	20	20	9	9	l-tryptophan	IFN	PA10323	3439	0.702
NULL	J_Korean_Assoc_Oral_Maxillofac_Surg_2014_Dec_26_40(6)_291-296.nxml.txt.nlp	25551094	SENT97	3	3	11	11	alendronate	M-CSF	PA448082	1435	0.702
NULL	Drug_Des_Devel_Ther_2014_Sep_26_8_1613-1619.nxml.txt.nlp	25302016	SENT129	11	11	18	18	nevirapine	CYP3A	PA450616	1574	0.702
NULL	Toxins_(Basel)_2010_Oct_28_2(11)_2584-2592.nxml.txt.nlp	22069565	SENT100	0	0	5	5	sertraline	CYP2D6	PA451333	1565	0.702
NULL	Mol_Cancer_2008_Jan_25_7_14.nxml.txt.nlp	18221502	SENT213	25	25	23	23	oxaliplatin	PSAT1	PA131285527	29968	0.702
NULL	Pharmaceuticals_(Basel)_2013_Apr_8_6(4)_500-509.nxml.txt.nlp	24276120	SENT2	19	19	39	39	benserazide	GPR35		2859	0.702
NULL	Br_J_Anaesth_2011_Oct_17_107(4)_490-502.nxml.txt.nlp	21852280	SENT24	24	24	13	13	capsaicin	TRPV1	PA448776	7442	0.702
NULL	Front_Genet_2013_Aug_30_4_166.nxml.txt.nlp	24009623	SENT120	15	15	5	5	everolimus	FLJ35220	PA164746311	284131	0.702
NULL	Acta_Pharmacol_Sin_2012_Dec_29_33(12)_1518-1524.nxml.txt.nlp	23103625	SENT128	9	9	12	12	telmisartan	ACE	PA451605	1636	0.702
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT52	13	13	2	2	trastuzumab	STAT3	PA451743	6774	0.702
NULL	ScientificWorldJournal_2012_Jul_31_2012_475675.nxml.txt.nlp	22919323	SENT39	29	29	35	35	metformin	LKB1	PA450395	6794	0.702
NULL	Biomed_Res_Int_2013_Jun_6_2013_928271.nxml.txt.nlp	23841099	SENT25	35	35	38	38	prasugrel	ADP	PA154410481	23038	0.702
NULL	AIDS_Res_Ther_2013_May_1_10_10.nxml.txt.nlp	23634877	SENT187	30	30	5	5	lovastatin	CXCR4	PA450272	7852	0.702
NULL	Cancer_Immunol_Immunother_2011_Jun_25_60(6)_793-808.nxml.txt.nlp	21350947	SENT195	37	37	34	34	sorafenib	IFN	PA7000	3439	0.702
NULL	Arthritis_Res_Ther_2013_Dec_30_15(6)_R223.nxml.txt.nlp	24373218	SENT17	2	2	16	16	carprofen	FN1	PA164781361	2335	0.702
NULL	Clin_Pharmacol_2013_Dec_10_5_193-199.nxml.txt.nlp	24353447	SENT82	9	9	12	12	midazolam	CYP3A4	PA450496	1576	0.702
NULL	Cancer_Microenviron_2009_Aug_15_2(Suppl_1)_205-214.nxml.txt.nlp	19685283	SENT192	0	0	2	2	imiquimod	IFN	PA449972	3439	0.702
NULL	J_Invest_Dermatol_2012_Nov_21_132(11)_2642-2651.nxml.txt.nlp	22718118	SENT76	2	2	6	6	collagenase	CCR2	PA449107	729230	0.702
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT31	3	3	5	5	sitagliptin	GLP-1	PA164748978	100125288	0.702
NULL	Oncol_Lett_2014_Oct_22_8(4)_1603-1607.nxml.txt.nlp	25202376	SENT103	25	25	17	17	cisplatin	BRCA1	PA449014	672	0.702
NULL	Oncotarget_2012_Sep_28_3(10)_1169-1181.nxml.txt.nlp	23045411	SENT204	26	26	10	10	doxorubicin	JIP1	PA449412	9479	0.702
NULL	Adv_Virol_2012_Jul_19_2012_267483.nxml.txt.nlp	22851970	SENT176	20	20	17	17	ribavirin	IFN	PA451241	3439	0.702
NULL	J_Oncol_2012_Feb_6_2012_737981.nxml.txt.nlp	22481932	SENT83	28	28	6	6	etoposide	MUC16	PA449552	94025	0.702
NULL	Oncol_Lett_2013_Feb_5_5(2)_521-526.nxml.txt.nlp	23420529	SENT64	21	21	11	11	trypsin	CO2	PA451806	4513	0.702
NULL	Mol_Cancer_2009_Dec_23_8_129.nxml.txt.nlp	20030852	SENT215	12	12	6	6	curcumin	ABCA1	PA151958596	19	0.702
NULL	Mol_Cancer_2013_Mar_5_12_17.nxml.txt.nlp	23497256	SENT198	32	32	28	28	sunitinib	p53	PA162372840	7157	0.702
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT146	0	0	5	5	erlotinib	CYP3A	PA134687924	1574	0.702
NULL	Food_Dig_2011_Dec_15_2(1-3)_52-61.nxml.txt.nlp	22558059	SENT81	14	14	12	12	lipase	LIP	PA450239	23049	0.702
NULL	Cell_Biol_Int_Rep_(2010)_2012_Jun_21_19(1)_e00017.nxml.txt.nlp	23124518	SENT83	32	32	34	34	etoposide	TRAIL	PA449552	8743	0.702
NULL	Arch_Med_Sci_2014_Aug_29_10(4)_684-691.nxml.txt.nlp	25276151	SENT26	12	12	41	41	dobutamine	CRT	PA449381	811	0.702
NULL	Ann_Hematol_2014_Mar_18_93(8)_1335-1344.nxml.txt.nlp	24638841	SENT92	38	38	19	19	fludarabine	CHOP	PA449655	1649	0.702
NULL	Clin_Exp_Otorhinolaryngol_2011_Dec_15_4(4)_177-183.nxml.txt.nlp	22232712	SENT129	3	3	14	14	doxycycline	p38	PA449415	10598;1432;7965	0.702
NULL	Br_J_Cancer_2011_Jul_12_105(2)_212-220.nxml.txt.nlp	21694723	SENT6	15	15	22	22	curcumin	STAT3	PA151958596	6774	0.702
NULL	J_Young_Pharm_2012_Oct-Dec_4(4)_235-244.nxml.txt.nlp	23493308	SENT59	5	5	18	18	paroxetine	BUP	PA450801	23412	0.702
NULL	Biomed_Res_Int_2014_Jun_26_2014_161346.nxml.txt.nlp	25054130	SENT239	3	3	5	5	curcumin	p47phox	PA151958596	653361	0.702
NULL	Diabetol_Metab_Syndr_2014_Mar_31_6_48.nxml.txt.nlp	24684803	SENT111	28	28	8	8	miglitol	STEP	PA164776726	84867	0.702
NULL	Neuropsychopharmacology_2009_Jul_25_34(8)_1968-1978.nxml.txt.nlp	19322168	SENT179	3	3	7	7	clozapine	PI3K	PA449061	5290	0.702
NULL	Emerg_Infect_Dis_2011_Mar_17(3)_432-440.nxml.txt.nlp	21392434	SENT112	24	24	17	17	isoniazid	DST	PA450112	667	0.702
NULL	Mol_Vis_2010_Sep_2_16_1781-1790.nxml.txt.nlp	20824160	SENT102	4	4	15	15	rolipram	ZO-1	PA153906323	7082	0.702
NULL	Clin_Sci_(Lond)_2009_Apr_1_116(Pt_8)_607-620.nxml.txt.nlp	19275766	SENT117	14	14	1	1	rosiglitazone	AMPK	PA451283	5563	0.702
NULL	Oncotarget_2014_Sep_3_5(19)_9362-9381.nxml.txt.nlp	25313139	SENT71	14	14	28	28	orlistat	AMPK	PA164776864	5563	0.702
NULL	Nucl_Recept_Signal_2009_Jan_16_7_e001.nxml.txt.nlp	19240808	SENT415	20	20	7	7	estradiol	SXR	PA449503	8856	0.702
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2013_Mar_1_69(Pt_3)_420-431.nxml.txt.nlp	23519417	SENT291	1	1	27	27	meropenem	hole	PA164764445	80757	0.702
NULL	Biomed_Res_Int_2013_Dec_29_2013_868321.nxml.txt.nlp	24459673	SENT82	14	14	9	9	probucol	NAC	PA451107	22861	0.702
NULL	EMBO_Mol_Med_2013_Feb_9_5(2)_309-325.nxml.txt.nlp	23300147	SENT190	1	1	7	7	geldanamycin	HER2	PA152031327	2064	0.702
NULL	Oxid_Med_Cell_Longev_2013_Apr_21_2013_412576.nxml.txt.nlp	23710286	SENT111	11	11	20	20	curcumin	KEAP1	PA151958596	9817	0.702
NULL	Diabetes_2009_Mar_58(3)_579-589.nxml.txt.nlp	19074989	SENT12	12	12	8	8	lipase	LIPE	PA450239	3991	0.702
NULL	Infect_Drug_Resist_2010_Oct_13_3_103-114.nxml.txt.nlp	21694899	SENT248	6	6	15	15	raltegravir	TRIO		7204	0.702
NULL	J_Breast_Cancer_2012_Jun_28_15(2)_148-156.nxml.txt.nlp	22807931	SENT111	42	42	30	30	tamoxifen	CD41	PA451581	3674	0.702
NULL	Mol_Pain_2014_Aug_15_10_53.nxml.txt.nlp	25127716	SENT114	13	13	11	11	paclitaxel	SDH	PA450761	1757;10993	0.702
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Sep_26_65(Pt_10)_o2518.nxml.txt.nlp	21577965	SENT66	11	11	6	6	benzaldehyde	mol	PA448571	90527	0.702
NULL	BMJ_Open_2013_Dec_4_3(12)_e004157.nxml.txt.nlp	24309172	SENT133	31	31	29	29	nitrofurantoin	TMP	PA450640	2012	0.702
NULL	N_Am_J_Med_Sci_2011_Jan_3(1)_1-12.nxml.txt.nlp	22540056	SENT135	15	15	28	28	gemcitabine	MRP5	PA449748	10057	0.702
NULL	Cancers_(Basel)_2014_Nov_14_6(4)_2275-2295.nxml.txt.nlp	25405526	SENT82	33	33	7	7	methotrexate	CHOP	PA450428	1649	0.702
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_79-96.nxml.txt.nlp	19305789	SENT184	0	0	9	9	capsaicin	TRPV1	PA448776	7442	0.702
NULL	Curr_Neuropharmacol_2014_Jul_12(4)_365-379.nxml.txt.nlp	25342944	SENT298	9	9	12	12	fluoxetine	cPLA2	PA449673	10524	0.702
NULL	Lab_Anim_Res_2014_Dec_24_30(4)_143-150.nxml.txt.nlp	25628724	SENT75	0	0	12	12	genistein	TRAMP	PA165109660	8718;23471;9189	0.702
NULL	Int_J_Endocrinol_2010_Mar_2_2010_621687.nxml.txt.nlp	20204178	SENT101	26	26	10	10	paricalcitol	PTH	PA450798	5741	0.702
NULL	Cell_Death_Dis_2013_Jul_11_4(7)_e719.nxml.txt.nlp	23846221	SENT69	7	7	5	5	cisplatin	TRAIL	PA449014	8743	0.702
NULL	Acta_Pharmacol_Sin_2011_Jun_3_32(6)_749-757.nxml.txt.nlp	21642946	SENT124	37	37	22	22	flecainide	FKBP12	PA449646	2280	0.702
NULL	Cancer_Manag_Res_2013_Mar_9_6_25-30.nxml.txt.nlp	23516140	SENT70	0	0	18	18	dasatinib	LCK	PA162372878	3932	0.702
NULL	Exp_Ther_Med_2013_Jan_19_5(1)_23-27.nxml.txt.nlp	23251236	SENT136	31	31	11	11	curcumin	EGFR	PA151958596	1956	0.702
NULL	Environ_Health_Perspect_2008_Mar_26_116(3)_322-328.nxml.txt.nlp	18335098	SENT99	16	16	28	28	genistein	PMI	PA165109660	8834;5373	0.702
NULL	Arch_Med_Sci_2013_Dec_30_9(6)_1090-1096.nxml.txt.nlp	24482655	SENT149	6	6	43	43	tacrolimus	IL-13	PA451578	3596	0.702
NULL	Diabetes_Care_2013_Aug_11_36(8)_2239-2246.nxml.txt.nlp	23514733	SENT175	39	39	18	18	anakinra	IL1RN	PA10799	3557	0.702
NULL	Ann_Lab_Med_2013_Jan_17_33(1)_86-88.nxml.txt.nlp	23301230	SENT52	34	34	12	12	gentamicin	CTX	PA449753	1593	0.702
NULL	Clin_Ophthalmol_2008_Dec_2(4)_919-930.nxml.txt.nlp	19668445	SENT256	0	0	6	6	bevacizumab	San	PA130232992	80218	0.702
NULL	Int_J_Mol_Sci_2014_Mar_27_15(4)_5388-5409.nxml.txt.nlp	24681585	SENT900	0	0	6	6	etoposide	AMPK	PA449552	5563	0.702
NULL	J_Immunother_2014_Apr_12_37(3)_180-186.nxml.txt.nlp	24598448	SENT175	7	7	15	15	sorafenib	IL-2	PA7000	3558	0.702
NULL	J_Cardiovasc_Magn_Reson_2014_Sep_27_16(1)_80.nxml.txt.nlp	25270330	SENT3	4	4	0	0	iron	MRI	PA450087	78996	0.702
NULL	Biomed_Res_Int_2013_Jun_6_2013_928271.nxml.txt.nlp	23841099	SENT25	33	33	38	38	clopidogrel	ADP	PA449053	23038	0.702
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jul_3_66(Pt_8)_o1888.nxml.txt.nlp	21588224	SENT58	15	15	26	26	ethanol	mol	PA448073	90527	0.702
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT220	20	20	25	25	doxorubicin	ABCG2	PA449412	9429	0.702
NULL	J_Immunol_Res_2014_May_21_2014_371087.nxml.txt.nlp	24963497	SENT327	11	11	7	7	decitabine	DAC	PA164749631	13	0.702
NULL	Eur_J_Med_Res_2011_Jul_25_16(7)_303-314.nxml.txt.nlp	21813371	SENT59	27	27	40	40	telaprevir	SOC	PA165958354	91544	0.702
NULL	Osteoporos_Int_2009_Sep_21_20(9)_1499-1506.nxml.txt.nlp	19156348	SENT28	7	7	24	24	clozapine	5-HT2A	PA449061	3356	0.702
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT192	12	12	37	37	trastuzumab	Yes	PA451743	7525	0.702
NULL	J_Mol_Signal_2009_May_14_4_3.nxml.txt.nlp	19442290	SENT83	29	29	18	18	genistein	BRCA2	PA165109660	675	0.702
NULL	J_Hematol_Oncol_2014_Aug_1_7_52.nxml.txt.nlp	25085632	SENT167	3	3	14	14	sunitinib	PTEN	PA162372840	5728	0.702
NULL	Biochimie_2010_Nov_92(11)_1546-1567.nxml.txt.nlp	20615447	SENT155	22	22	7	7	trypsin	KLK7	PA451806	5650	0.702
NULL	Diabetes_2008_Sep_57(9)_2296-2303.nxml.txt.nlp	18544705	SENT274	28	28	15	15	collagenase	Cc1	PA449107	9821	0.702
NULL	Brain_Behav_2013_Mar_14_3(2)_75-88.nxml.txt.nlp	23532969	SENT77	10	10	3	3	fluorescein	CDNF	PA164746009	441549	0.702
NULL	Br_J_Cancer_2010_Dec_7_103(12)_1815-1821.nxml.txt.nlp	21063408	SENT98	11	11	13	13	carboplatin	6-16	PA448803	2537	0.702
NULL	Indian_J_Endocrinol_Metab_2014_Jul-Aug_18(4)_546-551.nxml.txt.nlp	25143915	SENT64	11	11	8	8	denosumab	RANKL	PA166048634	8600	0.702
NULL	Oxid_Med_Cell_Longev_2011_Aug_15_2011_824597.nxml.txt.nlp	21904648	SENT220	24	24	21	21	cyclophosphamide	TPT	PA449165	23590;6469	0.702
NULL	Cancer_Immunol_Immunother_2012_Oct_8_61(10)_1713-1720.nxml.txt.nlp	22399057	SENT140	7	7	4	4	plerixafor	CXCR4	PA165958410	7852	0.702
NULL	Oxid_Med_Cell_Longev_2009_Apr-Jun_2(2)_73-81.nxml.txt.nlp	20357928	SENT86	3	3	11	11	l-carnitine	IL-2	PA450154	3558	0.702
NULL	Evid_Based_Complement_Alternat_Med_2004_Sep_1(2)_207-209.nxml.txt.nlp	15480447	SENT38	2	2	16	16	cisplatin	HER-2	PA449014	2064	0.702
NULL	Hum_Genomics_Proteomics_2010_Aug_3_2010_159761.nxml.txt.nlp	20981231	SENT365	21	21	10	10	lithium	NTRK2	PA450243	4915	0.702
NULL	J_Occup_Med_Toxicol_2008_Feb_27_3(Suppl_1)_S6.nxml.txt.nlp	18315837	SENT93	5	5	17	17	montelukast	IL-4	PA450546	3565	0.702
NULL	Br_J_Cancer_1995_Sep_72(3)_615-619.nxml.txt.nlp	7669570	SENT10	26	26	9	9	cisplatin	EGF	PA449014	1950	0.702
NULL	Mol_Cell_2014_May_8_54(3)_445-459.nxml.txt.nlp	24746700	SENT90	22	22	3	3	etoposide	BRCA1	PA449552	672	0.702
NULL	Diabetes_Care_2013_Jan_10_36(Suppl_1)_S11-S66.nxml.txt.nlp	23264422	SENT1959	15	15	6	6	rosiglitazone	DREAM	PA451283	30818	0.702
NULL	J_Cachexia_Sarcopenia_Muscle_2010_Sep_26_1(1)_43-128.nxml.txt.nlp	22477519	SENT748	0	0	11	11	phentolamine	ghrelin	PA450926	51738	0.702
NULL	Ann_Rheum_Dis_2013_Aug_21_72(8)_1287-1294.nxml.txt.nlp	22915624	SENT20	37	37	5	5	abatacept	MRI	PA164747080	78996	0.702
NULL	Biol_Proced_Online_2004_Mar_19_6_16-22.nxml.txt.nlp	15103396	SENT85	0	0	7	7	trypsin	HAND1	PA451806	9421	0.702
NULL	Int_J_Mol_Sci_2014_Oct_8_15(10)_17974-17999.nxml.txt.nlp	25299695	SENT139	4	4	18	18	curcumin	HO-1	PA151958596	3162	0.702
NULL	Springerplus_2014_Sep_11_3_516.nxml.txt.nlp	25279308	SENT159	22	22	11	11	ethanol	CS-1	PA448073	6744;51778	0.702
NULL	Cell_Death_Dis_2012_Jun_21_3(6)_e327.nxml.txt.nlp	22717582	SENT75	7	7	15	15	etoposide	PUMA	PA449552	27113	0.702
NULL	Case_Rep_Endocrinol_2013_Mar_28_2013_192573.nxml.txt.nlp	23607000	SENT59	18	18	9	9	sunitinib	RAI	PA162372840	10848;6050	0.702
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT4	13	13	7	7	estradiol	TNF	PA449503	7124	0.702
NULL	Acta_Pharmacol_Sin_2013_Sep_5_34(9)_1208-1216.nxml.txt.nlp	23852087	SENT98	4	4	10	10	disulfiram	HIF-1	PA449376	29072	0.702
NULL	Lancet_2011_Aug_13_378(9791)_595-605.nxml.txt.nlp	21784508	SENT272	23	23	6	6	risedronate	Yes	PA451255	7525	0.702
NULL	Curr_Chem_Genomics_2010_Mar_1_4_1-8.nxml.txt.nlp	20448812	SENT64	9	9	0	0	fluorescein	OATP1B1	PA164746009	10599	0.702
NULL	CNS_Spectr_2014_Oct_3_19(5)_391-402.nxml.txt.nlp	24698103	SENT100	6	6	25	25	diazepam	hang	PA449283	374879	0.702
NULL	Daru_2011_19(5)_326-331.nxml.txt.nlp	22615677	SENT106	8	8	13	13	cisplatin	p53	PA449014	7157	0.702
NULL	Eur_J_Clin_Pharmacol_2008_Feb_26_64(2)_133-157.nxml.txt.nlp	18224312	SENT205	23	23	15	15	acenocoumarol	CYP2C9	PA452632	1559	0.702
NULL	Int_J_Mol_Sci_2014_Nov_7_15(11)_20500-20517.nxml.txt.nlp	25387078	SENT630	0	0	12	12	vorinostat	CD95	PA164748224	355	0.701
NULL	Oncotarget_2013_Nov_24_4(12)_2186-2207.nxml.txt.nlp	24327604	SENT130	32	32	4	4	doxorubicin	MDM2	PA449412	4193	0.701
NULL	Cancers_(Basel)_2014_Jul_7_6(3)_1441-1463.nxml.txt.nlp	25003395	SENT203	3	3	11	11	cisplatin	PTEN	PA449014	5728	0.701
NULL	Oncol_Rep_2015_Feb_11_33(2)_526-532.nxml.txt.nlp	25501339	SENT13	15	15	23	23	gefitinib	PI3K	PA131301952	5290	0.701
NULL	Drug_Saf_2014_Feb_19_37(4)_201-211.nxml.txt.nlp	24550106	SENT147	9	9	19	19	tacrolimus	CYP2C19	PA451578	1557	0.701
NULL	Eur_J_Epidemiol_2010_Oct_25_25(10)_677-692.nxml.txt.nlp	20872047	SENT236	14	14	12	12	choline	B12	PA448976	7126;4709	0.701
NULL	Hematol_Rep_2010_Apr_13_2(1)_e2.nxml.txt.nlp	22184515	SENT262	35	35	29	29	thrombin	VIII	PA451674	1351	0.701
NULL	Oncoimmunology_2013_Jun_1_2(6)_e24677.nxml.txt.nlp	23894722	SENT11	28	28	33	33	cetuximab	CD107a	PA10040	3916	0.701
NULL	Br_J_Cancer_1998_77(2)_201-209.nxml.txt.nlp	9460989	SENT13	13	13	28	28	chlorambucil	MRP1	PA448926	4437	0.701
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT34	7	7	9	9	metformin	HIF-1	PA450395	29072	0.701
NULL	Comput_Struct_Biotechnol_J_2013_Feb_22_3_e201210020.nxml.txt.nlp	24688680	SENT51	25	25	3	3	naringenin	CHS	PA151958361	1130	0.701
NULL	Nature_2012_Aug_16_488(7411)_384-388.nxml.txt.nlp	22820255	SENT76	11	11	14	14	doxycycline	IL-2	PA449415	3558	0.701
NULL	Gut_2010_Nov_14_59(11)_1527-1534.nxml.txt.nlp	20947887	SENT115	19	19	7	7	cisplatin	CEA	PA449014	5670;1087	0.701
NULL	Mol_Vis_2012_Oct_5_18_2454-2467.nxml.txt.nlp	23077404	SENT86	2	2	11	11	bevacizumab	HIF-1	PA130232992	29072	0.701
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT83	11	11	6	6	atorvastatin	IL-6	PA448500	3569	0.701
NULL	Hum_Mol_Genet_2013_Nov_15_22(22)_4602-4615.nxml.txt.nlp	23814040	SENT160	2	2	12	12	l-cysteine	TRMU	PA449173	55687	0.701
NULL	Front_Microbiol_2014_Mar_27_5_124.nxml.txt.nlp	24723921	SENT358	12	12	27	27	nadh	ADP	PA164755085	23038	0.701
NULL	Breast_Cancer_Res_2007_Jun_29_9(3)_107.nxml.txt.nlp	17617929	SENT39	12	12	19	19	tamoxifen	EGFR	PA451581	1956	0.701
NULL	Endocrine_2012_Dec_14_42(3)_622-636.nxml.txt.nlp	22695986	SENT287	13	13	15	15	forskolin	PTH	PA146096022	5741	0.701
NULL	Front_Neurosci_2014_Dec_5_8_398.nxml.txt.nlp	25538552	SENT152	28	28	9	9	glucose	gamma	PA449773	9913	0.701
NULL	Curr_Biol_2009_Feb_24_19(4)_297-304.nxml.txt.nlp	19217292	SENT72	29	29	22	22	vasopressin	CLOCK	PA451858	9575	0.701
NULL	Emerg_Infect_Dis_2011_Mar_17(3)_495-497.nxml.txt.nlp	21392442	SENT32	26	26	9	9	ciprofloxacin	EMB	PA449009	133418	0.701
NULL	Antibiotics_(Basel)_2014_Oct_13_3(4)_461-492.nxml.txt.nlp	25419466	SENT226	33	33	35	35	bacitracin	UPP	PA448531	7378	0.701
NULL	Arthritis_Rheum_2011_Oct_63(10)_2854-2864.nxml.txt.nlp	21618201	SENT225	10	10	17	17	abatacept	ACR	PA164747080	49	0.701
NULL	Oncogene_2013_Sep_12_32(37)_4355-4365.nxml.txt.nlp	23108409	SENT95	31	31	27	27	hyaluronan	HAS2	PA165958431	3037	0.701
NULL	Breast_Cancer_Res_2002_Aug_27_4(6)_213-217.nxml.txt.nlp	12473165	SENT137	2	2	0	0	anastrozole	ATAC	PA448432	6375	0.701
NULL	Arthritis_Res_Ther_2006_Dec_16_8(1)_R15.nxml.txt.nlp	16507115	SENT65	15	15	10	10	fluorescein	CD303	PA164746009	170482	0.701
NULL	J_Bras_Pneumol_2013_Jan-Feb_39(1)_5-15.nxml.txt.nlp	23503480	SENT62	21	21	17	17	doxycycline	LAM	PA449415	7249;7248	0.701
NULL	Br_J_Cancer_2013_Feb_19_108(3)_557-563.nxml.txt.nlp	23361053	SENT232	5	5	8	8	tamoxifen	PAK1	PA451581	5585;5058	0.701
NULL	Endocrinol_Metab_(Seoul)_2013_Dec_12_28(4)_297-308.nxml.txt.nlp	24396695	SENT14	10	10	18	18	cerulenin	SREBP1	PA164764551	6720	0.701
NULL	Cancer_Med_2013_Jun_25_2(3)_277-285.nxml.txt.nlp	23930204	SENT193	8	8	27	27	mitomycin	MAX	PA450524	4149	0.701
NULL	Clin_Psychopharmacol_Neurosci_2011_Apr_30_9(1)_29-35.nxml.txt.nlp	23430964	SENT173	28	28	7	7	methylphenidate	Gen	PA450464	348654	0.701
NULL	Case_Rep_Infect_Dis_2013_May_12_2013_761793.nxml.txt.nlp	23762676	SENT50	4	4	22	22	vancomycin	TMX	PA451850	81542	0.701
NULL	J_Oncol_2009_Mar_24_2009_491985.nxml.txt.nlp	19325924	SENT101	8	8	13	13	genistein	CXCR4	PA165109660	7852	0.701
NULL	J_Geriatr_Cardiol_2014_Jun_11(2)_151-157.nxml.txt.nlp	25009566	SENT126	20	20	13	13	cilostazol	CDP	PA164746334	1523	0.701
NULL	J_Inflamm_(Lond)_2005_Oct_31_2_13.nxml.txt.nlp	16259632	SENT176	16	16	8	8	sulfasalazine	IL-10	PA451547	3586	0.701
NULL	J_Inflamm_(Lond)_2006_Jul_12_3_10.nxml.txt.nlp	16834783	SENT232	8	8	14	14	mometasone	IL-5	PA450541	3567	0.701
NULL	Gut_2010_Aug_28_59(8)_1037-1045.nxml.txt.nlp	20584780	SENT236	7	7	26	26	lidocaine	EGF	PA450226	1950	0.701
NULL	Anal_Bioanal_Chem_2012_Dec_4_404(10)_3071-3080.nxml.txt.nlp	23052869	SENT180	3	3	26	26	pilocarpine	CA1	PA450962	759	0.701
NULL	Oncoimmunology_2014_Jan_17_3_e27574.nxml.txt.nlp	24800167	SENT24	2	2	21	21	cyclophosphamide	CD11b	PA449165	3684	0.701
NULL	J_Antimicrob_Chemother_2014_Mar_13_69(3)_651-663.nxml.txt.nlp	24235095	SENT115	12	12	27	27	pentamidine	PAO	PA450850	196743;54498	0.701
NULL	Curr_Oncol_2006_Feb_13(1)_14-26.nxml.txt.nlp	17576437	SENT385	35	35	18	18	carboplatin	HER-2	PA448803	2064	0.701
NULL	J_Mol_Signal_2007_Sep_25_2_9.nxml.txt.nlp	17892597	SENT198	19	19	30	30	paraformaldehyde	San	PA450790	80218	0.701
NULL	Iran_Red_Crescent_Med_J_2013_Mar_5_15(3)_207-211.nxml.txt.nlp	23983999	SENT53	27	27	16	16	colistin	MTM	PA164760862	326343	0.701
NULL	Cancer_Metab_2013_Mar_7_1_10.nxml.txt.nlp	24280167	SENT153	4	4	13	13	resveratrol	SIRT1		23411	0.701
NULL	Int_J_Mol_Imaging_2011_Oct_26_2011_874585.nxml.txt.nlp	21490735	SENT153	22	22	27	27	tamoxifen	FDG	PA451581	23583	0.701
NULL	Drug_Des_Devel_Ther_2014_Sep_23_8_1527-1538.nxml.txt.nlp	25284985	SENT142	26	26	14	14	celecoxib	IFN	PA448871	3439	0.701
NULL	Arthritis_Res_Ther_2005_Apr_4_7(4)_R756-R768.nxml.txt.nlp	15987477	SENT140	20	20	37	37	hyaluronidase	PH-20	PA164745713	6677	0.701
NULL	Biosci_Rep_2012_Dec_1_32(Pt_6)_511-519.nxml.txt.nlp	NULL	SENT87	4	4	18	18	pitavastatin	Rho	PA142650384	29984	0.701
NULL	Cancers_(Basel)_2011_Apr_1_3(2)_1844-1860.nxml.txt.nlp	24212785	SENT65	38	38	18	18	irinotecan	KRAS	PA450085	3845	0.701
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT133	29	29	7	7	methotrexate	MSH2	PA450428	4436	0.701
NULL	Indian_J_Pharmacol_2013_Jan-Feb_45(1)_54-60.nxml.txt.nlp	23543867	SENT177	21	21	15	15	terlipressin	NAC	PA164781020	22861	0.701
NULL	EMBO_Mol_Med_2013_Aug_5_5(8)_1213-1226.nxml.txt.nlp	23918228	SENT85	15	15	10	10	cetuximab	EGFR	PA10040	1956	0.701
NULL	Cell_Death_Dis_2014_Jul_3_5(7)_e1316.nxml.txt.nlp	24991768	SENT65	4	4	19	19	pemetrexed	Mcl-1	PA10810	4170	0.701
NULL	Br_J_Cancer_2012_Feb_28_106(5)_876-882.nxml.txt.nlp	22333597	SENT134	5	5	17	17	everolimus	4E-BP1	PA164746311	1978	0.701
NULL	Scientifica_(Cairo)_2012_Nov_25_2012_473829.nxml.txt.nlp	24278698	SENT393	23	23	17	17	l-carnitine	OCTN1	PA450154	6583	0.701
NULL	Biologics_2013_Apr_15_7_77-90.nxml.txt.nlp	23723688	SENT97	16	16	27	27	cetuximab	CRT	PA10040	811	0.701
NULL	Cancer_Cell_Int_2005_Jul_24_5_22.nxml.txt.nlp	16042792	SENT85	2	2	6	6	vincristine	NAC	PA451879	22861	0.701
NULL	Int_J_Breast_Cancer_2012_May_9_2012_415170.nxml.txt.nlp	22649737	SENT214	13	13	9	9	ertumaxomab	HER2	PA165291442	2064	0.701
NULL	Indian_J_Med_Res_2012_May_135(5)_599-613.nxml.txt.nlp	22771588	SENT319	11	11	3	3	nadh	ND1	PA164755085	4535;10625	0.701
NULL	J_Exp_Med_2000_Nov_20_192(10)_1479-1490.nxml.txt.nlp	11085749	SENT379	11	11	5	5	glucose	USF2	PA449773	7392	0.701
NULL	Front_Aging_Neurosci_2010_Aug_6_2_26.nxml.txt.nlp	20802800	SENT281	8	8	22	22	memantine	CA1	PA10364	759	0.701
NULL	Front_Immunol_2012_Mar_19_3_47.nxml.txt.nlp	22566929	SENT118	3	3	15	15	abatacept	B7-1	PA164747080	941	0.701
NULL	Front_Immunol_2013_Oct_8_4_289.nxml.txt.nlp	24115947	SENT46	9	9	4	4	dextran	IL-18	PA449261	3606	0.701
NULL	Clinics_(Sao_Paulo)_2013_May_68(5)_694-701.nxml.txt.nlp	23778405	SENT137	5	5	12	12	curcumin	survivin	PA151958596	332	0.701
NULL	Daru_2012_Sep_3_20(1)_24.nxml.txt.nlp	23351176	SENT188	12	12	16	16	itopride	EPO	PA152432599	7076;8288;2056	0.701
NULL	Mol_Cancer_2012_Jul_12_11_45.nxml.txt.nlp	22788833	SENT102	2	2	9	9	cisplatin	EGFR	PA449014	1956	0.701
NULL	Core_Evid_2010_Jul_27_5_1-10.nxml.txt.nlp	20694135	SENT123	16	16	31	31	levodopa	CLE	PA450213	51637	0.701
NULL	Oncotarget_2013_Nov_23_5(1)_196-210.nxml.txt.nlp	24344116	SENT74	0	0	2	2	doxorubicin	p65	PA449412	5970	0.701
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT155	7	7	12	12	neratinib	HER3	PA165291472	2065	0.701
NULL	J_Hematol_Oncol_2012_Jul_2_5_35.nxml.txt.nlp	22747660	SENT17	2	2	10	10	imatinib	HER-2	PA10804	2064	0.701
NULL	Genet_Vaccines_Ther_2005_Jun_30_3_5.nxml.txt.nlp	15987532	SENT39	8	8	6	6	cetuximab	EGFR	PA10040	1956	0.701
NULL	Front_Endocrinol_(Lausanne)_2014_Nov_28_5_201.nxml.txt.nlp	25506340	SENT80	41	41	43	43	vasopressin	ANG	PA451858	283	0.701
NULL	Cancers_(Basel)_2013_Jun_5_5(2)_676-713.nxml.txt.nlp	24216997	SENT2372	0	0	14	14	vorinostat	PERK	PA164748224	9451	0.701
NULL	FASEB_J_2011_Apr_25(4)_1133-1144.nxml.txt.nlp	21163859	SENT341	10	10	15	15	ethanol	TC10	PA448073	23433	0.701
NULL	Clin_Pharmacokinet_2014_Sep_3_53(1)_1-16.nxml.txt.nlp	23999929	SENT278	28	28	16	16	rivaroxaban	CYP3A4	PA165958360	1576	0.701
NULL	Br_J_Cancer_1996_Sep_74(5)_704-710.nxml.txt.nlp	8795571	SENT19	6	6	15	15	paclitaxel	PA1	PA450761	79447	0.701
NULL	Arthritis_Res_Ther_2008_Mar_19_10(2)_R36.nxml.txt.nlp	18353171	SENT219	19	19	29	29	paraformaldehyde	CD69	PA450790	969	0.701
NULL	Indian_J_Pharmacol_2014_Nov-Dec_46(6)_627-632.nxml.txt.nlp	25538335	SENT163	23	23	21	21	metformin	Q10	PA450395	27161	0.701
NULL	Cancer_Cell_Int_2014_Jan_28_14_9.nxml.txt.nlp	24467921	SENT115	23	23	41	41	ampicillin	CO2	PA448419	4513	0.701
NULL	J_Oncol_2013_Apr_29_2013_854121.nxml.txt.nlp	23737784	SENT79	18	18	26	26	lapatinib	BCS	PA152241907	617	0.701
NULL	Diabetes_Care_2010_Jul_31_33(7)_1607-1609.nxml.txt.nlp	20357375	SENT53	6	6	8	8	sitagliptin	CD34	PA164748978	947	0.701
NULL	Ann_Lab_Med_2013_Jan_17_33(1)_86-88.nxml.txt.nlp	23301230	SENT52	26	26	12	12	cefoxitin	CTX	PA448856	1593	0.701
NULL	Oncotarget_2014_Jun_26_5(14)_5559-5569.nxml.txt.nlp	24980819	SENT184	27	27	21	21	vemurafenib	p53	PA165946873	7157	0.701
NULL	Clin_Ophthalmol_2012_Dec_13_6_1-4.nxml.txt.nlp	22259229	SENT64	8	8	11	11	travoprost	BAK	PA164781371	578	0.701
NULL	Eur_Radiol_2011_Jun_3_21(6)_1188-1199.nxml.txt.nlp	21127880	SENT65	13	13	0	0	cyclophosphamide	NAC	PA449165	22861	0.701
NULL	Br_J_Pharmacol_2011_Mar_162(5)_1074-1082.nxml.txt.nlp	20973779	SENT24	7	7	14	14	diltiazem	BTZ	PA449334	22794	0.701
NULL	Cell_Death_Dis_2014_Feb_27_5(2)_e1088.nxml.txt.nlp	24577086	SENT121	37	37	32	32	metformin	Bcl-2	PA450395	596	0.701
NULL	Chin_J_Cancer_2012_Nov_31(11)_507-518.nxml.txt.nlp	22640626	SENT174	11	11	17	17	nilotinib	c-ABL	PA165958345	25	0.701
NULL	Reprod_Biol_Endocrinol_2003_Aug_27_1_59.nxml.txt.nlp	12967350	SENT158	41	41	34	34	estradiol	XIAP	PA449503	331	0.701
NULL	Allergy_Asthma_Immunol_Res_2014_Nov_19_6(6)_548-557.nxml.txt.nlp	25374755	SENT203	0	0	14	14	lovastatin	IL-5	PA450272	3567	0.701
NULL	J_Biol_Eng_2010_Jan_29_4_2.nxml.txt.nlp	20205817	SENT184	7	7	18	18	hydralazine	zeta	PA449894	9907	0.701
NULL	Acta_Pharmacol_Sin_2012_May_4_33(5)_710-716.nxml.txt.nlp	22555373	SENT115	6	6	16	16	phenylbutazone	DOM	PA450932	6663	0.701
NULL	Bone_2014_Sep_66(100)_240-250.nxml.txt.nlp	24971713	SENT397	0	0	26	26	zoledronate	OCN	PA10235	632	0.701
NULL	Front_Neuroanat_2011_Jul_12_5_38.nxml.txt.nlp	21808606	SENT186	12	12	28	28	haloperidol	MSK1	PA449841	9252	0.701
NULL	J_Med_Case_Reports_2011_Oct_5_5_504.nxml.txt.nlp	21975443	SENT35	16	16	21	21	imatinib	KIT	PA10804	3815	0.701
NULL	JRSM_Cardiovasc_Dis_2012_Apr_5_1(1)_cvd_2012_012001.nxml.txt.nlp	24175062	SENT66	29	29	33	33	abacavir	HLA-B	PA448004	3106	0.701
NULL	Oncotarget_2014_Aug_12_5(20)_9710-9726.nxml.txt.nlp	25339152	SENT342	33	33	44	44	hydrocortisone	EGF	PA449905	1950	0.701
NULL	Hum_Genomics_Proteomics_2010_Sep_13_2010_754919.nxml.txt.nlp	20981234	SENT94	38	38	20	20	acenocoumarol	CYP2C9	PA452632	1559	0.701
NULL	Onco_Targets_Ther_2014_Sep_26_7_1761-1768.nxml.txt.nlp	25328409	SENT30	18	18	34	34	l-glutamine	CO2	PA10090	4513	0.701
NULL	Arthritis_Res_Ther_2008_Jan_18_10(1)_R8.nxml.txt.nlp	18205921	SENT138	25	25	10	10	vardenafil	IL-17	PA10229	3605	0.701
NULL	Breast_Cancer_Res_2014_Sep_25_16(5)_444.nxml.txt.nlp	25252859	SENT406	0	0	15	15	doxycycline	GLI1	PA449415	2735	0.701
NULL	Br_J_Haematol_2014_Jun_12_165(6)_768-776.nxml.txt.nlp	24617454	SENT180	13	13	22	22	vorinostat	CREBBP	PA164748224	1387	0.701
NULL	Clin_Genet_2014_Jan_1_86(1)_21-28.nxml.txt.nlp	24684508	SENT56	23	23	5	5	warfarin	VKORC1	PA451906	79001	0.701
NULL	J_Med_Case_Reports_2008_May_19_2_167.nxml.txt.nlp	18489739	SENT19	27	27	31	31	vincristine	CHOP	PA451879	1649	0.701
NULL	Biochim_Biophys_Acta_2014_Jun_1841(6)_906-917.nxml.txt.nlp	24657704	SENT30	17	17	2	2	lipase	ATGL	PA450239	57104	0.701
NULL	Endocrinology_2014_Oct_22_155(10)_3732-3738.nxml.txt.nlp	25051442	SENT68	2	2	16	16	sibutramine	ARC	PA451344	8996;23237	0.701
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_7-17.nxml.txt.nlp	17912633	SENT368	9	9	29	29	fulvestrant	AMH	PA164747170	268	0.701
NULL	Br_J_Clin_Pharmacol_2011_Oct_72(4)_647-657.nxml.txt.nlp	21518389	SENT161	21	21	10	10	thrombin	ADP	PA451674	23038	0.701
NULL	Nat_Commun_2013_4_1963.nxml.txt.nlp	23739639	SENT93	6	6	22	22	heparin	MARCO	PA449855	8685	0.701
NULL	Biomed_Res_Int_2014_Apr_29_2014_157923.nxml.txt.nlp	24877059	SENT194	40	40	33	33	ketamine	5-HT1B	PA450144	3351	0.701
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT87	9	9	15	15	tamoxifen	p27	PA451581	5715;10534	0.701
NULL	Biomed_Res_Int_2014_Aug_6_2014_967826.nxml.txt.nlp	25165721	SENT60	0	0	12	12	cisplatin	Bcl-2	PA449014	596	0.701
NULL	Front_Behav_Neurosci_2010_Jun_10_4_32.nxml.txt.nlp	20589092	SENT543	9	9	17	17	phencyclidine	5-HT2A	PA128406980	3356	0.701
NULL	Acta_Pharmacol_Sin_2014_Aug_21_35(8)_1082-1092.nxml.txt.nlp	25047514	SENT200	8	8	13	13	letrozole	Met	PA450196	79811	0.701
NULL	Br_J_Cancer_2012_Sep_4_107(6)_947-955.nxml.txt.nlp	22892392	SENT92	7	7	13	13	tamoxifen	ERBB2	PA451581	2064	0.701
NULL	Neural_Plast_2007_Jun_19_2007_52908.nxml.txt.nlp	17641734	SENT192	4	4	17	17	rimonabant	FAAH	PA152407999	79152;2166	0.701
NULL	Diabetes_Care_2012_Jan_13_35(Suppl_1)_S11-S63.nxml.txt.nlp	22187469	SENT1937	13	13	6	6	ramipril	DREAM	PA451223	30818	0.701
NULL	Front_Neurosci_2014_Jun_24_8_176.nxml.txt.nlp	25009459	SENT1043	6	6	11	11	ethanol	P2X4	PA448073	5025	0.701
NULL	Cell_Death_Dis_2010_May_13_1(5)_e41.nxml.txt.nlp	21364648	SENT332	10	10	15	15	etoposide	p53	PA449552	7157	0.701
NULL	Mar_Drugs_2011_Apr_18_9(4)_615-624.nxml.txt.nlp	21731553	SENT48	19	19	25	25	mannitol	PHB	PA450320	5245	0.701
NULL	Orthop_Rev_(Pavia)_2014_Sep_18_6(3)_5405.nxml.txt.nlp	25317308	SENT40	12	12	14	14	codeine	PRN	PA449088	64428	0.701
NULL	Cancer_Metastasis_Rev_2010_Sep_24_29(3)_465-482.nxml.txt.nlp	20730632	SENT330	2	2	7	7	genistein	TRAMP	PA165109660	8718;23471;9189	0.701
NULL	eLife_2014_Mar_26_3_e01438.nxml.txt.nlp	24670955	SENT583	22	22	14	14	quinidine	CTX	PA451209	1593	0.701
NULL	Environ_Health_Perspect_2004_Nov_16_112(15)_1519-1526.nxml.txt.nlp	15531437	SENT172	11	11	31	31	estradiol	CHIP	PA449503	10273	0.701
NULL	Cent_European_J_Urol_2011_Jun_2_64(2)_62-66.nxml.txt.nlp	24578865	SENT132	26	26	6	6	tamsulosin	Yes	PA451583	7525	0.701
NULL	Stroke_Res_Treat_2011_Jan_20_2011_712903.nxml.txt.nlp	21331163	SENT301	4	4	6	6	collagenase	MMP9	PA449107	4318	0.701
NULL	Mol_Cancer_2012_Aug_8_11_53.nxml.txt.nlp	22871047	SENT296	12	12	4	4	cisplatin	HIN-1	PA449014	92304	0.701
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT75	7	7	11	11	nutlin-3	IBP		706;50619	0.701
NULL	Int_Clin_Psychopharmacol_2014_Mar_31_29(2)_86-92.nxml.txt.nlp	24247740	SENT123	4	4	35	35	vilazodone	NNT	PA165958365	23530	0.701
NULL	Acta_Orthop_2010_Apr_6_81(2)_263-267.nxml.txt.nlp	20148646	SENT11	1	1	37	37	taurine	XBP1	PA451590	7494	0.701
NULL	J_Neural_Transm_2014_Mar_1_121(8)_799-817.nxml.txt.nlp	24578174	SENT159	21	21	24	24	ceftriaxone	EAAT2	PA448866	6506	0.701
NULL	Alzheimers_Res_Ther_2013_Oct_24_5(5)_50.nxml.txt.nlp	24401551	SENT239	0	0	9	9	donepezil	spatial	PA449394	219793	0.701
NULL	Int_J_Chron_Obstruct_Pulmon_Dis_2008_Dec_3(4)_781-790.nxml.txt.nlp	19281093	SENT166	20	20	24	24	tiotropium	AP-1	PA164769056	2353;3727;2354;3725	0.701
NULL	Mol_Cancer_2014_Jun_27_13_159.nxml.txt.nlp	24972933	SENT94	13	13	39	39	gemcitabine	BTK	PA449748	695	0.701
NULL	Am_J_Trop_Med_Hyg_2012_Mar_1_86(3)_489-495.nxml.txt.nlp	22403324	SENT194	8	8	15	15	ritonavir	P-gp	PA451260	5243	0.701
NULL	Diabetes_2009_Apr_23_58(4)_917-925.nxml.txt.nlp	19168598	SENT74	11	11	33	33	paraformaldehyde	AKT	PA450790	207	0.701
NULL	Front_Mol_Neurosci_2014_Nov_4_7_83.nxml.txt.nlp	25414638	SENT867	11	11	21	21	bortezomib	c-Jun	PA10252	3725	0.701
NULL	Cancer_Cell_Int_2011_Aug_19_11_29.nxml.txt.nlp	21854619	SENT9	13	13	20	20	cisplatin	BRCA1	PA449014	672	0.701
NULL	Mol_Cancer_2009_Nov_10_8_99.nxml.txt.nlp	19903356	SENT9	16	16	3	3	imatinib	IGFBP3	PA10804	3486	0.701
NULL	Nat_Commun_2014_Jul_16_5_4425.nxml.txt.nlp	25028121	SENT47	40	40	7	7	pp2	p62		8878;10657;23636	0.701
NULL	Ther_Clin_Risk_Manag_2007_Jun_3(3)_449-459.nxml.txt.nlp	18488069	SENT196	22	22	14	14	eletriptan	RIZ	PA134687947	7799	0.701
NULL	Arthritis_Res_Ther_2003_Apr_28_5(4)_R186-R192.nxml.txt.nlp	12823853	SENT131	5	5	21	21	genistein	TSG-6	PA165109660	7130	0.701
NULL	Eur_J_Pharm_Sci_2012_Jul_16_46(4)_244-258.nxml.txt.nlp	22085636	SENT358	20	20	5	5	pertuzumab	PTEN		5728	0.701
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT11	0	0	11	11	chloroquine	BMPR-II	PA448948	659	0.701
NULL	Int_J_Mol_Sci_2014_Jun_3_15(6)_9924-9944.nxml.txt.nlp	24897026	SENT180	5	5	27	27	ethanol	SREBP-1c	PA448073	6720	0.701
NULL	Breast_Cancer_Res_2009_Jun_29_11(3)_R41.nxml.txt.nlp	19563669	SENT19	25	25	5	5	trastuzumab	XIAP	PA451743	331	0.701
NULL	Exp_Ther_Med_2013_Aug_6_6(2)_427-434.nxml.txt.nlp	24137203	SENT145	30	30	3	3	fosinopril	MCP-1	PA449710	6347	0.701
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT65	7	7	9	9	curcumin	TRAIL	PA151958596	8743	0.701
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S31-S40.nxml.txt.nlp	20680106	SENT53	10	10	22	22	cetuximab	KRAS	PA10040	3845	0.701
NULL	J_Immunol_Res_2014_May_8_2014_565320.nxml.txt.nlp	24901010	SENT111	14	14	11	11	abacavir	HLA-B	PA448004	3106	0.701
NULL	Oncogene_2014_Aug_28_33(35)_4396-4406.nxml.txt.nlp	24531714	SENT58	0	0	14	14	nutlin-3	p53		7157	0.701
NULL	Front_Cell_Neurosci_2014_Jun_17_8_161.nxml.txt.nlp	24987330	SENT994	10	10	21	21	tiagabine	CA1	PA451682	759	0.701
NULL	Oncotarget_2014_Jun_8_5(13)_5040-5053.nxml.txt.nlp	24970815	SENT252	38	38	13	13	lapatinib	BRAF	PA152241907	673	0.701
NULL	Virol_J_2010_Oct_20_7_279.nxml.txt.nlp	20961433	SENT157	10	10	5	5	trypsin	VLP	PA451806	391104	0.701
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT61	1	1	4	4	cetuximab	EGFR	PA10040	1956	0.701
NULL	Biomed_Res_Int_2014_Apr_27_2014_180428.nxml.txt.nlp	24877063	SENT257	0	0	9	9	cisplatin	TRPA1	PA449014	8989	0.701
NULL	Int_J_Fertil_Steril_2014_Nov_1_Oct-Dec_8(3)_333-340.nxml.txt.nlp	25379163	SENT49	19	19	2	2	estradiol	RFRP	PA449503	64111	0.701
NULL	Breast_Cancer_Res_2007_Aug_8_9(4)_R50.nxml.txt.nlp	17686159	SENT268	19	19	10	10	trastuzumab	HRG	PA451743	3084;3273	0.701
NULL	Am_J_Trop_Med_Hyg_2012_Nov_7_87(5)_783-784.nxml.txt.nlp	23136171	SENT23	10	10	30	30	artemether	ACT	PA165111698	12;11332;9457;641455	0.701
NULL	Eur_J_Med_Res_2014_Sep_16_19(1)_50.nxml.txt.nlp	25223338	SENT246	11	11	2	2	gemcitabine	ERCC1	PA449748	2067	0.701
NULL	Front_Oncol_2014_Mar_25_4_54.nxml.txt.nlp	24724051	SENT51	12	12	30	30	nilotinib	ABL1	PA165958345	25	0.701
NULL	Daru_2012_Sep_3_20(1)_24.nxml.txt.nlp	23351176	SENT188	3	3	16	16	itopride	EPO	PA152432599	7076;8288;2056	0.701
NULL	Br_J_Clin_Pharmacol_2011_Oct_72(4)_647-657.nxml.txt.nlp	21518389	SENT95	12	12	7	7	prasugrel	CYP2C19	PA154410481	1557	0.701
NULL	Mol_Cancer_2009_Nov_19_8_108.nxml.txt.nlp	19925669	SENT92	7	7	12	12	doxorubicin	MRP3	PA449412	8714	0.701
NULL	Clinics_(Sao_Paulo)_2013_May_68(5)_592-598.nxml.txt.nlp	23778413	SENT220	31	31	4	4	docetaxel	HIF1A	PA449383	3091	0.701
NULL	Cancers_(Basel)_2011_Aug_5_3(3)_3114-3142.nxml.txt.nlp	24212948	SENT746	25	25	2	2	cyclophosphamide	CD4	PA449165	920	0.701
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT35	10	10	8	8	imatinib	CML	PA10804	613	0.701
NULL	J_Carcinog_2012_Oct_27_11_16.nxml.txt.nlp	23230393	SENT54	5	5	12	12	trastuzumab	HER-2	PA451743	2064	0.701
NULL	J_Exp_Med_1962_Feb_28_115(3)_623-639.nxml.txt.nlp	13891303	SENT2	12	12	26	26	papain	S20	PA450778	6224	0.701
NULL	Mol_Biol_Rep_2012_May_20_39(5)_5253-5267.nxml.txt.nlp	22183301	SENT206	3	3	10	10	gliclazide	NAC	PA10892	22861	0.701
NULL	Br_J_Cancer_2009_Jun_2_100(11)_1739-1745.nxml.txt.nlp	19436299	SENT28	32	32	15	15	everolimus	FDG	PA164746311	23583	0.701
NULL	Exp_Ther_Med_2012_Sep_12_4(3)_475-480.nxml.txt.nlp	23181121	SENT156	2	2	16	16	cyclophosphamide	CHOP	PA449165	1649	0.701
NULL	Crit_Care_2005_Aug_11_9(1)_86-91.nxml.txt.nlp	15693989	SENT83	19	19	7	7	dantrolene	CHS	PA449208	1130	0.701
NULL	Oncotarget_2010_May_1_1(1)_6-8.nxml.txt.nlp	21293050	SENT46	1	1	12	12	bortezomib	KIT	PA10252	3815	0.701
NULL	J_Geriatr_Cardiol_2013_Mar_10(1)_82-90.nxml.txt.nlp	23610578	SENT63	11	11	24	24	clopidogrel	P2Y12	PA449053	64805	0.701
NULL	J_Hematol_Oncol_2013_Aug_2_6_55.nxml.txt.nlp	23915913	SENT187	5	5	21	21	lenalidomide	FLG3	PA162363968	388697	0.701
NULL	Mol_Med_Rep_2015_Jan_17_11(1)_43-52.nxml.txt.nlp	25333456	SENT266	21	21	33	33	vincristine	DDP	PA451879	1678	0.701
NULL	J_Cardiovasc_Thorac_Res_2014_Jun_30_6(2)_97-100.nxml.txt.nlp	25031824	SENT73	9	9	14	14	heparin	ACT	PA449855	12;11332;9457;641455	0.701
NULL	Mol_Cancer_2008_Mar_26_7_27.nxml.txt.nlp	18366759	SENT274	19	19	12	12	etoposide	p53	PA449552	7157	0.701
NULL	Oncogene_2014_Feb_6_33(6)_734-744.nxml.txt.nlp	23376847	SENT115	0	0	4	4	tetracycline	SUV39H1	PA451640	6839	0.701
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT39	3	3	7	7	cisplatin	p53	PA449014	7157	0.701
NULL	Arthritis_Res_Ther_2013_Sep_12_15(5)_R117.nxml.txt.nlp	24028544	SENT84	30	30	11	11	cyclophosphamide	VDI	PA449165	7420	0.701
NULL	Ther_Clin_Risk_Manag_2007_Aug_3(4)_533-542.nxml.txt.nlp	18472974	SENT101	6	6	14	14	ketoconazole	CYP3A4	PA450146	1576	0.701
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT283	14	14	41	41	atorvastatin	AKT	PA448500	207	0.701
NULL	Oncol_Rep_2013_Apr_5_29(4)_1671-1677.nxml.txt.nlp	23404329	SENT35	14	14	16	16	aspirin	ASP	PA448497	259266;443;9474;29974;434;83853	0.701
NULL	Mycobiology_2010_Mar_31_38(1)_58-61.nxml.txt.nlp	23956626	SENT26	4	4	14	14	lipase	TES	PA450239	26136	0.701
NULL	Evid_Based_Complement_Alternat_Med_2013_Aug_12_2013_982689.nxml.txt.nlp	23997806	SENT9	9	9	0	0	tolbutamide	APE	PA451718	55704;328	0.701
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_May_14_67(Pt_6)_o1431.nxml.txt.nlp	21754810	SENT60	24	24	12	12	ethanol	mol	PA448073	90527	0.701
NULL	Front_Behav_Neurosci_2014_Nov_5_8_388.nxml.txt.nlp	25414651	SENT220	33	33	24	24	ketamine	NAC	PA450144	22861	0.701
NULL	Open_Ophthalmol_J_2011_Apr_28_5_27-31.nxml.txt.nlp	21633720	SENT105	34	34	9	9	guanabenz	ERG	PA164774903	2078	0.701
NULL	Anc_Sci_Life_1998_Oct-Dec_18(2)_134-144.nxml.txt.nlp	22556881	SENT8	10	10	19	19	phenol	TLC	PA450913	3933	0.701
NULL	Br_J_Cancer_2010_Jun_29_103(1)_52-60.nxml.txt.nlp	20531411	SENT46	29	29	27	27	gemcitabine	MTD	PA449748	4493	0.701
NULL	Int_J_Mol_Sci_2014_Nov_5_15(11)_20169-20208.nxml.txt.nlp	25380523	SENT1904	14	14	4	4	tamoxifen	Q10	PA451581	27161	0.701
NULL	Oxid_Med_Cell_Longev_2012_Aug_9_2012_680304.nxml.txt.nlp	22928083	SENT130	7	7	13	13	galactose	CLS	PA449725	1210	0.701
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1129-1136.nxml.txt.nlp	20234368	SENT182	9	9	30	30	imiquimod	IFN	PA449972	3439	0.701
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT29	2	2	11	11	trastuzumab	HER2	PA451743	2064	0.701
NULL	Eur_J_Plast_Surg_2011_Apr_22_34(2)_81-86.nxml.txt.nlp	21475651	SENT177	6	6	13	13	dobutamine	TRAM	PA449381	23471;353376	0.701
NULL	Mol_Cancer_2008_Jun_3_7_47.nxml.txt.nlp	18519000	SENT63	12	12	4	4	gefitinib	EGFR	PA131301952	1956	0.701
NULL	Breast_Cancer_Res_2004_Nov_7_6(1)_39-52.nxml.txt.nlp	14680484	SENT157	34	34	30	30	tamoxifen	SMRT	PA451581	9612	0.701
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_13_2012_636848.nxml.txt.nlp	23258994	SENT27	21	21	0	0	vincristine	TRPV4	PA451879	59341	0.701
NULL	Biosci_Rep_2012_Dec_20_33(1)_e00011.nxml.txt.nlp	23137297	SENT150	3	3	13	13	heparin	RPSA	PA449855	3921	0.701
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_3_2014_473213.nxml.txt.nlp	25538791	SENT213	14	14	16	16	fexofenadine	FEX	PA449621	8549	0.701
NULL	J_Cell_Biol_1998_Aug_24_142(4)_923-936.nxml.txt.nlp	9722606	SENT284	3	3	10	10	fluorescein	TGN	PA164746009	7038	0.701
NULL	Clin_Ophthalmol_2014_Jun_3_8_1057-1064.nxml.txt.nlp	24940042	SENT110	8	8	25	25	bevacizumab	CST	PA130232992	9514	0.701
NULL	Vet_Res_2013_Mar_28_44(1)_22.nxml.txt.nlp	23537375	SENT39	30	30	20	20	gentamicin	F12	PA449753	2161	0.701
NULL	J_Cell_Mol_Med_2014_Feb_25_18(2)_218-230.nxml.txt.nlp	24268047	SENT146	8	8	20	20	erlotinib	EGF	PA134687924	1950	0.701
NULL	Ann_Rheum_Dis_2008_Jun_2_68(5)_654-657.nxml.txt.nlp	18519424	SENT115	15	15	18	18	tocilizumab	IL6	PA165292659	3569	0.701
NULL	Diabetes_Care_2010_Aug_27_33(8)_1734-1737.nxml.txt.nlp	20424219	SENT53	11	11	14	14	exenatide	adiponectin	PA164749238	9370	0.701
NULL	Eur_J_Endocrinol_2011_Jan_164(1)_69-74.nxml.txt.nlp	20961967	SENT77	23	23	36	36	pioglitazone	adiponectin	PA450970	9370	0.701
NULL	J_Gen_Physiol_1990_Dec_1_96(6)_1247-1269.nxml.txt.nlp	1962815	SENT10	33	33	8	8	amiloride	CO2	PA448368	4513	0.701
NULL	J_Oral_Pathol_Med_2013_Jul_18_42(6)_499-506.nxml.txt.nlp	23331485	SENT14	6	6	18	18	celecoxib	IL-6	PA448871	3569	0.701
NULL	Bone_Marrow_Transplant_2012_Feb_28_47(2)_203-211.nxml.txt.nlp	21441963	SENT106	14	14	1	1	fludarabine	NMA	PA449655	25805	0.7
NULL	Cancer_Imaging_2006_Oct_31_6(Spec_No_A)_S32-S41.nxml.txt.nlp	NULL	SENT66	12	12	40	40	creatine	San	PA164778930	80218	0.7
NULL	Br_J_Cancer_2014_Jan_21_110(2)_510-519.nxml.txt.nlp	24327015	SENT214	17	17	28	28	gemcitabine	PLK1	PA449748	5347	0.7
NULL	Mol_Neurodegener_2011_Aug_8_6_57.nxml.txt.nlp	21819629	SENT93	14	14	9	9	arsenite	TDP-43	PA452638	23435	0.7
NULL	Nucleic_Acids_Res_2011_Mar_19_39(4)_1280-1293.nxml.txt.nlp	20959288	SENT43	37	37	21	21	paraformaldehyde	P14	PA450790	11102;;6280;56259	0.7
NULL	Hum_Genomics_2008_Sep_1_3(1)_7-16.nxml.txt.nlp	19129086	SENT35	25	25	19	19	repaglinide	OATP1B1	PA451234	10599	0.7
NULL	Br_J_Cancer_2009_Jul_21_101(2)_238-243.nxml.txt.nlp	19568242	SENT109	6	6	8	8	bevacizumab	IFN	PA130232992	3439	0.7
NULL	JAKSTAT_2013_Jul_1_2(3)_e24574.nxml.txt.nlp	24069558	SENT89	18	18	10	10	doxycycline	JAK2	PA449415	3717	0.7
NULL	Diabetologia_2010_Jan_6_53(1)_1-6.nxml.txt.nlp	19894028	SENT99	28	28	38	38	metformin	HSM	PA450395	94030	0.7
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT81	16	16	7	7	trastuzumab	EGF	PA451743	1950	0.7
NULL	ScientificWorldJournal_2014_Dec_11_2014_194652.nxml.txt.nlp	25580452	SENT58	14	14	4	4	ethanol	mol	PA448073	90527	0.7
NULL	J_Gastroenterol_2013_Jan_28_48(1)_1-12.nxml.txt.nlp	23188091	SENT122	21	21	0	0	ribavirin	ITPA	PA451241	3704	0.7
NULL	Curr_Neuropharmacol_2013_Dec_11(6)_652-663.nxml.txt.nlp	24396340	SENT240	5	5	16	16	capsaicin	TRPV3	PA448776	162514	0.7
NULL	Oncol_Lett_2013_Feb_7_5(2)_411-416.nxml.txt.nlp	23420500	SENT190	6	6	18	18	cetuximab	Bcl-2	PA10040	596	0.7
NULL	Eur_J_Clin_Pharmacol_2010_Feb_17_66(2)_165-170.nxml.txt.nlp	19838691	SENT143	41	41	27	27	midazolam	UGT2B4	PA450496	7363	0.7
NULL	Pharmaceutics_2011_Nov_18_3(4)_865-913.nxml.txt.nlp	24309312	SENT220	27	27	2	2	imatinib	CYP3A	PA10804	1574	0.7
NULL	Breast_Cancer_Res_Treat_2013_Oct_8_141(3)_437-446.nxml.txt.nlp	24101324	SENT277	8	8	13	13	trastuzumab	PTEN	PA451743	5728	0.7
NULL	Cell_Death_Dis_2013_Oct_3_4(10)_e828.nxml.txt.nlp	24091671	SENT75	45	45	29	29	cetuximab	CD54	PA10040	3383	0.7
NULL	Surg_Neurol_Int_2014_Jun_5_5_86.nxml.txt.nlp	25024886	SENT115	16	16	13	13	zidovudine	BEST	PA451954	7439	0.7
NULL	Mol_Cancer_2010_Nov_2_9_289.nxml.txt.nlp	21044322	SENT139	30	30	2	2	cisplatin	RGS10	PA449014	6001	0.7
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT145	40	40	25	25	l-methionine	ATP5A	PA450423	498	0.7
NULL	Br_J_Cancer_2013_Feb_19_108(3)_570-578.nxml.txt.nlp	23299527	SENT142	8	8	18	18	acetohexamide	MLC2	PA164777011	10398	0.7
NULL	Diabetes_Care_2010_May_3_33(5)_1028-1030.nxml.txt.nlp	20200309	SENT88	25	25	12	12	glimepiride	GLP-1	PA449761	100125288	0.7
NULL	Biomed_Res_Int_2014_Jan_20_2014_948427.nxml.txt.nlp	24563867	SENT81	18	18	28	28	urea	STZ	PA451831	6484	0.7
NULL	Chonnam_Med_J_2011_Aug_31_47(2)_130-133.nxml.txt.nlp	22111075	SENT31	8	8	17	17	thyroglobulin	TTF-1	PA164754910	7080	0.7
NULL	Br_J_Anaesth_2011_Oct_17_107(4)_490-502.nxml.txt.nlp	21852280	SENT67	30	30	5	5	capsaicin	TRPV1	PA448776	7442	0.7
NULL	Ann_Rehabil_Med_2012_Aug_27_36(4)_561-564.nxml.txt.nlp	22977784	SENT69	11	11	14	14	clonazepam	LAS	PA449050	11019	0.7
NULL	Br_J_Cancer_1998_Nov_78(9)_1170-1174.nxml.txt.nlp	9820175	SENT13	12	12	42	42	paclitaxel	CYP2D6	PA450761	1565	0.7
NULL	Pharmaceuticals_(Basel)_2012_Sep_12_5(9)_963-990.nxml.txt.nlp	24280700	SENT1225	8	8	15	15	tranylcypromine	LSD1	PA451741	23028	0.7
NULL	Clin_Ophthalmol_2008_Jun_2(2)_369-375.nxml.txt.nlp	19668728	SENT146	0	0	8	8	ranibizumab	San	PA164746012	80218	0.7
NULL	Oncotarget_2010_Aug_10_1(4)_239-245.nxml.txt.nlp	21304176	SENT41	11	11	13	13	dacarbazine	Bcl-2	PA449197	596	0.7
NULL	FEBS_Open_Bio_2014_Aug_1_4_722-729.nxml.txt.nlp	25161880	SENT264	1	1	7	7	cyanocobalamin	B12	PA451892	7126;4709	0.7
NULL	Front_Oncol_2014_Apr_9_4_75.nxml.txt.nlp	24782986	SENT203	32	32	8	8	paclitaxel	Oct4	PA450761	5460	0.7
NULL	Int_J_Endocrinol_2014_Feb_13_2014_329456.nxml.txt.nlp	24688539	SENT223	9	9	32	32	tadalafil	MCP-1	PA10333	6347	0.7
NULL	Nucleic_Acids_Res_2012_Jul_1_40(12)_5775-5786.nxml.txt.nlp	22383579	SENT231	8	8	10	10	theophylline	MS2	PA451647	101	0.7
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT245	7	7	0	0	cisplatin	MVP	PA449014	9961	0.7
NULL	Protein_Cell_2014_Apr_14_5(4)_265-296.nxml.txt.nlp	24622842	SENT63	20	20	34	34	s-adenosylmethionine	DNMT1	PA164754994	1786	0.7
NULL	Environ_Health_Perspect_2011_Mar_1_119(3)_371-376.nxml.txt.nlp	21041162	SENT14	10	10	2	2	cyclophosphamide	DES	PA449165	1674	0.7
NULL	Anc_Sci_Life_2012_Jan-Mar_31(3)_101-106.nxml.txt.nlp	23284215	SENT90	11	11	27	27	ethanol	mol	PA448073	90527	0.7
NULL	J_Physiol_2009_Feb_15_587(Pt_4)_731-744.nxml.txt.nlp	19074966	SENT146	13	13	8	8	taurine	PAT1	PA451590	10513;206358	0.7
NULL	Diabetes_2013_Oct_17_62(10)_3500-3513.nxml.txt.nlp	23884882	SENT10	32	32	17	17	resveratrol	FOXO1		2308	0.7
NULL	Int_J_Biomed_Sci_2014_Sep_10(3)_146-157.nxml.txt.nlp	25324695	SENT25	11	11	21	21	hyaluronan	TLR4	PA165958431	7099	0.7
NULL	Oncol_Lett_2013_Aug_14_6(2)_600-604.nxml.txt.nlp	24137378	SENT147	6	6	18	18	metoclopramide	SIRT1	PA450475	23411	0.7
NULL	Evid_Based_Complement_Alternat_Med_2012_Feb_12_2012_743075.nxml.txt.nlp	22454682	SENT154	7	7	14	14	forskolin	MDC	PA146096022	6367	0.7
NULL	Mol_Vis_2011_Feb_17_17_508-518.nxml.txt.nlp	21365018	SENT173	35	35	9	9	bleomycin	HMGB1	PA448645	3146	0.7
NULL	Mol_Neurodegener_2010_Nov_10_5_50.nxml.txt.nlp	21067605	SENT69	33	33	9	9	calcein	LIP	PA132595336	23049	0.7
NULL	Int_J_Mol_Sci_2014_Mar_18_15(3)_4747-4779.nxml.txt.nlp	24646914	SENT332	6	6	3	3	plerixafor	CXCR4	PA165958410	7852	0.7
NULL	J_Cell_Biol_2008_Jul_14_182(1)_197-213.nxml.txt.nlp	18625847	SENT308	28	28	31	31	nutlin-3	p53		7157	0.7
NULL	Croat_Med_J_2012_Dec_53(6)_605-611.nxml.txt.nlp	23275326	SENT187	13	13	3	3	propafenone	A10	PA451131	28870	0.7
NULL	Cell_Cycle_2013_Sep_1_12(17)_2899-2913.nxml.txt.nlp	23966157	SENT17	14	14	0	0	collagenase	EMMPRIN	PA449107	682	0.7
NULL	Indian_J_Ophthalmol_2007_Nov-Dec_55(6)_421-425.nxml.txt.nlp	17951897	SENT53	18	18	22	22	ranibizumab	VEGF-A	PA164746012	7422	0.7
NULL	J_Mol_Signal_2012_Aug_16_7_12.nxml.txt.nlp	22898329	SENT138	8	8	2	2	temozolomide	NOXA	PA451609	5366	0.7
NULL	Cell_Commun_Signal_2011_May_14_9_12.nxml.txt.nlp	21569606	SENT94	13	13	1	1	estradiol	FGF2	PA449503	2247;2258	0.7
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jun_13_68(Pt_7)_o2011.nxml.txt.nlp	22807839	SENT4	24	24	12	12	benzaldehyde	mol	PA448571	90527	0.7
NULL	Daru_2012_Sep_10_20(1)_30.nxml.txt.nlp	23351387	SENT133	20	20	27	27	indomethacin	IL-6	PA449982	3569	0.7
NULL	Iran_J_Pharm_Res_2014_Spring_13(2)_683-693.nxml.txt.nlp	25237365	SENT86	2	2	6	6	tamoxifen	CXCL12	PA451581	6387	0.7
NULL	Iran_J_Basic_Med_Sci_2012_Jan-Feb_15(1)_678-682.nxml.txt.nlp	23493931	SENT41	17	17	35	35	cefepime	MAST	PA164754876	51324	0.7
NULL	Front_Neurol_2014_Apr_9_5_44.nxml.txt.nlp	24782818	SENT293	12	12	15	15	methylprednisolone	TNF-alpha	PA450466	7124	0.7
NULL	Acta_Pharmacol_Sin_2014_Oct_25_35(10)_1293-1301.nxml.txt.nlp	25152022	SENT180	8	8	13	13	enalapril	NLRP3	PA449456	114548	0.7
NULL	Oncotarget_2013_Dec_18_5(2)_375-385.nxml.txt.nlp	24495868	SENT117	7	7	13	13	fludarabine	MCL1	PA449655	4170	0.7
NULL	Case_Rep_Oncol_2013_Jan_29_6(1)_72-77.nxml.txt.nlp	23466899	SENT103	17	17	4	4	gemcitabine	GTX	PA449748	84504	0.7
NULL	Front_Oncol_2014_Apr_17_4_81.nxml.txt.nlp	24860781	SENT55	5	5	3	3	hydrocortisone	EGF	PA449905	1950	0.7
NULL	J_Mol_Signal_2006_Dec_6_1_8.nxml.txt.nlp	17224083	SENT30	1	1	30	30	thrombin	Rho	PA451674	29984	0.7
NULL	Anticancer_Agents_Med_Chem_2010_Oct_10(8)_617-624.nxml.txt.nlp	21182469	SENT261	8	8	33	33	methotrexate	ABCC11	PA450428	85320	0.7
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT207	11	11	6	6	perifosine	DR5	PA165291471	8795	0.7
NULL	Cancer_Imaging_2012_Sep_28_12(2)_305-309.nxml.txt.nlp	23022887	SENT77	0	0	11	11	bevacizumab	VEGF-A	PA130232992	7422	0.7
NULL	Allergy_Asthma_Immunol_Res_2012_May_14_4(3)_137-142.nxml.txt.nlp	22548206	SENT134	15	15	25	25	diclofenac	PRX	PA449293	9588;57716	0.7
NULL	Cell_Mol_Life_Sci_2012_Jan_11_69(1)_149-163.nxml.txt.nlp	21667063	SENT311	15	15	3	3	curcumin	ATP7B	PA151958596	540	0.7
NULL	Cancer_Inform_2013_Feb_13_12_31-51.nxml.txt.nlp	23470717	SENT335	26	26	2	2	tamoxifen	p38	PA451581	10598;1432;7965	0.7
NULL	Ann_Thorac_Med_2013_Apr-Jun_8(2)_109-115.nxml.txt.nlp	23741274	SENT15	5	5	1	1	cisplatin	CRT	PA449014	811	0.7
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT109	3	3	5	5	tenofovir	ABCC1	PA10204	4363	0.7
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT277	16	16	22	22	resveratrol	TRAIL		8743	0.7
NULL	Stroke_Res_Treat_2009_Dec_20_2010_386389.nxml.txt.nlp	20700422	SENT160	4	4	6	6	ebselen	NAC	PA161660841	22861	0.7
NULL	J_Cell_Mol_Med_2014_May_14_18(5)_811-823.nxml.txt.nlp	24628949	SENT152	3	3	0	0	docetaxel	FOXM1	PA449383	2305	0.7
NULL	Nucleic_Acids_Res_2013_Apr_1_41(6)_3734-3747.nxml.txt.nlp	23376929	SENT72	30	30	42	42	streptomycin	CO2	PA451512	4513	0.7
NULL	Bone_Marrow_Transplant_2014_Feb_4_49(2)_201-205.nxml.txt.nlp	24185588	SENT103	15	15	26	26	plerixafor	CD34	PA165958410	947	0.7
NULL	J_Invest_Dermatol_2013_Sep_31_133(9)_2247-2254.nxml.txt.nlp	23370537	SENT73	17	17	8	8	chloroquine	p53	PA448948	7157	0.7
NULL	J_Neurosci_Res_2010_Jun_88(8)_1829-1840.nxml.txt.nlp	20091774	SENT154	5	5	7	7	l-serine	DAO	PA451330	26;1610	0.7
NULL	J_Cardiothorac_Surg_2010_Nov_3_5_101.nxml.txt.nlp	21047408	SENT203	7	7	20	20	lepirudin	IL-3	PA450195	3562	0.7
NULL	Diabetes_2009_Jan_58(1)_174-184.nxml.txt.nlp	18984736	SENT15	6	6	2	2	tranilast	TRPV2	PA131890628	51393	0.7
NULL	Indian_J_Pharmacol_2013_May-Jun_45(3)_274-277.nxml.txt.nlp	23833372	SENT46	6	6	9	9	colchicine	CA1	PA449092	759	0.7
NULL	Pain_Ther_2014_Jun_13_3(1)_59-69.nxml.txt.nlp	25135388	SENT124	2	2	8	8	curcumin	HSD1	PA151958596	26871	0.7
NULL	Cell_Commun_Signal_2009_Aug_13_7_19.nxml.txt.nlp	19678929	SENT38	42	42	25	25	bevacizumab	EGFR	PA130232992	1956	0.7
NULL	Oncotarget_2014_Oct_18_5(21)_10206-10221.nxml.txt.nlp	25344914	SENT216	40	40	27	27	vemurafenib	BRAF	PA165946873	673	0.7
NULL	Nat_Commun_2014_Dec_18_5_5815.nxml.txt.nlp	25519973	SENT30	7	7	10	10	tranylcypromine	ATN1	PA451741	1822	0.7
NULL	Exp_Ther_Med_2012_Sep_12_4(3)_475-480.nxml.txt.nlp	23181121	SENT159	2	2	16	16	cyclophosphamide	CHOP	PA449165	1649	0.7
NULL	Int_J_Hypertens_2012_Feb_8_2012_189512.nxml.txt.nlp	22518281	SENT131	7	7	10	10	hemin	HO-1	PA449849	3162	0.7
NULL	Int_J_Cell_Biol_2013_Sep_12_2013_153634.nxml.txt.nlp	24159334	SENT246	37	37	12	12	camptothecin	EWS	PA153590860	2130	0.7
NULL	Trials_2014_Sep_7_15(1)_352.nxml.txt.nlp	NULL	SENT16	9	9	20	20	atorvastatin	PMI	PA448500	8834;5373	0.7
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Jun_25_3(6)_e120.nxml.txt.nlp	24964282	SENT25	37	37	39	39	rifampin	CYP3A4	PA451250	1576	0.7
NULL	Mol_Cancer_2012_Jul_25_11_46.nxml.txt.nlp	22830422	SENT86	17	17	6	6	rolipram	ZO-1	PA153906323	7082	0.7
NULL	Arthritis_Res_Ther_2009_Jul_23_11(4)_236.nxml.txt.nlp	19664185	SENT69	27	27	38	38	benzbromarone	GLUT9	PA134852920	11182	0.7
NULL	Aging_(Albany_NY)_2011_Apr_6_3(4)_444-449.nxml.txt.nlp	21483037	SENT56	22	22	2	2	resveratrol	SIRT1		23411	0.7
NULL	Int_J_Endocrinol_Metab_2013_Jul_1_Summer_11(3)_184-190.nxml.txt.nlp	24348591	SENT132	4	4	8	8	liraglutide	INS-1	PA165958364	2305	0.7
NULL	Cancer_Med_2013_Aug_10_2(4)_496-506.nxml.txt.nlp	24156022	SENT236	19	19	4	4	irinotecan	KRAS	PA450085	3845	0.7
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT122	12	12	19	19	capsaicin	p53	PA448776	7157	0.7
NULL	Iran_J_Psychiatry_2012_Winter_7(1)_1-10.nxml.txt.nlp	23056111	SENT37	12	12	16	16	topiramate	BD1	PA451728	1672	0.7
NULL	Br_J_Cancer_2010_Jun_29_103(1)_61-72.nxml.txt.nlp	20588279	SENT270	8	8	21	21	trastuzumab	RhoB	PA451743	388	0.7
NULL	Acta_Histochem_Cytochem_2013_Oct_30_46(5)_129-136.nxml.txt.nlp	24194626	SENT54	10	10	12	12	thyroglobulin	TGB	PA164754910	5473	0.7
NULL	Mol_Biol_Cell_2012_May_15_23(10)_1812-1825.nxml.txt.nlp	22438585	SENT213	9	9	14	14	dextran	EGF	PA449261	1950	0.7
NULL	Int_J_Environ_Res_Public_Health_2011_Oct_29_8(10)_3889-3921.nxml.txt.nlp	22073019	SENT378	23	23	14	14	temozolomide	NF-kappaB	PA451609	4790	0.7
NULL	Clinics_2008_Apr_63(2)_207-214.nxml.txt.nlp	18438575	SENT64	18	18	23	23	fluorescein	San	PA164746009	80218	0.7
NULL	Arthritis_Res_Ther_2007_May_24_9(3)_211.nxml.txt.nlp	17540047	SENT55	24	24	39	39	methotrexate	ACR	PA450428	49	0.7
NULL	Cell_Cycle_2012_Nov_15_11(22)_4110.nxml.txt.nlp	23099922	SENT15	7	7	13	13	verapamil	P-gp	PA451868	5243	0.7
NULL	Lab_Anim_Res_2011_Sep_30_27(3)_245-250.nxml.txt.nlp	21998614	SENT77	13	13	8	8	mannitol	EPO	PA450320	7076;8288;2056	0.7
NULL	Clinics_(Sao_Paulo)_2013_May_68(5)_592-598.nxml.txt.nlp	23778413	SENT220	29	29	4	4	epirubicin	HIF1A	PA449476	3091	0.7
NULL	Oncoimmunology_2013_Jun_1_2(6)_e24677.nxml.txt.nlp	23894722	SENT113	23	23	17	17	cetuximab	CD80	PA10040	941	0.7
NULL	Br_J_Cancer_2013_May_14_108(9)_1862-1869.nxml.txt.nlp	23579219	SENT118	10	10	17	17	cetuximab	EGFR	PA10040	1956	0.7
NULL	Ann_Gastroenterol_2014_27(4)_313-319.nxml.txt.nlp	25331779	SENT145	9	9	18	18	azathioprine	POR	PA448515	5447	0.7
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT196	0	0	14	14	erlotinib	EGFR	PA134687924	1956	0.7
NULL	Curr_Neuropharmacol_2011_Dec_9(4)_530-552.nxml.txt.nlp	22654714	SENT837	9	9	3	3	clozapine	BDNF	PA449061	627	0.7
NULL	Adolesc_Health_Med_Ther_2010_Dec_23_2_1-8.nxml.txt.nlp	24600270	SENT32	0	0	6	6	etanercept	TNF-alpha	PA449515	7124	0.7
NULL	J_Nutr_Metab_2011_Oct_1_2011_525094.nxml.txt.nlp	21977315	SENT144	1	1	3	3	resveratrol	SIRT1		23411	0.7
NULL	Anesthesiol_Res_Pract_2012_Nov_24_2012_921405.nxml.txt.nlp	22162685	SENT140	31	31	4	4	clonidine	NPY	PA449051	4852	0.7
NULL	J_Anim_Sci_Biotechnol_2013_Jun_26_4(1)_23.nxml.txt.nlp	23800120	SENT163	0	0	2	2	estradiol	FGF7	PA449503	2252	0.7
NULL	Breast_Cancer_Res_2011_Nov_23_13(6)_R116.nxml.txt.nlp	22113133	SENT68	14	14	16	16	diethylstilbestrol	DES	PA449307	1674	0.7
NULL	Aging_(Albany_NY)_2014_Oct_30_6(10)_788-819.nxml.txt.nlp	25411230	SENT245	15	15	9	9	levodopa	COMT	PA450213	1312	0.7
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT174	14	14	16	16	metformin	HIF-1	PA450395	29072	0.7
NULL	Oncol_Rep_2013_Mar_8_29(3)_917-924.nxml.txt.nlp	23314174	SENT153	0	0	10	10	sorafenib	CD44	PA7000	960	0.7
NULL	J_Hematol_Oncol_2013_Jan_15_6_5.nxml.txt.nlp	23320987	SENT142	7	7	5	5	heparin	PI-PLC	PA449855	2923	0.7
NULL	Clin_Ophthalmol_2014_Sep_1_8_1675-1679.nxml.txt.nlp	25214760	SENT40	9	9	15	15	bevacizumab	San	PA130232992	80218	0.7
NULL	Mol_Cancer_2012_Jul_12_11_45.nxml.txt.nlp	22788833	SENT114	5	5	14	14	cisplatin	EGFR	PA449014	1956	0.7
NULL	Arthritis_Res_Ther_2003_Dec_2_5(Suppl_4)_S12-S16.nxml.txt.nlp	15180892	SENT75	30	30	32	32	rituximab	CHOP	PA451261	1649	0.7
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT2406	1	1	23	23	amiodarone	CYP3A4	PA448383	1576	0.7
NULL	Biochem_Res_Int_2012_Feb_12_2012_346972.nxml.txt.nlp	22400115	SENT190	1	1	3	3	hyaluronan	PI3K	PA165958431	5290	0.7
NULL	Mol_Cancer_2009_Nov_19_8_108.nxml.txt.nlp	19925669	SENT102	4	4	12	12	nitroprusside	MRP3	PA451406	8714	0.7
NULL	Cancer_Biol_Med_2013_Dec_10(4)_192-205.nxml.txt.nlp	24349829	SENT302	25	25	15	15	erlotinib	EGFR	PA134687924	1956	0.7
NULL	Aging_(Albany_NY)_2009_Dec_29_2(1)_63-68.nxml.txt.nlp	20228936	SENT81	19	19	0	0	nadh	CYB5R3	PA164755085	1727	0.7
NULL	Clin_Med_Insights_Cardiol_2011_Oct_6_5_103-119.nxml.txt.nlp	22084608	SENT328	6	6	13	13	metoprolol	CYP2D6	PA450480	1565	0.7
NULL	Clin_Pharmacol_2012_Feb_20_4_13-20.nxml.txt.nlp	22427735	SENT101	10	10	15	15	clopidogrel	LTA	PA449053	4049	0.7
NULL	Oncol_Lett_2013_Sep_8_6(3)_699-704.nxml.txt.nlp	24137393	SENT52	21	21	33	33	l-glutamine	CO2	PA10090	4513	0.7
NULL	Int_J_Endocrinol_2014_Feb_18_2014_232454.nxml.txt.nlp	24695544	SENT95	12	12	8	8	estradiol	adiponectin	PA449503	9370	0.7
NULL	Cancer_Med_2014_Jun_19_3(3)_555-564.nxml.txt.nlp	24648042	SENT188	27	27	3	3	rituximab	SF3B1	PA451261	23451	0.7
NULL	Curr_Neuropharmacol_2012_Mar_10(1)_53-63.nxml.txt.nlp	22942878	SENT33	25	25	27	27	vasopressin	AVP	PA451858	114548;551	0.7
NULL	EMBO_Mol_Med_2013_Dec_8_5(12)_1821-1834.nxml.txt.nlp	24293316	SENT45	11	11	14	14	doxorubicin	UNC5C	PA449412	8633	0.7
NULL	Oncoscience_2014_Mar_16_1(2)_132-157.nxml.txt.nlp	25594007	SENT31	0	0	14	14	cetuximab	KRAS	PA10040	3845	0.7
NULL	Clin_Pharmacokinet_2014_Nov_9_53(3)_283-293.nxml.txt.nlp	24214317	SENT191	1	1	8	8	oseltamivir	OAT1	PA450721	9356	0.7
NULL	Front_Pharmacol_2014_May_27_5_123.nxml.txt.nlp	24904424	SENT98	13	13	6	6	thrombin	PAR1	PA451674	79581;2149	0.7
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT73	5	5	16	16	neratinib	HER2	PA165291472	2064	0.7
NULL	Nat_Med_2013_Oct_8_19(10)_1313-1317.nxml.txt.nlp	24013700	SENT9	18	18	14	14	ribavirin	IFN	PA451241	3439	0.7
NULL	Cell_Death_Dis_2010_Oct_21_1(10)_e86.nxml.txt.nlp	21368859	SENT223	23	23	25	25	doxorubicin	TRAIL	PA449412	8743	0.7
NULL	Br_J_Cancer_1998_Apr_77(8)_1280-1286.nxml.txt.nlp	9579834	SENT0	22	22	40	40	dacarbazine	IL-2	PA449197	3558	0.7
NULL	Cell_Tissue_Res_2012_May_25_348(2)_335-370.nxml.txt.nlp	NULL	SENT678	17	17	30	30	simvastatin	RhoA	PA451363	387	0.7
NULL	Diabetes_2011_Mar_21_60(3)_936-946.nxml.txt.nlp	21289205	SENT323	23	23	9	9	rosiglitazone	adiponectin	PA451283	9370	0.7
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1149.nxml.txt.nlp	24675467	SENT122	42	42	19	19	trastuzumab	LC3	PA451743	84557	0.7
NULL	Mol_Neurodegener_2011_Aug_8_6_57.nxml.txt.nlp	21819629	SENT61	12	12	5	5	arsenite	TDP-43	PA452638	23435	0.7
NULL	Oncotarget_2014_Oct_23_5(22)_11154-11167.nxml.txt.nlp	25525888	SENT180	32	32	19	19	bevacizumab	VEGFR	PA130232992	3791	0.7
NULL	Int_J_Mol_Sci_2014_Nov_4_15(11)_20101-20116.nxml.txt.nlp	25375192	SENT208	4	4	10	10	fluorescein	AAT	PA164746009	5265	0.7
NULL	Acta_Pharmacol_Sin_2014_Sep_25_35(9)_1199-1206.nxml.txt.nlp	25152024	SENT157	11	11	5	5	cisplatin	mig-2	PA449014	10979	0.7
NULL	J_Immunol_Res_2014_May_21_2014_371087.nxml.txt.nlp	24963497	SENT322	11	11	7	7	decitabine	DAC	PA164749631	13	0.7
NULL	Int_J_Mol_Sci_2014_Nov_25_15(12)_21703-21722.nxml.txt.nlp	25429431	SENT157	15	15	23	23	curcumin	CEA	PA151958596	5670;1087	0.7
NULL	Ann_Indian_Acad_Neurol_2013_Jul-Sep_16(3)_338-341.nxml.txt.nlp	24101812	SENT116	29	29	8	8	ephedrine	Dok-7	PA449466	285489	0.7
NULL	Acta_Pharmacol_Sin_2012_May_4_33(5)_710-716.nxml.txt.nlp	22555373	SENT128	1	1	13	13	mexiletine	DOM	PA450488	6663	0.7
NULL	Cell_Commun_Signal_2013_Oct_1_11_73.nxml.txt.nlp	24083678	SENT15	0	0	7	7	sulindac	AP-1	PA451565	2353;3727;2354;3725	0.7
NULL	Mol_Cancer_2008_Sep_12_7_69.nxml.txt.nlp	18789131	SENT10	8	8	14	14	pp2	EGFR		1956	0.7
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2654-2664.nxml.txt.nlp	24136149	SENT256	27	27	16	16	doxorubicin	H2AFX	PA449412	3014	0.7
NULL	Pain_2014_Nov_155(11)_2306-2322.nxml.txt.nlp	25168672	SENT508	3	3	12	12	riluzole	TREK-1	PA451251	3776	0.7
NULL	J_Adv_Pract_Oncol_2013_Mar_1_Mar-Apr_4(2)_89-100.nxml.txt.nlp	25031987	SENT3	3	3	12	12	palifermin	BSN	PA164744014	8927	0.7
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT744	12	12	22	22	risperidone	Gen	PA451257	348654	0.7
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_55-78.nxml.txt.nlp	19305788	SENT819	32	32	17	17	loperamide	mGlu1	PA450262	2911	0.7
NULL	Indian_J_Med_Res_2013_Jan_137(1)_102-110.nxml.txt.nlp	23481058	SENT27	18	18	0	0	glucose	HIF-1	PA449773	29072	0.7
NULL	Oncotarget_2013_Aug_21_4(9)_1484-1495.nxml.txt.nlp	23986086	SENT156	22	22	7	7	metformin	PIK3CA	PA450395	5290	0.7
NULL	Pharmaceutics_2010_Sep_9_2(3)_291-299.nxml.txt.nlp	NULL	SENT56	11	11	16	16	tacrolimus	MDR1	PA451578	5243	0.7
NULL	Breast_Cancer_Res_2002_Sep_10_4(6)_218-221.nxml.txt.nlp	12473166	SENT84	22	22	3	3	tamoxifen	ATAC	PA451581	6375	0.7
NULL	Drug_Des_Devel_Ther_2014_Sep_23_8_1527-1538.nxml.txt.nlp	25284985	SENT10	4	4	2	2	celecoxib	IFN	PA448871	3439	0.7
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT122	37	37	26	26	capsaicin	p53	PA448776	7157	0.7
NULL	Mol_Med_Rep_2015_Jan_22_11(1)_83-90.nxml.txt.nlp	25338529	SENT135	10	10	13	13	octreotide	HO-1	PA450678	3162	0.7
NULL	Oncol_Lett_2014_Nov_12_8(5)_2203-2208.nxml.txt.nlp	25295109	SENT174	4	4	11	11	celecoxib	SMO	PA448871	6608;54498	0.7
NULL	Oncoimmunology_2013_Nov_1_2(11)_e27010.nxml.txt.nlp	24498547	SENT27	24	24	11	11	cisplatin	GEM	PA449014	2669	0.7
NULL	Front_Genet_2013_Aug_29_4_163.nxml.txt.nlp	24009622	SENT37	17	17	11	11	ethanol	ABCG2	PA448073	9429	0.7
NULL	Curr_Opin_Infect_Dis_2013_Dec_6_26(6)_538-544.nxml.txt.nlp	24126716	SENT135	20	20	24	24	amikacin	PARI	PA164744372	55010	0.7
NULL	Acta_Pharmacol_Sin_2012_May_4_33(5)_710-716.nxml.txt.nlp	22555373	SENT119	11	11	17	17	phenylbutazone	DOM	PA450932	6663	0.7
NULL	Cancers_(Basel)_2014_Feb_28_6(1)_472-490.nxml.txt.nlp	24589997	SENT192	3	3	10	10	imatinib	IL-10	PA10804	3586	0.7
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT2379	16	16	6	6	midazolam	CYP2C9	PA450496	1559	0.7
NULL	J_Med_Internet_Res_2013_Jul_12_15(7)_e138.nxml.txt.nlp	23853350	SENT186	29	29	24	24	warfarin	TTR	PA451906	7276	0.7
NULL	J_Nucl_Cardiol_2012_Dec_17_19(6)_1211-1225.nxml.txt.nlp	23073913	SENT106	6	6	4	4	simvastatin	FDG	PA451363	23583	0.7
NULL	Comput_Struct_Biotechnol_J_2013_Jan_16_3_e201210018.nxml.txt.nlp	24688678	SENT130	41	41	43	43	nadh	Hua	PA164755085	1994	0.7
NULL	Oncotarget_2012_Oct_20_3(10)_1236-1245.nxml.txt.nlp	23100449	SENT100	15	15	7	7	doxorubicin	NGAL	PA449412	3934	0.7
NULL	J_Carcinog_Mutagen_2013_Suppl_6_003.nxml.txt.nlp	25379355	SENT171	21	21	37	37	topotecan	PI3K	PA451729	5290	0.7
NULL	Ann_Gen_Psychiatry_2008_Aug_18_7_11.nxml.txt.nlp	18706108	SENT142	14	14	11	11	bupropion	CD50	PA448687	3385	0.7
NULL	Child_Adolesc_Psychiatry_Ment_Health_2008_Sep_15_2_25.nxml.txt.nlp	18793405	SENT113	6	6	11	11	atomoxetine	ANOVA	PA134688071	4858	0.7
NULL	Oncoimmunology_2013_Jan_1_2(1)_e22890.nxml.txt.nlp	23483066	SENT129	2	2	5	5	vemurafenib	IFN	PA165946873	3439	0.7
NULL	Core_Evid_2011_Mar_17_6_31-42.nxml.txt.nlp	21468241	SENT146	12	12	22	22	clopidogrel	ADP	PA449053	23038	0.7
NULL	Oncol_Lett_2014_Mar_2_7(3)_791-796.nxml.txt.nlp	24527087	SENT95	2	2	12	12	imatinib	CD34	PA10804	947	0.7
NULL	Breast_Cancer_Res_2005_Nov_23_7(1)_R119-R129.nxml.txt.nlp	15642160	SENT176	17	17	20	20	tamoxifen	B52	PA451581	6431	0.7
NULL	Evid_Based_Complement_Alternat_Med_2013_Dec_12_2013_324618.nxml.txt.nlp	24416065	SENT113	36	36	8	8	nevirapine	ATV	PA450616	4683	0.7
NULL	Ital_J_Pediatr_2010_Dec_22_36_79.nxml.txt.nlp	21176172	SENT103	15	15	17	17	atomoxetine	ATX	PA134688071	5168;23049	0.7
NULL	Iran_Red_Crescent_Med_J_2014_Feb_8_16(2)_e15809.nxml.txt.nlp	24719749	SENT133	17	17	9	9	propofol	IL-8	PA451141	3576	0.7
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Mar_29_70(Pt_4)_o500.nxml.txt.nlp	24826188	SENT78	5	5	31	31	benzaldehyde	mol	PA448571	90527	0.7
NULL	Emerg_Infect_Dis_2011_Mar_17(3)_510-513.nxml.txt.nlp	21392446	SENT24	11	11	0	0	kanamycin	DST	PA450137	667	0.7
NULL	Niger_Med_J_2014_May-Jun_55(3)_230-234.nxml.txt.nlp	25013255	SENT6	8	8	10	10	carbimazole	CARB	PA164742970	9482	0.7
NULL	J_Cancer_2011_May_25_2_317-323.nxml.txt.nlp	21716848	SENT57	5	5	14	14	trastuzumab	HER2	PA451743	2064	0.7
NULL	Mol_Cancer_2010_Aug_11_9_214.nxml.txt.nlp	20701798	SENT242	40	40	26	26	streptomycin	FBS	PA451512	64319;26269	0.7
NULL	Br_J_Cancer_2013_Feb_5_108(2)_334-341.nxml.txt.nlp	23257893	SENT156	6	6	10	10	sorafenib	NOXA	PA7000	5366	0.7
NULL	Oncotarget_2014_Jun_11_5(21)_10407-10420.nxml.txt.nlp	25431951	SENT194	24	24	26	26	imatinib	FIP1L1	PA10804	81608	0.7
NULL	Int_J_Mol_Sci_2012_Sep_26_13(10)_12336-12348.nxml.txt.nlp	23202901	SENT415	33	33	13	13	phenol	P90	PA450913	821	0.7
NULL	J_Korean_Med_Sci_2010_Jun_24_25(6)_829-834.nxml.txt.nlp	20514301	SENT120	0	0	8	8	papain	IL-25	PA450778	64806;56005	0.7
NULL	Anesth_Essays_Res_2012_Jul-Dec_6(2)_140-146.nxml.txt.nlp	NULL	SENT111	3	3	19	19	lidocaine	IL-6	PA450226	3569	0.7
NULL	Oncogene_2010_May_20_29(20)_2962-2972.nxml.txt.nlp	20228846	SENT91	15	15	12	12	imatinib	HIF-1	PA10804	29072	0.7
NULL	Cell_Death_Dis_2013_Jul_25_4(7)_e740.nxml.txt.nlp	23887631	SENT68	5	5	10	10	doxorubicin	CD133	PA449412	8842	0.7
NULL	Nucleic_Acids_Res_2005_Oct_12_33(18)_e155.nxml.txt.nlp	16221970	SENT151	10	10	32	32	doxycycline	FGFR2	PA449415	2263	0.7
NULL	Oncotarget_2013_Dec_5_5(1)_49-66.nxml.txt.nlp	24393708	SENT94	5	5	13	13	everolimus	FKBP12	PA164746311	2280	0.7
NULL	Onco_Targets_Ther_2014_Oct_4_7_1817-1828.nxml.txt.nlp	25336973	SENT71	23	23	5	5	irinotecan	UGT1A1	PA450085	54658	0.7
NULL	Braz_J_Microbiol_2009_Jun_1_Apr-Jun_40(2)_314-320.nxml.txt.nlp	24031364	SENT92	4	4	21	21	isoniazid	EMB	PA450112	133418	0.7
NULL	EMBO_J_2009_Apr_22_28(8)_1043-1054.nxml.txt.nlp	19300439	SENT121	16	16	14	14	genistein	PP2	PA165109660	4888	0.7
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Dec_3_65(Pt_1)_o9.nxml.txt.nlp	21581727	SENT57	33	33	9	9	ethanol	mol	PA448073	90527	0.7
NULL	Nucleic_Acids_Res_2011_Sep_23_39(17)_e113.nxml.txt.nlp	21700670	SENT40	23	23	19	19	doxycycline	c-Myc	PA449415	4609	0.7
NULL	Br_J_Haematol_2008_Jun_141(5)_659-671.nxml.txt.nlp	18410446	SENT155	30	30	38	38	cerulenin	JNK	PA164764551	5599	0.7
NULL	Int_J_Biol_Sci_2015_Jan_1_11(2)_144-155.nxml.txt.nlp	25561897	SENT24	19	19	27	27	cisplatin	POLB	PA449014	5423	0.7
NULL	EMBO_Mol_Med_2013_May_22_5(5)_776-794.nxml.txt.nlp	23606583	SENT174	42	42	27	27	maraviroc	CCL5	PA164768835	6352	0.7
NULL	An_Bras_Dermatol_2012_Nov-Dec_87(6)_857-861.nxml.txt.nlp	23197204	SENT92	18	18	5	5	chloramphenicol	PEN	PA448927	9933	0.7
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Aug_26_65(Pt_9)_o2234.nxml.txt.nlp	21577633	SENT71	26	26	13	13	ethanol	mol	PA448073	90527	0.7
NULL	Ann_Oncol_2013_Aug_12_24(8)_1994-1999.nxml.txt.nlp	23670096	SENT109	12	12	6	6	tamoxifen	STEPP	PA451581	222659	0.7
NULL	Ann_Gen_Psychiatry_2014_Apr_1_13_10.nxml.txt.nlp	24690136	SENT189	28	28	33	33	quetiapine	FGA	PA451201	2243	0.7
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2010_Apr_26_3_37-42.nxml.txt.nlp	22879785	SENT54	2	2	12	12	preotact	PTH	PA165958355	5741	0.7
NULL	Antiviral_Res_2010_Aug_87(2)_125-148.nxml.txt.nlp	19945487	SENT2117	0	0	9	9	ribavirin	XMP	PA451241	2013	0.7
NULL	J_Oncol_2012_Mar_8_2012_723541.nxml.txt.nlp	22481931	SENT185	34	34	27	27	heparin	PTGS2	PA449855	5743	0.7
NULL	J_Hematol_Oncol_2008_Aug_14_1_12.nxml.txt.nlp	18702822	SENT163	5	5	27	27	trastuzumab	ERBB2	PA451743	2064	0.7
NULL	Trials_2012_Aug_31_13_156.nxml.txt.nlp	22937736	SENT170	29	29	7	7	azithromycin	IL-6	PA448519	3569	0.7
NULL	Stroke_Res_Treat_2009_Dec_20_2010_386389.nxml.txt.nlp	20700422	SENT72	24	24	26	26	ebselen	NAC	PA161660841	22861	0.7
NULL	Breast_Cancer_Res_2009_Jan_16_11(1)_201.nxml.txt.nlp	19216727	SENT152	41	41	27	27	capecitabine	HER2	PA448771	2064	0.7
NULL	J_Oncol_2010_Feb_11_2010_361836.nxml.txt.nlp	20169138	SENT36	30	30	39	39	bevacizumab	San	PA130232992	80218	0.7
NULL	Br_J_Cancer_2009_Nov_3_101(9)_1549-1554.nxml.txt.nlp	19809436	SENT31	13	13	15	15	doxorubicin	ADM	PA449412	133	0.7
NULL	Aging_(Albany_NY)_2013_Feb_21_5(2)_94-95.nxml.txt.nlp	23518473	SENT14	4	4	6	6	resveratrol	SIRT1		23411	0.7
NULL	ScientificWorldJournal_2013_Dec_5_2013_247102.nxml.txt.nlp	24381515	SENT46	9	9	12	12	clopidogrel	EVI	PA449053	79971	0.7
NULL	Mol_Cancer_2014_Jun_13_13_149.nxml.txt.nlp	24925061	SENT199	4	4	13	13	metformin	PDK1	PA450395	5170;5163	0.7
NULL	J_Hematol_Oncol_2010_Mar_23_3_11.nxml.txt.nlp	20331897	SENT18	2	2	12	12	trastuzumab	HER2	PA451743	2064	0.7
NULL	Sensors_(Basel)_2010_Mar_23_10(3)_2438-2449.nxml.txt.nlp	22294934	SENT148	11	11	3	3	choline	NIR	PA448976	26155	0.7
NULL	Clin_Ophthalmol_2014_Jan_7_8_177-185.nxml.txt.nlp	24531415	SENT104	25	25	41	41	dorzolamide	ANOVA	PA164748765	4858	0.699
NULL	Pharmaceuticals_(Basel)_2011_Nov_10_4(11)_1488-1502.nxml.txt.nlp	NULL	SENT242	0	0	2	2	geldanamycin	HER2	PA152031327	2064	0.699
NULL	Cell_Death_Dis_2013_Oct_3_4(10)_e827.nxml.txt.nlp	24091670	SENT35	19	19	29	29	nilotinib	CD34	PA165958345	947	0.699
NULL	J_Cell_Biol_1998_May_4_141(3)_727-739.nxml.txt.nlp	9566972	SENT125	19	19	33	33	neomycin	NF-M	PA450608	4741	0.699
NULL	Arch_Drug_Inf_2008_Jul_1(1)_14-22.nxml.txt.nlp	20157364	SENT99	2	2	5	5	pravastatin	IL-6	PA451089	3569	0.699
NULL	J_Biol_Chem_2009_Sep_18_284(38)_26096-26105.nxml.txt.nlp	19628870	SENT88	29	29	3	3	ethanol	G10	PA448073	8896;221527	0.699
NULL	J_Cell_Biol_2001_Aug_6_154(3)_599-610.nxml.txt.nlp	11481345	SENT80	24	24	11	11	doxycycline	ARNO	PA449415	9266	0.699
NULL	J_Thromb_Haemost_2014_May_22_12(5)_748-760.nxml.txt.nlp	24612393	SENT111	7	7	18	18	thrombin	TSC2	PA451674	7249	0.699
NULL	Clin_Med_Insights_Cardiol_2013_Jul_23_7_115-126.nxml.txt.nlp	23926441	SENT23	0	0	12	12	everolimus	p27	PA164746311	5715;10534	0.699
NULL	Eur_J_Haematol_2009_May_82(5)_339-349.nxml.txt.nlp	19187276	SENT137	8	8	32	32	rivaroxaban	TKR	PA165958360	8277	0.699
NULL	Biologics_2013_Apr_15_7_77-90.nxml.txt.nlp	23723688	SENT246	2	2	10	10	cetuximab	EGFR	PA10040	1956	0.699
NULL	Mol_Cancer_2012_Mar_21_11_13.nxml.txt.nlp	22436134	SENT229	38	38	35	35	doxorubicin	HuR	PA449412	1994	0.699
NULL	Curr_Neuropharmacol_2009_Mar_7(1)_9-36.nxml.txt.nlp	19721815	SENT1235	29	29	4	4	pramipexole	alpha-synuclein	PA164742949	6622	0.699
NULL	Hum_Genomics_2009_Dec_1_4(2)_91-106.nxml.txt.nlp	20038497	SENT120	30	30	35	35	galantamine	CYP3A4	PA449726	1576	0.699
NULL	ScientificWorldJournal_2012_Feb_14_2012_402919.nxml.txt.nlp	22448133	SENT328	14	14	16	16	ciprofloxacin	CPX	PA449009	1371;10682;1377	0.699
NULL	Oxid_Med_Cell_Longev_2009_Apr-Jun_2(2)_73-81.nxml.txt.nlp	20357928	SENT92	9	9	23	23	l-carnitine	IL-2	PA450154	3558	0.699
NULL	J_Med_Case_Reports_2011_Jan_17_5_13.nxml.txt.nlp	21241493	SENT50	34	34	28	28	moxifloxacin	HCAP	PA450555	117159;9126	0.699
NULL	Acta_Neuropathol_2012_Mar_16_123(3)_369-380.nxml.txt.nlp	22083253	SENT275	4	4	9	9	octreotide	NF2	PA450678	4771	0.699
NULL	Front_Oncol_2014_Nov_18_4_334.nxml.txt.nlp	25478327	SENT20	14	14	6	6	afatinib	ERBB2	PA165981154	2064	0.699
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT6	1	1	24	24	metformin	EGFR	PA450395	1956	0.699
NULL	Mol_Cancer_2010_Apr_12_9_75.nxml.txt.nlp	20385023	SENT237	9	9	14	14	cetuximab	EGFR	PA10040	1956	0.699
NULL	J_Immunol_Res_2014_May_21_2014_371087.nxml.txt.nlp	24963497	SENT327	11	11	17	17	decitabine	DAC	PA164749631	13	0.699
NULL	BMJ_Open_2014_Feb_27_4(2)_e004071.nxml.txt.nlp	24578536	SENT25	16	16	24	24	warfarin	TTR	PA451906	7276	0.699
NULL	Cancers_(Basel)_2011_Oct_26_3(4)_4024-4045.nxml.txt.nlp	24213123	SENT176	10	10	20	20	resveratrol	PTEN		5728	0.699
NULL	Cell_Biol_Int_Rep_(2010)_2012_Jun_21_19(1)_e00017.nxml.txt.nlp	23124518	SENT111	11	11	14	14	etoposide	TRAIL	PA449552	8743	0.699
NULL	Cancer_Res_Treat_2013_Dec_31_45(4)_251-262.nxml.txt.nlp	24453997	SENT97	20	20	10	10	cisplatin	ASS1	PA449014	445	0.699
NULL	Basic_Res_Cardiol_2015_Jan_20_110_4.nxml.txt.nlp	25600226	SENT428	29	29	7	7	ezetimibe	PCSK9	PA10816	255738	0.699
NULL	Front_Neurol_2014_Feb_18_5_17.nxml.txt.nlp	24600432	SENT136	11	11	13	13	levetiracetam	C17	PA450206	54360	0.699
NULL	Ecancermedicalscience_2009_Oct_29_3_157.nxml.txt.nlp	22276018	SENT416	14	14	31	31	tamoxifen	ATAC	PA451581	6375	0.699
NULL	Clin_Ophthalmol_2009_Jun_2_3_155-166.nxml.txt.nlp	19668560	SENT145	12	12	15	15	bevacizumab	ERG	PA130232992	2078	0.699
NULL	Oncoimmunology_2013_Dec_1_2(12)_e26689.nxml.txt.nlp	24527364	SENT55	22	22	9	9	doxorubicin	STAT1	PA449412	6772	0.699
NULL	Apoptosis_2012_Sep_30_17(9)_989-997.nxml.txt.nlp	22460505	SENT4	4	4	15	15	thioridazine	CDK4	PA451666	1019	0.699
NULL	J_Cell_Biol_2001_Aug_6_154(3)_599-610.nxml.txt.nlp	11481345	SENT129	21	21	30	30	doxycycline	ARF6	PA449415	382	0.699
NULL	Mol_Cancer_2010_Apr_15_9_77.nxml.txt.nlp	20398291	SENT135	17	17	10	10	geldanamycin	survivin	PA152031327	332	0.699
NULL	Mol_Neurodegener_2011_Jun_22_6_43.nxml.txt.nlp	21696630	SENT147	12	12	3	3	carbachol	PKD1	PA448784	5310	0.699
NULL	Sci_Rep_2014_Dec_10_4_7403.nxml.txt.nlp	25492703	SENT527	12	12	24	24	ganciclovir	GAPDH	PA449733	2597	0.699
NULL	J_Carcinog_2013_Dec_31_12_22.nxml.txt.nlp	24574860	SENT235	30	30	14	14	docetaxel	STK11	PA449383	6794	0.699
NULL	J_Antimicrob_Chemother_2011_Aug_28_66(8)_1766-1772.nxml.txt.nlp	21622974	SENT63	19	19	35	35	l-glutamine	CO2	PA10090	4513	0.699
NULL	Acta_Orthop_2009_Jun_5_80(3)_357-362.nxml.txt.nlp	19421912	SENT117	13	13	11	11	triamcinolone	MMP9	PA451749	4318	0.699
NULL	Exp_Diabetes_Res_2012_Mar_28_2012_386831.nxml.txt.nlp	22536214	SENT5	32	32	34	34	streptozocin	STZ	PA451514	6484	0.699
NULL	Acta_Pharmacol_Sin_2013_Sep_5_34(9)_1237-1242.nxml.txt.nlp	23770984	SENT124	21	21	4	4	sulfaphenazole	DAI	PA130231310	81030	0.699
NULL	Oncoimmunology_2013_Jun_1_2(6)_e24677.nxml.txt.nlp	23894722	SENT109	22	22	16	16	cetuximab	CD83	PA10040	9308	0.699
NULL	J_Korean_Med_Sci_1998_Dec_13(6)_685-688.nxml.txt.nlp	9886182	SENT13	24	24	27	27	mitoxantrone	GM-CSF	PA450526	1437	0.699
NULL	Oxid_Med_Cell_Longev_2012_Jan_19_2012_390678.nxml.txt.nlp	22315655	SENT108	3	3	0	0	gliclazide	NAC	PA10892	22861	0.699
NULL	Oncotarget_2013_Aug_15_4(9)_1438-1448.nxml.txt.nlp	23988457	SENT119	28	28	46	46	lenalidomide	RINF	PA162363968	51523	0.699
NULL	J_Med_Case_Reports_2011_Aug_3_5_345.nxml.txt.nlp	21812958	SENT78	18	18	13	13	bevacizumab	IL-2	PA130232992	3558	0.699
NULL	Breast_Cancer_(Auckl)_2009_Apr_7_3_23-34.nxml.txt.nlp	21556247	SENT102	16	16	27	27	celecoxib	AKT	PA448871	207	0.699
NULL	Case_Rep_Oncol_Med_2012_Sep_11_2012_726424.nxml.txt.nlp	22997596	SENT84	9	9	13	13	rituximab	CHOP	PA451261	1649	0.699
NULL	Environ_Health_Perspect_2005_Oct_14_113(10)_1330-1335.nxml.txt.nlp	16203242	SENT221	0	0	15	15	arsenite	MLC	PA452638	23209	0.699
NULL	J_Lipid_Res_2013_Nov_54(11)_3085-3097.nxml.txt.nlp	23883581	SENT216	0	0	4	4	thrombin	PAR1	PA451674	79581;2149	0.699
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2705-2713.nxml.txt.nlp	24129232	SENT194	13	13	8	8	docetaxel	ACT	PA449383	12;11332;9457;641455	0.699
NULL	Front_Genet_2011_May_4_2_20.nxml.txt.nlp	22303316	SENT36	3	3	10	10	hyaluronan	HYAL3	PA165958431	8372	0.699
NULL	Front_Chem_2014_Dec_23_2_113.nxml.txt.nlp	25566531	SENT254	6	6	23	23	curcumin	Rho	PA151958596	29984	0.699
NULL	Adv_Hematol_2012_Jun_14_2012_523842.nxml.txt.nlp	22761620	SENT114	0	0	8	8	rituximab	IFN	PA451261	3439	0.699
NULL	Mol_Biol_Cell_2014_Jan_1_25(1)_184-195.nxml.txt.nlp	24196835	SENT277	26	26	38	38	l-glutamine	CO2	PA10090	4513	0.699
NULL	Brain_Res_2012_Feb_3_1436(C)_111-121.nxml.txt.nlp	22200378	SENT595	12	12	1	1	indomethacin	OAT	PA449982	4942	0.699
NULL	Clin_Endosc_2013_Jul_31_46(4)_311-312.nxml.txt.nlp	23964324	SENT0	21	21	40	40	midazolam	CHA	PA450496	10732	0.699
NULL	J_Vet_Med_Sci_2013_Nov_12_75(11)_1539-1542.nxml.txt.nlp	23856759	SENT43	20	20	22	22	oxytetracycline	OTC	PA450757	5009	0.699
NULL	Arch_Med_Sci_2013_Jun_20_9(3)_472-478.nxml.txt.nlp	23847669	SENT29	3	3	6	6	tamoxifen	aromatase	PA451581	1588	0.699
NULL	J_Gen_Physiol_2009_Apr_133(4)_421-438.nxml.txt.nlp	19289574	SENT313	13	13	6	6	forskolin	SLC26A9	PA146096022	115019	0.699
NULL	Int_J_Mol_Sci_2012_Apr_16_13(4)_4831-4838.nxml.txt.nlp	22606012	SENT43	0	0	7	7	curcumin	JNK	PA151958596	5599	0.699
NULL	J_Cardiovasc_Dis_Res_2012_Jan-Mar_3(1)_5-11.nxml.txt.nlp	22346138	SENT68	0	0	10	10	glimepiride	IL-6	PA449761	3569	0.699
NULL	J_Gynecol_Oncol_2013_Jul_4_24(3)_265-272.nxml.txt.nlp	23875077	SENT100	14	14	37	37	thrombin	DKK1	PA451674	22943	0.699
NULL	Iran_J_Pharm_Res_2013_Summer_12(3)_457-469.nxml.txt.nlp	24250652	SENT210	14	14	8	8	indomethacin	CA1	PA449982	759	0.699
NULL	Infect_Dis_Ther_2013_Dec_2_2(2)_123-144.nxml.txt.nlp	25134476	SENT268	8	8	10	10	fluoxetine	DIP	PA449673	23151;1831	0.699
NULL	Clin_Pediatr_Endocrinol_2004_Jul_7_13(1)_37-46.nxml.txt.nlp	24790296	SENT16	13	13	0	0	thyroglobulin	TPO	PA164754910	7066;7173	0.699
NULL	Eur_J_Pharm_Sci_2012_Jul_16_46(4)_244-258.nxml.txt.nlp	22085636	SENT50	15	15	18	18	pertuzumab	PI3K		5290	0.699
NULL	Parasit_Vectors_2009_Sep_25_2(Suppl_2)_S5.nxml.txt.nlp	19778466	SENT10	5	5	3	3	praziquantel	MOX	PA164764583	26002	0.699
NULL	Front_Endocrinol_(Lausanne)_2014_Oct_9_5_166.nxml.txt.nlp	25346724	SENT264	33	33	25	25	resveratrol	p38		10598;1432;7965	0.699
NULL	Curr_Neuropharmacol_2009_Jun_7(2)_83-95.nxml.txt.nlp	19949566	SENT445	18	18	32	32	lamotrigine	TGB	PA450164	5473	0.699
NULL	Clin_Toxicol_(Phila)_2007_Jun_20_Jun-Aug_45(5)_565-570.nxml.txt.nlp	17558630	SENT185	9	9	17	17	methacholine	Rho	PA165958382	29984	0.699
NULL	Arch_Osteoporos_2013_Oct_11_8(1-2)_136.nxml.txt.nlp	24113837	SENT3131	19	19	9	9	teriparatide	PTH	PA451620	5741	0.699
NULL	Indian_J_Pharmacol_2014_Jul-Aug_46(4)_453-454.nxml.txt.nlp	25097292	SENT51	15	15	22	22	olanzapine	BPAD	PA450688	4095	0.699
NULL	J_Med_Case_Reports_2011_Feb_14_5_62.nxml.txt.nlp	21320328	SENT136	33	33	9	9	cinnarizine	C1-INH	PA164749342	710	0.699
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT240	18	18	20	20	metformin	HIF-1	PA450395	29072	0.699
NULL	Breast_Cancer_Res_2005_Jan_26_7(2)_R256-R266.nxml.txt.nlp	15743506	SENT171	10	10	12	12	trastuzumab	HER-2	PA451743	2064	0.699
NULL	Drugs_R_D_2010_Sep_27_10(3)_165-178.nxml.txt.nlp	20945947	SENT215	20	20	31	31	erlotinib	KRAS	PA134687924	3845	0.699
NULL	Asian-Australas_J_Anim_Sci_2014_Dec_27(12)_1783-1793.nxml.txt.nlp	25358373	SENT189	2	2	15	15	capsaicin	BAX	PA448776	581	0.699
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT159	5	5	22	22	nutlin-3	PUMA		27113	0.699
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT254	22	22	30	30	resveratrol	NAC		22861	0.699
NULL	Oncotarget_2014_Jun_26_5(14)_5559-5569.nxml.txt.nlp	24980819	SENT3	4	4	8	8	vemurafenib	BRAF	PA165946873	673	0.699
NULL	Curr_Control_Trials_Cardiovasc_Med_2001_May_31_2(3)_129-140.nxml.txt.nlp	11806786	SENT33	0	0	31	31	thrombin	VIII	PA451674	1351	0.699
NULL	Air_Qual_Atmos_Health_2012_Jun_1_5(2)_243-258.nxml.txt.nlp	22662024	SENT109	0	0	15	15	sulfur	TSP	PA451558	7057	0.699
NULL	Acta_Pharmacol_Sin_2012_Jan_3_33(1)_49-56.nxml.txt.nlp	22212430	SENT119	0	0	18	18	thrombin	VIII	PA451674	1351	0.699
NULL	Drug_Des_Devel_Ther_2014_Sep_16_8_1391-1403.nxml.txt.nlp	25258509	SENT115	28	28	13	13	ethanol	ANOVA	PA448073	4858	0.699
NULL	Cardiovasc_Ther_2009_27(3)_151-158.nxml.txt.nlp	19604249	SENT6	19	19	11	11	amlodipine	AT1	PA448388	9197;185	0.699
NULL	Endocrinology_2014_Jun_31_155(6)_2144-2154.nxml.txt.nlp	24684305	SENT367	34	34	10	10	estradiol	MCT2	PA449503	9194	0.699
NULL	J_Gynecol_Oncol_2012_Jan_9_23(1)_35-42.nxml.txt.nlp	22355465	SENT106	19	19	12	12	cisplatin	CDK1	PA449014	983	0.699
NULL	Pain_Ther_2014_Jun_13_3(1)_59-69.nxml.txt.nlp	25135388	SENT171	0	0	20	20	curcumin	HSD1	PA151958596	26871	0.699
NULL	Exp_Cell_Res_2011_Apr_15_317(7)_1028-1039.nxml.txt.nlp	21237154	SENT116	13	13	4	4	staurosporine	JIP1	PA165109623	9479	0.699
NULL	Front_Genet_2014_Jun_2_5_161.nxml.txt.nlp	24917881	SENT867	0	0	13	13	ethanol	CA1	PA448073	759	0.699
NULL	Cell_Death_Dis_2010_Nov_18_1(11)_e102.nxml.txt.nlp	21368867	SENT336	19	19	1	1	gentamicin	14-3-3	PA449753	10971	0.699
NULL	Nat_Med_2011_Dec_11_18(1)_74-82.nxml.txt.nlp	22157681	SENT109	26	26	28	28	gefitinib	EGFR	PA131301952	1956	0.699
NULL	J_Ophthalmol_2013_Dec_18_2013_135798.nxml.txt.nlp	24455194	SENT77	8	8	16	16	tropicamide	ERG	PA164749389	2078	0.699
NULL	Croat_Med_J_2014_Jun_55(3)_206-217.nxml.txt.nlp	24891279	SENT107	40	40	26	26	cisplatin	p53	PA449014	7157	0.699
NULL	J_Exp_Med_2000_Mar_6_191(5)_859-870.nxml.txt.nlp	10704466	SENT167	1	1	4	4	arsenite	p38	PA452638	10598;1432;7965	0.699
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT376	10	10	14	14	neratinib	HER2	PA165291472	2064	0.699
NULL	Clin_Pharmacokinet_2014_Jul_24_53(1)_73-87.nxml.txt.nlp	23881596	SENT31	8	8	10	10	rosuvastatin	OATP1B1	PA134308647	10599	0.699
NULL	Mol_Cancer_2009_May_15_8_28.nxml.txt.nlp	19445670	SENT45	21	21	7	7	doxorubicin	Bcl-2	PA449412	596	0.699
NULL	JAKSTAT_2013_Jul_1_2(3)_e25025.nxml.txt.nlp	24069563	SENT180	15	15	11	11	anagrelide	IFN	PA164742986	3439	0.699
NULL	Br_J_Cancer_2012_Feb_14_106(4)_646-650.nxml.txt.nlp	22240794	SENT89	15	15	20	20	sunitinib	IFN	PA162372840	3439	0.699
NULL	eLife_2013_Nov_5_2_e00969.nxml.txt.nlp	24192036	SENT3	0	0	14	14	vemurafenib	BRAF	PA165946873	673	0.699
NULL	J_Cancer_Prev_2013_Jun_18(2)_186-191.nxml.txt.nlp	25337545	SENT101	3	3	13	13	curcumin	CDK4	PA151958596	1019	0.699
NULL	J_Biol_2009_Apr_15_8(3)_30.nxml.txt.nlp	19435483	SENT36	5	5	12	12	imatinib	NQO1	PA10804	1728	0.699
NULL	J_Hematol_Oncol_2012_Oct_11_5_63.nxml.txt.nlp	23057939	SENT109	15	15	7	7	bevacizumab	VEGFR1	PA130232992	2321	0.699
NULL	J_Mol_Med_(Berl)_2014_May_10_92(7)_709-722.nxml.txt.nlp	24811491	SENT250	12	12	4	4	cetuximab	BRAF	PA10040	673	0.699
NULL	Oncotarget_2014_Oct_21_5(22)_11180-11192.nxml.txt.nlp	25361003	SENT131	15	15	23	23	doxycycline	NTRK1	PA449415	4914	0.699
NULL	Anat_Cell_Biol_2010_Sep_30_43(3)_194-200.nxml.txt.nlp	21212859	SENT84	5	5	7	7	ethanol	PLP	PA448073	25824;5744	0.699
NULL	Biologics_2014_Jul_31_8_211-220.nxml.txt.nlp	25114503	SENT83	14	14	31	31	adalimumab	CD4	PA10004	920	0.699
NULL	Indian_J_Psychiatry_2007_Oct-Dec_49(4)_271-276.nxml.txt.nlp	20680140	SENT64	11	11	15	15	clozapine	spatial	PA449061	219793	0.699
NULL	EJC_Suppl_2013_Sep_5_11(2)_296-298.nxml.txt.nlp	NULL	SENT38	5	5	19	19	pemetrexed	B12	PA10810	7126;4709	0.699
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT151	23	23	29	29	perifosine	DR4	PA165291471	8797	0.699
NULL	Crit_Care_2002_May_24_6(4)_298-305.nxml.txt.nlp	12225603	SENT173	24	24	16	16	flutamide	IFN	PA449685	3439	0.699
NULL	Br_J_Cancer_2009_Oct_6_101(7)_1162-1167.nxml.txt.nlp	19724276	SENT8	28	28	23	23	gemcitabine	Gem	PA449748	51053	0.699
NULL	Oncotarget_2013_Jul_21_4(8)_1253-1265.nxml.txt.nlp	23896512	SENT200	27	27	25	25	erlotinib	EGFR	PA134687924	1956	0.699
NULL	Breast_Cancer_Res_2007_Dec_17_9(6)_115.nxml.txt.nlp	18190722	SENT67	36	36	26	26	tamoxifen	CYP2D6	PA451581	1565	0.699
NULL	Chromatographia_2015_Oct_30_78_21-30.nxml.txt.nlp	25568463	SENT140	27	27	17	17	ethanol	mol	PA448073	90527	0.699
NULL	Diabetes_Care_2010_Aug_27_33(8)_1734-1737.nxml.txt.nlp	20424219	SENT122	5	5	12	12	exenatide	adiponectin	PA164749238	9370	0.699
NULL	Ann_Hematol_2014_Sep_10_93(1)_1-11.nxml.txt.nlp	24018623	SENT109	3	3	10	10	lenalidomide	CD34	PA162363968	947	0.699
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT349	15	15	6	6	heparin	FGF2	PA449855	2247;2258	0.699
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT252	7	7	0	0	cisplatin	MVP	PA449014	9961	0.699
NULL	Int_J_Inflam_2011_Sep_20_2011_367284.nxml.txt.nlp	21941675	SENT422	2	2	4	4	dalteparin	PAR-1	PA165958404	2011;2149	0.699
NULL	Acta_Pharmacol_Sin_2014_Jul_9_35(7)_889-898.nxml.txt.nlp	24909515	SENT159	18	18	24	24	phenol	SULT2A1	PA450913	6822	0.699
NULL	Evid_Based_Complement_Alternat_Med_2013_Dec_18_2013_459390.nxml.txt.nlp	24454495	SENT205	23	23	20	20	berberine	C10	PA165860812	113246	0.699
NULL	Case_Rep_Oncol_2010_Apr_22_3(2)_98-105.nxml.txt.nlp	20740181	SENT20	28	28	34	34	erlotinib	EGFR	PA134687924	1956	0.699
NULL	Front_Genet_2011_May_20_2_21.nxml.txt.nlp	22303317	SENT831	5	5	26	26	valsartan	GNB3	PA451848	2784	0.699
NULL	Plant_Methods_2013_Jul_12_9_27.nxml.txt.nlp	23849546	SENT159	11	11	4	4	phenol	NO3	PA450913	4681	0.699
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT19	5	5	19	19	simvastatin	survivin	PA451363	332	0.699
NULL	Nanoscale_Res_Lett_2011_Jan_12_6(1)_66.nxml.txt.nlp	21711606	SENT35	22	22	9	9	mannitol	NO3	PA450320	4681	0.699
NULL	Ann_Dermatol_2013_Nov_30_25(4)_500-502.nxml.txt.nlp	24371403	SENT28	11	11	18	18	imatinib	LDE	PA10804	7957	0.699
NULL	Exp_Ther_Med_2012_Sep_12_4(3)_475-480.nxml.txt.nlp	23181121	SENT170	18	18	32	32	cyclophosphamide	CHOP	PA449165	1649	0.699
NULL	Front_Aging_Neurosci_2010_May_18_2_16.nxml.txt.nlp	20559464	SENT198	5	5	13	13	flurbiprofen	COX	PA449683	1351	0.699
NULL	Br_J_Cancer_2009_Jan_27_100(2)_298-304.nxml.txt.nlp	19127259	SENT161	3	3	31	31	cetuximab	EGF	PA10040	1950	0.699
NULL	Arthritis_Res_Ther_2007_Oct_9_9(5)_R104.nxml.txt.nlp	17925024	SENT198	10	10	26	26	glucosamine	p65	PA164747613	5970	0.699
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT120	24	24	10	10	vinorelbine	ASC	PA451881	29108	0.699
NULL	Cardiol_Res_Pract_2013_Feb_21_2013_127270.nxml.txt.nlp	23509665	SENT41	1	1	27	27	ticagrelor	IPA	PA165374673	3160	0.699
NULL	Environ_Health_Perspect_2006_Oct_15_114(10)_1547-1552.nxml.txt.nlp	17035141	SENT131	2	2	6	6	betaine	BHMT	PA448603	635	0.699
NULL	Support_Care_Cancer_2010_May_27_18(5)_529-541.nxml.txt.nlp	20191292	SENT62	5	5	10	10	vincristine	gamma	PA451879	9913	0.699
NULL	Curr_Neuropharmacol_2008_Jun_6(2)_151-163.nxml.txt.nlp	19305794	SENT373	13	13	31	31	capsaicin	VR1	PA448776	56664	0.699
NULL	Biosci_Rep_2013_Mar_13_33(2)_e00029.nxml.txt.nlp	23387308	SENT153	3	3	16	16	celecoxib	Bcl-2	PA448871	596	0.699
NULL	Exp_Diabetes_Res_2012_Nov_1_2012_892706.nxml.txt.nlp	23197976	SENT270	27	27	5	5	vildagliptin	HIF-1	PA165958346	29072	0.699
NULL	Br_J_Cancer_2009_Nov_3_101(9)_1620-1629.nxml.txt.nlp	19809428	SENT33	32	32	10	10	oxaliplatin	CXCL8	PA131285527	3576	0.699
NULL	Eur_J_Med_Res_2011_Jan_27_16(1)_20-28.nxml.txt.nlp	21345766	SENT247	19	19	39	39	aprotinin	BART	PA448472	7809;23568	0.699
NULL	Arthritis_Res_Ther_2009_Jun_5_11(3)_R84.nxml.txt.nlp	19500335	SENT219	4	4	37	37	infliximab	MCP-1	PA452639	6347	0.699
NULL	Cancer_Med_2014_Aug_14_3(4)_1010-1024.nxml.txt.nlp	24931821	SENT187	17	17	7	7	doxorubicin	IVL	PA449412	3713	0.699
NULL	An_Bras_Dermatol_2012_Nov-Dec_87(6)_857-861.nxml.txt.nlp	23197204	SENT92	23	23	5	5	clindamycin	PEN	PA449035	9933	0.699
NULL	Environ_Health_Perspect_2011_Mar_10_119(3)_357-363.nxml.txt.nlp	21362589	SENT19	21	21	16	16	picrotoxin	RDX	PA164777007	5962	0.699
NULL	Evid_Based_Complement_Alternat_Med_2012_Dec_20_2012_908601.nxml.txt.nlp	23326293	SENT24	14	14	7	7	daunorubicin	CD38	PA449212	952	0.699
NULL	Ann_Hematol_2014_Sep_10_93(1)_1-11.nxml.txt.nlp	24018623	SENT367	6	6	2	2	lenalidomide	RPS14	PA162363968	6208	0.699
NULL	Algorithms_Mol_Biol_2010_Jul_15_5_29.nxml.txt.nlp	20633297	SENT240	0	0	3	3	sildenafil	PDE4B	PA451346	5142	0.699
NULL	Exp_Diabetes_Res_2008_Oct_12_2008_638467.nxml.txt.nlp	18923682	SENT70	10	10	17	17	coumarin	STZ	PA134521193	6484	0.699
NULL	Diabetes_2009_Feb_58(2)_352-359.nxml.txt.nlp	19011168	SENT59	10	10	18	18	exenatide	San	PA164749238	80218	0.699
NULL	Acta_Pharmacol_Sin_2009_Feb_26_30(2)_219-227.nxml.txt.nlp	19169271	SENT172	5	5	18	18	atropine	CTX	PA448505	1593	0.699
NULL	Bioconjug_Chem_2010_Dec_15_21(12)_2327-2331.nxml.txt.nlp	21080622	SENT53	30	30	20	20	streptomycin	FBS	PA451512	64319;26269	0.699
NULL	Front_Neurosci_2011_Jan_14_4_207.nxml.txt.nlp	21258618	SENT380	5	5	1	1	ethanol	CRF1	PA448073	1394	0.699
NULL	Acta_Pharmacol_Sin_2010_Feb_5_31(2)_137-144.nxml.txt.nlp	20139896	SENT115	16	16	6	6	zileuton	5-LOX	PA451955	240	0.699
NULL	Cancer_Cell_Int_2013_Jun_26_13_64.nxml.txt.nlp	23802572	SENT92	6	6	30	30	curcumin	Bcl-2	PA151958596	596	0.699
NULL	Cancer_Cell_Int_2013_Mar_4_13_21.nxml.txt.nlp	23497288	SENT59	42	42	3	3	doxorubicin	EWS	PA449412	2130	0.699
NULL	Thorax_2009_Sep_3_64(9)_798-805.nxml.txt.nlp	19497921	SENT211	31	31	22	22	imiquimod	TNF-alpha	PA449972	7124	0.699
NULL	Br_J_Cancer_2011_Jun_7_104(12)_1816-1821.nxml.txt.nlp	21610711	SENT150	36	36	38	38	cisplatin	IL-2	PA449014	3558	0.699
NULL	Carcinogenesis_2010_Dec_27_31(12)_2049-2057.nxml.txt.nlp	20876285	SENT117	14	14	7	7	tamoxifen	HER2	PA451581	2064	0.699
NULL	Crit_Care_2012_Jul_26_16(4)_228.nxml.txt.nlp	22839302	SENT33	27	27	19	19	thrombin	ADP	PA451674	23038	0.699
NULL	Cancer_Med_2014_Jun_27_3(3)_462-471.nxml.txt.nlp	24573979	SENT282	11	11	3	3	bevacizumab	HIF-1	PA130232992	29072	0.699
NULL	Front_Mol_Neurosci_2012_Jan_23_5_2.nxml.txt.nlp	22291616	SENT518	12	12	9	9	forskolin	TRPV1	PA146096022	7442	0.699
NULL	Oncogene_2014_Feb_20_33(8)_1017-1026.nxml.txt.nlp	23435427	SENT259	13	13	18	18	doxycycline	HOXA1	PA449415	3198	0.699
NULL	J_Mol_Signal_2010_May_10_5_4.nxml.txt.nlp	20459745	SENT147	28	28	23	23	cisplatin	p53	PA449014	7157	0.699
NULL	J_Cancer_Res_Clin_Oncol_2010_May_11_136(5)_737-743.nxml.txt.nlp	19904559	SENT40	23	23	21	21	bevacizumab	IFL	PA130232992	3439	0.699
NULL	Clin_Infect_Dis_2015_Jan_15_60(2)_324-325.nxml.txt.nlp	25313251	SENT23	2	2	8	8	clindamycin	SAPS	PA449035	8935	0.699
NULL	Diabetol_Metab_Syndr_2014_Mar_31_6_48.nxml.txt.nlp	24684803	SENT120	16	16	8	8	mitiglinide	STEP	PA164748124	84867	0.699
NULL	Iran_Red_Crescent_Med_J_2014_Sep_5_16(9)_e20153.nxml.txt.nlp	25593732	SENT104	21	21	26	26	isoflurane	CYP2E1	PA450106	1571	0.699
NULL	Nucleic_Acids_Res_2010_Oct_27_38(19)_6774-6784.nxml.txt.nlp	20507914	SENT23	6	6	15	15	potassium	p53	PA451047	7157	0.699
NULL	Anticancer_Agents_Med_Chem_2012_Feb_12(2)_163-171.nxml.txt.nlp	22043994	SENT188	28	28	7	7	panitumumab	BRAF	PA162373091	673	0.699
NULL	Cell_Death_Dis_2014_Feb_13_5(2)_e1055.nxml.txt.nlp	24525731	SENT47	27	27	18	18	cisplatin	XRCC1	PA449014	7515	0.699
NULL	JAKSTAT_2013_Jan_1_2(1)_e22925.nxml.txt.nlp	24058789	SENT150	16	16	22	22	sorafenib	STAT3	PA7000	6774	0.699
NULL	Nat_Med_2012_Jan_22_18(2)_224-226.nxml.txt.nlp	22270723	SENT13	12	12	16	16	celecoxib	DNMT1	PA448871	1786	0.699
NULL	Acta_Pharmacol_Sin_2011_Mar_31_32(3)_295-302.nxml.txt.nlp	21278785	SENT144	9	9	19	19	evodiamine	spatial	PA165860788	219793	0.699
NULL	ScientificWorldJournal_2012_Dec_27_2012_740308.nxml.txt.nlp	23346021	SENT103	23	23	34	34	ethanol	OGC	PA448073	8402	0.699
NULL	Br_J_Cancer_2004_May_17_90(10)_2050-2051.nxml.txt.nlp	15138493	SENT27	10	10	25	25	irinotecan	UGT1A1	PA450085	54658	0.699
NULL	Oncotarget_2014_Oct_16_5(20)_9546-9563.nxml.txt.nlp	25337673	SENT109	13	13	10	10	lapatinib	AXL	PA152241907	558	0.699
NULL	Nucleic_Acids_Res_2012_Apr_16_40(8)_3641-3652.nxml.txt.nlp	22180534	SENT97	6	6	11	11	tobramycin	MS2	PA451704	101	0.699
NULL	Int_J_Mol_Sci_2014_Oct_8_15(10)_17974-17999.nxml.txt.nlp	25299695	SENT141	0	0	5	5	curcumin	HO-2	PA151958596	3163	0.699
NULL	Clin_Ophthalmol_2007_Mar_1(1)_61-64.nxml.txt.nlp	19668467	SENT77	13	13	10	10	ethanol	castor	PA448073	54897	0.699
NULL	Br_J_Cancer_2010_Nov_2_103(11)_1671-1679.nxml.txt.nlp	21045835	SENT212	13	13	20	20	gemcitabine	CXCL12	PA449748	6387	0.699
NULL	Exp_Diabetes_Res_2011_Dec_27_2011_604989.nxml.txt.nlp	21253359	SENT121	30	30	23	23	clonidine	GLP-1	PA449051	100125288	0.699
NULL	Cancers_(Basel)_2010_Jun_8_2(2)_1221-1235.nxml.txt.nlp	24281114	SENT699	6	6	0	0	trastuzumab	HER2	PA451743	2064	0.699
NULL	J_Clin_Immunol_2007_May_14_27(3)_275-283.nxml.txt.nlp	17510806	SENT116	13	13	10	10	rosiglitazone	ZO-1	PA451283	7082	0.699
NULL	Mol_Neurodegener_2011_Jun_22_6_43.nxml.txt.nlp	21696630	SENT147	12	12	16	16	carbachol	PKD1	PA448784	5310	0.699
NULL	Cancer_Med_2013_Dec_22_2(6)_862-871.nxml.txt.nlp	24403259	SENT160	9	9	0	0	everolimus	FDG	PA164746311	23583	0.699
NULL	Arthritis_Res_Ther_2006_Jul_21_8(4)_R130.nxml.txt.nlp	16859540	SENT11	7	7	3	3	atorvastatin	CD59	PA448500	966	0.699
NULL	Oncogenesis_2014_Dec_15_3(12)_e133.nxml.txt.nlp	25500906	SENT111	5	5	10	10	trastuzumab	HER2	PA451743	2064	0.699
NULL	Breast_Cancer_Res_2014_Jul_29_16(4)_412.nxml.txt.nlp	25410383	SENT106	15	15	4	4	tamoxifen	ESR1	PA451581	2099	0.699
NULL	J_Parasitol_Res_2013_Apr_3_2013_429736.nxml.txt.nlp	23691276	SENT4	8	8	12	12	artemisinin	ACT	PA165111696	12;11332;9457;641455	0.699
NULL	Exp_Mol_Med_2012_Aug_31_44(8)_473-482.nxml.txt.nlp	22627808	SENT222	9	9	21	21	lapatinib	HRG	PA152241907	3084;3273	0.699
NULL	Front_Genet_2011_May_20_2_21.nxml.txt.nlp	22303317	SENT205	22	22	3	3	sibutramine	GNA11	PA451344	2767	0.699
NULL	F1000Res_2013_Oct_8_2_173.nxml.txt.nlp	24555085	SENT227	44	44	38	38	hydrocortisone	BDP	PA449905	10620;152926	0.699
NULL	Cell_Death_Dis_2010_May_13_1(5)_e41.nxml.txt.nlp	21364648	SENT141	6	6	12	12	etoposide	DR3	PA449552	8718	0.699
NULL	Sci_Rep_2015_Jan_6_5_7641.nxml.txt.nlp	25560734	SENT137	8	8	5	5	tamoxifen	CLTC	PA451581	1213	0.699
NULL	J_Immunother_Cancer_2014_Jan_27_2_2.nxml.txt.nlp	24829759	SENT181	5	5	3	3	sorafenib	IL-21	PA7000	59067;50616;27189	0.699
NULL	Nat_Genet_2013_Jul_19_45(7)_10_1038_ng_2643.nxml.txt.nlp	23685749	SENT194	11	11	29	29	paraformaldehyde	FBS	PA450790	64319;26269	0.699
NULL	Onco_Targets_Ther_2014_Jun_9_7_947-956.nxml.txt.nlp	24959081	SENT56	9	9	22	22	fluorescein	San	PA164746009	80218	0.699
NULL	Oncogene_2014_Sep_18_33(38)_4664-4674.nxml.txt.nlp	24096486	SENT142	0	0	17	17	erlotinib	San	PA134687924	80218	0.699
NULL	Biomed_Eng_Online_2012_Nov_14_11_84.nxml.txt.nlp	23151049	SENT180	21	21	26	26	alendronate	PTH	PA448082	5741	0.699
NULL	Nat_Commun_2014_Nov_19_5_5479.nxml.txt.nlp	25407222	SENT543	11	11	19	19	dextran	YTS	PA449261	8565	0.699
NULL	Breast_Cancer_Res_Treat_2012_Jun_15_133(3)_1057-1065.nxml.txt.nlp	22418700	SENT3	28	28	19	19	trastuzumab	HER2	PA451743	2064	0.699
NULL	Front_Behav_Neurosci_2010_Dec_17_4_187.nxml.txt.nlp	21188275	SENT12	15	15	26	26	estradiol	spatial	PA449503	219793	0.699
NULL	Oncotarget_2012_May_18_3(5)_525-534.nxml.txt.nlp	22619113	SENT135	3	3	8	8	fludarabine	MCL1	PA449655	4170	0.699
NULL	J_Cardiothorac_Surg_2012_Sep_27_7_97.nxml.txt.nlp	23013706	SENT180	11	11	8	8	warfarin	CYP4F2	PA451906	8529	0.699
NULL	Mol_Biol_Cell_2012_Sep_1_23(17)_3473-3484.nxml.txt.nlp	22787275	SENT257	1	1	30	30	fluorescein	San	PA164746009	80218	0.699
NULL	Clin_Dev_Immunol_2008_Feb_25_2008_794050.nxml.txt.nlp	18354729	SENT10	7	7	9	9	methotrexate	DPPIV	PA450428	2191;1803	0.699
NULL	Ann_Hematol_2010_Sep_13_89(9)_861-871.nxml.txt.nlp	20387067	SENT148	3	3	15	15	dasatinib	CD34	PA162372878	947	0.699
NULL	Int_J_Endocrinol_Metab_2012_Sep_30_Autumn_10(4)_646-647.nxml.txt.nlp	23843842	SENT16	10	10	13	13	raloxifene	PTH	PA451221	5741	0.699
NULL	J_Cell_Mol_Med_2013_Sep_24_17(9)_1065-1087.nxml.txt.nlp	24151975	SENT341	3	3	35	35	palifermin	AT2	PA164744014	186	0.699
NULL	Gut_Liver_2013_Jul_20_7(4)_458-461.nxml.txt.nlp	23898387	SENT16	12	12	18	18	ribavirin	IFN	PA451241	3439	0.699
NULL	J_Res_Med_Sci_2011_Sep_16(9)_1176-1182.nxml.txt.nlp	22973386	SENT109	23	23	32	32	tramadol	ACL	PA451735	47	0.699
NULL	Surg_Neurol_Int_2013_Sep_18_4_118.nxml.txt.nlp	24083053	SENT603	0	0	14	14	thrombin	PAR-1	PA451674	2011;2149	0.699
NULL	Ann_Neurosci_2013_Jul_20(3)_115.nxml.txt.nlp	25206027	SENT8	19	19	10	10	axitinib	VEGFR2	PA164924493	3791	0.699
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT75	8	8	17	17	trastuzumab	STAT3	PA451743	6774	0.699
NULL	J_Biol_Chem_2013_Nov_22_288(47)_34217-34229.nxml.txt.nlp	24106270	SENT271	12	12	6	6	thrombin	RhoG	PA451674	391	0.699
NULL	Case_Rep_Oncol_Med_2011_Nov_22_2011_326815.nxml.txt.nlp	22606443	SENT45	34	34	15	15	thyroglobulin	CEA	PA164754910	5670;1087	0.699
NULL	Int_J_Ion_Mobil_Spectrom_2009_Aug_1_12(3)_91-102.nxml.txt.nlp	20835390	SENT154	4	4	17	17	glucosamine	mol	PA164747613	90527	0.699
NULL	J_Hematol_Oncol_2010_Mar_23_3_11.nxml.txt.nlp	20331897	SENT143	28	28	10	10	cisplatin	CRT	PA449014	811	0.699
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Nov_21_65(Pt_12)_o3125.nxml.txt.nlp	21578848	SENT59	4	4	13	13	isoniazid	mol	PA450112	90527	0.699
NULL	Part_Fibre_Toxicol_2013_Aug_13_10_39.nxml.txt.nlp	23937860	SENT132	4	4	29	29	anakinra	HMGB1	PA10799	3146	0.699
NULL	J_Exp_Clin_Cancer_Res_2009_Jun_6_28(1)_76.nxml.txt.nlp	19500405	SENT240	19	19	24	24	gemcitabine	p53	PA449748	7157	0.699
NULL	Biomed_Res_Int_2014_Apr_27_2014_180428.nxml.txt.nlp	24877063	SENT257	2	2	7	7	oxaliplatin	TRPV1	PA131285527	7442	0.699
NULL	Osteoporos_Int_2008_Apr_12_19(4)_399-428.nxml.txt.nlp	18266020	SENT303	10	10	15	15	alendronate	PTH	PA448082	5741	0.699
NULL	Oncotarget_2014_Dec_4_5(22)_11365-11380.nxml.txt.nlp	25426548	SENT3	9	9	25	25	nutlin-3	TP53		7157	0.699
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT192	10	10	47	47	lapatinib	Yes	PA152241907	7525	0.699
NULL	Int_J_Mol_Imaging_2011_Oct_26_2011_874585.nxml.txt.nlp	21490735	SENT131	8	8	26	26	docetaxel	FDG	PA449383	23583	0.699
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT281	16	16	14	14	neratinib	EGFR	PA165291472	1956	0.699
NULL	J_Clin_Biochem_Nutr_2010_Jul_17_47(1)_53-58.nxml.txt.nlp	20664731	SENT164	19	19	6	6	rabeprazole	CYP2C19	PA451216	1557	0.699
NULL	Acta_Pharmacol_Sin_2012_Mar_27_33(3)_342-350.nxml.txt.nlp	22367283	SENT196	3	3	11	11	thrombin	p115	PA451674	8615;393	0.699
NULL	Eur_J_Nucl_Med_Mol_Imaging_2005_Feb_4_32(2)_153-162.nxml.txt.nlp	15690223	SENT207	21	21	12	12	imatinib	FDG	PA10804	23583	0.699
NULL	Neural_Regen_Res_2014_Nov_1_9(21)_1870-1873.nxml.txt.nlp	25558231	SENT53	8	8	6	6	liraglutide	GLP-1	PA165958364	100125288	0.699
NULL	BMB_Rep_2013_Feb_46(2)_86-91.nxml.txt.nlp	23433110	SENT63	8	8	3	3	nadh	DHPR	PA164755085	5860	0.699
NULL	Breast_Cancer_Res_2007_Oct_26_9(5)_112.nxml.txt.nlp	17980056	SENT96	23	23	27	27	tamoxifen	HER2	PA451581	2064	0.699
NULL	Leukemia_2013_Dec_27_27(12)_2322-2331.nxml.txt.nlp	24072044	SENT109	6	6	16	16	plerixafor	CXCL12	PA165958410	6387	0.699
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT192	21	21	46	46	cetuximab	Yes	PA10040	7525	0.699
NULL	Carcinogenesis_2014_Sep_1_35(9)_1983-1992.nxml.txt.nlp	24692066	SENT173	6	6	37	37	doxycycline	CXCR4	PA449415	7852	0.699
NULL	Exp_Mol_Med_2012_Apr_30_44(4)_251-259.nxml.txt.nlp	22198296	SENT75	26	26	15	15	doxorubicin	ABCG2	PA449412	9429	0.699
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT43	8	8	10	10	ritonavir	CYP3A4	PA451260	1576	0.699
NULL	Indian_J_Pharmacol_2014_Nov-Dec_46(6)_627-632.nxml.txt.nlp	25538335	SENT42	0	0	3	3	metformin	Q10	PA450395	27161	0.699
NULL	J_Biomed_Sci_2013_Mar_15_20(1)_17.nxml.txt.nlp	23497194	SENT130	0	0	10	10	rivaroxaban	PAR2	PA165958360	2150;55065;8856	0.699
NULL	BMJ_Open_Respir_Res_2014_Dec_11_1(1)_e000061.nxml.txt.nlp	25553247	SENT4	17	17	1	1	pemetrexed	B12	PA10810	7126;4709	0.699
NULL	Mol_Vis_2007_Jun_14_13_873-880.nxml.txt.nlp	17615538	SENT56	11	11	4	4	paraformaldehyde	CO2	PA450790	4513	0.699
NULL	Diabetes_Care_2013_Jul_12_36(7)_1820-1822.nxml.txt.nlp	23801794	SENT67	11	11	21	21	acarbose	STOP	PA448010	4135	0.699
NULL	Case_Rep_Transplant_2012_Nov_4_2012_305920.nxml.txt.nlp	23213610	SENT44	8	8	16	16	everolimus	EVL	PA164746311	51466	0.699
NULL	Breast_Cancer_(Auckl)_2009_Sep_2_3_61-75.nxml.txt.nlp	19809577	SENT233	0	0	9	9	curcumin	BRCA1	PA151958596	672	0.699
NULL	Mol_Biol_Cell_2013_Jan_15_24(2)_74-84.nxml.txt.nlp	23155000	SENT289	27	27	37	37	l-glutamine	San	PA10090	80218	0.699
NULL	Indian_J_Pharm_Sci_2014_Mar-Apr_76(2)_116-124.nxml.txt.nlp	24843184	SENT16	7	7	19	19	pyrimethamine	TMP	PA451193	2012	0.699
NULL	Anticancer_Drugs_2015_Jan_28_26(1)_46-55.nxml.txt.nlp	25099621	SENT121	0	0	29	29	doxorubicin	KE-3	PA449412	6222	0.699
NULL	Case_Rep_Dent_2013_Jun_13_2013_852932.nxml.txt.nlp	23840974	SENT103	10	10	8	8	cyclophosphamide	CHOP	PA449165	1649	0.698
NULL	Ther_Clin_Risk_Manag_2007_Dec_3(6)_1097-1104.nxml.txt.nlp	18516268	SENT171	17	17	28	28	tenofovir	ATV	PA10204	4683	0.698
NULL	Breast_Cancer_Res_2014_Sep_12_16(5)_436.nxml.txt.nlp	25213081	SENT311	15	15	30	30	tamoxifen	Rho	PA451581	29984	0.698
NULL	Arthritis_Res_Ther_2010_Jul_1_12(4)_R127.nxml.txt.nlp	20594343	SENT62	16	16	23	23	collagenase	F12	PA449107	2161	0.698
NULL	J_Thorac_Oncol_2014_Apr_21_9(4)_483-487.nxml.txt.nlp	24736070	SENT155	19	19	9	9	erlotinib	EGFR	PA134687924	1956	0.698
NULL	Acta_Pharmacol_Sin_2014_Jul_9_35(7)_889-898.nxml.txt.nlp	24909515	SENT159	18	18	11	11	phenol	DRD2	PA450913	1813	0.698
NULL	Breast_Cancer_Res_2011_Apr_15_13(2)_R44.nxml.txt.nlp	21496232	SENT246	5	5	21	21	erlotinib	HER2	PA134687924	2064	0.698
NULL	J_Adv_Pharm_Technol_Res_2011_Apr-Jun_2(2)_81-87.nxml.txt.nlp	22171298	SENT184	10	10	24	24	budesonide	p53	PA448681	7157	0.698
NULL	Hum_Genomics_2009_Dec_1_4(2)_91-106.nxml.txt.nlp	20038497	SENT144	13	13	23	23	galantamine	APOE	PA449726	348	0.698
NULL	J_Korean_Med_Sci_2014_Jul_11_29(7)_965-972.nxml.txt.nlp	25045229	SENT90	13	13	8	8	metformin	B12	PA450395	7126;4709	0.698
NULL	Diabetes_Metab_Syndr_Obes_2014_Jul_17_7_313-319.nxml.txt.nlp	25092992	SENT17	16	16	4	4	glimepiride	adiponectin	PA449761	9370	0.698
NULL	J_Clin_Biochem_Nutr_2011_May_13_48(3)_237-244.nxml.txt.nlp	21562645	SENT163	15	15	29	29	resveratrol	AMPK		5563	0.698
NULL	J_Cell_Biol_2003_Aug_18_162(4)_587-597.nxml.txt.nlp	12913114	SENT148	21	21	6	6	etoposide	p53	PA449552	7157	0.698
NULL	J_Cell_Biol_1998_Jan_26_140(2)_335-345.nxml.txt.nlp	9442109	SENT230	20	20	10	10	chloroquine	NHE	PA448948	285335	0.698
NULL	J_Gastroenterol_2013_Jan_23_48(1)_31-72.nxml.txt.nlp	23090001	SENT949	10	10	6	6	mesalazine	CDAI	PA450384	146059	0.698
NULL	Iran_J_Neurol_2013_12(4)_157-165.nxml.txt.nlp	24250926	SENT208	20	20	11	11	topiramate	LGS	PA451728	51557	0.698
NULL	Mol_Vis_2011_Aug_11_17_2157-2170.nxml.txt.nlp	21850191	SENT193	10	10	28	28	tacrolimus	p50	PA451578	958;4790	0.698
NULL	Mol_Cancer_2012_Aug_8_11_53.nxml.txt.nlp	22871047	SENT305	14	14	8	8	cisplatin	ES2	PA449014	8220	0.698
NULL	Arthritis_Res_Ther_2012_Jul_27_14(4)_R174.nxml.txt.nlp	22838636	SENT119	26	26	41	41	thyroglobulin	TPO	PA164754910	7066;7173	0.698
NULL	Curr_Neuropharmacol_2014_May_12(3)_239-255.nxml.txt.nlp	24851088	SENT380	13	13	17	17	coumarin	BACE1	PA134521193	23621	0.698
NULL	Adipocyte_2013_Jan_1_2(1)_17-27.nxml.txt.nlp	23599907	SENT173	12	12	18	18	glucose	IRAP	PA449773	3557	0.698
NULL	Crit_Care_2006_Aug_29_10(4)_161.nxml.txt.nlp	16941756	SENT17	22	22	17	17	etomidate	IL-6	PA164743987	3569	0.698
NULL	Eur_J_Clin_Pharmacol_2010_Jun_31_66(6)_579-590.nxml.txt.nlp	20354687	SENT291	14	14	8	8	tacrolimus	ABCB1	PA451578	5243	0.698
NULL	Cell_Commun_Signal_2013_Oct_1_11_73.nxml.txt.nlp	24083678	SENT147	25	25	14	14	sulindac	p65	PA451565	5970	0.698
NULL	Diabetol_Metab_Syndr_2014_Mar_31_6_48.nxml.txt.nlp	24684803	SENT111	13	13	23	23	miglitol	STEP	PA164776726	84867	0.698
NULL	Iran_J_Psychiatry_2012_Winter_7(1)_1-10.nxml.txt.nlp	23056111	SENT40	12	12	22	22	topiramate	BD1	PA451728	1672	0.698
NULL	Int_J_Mol_Sci_2012_Apr_24_13(4)_5242-5253.nxml.txt.nlp	22606041	SENT124	16	16	5	5	ethanol	NO3	PA448073	4681	0.698
NULL	Osteoporos_Int_2012_Feb_4_23(Suppl_1)_S1-S23.nxml.txt.nlp	22311111	SENT469	6	6	11	11	teriparatide	PTH	PA451620	5741	0.698
NULL	Curr_Neuropharmacol_2013_Mar_11(2)_141-159.nxml.txt.nlp	23997750	SENT346	25	25	10	10	carbachol	SON	PA448784	6651	0.698
NULL	Oxid_Med_Cell_Longev_2012_May_28_2012_386527.nxml.txt.nlp	22690271	SENT151	14	14	40	40	resveratrol	p53		7157	0.698
NULL	Cancer_Manag_Res_2012_Nov_9_4_383-395.nxml.txt.nlp	23204869	SENT251	11	11	7	7	carmustine	PC-3	PA448810	692094	0.698
NULL	Cancer_Immunol_Immunother_2012_Jul_23_61(7)_1101-1111.nxml.txt.nlp	22193989	SENT125	2	2	9	9	oxaliplatin	CD80	PA131285527	941	0.698
NULL	Oxid_Med_Cell_Longev_2013_Jul_9_2013_574029.nxml.txt.nlp	23936610	SENT298	4	4	13	13	resveratrol	p65		5970	0.698
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT83	11	11	3	3	methotrexate	MSH2	PA450428	4436	0.698
NULL	Indian_J_Endocrinol_Metab_2012_May-Jun_16(3)_343-348.nxml.txt.nlp	22629497	SENT28	15	15	10	10	preotact	PTH	PA165958355	5741	0.698
NULL	Int_J_Gen_Med_2011_May_3_4_345-357.nxml.txt.nlp	21674027	SENT51	20	20	36	36	l-glutamine	CO2	PA10090	4513	0.698
NULL	Cell_Cycle_2013_Sep_1_12(17)_2899-2913.nxml.txt.nlp	23966157	SENT122	14	14	7	7	hyaluronan	EMMPRIN	PA165958431	682	0.698
NULL	Br_J_Cancer_2004_Mar_8_90(5)_955-961.nxml.txt.nlp	14997189	SENT3	11	11	31	31	thalidomide	ENL	PA451644	4298	0.698
NULL	Curr_Med_Chem_2013_Apr_20(10)_1241-1285.nxml.txt.nlp	23409712	SENT1006	14	14	27	27	amiloride	TRPP2	PA448368	5311	0.698
NULL	Oncotarget_2014_Oct_16_5(20)_9546-9563.nxml.txt.nlp	25337673	SENT184	17	17	7	7	lapatinib	AXL	PA152241907	558	0.698
NULL	J_Exp_Med_1998_Jun_1_187(11)_1885-1892.nxml.txt.nlp	9607928	SENT17	9	9	11	11	thalidomide	ENL	PA451644	4298	0.698
NULL	J_Mol_Signal_2011_May_16_6_4.nxml.txt.nlp	21575178	SENT135	0	0	8	8	forskolin	HSP27	PA146096022	3315	0.698
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT104	10	10	0	0	trastuzumab	STAT3	PA451743	6774	0.698
NULL	Oncogene_2010_Sep_16_29(37)_5193-5203.nxml.txt.nlp	20581867	SENT79	0	0	10	10	lapatinib	PI3K	PA152241907	5290	0.698
NULL	Br_J_Cancer_2010_Jan_5_102(1)_151-161.nxml.txt.nlp	19935791	SENT149	9	9	19	19	panitumumab	BRAF	PA162373091	673	0.698
NULL	Oncotarget_2013_Oct_19_4(11)_2045-2056.nxml.txt.nlp	24185104	SENT80	12	12	4	4	cisplatin	14-3-3	PA449014	10971	0.698
NULL	Indian_J_Med_Res_2014_Apr_139(4)_572-578.nxml.txt.nlp	24927344	SENT120	31	31	14	14	acenocoumarol	GGCX	PA452632	2677	0.698
NULL	J_Hematol_Oncol_2014_Apr_16_7_34.nxml.txt.nlp	24739401	SENT9	3	3	5	5	rituximab	CHOP	PA451261	1649	0.698
NULL	Int_J_Mol_Sci_2012_Feb_17_13(2)_2219-2238.nxml.txt.nlp	22408449	SENT741	15	15	8	8	choline	CA1	PA448976	759	0.698
NULL	Cancer_Cell_Int_2009_Sep_10_9_25.nxml.txt.nlp	19744341	SENT184	2	2	15	15	glucosamine	STAT3	PA164747613	6774	0.698
NULL	Br_J_Pharmacol_2011_Nov_164(5)_1522-1533.nxml.txt.nlp	21557728	SENT151	17	17	21	21	cangrelor	ADP	PA165945763	23038	0.698
NULL	Front_Immunol_2014_Apr_23_5_188.nxml.txt.nlp	24795730	SENT139	15	15	11	11	oxygen	CCL5	PA450744	6352	0.698
NULL	Int_Endod_J_2011_Dec_44(12)_1145-1154.nxml.txt.nlp	21902700	SENT43	20	20	14	14	ethanol	HEMA	PA448073	2157	0.698
NULL	Br_J_Haematol_2014_Feb_16_164(4)_586-596.nxml.txt.nlp	24236640	SENT190	39	39	37	37	carboplatin	EPO	PA448803	7076;8288;2056	0.698
NULL	Cancer_Med_2013_Feb_3_2(1)_86-98.nxml.txt.nlp	24133631	SENT21	2	2	0	0	cisplatin	HAI	PA449014	6692;6768	0.698
NULL	Oncogene_2013_Sep_26_32(39)_10_1038_onc_2012_491.nxml.txt.nlp	23108394	SENT99	24	24	10	10	epirubicin	FOXM1	PA449476	2305	0.698
NULL	Theranostics_2013_Jan_15_3(1)_47-75.nxml.txt.nlp	23382786	SENT391	7	7	4	4	plerixafor	CXCR4	PA165958410	7852	0.698
NULL	Mol_Cells_2014_Dec_31_37(12)_899a-906.nxml.txt.nlp	25431425	SENT178	6	6	26	26	curcumin	p65	PA151958596	5970	0.698
NULL	Cent_European_J_Urol_2013_Dec_19_66(4)_394-404.nxml.txt.nlp	24757527	SENT264	4	4	20	20	bevacizumab	IFN	PA130232992	3439	0.698
NULL	Br_J_Cancer_2010_Dec_7_103(12)_1822-1830.nxml.txt.nlp	21063405	SENT272	16	16	25	25	cisplatin	FGF2	PA449014	2247;2258	0.698
NULL	Oncotarget_2014_Mar_15_5(9)_2529-2541.nxml.txt.nlp	24796733	SENT352	15	15	7	7	gemcitabine	STAT3	PA449748	6774	0.698
NULL	F1000_Biol_Rep_2012_Mar_1_4_5.nxml.txt.nlp	22403588	SENT110	25	25	22	22	ribavirin	IFN	PA451241	3439	0.698
NULL	Oncol_Lett_2013_Apr_4_5(4)_1165-1170.nxml.txt.nlp	23599757	SENT30	0	0	38	38	pemetrexed	AICARFT	PA10810	471	0.698
NULL	J_Hematol_Oncol_2011_Apr_20_4_16.nxml.txt.nlp	21504625	SENT316	24	24	8	8	nutlin-3	MDM2		4193	0.698
NULL	J_Mol_Med_(Berl)_2013_Apr_10_91(4)_473-483.nxml.txt.nlp	23052483	SENT39	5	5	15	15	chloroquine	NAC	PA448948	22861	0.698
NULL	Breast_Cancer_Res_2014_May_23_16(3)_R50.nxml.txt.nlp	24887458	SENT82	28	28	15	15	docetaxel	HER2	PA449383	2064	0.698
NULL	Ecancermedicalscience_2010_May_11_4_182.nxml.txt.nlp	22276034	SENT112	3	3	0	0	melphalan	San	PA450354	80218	0.698
NULL	Mol_Cancer_2010_Jun_25_9_165.nxml.txt.nlp	20576164	SENT28	15	15	24	24	curcumin	STAT3	PA151958596	6774	0.698
NULL	J_Cereb_Blood_Flow_Metab_2012_Sep_20_32(9)_1699-1717.nxml.txt.nlp	22714048	SENT44	24	24	40	40	diazoxide	Sur2	PA449285	9439	0.698
NULL	Cancer_Manag_Res_2012_May_28_4_137-149.nxml.txt.nlp	22740774	SENT121	13	13	15	15	tamoxifen	aromatase	PA451581	1588	0.698
NULL	Exp_Ther_Med_2013_Jul_25_6(1)_109-114.nxml.txt.nlp	23935730	SENT121	3	3	6	6	rituximab	CHOP	PA451261	1649	0.698
NULL	Int_J_Mol_Sci_2014_Mar_20_15(3)_4977-4993.nxml.txt.nlp	24658441	SENT673	1	1	5	5	resveratrol	IL-6		3569	0.698
NULL	J_Vet_Med_Sci_2014_Feb_9_76(2)_273-276.nxml.txt.nlp	24107463	SENT224	12	12	17	17	pentoxifylline	CO2	PA450864	4513	0.698
NULL	Breast_Cancer_Res_2007_Jan_23_9(1)_R7.nxml.txt.nlp	17244352	SENT104	22	22	10	10	tamoxifen	CYP3A5	PA451581	1577	0.698
NULL	Oncoimmunology_2013_Jul_1_2(7)_e24679.nxml.txt.nlp	24073364	SENT46	8	8	24	24	sunitinib	IFN	PA162372840	3439	0.698
NULL	Acta_Pharmacol_Sin_2010_Sep_2_31(9)_1172-1180.nxml.txt.nlp	20676117	SENT101	3	3	5	5	bsi-201	PARP1		142	0.698
NULL	Nat_Med_2013_Mar_24_19(3)_351-357.nxml.txt.nlp	23435171	SENT23	24	24	5	5	oxygen	TSC1	PA450744	7248	0.698
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Mar_9_67(Pt_4)_o813.nxml.txt.nlp	21754099	SENT62	22	22	17	17	ethanol	mol	PA448073	90527	0.698
NULL	Evid_Based_Complement_Alternat_Med_2011_Jan_20_2011_713523.nxml.txt.nlp	21318104	SENT119	5	5	0	0	naproxen	SRM	PA450595	6723;6725	0.698
NULL	Mol_Cancer_2014_Jun_26_13_158.nxml.txt.nlp	24965046	SENT159	2	2	28	28	doxorubicin	FasL	PA449412	356	0.698
NULL	Mol_Pain_2013_Jan_2_9_1.nxml.txt.nlp	23279936	SENT56	13	13	6	6	capsaicin	TRPV1	PA448776	7442	0.698
NULL	Oncotarget_2013_Nov_19_5(1)_95-102.nxml.txt.nlp	24395633	SENT34	5	5	9	9	carboplatin	ICE	PA448803	834	0.698
NULL	Cancer_Cell_Int_2013_Apr_16_13_36.nxml.txt.nlp	23590596	SENT118	26	26	4	4	doxorubicin	HIF-1	PA449412	29072	0.698
NULL	Br_J_Cancer_2012_Jul_24_107(3)_435-441.nxml.txt.nlp	22767144	SENT28	6	6	32	32	docetaxel	TTP	PA449383	7538;11093	0.698
NULL	Int_J_Biomed_Sci_2014_Sep_10(3)_217-220.nxml.txt.nlp	25324704	SENT19	12	12	7	7	amiodarone	APT	PA448383	653639	0.698
NULL	Front_Neurosci_2014_Dec_5_8_398.nxml.txt.nlp	25538552	SENT244	17	17	11	11	glucose	gamma	PA449773	9913	0.698
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_55-78.nxml.txt.nlp	19305788	SENT658	16	16	33	33	memantine	CA1	PA10364	759	0.698
NULL	Genet_Mol_Biol_2009_Dec_1_Oct-Dec_32(4)_802-810.nxml.txt.nlp	21637458	SENT92	9	9	4	4	theobromine	AC1	PA451646	107	0.698
NULL	J_Mol_Med_2011_Jul_23_89(7)_667-676.nxml.txt.nlp	21431325	SENT43	15	15	12	12	metformin	AMPK	PA450395	5563	0.698
NULL	Front_Chem_2013_Jul_12_1_10.nxml.txt.nlp	24790939	SENT132	17	17	20	20	hydroquinone	mol	PA449924	90527	0.698
NULL	Neural_Plast_2013_Aug_18_2013_683909.nxml.txt.nlp	24024041	SENT191	31	31	16	16	fluoxetine	NPAS4	PA449673	266743	0.698
NULL	Asian_J_Androl_2014_Apr_25_Sep-Oct_16(5)_761-766.nxml.txt.nlp	24799635	SENT116	43	43	17	17	fructose	DM2	PA449716	28508	0.698
NULL	Arthritis_Res_Ther_2006_Apr_28_8(3)_R73.nxml.txt.nlp	16646979	SENT99	6	6	30	30	hyaluronidase	OP-1	PA164745713	655	0.698
NULL	J_Inflamm_(Lond)_2005_Oct_31_2_14.nxml.txt.nlp	16259633	SENT253	0	0	13	13	staurosporine	CCR2	PA165109623	729230	0.698
NULL	Front_Cell_Neurosci_2014_Jul_18_8_185.nxml.txt.nlp	25100946	SENT403	16	16	4	4	pp2	Isl-1		3670	0.698
NULL	Int_J_Mol_Sci_2014_Sep_26_15(10)_17204-17220.nxml.txt.nlp	25264738	SENT5	33	33	25	25	sildenafil	MPG	PA451346	4350	0.698
NULL	Indian_J_Pharmacol_2008_Jun_40(3)_95-102.nxml.txt.nlp	20040934	SENT262	3	3	15	15	etanercept	MIP-3	PA449515	6368	0.698
NULL	Int_J_Mol_Sci_2014_Mar_20_15(3)_4946-4964.nxml.txt.nlp	24658439	SENT667	32	32	11	11	l-arginine	GBF	PA448478	1316	0.698
NULL	Pediatr_Gastroenterol_Hepatol_Nutr_2013_Mar_31_16(1)_53-60.nxml.txt.nlp	24010107	SENT106	7	7	10	10	vasopressin	EEN	PA451858	6455	0.698
NULL	Aging_(Albany_NY)_2010_Nov_11_2(11)_760-774.nxml.txt.nlp	21084729	SENT162	17	17	12	12	phenformin	NEU	PA1000	2064	0.698
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT253	1	1	10	10	perifosine	DR5	PA165291471	8795	0.698
NULL	Ann_Hematol_2013_May_22_92(9)_1181-1188.nxml.txt.nlp	23694997	SENT90	6	6	8	8	idarubicin	AIDA	PA449961	64853	0.698
NULL	Nat_Commun_2014_Jul_16_5_4425.nxml.txt.nlp	25028121	SENT144	14	14	2	2	creatine	p47	PA164778930	3621;55968	0.698
NULL	J_Lipid_Res_2013_May_54(5)_1410-1420.nxml.txt.nlp	23419260	SENT186	18	18	36	36	tetracycline	IDOL	PA451640	29116	0.698
NULL	Oncotarget_2013_Jun_4_4(5)_772-784.nxml.txt.nlp	23800712	SENT163	17	17	11	11	cetuximab	EGFR	PA10040	1956	0.698
NULL	Exp_Diabetes_Res_2012_Oct_15_2012_465282.nxml.txt.nlp	23118742	SENT132	17	17	8	8	metformin	FGF21	PA450395	26291	0.698
NULL	Clin_Dev_Immunol_2011_Dec_6_2011_349575.nxml.txt.nlp	22190970	SENT145	20	20	17	17	ribavirin	IFN	PA451241	3439	0.698
NULL	Alzheimers_Res_Ther_2013_Oct_24_5(5)_50.nxml.txt.nlp	24401551	SENT321	4	4	19	19	donepezil	spatial	PA449394	219793	0.698
NULL	ScientificWorldJournal_2014_Dec_9_2014_808320.nxml.txt.nlp	25548793	SENT152	17	17	15	15	argatroban	RAC	PA164745516	207	0.698
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_24_2012_673132.nxml.txt.nlp	23133498	SENT135	25	25	27	27	ciprofloxacin	P-gp	PA449009	5243	0.698
NULL	Infect_Drug_Resist_2011_Mar_2_4_77-86.nxml.txt.nlp	21694911	SENT43	2	2	7	7	tigecycline	CABP	PA164746412	6277	0.698
NULL	Clin_Interv_Aging_2008_Sep_3(3)_483-489.nxml.txt.nlp	18982918	SENT152	4	4	11	11	alendronate	BSAP	PA448082	5079	0.698
NULL	Oncol_Rep_2014_Feb_13_31(2)_581-588.nxml.txt.nlp	24337105	SENT155	12	12	17	17	capsaicin	ATF4	PA448776	468	0.698
NULL	Br_J_Cancer_2013_Mar_19_108(5)_1052-1060.nxml.txt.nlp	23422754	SENT150	11	11	28	28	bevacizumab	VEGF-A	PA130232992	7422	0.698
NULL	Exp_Ther_Med_2013_Jun_9_5(6)_1770-1774.nxml.txt.nlp	23837071	SENT26	7	7	32	32	coumarin	p38	PA134521193	10598;1432;7965	0.698
NULL	Br_J_Cancer_2012_Nov_6_107(10)_1745-1753.nxml.txt.nlp	23099808	SENT155	28	28	18	18	gefitinib	EGFR	PA131301952	1956	0.698
NULL	Behav_Brain_Funct_2012_Jun_11_8_30.nxml.txt.nlp	22686184	SENT201	11	11	16	16	diazepam	CORT	PA449283	1325	0.698
NULL	New_Microbes_New_Infect_2014_May_4_2(3)_58-63.nxml.txt.nlp	25356345	SENT100	10	10	24	24	cefotaxime	ANK	PA448852	56172	0.698
NULL	Arthritis_Res_Ther_2006_Jul_26_8(4)_R132.nxml.txt.nlp	16872482	SENT36	25	25	12	12	thrombin	MT1-MMP	PA451674	4323	0.698
NULL	Curr_Neuropharmacol_2008_Jun_6(2)_151-163.nxml.txt.nlp	19305794	SENT551	15	15	39	39	capsaicin	VR1	PA448776	56664	0.698
NULL	Br_J_Cancer_2012_Sep_4_107(6)_947-955.nxml.txt.nlp	22892392	SENT106	9	9	20	20	tamoxifen	EGF	PA451581	1950	0.698
NULL	Cancer_Growth_Metastasis_2013_Aug_8_6_35-52.nxml.txt.nlp	24665206	SENT38	13	13	8	8	curcumin	CDH1	PA151958596	51343;999	0.698
NULL	J_Immunol_Res_2014_May_12_2014_897249.nxml.txt.nlp	24901013	SENT159	2	2	15	15	natalizumab	CD4	PA164747191	920	0.698
NULL	EMBO_Mol_Med_2012_Jun_13_4(6)_515-527.nxml.txt.nlp	22416035	SENT156	0	0	9	9	olaparib	p53		7157	0.698
NULL	Br_J_Cancer_2012_Jul_24_107(3)_516-526.nxml.txt.nlp	22782351	SENT335	10	10	12	12	tamoxifen	TIGAR	PA451581	57103	0.698
NULL	Br_J_Cancer_2010_Jan_5_102(1)_151-161.nxml.txt.nlp	19935791	SENT149	9	9	12	12	panitumumab	TOPK	PA162373091	55872	0.698
NULL	Diabetol_Metab_Syndr_2014_Mar_31_6_48.nxml.txt.nlp	24684803	SENT117	28	28	23	23	mitiglinide	STEP	PA164748124	84867	0.698
NULL	Cancers_(Basel)_2011_Sep_2_3(3)_3461-3495.nxml.txt.nlp	24212964	SENT993	10	10	0	0	cyclophosphamide	CD4	PA449165	920	0.698
NULL	Br_J_Cancer_2004_Mar_22_90(6)_1285-1292.nxml.txt.nlp	15026814	SENT131	0	0	5	5	doxorubicin	p53	PA449412	7157	0.698
NULL	Pharmaceuticals_(Basel)_2014_Jan_9_7(1)_46-57.nxml.txt.nlp	24451403	SENT126	26	26	9	9	ritonavir	AKT	PA451260	207	0.698
NULL	Croat_Med_J_2013_Apr_54(2)_171-179.nxml.txt.nlp	23630144	SENT140	33	33	25	25	taurine	STZ	PA451590	6484	0.698
NULL	J_Thorac_Oncol_2014_Jun_30_9(6)_775-783.nxml.txt.nlp	24828661	SENT126	1	1	12	12	crizotinib	EGFR	PA165946122	1956	0.698
NULL	Acta_Pharmacol_Sin_2012_Apr_5_33(4)_551-557.nxml.txt.nlp	22388075	SENT13	0	0	23	23	imatinib	Wip1	PA10804	8493	0.698
NULL	Arthritis_Res_2001_Sep_18_3(6)_381-388.nxml.txt.nlp	11714393	SENT138	5	5	17	17	collagenase	p38	PA449107	10598;1432;7965	0.698
NULL	Pharmaceuticals_(Basel)_2012_Feb_23_5(3)_249-278.nxml.txt.nlp	24281378	SENT357	2	2	20	20	capsaicin	TRPA1	PA448776	8989	0.698
NULL	J_Aging_Res_2012_Jul_19_2012_194821.nxml.txt.nlp	22888430	SENT311	5	5	18	18	resveratrol	UCP3		7352	0.698
NULL	Oncogenesis_2012_Apr_2_1(4)_e5.nxml.txt.nlp	23552603	SENT235	5	5	8	8	ns-398	cIAP2		330	0.698
NULL	Mol_Cancer_2010_Apr_23_9_87.nxml.txt.nlp	20416058	SENT183	7	7	9	9	etoposide	TRAIL	PA449552	8743	0.698
NULL	Cancer_Immunol_Immunother_2011_Jun_25_60(6)_793-808.nxml.txt.nlp	21350947	SENT42	20	20	18	18	sorafenib	IFN	PA7000	3439	0.698
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_33-43.nxml.txt.nlp	17912634	SENT7	4	4	6	6	letrozole	HER2	PA450196	2064	0.698
NULL	J_Cell_Mol_Med_2013_Nov_19_17(11)_1371-1384.nxml.txt.nlp	24251854	SENT179	12	12	15	15	palifermin	CD4	PA164744014	920	0.698
NULL	Int_J_Med_Sci_2015_Jan_1_12(1)_23-31.nxml.txt.nlp	25552915	SENT148	21	21	2	2	oxygen	CAT	PA450744	847	0.698
NULL	FASEB_J_2014_Feb_28(2)_923-934.nxml.txt.nlp	24249636	SENT214	14	14	20	20	chymotrypsin	KLKB1	PA448994	3818	0.698
NULL	Crit_Care_2011_Oct_25_15(5)_R255.nxml.txt.nlp	22026977	SENT8	14	14	16	16	vasopressin	AVP	PA451858	114548;551	0.698
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT303	0	0	4	4	resveratrol	IL-6		3569	0.698
NULL	Diabetes_Care_2012_Feb_16_35(2)_327-333.nxml.txt.nlp	22179958	SENT109	6	6	10	10	metformin	B12	PA450395	7126;4709	0.698
NULL	Mol_Cells_2014_Mar_31_37(3)_234-240.nxml.txt.nlp	24642709	SENT128	3	3	14	14	capsaicin	TLR4	PA448776	7099	0.698
NULL	J_Cardiovasc_Thorac_Res_2014_Jun_30_6(2)_97-100.nxml.txt.nlp	25031824	SENT35	18	18	25	25	heparin	ACT	PA449855	12;11332;9457;641455	0.698
NULL	Indian_J_Endocrinol_Metab_2012_Dec_16(Suppl_3)_S637-S643.nxml.txt.nlp	23565500	SENT119	4	4	11	11	metformin	adiponectin	PA450395	9370	0.698
NULL	Acta_Vet_Scand_2011_Feb_17_53(1)_11.nxml.txt.nlp	21324209	SENT82	6	6	20	20	cefazolin	OTC	PA448839	5009	0.698
NULL	Oncogene_2013_Sep_12_32(37)_4355-4365.nxml.txt.nlp	23108409	SENT184	9	9	7	7	hyaluronan	HAS2	PA165958431	3037	0.698
NULL	Indian_J_Pharmacol_2014_Nov-Dec_46(6)_627-632.nxml.txt.nlp	25538335	SENT4	16	16	20	20	metformin	STZ	PA450395	6484	0.698
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jan_11_68(Pt_2)_o314.nxml.txt.nlp	22346949	SENT58	19	19	6	6	ethanol	mol	PA448073	90527	0.698
NULL	Br_J_Cancer_1990_May_61(5)_749-754.nxml.txt.nlp	1692472	SENT9	34	34	29	29	melphalan	GM-CSF	PA450354	1437	0.698
NULL	Physiol_Rep_2014_Nov_20_2(11)_e12202.nxml.txt.nlp	25413322	SENT123	27	27	35	35	atropine	ANOVA	PA448505	4858	0.698
NULL	Case_Rep_Pulmonol_2012_Jul_29_2012_804789.nxml.txt.nlp	22934225	SENT99	12	12	21	21	isoflurane	CO2	PA450106	4513	0.698
NULL	Biomed_Res_Int_2013_Dec_31_2013_273498.nxml.txt.nlp	23484100	SENT141	6	6	10	10	genistein	OTC	PA165109660	5009	0.698
NULL	J_Oncol_2012_Mar_26_2012_198412.nxml.txt.nlp	22536237	SENT70	30	30	13	13	trastuzumab	HER2	PA451743	2064	0.698
NULL	Cancers_(Basel)_2013_Dec_27_6(1)_67-78.nxml.txt.nlp	24378752	SENT69	26	26	12	12	etoposide	Bcl-2	PA449552	596	0.698
NULL	BMB_Rep_2013_Apr_46(4)_230-235.nxml.txt.nlp	23615266	SENT18	21	21	16	16	protamine	PP2	PA10366	4888	0.698
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Sep_26_65(Pt_10)_o2518.nxml.txt.nlp	21577965	SENT66	11	11	14	14	benzaldehyde	mol	PA448571	90527	0.698
NULL	Int_Clin_Psychopharmacol_2014_Jul_26_29(4)_185-196.nxml.txt.nlp	24424469	SENT206	0	0	9	9	paroxetine	CYP2D6	PA450801	1565	0.698
NULL	Breast_Cancer_(Auckl)_2009_Apr_7_3_23-34.nxml.txt.nlp	21556247	SENT105	18	18	8	8	celecoxib	AKT	PA448871	207	0.698
NULL	Int_J_Biomed_Sci_2008_Mar_4(1)_8-13.nxml.txt.nlp	23675060	SENT56	17	17	10	10	estradiol	IFN	PA449503	3439	0.698
NULL	Biomed_Res_Int_2014_Feb_27_2014_214587.nxml.txt.nlp	24716192	SENT141	15	15	27	27	pioglitazone	LPA	PA450970	4018	0.698
NULL	Iran_J_Radiol_2014_May_15_11(2)_e7228.nxml.txt.nlp	25035706	SENT66	22	22	8	8	thrombin	IPA	PA451674	3160	0.698
NULL	Arthritis_Res_Ther_2008_Sep_9_10(5)_R107.nxml.txt.nlp	18782442	SENT278	25	25	8	8	glucose	HNE	PA449773	1991	0.698
NULL	Clin_Dev_Immunol_2011_Sep_14_2011_267539.nxml.txt.nlp	21922022	SENT37	0	0	7	7	erlotinib	San	PA134687924	80218	0.698
NULL	J_Immunotoxicol_2013_Jan_11_10(1)_75-82.nxml.txt.nlp	22967038	SENT101	25	25	2	2	muromonab	IFN	PA164743097	3439	0.698
NULL	Am_J_Transplant_2014_Nov_2_14(11)_2595-2606.nxml.txt.nlp	25278159	SENT169	6	6	19	19	collagenase	NB1	PA449107	57126	0.698
NULL	Diabetes_2011_Mar_21_60(3)_909-917.nxml.txt.nlp	21300843	SENT162	43	43	17	17	galactose	Sda	PA449725	124872	0.698
NULL	FEBS_Open_Bio_2014_Feb_28_4_260-265.nxml.txt.nlp	24649407	SENT252	15	15	7	7	pioglitazone	APOE	PA450970	348	0.698
NULL	Mol_Cancer_2009_Nov_24_8_109.nxml.txt.nlp	19930708	SENT72	3	3	8	8	exemestane	aromatase	PA449563	1588	0.698
NULL	Adipocyte_2013_Jan_1_2(1)_28-32.nxml.txt.nlp	23700549	SENT42	27	27	38	38	valsartan	IL-6	PA451848	3569	0.698
NULL	Mol_Biol_Cell_2012_Nov_1_23(21)_4212-4225.nxml.txt.nlp	22956765	SENT202	25	25	10	10	thrombin	SHP2	PA451674	5781	0.698
NULL	J_Exp_Clin_Cancer_Res_2009_Nov_24_28(1)_144.nxml.txt.nlp	19930704	SENT121	30	30	18	18	paclitaxel	P-gp	PA450761	5243	0.698
NULL	Mol_Cancer_2009_Dec_23_8_129.nxml.txt.nlp	20030852	SENT239	12	12	31	31	curcumin	CXCL1	PA151958596	2919	0.698
NULL	Exp_Hematol_Oncol_2013_Sep_5_2_24.nxml.txt.nlp	24007855	SENT55	3	3	5	5	imatinib	JAK2	PA10804	3717	0.698
NULL	Indian_J_Endocrinol_Metab_2012_Dec_16(Suppl_3)_S529-S531.nxml.txt.nlp	23565485	SENT19	0	0	13	13	metformin	AMPK	PA450395	5563	0.698
NULL	J_Thromb_Haemost_2011_Oct_9(10)_2103-2105.nxml.txt.nlp	21812912	SENT18	5	5	28	28	ticagrelor	mol	PA165374673	90527	0.698
NULL	Br_J_Cancer_2009_Jan_27_100(2)_315-321.nxml.txt.nlp	19127256	SENT121	22	22	15	15	everolimus	CYP3A4	PA164746311	1576	0.698
NULL	Case_Rep_Pediatr_2014_Jan_30_2014_163848.nxml.txt.nlp	24592349	SENT32	1	1	11	11	thyroglobulin	RAI	PA164754910	10848;6050	0.698
NULL	Chem_Res_Toxicol_2009_May_18_22(5)_759-778.nxml.txt.nlp	19397281	SENT1096	15	15	23	23	cisplatin	HRAS	PA449014	3265	0.698
NULL	Acta_Pharmacol_Sin_2014_Sep_25_35(9)_1215-1225.nxml.txt.nlp	25152023	SENT32	13	13	37	37	simvastatin	STZ	PA451363	6484	0.698
NULL	Breast_Cancer_Res_2007_Dec_20_9(Suppl_2)_S11.nxml.txt.nlp	NULL	SENT19	16	16	12	12	anastrozole	IMPACT	PA448432	55364	0.698
NULL	J_Mol_Med_(Berl)_2014_Jan_10_92(5)_497-507.nxml.txt.nlp	24408111	SENT157	21	21	6	6	pioglitazone	HIF-1	PA450970	29072	0.698
NULL	Eur_J_Nutr_2009_Jun_24_48(4)_229-234.nxml.txt.nlp	19238310	SENT4	3	3	17	17	capsaicin	GLP-1	PA448776	100125288	0.698
NULL	Oxid_Med_Cell_Longev_2012_Sep_6_2012_718491.nxml.txt.nlp	22991584	SENT180	0	0	14	14	curcumin	IIS	PA151958596	404552	0.698
NULL	Oncogene_2010_May_20_29(20)_2962-2972.nxml.txt.nlp	20228846	SENT153	17	17	12	12	imatinib	HIF-1	PA10804	29072	0.698
NULL	Front_Physiol_2011_Nov_29_2_89.nxml.txt.nlp	22164144	SENT168	31	31	6	6	thrombin	PAR1	PA451674	79581;2149	0.698
NULL	Mol_Cancer_2012_Jul_29_11_48.nxml.txt.nlp	22839996	SENT76	20	20	22	22	cisplatin	DDP	PA449014	1678	0.698
NULL	Behav_Brain_Funct_2012_Jul_10_8_20.nxml.txt.nlp	22559224	SENT0	25	25	14	14	baclofen	gamma	PA448533	9913	0.698
NULL	Orphanet_J_Rare_Dis_2013_Sep_13_8_142.nxml.txt.nlp	24034279	SENT47	13	13	22	22	vasopressin	ACTH	PA451858	5443	0.698
NULL	Mol_Cytogenet_2014_Jan_23_7_8.nxml.txt.nlp	24456987	SENT382	25	25	21	21	tamoxifen	HER2	PA451581	2064	0.698
NULL	J_Korean_Med_Sci_2010_Jan_26_25(1)_110-116.nxml.txt.nlp	20054409	SENT149	21	21	0	0	cyclophosphamide	BCS	PA449165	617	0.698
NULL	J_Breast_Cancer_2011_Jun_18_14(2)_135-139.nxml.txt.nlp	21847409	SENT21	21	21	36	36	toremifene	aromatase	PA451731	1588	0.698
NULL	Indian_J_Endocrinol_Metab_2014_Jul-Aug_18(4)_546-551.nxml.txt.nlp	25143915	SENT61	14	14	12	12	denosumab	RANKL	PA166048634	8600	0.698
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT102	22	22	9	9	imatinib	ABCB1	PA10804	5243	0.698
NULL	Indian_J_Ophthalmol_2010_May-Jun_58(3)_252-253.nxml.txt.nlp	20413936	SENT41	22	22	10	10	vancomycin	API	PA451850	5345	0.698
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT130	43	43	37	37	doxorubicin	B7-H1	PA449412	29126	0.698
NULL	ACS_Catal_2014_Jul_3_4(7)_2328-2332.nxml.txt.nlp	25061545	SENT0	25	25	0	0	oxygen	ACS	PA450744	55902;84680	0.698
NULL	Neural_Plast_2014_May_12_2014_563160.nxml.txt.nlp	24900924	SENT222	6	6	10	10	resveratrol	SIRT1		23411	0.698
NULL	Exp_Neurobiol_2013_Mar_31_22(1)_51-57.nxml.txt.nlp	23585723	SENT130	0	0	11	11	capsaicin	TRPV1	PA448776	7442	0.698
NULL	J_Cancer_2013_Nov_23_4(9)_736-754.nxml.txt.nlp	24312144	SENT34	6	6	4	4	crizotinib	EGFR	PA165946122	1956	0.698
NULL	Pharmaceuticals_(Basel)_2012_Aug_17_5(8)_837-852.nxml.txt.nlp	24280677	SENT72	15	15	4	4	capsaicin	TRPV1	PA448776	7442	0.698
NULL	Ther_Clin_Risk_Manag_2006_Mar_2(1)_59-75.nxml.txt.nlp	18360582	SENT224	19	19	28	28	telithromycin	CYP3A4	PA10202	1576	0.698
NULL	Parasit_Vectors_2013_Sep_24_6_278.nxml.txt.nlp	24499628	SENT195	15	15	17	17	primaquine	ACT	PA451103	12;11332;9457;641455	0.697
NULL	Front_Syst_Neurosci_2014_Aug_6_8_140.nxml.txt.nlp	25147510	SENT558	17	17	10	10	bromocriptine	DRD2	PA448671	1813	0.697
NULL	Exp_Anim_2014_Apr_26_63(2)_257-267.nxml.txt.nlp	24770651	SENT6	5	5	14	14	olmesartan	apelin	PA164742950	8862	0.697
NULL	Int_J_Endocrinol_2011_Dec_20_2011_746482.nxml.txt.nlp	22216029	SENT224	40	40	22	22	nifedipine	K60	PA450631	3576	0.697
NULL	Brain_Sci_2013_Jun_14_3(2)_941-963.nxml.txt.nlp	24961432	SENT248	0	0	18	18	ethanol	RhoA	PA448073	387	0.697
NULL	Acta_Pharmacol_Sin_2009_Apr_9_30(4)_467-477.nxml.txt.nlp	19270721	SENT164	25	25	30	30	cisplatin	IL-24	PA449014	11009	0.697
NULL	Kidney_Int_Suppl_(2011)_2012_Dec_15_2(5)_370-371.nxml.txt.nlp	25018964	SENT26	17	17	11	11	candesartan	SECRET	PA448765	10590	0.697
NULL	Diabetes_Care_2011_Oct_15_34(10)_2231-2236.nxml.txt.nlp	21816973	SENT180	23	23	9	9	rosiglitazone	adiponectin	PA451283	9370	0.697
NULL	Curr_Med_Chem_2011_Dec_18(35)_5424-5429.nxml.txt.nlp	22087835	SENT102	29	29	8	8	atorvastatin	FKBP51	PA448500	2289	0.697
NULL	Nat_Struct_Mol_Biol_2014_Jul_22_21(7)_633-640.nxml.txt.nlp	24952594	SENT194	14	14	26	26	l-glutamine	CO2	PA10090	4513	0.697
NULL	Arthritis_Res_Ther_2010_Jan_8_12(1)_R4.nxml.txt.nlp	20064200	SENT277	10	10	15	15	diclofenac	COX2	PA449293	4513;5743	0.697
NULL	Oncotarget_2012_Sep_27_3(10)_1137-1145.nxml.txt.nlp	23087155	SENT52	24	24	20	20	decitabine	DNMT1	PA164749631	1786	0.697
NULL	Cell_Cycle_2012_Nov_1_11(21)_4069-4078.nxml.txt.nlp	23095523	SENT78	34	34	9	9	imatinib	PERK	PA10804	9451	0.697
NULL	Oxid_Med_Cell_Longev_2012_Nov_28_2012_162934.nxml.txt.nlp	23251719	SENT32	9	9	18	18	creatine	PBR	PA164778930	706	0.697
NULL	Diabetes_Care_2012_Jan_13_35(Suppl_1)_S11-S63.nxml.txt.nlp	22187469	SENT1937	15	15	6	6	rosiglitazone	DREAM	PA451283	30818	0.697
NULL	Breast_Cancer_Res_2005_May_24_7(5)_R589-R597.nxml.txt.nlp	16168102	SENT193	19	19	30	30	doxorubicin	FBS	PA449412	64319;26269	0.697
NULL	J_Oncol_2010_Jan_3_2010_709678.nxml.txt.nlp	21274259	SENT25	12	12	6	6	cetuximab	EGFR	PA10040	1956	0.697
NULL	Diabetes_Care_2013_Jun_15_36(6)_1629-1634.nxml.txt.nlp	23321217	SENT152	10	10	16	16	atorvastatin	CD133	PA448500	8842	0.697
NULL	Apoptosis_2013_Jun_7_18(6)_664-680.nxml.txt.nlp	23468121	SENT310	19	19	6	6	staurosporine	PDCD2	PA165109623	5134	0.697
NULL	Blood_Cancer_J_2013_Jun_7_3(6)_e120.nxml.txt.nlp	23749045	SENT90	13	13	10	10	imatinib	IGF1R	PA10804	3480	0.697
NULL	Support_Care_Cancer_2011_Oct_12_19(10)_1609-1617.nxml.txt.nlp	20835873	SENT43	13	13	20	20	granisetron	HEC	PA449809	10403	0.697
NULL	FEBS_Open_Bio_2014_Jan_3_4_105-111.nxml.txt.nlp	24490134	SENT386	14	14	23	23	galactose	NAT	PA449725	6046	0.697
NULL	Oxid_Med_Cell_Longev_2011_Aug_15_2011_824597.nxml.txt.nlp	21904648	SENT210	8	8	10	10	topotecan	TPT	PA451729	23590;6469	0.697
NULL	Oxid_Med_Cell_Longev_2013_Dec_5_2013_963520.nxml.txt.nlp	24381719	SENT248	13	13	4	4	nitrogen	nNOS	PA450643	4842	0.697
NULL	Indian_J_Plast_Surg_2013_May-Aug_46(2)_408-418.nxml.txt.nlp	24516292	SENT279	29	29	19	19	minocycline	COX	PA450519	1351	0.697
NULL	Cardiovasc_Diabetol_2011_Dec_21_10_114.nxml.txt.nlp	22189162	SENT152	17	17	0	0	indomethacin	CYP2J2	PA449982	1573	0.697
NULL	Alcohol_Res_Health_2010_33(1-2)_76-86.nxml.txt.nlp	23579938	SENT168	20	20	7	7	ethanol	ALDH2	PA448073	217	0.697
NULL	Acta_Pharmacol_Sin_2009_Oct_21_30(10)_1392-1398.nxml.txt.nlp	19767766	SENT184	5	5	9	9	atorvastatin	NAC	PA448500	22861	0.697
NULL	Br_J_Cancer_2013_Mar_19_108(5)_1052-1060.nxml.txt.nlp	23422754	SENT155	33	33	21	21	bevacizumab	VEGF-A	PA130232992	7422	0.697
NULL	Pharmaceutics_2011_Oct_12_3(4)_680-705.nxml.txt.nlp	24309303	SENT56	12	12	16	16	repaglinide	OATP1B1	PA451234	10599	0.697
NULL	Nucl_Recept_Signal_2008_Feb_1_6_e003.nxml.txt.nlp	18301783	SENT111	0	0	9	9	raloxifene	AP-1	PA451221	2353;3727;2354;3725	0.697
NULL	Acta_Pharmacol_Sin_2013_Jun_8_34(6)_830-836.nxml.txt.nlp	23564080	SENT111	4	4	12	12	simvastatin	HMGB1	PA451363	3146	0.697
NULL	Mol_Biol_Int_2011_Feb_24_2011_137459.nxml.txt.nlp	22091395	SENT210	8	8	25	25	arsenite	TIA1	PA452638	7072	0.697
NULL	Breast_Cancer_Res_2005_Jul_18_7(5)_187-189.nxml.txt.nlp	16168136	SENT11	9	9	28	28	tamoxifen	AIB1	PA451581	8202	0.697
NULL	Indian_J_Med_Res_2014_Mar_139(3)_349-370.nxml.txt.nlp	24820829	SENT168	25	25	37	37	collagenase	DR6	PA449107	27242	0.697
NULL	J_Biol_Chem_2009_Dec_11_284(50)_35227-35239.nxml.txt.nlp	19833731	SENT29	36	36	23	23	suramin	ADP	PA10292	23038	0.697
NULL	Front_Immunol_2012_Mar_1_3_36.nxml.txt.nlp	22566919	SENT255	35	35	29	29	alefacept	CD2	PA164748040	914	0.697
NULL	Genome_Med_2010_Aug_11_2(8)_53.nxml.txt.nlp	20701793	SENT91	19	19	12	12	everolimus	VEGFR	PA164746311	3791	0.697
NULL	J_Invest_Dermatol_2012_Nov_21_132(11)_2642-2651.nxml.txt.nlp	22718118	SENT234	42	42	15	15	spermine	TLR7	PA164781199	51284	0.697
NULL	Breast_Cancer_(Auckl)_2009_Sep_2_3_61-75.nxml.txt.nlp	19809577	SENT19	3	3	15	15	curcumin	BRCA1	PA151958596	672	0.697
NULL	Cardiovasc_Ther_2009_27(4)_259-274.nxml.txt.nlp	19604248	SENT156	0	0	3	3	ticagrelor	IPA	PA165374673	3160	0.697
NULL	Nucleic_Acids_Res_2008_Feb_26_36(2)_435-443.nxml.txt.nlp	18039708	SENT128	13	13	11	11	hyaluronan	HAS2	PA165958431	3037	0.697
NULL	Curr_Genomics_2014_Jun_15(3)_217-230.nxml.txt.nlp	24955029	SENT189	37	37	40	40	oxygen	ROS	PA450744	6098	0.697
NULL	Nucleic_Acids_Res_2012_Apr_10_40(7)_2925-2939.nxml.txt.nlp	22156375	SENT40	27	27	34	34	heparin	CO2	PA449855	4513	0.697
NULL	Cell_Death_Dis_2012_Jun_21_3(6)_e327.nxml.txt.nlp	22717582	SENT75	7	7	10	10	etoposide	p53	PA449552	7157	0.697
NULL	J_Gastroenterol_2013_Jan_27_48(1)_22-30.nxml.txt.nlp	23104468	SENT71	3	3	20	20	ribavirin	IFN	PA451241	3439	0.697
NULL	J_Biol_Chem_2012_Aug_10_287(33)_28169-28179.nxml.txt.nlp	22584573	SENT280	40	40	14	14	rosiglitazone	HDX	PA451283	139324	0.697
NULL	J_Immunol_Res_2014_Jul_16_2014_696812.nxml.txt.nlp	25133198	SENT263	18	18	7	7	rifaximin	TLR2	PA164752443	7097	0.697
NULL	Biomed_Res_Int_2014_Jan_20_2014_948427.nxml.txt.nlp	24563867	SENT89	3	3	17	17	buspirone	STZ	PA448689	6484	0.697
NULL	FEBS_J_2009_Oct_276(19)_5571-5578.nxml.txt.nlp	19702827	SENT37	6	6	26	26	gefitinib	EGF	PA131301952	1950	0.697
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1013.nxml.txt.nlp	24457957	SENT69	12	12	16	16	bortezomib	NOXA	PA10252	5366	0.697
NULL	Front_Immunol_2013_Nov_8_4_363.nxml.txt.nlp	24265631	SENT255	16	16	21	21	cisplatin	CCL5	PA449014	6352	0.697
NULL	Pain_2014_Oct_155(10)_2097-2107.nxml.txt.nlp	25083927	SENT36	22	22	5	5	capsaicin	TRPV1	PA448776	7442	0.697
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT66	3	3	5	5	resveratrol	TRAIL		8743	0.697
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT423	11	11	4	4	docetaxel	TFF3	PA449383	7033	0.697
NULL	Chin_J_Cancer_2012_Jul_31(7)_319-326.nxml.txt.nlp	22257382	SENT77	2	2	8	8	cetuximab	EGFR	PA10040	1956	0.697
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_2_2013_482428.nxml.txt.nlp	23818926	SENT50	27	27	39	39	l-glutamine	CO2	PA10090	4513	0.697
NULL	Breast_Cancer_Res_2010_Jul_1_12(4)_R45.nxml.txt.nlp	20594311	SENT135	0	0	11	11	tamoxifen	AKT	PA451581	207	0.697
NULL	Arthritis_Res_Ther_2013_Dec_4_15(6)_R206.nxml.txt.nlp	24299152	SENT105	16	16	8	8	lepirudin	FXI	PA450195	2160	0.697
NULL	Cancer_Immunol_Immunother_2011_Jun_25_60(6)_793-808.nxml.txt.nlp	21350947	SENT204	20	20	18	18	sorafenib	IFN	PA7000	3439	0.697
NULL	Eur_J_Clin_Pharmacol_2014_Sep_27_70(1)_65-77.nxml.txt.nlp	24071959	SENT345	15	15	9	9	tacrolimus	CYP3A	PA451578	1574	0.697
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT206	4	4	10	10	resveratrol	p53		7157	0.697
NULL	J_Oncol_2011_Sep_15_2011_528353.nxml.txt.nlp	21941546	SENT467	0	0	15	15	celecoxib	Bcl-2	PA448871	596	0.697
NULL	Cancer_Cell_Int_2009_Feb_17_9_4.nxml.txt.nlp	19222856	SENT96	6	6	15	15	cisplatin	p53	PA449014	7157	0.697
NULL	Int_J_Gen_Med_2009_Dec_29_2_209-217.nxml.txt.nlp	20360906	SENT139	25	25	9	9	lisuride	PRL	PA164749019	5617	0.697
NULL	Breast_Cancer_Res_2005_Mar_4_7(3)_R345-R352.nxml.txt.nlp	15987429	SENT231	23	23	9	9	pirenzepine	CARB	PA10159	9482	0.697
NULL	Case_Rep_Otolaryngol_2014_Dec_10_2014_609784.nxml.txt.nlp	25574413	SENT55	5	5	9	9	dapsone	G6PD	PA449211	2539	0.697
NULL	Eur_J_Neurosci_2008_Jun_27(11)_2830-2837.nxml.txt.nlp	18588528	SENT98	12	12	24	24	choline	NeuN	PA448976	146713	0.697
NULL	Curr_Control_Trials_Cardiovasc_Med_2001_Oct_25_2(6)_260-262.nxml.txt.nlp	11806809	SENT67	26	26	0	0	tirofiban	ARTS	PA451698	5414	0.697
NULL	Patient_Prefer_Adherence_2010_Mar_24_4_61-68.nxml.txt.nlp	20361006	SENT168	21	21	17	17	glimepiride	GLP-1	PA449761	100125288	0.697
NULL	Scientifica_(Cairo)_2012_Nov_25_2012_473829.nxml.txt.nlp	24278698	SENT231	12	12	5	5	cisplatin	ATP7A	PA449014	538	0.697
NULL	Diabetes_Care_2009_Sep_29_32(9)_1620-1625.nxml.txt.nlp	19564453	SENT147	21	21	16	16	metformin	MEMO	PA450395	51072	0.697
NULL	J_Mol_Signal_2010_May_10_5_4.nxml.txt.nlp	20459745	SENT64	28	28	32	32	cisplatin	p53	PA449014	7157	0.697
NULL	J_Ophthalmol_2011_Jun_16_2011_159436.nxml.txt.nlp	21772983	SENT3	12	12	19	19	ranibizumab	San	PA164746012	80218	0.697
NULL	Cancer_Cell_Int_2004_Aug_17_4_5.nxml.txt.nlp	15315711	SENT15	11	11	18	18	genistein	NQO1	PA165109660	1728	0.697
NULL	Br_J_Cancer_2011_Jan_4_104(1)_91-100.nxml.txt.nlp	21139584	SENT66	4	4	10	10	geldanamycin	Hsp90	PA152031327	3320	0.697
NULL	Thorax_2009_Aug_12_64(8)_671-676.nxml.txt.nlp	19213775	SENT175	8	8	12	12	budesonide	NF-kappaB	PA448681	4790	0.697
NULL	Mol_Cells_2014_Dec_31_37(12)_899a-906.nxml.txt.nlp	25431425	SENT439	21	21	13	13	curcumin	NAC	PA151958596	22861	0.697
NULL	J_Oncol_2012_Feb_6_2012_737981.nxml.txt.nlp	22481932	SENT142	33	33	8	8	paclitaxel	MDR1	PA450761	5243	0.697
NULL	EMBO_Mol_Med_2010_Jan_2(1)_26-37.nxml.txt.nlp	20043279	SENT190	20	20	9	9	terbutaline	CAP1	PA451616	10487	0.697
NULL	Int_J_Mol_Sci_2014_May_8_15(5)_8106-8121.nxml.txt.nlp	24815071	SENT55	3	3	16	16	atorvastatin	LC3	PA448500	84557	0.697
NULL	Ann_Indian_Acad_Neurol_2009_Oct-Dec_12(4)_273-282.nxml.txt.nlp	20182575	SENT148	15	15	23	23	natalizumab	IFN	PA164747191	3439	0.697
NULL	Br_J_Cancer_2009_Sep_15_101(6)_957-966.nxml.txt.nlp	19738618	SENT132	19	19	41	41	dexrazoxane	THBS-1	PA449259	7057	0.697
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT253	1	1	14	14	perifosine	DR4	PA165291471	8797	0.697
NULL	Open_Cardiovasc_Med_J_2011_Jun_20_5_136-147.nxml.txt.nlp	21760856	SENT41	34	34	18	18	rosiglitazone	adiponectin	PA451283	9370	0.697
NULL	Breast_Cancer_Res_2010_Oct_14_12(5)_R84.nxml.txt.nlp	20946630	SENT238	32	32	16	16	choline	SLC22A1	PA448976	6580	0.697
NULL	Exp_Ther_Med_2013_May_15_5(5)_1327-1331.nxml.txt.nlp	23737873	SENT26	8	8	22	22	enalapril	AQP2	PA449456	359	0.697
NULL	eLife_2013_Nov_5_2_e00969.nxml.txt.nlp	24192036	SENT114	12	12	16	16	vemurafenib	NOXA	PA165946873	5366	0.697
NULL	Acta_Pharmacol_Sin_2010_Feb_5_31(2)_137-144.nxml.txt.nlp	20139896	SENT184	4	4	7	7	zileuton	5-LOX	PA451955	240	0.697
NULL	J_Cell_Mol_Med_2014_Jan_31_18(1)_27-37.nxml.txt.nlp	24373581	SENT189	0	0	31	31	alendronate	OPG	PA448082	690	0.697
NULL	Br_J_Cancer_2010_Aug_24_103(5)_663-667.nxml.txt.nlp	20700126	SENT76	27	27	4	4	trastuzumab	PTK6	PA451743	5753	0.697
NULL	Oxid_Med_Cell_Longev_2012_Jan_19_2012_390678.nxml.txt.nlp	22315655	SENT161	2	2	4	4	gliclazide	NAC	PA10892	22861	0.697
NULL	Indian_J_Psychol_Med_2013_Jul-Sep_35(3)_256-259.nxml.txt.nlp	24249927	SENT37	18	18	28	28	tramadol	5-HT2C	PA451735	3358	0.697
NULL	Biomed_Res_Int_2013_Jul_31_2013_692071.nxml.txt.nlp	23984399	SENT196	7	7	5	5	imatinib	OCT1	PA10804	5451;6580	0.697
NULL	J_Invest_Dermatol_2012_Apr_22_132(4)_1253-1262.nxml.txt.nlp	22189789	SENT282	3	3	14	14	capsaicin	TRPV3	PA448776	162514	0.697
NULL	Breast_Cancer_Res_2011_Jun_29_13(3)_R70.nxml.txt.nlp	21707964	SENT116	0	0	4	4	tamoxifen	zeta	PA451581	9907	0.697
NULL	Subst_Abuse_Rehabil_2013_Nov_6_4_75-82.nxml.txt.nlp	24648790	SENT88	21	21	0	0	pseudoephedrine	OTC	PA451170	5009	0.697
NULL	EMBO_Mol_Med_2013_May_15_5(5)_751-761.nxml.txt.nlp	23505126	SENT78	45	45	35	35	trypsin	Vel	PA451806	388588	0.697
NULL	Nat_Commun_2014_5_3206.nxml.txt.nlp	24487777	SENT216	16	16	35	35	l-glutamine	CO2	PA10090	4513	0.697
NULL	ScientificWorldJournal_2013_Apr_30_2013_823289.nxml.txt.nlp	23737729	SENT155	32	32	12	12	diazepam	SNK	PA449283	10769	0.697
NULL	Arthritis_Res_Ther_2005_Dec_1_7(1)_R149-R155.nxml.txt.nlp	15642135	SENT181	17	17	14	14	infliximab	IL-6	PA452639	3569	0.697
NULL	F1000_Med_Rep_2009_May_28_1_41.nxml.txt.nlp	20052398	SENT25	12	12	6	6	ribavirin	IFN	PA451241	3439	0.697
NULL	J_Breast_Cancer_2013_Mar_31_16(1)_23-31.nxml.txt.nlp	23593078	SENT115	8	8	26	26	resveratrol	MBD2		8932	0.697
NULL	JAKSTAT_2014_Jun_12_3_e29554.nxml.txt.nlp	25105067	SENT95	20	20	14	14	propofol	p65	PA451141	5970	0.697
NULL	Breast_Cancer_Res_2012_Jan_6_14(1)_R2.nxml.txt.nlp	22225778	SENT174	4	4	10	10	docetaxel	p65	PA449383	5970	0.697
NULL	Br_J_Cancer_1991_Dec_64(6)_1069-1075.nxml.txt.nlp	1764369	SENT15	8	8	10	10	melphalan	HAI	PA450354	6692;6768	0.697
NULL	Nat_Biotechnol_2013_Jul_30_31(7)_630-637.nxml.txt.nlp	23811600	SENT375	4	4	6	6	ponatinib	ABL1	PA165980594	25	0.697
NULL	Pharm_Pract_(Granada)_2011_Mar_15_Jan-Mar_9(1)_1-10.nxml.txt.nlp	25132883	SENT153	11	11	18	18	rivaroxaban	SPAF	PA165958360	166378	0.697
NULL	J_Korean_Med_Sci_2014_Jul_11_29(7)_965-972.nxml.txt.nlp	25045229	SENT63	18	18	22	22	metformin	B12	PA450395	7126;4709	0.697
NULL	Bull_Math_Biol_2012_May_5_74(5)_1098-1124.nxml.txt.nlp	22218880	SENT324	7	7	18	18	chloroquine	ACT	PA448948	12;11332;9457;641455	0.697
NULL	Indian_J_Pharm_Sci_2014_Sep-Oct_76(5)_423-429.nxml.txt.nlp	25425756	SENT65	2	2	6	6	metoclopramide	FOR	PA450475	51741	0.697
NULL	Front_Cell_Neurosci_2014_Jun_17_8_174.nxml.txt.nlp	24987335	SENT79	5	5	9	9	diazepam	TSPO	PA449283	706	0.697
NULL	F1000Prime_Rep_2013_Dec_3_5_56.nxml.txt.nlp	24381731	SENT63	11	11	4	4	thrombin	PAR-1	PA451674	2011;2149	0.697
NULL	Acta_Pharmacol_Sin_2009_Feb_5_30(2)_228-234.nxml.txt.nlp	19122672	SENT14	0	0	8	8	isoflurane	HO-1	PA450106	3162	0.697
NULL	Clin_Med_Insights_Oncol_2011_Nov_7_5_349-364.nxml.txt.nlp	22174596	SENT155	12	12	17	17	sunitinib	IFN	PA162372840	3439	0.697
NULL	Oncogene_2014_Jun_26_33(26)_3422-3431.nxml.txt.nlp	23912457	SENT192	45	45	23	23	l-glutamine	F12	PA10090	2161	0.697
NULL	Braz_J_Med_Biol_Res_2013_Sep_6_46(9)_746-751.nxml.txt.nlp	24036910	SENT140	21	21	23	23	genistein	PP1	PA165109660	5540;5464	0.697
NULL	Front_Neurosci_2014_Jun_24_8_176.nxml.txt.nlp	25009459	SENT326	2	2	6	6	ethanol	P2X4	PA448073	5025	0.697
NULL	Adv_Hematol_2011_Apr_10_2011_960137.nxml.txt.nlp	21547266	SENT0	11	11	30	30	rituximab	San	PA451261	80218	0.697
NULL	Mol_Vis_2010_Sep_2_16_1781-1790.nxml.txt.nlp	20824160	SENT101	5	5	11	11	rolipram	ZO-1	PA153906323	7082	0.697
NULL	J_Med_Case_Reports_2011_Feb_14_5_60.nxml.txt.nlp	21320326	SENT124	17	17	11	11	vincristine	CHOP	PA451879	1649	0.697
NULL	Diabetes_Metab_J_2013_Aug_14_37(4)_240-248.nxml.txt.nlp	23991401	SENT95	0	0	3	3	ezetimibe	NPC1L1	PA10816	29881	0.697
NULL	Clin_Drug_Investig_2013_Jan_27_33(1)_45-54.nxml.txt.nlp	23184666	SENT209	9	9	11	11	anagrelide	CYP1A2	PA164742986	1544	0.697
NULL	BMB_Rep_2014_Apr_47(4)_221-226.nxml.txt.nlp	24286312	SENT102	2	2	8	8	nutlin-3	p53		7157	0.697
NULL	J_Adv_Pharm_Technol_Res_2012_Oct-Dec_3(4)_202-209.nxml.txt.nlp	23378940	SENT177	11	11	0	0	aprepitant	HEC	PA164747039	10403	0.697
NULL	Br_J_Haematol_2014_Mar_13_164(1)_811-821.nxml.txt.nlp	24328678	SENT263	15	15	6	6	lenalidomide	IL8	PA162363968	3576	0.697
NULL	J_Immunol_Res_2014_May_21_2014_371087.nxml.txt.nlp	24963497	SENT317	11	11	17	17	decitabine	DAC	PA164749631	13	0.697
NULL	Diabetes_Care_2009_Apr_32(4)_531-540.nxml.txt.nlp	19336638	SENT202	17	17	6	6	thrombin	P2Y12	PA451674	64805	0.697
NULL	Med_Sci_Monit_2013_Oct_21_19_875-882.nxml.txt.nlp	24145180	SENT154	33	33	7	7	cyclophosphamide	CXCL8	PA449165	3576	0.697
NULL	Clin_Interv_Aging_2013_May_30_8_597-603.nxml.txt.nlp	23761968	SENT138	6	6	26	26	risedronate	BSAP	PA451255	5079	0.697
NULL	Oncotarget_2011_Dec_24_2(12)_896-917.nxml.txt.nlp	22203527	SENT339	25	25	11	11	metformin	p53	PA450395	7157	0.697
NULL	Cancer_Biol_Med_2013_Mar_10(1)_36-42.nxml.txt.nlp	23691443	SENT191	23	23	27	27	rituximab	PRIMA	PA451261	145270	0.697
NULL	Br_J_Pharmacol_2014_Oct_26_171(20)_4785-4796.nxml.txt.nlp	25074741	SENT20	6	6	4	4	guanfacine	NK1	PA449825	11126	0.697
NULL	Int_J_Environ_Res_Public_Health_2010_Apr_29_7(4)_1392-1431.nxml.txt.nlp	20617037	SENT775	5	5	1	1	ethanol	CRF1	PA448073	1394	0.697
NULL	Exp_Hematol_Oncol_2014_Mar_11_3_7.nxml.txt.nlp	24618035	SENT286	16	16	4	4	dasatinib	Mcl-1	PA162372878	4170	0.697
NULL	Iran_J_Neurol_2014_13(1)_33-39.nxml.txt.nlp	24800045	SENT134	6	6	12	12	gentamicin	CDP	PA449753	1523	0.697
NULL	Clin_Ophthalmol_2007_Sep_1(3)_273-284.nxml.txt.nlp	19668481	SENT188	9	9	16	16	bevacizumab	CRT	PA130232992	811	0.697
NULL	J_Cell_Mol_Med_2014_Feb_8_18(2)_197-207.nxml.txt.nlp	24400890	SENT122	5	5	43	43	ethanol	DNMT3B	PA448073	1789	0.697
NULL	AAPS_J_2012_Jan_4_14(1)_87-96.nxml.txt.nlp	22215264	SENT232	20	20	11	11	verapamil	P-gp	PA451868	5243	0.697
NULL	Aging_(Albany_NY)_2011_Dec_12_3(11)_1063-1077.nxml.txt.nlp	22170748	SENT18	7	7	12	12	metformin	AMPK	PA450395	5563	0.697
NULL	Breast_Cancer_Res_Treat_2014_Feb_23_144(2)_233-239.nxml.txt.nlp	24562824	SENT218	24	24	32	32	paclitaxel	HER2	PA450761	2064	0.697
NULL	Clin_Ophthalmol_2010_Oct_5_4_1137-1143.nxml.txt.nlp	20957061	SENT85	12	12	7	7	latanoprost	BAK	PA164774763	578	0.697
NULL	Br_J_Cancer_2009_Sep_15_101(6)_924-934.nxml.txt.nlp	19690550	SENT200	13	13	21	21	capecitabine	CRT	PA448771	811	0.697
NULL	Sensors_(Basel)_2010_Jun_21_10(6)_6195-6240.nxml.txt.nlp	22219709	SENT413	37	37	17	17	ethanol	CDC25	PA448073	5923	0.697
NULL	Int_J_Gen_Med_2012_Nov_9_5_935-942.nxml.txt.nlp	23204857	SENT81	37	37	12	12	isoflurane	AIDA	PA450106	64853	0.697
NULL	Biomed_Res_Int_2013_Jul_18_2013_909045.nxml.txt.nlp	23971048	SENT25	29	29	24	24	nimodipine	Q10	PA450633	27161	0.697
NULL	Acta_Histochem_Cytochem_2010_May_1_43(2)_61-68.nxml.txt.nlp	20514293	SENT62	8	8	0	0	hyaluronan	CD44	PA165958431	960	0.697
NULL	Cancer_Imaging_2006_Oct_31_6(Spec_No_A)_S107-S116.nxml.txt.nlp	17114062	SENT163	24	24	14	14	cetuximab	EGFR	PA10040	1956	0.697
NULL	Breast_Cancer_Res_2002_Jul_29_4(5)_202-204.nxml.txt.nlp	12223125	SENT97	23	23	4	4	tamoxifen	ATAC	PA451581	6375	0.697
NULL	Mol_Vis_2012_Oct_5_18_2454-2467.nxml.txt.nlp	23077404	SENT138	6	6	13	13	bevacizumab	VEGF-A	PA130232992	7422	0.697
NULL	Indian_J_Med_Res_2014_Feb_139(2)_205-215.nxml.txt.nlp	24718394	SENT39	18	18	8	8	lumefantrine	ACT	PA165111722	12;11332;9457;641455	0.697
NULL	Int_J_Hypertens_2012_Jun_26_2012_124758.nxml.txt.nlp	22792446	SENT251	6	6	22	22	vasopressin	AT2	PA451858	186	0.697
NULL	J_Neuroinflammation_2011_Aug_16_8_100.nxml.txt.nlp	21843370	SENT290	3	3	11	11	minocycline	GTS	PA450519	2973	0.697
NULL	Acta_Histochem_Cytochem_2013_Dec_28_46(6)_187-197.nxml.txt.nlp	24610966	SENT336	4	4	11	11	cevimeline	AQP5	PA164754754	362	0.697
NULL	Korean_Circ_J_2013_Sep_30_43(9)_581-591.nxml.txt.nlp	24174958	SENT82	16	16	4	4	s-adenosylmethionine	COMT	PA164754994	1312	0.697
NULL	Indian_J_Pharm_Sci_2008_Jan-Feb_70(1)_102-105.nxml.txt.nlp	20390092	SENT75	6	6	4	4	domperidone	DOM	PA134711056	6663	0.697
NULL	Drug_Saf_2014_Feb_19_37(4)_201-211.nxml.txt.nlp	24550106	SENT147	3	3	19	19	tacrolimus	CYP2C19	PA451578	1557	0.697
NULL	AIDS_Res_Ther_2007_Mar_13_4_6.nxml.txt.nlp	17352834	SENT142	23	23	12	12	nevirapine	CD4	PA450616	920	0.697
NULL	Exp_Ther_Med_2013_Apr_5_5(4)_1259-1263.nxml.txt.nlp	23596498	SENT95	0	0	9	9	propofol	TRPV1	PA451141	7442	0.697
NULL	Ann_Rheum_Dis_2009_Jan_5_68(6)_1051-1058.nxml.txt.nlp	18662930	SENT200	9	9	19	19	hyaluronan	NFkappaB	PA165958431	4790	0.697
NULL	Breast_Cancer_Res_2000_Jul_13_2(5)_360-366.nxml.txt.nlp	11250729	SENT25	20	20	30	30	tamoxifen	AF1	PA451581	1946	0.697
NULL	J_Hematol_Oncol_2012_Feb_14_5_3.nxml.txt.nlp	22333219	SENT3	10	10	17	17	vemurafenib	BRAF	PA165946873	673	0.697
NULL	Diabetes_Care_2012_Feb_16_35(2)_327-333.nxml.txt.nlp	22179958	SENT20	13	13	24	24	metformin	B12	PA450395	7126;4709	0.697
NULL	J_Med_Case_Reports_2011_Jan_12_5_5.nxml.txt.nlp	21226894	SENT65	14	14	9	9	doxorubicin	CHOP	PA449412	1649	0.697
NULL	EMBO_Mol_Med_2013_Jun_30_5(6)_870-890.nxml.txt.nlp	23630012	SENT443	26	26	8	8	l-glutamine	F12	PA10090	2161	0.697
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT192	21	21	9	9	cetuximab	Yes	PA10040	7525	0.697
NULL	JRSM_Cardiovasc_Dis_2012_Apr_5_1(1)_cvd_2012_012001.nxml.txt.nlp	24175062	SENT242	27	27	22	22	warfarin	CYP2C9	PA451906	1559	0.697
NULL	Arthritis_Res_Ther_2008_Oct_10_10(5)_224.nxml.txt.nlp	18947376	SENT182	0	0	26	26	2-methoxyestradiol	HIF-1	PA134967247	29072	0.697
NULL	Br_J_Haematol_2009_Nov_2_147(3)_396-410.nxml.txt.nlp	19758122	SENT20	17	17	21	21	dasatinib	CLB	PA162372878	171425	0.697
NULL	Oncotarget_2013_Oct_19_4(11)_2045-2056.nxml.txt.nlp	24185104	SENT81	7	7	4	4	cisplatin	p38	PA449014	10598;1432;7965	0.697
NULL	J_Cell_Biol_1990_Dec_1_111(6)_2885-2891.nxml.txt.nlp	1702786	SENT14	2	2	29	29	neomycin	ADP	PA450608	23038	0.697
NULL	J_Gen_Physiol_2003_Jan_121(1)_3-16.nxml.txt.nlp	12508050	SENT284	0	0	7	7	nifedipine	c-fos	PA450631	2353	0.697
NULL	J_Carcinog_2012_Oct_27_11_16.nxml.txt.nlp	23230393	SENT59	11	11	3	3	vorinostat	HER-2	PA164748224	2064	0.697
NULL	Breast_Cancer_Res_2012_Feb_14_14(1)_R30.nxml.txt.nlp	22333315	SENT167	11	11	3	3	celecoxib	CXCR3	PA448871	2833	0.697
NULL	Br_J_Cancer_2010_Oct_12_103(8)_1309-1310.nxml.txt.nlp	NULL	SENT15	13	13	27	27	bevacizumab	IFN	PA130232992	3439	0.697
NULL	J_Inflamm_(Lond)_2008_Dec_5_5_23.nxml.txt.nlp	19061493	SENT166	16	16	9	9	hemin	HO-1	PA449849	3162	0.697
NULL	Bone_Marrow_Res_2011_Mar_2_2011_924058.nxml.txt.nlp	22046572	SENT13	12	12	18	18	rituximab	CD38	PA451261	952	0.697
NULL	Onco_Targets_Ther_2014_Jul_12_7_1273-1284.nxml.txt.nlp	25050069	SENT36	34	34	9	9	trabectedin	CYP3A4	PA165958349	1576	0.697
NULL	J_Cell_Biol_1998_Jul_13_142(1)_101-115.nxml.txt.nlp	9660866	SENT137	28	28	22	22	dextran	mol	PA449261	90527	0.697
NULL	Pharmaceuticals_(Basel)_2011_May_24_4(5)_770-781.nxml.txt.nlp	NULL	SENT104	11	11	29	29	carvedilol	IL-6	PA448817	3569	0.697
NULL	F1000_Med_Rep_2009_Feb_24_1_13.nxml.txt.nlp	20948769	SENT79	33	33	27	27	chlorambucil	CHOP	PA448926	1649	0.697
NULL	Br_J_Cancer_2010_Nov_9_103(10)_1588-1596.nxml.txt.nlp	20978505	SENT172	0	0	5	5	temozolomide	TGD	PA451609	19	0.697
NULL	J_Cancer_2011_Mar_8_2_142-152.nxml.txt.nlp	21475719	SENT142	12	12	0	0	oxaliplatin	ERCC1	PA131285527	2067	0.697
NULL	Cell_Res_2010_Apr_26_20(4)_434-444.nxml.txt.nlp	20101261	SENT66	15	15	10	10	rosiglitazone	UCP1	PA451283	7350	0.697
NULL	J_Cell_Biol_2001_Oct_1_155(1)_133-144.nxml.txt.nlp	11581290	SENT196	38	38	16	16	pp2	PP2		4888	0.697
NULL	Biologics_2012_Dec_17_6_429-464.nxml.txt.nlp	23269860	SENT163	24	24	27	27	rituximab	ACR	PA451261	49	0.697
NULL	Cell_Biosci_2011_Nov_7_1_36.nxml.txt.nlp	22060137	SENT56	28	28	8	8	doxorubicin	MDR1	PA449412	5243	0.697
NULL	Daru_2011_19(2)_126-137.nxml.txt.nlp	22615649	SENT220	5	5	21	21	lamotrigine	C114	PA450164	79706	0.697
NULL	J_Biol_Chem_2013_Nov_15_288(46)_33049-33059.nxml.txt.nlp	24089524	SENT354	7	7	12	12	nicotine	GATA4	PA450626	2626	0.697
NULL	F1000Res_2013_Mar_5_2_74.nxml.txt.nlp	24358880	SENT386	10	10	7	7	capsaicin	TRPV1	PA448776	7442	0.697
NULL	Chem_Cent_J_2013_May_7_7_82.nxml.txt.nlp	23651877	SENT184	20	20	32	32	ethanol	mol	PA448073	90527	0.697
NULL	Int_J_Biol_Sci_2011_Nov_7_8(1)_15-29.nxml.txt.nlp	22211101	SENT27	31	31	18	18	gemcitabine	BTC	PA449748	685	0.697
NULL	Cancer_Manag_Res_2012_Nov_9_4_383-395.nxml.txt.nlp	23204869	SENT138	11	11	16	16	carmustine	Mcl-1	PA448810	4170	0.697
NULL	Int_J_Mol_Imaging_2012_Oct_2_2012_379807.nxml.txt.nlp	23091717	SENT230	4	4	14	14	bevacizumab	VEGF-A	PA130232992	7422	0.697
NULL	Br_J_Cancer_2010_Sep_7_103(6)_889-898.nxml.txt.nlp	20664599	SENT202	18	18	26	26	paclitaxel	AKT	PA450761	207	0.697
NULL	Crit_Care_2008_Oct_14_12(5)_227.nxml.txt.nlp	18983707	SENT6	27	27	34	34	vasopressin	EPO	PA451858	7076;8288;2056	0.697
NULL	Br_J_Cancer_2014_Apr_15_110(8)_2144-2158.nxml.txt.nlp	24667650	SENT200	0	0	3	3	diethylstilbestrol	BCAS2	PA449307	10286	0.697
NULL	Int_J_Endocrinol_2010_May_26_2010_906163.nxml.txt.nlp	20585352	SENT98	17	17	10	10	cinacalcet	PTH	PA164776671	5741	0.697
NULL	Exp_Diabetes_Res_2012_Oct_15_2012_465282.nxml.txt.nlp	23118742	SENT85	14	14	17	17	metformin	FGF21	PA450395	26291	0.697
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT210	38	38	47	47	docetaxel	B7-H1	PA449383	29126	0.697
NULL	J_Korean_Assoc_Oral_Maxillofac_Surg_2014_Dec_26_40(6)_291-296.nxml.txt.nlp	25551094	SENT125	7	7	19	19	alendronate	M-CSF	PA448082	1435	0.697
NULL	Chin_J_Cancer_2012_Feb_31(2)_51-57.nxml.txt.nlp	22257384	SENT42	27	27	13	13	valspodar	P-gp		5243	0.697
NULL	Mol_Cell_Biochem_2014_Oct_9_385(1-2)_265-275.nxml.txt.nlp	24104452	SENT149	0	0	6	6	bortezomib	U87	PA10252	677775;641648	0.697
NULL	Arthritis_Res_Ther_2007_Oct_19_9(Suppl_3)_P20.nxml.txt.nlp	NULL	SENT13	14	14	5	5	infliximab	p38	PA452639	10598;1432;7965	0.697
NULL	J_Biol_Chem_2009_Feb_20_284(8)_5186-5194.nxml.txt.nlp	19116207	SENT54	22	22	16	16	l-glutamine	CO2	PA10090	4513	0.697
NULL	Indian_J_Pharmacol_2008_Oct_40(Suppl_2)_S112-S142.nxml.txt.nlp	21593965	SENT1088	11	11	19	19	allopregnanolone	NPY	PA142320763	4852	0.697
NULL	Cancer_Cell_Int_2014_Jan_29_14_10.nxml.txt.nlp	24472145	SENT177	2	2	10	10	cisplatin	HER-2	PA449014	2064	0.697
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1542-1553.nxml.txt.nlp	21970874	SENT223	7	7	3	3	pemetrexed	EGFR	PA10810	1956	0.697
NULL	Hum_Mol_Genet_2013_Nov_15_22(22)_4616-4626.nxml.txt.nlp	23814041	SENT58	20	20	14	14	doxycycline	neuroserpin	PA449415	5274	0.697
NULL	Mol_Cancer_2010_Jun_25_9_166.nxml.txt.nlp	20579378	SENT51	15	15	11	11	gefitinib	EGFR	PA131301952	1956	0.697
NULL	Cancer_Res_Treat_2013_Dec_31_45(4)_251-262.nxml.txt.nlp	24453997	SENT99	14	14	5	5	oxaliplatin	ASS1	PA131285527	445	0.697
NULL	Nucleic_Acids_Res_2006_Jun_6_34(10)_3095-3106.nxml.txt.nlp	16757575	SENT422	7	7	31	31	tamoxifen	PS2	PA451581	5664	0.697
NULL	Crit_Care_2011_Aug_11_15(4)_R195.nxml.txt.nlp	21834973	SENT188	1	1	5	5	thrombin	PAR1	PA451674	79581;2149	0.697
NULL	Ann_Indian_Acad_Neurol_2011_Jul_14(Suppl1)_S65-S69.nxml.txt.nlp	21847332	SENT68	31	31	17	17	natalizumab	IFN	PA164747191	3439	0.697
NULL	Appl_Microbiol_Biotechnol_2014_Feb_18_98(8)_3829-3840.nxml.txt.nlp	24535257	SENT219	23	23	13	13	ethanol	CAT-1	PA448073	6541	0.697
NULL	Mol_Biol_Rep_2013_Sep_28_40(10)_5573-5585.nxml.txt.nlp	24078156	SENT58	41	41	18	18	iron	DMT1	PA450087	4891;1761	0.697
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_408-414.nxml.txt.nlp	21372831	SENT29	3	3	12	12	cyclophosphamide	CHOP	PA449165	1649	0.697
NULL	Gynecol_Oncol_Case_Rep_2013_Dec_28_8_4-6.nxml.txt.nlp	24567884	SENT83	8	8	4	4	cisplatin	NAC	PA449014	22861	0.697
NULL	J_Oncol_2012_Sep_29_2012_879623.nxml.txt.nlp	21977033	SENT175	9	9	29	29	oltipraz	NAC		22861	0.697
NULL	Virol_J_2011_May_17_8_234.nxml.txt.nlp	21575275	SENT83	18	18	10	10	ribavirin	IFN	PA451241	3439	0.697
NULL	J_Cell_Biol_2000_Feb_21_148(4)_811-824.nxml.txt.nlp	10684261	SENT261	8	8	6	6	thrombin	EGF	PA451674	1950	0.697
NULL	Breast_Cancer_Res_2001_Oct_1_3(6)_361-364.nxml.txt.nlp	11737886	SENT61	13	13	2	2	doxorubicin	p53	PA449412	7157	0.697
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2007_Dec_6_64(Pt_1)_o63.nxml.txt.nlp	21200940	SENT3	9	9	1	1	nitrile	mol	PA450636	90527	0.697
NULL	J_Vet_Med_Sci_2014_Jun_15_76(6)_813-817.nxml.txt.nlp	24531829	SENT115	15	15	20	20	artesunate	DPT	PA165111697	1805	0.697
NULL	Toxins_(Basel)_2010_Oct_26_2(11)_2490-2518.nxml.txt.nlp	22069563	SENT303	7	7	3	3	cisplatin	OCT2	PA449014	6582;5452	0.697
NULL	J_Cell_Biol_1993_May_1_121(3)_705-713.nxml.txt.nlp	8387532	SENT4	6	6	13	13	heparin	K-FGF	PA449855	2249	0.696
NULL	Acta_Pharmacol_Sin_2012_May_16_33(5)_682-690.nxml.txt.nlp	22504904	SENT126	3	3	8	8	celecoxib	IL-6	PA448871	3569	0.696
NULL	J_Hematol_Oncol_2013_Nov_5_6_83.nxml.txt.nlp	24283248	SENT74	23	23	15	15	nutlin-3	BAX		581	0.696
NULL	Br_J_Cancer_2010_Mar_2_102(5)_815-826.nxml.txt.nlp	20145614	SENT24	17	17	26	26	lapatinib	CD44	PA152241907	960	0.696
NULL	Cancers_(Basel)_2011_May_11_3(2)_2333-2357.nxml.txt.nlp	24212813	SENT106	13	13	15	15	amiodarone	ADN	PA448383	1675	0.696
NULL	Aging_(Albany_NY)_2010_Mar_17_2(3)_129-132.nxml.txt.nlp	20375467	SENT37	13	13	20	20	nadh	SIRT1	PA164755085	23411	0.696
NULL	Neuroscience_2009_Jun_30_161(2-3)_572-577.nxml.txt.nlp	19327387	SENT494	29	29	3	3	capsaicin	NAPE-PLD	PA448776	222236	0.696
NULL	J_Oncol_2010_Apr_18_2010_351908.nxml.txt.nlp	20414463	SENT71	2	2	8	8	temozolomide	HIF-1	PA451609	29072	0.696
NULL	Int_J_Alzheimers_Dis_2011_Jul_9_2011_929042.nxml.txt.nlp	21785702	SENT233	10	10	17	17	guanidine	BACE1-AS	PA164781028	100379571	0.696
NULL	Cancer_Immunol_Immunother_2012_Jul_23_61(7)_1101-1111.nxml.txt.nlp	22193989	SENT185	0	0	5	5	oxaliplatin	STAT3	PA131285527	6774	0.696
NULL	Physiol_Rep_2014_Sep_11_2(9)_e12144.nxml.txt.nlp	25214522	SENT305	6	6	1	1	cisplatin	SIRT1	PA449014	23411	0.696
NULL	Mol_Pain_2013_Jun_10_9_27.nxml.txt.nlp	23758830	SENT182	15	15	9	9	tetracaine	ASIC2a	PA451638	40	0.696
NULL	Mol_Cancer_2010_May_18_9_110.nxml.txt.nlp	20482802	SENT130	16	16	25	25	bortezomib	CHOP	PA10252	1649	0.696
NULL	Ann_Surg_Treat_Res_2014_Feb_22_86(2)_68-75.nxml.txt.nlp	24761411	SENT43	12	12	2	2	resveratrol	survivin		332	0.696
NULL	Diagn_Pathol_2013_Jul_31_8_125.nxml.txt.nlp	23902675	SENT143	4	4	12	12	sunitinib	KIT	PA162372840	3815	0.696
NULL	Biochim_Biophys_Acta_2014_Jul_1842(7)_959-970.nxml.txt.nlp	24594481	SENT812	34	34	32	32	lipase	HSL	PA450239	3991	0.696
NULL	Mol_Cancer_2013_Nov_11_12_134.nxml.txt.nlp	24215614	SENT202	0	0	7	7	trastuzumab	San	PA451743	80218	0.696
NULL	J_Ophthalmol_2012_Dec_18_2012_483034.nxml.txt.nlp	22220269	SENT154	0	0	7	7	bevacizumab	San	PA130232992	80218	0.696
NULL	Mol_Vis_2012_Jun_17_18_1609-1618.nxml.txt.nlp	22736950	SENT78	12	12	23	23	ketamine	CO2	PA450144	4513	0.696
NULL	Indian_J_Endocrinol_Metab_2012_May-Jun_16(3)_343-348.nxml.txt.nlp	22629497	SENT28	33	33	10	10	teriparatide	PTH	PA451620	5741	0.696
NULL	Cell_Death_Dis_2011_Apr_14_2(4)_e146.nxml.txt.nlp	21490678	SENT42	36	36	17	17	staurosporine	SMG1	PA165109623	23049	0.696
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT2379	8	8	0	0	diclofenac	CYP1A2	PA449293	1544	0.696
NULL	Clin_Ophthalmol_2013_Dec_31_7_39-45.nxml.txt.nlp	23308037	SENT36	24	24	31	31	bevacizumab	San	PA130232992	80218	0.696
NULL	Acta_Crystallogr_Sect_F_Struct_Biol_Cryst_Commun_2011_Aug_13_67(Pt_9)_998-1005.nxml.txt.nlp	21904040	SENT30	21	21	12	12	carbenicillin	TEM1	PA448788	57124	0.696
NULL	Pharmaceutics_2010_Sep_9_2(3)_291-299.nxml.txt.nlp	NULL	SENT58	17	17	14	14	tacrolimus	MDR2	PA451578	5244	0.696
NULL	Ann_Dermatol_2011_Sep_30_23(Suppl_1)_S53-S56.nxml.txt.nlp	22028573	SENT69	15	15	32	32	triamcinolone	LEMD3	PA451749	23592	0.696
NULL	Environ_Health_Perspect_2005_Aug_15_113(8)_1009-1014.nxml.txt.nlp	16079071	SENT11	0	0	12	12	losartan	p38	PA450268	10598;1432;7965	0.696
NULL	Breast_Cancer_Res_2011_Mar_11_13(2)_R29.nxml.txt.nlp	21396094	SENT134	31	31	9	9	fulvestrant	HRG	PA164747170	3084;3273	0.696
NULL	Ann_Thorac_Med_2012_Jan-Mar_7(1)_44-47.nxml.txt.nlp	22347351	SENT90	11	11	15	15	propranolol	CO2	PA451145	4513	0.696
NULL	Indian_J_Pharmacol_2014_Nov-Dec_46(6)_627-632.nxml.txt.nlp	25538335	SENT139	5	5	3	3	metformin	Q10	PA450395	27161	0.696
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT129	6	6	3	3	sulindac	AKT	PA451565	207	0.696
NULL	Cell_Death_Dis_2014_Jul_3_5(7)_e1313.nxml.txt.nlp	24991765	SENT223	14	14	21	21	staurosporine	parkin	PA165109623	5071	0.696
NULL	Biomed_Res_Int_2014_Feb_10_2014_305610.nxml.txt.nlp	24683545	SENT129	17	17	19	19	chlorpromazine	CPZ	PA448964	8532	0.696
NULL	Front_Physiol_2013_May_15_4_103.nxml.txt.nlp	23720630	SENT20	7	7	16	16	l-carnitine	Q10	PA450154	27161	0.696
NULL	Ann_Saudi_Med_2009_May-Jun_29(3)_219-222.nxml.txt.nlp	19448366	SENT3	19	19	2	2	melphalan	EMP	PA450354	10296	0.696
NULL	Cancer_Cell_Int_2008_Jan_4_8_1.nxml.txt.nlp	18177496	SENT9	24	24	22	22	gefitinib	c-Myc	PA131301952	4609	0.696
NULL	Clin_Exp_Gastroenterol_2012_Jul_19_5_139-150.nxml.txt.nlp	22888267	SENT125	16	16	6	6	indomethacin	I-FABP	PA449982	2169	0.696
NULL	J_Cell_Biol_1982_Oct_1_95(1)_118-126.nxml.txt.nlp	6292232	SENT2	31	31	43	43	hydrocortisone	EGF	PA449905	1950	0.696
NULL	Mol_Cancer_2010_Nov_8_9_291.nxml.txt.nlp	21059223	SENT190	14	14	24	24	paclitaxel	PARP	PA450761	142	0.696
NULL	Breast_Cancer_(Auckl)_2009_Sep_2_3_61-75.nxml.txt.nlp	19809577	SENT247	0	0	8	8	curcumin	BRCA1	PA151958596	672	0.696
NULL	Neuro_Oncol_2010_Apr_27_12(4)_389-400.nxml.txt.nlp	20308316	SENT107	0	0	6	6	chloroquine	p53	PA448948	7157	0.696
NULL	Clin_Med_Insights_Circ_Respir_Pulm_Med_2013_Nov_13_7_61-77.nxml.txt.nlp	24324354	SENT276	13	13	16	16	tobramycin	TIP	PA451704	81533;79828	0.696
NULL	Cancers_(Basel)_2010_May_26_2(2)_913-954.nxml.txt.nlp	24281100	SENT2943	25	25	8	8	paclitaxel	p53	PA450761	7157	0.696
NULL	Cells_2014_Jan_27_3(1)_53-78.nxml.txt.nlp	24709902	SENT22	13	13	19	19	trastuzumab	HER2	PA451743	2064	0.696
NULL	Front_Mol_Neurosci_2012_Nov_12_5_99.nxml.txt.nlp	23162427	SENT832	15	15	4	4	cocaine	AP-1	PA449072	2353;3727;2354;3725	0.696
NULL	Biol_Open_2014_Dec_12_4(1)_48-61.nxml.txt.nlp	25505152	SENT504	3	3	19	19	metformin	AMPK	PA450395	5563	0.696
NULL	Acta_Pharmacol_Sin_2010_Oct_13_31(10)_1243-1257.nxml.txt.nlp	20835267	SENT236	20	20	30	30	lipase	LCAT	PA450239	3931	0.696
NULL	Exp_Cell_Res_2011_Apr_15_317(7)_1028-1039.nxml.txt.nlp	21237154	SENT126	15	15	13	13	staurosporine	TRAIL	PA165109623	8743	0.696
NULL	Breast_Cancer_Res_2004_Oct_6_6(6)_269-274.nxml.txt.nlp	15535858	SENT18	0	0	20	20	letrozole	aromatase	PA450196	1588	0.696
NULL	J_Cell_Mol_Med_2014_Jan_4_18(1)_38-48.nxml.txt.nlp	24188742	SENT137	12	12	32	32	etoposide	PAX3	PA449552	5077	0.696
NULL	Oncotarget_2014_Aug_19_5(18)_8703-8715.nxml.txt.nlp	25237928	SENT42	9	9	0	0	glucose	CD44	PA449773	960	0.696
NULL	Cardiol_Res_Pract_2010_Jun_29_2010_824938.nxml.txt.nlp	20671994	SENT180	29	29	42	42	l-carnitine	B12	PA450154	7126;4709	0.696
NULL	Front_Syst_Neurosci_2014_Feb_10_8_7.nxml.txt.nlp	24574980	SENT155	6	6	26	26	isoflurane	ANOVA	PA450106	4858	0.696
NULL	Acta_Pharmacol_Sin_2012_Jan_3_33(1)_49-56.nxml.txt.nlp	22212430	SENT205	9	9	16	16	thrombin	PAR-1	PA451674	2011;2149	0.696
NULL	Iran_J_Neurol_2013_12(4)_157-165.nxml.txt.nlp	24250926	SENT208	23	23	11	11	lamotrigine	LGS	PA450164	51557	0.696
NULL	Biochimie_2013_Dec_1_95(12)_2271-2285.nxml.txt.nlp	23827856	SENT134	30	30	27	27	bevacizumab	VEGF-A	PA130232992	7422	0.696
NULL	Indian_J_Anaesth_2010_Jul-Aug_54(4)_324-326.nxml.txt.nlp	20882175	SENT78	13	13	7	7	bupivacaine	SGB	PA135057240	2719	0.696
NULL	Oncoimmunology_2013_Oct_1_2(10)_e27025.nxml.txt.nlp	24353914	SENT179	12	12	28	28	vinorelbine	CD25	PA451881	3669;3559	0.696
NULL	Acta_Pharmacol_Sin_2009_Jun_5_30(6)_859-867.nxml.txt.nlp	19498425	SENT24	5	5	22	22	carbachol	CA3	PA448784	761	0.696
NULL	J_Gastroenterol_2013_Jan_27_48(1)_22-30.nxml.txt.nlp	23104468	SENT319	15	15	3	3	ribavirin	ITPA	PA451241	3704	0.696
NULL	AIDS_Res_Ther_2008_Aug_15_5_19.nxml.txt.nlp	18702834	SENT40	10	10	35	35	maraviroc	CD4	PA164768835	920	0.696
NULL	Int_J_Mol_Sci_2013_Apr_25_14(5)_8924-8947.nxml.txt.nlp	23698756	SENT409	4	4	15	15	octreotide	HO-1	PA450678	3162	0.696
NULL	Oncol_Rep_2014_Aug_12_32(2)_469-474.nxml.txt.nlp	24926795	SENT28	6	6	0	0	cisplatin	OCT1	PA449014	5451;6580	0.696
NULL	Indian_J_Psychiatry_2011_Apr-Jun_53(2)_111-120.nxml.txt.nlp	21772642	SENT209	34	34	16	16	imipramine	CYP2C19	PA449969	1557	0.696
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT252	7	7	9	9	tacrolimus	RANKL	PA451578	8600	0.696
NULL	Nat_Commun_2013_4_3000.nxml.txt.nlp	24346612	SENT250	13	13	5	5	heparin	CO2	PA449855	4513	0.696
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_3_2012_908562.nxml.txt.nlp	23082087	SENT39	0	0	12	12	hesperidin	mol	PA449867	90527	0.696
NULL	Diabetes_Care_2010_Feb_33(2)_e20-e25.nxml.txt.nlp	20103551	SENT79	0	0	11	11	pioglitazone	adiponectin	PA450970	9370	0.696
NULL	Hum_Genomics_2009_Jan_1_3(2)_128-142.nxml.txt.nlp	19164090	SENT196	34	34	10	10	carboplatin	CD44	PA448803	960	0.696
NULL	Cell_Cycle_2012_Nov_1_11(21)_4069-4078.nxml.txt.nlp	23095523	SENT151	32	32	21	21	imatinib	ATF6	PA10804	22926	0.696
NULL	Nat_Commun_2014_Nov_19_5_5479.nxml.txt.nlp	25407222	SENT43	5	5	29	29	dextran	YTS	PA449261	8565	0.696
NULL	Cardiovasc_Ther_2009_27(4)_259-274.nxml.txt.nlp	19604248	SENT219	22	22	3	3	ticagrelor	IPA	PA165374673	3160	0.696
NULL	J_Antimicrob_Chemother_2012_Feb_17_67(2)_404-414.nxml.txt.nlp	22101217	SENT129	7	7	17	17	isoniazid	EMB	PA450112	133418	0.696
NULL	G3_(Bethesda)_2014_Feb_5_4(4)_613-622.nxml.txt.nlp	24504254	SENT104	5	5	21	21	nadh	ADP	PA164755085	23038	0.696
NULL	Mol_Cancer_2010_Nov_25_9_305.nxml.txt.nlp	21108789	SENT77	21	21	27	27	doxorubicin	PTEN	PA449412	5728	0.696
NULL	J_Hematol_Oncol_2012_Oct_15_5_65.nxml.txt.nlp	23067373	SENT47	26	26	45	45	heparin	ADAMTS13	PA449855	11093	0.696
NULL	J_Cell_Biol_1998_Jul_13_142(1)_101-115.nxml.txt.nlp	9660866	SENT137	28	28	40	40	dextran	mol	PA449261	90527	0.696
NULL	Br_J_Pharmacol_2008_Oct_18_155(4)_596-605.nxml.txt.nlp	18852694	SENT89	0	0	14	14	fenofibrate	San	PA449594	80218	0.696
NULL	Cancer_Biol_Med_2012_Jun_9(2)_141-143.nxml.txt.nlp	23691471	SENT32	20	20	12	12	vincristine	ADM	PA451879	133	0.696
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT315	6	6	3	3	metformin	CCL16	PA450395	6360	0.696
NULL	Semin_Immunopathol_2013_Jan_26_35(1)_39-52.nxml.txt.nlp	22829332	SENT197	28	28	18	18	rituximab	CHOP	PA451261	1649	0.696
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT137	6	6	8	8	adalimumab	CD36	PA10004	948	0.696
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT404	4	4	8	8	heparin	FGF1	PA449855	2246	0.696
NULL	Aging_(Albany_NY)_2009_Feb_18_1(3)_335-349.nxml.txt.nlp	20195489	SENT67	21	21	15	15	etoposide	p65	PA449552	5970	0.696
NULL	Br_J_Cancer_1988_Sep_58(3)_335-340.nxml.txt.nlp	3179186	SENT7	25	25	8	8	doxorubicin	TFP	PA449412	7034	0.696
NULL	Angiogenesis_2013_Apr_10_16(2)_373-386.nxml.txt.nlp	23143659	SENT142	33	33	28	28	vincristine	P-gp	PA451879	5243	0.696
NULL	Blood_Cancer_J_2012_Mar_9_2(3)_e60.nxml.txt.nlp	22829255	SENT123	4	4	6	6	flavopiridol	FLT3	PA452627	2322	0.696
NULL	Neural_Plast_2007_Dec_11_2007_73079.nxml.txt.nlp	NULL	SENT3499	2	2	4	4	clozapine	NOT	PA449061	4929	0.696
NULL	Anal_Bioanal_Chem_2013_Jul_23_405(23)_7337-7345.nxml.txt.nlp	23877175	SENT124	11	11	31	31	pilocarpine	CA3	PA450962	761	0.696
NULL	J_Young_Pharm_2011_Oct-Dec_3(4)_310-314.nxml.txt.nlp	22224038	SENT26	25	25	10	10	ethanol	mol	PA448073	90527	0.696
NULL	Mol_Brain_2013_May_4_6_22.nxml.txt.nlp	23641686	SENT148	19	19	1	1	memantine	GLAST	PA10364	6507	0.696
NULL	Cell_Death_Differ_2010_Nov_13_17(11)_1672-1683.nxml.txt.nlp	20706276	SENT194	31	31	24	24	l-glutamine	EGF	PA10090	1950	0.696
NULL	Biomed_Res_Int_2014_Jan_8_2014_595286.nxml.txt.nlp	24511539	SENT217	13	13	15	15	imiquimod	CO2	PA449972	4513	0.696
NULL	Mol_Cancer_2013_Mar_5_12_17.nxml.txt.nlp	23497256	SENT11	30	30	10	10	sunitinib	CXCL12	PA162372840	6387	0.696
NULL	Oncotarget_2012_Jul_10_3(6)_640-650.nxml.txt.nlp	22791660	SENT192	3	3	22	22	curcumin	MRP1	PA151958596	4437	0.696
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_39-54.nxml.txt.nlp	19305787	SENT230	22	22	8	8	ethanol	PP1	PA448073	5540;5464	0.696
NULL	Acta_Histochem_Cytochem_2006_Apr_22_39(2)_35-45.nxml.txt.nlp	17375208	SENT29	14	14	26	26	fluorescein	ZO-1	PA164746009	7082	0.696
NULL	Mol_Vis_2012_Jan_1_18_1-9.nxml.txt.nlp	22232563	SENT120	3	3	17	17	bevacizumab	HIF-1	PA130232992	29072	0.696
NULL	J_Adv_Pharm_Technol_Res_2011_Apr-Jun_2(2)_81-87.nxml.txt.nlp	22171298	SENT184	27	27	24	24	leuprolide	p53	PA450203	7157	0.696
NULL	Oncotarget_2012_Oct_20_3(10)_1236-1245.nxml.txt.nlp	23100449	SENT108	32	32	22	22	doxorubicin	NGAL	PA449412	3934	0.696
NULL	ScientificWorldJournal_2014_May_14_2014_191847.nxml.txt.nlp	24963500	SENT70	0	0	9	9	ranibizumab	San	PA164746012	80218	0.696
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT135	17	17	14	14	cisplatin	IBP	PA449014	706;50619	0.696
NULL	Pharmaceuticals_(Basel)_2011_Jan_12_4(1)_187-201.nxml.txt.nlp	NULL	SENT139	15	15	5	5	l-arginine	ANOVA	PA448478	4858	0.696
NULL	Nucleic_Acids_Res_2013_Nov_27_41(21)_9786-9799.nxml.txt.nlp	23982513	SENT229	16	16	11	11	arsenite	TIAR	PA452638	7073	0.696
NULL	Ann_Indian_Acad_Neurol_2010_Jul-Sep_13(3)_207-210.nxml.txt.nlp	21085534	SENT52	9	9	13	13	pentoxifylline	MRI	PA450864	78996	0.696
NULL	Exp_Hematol_2012_Feb_40(2)_97-106.nxml.txt.nlp	22085453	SENT100	12	12	2	2	sitagliptin	DPPIV	PA164748978	2191;1803	0.696
NULL	Oncogenesis_2012_Apr_2_1(4)_e5.nxml.txt.nlp	23552603	SENT568	33	33	6	6	celecoxib	Bcl-2	PA448871	596	0.696
NULL	EMBO_Mol_Med_2012_Jul_11_4(7)_577-593.nxml.txt.nlp	22496117	SENT145	6	6	2	2	clofazimine	PAP-1	PA164748759	6100	0.696
NULL	Europace_2014_Oct_12_16(10)_1443-1449.nxml.txt.nlp	25115168	SENT68	1	1	6	6	heparin	ACT	PA449855	12;11332;9457;641455	0.696
NULL	Ther_Clin_Risk_Manag_2006_Jun_2(2)_129-158.nxml.txt.nlp	18360588	SENT174	3	3	0	0	indinavir	CYP3A4	PA449977	1576	0.696
NULL	Oncogene_2014_Oct_9_33(41)_4941-4951.nxml.txt.nlp	24681952	SENT88	15	15	19	19	metformin	HNF4	PA450395	3172	0.696
NULL	J_Hepatol_2010_Sep_53(3-2)_519-527.nxml.txt.nlp	20579762	SENT283	3	3	15	15	collagenase	p38	PA449107	10598;1432;7965	0.696
NULL	Eur_J_Clin_Pharmacol_2013_Mar_11_69(3)_327-339.nxml.txt.nlp	22782539	SENT188	22	22	11	11	clopidogrel	ADP	PA449053	23038	0.696
NULL	Front_Endocrinol_(Lausanne)_2014_Oct_2_5_158.nxml.txt.nlp	25324831	SENT145	7	7	12	12	carrageenan	NPFFR2	PA448814	10886	0.696
NULL	J_Adv_Pharm_Technol_Res_2012_Oct-Dec_3(4)_202-209.nxml.txt.nlp	23378940	SENT177	20	20	0	0	ondansetron	HEC	PA450705	10403	0.696
NULL	Bioinform_Biol_Insights_2014_Jun_23_8_159-168.nxml.txt.nlp	25002815	SENT171	16	16	7	7	naringenin	MVD	PA151958361	4597	0.696
NULL	J_Vet_Med_Sci_2014_Aug_15_76(8)_1119-1127.nxml.txt.nlp	24829081	SENT183	8	8	20	20	trypsin	IL-8	PA451806	3576	0.696
NULL	Cancer_Immunol_Immunother_2013_Aug_27_62(10)_1637-1648.nxml.txt.nlp	23982484	SENT227	3	3	30	30	lenalidomide	IFN	PA162363968	3439	0.696
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT155	11	11	13	13	metformin	HIF-1	PA450395	29072	0.696
NULL	ScientificWorldJournal_2013_Sep_19_2013_809891.nxml.txt.nlp	24170983	SENT180	0	0	4	4	dexketoprofen	CD86	PA166049175	942	0.696
NULL	J_Cancer_2014_Jul_4_5(7)_559-571.nxml.txt.nlp	25057307	SENT229	15	15	21	21	tamoxifen	CD24	PA451581	100133941	0.696
NULL	J_Gen_Physiol_2004_Aug_124(2)_125-137.nxml.txt.nlp	15277574	SENT155	36	36	24	24	forskolin	CFTR	PA146096022	1080	0.696
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT90	23	23	30	30	tamoxifen	p27	PA451581	5715;10534	0.696
NULL	Oxid_Med_Cell_Longev_2013_Jun_16_2013_194546.nxml.txt.nlp	23844272	SENT182	21	21	31	31	glibenclamide	SUR1	PA449782	6833	0.696
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT148	14	14	9	9	glucose	p38	PA449773	10598;1432;7965	0.696
NULL	Biochim_Biophys_Acta_2014_Jun_1841(6)_827-835.nxml.txt.nlp	24603323	SENT36	34	34	43	43	lipase	PLTP	PA450239	5360	0.696
NULL	Acta_Pharmacol_Sin_2013_Sep_5_34(9)_1192-1200.nxml.txt.nlp	23685957	SENT15	2	2	30	30	curcumin	AP-2	PA151958596	7020	0.696
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT129	2	2	5	5	metformin	HIF-1	PA450395	29072	0.696
NULL	Acta_Neuropathol_Commun_2013_Sep_6_1_57.nxml.txt.nlp	24252176	SENT8	20	20	5	5	creatine	AMPK	PA164778930	5563	0.696
NULL	Cancer_Med_2013_Jun_25_2(3)_277-285.nxml.txt.nlp	23930204	SENT139	40	40	8	8	bevacizumab	PTEN	PA130232992	5728	0.696
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT373	11	11	7	7	clozapine	PRL	PA449061	5617	0.696
NULL	Mol_Cell_Proteomics_2014_Jun_2_13(6)_1495-1509.nxml.txt.nlp	24696502	SENT930	9	9	17	17	imatinib	NQO2	PA10804	4835	0.696
NULL	ScientificWorldJournal_2012_Mar_12_2012_359721.nxml.txt.nlp	22536136	SENT182	7	7	9	9	cyanocobalamin	B12	PA451892	7126;4709	0.696
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2751-2762.nxml.txt.nlp	24169358	SENT205	17	17	27	27	anastrozole	HER2	PA448432	2064	0.696
NULL	Biologics_2013_Apr_15_7_77-90.nxml.txt.nlp	23723688	SENT293	5	5	7	7	cetuximab	CRT	PA10040	811	0.696
NULL	Biologics_2009_Oct_12_3_469-474.nxml.txt.nlp	19851472	SENT98	34	34	0	0	mometasone	IFN	PA450541	3439	0.696
NULL	Aging_(Albany_NY)_2009_Mar_31_1(4)_412-424.nxml.txt.nlp	20195491	SENT140	17	17	25	25	resveratrol	TXNIP		10628	0.696
NULL	Exp_Transl_Stroke_Med_2011_Sep_12_3_8.nxml.txt.nlp	21910904	SENT209	27	27	30	30	resveratrol	SIRT1		23411	0.696
NULL	J_Korean_Med_Sci_2010_Nov_26_25(11)_1683-1687.nxml.txt.nlp	21060764	SENT56	13	13	8	8	thyroglobulin	p63	PA164754910	8626	0.696
NULL	Nat_Commun_2013_Oct_1_4_2516.nxml.txt.nlp	24084631	SENT9	11	11	25	25	hyaluronan	CCN2	PA165958431	1490	0.696
NULL	J_Hematol_Oncol_2013_Jan_15_6_5.nxml.txt.nlp	23320987	SENT123	28	28	26	26	heparin	PI-PLC	PA449855	2923	0.696
NULL	J_Gen_Physiol_1976_Jul_1_68(1)_1-11.nxml.txt.nlp	181525	SENT8	0	0	5	5	papaverine	GMP	PA164745550	22978	0.696
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT91	19	19	24	24	l-cysteine	p27	PA449173	5715;10534	0.696
NULL	Biochem_Res_Int_2012_Feb_12_2012_346972.nxml.txt.nlp	22400115	SENT237	20	20	10	10	hyaluronan	CXCL13	PA165958431	10563	0.696
NULL	Br_J_Cancer_2013_Dec_10_109(12)_2954-2958.nxml.txt.nlp	24231949	SENT7	14	14	11	11	nutlin-3	p53		7157	0.696
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1059-1066.nxml.txt.nlp	21364577	SENT59	29	29	18	18	letrozole	aromatase	PA450196	1588	0.696
NULL	Nucleic_Acids_Res_2012_Jan_9_40(1)_181-195.nxml.txt.nlp	21908405	SENT264	12	12	15	15	bleomycin	53BP1	PA448645	7158	0.696
NULL	Curr_Control_Trials_Cardiovasc_Med_2001_May_31_2(3)_129-140.nxml.txt.nlp	11806786	SENT91	26	26	1	1	abciximab	NICE-4	PA448006	9898	0.696
NULL	Curr_Neuropharmacol_2012_Mar_10(1)_12-48.nxml.txt.nlp	22942876	SENT823	21	21	13	13	fluvoxamine	GRM2	PA449690	2912	0.696
NULL	Oncologist_2010_Mar_9_15(3)_236-245.nxml.txt.nlp	20215359	SENT95	37	37	41	41	sunitinib	IFN	PA162372840	3439	0.696
NULL	J_Korean_Med_Sci_2005_Jun_30_20(3)_456-460.nxml.txt.nlp	15953869	SENT81	20	20	43	43	lipase	UPP2	PA450239	151531	0.696
NULL	Comp_Funct_Genomics_2012_May_14_2012_178525.nxml.txt.nlp	22666083	SENT187	12	12	14	14	gemcitabine	GEM	PA449748	2669	0.696
NULL	Anesth_Essays_Res_2010_Jan-Jun_4(1)_41-43.nxml.txt.nlp	NULL	SENT19	15	15	39	39	midazolam	NIBP	PA450496	83696	0.696
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Oct_24_70(Pt_11)_o1183-o1184.nxml.txt.nlp	25484819	SENT11	29	29	6	6	lamivudine	API	PA450163	5345	0.696
NULL	Mediators_Inflamm_2010_May_18_2010_359732.nxml.txt.nlp	20508722	SENT107	2	2	34	34	hemin	JNK	PA449849	5599	0.696
NULL	J_Immunother_Cancer_2014_Jul_15_2_24.nxml.txt.nlp	25089198	SENT84	0	0	28	28	sunitinib	IFN	PA162372840	3439	0.696
NULL	Curr_Pharm_Des_2011_Feb_17(6)_578-590.nxml.txt.nlp	21391908	SENT197	5	5	8	8	celecoxib	E2F1	PA448871	1869	0.696
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT109	2	2	26	26	tamoxifen	S6K1	PA451581	6198	0.696
NULL	Indian_J_Dermatol_2013_Mar-Apr_58(2)_159a.nxml.txt.nlp	23716826	SENT83	20	20	26	26	imiquimod	gamma	PA449972	9913	0.696
NULL	Clin_Epidemiol_2010_Aug_9_2_145-151.nxml.txt.nlp	20865112	SENT117	8	8	24	24	etravirine	TRIO	PA166014703	7204	0.696
NULL	Br_J_Cancer_2010_Jan_5_102(1)_80-86.nxml.txt.nlp	19920817	SENT27	15	15	17	17	bevacizumab	IFN	PA130232992	3439	0.696
NULL	Ther_Clin_Risk_Manag_2007_Jun_3(2)_333-339.nxml.txt.nlp	18360642	SENT136	7	7	17	17	droperidol	NK1	PA449422	11126	0.696
NULL	Int_J_Surg_Oncol_2012_May_17_2012_406830.nxml.txt.nlp	22675625	SENT196	20	20	23	23	capecitabine	CRT	PA448771	811	0.696
NULL	Br_J_Pharmacol_2014_Aug_17_171(15)_3651-3665.nxml.txt.nlp	24712679	SENT102	12	12	0	0	exenatide	GLP-1	PA164749238	100125288	0.696
NULL	An_Bras_Dermatol_2012_Nov-Dec_87(6)_857-861.nxml.txt.nlp	23197204	SENT92	13	13	5	5	erythromycin	PEN	PA449493	9933	0.696
NULL	J_Hematol_Oncol_2013_Jun_3_6_38.nxml.txt.nlp	23731980	SENT123	43	43	17	17	trastuzumab	HER2	PA451743	2064	0.696
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT263	7	7	11	11	resveratrol	ROS		6098	0.696
NULL	eLife_2014_May_6_3_e02482.nxml.txt.nlp	24843002	SENT215	33	33	27	27	etoposide	SETD2	PA449552	29072	0.696
NULL	EMBO_Mol_Med_2012_Apr_4(4)_298-312.nxml.txt.nlp	22331558	SENT167	7	7	15	15	etoposide	SIRT1	PA449552	23411	0.696
NULL	Pharmaceuticals_(Basel)_2014_Mar_5_7(3)_311-338.nxml.txt.nlp	24603603	SENT228	15	15	17	17	cetuximab	EGFR	PA10040	1956	0.696
NULL	Aging_(Albany_NY)_2012_Jul_22_4(7)_480-498.nxml.txt.nlp	22837425	SENT90	7	7	39	39	metformin	LKB1	PA450395	6794	0.696
NULL	J_Clin_Biochem_Nutr_2010_Mar_27_46(2)_126-134.nxml.txt.nlp	20216945	SENT64	13	13	20	20	taurine	Met	PA451590	79811	0.696
NULL	Indian_J_Psychiatry_2011_Apr-Jun_53(2)_111-120.nxml.txt.nlp	21772642	SENT209	34	34	14	14	imipramine	CYP2D6	PA449969	1565	0.696
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Mar_15_67(Pt_4)_o892.nxml.txt.nlp	21754167	SENT3	16	16	3	3	coumarin	mol	PA134521193	90527	0.696
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT299	14	14	6	6	nelfinavir	ABCC1	PA450606	4363	0.696
NULL	Mol_Vis_2011_Feb_1_17_332-340.nxml.txt.nlp	21297899	SENT15	12	12	14	14	telmisartan	DPI	PA451605	1832	0.696
NULL	J_Cell_Biol_2002_Nov_11_159(3)_465-476.nxml.txt.nlp	12427869	SENT675	24	24	28	28	neomycin	p120	PA450608	4839;1500;55695;10902	0.696
NULL	Front_Genet_2013_Aug_29_4_163.nxml.txt.nlp	24009622	SENT42	2	2	6	6	ethanol	ABCG2	PA448073	9429	0.696
NULL	Oncogene_2014_Jun_5_33(23)_3033-3042.nxml.txt.nlp	23851504	SENT104	9	9	4	4	doxycycline	AIB1	PA449415	8202	0.696
NULL	Front_Genet_2012_Nov_2_3_229.nxml.txt.nlp	23130019	SENT502	11	11	35	35	nifedipine	CYP3A	PA450631	1574	0.696
NULL	Front_Neurol_2011_Dec_26_2_83.nxml.txt.nlp	22363312	SENT622	20	20	5	5	prasugrel	P2Y12	PA154410481	64805	0.696
NULL	Case_Rep_Pathol_2014_Sep_9_2014_301780.nxml.txt.nlp	25295208	SENT27	27	27	16	16	thyroglobulin	TTF-1	PA164754910	7080	0.696
NULL	Br_J_Cancer_2010_Jan_5_102(1)_124-133.nxml.txt.nlp	19953093	SENT31	0	0	33	33	fluorescein	San	PA164746009	80218	0.696
NULL	Biomed_Eng_Online_2012_Nov_14_11_84.nxml.txt.nlp	23151049	SENT180	23	23	26	26	ibandronate	PTH	PA10270	5741	0.696
NULL	Int_J_Gen_Med_2011_Jul_20_4_539-545.nxml.txt.nlp	21845063	SENT66	1	1	4	4	miglitol	adiponectin	PA164776726	9370	0.696
NULL	Clin_Sci_(Lond)_2013_May_1_124(Pt_9)_567-578.nxml.txt.nlp	23113760	SENT288	24	24	9	9	gemcitabine	RRM2	PA449748	6241	0.696
NULL	Case_Rep_Transplant_2013_Aug_28_2013_969186.nxml.txt.nlp	24066254	SENT23	7	7	3	3	basiliximab	IL-2	PA164747126	3558	0.696
NULL	Trials_2012_Sep_8_13_160.nxml.txt.nlp	22958580	SENT47	28	28	14	14	vecuronium	MVD	PA164748865	4597	0.696
NULL	Curr_Neuropharmacol_2008_Jun_6(2)_151-163.nxml.txt.nlp	19305794	SENT146	13	13	23	23	kanamycin	TRPV1	PA450137	7442	0.696
NULL	J_Clin_Exp_Pathol_2012_May_17_Suppl_4_7327.nxml.txt.nlp	25379357	SENT195	0	0	37	37	resveratrol	PI3K		5290	0.696
NULL	Eur_J_Clin_Pharmacol_2013_Mar_11_69(3)_327-339.nxml.txt.nlp	22782539	SENT193	2	2	28	28	clopidogrel	IPA	PA449053	3160	0.696
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1059-1066.nxml.txt.nlp	21364577	SENT3	15	15	25	25	letrozole	aromatase	PA450196	1588	0.696
NULL	Front_Neurosci_2012_May_30_6_77.nxml.txt.nlp	22661925	SENT295	17	17	14	14	ethanol	HEC	PA448073	10403	0.696
NULL	Pharmaceuticals_(Basel)_2011_Jul_13_4(7)_1019-1031.nxml.txt.nlp	NULL	SENT377	14	14	1	1	echinacea	Gen	PA131550706	348654	0.696
NULL	Br_J_Cancer_2009_Mar_24_100(6)_1017.nxml.txt.nlp	19293816	SENT9	5	5	0	0	irinotecan	CYP3A4	PA450085	1576	0.696
NULL	Arthritis_Res_Ther_2013_Feb_11_15(Suppl_1)_S1.nxml.txt.nlp	23566714	SENT221	0	0	16	16	dextran	B10	PA449261	5169	0.696
NULL	Acta_Orthop_2010_Apr_6_81(2)_263-267.nxml.txt.nlp	20148646	SENT158	5	5	26	26	taurine	ATF4	PA451590	468	0.696
NULL	Mol_Cells_2014_Mar_31_37(3)_264-269.nxml.txt.nlp	24646834	SENT203	7	7	10	10	nutlin-3	Bcl-2		596	0.696
NULL	Acta_Pharmacol_Sin_2011_Jul_9_32(7)_879-887.nxml.txt.nlp	21552292	SENT109	32	32	13	13	metformin	AKT	PA450395	207	0.696
NULL	Biomed_Res_Int_2014_Jan_15_2014_859871.nxml.txt.nlp	24527460	SENT97	16	16	14	14	cetuximab	EGFR	PA10040	1956	0.696
NULL	Indian_J_Pharmacol_2014_Nov-Dec_46(6)_627-632.nxml.txt.nlp	25538335	SENT108	5	5	3	3	metformin	Q10	PA450395	27161	0.696
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT111	24	24	6	6	trastuzumab	MUC1	PA451743	4582	0.696
NULL	Diabetes_2009_Dec_31_58(12)_2851-2862.nxml.txt.nlp	19720788	SENT212	39	39	5	5	forskolin	Bcl-2	PA146096022	596	0.696
NULL	Alcohol_Res_Health_2008_31(3)_251-255.nxml.txt.nlp	23584870	SENT101	14	14	23	23	trypsin	SRM	PA451806	6723;6725	0.696
NULL	Breast_Cancer_Res_2005_Apr_12_7(4)_R570-R579.nxml.txt.nlp	15987464	SENT104	8	8	23	23	gefitinib	EGF	PA131301952	1950	0.696
NULL	Curr_Cardiol_Rev_2009_May_5(2)_87-104.nxml.txt.nlp	20436849	SENT107	0	0	7	7	carvedilol	IFN	PA448817	3439	0.696
NULL	Breast_Cancer_Res_2008_Dec_4_10(6)_R103.nxml.txt.nlp	19055788	SENT185	39	39	12	12	tamoxifen	ATAC	PA451581	6375	0.696
NULL	Exp_Ther_Med_2012_Sep_12_4(3)_475-480.nxml.txt.nlp	23181121	SENT8	28	28	19	19	rituximab	CHOP	PA451261	1649	0.696
NULL	J_Ind_Microbiol_Biotechnol_2013_Jul_30_40(10)_1153-1160.nxml.txt.nlp	23896974	SENT172	15	15	29	29	nadh	GPD2	PA164755085	2820	0.696
NULL	Ann_Hematol_2010_Sep_13_89(9)_861-871.nxml.txt.nlp	20387067	SENT212	22	22	16	16	dasatinib	CD34	PA162372878	947	0.696
NULL	Nat_Commun_2014_Jun_20_5_4122.nxml.txt.nlp	24947823	SENT389	25	25	6	6	capsaicin	TRPV1	PA448776	7442	0.696
NULL	F1000Res_2013_Feb_28_2_65.nxml.txt.nlp	24358861	SENT58	20	20	26	26	naloxone	TLR4	PA450586	7099	0.696
NULL	Core_Evid_2010_Oct_22_5_91-105.nxml.txt.nlp	21468365	SENT110	8	8	10	10	atorvastatin	CYP3A4	PA448500	1576	0.696
NULL	J_Hematol_Oncol_2011_Feb_23_4_8.nxml.txt.nlp	21345215	SENT143	6	6	24	24	bortezomib	ATF4	PA10252	468	0.695
NULL	Case_Rep_Psychiatry_2012_Oct_9_2012_642752.nxml.txt.nlp	23094178	SENT66	29	29	34	34	escitalopram	CYP2C19	PA10074	1557	0.695
NULL	Int_J_Mol_Cell_Med_2012_Winter_1(1)_30-38.nxml.txt.nlp	24551756	SENT153	7	7	20	20	iron	14-3-3	PA450087	10971	0.695
NULL	Br_J_Cancer_2012_Jan_17_106(2)_284-289.nxml.txt.nlp	22215065	SENT4	14	14	10	10	atrasentan	IFN	PA143414738	3439	0.695
NULL	Diabetes_Care_2010_Oct_13_33(10)_2250-2253.nxml.txt.nlp	20628086	SENT23	38	38	14	14	glucose	DREAM	PA449773	30818	0.695
NULL	Cancer_Inform_2007_Jan_12_3_275-284.nxml.txt.nlp	19455247	SENT248	6	6	37	37	cetuximab	EGFR	PA10040	1956	0.695
NULL	Viruses_2014_Apr_14_6(4)_1715-1758.nxml.txt.nlp	24736215	SENT132	0	0	12	12	disulfiram	AKT	PA449376	207	0.695
NULL	Crit_Care_2010_Mar_1_14(Suppl_1)_P584.nxml.txt.nlp	NULL	SENT13	7	7	36	36	estradiol	IL-10	PA449503	3586	0.695
NULL	Ann_Dermatol_2014_Feb_17_26(1)_1-10.nxml.txt.nlp	24648680	SENT55	5	5	24	24	fluorescein	San	PA164746009	80218	0.695
NULL	Indian_J_Pharm_Sci_2008_Jan-Feb_70(1)_102-105.nxml.txt.nlp	20390092	SENT40	17	17	19	19	lansoprazole	LAN	PA450180	9993	0.695
NULL	Comp_Hepatol_2004_Jan_14_3(Suppl_1)_S46.nxml.txt.nlp	14960198	SENT130	5	5	17	17	allopurinol	AAP	PA448320	5345	0.695
NULL	Breast_Cancer_Res_2000_Dec_17_2(1)_10-12.nxml.txt.nlp	11250686	SENT49	34	34	16	16	raloxifene	STAR	PA451221	6770;2984	0.695
NULL	J_Cancer_2013_Mar_15_4(3)_262-269.nxml.txt.nlp	23459716	SENT37	17	17	12	12	oxaliplatin	IFL	PA131285527	3439	0.695
NULL	Front_Neural_Circuits_2015_Jan_12_8_150.nxml.txt.nlp	25628540	SENT268	0	0	25	25	midazolam	CA1	PA450496	759	0.695
NULL	Front_Hum_Neurosci_2013_Jan_24_7_1.nxml.txt.nlp	23355817	SENT469	17	17	10	10	bromocriptine	DRD2	PA448671	1813	0.695
NULL	Indian_J_Med_Res_2014_Jul_140(1)_130-137.nxml.txt.nlp	25222788	SENT56	34	34	21	21	gentamicin	CTX	PA449753	1593	0.695
NULL	Int_J_Surg_Oncol_2012_May_17_2012_406830.nxml.txt.nlp	22675625	SENT239	18	18	13	13	bevacizumab	IFL	PA130232992	3439	0.695
NULL	Harm_Reduct_J_2010_Dec_1_7_29.nxml.txt.nlp	21122129	SENT23	10	10	7	7	buprenorphine	OST	PA448685	1650;23263	0.695
NULL	J_Invest_Dermatol_2012_Sep_19_132(9)_2198-2205.nxml.txt.nlp	22513780	SENT57	0	0	9	9	isotretinoin	IL-6	PA450128	3569	0.695
NULL	Br_J_Cancer_2003_Mar_10_88(5)_788-795.nxml.txt.nlp	12618891	SENT118	20	20	46	46	bosentan	FasL	PA10034	356	0.695
NULL	Cancer_Cell_Int_2013_Jun_17_13_61.nxml.txt.nlp	23773282	SENT242	0	0	3	3	cisplatin	DR5	PA449014	8795	0.695
NULL	Biosci_Rep_2012_Aug_1_32(Pt_4)_361-374.nxml.txt.nlp	22762204	SENT209	35	35	16	16	paclitaxel	p16INK4a	PA450761	1029	0.695
NULL	N_Am_J_Med_Sci_2013_Feb_5(2)_82-87.nxml.txt.nlp	23641367	SENT145	23	23	25	25	trimethoprim	TMP	PA451788	2012	0.695
NULL	Br_J_Haematol_2014_Jan_28_164(2)_233-244.nxml.txt.nlp	24206017	SENT186	22	22	0	0	lenalidomide	CRBN	PA162363968	51185	0.695
NULL	J_Cell_Sci_2014_May_1_127(9)_2106-2119.nxml.txt.nlp	24569881	SENT207	26	26	13	13	rolipram	SUR1	PA153906323	6833	0.695
NULL	Evid_Based_Complement_Alternat_Med_2013_Jul_8_2013_636194.nxml.txt.nlp	23935670	SENT154	44	44	10	10	lipase	PPL	PA450239	5493	0.695
NULL	Cell_Oncol_(Dordr)_2012_Jun_15_35(3)_217-227.nxml.txt.nlp	22700320	SENT195	26	26	3	3	nadh	MCT2	PA164755085	9194	0.695
NULL	Chemother_Res_Pract_2011_Feb_27_2011_175054.nxml.txt.nlp	22295203	SENT60	35	35	45	45	cisplatin	MBT	PA449014	5657	0.695
NULL	Brain_Sci_2013_Jun_19_3(2)_964-991.nxml.txt.nlp	24961433	SENT350	0	0	12	12	ethanol	Bcl-2	PA448073	596	0.695
NULL	Nucleic_Acids_Res_2012_Jul_5_40(13)_5988-6000.nxml.txt.nlp	22492511	SENT260	9	9	19	19	flavopiridol	CDK9	PA452627	1025	0.695
NULL	Mol_Cancer_2010_Oct_12_9_269.nxml.txt.nlp	20939893	SENT133	4	4	10	10	isoproterenol	STAT3	PA450121	6774	0.695
NULL	Diabetes_2013_Oct_17_62(10)_3547-3552.nxml.txt.nlp	23863812	SENT71	13	13	26	26	pravastatin	ANOVA	PA451089	4858	0.695
NULL	Diabetes_2013_Nov_18_62(11)_3909-3919.nxml.txt.nlp	23835339	SENT229	4	4	18	18	gliclazide	SUR1	PA10892	6833	0.695
NULL	Bioinformation_2012_Jan_6_8(1)_13-19.nxml.txt.nlp	22359429	SENT81	4	4	6	6	curcumin	MRP1	PA151958596	4437	0.695
NULL	Mol_Imaging_Biol_2013_Apr_11_15(2)_136-147.nxml.txt.nlp	22886728	SENT202	8	8	6	6	orlistat	ACSS1	PA164776864	84532	0.695
NULL	Trials_2014_Sep_7_15(1)_352.nxml.txt.nlp	NULL	SENT14	5	5	13	13	atorvastatin	PMI	PA448500	8834;5373	0.695
NULL	Nat_Commun_2013_Sep_17_4_2464.nxml.txt.nlp	24043118	SENT580	17	17	12	12	estradiol	FGFR2	PA449503	2263	0.695
NULL	Br_J_Cancer_2010_Jan_5_102(1)_80-86.nxml.txt.nlp	19920817	SENT78	21	21	23	23	bevacizumab	IFN	PA130232992	3439	0.695
NULL	Int_J_Mol_Sci_2014_Mar_5_15(3)_3970-3988.nxml.txt.nlp	24603537	SENT147	27	27	15	15	ethanol	mol	PA448073	90527	0.695
NULL	Ann_Hematol_2010_Sep_13_89(9)_861-871.nxml.txt.nlp	20387067	SENT154	0	0	8	8	dasatinib	CD34	PA162372878	947	0.695
NULL	Open_AIDS_J_2008_Dec_18_2_89-93.nxml.txt.nlp	19274065	SENT41	32	32	8	8	nevirapine	CD4	PA450616	920	0.695
NULL	J_Psychopharmacol_2014_Oct_28(10)_891-902.nxml.txt.nlp	25122043	SENT206	13	13	24	24	escitalopram	ANOVA	PA10074	4858	0.695
NULL	J_Cell_Biol_2000_Jul_10_150(1)_155-164.nxml.txt.nlp	10893264	SENT11	37	37	16	16	etoposide	CD95	PA449552	355	0.695
NULL	Ann_Oncol_2013_Aug_12_24(8)_1994-1999.nxml.txt.nlp	23670096	SENT34	31	31	8	8	tamoxifen	AIB1	PA451581	8202	0.695
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT199	21	21	38	38	metformin	p53	PA450395	7157	0.695
NULL	J_Biol_Chem_2009_Apr_24_284(17)_11613-11621.nxml.txt.nlp	19234302	SENT148	0	0	16	16	gentamicin	CTRL	PA449753	1506	0.695
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT11	24	24	16	16	neratinib	EGFR	PA165291472	1956	0.695
NULL	Nat_Commun_2014_Jun_19_5_4196.nxml.txt.nlp	24943270	SENT142	5	5	3	3	thrombin	PAR1	PA451674	79581;2149	0.695
NULL	Bone_2011_Jul_49(1)_133-139.nxml.txt.nlp	21497678	SENT402	6	6	21	21	risedronate	ANOVA	PA451255	4858	0.695
NULL	J_Nutr_Metab_2011_Oct_1_2011_525094.nxml.txt.nlp	21977315	SENT154	20	20	31	31	resveratrol	SIRT1		23411	0.695
NULL	Br_J_Pharmacol_2014_Sep_28_171(18)_4255-4272.nxml.txt.nlp	24846338	SENT22	23	23	9	9	duloxetine	5-HT1B	PA10066	3351	0.695
NULL	Ann_Surg_Treat_Res_2014_Feb_22_86(2)_68-75.nxml.txt.nlp	24761411	SENT15	14	14	19	19	resveratrol	survivin		332	0.695
NULL	Mol_Biol_Cell_2013_Sep_1_24(17)_2678-2688.nxml.txt.nlp	23864716	SENT134	0	0	6	6	thrombin	PAK1	PA451674	5585;5058	0.695
NULL	Mol_Pain_2014_Apr_18_10_27.nxml.txt.nlp	24742127	SENT254	43	43	34	34	sr144528	CB1		1268	0.695
NULL	Drug_Healthc_Patient_Saf_2013_Jun_10_5_133-141.nxml.txt.nlp	23788840	SENT143	12	12	19	19	heparin	PF4	PA449855	5196	0.695
NULL	Br_J_Cancer_2011_Sep_6_105(6)_807-813.nxml.txt.nlp	21847121	SENT114	7	7	21	21	pha-665752	HER3		2065	0.695
NULL	Calcif_Tissue_Int_2011_Aug_3_89(2)_91-104.nxml.txt.nlp	21637997	SENT247	5	5	7	7	teriparatide	PTH	PA451620	5741	0.695
NULL	EJC_Suppl_2013_Sep_5_11(2)_23-26.nxml.txt.nlp	NULL	SENT38	18	18	20	20	tamoxifen	aromatase	PA451581	1588	0.695
NULL	Clin_Exp_Otorhinolaryngol_2011_Jun_31_4(2)_77-82.nxml.txt.nlp	21716954	SENT39	16	16	31	31	minocycline	Bcl-2	PA450519	596	0.695
NULL	Int_J_Endocrinol_2014_Aug_11_2014_312452.nxml.txt.nlp	25183970	SENT138	6	6	3	3	liraglutide	GLP-1	PA165958364	100125288	0.695
NULL	Acta_Pharmacol_Sin_2011_Jul_13_32(7)_967-972.nxml.txt.nlp	21666702	SENT16	13	13	3	3	losartan	P-gp	PA450268	5243	0.695
NULL	Cytometry_B_Clin_Cytom_2008_Feb_28_74B(Suppl_1)_S90-S97.nxml.txt.nlp	18307249	SENT105	14	14	5	5	fluorescein	CD4	PA164746009	920	0.695
NULL	Case_Rep_Psychiatry_2012_Oct_9_2012_642752.nxml.txt.nlp	23094178	SENT66	29	29	39	39	escitalopram	CYP3A4	PA10074	1576	0.695
NULL	J_Gen_Physiol_2010_Feb_135(2)_135-147.nxml.txt.nlp	20100893	SENT52	15	15	10	10	l-glutamine	FBS	PA10090	64319;26269	0.695
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT846	45	45	38	38	resveratrol	IL-6		3569	0.695
NULL	Mol_Cancer_2010_Aug_20_9_220.nxml.txt.nlp	20727180	SENT144	16	16	22	22	nicotine	p53	PA450626	7157	0.695
NULL	Behav_Neurosci_2014_Aug_16_128(4)_504-522.nxml.txt.nlp	24933661	SENT800	15	15	19	19	physostigmine	CA3	PA450957	761	0.695
NULL	Br_J_Haematol_2009_Nov_2_147(3)_396-410.nxml.txt.nlp	19758122	SENT28	0	0	13	13	dasatinib	p53	PA162372878	7157	0.695
NULL	Acta_Diabetol_2011_Mar_21_48(1)_71-77.nxml.txt.nlp	20963449	SENT10	1	1	11	11	miglitol	PPG	PA164776726	5552	0.695
NULL	Biomed_Res_Int_2013_May_22_2013_430791.nxml.txt.nlp	23762845	SENT198	6	6	0	0	fasudil	SDH	PA165946121	1757;10993	0.695
NULL	J_Mol_Signal_2009_Apr_28_4_2.nxml.txt.nlp	19400946	SENT13	5	5	14	14	genistein	JNK	PA165109660	5599	0.695
NULL	Acta_Pharmacol_Sin_2011_Sep_5_32(9)_1128-1137.nxml.txt.nlp	21892192	SENT271	2	2	9	9	hydroxyzine	HERG	PA449943	3757	0.695
NULL	Clin_Pract_2014_Aug_21_4(2)_656.nxml.txt.nlp	25332764	SENT29	29	29	20	20	ethambutol	AKT	PA164784021	207	0.695
NULL	Nat_Commun_2013_Sep_3_4_2394.nxml.txt.nlp	23999152	SENT73	4	4	28	28	dextran	BDNF	PA449261	627	0.695
NULL	Clin_Interv_Aging_2013_Sep_27_8_1313-1321.nxml.txt.nlp	24101867	SENT141	31	31	11	11	alfacalcidol	BSAP	PA164746469	5079	0.695
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT192	14	14	30	30	pertuzumab	Yes		7525	0.695
NULL	Iran_J_Pharm_Res_2013_Summer_12(3)_457-469.nxml.txt.nlp	24250652	SENT211	5	5	13	13	indomethacin	spatial	PA449982	219793	0.695
NULL	Angiogenesis_2012_Jun_2_15(2)_275-286.nxml.txt.nlp	22382585	SENT3	12	12	6	6	celecoxib	CTX	PA448871	1593	0.695
NULL	Oncotarget_2014_Oct_23_5(22)_11154-11167.nxml.txt.nlp	25525888	SENT180	34	34	14	14	sunitinib	VEGFR	PA162372840	3791	0.695
NULL	Anal_Bioanal_Chem_2014_Jan_23_406(15)_3667-3680.nxml.txt.nlp	24452745	SENT60	12	12	14	14	ketoprofen	KET	PA450149	8626	0.695
NULL	Alcohol_Res_2012_34(3)_367-374.nxml.txt.nlp	23134054	SENT49	19	19	12	12	ethanol	MPDZ	PA448073	8777;84708	0.695
NULL	Biomed_Res_Int_2014_Apr_10_2014_615363.nxml.txt.nlp	24818147	SENT134	16	16	11	11	thrombin	ADP	PA451674	23038	0.695
NULL	Front_Oncol_2013_Aug_26_3_214.nxml.txt.nlp	23986881	SENT173	17	17	20	20	rituximab	CHOP	PA451261	1649	0.695
NULL	Int_J_Mol_Med_2015_Jan_29_35(1)_59-71.nxml.txt.nlp	25355277	SENT82	5	5	19	19	mannitol	DNMT1	PA450320	1786	0.695
NULL	Front_Genet_2013_Aug_30_4_166.nxml.txt.nlp	24009623	SENT579	0	0	16	16	sirolimus	MDR1	PA451365	5243	0.695
NULL	J_Nat_Sci_Biol_Med_2012_Jul-Dec_3(2)_189-191.nxml.txt.nlp	23225984	SENT74	16	16	21	21	vincristine	CHOP	PA451879	1649	0.695
NULL	BMJ_Open_2013_Oct_14_3(10)_e003912.nxml.txt.nlp	24127058	SENT40	31	31	15	15	linezolid	HAP	PA450233	5915;10313	0.695
NULL	Antibiotics_(Basel)_2014_Jul_1_3(3)_285-316.nxml.txt.nlp	25364574	SENT284	13	13	5	5	imipenem	IMP-1	PA449968	10642	0.695
NULL	Mol_Cancer_2008_Mar_6_7_24.nxml.txt.nlp	18325101	SENT38	22	22	35	35	cisplatin	BRCA1	PA449014	672	0.695
NULL	Nucleic_Acids_Res_2005_Jun_9_33(10)_3323-3330.nxml.txt.nlp	15947132	SENT46	0	0	5	5	cisplatin	MSH2	PA449014	4436	0.695
NULL	Clin_Pharmacol_2012_Feb_20_4_13-20.nxml.txt.nlp	22427735	SENT98	10	10	14	14	clopidogrel	LTA	PA449053	4049	0.695
NULL	Cell_Death_Dis_2012_Jun_21_3(6)_e330.nxml.txt.nlp	22717585	SENT293	0	0	21	21	simvastatin	PERK	PA451363	9451	0.695
NULL	Front_Oncol_2013_Oct_29_3_269.nxml.txt.nlp	24195060	SENT120	24	24	5	5	paclitaxel	THBS1	PA450761	7057	0.695
NULL	Cancers_(Basel)_2012_May_29_4(2)_531-548.nxml.txt.nlp	24213323	SENT117	2	2	14	14	hyaluronan	POSTN	PA165958431	10631	0.695
NULL	J_Cell_Biol_1984_Feb_1_98(2)_748-760.nxml.txt.nlp	6229546	SENT8	3	3	19	19	thrombin	PF4	PA451674	5196	0.695
NULL	Biomed_Res_Int_2013_Nov_7_2013_451349.nxml.txt.nlp	24307998	SENT230	7	7	14	14	coumarin	CX3CR1	PA134521193	1524	0.695
NULL	AIDS_Res_Ther_2013_May_1_10_10.nxml.txt.nlp	23634877	SENT156	12	12	3	3	lovastatin	CCL3	PA450272	6348	0.695
NULL	Front_Neuroengineering_2009_Jun_18_2_9.nxml.txt.nlp	19562090	SENT71	23	23	6	6	paraformaldehyde	F12	PA450790	2161	0.695
NULL	Front_Genet_2014_Oct_31_5_379.nxml.txt.nlp	25400658	SENT321	0	0	15	15	estradiol	H19	PA449503	283120	0.695
NULL	Indian_J_Endocrinol_Metab_2011_Oct_15(Suppl4)_S281-S288.nxml.txt.nlp	22145130	SENT143	6	6	8	8	vasopressin	AVP	PA451858	114548;551	0.695
NULL	FEBS_Open_Bio_2012_Jul_20_2_179-186.nxml.txt.nlp	23650597	SENT271	37	37	46	46	imiquimod	MxA	PA449972	4599	0.695
NULL	J_Occup_Med_Toxicol_2008_Feb_27_3(Suppl_1)_S6.nxml.txt.nlp	18315837	SENT93	5	5	9	9	montelukast	IL-5	PA450546	3567	0.695
NULL	Oncol_Rep_2014_Aug_12_32(2)_469-474.nxml.txt.nlp	24926795	SENT28	8	8	0	0	oxaliplatin	OCT1	PA131285527	5451;6580	0.695
NULL	Clinics_(Sao_Paulo)_2014_Jun_69(6)_438-446.nxml.txt.nlp	24964310	SENT65	0	0	2	2	denosumab	RANKL	PA166048634	8600	0.695
NULL	Lancet_2011_Aug_13_378(9791)_595-605.nxml.txt.nlp	21784508	SENT272	23	23	0	0	risedronate	P14	PA451255	11102;;6280;56259	0.695
NULL	Breast_Cancer_Res_2007_Jul_5_9(4)_R41.nxml.txt.nlp	17612393	SENT182	21	21	10	10	celecoxib	Bcl-2	PA448871	596	0.695
NULL	Br_J_Cancer_2011_Aug_23_105(5)_658-665.nxml.txt.nlp	21829201	SENT56	35	35	39	39	cisplatin	DCX	PA449014	1641	0.695
NULL	Diabetes_2009_Feb_58(2)_422-432.nxml.txt.nlp	19033399	SENT152	5	5	12	12	carbachol	PERK	PA448784	9451	0.695
NULL	Exp_Ther_Med_2013_Dec_15_6(6)_1565-1569.nxml.txt.nlp	24255692	SENT76	4	4	9	9	atorvastatin	adiponectin	PA448500	9370	0.695
NULL	Mol_Cancer_2014_Jan_13_13_7.nxml.txt.nlp	24418169	SENT239	0	0	8	8	sorafenib	SHP-1	PA7000	5777	0.695
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT154	45	45	29	29	vinorelbine	MVP	PA451881	9961	0.695
NULL	Br_J_Pharmacol_2011_Jul_163(6)_1263-1275.nxml.txt.nlp	21391977	SENT227	29	29	14	14	ketoconazole	CYP3A4	PA450146	1576	0.695
NULL	Neuro_Oncol_2010_Apr_27_12(4)_389-400.nxml.txt.nlp	20308316	SENT173	12	12	4	4	chloroquine	p53	PA448948	7157	0.695
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_May_23_68(Pt_6)_o1860.nxml.txt.nlp	22719625	SENT72	19	19	9	9	ethanol	mol	PA448073	90527	0.695
NULL	Biomed_Res_Int_2014_Jun_4_2014_105214.nxml.txt.nlp	24991534	SENT24	15	15	20	20	carvedilol	STZ	PA448817	6484	0.695
NULL	J_Gastroenterol_2014_Dec_24_49(12)_1536-1547.nxml.txt.nlp	24366288	SENT117	31	31	40	40	rabeprazole	CYP2C19	PA451216	1557	0.695
NULL	Cancer_Med_2013_Jun_23_2(3)_296-304.nxml.txt.nlp	23930206	SENT200	9	9	14	14	erlotinib	EGFR	PA134687924	1956	0.695
NULL	Environ_Health_Perspect_2010_Dec_12_118(12)_1707-1713.nxml.txt.nlp	20705543	SENT141	25	25	3	3	bleomycin	XRCC1	PA448645	7515	0.695
NULL	Cancer_Cell_2007_Dec_11_12(6)_514-527.nxml.txt.nlp	18068629	SENT81	9	9	7	7	paclitaxel	TGFBI	PA450761	7045	0.695
NULL	Open_Virol_J_2014_Mar_7_8_1-8.nxml.txt.nlp	24799968	SENT101	25	25	28	28	emtricitabine	PKR	PA10069	5610	0.695
NULL	Ann_Surg_Oncol_2007_Apr_26_14(4)_1499-1506.nxml.txt.nlp	17253101	SENT240	31	31	28	28	melphalan	gamma	PA450354	9913	0.695
NULL	Clin_Psychopharmacol_Neurosci_2014_Dec_26_12(3)_180-188.nxml.txt.nlp	25598820	SENT41	29	29	7	7	minocycline	Bcl-2	PA450519	596	0.695
NULL	BMB_Rep_2013_Jan_46(1)_59-64.nxml.txt.nlp	23351386	SENT32	11	11	14	14	auranofin	STAT3	PA448510	6774	0.695
NULL	EMBO_J_2009_Oct_7_28(19)_3015-3026.nxml.txt.nlp	19713938	SENT178	28	28	13	13	l-glutamine	F12	PA10090	2161	0.695
NULL	J_Cell_Biol_2000_Dec_25_151(7)_1381-1390.nxml.txt.nlp	11134068	SENT41	35	35	28	28	neomycin	53BP1	PA450608	7158	0.695
NULL	J_Biol_2003_Sep_24_2(4)_28.nxml.txt.nlp	14511394	SENT118	17	17	4	4	phenformin	LKB1	PA1000	6794	0.695
NULL	Diabetes_Care_2013_Jul_12_36(7)_2015-2019.nxml.txt.nlp	23340883	SENT54	23	23	13	13	glucose	SII	PA449773	6917	0.695
NULL	Korean_J_Anesthesiol_2013_Jan_21_64(1)_47-53.nxml.txt.nlp	23372886	SENT122	12	12	24	24	bupivacaine	PTG	PA135057240	5507	0.695
NULL	Theranostics_2014_Aug_15_4(11)_1072-1084.nxml.txt.nlp	25250092	SENT190	16	16	12	12	trastuzumab	EGFR	PA451743	1956	0.695
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT166	8	8	31	31	pp2	PP2		4888	0.695
NULL	Mol_Biol_Cell_2012_Sep_1_23(17)_3473-3484.nxml.txt.nlp	22787275	SENT169	35	35	27	27	doxorubicin	ABCC1	PA449412	4363	0.695
NULL	Drug_Des_Devel_Ther_2014_Sep_23_8_1527-1538.nxml.txt.nlp	25284985	SENT184	36	36	34	34	celecoxib	IFN	PA448871	3439	0.695
NULL	Breast_Cancer_Res_2010_Oct_22_12(Suppl_2)_S1.nxml.txt.nlp	21050422	SENT109	13	13	25	25	trastuzumab	DM1	PA451743	338023;1760;28509	0.695
NULL	Case_Rep_Hematol_2012_Oct_2_2012_620967.nxml.txt.nlp	23082258	SENT56	10	10	37	37	ponatinib	MPN	PA165980594	83886	0.695
NULL	Oncotarget_2013_Apr_16_4(5)_677-690.nxml.txt.nlp	23633472	SENT98	11	11	5	5	doxorubicin	XIAP	PA449412	331	0.695
NULL	Biochimie_2014_Jun_101(100)_67-74.nxml.txt.nlp	24394625	SENT67	23	23	34	34	l-cystine	CO2	PA449176	4513	0.695
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_P64.nxml.txt.nlp	NULL	SENT16	42	42	30	30	ceftriaxone	PPL	PA448866	5493	0.695
NULL	Anal_Bioanal_Chem_2012_Feb_16_402(4)_1611-1623.nxml.txt.nlp	22173207	SENT209	14	14	0	0	oseltamivir	SRM	PA450721	6723;6725	0.695
NULL	Ann_Med_Health_Sci_Res_2014_Mar-Apr_4(Suppl_1)_S43-S44.nxml.txt.nlp	25031906	SENT49	14	14	33	33	tetracycline	B12	PA451640	7126;4709	0.695
NULL	Oxid_Med_Cell_Longev_2012_Aug_9_2012_680304.nxml.txt.nlp	22928083	SENT149	5	5	27	27	ethanol	CLS	PA448073	1210	0.695
NULL	Front_Oncol_2014_Apr_28_4_90.nxml.txt.nlp	24809021	SENT86	4	4	15	15	phenol	U87	PA450913	677775;641648	0.695
NULL	Ann_Rheum_Dis_2008_Nov_14_67(11)_1516-1523.nxml.txt.nlp	18625622	SENT160	28	28	0	0	tocilizumab	TNF	PA165292659	7124	0.695
NULL	Clinics_(Sao_Paulo)_2012_Jan_67(1)_79-82.nxml.txt.nlp	22249485	SENT12	12	12	35	35	vasopressin	AVPR2	PA451858	554	0.695
NULL	J_Immunol_Res_2014_Jul_16_2014_696812.nxml.txt.nlp	25133198	SENT280	19	19	3	3	rifaximin	CTR	PA164752443	799	0.695
NULL	BMJ_2009_Jul_14_339_b2538.nxml.txt.nlp	19602530	SENT9	7	7	2	2	celecoxib	COX	PA448871	1351	0.695
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Nov_4_9_31.nxml.txt.nlp	21050425	SENT90	26	26	32	32	ciprofloxacin	Gen	PA449009	348654	0.695
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT33	4	4	21	21	resveratrol	IL-6		3569	0.695
NULL	Case_Rep_Oncol_Med_2012_Sep_11_2012_726424.nxml.txt.nlp	22997596	SENT13	17	17	15	15	rituximab	CHOP	PA451261	1649	0.695
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_13_2014_478653.nxml.txt.nlp	25477992	SENT573	18	18	9	9	gefitinib	p38	PA131301952	10598;1432;7965	0.695
NULL	Mol_Cancer_2010_May_18_9_110.nxml.txt.nlp	20482802	SENT105	32	32	9	9	cisplatin	MDR1	PA449014	5243	0.695
NULL	Neurobiol_Aging_2012_Mar_33(3)_603-616_e3.nxml.txt.nlp	20471138	SENT104	23	23	13	13	urokinase	CD68	PA451836	968	0.695
NULL	Osteoporos_Int_2012_Jan_28_23(1)_213-221.nxml.txt.nlp	21953472	SENT31	16	16	39	39	risedronate	PTH	PA451255	5741	0.695
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT219	20	20	14	14	atorvastatin	OPG	PA448500	690	0.695
NULL	Cell_Death_Dis_2013_Jul_11_4(7)_e719.nxml.txt.nlp	23846221	SENT56	7	7	16	16	cisplatin	TRAIL	PA449014	8743	0.695
NULL	Biomed_Res_Int_2014_May_28_2014_203601.nxml.txt.nlp	24991539	SENT321	7	7	15	15	bevacizumab	VEGF-A	PA130232992	7422	0.695
NULL	Aging_(Albany_NY)_2009_Jun_3_1(6)_515-528.nxml.txt.nlp	20157535	SENT193	1	1	30	30	resveratrol	San		80218	0.695
NULL	Bioinform_Biol_Insights_2014_Apr_16_8_83-91.nxml.txt.nlp	24812497	SENT99	24	24	27	27	vanillin	FBA	PA451852	26273	0.695
NULL	Front_Oncol_2014_Sep_16_4_238.nxml.txt.nlp	25279350	SENT11	10	10	6	6	erlotinib	EGFR	PA134687924	1956	0.695
NULL	Clin_Pharmacokinet_2014_Jul_24_53(1)_73-87.nxml.txt.nlp	23881596	SENT256	36	36	28	28	cyclosporine	OATP1B3	PA449167	28234	0.695
NULL	Mol_Biol_Rep_2013_May_16_40(9)_5315-5326.nxml.txt.nlp	23677714	SENT292	2	2	5	5	gefitinib	EGF	PA131301952	1950	0.695
NULL	Br_J_Cancer_1998_Nov_78(10)_1361-1367.nxml.txt.nlp	9823980	SENT15	22	22	12	12	dextromethorphan	CYP2D6	PA449273	1565	0.695
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT191	4	4	14	14	curcumin	p53	PA151958596	7157	0.695
NULL	Cardiovasc_Ther_2009_27(4)_259-274.nxml.txt.nlp	19604248	SENT156	27	27	3	3	clopidogrel	IPA	PA449053	3160	0.695
NULL	Oncotarget_2013_Dec_2_4(12)_2523-2531.nxml.txt.nlp	24344114	SENT44	28	28	9	9	paraformaldehyde	RP53	PA450790	145226	0.695
NULL	J_Immunother_Cancer_2013_May_29_1_4.nxml.txt.nlp	NULL	SENT279	28	28	4	4	imatinib	NKp30	PA10804	259197	0.695
NULL	Biologics_2009_Oct_12_3_469-474.nxml.txt.nlp	19851472	SENT103	31	31	0	0	desloratadine	IFN	PA164776964	3439	0.695
NULL	Eur_J_Med_Res_2010_Feb_26_15(2)_59-65.nxml.txt.nlp	20452885	SENT57	9	9	21	21	thrombin	ADP	PA451674	23038	0.695
NULL	Oncotarget_2014_Oct_21_5(22)_11252-11268.nxml.txt.nlp	25361004	SENT11	24	24	2	2	metformin	CLIC1	PA450395	1192	0.695
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT110	13	13	17	17	nifedipine	CYP2C8	PA450631	1558	0.695
NULL	Cancer_Metastasis_Rev_2010_Dec_10_29(4)_581-594.nxml.txt.nlp	20830503	SENT167	31	31	15	15	tamoxifen	ARNO	PA451581	9266	0.695
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Dec_19_66(Pt_1)_o194-o195.nxml.txt.nlp	21580078	SENT82	46	46	14	14	ethanol	mol	PA448073	90527	0.695
NULL	Oncotarget_2014_Aug_19_5(18)_8737-8749.nxml.txt.nlp	25228590	SENT83	22	22	19	19	crizotinib	AKT	PA165946122	207	0.695
NULL	Nat_Neurosci_2013_Dec_10_16(12)_1794-1801.nxml.txt.nlp	24212673	SENT78	18	18	12	12	betaine	SLC6A12	PA448603	6539	0.695
NULL	Amino_Acids_2012_Jun_3_42(6)_2111-2119.nxml.txt.nlp	21638020	SENT0	11	11	30	30	l-arginine	VEGFA	PA448478	7422	0.695
NULL	Amino_Acids_2012_Aug_29_43(2)_617-627.nxml.txt.nlp	22038179	SENT14	5	5	7	7	vasopressin	AVP	PA451858	114548;551	0.695
NULL	Clin_Ophthalmol_2008_Sep_2(3)_657-660.nxml.txt.nlp	19668770	SENT20	0	0	9	9	bevacizumab	San	PA130232992	80218	0.695
NULL	Front_Neurosci_2012_May_30_6_77.nxml.txt.nlp	22661925	SENT156	11	11	0	0	ethanol	DCX	PA448073	1641	0.695
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT426	18	18	3	3	irinotecan	KRAS	PA450085	3845	0.695
NULL	Int_J_Gen_Med_2011_Jun_7_4_425-442.nxml.txt.nlp	21731894	SENT420	7	7	21	21	methylphenidate	Gen	PA450464	348654	0.695
NULL	Evid_Based_Complement_Alternat_Med_2012_Dec_6_2012_164219.nxml.txt.nlp	23304193	SENT146	5	5	8	8	sitagliptin	GLP-1	PA164748978	100125288	0.695
NULL	J_Anaesthesiol_Clin_Pharmacol_2011_Oct-Dec_27(4)_435-437.nxml.txt.nlp	22096272	SENT62	12	12	4	4	isoflurane	REL	PA450106	5966	0.695
NULL	Oncotarget_2014_Aug_4_5(17)_7760-7775.nxml.txt.nlp	25226615	SENT224	7	7	9	9	cisplatin	DDP	PA449014	1678	0.695
NULL	Daru_2012_Oct_30_20(1)_69.nxml.txt.nlp	23351548	SENT154	12	12	43	43	coumarin	JNK	PA134521193	5599	0.695
NULL	Stroke_Res_Treat_2009_Dec_20_2010_386389.nxml.txt.nlp	20700422	SENT217	8	8	11	11	pioglitazone	NAC	PA450970	22861	0.695
NULL	Oncotarget_2011_Nov_30_2(11)_874-885.nxml.txt.nlp	22141136	SENT2	6	6	3	3	imatinib	AXL	PA10804	558	0.695
NULL	EMBO_J_2009_Apr_8_28(7)_854-865.nxml.txt.nlp	19214185	SENT293	39	39	31	31	cisplatin	SSRP1	PA449014	6749	0.695
NULL	Clin_Ophthalmol_2008_Dec_2(4)_821-828.nxml.txt.nlp	19668436	SENT142	15	15	25	25	nilvadipine	ERG	PA165958385	2078	0.695
NULL	Clin_Med_Insights_Oncol_2011_Sep_21_5_315-323.nxml.txt.nlp	22084620	SENT126	23	23	25	25	gemcitabine	Bcl-2	PA449748	596	0.695
NULL	Drugs_2014_Apr_17_74(6)_659-674.nxml.txt.nlp	24740824	SENT430	21	21	13	13	daclizumab	CD56	PA164764446	4684	0.695
NULL	J_Pain_Res_2014_Sep_11_7_547-554.nxml.txt.nlp	25246806	SENT131	0	0	14	14	capsaicin	TRPV1	PA448776	7442	0.695
NULL	BMB_Rep_2013_Nov_46(11)_544-549.nxml.txt.nlp	24152910	SENT61	23	23	8	8	thrombin	HMGB1	PA451674	3146	0.695
NULL	Int_J_Mol_Sci_2013_Apr_8_14(4)_7542-7570.nxml.txt.nlp	23567270	SENT177	23	23	30	30	ebselen	PGIS	PA161660841	5740	0.695
NULL	Braz_J_Med_Biol_Res_2013_Aug_13_46(8)_650-658.nxml.txt.nlp	23969971	SENT13	9	9	44	44	cisplatin	STAT3	PA449014	6774	0.695
NULL	J_Immunother_Cancer_2014_Jan_27_2_2.nxml.txt.nlp	24829759	SENT67	18	18	14	14	sorafenib	IL-21	PA7000	59067;50616;27189	0.695
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT192	21	21	47	47	cetuximab	Yes	PA10040	7525	0.695
NULL	Curr_Neuropharmacol_2007_Dec_5(4)_232-243.nxml.txt.nlp	19305740	SENT116	24	24	14	14	indomethacin	COX	PA449982	1351	0.695
NULL	Biomed_Res_Int_2013_May_16_2013_389672.nxml.txt.nlp	23762842	SENT3	26	26	9	9	imatinib	FDG	PA10804	23583	0.695
NULL	Br_J_Dermatol_2014_Feb_18_170(1)_342-351.nxml.txt.nlp	24547721	SENT82	38	38	11	11	lansoprazole	DIF	PA450180	7124	0.695
NULL	J_Cell_Mol_Med_2014_Nov_12_18(11)_2135-2146.nxml.txt.nlp	25216213	SENT130	31	31	13	13	isoproterenol	AKAP18	PA450121	9465	0.695
NULL	Indian_J_Psychiatry_2009_Jan_51(Suppl1)_S44-S51.nxml.txt.nlp	21416016	SENT237	14	14	3	3	nimodipine	CDP	PA450633	1523	0.695
NULL	Clin_Ophthalmol_2008_Sep_2(3)_613-621.nxml.txt.nlp	19668762	SENT33	3	3	7	7	travoprost	BAK	PA164781371	578	0.695
NULL	J_Headache_Pain_2009_Apr_27_10(2)_105-110.nxml.txt.nlp	19172228	SENT3	41	41	15	15	capsaicin	c-fos	PA448776	2353	0.695
NULL	Adipocyte_2014_Jul_1_3(3)_190-196.nxml.txt.nlp	25068085	SENT13	29	29	37	37	lipase	TWIST1	PA450239	7291	0.695
NULL	Arthritis_Res_Ther_2013_Dec_3_15(6)_R205.nxml.txt.nlp	24295447	SENT131	0	0	2	2	methotrexate	RANKL	PA450428	8600	0.695
NULL	Mol_Cancer_2010_Aug_23_9_222.nxml.txt.nlp	20731837	SENT232	16	16	3	3	paraformaldehyde	CO2	PA450790	4513	0.695
NULL	J_Clin_Biochem_Nutr_2008_May_29_42(3)_197-203.nxml.txt.nlp	18545641	SENT44	3	3	5	5	curcumin	HO-1	PA151958596	3162	0.695
NULL	Bioconjug_Chem_2013_Apr_17_24(4)_712-723.nxml.txt.nlp	23488616	SENT228	23	23	34	34	indomethacin	COX	PA449982	1351	0.694
NULL	Indian_J_Nephrol_2013_Sep-Oct_23(5)_332-337.nxml.txt.nlp	24049267	SENT104	3	3	28	28	iron	CAD	PA450087	1677;790	0.694
NULL	Cell_Death_Dis_2013_Jul_18_4(7)_e732.nxml.txt.nlp	23868065	SENT10	7	7	18	18	glucosamine	HBP	PA164747613	3069;50865;7884;566	0.694
NULL	J_Korean_Med_Sci_2014_Jan_26_29(1)_53-60.nxml.txt.nlp	24431906	SENT31	7	7	21	21	rituximab	CHOP	PA451261	1649	0.694
NULL	Oncotarget_2014_Jun_8_5(17)_7446-7457.nxml.txt.nlp	25277184	SENT43	18	18	11	11	nutlin-3	MDM2		4193	0.694
NULL	J_Biomed_Sci_2013_May_20_20(1)_30.nxml.txt.nlp	23687991	SENT218	19	19	17	17	ethanol	PGD2	PA448073	27306	0.694
NULL	J_Cell_Biol_1997_Jun_30_137(7)_1483-1493.nxml.txt.nlp	9199165	SENT79	19	19	25	25	ampicillin	BiP	PA448419	3309	0.694
NULL	Eur_J_Clin_Pharmacol_2014_Oct_8_70(1)_37-45.nxml.txt.nlp	24100471	SENT200	16	16	12	12	pioglitazone	CYP3A4	PA450970	1576	0.694
NULL	J_Cell_Biol_1997_Mar_10_136(5)_995-1005.nxml.txt.nlp	9060465	SENT46	10	10	2	2	dibucaine	CPZ	PA449286	8532	0.694
NULL	J_Breast_Cancer_2013_Jun_28_16(2)_164-170.nxml.txt.nlp	23843848	SENT55	14	14	33	33	doxorubicin	p53	PA449412	7157	0.694
NULL	Aging_(Albany_NY)_2010_Sep_18_2(9)_535-537.nxml.txt.nlp	20876940	SENT16	6	6	23	23	doxorubicin	CDKN1A	PA449412	1026	0.694
NULL	Leukemia_2013_Apr_14_27(4)_803-812.nxml.txt.nlp	23238589	SENT37	29	29	4	4	imatinib	IFN	PA10804	3439	0.694
NULL	Diabetes_Care_2013_Mar_13_36(3)_683-689.nxml.txt.nlp	23069838	SENT217	24	24	11	11	glimepiride	GLP-1	PA449761	100125288	0.694
NULL	J_Korean_Med_Sci_2006_Jun_21_21(3)_418-424.nxml.txt.nlp	16778382	SENT162	0	0	2	2	hemin	HO-1	PA449849	3162	0.694
NULL	Br_J_Cancer_2011_Oct_25_105(9)_1331-1337.nxml.txt.nlp	21970881	SENT209	32	32	7	7	olmesartan	CD34	PA164742950	947	0.694
NULL	Front_Physiol_2013_May_15_4_103.nxml.txt.nlp	23720630	SENT102	19	19	26	26	simvastatin	ADP	PA451363	23038	0.694
NULL	Paediatr_Drugs_2013_Apr_20_15(2)_119-131.nxml.txt.nlp	23512128	SENT284	7	7	17	17	ilaprazole	CYP2C19	PA165947499	1557	0.694
NULL	Gene_Ther_2010_Aug_1_17(8)_1042-1051.nxml.txt.nlp	20596059	SENT19	0	0	4	4	bevacizumab	VEGF-A	PA130232992	7422	0.694
NULL	Breast_Cancer_Res_2010_Jun_24_12(3)_R41.nxml.txt.nlp	20576088	SENT253	7	7	36	36	paclitaxel	p53	PA450761	7157	0.694
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT247	13	13	7	7	gemcitabine	MLH1	PA449748	4292	0.694
NULL	Neural_Plast_2014_Sep_9_2014_360481.nxml.txt.nlp	25313338	SENT146	32	32	24	24	minocycline	COX	PA450519	1351	0.694
NULL	J_Biol_Chem_2012_Apr_6_287(15)_12433-12444.nxml.txt.nlp	22351758	SENT504	24	24	12	12	hyaluronan	TSG-6	PA165958431	7130	0.694
NULL	Mol_Cancer_2010_Nov_2_9_289.nxml.txt.nlp	21044322	SENT188	32	32	14	14	cisplatin	RGS17	PA449014	26575	0.694
NULL	Int_J_Mol_Sci_2012_Aug_10_13(8)_9971-9979.nxml.txt.nlp	22949842	SENT196	22	22	17	17	lipase	mol	PA450239	90527	0.694
NULL	Crit_Care_2011_Aug_16_15(4)_228.nxml.txt.nlp	21884646	SENT175	22	22	5	5	cisplatin	IL-10	PA449014	3586	0.694
NULL	Br_J_Cancer_2010_Jun_29_103(1)_6-11.nxml.txt.nlp	20551960	SENT28	3	3	15	15	cisplatin	ADM	PA449014	133	0.694
NULL	Front_Endocrinol_(Lausanne)_2013_Jan_7_3_180.nxml.txt.nlp	23316185	SENT66	12	12	2	2	glucose	CRF2	PA449773	1395	0.694
NULL	Diabetes_2011_May_23_60(5)_1370-1379.nxml.txt.nlp	21525508	SENT121	19	19	45	45	anakinra	IL-6	PA10799	3569	0.694
NULL	Sensors_(Basel)_2010_May_19_10(5)_5031-5053.nxml.txt.nlp	22399922	SENT164	4	4	11	11	resveratrol	HNF4A		3172	0.694
NULL	Arthritis_Res_Ther_2008_Aug_18_10(4)_R93.nxml.txt.nlp	18710567	SENT142	32	32	21	21	etanercept	IL-23	PA449515	51561	0.694
NULL	J_Gen_Physiol_2009_Feb_133(2)_171-188.nxml.txt.nlp	19171770	SENT763	14	14	18	18	diazepam	CA1	PA449283	759	0.694
NULL	Mol_Cancer_2010_Aug_11_9_214.nxml.txt.nlp	20701798	SENT241	18	18	12	12	streptomycin	FBS	PA451512	64319;26269	0.694
NULL	Curr_Pharm_Des_2011_Feb_17(6)_578-590.nxml.txt.nlp	21391908	SENT181	15	15	19	19	doxorubicin	E2F1	PA449412	1869	0.694
NULL	Nat_Med_2010_Jul_16_16(7)_767-773.nxml.txt.nlp	20473305	SENT198	7	7	14	14	arsenite	RTP801	PA452638	54541	0.694
NULL	ScientificWorldJournal_2014_Dec_31_2014_508178.nxml.txt.nlp	25614889	SENT20	18	18	22	22	ustekinumab	p40	PA166048654	3921;339541;10314	0.694
NULL	Arthritis_Res_Ther_2013_Aug_21_15(4)_R93.nxml.txt.nlp	23965253	SENT19	19	19	12	12	collagenase	MMP9	PA449107	4318	0.694
NULL	Cancer_Manag_Res_2011_Mar_3_3_57-64.nxml.txt.nlp	21556317	SENT165	10	10	20	20	oxaliplatin	A30	PA131285527	28937	0.694
NULL	Mol_Cancer_2012_Jun_26_11_43.nxml.txt.nlp	22731636	SENT134	4	4	0	0	pp2	CD24		100133941	0.694
NULL	ScientificWorldJournal_2014_Mar_24_2014_694326.nxml.txt.nlp	24782665	SENT8	24	24	17	17	metformin	FDG	PA450395	23583	0.694
NULL	Clin_Epidemiol_2010_Aug_9_2_145-151.nxml.txt.nlp	20865112	SENT84	3	3	21	21	zidovudine	CD4	PA451954	920	0.694
NULL	Breast_Cancer_Res_2010_Mar_5_12(2)_R16.nxml.txt.nlp	20205716	SENT362	0	0	4	4	lovastatin	E2F1	PA450272	1869	0.694
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT238	7	7	0	0	cisplatin	MVP	PA449014	9961	0.694
NULL	Acta_Histochem_Cytochem_2011_Apr_28_44(2)_113-118.nxml.txt.nlp	21614172	SENT336	0	0	3	3	everolimus	FKBP12	PA164746311	2280	0.694
NULL	Breast_Cancer_Res_2004_Mar_18_6(3)_128-132.nxml.txt.nlp	15084233	SENT30	0	0	7	7	bevacizumab	San	PA130232992	80218	0.694
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT173	7	7	9	9	resveratrol	TRAIL		8743	0.694
NULL	Pharmaceuticals_(Basel)_2012_Feb_2_5(2)_114-132.nxml.txt.nlp	24288084	SENT143	39	39	6	6	celecoxib	TRPV1	PA448871	7442	0.694
NULL	Nat_Commun_2013_Oct_25_4_2667.nxml.txt.nlp	24157709	SENT72	4	4	8	8	cisplatin	ETO	PA449014	862	0.694
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT71	14	14	10	10	pemetrexed	UNG	PA10810	7374	0.694
NULL	Arch_Med_Sci_2013_Dec_30_9(6)_1090-1096.nxml.txt.nlp	24482655	SENT149	6	6	38	38	tacrolimus	IL-2	PA451578	3558	0.694
NULL	Cardiol_Ther_2013_Jun_7_2(1)_57-68.nxml.txt.nlp	25135289	SENT60	17	17	5	5	thrombin	PAR-1	PA451674	2011;2149	0.694
NULL	J_Cell_Biol_2008_Jul_14_182(1)_171-184.nxml.txt.nlp	18606850	SENT318	15	15	27	27	l-glutamine	CO2	PA10090	4513	0.694
NULL	Diabetes_2013_Oct_17_62(10)_3500-3513.nxml.txt.nlp	23884882	SENT207	0	0	14	14	resveratrol	PDX1		8050;3651	0.694
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT83	5	5	10	10	erlotinib	AKT	PA134687924	207	0.694
NULL	Front_Syst_Neurosci_2009_Nov_3_3_13.nxml.txt.nlp	20057934	SENT269	15	15	17	17	ketamine	PCP	PA450144	5547	0.694
NULL	Ann_Oncol_2012_Dec_2_23(12)_3007-3016.nxml.txt.nlp	22865781	SENT113	18	18	10	10	trastuzumab	PTEN	PA451743	5728	0.694
NULL	Oncogene_2014_Aug_21_33(34)_4316-4329.nxml.txt.nlp	24362530	SENT133	13	13	0	0	epirubicin	FOXM1	PA449476	2305	0.694
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1563-1573.nxml.txt.nlp	22015557	SENT121	4	4	6	6	sunitinib	c-Myc	PA162372840	4609	0.694
NULL	Breast_Cancer_Res_Treat_2013_Jun_5_139(3)_649-655.nxml.txt.nlp	23736997	SENT213	11	11	2	2	tamoxifen	CYP2D6	PA451581	1565	0.694
NULL	J_Breast_Cancer_2014_Dec_26_17(4)_308-313.nxml.txt.nlp	25548577	SENT137	22	22	10	10	cyclophosphamide	HER2	PA449165	2064	0.694
NULL	Cancers_(Basel)_2013_Jul_26_5(3)_943-958.nxml.txt.nlp	24202328	SENT853	10	10	4	4	olaparib	ADP		23038	0.694
NULL	Clin_Med_Insights_Cardiol_2010_Oct_11_4_89-93.nxml.txt.nlp	20981132	SENT15	23	23	18	18	benazepril	TNF	PA448561	7124	0.694
NULL	Anal_Bioanal_Chem_2009_Oct_30_395(4)_893-905.nxml.txt.nlp	19484227	SENT77	21	21	13	13	ciprofloxacin	OTC	PA449009	5009	0.694
NULL	N_Am_J_Med_Sci_2013_Dec_5(12)_721-723.nxml.txt.nlp	24404557	SENT62	16	16	7	7	methotrexate	CHOP	PA450428	1649	0.694
NULL	Blood_Res_2014_Dec_23_49(4)_253-258.nxml.txt.nlp	25548759	SENT75	24	24	17	17	rituximab	CHOP	PA451261	1649	0.694
NULL	Ann_Lab_Med_2012_Jul_20_32(4)_298-303.nxml.txt.nlp	22779073	SENT117	8	8	22	22	rifampin	MOX	PA451250	26002	0.694
NULL	Front_Cell_Neurosci_2013_Apr_23_7_39.nxml.txt.nlp	23630460	SENT1433	16	16	3	3	l-serine	ASCT1	PA451330	6509	0.694
NULL	J_Hematol_Oncol_2009_Aug_12_2_36.nxml.txt.nlp	19674465	SENT78	0	0	20	20	lenalidomide	PI3K	PA162363968	5290	0.694
NULL	Nat_Commun_2013_Apr_9_4_1684.nxml.txt.nlp	23575688	SENT112	6	6	34	34	rolipram	CYLD	PA153906323	1540	0.694
NULL	Cancer_Cell_Int_2002_Nov_20_2_16.nxml.txt.nlp	12495439	SENT254	20	20	6	6	theophylline	NF-kappaB	PA451647	4790	0.694
NULL	Ther_Clin_Risk_Manag_2007_Jun_3(3)_363-379.nxml.txt.nlp	18488081	SENT57	30	30	15	15	lansoprazole	CYP2C19	PA450180	1557	0.694
NULL	Cancer_Cell_Int_2005_Jul_24_5_22.nxml.txt.nlp	16042792	SENT93	2	2	6	6	vincristine	NAC	PA451879	22861	0.694
NULL	Ital_J_Pediatr_2011_Aug_22_37_39.nxml.txt.nlp	21859484	SENT53	24	24	16	16	salbutamol	BDP	PA448068	10620;152926	0.694
NULL	J_Gen_Physiol_1996_May_1_107(5)_643-658.nxml.txt.nlp	8740377	SENT0	12	12	1	1	lidocaine	Gen	PA450226	348654	0.694
NULL	Indian_J_Ophthalmol_2014_Oct_62(10)_999-1002.nxml.txt.nlp	25449934	SENT28	32	32	20	20	propylthiouracil	RAI	PA451156	10848;6050	0.694
NULL	Front_Neurosci_2011_Jul_26_5_92.nxml.txt.nlp	21845173	SENT14	13	13	16	16	naloxone	NRM	PA450586	11270	0.694
NULL	Gut_2008_Nov_2_57(11)_1509-1517.nxml.txt.nlp	18596194	SENT185	7	7	18	18	curcumin	JNK	PA151958596	5599	0.694
NULL	Ann_Oncol_2009_Aug_17_20(8)_1319-1329.nxml.txt.nlp	19535820	SENT349	31	31	43	43	trastuzumab	San	PA451743	80218	0.694
NULL	J_Cell_Mol_Med_2014_Aug_1_18(8)_1599-1611.nxml.txt.nlp	24889822	SENT314	15	15	2	2	resveratrol	FOXO1		2308	0.694
NULL	J_Hum_Genet_2013_Jun_16_58(6)_353-361.nxml.txt.nlp	23677058	SENT155	8	8	5	5	cytarabine	CNT3	PA449177	64078	0.694
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_321-328.nxml.txt.nlp	21372824	SENT173	31	31	16	16	fluvastatin	STZ	PA449688	6484	0.694
NULL	J_Young_Pharm_2012_Oct-Dec_4(4)_235-244.nxml.txt.nlp	23493308	SENT59	16	16	18	18	bupropion	BUP	PA448687	23412	0.694
NULL	Onco_Targets_Ther_2014_Mar_24_7_491-500.nxml.txt.nlp	24711706	SENT151	4	4	9	9	pertuzumab	ERBB2		2064	0.694
NULL	Int_J_Mol_Sci_2013_Apr_29_14(5)_9338-9364.nxml.txt.nlp	23629668	SENT770	5	5	25	25	mitomycin	MAX	PA450524	4149	0.694
NULL	Hum_Genomics_2008_Sep_1_3(1)_7-16.nxml.txt.nlp	19129086	SENT126	0	0	4	4	rosiglitazone	CYP2C8	PA451283	1558	0.694
NULL	Eur_J_Haematol_2014_Feb_25_92(2)_127-136.nxml.txt.nlp	24118452	SENT62	26	26	14	14	anagrelide	CRT	PA164742986	811	0.694
NULL	J_Korean_Med_Sci_2007_Dec_20_22(6)_952-956.nxml.txt.nlp	18162705	SENT15	29	29	1	1	nadh	SLC25A13	PA164755085	10165	0.694
NULL	Alcohol_Res_2013_35(1)_57-67.nxml.txt.nlp	24313165	SENT34	11	11	29	29	ethanol	CYP2E1	PA448073	1571	0.694
NULL	Mol_Cancer_2006_Oct_17_5_45.nxml.txt.nlp	17044934	SENT12	36	36	14	14	resveratrol	COX		1351	0.694
NULL	Ann_Dermatol_2014_Apr_30_26(2)_195-202.nxml.txt.nlp	24882974	SENT153	31	31	17	17	sorafenib	NRAS	PA7000	4893	0.694
NULL	Mol_Cancer_2012_Jul_25_11_46.nxml.txt.nlp	22830422	SENT141	28	28	19	19	rolipram	AKT	PA153906323	207	0.694
NULL	J_Cardiothorac_Surg_2013_May_13_8_127.nxml.txt.nlp	23668669	SENT41	14	14	16	16	sufentanil	EDA	PA451527	1896	0.694
NULL	J_Oncol_2010_Aug_24_2010_654348.nxml.txt.nlp	20871846	SENT53	16	16	10	10	tamoxifen	ATAC	PA451581	6375	0.694
NULL	Anesth_Essays_Res_2012_Jul-Dec_6(2)_140-146.nxml.txt.nlp	NULL	SENT101	28	28	11	11	lidocaine	C3a	PA450226	718	0.694
NULL	Adipocyte_2014_Jul_1_3(3)_190-196.nxml.txt.nlp	25068085	SENT13	29	29	15	15	lipase	CCL2	PA450239	6347	0.694
NULL	Arthritis_Res_2001_Jan_26_3(Suppl_A)_P094.nxml.txt.nlp	NULL	SENT5	15	15	5	5	infliximab	OPG	PA452639	690	0.694
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT143	3	3	5	5	tacrolimus	RANKL	PA451578	8600	0.694
NULL	Iran_J_Pharm_Res_2014_Winter_13(1)_279-282.nxml.txt.nlp	24734081	SENT100	19	19	8	8	cyclosporine	MDR1	PA449167	5243	0.694
NULL	Curr_Oncol_2008_Oct_15(5)_229-233.nxml.txt.nlp	19008997	SENT136	10	10	22	22	chlorambucil	Yes	PA448926	7525	0.694
NULL	Front_Immunol_2014_Feb_10_5_23.nxml.txt.nlp	24575090	SENT60	9	9	24	24	clobetasol	CD95	PA164744375	355	0.694
NULL	Front_Oncol_2014_Mar_6_4_40.nxml.txt.nlp	24639951	SENT47	10	10	20	20	chlorambucil	ETO	PA448926	862	0.694
NULL	Acta_Neuropathol_Commun_2014_Oct_21_2(1)_149.nxml.txt.nlp	NULL	SENT204	25	25	11	11	riluzole	ANOVA	PA451251	4858	0.694
NULL	Br_J_Cancer_2010_Oct_12_103(8)_1309-1310.nxml.txt.nlp	NULL	SENT12	5	5	7	7	bevacizumab	IFN	PA130232992	3439	0.694
NULL	Biologics_2012_Sep_26_6_347-354.nxml.txt.nlp	23055692	SENT51	26	26	15	15	rituximab	CD27	PA451261	939	0.694
NULL	Ann_Surg_Oncol_2014_Feb_13_21(5)_1575-1582.nxml.txt.nlp	24522992	SENT10	19	19	16	16	letrozole	BCS	PA450196	617	0.694
NULL	Clin_Exp_Otorhinolaryngol_2013_Mar_1_6(1)_48-51.nxml.txt.nlp	23526700	SENT56	24	24	8	8	thyroglobulin	TTF-1	PA164754910	7080	0.694
NULL	Cancer_Immunol_Immunother_2013_Aug_27_62(10)_1637-1648.nxml.txt.nlp	23982484	SENT121	4	4	23	23	lenalidomide	IFN	PA162363968	3439	0.694
NULL	Cancer_Cell_Int_2010_Oct_25_10_40.nxml.txt.nlp	20974006	SENT110	46	46	26	26	paraformaldehyde	DR5	PA450790	8795	0.694
NULL	Front_Immunol_2014_Apr_23_5_188.nxml.txt.nlp	24795730	SENT139	17	17	11	11	nitrogen	CCL5	PA450643	6352	0.694
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT314	5	5	24	24	resveratrol	p53		7157	0.694
NULL	J_Clin_Biochem_Nutr_2009_Nov_28_45(3)_285-291.nxml.txt.nlp	19902018	SENT337	5	5	12	12	hesperetin	XDH	PA164742902	7498	0.694
NULL	Acta_Pharmacol_Sin_2014_Aug_30_35(8)_1045-1054.nxml.txt.nlp	24976155	SENT129	9	9	19	19	resveratrol	STAT3		6774	0.694
NULL	Eur_J_Nutr_2012_Aug_15_51(5)_513-528.nxml.txt.nlp	22584415	SENT138	7	7	9	9	adalimumab	adiponectin	PA10004	9370	0.694
NULL	Indian_J_Pharm_Sci_2014_Mar-Apr_76(2)_166-169.nxml.txt.nlp	24843191	SENT79	9	9	19	19	nebivolol	HEC	PA151958426	10403	0.694
NULL	Front_Oncol_2014_Sep_23_4_264.nxml.txt.nlp	25295231	SENT172	8	8	4	4	lenalidomide	CD34	PA162363968	947	0.694
NULL	Asian_J_Androl_2014_Apr_8_May-Jun_16(3)_372-377.nxml.txt.nlp	24759579	SENT139	0	0	8	8	cabozantinib	San	PA165906891	80218	0.694
NULL	Mol_Vis_2012_Nov_29_18_2839-2846.nxml.txt.nlp	23233786	SENT167	6	6	31	31	geldanamycin	CB2	PA152031327	1269	0.694
NULL	Front_Neurosci_2014_Jun_3_8_128.nxml.txt.nlp	24917782	SENT16	5	5	12	12	ethanol	MC4R	PA448073	4160	0.694
NULL	Acta_Pharmacol_Sin_2012_Jul_18_33(7)_861-872.nxml.txt.nlp	22705730	SENT247	23	23	14	14	atorvastatin	PDK1	PA448500	5170;5163	0.694
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT102	4	4	9	9	imatinib	ABCB1	PA10804	5243	0.694
NULL	Cholesterol_2012_Jul_25_2012_861924.nxml.txt.nlp	22888414	SENT92	21	21	12	12	simvastatin	SHARP	PA451363	23013	0.694
NULL	Biochimie_2015_Jan_108_40-47.nxml.txt.nlp	25447146	SENT202	10	10	0	0	thiamylal	CPZ	PA164746997	8532	0.694
NULL	Acta_Pharmacol_Sin_2014_Aug_7_35(8)_1023-1030.nxml.txt.nlp	24998255	SENT129	3	3	12	12	octreotide	STAT3	PA450678	6774	0.694
NULL	Br_J_Pharmacol_2008_Nov_11_155(6)_896-905.nxml.txt.nlp	18695641	SENT135	3	3	13	13	genistein	CTX	PA165109660	1593	0.694
NULL	Mol_Cancer_2012_Dec_12_11_91.nxml.txt.nlp	23234355	SENT196	7	7	2	2	erlotinib	EGFR	PA134687924	1956	0.694
NULL	Nat_Med_2011_Dec_11_18(1)_74-82.nxml.txt.nlp	22157681	SENT237	19	19	13	13	gefitinib	BIM	PA131301952	10018	0.694
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_91-103.nxml.txt.nlp	17912639	SENT72	4	4	33	33	letrozole	HER2	PA450196	2064	0.694
NULL	Chemother_Res_Pract_2011_Dec_1_2011_715469.nxml.txt.nlp	22312557	SENT94	0	0	4	4	cisplatin	p53	PA449014	7157	0.694
NULL	Diabetes_2009_Dec_31_58(12)_2851-2862.nxml.txt.nlp	19720788	SENT174	2	2	4	4	forskolin	BiP	PA146096022	3309	0.694
NULL	Diabetes_Care_2013_Aug_17_36(Suppl_2)_S180-S189.nxml.txt.nlp	23882044	SENT224	7	7	26	26	metformin	GLP-1	PA450395	100125288	0.694
NULL	Br_J_Cancer_2010_Jul_13_103(2)_265-274.nxml.txt.nlp	20551953	SENT202	22	22	17	17	cisplatin	JNK	PA449014	5599	0.694
NULL	J_Young_Pharm_2012_Apr-Jun_4(2)_82-87.nxml.txt.nlp	22754259	SENT33	17	17	7	7	ethanol	mol	PA448073	90527	0.694
NULL	J_Clin_Biochem_Nutr_2009_Jul_30_45(1)_9-13.nxml.txt.nlp	19590701	SENT22	16	16	10	10	lansoprazole	HO-1	PA450180	3162	0.694
NULL	Exp_Diabetes_Res_2012_Oct_15_2012_465282.nxml.txt.nlp	23118742	SENT9	20	20	1	1	metformin	FGF21	PA450395	26291	0.694
NULL	Cancers_(Basel)_2011_Sep_28_3(4)_3740-3761.nxml.txt.nlp	24213109	SENT97	0	0	14	14	hyaluronan	TLR4	PA165958431	7099	0.694
NULL	Br_J_Cancer_2013_Feb_19_108(3)_557-563.nxml.txt.nlp	23361053	SENT13	14	14	10	10	tamoxifen	PAK1	PA451581	5585;5058	0.694
NULL	Int_J_Mol_Sci_2014_Oct_14_15(10)_18557-18573.nxml.txt.nlp	25318057	SENT1045	0	0	10	10	bortezomib	TRAIL	PA10252	8743	0.694
NULL	Dent_Res_J_(Isfahan)_2009_Spring_6(1)_29-37.nxml.txt.nlp	21528027	SENT109	10	10	5	5	ethanol	HEMA	PA448073	2157	0.694
NULL	J_Inflamm_(Lond)_2006_Jul_12_3_10.nxml.txt.nlp	16834783	SENT190	5	5	9	9	mometasone	IL-8	PA450541	3576	0.694
NULL	J_Radiat_Res_2014_Jul_11_55(4)_613-628.nxml.txt.nlp	24522270	SENT72	1	1	16	16	curcumin	DNA-PKcs	PA151958596	5591	0.694
NULL	Clin_Ophthalmol_2012_Oct_30_6_1749-1753.nxml.txt.nlp	23152652	SENT58	1	1	27	27	bimatoprost	ANOVA	PA164748867	4858	0.694
NULL	Mol_Cancer_2014_Jan_24_13_11.nxml.txt.nlp	24456667	SENT128	0	0	11	11	doxycycline	MLH1	PA449415	4292	0.694
NULL	J_Breast_Cancer_2013_Mar_31_16(1)_23-31.nxml.txt.nlp	23593078	SENT115	4	4	21	21	genistein	HDAC1	PA165109660	3065	0.694
NULL	J_Thyroid_Res_2010_Nov_10_2011_634170.nxml.txt.nlp	21113383	SENT38	22	22	32	32	thyroglobulin	RAI	PA164754910	10848;6050	0.694
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Nov_4_9_31.nxml.txt.nlp	21050425	SENT90	39	39	32	32	mupirocin	Gen	PA164764568	348654	0.694
NULL	Br_J_Cancer_2012_Dec_4_107(12)_1950-1955.nxml.txt.nlp	23169295	SENT15	20	20	6	6	oxaliplatin	DPD	PA131285527	1806	0.694
NULL	Oncotarget_2012_Aug_9_3(8)_774-782.nxml.txt.nlp	22885298	SENT52	38	38	7	7	tetracycline	IDH1	PA451640	3417	0.694
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT1245	4	4	11	11	tenofovir	ABCB1	PA10204	5243	0.694
NULL	Front_Neural_Circuits_2010_Apr_22_4_11.nxml.txt.nlp	20461235	SENT606	3	3	11	11	riluzole	TREK-1	PA451251	3776	0.694
NULL	Anesth_Pain_Med_2014_Sep_9_4(4)_e14221.nxml.txt.nlp	25599022	SENT178	20	20	33	33	cisplatin	Bcl-2	PA449014	596	0.694
NULL	Cell_Biosci_2011_Nov_7_1_36.nxml.txt.nlp	22060137	SENT52	19	19	5	5	cisplatin	AEG-1	PA449014	92140	0.694
NULL	J_Inherit_Metab_Dis_2012_Nov_24_35(6)_1137-1145.nxml.txt.nlp	22447153	SENT210	5	5	17	17	fenofibrate	ABCD3	PA449594	5825	0.694
NULL	Diabetol_Metab_Syndr_2014_Mar_31_6_48.nxml.txt.nlp	24684803	SENT117	13	13	8	8	mitiglinide	STEP	PA164748124	84867	0.694
NULL	Oxid_Med_Cell_Longev_2011_Oct_9_2011_756938.nxml.txt.nlp	22007271	SENT200	11	11	37	37	forskolin	PNMT	PA146096022	5409	0.694
NULL	Oncotarget_2013_Nov_22_5(4)_933-943.nxml.txt.nlp	24659749	SENT52	16	16	3	3	nutlin-3	AML3		860	0.694
NULL	Exp_Ther_Med_2014_Mar_10_7(3)_640-648.nxml.txt.nlp	24520260	SENT10	22	22	5	5	triciribine	p38	PA165958661	10598;1432;7965	0.694
NULL	Drug_Target_Insights_2012_Aug_6_6_19-39.nxml.txt.nlp	22915839	SENT112	1	1	3	3	doxorubicin	p53	PA449412	7157	0.694
NULL	Cell_Death_Dis_2014_Mar_6_5(3)_e1108.nxml.txt.nlp	24603336	SENT52	28	28	11	11	etoposide	CYP3A4	PA449552	1576	0.694
NULL	J_Invest_Dermatol_2014_Jun_17_134(6)_1589-1598.nxml.txt.nlp	24499735	SENT75	8	8	3	3	lipase	HSL	PA450239	3991	0.694
NULL	Adv_Hematol_2010_Dec_30_2010_624040.nxml.txt.nlp	21234357	SENT112	7	7	20	20	doxorubicin	CHOP	PA449412	1649	0.694
NULL	Int_J_Biol_Sci_2014_Jun_3_10(6)_602-613.nxml.txt.nlp	24948873	SENT232	9	9	5	5	estradiol	CYP19A1	PA449503	1588	0.694
NULL	Acta_Pharmacol_Sin_2011_Jul_13_32(7)_967-972.nxml.txt.nlp	21666702	SENT134	6	6	11	11	ticlopidine	CYP2C9	PA451686	1559	0.694
NULL	Breast_Cancer_Res_2008_Mar_27_10(2)_R26.nxml.txt.nlp	18371194	SENT296	44	44	28	28	epirubicin	BRCA2	PA449476	675	0.694
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Feb_10_68(Pt_3)_o656.nxml.txt.nlp	22412559	SENT77	23	23	9	9	ethanol	mol	PA448073	90527	0.694
NULL	Evid_Based_Complement_Alternat_Med_2012_Aug_27_2012_361516.nxml.txt.nlp	22969825	SENT91	22	22	15	15	verapamil	P-gp	PA451868	5243	0.694
NULL	Braz_J_Microbiol_2011_Dec_1_Oct-Dec_42(4)_1384-1389.nxml.txt.nlp	24031767	SENT36	12	12	15	15	nitrogen	CSL	PA450643	1444	0.694
NULL	J_Clin_Biochem_Nutr_2010_Jan_29_46(1)_87-92.nxml.txt.nlp	20104270	SENT8	0	0	30	30	hesperidin	STZ	PA449867	6484	0.694
NULL	Ann_Oncol_2014_Apr_26_25(4)_801-807.nxml.txt.nlp	24577117	SENT17	1	1	10	10	cetuximab	p16	PA10040	1029	0.694
NULL	J_Exp_Clin_Cancer_Res_2009_Oct_7_28(1)_134.nxml.txt.nlp	19811659	SENT98	0	0	10	10	nilotinib	PDGFRA	PA165958345	5156	0.694
NULL	Cell_Death_Dis_2013_Sep_5_4(9)_e791.nxml.txt.nlp	24008735	SENT9	8	8	10	10	gemcitabine	PUMA	PA449748	27113	0.694
NULL	Hum_Genomics_Proteomics_2010_Aug_3_2010_159761.nxml.txt.nlp	20981231	SENT255	21	21	27	27	lithium	NTRK2	PA450243	4915	0.694
NULL	J_Oncol_2010_Apr_18_2010_351908.nxml.txt.nlp	20414463	SENT152	11	11	21	21	etoposide	U87	PA449552	677775;641648	0.694
NULL	Iran_Red_Crescent_Med_J_2014_Aug_5_16(8)_e6915.nxml.txt.nlp	25389496	SENT133	17	17	9	9	simvastatin	adiponectin	PA451363	9370	0.694
NULL	Mol_Vis_2012_Jan_1_18_1-9.nxml.txt.nlp	22232563	SENT48	13	13	22	22	bevacizumab	San	PA130232992	80218	0.694
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT180	25	25	13	13	perifosine	JNK	PA165291471	5599	0.694
NULL	F1000_Biol_Rep_2010_May_24_2_40.nxml.txt.nlp	20948793	SENT46	21	21	35	35	ustekinumab	IL-23	PA166048654	51561	0.694
NULL	Oncogene_2010_Sep_16_29(37)_5193-5203.nxml.txt.nlp	20581867	SENT169	11	11	13	13	lapatinib	HRG	PA152241907	3084;3273	0.694
NULL	Oncotarget_2013_Dec_16_5(6)_1439-1451.nxml.txt.nlp	24742402	SENT74	36	36	1	1	oxygen	RHC	PA450744	3057	0.694
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT2406	1	1	31	31	amiodarone	CYP3A4	PA448383	1576	0.694
NULL	Exp_Cell_Res_2013_Aug_1_319(13)_2037-2048.nxml.txt.nlp	23562655	SENT239	24	24	10	10	urokinase	AP-1	PA451836	2353;3727;2354;3725	0.694
NULL	Evid_Based_Complement_Alternat_Med_2012_Aug_7_2012_140103.nxml.txt.nlp	21837246	SENT65	6	6	2	2	pentobarbital	STZ	PA450859	6484	0.694
NULL	Pain_2014_Nov_155(11)_2306-2322.nxml.txt.nlp	25168672	SENT179	5	5	7	7	loxapine	LOX	PA450273	4015	0.694
NULL	Arthritis_Res_Ther_2009_Feb_9_11(1)_R19.nxml.txt.nlp	19203382	SENT243	22	22	38	38	infliximab	IL-6	PA452639	3569	0.694
NULL	J_Ophthalmol_2012_Nov_29_2012_861384.nxml.txt.nlp	22174999	SENT20	0	0	6	6	bevacizumab	San	PA130232992	80218	0.694
NULL	Curr_Neuropharmacol_2014_Jul_12(4)_365-379.nxml.txt.nlp	25342944	SENT235	17	17	6	6	fluoxetine	5-HT2B	PA449673	3357	0.694
NULL	J_Cardiothorac_Surg_2010_Nov_3_5_101.nxml.txt.nlp	21047408	SENT203	9	9	20	20	argatroban	IL-3	PA164745516	3562	0.694
NULL	Oncoimmunology_2012_Dec_1_1(9)_1661-1663.nxml.txt.nlp	23264929	SENT17	35	35	29	29	imiquimod	TLR7	PA449972	51284	0.693
NULL	Mol_Cancer_2010_Nov_25_9_305.nxml.txt.nlp	21108789	SENT121	23	23	14	14	paclitaxel	TRAIL	PA450761	8743	0.693
NULL	Autophagy_2013_Jul_1_9(7)_996-1008.nxml.txt.nlp	23580233	SENT137	10	10	15	15	cisplatin	LC3	PA449014	84557	0.693
NULL	Curr_Neuropharmacol_2013_Sep_11(5)_521-534.nxml.txt.nlp	24403876	SENT115	28	28	12	12	methamphetamine	DOM	PA450403	6663	0.693
NULL	Int_J_Med_Sci_2014_Sep_13_11(12)_1208-1217.nxml.txt.nlp	25317066	SENT72	29	29	15	15	trypsin	CO2	PA451806	4513	0.693
NULL	Environ_Health_Perspect_2006_Sep_23_114(9)_1401-1406.nxml.txt.nlp	16966095	SENT114	0	0	24	24	tetracycline	p53	PA451640	7157	0.693
NULL	Case_Rep_Gastroenterol_2012_Jul_24_6(2)_496-501.nxml.txt.nlp	22855667	SENT39	6	6	20	20	enalapril	B12	PA449456	7126;4709	0.693
NULL	Braz_J_Med_Biol_Res_2014_Oct_14_47(12)_1096-1101.nxml.txt.nlp	25387678	SENT34	23	23	12	12	imatinib	PI3K	PA10804	5290	0.693
NULL	Biologics_2012_Dec_17_6_429-464.nxml.txt.nlp	23269860	SENT162	13	13	19	19	adalimumab	ACR	PA10004	49	0.693
NULL	Nat_Commun_2014_Nov_25_5_5548.nxml.txt.nlp	25420520	SENT43	5	5	3	3	tetracycline	ERG	PA451640	2078	0.693
NULL	Lab_Invest_2009_Nov_7_89(11)_1275-1290.nxml.txt.nlp	19736547	SENT172	8	8	13	13	curcumin	LOX-1	PA151958596	4973	0.693
NULL	Oncotarget_2014_Nov_3_5(20)_10127-10139.nxml.txt.nlp	25333256	SENT7	4	4	7	7	vemurafenib	TRIM16	PA165946873	10626	0.693
NULL	J_Biol_Chem_2012_Aug_24_287(35)_30000-30013.nxml.txt.nlp	22773837	SENT250	31	31	13	13	thrombin	GPVI	PA451674	51206	0.693
NULL	J_Nutr_Metab_2011_Oct_1_2011_525094.nxml.txt.nlp	21977315	SENT31	8	8	28	28	resveratrol	SIRT4		23409	0.693
NULL	Ann_Oncol_2011_Jan_13_22(1)_215-223.nxml.txt.nlp	20627875	SENT306	3	3	11	11	cyclophosphamide	CHOP	PA449165	1649	0.693
NULL	J_Antimicrob_Chemother_2011_Jun_25_66(6)_1332-1339.nxml.txt.nlp	21441248	SENT33	20	20	7	7	nevirapine	CYP2B6	PA450616	1555	0.693
NULL	Mol_Cancer_2013_Oct_8_12_119.nxml.txt.nlp	24103454	SENT216	5	5	2	2	etoposide	TOP2A	PA449552	7153	0.693
NULL	Indian_J_Urol_2009_Jul-Sep_25(3)_296-301.nxml.txt.nlp	19881119	SENT103	8	8	17	17	clopidogrel	GOR	PA449053	254958	0.693
NULL	Clin_Interv_Aging_2009_May_14_4_101-107.nxml.txt.nlp	19503772	SENT51	0	0	6	6	bevacizumab	San	PA130232992	80218	0.693
NULL	Mol_Cancer_2014_Feb_4_13_21.nxml.txt.nlp	24495750	SENT144	22	22	11	11	oxaliplatin	Mcl-1	PA131285527	4170	0.693
NULL	Mol_Neurodegener_2011_Nov_23_6_79.nxml.txt.nlp	22112803	SENT191	10	10	39	39	glutaraldehyde	TTR	PA449777	7276	0.693
NULL	Oncol_Lett_2015_Jan_4_9(1)_91-95.nxml.txt.nlp	25435939	SENT82	15	15	11	11	etoposide	NACT	PA449552	284111	0.693
NULL	Cancers_(Basel)_2012_Oct_12_4(4)_989-1035.nxml.txt.nlp	24213498	SENT436	12	12	6	6	gemcitabine	CD24	PA449748	100133941	0.693
NULL	Ann_N_Y_Acad_Sci_2014_Nov_5_1329(1)_93-106.nxml.txt.nlp	25377080	SENT189	8	8	17	17	warfarin	TTR	PA451906	7276	0.693
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1724-1730.nxml.txt.nlp	19861964	SENT146	29	29	7	7	temozolomide	BRAF	PA451609	673	0.693
NULL	Br_J_Cancer_2013_May_14_108(9)_1862-1869.nxml.txt.nlp	23579219	SENT28	29	29	32	32	bevacizumab	ANXA11	PA130232992	311	0.693
NULL	Anal_Bioanal_Chem_2009_Oct_30_395(4)_893-905.nxml.txt.nlp	19484227	SENT186	19	19	8	8	spectinomycin	OTC	PA164781342	5009	0.693
NULL	Cell_Death_Dis_2010_Nov_18_1(11)_e102.nxml.txt.nlp	21368867	SENT121	17	17	10	10	gentamicin	14-3-3	PA449753	10971	0.693
NULL	Biologics_2014_Dec_4_8_281-291.nxml.txt.nlp	25506209	SENT115	20	20	5	5	vemurafenib	BRAF	PA165946873	673	0.693
NULL	Oncotarget_2011_Mar_27_2(3)_209-221.nxml.txt.nlp	21444945	SENT130	3	3	5	5	bortezomib	p53	PA10252	7157	0.693
NULL	J_Ophthalmol_2013_Dec_18_2013_135798.nxml.txt.nlp	24455194	SENT77	12	12	19	19	phenylephrine	ERG	PA450935	2078	0.693
NULL	Exp_Ther_Med_2013_Aug_20_6(2)_310-316.nxml.txt.nlp	24137180	SENT134	7	7	19	19	fasudil	MCP-1	PA165946121	6347	0.693
NULL	J_Cell_Biol_1998_Apr_20_141(2)_493-501.nxml.txt.nlp	9548726	SENT80	36	36	38	38	forskolin	GGF	PA146096022	3084	0.693
NULL	Exp_Mol_Med_2012_Jun_30_44(6)_394-402.nxml.txt.nlp	22495003	SENT77	29	29	15	15	glucose	ADIPOR1	PA449773	51094	0.693
NULL	Int_J_Biomed_Sci_2007_Jun_3(2)_123-130.nxml.txt.nlp	23675034	SENT17	7	7	20	20	famotidine	RAN	PA449586	5901	0.693
NULL	Mol_Biol_Rep_2012_Jul_12_39(7)_7487-7496.nxml.txt.nlp	22327778	SENT306	10	10	8	8	cisplatin	p53	PA449014	7157	0.693
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT37	15	15	21	21	tacrolimus	RANKL	PA451578	8600	0.693
NULL	J_Oncol_2012_Jul_14_2012_193436.nxml.txt.nlp	21804824	SENT160	15	15	37	37	temozolomide	SNO	PA451609	6498	0.693
NULL	Int_J_Biol_Sci_2012_Jul_12_8(7)_964-978.nxml.txt.nlp	22811618	SENT247	15	15	8	8	imatinib	EGFR	PA10804	1956	0.693
NULL	Arq_Bras_Cardiol_2014_Jul_103(1)_4-12.nxml.txt.nlp	25014056	SENT35	4	4	6	6	pitavastatin	CYP3A4	PA142650384	1576	0.693
NULL	Br_J_Cancer_2006_Feb_13_94(3)_407-426.nxml.txt.nlp	16434996	SENT4	7	7	20	20	genistein	BRCA2	PA165109660	675	0.693
NULL	Evid_Based_Complement_Alternat_Med_2013_Aug_12_2013_982689.nxml.txt.nlp	23997806	SENT152	10	10	25	25	tolbutamide	APE	PA451718	55704;328	0.693
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_33-43.nxml.txt.nlp	17912634	SENT198	24	24	18	18	letrozole	HER2	PA450196	2064	0.693
NULL	Biol_Open_2014_Dec_12_4(1)_48-61.nxml.txt.nlp	25505152	SENT362	19	19	5	5	metformin	SNRK	PA450395	54861	0.693
NULL	Biomed_Res_Int_2014_Jan_29_2014_458592.nxml.txt.nlp	24592391	SENT10	3	3	7	7	curcumin	HO-1	PA151958596	3162	0.693
NULL	ScientificWorldJournal_2012_Dec_5_2012_925925.nxml.txt.nlp	23304092	SENT194	27	27	18	18	carrageenan	COX	PA448814	1351	0.693
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Dec_4_66(Pt_1)_o56.nxml.txt.nlp	21580158	SENT58	28	28	5	5	coumarin	C17	PA134521193	54360	0.693
NULL	Child_Adolesc_Psychiatry_Ment_Health_2013_Aug_15_7_31.nxml.txt.nlp	23947389	SENT389	9	9	13	13	perphenazine	Gen	PA450882	348654	0.693
NULL	Oncoimmunology_2013_Oct_1_2(10)_e25997.nxml.txt.nlp	24404422	SENT58	4	4	2	2	imiquimod	TLR7	PA449972	51284	0.693
NULL	Cancer_Cell_Int_2013_Mar_4_13_21.nxml.txt.nlp	23497288	SENT59	29	29	3	3	etoposide	EWS	PA449552	2130	0.693
NULL	J_Clin_Exp_Pathol_2012_May_17_Suppl_4_7327.nxml.txt.nlp	25379357	SENT194	10	10	13	13	resveratrol	AMPK		5563	0.693
NULL	Eur_J_Pharm_Sci_2012_Jul_16_46(4)_244-258.nxml.txt.nlp	22085636	SENT392	8	8	11	11	pertuzumab	PTEN		5728	0.693
NULL	Oncol_Lett_2014_Apr_4_7(4)_1007-1010.nxml.txt.nlp	24944659	SENT45	28	28	36	36	streptomycin	CO2	PA451512	4513	0.693
NULL	Neuropsychopharmacology_2009_Jul_11_34(8)_1946-1957.nxml.txt.nlp	19279569	SENT8	15	15	31	31	cocaine	DOR	PA449072	58476	0.693
NULL	Diabetes_Care_2012_Feb_16_35(2)_327-333.nxml.txt.nlp	22179958	SENT148	22	22	14	14	metformin	B12	PA450395	7126;4709	0.693
NULL	Biologics_2014_Feb_15_8_67-81.nxml.txt.nlp	24600203	SENT162	23	23	5	5	anakinra	IFN	PA10799	3439	0.693
NULL	Environ_Health_Perspect_2007_Oct_28_115(10)_1503-1509.nxml.txt.nlp	17938743	SENT45	4	4	26	26	s-adenosylmethionine	B12	PA164754994	7126;4709	0.693
NULL	Adv_Hematol_2010_Jun_27_2010_343089.nxml.txt.nlp	20671999	SENT197	5	5	9	9	denosumab	RANKL	PA166048634	8600	0.693
NULL	Brain_Sci_2013_Apr_26_3(2)_670-703.nxml.txt.nlp	24961420	SENT74	2	2	26	26	ethanol	JNK	PA448073	5599	0.693
NULL	Exp_Ther_Med_2012_Sep_12_4(3)_475-480.nxml.txt.nlp	23181121	SENT170	28	28	16	16	rituximab	CHOP	PA451261	1649	0.693
NULL	Contemp_Clin_Dent_2011_Oct-Dec_2(4)_278-282.nxml.txt.nlp	22346152	SENT82	4	4	11	11	potassium	GCF	PA451047	6936	0.693
NULL	Oncotarget_2013_Nov_15_5(6)_1458-1474.nxml.txt.nlp	24681547	SENT109	18	18	26	26	celecoxib	COX2	PA448871	4513;5743	0.693
NULL	Mol_Cancer_2009_Nov_10_8_99.nxml.txt.nlp	19903356	SENT123	24	24	21	21	imatinib	IGFBP3	PA10804	3486	0.693
NULL	J_Biomed_Sci_2014_Feb_12_21(1)_14.nxml.txt.nlp	24521134	SENT52	10	10	3	3	heparin	PSGL-1	PA449855	6404	0.693
NULL	Cancer_Manag_Res_2012_Nov_9_4_383-395.nxml.txt.nlp	23204869	SENT6	11	11	2	2	carmustine	PC-3	PA448810	692094	0.693
NULL	Hum_Genomics_Proteomics_2010_Sep_13_2010_754919.nxml.txt.nlp	20981234	SENT101	12	12	6	6	acenocoumarol	CYP2C9	PA452632	1559	0.693
NULL	Oncotarget_2013_Dec_18_5(2)_375-385.nxml.txt.nlp	24495868	SENT116	3	3	5	5	fludarabine	MCL1	PA449655	4170	0.693
NULL	J_Ginseng_Res_2011_Sep_35(3)_261-271.nxml.txt.nlp	23717069	SENT287	20	20	17	17	diltiazem	gamma	PA449334	9913	0.693
NULL	Clin_Transl_Allergy_2013_Sep_2_3_29.nxml.txt.nlp	24004581	SENT180	0	0	10	10	omalizumab	CD23	PA164752253	2208	0.693
NULL	Acta_Pharmacol_Sin_2013_Feb_31_34(2)_231-238.nxml.txt.nlp	23274414	SENT132	4	4	9	9	amiloride	Bcl-2	PA448368	596	0.693
NULL	Addiction_2007_Oct_102(10)_1657-1664.nxml.txt.nlp	17854342	SENT44	29	29	36	36	bupropion	SRM	PA448687	6723;6725	0.693
NULL	Oxid_Med_Cell_Longev_2013_Nov_12_2013_912310.nxml.txt.nlp	24392181	SENT72	22	22	20	20	forskolin	EGF	PA146096022	1950	0.693
NULL	Oncotarget_2013_Nov_23_5(1)_196-210.nxml.txt.nlp	24344116	SENT37	24	24	18	18	doxorubicin	p50	PA449412	958;4790	0.693
NULL	Br_J_Cancer_2011_Oct_25_105(9)_1295-1301.nxml.txt.nlp	21979421	SENT45	11	11	28	28	fluorescein	San	PA164746009	80218	0.693
NULL	Breast_Cancer_Res_2010_Apr_9_12(2)_202.nxml.txt.nlp	20398329	SENT149	22	22	3	3	gefitinib	PTEN	PA131301952	5728	0.693
NULL	Acta_Vet_Scand_2011_Feb_17_53(1)_11.nxml.txt.nlp	21324209	SENT61	30	30	24	24	chloramphenicol	OTC	PA448927	5009	0.693
NULL	J_Gen_Physiol_2008_Nov_132(5)_521-535.nxml.txt.nlp	18852303	SENT439	19	19	32	32	thrombin	CAP2	PA451674	5271;10486	0.693
NULL	Indian_J_Anaesth_2014_Sep-Oct_58(5)_515-523.nxml.txt.nlp	25535411	SENT204	0	0	17	17	desmopressin	VIII	PA449237	1351	0.693
NULL	Biol_Open_2014_Jul_25_3(8)_741-758.nxml.txt.nlp	25063196	SENT493	3	3	11	11	ethanol	NF1	PA448073	4763	0.693
NULL	Adv_Ther_2013_May_15_30(5)_487-502.nxml.txt.nlp	23674163	SENT161	27	27	36	36	estradiol	PTH	PA449503	5741	0.693
NULL	Open_Biochem_J_2008_Nov_18_2_143-149.nxml.txt.nlp	19238188	SENT244	3	3	6	6	heparin	ATIII	PA449855	462	0.693
NULL	Arthritis_Rheumatol_2014_Jun_27_66(6)_1574-1582.nxml.txt.nlp	24577881	SENT111	0	0	14	14	hydralazine	CD28	PA449894	1493;940	0.693
NULL	Front_Immunol_2013_Sep_17_4_281.nxml.txt.nlp	24062747	SENT389	12	12	44	44	atorvastatin	MxA	PA448500	4599	0.693
NULL	Ther_Clin_Risk_Manag_2006_Jun_2(2)_129-158.nxml.txt.nlp	18360588	SENT179	6	6	11	11	voriconazole	CYP3A4	PA10233	1576	0.693
NULL	J_Cell_Mol_Med_2014_Aug_3_18(8)_1631-1643.nxml.txt.nlp	24894806	SENT57	13	13	30	30	l-glutamine	CO2	PA10090	4513	0.693
NULL	Breast_Cancer_Res_2011_May_19_13(3)_R52.nxml.txt.nlp	21595894	SENT345	12	12	5	5	tamoxifen	CXCL12	PA451581	6387	0.693
NULL	Front_Neurosci_2014_Jan_10_7_270.nxml.txt.nlp	24454277	SENT196	37	37	18	18	resveratrol	SUR1		6833	0.693
NULL	Exp_Neurobiol_2013_Mar_31_22(1)_45-50.nxml.txt.nlp	23585722	SENT108	4	4	6	6	fluoxetine	EPO	PA449673	7076;8288;2056	0.693
NULL	J_Geriatr_Cardiol_2014_Jun_11(2)_151-157.nxml.txt.nlp	25009566	SENT132	2	2	7	7	cilostazol	CDP	PA164746334	1523	0.693
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT17	0	0	7	7	erlotinib	San	PA134687924	80218	0.693
NULL	Chemother_Res_Pract_2011_Sep_25_2011_730360.nxml.txt.nlp	22295205	SENT236	4	4	6	6	trastuzumab	DM1	PA451743	338023;1760;28509	0.693
NULL	Ther_Clin_Risk_Manag_2006_Mar_2(1)_59-75.nxml.txt.nlp	18360582	SENT237	19	19	13	13	telithromycin	CYP3A4	PA10202	1576	0.693
NULL	Exp_Ther_Med_2013_Jul_25_6(1)_109-114.nxml.txt.nlp	23935730	SENT137	15	15	19	19	vincristine	CHOP	PA451879	1649	0.693
NULL	Arthritis_Res_Ther_2012_Apr_30_14(2)_210.nxml.txt.nlp	22569190	SENT202	3	3	8	8	abatacept	CD28	PA164747080	1493;940	0.693
NULL	Cardiol_Res_Pract_2013_Jan_31_2013_128795.nxml.txt.nlp	23431496	SENT145	6	6	3	3	clopidogrel	CYP2C19	PA449053	1557	0.693
NULL	Eur_J_Med_Res_2010_Aug_20_15(8)_337-344.nxml.txt.nlp	20947470	SENT33	34	34	36	36	bleomycin	BLM	PA448645	641	0.693
NULL	Braz_J_Microbiol_2012_Jun_1_Jan-Mar_43(1)_78-88.nxml.txt.nlp	24031806	SENT289	6	6	18	18	bacitracin	Gen	PA448531	348654	0.693
NULL	Surf_Sci_2012_Aug_606(15-16)_L55-L58.nxml.txt.nlp	23470898	SENT39	20	20	5	5	oxygen	AES	PA450744	166	0.693
NULL	Arthritis_Res_Ther_2008_Mar_17_10(2)_R33.nxml.txt.nlp	18346273	SENT139	9	9	2	2	infliximab	HMGB1	PA452639	3146	0.693
NULL	Acta_Neuropathol_Commun_2013_Aug_9_1_49.nxml.txt.nlp	24252504	SENT110	3	3	5	5	arsenite	TDP-43	PA452638	23435	0.693
NULL	Arthritis_Res_Ther_2013_Sep_10_15(5)_R110.nxml.txt.nlp	24020899	SENT155	11	11	9	9	pioglitazone	IL-6	PA450970	3569	0.693
NULL	Cardiovasc_Diabetol_2013_Oct_17_12_150.nxml.txt.nlp	24134550	SENT34	43	43	5	5	metformin	activin	PA450395	83729	0.693
NULL	Mol_Cancer_2008_Mar_26_7_27.nxml.txt.nlp	18366759	SENT262	18	18	22	22	etoposide	JUN	PA449552	3725	0.693
NULL	Clin_Med_Insights_Oncol_2011_Jun_23_5_185-199.nxml.txt.nlp	21792346	SENT60	19	19	30	30	imatinib	ABL1	PA10804	25	0.693
NULL	Arthritis_Res_Ther_2006_Jul_28_8(Suppl_2)_S4.nxml.txt.nlp	16899108	SENT38	12	12	23	23	tocilizumab	IL-6	PA165292659	3569	0.693
NULL	Front_Microbiol_2014_Sep_11_5_477.nxml.txt.nlp	25309517	SENT1301	6	6	4	4	daclizumab	CD25	PA164764446	3669;3559	0.693
NULL	Clin_Pharmacokinet_2014_Sep_3_53(1)_1-16.nxml.txt.nlp	23999929	SENT287	40	40	10	10	rivaroxaban	P-gp	PA165958360	5243	0.693
NULL	Eur_J_Clin_Pharmacol_2008_Feb_26_64(2)_133-157.nxml.txt.nlp	18224312	SENT544	45	45	9	9	trimipramine	CYP2C19	PA451791	1557	0.693
NULL	Oxid_Med_Cell_Longev_2013_Apr_21_2013_412576.nxml.txt.nlp	23710286	SENT111	11	11	18	18	curcumin	NRF2	PA151958596	2551;4780	0.693
NULL	Clinics_(Sao_Paulo)_2012_Jan_67(1)_61-67.nxml.txt.nlp	22249482	SENT28	0	0	7	7	bevacizumab	San	PA130232992	80218	0.693
NULL	Oncol_Lett_2014_Mar_16_7(3)_827-833.nxml.txt.nlp	24527090	SENT56	12	12	9	9	cisplatin	IFN	PA449014	3439	0.693
NULL	Mol_Cancer_2009_Jun_9_8_37.nxml.txt.nlp	19508729	SENT74	19	19	2	2	gemcitabine	HO-1	PA449748	3162	0.693
NULL	Mol_Cell_Endocrinol_2011_Jan_15_331(2)_194-204.nxml.txt.nlp	20688134	SENT889	19	19	24	24	buserelin	Yes	PA10253	7525	0.693
NULL	Oncotarget_2012_Sep_28_3(10)_1169-1181.nxml.txt.nlp	23045411	SENT254	7	7	2	2	doxorubicin	JIP1	PA449412	9479	0.693
NULL	Cell_Commun_Signal_2013_Nov_11_11_86.nxml.txt.nlp	24215724	SENT267	17	17	13	13	thrombin	PAR1	PA451674	79581;2149	0.693
NULL	AIDS_Res_Treat_2012_Mar_21_2012_186987.nxml.txt.nlp	22536495	SENT38	28	28	20	20	etravirine	TYPE	PA166014703	6445	0.693
NULL	Front_Cell_Neurosci_2013_Dec_20_7_268.nxml.txt.nlp	24391545	SENT1423	0	0	8	8	hyaluronan	TLR2	PA165958431	7097	0.693
NULL	Oncol_Lett_2013_Oct_26_6(4)_947-949.nxml.txt.nlp	24137442	SENT48	37	37	15	15	creatine	PDGFRA	PA164778930	5156	0.693
NULL	Behav_Brain_Funct_2012_Jul_10_8_20.nxml.txt.nlp	22559224	SENT129	4	4	1	1	baclofen	ANOVA	PA448533	4858	0.693
NULL	Clin_Kidney_J_2012_Oct_5(5)_434-437.nxml.txt.nlp	23986860	SENT71	13	13	16	16	ganciclovir	SPK	PA449733	55872;8189	0.693
NULL	Toxins_(Basel)_2010_Oct_28_2(11)_2584-2592.nxml.txt.nlp	22069565	SENT88	9	9	11	11	warfarin	CYP2C9	PA451906	1559	0.693
NULL	Clin_Genet_2011_Jun_79(6)_582-587.nxml.txt.nlp	20573158	SENT21	2	2	22	22	diazoxide	ADP	PA449285	23038	0.693
NULL	Case_Rep_Oncol_2013_Jul_20_6(2)_382-386.nxml.txt.nlp	23904849	SENT37	8	8	19	19	cetuximab	BRAF	PA10040	673	0.693
NULL	Arthritis_Res_Ther_2005_Jun_23_7(5)_R1023-R1033.nxml.txt.nlp	16207318	SENT22	18	18	0	0	collagenase	CD147	PA449107	682	0.693
NULL	Neuroscience_2015_Jan_22_284_872-887.nxml.txt.nlp	25450967	SENT53	18	18	3	3	choline	PPG	PA448976	5552	0.693
NULL	Nat_Commun_2014_Aug_6_5_4602.nxml.txt.nlp	25098764	SENT507	18	18	3	3	rosiglitazone	IL-6	PA451283	3569	0.693
NULL	Biomed_Res_Int_2014_Jun_26_2014_161346.nxml.txt.nlp	25054130	SENT240	7	7	30	30	curcumin	STZ	PA151958596	6484	0.693
NULL	Anal_Bioanal_Chem_2012_Dec_4_404(10)_3071-3080.nxml.txt.nlp	23052869	SENT180	3	3	15	15	pilocarpine	CA3	PA450962	761	0.693
NULL	Oncotarget_2014_Oct_21_5(22)_11252-11268.nxml.txt.nlp	25361004	SENT79	0	0	9	9	metformin	CLIC1	PA450395	1192	0.693
NULL	Virol_J_2010_Oct_27_7_285.nxml.txt.nlp	20979618	SENT165	24	24	17	17	collagenase	AP-1	PA449107	2353;3727;2354;3725	0.693
NULL	Crit_Care_2006_Jan_23_10(1)_113.nxml.txt.nlp	16469122	SENT35	0	0	4	4	simvastatin	HO-1	PA451363	3162	0.693
NULL	Exp_Ther_Med_2013_Nov_13_6(5)_1317-1321.nxml.txt.nlp	24223665	SENT110	13	13	34	34	curcumin	CD133	PA151958596	8842	0.693
NULL	Sci_Rep_2014_Dec_4_4_7315.nxml.txt.nlp	25472865	SENT32	25	25	17	17	thrombin	GT24	PA451674	1501	0.693
NULL	Anc_Sci_Life_2014_Jan-Mar_33(3)_165-171.nxml.txt.nlp	25538352	SENT82	30	30	12	12	ethanol	API	PA448073	5345	0.693
NULL	Front_Behav_Neurosci_2010_Apr_5_4_14.nxml.txt.nlp	20407577	SENT732	14	14	1	1	cocaine	BDNF	PA449072	627	0.693
NULL	Exp_Diabetes_Res_2011_Dec_27_2011_604989.nxml.txt.nlp	21253359	SENT98	15	15	9	9	clonidine	GLP-1	PA449051	100125288	0.693
NULL	J_Immunotoxicol_2013_Jan_11_10(1)_75-82.nxml.txt.nlp	22967038	SENT101	25	25	15	15	muromonab	IFN	PA164743097	3439	0.693
NULL	Carcinogenesis_2008_Sep_9_29(9)_1734-1741.nxml.txt.nlp	18544564	SENT306	3	3	12	12	bortezomib	TRAIL	PA10252	8743	0.693
NULL	Mol_Cell_Biochem_2014_Oct_9_385(1-2)_265-275.nxml.txt.nlp	24104452	SENT191	29	29	17	17	bortezomib	U87	PA10252	677775;641648	0.693
NULL	Br_J_Cancer_2003_Mar_24_88(6)_863-870.nxml.txt.nlp	12644823	SENT105	44	44	19	19	tamoxifen	maspin	PA451581	5268	0.693
NULL	J_Inflamm_(Lond)_2007_Mar_30_4_7.nxml.txt.nlp	17397554	SENT27	0	0	4	4	cyclophosphamide	CD4	PA449165	920	0.693
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT7	5	5	10	10	metformin	HIF-1	PA450395	29072	0.693
NULL	Infect_Agent_Cancer_2012_Apr_19_7(Suppl_1)_P22.nxml.txt.nlp	NULL	SENT5	9	9	11	11	rituximab	CHOP	PA451261	1649	0.693
NULL	J_Obes_2010_Oct_31_2010_892081.nxml.txt.nlp	21052532	SENT6	12	12	3	3	glucose	adiponectin	PA449773	9370	0.693
NULL	J_Cardiothorac_Surg_2014_Sep_17_9(1)_129.nxml.txt.nlp	NULL	SENT75	0	0	7	7	heparin	ACT	PA449855	12;11332;9457;641455	0.693
NULL	Nanoscale_Res_Lett_2013_Sep_26_8(1)_399.nxml.txt.nlp	24066922	SENT135	18	18	29	29	fluorescein	VEGFR2	PA164746009	3791	0.693
NULL	Ther_Clin_Risk_Manag_2006_Sep_2(3)_235-249.nxml.txt.nlp	18360599	SENT300	13	13	3	3	alendronate	PTH	PA448082	5741	0.693
NULL	Cancers_(Basel)_2011_Sep_28_3(4)_3740-3761.nxml.txt.nlp	24213109	SENT21	9	9	20	20	hyaluronan	spatial	PA165958431	219793	0.693
NULL	Oncoimmunology_2012_Oct_1_1(7)_1004-1016.nxml.txt.nlp	23170249	SENT115	0	0	18	18	paclitaxel	HER-2	PA450761	2064	0.693
NULL	Nat_Commun_2013_4_1449.nxml.txt.nlp	23385593	SENT104	4	4	7	7	nadh	BRCA1	PA164755085	672	0.693
NULL	Acta_Pharmacol_Sin_2011_Oct_15_32(10)_1233-1238.nxml.txt.nlp	21841815	SENT74	0	0	8	8	naloxone	CTX	PA450586	1593	0.693
NULL	Oxid_Med_Cell_Longev_2013_Mar_5_2013_264935.nxml.txt.nlp	23533686	SENT180	27	27	15	15	hemin	HO-1	PA449849	3162	0.693
NULL	Lipids_Health_Dis_2011_Dec_29_10_245.nxml.txt.nlp	22206454	SENT152	6	6	12	12	phenol	San	PA450913	80218	0.693
NULL	Arthritis_Rheum_2013_Sep_26_65(9)_2290-2300.nxml.txt.nlp	23740547	SENT57	34	34	26	26	doxycycline	DIP	PA449415	23151;1831	0.693
NULL	ScientificWorldJournal_2012_Sep_17_2012_637953.nxml.txt.nlp	23028251	SENT503	32	32	6	6	celiprolol	CYP3A4		1576	0.693
NULL	Int_J_Endocrinol_Metab_2013_Oct_21_11(4)_e10266.nxml.txt.nlp	24719624	SENT55	21	21	23	23	streptozocin	STZ	PA451514	6484	0.693
NULL	Arthritis_Res_Ther_2004_Sep_13_6(Suppl_3)_16.nxml.txt.nlp	NULL	SENT4	0	0	5	5	capsaicin	TRPV1	PA448776	7442	0.693
NULL	Br_J_Cancer_2012_Apr_24_106(9)_1486-1494.nxml.txt.nlp	22472882	SENT119	6	6	17	17	rosiglitazone	TIMP3	PA451283	7078	0.693
NULL	Alzheimers_Res_Ther_2010_Oct_29_2(5)_31.nxml.txt.nlp	21062519	SENT65	7	7	15	15	atorvastatin	PSEN1	PA448500	5663	0.693
NULL	Front_Pharmacol_2014_Nov_25_5_256.nxml.txt.nlp	25505414	SENT111	12	12	20	20	ketamine	KCC2	PA450144	57468	0.693
NULL	J_Gen_Physiol_2010_Feb_135(2)_149-167.nxml.txt.nlp	20100894	SENT208	26	26	4	4	spermine	CNGA1	PA164781199	1259	0.693
NULL	Eur_J_Epidemiol_2011_Aug_30_26(8)_657-686.nxml.txt.nlp	21877163	SENT959	11	11	8	8	metformin	MATE1	PA450395	55244	0.693
NULL	J_Exp_Clin_Cancer_Res_2009_Feb_15_28(1)_19.nxml.txt.nlp	19216799	SENT12	16	16	20	20	doxorubicin	AEG-1	PA449412	92140	0.693
NULL	Breast_Cancer_Res_2011_Nov_30_13(6)_R123.nxml.txt.nlp	22129105	SENT192	10	10	26	26	trastuzumab	IFN	PA451743	3439	0.693
NULL	Br_J_Cancer_2012_Jan_17_106(2)_284-289.nxml.txt.nlp	22215065	SENT164	6	6	3	3	atrasentan	IFN	PA143414738	3439	0.693
NULL	Acta_Naturae_2010_Jul-Sep_2(3)_21-29.nxml.txt.nlp	22649649	SENT190	1	1	4	4	imiquimod	TLR7	PA449972	51284	0.693
NULL	Indian_J_Anaesth_2014_Jan-Feb_58(1)_63-65.nxml.txt.nlp	24700903	SENT97	19	19	11	11	propofol	adrenoleukodystrophy	PA451141	215	0.693
NULL	Mol_Syst_Biol_2009_Jul_28_5_288.nxml.txt.nlp	19638969	SENT447	3	3	5	5	resveratrol	HuR		1994	0.693
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT192	21	21	8	8	cetuximab	Yes	PA10040	7525	0.693
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT84	20	20	22	22	resveratrol	TRAIL		8743	0.693
NULL	Int_J_Cell_Biol_2009_Apr_14_2009_243532.nxml.txt.nlp	20414334	SENT22	21	21	10	10	mitomycin	YB-1	PA450524	4904	0.693
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1059-1066.nxml.txt.nlp	21364577	SENT101	20	20	25	25	tamoxifen	TTR	PA451581	7276	0.693
NULL	Indian_J_Urol_2011_Jan-Mar_27(1)_74-85.nxml.txt.nlp	21716893	SENT185	13	13	3	3	l-cysteine	NAC	PA449173	22861	0.693
NULL	Biochem_Res_Int_2012_Jun_25_2012_518437.nxml.txt.nlp	22792465	SENT111	16	16	38	38	doxycycline	RGS5	PA449415	8490	0.693
NULL	Exp_Diabetes_Res_2012_May_28_2012_924168.nxml.txt.nlp	22693487	SENT37	8	8	6	6	exenatide	GLP-1	PA164749238	100125288	0.693
NULL	Biomed_Res_Int_2013_Jan_21_2013_581631.nxml.txt.nlp	23484133	SENT172	6	6	16	16	infliximab	p38	PA452639	10598;1432;7965	0.693
NULL	Iran_J_Basic_Med_Sci_2012_Jan-Feb_15(1)_678-682.nxml.txt.nlp	23493931	SENT58	9	9	16	16	ceftriaxone	CTX	PA448866	1593	0.693
NULL	Oncol_Lett_2014_Mar_17_7(3)_815-819.nxml.txt.nlp	24520299	SENT30	33	33	46	46	l-glutamine	CO2	PA10090	4513	0.693
NULL	Oncol_Lett_2014_Oct_9_8(4)_1551-1556.nxml.txt.nlp	25202366	SENT97	32	32	21	21	rituximab	CHOP	PA451261	1649	0.693
NULL	Virol_J_2009_Feb_14_6_22.nxml.txt.nlp	19216793	SENT268	31	31	18	18	trypsin	F12	PA451806	2161	0.693
NULL	J_Oncol_2012_Feb_6_2012_737981.nxml.txt.nlp	22481932	SENT83	8	8	6	6	cisplatin	MUC16	PA449014	94025	0.693
NULL	Cell_Commun_Signal_2013_Oct_1_11_73.nxml.txt.nlp	24083678	SENT119	26	26	15	15	sulindac	c-Jun	PA451565	3725	0.693
NULL	Oncotarget_2013_Aug_24_4(10)_1618-1631.nxml.txt.nlp	24113128	SENT205	10	10	17	17	sorafenib	p53	PA7000	7157	0.693
NULL	Mol_Cancer_2008_Mar_26_7_27.nxml.txt.nlp	18366759	SENT212	17	17	6	6	etoposide	HIF-1	PA449552	29072	0.693
NULL	Eur_J_Haematol_2009_Apr_82(4)_277-287.nxml.txt.nlp	19187270	SENT186	10	10	6	6	pha-665752	IL-6		3569	0.693
NULL	Clin_Ophthalmol_2010_May_14_4_437-445.nxml.txt.nlp	20505836	SENT11	15	15	23	23	bimatoprost	BAK	PA164748867	578	0.693
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT57	28	28	45	45	cisplatin	ASC	PA449014	29108	0.693
NULL	J_Gen_Physiol_1997_Feb_1_109(2)_229-243.nxml.txt.nlp	9041451	SENT16	13	13	28	28	spermine	IRK1	PA164781199	3759	0.693
NULL	Front_Genet_2012_Nov_5_3_236.nxml.txt.nlp	23133441	SENT118	10	10	12	12	efavirenz	ABCB1	PA449441	5243	0.693
NULL	J_Radiat_Res_2014_Mar_1_55(2)_359-363.nxml.txt.nlp	24187329	SENT43	18	18	0	0	vincristine	CHOP	PA451879	1649	0.693
NULL	J_Phys_Ther_Sci_2014_Nov_13_26(11)_1723-1727.nxml.txt.nlp	25435686	SENT25	14	14	5	5	glucose	adiponectin	PA449773	9370	0.693
NULL	J_Biol_Eng_2009_Oct_16_3_18.nxml.txt.nlp	19835592	SENT138	26	26	39	39	erythromycin	CPZ	PA449493	8532	0.693
NULL	Nat_Neurosci_2014_Jan_8_17(1)_131-143.nxml.txt.nlp	24316888	SENT341	13	13	43	43	papain	CO2	PA450778	4513	0.693
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT376	19	19	17	17	pp2	PP1		5540;5464	0.693
NULL	Br_J_Cancer_2011_Aug_23_105(5)_649-657.nxml.txt.nlp	21811251	SENT84	9	9	27	27	gefitinib	AKT	PA131301952	207	0.693
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Apr_8_65(Pt_5)_o979.nxml.txt.nlp	21584018	SENT62	13	13	22	22	ethanol	mol	PA448073	90527	0.693
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1224-1233.nxml.txt.nlp	22353810	SENT193	13	13	10	10	doxorubicin	MRP-1	PA449412	928	0.693
NULL	Cancer_Cell_2013_Nov_11_24(5)_617-630.nxml.txt.nlp	24229709	SENT81	16	16	12	12	tamoxifen	p110	PA451581	9733	0.693
NULL	Diabetologia_2010_Jun_27_53(6)_1142-1150.nxml.txt.nlp	20349036	SENT44	6	6	14	14	nitroprusside	AMPK	PA451406	5563	0.693
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT37	21	21	18	18	lapatinib	PI3K	PA152241907	5290	0.693
NULL	Scientifica_(Cairo)_2012_Nov_25_2012_473829.nxml.txt.nlp	24278698	SENT336	10	10	12	12	cisplatin	OCT3	PA449014	5460;6581	0.693
NULL	Front_Behav_Neurosci_2010_Dec_17_4_187.nxml.txt.nlp	21188275	SENT38	6	6	13	13	estradiol	spatial	PA449503	219793	0.693
NULL	Asian_J_Androl_2014_May_30_Sep-Oct_16(5)_669-674.nxml.txt.nlp	24923457	SENT16	10	10	21	21	protamine	MTHFR	PA10366	4524	0.693
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT235	10	10	21	21	cisplatin	p53	PA449014	7157	0.693
NULL	Int_J_Mol_Sci_2014_Mar_12_15(3)_4393-4414.nxml.txt.nlp	24625664	SENT617	12	12	5	5	cisplatin	gamma	PA449014	9913	0.693
NULL	Breast_Cancer_Res_2011_Jan_21_13(1)_R9.nxml.txt.nlp	21255398	SENT235	19	19	3	3	etoposide	RAD21	PA449552	5885	0.693
NULL	Front_Neurosci_2014_Jan_10_7_270.nxml.txt.nlp	24454277	SENT76	0	0	6	6	resveratrol	SIRT1		23411	0.693
NULL	Front_Neurol_2011_Dec_26_2_83.nxml.txt.nlp	22363312	SENT275	36	36	26	26	clopidogrel	CYP2C19	PA449053	1557	0.693
NULL	Ann_Rheum_Dis_2013_Aug_21_72(8)_1287-1294.nxml.txt.nlp	22915624	SENT187	43	43	32	32	abatacept	MRI	PA164747080	78996	0.693
NULL	Pharmacogn_Mag_2014_Oct-Dec_10(40)_536-540.nxml.txt.nlp	25422558	SENT110	22	22	5	5	ethanol	SLB	PA448073	26160	0.693
NULL	Oncol_Lett_2014_Apr_4_7(4)_1011-1014.nxml.txt.nlp	24944660	SENT56	25	25	12	12	thyroglobulin	CK7	PA164754910	3855	0.693
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT250	5	5	7	7	doxorubicin	B7-H1	PA449412	29126	0.693
NULL	Cancers_(Basel)_2012_Oct_29_4(4)_1146-1160.nxml.txt.nlp	24213502	SENT491	0	0	10	10	letrozole	BRCA1	PA450196	672	0.693
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Dec_19_66(Pt_1)_o194-o195.nxml.txt.nlp	21580078	SENT82	46	46	24	24	ethanol	mol	PA448073	90527	0.693
NULL	J_Ayurveda_Integr_Med_2013_Apr-Jun_4(2)_99-106.nxml.txt.nlp	23930042	SENT41	37	37	2	2	atorvastatin	STZ	PA448500	6484	0.693
NULL	Diabetes_Care_2013_Aug_11_36(8)_2239-2246.nxml.txt.nlp	23514733	SENT175	34	34	18	18	anakinra	IL1RN	PA10799	3557	0.693
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Apr_7_9_12.nxml.txt.nlp	20374640	SENT83	8	8	23	23	ampicillin	CHL	PA448419	91851	0.693
NULL	Front_Genet_2013_Aug_29_4_163.nxml.txt.nlp	24009622	SENT121	9	9	4	4	ethanol	ABCG2	PA448073	9429	0.693
NULL	Front_Oncol_2013_Oct_1_3_259.nxml.txt.nlp	24102047	SENT105	33	33	31	31	brivanib	FGFR2	PA164924492	2263	0.693
NULL	Acta_Pharmacol_Sin_2011_Dec_10_32(12)_1529-1536.nxml.txt.nlp	21986580	SENT152	3	3	15	15	cisplatin	p53	PA449014	7157	0.693
NULL	J_Cell_Biol_1999_Jul_12_146(1)_243-254.nxml.txt.nlp	10402474	SENT484	7	7	0	0	collagenase	EGF	PA449107	1950	0.693
NULL	J_Infect_Dis_2011_May_1_203(9)_1204-1214.nxml.txt.nlp	21459813	SENT298	8	8	24	24	etravirine	TRIO	PA166014703	7204	0.693
NULL	Arthritis_Res_Ther_2011_Feb_16_13(1)_R25.nxml.txt.nlp	21324169	SENT82	16	16	27	27	anakinra	TNF	PA10799	7124	0.693
NULL	Arch_Drug_Inf_2008_Dec_1(3)_97-106.nxml.txt.nlp	19639031	SENT143	36	36	26	26	irinotecan	UGT1A1	PA450085	54658	0.693
NULL	J_Biomed_Biotechnol_2010_Jun_30_2010_485468.nxml.txt.nlp	20671927	SENT7	3	3	28	28	hyaluronan	MMP2	PA165958431	4313	0.693
NULL	eLife_2014_Mar_4_3_e01630.nxml.txt.nlp	24596151	SENT297	23	23	11	11	trypsin	CDK2	PA451806	1017	0.693
NULL	J_Vet_Med_Sci_2014_Feb_21_76(2)_219-227.nxml.txt.nlp	24141321	SENT268	13	13	5	5	vasopressin	ACTH	PA451858	5443	0.693
NULL	Emerg_Infect_Dis_2013_Nov_19(11)_1721-1730.nxml.txt.nlp	24207100	SENT134	11	11	26	26	hydroxychloroquine	VAN	PA164777036	10318	0.693
NULL	J_Immune_Based_Ther_Vaccines_2008_Jun_9_6_3.nxml.txt.nlp	18541039	SENT134	0	0	8	8	ribavirin	IL-10	PA451241	3586	0.693
NULL	J_Immunol_Res_2014_May_21_2014_371087.nxml.txt.nlp	24963497	SENT317	11	11	7	7	decitabine	DAC	PA164749631	13	0.693
NULL	Mol_Cancer_2012_May_28_11_36.nxml.txt.nlp	22640878	SENT286	30	30	8	8	paclitaxel	TGFBI	PA450761	7045	0.693
NULL	Front_Immunol_2013_May_15_4_116.nxml.txt.nlp	23720663	SENT243	16	16	18	18	cyclophosphamide	CTX	PA449165	1593	0.693
NULL	Cell_Death_Dis_2014_Mar_13_5(3)_e1125.nxml.txt.nlp	24625984	SENT19	19	19	39	39	suramin	TNF	PA10292	7124	0.693
NULL	Biosci_Rep_2013_Sep_6_33(5)_e00065.nxml.txt.nlp	23895241	SENT51	4	4	9	9	rosiglitazone	UCP1	PA451283	7350	0.693
NULL	Tumour_Biol_2012_Jun_21_33(3)_607-615.nxml.txt.nlp	22270450	SENT141	33	33	16	16	erlotinib	EGFR	PA134687924	1956	0.693
NULL	Cell_Death_Dis_2012_Oct_11_3(10)_e403.nxml.txt.nlp	23059822	SENT50	30	30	8	8	allopurinol	MSU	PA448320	593	0.693
NULL	J_Oncol_2009_Mar_24_2009_491985.nxml.txt.nlp	19325924	SENT76	16	16	38	38	genistein	CXCL12	PA165109660	6387	0.692
NULL	Br_J_Cancer_2011_Aug_23_105(5)_618-627.nxml.txt.nlp	21829197	SENT161	8	8	14	14	lapatinib	CRT	PA152241907	811	0.692
NULL	FEBS_Open_Bio_2013_Dec_30_4_96-104.nxml.txt.nlp	24490130	SENT574	6	6	14	14	cisplatin	BRCA1	PA449014	672	0.692
NULL	Clin_Psychopharmacol_Neurosci_2012_Apr_30_10(1)_25-33.nxml.txt.nlp	23429852	SENT98	8	8	41	41	haloperidol	SNAP-25	PA449841	6616	0.692
NULL	Crit_Care_2010_Sep_14_14(5)_R166.nxml.txt.nlp	20840773	SENT221	12	12	21	21	galactose	GDH	PA449725	51084;2746	0.692
NULL	Breast_Cancer_Res_Treat_2013_Aug_20_141(1)_43-53.nxml.txt.nlp	23959396	SENT29	23	23	21	21	pertuzumab	HER2		2064	0.692
NULL	J_Immunol_Res_2014_May_12_2014_897249.nxml.txt.nlp	24901013	SENT129	11	11	14	14	natalizumab	PTEN	PA164747191	5728	0.692
NULL	Arch_Med_Sci_2013_Aug_30_9(4)_739-744.nxml.txt.nlp	24049538	SENT49	8	8	13	13	candesartan	PC-3	PA448765	692094	0.692
NULL	Int_J_Fertil_Steril_2013_Mar_3_Jan-Mar_6(4)_258-265.nxml.txt.nlp	24520449	SENT31	6	6	19	19	creatine	ADP	PA164778930	23038	0.692
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Dec_10_3(12)_e151.nxml.txt.nlp	25494035	SENT80	25	25	18	18	rosuvastatin	OATP1B1	PA134308647	10599	0.692
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT6	12	12	3	3	celecoxib	IL-6	PA448871	3569	0.692
NULL	J_Headache_Pain_2013_Dec_11_14(1)_96.nxml.txt.nlp	24330707	SENT139	7	7	1	1	frovatriptan	COX	PA164754891	1351	0.692
NULL	Acta_Pharmacol_Sin_2011_Jul_13_32(7)_967-972.nxml.txt.nlp	21666702	SENT141	31	31	27	27	losartan	CYP2C	PA450268	1562	0.692
NULL	J_Immunother_Cancer_2013_Jul_15_1_10.nxml.txt.nlp	24829747	SENT56	6	6	16	16	oxygen	NOS2	PA450744	339345;4843	0.692
NULL	Cell_Death_Dis_2014_Mar_13_5(3)_e1118.nxml.txt.nlp	24625977	SENT81	36	36	15	15	etoposide	p53	PA449552	7157	0.692
NULL	Br_J_Cancer_2010_Jul_13_103(2)_186-195.nxml.txt.nlp	20588277	SENT186	0	0	8	8	nutlin-3	p53		7157	0.692
NULL	Oncotarget_2011_Sep_9_2(9)_658-668.nxml.txt.nlp	21911919	SENT122	27	27	3	3	cytarabine	HO-1	PA449177	3162	0.692
NULL	Libyan_J_Med_2006_Jul_28_1(1)_42-59.nxml.txt.nlp	21526020	SENT203	14	14	18	18	irinotecan	IFL	PA450085	3439	0.692
NULL	Ann_Hematol_2010_Sep_13_89(9)_861-871.nxml.txt.nlp	20387067	SENT90	0	0	13	13	dasatinib	CD34	PA162372878	947	0.692
NULL	Cardiovasc_Diabetol_2011_Dec_22_10_115.nxml.txt.nlp	22189184	SENT117	10	10	33	33	miglitol	GLP-1	PA164776726	100125288	0.692
NULL	J_Vet_Med_Sci_2014_Jan_27_76(1)_15-23.nxml.txt.nlp	23986119	SENT118	31	31	27	27	lipase	FABP4	PA450239	2167	0.692
NULL	Br_J_Cancer_2013_Jun_25_108(12)_2464-2469.nxml.txt.nlp	23695016	SENT162	25	25	31	31	cisplatin	CRT	PA449014	811	0.692
NULL	Breast_Cancer_Res_2004_Jun_18_6(4)_179-180.nxml.txt.nlp	NULL	SENT41	10	10	2	2	gefitinib	aromatase	PA131301952	1588	0.692
NULL	Arthritis_Res_Ther_2003_Dec_2_5(Suppl_4)_S12-S16.nxml.txt.nlp	15180892	SENT99	2	2	0	0	cyclophosphamide	CHOP	PA449165	1649	0.692
NULL	Crit_Care_2000_Mar_21_4(Suppl_1)_P26.nxml.txt.nlp	NULL	SENT16	19	19	13	13	staurosporine	CXCR1	PA165109623	3577	0.692
NULL	J_Biomed_Biotechnol_2008_Jul_8_2008_597913.nxml.txt.nlp	18629230	SENT379	15	15	31	31	nadh	ADP	PA164755085	23038	0.692
NULL	Cancers_(Basel)_2010_Jul_27_2(3)_1528-1554.nxml.txt.nlp	24281171	SENT263	2	2	0	0	doxorubicin	ABCG5	PA449412	64240	0.692
NULL	J_Cardiothorac_Surg_2013_May_13_8_127.nxml.txt.nlp	23668669	SENT41	8	8	16	16	ropivacaine	EDA	PA451271	1896	0.692
NULL	Oncotarget_2013_Nov_7_4(12)_2550-2566.nxml.txt.nlp	24334291	SENT220	16	16	23	23	fludarabine	CHOP	PA449655	1649	0.692
NULL	Angiogenesis_2012_Sep_27_15(3)_361-376.nxml.txt.nlp	22451299	SENT59	21	21	40	40	streptomycin	FBS	PA451512	64319;26269	0.692
NULL	Daru_2011_19(6)_455-461.nxml.txt.nlp	23008692	SENT149	8	8	13	13	mitoxantrone	survivin	PA450526	332	0.692
NULL	Front_Neurosci_2014_May_27_8_129.nxml.txt.nlp	24904269	SENT129	26	26	5	5	ethanol	ANOVA	PA448073	4858	0.692
NULL	New_Microbes_New_Infect_2014_May_4_2(3)_58-63.nxml.txt.nlp	25356345	SENT100	14	14	24	24	ceftazidime	ANK	PA448861	56172	0.692
NULL	Oncotarget_2014_Feb_25_5(5)_1304-1314.nxml.txt.nlp	24675421	SENT33	20	20	0	0	cisplatin	RIP1	PA449014	10928;7386	0.692
NULL	Clin_Dev_Immunol_2013_Sep_22_2013_317682.nxml.txt.nlp	24171032	SENT11	24	24	15	15	hyaluronan	IL-6	PA165958431	3569	0.692
NULL	J_Gen_Physiol_1962_Nov_1_46(2)_189-199.nxml.txt.nlp	13941048	SENT4	10	10	26	26	choline	NO3	PA448976	4681	0.692
NULL	Eur_J_Immunol_2014_Jun_10_44(6)_1759-1769.nxml.txt.nlp	24595810	SENT45	14	14	6	6	fludrocortisone	CD4	PA164743961	920	0.692
NULL	Int_J_Surg_Oncol_2012_Jun_12_2012_862879.nxml.txt.nlp	22778941	SENT128	3	3	7	7	cisplatin	c-Myc	PA449014	4609	0.692
NULL	Br_J_Cancer_2003_Mar_10_88(5)_788-795.nxml.txt.nlp	12618891	SENT144	20	20	22	22	bosentan	FasL	PA10034	356	0.692
NULL	J_Biol_2003_Sep_24_2(4)_28.nxml.txt.nlp	14511394	SENT150	21	21	1	1	phenformin	LKB1	PA1000	6794	0.692
NULL	Front_Comput_Neurosci_2013_Apr_5_7_22.nxml.txt.nlp	23576979	SENT56	38	38	9	9	ketamine	HCN1	PA450144	348980	0.692
NULL	Crit_Care_2012_Jul_26_16(4)_R137.nxml.txt.nlp	22835277	SENT269	24	24	32	32	oxygen	ROS	PA450744	6098	0.692
NULL	Breast_Cancer_Res_2012_Jul_23_14(4)_R112.nxml.txt.nlp	22824341	SENT236	10	10	5	5	doxorubicin	RANKL	PA449412	8600	0.692
NULL	Cell_Commun_Signal_2013_Nov_11_11_86.nxml.txt.nlp	24215724	SENT31	14	14	11	11	thrombin	PAR4	PA451674	9002;5074	0.692
NULL	Oncol_Lett_2014_Jun_4_7(6)_2175-2179.nxml.txt.nlp	24932311	SENT122	10	10	8	8	choline	CDP	PA448976	1523	0.692
NULL	Neuropsychopharmacology_2009_Nov_5_34(12)_2560-2573.nxml.txt.nlp	19657330	SENT9	30	30	17	17	flupenthixol	CB1	PA10268	1268	0.692
NULL	Front_Neurosci_2010_Jun_17_4_35.nxml.txt.nlp	20661455	SENT94	5	5	16	16	buspirone	5-HT1A	PA448689	3350	0.692
NULL	Appl_Clin_Genet_2013_Oct_18_6_91-101.nxml.txt.nlp	24159262	SENT18	29	29	10	10	thrombin	VIII	PA451674	1351	0.692
NULL	Int_J_Mol_Sci_2014_Nov_7_15(11)_20500-20517.nxml.txt.nlp	25387078	SENT115	5	5	13	13	sorafenib	AKT	PA7000	207	0.692
NULL	Int_J_Circumpolar_Health_2013_Aug_5_72_10_3402_ijch_v72i0_20854.nxml.txt.nlp	23984273	SENT120	23	23	15	15	ceftriaxone	19A	PA448866	57823	0.692
NULL	Infect_Dis_Obstet_Gynecol_2008_May_29_2008_493508.nxml.txt.nlp	18528520	SENT132	5	5	7	7	tetracycline	CDR1	PA451640	1038	0.692
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT333	0	0	9	9	resveratrol	IL-6		3569	0.692
NULL	Oxid_Med_Cell_Longev_2013_Jun_2_2013_793525.nxml.txt.nlp	23819014	SENT209	15	15	36	36	resveratrol	ROS		6098	0.692
NULL	Breast_Cancer_Res_2012_Feb_14_14(1)_R30.nxml.txt.nlp	22333315	SENT153	20	20	25	25	indomethacin	IFN	PA449982	3439	0.692
NULL	J_Cell_Mol_Med_2014_Dec_22_18(12)_2519-2529.nxml.txt.nlp	25338520	SENT139	1	1	12	12	oxygen	IL-6	PA450744	3569	0.692
NULL	Cancer_Med_2014_Oct_2_3(5)_1385-1395.nxml.txt.nlp	24890702	SENT106	18	18	0	0	oxaliplatin	EGFR	PA131285527	1956	0.692
NULL	Crit_Care_2011_Mar_22_15(2)_211.nxml.txt.nlp	21457505	SENT41	5	5	26	26	heparin	PF4	PA449855	5196	0.692
NULL	Biochem_Res_Int_2012_Mar_4_2012_685267.nxml.txt.nlp	22496978	SENT214	7	7	26	26	thrombin	MT1-MMP	PA451674	4323	0.692
NULL	Clin_Ophthalmol_2012_Feb_20_6_277-282.nxml.txt.nlp	22375096	SENT113	25	25	20	20	triamcinolone	STA	PA451749	2010;2656	0.692
NULL	Oxid_Med_Cell_Longev_2012_Jul_1_2012_324256.nxml.txt.nlp	22811764	SENT148	5	5	37	37	curcumin	AP-1	PA151958596	2353;3727;2354;3725	0.692
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_10_2014_838101.nxml.txt.nlp	25435894	SENT457	10	10	6	6	curcumin	EGF	PA151958596	1950	0.692
NULL	J_Cancer_2013_Sep_10_4(8)_614-625.nxml.txt.nlp	24155773	SENT260	35	35	37	37	bortezomib	BTZ	PA10252	22794	0.692
NULL	Int_J_Chron_Obstruct_Pulmon_Dis_2007_Dec_2(4)_409-428.nxml.txt.nlp	18268916	SENT132	13	13	5	5	urokinase	SERPINE2	PA451836	5270	0.692
NULL	Br_J_Cancer_2011_Jan_4_104(1)_91-100.nxml.txt.nlp	21139584	SENT162	15	15	30	30	coumarin	Raf-1	PA134521193	5894	0.692
NULL	Mol_Cancer_2010_Apr_15_9_77.nxml.txt.nlp	20398291	SENT8	8	8	16	16	geldanamycin	survivin	PA152031327	332	0.692
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_3_2012_908562.nxml.txt.nlp	23082087	SENT39	0	0	2	2	hesperidin	mol	PA449867	90527	0.692
NULL	Mol_Cancer_2009_Dec_23_8_129.nxml.txt.nlp	20030852	SENT239	12	12	6	6	curcumin	ABCA1	PA151958596	19	0.692
NULL	Clin_Med_Insights_Cardiol_2012_Feb_1_6_17-33.nxml.txt.nlp	22442638	SENT185	20	20	16	16	rosuvastatin	CYP2C9	PA134308647	1559	0.692
NULL	Semin_Immunopathol_2013_Jan_26_35(1)_39-52.nxml.txt.nlp	22829332	SENT197	16	16	30	30	melphalan	CHOP	PA450354	1649	0.692
NULL	Cancers_(Basel)_2014_Apr_4_6(2)_796-812.nxml.txt.nlp	24713998	SENT86	8	8	11	11	imatinib	NGAL	PA10804	3934	0.692
NULL	Biomed_Res_Int_2013_May_22_2013_430791.nxml.txt.nlp	23762845	SENT8	0	0	10	10	fasudil	SDH	PA165946121	1757;10993	0.692
NULL	Br_J_Cancer_2012_May_8_106(10)_1587-1590.nxml.txt.nlp	22568998	SENT68	25	25	15	15	sunitinib	TOX	PA162372840	9760	0.692
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT192	12	12	33	33	trastuzumab	Yes	PA451743	7525	0.692
NULL	Front_Physiol_2013_Nov_14_4_323.nxml.txt.nlp	24294204	SENT200	35	35	29	29	carvedilol	CYP2D6	PA448817	1565	0.692
NULL	Breast_Cancer_Res_Treat_2014_Apr_6_145(1)_33-44.nxml.txt.nlp	24706169	SENT105	27	27	25	25	trastuzumab	HER2	PA451743	2064	0.692
NULL	Biomed_Res_Int_2013_Dec_30_2013_187204.nxml.txt.nlp	23533994	SENT289	23	23	15	15	cetuximab	VEGFR2	PA10040	3791	0.692
NULL	J_Immunother_Cancer_2013_Nov_7_1(Suppl_1)_O17.nxml.txt.nlp	NULL	SENT10	34	34	26	26	imiquimod	TLR9	PA449972	54106	0.692
NULL	Acta_Ortop_Bras_2012_20(5)_258-261.nxml.txt.nlp	24453613	SENT9	6	6	16	16	bupivacaine	ACL	PA135057240	47	0.692
NULL	Addict_Health_2012_Summer-Autumn_4(3-4)_79-86.nxml.txt.nlp	24494140	SENT169	13	13	1	1	tizanidine	Gen	PA451701	348654	0.692
NULL	Biomed_Res_Int_2014_Feb_6_2014_323594.nxml.txt.nlp	24689036	SENT125	27	27	40	40	raloxifene	F12	PA451221	2161	0.692
NULL	Cardiovasc_Diabetol_2013_Jul_6_12_99.nxml.txt.nlp	23829275	SENT71	16	16	0	0	phenylephrine	STZ	PA450935	6484	0.692
NULL	Int_J_Mol_Sci_2012_Apr_16_13(4)_4831-4838.nxml.txt.nlp	22606012	SENT40	1	1	21	21	curcumin	p65	PA151958596	5970	0.692
NULL	Int_J_Surg_Oncol_2012_May_17_2012_406830.nxml.txt.nlp	22675625	SENT196	18	18	23	23	oxaliplatin	CRT	PA131285527	811	0.692
NULL	J_Bras_Pneumol_2014_May-Jun_40(3)_313-318.nxml.txt.nlp	25029655	SENT87	24	24	26	26	venlafaxine	CYP2D6	PA451866	1565	0.692
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT251	17	17	28	28	lapatinib	HRG	PA152241907	3084;3273	0.692
NULL	Brain_2008_Dec_6_131(12)_3361-3379.nxml.txt.nlp	18988638	SENT163	5	5	14	14	apomorphine	ANOVA	PA164781163	4858	0.692
NULL	Allergy_Asthma_Immunol_Res_2010_Jan_30_2(1)_48-54.nxml.txt.nlp	20224678	SENT24	40	40	43	43	pranlukast	CYSLTR2	PA134698661	57105	0.692
NULL	Braz_J_Med_Biol_Res_2012_Sep_21_45(12)_1240-1243.nxml.txt.nlp	22983178	SENT68	9	9	19	19	diclofenac	DIP	PA449293	23151;1831	0.692
NULL	J_Equine_Sci_2014_Apr_22_25(1)_7-13.nxml.txt.nlp	24834008	SENT78	25	25	8	8	genistein	NKD1	PA165109660	85407	0.692
NULL	Adv_Ther_2013_Nov_28_30(12)_1067-1085.nxml.txt.nlp	24287690	SENT107	12	12	9	9	rifampin	P-gp	PA451250	5243	0.692
NULL	Acta_Pharmacol_Sin_2011_Aug_18_32(8)_1078-1084.nxml.txt.nlp	21765448	SENT112	15	15	6	6	iptakalim	KCNJ11	PA165949694	3767	0.692
NULL	J_Cell_Biol_1998_Jul_13_142(1)_101-115.nxml.txt.nlp	9660866	SENT137	28	28	30	30	dextran	mol	PA449261	90527	0.692
NULL	Cancer_Cell_Int_2009_Sep_10_9_25.nxml.txt.nlp	19744341	SENT192	0	0	13	13	glucosamine	STAT3	PA164747613	6774	0.692
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT79	0	0	18	18	metformin	LKB1	PA450395	6794	0.692
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT39	35	35	20	20	capsaicin	p53	PA448776	7157	0.692
NULL	Cancers_(Basel)_2010_Apr_8_2(2)_376-396.nxml.txt.nlp	24281075	SENT81	14	14	16	16	arsenite	AS3MT	PA452638	57412	0.692
NULL	Amino_Acids_2013_Aug_19_45(2)_351-358.nxml.txt.nlp	23685963	SENT68	24	24	36	36	l-tryptophan	PLP	PA10323	25824;5744	0.692
NULL	Nanoscale_Res_Lett_2010_May_9_5(7)_1093-1101.nxml.txt.nlp	20596329	SENT43	43	43	16	16	l-glutamine	F12	PA10090	2161	0.692
NULL	Eur_J_Clin_Pharmacol_2014_May_21_70(8)_915-920.nxml.txt.nlp	24839948	SENT135	10	10	16	16	midazolam	CYP3A	PA450496	1574	0.692
NULL	Cell_Cycle_2013_Jul_15_12(14)_2291-2296.nxml.txt.nlp	24067371	SENT119	12	12	20	20	paclitaxel	PLK1	PA450761	5347	0.692
NULL	Aging_(Albany_NY)_2009_Feb_5_1(2)_219-233.nxml.txt.nlp	20157511	SENT4	16	16	0	0	hydroxyurea	WRN	PA449942	7486	0.692
NULL	Diabetol_Metab_Syndr_2014_Mar_31_6_48.nxml.txt.nlp	24684803	SENT122	13	13	8	8	mitiglinide	STEP	PA164748124	84867	0.692
NULL	Exp_Mol_Med_2012_Nov_30_44(11)_684-693.nxml.txt.nlp	22940736	SENT145	20	20	24	24	omeprazole	San	PA450704	80218	0.692
NULL	Nat_Med_2013_Mar_10_19(3)_313-321.nxml.txt.nlp	23396211	SENT303	4	4	10	10	amlexanox	TBK1	PA164745310	29110	0.692
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2675-2684.nxml.txt.nlp	24129246	SENT237	26	26	18	18	etoposide	p53	PA449552	7157	0.692
NULL	Biomed_Res_Int_2014_Jun_26_2014_161346.nxml.txt.nlp	25054130	SENT236	7	7	30	30	curcumin	STZ	PA151958596	6484	0.692
NULL	J_Gen_Physiol_2004_Apr_123(4)_427-439.nxml.txt.nlp	15024039	SENT296	23	23	15	15	pp2	PP2		4888	0.692
NULL	Biomed_Res_Int_2014_Jan_29_2014_458592.nxml.txt.nlp	24592391	SENT44	22	22	18	18	curcumin	HO-1	PA151958596	3162	0.692
NULL	J_Occup_Med_Toxicol_2008_Feb_27_3(Suppl_1)_S6.nxml.txt.nlp	18315837	SENT93	5	5	7	7	montelukast	IL-4	PA450546	3565	0.692
NULL	Iran_J_Public_Health_2012_Jan_31_41(1)_37-44.nxml.txt.nlp	23113120	SENT161	11	11	9	9	imatinib	survivin	PA10804	332	0.692
NULL	J_Cell_Mol_Med_2014_Oct_11_18(10)_2031-2043.nxml.txt.nlp	25109475	SENT363	0	0	4	4	valsartan	AMPK	PA451848	5563	0.692
NULL	Nat_Commun_2012_Dec_27_3_1316.nxml.txt.nlp	23271650	SENT518	26	26	33	33	tamoxifen	CA1	PA451581	759	0.692
NULL	Iran_J_Pharm_Res_2014_Spring_13(2)_635-639.nxml.txt.nlp	25237359	SENT18	5	5	39	39	chlorzoxazone	CYP2E1	PA448971	1571	0.692
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT216	40	40	21	21	cisplatin	MDM2	PA449014	4193	0.692
NULL	Hum_Genomics_2008_Sep_1_3(1)_7-16.nxml.txt.nlp	19129086	SENT195	6	6	3	3	rosiglitazone	CYP2C8	PA451283	1558	0.692
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT189	13	13	15	15	pertuzumab	KRT5		3852	0.692
NULL	Pharmaceutics_2011_Nov_18_3(4)_865-913.nxml.txt.nlp	24309312	SENT138	10	10	16	16	tacrolimus	CYP3A	PA451578	1574	0.692
NULL	Cell_Death_Dis_2012_Mar_1_3(3)_e275.nxml.txt.nlp	22378068	SENT81	2	2	19	19	metformin	CD34	PA450395	947	0.692
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT189	17	17	7	7	methotrexate	MSH2	PA450428	4436	0.692
NULL	Clin_Ophthalmol_2014_Jan_13_8_219-228.nxml.txt.nlp	24531757	SENT157	12	12	4	4	timolol	TIM	PA451690	7984;8914	0.692
NULL	J_Immunol_Res_2014_Jul_16_2014_696812.nxml.txt.nlp	25133198	SENT255	29	29	10	10	rifaximin	TLR2	PA164752443	7097	0.692
NULL	Arthritis_Res_Ther_2010_Apr_14_12(2)_R67.nxml.txt.nlp	20398273	SENT34	7	7	14	14	abatacept	CDP	PA164747080	1523	0.692
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT57	11	11	20	20	neratinib	HER2	PA165291472	2064	0.692
NULL	J_Invest_Dermatol_2012_Nov_21_132(11)_2642-2651.nxml.txt.nlp	22718118	SENT51	12	12	3	3	collagenase	CD11b	PA449107	3684	0.692
NULL	Mol_Biol_Cell_2013_Jul_1_24(13)_2134-2145.nxml.txt.nlp	23657817	SENT162	8	8	13	13	pp2	EGF		1950	0.692
NULL	Evid_Based_Complement_Alternat_Med_2014_Jul_1_2014_248768.nxml.txt.nlp	25104965	SENT161	1	1	45	45	ethanol	ADP	PA448073	23038	0.692
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_55-78.nxml.txt.nlp	19305788	SENT887	15	15	3	3	memantine	spatial	PA10364	219793	0.692
NULL	Part_Fibre_Toxicol_2011_Feb_9_8_8.nxml.txt.nlp	21306632	SENT149	17	17	34	34	gentamicin	CO2	PA449753	4513	0.692
NULL	Acta_Pharmacol_Sin_2011_Nov_10_32(11)_1402-1410.nxml.txt.nlp	21986579	SENT186	4	4	15	15	curcumin	p38	PA151958596	10598;1432;7965	0.692
NULL	Front_Physiol_2012_Oct_29_3_409.nxml.txt.nlp	23112775	SENT56	26	26	43	43	l-glutamine	CO2	PA10090	4513	0.692
NULL	Cancer_Cell_Int_2014_Jul_2_14_59.nxml.txt.nlp	25120382	SENT152	27	27	29	29	metformin	Met	PA450395	79811	0.692
NULL	Int_J_Mol_Sci_2014_Sep_29_15(10)_17366-17379.nxml.txt.nlp	25268612	SENT30	8	8	2	2	teriparatide	PTH	PA451620	5741	0.692
NULL	Breast_Cancer_Res_2014_Sep_11_16(5)_430.nxml.txt.nlp	25212826	SENT540	22	22	9	9	tamoxifen	PTEN	PA451581	5728	0.692
NULL	Case_Rep_Med_2012_Dec_3_2012_163173.nxml.txt.nlp	23326270	SENT16	0	0	21	21	bezafibrate	CPT2	PA162364313	1376	0.692
NULL	Mediators_Inflamm_2010_May_18_2010_359732.nxml.txt.nlp	20508722	SENT107	2	2	29	29	hemin	AP-1	PA449849	2353;3727;2354;3725	0.692
NULL	Eur_J_Med_Res_2009_Dec_7_14(Suppl_4)_108-111.nxml.txt.nlp	20156738	SENT75	28	28	4	4	budesonide	FKBP51	PA448681	2289	0.692
NULL	Ayu_2013_Jul-Sep_34(3)_297-301.nxml.txt.nlp	24501527	SENT85	7	7	13	13	carrageenan	LPO	PA448814	4025	0.692
NULL	Allergy_Asthma_Clin_Immunol_2007_Mar_15_3(1)_1-9.nxml.txt.nlp	20525147	SENT127	13	13	0	0	trypsin	IFN	PA451806	3439	0.692
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT8	10	10	12	12	curcumin	TRAIL	PA151958596	8743	0.692
NULL	Br_J_Cancer_2010_May_25_102(11)_1578-1591.nxml.txt.nlp	20502461	SENT176	16	16	10	10	geldanamycin	Hsp90	PA152031327	3320	0.692
NULL	J_Cancer_Prev_2014_Mar_19(1)_39-46.nxml.txt.nlp	25337571	SENT10	9	9	5	5	ethanol	p38	PA448073	10598;1432;7965	0.692
NULL	Exp_Cell_Res_2013_Aug_1_319(13)_2037-2048.nxml.txt.nlp	23562655	SENT15	33	33	36	36	urokinase	PLAUR	PA451836	5329	0.692
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT104	0	0	7	7	pertuzumab	HER3		2065	0.692
NULL	Br_J_Pharmacol_2014_Feb_24_171(1)_1019-1032.nxml.txt.nlp	24251620	SENT175	20	20	13	13	nitrendipine	TRPM3	PA146096020	80036	0.692
NULL	Acta_Pharmacol_Sin_2012_Feb_3_33(2)_173-181.nxml.txt.nlp	22301857	SENT245	11	11	15	15	sibutramine	Yes	PA451344	7525	0.692
NULL	Diabetes_Care_2011_Apr_21_34(4)_916-922.nxml.txt.nlp	21447663	SENT213	17	17	15	15	troglitazone	gamma	PA451799	9913	0.692
NULL	Front_Genet_2014_Nov_14_5_391.nxml.txt.nlp	25452763	SENT1057	10	10	2	2	cisplatin	ERCC1	PA449014	2067	0.692
NULL	Front_Genet_2013_Dec_16_4_281.nxml.txt.nlp	24379827	SENT319	33	33	24	24	nadh	HTR7	PA164755085	3363	0.692
NULL	BMJ_2009_Jul_14_339_b2538.nxml.txt.nlp	19602530	SENT113	25	25	16	16	etoricoxib	COX	PA164776853	1351	0.692
NULL	Front_Neurol_2014_Feb_18_5_17.nxml.txt.nlp	24600432	SENT159	6	6	15	15	levetiracetam	CD95	PA450206	355	0.692
NULL	Int_J_Inflam_2010_Aug_9_2010_151097.nxml.txt.nlp	21152121	SENT15	14	14	9	9	thrombin	C5a	PA451674	727	0.692
NULL	Oncotarget_2014_Sep_16_5(20)_10034-10047.nxml.txt.nlp	25296981	SENT194	15	15	5	5	doxorubicin	CHK1	PA449412	1111	0.692
NULL	Mol_Vis_2011_Aug_25_17_2297-2310.nxml.txt.nlp	21921981	SENT11	13	13	3	3	estradiol	HSD17B1	PA449503	3292	0.692
NULL	Diabetes_2011_Nov_17_60(11)_2691-2700.nxml.txt.nlp	21896928	SENT145	14	14	16	16	resveratrol	SIRT1		23411	0.692
NULL	Physiol_Rep_2014_Sep_11_2(9)_e12144.nxml.txt.nlp	25214522	SENT305	6	6	13	13	cisplatin	p53	PA449014	7157	0.692
NULL	Case_Rep_Hematol_2012_Dec_26_2012_803298.nxml.txt.nlp	23326737	SENT7	30	30	32	32	rituximab	CHOP	PA451261	1649	0.692
NULL	J_Phys_Ther_Sci_2014_Feb_28_26(2)_275-279.nxml.txt.nlp	24648648	SENT75	7	7	19	19	dextran	DTD	PA449261	1728	0.692
NULL	J_Carcinog_2014_Feb_20_13_4.nxml.txt.nlp	24737952	SENT300	24	24	8	8	oxaliplatin	EGFR	PA131285527	1956	0.692
NULL	Indian_J_Ophthalmol_2007_Nov-Dec_55(6)_421-425.nxml.txt.nlp	17951897	SENT46	0	0	7	7	bevacizumab	San	PA130232992	80218	0.692
NULL	Br_J_Cancer_2012_Jan_3_106(1)_18-24.nxml.txt.nlp	22108516	SENT167	16	16	24	24	irinotecan	Yes	PA450085	7525	0.692
NULL	J_Int_Soc_Sports_Nutr_2011_Nov_7_8(Suppl_1)_P25.nxml.txt.nlp	NULL	SENT18	2	2	4	4	creatine	GAA	PA164778930	2548	0.692
NULL	J_Biol_Chem_2012_Apr_20_287(17)_14122-14135.nxml.txt.nlp	22351750	SENT1128	15	15	9	9	hyaluronan	TSG-6	PA165958431	7130	0.692
NULL	Nat_Commun_2013_Sep_3_4_2394.nxml.txt.nlp	23999152	SENT64	8	8	3	3	dextran	BDNF	PA449261	627	0.692
NULL	Diabetes_Metab_J_2012_Oct_18_36(5)_328-335.nxml.txt.nlp	23130316	SENT8	14	14	9	9	rosiglitazone	adiponectin	PA451283	9370	0.692
NULL	Clin_Pharmacol_2011_Jun_22_3_13-25.nxml.txt.nlp	22287853	SENT181	22	22	19	19	simvastatin	CYP3A4	PA451363	1576	0.692
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT192	14	14	37	37	pertuzumab	Yes		7525	0.692
NULL	JAKSTAT_2013_Jan_1_2(1)_e23576.nxml.txt.nlp	24058797	SENT58	22	22	19	19	staurosporine	IFN	PA165109623	3439	0.692
NULL	Indian_J_Pharm_Sci_2008_Mar-Apr_70(2)_251-255.nxml.txt.nlp	20046726	SENT80	15	15	19	19	fluoxetine	TLC	PA449673	3933	0.692
NULL	Int_J_Biol_Sci_2012_Jan_6_8(2)_249-257.nxml.txt.nlp	22253568	SENT172	15	15	10	10	lipase	IL-22	PA450239	50616;53342	0.692
NULL	Br_J_Cancer_2010_Sep_7_103(6)_812-819.nxml.txt.nlp	20700124	SENT84	4	4	10	10	rituximab	San	PA451261	80218	0.692
NULL	Cell_Commun_Signal_2013_Oct_1_11_73.nxml.txt.nlp	24083678	SENT206	8	8	12	12	sulindac	A20	PA451565	7128;28935	0.692
NULL	J_Cancer_2012_Dec_25_4(1)_57-65.nxml.txt.nlp	23386905	SENT103	3	3	6	6	bleomycin	IL-22	PA448645	50616;53342	0.692
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_33-43.nxml.txt.nlp	17912634	SENT145	26	26	14	14	tamoxifen	HER2	PA451581	2064	0.692
NULL	Eur_J_Clin_Pharmacol_2012_Apr_8_68(4)_363-370.nxml.txt.nlp	21984116	SENT118	27	27	12	12	paroxetine	CYP2D6	PA450801	1565	0.692
NULL	Front_Genet_2012_Nov_2_3_234.nxml.txt.nlp	23130020	SENT108	11	11	7	7	bevacizumab	EGFR	PA130232992	1956	0.692
NULL	Environ_Health_Perspect_2006_Sep_23_114(9)_1401-1406.nxml.txt.nlp	16966095	SENT159	0	0	6	6	arsenite	p53	PA452638	7157	0.692
NULL	Eur_J_Appl_Physiol_2011_Feb_24_111(2)_275-283.nxml.txt.nlp	20865425	SENT195	29	29	37	37	glucose	MRS	PA449773	8011	0.692
NULL	Adv_Hematol_2014_Nov_27_2014_986938.nxml.txt.nlp	25525436	SENT126	0	0	7	7	ciprofloxacin	solo	PA449009	55701	0.692
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1047.nxml.txt.nlp	24503539	SENT152	6	6	3	3	resveratrol	SIRT3		23410	0.692
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT403	9	9	2	2	cetuximab	HER2	PA10040	2064	0.692
NULL	Cells_2012_Aug_3_1(3)_492-519.nxml.txt.nlp	24710487	SENT200	21	21	7	7	dextran	STAT3	PA449261	6774	0.692
NULL	Asian_J_Androl_2014_Dec_16_Jan-Feb_16(1)_146-152.nxml.txt.nlp	24369149	SENT83	4	4	9	9	estradiol	aromatase	PA449503	1588	0.692
NULL	Exp_Ther_Med_2014_Mar_10_7(3)_640-648.nxml.txt.nlp	24520260	SENT9	5	5	27	27	resveratrol	JNK		5599	0.692
NULL	Patient_Prefer_Adherence_2010_Feb_4_4_11-16.nxml.txt.nlp	20165594	SENT74	16	16	26	26	duloxetine	BPI	PA10066	671	0.692
NULL	Core_Evid_2010_Jul_27_5_1-10.nxml.txt.nlp	20694135	SENT36	11	11	7	7	entacapone	CLE	PA164748726	51637	0.692
NULL	Breast_Cancer_Res_2014_Nov_8_16(6)_470.nxml.txt.nlp	25380620	SENT111	18	18	3	3	urokinase	FZD4	PA451836	8322	0.692
NULL	EMBO_Mol_Med_2012_Jul_11_4(7)_577-593.nxml.txt.nlp	22496117	SENT83	21	21	17	17	clofazimine	PAP-1	PA164748759	6100	0.692
NULL	Clin_Ophthalmol_2014_Jan_13_8_219-228.nxml.txt.nlp	24531757	SENT174	12	12	4	4	timolol	TIM	PA451690	7984;8914	0.692
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT157	42	42	31	31	pp2	PP2		4888	0.692
NULL	Int_J_Biol_Sci_2014_Jan_11_10(2)_142-148.nxml.txt.nlp	24520212	SENT107	14	14	11	11	tamoxifen	WWOX	PA451581	51741	0.692
NULL	Int_J_Biol_Sci_2014_Sep_13_10(10)_1084-1096.nxml.txt.nlp	25332683	SENT319	22	22	14	14	berberine	San	PA165860812	80218	0.692
NULL	Case_Rep_Endocrinol_2013_Dec_22_2013_675298.nxml.txt.nlp	24455332	SENT154	13	13	15	15	dacarbazine	ACTH	PA449197	5443	0.692
NULL	Cancer_Metab_2014_May_28_2(Suppl_1)_P65.nxml.txt.nlp	NULL	SENT5	8	8	30	30	resveratrol	SIRT1		23411	0.692
NULL	Front_Genet_2012_Nov_22_3_249.nxml.txt.nlp	23189085	SENT151	32	32	40	40	s-adenosylmethionine	TPMT	PA164754994	7172	0.692
NULL	Front_Physiol_2013_Feb_27_4_30.nxml.txt.nlp	23450717	SENT211	15	15	0	0	resveratrol	SIRT1		23411	0.692
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_112-117.nxml.txt.nlp	23864844	SENT84	2	2	4	4	rituximab	CHOP	PA451261	1649	0.692
NULL	J_Korean_Med_Sci_2013_Dec_26_28(12)_1774-1780.nxml.txt.nlp	24339708	SENT143	25	25	15	15	octreotide	OST	PA450678	1650;23263	0.692
NULL	Front_Physiol_2015_Jan_5_5_501.nxml.txt.nlp	25601838	SENT195	2	2	14	14	etanercept	IL-6	PA449515	3569	0.692
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT83	30	30	21	21	celecoxib	IL-6	PA448871	3569	0.692
NULL	Cancer_Med_2014_Oct_25_3(5)_1099-1111.nxml.txt.nlp	24961511	SENT337	19	19	10	10	cisplatin	DUSP6	PA449014	1848	0.692
NULL	Clin_Ophthalmol_2007_Sep_1(3)_297-303.nxml.txt.nlp	19668484	SENT112	10	10	3	3	cyclosporine	MDR1	PA449167	5243	0.692
NULL	Oncogene_2014_Sep_11_33(37)_4579-4588.nxml.txt.nlp	24662835	SENT7	20	20	2	2	tamoxifen	MAGEA2	PA451581	4101;266740	0.692
NULL	Breast_Cancer_Res_2007_May_30_9(3)_R34.nxml.txt.nlp	17537232	SENT173	41	41	34	34	tamoxifen	TP53	PA451581	7157	0.692
NULL	Diabetes_2013_Nov_18_62(11)_3663-3665.nxml.txt.nlp	24158994	SENT70	9	9	19	19	acarbose	STOP	PA448010	4135	0.692
NULL	Diabetologia_2010_Jan_6_53(1)_1-6.nxml.txt.nlp	19894028	SENT110	18	18	11	11	sitagliptin	HIP	PA164748978	6767;6159;64399;5068	0.692
NULL	Br_J_Cancer_1991_Aug_64(2)_215-220.nxml.txt.nlp	1892748	SENT8	34	34	36	36	carboplatin	CHIP	PA448803	10273	0.692
NULL	Eur_J_Appl_Physiol_2011_Feb_24_111(2)_275-283.nxml.txt.nlp	20865425	SENT31	8	8	1	1	glucose	MRS	PA449773	8011	0.692
NULL	J_Physiol_2014_Nov_15_592(22)_5093-5107.nxml.txt.nlp	25239460	SENT209	3	3	0	0	sc-560	PAG		55824	0.692
NULL	Oncol_Lett_2014_Mar_16_7(3)_871-877.nxml.txt.nlp	24527095	SENT210	29	29	0	0	paclitaxel	TLR4	PA450761	7099	0.692
NULL	J_Hematol_Oncol_2012_Sep_18_5_57.nxml.txt.nlp	22989009	SENT205	20	20	15	15	nutlin-3	HDM2		4193	0.692
NULL	Arch_Drug_Inf_2008_Jul_1(1)_14-22.nxml.txt.nlp	20157364	SENT82	23	23	4	4	pravastatin	IL-6	PA451089	3569	0.692
NULL	Int_J_Biomed_Sci_2006_Jun_2(2)_121-134.nxml.txt.nlp	23674974	SENT178	2	2	21	21	lisinopril	CTR2	PA450242	1318	0.692
NULL	Br_J_Cancer_2011_Jun_28_105(1)_1-8.nxml.txt.nlp	21654681	SENT49	35	35	9	9	erlotinib	EGFR	PA134687924	1956	0.692
NULL	Oncotarget_2014_Aug_27_5(19)_9227-9238.nxml.txt.nlp	25193861	SENT135	24	24	10	10	cisplatin	PUMA	PA449014	27113	0.692
NULL	Asia_Pac_Allergy_2013_Oct_31_3(4)_266-280.nxml.txt.nlp	24260732	SENT61	6	6	18	18	diclofenac	CD63	PA449293	967	0.692
NULL	Breast_Cancer_Res_2011_Mar_11_13(2)_R30.nxml.txt.nlp	21396117	SENT18	32	32	5	5	erlotinib	p53	PA134687924	7157	0.692
NULL	Br_J_Cancer_1988_Jul_58(1)_42-45.nxml.txt.nlp	3166892	SENT10	22	22	24	24	metronidazole	MTR	PA450484	4548	0.692
NULL	Indian_J_Anaesth_2009_Aug_53(4)_399-400.nxml.txt.nlp	20640200	SENT12	22	22	11	11	propofol	NMB	PA451141	10457;4828	0.692
NULL	Mol_Cancer_2014_Jun_26_13_158.nxml.txt.nlp	24965046	SENT120	2	2	11	11	sorafenib	CD68	PA7000	968	0.692
NULL	Channels_(Austin)_2010_Jan_1_4(1)_22-41.nxml.txt.nlp	19934650	SENT15	1	1	6	6	quinidine	Slo3	PA451209	157855	0.692
NULL	Oncol_Lett_2014_Jan_29_7(1)_121-124.nxml.txt.nlp	24348832	SENT87	4	4	9	9	cisplatin	p53	PA449014	7157	0.692
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2009_Jun_1_65(Pt_6)_513-522.nxml.txt.nlp	19465765	SENT33	3	3	28	28	chloramphenicol	CLS	PA448927	1210	0.692
NULL	J_Biomed_Biotechnol_2010_May_13_2010_270985.nxml.txt.nlp	20490265	SENT39	31	31	29	29	neomycin	CEA	PA450608	5670;1087	0.692
NULL	Indian_J_Pharmacol_2013_Jul-Aug_45(4)_325-329.nxml.txt.nlp	24014904	SENT83	40	40	29	29	hydrocortisone	EGF	PA449905	1950	0.692
NULL	Case_Rep_Pediatr_2012_Aug_9_2012_323681.nxml.txt.nlp	22924145	SENT92	14	14	16	16	tocilizumab	IL-6	PA165292659	3569	0.692
NULL	Emerg_Infect_Dis_2011_Mar_17(3)_510-513.nxml.txt.nlp	21392446	SENT53	30	30	16	16	kanamycin	EMB	PA450137	133418	0.692
NULL	Oxid_Med_Cell_Longev_2013_Nov_28_2013_568093.nxml.txt.nlp	24379901	SENT53	20	20	14	14	resveratrol	SIRT1		23411	0.692
NULL	Int_J_Gen_Med_2011_Apr_19_4_333-343.nxml.txt.nlp	21674026	SENT302	8	8	18	18	ofloxacin	AK1	PA450684	203	0.692
NULL	J_Korean_Med_Sci_2010_Sep_14_25(9)_1277-1283.nxml.txt.nlp	20808669	SENT141	19	19	4	4	pamidronate	CTX	PA450767	1593	0.692
NULL	Front_Oncol_2013_Sep_23_3_250.nxml.txt.nlp	24069582	SENT427	6	6	8	8	metformin	HER2	PA450395	2064	0.692
NULL	Exp_Ther_Med_2014_Mar_17_7(3)_703-708.nxml.txt.nlp	24520271	SENT129	15	15	32	32	doxorubicin	IFN	PA449412	3439	0.692
NULL	Endocrinol_Metab_(Seoul)_2013_Dec_12_28(4)_262-274.nxml.txt.nlp	24396690	SENT51	22	22	14	14	exenatide	GLP-1	PA164749238	100125288	0.692
NULL	J_Oncol_2009_Mar_24_2009_491985.nxml.txt.nlp	19325924	SENT97	0	0	13	13	genistein	CXCL12	PA165109660	6387	0.692
NULL	J_Hematol_Oncol_2012_Aug_16_5_52.nxml.txt.nlp	22897982	SENT28	9	9	24	24	panitumumab	EGFR	PA162373091	1956	0.692
NULL	Clin_Ophthalmol_2014_Jan_13_8_219-228.nxml.txt.nlp	24531757	SENT181	17	17	9	9	timolol	TIM	PA451690	7984;8914	0.692
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT218	7	7	9	9	erlotinib	EGFR	PA134687924	1956	0.692
NULL	Scientifica_(Cairo)_2012_Nov_25_2012_478631.nxml.txt.nlp	24278700	SENT287	2	2	11	11	telaprevir	BOC	PA165958354	91653	0.692
NULL	Ann_Rheum_Dis_2010_Jun_1_69(6)_1029-1035.nxml.txt.nlp	20444755	SENT100	42	42	31	31	infliximab	TNF	PA452639	7124	0.692
NULL	Croat_Med_J_2014_Jun_55(3)_206-217.nxml.txt.nlp	24891279	SENT107	40	40	34	34	cisplatin	p53	PA449014	7157	0.691
NULL	Int_J_Biol_Sci_2012_Jul_7_8(6)_913-934.nxml.txt.nlp	22811614	SENT417	21	21	23	23	sitagliptin	GLP-1	PA164748978	100125288	0.691
NULL	Clinicoecon_Outcomes_Res_2014_Oct_17_6_451-461.nxml.txt.nlp	25378939	SENT30	12	12	25	25	linezolid	HAP	PA450233	5915;10313	0.691
NULL	Pan_Afr_Med_J_2014_Jun_2_18_107.nxml.txt.nlp	25404967	SENT57	8	8	10	10	cyanocobalamin	B12	PA451892	7126;4709	0.691
NULL	Reprod_Biol_Endocrinol_2003_Oct_3_1_62.nxml.txt.nlp	14567758	SENT195	24	24	26	26	lindane	ANOVA	PA164754914	4858	0.691
NULL	Eur_J_Haematol_2009_Apr_82(4)_277-287.nxml.txt.nlp	19187270	SENT212	17	17	22	22	pha-665752	IL-6		3569	0.691
NULL	Breast_Cancer_Res_2014_Jul_24_16(4)_411.nxml.txt.nlp	25056669	SENT10	14	14	32	32	tamoxifen	CD49b	PA451581	3673	0.691
NULL	Nucleic_Acids_Res_2012_Jul_5_40(13)_5988-6000.nxml.txt.nlp	22492511	SENT260	9	9	26	26	flavopiridol	MYB	PA452627	4602	0.691
NULL	Cardiol_Ther_2013_Jun_1_2(1)_111-124.nxml.txt.nlp	25135294	SENT121	10	10	2	2	dabigatran	P-gp		5243	0.691
NULL	Ann_Surg_Treat_Res_2014_Feb_22_86(2)_68-75.nxml.txt.nlp	24761411	SENT181	12	12	2	2	resveratrol	survivin		332	0.691
NULL	Case_Rep_Transplant_2014_Jan_2_2014_548243.nxml.txt.nlp	24575309	SENT12	23	23	28	28	ranolazine	CYP3A4	PA164746007	1576	0.691
NULL	Br_J_Cancer_2010_Jun_8_102(12)_1707-1716.nxml.txt.nlp	20461078	SENT170	34	34	8	8	bortezomib	IAP	PA10252	3375;84061;961	0.691
NULL	Crit_Care_2011_Oct_25_15(5)_R255.nxml.txt.nlp	22026977	SENT128	8	8	17	17	vasopressin	AVP	PA451858	114548;551	0.691
NULL	Cardiol_Res_Pract_2014_Nov_20_2014_784018.nxml.txt.nlp	25506463	SENT156	15	15	19	19	heparin	ACT	PA449855	12;11332;9457;641455	0.691
NULL	Curr_Neuropharmacol_2010_Sep_8(3)_254-267.nxml.txt.nlp	21358975	SENT191	21	21	32	32	eslicarbazepine	CYP3A4	PA165947475	1576	0.691
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT115	5	5	20	20	pertuzumab	HER3		2065	0.691
NULL	Front_Neurol_2014_Feb_18_5_17.nxml.txt.nlp	24600432	SENT105	21	21	2	2	levetiracetam	CD95	PA450206	355	0.691
NULL	J_Mol_Med_(Berl)_2014_Jan_10_92(5)_497-507.nxml.txt.nlp	24408111	SENT293	7	7	2	2	pioglitazone	gamma	PA450970	9913	0.691
NULL	Subst_Abuse_Treat_Prev_Policy_2008_Nov_18_3_22.nxml.txt.nlp	19017405	SENT26	17	17	32	32	methamphetamine	MTF	PA450403	4500	0.691
NULL	J_Cell_Biol_1998_Nov_2_143(3)_837-847.nxml.txt.nlp	9813101	SENT262	3	3	0	0	paraformaldehyde	CD44	PA450790	960	0.691
NULL	Oncoscience_2014_Apr_30_1(4)_272-282.nxml.txt.nlp	25594019	SENT115	11	11	8	8	flurbiprofen	FAAH	PA449683	79152;2166	0.691
NULL	Breast_Cancer_Res_2010_Jun_28_12(3)_R43.nxml.txt.nlp	20579400	SENT278	0	0	4	4	fulvestrant	MAPT	PA164747170	4137	0.691
NULL	Int_J_Mol_Sci_2014_Nov_25_15(12)_21703-21722.nxml.txt.nlp	25429431	SENT985	15	15	27	27	mitoxantrone	ABCC1	PA450526	4363	0.691
NULL	Ann_Rheum_Dis_2008_Jul_26_67(7)_917-925.nxml.txt.nlp	17965121	SENT86	6	6	3	3	rituximab	ACPA	PA451261	5657	0.691
NULL	J_Nat_Sci_Biol_Med_2011_Jan-Jun_2(1)_119-124.nxml.txt.nlp	22470245	SENT142	0	0	10	10	ondansetron	NNT	PA450705	23530	0.691
NULL	Eur_J_Dent_2011_Jan_5(1)_77-83.nxml.txt.nlp	21228958	SENT99	39	39	32	32	chlorhexidine	HEMA	PA164776863	2157	0.691
NULL	Environ_Health_Perspect_2005_Oct_14_113(10)_1330-1335.nxml.txt.nlp	16203242	SENT155	6	6	18	18	phenylephrine	MLC	PA450935	23209	0.691
NULL	Diabetes_2009_Jan_58(1)_250-259.nxml.txt.nlp	18840786	SENT261	32	32	29	29	rosiglitazone	FGF21	PA451283	26291	0.691
NULL	Cancers_(Basel)_2013_Jun_5_5(2)_676-713.nxml.txt.nlp	24216997	SENT2372	0	0	12	12	vorinostat	CD95	PA164748224	355	0.691
NULL	Trials_2014_Jan_7_15_9.nxml.txt.nlp	24398143	SENT27	24	24	28	28	paclitaxel	PES	PA450761	23481	0.691
NULL	Adv_Biomed_Res_2014_Sep_8_3_189.nxml.txt.nlp	25298958	SENT75	22	22	30	30	amoxicillin	NAC	PA448406	22861	0.691
NULL	Front_Immunol_2014_Aug_12_5_391.nxml.txt.nlp	25161656	SENT442	15	15	25	25	valganciclovir	CD4	PA10227	920	0.691
NULL	Acta_Pharmacol_Sin_2014_Jun_4_35(6)_752-757.nxml.txt.nlp	24902786	SENT98	16	16	5	5	letrozole	STL2	PA450196	1301	0.691
NULL	Mol_Cancer_2009_Aug_25_8_66.nxml.txt.nlp	19706164	SENT171	4	4	21	21	celecoxib	LC3	PA448871	84557	0.691
NULL	J_Headache_Pain_2010_Feb_18_11(1)_13-19.nxml.txt.nlp	20020170	SENT76	7	7	25	25	naratriptan	OTC	PA450597	5009	0.691
NULL	Anat_Cell_Biol_2011_Sep_29_44(3)_169-175.nxml.txt.nlp	22025968	SENT73	10	10	12	12	ethanol	CLU	PA448073	1191	0.691
NULL	Diagn_Pathol_2013_May_15_8_81.nxml.txt.nlp	23675804	SENT21	28	28	33	33	vincristine	CHOP	PA451879	1649	0.691
NULL	EPMA_J_2010_Sep_20_1(3)_421-437.nxml.txt.nlp	23199086	SENT273	26	26	18	18	docetaxel	HER2	PA449383	2064	0.691
NULL	Cell_Death_Dis_2014_Apr_17_5(4)_e1188.nxml.txt.nlp	24743743	SENT390	14	14	25	25	dantrolene	IRE1	PA449208	2081	0.691
NULL	Front_Endocrinol_(Lausanne)_2015_Jan_9_5_235.nxml.txt.nlp	25620956	SENT34	21	21	7	7	glucosamine	OGT	PA164747613	8473	0.691
NULL	J_Immunother_Cancer_2013_Nov_7_1(Suppl_1)_P88.nxml.txt.nlp	NULL	SENT12	28	28	30	30	bortezomib	DLL1	PA10252	28514	0.691
NULL	Drugs_R_D_2010_Sep_27_10(3)_203-210.nxml.txt.nlp	20945949	SENT11	26	26	32	32	boceprevir	SOC	PA165948902	91544	0.691
NULL	Cancers_(Basel)_2011_Apr_1_3(2)_1844-1860.nxml.txt.nlp	24212785	SENT566	12	12	18	18	cetuximab	KRAS	PA10040	3845	0.691
NULL	J_Biol_Chem_2013_May_3_288(18)_12459-12468.nxml.txt.nlp	23508951	SENT398	13	13	18	18	mibefradil	CA1	PA450492	759	0.691
NULL	J_Hematol_Oncol_2013_Oct_1_6_75.nxml.txt.nlp	24279871	SENT243	6	6	30	30	cyclophosphamide	IL-15	PA449165	3600	0.691
NULL	Open_Virol_J_2012_Feb_16_6_12-22.nxml.txt.nlp	22383906	SENT47	32	32	44	44	l-glutamine	CO2	PA10090	4513	0.691
NULL	Front_Mol_Neurosci_2012_Mar_26_5_37.nxml.txt.nlp	22470318	SENT108	6	6	11	11	resveratrol	SIRT1		23411	0.691
NULL	Hum_Genomics_2008_Sep_1_3(1)_7-16.nxml.txt.nlp	19129086	SENT175	24	24	6	6	rosiglitazone	SLCO1B1	PA451283	10599	0.691
NULL	Cell_Death_Differ_2009_Aug_20_16(8)_1135-1145.nxml.txt.nlp	19300452	SENT334	12	12	9	9	doxycycline	PUMA	PA449415	27113	0.691
NULL	Mol_Biol_Cell_2012_Mar_15_23(6)_996-1009.nxml.txt.nlp	22278744	SENT114	5	5	12	12	forskolin	14-3-3	PA146096022	10971	0.691
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jul_31_66(Pt_8)_o2157.nxml.txt.nlp	21588441	SENT47	8	8	11	11	benzaldehyde	mol	PA448571	90527	0.691
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Oct_14_6_159-168.nxml.txt.nlp	25339848	SENT135	17	17	12	12	trastuzumab	GM-CSF	PA451743	1437	0.691
NULL	Breast_Cancer_Res_2010_Mar_5_12(2)_R16.nxml.txt.nlp	20205716	SENT326	31	31	25	25	lovastatin	SDHA	PA450272	6389	0.691
NULL	Avicenna_J_Med_Biotechnol_2014_Jan-Mar_6(1)_27-37.nxml.txt.nlp	24551432	SENT29	5	5	0	0	gemcitabine	IP-10	PA449748	3627	0.691
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1724-1730.nxml.txt.nlp	19861964	SENT208	23	23	5	5	temozolomide	BRAF	PA451609	673	0.691
NULL	Br_J_Cancer_2011_Sep_27_105(7)_1030-1038.nxml.txt.nlp	21863025	SENT204	27	27	32	32	saracatinib	COPA		1314	0.691
NULL	Chin_J_Cancer_2011_Oct_30(10)_690-700.nxml.txt.nlp	21959046	SENT37	22	22	16	16	camptothecin	TPT	PA153590860	23590;6469	0.691
NULL	Cardiovasc_Diabetol_2013_May_29_12_80.nxml.txt.nlp	23718574	SENT203	0	0	14	14	mannitol	CD83	PA450320	9308	0.691
NULL	Mol_Neurodegener_2011_Jun_7_6_40.nxml.txt.nlp	21649894	SENT45	9	9	5	5	heparin	PTN	PA449855	5764	0.691
NULL	Croat_Med_J_2012_Jun_53(3)_214-223.nxml.txt.nlp	22661134	SENT101	26	26	34	34	reserpine	ACTH	PA451236	5443	0.691
NULL	Front_Genet_2013_Aug_29_4_163.nxml.txt.nlp	24009622	SENT15	6	6	2	2	ethanol	DDP	PA448073	1678	0.691
NULL	Breast_Cancer_Res_2010_Nov_16_12(6)_R96.nxml.txt.nlp	21080941	SENT301	10	10	20	20	lapatinib	HRG	PA152241907	3084;3273	0.691
NULL	Physiol_Rep_2014_Oct_10_2(10)_e12177.nxml.txt.nlp	25303952	SENT533	3	3	10	10	estradiol	CD16	PA449503	2215;2214	0.691
NULL	Niger_Med_J_2013_Mar-Apr_54(2)_100-106.nxml.txt.nlp	23798795	SENT73	3	3	10	10	indomethacin	PTEN	PA449982	5728	0.691
NULL	Diabetes_2008_Sep_57(9)_2272-2279.nxml.txt.nlp	18519799	SENT154	4	4	6	6	rosiglitazone	PDK4	PA451283	5166	0.691
NULL	Allergy_Asthma_Immunol_Res_2012_Sep_21_4(5)_290-294.nxml.txt.nlp	22950035	SENT70	20	20	33	33	simvastatin	IL-4	PA451363	3565	0.691
NULL	Int_J_Inflam_2010_Aug_9_2010_151097.nxml.txt.nlp	21152121	SENT334	20	20	24	24	thrombin	C3a	PA451674	718	0.691
NULL	Arthritis_Res_Ther_2008_Oct_15_10(Suppl_1)_S4.nxml.txt.nlp	19007424	SENT34	38	38	33	33	rituximab	ACR	PA451261	49	0.691
NULL	J_Cell_Mol_Med_2014_Dec_7_18(12)_2536-2552.nxml.txt.nlp	25287328	SENT173	15	15	22	22	estradiol	PKD1	PA449503	5310	0.691
NULL	Indian_J_Crit_Care_Med_2010_Oct-Dec_14(4)_188-195.nxml.txt.nlp	21572750	SENT68	32	32	25	25	thrombin	P2Y12	PA451674	64805	0.691
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT16	4	4	19	19	gefitinib	KRAS	PA131301952	3845	0.691
NULL	Diabetes_2009_Apr_23_58(4)_917-925.nxml.txt.nlp	19168598	SENT74	11	11	28	28	paraformaldehyde	FOXO1	PA450790	2308	0.691
NULL	Environ_Health_Perspect_2010_Jun_25_118(6)_864-870.nxml.txt.nlp	20100676	SENT150	19	19	11	11	arsenite	INS-1	PA452638	2305	0.691
NULL	Gynecol_Oncol_Case_Rep_2013_Sep_21_6_42-44.nxml.txt.nlp	24371718	SENT100	11	11	28	28	tamoxifen	ATAC	PA451581	6375	0.691
NULL	Indian_J_Pharm_Sci_2012_Nov-Dec_74(6)_505-511.nxml.txt.nlp	23798775	SENT84	9	9	24	24	indomethacin	IL20	PA449982	50604	0.691
NULL	Eur_J_Med_Res_2009_Nov_24_14(Suppl_3)_36-42.nxml.txt.nlp	19959415	SENT34	7	7	14	14	didanosine	gamma	PA449301	9913	0.691
NULL	Emerg_Infect_Dis_2005_Jun_11(6)_839-843.nxml.txt.nlp	15963277	SENT239	17	17	6	6	tetracycline	Ray	PA451640	26751	0.691
NULL	Oncoimmunology_2013_Jun_1_2(6)_e24614.nxml.txt.nlp	23894721	SENT15	4	4	31	31	trabectedin	TRAIL	PA165958349	8743	0.691
NULL	Pak_J_Med_Sci_2014_May-Jun_30(3)_488-492.nxml.txt.nlp	24948964	SENT104	18	18	5	5	docetaxel	RRM2	PA449383	6241	0.691
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT151	10	10	5	5	doxorubicin	SLK	PA449412	9748;2534	0.691
NULL	Mol_Cancer_2014_Jun_27_13_159.nxml.txt.nlp	24972933	SENT132	13	13	22	22	rituximab	CTRL	PA451261	1506	0.691
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT101	0	0	10	10	resveratrol	TRAIL-R2		8795	0.691
NULL	Int_J_Gen_Med_2011_Jul_20_4_539-545.nxml.txt.nlp	21845063	SENT29	11	11	20	20	miglitol	adiponectin	PA164776726	9370	0.691
NULL	Cell_Tissue_Res_2012_Sep_10_349(3)_635-647.nxml.txt.nlp	22322423	SENT200	3	3	5	5	diethylstilbestrol	DES	PA449307	1674	0.691
NULL	Cancer_Manag_Res_2011_Aug_10_3_273-285.nxml.txt.nlp	21931501	SENT318	13	13	15	15	bevacizumab	IFN	PA130232992	3439	0.691
NULL	J_Gen_Physiol_1990_Sep_1_96(3)_535-557.nxml.txt.nlp	2230711	SENT0	16	16	1	1	nifedipine	Gen	PA450631	348654	0.691
NULL	Cancer_Cell_Int_2011_Nov_17_11_40.nxml.txt.nlp	22088142	SENT102	0	0	9	9	gemcitabine	MAPK14	PA449748	1432	0.691
NULL	Drugs_R_D_2010_Nov_25_10(4)_219-224.nxml.txt.nlp	21171668	SENT103	22	22	10	10	clopidogrel	DES	PA449053	1674	0.691
NULL	Biomed_Res_Int_2013_Jan_21_2013_581631.nxml.txt.nlp	23484133	SENT127	20	20	30	30	infliximab	VEGF-A	PA452639	7422	0.691
NULL	Infect_Dis_Obstet_Gynecol_2008_May_29_2008_493508.nxml.txt.nlp	18528520	SENT89	19	19	21	21	tetracycline	CDR1	PA451640	1038	0.691
NULL	Diabetologia_2010_Jun_27_53(6)_1142-1150.nxml.txt.nlp	20349036	SENT248	7	7	19	19	spermine	AMPK	PA164781199	5563	0.691
NULL	Acta_Orthop_2010_Apr_6_81(2)_263-267.nxml.txt.nlp	20148646	SENT158	31	31	26	26	taurine	ATF4	PA451590	468	0.691
NULL	J_Biol_Chem_2009_Sep_11_284(37)_24965-24971.nxml.txt.nlp	19592485	SENT7	29	29	33	33	vasopressin	NKCC2	PA451858	6557	0.691
NULL	Int_J_Mol_Imaging_2011_Oct_26_2011_874585.nxml.txt.nlp	21490735	SENT124	13	13	3	3	doxorubicin	FDG	PA449412	23583	0.691
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT156	8	8	3	3	doxorubicin	ABCB1	PA449412	5243	0.691
NULL	Oncotarget_2014_Feb_16_5(3)_587-598.nxml.txt.nlp	24583822	SENT110	15	15	26	26	carboplatin	IRF7	PA448803	3665	0.691
NULL	eLife_2014_Mar_26_3_e01438.nxml.txt.nlp	24670955	SENT583	22	22	9	9	quinidine	Slo3	PA451209	157855	0.691
NULL	J_Breast_Cancer_2014_Mar_28_17(1)_61-68.nxml.txt.nlp	24744799	SENT152	22	22	31	31	sorafenib	HER2	PA7000	2064	0.691
NULL	Diabetes_Care_2012_Feb_16_35(2)_327-333.nxml.txt.nlp	22179958	SENT80	37	37	31	31	metformin	B12	PA450395	7126;4709	0.691
NULL	Ann_Surg_Treat_Res_2014_Feb_22_86(2)_68-75.nxml.txt.nlp	24761411	SENT144	16	16	9	9	oxaliplatin	Bcl-2	PA131285527	596	0.691
NULL	AIDS_2013_Oct_23_27(16)_2587-2592.nxml.txt.nlp	23921616	SENT116	11	11	6	6	abacavir	HLA-B	PA448004	3106	0.691
NULL	Endocrinology_2014_Aug_30_155(8)_2976-2985.nxml.txt.nlp	24877623	SENT12	14	14	40	40	estradiol	TSPO	PA449503	706	0.691
NULL	Acta_Neuropathol_Commun_2013_May_20_1_17.nxml.txt.nlp	24252689	SENT6	33	33	18	18	fluvastatin	ICAM1	PA449688	3383	0.691
NULL	Biomed_Res_Int_2013_Dec_5_2013_642848.nxml.txt.nlp	24381940	SENT160	4	4	10	10	telmisartan	IL-6	PA451605	3569	0.691
NULL	Breast_Cancer_Res_Treat_2012_Nov_29_136(1)_129-142.nxml.txt.nlp	23053642	SENT44	35	35	46	46	l-glutamine	CO2	PA10090	4513	0.691
NULL	Oncol_Rep_2014_Feb_16_31(2)_573-580.nxml.txt.nlp	24337632	SENT41	16	16	25	25	l-glutamine	CO2	PA10090	4513	0.691
NULL	Evid_Based_Complement_Alternat_Med_2014_Sep_3_2014_809083.nxml.txt.nlp	25276218	SENT166	7	7	13	13	berberine	TLR4	PA165860812	7099	0.691
NULL	Mol_Cancer_2012_Jul_25_11_46.nxml.txt.nlp	22830422	SENT80	17	17	6	6	rolipram	ZO-1	PA153906323	7082	0.691
NULL	Eur_J_Histochem_2011_Apr_1_55(2)_e11.nxml.txt.nlp	22073367	SENT134	2	2	21	21	hyaluronan	DR5	PA165958431	8795	0.691
NULL	Br_J_Cancer_2011_Apr_12_104(8)_1256-1261.nxml.txt.nlp	21448165	SENT161	10	10	35	35	sorafenib	IL2	PA7000	3558	0.691
NULL	Adv_Appl_Bioinforma_Chem_2008_Oct_30_1_85-98.nxml.txt.nlp	21918608	SENT80	4	4	6	6	bortezomib	SPARC	PA10252	6678	0.691
NULL	Int_J_Environ_Res_Public_Health_2013_Sep_17_10(9)_4352-4389.nxml.txt.nlp	24048206	SENT7	10	10	7	7	betaine	B12	PA448603	7126;4709	0.691
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT160	11	11	16	16	perifosine	DR4	PA165291471	8797	0.691
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2011_Sep_13_4_47-62.nxml.txt.nlp	22879794	SENT62	16	16	0	0	liraglutide	PPG	PA165958364	5552	0.691
NULL	Arthritis_Res_Ther_2013_Mar_25_15(Suppl_1)_S3.nxml.txt.nlp	23566754	SENT80	43	43	35	35	rituximab	BAFF	PA451261	10673	0.691
NULL	Breast_Cancer_Res_2009_Jul_22_11(4)_R50.nxml.txt.nlp	19624808	SENT213	17	17	7	7	pertuzumab	EGFR		1956	0.691
NULL	J_Hematol_Oncol_2012_Sep_18_5_57.nxml.txt.nlp	22989009	SENT234	0	0	3	3	nutlin-3	p53		7157	0.691
NULL	Br_J_Cancer_2013_Jan_15_108(1)_82-90.nxml.txt.nlp	23321512	SENT219	12	12	27	27	cisplatin	TUBB3	PA449014	10381	0.691
NULL	Acta_Neuropathol_2010_Nov_17_120(5)_567-584.nxml.txt.nlp	20714900	SENT418	25	25	13	13	temozolomide	ADP	PA451609	23038	0.691
NULL	Allergy_Asthma_Clin_Immunol_2013_Aug_15_9(1)_30.nxml.txt.nlp	23947590	SENT325	12	12	2	2	cosyntropin	ACTH	PA164749052	5443	0.691
NULL	J_Immunother_Cancer_2013_Nov_7_1(Suppl_1)_P1.nxml.txt.nlp	NULL	SENT5	12	12	20	20	fludarabine	IL-2	PA449655	3558	0.691
NULL	Adv_Ther_2014_Oct_21_31(10)_1082-1094.nxml.txt.nlp	25331616	SENT249	3	3	0	0	melphalan	San	PA450354	80218	0.691
NULL	Autophagy_2012_May_1_8(5)_853-855.nxml.txt.nlp	22617440	SENT58	16	16	3	3	imatinib	MIR30A	PA10804	407029	0.691
NULL	Br_J_Pharmacol_2014_Sep_28_171(18)_4255-4272.nxml.txt.nlp	24846338	SENT196	13	13	10	10	escitalopram	gamma	PA10074	9913	0.691
NULL	J_Cardiothorac_Surg_2013_Apr_29_8_113.nxml.txt.nlp	23628149	SENT52	19	19	27	27	heparin	ACT	PA449855	12;11332;9457;641455	0.691
NULL	Biologics_2011_Aug_9_5_87-94.nxml.txt.nlp	21847344	SENT147	17	17	38	38	cisplatin	HER2	PA449014	2064	0.691
NULL	Braz_J_Med_Biol_Res_2014_May_9_47(6)_478-482.nxml.txt.nlp	24770568	SENT82	6	6	15	15	cisplatin	CD133	PA449014	8842	0.691
NULL	J_Geriatr_Cardiol_2013_Jun_10(2)_151-158.nxml.txt.nlp	23888175	SENT4	7	7	36	36	rosuvastatin	ACE2	PA134308647	59272	0.691
NULL	Ann_Lab_Med_2013_Sep_8_33(5)_383-385.nxml.txt.nlp	24003434	SENT83	20	20	6	6	cefepime	CTX	PA164754876	1593	0.691
NULL	Br_J_Cancer_2011_Jan_4_104(1)_91-100.nxml.txt.nlp	21139584	SENT194	6	6	12	12	geldanamycin	Hsp90	PA152031327	3320	0.691
NULL	Aging_(Albany_NY)_2010_Sep_18_2(9)_535-537.nxml.txt.nlp	20876940	SENT33	17	17	23	23	doxorubicin	CDKN1A	PA449412	1026	0.691
NULL	Arthritis_Res_Ther_2008_Aug_15_10(4)_R92.nxml.txt.nlp	18706093	SENT138	4	4	13	13	collagenase	MT1-MMP	PA449107	4323	0.691
NULL	Ann_Gastroenterol_2014_27(4)_313-319.nxml.txt.nlp	25331779	SENT66	21	21	10	10	metronidazole	POR	PA450484	5447	0.691
NULL	Int_J_Alzheimer_Dis_2010_Jun_14_2010_732806.nxml.txt.nlp	20798769	SENT215	21	21	8	8	rofecoxib	COX	PA451268	1351	0.691
NULL	Indian_J_Dermatol_2010_Apr-Jun_55(2)_195-197.nxml.txt.nlp	20606896	SENT47	14	14	10	10	ivermectin	gamma	PA450133	9913	0.691
NULL	Diabetes_Care_2010_Mar_15_33(3)_608-613.nxml.txt.nlp	20009095	SENT130	6	6	2	2	ramipril	DREAM	PA451223	30818	0.691
NULL	Trials_2014_Oct_7_15(1)_391.nxml.txt.nlp	NULL	SENT288	3	3	11	11	varenicline	Gen	PA164781343	348654	0.691
NULL	ISRN_Otolaryngol_2012_Oct_16_2012_706896.nxml.txt.nlp	23762616	SENT24	11	11	30	30	vasopressin	AQP5	PA451858	362	0.691
NULL	EMBO_Mol_Med_2012_Jul_11_4(7)_577-593.nxml.txt.nlp	22496117	SENT265	39	39	35	35	clofazimine	PAP-1	PA164748759	6100	0.691
NULL	Cell_Death_Dis_2010_Jul_1_1(7)_e51.nxml.txt.nlp	21364656	SENT78	3	3	18	18	gentamicin	survivin	PA449753	332	0.691
NULL	Open_Biochem_J_2012_Jul_27_6_78-93.nxml.txt.nlp	22888373	SENT231	36	36	3	3	thrombin	HDL2	PA451674	57338	0.691
NULL	Mol_Cancer_2009_Dec_23_8_129.nxml.txt.nlp	20030852	SENT176	3	3	5	5	curcumin	p65	PA151958596	5970	0.691
NULL	Cancer_Cell_Int_2013_Jun_26_13_63.nxml.txt.nlp	23800022	SENT140	34	34	36	36	genistein	XIAP	PA165109660	331	0.691
NULL	Channels_(Austin)_2010_Jan_1_4(1)_22-41.nxml.txt.nlp	19934650	SENT340	15	15	26	26	quinidine	Slo3	PA451209	157855	0.691
NULL	Int_J_Mol_Sci_2012_Sep_26_13(10)_12336-12348.nxml.txt.nlp	23202901	SENT59	15	15	1	1	phenol	P90	PA450913	821	0.691
NULL	Cell_Commun_Signal_2013_Nov_11_11_86.nxml.txt.nlp	24215724	SENT273	30	30	22	22	thrombin	PAR3	PA451674	56288;2151	0.691
NULL	Indian_J_Pharmacol_2008_Oct_40(Suppl_2)_S112-S142.nxml.txt.nlp	21593965	SENT1761	5	5	12	12	l-arginine	EPM	PA448478	2054	0.691
NULL	Cardiovasc_Ultrasound_2007_Jan_25_5_4.nxml.txt.nlp	17254324	SENT145	32	32	20	20	vincristine	CHOP	PA451879	1649	0.691
NULL	Pharmaceuticals_(Basel)_2011_Nov_11_4(11)_1503-1517.nxml.txt.nlp	NULL	SENT458	4	4	15	15	capsaicin	TRPV1	PA448776	7442	0.691
NULL	Clin_Psychopharmacol_Neurosci_2012_Aug_31_10(2)_78-87.nxml.txt.nlp	23430971	SENT75	28	28	22	22	olanzapine	FES	PA450688	2242	0.691
NULL	Mol_Biol_Cell_2012_May_15_23(10)_1812-1825.nxml.txt.nlp	22438585	SENT213	3	3	14	14	amiloride	EGF	PA448368	1950	0.691
NULL	Oncotarget_2011_Dec_24_2(12)_896-917.nxml.txt.nlp	22203527	SENT167	2	2	7	7	metformin	HER2	PA450395	2064	0.691
NULL	J_RNAi_Gene_Silencing_2010_May_29_6(1)_386-400.nxml.txt.nlp	20628499	SENT368	20	20	10	10	flavopiridol	Dicer	PA452627	23405	0.691
NULL	Pain_Ther_2014_Jun_13_3(1)_59-69.nxml.txt.nlp	25135388	SENT180	0	0	20	20	curcumin	HSD1	PA151958596	26871	0.691
NULL	Hum_Mol_Genet_2013_Aug_1_22(15)_3112-3122.nxml.txt.nlp	23575225	SENT279	24	24	20	20	gentamicin	B27	PA449753	56246	0.691
NULL	J_Korean_Med_Sci_2013_Jun_3_28(6)_939-945.nxml.txt.nlp	23772162	SENT142	7	7	14	14	resveratrol	IVD		3712	0.691
NULL	J_Exp_Clin_Cancer_Res_2010_Apr_27_29(1)_38.nxml.txt.nlp	20423465	SENT147	15	15	7	7	pemetrexed	B12	PA10810	7126;4709	0.691
NULL	Biochem_Res_Int_2012_Feb_12_2012_346972.nxml.txt.nlp	22400115	SENT5	1	1	9	9	hyaluronan	CD44	PA165958431	960	0.691
NULL	J_Inherit_Metab_Dis_2012_Jan_10_35(1)_141-149.nxml.txt.nlp	21556832	SENT184	7	7	18	18	creatine	CRTR	PA164778930	6535	0.691
NULL	J_Invest_Dermatol_2012_Nov_21_132(11)_2642-2651.nxml.txt.nlp	22718118	SENT251	8	8	3	3	collagenase	CD11b	PA449107	3684	0.691
NULL	Adv_Pharmacol_Sci_2014_Nov_20_2014_373295.nxml.txt.nlp	25505905	SENT245	10	10	6	6	curcumin	EGF	PA151958596	1950	0.691
NULL	Pharm_Pract_(Granada)_2011_Mar_15_Jan-Mar_9(1)_1-10.nxml.txt.nlp	25132883	SENT151	8	8	15	15	rivaroxaban	SPAF	PA165958360	166378	0.691
NULL	Mediators_Inflamm_2010_Jun_8_2010_642462.nxml.txt.nlp	20628562	SENT20	17	17	23	23	choline	HMGB1	PA448976	3146	0.691
NULL	Health_Policy_Plan_2013_Sep_17_28(6)_616-625.nxml.txt.nlp	23161588	SENT119	16	16	23	23	amodiaquine	IPT	PA448404	54802	0.691
NULL	EMBO_Mol_Med_2012_Mar_4(3)_180-191.nxml.txt.nlp	22174035	SENT163	10	10	21	21	dantrolene	RYR2	PA449208	6262	0.691
NULL	J_Mammary_Gland_Biol_Neoplasia_2010_Mar_27_15(1)_5-17.nxml.txt.nlp	20101446	SENT179	4	4	15	15	tamoxifen	HuR	PA451581	1994	0.691
NULL	Front_Endocrinol_(Lausanne)_2015_Jan_9_5_235.nxml.txt.nlp	25620956	SENT154	25	25	15	15	glucosamine	OGT	PA164747613	8473	0.691
NULL	J_Asthma_Allergy_2008_Sep_19_1_19-29.nxml.txt.nlp	21436982	SENT110	0	0	26	26	fexofenadine	TARC	PA449621	6361	0.691
NULL	Oncotarget_2013_Jul_18_4(10)_1582-1591.nxml.txt.nlp	24123600	SENT139	33	33	30	30	imatinib	SLC22A1	PA10804	6580	0.691
NULL	Indian_J_Dermatol_2014_Sep-Oct_59(5)_425-441.nxml.txt.nlp	25284845	SENT121	0	0	12	12	alefacept	CD2	PA164748040	914	0.691
NULL	J_Exp_Med_2000_Mar_6_191(5)_859-870.nxml.txt.nlp	10704466	SENT141	20	20	15	15	arsenite	p38	PA452638	10598;1432;7965	0.691
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Apr_29_67(Pt_5)_o1266-o1267.nxml.txt.nlp	21754553	SENT71	38	38	19	19	ethanol	mol	PA448073	90527	0.691
NULL	J_Lipid_Res_2012_May_53(5)_1000-1011.nxml.txt.nlp	22368281	SENT222	22	22	5	5	pravastatin	LPA	PA451089	4018	0.691
NULL	Biochem_Res_Int_2012_Mar_4_2012_685267.nxml.txt.nlp	22496978	SENT7	21	21	11	11	thrombin	HSPC	PA451674	5688	0.691
NULL	Int_J_Mol_Sci_2012_Feb_28_13(3)_2692-2706.nxml.txt.nlp	22489118	SENT37	21	21	11	11	naringenin	CHS	PA151958361	1130	0.691
NULL	Acta_Pharmacol_Sin_2009_Jul_3_30(7)_889-898.nxml.txt.nlp	19574994	SENT149	37	37	14	14	pp2	EGFR		1956	0.691
NULL	Hum_Genomics_2009_Jan_1_3(2)_128-142.nxml.txt.nlp	19164090	SENT168	31	31	10	10	carboplatin	CD44	PA448803	960	0.691
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT403	16	16	8	8	heparin	FGF1	PA449855	2246	0.691
NULL	J_Cell_Biol_2004_Jul_5_166(1)_121-131.nxml.txt.nlp	15226307	SENT285	27	27	30	30	fluorescein	CTB	PA164746009	9468	0.691
NULL	Oncotarget_2014_Sep_3_5(19)_9362-9381.nxml.txt.nlp	25313139	SENT269	22	22	15	15	orlistat	SREBP2	PA164776864	6721	0.691
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT166	16	16	41	41	trastuzumab	HER3	PA451743	2065	0.691
NULL	Cancer_Med_2013_Jun_25_2(3)_277-285.nxml.txt.nlp	23930204	SENT121	6	6	19	19	capecitabine	PTEN	PA448771	5728	0.691
NULL	Case_Rep_Transplant_2014_Jan_2_2014_548243.nxml.txt.nlp	24575309	SENT100	24	24	8	8	sirolimus	CYP3A4	PA451365	1576	0.691
NULL	Br_J_Cancer_2010_Oct_26_103(9)_1331-1334.nxml.txt.nlp	20877352	SENT36	9	9	4	4	trastuzumab	GM-CSF	PA451743	1437	0.691
NULL	Neural_Regen_Res_2014_Jun_1_9(11)_1129-1137.nxml.txt.nlp	25206772	SENT49	7	7	11	11	trypsin	San	PA451806	80218	0.691
NULL	Biomed_Res_Int_2014_Jan_14_2014_182197.nxml.txt.nlp	24551841	SENT49	3	3	14	14	vancomycin	GIT	PA451850	5034	0.691
NULL	Front_Behav_Neurosci_2009_Jan_27_3_1.nxml.txt.nlp	19194528	SENT384	19	19	2	2	olanzapine	spatial	PA450688	219793	0.691
NULL	Cancer_Immunol_Immunother_2012_Oct_8_61(10)_1713-1720.nxml.txt.nlp	22399057	SENT8	4	4	10	10	plerixafor	CXCR4	PA165958410	7852	0.691
NULL	Crit_Care_2010_Feb_16_14(1)_R21.nxml.txt.nlp	20158893	SENT157	0	0	7	7	sevoflurane	Bcl-2	PA451341	596	0.691
NULL	Hum_Genomics_2008_Sep_1_3(1)_7-16.nxml.txt.nlp	19129086	SENT147	4	4	12	12	rosiglitazone	SLCO1B1	PA451283	10599	0.691
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_650809.nxml.txt.nlp	23258995	SENT202	7	7	22	22	vasopressin	AQP2	PA451858	359	0.691
NULL	Front_Oncol_2014_Jun_18_4_159.nxml.txt.nlp	24995161	SENT154	2	2	19	19	estradiol	AKR1C3	PA449503	8644	0.691
NULL	Br_J_Cancer_2011_Mar_15_104(6)_941-947.nxml.txt.nlp	21407223	SENT159	13	13	16	16	sorafenib	survivin	PA7000	332	0.691
NULL	Eur_J_Neurosci_2009_Aug_30(3)_347-354.nxml.txt.nlp	19614749	SENT137	5	5	15	15	scopolamine	gamma	PA451308	9913	0.691
NULL	BMB_Rep_2013_Mar_46(3)_157-162.nxml.txt.nlp	23527859	SENT110	17	17	9	9	galactose	mol	PA449725	90527	0.691
NULL	Anal_Chem_Insights_2007_Sep_17_2_69-74.nxml.txt.nlp	19662179	SENT54	15	15	10	10	trypsin	hole	PA451806	80757	0.691
NULL	J_Cell_Biol_1998_May_18_141(4)_1083-1093.nxml.txt.nlp	9585425	SENT52	8	8	17	17	trypsin	CO2	PA451806	4513	0.691
NULL	Antimicrob_Agents_Chemother_2014_Oct_58(10)_5900-5908.nxml.txt.nlp	25070091	SENT241	2	2	12	12	metoprolol	CYP2D6	PA450480	1565	0.691
NULL	Cancer_Manag_Res_2013_Jun_11_5_103-115.nxml.txt.nlp	23807861	SENT56	23	23	8	8	bevacizumab	VEGF-A	PA130232992	7422	0.691
NULL	J_Psychopharmacol_2014_Sep_28(9)_837-846.nxml.txt.nlp	25035246	SENT5	4	4	6	6	atomoxetine	ATX	PA134688071	5168;23049	0.691
NULL	Drug_Saf_2014_Feb_19_37(4)_201-211.nxml.txt.nlp	24550106	SENT303	2	2	9	9	fluvoxamine	CYP2C19	PA449690	1557	0.691
NULL	Br_J_Nutr_2011_Dec_14_106(11)_1655-1663.nxml.txt.nlp	21736792	SENT238	16	16	23	23	resveratrol	AMPK		5563	0.691
NULL	J_Biol_Chem_2012_Aug_24_287(35)_30000-30013.nxml.txt.nlp	22773837	SENT14	25	25	13	13	thrombin	GPVI	PA451674	51206	0.691
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1522-1532.nxml.txt.nlp	21997136	SENT256	6	6	19	19	lapatinib	ABCG2	PA152241907	9429	0.691
NULL	Clin_Med_Oncol_2008_Mar_1_2_135-144.nxml.txt.nlp	21892276	SENT103	18	18	23	23	oxaliplatin	CRT	PA131285527	811	0.691
NULL	J_Occup_Med_Toxicol_2008_Feb_27_3(Suppl_1)_S6.nxml.txt.nlp	18315837	SENT67	6	6	12	12	salbutamol	IL-13	PA448068	3596	0.691
NULL	Arch_Osteoporos_2013_Sep_13_8(1-2)_144.nxml.txt.nlp	24030479	SENT1004	9	9	30	30	alendronate	PTH	PA448082	5741	0.691
NULL	Mol_Cancer_2014_Jun_5_13_143.nxml.txt.nlp	24898067	SENT39	24	24	26	26	trastuzumab	HER-2	PA451743	2064	0.691
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT64	3	3	37	37	metformin	p53	PA450395	7157	0.691
NULL	J_Immunother_Cancer_2013_Sep_23_1_16.nxml.txt.nlp	24829752	SENT19	23	23	12	12	methylcholanthrene	IFN	PA165816878	3439	0.691
NULL	Front_Neuroanat_2015_Jan_6_8_156.nxml.txt.nlp	25610374	SENT51	14	14	36	36	tamoxifen	E12	PA451581	64100	0.691
NULL	Pharmaceuticals_(Basel)_2013_Aug_21_6(8)_988-1038.nxml.txt.nlp	24276379	SENT498	20	20	28	28	oxaliplatin	CD133	PA131285527	8842	0.691
NULL	Diabetes_2009_Jul_28_58(7)_1518-1525.nxml.txt.nlp	19401427	SENT298	2	2	10	10	simvastatin	PC-3	PA451363	692094	0.691
NULL	Diabetes_Care_2009_Nov_32(Suppl_2)_S403-S409.nxml.txt.nlp	19875589	SENT225	10	10	3	3	sibutramine	S24	PA451344	6229	0.691
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_P98.nxml.txt.nlp	NULL	SENT19	7	7	4	4	lornoxicam	DPT	PA165958395	1805	0.691
NULL	Breast_Cancer_Res_2003_Jul_29_5(5)_235-238.nxml.txt.nlp	12927031	SENT24	10	10	7	7	thyroglobulin	TPO	PA164754910	7066;7173	0.691
NULL	Front_Pharmacol_2014_Sep_17_5_212.nxml.txt.nlp	25278898	SENT48	11	11	33	33	ethanol	ACTH	PA448073	5443	0.691
NULL	Drug_Healthc_Patient_Saf_2012_Nov_29_4_173-180.nxml.txt.nlp	23236256	SENT66	36	36	22	22	clozapine	FGA	PA449061	2243	0.691
NULL	Cent_European_J_Urol_2013_Apr_26_66(1)_39-44.nxml.txt.nlp	24578986	SENT87	31	31	23	23	ifosfamide	ADM	PA449964	133	0.691
NULL	Diagn_Pathol_2013_May_1_8_70.nxml.txt.nlp	23635099	SENT48	19	19	31	31	l-glutamine	CO2	PA10090	4513	0.691
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT139	0	0	2	2	perifosine	DR4	PA165291471	8797	0.691
NULL	J_Autom_Methods_Manag_Chem_2008_Apr_5_2008_502953.nxml.txt.nlp	19365566	SENT1469	8	8	5	5	imipramine	DMPK	PA449969	1760	0.691
NULL	BMJ_Open_2014_Feb_15_4(2)_e004104.nxml.txt.nlp	24534257	SENT106	10	10	14	14	artemisinin	TRAC	PA165111696	28755	0.691
NULL	Clin_Mol_Hepatol_2012_Jun_26_18(2)_109-162.nxml.txt.nlp	22893865	SENT694	17	17	12	12	telbivudine	IFN	PA164760861	3439	0.691
NULL	Lab_Invest_2013_Mar_7_93(3)_354-364.nxml.txt.nlp	23295648	SENT42	18	18	43	43	l-glutamine	CO2	PA10090	4513	0.691
NULL	Arthritis_Res_Ther_2010_Apr_29_12(2)_R73.nxml.txt.nlp	20429888	SENT161	4	4	32	32	bortezomib	AP2	PA10252	2971	0.691
NULL	Front_Neurosci_2014_Jun_3_8_128.nxml.txt.nlp	24917782	SENT17	14	14	21	21	ethanol	MC3R	PA448073	4159	0.691
NULL	Ann_Rheum_Dis_2010_Jun_1_69(6)_1029-1035.nxml.txt.nlp	20444755	SENT151	26	26	12	12	acenocoumarol	CYP2C9	PA452632	1559	0.691
NULL	Cancer_Med_2013_Feb_3_2(1)_99-107.nxml.txt.nlp	24133632	SENT90	11	11	20	20	metformin	CEA	PA450395	5670;1087	0.691
NULL	Cell_Death_Dis_2014_Mar_13_5(3)_e1113.nxml.txt.nlp	24625972	SENT52	0	0	14	14	chymotrypsin	BI-1	PA448994	7009	0.691
NULL	Clin_Ophthalmol_2010_Oct_21_4_1217-1222.nxml.txt.nlp	21060675	SENT14	11	11	8	8	latanoprost	BAK	PA164774763	578	0.691
NULL	J_Cell_Mol_Med_2014_Oct_11_18(10)_2031-2043.nxml.txt.nlp	25109475	SENT183	1	1	22	22	valsartan	AMPK	PA451848	5563	0.691
NULL	EPMA_J_2010_Mar_24_1(1)_19-31.nxml.txt.nlp	23199038	SENT155	11	11	5	5	heparin	INS-1	PA449855	2305	0.691
NULL	Ther_Clin_Risk_Manag_2006_Sep_2(3)_235-249.nxml.txt.nlp	18360599	SENT321	24	24	5	5	alendronate	PTH	PA448082	5741	0.691
NULL	Emerg_Med_J_2014_Feb_22_31(2)_163-168.nxml.txt.nlp	23435652	SENT76	25	25	30	30	thrombin	VIII	PA451674	1351	0.691
NULL	Carcinogenesis_2008_Jun_21_29(6)_1184-1191.nxml.txt.nlp	18499698	SENT214	8	8	1	1	phenol	SULT1A1	PA450913	6817	0.691
NULL	J_Cell_Biol_2004_Jul_5_166(1)_37-47.nxml.txt.nlp	15240568	SENT119	15	15	3	3	doxycycline	SOX9	PA449415	6662	0.691
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Oct_29_67(Pt_11)_o3069-o3070.nxml.txt.nlp	22220078	SENT65	15	15	18	18	benzaldehyde	mol	PA448571	90527	0.691
NULL	Br_J_Cancer_2010_Jan_5_102(1)_134-143.nxml.txt.nlp	19920829	SENT183	20	20	14	14	pertuzumab	IL-2		3558	0.691
NULL	J_Adv_Pharm_Technol_Res_2010_Jan-Mar_1(1)_78-82.nxml.txt.nlp	22247834	SENT0	23	23	19	19	aceclofenac	FOR	PA166049185	51741	0.691
NULL	Front_Neuroendocrinol_2011_Aug_32(3)_265-286.nxml.txt.nlp	21144857	SENT1768	4	4	14	14	estradiol	aromatase	PA449503	1588	0.691
NULL	Virulence_2013_Nov_15_4(8)_833-846.nxml.txt.nlp	24225421	SENT85	29	29	14	14	galactose	CLC	PA449725	23529;1178	0.691
NULL	Int_J_Endocrinol_2011_Aug_21_2011_742719.nxml.txt.nlp	21869886	SENT265	34	34	28	28	clopidogrel	DES	PA449053	1674	0.69
NULL	Oncotarget_2014_Nov_2_5(21)_10222-10236.nxml.txt.nlp	25400118	SENT217	15	15	17	17	paclitaxel	HE2	PA450761	653423;10407	0.69
NULL	Breast_Cancer_Res_2003_Jul_28_5(5)_276-279.nxml.txt.nlp	12927039	SENT18	28	28	7	7	raloxifene	STAR	PA451221	6770;2984	0.69
NULL	J_Cell_Mol_Med_2013_Jun_15_17(6)_792-799.nxml.txt.nlp	23672538	SENT64	32	32	28	28	fluorescein	CD2	PA164746009	914	0.69
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Nov_27_66(Pt_12)_o3309.nxml.txt.nlp	21589587	SENT3	9	9	15	15	curcumin	mol	PA151958596	90527	0.69
NULL	J_Cell_Biol_2000_Feb_21_148(4)_791-800.nxml.txt.nlp	10684259	SENT199	7	7	21	21	estradiol	Raf-1	PA449503	5894	0.69
NULL	Oncotarget_2014_Sep_16_5(20)_10034-10047.nxml.txt.nlp	25296981	SENT183	0	0	17	17	doxorubicin	CHK2	PA449412	11200	0.69
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_127043.nxml.txt.nlp	23227093	SENT132	7	7	12	12	lovastatin	CYP2B6	PA450272	1555	0.69
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT2379	16	16	0	0	midazolam	CYP1A2	PA450496	1544	0.69
NULL	Adv_Hematol_2014_Nov_9_2014_369084.nxml.txt.nlp	25431593	SENT26	7	7	19	19	warfarin	VKORC1	PA451906	79001	0.69
NULL	Mol_Neurodegener_2011_Aug_8_6_57.nxml.txt.nlp	21819629	SENT242	15	15	31	31	arsenite	TDP-43	PA452638	23435	0.69
NULL	Gut_Liver_2011_Sep_18_5(3)_293-297.nxml.txt.nlp	21927656	SENT33	27	27	11	11	lansoprazole	ESD	PA450180	2098	0.69
NULL	Neuropsychopharmacology_2011_May_23_36(6)_1237-1247.nxml.txt.nlp	21346736	SENT225	19	19	26	26	methylphenidate	ATX	PA450464	5168;23049	0.69
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1067-1070.nxml.txt.nlp	21386841	SENT81	26	26	24	24	cisplatin	STZ	PA449014	6484	0.69
NULL	Oncotarget_2011_Dec_20_2(12)_1075-1093.nxml.txt.nlp	22185818	SENT123	21	21	11	11	doxorubicin	ANXA2	PA449412	302	0.69
NULL	Aging_(Albany_NY)_2011_Aug_21_3(8)_716-732.nxml.txt.nlp	21869457	SENT243	2	2	14	14	spermine	CCL2	PA164781199	6347	0.69
NULL	Cancer_Med_2014_Aug_10_3(4)_759-774.nxml.txt.nlp	24723436	SENT429	25	25	11	11	pp2	PP2		4888	0.69
NULL	Carcinogenesis_2014_May_13_35(5)_1055-1066.nxml.txt.nlp	24419232	SENT200	0	0	12	12	metformin	CYP1B1	PA450395	1545	0.69
NULL	Indian_J_Endocrinol_Metab_2013_Jul-Aug_17(4)_636-646.nxml.txt.nlp	23961479	SENT251	9	9	4	4	pitavastatin	TGS	PA142650384	286826	0.69
NULL	Breast_Cancer_(Auckl)_2012_Mar_7_6_67-77.nxml.txt.nlp	22438669	SENT73	14	14	0	0	lapatinib	HER2	PA152241907	2064	0.69
NULL	Oncotarget_2013_Nov_23_5(1)_196-210.nxml.txt.nlp	24344116	SENT76	6	6	23	23	doxorubicin	CXCL1	PA449412	2919	0.69
NULL	Breast_Cancer_Res_2011_Mar_14_13(2)_205.nxml.txt.nlp	21457526	SENT21	14	14	8	8	exemestane	aromatase	PA449563	1588	0.69
NULL	ScientificWorldJournal_2014_Mar_24_2014_694326.nxml.txt.nlp	24782665	SENT100	9	9	25	25	metformin	FDG	PA450395	23583	0.69
NULL	Subst_Abuse_Rehabil_2014_Jan_23_5_1-12.nxml.txt.nlp	24648792	SENT195	15	15	24	24	naltrexone	OPRM1	PA450588	4988	0.69
NULL	J_Hematol_Oncol_2013_Jan_15_6_5.nxml.txt.nlp	23320987	SENT8	11	11	8	8	heparin	PI-PLC	PA449855	2923	0.69
NULL	J_Gastroenterol_2014_Dec_24_49(12)_1536-1547.nxml.txt.nlp	24366288	SENT153	25	25	41	41	rabeprazole	CYP2C19	PA451216	1557	0.69
NULL	Cancers_(Basel)_2009_Dec_15_1(1)_23-28.nxml.txt.nlp	20535236	SENT126	13	13	8	8	cisplatin	SOD1	PA449014	6647	0.69
NULL	Acta_Orthop_2010_Apr_6_81(2)_263-267.nxml.txt.nlp	20148646	SENT158	5	5	29	29	taurine	CHOP	PA451590	1649	0.69
NULL	Adv_Hematol_2012_Aug_2_2012_842945.nxml.txt.nlp	22919394	SENT80	0	0	6	6	lenalidomide	IL-6	PA162363968	3569	0.69
NULL	Int_J_Anal_Chem_2014_Nov_18_2014_536823.nxml.txt.nlp	25484901	SENT187	10	10	15	15	glutaraldehyde	DTNB	PA449777	1838	0.69
NULL	Arthritis_Res_Ther_2011_Jul_6_13(4)_227.nxml.txt.nlp	21745420	SENT173	15	15	3	3	heparin	BAFF	PA449855	10673	0.69
NULL	Breast_Cancer_(Auckl)_2009_Sep_2_3_61-75.nxml.txt.nlp	19809577	SENT115	4	4	9	9	curcumin	BRCA1	PA151958596	672	0.69
NULL	Evid_Based_Complement_Alternat_Med_2011_Feb_14_2011_248231.nxml.txt.nlp	19233878	SENT108	19	19	2	2	pentobarbital	DBT	PA450859	1629	0.69
NULL	J_Korean_Med_Sci_2010_May_16_25(5)_738-745.nxml.txt.nlp	20436711	SENT12	28	28	10	10	tenofovir	NUC	PA10204	4924	0.69
NULL	Cancer_Cell_Int_2014_Jun_11_14_49.nxml.txt.nlp	24991192	SENT111	2	2	25	25	resveratrol	AMPK		5563	0.69
NULL	Int_J_Alzheimers_Dis_2010_Dec_27_2011_231595.nxml.txt.nlp	21234401	SENT111	12	12	7	7	copper	APP	PA449114	351	0.69
NULL	J_Korean_Med_Sci_2013_Apr_27_28(4)_527-533.nxml.txt.nlp	23580227	SENT13	7	7	10	10	genistein	TRAIL	PA165109660	8743	0.69
NULL	J_Biomed_Sci_2014_Feb_3_21(1)_10.nxml.txt.nlp	24490900	SENT199	5	5	20	20	alendronate	M-CSF	PA448082	1435	0.69
NULL	Cancer_Med_2014_Jun_14_3(3)_580-591.nxml.txt.nlp	24574330	SENT40	14	14	17	17	bevacizumab	VEGF-D	PA130232992	2277	0.69
NULL	J_Biomed_Sci_2014_Aug_5_21(1)_67.nxml.txt.nlp	25091805	SENT99	10	10	15	15	doxycycline	DEPDC1B	PA449415	55789	0.69
NULL	Br_J_Haematol_2014_Mar_13_164(1)_811-821.nxml.txt.nlp	24328678	SENT141	14	14	18	18	lenalidomide	IL2	PA162363968	3558	0.69
NULL	Br_J_Haematol_2008_Aug_28_142(4)_505-514.nxml.txt.nlp	18510682	SENT150	21	21	9	9	tacrolimus	B19	PA451578	59271	0.69
NULL	Indian_J_Pharmacol_2009_Aug_41(4)_167-172.nxml.txt.nlp	20523867	SENT40	42	42	21	21	acetaminophen	CYP2D6	PA448015	1565	0.69
NULL	Support_Care_Cancer_2014_Dec_14_22(3)_837-846.nxml.txt.nlp	24337717	SENT19	10	10	5	5	rifampin	CYP3A4	PA451250	1576	0.69
NULL	J_Inherit_Metab_Dis_2010_Oct_3_33(5)_625-632.nxml.txt.nlp	20814828	SENT109	11	11	16	16	simvastatin	RhoA	PA451363	387	0.69
NULL	Hum_Genomics_2004_Aug_1_1(5)_375-380.nxml.txt.nlp	15588498	SENT122	21	21	13	13	sparteine	CYP2D6	PA452610	1565	0.69
NULL	J_Thyroid_Res_2011_Apr_10_2011_895923.nxml.txt.nlp	21603172	SENT272	4	4	21	21	thyroglobulin	IL-4	PA164754910	3565	0.69
NULL	Adv_Hematol_2011_Apr_10_2011_960137.nxml.txt.nlp	21547266	SENT88	8	8	22	22	vincristine	NHL	PA451879	51750	0.69
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1013.nxml.txt.nlp	24457957	SENT122	14	14	5	5	bortezomib	NOXA	PA10252	5366	0.69
NULL	Indian_J_Pharmacol_2013_May-Jun_45(3)_286-288.nxml.txt.nlp	23833375	SENT56	5	5	3	3	montelukast	NMU	PA450546	10874	0.69
NULL	Br_J_Cancer_2006_Dec_4_95(11)_1483-1489.nxml.txt.nlp	17106442	SENT81	8	8	14	14	gefitinib	EGFR	PA131301952	1956	0.69
NULL	J_Exp_Med_2000_Mar_6_191(5)_859-870.nxml.txt.nlp	10704466	SENT163	5	5	15	15	arsenite	p38	PA452638	10598;1432;7965	0.69
NULL	J_Immunother_Cancer_2014_Jan_27_2_2.nxml.txt.nlp	24829759	SENT4	20	20	9	9	sorafenib	IL-21	PA7000	59067;50616;27189	0.69
NULL	Pharm_Methods_2012_Jul-Dec_3(2)_112-116.nxml.txt.nlp	23781490	SENT3	18	18	24	24	telmisartan	ATV	PA451605	4683	0.69
NULL	Biomed_Res_Int_2014_Jan_20_2014_948427.nxml.txt.nlp	24563867	SENT87	3	3	19	19	buspirone	STZ	PA448689	6484	0.69
NULL	Mol_Vis_2011_Aug_18_17_2221-2227.nxml.txt.nlp	21897744	SENT54	12	12	16	16	l-arginine	NAC	PA448478	22861	0.69
NULL	Iran_J_Pharm_Res_2014_Autumn_13(4)_1327-1334.nxml.txt.nlp	25587322	SENT172	3	3	16	16	econazole	PC3	PA164746010	57332;7832;5122	0.69
NULL	Br_J_Cancer_2013_Mar_5_108(4)_983-992.nxml.txt.nlp	23361057	SENT160	24	24	3	3	cytarabine	MLH1	PA449177	4292	0.69
NULL	Cell_Death_Dis_2014_Jul_10_5(7)_e1318.nxml.txt.nlp	25010984	SENT136	31	31	38	38	nutlin-3	p53		7157	0.69
NULL	J_Oncol_2012_Aug_9_2012_685213.nxml.txt.nlp	22934113	SENT137	19	19	8	8	bromocriptine	PRL	PA448671	5617	0.69
NULL	Indian_J_Pharmacol_2014_Nov-Dec_46(6)_627-632.nxml.txt.nlp	25538335	SENT133	6	6	4	4	metformin	Q10	PA450395	27161	0.69
NULL	Drug_Des_Devel_Ther_2014_Sep_23_8_1527-1538.nxml.txt.nlp	25284985	SENT87	22	22	18	18	celecoxib	IFN	PA448871	3439	0.69
NULL	EMBO_Rep_2013_Dec_18_14(12)_1113-1119.nxml.txt.nlp	24136413	SENT54	8	8	0	0	spermine	TPO1	PA164781199	256987	0.69
NULL	Mol_Cancer_2012_May_14_11_34.nxml.txt.nlp	22583868	SENT12	21	21	12	12	resveratrol	JNK		5599	0.69
NULL	Breast_Cancer_Res_2004_Mar_26_6(3)_R252-R263.nxml.txt.nlp	15084249	SENT110	40	40	14	14	tamoxifen	SULT2B1	PA451581	6820	0.69
NULL	Blood_Res_2014_Jun_25_49(2)_85-94.nxml.txt.nlp	25025009	SENT104	22	22	2	2	warfarin	VIII	PA451906	1351	0.69
NULL	Neuropsychopharmacology_2009_May_1_34(6)_1443-1453.nxml.txt.nlp	18830237	SENT154	23	23	6	6	ethanol	AP-5	PA448073	91056	0.69
NULL	Int_J_Biol_Sci_2015_Jan_1_11(1)_48-58.nxml.txt.nlp	25552929	SENT209	15	15	1	1	paclitaxel	LDM	PA450761	1595	0.69
NULL	Indian_J_Ophthalmol_2014_Apr_62(4)_513-515.nxml.txt.nlp	23571248	SENT45	8	8	30	30	fluorescein	ERG	PA164746009	2078	0.69
NULL	Clin_Ophthalmol_2011_Nov_1_5_1575-1583.nxml.txt.nlp	22125404	SENT63	12	12	16	16	latanoprost	BAK	PA164774763	578	0.69
NULL	Clin_Ophthalmol_2014_Jan_13_8_219-228.nxml.txt.nlp	24531757	SENT166	12	12	4	4	timolol	TIM	PA451690	7984;8914	0.69
NULL	Leukemia_2014_Mar_13_28(3)_629-641.nxml.txt.nlp	24263804	SENT201	34	34	8	8	imatinib	PAK1	PA10804	5585;5058	0.69
NULL	Gastroenterol_Hepatol_Bed_Bench_2011_Spring_4(2)_43-52.nxml.txt.nlp	24834156	SENT112	12	12	14	14	trypsin	TATI	PA451806	6690	0.69
NULL	Acta_Pharmacol_Sin_2011_Oct_15_32(10)_1303-1308.nxml.txt.nlp	21841812	SENT126	16	16	8	8	losartan	CYP2C9	PA450268	1559	0.69
NULL	Breast_Cancer_Res_Treat_2012_Jul_31_134(1)_199-205.nxml.txt.nlp	22290080	SENT158	9	9	2	2	estradiol	c-fos	PA449503	2353	0.69
NULL	Asian-Australas_J_Anim_Sci_2014_Dec_27(12)_1783-1793.nxml.txt.nlp	25358373	SENT130	30	30	10	10	capsaicin	FABP4	PA448776	2167	0.69
NULL	Acta_Pharmacol_Sin_2009_Jul_22_30(7)_956-964.nxml.txt.nlp	19543298	SENT161	3	3	20	20	atorvastatin	SLC22A1	PA448500	6580	0.69
NULL	Nat_Genet_2011_Feb_26_43(2)_117-120.nxml.txt.nlp	21186350	SENT191	0	0	4	4	metformin	AMPK	PA450395	5563	0.69
NULL	Arthritis_Res_Ther_2014_Apr_3_16(2)_R86.nxml.txt.nlp	24708674	SENT15	1	1	12	12	bleomycin	Fli1	PA448645	2314	0.69
NULL	Biologics_2012_Dec_17_6_429-464.nxml.txt.nlp	23269860	SENT11	34	34	18	18	tocilizumab	ACR	PA165292659	49	0.69
NULL	J_Adv_Pharm_Technol_Res_2012_Oct-Dec_3(4)_202-209.nxml.txt.nlp	23378940	SENT169	2	2	12	12	aprepitant	CYP3A4	PA164747039	1576	0.69
NULL	Korean_J_Anesthesiol_2013_Dec_26_65(6_Suppl)_S1-S3.nxml.txt.nlp	24478828	SENT13	35	35	28	28	atracurium	BCHE	PA164776840	590	0.69
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Dec_18_67(Pt_1)_o165.nxml.txt.nlp	21522672	SENT68	23	23	10	10	ethanol	mol	PA448073	90527	0.69
NULL	Core_Evid_2007_Nov_30_2(2)_111-119.nxml.txt.nlp	21221179	SENT228	16	16	1	1	gemcitabine	MB1	PA449748	5693	0.69
NULL	Front_Synaptic_Neurosci_2014_May_30_6_12.nxml.txt.nlp	24910611	SENT144	6	6	2	2	l-asparagine	ASCT2	PA164776968	6510	0.69
NULL	Drug_Des_Devel_Ther_2014_Oct_14_8_1839-1849.nxml.txt.nlp	25342883	SENT196	22	22	6	6	paclitaxel	p200	PA450761	10565	0.69
NULL	J_Hematol_Oncol_2013_Jun_3_6_38.nxml.txt.nlp	23731980	SENT36	10	10	14	14	trastuzumab	HER2	PA451743	2064	0.69
NULL	Oxid_Med_Cell_Longev_2012_Jan_19_2012_390678.nxml.txt.nlp	22315655	SENT90	4	4	6	6	gliclazide	NAC	PA10892	22861	0.69
NULL	Oncotarget_2011_Mar_28_2(3)_109-112.nxml.txt.nlp	21487160	SENT57	3	3	28	28	metformin	AMPK	PA450395	5563	0.69
NULL	Breast_Cancer_Res_2010_Oct_22_12(Suppl_2)_S1.nxml.txt.nlp	21050422	SENT109	8	8	25	25	trastuzumab	DM1	PA451743	338023;1760;28509	0.69
NULL	Nucleic_Acids_Res_2008_Feb_20_36(3)_998-1008.nxml.txt.nlp	18096616	SENT31	0	0	3	3	heparin	PKR	PA449855	5610	0.69
NULL	Br_J_Clin_Pharmacol_2013_Aug_23_76(2)_299-315.nxml.txt.nlp	23701319	SENT186	18	18	0	0	alemtuzumab	TGN	PA164783958	7038	0.69
NULL	Clin_Med_Insights_Cardiol_2011_Oct_6_5_103-119.nxml.txt.nlp	22084608	SENT328	8	8	13	13	dronedarone	CYP2D6	PA153619853	1565	0.69
NULL	Open_Access_J_Urol_2010_Apr_22_2_41-55.nxml.txt.nlp	24198613	SENT120	0	0	2	2	losartan	AT2	PA450268	186	0.69
NULL	J_Gen_Physiol_1991_Apr_1_97(4)_749-776.nxml.txt.nlp	1647438	SENT14	0	0	2	2	diethylstilbestrol	DES	PA449307	1674	0.69
NULL	Acta_Pharmacol_Sin_2009_Oct_21_30(10)_1392-1398.nxml.txt.nlp	19767766	SENT160	5	5	9	9	atorvastatin	NAC	PA448500	22861	0.69
NULL	J_Anim_Sci_Biotechnol_2013_Jun_26_4(1)_23.nxml.txt.nlp	23800120	SENT50	16	16	18	18	estradiol	OXT	PA449503	5020	0.69
NULL	Nucleic_Acids_Res_2013_Nov_27_41(21)_9786-9799.nxml.txt.nlp	23982513	SENT197	4	4	6	6	arsenite	TIAR	PA452638	7073	0.69
NULL	Ann_Surg_Oncol_2010_Apr_20_17(4)_1168-1176.nxml.txt.nlp	19936839	SENT162	9	9	2	2	cetuximab	HER2	PA10040	2064	0.69
NULL	JAKSTAT_2012_Oct_1_1(4)_292-299.nxml.txt.nlp	24058786	SENT116	0	0	8	8	pimozide	JAK2	PA450965	3717	0.69
NULL	Virol_J_2009_Feb_17_6_25.nxml.txt.nlp	19222836	SENT205	0	0	9	9	eptifibatide	San	PA449483	80218	0.69
NULL	Cell_Commun_Signal_2013_Sep_18_11_69.nxml.txt.nlp	24047462	SENT309	38	38	9	9	doxorubicin	TOB	PA449412	10140	0.69
NULL	Clin_Dev_Immunol_2011_Nov_24_2011_174149.nxml.txt.nlp	22162710	SENT144	5	5	7	7	oxaliplatin	HMGB1	PA131285527	3146	0.69
NULL	Iran_J_Basic_Med_Sci_2012_Jan-Feb_15(1)_678-682.nxml.txt.nlp	23493931	SENT58	4	4	16	16	ceftazidime	CTX	PA448861	1593	0.69
NULL	Mol_Brain_2014_Aug_29_7_62.nxml.txt.nlp	25167838	SENT33	5	5	13	13	resveratrol	SIRT1		23411	0.69
NULL	Indian_J_Med_Res_2011_Jan_133(1)_15-26.nxml.txt.nlp	21321416	SENT184	0	0	21	21	cyclosporine	gamma	PA449167	9913	0.69
NULL	Arch_Gynecol_Obstet_2012_May_25_285(5)_1331-1338.nxml.txt.nlp	22116314	SENT79	6	6	32	32	alendronate	OCN	PA448082	632	0.69
NULL	Biomed_Res_Int_2014_Jun_4_2014_253243.nxml.txt.nlp	24995279	SENT45	16	16	7	7	cyclophosphamide	CHOP	PA449165	1649	0.69
NULL	J_Cancer_2013_Aug_28_4(7)_585-596.nxml.txt.nlp	24069069	SENT191	14	14	4	4	verteporfin	p62	PA451871	8878;10657;23636	0.69
NULL	J_Thromb_Haemost_2007_May_5(5)_1010-1018.nxml.txt.nlp	17355572	SENT185	7	7	17	17	thrombin	VWF	PA451674	7450	0.69
NULL	Int_J_Anal_Chem_2011_Oct_10_2011_124917.nxml.txt.nlp	22007220	SENT180	9	9	13	13	risperidone	API	PA451257	5345	0.69
NULL	Front_Oncol_2014_Jun_18_4_153.nxml.txt.nlp	24995158	SENT546	39	39	22	22	etoposide	p53	PA449552	7157	0.69
NULL	Biologics_2012_Dec_17_6_429-464.nxml.txt.nlp	23269860	SENT173	10	10	14	14	etanercept	NMA	PA449515	25805	0.69
NULL	J_Korean_Med_Sci_2006_Dec_31_21(6)_973-978.nxml.txt.nlp	17179671	SENT167	30	30	8	8	amikacin	CTX	PA164744372	1593	0.69
NULL	J_Biol_Eng_2009_Oct_16_3_18.nxml.txt.nlp	19835592	SENT138	31	31	39	39	tetracycline	CPZ	PA451640	8532	0.69
NULL	F1000_Biol_Rep_2012_Mar_1_4_5.nxml.txt.nlp	22403588	SENT77	20	20	17	17	ribavirin	IFN	PA451241	3439	0.69
NULL	J_Cardiovasc_Dis_Res_2010_Jan-Mar_1(1)_29-36.nxml.txt.nlp	21188088	SENT174	30	30	16	16	fluorescein	TIP	PA164746009	81533;79828	0.69
NULL	Clin_Med_Insights_Cardiol_2010_Oct_11_4_89-93.nxml.txt.nlp	20981132	SENT89	34	34	38	38	benazepril	TLR4	PA448561	7099	0.69
NULL	J_Thorac_Oncol_2014_Feb_23_9(2)_189-194.nxml.txt.nlp	24419415	SENT48	23	23	11	11	gefitinib	EGFR	PA131301952	1956	0.69
NULL	Exp_Diabetes_Res_2012_Sep_20_2012_936518.nxml.txt.nlp	23049542	SENT153	8	8	13	13	glucose	TRPV4	PA449773	59341	0.69
NULL	Case_Rep_Hematol_2011_Nov_3_2011_263725.nxml.txt.nlp	22937303	SENT107	18	18	5	5	imatinib	ELN	PA10804	2006	0.69
NULL	Arthritis_Res_Ther_2014_Jan_24_16(1)_R23.nxml.txt.nlp	24460726	SENT1	28	28	11	11	hydroxychloroquine	CCL2	PA164777036	6347	0.69
NULL	Clin_Exp_Otorhinolaryngol_2011_Mar_17_4(1)_18-23.nxml.txt.nlp	21461058	SENT94	20	20	25	25	furosemide	NKCC1	PA449719	6558	0.69
NULL	Exp_Dermatol_2013_Jul_25_22(7)_502-504.nxml.txt.nlp	23800068	SENT45	9	9	12	12	doxycycline	CRM1	PA449415	7514	0.69
NULL	Psychiatr_Genet_2013_Aug_28_23(4)_153-162.nxml.txt.nlp	23811784	SENT29	11	11	17	17	haloperidol	5-HT2A	PA449841	3356	0.69
NULL	Cancers_(Basel)_2014_Apr_9_6(2)_829-859.nxml.txt.nlp	24722453	SENT256	3	3	12	12	auranofin	JAK1	PA448510	3716	0.69
NULL	J_Korean_Med_Sci_2010_Aug_21_25(8)_1222-1227.nxml.txt.nlp	20676337	SENT59	14	14	9	9	aminophylline	LPA	PA164781029	4018	0.69
NULL	Front_Synaptic_Neurosci_2014_Sep_5_6_18.nxml.txt.nlp	25249974	SENT229	18	18	9	9	nicotine	DSI	PA450626	5034	0.69
NULL	Oncotarget_2013_Aug_24_4(10)_1618-1631.nxml.txt.nlp	24113128	SENT132	30	30	16	16	sorafenib	p53	PA7000	7157	0.69
NULL	Clinics_(Sao_Paulo)_2013_Oct_68(10)_1325-1332.nxml.txt.nlp	24212839	SENT41	25	25	22	22	ribavirin	IFN	PA451241	3439	0.69
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT38	44	44	21	21	mannitol	FBS	PA450320	64319;26269	0.69
NULL	Cell_Cycle_2012_Jun_15_11(12)_2227.nxml.txt.nlp	22684296	SENT20	14	14	11	11	gemcitabine	p53	PA449748	7157	0.69
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Mar_31_66(Pt_4)_m479.nxml.txt.nlp	21580559	SENT77	40	40	28	28	ethanol	mol	PA448073	90527	0.69
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Nov_30_67(Pt_12)_o3476-o3477.nxml.txt.nlp	22199950	SENT76	26	26	14	14	ethanol	mol	PA448073	90527	0.69
NULL	Br_J_Cancer_2013_Mar_19_108(5)_1079-1091.nxml.txt.nlp	23449353	SENT9	31	31	5	5	docetaxel	MIC-1	PA449383	29919;9518	0.69
NULL	Mol_Cancer_2007_Mar_7_6_18.nxml.txt.nlp	17343740	SENT312	10	10	18	18	alendronate	CD44	PA448082	960	0.69
NULL	Genome_Biol_2008_Mar_11_9(3)_R53.nxml.txt.nlp	18334025	SENT379	11	11	4	4	bortezomib	p65	PA10252	5970	0.69
NULL	Exp_Ther_Med_2013_Aug_14_6(2)_574-578.nxml.txt.nlp	24137229	SENT147	29	29	19	19	propranolol	PARP1	PA451145	142	0.69
NULL	Breast_Cancer_Res_2010_Mar_5_12(2)_R16.nxml.txt.nlp	20205716	SENT362	0	0	24	24	lovastatin	MSH2	PA450272	4436	0.69
NULL	Clin_Ophthalmol_2007_Jun_1(2)_149-155.nxml.txt.nlp	19668504	SENT36	1	1	8	8	bevacizumab	San	PA130232992	80218	0.69
NULL	Cancer_Res_Treat_2014_Jan_15_46(1)_48-54.nxml.txt.nlp	24520223	SENT129	28	28	22	22	bevacizumab	KRAS	PA130232992	3845	0.69
NULL	Breast_Cancer_(Auckl)_2012_Nov_19_6_191-207.nxml.txt.nlp	23226023	SENT278	35	35	44	44	docetaxel	HER-2	PA449383	2064	0.69
NULL	Acta_Pharmacol_Sin_2009_Jul_3_30(7)_889-898.nxml.txt.nlp	19574994	SENT150	0	0	7	7	pp2	EGFR		1956	0.69
NULL	Diabetes_Care_2013_Jun_15_36(6)_e81.nxml.txt.nlp	23704689	SENT24	12	12	22	22	acarbose	STOP	PA448010	4135	0.69
NULL	Fibrogenesis_Tissue_Repair_2012_Apr_28_5_6.nxml.txt.nlp	22541002	SENT81	20	20	17	17	trypsin	ICAT	PA451806	56998	0.69
NULL	F1000Res_2013_Oct_8_2_173.nxml.txt.nlp	24555085	SENT38	18	18	9	9	budesonide	BDP	PA448681	10620;152926	0.69
NULL	Br_J_Cancer_2009_Jul_21_101(2)_238-243.nxml.txt.nlp	19568242	SENT118	25	25	27	27	bevacizumab	IFN	PA130232992	3439	0.69
NULL	Ann_Hematol_2007_Dec_14_86(12)_871-877.nxml.txt.nlp	17874322	SENT102	30	30	23	23	dapsone	CHOP	PA449211	1649	0.69
NULL	Drug_Des_Devel_Ther_2014_Oct_14_8_1839-1849.nxml.txt.nlp	25342883	SENT196	15	15	6	6	paclitaxel	p200	PA450761	10565	0.69
NULL	Nat_Med_2014_Jun_18_20(6)_624-632.nxml.txt.nlp	24836577	SENT87	39	39	4	4	isoproterenol	BIN1	PA450121	274	0.69
NULL	Evid_Based_Complement_Alternat_Med_2012_May_7_2012_242810.nxml.txt.nlp	22645625	SENT135	2	2	5	5	rifampin	CYP3A4	PA451250	1576	0.69
NULL	Extremophiles_2009_Nov_23_13(6)_885-894.nxml.txt.nlp	19701714	SENT136	23	23	39	39	ethanol	CO2	PA448073	4513	0.69
NULL	Exp_Ther_Med_2013_Nov_13_6(5)_1317-1321.nxml.txt.nlp	24223665	SENT24	3	3	36	36	curcumin	ABCG2	PA151958596	9429	0.69
NULL	Oncotarget_2014_Mar_26_5(19)_8959-8969.nxml.txt.nlp	25344859	SENT237	21	21	14	14	lovastatin	EAF2	PA450272	55929;55840	0.69
NULL	Oncol_Rep_2013_Mar_3_29(3)_855-860.nxml.txt.nlp	23291663	SENT73	0	0	14	14	metformin	HER2	PA450395	2064	0.69
NULL	Br_J_Cancer_2013_Jul_23_109(2)_351-359.nxml.txt.nlp	23799854	SENT276	14	14	11	11	paclitaxel	BLT2	PA450761	56413	0.69
NULL	Scientifica_(Cairo)_2013_Dec_5_2013_317186.nxml.txt.nlp	24381788	SENT122	6	6	25	25	flavopiridol	PC3	PA452627	57332;7832;5122	0.69
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Nov_5_67(Pt_12)_o3168.nxml.txt.nlp	22199692	SENT70	21	21	9	9	ethanol	mol	PA448073	90527	0.69
NULL	Ann_Hematol_2007_Dec_14_86(12)_871-877.nxml.txt.nlp	17874322	SENT26	16	16	25	25	azathioprine	CHOP	PA448515	1649	0.69
NULL	Exp_Ther_Med_2013_Mar_8_5(3)_707-710.nxml.txt.nlp	23404433	SENT81	22	22	30	30	cisplatin	Bcl-2	PA449014	596	0.69
NULL	Case_Rep_Oncol_Med_2012_Sep_11_2012_726424.nxml.txt.nlp	22997596	SENT11	23	23	15	15	vincristine	PRL	PA451879	5617	0.69
NULL	J_Clin_Biochem_Nutr_2007_Jul_27_41(1)_32-42.nxml.txt.nlp	18392098	SENT602	42	42	5	5	curcumin	ROS	PA151958596	6098	0.69
NULL	Int_J_Mol_Sci_2014_Oct_20_15(10)_18856-18891.nxml.txt.nlp	25334061	SENT768	1	1	7	7	arsenite	PI3K	PA452638	5290	0.69
NULL	Front_Neurosci_2014_Jun_3_8_128.nxml.txt.nlp	24917782	SENT137	25	25	14	14	ethanol	MC4R	PA448073	4160	0.69
NULL	Br_J_Cancer_2013_May_14_108(9)_1862-1869.nxml.txt.nlp	23579219	SENT138	29	29	15	15	bevacizumab	ANXA11	PA130232992	311	0.69
NULL	Biomed_Res_Int_2013_Aug_6_2013_602987.nxml.txt.nlp	24027759	SENT308	11	11	6	6	cyclophosphamide	SMF	PA449165	22993	0.69
NULL	Acta_Pharmacol_Sin_2014_Oct_25_35(10)_1293-1301.nxml.txt.nlp	25152022	SENT188	2	2	14	14	enalapril	IL-18	PA449456	3606	0.69
NULL	Adv_Hematol_2012_Sep_19_2012_879368.nxml.txt.nlp	21941554	SENT89	40	40	22	22	curcumin	p38	PA151958596	10598;1432;7965	0.69
NULL	J_Gen_Physiol_2008_Nov_132(5)_521-535.nxml.txt.nlp	18852303	SENT105	6	6	3	3	trypsin	CAP2	PA451806	5271;10486	0.69
NULL	Mol_Cell_2013_Mar_7_49(5)_922-933.nxml.txt.nlp	23375502	SENT261	45	45	8	8	l-glutamine	CO2	PA10090	4513	0.69
NULL	Br_J_Cancer_2011_Oct_11_105(8)_1176-1182.nxml.txt.nlp	21915118	SENT28	0	0	6	6	trastuzumab	San	PA451743	80218	0.69
NULL	Onco_Targets_Ther_2014_Jul_31_7_1367-1373.nxml.txt.nlp	25114575	SENT33	5	5	12	12	trastuzumab	HER2	PA451743	2064	0.69
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT189	4	4	14	14	bevacizumab	PlGF-2	PA130232992	5228	0.69
NULL	Mol_Cancer_2010_Aug_20_9_220.nxml.txt.nlp	20727180	SENT12	8	8	16	16	nicotine	p53	PA450626	7157	0.69
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT94	8	8	5	5	imatinib	ABCG2	PA10804	9429	0.69
NULL	Indian_J_Psychiatry_2013_Jul_55(Suppl_3)_S405-S408.nxml.txt.nlp	24049209	SENT118	40	40	42	42	vasopressin	AVP	PA451858	114548;551	0.69
NULL	BMJ_2011_Aug_4_343_d4588.nxml.txt.nlp	21816733	SENT445	15	15	3	3	clopidogrel	CYP2C19	PA449053	1557	0.69
NULL	Arthritis_Res_Ther_2010_Apr_29_12(2)_R73.nxml.txt.nlp	20429888	SENT160	2	2	10	10	bortezomib	SP1	PA10252	6667	0.69
NULL	Oncogene_2013_Sep_26_32(39)_10_1038_onc_2012_491.nxml.txt.nlp	23108394	SENT48	7	7	0	0	epirubicin	FOXM1	PA449476	2305	0.69
NULL	Hum_Genomics_2013_Apr_5_7(1)_10.nxml.txt.nlp	23561625	SENT10	17	17	19	19	flavopiridol	CDK7	PA452627	1022	0.69
NULL	Breast_Cancer_Res_2011_Aug_11_13(3)_R80.nxml.txt.nlp	21834972	SENT232	10	10	6	6	tamoxifen	E2F1	PA451581	1869	0.69
NULL	Int_J_Tryptophan_Res_2013_Aug_19_6_35-45.nxml.txt.nlp	24023520	SENT88	10	10	15	15	hydroquinone	NQO1	PA449924	1728	0.69
NULL	Indian_J_Pharmacol_2014_Nov-Dec_46(6)_627-632.nxml.txt.nlp	25538335	SENT39	21	21	25	25	metformin	STZ	PA450395	6484	0.69
NULL	Br_J_Cancer_2009_Sep_15_101(6)_957-966.nxml.txt.nlp	19738618	SENT191	9	9	15	15	trastuzumab	mol	PA451743	90527	0.69
NULL	Acta_Pharmacol_Sin_2010_Jul_28_31(7)_867-873.nxml.txt.nlp	20581857	SENT154	15	15	17	17	docetaxel	PC3	PA449383	57332;7832;5122	0.69
NULL	Mol_Biol_Cell_2012_Nov_1_23(21)_4212-4225.nxml.txt.nlp	22956765	SENT13	15	15	3	3	thrombin	SHP2	PA451674	5781	0.69
NULL	Oncotarget_2014_Nov_12_5(20)_9626-9640.nxml.txt.nlp	25275299	SENT78	19	19	6	6	thrombin	RhoA	PA451674	387	0.69
NULL	Cancers_(Basel)_2012_Mar_7_4(1)_257-280.nxml.txt.nlp	24213239	SENT729	11	11	7	7	marimastat	gamma	PA164748329	9913	0.69
NULL	Breast_Cancer_Res_2002_Jan_14_4(2)_65-69.nxml.txt.nlp	11879566	SENT108	23	23	19	19	estradiol	aromatase	PA449503	1588	0.69
NULL	Oncol_Lett_2014_Jul_16_8(1)_211-217.nxml.txt.nlp	24959248	SENT6	18	18	0	0	cisplatin	ANGPTL4	PA449014	51129	0.69
NULL	Oncogene_2010_Sep_16_29(37)_5182-5192.nxml.txt.nlp	20581861	SENT107	0	0	4	4	sulindac	ATF3	PA451565	467	0.69
NULL	Oncotarget_2014_Nov_11_5(22)_10963-10964.nxml.txt.nlp	25460503	SENT11	21	21	4	4	trastuzumab	ADAM10	PA451743	102	0.69
NULL	Scientifica_(Cairo)_2012_Aug_30_2012_525374.nxml.txt.nlp	24278711	SENT131	10	10	22	22	thrombin	ADP	PA451674	23038	0.69
NULL	Iran_J_Neurol_2014_13(1)_33-39.nxml.txt.nlp	24800045	SENT133	21	21	0	0	gentamicin	CDP	PA449753	1523	0.69
NULL	Acta_Pharmacol_Sin_2011_Aug_11_32(8)_999-1008.nxml.txt.nlp	21743486	SENT187	0	0	9	9	fasudil	JNK	PA165946121	5599	0.69
NULL	Clin_Ophthalmol_2012_May_14_6_747-754.nxml.txt.nlp	22654502	SENT119	4	4	34	34	etanercept	San	PA449515	80218	0.69
NULL	Diabetes_2011_May_23_60(5)_1504-1511.nxml.txt.nlp	21421806	SENT52	13	13	11	11	dextran	HDL2	PA449261	57338	0.69
NULL	Acta_Naturae_2013_Oct-Dec_5(4)_71-77.nxml.txt.nlp	24455185	SENT77	11	11	23	23	iron	TNF	PA450087	7124	0.69
NULL	J_Adv_Pract_Oncol_2013_Jul_1_Jul-Aug_4(4)_238-250.nxml.txt.nlp	25032004	SENT161	9	9	4	4	imatinib	CYP3A4	PA10804	1576	0.69
NULL	J_Cell_Mol_Med_2014_Jan_4_18(1)_38-48.nxml.txt.nlp	24188742	SENT9	15	15	0	0	cisplatin	PAX3	PA449014	5077	0.69
NULL	Int_J_Biomed_Sci_2007_Sep_3(3)_176-184.nxml.txt.nlp	23675041	SENT116	8	8	10	10	cisplatin	Bcl-2	PA449014	596	0.69
NULL	J_Pain_Res_2015_Jan_14_8_33-37.nxml.txt.nlp	25609996	SENT52	6	6	14	14	hyaluronidase	San	PA164745713	80218	0.69
NULL	J_Psychopharmacol_2010_Nov_24(4_supplement)_91-118.nxml.txt.nlp	18801830	SENT352	25	25	28	28	clozapine	ACTH	PA449061	5443	0.69
NULL	Cancer_Immunol_Immunother_2012_Jul_23_61(7)_1101-1111.nxml.txt.nlp	22193989	SENT201	10	10	18	18	oxaliplatin	STAT3	PA131285527	6774	0.69
NULL	Biosci_Rep_2014_Jul_29_34(4)_e00126.nxml.txt.nlp	24935351	SENT373	12	12	14	14	doxorubicin	TP53	PA449412	7157	0.69
NULL	Acta_Pharmacol_Sin_2010_Jun_4_31(6)_709-717.nxml.txt.nlp	20523342	SENT45	8	8	20	20	glucose	PPG	PA449773	5552	0.69
NULL	Diabetes_Metab_Syndr_Obes_2014_Jun_24_7_241-253.nxml.txt.nlp	25018645	SENT134	30	30	16	16	metformin	AMPK	PA450395	5563	0.69
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Aug_28_66(Pt_9)_o2417.nxml.txt.nlp	21588743	SENT58	8	8	17	17	benzaldehyde	mol	PA448571	90527	0.69
NULL	Nat_Med_2013_Oct_8_19(10)_1313-1317.nxml.txt.nlp	24013700	SENT52	38	38	34	34	ribavirin	IFN	PA451241	3439	0.69
NULL	J_Exp_Bot_2012_Jun_13_63(10)_3617-3629.nxml.txt.nlp	22442421	SENT59	22	22	3	3	betaine	DPI	PA448603	1832	0.69
NULL	Patient_Prefer_Adherence_2014_Apr_8_8_463-471.nxml.txt.nlp	24748775	SENT66	1	1	4	4	denosumab	RANKL	PA166048634	8600	0.69
NULL	J_Cell_Biol_2004_Feb_16_164(4)_613-623.nxml.txt.nlp	14769860	SENT514	10	10	1	1	collagenase	p38	PA449107	10598;1432;7965	0.69
NULL	Br_J_Cancer_2004_May_17_90(10)_2032-2041.nxml.txt.nlp	15138490	SENT171	21	21	14	14	trastuzumab	HER-2	PA451743	2064	0.69
NULL	Breast_Cancer_Res_2012_Mar_14_14(2)_R46.nxml.txt.nlp	22417870	SENT31	30	30	11	11	trastuzumab	HER2	PA451743	2064	0.69
NULL	Am_J_Med_Genet_A_2011_Oct_9_155(10)_2446-2452.nxml.txt.nlp	21910234	SENT30	25	25	11	11	creatine	SLC6A8	PA164778930	6535	0.69
NULL	Leukemia_2014_Jun_17_28(6)_1216-1226.nxml.txt.nlp	24301524	SENT6	3	3	29	29	bortezomib	p65	PA10252	5970	0.69
NULL	Eur_J_Cancer_2013_Oct_49(15)_3366-3375.nxml.txt.nlp	23790465	SENT231	1	1	27	27	sunitinib	ABCB1	PA162372840	5243	0.69
NULL	Diabetes_Metab_Syndr_Obes_2010_Aug_24_3_297-299.nxml.txt.nlp	21437098	SENT56	8	8	1	1	exenatide	GLP-1	PA164749238	100125288	0.69
NULL	Acta_Histochem_Cytochem_2013_Dec_28_46(6)_187-197.nxml.txt.nlp	24610966	SENT27	10	10	12	12	pilocarpine	AQP5	PA450962	362	0.69
NULL	Clin_Ophthalmol_2007_Sep_1(3)_273-284.nxml.txt.nlp	19668481	SENT17	0	0	7	7	bevacizumab	San	PA130232992	80218	0.69
NULL	Exp_Ther_Med_2013_Feb_13_5(2)_581-585.nxml.txt.nlp	23403473	SENT96	13	13	30	30	etanercept	HMGB1	PA449515	3146	0.69
NULL	J_Lipid_Res_2014_Oct_55(10)_2103-2112.nxml.txt.nlp	25139399	SENT637	2	2	18	18	niacin	APOE	PA450617	348	0.69
NULL	J_Cell_Biol_2002_Oct_14_159(1)_91-102.nxml.txt.nlp	12370241	SENT298	0	0	2	2	dextran	mol	PA449261	90527	0.69
NULL	Ann_Hematol_2007_Dec_14_86(12)_871-877.nxml.txt.nlp	17874322	SENT102	17	17	23	23	cyclophosphamide	CHOP	PA449165	1649	0.69
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT258	12	12	8	8	resveratrol	TNF		7124	0.69
NULL	Cancer_Cell_Int_2005_Jul_24_5_22.nxml.txt.nlp	16042792	SENT40	20	20	15	15	vincristine	NAC	PA451879	22861	0.69
NULL	Cancer_Cell_Int_2013_Feb_8_13_11.nxml.txt.nlp	23394616	SENT11	13	13	33	33	geldanamycin	Hsp90	PA152031327	3320	0.69
NULL	Acta_Pharmacol_Sin_2011_Jun_23_32(6)_765-780.nxml.txt.nlp	21602835	SENT141	5	5	8	8	diazoxide	SUR1	PA449285	6833	0.69
NULL	J_Cell_Biol_2005_Jul_4_170(1)_49-59.nxml.txt.nlp	15983061	SENT106	8	8	15	15	forskolin	MITF	PA146096022	4286	0.69
NULL	Mol_Cancer_2014_Jun_27_13_159.nxml.txt.nlp	24972933	SENT94	22	22	39	39	bortezomib	BTK	PA10252	695	0.69
NULL	Parasit_Vectors_2011_Aug_24_4_164.nxml.txt.nlp	21864384	SENT8	12	12	6	6	artesunate	LAMP	PA165111697	4045;27074	0.689
NULL	Cell_Biol_Int_Rep_(2010)_2012_Jun_21_19(1)_e00017.nxml.txt.nlp	23124518	SENT86	31	31	33	33	etoposide	TRAIL	PA449552	8743	0.689
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT82	18	18	22	22	nutlin-3	p53		7157	0.689
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_127043.nxml.txt.nlp	23227093	SENT138	10	10	4	4	lovastatin	P-gp	PA450272	5243	0.689
NULL	Carcinogenesis_2010_Dec_27_31(12)_2049-2057.nxml.txt.nlp	20876285	SENT260	32	32	12	12	tamoxifen	HER2	PA451581	2064	0.689
NULL	Int_J_Breast_Cancer_2012_May_9_2012_415170.nxml.txt.nlp	22649737	SENT103	17	17	19	19	lapatinib	HER2	PA152241907	2064	0.689
NULL	Mol_Cancer_2007_Oct_25_6_67.nxml.txt.nlp	17958915	SENT307	15	15	10	10	nilotinib	GM-CSF	PA165958345	1437	0.689
NULL	J_Biomed_Sci_2014_Feb_12_21(1)_14.nxml.txt.nlp	24521134	SENT52	10	10	1	1	heparin	SCARB2	PA449855	950	0.689
NULL	Ann_Lab_Med_2012_Jul_20_32(4)_298-303.nxml.txt.nlp	22779073	SENT117	36	36	22	22	ciprofloxacin	MOX	PA449009	26002	0.689
NULL	Acta_Pharmacol_Sin_2010_Aug_19_31(8)_963-969.nxml.txt.nlp	20644547	SENT96	8	8	16	16	fenofibrate	PDX-1	PA449594	3651	0.689
NULL	Diabetes_Care_2010_Jul_31_33(7)_1544-1548.nxml.txt.nlp	20357370	SENT101	3	3	11	11	metformin	STK11	PA450395	6794	0.689
NULL	Pharmaceutics_2011_Oct_12_3(4)_680-705.nxml.txt.nlp	24309303	SENT791	2	2	8	8	glibenclamide	MRP1	PA449782	4437	0.689
NULL	Diabetes_2009_Dec_31_58(12)_2851-2862.nxml.txt.nlp	19720788	SENT88	32	32	21	21	forskolin	SERCA2	PA146096022	488	0.689
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT76	17	17	30	30	l-cysteine	p27	PA449173	5715;10534	0.689
NULL	Breast_Cancer_Res_Treat_2012_Jul_28_134(1)_267-276.nxml.txt.nlp	22453754	SENT10	0	0	2	2	tamoxifen	aromatase	PA451581	1588	0.689
NULL	Breast_Cancer_Res_2012_Feb_14_14(1)_R30.nxml.txt.nlp	22333315	SENT21	11	11	28	28	indomethacin	COX	PA449982	1351	0.689
NULL	J_Immune_Based_Ther_Vaccines_2011_Jan_12_9_1.nxml.txt.nlp	21226916	SENT93	14	14	12	12	imiquimod	IL-2	PA449972	3558	0.689
NULL	Biologics_2012_Jul_13_6_221-231.nxml.txt.nlp	22904614	SENT72	13	13	17	17	gefitinib	EGFR	PA131301952	1956	0.689
NULL	Behav_Brain_Res_2012_Dec_1_235(2)_273-279.nxml.txt.nlp	22917527	SENT292	3	3	13	13	fenfluramine	5-HT2A	PA449592	3356	0.689
NULL	J_Hematol_Oncol_2013_May_16_6_36.nxml.txt.nlp	23680477	SENT184	8	8	20	20	geldanamycin	Hsp90	PA152031327	3320	0.689
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Nov_4_9_31.nxml.txt.nlp	21050425	SENT126	25	25	11	11	trimethoprim	Gen	PA451788	348654	0.689
NULL	Cases_J_2009_Mar_10_2_6464.nxml.txt.nlp	20181162	SENT6	37	37	24	24	ribavirin	IFN	PA451241	3439	0.689
NULL	Chin_J_Cancer_2011_Aug_30(8)_526-539.nxml.txt.nlp	21801601	SENT47	36	36	26	26	nadh	CO2	PA164755085	4513	0.689
NULL	Crit_Care_2006_May_12_10(3)_R75.nxml.txt.nlp	16696866	SENT167	9	9	11	11	vasopressin	AVP	PA451858	114548;551	0.689
NULL	J_Cell_Mol_Med_2014_Apr_20_18(4)_709-720.nxml.txt.nlp	24444314	SENT144	2	2	8	8	losartan	p53	PA450268	7157	0.689
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT286	12	12	14	14	curcumin	TRAIL	PA151958596	8743	0.689
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_4_2013_378657.nxml.txt.nlp	23662132	SENT495	9	9	34	34	liraglutide	GLP-1	PA165958364	100125288	0.689
NULL	Aging_(Albany_NY)_2009_Mar_31_1(4)_412-424.nxml.txt.nlp	20195491	SENT145	18	18	2	2	resveratrol	TXNIP		10628	0.689
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT474	7	7	0	0	iloperidone	PRL	PA161199368	5617	0.689
NULL	Autophagy_2013_Jul_1_9(7)_985-995.nxml.txt.nlp	23584039	SENT150	27	27	18	18	propranolol	LC3	PA451145	84557	0.689
NULL	J_Headache_Pain_2013_Aug_13_14(1)_71.nxml.txt.nlp	23941062	SENT68	17	17	19	19	bortezomib	TRPA1	PA10252	8989	0.689
NULL	Pharmaceuticals_(Basel)_2012_Sep_12_5(9)_1008-1020.nxml.txt.nlp	24280702	SENT93	0	0	21	21	geldanamycin	Hsp90	PA152031327	3320	0.689
NULL	Indian_J_Anaesth_2011_Mar-Apr_55(2)_190-192.nxml.txt.nlp	21712882	SENT68	19	19	15	15	metformin	G6PD	PA450395	2539	0.689
NULL	Front_Oncol_2014_Jun_18_4_159.nxml.txt.nlp	24995161	SENT75	44	44	25	25	estradiol	PGD2	PA449503	27306	0.689
NULL	Anal_Chem_Insights_2013_Apr_16_8_9-20.nxml.txt.nlp	23700362	SENT84	19	19	22	22	oseltamivir	TOB	PA450721	10140	0.689
NULL	Ann_Oncol_2012_Nov_22_23(11)_2782-2790.nxml.txt.nlp	22730099	SENT122	15	15	17	17	estradiol	OPG	PA449503	690	0.689
NULL	Emerg_Infect_Dis_2011_Mar_17(3)_510-513.nxml.txt.nlp	21392446	SENT53	26	26	36	36	ofloxacin	ETO	PA450684	862	0.689
NULL	J_Inj_Violence_Res_2014_Jul_6(2)_72-78.nxml.txt.nlp	24121451	SENT15	24	24	21	21	ibudilast	TLR4	PA165958351	7099	0.689
NULL	Oncol_Rep_2013_Apr_5_29(4)_1671-1677.nxml.txt.nlp	23404329	SENT6	11	11	13	13	aspirin	ASP	PA448497	259266;443;9474;29974;434;83853	0.689
NULL	Mol_Pain_2013_Jul_31_9_38.nxml.txt.nlp	23898828	SENT149	23	23	29	29	losartan	p38	PA450268	10598;1432;7965	0.689
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT1783	22	22	2	2	pitavastatin	OATP1B1	PA142650384	10599	0.689
NULL	Cancers_(Basel)_2012_Apr_25_4(2)_442-473.nxml.txt.nlp	24213319	SENT496	23	23	29	29	arsenite	MRP1	PA452638	4437	0.689
NULL	Open_Biol_2014_Nov_4(11)_140180.nxml.txt.nlp	25392452	SENT220	2	2	8	8	imatinib	LEF1	PA10804	51176	0.689
NULL	Virol_J_2012_Aug_3_9_143.nxml.txt.nlp	22863531	SENT257	28	28	26	26	ribavirin	IFN	PA451241	3439	0.689
NULL	Oncogene_2009_Apr_2_28(13)_1616-1625.nxml.txt.nlp	19219073	SENT100	16	16	18	18	nutlin-3	p53		7157	0.689
NULL	J_Hematol_Oncol_2008_Oct_23_1_19.nxml.txt.nlp	18947412	SENT32	0	0	6	6	alemtuzumab	CD52	PA164783958	1043	0.689
NULL	Lab_Invest_2011_Jun_14_91(6)_852-858.nxml.txt.nlp	21403643	SENT11	21	21	6	6	tenofovir	OAT1	PA10204	9356	0.689
NULL	Aging_(Albany_NY)_2012_Jun_11_4(6)_402-416.nxml.txt.nlp	22691943	SENT197	24	24	15	15	tamoxifen	SIRT1	PA451581	23411	0.689
NULL	Acta_Pharmacol_Sin_2011_Jul_13_32(7)_967-972.nxml.txt.nlp	21666702	SENT149	15	15	3	3	losartan	P-gp	PA450268	5243	0.689
NULL	Diabetes_Care_2011_Aug_16_34(8)_1854-1859.nxml.txt.nlp	21715518	SENT117	2	2	17	17	estradiol	aromatase	PA449503	1588	0.689
NULL	Cardiol_Res_Pract_2011_Apr_26_2011_837841.nxml.txt.nlp	21577267	SENT46	12	12	31	31	heparin	ACT	PA449855	12;11332;9457;641455	0.689
NULL	J_Oncol_2010_May_19_2010_285191.nxml.txt.nlp	20508725	SENT204	14	14	1	1	cerulenin	AKT	PA164764551	207	0.689
NULL	Crit_Care_2007_Dec_6_11(6)_235.nxml.txt.nlp	18177512	SENT133	25	25	3	3	metoprolol	CASH	PA450480	8837	0.689
NULL	Cancer_Cell_Int_2009_Oct_29_9_27.nxml.txt.nlp	19874583	SENT337	30	30	42	42	l-glutamine	CO2	PA10090	4513	0.689
NULL	Braz_J_Med_Biol_Res_2014_Apr_15_47(5)_426-431.nxml.txt.nlp	24760118	SENT116	25	25	29	29	simvastatin	CRP	PA451363	1401;140913	0.689
NULL	Chemother_Res_Pract_2012_Aug_29_2012_817297.nxml.txt.nlp	22970367	SENT190	12	12	5	5	afatinib	EGFR	PA165981154	1956	0.689
NULL	J_Cancer_2014_Jul_4_5(7)_559-571.nxml.txt.nlp	25057307	SENT230	14	14	9	9	tamoxifen	STAT3	PA451581	6774	0.689
NULL	Open_AIDS_J_2011_Apr_22_5_44-50.nxml.txt.nlp	21643422	SENT45	23	23	43	43	zidovudine	ATV	PA451954	4683	0.689
NULL	Iran_J_Basic_Med_Sci_2013_Apr_16(4)_610-614.nxml.txt.nlp	24250937	SENT32	8	8	40	40	coumarin	CYP2A6	PA134521193	1548	0.689
NULL	Mol_Cancer_2012_Mar_21_11_13.nxml.txt.nlp	22436134	SENT64	15	15	2	2	doxorubicin	HuR	PA449412	1994	0.689
NULL	Oncotarget_2013_Dec_18_5(3)_634-648.nxml.txt.nlp	24504138	SENT189	18	18	27	27	bortezomib	IL-6	PA10252	3569	0.689
NULL	Acta_Pharmacol_Sin_2009_Dec_4_30(12)_1601-1606.nxml.txt.nlp	19960006	SENT14	14	14	16	16	suramin	DPI	PA10292	1832	0.689
NULL	Int_J_Mol_Imaging_2011_Oct_26_2011_874585.nxml.txt.nlp	21490735	SENT125	14	14	43	43	doxorubicin	FDG	PA449412	23583	0.689
NULL	Eur_J_Epidemiol_2009_Sep_2_24(9)_553-572.nxml.txt.nlp	19728115	SENT1566	11	11	21	21	coumarin	PAGM	PA134521193	5238	0.689
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Apr_7_9_12.nxml.txt.nlp	20374640	SENT10	21	21	5	5	chloramphenicol	TEM	PA448927	64102	0.689
NULL	Chem_Rev_2014_Jun_11_114(11)_5753-5774.nxml.txt.nlp	24758331	SENT427	11	11	3	3	verapamil	P-gp	PA451868	5243	0.689
NULL	Acta_Pharmacol_Sin_2013_Aug_5_34(8)_998-1006.nxml.txt.nlp	23852086	SENT64	3	3	11	11	lansoprazole	CYP2C19	PA450180	1557	0.689
NULL	J_Biol_Chem_2008_Nov_14_283(46)_31679-31689.nxml.txt.nlp	18755684	SENT29	14	14	18	18	iron	FTL	PA450087	2512	0.689
NULL	Nucleic_Acids_Res_2012_Jul_5_40(13)_5988-6000.nxml.txt.nlp	22492511	SENT130	4	4	8	8	flavopiridol	MYB	PA452627	4602	0.689
NULL	Oncotarget_2012_May_19_3(5)_535-545.nxml.txt.nlp	22619121	SENT101	7	7	11	11	camptothecin	MYCN	PA153590860	4613	0.689
NULL	Cell_Commun_Signal_2013_Oct_1_11_73.nxml.txt.nlp	24083678	SENT215	0	0	12	12	sulindac	AP-1	PA451565	2353;3727;2354;3725	0.689
NULL	Biochemistry_2010_Feb_16_49(6)_1268-1280.nxml.txt.nlp	20052994	SENT25	13	13	24	24	amiloride	AOC3	PA448368	8639	0.689
NULL	Clin_Interv_Aging_2011_Jul_7_6_193-198.nxml.txt.nlp	21822374	SENT62	17	17	20	20	clopidogrel	DES	PA449053	1674	0.689
NULL	Nat_Med_2010_Nov_24_16(11)_1299-1304.nxml.txt.nlp	20972434	SENT190	0	0	11	11	forskolin	VASP	PA146096022	7408	0.689
NULL	Int_Arch_Med_2010_Dec_8_3_35.nxml.txt.nlp	21143863	SENT35	7	7	5	5	cisapride	Q10	PA449011	27161	0.689
NULL	J_Immunol_Res_2014_Apr_9_2014_657625.nxml.txt.nlp	24818168	SENT39	12	12	15	15	arsenite	HLA-G	PA452638	3135	0.689
NULL	Chemother_Res_Pract_2012_Aug_29_2012_817297.nxml.txt.nlp	22970367	SENT40	18	18	5	5	erlotinib	BRCA1	PA134687924	672	0.689
NULL	J_Antimicrob_Chemother_2009_Feb_28_63(2)_389-395.nxml.txt.nlp	19042940	SENT34	34	34	14	14	trimethoprim	UTI	PA451788	259	0.689
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Dec_18_67(Pt_1)_o202.nxml.txt.nlp	21522704	SENT59	12	12	18	18	ethanol	mol	PA448073	90527	0.689
NULL	Eur_Arch_Psychiatry_Clin_Neurosci_2012_Dec_28_262(8)_667-676.nxml.txt.nlp	22454241	SENT282	4	4	8	8	clozapine	spatial	PA449061	219793	0.689
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Aug_4_6_123-133.nxml.txt.nlp	25177151	SENT58	11	11	18	18	fulvestrant	CDK4	PA164747170	1019	0.689
NULL	Mar_Drugs_2011_Sep_9_9(9)_1510-1533.nxml.txt.nlp	22131955	SENT411	6	6	3	3	lactulose	CO2	PA164748762	4513	0.689
NULL	Front_Physiol_2011_Jun_14_2_26.nxml.txt.nlp	21716655	SENT224	39	39	21	21	lipase	SCAD	PA450239	35	0.689
NULL	Ann_Gen_Psychiatry_2008_Oct_15_7_19.nxml.txt.nlp	18922171	SENT151	13	13	5	5	bupropion	CD50	PA448687	3385	0.689
NULL	Front_Oncol_2014_Jun_11_4_145.nxml.txt.nlp	24967214	SENT409	16	16	22	22	melphalan	B7-1	PA450354	941	0.689
NULL	Ital_J_Pediatr_2011_Dec_19_37_58.nxml.txt.nlp	22182677	SENT169	20	20	9	9	flunarizine	LGS	PA164776636	51557	0.689
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Aug_6_64(Pt_9)_o1695.nxml.txt.nlp	21201684	SENT58	23	23	14	14	ethanol	mol	PA448073	90527	0.689
NULL	Open_Biol_2014_Apr_4(4)_130224.nxml.txt.nlp	24718598	SENT350	23	23	20	20	erythromycin	L22	PA449493	6146	0.689
NULL	Target_Oncol_2013_Jun_27_8(2)_127-136.nxml.txt.nlp	23625191	SENT66	18	18	7	7	panitumumab	KRAS	PA162373091	3845	0.689
NULL	Breast_Cancer_Res_2011_Jun_9_13(3)_R57.nxml.txt.nlp	21658222	SENT24	25	25	7	7	epirubicin	UGT1A1	PA449476	54658	0.689
NULL	BMB_Rep_2013_Nov_46(11)_544-549.nxml.txt.nlp	24152910	SENT61	23	23	14	14	thrombin	p38	PA451674	10598;1432;7965	0.689
NULL	J_Biol_Chem_2009_Jul_24_284(30)_20011-20021.nxml.txt.nlp	19473976	SENT193	0	0	4	4	trypsin	MCT1	PA451806	6566	0.689
NULL	J_Cell_Mol_Med_2014_May_14_18(5)_811-823.nxml.txt.nlp	24628949	SENT215	3	3	12	12	docetaxel	FOXM1	PA449383	2305	0.689
NULL	Daru_2011_19(5)_326-331.nxml.txt.nlp	22615677	SENT93	8	8	13	13	cisplatin	p53	PA449014	7157	0.689
NULL	Front_Oncol_2014_May_26_4_123.nxml.txt.nlp	24904834	SENT369	0	0	2	2	resveratrol	AMPK		5563	0.689
NULL	Mar_Drugs_2014_Jun_27_12(7)_3818-3837.nxml.txt.nlp	24979269	SENT63	8	8	6	6	doxorubicin	P-gp	PA449412	5243	0.689
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jul_14_66(Pt_8)_o1995.nxml.txt.nlp	21588309	SENT74	25	25	7	7	ethanol	mol	PA448073	90527	0.689
NULL	Oncol_Lett_2013_Aug_17_6(2)_295-305.nxml.txt.nlp	24137320	SENT42	34	34	24	24	fulvestrant	aromatase	PA164747170	1588	0.689
NULL	Support_Care_Cancer_2014_Oct_19_22(2)_469-477.nxml.txt.nlp	24141698	SENT155	20	20	25	25	cyclophosphamide	NK1	PA449165	11126	0.689
NULL	J_Cell_Biol_1986_Sep_1_103(3)_1109-1119.nxml.txt.nlp	3528169	SENT8	15	15	3	3	guanidine	STBM	PA164781028	57216	0.689
NULL	Carcinogenesis_2010_Dec_27_31(12)_2049-2057.nxml.txt.nlp	20876285	SENT242	10	10	25	25	fulvestrant	HER2	PA164747170	2064	0.689
NULL	J_Exp_Clin_Cancer_Res_2009_Oct_7_28(1)_134.nxml.txt.nlp	19811659	SENT98	0	0	14	14	nilotinib	DDR1	PA165958345	780	0.689
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_P108.nxml.txt.nlp	NULL	SENT15	30	30	0	0	piperacillin	CD4	PA450975	920	0.689
NULL	Iran_J_Basic_Med_Sci_2013_Jun_16(6)_772-780.nxml.txt.nlp	23997903	SENT51	35	35	15	15	omeprazole	B12	PA450704	7126;4709	0.689
NULL	Pharm_Methods_2011_Jan-Mar_2(1)_3-8.nxml.txt.nlp	23781422	SENT119	13	13	23	23	caffeine	TLC	PA448710	3933	0.689
NULL	Br_J_Cancer_2006_Feb_13_94(3)_407-426.nxml.txt.nlp	16434996	SENT120	8	8	2	2	genistein	BRCA1	PA165109660	672	0.689
NULL	Open_Biol_2013_Nov_3(11)_130130.nxml.txt.nlp	24258275	SENT159	7	7	3	3	etoposide	SIRT1	PA449552	23411	0.689
NULL	Hum_Genomics_2009_Jan_1_3(2)_121-127.nxml.txt.nlp	19164089	SENT86	39	39	24	24	ethanol	ALDH2	PA448073	217	0.689
NULL	J_Cell_Biol_2002_Sep_16_158(6)_1017-1027.nxml.txt.nlp	12221072	SENT49	0	0	4	4	methotrexate	DHFR	PA450428	1719	0.689
NULL	Breast_Cancer_Res_2011_Oct_12_13(5)_220.nxml.txt.nlp	22018398	SENT244	8	8	6	6	trastuzumab	EPO	PA451743	7076;8288;2056	0.689
NULL	Indian_J_Pharm_Sci_2008_May-Jun_70(3)_386-390.nxml.txt.nlp	20046755	SENT18	12	12	4	4	rabeprazole	USP1	PA451216	7398	0.689
NULL	Arthritis_Res_Ther_2013_Aug_30_15(4)_R100.nxml.txt.nlp	24000795	SENT206	6	6	20	20	paraformaldehyde	HNF4	PA450790	3172	0.689
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2675-2684.nxml.txt.nlp	24129246	SENT308	19	19	5	5	etoposide	p53	PA449552	7157	0.689
NULL	Pharmaceutics_2012_Jan_31_4(1)_104-129.nxml.txt.nlp	24300183	SENT247	20	20	13	13	fluorescein	SMO	PA164746009	6608;54498	0.689
NULL	Asian_J_Androl_2014_Jan_17_Mar-Apr_16(2)_274-279.nxml.txt.nlp	24457841	SENT89	35	35	15	15	dutasteride	ARIA	PA164749300	641700	0.689
NULL	Arthritis_Res_2002_Jul_26_4(5)_R9.nxml.txt.nlp	12223112	SENT61	0	0	30	30	fluorescein	San	PA164746009	80218	0.689
NULL	Case_Rep_Endocrinol_2012_Dec_3_2012_580481.nxml.txt.nlp	23243525	SENT46	33	33	20	20	hydrocortisone	ACTH	PA449905	5443	0.689
NULL	Clin_Interv_Aging_2012_Jul_12_7_235-247.nxml.txt.nlp	22866001	SENT133	22	22	9	9	alendronate	PTH	PA448082	5741	0.689
NULL	Subst_Abuse_Treat_Prev_Policy_2009_Apr_17_4_6.nxml.txt.nlp	19374740	SENT42	12	12	18	18	buprenorphine	OST	PA448685	1650;23263	0.689
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Aug_23_70(Pt_9)_142-144.nxml.txt.nlp	25309163	SENT17	28	28	25	25	ethanol	mol	PA448073	90527	0.689
NULL	Arthritis_Res_Ther_2012_Jun_25_14(3)_215.nxml.txt.nlp	22731694	SENT70	23	23	17	17	rituximab	RIBA	PA451261	6014	0.689
NULL	BMB_Rep_2014_Apr_47(4)_192-196.nxml.txt.nlp	24755554	SENT357	2	2	14	14	isoproterenol	GATA6	PA450121	2627	0.689
NULL	J_Med_Case_Reports_2011_May_3_5_168.nxml.txt.nlp	21539737	SENT54	11	11	8	8	cyclophosphamide	CHOP	PA449165	1649	0.689
NULL	J_Neurosci_Methods_2012_Jun_15_207-540(2-7)_148-160.nxml.txt.nlp	22524994	SENT290	27	27	22	22	oxygen	CO2	PA450744	4513	0.689
NULL	Indian_J_Med_Paediatr_Oncol_2013_Oct-Dec_34(4)_292-298.nxml.txt.nlp	24604960	SENT45	17	17	20	20	rituximab	CHOP	PA451261	1649	0.689
NULL	Oncoimmunology_2013_Jan_1_2(1)_e22546.nxml.txt.nlp	23483661	SENT53	24	24	27	27	clopidogrel	CD40	PA449053	958	0.689
NULL	Eur_J_Neurosci_2014_Feb_4_39(3)_419-434.nxml.txt.nlp	24494682	SENT471	4	4	11	11	lipase	EP3	PA450239	5733	0.689
NULL	Arthritis_Res_Ther_2010_Apr_29_12(2)_R73.nxml.txt.nlp	20429888	SENT219	0	0	8	8	bortezomib	c-Jun	PA10252	3725	0.689
NULL	eLife_2013_Oct_8_2_e01009.nxml.txt.nlp	24137539	SENT514	22	22	9	9	quinidine	Slo3	PA451209	157855	0.689
NULL	J_Gen_Physiol_1923_May_20_5(5)_647-659.nxml.txt.nlp	19872026	SENT0	29	29	1	1	trypsin	Gen	PA451806	348654	0.689
NULL	Front_Cell_Neurosci_2014_Feb_6_8_27.nxml.txt.nlp	24567703	SENT1080	1	1	11	11	creatine	KCC2	PA164778930	57468	0.689
NULL	CNS_Drugs_2014_May_1_28(6)_497-511.nxml.txt.nlp	24788672	SENT4	21	21	32	32	lisdexamfetamine	NOT	PA164748975	4929	0.689
NULL	Environ_Health_Perspect_2010_Jul_3_118(7)_936-942.nxml.txt.nlp	20199942	SENT171	28	28	19	19	arsenite	p53	PA452638	7157	0.689
NULL	Cancer_Immunol_Immunother_2011_Jun_25_60(6)_793-808.nxml.txt.nlp	21350947	SENT256	34	34	32	32	sorafenib	IFN	PA7000	3439	0.689
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT153	3	3	5	5	curcumin	TRAIL	PA151958596	8743	0.689
NULL	Adv_Ther_2013_Nov_22_30(12)_1031-1032.nxml.txt.nlp	24263555	SENT12	21	21	3	3	saxagliptin	GLP-1	PA165958362	100125288	0.689
NULL	Oncotarget_2013_Feb_27_4(2)_329-345.nxml.txt.nlp	23593654	SENT277	3	3	15	15	paclitaxel	CD44	PA450761	960	0.689
NULL	Hum_Genomics_Proteomics_2010_Aug_3_2010_159761.nxml.txt.nlp	20981231	SENT365	21	21	7	7	lithium	BDNF	PA450243	627	0.689
NULL	Clinicoecon_Outcomes_Res_2014_Oct_17_6_451-461.nxml.txt.nlp	25378939	SENT126	12	12	17	17	linezolid	HAP	PA450233	5915;10313	0.689
NULL	Bone_2012_Jan_50(1)_218-225.nxml.txt.nlp	22023931	SENT204	11	11	30	30	phosphorus	FGF23	PA450954	8074	0.689
NULL	Exp_Ther_Med_2013_Aug_20_6(2)_310-316.nxml.txt.nlp	24137180	SENT85	16	16	23	23	fasudil	MCP-1	PA165946121	6347	0.689
NULL	Osteoporos_Int_2011_Jan_1_22(1)_27-35.nxml.txt.nlp	20358360	SENT66	33	33	26	26	risedronate	PTH	PA451255	5741	0.689
NULL	ScientificWorldJournal_2013_Oct_24_2013_726912.nxml.txt.nlp	24282387	SENT86	7	7	11	11	fluorescein	AVP	PA164746009	114548;551	0.689
NULL	J_Biol_Chem_2013_Nov_22_288(47)_34217-34229.nxml.txt.nlp	24106270	SENT374	15	15	9	9	thrombin	RhoG	PA451674	391	0.689
NULL	Oncotarget_2011_Nov_9_2(11)_850-861.nxml.txt.nlp	22081665	SENT144	13	13	16	16	idarubicin	DNMT3A	PA449961	1788	0.689
NULL	Arthritis_Res_Ther_2006_Apr_12_8(Suppl_1)_S3.nxml.txt.nlp	16820042	SENT148	34	34	12	12	colchicine	MSU	PA449092	593	0.689
NULL	Springerplus_2013_Feb_11_2_44.nxml.txt.nlp	23503672	SENT109	22	22	4	4	mannitol	fru	PA450320	9278	0.689
NULL	Core_Evid_2011_Feb_8_6_23-29.nxml.txt.nlp	21468240	SENT49	10	10	26	26	plerixafor	CD34	PA165958410	947	0.689
NULL	Cell_Regen_(Lond)_2012_Jun_28_1(1)_3.nxml.txt.nlp	25408866	SENT266	13	13	4	4	glucose	beta-catenin	PA449773	1499	0.689
NULL	Braz_J_Med_Biol_Res_2014_Feb_17_47(2)_101-109.nxml.txt.nlp	24519125	SENT142	0	0	2	2	forskolin	IL-6	PA146096022	3569	0.689
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT44	11	11	20	20	bevacizumab	VEGF-A	PA130232992	7422	0.689
NULL	Arthritis_Res_Ther_2009_Aug_24_11(4)_R127.nxml.txt.nlp	19703304	SENT56	21	21	7	7	adalimumab	OASIS	PA10004	90993	0.689
NULL	J_Cell_Biol_2001_Oct_29_155(3)_427-438.nxml.txt.nlp	11673478	SENT11	8	8	19	19	genistein	PP2	PA165109660	4888	0.689
NULL	BMJ_Open_2014_Feb_15_4(2)_e004104.nxml.txt.nlp	24534257	SENT108	12	12	15	15	artemisinin	TRAC	PA165111696	28755	0.689
NULL	Anal_Bioanal_Chem_2009_Oct_30_395(4)_893-905.nxml.txt.nlp	19484227	SENT242	17	17	19	19	tetracycline	OTC	PA451640	5009	0.689
NULL	Cerebrospinal_Fluid_Res_2010_Aug_13_7_13.nxml.txt.nlp	20707896	SENT4	7	7	9	9	vasopressin	AVP	PA451858	114548;551	0.689
NULL	Basic_Clin_Pharmacol_Toxicol_2013_Feb_5_112(2)_132-137.nxml.txt.nlp	22900583	SENT154	9	9	5	5	ketoconazole	CYP3A	PA450146	1574	0.689
NULL	Infect_Drug_Resist_2010_Oct_28_3_123-132.nxml.txt.nlp	21694901	SENT36	37	37	23	23	aztreonam	PARI	PA448523	55010	0.689
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_112-114.nxml.txt.nlp	25568847	SENT65	15	15	7	7	heparin	ACT	PA449855	12;11332;9457;641455	0.689
NULL	J_Vet_Med_Sci_2014_Aug_15_76(8)_1119-1127.nxml.txt.nlp	24829081	SENT129	6	6	36	36	trypsin	fractalkine	PA451806	6376	0.689
NULL	Breast_Cancer_Res_2004_Mar_26_6(3)_R252-R263.nxml.txt.nlp	15084249	SENT169	31	31	13	13	tamoxifen	NAT1	PA451581	9;1982	0.689
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1148.nxml.txt.nlp	24675466	SENT5	37	37	39	39	vasopressin	AVP	PA451858	114548;551	0.689
NULL	J_Thromb_Haemost_2010_Nov_8(11)_2530-2541.nxml.txt.nlp	20723025	SENT72	17	17	39	39	indomethacin	ADP	PA449982	23038	0.689
NULL	J_Int_AIDS_Soc_2010_Nov_8_13(Suppl_4)_P95.nxml.txt.nlp	NULL	SENT23	22	22	1	1	didanosine	CD4	PA449301	920	0.689
NULL	Oxid_Med_Cell_Longev_2012_Jan_19_2012_390678.nxml.txt.nlp	22315655	SENT171	3	3	5	5	gliclazide	NAC	PA10892	22861	0.689
NULL	Environ_Health_Perspect_2009_Jan_22_117(1)_112-116.nxml.txt.nlp	19165396	SENT16	29	29	37	37	vasopressin	PRL	PA451858	5617	0.689
NULL	Alcohol_Res_Health_2011_34(1)_106-120.nxml.txt.nlp	23580048	SENT93	9	9	16	16	ethanol	CA3	PA448073	761	0.689
NULL	Arthritis_Res_Ther_2014_Apr_28_16(2)_R104.nxml.txt.nlp	24774748	SENT206	18	18	11	11	cyclophosphamide	CD4	PA449165	920	0.689
NULL	Eur_J_Clin_Pharmacol_2014_Mar_22_70(6)_685-693.nxml.txt.nlp	24658827	SENT225	26	26	21	21	midazolam	CYP3A5	PA450496	1577	0.689
NULL	AoB_Plants_2014_Aug_19_6_plu049.nxml.txt.nlp	25139768	SENT212	9	9	15	15	betaine	mol	PA448603	90527	0.689
NULL	Front_Genet_2012_May_30_3_94.nxml.txt.nlp	22666228	SENT1509	13	13	26	26	vinblastine	JNK	PA451877	5599	0.689
NULL	Emerg_Infect_Dis_2012_Feb_18(2)_302-304.nxml.txt.nlp	22305387	SENT113	28	28	14	14	sulfadiazine	PYM	PA451539	84305	0.689
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jun_5_66(Pt_7)_o1583.nxml.txt.nlp	21587823	SENT59	15	15	6	6	ethanol	mol	PA448073	90527	0.689
NULL	Br_J_Haematol_2014_Mar_13_164(1)_811-821.nxml.txt.nlp	24328678	SENT259	15	15	6	6	lenalidomide	IL8	PA162363968	3576	0.689
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT1856	32	32	35	35	fluorescein	MRP2	PA164746009	100130958;57626;1244	0.689
NULL	Front_Neuroanat_2011_Jul_12_5_38.nxml.txt.nlp	21808606	SENT101	15	15	6	6	haloperidol	DARPP-32	PA449841	84152	0.689
NULL	J_Gen_Physiol_1922_Jan_20_4(3)_227-244.nxml.txt.nlp	19871928	SENT0	12	12	1	1	trypsin	Gen	PA451806	348654	0.689
NULL	Ann_Surg_Oncol_2012_Feb_12_19(2)_527-535.nxml.txt.nlp	21748247	SENT54	27	27	43	43	heparin	CO2	PA449855	4513	0.689
NULL	Clin_Sci_(Lond)_2013_Aug_1_125(Pt_3)_121-130.nxml.txt.nlp	23577635	SENT158	36	36	24	24	lipase	ATGL	PA450239	57104	0.689
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT100	8	8	10	10	trastuzumab	HER2	PA451743	2064	0.689
NULL	Allergy_Asthma_Immunol_Res_2013_Jan_28_5(1)_3-15.nxml.txt.nlp	23277873	SENT224	4	4	13	13	omalizumab	San	PA164752253	80218	0.689
NULL	Acta_Vet_Scand_2011_Feb_17_53(1)_11.nxml.txt.nlp	21324209	SENT55	2	2	24	24	ampicillin	OTC	PA448419	5009	0.689
NULL	J_Hematol_Oncol_2012_Sep_18_5_57.nxml.txt.nlp	22989009	SENT169	28	28	2	2	nutlin-3	p53		7157	0.689
NULL	Anal_Bioanal_Chem_2012_Apr_7_403(1)_215-226.nxml.txt.nlp	22395449	SENT70	24	24	33	33	trypsin	C23	PA451806	4691	0.689
NULL	Int_J_Mol_Sci_2014_Sep_5_15(9)_15754-15765.nxml.txt.nlp	25198898	SENT395	1	1	12	12	curcumin	NF-kappaB	PA151958596	4790	0.689
NULL	J_Cell_Biol_2001_Aug_6_154(3)_599-610.nxml.txt.nlp	11481345	SENT318	14	14	24	24	doxycycline	ARF6	PA449415	382	0.689
NULL	Breast_Cancer_Res_2011_Jan_21_13(1)_R9.nxml.txt.nlp	21255398	SENT235	17	17	3	3	cyclophosphamide	RAD21	PA449165	5885	0.689
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT179	4	4	9	9	doxorubicin	B7-H1	PA449412	29126	0.689
NULL	Clin_Exp_Otorhinolaryngol_2011_Mar_17_4(1)_18-23.nxml.txt.nlp	21461058	SENT78	14	14	4	4	furosemide	KCC2	PA449719	57468	0.689
NULL	Oncogene_2013_Sep_26_32(39)_10_1038_onc_2012_491.nxml.txt.nlp	23108394	SENT99	24	24	28	28	epirubicin	FOXM1	PA449476	2305	0.689
NULL	Clin_Med_Insights_Oncol_2011_Nov_9_5_365-379.nxml.txt.nlp	22174597	SENT134	13	13	6	6	imatinib	KIT	PA10804	3815	0.689
NULL	Br_J_Pharmacol_2014_Jan_23_171(2)_523-535.nxml.txt.nlp	24372553	SENT181	0	0	3	3	metformin	SIRT1	PA450395	23411	0.689
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT292	2	2	7	7	olanzapine	PRL	PA450688	5617	0.689
NULL	Biomed_Res_Int_2013_Sep_4_2013_419176.nxml.txt.nlp	24093097	SENT70	15	15	2	2	sunitinib	FGF2	PA162372840	2247;2258	0.689
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Sep_18_69(Pt_10)_o1545.nxml.txt.nlp	24098230	SENT70	10	10	13	13	benzaldehyde	mol	PA448571	90527	0.689
NULL	Biomed_Res_Int_2014_May_20_2014_309307.nxml.txt.nlp	24967350	SENT125	27	27	42	42	l-glutamine	CO2	PA10090	4513	0.689
NULL	J_Viral_Hepat_2014_Jul_12_21(7)_e39-e47.nxml.txt.nlp	24620791	SENT84	26	26	41	41	fluorescein	CD25	PA164746009	3669;3559	0.689
NULL	Br_J_Cancer_2000_Jul_3_83(3)_375-383.nxml.txt.nlp	10917554	SENT4	5	5	3	3	daunorubicin	MRP1	PA449212	4437	0.689
NULL	Ann_Lab_Med_2012_Jul_20_32(4)_298-303.nxml.txt.nlp	22779073	SENT117	32	32	22	22	pyrazinamide	MOX	PA451182	26002	0.689
NULL	Oncotarget_2014_Aug_4_5(16)_6867-6884.nxml.txt.nlp	25149539	SENT306	10	10	5	5	curcumin	PKD1	PA151958596	5310	0.689
NULL	New_Microbes_New_Infect_2014_May_4_2(3)_58-63.nxml.txt.nlp	25356345	SENT100	6	6	20	20	cefoxitin	GEM	PA448856	2669	0.689
NULL	J_Vet_Emerg_Crit_Care_(San_Antonio)_2013_Mar_8_23(2)_134-162.nxml.txt.nlp	23566108	SENT62	3	3	17	17	calcidiol	CYP2R1	PA164745614	120227	0.689
NULL	Oncotarget_2012_Oct_27_3(10)_1052-1053.nxml.txt.nlp	23165648	SENT25	26	26	23	23	nutlin-3	p53		7157	0.689
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_21-38.nxml.txt.nlp	19305786	SENT123	11	11	21	21	capsaicin	TRPV1	PA448776	7442	0.689
NULL	Br_J_Cancer_2006_Feb_13_94(3)_407-426.nxml.txt.nlp	16434996	SENT347	19	19	7	7	genistein	BRCA1	PA165109660	672	0.689
NULL	Nat_Med_2013_Oct_8_19(10)_1313-1317.nxml.txt.nlp	24013700	SENT65	15	15	11	11	ribavirin	IFN	PA451241	3439	0.689
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT166	42	42	31	31	pp2	PP2		4888	0.689
NULL	Mol_Biol_Evol_2013_Feb_27_30(2)_448-456.nxml.txt.nlp	23104081	SENT52	7	7	10	10	doxycycline	LCB2	PA449415	9517	0.689
NULL	Br_J_Cancer_2010_Jan_5_102(1)_80-86.nxml.txt.nlp	19920817	SENT123	27	27	14	14	bevacizumab	IFN	PA130232992	3439	0.689
NULL	Br_J_Cancer_2012_Feb_14_106(4)_685-692.nxml.txt.nlp	22294184	SENT125	35	35	41	41	docetaxel	survivin	PA449383	332	0.689
NULL	Mol_Cancer_2009_Dec_3_8_115.nxml.txt.nlp	19958544	SENT28	10	10	8	8	nutlin-3	MDM2		4193	0.689
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT121	23	23	26	26	nutlin-3	p53		7157	0.689
NULL	J_Immunol_Res_2014_Jul_16_2014_696812.nxml.txt.nlp	25133198	SENT262	23	23	14	14	rifaximin	TLR4	PA164752443	7099	0.689
NULL	Front_Endocrinol_(Lausanne)_2014_Aug_28_5_137.nxml.txt.nlp	25221541	SENT21	5	5	12	12	metformin	GLP-1	PA450395	100125288	0.689
NULL	Eur_J_Clin_Pharmacol_2014_Oct_8_70(1)_37-45.nxml.txt.nlp	24100471	SENT205	10	10	7	7	rosuvastatin	OATP1B1	PA134308647	10599	0.689
NULL	Clin_Med_Insights_Oncol_2011_Sep_21_5_315-323.nxml.txt.nlp	22084620	SENT141	4	4	6	6	gemcitabine	INF	PA449748	2694	0.689
NULL	Braz_J_Med_Biol_Res_2011_Nov_25_45(1)_58-67.nxml.txt.nlp	22124704	SENT130	32	32	39	39	staurosporine	ANOVA	PA165109623	4858	0.689
NULL	Allergy_Asthma_Immunol_Res_2014_Nov_19_6(6)_548-557.nxml.txt.nlp	25374755	SENT164	2	2	4	4	lovastatin	MUC5AC	PA450272	4586	0.689
NULL	Front_Psychol_2014_Jun_27_5_658.nxml.txt.nlp	25018744	SENT321	14	14	16	16	vasopressin	AVP	PA451858	114548;551	0.689
NULL	Clin_Epigenetics_2011_May_7_2(2)_249-256.nxml.txt.nlp	22704340	SENT139	7	7	16	16	l-methionine	RELN	PA450423	5649	0.689
NULL	Ther_Clin_Risk_Manag_2006_Dec_2(4)_365-375.nxml.txt.nlp	18360649	SENT110	13	13	0	0	abatacept	ACR	PA164747080	49	0.689
NULL	Br_J_Cancer_2010_Feb_2_102(3)_520-529.nxml.txt.nlp	20029417	SENT135	25	25	27	27	cetuximab	IL-21	PA10040	59067;50616;27189	0.688
NULL	Ecancermedicalscience_2008_Jun_9_2_81.nxml.txt.nlp	22275970	SENT137	16	16	10	10	pentoxifylline	gamma	PA450864	9913	0.688
NULL	Allergy_Asthma_Clin_Immunol_2013_Oct_17_9(1)_41.nxml.txt.nlp	24499258	SENT168	8	8	22	22	omalizumab	IL-8	PA164752253	3576	0.688
NULL	Mol_Vis_2012_May_1_18_1115-1122.nxml.txt.nlp	22605923	SENT13	3	3	13	13	estradiol	IL-6	PA449503	3569	0.688
NULL	Nat_Biotechnol_2013_Jul_30_31(7)_630-637.nxml.txt.nlp	23811600	SENT375	4	4	8	8	ponatinib	FLT3	PA165980594	2322	0.688
NULL	ScientificWorldJournal_2014_Oct_30_2014_492178.nxml.txt.nlp	25544956	SENT14	14	14	4	4	stavudine	Hua	PA451494	1994	0.688
NULL	Biomed_Res_Int_2013_Jul_25_2013_316286.nxml.txt.nlp	23984341	SENT115	15	15	11	11	cisplatin	XPC	PA449014	7508	0.688
NULL	Jpn_Clin_Med_2013_Mar_6_4_7-13.nxml.txt.nlp	23966811	SENT8	10	10	25	25	esomeprazole	ESD	PA10075	2098	0.688
NULL	Br_J_Cancer_2010_Jun_29_103(1)_61-72.nxml.txt.nlp	20588279	SENT246	5	5	11	11	trastuzumab	RhoB	PA451743	388	0.688
NULL	Iran_J_Public_Health_2012_Nov_1_41(11)_1-9.nxml.txt.nlp	23304670	SENT204	9	9	11	11	tamoxifen	aromatase	PA451581	1588	0.688
NULL	Cancer_Med_2013_Feb_3_2(1)_11-20.nxml.txt.nlp	24133623	SENT30	10	10	13	13	cetuximab	KRAS	PA10040	3845	0.688
NULL	Evid_Based_Complement_Alternat_Med_2012_Aug_29_2012_149256.nxml.txt.nlp	22973399	SENT227	1	1	12	12	imipramine	GDNF	PA449969	2668	0.688
NULL	Oncoimmunology_2013_Sep_1_2(9)_e25789.nxml.txt.nlp	24244905	SENT22	4	4	24	24	cyclophosphamide	CCL2	PA449165	6347	0.688
NULL	ScientificWorldJournal_2013_Dec_26_2013_451629.nxml.txt.nlp	24453851	SENT30	16	16	7	7	ethanol	mol	PA448073	90527	0.688
NULL	J_Invest_Dermatol_2013_Jun_14_133(6)_1541-1549.nxml.txt.nlp	23407395	SENT41	11	11	20	20	imiquimod	IL-8	PA449972	3576	0.688
NULL	Clin_Ophthalmol_2011_Apr_26_5_517-525.nxml.txt.nlp	21573041	SENT96	1	1	7	7	latanoprost	BAK	PA164774763	578	0.688
NULL	Gut_2011_Sep_8_60(9)_1284-1293.nxml.txt.nlp	21303914	SENT32	46	46	43	43	ribavirin	IFN	PA451241	3439	0.688
NULL	Cancer_Cell_Int_2014_Jan_14_14_4.nxml.txt.nlp	24423208	SENT60	22	22	4	4	cisplatin	IL-2	PA449014	3558	0.688
NULL	Front_Neurosci_2014_Dec_5_8_398.nxml.txt.nlp	25538552	SENT730	1	1	6	6	glucose	gamma	PA449773	9913	0.688
NULL	Cancers_(Basel)_2011_Aug_15_3(3)_3331-3352.nxml.txt.nlp	24212957	SENT242	11	11	8	8	bevacizumab	CD144	PA130232992	1003	0.688
NULL	Cell_Death_Dis_2014_Jan_16_5(1)_e1000.nxml.txt.nlp	24434508	SENT292	13	13	25	25	bleomycin	p53	PA448645	7157	0.688
NULL	J_Biomed_Sci_2013_Dec_20_20(1)_99.nxml.txt.nlp	24358977	SENT195	38	38	35	35	methotrexate	DHFR	PA450428	1719	0.688
NULL	Behav_Brain_Funct_2010_Aug_30_6_50.nxml.txt.nlp	20799992	SENT59	13	13	15	15	heroin	LSD	PA452619	1776	0.688
NULL	Clin_Dev_Immunol_2011_Dec_5_2011_894704.nxml.txt.nlp	22190975	SENT230	10	10	7	7	cyclophosphamide	CHOP	PA449165	1649	0.688
NULL	Oxid_Med_Cell_Longev_2012_May_30_2012_452902.nxml.txt.nlp	22701146	SENT279	7	7	26	26	ifosfamide	OCTN2	PA449964	6584	0.688
NULL	Indian_J_Pharmacol_2008_Mar-Apr_40(2)_84-86.nxml.txt.nlp	21279172	SENT85	7	7	5	5	lidocaine	CYP3A4	PA450226	1576	0.688
NULL	Breast_Cancer_Res_2007_Oct_26_9(5)_306.nxml.txt.nlp	17980055	SENT42	38	38	7	7	tamoxifen	BCL2	PA451581	596	0.688
NULL	Clin_Med_Insights_Oncol_2012_Feb_28_6_125-135.nxml.txt.nlp	22408376	SENT66	21	21	29	29	oxaliplatin	KRAS	PA131285527	3845	0.688
NULL	Antibiotics_(Basel)_2014_Oct_13_3(4)_461-492.nxml.txt.nlp	25419466	SENT226	33	33	27	27	bacitracin	UPP	PA448531	7378	0.688
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT2405	21	21	6	6	amiodarone	CYP3A4	PA448383	1576	0.688
NULL	Scientifica_(Cairo)_2012_Nov_25_2012_473829.nxml.txt.nlp	24278698	SENT242	31	31	25	25	oxaliplatin	ATP7A	PA131285527	538	0.688
NULL	Breast_Cancer_Res_2007_Aug_8_9(4)_R50.nxml.txt.nlp	17686159	SENT258	21	21	12	12	gefitinib	HRG	PA131301952	3084;3273	0.688
NULL	Clin_Sci_(Lond)_2012_Oct_1_123(Pt_8)_473-486.nxml.txt.nlp	22757958	SENT135	6	6	10	10	glucosamine	OGT	PA164747613	8473	0.688
NULL	J_Hematol_Oncol_2013_Jun_3_6_38.nxml.txt.nlp	23731980	SENT70	10	10	1	1	lapatinib	San	PA152241907	80218	0.688
NULL	Br_J_Cancer_2012_Jan_17_106(2)_284-289.nxml.txt.nlp	22215065	SENT180	12	12	22	22	atrasentan	IFN	PA143414738	3439	0.688
NULL	Acta_Pharmacol_Sin_2013_Mar_21_34(3)_352-359.nxml.txt.nlp	23334241	SENT99	3	3	15	15	eplerenone	NOX4	PA164749044	50507	0.688
NULL	Evid_Based_Complement_Alternat_Med_2011_Aug_18_2011_164139.nxml.txt.nlp	21941584	SENT32	25	25	13	13	scopolamine	spatial	PA451308	219793	0.688
NULL	Environ_Health_Perspect_2009_Jan_22_117(1)_112-116.nxml.txt.nlp	19165396	SENT133	29	29	15	15	estradiol	PRL	PA449503	5617	0.688
NULL	Neuro_Oncol_2014_Jan_10_16(1)_21-28.nxml.txt.nlp	24335554	SENT205	14	14	19	19	bevacizumab	CXCR4	PA130232992	7852	0.688
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1049.nxml.txt.nlp	24503541	SENT127	12	12	2	2	staurosporine	PP2	PA165109623	4888	0.688
NULL	Curr_Cardiol_Rev_2011_Nov_7(4)_245-249.nxml.txt.nlp	22758625	SENT19	5	5	11	11	trastuzumab	HER2	PA451743	2064	0.688
NULL	Mol_Imaging_Radionucl_Ther_2013_Aug_1_22(2)_49-55.nxml.txt.nlp	24003397	SENT2	17	17	24	24	octreotide	ACTH	PA450678	5443	0.688
NULL	Eur_J_Immunol_2014_Jun_10_44(6)_1759-1769.nxml.txt.nlp	24595810	SENT30	0	0	10	10	fludrocortisone	CD4	PA164743961	920	0.688
NULL	EMBO_Mol_Med_2013_Mar_18_5(3)_344-352.nxml.txt.nlp	23417962	SENT98	6	6	27	27	resveratrol	p53		7157	0.688
NULL	Indian_J_Pharm_Sci_2012_Jul-Aug_74(4)_360-364.nxml.txt.nlp	23626393	SENT85	8	8	5	5	zonisamide	FOR	PA451978	51741	0.688
NULL	Iran_J_Pharm_Res_2013_Summer_12(3)_457-469.nxml.txt.nlp	24250652	SENT147	8	8	22	22	indomethacin	spatial	PA449982	219793	0.688
NULL	Core_Evid_2015_Jan_13_10_23-38.nxml.txt.nlp	25610345	SENT125	0	0	9	9	rasburicase	G6PD	PA10176	2539	0.688
NULL	Curr_Cardiol_Rev_2008_Nov_4(4)_309-322.nxml.txt.nlp	20066139	SENT52	21	21	30	30	estradiol	CEE	PA449503	51608	0.688
NULL	Arthritis_Res_Ther_2013_Sep_26_15(5)_R137.nxml.txt.nlp	24286509	SENT178	4	4	20	20	pegloticase	CAPER	PA165963961	9584	0.688
NULL	Int_J_Mol_Sci_2014_Mar_20_15(3)_4965-4976.nxml.txt.nlp	24658440	SENT72	41	41	23	23	infliximab	CD19	PA452639	930	0.688
NULL	Cancer_Immunol_Immunother_2011_Jan_22_60(1)_37-47.nxml.txt.nlp	20859626	SENT71	17	17	29	29	fluorescein	San	PA164746009	80218	0.688
NULL	Front_Oncol_2014_Apr_14_4_64.nxml.txt.nlp	24782981	SENT244	21	21	11	11	hydroxychloroquine	ATG5	PA164777036	9474	0.688
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jul_21_66(Pt_8)_o2077.nxml.txt.nlp	21588377	SENT62	24	24	9	9	ethanol	mol	PA448073	90527	0.688
NULL	J_Cell_Biol_1998_Aug_24_142(4)_923-936.nxml.txt.nlp	9722606	SENT288	31	31	34	34	fluorescein	TGN	PA164746009	7038	0.688
NULL	New_Microbes_New_Infect_2014_May_4_2(3)_58-63.nxml.txt.nlp	25356345	SENT100	30	30	24	24	ciprofloxacin	ANK	PA449009	56172	0.688
NULL	Iran_J_Pharm_Res_2014_Winter_13(Suppl)_125-132.nxml.txt.nlp	24711838	SENT131	0	0	16	16	pilocarpine	IFF	PA450962	3456	0.688
NULL	J_Geriatr_Cardiol_2012_Jun_9(2)_209-210.nxml.txt.nlp	23097648	SENT13	17	17	6	6	warfarin	CYP4F2	PA451906	8529	0.688
NULL	Eur_J_Drug_Metab_Pharmacokinet_2011_Jan_30_35(3-4)_79-82.nxml.txt.nlp	21302032	SENT65	17	17	0	0	lamotrigine	UGT1A	PA450164	7361;54658	0.688
NULL	Chin_J_Cancer_2012_Jul_31(7)_327-334.nxml.txt.nlp	22640628	SENT139	11	11	4	4	tamoxifen	PIK3CA	PA451581	5290	0.688
NULL	Asian-Australas_J_Anim_Sci_2013_Apr_26(4)_537-544.nxml.txt.nlp	25049820	SENT132	31	31	19	19	galactose	PKE	PA449725	282974	0.688
NULL	Pharmaceuticals_(Basel)_2014_Jan_27_7(2)_169-191.nxml.txt.nlp	24473270	SENT704	8	8	24	24	labetalol	BCS	PA164743150	617	0.688
NULL	Evid_Based_Complement_Alternat_Med_2006_Sep_11_3(3)_317-327.nxml.txt.nlp	16951716	SENT173	5	5	8	8	naringenin	PI3K	PA151958361	5290	0.688
NULL	Cell_Commun_Signal_2014_Mar_11_12_16.nxml.txt.nlp	24618498	SENT433	24	24	22	22	niclosamide	STAT3	PA165958408	6774	0.688
NULL	Indian_J_Endocrinol_Metab_2013_Jul-Aug_17(4)_636-646.nxml.txt.nlp	23961479	SENT138	14	14	9	9	fluvastatin	CYP3A4	PA449688	1576	0.688
NULL	Am_J_Cardiovasc_Drugs_2013_Jun_20_13(5)_331-342.nxml.txt.nlp	23784266	SENT195	4	4	33	33	verapamil	P-gp	PA451868	5243	0.688
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT280	23	23	3	3	cetuximab	PTEN	PA10040	5728	0.688
NULL	Br_J_Cancer_2010_Feb_2_102(3)_520-529.nxml.txt.nlp	20029417	SENT146	22	22	24	24	cetuximab	IL-21	PA10040	59067;50616;27189	0.688
NULL	J_Int_AIDS_Soc_2011_Feb_9_14_7.nxml.txt.nlp	21306608	SENT74	34	34	23	23	lopinavir	ATV	PA450264	4683	0.688
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S279-S284.nxml.txt.nlp	21525469	SENT131	34	34	37	37	exenatide	GLP-1	PA164749238	100125288	0.688
NULL	Diabetes_Care_2012_Feb_16_35(2)_327-333.nxml.txt.nlp	22179958	SENT49	6	6	9	9	metformin	B12	PA450395	7126;4709	0.688
NULL	Breast_Cancer_Res_2004_Jun_29_6(5)_R488-R498.nxml.txt.nlp	15318931	SENT196	8	8	16	16	estradiol	UGT2B15	PA449503	7366	0.688
NULL	Mol_Biol_Rep_2012_May_20_39(5)_5253-5267.nxml.txt.nlp	22183301	SENT205	12	12	10	10	gliclazide	NAC	PA10892	22861	0.688
NULL	Diabetes_2013_Sep_15_62(9)_3232-3240.nxml.txt.nlp	23835329	SENT159	15	15	2	2	aripiprazole	GLP-1	PA10026	100125288	0.688
NULL	Oncotarget_2014_Oct_21_5(22)_11252-11268.nxml.txt.nlp	25361004	SENT61	6	6	13	13	metformin	CLIC1	PA450395	1192	0.688
NULL	Front_Pharmacol_2014_Oct_31_5_231.nxml.txt.nlp	25400580	SENT2979	20	20	7	7	paclitaxel	RRM1	PA450761	6240	0.688
NULL	Pharmaceuticals_(Basel)_2014_Mar_5_7(3)_311-338.nxml.txt.nlp	24603603	SENT699	9	9	6	6	cetuximab	EGFR	PA10040	1956	0.688
NULL	Clin_Med_Insights_Oncol_2012_Mar_12_6_137-147.nxml.txt.nlp	22550402	SENT9	0	0	5	5	erlotinib	EGFR	PA134687924	1956	0.688
NULL	Front_Neurosci_2014_May_27_8_129.nxml.txt.nlp	24904269	SENT117	26	26	5	5	ethanol	ANOVA	PA448073	4858	0.688
NULL	Iran_J_Pharm_Res_2013_Summer_12(3)_457-469.nxml.txt.nlp	24250652	SENT39	6	6	22	22	indomethacin	spatial	PA449982	219793	0.688
NULL	Oncotarget_2014_Mar_16_5(12)_4087-4102.nxml.txt.nlp	24961479	SENT132	0	0	4	4	hemin	HO-1	PA449849	3162	0.688
NULL	Carcinogenesis_2013_Nov_10_34(11)_2580-2586.nxml.txt.nlp	23843037	SENT280	3	3	9	9	mesalazine	NF-kappaB	PA450384	4790	0.688
NULL	Orphanet_J_Rare_Dis_2007_Jan_23_2_6.nxml.txt.nlp	17244349	SENT101	8	8	20	20	methotrexate	ADM	PA450428	133	0.688
NULL	Oncol_Rep_2013_Apr_23_29(4)_1268-1274.nxml.txt.nlp	23354756	SENT171	22	22	9	9	trastuzumab	SLC25A43	PA451743	203427	0.688
NULL	Eur_J_Clin_Pharmacol_2014_Mar_22_70(6)_685-693.nxml.txt.nlp	24658827	SENT142	0	0	14	14	cyclosporine	CYP3A5	PA449167	1577	0.688
NULL	Oncotarget_2011_Dec_31_2(12)_1322-1328.nxml.txt.nlp	22249159	SENT27	15	15	7	7	imatinib	PI3	PA10804	5266	0.688
NULL	Cell_Death_Dis_2013_Jun_27_4(6)_e694.nxml.txt.nlp	23807223	SENT99	4	4	13	13	chloroquine	P62	PA448948	2965	0.688
NULL	J_Cell_Biol_2000_Jul_10_150(1)_5-8.nxml.txt.nlp	10893276	SENT89	14	14	9	9	etoposide	CD95	PA449552	355	0.688
NULL	Int_J_Fertil_Steril_2014_Nov_1_Oct-Dec_8(3)_243-248.nxml.txt.nlp	25379151	SENT43	9	9	17	17	indomethacin	ART	PA449982	181	0.688
NULL	Diabetol_Metab_Syndr_2014_Sep_16_6(1)_99.nxml.txt.nlp	NULL	SENT184	3	3	8	8	pioglitazone	adiponectin	PA450970	9370	0.688
NULL	Mol_Brain_2014_Nov_12_7(1)_81.nxml.txt.nlp	NULL	SENT129	8	8	10	10	rosiglitazone	spatial	PA451283	219793	0.688
NULL	Oncologist_2010_Feb_15_15(2)_122-129.nxml.txt.nlp	20156908	SENT31	38	38	11	11	anastrozole	HER-2	PA448432	2064	0.688
NULL	J_Addict_2013_Aug_27_2013_307845.nxml.txt.nlp	24804142	SENT52	17	17	27	27	cocaine	LSD	PA449072	1776	0.688
NULL	Arthritis_Res_Ther_2010_Jun_2_12(3)_R107.nxml.txt.nlp	20525198	SENT20	12	12	2	2	adalimumab	TNF	PA10004	7124	0.688
NULL	Mol_Vis_2011_Feb_1_17_332-340.nxml.txt.nlp	21297899	SENT14	0	0	7	7	benazepril	NAC	PA448561	22861	0.688
NULL	Environ_Health_Perspect_2007_May_115(5)_A242.nxml.txt.nlp	17520034	SENT23	23	23	25	25	diethylstilbestrol	DES	PA449307	1674	0.688
NULL	Curr_Oncol_2009_Jul_16(Suppl_2)_S14-S23.nxml.txt.nlp	19672417	SENT140	14	14	9	9	anastrozole	ATAC	PA448432	6375	0.688
NULL	Nat_Commun_2014_Apr_8_5_3563.nxml.txt.nlp	24714520	SENT556	3	3	23	23	glucosamine	HIF-1alpha	PA164747613	3091	0.688
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT154	13	13	6	6	metformin	PTEN	PA450395	5728	0.688
NULL	EMBO_Mol_Med_2011_Nov_3(11)_623-636.nxml.txt.nlp	21953712	SENT194	8	8	16	16	trastuzumab	PIK3CA	PA451743	5290	0.688
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_May_29_65(Pt_6)_o1404-o1405.nxml.txt.nlp	21583249	SENT75	7	7	10	10	benzaldehyde	mol	PA448571	90527	0.688
NULL	Eur_J_Clin_Pharmacol_2013_Mar_11_69(3)_327-339.nxml.txt.nlp	22782539	SENT192	4	4	11	11	dabigatran	IPA		3160	0.688
NULL	Breast_Cancer_Res_2000_Mar_25_2(3)_184-190.nxml.txt.nlp	11250708	SENT58	17	17	3	3	carbachol	EGFR	PA448784	1956	0.688
NULL	J_Gerontol_A_Biol_Sci_Med_Sci_2014_Jun_8_69(Suppl_1)_S21-S27.nxml.txt.nlp	24833582	SENT337	1	1	20	20	metformin	LKB1	PA450395	6794	0.688
NULL	Contemp_Oncol_(Pozn)_2012_Feb_29_16(1)_86-89.nxml.txt.nlp	23788860	SENT76	9	9	11	11	irinotecan	DDP	PA450085	1678	0.688
NULL	J_Gen_Physiol_1997_Dec_1_110(6)_643-654.nxml.txt.nlp	9382893	SENT129	4	4	2	2	diazoxide	ADP	PA449285	23038	0.688
NULL	Mol_Cell_Proteomics_2012_Feb_6_11(2)_M111_015222.nxml.txt.nlp	22147731	SENT295	7	7	14	14	gefitinib	CLDN4	PA131301952	1364	0.688
NULL	Cancer_Cell_Int_2005_Jul_24_5_22.nxml.txt.nlp	16042792	SENT112	23	23	4	4	vincristine	NAC	PA451879	22861	0.688
NULL	Br_J_Sports_Med_2012_Apr_29_46(7)_471-476.nxml.txt.nlp	22522585	SENT157	24	24	16	16	methacholine	ski	PA165958382	55733	0.688
NULL	Ecancermedicalscience_2009_Oct_29_3_157.nxml.txt.nlp	22276018	SENT71	17	17	12	12	tamoxifen	HER3	PA451581	2065	0.688
NULL	Int_J_Med_Sci_2014_Jan_11_11(3)_226-233.nxml.txt.nlp	24516345	SENT142	2	2	12	12	dexmedetomidine	IL-10	PA449256	3586	0.688
NULL	Biochimie_2011_Oct_93(10)_1747-1754.nxml.txt.nlp	21703329	SENT154	23	23	30	30	galactose	GALE	PA449725	2582	0.688
NULL	Ann_Rheum_Dis_2011_Aug_22_70(12)_2119-2125.nxml.txt.nlp	21859685	SENT134	2	2	12	12	ofatumumab	CD19	PA165291493	930	0.688
NULL	Asian-Australas_J_Anim_Sci_2012_Jun_25(6)_852-860.nxml.txt.nlp	25049637	SENT52	23	23	16	16	galactose	mol	PA449725	90527	0.688
NULL	Clin_Interv_Aging_2009_Jun_29_4_289-303.nxml.txt.nlp	19750231	SENT48	0	0	3	3	teriparatide	PTH	PA451620	5741	0.688
NULL	Nucleic_Acids_Res_2005_Apr_22_33(7)_2310-2317.nxml.txt.nlp	15849317	SENT122	10	10	18	18	geldanamycin	Hsp90	PA152031327	3320	0.688
NULL	Drug_Healthc_Patient_Saf_2013_Jun_10_5_133-141.nxml.txt.nlp	23788840	SENT48	34	34	29	29	filgrastim	zeta	PA449626	9907	0.688
NULL	Curr_Neuropharmacol_2013_May_11(3)_276-297.nxml.txt.nlp	24179464	SENT787	11	11	14	14	pimozide	CA1	PA450965	759	0.688
NULL	Nucleic_Acids_Res_2014_Jan_2_42(Database_issue)_D178-D183.nxml.txt.nlp	24302579	SENT124	11	11	25	25	estradiol	ESR1	PA449503	2099	0.688
NULL	Infect_Agent_Cancer_2012_Apr_19_7(Suppl_1)_P22.nxml.txt.nlp	NULL	SENT8	25	25	38	38	rituximab	CHOP	PA451261	1649	0.688
NULL	Cancer_Immunol_Immunother_2011_Jun_25_60(6)_793-808.nxml.txt.nlp	21350947	SENT287	21	21	9	9	sorafenib	IFNAR2	PA7000	3455	0.688
NULL	Front_Immunol_2013_Nov_7_4_360.nxml.txt.nlp	24223576	SENT22	0	0	7	7	imiquimod	TLR7	PA449972	51284	0.688
NULL	Oncotarget_2010_Nov_22_1(7)_606-619.nxml.txt.nlp	21317456	SENT96	12	12	16	16	doxorubicin	RAD51	PA449412	5888	0.688
NULL	BMJ_Open_2013_Dec_18_3(12)_e003815.nxml.txt.nlp	24353255	SENT133	8	8	17	17	levonorgestrel	UPA	PA450218	118471;5328	0.688
NULL	Cell_Commun_Signal_2009_Oct_27_7_25.nxml.txt.nlp	19860902	SENT155	3	3	12	12	thiopental	IL-2	PA451664	3558	0.688
NULL	J_Antimicrob_Chemother_2011_Jun_25_66(6)_1332-1339.nxml.txt.nlp	21441248	SENT162	34	34	31	31	nevirapine	CYP2B6	PA450616	1555	0.688
NULL	Ann_Rheum_Dis_2013_Dec_5_72(12)_1897-1904.nxml.txt.nlp	23918035	SENT252	26	26	32	32	methotrexate	ACT	PA450428	12;11332;9457;641455	0.688
NULL	Cell_Death_Dis_2013_Sep_5_4(9)_e791.nxml.txt.nlp	24008735	SENT283	5	5	11	11	gemcitabine	p53	PA449748	7157	0.688
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT256	5	5	8	8	aripiprazole	PRL	PA10026	5617	0.688
NULL	Cell_Cycle_2012_Dec_15_11(24)_4661-4672.nxml.txt.nlp	23187802	SENT89	12	12	10	10	doxorubicin	DREAM	PA449412	30818	0.688
NULL	J_Asthma_Allergy_2008_Sep_19_1_19-29.nxml.txt.nlp	21436982	SENT76	7	7	9	9	fexofenadine	OAT	PA449621	4942	0.688
NULL	Cancer_Microenviron_2008_Dec_26_1(1)_93-102.nxml.txt.nlp	19308688	SENT102	7	7	1	1	collagenase	CCN3	PA449107	4856	0.688
NULL	Int_J_Chron_Obstruct_Pulmon_Dis_2006_Dec_1(4)_373-379.nxml.txt.nlp	18044094	SENT50	5	5	20	20	roflumilast	PDE4B	PA165948052	5142	0.688
NULL	Acta_Pharmacol_Sin_2010_Sep_2_31(9)_1172-1180.nxml.txt.nlp	20676117	SENT101	3	3	10	10	bsi-201	PARP1		142	0.688
NULL	Breast_Cancer_Res_2004_Mar_26_6(3)_R252-R263.nxml.txt.nlp	15084249	SENT110	40	40	10	10	tamoxifen	FMO5	PA451581	2330	0.688
NULL	Asian-Australas_J_Anim_Sci_2013_Feb_26(2)_233-240.nxml.txt.nlp	25049781	SENT15	5	5	19	19	l-carnitine	HGB	PA450154	114757	0.688
NULL	J_Cell_Biol_2008_Jul_28_182(2)_367-379.nxml.txt.nlp	18644892	SENT205	29	29	14	14	pp2	PP2		4888	0.688
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1449-1456.nxml.txt.nlp	24077631	SENT150	29	29	9	9	tolbutamide	CYP2C9	PA451718	1559	0.688
NULL	Eur_Radiol_2011_Jun_3_21(6)_1188-1199.nxml.txt.nlp	21127880	SENT59	29	29	34	34	trastuzumab	HER2	PA451743	2064	0.688
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT19	5	5	15	15	simvastatin	AKT	PA451363	207	0.688
NULL	Physiol_Rep_2014_Sep_11_2(9)_e12133.nxml.txt.nlp	25214520	SENT177	9	9	15	15	bleomycin	CD68	PA448645	968	0.688
NULL	FASEB_J_2014_Nov_28(11)_4610-4616.nxml.txt.nlp	25145629	SENT99	7	7	37	37	carbachol	PER2	PA448784	8864	0.688
NULL	Exp_Ther_Med_2013_Dec_23_6(6)_1494-1498.nxml.txt.nlp	24255680	SENT141	0	0	11	11	losartan	ILK	PA450268	3611	0.688
NULL	Biologics_2009_Oct_12_3_469-474.nxml.txt.nlp	19851472	SENT98	37	37	0	0	desloratadine	IFN	PA164776964	3439	0.688
NULL	Front_Microbiol_2014_Mar_14_5_99.nxml.txt.nlp	24672516	SENT84	0	0	16	16	micafungin	IL-10	PA164781026	3586	0.688
NULL	Amino_Acids_2011_May_30_40(5)_1271-1296.nxml.txt.nlp	21448658	SENT472	26	26	37	37	creatine	Gen	PA164778930	348654	0.688
NULL	Cancers_(Basel)_2011_Mar_29_3(2)_1708-1731.nxml.txt.nlp	24212779	SENT1591	2	2	11	11	oxaliplatin	IL-2	PA131285527	3558	0.688
NULL	Cancers_(Basel)_2010_Sep_9_2(3)_1661-1682.nxml.txt.nlp	24281180	SENT1059	9	9	1	1	collagenase	EMMPRIN	PA449107	682	0.688
NULL	Breast_Cancer_(Auckl)_2014_May_12_8_81-88.nxml.txt.nlp	24855372	SENT138	0	0	6	6	trastuzumab	HER2	PA451743	2064	0.688
NULL	Cancer_Immunol_Immunother_2012_Jul_23_61(7)_1101-1111.nxml.txt.nlp	22193989	SENT144	17	17	0	0	oxaliplatin	PD-L1	PA131285527	29126	0.688
NULL	Cancers_(Basel)_2012_Apr_5_4(2)_354-378.nxml.txt.nlp	24213315	SENT164	12	12	14	14	sorafenib	TRAIL	PA7000	8743	0.688
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1699-1708.nxml.txt.nlp	19861960	SENT163	9	9	5	5	dasatinib	mol	PA162372878	90527	0.688
NULL	J_Cardiothorac_Surg_2014_Feb_17_9_35.nxml.txt.nlp	24533613	SENT171	14	14	18	18	heparin	ACT	PA449855	12;11332;9457;641455	0.688
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT366	18	18	16	16	pp2	PP1		5540;5464	0.688
NULL	Biomed_Res_Int_2014_Jun_25_2014_539151.nxml.txt.nlp	25057494	SENT115	0	0	8	8	warfarin	GGCX	PA451906	2677	0.688
NULL	F1000Res_2013_Feb_28_2_65.nxml.txt.nlp	24358861	SENT433	27	27	39	39	naloxone	TLR4	PA450586	7099	0.688
NULL	Br_J_Cancer_2012_Oct_9_107(8)_1327-1336.nxml.txt.nlp	22990650	SENT15	14	14	1	1	carboplatin	FGF1	PA448803	2246	0.688
NULL	Int_J_Mol_Sci_2014_Mar_5_15(3)_3970-3988.nxml.txt.nlp	24603537	SENT245	13	13	0	0	curcumin	MCH	PA151958596	5367	0.688
NULL	Front_Pharmacol_2014_Dec_10_5_273.nxml.txt.nlp	25540622	SENT121	16	16	9	9	mitoxantrone	IL-6	PA450526	3569	0.688
NULL	Arthritis_Res_Ther_2003_Aug_5_5(6)_R310-R316.nxml.txt.nlp	12932295	SENT55	22	22	35	35	gentamicin	CO2	PA449753	4513	0.688
NULL	Drug_Des_Devel_Ther_2014_Sep_23_8_1527-1538.nxml.txt.nlp	25284985	SENT194	36	36	34	34	celecoxib	IFN	PA448871	3439	0.688
NULL	Bioarchitecture_2011_Sep_1_1(5)_245-249.nxml.txt.nlp	22754617	SENT48	4	4	10	10	paraformaldehyde	FLNA	PA450790	2316	0.688
NULL	J_Cell_Biol_2001_May_28_153(5)_905-916.nxml.txt.nlp	11381078	SENT375	6	6	3	3	lovastatin	LFA-1	PA450272	3683;3689	0.688
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1709-1716.nxml.txt.nlp	19844235	SENT13	6	6	8	8	gemcitabine	B7-H3	PA449748	80381	0.688
NULL	Br_J_Cancer_2013_Aug_6_109(3)_589-596.nxml.txt.nlp	23868011	SENT117	24	24	11	11	anastrozole	ATAC	PA448432	6375	0.688
NULL	Oxid_Med_Cell_Longev_2013_Apr_17_2013_737591.nxml.txt.nlp	23710289	SENT169	19	19	6	6	ethanol	STAT3	PA448073	6774	0.688
NULL	Cell_Biol_Toxicol_2012_Apr_19_28(2)_69-87.nxml.txt.nlp	22258563	SENT104	24	24	33	33	midazolam	CYP1A2	PA450496	1544	0.688
NULL	J_Signal_Transduct_2011_Jan_5_2011_821615.nxml.txt.nlp	21637381	SENT137	12	12	16	16	estradiol	StAR	PA449503	6770	0.688
NULL	J_Oncol_2010_May_24_2010_729725.nxml.txt.nlp	20508816	SENT106	0	0	13	13	vatalanib	FLT3	PA7001	2322	0.688
NULL	J_Exerc_Rehabil_2014_Jun_30_10(3)_155-161.nxml.txt.nlp	25061594	SENT20	8	8	18	18	scopolamine	spatial	PA451308	219793	0.688
NULL	Indian_J_Anaesth_2014_Jul-Aug_58(4)_423-429.nxml.txt.nlp	25197110	SENT43	12	12	3	3	ondansetron	ODF4	PA450705	146852	0.688
NULL	Nanoscale_Res_Lett_2014_Jul_15_9(1)_353.nxml.txt.nlp	25114645	SENT30	5	5	13	13	dienestrol	HEX	PA164745534	3087	0.688
NULL	Front_Neuroendocrinol_2012_Jan_33(1)_45-66.nxml.txt.nlp	21802439	SENT2295	11	11	3	3	vasopressin	apelin	PA451858	8862	0.688
NULL	Mediators_Inflamm_2001_Oct_10(5)_253-258.nxml.txt.nlp	11759109	SENT3	27	27	25	25	ribavirin	IFN	PA451241	3439	0.688
NULL	Oncogene_2014_Jul_17_33(29)_3784-3793.nxml.txt.nlp	24013225	SENT140	17	17	29	29	heparin	EGFR	PA449855	1956	0.688
NULL	Int_J_Biol_Sci_2015_Jan_1_11(1)_48-58.nxml.txt.nlp	25552929	SENT165	4	4	16	16	paclitaxel	TSP-1	PA450761	7057	0.688
NULL	J_Med_Case_Reports_2011_Jan_12_5_5.nxml.txt.nlp	21226894	SENT101	25	25	5	5	bexarotene	CHOP	PA164752250	1649	0.688
NULL	Diabetes_Care_2010_Jun_33(6)_e73-e78.nxml.txt.nlp	20508223	SENT7	18	18	25	25	metformin	B12	PA450395	7126;4709	0.688
NULL	Blood_Cancer_J_2012_Mar_9_2(3)_e60.nxml.txt.nlp	22829255	SENT222	0	0	15	15	flavopiridol	FLT3	PA452627	2322	0.688
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT315	35	35	17	17	heparin	FGF1	PA449855	2246	0.688
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2675-2684.nxml.txt.nlp	24129246	SENT121	7	7	44	44	paraformaldehyde	p53	PA450790	7157	0.688
NULL	J_Infect_Dis_2011_May_1_203(9)_1204-1214.nxml.txt.nlp	21459813	SENT144	19	19	4	4	emtricitabine	INI	PA10069	84844	0.688
NULL	Clin_Interv_Aging_2012_Jul_12_7_235-247.nxml.txt.nlp	22866001	SENT131	42	42	32	32	alendronate	PTH	PA448082	5741	0.688
NULL	Oncotarget_2013_Nov_22_5(4)_933-943.nxml.txt.nlp	24659749	SENT112	14	14	2	2	nutlin-3	AML2		864	0.688
NULL	Acta_Pharmacol_Sin_2009_Jul_22_30(7)_956-964.nxml.txt.nlp	19543298	SENT161	5	5	20	20	simvastatin	SLC22A1	PA451363	6580	0.688
NULL	Cancer_Cell_Int_2009_Jan_8_9_3.nxml.txt.nlp	19128511	SENT7	15	15	8	8	oxaliplatin	PI3K	PA131285527	5290	0.688
NULL	J_Cell_Biol_2001_Oct_29_155(3)_427-438.nxml.txt.nlp	11673478	SENT177	7	7	5	5	pp2	PP1		5540;5464	0.688
NULL	Mol_Cancer_2012_Apr_26_11_26.nxml.txt.nlp	22537224	SENT125	13	13	23	23	chloroquine	FANCF	PA448948	2188	0.688
NULL	Diabetes_2011_Nov_17_60(11)_2995-3005.nxml.txt.nlp	21911748	SENT307	18	18	1	1	oxygen	EPO	PA450744	7076;8288;2056	0.688
NULL	Int_J_Mol_Sci_2014_Nov_25_15(12)_21703-21722.nxml.txt.nlp	25429431	SENT34	36	36	8	8	etoposide	MUC16	PA449552	94025	0.688
NULL	J_Hematol_Oncol_2011_Dec_21_4_53.nxml.txt.nlp	22189016	SENT70	18	18	22	22	amiodarone	P-gp	PA448383	5243	0.688
NULL	Ann_Clin_Microbiol_Antimicrob_2005_Jan_20_4_3.nxml.txt.nlp	15659247	SENT18	7	7	30	30	nelfinavir	CD4	PA450606	920	0.688
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2010_Apr_26_3_37-42.nxml.txt.nlp	22879785	SENT7	22	22	14	14	nitroprusside	PTH	PA451406	5741	0.688
NULL	Protein_Cell_2014_Jun_19_5(6)_469-479.nxml.txt.nlp	24748116	SENT82	7	7	5	5	paclitaxel	EB1	PA450761	9167;22919;10982	0.688
NULL	Indian_J_Ophthalmol_2009_Jul-Aug_57(4)_330-335.nxml.txt.nlp	NULL	SENT233	14	14	24	24	bevacizumab	VEGF-A	PA130232992	7422	0.688
NULL	Arthritis_Res_Ther_2006_Mar_6_8(2)_R53.nxml.txt.nlp	16519795	SENT22	2	2	16	16	methotrexate	IL-10	PA450428	3586	0.688
NULL	Breast_Cancer_Res_2014_Nov_8_16(6)_470.nxml.txt.nlp	25380620	SENT111	18	18	13	13	urokinase	PLAU	PA451836	5328	0.688
NULL	Allergy_Asthma_Immunol_Res_2013_Jan_29_5(1)_55-58.nxml.txt.nlp	23277879	SENT38	16	16	21	21	acetaminophen	IPA	PA448015	3160	0.688
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jan_26_67(Pt_2)_o493.nxml.txt.nlp	21523149	SENT49	27	27	30	30	hemin	B12	PA449849	7126;4709	0.688
NULL	J_Antimicrob_Chemother_2012_Feb_17_67(2)_404-414.nxml.txt.nlp	22101217	SENT180	2	2	12	12	isoniazid	EMB	PA450112	133418	0.688
NULL	Evid_Based_Complement_Alternat_Med_2014_Dec_25_2014_871720.nxml.txt.nlp	25610485	SENT87	25	25	14	14	berberine	G6PD	PA165860812	2539	0.688
NULL	J_Biol_Chem_2008_Nov_14_283(46)_31679-31689.nxml.txt.nlp	18755684	SENT201	11	11	6	6	iron	FAC	PA450087	2176	0.688
NULL	J_Clin_Biochem_Nutr_2009_Jan_27_44(1)_28-40.nxml.txt.nlp	19177185	SENT229	10	10	7	7	arsenite	HO-1	PA452638	3162	0.688
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT266	7	7	9	9	resveratrol	TRAIL		8743	0.688
NULL	Cancer_Cell_Int_2010_Sep_6_10_31.nxml.txt.nlp	20819205	SENT85	15	15	9	9	cisplatin	CIS	PA449014	1154	0.688
NULL	Crit_Care_2008_Jan_24_12(1)_R27.nxml.txt.nlp	18304335	SENT191	3	3	7	7	thrombin	Rho	PA451674	29984	0.688
NULL	Oncotarget_2012_May_18_3(5)_525-534.nxml.txt.nlp	22619113	SENT94	7	7	15	15	fludarabine	BIRC5	PA449655	332	0.688
NULL	Int_J_Endocrinol_2014_Apr_30_2014_674987.nxml.txt.nlp	24883061	SENT39	8	8	22	22	glucose	SDH	PA449773	1757;10993	0.688
NULL	Basic_Clin_Neurosci_2014_Winter_5(1)_74-79.nxml.txt.nlp	25436087	SENT108	2	2	4	4	fluoxetine	AQP4	PA449673	361	0.688
NULL	Front_Oncol_2014_Mar_6_4_40.nxml.txt.nlp	24639951	SENT47	6	6	20	20	cisplatin	ETO	PA449014	862	0.687
NULL	Oxid_Med_Cell_Longev_2011_Aug_15_2011_824597.nxml.txt.nlp	21904648	SENT207	8	8	10	10	topotecan	TPT	PA451729	23590;6469	0.687
NULL	Diabetes_2009_Apr_9_58(4)_965-974.nxml.txt.nlp	19136651	SENT351	9	9	20	20	resveratrol	SIRT1		23411	0.687
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT230	2	2	0	0	mitomycin	MVP	PA450524	9961	0.687
NULL	Diabetes_Care_2009_Nov_32(Suppl_2)_S217-S222.nxml.txt.nlp	19875555	SENT57	27	27	38	38	acarbose	GLP-1	PA448010	100125288	0.687
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT365	5	5	14	14	cisplatin	ATP7A	PA449014	538	0.687
NULL	Front_Neurosci_2014_Jun_3_8_128.nxml.txt.nlp	24917782	SENT140	13	13	6	6	ethanol	MC3R	PA448073	4159	0.687
NULL	Acta_Pharmacol_Sin_2009_Nov_12_30(11)_1566-1572.nxml.txt.nlp	19820718	SENT150	14	14	27	27	ketoconazole	P-gp	PA450146	5243	0.687
NULL	Pharmaceuticals_(Basel)_2013_Jul_4_6(7)_851-866.nxml.txt.nlp	24276318	SENT628	16	16	4	4	nesiritide	VMAC	PA164781045	400673	0.687
NULL	Virol_J_2008_Oct_6_5_114.nxml.txt.nlp	18838000	SENT68	20	20	27	27	nadh	IFN	PA164755085	3439	0.687
NULL	Orthop_J_Sports_Med_2014_May_1_2(5)_http_ojs_sagepub_com_content_2_5_2325967114529537_full.nxml.txt.nlp	25401118	SENT85	29	29	25	25	ketorolac	ACL	PA450150	47	0.687
NULL	Sci_Rep_2015_Jan_14_5_7760.nxml.txt.nlp	25585590	SENT213	2	2	4	4	cyclophosphamide	IL-2	PA449165	3558	0.687
NULL	J_Cell_Biol_1998_Jan_26_140(2)_335-345.nxml.txt.nlp	9442109	SENT206	27	27	16	16	chloroquine	NHE	PA448948	285335	0.687
NULL	Appl_Microbiol_Biotechnol_2012_Feb_11_93(4)_1377-1387.nxml.txt.nlp	22234536	SENT158	26	26	17	17	nadh	mol	PA164755085	90527	0.687
NULL	Environ_Health_Perspect_2009_Oct_1_117(10)_1477-1480.nxml.txt.nlp	20019894	SENT87	29	29	5	5	permethrin	TDI	PA164743137	100038246	0.687
NULL	Acta_Pharmacol_Sin_2012_Jan_3_33(1)_49-56.nxml.txt.nlp	22212430	SENT103	6	6	13	13	thrombin	JNK	PA451674	5599	0.687
NULL	Adv_Ther_2014_Jul_2_31(7)_762-775.nxml.txt.nlp	24985411	SENT260	7	7	17	17	hydrochlorothiazide	Xin	PA449899	165904	0.687
NULL	Diabetes_Metab_Syndr_Obes_2014_Jun_24_7_229-239.nxml.txt.nlp	25018644	SENT55	15	15	6	6	exenatide	GLP-1	PA164749238	100125288	0.687
NULL	ScientificWorldJournal_2012_Dec_17_2012_916381.nxml.txt.nlp	23319889	SENT188	12	12	25	25	ciprofloxacin	CTX	PA449009	1593	0.687
NULL	Pharmaceuticals_(Basel)_2012_Nov_1_5(11)_1177-1209.nxml.txt.nlp	24223492	SENT347	11	11	17	17	calcein	GALA	PA132595336	2717	0.687
NULL	Indian_J_Pharm_Sci_2013_Jan-Feb_75(1)_94-98.nxml.txt.nlp	23901167	SENT30	14	14	34	34	bupropion	CYP2B6	PA448687	1555	0.687
NULL	J_Immune_Based_Ther_Vaccines_2006_Mar_17_4_1.nxml.txt.nlp	16545119	SENT103	9	9	35	35	glucose	UCP2	PA449773	7351	0.687
NULL	Exp_Ther_Med_2013_Feb_13_5(2)_581-585.nxml.txt.nlp	23403473	SENT6	1	1	16	16	etanercept	p38	PA449515	10598;1432;7965	0.687
NULL	Breast_Cancer_Res_Treat_2012_Aug_5_134(3)_1149-1159.nxml.txt.nlp	22763464	SENT267	24	24	16	16	cisplatin	EGFR	PA449014	1956	0.687
NULL	ISRN_Obes_2014_Jan_23_2014_540582.nxml.txt.nlp	24587943	SENT157	26	26	16	16	lipase	ATGL	PA450239	57104	0.687
NULL	Cardiol_Res_Pract_2012_Aug_15_2012_713294.nxml.txt.nlp	22928146	SENT50	22	22	19	19	l-carnitine	Q10	PA450154	27161	0.687
NULL	Cancers_(Basel)_2014_Aug_12_6(3)_1631-1669.nxml.txt.nlp	25119536	SENT441	4	4	6	6	imatinib	Met	PA10804	79811	0.687
NULL	J_Vet_Med_Sci_2014_Oct_16_76(10)_1383-1387.nxml.txt.nlp	24931645	SENT66	5	5	21	21	liraglutide	GLP-1	PA165958364	100125288	0.687
NULL	J_Psychopharmacol_2010_Nov_24(4_supplement)_91-118.nxml.txt.nlp	18801830	SENT427	15	15	17	17	vasopressin	AVP	PA451858	114548;551	0.687
NULL	ScientificWorldJournal_2014_Mar_12_2014_251067.nxml.txt.nlp	24744681	SENT34	4	4	10	10	bleomycin	IL-17A	PA448645	3605	0.687
NULL	Int_J_Biol_Sci_2015_Jan_1_11(1)_48-58.nxml.txt.nlp	25552929	SENT144	22	22	24	24	paclitaxel	LDM	PA450761	1595	0.687
NULL	Mol_Cell_Biochem_2014_Oct_9_385(1-2)_265-275.nxml.txt.nlp	24104452	SENT44	15	15	9	9	bortezomib	U87	PA10252	677775;641648	0.687
NULL	Lab_Invest_2011_Apr_14_91(4)_598-608.nxml.txt.nlp	21321535	SENT127	6	6	8	8	sorafenib	CD4	PA7000	920	0.687
NULL	Oncoimmunology_2014_Jan_17_3_e27574.nxml.txt.nlp	24800167	SENT20	3	3	22	22	cyclophosphamide	IL-17	PA449165	3605	0.687
NULL	J_Korean_Med_Sci_2013_Sep_28_28(9)_1307-1315.nxml.txt.nlp	24015035	SENT73	26	26	38	38	heparin	TFI	PA449855	7035	0.687
NULL	Arthritis_Res_Ther_2003_Sep_3_5(6)_R317-R328.nxml.txt.nlp	14680506	SENT166	0	0	4	4	rolipram	IL-10	PA153906323	3586	0.687
NULL	Nat_Med_2013_Mar_24_19(3)_351-357.nxml.txt.nlp	23435171	SENT23	24	24	2	2	oxygen	hamartin	PA450744	7248	0.687
NULL	Arthritis_Res_Ther_2010_Oct_14_12(5)_R190.nxml.txt.nlp	20942979	SENT72	4	4	13	13	fluorescein	CD29	PA164746009	3688	0.687
NULL	Mol_Clin_Oncol_2013_Jul_30_1(4)_655-660.nxml.txt.nlp	24649224	SENT199	28	28	22	22	vincristine	CHOP	PA451879	1649	0.687
NULL	Nucleic_Acids_Res_2010_Oct_27_38(18)_6265-6273.nxml.txt.nlp	20507909	SENT41	20	20	34	34	streptomycin	CO2	PA451512	4513	0.687
NULL	Gut_2012_Jan_3_61(1)_6-32.nxml.txt.nlp	22052063	SENT707	20	20	18	18	cisplatin	STZ	PA449014	6484	0.687
NULL	Oncotarget_2014_Jun_7_5(14)_5257-5271.nxml.txt.nlp	24913448	SENT117	30	30	25	25	forskolin	LASP1	PA146096022	3927	0.687
NULL	J_Infect_Dis_2011_May_1_203(9)_1204-1214.nxml.txt.nlp	21459813	SENT144	26	26	4	4	efavirenz	INI	PA449441	84844	0.687
NULL	Anesth_Essays_Res_2013_Sep-Dec_7(3)_319-325.nxml.txt.nlp	NULL	SENT30	4	4	24	24	propofol	AVP	PA451141	114548;551	0.687
NULL	Pain_Ther_2014_Jun_13_3(1)_59-69.nxml.txt.nlp	25135388	SENT132	2	2	8	8	curcumin	HSD1	PA151958596	26871	0.687
NULL	JAKSTAT_2012_Apr_1_1(2)_77-79.nxml.txt.nlp	24058754	SENT59	38	38	9	9	nilotinib	Hsp90	PA165958345	3320	0.687
NULL	Acta_Pharmacol_Sin_2011_Oct_5_32(10)_1276-1284.nxml.txt.nlp	21970838	SENT35	10	10	2	2	ritonavir	KET	PA451260	8626	0.687
NULL	Acta_Neuropathol_2014_Nov_9_127(2)_303-305.nxml.txt.nlp	24212601	SENT35	23	23	13	13	trypsin	RD3	PA451806	343035	0.687
NULL	J_Mol_Signal_2010_Feb_18_5_1.nxml.txt.nlp	20167101	SENT123	8	8	10	10	metformin	adiponectin	PA450395	9370	0.687
NULL	Korean_J_Anesthesiol_2013_Dec_26_65(6)_501-507.nxml.txt.nlp	24427455	SENT121	24	24	18	18	neostigmine	NMB	PA450611	10457;4828	0.687
NULL	Archaea_2012_Aug_15_2012_315153.nxml.txt.nlp	22927778	SENT314	32	32	22	22	nadh	ADP	PA164755085	23038	0.687
NULL	Pain_Res_Treat_2011_Jun_15_2011_738645.nxml.txt.nlp	22110931	SENT199	18	18	7	7	bumetanide	KCC2	PA448682	57468	0.687
NULL	Neuroscience_2013_Oct_10_250(100)_493-506.nxml.txt.nlp	23892006	SENT187	5	5	12	12	ethanol	ZO-1	PA448073	7082	0.687
NULL	Front_Physiol_2013_May_15_4_103.nxml.txt.nlp	23720630	SENT20	21	21	16	16	simvastatin	Q10	PA451363	27161	0.687
NULL	Korean_Circ_J_2013_May_31_43(5)_343-346.nxml.txt.nlp	23755082	SENT10	32	32	24	24	prasugrel	DES	PA154410481	1674	0.687
NULL	Oncotarget_2014_Dec_4_5(22)_11365-11380.nxml.txt.nlp	25426548	SENT3	9	9	11	11	nutlin-3	p53		7157	0.687
NULL	Cancers_(Basel)_2014_Jul_7_6(3)_1441-1463.nxml.txt.nlp	25003395	SENT209	6	6	4	4	cisplatin	FOXO1	PA449014	2308	0.687
NULL	Proteome_Sci_2009_Mar_19_7_10.nxml.txt.nlp	19298663	SENT148	8	8	21	21	heparin	GSTP	PA449855	2950	0.687
NULL	Asian_Spine_J_2014_Feb_6_8(1)_97-111.nxml.txt.nlp	24596613	SENT397	2	2	16	16	isoniazid	EMB	PA450112	133418	0.687
NULL	Cardiovasc_Diabetol_2013_Oct_17_12_150.nxml.txt.nlp	24134550	SENT96	4	4	7	7	metformin	activin	PA450395	83729	0.687
NULL	Bioinformation_2006_Dec_6_1(8)_281-284.nxml.txt.nlp	17597908	SENT8	17	17	13	13	thyroglobulin	neurotactin	PA164754910	6376	0.687
NULL	Breast_Cancer_Res_2010_Oct_22_12(Suppl_2)_S1.nxml.txt.nlp	21050422	SENT206	0	0	3	3	pertuzumab	HER2		2064	0.687
NULL	Avicenna_J_Med_2011_Oct-Dec_1(2)_52-54.nxml.txt.nlp	23210009	SENT50	32	32	28	28	erlotinib	EGFR	PA134687924	1956	0.687
NULL	Exp_Mol_Med_2012_Mar_31_44(3)_191-201.nxml.txt.nlp	22170035	SENT76	32	32	19	19	genistein	AMPK	PA165109660	5563	0.687
NULL	Int_J_Mol_Sci_2014_Nov_25_15(12)_21703-21722.nxml.txt.nlp	25429431	SENT34	10	10	8	8	cisplatin	MUC16	PA449014	94025	0.687
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT117	14	14	16	16	doxorubicin	B7-H1	PA449412	29126	0.687
NULL	Case_Rep_Oncol_Med_2012_Sep_11_2012_726424.nxml.txt.nlp	22997596	SENT77	27	27	25	25	rituximab	CHOP	PA451261	1649	0.687
NULL	Front_Endocrinol_(Lausanne)_2013_Jun_26_4_75.nxml.txt.nlp	23805127	SENT135	10	10	7	7	gemfibrozil	UGT2B7	PA449750	7364	0.687
NULL	Mol_Cancer_2012_Mar_8_11_9.nxml.txt.nlp	22401581	SENT126	16	16	29	29	calcein	IGFBP3	PA132595336	3486	0.687
NULL	Oxid_Med_Cell_Longev_2012_Aug_22_2012_534705.nxml.txt.nlp	22966415	SENT318	21	21	9	9	riluzole	GLT-1	PA451251	6506	0.687
NULL	J_Korean_Med_Sci_2014_Jul_11_29(7)_965-972.nxml.txt.nlp	25045229	SENT95	19	19	6	6	metformin	B12	PA450395	7126;4709	0.687
NULL	Clin_Sci_(Lond)_2013_May_1_124(Pt_9)_567-578.nxml.txt.nlp	23113760	SENT294	18	18	7	7	hydroxyurea	RNR2	PA449942	6053	0.687
NULL	Front_Comput_Neurosci_2013_Apr_5_7_22.nxml.txt.nlp	23576979	SENT56	40	40	9	9	propofol	HCN1	PA451141	348980	0.687
NULL	J_Antimicrob_Chemother_2014_Nov_17_69(11)_2920-2927.nxml.txt.nlp	25038069	SENT139	19	19	29	29	tetracycline	TMP	PA451640	2012	0.687
NULL	J_Biol_Chem_2014_Dec_26_289(52)_36018-36030.nxml.txt.nlp	25336647	SENT20	16	16	4	4	sulfur	CBS	PA451558	875	0.687
NULL	Nat_Commun_2013_Oct_1_4_2516.nxml.txt.nlp	24084631	SENT59	3	3	14	14	losartan	AK4	PA450268	205	0.687
NULL	Acta_Pharmacol_Sin_2010_Apr_22_31(4)_476-484.nxml.txt.nlp	20305681	SENT63	32	32	42	42	fluorescein	CD133	PA164746009	8842	0.687
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT269	7	7	9	9	resveratrol	TRAIL		8743	0.687
NULL	BioDrugs_2014_Jul_8_28(5)_451-459.nxml.txt.nlp	25001079	SENT44	3	3	12	12	trastuzumab	HER2	PA451743	2064	0.687
NULL	Exp_Ther_Med_2013_May_15_5(5)_1327-1331.nxml.txt.nlp	23737873	SENT130	0	0	7	7	imidapril	AVP	PA452640	114548;551	0.687
NULL	Mol_Cancer_2010_Dec_20_9_317.nxml.txt.nlp	21172025	SENT91	16	16	14	14	tamoxifen	HER2	PA451581	2064	0.687
NULL	Oncotarget_2014_Aug_29_5(19)_8947-8958.nxml.txt.nlp	25333254	SENT129	15	15	27	27	plerixafor	CD49d	PA165958410	3676	0.687
NULL	Ann_Rheum_Dis_2012_Sep_71(9)_1510-1516.nxml.txt.nlp	22440821	SENT155	2	2	20	20	adalimumab	ACPA	PA10004	5657	0.687
NULL	J_Biomed_Sci_2013_Jan_23_20(1)_3.nxml.txt.nlp	23343355	SENT131	9	9	14	14	cisplatin	p53	PA449014	7157	0.687
NULL	Front_Genet_2013_Aug_29_4_163.nxml.txt.nlp	24009622	SENT119	2	2	21	21	ethanol	ABCG2	PA448073	9429	0.687
NULL	Case_Rep_Oncol_2009_Jan_17_2(1)_1-6.nxml.txt.nlp	20844570	SENT36	9	9	12	12	daunorubicin	LAM	PA449212	7249;7248	0.687
NULL	Int_J_Biol_Sci_2014_Feb_20_10(3)_268-277.nxml.txt.nlp	24644425	SENT105	0	0	19	19	metformin	AMPK	PA450395	5563	0.687
NULL	Iran_J_Pharm_Res_2014_Summer_13(3)_919-926.nxml.txt.nlp	25276192	SENT125	4	4	6	6	doxorubicin	Bcl-2	PA449412	596	0.687
NULL	Case_Rep_Oncol_2010_Jul_31_3(2)_282-286.nxml.txt.nlp	21347194	SENT38	28	28	34	34	cetuximab	KRAS	PA10040	3845	0.687
NULL	Acta_Naturae_2010_Jul-Sep_2(3)_110-121.nxml.txt.nlp	22649658	SENT12	22	22	4	4	kanamycin	VIII	PA450137	1351	0.687
NULL	Mol_Clin_Oncol_2013_Sep_18_1(5)_839-844.nxml.txt.nlp	24649257	SENT134	8	8	25	25	docetaxel	NAC	PA449383	22861	0.687
NULL	Alcohol_Res_Health_2007_30(1)_38-47.nxml.txt.nlp	17718399	SENT194	40	40	24	24	ethanol	CYP2E1	PA448073	1571	0.687
NULL	Breast_Cancer_Res_2005_Jan_12_7(2)_48-51.nxml.txt.nlp	15743510	SENT84	17	17	34	34	tamoxifen	ATAC	PA451581	6375	0.687
NULL	Pharmaceutics_2011_Oct_12_3(4)_680-705.nxml.txt.nlp	24309303	SENT119	16	16	2	2	metformin	P-gp	PA450395	5243	0.687
NULL	Core_Evid_2010_Jul_27_5_1-10.nxml.txt.nlp	20694135	SENT49	11	11	2	2	levodopa	COMT	PA450213	1312	0.687
NULL	Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_1029-1037.nxml.txt.nlp	25049660	SENT128	32	32	26	26	l-cysteine	MC1R	PA449173	4157	0.687
NULL	Oncol_Lett_2014_Nov_12_8(5)_2203-2208.nxml.txt.nlp	25295109	SENT133	6	6	11	11	celecoxib	GLI1	PA448871	2735	0.687
NULL	Parasit_Vectors_2009_Sep_25_2(Suppl_2)_S4.nxml.txt.nlp	19778465	SENT95	31	31	38	38	ivermectin	MOX	PA450133	26002	0.687
NULL	Br_J_Haematol_2014_Feb_16_164(4)_469-480.nxml.txt.nlp	24372186	SENT5	35	35	8	8	rasburicase	G6PD	PA10176	2539	0.687
NULL	Front_Oncol_2012_Oct_31_2_157.nxml.txt.nlp	23120745	SENT1143	10	10	2	2	temozolomide	p53	PA451609	7157	0.687
NULL	J_Infect_Dis_2011_May_1_203(9)_1204-1214.nxml.txt.nlp	21459813	SENT57	25	25	3	3	elvitegravir	INI	PA165291498	84844	0.687
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT145	0	0	26	26	dasatinib	JNK	PA162372878	5599	0.687
NULL	Front_Genet_2014_Aug_27_5_281.nxml.txt.nlp	25221567	SENT185	0	0	14	14	sildenafil	CYP3A4	PA451346	1576	0.687
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_14_2012_617085.nxml.txt.nlp	23097677	SENT196	9	9	0	0	azacitidine	DNMT1	PA451996	1786	0.687
NULL	Int_Clin_Psychopharmacol_2014_Jul_26_29(4)_229-234.nxml.txt.nlp	24419004	SENT130	16	16	1	1	olanzapine	Gen	PA450688	348654	0.687
NULL	J_Cell_Biol_1979_Sep_1_82(3)_644-653.nxml.txt.nlp	511930	SENT1	34	34	36	36	dextran	mol	PA449261	90527	0.687
NULL	Behav_Sci_(Basel)_2012_Jun_21_2(2)_135-171.nxml.txt.nlp	23077729	SENT289	10	10	12	12	vasopressin	AVP	PA451858	114548;551	0.687
NULL	Hum_Mol_Genet_2013_Nov_15_22(22)_4602-4615.nxml.txt.nlp	23814040	SENT158	15	15	32	32	l-cysteine	TRMU	PA449173	55687	0.687
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT188	0	0	11	11	curcumin	PUMA	PA151958596	27113	0.687
NULL	Hematol_Rep_2011_Oct_10_3(2)_e16.nxml.txt.nlp	22184537	SENT71	2	2	5	5	bosentan	CYP3A4	PA10034	1576	0.687
NULL	Cell_Death_Dis_2012_Jul_19_3(7)_e352.nxml.txt.nlp	22825470	SENT80	1	1	4	4	tamoxifen	EMT	PA451581	3702;6581	0.687
NULL	Front_Neurosci_2012_May_30_6_77.nxml.txt.nlp	22661925	SENT203	0	0	12	12	ethanol	DCX	PA448073	1641	0.687
NULL	Nat_Med_2013_Jun_26_19(6)_713-721.nxml.txt.nlp	23708291	SENT119	28	28	22	22	celecoxib	COX1	PA448871	4512;5742	0.687
NULL	Curr_Oncol_2006_Feb_13(1)_14-26.nxml.txt.nlp	17576437	SENT210	0	0	9	9	artemisinin	KDR	PA165111696	3791	0.687
NULL	Front_Immunol_2012_Jul_18_3_198.nxml.txt.nlp	22826708	SENT1924	5	5	3	3	alemtuzumab	BAFF	PA164783958	10673	0.687
NULL	Emerg_Infect_Dis_2013_Jan_19(1)_133-136.nxml.txt.nlp	23260464	SENT37	43	43	29	29	ceftazidime	TOB	PA448861	10140	0.687
NULL	J_Korean_Med_Sci_2013_Apr_27_28(4)_527-533.nxml.txt.nlp	23580227	SENT127	13	13	15	15	genistein	TRAIL	PA165109660	8743	0.687
NULL	Virol_J_2011_Nov_28_8_523.nxml.txt.nlp	22122911	SENT6	11	11	13	13	heparin	RANTES	PA449855	6352	0.687
NULL	Oncotarget_2012_Oct_20_3(10)_1068-1111.nxml.txt.nlp	23085539	SENT727	22	22	45	45	imatinib	CD19	PA10804	930	0.687
NULL	Exp_Diabetes_Res_2011_Jun_4_2011_489708.nxml.txt.nlp	21747829	SENT28	19	19	29	29	aliskiren	GLP-1	PA143487910	100125288	0.687
NULL	Eur_J_Clin_Pharmacol_2013_Jan_11_69(6)_1275-1283.nxml.txt.nlp	23307232	SENT81	9	9	4	4	warfarin	CYP2C9	PA451906	1559	0.687
NULL	Br_J_Cancer_2009_Nov_3_101(9)_1620-1629.nxml.txt.nlp	19809428	SENT21	0	0	5	5	geldanamycin	Hsp90	PA152031327	3320	0.687
NULL	An_Bras_Dermatol_2013_May-Jun_88(3)_355-360.nxml.txt.nlp	23793207	SENT108	1	1	8	8	thrombin	PAR-1	PA451674	2011;2149	0.687
NULL	Cell_Prolif_2013_Dec_24_46(6)_677-684.nxml.txt.nlp	24152244	SENT190	29	29	2	2	estradiol	aromatase	PA449503	1588	0.687
NULL	Aging_(Albany_NY)_2009_Apr_9_1(4)_425-437.nxml.txt.nlp	20157526	SENT224	7	7	23	23	paraformaldehyde	p62	PA450790	8878;10657;23636	0.687
NULL	J_Biol_Chem_2011_Sep_16_286(37)_31984-31992.nxml.txt.nlp	21768113	SENT14	13	13	16	16	heparin	CD81	PA449855	975	0.687
NULL	AAPS_PharmSciTech_2011_Apr_1_12(2)_461-467.nxml.txt.nlp	21455817	SENT200	3	3	0	0	melphalan	San	PA450354	80218	0.687
NULL	Acta_Pharmacol_Sin_2009_Nov_12_30(11)_1566-1572.nxml.txt.nlp	19820718	SENT13	1	1	33	33	omeprazole	P-gp	PA450704	5243	0.687
NULL	Adv_Hematol_2010_May_16_2010_672137.nxml.txt.nlp	20490274	SENT3	23	23	18	18	mitoxantrone	AIDA	PA450526	64853	0.687
NULL	Clin_Med_Insights_Oncol_2012_Jul_30_6_275-286.nxml.txt.nlp	22904648	SENT209	6	6	9	9	hydroxyurea	IL-2	PA449942	3558	0.687
NULL	J_Cell_Biol_1999_Jan_11_144(1)_125-138.nxml.txt.nlp	9885249	SENT37	18	18	6	6	glucose	HSS	PA449773	9043;2671;6448;80025	0.687
NULL	Clin_Exp_Metastasis_2014_Sep_17_31(1)_135-147.nxml.txt.nlp	24043563	SENT29	34	34	30	30	urokinase	MMP7	PA451836	4316	0.687
NULL	Diabetes_2009_Jun_31_58(6)_1434-1439.nxml.txt.nlp	19336679	SENT112	6	6	12	12	metformin	SLC22A1	PA450395	6580	0.687
NULL	Nucleic_Acids_Res_2011_Oct_6_39(18)_7992-8004.nxml.txt.nlp	21737425	SENT139	9	9	18	18	colchicine	CO2	PA449092	4513	0.687
NULL	Mol_Cancer_2010_Dec_20_9_317.nxml.txt.nlp	21172025	SENT284	11	11	5	5	trastuzumab	HER2	PA451743	2064	0.687
NULL	Exp_Ther_Med_2013_Jan_10_5(1)_11-16.nxml.txt.nlp	23251234	SENT50	34	34	26	26	cetuximab	UST	PA10040	10090	0.687
NULL	Indian_J_Ophthalmol_2007_Nov-Dec_55(6)_421-425.nxml.txt.nlp	17951897	SENT49	0	0	10	10	ranibizumab	San	PA164746012	80218	0.687
NULL	J_Oncol_2012_Mar_26_2012_198412.nxml.txt.nlp	22536237	SENT4	13	13	18	18	gemcitabine	HER2	PA449748	2064	0.687
NULL	Pharmaceutics_2011_Nov_18_3(4)_865-913.nxml.txt.nlp	24309312	SENT275	8	8	13	13	amprenavir	CYP3A4	PA448422	1576	0.687
NULL	Core_Evid_2010_Jul_27_5_1-10.nxml.txt.nlp	20694135	SENT264	30	30	11	11	levodopa	CLE	PA450213	51637	0.687
NULL	Clin_J_Gastroenterol_2014_Jun_6_7(4)_355-360.nxml.txt.nlp	25132867	SENT3	6	6	3	3	ribavirin	IFN	PA451241	3439	0.687
NULL	Biomed_Res_Int_2013_Mar_28_2013_154073.nxml.txt.nlp	23607088	SENT124	15	15	6	6	clopidogrel	CYP2C19	PA449053	1557	0.687
NULL	Acta_Pharmacol_Sin_2013_Jan_3_34(1)_119-128.nxml.txt.nlp	23202804	SENT143	0	0	20	20	rimonabant	CB1	PA152407999	1268	0.687
NULL	Oncol_Lett_2014_Jul_16_8(1)_211-217.nxml.txt.nlp	24959248	SENT119	4	4	6	6	cisplatin	ALDOA	PA449014	226	0.687
NULL	Biosci_Rep_2013_Feb_7_33(2)_e00023.nxml.txt.nlp	23249249	SENT123	11	11	44	44	paraformaldehyde	Fis1	PA450790	51024	0.687
NULL	Aging_(Albany_NY)_2009_Mar_31_1(4)_412-424.nxml.txt.nlp	20195491	SENT37	6	6	12	12	resveratrol	TXNIP		10628	0.687
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Nov_13_64(Pt_12)_o2309.nxml.txt.nlp	21581286	SENT6	13	13	1	1	piperazine	mol	PA450977	90527	0.687
NULL	Cancers_(Basel)_2014_Nov_14_6(4)_2275-2295.nxml.txt.nlp	25405526	SENT82	35	35	7	7	cytarabine	CHOP	PA449177	1649	0.687
NULL	Cell_Commun_Signal_2012_Aug_8_10_23.nxml.txt.nlp	22873932	SENT35	11	11	4	4	heparin	EGF	PA449855	1950	0.687
NULL	Br_J_Cancer_2009_Nov_3_101(9)_1620-1629.nxml.txt.nlp	19809428	SENT9	0	0	11	11	geldanamycin	PC3	PA152031327	57332;7832;5122	0.687
NULL	Oncotarget_2012_May_18_3(5)_525-534.nxml.txt.nlp	22619113	SENT135	3	3	10	10	fludarabine	BIRC5	PA449655	332	0.687
NULL	Curr_Respir_Med_Rev_2013_Aug_9(4)_238-247.nxml.txt.nlp	24634642	SENT24	13	13	11	11	rituximab	CHOP	PA451261	1649	0.687
NULL	J_Exp_Bot_2012_May_22_63(8)_3173-3184.nxml.txt.nlp	22357599	SENT29	6	6	8	8	asparaginase	ASPG	PA448492		0.687
NULL	Colorectal_Dis_2012_Feb_14(2)_e31-e47.nxml.txt.nlp	21848897	SENT118	14	14	11	11	cetuximab	KRAS	PA10040	3845	0.687
NULL	Mol_Cancer_2009_Aug_25_8_66.nxml.txt.nlp	19706164	SENT72	8	8	30	30	celecoxib	p53	PA448871	7157	0.687
NULL	Front_Neurosci_2012_May_30_6_77.nxml.txt.nlp	22661925	SENT313	34	34	4	4	ethanol	HEC	PA448073	10403	0.687
NULL	AIDS_Res_Ther_2013_May_1_10_10.nxml.txt.nlp	23634877	SENT152	8	8	3	3	lovastatin	CXCR4	PA450272	7852	0.687
NULL	Cell_Death_Dis_2012_Nov_15_3(11)_e418.nxml.txt.nlp	23152054	SENT47	0	0	3	3	chloroquine	LC3	PA448948	84557	0.687
NULL	Indian_J_Psychiatry_2010_Jan_52(Suppl1)_S317-S340.nxml.txt.nlp	21836703	SENT120	28	28	17	17	thiothixene	TFP	PA451669	7034	0.687
NULL	Adv_Prev_Med_2012_Dec_6_2012_103728.nxml.txt.nlp	23304534	SENT55	19	19	0	0	ezetimibe	STAT2	PA10816	6773	0.687
NULL	Pharmaceutics_2012_Jan_31_4(1)_104-129.nxml.txt.nlp	24300183	SENT244	22	22	6	6	fluorescein	SMO	PA164746009	6608;54498	0.687
NULL	Cell_Mol_Life_Sci_2011_Aug_24_68(16)_2797-2809.nxml.txt.nlp	21104292	SENT350	5	5	3	3	vasopressin	c-fos	PA451858	2353	0.687
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Jul_23_3(7)_e126.nxml.txt.nlp	25054314	SENT24	8	8	17	17	docetaxel	MRP2	PA449383	100130958;57626;1244	0.687
NULL	Arthritis_Res_Ther_2004_Sep_23_6(6)_R535-R543.nxml.txt.nlp	15535831	SENT168	0	0	33	33	infliximab	p55	PA452639	6624;2078;8503;5718	0.687
NULL	Hum_Mol_Genet_2013_Oct_15_22(20)_4180-4193.nxml.txt.nlp	23760082	SENT161	16	16	6	6	nadh	NIPBL	PA164755085	25836	0.687
NULL	Br_J_Cancer_2009_Sep_15_101(6)_957-966.nxml.txt.nlp	19738618	SENT132	19	19	33	33	dexrazoxane	THBS-1	PA449259	7057	0.687
NULL	Int_J_Mol_Sci_2013_Apr_10_14(4)_7742-7756.nxml.txt.nlp	23574936	SENT827	8	8	3	3	carboplatin	ATX	PA448803	5168;23049	0.687
NULL	Ital_J_Pediatr_2011_Dec_19_37_58.nxml.txt.nlp	22182677	SENT162	24	24	3	3	primidone	LGS	PA451105	51557	0.687
NULL	Diabetologia_2007_Jun_6_50(6)_1288-1293.nxml.txt.nlp	17415544	SENT195	20	20	0	0	hyaluronan	ATV	PA165958431	4683	0.687
NULL	Cancer_Biol_Med_2013_Mar_10(1)_36-42.nxml.txt.nlp	23691443	SENT72	15	15	9	9	fludarabine	CHOP	PA449655	1649	0.687
NULL	Diabetes_Metab_J_2014_Apr_18_38(2)_100-106.nxml.txt.nlp	24851203	SENT115	4	4	23	23	acetone	JNK	PA448025	5599	0.687
NULL	Front_Oncol_2014_Apr_1_4_67.nxml.txt.nlp	24744992	SENT39	27	27	13	13	erlotinib	EGFR	PA134687924	1956	0.687
NULL	Diagn_Pathol_2013_Nov_25_8_192.nxml.txt.nlp	24274261	SENT89	12	12	14	14	carboplatin	IFN	PA448803	3439	0.687
NULL	Neural_Plast_2012_Nov_2_2012_309494.nxml.txt.nlp	22164341	SENT7	5	5	15	15	tamoxifen	CA1	PA451581	759	0.687
NULL	Reprod_Biol_Endocrinol_2003_Oct_7_1_66.nxml.txt.nlp	14609433	SENT97	29	29	23	23	cisplatin	p53	PA449014	7157	0.687
NULL	Arthritis_Res_Ther_2009_Jul_23_11(4)_236.nxml.txt.nlp	19664185	SENT69	27	27	2	2	benzbromarone	URAT1	PA134852920	116085	0.687
NULL	Crit_Care_2008_Mar_13_12(Suppl_2)_P405.nxml.txt.nlp	NULL	SENT2	8	8	10	10	vasopressin	AVP	PA451858	114548;551	0.687
NULL	J_Korean_Med_Sci_2010_Feb_21_25(2)_197-202.nxml.txt.nlp	20119570	SENT117	14	14	28	28	gentamicin	VAN	PA449753	10318	0.687
NULL	Int_J_Mol_Sci_2014_Nov_18_15(11)_21401-21418.nxml.txt.nlp	25411802	SENT143	3	3	8	8	nadh	AMPK	PA164755085	5563	0.687
NULL	Oncol_Lett_2013_Sep_12_6(3)_860-864.nxml.txt.nlp	24137426	SENT65	19	19	14	14	ketoconazole	CYP1A2	PA450146	1544	0.687
NULL	Exp_Diabetes_Res_2011_Apr_6_2011_928523.nxml.txt.nlp	21603181	SENT155	22	22	10	10	bromocriptine	DRD3	PA448671	1814	0.687
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT277	6	6	18	18	atorvastatin	PIK3CA	PA448500	5290	0.687
NULL	Int_J_Gen_Med_2009_Jul_30_2_129-140.nxml.txt.nlp	20360896	SENT163	24	24	6	6	anastrozole	IMPACT	PA448432	55364	0.687
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT477	4	4	18	18	iloperidone	PRL	PA161199368	5617	0.687
NULL	Stroke_Res_Treat_2009_Dec_20_2010_386389.nxml.txt.nlp	20700422	SENT72	29	29	26	26	pioglitazone	NAC	PA450970	22861	0.687
NULL	Arch_Toxicol_2011_Feb_12_85(2)_79-117.nxml.txt.nlp	21225242	SENT752	25	25	27	27	bufuralol	CYP2D6	PA166110256	1565	0.687
NULL	F1000_Med_Rep_2009_May_8_1_40.nxml.txt.nlp	20948740	SENT12	15	15	28	28	octreotide	SSTR3	PA450678	6753	0.687
NULL	Mol_Cancer_2007_Sep_26_6_61.nxml.txt.nlp	17894897	SENT101	4	4	7	7	etoposide	HIF-1	PA449552	29072	0.687
NULL	Ann_Thorac_Med_2013_Apr-Jun_8(2)_109-115.nxml.txt.nlp	23741274	SENT15	10	10	1	1	cisplatin	CRT	PA449014	811	0.687
NULL	Clin_Med_Insights_Oncol_2013_Feb_28_7_53-73.nxml.txt.nlp	23492937	SENT303	3	3	0	0	melphalan	San	PA450354	80218	0.687
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jan_31_65(Pt_2)_o439.nxml.txt.nlp	21582024	SENT69	0	0	3	3	benzaldehyde	mol	PA448571	90527	0.687
NULL	Breast_Cancer_Res_2011_Nov_23_13(6)_R117.nxml.txt.nlp	22112244	SENT27	16	16	31	31	paclitaxel	IL-8	PA450761	3576	0.687
NULL	Open_Ophthalmol_J_2011_Apr_28_5_27-31.nxml.txt.nlp	21633720	SENT11	7	7	13	13	guanabenz	ERG	PA164774903	2078	0.687
NULL	Angew_Chem_Int_Ed_Engl_2013_Jan_21_52(4)_1253-1256.nxml.txt.nlp	23225333	SENT72	2	2	21	21	ethanol	CO2	PA448073	4513	0.687
NULL	Glycobiology_2012_Jan_26_22(1)_134-145.nxml.txt.nlp	21873605	SENT98	21	21	24	24	heparin	IL-8	PA449855	3576	0.687
NULL	Acta_Pharmacol_Sin_2009_Jul_22_30(7)_956-964.nxml.txt.nlp	19543298	SENT161	5	5	15	15	simvastatin	SLCO1B1	PA451363	10599	0.687
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT138	9	9	23	23	perifosine	DR4	PA165291471	8797	0.686
NULL	F1000Res_2013_Jul_9_2_152.nxml.txt.nlp	24555070	SENT129	17	17	29	29	imatinib	KIT	PA10804	3815	0.686
NULL	Case_Rep_Ophthalmol_2012_Oct_23_3(3)_364-369.nxml.txt.nlp	23185178	SENT53	1	1	22	22	triamcinolone	San	PA451749	80218	0.686
NULL	J_Korean_Med_Sci_2005_Dec_31_20(6)_1076-1078.nxml.txt.nlp	16361827	SENT44	34	34	29	29	vasopressin	VIII	PA451858	1351	0.686
NULL	Curr_Med_Chem_2011_Dec_18(35)_5476-5482.nxml.txt.nlp	22087839	SENT130	16	16	12	12	cisplatin	S15	PA449014	6209	0.686
NULL	Nucleic_Acids_Res_2012_Jul_1_40(12)_5775-5786.nxml.txt.nlp	22383579	SENT268	20	20	22	22	theophylline	MS2	PA451647	101	0.686
NULL	Mol_Cancer_2009_Dec_31_8_131.nxml.txt.nlp	20042122	SENT256	13	13	0	0	choline	BTC	PA448976	685	0.686
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT99	2	2	22	22	curcumin	Bcl-2	PA151958596	596	0.686
NULL	FEBS_Open_Bio_2011_Dec_27_2_1-5.nxml.txt.nlp	23650573	SENT293	20	20	13	13	sunitinib	MDM2	PA162372840	4193	0.686
NULL	Biologics_2009_Sep_15_3_429-441.nxml.txt.nlp	19774210	SENT300	16	16	47	47	leucovorin	IFL	PA450198	3439	0.686
NULL	Cancer_Cell_Int_2011_Aug_19_11_29.nxml.txt.nlp	21854619	SENT220	41	41	30	30	platinum	BRCA1	PA150595617	672	0.686
NULL	Ann_Intensive_Care_2011_Mar_21_1_3.nxml.txt.nlp	21906325	SENT111	27	27	11	11	cisplatin	EPO	PA449014	7076;8288;2056	0.686
NULL	Drugs_R_D_2010_Sep_27_10(3)_203-210.nxml.txt.nlp	20945949	SENT11	38	38	43	43	ribavirin	SOC	PA451241	91544	0.686
NULL	Arthritis_Res_Ther_2005_Apr_4_7(3)_R666-R676.nxml.txt.nlp	15899052	SENT19	11	11	16	16	adalimumab	p75	PA10004	7133;11168	0.686
NULL	Mol_Pain_2012_Sep_22_8_71.nxml.txt.nlp	22998838	SENT92	41	41	32	32	cisplatin	CB1	PA449014	1268	0.686
NULL	Oncotarget_2014_Jun_1_5(13)_4868-4880.nxml.txt.nlp	24947902	SENT5	21	21	8	8	afatinib	HER2	PA165981154	2064	0.686
NULL	Biomed_Res_Int_2014_Mar_6_2014_712893.nxml.txt.nlp	24734240	SENT119	4	4	7	7	ethanol	HIF-1alpha	PA448073	3091	0.686
NULL	Breast_Cancer_Res_2011_Nov_23_13(6)_R116.nxml.txt.nlp	22113133	SENT69	31	31	33	33	dextran	FBS	PA449261	64319;26269	0.686
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_24_2012_673132.nxml.txt.nlp	23133498	SENT125	4	4	18	18	berberine	CYP3A	PA165860812	1574	0.686
NULL	Breast_Cancer_Res_2000_Dec_17_2(1)_10-12.nxml.txt.nlp	11250686	SENT53	25	25	21	21	tamoxifen	STAR	PA451581	6770;2984	0.686
NULL	Breast_Cancer_Res_2010_Jun_28_12(3)_R43.nxml.txt.nlp	20579400	SENT39	2	2	10	10	fulvestrant	MAPT	PA164747170	4137	0.686
NULL	JAKSTAT_2014_Jun_12_3_e29554.nxml.txt.nlp	25105067	SENT119	0	0	2	2	propofol	STAT3	PA451141	6774	0.686
NULL	Cell_Death_Differ_2010_Mar_16_17(3)_499-512.nxml.txt.nlp	19834490	SENT339	4	4	10	10	bevacizumab	VEGFR1	PA130232992	2321	0.686
NULL	Int_J_Breast_Cancer_2011_Sep_6_2011_352182.nxml.txt.nlp	22295219	SENT119	16	16	10	10	hyaluronan	CD44	PA165958431	960	0.686
NULL	Front_Oncol_2014_Oct_21_4_285.nxml.txt.nlp	25374842	SENT692	11	11	2	2	nutlin-3	p53		7157	0.686
NULL	Breast_Cancer_Res_2005_May_24_7(5)_R589-R597.nxml.txt.nlp	16168102	SENT88	41	41	23	23	doxorubicin	HER2	PA449412	2064	0.686
NULL	Exp_Ther_Med_2013_Apr_29_5(4)_1093-1096.nxml.txt.nlp	23596475	SENT113	2	2	7	7	ketamine	IL-6	PA450144	3569	0.686
NULL	Nucleic_Acids_Res_2005_Jun_8_33(10)_3283-3291.nxml.txt.nlp	15944449	SENT114	24	24	17	17	sjg-136	XRCC3		7517	0.686
NULL	Sci_Rep_2014_Dec_1_4_7268.nxml.txt.nlp	25434695	SENT215	0	0	19	19	afatinib	EGFR	PA165981154	1956	0.686
NULL	Cancer_Med_2013_Jun_25_2(3)_277-285.nxml.txt.nlp	23930204	SENT195	19	19	3	3	capecitabine	KRAS	PA448771	3845	0.686
NULL	Med_Sci_Monit_2013_Oct_21_19_875-882.nxml.txt.nlp	24145180	SENT173	16	16	11	11	bevacizumab	CXCL8	PA130232992	3576	0.686
NULL	Arch_Toxicol_2014_Nov_5_88(12)_2135-2190.nxml.txt.nlp	25370008	SENT1025	14	14	7	7	4-methylumbelliferone	UGT	PA154081778	7361;7355	0.686
NULL	Acta_Neuropathol_Commun_2014_May_30_2_57.nxml.txt.nlp	24887326	SENT11	4	4	2	2	vardenafil	ABCB1	PA10229	5243	0.686
NULL	Curr_Med_Chem_2009_Aug_16(23)_3041-3053.nxml.txt.nlp	19689281	SENT179	7	7	1	1	troglitazone	SOD2	PA451799	6648	0.686
NULL	Ann_Oncol_2010_Jan_21(1)_133-139.nxml.txt.nlp	20019090	SENT25	1	1	3	3	rituximab	CHOP	PA451261	1649	0.686
NULL	Cancer_Cell_Int_2005_Jun_1_5_18.nxml.txt.nlp	15929791	SENT140	5	5	17	17	bortezomib	p53	PA10252	7157	0.686
NULL	Med_Sci_Monit_2012_Jul_1_18(7)_CS57-CS62.nxml.txt.nlp	22739739	SENT103	28	28	15	15	sulfapyridine	CYP3A4	PA164779050	1576	0.686
NULL	Case_Rep_Med_2013_Nov_28_2013_284323.nxml.txt.nlp	24369471	SENT22	29	29	14	14	octreotide	EGFR	PA450678	1956	0.686
NULL	Case_Rep_Endocrinol_2014_Aug_10_2014_680876.nxml.txt.nlp	25177504	SENT90	9	9	7	7	thyroglobulin	PTH	PA164754910	5741	0.686
NULL	Nat_Biotechnol_2010_Aug_2_28(8)_839-847.nxml.txt.nlp	20601939	SENT183	23	23	33	33	l-glutamine	TPO	PA10090	7066;7173	0.686
NULL	Int_J_Endocrinol_2014_Jul_14_2014_535401.nxml.txt.nlp	25132853	SENT139	21	21	8	8	chloramphenicol	FBP1	PA448927	2203	0.686
NULL	Oxid_Med_Cell_Longev_2013_Mar_18_2013_746432.nxml.txt.nlp	23577226	SENT173	18	18	2	2	cisplatin	KEAP1	PA449014	9817	0.686
NULL	Arthritis_Res_Ther_2007_Mar_3_9(2)_R23.nxml.txt.nlp	17335581	SENT163	13	13	17	17	sulfasalazine	NAT2	PA451547	10;81539	0.686
NULL	Oncotarget_2013_Nov_22_5(4)_933-943.nxml.txt.nlp	24659749	SENT92	18	18	7	7	nutlin-3	p53		7157	0.686
NULL	Arthritis_Res_Ther_2007_Sep_23_9(5)_R96.nxml.txt.nlp	17888176	SENT5	12	12	18	18	etanercept	IL-17	PA449515	3605	0.686
NULL	J_Oncol_2013_Feb_17_2013_872957.nxml.txt.nlp	23476648	SENT208	3	3	16	16	cisplatin	SFN	PA449014	25996;2810	0.686
NULL	Mol_Biol_Cell_2012_Sep_1_23(17)_3473-3484.nxml.txt.nlp	22787275	SENT228	9	9	17	17	doxorubicin	ABCC6	PA449412	368	0.686
NULL	J_Cell_Biol_2002_Nov_11_159(3)_465-476.nxml.txt.nlp	12427869	SENT675	24	24	8	8	neomycin	armadillo	PA450608	1499	0.686
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT192	14	14	9	9	pertuzumab	Yes		7525	0.686
NULL	Acta_Pharmacol_Sin_2012_Jun_14_33(6)_832-838.nxml.txt.nlp	22580740	SENT23	16	16	7	7	methotrexate	ADM	PA450428	133	0.686
NULL	Oncoimmunology_2012_May_1_1(3)_287-357.nxml.txt.nlp	22737604	SENT231	24	24	22	22	sargramostim	GM-CSF	PA164748631	1437	0.686
NULL	Acta_Pharmacol_Sin_2012_Jul_18_33(7)_918-923.nxml.txt.nlp	22705728	SENT100	1	1	23	23	estradiol	San	PA449503	80218	0.686
NULL	J_Korean_Neurosurg_Soc_2014_Jul_31_56(1)_1-4.nxml.txt.nlp	25289117	SENT76	11	11	4	4	curcumin	p38	PA151958596	10598;1432;7965	0.686
NULL	Acta_Pharmacol_Sin_2011_Jan_29_32(1)_38-44.nxml.txt.nlp	21113177	SENT101	15	15	7	7	chloroquine	LC3	PA448948	84557	0.686
NULL	Indian_J_Nephrol_2013_Jul-Aug_23(4)_276-279.nxml.txt.nlp	23960344	SENT96	20	20	0	0	icodextrin	MIDAS	PA164743096	64083	0.686
NULL	Ann_Intensive_Care_2012_May_30_2_13.nxml.txt.nlp	22647340	SENT195	12	12	0	0	fludrocortisone	STR	PA164743961	6779	0.686
NULL	Arthritis_Res_Ther_2014_Jan_15_16(1)_R10.nxml.txt.nlp	24423138	SENT291	30	30	6	6	collagenase	TRPV1	PA449107	7442	0.686
NULL	Oncotarget_2013_Nov_24_5(1)_11-28.nxml.txt.nlp	24429466	SENT251	25	25	5	5	erlotinib	TFP	PA134687924	7034	0.686
NULL	Mol_Cancer_2012_Jul_12_11_45.nxml.txt.nlp	22788833	SENT139	15	15	17	17	cisplatin	EGFR	PA449014	1956	0.686
NULL	Biochem_Res_Int_2011_Sep_22_2011_285618.nxml.txt.nlp	21949907	SENT45	23	23	30	30	resveratrol	adiponectin		9370	0.686
NULL	Comp_Hepatol_2004_Jan_14_3(Suppl_1)_S21.nxml.txt.nlp	14960173	SENT52	31	31	33	33	simvastatin	GGTI	PA451363	5229	0.686
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jul_23_67(Pt_8)_m1132.nxml.txt.nlp	22090894	SENT58	12	12	38	38	ethanol	mol	PA448073	90527	0.686
NULL	Evid_Based_Complement_Alternat_Med_2013_Dec_18_2013_459390.nxml.txt.nlp	24454495	SENT188	6	6	38	38	berberine	AMPK	PA165860812	5563	0.686
NULL	Indian_J_Ophthalmol_2011_Jul-Aug_59(4)_273-277.nxml.txt.nlp	21666310	SENT53	10	10	15	15	vincristine	CHOP	PA451879	1649	0.686
NULL	Brain_2014_Apr_27_137(4)_1145-1155.nxml.txt.nlp	24578545	SENT130	25	25	34	34	citalopram	MRI	PA449015	78996	0.686
NULL	Acta_Orthop_2009_Oct_1_80(5)_508-513.nxml.txt.nlp	19916680	SENT96	3	3	21	21	gentamicin	90K	PA449753	3959	0.686
NULL	J_Hematol_Oncol_2011_Feb_7_4_6.nxml.txt.nlp	21299849	SENT109	2	2	10	10	imatinib	RPS6	PA10804	6194	0.686
NULL	Oncoscience_2013_Dec_11_1(1)_21-29.nxml.txt.nlp	25593981	SENT124	22	22	32	32	disulfiram	HSP27	PA449376	3315	0.686
NULL	Onco_Targets_Ther_2014_May_23_7_799-805.nxml.txt.nlp	24920920	SENT5	20	20	12	12	pemetrexed	EGFR	PA10810	1956	0.686
NULL	J_Ophthalmol_2012_Jan_9_2012_209538.nxml.txt.nlp	22272370	SENT180	1	1	7	7	bevacizumab	San	PA130232992	80218	0.686
NULL	Mol_Cancer_2010_Aug_23_9_222.nxml.txt.nlp	20731837	SENT276	11	11	4	4	gefitinib	CAD	PA131301952	1677;790	0.686
NULL	Int_J_Endocrinol_2014_Aug_11_2014_312452.nxml.txt.nlp	25183970	SENT222	2	2	4	4	liraglutide	PI3K	PA165958364	5290	0.686
NULL	F1000_Biol_Rep_2012_Mar_1_4_5.nxml.txt.nlp	22403588	SENT116	32	32	29	29	ribavirin	IFN	PA451241	3439	0.686
NULL	Front_Neurosci_2014_Feb_6_8_12.nxml.txt.nlp	24567701	SENT337	18	18	15	15	paroxetine	IFN	PA450801	3439	0.686
NULL	Cell_Commun_Signal_2014_Mar_11_12_16.nxml.txt.nlp	24618498	SENT240	43	43	41	41	niclosamide	STAT3	PA165958408	6774	0.686
NULL	Bioinform_Biol_Insights_2009_Oct_5_3_109-127.nxml.txt.nlp	20140064	SENT523	13	13	27	27	zidovudine	P200	PA451954	5035	0.686
NULL	F1000_Med_Rep_2009_May_28_1_41.nxml.txt.nlp	20052398	SENT25	8	8	25	25	ribavirin	IFN	PA451241	3439	0.686
NULL	Ann_Hematol_2012_May_11_91(5)_697-703.nxml.txt.nlp	22071570	SENT148	4	4	7	7	rituximab	CHOP	PA451261	1649	0.686
NULL	Libyan_J_Med_2007_Dec_1_2(4)_169-175.nxml.txt.nlp	21503240	SENT93	15	15	8	8	nifedipine	5-HT1A	PA450631	3350	0.686
NULL	Blood_Res_2014_Mar_24_49(1)_3-4.nxml.txt.nlp	24724058	SENT19	6	6	12	12	mercaptopurine	TPMT	PA450379	7172	0.686
NULL	Oncotarget_2011_Mar_10_2(3)_186-196.nxml.txt.nlp	21406729	SENT122	14	14	20	20	orlistat	FASN	PA164776864	2194	0.686
NULL	Curr_Cardiol_Rev_2012_May_8(2)_158-165.nxml.txt.nlp	22708914	SENT134	9	9	22	22	rivaroxaban	TKR	PA165958360	8277	0.686
NULL	Mol_Cancer_2010_Aug_23_9_222.nxml.txt.nlp	20731837	SENT88	2	2	11	11	gefitinib	ATM	PA131301952	472	0.686
NULL	Nucleic_Acids_Res_2007_Jan_7_35(1)_186-192.nxml.txt.nlp	17158155	SENT61	27	27	6	6	nadh	ADP	PA164755085	23038	0.686
NULL	J_Biol_Chem_2009_Oct_16_284(42)_28885-28895.nxml.txt.nlp	19687008	SENT36	16	16	12	12	pravastatin	PCSK9	PA451089	255738	0.686
NULL	Acta_Pharmacol_Sin_2009_Jun_5_30(6)_702-714.nxml.txt.nlp	19498416	SENT119	0	0	9	9	galantamine	PI3K	PA449726	5290	0.686
NULL	Breast_Cancer_Res_2012_Feb_14_14(1)_R31.nxml.txt.nlp	22333393	SENT271	4	4	18	18	tamoxifen	NAT1	PA451581	9;1982	0.686
NULL	Cardiovasc_Diabetol_2011_Aug_10_10_74.nxml.txt.nlp	21827713	SENT122	36	36	10	10	olmesartan	AT1	PA164742950	9197;185	0.686
NULL	Open_Ophthalmol_J_2013_Feb_1_7_4-10.nxml.txt.nlp	23459241	SENT112	0	0	7	7	ranibizumab	San	PA164746012	80218	0.686
NULL	Front_Chem_2014_Dec_23_2_113.nxml.txt.nlp	25566531	SENT254	6	6	37	37	curcumin	ROCK1	PA151958596	6093	0.686
NULL	Breast_Cancer_Res_2008_Jan_8_10(1)_R2.nxml.txt.nlp	18182100	SENT216	26	26	21	21	tamoxifen	HER3	PA451581	2065	0.686
NULL	Indian_J_Pharmacol_2014_Jan-Feb_46(1)_3-12.nxml.txt.nlp	24550577	SENT221	38	38	7	7	vismodegib	CYP3A4		1576	0.686
NULL	Front_Microbiol_2014_Mar_14_5_99.nxml.txt.nlp	24672516	SENT85	4	4	6	6	micafungin	IL-10	PA164781026	3586	0.686
NULL	J_Immunol_Res_2014_Feb_9_2014_897487.nxml.txt.nlp	24741630	SENT16	18	18	8	8	hyaluronan	IL-6	PA165958431	3569	0.686
NULL	Aging_(Albany_NY)_2013_Feb_21_5(2)_94-95.nxml.txt.nlp	23518473	SENT23	2	2	14	14	resveratrol	SIRT1		23411	0.686
NULL	Acta_Pharmacol_Sin_2013_Jan_23_34(1)_33-38.nxml.txt.nlp	22820909	SENT87	20	20	7	7	amiloride	ASIC3	PA448368	9311	0.686
NULL	Breast_Cancer_Res_Treat_2013_Jan_15_137(2)_397-406.nxml.txt.nlp	23242584	SENT193	4	4	21	21	tamoxifen	HER2	PA451581	2064	0.686
NULL	Oncol_Lett_2014_Mar_2_7(3)_791-796.nxml.txt.nlp	24527087	SENT29	25	25	27	27	imatinib	CD34	PA10804	947	0.686
NULL	Eur_Radiol_2011_May_23_21(5)_1034-1042.nxml.txt.nlp	20972569	SENT221	29	29	13	13	gadobutrol	spatial	PA165958377	219793	0.686
NULL	Acta_Orthop_2010_Apr_6_81(2)_263-267.nxml.txt.nlp	20148646	SENT148	17	17	28	28	taurine	LIR	PA451590	10871	0.686
NULL	Mol_Brain_2013_Dec_16_6_56.nxml.txt.nlp	24330819	SENT209	0	0	5	5	dantrolene	c-fos	PA449208	2353	0.686
NULL	Eur_J_Clin_Pharmacol_2010_Nov_29_66(11)_1131-1136.nxml.txt.nlp	20669013	SENT119	28	28	38	38	voriconazole	CYP2C19	PA10233	1557	0.686
NULL	J_Oncol_2012_Mar_8_2012_723541.nxml.txt.nlp	22481931	SENT185	34	34	30	30	heparin	EGFR	PA449855	1956	0.686
NULL	Acta_Pharmacol_Sin_2012_Jan_28_33(1)_75-81.nxml.txt.nlp	22120969	SENT91	3	3	1	1	exenatide	GLP-1	PA164749238	100125288	0.686
NULL	J_Physiol_2009_Feb_15_587(Pt_4)_731-744.nxml.txt.nlp	19074966	SENT268	28	28	11	11	taurine	PAT1	PA451590	10513;206358	0.686
NULL	ScientificWorldJournal_2012_Nov_4_2012_897178.nxml.txt.nlp	23213304	SENT10	5	5	10	10	rituximab	CHOP	PA451261	1649	0.686
NULL	Cardiovasc_Diabetol_2010_Oct_22_9_66.nxml.txt.nlp	20969783	SENT166	9	9	22	22	glucose	p38	PA449773	10598;1432;7965	0.686
NULL	Biomed_Res_Int_2014_Aug_4_2014_459452.nxml.txt.nlp	25162013	SENT225	4	4	13	13	podophyllum	PC3	PA10162	57332;7832;5122	0.686
NULL	Patient_Prefer_Adherence_2012_Oct_19_6_741-748.nxml.txt.nlp	23118530	SENT14	3	3	1	1	capecitabine	CAPER	PA448771	9584	0.686
NULL	Oncotarget_2014_Oct_21_5(22)_11252-11268.nxml.txt.nlp	25361004	SENT7	0	0	3	3	metformin	CLIC1	PA450395	1192	0.686
NULL	Indian_J_Med_Res_2014_Mar_139(3)_393-401.nxml.txt.nlp	24820833	SENT51	5	5	1	1	cosyntropin	ACTH	PA164749052	5443	0.686
NULL	Acta_Neuropathol_Commun_2014_Jan_2_2_3.nxml.txt.nlp	24383546	SENT270	27	27	16	16	resveratrol	SIRT1		23411	0.686
NULL	AIDS_Res_Treat_2012_Nov_8_2012_595762.nxml.txt.nlp	23193464	SENT89	43	43	1	1	enfuvirtide	DUET	PA164744517	8997	0.686
NULL	Curr_Neuropharmacol_2009_Jun_7(2)_83-95.nxml.txt.nlp	19949566	SENT515	18	18	32	32	lamotrigine	TGB	PA450164	5473	0.686
NULL	Indian_J_Pharm_Sci_2013_Jul-Aug_75(4)_427-434.nxml.txt.nlp	24302797	SENT176	14	14	9	9	ethanol	flower	PA448073	11094	0.686
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT192	14	14	19	19	pertuzumab	Yes		7525	0.686
NULL	Clin_Interv_Aging_2008_Sep_3(3)_421-430.nxml.txt.nlp	18982913	SENT58	0	0	2	2	buprenorphine	ORL1	PA448685	4987	0.686
NULL	Bioinorg_Chem_Appl_2012_Oct_2_2012_948534.nxml.txt.nlp	23082074	SENT89	16	16	30	30	l-glutamine	CO2	PA10090	4513	0.686
NULL	Indian_J_Pharm_Sci_2008_Jan-Feb_70(1)_128-131.nxml.txt.nlp	20390100	SENT30	3	3	10	10	esomeprazole	DOM	PA10075	6663	0.686
NULL	Front_Neurosci_2008_Dec_15_2(2)_135-136.nxml.txt.nlp	19225584	SENT11	13	13	25	25	choline	spatial	PA448976	219793	0.686
NULL	Ann_Lab_Med_2012_Jul_20_32(4)_298-303.nxml.txt.nlp	22779073	SENT117	12	12	22	22	ethambutol	MOX	PA164784021	26002	0.686
NULL	Clin_Kidney_J_2013_Jun_11_6(3)_287-294.nxml.txt.nlp	23717787	SENT184	25	25	34	34	cinacalcet	PTH	PA164776671	5741	0.686
NULL	Case_Rep_Pathol_2013_Feb_21_2013_687427.nxml.txt.nlp	23533895	SENT51	12	12	9	9	thyroglobulin	TTF-1	PA164754910	7080	0.686
NULL	J_Carcinog_2014_Feb_7_13_1.nxml.txt.nlp	24737949	SENT12	10	10	17	17	dacarbazine	IL-2	PA449197	3558	0.686
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Jan_11_64(Pt_2)_o430.nxml.txt.nlp	21201457	SENT53	28	28	14	14	ethanol	mol	PA448073	90527	0.686
NULL	Bone_Joint_Res_2014_Mar_1_3(3)_51-59.nxml.txt.nlp	24615710	SENT27	0	0	15	15	resveratrol	RUNX2		860	0.686
NULL	Am_J_Cardiovasc_Drugs_2013_Jun_20_13(5)_331-342.nxml.txt.nlp	23784266	SENT195	11	11	33	33	dronedarone	P-gp	PA153619853	5243	0.686
NULL	Clinicoecon_Outcomes_Res_2014_Oct_17_6_451-461.nxml.txt.nlp	25378939	SENT126	32	32	34	34	linezolid	HAP	PA450233	5915;10313	0.686
NULL	Iran_J_Pharm_Res_2013_Summer_12(3)_457-469.nxml.txt.nlp	24250652	SENT204	11	11	28	28	indomethacin	ANOVA	PA449982	4858	0.686
NULL	Clin_Pharmacokinet_2014_Jul_24_53(1)_73-87.nxml.txt.nlp	23881596	SENT146	25	25	4	4	rosuvastatin	OATP1B1	PA134308647	10599	0.686
NULL	Patient_Prefer_Adherence_2010_Mar_24_4_61-68.nxml.txt.nlp	20361006	SENT90	35	35	38	38	liraglutide	GLP-1	PA165958364	100125288	0.686
NULL	Environ_Health_Perspect_2006_Sep_23_114(9)_1401-1406.nxml.txt.nlp	16966095	SENT155	31	31	13	13	arsenite	p53	PA452638	7157	0.686
NULL	J_Cancer_2013_Mar_15_4(3)_262-269.nxml.txt.nlp	23459716	SENT34	14	14	5	5	leucovorin	PSM	PA450198	2346	0.686
NULL	Cell_Death_Dis_2014_Mar_13_5(3)_e1112.nxml.txt.nlp	24625971	SENT121	26	26	22	22	curcumin	CHOP	PA151958596	1649	0.686
NULL	Diabetol_Metab_Syndr_2014_Mar_31_6_48.nxml.txt.nlp	24684803	SENT110	17	17	9	9	miglitol	STEP	PA164776726	84867	0.686
NULL	Front_Oncol_2014_Jun_18_4_159.nxml.txt.nlp	24995161	SENT152	36	36	5	5	estradiol	AKR1C3	PA449503	8644	0.686
NULL	Mol_Brain_2013_Apr_9_6_16.nxml.txt.nlp	23570271	SENT236	11	11	14	14	celecoxib	cPLA2	PA448871	10524	0.686
NULL	Breast_Cancer_Res_2011_Feb_4_13(1)_R17.nxml.txt.nlp	21294885	SENT267	27	27	13	13	trastuzumab	CDR1	PA451743	1038	0.686
NULL	Curr_Neuropharmacol_2014_Jan_12(1)_2-36.nxml.txt.nlp	24533013	SENT1173	5	5	10	10	coumarin	BACE1	PA134521193	23621	0.686
NULL	Case_Rep_Gastroenterol_2007_Oct_12_1(1)_103-109.nxml.txt.nlp	21487554	SENT40	38	38	36	36	lipase	p53	PA450239	7157	0.686
NULL	Vet_Res_2013_Dec_11_44(1)_121.nxml.txt.nlp	24330735	SENT143	4	4	7	7	carbachol	ATP4A	PA448784	495	0.686
NULL	Indian_J_Med_Paediatr_Oncol_2012_Oct-Dec_33(4)_253a.nxml.txt.nlp	23580831	SENT2	17	17	23	23	heparin	PF4	PA449855	5196	0.686
NULL	Exp_Ther_Med_2013_Dec_15_6(6)_1565-1569.nxml.txt.nlp	24255692	SENT96	2	2	6	6	atorvastatin	adiponectin	PA448500	9370	0.686
NULL	Diabetes_Care_2010_Aug_33(8)_1905-1907.nxml.txt.nlp	20668158	SENT7	0	0	5	5	valsartan	AT-1	PA451848	9197	0.686
NULL	Drug_Des_Devel_Ther_2014_Sep_23_8_1527-1538.nxml.txt.nlp	25284985	SENT176	25	25	23	23	celecoxib	IFN	PA448871	3439	0.686
NULL	Front_Neurol_2011_Nov_21_2_68.nxml.txt.nlp	22125548	SENT240	0	0	10	10	rasagiline	GDNF	PA164764584	2668	0.686
NULL	Front_Neurosci_2012_May_30_6_77.nxml.txt.nlp	22661925	SENT173	13	13	16	16	ethanol	DCX	PA448073	1641	0.686
NULL	Chin_J_Cancer_2011_Sep_30(9)_645-654.nxml.txt.nlp	21880186	SENT199	32	32	10	10	cisplatin	NACT	PA449014	284111	0.686
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Nov_26_3(11)_e149.nxml.txt.nlp	25426564	SENT214	29	29	7	7	ezetimibe	PCSK9	PA10816	255738	0.686
NULL	J_Exp_Med_2000_Mar_6_191(5)_859-870.nxml.txt.nlp	10704466	SENT223	21	21	3	3	arsenite	p38	PA452638	10598;1432;7965	0.686
NULL	Eur_J_Histochem_2010_Jun_14_54(2)_e15.nxml.txt.nlp	20558338	SENT125	37	37	15	15	flutamide	ROD	PA449685	9735	0.686
NULL	J_Cell_Biol_2001_Oct_29_155(3)_427-438.nxml.txt.nlp	11673478	SENT177	10	10	7	7	genistein	PP2	PA165109660	4888	0.686
NULL	Biochem_Res_Int_2012_Feb_12_2012_346972.nxml.txt.nlp	22400115	SENT99	1	1	3	3	hyaluronan	CD44	PA165958431	960	0.686
NULL	Environ_Health_Perspect_2010_Jul_3_118(7)_936-942.nxml.txt.nlp	20199942	SENT167	8	8	12	12	arsenite	mot-2	PA452638	3313	0.686
NULL	Cell_Death_Dis_2013_Sep_19_4(9)_e807.nxml.txt.nlp	24052075	SENT11	0	0	3	3	doxorubicin	p53	PA449412	7157	0.686
NULL	Alcohol_Res_Health_2007_30(1)_5-13.nxml.txt.nlp	17718394	SENT174	6	6	1	1	ethanol	ALDH2	PA448073	217	0.686
NULL	Exp_Ther_Med_2014_Apr_13_7(4)_799-803.nxml.txt.nlp	24669235	SENT69	7	7	3	3	vildagliptin	GLP-1	PA165958346	100125288	0.686
NULL	Oncotarget_2014_Oct_21_5(22)_11252-11268.nxml.txt.nlp	25361004	SENT122	25	25	23	23	metformin	CLIC1	PA450395	1192	0.686
NULL	Mol_Cancer_2009_Dec_10_8_118.nxml.txt.nlp	20003259	SENT49	30	30	24	24	sorafenib	ERM	PA7000	2119	0.686
NULL	J_Gen_Physiol_2012_Nov_140(5)_541-555.nxml.txt.nlp	23109716	SENT46	12	12	7	7	capsaicin	TRPV1	PA448776	7442	0.686
NULL	Indian_J_Anaesth_2014_Jul-Aug_58(4)_423-429.nxml.txt.nlp	25197110	SENT166	12	12	17	17	palonosetron	ODF	PA10352	8600	0.686
NULL	Int_J_Vasc_Med_2011_Aug_11_2011_867964.nxml.txt.nlp	21860799	SENT85	20	20	16	16	cilostazol	DES	PA164746334	1674	0.686
NULL	J_Korean_Med_Sci_2010_Apr_19_25(4)_557-563.nxml.txt.nlp	20357998	SENT110	18	18	21	21	cisplatin	IL-10	PA449014	3586	0.686
NULL	Oncol_Lett_2014_Mar_16_7(3)_827-833.nxml.txt.nlp	24527090	SENT46	11	11	8	8	cisplatin	IFN	PA449014	3439	0.686
NULL	Nucleic_Acids_Res_2013_May_20_41(9)_e104.nxml.txt.nlp	23519618	SENT56	19	19	21	21	topotecan	TPT	PA451729	23590;6469	0.686
NULL	J_Biomed_Biotechnol_2010_Nov_1_2010_617521.nxml.txt.nlp	19888437	SENT85	12	12	10	10	lovastatin	P-gp	PA450272	5243	0.686
NULL	Nutr_J_2014_Jan_24_13_11.nxml.txt.nlp	24461029	SENT172	28	28	34	34	curcumin	CTR	PA151958596	799	0.686
NULL	Ann_Surg_Treat_Res_2014_Feb_22_86(2)_68-75.nxml.txt.nlp	24761411	SENT18	18	18	3	3	oxaliplatin	survivin	PA131285527	332	0.686
NULL	J_Exp_Med_2003_Dec_1_198(11)_1643-1652.nxml.txt.nlp	14638845	SENT42	10	10	46	46	collagenase	CO2	PA449107	4513	0.686
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT119	35	35	33	33	nilotinib	ABCB1	PA165958345	5243	0.686
NULL	Ann_Rheum_Dis_2008_Sep_11_68(7)_1146-1152.nxml.txt.nlp	18794178	SENT64	12	12	32	32	etanercept	ACR	PA449515	49	0.686
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_May_14_65(Pt_6)_o1266.nxml.txt.nlp	21583130	SENT51	35	35	41	41	benzaldehyde	mol	PA448571	90527	0.686
NULL	Inflamm_Res_2010_Sep_26_59(9)_699-709.nxml.txt.nlp	20339899	SENT35	13	13	7	7	trypsin	PAR2	PA451806	2150;55065;8856	0.686
NULL	Acta_Pharmacol_Sin_2010_Dec_3_31(12)_1635-1642.nxml.txt.nlp	21127497	SENT82	0	0	14	14	fluconazole	UGT	PA449653	7361;7355	0.686
NULL	Oncotarget_2014_Mar_14_5(5)_1149-1156.nxml.txt.nlp	24658419	SENT48	4	4	8	8	doxorubicin	p53	PA449412	7157	0.686
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT157	42	42	8	8	pp2	PP2		4888	0.686
NULL	Clinicoecon_Outcomes_Res_2014_Oct_17_6_451-461.nxml.txt.nlp	25378939	SENT19	0	0	12	12	vancomycin	HAP	PA451850	5915;10313	0.686
NULL	Curr_Oncol_2006_Feb_13(1)_14-26.nxml.txt.nlp	17576437	SENT39	3	3	9	9	bevacizumab	San	PA130232992	80218	0.686
NULL	Endocrinology_2014_Aug_30_155(8)_2976-2985.nxml.txt.nlp	24877623	SENT36	0	0	13	13	estradiol	AC1	PA449503	107	0.686
NULL	Clinics_(Sao_Paulo)_2014_Jan_69(1)_68-74.nxml.txt.nlp	24473562	SENT27	5	5	8	8	nutlin-3	SOCS-1		8651	0.686
NULL	Psychiatr_Genet_2013_Aug_28_23(4)_153-162.nxml.txt.nlp	23811784	SENT157	13	13	11	11	clozapine	AGTRAP	PA449061	57085	0.686
NULL	Br_J_Cancer_2014_Jul_15_111(2)_318-325.nxml.txt.nlp	24874484	SENT37	27	27	40	40	gemcitabine	CDP	PA449748	1523	0.686
NULL	Cell_Tissue_Res_2013_May_17_354(1)_259-271.nxml.txt.nlp	23681253	SENT25	23	23	39	39	methylphenidate	ATX	PA450464	5168;23049	0.686
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Jul_23_6_103-113.nxml.txt.nlp	25114588	SENT36	18	18	4	4	trastuzumab	HER2	PA451743	2064	0.686
NULL	Alcohol_Res_Health_2010_33(1-2)_76-86.nxml.txt.nlp	23579938	SENT170	24	24	34	34	ethanol	ALDH2	PA448073	217	0.686
NULL	J_Immunol_Res_2014_Jul_16_2014_696812.nxml.txt.nlp	25133198	SENT249	14	14	5	5	rifaximin	TLR4	PA164752443	7099	0.686
NULL	EMBO_Mol_Med_2012_Apr_4(4)_298-312.nxml.txt.nlp	22331558	SENT147	38	38	7	7	etoposide	p53	PA449552	7157	0.686
NULL	Oncoimmunology_2014_Jun_3_3_e29030.nxml.txt.nlp	25083328	SENT74	35	35	39	39	imiquimod	IFN	PA449972	3439	0.686
NULL	J_Exp_Clin_Cancer_Res_2009_Feb_15_28(1)_19.nxml.txt.nlp	19216799	SENT169	13	13	5	5	doxorubicin	AEG-1	PA449412	92140	0.686
NULL	Mol_Biol_Int_2014_Nov_20_2014_686984.nxml.txt.nlp	25505994	SENT158	18	18	23	23	staurosporine	4E-BP1	PA165109623	1978	0.686
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2675-2684.nxml.txt.nlp	24129246	SENT235	22	22	13	13	etoposide	p53	PA449552	7157	0.686
NULL	Cent_European_J_Urol_2013_Dec_19_66(4)_394-404.nxml.txt.nlp	24757527	SENT260	4	4	6	6	bevacizumab	IFN	PA130232992	3439	0.686
NULL	Biomed_Res_Int_2013_Dec_30_2013_470217.nxml.txt.nlp	23509726	SENT64	36	36	29	29	ethanol	CO2	PA448073	4513	0.686
NULL	Arthritis_Res_Ther_2009_Jan_30_11(1)_205.nxml.txt.nlp	19232061	SENT181	23	23	4	4	abatacept	STAR	PA164747080	6770;2984	0.686
NULL	Exp_Ther_Med_2014_Aug_4_8(2)_657-661.nxml.txt.nlp	25009636	SENT104	30	30	20	20	propofol	CCR2	PA451141	729230	0.686
NULL	Int_J_Breast_Cancer_2012_Feb_26_2012_761917.nxml.txt.nlp	22482061	SENT121	37	37	40	40	lapatinib	PTEN	PA152241907	5728	0.686
NULL	J_Korean_Med_Sci_2005_Oct_31_20(5)_883-885.nxml.txt.nlp	16224167	SENT74	23	23	26	26	cyclosporine	gamma	PA449167	9913	0.685
NULL	Clin_Pharmacol_2013_Apr_19_5_67-83.nxml.txt.nlp	23650452	SENT178	14	14	21	21	everolimus	P2Y12	PA164746311	64805	0.685
NULL	Arch_Med_Sci_2013_Aug_30_9(4)_724-730.nxml.txt.nlp	24049536	SENT89	13	13	6	6	genistein	PTH	PA165109660	5741	0.685
NULL	J_Cardiothorac_Surg_2011_Aug_30_6_103.nxml.txt.nlp	21878108	SENT134	18	18	22	22	aprotinin	BART	PA448472	7809;23568	0.685
NULL	Blood_Res_2014_Jun_25_49(2)_85-94.nxml.txt.nlp	25025009	SENT98	17	17	35	35	thrombin	VIII	PA451674	1351	0.685
NULL	Breast_Cancer_(Auckl)_2014_Mar_23_8_51-56.nxml.txt.nlp	24678242	SENT21	5	5	12	12	carboplatin	BRCA1	PA448803	672	0.685
NULL	J_Cancer_2013_Jun_21_4(5)_383-390.nxml.txt.nlp	23833683	SENT36	31	31	9	9	gentamicin	TNF	PA449753	7124	0.685
NULL	Arthritis_Res_Ther_2011_Feb_28_13(1)_205.nxml.txt.nlp	21371351	SENT62	9	9	24	24	etanercept	TNF	PA449515	7124	0.685
NULL	Evid_Based_Complement_Alternat_Med_2013_May_16_2013_379536.nxml.txt.nlp	23762128	SENT40	12	12	39	39	fluorescein	San	PA164746009	80218	0.685
NULL	Cancer_Med_2013_Oct_19_2(5)_646-653.nxml.txt.nlp	24403230	SENT94	14	14	7	7	trastuzumab	MKK6	PA451743	5608	0.685
NULL	Chem_Senses_2008_Sep_5_33(7)_665-680.nxml.txt.nlp	18603652	SENT387	15	15	11	11	amiloride	TRPV1	PA448368	7442	0.685
NULL	Cell_Death_Dis_2014_Jan_16_5(1)_e1004.nxml.txt.nlp	24434512	SENT78	14	14	35	35	etoposide	RIPK1	PA449552	8737	0.685
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT210	36	36	47	47	cisplatin	B7-H1	PA449014	29126	0.685
NULL	Biochemistry_2014_Jan_28_53(3)_505-517.nxml.txt.nlp	24383758	SENT35	21	21	29	29	alteplase	San	PA164776730	80218	0.685
NULL	J_Antimicrob_Chemother_2010_Mar_18_65(3)_390-398.nxml.txt.nlp	20022938	SENT31	10	10	24	24	sulfadoxine	ATV	PA451540	4683	0.685
NULL	Aging_(Albany_NY)_2009_Dec_31_1(12)_988-1007.nxml.txt.nlp	20157582	SENT101	8	8	10	10	thalidomide	CTX	PA451644	1593	0.685
NULL	Oncoimmunology_2013_Nov_1_2(11)_e27010.nxml.txt.nlp	24498547	SENT27	9	9	11	11	gemcitabine	GEM	PA449748	2669	0.685
NULL	Br_J_Cancer_2012_Oct_9_107(8)_1277-1285.nxml.txt.nlp	22990652	SENT166	1	1	22	22	paclitaxel	CYP2C8	PA450761	1558	0.685
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1196-1204.nxml.txt.nlp	22315058	SENT18	20	20	18	18	cetuximab	EGFR	PA10040	1956	0.685
NULL	Exp_Ther_Med_2012_Sep_12_4(3)_475-480.nxml.txt.nlp	23181121	SENT163	18	18	6	6	rituximab	CHOP	PA451261	1649	0.685
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Apr_22_67(Pt_5)_o1196.nxml.txt.nlp	21754498	SENT69	31	31	7	7	ethanol	mol	PA448073	90527	0.685
NULL	Oxid_Med_Cell_Longev_2011_Aug_15_2011_824597.nxml.txt.nlp	21904648	SENT204	8	8	10	10	topotecan	TPT	PA451729	23590;6469	0.685
NULL	Mol_Cancer_2008_Jun_5_7_50.nxml.txt.nlp	18534018	SENT11	21	21	35	35	bortezomib	HSP	PA10252	7190	0.685
NULL	Case_Rep_Ophthalmol_2010_Dec_8_1(2)_110-113.nxml.txt.nlp	21373383	SENT24	3	3	17	17	bevacizumab	PED	PA130232992	8682	0.685
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT166	42	42	8	8	pp2	PP2		4888	0.685
NULL	J_Exp_Med_1967_Jul_1_126(1)_171-188.nxml.txt.nlp	4165501	SENT6	0	0	14	14	sulfinpyrazone	gamma	PA451550	9913	0.685
NULL	Cancer_Med_2014_Apr_7_3(2)_362-375.nxml.txt.nlp	24515916	SENT176	2	2	11	11	zoledronate	IFN	PA10235	3439	0.685
NULL	Arthritis_Res_Ther_2011_Oct_31_13(5)_245.nxml.txt.nlp	22044622	SENT52	0	0	23	23	hydralazine	DNMT1	PA449894	1786	0.685
NULL	Int_J_Surg_Oncol_2011_Aug_8_2011_374012.nxml.txt.nlp	22312502	SENT176	5	5	7	7	raloxifene	STAR	PA451221	6770;2984	0.685
NULL	Br_J_Cancer_2010_Jan_5_102(1)_80-86.nxml.txt.nlp	19920817	SENT116	19	19	23	23	sunitinib	IFN	PA162372840	3439	0.685
NULL	Exp_Ther_Med_2014_Mar_24_7(3)_663-668.nxml.txt.nlp	24520264	SENT167	2	2	6	6	curcumin	IL-6	PA151958596	3569	0.685
NULL	Ann_Surg_Treat_Res_2014_Feb_22_86(2)_68-75.nxml.txt.nlp	24761411	SENT178	27	27	23	23	resveratrol	survivin		332	0.685
NULL	Cancers_(Basel)_2013_Nov_8_5(4)_1504-1521.nxml.txt.nlp	24217116	SENT26	22	22	15	15	erlotinib	CDH1	PA134687924	51343;999	0.685
NULL	Mol_Cancer_2012_Sep_21_11_72.nxml.txt.nlp	22995644	SENT47	4	4	7	7	imatinib	PRL-3	PA10804	11156	0.685
NULL	Biosci_Rep_2012_Apr_1_32(Pt_2)_105-112.nxml.txt.nlp	22115362	SENT129	2	2	23	23	infliximab	IL-8	PA452639	3576	0.685
NULL	Protein_Cell_2014_Jul_2_5(7)_544-551.nxml.txt.nlp	24691905	SENT106	16	16	9	9	doxorubicin	p53	PA449412	7157	0.685
NULL	Support_Care_Cancer_2014_Oct_13_22(2)_417-426.nxml.txt.nlp	24122403	SENT228	9	9	0	0	melphalan	San	PA450354	80218	0.685
NULL	Vet_Res_Forum_2013_Autumn_4(4)_227-231.nxml.txt.nlp	25568676	SENT59	16	16	14	14	nadh	ND1	PA164755085	4535;10625	0.685
NULL	Bioinorg_Chem_Appl_2014_Feb_23_2014_276598.nxml.txt.nlp	24707242	SENT71	23	23	38	38	ethanol	mol	PA448073	90527	0.685
NULL	Oncotarget_2014_Oct_16_5(20)_9546-9563.nxml.txt.nlp	25337673	SENT159	9	9	18	18	dextran	AXL	PA449261	558	0.685
NULL	Int_J_Mol_Sci_2014_Mar_20_15(3)_4977-4993.nxml.txt.nlp	24658441	SENT623	2	2	11	11	resveratrol	HER-2		2064	0.685
NULL	Oncotarget_2014_May_27_5(19)_9049-9064.nxml.txt.nlp	24979294	SENT200	3	3	15	15	fulvestrant	IGFR	PA164747170	3480	0.685
NULL	Environ_Microbiol_2013_Jan_15_15(1)_297-304.nxml.txt.nlp	23157680	SENT51	26	26	45	45	kanamycin	TMP	PA450137	2012	0.685
NULL	Arthritis_Res_Ther_2009_Jun_25_11(3)_R97.nxml.txt.nlp	19555469	SENT51	18	18	33	33	estradiol	aromatase	PA449503	1588	0.685
NULL	Arthritis_Res_Ther_2003_Aug_5_5(5)_214-222.nxml.txt.nlp	12932280	SENT102	4	4	2	2	estradiol	PTH	PA449503	5741	0.685
NULL	Cell_Biochem_Biophys_2013_Jun_4_67(3)_1433-1439.nxml.txt.nlp	23733672	SENT105	5	5	7	7	heparin	CHOP	PA449855	1649	0.685
NULL	Indian_J_Pharm_Sci_2014_May-Jun_76(3)_203-210.nxml.txt.nlp	25035531	SENT160	0	0	6	6	pindolol	5-HT1A	PA450966	3350	0.685
NULL	Front_Genet_2012_Oct_26_3_222.nxml.txt.nlp	23112806	SENT290	14	14	1	1	isoflurane	p38	PA450106	10598;1432;7965	0.685
NULL	Biomed_Eng_Online_2007_Apr_20_6_14.nxml.txt.nlp	17448235	SENT105	14	14	10	10	nadh	ADP	PA164755085	23038	0.685
NULL	Front_Genet_2012_Sep_6_3_173.nxml.txt.nlp	22973297	SENT17	17	17	23	23	gemcitabine	FKBP5	PA449748	2289	0.685
NULL	Oncotarget_2010_Nov_25_1(7)_662-673.nxml.txt.nlp	21317461	SENT50	5	5	12	12	protamine	PF4	PA10366	5196	0.685
NULL	Int_J_Mol_Sci_2010_Sep_13_11(9)_3195-3208.nxml.txt.nlp	20957088	SENT46	48	48	9	9	lipase	AT2	PA450239	186	0.685
NULL	Front_Neuroanat_2014_Oct_22_8_117.nxml.txt.nlp	25374513	SENT70	12	12	1	1	isoflurane	P28	PA450106	9446;7802;9527	0.685
NULL	Front_Behav_Neurosci_2015_Jan_6_8_445.nxml.txt.nlp	25610380	SENT504	0	0	4	4	clomipramine	CYP2D6	PA449048	1565	0.685
NULL	J_Gen_Physiol_2000_Jun_1_115(6)_783-798.nxml.txt.nlp	10828251	SENT473	9	9	1	1	spermine	GMP	PA164781199	22978	0.685
NULL	J_Ophthalmic_Inflamm_Infect_2013_Jan_28_3_22.nxml.txt.nlp	23514095	SENT92	7	7	10	10	timolol	BAK	PA451690	578	0.685
NULL	Oncoimmunology_2012_Oct_1_1(7)_1004-1016.nxml.txt.nlp	23170249	SENT16	24	24	11	11	trastuzumab	HER-2	PA451743	2064	0.685
NULL	Mol_Cells_2014_Dec_31_37(12)_899a-906.nxml.txt.nlp	25431425	SENT38	7	7	31	31	curcumin	LOX	PA151958596	4015	0.685
NULL	FEBS_Open_Bio_2012_Aug_22_2_279-283.nxml.txt.nlp	23650611	SENT348	19	19	21	21	tamoxifen	IFN	PA451581	3439	0.685
NULL	J_Oral_Pathol_Med_2013_Jul_18_42(6)_499-506.nxml.txt.nlp	23331485	SENT111	5	5	15	15	indomethacin	IL-6	PA449982	3569	0.685
NULL	Biomed_Eng_Online_2012_Nov_14_11_84.nxml.txt.nlp	23151049	SENT173	14	14	19	19	alendronate	PTH	PA448082	5741	0.685
NULL	J_Obes_2011_Aug_16_2011_686952.nxml.txt.nlp	20847891	SENT229	7	7	26	26	enalapril	adiponectin	PA449456	9370	0.685
NULL	Int_Clin_Psychopharmacol_2014_Nov_3_29(6)_299-312.nxml.txt.nlp	24815672	SENT330	28	28	21	21	olanzapine	CYP2D6	PA450688	1565	0.685
NULL	Breast_Cancer_Res_2012_Mar_16_14(2)_206.nxml.txt.nlp	22423895	SENT187	12	12	1	1	estradiol	FES	PA449503	2242	0.685
NULL	Drug_Des_Devel_Ther_2014_Sep_23_8_1527-1538.nxml.txt.nlp	25284985	SENT98	41	41	38	38	celecoxib	IFN	PA448871	3439	0.685
NULL	J_Korean_Med_Sci_2013_Feb_29_28(2)_308-314.nxml.txt.nlp	23399960	SENT163	2	2	19	19	gabapentin	IL-6	PA449720	3569	0.685
NULL	Cardiovasc_Ultrasound_2011_Feb_7_9_5.nxml.txt.nlp	21299902	SENT78	18	18	8	8	rosuvastatin	TDI	PA134308647	100038246	0.685
NULL	Mar_Drugs_2014_Jun_27_12(7)_3818-3837.nxml.txt.nlp	24979269	SENT314	4	4	10	10	dasatinib	ABCG2	PA162372878	9429	0.685
NULL	ACS_Nano_2014_Mar_25_8(3)_2018-2032.nxml.txt.nlp	24555414	SENT254	7	7	29	29	ethanol	mol	PA448073	90527	0.685
NULL	Core_Evid_2009_Jun_15_4_83-92.nxml.txt.nlp	20694067	SENT11	2	2	9	9	vasopressin	AVP	PA451858	114548;551	0.685
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Mar_19_65(Pt_4)_o786.nxml.txt.nlp	21582511	SENT65	21	21	12	12	ethanol	mol	PA448073	90527	0.685
NULL	Oncotarget_2013_Nov_7_4(12)_2550-2566.nxml.txt.nlp	24334291	SENT42	6	6	21	21	dasatinib	CD38	PA162372878	952	0.685
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Mar_5_67(Pt_4)_o790.nxml.txt.nlp	21754081	SENT66	18	18	6	6	ethanol	mol	PA448073	90527	0.685
NULL	J_Physiol_2009_Feb_15_587(Pt_4)_731-744.nxml.txt.nlp	19074966	SENT10	11	11	14	14	taurine	PAT1	PA451590	10513;206358	0.685
NULL	Carcinogenesis_2010_Dec_27_31(12)_2049-2057.nxml.txt.nlp	20876285	SENT124	15	15	25	25	tamoxifen	HER2	PA451581	2064	0.685
NULL	Int_J_Inflam_2014_Dec_24_2014_690596.nxml.txt.nlp	25610704	SENT170	0	0	13	13	diclofenac	ALP	PA449293	6590;10850;27295;80150;470;26033	0.685
NULL	J_Cell_Mol_Med_2013_Jun_26_17(6)_743-753.nxml.txt.nlp	23617620	SENT173	5	5	13	13	staurosporine	LC3	PA165109623	84557	0.685
NULL	Oncol_Lett_2013_Mar_28_5(3)_935-942.nxml.txt.nlp	23426424	SENT43	5	5	7	7	cisplatin	DDP	PA449014	1678	0.685
NULL	Arthritis_Res_Ther_2012_Mar_5_14(2)_R45.nxml.txt.nlp	22390640	SENT69	0	0	10	10	fluorescein	CD11c	PA164746009	3687	0.685
NULL	Arthritis_Res_Ther_2011_Jul_30_13(4)_R126.nxml.txt.nlp	21801431	SENT34	19	19	12	12	etanercept	IL-23	PA449515	51561	0.685
NULL	Clin_Pharmacokinet_2014_Jul_24_53(1)_73-87.nxml.txt.nlp	23881596	SENT150	20	20	22	22	rosuvastatin	OATP1B1	PA134308647	10599	0.685
NULL	Food_Nutr_Res_2011_Jan_14_55_10_3402_fnr_v55i0_5455.nxml.txt.nlp	21249160	SENT108	15	15	29	29	spermine	mol	PA164781199	90527	0.685
NULL	Nat_Biotechnol_2010_Mar_14_28(3)_249-255.nxml.txt.nlp	20160716	SENT198	8	8	17	17	scopolamine	ANOVA	PA451308	4858	0.685
NULL	Ann_Gen_Psychiatry_2008_Oct_15_7_19.nxml.txt.nlp	18922171	SENT150	37	37	14	14	bupropion	CD50	PA448687	3385	0.685
NULL	Basic_Res_Cardiol_2008_May_15_103(3)_232-243.nxml.txt.nlp	18274801	SENT103	21	21	42	42	cyclosporine	FFR	PA449167	738	0.685
NULL	Arthritis_Res_Ther_2014_Sep_18_16(5)_427.nxml.txt.nlp	25230745	SENT327	10	10	13	13	bevacizumab	ACL	PA130232992	47	0.685
NULL	Curr_Opin_Nephrol_Hypertens_2015_Jan_4_24(1)_37-46.nxml.txt.nlp	25427230	SENT179	19	19	8	8	troglitazone	ANG	PA451799	283	0.685
NULL	Arthritis_Res_Ther_2006_Nov_9_8(1)_R2.nxml.txt.nlp	16356188	SENT5	21	21	34	34	aceclofenac	COX	PA166049185	1351	0.685
NULL	Eur_Biophys_J_2007_Jul_27_36(6)_589-599.nxml.txt.nlp	17333164	SENT181	18	18	21	21	propranolol	CYP2D6	PA451145	1565	0.685
NULL	Curr_Pharm_Biotechnol_2011_Feb_12(2)_268-274.nxml.txt.nlp	21050165	SENT109	0	0	3	3	aldesleukin	IL-2	PA448081	3558	0.685
NULL	J_Cell_Biol_1998_Jul_13_142(1)_101-115.nxml.txt.nlp	9660866	SENT137	38	38	22	22	dextran	mol	PA449261	90527	0.685
NULL	Mol_Cancer_2013_May_4_12_37.nxml.txt.nlp	23642048	SENT32	2	2	23	23	curcumin	p27	PA151958596	5715;10534	0.685
NULL	Cardiovasc_Diabetol_2010_Nov_16_9_76.nxml.txt.nlp	21080957	SENT320	4	4	30	30	exenatide	GLP-1	PA164749238	100125288	0.685
NULL	Front_Neuroenergetics_2012_Feb_1_4_2.nxml.txt.nlp	22347180	SENT315	1	1	9	9	nadh	PDH	PA164755085	54704	0.685
NULL	EMBO_Mol_Med_2012_Jun_13_4(6)_515-527.nxml.txt.nlp	22416035	SENT90	12	12	7	7	olaparib	p53		7157	0.685
NULL	F1000Res_2013_Aug_29_2_129.nxml.txt.nlp	24715954	SENT81	16	16	22	22	estradiol	San	PA449503	80218	0.685
NULL	Hum_Genomics_2013_Sep_23_7(1)_20.nxml.txt.nlp	24060470	SENT95	15	15	21	21	nutlin-3	p53		7157	0.685
NULL	Breast_Cancer_Res_2005_May_12_7(4)_153-162.nxml.txt.nlp	15987467	SENT229	18	18	22	22	estradiol	FES	PA449503	2242	0.685
NULL	Crit_Care_2009_Jun_22_13(3)_157.nxml.txt.nlp	19591641	SENT57	24	24	21	21	mannitol	HSL	PA450320	3991	0.685
NULL	Hum_Genomics_2009_Jan_1_3(2)_128-142.nxml.txt.nlp	19164090	SENT108	18	18	9	9	carboplatin	CD44	PA448803	960	0.685
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT161	8	8	12	12	glucose	EGFR	PA449773	1956	0.685
NULL	Drugs_R_D_2010_Sep_27_10(3)_165-178.nxml.txt.nlp	20945947	SENT214	0	0	8	8	ridaforolimus	KRAS	PA165291475	3845	0.685
NULL	Front_Neurol_2013_Nov_18_4_189.nxml.txt.nlp	24302917	SENT74	0	0	13	13	methamphetamine	spatial	PA450403	219793	0.685
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT166	6	6	15	15	atorvastatin	RANKL	PA448500	8600	0.685
NULL	Environ_Health_Perspect_1996_Jul_104(7)_744-749.nxml.txt.nlp	8841760	SENT5	11	11	13	13	colchicine	CLC	PA449092	23529;1178	0.685
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2007_Dec_6_64(Pt_1)_o124.nxml.txt.nlp	21200688	SENT6	12	12	1	1	phenol	mol	PA450913	90527	0.685
NULL	Cancer_Immunol_Immunother_2012_Jul_23_61(7)_1101-1111.nxml.txt.nlp	22193989	SENT205	10	10	18	18	oxaliplatin	STAT6	PA131285527	6778	0.685
NULL	Br_J_Anaesth_2014_Jul_22_113(1)_157-167.nxml.txt.nlp	24154701	SENT57	7	7	2	2	sevoflurane	TREK-1	PA451341	3776	0.685
NULL	Case_Rep_Oncol_Med_2012_Sep_11_2012_726424.nxml.txt.nlp	22997596	SENT104	39	39	37	37	rituximab	CHOP	PA451261	1649	0.685
NULL	Clin_Drug_Investig_2013_Jun_20_33(6)_419-427.nxml.txt.nlp	23605507	SENT168	6	6	14	14	tobramycin	DPI	PA451704	1832	0.685
NULL	Curr_Neuropharmacol_2009_Jun_7(2)_83-95.nxml.txt.nlp	19949566	SENT474	18	18	32	32	lamotrigine	TGB	PA450164	5473	0.685
NULL	Arthritis_Res_2002_Feb_4_4(Suppl_1)_40.nxml.txt.nlp	NULL	SENT4	11	11	13	13	thrombin	PAR2	PA451674	2150;55065;8856	0.685
NULL	Cardiovasc_Diabetol_2013_Mar_18_12_46.nxml.txt.nlp	23497197	SENT125	7	7	14	14	metformin	adiponectin	PA450395	9370	0.685
NULL	J_Gerontol_A_Biol_Sci_Med_Sci_2014_Jun_8_69(Suppl_1)_S21-S27.nxml.txt.nlp	24833582	SENT337	1	1	18	18	metformin	AMPK	PA450395	5563	0.685
NULL	Trials_2012_Nov_29_13_228.nxml.txt.nlp	23190503	SENT48	28	28	22	22	cisplatin	Gem	PA449014	51053	0.685
NULL	Exp_Diabetes_Res_2011_Oct_29_2011_596060.nxml.txt.nlp	22110473	SENT163	40	40	33	33	lipase	adiponectin	PA450239	9370	0.685
NULL	FEBS_Open_Bio_2012_Aug_22_2_279-283.nxml.txt.nlp	23650611	SENT371	19	19	21	21	raloxifene	IFN	PA451221	3439	0.685
NULL	Acta_Pharmacol_Sin_2012_May_16_33(5)_682-690.nxml.txt.nlp	22504904	SENT172	22	22	17	17	celecoxib	Bcl-2	PA448871	596	0.685
NULL	Environ_Health_Perspect_1999_Mar_107(3)_173-177.nxml.txt.nlp	10064545	SENT10	1	1	6	6	permethrin	pS2	PA164743137	7031	0.685
NULL	Indian_J_Urol_2009_Oct-Dec_25(4)_427-436.nxml.txt.nlp	19955664	SENT83	17	17	22	22	sunitinib	IFN	PA162372840	3439	0.685
NULL	J_Cell_Mol_Med_2014_Apr_20_18(4)_709-720.nxml.txt.nlp	24444314	SENT167	22	22	24	24	metformin	Met	PA450395	79811	0.685
NULL	Autophagy_2013_Jul_1_9(7)_985-995.nxml.txt.nlp	23584039	SENT87	23	23	21	21	resveratrol	DPI		1832	0.685
NULL	Arthritis_Res_Ther_2010_Apr_9_12(2)_R65.nxml.txt.nlp	20380722	SENT85	20	20	35	35	imatinib	IL6	PA10804	3569	0.685
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Feb_13_66(Pt_3)_m301.nxml.txt.nlp	21580244	SENT60	35	35	9	9	nitrogen	mol	PA450643	90527	0.685
NULL	Arthritis_Res_Ther_2008_Jan_18_10(1)_R8.nxml.txt.nlp	18205921	SENT60	34	34	30	30	hyaluronan	mol	PA165958431	90527	0.685
NULL	J_Biol_Chem_2013_May_24_288(21)_15256-15267.nxml.txt.nlp	23525104	SENT82	26	26	17	17	tetracycline	CO2	PA451640	4513	0.685
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1063.nxml.txt.nlp	24556678	SENT10	10	10	3	3	thioridazine	c-FLIP	PA451666	8837	0.685
NULL	Ann_Clin_Microbiol_Antimicrob_2008_Jan_28_7_3.nxml.txt.nlp	18226256	SENT63	0	0	5	5	ritonavir	SXR	PA451260	8856	0.685
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT376	0	0	9	9	resveratrol	CBP		55824;1387	0.685
NULL	Cardiovasc_Res_2011_Apr_1_90(1)_105-112.nxml.txt.nlp	21123217	SENT146	37	37	28	28	flunarizine	AMN	PA164776636	215;81693	0.685
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Jul_23_3(7)_e126.nxml.txt.nlp	25054314	SENT71	15	15	20	20	docetaxel	MRP2	PA449383	100130958;57626;1244	0.685
NULL	Iran_Red_Crescent_Med_J_2013_Jul_5_15(7)_554-559.nxml.txt.nlp	24396573	SENT201	11	11	6	6	pioglitazone	gamma	PA450970	9913	0.685
NULL	Int_J_Breast_Cancer_2012_Jan_24_2012_385978.nxml.txt.nlp	22461984	SENT13	17	17	19	19	tamoxifen	aromatase	PA451581	1588	0.685
NULL	Mol_Cells_2014_Sep_30_37(9)_664-671.nxml.txt.nlp	25234467	SENT205	6	6	10	10	cisplatin	miR-217	PA449014	406999	0.685
NULL	Oncol_Lett_2013_Sep_12_6(3)_860-864.nxml.txt.nlp	24137426	SENT65	19	19	22	22	ketoconazole	CYP3A4	PA450146	1576	0.685
NULL	Biomed_Opt_Express_2014_Jul_17_5(8)_2686-2696.nxml.txt.nlp	25136494	SENT103	30	30	38	38	streptomycin	CO2	PA451512	4513	0.685
NULL	Breast_Cancer_Res_Treat_2013_Jan_13_137(2)_471-482.nxml.txt.nlp	23239151	SENT195	19	19	28	28	paclitaxel	HER2	PA450761	2064	0.685
NULL	Clin_Microbiol_Infect_2014_Jun_21_20(6)_536-541.nxml.txt.nlp	24107197	SENT12	21	21	35	35	isoniazid	DST	PA450112	667	0.685
NULL	Biomed_Res_Int_2014_Jun_26_2014_161346.nxml.txt.nlp	25054130	SENT137	3	3	5	5	curcumin	p47phox	PA151958596	653361	0.685
NULL	Cell_Death_Dis_2014_Feb_13_5(2)_e1055.nxml.txt.nlp	24525731	SENT24	20	20	13	13	cisplatin	DDP	PA449014	1678	0.685
NULL	Br_J_Cancer_2006_Feb_13_94(3)_407-426.nxml.txt.nlp	16434996	SENT298	32	32	39	39	genistein	BRCA1	PA165109660	672	0.685
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT152	19	19	1	1	phenprocoumon	VKORC1	PA450921	79001	0.685
NULL	Mol_Cancer_2010_May_17_9_108.nxml.txt.nlp	20478051	SENT276	19	19	13	13	deferoxamine	PC-3	PA164746490	692094	0.685
NULL	Cell_Death_Dis_2013_Jul_11_4(7)_e719.nxml.txt.nlp	23846221	SENT72	22	22	20	20	cisplatin	TRAIL	PA449014	8743	0.685
NULL	Clin_Exp_Reprod_Med_2011_Sep_30_38(3)_119-125.nxml.txt.nlp	22384430	SENT74	15	15	24	24	thrombin	IL-8	PA451674	3576	0.685
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_321-328.nxml.txt.nlp	21372824	SENT178	39	39	16	16	fluvastatin	STZ	PA449688	6484	0.685
NULL	Emerg_Infect_Dis_2013_Jan_19(1)_133-136.nxml.txt.nlp	23260464	SENT49	23	23	9	9	imipenem	TOB	PA449968	10140	0.685
NULL	Cases_J_2009_Mar_10_2_6464.nxml.txt.nlp	20181162	SENT66	4	4	14	14	ribavirin	IFN	PA451241	3439	0.685
NULL	J_Oncol_2013_Apr_29_2013_854121.nxml.txt.nlp	23737784	SENT79	20	20	26	26	trastuzumab	BCS	PA451743	617	0.685
NULL	Oncotarget_2013_Nov_7_4(12)_2550-2566.nxml.txt.nlp	24334291	SENT207	5	5	36	36	dasatinib	p53	PA162372878	7157	0.685
NULL	Indian_J_Med_Res_2012_Sep_136(3)_391-403.nxml.txt.nlp	23041732	SENT186	9	9	19	19	erlotinib	HCC	PA134687924	84668	0.685
NULL	Breast_Cancer_Res_2008_Mar_29_10(2)_R28.nxml.txt.nlp	18373870	SENT136	7	7	18	18	estradiol	HSPC111	PA449503	51491	0.685
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT341	18	18	10	10	ranibizumab	VEGF-A	PA164746012	7422	0.685
NULL	Adv_Hematol_2010_Dec_2_2010_424786.nxml.txt.nlp	21188274	SENT22	9	9	15	15	vincristine	CHOP	PA451879	1649	0.685
NULL	Breast_Cancer_Res_2011_Jun_9_13(3)_R57.nxml.txt.nlp	21658222	SENT24	25	25	15	15	epirubicin	UGT1A9	PA449476	54600	0.685
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT198	9	9	6	6	doxorubicin	ABCB1	PA449412	5243	0.685
NULL	Basic_Clin_Neurosci_2014_Summer_5(3)_182-190.nxml.txt.nlp	25337378	SENT196	11	11	8	8	bupropion	mol	PA448687	90527	0.685
NULL	Food_Nutr_Res_2011_Jan_14_55_10_3402_fnr_v55i0_5455.nxml.txt.nlp	21249160	SENT108	15	15	22	22	spermine	mol	PA164781199	90527	0.685
NULL	J_Breast_Cancer_2013_Jun_28_16(2)_133-137.nxml.txt.nlp	23843843	SENT33	18	18	26	26	curcumin	p53	PA151958596	7157	0.685
NULL	J_Korean_Med_Sci_2010_Jun_24_25(6)_829-834.nxml.txt.nlp	20514301	SENT128	13	13	3	3	papain	IL-25	PA450778	64806;56005	0.685
NULL	Ann_Indian_Acad_Neurol_2009_Oct-Dec_12(4)_273-282.nxml.txt.nlp	20182575	SENT148	5	5	23	23	natalizumab	IFN	PA164747191	3439	0.685
NULL	Mol_Vis_2010_Sep_4_16_1823-1831.nxml.txt.nlp	21045919	SENT41	5	5	21	21	l-carnitine	OCTN1	PA450154	6583	0.685
NULL	Front_Oncol_2014_Oct_21_4_285.nxml.txt.nlp	25374842	SENT250	26	26	20	20	nutlin-3	p53		7157	0.685
NULL	Aging_(Albany_NY)_2012_Jul_22_4(7)_480-498.nxml.txt.nlp	22837425	SENT22	30	30	17	17	metformin	ADP	PA450395	23038	0.685
NULL	Int_J_Tryptophan_Res_2009_Mar_23_2_45-60.nxml.txt.nlp	20651948	SENT370	6	6	9	9	clomipramine	Gen	PA449048	348654	0.685
NULL	Curr_Cardiol_Rev_2012_Aug_8(3)_239-249.nxml.txt.nlp	22935021	SENT80	21	21	7	7	clopidogrel	P2Y12	PA449053	64805	0.685
NULL	Mol_Vis_2012_May_1_18_1115-1122.nxml.txt.nlp	22605923	SENT185	6	6	16	16	estradiol	IL-6	PA449503	3569	0.685
NULL	Indian_J_Pharmacol_2013_Sep-Oct_45(5)_458-463.nxml.txt.nlp	24130379	SENT157	33	33	9	9	carvedilol	TLR4	PA448817	7099	0.685
NULL	Exp_Diabetes_Res_2012_Oct_15_2012_465282.nxml.txt.nlp	23118742	SENT155	6	6	8	8	metformin	FGF21	PA450395	26291	0.685
NULL	Emerg_Infect_Dis_2012_Jun_18(6)_1019-1020.nxml.txt.nlp	22608263	SENT34	30	30	20	20	levofloxacin	TOB	PA450214	10140	0.685
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Mar_10_68(Pt_4)_o1037-o1038.nxml.txt.nlp	22589908	SENT80	0	0	24	24	triprolidine	mol	PA451797	90527	0.685
NULL	Biomed_Res_Int_2013_Dec_5_2013_642848.nxml.txt.nlp	24381940	SENT160	4	4	17	17	telmisartan	IL-6	PA451605	3569	0.685
NULL	Exp_Hematol_2014_Dec_42(12)_1053-1058_e1.nxml.txt.nlp	25127743	SENT7	15	15	25	25	potassium	KCNQ1	PA451047	3784	0.685
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT130	3	3	9	9	doxorubicin	SLK	PA449412	9748;2534	0.685
NULL	J_Korean_Med_Sci_2007_Sep_30_22(Suppl)_S109-S114.nxml.txt.nlp	17923735	SENT45	12	12	16	16	trypsin	VIII	PA451806	1351	0.685
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Nov_4_65(Pt_12)_o2997.nxml.txt.nlp	21578737	SENT3	18	18	1	1	piperazine	mol	PA450977	90527	0.685
NULL	Neural_Regen_Res_2014_Mar_15_9(6)_622-629.nxml.txt.nlp	25206865	SENT66	0	0	9	9	vasopressin	p38	PA451858	10598;1432;7965	0.685
NULL	Biologics_2013_May_29_7_131-138.nxml.txt.nlp	23807836	SENT168	8	8	5	5	ribavirin	IFN	PA451241	3439	0.685
NULL	J_Cell_Mol_Med_2014_Mar_22_18(3)_422-433.nxml.txt.nlp	24450475	SENT13	4	4	6	6	hyaluronan	CD44	PA165958431	960	0.685
NULL	Clin_Ophthalmol_2011_May_24_5_697-704.nxml.txt.nlp	21629577	SENT21	0	0	7	7	bevacizumab	San	PA130232992	80218	0.685
NULL	Aging_(Albany_NY)_2011_Apr_6_3(4)_444-449.nxml.txt.nlp	21483037	SENT71	3	3	6	6	resveratrol	SIRT1		23411	0.685
NULL	Endocrinol_Diabetes_Metab_Case_Rep_2014_Mar_1_2014_140001.nxml.txt.nlp	24683487	SENT50	17	17	6	6	octreotide	ACTH	PA450678	5443	0.685
NULL	Springerplus_2014_Sep_15_3_526.nxml.txt.nlp	25279317	SENT9	4	4	15	15	sugar	CD62L	PA451529	6402	0.685
NULL	Clin_Sci_(Lond)_2012_Oct_1_123(Pt_8)_473-486.nxml.txt.nlp	22757958	SENT146	6	6	18	18	glucosamine	p38	PA164747613	10598;1432;7965	0.685
NULL	Clin_Ophthalmol_2008_Mar_2(1)_159-166.nxml.txt.nlp	19668400	SENT49	5	5	11	11	bevacizumab	San	PA130232992	80218	0.685
NULL	Bioinformation_2012_Jan_6_8(1)_13-19.nxml.txt.nlp	22359429	SENT171	27	27	16	16	calcein	MRP1	PA132595336	4437	0.685
NULL	Front_Physiol_2013_May_15_4_103.nxml.txt.nlp	23720630	SENT590	0	0	2	2	simvastatin	PC3	PA451363	57332;7832;5122	0.685
NULL	Aging_(Albany_NY)_2009_Jun_3_1(6)_515-528.nxml.txt.nlp	20157535	SENT22	22	22	8	8	resveratrol	SIRT1		23411	0.685
NULL	Breast_Cancer_Res_2009_Jul_15_11(4)_207.nxml.txt.nlp	19664181	SENT172	36	36	22	22	trastuzumab	PTEN	PA451743	5728	0.685
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT374	5	5	3	3	pp2	PP1		5540;5464	0.685
NULL	J_Gen_Physiol_2012_Nov_140(5)_541-555.nxml.txt.nlp	23109716	SENT333	19	19	24	24	capsaicin	TRPV1	PA448776	7442	0.685
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT7	2	2	17	17	perifosine	DR4	PA165291471	8797	0.685
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_9_2013_456747.nxml.txt.nlp	23653662	SENT125	5	5	13	13	berberine	KDR	PA165860812	3791	0.685
NULL	J_Adv_Pract_Oncol_2012_Nov_1_Nov-Dec_3(6)_391-394.nxml.txt.nlp	25031970	SENT64	14	14	29	29	trastuzumab	HER2	PA451743	2064	0.685
NULL	Clin_Ophthalmol_2008_Jun_2(2)_355-368.nxml.txt.nlp	19668727	SENT213	10	10	19	19	nepafenac	PRK	PA165958407	1263	0.685
NULL	New_Microbes_New_Infect_2014_May_4_2(3)_58-63.nxml.txt.nlp	25356345	SENT100	34	34	20	20	colistin	GEM	PA164760862	2669	0.685
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT192	14	14	20	20	pertuzumab	Yes		7525	0.684
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Nov_4_9_31.nxml.txt.nlp	21050425	SENT90	22	22	32	32	erythromycin	Gen	PA449493	348654	0.684
NULL	Br_J_Cancer_2012_Oct_9_107(8)_1327-1336.nxml.txt.nlp	22990650	SENT109	22	22	16	16	carboplatin	FGF1	PA448803	2246	0.684
NULL	J_Korean_Med_Sci_2011_Dec_29_26(12)_1556-1562.nxml.txt.nlp	22147991	SENT32	27	27	32	32	vincristine	CHOP	PA451879	1649	0.684
NULL	Oncotarget_2014_Jul_25_5(21)_10460-10472.nxml.txt.nlp	25361005	SENT131	2	2	7	7	everolimus	AKT	PA164746311	207	0.684
NULL	J_Adv_Pharm_Technol_Res_2011_Jan-Mar_2(1)_51-55.nxml.txt.nlp	22171293	SENT102	4	4	13	13	metformin	mol	PA450395	90527	0.684
NULL	J_Exp_Bot_2011_Oct_4_62(14)_4787-4803.nxml.txt.nlp	21821598	SENT34	8	8	4	4	mannitol	M6PR	PA450320	4074	0.684
NULL	Clin_Ophthalmol_2014_Jun_24_8_1187-1198.nxml.txt.nlp	25028531	SENT19	15	15	18	18	ranibizumab	VEGF-A	PA164746012	7422	0.684
NULL	Br_J_Cancer_2011_Jun_7_104(12)_1848-1853.nxml.txt.nlp	21610704	SENT157	13	13	10	10	panitumumab	KRAS	PA162373091	3845	0.684
NULL	Int_J_Mol_Sci_2012_Apr_23_13(4)_5060-5073.nxml.txt.nlp	22606030	SENT55	17	17	38	38	artemisinin	ANOVA	PA165111696	4858	0.684
NULL	Eur_J_Appl_Physiol_2011_Feb_24_111(2)_275-283.nxml.txt.nlp	20865425	SENT156	15	15	30	30	glucose	APE	PA449773	55704;328	0.684
NULL	Diabetes_2009_Jul_14_58(7)_1509-1517.nxml.txt.nlp	19366864	SENT409	3	3	14	14	resveratrol	SIRT1		23411	0.684
NULL	Front_Oncol_2014_Mar_25_4_59.nxml.txt.nlp	24724053	SENT137	16	16	11	11	heparin	syndecan	PA449855	6382	0.684
NULL	J_Antimicrob_Chemother_2013_Mar_9_68(3)_697-707.nxml.txt.nlp	23143901	SENT152	11	11	23	23	oseltamivir	ZAN	PA450721	7455	0.684
NULL	Aging_(Albany_NY)_2009_Mar_31_1(4)_412-424.nxml.txt.nlp	20195491	SENT73	6	6	12	12	resveratrol	TXNIP		10628	0.684
NULL	Exp_Ther_Med_2014_Sep_20_8(3)_968-972.nxml.txt.nlp	25120631	SENT83	2	2	9	9	naringin	PF4	PA151958360	5196	0.684
NULL	Neural_Regen_Res_2013_Oct_25_8(30)_2800-2810.nxml.txt.nlp	25206601	SENT136	33	33	16	16	estradiol	CA1	PA449503	759	0.684
NULL	Oncogene_2014_Aug_28_33(35)_4407-4417.nxml.txt.nlp	24469038	SENT51	1	1	28	28	cisplatin	p53	PA449014	7157	0.684
NULL	Cell_Mol_Life_Sci_2012_Apr_22_69(8)_1353-1375.nxml.txt.nlp	22105709	SENT280	28	28	30	30	chlorpromazine	CPZ	PA448964	8532	0.684
NULL	Nat_Commun_2011_Jul_19_2_402.nxml.txt.nlp	21772273	SENT748	13	13	6	6	etoposide	CHK2	PA449552	11200	0.684
NULL	J_Cell_Biol_2004_Apr_12_165(1)_77-86.nxml.txt.nlp	15067018	SENT52	32	32	36	36	collagenase	MMP13	PA449107	4322	0.684
NULL	J_Mol_Signal_2010_Dec_13_5_20.nxml.txt.nlp	21144036	SENT227	17	17	25	25	rosiglitazone	TRG	PA451283	6965	0.684
NULL	Orphanet_J_Rare_Dis_2014_Nov_19_9(1)_155.nxml.txt.nlp	NULL	SENT68	34	34	4	4	l-glutamine	CD14	PA10090	929	0.684
NULL	Front_Comput_Neurosci_2014_Oct_17_8_133.nxml.txt.nlp	25368573	SENT177	5	5	8	8	ketamine	gamma	PA450144	9913	0.684
NULL	Mol_Cancer_2010_May_28_9_130.nxml.txt.nlp	20509890	SENT113	10	10	19	19	paclitaxel	TGFBI	PA450761	7045	0.684
NULL	Oncoimmunology_2012_Oct_1_1(7)_1004-1016.nxml.txt.nlp	23170249	SENT216	26	26	28	28	paclitaxel	HER-2	PA450761	2064	0.684
NULL	Mol_Cancer_2008_Jun_3_7_47.nxml.txt.nlp	18519000	SENT98	5	5	9	9	gefitinib	EGFR	PA131301952	1956	0.684
NULL	J_Cancer_2011_Mar_8_2_142-152.nxml.txt.nlp	21475719	SENT42	9	9	11	11	lipase	7-60	PA450239	11054	0.684
NULL	J_Cardiothorac_Surg_2013_May_13_8_127.nxml.txt.nlp	23668669	SENT23	37	37	27	27	oxycodone	EDA	PA450741	1896	0.684
NULL	Biomed_Res_Int_2014_Feb_10_2014_305610.nxml.txt.nlp	24683545	SENT131	14	14	16	16	chlorpromazine	CPZ	PA448964	8532	0.684
NULL	Front_Endocrinol_(Lausanne)_2014_Jan_16_5_1.nxml.txt.nlp	24474947	SENT163	39	39	43	43	estradiol	GPER	PA449503	2852	0.684
NULL	Arthritis_Res_Ther_2010_Jan_22_12(1)_R11.nxml.txt.nlp	20096109	SENT178	7	7	11	11	etanercept	IFN	PA449515	3439	0.684
NULL	J_Hematol_Oncol_2013_Nov_5_6_83.nxml.txt.nlp	24283248	SENT74	23	23	13	13	nutlin-3	CDKN1A		1026	0.684
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_17_2013_549174.nxml.txt.nlp	23843879	SENT185	0	0	19	19	resveratrol	IRE1		2081	0.684
NULL	Br_J_Cancer_2011_May_24_104(11)_1786-1790.nxml.txt.nlp	21559018	SENT108	17	17	24	24	cetuximab	EGFR	PA10040	1956	0.684
NULL	Br_J_Cancer_2012_May_22_106(11)_1742-1752.nxml.txt.nlp	22538973	SENT127	25	25	7	7	imatinib	IFN	PA10804	3439	0.684
NULL	Nanoscale_Res_Lett_2010_Sep_2_6(1)_24.nxml.txt.nlp	NULL	SENT62	12	12	4	4	copper	TEM	PA449114	64102	0.684
NULL	Acta_Pharmacol_Sin_2014_Aug_7_35(8)_1015-1022.nxml.txt.nlp	24998256	SENT197	5	5	2	2	ethanol	ALDH2	PA448073	217	0.684
NULL	Arthritis_Res_Ther_2007_Oct_9_9(5)_R104.nxml.txt.nlp	17925024	SENT147	9	9	14	14	glucosamine	JNK	PA164747613	5599	0.684
NULL	Br_J_Cancer_2004_Mar_22_90(6)_1285-1292.nxml.txt.nlp	15026814	SENT154	36	36	23	23	cisplatin	p53	PA449014	7157	0.684
NULL	Environ_Health_Perspect_2010_Jul_3_118(7)_936-942.nxml.txt.nlp	20199942	SENT158	26	26	15	15	arsenite	p53	PA452638	7157	0.684
NULL	Oncologist_2011_Jan_6_16(1)_5-24.nxml.txt.nlp	21212434	SENT195	10	10	12	12	thalidomide	IFN	PA451644	3439	0.684
NULL	Int_J_Breast_Cancer_2012_May_9_2012_415170.nxml.txt.nlp	22649737	SENT217	18	18	26	26	trastuzumab	HER2	PA451743	2064	0.684
NULL	JAKSTAT_2012_Apr_1_1(2)_83-89.nxml.txt.nlp	24058756	SENT97	4	4	10	10	losartan	IL-6	PA450268	3569	0.684
NULL	Open_Orthop_J_2008_Jul_14_2_115-120.nxml.txt.nlp	19478935	SENT32	0	0	2	2	amifostine	AMF	PA448365	2821	0.684
NULL	Front_Physiol_2010_Sep_9_1_21.nxml.txt.nlp	21423363	SENT320	26	26	2	2	pioglitazone	CD68	PA450970	968	0.684
NULL	Crit_Care_2007_Dec_13_11(6)_R129.nxml.txt.nlp	18078508	SENT113	30	30	12	12	vasopressin	ANOVA	PA451858	4858	0.684
NULL	Europace_2014_Aug_19_16(8)_1145-1153.nxml.txt.nlp	24843051	SENT182	17	17	20	20	heparin	ACT	PA449855	12;11332;9457;641455	0.684
NULL	Exp_Ther_Med_2015_Jan_18_9(1)_105-111.nxml.txt.nlp	25452783	SENT118	2	2	11	11	celecoxib	ABCG2	PA448871	9429	0.684
NULL	Oncotarget_2012_May_4_3(4)_371-394.nxml.txt.nlp	22564882	SENT234	12	12	7	7	imatinib	PI3K	PA10804	5290	0.684
NULL	Arthritis_Res_Ther_2008_Jan_7_10(1)_R1.nxml.txt.nlp	18179697	SENT52	9	9	14	14	cisplatin	HMGB1	PA449014	3146	0.684
NULL	Cardiovasc_Ther_2009_27(4)_259-274.nxml.txt.nlp	19604248	SENT50	1	1	5	5	ticagrelor	ADP	PA165374673	23038	0.684
NULL	Int_J_Biol_Sci_2011_Nov_7_8(1)_15-29.nxml.txt.nlp	22211101	SENT27	14	14	18	18	gemcitabine	BTC	PA449748	685	0.684
NULL	F1000Res_2013_Oct_8_2_173.nxml.txt.nlp	24555085	SENT227	29	29	38	38	hydrocortisone	BDP	PA449905	10620;152926	0.684
NULL	Clin_Exp_Otorhinolaryngol_2011_Dec_15_4(4)_177-183.nxml.txt.nlp	22232712	SENT110	9	9	4	4	doxycycline	p38	PA449415	10598;1432;7965	0.684
NULL	Eur_J_Pharm_Sci_2012_Jul_16_46(4)_244-258.nxml.txt.nlp	22085636	SENT352	8	8	24	24	pertuzumab	PTEN		5728	0.684
NULL	Br_J_Cancer_2011_Jun_7_104(12)_1805-1809.nxml.txt.nlp	21587260	SENT123	37	37	18	18	plerixafor	CD11b	PA165958410	3684	0.684
NULL	Cancers_(Basel)_2011_Mar_2_3(1)_971-981.nxml.txt.nlp	24212649	SENT470	10	10	1	1	heparin	CHRM3	PA449855	1131	0.684
NULL	Acta_Pharmacol_Sin_2012_May_4_33(5)_710-716.nxml.txt.nlp	22555373	SENT116	0	0	3	3	diazepam	DOM	PA449283	6663	0.684
NULL	Clin_Interv_Aging_2013_May_30_8_597-603.nxml.txt.nlp	23761968	SENT138	6	6	32	32	risedronate	CTX	PA451255	1593	0.684
NULL	Curr_Hepat_Rep_2010_May_21_9(2)_75-90.nxml.txt.nlp	20461127	SENT300	19	19	17	17	tenofovir	LAM	PA10204	7249;7248	0.684
NULL	J_Breast_Cancer_2011_Jun_18_14(2)_140-146.nxml.txt.nlp	21847410	SENT170	13	13	36	36	vinorelbine	HER2	PA451881	2064	0.684
NULL	J_Invest_Dermatol_2012_Sep_10_132(9)_2255-2262.nxml.txt.nlp	22572817	SENT217	19	19	11	11	forskolin	ASIP	PA146096022	434;56288	0.684
NULL	Oncogenesis_2012_Apr_2_1(4)_e5.nxml.txt.nlp	23552603	SENT288	0	0	7	7	celecoxib	p65	PA448871	5970	0.684
NULL	Front_Pharmacol_2014_Sep_17_5_212.nxml.txt.nlp	25278898	SENT41	17	17	21	21	escitalopram	P28	PA10074	9446;7802;9527	0.684
NULL	Front_Neuroeng_2012_Jan_12_4_20.nxml.txt.nlp	22319493	SENT21	31	31	16	16	nitrogen	CO2	PA450643	4513	0.684
NULL	Cardiovasc_Res_2011_Apr_1_90(1)_105-112.nxml.txt.nlp	21123217	SENT39	12	12	34	34	flunarizine	San	PA164776636	80218	0.684
NULL	Environ_Health_Perspect_2012_Jul_25_120(7)_984-989.nxml.txt.nlp	22763116	SENT289	7	7	13	13	caffeine	adiponectin	PA448710	9370	0.684
NULL	Exp_Diabetes_Res_2012_May_17_2012_137607.nxml.txt.nlp	22675339	SENT20	3	3	24	24	probucol	NAC	PA451107	22861	0.684
NULL	Br_J_Cancer_2013_Jun_25_108(12)_2464-2469.nxml.txt.nlp	23695016	SENT141	17	17	13	13	paclitaxel	NACT	PA450761	284111	0.684
NULL	BMB_Rep_2013_Sep_46(9)_448-453.nxml.txt.nlp	24064059	SENT75	6	6	3	3	dextran	CD83	PA449261	9308	0.684
NULL	Pharmaceuticals_(Basel)_2013_Aug_2_6(8)_915-928.nxml.txt.nlp	24276376	SENT209	18	18	22	22	aspirin	P2Y12	PA448497	64805	0.684
NULL	J_Immunol_Res_2014_Jul_13_2014_964069.nxml.txt.nlp	25126586	SENT116	9	9	23	23	imiquimod	IL-6	PA449972	3569	0.684
NULL	J_Int_Soc_Sports_Nutr_2014_Dec_14_11(1)_61.nxml.txt.nlp	NULL	SENT106	0	0	13	13	l-arginine	NOS2	PA448478	339345;4843	0.684
NULL	Protein_Cell_2014_Jun_19_5(6)_469-479.nxml.txt.nlp	24748116	SENT171	18	18	4	4	paclitaxel	EB1	PA450761	9167;22919;10982	0.684
NULL	Eur_J_Clin_Pharmacol_2007_Apr_21_63(4)_335-343.nxml.txt.nlp	17318526	SENT216	8	8	39	39	warfarin	VKORC1	PA451906	79001	0.684
NULL	Europace_2012_Dec_6_14(12)_1700-1707.nxml.txt.nlp	22772054	SENT88	8	8	33	33	heparin	ACT	PA449855	12;11332;9457;641455	0.684
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Apr_29_67(Pt_5)_o1256.nxml.txt.nlp	21754546	SENT68	23	23	9	9	acetone	mol	PA448025	90527	0.684
NULL	Breast_Cancer_Res_2011_May_20_13(3)_106.nxml.txt.nlp	21639949	SENT29	6	6	26	26	fulvestrant	AKT	PA164747170	207	0.684
NULL	Arthritis_Res_Ther_2013_Nov_1_15(6)_R176.nxml.txt.nlp	24456929	SENT274	21	21	8	8	pp2	PP2		4888	0.684
NULL	Oncol_Lett_2014_Nov_10_8(5)_2333-2339.nxml.txt.nlp	25295120	SENT167	11	11	0	0	sorafenib	ADM	PA7000	133	0.684
NULL	Asian_J_Transfus_Sci_2014_8(Suppl1)_S26-S87.nxml.txt.nlp	NULL	SENT2425	7	7	4	4	chloroquine	VIII	PA448948	1351	0.684
NULL	Nucleic_Acids_Res_2012_Apr_16_40(8)_3511-3523.nxml.txt.nlp	22180533	SENT153	9	9	12	12	doxycycline	E2F7	PA449415	144455	0.684
NULL	Hum_Mol_Genet_2013_Nov_15_22(22)_4616-4626.nxml.txt.nlp	23814041	SENT49	30	30	36	36	doxycycline	neuroserpin	PA449415	5274	0.684
NULL	Acta_Pharmacol_Sin_2012_Jan_21_33(1)_41-48.nxml.txt.nlp	22101169	SENT52	18	18	35	35	heparin	CO2	PA449855	4513	0.684
NULL	Arthritis_Res_Ther_2003_Apr_28_5(4)_R186-R192.nxml.txt.nlp	12823853	SENT100	18	18	13	13	genistein	IL-17	PA165109660	3605	0.684
NULL	Nat_Genet_2013_Nov_6_45(11)_1345-1352.nxml.txt.nlp	24097064	SENT72	5	5	21	21	lipase	LPL	PA450239	4023	0.684
NULL	Front_Pharmacol_2014_May_27_5_116.nxml.txt.nlp	24904419	SENT1104	16	16	7	7	methamphetamine	mGlu5	PA450403	2915	0.684
NULL	Oncotarget_2014_Nov_3_5(20)_10127-10139.nxml.txt.nlp	25333256	SENT147	23	23	9	9	vemurafenib	TRIM16	PA165946873	10626	0.684
NULL	Cancer_Med_2014_Aug_4_3(4)_865-877.nxml.txt.nlp	24898306	SENT340	10	10	7	7	genistein	PC3	PA165109660	57332;7832;5122	0.684
NULL	J_Exp_Clin_Cancer_Res_2009_Feb_15_28(1)_19.nxml.txt.nlp	19216799	SENT137	9	9	3	3	doxorubicin	AEG-1	PA449412	92140	0.684
NULL	Cells_2014_May_23_3(2)_500-516.nxml.txt.nlp	24861976	SENT328	8	8	1	1	menthol	TRP	PA164776605	7306	0.684
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT49	34	34	3	3	diclofenac	CYP3A	PA449293	1574	0.684
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_3_2014_473213.nxml.txt.nlp	25538791	SENT122	15	15	23	23	fexofenadine	MDR1	PA449621	5243	0.684
NULL	J_Cell_Biol_1997_Jul_28_138(2)_323-330.nxml.txt.nlp	9230074	SENT93	2	2	4	4	thrombin	ADP	PA451674	23038	0.684
NULL	Int_J_Gen_Med_2012_Nov_9_5_935-942.nxml.txt.nlp	23204857	SENT81	22	22	12	12	pentobarbital	AIDA	PA450859	64853	0.684
NULL	ScientificWorldJournal_2014_Mar_12_2014_731462.nxml.txt.nlp	24715817	SENT168	17	17	7	7	diclofenac	IL-6	PA449293	3569	0.684
NULL	Indian_J_Endocrinol_Metab_2012_Dec_16(Suppl_3)_S529-S531.nxml.txt.nlp	23565485	SENT30	3	3	5	5	metformin	AMPK	PA450395	5563	0.684
NULL	Front_Immunol_2012_May_4_3_98.nxml.txt.nlp	22566974	SENT29	7	7	16	16	cyclophosphamide	CHOP	PA449165	1649	0.684
NULL	Clinics_(Sao_Paulo)_2014_Aug_69(8)_505-508.nxml.txt.nlp	25141107	SENT29	21	21	24	24	hyaluronan	LYVE-1	PA165958431	10894	0.684
NULL	J_Clin_Biochem_Nutr_2010_Sep_3_47(2)_138-147.nxml.txt.nlp	20838569	SENT18	0	0	7	7	rofecoxib	COX	PA451268	1351	0.684
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT85	3	3	14	14	curcumin	DR5	PA151958596	8795	0.684
NULL	Biol_Open_2013_Apr_8_2(5)_499-504.nxml.txt.nlp	23789099	SENT241	7	7	23	23	paraformaldehyde	LC3	PA450790	84557	0.684
NULL	Mol_Brain_2013_Jan_16_6_4.nxml.txt.nlp	23324492	SENT185	11	11	14	14	tamoxifen	flower	PA451581	11094	0.684
NULL	Clin_Epigenetics_2011_Feb_8_2(1)_55-61.nxml.txt.nlp	22704269	SENT72	12	12	8	8	decitabine	DAC	PA164749631	13	0.684
NULL	Br_J_Pharmacol_2014_Sep_28_171(18)_4255-4272.nxml.txt.nlp	24846338	SENT22	23	23	6	6	duloxetine	5-HT1A	PA10066	3350	0.684
NULL	Int_J_Mol_Sci_2014_Nov_25_15(12)_21703-21722.nxml.txt.nlp	25429431	SENT157	17	17	23	23	docetaxel	CEA	PA449383	5670;1087	0.684
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1137-1144.nxml.txt.nlp	20234366	SENT144	14	14	16	16	cetuximab	KRAS	PA10040	3845	0.684
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT195	2	2	25	25	metformin	HIP	PA450395	6767;6159;64399;5068	0.684
NULL	Case_Rep_Rheumatol_2012_Dec_24_2012_270315.nxml.txt.nlp	23424706	SENT50	14	14	24	24	tocilizumab	IL-8	PA165292659	3576	0.684
NULL	Evid_Based_Complement_Alternat_Med_2011_Jan_12_2011_690518.nxml.txt.nlp	19687188	SENT172	11	11	13	13	ampicillin	APCL	PA448419	10297	0.684
NULL	Front_Immunol_2013_Mar_27_4_76.nxml.txt.nlp	23543707	SENT943	0	0	11	11	rituximab	CD16	PA451261	2215;2214	0.684
NULL	Acta_Pharmacol_Sin_2009_Jul_3_30(7)_889-898.nxml.txt.nlp	19574994	SENT261	14	14	18	18	pp2	EGFR		1956	0.684
NULL	Diabetes_Care_2011_Mar_17_34(3)_782-784.nxml.txt.nlp	21357366	SENT32	30	30	22	22	aspirin	ADA	PA448497	100	0.684
NULL	Breast_Cancer_Res_Treat_2013_Apr_12_138(2)_427-435.nxml.txt.nlp	23479422	SENT26	30	30	17	17	capecitabine	HER2	PA448771	2064	0.684
NULL	Br_J_Cancer_2011_May_10_104(10)_1558-1563.nxml.txt.nlp	21522148	SENT116	18	18	2	2	tamoxifen	ATAC	PA451581	6375	0.684
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_May_14_65(Pt_6)_o1257.nxml.txt.nlp	21583122	SENT58	15	15	6	6	ethanol	mol	PA448073	90527	0.684
NULL	Breast_Cancer_Res_2003_Oct_9_5(6)_309-312.nxml.txt.nlp	14580248	SENT66	10	10	14	14	tamoxifen	BCS	PA451581	617	0.684
NULL	Diabetes_2008_Sep_57(9)_2470-2479.nxml.txt.nlp	18511847	SENT12	12	12	1	1	pioglitazone	adiponectin	PA450970	9370	0.684
NULL	Front_Immunol_2013_Nov_7_4_360.nxml.txt.nlp	24223576	SENT168	0	0	11	11	imiquimod	CCR7	PA449972	1236	0.684
NULL	Ann_Clin_Microbiol_Antimicrob_2014_Jan_6_13_2.nxml.txt.nlp	24393536	SENT42	28	28	14	14	ceftazidime	TOB	PA448861	10140	0.684
NULL	J_Cancer_Prev_2013_Sep_18(3)_227-234.nxml.txt.nlp	25337550	SENT99	2	2	19	19	decitabine	p16	PA164749631	1029	0.684
NULL	Br_J_Ophthalmol_2008_Sep_22_92(9)_1275-1282.nxml.txt.nlp	18723745	SENT56	22	22	42	42	tafluprost	BAK	PA165958432	578	0.684
NULL	Toxins_(Basel)_2010_Mar_31_2(4)_517-551.nxml.txt.nlp	22069598	SENT131	0	0	11	11	curcumin	STAT3	PA151958596	6774	0.684
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT37	38	38	40	40	cisplatin	MVP	PA449014	9961	0.684
NULL	Cases_J_2009_Jul_30_2_7134.nxml.txt.nlp	19829918	SENT69	13	13	4	4	ropinirole	LCE	PA164749035	79071	0.684
NULL	Pain_2011_Aug_152(8)_1899-1908.nxml.txt.nlp	21600693	SENT492	11	11	22	22	capsaicin	ADP	PA448776	23038	0.684
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_May_24_70(Pt_6)_o713.nxml.txt.nlp	24940283	SENT75	0	0	18	18	benzaldehyde	mol	PA448571	90527	0.684
NULL	Onco_Targets_Ther_2014_Mar_20_7_447-456.nxml.txt.nlp	24672247	SENT151	17	17	15	15	paclitaxel	CLU	PA450761	1191	0.684
NULL	Sci_Rep_2014_Dec_12_4_7467.nxml.txt.nlp	25502280	SENT56	20	20	3	3	taurine	spatial	PA451590	219793	0.684
NULL	Mol_Cancer_2012_Jul_12_11_45.nxml.txt.nlp	22788833	SENT138	9	9	20	20	cisplatin	EGFR	PA449014	1956	0.684
NULL	J_Hematol_Oncol_2013_Nov_5_6_83.nxml.txt.nlp	24283248	SENT33	17	17	23	23	nutlin-3	TP53		7157	0.684
NULL	Int_J_Biol_Sci_2014_Sep_21_10(10)_1108-1115.nxml.txt.nlp	25332685	SENT143	7	7	9	9	dexmedetomidine	DMT	PA449256	2039	0.684
NULL	J_Antimicrob_Chemother_2009_Nov_18_64(5)_910-928.nxml.txt.nlp	19767318	SENT111	40	40	8	8	efavirenz	CD4	PA449441	920	0.684
NULL	Cancer_Cell_Int_2010_Sep_9_10_32.nxml.txt.nlp	20828393	SENT149	14	14	11	11	cisplatin	ATF3	PA449014	467	0.684
NULL	Cells_2012_Aug_3_1(3)_492-519.nxml.txt.nlp	24710487	SENT200	21	21	2	2	dextran	PTPN2	PA449261	5771	0.684
NULL	Ann_Lab_Med_2012_Jul_20_32(4)_264-269.nxml.txt.nlp	22779067	SENT117	10	10	6	6	rifampin	DST	PA451250	667	0.684
NULL	Breast_Cancer_Res_2010_Sep_29_12(5)_209.nxml.txt.nlp	21067536	SENT255	0	0	7	7	erlotinib	San	PA134687924	80218	0.684
NULL	J_Cell_Biol_2000_Feb_21_148(4)_811-824.nxml.txt.nlp	10684261	SENT42	31	31	16	16	thrombin	EGF	PA451674	1950	0.684
NULL	Front_Genet_2014_Oct_29_5_366.nxml.txt.nlp	25400656	SENT401	4	4	12	12	camptothecin	WRN	PA153590860	7486	0.684
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_May_31_70(Pt_6)_o733-o734.nxml.txt.nlp	24940299	SENT80	14	14	28	28	ethanol	mol	PA448073	90527	0.684
NULL	Indian_J_Urol_2009_Oct-Dec_25(4)_427-436.nxml.txt.nlp	19955664	SENT84	7	7	12	12	sunitinib	IFN	PA162372840	3439	0.684
NULL	J_Adv_Pharm_Technol_Res_2014_Oct-Dec_5(4)_185-190.nxml.txt.nlp	25364697	SENT139	4	4	14	14	propranolol	MDR1	PA451145	5243	0.684
NULL	Cell_Death_Dis_2014_Jul_10_5(7)_e1321.nxml.txt.nlp	25010987	SENT313	3	3	0	0	staurosporine	HuR	PA165109623	1994	0.684
NULL	Br_J_Cancer_2012_Jan_3_106(1)_107-115.nxml.txt.nlp	22116303	SENT214	8	8	14	14	vorinostat	AKT	PA164748224	207	0.684
NULL	EPMA_J_2010_Mar_1_1(1)_73-77.nxml.txt.nlp	23199042	SENT61	5	5	13	13	rosiglitazone	gamma	PA451283	9913	0.684
NULL	Dermatoendocrinol_2012_Jul_1_4(3)_253-258.nxml.txt.nlp	23467280	SENT149	29	29	35	35	hyaluronan	p38	PA165958431	10598;1432;7965	0.684
NULL	Int_J_Med_Chem_2012_Sep_25_2012_196921.nxml.txt.nlp	25374683	SENT150	32	32	40	40	l-glutamine	FBS	PA10090	64319;26269	0.684
NULL	Arthritis_Res_Ther_2009_Nov_13_11(6)_R172.nxml.txt.nlp	19912653	SENT31	6	6	13	13	simvastatin	IVD	PA451363	3712	0.684
NULL	BMJ_Open_2013_Oct_14_3(10)_e003912.nxml.txt.nlp	24127058	SENT52	5	5	12	12	linezolid	HAP	PA450233	5915;10313	0.684
NULL	Breast_Cancer_Res_2010_Oct_14_12(5)_R84.nxml.txt.nlp	20946630	SENT269	22	22	12	12	choline	SLC5A7	PA448976	60482	0.684
NULL	Mucosal_Immunol_2012_May_8_5(3)_288-298.nxml.txt.nlp	22318495	SENT5	6	6	15	15	dextran	NLRC4	PA449261	58484	0.684
NULL	Gut_Liver_2012_Oct_18_6(4)_464-470.nxml.txt.nlp	23170151	SENT136	23	23	29	29	propofol	ESD	PA451141	2098	0.684
NULL	Nat_Biotechnol_2013_Jan_16_31(1)_63-70.nxml.txt.nlp	23242163	SENT242	7	7	5	5	marimastat	DDC	PA164748329	1644	0.684
NULL	J_Oncol_2009_Mar_24_2009_491985.nxml.txt.nlp	19325924	SENT102	13	13	18	18	genistein	CXCL12	PA165109660	6387	0.684
NULL	Breast_Cancer_(Auckl)_2012_Mar_7_6_67-77.nxml.txt.nlp	22438669	SENT48	3	3	1	1	trastuzumab	HER2	PA451743	2064	0.684
NULL	Br_J_Cancer_2012_Jan_17_106(2)_284-289.nxml.txt.nlp	22215065	SENT126	22	22	24	24	atrasentan	IFN	PA143414738	3439	0.684
NULL	Exp_Diabetes_Res_2012_Sep_20_2012_936518.nxml.txt.nlp	23049542	SENT172	10	10	13	13	glucose	TRPV4	PA449773	59341	0.684
NULL	Mol_Med_Rep_2015_Feb_5_11(2)_805-814.nxml.txt.nlp	25373883	SENT222	12	12	3	3	colchicine	APE	PA449092	55704;328	0.684
NULL	J_Neuroinflammation_2011_Feb_4_8_10.nxml.txt.nlp	21294877	SENT22	30	30	9	9	capsaicin	TAC1	PA448776	6863	0.684
NULL	Biofactors_2014_May_6_40(3)_277-283.nxml.txt.nlp	24353111	SENT78	14	14	27	27	choline	BHMT	PA448976	635	0.684
NULL	Pharmaceuticals_(Basel)_2014_Sep_4_7(9)_913-942.nxml.txt.nlp	25192192	SENT303	3	3	20	20	resveratrol	XIAP		331	0.684
NULL	Cancer_Immunol_Immunother_2012_Jul_23_61(7)_1101-1111.nxml.txt.nlp	22193989	SENT185	0	0	3	3	oxaliplatin	STAT1	PA131285527	6772	0.684
NULL	Cell_Death_Dis_2014_Jul_17_5(7)_e1333.nxml.txt.nlp	25032856	SENT34	18	18	28	28	candesartan	EAAC1	PA448765	6505	0.684
NULL	Asia_Pac_Allergy_2014_Jul_29_4(3)_156-163.nxml.txt.nlp	25097851	SENT16	17	17	19	19	ethambutol	EMB	PA164784021	133418	0.684
NULL	Oncotarget_2014_Dec_4_5(22)_11365-11380.nxml.txt.nlp	25426548	SENT138	19	19	28	28	nutlin-3	p53		7157	0.684
NULL	Mol_Cancer_2010_Dec_20_9_316.nxml.txt.nlp	21172016	SENT163	22	22	42	42	heparin	CCL21	PA449855	6366	0.684
NULL	J_Biomed_Biotechnol_2010_Sep_19_2010_518743.nxml.txt.nlp	20886007	SENT327	10	10	8	8	nadh	CO2	PA164755085	4513	0.684
NULL	J_Cardiovasc_Med_(Hagerstown)_2014_Dec_7_15(12)_873-879.nxml.txt.nlp	25304034	SENT124	10	10	4	4	warfarin	TTR	PA451906	7276	0.684
NULL	Clin_Ophthalmol_2008_Mar_2(1)_1-14.nxml.txt.nlp	19668384	SENT31	0	0	8	8	ranibizumab	San	PA164746012	80218	0.684
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1692-1698.nxml.txt.nlp	19861963	SENT72	33	33	46	46	l-glutamine	CO2	PA10090	4513	0.684
NULL	Br_J_Cancer_2014_Nov_25_111(11)_2091-2102.nxml.txt.nlp	25349971	SENT245	34	34	28	28	imatinib	PTPN18	PA10804	26469	0.684
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT294	26	26	28	28	metformin	HIF-1	PA450395	29072	0.684
NULL	Mol_Biol_Int_2011_Jun_8_2011_571242.nxml.txt.nlp	22091408	SENT379	12	12	8	8	lovastatin	MRP1	PA450272	4437	0.684
NULL	BMB_Rep_2014_Apr_47(4)_221-226.nxml.txt.nlp	24286312	SENT7	7	7	24	24	nutlin-3	TP53		7157	0.684
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1224-1233.nxml.txt.nlp	22353810	SENT295	12	12	20	20	doxorubicin	MRP-1	PA449412	928	0.684
NULL	Oncotarget_2014_Sep_3_5(19)_9362-9381.nxml.txt.nlp	25313139	SENT127	7	7	18	18	orlistat	SREBP2	PA164776864	6721	0.684
NULL	Evid_Based_Complement_Alternat_Med_2011_Aug_11_2011_657056.nxml.txt.nlp	21876711	SENT8	3	3	6	6	ethanol	p38	PA448073	10598;1432;7965	0.684
NULL	Cell_Biochem_Biophys_2013_May_24_66(1)_53-63.nxml.txt.nlp	22918821	SENT22	2	2	8	8	lubiprostone	ClC-2	PA164777012	1181	0.684
NULL	Mol_Biol_Cell_2014_Mar_15_25(6)_828-840.nxml.txt.nlp	24478456	SENT69	3	3	21	21	staurosporine	LIMK1	PA165109623	3984	0.684
NULL	Cell_Tissue_Res_2014_Apr_1_356(2)_333-340.nxml.txt.nlp	24687306	SENT55	18	18	8	8	collagenase	DPPIV	PA449107	2191;1803	0.684
NULL	Eur_J_Pharmacol_2014_Apr_15_729(100)_75-85.nxml.txt.nlp	24534492	SENT36	19	19	7	7	fluorescein	CCR4	PA164746009	25819;57472;1233	0.684
NULL	Enzyme_Res_2009_Nov_1_2010_165878.nxml.txt.nlp	21048860	SENT5	16	16	18	18	l-methionine	Met	PA450423	79811	0.684
NULL	Br_J_Cancer_2013_Mar_19_108(5)_1052-1060.nxml.txt.nlp	23422754	SENT181	18	18	7	7	bevacizumab	VEGF-A	PA130232992	7422	0.684
NULL	Diabetes_2013_Mar_14_62(3)_789-800.nxml.txt.nlp	22966074	SENT12	6	6	21	21	forskolin	AMPK	PA146096022	5563	0.684
NULL	J_Biol_Chem_2013_May_3_288(18)_12459-12468.nxml.txt.nlp	23508951	SENT398	15	15	18	18	pimozide	CA1	PA450965	759	0.684
NULL	Evid_Based_Complement_Alternat_Med_2014_Sep_11_2014_895272.nxml.txt.nlp	25295069	SENT201	4	4	6	6	curcumin	AMPK	PA151958596	5563	0.684
NULL	J_Gen_Physiol_2012_May_139(5)_321-331.nxml.txt.nlp	22547663	SENT222	5	5	44	44	calcein	PPX	PA132595336	5531	0.684
NULL	ScientificWorldJournal_2014_Mar_24_2014_694326.nxml.txt.nlp	24782665	SENT126	19	19	9	9	metformin	FDG	PA450395	23583	0.684
NULL	Exp_Cell_Res_2011_Apr_15_317(7)_1028-1039.nxml.txt.nlp	21237154	SENT11	6	6	4	4	staurosporine	TRAIL	PA165109623	8743	0.684
NULL	Drugs_R_D_2014_Sep_28_14(3)_159-164.nxml.txt.nlp	24973042	SENT32	26	26	19	19	warfarin	CYP2C9	PA451906	1559	0.684
NULL	Int_J_Mol_Sci_2014_Sep_11_15(9)_16043-16056.nxml.txt.nlp	25216337	SENT719	3	3	7	7	estradiol	IL-2	PA449503	3558	0.684
NULL	J_Gen_Physiol_2009_Sep_134(3)_243-258.nxml.txt.nlp	19720962	SENT728	7	7	10	10	capsaicin	TRPV1	PA448776	7442	0.684
NULL	J_Vet_Med_Sci_2014_Feb_8_76(2)_173-182.nxml.txt.nlp	24107430	SENT14	27	27	33	33	yohimbine	AVP	PA451946	114548;551	0.684
NULL	Exp_Hematol_Oncol_2014_Dec_17_3(1)_30.nxml.txt.nlp	NULL	SENT90	5	5	14	14	rivaroxaban	THP1	PA165958360	2736	0.684
NULL	Front_Physiol_2011_Jun_14_2_26.nxml.txt.nlp	21716655	SENT224	39	39	28	28	lipase	NEFA	PA450239	4925	0.684
NULL	Mol_Cancer_2007_Oct_11_6_63.nxml.txt.nlp	17931419	SENT113	26	26	22	22	cetuximab	HIF-1	PA10040	29072	0.684
NULL	Cell_Host_Microbe_2014_Sep_10_16(3)_291-303.nxml.txt.nlp	25211072	SENT86	3	3	9	9	genistein	PP2	PA165109660	4888	0.684
NULL	Br_J_Cancer_2004_May_17_90(10)_2032-2041.nxml.txt.nlp	15138490	SENT158	24	24	13	13	trastuzumab	HER-2	PA451743	2064	0.684
NULL	Diabetes_2013_May_16_62(5)_1464-1477.nxml.txt.nlp	23349479	SENT24	14	14	16	16	lipase	ATGL	PA450239	57104	0.684
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT277	28	28	9	9	neratinib	EGFR	PA165291472	1956	0.684
NULL	Diabetes_Metab_J_2013_Aug_14_37(4)_240-248.nxml.txt.nlp	23991401	SENT90	5	5	23	23	ezetimibe	NPC1L1	PA10816	29881	0.684
NULL	Eur_J_Med_Res_2009_Dec_7_14(Suppl_4)_32-37.nxml.txt.nlp	20156721	SENT100	9	9	1	1	ketanserin	ANOVA	PA131053734	4858	0.684
NULL	Mol_Cancer_2010_Apr_12_9_75.nxml.txt.nlp	20385023	SENT309	34	34	32	32	trastuzumab	PTEN	PA451743	5728	0.684
NULL	Breast_Cancer_Res_Treat_2014_Feb_23_144(2)_233-239.nxml.txt.nlp	24562824	SENT218	26	26	32	32	trastuzumab	HER2	PA451743	2064	0.684
NULL	Atten_Defic_Hyperact_Disord_2010_Dec_30_2(4)_213-220.nxml.txt.nlp	21258431	SENT19	39	39	41	41	atomoxetine	ATX	PA134688071	5168;23049	0.684
NULL	Oncotarget_2014_Jul_25_5(21)_10460-10472.nxml.txt.nlp	25361005	SENT134	15	15	9	9	everolimus	AKT	PA164746311	207	0.684
NULL	Front_Physiol_2011_Jul_19_2_40.nxml.txt.nlp	21811470	SENT170	5	5	21	21	candesartan	RVR	PA448765	9975	0.684
NULL	Drug_Des_Devel_Ther_2014_Sep_23_8_1527-1538.nxml.txt.nlp	25284985	SENT204	36	36	34	34	celecoxib	IFN	PA448871	3439	0.684
NULL	Front_Oncol_2014_Sep_29_4_256.nxml.txt.nlp	25325013	SENT162	16	16	33	33	afatinib	EGFR	PA165981154	1956	0.684
NULL	Exp_Hematol_Oncol_2013_Aug_8_2_21.nxml.txt.nlp	23927414	SENT95	24	24	6	6	enoxaparin	HARE	PA449463	55576	0.684
NULL	J_Korean_Med_Sci_2011_Jul_20_26(7)_945-950.nxml.txt.nlp	21738350	SENT36	1	1	16	16	heparin	ACT	PA449855	12;11332;9457;641455	0.684
NULL	Nat_Commun_2013_Oct_1_4_2516.nxml.txt.nlp	24084631	SENT68	2	2	22	22	lisinopril	AT1	PA450242	9197;185	0.684
NULL	Eur_J_Clin_Pharmacol_2014_Mar_22_70(6)_685-693.nxml.txt.nlp	24658827	SENT239	14	14	8	8	tacrolimus	CYP3A4	PA451578	1576	0.684
NULL	Cancers_(Basel)_2010_Jan_14_2(1)_1-19.nxml.txt.nlp	24281029	SENT373	11	11	28	28	bevacizumab	San	PA130232992	80218	0.684
NULL	Sensors_(Basel)_2010_Mar_25_10(4)_2626-2637.nxml.txt.nlp	22319264	SENT129	24	24	22	22	ethanol	ADP	PA448073	23038	0.684
NULL	Aging_(Albany_NY)_2010_Dec_20_2(12)_959-968.nxml.txt.nlp	21191146	SENT90	0	0	19	19	cisplatin	Rpn13	PA449014	11047	0.684
NULL	Case_Rep_Rheumatol_2012_Dec_24_2012_270315.nxml.txt.nlp	23424706	SENT86	15	15	25	25	tocilizumab	IL-8	PA165292659	3576	0.684
NULL	J_Cell_Mol_Med_2014_Aug_1_18(8)_1509-1518.nxml.txt.nlp	24981391	SENT51	10	10	19	19	collagenase	F10	PA449107	2159	0.684
NULL	Virol_J_2009_Jun_3_6_70.nxml.txt.nlp	19493343	SENT244	13	13	10	10	ribavirin	IFN	PA451241	3439	0.684
NULL	J_Cancer_Prev_2013_Jun_18(2)_186-191.nxml.txt.nlp	25337545	SENT71	24	24	29	29	curcumin	STAT3	PA151958596	6774	0.684
NULL	Front_Neural_Circuits_2013_Oct_2_7_155.nxml.txt.nlp	24106462	SENT192	15	15	18	18	apomorphine	gamma	PA164781163	9913	0.684
NULL	Core_Evid_2010_Oct_21_5_61-76.nxml.txt.nlp	21042543	SENT56	15	15	31	31	leucovorin	EGFR	PA450198	1956	0.684
NULL	Korean_J_Radiol_2010_Feb_22_Mar-Apr_11(2)_234-238.nxml.txt.nlp	20191072	SENT62	22	22	33	33	vincristine	CHOP	PA451879	1649	0.684
NULL	Oncotarget_2012_May_18_3(5)_525-534.nxml.txt.nlp	22619113	SENT82	15	15	34	34	fludarabine	AKT	PA449655	207	0.684
NULL	Cell_Death_Dis_2010_Sep_23_1(9)_e78.nxml.txt.nlp	21364680	SENT19	8	8	12	12	cisplatin	P31	PA449014	529	0.684
NULL	Oncol_Lett_2015_Feb_3_9(2)_757-761.nxml.txt.nlp	25621047	SENT12	13	13	20	20	olaparib	RAD51		5888	0.684
NULL	Braz_J_Med_Biol_Res_2012_Apr_27_45(7)_637-643.nxml.txt.nlp	22527128	SENT49	15	15	22	22	oxacillin	VAN	PA450725	10318	0.684
NULL	Int_Semin_Surg_Oncol_2007_Feb_14_4_5.nxml.txt.nlp	17394628	SENT176	9	9	11	11	cisplatin	PMS2	PA449014	5395	0.684
NULL	Cell_Death_Dis_2014_Jul_10_5(7)_e1318.nxml.txt.nlp	25010984	SENT41	14	14	23	23	nutlin-3	p53		7157	0.684
NULL	Aging_(Albany_NY)_2011_Apr_6_3(4)_444-449.nxml.txt.nlp	21483037	SENT58	10	10	13	13	resveratrol	SIRT1		23411	0.684
NULL	J_Antimicrob_Chemother_2010_Mar_18_65(3)_390-398.nxml.txt.nlp	20022938	SENT13	14	14	26	26	artemisinin	ACT	PA165111696	12;11332;9457;641455	0.684
NULL	Oncotarget_2014_Feb_25_5(5)_1304-1314.nxml.txt.nlp	24675421	SENT154	7	7	10	10	cisplatin	JNK	PA449014	5599	0.684
NULL	Arthritis_Res_Ther_2010_Oct_28_12(5)_219.nxml.txt.nlp	21062511	SENT144	6	6	13	13	infliximab	IFN	PA452639	3439	0.684
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT282	18	18	20	20	nutlin-3	DR5		8795	0.684
NULL	Cell_Death_Dis_2014_Jan_16_5(1)_e1000.nxml.txt.nlp	24434508	SENT86	2	2	25	25	bortezomib	p53	PA10252	7157	0.684
NULL	Arthritis_Res_Ther_2009_Aug_17_11(4)_R123.nxml.txt.nlp	19686595	SENT245	44	44	11	11	rituximab	CD38	PA451261	952	0.684
NULL	Cancer_Med_2014_Oct_2_3(5)_1385-1395.nxml.txt.nlp	24890702	SENT116	18	18	0	0	oxaliplatin	EGFR	PA131285527	1956	0.684
NULL	Emerg_Infect_Dis_2011_Mar_17(3)_510-513.nxml.txt.nlp	21392446	SENT53	10	10	16	16	isoniazid	EMB	PA450112	133418	0.684
NULL	J_Physiol_2009_Feb_15_587(Pt_4)_731-744.nxml.txt.nlp	19074966	SENT170	13	13	8	8	taurine	PAT1	PA451590	10513;206358	0.684
NULL	J_Immunotoxicol_2013_Jan_11_10(1)_75-82.nxml.txt.nlp	22967038	SENT101	10	10	27	27	rituximab	IFN	PA451261	3439	0.683
NULL	Mol_Cancer_2007_Oct_25_6_67.nxml.txt.nlp	17958915	SENT162	14	14	20	20	imatinib	GM-CSF	PA10804	1437	0.683
NULL	Nucleic_Acids_Res_2012_Jan_9_40(1)_181-195.nxml.txt.nlp	21908405	SENT359	18	18	11	11	camptothecin	MLH1	PA153590860	4292	0.683
NULL	Int_J_Mol_Sci_2014_Sep_5_15(9)_15754-15765.nxml.txt.nlp	25198898	SENT69	6	6	19	19	curcumin	JNK	PA151958596	5599	0.683
NULL	J_Oncol_2012_Feb_6_2012_737981.nxml.txt.nlp	22481932	SENT83	8	8	37	37	cisplatin	MUC16	PA449014	94025	0.683
NULL	Br_J_Cancer_1997_76(10)_1322-1327.nxml.txt.nlp	9374378	SENT5	17	17	10	10	cisplatin	p53	PA449014	7157	0.683
NULL	Biochimie_2015_Jan_108_40-47.nxml.txt.nlp	25447146	SENT202	10	10	2	2	thiamylal	TFP	PA164746997	7034	0.683
NULL	Front_Neurosci_2013_Jan_10_6_191.nxml.txt.nlp	23335875	SENT117	5	5	7	7	vasopressin	AVP	PA451858	114548;551	0.683
NULL	Exp_Ther_Med_2013_Dec_23_6(6)_1494-1498.nxml.txt.nlp	24255680	SENT116	25	25	23	23	losartan	ILK	PA450268	3611	0.683
NULL	J_Thromb_Haemost_2007_May_5(5)_1010-1018.nxml.txt.nlp	17355572	SENT160	5	5	11	11	thrombin	VWF	PA451674	7450	0.683
NULL	Toxins_(Basel)_2010_Jun_9_2(6)_1381-1398.nxml.txt.nlp	22069643	SENT169	10	10	0	0	vinblastine	P-gp	PA451877	5243	0.683
NULL	Oncotarget_2013_Nov_23_5(1)_196-210.nxml.txt.nlp	24344116	SENT76	6	6	25	25	doxorubicin	TNFAIP3	PA449412	7128	0.683
NULL	Breast_Cancer_Res_2007_Oct_26_9(5)_306.nxml.txt.nlp	17980055	SENT42	38	38	9	9	tamoxifen	BAG1	PA451581	573	0.683
NULL	Int_J_Endocrinol_Metab_2013_Dec_21_Winter_11(1)_57-61.nxml.txt.nlp	23853622	SENT123	4	4	8	8	bromocriptine	PRL	PA448671	5617	0.683
NULL	Clin_Ophthalmol_2014_Jan_13_8_219-228.nxml.txt.nlp	24531757	SENT145	17	17	9	9	timolol	TIM	PA451690	7984;8914	0.683
NULL	Front_Behav_Neurosci_2009_Jun_29_3_10.nxml.txt.nlp	19587848	SENT1232	1	1	7	7	diethylstilbestrol	c-fos	PA449307	2353	0.683
NULL	Cancers_(Basel)_2014_Nov_6_6(4)_2243-2258.nxml.txt.nlp	25383481	SENT454	3	3	15	15	auranofin	STAT3	PA448510	6774	0.683
NULL	Leukemia_2013_Apr_8_27(4)_762-772.nxml.txt.nlp	23385376	SENT74	12	12	14	14	rituximab	CHOP	PA451261	1649	0.683
NULL	Int_J_Environ_Res_Public_Health_2012_Sep_19_9(9)_3354-3364.nxml.txt.nlp	23202692	SENT270	0	0	17	17	resveratrol	HO-1		3162	0.683
NULL	Carcinogenesis_2010_Dec_27_31(12)_2049-2057.nxml.txt.nlp	20876285	SENT336	19	19	33	33	letrozole	Bcl-2	PA450196	596	0.683
NULL	J_Biomed_Biotechnol_2010_Sep_14_2010_326020.nxml.txt.nlp	20936132	SENT48	31	31	35	35	methotrexate	San	PA450428	80218	0.683
NULL	Indian_J_Med_Res_2012_Dec_136(6)_926-941.nxml.txt.nlp	23391788	SENT117	8	8	16	16	clopidogrel	DES	PA449053	1674	0.683
NULL	Pharmaceuticals_(Basel)_2011_Nov_10_4(11)_1488-1502.nxml.txt.nlp	NULL	SENT114	3	3	19	19	geldanamycin	HER2	PA152031327	2064	0.683
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT26	6	6	2	2	cisplatin	MDM2	PA449014	4193	0.683
NULL	Breast_Cancer_Res_2012_Mar_12_14(2)_R43.nxml.txt.nlp	22410125	SENT32	20	20	32	32	heparin	FGFR2	PA449855	2263	0.683
NULL	Nucleic_Acids_Res_2013_May_5_41(10)_5210-5222.nxml.txt.nlp	23563151	SENT257	27	27	5	5	arsenite	GADD45	PA452638	1647	0.683
NULL	J_Clin_Biochem_Nutr_2009_Jul_30_45(1)_9-13.nxml.txt.nlp	19590701	SENT5	16	16	12	12	lansoprazole	HO-1	PA450180	3162	0.683
NULL	Anesthesiol_Res_Pract_2014_Feb_11_2014_848051.nxml.txt.nlp	24672542	SENT114	31	31	29	29	rocuronium	NMB	PA164754992	10457;4828	0.683
NULL	Br_J_Cancer_2013_Sep_3_109(5)_1214-1222.nxml.txt.nlp	23922104	SENT238	23	23	5	5	dasatinib	p53	PA162372878	7157	0.683
NULL	Int_J_Mol_Sci_2012_Aug_13_13(8)_10091-10112.nxml.txt.nlp	22949849	SENT178	27	27	3	3	ethanol	PPL	PA448073	5493	0.683
NULL	Breast_Cancer_Res_2001_Mar_28_3(3)_150-153.nxml.txt.nlp	11305949	SENT56	0	0	18	18	paclitaxel	ERK2	PA450761	5594	0.683
NULL	FEBS_Open_Bio_2014_Jan_6_4_77-89.nxml.txt.nlp	24490132	SENT179	23	23	37	37	ebselen	NAC	PA161660841	22861	0.683
NULL	Iran_J_Pharm_Res_2013_Summer_12(3)_411-421.nxml.txt.nlp	24250648	SENT108	13	13	5	5	vanillin	ANOVA	PA451852	4858	0.683
NULL	Nat_Chem_Biol_2010_Apr_28_6(4)_291-299.nxml.txt.nlp	20190765	SENT117	9	9	17	17	dasatinib	EGFR	PA162372878	1956	0.683
NULL	Cancers_(Basel)_2012_Sep_25_4(4)_969-988.nxml.txt.nlp	24213497	SENT200	13	13	43	43	fulvestrant	EGFR	PA164747170	1956	0.683
NULL	Iran_J_Pharm_Res_2014_Spring_13(2)_417-429.nxml.txt.nlp	25237337	SENT211	16	16	5	5	salbutamol	NIP	PA448068	90527;10755	0.683
NULL	Indian_J_Nephrol_2013_Sep-Oct_23(5)_332-337.nxml.txt.nlp	24049267	SENT104	3	3	34	34	iron	CAD	PA450087	1677;790	0.683
NULL	Diabetes_Care_2013_Feb_17_36(2)_216-221.nxml.txt.nlp	23002085	SENT181	24	24	0	0	metformin	Gen	PA450395	348654	0.683
NULL	J_Anaesthesiol_Clin_Pharmacol_2011_Jul-Sep_27(3)_315-322.nxml.txt.nlp	21897499	SENT48	9	9	7	7	bupivacaine	CNB	PA135057240	5534	0.683
NULL	Acta_Pharmacol_Sin_2010_Oct_27_31(10)_1389-1394.nxml.txt.nlp	20871620	SENT116	8	8	15	15	carbachol	JNK	PA448784	5599	0.683
NULL	Arthritis_Res_Ther_2013_Jul_9_15(4)_R73.nxml.txt.nlp	23837669	SENT276	14	14	20	20	colchicine	MSU	PA449092	593	0.683
NULL	Ann_Gen_Psychiatry_2013_Jan_24_12_1.nxml.txt.nlp	23347694	SENT383	12	12	8	8	ziprasidone	CYP3A4	PA451974	1576	0.683
NULL	Br_J_Cancer_2013_Sep_3_109(5)_1214-1222.nxml.txt.nlp	23922104	SENT238	23	23	7	7	dasatinib	MDM2	PA162372878	4193	0.683
NULL	Cancer_Immunol_Immunother_2012_Jul_23_61(7)_1101-1111.nxml.txt.nlp	22193989	SENT124	1	1	10	10	oxaliplatin	CD86	PA131285527	942	0.683
NULL	Open_Biol_2014_May_4(5)_140065.nxml.txt.nlp	24850914	SENT255	17	17	19	19	bortezomib	ALK3	PA10252	657	0.683
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Jul_13_69(Pt_8)_o1242.nxml.txt.nlp	24109332	SENT64	16	16	4	4	ethanol	mol	PA448073	90527	0.683
NULL	Alzheimers_Res_Ther_2013_Oct_24_5(5)_50.nxml.txt.nlp	24401551	SENT328	19	19	29	29	donepezil	spatial	PA449394	219793	0.683
NULL	J_Med_Internet_Res_2013_Jul_12_15(7)_e138.nxml.txt.nlp	23853350	SENT191	18	18	26	26	warfarin	TTR	PA451906	7276	0.683
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Dec_17_3(12)_e152.nxml.txt.nlp	25518025	SENT252	9	9	23	23	oxycodone	ABCB1	PA450741	5243	0.683
NULL	Indian_J_Pharmacol_2008_Jun_40(3)_95-102.nxml.txt.nlp	20040934	SENT262	3	3	13	13	etanercept	IL-8	PA449515	3576	0.683
NULL	Open_Ophthalmol_J_2011_Dec_19_5_59-62.nxml.txt.nlp	22216076	SENT12	0	0	6	6	bevacizumab	San	PA130232992	80218	0.683
NULL	Int_J_Mol_Sci_2014_Mar_6_15(3)_4088-4103.nxml.txt.nlp	24663083	SENT100	14	14	18	18	l-arginine	PRMT1	PA448478	3276	0.683
NULL	Mol_Cancer_2009_Nov_19_8_108.nxml.txt.nlp	19925669	SENT62	18	18	9	9	doxorubicin	CTRL	PA449412	1506	0.683
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1063.nxml.txt.nlp	24556678	SENT31	0	0	2	2	thioridazine	TRAIL	PA451666	8743	0.683
NULL	Nat_Chem_Biol_2010_Apr_28_6(4)_291-299.nxml.txt.nlp	20190765	SENT183	9	9	2	2	dasatinib	ILK	PA162372878	3611	0.683
NULL	Case_Rep_Infect_Dis_2012_Aug_16_2012_640104.nxml.txt.nlp	22953083	SENT62	5	5	9	9	trimethoprim	TMP	PA451788	2012	0.683
NULL	Oncotarget_2013_Dec_28_5(6)_1475-1490.nxml.txt.nlp	24721996	SENT74	10	10	12	12	celecoxib	CD133	PA448871	8842	0.683
NULL	BioDrugs_2013_May_9_27(5)_469-478.nxml.txt.nlp	23658121	SENT259	5	5	16	16	carboplatin	HER2	PA448803	2064	0.683
NULL	EMBO_Mol_Med_2013_Aug_5_5(8)_1213-1226.nxml.txt.nlp	23918228	SENT69	5	5	8	8	cetuximab	EGFR	PA10040	1956	0.683
NULL	Hum_Genomics_2004_Jan_1_1(2)_111-125.nxml.txt.nlp	15601539	SENT16	18	18	26	26	lipase	APOC2	PA450239	344	0.683
NULL	Adolesc_Health_Med_Ther_2014_Nov_27_5_211-221.nxml.txt.nlp	25473324	SENT153	41	41	7	7	aripiprazole	ERG	PA10026	2078	0.683
NULL	Br_J_Pharmacol_2014_Jan_23_171(2)_523-535.nxml.txt.nlp	24372553	SENT209	7	7	9	9	metformin	SIRT1	PA450395	23411	0.683
NULL	Oncogene_2013_Sep_12_32(37)_4355-4365.nxml.txt.nlp	23108409	SENT27	35	35	18	18	hyaluronan	HAS2	PA165958431	3037	0.683
NULL	Biochemistry_2009_Feb_3_48(4)_800-809.nxml.txt.nlp	19132922	SENT147	9	9	7	7	allopurinol	XOR	PA448320	7498	0.683
NULL	Mol_Pain_2013_May_13_9_24.nxml.txt.nlp	23668392	SENT277	11	11	5	5	capsaicin	TRPV1	PA448776	7442	0.683
NULL	J_Anaesthesiol_Clin_Pharmacol_2011_Oct-Dec_27(4)_435-437.nxml.txt.nlp	22096272	SENT62	17	17	4	4	sevoflurane	REL	PA451341	5966	0.683
NULL	Int_J_Biol_Sci_2014_Feb_20_10(3)_268-277.nxml.txt.nlp	24644425	SENT255	0	0	4	4	metformin	AMPK	PA450395	5563	0.683
NULL	Behav_Neurosci_2014_Aug_16_128(4)_504-522.nxml.txt.nlp	24933661	SENT800	15	15	7	7	physostigmine	CA3	PA450957	761	0.683
NULL	Scientifica_(Cairo)_2013_Jan_17_2013_795964.nxml.txt.nlp	24278786	SENT156	9	9	35	35	xanthophyll	NPQ	PA164748318	80763	0.683
NULL	Int_J_Environ_Res_Public_Health_2005_May_30_2(1)_156-163.nxml.txt.nlp	16705813	SENT65	27	27	38	38	estradiol	CO2	PA449503	4513	0.683
NULL	Mol_Cancer_2007_May_11_6_33.nxml.txt.nlp	17498302	SENT93	0	0	9	9	daunorubicin	TP53	PA449212	7157	0.683
NULL	Biosci_Rep_2014_Jun_25_34(3)_e00115.nxml.txt.nlp	24877606	SENT707	1	1	6	6	thrombin	IL-8	PA451674	3576	0.683
NULL	Aging_(Albany_NY)_2012_Jul_22_4(7)_480-498.nxml.txt.nlp	22837425	SENT33	26	26	28	28	metformin	B12	PA450395	7126;4709	0.683
NULL	Cancers_(Basel)_2010_May_26_2(2)_913-954.nxml.txt.nlp	24281100	SENT3263	13	13	6	6	paclitaxel	CD24	PA450761	100133941	0.683
NULL	Indian_J_Psychiatry_2007_Jan-Mar_49(1)_26-33.nxml.txt.nlp	20640062	SENT140	16	16	25	25	acamprosate	NNT	PA10344	23530	0.683
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT17	28	28	8	8	phenprocoumon	EPHX1	PA450921	2052	0.683
NULL	Biosci_Rep_2013_Sep_17_33(5)_e00068.nxml.txt.nlp	23919527	SENT255	6	6	16	16	guanidine	CXCL8	PA164781028	3576	0.683
NULL	Acta_Pharmacol_Sin_2012_Jan_3_33(1)_82-90.nxml.txt.nlp	22212431	SENT158	0	0	3	3	rosiglitazone	adiponectin	PA451283	9370	0.683
NULL	Eur_J_Dent_2012_Oct_6(4)_349-360.nxml.txt.nlp	23077413	SENT318	36	36	22	22	ethanol	HEMA	PA448073	2157	0.683
NULL	Oncogene_2009_Dec_3_28(48)_4237-4248.nxml.txt.nlp	19734937	SENT137	29	29	16	16	collagenase	PAR-1	PA449107	2011;2149	0.683
NULL	Acta_Pharmacol_Sin_2011_Nov_3_32(11)_1364-1372.nxml.txt.nlp	21963898	SENT236	0	0	16	16	yohimbine	TLR4	PA451946	7099	0.683
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT110	7	7	9	9	chloroquine	BMPR-II	PA448948	659	0.683
NULL	Ann_Thorac_Med_2013_Apr-Jun_8(2)_109-115.nxml.txt.nlp	23741274	SENT169	13	13	4	4	cisplatin	CRT	PA449014	811	0.683
NULL	F1000_Med_Rep_2012_Mar_1_4_5.nxml.txt.nlp	22403586	SENT55	17	17	10	10	tocilizumab	IL-5	PA165292659	3567	0.683
NULL	Cell_Biochem_Biophys_2013_Jan_13_66(3)_499-512.nxml.txt.nlp	23314884	SENT380	16	16	7	7	resveratrol	DR5		8795	0.683
NULL	Breast_Cancer_Res_2009_May_18_11(3)_303.nxml.txt.nlp	19519950	SENT10	13	13	11	11	doxorubicin	ACT	PA449412	12;11332;9457;641455	0.683
NULL	Indian_J_Psychiatry_2010_Jan_52(Suppl1)_S317-S340.nxml.txt.nlp	21836703	SENT120	21	21	17	17	triflupromazine	TFP	PA451773	7034	0.683
NULL	Nat_Commun_2014_Dec_10_5_5715.nxml.txt.nlp	25493654	SENT70	20	20	15	15	dextran	LAMP1	PA449261	3916	0.683
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_3_2014_473213.nxml.txt.nlp	25538791	SENT209	16	16	6	6	fexofenadine	P-gp	PA449621	5243	0.683
NULL	Oncol_Lett_2013_Oct_24_6(4)_985-989.nxml.txt.nlp	24137450	SENT129	23	23	33	33	vincristine	ADM	PA451879	133	0.683
NULL	Int_J_Mol_Sci_2013_Apr_24_14(5)_8740-8774.nxml.txt.nlp	23615468	SENT1292	11	11	0	0	trypsin	BAK1	PA451806	578	0.683
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Sep_30_64(Pt_10)_o2033.nxml.txt.nlp	21201227	SENT61	25	25	20	20	ethanol	mol	PA448073	90527	0.683
NULL	Ann_Hematol_2010_Nov_25_89(11)_1115-1124.nxml.txt.nlp	20499237	SENT6	6	6	18	18	simvastatin	BAX	PA451363	581	0.683
NULL	Allergy_Asthma_Immunol_Res_2013_Jul_27_5(4)_224-231.nxml.txt.nlp	23814676	SENT45	11	11	4	4	forskolin	PI3K	PA146096022	5290	0.683
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Feb_10_68(Pt_3)_o661.nxml.txt.nlp	22412563	SENT3	20	20	33	33	arteether	mol	PA165260403	90527	0.683
NULL	Arthritis_Res_Ther_2014_Aug_22_16(4)_423.nxml.txt.nlp	25606590	SENT226	14	14	21	21	methotrexate	FDG	PA450428	23583	0.683
NULL	Breast_Cancer_Res_2011_Dec_1_13(6)_R124.nxml.txt.nlp	22132731	SENT70	26	26	18	18	fluorescein	San	PA164746009	80218	0.683
NULL	Front_Behav_Neurosci_2009_Jan_27_3_1.nxml.txt.nlp	19194528	SENT126	3	3	12	12	imipramine	spatial	PA449969	219793	0.683
NULL	Arch_Med_Sci_2011_Dec_31_7(6)_977-983.nxml.txt.nlp	22328880	SENT127	14	14	22	22	heparin	PAPP-A	PA449855	5069	0.683
NULL	Mol_Brain_2014_Sep_4_7(1)_69.nxml.txt.nlp	NULL	SENT169	0	0	34	34	sevoflurane	CCL2	PA451341	6347	0.683
NULL	Mediators_Inflamm_1996_Feb_5(1)_51-55.nxml.txt.nlp	18475698	SENT7	12	12	1	1	protamine	C3a	PA10366	718	0.683
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT223	10	10	22	22	sitagliptin	HIP	PA164748978	6767;6159;64399;5068	0.683
NULL	Biosci_Rep_2012_Aug_1_32(Pt_4)_361-374.nxml.txt.nlp	22762204	SENT1038	16	16	5	5	paclitaxel	p27	PA450761	5715;10534	0.683
NULL	Mol_Med_Rep_2015_Feb_5_11(2)_805-814.nxml.txt.nlp	25373883	SENT62	5	5	7	7	colchicine	APE	PA449092	55704;328	0.683
NULL	J_Invest_Dermatol_2013_Sep_31_133(9)_2247-2254.nxml.txt.nlp	23370537	SENT11	2	2	14	14	chloroquine	PUMA	PA448948	27113	0.683
NULL	Pain_Res_Treat_2011_Dec_12_2011_507029.nxml.txt.nlp	22220274	SENT42	0	0	2	2	ceftriaxone	CTX	PA448866	1593	0.683
NULL	Biologics_2012_Jan_5_6_13-20.nxml.txt.nlp	22291463	SENT73	2	2	6	6	panitumumab	EGFR	PA162373091	1956	0.683
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1717-1723.nxml.txt.nlp	19844230	SENT130	10	10	2	2	pazopanib	GM-CSF	PA165291492	1437	0.683
NULL	J_Nutr_Metab_2011_Oct_1_2011_525094.nxml.txt.nlp	21977315	SENT184	3	3	9	9	resveratrol	SIRT3		23410	0.683
NULL	J_Adv_Pharm_Technol_Res_2013_Jan-Mar_4(1)_18-24.nxml.txt.nlp	23662278	SENT4	15	15	17	17	atorvastatin	ATV	PA448500	4683	0.683
NULL	FEBS_Open_Bio_2014_Jan_21_4_147-152.nxml.txt.nlp	24490139	SENT36	17	17	4	4	staurosporine	Mcl-1	PA165109623	4170	0.683
NULL	J_Cancer_2014_Jan_5_5(2)_86-97.nxml.txt.nlp	24494026	SENT94	5	5	3	3	cisplatin	EGFR	PA449014	1956	0.683
NULL	Cancer_Manag_Res_2011_Aug_10_3_273-285.nxml.txt.nlp	21931501	SENT49	1	1	8	8	pazopanib	VEGFR	PA165291492	3791	0.683
NULL	EMBO_Mol_Med_2013_Aug_5_5(8)_1213-1226.nxml.txt.nlp	23918228	SENT41	21	21	16	16	cetuximab	EGFR	PA10040	1956	0.683
NULL	Clin_J_Gastroenterol_2014_Jun_6_7(4)_355-360.nxml.txt.nlp	25132867	SENT1	19	19	23	23	ribavirin	IFN	PA451241	3439	0.683
NULL	Iran_J_Basic_Med_Sci_2012_Nov-Dec_15(6)_1202-1209.nxml.txt.nlp	23653852	SENT126	2	2	4	4	metformin	VEGF-A	PA450395	7422	0.683
NULL	Mol_Cancer_2006_Oct_17_5_45.nxml.txt.nlp	17044934	SENT149	12	12	25	25	resveratrol	COX		1351	0.683
NULL	J_Biol_Chem_2013_Dec_6_288(49)_35387-35395.nxml.txt.nlp	24142790	SENT156	37	37	6	6	meclizine	PCYT2	PA450338	5833	0.683
NULL	Oncoscience_2014_Aug_21_1(8)_513-521.nxml.txt.nlp	25594058	SENT27	18	18	21	21	docetaxel	EGFR	PA449383	1956	0.683
NULL	Mol_Biol_Cell_2013_Dec_15_24(24)_3939-3944.nxml.txt.nlp	24152728	SENT89	5	5	10	10	tamoxifen	CCN2	PA451581	1490	0.683
NULL	Crit_Care_2009_Feb_6_13(1)_R11.nxml.txt.nlp	19196475	SENT169	12	12	3	3	clonidine	IL-6	PA449051	3569	0.683
NULL	Arthritis_Res_Ther_2008_Dec_1_10(6)_R139.nxml.txt.nlp	19046432	SENT344	13	13	21	21	rosiglitazone	AP-1	PA451283	2353;3727;2354;3725	0.683
NULL	Br_J_Pharmacol_2008_Dec_25_155(7)_1056-1065.nxml.txt.nlp	18724386	SENT292	19	19	21	21	forskolin	GLP-1	PA146096022	100125288	0.683
NULL	Arch_Gynecol_Obstet_2014_May_13_290(4)_757-762.nxml.txt.nlp	24818590	SENT78	10	10	21	21	fluorescein	CD56	PA164746009	4684	0.683
NULL	Eur_J_Clin_Microbiol_Infect_Dis_2011_Nov_20_30(11)_1431-1436.nxml.txt.nlp	21503840	SENT129	25	25	15	15	ciprofloxacin	Kist	PA449009	127933	0.683
NULL	Int_J_Hypertens_2012_Feb_8_2012_189512.nxml.txt.nlp	22518281	SENT104	7	7	4	4	hemin	HO-2	PA449849	3163	0.683
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT289	23	23	15	15	paclitaxel	CYP2C8	PA450761	1558	0.683
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT295	5	5	0	0	panitumumab	EGFR	PA162373091	1956	0.683
NULL	Clin_Dev_Immunol_2013_Sep_17_2013_791262.nxml.txt.nlp	24151519	SENT210	16	16	3	3	heparin	CCR2	PA449855	729230	0.683
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT129	2	2	12	12	atorvastatin	RANKL	PA448500	8600	0.683
NULL	Arthritis_Res_Ther_2009_Aug_28_11(4)_R131.nxml.txt.nlp	19715572	SENT170	0	0	4	4	rituximab	CD19	PA451261	930	0.683
NULL	Endocrine_2012_Dec_14_42(3)_622-636.nxml.txt.nlp	22695986	SENT261	8	8	6	6	forskolin	PTH	PA146096022	5741	0.683
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Dec_4_66(Pt_1)_o48-o49.nxml.txt.nlp	21580151	SENT78	44	44	12	12	ethanol	mol	PA448073	90527	0.683
NULL	Br_J_Cancer_2009_Oct_6_101(7)_1033-1038.nxml.txt.nlp	19789532	SENT119	1	1	9	9	bevacizumab	IFL	PA130232992	3439	0.683
NULL	Diabetes_2013_May_16_62(5)_1709-1717.nxml.txt.nlp	23328126	SENT295	35	35	11	11	pioglitazone	CD68	PA450970	968	0.683
NULL	N_Am_J_Med_Sci_2014_Jul_6(7)_342-345.nxml.txt.nlp	25077084	SENT111	10	10	8	8	cyclophosphamide	CAV	PA449165	763;858	0.683
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT42	25	25	40	40	gefitinib	KRAS	PA131301952	3845	0.683
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT128	17	17	4	4	lidocaine	CYP3A4	PA450226	1576	0.683
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT279	19	19	13	13	gemcitabine	ABCC5	PA449748	10057	0.683
NULL	Cancer_Cell_Int_2014_Jan_14_14_4.nxml.txt.nlp	24423208	SENT60	14	14	8	8	bevacizumab	IL-2	PA130232992	3558	0.683
NULL	Br_J_Cancer_1997_75(11)_1593-1600.nxml.txt.nlp	9184173	SENT13	5	5	23	23	lovastatin	PC-3	PA450272	692094	0.683
NULL	Clinics_(Sao_Paulo)_2012_Jan_67(1)_79-82.nxml.txt.nlp	22249485	SENT9	37	37	39	39	vasopressin	AVP	PA451858	114548;551	0.683
NULL	Evid_Based_Complement_Alternat_Med_2011_Jan_20_2011_713523.nxml.txt.nlp	21318104	SENT103	21	21	8	8	verapamil	P-gp	PA451868	5243	0.683
NULL	Oncotarget_2012_May_18_3(5)_525-534.nxml.txt.nlp	22619113	SENT93	31	31	14	14	fludarabine	BIRC5	PA449655	332	0.683
NULL	Indian_J_Med_Res_2014_Feb_139(2)_216-225.nxml.txt.nlp	24718395	SENT127	25	25	4	4	amitriptyline	PMPS	PA448385	5377	0.683
NULL	Ann_N_Y_Acad_Sci_2012_Oct_10_1271(1)_58-67.nxml.txt.nlp	23050965	SENT122	1	1	35	35	cisplatin	PTEN	PA449014	5728	0.683
NULL	Aging_(Albany_NY)_2010_Nov_15_2(11)_823-842.nxml.txt.nlp	21084727	SENT76	26	26	37	37	nadh	NDUFA6	PA164755085	4700	0.683
NULL	Clin_Mol_Hepatol_2014_Sep_25_20(3)_283-290.nxml.txt.nlp	25320732	SENT32	23	23	21	21	propranolol	EVL	PA451145	51466	0.683
NULL	Mol_Imaging_Radionucl_Ther_2012_Apr_1_21(1)_38-41.nxml.txt.nlp	23487501	SENT40	12	12	14	14	thyroglobulin	TTF1	PA164754910	7080;7270	0.683
NULL	Front_Genet_2014_Dec_19_5_438.nxml.txt.nlp	25566322	SENT334	12	12	22	22	choline	B12	PA448976	7126;4709	0.683
NULL	Breast_Cancer_Res_2011_Nov_28_13(6)_R121.nxml.txt.nlp	22123186	SENT295	4	4	2	2	lapatinib	HER2	PA152241907	2064	0.683
NULL	J_Autom_Methods_Manag_Chem_2007_Jun_19_2007_86857.nxml.txt.nlp	17671612	SENT196	13	13	31	31	tinidazole	mol	PA10813	90527	0.683
NULL	An_Bras_Dermatol_2014_Mar-Apr_89(2)_266-273.nxml.txt.nlp	24770503	SENT112	9	9	4	4	thalidomide	ENL	PA451644	4298	0.683
NULL	J_Oncol_2009_Mar_24_2009_491985.nxml.txt.nlp	19325924	SENT117	14	14	18	18	genistein	CXCL12	PA165109660	6387	0.683
NULL	Environ_Health_2006_Mar_30_5_9.nxml.txt.nlp	16573822	SENT60	17	17	19	19	diethylstilbestrol	DES	PA449307	1674	0.683
NULL	Ther_Clin_Risk_Manag_2007_Jun_3(3)_411-420.nxml.txt.nlp	18488075	SENT154	0	0	28	28	alefacept	CD4	PA164748040	920	0.683
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1129-1136.nxml.txt.nlp	20234368	SENT137	14	14	24	24	imiquimod	CD4	PA449972	920	0.683
NULL	Infect_Drug_Resist_2010_Aug_9_3_87-94.nxml.txt.nlp	21694897	SENT62	36	36	19	19	artemisinin	ACT	PA165111696	12;11332;9457;641455	0.683
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1046.nxml.txt.nlp	24503538	SENT203	38	38	15	15	oxaliplatin	FGFR4	PA131285527	2264	0.683
NULL	Eur_J_Clin_Pharmacol_2011_Dec_23_67(12)_1231-1241.nxml.txt.nlp	21698374	SENT218	19	19	13	13	tacrolimus	CYP3A5	PA451578	1577	0.683
NULL	J_Biomed_Sci_2014_May_24_21(1)_51.nxml.txt.nlp	24885898	SENT155	10	10	13	13	taurine	spatial	PA451590	219793	0.683
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Nov_23_69(Pt_12)_o1813-o1814.nxml.txt.nlp	24454243	SENT8	1	1	36	36	piperazine	mol	PA450977	90527	0.683
NULL	J_Ophthalmol_2012_Aug_27_2012_285851.nxml.txt.nlp	23050121	SENT135	19	19	37	37	fluorescein	BAK	PA164746009	578	0.683
NULL	Mol_Cells_2014_Aug_31_37(8)_585-591.nxml.txt.nlp	25134539	SENT99	20	20	32	32	indacaterol	ADRB2	PA165958348	154	0.683
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Mar_28_65(Pt_4)_o885.nxml.txt.nlp	21582594	SENT76	22	22	10	10	ethanol	mol	PA448073	90527	0.683
NULL	J_Gynecol_Oncol_2013_Apr_5_24(2)_177-185.nxml.txt.nlp	23653836	SENT192	27	27	40	40	cisplatin	AMH	PA449014	268	0.683
NULL	Front_Mol_Neurosci_2014_Oct_14_7_80.nxml.txt.nlp	25352776	SENT42	14	14	22	22	l-lysine	GDNF	PA450280	2668	0.683
NULL	BMJ_2011_Aug_4_343_d4588.nxml.txt.nlp	21816733	SENT438	15	15	2	2	clopidogrel	CYP3A4	PA449053	1576	0.683
NULL	Int_J_Nanomedicine_2012_Oct_25_7_5565-5575.nxml.txt.nlp	23118538	SENT14	20	20	14	14	fenofibrate	CO2	PA449594	4513	0.683
NULL	Blood_Res_2014_Mar_24_49(1)_36-41.nxml.txt.nlp	24724065	SENT107	48	48	33	33	rituximab	CHOP	PA451261	1649	0.683
NULL	Br_J_Cancer_2011_Sep_6_105(6)_807-813.nxml.txt.nlp	21847121	SENT114	7	7	19	19	pha-665752	HER2		2064	0.683
NULL	ISRN_AIDS_2012_Jul_12_2012_485307.nxml.txt.nlp	24052874	SENT120	2	2	9	9	tenofovir	PTH	PA10204	5741	0.683
NULL	Cell_Death_Dis_2014_Feb_27_5(2)_e1088.nxml.txt.nlp	24577086	SENT88	4	4	0	0	metformin	AMPK	PA450395	5563	0.683
NULL	Eur_J_Pharmacol_2012_Jul_5_686(1-3)_22-31.nxml.txt.nlp	22564863	SENT33	18	18	38	38	memantine	GluN3A	PA10364	116443	0.683
NULL	Mol_Cancer_2010_Nov_23_9_301.nxml.txt.nlp	21092273	SENT186	15	15	29	29	pentazocine	TRAIL	PA164744326	8743	0.683
NULL	Oncotarget_2013_Nov_22_5(4)_933-943.nxml.txt.nlp	24659749	SENT32	6	6	28	28	nutlin-3	AML3		860	0.683
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_16_2014_926087.nxml.txt.nlp	25478000	SENT214	28	28	6	6	ezetimibe	PCSK9	PA10816	255738	0.683
NULL	Acta_Pharmacol_Sin_2012_Nov_23_33(11)_1409-1416.nxml.txt.nlp	22820910	SENT35	13	13	7	7	clozapine	CYP1A2	PA449061	1544	0.683
NULL	J_Mol_Signal_2006_Dec_6_1_8.nxml.txt.nlp	17224083	SENT65	10	10	0	0	thrombin	Rho	PA451674	29984	0.683
NULL	J_Immunother_Cancer_2013_Nov_7_1(Suppl_1)_P88.nxml.txt.nlp	NULL	SENT12	2	2	30	30	bortezomib	DLL1	PA10252	28514	0.683
NULL	J_Int_Soc_Sports_Nutr_2015_Jan_21_12(1)_5.nxml.txt.nlp	NULL	SENT111	23	23	9	9	curcumin	IL-6	PA151958596	3569	0.683
NULL	Clin_Infect_Dis_2013_Mar_1_56(5)_694-696.nxml.txt.nlp	23175557	SENT46	22	22	44	44	primaquine	G6PD	PA451103	2539	0.683
NULL	J_Biol_Chem_2013_Oct_11_288(41)_29642-29653.nxml.txt.nlp	24005673	SENT1001	15	15	9	9	hyaluronan	TSG-6	PA165958431	7130	0.683
NULL	J_Cell_Mol_Med_2014_May_14_18(5)_811-823.nxml.txt.nlp	24628949	SENT224	8	8	13	13	docetaxel	FOXM1	PA449383	2305	0.683
NULL	Environ_Microbiol_2013_Jan_15_15(1)_297-304.nxml.txt.nlp	23157680	SENT66	26	26	16	16	gentamicin	TMP	PA449753	2012	0.683
NULL	Clin_Ophthalmol_2014_Sep_15_8_1745-1755.nxml.txt.nlp	25246758	SENT70	14	14	22	22	bevacizumab	San	PA130232992	80218	0.683
NULL	J_Gen_Intern_Med_2009_May_21_24(5)_656-664.nxml.txt.nlp	19306050	SENT336	24	24	6	6	warfarin	CYP2C9	PA451906	1559	0.683
NULL	Biosci_Rep_2013_Sep_17_33(5)_e00068.nxml.txt.nlp	23919527	SENT255	6	6	22	22	guanidine	CXCL8	PA164781028	3576	0.683
NULL	J_Parasitol_Res_2012_Aug_13_2012_296856.nxml.txt.nlp	22934153	SENT174	18	18	4	4	praziquantel	IL-5	PA164764583	3567	0.683
NULL	Blood_Cancer_J_2013_Jun_7_3(6)_e120.nxml.txt.nlp	23749045	SENT90	13	13	22	22	imatinib	JAG2	PA10804	3714	0.683
NULL	Mol_Med_Rep_2015_Feb_5_11(2)_805-814.nxml.txt.nlp	25373883	SENT142	12	12	0	0	colchicine	APE	PA449092	55704;328	0.683
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT271	30	30	15	15	phenprocoumon	GGCX	PA450921	2677	0.683
NULL	J_Adv_Pharm_Technol_Res_2013_Jan-Mar_4(1)_65-68.nxml.txt.nlp	23662284	SENT46	29	29	24	24	dexibuprofen	AMH	PA166049174	268	0.683
NULL	Endocrinol_Metab_(Seoul)_2014_Sep_25_29(3)_379-387.nxml.txt.nlp	25309798	SENT120	6	6	19	19	resveratrol	SIRT1		23411	0.683
NULL	Cardiovasc_Drugs_Ther_2014_May_20_28(3)_281-289.nxml.txt.nlp	24842558	SENT232	28	28	6	6	ezetimibe	PCSK9	PA10816	255738	0.683
NULL	Ann_Med_Health_Sci_Res_2013_Oct-Dec_3(4)_498-503.nxml.txt.nlp	24379998	SENT108	29	29	10	10	cyclophosphamide	CD4	PA449165	920	0.683
NULL	Cells_2014_Apr_8_3(2)_258-287.nxml.txt.nlp	24717323	SENT104	26	26	21	21	capsaicin	TRPV1	PA448776	7442	0.683
NULL	Front_Neural_Circuits_2014_Apr_8_8_33.nxml.txt.nlp	24782714	SENT434	4	4	19	19	guanfacine	spatial	PA449825	219793	0.683
NULL	Cancers_(Basel)_2011_Apr_11_3(2)_1929-1946.nxml.txt.nlp	24212789	SENT79	28	28	20	20	daunorubicin	TRAIL	PA449212	8743	0.683
NULL	Anesth_Essays_Res_2012_Jul-Dec_6(2)_140-146.nxml.txt.nlp	NULL	SENT101	28	28	7	7	lidocaine	IL6	PA450226	3569	0.683
NULL	Biomed_Res_Int_2014_Jan_16_2014_706302.nxml.txt.nlp	24551852	SENT68	5	5	25	25	ethanol	CYP2E1	PA448073	1571	0.683
NULL	J_Int_Soc_Sports_Nutr_2012_Jan_31_9_2.nxml.txt.nlp	22293241	SENT53	31	31	26	26	creatine	IL-6	PA164778930	3569	0.683
NULL	Bioinformation_2012_Jan_6_8(1)_13-19.nxml.txt.nlp	22359429	SENT118	14	14	16	16	curcumin	LGA	PA151958596	27165	0.683
NULL	Int_J_Nanomedicine_2012_Oct_25_7_5565-5575.nxml.txt.nlp	23118538	SENT51	15	15	12	12	fenofibrate	CO2	PA449594	4513	0.683
NULL	Mol_Med_Rep_2015_Jan_16_11(1)_91-98.nxml.txt.nlp	25322694	SENT95	6	6	12	12	cisplatin	LC3	PA449014	84557	0.683
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT46	5	5	0	0	trastuzumab	PTEN	PA451743	5728	0.683
NULL	Curr_Pharm_Biotechnol_2011_Jan_12(1)_35-41.nxml.txt.nlp	20932261	SENT136	6	6	26	26	hyperforin	TRPC7	PA165985514	57113	0.683
NULL	J_Cell_Biol_2002_Mar_4_156(5)_791-795.nxml.txt.nlp	11877457	SENT93	11	11	2	2	staurosporine	AP2	PA165109623	2971	0.683
NULL	Korean_J_Anesthesiol_2013_Jun_24_64(6)_517-523.nxml.txt.nlp	23814652	SENT129	39	39	27	27	ondansetron	CYP2D6	PA450705	1565	0.683
NULL	Neuropsychopharmacology_2009_Jul_25_34(8)_1968-1978.nxml.txt.nlp	19322168	SENT258	22	22	35	35	clozapine	PI3K	PA449061	5290	0.683
NULL	Breast_Cancer_Res_2010_Oct_26_12(5)_210.nxml.txt.nlp	21067538	SENT61	26	26	6	6	urokinase	HOXD10	PA451836	3236	0.683
NULL	Oncogene_2009_Dec_3_28(48)_4237-4248.nxml.txt.nlp	19734937	SENT75	4	4	18	18	collagenase	PAR-1	PA449107	2011;2149	0.683
NULL	Ann_Intensive_Care_2011_Dec_30_1_53.nxml.txt.nlp	22208725	SENT8	26	26	6	6	potassium	ACTH	PA451047	5443	0.683
NULL	Gene_Regul_Syst_Bio_2014_Mar_4_8_63-73.nxml.txt.nlp	24634581	SENT193	0	0	5	5	minocycline	BNIP3	PA450519	664	0.682
NULL	An_Bras_Dermatol_2013_Nov-Dec_88(6_Suppl_1)_120-123.nxml.txt.nlp	24346897	SENT25	11	11	16	16	tacrolimus	CO2	PA451578	4513	0.682
NULL	Nat_Commun_2010_Nov_30_1_130.nxml.txt.nlp	21119643	SENT64	3	3	8	8	fenofibrate	PS1	PA449594	5663	0.682
NULL	Int_J_Endocrinol_2011_Aug_21_2011_742719.nxml.txt.nlp	21869886	SENT139	25	25	12	12	clopidogrel	DES	PA449053	1674	0.682
NULL	Mol_Pain_2014_Apr_9_10_24.nxml.txt.nlp	24716552	SENT51	2	2	10	10	capsaicin	NK1R	PA448776	6869	0.682
NULL	Brain_Sci_2013_Jun_3_3(2)_877-907.nxml.txt.nlp	24961429	SENT797	1	1	17	17	taurine	CA1	PA451590	759	0.682
NULL	Chin_J_Cancer_2012_Apr_31(4)_178-184.nxml.txt.nlp	22237038	SENT59	4	4	9	9	niclosamide	TAK1	PA165958408	7182	0.682
NULL	Amino_Acids_2014_Feb_20_46(5)_1275-1283.nxml.txt.nlp	24553827	SENT23	9	9	0	0	taurine	CDO	PA451590	50937	0.682
NULL	Breast_Cancer_(Auckl)_2012_Mar_7_6_67-77.nxml.txt.nlp	22438669	SENT69	11	11	25	25	lapatinib	HER2	PA152241907	2064	0.682
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT49	39	39	3	3	dextromethorphan	CYP3A	PA449273	1574	0.682
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT144	7	7	20	20	capsaicin	p53	PA448776	7157	0.682
NULL	Behav_Neurol_2014_Nov_16_2014_360978.nxml.txt.nlp	25477708	SENT154	7	7	3	3	nicotine	EPM	PA450626	2054	0.682
NULL	J_Korean_Med_Sci_2010_Aug_21_25(8)_1222-1227.nxml.txt.nlp	20676337	SENT54	29	29	34	34	aminophylline	ANOVA	PA164781029	4858	0.682
NULL	Exp_Diabetes_Res_2011_Dec_27_2011_604989.nxml.txt.nlp	21253359	SENT76	12	12	20	20	clonidine	INS-1	PA449051	2305	0.682
NULL	Apoptosis_2013_Aug_23_18(11)_1306-1318.nxml.txt.nlp	23975731	SENT56	24	24	34	34	hydrocortisone	IL-3	PA449905	3562	0.682
NULL	FEBS_Open_Bio_2013_Feb_16_3_144-150.nxml.txt.nlp	23772386	SENT202	22	22	5	5	warfarin	VKORC1	PA451906	79001	0.682
NULL	J_Exerc_Nutrition_Biochem_2014_Mar_8_18(1)_69-78.nxml.txt.nlp	25566441	SENT144	20	20	8	8	creatine	ADP	PA164778930	23038	0.682
NULL	Braz_J_Med_Biol_Res_2013_Apr_12_46(4)_327-338.nxml.txt.nlp	23579631	SENT208	6	6	8	8	estradiol	AVP	PA449503	114548;551	0.682
NULL	Core_Evid_2009_Jun_15_4_49-65.nxml.txt.nlp	20694065	SENT60	31	31	7	7	clopidogrel	ADP	PA449053	23038	0.682
NULL	J_Invest_Dermatol_2012_May_16_132(5)_1435-1442.nxml.txt.nlp	22336948	SENT235	0	0	4	4	doxycycline	TLSP	PA449415	11012	0.682
NULL	Cancer_Med_2013_Dec_31_2(6)_826-835.nxml.txt.nlp	24403256	SENT218	16	16	7	7	nutlin-3	p53		7157	0.682
NULL	ScientificWorldJournal_2014_Mar_24_2014_694326.nxml.txt.nlp	24782665	SENT93	36	36	23	23	metformin	FDG	PA450395	23583	0.682
NULL	Oncol_Rep_2014_Feb_13_31(2)_581-588.nxml.txt.nlp	24337105	SENT197	2	2	12	12	capsaicin	Bcl-2	PA448776	596	0.682
NULL	F1000Res_2014_Aug_21_3_201.nxml.txt.nlp	25520779	SENT306	17	17	13	13	estradiol	MRP2	PA449503	100130958;57626;1244	0.682
NULL	Cell_Death_Dis_2013_Sep_5_4(9)_e789.nxml.txt.nlp	24008733	SENT141	15	15	22	22	minocycline	TTR	PA450519	7276	0.682
NULL	Cardiol_Res_Pract_2013_Feb_19_2013_195456.nxml.txt.nlp	23533940	SENT119	12	12	0	0	clopidogrel	ABCB1	PA449053	5243	0.682
NULL	Front_Immunol_2013_Mar_27_4_76.nxml.txt.nlp	23543707	SENT235	18	18	7	7	rituximab	CD16	PA451261	2215;2214	0.682
NULL	Environ_Microbiol_2013_Jan_15_15(1)_297-304.nxml.txt.nlp	23157680	SENT66	30	30	16	16	kanamycin	TMP	PA450137	2012	0.682
NULL	Cancer_Microenviron_2009_May_6_2(1)_59-67.nxml.txt.nlp	19418243	SENT42	15	15	19	19	tetracycline	CCL21	PA451640	6366	0.682
NULL	Oncotarget_2014_Feb_7_5(3)_775-787.nxml.txt.nlp	24519956	SENT201	21	21	7	7	ethanol	PC3	PA448073	57332;7832;5122	0.682
NULL	Mol_Cancer_2010_Nov_8_9_291.nxml.txt.nlp	21059223	SENT10	12	12	30	30	paclitaxel	Bcl-2	PA450761	596	0.682
NULL	Oncotarget_2013_Aug_14_4(10)_1606-1617.nxml.txt.nlp	24091475	SENT139	0	0	8	8	troglitazone	BiP	PA451799	3309	0.682
NULL	Child_Adolesc_Psychiatry_Ment_Health_2009_Mar_19_3_11.nxml.txt.nlp	19298659	SENT309	12	12	5	5	sertraline	Gen	PA451333	348654	0.682
NULL	J_Korean_Med_Sci_2011_Feb_24_26(2)_214-221.nxml.txt.nlp	21286012	SENT131	5	5	29	29	gefitinib	EGFR	PA131301952	1956	0.682
NULL	Iran_Red_Crescent_Med_J_2013_Feb_5_15(2)_147-151.nxml.txt.nlp	23682327	SENT5	11	11	24	24	methylprednisolone	IL-6	PA450466	3569	0.682
NULL	Neuropsychopharmacology_2009_Jul_11_34(8)_1946-1957.nxml.txt.nlp	19279569	SENT192	1	1	13	13	cocaine	DOR	PA449072	58476	0.682
NULL	Cardiovasc_Diabetol_2011_Dec_22_10_115.nxml.txt.nlp	22189184	SENT15	25	25	27	27	sitagliptin	GLP-1	PA164748978	100125288	0.682
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Dec_15_67(Pt_1)_o128-o129.nxml.txt.nlp	21522639	SENT68	36	36	14	14	ethanol	mol	PA448073	90527	0.682
NULL	Nat_Chem_Biol_2013_Feb_9_9(2)_112-118.nxml.txt.nlp	23222885	SENT162	0	0	16	16	geldanamycin	Hsp40	PA152031327	3337	0.682
NULL	Oxid_Med_Cell_Longev_2012_Oct_24_2012_906252.nxml.txt.nlp	23150750	SENT648	12	12	24	24	lipase	Cocoa	PA450239	57658	0.682
NULL	Arthritis_Res_Ther_2005_Dec_1_7(1)_R149-R155.nxml.txt.nlp	15642135	SENT193	18	18	31	31	infliximab	ACR	PA452639	49	0.682
NULL	Cancer_Immunol_Immunother_2015_Oct_7_64_61-73.nxml.txt.nlp	25287778	SENT199	11	11	15	15	lenalidomide	IL-2	PA162363968	3558	0.682
NULL	Allergy_2014_Jul_29_69(7)_817-827.nxml.txt.nlp	24773466	SENT214	29	29	13	13	theophylline	HDAC2	PA451647	3066	0.682
NULL	Biologics_2014_May_27_8_207-210.nxml.txt.nlp	24904202	SENT29	2	2	23	23	infliximab	ACT	PA452639	12;11332;9457;641455	0.682
NULL	Indian_J_Endocrinol_Metab_2013_Jul-Aug_17(4)_636-646.nxml.txt.nlp	23961479	SENT157	14	14	24	24	lovastatin	CYP3A4	PA450272	1576	0.682
NULL	Acta_Pharmacol_Sin_2009_Feb_5_30(2)_228-234.nxml.txt.nlp	19122672	SENT136	17	17	23	23	isoflurane	HO-1	PA450106	3162	0.682
NULL	J_Cancer_Prev_2014_Mar_19(1)_39-46.nxml.txt.nlp	25337571	SENT19	5	5	22	22	ethanol	JNK	PA448073	5599	0.682
NULL	Diabetes_Care_2011_Mar_17_34(3)_782-784.nxml.txt.nlp	21357366	SENT57	32	32	4	4	aspirin	ADA	PA448497	100	0.682
NULL	Int_J_Mol_Sci_2012_Sep_5_13(9)_11012-11026.nxml.txt.nlp	23109835	SENT121	12	12	18	18	cisplatin	Bcl-2	PA449014	596	0.682
NULL	Mol_Cancer_2010_May_26_9_121.nxml.txt.nlp	20500904	SENT52	33	33	26	26	gefitinib	HRG1	PA131301952	55652	0.682
NULL	Biomed_Res_Int_2014_Mar_6_2014_712893.nxml.txt.nlp	24734240	SENT123	18	18	6	6	ethanol	HIF-1alpha	PA448073	3091	0.682
NULL	BMJ_2013_Apr_18_346_f2310.nxml.txt.nlp	23599320	SENT234	21	21	24	24	capsaicin	TRPV1	PA448776	7442	0.682
NULL	Am_J_Physiol_Cell_Physiol_2009_Oct_5_297(4)_C898-C906.nxml.txt.nlp	19657054	SENT284	9	9	21	21	collagenase	p38	PA449107	10598;1432;7965	0.682
NULL	J_Antimicrob_Chemother_2013_Mar_9_68(3)_697-707.nxml.txt.nlp	23143901	SENT150	11	11	23	23	oseltamivir	ZAN	PA450721	7455	0.682
NULL	Oxid_Med_Cell_Longev_2013_Jun_6_2013_462361.nxml.txt.nlp	23840917	SENT278	8	8	15	15	taurine	p67phox	PA451590	4688	0.682
NULL	J_Gen_Physiol_2000_Jun_1_115(6)_685-696.nxml.txt.nlp	10828243	SENT159	5	5	10	10	genistein	OLF	PA165109660	83857	0.682
NULL	Head_Face_Med_2011_Jul_7_7_11.nxml.txt.nlp	21736714	SENT17	0	0	2	2	bleomycin	BLM	PA448645	641	0.682
NULL	J_Biol_Chem_2013_Jul_19_288(29)_21412-21421.nxml.txt.nlp	23740251	SENT105	12	12	36	36	suramin	P2X2	PA10292	22953	0.682
NULL	Neural_Regen_Res_2013_Jul_15_8(20)_1853-1862.nxml.txt.nlp	25206494	SENT17	0	0	3	3	ethanol	p53	PA448073	7157	0.682
NULL	Mol_Cancer_2009_Nov_19_8_108.nxml.txt.nlp	19925669	SENT407	3	3	25	25	doxorubicin	GMP	PA449412	22978	0.682
NULL	Cancer_Immunol_Immunother_2013_May_16_62(5)_897-908.nxml.txt.nlp	23589107	SENT4	5	5	13	13	cyclophosphamide	IL-2	PA449165	3558	0.682
NULL	Angiogenesis_2012_Jun_2_15(2)_275-286.nxml.txt.nlp	22382585	SENT3	4	4	6	6	cyclophosphamide	CTX	PA449165	1593	0.682
NULL	Curr_Neuropharmacol_2013_May_11(3)_276-297.nxml.txt.nlp	24179464	SENT777	28	28	32	32	glucose	CA1	PA449773	759	0.682
NULL	Ann_Surg_Oncol_2012_Dec_6_19(13)_4287-4299.nxml.txt.nlp	22766981	SENT20	15	15	30	30	capecitabine	EGFR	PA448771	1956	0.682
NULL	Front_Endocrinol_(Lausanne)_2013_Oct_18_4_151.nxml.txt.nlp	24151489	SENT352	14	14	0	0	estradiol	Gen	PA449503	348654	0.682
NULL	Am_J_Physiol_Cell_Physiol_2009_Jul_6_297(1)_C160-C168.nxml.txt.nlp	19419997	SENT66	25	25	40	40	l-glutamine	CO2	PA10090	4513	0.682
NULL	J_Gen_Physiol_1997_Dec_1_110(6)_643-654.nxml.txt.nlp	9382893	SENT161	7	7	5	5	diazoxide	ADP	PA449285	23038	0.682
NULL	Mediators_Inflamm_2010_Mar_7_2010_364957.nxml.txt.nlp	20224654	SENT115	4	4	16	16	sibutramine	IL-6	PA451344	3569	0.682
NULL	Cancers_(Basel)_2012_Jul_16_4(3)_673-700.nxml.txt.nlp	24213461	SENT691	15	15	30	30	dextran	beta-catenin	PA449261	1499	0.682
NULL	Semin_Immunopathol_2009_Sep_26_31(3)_383-397.nxml.txt.nlp	19468733	SENT75	7	7	31	31	l-methionine	CD4	PA450423	920	0.682
NULL	Breast_Cancer_Res_2011_Apr_15_13(2)_R44.nxml.txt.nlp	21496232	SENT82	0	0	7	7	lapatinib	San	PA152241907	80218	0.682
NULL	Exp_Mol_Med_2012_Dec_17_44(12)_707-722.nxml.txt.nlp	23143559	SENT137	8	8	10	10	staurosporine	BIM	PA165109623	10018	0.682
NULL	Mol_Cancer_2010_Nov_25_9_305.nxml.txt.nlp	21108789	SENT77	29	29	27	27	doxorubicin	PTEN	PA449412	5728	0.682
NULL	Mol_Pain_2012_Sep_22_8_71.nxml.txt.nlp	22998838	SENT92	41	41	22	22	cisplatin	CB2	PA449014	1269	0.682
NULL	J_Sens_Technol_2013_Sep_3(3)_10_4236_jst_2013_33015.nxml.txt.nlp	24409399	SENT88	17	17	15	15	ketamine	DC3	PA450144	347516	0.682
NULL	Breast_Cancer_Res_2011_Oct_24_13(5)_R102.nxml.txt.nlp	22023734	SENT85	0	0	13	13	fluorescein	San	PA164746009	80218	0.682
NULL	Oncol_Lett_2013_Feb_7_5(2)_440-446.nxml.txt.nlp	23420122	SENT113	3	3	9	9	gemcitabine	Bcl-2	PA449748	596	0.682
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jul_6_67(Pt_8)_o1933.nxml.txt.nlp	22090977	SENT73	27	27	6	6	ethanol	mol	PA448073	90527	0.682
NULL	Int_J_Breast_Cancer_2011_Feb_24_2011_967419.nxml.txt.nlp	22332018	SENT107	12	12	19	19	topotecan	MRP2	PA451729	100130958;57626;1244	0.682
NULL	Front_Behav_Neurosci_2013_Dec_9_7_193.nxml.txt.nlp	24367309	SENT117	9	9	2	2	diltiazem	CNGA3	PA449334	1261	0.682
NULL	Mol_Syst_Biol_2010_Jul_27_6_391.nxml.txt.nlp	20664637	SENT185	12	12	25	25	sugar	CHKA	PA451529	1119	0.682
NULL	J_Neuroinflammation_2010_Nov_18_7_81.nxml.txt.nlp	21087489	SENT70	34	34	10	10	pilocarpine	CA1	PA450962	759	0.682
NULL	J_Cell_Biol_2005_Nov_21_171(4)_729-738.nxml.txt.nlp	16286510	SENT87	28	28	3	3	trypsin	FGF2	PA451806	2247;2258	0.682
NULL	Exp_Hematol_Oncol_2013_Apr_10_2_11.nxml.txt.nlp	23574711	SENT143	24	24	3	3	l-arginine	OTC	PA448478	5009	0.682
NULL	J_Mol_Med_(Berl)_2012_Apr_30_90(4)_401-411.nxml.txt.nlp	22038171	SENT142	12	12	5	5	tetracycline	PTH	PA451640	5741	0.682
NULL	Biologics_2009_Jul_13_3_289-301.nxml.txt.nlp	19707416	SENT83	20	20	28	28	trastuzumab	HER2	PA451743	2064	0.682
NULL	Exp_Ther_Med_2013_Feb_13_5(2)_581-585.nxml.txt.nlp	23403473	SENT8	13	13	30	30	etanercept	HMGB1	PA449515	3146	0.682
NULL	J_Obes_2011_Sep_18_2011_407237.nxml.txt.nlp	21941635	SENT135	3	3	5	5	sugar	DES	PA451529	1674	0.682
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Oct_9_66(Pt_11)_o2724.nxml.txt.nlp	21588935	SENT57	22	22	13	13	ethanol	mol	PA448073	90527	0.682
NULL	J_Inj_Violence_Res_2014_Jul_6(2)_72-78.nxml.txt.nlp	24121451	SENT42	25	25	22	22	ibudilast	TLR4	PA165958351	7099	0.682
NULL	Mol_Pain_2012_Sep_21_8_70.nxml.txt.nlp	22998799	SENT248	14	14	7	7	capsaicin	TRPV1	PA448776	7442	0.682
NULL	Cell_Death_Dis_2014_Mar_13_5(3)_e1112.nxml.txt.nlp	24625971	SENT99	18	18	12	12	curcumin	CHOP	PA151958596	1649	0.682
NULL	Br_J_Cancer_2013_Mar_19_108(5)_1079-1091.nxml.txt.nlp	23449353	SENT228	29	29	19	19	docetaxel	MIC-1	PA449383	29919;9518	0.682
NULL	Eur_J_Nutr_2009_Jun_24_48(4)_229-234.nxml.txt.nlp	19238310	SENT43	7	7	37	37	capsaicin	ghrelin	PA448776	51738	0.682
NULL	Mol_Vis_2011_May_4_17_1172-1181.nxml.txt.nlp	21617754	SENT226	19	19	8	8	staurosporine	FKBP51	PA165109623	2289	0.682
NULL	J_Korean_Med_Sci_2010_Apr_19_25(4)_619-625.nxml.txt.nlp	20358008	SENT35	12	12	20	20	trypsin	BRL	PA451806	23774	0.682
NULL	Clin_Ophthalmol_2014_Jun_3_8_1057-1064.nxml.txt.nlp	24940042	SENT68	3	3	11	11	bevacizumab	CST	PA130232992	9514	0.682
NULL	Clin_Pharmacol_2013_Dec_10_5_193-199.nxml.txt.nlp	24353447	SENT82	15	15	32	32	fexofenadine	CYP3A4	PA449621	1576	0.682
NULL	Oncogene_2013_Oct_17_32(42)_5089-5100.nxml.txt.nlp	23178492	SENT74	15	15	13	13	vorinostat	TGFBR2	PA164748224	7048	0.682
NULL	Clin_Interv_Aging_2010_Sep_7_5_253-258.nxml.txt.nlp	20852672	SENT159	12	12	22	22	risperidone	Gen	PA451257	348654	0.682
NULL	Oncol_Lett_2014_Jun_2_7(6)_1889-1894.nxml.txt.nlp	24932254	SENT115	25	25	11	11	paclitaxel	OCT1	PA450761	5451;6580	0.682
NULL	Mol_Pain_2014_Apr_9_10_24.nxml.txt.nlp	24716552	SENT161	21	21	17	17	capsaicin	NK1R	PA448776	6869	0.682
NULL	ScientificWorldJournal_2014_Dec_31_2014_508178.nxml.txt.nlp	25614889	SENT20	18	18	27	27	ustekinumab	IL-23	PA166048654	51561	0.682
NULL	Clin_Ophthalmol_2008_Jun_2(2)_339-346.nxml.txt.nlp	19668725	SENT119	19	19	9	9	bevacizumab	VEGF-A	PA130232992	7422	0.682
NULL	Avicenna_J_Phytomed_2014_Nov-Dec_4(6)_377-384.nxml.txt.nlp	25386401	SENT110	0	0	2	2	piroxicam	GIT	PA450985	5034	0.682
NULL	Orphanet_J_Rare_Dis_2007_Jan_23_2_6.nxml.txt.nlp	17244349	SENT101	13	13	20	20	cisplatin	ADM	PA449014	133	0.682
NULL	Mol_Cancer_2007_Jan_14_6_5.nxml.txt.nlp	17222355	SENT7	16	16	23	23	doxorubicin	HMGA2	PA449412	8091	0.682
NULL	Oncotarget_2014_Sep_10_5(19)_8924-8936.nxml.txt.nlp	25238040	SENT88	5	5	22	22	decitabine	p53	PA164749631	7157	0.682
NULL	Braz_J_Microbiol_2011_Dec_1_Oct-Dec_42(4)_1434-1436.nxml.txt.nlp	24031774	SENT34	35	35	20	20	ceftriaxone	TOB	PA448866	10140	0.682
NULL	Int_J_Inflam_2010_Aug_9_2010_151097.nxml.txt.nlp	21152121	SENT334	20	20	26	26	thrombin	C5a	PA451674	727	0.682
NULL	J_Breast_Cancer_2011_Dec_27_14(4)_276-282.nxml.txt.nlp	22323913	SENT20	9	9	22	22	trastuzumab	HER2	PA451743	2064	0.682
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Feb_17_68(Pt_3)_o764.nxml.txt.nlp	22412639	SENT66	16	16	7	7	ethanol	mol	PA448073	90527	0.682
NULL	EJC_Suppl_2013_Sep_5_11(2)_307-309.nxml.txt.nlp	NULL	SENT148	4	4	23	23	crizotinib	LBA1	PA165946122	9881	0.682
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Feb_4_68(Pt_3)_o625-o626.nxml.txt.nlp	22412532	SENT83	18	18	33	33	ethanol	ski	PA448073	55733	0.682
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Aug_6_64(Pt_9)_o1693.nxml.txt.nlp	21201682	SENT61	23	23	14	14	ethanol	mol	PA448073	90527	0.682
NULL	Cancer_2014_Jun_15_120(12)_1871-1880.nxml.txt.nlp	24634003	SENT4	2	2	23	23	sunitinib	IFN	PA162372840	3439	0.682
NULL	FEBS_Open_Bio_2013_Aug_19_3_379-386.nxml.txt.nlp	24251099	SENT191	13	13	7	7	nadh	LDHA	PA164755085	3939	0.682
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT90	0	0	2	2	nevirapine	CYP3A4	PA450616	1576	0.682
NULL	Adv_Biomed_Res_2013_Jul_30_2_60.nxml.txt.nlp	24223375	SENT55	11	11	27	27	remifentanil	ANOVA	PA451232	4858	0.682
NULL	Cell_Cycle_2013_Jan_15_12(2)_203.nxml.txt.nlp	23287473	SENT31	6	6	4	4	cisplatin	p53	PA449014	7157	0.682
NULL	J_Nutr_Biochem_2012_Apr_23(4-2)_332-340.nxml.txt.nlp	21543215	SENT155	10	10	22	22	lipase	HSL	PA450239	3991	0.682
NULL	Mol_Cancer_2012_Jul_12_11_45.nxml.txt.nlp	22788833	SENT12	5	5	22	22	cisplatin	HER2	PA449014	2064	0.682
NULL	Crit_Care_2010_Oct_13_14(5)_R181.nxml.txt.nlp	20942931	SENT311	20	20	5	5	cisplatin	IL-6	PA449014	3569	0.682
NULL	J_Korean_Med_Sci_2006_Dec_31_21(6)_1037-1040.nxml.txt.nlp	17179683	SENT93	15	15	8	8	metronidazole	BAM	PA450484	9126	0.682
NULL	Braz_J_Med_Biol_Res_2014_May_23_47(7)_548-553.nxml.txt.nlp	24863648	SENT38	27	27	47	47	l-glutamine	CO2	PA10090	4513	0.682
NULL	Cancer_Metab_2014_May_28_2(Suppl_1)_P65.nxml.txt.nlp	NULL	SENT5	22	22	30	30	resveratrol	SIRT1		23411	0.682
NULL	Cell_Mol_Life_Sci_2012_Apr_1_69(8)_1377-1389.nxml.txt.nlp	22130515	SENT99	11	11	14	14	tamoxifen	TBX3	PA451581	6926	0.682
NULL	Diabetes_Care_2010_Jul_33(7)_1674-1685.nxml.txt.nlp	20587728	SENT441	12	12	14	14	metformin	HER2	PA450395	2064	0.682
NULL	Int_J_Breast_Cancer_2013_Jun_24_2013_137414.nxml.txt.nlp	23864953	SENT254	32	32	36	36	lapatinib	HER-2	PA152241907	2064	0.682
NULL	Environ_Health_Perspect_2005_Jun_14_113(6)_749-755.nxml.txt.nlp	15929899	SENT123	26	26	18	18	l-glutamine	RANKL	PA10090	8600	0.682
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT328	12	12	16	16	risperidone	PRL	PA451257	5617	0.682
NULL	Stroke_Res_Treat_2009_Dec_20_2010_386389.nxml.txt.nlp	20700422	SENT291	26	26	23	23	pioglitazone	NAC	PA450970	22861	0.682
NULL	AIDS_Res_Treat_2012_Mar_5_2012_703604.nxml.txt.nlp	22500218	SENT106	24	24	9	9	artesunate	CYP2A6	PA165111697	1548	0.682
NULL	Cell_Cycle_2013_Sep_1_12(17)_2794-2808.nxml.txt.nlp	23966170	SENT121	34	34	36	36	galactose	GAL	PA449725	51083	0.682
NULL	Biology_(Basel)_2012_Dec_31_2(1)_40-63.nxml.txt.nlp	24832651	SENT40	22	22	0	0	hydroxyurea	BRCA2	PA449942	675	0.682
NULL	JAKSTAT_2013_Jan_1_2(1)_e22925.nxml.txt.nlp	24058789	SENT324	2	2	15	15	curcumin	JAK1	PA151958596	3716	0.682
NULL	Cells_2014_Apr_8_3(2)_258-287.nxml.txt.nlp	24717323	SENT283	40	40	17	17	forskolin	TRPV1	PA146096022	7442	0.682
NULL	Breast_Cancer_Res_2007_May_30_9(3)_R34.nxml.txt.nlp	17537232	SENT174	18	18	10	10	tamoxifen	TP53	PA451581	7157	0.682
NULL	Front_Oncol_2014_Sep_16_4_238.nxml.txt.nlp	25279350	SENT196	16	16	33	33	afatinib	EGFR	PA165981154	1956	0.682
NULL	Arthritis_Res_Ther_2013_Jul_9_15(4)_R73.nxml.txt.nlp	23837669	SENT263	20	20	8	8	colchicine	IL-8	PA449092	3576	0.682
NULL	Mol_Biol_Cell_2012_Sep_1_23(17)_3473-3484.nxml.txt.nlp	22787275	SENT233	12	12	18	18	doxorubicin	ABCC1	PA449412	4363	0.682
NULL	Cell_Death_Differ_2010_Sep_5_17(9)_1511-1523.nxml.txt.nlp	20203690	SENT319	8	8	6	6	ethanol	NF-YA	PA448073	4800	0.682
NULL	Cell_Res_2014_Jun_18_24(6)_665-679.nxml.txt.nlp	24638034	SENT46	24	24	30	30	heparin	EGF	PA449855	1950	0.682
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_33-43.nxml.txt.nlp	17912634	SENT152	34	34	7	7	letrozole	HER2	PA450196	2064	0.682
NULL	Cardiovasc_Diabetol_2005_Dec_1_4_18.nxml.txt.nlp	16321162	SENT26	9	9	20	20	aspirin	ADA	PA448497	100	0.682
NULL	Br_J_Pharmacol_2012_Aug_166(8)_2263-2276.nxml.txt.nlp	22471905	SENT53	32	32	26	26	choline	CDP	PA448976	1523	0.682
NULL	Cerebrovasc_Dis_Extra_2013_Jun_11_3(1)_85-94.nxml.txt.nlp	23885261	SENT127	18	18	15	15	alteplase	OCSP	PA164776730	83882	0.682
NULL	Biologics_2010_Dec_2_4_315-323.nxml.txt.nlp	21209726	SENT138	18	18	12	12	imatinib	CML	PA10804	613	0.682
NULL	Acta_Orthop_2012_Oct_22_83(5)_523-528.nxml.txt.nlp	23043271	SENT23	23	23	6	6	zinc	ECM	PA451956	22915	0.682
NULL	Environ_Health_Perspect_2009_Jul_23_117(7)_1155-1161.nxml.txt.nlp	19654927	SENT94	19	19	24	24	dextran	FBS	PA449261	64319;26269	0.682
NULL	BMB_Rep_2013_Aug_46(8)_410-415.nxml.txt.nlp	23977989	SENT107	8	8	5	5	curcumin	HO-1	PA151958596	3162	0.682
NULL	J_Lipid_Res_2015_Jan_56(1)_109-121.nxml.txt.nlp	25421061	SENT775	21	21	29	29	lipase	ABHD5	PA450239	51099	0.682
NULL	J_Autom_Methods_Manag_Chem_2008_Apr_5_2008_502953.nxml.txt.nlp	19365566	SENT2703	11	11	3	3	abacavir	FOR	PA448004	51741	0.682
NULL	Open_Orthop_J_2008_Jul_14_2_115-120.nxml.txt.nlp	19478935	SENT40	0	0	2	2	amifostine	AMF	PA448365	2821	0.682
NULL	J_Cardiothorac_Surg_2013_Apr_4_8_63.nxml.txt.nlp	23557204	SENT175	11	11	27	27	glucose	FDG	PA449773	23583	0.682
NULL	Oncol_Lett_2013_Feb_7_5(2)_440-446.nxml.txt.nlp	23420122	SENT247	29	29	16	16	gemcitabine	Gem	PA449748	51053	0.682
NULL	J_Cell_Biol_2000_Jul_10_150(1)_131-144.nxml.txt.nlp	10893262	SENT30	36	36	30	30	staurosporine	PC6	PA165109623	5125	0.682
NULL	Calcif_Tissue_Int_2011_Aug_3_89(2)_140-150.nxml.txt.nlp	21633782	SENT280	4	4	13	13	heparin	FGF23	PA449855	8074	0.682
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_79-96.nxml.txt.nlp	19305789	SENT166	19	19	13	13	capsaicin	TRPV1	PA448776	7442	0.682
NULL	Daru_2011_19(3)_173-186.nxml.txt.nlp	22615655	SENT52	20	20	9	9	choline	VIII	PA448976	1351	0.682
NULL	Biol_Open_2014_Nov_13_3(12)_1164-1172.nxml.txt.nlp	25395667	SENT94	16	16	23	23	capsaicin	TRPV1	PA448776	7442	0.682
NULL	Eur_J_Epidemiol_2009_Sep_2_24(9)_553-572.nxml.txt.nlp	19728115	SENT1531	12	12	26	26	phenprocoumon	PAGM	PA450921	5238	0.682
NULL	Clin_Sci_(Lond)_2012_Oct_1_123(Pt_8)_473-486.nxml.txt.nlp	22757958	SENT74	17	17	28	28	glucosamine	HBP	PA164747613	3069;50865;7884;566	0.682
NULL	Breast_Cancer_Res_2007_Mar_2_9(2)_205.nxml.txt.nlp	NULL	SENT137	32	32	22	22	bevacizumab	HER-2	PA130232992	2064	0.682
NULL	J_Skin_Cancer_2012_Jun_13_2012_410925.nxml.txt.nlp	22745913	SENT100	24	24	7	7	lipase	IL1R2	PA450239	7850	0.682
NULL	Pharmaceuticals_(Basel)_2012_Oct_25_5(11)_1147-1159.nxml.txt.nlp	23580869	SENT211	6	6	0	0	ethionamide	FMO5	PA164768738	2330	0.682
NULL	Neuro_Oncol_2011_Nov_22_13(11)_1178-1191.nxml.txt.nlp	21940738	SENT301	2	2	19	19	hydroxyurea	CXCR4	PA449942	7852	0.682
NULL	Oncotarget_2014_Feb_7_5(3)_775-787.nxml.txt.nlp	24519956	SENT111	20	20	8	8	docetaxel	PC3	PA449383	57332;7832;5122	0.682
NULL	Br_J_Cancer_2002_Jan_21_86(2)_218-221.nxml.txt.nlp	11870509	SENT80	6	6	15	15	tamoxifen	BRCA1	PA451581	672	0.682
NULL	J_Korean_Med_Sci_2010_Jun_24_25(6)_817-823.nxml.txt.nlp	20514299	SENT89	1	1	14	14	erythromycin	VIII	PA449493	1351	0.682
NULL	Front_Neurol_2014_Sep_3_5_169.nxml.txt.nlp	25232349	SENT208	27	27	22	22	estradiol	aromatase	PA449503	1588	0.682
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_24_2012_673132.nxml.txt.nlp	23133498	SENT110	4	4	9	9	ciprofloxacin	P-gp	PA449009	5243	0.682
NULL	J_Immunol_Res_2014_May_21_2014_371087.nxml.txt.nlp	24963497	SENT322	11	11	17	17	decitabine	DAC	PA164749631	13	0.682
NULL	Br_J_Cancer_2004_Mar_22_90(6)_1285-1292.nxml.txt.nlp	15026814	SENT122	10	10	8	8	cisplatin	p53	PA449014	7157	0.682
NULL	EMBO_Rep_2010_Aug_18_11(8)_633-639.nxml.txt.nlp	20559324	SENT74	2	2	25	25	cisplatin	p63	PA449014	8626	0.682
NULL	Breast_Cancer_(Auckl)_2014_Oct_12_8_135-144.nxml.txt.nlp	25368520	SENT5	31	31	8	8	cisplatin	RAD51B	PA449014	5890	0.682
NULL	Breast_Cancer_Res_2002_May_23_4(4)_141-144.nxml.txt.nlp	12100738	SENT57	13	13	24	24	tamoxifen	HER-2	PA451581	2064	0.682
NULL	Nucleic_Acids_Res_2013_May_29_41(9)_4926-4937.nxml.txt.nlp	23543461	SENT90	12	12	29	29	paclitaxel	ADP	PA450761	23038	0.682
NULL	J_Hematol_Oncol_2008_Aug_11_1_11.nxml.txt.nlp	18694493	SENT94	19	19	12	12	temsirolimus	IFN	PA164746890	3439	0.682
NULL	Ann_Oncol_2011_Mar_8_22(3)_503-514.nxml.txt.nlp	20616198	SENT307	8	8	25	25	tamoxifen	ATAC	PA451581	6375	0.682
NULL	Clin_Dev_Immunol_2011_Dec_26_2011_890758.nxml.txt.nlp	22235224	SENT146	0	0	16	16	pertuzumab	HER2		2064	0.682
NULL	Oncotarget_2014_Oct_18_5(22)_11552-11563.nxml.txt.nlp	25344911	SENT27	15	15	22	22	vincristine	DDP	PA451879	1678	0.682
NULL	Environ_Health_Perspect_2007_Dec_8_115(Suppl_1)_129-136.nxml.txt.nlp	18174961	SENT19	18	18	35	35	lindane	Bcl-2	PA164754914	596	0.682
NULL	Nat_Commun_2012_Jun_12_3_902.nxml.txt.nlp	22692545	SENT59	38	38	47	47	lipase	ATGL	PA450239	57104	0.682
NULL	Front_Microbiol_2014_Mar_27_5_124.nxml.txt.nlp	24723921	SENT202	23	23	15	15	nadh	ADP	PA164755085	23038	0.682
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Apr_15_6_37-41.nxml.txt.nlp	24833915	SENT38	32	32	27	27	maytansine	DM1	PA165291473	338023;1760;28509	0.682
NULL	Ann_Rheum_Dis_2011_Mar_17_70(6)_996-1002.nxml.txt.nlp	21415050	SENT95	21	21	12	12	methotrexate	NNT	PA450428	23530	0.682
NULL	Acta_Orthop_2014_Feb_25_85(1)_3-5.nxml.txt.nlp	24171686	SENT40	0	0	2	2	teriparatide	PTH	PA451620	5741	0.682
NULL	Mol_Med_Rep_2015_Feb_29_11(2)_924-930.nxml.txt.nlp	25351620	SENT119	18	18	34	34	paclitaxel	p27	PA450761	5715;10534	0.682
NULL	J_Nutr_Biochem_2012_Apr_23(4-2)_332-340.nxml.txt.nlp	21543215	SENT155	10	10	12	12	lipase	ATGL	PA450239	57104	0.682
NULL	Anticancer_Drugs_2015_Jan_28_26(1)_46-55.nxml.txt.nlp	25099621	SENT239	8	8	23	23	cisplatin	LAK	PA449014	10123	0.682
NULL	Indian_Dermatol_Online_J_2014_Dec_5(Suppl_2)_S130-S131.nxml.txt.nlp	25593805	SENT14	4	4	8	8	acitretin	CO2	PA448039	4513	0.682
NULL	Front_Genet_2014_Jun_2_5_154.nxml.txt.nlp	24917878	SENT54	19	19	21	21	vasopressin	AVP	PA451858	114548;551	0.682
NULL	Int_J_Mol_Sci_2014_Nov_10_15(11)_20607-20637.nxml.txt.nlp	25391045	SENT40	27	27	31	31	fluvastatin	CYP2C9	PA449688	1559	0.682
NULL	Stroke_Res_Treat_2009_Dec_20_2010_386389.nxml.txt.nlp	20700422	SENT205	11	11	9	9	pioglitazone	gamma	PA450970	9913	0.682
NULL	Front_Behav_Neurosci_2010_Apr_5_4_14.nxml.txt.nlp	20407577	SENT656	6	6	16	16	cocaine	NAC1	PA449072	112939;6323	0.682
NULL	Front_Mol_Neurosci_2015_Jan_9_7_103.nxml.txt.nlp	25620909	SENT123	2	2	13	13	choline	spatial	PA448976	219793	0.682
NULL	Pharmaceutics_2011_Oct_12_3(4)_680-705.nxml.txt.nlp	24309303	SENT91	31	31	11	11	cimetidine	SLC22A2	PA449001	6582	0.682
NULL	Nature_2012_Dec_13_492(7428)_285-289.nxml.txt.nlp	23103865	SENT202	19	19	25	25	doxycycline	TPP1	PA449415	1200	0.682
NULL	Breast_Cancer_Res_2007_Dec_20_9(Suppl_2)_S19.nxml.txt.nlp	NULL	SENT9	37	37	11	11	tamoxifen	IMPACT	PA451581	55364	0.682
NULL	Iran_J_Basic_Med_Sci_2011_Sep-Oct_14(5)_436-442.nxml.txt.nlp	23493930	SENT93	31	31	1	1	glibenclamide	ANOVA	PA449782	4858	0.682
NULL	Infect_Drug_Resist_2010_Oct_13_3_103-114.nxml.txt.nlp	21694899	SENT46	20	20	7	7	raltegravir	UGT1A1		54658	0.682
NULL	Crit_Care_2006_May_25_10(3)_144.nxml.txt.nlp	16732898	SENT2	22	22	24	24	vasopressin	AVP	PA451858	114548;551	0.682
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2011_Mar_14_4_13-24.nxml.txt.nlp	22879790	SENT150	20	20	8	8	metformin	GLP-1	PA450395	100125288	0.682
NULL	Pharm_Methods_2011_Jul-Sep_2(3)_178-183.nxml.txt.nlp	23781452	SENT18	0	0	2	2	lornoxicam	LOR	PA165958395	4014	0.682
NULL	J_Immunotoxicol_2013_Jan_11_10(1)_75-82.nxml.txt.nlp	22967038	SENT97	9	9	18	18	muromonab	IL-2	PA164743097	3558	0.682
NULL	Diabetol_Metab_Syndr_2014_Mar_31_6_48.nxml.txt.nlp	24684803	SENT119	16	16	9	9	mitiglinide	STEP	PA164748124	84867	0.682
NULL	J_Cell_Mol_Med_2014_Oct_11_18(10)_2031-2043.nxml.txt.nlp	25109475	SENT268	0	0	11	11	valsartan	TLR-4	PA451848	7099	0.682
NULL	Breast_Cancer_(Auckl)_2010_Feb_16_4_1-3.nxml.txt.nlp	20697527	SENT19	30	30	32	32	curcumin	CTX	PA151958596	1593	0.682
NULL	Acta_Pharmacol_Sin_2012_Jan_28_33(1)_66-74.nxml.txt.nlp	22120966	SENT175	32	32	9	9	genistein	OPG	PA165109660	690	0.682
NULL	Cancer_Med_2013_Aug_30_2(4)_457-467.nxml.txt.nlp	24156018	SENT257	31	31	17	17	marimastat	IDH1	PA164748329	3417	0.682
NULL	Cancer_Cell_Int_2013_Mar_4_13_21.nxml.txt.nlp	23497288	SENT59	39	39	3	3	ifosfamide	EWS	PA449964	2130	0.682
NULL	Clin_Pharmacol_2013_Dec_10_5_193-199.nxml.txt.nlp	24353447	SENT29	27	27	43	43	dextromethorphan	CYP2D6	PA449273	1565	0.682
NULL	Acta_Pharmacol_Sin_2013_Oct_7_34(10)_1349-1358.nxml.txt.nlp	23892274	SENT192	20	20	12	12	etoposide	P-gp	PA449552	5243	0.682
NULL	J_Nutr_Metab_2011_Oct_1_2011_525094.nxml.txt.nlp	21977315	SENT146	1	1	4	4	resveratrol	SIRT3		23410	0.682
NULL	New_Microbes_New_Infect_2014_May_4_2(3)_58-63.nxml.txt.nlp	25356345	SENT100	34	34	24	24	colistin	ANK	PA164760862	56172	0.682
NULL	Ital_J_Pediatr_2011_Dec_19_37_58.nxml.txt.nlp	22182677	SENT162	12	12	8	8	diazepam	CLB	PA449283	171425	0.682
NULL	J_Vis_Exp_2014_Jun_28_(88)_51278.nxml.txt.nlp	24998179	SENT45	11	11	5	5	aprotinin	LRP1	PA448472	10438;4035	0.681
NULL	Breast_Cancer_Res_2006_Oct_24_8(5)_R59.nxml.txt.nlp	17062128	SENT15	13	13	17	17	urokinase	UPA	PA451836	118471;5328	0.681
NULL	Evid_Based_Complement_Alternat_Med_2011_Feb_14_2011_248231.nxml.txt.nlp	19233878	SENT241	5	5	12	12	rosiglitazone	AMPK	PA451283	5563	0.681
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_321-328.nxml.txt.nlp	21372824	SENT7	17	17	12	12	fluvastatin	STZ	PA449688	6484	0.681
NULL	Emerg_Infect_Dis_2012_Jun_18(6)_1019-1020.nxml.txt.nlp	22608263	SENT34	18	18	36	36	gentamicin	NXN	PA449753	64359	0.681
NULL	Endocrinol_Metab_(Seoul)_2014_Sep_25_29(3)_379-387.nxml.txt.nlp	25309798	SENT111	9	9	21	21	resveratrol	SIRT1		23411	0.681
NULL	ScientificWorldJournal_2012_Dec_17_2012_916381.nxml.txt.nlp	23319889	SENT6	7	7	26	26	ciprofloxacin	CTX	PA449009	1593	0.681
NULL	Braz_J_Med_Biol_Res_2013_Jul_2_46(6)_465-485.nxml.txt.nlp	23828584	SENT222	15	15	23	23	lisinopril	GGH	PA450242	8836	0.681
NULL	EMBO_Mol_Med_2013_Aug_5_5(8)_1149-1150.nxml.txt.nlp	23918227	SENT18	2	2	6	6	rituximab	CHOP	PA451261	1649	0.681
NULL	Oxid_Med_Cell_Longev_2011_Aug_4_2011_471590.nxml.txt.nlp	21904644	SENT65	28	28	32	32	probucol	CA1	PA451107	759	0.681
NULL	Nucleic_Acids_Res_2013_Nov_27_41(21)_9786-9799.nxml.txt.nlp	23982513	SENT198	4	4	10	10	arsenite	ADAR1	PA452638	103	0.681
NULL	J_Thromb_Haemost_2011_Oct_9(10)_2103-2105.nxml.txt.nlp	21812912	SENT17	4	4	23	23	ticagrelor	ADP	PA165374673	23038	0.681
NULL	Cancer_2014_Apr_8_120(8)_1145-1154.nxml.txt.nlp	24501009	SENT86	16	16	6	6	erlotinib	EGFR	PA134687924	1956	0.681
NULL	Diabetes_Care_2010_Feb_23_33(2)_246-251.nxml.txt.nlp	19933994	SENT134	2	2	11	11	metformin	B12	PA450395	7126;4709	0.681
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S101-S106.nxml.txt.nlp	21525438	SENT57	0	0	9	9	torcetrapib	CETP	PA145007158	1071	0.681
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT1245	4	4	16	16	tenofovir	ABCC2	PA10204	1244	0.681
NULL	Biochemistry_2009_Feb_3_48(4)_800-809.nxml.txt.nlp	19132922	SENT160	12	12	14	14	allopurinol	XOR	PA448320	7498	0.681
NULL	Nucleic_Acids_Res_2006_Jul_1_34(Web_Server_issue)_W635-W641.nxml.txt.nlp	16845089	SENT340	14	14	3	3	warfarin	VKORC1	PA451906	79001	0.681
NULL	Nat_Med_2013_Dec_17_19(12)_1643-1648.nxml.txt.nlp	24240184	SENT261	14	14	11	11	bumetanide	NKCC1	PA448682	6558	0.681
NULL	Arthritis_Res_Ther_2008_Jan_7_10(1)_R1.nxml.txt.nlp	18179697	SENT210	26	26	9	9	oxaliplatin	HMGB1	PA131285527	3146	0.681
NULL	Nucleic_Acids_Res_2005_Aug_12_33(14)_4584-4592.nxml.txt.nlp	16100380	SENT115	18	18	11	11	paromomycin	GCN2	PA164784023	440275	0.681
NULL	Cancers_(Basel)_2010_Aug_18_2(3)_1576-1596.nxml.txt.nlp	24281174	SENT230	24	24	40	40	perifosine	ABCG2	PA165291471	9429	0.681
NULL	Core_Evid_2009_Jun_15_4_25-36.nxml.txt.nlp	20694062	SENT161	15	15	18	18	febuxostat	FACT	PA165958521	11198	0.681
NULL	Surg_Today_2012_Jan_6_42(1)_8-28.nxml.txt.nlp	22139128	SENT230	37	37	23	23	tegafur	PSK	PA452620	9344	0.681
NULL	Arthritis_Res_Ther_2005_Mar_16_7(Suppl_2)_S4-S14.nxml.txt.nlp	15833146	SENT224	0	0	25	25	methotrexate	IL-10	PA450428	3586	0.681
NULL	Nat_Neurosci_2012_Sep_5_15(9)_1245-1254.nxml.txt.nlp	22864611	SENT88	11	11	16	16	clozapine	HDAC2	PA449061	3066	0.681
NULL	Acta_Pharmacol_Sin_2012_Nov_22_33(11)_1395-1400.nxml.txt.nlp	23085738	SENT131	31	31	17	17	prasugrel	CYP2C19	PA154410481	1557	0.681
NULL	Mol_Neurodegener_2011_Aug_16_6_58.nxml.txt.nlp	21846363	SENT76	0	0	24	24	candesartan	p47phox	PA448765	653361	0.681
NULL	J_Vet_Med_Sci_2014_Aug_1_76(8)_1153-1156.nxml.txt.nlp	24784438	SENT41	7	7	17	17	cefazolin	OTC	PA448839	5009	0.681
NULL	Acta_Pharmacol_Sin_2013_Jun_8_34(6)_830-836.nxml.txt.nlp	23564080	SENT111	4	4	15	15	simvastatin	RAGE	PA451363	177	0.681
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT120	5	5	12	12	sitagliptin	HIP	PA164748978	6767;6159;64399;5068	0.681
NULL	Mol_Vis_2012_Aug_10_18_2255-2264.nxml.txt.nlp	22933838	SENT138	12	12	2	2	dextran	CD11c	PA449261	3687	0.681
NULL	Clin_Ophthalmol_2012_Jul_12_6_1057-1062.nxml.txt.nlp	22888203	SENT28	0	0	7	7	bevacizumab	San	PA130232992	80218	0.681
NULL	Cell_Commun_Signal_2010_Sep_22_8_27.nxml.txt.nlp	20860841	SENT177	23	23	9	9	hydroxyurea	CHK1	PA449942	1111	0.681
NULL	Adv_Urol_2012_Oct_26_2012_812398.nxml.txt.nlp	22110495	SENT63	30	30	45	45	cisplatin	ERCC1	PA449014	2067	0.681
NULL	Exp_Diabetes_Res_2011_Dec_27_2011_604989.nxml.txt.nlp	21253359	SENT118	8	8	12	12	clonidine	GLP-1	PA449051	100125288	0.681
NULL	Antiviral_Res_2009_May_82(2)_A99-A109.nxml.txt.nlp	19176219	SENT279	20	20	11	11	nelfinavir	P85	PA450606	8874	0.681
NULL	J_Cell_Biol_2001_Jul_9_154(1)_33-48.nxml.txt.nlp	11448988	SENT379	22	22	13	13	tetracycline	CO2	PA451640	4513	0.681
NULL	Mol_Pain_2012_Sep_10_8_64.nxml.txt.nlp	22963197	SENT116	22	22	37	37	glutaraldehyde	P2X3	PA449777	5024	0.681
NULL	Cancer_Res_Treat_2012_Mar_31_44(1)_32-36.nxml.txt.nlp	22500158	SENT102	12	12	0	0	fluorouracil	CEA	PA128406956	5670;1087	0.681
NULL	Mol_Cancer_2012_Aug_8_11_53.nxml.txt.nlp	22871047	SENT296	12	12	6	6	cisplatin	ES2	PA449014	8220	0.681
NULL	Endocrinology_2011_Feb_5_152(2)_405-413.nxml.txt.nlp	21209017	SENT156	5	5	11	11	glucosamine	GLP-1	PA164747613	100125288	0.681
NULL	Cases_J_2008_Oct_17_1_248.nxml.txt.nlp	18928542	SENT16	16	16	18	18	vasopressin	AVP	PA451858	114548;551	0.681
NULL	Cancers_(Basel)_2011_Oct_28_3(4)_4061-4089.nxml.txt.nlp	24213125	SENT781	11	11	7	7	marimastat	gamma	PA164748329	9913	0.681
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_May_5_68(Pt_6)_o1637.nxml.txt.nlp	22719438	SENT61	24	24	12	12	ethanol	mol	PA448073	90527	0.681
NULL	Mol_Cancer_2012_Dec_12_11_91.nxml.txt.nlp	23234355	SENT172	15	15	10	10	gefitinib	HER2	PA131301952	2064	0.681
NULL	Cardiovasc_Diabetol_2010_Mar_24_9_12.nxml.txt.nlp	20334663	SENT33	9	9	4	4	nateglinide	solo	PA450600	55701	0.681
NULL	Arthritis_Res_Ther_2013_Dec_27_15(6)_R222.nxml.txt.nlp	24369907	SENT181	3	3	15	15	collagenase	p38	PA449107	10598;1432;7965	0.681
NULL	J_Oncol_2009_Mar_24_2009_491985.nxml.txt.nlp	19325924	SENT122	7	7	12	12	genistein	CXCR4	PA165109660	7852	0.681
NULL	Br_J_Cancer_2011_Aug_23_105(5)_649-657.nxml.txt.nlp	21811251	SENT4	19	19	17	17	gefitinib	EGFR	PA131301952	1956	0.681
NULL	J_Hematol_Oncol_2012_Jun_8_5_29.nxml.txt.nlp	22682059	SENT148	4	4	1	1	imatinib	NRM	PA10804	11270	0.681
NULL	Clin_Psychopharmacol_Neurosci_2011_Apr_30_9(1)_36-43.nxml.txt.nlp	23431025	SENT18	1	1	5	5	aripiprazole	FLI	PA10026	2314	0.681
NULL	Int_J_Cell_Biol_2014_Jan_22_2014_709828.nxml.txt.nlp	24578708	SENT93	16	16	24	24	choline	DAG	PA448976	1605	0.681
NULL	Oncotarget_2014_Oct_18_5(21)_10206-10221.nxml.txt.nlp	25344914	SENT216	40	40	21	21	vemurafenib	BRAF	PA165946873	673	0.681
NULL	Diabetes_Metab_Syndr_Obes_2010_May_10_3_117-124.nxml.txt.nlp	21437082	SENT81	13	13	2	2	saxagliptin	GLP-1	PA165958362	100125288	0.681
NULL	Toxins_(Basel)_2010_Oct_25_2(10)_2467-2477.nxml.txt.nlp	22069561	SENT28	10	10	18	18	cisplatin	Bcl-2	PA449014	596	0.681
NULL	Biomed_Res_Int_2013_Dec_30_2013_482160.nxml.txt.nlp	23509727	SENT204	12	12	24	24	vincristine	ADM	PA451879	133	0.681
NULL	Ann_Neurosci_2012_Jan_19(1)_31-39.nxml.txt.nlp	25205961	SENT166	15	15	28	28	tetracaine	TRAAK	PA451638	50801	0.681
NULL	Oncotarget_2013_Nov_4_5(1)_161-172.nxml.txt.nlp	24389287	SENT158	0	0	8	8	propranolol	p53	PA451145	7157	0.681
NULL	J_Cardiothorac_Surg_2014_Sep_17_9(1)_129.nxml.txt.nlp	NULL	SENT174	7	7	10	10	heparin	ACT	PA449855	12;11332;9457;641455	0.681
NULL	Oncoimmunology_2012_Sep_1_1(6)_957-958.nxml.txt.nlp	23162770	SENT9	10	10	8	8	rituximab	HER2	PA451261	2064	0.681
NULL	AAPS_J_2014_Jun_11_16(5)_1029-1037.nxml.txt.nlp	24917180	SENT190	13	13	8	8	quinidine	P-gp	PA451209	5243	0.681
NULL	Eur_J_Nutr_2009_Jun_24_48(4)_229-234.nxml.txt.nlp	19238310	SENT41	17	17	26	26	capsaicin	ghrelin	PA448776	51738	0.681
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT14	7	7	11	11	phenprocoumon	VKORC1	PA450921	79001	0.681
NULL	Mol_Cancer_2008_Mar_6_7_24.nxml.txt.nlp	18325101	SENT99	16	16	12	12	cisplatin	FANCD2	PA449014	2177	0.681
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1059-1066.nxml.txt.nlp	21364577	SENT95	0	0	27	27	anastrozole	TTR	PA448432	7276	0.681
NULL	Oncotarget_2013_Nov_23_5(1)_196-210.nxml.txt.nlp	24344116	SENT206	21	21	8	8	doxorubicin	p53	PA449412	7157	0.681
NULL	Front_Pharmacol_2014_May_30_5_132.nxml.txt.nlp	24910615	SENT54	29	29	27	27	estradiol	NMI	PA449503	9111	0.681
NULL	Eur_J_Med_Res_2011_May_12_16(5)_206-212.nxml.txt.nlp	21719393	SENT29	6	6	44	44	imatinib	KIT	PA10804	3815	0.681
NULL	Eur_J_Clin_Nutr_2014_Oct_25_68(10)_1148-1153.nxml.txt.nlp	24961547	SENT110	16	16	22	22	mannitol	GCLC	PA450320	2729	0.681
NULL	Biologics_2012_Jul_13_6_221-231.nxml.txt.nlp	22904614	SENT73	21	21	3	3	cetuximab	EGFR	PA10040	1956	0.681
NULL	Iran_J_Basic_Med_Sci_2012_May-Jun_15(3)_795-802.nxml.txt.nlp	23493622	SENT72	12	12	22	22	capsaicin	URB	PA448776	151887	0.681
NULL	J_Oncol_2013_Feb_17_2013_872957.nxml.txt.nlp	23476648	SENT9	21	21	4	4	cisplatin	SFN	PA449014	25996;2810	0.681
NULL	Arthritis_Res_Ther_2011_Sep_21_13(5)_239.nxml.txt.nlp	21955617	SENT169	2	2	13	13	celecoxib	RANKL	PA448871	8600	0.681
NULL	Angiogenesis_2010_Dec_7_13(4)_305-315.nxml.txt.nlp	20927579	SENT195	9	9	25	25	resveratrol	TSP1		7057	0.681
NULL	Indian_J_Anaesth_2014_Jul-Aug_58(4)_423-429.nxml.txt.nlp	25197110	SENT131	17	17	3	3	ondansetron	ODF	PA450705	8600	0.681
NULL	Iran_J_Reprod_Med_2013_Jul_11(7)_565-576.nxml.txt.nlp	24639792	SENT93	9	9	19	19	berberine	SLPI	PA165860812	6590	0.681
NULL	Comp_Hepatol_2005_Feb_8_4_2.nxml.txt.nlp	15701172	SENT104	37	37	9	9	coumarin	CYP3A	PA134521193	1574	0.681
NULL	Indian_J_Psychiatry_2010_Jan-Mar_52(1)_90-93.nxml.txt.nlp	20174532	SENT50	10	10	24	24	lithium	SMS	PA450243	6611;10743	0.681
NULL	Indian_J_Pharmacol_2008_Jan-Feb_40(1)_10-14.nxml.txt.nlp	21264154	SENT100	11	11	8	8	vildagliptin	GLP-1	PA165958346	100125288	0.681
NULL	Acta_Pharmacol_Sin_2012_May_4_33(5)_710-716.nxml.txt.nlp	22555373	SENT177	1	1	8	8	mexiletine	DOM	PA450488	6663	0.681
NULL	Cancer_Immunol_Immunother_2012_Jul_23_61(7)_1101-1111.nxml.txt.nlp	22193989	SENT12	1	1	11	11	oxaliplatin	CD80	PA131285527	941	0.681
NULL	Acta_Histochem_Cytochem_2007_May_12_40(2)_35-41.nxml.txt.nlp	17576431	SENT385	6	6	4	4	nifedipine	DHPR	PA450631	5860	0.681
NULL	Emerg_Infect_Dis_2012_Feb_18(2)_302-304.nxml.txt.nlp	22305387	SENT113	24	24	14	14	albendazole	PYM	PA164746058	84305	0.681
NULL	Acta_Pharmacol_Sin_2009_Jul_22_30(7)_956-964.nxml.txt.nlp	19543298	SENT161	5	5	13	13	simvastatin	ABCG2	PA451363	9429	0.681
NULL	J_Biol_2006_Nov_30_5(7)_22.nxml.txt.nlp	17125495	SENT63	1	1	28	28	cisplatin	NRP	PA449014	8829;4673;10133	0.681
NULL	Springerplus_2014_Sep_9_3_510.nxml.txt.nlp	25279302	SENT184	15	15	8	8	creatine	spatial	PA164778930	219793	0.681
NULL	Cancer_Metab_2014_May_28_2(Suppl_1)_P65.nxml.txt.nlp	NULL	SENT20	0	0	3	3	resveratrol	NAMPT		10135	0.681
NULL	Blood_Cancer_J_2013_Sep_13_3(9)_e146.nxml.txt.nlp	24036945	SENT27	10	10	28	28	ribavirin	AKT	PA451241	207	0.681
NULL	Cancer_Cell_Int_2013_Oct_22_13_101.nxml.txt.nlp	24148231	SENT127	21	21	25	25	staurosporine	FBS	PA165109623	64319;26269	0.681
NULL	Oncol_Lett_2014_Nov_12_8(5)_2203-2208.nxml.txt.nlp	25295109	SENT131	15	15	21	21	celecoxib	GLI1	PA448871	2735	0.681
NULL	Clin_Psychopharmacol_Neurosci_2011_Aug_31_9(2)_78-85.nxml.txt.nlp	23429185	SENT133	5	5	36	36	clozapine	PPL	PA449061	5493	0.681
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT3	5	5	31	31	trastuzumab	STAT3	PA451743	6774	0.681
NULL	Indian_J_Med_Res_2012_May_135(5)_599-613.nxml.txt.nlp	22771588	SENT319	11	11	5	5	nadh	ND2	PA164755085	4536	0.681
NULL	J_Oncol_2009_Mar_24_2009_491985.nxml.txt.nlp	19325924	SENT140	18	18	6	6	genistein	CXCL12	PA165109660	6387	0.681
NULL	Behav_Brain_Funct_2013_Nov_26_9_43.nxml.txt.nlp	24279870	SENT119	5	5	25	25	ethanol	ANOVA	PA448073	4858	0.681
NULL	Br_J_Cancer_2010_Sep_7_103(6)_765-771.nxml.txt.nlp	20700120	SENT36	13	13	5	5	tamoxifen	CYP2D6	PA451581	1565	0.681
NULL	Oncol_Lett_2013_Feb_7_5(2)_440-446.nxml.txt.nlp	23420122	SENT121	11	11	25	25	gemcitabine	Bcl-2	PA449748	596	0.681
NULL	Ann_Oncol_2010_Mar_18_21(3)_655-661.nxml.txt.nlp	19767314	SENT149	7	7	15	15	temozolomide	GEM	PA451609	2669	0.681
NULL	Appl_Microbiol_Biotechnol_2014_Feb_18_98(8)_3829-3840.nxml.txt.nlp	24535257	SENT219	23	23	15	15	ethanol	PE-2	PA448073	2077	0.681
NULL	Eur_J_Immunol_2013_Dec_21_43(12)_3098-3107.nxml.txt.nlp	23966272	SENT107	25	25	7	7	dextran	TED	PA449261	27112	0.681
NULL	Arch_Med_Sci_2011_Dec_31_7(6)_977-983.nxml.txt.nlp	22328880	SENT93	12	12	1	1	heparin	PAPP-A	PA449855	5069	0.681
NULL	Arthritis_Res_Ther_2005_Feb_17_7(Suppl_1)_P30.nxml.txt.nlp	NULL	SENT4	4	4	18	18	infliximab	TP1	PA452639	7011	0.681
NULL	EMBO_Mol_Med_2011_Jul_3(7)_370-384.nxml.txt.nlp	21591259	SENT26	14	14	4	4	thrombin	PAR1	PA451674	79581;2149	0.681
NULL	Crit_Care_2001_Mar_2_5(Suppl_1)_P208.nxml.txt.nlp	NULL	SENT7	11	11	1	1	propofol	PTH	PA451141	5741	0.681
NULL	J_Korean_Med_Sci_2006_Apr_20_21(2)_188-192.nxml.txt.nlp	16614499	SENT109	18	18	4	4	teicoplanin	VAN	PA164746244	10318	0.681
NULL	JAKSTAT_2012_Apr_1_1(2)_55-64.nxml.txt.nlp	24058751	SENT139	3	3	11	11	flavopiridol	STAT3	PA452627	6774	0.681
NULL	Oncogene_2013_Nov_28_32(48)_5439-5448.nxml.txt.nlp	23563182	SENT174	19	19	23	23	etoposide	TRAIL	PA449552	8743	0.681
NULL	Amino_Acids_2012_May_25_42(5)_1529-1539.nxml.txt.nlp	21437784	SENT138	8	8	20	20	taurine	ADP	PA451590	23038	0.681
NULL	Clin_Exp_Pharmacol_Physiol_2014_Mar_18_41(3)_227-237.nxml.txt.nlp	24471737	SENT295	5	5	20	20	losartan	ANG	PA450268	283	0.681
NULL	J_Antimicrob_Chemother_2013_May_1_68(5)_1066-1070.nxml.txt.nlp	23378414	SENT93	2	2	19	19	erythromycin	NOV	PA449493	4856;5361;6134	0.681
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT164	0	0	4	4	atorvastatin	RANK	PA448500	8792	0.681
NULL	Exp_Ther_Med_2014_May_20_7(5)_1354-1358.nxml.txt.nlp	24940438	SENT29	6	6	40	40	dextran	San	PA449261	80218	0.681
NULL	Semin_Immunol_2011_Feb_23(1)_28-41.nxml.txt.nlp	21295490	SENT245	21	21	35	35	ustekinumab	IL-23	PA166048654	51561	0.681
NULL	Gut_2011_Sep_9_60(9)_1204-1212.nxml.txt.nlp	21307168	SENT265	8	8	25	25	geldanamycin	beta-catenin	PA152031327	1499	0.681
NULL	Environ_Health_Perspect_2008_Sep_116(9)_A402a.nxml.txt.nlp	NULL	SENT13	22	22	2	2	iron	HFE	PA450087	3077	0.681
NULL	Oncotarget_2014_Feb_14_5(5)_1279-1289.nxml.txt.nlp	24658133	SENT217	16	16	7	7	cisplatin	PUMA	PA449014	27113	0.681
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT234	7	7	9	9	cisplatin	p53	PA449014	7157	0.681
NULL	Braz_J_Med_Biol_Res_2014_May_9_47(6)_478-482.nxml.txt.nlp	24770568	SENT118	2	2	15	15	cisplatin	CD133	PA449014	8842	0.681
NULL	Exp_Neurol_2014_Nov_261_654-665.nxml.txt.nlp	25158309	SENT196	0	0	18	18	minocycline	COX	PA450519	1351	0.681
NULL	Front_Physiol_2013_Nov_14_4_323.nxml.txt.nlp	24294204	SENT256	17	17	2	2	carvedilol	ADRB1	PA448817	153	0.681
NULL	Gut_Liver_2011_Sep_18_5(3)_293-297.nxml.txt.nlp	21927656	SENT33	21	21	11	11	omeprazole	ESD	PA450704	2098	0.681
NULL	Breast_Cancer_Res_2005_Apr_12_7(4)_R570-R579.nxml.txt.nlp	15987464	SENT103	6	6	13	13	gefitinib	EGFR	PA131301952	1956	0.681
NULL	Arthritis_Res_Ther_2009_Jan_30_11(1)_206.nxml.txt.nlp	19232066	SENT304	12	12	10	10	tocilizumab	IL-6	PA165292659	3569	0.681
NULL	Behav_Brain_Funct_2012_Feb_28_8_11.nxml.txt.nlp	22369141	SENT29	17	17	8	8	clozapine	AAP	PA449061	5345	0.681
NULL	Clin_Exp_Otorhinolaryngol_2013_Mar_1_6(1)_48-51.nxml.txt.nlp	23526700	SENT81	11	11	5	5	thyroglobulin	TTF-1	PA164754910	7080	0.681
NULL	Arthritis_Res_Ther_2014_Oct_10_16(5)_454.nxml.txt.nlp	25301447	SENT37	12	12	5	5	creatine	BAFF	PA164778930	10673	0.681
NULL	Oncoscience_2014_Mar_24_1(3)_196-204.nxml.txt.nlp	25594012	SENT117	11	11	2	2	lapatinib	PTEN	PA152241907	5728	0.681
NULL	Indian_J_Nephrol_2013_Jul-Aug_23(4)_276-279.nxml.txt.nlp	23960344	SENT96	5	5	0	0	icodextrin	MIDAS	PA164743096	64083	0.681
NULL	Mol_Cancer_2010_Dec_20_9_316.nxml.txt.nlp	21172016	SENT163	31	31	45	45	heparin	CCL21	PA449855	6366	0.681
NULL	Clin_Mol_Allergy_2004_May_14_2_7.nxml.txt.nlp	15144561	SENT266	4	4	21	21	methylprednisolone	CD11b	PA450466	3684	0.681
NULL	Carcinogenesis_2014_May_13_35(5)_1055-1066.nxml.txt.nlp	24419232	SENT194	10	10	4	4	metformin	CYP1B1	PA450395	1545	0.681
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT13	15	15	12	12	metformin	HIF-1	PA450395	29072	0.681
NULL	Arthritis_Res_Ther_2007_Oct_10_9(5)_R105.nxml.txt.nlp	17927818	SENT132	27	27	12	12	pp2	PP2		4888	0.681
NULL	Allergy_Asthma_Clin_Immunol_2013_Oct_17_9(1)_41.nxml.txt.nlp	24499258	SENT168	8	8	18	18	omalizumab	IL-4	PA164752253	3565	0.681
NULL	Nat_Med_2013_Nov_27_19(11)_10_1038_nm_3364.nxml.txt.nlp	24162813	SENT52	6	6	0	0	imatinib	PTH	PA10804	5741	0.681
NULL	J_Immunol_Res_2014_Sep_1_2014_246171.nxml.txt.nlp	25254222	SENT94	35	35	38	38	abacavir	HLA-B	PA448004	3106	0.681
NULL	Front_Neurosci_2015_Jan_6_8_420.nxml.txt.nlp	25610363	SENT880	7	7	11	11	estradiol	spatial	PA449503	219793	0.681
NULL	Acta_Neuropathol_Commun_2013_May_20_1_17.nxml.txt.nlp	24252689	SENT6	33	33	20	20	fluvastatin	CRK	PA449688	1398	0.681
NULL	Cell_Cycle_2013_Sep_15_12(18)_3013-3024.nxml.txt.nlp	23974104	SENT64	0	0	4	4	disulfiram	MYH9	PA449376	4627	0.681
NULL	Mol_Imaging_Biol_2011_Dec_16_13(6)_1234-1240.nxml.txt.nlp	21161686	SENT198	10	10	19	19	imatinib	FDG	PA10804	23583	0.681
NULL	Protein_Cell_2014_Feb_29_5(2)_113-123.nxml.txt.nlp	24474196	SENT127	5	5	12	12	metformin	AMPK	PA450395	5563	0.681
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Sep_9_65(Pt_10)_o2403-o2404.nxml.txt.nlp	21577866	SENT83	0	0	21	21	haloperidol	mol	PA449841	90527	0.681
NULL	Neuro_Oncol_2010_Aug_14_12(8)_882-889.nxml.txt.nlp	20472883	SENT143	7	7	28	28	gefitinib	EGFR	PA131301952	1956	0.681
NULL	J_Obes_2011_Apr_28_2011_587495.nxml.txt.nlp	21603273	SENT178	13	13	8	8	lipase	HSL	PA450239	3991	0.681
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT33	19	19	7	7	lapatinib	HER2	PA152241907	2064	0.681
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT119	5	5	17	17	l-cysteine	S6K1	PA449173	6198	0.681
NULL	J_Vis_Exp_2009_Jun_9_(28)_1305.nxml.txt.nlp	19513018	SENT26	3	3	21	21	hyaluronidase	sit	PA164745713	55733	0.681
NULL	Case_Rep_Oncol_2012_Sep_28_5(3)_515-519.nxml.txt.nlp	23139664	SENT70	10	10	2	2	sorafenib	SHARP	PA7000	23013	0.681
NULL	Org_Med_Chem_Lett_2012_May_21_2_18.nxml.txt.nlp	22613014	SENT5	18	18	37	37	capsaicin	TRPV1	PA448776	7442	0.681
NULL	Exp_Ther_Med_2013_Feb_29_5(2)_527-532.nxml.txt.nlp	23404385	SENT107	12	12	3	3	tacrolimus	CYP3A5	PA451578	1577	0.681
NULL	Int_J_Nanomedicine_2009_Dec_29_4_289-297.nxml.txt.nlp	20054433	SENT3	25	25	10	10	gentamicin	zeta	PA449753	9907	0.681
NULL	Mol_Pain_2013_Jan_2_9_1.nxml.txt.nlp	23279936	SENT70	28	28	24	24	capsaicin	TRPV1	PA448776	7442	0.681
NULL	Basic_Clin_Pharmacol_Toxicol_2013_Feb_5_112(2)_132-137.nxml.txt.nlp	22900583	SENT54	22	22	36	36	omeprazole	CYP3A	PA450704	1574	0.681
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Jun_23_70(Pt_7)_31-35.nxml.txt.nlp	25161500	SENT64	36	36	30	30	ethanol	mol	PA448073	90527	0.681
NULL	Br_J_Cancer_2010_Oct_26_103(9)_1380-1390.nxml.txt.nlp	20877355	SENT14	7	7	9	9	etoposide	TRAIL	PA449552	8743	0.681
NULL	Arthritis_Res_2001_Nov_9_3(1)_65-71.nxml.txt.nlp	11178128	SENT124	23	23	29	29	methylprednisolone	CXCL8	PA450466	3576	0.681
NULL	Biol_Open_2012_Sep_7_1(11)_1118-1127.nxml.txt.nlp	23213392	SENT237	39	39	26	26	l-glutamine	KSR	PA10090	10256	0.681
NULL	JAKSTAT_2014_Jun_12_3_e29554.nxml.txt.nlp	25105067	SENT64	8	8	11	11	propofol	STAT3	PA451141	6774	0.681
NULL	Biomed_Res_Int_2013_Dec_5_2013_642848.nxml.txt.nlp	24381940	SENT138	4	4	11	11	telmisartan	IL-6	PA451605	3569	0.681
NULL	Evid_Based_Complement_Alternat_Med_2013_Mar_26_2013_974313.nxml.txt.nlp	23589723	SENT172	27	27	17	17	metformin	HIF1	PA450395	3091	0.681
NULL	Front_Aging_Neurosci_2015_Jan_6_6_342.nxml.txt.nlp	25610395	SENT167	28	28	31	31	imatinib	GSAP	PA10804	54103	0.681
NULL	J_Vet_Med_Sci_2014_Jul_18_76(7)_937-945.nxml.txt.nlp	24646457	SENT123	30	30	40	40	gentamicin	OTC	PA449753	5009	0.681
NULL	Cancer_Cell_Int_2014_Jan_14_14_4.nxml.txt.nlp	24423208	SENT60	27	27	8	8	sunitinib	IL-2	PA162372840	3558	0.681
NULL	Chin_J_Cancer_2011_May_30(5)_327-335.nxml.txt.nlp	21527065	SENT35	44	44	15	15	lapatinib	PIK3CA	PA152241907	5290	0.681
NULL	Cardiovasc_Res_2011_Mar_1_89(4)_794-804.nxml.txt.nlp	20621925	SENT232	40	40	34	34	isoproterenol	PES	PA450121	23481	0.681
NULL	Br_J_Cancer_2012_Jan_17_106(2)_284-289.nxml.txt.nlp	22215065	SENT182	11	11	8	8	atrasentan	IFN	PA143414738	3439	0.681
NULL	Mol_Cancer_2012_Dec_12_11_91.nxml.txt.nlp	23234355	SENT61	0	0	7	7	erlotinib	EGFR	PA134687924	1956	0.681
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jan_21_68(Pt_2)_o464.nxml.txt.nlp	22347073	SENT67	13	13	6	6	ethanol	mol	PA448073	90527	0.681
NULL	Oncotarget_2014_Dec_4_5(22)_11365-11380.nxml.txt.nlp	25426548	SENT35	22	22	27	27	nutlin-3	p53		7157	0.681
NULL	Br_J_Cancer_1984_Jun_49(6)_779-786.nxml.txt.nlp	6203548	SENT2	10	10	12	12	bleomycin	BLM	PA448645	641	0.681
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT141	3	3	5	5	curcumin	TRAIL	PA151958596	8743	0.681
NULL	Clin_Epidemiol_2010_Oct_22_2_241-246.nxml.txt.nlp	21152250	SENT7	15	15	20	20	tamoxifen	CYP2D6	PA451581	1565	0.681
NULL	Mol_Cancer_2007_Apr_2_6_25.nxml.txt.nlp	17407558	SENT201	0	0	11	11	bevacizumab	VEGFR2	PA130232992	3791	0.681
NULL	J_Headache_Pain_2011_Apr_5_12(2)_127-133.nxml.txt.nlp	21298314	SENT97	27	27	4	4	amitriptyline	OTC	PA448385	5009	0.681
NULL	AMB_Express_2012_Jul_29_2_38.nxml.txt.nlp	22838397	SENT133	5	5	7	7	ethanol	EPG	PA448073	255324	0.681
NULL	Arthritis_Res_Ther_2014_Dec_3_16(6)_484.nxml.txt.nlp	25465897	SENT181	8	8	6	6	hyaluronan	UGDH	PA165958431	7358	0.681
NULL	Viruses_2014_Sep_16_6(9)_3428-3437.nxml.txt.nlp	25256391	SENT285	11	11	1	1	atazanavir	Spartan	PA10251	83932	0.681
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_24_2012_673132.nxml.txt.nlp	23133498	SENT135	16	16	27	27	berberine	P-gp	PA165860812	5243	0.681
NULL	Cancer_Metab_2013_Feb_4_1_7.nxml.txt.nlp	24280108	SENT248	9	9	7	7	glucose	MYC	PA449773	4609	0.681
NULL	Endocrinology_2014_Oct_22_155(10)_3732-3738.nxml.txt.nlp	25051442	SENT7	24	24	27	27	sibutramine	POMC	PA451344	5443	0.681
NULL	Mol_Biol_Cell_2014_Jun_1_25(11)_1782-1792.nxml.txt.nlp	24719457	SENT155	0	0	23	23	nicotine	BDNF	PA450626	627	0.681
NULL	J_Med_Case_Reports_2012_Feb_10_6_55.nxml.txt.nlp	22325469	SENT10	16	16	9	9	creatine	Q10	PA164778930	27161	0.681
NULL	Br_J_Cancer_2010_Jul_13_103(2)_186-195.nxml.txt.nlp	20588277	SENT114	32	32	26	26	nutlin-3	p53		7157	0.681
NULL	J_Cell_Biol_2001_Aug_6_154(3)_599-610.nxml.txt.nlp	11481345	SENT129	28	28	30	30	doxycycline	ARF6	PA449415	382	0.681
NULL	Biologics_2010_Dec_6_4_299-313.nxml.txt.nlp	21209725	SENT313	6	6	25	25	miglustat	OGT	PA10140	8473	0.681
NULL	Diabetes_Care_2009_Nov_32(Suppl_2)_S373-S377.nxml.txt.nlp	19875584	SENT105	7	7	12	12	atorvastatin	HDL2	PA448500	57338	0.681
NULL	J_Immunother_Cancer_2014_Mar_11_2_5.nxml.txt.nlp	24829762	SENT220	5	5	26	26	l-arginine	ARG1	PA448478	383;64129	0.681
NULL	Clin_Dev_Immunol_2013_May_22_2013_701305.nxml.txt.nlp	23762095	SENT80	7	7	4	4	vinblastine	MCL1	PA451877	4170	0.681
NULL	J_Cell_Biol_2000_Feb_21_148(4)_811-824.nxml.txt.nlp	10684261	SENT290	28	28	7	7	collagenase	syndecan	PA449107	6382	0.681
NULL	Acta_Vet_Scand_2011_Feb_17_53(1)_11.nxml.txt.nlp	21324209	SENT55	6	6	24	24	cefazolin	OTC	PA448839	5009	0.681
NULL	Front_Chem_2014_Dec_23_2_113.nxml.txt.nlp	25566531	SENT158	5	5	11	11	curcumin	ACOX1	PA151958596	51	0.681
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT48	38	38	42	42	pertuzumab	HER-2		2064	0.681
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT2400	19	19	11	11	tamoxifen	CYP3A4	PA451581	1576	0.681
NULL	Cancer_Metab_2014_Feb_4_2_3.nxml.txt.nlp	24491179	SENT266	19	19	30	30	nadh	NDUFA4L2	PA164755085	56901	0.681
NULL	J_Antimicrob_Chemother_2008_Nov_27_62(5)_929-933.nxml.txt.nlp	18755696	SENT60	34	34	20	20	tetracycline	CTX	PA451640	1593	0.681
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT52	13	13	6	6	trastuzumab	PTEN	PA451743	5728	0.681
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT100	2	2	26	26	tamoxifen	4E-BP1	PA451581	1978	0.681
NULL	Front_Chem_2014_Dec_23_2_113.nxml.txt.nlp	25566531	SENT158	5	5	13	13	curcumin	GSTT1	PA151958596	2952	0.681
NULL	Curr_Oncol_2006_Feb_13(1)_8-13.nxml.txt.nlp	17576436	SENT28	0	0	6	6	trastuzumab	San	PA451743	80218	0.681
NULL	Reprod_Biol_Endocrinol_2004_Aug_4_2_59.nxml.txt.nlp	15294019	SENT88	4	4	8	8	forskolin	EGF	PA146096022	1950	0.681
NULL	Behav_Neurol_2014_Nov_16_2014_360978.nxml.txt.nlp	25477708	SENT99	7	7	17	17	nicotine	P28	PA450626	9446;7802;9527	0.681
NULL	Clin_Pharmacol_2012_Feb_20_4_13-20.nxml.txt.nlp	22427735	SENT3	19	19	7	7	clopidogrel	PON1	PA449053	5444	0.681
NULL	Cancers_(Basel)_2013_Aug_22_5(3)_1086-1102.nxml.txt.nlp	24202335	SENT116	3	3	9	9	imatinib	TERT	PA10804	7015	0.681
NULL	Biomed_Res_Int_2014_Feb_6_2014_323594.nxml.txt.nlp	24689036	SENT383	14	14	4	4	raloxifene	PC3	PA451221	57332;7832;5122	0.681
NULL	Oncotarget_2013_Nov_4_5(1)_161-172.nxml.txt.nlp	24389287	SENT120	3	3	10	10	propranolol	p53	PA451145	7157	0.681
NULL	Pharmaceutics_2011_Oct_12_3(4)_680-705.nxml.txt.nlp	24309303	SENT57	21	21	12	12	rosiglitazone	BSP	PA451283	3381	0.681
NULL	Int_J_Mol_Sci_2014_Oct_29_15(11)_19700-19728.nxml.txt.nlp	25356505	SENT751	5	5	13	13	allopurinol	p38	PA448320	10598;1432;7965	0.681
NULL	Cell_Cycle_2012_Nov_1_11(21)_3917-3918.nxml.txt.nlp	23032263	SENT8	40	40	10	10	camptothecin	JNK	PA153590860	5599	0.681
NULL	Surg_Today_2015_Oct_14_45_221-226.nxml.txt.nlp	25734195	SENT108	16	16	3	3	doxorubicin	CRT	PA449412	811	0.681
NULL	Biomed_Res_Int_2013_Jan_21_2013_581631.nxml.txt.nlp	23484133	SENT58	14	14	1	1	infliximab	ACT	PA452639	12;11332;9457;641455	0.681
NULL	Clin_Ophthalmol_2007_Mar_1(1)_61-64.nxml.txt.nlp	19668467	SENT87	27	27	29	29	ethanol	castor	PA448073	54897	0.681
NULL	Cancer_Med_2014_Feb_10_3(1)_134-142.nxml.txt.nlp	24407937	SENT249	3	3	33	33	tamoxifen	HER-2	PA451581	2064	0.681
NULL	Exp_Diabetes_Res_2011_Apr_6_2011_928523.nxml.txt.nlp	21603181	SENT172	2	2	14	14	haloperidol	adiponectin	PA449841	9370	0.681
NULL	J_Cell_Biol_1998_Jan_26_140(2)_335-345.nxml.txt.nlp	9442109	SENT218	13	13	8	8	chloroquine	NHE	PA448948	285335	0.681
NULL	Breast_Cancer_Res_2014_May_7_16(3)_207.nxml.txt.nlp	25223380	SENT162	20	20	30	30	anastrozole	HER2	PA448432	2064	0.681
NULL	Proteome_Sci_2010_Jun_7_8_28.nxml.txt.nlp	20529248	SENT223	26	26	13	13	tetracycline	Hsp90	PA451640	3320	0.681
NULL	Arthritis_Res_Ther_2013_Feb_11_15(Suppl_1)_S2.nxml.txt.nlp	23566295	SENT53	18	18	41	41	rituximab	BAFF	PA451261	10673	0.681
NULL	Indian_J_Anaesth_2014_Jan-Feb_58(1)_101-102.nxml.txt.nlp	24700924	SENT18	19	19	10	10	propofol	NIBP	PA451141	83696	0.681
NULL	J_Viral_Hepat_2010_Feb_17(2)_139-147.nxml.txt.nlp	19674282	SENT135	16	16	23	23	ribavirin	RVR	PA451241	9975	0.681
NULL	Breast_Cancer_Res_2011_Jun_29_13(3)_R70.nxml.txt.nlp	21707964	SENT150	12	12	15	15	tamoxifen	14-3-3	PA451581	10971	0.681
NULL	Breast_Cancer_Res_2008_Dec_4_10(6)_R103.nxml.txt.nlp	19055788	SENT30	12	12	19	19	tamoxifen	AF-1	PA451581	3460;5710	0.681
NULL	F1000Res_2013_Mar_5_2_74.nxml.txt.nlp	24358880	SENT21	8	8	0	0	benzaldehyde	TRPV1	PA448571	7442	0.681
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Nov_13_64(Pt_12)_o2338.nxml.txt.nlp	21581313	SENT73	39	39	19	19	ethanol	mol	PA448073	90527	0.681
NULL	Cancers_(Basel)_2011_Aug_15_3(3)_3331-3352.nxml.txt.nlp	24212957	SENT238	18	18	44	44	bevacizumab	CD133	PA130232992	8842	0.68
NULL	Breast_Cancer_Res_2004_Jun_29_6(5)_R488-R498.nxml.txt.nlp	15318931	SENT22	8	8	1	1	estradiol	UGT1A1	PA449503	54658	0.68
NULL	Diabetes_Metab_J_2014_Aug_20_38(4)_274-277.nxml.txt.nlp	25215273	SENT32	26	26	5	5	glucose	LPL	PA449773	4023	0.68
NULL	Br_J_Cancer_2013_Jun_11_108(11)_2241-2249.nxml.txt.nlp	23674086	SENT125	30	30	8	8	tamoxifen	BRCA1	PA451581	672	0.68
NULL	Biochem_Biophys_Res_Commun_2009_May_22_383(1)_63-67.nxml.txt.nlp	19332024	SENT17	31	31	26	26	lipase	HSL	PA450239	3991	0.68
NULL	EMBO_Mol_Med_2011_Nov_3(11)_617-619.nxml.txt.nlp	21954211	SENT31	8	8	14	14	eculizumab	STOP	PA164776637	4135	0.68
NULL	Open_Neurol_J_2013_May_31_7_23-31.nxml.txt.nlp	23894259	SENT116	12	12	36	36	olanzapine	adiponectin	PA450688	9370	0.68
NULL	Bone_Marrow_Res_2011_Mar_2_2011_924058.nxml.txt.nlp	22046572	SENT60	13	13	9	9	tocilizumab	IL-6	PA165292659	3569	0.68
NULL	Oncol_Rep_2012_Oct_26_28(4)_1139-1145.nxml.txt.nlp	22842551	SENT9	19	19	26	26	urokinase	CXCR4	PA451836	7852	0.68
NULL	Cereb_Cortex_2014_Jan_9_24(1)_174-185.nxml.txt.nlp	23048018	SENT8	2	2	11	11	methylphenidate	ATX	PA450464	5168;23049	0.68
NULL	Core_Evid_2013_Jul_11_8_47-56.nxml.txt.nlp	23874242	SENT2	9	9	11	11	vasopressin	AVP	PA451858	114548;551	0.68
NULL	Oncogene_2013_Sep_26_32(39)_10_1038_onc_2012_491.nxml.txt.nlp	23108394	SENT42	16	16	14	14	epirubicin	FOXM1	PA449476	2305	0.68
NULL	Indian_J_Med_Res_2010_Dec_132(6)_676-682.nxml.txt.nlp	21245614	SENT99	10	10	5	5	zinc	p53	PA451956	7157	0.68
NULL	EJC_Suppl_2013_Sep_5_11(2)_307-309.nxml.txt.nlp	NULL	SENT148	6	6	23	23	pemetrexed	LBA1	PA10810	9881	0.68
NULL	Aging_(Albany_NY)_2012_Jul_31_4(7)_499-508.nxml.txt.nlp	22868943	SENT49	0	0	15	15	resveratrol	ANOVA		4858	0.68
NULL	Int_J_Nanomedicine_2012_Sep_24_7_5109-5117.nxml.txt.nlp	23055723	SENT127	22	22	29	29	cyclosporine	Q10	PA449167	27161	0.68
NULL	Environ_Health_Perspect_2011_Dec_10_119(12)_1788-1793.nxml.txt.nlp	21831745	SENT152	21	21	8	8	estradiol	aromatase	PA449503	1588	0.68
NULL	Biomed_Res_Int_2014_Jan_29_2014_458592.nxml.txt.nlp	24592391	SENT53	0	0	7	7	curcumin	HO-1	PA151958596	3162	0.68
NULL	Cancer_Cell_Int_2014_Jun_11_14_49.nxml.txt.nlp	24991192	SENT111	7	7	25	25	capsaicin	AMPK	PA448776	5563	0.68
NULL	Arthritis_Res_Ther_2004_Sep_23_6(6)_R535-R543.nxml.txt.nlp	15535831	SENT168	0	0	35	35	infliximab	p75	PA452639	7133;11168	0.68
NULL	J_Oncol_2010_Aug_11_2010_969084.nxml.txt.nlp	19680458	SENT282	6	6	4	4	tamoxifen	BCAR1	PA451581	9564	0.68
NULL	Exp_Ther_Med_2013_May_15_5(5)_1327-1331.nxml.txt.nlp	23737873	SENT150	4	4	6	6	imidapril	AQP2	PA452640	359	0.68
NULL	Surg_Neurol_Int_2010_May_31_1_11.nxml.txt.nlp	20657692	SENT71	3	3	7	7	glibenclamide	SUR1	PA449782	6833	0.68
NULL	Oncol_Lett_2014_May_7_7(5)_1439-1442.nxml.txt.nlp	24765152	SENT9	0	0	5	5	chloramphenicol	EGF	PA448927	1950	0.68
NULL	Oncogenesis_2012_Apr_16_1(4)_e7.nxml.txt.nlp	23552604	SENT259	20	20	6	6	etoposide	CTRL	PA449552	1506	0.68
NULL	Drug_Des_Devel_Ther_2014_Oct_31_8_2121-2128.nxml.txt.nlp	25382970	SENT9	21	21	14	14	curcumin	TTR	PA151958596	7276	0.68
NULL	Chemother_Res_Pract_2011_Sep_21_2011_839742.nxml.txt.nlp	22295206	SENT90	25	25	20	20	gefitinib	EGFR	PA131301952	1956	0.68
NULL	Oncol_Lett_2014_Jan_29_7(1)_121-124.nxml.txt.nlp	24348832	SENT89	6	6	16	16	cisplatin	p53	PA449014	7157	0.68
NULL	Breast_Cancer_(Auckl)_2012_Nov_19_6_191-207.nxml.txt.nlp	23226023	SENT97	14	14	26	26	trastuzumab	HER2	PA451743	2064	0.68
NULL	J_Cardiothorac_Surg_2013_May_13_8_127.nxml.txt.nlp	23668669	SENT5	34	34	36	36	sufentanil	EDA	PA451527	1896	0.68
NULL	Aging_(Albany_NY)_2009_May_22_1(6)_557-572.nxml.txt.nlp	20195383	SENT2	0	0	8	8	creatine	gamma	PA164778930	9913	0.68
NULL	Indian_J_Med_Res_2014_Feb_139(2)_205-215.nxml.txt.nlp	24718394	SENT39	2	2	8	8	artesunate	ACT	PA165111697	12;11332;9457;641455	0.68
NULL	Cancer_Metab_2013_Feb_4_1_7.nxml.txt.nlp	24280108	SENT75	21	21	10	10	glucose	FBS	PA449773	64319;26269	0.68
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1449-1456.nxml.txt.nlp	24077631	SENT112	31	31	37	37	tolbutamide	CYP2C9	PA451718	1559	0.68
NULL	Lipids_Health_Dis_2011_Jan_18_10_8.nxml.txt.nlp	21241519	SENT160	10	10	16	16	simvastatin	ABCB4	PA451363	5244	0.68
NULL	Bioinformation_2011_Feb_15_5(10)_422-429.nxml.txt.nlp	21423888	SENT144	24	24	12	12	galactose	GAL	PA449725	51083	0.68
NULL	Cell_Microbiol_2010_Dec_3_12(12)_1718-1731.nxml.txt.nlp	20618342	SENT273	6	6	8	8	staurosporine	STS	PA165109623	412	0.68
NULL	Mol_Biol_Cell_2013_Jun_1_24(11)_1619-1637.nxml.txt.nlp	23576546	SENT111	4	4	15	15	trypsin	SIMPLE	PA451806	9516	0.68
NULL	Adv_Urol_2014_Jan_9_2014_327917.nxml.txt.nlp	24511310	SENT177	10	10	5	5	vincristine	CHOP	PA451879	1649	0.68
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT225	10	10	15	15	atorvastatin	RANKL	PA448500	8600	0.68
NULL	J_Thyroid_Res_2011_Apr_10_2011_895923.nxml.txt.nlp	21603172	SENT272	4	4	23	23	thyroglobulin	IFN	PA164754910	3439	0.68
NULL	Chemother_Res_Pract_2012_Aug_29_2012_817297.nxml.txt.nlp	22970367	SENT124	6	6	4	4	erlotinib	AXL	PA134687924	558	0.68
NULL	Oncotarget_2013_Dec_18_5(2)_375-385.nxml.txt.nlp	24495868	SENT106	3	3	8	8	fludarabine	MCL1	PA449655	4170	0.68
NULL	Diabetes_2008_Sep_57(9)_2470-2479.nxml.txt.nlp	18511847	SENT143	3	3	20	20	pioglitazone	adiponectin	PA450970	9370	0.68
NULL	Diabetol_Metab_Syndr_2014_Mar_31_6_47.nxml.txt.nlp	24684779	SENT100	0	0	11	11	simvastatin	MCP-1	PA451363	6347	0.68
NULL	Arthritis_Res_Ther_2008_Jun_30_10(3)_209.nxml.txt.nlp	18598385	SENT132	21	21	9	9	ethanol	HMGB1	PA448073	3146	0.68
NULL	Diabetes_2009_Apr_23_58(4)_917-925.nxml.txt.nlp	19168598	SENT74	11	11	25	25	paraformaldehyde	FOXO1	PA450790	2308	0.68
NULL	Biologics_2009_Sep_15_3_429-441.nxml.txt.nlp	19774210	SENT309	12	12	43	43	leucovorin	IFL	PA450198	3439	0.68
NULL	Acta_Orthop_2009_Jun_5_80(3)_357-362.nxml.txt.nlp	19421912	SENT117	13	13	9	9	triamcinolone	MMP2	PA451749	4313	0.68
NULL	Case_Rep_Anesthesiol_2014_Feb_5_2014_853243.nxml.txt.nlp	24653844	SENT65	21	21	14	14	bupivacaine	PPG	PA135057240	5552	0.68
NULL	Nucl_Recept_Signal_2006_Oct_30_4_e024.nxml.txt.nlp	17088940	SENT17	4	4	13	13	estradiol	RIP140	PA449503	8204	0.68
NULL	Arthritis_Res_Ther_2011_Feb_28_13(1)_205.nxml.txt.nlp	21371351	SENT147	12	12	7	7	rituximab	BAFF	PA451261	10673	0.68
NULL	Br_J_Cancer_1998_Sep_78(5)_625-630.nxml.txt.nlp	9744503	SENT10	11	11	26	26	tegafur	mol	PA452620	90527	0.68
NULL	Curr_Cardiol_Rev_2012_Aug_8(3)_239-249.nxml.txt.nlp	22935021	SENT30	0	0	8	8	clopidogrel	P2Y12	PA449053	64805	0.68
NULL	Breast_Cancer_Res_2008_May_12_10(3)_R45.nxml.txt.nlp	18474099	SENT200	38	38	15	15	paclitaxel	IL-10	PA450761	3586	0.68
NULL	J_Korean_Med_Sci_2010_Feb_19_25(2)_304-308.nxml.txt.nlp	20119588	SENT40	19	19	16	16	clarithromycin	EMB	PA449028	133418	0.68
NULL	Cell_Commun_Signal_2013_Apr_16_11_25.nxml.txt.nlp	23590831	SENT130	5	5	0	0	etoposide	CYLD	PA449552	1540	0.68
NULL	Neuropsychopharmacology_2011_May_23_36(6)_1237-1247.nxml.txt.nlp	21346736	SENT4	3	3	13	13	methylphenidate	ATX	PA450464	5168;23049	0.68
NULL	Arthritis_Res_Ther_2014_Oct_30_16(5)_467.nxml.txt.nlp	25359150	SENT125	0	0	9	9	adalimumab	ACR	PA10004	49	0.68
NULL	Braz_J_Med_Biol_Res_2014_Jan_10_47(1)_60-69.nxml.txt.nlp	24519092	SENT208	30	30	15	15	doxorubicin	YWHAZ	PA449412	7534	0.68
NULL	Free_Radic_Biol_Med_2014_Mar_68(100)_134-147.nxml.txt.nlp	24291398	SENT53	18	18	32	32	heparin	CO2	PA449855	4513	0.68
NULL	Crit_Care_2000_Apr_12_4(3)_156-168.nxml.txt.nlp	11094500	SENT328	4	4	14	14	aprotinin	CO2	PA448472	4513	0.68
NULL	Target_Oncol_2009_Sep_16_4(3)_235-252.nxml.txt.nlp	19756916	SENT208	16	16	7	7	gefitinib	PI3K	PA131301952	5290	0.68
NULL	Crit_Care_2009_Mar_13_13(Suppl_1)_P168.nxml.txt.nlp	NULL	SENT3	12	12	29	29	levosimendan	LCO	PA164749138	3935	0.68
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT430	14	14	22	22	cisplatin	p53	PA449014	7157	0.68
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jun_30_66(Pt_7)_o1881.nxml.txt.nlp	21588075	SENT60	15	15	26	26	ethanol	mol	PA448073	90527	0.68
NULL	Sci_Rep_2014_Dec_19_4_7571.nxml.txt.nlp	25524368	SENT73	37	37	14	14	estradiol	mer	PA449503	10461	0.68
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Jun_7_64(Pt_7)_o1211.nxml.txt.nlp	21202850	SENT72	30	30	36	36	ethanol	mol	PA448073	90527	0.68
NULL	Cancer_Metab_2013_Dec_23_1_23.nxml.txt.nlp	24359630	SENT358	35	35	16	16	glucose	p53	PA449773	7157	0.68
NULL	Indian_J_Endocrinol_Metab_2012_May-Jun_16(3)_343-348.nxml.txt.nlp	22629497	SENT6	34	34	14	14	teriparatide	PTH	PA451620	5741	0.68
NULL	Behav_Brain_Funct_2010_Aug_30_6_50.nxml.txt.nlp	20799992	SENT164	12	12	8	8	methamphetamine	alpha-synuclein	PA450403	6622	0.68
NULL	Cancers_(Basel)_2012_Jun_27_4(3)_618-657.nxml.txt.nlp	22946011	SENT705	2	2	4	4	hyaluronan	LYVE-1	PA165958431	10894	0.68
NULL	J_Hematol_Oncol_2008_Oct_23_1_19.nxml.txt.nlp	18947412	SENT110	19	19	26	26	alemtuzumab	CD52	PA164783958	1043	0.68
NULL	Acta_Pharmacol_Sin_2009_Jul_3_30(7)_879-888.nxml.txt.nlp	19574993	SENT154	6	6	25	25	galantamine	spatial	PA449726	219793	0.68
NULL	Diabetes_2009_Aug_28_58(8)_1816-1825.nxml.txt.nlp	19401425	SENT169	22	22	25	25	diazoxide	GLP-1	PA449285	100125288	0.68
NULL	Int_J_Endocrinol_2013_May_22_2013_821745.nxml.txt.nlp	23818897	SENT30	32	32	16	16	ethanol	B12	PA448073	7126;4709	0.68
NULL	J_Carcinog_2011_Aug_23_10_20.nxml.txt.nlp	21886458	SENT174	13	13	5	5	bicalutamide	IL-8	PA164746255	3576	0.68
NULL	Mol_Biol_Rep_2013_Sep_28_40(10)_5573-5585.nxml.txt.nlp	24078156	SENT38	6	6	10	10	iron	FPN1	PA450087	30061	0.68
NULL	Breast_Cancer_Res_2010_May_18_12(Suppl_1)_P48.nxml.txt.nlp	NULL	SENT18	6	6	10	10	tamoxifen	CYP2D6	PA451581	1565	0.68
NULL	Biochemistry_2008_Aug_19_47(33)_8689-8696.nxml.txt.nlp	18642884	SENT88	21	21	12	12	nadh	XMP	PA164755085	2013	0.68
NULL	Nucleic_Acids_Res_2012_Apr_18_40(8)_e59.nxml.txt.nlp	22259038	SENT218	31	31	14	14	erythromycin	L28	PA449493	6158	0.68
NULL	Anal_Bioanal_Chem_2011_Jan_3_399(2)_527-539.nxml.txt.nlp	20814668	SENT204	15	15	6	6	heparin	API	PA449855	5345	0.68
NULL	Case_Rep_Hematol_2012_Mar_26_2012_954201.nxml.txt.nlp	22953081	SENT36	14	14	19	19	doxorubicin	CHOP	PA449412	1649	0.68
NULL	Cent_European_J_Urol_2013_Dec_19_66(4)_394-404.nxml.txt.nlp	24757527	SENT262	4	4	6	6	bevacizumab	IFN	PA130232992	3439	0.68
NULL	J_Cancer_2013_Sep_26_4(8)_653-661.nxml.txt.nlp	24155777	SENT104	20	20	33	33	tamoxifen	KISS1R	PA451581	84634	0.68
NULL	Int_J_Biol_Sci_2013_Sep_20_9(9)_917-933.nxml.txt.nlp	24155666	SENT423	21	21	24	24	troglitazone	STAT3	PA451799	6774	0.68
NULL	J_Orthop_Traumatol_2012_Sep_9_13(3)_119-123.nxml.txt.nlp	22684544	SENT162	3	3	0	0	pravastatin	Yama	PA451089	836	0.68
NULL	Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.nxml.txt.nlp	24736980	SENT181	3	3	28	28	rosuvastatin	OATP1B1	PA134308647	10599	0.68
NULL	J_Biol_Chem_2013_Mar_29_288(13)_9035-9048.nxml.txt.nlp	23362266	SENT964	4	4	16	16	tamoxifen	AP-1	PA451581	2353;3727;2354;3725	0.68
NULL	Cell_Res_2014_Feb_12_24(2)_143-160.nxml.txt.nlp	24217768	SENT68	16	16	4	4	heparin	FGFR1	PA449855	2260	0.68
NULL	Diabetes_Care_2012_Feb_16_35(2)_327-333.nxml.txt.nlp	22179958	SENT142	8	8	11	11	metformin	B12	PA450395	7126;4709	0.68
NULL	Part_Fibre_Toxicol_2013_Aug_13_10_39.nxml.txt.nlp	23937860	SENT132	4	4	15	15	anakinra	IL-6	PA10799	3569	0.68
NULL	Diabetes_Metab_J_2012_Aug_20_36(4)_293-299.nxml.txt.nlp	22950061	SENT141	14	14	6	6	metformin	PI3K	PA450395	5290	0.68
NULL	Front_Oncol_2012_Oct_31_2_157.nxml.txt.nlp	23120745	SENT1149	11	11	3	3	temozolomide	p53	PA451609	7157	0.68
NULL	Int_J_Surg_Oncol_2012_Jun_12_2012_862879.nxml.txt.nlp	22778941	SENT236	5	5	10	10	cisplatin	PARP1	PA449014	142	0.68
NULL	Breast_Cancer_Res_2002_Jul_29_4(5)_202-204.nxml.txt.nlp	12223125	SENT97	23	23	40	40	tamoxifen	ATAC	PA451581	6375	0.68
NULL	Ann_N_Y_Acad_Sci_2014_Nov_5_1329(1)_93-106.nxml.txt.nlp	25377080	SENT193	25	25	6	6	warfarin	TTR	PA451906	7276	0.68
NULL	Mol_Biol_Int_2012_May_24_2012_705948.nxml.txt.nlp	22693671	SENT36	10	10	4	4	cisplatin	RASSF2	PA449014	9770	0.68
NULL	Allergy_Asthma_Clin_Immunol_2011_Apr_20_7(1)_7.nxml.txt.nlp	21507228	SENT92	17	17	4	4	heparin	CD4	PA449855	920	0.68
NULL	JAKSTAT_2014_Jun_12_3_e29554.nxml.txt.nlp	25105067	SENT95	3	3	14	14	propofol	p65	PA451141	5970	0.68
NULL	Cancer_Cell_Int_2005_Jul_29_5_24.nxml.txt.nlp	16053526	SENT120	7	7	18	18	estradiol	p53	PA449503	7157	0.68
NULL	Oncoimmunology_2013_Jan_1_2(1)_e22890.nxml.txt.nlp	23483066	SENT18	4	4	10	10	vemurafenib	IFN	PA165946873	3439	0.68
NULL	J_Breast_Cancer_2014_Mar_28_17(1)_61-68.nxml.txt.nlp	24744799	SENT157	11	11	20	20	sorafenib	HER2	PA7000	2064	0.68
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT123	33	33	18	18	vinorelbine	ASC	PA451881	29108	0.68
NULL	Clin_Ophthalmol_2011_Feb_11_5_167-170.nxml.txt.nlp	21383944	SENT22	9	9	1	1	ranibizumab	hole	PA164746012	80757	0.68
NULL	Exp_Dermatol_2013_Jul_25_22(7)_502-504.nxml.txt.nlp	23800068	SENT10	0	0	7	7	erythromycin	TSC2	PA449493	7249	0.68
NULL	Pharmaceuticals_(Basel)_2011_May_31_4(6)_794-803.nxml.txt.nlp	NULL	SENT265	11	11	7	7	amiodarone	NIF	PA448383	6280	0.68
NULL	Front_Oncol_2013_Oct_1_3_259.nxml.txt.nlp	24102047	SENT105	23	23	31	31	sunitinib	FGFR2	PA162372840	2263	0.68
NULL	Curr_Gerontol_Geriatr_Res_2012_Mar_21_2012_302875.nxml.txt.nlp	22536229	SENT356	18	18	14	14	choline	NNMT	PA448976	4837	0.68
NULL	Hum_Genomics_2010_Apr_1_4(4)_238-249.nxml.txt.nlp	20511137	SENT70	28	28	15	15	irinotecan	UGT1A1	PA450085	54658	0.68
NULL	Cancer_Cell_Int_2004_Mar_19_4_3.nxml.txt.nlp	15035672	SENT33	10	10	3	3	etoposide	PC3	PA449552	57332;7832;5122	0.68
NULL	J_Cell_Biol_2001_Aug_6_154(3)_599-610.nxml.txt.nlp	11481345	SENT125	30	30	17	17	doxycycline	ARNO	PA449415	9266	0.68
NULL	Breast_Cancer_Res_2014_May_23_16(3)_R50.nxml.txt.nlp	24887458	SENT100	28	28	15	15	docetaxel	HER2	PA449383	2064	0.68
NULL	Ann_Oncol_2009_Aug_20(Suppl_6)_vi30-vi34.nxml.txt.nlp	19617295	SENT104	12	12	14	14	isotretinoin	IFN	PA450128	3439	0.68
NULL	Oncoimmunology_2013_Jun_1_2(6)_e24677.nxml.txt.nlp	23894722	SENT12	2	2	9	9	cetuximab	CD80	PA10040	941	0.68
NULL	Onco_Targets_Ther_2014_Jun_19_7_1025-1032.nxml.txt.nlp	24971016	SENT101	22	22	8	8	olaparib	ADP		23038	0.68
NULL	J_Korean_Assoc_Oral_Maxillofac_Surg_2014_Dec_26_40(6)_291-296.nxml.txt.nlp	25551094	SENT96	2	2	6	6	alendronate	M-CSF	PA448082	1435	0.68
NULL	J_Interv_Card_Electrophysiol_2012_Aug_28_34(2)_115-123.nxml.txt.nlp	22367051	SENT162	25	25	10	10	heparin	ACT	PA449855	12;11332;9457;641455	0.68
NULL	Arthritis_Res_Ther_2010_Apr_29_12(2)_R73.nxml.txt.nlp	20429888	SENT271	18	18	34	34	bortezomib	COL1A2	PA10252	1278	0.68
NULL	Curr_Neuropharmacol_2014_Mar_12(2)_186-192.nxml.txt.nlp	24669211	SENT220	28	28	20	20	metformin	Met	PA450395	79811	0.68
NULL	Arthritis_Res_Ther_2005_Mar_16_7(Suppl_2)_S4-S14.nxml.txt.nlp	15833146	SENT224	0	0	9	9	methotrexate	IL-2	PA450428	3558	0.68
NULL	Acta_Oncol_2014_Oct_9_53(10)_1347-1355.nxml.txt.nlp	24909504	SENT30	21	21	6	6	doxorubicin	HER2	PA449412	2064	0.68
NULL	Oncoscience_2014_Mar_12_1(2)_158-166.nxml.txt.nlp	25594008	SENT155	43	43	10	10	dasatinib	ANXA1	PA162372878	301	0.68
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT52	0	0	7	7	pemetrexed	UNG	PA10810	7374	0.68
NULL	Breast_Cancer_Res_2013_Oct_17_15(5)_R96.nxml.txt.nlp	24131622	SENT183	9	9	31	31	tamoxifen	HER2	PA451581	2064	0.68
NULL	J_Hematol_Oncol_2009_Aug_12_2_36.nxml.txt.nlp	19674465	SENT78	0	0	8	8	lenalidomide	CD28	PA162363968	1493;940	0.68
NULL	Clin_Infect_Dis_2013_Mar_1_56(5)_694-696.nxml.txt.nlp	23175557	SENT30	22	22	30	30	primaquine	G6PD	PA451103	2539	0.68
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT181	3	3	14	14	adalimumab	CD36	PA10004	948	0.68
NULL	Pak_J_Med_Sci_2014_May-Jun_30(3)_488-492.nxml.txt.nlp	24948964	SENT104	18	18	3	3	docetaxel	RRM1	PA449383	6240	0.68
NULL	Clin_Ophthalmol_2008_Jun_2(2)_339-346.nxml.txt.nlp	19668725	SENT119	24	24	9	9	ranibizumab	VEGF-A	PA164746012	7422	0.68
NULL	Nat_Commun_2013_Nov_12_4_2760.nxml.txt.nlp	24217681	SENT493	23	23	18	18	scopolamine	CA1	PA451308	759	0.68
NULL	Int_J_Med_Sci_2014_Jul_10_11(9)_962-970.nxml.txt.nlp	25076851	SENT173	25	25	6	6	chloroquine	DHRSX	PA448948	207063	0.68
NULL	AIDS_Res_Treat_2013_Sep_17_2013_231956.nxml.txt.nlp	24159383	SENT106	15	15	11	11	buprenorphine	OAT	PA448685	4942	0.68
NULL	Amino_Acids_2012_Aug_29_43(2)_617-627.nxml.txt.nlp	22038179	SENT18	5	5	7	7	vasopressin	AVP	PA451858	114548;551	0.68
NULL	Braz_J_Med_Biol_Res_2014_Sep_5_47(11)_1008-1015.nxml.txt.nlp	25296365	SENT122	34	34	19	19	paroxetine	CYP2D6	PA450801	1565	0.68
NULL	Cancer_Manag_Res_2011_May_10_3_157-175.nxml.txt.nlp	21625399	SENT54	10	10	24	24	dextromethorphan	CYP3A4	PA449273	1576	0.68
NULL	J_Cell_Biol_1997_Jun_30_137(7)_1603-1613.nxml.txt.nlp	9199174	SENT213	25	25	20	20	thrombin	LPA	PA451674	4018	0.68
NULL	Int_J_Endocrinol_2010_Aug_19_2010_320721.nxml.txt.nlp	20016682	SENT33	24	24	26	26	raloxifene	PTH	PA451221	5741	0.68
NULL	Acta_Pharmacol_Sin_2013_Jan_5_34(1)_24-32.nxml.txt.nlp	23123646	SENT87	0	0	3	3	diazoxide	SUR1	PA449285	6833	0.68
NULL	Front_Genet_2014_Aug_26_5_285.nxml.txt.nlp	25206361	SENT287	5	5	22	22	ethanol	SP1	PA448073	6667	0.68
NULL	Breast_Cancer_Res_2011_Nov_7_13(6)_R112.nxml.txt.nlp	22060274	SENT118	12	12	3	3	fluorescein	ARTN	PA164746009	9048	0.68
NULL	EMBO_J_2009_Apr_8_28(7)_854-865.nxml.txt.nlp	19214185	SENT293	39	39	19	19	cisplatin	SSRP1	PA449014	6749	0.68
NULL	Indian_J_Dermatol_2014_Sep-Oct_59(5)_460-464.nxml.txt.nlp	25284850	SENT81	16	16	28	28	cosyntropin	ACTH	PA164749052	5443	0.68
NULL	J_Lipids_2011_Jan_13_2011_565316.nxml.txt.nlp	21490804	SENT199	15	15	17	17	cisplatin	TRAIL	PA449014	8743	0.68
NULL	Indian_J_Endocrinol_Metab_2013_May-Jun_17(3)_430-441.nxml.txt.nlp	23869298	SENT24	30	30	25	25	lipase	GCK	PA450239	5871;2645	0.68
NULL	J_Cardiovasc_Magn_Reson_2008_Feb_6_10(1)_9.nxml.txt.nlp	18275592	SENT6	6	6	0	0	creatine	GAMT	PA164778930	2593	0.68
NULL	Pharmaceuticals_(Basel)_2012_Jun_28_5(7)_690-718.nxml.txt.nlp	24281707	SENT367	28	28	24	24	moxifloxacin	EMB	PA450555	133418	0.68
NULL	Mol_Cancer_2012_Sep_25_11_73.nxml.txt.nlp	23009336	SENT143	24	24	0	0	pp2	EGFR		1956	0.68
NULL	Arthritis_Res_Ther_2003_Sep_12_5(Suppl_3)_65.nxml.txt.nlp	NULL	SENT18	25	25	10	10	rofecoxib	EP4	PA451268	5734	0.68
NULL	J_Biol_Chem_2013_Oct_11_288(41)_29642-29653.nxml.txt.nlp	24005673	SENT9	9	9	4	4	hyaluronan	TSG-6	PA165958431	7130	0.68
NULL	Oncol_Lett_2013_Oct_26_6(4)_947-949.nxml.txt.nlp	24137442	SENT48	37	37	13	13	creatine	CD117	PA164778930	3815	0.68
NULL	Int_J_Mol_Sci_2014_Nov_7_15(11)_20500-20517.nxml.txt.nlp	25387078	SENT115	31	31	13	13	sorafenib	AKT	PA7000	207	0.68
NULL	Cough_2005_Oct_19_1_10.nxml.txt.nlp	16270907	SENT6	7	7	27	27	capsaicin	GOR	PA448776	254958	0.68
NULL	Neural_Dev_2014_Feb_5_9_2.nxml.txt.nlp	24495295	SENT60	8	8	27	27	choline	IPL	PA448976	7262	0.68
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Mar_5_67(Pt_4)_o785.nxml.txt.nlp	21754076	SENT56	17	17	13	13	ethanol	mol	PA448073	90527	0.68
NULL	Br_J_Cancer_2009_Oct_6_101(7)_1033-1038.nxml.txt.nlp	19789532	SENT137	14	14	10	10	cetuximab	EGFR	PA10040	1956	0.68
NULL	Br_J_Cancer_2009_Sep_15_101(6)_957-966.nxml.txt.nlp	19738618	SENT191	9	9	24	24	trastuzumab	THBS-1	PA451743	7057	0.68
NULL	Alcohol_Res_2012_34(4)_459-467.nxml.txt.nlp	23584112	SENT116	3	3	6	6	cosyntropin	ACTH	PA164749052	5443	0.68
NULL	J_Breast_Cancer_2013_Jun_28_16(2)_164-170.nxml.txt.nlp	23843848	SENT12	22	22	31	31	doxorubicin	p53	PA449412	7157	0.68
NULL	Arthritis_Res_Ther_2014_Oct_30_16(5)_474.nxml.txt.nlp	25359291	SENT63	27	27	7	7	adalimumab	ACPA	PA10004	5657	0.68
NULL	Br_J_Cancer_1997_75(10)_1447-1453.nxml.txt.nlp	9166936	SENT12	25	25	21	21	melphalan	TNF-alpha	PA450354	7124	0.68
NULL	Br_J_Nutr_2013_May_14_109(9)_1678-1687.nxml.txt.nlp	22935250	SENT210	7	7	20	20	creatine	SGK1	PA164778930	6446	0.68
NULL	Clin_Med_Insights_Cardiol_2010_Oct_11_4_89-93.nxml.txt.nlp	20981132	SENT65	20	20	15	15	benazepril	TNF	PA448561	7124	0.68
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Jan_15_70(Pt_2)_o140.nxml.txt.nlp	24764866	SENT75	31	31	12	12	benzaldehyde	mol	PA448571	90527	0.68
NULL	Oncogenesis_2012_Apr_16_1(4)_e7.nxml.txt.nlp	23552604	SENT259	4	4	18	18	etoposide	CTRL	PA449552	1506	0.68
NULL	Breast_Cancer_Res_Treat_2009_Jul_22_116(2)_371-378.nxml.txt.nlp	18941892	SENT23	38	38	6	6	tamoxifen	aromatase	PA451581	1588	0.68
NULL	J_Korean_Med_Sci_2007_Dec_20_22(6)_1055-1059.nxml.txt.nlp	18162722	SENT13	8	8	16	16	famotidine	ESD	PA449586	2098	0.68
NULL	Oncoimmunology_2012_Oct_1_1(7)_1038-1047.nxml.txt.nlp	23170252	SENT61	15	15	5	5	cyclophosphamide	CT26	PA449165	168400	0.68
NULL	Anesth_Pain_Med_2014_Sep_9_4(4)_e14221.nxml.txt.nlp	25599022	SENT134	5	5	7	7	cisplatin	LPO	PA449014	4025	0.68
NULL	Emerg_Infect_Dis_2012_Nov_18(11)_e2.nxml.txt.nlp	23092736	SENT64	5	5	3	3	ethambutol	DST	PA164784021	667	0.68
NULL	Clin_Exp_Otorhinolaryngol_2013_Mar_1_6(1)_48-51.nxml.txt.nlp	23526700	SENT82	24	24	29	29	thyroglobulin	CK20	PA164754910	54474	0.68
NULL	Cancer_Immunol_Immunother_2012_Jul_23_61(7)_1101-1111.nxml.txt.nlp	22193989	SENT173	24	24	30	30	oxaliplatin	IFN	PA131285527	3439	0.68
NULL	Front_Physiol_2013_Jun_18_4_144.nxml.txt.nlp	23785333	SENT155	36	36	14	14	l-arginine	IL-10	PA448478	3586	0.68
NULL	J_Hematol_Oncol_2010_Mar_23_3_11.nxml.txt.nlp	20331897	SENT19	4	4	15	15	trastuzumab	HER2	PA451743	2064	0.68
NULL	Eur_Radiol_2011_Jun_3_21(6)_1188-1199.nxml.txt.nlp	21127880	SENT58	9	9	4	4	epirubicin	NAC	PA449476	22861	0.68
NULL	J_Cell_Mol_Med_2014_Apr_20_18(4)_709-720.nxml.txt.nlp	24444314	SENT127	8	8	10	10	metformin	Met	PA450395	79811	0.68
NULL	Front_Oncol_2012_Sep_12_2_114.nxml.txt.nlp	22988546	SENT59	21	21	9	9	ifosfamide	CTX	PA449964	1593	0.68
NULL	Adipocyte_2012_Jul_1_1(3)_123-131.nxml.txt.nlp	23145367	SENT136	27	27	12	12	lipase	CGI-58	PA450239	51099	0.68
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT292	8	8	17	17	tacrolimus	IL-6	PA451578	3569	0.68
NULL	Case_Rep_Ophthalmol_2010_Dec_8_1(2)_110-113.nxml.txt.nlp	21373383	SENT46	39	39	25	25	ranibizumab	PED	PA164746012	8682	0.68
NULL	Cancers_(Basel)_2014_Mar_26_6(2)_741-755.nxml.txt.nlp	24675570	SENT78	13	13	16	16	cisplatin	OSM	PA449014	5008	0.68
NULL	Br_J_Pharmacol_2008_Dec_25_155(7)_1056-1065.nxml.txt.nlp	18724386	SENT75	19	19	21	21	forskolin	GLP-1	PA146096022	100125288	0.68
NULL	Oxid_Med_Cell_Longev_2012_Jul_22_2012_785743.nxml.txt.nlp	22919441	SENT128	36	36	10	10	etoposide	Bcl-2	PA449552	596	0.68
NULL	Int_J_Mol_Imaging_2011_Oct_26_2011_874585.nxml.txt.nlp	21490735	SENT124	13	13	30	30	doxorubicin	FDG	PA449412	23583	0.68
NULL	Environ_Microbiol_2013_Jan_15_15(1)_297-304.nxml.txt.nlp	23157680	SENT51	18	18	45	45	cefotaxime	TMP	PA448852	2012	0.68
NULL	J_Breast_Cancer_2013_Mar_31_16(1)_12-15.nxml.txt.nlp	23593076	SENT61	29	29	21	21	vinorelbine	TPC	PA451881	8030;60386	0.68
NULL	Aquat_Biosyst_2012_Apr_17_8_9.nxml.txt.nlp	22510370	SENT260	8	8	18	18	nadh	PHB	PA164755085	5245	0.68
NULL	Arch_Toxicol_2014_Nov_5_88(12)_2135-2190.nxml.txt.nlp	25370008	SENT1025	14	14	11	11	4-methylumbelliferone	UGT1	PA154081778	7355	0.68
NULL	Pharmaceuticals_(Basel)_2011_Jun_14_4(6)_804-821.nxml.txt.nlp	23997653	SENT164	16	16	11	11	ethanol	OX2R	PA448073	3062;131450	0.68
NULL	Diabetes_2008_Sep_57(9)_2321-2331.nxml.txt.nlp	18599527	SENT342	47	47	23	23	pioglitazone	CD68	PA450970	968	0.68
NULL	Breast_Cancer_(Auckl)_2012_Mar_7_6_67-77.nxml.txt.nlp	22438669	SENT85	20	20	38	38	trastuzumab	HER2	PA451743	2064	0.68
NULL	Genome_Biol_2011_Mar_17_12(3)_218.nxml.txt.nlp	21401968	SENT179	7	7	4	4	capsaicin	TRPV1	PA448776	7442	0.68
NULL	Alcohol_Res_Health_2007_30(1)_5-13.nxml.txt.nlp	17718394	SENT50	15	15	0	0	ethanol	ADH5	PA448073	128	0.68
NULL	J_Cancer_Prev_2014_Mar_19(1)_39-46.nxml.txt.nlp	25337571	SENT12	0	0	6	6	ethanol	p53	PA448073	7157	0.68
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Feb_6_65(Pt_3)_o482.nxml.txt.nlp	21582151	SENT72	30	30	28	28	ethanol	mol	PA448073	90527	0.68
NULL	Br_J_Cancer_2011_Mar_1_104(5)_750-755.nxml.txt.nlp	21326243	SENT129	11	11	5	5	dacarbazine	MPG	PA449197	4350	0.68
NULL	Pain_Res_Treat_2011_Apr_7_2011_968218.nxml.txt.nlp	22110937	SENT97	6	6	12	12	naloxone	IL-2	PA450586	3558	0.68
NULL	J_Hematol_Oncol_2013_Sep_5_6_66.nxml.txt.nlp	24010946	SENT237	23	23	7	7	etoposide	CRT	PA449552	811	0.68
NULL	Oncoimmunology_2014_Jun_3_3_e29030.nxml.txt.nlp	25083328	SENT78	29	29	4	4	trastuzumab	IL-2	PA451743	3558	0.679
NULL	J_Hematol_Oncol_2013_Jun_3_6_38.nxml.txt.nlp	23731980	SENT181	15	15	22	22	neratinib	HER2	PA165291472	2064	0.679
NULL	J_Biomed_Opt_2013_Dec_20_18(12)_126017.nxml.txt.nlp	24362926	SENT80	24	24	19	19	proflavine	spatial	PA164748742	219793	0.679
NULL	Cent_European_J_Urol_2013_Nov_18_66(3)_344-349.nxml.txt.nlp	24707382	SENT52	12	12	5	5	tacrolimus	ABO	PA451578	28	0.679
NULL	Int_J_Mol_Sci_2014_Sep_5_15(9)_15767-15777.nxml.txt.nlp	25198900	SENT262	15	15	5	5	irinotecan	p53	PA450085	7157	0.679
NULL	Drug_Des_Devel_Ther_2014_Sep_23_8_1527-1538.nxml.txt.nlp	25284985	SENT149	26	26	10	10	celecoxib	IFN	PA448871	3439	0.679
NULL	Cell_Death_Dis_2014_Jul_17_5(7)_e1333.nxml.txt.nlp	25032856	SENT55	23	23	25	25	candesartan	TLR4	PA448765	7099	0.679
NULL	Curr_Cardiol_Rev_2009_May_5(2)_87-104.nxml.txt.nlp	20436849	SENT263	40	40	23	23	tobramycin	San	PA451704	80218	0.679
NULL	Acta_Pharmacol_Sin_2013_Mar_11_34(3)_403-413.nxml.txt.nlp	23396374	SENT194	30	30	16	16	methotrexate	RANKL	PA450428	8600	0.679
NULL	Age_(Dordr)_2010_Mar_12_32(1)_109-121.nxml.txt.nlp	19908165	SENT82	12	12	34	34	fluorescein	CD41	PA164746009	3674	0.679
NULL	Autophagy_2013_Jul_1_9(7)_996-1008.nxml.txt.nlp	23580233	SENT85	10	10	19	19	cisplatin	CASP3	PA449014	836	0.679
NULL	Crit_Care_2011_Jul_8_15(4)_R163.nxml.txt.nlp	21740551	SENT212	24	24	4	4	clopidogrel	CD40	PA449053	958	0.679
NULL	Mediators_Inflamm_2011_Jul_3_2011_296069.nxml.txt.nlp	21765615	SENT20	8	8	0	0	heparin	TSP-1	PA449855	7057	0.679
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_24_2012_673132.nxml.txt.nlp	23133498	SENT114	12	12	6	6	ciprofloxacin	P-gp	PA449009	5243	0.679
NULL	J_Cell_Biol_2003_Dec_22_163(6)_1385-1395.nxml.txt.nlp	14676308	SENT166	33	33	26	26	thrombin	RhoA	PA451674	387	0.679
NULL	JAKSTAT_2014_Jun_12_3_e29554.nxml.txt.nlp	25105067	SENT60	9	9	15	15	propofol	STAT3	PA451141	6774	0.679
NULL	Case_Rep_Oncol_2012_Jul_3_5(2)_339-346.nxml.txt.nlp	22807902	SENT53	3	3	22	22	rituximab	CHOP	PA451261	1649	0.679
NULL	eLife_2013_Nov_19_2_e01157.nxml.txt.nlp	24252875	SENT298	3	3	25	25	zolpidem	MSN	PA451976	4478	0.679
NULL	Genome_Announc_2014_Jul_10_2(4)_e00688-14.nxml.txt.nlp	25013145	SENT5	35	35	40	40	vancomycin	VISA	PA451850	57506	0.679
NULL	Mol_Cancer_2013_Sep_11_12_104.nxml.txt.nlp	24025152	SENT141	3	3	5	5	gemcitabine	STAT3	PA449748	6774	0.679
NULL	Cell_Res_2013_Sep_25_23(9)_1075-1090.nxml.txt.nlp	23797856	SENT358	10	10	8	8	tamoxifen	E12	PA451581	64100	0.679
NULL	Br_J_Cancer_2010_May_11_102(10)_1495-1502.nxml.txt.nlp	20461092	SENT238	27	27	10	10	lapatinib	EGFR	PA152241907	1956	0.679
NULL	Case_Rep_Hematol_2013_Sep_5_2013_708489.nxml.txt.nlp	24083040	SENT106	22	22	19	19	iron	B12	PA450087	7126;4709	0.679
NULL	J_Korean_Med_Sci_2011_Jan_22_26(1)_47-52.nxml.txt.nlp	21218029	SENT23	25	25	20	20	creatine	H-FABP	PA164778930	2170	0.679
NULL	Crit_Care_2010_Sep_1_14(Suppl_2)_P17.nxml.txt.nlp	NULL	SENT16	5	5	21	21	ethanol	IFN	PA448073	3439	0.679
NULL	Ann_Dermatol_2014_Aug_31_26(4)_517-520.nxml.txt.nlp	25143685	SENT38	19	19	24	24	tazarotene	Bcl-2	PA164746821	596	0.679
NULL	Breast_Cancer_Res_2012_Feb_7_14(1)_R23.nxml.txt.nlp	22314082	SENT330	35	35	43	43	hyaluronan	LYVE-1	PA165958431	10894	0.679
NULL	Oxid_Med_Cell_Longev_2013_Feb_24_2013_375893.nxml.txt.nlp	23533689	SENT105	13	13	29	29	paraformaldehyde	San	PA450790	80218	0.679
NULL	Cancers_(Basel)_2010_Dec_23_3(1)_17-42.nxml.txt.nlp	24212604	SENT697	18	18	12	12	vinorelbine	PPX	PA451881	5531	0.679
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Oct_10_65(Pt_11)_o2696-o2697.nxml.txt.nlp	21578300	SENT71	16	16	25	25	phenol	mol	PA450913	90527	0.679
NULL	Sci_Rep_2015_Jan_6_5_7641.nxml.txt.nlp	25560734	SENT127	9	9	5	5	tamoxifen	CLTC	PA451581	1213	0.679
NULL	Mol_Vis_2011_Jun_9_17_1564-1576.nxml.txt.nlp	21738386	SENT74	9	9	11	11	ethambutol	EMB	PA164784021	133418	0.679
NULL	Biomed_Res_Int_2014_Aug_6_2014_310194.nxml.txt.nlp	25165698	SENT50	26	26	16	16	ethambutol	DST	PA164784021	667	0.679
NULL	Diabetes_Care_2010_Apr_12_33(4)_861-868.nxml.txt.nlp	20067962	SENT160	9	9	7	7	hyaluronan	HMGB1	PA165958431	3146	0.679
NULL	Arthritis_Res_Ther_2006_Jul_28_8(Suppl_2)_S4.nxml.txt.nlp	16899108	SENT38	25	25	23	23	tocilizumab	IL-6	PA165292659	3569	0.679
NULL	Biologics_2012_Dec_17_6_429-464.nxml.txt.nlp	23269860	SENT183	27	27	31	31	etanercept	ACR	PA449515	49	0.679
NULL	Cardiovasc_Diabetol_2013_Nov_4_12_159.nxml.txt.nlp	24180232	SENT132	4	4	17	17	valsartan	URAT1	PA451848	116085	0.679
NULL	Arthritis_Res_Ther_2011_May_25_13(Suppl_1)_S2.nxml.txt.nlp	21624181	SENT245	0	0	18	18	infliximab	IMPACT	PA452639	55364	0.679
NULL	Scientifica_(Cairo)_2013_Feb_7_2013_249101.nxml.txt.nlp	24278770	SENT192	7	7	9	9	alemtuzumab	IFN	PA164783958	3439	0.679
NULL	J_Exp_Biol_2014_May_15_217(10)_1790-1798.nxml.txt.nlp	24577446	SENT316	4	4	18	18	benzaldehyde	mol	PA448571	90527	0.679
NULL	Mar_Drugs_2011_Nov_29_9(12)_2514-2525.nxml.txt.nlp	22363237	SENT119	3	3	14	14	carrageenan	LOX	PA448814	4015	0.679
NULL	J_Gen_Physiol_1997_Jul_1_110(1)_45-58.nxml.txt.nlp	9234170	SENT282	17	17	21	21	nitroprusside	GMP	PA451406	22978	0.679
NULL	Ann_Hematol_2010_Sep_13_89(9)_861-871.nxml.txt.nlp	20387067	SENT196	18	18	11	11	dasatinib	IL-3	PA162372878	3562	0.679
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_24_2012_673132.nxml.txt.nlp	23133498	SENT114	22	22	6	6	verapamil	P-gp	PA451868	5243	0.679
NULL	Front_Oncol_2014_Sep_29_4_251.nxml.txt.nlp	25325012	SENT301	9	9	22	22	etoposide	TTF1	PA449552	7080;7270	0.679
NULL	Clinics_(Sao_Paulo)_2010_Jun_65(6)_645-646.nxml.txt.nlp	20613942	SENT38	11	11	3	3	orlistat	CEA	PA164776864	5670;1087	0.679
NULL	Front_Pharmacol_2014_May_9_5_103.nxml.txt.nlp	24847272	SENT223	17	17	13	13	midazolam	CYP3A	PA450496	1574	0.679
NULL	J_Antimicrob_Chemother_2009_Jul_18_64(1)_9-15.nxml.txt.nlp	19451132	SENT93	10	10	19	19	mupirocin	MetRS	PA164764568	4141	0.679
NULL	J_Thorac_Oncol_2014_Feb_23_9(2)_205-213.nxml.txt.nlp	24419418	SENT178	17	17	9	9	erlotinib	KRAS	PA134687924	3845	0.679
NULL	Biologics_2013_May_3_7_103-113.nxml.txt.nlp	23662043	SENT181	7	7	4	4	icatibant	C1-INH	PA164749185	710	0.679
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT37	10	10	28	28	cisplatin	p53	PA449014	7157	0.679
NULL	Stroke_Res_Treat_2009_Dec_20_2010_386389.nxml.txt.nlp	20700422	SENT289	33	33	30	30	pioglitazone	NAC	PA450970	22861	0.679
NULL	Br_J_Cancer_2010_Jun_29_103(1)_6-11.nxml.txt.nlp	20551960	SENT28	8	8	15	15	vincristine	ADM	PA451879	133	0.679
NULL	Bioinform_Biol_Insights_2012_Dec_3_6_287-302.nxml.txt.nlp	23236254	SENT37	14	14	31	31	chloroquine	DHPS	PA448948	1725	0.679
NULL	Ann_Lab_Med_2012_Jul_20_32(4)_298-303.nxml.txt.nlp	22779073	SENT86	44	44	37	37	ciprofloxacin	EMB	PA449009	133418	0.679
NULL	Sensors_(Basel)_2012_Nov_26_12(12)_16368-16389.nxml.txt.nlp	23443383	SENT86	4	4	8	8	chlorophyll	EVI	PA448942	79971	0.679
NULL	Diabetes_2009_Jul_28_58(7)_1518-1525.nxml.txt.nlp	19401427	SENT185	4	4	9	9	lisinopril	HMGCR	PA450242	3156	0.679
NULL	Hematol_Rep_2011_Nov_21_3(3)_e27.nxml.txt.nlp	22593818	SENT96	14	14	11	11	hydroxyurea	IFN	PA449942	3439	0.679
NULL	J_Immunother_Cancer_2014_Apr_15_2_7.nxml.txt.nlp	24855562	SENT94	11	11	5	5	cyclophosphamide	OX40	PA449165	7293	0.679
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_17_2013_549174.nxml.txt.nlp	23843879	SENT100	12	12	36	36	curcumin	HO-1	PA151958596	3162	0.679
NULL	ScientificWorldJournal_2013_Dec_5_2013_643954.nxml.txt.nlp	24382946	SENT142	15	15	12	12	cyproheptadine	ghrelin	PA164749366	51738	0.679
NULL	Front_Genet_2012_Nov_22_3_249.nxml.txt.nlp	23189085	SENT116	16	16	20	20	etoposide	CYP3A	PA449552	1574	0.679
NULL	J_Cardiovasc_Thorac_Res_2014_Jun_30_6(2)_97-100.nxml.txt.nlp	25031824	SENT5	17	17	8	8	heparin	ACT	PA449855	12;11332;9457;641455	0.679
NULL	Sci_Rep_2014_Dec_9_4_7375.nxml.txt.nlp	25487878	SENT55	34	34	23	23	lipase	CD36	PA450239	948	0.679
NULL	J_Gastroenterol_2014_Dec_24_49(12)_1536-1547.nxml.txt.nlp	24366288	SENT211	2	2	11	11	rabeprazole	CYP2C19	PA451216	1557	0.679
NULL	Oxid_Med_Cell_Longev_2013_Jun_11_2013_870472.nxml.txt.nlp	23840921	SENT74	13	13	6	6	chloroquine	HO-1	PA448948	3162	0.679
NULL	Exp_Lung_Res_2013_Oct_1_39(8)_336-348.nxml.txt.nlp	23919450	SENT244	11	11	8	8	thrombin	PAR-1	PA451674	2011;2149	0.679
NULL	Braz_J_Med_Biol_Res_2013_Nov_29_47(1)_50-59.nxml.txt.nlp	24519091	SENT48	20	20	44	44	l-glutamine	CO2	PA10090	4513	0.679
NULL	Oncol_Lett_2014_Jan_29_7(1)_121-124.nxml.txt.nlp	24348832	SENT89	6	6	8	8	cisplatin	Bcl-2	PA449014	596	0.679
NULL	Breast_Cancer_Res_2012_May_18_14(3)_R78.nxml.txt.nlp	22608253	SENT212	0	0	27	27	nilotinib	GREB1	PA165958345	9687	0.679
NULL	Gastric_Cancer_2013_Jul_12_16(3)_345-354.nxml.txt.nlp	22968820	SENT137	8	8	6	6	oxaliplatin	FANCJ	PA131285527	83990	0.679
NULL	Cancer_Cell_Int_2010_Oct_25_10_40.nxml.txt.nlp	20974006	SENT161	19	19	26	26	paraformaldehyde	DR5	PA450790	8795	0.679
NULL	Case_Rep_Pathol_2013_Jul_14_2013_198643.nxml.txt.nlp	23936709	SENT73	18	18	21	21	thyroglobulin	PTH	PA164754910	5741	0.679
NULL	Ther_Clin_Risk_Manag_2007_Dec_3(6)_1009-1020.nxml.txt.nlp	18516316	SENT180	24	24	22	22	aprepitant	NK-1	PA164747039	27087	0.679
NULL	Diabetologia_2010_Jul_2_53(7)_1270-1287.nxml.txt.nlp	20361178	SENT245	2	2	17	17	pioglitazone	NEFA	PA450970	4925	0.679
NULL	Indian_J_Pharm_Sci_2013_Nov-Dec_75(6)_680-687.nxml.txt.nlp	24591743	SENT35	32	32	15	15	gemfibrozil	CYP2C8	PA449750	1558	0.679
NULL	Cancer_Cell_Int_2011_Nov_17_11_40.nxml.txt.nlp	22088142	SENT154	5	5	11	11	gefitinib	MRP2	PA131301952	100130958;57626;1244	0.679
NULL	Br_J_Cancer_2010_May_11_102(10)_1456-1460.nxml.txt.nlp	20461090	SENT75	18	18	22	22	temsirolimus	IFN	PA164746890	3439	0.679
NULL	Mol_Cancer_2012_Jun_26_11_43.nxml.txt.nlp	22731636	SENT207	21	21	6	6	pp2	CD24		100133941	0.679
NULL	Gut_Liver_2011_Jun_24_5(2)_160-164.nxml.txt.nlp	21814595	SENT108	15	15	21	21	midazolam	ESD	PA450496	2098	0.679
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT187	32	32	21	21	lapatinib	EGFR	PA152241907	1956	0.679
NULL	Int_J_Biol_Sci_2005_Dec_1_1(4)_146-151.nxml.txt.nlp	18167569	SENT140	18	18	22	22	zinc	IMAC	PA451956	10344	0.679
NULL	Gut_Liver_2011_Sep_18_5(3)_293-297.nxml.txt.nlp	21927656	SENT33	16	16	4	4	rabeprazole	ESD	PA451216	2098	0.679
NULL	Environ_Health_Perspect_2009_Feb_26_117(2)_254-260.nxml.txt.nlp	19270796	SENT208	3	3	30	30	creatine	AGAT	PA164778930	2628	0.679
NULL	Oncol_Rep_2012_Apr_30_27(4)_923-928.nxml.txt.nlp	22209766	SENT85	0	0	3	3	erlotinib	EGFR	PA134687924	1956	0.679
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT74	11	11	4	4	curcumin	Bcl-2	PA151958596	596	0.679
NULL	Clin_Ophthalmol_2014_Jan_13_8_219-228.nxml.txt.nlp	24531757	SENT141	12	12	4	4	timolol	TIM	PA451690	7984;8914	0.679
NULL	Mol_Cancer_2014_Jun_26_13_158.nxml.txt.nlp	24965046	SENT8	2	2	9	9	cyclophosphamide	CD11b	PA449165	3684	0.679
NULL	Can_Geriatr_J_2013_Jun_3_16(2)_66-103.nxml.txt.nlp	NULL	SENT672	35	35	4	4	galantamine	NMA	PA449726	25805	0.679
NULL	Scientifica_(Cairo)_2012_Dec_13_2012_132370.nxml.txt.nlp	24278669	SENT242	24	24	18	18	clopidogrel	CEA	PA449053	5670;1087	0.679
NULL	Brain_Sci_2013_Apr_10_3(2)_504-520.nxml.txt.nlp	24961412	SENT288	18	18	10	10	ketanserin	5-HT2A	PA131053734	3356	0.679
NULL	BMB_Rep_2014_May_47(5)_274-279.nxml.txt.nlp	24286313	SENT131	24	24	44	44	l-glutamine	CO2	PA10090	4513	0.679
NULL	Tuberc_Respir_Dis_(Seoul)_2014_Apr_25_76(4)_160-162.nxml.txt.nlp	24851128	SENT47	17	17	3	3	streptokinase	MIST1	PA164754919	168620	0.679
NULL	Pharmaceutics_2012_Feb_16_4(1)_179-196.nxml.txt.nlp	24300187	SENT137	4	4	6	6	trimethoprim	TMP	PA451788	2012	0.679
NULL	Indian_J_Radiol_Imaging_2010_Feb_20(1)_13-19.nxml.txt.nlp	20351986	SENT58	14	14	26	26	furosemide	FDG	PA449719	23583	0.679
NULL	J_Biol_Chem_2012_Apr_13_287(16)_12952-12965.nxml.txt.nlp	22371491	SENT63	16	16	10	10	vasopressin	CCL2	PA451858	6347	0.679
NULL	Int_J_Med_Sci_2015_Jan_12_12(2)_187-200.nxml.txt.nlp	25589895	SENT213	17	17	10	10	paclitaxel	EGFR	PA450761	1956	0.679
NULL	Int_J_Mol_Sci_2012_Sep_20_13(9)_11912-11922.nxml.txt.nlp	23109891	SENT83	30	30	41	41	l-glutamine	CO2	PA10090	4513	0.679
NULL	Indian_J_Anaesth_2010_Mar-Apr_54(2)_137-141.nxml.txt.nlp	20661352	SENT130	9	9	26	26	midazolam	CO2	PA450496	4513	0.679
NULL	Oncoimmunology_2014_Jan_1_3_e27358.nxml.txt.nlp	24701373	SENT28	30	30	12	12	glucosamine	TERF2	PA164747613	7014	0.679
NULL	Onco_Targets_Ther_2014_Sep_5_7_1551-1562.nxml.txt.nlp	25228814	SENT127	34	34	4	4	bevacizumab	MMP9	PA130232992	4318	0.679
NULL	Oncoimmunology_2013_Oct_1_2(10)_e26333.nxml.txt.nlp	24251081	SENT62	0	0	22	22	pertuzumab	PI3K		5290	0.679
NULL	J_Asthma_Allergy_2008_Sep_19_1_19-29.nxml.txt.nlp	21436982	SENT110	15	15	19	19	fexofenadine	RANTES	PA449621	6352	0.679
NULL	Cancers_(Basel)_2013_Nov_26_5(4)_1601-1618.nxml.txt.nlp	24287743	SENT168	35	35	2	2	gefitinib	Met	PA131301952	79811	0.679
NULL	Cancer_Cell_Int_2011_Aug_19_11_29.nxml.txt.nlp	21854619	SENT215	28	28	24	24	platinum	BRCA1	PA150595617	672	0.679
NULL	Breast_Cancer_Res_2014_Sep_11_16(5)_430.nxml.txt.nlp	25212826	SENT543	11	11	4	4	trastuzumab	PTEN	PA451743	5728	0.679
NULL	Clin_Dev_Immunol_2013_Sep_17_2013_791262.nxml.txt.nlp	24151519	SENT210	16	16	8	8	heparin	TLR7	PA449855	51284	0.679
NULL	Clin_Interv_Aging_2009_May_14_4_191-196.nxml.txt.nlp	19503781	SENT167	13	13	23	23	tolterodine	STAR	PA164746757	6770;2984	0.679
NULL	Clin_Ophthalmol_2012_Sep_7_6_1471-1476.nxml.txt.nlp	23055666	SENT110	12	12	17	17	betaxolol	NAC	PA448611	22861	0.679
NULL	Int_J_Endocrinol_2014_Apr_30_2014_674987.nxml.txt.nlp	24883061	SENT122	34	34	25	25	collagenase	JUN	PA449107	3725	0.679
NULL	EMBO_J_2009_Mar_18_28(6)_663-676.nxml.txt.nlp	19214186	SENT371	15	15	24	24	oxaliplatin	U87	PA131285527	677775;641648	0.679
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT248	0	0	15	15	tacrolimus	M-CSF	PA451578	1435	0.679
NULL	AIDS_Res_Treat_2013_Sep_17_2013_231956.nxml.txt.nlp	24159383	SENT166	26	26	9	9	buprenorphine	OAT	PA448685	4942	0.679
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Nov_8_64(Pt_12)_o2276.nxml.txt.nlp	21581256	SENT68	8	8	17	17	benzaldehyde	mol	PA448571	90527	0.679
NULL	Exp_Ther_Med_2013_Mar_21_5(3)_987-991.nxml.txt.nlp	23407636	SENT13	0	0	9	9	losartan	AT-1	PA450268	9197	0.679
NULL	Breast_Cancer_Res_2002_Sep_10_4(6)_218-221.nxml.txt.nlp	12473166	SENT84	6	6	3	3	tamoxifen	ATAC	PA451581	6375	0.679
NULL	Eur_J_Med_Res_2010_May_18_15(5)_220-224.nxml.txt.nlp	20562062	SENT46	4	4	12	12	clopidogrel	ADP	PA449053	23038	0.679
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Nov_21_70(Pt_12)_562-565.nxml.txt.nlp	25552993	SENT7	15	15	1	1	benzaldehyde	mol	PA448571	90527	0.679
NULL	Front_Endocrinol_(Lausanne)_2014_Dec_18_5_218.nxml.txt.nlp	25566190	SENT314	7	7	2	2	glucose	MUP1	PA449773	60386	0.679
NULL	J_Hematol_Oncol_2014_Aug_1_7_52.nxml.txt.nlp	25085632	SENT154	10	10	21	21	sunitinib	PTEN	PA162372840	5728	0.679
NULL	Br_J_Cancer_2011_Aug_23_105(5)_658-665.nxml.txt.nlp	21829201	SENT7	12	12	16	16	cisplatin	DCX	PA449014	1641	0.679
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT267	0	0	3	3	metformin	HIF-1	PA450395	29072	0.679
NULL	J_Inflamm_(Lond)_2007_May_4_4_10.nxml.txt.nlp	17480224	SENT303	16	16	26	26	ketamine	IL-4	PA450144	3565	0.679
NULL	Biosci_Rep_2012_Dec_20_33(1)_e00011.nxml.txt.nlp	23137297	SENT266	32	32	18	18	heparin	RPSA	PA449855	3921	0.679
NULL	Crit_Care_2007_Dec_13_11(6)_R129.nxml.txt.nlp	18078508	SENT113	37	37	12	12	vasopressin	ANOVA	PA451858	4858	0.679
NULL	Oncotarget_2013_Jul_31_4(10)_1572-1581.nxml.txt.nlp	24197907	SENT100	22	22	29	29	cisplatin	BRCA1	PA449014	672	0.679
NULL	Oncogene_2010_Jul_8_29(27)_3896-3907.nxml.txt.nlp	20453888	SENT144	6	6	13	13	trastuzumab	HER2	PA451743	2064	0.679
NULL	Br_J_Cancer_2013_Feb_5_108(2)_334-341.nxml.txt.nlp	23257893	SENT144	0	0	11	11	sorafenib	NOXA	PA7000	5366	0.679
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_16_2014_926087.nxml.txt.nlp	25478000	SENT96	11	11	16	16	fenofibrate	PCSK9	PA449594	255738	0.679
NULL	ScientificWorldJournal_2013_Apr_24_2013_928197.nxml.txt.nlp	23737732	SENT59	4	4	18	18	enalapril	AMPK	PA449456	5563	0.679
NULL	Oncotarget_2014_Feb_25_5(5)_1304-1314.nxml.txt.nlp	24675421	SENT142	25	25	8	8	cisplatin	JNK	PA449014	5599	0.679
NULL	Front_Neurosci_2011_Mar_3_5_23.nxml.txt.nlp	21519398	SENT246	32	32	14	14	liraglutide	GLP-1	PA165958364	100125288	0.679
NULL	Acta_Pharmacol_Sin_2011_Sep_5_32(9)_1128-1137.nxml.txt.nlp	21892192	SENT119	20	20	24	24	hydroxyzine	HERG	PA449943	3757	0.679
NULL	Adv_Hematol_2011_Oct_15_2011_196135.nxml.txt.nlp	22013445	SENT132	38	38	24	24	thrombin	PF4	PA451674	5196	0.679
NULL	Cardiovasc_Diabetol_2010_Nov_16_9_76.nxml.txt.nlp	21080957	SENT47	9	9	33	33	ketamine	L15	PA450144	6138;91057	0.679
NULL	Oncotarget_2014_Oct_21_5(22)_11237-11251.nxml.txt.nlp	25365078	SENT116	17	17	6	6	etoposide	p53	PA449552	7157	0.679
NULL	F1000_Biol_Rep_2012_Mar_1_4_5.nxml.txt.nlp	22403588	SENT79	18	18	15	15	ribavirin	IFN	PA451241	3439	0.679
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Mar_26_3(3)_e107.nxml.txt.nlp	24670388	SENT143	14	14	4	4	warfarin	CTRC	PA451906	11330	0.679
NULL	EMBO_Mol_Med_2011_Nov_3(11)_623-636.nxml.txt.nlp	21953712	SENT194	8	8	18	18	trastuzumab	PTEN	PA451743	5728	0.679
NULL	Pharm_Pract_(Granada)_2011_Mar_15_Jan-Mar_9(1)_1-10.nxml.txt.nlp	25132883	SENT161	9	9	13	13	enoxaparin	SPAF	PA449463	166378	0.679
NULL	Mol_Brain_2014_Sep_16_7(1)_63.nxml.txt.nlp	NULL	SENT83	38	38	23	23	forskolin	GDNF	PA146096022	2668	0.679
NULL	Osong_Public_Health_Res_Perspect_2013_Feb_4(1)_27-33.nxml.txt.nlp	24159526	SENT174	37	37	12	12	tetracycline	CTX	PA451640	1593	0.679
NULL	Afr_J_Infect_Dis_2010_4(2)_20-28.nxml.txt.nlp	23878697	SENT39	6	6	16	16	artemether	ACT	PA165111698	12;11332;9457;641455	0.679
NULL	Environ_Health_Perspect_2008_Mar_26_116(3)_322-328.nxml.txt.nlp	18335098	SENT108	6	6	14	14	estradiol	PMI	PA449503	8834;5373	0.679
NULL	Genome_Biol_2003_May_29_4(6)_216.nxml.txt.nlp	12801404	SENT194	19	19	7	7	collagenase	perlecan	PA449107	3339	0.679
NULL	Allergy_Asthma_Immunol_Res_2014_Nov_24_6(6)_558-566.nxml.txt.nlp	25374756	SENT69	13	13	23	23	fluorescein	GK1	PA164746009	2710	0.679
NULL	Mol_Imaging_Radionucl_Ther_2013_Aug_1_22(2)_49-55.nxml.txt.nlp	24003397	SENT31	15	15	23	23	octreotide	ACTH	PA450678	5443	0.679
NULL	Diabetes_Care_2009_Nov_32(Suppl_2)_S342-S348.nxml.txt.nlp	19875578	SENT114	27	27	24	24	exenatide	GLP-1	PA164749238	100125288	0.679
NULL	Mol_Cancer_2013_Nov_13_12_137.nxml.txt.nlp	24225025	SENT241	35	35	12	12	irinotecan	CTRL	PA450085	1506	0.679
NULL	Nat_Med_2010_Jun_23_16(6)_671-677.nxml.txt.nlp	20495567	SENT244	23	23	8	8	sorafenib	ATF5	PA7000	22809	0.679
NULL	Mol_Brain_2013_Feb_12_6_8.nxml.txt.nlp	23402298	SENT171	7	7	13	13	remifentanil	CACNA2D2	PA451232	9254	0.679
NULL	J_Gastroenterol_2014_Dec_24_49(12)_1536-1547.nxml.txt.nlp	24366288	SENT131	32	32	41	41	rabeprazole	CYP2C19	PA451216	1557	0.679
NULL	Iran_J_Microbiol_2013_Mar_5(1)_48-55.nxml.txt.nlp	23466743	SENT131	4	4	14	14	imipenem	CTX	PA449968	1593	0.679
NULL	Cell_Mol_Life_Sci_2011_Feb_24_68(3)_369-395.nxml.txt.nlp	21107637	SENT418	25	25	20	20	cyclosporine	HLA-G	PA449167	3135	0.679
NULL	EMBO_Mol_Med_2011_Nov_3(11)_623-636.nxml.txt.nlp	21953712	SENT184	20	20	16	16	trastuzumab	HER2	PA451743	2064	0.679
NULL	Front_Immunol_2013_Mar_27_4_76.nxml.txt.nlp	23543707	SENT112	17	17	7	7	trastuzumab	EGFR	PA451743	1956	0.679
NULL	Diabetes_2011_Jun_21_60(6)_1705-1715.nxml.txt.nlp	21521872	SENT140	6	6	9	9	doxycycline	STZ	PA449415	6484	0.679
NULL	Diabetes_2009_Apr_9_58(4)_965-974.nxml.txt.nlp	19136651	SENT20	3	3	6	6	nadh	NQO1	PA164755085	1728	0.679
NULL	Pain_Res_Treat_2011_Dec_12_2011_507029.nxml.txt.nlp	22220274	SENT12	11	11	13	13	ceftriaxone	CTX	PA448866	1593	0.679
NULL	ScientificWorldJournal_2013_Sep_30_2013_482689.nxml.txt.nlp	24194682	SENT59	22	22	40	40	estradiol	PRL	PA449503	5617	0.679
NULL	J_Exp_Bot_2011_Oct_4_62(14)_4787-4803.nxml.txt.nlp	21821598	SENT31	11	11	25	25	mannitol	M6PR	PA450320	4074	0.679
NULL	Indian_J_Psychol_Med_2014_Jan-Mar_36(1)_33-39.nxml.txt.nlp	24701007	SENT90	1	1	7	7	risperidone	FGA	PA451257	2243	0.679
NULL	Arch_Toxicol_2014_Nov_5_88(12)_2135-2190.nxml.txt.nlp	25370008	SENT1110	19	19	16	16	procainamide	NAT	PA451108	6046	0.679
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT300	10	10	12	12	cisplatin	JNK	PA449014	5599	0.679
NULL	Front_Neural_Circuits_2013_Oct_2_7_155.nxml.txt.nlp	24106462	SENT145	26	26	38	38	apomorphine	gamma	PA164781163	9913	0.679
NULL	Mol_Biol_Cell_2012_Jul_1_23(13)_2571-2582.nxml.txt.nlp	22573884	SENT180	12	12	10	10	dextran	EGFR	PA449261	1956	0.679
NULL	Indian_J_Urol_2009_Oct-Dec_25(4)_427-436.nxml.txt.nlp	19955664	SENT106	20	20	18	18	bevacizumab	VEGFR	PA130232992	3791	0.679
NULL	Gene_Regul_Syst_Bio_2014_Mar_4_8_63-73.nxml.txt.nlp	24634581	SENT96	24	24	2	2	minocycline	NANOS1	PA450519	340719	0.679
NULL	Hum_Mol_Genet_2013_Dec_15_22(24)_4952-4966.nxml.txt.nlp	23900079	SENT746	17	17	1	1	daclizumab	CD56	PA164764446	4684	0.679
NULL	Clin_Med_Insights_Oncol_2012_Apr_3_6_179-187.nxml.txt.nlp	22518088	SENT58	4	4	6	6	trastuzumab	DM1	PA451743	338023;1760;28509	0.679
NULL	Int_J_Mol_Sci_2012_Feb_24_13(3)_2590-2617.nxml.txt.nlp	22489113	SENT214	15	15	33	33	benzaldehyde	mol	PA448571	90527	0.679
NULL	Adv_Pharmacol_Sci_2013_Jun_18_2013_718313.nxml.txt.nlp	23853606	SENT197	3	3	14	14	nitroprusside	PE-1	PA451406	2117	0.679
NULL	Cell_Death_Dis_2010_Oct_21_1(10)_e86.nxml.txt.nlp	21368859	SENT203	20	20	22	22	doxorubicin	TRAIL	PA449412	8743	0.679
NULL	Indian_J_Med_Res_2013_Dec_138(6)_1022-1024.nxml.txt.nlp	24521652	SENT9	22	22	31	31	vancomycin	VISA	PA451850	57506	0.679
NULL	Evid_Based_Complement_Alternat_Med_2013_Dec_15_2013_560417.nxml.txt.nlp	24489585	SENT156	19	19	16	16	ribavirin	IFN	PA451241	3439	0.679
NULL	Diabetes_2011_Jul_20_60(7)_1990-1999.nxml.txt.nlp	21617181	SENT269	26	26	11	11	rosiglitazone	IL-6	PA451283	3569	0.679
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2751-2762.nxml.txt.nlp	24169358	SENT206	6	6	15	15	letrozole	HER2	PA450196	2064	0.679
NULL	Nat_Commun_2010_Sep_1(6)_1-8.nxml.txt.nlp	20842194	SENT449	15	15	18	18	vasopressin	AVP	PA451858	114548;551	0.679
NULL	J_Infect_Dis_2011_Jun_15_203(12)_1775-1783.nxml.txt.nlp	21606536	SENT21	15	15	18	18	heparin	DC-SIGN	PA449855	30835	0.679
NULL	Int_J_Hypertens_2012_Feb_8_2012_189512.nxml.txt.nlp	22518281	SENT127	18	18	29	29	hemin	HO-1	PA449849	3162	0.679
NULL	Cardiovasc_Res_2012_Mar_15_93(4)_674-681.nxml.txt.nlp	22166712	SENT194	22	22	28	28	simvastatin	CYP3A	PA451363	1574	0.679
NULL	Basic_Clin_Neurosci_2013_Winter_4(1)_5-23.nxml.txt.nlp	25337323	SENT713	15	15	3	3	memantine	spatial	PA10364	219793	0.679
NULL	J_Inflamm_(Lond)_2007_May_4_4_10.nxml.txt.nlp	17480224	SENT206	5	5	10	10	ketamine	IL-13	PA450144	3596	0.679
NULL	Oncotarget_2011_Sep_8_2(9)_728-736.nxml.txt.nlp	21908901	SENT71	0	0	5	5	pertuzumab	HER2		2064	0.679
NULL	Cell_Death_Dis_2013_Jul_4_4(7)_e702.nxml.txt.nlp	23828565	SENT67	23	23	41	41	doxorubicin	TRAIL	PA449412	8743	0.679
NULL	Breast_Cancer_Res_2006_Nov_6_8(6)_215.nxml.txt.nlp	17096862	SENT12	0	0	5	5	trastuzumab	HER2	PA451743	2064	0.679
NULL	Emerg_Infect_Dis_2013_Jan_19(1)_133-136.nxml.txt.nlp	23260464	SENT49	27	27	9	9	ceftazidime	TOB	PA448861	10140	0.679
NULL	Iran_Red_Crescent_Med_J_2014_Mar_5_16(3)_e15344.nxml.txt.nlp	24829782	SENT10	17	17	28	28	phenytoin	slim	PA450947	23008	0.679
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Mar_13_66(Pt_4)_o816.nxml.txt.nlp	21580648	SENT70	22	22	17	17	ethanol	mol	PA448073	90527	0.679
NULL	Emerg_Infect_Dis_2013_Jan_19(1)_133-136.nxml.txt.nlp	23260464	SENT37	15	15	29	29	gentamicin	TOB	PA449753	10140	0.679
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Apr_18_65(Pt_5)_o1065.nxml.txt.nlp	21583881	SENT57	22	22	39	39	ethanol	mol	PA448073	90527	0.679
NULL	Nature_2012_Apr_8_485(7396)_128-132.nxml.txt.nlp	22495310	SENT13	5	5	30	30	cyclosporine	PP1	PA449167	5540;5464	0.679
NULL	Mol_Vis_2011_May_4_17_1172-1181.nxml.txt.nlp	21617754	SENT196	7	7	0	0	staurosporine	FKBP51	PA165109623	2289	0.678
NULL	Front_Immunol_2012_May_4_3_103.nxml.txt.nlp	22566975	SENT180	15	15	17	17	cyclophosphamide	CTX	PA449165	1593	0.678
NULL	Adv_Ther_2014_Jan_30_31(2)_202-216.nxml.txt.nlp	24477354	SENT29	15	15	38	38	metformin	GLP-1	PA450395	100125288	0.678
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Feb_20_69(Pt_3)_o398-o399.nxml.txt.nlp	23476581	SENT79	12	12	6	6	ethanol	mol	PA448073	90527	0.678
NULL	Br_J_Cancer_2002_Jan_21_86(2)_179-184.nxml.txt.nlp	11870502	SENT23	26	26	40	40	tamoxifen	IFN	PA451581	3439	0.678
NULL	Exp_Diabetes_Res_2011_Dec_27_2011_604989.nxml.txt.nlp	21253359	SENT121	30	30	15	15	clonidine	INS-1	PA449051	2305	0.678
NULL	Oncol_Lett_2013_Feb_27_5(2)_483-488.nxml.txt.nlp	23420047	SENT203	21	21	5	5	cetuximab	PTEN	PA10040	5728	0.678
NULL	Mol_Brain_2013_May_4_6_22.nxml.txt.nlp	23641686	SENT190	32	32	8	8	ethanol	P35	PA448073	2220	0.678
NULL	Mol_Cancer_2014_Feb_5_13_24.nxml.txt.nlp	24495306	SENT294	9	9	18	18	collagenase	ADAM17	PA449107	6868	0.678
NULL	Tuberculosis_(Edinb)_2010_Jul_90(4)_236-244.nxml.txt.nlp	20541977	SENT99	33	33	47	47	l-glutamine	Tech	PA10090	57449	0.678
NULL	J_Lipids_2014_Dec_22_2014_564851.nxml.txt.nlp	25587451	SENT148	12	12	5	5	xanthophyll	flower	PA164748318	11094	0.678
NULL	Diabetes_Care_2011_Jun_20_34(6)_e61-e99.nxml.txt.nlp	21617108	SENT683	22	22	18	18	nadh	HBA	PA164755085	85340	0.678
NULL	J_Oncol_2012_Apr_23_2012_901956.nxml.txt.nlp	22619676	SENT157	16	16	8	8	docetaxel	eIF3a	PA449383	8661	0.678
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_55-66.nxml.txt.nlp	17912636	SENT119	21	21	12	12	anastrozole	ATAC	PA448432	6375	0.678
NULL	Acta_Neuropathol_2012_Mar_16_123(3)_369-380.nxml.txt.nlp	22083253	SENT82	4	4	2	2	carboplatin	NF1	PA448803	4763	0.678
NULL	Ann_Hematol_2014_Apr_1_93(8)_1371-1380.nxml.txt.nlp	24687382	SENT30	0	0	6	6	lenalidomide	IKZF3	PA162363968	22806	0.678
NULL	FEBS_Open_Bio_2014_Jan_3_4_105-111.nxml.txt.nlp	24490134	SENT408	29	29	38	38	galactose	NAT	PA449725	6046	0.678
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Jul_9_64(Pt_8)_o1436.nxml.txt.nlp	21203151	SENT7	3	3	11	11	nitrile	mol	PA450636	90527	0.678
NULL	Drugs_R_D_2010_Sep_27_10(3)_165-178.nxml.txt.nlp	20945947	SENT215	12	12	31	31	ridaforolimus	KRAS	PA165291475	3845	0.678
NULL	Hum_Genomics_2013_Apr_5_7(1)_10.nxml.txt.nlp	23561625	SENT1	17	17	19	19	flavopiridol	CDK7	PA452627	1022	0.678
NULL	Cell_J_2014_May_25_Summer_16(2)_163-170.nxml.txt.nlp	24567946	SENT102	6	6	16	16	naloxone	OAT	PA450586	4942	0.678
NULL	Diabetes_2009_Jan_58(1)_250-259.nxml.txt.nlp	18840786	SENT129	8	8	14	14	rosiglitazone	CD36	PA451283	948	0.678
NULL	Mol_Imaging_Biol_2012_Dec_3_14(6)_771-776.nxml.txt.nlp	22476967	SENT204	15	15	4	4	verapamil	P-gp	PA451868	5243	0.678
NULL	Crit_Care_2004_Mar_15_8(Suppl_1)_P246.nxml.txt.nlp	NULL	SENT12	28	28	13	13	vasopressin	ACTH	PA451858	5443	0.678
NULL	EJC_Suppl_2013_Sep_5_11(2)_45-59.nxml.txt.nlp	NULL	SENT209	6	6	15	15	bevacizumab	CRT	PA130232992	811	0.678
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Nov_13_64(Pt_12)_o2319.nxml.txt.nlp	21581295	SENT58	8	8	17	17	benzaldehyde	mol	PA448571	90527	0.678
NULL	Blood_Res_2014_Dec_23_49(4)_253-258.nxml.txt.nlp	25548759	SENT75	15	15	26	26	doxorubicin	CHOP	PA449412	1649	0.678
NULL	Summit_on_Translat_Bioinforma_2009_Mar_1_2009_124-128.nxml.txt.nlp	21347183	SENT69	11	11	40	40	thioguanine	TPMT	PA451663	7172	0.678
NULL	Anticancer_Agents_Med_Chem_2012_Feb_12(2)_163-171.nxml.txt.nlp	22043994	SENT178	31	31	20	20	panitumumab	BRAF	PA162373091	673	0.678
NULL	Br_J_Pharmacol_2008_Sep_9_155(1)_127-137.nxml.txt.nlp	18536750	SENT190	19	19	8	8	piroxicam	IL-10	PA450985	3586	0.678
NULL	Arthritis_Res_2002_Nov_23_4(3)_157-164.nxml.txt.nlp	12010565	SENT147	35	35	18	18	collagenase	p38	PA449107	10598;1432;7965	0.678
NULL	AMB_Express_2014_Aug_30_4_63.nxml.txt.nlp	25401066	SENT148	36	36	25	25	ethanol	CO2	PA448073	4513	0.678
NULL	Anesth_Pain_Med_2013_Dec_27_4(1)_e11906.nxml.txt.nlp	24660144	SENT107	11	11	19	19	cyclophosphamide	VIII	PA449165	1351	0.678
NULL	Adv_Ther_2014_Dec_2_31_1228-1246.nxml.txt.nlp	25447269	SENT9	26	26	28	28	timolol	TIM	PA451690	7984;8914	0.678
NULL	J_Gen_Physiol_2004_Apr_123(4)_427-439.nxml.txt.nlp	15024039	SENT65	16	16	18	18	collagenase	CLS	PA449107	1210	0.678
NULL	Front_Behav_Neurosci_2014_Nov_28_8_416.nxml.txt.nlp	25506320	SENT146	24	24	26	26	chlorpromazine	CPZ	PA448964	8532	0.678
NULL	J_Antimicrob_Chemother_2010_Jul_30_65(7)_1441-1447.nxml.txt.nlp	20435780	SENT65	6	6	20	20	moxifloxacin	TOB	PA450555	10140	0.678
NULL	Nucleic_Acids_Res_2012_Jul_5_40(13)_5988-6000.nxml.txt.nlp	22492511	SENT39	15	15	38	38	l-glutamine	CO2	PA10090	4513	0.678
NULL	Breast_Cancer_(Auckl)_2011_Jul_27_5_175-199.nxml.txt.nlp	21863131	SENT325	10	10	29	29	ixabepilone	San		80218	0.678
NULL	Biomed_Res_Int_2014_Jan_29_2014_458592.nxml.txt.nlp	24592391	SENT6	9	9	5	5	curcumin	HO-1	PA151958596	3162	0.678
NULL	Drugs_Context_2012_Nov_26_2012_212243.nxml.txt.nlp	24432032	SENT406	2	2	7	7	cilomilast	TNF-alpha	PA165948031	7124	0.678
NULL	Basic_Res_Cardiol_2011_Sep_20_106(5)_735-747.nxml.txt.nlp	21598086	SENT235	13	13	3	3	oxygen	p22	PA450744	11331;11261;1778	0.678
NULL	Mol_Cell_Biochem_2014_Oct_9_385(1-2)_265-275.nxml.txt.nlp	24104452	SENT170	22	22	10	10	bortezomib	U87	PA10252	677775;641648	0.678
NULL	Leukemia_2014_Apr_14_28(4)_961-964.nxml.txt.nlp	24418991	SENT45	17	17	20	20	nilotinib	P-gp	PA165958345	5243	0.678
NULL	Kidney_Int_Suppl_(2011)_2013_Dec_27_3(4)_392-409.nxml.txt.nlp	NULL	SENT644	9	9	2	2	curcumin	OCT1	PA151958596	5451;6580	0.678
NULL	Exp_Transl_Stroke_Med_2009_Oct_21_1_4.nxml.txt.nlp	20142991	SENT52	12	12	6	6	staurosporine	EPO	PA165109623	7076;8288;2056	0.678
NULL	Br_J_Cancer_2003_Mar_24_88(6)_822-827.nxml.txt.nlp	12644816	SENT70	5	5	12	12	thalidomide	PSA	PA451644	29968;9520;354	0.678
NULL	Front_Endocrinol_(Lausanne)_2011_Mar_3_2_6.nxml.txt.nlp	21633718	SENT119	17	17	6	6	tetracycline	GPCR	PA451640	151306;165140	0.678
NULL	J_Lipid_Res_2014_Feb_55(2)_307-312.nxml.txt.nlp	24262094	SENT12	21	21	23	23	lipase	PNLIP	PA450239	5406	0.678
NULL	J_Gen_Physiol_2000_Jun_1_115(6)_685-696.nxml.txt.nlp	10828243	SENT120	17	17	28	28	genistein	OLF	PA165109660	83857	0.678
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT306	23	23	1	1	neratinib	EGFR	PA165291472	1956	0.678
NULL	Iran_J_Reprod_Med_2013_Feb_11(2)_151-158.nxml.txt.nlp	24639741	SENT68	0	0	6	6	sildenafil	p53	PA451346	7157	0.678
NULL	Oncotarget_2014_Sep_3_5(19)_9362-9381.nxml.txt.nlp	25313139	SENT267	20	20	9	9	orlistat	SREBP1	PA164776864	6720	0.678
NULL	Adv_Hematol_2012_Aug_2_2012_842945.nxml.txt.nlp	22919394	SENT181	0	0	8	8	lenalidomide	CRBN	PA162363968	51185	0.678
NULL	Ital_J_Pediatr_2011_Aug_22_37_39.nxml.txt.nlp	21859484	SENT53	14	14	16	16	salbutamol	BDP	PA448068	10620;152926	0.678
NULL	Front_Aging_Neurosci_2010_Jan_4_1_6.nxml.txt.nlp	20552057	SENT136	34	34	21	21	curcumin	spatial	PA151958596	219793	0.678
NULL	J_Mol_Signal_2011_May_16_6_4.nxml.txt.nlp	21575178	SENT134	26	26	30	30	forskolin	HSP27	PA146096022	3315	0.678
NULL	Exp_Ther_Med_2013_Jan_1_5(1)_338-342.nxml.txt.nlp	23251295	SENT92	12	12	22	22	everolimus	HK2	PA164746311	3796;3099;29911;3741	0.678
NULL	Scientifica_(Cairo)_2012_Jul_8_2012_128382.nxml.txt.nlp	24278667	SENT178	21	21	29	29	ribavirin	IFN	PA451241	3439	0.678
NULL	Diabetes_2011_Jun_21_60(6)_1770-1778.nxml.txt.nlp	21562078	SENT301	0	0	6	6	metformin	AMPK	PA450395	5563	0.678
NULL	Fibrogenesis_Tissue_Repair_2012_Jul_23_5_11.nxml.txt.nlp	22824096	SENT74	40	40	28	28	bleomycin	IL-17	PA448645	3605	0.678
NULL	Oncogene_2013_Nov_28_32(48)_5439-5448.nxml.txt.nlp	23563182	SENT142	4	4	14	14	vincristine	Mcl-1	PA451879	4170	0.678
NULL	Br_J_Clin_Pharmacol_2013_Aug_23_76(2)_299-315.nxml.txt.nlp	23701319	SENT122	7	7	12	12	alemtuzumab	IL-8	PA164783958	3576	0.678
NULL	Cancer_Immunol_Immunother_2015_Oct_7_64_61-73.nxml.txt.nlp	25287778	SENT193	19	19	22	22	lenalidomide	IL-2	PA162363968	3558	0.678
NULL	Braz_J_Med_Biol_Res_2014_Mar_3_47(3)_245-251.nxml.txt.nlp	24554037	SENT162	5	5	15	15	atorvastatin	IFN	PA448500	3439	0.678
NULL	Nat_Chem_Biol_2014_Feb_15_10(2)_156-163.nxml.txt.nlp	24316736	SENT138	7	7	29	29	paclitaxel	FKBP12	PA450761	2280	0.678
NULL	Case_Rep_Dermatol_2014_Feb_12_6(1)_37-42.nxml.txt.nlp	24707248	SENT11	9	9	6	6	vincristine	CHOP	PA451879	1649	0.678
NULL	Breast_Cancer_Res_2012_Jul_20_14(4)_R110.nxml.txt.nlp	22817698	SENT5	11	11	14	14	cisplatin	BRCA1	PA449014	672	0.678
NULL	Nucleic_Acids_Res_2012_Jul_19_40(13)_5910-5925.nxml.txt.nlp	22434882	SENT344	14	14	9	9	etoposide	p65	PA449552	5970	0.678
NULL	Cough_2007_Oct_31_3_9.nxml.txt.nlp	17971242	SENT38	22	22	5	5	capsaicin	TRPV1	PA448776	7442	0.678
NULL	Aging_Cell_2013_Jun_19_12(3)_446-458.nxml.txt.nlp	23496142	SENT241	17	17	11	11	l-glutamine	F12	PA10090	2161	0.678
NULL	J_Antimicrob_Chemother_2010_Aug_16_65(8)_1784-1791.nxml.txt.nlp	20554570	SENT143	43	43	20	20	daptomycin	CLCR	PA164768820	11330	0.678
NULL	Exp_Ther_Med_2015_Jan_18_9(1)_105-111.nxml.txt.nlp	25452783	SENT179	13	13	32	32	celecoxib	ABCG2	PA448871	9429	0.678
NULL	J_Exp_Clin_Cancer_Res_2009_Aug_14_28(1)_113.nxml.txt.nlp	19682368	SENT32	8	8	22	22	cetuximab	EGFR	PA10040	1956	0.678
NULL	Int_Neurourol_J_2014_Sep_24_18(3)_115-125.nxml.txt.nlp	25279238	SENT210	2	2	8	8	berberine	PI3K	PA165860812	5290	0.678
NULL	J_Int_Soc_Sports_Nutr_2009_Feb_19_6_6.nxml.txt.nlp	19228401	SENT17	24	24	10	10	creatine	ADP	PA164778930	23038	0.678
NULL	Gut_Liver_2011_Jun_24_5(2)_117-132.nxml.txt.nlp	21814590	SENT197	17	17	14	14	ribavirin	IFN	PA451241	3439	0.678
NULL	AAPS_J_2012_Jan_4_14(1)_87-96.nxml.txt.nlp	22215264	SENT238	3	3	9	9	quinidine	P-gp	PA451209	5243	0.678
NULL	Cent_European_J_Urol_2013_Apr_26_66(1)_39-44.nxml.txt.nlp	24578986	SENT87	31	31	13	13	ifosfamide	ACT	PA449964	12;11332;9457;641455	0.678
NULL	J_Allergy_(Cairo)_2011_Oct_24_2011_457169.nxml.txt.nlp	22121382	SENT168	19	19	6	6	salmeterol	IL-6	PA451300	3569	0.678
NULL	Acta_Pharmacol_Sin_2013_Sep_5_34(9)_1229-1236.nxml.txt.nlp	23892269	SENT108	5	5	10	10	sulfaphenazole	CYP2D	PA130231310	1565	0.678
NULL	Braz_J_Microbiol_2010_Jun_1_Apr-Jun_41(2)_452-460.nxml.txt.nlp	24031516	SENT115	40	40	42	42	oxytetracycline	OTC	PA450757	5009	0.678
NULL	Front_Immunol_2012_Mar_21_3_57.nxml.txt.nlp	22566938	SENT55	13	13	15	15	vasopressin	IRAP	PA451858	3557	0.678
NULL	Breast_Cancer_Res_2008_Dec_18_10(Suppl_4)_S26.nxml.txt.nlp	19128440	SENT61	28	28	0	0	tamoxifen	ATAC	PA451581	6375	0.678
NULL	Oncoimmunology_2012_Oct_1_1(7)_1004-1016.nxml.txt.nlp	23170249	SENT195	20	20	7	7	paclitaxel	HER-2	PA450761	2064	0.678
NULL	J_Lipid_Res_2014_Oct_55(10)_2103-2112.nxml.txt.nlp	25139399	SENT528	29	29	7	7	ezetimibe	PCSK9	PA10816	255738	0.678
NULL	Acta_Pharmacol_Sin_2009_Nov_5_30(11)_1522-1528.nxml.txt.nlp	19890360	SENT147	16	16	2	2	fenoterol	CD14	PA10079	929	0.678
NULL	Braz_J_Med_Biol_Res_2014_Sep_5_47(11)_929-939.nxml.txt.nlp	25296354	SENT78	14	14	3	3	erlotinib	EGFR	PA134687924	1956	0.678
NULL	Front_Pharmacol_2014_Sep_10_5_208.nxml.txt.nlp	25309440	SENT624	19	19	24	24	neomycin	IGFBP-4	PA450608	3487	0.678
NULL	Int_Clin_Psychopharmacol_2014_Jul_26_29(4)_206-211.nxml.txt.nlp	24374906	SENT79	17	17	9	9	doxepin	CYP2C9	PA449409	1559	0.678
NULL	Case_Rep_Endocrinol_2014_Aug_18_2014_802473.nxml.txt.nlp	25202461	SENT9	0	0	8	8	teriparatide	PTH	PA451620	5741	0.678
NULL	Iran_J_Microbiol_2013_Mar_5(1)_48-55.nxml.txt.nlp	23466743	SENT131	28	28	14	14	ciprofloxacin	CTX	PA449009	1593	0.678
NULL	Arthritis_Res_Ther_2009_Jan_30_11(1)_205.nxml.txt.nlp	19232061	SENT181	21	21	4	4	adalimumab	STAR	PA10004	6770;2984	0.678
NULL	ScientificWorldJournal_2013_Apr_24_2013_928197.nxml.txt.nlp	23737732	SENT55	0	0	26	26	candesartan	RAGE	PA448765	177	0.678
NULL	Acta_Pharmacol_Sin_2013_Sep_5_34(9)_1192-1200.nxml.txt.nlp	23685957	SENT257	2	2	14	14	curcumin	AKT	PA151958596	207	0.678
NULL	Biomed_Res_Int_2014_Feb_26_2014_236930.nxml.txt.nlp	24719848	SENT238	22	22	24	24	theophylline	NAC	PA451647	22861	0.678
NULL	Clin_Interv_Aging_2009_Jun_29_4_315-317.nxml.txt.nlp	19750233	SENT56	5	5	29	29	fluorescein	PED	PA164746009	8682	0.678
NULL	Nat_Commun_2014_Nov_19_5_5479.nxml.txt.nlp	25407222	SENT50	12	12	35	35	fluorescein	YTS	PA164746009	8565	0.678
NULL	J_Thromb_Haemost_2011_Oct_9(10)_2103-2105.nxml.txt.nlp	21812912	SENT38	32	32	12	12	ticagrelor	mol	PA165374673	90527	0.678
NULL	Mediators_Inflamm_2010_Mar_7_2010_364957.nxml.txt.nlp	20224654	SENT109	0	0	5	5	orlistat	IL-6	PA164776864	3569	0.678
NULL	Br_J_Ophthalmol_2008_Sep_22_92(9)_1275-1282.nxml.txt.nlp	18723745	SENT56	30	30	42	42	latanoprost	BAK	PA164774763	578	0.678
NULL	Behav_Brain_Funct_2010_Dec_29_6_76.nxml.txt.nlp	21190576	SENT70	10	10	6	6	thyroglobulin	NPY	PA164754910	4852	0.678
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1126-1134.nxml.txt.nlp	21364592	SENT32	25	25	10	10	cisplatin	ERCC1	PA449014	2067	0.678
NULL	Br_J_Cancer_1999_Jun_80(8)_1245-1251.nxml.txt.nlp	10376978	SENT9	7	7	15	15	cisplatin	ERCC4	PA449014	2072	0.678
NULL	J_Cancer_2013_Nov_23_4(9)_736-754.nxml.txt.nlp	24312144	SENT223	4	4	1	1	sorafenib	VEGFR	PA7000	3791	0.678
NULL	J_Hematol_Oncol_2011_Jan_21_4_5.nxml.txt.nlp	21255411	SENT152	28	28	18	18	gefitinib	EGFR	PA131301952	1956	0.678
NULL	Oncoimmunology_2012_Oct_1_1(7)_1048-1060.nxml.txt.nlp	23170253	SENT198	13	13	23	23	pertuzumab	HER-2		2064	0.678
NULL	Facts_Views_Vis_Obgyn_2011_3(3)_189-202.nxml.txt.nlp	24753865	SENT99	35	35	16	16	paclitaxel	ERCC1	PA450761	2067	0.678
NULL	Oncoimmunology_2013_Sep_1_2(9)_e25773.nxml.txt.nlp	24319639	SENT28	35	35	5	5	cetuximab	SIRP	PA10040	140885	0.678
NULL	Biologics_2012_Dec_17_6_429-464.nxml.txt.nlp	23269860	SENT183	27	27	15	15	etanercept	ACR	PA449515	49	0.678
NULL	Clin_Dev_Immunol_2013_Sep_30_2013_238035.nxml.txt.nlp	24194771	SENT35	12	12	21	21	methotrexate	CTX	PA450428	1593	0.678
NULL	Acta_Physiol_(Oxf)_2007_Sep_191(1)_43-57.nxml.txt.nlp	17524066	SENT237	26	26	14	14	nifedipine	LQT5	PA450631	3753	0.678
NULL	Sci_Rep_2014_Dec_23_4_7593.nxml.txt.nlp	25534349	SENT57	36	36	30	30	atorvastatin	PC-3	PA448500	692094	0.678
NULL	Indian_J_Med_Res_2012_Aug_136(2)_249-259.nxml.txt.nlp	22960892	SENT127	26	26	17	17	sn-38	UGT1A1		54658	0.678
NULL	Indian_J_Pharmacol_2014_Jan-Feb_46(1)_3-12.nxml.txt.nlp	24550577	SENT222	32	32	16	16	azithromycin	P-gp	PA448519	5243	0.678
NULL	J_Gen_Physiol_1969_May_1_53(5)_530-540.nxml.txt.nlp	5769420	SENT0	13	13	1	1	glutaraldehyde	Gen	PA449777	348654	0.678
NULL	Ann_Gen_Psychiatry_2014_Jun_13_13_17.nxml.txt.nlp	25053968	SENT94	14	14	8	8	citalopram	IDO1	PA449015	3620	0.678
NULL	Breast_Cancer_Res_2011_Jan_17_13(1)_R5.nxml.txt.nlp	21241485	SENT43	14	14	11	11	genistein	p38	PA165109660	10598;1432;7965	0.678
NULL	Nat_Med_2014_Jun_4_20(6)_607-615.nxml.txt.nlp	24793239	SENT174	16	16	12	12	bevacizumab	IFN	PA130232992	3439	0.678
NULL	Ann_Oncol_2012_Nov_22_23(11)_2782-2790.nxml.txt.nlp	22730099	SENT122	22	22	24	24	estradiol	OPG	PA449503	690	0.678
NULL	Int_J_Mol_Sci_2014_Oct_31_15(11)_19832-19846.nxml.txt.nlp	25365174	SENT193	20	20	34	34	ethanol	Bcl-2	PA448073	596	0.678
NULL	Arch_Osteoporos_2013_Sep_13_8(1-2)_144.nxml.txt.nlp	24030479	SENT1004	21	21	30	30	denosumab	PTH	PA166048634	5741	0.678
NULL	Nat_Commun_2013_Oct_1_4_2516.nxml.txt.nlp	24084631	SENT52	0	0	3	3	losartan	CCN2	PA450268	1490	0.678
NULL	J_Hematol_Oncol_2013_Jun_3_6_38.nxml.txt.nlp	23731980	SENT157	14	14	22	22	afatinib	HER2	PA165981154	2064	0.678
NULL	Case_Rep_Orthop_2012_Dec_31_2012_180506.nxml.txt.nlp	23346439	SENT28	11	11	2	2	creatine	B12	PA164778930	7126;4709	0.678
NULL	Environ_Health_Perspect_2011_Aug_4_119(8)_1142-1148.nxml.txt.nlp	21543282	SENT233	16	16	0	0	tamoxifen	Gen	PA451581	348654	0.678
NULL	Proteome_Sci_2009_May_28_7_20.nxml.txt.nlp	19476632	SENT146	6	6	16	16	galactose	IDH3A	PA449725	3419	0.678
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT314	12	12	3	3	cisplatin	p38	PA449014	10598;1432;7965	0.678
NULL	Indian_J_Med_Res_2013_Jan_137(1)_102-110.nxml.txt.nlp	23481058	SENT141	14	14	2	2	oxygen	HIF-1	PA450744	29072	0.678
NULL	Nat_Med_2014_Mar_23_20(3)_291-295.nxml.txt.nlp	24562381	SENT244	16	16	10	10	reserpine	ADX	PA451236	2230	0.678
NULL	Mol_Vis_2010_Oct_8_16_2033-2042.nxml.txt.nlp	21042558	SENT252	0	0	33	33	genistein	p38	PA165109660	10598;1432;7965	0.678
NULL	Exp_Diabetes_Res_2011_Dec_27_2011_604989.nxml.txt.nlp	21253359	SENT175	15	15	9	9	clonidine	GLP-1	PA449051	100125288	0.678
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1046.nxml.txt.nlp	24503538	SENT11	19	19	10	10	oxaliplatin	FGFR4	PA131285527	2264	0.678
NULL	Oncoscience_2014_Jun_6_1(6)_423-426.nxml.txt.nlp	25594040	SENT28	7	7	2	2	imatinib	PI3K	PA10804	5290	0.678
NULL	J_Korean_Med_Sci_2006_Jun_21_21(3)_418-424.nxml.txt.nlp	16778382	SENT121	0	0	5	5	hemin	HO-1	PA449849	3162	0.678
NULL	Arthritis_Res_Ther_2008_Jan_7_10(1)_R1.nxml.txt.nlp	18179697	SENT52	11	11	14	14	oxaliplatin	HMGB1	PA131285527	3146	0.678
NULL	Angiogenesis_2010_Dec_7_13(4)_305-315.nxml.txt.nlp	20927579	SENT158	0	0	6	6	resveratrol	HIF-1		29072	0.678
NULL	J_Oncol_2012_Apr_10_2012_931071.nxml.txt.nlp	22570654	SENT51	20	20	10	10	plerixafor	CD34	PA165958410	947	0.678
NULL	Cases_J_2009_Oct_30_2_176.nxml.txt.nlp	19946487	SENT22	0	0	6	6	bevacizumab	San	PA130232992	80218	0.678
NULL	Oncotarget_2012_May_4_3(4)_395-398.nxml.txt.nlp	22565037	SENT19	0	0	6	6	metformin	CD44	PA450395	960	0.678
NULL	Cell_Death_Dis_2010_Feb_4_1(2)_e23.nxml.txt.nlp	21364631	SENT100	30	30	17	17	imipramine	ZAP70	PA449969	7535	0.678
NULL	J_Clin_Biochem_Nutr_2009_Nov_28_45(3)_285-291.nxml.txt.nlp	19902018	SENT116	4	4	14	14	allopurinol	XOR	PA448320	7498	0.678
NULL	J_Infect_Dis_2012_Apr_15_205(8)_1278-1286.nxml.txt.nlp	22396598	SENT177	17	17	13	13	atovaquone	DHODH	PA448502	1723	0.678
NULL	Mediators_Inflamm_2010_Jun_9_2010_704202.nxml.txt.nlp	20628516	SENT91	9	9	19	19	hyaluronan	TLR4	PA165958431	7099	0.678
NULL	Environ_Health_Perspect_2005_Aug_12_113(8)_1100-1107.nxml.txt.nlp	16079085	SENT117	6	6	8	8	diethylstilbestrol	DES	PA449307	1674	0.678
NULL	J_Cell_Biol_1986_May_1_102(5)_1630-1637.nxml.txt.nlp	3009490	SENT5	9	9	16	16	forskolin	ACTH	PA146096022	5443	0.678
NULL	Crit_Care_2005_Aug_25_9(Suppl_4)_S27-S32.nxml.txt.nlp	16168071	SENT140	11	11	0	0	oxygen	APC	PA450744	324	0.678
NULL	F1000_Med_Rep_2010_Jul_14_2_52.nxml.txt.nlp	21170362	SENT96	6	6	31	31	pregabalin	TRPV1	PA164754814	7442	0.678
NULL	Ann_Oncol_2009_Aug_17_20(8)_1319-1329.nxml.txt.nlp	19535820	SENT349	11	11	43	43	doxorubicin	San	PA449412	80218	0.678
NULL	J_Cardiovasc_Pharmacol_2014_Sep_18_64(3)_199-208.nxml.txt.nlp	24785346	SENT306	5	5	10	10	levosimendan	p38	PA164749138	10598;1432;7965	0.678
NULL	J_Med_Chem_2014_Feb_13_57(3)_539-566.nxml.txt.nlp	24025027	SENT1350	8	8	24	24	etravirine	TRIO	PA166014703	7204	0.678
NULL	Adv_Biomed_Res_2014_Nov_29_3_232.nxml.txt.nlp	25538918	SENT156	19	19	34	34	ropivacaine	ACL	PA451271	47	0.678
NULL	BMJ_2009_Jul_14_339_b2538.nxml.txt.nlp	19602530	SENT9	9	9	2	2	etoricoxib	COX	PA164776853	1351	0.678
NULL	Crit_Care_2008_Jun_25_12(3)_R84.nxml.txt.nlp	18578859	SENT96	16	16	1	1	heparin	PF4	PA449855	5196	0.678
NULL	Bioinformation_2008_Jan_27_2(6)_240-244.nxml.txt.nlp	18317572	SENT38	36	36	43	43	galactose	NAG	PA449725	51594;4669	0.678
NULL	Cell_Commun_Signal_2014_Mar_28_12_23.nxml.txt.nlp	24679124	SENT120	4	4	29	29	curcumin	LAMP1	PA151958596	3916	0.678
NULL	Front_Genet_2013_Dec_16_4_281.nxml.txt.nlp	24379827	SENT319	33	33	16	16	nadh	CACNA1F	PA164755085	778	0.678
NULL	Int_J_Gen_Med_2012_Nov_23_5_983-990.nxml.txt.nlp	23226071	SENT45	21	21	7	7	nevirapine	ART	PA450616	181	0.678
NULL	Endocrinol_Diabetes_Metab_Case_Rep_2014_Mar_1_2014_140001.nxml.txt.nlp	24683487	SENT50	28	28	6	6	bromocriptine	ACTH	PA448671	5443	0.678
NULL	Arthritis_Res_Ther_2008_Jan_31_10(1)_R16.nxml.txt.nlp	18234118	SENT166	25	25	35	35	infliximab	HO-1	PA452639	3162	0.678
NULL	J_Clin_Biochem_Nutr_2010_Jan_29_46(1)_87-92.nxml.txt.nlp	20104270	SENT321	15	15	13	13	hesperidin	STZ	PA449867	6484	0.678
NULL	Mol_Cancer_2012_Jun_26_11_43.nxml.txt.nlp	22731636	SENT242	29	29	1	1	pp2	PP2		4888	0.678
NULL	Int_J_Mol_Sci_2014_Mar_3_15(3)_3768-3783.nxml.txt.nlp	24595239	SENT112	7	7	2	2	hyaluronan	CD44	PA165958431	960	0.678
NULL	Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.nxml.txt.nlp	24736980	SENT181	38	38	28	28	rosuvastatin	OATP1B1	PA134308647	10599	0.678
NULL	Indian_J_Med_Res_2012_Sep_136(3)_391-403.nxml.txt.nlp	23041732	SENT186	7	7	19	19	sorafenib	HCC	PA7000	84668	0.678
NULL	Biomed_Eng_Online_2012_Nov_14_11_84.nxml.txt.nlp	23151049	SENT186	22	22	25	25	ibandronate	PTH	PA10270	5741	0.678
NULL	Mol_Cancer_2009_Oct_1_8_81.nxml.txt.nlp	19796390	SENT13	11	11	16	16	celecoxib	Bcl-2	PA448871	596	0.678
NULL	Biochem_Res_Int_2012_Feb_12_2012_346972.nxml.txt.nlp	22400115	SENT198	6	6	24	24	hyaluronan	YB-1	PA165958431	4904	0.678
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT272	8	8	10	10	lapatinib	HER2	PA152241907	2064	0.678
NULL	Int_J_Vasc_Med_2011_Aug_11_2011_867964.nxml.txt.nlp	21860799	SENT13	0	0	23	23	clopidogrel	ADP	PA449053	23038	0.678
NULL	Oncol_Lett_2014_Apr_12_7(4)_1049-1052.nxml.txt.nlp	24944667	SENT52	22	22	6	6	fluorouracil	GEM	PA128406956	2669	0.678
NULL	Chemother_Res_Pract_2011_Nov_2_2011_878912.nxml.txt.nlp	22295207	SENT194	5	5	12	12	temozolomide	PCB	PA451609	5091	0.678
NULL	J_Cell_Biol_2005_Nov_21_171(4)_729-738.nxml.txt.nlp	16286510	SENT87	28	28	11	11	trypsin	syndecan	PA451806	6382	0.678
NULL	Int_J_Mol_Sci_2012_Feb_10_13(2)_1886-1918.nxml.txt.nlp	22408430	SENT250	21	21	31	31	sorafenib	Bcl-2	PA7000	596	0.678
NULL	Open_Ophthalmol_J_2013_Feb_1_7_4-10.nxml.txt.nlp	23459241	SENT122	0	0	7	7	bevacizumab	San	PA130232992	80218	0.678
NULL	Evid_Based_Complement_Alternat_Med_2006_Sep_20_3(3)_365-372.nxml.txt.nlp	16951721	SENT104	16	16	5	5	ginseng	Bcl-2	PA164781150	596	0.678
NULL	Nat_Neurosci_2012_Mar_4_15(4)_565-573.nxml.txt.nlp	22388960	SENT127	7	7	21	21	isoflurane	Hv1	PA450106	84329	0.678
NULL	Int_J_Biol_Sci_2013_Apr_22_9(4)_350-360.nxml.txt.nlp	23630447	SENT164	22	22	28	28	doxorubicin	AKT	PA449412	207	0.678
NULL	Oxid_Med_Cell_Longev_2013_Jun_6_2013_891748.nxml.txt.nlp	23840922	SENT87	0	0	11	11	resveratrol	SIRT1		23411	0.678
NULL	Int_J_Med_Sci_2015_Jan_1_12(1)_23-31.nxml.txt.nlp	25552915	SENT148	36	36	26	26	oxygen	CAT	PA450744	847	0.678
NULL	Can_Geriatr_J_2013_Jun_3_16(2)_66-103.nxml.txt.nlp	NULL	SENT672	31	31	4	4	donepezil	NMA	PA449394	25805	0.678
NULL	Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.nxml.txt.nlp	24736980	SENT269	19	19	21	21	rosuvastatin	OATP1B1	PA134308647	10599	0.678
NULL	Drug_Target_Insights_2007_Feb_5_2_9-18.nxml.txt.nlp	21901058	SENT106	21	21	11	11	ribavirin	IFN	PA451241	3439	0.678
NULL	Asia_Pac_Allergy_2014_Jul_29_4(3)_156-163.nxml.txt.nlp	25097851	SENT34	20	20	22	22	ethambutol	EMB	PA164784021	133418	0.678
NULL	Arthritis_Res_Ther_2009_Apr_6_11(Suppl_1)_S1.nxml.txt.nlp	19368701	SENT107	4	4	0	0	rituximab	ACR	PA451261	49	0.678
NULL	Gut_Liver_2011_Jun_24_5(2)_171-180.nxml.txt.nlp	21814597	SENT29	30	30	18	18	imatinib	PDGFRA	PA10804	5156	0.678
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT50	16	16	18	18	erlotinib	CYP3A	PA134687924	1574	0.678
NULL	J_Cell_Biol_1998_Jan_26_140(2)_335-345.nxml.txt.nlp	9442109	SENT88	5	5	7	7	chloroquine	NHE	PA448948	285335	0.678
NULL	J_Thorac_Oncol_2014_Feb_23_9(2)_205-213.nxml.txt.nlp	24419418	SENT178	17	17	7	7	erlotinib	EGFR	PA134687924	1956	0.678
NULL	Front_Genet_2014_Oct_31_5_379.nxml.txt.nlp	25400658	SENT272	9	9	11	11	estradiol	MALAT1	PA449503	378938	0.678
NULL	Saline_Systems_2005_Aug_4_1_5.nxml.txt.nlp	16176595	SENT112	17	17	23	23	betaine	mol	PA448603	90527	0.678
NULL	Oncotarget_2014_Jun_30_5(14)_5637-5650.nxml.txt.nlp	25026298	SENT185	7	7	22	22	cisplatin	CHK1	PA449014	1111	0.678
NULL	Biomed_Res_Int_2013_Aug_6_2013_602987.nxml.txt.nlp	24027759	SENT289	17	17	19	19	cisplatin	DDP	PA449014	1678	0.678
NULL	Br_J_Cancer_2009_Jul_21_101(2)_238-243.nxml.txt.nlp	19568242	SENT17	8	8	10	10	bevacizumab	IFN	PA130232992	3439	0.678
NULL	Front_Neuroanat_2011_Jul_15_5_40.nxml.txt.nlp	21811438	SENT141	19	19	13	13	haloperidol	DARPP-32	PA449841	84152	0.678
NULL	Int_J_Mol_Sci_2007_Jun_4_8(6)_478-491.nxml.txt.nlp	NULL	SENT101	19	19	21	21	cyclophosphamide	CTX	PA449165	1593	0.678
NULL	EMBO_Mol_Med_2012_Jul_11_4(7)_577-593.nxml.txt.nlp	22496117	SENT229	32	32	28	28	clofazimine	PAP-1	PA164748759	6100	0.678
NULL	Br_J_Pharmacol_2014_Feb_24_171(1)_1019-1032.nxml.txt.nlp	24251620	SENT115	4	4	6	6	nifedipine	TRPM3	PA450631	80036	0.678
NULL	Front_Oncol_2014_Apr_1_4_67.nxml.txt.nlp	24744992	SENT32	0	0	23	23	erlotinib	San	PA134687924	80218	0.678
NULL	Cell_Res_2014_Jul_9_24(7)_820-841.nxml.txt.nlp	24810299	SENT131	15	15	33	33	doxycycline	CD14	PA449415	929	0.678
NULL	Alzheimers_Res_Ther_2013_Oct_24_5(5)_50.nxml.txt.nlp	24401551	SENT221	19	19	26	26	donepezil	spatial	PA449394	219793	0.678
NULL	Exp_Diabetes_Res_2012_Oct_15_2012_465282.nxml.txt.nlp	23118742	SENT132	17	17	22	22	metformin	FGF21	PA450395	26291	0.678
NULL	Bone_Joint_Res_2014_Mar_1_3(3)_51-59.nxml.txt.nlp	24615710	SENT151	19	19	9	9	resveratrol	SIRT1		23411	0.678
NULL	Breast_Cancer_Res_2000_Mar_25_2(3)_184-190.nxml.txt.nlp	11250708	SENT63	4	4	2	2	carbachol	LPA	PA448784	4018	0.678
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1150.nxml.txt.nlp	24675468	SENT103	8	8	19	19	ethanol	PARP-1	PA448073	25976	0.678
NULL	Int_J_Womens_Health_2012_Oct_10_4_543-549.nxml.txt.nlp	23091400	SENT94	20	20	2	2	resveratrol	aromatase		1588	0.678
NULL	Int_J_Mol_Sci_2014_Nov_24_15(11)_21587-21602.nxml.txt.nlp	25421248	SENT158	15	15	6	6	ethanol	mol	PA448073	90527	0.678
NULL	Ann_Oncol_2013_Aug_12_24(8)_1994-1999.nxml.txt.nlp	23670096	SENT130	9	9	36	36	tamoxifen	AIB1	PA451581	8202	0.678
NULL	Case_Rep_Dermatol_2012_Jul_12_4(2)_158-162.nxml.txt.nlp	22807901	SENT44	0	0	23	23	tacrolimus	IL-5	PA451578	3567	0.678
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_39-54.nxml.txt.nlp	19305787	SENT239	42	42	35	35	ethanol	DARPP-32	PA448073	84152	0.678
NULL	Acta_Pharmacol_Sin_2009_Mar_5_30(3)_355-363.nxml.txt.nlp	19262559	SENT88	19	19	29	29	fluorescein	CD11c	PA164746009	3687	0.678
NULL	Arthritis_Res_Ther_2014_Jan_15_16(1)_R10.nxml.txt.nlp	24423138	SENT288	6	6	1	1	collagenase	TRPV1	PA449107	7442	0.678
NULL	Exp_Hematol_Oncol_2014_Jan_11_3_2.nxml.txt.nlp	24410791	SENT105	0	0	6	6	temsirolimus	EGFR	PA164746890	1956	0.678
NULL	Cell_Biol_Int_Rep_(2010)_2012_Jun_21_19(1)_e00017.nxml.txt.nlp	23124518	SENT70	0	0	2	2	etoposide	TRAIL-R2	PA449552	8795	0.678
NULL	Aging_(Albany_NY)_2009_Jun_3_1(6)_515-528.nxml.txt.nlp	20157535	SENT193	35	35	30	30	resveratrol	San		80218	0.678
NULL	Exp_Diabetes_Res_2011_Jun_4_2011_489708.nxml.txt.nlp	21747829	SENT188	15	15	7	7	aliskiren	GLP-1	PA143487910	100125288	0.678
NULL	Ther_Clin_Risk_Manag_2007_Jun_3(3)_401-410.nxml.txt.nlp	18488071	SENT207	0	0	11	11	tramadol	ACR	PA451735	49	0.678
NULL	Oncol_Lett_2013_Oct_26_6(4)_1063-1067.nxml.txt.nlp	24137465	SENT9	22	22	17	17	afatinib	HER2	PA165981154	2064	0.678
NULL	Arch_Med_Sci_2011_Feb_8_7(1)_67-72.nxml.txt.nlp	22291735	SENT109	15	15	10	10	simvastatin	PMI	PA451363	8834;5373	0.678
NULL	J_Cell_Biol_2007_Apr_23_177(2)_265-275.nxml.txt.nlp	17452530	SENT223	34	34	43	43	imiquimod	TLR9	PA449972	54106	0.678
NULL	Oncol_Rep_2014_Mar_14_31(3)_1035-1042.nxml.txt.nlp	24424445	SENT80	46	46	9	9	doxorubicin	TIC	PA449412	23550	0.677
NULL	Mol_Cell_Proteomics_2012_Feb_6_11(2)_M111_015222.nxml.txt.nlp	22147731	SENT295	7	7	11	11	gefitinib	JUN	PA131301952	3725	0.677
NULL	Ann_Rheum_Dis_2008_Oct_25_68(10)_1644-1650.nxml.txt.nlp	18957484	SENT192	17	17	10	10	leflunomide	STAT6	PA450192	6778	0.677
NULL	Contemp_Oncol_(Pozn)_2013_Apr_29_17(2)_137-143.nxml.txt.nlp	23788980	SENT183	15	15	34	34	bromocriptine	PRL	PA448671	5617	0.677
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1013.nxml.txt.nlp	24457957	SENT17	7	7	14	14	orlistat	NOXA	PA164776864	5366	0.677
NULL	Clin_Med_Insights_Oncol_2012_May_16_6_205-217.nxml.txt.nlp	22654526	SENT197	23	23	39	39	plerixafor	CXCL12	PA165958410	6387	0.677
NULL	Acta_Vet_Scand_2011_Feb_17_53(1)_11.nxml.txt.nlp	21324209	SENT75	14	14	16	16	kanamycin	OTC	PA450137	5009	0.677
NULL	Am_J_Trop_Med_Hyg_2012_Nov_7_87(5_Suppl)_137-143.nxml.txt.nlp	23136289	SENT199	13	13	19	19	amoxicillin	MASS	PA448406	2200	0.677
NULL	Acta_Pharmacol_Sin_2014_Aug_21_35(8)_1082-1092.nxml.txt.nlp	25047514	SENT28	14	14	23	23	exemestane	aromatase	PA449563	1588	0.677
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1013.nxml.txt.nlp	24457957	SENT80	14	14	21	21	orlistat	NOXA	PA164776864	5366	0.677
NULL	Br_J_Cancer_2012_Feb_14_106(4)_685-692.nxml.txt.nlp	22294184	SENT197	24	24	9	9	lovastatin	JNK	PA450272	5599	0.677
NULL	Diabetes_2013_Oct_17_62(10)_3547-3552.nxml.txt.nlp	23863812	SENT8	10	10	17	17	pravastatin	adiponectin	PA451089	9370	0.677
NULL	Korean_Circ_J_2013_Jun_30_43(6)_400-407.nxml.txt.nlp	23882289	SENT90	15	15	8	8	doxorubicin	survivin	PA449412	332	0.677
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT190	10	10	25	25	phenprocoumon	CYP2C9	PA450921	1559	0.677
NULL	Int_J_Mol_Sci_2014_Nov_25_15(12)_21703-21722.nxml.txt.nlp	25429431	SENT34	34	34	8	8	doxorubicin	MUC16	PA449412	94025	0.677
NULL	Oncogenesis_2012_Apr_2_1(4)_e5.nxml.txt.nlp	23552603	SENT250	10	10	4	4	celecoxib	BAX	PA448871	581	0.677
NULL	Breast_Cancer_Res_2011_Jan_26_13(1)_R10.nxml.txt.nlp	21269472	SENT196	22	22	16	16	estradiol	PPARGC1B	PA449503	133522	0.677
NULL	Br_J_Cancer_1996_Jul_74(1)_63-68.nxml.txt.nlp	8679460	SENT13	36	36	14	14	cyclophosphamide	p53	PA449165	7157	0.677
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jan_12_67(Pt_2)_o315.nxml.txt.nlp	21523002	SENT64	21	21	10	10	ethanol	mol	PA448073	90527	0.677
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jul_16_67(Pt_8)_o2069.nxml.txt.nlp	22091093	SENT52	15	15	18	18	benzaldehyde	mol	PA448571	90527	0.677
NULL	Evid_Based_Complement_Alternat_Med_2014_Sep_2_2014_627181.nxml.txt.nlp	25258643	SENT41	0	0	14	14	phenylephrine	DPI	PA450935	1832	0.677
NULL	Oncotarget_2011_Jan_25_2(1-2)_8-17.nxml.txt.nlp	21378407	SENT52	18	18	29	29	thrombin	PAR-1	PA451674	2011;2149	0.677
NULL	Neural_Plast_2007_Jan_1_2007_30585.nxml.txt.nlp	25148070	SENT3514	16	16	24	24	citalopram	VPAC2	PA449015	7434	0.677
NULL	Iran_J_Pharm_Res_2014_Summer_13(3)_785-795.nxml.txt.nlp	25276179	SENT150	5	5	2	2	budesonide	zeta	PA448681	9907	0.677
NULL	Cancer_Med_2013_Aug_10_2(4)_488-495.nxml.txt.nlp	24156021	SENT121	30	30	20	20	mitomycin	GEM	PA450524	2669	0.677
NULL	Front_Endocrinol_(Lausanne)_2014_Oct_9_5_166.nxml.txt.nlp	25346724	SENT180	5	5	7	7	resveratrol	SIRT1		23411	0.677
NULL	Biomed_Res_Int_2013_Dec_10_2013_159786.nxml.txt.nlp	24386633	SENT30	20	20	4	4	etoposide	GMF	PA449552	2764	0.677
NULL	Biomed_Res_Int_2014_Jan_29_2014_831845.nxml.txt.nlp	24605337	SENT123	23	23	45	45	bupivacaine	S6K1	PA135057240	6198	0.677
NULL	Eur_J_Clin_Pharmacol_2012_May_21_68(5)_553-560.nxml.txt.nlp	22189672	SENT184	21	21	13	13	diazepam	CYP2C19	PA449283	1557	0.677
NULL	Indian_J_Pharmacol_2014_Nov-Dec_46(6)_627-632.nxml.txt.nlp	25538335	SENT131	5	5	3	3	metformin	Q10	PA450395	27161	0.677
NULL	Aging_(Albany_NY)_2012_Mar_12_4(3)_146-158.nxml.txt.nlp	22436213	SENT60	4	4	8	8	resveratrol	SIRT1		23411	0.677
NULL	Curr_Med_Chem_2014_Oct_21(32)_3673-3686.nxml.txt.nlp	25174918	SENT309	19	19	23	23	verapamil	GMP	PA451868	22978	0.677
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Jul_23_6_103-113.nxml.txt.nlp	25114588	SENT73	11	11	9	9	trastuzumab	DM1	PA451743	338023;1760;28509	0.677
NULL	Front_Neural_Circuits_2013_Oct_2_7_155.nxml.txt.nlp	24106462	SENT141	25	25	17	17	haloperidol	gamma	PA449841	9913	0.677
NULL	Mol_Cancer_2012_Apr_5_11_20.nxml.txt.nlp	22480225	SENT211	17	17	1	1	temozolomide	SPARC	PA451609	6678	0.677
NULL	Clin_Med_Insights_Oncol_2012_Feb_28_6_125-135.nxml.txt.nlp	22408376	SENT186	17	17	23	23	panitumumab	KRAS	PA162373091	3845	0.677
NULL	Mol_Vis_2012_May_1_18_1115-1122.nxml.txt.nlp	22605923	SENT111	5	5	13	13	estradiol	IL-6	PA449503	3569	0.677
NULL	Front_Aging_Neurosci_2010_May_21_2_21.nxml.txt.nlp	20725514	SENT1038	7	7	9	9	rosiglitazone	spatial	PA451283	219793	0.677
NULL	Breast_Cancer_Res_2010_Jun_28_12(3)_R43.nxml.txt.nlp	20579400	SENT235	4	4	6	6	tamoxifen	MAPT	PA451581	4137	0.677
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Nov_26_3(11)_e149.nxml.txt.nlp	25426564	SENT81	39	39	24	24	atorvastatin	PCSK9	PA448500	255738	0.677
NULL	Int_J_Mol_Sci_2012_Feb_24_13(3)_2590-2617.nxml.txt.nlp	22489113	SENT231	14	14	32	32	benzaldehyde	mol	PA448571	90527	0.677
NULL	Protein_Cell_2014_Jul_2_5(7)_544-551.nxml.txt.nlp	24691905	SENT65	32	32	6	6	doxorubicin	p53	PA449412	7157	0.677
NULL	Acta_Histochem_Cytochem_2007_Feb_27_40(1)_9-17.nxml.txt.nlp	17375204	SENT40	11	11	15	15	heparin	L15	PA449855	6138;91057	0.677
NULL	Korean_Circ_J_2013_Aug_31_43(8)_541-549.nxml.txt.nlp	24044013	SENT23	16	16	3	3	clopidogrel	ABCB1	PA449053	5243	0.677
NULL	Cholesterol_2011_Feb_22_2011_503028.nxml.txt.nlp	21490773	SENT104	31	31	5	5	methotrexate	ABCA1	PA450428	19	0.677
NULL	Br_J_Cancer_2012_Jul_10_107(2)_360-369.nxml.txt.nlp	22713663	SENT231	7	7	3	3	bevacizumab	DDP	PA130232992	1678	0.677
NULL	Arch_Osteoporos_2009_Dec_18_4(1-2)_1-8.nxml.txt.nlp	20234790	SENT76	11	11	28	28	raloxifene	PTH	PA451221	5741	0.677
NULL	Oncol_Rep_2012_Oct_26_28(4)_1139-1145.nxml.txt.nlp	22842551	SENT9	19	19	17	17	urokinase	PLAU	PA451836	5328	0.677
NULL	J_Ophthalmol_2012_Aug_27_2012_285851.nxml.txt.nlp	23050121	SENT126	22	22	25	25	timolol	BAK	PA451690	578	0.677
NULL	Mol_Cancer_2013_Sep_23_12_107.nxml.txt.nlp	24053443	SENT133	7	7	14	14	thrombin	C5a	PA451674	727	0.677
NULL	J_Biomed_Sci_2014_Feb_3_21(1)_10.nxml.txt.nlp	24490900	SENT149	26	26	30	30	alendronate	RANKL	PA448082	8600	0.677
NULL	J_Exp_Clin_Cancer_Res_2009_Feb_13_28(1)_17.nxml.txt.nlp	19216775	SENT191	16	16	27	27	cisplatin	CCND1	PA449014	595	0.677
NULL	Int_J_Endocrinol_2011_Aug_21_2011_742719.nxml.txt.nlp	21869886	SENT262	47	47	31	31	cilostazol	DES	PA164746334	1674	0.677
NULL	J_Mol_Signal_2010_Dec_13_5_20.nxml.txt.nlp	21144036	SENT227	19	19	25	25	pioglitazone	TRG	PA450970	6965	0.677
NULL	Br_J_Cancer_2012_Jan_3_106(1)_18-24.nxml.txt.nlp	22108516	SENT110	22	22	28	28	camptothecin	TDP1	PA153590860	55775	0.677
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT333	31	31	19	19	cisplatin	ATG5	PA449014	9474	0.677
NULL	Orphanet_J_Rare_Dis_2007_Jan_23_2_6.nxml.txt.nlp	17244349	SENT101	13	13	15	15	cisplatin	CDP	PA449014	1523	0.677
NULL	Biochem_Res_Int_2012_Nov_1_2012_738471.nxml.txt.nlp	22110962	SENT55	22	22	20	20	choline	CDP	PA448976	1523	0.677
NULL	CNS_Drugs_2014_May_1_28(6)_497-511.nxml.txt.nlp	24788672	SENT46	12	12	23	23	lisdexamfetamine	NOT	PA164748975	4929	0.677
NULL	Anesthesiol_Res_Pract_2008_Mar_27_2008_581948.nxml.txt.nlp	21197458	SENT81	13	13	16	16	sevoflurane	CO2	PA451341	4513	0.677
NULL	Mol_Cell_Proteomics_2012_Feb_6_11(2)_M111_015222.nxml.txt.nlp	22147731	SENT295	18	18	11	11	cetuximab	JUN	PA10040	3725	0.677
NULL	J_Oncol_2010_Jun_10_2010_652320.nxml.txt.nlp	20628530	SENT223	6	6	33	33	bevacizumab	VEGFR2	PA130232992	3791	0.677
NULL	Cancer_Med_2013_Apr_6_2(2)_234-242.nxml.txt.nlp	23634291	SENT175	27	27	20	20	bevacizumab	VEGF-A	PA130232992	7422	0.677
NULL	Cell_Death_Dis_2014_Jul_31_5(7)_e1353.nxml.txt.nlp	25077539	SENT12	36	36	33	33	potassium	spatial	PA451047	219793	0.677
NULL	Evid_Based_Complement_Alternat_Med_2012_May_7_2012_242810.nxml.txt.nlp	22645625	SENT229	15	15	3	3	rifampin	UGT1A1	PA451250	54658	0.677
NULL	EMBO_Mol_Med_2012_Oct_30_4(10)_1087-1096.nxml.txt.nlp	22933245	SENT236	1	1	22	22	olaparib	BRCA2		675	0.677
NULL	Mol_Cancer_2012_Mar_21_11_13.nxml.txt.nlp	22436134	SENT333	10	10	2	2	doxorubicin	HuR	PA449412	1994	0.677
NULL	J_Gen_Physiol_2009_Jun_133(6)_623-625.nxml.txt.nlp	19468076	SENT24	0	0	3	3	caffeine	TRPA1	PA448710	8989	0.677
NULL	Aging_(Albany_NY)_2010_Nov_6_2(11)_748.nxml.txt.nlp	21068468	SENT12	6	6	26	26	doxorubicin	p53	PA449412	7157	0.677
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1709-1716.nxml.txt.nlp	19844235	SENT179	12	12	14	14	gemcitabine	B7-H3	PA449748	80381	0.677
NULL	AIDS_Res_Ther_2013_May_1_10_10.nxml.txt.nlp	23634877	SENT156	12	12	7	7	lovastatin	CCL5	PA450272	6352	0.677
NULL	Biochem_Biophys_Res_Commun_2011_Sep_9_412(4)_747-751.nxml.txt.nlp	21871446	SENT111	11	11	19	19	l-arginine	PI3	PA448478	5266	0.677
NULL	Cell_Death_Dis_2014_Mar_13_5(3)_e1118.nxml.txt.nlp	24625977	SENT45	10	10	5	5	etoposide	UBXN2A	PA449552	165324	0.677
NULL	ScientificWorldJournal_2014_May_13_2014_701329.nxml.txt.nlp	24959618	SENT56	13	13	22	22	neostigmine	NMT	PA450611	4836	0.677
NULL	J_Biol_Chem_2012_Apr_20_287(17)_13868-13876.nxml.txt.nlp	22389490	SENT172	31	31	17	17	capsaicin	TRPV1	PA448776	7442	0.677
NULL	Case_Rep_Ophthalmol_Med_2014_Oct_27_2014_326957.nxml.txt.nlp	25400961	SENT40	33	33	23	23	doxycycline	TMP	PA449415	2012	0.677
NULL	Anal_Bioanal_Chem_2011_Jul_3_400(10)_3473-3479.nxml.txt.nlp	21537911	SENT39	5	5	12	12	oseltamivir	OSC	PA450721	4047	0.677
NULL	Diabetes_2009_Mar_58(3)_527-535.nxml.txt.nlp	19066312	SENT198	6	6	20	20	rosiglitazone	CPT1	PA451283	56994	0.677
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_May_20_67(Pt_6)_o1438.nxml.txt.nlp	21754816	SENT6	13	13	21	21	phenol	mol	PA450913	90527	0.677
NULL	Arch_Drug_Inf_2009_Sep_2(3)_41-50.nxml.txt.nlp	19915711	SENT147	8	8	25	25	atenolol	SLC6A8	PA448499	6535	0.677
NULL	Chem_Cent_J_2012_Jun_20_6_58.nxml.txt.nlp	22716299	SENT198	4	4	21	21	indomethacin	IFN	PA449982	3439	0.677
NULL	J_Int_AIDS_Soc_2010_Nov_8_13(Suppl_4)_P82.nxml.txt.nlp	NULL	SENT5	37	37	20	20	indinavir	CD4	PA449977	920	0.677
NULL	Cells_2012_Jun_20_1(2)_168-203.nxml.txt.nlp	24710422	SENT212	10	10	6	6	lipase	HSL	PA450239	3991	0.677
NULL	New_Microbes_New_Infect_2014_May_4_2(3)_58-63.nxml.txt.nlp	25356345	SENT100	30	30	8	8	ciprofloxacin	CTX	PA449009	1593	0.677
NULL	Theranostics_2013_Jan_15_3(1)_47-75.nxml.txt.nlp	23382786	SENT332	0	0	22	22	spermine	CXCR4	PA164781199	7852	0.677
NULL	Int_J_Genomics_2014_Sep_15_2014_967461.nxml.txt.nlp	25309901	SENT220	23	23	9	9	lipase	PIWI	PA450239	9271	0.677
NULL	Breast_Cancer_Res_2011_Jul_26_13(4)_214.nxml.txt.nlp	21867572	SENT97	30	30	15	15	medroxyprogesterone	RANKL	PA450344	8600	0.677
NULL	J_Inflamm_(Lond)_2008_Mar_10_5_4.nxml.txt.nlp	18331642	SENT232	11	11	25	25	piroxicam	IL-10	PA450985	3586	0.677
NULL	Iran_J_Neurol_2013_12(4)_129-135.nxml.txt.nlp	24250922	SENT112	10	10	35	35	thrombin	JNK	PA451674	5599	0.677
NULL	Mol_Cancer_2014_Jun_5_13_143.nxml.txt.nlp	24898067	SENT54	10	10	0	0	trastuzumab	HER-2	PA451743	2064	0.677
NULL	Exp_Ther_Med_2012_Sep_12_4(3)_475-480.nxml.txt.nlp	23181121	SENT8	15	15	19	19	vincristine	CHOP	PA451879	1649	0.677
NULL	Front_Immunol_2012_Mar_19_3_47.nxml.txt.nlp	22566929	SENT58	3	3	10	10	abatacept	B7-H2	PA164747080	23308	0.677
NULL	Cell_Death_Dis_2013_Jan_24_4(1)_e469.nxml.txt.nlp	23348583	SENT232	6	6	8	8	mitomycin	CT26	PA450524	168400	0.677
NULL	Mol_Cancer_2014_Jun_26_13_158.nxml.txt.nlp	24965046	SENT201	22	22	25	25	paraformaldehyde	CD31	PA450790	5175	0.677
NULL	Oncotarget_2014_Oct_21_5(22)_11252-11268.nxml.txt.nlp	25361004	SENT56	9	9	13	13	metformin	U87	PA450395	677775;641648	0.677
NULL	Mol_Syst_Biol_2010_Apr_13_6_356.nxml.txt.nlp	20393576	SENT268	18	18	7	7	ethanol	GCR2	PA448073	11319	0.677
NULL	Pharm_Pract_(Granada)_2011_Mar_15_Jan-Mar_9(1)_1-10.nxml.txt.nlp	25132883	SENT161	5	5	13	13	rivaroxaban	SPAF	PA165958360	166378	0.677
NULL	Cardiovasc_Diabetol_2013_Jun_7_12_84.nxml.txt.nlp	23759020	SENT11	14	14	7	7	dipyridamole	LSR	PA449367	51599	0.677
NULL	Oxid_Med_Cell_Longev_2012_Jan_19_2012_390678.nxml.txt.nlp	22315655	SENT166	2	2	4	4	gliclazide	NAC	PA10892	22861	0.677
NULL	J_Headache_Pain_2009_Apr_27_10(2)_105-110.nxml.txt.nlp	19172228	SENT99	17	17	27	27	capsaicin	c-fos	PA448776	2353	0.677
NULL	Case_Rep_Oncol_2012_May_15_5(2)_238-245.nxml.txt.nlp	22679430	SENT14	13	13	8	8	rituximab	CHOP	PA451261	1649	0.677
NULL	Cell_Death_Dis_2014_Feb_13_5(2)_e1055.nxml.txt.nlp	24525731	SENT309	35	35	40	40	cisplatin	XRCC1	PA449014	7515	0.677
NULL	Diabetologia_2010_Jun_27_53(6)_1142-1150.nxml.txt.nlp	20349036	SENT22	14	14	23	23	spermine	AMPK	PA164781199	5563	0.677
NULL	Mol_Cancer_2010_Dec_20_9_317.nxml.txt.nlp	21172025	SENT9	23	23	20	20	tamoxifen	HER2	PA451581	2064	0.677
NULL	Indian_J_Crit_Care_Med_2011_Apr-Jun_15(2)_71-77.nxml.txt.nlp	21814369	SENT163	0	0	13	13	vasopressin	VWF	PA451858	7450	0.677
NULL	Allergy_Asthma_Clin_Immunol_2007_Jun_15_3(2)_70-72.nxml.txt.nlp	20525146	SENT7	15	15	6	6	amoxicillin	DLST	PA448406	1743	0.677
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_75-89.nxml.txt.nlp	17912638	SENT577	15	15	7	7	anastrozole	ATAC	PA448432	6375	0.677
NULL	Cell_Death_Dis_2013_Sep_5_4(9)_e791.nxml.txt.nlp	24008735	SENT137	3	3	12	12	gemcitabine	PUMA	PA449748	27113	0.677
NULL	Arthritis_Res_Ther_2005_Apr_4_7(4)_R756-R768.nxml.txt.nlp	15987477	SENT184	14	14	2	2	hyaluronidase	PH-20	PA164745713	6677	0.677
NULL	Mol_Biol_Cell_2014_Jul_1_25(13)_2105-2115.nxml.txt.nlp	24807909	SENT201	2	2	21	21	thrombin	GRK5	PA451674	2869	0.677
NULL	J_Gen_Physiol_2004_Jul_124(1)_1b.nxml.txt.nlp	NULL	SENT1339	47	47	45	45	thrombin	EGF	PA451674	1950	0.677
NULL	Cell_Death_Dis_2014_Feb_27_5(2)_e1088.nxml.txt.nlp	24577086	SENT91	2	2	15	15	metformin	Bcl-2	PA450395	596	0.677
NULL	Emerg_Infect_Dis_2013_Nov_19(11)_1721-1730.nxml.txt.nlp	24207100	SENT134	6	6	26	26	gentamicin	VAN	PA449753	10318	0.677
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT120	13	13	4	4	tenofovir	SLC28A1	PA10204	9154	0.677
NULL	Front_Oncol_2013_Aug_20_3_202.nxml.txt.nlp	23971004	SENT450	9	9	18	18	vanillin	PI3K	PA451852	5290	0.677
NULL	JAKSTAT_2012_Oct_1_1(4)_292-299.nxml.txt.nlp	24058786	SENT199	14	14	18	18	pyrimethamine	STAT3	PA451193	6774	0.677
NULL	Sci_Rep_2014_Dec_17_4_7519.nxml.txt.nlp	25515777	SENT218	19	19	12	12	l-glutamine	KSR	PA10090	10256	0.677
NULL	Indian_J_Pharmacol_2013_Jan-Feb_45(1)_9-12.nxml.txt.nlp	23543259	SENT17	5	5	0	0	salbutamol	eNOS	PA448068	4846	0.677
NULL	Iran_J_Pharm_Res_2013_Winter_12(1)_141-146.nxml.txt.nlp	24250582	SENT24	35	35	29	29	rifampin	NAC	PA451250	22861	0.677
NULL	Mol_Cancer_2012_Mar_21_11_13.nxml.txt.nlp	22436134	SENT104	2	2	4	4	doxorubicin	HuR	PA449412	1994	0.677
NULL	Front_Oncol_2013_Sep_11_3_228.nxml.txt.nlp	24062981	SENT189	21	21	3	3	camptothecin	PARP1	PA153590860	142	0.677
NULL	Clin_Psychopharmacol_Neurosci_2011_Apr_30_9(1)_36-43.nxml.txt.nlp	23431025	SENT36	36	36	29	29	haloperidol	HIP	PA449841	6767;6159;64399;5068	0.677
NULL	Curr_Clin_Pharmacol_2013_May_8(2)_135-155.nxml.txt.nlp	23062036	SENT162	5	5	8	8	raloxifene	STAR	PA451221	6770;2984	0.677
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT192	14	14	8	8	pertuzumab	Yes		7525	0.677
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Jun_19_69(Pt_7)_o1121.nxml.txt.nlp	24046676	SENT63	26	26	12	12	ethanol	mol	PA448073	90527	0.677
NULL	Mol_Cancer_2012_Sep_25_11_73.nxml.txt.nlp	23009336	SENT118	8	8	15	15	gefitinib	EGFR	PA131301952	1956	0.677
NULL	Case_Rep_Hematol_2013_Jul_7_2013_896394.nxml.txt.nlp	23936694	SENT36	41	41	37	37	idarubicin	AIDA	PA449961	64853	0.677
NULL	Diabetol_Metab_Syndr_2014_Sep_8_6(1)_95.nxml.txt.nlp	NULL	SENT7	0	0	6	6	liraglutide	GLP-1	PA165958364	100125288	0.677
NULL	Indian_J_Dermatol_2013_Sep-Oct_58(5)_388-392.nxml.txt.nlp	24082187	SENT20	13	13	9	9	imatinib	LDE	PA10804	7957	0.677
NULL	Pain_Ther_2014_Jun_13_3(1)_59-69.nxml.txt.nlp	25135388	SENT120	2	2	8	8	curcumin	HSD1	PA151958596	26871	0.677
NULL	Int_J_Mol_Imaging_2011_Apr_5_2011_796025.nxml.txt.nlp	21603240	SENT208	0	0	2	2	arcitumomab	CEA	PA164746540	5670;1087	0.677
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Dec_14_70(Pt_1)_o57-o58.nxml.txt.nlp	24526998	SENT83	13	13	30	30	ethanol	mol	PA448073	90527	0.677
NULL	BMB_Rep_2014_Jan_47(1)_33-38.nxml.txt.nlp	24209634	SENT22	19	19	5	5	cisplatin	CXCR4	PA449014	7852	0.677
NULL	Infect_Dis_Rep_2012_Mar_5_4(1)_e22.nxml.txt.nlp	24470929	SENT5	13	13	15	15	starch	HSS	PA451492	9043;2671;6448;80025	0.677
NULL	Iran_J_Pharm_Res_2013_Summer_12(3)_457-469.nxml.txt.nlp	24250652	SENT210	14	14	17	17	indomethacin	spatial	PA449982	219793	0.677
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT198	9	9	15	15	curcumin	TRAIL	PA151958596	8743	0.677
NULL	J_Mol_Signal_2008_Dec_1_3_18.nxml.txt.nlp	19046439	SENT139	20	20	13	13	metformin	Met	PA450395	79811	0.677
NULL	Mol_Vis_2012_Apr_11_18_901-908.nxml.txt.nlp	22539869	SENT16	0	0	7	7	curcumin	HO-1	PA151958596	3162	0.677
NULL	Diabetes_Care_2010_May_15_33(5)_1134-1139.nxml.txt.nlp	20185740	SENT109	5	5	23	23	ezetimibe	IL-6	PA10816	3569	0.677
NULL	Front_Genet_2014_Jul_1_5_193.nxml.txt.nlp	25071823	SENT120	29	29	3	3	tolbutamide	KCNQ1	PA451718	3784	0.677
NULL	Pain_Ther_2014_Jun_13_3(1)_59-69.nxml.txt.nlp	25135388	SENT140	2	2	10	10	curcumin	HSD1	PA151958596	26871	0.677
NULL	Mol_Cancer_2009_Nov_24_8_109.nxml.txt.nlp	19930708	SENT158	13	13	20	20	exemestane	aromatase	PA449563	1588	0.677
NULL	Ann_Intensive_Care_2011_May_25_1_14.nxml.txt.nlp	21906345	SENT157	24	24	1	1	colistin	San	PA164760862	80218	0.677
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_1_2012_490843.nxml.txt.nlp	23243450	SENT234	4	4	21	21	berberine	p38	PA165860812	10598;1432;7965	0.677
NULL	Front_Pharmacol_2014_Oct_20_5_230.nxml.txt.nlp	25368579	SENT91	0	0	8	8	berberine	IL-6	PA165860812	3569	0.677
NULL	Oncotarget_2011_Jan_25_2(1-2)_8-17.nxml.txt.nlp	21378407	SENT38	0	0	4	4	thrombin	PAR-1	PA451674	2011;2149	0.677
NULL	Ann_Oncol_2009_Aug_17_20(8)_1319-1329.nxml.txt.nlp	19535820	SENT117	16	16	33	33	ixabepilone	ADP		23038	0.677
NULL	Gut_Pathog_2013_Mar_22_5_6.nxml.txt.nlp	23522652	SENT238	25	25	11	11	sulfamethoxazole	CTX	PA451544	1593	0.677
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT49	23	23	3	3	phenacetin	CYP3A	PA450897	1574	0.677
NULL	Mol_Vis_2014_Dec_19_20_1680-1694.nxml.txt.nlp	25558172	SENT150	25	25	18	18	ranibizumab	VEGFR2	PA164746012	3791	0.677
NULL	Biologics_2013_Jun_19_7_149-159.nxml.txt.nlp	23818756	SENT38	5	5	1	1	paclitaxel	DES	PA450761	1674	0.677
NULL	Lab_Invest_2014_May_10_94(5)_503-516.nxml.txt.nlp	24614199	SENT187	5	5	23	23	curcumin	RAGE	PA151958596	177	0.677
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Oct_29_67(Pt_11)_o3100.nxml.txt.nlp	22220104	SENT63	5	5	11	11	nitrile	C17	PA450636	54360	0.677
NULL	Diabetologia_2010_Jun_27_53(6)_1142-1150.nxml.txt.nlp	20349036	SENT45	10	10	30	30	nitroprusside	AMPK	PA451406	5563	0.677
NULL	Clin_Kidney_J_2013_Jun_11_6(3)_287-294.nxml.txt.nlp	23717787	SENT165	1	1	5	5	cinacalcet	PTH	PA164776671	5741	0.677
NULL	Arthritis_Res_Ther_2012_Jan_4_14(1)_R1.nxml.txt.nlp	22217359	SENT60	18	18	29	29	l-glutamine	CO2	PA10090	4513	0.677
NULL	Acta_Pharmacol_Sin_2013_Dec_18_34(12)_1508-1514.nxml.txt.nlp	24241347	SENT35	9	9	13	13	ketanserin	5-HT2A	PA131053734	3356	0.677
NULL	Cell_Death_Dis_2014_Mar_13_5(3)_e1118.nxml.txt.nlp	24625977	SENT91	30	30	37	37	etoposide	UBXN2A	PA449552	165324	0.677
NULL	Br_J_Cancer_2010_Oct_26_103(9)_1380-1390.nxml.txt.nlp	20877355	SENT214	8	8	14	14	etoposide	FasL	PA449552	356	0.677
NULL	Biomed_Res_Int_2013_Jun_13_2013_851428.nxml.txt.nlp	23841096	SENT36	33	33	20	20	l-serine	PLP	PA451330	25824;5744	0.677
NULL	Ann_Hematol_2010_Sep_13_89(9)_861-871.nxml.txt.nlp	20387067	SENT129	0	0	5	5	dasatinib	CD34	PA162372878	947	0.677
NULL	Arthritis_Res_Ther_2010_Apr_1_12(2)_R60.nxml.txt.nlp	20359365	SENT178	6	6	4	4	bleomycin	BLM	PA448645	641	0.677
NULL	Front_Chem_2014_Dec_23_2_113.nxml.txt.nlp	25566531	SENT168	0	0	3	3	curcumin	PTPN1	PA151958596	5770	0.677
NULL	Arthritis_Res_Ther_2014_Apr_3_16(2)_R86.nxml.txt.nlp	24708674	SENT250	9	9	24	24	bosentan	CCN2	PA10034	1490	0.677
NULL	Int_J_Endocrinol_Metab_2014_Apr_1_12(2)_e14098.nxml.txt.nlp	24803942	SENT121	11	11	13	13	vasopressin	AVP	PA451858	114548;551	0.677
NULL	Med_Sci_Monit_2013_Oct_21_19_875-882.nxml.txt.nlp	24145180	SENT34	19	19	6	6	bevacizumab	CXCL8	PA130232992	3576	0.677
NULL	J_Korean_Med_Sci_2014_Jul_11_29(7)_965-972.nxml.txt.nlp	25045229	SENT133	12	12	16	16	metformin	B12	PA450395	7126;4709	0.677
NULL	Br_J_Cancer_2010_Jan_5_102(1)_234-235.nxml.txt.nlp	NULL	SENT8	25	25	31	31	bevacizumab	IFN	PA130232992	3439	0.677
NULL	Breast_Cancer_Res_2010_Nov_16_12(6)_R96.nxml.txt.nlp	21080941	SENT197	18	18	10	10	lapatinib	HRG	PA152241907	3084;3273	0.677
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT160	3	3	7	7	curcumin	TRAIL	PA151958596	8743	0.677
NULL	Cell_Tissue_Res_2013_May_17_354(1)_259-271.nxml.txt.nlp	23681253	SENT25	37	37	30	30	atomoxetine	AMPH	PA134688071	273	0.677
NULL	Oncogenesis_2014_Dec_15_3(12)_e133.nxml.txt.nlp	25500906	SENT8	40	40	32	32	trastuzumab	PI3K	PA451743	5290	0.677
NULL	J_Exp_Clin_Cancer_Res_2009_Aug_19_28(1)_116.nxml.txt.nlp	19689822	SENT22	30	30	34	34	vincristine	CHOP	PA451879	1649	0.677
NULL	Biosci_Rep_2012_Aug_1_32(Pt_4)_361-374.nxml.txt.nlp	22762204	SENT112	31	31	19	19	cyclophosphamide	p16INK4a	PA449165	1029	0.677
NULL	Oncotarget_2014_Jun_1_5(13)_4868-4880.nxml.txt.nlp	24947902	SENT315	4	4	6	6	afatinib	HER2	PA165981154	2064	0.677
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_127043.nxml.txt.nlp	23227093	SENT175	7	7	10	10	lovastatin	RYR	PA450272	6261	0.677
NULL	Cancer_Microenviron_2009_May_6_2(1)_59-67.nxml.txt.nlp	19418243	SENT106	17	17	23	23	tetracycline	CCL21	PA451640	6366	0.677
NULL	Nanoscale_Res_Lett_2014_Jul_15_9(1)_353.nxml.txt.nlp	25114645	SENT2	23	23	31	31	dienestrol	HEX	PA164745534	3087	0.677
NULL	Evid_Based_Complement_Alternat_Med_2013_Mar_26_2013_625892.nxml.txt.nlp	23589719	SENT250	0	0	8	8	probenecid	TAS2R43	PA451106	259289	0.677
NULL	Breast_Cancer_Res_2004_Mar_26_6(3)_R252-R263.nxml.txt.nlp	15084249	SENT110	40	40	12	12	tamoxifen	NAT1	PA451581	9;1982	0.677
NULL	Infect_Drug_Resist_2011_Feb_3_4_43-53.nxml.txt.nlp	21694908	SENT117	18	18	1	1	voriconazole	CYP3A4	PA10233	1576	0.677
NULL	Front_Aging_Neurosci_2014_Sep_1_6_234.nxml.txt.nlp	25225484	SENT1067	23	23	8	8	ramelteon	spatial	PA164744896	219793	0.677
NULL	Oncotarget_2011_Sep_22_2(9)_713-727.nxml.txt.nlp	21946665	SENT23	10	10	2	2	cytarabine	IFN	PA449177	3439	0.677
NULL	Biomed_Res_Int_2014_Aug_5_2014_312847.nxml.txt.nlp	25162007	SENT23	18	18	26	26	bevacizumab	EGFR	PA130232992	1956	0.677
NULL	Korean_J_Anesthesiol_2013_Jan_21_64(1)_47-53.nxml.txt.nlp	23372886	SENT85	40	40	10	10	bupivacaine	PTG	PA135057240	5507	0.677
NULL	J_Gen_Physiol_2009_May_133(5)_525-546.nxml.txt.nlp	19398778	SENT556	10	10	12	12	capsaicin	TRPM8	PA448776	79054	0.677
NULL	Dement_Geriatr_Cogn_Dis_Extra_2012_Aug_16_2(1)_304-311.nxml.txt.nlp	22962554	SENT11	9	9	22	22	celecoxib	APOE	PA448871	348	0.677
NULL	Indian_J_Anaesth_2012_Mar-Apr_56(2)_129-134.nxml.txt.nlp	22701202	SENT30	19	19	30	30	bupivacaine	CEA	PA135057240	5670;1087	0.677
NULL	J_Hematol_Oncol_2013_Aug_19_6_59.nxml.txt.nlp	23958373	SENT176	26	26	4	4	vincristine	ALL-1	PA451879	4297	0.677
NULL	J_Addict_2013_Aug_27_2013_307845.nxml.txt.nlp	24804142	SENT52	20	20	27	27	ketamine	LSD	PA450144	1776	0.677
NULL	Leukemia_2013_Jan_11_27(1)_32-40.nxml.txt.nlp	22781593	SENT100	0	0	23	23	ponatinib	ZNF112	PA165980594	7771	0.677
NULL	Clin_Psychopharmacol_Neurosci_2011_Apr_30_9(1)_36-43.nxml.txt.nlp	23431025	SENT100	6	6	18	18	aripiprazole	c-fos	PA10026	2353	0.677
NULL	Curr_Cardiol_Rev_2012_Aug_8(3)_209-214.nxml.txt.nlp	22920488	SENT107	10	10	12	12	abciximab	AIDA	PA448006	64853	0.677
NULL	Oncotarget_2013_Nov_23_5(1)_196-210.nxml.txt.nlp	24344116	SENT76	6	6	19	19	doxorubicin	IL8	PA449412	3576	0.677
NULL	Clin_Interv_Aging_2009_May_14_4_109-113.nxml.txt.nlp	19503773	SENT4	12	12	9	9	tolcapone	COMT	PA451720	1312	0.677
NULL	Biologics_2012_Dec_17_6_429-464.nxml.txt.nlp	23269860	SENT163	24	24	11	11	rituximab	ACR	PA451261	49	0.677
NULL	J_Biomed_Sci_2013_Jan_25_20(1)_4.nxml.txt.nlp	23350663	SENT188	16	16	9	9	thrombin	PAR3	PA451674	56288;2151	0.677
NULL	Cancers_(Basel)_2012_Apr_5_4(2)_354-378.nxml.txt.nlp	24213315	SENT836	1	1	8	8	genistein	p38	PA165109660	10598;1432;7965	0.677
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_79-96.nxml.txt.nlp	19305789	SENT67	35	35	22	22	capsaicin	TRPV1	PA448776	7442	0.677
NULL	Onco_Targets_Ther_2014_Jun_11_7_969-983.nxml.txt.nlp	24959084	SENT115	17	17	20	20	ritonavir	CYP3A4	PA451260	1576	0.677
NULL	Cancers_(Basel)_2013_Feb_28_5(1)_234-254.nxml.txt.nlp	24216706	SENT1173	15	15	12	12	melphalan	gamma	PA450354	9913	0.677
NULL	J_Immunother_Cancer_2013_Nov_7_1(Suppl_1)_P29.nxml.txt.nlp	NULL	SENT6	21	21	11	11	famotidine	IL-2	PA449586	3558	0.677
NULL	Clin_Genet_2014_Jan_1_86(1)_21-28.nxml.txt.nlp	24684508	SENT179	11	11	6	6	warfarin	CYP2C9	PA451906	1559	0.677
NULL	Case_Rep_Pathol_2012_Oct_10_2012_326418.nxml.txt.nlp	23094172	SENT55	18	18	15	15	thyroglobulin	TTF-1	PA164754910	7080	0.677
NULL	J_Hematol_Oncol_2010_Mar_23_3_11.nxml.txt.nlp	20331897	SENT146	26	26	30	30	cisplatin	CRT	PA449014	811	0.677
NULL	Int_J_Breast_Cancer_2012_Feb_26_2012_761917.nxml.txt.nlp	22482061	SENT52	0	0	12	12	estradiol	HER2	PA449503	2064	0.677
NULL	Indian_J_Pharmacol_2013_Jan-Feb_45(1)_54-60.nxml.txt.nlp	23543867	SENT145	25	25	27	27	bosentan	NAC	PA10034	22861	0.677
NULL	Ann_Dermatol_2011_Aug_6_23(3)_365-368.nxml.txt.nlp	21909210	SENT38	9	9	22	22	acitretin	gamma	PA448039	9913	0.677
NULL	Curr_Oncol_2008_Oct_15(5)_229-233.nxml.txt.nlp	19008997	SENT136	6	6	13	13	chlorambucil	Yes	PA448926	7525	0.677
NULL	Cardiovasc_Diabetol_2008_Jun_22_7_20.nxml.txt.nlp	18570678	SENT155	3	3	18	18	rosiglitazone	CD11b	PA451283	3684	0.677
NULL	Mol_Vis_2012_Oct_5_18_2454-2467.nxml.txt.nlp	23077404	SENT138	11	11	13	13	bevacizumab	VEGF-A	PA130232992	7422	0.677
NULL	Alcohol_Res_Health_2010_33(1-2)_109-117.nxml.txt.nlp	23579941	SENT169	29	29	31	31	vasopressin	AVP	PA451858	114548;551	0.677
NULL	Breast_Cancer_Res_2004_Nov_7_6(1)_39-52.nxml.txt.nlp	14680484	SENT157	34	34	28	28	tamoxifen	N-CoR	PA451581	9611	0.677
NULL	Acta_Pharmacol_Sin_2014_Jan_9_35(1)_1-10.nxml.txt.nlp	24317012	SENT132	2	2	0	0	tegafur	CYP2A6	PA452620	1548	0.677
NULL	Clin_Med_Insights_Oncol_2011_Feb_14_5_15-21.nxml.txt.nlp	21499558	SENT89	20	20	6	6	bevacizumab	OST	PA130232992	1650;23263	0.677
NULL	Breast_Cancer_Res_2007_Feb_6_9(1)_R17.nxml.txt.nlp	17280616	SENT28	0	0	2	2	tamoxifen	aromatase	PA451581	1588	0.677
NULL	Arthritis_Res_Ther_2014_Jan_15_16(1)_R10.nxml.txt.nlp	24423138	SENT366	15	15	11	11	collagenase	TRPV1	PA449107	7442	0.677
NULL	Nanoscale_Res_Lett_2014_Feb_15_9(1)_76.nxml.txt.nlp	24528570	SENT139	25	25	22	22	hydroquinone	mol	PA449924	90527	0.677
NULL	J_Cell_Biol_1998_Jan_26_140(2)_335-345.nxml.txt.nlp	9442109	SENT329	2	2	4	4	chloroquine	NHE	PA448948	285335	0.677
NULL	Clin_Psychopharmacol_Neurosci_2012_Aug_31_10(2)_71-77.nxml.txt.nlp	23431082	SENT75	23	23	8	8	clozapine	MEIS2	PA449061	4212	0.677
NULL	Core_Evid_2007_Nov_30_2(2)_81-88.nxml.txt.nlp	21221177	SENT220	8	8	10	10	leucovorin	IFL	PA450198	3439	0.677
NULL	Oncoimmunology_2013_Aug_1_2(8)_e25375.nxml.txt.nlp	24167764	SENT15	0	0	21	21	ethanol	TLR2	PA448073	7097	0.677
NULL	J_Anim_Sci_Biotechnol_2013_Feb_25_4(1)_5.nxml.txt.nlp	23442379	SENT40	10	10	17	17	gentamicin	SPI-1	PA449753	6688	0.677
NULL	Hum_Genomics_2012_Dec_1_6(1)_25.nxml.txt.nlp	23199258	SENT49	30	30	23	23	cyclophosphamide	ALDH1A1	PA449165	216	0.677
NULL	Indian_J_Pharmacol_2014_Nov-Dec_46(6)_627-632.nxml.txt.nlp	25538335	SENT112	8	8	6	6	metformin	Q10	PA450395	27161	0.677
NULL	Mol_Cancer_2010_Nov_25_9_305.nxml.txt.nlp	21108789	SENT121	18	18	14	14	cisplatin	TRAIL	PA449014	8743	0.677
NULL	Behav_Brain_Funct_2009_Jan_15_5_3.nxml.txt.nlp	19146665	SENT223	23	23	26	26	ethanol	P90	PA448073	821	0.677
NULL	Mol_Biol_Int_2011_Feb_24_2011_137459.nxml.txt.nlp	22091395	SENT201	8	8	40	40	arsenite	PRMT7	PA452638	54496	0.677
NULL	Cancer_Cell_Int_2012_Mar_23_12_10.nxml.txt.nlp	22443202	SENT47	27	27	14	14	streptomycin	FBS	PA451512	64319;26269	0.677
NULL	Breast_Cancer_Res_2005_Mar_4_7(3)_R345-R352.nxml.txt.nlp	15987429	SENT221	41	41	17	17	atropine	CARB	PA448505	9482	0.677
NULL	ChemistryOpen_2014_Dec_21_3(6)_256-263.nxml.txt.nlp	25558444	SENT91	15	15	36	36	zinc	IRAP	PA451956	3557	0.677
NULL	Biosci_Rep_2012_Aug_1_32(Pt_4)_361-374.nxml.txt.nlp	22762204	SENT1324	4	4	2	2	tamoxifen	BRCA1	PA451581	672	0.677
NULL	Int_J_Breast_Cancer_2011_Sep_6_2011_352182.nxml.txt.nlp	22295219	SENT120	8	8	17	17	hyaluronan	PI3K	PA165958431	5290	0.677
NULL	Arch_Virol_2014_Dec_24_159(6)_1365-1371.nxml.txt.nlp	24366548	SENT54	14	14	29	29	ribavirin	IFI27	PA451241	3429	0.677
NULL	Cell_Death_Dis_2012_Jun_21_3(6)_e327.nxml.txt.nlp	22717582	SENT9	12	12	29	29	vincristine	NOXA	PA451879	5366	0.677
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1063.nxml.txt.nlp	24556678	SENT204	21	21	10	10	thioridazine	TRAIL	PA451666	8743	0.677
NULL	J_Hum_Genet_2013_Jun_16_58(6)_353-361.nxml.txt.nlp	23677058	SENT145	13	13	5	5	busulfan	GSTM1	PA448691	2944	0.677
NULL	J_Korean_Med_Sci_2006_Dec_31_21(6)_973-978.nxml.txt.nlp	17179671	SENT167	26	26	8	8	gentamicin	CTX	PA449753	1593	0.677
NULL	Diabetes_Care_2010_Apr_12_33(4)_861-868.nxml.txt.nlp	20067962	SENT14	17	17	2	2	hyaluronan	TLR2	PA165958431	7097	0.677
NULL	Oncol_Lett_2014_Jun_4_7(6)_2175-2179.nxml.txt.nlp	24932311	SENT103	1	1	5	5	choline	PEMT	PA448976	10400	0.676
NULL	J_Cancer_2012_Dec_25_4(1)_57-65.nxml.txt.nlp	23386905	SENT106	20	20	16	16	bleomycin	IL-17A	PA448645	3605	0.676
NULL	Br_J_Cancer_2011_Sep_6_105(6)_778-786.nxml.txt.nlp	21847128	SENT210	11	11	13	13	zoledronate	IL-2	PA10235	3558	0.676
NULL	Cell_Commun_Signal_2003_Nov_24_1_5.nxml.txt.nlp	14636425	SENT83	3	3	9	9	heparin	CCN5	PA449855	8839	0.676
NULL	Curr_Neuropharmacol_2014_Jul_12(4)_308-323.nxml.txt.nlp	25342939	SENT377	11	11	13	13	isoproterenol	EGF	PA450121	1950	0.676
NULL	Oncotarget_2013_Mar_26_4(3)_397-412.nxml.txt.nlp	23651630	SENT308	34	34	18	18	doxorubicin	CHOP	PA449412	1649	0.676
NULL	J_Cell_Biol_2004_Apr_12_165(1)_77-86.nxml.txt.nlp	15067018	SENT53	13	13	6	6	collagenase	AP-1	PA449107	2353;3727;2354;3725	0.676
NULL	Neural_Plast_2012_Oct_24_2012_832757.nxml.txt.nlp	23150836	SENT222	5	5	17	17	haloperidol	spatial	PA449841	219793	0.676
NULL	Breast_Cancer_Res_2011_Jun_9_13(3)_R57.nxml.txt.nlp	21658222	SENT24	25	25	13	13	epirubicin	UGT1A6	PA449476	54578	0.676
NULL	J_Carcinog_2012_Oct_27_11_16.nxml.txt.nlp	23230393	SENT59	9	9	3	3	perifosine	HER-2	PA165291471	2064	0.676
NULL	Behav_Brain_Res_2010_Dec_1_213(2)_269-277.nxml.txt.nlp	20570596	SENT254	1	1	5	5	baclofen	c-fos	PA448533	2353	0.676
NULL	Biomed_Res_Int_2014_Apr_10_2014_580852.nxml.txt.nlp	24812624	SENT45	9	9	18	18	resveratrol	PTEN		5728	0.676
NULL	J_Biomed_Sci_2014_Jul_5_21(1)_61.nxml.txt.nlp	24997497	SENT56	25	25	37	37	streptomycin	CO2	PA451512	4513	0.676
NULL	Oncotarget_2014_Aug_19_5(18)_8703-8715.nxml.txt.nlp	25237928	SENT55	19	19	9	9	glucose	CD44	PA449773	960	0.676
NULL	J_Oncol_2012_Sep_5_2012_141236.nxml.txt.nlp	21904550	SENT157	16	16	19	19	bevacizumab	VEGFR	PA130232992	3791	0.676
NULL	Ann_Gastroenterol_2014_27(3)_200-206.nxml.txt.nlp	24976114	SENT83	8	8	18	18	thrombin	PAR4	PA451674	9002;5074	0.676
NULL	Int_J_Breast_Cancer_2012_May_9_2012_415170.nxml.txt.nlp	22649737	SENT76	38	38	26	26	trastuzumab	MUC4	PA451743	4585	0.676
NULL	Front_Immunol_2013_Oct_31_4_351.nxml.txt.nlp	24198817	SENT444	25	25	31	31	anakinra	IL1RN	PA10799	3557	0.676
NULL	Int_J_Surg_Oncol_2012_Jun_12_2012_862879.nxml.txt.nlp	22778941	SENT128	10	10	7	7	cisplatin	c-Myc	PA449014	4609	0.676
NULL	Int_J_Environ_Res_Public_Health_2011_Jun_23_8(6)_2533-2555.nxml.txt.nlp	21776245	SENT133	35	35	29	29	pentobarbital	castor	PA450859	54897	0.676
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT257	1	1	3	3	doxorubicin	ABCB1	PA449412	5243	0.676
NULL	Indian_J_Ophthalmol_2012_Jul-Aug_60(4)_311-313.nxml.txt.nlp	22824601	SENT22	9	9	16	16	bevacizumab	San	PA130232992	80218	0.676
NULL	Dermatoendocrinol_2013_Apr_1_5(2)_239-251.nxml.txt.nlp	24194964	SENT194	0	0	3	3	vemurafenib	BRAF	PA165946873	673	0.676
NULL	Arthritis_Res_Ther_2009_Jul_23_11(4)_236.nxml.txt.nlp	19664185	SENT69	25	25	38	38	probenecid	GLUT9	PA451106	11182	0.676
NULL	J_Int_Soc_Sports_Nutr_2010_Jun_4_7_23.nxml.txt.nlp	20525371	SENT79	6	6	17	17	creatine	IL-6	PA164778930	3569	0.676
NULL	Reprod_Biol_Endocrinol_2013_Jul_11_11_60.nxml.txt.nlp	23844593	SENT37	10	10	15	15	estradiol	AMH	PA449503	268	0.676
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_P137.nxml.txt.nlp	NULL	SENT0	29	29	31	31	thiopental	COX2	PA451664	4513;5743	0.676
NULL	Mol_Med_Rep_2015_Feb_3_11(2)_968-974.nxml.txt.nlp	25371265	SENT78	26	26	28	28	cyclophosphamide	CTX	PA449165	1593	0.676
NULL	Front_Neurol_2011_Dec_26_2_83.nxml.txt.nlp	22363312	SENT775	7	7	20	20	cilostazol	P2Y12	PA164746334	64805	0.676
NULL	Reprod_Biol_Endocrinol_2004_Mar_24_2_13.nxml.txt.nlp	15040802	SENT181	29	29	36	36	baclofen	PCNA	PA448533	5111	0.676
NULL	Toxins_(Basel)_2010_Mar_31_2(4)_517-551.nxml.txt.nlp	22069598	SENT1541	15	15	6	6	resveratrol	DR5		8795	0.676
NULL	Arthritis_Res_Ther_2004_Jun_21_6(Suppl_2)_S12-S18.nxml.txt.nlp	15228616	SENT52	5	5	0	0	adalimumab	STAR	PA10004	6770;2984	0.676
NULL	J_Agric_Food_Chem_2010_Apr_28_58(8)_4632-4637.nxml.txt.nlp	20349979	SENT399	25	25	17	17	choline	B12	PA448976	7126;4709	0.676
NULL	Cardiol_Res_Pract_2013_Jan_31_2013_128795.nxml.txt.nlp	23431496	SENT105	4	4	28	28	clopidogrel	CYP2C19	PA449053	1557	0.676
NULL	J_Biol_2003_Sep_24_2(4)_28.nxml.txt.nlp	14511394	SENT129	13	13	21	21	phenformin	AMPK	PA1000	5563	0.676
NULL	J_Obes_2011_Dec_26_2011_329038.nxml.txt.nlp	21253498	SENT148	7	7	15	15	lipase	LYPLAL1	PA450239	127018	0.676
NULL	Autophagy_2013_Apr_1_9(4)_581-594.nxml.txt.nlp	23360789	SENT314	16	16	26	26	chloroquine	CO2	PA448948	4513	0.676
NULL	Gut_Liver_2013_Jul_20_7(4)_458-461.nxml.txt.nlp	23898387	SENT16	20	20	26	26	ribavirin	IFN	PA451241	3439	0.676
NULL	Clin_Med_Insights_Oncol_2011_May_18_5_145-156.nxml.txt.nlp	21695099	SENT287	11	11	6	6	vincristine	BOP	PA451879	611;150572	0.676
NULL	Biomed_Res_Int_2013_Nov_5_2013_703626.nxml.txt.nlp	24298554	SENT42	0	0	10	10	ethanol	BAX	PA448073	581	0.676
NULL	Mar_Drugs_2014_Jun_27_12(7)_3818-3837.nxml.txt.nlp	24979269	SENT209	23	23	18	18	mitoxantrone	P-gp	PA450526	5243	0.676
NULL	Mol_Imaging_Radionucl_Ther_2011_Dec_1_20(3)_114-116.nxml.txt.nlp	23486704	SENT35	0	0	6	6	metformin	FDG	PA450395	23583	0.676
NULL	Support_Care_Cancer_2014_Dec_14_22(3)_837-846.nxml.txt.nlp	24337717	SENT19	12	12	5	5	phenytoin	CYP3A4	PA450947	1576	0.676
NULL	Brain_Sci_2014_May_6_4(2)_356-375.nxml.txt.nlp	24961766	SENT224	33	33	6	6	propofol	NeuN	PA451141	146713	0.676
NULL	J_Hematol_Oncol_2012_May_15_5_23.nxml.txt.nlp	22587422	SENT10	17	17	9	9	dasatinib	ALL	PA162372878	613	0.676
NULL	Acta_Orthop_2010_Apr_6_81(2)_263-267.nxml.txt.nlp	20148646	SENT116	0	0	21	21	taurine	LIR	PA451590	10871	0.676
NULL	Breast_Cancer_Res_2010_Sep_29_12(5)_209.nxml.txt.nlp	21067536	SENT53	32	32	20	20	paclitaxel	HER2	PA450761	2064	0.676
NULL	Cent_European_J_Urol_2013_Apr_26_66(1)_39-44.nxml.txt.nlp	24578986	SENT87	21	21	13	13	doxorubicin	ACT	PA449412	12;11332;9457;641455	0.676
NULL	Int_J_Mol_Sci_2012_Feb_10_13(2)_1858-1885.nxml.txt.nlp	22408429	SENT883	1	1	11	11	nadh	ADP	PA164755085	23038	0.676
NULL	Int_J_Mol_Sci_2014_May_8_15(5)_8138-8152.nxml.txt.nlp	24815073	SENT434	5	5	20	20	lapatinib	HER2	PA152241907	2064	0.676
NULL	Exp_Hematol_Oncol_2013_Aug_28_2_23.nxml.txt.nlp	24499526	SENT29	8	8	0	0	heparin	OPTC	PA449855	26254	0.676
NULL	Case_Rep_Oncol_Med_2012_Nov_6_2012_164082.nxml.txt.nlp	23198199	SENT64	15	15	26	26	cyclophosphamide	ACTH	PA449165	5443	0.676
NULL	Curr_Neuropharmacol_2009_Mar_7(1)_37-49.nxml.txt.nlp	19721816	SENT477	12	12	15	15	estradiol	aromatase	PA449503	1588	0.676
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT936	6	6	25	25	quetiapine	Gen	PA451201	348654	0.676
NULL	Front_Synaptic_Neurosci_2014_May_30_6_12.nxml.txt.nlp	24910611	SENT138	19	19	28	28	l-serine	ASCT2	PA451330	6510	0.676
NULL	Oncotarget_2014_Mar_16_5(12)_4087-4102.nxml.txt.nlp	24961479	SENT48	17	17	24	24	hemin	HO-1	PA449849	3162	0.676
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Oct_13_68(Pt_11)_o3116.nxml.txt.nlp	23284441	SENT63	15	15	27	27	ethanol	mol	PA448073	90527	0.676
NULL	Cell_Cycle_2013_Sep_15_12(18)_3013-3024.nxml.txt.nlp	23974104	SENT64	0	0	2	2	disulfiram	IQGAP1	PA449376	8826	0.676
NULL	Cancer_Cell_Int_2013_May_24_13_48.nxml.txt.nlp	23706027	SENT39	12	12	14	14	cisplatin	DDP	PA449014	1678	0.676
NULL	J_Cell_Mol_Med_2014_Oct_11_18(10)_2031-2043.nxml.txt.nlp	25109475	SENT12	0	0	13	13	valsartan	LKB1	PA451848	6794	0.676
NULL	Nat_Commun_2011_Feb_8_2_187.nxml.txt.nlp	21304516	SENT207	17	17	7	7	pentobarbital	DSI	PA450859	5034	0.676
NULL	Int_J_Biol_Sci_2015_Jan_5_11(2)_186-198.nxml.txt.nlp	25561901	SENT38	14	14	6	6	urokinase	FOXM1	PA451836	2305	0.676
NULL	J_Young_Pharm_2012_Oct-Dec_4(4)_201-208.nxml.txt.nlp	23493037	SENT46	11	11	15	15	ranitidine	K100	PA451224	389941	0.676
NULL	Case_Rep_Ophthalmol_2011_Sep_23_2(3)_314-318.nxml.txt.nlp	22125532	SENT20	9	9	18	18	bevacizumab	San	PA130232992	80218	0.676
NULL	Behav_Brain_Funct_2014_Feb_13_10_5.nxml.txt.nlp	24524628	SENT16	10	10	3	3	capsaicin	TRPV1	PA448776	7442	0.676
NULL	Expert_Rev_Mol_Med_2010_Nov_12_e37.nxml.txt.nlp	21114891	SENT478	10	10	20	20	cyanocobalamin	cblC	PA451892	25974	0.676
NULL	Oncoimmunology_2014_May_29_3_e28925.nxml.txt.nlp	25083322	SENT82	10	10	17	17	nilotinib	CD4	PA165958345	920	0.676
NULL	EMBO_Mol_Med_2013_Aug_5_5(8)_1149-1150.nxml.txt.nlp	23918227	SENT15	24	24	17	17	vincristine	CHOP	PA451879	1649	0.676
NULL	Leukemia_2014_Apr_14_28(4)_961-964.nxml.txt.nlp	24418991	SENT35	7	7	13	13	nilotinib	P-gp	PA165958345	5243	0.676
NULL	Front_Pharmacol_2014_Nov_28_5_255.nxml.txt.nlp	25506327	SENT232	12	12	9	9	sumatriptan	5-HT1B	PA451566	3351	0.676
NULL	Cancer_Res_Treat_2013_Sep_30_45(3)_178-185.nxml.txt.nlp	24155676	SENT87	11	11	13	13	gefitinib	EGFR	PA131301952	1956	0.676
NULL	Clin_Psychopharmacol_Neurosci_2011_Apr_30_9(1)_36-43.nxml.txt.nlp	23431025	SENT90	17	17	22	22	haloperidol	CA3	PA449841	761	0.676
NULL	Nat_Commun_2013_Sep_20_4_2444.nxml.txt.nlp	24051492	SENT49	13	13	6	6	nutlin-3	PER2		8864	0.676
NULL	Cancer_Cell_Int_2013_Jun_26_13_64.nxml.txt.nlp	23802572	SENT18	13	13	24	24	curcumin	Bcl-2	PA151958596	596	0.676
NULL	Diabetes_2009_Jul_7_58(7)_1550-1557.nxml.txt.nlp	19351711	SENT301	31	31	7	7	pioglitazone	CD68	PA450970	968	0.676
NULL	Ann_Oncol_2010_Oct_19_21(10)_1952-1960.nxml.txt.nlp	20305037	SENT134	8	8	19	19	docetaxel	p16	PA449383	1029	0.676
NULL	FASEB_J_2010_May_24(5)_1541-1551.nxml.txt.nlp	20026682	SENT200	22	22	37	37	ethanol	JNK	PA448073	5599	0.676
NULL	Acta_Pharmacol_Sin_2011_Oct_15_32(10)_1233-1238.nxml.txt.nlp	21841815	SENT24	13	13	20	20	atropine	CTX	PA448505	1593	0.676
NULL	J_Breast_Cancer_2011_Dec_27_14(4)_333-336.nxml.txt.nlp	22323922	SENT26	12	12	20	20	cyclophosphamide	CHOP	PA449165	1649	0.676
NULL	J_Res_Med_Sci_2010_Nov-Dec_15(6)_331-343.nxml.txt.nlp	21526106	SENT165	3	3	8	8	l-arginine	HDEL	PA448478	10945	0.676
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT773	19	19	9	9	risperidone	MDR1	PA451257	5243	0.676
NULL	Oncoimmunology_2014_Apr_25_3_e28518.nxml.txt.nlp	25071979	SENT156	9	9	21	21	oxaliplatin	HMGB1	PA131285527	3146	0.676
NULL	Oncoimmunology_2012_Dec_1_1(9)_1577-1583.nxml.txt.nlp	23264903	SENT44	10	10	4	4	fludarabine	CTX	PA449655	1593	0.676
NULL	Nat_Commun_2014_Dec_8_5_5736.nxml.txt.nlp	25484020	SENT19	10	10	30	30	letrozole	aromatase	PA450196	1588	0.676
NULL	Tumour_Biol_2014_Apr_14_35(4)_3525-3534.nxml.txt.nlp	24338765	SENT58	22	22	11	11	trypsin	CO2	PA451806	4513	0.676
NULL	Oncogenesis_2012_Apr_2_1(4)_e5.nxml.txt.nlp	23552603	SENT568	35	35	8	8	ns-398	BAX		581	0.676
NULL	Allergy_Asthma_Immunol_Res_2010_Jul_19_2(3)_177-182.nxml.txt.nlp	20592916	SENT99	19	19	13	13	tiotropium	ADRB2	PA164769056	154	0.676
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Apr_22_67(Pt_5)_o1175-o1176.nxml.txt.nlp	21754480	SENT79	29	29	12	12	ethanol	mol	PA448073	90527	0.676
NULL	Mol_Cancer_2011_Sep_7_10_109.nxml.txt.nlp	21899742	SENT217	5	5	22	22	etoposide	TRAIL-R2	PA449552	8795	0.676
NULL	Archaea_2013_Feb_21_2013_732864.nxml.txt.nlp	23533331	SENT174	26	26	3	3	arsenite	ArsB	PA452638	57152	0.676
NULL	Basic_Clin_Neurosci_2013_Autumn_4(4)_323-328.nxml.txt.nlp	25337364	SENT204	14	14	16	16	colchicine	CA1	PA449092	759	0.676
NULL	Arthritis_Res_Ther_2008_Mar_6_10(2)_R29.nxml.txt.nlp	18321389	SENT276	8	8	25	25	hydroxychloroquine	IFN	PA164777036	3439	0.676
NULL	Acta_Histochem_Cytochem_2011_Apr_28_44(2)_81-90.nxml.txt.nlp	21614169	SENT329	6	6	8	8	hyaluronan	LYVE-1	PA165958431	10894	0.676
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_May_31_70(Pt_6)_o733-o734.nxml.txt.nlp	24940299	SENT80	5	5	11	11	benzaldehyde	mol	PA448571	90527	0.676
NULL	J_Breast_Cancer_2011_Sep_29_14(3)_223-228.nxml.txt.nlp	22031805	SENT130	4	4	34	34	methotrexate	gamma	PA450428	9913	0.676
NULL	Breast_Cancer_Res_2010_Oct_14_12(5)_R84.nxml.txt.nlp	20946630	SENT231	30	30	22	22	choline	Hsp90	PA448976	3320	0.676
NULL	Emerg_Infect_Dis_2013_Jan_19(1)_133-136.nxml.txt.nlp	23260464	SENT37	35	35	29	29	ceftriaxone	TOB	PA448866	10140	0.676
NULL	J_Antimicrob_Chemother_2009_Jun_28_63(6)_1233-1243.nxml.txt.nlp	19329800	SENT87	24	24	14	14	saquinavir	ATV	PA451305	4683	0.676
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT129	9	9	4	4	nutlin-3	p53		7157	0.676
NULL	ISRN_Otolaryngol_2012_Nov_14_2012_797619.nxml.txt.nlp	23762619	SENT193	0	0	22	22	gefitinib	EGFR	PA131301952	1956	0.676
NULL	Diabetes_Metab_Syndr_Obes_2014_Jul_17_7_313-319.nxml.txt.nlp	25092992	SENT107	5	5	24	24	pioglitazone	adiponectin	PA450970	9370	0.676
NULL	Mucosal_Immunol_2014_May_13_7(3)_718-729.nxml.txt.nlp	24220297	SENT83	0	0	18	18	doxycycline	CC10	PA449415	7356	0.676
NULL	J_Cell_Mol_Med_2014_May_14_18(5)_811-823.nxml.txt.nlp	24628949	SENT168	19	19	25	25	docetaxel	MCAK	PA449383	11004	0.676
NULL	Mol_Vis_2010_Sep_2_16_1781-1790.nxml.txt.nlp	20824160	SENT156	16	16	4	4	forskolin	p38	PA146096022	10598;1432;7965	0.676
NULL	Korean_Circ_J_2013_Aug_31_43(8)_534-540.nxml.txt.nlp	24044012	SENT75	18	18	1	1	creatine	FFR	PA164778930	738	0.676
NULL	J_Biomed_Biotechnol_2002_2(2)_106-113.nxml.txt.nlp	12488590	SENT54	20	20	3	3	cisplatin	XRCC2	PA449014	7516	0.676
NULL	Reprod_Biol_Endocrinol_2013_Jul_25_11_71.nxml.txt.nlp	23883350	SENT72	6	6	34	34	estradiol	PROC	PA449503	5624	0.676
NULL	Lipids_Health_Dis_2011_Jan_18_10_8.nxml.txt.nlp	21241519	SENT12	7	7	13	13	simvastatin	ABCB4	PA451363	5244	0.676
NULL	Biomed_Res_Int_2014_Mar_6_2014_712893.nxml.txt.nlp	24734240	SENT120	3	3	6	6	ethanol	HIF-1alpha	PA448073	3091	0.676
NULL	Diabetes_2011_Jul_20_60(7)_1990-1999.nxml.txt.nlp	21617181	SENT283	9	9	14	14	nadh	PPARgamma	PA164755085	5468	0.676
NULL	Biomed_Res_Int_2013_Dec_30_2013_735835.nxml.txt.nlp	24490170	SENT177	14	14	40	40	cetirizine	FEX	PA448905	8549	0.676
NULL	Nucleic_Acids_Res_2013_Oct_17_41(18)_8601-8614.nxml.txt.nlp	23863842	SENT197	29	29	9	9	tamoxifen	JAG1	PA451581	182	0.676
NULL	Adv_Ther_2014_Jul_2_31(7)_762-775.nxml.txt.nlp	24985411	SENT235	9	9	30	30	valsartan	Xin	PA451848	165904	0.676
NULL	F1000Prime_Rep_2014_Dec_1_6_117.nxml.txt.nlp	25580271	SENT143	14	14	17	17	bevacizumab	EGFR	PA130232992	1956	0.676
NULL	Nat_Med_2012_Jul_18(7)_1118-1122.nxml.txt.nlp	22683780	SENT118	26	26	5	5	crizotinib	HGF	PA165946122	3569;6654;3082	0.676
NULL	Pain_2009_Jul_144(1-2)_110-118.nxml.txt.nlp	19410369	SENT128	28	28	34	34	capsaicin	ANOVA	PA448776	4858	0.676
NULL	Leukemia_2013_Apr_14_27(4)_803-812.nxml.txt.nlp	23238589	SENT29	14	14	18	18	cytarabine	IFN	PA449177	3439	0.676
NULL	J_Radiat_Res_2014_Mar_1_55(2)_359-363.nxml.txt.nlp	24187329	SENT43	24	24	0	0	doxorubicin	CHOP	PA449412	1649	0.676
NULL	Evid_Based_Complement_Alternat_Med_2012_Aug_5_2012_605303.nxml.txt.nlp	22919414	SENT288	0	0	16	16	resveratrol	VEGFR2		3791	0.676
NULL	Diabetes_Care_2009_Aug_26_32(8)_1411-1417.nxml.txt.nlp	19470837	SENT208	33	33	12	12	pramlintide	San	PA164781394	80218	0.676
NULL	Mol_Cancer_2013_Mar_5_12_17.nxml.txt.nlp	23497256	SENT193	5	5	3	3	sunitinib	HDMX	PA162372840	4194;4193	0.676
NULL	Mol_Biol_Rep_2013_May_16_40(8)_4995-5004.nxml.txt.nlp	23677713	SENT155	17	17	11	11	camptothecin	TERT	PA153590860	7015	0.676
NULL	Acta_Pharmacol_Sin_2011_Jan_6_32(1)_133-138.nxml.txt.nlp	21131997	SENT46	7	7	10	10	heparin	ACT	PA449855	12;11332;9457;641455	0.676
NULL	Exp_Ther_Med_2012_Sep_12_4(3)_475-480.nxml.txt.nlp	23181121	SENT22	11	11	15	15	vincristine	CHOP	PA451879	1649	0.676
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT166	42	42	32	32	trastuzumab	MUC4	PA451743	4585	0.676
NULL	CNS_Drugs_2014_Jul_20_28(11)_1059-1069.nxml.txt.nlp	25038977	SENT35	13	13	15	15	atomoxetine	ATX	PA134688071	5168;23049	0.676
NULL	J_Biol_Chem_2013_Jun_28_288(26)_18789-18802.nxml.txt.nlp	23625922	SENT344	8	8	15	15	thrombin	C5a	PA451674	727	0.676
NULL	Diabetes_2009_Jan_58(1)_250-259.nxml.txt.nlp	18840786	SENT129	8	8	12	12	rosiglitazone	aP2	PA451283	2167	0.676
NULL	Arthritis_Res_Ther_2013_Aug_21_15(4)_R93.nxml.txt.nlp	23965253	SENT19	19	19	7	7	collagenase	MMP3	PA449107	4314	0.676
NULL	Front_Neurosci_2013_Jan_31_7_3.nxml.txt.nlp	23386808	SENT331	11	11	2	2	vasopressin	TRPV4	PA451858	59341	0.676
NULL	Open_Biochem_J_2011_Sep_23_5_45-51.nxml.txt.nlp	21966325	SENT7	2	2	24	24	diclofenac	XBP1	PA449293	7494	0.676
NULL	Crit_Care_2006_May_25_10(3)_144.nxml.txt.nlp	16732898	SENT9	25	25	27	27	vasopressin	AVP	PA451858	114548;551	0.676
NULL	Eur_J_Appl_Physiol_2011_Feb_24_111(2)_275-283.nxml.txt.nlp	20865425	SENT105	9	9	5	5	glucose	APE	PA449773	55704;328	0.676
NULL	Ann_Dermatol_2011_Dec_27_23(Suppl_3)_S350-S353.nxml.txt.nlp	22346276	SENT43	9	9	2	2	erlotinib	EGFR	PA134687924	1956	0.676
NULL	Daru_2012_Nov_30_20(1)_82.nxml.txt.nlp	23351311	SENT159	29	29	21	21	curcumin	p53	PA151958596	7157	0.676
NULL	J_Cancer_Res_Clin_Oncol_2010_May_11_136(5)_737-743.nxml.txt.nlp	19904559	SENT82	23	23	38	38	bevacizumab	IFL	PA130232992	3439	0.676
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Mar_28_65(Pt_4)_o892.nxml.txt.nlp	21582600	SENT63	21	21	12	12	ethanol	mol	PA448073	90527	0.676
NULL	Acta_Pharmacol_Sin_2010_Jan_21_31(1)_35-42.nxml.txt.nlp	20023693	SENT213	2	2	9	9	atorvastatin	IL-6	PA448500	3569	0.676
NULL	Br_J_Pharmacol_2014_Jun_15_171(11)_2705-2725.nxml.txt.nlp	24467436	SENT286	22	22	13	13	isoniazid	NAT	PA450112	6046	0.676
NULL	Clin_Med_Insights_Cardiol_2010_Dec_1_4_117-128.nxml.txt.nlp	21151850	SENT266	15	15	4	4	clopidogrel	ABCB1	PA449053	5243	0.676
NULL	Diabetes_2011_Jul_20_60(7)_1990-1999.nxml.txt.nlp	21617181	SENT126	0	0	7	7	geldanamycin	SOCS3	PA152031327	9021	0.676
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT246	36	36	38	38	ranibizumab	RAN	PA164746012	5901	0.676
NULL	Emerg_Infect_Dis_2013_Jan_19(1)_133-136.nxml.txt.nlp	23260464	SENT42	34	34	20	20	amikacin	TOB	PA164744372	10140	0.676
NULL	Paediatr_Drugs_2013_Apr_20_15(2)_119-131.nxml.txt.nlp	23512128	SENT139	13	13	5	5	pantoprazole	CYP2C19	PA450774	1557	0.676
NULL	Front_Genet_2012_Nov_12_3_235.nxml.txt.nlp	23162568	SENT153	20	20	10	10	methamphetamine	CYP2D6	PA450403	1565	0.676
NULL	Acta_Pharmacol_Sin_2011_Jun_23_32(6)_765-780.nxml.txt.nlp	21602835	SENT173	8	8	23	23	diazoxide	SUR1	PA449285	6833	0.676
NULL	Infect_Dis_Obstet_Gynecol_2012_Feb_25_2012_157159.nxml.txt.nlp	22505797	SENT166	21	21	31	31	metronidazole	PTB	PA450484	58155	0.676
NULL	Acta_Pharmacol_Sin_2013_Apr_11_34(4)_473-479.nxml.txt.nlp	23474709	SENT126	15	15	7	7	carbamazepine	MRP1	PA448785	4437	0.676
NULL	Diabetes_Care_2010_Jan_21_33(1)_156-161.nxml.txt.nlp	19846797	SENT178	20	20	15	15	metformin	B12	PA450395	7126;4709	0.676
NULL	Arch_Virol_2014_Dec_24_159(6)_1365-1371.nxml.txt.nlp	24366548	SENT54	14	14	16	16	ribavirin	IL28B	PA451241	282617	0.676
NULL	Atten_Defic_Hyperact_Disord_2014_Jul_14_6(3)_175-202.nxml.txt.nlp	25017045	SENT308	26	26	19	19	citalopram	DRD2	PA449015	1813	0.676
NULL	Eur_J_Clin_Pharmacol_2014_Oct_8_70(12)_1433-1441.nxml.txt.nlp	25291992	SENT127	5	5	11	11	olanzapine	OCM	PA450688	654231	0.676
NULL	Mol_Cancer_2008_Mar_26_7_27.nxml.txt.nlp	18366759	SENT80	7	7	13	13	etoposide	MCL1	PA449552	4170	0.676
NULL	Nat_Commun_2011_Oct_25_2_510.nxml.txt.nlp	22027590	SENT195	16	16	12	12	l-glutamine	B27	PA10090	56246	0.676
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jul_6_67(Pt_8)_o1927.nxml.txt.nlp	22090972	SENT5	25	25	29	29	piperazine	mol	PA450977	90527	0.676
NULL	EPMA_J_2012_Sep_27_3(1)_10.nxml.txt.nlp	23016735	SENT150	10	10	4	4	warfarin	CYP4F2	PA451906	8529	0.676
NULL	Clin_Ophthalmol_2011_Feb_15_5_201-207.nxml.txt.nlp	21386912	SENT137	7	7	12	12	bepotastine	CD54	PA164781356	3383	0.676
NULL	Exp_Diabetes_Res_2011_Jun_27_2011_947138.nxml.txt.nlp	21754922	SENT221	6	6	26	26	atropine	STZ	PA448505	6484	0.676
NULL	Front_Oncol_2014_Apr_9_4_75.nxml.txt.nlp	24782986	SENT231	28	28	13	13	paclitaxel	CD117	PA450761	3815	0.676
NULL	Gut_2013_Apr_14_62(4)_540-549.nxml.txt.nlp	22798500	SENT270	22	22	28	28	cetuximab	KRAS	PA10040	3845	0.676
NULL	Indian_J_Radiol_Imaging_2013_Oct-Dec_23(4)_373-378.nxml.txt.nlp	24604944	SENT77	18	18	5	5	mannitol	ANOVA	PA450320	4858	0.676
NULL	J_Biomed_Biotechnol_2010_Jun_7_2010_150960.nxml.txt.nlp	20617134	SENT241	22	22	16	16	bevacizumab	KRAS	PA130232992	3845	0.676
NULL	Arthritis_Res_Ther_2005_Mar_16_7(Suppl_2)_S21-S25.nxml.txt.nlp	15833145	SENT26	6	6	13	13	abatacept	CD86	PA164747080	942	0.676
NULL	Clin_Interv_Aging_2010_Nov_26_5_365-368.nxml.txt.nlp	21152238	SENT75	1	1	5	5	bisoprolol	CTR	PA448641	799	0.676
NULL	Oncotarget_2012_Oct_27_3(10)_1052-1053.nxml.txt.nlp	23165648	SENT25	26	26	31	31	nutlin-3	p53		7157	0.676
NULL	Mol_Vis_2011_Oct_19_17_2724-2737.nxml.txt.nlp	22065926	SENT148	13	13	6	6	paclitaxel	zeta	PA450761	9907	0.676
NULL	Indian_J_Ophthalmol_2013_Dec_61(12)_705-710.nxml.txt.nlp	24413824	SENT20	0	0	8	8	bevacizumab	San	PA130232992	80218	0.676
NULL	Front_Pharmacol_2014_Oct_20_5_230.nxml.txt.nlp	25368579	SENT17	0	0	10	10	berberine	IL-6	PA165860812	3569	0.676
NULL	J_Korean_Med_Sci_2011_Jan_22_26(1)_33-41.nxml.txt.nlp	21218027	SENT169	26	26	8	8	ofloxacin	EMB	PA450684	133418	0.676
NULL	Br_J_Cancer_2012_Jan_17_106(2)_333-343.nxml.txt.nlp	22166800	SENT160	8	8	14	14	bortezomib	ABCC4	PA10252	10257	0.676
NULL	Clin_Med_Insights_Cardiol_2010_Oct_11_4_89-93.nxml.txt.nlp	20981132	SENT15	23	23	13	13	benazepril	TLR4	PA448561	7099	0.676
NULL	Neural_Plast_2007_Jun_19_2007_52908.nxml.txt.nlp	17641734	SENT45	22	22	9	9	lipase	NAPE-PLD	PA450239	222236	0.676
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1033-1038.nxml.txt.nlp	22374460	SENT8	14	14	25	25	trastuzumab	HER2	PA451743	2064	0.676
NULL	Biosci_Rep_2014_Jul_29_34(4)_e00126.nxml.txt.nlp	24935351	SENT51	8	8	20	20	trypsin	CO2	PA451806	4513	0.676
NULL	Hum_Genomics_2013_Apr_5_7(1)_10.nxml.txt.nlp	23561625	SENT167	3	3	8	8	flavopiridol	CDK7	PA452627	1022	0.676
NULL	Br_J_Cancer_2013_Jun_25_108(12)_2464-2469.nxml.txt.nlp	23695016	SENT33	12	12	15	15	carboplatin	CRT	PA448803	811	0.676
NULL	Br_J_Ophthalmol_2008_Sep_22_92(9)_1275-1282.nxml.txt.nlp	18723745	SENT13	19	19	21	21	latanoprost	BAK	PA164774763	578	0.676
NULL	J_Breast_Cancer_2011_Jun_18_14(2)_129-134.nxml.txt.nlp	21847408	SENT128	8	8	18	18	doxorubicin	B27	PA449412	56246	0.676
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Nov_5_67(Pt_12)_o3215.nxml.txt.nlp	22199732	SENT69	25	25	16	16	ethanol	mol	PA448073	90527	0.676
NULL	J_Exp_Med_1977_Dec_1_146(6)_1484-1499.nxml.txt.nlp	925610	SENT6	7	7	22	22	trypsin	C42	PA451806	51654	0.676
NULL	Biomed_Eng_Online_2012_Nov_14_11_84.nxml.txt.nlp	23151049	SENT186	20	20	25	25	alendronate	PTH	PA448082	5741	0.676
NULL	Biomed_Res_Int_2013_Dec_30_2013_735835.nxml.txt.nlp	24490170	SENT173	14	14	40	40	cetirizine	FEX	PA448905	8549	0.676
NULL	BMB_Rep_2013_Apr_46(4)_181-187.nxml.txt.nlp	23615258	SENT722	0	0	17	17	metformin	AMPK	PA450395	5563	0.676
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1049.nxml.txt.nlp	24503541	SENT127	15	15	2	2	mitomycin	PP2	PA450524	4888	0.676
NULL	ScientificWorldJournal_2013_Oct_29_2013_274570.nxml.txt.nlp	24288475	SENT210	12	12	4	4	pyrazinamide	CPX	PA451182	1371;10682;1377	0.676
NULL	J_Viral_Hepat_2008_Dec_15(12)_849-854.nxml.txt.nlp	19087224	SENT22	16	16	30	30	lipase	DC-SIGN	PA450239	30835	0.676
NULL	Eur_J_Clin_Microbiol_Infect_Dis_2010_May_13_29(5)_543-550.nxml.txt.nlp	20229224	SENT73	29	29	47	47	gentamicin	VAN	PA449753	10318	0.676
NULL	Int_J_Gen_Med_2012_Jan_31_5_105-115.nxml.txt.nlp	22319248	SENT75	21	21	16	16	sargramostim	GM-CSF	PA164748631	1437	0.676
NULL	J_Allergy_(Cairo)_2011_Oct_24_2011_457169.nxml.txt.nlp	22121382	SENT168	19	19	24	24	salmeterol	IL-6	PA451300	3569	0.676
NULL	EMBO_Mol_Med_2012_Apr_4(4)_298-312.nxml.txt.nlp	22331558	SENT147	38	38	27	27	etoposide	p53	PA449552	7157	0.676
NULL	Nat_Commun_2014_Aug_22_5_4684.nxml.txt.nlp	25147954	SENT324	3	3	14	14	adalimumab	IL-6	PA10004	3569	0.676
NULL	Front_Pharmacol_2014_Dec_10_5_271.nxml.txt.nlp	25540621	SENT133	0	0	3	3	fenfluramine	ghrelin	PA449592	51738	0.676
NULL	Oxid_Med_Cell_Longev_2013_Nov_28_2013_568093.nxml.txt.nlp	24379901	SENT77	0	0	2	2	resveratrol	AMPK		5563	0.676
NULL	Scientifica_(Cairo)_2013_Dec_10_2013_691251.nxml.txt.nlp	24386592	SENT186	7	7	9	9	staurosporine	SIRT3	PA165109623	23410	0.676
NULL	Front_Endocrinol_(Lausanne)_2014_Dec_12_5_207.nxml.txt.nlp	25566184	SENT341	11	11	19	19	protamine	ZO-1	PA10366	7082	0.676
NULL	Diabetes_Obes_Metab_2012_Apr_14(4)_304-314.nxml.txt.nlp	22051096	SENT142	8	8	5	5	exenatide	PPG	PA164749238	5552	0.676
NULL	Eur_J_Clin_Pharmacol_2011_May_8_67(5)_493-506.nxml.txt.nlp	21140139	SENT32	11	11	13	13	oxymorphone	CYP2D6	PA450748	1565	0.676
NULL	Gut_Liver_2013_Sep_14_7(5)_552-559.nxml.txt.nlp	24073313	SENT79	7	7	16	16	celecoxib	EGFR	PA448871	1956	0.676
NULL	Mol_Brain_2014_Aug_21_7_59.nxml.txt.nlp	25139109	SENT99	0	0	14	14	chloroquine	TRPA1	PA448948	8989	0.676
NULL	ScientificWorldJournal_2013_Oct_1_2013_654829.nxml.txt.nlp	24198725	SENT303	6	6	18	18	naproxen	NF2	PA450595	4771	0.676
NULL	Pharmaceuticals_(Basel)_2013_Aug_2_6(8)_915-928.nxml.txt.nlp	24276376	SENT281	10	10	24	24	heparin	JAMA	PA449855	50848	0.676
NULL	Cases_J_2009_Aug_11_2_8875.nxml.txt.nlp	20184702	SENT69	0	0	4	4	rituximab	CHOP	PA451261	1649	0.676
NULL	Br_J_Cancer_2011_Jun_7_104(12)_1848-1853.nxml.txt.nlp	21610704	SENT163	13	13	10	10	panitumumab	KRAS	PA162373091	3845	0.676
NULL	Clin_Ophthalmol_2014_Jan_13_8_219-228.nxml.txt.nlp	24531757	SENT153	12	12	4	4	timolol	TIM	PA451690	7984;8914	0.676
NULL	Mol_Cancer_2010_Nov_2_9_289.nxml.txt.nlp	21044322	SENT188	32	32	12	12	cisplatin	RGS10	PA449014	6001	0.676
NULL	Cell_Mol_Life_Sci_2012_May_6_69(10)_1625-1634.nxml.txt.nlp	22481437	SENT246	17	17	10	10	rituximab	CD27	PA451261	939	0.676
NULL	Curr_Neuropharmacol_2014_Mar_12(2)_186-192.nxml.txt.nlp	24669211	SENT220	15	15	20	20	metformin	Met	PA450395	79811	0.676
NULL	J_Cell_Biol_2001_Nov_12_155(4)_637-648.nxml.txt.nlp	11696559	SENT175	2	2	24	24	etoposide	Bcl-2	PA449552	596	0.676
NULL	J_Mol_Signal_2012_May_14_7_4.nxml.txt.nlp	22583680	SENT66	19	19	8	8	isoproterenol	ERK1	PA450121	5595	0.676
NULL	Osteoporos_Int_2012_Feb_4_23(Suppl_1)_S1-S23.nxml.txt.nlp	22311111	SENT781	9	9	6	6	denosumab	NF-kappaB	PA166048634	4790	0.676
NULL	Mol_Cancer_2013_May_24_12_47.nxml.txt.nlp	23705854	SENT249	13	13	19	19	naproxen	P-gp	PA450595	5243	0.676
NULL	Biologics_2009_Oct_12_3_469-474.nxml.txt.nlp	19851472	SENT103	28	28	0	0	mometasone	IFN	PA450541	3439	0.676
NULL	Exp_Diabetes_Res_2012_Nov_1_2012_972679.nxml.txt.nlp	22110483	SENT70	27	27	14	14	resveratrol	HO-1		3162	0.676
NULL	Oncoimmunology_2014_Jun_25_3_e29080.nxml.txt.nlp	25101222	SENT103	26	26	21	21	hyaluronan	LYVE-1	PA165958431	10894	0.676
NULL	Cell_Cycle_2013_Mar_15_12(6)_868.nxml.txt.nlp	23442795	SENT33	24	24	6	6	bortezomib	p53	PA10252	7157	0.676
NULL	FEBS_Open_Bio_2012_Jul_20_2_179-186.nxml.txt.nlp	23650597	SENT96	2	2	11	11	imiquimod	MxA	PA449972	4599	0.676
NULL	Oncotarget_2014_Aug_19_5(18)_8703-8715.nxml.txt.nlp	25237928	SENT98	22	22	13	13	glucose	CD44	PA449773	960	0.675
NULL	Clinics_(Sao_Paulo)_2012_Mar_67(3)_283-287.nxml.txt.nlp	22473412	SENT112	41	41	3	3	rosiglitazone	SHBG	PA451283	6462	0.675
NULL	Br_J_Cancer_2003_Mar_24_88(6)_822-827.nxml.txt.nlp	12644816	SENT71	9	9	25	25	thalidomide	PSA	PA451644	29968;9520;354	0.675
NULL	Acta_Pharmacol_Sin_2009_Jul_3_30(7)_980-986.nxml.txt.nlp	19575001	SENT29	26	26	4	4	caspofungin	IPA	PA164743013	3160	0.675
NULL	J_Gastrointest_Surg_2012_Apr_13_16(4)_842-848.nxml.txt.nlp	22246855	SENT94	24	24	16	16	erlotinib	HER2	PA134687924	2064	0.675
NULL	Front_Neuroenergetics_2009_Mar_24_1_1.nxml.txt.nlp	19584905	SENT114	10	10	12	12	nadh	GAPDH	PA164755085	2597	0.675
NULL	Crit_Care_2011_Aug_11_15(4)_226.nxml.txt.nlp	21892977	SENT347	19	19	5	5	vasopressin	LNPEP	PA451858	4012	0.675
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT11	24	24	33	33	neratinib	EGFR	PA165291472	1956	0.675
NULL	Arthritis_Res_Ther_2013_Nov_7_15(6)_R183.nxml.txt.nlp	24286535	SENT72	27	27	8	8	paraformaldehyde	IFN	PA450790	3439	0.675
NULL	Anesth_Essays_Res_2012_Jul-Dec_6(2)_140-146.nxml.txt.nlp	NULL	SENT19	15	15	3	3	lidocaine	IL6	PA450226	3569	0.675
NULL	Br_J_Cancer_2010_Nov_2_103(11)_1671-1679.nxml.txt.nlp	21045835	SENT139	8	8	5	5	gemcitabine	CXCR4	PA449748	7852	0.675
NULL	J_Med_Chem_2014_Jan_23_57(2)_449-461.nxml.txt.nlp	24387105	SENT146	28	28	33	33	benzaldehyde	ALDH3A1	PA448571	218	0.675
NULL	Curr_Neuropharmacol_2009_Jun_7(2)_83-95.nxml.txt.nlp	19949566	SENT515	10	10	32	32	gabapentin	TGB	PA449720	5473	0.675
NULL	Ann_Rheum_Dis_2009_Jul_4_68(7)_1220-1227.nxml.txt.nlp	18772191	SENT195	22	22	9	9	abatacept	IFN	PA164747080	3439	0.675
NULL	Ann_Hematol_2013_Aug_24_92(11)_1521-1528.nxml.txt.nlp	23978945	SENT185	14	14	31	31	alemtuzumab	ACT	PA164783958	12;11332;9457;641455	0.675
NULL	Fibrogenesis_Tissue_Repair_2012_Jun_6_5(Suppl_1)_S13.nxml.txt.nlp	23259677	SENT114	27	27	33	33	pentoxifylline	GAPDH	PA450864	2597	0.675
NULL	Cough_2005_Oct_19_1_10.nxml.txt.nlp	16270907	SENT108	10	10	17	17	omeprazole	GOR	PA450704	254958	0.675
NULL	J_Radiat_Res_2014_Mar_1_55(2)_359-363.nxml.txt.nlp	24187329	SENT43	28	28	0	0	vincristine	CHOP	PA451879	1649	0.675
NULL	Endocrinology_2014_Oct_22_155(10)_3732-3738.nxml.txt.nlp	25051442	SENT69	12	12	23	23	sibutramine	POMC	PA451344	5443	0.675
NULL	J_Invest_Dermatol_2011_Dec_22_131(12)_2467-2476.nxml.txt.nlp	21938011	SENT237	16	16	3	3	temsirolimus	MVD	PA164746890	4597	0.675
NULL	Oxid_Med_Cell_Longev_2013_Jun_6_2013_891748.nxml.txt.nlp	23840922	SENT265	2	2	18	18	resveratrol	Bcl-2		596	0.675
NULL	Evid_Based_Complement_Alternat_Med_2011_Feb_14_2011_752302.nxml.txt.nlp	19942664	SENT135	10	10	19	19	alendronate	DPD	PA448082	1806	0.675
NULL	Nat_Commun_2014_Dec_18_5_5585.nxml.txt.nlp	25519239	SENT187	10	10	14	14	nadh	ADP	PA164755085	23038	0.675
NULL	Cell_Cycle_2012_Apr_15_11(8)_1487.nxml.txt.nlp	22544077	SENT23	0	0	26	26	metformin	AMPK	PA450395	5563	0.675
NULL	J_Mol_Signal_2006_Dec_6_1_8.nxml.txt.nlp	17224083	SENT64	22	22	25	25	thrombin	Rho	PA451674	29984	0.675
NULL	J_Cell_Biol_1998_May_4_141(3)_839-847.nxml.txt.nlp	9566981	SENT279	6	6	20	20	guanidine	osteoadherin	PA164781028	4958	0.675
NULL	Adv_Biomed_Res_2014_Sep_8_3_189.nxml.txt.nlp	25298958	SENT6	23	23	37	37	omeprazole	NAC	PA450704	22861	0.675
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1495-1502.nxml.txt.nlp	21989186	SENT139	14	14	11	11	panitumumab	KRAS	PA162373091	3845	0.675
NULL	Arthritis_Res_Ther_2010_Feb_9_12(1)_R21.nxml.txt.nlp	20144213	SENT254	3	3	14	14	naproxen	5-LOX	PA450595	240	0.675
NULL	J_Hematol_Oncol_2012_Mar_7_5_5.nxml.txt.nlp	22397365	SENT32	38	38	2	2	nadh	IDH2	PA164755085	3418	0.675
NULL	Mol_Cancer_2009_Jun_8_8_34.nxml.txt.nlp	19500427	SENT121	24	24	9	9	gemcitabine	CLSPN	PA449748	63967	0.675
NULL	Oncotarget_2013_Nov_22_5(4)_933-943.nxml.txt.nlp	24659749	SENT53	10	10	16	16	nutlin-3	p53		7157	0.675
NULL	Nutr_J_2014_Sep_4_13(1)_88.nxml.txt.nlp	NULL	SENT82	5	5	0	0	ethanol	Men	PA448073	8178	0.675
NULL	Int_J_Nanomedicine_2012_Oct_25_7_5565-5575.nxml.txt.nlp	23118538	SENT10	6	6	1	1	fenofibrate	CO2	PA449594	4513	0.675
NULL	Antibiotics_(Basel)_2014_Jul_1_3(3)_285-316.nxml.txt.nlp	25364574	SENT180	11	11	9	9	cefalotin	IMP-1	PA448886	10642	0.675
NULL	Emerg_Infect_Dis_2013_Jan_19(1)_21-28.nxml.txt.nlp	23260763	SENT79	25	25	0	0	trimethoprim	DHPS	PA451788	1725	0.675
NULL	Mol_Vis_2011_Dec_15_17_3254-3261.nxml.txt.nlp	22194651	SENT99	3	3	5	5	vasopressin	AVP	PA451858	114548;551	0.675
NULL	Mol_Cancer_2009_Apr_22_8_26.nxml.txt.nlp	19386116	SENT148	5	5	9	9	ritonavir	AKT	PA451260	207	0.675
NULL	Front_Immunol_2013_Nov_20_4_385.nxml.txt.nlp	24312095	SENT350	13	13	28	28	dextran	CD4	PA449261	920	0.675
NULL	Oncotarget_2014_Jun_6_5(12)_4516-4528.nxml.txt.nlp	24980831	SENT9	10	10	12	12	temozolomide	JNK	PA451609	5599	0.675
NULL	Acta_Vet_Scand_2011_Feb_17_53(1)_11.nxml.txt.nlp	21324209	SENT55	18	18	24	24	gentamicin	OTC	PA449753	5009	0.675
NULL	Diabetes_Care_2009_Apr_29_32(4)_541-546.nxml.txt.nlp	19114614	SENT164	5	5	0	0	atorvastatin	Men	PA448500	8178	0.675
NULL	Pharmaceutics_2011_Mar_9_3(1)_73-87.nxml.txt.nlp	24310426	SENT2	25	25	20	20	hydrocodone	API	PA449900	5345	0.675
NULL	Lipids_Health_Dis_2011_Jan_18_10_8.nxml.txt.nlp	21241519	SENT12	7	7	32	32	simvastatin	ABCA1	PA451363	19	0.675
NULL	Gut_2012_May_3_61(5)_695-705.nxml.txt.nlp	21813473	SENT354	30	30	18	18	dextran	CXCR3	PA449261	2833	0.675
NULL	Scientifica_(Cairo)_2013_Nov_28_2013_518909.nxml.txt.nlp	24381790	SENT414	16	16	4	4	estradiol	ghrelin	PA449503	51738	0.675
NULL	New_Microbes_New_Infect_2014_May_4_2(3)_58-63.nxml.txt.nlp	25356345	SENT100	14	14	20	20	ceftazidime	GEM	PA448861	2669	0.675
NULL	Breast_Cancer_Res_Treat_2014_Apr_6_145(3)_725-734.nxml.txt.nlp	24706168	SENT78	3	3	5	5	cyclophosphamide	ACT	PA449165	12;11332;9457;641455	0.675
NULL	Indian_J_Crit_Care_Med_2010_Oct-Dec_14(4)_188-195.nxml.txt.nlp	21572750	SENT78	13	13	10	10	thrombin	ADP	PA451674	23038	0.675
NULL	Oncotarget_2014_Feb_7_5(3)_775-787.nxml.txt.nlp	24519956	SENT121	11	11	35	35	docetaxel	PC3	PA449383	57332;7832;5122	0.675
NULL	Int_J_Med_Sci_2012_Aug_10_9(6)_472-479.nxml.txt.nlp	22927772	SENT22	21	21	4	4	warfarin	CYP2C9	PA451906	1559	0.675
NULL	J_Vis_Exp_2011_Apr_25_(50)_2634.nxml.txt.nlp	21540826	SENT29	16	16	30	30	l-glutamine	B27	PA10090	56246	0.675
NULL	Oncotarget_2013_Aug_8_4(8)_1130-1142.nxml.txt.nlp	24029073	SENT1	35	35	10	10	oxygen	NRF2	PA450744	2551;4780	0.675
NULL	Mol_Cancer_2009_Jul_31_8_57.nxml.txt.nlp	19646263	SENT221	25	25	19	19	staurosporine	PC-3	PA165109623	692094	0.675
NULL	J_Cell_Biol_1998_Nov_16_143(4)_1077-1086.nxml.txt.nlp	9817763	SENT240	13	13	15	15	dextran	mol	PA449261	90527	0.675
NULL	Br_J_Cancer_2010_Jun_29_103(1)_52-60.nxml.txt.nlp	20531411	SENT155	16	16	13	13	gemcitabine	MTD	PA449748	4493	0.675
NULL	J_Lipid_Res_2014_Dec_55(12)_2562-2575.nxml.txt.nlp	25316883	SENT196	35	35	28	28	lipase	ATGL	PA450239	57104	0.675
NULL	J_Carcinog_Mutagen_2013_Suppl_6_003.nxml.txt.nlp	25379355	SENT171	9	9	37	37	doxorubicin	PI3K	PA449412	5290	0.675
NULL	Oncotarget_2014_Jun_8_5(13)_5040-5053.nxml.txt.nlp	24970815	SENT65	32	32	10	10	cisplatin	LOX	PA449014	4015	0.675
NULL	Mol_Cancer_2009_Nov_24_8_109.nxml.txt.nlp	19930708	SENT136	3	3	5	5	exemestane	EGFR	PA449563	1956	0.675
NULL	Front_Behav_Neurosci_2014_Sep_3_8_291.nxml.txt.nlp	25232308	SENT663	6	6	10	10	risperidone	gamma	PA451257	9913	0.675
NULL	Oncotarget_2012_Nov_17_4(1)_18-28.nxml.txt.nlp	23248157	SENT81	12	12	28	28	pargyline	p53	PA450797	7157	0.675
NULL	ScientificWorldJournal_2013_Apr_18_2013_808460.nxml.txt.nlp	23710149	SENT136	17	17	4	4	carrageenan	BOR	PA448814	55143	0.675
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Jun_15_69(Pt_7)_o1104.nxml.txt.nlp	24046664	SENT5	4	4	13	13	nitrile	mol	PA450636	90527	0.675
NULL	Oncotarget_2014_Oct_16_5(20)_9546-9563.nxml.txt.nlp	25337673	SENT190	27	27	17	17	erlotinib	AXL	PA134687924	558	0.675
NULL	Int_J_Gen_Med_2013_Dec_4_6_877-895.nxml.txt.nlp	24403842	SENT176	5	5	0	0	metformin	PPG	PA450395	5552	0.675
NULL	J_Korean_Med_Sci_2013_Apr_27_28(4)_527-533.nxml.txt.nlp	23580227	SENT139	4	4	11	11	genistein	TRAIL	PA165109660	8743	0.675
NULL	Biochemistry_2011_Feb_8_50(5)_715-726.nxml.txt.nlp	21182262	SENT289	6	6	11	11	glutaraldehyde	Cby	PA449777	25776	0.675
NULL	Cancers_(Basel)_2014_Jul_8_6(3)_1487-1499.nxml.txt.nlp	25006835	SENT100	7	7	2	2	cisplatin	STAT3	PA449014	6774	0.675
NULL	Diabetes_Care_2013_May_13_36(5)_1074-1082.nxml.txt.nlp	23275352	SENT161	10	10	13	13	liraglutide	ZAG	PA165958364	563	0.675
NULL	Oncotarget_2011_May_16_2(5)_418-421.nxml.txt.nlp	21789791	SENT26	27	27	31	31	bortezomib	TRAIL	PA10252	8743	0.675
NULL	Oncotarget_2011_Dec_20_2(12)_1094-1108.nxml.txt.nlp	22190353	SENT127	29	29	47	47	doxorubicin	S5B	PA449412	5711	0.675
NULL	Adv_Biomed_Res_2014_Oct_21_3_219.nxml.txt.nlp	25371876	SENT211	14	14	28	28	raloxifene	CA1	PA451221	759	0.675
NULL	Breast_Cancer_Res_2014_Jul_24_16(4)_411.nxml.txt.nlp	25056669	SENT115	32	32	18	18	tamoxifen	CD49b	PA451581	3673	0.675
NULL	Int_J_Biol_Sci_2006_Mar_1_2(1)_1-9.nxml.txt.nlp	16585947	SENT53	19	19	6	6	pp2	PP2		4888	0.675
NULL	Ann_Neurosci_2011_Jan_18(1)_8-13.nxml.txt.nlp	25205911	SENT23	0	0	13	13	scopolamine	spatial	PA451308	219793	0.675
NULL	Case_Rep_Med_2013_Mar_30_2013_520181.nxml.txt.nlp	23606854	SENT26	13	13	21	21	primaquine	G6PD	PA451103	2539	0.675
NULL	Br_J_Cancer_2010_Dec_7_103(12)_1822-1830.nxml.txt.nlp	21063405	SENT158	7	7	33	33	cisplatin	NBS1	PA449014	55655	0.675
NULL	Clin_Med_Insights_Cardiol_2011_Jun_28_5_55-66.nxml.txt.nlp	21792345	SENT174	21	21	10	10	carvedilol	ADRB2	PA448817	154	0.675
NULL	Cell_Death_Differ_2010_Oct_30_17(10)_1624-1635.nxml.txt.nlp	20431602	SENT58	1	1	7	7	paclitaxel	Bcl-2	PA450761	596	0.675
NULL	Diabetologia_2010_Apr_26_53(4)_606-613.nxml.txt.nlp	20101384	SENT68	26	26	17	17	lipase	FIAF	PA450239	51129	0.675
NULL	Int_J_Mol_Sci_2013_Apr_24_14(5)_8818-8831.nxml.txt.nlp	23615472	SENT26	44	44	39	39	papain	VIII	PA450778	1351	0.675
NULL	Br_J_Cancer_2012_Jan_3_106(1)_18-24.nxml.txt.nlp	22108516	SENT54	9	9	11	11	camptothecin	TDP1	PA153590860	55775	0.675
NULL	Mol_Brain_2013_Dec_16_6_56.nxml.txt.nlp	24330819	SENT202	24	24	12	12	dantrolene	c-fos	PA449208	2353	0.675
NULL	N_Am_J_Med_Sci_2014_Aug_6(8)_422-424.nxml.txt.nlp	25210678	SENT50	10	10	15	15	vincristine	CHOP	PA451879	1649	0.675
NULL	Clinics_(Sao_Paulo)_2011_Aug_66(8)_1457-1462.nxml.txt.nlp	21915500	SENT104	31	31	44	44	oxygen	p47phox	PA450744	653361	0.675
NULL	Nat_Commun_2014_Nov_19_5_5479.nxml.txt.nlp	25407222	SENT534	27	27	10	10	dextran	YTS	PA449261	8565	0.675
NULL	J_Antimicrob_Chemother_2008_Nov_27_62(5)_929-933.nxml.txt.nlp	18755696	SENT60	10	10	20	20	ampicillin	CTX	PA448419	1593	0.675
NULL	Orphanet_J_Rare_Dis_2014_Nov_15_9(1)_161.nxml.txt.nlp	NULL	SENT205	28	28	19	19	s-adenosylmethionine	B12	PA164754994	7126;4709	0.675
NULL	Mol_Imaging_Biol_2013_Apr_11_15(2)_136-147.nxml.txt.nlp	22886728	SENT207	4	4	29	29	orlistat	FDG	PA164776864	23583	0.675
NULL	Clin_Mol_Hepatol_2013_Sep_30_19(3)_216-254.nxml.txt.nlp	24133661	SENT497	28	28	30	30	misoprostol	adiponectin	PA450523	9370	0.675
NULL	Case_Rep_Ophthalmol_2010_Aug_18_1(1)_36-41.nxml.txt.nlp	21369348	SENT58	7	7	13	13	bevacizumab	PED	PA130232992	8682	0.675
NULL	Apoptosis_2013_Jun_7_18(6)_664-680.nxml.txt.nlp	23468121	SENT310	19	19	24	24	staurosporine	PDCD2	PA165109623	5134	0.675
NULL	Indian_J_Med_Res_2012_Dec_136(6)_926-941.nxml.txt.nlp	23391788	SENT177	38	38	30	30	clopidogrel	CYP2C19	PA449053	1557	0.675
NULL	Cell_Commun_Signal_2009_Oct_27_7_25.nxml.txt.nlp	19860902	SENT237	0	0	12	12	tropisetron	AP-1	PA161925594	2353;3727;2354;3725	0.675
NULL	Nature_2012_Dec_20_492(7429)_387-392.nxml.txt.nlp	23222541	SENT309	2	2	24	24	thrombin	PAR1	PA451674	79581;2149	0.675
NULL	J_Oncol_2010_May_4_2010_373491.nxml.txt.nlp	20454582	SENT134	12	12	29	29	temozolomide	TRG	PA451609	6965	0.675
NULL	Int_J_Mol_Sci_2013_Apr_26_14(5)_9111-9125.nxml.txt.nlp	23624604	SENT92	33	33	15	15	iron	gamma	PA450087	9913	0.675
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT282	22	22	31	31	trastuzumab	HER2	PA451743	2064	0.675
NULL	Int_Clin_Psychopharmacol_2014_Jul_26_29(4)_185-196.nxml.txt.nlp	24424469	SENT100	12	12	5	5	paroxetine	CYP2D6	PA450801	1565	0.675
NULL	Breast_Cancer_Res_Treat_2014_Apr_9_145(1)_73-82.nxml.txt.nlp	24715380	SENT126	11	11	7	7	tamoxifen	CXCR3	PA451581	2833	0.675
NULL	Curr_Neuropharmacol_2009_Jun_7(2)_83-95.nxml.txt.nlp	19949566	SENT474	38	38	32	32	topiramate	TGB	PA451728	5473	0.675
NULL	Ann_Hematol_2012_Jul_12_91(7)_981-996.nxml.txt.nlp	22526361	SENT462	17	17	10	10	rituximab	CD27	PA451261	939	0.675
NULL	Cell_Biol_Int_Rep_(2010)_2012_Jun_21_19(1)_e00017.nxml.txt.nlp	23124518	SENT135	2	2	5	5	etoposide	TRAIL	PA449552	8743	0.675
NULL	J_Lipid_Res_2010_Sep_51(9)_2775-2784.nxml.txt.nlp	20519739	SENT122	9	9	18	18	amiloride	ETV5	PA448368	2119	0.675
NULL	Med_Sci_Monit_2013_May_1_19_317-326.nxml.txt.nlp	23632427	SENT277	4	4	14	14	ampicillin	CTX	PA448419	1593	0.675
NULL	Oncotarget_2011_Nov_30_2(11)_874-885.nxml.txt.nlp	22141136	SENT228	10	10	17	17	pp2	San		80218	0.675
NULL	J_Biol_Chem_2009_Oct_2_284(40)_27273-27280.nxml.txt.nlp	19666463	SENT69	41	41	22	22	streptomycin	CO2	PA451512	4513	0.675
NULL	Diabetes_Care_2013_Aug_17_36(Suppl_2)_S139-S144.nxml.txt.nlp	23882038	SENT79	3	3	0	0	exenatide	GLP-1	PA164749238	100125288	0.675
NULL	J_Oncol_2013_Feb_17_2013_872957.nxml.txt.nlp	23476648	SENT111	28	28	25	25	cisplatin	SFN	PA449014	25996;2810	0.675
NULL	J_Immunol_Res_2014_May_8_2014_565320.nxml.txt.nlp	24901010	SENT80	29	29	18	18	allopurinol	HLA-B	PA448320	3106	0.675
NULL	Glycobiology_2009_Jun_24_19(6)_576-582.nxml.txt.nlp	19240275	SENT168	42	42	24	24	desipramine	DPI	PA449233	1832	0.675
NULL	Ann_Lab_Med_2013_Jan_17_33(1)_86-88.nxml.txt.nlp	23301230	SENT52	30	30	12	12	aztreonam	CTX	PA448523	1593	0.675
NULL	Int_J_Endocrinol_2013_Nov_13_2013_686315.nxml.txt.nlp	24324494	SENT166	31	31	26	26	metformin	OCT1	PA450395	5451;6580	0.675
NULL	Vet_Res_2014_Mar_6_45(1)_28.nxml.txt.nlp	24597857	SENT67	32	32	44	44	gentamicin	CO2	PA449753	4513	0.675
NULL	J_Biomed_Biotechnol_2010_Sep_19_2010_518743.nxml.txt.nlp	20886007	SENT319	10	10	2	2	nadh	ADP	PA164755085	23038	0.675
NULL	Mol_Biol_Cell_2012_Oct_15_23(20)_3970-3981.nxml.txt.nlp	22918942	SENT138	4	4	6	6	flavopiridol	CDK1	PA452627	983	0.675
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT144	42	42	32	32	vinorelbine	ASC	PA451881	29108	0.675
NULL	Br_J_Cancer_2009_Oct_20_101(8)_1253-1260.nxml.txt.nlp	19755984	SENT8	42	42	18	18	letrozole	HER-2	PA450196	2064	0.675
NULL	Patient_Prefer_Adherence_2013_May_7_7_391-400.nxml.txt.nlp	23687442	SENT47	13	13	27	27	fosaprepitant	CYP3A4	PA165958390	1576	0.675
NULL	J_Korean_Med_Sci_1990_Dec_5(4)_185-188.nxml.txt.nlp	1966034	SENT14	2	2	16	16	methacholine	TDI	PA165958382	100038246	0.675
NULL	Br_J_Cancer_2011_Mar_15_104(6)_899-902.nxml.txt.nlp	21343938	SENT51	21	21	3	3	anastrozole	ATAC	PA448432	6375	0.675
NULL	Acta_Pharmacol_Sin_2013_Jun_8_34(6)_830-836.nxml.txt.nlp	23564080	SENT109	6	6	22	22	simvastatin	HMGB1	PA451363	3146	0.675
NULL	J_Exp_Med_1968_Oct_1_128(4)_699-713.nxml.txt.nlp	19867304	SENT7	6	6	9	9	galactose	NAG	PA449725	51594;4669	0.675
NULL	ScientificWorldJournal_2013_Oct_1_2013_654829.nxml.txt.nlp	24198725	SENT279	26	26	15	15	naproxen	NF1	PA450595	4763	0.675
NULL	Mol_Cancer_2010_Aug_16_9_217.nxml.txt.nlp	20712901	SENT111	8	8	14	14	curcumin	STAT3	PA151958596	6774	0.675
NULL	Front_Neuroendocrinol_2014_Aug_35(3)_370-384.nxml.txt.nlp	24607323	SENT1553	15	15	44	44	estradiol	GDX	PA449503	8266	0.675
NULL	J_Ophthalmol_2009_Mar_9_2009_672178.nxml.txt.nlp	20339449	SENT34	0	0	9	9	ranibizumab	San	PA164746012	80218	0.675
NULL	Front_Plant_Sci_2012_Jul_2_3_147.nxml.txt.nlp	22783267	SENT95	0	0	32	32	lipase	DAG	PA450239	1605	0.675
NULL	Oncol_Lett_2014_Mar_16_7(3)_827-833.nxml.txt.nlp	24527090	SENT135	6	6	3	3	cisplatin	IFN	PA449014	3439	0.675
NULL	Int_J_Endocrinol_2013_Sep_5_2013_895102.nxml.txt.nlp	24089613	SENT21	15	15	24	24	saxagliptin	GLP-1	PA165958362	100125288	0.675
NULL	Br_J_Cancer_2011_Sep_6_105(6)_807-813.nxml.txt.nlp	21847121	SENT114	7	7	17	17	pha-665752	EGFR		1956	0.675
NULL	Oxid_Med_Cell_Longev_2013_Mar_5_2013_264935.nxml.txt.nlp	23533686	SENT121	3	3	6	6	hemin	HO-1	PA449849	3162	0.675
NULL	Mol_Cancer_2010_Nov_8_9_291.nxml.txt.nlp	21059223	SENT160	7	7	0	0	paclitaxel	ZNF217	PA450761	7764	0.675
NULL	Mol_Cell_Biochem_2015_Oct_8_398(1-2)_165-173.nxml.txt.nlp	25292312	SENT174	19	19	15	15	bortezomib	CHOP	PA10252	1649	0.675
NULL	Front_Neurosci_2014_May_27_8_129.nxml.txt.nlp	24904269	SENT123	26	26	5	5	ethanol	ANOVA	PA448073	4858	0.675
NULL	Pharmaceuticals_(Basel)_2011_Oct_27_4(11)_1450-1474.nxml.txt.nlp	NULL	SENT670	5	5	7	7	taurine	COX	PA451590	1351	0.675
NULL	Diabetes_Care_2009_Sep_5_32(9)_1589-1590.nxml.txt.nlp	19502536	SENT70	13	13	16	16	rosiglitazone	B12	PA451283	7126;4709	0.675
NULL	Oncotarget_2014_May_27_5(19)_9049-9064.nxml.txt.nlp	24979294	SENT217	10	10	39	39	dasatinib	EGF	PA162372878	1950	0.675
NULL	Cancers_(Basel)_2011_Sep_28_3(4)_3740-3761.nxml.txt.nlp	24213109	SENT811	19	19	7	7	collagenase	perlecan	PA449107	3339	0.675
NULL	Int_J_Mol_Sci_2014_Sep_4_15(9)_15622-15637.nxml.txt.nlp	25192287	SENT128	10	10	25	25	cisplatin	survivin	PA449014	332	0.675
NULL	Mol_Cell_Proteomics_2013_Aug_14_12(8)_2313-2323.nxml.txt.nlp	23674616	SENT203	5	5	23	23	levamisole	LPP3	PA450205	8613	0.675
NULL	Basic_Res_Cardiol_2015_Jan_20_110_4.nxml.txt.nlp	25600226	SENT117	0	0	3	3	berberine	PCSK9	PA165860812	255738	0.675
NULL	Br_J_Cancer_2012_Oct_9_107(8)_1327-1336.nxml.txt.nlp	22990650	SENT15	12	12	1	1	cisplatin	FGF1	PA449014	2246	0.675
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1033-1038.nxml.txt.nlp	22374460	SENT106	33	33	35	35	capecitabine	HER2	PA448771	2064	0.675
NULL	Oncotarget_2010_Oct_25_1(7)_497-514.nxml.txt.nlp	21165163	SENT160	19	19	12	12	erlotinib	IL-6	PA134687924	3569	0.675
NULL	Sci_Rep_2014_Dec_3_4_7242.nxml.txt.nlp	25467815	SENT364	7	7	23	23	estradiol	HSD7	PA449503	6060	0.675
NULL	Arthritis_Rheum_2011_Nov_63(11)_3512-3521.nxml.txt.nlp	21739425	SENT134	37	37	27	27	thrombin	FIX	PA451674	2158	0.675
NULL	Nucleic_Acids_Res_2013_May_3_41(10)_5413-5427.nxml.txt.nlp	23558745	SENT109	26	26	9	9	chloramphenicol	SOC	PA448927	91544	0.675
NULL	Hum_Genomics_2005_Jun_1_2(2)_138-143.nxml.txt.nlp	16004729	SENT37	43	43	8	8	nadh	ALDH3A1	PA164755085	218	0.675
NULL	Int_J_Tryptophan_Res_2009_Mar_23_2_45-60.nxml.txt.nlp	20651948	SENT284	3	3	8	8	tranylcypromine	Gen	PA451741	348654	0.675
NULL	Oncotarget_2014_Feb_7_5(3)_775-787.nxml.txt.nlp	24519956	SENT119	43	43	28	28	dasatinib	PC3	PA162372878	57332;7832;5122	0.675
NULL	Oncol_Lett_2013_Sep_12_6(3)_860-864.nxml.txt.nlp	24137426	SENT98	28	28	21	21	ketoconazole	CYP1A1	PA450146	1543	0.675
NULL	Front_Neurol_2014_Sep_11_5_173.nxml.txt.nlp	25309501	SENT160	2	2	9	9	hyaluronidase	HYAL1	PA164745713	3373	0.675
NULL	Oncol_Lett_2014_Oct_22_8(4)_1603-1607.nxml.txt.nlp	25202376	SENT130	11	11	39	39	cisplatin	XRCC1	PA449014	7515	0.675
NULL	Front_Endocrinol_(Lausanne)_2013_Nov_11_4_171.nxml.txt.nlp	24273532	SENT135	23	23	4	4	forskolin	RXFP1	PA146096022	59350	0.675
NULL	Cardiovasc_Diabetol_2007_Aug_15_6_20.nxml.txt.nlp	17697384	SENT70	22	22	3	3	rosiglitazone	DREAM	PA451283	30818	0.675
NULL	J_Cell_Mol_Med_2014_Jan_31_18(1)_27-37.nxml.txt.nlp	24373581	SENT173	0	0	42	42	alendronate	cadherin	PA448082	1015	0.675
NULL	Breast_Cancer_Res_2011_Apr_15_13(2)_R44.nxml.txt.nlp	21496232	SENT21	17	17	5	5	heparin	EGF	PA449855	1950	0.675
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Apr_28_68(Pt_5)_o1566.nxml.txt.nlp	22590424	SENT70	4	4	14	14	coumarin	mol	PA134521193	90527	0.675
NULL	Case_Rep_Gastrointest_Med_2011_Jul_9_2011_628902.nxml.txt.nlp	22606424	SENT28	29	29	4	4	rituximab	SHARP	PA451261	23013	0.675
NULL	Crit_Care_2006_Dec_7_10(6)_239.nxml.txt.nlp	17169139	SENT70	7	7	9	9	thrombin	PAR1	PA451674	79581;2149	0.675
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1149.nxml.txt.nlp	24675467	SENT312	18	18	2	2	trastuzumab	CD44	PA451743	960	0.675
NULL	Front_Chem_2014_Jul_4_2_44.nxml.txt.nlp	25072052	SENT40	22	22	36	36	lipase	PPL	PA450239	5493	0.675
NULL	Pharmaceuticals_(Basel)_2013_Aug_21_6(8)_988-1038.nxml.txt.nlp	24276379	SENT475	24	24	14	14	vemurafenib	PTEN	PA165946873	5728	0.675
NULL	J_Med_Internet_Res_2014_Jun_25_16(6)_e159.nxml.txt.nlp	24966165	SENT149	10	10	15	15	platinum	CIR	PA150595617	3762;9541	0.675
NULL	Oncol_Lett_2014_Apr_4_7(4)_1011-1014.nxml.txt.nlp	24944660	SENT56	25	25	23	23	thyroglobulin	TTF-1	PA164754910	7080	0.675
NULL	Crit_Care_2008_Jun_25_12(3)_R84.nxml.txt.nlp	18578859	SENT90	27	27	5	5	heparin	PF4	PA449855	5196	0.675
NULL	Biomed_Res_Int_2013_Dec_30_2013_735835.nxml.txt.nlp	24490170	SENT169	30	30	40	40	desloratadine	FEX	PA164776964	8549	0.675
NULL	Exp_Ther_Med_2013_Mar_21_5(3)_987-991.nxml.txt.nlp	23407636	SENT14	2	2	5	5	losartan	IL-8	PA450268	3576	0.675
NULL	ScientificWorldJournal_2014_Mar_17_2014_709801.nxml.txt.nlp	24778598	SENT66	10	10	19	19	glycopyrrolate	NMT	PA164754882	4836	0.675
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT257	17	17	10	10	simvastatin	TNF	PA451363	7124	0.675
NULL	Asian_J_Androl_2015_Aug_15_Jan-Feb_17(1)_143-148.nxml.txt.nlp	25155105	SENT130	40	40	31	31	udenafil	TNF	PA164776753	7124	0.675
NULL	Arthritis_Res_Ther_2008_May_27_10(3)_110.nxml.txt.nlp	18510784	SENT218	11	11	31	31	etanercept	RAC	PA449515	207	0.675
NULL	Diabetes_Care_2009_Nov_32(Suppl_2)_S232-S236.nxml.txt.nlp	19875557	SENT52	11	11	20	20	glucose	TRAP	PA449773	959;54;57410	0.675
NULL	Iran_J_Pharm_Res_2013_Summer_12(3)_457-469.nxml.txt.nlp	24250652	SENT12	11	11	5	5	indomethacin	CA1	PA449982	759	0.675
NULL	Breast_Cancer_Res_Treat_2009_Jul_22_116(2)_371-378.nxml.txt.nlp	18941892	SENT84	18	18	11	11	letrozole	aromatase	PA450196	1588	0.675
NULL	Chem_Rev_2011_Oct_12_111(10)_5899-5921.nxml.txt.nlp	21923193	SENT404	1	1	3	3	lipase	FAAH	PA450239	79152;2166	0.675
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT307	19	19	13	13	cisplatin	p38	PA449014	10598;1432;7965	0.675
NULL	Arthritis_Res_Ther_2014_Jul_18_16(4)_R153.nxml.txt.nlp	25037855	SENT98	6	6	15	15	adalimumab	CD14	PA10004	929	0.675
NULL	Oncol_Lett_2014_Nov_12_8(5)_2203-2208.nxml.txt.nlp	25295109	SENT174	4	4	9	9	celecoxib	PTCH1	PA448871	5727	0.675
NULL	J_Cancer_Prev_2014_Mar_19(1)_39-46.nxml.txt.nlp	25337571	SENT98	24	24	11	11	ethanol	p53	PA448073	7157	0.675
NULL	Int_J_Mol_Sci_2013_Apr_29_14(5)_9338-9364.nxml.txt.nlp	23629668	SENT1172	36	36	3	3	cetuximab	CD133	PA10040	8842	0.675
NULL	Cell_Death_Dis_2010_Nov_18_1(11)_e102.nxml.txt.nlp	21368867	SENT10	0	0	16	16	gentamicin	14-3-3	PA449753	10971	0.675
NULL	J_Biol_Chem_2008_May_30_283(22)_15309-15318.nxml.txt.nlp	18362142	SENT86	24	24	4	4	paraformaldehyde	IL-17A	PA450790	3605	0.675
NULL	EMBO_Mol_Med_2012_Jun_13_4(6)_515-527.nxml.txt.nlp	22416035	SENT148	17	17	12	12	olaparib	p53		7157	0.675
NULL	Oncol_Lett_2013_Feb_7_5(2)_440-446.nxml.txt.nlp	23420122	SENT150	12	12	16	16	gemcitabine	AKT	PA449748	207	0.675
NULL	Cancers_(Basel)_2013_Jan_21_5(1)_64-91.nxml.txt.nlp	24216699	SENT49	0	0	3	3	cetuximab	EGFR	PA10040	1956	0.675
NULL	Ther_Clin_Risk_Manag_2006_Dec_2(4)_365-375.nxml.txt.nlp	18360649	SENT114	4	4	14	14	abatacept	ACR	PA164747080	49	0.675
NULL	Nucleic_Acids_Res_2005_Jun_8_33(10)_3283-3291.nxml.txt.nlp	15944449	SENT169	12	12	15	15	sjg-136	XPB		2071	0.675
NULL	Cent_European_J_Urol_2013_Apr_26_66(1)_39-44.nxml.txt.nlp	24578986	SENT87	21	21	23	23	doxorubicin	ADM	PA449412	133	0.675
NULL	Indian_J_Pharmacol_2014_Nov-Dec_46(6)_627-632.nxml.txt.nlp	25538335	SENT114	11	11	9	9	metformin	Q10	PA450395	27161	0.675
NULL	Breast_Cancer_Res_2007_Aug_8_9(4)_R50.nxml.txt.nlp	17686159	SENT172	4	4	6	6	gefitinib	HRG	PA131301952	3084;3273	0.675
NULL	Reprod_Biol_Endocrinol_2004_Aug_4_2_59.nxml.txt.nlp	15294019	SENT117	3	3	5	5	forskolin	EGF	PA146096022	1950	0.675
NULL	J_Gynecol_Oncol_2013_Apr_5_24(2)_177-185.nxml.txt.nlp	23653836	SENT192	19	19	40	40	cisplatin	AMH	PA449014	268	0.675
NULL	Nat_Genet_2011_Oct_9_43(11)_1066-1073.nxml.txt.nlp	21983784	SENT283	10	10	5	5	paraformaldehyde	NOD2	PA450790	64127	0.675
NULL	Int_J_Endocrinol_Metab_2013_Jul_1_Summer_11(3)_184-190.nxml.txt.nlp	24348591	SENT156	25	25	8	8	liraglutide	INS-1	PA165958364	2305	0.675
NULL	Cardiovasc_Diabetol_2005_Oct_5_4_16.nxml.txt.nlp	16207378	SENT24	7	7	18	18	glucosamine	GFAT	PA164747613	2673	0.675
NULL	Br_J_Cancer_2010_Oct_26_103(9)_1380-1390.nxml.txt.nlp	20877355	SENT214	8	8	12	12	etoposide	TRAIL	PA449552	8743	0.675
NULL	Front_Oncol_2014_Sep_15_4_244.nxml.txt.nlp	25309870	SENT90	9	9	11	11	erlotinib	EGFR	PA134687924	1956	0.675
NULL	Br_J_Cancer_2010_Nov_2_103(11)_1671-1679.nxml.txt.nlp	21045835	SENT207	7	7	16	16	gemcitabine	CXCL12	PA449748	6387	0.675
NULL	Genet_Mol_Biol_2010_Dec_1_Oct-Dec_33(4)_756-760.nxml.txt.nlp	21637587	SENT31	0	0	2	2	bleomycin	BLM	PA448645	641	0.675
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Apr_23_64(Pt_5)_o895.nxml.txt.nlp	21202378	SENT3	25	25	17	17	phenol	mol	PA450913	90527	0.675
NULL	Mol_Med_Rep_2015_Feb_29_11(2)_924-930.nxml.txt.nlp	25351620	SENT47	17	17	13	13	streptomycin	FBS	PA451512	64319;26269	0.675
NULL	Oncol_Rep_2014_Jan_13_31(1)_376-383.nxml.txt.nlp	24220856	SENT13	29	29	8	8	paclitaxel	PA1	PA450761	79447	0.675
NULL	J_Hepatol_2010_Sep_53(3-2)_519-527.nxml.txt.nlp	20579762	SENT283	32	32	15	15	collagenase	p38	PA449107	10598;1432;7965	0.675
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_321-328.nxml.txt.nlp	21372824	SENT173	43	43	16	16	fluvastatin	STZ	PA449688	6484	0.675
NULL	Orphanet_J_Rare_Dis_2013_Apr_19_8_60.nxml.txt.nlp	23601510	SENT168	11	11	20	20	glucosamine	GNE	PA164747613	10020	0.675
NULL	Diabetes_2008_Sep_57(9)_2272-2279.nxml.txt.nlp	18519799	SENT207	5	5	18	18	rosiglitazone	CO2	PA451283	4513	0.675
NULL	Environ_Health_Perspect_2009_Feb_26_117(2)_254-260.nxml.txt.nlp	19270796	SENT208	24	24	30	30	creatine	AGAT	PA164778930	2628	0.675
NULL	Mol_Cancer_2012_Jun_26_11_43.nxml.txt.nlp	22731636	SENT119	9	9	31	31	pp2	p38		10598;1432;7965	0.675
NULL	Cell_Commun_Signal_2013_Dec_23_11_100.nxml.txt.nlp	24364863	SENT183	28	28	17	17	pp2	EGFR		1956	0.675
NULL	Cancer_Metab_2013_Jan_23_1_3.nxml.txt.nlp	24280005	SENT226	37	37	9	9	ethanol	SREBP1	PA448073	6720	0.675
NULL	Clin_Microbiol_Infect_2014_Jun_21_20(6)_536-541.nxml.txt.nlp	24107197	SENT41	24	24	19	19	isoniazid	DST	PA450112	667	0.675
NULL	Mol_Cancer_2010_Apr_23_9_87.nxml.txt.nlp	20416058	SENT259	12	12	30	30	doxorubicin	TRAIL	PA449412	8743	0.675
NULL	Enzyme_Res_2009_Nov_1_2010_165878.nxml.txt.nlp	21048860	SENT5	16	16	24	24	l-methionine	NAC	PA450423	22861	0.675
NULL	J_Basic_Clin_Pharm_2010_Mar_15_1(2)_115-118.nxml.txt.nlp	24825976	SENT0	25	25	21	21	lornoxicam	FOR	PA165958395	51741	0.674
NULL	J_Adv_Pract_Oncol_2014_May_1_May-Jun_5(3)_205-210.nxml.txt.nlp	25089219	SENT85	7	7	2	2	capecitabine	DPD	PA448771	1806	0.674
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_17_2013_514719.nxml.txt.nlp	23843876	SENT128	20	20	10	10	docetaxel	LC3	PA449383	84557	0.674
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT157	8	8	31	31	pp2	PP2		4888	0.674
NULL	J_Asthma_Allergy_2013_Feb_22_6_31-39.nxml.txt.nlp	23459334	SENT116	8	8	25	25	rupatadine	ANOVA		4858	0.674
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_May_8_66(Pt_6)_m617.nxml.txt.nlp	21579276	SENT65	25	25	5	5	ethanol	NO3	PA448073	4681	0.674
NULL	Clin_Med_Insights_Arthritis_Musculoskelet_Disord_2012_Jan_5_5_1-14.nxml.txt.nlp	22267947	SENT53	15	15	26	26	risedronate	HIP	PA451255	6767;6159;64399;5068	0.674
NULL	Daru_2012_Sep_3_20(1)_24.nxml.txt.nlp	23351176	SENT188	12	12	7	7	itopride	EPO	PA152432599	7076;8288;2056	0.674
NULL	Curr_Infect_Dis_Rep_2010_Mar_24_12(2)_126-133.nxml.txt.nlp	20461117	SENT105	18	18	8	8	imiquimod	CO2	PA449972	4513	0.674
NULL	Oncol_Lett_2014_Jan_11_7(1)_156-158.nxml.txt.nlp	24348840	SENT38	25	25	7	7	vindesine	CHOP	PA10232	1649	0.674
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT12	3	3	5	5	tacrolimus	RANKL	PA451578	8600	0.674
NULL	Case_Rep_Obstet_Gynecol_2012_Sep_4_2012_485452.nxml.txt.nlp	22988533	SENT63	19	19	34	34	hydroxocobalamin	B12	PA164768689	7126;4709	0.674
NULL	Front_Immunol_2014_Feb_10_5_23.nxml.txt.nlp	24575090	SENT60	7	7	24	24	hydrocortisone	CD95	PA449905	355	0.674
NULL	J_Inherit_Metab_Dis_2014_Feb_14_37(5)_801-812.nxml.txt.nlp	24526388	SENT123	10	10	16	16	zonisamide	ACTH	PA451978	5443	0.674
NULL	Genetics_2015_Jan_13_199(1)_247-262.nxml.txt.nlp	25398792	SENT350	35	35	11	11	galactose	GAL	PA449725	51083	0.674
NULL	Case_Rep_Oncol_Med_2014_Dec_23_2014_597291.nxml.txt.nlp	25587475	SENT125	23	23	26	26	melphalan	TNF-alpha	PA450354	7124	0.674
NULL	Oncol_Rep_2012_Oct_13_28(4)_1146-1152.nxml.txt.nlp	22797812	SENT102	5	5	7	7	doxorubicin	ADM	PA449412	133	0.674
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT303	8	8	13	13	risperidone	PRL	PA451257	5617	0.674
NULL	Exp_Ther_Med_2013_Dec_26_6(6)_1359-1364.nxml.txt.nlp	24255662	SENT160	4	4	12	12	dexmedetomidine	IL-6	PA449256	3569	0.674
NULL	Mol_Pain_2013_Jun_10_9_27.nxml.txt.nlp	23758830	SENT77	26	26	5	5	tetracaine	ASIC3	PA451638	9311	0.674
NULL	Basic_Res_Cardiol_2012_Sep_4_107(5)_276.nxml.txt.nlp	22760499	SENT205	10	10	14	14	creatine	GAMT	PA164778930	2593	0.674
NULL	Ann_Rheum_Dis_2014_Jun_30_73(6)_990-999.nxml.txt.nlp	24482301	SENT86	18	18	27	27	methotrexate	UST	PA450428	10090	0.674
NULL	Indian_J_Pharmacol_2014_Nov-Dec_46(6)_608-612.nxml.txt.nlp	25538331	SENT8	22	22	12	12	gentamicin	gamma	PA449753	9913	0.674
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Apr_13_68(Pt_5)_o1347.nxml.txt.nlp	22590243	SENT66	23	23	9	9	ethanol	mol	PA448073	90527	0.674
NULL	Curr_Gerontol_Geriatr_Res_2010_Jun_20_2010_348174.nxml.txt.nlp	20672050	SENT57	38	38	33	33	gefitinib	EGFR	PA131301952	1956	0.674
NULL	AIDS_2013_Sep_24_27(15)_2413-2423.nxml.txt.nlp	24037210	SENT298	13	13	5	5	efavirenz	CYP2B6	PA449441	1555	0.674
NULL	J_Cell_Sci_2014_Nov_1_127(21)_4728-4739.nxml.txt.nlp	25179605	SENT82	15	15	17	17	bortezomib	BTZ	PA10252	22794	0.674
NULL	Biomed_Res_Int_2014_Jun_3_2014_757219.nxml.txt.nlp	24991566	SENT401	32	32	9	9	betaine	LOX	PA448603	4015	0.674
NULL	J_Thromb_Haemost_2007_May_5(5)_1010-1018.nxml.txt.nlp	17355572	SENT14	4	4	20	20	thrombin	VWF	PA451674	7450	0.674
NULL	Neural_Regen_Res_2013_Jul_15_8(20)_1853-1862.nxml.txt.nlp	25206494	SENT137	18	18	5	5	ethanol	p53	PA448073	7157	0.674
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT263	7	7	9	9	resveratrol	TRAIL		8743	0.674
NULL	Biotechnol_Res_Int_2013_Dec_1_2013_253286.nxml.txt.nlp	24363937	SENT120	13	13	15	15	urea	DAP	PA451831	23549;3375;1611	0.674
NULL	Clinics_(Sao_Paulo)_2013_May_68(5)_694-701.nxml.txt.nlp	23778405	SENT188	22	22	33	33	curcumin	survivin	PA151958596	332	0.674
NULL	Arch_Med_Sci_2013_Apr_20_9(2)_361-367.nxml.txt.nlp	23671450	SENT126	7	7	11	11	budesonide	HIF-1	PA448681	29072	0.674
NULL	Front_Neurol_2014_May_9_5_69.nxml.txt.nlp	24847308	SENT139	21	21	34	34	curcumin	ANOVA	PA151958596	4858	0.674
NULL	Diabetes_Care_2012_Feb_16_35(2)_299-304.nxml.txt.nlp	22266734	SENT170	12	12	1	1	metformin	Gen	PA450395	348654	0.674
NULL	J_Cardiothorac_Surg_2012_Sep_27_7_97.nxml.txt.nlp	23013706	SENT146	25	25	18	18	warfarin	CYP4F2	PA451906	8529	0.674
NULL	Cancer_Cell_Int_2012_Jun_18_12_30.nxml.txt.nlp	22709569	SENT98	19	19	2	2	doxorubicin	CALM1	PA449412	801	0.674
NULL	Clin_Med_Insights_Case_Rep_2012_Feb_16_5_13-17.nxml.txt.nlp	22399868	SENT30	4	4	24	24	adalimumab	CD4	PA10004	920	0.674
NULL	Clin_Dev_Immunol_2011_Dec_5_2011_894704.nxml.txt.nlp	22190975	SENT233	2	2	4	4	alemtuzumab	CD52	PA164783958	1043	0.674
NULL	Croat_Med_J_2014_Jun_55(3)_206-217.nxml.txt.nlp	24891279	SENT154	26	26	13	13	doxorubicin	SDH	PA449412	1757;10993	0.674
NULL	Acta_Pharmacol_Sin_2009_Dec_4_30(12)_1674-1687.nxml.txt.nlp	19960012	SENT352	11	11	21	21	lipase	FBA	PA450239	26273	0.674
NULL	Diabetes_2008_Sep_57(9)_2272-2279.nxml.txt.nlp	18519799	SENT134	3	3	32	32	rosiglitazone	PDK4	PA451283	5166	0.674
NULL	Biologics_2010_Dec_2_4_315-323.nxml.txt.nlp	21209726	SENT163	12	12	28	28	imatinib	CML	PA10804	613	0.674
NULL	BMJ_Open_2014_Oct_31_4(10)_e005762.nxml.txt.nlp	25361836	SENT207	2	2	7	7	capecitabine	HER2	PA448771	2064	0.674
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Jul_11_70(Pt_8)_m296-m297.nxml.txt.nlp	25249880	SENT4	12	12	15	15	benzaldehyde	mol	PA448571	90527	0.674
NULL	J_Immunotoxicol_2013_Jan_11_10(1)_75-82.nxml.txt.nlp	22967038	SENT101	10	10	15	15	rituximab	IFN	PA451261	3439	0.674
NULL	Breast_Cancer_Res_2011_Jun_29_13(3)_R70.nxml.txt.nlp	21707964	SENT192	16	16	24	24	tamoxifen	14-3-3	PA451581	10971	0.674
NULL	Exp_Ther_Med_2013_Jun_2_5(6)_1701-1709.nxml.txt.nlp	23837058	SENT278	18	18	3	3	cisplatin	HK1	PA449014	3098;51361;3739	0.674
NULL	Support_Care_Cancer_2012_Jul_27_20(7)_1353-1360.nxml.txt.nlp	22539050	SENT140	3	3	0	0	denosumab	NNT	PA166048634	23530	0.674
NULL	Mol_Cell_Proteomics_2012_Feb_6_11(2)_M111_015222.nxml.txt.nlp	22147731	SENT313	4	4	6	6	cetuximab	CCDC50	PA10040	152137	0.674
NULL	Comp_Hepatol_2005_Feb_8_4_2.nxml.txt.nlp	15701172	SENT160	17	17	15	15	ketoconazole	CYP3A	PA450146	1574	0.674
NULL	Br_J_Cancer_2011_Apr_12_104(8)_1256-1261.nxml.txt.nlp	21448165	SENT114	18	18	20	20	sorafenib	IL-2	PA7000	3558	0.674
NULL	Brain_Res_2013_Jul_12_1521(100)_1-15.nxml.txt.nlp	22789905	SENT70	21	21	4	4	colchicine	P-gp	PA449092	5243	0.674
NULL	ScientificWorldJournal_2013_Sep_19_2013_809891.nxml.txt.nlp	24170983	SENT133	2	2	7	7	dexketoprofen	CD80	PA166049175	941	0.674
NULL	Exp_Hematol_Oncol_2012_Sep_11_1_27.nxml.txt.nlp	23210501	SENT59	0	0	9	9	lenalidomide	CD28	PA162363968	1493;940	0.674
NULL	Free_Radic_Biol_Med_2013_Aug_61(100)_438-452.nxml.txt.nlp	23608463	SENT117	7	7	14	14	apomorphine	SOD1	PA164781163	6647	0.674
NULL	Oncotarget_2014_Sep_10_5(20)_9877-9888.nxml.txt.nlp	25245676	SENT23	10	10	2	2	cetuximab	EGFR	PA10040	1956	0.674
NULL	Blood_Cancer_J_2013_Oct_18_3(10)_e153.nxml.txt.nlp	24141622	SENT92	19	19	15	15	fludarabine	XIAP	PA449655	331	0.674
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT219	21	21	34	34	paclitaxel	B7-H1	PA450761	29126	0.674
NULL	Acta_Pharmacol_Sin_2011_Nov_10_32(11)_1402-1410.nxml.txt.nlp	21986579	SENT205	8	8	30	30	curcumin	CDK2	PA151958596	1017	0.674
NULL	Clin_Interv_Aging_2012_Sep_17_7_363-372.nxml.txt.nlp	23049248	SENT54	9	9	7	7	denosumab	RANKL	PA166048634	8600	0.674
NULL	Evid_Based_Complement_Alternat_Med_2014_May_8_2014_364819.nxml.txt.nlp	24899907	SENT235	8	8	3	3	tacrolimus	FKBP52	PA451578	2288	0.674
NULL	Cell_Death_Dis_2013_Jan_31_4(1)_e480.nxml.txt.nlp	23370280	SENT119	40	40	35	35	cisplatin	WWOX	PA449014	51741	0.674
NULL	Brain_Stimul_2014_Mar_7(2)_252-259.nxml.txt.nlp	24439959	SENT35	29	29	25	25	lamotrigine	DPD	PA450164	1806	0.674
NULL	Genome_Biol_2003_Jan_30_4(2)_305.nxml.txt.nlp	12620114	SENT145	42	42	26	26	geldanamycin	Hsp90	PA152031327	3320	0.674
NULL	Indian_J_Endocrinol_Metab_2012_Dec_16(Suppl_2)_S294-S296.nxml.txt.nlp	23565404	SENT41	3	3	1	1	estradiol	PRL	PA449503	5617	0.674
NULL	Breast_Cancer_Res_2008_Jul_24_10(4)_211.nxml.txt.nlp	18671839	SENT97	0	0	10	10	bortezomib	HER2	PA10252	2064	0.674
NULL	Chin_J_Cancer_2012_Feb_31(2)_73-99.nxml.txt.nlp	22098950	SENT84	18	18	12	12	methotrexate	TPT	PA450428	23590;6469	0.674
NULL	Clin_Psychopharmacol_Neurosci_2011_Apr_30_9(1)_36-43.nxml.txt.nlp	23431025	SENT94	3	3	9	9	haloperidol	FLI	PA449841	2314	0.674
NULL	J_Cardiothorac_Surg_2012_Sep_27_7_97.nxml.txt.nlp	23013706	SENT178	19	19	9	9	warfarin	CYP4F2	PA451906	8529	0.674
NULL	Eur_J_Clin_Pharmacol_2010_Feb_17_66(2)_165-170.nxml.txt.nlp	19838691	SENT134	16	16	8	8	midazolam	CYP3A	PA450496	1574	0.674
NULL	Asian_J_Androl_2014_Jan_17_Mar-Apr_16(2)_274-279.nxml.txt.nlp	24457841	SENT89	35	35	22	22	dutasteride	ARIA	PA164749300	641700	0.674
NULL	Exp_Diabetes_Res_2012_Nov_1_2012_892706.nxml.txt.nlp	23197976	SENT161	12	12	4	4	vildagliptin	GLP-1	PA165958346	100125288	0.674
NULL	Atherosclerosis_2011_Nov_219(1)_109-115.nxml.txt.nlp	21820657	SENT183	21	21	29	29	probucol	CETP	PA451107	1071	0.674
NULL	Int_J_Mol_Sci_2014_Nov_17_15(11)_21270-21285.nxml.txt.nlp	25407530	SENT353	4	4	18	18	collagenase	c-Jun	PA449107	3725	0.674
NULL	J_Cancer_Res_Clin_Oncol_2011_Feb_11_137(2)_183-192.nxml.txt.nlp	21069385	SENT31	24	24	34	34	trastuzumab	HER2	PA451743	2064	0.674
NULL	Breast_Cancer_2012_Oct_19_19(4)_302-308.nxml.txt.nlp	22711317	SENT59	6	6	25	25	estradiol	RANK	PA449503	8792	0.674
NULL	Breast_Cancer_Res_2002_Jun_21_4(5)_R9.nxml.txt.nlp	12223126	SENT16	19	19	7	7	tamoxifen	FasL	PA451581	356	0.674
NULL	Endocrinology_2014_Oct_22_155(10)_3732-3738.nxml.txt.nlp	25051442	SENT117	19	19	21	21	sibutramine	ARC	PA451344	8996;23237	0.674
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Sep_12_65(Pt_10)_o2446.nxml.txt.nlp	21577901	SENT57	4	4	7	7	coumarin	mol	PA134521193	90527	0.674
NULL	Indian_J_Ophthalmol_2010_May-Jun_58(3)_232-234.nxml.txt.nlp	20413928	SENT36	4	4	9	9	triamcinolone	hole	PA451749	80757	0.674
NULL	Am_J_Trop_Med_Hyg_2014_Jul_2_91(1)_3-4.nxml.txt.nlp	24752685	SENT17	5	5	9	9	primaquine	G6PD	PA451103	2539	0.674
NULL	Arthritis_Res_Ther_2005_Feb_17_7(Suppl_1)_P81.nxml.txt.nlp	NULL	SENT14	3	3	5	5	etanercept	RANKL	PA449515	8600	0.674
NULL	Breast_Cancer_Res_2004_Jun_29_6(5)_R488-R498.nxml.txt.nlp	15318931	SENT193	18	18	32	32	tamoxifen	SULT	PA451581	6816	0.674
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT190	10	10	14	14	phenprocoumon	CYP2C9	PA450921	1559	0.674
NULL	Eur_J_Med_Res_2009_Nov_24_14(Suppl_3)_22-29.nxml.txt.nlp	19959413	SENT6	25	25	19	19	raltegravir	CD4		920	0.674
NULL	J_Infect_Dis_2013_Sep_1_208(5)_801-812.nxml.txt.nlp	23766527	SENT121	20	20	4	4	chloroquine	LUM	PA448948	4060	0.674
NULL	ScientificWorldJournal_2012_May_1_2012_412580.nxml.txt.nlp	22623896	SENT96	11	11	3	3	octreotide	SSTR3	PA450678	6753	0.674
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jan_11_68(Pt_2)_o315.nxml.txt.nlp	22346950	SENT63	19	19	6	6	ethanol	mol	PA448073	90527	0.674
NULL	Clin_Dev_Immunol_2011_Oct_20_2011_947858.nxml.txt.nlp	22046194	SENT134	23	23	16	16	dasatinib	NKG2D	PA162372878	22914	0.674
NULL	Drugs_Context_2012_Nov_19_2012_212242.nxml.txt.nlp	24432031	SENT306	21	21	17	17	vemurafenib	IL-2	PA165946873	3558	0.674
NULL	Eur_J_Histochem_2010_Mar_20_54(1)_e7.nxml.txt.nlp	20353914	SENT23	37	37	39	39	dextran	mol	PA449261	90527	0.674
NULL	Clin_Microbiol_Infect_2014_Jun_21_20(6)_536-541.nxml.txt.nlp	24107197	SENT114	12	12	16	16	isoniazid	DST	PA450112	667	0.674
NULL	Oncol_Lett_2014_Mar_16_7(3)_827-833.nxml.txt.nlp	24527090	SENT39	12	12	9	9	cisplatin	IFN	PA449014	3439	0.674
NULL	Br_J_Cancer_1994_Mar_69(3)_537-540.nxml.txt.nlp	8123484	SENT8	10	10	21	21	cisplatin	GM-CSF	PA449014	1437	0.674
NULL	Biosci_Rep_2014_Aug_6_34(4)_e00131.nxml.txt.nlp	24975826	SENT153	11	11	26	26	pp2	TRPA1		8989	0.674
NULL	Ann_Hematol_2010_Sep_13_89(9)_861-871.nxml.txt.nlp	20387067	SENT144	29	29	33	33	dasatinib	CD34	PA162372878	947	0.674
NULL	Br_J_Cancer_1999_Feb_79(3-4)_393-400.nxml.txt.nlp	10027304	SENT10	0	0	8	8	indomethacin	p53	PA449982	7157	0.674
NULL	J_Clin_Biochem_Nutr_2011_Mar_29_48(2)_122-125.nxml.txt.nlp	21373264	SENT41	12	12	23	23	alendronate	ghrelin	PA448082	51738	0.674
NULL	Br_J_Cancer_2009_Jan_13_100(1)_19-23.nxml.txt.nlp	19018262	SENT74	3	3	5	5	bevacizumab	EGFR	PA130232992	1956	0.674
NULL	Cent_European_J_Urol_2013_Apr_26_66(1)_39-44.nxml.txt.nlp	24578986	SENT87	26	26	13	13	cyclophosphamide	ACT	PA449165	12;11332;9457;641455	0.674
NULL	Environ_Health_Perspect_2008_Mar_26_116(3)_322-328.nxml.txt.nlp	18335098	SENT24	29	29	23	23	estradiol	FES	PA449503	2242	0.674
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1224-1233.nxml.txt.nlp	22353810	SENT193	7	7	19	19	etoposide	MRP-1	PA449552	928	0.674
NULL	J_Invest_Dermatol_2012_Sep_10_132(9)_2255-2262.nxml.txt.nlp	22572817	SENT93	29	29	34	34	forskolin	MC1R	PA146096022	4157	0.674
NULL	Breast_Cancer_Res_2008_Dec_9_10(Suppl_1)_S3.nxml.txt.nlp	19091007	SENT170	12	12	1	1	estradiol	FES	PA449503	2242	0.674
NULL	Exp_Cell_Res_2011_Apr_15_317(7)_1028-1039.nxml.txt.nlp	21237154	SENT250	25	25	23	23	staurosporine	TRAIL	PA165109623	8743	0.674
NULL	Ann_Oncol_2012_Dec_2_23(12)_3007-3016.nxml.txt.nlp	22865781	SENT113	18	18	6	6	trastuzumab	HER2	PA451743	2064	0.674
NULL	Front_Psychol_2012_Aug_17_3_297.nxml.txt.nlp	22912626	SENT245	9	9	12	12	imipramine	HDAC5	PA449969	10014	0.674
NULL	Osteoporos_Int_2011_May_30_22(5)_1513-1523.nxml.txt.nlp	21052641	SENT234	2	2	5	5	estradiol	aromatase	PA449503	1588	0.674
NULL	Emerg_Infect_Dis_2013_Jan_19(1)_133-136.nxml.txt.nlp	23260464	SENT54	14	14	24	24	cefepime	TOB	PA164754876	10140	0.674
NULL	Sci_Rep_2015_Jan_22_5_7955.nxml.txt.nlp	25609008	SENT223	15	15	38	38	paraformaldehyde	ZO-1	PA450790	7082	0.674
NULL	Mol_Cancer_2006_Oct_17_5_45.nxml.txt.nlp	17044934	SENT35	9	9	14	14	resveratrol	COX		1351	0.674
NULL	J_Cardiovasc_Magn_Reson_2008_Jan_22_10(1)_5.nxml.txt.nlp	18272009	SENT68	5	5	28	28	trastuzumab	HER2	PA451743	2064	0.674
NULL	Cancer_Manag_Res_2011_Aug_10_3_273-285.nxml.txt.nlp	21931501	SENT318	11	11	15	15	sunitinib	IFN	PA162372840	3439	0.674
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT271	30	30	17	17	phenprocoumon	CALU	PA450921	813	0.674
NULL	Acta_Pharmacol_Sin_2011_Oct_12_32(10)_1259-1265.nxml.txt.nlp	21909126	SENT125	8	8	13	13	simvastatin	MCP-1	PA451363	6347	0.674
NULL	Diabetol_Metab_Syndr_2014_Dec_2_6(1)_132.nxml.txt.nlp	NULL	SENT64	25	25	11	11	heparin	adiponectin	PA449855	9370	0.674
NULL	Indian_J_Pharmacol_2012_Sep-Oct_44(5)_624-628.nxml.txt.nlp	23112426	SENT4	3	3	7	7	pravastatin	P-gp	PA451089	5243	0.674
NULL	Oncotarget_2013_Nov_24_4(12)_2186-2207.nxml.txt.nlp	24327604	SENT119	21	21	18	18	bortezomib	P-gp	PA10252	5243	0.674
NULL	J_Cancer_Prev_2014_Jun_19(2)_111-117.nxml.txt.nlp	25337579	SENT151	4	4	13	13	bortezomib	AKR1B10	PA10252	57016	0.674
NULL	Structure_2013_Sep_3_21(9)_1648-1658.nxml.txt.nlp	23932590	SENT131	18	18	13	13	mitomycin	FANCD2	PA450524	2177	0.674
NULL	Diabetes_2013_Jun_17_62(6)_2141-2150.nxml.txt.nlp	23378610	SENT117	14	14	11	11	betaine	BHMT	PA448603	635	0.674
NULL	ScientificWorldJournal_2012_Dec_17_2012_916381.nxml.txt.nlp	23319889	SENT6	9	9	26	26	ceftriaxone	CTX	PA448866	1593	0.674
NULL	Int_J_Surg_Oncol_2012_Aug_9_2012_246290.nxml.txt.nlp	22928098	SENT14	21	21	12	12	cisplatin	BIN1	PA449014	274	0.674
NULL	Oncol_Rep_2014_Aug_12_32(2)_469-474.nxml.txt.nlp	24926795	SENT28	6	6	4	4	cisplatin	OCT3	PA449014	5460;6581	0.674
NULL	Cell_Oncol_(Dordr)_2011_Apr_11_34(2)_89-95.nxml.txt.nlp	21394646	SENT145	32	32	8	8	trastuzumab	HER2	PA451743	2064	0.674
NULL	Acta_Pharmacol_Sin_2010_Feb_5_31(2)_137-144.nxml.txt.nlp	20139896	SENT174	4	4	7	7	zileuton	ROS	PA451955	6098	0.674
NULL	Diabetes_Care_2009_Nov_32(Suppl_2)_S342-S348.nxml.txt.nlp	19875578	SENT114	27	27	44	44	exenatide	GLP-1	PA164749238	100125288	0.674
NULL	Arthritis_Res_Ther_2005_Feb_21_7(3)_R439-R444.nxml.txt.nlp	15899030	SENT34	10	10	15	15	infliximab	TP2	PA452639	7015;7142	0.674
NULL	ScientificWorldJournal_2012_Jul_31_2012_475675.nxml.txt.nlp	22919323	SENT39	29	29	8	8	metformin	TORC2	PA450395	200186	0.674
NULL	J_Cardiothorac_Surg_2013_Nov_18_8_214.nxml.txt.nlp	24245511	SENT61	25	25	16	16	potassium	BDM	PA451047	625	0.674
NULL	J_Lipid_Res_2013_Nov_54(11)_3085-3097.nxml.txt.nlp	23883581	SENT221	11	11	22	22	pp2	MEK1		5604	0.674
NULL	Curr_Neuropharmacol_2009_Jun_7(2)_83-95.nxml.txt.nlp	19949566	SENT445	38	38	32	32	topiramate	TGB	PA451728	5473	0.674
NULL	Scientifica_(Cairo)_2013_Dec_30_2013_637629.nxml.txt.nlp	24490108	SENT251	16	16	12	12	neomycin	PSMB9	PA450608	5698	0.674
NULL	Adv_Urol_2011_Oct_20_2011_854792.nxml.txt.nlp	22046183	SENT247	17	17	9	9	indinavir	CD4	PA449977	920	0.674
NULL	Acta_Pharmacol_Sin_2011_Nov_10_32(11)_1402-1410.nxml.txt.nlp	21986579	SENT205	8	8	37	37	curcumin	p27	PA151958596	5715;10534	0.674
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT72	6	6	1	1	pp2	PP2		4888	0.674
NULL	Cell_Commun_Signal_2014_Mar_10_12_13.nxml.txt.nlp	24606867	SENT81	9	9	13	13	lipase	TCPTP	PA450239	5771	0.674
NULL	Environ_Health_Perspect_2008_Mar_26_116(3)_322-328.nxml.txt.nlp	18335098	SENT247	8	8	12	12	estradiol	PMI	PA449503	8834;5373	0.674
NULL	Oncotarget_2014_Sep_8_5(20)_9619-9625.nxml.txt.nlp	25294813	SENT62	23	23	10	10	trastuzumab	TAZ	PA451743	25937;6901	0.674
NULL	Curr_Neuropharmacol_2013_Dec_11(6)_652-663.nxml.txt.nlp	24396340	SENT537	15	15	12	12	forskolin	TRPV1	PA146096022	7442	0.674
NULL	Int_J_Biomed_Imaging_2007_Apr_24_2007_13963.nxml.txt.nlp	17710251	SENT60	16	16	10	10	flumazenil	FDG	PA449659	23583	0.674
NULL	Oncotarget_2013_Nov_23_5(1)_196-210.nxml.txt.nlp	24344116	SENT76	6	6	21	21	doxorubicin	ICAM1	PA449412	3383	0.674
NULL	Air_Qual_Atmos_Health_2010_Mar_4_3(1)_29-39.nxml.txt.nlp	20376166	SENT36	16	16	33	33	ethanol	MASP	PA448073	5648	0.674
NULL	Front_Neural_Circuits_2010_Apr_22_4_11.nxml.txt.nlp	20461235	SENT606	3	3	13	13	riluzole	TRAAK	PA451251	50801	0.674
NULL	Oncotarget_2011_Sep_9_2(9)_658-668.nxml.txt.nlp	21911919	SENT106	19	19	23	23	daunorubicin	NAC	PA449212	22861	0.674
NULL	Acta_Pharmacol_Sin_2010_Sep_2_31(9)_1172-1180.nxml.txt.nlp	20676117	SENT101	3	3	16	16	bsi-201	PARP1		142	0.674
NULL	Acta_Pharmacol_Sin_2014_Aug_21_35(8)_994-1004.nxml.txt.nlp	25042549	SENT16	33	33	30	30	pravastatin	PCSK9	PA451089	255738	0.674
NULL	Int_J_Mol_Sci_2013_Aug_14_14(8)_16719-16731.nxml.txt.nlp	23949634	SENT26	0	0	21	21	thrombin	RhoA	PA451674	387	0.674
NULL	Eur_J_Nutr_2013_Feb_3_52(1)_203-215.nxml.txt.nlp	22302614	SENT236	13	13	8	8	genistein	DPD	PA165109660	1806	0.674
NULL	Clin_Med_Insights_Arthritis_Musculoskelet_Disord_2012_Jan_5_5_1-14.nxml.txt.nlp	22267947	SENT102	19	19	5	5	alendronate	FACT	PA448082	11198	0.674
NULL	Cardiovasc_Diabetol_2013_Oct_17_12_150.nxml.txt.nlp	24134550	SENT137	29	29	13	13	pioglitazone	activin	PA450970	83729	0.674
NULL	Indian_J_Pharmacol_2014_Nov-Dec_46(6)_590-595.nxml.txt.nlp	25538328	SENT124	28	28	26	26	colchicine	IL-6	PA449092	3569	0.674
NULL	J_Thromb_Haemost_2011_May_9(5)_979-986.nxml.txt.nlp	21251205	SENT138	30	30	6	6	thrombin	mol	PA451674	90527	0.674
NULL	J_Mol_Signal_2012_Aug_16_7_12.nxml.txt.nlp	22898329	SENT138	33	33	2	2	oxaliplatin	NOXA	PA131285527	5366	0.674
NULL	Front_Oncol_2013_Sep_4_3_212.nxml.txt.nlp	24027671	SENT261	16	16	20	20	rituximab	PRIMA	PA451261	145270	0.674
NULL	J_Adv_Pract_Oncol_2014_May_1_May-Jun_5(3)_205-210.nxml.txt.nlp	25089219	SENT65	16	16	10	10	capecitabine	DPD	PA448771	1806	0.674
NULL	Int_J_Ion_Mobil_Spectrom_2009_Aug_1_12(3)_91-102.nxml.txt.nlp	20835390	SENT154	13	13	17	17	glucosamine	mol	PA164747613	90527	0.674
NULL	J_Cell_Biol_2000_Jul_10_150(1)_13-26.nxml.txt.nlp	10893252	SENT252	18	18	33	33	phosphorus	ESI	PA450954	5266	0.674
NULL	Front_Oncol_2014_Jun_18_4_159.nxml.txt.nlp	24995161	SENT38	23	23	32	32	estradiol	AKR1C3	PA449503	8644	0.674
NULL	J_Cell_Biol_1994_Feb_1_124(3)_273-287.nxml.txt.nlp	8294512	SENT3	34	34	32	32	choline	CDP	PA448976	1523	0.674
NULL	Osteoporos_Int_2011_Jan_1_22(1)_27-35.nxml.txt.nlp	20358360	SENT66	24	24	26	26	pamidronate	PTH	PA450767	5741	0.674
NULL	Curr_Neuropharmacol_2009_Jun_7(2)_83-95.nxml.txt.nlp	19949566	SENT453	38	38	32	32	topiramate	TGB	PA451728	5473	0.674
NULL	Environ_Health_Perspect_2007_Apr_8_115(4)_586-591.nxml.txt.nlp	17450228	SENT184	23	23	36	36	arsenite	RAGE	PA452638	177	0.674
NULL	Sleep_Disord_2014_Jul_10_2014_767181.nxml.txt.nlp	25126427	SENT109	11	11	15	15	levodopa	LDE	PA450213	7957	0.674
NULL	Pharmaceutics_2011_Feb_7_3(1)_53-72.nxml.txt.nlp	24310425	SENT200	27	27	0	0	ondansetron	CYP2D6	PA450705	1565	0.674
NULL	Arch_Med_Sci_2012_Feb_29_8(1)_138-153.nxml.txt.nlp	22457688	SENT192	27	27	13	13	trypsin	MetRS	PA451806	4141	0.674
NULL	Sensors_(Basel)_2013_Dec_27_14(1)_458-467.nxml.txt.nlp	24379050	SENT106	15	15	12	12	glucose	MTB	PA449773	54892;4498	0.674
NULL	Mol_Cell_Biol_2013_Oct_33(20)_4041-4050.nxml.txt.nlp	23959798	SENT150	24	24	10	10	hydroxyurea	CTR1	PA449942	1317	0.674
NULL	Oncotarget_2014_Sep_29_5(20)_10084-10099.nxml.txt.nlp	25275296	SENT70	6	6	13	13	bortezomib	HAX1	PA10252	10456	0.674
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_13_2014_849783.nxml.txt.nlp	25477998	SENT145	5	5	7	7	isoproterenol	Bcl-2	PA450121	596	0.674
NULL	Indian_J_Pharm_Sci_2014_Mar-Apr_76(2)_125-131.nxml.txt.nlp	24843185	SENT164	24	24	27	27	resveratrol	S100B		6285	0.674
NULL	Mol_Cancer_2012_Jul_12_11_45.nxml.txt.nlp	22788833	SENT9	24	24	15	15	cisplatin	EGFR	PA449014	1956	0.674
NULL	Exp_Lung_Res_2013_Oct_1_39(8)_336-348.nxml.txt.nlp	23919450	SENT98	2	2	4	4	thrombin	PAR-1	PA451674	2011;2149	0.674
NULL	Br_J_Cancer_2012_Jan_31_106(3)_482-489.nxml.txt.nlp	22233925	SENT167	10	10	15	15	carboplatin	PEO1	PA448803	56652	0.674
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT236	32	32	15	15	risperidone	PRL	PA451257	5617	0.674
NULL	J_Gastrointest_Surg_2012_Apr_13_16(4)_842-848.nxml.txt.nlp	22246855	SENT96	21	21	15	15	oxaliplatin	BTC	PA131285527	685	0.674
NULL	Trials_2014_Sep_7_15(1)_352.nxml.txt.nlp	NULL	SENT6	31	31	36	36	atorvastatin	PMI	PA448500	8834;5373	0.674
NULL	Br_J_Cancer_1998_Apr_77(8)_1311-1317.nxml.txt.nlp	9579838	SENT20	28	28	13	13	tamoxifen	IL-2	PA451581	3558	0.674
NULL	J_Korean_Med_Sci_2010_Aug_21_25(8)_1222-1227.nxml.txt.nlp	20676337	SENT153	24	24	21	21	aminophylline	LPA	PA164781029	4018	0.674
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT186	30	30	9	9	phenprocoumon	VKORC1	PA450921	79001	0.674
NULL	Ann_Gen_Psychiatry_2007_Oct_9_6_27.nxml.txt.nlp	17925035	SENT272	14	14	12	12	chlorpromazine	Gen	PA448964	348654	0.674
NULL	J_Int_AIDS_Soc_2011_Feb_9_14_7.nxml.txt.nlp	21306608	SENT74	42	42	23	23	ritonavir	ATV	PA451260	4683	0.674
NULL	Oncotarget_2012_May_18_3(5)_525-534.nxml.txt.nlp	22619113	SENT89	28	28	17	17	fludarabine	RPS14	PA449655	6208	0.674
NULL	Nucleic_Acids_Res_2011_Mar_4_39(5)_1843-1854.nxml.txt.nlp	21051342	SENT197	13	13	10	10	carbenicillin	IFN	PA448788	3439	0.674
NULL	Indian_J_Ophthalmol_2013_May_61(5)_235-237.nxml.txt.nlp	23619488	SENT41	4	4	20	20	fluorescein	hole	PA164746009	80757	0.674
NULL	Case_Rep_Surg_2012_Oct_3_2012_670289.nxml.txt.nlp	23091767	SENT23	18	18	35	35	rituximab	ABO	PA451261	28	0.674
NULL	AIDS_Res_Ther_2014_Aug_4_11_25.nxml.txt.nlp	25120580	SENT19	0	0	17	17	voriconazole	CYP3A4	PA10233	1576	0.674
NULL	Oncogene_2013_Sep_26_32(39)_10_1038_onc_2012_491.nxml.txt.nlp	23108394	SENT244	4	4	2	2	epirubicin	FOXM1	PA449476	2305	0.674
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT102	4	4	28	28	imatinib	ABCB1	PA10804	5243	0.674
NULL	ARYA_Atheroscler_2012_Winter_7(4)_133-137.nxml.txt.nlp	23205044	SENT97	2	2	18	18	atorvastatin	CD40	PA448500	958	0.674
NULL	Int_J_Mol_Sci_2012_Sep_26_13(10)_12336-12348.nxml.txt.nlp	23202901	SENT94	11	11	21	21	phenol	P90	PA450913	821	0.674
NULL	Int_J_Surg_Oncol_2012_Jun_12_2012_862879.nxml.txt.nlp	22778941	SENT7	27	27	22	22	cisplatin	BIN1	PA449014	274	0.674
NULL	J_Biomed_Biotechnol_2011_Jan_26_2011_797383.nxml.txt.nlp	21331361	SENT373	27	27	14	14	milrinone	gamma	PA164749171	9913	0.674
NULL	Front_Endocrinol_(Lausanne)_2014_Oct_2_5_158.nxml.txt.nlp	25324831	SENT145	7	7	10	10	carrageenan	NPFF	PA448814	8620	0.674
NULL	Eur_J_Clin_Pharmacol_2014_Oct_8_70(12)_1433-1441.nxml.txt.nlp	25291992	SENT140	2	2	8	8	olanzapine	OCM	PA450688	654231	0.674
NULL	Clin_Ophthalmol_2007_Sep_1(3)_347-351.nxml.txt.nlp	19668494	SENT24	7	7	15	15	bevacizumab	San	PA130232992	80218	0.674
NULL	Reprod_Biol_Endocrinol_2004_Jul_5_2_48.nxml.txt.nlp	15236654	SENT76	32	32	12	12	estradiol	EGF	PA449503	1950	0.674
NULL	Crit_Care_2003_Mar_3_7(Suppl_2)_P003.nxml.txt.nlp	NULL	SENT10	7	7	0	0	estradiol	Men	PA449503	8178	0.674
NULL	Anesth_Essays_Res_2013_May-Aug_7(2)_178-182.nxml.txt.nlp	NULL	SENT111	7	7	20	20	fentanyl	CO2	PA449599	4513	0.674
NULL	ARYA_Atheroscler_2012_Winter_7(4)_133-137.nxml.txt.nlp	23205044	SENT75	6	6	17	17	pentoxifylline	p50	PA450864	958;4790	0.674
NULL	JRSM_Short_Rep_2012_Feb_14_3(2)_10.nxml.txt.nlp	22393471	SENT39	8	8	0	0	clarithromycin	CHOP	PA449028	1649	0.674
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT44	9	9	22	22	trastuzumab	HER-2	PA451743	2064	0.674
NULL	BMB_Rep_2014_Jan_47(1)_33-38.nxml.txt.nlp	24209634	SENT82	9	9	6	6	cisplatin	CXCR4	PA449014	7852	0.674
NULL	J_Neuroinflammation_2011_Feb_7_8_11.nxml.txt.nlp	21299846	SENT210	18	18	28	28	forskolin	ANOVA	PA146096022	4858	0.674
NULL	Biologics_2012_Dec_17_6_429-464.nxml.txt.nlp	23269860	SENT11	15	15	18	18	infliximab	ACR	PA452639	49	0.674
NULL	J_Korean_Med_Sci_2013_Feb_29_28(2)_308-314.nxml.txt.nlp	23399960	SENT152	15	15	18	18	gabapentin	IL-10	PA449720	3586	0.674
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2007_Dec_21_64(Pt_1)_o313.nxml.txt.nlp	21200875	SENT59	35	35	29	29	acetone	mol	PA448025	90527	0.674
NULL	Springerplus_2013_Jul_3_2_299.nxml.txt.nlp	23888270	SENT179	31	31	34	34	nadh	SDHB	PA164755085	6390	0.674
NULL	Int_J_Mol_Sci_2014_Jun_5_15(6)_10083-10100.nxml.txt.nlp	24905407	SENT104	24	24	28	28	tetracycline	STP	PA451640	9322	0.674
NULL	Environ_Health_Perspect_2011_Mar_10_119(3)_357-363.nxml.txt.nlp	21362589	SENT147	13	13	9	9	picrotoxin	RDX	PA164777007	5962	0.674
NULL	Front_Mol_Neurosci_2012_Nov_12_5_99.nxml.txt.nlp	23162427	SENT258	20	20	7	7	cocaine	HDAC5	PA449072	10014	0.674
NULL	Front_Endocrinol_(Lausanne)_2011_Dec_21_2_84.nxml.txt.nlp	22654830	SENT23	26	26	28	28	lipase	ATGL	PA450239	57104	0.674
NULL	Biomed_Res_Int_2014_Aug_6_2014_967826.nxml.txt.nlp	25165721	SENT239	18	18	2	2	cisplatin	IL-10	PA449014	3586	0.674
NULL	Cancer_Cell_Int_2006_Mar_23_6_6.nxml.txt.nlp	16556298	SENT8	5	5	10	10	docetaxel	FDG	PA449383	23583	0.674
NULL	J_Biomed_Biotechnol_2010_Mar_21_2010_923193.nxml.txt.nlp	20339517	SENT30	34	34	39	39	cyclosporine	IL-2	PA449167	3558	0.674
NULL	Mol_Pain_2013_Jun_10_9_27.nxml.txt.nlp	23758830	SENT76	12	12	7	7	tetracaine	ASIC3	PA451638	9311	0.674
NULL	Arthritis_Res_Ther_2013_Mar_4_15(2)_R39.nxml.txt.nlp	23497717	SENT88	27	27	34	34	imiquimod	San	PA449972	80218	0.674
NULL	Breast_Cancer_(Auckl)_2009_Sep_2_3_61-75.nxml.txt.nlp	19809577	SENT101	8	8	5	5	curcumin	BRCA1	PA151958596	672	0.674
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1449-1456.nxml.txt.nlp	24077631	SENT105	9	9	6	6	tolbutamide	CYP2C9	PA451718	1559	0.674
NULL	J_Cell_Biol_2001_Oct_1_155(1)_133-144.nxml.txt.nlp	11581290	SENT196	16	16	34	34	pp2	PP2		4888	0.674
NULL	J_Young_Pharm_2011_Apr-Jun_3(2)_97-104.nxml.txt.nlp	21731353	SENT194	3	3	17	17	glipizide	CS3	PA449762	91977	0.674
NULL	Nat_Chem_2011_Nov_20_4(2)_99-104.nxml.txt.nlp	22270625	SENT80	7	7	18	18	fluorescein	p53	PA164746009	7157	0.674
NULL	Patient_Prefer_Adherence_2011_Dec_23_6_1-9.nxml.txt.nlp	22272064	SENT10	0	0	2	2	telmisartan	ACE	PA451605	1636	0.674
NULL	Mol_Cancer_2009_Dec_23_8_129.nxml.txt.nlp	20030852	SENT196	1	1	10	10	curcumin	ABCA1	PA151958596	19	0.674
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Jun_27_5_15.nxml.txt.nlp	16803618	SENT244	0	0	3	3	flucloxacillin	LTA	PA164781042	4049	0.674
NULL	Cardiovasc_Diabetol_2013_Oct_17_12_150.nxml.txt.nlp	24134550	SENT15	9	9	4	4	pioglitazone	activin	PA450970	83729	0.674
NULL	Acta_Pharmacol_Sin_2012_May_4_33(5)_710-716.nxml.txt.nlp	22555373	SENT115	6	6	9	9	phenylbutazone	DOM	PA450932	6663	0.674
NULL	Diabetes_2011_May_23_60(5)_1458-1466.nxml.txt.nlp	21464445	SENT250	25	25	29	29	lipase	ATGL	PA450239	57104	0.674
NULL	Environ_Health_Perspect_2010_Sep_28_118(9)_1267-1272.nxml.txt.nlp	20427257	SENT203	33	33	10	10	estradiol	BPA	PA449503	667	0.674
NULL	F1000Prime_Rep_2014_Aug_1_6_68.nxml.txt.nlp	25165567	SENT191	8	8	18	18	risperidone	Gen	PA451257	348654	0.674
NULL	Iran_Red_Crescent_Med_J_2014_Mar_5_16(3)_e15344.nxml.txt.nlp	24829782	SENT10	14	14	22	22	bumetanide	slim	PA448682	23008	0.674
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT228	23	23	18	18	perifosine	DR4	PA165291471	8797	0.674
NULL	Front_Endocrinol_(Lausanne)_2013_Jul_29_4_94.nxml.txt.nlp	23908645	SENT131	7	7	15	15	estradiol	UGT2B17	PA449503	7367	0.674
NULL	Oxid_Med_Cell_Longev_2013_Apr_28_2013_702120.nxml.txt.nlp	23738040	SENT108	24	24	10	10	hydroquinone	MC1R	PA449924	4157	0.674
NULL	Front_Oncol_2014_Mar_6_4_40.nxml.txt.nlp	24639951	SENT47	30	30	20	20	ifosfamide	ETO	PA449964	862	0.674
NULL	Nat_Med_2010_Jun_23_16(6)_671-677.nxml.txt.nlp	20495567	SENT243	25	25	8	8	sorafenib	ATF5	PA7000	22809	0.674
NULL	Case_Rep_Med_2013_Dec_4_2013_250716.nxml.txt.nlp	24368917	SENT4	1	1	17	17	ethanol	CYP2E1	PA448073	1571	0.674
NULL	Cell_Death_Dis_2010_Jul_1_1(7)_e51.nxml.txt.nlp	21364656	SENT78	3	3	12	12	gentamicin	survivin	PA449753	332	0.674
NULL	New_Microbes_New_Infect_2014_May_4_2(3)_58-63.nxml.txt.nlp	25356345	SENT100	46	46	20	20	tigecycline	GEM	PA164746412	2669	0.674
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Apr_29_67(Pt_5)_o1215.nxml.txt.nlp	21754513	SENT70	16	16	19	19	benzaldehyde	mol	PA448571	90527	0.674
NULL	Int_J_Anal_Chem_2013_Jul_16_2013_419716.nxml.txt.nlp	23956748	SENT65	8	8	29	29	heparin	PF6	PA449855	200162	0.674
NULL	Korean_J_Thorac_Cardiovasc_Surg_2014_Jun_5_47(3)_249-254.nxml.txt.nlp	25207222	SENT129	7	7	21	21	remifentanil	AVP	PA451232	114548;551	0.674
NULL	Target_Oncol_2013_Jun_27_8(2)_127-136.nxml.txt.nlp	23625191	SENT22	37	37	33	33	panitumumab	KRAS	PA162373091	3845	0.673
NULL	Mol_Cell_Biochem_2013_Jun_20_378(1-2)_257-266.nxml.txt.nlp	23512522	SENT67	22	22	30	30	l-glutamine	CO2	PA10090	4513	0.673
NULL	Int_J_Nanomedicine_2008_Sep_3(3)_359-372.nxml.txt.nlp	18990945	SENT285	16	16	25	25	methylprednisolone	CDP	PA450466	1523	0.673
NULL	Cancers_(Basel)_2010_Dec_22_2(4)_2153-2170.nxml.txt.nlp	21390244	SENT604	22	22	28	28	erlotinib	EGFR	PA134687924	1956	0.673
NULL	J_Hematol_Oncol_2011_Jan_21_4_5.nxml.txt.nlp	21255411	SENT159	2	2	4	4	paclitaxel	EGFR	PA450761	1956	0.673
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2675-2684.nxml.txt.nlp	24129246	SENT198	37	37	35	35	etoposide	DBC1	PA449552	57805;1620	0.673
NULL	J_Biol_Chem_2009_Mar_27_284(13)_8395-8405.nxml.txt.nlp	19144645	SENT242	9	9	22	22	tetracycline	GAL4	PA451640	3960	0.673
NULL	Ann_Rehabil_Med_2012_Aug_27_36(4)_561-564.nxml.txt.nlp	22977784	SENT48	23	23	17	17	clonazepam	LAS	PA449050	11019	0.673
NULL	Front_Immunol_2013_Mar_8_4_50.nxml.txt.nlp	23483669	SENT177	9	9	4	4	tocilizumab	IL-6	PA165292659	3569	0.673
NULL	Oncol_Rep_2013_Apr_23_29(4)_1268-1274.nxml.txt.nlp	23354756	SENT101	13	13	6	6	trastuzumab	SLC25A43	PA451743	203427	0.673
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT146	19	19	10	10	gefitinib	KRAS	PA131301952	3845	0.673
NULL	Drugs_2012_Sep_6_72(9)_e1-e25.nxml.txt.nlp	22686620	SENT1060	8	8	24	24	etravirine	TRIO	PA166014703	7204	0.673
NULL	Diabetes_Care_2013_Jul_12_36(7)_1913-1918.nxml.txt.nlp	23359361	SENT85	41	41	18	18	sitagliptin	GLP-1	PA164748978	100125288	0.673
NULL	Breast_Cancer_Res_2011_Apr_14_13(2)_R43.nxml.txt.nlp	21492444	SENT152	6	6	8	8	tamoxifen	PAX2	PA451581	5076	0.673
NULL	Mol_Vis_2007_Feb_22_13_243-251.nxml.txt.nlp	17356511	SENT334	17	17	4	4	triamcinolone	KGA	PA451749	3760	0.673
NULL	Cardiol_Res_Pract_2011_Aug_15_2011_156146.nxml.txt.nlp	21876822	SENT195	23	23	26	26	potassium	KIR	PA451047	2669	0.673
NULL	Braz_J_Med_Biol_Res_2012_Jul_20_45(10)_935-941.nxml.txt.nlp	22801415	SENT175	7	7	9	9	pioglitazone	ghrelin	PA450970	51738	0.673
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1676-1682.nxml.txt.nlp	19844234	SENT147	15	15	10	10	lapatinib	IGF1R	PA152241907	3480	0.673
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT147	42	42	31	31	pp2	PP2		4888	0.673
NULL	Indian_J_Ophthalmol_2011_May-Jun_59(3)_197-200.nxml.txt.nlp	21586839	SENT25	8	8	38	38	phenylephrine	San	PA450935	80218	0.673
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Feb_27_66(Pt_3)_o714-o715.nxml.txt.nlp	21580452	SENT82	3	3	19	19	pefloxacin	mol	PA164742856	90527	0.673
NULL	Mol_Biol_Cell_2012_Sep_1_23(17)_3473-3484.nxml.txt.nlp	22787275	SENT188	33	33	36	36	doxorubicin	ABCC1	PA449412	4363	0.673
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1013.nxml.txt.nlp	24457957	SENT309	24	24	12	12	orlistat	NOXA	PA164776864	5366	0.673
NULL	J_Cancer_Prev_2014_Mar_19(1)_39-46.nxml.txt.nlp	25337571	SENT12	0	0	8	8	ethanol	p53	PA448073	7157	0.673
NULL	Emerg_Infect_Dis_2011_Mar_17(3)_510-513.nxml.txt.nlp	21392446	SENT53	26	26	16	16	ofloxacin	EMB	PA450684	133418	0.673
NULL	Osteoporos_Int_2012_Jan_28_23(1)_213-221.nxml.txt.nlp	21953472	SENT31	12	12	39	39	denosumab	PTH	PA166048634	5741	0.673
NULL	Int_J_Endocrinol_2014_Aug_11_2014_312452.nxml.txt.nlp	25183970	SENT159	11	11	16	16	liraglutide	PI3K	PA165958364	5290	0.673
NULL	Diabetes_Care_2013_Jul_12_36(7)_2098-2106.nxml.txt.nlp	23695817	SENT288	11	11	9	9	liraglutide	GLP-1	PA165958364	100125288	0.673
NULL	Arthritis_Rheumatol_2014_Jun_27_66(6)_1574-1582.nxml.txt.nlp	24577881	SENT105	11	11	20	20	hydralazine	CD28	PA449894	1493;940	0.673
NULL	Mol_Biol_Cell_2014_Jan_1_25(1)_145-159.nxml.txt.nlp	24196833	SENT250	18	18	10	10	valinomycin	Fis1	PA151917011	51024	0.673
NULL	BMB_Rep_2014_Jul_47(7)_376-381.nxml.txt.nlp	24286332	SENT6	5	5	3	3	thrombin	PPG	PA451674	5552	0.673
NULL	Basic_Clin_Pharmacol_Toxicol_2013_Feb_5_112(2)_132-137.nxml.txt.nlp	22900583	SENT25	25	25	13	13	prasugrel	CYP3A	PA154410481	1574	0.673
NULL	Cancer_Cell_Int_2010_Jul_8_10_23.nxml.txt.nlp	20615241	SENT61	10	10	24	24	erlotinib	BAR	PA134687924	154;51283	0.673
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT23	17	17	4	4	trastuzumab	STAT3	PA451743	6774	0.673
NULL	Eur_J_Neurosci_2011_Mar_33(5)_914-922.nxml.txt.nlp	21255131	SENT117	21	21	13	13	pentobarbital	gamma	PA450859	9913	0.673
NULL	Br_J_Cancer_2010_Dec_7_103(12)_1822-1830.nxml.txt.nlp	21063405	SENT158	19	19	33	33	cisplatin	NBS1	PA449014	55655	0.673
NULL	Arch_Orthop_Trauma_Surg_2009_Nov_7_129(11)_1495-1504.nxml.txt.nlp	18989686	SENT216	8	8	11	11	vancomycin	VISA	PA451850	57506	0.673
NULL	Breast_Cancer_Res_2012_Jul_19_14(4)_R109.nxml.txt.nlp	22812567	SENT296	23	23	20	20	gemcitabine	RRM2	PA449748	6241	0.673
NULL	Curr_Cardiol_Rev_2012_Nov_8(4)_253-264.nxml.txt.nlp	22920475	SENT171	4	4	6	6	verapamil	TXNIP	PA451868	10628	0.673
NULL	Biomed_Res_Int_2014_Jun_3_2014_757219.nxml.txt.nlp	24991566	SENT419	36	36	2	2	betaine	APX	PA448603	328	0.673
NULL	Oncogene_2010_Sep_23_29(38)_5286-5298.nxml.txt.nlp	20603611	SENT154	20	20	33	33	paraformaldehyde	San	PA450790	80218	0.673
NULL	Ann_Rheum_Dis_2014_Mar_11_73(3)_536-543.nxml.txt.nlp	23316080	SENT87	5	5	10	10	adalimumab	ACR	PA10004	49	0.673
NULL	Ann_Rheum_Dis_2009_Dec_4_68(12)_1870-1877.nxml.txt.nlp	19124524	SENT160	36	36	16	16	methotrexate	ACR	PA450428	49	0.673
NULL	Clin_Pharmacol_2012_Feb_20_4_13-20.nxml.txt.nlp	22427735	SENT84	23	23	7	7	clopidogrel	PON1	PA449053	5444	0.673
NULL	Ital_J_Pediatr_2014_Feb_13_40_17.nxml.txt.nlp	24524345	SENT99	17	17	6	6	methylprednisolone	CHP	PA450466	11261	0.673
NULL	J_Int_Soc_Sports_Nutr_2013_Aug_22_10_39.nxml.txt.nlp	23967897	SENT34	28	28	12	12	s-adenosylmethionine	Met	PA164754994	79811	0.673
NULL	Allergy_Asthma_Immunol_Res_2014_Nov_19_6(6)_548-557.nxml.txt.nlp	25374755	SENT88	6	6	27	27	lovastatin	IL-6	PA450272	3569	0.673
NULL	Ther_Clin_Risk_Manag_2006_Sep_2(3)_303-308.nxml.txt.nlp	18360605	SENT39	3	3	10	10	frovatriptan	5-HT7	PA164754891	3363	0.673
NULL	Springerplus_2013_Feb_11_2_44.nxml.txt.nlp	23503672	SENT127	22	22	4	4	mannitol	fru	PA450320	9278	0.673
NULL	Br_J_Cancer_2014_Nov_25_111(11)_2091-2102.nxml.txt.nlp	25349971	SENT180	21	21	8	8	imatinib	PTPN18	PA10804	26469	0.673
NULL	Case_Rep_Ophthalmol_Med_2011_Jan_31_2011_679751.nxml.txt.nlp	22606470	SENT38	14	14	42	42	bevacizumab	hole	PA130232992	80757	0.673
NULL	Evid_Based_Complement_Alternat_Med_2012_May_7_2012_808979.nxml.txt.nlp	22611433	SENT56	27	27	29	29	ethambutol	EMB	PA164784021	133418	0.673
NULL	Front_Behav_Neurosci_2013_Dec_18_7_203.nxml.txt.nlp	24385956	SENT795	15	15	3	3	memantine	spatial	PA10364	219793	0.673
NULL	Indian_J_Dermatol_2013_Jul-Aug_58(4)_249-254.nxml.txt.nlp	23918993	SENT75	0	0	9	9	ketoconazole	CYP3A4	PA450146	1576	0.673
NULL	Oncogene_2014_Jul_17_33(29)_3784-3793.nxml.txt.nlp	24013225	SENT140	8	8	3	3	heparin	HBEGF	PA449855	1839	0.673
NULL	Front_Genet_2012_Oct_10_3_206.nxml.txt.nlp	23087703	SENT124	7	7	12	12	raloxifene	CYP2C19	PA451221	1557	0.673
NULL	Ann_Clin_Microbiol_Antimicrob_2014_Jan_6_13_2.nxml.txt.nlp	24393536	SENT42	24	24	14	14	meropenem	TOB	PA164764445	10140	0.673
NULL	Biologics_2010_Aug_9_4_173-185.nxml.txt.nlp	20714355	SENT266	24	24	16	16	cetuximab	gamma	PA10040	9913	0.673
NULL	Oncotarget_2013_Jul_7_4(7)_1065-1074.nxml.txt.nlp	23867252	SENT4	13	13	30	30	geldanamycin	Hsp90	PA152031327	3320	0.673
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT57	8	8	14	14	chloroquine	BMPR-II	PA448948	659	0.673
NULL	Curr_Opin_Endocrinol_Diabetes_Obes_2014_Feb_2_21(1)_15-21.nxml.txt.nlp	24296462	SENT27	13	13	3	3	dextran	CLEC7A	PA449261	64581	0.673
NULL	Mol_Syst_Biol_2010_Jul_27_6_391.nxml.txt.nlp	20664637	SENT185	12	12	23	23	sugar	IRF6	PA451529	3664	0.673
NULL	AMB_Express_2011_Sep_30_1_26.nxml.txt.nlp	21961566	SENT281	21	21	13	13	heparin	Gen	PA449855	348654	0.673
NULL	Clin_Ophthalmol_2007_Sep_1(3)_297-303.nxml.txt.nlp	19668484	SENT117	10	10	3	3	cyclosporine	MDR1	PA449167	5243	0.673
NULL	AIDS_Res_Ther_2009_Apr_9_6_3.nxml.txt.nlp	19358725	SENT115	18	18	10	10	zidovudine	ATV	PA451954	4683	0.673
NULL	Diabetes_2009_Feb_58(2)_344-351.nxml.txt.nlp	19008341	SENT216	16	16	3	3	resveratrol	SIRT1		23411	0.673
NULL	Oncol_Lett_2014_Jun_28_7(6)_1843-1846.nxml.txt.nlp	24932245	SENT49	5	5	13	13	cyclophosphamide	CHOP	PA449165	1649	0.673
NULL	Iran_J_Pharm_Res_2014_Winter_13(Suppl)_125-132.nxml.txt.nlp	24711838	SENT145	27	27	20	20	pilocarpine	CA1	PA450962	759	0.673
NULL	Basic_Clin_Neurosci_2014_Summer_5(3)_191-198.nxml.txt.nlp	25337379	SENT113	7	7	1	1	naloxone	ANOVA	PA450586	4858	0.673
NULL	Calcif_Tissue_Int_2013_Jan_13_92(1)_59-67.nxml.txt.nlp	23150144	SENT138	31	31	4	4	risedronate	BMD	PA451255	1756;7439	0.673
NULL	Blood_Cancer_J_2013_Oct_18_3(10)_e153.nxml.txt.nlp	24141622	SENT90	3	3	19	19	bortezomib	XIAP	PA10252	331	0.673
NULL	Clin_Med_Insights_Oncol_2012_Feb_28_6_125-135.nxml.txt.nlp	22408376	SENT66	23	23	29	29	irinotecan	KRAS	PA450085	3845	0.673
NULL	Alcohol_Res_2013_35(1)_25-35.nxml.txt.nlp	24313162	SENT143	4	4	8	8	ethanol	MTR	PA448073	4548	0.673
NULL	Oncoimmunology_2014_Jan_17_3_e27574.nxml.txt.nlp	24800167	SENT24	2	2	19	19	cyclophosphamide	CD103	PA449165	3682	0.673
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Oct_31_66(Pt_11)_m1490-m1491.nxml.txt.nlp	21588904	SENT62	14	14	5	5	lomefloxacin	NO3	PA164749165	4681	0.673
NULL	Mol_Cancer_2010_Nov_23_9_301.nxml.txt.nlp	21092273	SENT281	25	25	9	9	pentazocine	MCSP	PA164744326	1464;2879	0.673
NULL	Ann_Hematol_2012_Sep_28_91(9)_1499-1500.nxml.txt.nlp	22281990	SENT12	9	9	14	14	vincristine	CHOP	PA451879	1649	0.673
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT82	5	5	8	8	cisplatin	p53	PA449014	7157	0.673
NULL	J_Gen_Physiol_1970_Nov_1_56(5)_583-620.nxml.txt.nlp	5475997	SENT4	9	9	2	2	creatine	ADP	PA164778930	23038	0.673
NULL	Clin_Ophthalmol_2012_Aug_27_6_1373-1376.nxml.txt.nlp	22969281	SENT46	0	0	20	20	fluorescein	PED	PA164746009	8682	0.673
NULL	Mol_Clin_Oncol_2013_Jul_30_1(4)_655-660.nxml.txt.nlp	24649224	SENT199	34	34	22	22	methotrexate	CHOP	PA450428	1649	0.673
NULL	J_Ophthalmol_2011_Oct_20_2011_252549.nxml.txt.nlp	22046503	SENT144	30	30	6	6	bevacizumab	LOC387715	PA130232992	387715	0.673
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT38	4	4	9	9	curcumin	TRAIL	PA151958596	8743	0.673
NULL	Br_J_Cancer_2010_Jul_13_103(2)_265-274.nxml.txt.nlp	20551953	SENT202	4	4	6	6	cisplatin	JNK	PA449014	5599	0.673
NULL	J_Invest_Dermatol_2012_Sep_10_132(9)_2255-2262.nxml.txt.nlp	22572817	SENT157	11	11	21	21	forskolin	ASIP	PA146096022	434;56288	0.673
NULL	Hematol_Rep_2012_Dec_6_4(4)_e26.nxml.txt.nlp	23355944	SENT46	14	14	24	24	plerixafor	CD34	PA165958410	947	0.673
NULL	Breast_Cancer_(Auckl)_2009_Sep_2_3_61-75.nxml.txt.nlp	19809577	SENT111	19	19	12	12	curcumin	BRCA1	PA151958596	672	0.673
NULL	Iran_J_Pharm_Res_2014_Spring_13(2)_659-664.nxml.txt.nlp	25237362	SENT148	34	34	23	23	pantoprazole	NF-kappaB	PA450774	4790	0.673
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_75-89.nxml.txt.nlp	17912638	SENT372	33	33	7	7	tamoxifen	ATAC	PA451581	6375	0.673
NULL	Aging_(Albany_NY)_2010_Dec_8_2(12)_892-893.nxml.txt.nlp	21149896	SENT23	20	20	13	13	etoposide	p53	PA449552	7157	0.673
NULL	Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.nxml.txt.nlp	24736980	SENT181	26	26	28	28	rosuvastatin	OATP1B1	PA134308647	10599	0.673
NULL	Clin_Ophthalmol_2008_Jun_2(2)_355-368.nxml.txt.nlp	19668727	SENT215	11	11	17	17	ketorolac	PRK	PA450150	1263	0.673
NULL	Cerebrospinal_Fluid_Res_2007_Sep_20_4_8.nxml.txt.nlp	17883837	SENT364	16	16	25	25	amiloride	NHE	PA448368	285335	0.673
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2751-2762.nxml.txt.nlp	24169358	SENT181	0	0	23	23	fulvestrant	BAF47	PA164747170	6598	0.673
NULL	Mol_Cancer_2010_Mar_25_9_68.nxml.txt.nlp	20338046	SENT317	14	14	3	3	hyaluronan	MDR1	PA165958431	5243	0.673
NULL	Clin_Mol_Hepatol_2014_Sep_25_20(3)_291-299.nxml.txt.nlp	25320733	SENT186	21	21	7	7	tacrolimus	ACR	PA451578	49	0.673
NULL	Med_Sci_Monit_2013_Sep_9_19_751-756.nxml.txt.nlp	24019010	SENT18	12	12	14	14	lamivudine	LAM	PA450163	7249;7248	0.673
NULL	Breast_Cancer_Res_2010_Jun_24_12(3)_R41.nxml.txt.nlp	20576088	SENT253	7	7	33	33	paclitaxel	PPM1D	PA450761	8493	0.673
NULL	Indian_J_Med_Res_2013_Oct_138(4)_549-556.nxml.txt.nlp	24434263	SENT128	12	12	17	17	vancomycin	Gen	PA451850	348654	0.673
NULL	Mol_Cancer_2012_Jul_12_11_45.nxml.txt.nlp	22788833	SENT143	15	15	4	4	cisplatin	EGFR	PA449014	1956	0.673
NULL	Ann_Rheum_Dis_2008_Aug_29_67(8)_1096-1103.nxml.txt.nlp	18055472	SENT122	10	10	15	15	abatacept	ACR	PA164747080	49	0.673
NULL	Front_Cell_Neurosci_2014_Jun_25_8_167.nxml.txt.nlp	24987334	SENT2298	8	8	14	14	lorazepam	APOE	PA450267	348	0.673
NULL	Multidiscip_Respir_Med_2011_Oct_31_6(5)_270-271.nxml.txt.nlp	22958595	SENT2	25	25	19	19	methacholine	ACT	PA165958382	12;11332;9457;641455	0.673
NULL	J_Cell_Biol_2001_Jun_11_153(6)_1287-1300.nxml.txt.nlp	11402071	SENT529	12	12	22	22	paraformaldehyde	BAP31	PA450790	10134	0.673
NULL	Int_J_Mol_Sci_2014_Oct_31_15(11)_19791-19815.nxml.txt.nlp	25365172	SENT287	3	3	12	12	deferoxamine	p300	PA164746490	2033	0.673
NULL	Pharmaceuticals_(Basel)_2012_Nov_20_5(11)_1236-1264.nxml.txt.nlp	24281308	SENT918	5	5	3	3	pioglitazone	gamma	PA450970	9913	0.673
NULL	eLife_2013_Nov_5_2_e00969.nxml.txt.nlp	24192036	SENT168	2	2	6	6	vemurafenib	JNK	PA165946873	5599	0.673
NULL	Cancers_(Basel)_2014_Feb_13_6(1)_396-415.nxml.txt.nlp	24531055	SENT522	3	3	5	5	collagenase	MMP2	PA449107	4313	0.673
NULL	Crit_Care_2007_Mar_22_11(Suppl_2)_P360.nxml.txt.nlp	NULL	SENT18	10	10	17	17	etomidate	ACTH	PA164743987	5443	0.673
NULL	Archaea_2013_Jun_2_2013_104147.nxml.txt.nlp	23818813	SENT178	28	28	8	8	l-glutamine	F12	PA10090	2161	0.673
NULL	Parasit_Vectors_2010_Sep_6_3_83.nxml.txt.nlp	20819214	SENT32	2	2	6	6	artemisinin	ACT	PA165111696	12;11332;9457;641455	0.673
NULL	Cells_2014_May_23_3(2)_517-545.nxml.txt.nlp	24861977	SENT1073	3	3	5	5	gentamicin	TRPV1	PA449753	7442	0.673
NULL	Case_Rep_Oncol_2013_Jan_29_6(1)_72-77.nxml.txt.nlp	23466899	SENT106	13	13	19	19	paclitaxel	SPARC	PA450761	6678	0.673
NULL	Braz_J_Microbiol_2010_Jun_1_Apr-Jun_41(2)_452-460.nxml.txt.nlp	24031516	SENT121	20	20	27	27	ceftriaxone	STX	PA448866	8128	0.673
NULL	Iran_J_Pharm_Res_2013_Summer_12(3)_457-469.nxml.txt.nlp	24250652	SENT143	6	6	18	18	indomethacin	spatial	PA449982	219793	0.673
NULL	Exp_Ther_Med_2013_Nov_13_6(5)_1317-1321.nxml.txt.nlp	24223665	SENT110	13	13	20	20	curcumin	CD133	PA151958596	8842	0.673
NULL	BioDrugs_2013_Jun_7_27(6)_591-603.nxml.txt.nlp	23743670	SENT272	14	14	22	22	melphalan	gamma	PA450354	9913	0.673
NULL	Behav_Brain_Funct_2006_Aug_23_2_30.nxml.txt.nlp	16925830	SENT398	15	15	8	8	creatine	ADP	PA164778930	23038	0.673
NULL	Neuropsychopharmacology_2009_Jul_11_34(8)_1946-1957.nxml.txt.nlp	19279569	SENT170	17	17	38	38	cocaine	DOR	PA449072	58476	0.673
NULL	Emerg_Infect_Dis_2013_Nov_19(11)_1721-1730.nxml.txt.nlp	24207100	SENT134	20	20	26	26	ceftriaxone	VAN	PA448866	10318	0.673
NULL	J_Biol_Chem_2009_Jul_24_284(30)_20011-20021.nxml.txt.nlp	19473976	SENT187	3	3	18	18	trypsin	MCT1	PA451806	6566	0.673
NULL	Breast_Cancer_(Auckl)_2012_Nov_19_6_191-207.nxml.txt.nlp	23226023	SENT89	17	17	7	7	capecitabine	HER2	PA448771	2064	0.673
NULL	Iran_J_Psychiatry_Behav_Sci_2012_Autumn-Winter_6(2)_33-41.nxml.txt.nlp	24644480	SENT235	9	9	0	0	methamphetamine	San	PA450403	80218	0.673
NULL	Oncotarget_2013_Nov_22_5(4)_933-943.nxml.txt.nlp	24659749	SENT49	15	15	7	7	nutlin-3	AML2		864	0.673
NULL	Basic_Res_Cardiol_2012_Mar_11_107(2)_245.nxml.txt.nlp	22234702	SENT144	8	8	23	23	cocaine	AP-1	PA449072	2353;3727;2354;3725	0.673
NULL	Nat_Commun_2014_Nov_20_5_5481.nxml.txt.nlp	25410595	SENT125	20	20	32	32	l-glutamine	CO2	PA10090	4513	0.673
NULL	Neuroscience_2010_Feb_17_165(4)_1412-1419.nxml.txt.nlp	19961905	SENT146	0	0	11	11	capsaicin	TRPV1	PA448776	7442	0.673
NULL	Int_J_Mol_Sci_2014_Oct_23_15(10)_19265-19280.nxml.txt.nlp	25342321	SENT60	11	11	17	17	cisplatin	MVD	PA449014	4597	0.673
NULL	Neural_Plast_2007_Dec_11_2007_73079.nxml.txt.nlp	NULL	SENT151	13	13	15	15	clozapine	NOT	PA449061	4929	0.673
NULL	Eur_J_Med_Chem_2011_Nov_46(11)_5456-5464.nxml.txt.nlp	21940073	SENT88	11	11	25	25	cisplatin	CH1	PA449014	51430	0.673
NULL	Indian_Dermatol_Online_J_2010_Jul-Dec_1(1)_14-17.nxml.txt.nlp	23130185	SENT12	17	17	13	13	lapatinib	EGFR	PA152241907	1956	0.673
NULL	J_Hum_Kinet_2013_Dec_31_39_137-145.nxml.txt.nlp	24511349	SENT12	32	32	47	47	creatine	ADP	PA164778930	23038	0.673
NULL	J_Cell_Mol_Med_2014_Apr_20_18(4)_709-720.nxml.txt.nlp	24444314	SENT213	7	7	9	9	metformin	Met	PA450395	79811	0.673
NULL	Front_Chem_2014_Dec_23_2_113.nxml.txt.nlp	25566531	SENT669	0	0	24	24	curcumin	Rho	PA151958596	29984	0.673
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT380	5	5	3	3	pp2	PP1		5540;5464	0.673
NULL	Nat_Commun_2012_Jun_12_3_902.nxml.txt.nlp	22692545	SENT59	45	45	40	40	lipase	HSL	PA450239	3991	0.673
NULL	Indian_J_Pharm_Sci_2013_May-Jun_75(3)_277-283.nxml.txt.nlp	24082343	SENT165	6	6	18	18	dextran	GIT	PA449261	5034	0.673
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT277	16	16	3	3	metformin	HIF-1	PA450395	29072	0.673
NULL	Infect_Dis_Ther_2014_Dec_5_3(2)_69-81.nxml.txt.nlp	25475412	SENT80	6	6	24	24	vancomycin	DAP	PA451850	23549;3375;1611	0.673
NULL	BMB_Rep_2013_Apr_46(4)_181-187.nxml.txt.nlp	23615258	SENT722	0	0	19	19	metformin	LKB1	PA450395	6794	0.673
NULL	Clin_Infect_Dis_2011_Mar_15_52(6)_717-725.nxml.txt.nlp	21293047	SENT235	3	3	27	27	glibenclamide	CXCR2	PA449782	3579	0.673
NULL	Oncotarget_2014_Aug_4_5(17)_7843-7857.nxml.txt.nlp	25151659	SENT198	29	29	19	19	creatine	Q10	PA164778930	27161	0.673
NULL	Int_J_Biomed_Sci_2006_Jun_2(2)_114-120.nxml.txt.nlp	23674973	SENT111	12	12	24	24	hydrocortisone	IFN	PA449905	3439	0.673
NULL	Cardiovasc_Res_2010_Jul_1_87(1)_60-72.nxml.txt.nlp	20110334	SENT120	18	18	12	12	propranolol	SCN5A	PA451145	6331	0.673
NULL	Anc_Sci_Life_2013_Jan_32(Suppl_2)_S7.nxml.txt.nlp	NULL	SENT9	43	43	35	35	curcumin	CO2	PA151958596	4513	0.673
NULL	Evid_Based_Complement_Alternat_Med_2004_Jun_1(1)_83-91.nxml.txt.nlp	15257329	SENT119	18	18	12	12	ginseng	SKT	PA164781150	56243	0.673
NULL	J_Gen_Physiol_2009_Jun_133(6)_623-625.nxml.txt.nlp	19468076	SENT26	0	0	3	3	menthol	TRPA1	PA164776605	8989	0.673
NULL	J_Breast_Cancer_2012_Dec_31_15(4)_388-392.nxml.txt.nlp	23346166	SENT45	15	15	36	36	paraformaldehyde	San	PA450790	80218	0.673
NULL	Br_J_Cancer_2002_Jan_21_86(2)_218-221.nxml.txt.nlp	11870509	SENT61	6	6	8	8	tamoxifen	BRCA1	PA451581	672	0.673
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2675-2684.nxml.txt.nlp	24129246	SENT278	13	13	2	2	etoposide	KSR1	PA449552	8844	0.673
NULL	Indian_J_Med_Res_2011_Apr_133(4)_434-441.nxml.txt.nlp	21537099	SENT32	15	15	10	10	cyclosporine	EGF	PA449167	1950	0.673
NULL	Ann_Rheum_Dis_2014_Oct_29_73(10)_1906-1908.nxml.txt.nlp	25074690	SENT32	24	24	17	17	rituximab	ACR	PA451261	49	0.673
NULL	Physiol_Rep_2014_Sep_11_2(9)_e12144.nxml.txt.nlp	25214522	SENT182	2	2	38	38	resveratrol	RVR		9975	0.673
NULL	Kidney_Int_Suppl_(2011)_2013_Dec_27_3(4)_372-376.nxml.txt.nlp	25019022	SENT90	29	29	14	14	simvastatin	SHARP	PA451363	23013	0.673
NULL	Arthritis_Res_Ther_2013_Nov_1_15(6)_R176.nxml.txt.nlp	24456929	SENT80	31	31	37	37	pp2	San		80218	0.673
NULL	Exp_Diabetes_Res_2012_Nov_14_2012_386524.nxml.txt.nlp	23213322	SENT100	1	1	7	7	troglitazone	adiponectin	PA451799	9370	0.673
NULL	Protein_Cell_2014_Jun_19_5(6)_469-479.nxml.txt.nlp	24748116	SENT160	8	8	6	6	paclitaxel	EB1	PA450761	9167;22919;10982	0.673
NULL	Br_J_Pharmacol_2014_Jun_15_171(11)_2705-2725.nxml.txt.nlp	24467436	SENT8	14	14	17	17	hydralazine	NAT1	PA449894	9;1982	0.673
NULL	Structure_2013_Jun_4_21(6)_986-996.nxml.txt.nlp	23665168	SENT215	19	19	38	38	nadh	DYRK1A	PA164755085	1859	0.673
NULL	Breast_Cancer_Res_2010_Aug_23_12(4)_R64.nxml.txt.nlp	20731819	SENT15	1	1	20	20	tamoxifen	MAF	PA451581	4094	0.673
NULL	Int_J_Biol_Sci_2013_Nov_21_9(10)_1089-1098.nxml.txt.nlp	24339730	SENT183	25	25	17	17	genistein	COL16A1	PA165109660	1307	0.673
NULL	Contemp_Oncol_(Pozn)_2012_Jul_6_16(3)_197-200.nxml.txt.nlp	23788878	SENT79	14	14	11	11	pazopanib	VEGFR	PA165291492	3791	0.673
NULL	Curr_Neuropharmacol_2008_Jun_6(2)_151-163.nxml.txt.nlp	19305794	SENT52	5	5	12	12	capsaicin	CA1	PA448776	759	0.673
NULL	Breast_Cancer_Res_2000_Jul_11_2(6)_423-429.nxml.txt.nlp	11250736	SENT101	42	42	27	27	estradiol	pS2	PA449503	7031	0.673
NULL	Ann_Hematol_2014_Sep_10_93(1)_1-11.nxml.txt.nlp	24018623	SENT177	0	0	17	17	lenalidomide	IL-6	PA162363968	3569	0.673
NULL	J_Young_Pharm_2011_Apr-Jun_3(2)_97-104.nxml.txt.nlp	21731353	SENT194	3	3	13	13	glipizide	CS1	PA449762	57823	0.673
NULL	J_Cell_Biol_1982_Oct_1_95(1)_118-126.nxml.txt.nlp	6292232	SENT3	36	36	24	24	hydrocortisone	EGF	PA449905	1950	0.673
NULL	Cancer_Immunol_Immunother_2012_Jul_23_61(7)_1101-1111.nxml.txt.nlp	22193989	SENT171	0	0	3	3	oxaliplatin	STAT1	PA131285527	6772	0.673
NULL	J_Inflamm_(Lond)_2008_Dec_5_5_23.nxml.txt.nlp	19061493	SENT193	0	0	12	12	hemin	HO-1	PA449849	3162	0.673
NULL	Korean_J_Anesthesiol_2013_Dec_26_65(6)_501-507.nxml.txt.nlp	24427455	SENT44	17	17	25	25	neostigmine	NMB	PA450611	10457;4828	0.673
NULL	Br_J_Cancer_2013_Aug_6_109(3)_686-693.nxml.txt.nlp	23839492	SENT142	9	9	19	19	sunitinib	IL-8	PA162372840	3576	0.673
NULL	J_Antimicrob_Chemother_2014_Nov_17_69(11)_2920-2927.nxml.txt.nlp	25038069	SENT139	10	10	29	29	oxacillin	TMP	PA450725	2012	0.673
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_79-96.nxml.txt.nlp	19305789	SENT219	21	21	14	14	vanillin	TRPV3	PA451852	162514	0.673
NULL	Mol_Cancer_2014_Jun_20_13_155.nxml.txt.nlp	24950741	SENT132	44	44	6	6	bortezomib	p53	PA10252	7157	0.673
NULL	Mol_Vis_2010_Sep_2_16_1781-1790.nxml.txt.nlp	20824160	SENT156	18	18	4	4	rolipram	p38	PA153906323	10598;1432;7965	0.673
NULL	Evid_Based_Complement_Alternat_Med_2011_Mar_1_2011_207034.nxml.txt.nlp	21423686	SENT112	19	19	7	7	clopidogrel	ADP	PA449053	23038	0.673
NULL	Blood_Res_2013_Mar_25_48(1)_58-62.nxml.txt.nlp	23589798	SENT61	20	20	0	0	thrombin	FVIII	PA451674	2157	0.673
NULL	Case_Rep_Oncol_2013_Jan_29_6(1)_72-77.nxml.txt.nlp	23466899	SENT98	7	7	9	9	capecitabine	GTX	PA448771	84504	0.673
NULL	Open_Cardiovasc_Med_J_2011_Feb_24_5_49-63.nxml.txt.nlp	21643501	SENT60	13	13	5	5	darunavir	ARTEMIS	PA163522472	64421	0.673
NULL	Infect_Drug_Resist_2011_Jan_12_4_11-18.nxml.txt.nlp	21694905	SENT106	24	24	7	7	ribavirin	RVR	PA451241	9975	0.673
NULL	Gut_2011_Jun_17_60(6)_799-805.nxml.txt.nlp	21242260	SENT228	22	22	14	14	oxaliplatin	SLC22A3	PA131285527	6581	0.673
NULL	Mol_Cancer_2013_Oct_24_12_128.nxml.txt.nlp	24156782	SENT229	4	4	9	9	gefitinib	AKT	PA131301952	207	0.673
NULL	N_Am_J_Med_Sci_2011_Jan_3(1)_1-12.nxml.txt.nlp	22540056	SENT133	5	5	14	14	gemcitabine	MRP5	PA449748	10057	0.673
NULL	Acta_Pharmacol_Sin_2011_Oct_5_32(10)_1276-1284.nxml.txt.nlp	21970838	SENT35	21	21	2	2	quinidine	KET	PA451209	8626	0.673
NULL	J_Korean_Med_Sci_2010_Feb_19_25(2)_304-308.nxml.txt.nlp	20119588	SENT87	39	39	29	29	kanamycin	EMB	PA450137	133418	0.673
NULL	Indian_J_Pharm_Sci_2013_Jul-Aug_75(4)_420-426.nxml.txt.nlp	24302796	SENT113	11	11	8	8	paclitaxel	FOR	PA450761	51741	0.673
NULL	Br_J_Cancer_2009_Jul_21_101(2)_238-243.nxml.txt.nlp	19568242	SENT27	15	15	22	22	sunitinib	IFN	PA162372840	3439	0.673
NULL	Iran_J_Pharm_Res_2014_Spring_13(2)_583-590.nxml.txt.nlp	25237354	SENT114	30	30	23	23	enoxaparin	IL-6	PA449463	3569	0.673
NULL	Curr_Biol_2009_Feb_24_19(4)_297-304.nxml.txt.nlp	19217292	SENT392	20	20	22	22	vasopressin	AVP	PA451858	114548;551	0.673
NULL	Drug_Des_Devel_Ther_2014_Sep_16_8_1391-1403.nxml.txt.nlp	25258509	SENT134	5	5	1	1	ethanol	ANOVA	PA448073	4858	0.673
NULL	Br_J_Cancer_2011_Nov_22_105(11)_1759-1767.nxml.txt.nlp	22045189	SENT32	26	26	35	35	cetuximab	XRCC1	PA10040	7515	0.673
NULL	J_Korean_Med_Sci_2012_Sep_22_27(9)_1009-1013.nxml.txt.nlp	22969245	SENT42	8	8	19	19	fluorescein	CD4	PA164746009	920	0.673
NULL	Cell_Death_Dis_2014_Jan_9_5(1)_e982.nxml.txt.nlp	24407235	SENT143	23	23	42	42	l-glutamine	NT3	PA10090	4877;6272	0.673
NULL	Breast_Cancer_Res_2011_Jun_29_13(3)_R70.nxml.txt.nlp	21707964	SENT118	15	15	24	24	tamoxifen	14-3-3	PA451581	10971	0.673
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_17_2013_237096.nxml.txt.nlp	23843865	SENT50	13	13	6	6	ethanol	GPE	PA448073	2996	0.673
NULL	Environ_Health_Perspect_2013_Oct_1_121(10)_1194-1199.nxml.txt.nlp	23959441	SENT44	4	4	13	13	estradiol	SULT1E1	PA449503	6783	0.673
NULL	Br_J_Cancer_2011_Jul_26_105(3)_393-402.nxml.txt.nlp	21750550	SENT169	7	7	10	10	etodolac	SNAIL	PA449550	6615	0.673
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1021.nxml.txt.nlp	24457965	SENT66	32	32	34	34	cisplatin	NAC	PA449014	22861	0.673
NULL	J_Bras_Pneumol_2013_Jan-Feb_39(1)_5-15.nxml.txt.nlp	23503480	SENT14	4	4	1	1	doxycycline	LAM	PA449415	7249;7248	0.673
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Sep_30_67(Pt_10)_o2788.nxml.txt.nlp	22058822	SENT60	0	0	16	16	sulfanilamide	DHPS	PA451545	1725	0.673
NULL	Oncoimmunology_2013_Sep_1_2(9)_e25789.nxml.txt.nlp	24244905	SENT31	3	3	32	32	cyclophosphamide	IFN	PA449165	3439	0.673
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT229	17	17	13	13	perifosine	DR4	PA165291471	8797	0.673
NULL	Case_Rep_Hematol_2014_Dec_11_2014_743856.nxml.txt.nlp	25580315	SENT38	9	9	26	26	vincristine	CHOP	PA451879	1649	0.673
NULL	Arthritis_Res_Ther_2005_May_18_7(Suppl_3)_S19-S25.nxml.txt.nlp	15960818	SENT168	39	39	33	33	rituximab	CHOP	PA451261	1649	0.673
NULL	Stroke_Res_Treat_2009_Dec_20_2010_386389.nxml.txt.nlp	20700422	SENT159	29	29	26	26	ebselen	NAC	PA161660841	22861	0.673
NULL	Front_Oncol_2014_Sep_15_4_244.nxml.txt.nlp	25309870	SENT162	16	16	33	33	afatinib	EGFR	PA165981154	1956	0.673
NULL	J_Korean_Neurosurg_Soc_2013_Oct_31_54(4)_280-288.nxml.txt.nlp	24294450	SENT11	9	9	11	11	acetazolamide	ACZ	PA448018	27445	0.673
NULL	Acta_Pharmacol_Sin_2011_Jul_9_32(7)_879-887.nxml.txt.nlp	21552292	SENT109	32	32	15	15	metformin	AMPK	PA450395	5563	0.673
NULL	Oncotarget_2012_May_18_3(5)_525-534.nxml.txt.nlp	22619113	SENT102	0	0	11	11	fludarabine	BIRC5	PA449655	332	0.673
NULL	J_Psychopharmacol_2012_Nov_26(11)_1417-1423.nxml.txt.nlp	22596208	SENT267	18	18	1	1	memantine	Gen	PA10364	348654	0.673
NULL	Evid_Based_Complement_Alternat_Med_2013_Mar_19_2013_731940.nxml.txt.nlp	23573148	SENT95	20	20	3	3	naringenin	TRAIL-R2	PA151958361	8795	0.673
NULL	BMB_Rep_2014_Sep_47(9)_483-487.nxml.txt.nlp	25027595	SENT35	27	27	39	39	gefitinib	TM4SF5	PA131301952	9032	0.673
NULL	Bioinorg_Chem_Appl_2014_Jul_21_2014_865407.nxml.txt.nlp	25140121	SENT70	22	22	12	12	phenol	mol	PA450913	90527	0.673
NULL	Cancer_Cell_Int_2011_May_15_11_13.nxml.txt.nlp	21569620	SENT154	12	12	27	27	bortezomib	PC-3	PA10252	692094	0.673
NULL	Neural_Regen_Res_2013_May_5_8(13)_1180-1189.nxml.txt.nlp	25206412	SENT125	0	0	18	18	fasudil	RhoA	PA165946121	387	0.673
NULL	Med_Sci_Monit_2013_May_1_19_317-326.nxml.txt.nlp	23632427	SENT277	28	28	14	14	aztreonam	CTX	PA448523	1593	0.673
NULL	Cancers_(Basel)_2014_Nov_25_6(4)_2313-2329.nxml.txt.nlp	25534569	SENT176	10	10	8	8	crizotinib	HGF	PA165946122	3569;6654;3082	0.673
NULL	Br_J_Cancer_2013_Sep_3_109(5)_1157-1164.nxml.txt.nlp	23942075	SENT8	17	17	3	3	docetaxel	NAT	PA449383	6046	0.673
NULL	Exp_Ther_Med_2014_Sep_20_8(3)_968-972.nxml.txt.nlp	25120631	SENT87	2	2	10	10	naringin	FIB	PA151958360	2091	0.673
NULL	J_Inflamm_(Lond)_2006_Jul_12_3_10.nxml.txt.nlp	16834783	SENT20	19	19	24	24	mometasone	IL-5	PA450541	3567	0.673
NULL	Front_Chem_2014_Aug_25_2_69.nxml.txt.nlp	25202689	SENT43	0	0	10	10	trastuzumab	HER2	PA451743	2064	0.673
NULL	Case_Rep_Oncol_2013_May_30_6(2)_285-288.nxml.txt.nlp	23898270	SENT6	11	11	18	18	vemurafenib	BRAF	PA165946873	673	0.673
NULL	Arthritis_Res_Ther_2013_Jul_9_15(4)_R73.nxml.txt.nlp	23837669	SENT102	10	10	39	39	colchicine	MSU	PA449092	593	0.673
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_3_2014_473213.nxml.txt.nlp	25538791	SENT213	9	9	16	16	midazolam	FEX	PA450496	8549	0.673
NULL	Br_J_Cancer_2011_Jan_4_104(1)_91-100.nxml.txt.nlp	21139584	SENT155	24	24	44	44	doxorubicin	p53	PA449412	7157	0.673
NULL	Cell_Death_Dis_2010_Nov_18_1(11)_e102.nxml.txt.nlp	21368867	SENT94	6	6	3	3	gentamicin	14-3-3	PA449753	10971	0.673
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jun_16_68(Pt_7)_o2121.nxml.txt.nlp	22798797	SENT68	38	38	19	19	ethanol	mol	PA448073	90527	0.673
NULL	Cell_Cycle_2013_Jun_15_12(12)_1811-1812.nxml.txt.nlp	23708513	SENT5	20	20	24	24	vincristine	CHOP	PA451879	1649	0.673
NULL	Pharm_Pract_(Granada)_2011_Mar_15_Jan-Mar_9(1)_1-10.nxml.txt.nlp	25132883	SENT125	13	13	23	23	rivaroxaban	SPAF	PA165958360	166378	0.673
NULL	Eur_J_Med_Res_2011_Feb_24_16(2)_63-66.nxml.txt.nlp	21463983	SENT130	23	23	16	16	tobramycin	PARI	PA451704	55010	0.673
NULL	J_Korean_Med_Sci_2014_Jul_11_29(7)_965-972.nxml.txt.nlp	25045229	SENT167	9	9	18	18	metformin	B12	PA450395	7126;4709	0.673
NULL	Front_Physiol_2013_Jul_24_4_181.nxml.txt.nlp	23898301	SENT242	18	18	22	22	naratriptan	PAG	PA450597	55824	0.673
NULL	Indian_J_Pharm_Sci_2013_Sep-Oct_75(5)_610-614.nxml.txt.nlp	24403665	SENT80	19	19	6	6	glibenclamide	MESD	PA449782	23184	0.672
NULL	Nat_Methods_2013_Dec_3_10(12)_10_1038_nmeth_2724.nxml.txt.nlp	24185838	SENT111	28	28	11	11	nadh	ADP	PA164755085	23038	0.672
NULL	Diabetes_2011_Jul_20_60(7)_1917-1925.nxml.txt.nlp	21593202	SENT311	24	24	19	19	troglitazone	adiponectin	PA451799	9370	0.672
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT17	28	28	6	6	phenprocoumon	CALU	PA450921	813	0.672
NULL	Iran_J_Reprod_Med_2014_Feb_12(2)_111-116.nxml.txt.nlp	24799868	SENT28	12	12	18	18	estradiol	aromatase	PA449503	1588	0.672
NULL	Case_Rep_Pathol_2013_Jul_14_2013_198643.nxml.txt.nlp	23936709	SENT73	35	35	21	21	thyroglobulin	PTH	PA164754910	5741	0.672
NULL	BMB_Rep_2013_Aug_46(8)_410-415.nxml.txt.nlp	23977989	SENT35	5	5	7	7	curcumin	HO-1	PA151958596	3162	0.672
NULL	J_Mol_Signal_2008_Mar_31_3_8.nxml.txt.nlp	18377662	SENT221	0	0	8	8	pp2	San		80218	0.672
NULL	J_Korean_Med_Sci_2010_Mar_19_25(3)_481-484.nxml.txt.nlp	20191052	SENT75	7	7	11	11	vincristine	CHOP	PA451879	1649	0.672
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Jul_21_9_20.nxml.txt.nlp	20663145	SENT108	8	8	12	12	clarithromycin	LBH	PA449028	81606;221491	0.672
NULL	Br_J_Cancer_2004_May_17_90(10)_2032-2041.nxml.txt.nlp	15138490	SENT79	19	19	12	12	trastuzumab	HER-2	PA451743	2064	0.672
NULL	Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.nxml.txt.nlp	24736980	SENT236	3	3	5	5	rosuvastatin	OATP1B1	PA134308647	10599	0.672
NULL	Int_J_Mol_Sci_2007_Jan_29_8(1)_13-28.nxml.txt.nlp	NULL	SENT76	17	17	19	19	galactose	NAG	PA449725	51594;4669	0.672
NULL	Eur_J_Clin_Microbiol_Infect_Dis_2012_May_7_31(5)_739-745.nxml.txt.nlp	21822974	SENT63	10	10	19	19	tigecycline	VAN	PA164746412	10318	0.672
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_18_2012_382763.nxml.txt.nlp	23243442	SENT209	6	6	11	11	rosiglitazone	PON2	PA451283	5445	0.672
NULL	Emerg_Infect_Dis_2013_Jan_19(1)_133-136.nxml.txt.nlp	23260464	SENT54	42	42	24	24	aztreonam	TOB	PA448523	10140	0.672
NULL	Patient_Prefer_Adherence_2013_Jul_3_7_633-641.nxml.txt.nlp	23861580	SENT201	23	23	7	7	acetazolamide	CO2	PA448018	4513	0.672
NULL	Br_J_Cancer_2011_Jun_7_104(12)_1848-1853.nxml.txt.nlp	21610704	SENT101	24	24	21	21	panitumumab	KRAS	PA162373091	3845	0.672
NULL	Oncol_Lett_2013_Apr_4_5(4)_1165-1170.nxml.txt.nlp	23599757	SENT5	36	36	20	20	pemetrexed	MTHFR	PA10810	4524	0.672
NULL	Breast_Cancer_Res_Treat_2013_Jan_6_137(1)_167-174.nxml.txt.nlp	23129173	SENT25	0	0	4	4	letrozole	aromatase	PA450196	1588	0.672
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT210	20	20	11	11	curcumin	DR4	PA151958596	8797	0.672
NULL	Psychiatry_Investig_2009_Mar_31_6(1)_1-6.nxml.txt.nlp	20046366	SENT38	28	28	13	13	citalopram	STAR	PA449015	6770;2984	0.672
NULL	BMJ_Open_Diabetes_Res_Care_2014_Dec_3_2(1)_e000034.nxml.txt.nlp	25512873	SENT4	8	8	4	4	lipase	ANGPTL4	PA450239	51129	0.672
NULL	J_Gen_Physiol_2008_Nov_132(5)_547-562.nxml.txt.nlp	18955595	SENT49	20	20	14	14	capsaicin	TRPV1	PA448776	7442	0.672
NULL	Breast_Cancer_Res_2010_Jul_1_12(4)_R45.nxml.txt.nlp	20594311	SENT141	9	9	0	0	nelfinavir	BiP	PA450606	3309	0.672
NULL	Cancer_Cell_Int_2013_Oct_11_13_97.nxml.txt.nlp	24119761	SENT21	19	19	15	15	heparin	epigen	PA449855	255324	0.672
NULL	Oncol_Rep_2014_Mar_14_31(3)_1035-1042.nxml.txt.nlp	24424445	SENT144	35	35	23	23	doxorubicin	Oct4	PA449412	5460	0.672
NULL	Korean_J_Anesthesiol_2013_Dec_26_65(6)_501-507.nxml.txt.nlp	24427455	SENT41	34	34	41	41	rocuronium	NMB	PA164754992	10457;4828	0.672
NULL	Nat_Chem_Biol_2013_Oct_11_9(10)_10_1038_nchembio_1315.nxml.txt.nlp	23934245	SENT150	13	13	30	30	l-glutamine	CO2	PA10090	4513	0.672
NULL	Diabetes_2013_Mar_14_62(3)_811-824.nxml.txt.nlp	23209186	SENT325	0	0	21	21	bortezomib	JNK	PA10252	5599	0.672
NULL	Breast_Cancer_Res_2002_Sep_10_4(6)_218-221.nxml.txt.nlp	12473166	SENT84	6	6	39	39	tamoxifen	ATAC	PA451581	6375	0.672
NULL	Acta_Pharmacol_Sin_2012_May_16_33(5)_682-690.nxml.txt.nlp	22504904	SENT125	0	0	4	4	celecoxib	IL-6	PA448871	3569	0.672
NULL	J_Gynecol_Oncol_2014_Apr_9_25(2)_130-135.nxml.txt.nlp	24761217	SENT119	1	1	8	8	paclitaxel	P-gp	PA450761	5243	0.672
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT138	9	9	21	21	perifosine	DR5	PA165291471	8795	0.672
NULL	Int_J_Vasc_Med_2013_Mar_31_2013_543141.nxml.txt.nlp	23606968	SENT242	0	0	19	19	etanercept	IL-13	PA449515	3596	0.672
NULL	Eur_J_Clin_Pharmacol_2012_Jan_7_68(1)_55-64.nxml.txt.nlp	21735164	SENT0	17	17	14	14	oxycodone	CYP2D6	PA450741	1565	0.672
NULL	Mol_Vis_2012_Mar_27_18_730-743.nxml.txt.nlp	22509103	SENT204	14	14	6	6	l-tryptophan	IDO1	PA10323	3620	0.672
NULL	Exp_Ther_Med_2013_Apr_29_5(4)_1093-1096.nxml.txt.nlp	23596475	SENT76	8	8	14	14	ketamine	IL-6	PA450144	3569	0.672
NULL	Mol_Cancer_2007_Mar_7_6_18.nxml.txt.nlp	17343740	SENT221	18	18	12	12	pamidronate	PC3	PA450767	57332;7832;5122	0.672
NULL	Int_J_Mol_Sci_2012_Dec_7_13(12)_16751-16768.nxml.txt.nlp	23222680	SENT539	8	8	15	15	tranylcypromine	LSD1	PA451741	23028	0.672
NULL	Mol_Cancer_2006_Oct_17_5_45.nxml.txt.nlp	17044934	SENT67	5	5	7	7	resveratrol	COX		1351	0.672
NULL	Biologics_2012_Jul_26_6_233-244.nxml.txt.nlp	22904615	SENT253	9	9	3	3	olaparib	ADP		23038	0.672
NULL	Oncol_Lett_2014_Nov_12_8(5)_2203-2208.nxml.txt.nlp	25295109	SENT84	4	4	9	9	celecoxib	PTCH1	PA448871	5727	0.672
NULL	Drug_Target_Insights_2013_Aug_19_7_27-34.nxml.txt.nlp	24023511	SENT34	22	22	12	12	tariquidar	P-gp		5243	0.672
NULL	Trials_2012_Aug_31_13_156.nxml.txt.nlp	22937736	SENT170	29	29	11	11	azithromycin	IP-10	PA448519	3627	0.672
NULL	Indian_J_Pharmacol_2014_Nov-Dec_46(6)_627-632.nxml.txt.nlp	25538335	SENT126	10	10	8	8	metformin	Q10	PA450395	27161	0.672
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_May_5_68(Pt_6)_o1638.nxml.txt.nlp	22719439	SENT60	24	24	12	12	ethanol	mol	PA448073	90527	0.672
NULL	J_Gen_Physiol_2000_Jun_1_115(6)_685-696.nxml.txt.nlp	10828243	SENT120	7	7	23	23	genistein	OLF	PA165109660	83857	0.672
NULL	Exp_Ther_Med_2014_Feb_4_7(2)_478-482.nxml.txt.nlp	24396429	SENT119	19	19	11	11	glucose	HO-1	PA449773	3162	0.672
NULL	Aging_(Albany_NY)_2009_Jul_30_1(7)_669-673.nxml.txt.nlp	20157548	SENT61	0	0	17	17	resveratrol	FOXO1		2308	0.672
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT166	10	10	13	13	perifosine	JNK	PA165291471	5599	0.672
NULL	Acta_Orthop_2012_Dec_26_83(6)_642-647.nxml.txt.nlp	23140090	SENT90	6	6	43	43	etoricoxib	ANOVA	PA164776853	4858	0.672
NULL	Oncol_Lett_2014_Sep_19_8(3)_1269-1274.nxml.txt.nlp	25120704	SENT28	21	21	7	7	cisplatin	Met	PA449014	79811	0.672
NULL	J_Biomed_Sci_2014_Feb_3_21(1)_10.nxml.txt.nlp	24490900	SENT149	26	26	34	34	alendronate	M-CSF	PA448082	1435	0.672
NULL	Cerebrovasc_Dis_Extra_2014_Mar_28_4(1)_69-76.nxml.txt.nlp	24803915	SENT91	8	8	14	14	aspirin	MRI	PA448497	78996	0.672
NULL	Ital_J_Pediatr_2014_Feb_13_40_17.nxml.txt.nlp	24524345	SENT85	22	22	14	14	methylprednisolone	CHP	PA450466	11261	0.672
NULL	Arthritis_Res_Ther_2009_Aug_17_11(4)_R123.nxml.txt.nlp	19686595	SENT245	44	44	22	22	rituximab	CD27	PA451261	939	0.672
NULL	Curr_Biol_2012_Mar_6_22(5)_397-402.nxml.txt.nlp	22305751	SENT31	32	32	40	40	physostigmine	spatial	PA450957	219793	0.672
NULL	Diabetes_Metab_J_2014_Apr_18_38(2)_100-106.nxml.txt.nlp	24851203	SENT27	9	9	1	1	glucose	MET	PA449773	4233	0.672
NULL	Int_J_Biol_Sci_2014_Jan_18_10(2)_160-170.nxml.txt.nlp	24520214	SENT27	14	14	9	9	hyaluronan	LYVE-1	PA165958431	10894	0.672
NULL	Br_J_Haematol_2014_Mar_13_164(1)_811-821.nxml.txt.nlp	24328678	SENT188	19	19	28	28	lenalidomide	IL2	PA162363968	3558	0.672
NULL	Biologics_2013_Apr_15_7_77-90.nxml.txt.nlp	23723688	SENT23	4	4	6	6	cetuximab	EGFR	PA10040	1956	0.672
NULL	Front_Neurol_2012_Feb_7_3_11.nxml.txt.nlp	22347210	SENT126	15	15	17	17	vasopressin	AVP	PA451858	114548;551	0.672
NULL	Core_Evid_2011_Mar_17_6_31-42.nxml.txt.nlp	21468241	SENT273	4	4	8	8	ticagrelor	P2Y12	PA165374673	64805	0.672
NULL	Front_Chem_2013_Jun_26_1_8.nxml.txt.nlp	24790937	SENT424	13	13	9	9	ethanol	CO2	PA448073	4513	0.672
NULL	Exp_Ther_Med_2013_Jan_10_5(1)_287-291.nxml.txt.nlp	23251285	SENT101	12	12	9	9	aspirin	APS	PA448497	10603	0.672
NULL	Basic_Clin_Neurosci_2014_Summer_5(3)_182-190.nxml.txt.nlp	25337378	SENT146	11	11	8	8	bupropion	mol	PA448687	90527	0.672
NULL	J_Thromb_Thrombolysis_2011_Nov_26_32(4)_459-466.nxml.txt.nlp	21706290	SENT150	16	16	3	3	clopidogrel	ABCB1	PA449053	5243	0.672
NULL	Oncotarget_2013_Nov_7_4(12)_2550-2566.nxml.txt.nlp	24334291	SENT220	27	27	23	23	doxorubicin	CHOP	PA449412	1649	0.672
NULL	Bioinformation_2012_Jan_6_8(1)_13-19.nxml.txt.nlp	22359429	SENT128	10	10	12	12	curcumin	MRP1	PA151958596	4437	0.672
NULL	Curr_Med_Chem_2014_Feb_21_1129-1145.nxml.txt.nlp	24304271	SENT268	6	6	13	13	genistein	DES	PA165109660	1674	0.672
NULL	Cancers_(Basel)_2012_Jun_18_4(2)_581-600.nxml.txt.nlp	24213326	SENT362	1	1	7	7	cyclophosphamide	CD25	PA449165	3669;3559	0.672
NULL	Biologics_2012_Jun_5_6_125-134.nxml.txt.nlp	22740771	SENT101	15	15	4	4	infliximab	ACT	PA452639	12;11332;9457;641455	0.672
NULL	Int_J_Biol_Sci_2015_Jan_1_11(2)_144-155.nxml.txt.nlp	25561897	SENT183	39	39	7	7	epirubicin	POLB	PA449476	5423	0.672
NULL	Semin_Dial_2013_Sep_17_26(5)_546-567.nxml.txt.nlp	23859229	SENT588	10	10	31	31	cyanocobalamin	B12	PA451892	7126;4709	0.672
NULL	Chem_Cent_J_2012_Nov_23_6_139.nxml.txt.nlp	23173901	SENT200	26	26	28	28	thrombin	IL-6	PA451674	3569	0.672
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1420-1426.nxml.txt.nlp	24056704	SENT37	13	13	11	11	midazolam	CYP3A	PA450496	1574	0.672
NULL	Int_J_Mol_Sci_2014_Sep_30_15(10)_17733-17750.nxml.txt.nlp	25272228	SENT141	5	5	13	13	oxygen	HIF-1	PA450744	29072	0.672
NULL	Br_J_Cancer_2014_Aug_12_111(4)_640-645.nxml.txt.nlp	24642617	SENT72	29	29	24	24	vemurafenib	BRAF	PA165946873	673	0.672
NULL	Clin_Pharmacol_2011_Jun_22_3_13-25.nxml.txt.nlp	22287853	SENT181	42	42	40	40	ketoconazole	CYP3A4	PA450146	1576	0.672
NULL	Avicenna_J_Med_2013_Apr-Jun_3(2)_37-47.nxml.txt.nlp	23930241	SENT202	27	27	22	22	methotrexate	CD4	PA450428	920	0.672
NULL	J_Clin_Biochem_Nutr_2009_Nov_28_45(3)_285-291.nxml.txt.nlp	19902018	SENT33	10	10	19	19	hesperetin	XDH	PA164742902	7498	0.672
NULL	Anal_Bioanal_Chem_2013_Jul_23_405(23)_7337-7345.nxml.txt.nlp	23877175	SENT134	11	11	8	8	creatine	spatial	PA164778930	219793	0.672
NULL	Cases_J_2008_Dec_16_1_402.nxml.txt.nlp	19087338	SENT112	0	0	6	6	creatine	Q10	PA164778930	27161	0.672
NULL	Glycobiology_2009_Feb_24_19(2)_126-134.nxml.txt.nlp	18952826	SENT132	0	0	12	12	rituximab	San	PA451261	80218	0.672
NULL	Crit_Care_2008_Aug_4_12(4)_R99.nxml.txt.nlp	18680591	SENT163	8	8	16	16	dobutamine	AVP	PA449381	114548;551	0.672
NULL	Oncotarget_2014_Aug_27_5(21)_10486-10502.nxml.txt.nlp	25401222	SENT124	37	37	31	31	gefitinib	PP2	PA131301952	4888	0.672
NULL	Acta_Crystallogr_Sect_F_Struct_Biol_Cryst_Commun_2011_Aug_16_67(Pt_9)_1070-1077.nxml.txt.nlp	21904052	SENT143	10	10	19	19	raltitrexed	DHFR	PA131625240	1719	0.672
NULL	Eur_J_Med_Res_2010_Nov_30_15(12)_571-576.nxml.txt.nlp	21163732	SENT65	8	8	5	5	linezolid	MRB	PA450233	54538	0.672
NULL	Clin_Sci_(Lond)_2011_Apr_1_120(Pt_8)_335-345.nxml.txt.nlp	21091432	SENT142	0	0	13	13	ramipril	ACE2	PA451223	59272	0.672
NULL	Oncol_Lett_2014_Mar_19_7(3)_674-678.nxml.txt.nlp	24527071	SENT115	12	12	19	19	cisplatin	p38	PA449014	10598;1432;7965	0.672
NULL	Front_Oncol_2014_Apr_10_4_76.nxml.txt.nlp	24782987	SENT118	33	33	37	37	rituximab	PRIMA	PA451261	145270	0.672
NULL	Clin_Ophthalmol_2008_Jun_2(2)_355-368.nxml.txt.nlp	19668727	SENT43	18	18	10	10	amfenac	COX	PA166049186	1351	0.672
NULL	Indian_J_Pharm_Sci_2013_Sep-Oct_75(5)_578-584.nxml.txt.nlp	24403659	SENT37	18	18	20	20	gemcitabine	GEM	PA449748	2669	0.672
NULL	Saudi_J_Anaesth_2013_Apr-Jun_7(2)_151-154.nxml.txt.nlp	23956714	SENT89	7	7	9	9	theophylline	NAC	PA451647	22861	0.672
NULL	Clin_Exp_Otorhinolaryngol_2011_Dec_15_4(4)_177-183.nxml.txt.nlp	22232712	SENT119	19	19	9	9	doxycycline	p38	PA449415	10598;1432;7965	0.672
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_May_22_66(Pt_6)_o1397.nxml.txt.nlp	21579476	SENT47	8	8	11	11	benzaldehyde	mol	PA448571	90527	0.672
NULL	Bioinformation_2012_Jan_20_8(2)_81-86.nxml.txt.nlp	22359440	SENT25	13	13	15	15	bosentan	ETB	PA10034	1910	0.672
NULL	Protein_Cell_2014_Jun_7_5(6)_457-468.nxml.txt.nlp	24801752	SENT201	11	11	18	18	gemcitabine	EGFR	PA449748	1956	0.672
NULL	Exp_Ther_Med_2015_Feb_16_9(2)_435-445.nxml.txt.nlp	25574212	SENT118	14	14	24	24	creatine	IL-6	PA164778930	3569	0.672
NULL	Cardiovasc_Diabetol_2013_Oct_17_12_150.nxml.txt.nlp	24134550	SENT117	16	16	8	8	pioglitazone	activin	PA450970	83729	0.672
NULL	J_Cell_Biol_1998_Jan_26_140(2)_335-345.nxml.txt.nlp	9442109	SENT175	9	9	12	12	chloroquine	NHE	PA448948	285335	0.672
NULL	Database_(Oxford)_2013_Jul_18_2013_bat049.nxml.txt.nlp	23868908	SENT86	2	2	5	5	imatinib	NQO2	PA10804	4835	0.672
NULL	Cardiol_Ther_2013_Jun_28_2(1)_47-56.nxml.txt.nlp	25135288	SENT155	3	3	21	21	clopidogrel	OASIS	PA449053	90993	0.672
NULL	Evid_Based_Complement_Alternat_Med_2013_May_16_2013_857929.nxml.txt.nlp	23762164	SENT126	22	22	12	12	doxorubicin	p53	PA449412	7157	0.672
NULL	Biosci_Rep_2014_Dec_12_34(6)_e00160.nxml.txt.nlp	25495645	SENT277	8	8	5	5	lipase	ANGPTL4	PA450239	51129	0.672
NULL	Open_Access_J_Urol_2011_May_10_3_69-82.nxml.txt.nlp	24198638	SENT95	22	22	24	24	sorafenib	IFN	PA7000	3439	0.672
NULL	Diabetes_2008_Sep_57(9)_2470-2479.nxml.txt.nlp	18511847	SENT127	0	0	29	29	pioglitazone	CD68	PA450970	968	0.672
NULL	Int_J_Mol_Sci_2014_Nov_21_15(11)_21433-21454.nxml.txt.nlp	25421240	SENT240	7	7	1	1	atropine	EGF	PA448505	1950	0.672
NULL	Proteins_2013_Aug_1_81(8)_1457-1465.nxml.txt.nlp	23589421	SENT158	12	12	38	38	l-alanine	AGT	PA448055	183;189	0.672
NULL	Cytotherapy_2013_Jan_15(1)_89-101.nxml.txt.nlp	23260089	SENT177	28	28	25	25	lipase	adiponectin	PA450239	9370	0.672
NULL	Front_Endocrinol_(Lausanne)_2013_Jun_12_4_71.nxml.txt.nlp	23781214	SENT187	15	15	1	1	lipase	PDE3B	PA450239	5140	0.672
NULL	Cancers_(Basel)_2014_May_7_6(2)_1098-1110.nxml.txt.nlp	24810425	SENT142	30	30	23	23	cisplatin	PLCL	PA449014	5334	0.672
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT125	12	12	32	32	doxorubicin	SLK	PA449412	9748;2534	0.672
NULL	Nat_Commun_2013_Sep_20_4_2444.nxml.txt.nlp	24051492	SENT47	31	31	25	25	nutlin-3	PER2		8864	0.672
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT3271	0	0	23	23	flucloxacillin	CYP3A4	PA164781042	1576	0.672
NULL	J_Exp_Med_1964_May_1_119(5)_851-868.nxml.txt.nlp	14157034	SENT4	42	42	27	27	cyclophosphamide	gamma	PA449165	9913	0.672
NULL	Oncotarget_2014_Feb_19_5(8)_2085-2095.nxml.txt.nlp	24742694	SENT296	20	20	6	6	suramin	SIRT1	PA10292	23411	0.672
NULL	Cancer_Cell_Int_2005_Jul_24_5_22.nxml.txt.nlp	16042792	SENT79	2	2	4	4	vincristine	NAC	PA451879	22861	0.672
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT110	19	19	6	6	paclitaxel	CYP3A	PA450761	1574	0.672
NULL	Eur_Radiol_2011_Feb_22_21(2)_265-273.nxml.txt.nlp	20730540	SENT42	11	11	1	1	capecitabine	CRT	PA448771	811	0.672
NULL	Multidiscip_Respir_Med_2013_Sep_4_8(1)_59.nxml.txt.nlp	24135224	SENT139	34	34	31	31	voriconazole	IPA	PA10233	3160	0.672
NULL	Diabetes_Care_2009_Oct_32(10)_1753-1768.nxml.txt.nlp	19794001	SENT207	19	19	26	26	exenatide	GLP-1	PA164749238	100125288	0.672
NULL	Diabetes_2013_Mar_14_62(3)_953-964.nxml.txt.nlp	23223176	SENT169	32	32	36	36	paroxetine	ROS	PA450801	6098	0.672
NULL	Am_J_Case_Rep_2013_Jul_29_14_284-287.nxml.txt.nlp	23919102	SENT93	9	9	16	16	fluoxetine	PSP	PA449673	140683;5623;10247;4477;5967	0.672
NULL	Front_Endocrinol_(Lausanne)_2014_Oct_2_5_158.nxml.txt.nlp	25324831	SENT404	28	28	16	16	carrageenan	26RFa	PA448814	347148	0.672
NULL	Emerg_Infect_Dis_2013_Jan_19(1)_133-136.nxml.txt.nlp	23260464	SENT49	19	19	9	9	aztreonam	TOB	PA448523	10140	0.672
NULL	BMB_Rep_2013_Jan_46(1)_59-64.nxml.txt.nlp	23351386	SENT335	3	3	15	15	auranofin	STAT3	PA448510	6774	0.672
NULL	Int_J_Mol_Sci_2014_Nov_25_15(12)_21703-21722.nxml.txt.nlp	25429431	SENT61	11	11	17	17	curcumin	mol	PA151958596	90527	0.672
NULL	J_Cardiothorac_Surg_2011_Oct_12_6_135.nxml.txt.nlp	21992542	SENT48	6	6	0	0	cisplatin	CRT	PA449014	811	0.672
NULL	Nat_Med_2014_Jan_15_20(1)_54-61.nxml.txt.nlp	24336249	SENT98	15	15	45	45	anakinra	IL-17	PA10799	3605	0.672
NULL	J_Cancer_2013_Sep_27_4(8)_662-670.nxml.txt.nlp	24155778	SENT242	18	18	31	31	cisplatin	GAPDH	PA449014	2597	0.672
NULL	Trials_2012_Dec_13_13_239.nxml.txt.nlp	23237631	SENT8	14	14	34	34	acenocoumarol	CYP4F2	PA452632	8529	0.672
NULL	Eur_J_Med_Res_2010_Feb_26_15(2)_47-53.nxml.txt.nlp	20452883	SENT94	20	20	9	9	etomidate	ESG	PA164743987	7089;7088;7090;7091	0.672
NULL	Alcohol_Res_Health_2011_34(1)_106-120.nxml.txt.nlp	23580048	SENT132	17	17	30	30	ethanol	CA3	PA448073	761	0.672
NULL	Mol_Cancer_2011_Sep_7_10_109.nxml.txt.nlp	21899742	SENT217	11	11	22	22	resveratrol	TRAIL-R2		8795	0.672
NULL	Exp_Neurobiol_2013_Sep_30_22(3)_167-172.nxml.txt.nlp	24167412	SENT78	4	4	21	21	rasagiline	Bcl-2	PA164764584	596	0.672
NULL	Cancer_Cell_Int_2011_Mar_10_11_6.nxml.txt.nlp	21392380	SENT7	7	7	12	12	imipramine	HERG	PA449969	3757	0.672
NULL	Brain_Sci_2014_May_6_4(2)_356-375.nxml.txt.nlp	24961766	SENT293	21	21	12	12	propofol	G18	PA451141	1154;63940	0.672
NULL	Arthritis_Res_Ther_2014_Sep_24_16(5)_434.nxml.txt.nlp	25249397	SENT9	35	35	11	11	methotrexate	CXCL13	PA450428	10563	0.672
NULL	Clinics_(Sao_Paulo)_2013_Sep_68(9)_1255-1262.nxml.txt.nlp	24141843	SENT17	4	4	10	10	estradiol	spatial	PA449503	219793	0.672
NULL	Environ_Health_Perspect_2006_Aug_10_114(8)_1193-1198.nxml.txt.nlp	16882524	SENT223	15	15	33	33	arsenite	p53	PA452638	7157	0.672
NULL	Mol_Clin_Oncol_2013_Jul_27_1(4)_768-772.nxml.txt.nlp	24649244	SENT33	3	3	13	13	tegafur	CDHP	PA452620	1001	0.672
NULL	J_Phys_Ther_Sci_2014_Apr_23_26(4)_487-490.nxml.txt.nlp	24764617	SENT24	25	25	40	40	hyaluronan	COMP	PA165958431	1311	0.672
NULL	Breast_Cancer_Res_2012_Feb_14_14(1)_R30.nxml.txt.nlp	22333315	SENT230	10	10	32	32	celecoxib	CXCR3	PA448871	2833	0.672
NULL	Br_J_Cancer_2012_Feb_14_106(4)_685-692.nxml.txt.nlp	22294184	SENT252	6	6	8	8	lovastatin	L12	PA450272	26156;6136	0.672
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT113	7	7	11	11	glucose	EGFR	PA449773	1956	0.672
NULL	J_Gen_Physiol_1929_Jan_20_12(3)_435-461.nxml.txt.nlp	19872472	SENT2	34	34	21	21	phenol	CO2	PA450913	4513	0.672
NULL	Br_J_Cancer_2012_Sep_4_107(6)_947-955.nxml.txt.nlp	22892392	SENT143	9	9	27	27	doxorubicin	BCAR4	PA449412	400500	0.672
NULL	Mol_Brain_2014_May_15_7_37.nxml.txt.nlp	24886748	SENT73	20	20	31	31	vorinostat	p24	PA164748224	11261;140767	0.672
NULL	Arthritis_Res_Ther_2004_Feb_24_6(Suppl_1)_24.nxml.txt.nlp	NULL	SENT14	3	3	5	5	etanercept	OPGL	PA449515	8600	0.672
NULL	Mediators_Inflamm_2010_Mar_7_2010_364957.nxml.txt.nlp	20224654	SENT115	4	4	25	25	sibutramine	IL-10	PA451344	3586	0.672
NULL	Exp_Ther_Med_2013_Aug_7_6(2)_485-488.nxml.txt.nlp	24137213	SENT128	3	3	8	8	heparin	PAPP-A	PA449855	5069	0.672
NULL	Biochemistry_2009_Feb_3_48(4)_800-809.nxml.txt.nlp	19132922	SENT210	9	9	7	7	allopurinol	XOR	PA448320	7498	0.672
NULL	Cell_Death_Dis_2010_Oct_21_1(10)_e86.nxml.txt.nlp	21368859	SENT74	28	28	26	26	doxorubicin	TRAIL	PA449412	8743	0.672
NULL	Oncoimmunology_2013_Jun_1_2(6)_e24677.nxml.txt.nlp	23894722	SENT109	22	22	18	18	cetuximab	CD86	PA10040	942	0.672
NULL	J_Gastroenterol_2013_Mar_9_48(3)_382-390.nxml.txt.nlp	22875473	SENT74	15	15	10	10	ribavirin	IFN	PA451241	3439	0.672
NULL	Int_J_Biol_Sci_2013_Apr_13_9(4)_343-349.nxml.txt.nlp	23630446	SENT181	2	2	11	11	vasopressin	ACTH	PA451858	5443	0.672
NULL	Cells_2014_Nov_27_3(4)_1089-1101.nxml.txt.nlp	25437439	SENT795	13	13	25	25	potassium	TRPM7	PA451047	54822	0.672
NULL	J_Gen_Physiol_2009_Apr_133(4)_421-438.nxml.txt.nlp	19289574	SENT310	25	25	11	11	forskolin	SLC26A9	PA146096022	115019	0.672
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT212	5	5	7	7	doxorubicin	B7-H1	PA449412	29126	0.672
NULL	Ther_Clin_Risk_Manag_2006_Sep_2(3)_297-301.nxml.txt.nlp	18360604	SENT51	11	11	13	13	paricalcitol	PTH	PA450798	5741	0.672
NULL	Sensors_(Basel)_2013_Mar_28_13(4)_4289-4302.nxml.txt.nlp	23539032	SENT376	8	8	3	3	capsaicin	TRPV1	PA448776	7442	0.672
NULL	Mol_Cancer_2010_Mar_25_9_68.nxml.txt.nlp	20338046	SENT178	33	33	6	6	tamoxifen	FOXC1	PA451581	2296	0.672
NULL	Cancers_(Basel)_2014_Oct_24_6(4)_2187-2223.nxml.txt.nlp	25347122	SENT1442	14	14	25	25	cetuximab	San	PA10040	80218	0.672
NULL	Aging_(Albany_NY)_2012_Jul_22_4(7)_480-498.nxml.txt.nlp	22837425	SENT139	0	0	8	8	metformin	B12	PA450395	7126;4709	0.672
NULL	An_Bras_Dermatol_2013_Sep-Oct_88(5)_775-786.nxml.txt.nlp	24173184	SENT175	0	0	20	20	imiquimod	IL-2	PA449972	3558	0.672
NULL	Crit_Care_2010_Sep_14_14(5)_R166.nxml.txt.nlp	20840773	SENT223	39	39	1	1	mannitol	GDH	PA450320	51084;2746	0.672
NULL	Front_Immunol_2012_Jul_16_3_205.nxml.txt.nlp	22811680	SENT117	8	8	13	13	paraformaldehyde	ADP	PA450790	23038	0.672
NULL	Br_J_Pharmacol_2012_Jan_165(2)_390-400.nxml.txt.nlp	21671897	SENT229	24	24	12	12	suramin	P2X1	PA10292	5023	0.672
NULL	Arthritis_Res_Ther_2014_Apr_30_16(2)_R90.nxml.txt.nlp	25167216	SENT294	34	34	21	21	tocilizumab	CXCL13	PA165292659	10563	0.672
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S18-S30.nxml.txt.nlp	20680104	SENT294	27	27	3	3	panitumumab	STEPP	PA162373091	222659	0.672
NULL	Environ_Health_Perspect_2011_Aug_30_119(8)_1047-1052.nxml.txt.nlp	21118785	SENT21	12	12	14	14	diethylstilbestrol	DES	PA449307	1674	0.672
NULL	Korean_J_Radiol_2011_Jul_22_Jul-Aug_12(4)_510-514.nxml.txt.nlp	21852913	SENT23	19	19	13	13	lipase	CEA	PA450239	5670;1087	0.672
NULL	Core_Evid_2011_Mar_17_6_31-42.nxml.txt.nlp	21468241	SENT82	32	32	23	23	clopidogrel	IPA	PA449053	3160	0.672
NULL	Autophagy_2012_May_1_8(5)_853-855.nxml.txt.nlp	22617440	SENT35	23	23	16	16	imatinib	ATG5	PA10804	9474	0.672
NULL	Nucleic_Acids_Res_2013_Nov_27_41(21)_9786-9799.nxml.txt.nlp	23982513	SENT265	4	4	10	10	arsenite	ZBP1	PA452638	81030	0.672
NULL	Iran_Red_Crescent_Med_J_2012_Jul_30_14(7)_422-429.nxml.txt.nlp	22997558	SENT75	36	36	34	34	glutaraldehyde	VIII	PA449777	1351	0.672
NULL	Crit_Care_2008_Nov_26_12(Suppl_6)_S3.nxml.txt.nlp	19105796	SENT141	5	5	10	10	thrombin	PAR2	PA451674	2150;55065;8856	0.672
NULL	Diabetes_Metab_Syndr_Obes_2010_May_17_3_155-163.nxml.txt.nlp	21437085	SENT52	1	1	8	8	exenatide	GLP-1	PA164749238	100125288	0.672
NULL	Breast_Cancer_Res_2013_Sep_25_15(5)_R88.nxml.txt.nlp	24063698	SENT177	10	10	32	32	carboplatin	SOC	PA448803	91544	0.672
NULL	J_Young_Pharm_2012_Oct-Dec_4(4)_235-244.nxml.txt.nlp	23493308	SENT59	10	10	18	18	venlafaxine	BUP	PA451866	23412	0.672
NULL	Neuropsychopharmacology_2009_Aug_25_34(9)_2072-2080.nxml.txt.nlp	19322169	SENT103	8	8	2	2	rimonabant	ANOVA	PA152407999	4858	0.672
NULL	Clin_Interv_Aging_2014_Apr_8_9_593-601.nxml.txt.nlp	24748777	SENT72	4	4	6	6	denosumab	RANKL	PA166048634	8600	0.672
NULL	Int_J_Mol_Sci_2013_Aug_14_14(8)_16719-16731.nxml.txt.nlp	23949634	SENT28	7	7	25	25	thrombin	CA1	PA451674	759	0.672
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_321-328.nxml.txt.nlp	21372824	SENT173	37	37	16	16	fluvastatin	STZ	PA449688	6484	0.672
NULL	Chem_Res_Toxicol_2011_Aug_15_24(8)_1275-1282.nxml.txt.nlp	21749116	SENT126	17	17	7	7	geldanamycin	Hsp90	PA152031327	3320	0.672
NULL	Clin_Ophthalmol_2014_Jan_13_8_219-228.nxml.txt.nlp	24531757	SENT150	12	12	4	4	timolol	TIM	PA451690	7984;8914	0.672
NULL	Cancer_Manag_Res_2012_Sep_12_4_299-307.nxml.txt.nlp	23049279	SENT28	0	0	7	7	vemurafenib	San	PA165946873	80218	0.672
NULL	Mol_Cancer_2010_Nov_2_9_289.nxml.txt.nlp	21044322	SENT166	29	29	8	8	docetaxel	RGS17	PA449383	26575	0.672
NULL	Oncol_Lett_2013_Feb_7_5(2)_440-446.nxml.txt.nlp	23420122	SENT247	29	29	0	0	gemcitabine	Gem	PA449748	51053	0.672
NULL	Cell_Biol_Int_Rep_(2010)_2012_Jun_21_19(1)_e00017.nxml.txt.nlp	23124518	SENT113	17	17	19	19	etoposide	TRAIL	PA449552	8743	0.672
NULL	Am_J_Physiol_Cell_Physiol_2014_Jan_15_306(2)_C89-C97.nxml.txt.nlp	24133067	SENT194	5	5	13	13	hyaluronan	CD44	PA165958431	960	0.672
NULL	Acta_Pharmacol_Sin_2013_May_18_34(5)_605-611.nxml.txt.nlp	23416930	SENT42	27	27	21	21	resveratrol	p53		7157	0.672
NULL	Bone_Joint_Res_2014_Nov_1_3(11)_310-316.nxml.txt.nlp	25376625	SENT100	20	20	7	7	collagenase	F12	PA449107	2161	0.672
NULL	J_Exp_Clin_Cancer_Res_2009_Oct_7_28(1)_134.nxml.txt.nlp	19811659	SENT95	3	3	15	15	dasatinib	DDR2	PA162372878	4921	0.672
NULL	Arthritis_Res_Ther_2014_Jan_31_16(1)_R37.nxml.txt.nlp	24479426	SENT117	11	11	4	4	collagenase	LRP5	PA449107	4041	0.672
NULL	Br_J_Cancer_2009_Jan_27_100(2)_251-258.nxml.txt.nlp	19165196	SENT22	15	15	19	19	capecitabine	ACRC	PA448771	93953	0.672
NULL	Arthritis_Res_Ther_2006_May_11_8(3)_209.nxml.txt.nlp	16712713	SENT123	23	23	6	6	piroxicam	AAP	PA450985	5345	0.672
NULL	FEBS_Open_Bio_2014_Jan_6_4_77-89.nxml.txt.nlp	24490132	SENT198	28	28	21	21	ebselen	GDH	PA161660841	51084;2746	0.672
NULL	Cancer_Med_2013_Aug_30_2(4)_457-467.nxml.txt.nlp	24156018	SENT112	4	4	16	16	marimastat	U87	PA164748329	677775;641648	0.672
NULL	Infect_Drug_Resist_2010_Oct_13_3_103-114.nxml.txt.nlp	21694899	SENT238	8	8	26	26	etravirine	TRIO	PA166014703	7204	0.672
NULL	Oncol_Lett_2013_Feb_7_5(2)_440-446.nxml.txt.nlp	23420122	SENT247	7	7	0	0	sorafenib	Gem	PA7000	51053	0.672
NULL	Arthritis_Res_2002_May_9_4(Suppl_3)_S183-S188.nxml.txt.nlp	12110138	SENT165	19	19	34	34	dextran	NK1	PA449261	11126	0.672
NULL	Exp_Ther_Med_2014_Feb_19_7(2)_389-392.nxml.txt.nlp	24396411	SENT10	21	21	15	15	metformin	AMPK	PA450395	5563	0.672
NULL	Braz_J_Med_Biol_Res_2014_May_23_47(7)_548-553.nxml.txt.nlp	24863648	SENT38	27	27	20	20	l-glutamine	F12	PA10090	2161	0.672
NULL	Mol_Cancer_2007_Aug_21_6_53.nxml.txt.nlp	17711579	SENT217	4	4	10	10	cisplatin	p53	PA449014	7157	0.672
NULL	Mol_Med_Rep_2014_Nov_5_10(5)_2334-2340.nxml.txt.nlp	25189202	SENT174	10	10	12	12	ceftazidime	CFP	PA448861	5199	0.672
NULL	Cancers_(Basel)_2014_Mar_26_6(2)_708-722.nxml.txt.nlp	24675568	SENT107	27	27	10	10	afatinib	IL-6	PA165981154	3569	0.672
NULL	J_Ginseng_Res_2012_Jan_36(1)_40-46.nxml.txt.nlp	23717102	SENT170	19	19	24	24	thrombin	TXAS	PA451674	6916	0.672
NULL	Chemother_Res_Pract_2011_Sep_21_2011_839742.nxml.txt.nlp	22295206	SENT145	13	13	6	6	tegafur	CRT	PA452620	811	0.672
NULL	Front_Neurosci_2014_Jun_3_8_128.nxml.txt.nlp	24917782	SENT91	26	26	30	30	ethanol	POMC	PA448073	5443	0.672
NULL	Clin_Ophthalmol_2010_Nov_23_4_1355-1359.nxml.txt.nlp	21179218	SENT70	8	8	20	20	latanoprost	BAK	PA164774763	578	0.672
NULL	Nat_Methods_2011_Jun_24_8(6)_487-493.nxml.txt.nlp	21516115	SENT67	30	30	17	17	erlotinib	EGF	PA134687924	1950	0.672
NULL	Asian_J_Androl_2014_Apr_8_May-Jun_16(3)_372-377.nxml.txt.nlp	24759579	SENT54	0	0	6	6	bevacizumab	San	PA130232992	80218	0.672
NULL	Aging_(Albany_NY)_2011_Aug_22_3(8)_782-793.nxml.txt.nlp	21869459	SENT109	13	13	21	21	doxorubicin	AC3	PA449412	109	0.672
NULL	Front_Endocrinol_(Lausanne)_2013_Jun_10_4_69.nxml.txt.nlp	23772224	SENT953	4	4	7	7	metformin	apelin	PA450395	8862	0.671
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Apr_18_65(Pt_5)_o1066.nxml.txt.nlp	21583882	SENT55	22	22	39	39	ethanol	mol	PA448073	90527	0.671
NULL	Mol_Cancer_2010_Mar_2_9_47.nxml.txt.nlp	20196847	SENT79	8	8	24	24	paclitaxel	SFN	PA450761	25996;2810	0.671
NULL	Carcinogenesis_2013_Mar_7_34(3)_703-712.nxml.txt.nlp	23222814	SENT89	0	0	19	19	curcumin	CDK6	PA151958596	1021	0.671
NULL	Clin_Interv_Aging_2010_Nov_19_5_345-354.nxml.txt.nlp	21228900	SENT124	12	12	17	17	denosumab	RANK	PA166048634	8792	0.671
NULL	Cell_Cycle_2012_Aug_1_11(15)_2947-2955.nxml.txt.nlp	22828653	SENT182	9	9	36	36	paraformaldehyde	FANCD2	PA450790	2177	0.671
NULL	Diabetes_Metab_Syndr_Obes_2010_Oct_27_3_363-372.nxml.txt.nlp	21437106	SENT117	44	44	41	41	exenatide	GLP-1	PA164749238	100125288	0.671
NULL	Biochemistry_2013_Oct_15_52(41)_7167-7169.nxml.txt.nlp	24083983	SENT29	5	5	24	24	cyclosporine	P-gp	PA449167	5243	0.671
NULL	Arthritis_Res_Ther_2008_Aug_18_10(4)_R93.nxml.txt.nlp	18710567	SENT142	32	32	9	9	etanercept	IL-23	PA449515	51561	0.671
NULL	Angiogenesis_2012_Jun_2_15(2)_275-286.nxml.txt.nlp	22382585	SENT92	27	27	23	23	celecoxib	CTX	PA448871	1593	0.671
NULL	Breast_Cancer_Res_2011_Nov_23_13(6)_R116.nxml.txt.nlp	22113133	SENT68	4	4	16	16	estradiol	DES	PA449503	1674	0.671
NULL	Gut_Liver_2013_Sep_11_7(5)_560-568.nxml.txt.nlp	24073314	SENT120	7	7	4	4	lansoprazole	ATP4A	PA450180	495	0.671
NULL	Biotechnol_Res_Int_2013_Dec_1_2013_253286.nxml.txt.nlp	24363937	SENT6	17	17	19	19	urea	DAP	PA451831	23549;3375;1611	0.671
NULL	Cancer_Microenviron_2008_Dec_20_1(1)_103-111.nxml.txt.nlp	19308689	SENT32	7	7	20	20	thrombin	PAFR	PA451674	64582	0.671
NULL	Indian_J_Pharmacol_2008_Oct_40(Suppl_2)_S112-S142.nxml.txt.nlp	21593965	SENT1383	8	8	14	14	perindopril	STZ	PA450877	6484	0.671
NULL	Curr_Med_Chem_2014_Jul_21_663-688.nxml.txt.nlp	24251566	SENT355	3	3	31	31	celecoxib	CA1	PA448871	759	0.671
NULL	Niger_Med_J_2014_Jul-Aug_55(4)_327-332.nxml.txt.nlp	25114369	SENT15	14	14	21	21	pyrazinamide	EMB	PA451182	133418	0.671
NULL	Curr_Opin_Organ_Transplant_2015_Feb_8_20(1)_94-102.nxml.txt.nlp	25565444	SENT69	13	13	9	9	tacrolimus	SPK	PA451578	55872;8189	0.671
NULL	Int_J_Endocrinol_2011_Aug_21_2011_742719.nxml.txt.nlp	21869886	SENT262	38	38	31	31	clopidogrel	DES	PA449053	1674	0.671
NULL	Front_Immunol_2014_Apr_23_5_188.nxml.txt.nlp	24795730	SENT139	17	17	8	8	nitrogen	TNF	PA450643	7124	0.671
NULL	Behav_Neurol_2014_Nov_16_2014_360978.nxml.txt.nlp	25477708	SENT99	7	7	34	34	nicotine	P56	PA450626	8999	0.671
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT288	32	32	8	8	cetuximab	KRAS	PA10040	3845	0.671
NULL	Crit_Care_2006_Feb_3_10(1)_R24.nxml.txt.nlp	16469128	SENT107	28	28	12	12	heparin	MARS	PA449855	4141	0.671
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT49	31	31	3	3	coumarin	CYP3A	PA134521193	1574	0.671
NULL	Oncol_Lett_2014_Jan_29_7(1)_183-188.nxml.txt.nlp	24348845	SENT132	14	14	26	26	paclitaxel	PC3	PA450761	57332;7832;5122	0.671
NULL	Brain_Sci_2013_Apr_26_3(2)_670-703.nxml.txt.nlp	24961420	SENT1089	8	8	5	5	ethanol	GDNF	PA448073	2668	0.671
NULL	Br_J_Pharmacol_2014_Feb_24_171(1)_1019-1032.nxml.txt.nlp	24251620	SENT121	8	8	19	19	nifedipine	TRPM3	PA450631	80036	0.671
NULL	Evid_Based_Complement_Alternat_Med_2011_Feb_14_2011_650263.nxml.txt.nlp	21799686	SENT13	9	9	7	7	atropine	AKT2	PA448505	208	0.671
NULL	Allergy_Asthma_Immunol_Res_2014_Nov_19_6(6)_548-557.nxml.txt.nlp	25374755	SENT88	6	6	19	19	lovastatin	MUC5AC	PA450272	4586	0.671
NULL	Clin_Sci_(Lond)_2013_Feb_1_124(Pt_3)_153-164.nxml.txt.nlp	23075334	SENT184	6	6	16	16	resveratrol	p53		7157	0.671
NULL	Biomed_Res_Int_2014_Aug_6_2014_967826.nxml.txt.nlp	25165721	SENT72	26	26	10	10	taurine	p53	PA451590	7157	0.671
NULL	Eur_J_Clin_Microbiol_Infect_Dis_2012_May_7_31(5)_739-745.nxml.txt.nlp	21822974	SENT63	6	6	19	19	linezolid	VAN	PA450233	10318	0.671
NULL	J_Immunol_Res_2014_May_21_2014_371087.nxml.txt.nlp	24963497	SENT309	11	11	7	7	decitabine	DAC	PA164749631	13	0.671
NULL	Case_Rep_Hematol_2013_Sep_5_2013_708489.nxml.txt.nlp	24083040	SENT128	12	12	9	9	iron	B12	PA450087	7126;4709	0.671
NULL	Mol_Cancer_2008_Oct_23_7_82.nxml.txt.nlp	18947424	SENT680	47	47	32	32	cyclosporine	P-gp	PA449167	5243	0.671
NULL	Breast_Cancer_Res_2012_Feb_8_14(1)_R26.nxml.txt.nlp	22316048	SENT294	14	14	17	17	letrozole	aromatase	PA450196	1588	0.671
NULL	Breast_Cancer_Res_Treat_2013_Jan_13_137(2)_471-482.nxml.txt.nlp	23239151	SENT195	20	20	28	28	carboplatin	HER2	PA448803	2064	0.671
NULL	Cases_J_2009_Oct_30_2_176.nxml.txt.nlp	19946487	SENT4	0	0	6	6	bevacizumab	San	PA130232992	80218	0.671
NULL	Braz_J_Med_Biol_Res_2013_Jun_25_46(6)_528-532.nxml.txt.nlp	23802228	SENT83	5	5	24	24	rosiglitazone	survivin	PA451283	332	0.671
NULL	Br_J_Cancer_2009_Sep_15_101(6)_957-966.nxml.txt.nlp	19738618	SENT191	9	9	11	11	trastuzumab	THBS-1	PA451743	7057	0.671
NULL	Cancer_Immunol_Immunother_2015_Oct_7_64_61-73.nxml.txt.nlp	25287778	SENT220	34	34	30	30	lenalidomide	CD56	PA162363968	4684	0.671
NULL	Front_Genet_2012_Nov_5_3_236.nxml.txt.nlp	23133441	SENT396	14	14	7	7	efavirenz	CYP2B6	PA449441	1555	0.671
NULL	Oncotarget_2011_Apr_20_2(4)_274-276.nxml.txt.nlp	21512204	SENT19	3	3	7	7	nutlin-3	PLK1		5347	0.671
NULL	Int_J_Surg_Oncol_2012_May_17_2012_406830.nxml.txt.nlp	22675625	SENT63	0	0	13	13	bevacizumab	VEGF-A	PA130232992	7422	0.671
NULL	Breast_Cancer_Res_2009_Jul_15_11(4)_207.nxml.txt.nlp	19664181	SENT112	31	31	19	19	lapatinib	HER2	PA152241907	2064	0.671
NULL	J_Hum_Genet_2009_Sep_24_54(9)_516-524.nxml.txt.nlp	19629138	SENT103	18	18	10	10	doxycycline	POLG	PA449415	5428	0.671
NULL	Genetics_2013_Jan_193(1)_1-50.nxml.txt.nlp	23275493	SENT190	7	7	32	32	lipase	DAG	PA450239	1605	0.671
NULL	Acta_Pharmacol_Sin_2010_Mar_22_31(3)_329-340.nxml.txt.nlp	20173759	SENT193	9	9	14	14	ethanol	MEF2D	PA448073	4209	0.671
NULL	Iran_J_Pharm_Res_2013_Summer_12(3)_457-469.nxml.txt.nlp	24250652	SENT147	14	14	22	22	indomethacin	spatial	PA449982	219793	0.671
NULL	Oncotarget_2011_Nov_9_2(11)_850-861.nxml.txt.nlp	22081665	SENT145	13	13	16	16	daunorubicin	DNMT3A	PA449212	1788	0.671
NULL	Oncol_Lett_2013_Feb_7_5(2)_440-446.nxml.txt.nlp	23420122	SENT247	18	18	0	0	sorafenib	Gem	PA7000	51053	0.671
NULL	Breast_Cancer_Res_2009_Jul_15_11(4)_207.nxml.txt.nlp	19664181	SENT226	13	13	20	20	trastuzumab	HER2	PA451743	2064	0.671
NULL	Arthritis_Res_Ther_2004_Nov_7_6(1)_R56-R64.nxml.txt.nlp	14979938	SENT188	6	6	17	17	collagenase	p38	PA449107	10598;1432;7965	0.671
NULL	J_Vet_Med_Sci_2014_Jul_18_76(7)_937-945.nxml.txt.nlp	24646457	SENT123	18	18	40	40	cefpodoxime	OTC	PA164746385	5009	0.671
NULL	Cancer_Cell_Int_2012_Feb_21_12_5.nxml.txt.nlp	22353776	SENT128	8	8	20	20	sorafenib	MAT1A	PA7000	4143	0.671
NULL	J_Thromb_Haemost_2014_May_22_12(5)_748-760.nxml.txt.nlp	24612393	SENT119	13	13	2	2	thrombin	PI3	PA451674	5266	0.671
NULL	Mol_Cell_Proteomics_2012_Feb_6_11(2)_M111_015222.nxml.txt.nlp	22147731	SENT295	18	18	14	14	cetuximab	CLDN4	PA10040	1364	0.671
NULL	J_Cell_Mol_Med_2013_Jun_4_17(6)_713-722.nxml.txt.nlp	23551576	SENT131	6	6	31	31	cblb502	TLR5		7100	0.671
NULL	Cell_Biol_Int_Rep_(2010)_2012_Jun_21_19(1)_e00017.nxml.txt.nlp	23124518	SENT163	20	20	22	22	etoposide	TRAIL	PA449552	8743	0.671
NULL	Pharmaceuticals_(Basel)_2011_Nov_10_4(11)_1488-1502.nxml.txt.nlp	NULL	SENT198	15	15	13	13	trastuzumab	PTEN	PA451743	5728	0.671
NULL	Mol_Cancer_2012_Jun_26_11_43.nxml.txt.nlp	22731636	SENT130	13	13	27	27	pp2	PP2		4888	0.671
NULL	Clin_Epigenetics_2011_May_7_2(2)_249-256.nxml.txt.nlp	22704340	SENT139	7	7	31	31	l-methionine	GAD1	PA450423	2571	0.671
NULL	Int_J_Mol_Sci_2013_Aug_14_14(8)_16719-16731.nxml.txt.nlp	23949634	SENT167	34	34	15	15	thrombin	TPC	PA451674	8030;60386	0.671
NULL	Indian_J_Pharm_Sci_2013_Jan-Feb_75(1)_94-98.nxml.txt.nlp	23901167	SENT69	16	16	33	33	bupropion	CYP2C9	PA448687	1559	0.671
NULL	Nat_Neurosci_2012_Sep_5_15(9)_1245-1254.nxml.txt.nlp	22864611	SENT53	5	5	32	32	fluoxetine	mGlu3	PA449673	2913	0.671
NULL	J_Cell_Biol_1998_Jan_12_140(1)_171-182.nxml.txt.nlp	9425165	SENT167	10	10	19	19	paraformaldehyde	CD95	PA450790	355	0.671
NULL	Arthritis_Rheum_2013_Sep_26_65(9)_2290-2300.nxml.txt.nlp	23740547	SENT200	19	19	6	6	doxycycline	S100A8	PA449415	6279	0.671
NULL	Pharmaceuticals_(Basel)_2011_Jan_25_4(2)_244-272.nxml.txt.nlp	NULL	SENT194	0	0	12	12	cinacalcet	PTH	PA164776671	5741	0.671
NULL	Diabetes_Care_2013_Jan_11_36(1)_e13.nxml.txt.nlp	23264296	SENT26	12	12	0	0	glucose	JAMA	PA449773	50848	0.671
NULL	Aging_(Albany_NY)_2009_Sep_25_1(10)_845-854.nxml.txt.nlp	20157557	SENT201	10	10	7	7	doxorubicin	p53	PA449412	7157	0.671
NULL	Oncol_Lett_2014_Sep_19_8(3)_1320-1322.nxml.txt.nlp	25120716	SENT35	5	5	7	7	gemcitabine	GEM	PA449748	2669	0.671
NULL	Cardiovasc_J_Afr_2013_Apr_24(3)_78-81.nxml.txt.nlp	23736131	SENT72	12	12	19	19	hemin	HO-1	PA449849	3162	0.671
NULL	Br_J_Cancer_2012_Apr_24_106(9)_1543-1550.nxml.txt.nlp	22531721	SENT135	15	15	19	19	trastuzumab	CD46	PA451743	4179	0.671
NULL	Br_J_Pharmacol_2014_Aug_17_171(15)_3651-3665.nxml.txt.nlp	24712679	SENT275	2	2	6	6	exenatide	GLP-1	PA164749238	100125288	0.671
NULL	Protein_Cell_2014_Jun_19_5(6)_469-479.nxml.txt.nlp	24748116	SENT171	10	10	26	26	paclitaxel	EB1	PA450761	9167;22919;10982	0.671
NULL	Cell_Commun_Signal_2013_Jan_11_11_2.nxml.txt.nlp	23305203	SENT239	15	15	0	0	forskolin	RACK1	PA146096022	10399	0.671
NULL	Case_Rep_Med_2010_Dec_26_2010_403237.nxml.txt.nlp	21209804	SENT16	16	16	14	14	cyclophosphamide	CHOP	PA449165	1649	0.671
NULL	Cancers_(Basel)_2013_Jul_4_5(3)_838-856.nxml.txt.nlp	24202322	SENT206	28	28	24	24	camptothecin	p53	PA153590860	7157	0.671
NULL	Front_Chem_2013_Jul_12_1_10.nxml.txt.nlp	24790939	SENT132	17	17	13	13	hydroquinone	mol	PA449924	90527	0.671
NULL	Exp_Diabetes_Res_2012_Mar_15_2012_146194.nxml.txt.nlp	22474415	SENT213	5	5	8	8	valsartan	GLP-1	PA451848	100125288	0.671
NULL	Mult_Scler_Int_2014_Jul_22_2014_436764.nxml.txt.nlp	25152817	SENT83	28	28	17	17	natalizumab	IFN	PA164747191	3439	0.671
NULL	Allergy_Asthma_Immunol_Res_2014_Mar_15_6(2)_126-130.nxml.txt.nlp	24587948	SENT109	8	8	14	14	salbutamol	TTN	PA448068	7273	0.671
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Jul_20_69(Pt_8)_o1276.nxml.txt.nlp	24109358	SENT72	10	10	28	28	benzaldehyde	mol	PA448571	90527	0.671
NULL	Eur_J_Clin_Pharmacol_2014_Oct_8_70(12)_1433-1441.nxml.txt.nlp	25291992	SENT140	4	4	8	8	risperidone	OCM	PA451257	654231	0.671
NULL	Child_Adolesc_Psychiatry_Ment_Health_2009_Mar_12_3_9.nxml.txt.nlp	19284622	SENT44	35	35	21	21	ziprasidone	PES	PA451974	23481	0.671
NULL	Evid_Based_Complement_Alternat_Med_2012_Dec_1_2012_417346.nxml.txt.nlp	22203872	SENT51	0	0	20	20	collagenase	San	PA449107	80218	0.671
NULL	Nutr_J_2014_Sep_4_13(1)_88.nxml.txt.nlp	NULL	SENT82	37	37	0	0	ethanol	Men	PA448073	8178	0.671
NULL	Clinics_(Sao_Paulo)_2013_May_68(5)_592-598.nxml.txt.nlp	23778413	SENT84	33	33	17	17	epirubicin	HIF2A	PA449476	2034	0.671
NULL	Cancer_Cell_Int_2011_May_15_11_13.nxml.txt.nlp	21569620	SENT74	0	0	15	15	bortezomib	PC-3	PA10252	692094	0.671
NULL	Clin_Exp_Otorhinolaryngol_2011_Jun_31_4(2)_77-82.nxml.txt.nlp	21716954	SENT159	3	3	5	5	minocycline	Bcl-2	PA450519	596	0.671
NULL	Front_Endocrinol_(Lausanne)_2013_Sep_18_4_128.nxml.txt.nlp	24065955	SENT351	8	8	15	15	fluoxetine	c-fos	PA449673	2353	0.671
NULL	BMB_Rep_2014_Jan_47(1)_1-7.nxml.txt.nlp	24388105	SENT68	12	12	14	14	pravastatin	LOX-1	PA451089	4973	0.671
NULL	J_Biol_Eng_2009_Oct_16_3_18.nxml.txt.nlp	19835592	SENT138	21	21	39	39	chloramphenicol	CPZ	PA448927	8532	0.671
NULL	Front_Immunol_2012_Jan_24_3_3.nxml.txt.nlp	22566889	SENT191	24	24	11	11	rituximab	CHOP	PA451261	1649	0.671
NULL	J_Neurol_2013_Feb_4_260(2)_351-367.nxml.txt.nlp	22760942	SENT520	20	20	33	33	naproxen	IFN	PA450595	3439	0.671
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT189	6	6	14	14	ranibizumab	PlGF-2	PA164746012	5228	0.671
NULL	Br_J_Cancer_1997_75(10)_1447-1453.nxml.txt.nlp	9166936	SENT23	7	7	2	2	melphalan	TNF-alpha	PA450354	7124	0.671
NULL	Small_GTPases_2012_Oct_1_3(4)_202-208.nxml.txt.nlp	22858691	SENT28	4	4	0	0	lipase	PLD2	PA450239	5338	0.671
NULL	Front_Immunol_2012_Feb_6_3_11.nxml.txt.nlp	22566897	SENT117	9	9	11	11	bleomycin	IL-22	PA448645	50616;53342	0.671
NULL	Braz_J_Med_Biol_Res_2013_Dec_10_46(12)_1033-1039.nxml.txt.nlp	24345912	SENT181	7	7	13	13	ethanol	IL-6	PA448073	3569	0.671
NULL	Ann_Lab_Med_2013_Jan_17_33(1)_86-88.nxml.txt.nlp	23301230	SENT52	22	22	12	12	cefepime	CTX	PA164754876	1593	0.671
NULL	Front_Comput_Neurosci_2014_Jul_1_8_64.nxml.txt.nlp	25071536	SENT538	3	3	5	5	ethanol	spatial	PA448073	219793	0.671
NULL	Front_Neurosci_2014_Jan_31_8_6.nxml.txt.nlp	24550768	SENT223	12	12	27	27	vanillin	ANOVA	PA451852	4858	0.671
NULL	Int_J_Mol_Sci_2012_Dec_5_13(12)_16514-16543.nxml.txt.nlp	23443116	SENT258	44	44	25	25	l-carnitine	CO2	PA450154	4513	0.671
NULL	Case_Rep_Transplant_2012_Nov_4_2012_305920.nxml.txt.nlp	23213610	SENT44	14	14	10	10	everolimus	EVL	PA164746311	51466	0.671
NULL	Clin_Ophthalmol_2007_Jun_1(2)_93-97.nxml.txt.nlp	19668496	SENT87	22	22	6	6	betaxolol	CNTF	PA448611	1270	0.671
NULL	Biomed_Res_Int_2013_Dec_31_2013_273498.nxml.txt.nlp	23484100	SENT8	6	6	1	1	genistein	OTC	PA165109660	5009	0.671
NULL	F1000Res_2014_Feb_4_3_35.nxml.txt.nlp	24715978	SENT74	24	24	16	16	choline	B12	PA448976	7126;4709	0.671
NULL	Pediatr_Cardiol_2010_Jan_14_31(1)_90-95.nxml.txt.nlp	19915892	SENT113	35	35	18	18	palivizumab	AAP	PA164748781	5345	0.671
NULL	Cancer_Cell_Int_2014_Jun_11_14_49.nxml.txt.nlp	24991192	SENT4	12	12	38	38	berberine	AMPK	PA165860812	5563	0.671
NULL	ScientificWorldJournal_2014_Dec_9_2014_808320.nxml.txt.nlp	25548793	SENT120	31	31	12	12	heparin	RAC	PA449855	207	0.671
NULL	J_Neurochem_2010_Jun_113(5)_1177-1187.nxml.txt.nlp	20374431	SENT203	11	11	15	15	forskolin	P2X1	PA146096022	5023	0.671
NULL	J_Hematol_Oncol_2013_Jun_3_6_38.nxml.txt.nlp	23731980	SENT187	14	14	23	23	paclitaxel	HER2	PA450761	2064	0.671
NULL	Cell_Death_Differ_2010_Mar_16_17(3)_499-512.nxml.txt.nlp	19834490	SENT116	25	25	12	12	bevacizumab	VEGFR2	PA130232992	3791	0.671
NULL	Biomed_Res_Int_2013_Oct_21_2013_386784.nxml.txt.nlp	24228246	SENT34	14	14	26	26	estradiol	CYP2A6	PA449503	1548	0.671
NULL	Mol_Cancer_2007_Oct_11_6_63.nxml.txt.nlp	17931419	SENT85	3	3	8	8	gefitinib	EGFR	PA131301952	1956	0.671
NULL	J_Cell_Mol_Med_2014_Jan_21_18(1)_15-26.nxml.txt.nlp	24256364	SENT189	30	30	21	21	salmeterol	CRHR1	PA451300	1394	0.671
NULL	Front_Immunol_2013_May_15_4_116.nxml.txt.nlp	23720663	SENT15	9	9	11	11	cyclophosphamide	CTX	PA449165	1593	0.671
NULL	Exp_Diabetes_Res_2012_Jan_29_2012_159874.nxml.txt.nlp	22319521	SENT230	21	21	33	33	candesartan	Hes1	PA448765	3280	0.671
NULL	Clin_Pharmacol_2013_Dec_9_5_185-192.nxml.txt.nlp	24353446	SENT75	4	4	14	14	clopidogrel	CYP3A4	PA449053	1576	0.671
NULL	J_Gen_Physiol_1924_Jan_20_6(3)_337-347.nxml.txt.nlp	19872075	SENT0	19	19	1	1	trypsin	Gen	PA451806	348654	0.671
NULL	Diabetes_Metab_J_2012_Oct_18_36(5)_328-335.nxml.txt.nlp	23130316	SENT77	9	9	15	15	lipase	PDK4	PA450239	5166	0.671
NULL	J_Korean_Med_Sci_2005_Jun_30_20(3)_456-460.nxml.txt.nlp	15953869	SENT13	2	2	12	12	lipase	UPP1	PA450239	7378	0.671
NULL	Oncotarget_2014_Oct_21_5(22)_11252-11268.nxml.txt.nlp	25361004	SENT120	3	3	5	5	metformin	CLIC1	PA450395	1192	0.671
NULL	Core_Evid_2009_Jun_15_4_181-189.nxml.txt.nlp	20694074	SENT22	0	0	9	9	tocilizumab	IL-6	PA165292659	3569	0.671
NULL	Colomb_Med_(Cali)_45(1)_39-44.nxml.txt.nlp	24970958	SENT30	17	17	14	14	ampicillin	TMP	PA448419	2012	0.671
NULL	Ann_Surg_Treat_Res_2014_Feb_22_86(2)_68-75.nxml.txt.nlp	24761411	SENT154	23	23	13	13	oxaliplatin	survivin	PA131285527	332	0.671
NULL	J_Gen_Physiol_1923_May_20_5(5)_647-659.nxml.txt.nlp	19872026	SENT4	25	25	1	1	trypsin	PDF	PA451806	64146;9518	0.671
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT124	3	3	41	41	metformin	HIP	PA450395	6767;6159;64399;5068	0.671
NULL	Biomed_Res_Int_2014_Jan_20_2014_948427.nxml.txt.nlp	24563867	SENT75	3	3	25	25	buspirone	STZ	PA448689	6484	0.671
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_75-89.nxml.txt.nlp	17912638	SENT375	25	25	7	7	tamoxifen	ATAC	PA451581	6375	0.671
NULL	Eur_J_Clin_Pharmacol_2008_Feb_26_64(2)_133-157.nxml.txt.nlp	18224312	SENT544	11	11	40	40	trimipramine	CYP2C9	PA451791	1559	0.671
NULL	Chin_J_Cancer_2012_Feb_31(2)_100-109.nxml.txt.nlp	22237039	SENT82	24	24	21	21	doxorubicin	P-gp	PA449412	5243	0.671
NULL	Indian_J_Pharm_Sci_2013_May-Jun_75(3)_284-290.nxml.txt.nlp	24082344	SENT18	6	6	17	17	montelukast	FEX	PA450546	8549	0.671
NULL	Diabetes_2011_May_23_60(5)_1458-1466.nxml.txt.nlp	21464445	SENT115	15	15	23	23	lipase	HSL	PA450239	3991	0.671
NULL	Acta_Pharmacol_Sin_2012_May_16_33(5)_682-690.nxml.txt.nlp	22504904	SENT42	14	14	4	4	celecoxib	STAT3	PA448871	6774	0.671
NULL	J_Inflamm_(Lond)_2005_Oct_31_2_14.nxml.txt.nlp	16259633	SENT330	6	6	8	8	staurosporine	IFN	PA165109623	3439	0.671
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT209	2	2	4	4	capsaicin	p53	PA448776	7157	0.671
NULL	Breast_Cancer_Res_2010_Oct_14_12(5)_R84.nxml.txt.nlp	20946630	SENT269	22	22	19	19	choline	SLC44A1	PA448976	23446	0.671
NULL	Nat_Med_2013_Sep_11_19(9)_1147-1152.nxml.txt.nlp	23933984	SENT92	26	26	19	19	vasopressin	FGF21	PA451858	26291	0.671
NULL	Front_Neurosci_2012_May_30_6_77.nxml.txt.nlp	22661925	SENT186	0	0	2	2	ethanol	DCX	PA448073	1641	0.671
NULL	J_Infect_Dis_2014_May_1_209(9)_1469-1478.nxml.txt.nlp	24286983	SENT108	24	24	26	26	vancomycin	VAN	PA451850	10318	0.671
NULL	Breast_Cancer_Res_Treat_2012_Jul_31_134(1)_199-205.nxml.txt.nlp	22290080	SENT172	6	6	31	31	estradiol	c-fos	PA449503	2353	0.671
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT34	11	11	2	2	imatinib	CML	PA10804	613	0.671
NULL	Nat_Commun_2014_Nov_19_5_5479.nxml.txt.nlp	25407222	SENT503	11	11	25	25	dextran	YTS	PA449261	8565	0.671
NULL	Mol_Cancer_2012_Mar_21_11_13.nxml.txt.nlp	22436134	SENT56	11	11	2	2	doxorubicin	HuR	PA449412	1994	0.671
NULL	J_Exp_Med_2000_May_15_191(10)_1789-1798.nxml.txt.nlp	10811871	SENT91	31	31	27	27	tetracycline	p53	PA451640	7157	0.671
NULL	Oncol_Lett_2014_Mar_19_7(3)_674-678.nxml.txt.nlp	24527071	SENT39	12	12	20	20	cisplatin	AKR1C2	PA449014	1646	0.671
NULL	Biologics_2009_Jul_13_3_289-301.nxml.txt.nlp	19707416	SENT199	37	37	25	25	capecitabine	HER2	PA448771	2064	0.671
NULL	Mol_Biol_Cell_2013_Sep_1_24(17)_2678-2688.nxml.txt.nlp	23864716	SENT186	13	13	10	10	thrombin	Rho	PA451674	29984	0.671
NULL	Biol_Proced_Online_2004_Mar_19_6_35-54.nxml.txt.nlp	15103398	SENT369	37	37	3	3	kanamycin	IF2	PA450137	9669	0.671
NULL	Indian_J_Pharm_Sci_2008_Jan-Feb_70(1)_102-105.nxml.txt.nlp	20390092	SENT40	5	5	19	19	lansoprazole	LAN	PA450180	9993	0.671
NULL	Biosci_Rep_2012_Apr_1_32(Pt_2)_105-112.nxml.txt.nlp	22115362	SENT129	2	2	21	21	infliximab	IL-6	PA452639	3569	0.671
NULL	Int_J_Biol_Sci_2014_Sep_21_10(10)_1108-1115.nxml.txt.nlp	25332685	SENT191	7	7	9	9	dexmedetomidine	DMT	PA449256	2039	0.671
NULL	Gut_2008_Jul_4_57(7)_923-929.nxml.txt.nlp	18252749	SENT2	1	1	3	3	capsaicin	TRPV1	PA448776	7442	0.671
NULL	Oxid_Med_Cell_Longev_2012_Aug_9_2012_794237.nxml.txt.nlp	22928087	SENT234	8	8	21	21	hemin	AMPK	PA449849	5563	0.671
NULL	Tumour_Biol_2013_Apr_29_34(2)_661-668.nxml.txt.nlp	23192642	SENT17	22	22	13	13	sorafenib	EGF	PA7000	1950	0.671
NULL	Nat_Med_2011_Aug_28_17(9)_1094-1100.nxml.txt.nlp	21873989	SENT30	2	2	12	12	imatinib	CD4	PA10804	920	0.671
NULL	Infect_Dis_Obstet_Gynecol_2008_May_29_2008_493508.nxml.txt.nlp	18528520	SENT134	23	23	18	18	tetracycline	CDR1	PA451640	1038	0.671
NULL	J_Int_AIDS_Soc_2012_Feb_17_15_7.nxml.txt.nlp	22340703	SENT172	14	14	19	19	dapsone	CD4	PA449211	920	0.671
NULL	Cardiovasc_J_Afr_2008_Oct_19(5)_246-253.nxml.txt.nlp	18997985	SENT161	28	28	14	14	indomethacin	EDRF	PA449982	51327	0.671
NULL	Angiogenesis_2010_Dec_7_13(4)_305-315.nxml.txt.nlp	20927579	SENT163	2	2	11	11	resveratrol	TSP1		7057	0.671
NULL	Int_J_Environ_Res_Public_Health_2011_Dec_30_8(12)_4460-4476.nxml.txt.nlp	22408583	SENT173	11	11	3	3	erythromycin	ST5	PA449493	6764	0.671
NULL	Case_Rep_Rheumatol_2014_Jul_3_2014_358567.nxml.txt.nlp	25097790	SENT60	2	2	11	11	etanercept	IL-2	PA449515	3558	0.671
NULL	Biochimie_2015_Jan_108_40-47.nxml.txt.nlp	25447146	SENT194	8	8	16	16	chymotrypsin	TFP	PA448994	7034	0.671
NULL	Biomed_Res_Int_2013_Dec_30_2013_253483.nxml.txt.nlp	24490151	SENT184	18	18	14	14	carrageenan	IL-8	PA448814	3576	0.671
NULL	Virol_J_2010_Oct_20_7_279.nxml.txt.nlp	20961433	SENT155	2	2	18	18	trypsin	GP2	PA451806	2813	0.671
NULL	Mol_Cancer_2010_Apr_23_9_87.nxml.txt.nlp	20416058	SENT262	27	27	9	9	etoposide	TRAIL	PA449552	8743	0.671
NULL	Infect_Dis_Rep_2012_Mar_5_4(1)_e22.nxml.txt.nlp	24470929	SENT220	10	10	12	12	starch	HSS	PA451492	9043;2671;6448;80025	0.671
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S279-S284.nxml.txt.nlp	21525469	SENT63	17	17	11	11	exenatide	GLP-1	PA164749238	100125288	0.671
NULL	Environ_Microbiol_2013_Jan_15_15(1)_297-304.nxml.txt.nlp	23157680	SENT51	43	43	45	45	tetracycline	TMP	PA451640	2012	0.671
NULL	Mol_Cell_Biochem_2015_Oct_8_398(1-2)_165-173.nxml.txt.nlp	25292312	SENT143	27	27	11	11	bortezomib	ORP150	PA10252	10525	0.671
NULL	Biol_Open_2014_Sep_12_3(10)_895-903.nxml.txt.nlp	25217617	SENT320	16	16	33	33	kanamycin	SOC	PA450137	91544	0.671
NULL	Clin_Med_Insights_Cardiol_2010_Oct_11_4_89-93.nxml.txt.nlp	20981132	SENT89	34	34	40	40	benazepril	TNF	PA448561	7124	0.671
NULL	Int_J_Med_Sci_2013_Jan_3_10(2)_141-147.nxml.txt.nlp	23329885	SENT33	22	22	10	10	s-adenosylmethionine	GAMT	PA164754994	2593	0.671
NULL	Exp_Ther_Med_2013_Mar_21_5(3)_987-991.nxml.txt.nlp	23407636	SENT94	11	11	13	13	losartan	CX3CR1	PA450268	1524	0.671
NULL	Front_Physiol_2015_Jan_5_5_501.nxml.txt.nlp	25601838	SENT42	22	22	20	20	thrombin	ADP	PA451674	23038	0.671
NULL	Biologics_2014_Apr_23_8_183-192.nxml.txt.nlp	24790411	SENT145	7	7	21	21	afatinib	EGFR	PA165981154	1956	0.671
NULL	Nat_Commun_2013_4_1966.nxml.txt.nlp	23739662	SENT81	21	21	28	28	doxycycline	ORF	PA449415	537	0.671
NULL	Iran_J_Public_Health_2011_Sep_30_40(3)_63-70.nxml.txt.nlp	23113087	SENT167	19	19	9	9	glucose	FBS	PA449773	64319;26269	0.671
NULL	Toxins_(Basel)_2011_Apr_29_3(5)_420-441.nxml.txt.nlp	22069717	SENT84	3	3	19	19	galactose	gamma	PA449725	9913	0.671
NULL	Ann_Oncol_2009_Nov_23_20(11)_1803-1812.nxml.txt.nlp	19549706	SENT21	7	7	14	14	sunitinib	IFN	PA162372840	3439	0.671
NULL	J_Geriatr_Cardiol_2012_Sep_9(3)_305-317.nxml.txt.nlp	23097661	SENT156	17	17	11	11	cholestyramine	STAR	PA448974	6770;2984	0.671
NULL	J_Int_AIDS_Soc_2010_Nov_8_13(Suppl_4)_P82.nxml.txt.nlp	NULL	SENT5	38	38	20	20	atazanavir	CD4	PA10251	920	0.671
NULL	Ann_Thorac_Med_2013_Apr-Jun_8(2)_109-115.nxml.txt.nlp	23741274	SENT167	25	25	32	32	docetaxel	CRT	PA449383	811	0.671
NULL	Biomed_Opt_Express_2013_Mar_1_4(4)_490-499.nxml.txt.nlp	23577284	SENT52	17	17	36	36	l-glutamine	CO2	PA10090	4513	0.671
NULL	Mol_Cancer_2009_Nov_24_8_109.nxml.txt.nlp	19930708	SENT50	8	8	10	10	exemestane	aromatase	PA449563	1588	0.671
NULL	Acta_Histochem_Cytochem_2010_May_1_43(2)_61-68.nxml.txt.nlp	20514293	SENT62	8	8	2	2	hyaluronan	LYVE-1	PA165958431	10894	0.671
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT110	17	17	30	30	curcumin	cIAP2	PA151958596	330	0.671
NULL	Korean_J_Anesthesiol_2013_Jan_21_64(1)_47-53.nxml.txt.nlp	23372886	SENT119	19	19	10	10	bupivacaine	PTG	PA135057240	5507	0.671
NULL	Indian_J_Dermatol_2012_Mar-Apr_57(2)_157-158.nxml.txt.nlp	22615522	SENT26	7	7	5	5	cyclophosphamide	CHOP	PA449165	1649	0.671
NULL	Emerg_Infect_Dis_2011_Mar_17(3)_495-497.nxml.txt.nlp	21392442	SENT32	28	28	9	9	levofloxacin	EMB	PA450214	133418	0.671
NULL	Mol_Cancer_2009_Aug_25_8_66.nxml.txt.nlp	19706164	SENT230	12	12	29	29	oxygen	p53	PA450744	7157	0.671
NULL	Infect_Ecol_Epidemiol_2012_Mar_27_2_10_3402_iee_v2i0_7438.nxml.txt.nlp	22957135	SENT59	14	14	16	16	vancomycin	VAN	PA451850	10318	0.671
NULL	Breast_Cancer_Res_2002_Jul_29_4(5)_202-204.nxml.txt.nlp	12223125	SENT97	7	7	4	4	tamoxifen	ATAC	PA451581	6375	0.671
NULL	Clin_Toxicol_(Phila)_2007_Jun_20_Jun-Aug_45(5)_565-570.nxml.txt.nlp	17558630	SENT156	21	21	28	28	methacholine	Rho	PA165958382	29984	0.671
NULL	Adv_Hematol_2010_Aug_25_2010_268921.nxml.txt.nlp	20862197	SENT147	11	11	5	5	decitabine	IFN	PA164749631	3439	0.671
NULL	Subst_Abuse_Rehabil_2013_Nov_6_4_75-82.nxml.txt.nlp	24648790	SENT129	0	0	7	7	guaifenesin	OTC	PA449818	5009	0.671
NULL	J_Cell_Mol_Med_2014_Sep_3_18(9)_1840-1850.nxml.txt.nlp	24894955	SENT243	32	32	3	3	ethanol	TFR1	PA448073	7037	0.671
NULL	Mol_Vis_2010_Sep_12_16_1848-1853.nxml.txt.nlp	21031022	SENT51	5	5	11	11	bevacizumab	San	PA130232992	80218	0.671
NULL	J_Cell_Mol_Med_2014_Dec_7_18(12)_2536-2552.nxml.txt.nlp	25287328	SENT326	22	22	12	12	tamoxifen	PKD1	PA451581	5310	0.671
NULL	AIDS_Res_Ther_2014_Aug_4_11_25.nxml.txt.nlp	25120580	SENT64	3	3	9	9	voriconazole	CYP3A4	PA10233	1576	0.67
NULL	Br_J_Anaesth_2014_Jul_22_113(1)_157-167.nxml.txt.nlp	24154701	SENT244	3	3	8	8	sevoflurane	TREK-1	PA451341	3776	0.67
NULL	Oxid_Med_Cell_Longev_2013_Nov_28_2013_568093.nxml.txt.nlp	24379901	SENT94	11	11	16	16	resveratrol	p53		7157	0.67
NULL	Oncotarget_2011_Dec_24_2(12)_896-917.nxml.txt.nlp	22203527	SENT261	19	19	8	8	metformin	p53	PA450395	7157	0.67
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1046.nxml.txt.nlp	24503538	SENT203	38	38	42	42	oxaliplatin	FGFR4	PA131285527	2264	0.67
NULL	Mol_Neurodegener_2010_Nov_10_5_50.nxml.txt.nlp	21067605	SENT151	13	13	32	32	l-glutamine	CO2	PA10090	4513	0.67
NULL	J_Geriatr_Cardiol_2012_Sep_9(3)_305-317.nxml.txt.nlp	23097661	SENT154	28	28	12	12	colestipol	FATS	PA449096	118611	0.67
NULL	Nat_Commun_2013_4_2910.nxml.txt.nlp	24335996	SENT70	6	6	35	35	prazosin	GRAF3	PA451093	143872	0.67
NULL	Br_J_Cancer_2009_May_5_100(9)_1379-1384.nxml.txt.nlp	19401697	SENT4	18	18	10	10	bortezomib	EGFR	PA10252	1956	0.67
NULL	Br_J_Cancer_2013_Feb_19_108(3)_557-563.nxml.txt.nlp	23361053	SENT112	11	11	8	8	tamoxifen	PAK1	PA451581	5585;5058	0.67
NULL	Cancer_Med_2013_Jun_23_2(3)_296-304.nxml.txt.nlp	23930206	SENT183	33	33	23	23	erlotinib	EGFR	PA134687924	1956	0.67
NULL	Breast_Cancer_Res_2007_Dec_18_9(6)_216.nxml.txt.nlp	18190723	SENT150	33	33	20	20	bevacizumab	KDR	PA130232992	3791	0.67
NULL	Eur_J_Clin_Pharmacol_2012_Sep_15_68(9)_1267-1274.nxml.txt.nlp	22418828	SENT102	2	2	8	8	pantoprazole	CYP2C19	PA450774	1557	0.67
NULL	Sci_Rep_2015_Jan_15_5_7817.nxml.txt.nlp	25588710	SENT205	14	14	2	2	trastuzumab	MPL	PA451743	4352	0.67
NULL	Br_J_Cancer_1998_Nov_78(10)_1361-1367.nxml.txt.nlp	9823980	SENT15	22	22	10	10	dextromethorphan	NAT2	PA449273	10;81539	0.67
NULL	Case_Rep_Crit_Care_2014_Aug_19_2014_242703.nxml.txt.nlp	25215245	SENT246	11	11	4	4	nicardipine	APE	PA450620	55704;328	0.67
NULL	Oncol_Lett_2013_Mar_8_5(3)_805-812.nxml.txt.nlp	23426281	SENT9	9	9	18	18	gemcitabine	survivin	PA449748	332	0.67
NULL	Chin_J_Cancer_2012_Feb_31(2)_58-72.nxml.txt.nlp	22098952	SENT238	16	16	3	3	vinblastine	MRP7	PA451877	89845;1080	0.67
NULL	Oncotarget_2013_Nov_24_4(12)_2186-2207.nxml.txt.nlp	24327604	SENT119	21	21	14	14	bortezomib	P-gp	PA10252	5243	0.67
NULL	J_Mol_Signal_2011_Aug_12_6_9.nxml.txt.nlp	21838893	SENT248	20	20	16	16	formoterol	SSTR5	PA134687907	6755	0.67
NULL	Acta_Pharmacol_Sin_2012_Nov_4_33(11)_1387-1394.nxml.txt.nlp	22659624	SENT54	13	13	16	16	bivalirudin	ACT	PA10032	12;11332;9457;641455	0.67
NULL	Genet_Mol_Biol_2009_Sep_1_Jul-Sep_32(3)_516-520.nxml.txt.nlp	21637514	SENT65	0	0	8	8	estradiol	IGF1	PA449503	3479	0.67
NULL	Biomed_Res_Int_2014_Apr_14_2014_209163.nxml.txt.nlp	24822183	SENT309	5	5	12	12	staurosporine	ZO-1	PA165109623	7082	0.67
NULL	Ann_Rheum_Dis_2013_Aug_21_72(8)_1287-1294.nxml.txt.nlp	22915624	SENT226	19	19	28	28	methotrexate	MRI	PA450428	78996	0.67
NULL	J_Biol_2004_Aug_23_3(4)_15.nxml.txt.nlp	15345036	SENT347	28	28	17	17	paraformaldehyde	E12	PA450790	64100	0.67
NULL	J_Anaesthesiol_Clin_Pharmacol_2012_Oct-Dec_28(4)_510-513.nxml.txt.nlp	23225936	SENT30	20	20	4	4	bupivacaine	CSE	PA135057240	1433	0.67
NULL	Int_J_Gen_Med_2011_Jul_20_4_539-545.nxml.txt.nlp	21845063	SENT155	17	17	13	13	miglitol	adiponectin	PA164776726	9370	0.67
NULL	J_Korean_Med_Sci_2010_Jan_26_25(1)_110-116.nxml.txt.nlp	20054409	SENT149	25	25	0	0	cyclophosphamide	BCS	PA449165	617	0.67
NULL	Acta_Pharmacol_Sin_2014_Aug_21_35(8)_994-1004.nxml.txt.nlp	25042549	SENT205	3	3	5	5	berberine	PCSK9	PA165860812	255738	0.67
NULL	Clin_Endosc_2013_Jul_31_46(4)_311-312.nxml.txt.nlp	23964324	SENT28	12	12	5	5	midazolam	solo	PA450496	55701	0.67
NULL	Diabetes_2009_Dec_31_58(12)_2851-2862.nxml.txt.nlp	19720788	SENT149	10	10	5	5	forskolin	CHOP	PA146096022	1649	0.67
NULL	J_Mol_Signal_2014_Aug_8_9_8.nxml.txt.nlp	25237386	SENT279	34	34	42	42	streptomycin	CO2	PA451512	4513	0.67
NULL	Arthritis_Res_Ther_2010_Jul_7_12(4)_R131.nxml.txt.nlp	20609215	SENT205	32	32	5	5	iloprost	TFPI2	PA164746843	7980	0.67
NULL	Clin_J_Gastroenterol_2014_Jun_6_7(4)_355-360.nxml.txt.nlp	25132867	SENT2	10	10	7	7	ribavirin	IFN	PA451241	3439	0.67
NULL	Cell_Death_Dis_2011_Aug_11_2(8)_e191.nxml.txt.nlp	21833029	SENT63	41	41	4	4	oxaliplatin	CT26	PA131285527	168400	0.67
NULL	Cell_Commun_Signal_2013_Oct_1_11_73.nxml.txt.nlp	24083678	SENT193	1	1	16	16	sulindac	A20	PA451565	7128;28935	0.67
NULL	Leukemia_2014_Jun_17_28(6)_1216-1226.nxml.txt.nlp	24301524	SENT6	3	3	31	31	bortezomib	p50	PA10252	958;4790	0.67
NULL	Breast_Cancer_Res_2007_Oct_19_9(5)_111.nxml.txt.nlp	17983482	SENT4	18	18	8	8	trastuzumab	HER3	PA451743	2065	0.67
NULL	BMB_Rep_2014_Jan_47(1)_33-38.nxml.txt.nlp	24209634	SENT112	6	6	13	13	cisplatin	CXCR4	PA449014	7852	0.67
NULL	ScientificWorldJournal_2012_Apr_29_2012_842348.nxml.txt.nlp	22649325	SENT189	30	30	26	26	ciprofloxacin	GIT	PA449009	5034	0.67
NULL	Indian_J_Pharmacol_2014_Nov-Dec_46(6)_627-632.nxml.txt.nlp	25538335	SENT163	23	23	16	16	metformin	Q10	PA450395	27161	0.67
NULL	Asian-Australas_J_Anim_Sci_2014_Dec_27(12)_1783-1793.nxml.txt.nlp	25358373	SENT178	0	0	3	3	capsaicin	PPARG	PA448776	5468	0.67
NULL	Environ_Health_Perspect_2013_May_22_121(5)_551-557.nxml.txt.nlp	23434795	SENT172	8	8	12	12	hyaluronan	AHR	PA165958431	196	0.67
NULL	Arch_Toxicol_2014_Nov_5_88(12)_2135-2190.nxml.txt.nlp	25370008	SENT1064	25	25	32	32	minoxidil	SULT	PA450521	6816	0.67
NULL	Biomed_Res_Int_2014_Apr_10_2014_292017.nxml.txt.nlp	24818137	SENT70	35	35	26	26	nadh	MT-ND6	PA164755085	4541	0.67
NULL	Acta_Neuropathol_2015_Oct_17_129_81-96.nxml.txt.nlp	25322817	SENT273	2	2	6	6	capsaicin	TRPV1	PA448776	7442	0.67
NULL	Int_J_Environ_Res_Public_Health_2013_Sep_12_10(9)_4274-4305.nxml.txt.nlp	24036486	SENT71	5	5	11	11	ertapenem	HCAP	PA164777032	117159;9126	0.67
NULL	Lab_Invest_2011_Oct_18_91(10)_1414-1426.nxml.txt.nlp	21769085	SENT48	33	33	27	27	hydrocortisone	F12	PA449905	2161	0.67
NULL	J_Mol_Signal_2008_Dec_1_3_18.nxml.txt.nlp	19046439	SENT11	5	5	12	12	metformin	AMPK	PA450395	5563	0.67
NULL	Acta_Pharmacol_Sin_2010_Feb_21_31(2)_145-149.nxml.txt.nlp	20023694	SENT20	13	13	15	15	vasopressin	AVP	PA451858	114548;551	0.67
NULL	Oncol_Rep_2013_Jan_26_29(1)_297-305.nxml.txt.nlp	23129017	SENT201	33	33	22	22	doxycycline	TR2	PA449415	80834;114112;8764	0.67
NULL	Case_Rep_Hematol_2012_Dec_26_2012_803298.nxml.txt.nlp	23326737	SENT17	39	39	41	41	rituximab	CHOP	PA451261	1649	0.67
NULL	Stroke_Res_Treat_2011_Nov_10_2011_212485.nxml.txt.nlp	22135769	SENT125	14	14	18	18	acenocoumarol	CYP4F2	PA452632	8529	0.67
NULL	Diabetes_Care_2009_Oct_8_32(10)_1873-1879.nxml.txt.nlp	19587362	SENT106	26	26	9	9	irbesartan	ANG	PA450084	283	0.67
NULL	Ann_Clin_Transl_Neurol_2014_Dec_21_1(12)_996-1005.nxml.txt.nlp	25574474	SENT20	0	0	19	19	riluzole	P-gp	PA451251	5243	0.67
NULL	Oncotarget_2011_Dec_20_2(12)_1094-1108.nxml.txt.nlp	22190353	SENT88	20	20	11	11	doxorubicin	PUMA	PA449412	27113	0.67
NULL	Clin_Mol_Allergy_2010_Feb_16_8_2.nxml.txt.nlp	20158902	SENT219	16	16	9	9	amoxicillin	CD63	PA448406	967	0.67
NULL	Mol_Cancer_2009_Nov_10_8_99.nxml.txt.nlp	19903356	SENT117	8	8	3	3	paclitaxel	IGFBP3	PA450761	3486	0.67
NULL	Biomed_Res_Int_2013_Dec_4_2013_305089.nxml.txt.nlp	24369011	SENT184	4	4	13	13	dacarbazine	DR5	PA449197	8795	0.67
NULL	Appl_Microbiol_Biotechnol_2012_Feb_11_93(4)_1377-1387.nxml.txt.nlp	22234536	SENT158	26	26	31	31	nadh	mol	PA164755085	90527	0.67
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1699-1708.nxml.txt.nlp	19861960	SENT191	5	5	13	13	dasatinib	Yes	PA162372878	7525	0.67
NULL	BMB_Rep_2013_Nov_46(11)_544-549.nxml.txt.nlp	24152910	SENT51	10	10	7	7	thrombin	HMGB1	PA451674	3146	0.67
NULL	Gut_2012_May_7_61(5)_673-684.nxml.txt.nlp	22315472	SENT303	26	26	16	16	erlotinib	EGFR	PA134687924	1956	0.67
NULL	Contemp_Clin_Dent_2013_Apr-Jun_4(2)_156-161.nxml.txt.nlp	24015002	SENT99	19	19	17	17	chlorhexidine	SRP	PA164776863	90226	0.67
NULL	Int_J_Biol_Sci_2006_Nov_25_3(2)_71-76.nxml.txt.nlp	17205106	SENT188	11	11	9	9	neomycin	TAB1	PA450608	10454	0.67
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT9	6	6	17	17	ranibizumab	VEGF-A	PA164746012	7422	0.67
NULL	Biomed_Res_Int_2014_Feb_17_2014_429198.nxml.txt.nlp	24696850	SENT316	15	15	25	25	cyclophosphamide	FMI	PA449165	10076	0.67
NULL	Br_J_Cancer_2001_Jul_85(2)_303-311.nxml.txt.nlp	11461094	SENT5	21	21	10	10	paclitaxel	JNK	PA450761	5599	0.67
NULL	Front_Genet_2012_May_16_3_77.nxml.txt.nlp	22623924	SENT36	0	0	19	19	ethanol	CD133	PA448073	8842	0.67
NULL	Biologics_2014_Apr_10_8_129-139.nxml.txt.nlp	24748771	SENT85	0	0	4	4	sunitinib	VEGFR	PA162372840	3791	0.67
NULL	J_Inherit_Metab_Dis_2011_Apr_13_34(2)_257-260.nxml.txt.nlp	20625932	SENT4	11	11	23	23	galactose	GALT	PA449725	2592	0.67
NULL	JAKSTAT_2014_Jun_12_3_e29554.nxml.txt.nlp	25105067	SENT55	6	6	9	9	propofol	STAT3	PA451141	6774	0.67
NULL	Br_J_Cancer_2011_Jul_12_105(2)_189-193.nxml.txt.nlp	21694726	SENT99	14	14	2	2	tamoxifen	ATAC	PA451581	6375	0.67
NULL	Neural_Regen_Res_2014_Apr_1_9(7)_749-756.nxml.txt.nlp	25206883	SENT57	14	14	16	16	streptozocin	Xin	PA451514	165904	0.67
NULL	Hum_Genomics_2009_Dec_1_4(2)_91-106.nxml.txt.nlp	20038497	SENT69	17	17	4	4	donepezil	CYP3A4	PA449394	1576	0.67
NULL	J_Gynecol_Oncol_2013_Jan_8_24(1)_66-82.nxml.txt.nlp	23346316	SENT245	13	13	8	8	trastuzumab	HER2	PA451743	2064	0.67
NULL	Mol_Brain_2014_Aug_21_7_59.nxml.txt.nlp	25139109	SENT83	24	24	31	31	chloroquine	TLR4	PA448948	7099	0.67
NULL	J_Med_Case_Reports_2011_Mar_28_5_117.nxml.txt.nlp	21443773	SENT20	6	6	3	3	exenatide	GLP-1	PA164749238	100125288	0.67
NULL	Acta_Pharmacol_Sin_2010_Jun_4_31(6)_741-745.nxml.txt.nlp	20523344	SENT133	3	3	12	12	gemcitabine	Bcl-2	PA449748	596	0.67
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Jul_13_69(Pt_8)_o1242.nxml.txt.nlp	24109332	SENT8	6	6	13	13	indomethacin	mol	PA449982	90527	0.67
NULL	Br_J_Cancer_2013_Jun_25_108(12)_2464-2469.nxml.txt.nlp	23695016	SENT169	28	28	37	37	carboplatin	CRT	PA448803	811	0.67
NULL	Pharmaceuticals_(Basel)_2011_Nov_11_4(11)_1503-1517.nxml.txt.nlp	NULL	SENT116	30	30	16	16	capsaicin	TRPV1	PA448776	7442	0.67
NULL	Clin_Ophthalmol_2014_Jun_3_8_1057-1064.nxml.txt.nlp	24940042	SENT8	1	1	11	11	bevacizumab	CST	PA130232992	9514	0.67
NULL	Cancer_Imaging_2006_Oct_31_6(Spec_No_A)_S126-S130.nxml.txt.nlp	17114065	SENT75	14	14	17	17	trastuzumab	HER-2	PA451743	2064	0.67
NULL	J_Cell_Mol_Med_2013_Dec_6_17(12)_1588-1597.nxml.txt.nlp	24199964	SENT20	13	13	0	0	doxycycline	APT	PA449415	653639	0.67
NULL	Emerg_Infect_Dis_2012_Jun_18(6)_1019-1020.nxml.txt.nlp	22608263	SENT34	26	26	36	36	ciprofloxacin	NXN	PA449009	64359	0.67
NULL	Ann_Saudi_Med_2011_May-Jun_31(3)_279-283.nxml.txt.nlp	21623058	SENT23	26	26	16	16	daclizumab	CD52	PA164764446	1043	0.67
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT31	31	31	13	13	celecoxib	IL-6	PA448871	3569	0.67
NULL	Acta_Neuropathol_2014_May_1_128(1)_99-109.nxml.txt.nlp	24788821	SENT10	9	9	14	14	levodopa	B12	PA450213	7126;4709	0.67
NULL	Patient_Prefer_Adherence_2009_Nov_3_3_31-43.nxml.txt.nlp	19936143	SENT182	6	6	13	13	citalopram	STAR	PA449015	6770;2984	0.67
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT202	5	5	9	9	nutlin-3	TRAIL		8743	0.67
NULL	Exp_Mol_Med_2012_Oct_31_44(10)_603-614.nxml.txt.nlp	22859500	SENT23	17	17	12	12	lipase	HSL	PA450239	3991	0.67
NULL	J_Thromb_Thrombolysis_2011_Nov_26_32(4)_459-466.nxml.txt.nlp	21706290	SENT224	15	15	4	4	clopidogrel	ABCB1	PA449053	5243	0.67
NULL	Exp_Hematol_Oncol_2012_Aug_13_1_19.nxml.txt.nlp	23210921	SENT79	10	10	7	7	cyclophosphamide	CHOP	PA449165	1649	0.67
NULL	Mar_Drugs_2008_Aug_21_6(3)_456-479.nxml.txt.nlp	19005579	SENT120	2	2	23	23	mannitol	CTX	PA450320	1593	0.67
NULL	Physiol_Rep_2014_Nov_26_2(11)_e12208.nxml.txt.nlp	25428948	SENT502	31	31	7	7	lisinopril	NGAL	PA450242	3934	0.67
NULL	J_Cell_Mol_Med_2014_Apr_20_18(4)_709-720.nxml.txt.nlp	24444314	SENT191	7	7	9	9	metformin	Met	PA450395	79811	0.67
NULL	Pain_Ther_2014_Jun_13_3(1)_59-69.nxml.txt.nlp	25135388	SENT128	2	2	8	8	curcumin	HSD1	PA151958596	26871	0.67
NULL	Front_Physiol_2013_May_15_4_103.nxml.txt.nlp	23720630	SENT312	16	16	11	11	simvastatin	PC3	PA451363	57332;7832;5122	0.67
NULL	Clin_Ophthalmol_2013_Dec_21_7_7-14.nxml.txt.nlp	23293509	SENT97	7	7	21	21	tafluprost	BAK	PA165958432	578	0.67
NULL	Emerg_Infect_Dis_2012_Jun_18(6)_1019-1020.nxml.txt.nlp	22608263	SENT34	22	22	36	36	tobramycin	NXN	PA451704	64359	0.67
NULL	Case_Rep_Med_2014_Jan_16_2014_389425.nxml.txt.nlp	24550989	SENT40	17	17	42	42	lipase	CD56	PA450239	4684	0.67
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_May_12_66(Pt_6)_o1310.nxml.txt.nlp	21579405	SENT58	1	1	5	5	coumarin	mol	PA134521193	90527	0.67
NULL	Diabetologia_2010_Jun_27_53(6)_1142-1150.nxml.txt.nlp	20349036	SENT145	0	0	15	15	spermine	AMPK	PA164781199	5563	0.67
NULL	Scientifica_(Cairo)_2012_Sep_3_2012_757890.nxml.txt.nlp	24278738	SENT125	7	7	12	12	curcumin	c-Jun	PA151958596	3725	0.67
NULL	Int_J_Mol_Sci_2014_Mar_5_15(3)_3970-3988.nxml.txt.nlp	24603537	SENT560	19	19	27	27	curcumin	MCH	PA151958596	5367	0.67
NULL	Cancers_(Basel)_2014_Apr_9_6(2)_829-859.nxml.txt.nlp	24722453	SENT280	15	15	27	27	carboplatin	STAT3	PA448803	6774	0.67
NULL	Environ_Health_2013_Apr_16_12_33.nxml.txt.nlp	23590724	SENT29	19	19	25	25	choline	B12	PA448976	7126;4709	0.67
NULL	Front_Pharmacol_2014_Oct_27_5_228.nxml.txt.nlp	25452728	SENT686	0	0	2	2	ethanol	p190RhoGAP	PA448073	2909	0.67
NULL	Acta_Pharmacol_Sin_2010_Oct_27_31(10)_1389-1394.nxml.txt.nlp	20871620	SENT122	12	12	19	19	carbachol	JNK	PA448784	5599	0.67
NULL	J_Cell_Biol_1998_Jun_15_141(6)_1449-1465.nxml.txt.nlp	9628900	SENT412	26	26	28	28	genistein	Gen	PA165109660	348654	0.67
NULL	ScientificWorldJournal_2014_Dec_30_2014_979648.nxml.txt.nlp	25610915	SENT140	27	27	16	16	meropenem	IMP-1	PA164764445	10642	0.67
NULL	Oncoimmunology_2014_Jan_16_3_e27812.nxml.txt.nlp	25061546	SENT13	28	28	23	23	doxycycline	MYC	PA449415	4609	0.67
NULL	Clin_Pediatr_Endocrinol_2007_Dec_7_16(1)_1-9.nxml.txt.nlp	24790338	SENT113	1	1	8	8	hydrocortisone	ACTH	PA449905	5443	0.67
NULL	Nucl_Recept_Signal_2009_Jan_16_7_e001.nxml.txt.nlp	19240808	SENT412	25	25	22	22	paclitaxel	MDR1	PA450761	5243	0.67
NULL	Breast_Cancer_Res_2002_Aug_27_4(6)_213-217.nxml.txt.nlp	12473165	SENT141	14	14	31	31	tamoxifen	ATAC	PA451581	6375	0.67
NULL	J_Inherit_Metab_Dis_2012_Jan_10_35(1)_141-149.nxml.txt.nlp	21556832	SENT49	16	16	13	13	l-arginine	GAMT	PA448478	2593	0.67
NULL	Diabetes_2011_Jun_21_60(6)_1734-1742.nxml.txt.nlp	21498783	SENT4	12	12	14	14	lipase	ATGL	PA450239	57104	0.67
NULL	Case_Rep_Ophthalmol_2010_Aug_18_1(1)_36-41.nxml.txt.nlp	21369348	SENT31	0	0	24	24	fluorescein	hole	PA164746009	80757	0.67
NULL	J_Antimicrob_Chemother_2008_Nov_27_62(5)_929-933.nxml.txt.nlp	18755696	SENT60	14	14	20	20	ceftazidime	CTX	PA448861	1593	0.67
NULL	Oncotarget_2011_Apr_10_2(4)_313-320.nxml.txt.nlp	21487158	SENT124	9	9	14	14	rituximab	IL-2	PA451261	3558	0.67
NULL	Onco_Targets_Ther_2014_May_16_7_761-770.nxml.txt.nlp	24876785	SENT64	27	27	10	10	gefitinib	EGFR	PA131301952	1956	0.67
NULL	Oncogenesis_2012_Apr_16_1(4)_e7.nxml.txt.nlp	23552604	SENT259	16	16	6	6	etoposide	CTRL	PA449552	1506	0.67
NULL	Neural_Plast_2014_May_4_2014_574159.nxml.txt.nlp	24883213	SENT281	9	9	4	4	bromocriptine	PRL	PA448671	5617	0.67
NULL	Bone_2014_Sep_66(100)_240-250.nxml.txt.nlp	24971713	SENT397	4	4	28	28	clodronate	MSX1	PA10239	4487	0.67
NULL	Chin_J_Cancer_2012_Feb_31(2)_73-99.nxml.txt.nlp	22098950	SENT84	28	28	12	12	doxorubicin	TPT	PA449412	23590;6469	0.67
NULL	J_Young_Pharm_2011_Jul-Sep_3(3)_216-220.nxml.txt.nlp	21897661	SENT52	5	5	8	8	ramipril	SLN	PA451223	6588	0.67
NULL	Br_J_Cancer_2011_Jun_7_104(12)_1816-1821.nxml.txt.nlp	21610711	SENT114	5	5	7	7	cisplatin	IL-2	PA449014	3558	0.67
NULL	Ann_Lab_Med_2012_Jul_20_32(4)_298-303.nxml.txt.nlp	22779073	SENT117	16	16	22	22	amikacin	MOX	PA164744372	26002	0.67
NULL	Front_Genet_2014_Nov_28_5_386.nxml.txt.nlp	25506353	SENT270	34	34	40	40	collagenase	F12	PA449107	2161	0.67
NULL	Int_J_Mol_Sci_2014_Nov_7_15(11)_20500-20517.nxml.txt.nlp	25387078	SENT115	31	31	39	39	sorafenib	AKT	PA7000	207	0.67
NULL	J_Lipid_Res_2014_Apr_55(4)_645-658.nxml.txt.nlp	24493834	SENT358	33	33	25	25	lipase	ATGL	PA450239	57104	0.67
NULL	Indian_J_Med_Res_2012_May_135(5)_703-730.nxml.txt.nlp	22771605	SENT344	8	8	17	17	isoniazid	DST	PA450112	667	0.67
NULL	J_Biol_Chem_2013_Feb_1_288(5)_3512-3522.nxml.txt.nlp	23239883	SENT334	12	12	7	7	calcein	mol	PA132595336	90527	0.67
NULL	Clin_Dev_Immunol_2013_Sep_17_2013_791262.nxml.txt.nlp	24151519	SENT176	0	0	10	10	heparin	HMGB1	PA449855	3146	0.67
NULL	Clin_Ophthalmol_2008_Dec_2(4)_743-752.nxml.txt.nlp	19668425	SENT158	21	21	13	13	potassium	TNF	PA451047	7124	0.67
NULL	Hum_Genomics_2008_Sep_1_3(1)_7-16.nxml.txt.nlp	19129086	SENT161	34	34	17	17	rosiglitazone	CYP2C8	PA451283	1558	0.67
NULL	J_Korean_Med_Sci_2013_Feb_29_28(2)_308-314.nxml.txt.nlp	23399960	SENT113	27	27	23	23	gabapentin	IL-6	PA449720	3569	0.67
NULL	Ann_Hematol_2014_Apr_1_93(8)_1371-1380.nxml.txt.nlp	24687382	SENT29	1	1	11	11	lenalidomide	CRBN	PA162363968	51185	0.67
NULL	Oncol_Lett_2014_Jan_29_7(1)_121-124.nxml.txt.nlp	24348832	SENT87	4	4	11	11	cisplatin	Bcl-2	PA449014	596	0.67
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Jul_23_3(7)_e126.nxml.txt.nlp	25054314	SENT73	8	8	5	5	docetaxel	K10	PA449383	3858	0.67
NULL	Front_Neurosci_2014_Dec_5_8_398.nxml.txt.nlp	25538552	SENT220	7	7	24	24	glucose	gamma	PA449773	9913	0.67
NULL	Int_J_Mol_Sci_2014_Oct_6_15(10)_17886-17900.nxml.txt.nlp	25290095	SENT3	29	29	32	32	resveratrol	OPG		690	0.67
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT142	20	20	23	23	simvastatin	survivin	PA451363	332	0.67
NULL	Iran_J_Pharm_Res_2015_Winter_14(1)_27-34.nxml.txt.nlp	25561909	SENT44	8	8	14	14	rifampin	MSN	PA451250	4478	0.67
NULL	Acta_Pharmacol_Sin_2012_Aug_23_33(8)_1095-1100.nxml.txt.nlp	22820908	SENT115	11	11	4	4	ilaprazole	CYP3A	PA165947499	1574	0.67
NULL	J_Hematol_Oncol_2008_Aug_11_1_11.nxml.txt.nlp	18694493	SENT409	21	21	33	33	ketoconazole	C17	PA450146	54360	0.67
NULL	Case_Rep_Transplant_2011_Jan_5_2011_210178.nxml.txt.nlp	23213600	SENT39	29	29	21	21	tacrolimus	CYP3A	PA451578	1574	0.67
NULL	Cancer_Cell_Int_2011_Nov_17_11_40.nxml.txt.nlp	22088142	SENT153	16	16	9	9	gefitinib	MRP2	PA131301952	100130958;57626;1244	0.67
NULL	Cell_Res_2013_Jun_21_23(6)_746-758.nxml.txt.nlp	23689277	SENT62	10	10	8	8	resveratrol	SIRT1		23411	0.67
NULL	Cardiovasc_Diabetol_2011_Dec_22_10_115.nxml.txt.nlp	22189184	SENT130	5	5	14	14	miglitol	GLP-1	PA164776726	100125288	0.67
NULL	Drug_Des_Devel_Ther_2014_Sep_26_8_1613-1619.nxml.txt.nlp	25302016	SENT129	11	11	22	22	nevirapine	CYP3A4	PA450616	1576	0.67
NULL	Diabetes_Care_2009_Jan_32(1)_84-90.nxml.txt.nlp	18931095	SENT181	31	31	29	29	liraglutide	GLP-1	PA165958364	100125288	0.67
NULL	Int_J_Mol_Sci_2013_Aug_14_14(8)_16719-16731.nxml.txt.nlp	23949634	SENT70	11	11	29	29	thrombin	TPC	PA451674	8030;60386	0.67
NULL	Br_J_Cancer_2012_Sep_25_107(7)_1009-1016.nxml.txt.nlp	22948724	SENT67	38	38	8	8	sorafenib	CAIX	PA7000	768	0.67
NULL	Cell_Commun_Signal_2014_May_15_12_34.nxml.txt.nlp	24885272	SENT167	3	3	23	23	heparin	FGF2	PA449855	2247;2258	0.67
NULL	FEBS_Open_Bio_2011_Dec_27_2_1-5.nxml.txt.nlp	23650573	SENT110	4	4	9	9	sunitinib	MDM2	PA162372840	4193	0.67
NULL	Oncotarget_2014_Sep_16_5(20)_9966-9979.nxml.txt.nlp	25294818	SENT68	3	3	6	6	glipizide	CD31	PA449762	5175	0.67
NULL	J_Histochem_Cytochem_2012_Oct_60(10)_749-760.nxml.txt.nlp	22821669	SENT34	0	0	19	19	hyaluronan	TSG-6	PA165958431	7130	0.67
NULL	Arthritis_Res_Ther_2007_May_14_9(3)_210.nxml.txt.nlp	17509159	SENT154	9	9	11	11	hydralazine	DNMT1	PA449894	1786	0.67
NULL	Br_J_Cancer_2010_Jan_5_102(1)_115-123.nxml.txt.nlp	19997099	SENT221	17	17	24	24	oxaliplatin	GEM	PA131285527	2669	0.67
NULL	Front_Endocrinol_(Lausanne)_2014_Oct_9_5_161.nxml.txt.nlp	25346723	SENT418	1	1	3	3	metformin	GLP-1	PA450395	100125288	0.67
NULL	Oncogene_2013_Sep_26_32(39)_10_1038_onc_2012_491.nxml.txt.nlp	23108394	SENT10	22	22	10	10	epirubicin	BRIP1	PA449476	64979;83990	0.67
NULL	Breast_Cancer_Res_Treat_2012_Jun_18_133(3)_937-947.nxml.txt.nlp	22094936	SENT180	20	20	12	12	tamoxifen	CCNE1	PA451581	898	0.67
NULL	Oxid_Med_Cell_Longev_2011_Aug_17_2011_450317.nxml.txt.nlp	21904643	SENT200	12	12	9	9	l-leucine	DTNB	PA450197	1838	0.67
NULL	Biosensors_(Basel)_2013_Jun_28_3(3)_238-258.nxml.txt.nlp	25506422	SENT258	20	20	22	22	etoposide	p53	PA449552	7157	0.67
NULL	Eur_J_Med_Res_2011_Jul_25_16(7)_303-314.nxml.txt.nlp	21813371	SENT59	11	11	29	29	telaprevir	SOC	PA165958354	91544	0.67
NULL	Int_J_Mol_Sci_2014_Oct_8_15(10)_17974-17999.nxml.txt.nlp	25299695	SENT151	19	19	24	24	curcumin	HO-1	PA151958596	3162	0.67
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Jul_23_3(7)_e126.nxml.txt.nlp	25054314	SENT60	33	33	21	21	docetaxel	MRP2	PA449383	100130958;57626;1244	0.67
NULL	J_Cancer_Prev_2014_Mar_19(1)_39-46.nxml.txt.nlp	25337571	SENT84	8	8	5	5	ethanol	JNK	PA448073	5599	0.67
NULL	Oncogenesis_2012_Apr_2_1(4)_e5.nxml.txt.nlp	23552603	SENT573	5	5	14	14	celecoxib	DR5	PA448871	8795	0.67
NULL	Case_Rep_Pediatr_2012_Aug_9_2012_323681.nxml.txt.nlp	22924145	SENT92	1	1	10	10	tocilizumab	IL-6	PA165292659	3569	0.67
NULL	Oncol_Lett_2013_Jul_8_6(1)_75-80.nxml.txt.nlp	23946780	SENT47	22	22	32	32	kanamycin	CO2	PA450137	4513	0.67
NULL	Oncotarget_2014_Dec_1_5(22)_10965-10966.nxml.txt.nlp	25473898	SENT13	27	27	12	12	rituximab	STAT6	PA451261	6778	0.67
NULL	Behav_Brain_Funct_2007_Jun_13_3_28.nxml.txt.nlp	17567902	SENT384	17	17	19	19	vasopressin	AVP	PA451858	114548;551	0.67
NULL	Front_Genet_2012_Oct_10_3_206.nxml.txt.nlp	23087703	SENT361	8	8	17	17	mephenytoin	CYP2C19	PA450373	1557	0.67
NULL	Cancer_Cell_Int_2005_Jul_29_5_24.nxml.txt.nlp	16053526	SENT45	9	9	26	26	estradiol	p53	PA449503	7157	0.67
NULL	Onco_Targets_Ther_2014_Mar_6_7_395-404.nxml.txt.nlp	24623982	SENT105	22	22	2	2	imatinib	IFN	PA10804	3439	0.67
NULL	Mol_Biol_Cell_2014_Jun_1_25(11)_1782-1792.nxml.txt.nlp	24719457	SENT242	21	21	11	11	mecamylamine	BDNF	PA450334	627	0.67
NULL	Nat_Commun_2011_May_24_2_326.nxml.txt.nlp	21610729	SENT61	11	11	2	2	l-tyrosine	TYR	PA451822	7299	0.67
NULL	Semin_Immunol_2014_Aug_26(4)_329-340.nxml.txt.nlp	25028340	SENT489	9	9	24	24	dextran	IL-13	PA449261	3596	0.67
NULL	J_Ophthalmol_2011_Mar_30_2011_584238.nxml.txt.nlp	21584260	SENT27	0	0	7	7	bevacizumab	San	PA130232992	80218	0.67
NULL	Front_Oncol_2012_Sep_14_2_108.nxml.txt.nlp	23050240	SENT16	6	6	20	20	thrombin	spatial	PA451674	219793	0.67
NULL	Front_Genet_2012_Nov_2_3_229.nxml.txt.nlp	23130019	SENT481	13	13	3	3	tamoxifen	UGT	PA451581	7361;7355	0.67
NULL	Mol_Cancer_2010_May_26_9_123.nxml.txt.nlp	20504344	SENT174	11	11	7	7	fludarabine	p53	PA449655	7157	0.67
NULL	Nat_Med_2010_Sep_22_16(9)_998-1000.nxml.txt.nlp	20729864	SENT20	0	0	13	13	staurosporine	LRRK2	PA165109623	120892	0.67
NULL	J_Cell_Biol_2001_Apr_2_153(1)_221-228.nxml.txt.nlp	11285287	SENT43	10	10	26	26	etoposide	TRAIL	PA449552	8743	0.67
NULL	Br_J_Cancer_2009_Mar_24_100(6)_870-873.nxml.txt.nlp	19293806	SENT21	6	6	12	12	gemcitabine	DCK	PA449748	1633	0.67
NULL	Breast_Cancer_Res_2005_Jul_27_7(5)_R753-R764.nxml.txt.nlp	16168121	SENT43	19	19	41	41	l-glutamine	CO2	PA10090	4513	0.67
NULL	Diabetologia_2010_Jan_6_53(1)_1-6.nxml.txt.nlp	19894028	SENT38	22	22	20	20	liraglutide	GLP-1	PA165958364	100125288	0.67
NULL	Can_J_Anaesth_2012_Jun_31_59(6)_516-521.nxml.txt.nlp	22467068	SENT132	27	27	8	8	atorvastatin	STAR	PA448500	6770;2984	0.67
NULL	Cell_Commun_Signal_2011_May_15_9_13.nxml.txt.nlp	21569639	SENT333	27	27	34	34	quinacrine	AKT	PA164745551	207	0.67
NULL	J_Obes_2011_Feb_8_2011_636181.nxml.txt.nlp	21331293	SENT188	3	3	0	0	exenatide	GLP-1	PA164749238	100125288	0.67
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Jun_27_5_15.nxml.txt.nlp	16803618	SENT13	23	23	26	26	gentamicin	LTA	PA449753	4049	0.67
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_May_12_68(Pt_6)_o1668.nxml.txt.nlp	22719463	SENT67	1	1	4	4	benzaldehyde	mol	PA448571	90527	0.67
NULL	Open_AIDS_J_2011_Apr_22_5_44-50.nxml.txt.nlp	21643422	SENT45	13	13	43	43	ritonavir	ATV	PA451260	4683	0.67
NULL	Open_Dent_J_2014_May_16_8_77-84.nxml.txt.nlp	24894571	SENT188	21	21	10	10	minocycline	BOP	PA450519	611;150572	0.67
NULL	Oncotarget_2013_Jun_4_4(5)_772-784.nxml.txt.nlp	23800712	SENT11	22	22	15	15	erlotinib	EGFR	PA134687924	1956	0.67
NULL	Cardiovasc_Res_2010_Mar_1_85(4)_825-835.nxml.txt.nlp	19840952	SENT95	19	19	8	8	staurosporine	CX3CL1	PA165109623	6376	0.67
NULL	Genome_Med_2010_Jun_14_2(6)_37.nxml.txt.nlp	20546595	SENT270	13	13	9	9	doxorubicin	p53	PA449412	7157	0.67
NULL	Eur_J_Pharmacol_2013_Sep_15_716(1-3)_188-202.nxml.txt.nlp	23500200	SENT246	19	19	4	4	abatacept	CD4	PA164747080	920	0.67
NULL	Ann_Lab_Med_2012_Jul_20_32(4)_298-303.nxml.txt.nlp	22779073	SENT117	4	4	10	10	isoniazid	EMB	PA450112	133418	0.67
NULL	J_Invest_Dermatol_2013_Oct_14_133(10)_2332-2339.nxml.txt.nlp	23677168	SENT27	26	26	34	34	choline	LPA	PA448976	4018	0.67
NULL	Oxid_Med_Cell_Longev_2013_Apr_21_2013_412576.nxml.txt.nlp	23710286	SENT238	2	2	9	9	curcumin	NRF1	PA151958596	4899;4779	0.67
NULL	Am_J_Case_Rep_2012_Jun_5_13_96-98.nxml.txt.nlp	23569499	SENT15	11	11	7	7	rituximab	CHOP	PA451261	1649	0.67
NULL	Acta_Pharmacol_Sin_2011_Nov_10_32(11)_1402-1410.nxml.txt.nlp	21986579	SENT205	8	8	32	32	curcumin	CDK4	PA151958596	1019	0.67
NULL	Allergy_Asthma_Clin_Immunol_2007_Mar_15_3(1)_1-9.nxml.txt.nlp	20525147	SENT182	29	29	23	23	chymotrypsin	IFN	PA448994	3439	0.67
NULL	Int_J_Med_Sci_2015_Jan_5_12(2)_135-140.nxml.txt.nlp	25589889	SENT15	11	11	5	5	haloperidol	NMS	PA449841	129521	0.67
NULL	Indian_J_Pharmacol_2013_May-Jun_45(3)_286-288.nxml.txt.nlp	23833375	SENT57	2	2	0	0	tamoxifen	NMU	PA451581	10874	0.67
NULL	J_Cell_Mol_Med_2014_Aug_1_18(8)_1599-1611.nxml.txt.nlp	24889822	SENT263	0	0	7	7	resveratrol	FOXO1		2308	0.67
NULL	Mol_Biol_Cell_2014_Mar_15_25(6)_828-840.nxml.txt.nlp	24478456	SENT61	12	12	10	10	staurosporine	LIMK1	PA165109623	3984	0.67
NULL	Oncotarget_2014_Aug_26_5(17)_7272-7284.nxml.txt.nlp	25261375	SENT201	5	5	19	19	geldanamycin	MUC1	PA152031327	4582	0.67
NULL	Mol_Cells_2014_Mar_31_37(3)_234-240.nxml.txt.nlp	24642709	SENT114	0	0	6	6	capsaicin	HO-1	PA448776	3162	0.67
NULL	Indian_J_Endocrinol_Metab_2013_Jul-Aug_17(4)_636-646.nxml.txt.nlp	23961479	SENT138	11	11	9	9	rosuvastatin	CYP3A4	PA134308647	1576	0.67
NULL	Adv_Hematol_2012_Apr_3_2012_460801.nxml.txt.nlp	22548066	SENT112	23	23	18	18	rituximab	BCL2	PA451261	596	0.67
NULL	Virol_J_2011_May_17_8_234.nxml.txt.nlp	21575275	SENT39	42	42	35	35	ribavirin	IFN	PA451241	3439	0.67
NULL	Cell_Res_2013_Feb_15_23(2)_201-212.nxml.txt.nlp	23318584	SENT33	39	39	5	5	l-cysteine	NLRP3	PA449173	114548	0.67
NULL	Viruses_2014_Dec_5_6(12)_4856-4879.nxml.txt.nlp	25490765	SENT253	37	37	23	23	heparin	NOK	PA449855	55359	0.67
NULL	Clin_Ophthalmol_2007_Sep_1(3)_273-284.nxml.txt.nlp	19668481	SENT182	5	5	12	12	bevacizumab	CRT	PA130232992	811	0.67
NULL	Breast_Cancer_(Auckl)_2009_Sep_2_3_61-75.nxml.txt.nlp	19809577	SENT218	10	10	2	2	genistein	BRCA2	PA165109660	675	0.67
NULL	Acta_Pharmacol_Sin_2012_Feb_3_33(2)_173-181.nxml.txt.nlp	22301857	SENT15	28	28	34	34	liraglutide	GLP	PA165958364	342096	0.67
NULL	Mol_Pain_2013_Jun_10_9_27.nxml.txt.nlp	23758830	SENT75	16	16	11	11	tetracaine	ASIC3	PA451638	9311	0.669
NULL	Exp_Ther_Med_2013_Jan_10_5(1)_11-16.nxml.txt.nlp	23251234	SENT5	25	25	19	19	cetuximab	UST	PA10040	10090	0.669
NULL	J_Korean_Med_Sci_2010_Apr_19_25(4)_557-563.nxml.txt.nlp	20357998	SENT110	18	18	6	6	cisplatin	IL-10	PA449014	3586	0.669
NULL	J_Int_AIDS_Soc_2011_Mar_26_14_14.nxml.txt.nlp	21439074	SENT114	16	16	30	30	lopinavir	ATV	PA450264	4683	0.669
NULL	Nat_Commun_2013_4_10_1038_ncomms3633.nxml.txt.nlp	24129709	SENT256	24	24	5	5	ethanol	CNTF	PA448073	1270	0.669
NULL	Biomed_Res_Int_2013_Dec_30_2013_735835.nxml.txt.nlp	24490170	SENT173	30	30	40	40	desloratadine	FEX	PA164776964	8549	0.669
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_May_5_68(Pt_6)_o1664.nxml.txt.nlp	22719459	SENT59	24	24	12	12	ethanol	mol	PA448073	90527	0.669
NULL	Protein_Cell_2014_Jul_2_5(7)_544-551.nxml.txt.nlp	24691905	SENT72	24	24	8	8	nutlin-3	p53		7157	0.669
NULL	Fibrogenesis_Tissue_Repair_2012_Jul_23_5_11.nxml.txt.nlp	22824096	SENT392	16	16	10	10	thrombin	PAR-1	PA451674	2011;2149	0.669
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT46	8	8	14	14	trastuzumab	HER2	PA451743	2064	0.669
NULL	Front_Oncol_2014_Oct_9_4_277.nxml.txt.nlp	25346912	SENT158	18	18	27	27	epirubicin	CHOP	PA449476	1649	0.669
NULL	Eur_J_Med_Res_2010_Apr_8_15(4)_145-151.nxml.txt.nlp	20554495	SENT65	7	7	27	27	abacavir	HLA-B	PA448004	3106	0.669
NULL	J_Ophthalmol_2009_Mar_9_2009_672178.nxml.txt.nlp	20339449	SENT32	0	0	7	7	bevacizumab	San	PA130232992	80218	0.669
NULL	J_Cell_Biol_2001_Dec_24_155(7)_1319-1332.nxml.txt.nlp	11756480	SENT176	29	29	15	15	staurosporine	LPA	PA165109623	4018	0.669
NULL	Diabetol_Metab_Syndr_2014_Mar_31_6_48.nxml.txt.nlp	24684803	SENT111	28	28	23	23	miglitol	STEP	PA164776726	84867	0.669
NULL	J_Cell_Biol_2005_Nov_7_171(3)_559-568.nxml.txt.nlp	16275757	SENT106	4	4	30	30	heparin	CCN1	PA449855	3491	0.669
NULL	Mol_Biol_Cell_2013_Sep_15_24(18)_2943-2953.nxml.txt.nlp	23904269	SENT281	14	14	10	10	paraformaldehyde	CSK	PA450790	1445	0.669
NULL	AMB_Express_2011_Sep_30_1_26.nxml.txt.nlp	21961566	SENT281	7	7	13	13	papain	Gen	PA450778	348654	0.669
NULL	Behav_Brain_Res_2011_Sep_12_222(1)_274-278.nxml.txt.nlp	21440571	SENT15	12	12	14	14	glucosamine	GSN	PA164747613	2934	0.669
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT1121	16	16	20	20	oxygen	CO2	PA450744	4513	0.669
NULL	Arthritis_Res_Ther_2010_Mar_25_12(2)_R54.nxml.txt.nlp	20338043	SENT37	9	9	21	21	rituximab	BAFF	PA451261	10673	0.669
NULL	Cancers_(Basel)_2011_May_18_3(2)_2444-2461.nxml.txt.nlp	24212818	SENT116	14	14	5	5	estradiol	EGF	PA449503	1950	0.669
NULL	J_Lipid_Res_2010_Sep_51(9)_2775-2784.nxml.txt.nlp	20519739	SENT122	9	9	16	16	amiloride	ETV4	PA448368	2118	0.669
NULL	Arthritis_Res_Ther_2003_Sep_3_5(6)_R317-R328.nxml.txt.nlp	14680506	SENT303	0	0	4	4	rolipram	IL-10	PA153906323	3586	0.669
NULL	Cancer_Med_2014_Feb_10_3(1)_134-142.nxml.txt.nlp	24407937	SENT249	1	1	33	33	letrozole	HER-2	PA450196	2064	0.669
NULL	Ann_Surg_Treat_Res_2014_Feb_22_86(2)_68-75.nxml.txt.nlp	24761411	SENT154	23	23	17	17	oxaliplatin	survivin	PA131285527	332	0.669
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT145	5	5	2	2	capsaicin	p53	PA448776	7157	0.669
NULL	Biol_Open_2014_Nov_21_3(12)_1207-1216.nxml.txt.nlp	25416063	SENT23	17	17	24	24	zinc	NANOS3	PA451956	342977	0.669
NULL	Front_Behav_Neurosci_2014_Sep_19_8_332.nxml.txt.nlp	25285073	SENT845	15	15	3	3	memantine	spatial	PA10364	219793	0.669
NULL	Front_Oncol_2013_Nov_15_3_281.nxml.txt.nlp	24298448	SENT193	14	14	40	40	cetuximab	BRAF	PA10040	673	0.669
NULL	Int_J_Mol_Sci_2013_Aug_15_14(8)_16836-16850.nxml.txt.nlp	23955267	SENT46	9	9	23	23	trastuzumab	HER2	PA451743	2064	0.669
NULL	Front_Cell_Neurosci_2014_Feb_6_8_27.nxml.txt.nlp	24567703	SENT376	16	16	23	23	creatine	KCC2	PA164778930	57468	0.669
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT221	28	28	18	18	heparin	FGF1	PA449855	2246	0.669
NULL	Oncotarget_2013_Oct_19_4(11)_2045-2056.nxml.txt.nlp	24185104	SENT94	6	6	3	3	cisplatin	14-3-3	PA449014	10971	0.669
NULL	Allergy_Asthma_Immunol_Res_2010_Jul_15_2(3)_155-164.nxml.txt.nlp	20592913	SENT106	14	14	29	29	tiotropium	TBXA2R	PA164769056	6915	0.669
NULL	Nucleic_Acids_Res_2011_Sep_17_39(17)_7512-7528.nxml.txt.nlp	21690099	SENT405	15	15	9	9	betaine	bet	PA448603	92737	0.669
NULL	Mol_Immunol_2009_Dec_47(2-3)_485-492.nxml.txt.nlp	19767105	SENT348	0	0	9	9	heparin	I-TAC	PA449855	6373	0.669
NULL	Oncol_Rep_2012_Apr_30_27(4)_923-928.nxml.txt.nlp	22209766	SENT93	5	5	12	12	erlotinib	EGFR	PA134687924	1956	0.669
NULL	Clin_Mol_Hepatol_2014_Sep_25_20(3)_291-299.nxml.txt.nlp	25320733	SENT130	30	30	13	13	tacrolimus	ACR	PA451578	49	0.669
NULL	Nat_Commun_2011_Apr_5_2_269.nxml.txt.nlp	21468021	SENT117	13	13	21	21	tamoxifen	CD4	PA451581	920	0.669
NULL	Clin_Pharmacol_2013_Nov_19_5_167-174.nxml.txt.nlp	24277991	SENT102	32	32	29	29	berberine	P-gp	PA165860812	5243	0.669
NULL	Core_Evid_2011_Mar_17_6_31-42.nxml.txt.nlp	21468241	SENT263	15	15	4	4	clopidogrel	ABCB1	PA449053	5243	0.669
NULL	Contemp_Clin_Dent_2013_Apr-Jun_4(2)_156-161.nxml.txt.nlp	24015002	SENT119	20	20	26	26	chlorhexidine	SRP	PA164776863	90226	0.669
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Sep_20_64(Pt_10)_o1961-o1962.nxml.txt.nlp	21201163	SENT75	20	20	11	11	ethanol	mol	PA448073	90527	0.669
NULL	Leukemia_2013_Jan_11_27(1)_32-40.nxml.txt.nlp	22781593	SENT102	0	0	15	15	ponatinib	FGFR1	PA165980594	2260	0.669
NULL	Indian_J_Anaesth_2014_Jul-Aug_58(4)_423-429.nxml.txt.nlp	25197110	SENT35	6	6	4	4	ondansetron	ODF	PA450705	8600	0.669
NULL	Br_J_Cancer_2009_Mar_10_100(5)_758-763.nxml.txt.nlp	19259094	SENT71	11	11	21	21	belinostat	MLH1		4292	0.669
NULL	J_Immunother_Cancer_2014_Mar_12_2(Suppl_2)_I12.nxml.txt.nlp	NULL	SENT13	1	1	23	23	paclitaxel	IFN	PA450761	3439	0.669
NULL	Int_J_Mol_Sci_2013_Apr_16_14(4)_8291-8305.nxml.txt.nlp	23591843	SENT24	0	0	6	6	bevacizumab	San	PA130232992	80218	0.669
NULL	J_Exp_Med_1998_May_18_187(10)_1633-1640.nxml.txt.nlp	9584141	SENT252	21	21	8	8	copper	ASM	PA449114	6609;283120	0.669
NULL	Biomed_Res_Int_2013_Jul_31_2013_692071.nxml.txt.nlp	23984399	SENT118	12	12	22	22	estradiol	OCT1	PA449503	5451;6580	0.669
NULL	Evid_Based_Complement_Alternat_Med_2011_Feb_13_2011_248481.nxml.txt.nlp	19861508	SENT63	26	26	15	15	phenol	mol	PA450913	90527	0.669
NULL	Int_J_Nephrol_2011_Apr_26_2011_245823.nxml.txt.nlp	21603155	SENT131	30	30	23	23	telaprevir	IFN	PA165958354	3439	0.669
NULL	Front_Oncol_2014_Sep_23_4_264.nxml.txt.nlp	25295231	SENT100	24	24	30	30	lenalidomide	p53	PA162363968	7157	0.669
NULL	Int_J_Biol_Sci_2014_Sep_21_10(10)_1108-1115.nxml.txt.nlp	25332685	SENT159	13	13	15	15	dexmedetomidine	DMT	PA449256	2039	0.669
NULL	Eur_J_Clin_Microbiol_Infect_Dis_2012_May_7_31(5)_739-745.nxml.txt.nlp	21822974	SENT63	2	2	19	19	daptomycin	VAN	PA164768820	10318	0.669
NULL	Int_J_Environ_Res_Public_Health_2013_Sep_17_10(9)_4352-4389.nxml.txt.nlp	24048206	SENT286	0	0	4	4	choline	B12	PA448976	7126;4709	0.669
NULL	Reprod_Biol_Endocrinol_2004_Jan_7_2_2.nxml.txt.nlp	14711377	SENT160	13	13	7	7	thrombin	PAR1	PA451674	79581;2149	0.669
NULL	Croat_Med_J_2012_Aug_53(4)_343-349.nxml.txt.nlp	22911527	SENT54	13	13	7	7	isoproterenol	NIF	PA450121	6280	0.669
NULL	J_Oncol_2012_Sep_18_2012_125278.nxml.txt.nlp	21941547	SENT406	16	16	34	34	cilengitide	VEGFR2	PA164924491	3791	0.669
NULL	J_Hematol_Oncol_2009_Mar_24_2_14.nxml.txt.nlp	19309523	SENT20	5	5	9	9	vincristine	CHOP	PA451879	1649	0.669
NULL	Breast_Cancer_Res_2012_Mar_20_14(2)_R53.nxml.txt.nlp	22433433	SENT318	16	16	7	7	cisplatin	CCNE1	PA449014	898	0.669
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Apr_15_9_13.nxml.txt.nlp	20398300	SENT134	18	18	11	11	moxifloxacin	LAM	PA450555	7249;7248	0.669
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_321-328.nxml.txt.nlp	21372824	SENT178	45	45	16	16	fluvastatin	STZ	PA449688	6484	0.669
NULL	Mol_Vis_2012_May_6_18_1189-1196.nxml.txt.nlp	22605930	SENT212	8	8	16	16	travoprost	BAK	PA164781371	578	0.669
NULL	Ann_Nucl_Med_2014_Jul_8_28(9)_836-850.nxml.txt.nlp	25001261	SENT180	16	16	22	22	acetazolamide	spatial	PA448018	219793	0.669
NULL	Oncotarget_2014_Aug_29_5(17)_7217-7259.nxml.txt.nlp	25277175	SENT644	14	14	30	30	denosumab	RANKL	PA166048634	8600	0.669
NULL	J_Mol_Signal_2010_May_10_5_4.nxml.txt.nlp	20459745	SENT85	41	41	26	26	cisplatin	p53	PA449014	7157	0.669
NULL	Diabetes_2009_Apr_16_58(4)_975-983.nxml.txt.nlp	19151200	SENT175	0	0	2	2	liraglutide	LIR	PA165958364	10871	0.669
NULL	Curr_Neuropharmacol_2009_Jun_7(2)_83-95.nxml.txt.nlp	19949566	SENT474	2	2	32	32	carbamazepine	TGB	PA448785	5473	0.669
NULL	J_Biol_Chem_2012_Apr_27_287(18)_14644-14658.nxml.txt.nlp	22375002	SENT246	14	14	7	7	forskolin	CC2D1A	PA146096022	54862	0.669
NULL	Br_J_Cancer_2011_Jun_28_105(1)_118-123.nxml.txt.nlp	21654685	SENT11	6	6	15	15	dasatinib	HOXC11	PA162372878	3227	0.669
NULL	Iran_J_Pharm_Res_2013_Summer_12(3)_457-469.nxml.txt.nlp	24250652	SENT13	6	6	13	13	indomethacin	spatial	PA449982	219793	0.669
NULL	Biochem_Res_Int_2011_Sep_12_2011_739712.nxml.txt.nlp	21918721	SENT136	4	4	13	13	isoflurane	GAPDH	PA450106	2597	0.669
NULL	Sensors_(Basel)_2010_Jul_23_10(7)_7044-7056.nxml.txt.nlp	22163588	SENT115	3	3	10	10	ethanol	MRF	PA448073	745	0.669
NULL	Acta_Pharmacol_Sin_2009_Jul_22_30(7)_956-964.nxml.txt.nlp	19543298	SENT161	3	3	13	13	atorvastatin	ABCG2	PA448500	9429	0.669
NULL	Acta_Pharmacol_Sin_2010_Mar_22_31(3)_329-340.nxml.txt.nlp	20173759	SENT13	4	4	10	10	ethanol	MEF2A	PA448073	4205	0.669
NULL	Int_J_Mol_Sci_2014_Sep_25_15(9)_17065-17076.nxml.txt.nlp	25257528	SENT56	5	5	16	16	decitabine	SMG1	PA164749631	23049	0.669
NULL	Breast_Cancer_Res_2007_Jun_4_9(3)_207.nxml.txt.nlp	17561991	SENT12	11	11	18	18	trastuzumab	San	PA451743	80218	0.669
NULL	Acta_Pharmacol_Sin_2009_Sep_24_30(9)_1262-1275.nxml.txt.nlp	19701231	SENT148	0	0	6	6	lovastatin	LRP1	PA450272	10438;4035	0.669
NULL	Acta_Pharmacol_Sin_2011_Nov_10_32(11)_1402-1410.nxml.txt.nlp	21986579	SENT235	8	8	39	39	curcumin	CDK2	PA151958596	1017	0.669
NULL	Anal_Bioanal_Chem_2014_Jan_23_406(15)_3667-3680.nxml.txt.nlp	24452745	SENT220	2	2	12	12	ketoprofen	KET	PA450149	8626	0.669
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT557	6	6	16	16	haloperidol	PRL	PA449841	5617	0.669
NULL	Acta_Pharmacol_Sin_2013_Apr_18_34(4)_555-560.nxml.txt.nlp	23503472	SENT38	25	25	20	20	cyclosporine	NR1I2	PA449167	8856	0.669
NULL	Arch_Med_Sci_2014_Aug_29_10(4)_643-650.nxml.txt.nlp	25276146	SENT8	27	27	25	25	sirolimus	DES	PA451365	1674	0.669
NULL	Ann_Clin_Microbiol_Antimicrob_2014_Jan_6_13_2.nxml.txt.nlp	24393536	SENT42	8	8	14	14	gentamicin	TOB	PA449753	10140	0.669
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_9_2013_456747.nxml.txt.nlp	23653662	SENT125	5	5	11	11	berberine	IL1R1	PA165860812	3554	0.669
NULL	Ann_Rheum_Dis_2011_Oct_12_71(4)_541-548.nxml.txt.nlp	21994233	SENT222	8	8	31	31	infliximab	IMPACT	PA452639	55364	0.669
NULL	Small_GTPases_2012_Jan_1_3(1)_53-59.nxml.txt.nlp	22714418	SENT129	32	32	21	21	hyaluronan	MDR1	PA165958431	5243	0.669
NULL	J_Clin_Biochem_Nutr_2010_Jan_29_46(1)_87-92.nxml.txt.nlp	20104270	SENT24	19	19	26	26	hesperidin	STZ	PA449867	6484	0.669
NULL	Nat_Commun_2013_Sep_20_4_2443.nxml.txt.nlp	24051437	SENT13	23	23	18	18	tamoxifen	PHB2	PA451581	11331	0.669
NULL	Acta_Neuropathol_Commun_2013_Aug_9_1_49.nxml.txt.nlp	24252504	SENT111	15	15	39	39	arsenite	ANOVA	PA452638	4858	0.669
NULL	Mol_Cancer_2008_Sep_12_7_70.nxml.txt.nlp	18789133	SENT7	26	26	34	34	belinostat	HDAC1		3065	0.669
NULL	Case_Rep_Gastroenterol_2011_May_3_5(2)_262-266.nxml.txt.nlp	21887126	SENT46	2	2	0	0	cyclophosphamide	CHOP	PA449165	1649	0.669
NULL	Cell_Commun_Signal_2012_Aug_1_10_22.nxml.txt.nlp	22852877	SENT97	3	3	22	22	meloxicam	IL-6	PA450353	3569	0.669
NULL	Br_J_Cancer_2014_Jan_21_110(2)_520-529.nxml.txt.nlp	24335922	SENT136	29	29	34	34	sorafenib	BRAF	PA7000	673	0.669
NULL	Eur_J_Clin_Pharmacol_2014_Oct_8_70(1)_37-45.nxml.txt.nlp	24100471	SENT198	22	22	18	18	pioglitazone	CYP2C8	PA450970	1558	0.669
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT168	15	15	4	4	doxorubicin	SLK	PA449412	9748;2534	0.669
NULL	ScientificWorldJournal_2013_Feb_3_2013_593267.nxml.txt.nlp	23431256	SENT135	5	5	10	10	chloramphenicol	c-Myc	PA448927	4609	0.669
NULL	Front_Behav_Neurosci_2012_Sep_18_6_61.nxml.txt.nlp	23049505	SENT227	27	27	8	8	donepezil	ANOVA	PA449394	4858	0.669
NULL	J_Headache_Pain_2011_Aug_29_12(4)_411-417.nxml.txt.nlp	21626018	SENT28	13	13	28	28	capsaicin	5-HT1B	PA448776	3351	0.669
NULL	Clin_Sarcoma_Res_2014_Jan_31_4_2.nxml.txt.nlp	24484617	SENT123	18	18	27	27	paclitaxel	SPARC	PA450761	6678	0.669
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT28	15	15	20	20	atorvastatin	KRAS	PA448500	3845	0.669
NULL	Br_J_Cancer_2013_Aug_6_109(3)_714-722.nxml.txt.nlp	23799849	SENT213	12	12	4	4	methotrexate	MRP1	PA450428	4437	0.669
NULL	Neural_Regen_Res_2013_Mar_25_8(9)_825-832.nxml.txt.nlp	25206730	SENT123	3	3	24	24	isoflurane	P2X7	PA450106	5027	0.669
NULL	Gastric_Cancer_2013_Jul_12_16(3)_345-354.nxml.txt.nlp	22968820	SENT180	18	18	11	11	oxaliplatin	FANCJ	PA131285527	83990	0.669
NULL	J_Physiol_2009_Feb_15_587(Pt_4)_731-744.nxml.txt.nlp	19074966	SENT260	29	29	16	16	taurine	PAT1	PA451590	10513;206358	0.669
NULL	Br_J_Cancer_2010_Jan_5_102(1)_80-86.nxml.txt.nlp	19920817	SENT123	17	17	14	14	sunitinib	IFN	PA162372840	3439	0.669
NULL	Acta_Vet_Scand_2011_Feb_17_53(1)_11.nxml.txt.nlp	21324209	SENT75	2	2	16	16	ampicillin	OTC	PA448419	5009	0.669
NULL	Biologics_2012_Dec_17_6_429-464.nxml.txt.nlp	23269860	SENT246	17	17	11	11	infliximab	ACR	PA452639	49	0.669
NULL	Front_Endocrinol_(Lausanne)_2013_Nov_11_4_165.nxml.txt.nlp	24273530	SENT96	9	9	0	0	taurine	GAT2	PA451590	6540	0.669
NULL	J_Cell_Mol_Med_2013_May_4_17(5)_672-680.nxml.txt.nlp	23551430	SENT62	26	26	17	17	l-glutamine	CO2	PA10090	4513	0.669
NULL	Breast_Cancer_Res_2007_Aug_8_9(4)_R50.nxml.txt.nlp	17686159	SENT268	17	17	10	10	gefitinib	HRG	PA131301952	3084;3273	0.669
NULL	Cancer_Imaging_2012_Sep_28_12(2)_324-335.nxml.txt.nlp	23023063	SENT231	14	14	7	7	rituximab	CHOP	PA451261	1649	0.669
NULL	Nanoscale_Res_Lett_2014_Feb_15_9(1)_76.nxml.txt.nlp	24528570	SENT120	24	24	21	21	hydroquinone	mol	PA449924	90527	0.669
NULL	Cerebrospinal_Fluid_Res_2008_Jan_11_5_1.nxml.txt.nlp	18186943	SENT34	8	8	32	32	doxycycline	EGFR	PA449415	1956	0.669
NULL	Cancer_Metab_2013_Dec_23_1_23.nxml.txt.nlp	24359630	SENT60	7	7	18	18	glucose	CO2	PA449773	4513	0.669
NULL	Acta_Pharmacol_Sin_2010_Aug_5_31(8)_970-976.nxml.txt.nlp	20686521	SENT27	0	0	12	12	doxorubicin	CDP	PA449412	1523	0.669
NULL	J_Hepatol_2010_Sep_53(3-2)_519-527.nxml.txt.nlp	20579762	SENT283	29	29	15	15	collagenase	p38	PA449107	10598;1432;7965	0.669
NULL	Exp_Ther_Med_2013_May_15_5(5)_1327-1331.nxml.txt.nlp	23737873	SENT5	7	7	9	9	imidapril	AQP2	PA452640	359	0.669
NULL	Crit_Care_2008_Aug_4_12(4)_R99.nxml.txt.nlp	18680591	SENT163	6	6	16	16	milrinone	AVP	PA164749171	114548;551	0.669
NULL	Curr_Neuropharmacol_2014_Jul_12(4)_365-379.nxml.txt.nlp	25342944	SENT462	30	30	10	10	fluoxetine	AKT	PA449673	207	0.669
NULL	Int_J_Environ_Res_Public_Health_2010_Feb_12_7(2)_565-582.nxml.txt.nlp	20616991	SENT168	19	19	10	10	zinc	STP	PA451956	9322	0.669
NULL	Curr_Nutr_Rep_2012_Jul_10_1(3)_132-141.nxml.txt.nlp	24392268	SENT167	3	3	12	12	resveratrol	SIRT1		23411	0.669
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT76	21	21	30	30	l-methionine	p27	PA450423	5715;10534	0.669
NULL	Adv_Urol_2010_Jul_20_2010_687043.nxml.txt.nlp	20721275	SENT18	0	0	13	13	bevacizumab	VEGF-A	PA130232992	7422	0.669
NULL	Pharmaceutics_2011_Nov_18_3(4)_865-913.nxml.txt.nlp	24309312	SENT202	3	3	21	21	lamotrigine	UGT	PA450164	7361;7355	0.669
NULL	Patient_Prefer_Adherence_2010_Dec_2_4_415-424.nxml.txt.nlp	21206517	SENT218	17	17	7	7	clodronate	PAM	PA10239	5066;23077	0.669
NULL	J_Immunol_Res_2014_Oct_12_2014_570685.nxml.txt.nlp	25371908	SENT14	22	22	12	12	levofloxacin	IFN	PA450214	3439	0.669
NULL	Oncoscience_2014_Jun_3_1(6)_434-445.nxml.txt.nlp	25594042	SENT260	10	10	31	31	collagenase	CD133	PA449107	8842	0.669
NULL	Hematol_Rep_2011_Oct_27_3(3)_e20.nxml.txt.nlp	22593812	SENT58	2	2	8	8	eltrombopag	TPO	PA165981594	7066;7173	0.669
NULL	ScientificWorldJournal_2013_Dec_30_2013_565813.nxml.txt.nlp	24489506	SENT235	19	19	10	10	cisplatin	Q10	PA449014	27161	0.669
NULL	Angiogenesis_2010_Dec_7_13(4)_305-315.nxml.txt.nlp	20927579	SENT202	9	9	31	31	resveratrol	HIF-1		29072	0.669
NULL	J_Cell_Biol_1982_Oct_1_95(1)_316-322.nxml.txt.nlp	6982901	SENT2	40	40	11	11	hydroxyurea	EGF	PA449942	1950	0.669
NULL	Core_Evid_2011_Feb_8_6_23-29.nxml.txt.nlp	21468240	SENT84	6	6	35	35	plerixafor	CD34	PA165958410	947	0.669
NULL	J_Physiol_2011_Mar_1_589(Pt_5)_1081-1093.nxml.txt.nlp	21224236	SENT190	39	39	36	36	diazoxide	mol	PA449285	90527	0.669
NULL	Exp_Neurobiol_2013_Mar_31_22(1)_51-57.nxml.txt.nlp	23585723	SENT14	6	6	3	3	capsaicin	TRPV1	PA448776	7442	0.669
NULL	F1000Res_2014_Apr_3_3_83.nxml.txt.nlp	24860645	SENT44	24	24	31	31	baclofen	CMT1A	PA448533	1248	0.669
NULL	Indian_J_Pharmacol_2014_Nov-Dec_46(6)_627-632.nxml.txt.nlp	25538335	SENT168	7	7	5	5	metformin	Q10	PA450395	27161	0.669
NULL	Environ_Health_2010_Aug_18_9_50.nxml.txt.nlp	20718963	SENT131	15	15	18	18	permethrin	Yes	PA164743137	7525	0.669
NULL	Oncol_Rep_2012_Aug_1_28(2)_446-452.nxml.txt.nlp	22664791	SENT8	24	24	7	7	cisplatin	CRT	PA449014	811	0.669
NULL	Eur_J_Clin_Pharmacol_2011_May_2_67(Suppl_1)_87-107.nxml.txt.nlp	21287160	SENT304	13	13	10	10	sn-38	UGT1A1		54658	0.669
NULL	Mol_Cancer_2010_Jun_3_9_137.nxml.txt.nlp	20525240	SENT40	8	8	19	19	curcumin	p53	PA151958596	7157	0.669
NULL	Oncol_Rep_2013_Jun_22_29(6)_2479-2485.nxml.txt.nlp	23525656	SENT115	16	16	11	11	cisplatin	MRP7	PA449014	89845;1080	0.669
NULL	Mol_Pain_2014_Apr_9_10_24.nxml.txt.nlp	24716552	SENT6	22	22	7	7	capsaicin	NK1R	PA448776	6869	0.669
NULL	Nat_Med_2010_Jun_23_16(6)_671-677.nxml.txt.nlp	20495567	SENT191	29	29	24	24	sorafenib	ATF5	PA7000	22809	0.669
NULL	Int_J_Chron_Obstruct_Pulmon_Dis_2006_Sep_1(3)_321-334.nxml.txt.nlp	18046869	SENT57	7	7	25	25	cilomilast	PDE4D	PA165948031	5144	0.669
NULL	Clin_Ophthalmol_2008_Jun_2(2)_355-368.nxml.txt.nlp	19668727	SENT81	22	22	18	18	ketorolac	COX	PA450150	1351	0.669
NULL	Front_Genet_2014_Nov_14_5_391.nxml.txt.nlp	25452763	SENT1057	10	10	0	0	cisplatin	CYP2A6	PA449014	1548	0.669
NULL	Mol_Biol_Cell_2013_Sep_1_24(17)_2678-2688.nxml.txt.nlp	23864716	SENT235	23	23	12	12	thrombin	PP2	PA451674	4888	0.669
NULL	Acta_Vet_Scand_2011_Feb_17_53(1)_11.nxml.txt.nlp	21324209	SENT75	22	22	16	16	chloramphenicol	OTC	PA448927	5009	0.669
NULL	Breast_Cancer_Res_2009_Nov_18_11(6)_R85.nxml.txt.nlp	19922614	SENT103	35	35	14	14	tamoxifen	BCS	PA451581	617	0.669
NULL	Child_Adolesc_Psychiatry_Ment_Health_2009_Mar_19_3_11.nxml.txt.nlp	19298659	SENT174	13	13	19	19	fluoxetine	PROC	PA449673	5624	0.669
NULL	Gastroenterol_Hepatol_Bed_Bench_2011_Spring_4(2)_43-52.nxml.txt.nlp	24834156	SENT104	11	11	13	13	trypsin	TATI	PA451806	6690	0.669
NULL	Br_J_Cancer_2011_Aug_23_105(5)_649-657.nxml.txt.nlp	21811251	SENT180	34	34	36	36	gefitinib	IGF1R	PA131301952	3480	0.669
NULL	Breast_Cancer_Res_2010_Sep_29_12(5)_209.nxml.txt.nlp	21067536	SENT31	0	0	7	7	bevacizumab	San	PA130232992	80218	0.669
NULL	Carcinogenesis_2010_Dec_27_31(12)_2049-2057.nxml.txt.nlp	20876285	SENT260	32	32	9	9	tamoxifen	HER2	PA451581	2064	0.669
NULL	Iran_J_Pharm_Res_2013_Summer_12(3)_457-469.nxml.txt.nlp	24250652	SENT196	10	10	20	20	indomethacin	spatial	PA449982	219793	0.669
NULL	J_Korean_Med_Sci_2010_Feb_21_25(2)_197-202.nxml.txt.nlp	20119570	SENT117	22	22	28	28	tetracycline	VAN	PA451640	10318	0.669
NULL	Int_J_Mol_Sci_2012_Sep_26_13(10)_12336-12348.nxml.txt.nlp	23202901	SENT94	26	26	21	21	phenol	P90	PA450913	821	0.669
NULL	Diabetes_Care_2013_Feb_17_36(2)_185-187.nxml.txt.nlp	23349149	SENT78	11	11	9	9	liraglutide	GLP-1	PA165958364	100125288	0.669
NULL	J_Cell_Sci_2013_Nov_15_126(22)_5259-5270.nxml.txt.nlp	24006262	SENT522	8	8	10	10	hyaluronan	LYVE-1	PA165958431	10894	0.669
NULL	Front_Oncol_2014_Jun_11_4_145.nxml.txt.nlp	24967214	SENT380	13	13	19	19	cyclophosphamide	CD25	PA449165	3669;3559	0.669
NULL	Emerg_Infect_Dis_2013_Jul_19(7)_1138-1141.nxml.txt.nlp	23764343	SENT68	39	39	41	41	isoniazid	ETB	PA450112	1910	0.669
NULL	Emerg_Infect_Dis_2012_Jul_18(7)_1072-1080.nxml.txt.nlp	22709685	SENT65	15	15	20	20	vancomycin	VISA	PA451850	57506	0.669
NULL	Eur_J_Immunol_2014_Jun_10_44(6)_1759-1769.nxml.txt.nlp	24595810	SENT30	0	0	20	20	fludrocortisone	CD4	PA164743961	920	0.669
NULL	EMBO_J_2010_Sep_15_29(18)_3170-3183.nxml.txt.nlp	20676059	SENT243	4	4	7	7	fluoxetine	CTB	PA449673	9468	0.669
NULL	Oncoimmunology_2012_Aug_1_1(5)_699-716.nxml.txt.nlp	22934262	SENT272	8	8	18	18	carboplatin	TLR9	PA448803	54106	0.669
NULL	Clin_Exp_Otorhinolaryngol_2012_Sep_27_5(3)_117-121.nxml.txt.nlp	22977707	SENT28	22	22	14	14	kanamycin	NKCC1	PA450137	6558	0.669
NULL	Hum_Genomics_2009_Jan_1_3(2)_128-142.nxml.txt.nlp	19164090	SENT176	18	18	14	14	carboplatin	CD44	PA448803	960	0.669
NULL	Case_Rep_Genet_2014_Jan_22_2014_413743.nxml.txt.nlp	24627811	SENT71	13	13	20	20	warfarin	CYP2C9	PA451906	1559	0.669
NULL	Curr_Health_Sci_J_2014_Dec_29_Jan-Mar_40(1)_12-17.nxml.txt.nlp	24791199	SENT53	19	19	33	33	olanzapine	ARC	PA450688	8996;23237	0.669
NULL	ScientificWorldJournal_2014_Mar_12_2014_731462.nxml.txt.nlp	24715817	SENT138	13	13	21	21	carrageenan	IL-6	PA448814	3569	0.669
NULL	J_Geriatr_Cardiol_2014_Mar_11(1)_44-49.nxml.txt.nlp	24748881	SENT58	12	12	19	19	clopidogrel	DES	PA449053	1674	0.669
NULL	Nat_Med_2013_Mar_24_19(3)_351-357.nxml.txt.nlp	23435171	SENT23	25	25	5	5	glucose	TSC1	PA449773	7248	0.669
NULL	Br_J_Cancer_2013_Oct_15_109(8)_2155-2166.nxml.txt.nlp	24045666	SENT146	5	5	11	11	cetuximab	IFN	PA10040	3439	0.669
NULL	J_Immunother_Cancer_2013_May_29_1_5.nxml.txt.nlp	24764535	SENT167	10	10	8	8	aldesleukin	IL-2	PA448081	3558	0.669
NULL	Diabetes_2009_Mar_58(3)_527-535.nxml.txt.nlp	19066312	SENT198	6	6	15	15	rosiglitazone	CD36	PA451283	948	0.669
NULL	Am_J_Clin_Nutr_2011_Jul_18_94(1)_337S-342S.nxml.txt.nlp	21593497	SENT248	30	30	22	22	choline	B12	PA448976	7126;4709	0.669
NULL	Br_J_Cancer_2012_Jan_17_106(2)_333-343.nxml.txt.nlp	22166800	SENT160	8	8	12	12	bortezomib	TOP2A	PA10252	7153	0.669
NULL	Cancers_(Basel)_2010_Jun_14_2(2)_1312-1327.nxml.txt.nlp	24281117	SENT645	4	4	0	0	trypsin	TATI	PA451806	6690	0.669
NULL	ScientificWorldJournal_2012_Apr_1_2012_159456.nxml.txt.nlp	22547977	SENT264	31	31	19	19	doxycycline	OTC	PA449415	5009	0.669
NULL	Ann_Gastroenterol_2013_26(3)_233-238.nxml.txt.nlp	NULL	SENT33	21	21	40	40	natalizumab	NAT	PA164747191	6046	0.669
NULL	J_Gen_Physiol_1978_Feb_1_71(2)_223-225.nxml.txt.nlp	641522	SENT0	16	16	1	1	benzocaine	Gen	PA448576	348654	0.669
NULL	Clinics_(Sao_Paulo)_2013_Mar_68(3)_297-303.nxml.txt.nlp	23644847	SENT106	17	17	28	28	cisplatin	p53	PA449014	7157	0.669
NULL	Cancer_Cell_Int_2005_Aug_23_5_27.nxml.txt.nlp	16117829	SENT194	29	29	20	20	doxycycline	p53	PA449415	7157	0.669
NULL	Clin_Med_Insights_Cardiol_2013_Jul_23_7_115-126.nxml.txt.nlp	23926441	SENT17	39	39	19	19	paclitaxel	DES	PA450761	1674	0.669
NULL	Biotechnol_Res_Int_2014_Jul_24_2014_319397.nxml.txt.nlp	25170426	SENT212	30	30	7	7	fluoxetine	mol	PA449673	90527	0.669
NULL	J_Hematol_Oncol_2011_Feb_23_4_8.nxml.txt.nlp	21345215	SENT143	6	6	30	30	bortezomib	CHOP	PA10252	1649	0.669
NULL	Lab_Invest_2010_Oct_28_90(10)_1415-1424.nxml.txt.nlp	20585313	SENT145	9	9	19	19	celecoxib	HRG	PA448871	3084;3273	0.669
NULL	J_Obes_2011_Dec_15_2011_928165.nxml.txt.nlp	21197151	SENT182	0	0	15	15	pramlintide	GIT	PA164781394	5034	0.669
NULL	Front_Neurosci_2012_May_30_6_77.nxml.txt.nlp	22661925	SENT258	34	34	29	29	ethanol	DCX	PA448073	1641	0.669
NULL	Oncol_Lett_2014_Jul_25_8(1)_62-66.nxml.txt.nlp	24959219	SENT20	11	11	15	15	vincristine	CHOP	PA451879	1649	0.669
NULL	Front_Aging_Neurosci_2010_Feb_3_2_2.nxml.txt.nlp	20552042	SENT97	6	6	13	13	nimodipine	CA1	PA450633	759	0.669
NULL	Neuropsychopharmacology_2009_Jul_11_34(8)_1946-1957.nxml.txt.nlp	19279569	SENT124	9	9	29	29	cocaine	DOR	PA449072	58476	0.669
NULL	Mol_Cell_Proteomics_2012_Jul_11(7)_M111_013243.nxml.txt.nlp	22442257	SENT54	37	37	13	13	trypsin	Met	PA451806	79811	0.669
NULL	Mar_Drugs_2012_Aug_20_10(8)_1799-1811.nxml.txt.nlp	23015775	SENT41	2	2	11	11	ether	TLC	PA449525	3933	0.669
NULL	Br_J_Pharmacol_2012_Jan_165(2)_390-400.nxml.txt.nlp	21671897	SENT197	16	16	40	40	suramin	P2X1	PA10292	5023	0.669
NULL	Br_J_Haematol_2008_Jun_141(5)_659-671.nxml.txt.nlp	18410446	SENT154	0	0	12	12	cerulenin	JNK	PA164764551	5599	0.669
NULL	Ther_Clin_Risk_Manag_2006_Mar_2(1)_59-75.nxml.txt.nlp	18360582	SENT224	19	19	24	24	telithromycin	CYP3A4	PA10202	1576	0.669
NULL	Environ_Health_Perspect_1996_Dec_104(Suppl_6)_1177-1182.nxml.txt.nlp	9118890	SENT6	2	2	9	9	hydroquinone	NQO1	PA449924	1728	0.669
NULL	Oncogenesis_2014_May_12_3(5)_e102.nxml.txt.nlp	24819061	SENT204	17	17	11	11	nadh	NQO1	PA164755085	1728	0.669
NULL	Cancer_Cell_Int_2010_Sep_6_10_31.nxml.txt.nlp	20819205	SENT85	27	27	9	9	doxycycline	CIS	PA449415	1154	0.669
NULL	J_Inflamm_(Lond)_2008_Jul_29_5_11.nxml.txt.nlp	18664275	SENT121	15	15	7	7	erythromycin	IL-8	PA449493	3576	0.669
NULL	Mol_Pain_2013_Jun_10_9_27.nxml.txt.nlp	23758830	SENT85	6	6	3	3	tetracaine	ASIC3	PA451638	9311	0.669
NULL	Cell_Commun_Signal_2013_Feb_20_11_13.nxml.txt.nlp	23425659	SENT163	18	18	38	38	clonazepam	IL-6	PA449050	3569	0.669
NULL	Crit_Care_2011_Mar_11_15(Suppl_1)_P91.nxml.txt.nlp	NULL	SENT2	1	1	3	3	vasopressin	AVP	PA451858	114548;551	0.669
NULL	Curr_Control_Trials_Cardiovasc_Med_2001_May_31_2(3)_129-140.nxml.txt.nlp	11806786	SENT407	8	8	16	16	eptifibatide	IMPACT	PA449483	55364	0.669
NULL	Pharmaceuticals_(Basel)_2011_Oct_25_4(11)_1400-1422.nxml.txt.nlp	NULL	SENT23	23	23	25	25	geldanamycin	GdA	PA152031327	5047	0.669
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT168	3	3	7	7	curcumin	TRAIL	PA151958596	8743	0.669
NULL	J_Biol_Chem_2011_Sep_16_286(37)_32684-32696.nxml.txt.nlp	21768105	SENT24	33	33	35	35	lipase	ANGPTL3	PA450239	27329	0.669
NULL	Eur_J_Clin_Pharmacol_2012_Jan_8_68(1)_29-37.nxml.txt.nlp	21739267	SENT12	16	16	18	18	aripiprazole	CYP2D6	PA10026	1565	0.669
NULL	EMBO_J_2008_Jan_23_27(2)_384-393.nxml.txt.nlp	18188154	SENT260	17	17	5	5	forskolin	PDE4D	PA146096022	5144	0.669
NULL	Exp_Ther_Med_2013_Jan_10_5(1)_11-16.nxml.txt.nlp	23251234	SENT5	25	25	9	9	cetuximab	CNTRL	PA10040	11064	0.669
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT32	21	21	19	19	cisplatin	MDM2	PA449014	4193	0.669
NULL	J_Infect_Dis_2014_May_1_209(9)_1469-1478.nxml.txt.nlp	24286983	SENT136	8	8	10	10	linezolid	VAN	PA450233	10318	0.669
NULL	Cancer_Cell_Int_2011_Aug_19_11_29.nxml.txt.nlp	21854619	SENT271	7	7	14	14	cisplatin	BRCA1	PA449014	672	0.669
NULL	J_Physiol_2014_Nov_15_592(22)_5093-5107.nxml.txt.nlp	25239460	SENT128	3	3	10	10	sc-560	Sky		7301	0.669
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT253	1	1	8	8	perifosine	DR5	PA165291471	8795	0.669
NULL	J_Cardiovasc_Dis_Res_2012_Jan-Mar_3(1)_5-11.nxml.txt.nlp	22346138	SENT132	36	36	17	17	repaglinide	IL-6	PA451234	3569	0.669
NULL	Int_J_Biol_Macromol_2012_Mar_1_50(2)_362-368.nxml.txt.nlp	22210486	SENT163	19	19	21	21	lamivudine	LAM	PA450163	7249;7248	0.669
NULL	ScientificWorldJournal_2013_Dec_19_2013_313492.nxml.txt.nlp	24453831	SENT5	19	19	29	29	clopidogrel	VWF	PA449053	7450	0.669
NULL	Eur_J_Clin_Pharmacol_2009_Dec_8_65(12)_1245-1251.nxml.txt.nlp	19669131	SENT171	8	8	24	24	apomorphine	DRD2	PA164781163	1813	0.669
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jan_8_67(Pt_2)_o269.nxml.txt.nlp	21522961	SENT3	23	23	17	17	naphthol	mol	PA154081779	90527	0.669
NULL	Mol_Imaging_Radionucl_Ther_2011_Apr_1_20(1)_1-6.nxml.txt.nlp	23486728	SENT53	0	0	2	2	cisplatin	DBL	PA449014	4168	0.669
NULL	Evid_Based_Complement_Alternat_Med_2012_Sep_25_2012_197309.nxml.txt.nlp	23049605	SENT70	15	15	31	31	l-glutamine	CO2	PA10090	4513	0.669
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT20	21	21	17	17	maytansine	DM1	PA165291473	338023;1760;28509	0.669
NULL	Oncol_Rep_2014_Mar_14_31(3)_1035-1042.nxml.txt.nlp	24424445	SENT144	33	33	23	23	cisplatin	Oct4	PA449014	5460	0.669
NULL	Mol_Brain_2014_Apr_3_7_25.nxml.txt.nlp	24708812	SENT167	0	0	10	10	chlorpheniramine	ERK	PA448960	5594	0.669
NULL	Cancers_(Basel)_2011_Oct_26_3(4)_4024-4045.nxml.txt.nlp	24213123	SENT176	8	8	20	20	curcumin	PTEN	PA151958596	5728	0.668
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jan_18_68(Pt_2)_o440.nxml.txt.nlp	22347051	SENT73	15	15	6	6	ethanol	mol	PA448073	90527	0.668
NULL	Breast_Cancer_Res_2010_Jul_22_12(4)_R53.nxml.txt.nlp	20649975	SENT124	5	5	12	12	tamoxifen	HOXB13	PA451581	10481	0.668
NULL	Int_J_Gen_Med_2012_Oct_25_5_849-859.nxml.txt.nlp	23204853	SENT178	40	40	1	1	hyaluronan	TLR2	PA165958431	7097	0.668
NULL	Clin_Immunol_2010_Oct_137(1-3)_1-4.nxml.txt.nlp	20570568	SENT146	29	29	23	23	itraconazole	TMP	PA450132	2012	0.668
NULL	Front_Behav_Neurosci_2012_Sep_18_6_61.nxml.txt.nlp	23049505	SENT199	17	17	4	4	donepezil	ANOVA	PA449394	4858	0.668
NULL	Nucleic_Acids_Res_2005_Jun_8_33(10)_3283-3291.nxml.txt.nlp	15944449	SENT96	2	2	13	13	melphalan	XPB	PA450354	2071	0.668
NULL	Front_Psychol_2012_Aug_17_3_297.nxml.txt.nlp	22912626	SENT245	9	9	3	3	imipramine	HDAC5	PA449969	10014	0.668
NULL	Cancer_2014_Jan_15_120(2)_229-237.nxml.txt.nlp	24122122	SENT159	9	9	3	3	bevacizumab	VEGF-A	PA130232992	7422	0.668
NULL	J_Cell_Biol_2007_Apr_23_177(2)_265-275.nxml.txt.nlp	17452530	SENT223	34	34	38	38	imiquimod	TLR7	PA449972	51284	0.668
NULL	J_Med_Case_Reports_2008_May_16_2_159.nxml.txt.nlp	18485212	SENT22	28	28	35	35	creatine	G6PD	PA164778930	2539	0.668
NULL	Allergy_Asthma_Clin_Immunol_2010_Jul_28_6(1)_14.nxml.txt.nlp	20667117	SENT7	27	27	7	7	icatibant	C1-INH	PA164749185	710	0.668
NULL	Nat_Neurosci_2011_May_17_14(5)_612-619.nxml.txt.nlp	21499254	SENT122	8	8	18	18	ethanol	GAL4	PA448073	3960	0.668
NULL	Nat_Commun_2013_Oct_1_4_2516.nxml.txt.nlp	24084631	SENT122	12	12	23	23	doxorubicin	AK4	PA449412	205	0.668
NULL	Breast_Cancer_Res_Treat_2014_Apr_6_145(1)_33-44.nxml.txt.nlp	24706169	SENT43	14	14	12	12	trastuzumab	HER2	PA451743	2064	0.668
NULL	Hum_Genomics_2008_Sep_1_3(1)_7-16.nxml.txt.nlp	19129086	SENT12	21	21	6	6	rosiglitazone	CYP2C8	PA451283	1558	0.668
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Nov_17_66(Pt_12)_o3194.nxml.txt.nlp	21589488	SENT60	26	26	14	14	ethanol	mol	PA448073	90527	0.668
NULL	Biomed_Res_Int_2014_Jun_24_2014_132702.nxml.txt.nlp	25050322	SENT172	12	12	6	6	metformin	LKB1	PA450395	6794	0.668
NULL	J_Neurosci_Methods_2011_Sep_30_201(1)_228-238.nxml.txt.nlp	21855577	SENT132	12	12	4	4	dextran	CST	PA449261	9514	0.668
NULL	Front_Neurol_2013_May_15_4_53.nxml.txt.nlp	23720649	SENT272	5	5	25	25	geldanamycin	Hsp90	PA152031327	3320	0.668
NULL	Infect_Drug_Resist_2008_Sep_9_1_27-44.nxml.txt.nlp	21694878	SENT170	15	15	9	9	vancomycin	HAP	PA451850	5915;10313	0.668
NULL	Front_Neural_Circuits_2011_Aug_23_5_9.nxml.txt.nlp	21897809	SENT343	11	11	16	16	forskolin	CNGA2	PA146096022	1260	0.668
NULL	Avicenna_J_Med_2013_Apr-Jun_3(2)_37-47.nxml.txt.nlp	23930241	SENT201	13	13	16	16	methotrexate	CD4	PA450428	920	0.668
NULL	Br_J_Cancer_2013_Mar_5_108(4)_983-992.nxml.txt.nlp	23361057	SENT139	0	0	18	18	cytarabine	MLH1	PA449177	4292	0.668
NULL	Arthritis_Res_Ther_2013_Aug_21_15(4)_R93.nxml.txt.nlp	23965253	SENT19	4	4	17	17	collagenase	MMP13	PA449107	4322	0.668
NULL	Diabetes_2009_Dec_15_58(12)_2766-2775.nxml.txt.nlp	19755527	SENT214	17	17	7	7	fructose	PFK-1	PA449716	5213	0.668
NULL	Biomed_Imaging_Interv_J_2010_Jul_1_6(3)_e23.nxml.txt.nlp	21611042	SENT158	17	17	19	19	carboplatin	TIC	PA448803	23550	0.668
NULL	Chin_J_Cancer_2012_Feb_31(2)_73-99.nxml.txt.nlp	22098950	SENT84	32	32	12	12	mitoxantrone	TPT	PA450526	23590;6469	0.668
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT119	5	5	15	15	l-cysteine	4E-BP1	PA449173	1978	0.668
NULL	Vet_Res_Forum_2013_Winter_4(1)_19-24.nxml.txt.nlp	25593681	SENT9	13	13	1	1	diclofenac	B12	PA449293	7126;4709	0.668
NULL	Cell_Cycle_2013_Sep_15_12(18)_3013-3024.nxml.txt.nlp	23974104	SENT8	21	21	15	15	disulfiram	MYH9	PA449376	4627	0.668
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT191	18	18	12	12	doxorubicin	SLK	PA449412	9748;2534	0.668
NULL	Breast_Cancer_Res_2006_Oct_24_8(5)_R59.nxml.txt.nlp	17062128	SENT15	13	13	8	8	urokinase	IL-6	PA451836	3569	0.668
NULL	Oncotarget_2011_Mar_10_2(3)_186-196.nxml.txt.nlp	21406729	SENT8	13	13	33	33	orlistat	TRAIL	PA164776864	8743	0.668
NULL	Ann_Hematol_2010_Nov_25_89(11)_1115-1124.nxml.txt.nlp	20499237	SENT258	10	10	25	25	simvastatin	Rho	PA451363	29984	0.668
NULL	ScientificWorldJournal_2014_Mar_24_2014_694326.nxml.txt.nlp	24782665	SENT66	10	10	3	3	metformin	FDG	PA450395	23583	0.668
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT795	2	2	18	18	nilotinib	ABCC10	PA165958345	89845	0.668
NULL	Curr_Med_Chem_2012_May_19(14)_2104-2127.nxml.txt.nlp	22414102	SENT929	16	16	11	11	carrageenan	Yes	PA448814	7525	0.668
NULL	Med_Sci_Monit_2013_Nov_14_19_993-1000.nxml.txt.nlp	24226381	SENT181	0	0	5	5	tropisetron	5-HT4	PA161925594	3360	0.668
NULL	Indian_J_Endocrinol_Metab_2011_Oct_15(Suppl4)_S313-S316.nxml.txt.nlp	22145133	SENT122	0	0	8	8	ketoconazole	ACTH	PA450146	5443	0.668
NULL	Cell_Host_Microbe_2010_Sep_16_8(3)_225-235.nxml.txt.nlp	20833374	SENT314	3	3	13	13	thrombin	MKP-1	PA451674	1843	0.668
NULL	Calcif_Tissue_Int_2010_Dec_16_87(6)_485-492.nxml.txt.nlp	20953593	SENT49	19	19	40	40	teriparatide	PTH	PA451620	5741	0.668
NULL	J_Inherit_Metab_Dis_2012_May_19_35(3)_531-540.nxml.txt.nlp	22008945	SENT175	15	15	30	30	heparin	GPIHBP1	PA449855	338328	0.668
NULL	Cell_Death_Dis_2013_Jul_18_4(7)_e732.nxml.txt.nlp	23868065	SENT10	7	7	37	37	glucosamine	HBP	PA164747613	3069;50865;7884;566	0.668
NULL	J_Epilepsy_Res_2014_Jun_30_4(1)_7-13.nxml.txt.nlp	24977124	SENT68	17	17	8	8	pilocarpine	CA3	PA450962	761	0.668
NULL	Breast_Cancer_Res_2007_May_30_9(3)_R34.nxml.txt.nlp	17537232	SENT141	15	15	6	6	tamoxifen	MDM2	PA451581	4193	0.668
NULL	Anal_Bioanal_Chem_2013_Jul_23_405(23)_7337-7345.nxml.txt.nlp	23877175	SENT14	31	31	21	21	creatine	spatial	PA164778930	219793	0.668
NULL	Oncotarget_2013_Oct_19_4(11)_2045-2056.nxml.txt.nlp	24185104	SENT66	17	17	7	7	cisplatin	14-3-3	PA449014	10971	0.668
NULL	Indian_J_Med_Res_2012_Sep_136(3)_391-403.nxml.txt.nlp	23041732	SENT186	11	11	19	19	sorafenib	HCC	PA7000	84668	0.668
NULL	Front_Oncol_2013_Nov_15_3_281.nxml.txt.nlp	24298448	SENT85	38	38	22	22	panitumumab	KRAS	PA162373091	3845	0.668
NULL	Oncogene_2013_Nov_28_32(48)_5439-5448.nxml.txt.nlp	23563182	SENT142	2	2	14	14	etoposide	Mcl-1	PA449552	4170	0.668
NULL	Mol_Clin_Oncol_2013_Jul_26_1(4)_649-654.nxml.txt.nlp	24649223	SENT205	1	1	5	5	cyclophosphamide	CD4	PA449165	920	0.668
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_2_2013_482428.nxml.txt.nlp	23818926	SENT50	22	22	39	39	streptomycin	CO2	PA451512	4513	0.668
NULL	EMBO_Mol_Med_2013_Dec_8_5(12)_1821-1834.nxml.txt.nlp	24293316	SENT45	11	11	16	16	doxorubicin	UNC5D	PA449412	137970	0.668
NULL	Oxid_Med_Cell_Longev_2012_Jan_19_2012_390678.nxml.txt.nlp	22315655	SENT155	2	2	4	4	gliclazide	NAC	PA10892	22861	0.668
NULL	Biosci_Rep_2013_Oct_31_33(5)_e00078.nxml.txt.nlp	24073800	SENT181	2	2	7	7	capsaicin	TRPV1	PA448776	7442	0.668
NULL	Bone_Joint_Res_2014_Sep_1_3(9)_280-288.nxml.txt.nlp	25237168	SENT207	14	14	26	26	celecoxib	JNK	PA448871	5599	0.668
NULL	J_Clin_Biochem_Nutr_2010_Jan_29_46(1)_87-92.nxml.txt.nlp	20104270	SENT309	15	15	13	13	hesperidin	STZ	PA449867	6484	0.668
NULL	Calcif_Tissue_Int_2014_Aug_21_94(2)_170-175.nxml.txt.nlp	23963633	SENT16	5	5	19	19	teriparatide	PTH	PA451620	5741	0.668
NULL	Arthritis_Res_Ther_2011_Dec_12_13(6)_R204.nxml.txt.nlp	22151924	SENT87	45	45	8	8	efalizumab	CFB	PA164748817	629	0.668
NULL	Cancer_Cell_Int_2014_Jan_14_14_4.nxml.txt.nlp	24423208	SENT60	27	27	4	4	sunitinib	IL-2	PA162372840	3558	0.668
NULL	Clin_Mol_Hepatol_2014_Sep_25_20(3)_283-290.nxml.txt.nlp	25320732	SENT5	19	19	12	12	propranolol	EVL	PA451145	51466	0.668
NULL	Breast_Cancer_Res_2009_Nov_18_11(6)_R85.nxml.txt.nlp	19922614	SENT103	35	35	21	21	tamoxifen	BCS	PA451581	617	0.668
NULL	Arthritis_Res_Ther_2014_Apr_15_16(2)_208.nxml.txt.nlp	25099015	SENT145	29	29	10	10	adalimumab	CD4	PA10004	920	0.668
NULL	Oxid_Med_Cell_Longev_2013_Dec_5_2013_963520.nxml.txt.nlp	24381719	SENT249	11	11	0	0	l-arginine	NOS	PA448478	4843	0.668
NULL	Int_J_Tryptophan_Res_2009_Mar_23_2_45-60.nxml.txt.nlp	20651948	SENT365	7	7	15	15	imipramine	Gen	PA449969	348654	0.668
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT168	9	9	6	6	metformin	HIF-1	PA450395	29072	0.668
NULL	Child_Adolesc_Psychiatry_Ment_Health_2012_Jun_22_6_25.nxml.txt.nlp	22726236	SENT14	17	17	23	23	risperidone	B12	PA451257	7126;4709	0.668
NULL	New_Microbes_New_Infect_2014_May_4_2(3)_58-63.nxml.txt.nlp	25356345	SENT100	18	18	8	8	cefepime	CTX	PA164754876	1593	0.668
NULL	Eur_J_Drug_Metab_Pharmacokinet_2011_Jan_30_35(3-4)_79-82.nxml.txt.nlp	21302032	SENT65	17	17	5	5	lamotrigine	UGT1A4	PA450164	54657	0.668
NULL	Clin_Epidemiol_2011_May_19_3_175-191.nxml.txt.nlp	21750627	SENT375	4	4	27	27	infliximab	Gen	PA452639	348654	0.668
NULL	Clin_Ophthalmol_2012_Jul_12_6_1063-1071.nxml.txt.nlp	22888204	SENT43	10	10	18	18	thyroglobulin	TPO	PA164754910	7066;7173	0.668
NULL	Chem_Cent_J_2013_Sep_17_7_157.nxml.txt.nlp	24041220	SENT35	19	19	42	42	l-glutamine	CO2	PA10090	4513	0.668
NULL	Front_Neurosci_2011_Jan_14_4_207.nxml.txt.nlp	21258618	SENT158	28	28	12	12	ethanol	AC7	PA448073	113	0.668
NULL	Cancer_Cell_Int_2013_Sep_23_13_94.nxml.txt.nlp	24059699	SENT41	25	25	32	32	bevacizumab	VEGFA	PA130232992	7422	0.668
NULL	Mol_Cancer_2012_May_28_11_36.nxml.txt.nlp	22640878	SENT43	19	19	13	13	paclitaxel	TGFBI	PA450761	7045	0.668
NULL	J_Biol_Chem_2009_Dec_18_284(51)_35588-35596.nxml.txt.nlp	19773554	SENT195	16	16	14	14	heparin	perlecan	PA449855	3339	0.668
NULL	Nucleic_Acids_Res_2005_Sep_12_33(16)_5208-5218.nxml.txt.nlp	16157866	SENT96	0	0	14	14	heparin	FGF8	PA449855	2253	0.668
NULL	Mol_Cancer_2010_Oct_12_9_269.nxml.txt.nlp	20939893	SENT66	0	0	9	9	isoproterenol	AP-1	PA450121	2353;3727;2354;3725	0.668
NULL	Indian_J_Med_Res_2011_Sep_134(3)_295-301.nxml.txt.nlp	21985811	SENT111	11	11	28	28	phenobarbital	CYP3A4	PA450911	1576	0.668
NULL	Braz_J_Med_Biol_Res_2012_Sep_21_45(12)_1240-1243.nxml.txt.nlp	22983178	SENT36	32	32	17	17	indomethacin	CB2	PA449982	1269	0.668
NULL	Comp_Hepatol_2004_Jan_14_3(Suppl_1)_S37.nxml.txt.nlp	14960189	SENT90	2	2	4	4	thalidomide	TNF-alpha	PA451644	7124	0.668
NULL	Case_Rep_Pediatr_2011_Nov_24_2011_562620.nxml.txt.nlp	22606516	SENT19	20	20	5	5	vancomycin	CD69	PA451850	969	0.668
NULL	Iran_J_Pharm_Res_2014_Autumn_13(4)_1431-1436.nxml.txt.nlp	25587334	SENT79	19	19	41	41	lidocaine	ANOVA	PA450226	4858	0.668
NULL	Br_J_Cancer_2003_Mar_10_88(5)_754-759.nxml.txt.nlp	12618886	SENT124	0	0	5	5	amifostine	p53	PA448365	7157	0.668
NULL	J_Neuroinflammation_2011_Feb_7_8_11.nxml.txt.nlp	21299846	SENT257	19	19	30	30	forskolin	ANOVA	PA146096022	4858	0.668
NULL	ScientificWorldJournal_2013_Dec_30_2013_645653.nxml.txt.nlp	24489509	SENT236	21	21	23	23	tobramycin	TOB	PA451704	10140	0.668
NULL	Oncol_Lett_2014_Nov_14_8(5)_2086-2092.nxml.txt.nlp	25295095	SENT136	39	39	22	22	gemcitabine	CHK2	PA449748	11200	0.668
NULL	Age_(Dordr)_2011_Dec_11_33(4)_565-578.nxml.txt.nlp	21222044	SENT163	32	32	16	16	estradiol	GDX	PA449503	8266	0.668
NULL	Br_J_Cancer_2011_Nov_22_105(11)_1759-1767.nxml.txt.nlp	22045189	SENT32	19	19	15	15	oxaliplatin	EGFR	PA131285527	1956	0.668
NULL	AMB_Express_2012_Aug_29_2_46.nxml.txt.nlp	22931793	SENT125	5	5	24	24	ethanol	SHF	PA448073	90525	0.668
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT6	17	17	14	14	cisplatin	MDM2	PA449014	4193	0.668
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Apr_18_68(Pt_5)_o1416.nxml.txt.nlp	22590302	SENT60	5	5	15	15	l-carnitine	CO2	PA450154	4513	0.668
NULL	Croat_Med_J_2013_Apr_54(2)_171-179.nxml.txt.nlp	23630144	SENT113	2	2	19	19	taurine	STZ	PA451590	6484	0.668
NULL	Br_J_Cancer_2013_Dec_10_109(12)_2954-2958.nxml.txt.nlp	24231949	SENT95	17	17	26	26	gemcitabine	p53	PA449748	7157	0.668
NULL	Drug_Target_Insights_2012_Aug_6_6_19-39.nxml.txt.nlp	22915839	SENT119	0	0	11	11	doxorubicin	Hsp90	PA449412	3320	0.668
NULL	Front_Oncol_2014_Apr_1_4_67.nxml.txt.nlp	24744992	SENT157	3	3	17	17	temozolomide	EGFR	PA451609	1956	0.668
NULL	Exp_Mol_Med_2012_May_31_44(5)_311-318.nxml.txt.nlp	22282402	SENT77	11	11	19	19	cilostazol	MCP-1	PA164746334	6347	0.668
NULL	J_Exp_Med_1968_Oct_1_128(4)_699-713.nxml.txt.nlp	19867304	SENT7	22	22	25	25	galactose	NAG	PA449725	51594;4669	0.668
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Mar_29_70(Pt_4)_o500.nxml.txt.nlp	24826188	SENT78	5	5	11	11	benzaldehyde	mol	PA448571	90527	0.668
NULL	Ann_N_Y_Acad_Sci_2012_Oct_10_1271(1)_58-67.nxml.txt.nlp	23050965	SENT122	1	1	9	9	cisplatin	p53	PA449014	7157	0.668
NULL	Acta_Pharmacol_Sin_2013_Jun_8_34(6)_830-836.nxml.txt.nlp	23564080	SENT141	2	2	9	9	simvastatin	RAGE	PA451363	177	0.668
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_May_3_64(Pt_6)_o965.nxml.txt.nlp	21202695	SENT6	4	4	12	12	nitrile	mol	PA450636	90527	0.668
NULL	Dermatoendocrinol_2013_Apr_1_5(2)_239-251.nxml.txt.nlp	24194964	SENT196	6	6	11	11	vemurafenib	HIF-1	PA165946873	29072	0.668
NULL	Patient_Prefer_Adherence_2008_Feb_2_2_387-392.nxml.txt.nlp	19920986	SENT148	11	11	17	17	azathioprine	IFN	PA448515	3439	0.668
NULL	Oncogene_2010_Jun_10_29(23)_3335-3348.nxml.txt.nlp	20383197	SENT121	16	16	4	4	lapatinib	HER2	PA152241907	2064	0.668
NULL	Environ_Health_Perspect_2005_Oct_14_113(10)_1330-1335.nxml.txt.nlp	16203242	SENT196	12	12	3	3	phenylephrine	MLC	PA450935	23209	0.668
NULL	Emerg_Infect_Dis_2013_Jan_19(1)_133-136.nxml.txt.nlp	23260464	SENT42	18	18	20	20	tetracycline	TOB	PA451640	10140	0.668
NULL	Indian_J_Anaesth_2014_Jan-Feb_58(1)_63-65.nxml.txt.nlp	24700903	SENT97	21	21	11	11	remifentanil	adrenoleukodystrophy	PA451232	215	0.668
NULL	Biomed_Eng_Online_2012_Nov_14_11_84.nxml.txt.nlp	23151049	SENT173	16	16	19	19	ibandronate	PTH	PA10270	5741	0.668
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_3_2012_908562.nxml.txt.nlp	23082087	SENT180	12	12	23	23	hesperidin	IL-5	PA449867	3567	0.668
NULL	Acta_Pharmacol_Sin_2009_Jun_5_30(6)_859-867.nxml.txt.nlp	19498425	SENT75	13	13	5	5	carbachol	CA3	PA448784	761	0.668
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jun_16_66(Pt_7)_o1656-o1657.nxml.txt.nlp	21587884	SENT68	14	14	20	20	benzaldehyde	mol	PA448571	90527	0.668
NULL	Diabetes_Obes_Metab_2011_Nov_13(11)_982-989.nxml.txt.nlp	21615670	SENT168	9	9	13	13	exenatide	GLP-1	PA164749238	100125288	0.668
NULL	Arthritis_Res_Ther_2005_Apr_4_7(4)_R756-R768.nxml.txt.nlp	15987477	SENT126	23	23	4	4	hyaluronidase	PH-20	PA164745713	6677	0.668
NULL	Cancers_(Basel)_2010_Aug_19_2(3)_1629-1641.nxml.txt.nlp	24281178	SENT119	4	4	27	27	gemcitabine	CD44	PA449748	960	0.668
NULL	Hum_Genomics_2009_Jan_1_3(2)_103-105.nxml.txt.nlp	19164087	SENT41	7	7	18	18	ethanol	CYP2E1	PA448073	1571	0.668
NULL	Indian_J_Endocrinol_Metab_2013_Jul-Aug_17(4)_568-579.nxml.txt.nlp	23961471	SENT98	9	9	11	11	vasopressin	AVP	PA451858	114548;551	0.668
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2011_Sep_13_4_47-62.nxml.txt.nlp	22879794	SENT48	42	42	6	6	rosiglitazone	PPG	PA451283	5552	0.668
NULL	Genet_Vaccines_Ther_2008_Feb_15_6_7.nxml.txt.nlp	18279512	SENT188	4	4	9	9	imiquimod	IL-5	PA449972	3567	0.668
NULL	Int_J_Mol_Sci_2014_Sep_17_15(9)_16430-16457.nxml.txt.nlp	25233127	SENT277	23	23	16	16	capsaicin	TRPV1	PA448776	7442	0.668
NULL	Mol_Syst_Biol_2010_Apr_13_6_356.nxml.txt.nlp	20393576	SENT275	18	18	7	7	ethanol	GCR2	PA448073	11319	0.668
NULL	Tech_Coloproctol_2014_Jul_4_18(10)_921-928.nxml.txt.nlp	24993838	SENT0	29	29	0	0	gentamicin	Tech	PA449753	57449	0.668
NULL	Bioinform_Biol_Insights_2009_Oct_5_3_109-127.nxml.txt.nlp	20140064	SENT431	10	10	23	23	lamivudine	P62	PA450163	2965	0.668
NULL	Pharmaceuticals_(Basel)_2014_Mar_5_7(3)_311-338.nxml.txt.nlp	24603603	SENT44	3	3	5	5	cetuximab	EGFR	PA10040	1956	0.668
NULL	Pharmaceutics_2011_Oct_12_3(4)_680-705.nxml.txt.nlp	24309303	SENT136	7	7	16	16	metformin	MATE1	PA450395	55244	0.668
NULL	Indian_J_Pharmacol_2014_Nov-Dec_46(6)_627-632.nxml.txt.nlp	25538335	SENT167	18	18	16	16	metformin	Q10	PA450395	27161	0.668
NULL	Curr_Neuropharmacol_2009_Jun_7(2)_83-95.nxml.txt.nlp	19949566	SENT453	46	46	32	32	zonisamide	TGB	PA451978	5473	0.668
NULL	Diabetes_2009_Jan_58(1)_165-173.nxml.txt.nlp	18984741	SENT74	0	0	30	30	fluorescein	San	PA164746009	80218	0.668
NULL	Biosci_Rep_2012_Dec_13_33(1)_e00007.nxml.txt.nlp	23095119	SENT8	19	19	7	7	lipase	AMPK	PA450239	5563	0.668
NULL	Drugs_Context_2012_Nov_19_2012_212242.nxml.txt.nlp	24432031	SENT86	16	16	19	19	temozolomide	IFN	PA451609	3439	0.668
NULL	Iran_Red_Crescent_Med_J_2014_Aug_5_16(8)_e6915.nxml.txt.nlp	25389496	SENT6	12	12	17	17	simvastatin	adiponectin	PA451363	9370	0.668
NULL	Mol_Cancer_2009_Nov_24_8_109.nxml.txt.nlp	19930708	SENT188	0	0	7	7	exemestane	aromatase	PA449563	1588	0.668
NULL	Ann_Rehabil_Med_2012_Aug_27_36(4)_466-473.nxml.txt.nlp	22977771	SENT14	7	7	3	3	hyaluronidase	ILEI	PA164745713	10447	0.668
NULL	Adv_Hematol_2011_Apr_10_2011_960137.nxml.txt.nlp	21547266	SENT71	8	8	20	20	rituximab	CAD	PA451261	1677;790	0.668
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_May_21_3(5)_e115.nxml.txt.nlp	24850445	SENT221	17	17	30	30	trastuzumab	HER-2	PA451743	2064	0.668
NULL	Acta_Pharmacol_Sin_2012_Jan_3_33(1)_49-56.nxml.txt.nlp	22212430	SENT156	16	16	7	7	thrombin	A10	PA451674	28870	0.668
NULL	J_Cell_Biol_1997_Mar_10_136(5)_995-1005.nxml.txt.nlp	9060465	SENT49	23	23	25	25	dextran	mol	PA449261	90527	0.668
NULL	Hum_Genomics_2009_Jan_1_3(2)_128-142.nxml.txt.nlp	19164090	SENT179	8	8	15	15	carboplatin	CD44	PA448803	960	0.668
NULL	Front_Oncol_2013_Nov_27_3_290.nxml.txt.nlp	24350055	SENT89	6	6	4	4	cisplatin	PARP-1	PA449014	25976	0.668
NULL	AIDS_Res_Ther_2011_Oct_6_8_36.nxml.txt.nlp	21978457	SENT101	7	7	18	18	zinc	TNF	PA451956	7124	0.668
NULL	Braz_J_Med_Biol_Res_2014_Oct_24_48(1)_65-76.nxml.txt.nlp	25493385	SENT165	28	28	6	6	aliskiren	AT1	PA143487910	9197;185	0.668
NULL	J_Res_Med_Sci_2011_Sep_16(9)_1176-1182.nxml.txt.nlp	22973386	SENT37	20	20	27	27	tramadol	ACL	PA451735	47	0.668
NULL	Curr_Neuropharmacol_2013_Jul_11(4)_338-378.nxml.txt.nlp	24381528	SENT1167	17	17	26	26	curcumin	STZ	PA151958596	6484	0.668
NULL	Curr_Neuropharmacol_2008_Jun_6(2)_151-163.nxml.txt.nlp	19305794	SENT275	2	2	11	11	capsaicin	TRPV1	PA448776	7442	0.668
NULL	Crit_Care_2005_Sep_9_9(2)_212-222.nxml.txt.nlp	15774080	SENT15	13	13	15	15	vasopressin	AVP	PA451858	114548;551	0.668
NULL	Curr_Control_Trials_Cardiovasc_Med_2001_Oct_16_2(6)_271-277.nxml.txt.nlp	11806813	SENT60	10	10	16	16	enalapril	IL-6	PA449456	3569	0.668
NULL	Pharmaceutics_2013_Dec_19_6(1)_1-25.nxml.txt.nlp	24662363	SENT259	13	13	6	6	doxorubicin	DC8	PA449412	25936	0.668
NULL	J_Cell_Mol_Med_2014_Aug_1_18(8)_1599-1611.nxml.txt.nlp	24889822	SENT110	14	14	10	10	resveratrol	SIRT1		23411	0.668
NULL	Korean_J_Anesthesiol_2013_Feb_15_64(2)_105-111.nxml.txt.nlp	23459312	SENT81	15	15	23	23	heparin	ACT	PA449855	12;11332;9457;641455	0.668
NULL	Curr_Genomics_2014_Jun_15(3)_217-230.nxml.txt.nlp	24955029	SENT430	11	11	15	15	oxygen	HIF-1	PA450744	29072	0.668
NULL	J_Oncol_2009_Mar_24_2009_491985.nxml.txt.nlp	19325924	SENT172	0	0	7	7	genistein	CXCL12	PA165109660	6387	0.668
NULL	Int_J_Endocrinol_2011_Aug_21_2011_742719.nxml.txt.nlp	21869886	SENT265	43	43	28	28	cilostazol	DES	PA164746334	1674	0.668
NULL	Environ_Health_Perspect_2008_Jan_5_116(1)_1-6.nxml.txt.nlp	18197291	SENT85	18	18	9	9	gentamicin	FBS	PA449753	64319;26269	0.668
NULL	Acta_Pharmacol_Sin_2011_Oct_15_32(10)_1253-1258.nxml.txt.nlp	21970837	SENT150	4	4	9	9	darapladib	IL-6	PA165884699	3569	0.668
NULL	Cell_Biochem_Biophys_2013_May_28_67(1)_25-43.nxml.txt.nlp	23712866	SENT146	19	19	21	21	doxorubicin	TAK1	PA449412	7182	0.668
NULL	Int_J_Biol_Sci_2014_Sep_21_10(10)_1108-1115.nxml.txt.nlp	25332685	SENT162	5	5	7	7	dexmedetomidine	DMT	PA449256	2039	0.668
NULL	Front_Immunol_2013_Mar_8_4_50.nxml.txt.nlp	23483669	SENT159	0	0	12	12	anakinra	IL1R1	PA10799	3554	0.668
NULL	Oxid_Med_Cell_Longev_2013_Apr_21_2013_412576.nxml.txt.nlp	23710286	SENT161	19	19	9	9	curcumin	NRF1	PA151958596	4899;4779	0.668
NULL	eLife_2013_Oct_29_2_e01236.nxml.txt.nlp	24171104	SENT8	15	15	9	9	bortezomib	HSF1	PA10252	3297	0.668
NULL	Int_J_Biomater_2012_Mar_12_2012_397813.nxml.txt.nlp	22481939	SENT68	7	7	15	15	collagenase	CO2	PA449107	4513	0.668
NULL	Arthritis_Res_Ther_2005_Feb_18_7(3)_R476-R484.nxml.txt.nlp	15899034	SENT8	7	7	23	23	thrombin	IL-6	PA451674	3569	0.668
NULL	Oncoscience_2014_Mar_12_1(2)_158-166.nxml.txt.nlp	25594008	SENT47	20	20	16	16	dasatinib	PTRF	PA162372878	284119	0.668
NULL	Iran_J_Basic_Med_Sci_2012_Jul-Aug_15(4)_965-974.nxml.txt.nlp	23493093	SENT155	5	5	13	13	ethanol	CYP2E1	PA448073	1571	0.668
NULL	Front_Genet_2013_Aug_29_4_163.nxml.txt.nlp	24009622	SENT205	25	25	27	27	ethanol	DDP	PA448073	1678	0.668
NULL	Summit_on_Translat_Bioinforma_2009_Mar_1_2009_124-128.nxml.txt.nlp	21347183	SENT69	22	22	26	26	azathioprine	TPMT	PA448515	7172	0.668
NULL	Curr_Neuropharmacol_2014_Jul_12(4)_308-323.nxml.txt.nlp	25342939	SENT495	10	10	29	29	vasopressin	AVP	PA451858	114548;551	0.668
NULL	J_Allergy_(Cairo)_2011_Oct_24_2011_457169.nxml.txt.nlp	22121382	SENT212	0	0	21	21	salmeterol	IL-6	PA451300	3569	0.668
NULL	Ann_Clin_Microbiol_Antimicrob_2007_Oct_30_6_13.nxml.txt.nlp	17967199	SENT90	21	21	14	14	vancomycin	VISA	PA451850	57506	0.668
NULL	Nucleic_Acids_Res_2011_Sep_23_39(17)_e113.nxml.txt.nlp	21700670	SENT40	23	23	13	13	doxycycline	Oct4	PA449415	5460	0.668
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT37	11	11	13	13	erlotinib	CYP3A	PA134687924	1574	0.668
NULL	Oncogene_2010_Mar_4_29(9)_1280-1292.nxml.txt.nlp	19935698	SENT81	30	30	14	14	cisplatin	Hsp90	PA449014	3320	0.668
NULL	Summit_on_Translat_Bioinforma_2009_Mar_1_2009_124-128.nxml.txt.nlp	21347183	SENT69	38	38	13	13	thioguanine	TPMT	PA451663	7172	0.668
NULL	Breast_Cancer_Res_2008_May_13_10(Suppl_2)_P33.nxml.txt.nlp	NULL	SENT22	7	7	4	4	collagenase	CD44	PA449107	960	0.668
NULL	Cancers_(Basel)_2011_Nov_10_3(4)_4139-4150.nxml.txt.nlp	24213130	SENT472	1	1	5	5	cyclophosphamide	CD4	PA449165	920	0.668
NULL	Cancers_(Basel)_2010_Feb_25_2(1)_114-132.nxml.txt.nlp	24281035	SENT160	0	0	4	4	thalidomide	IFN	PA451644	3439	0.668
NULL	Br_J_Cancer_2013_Jun_25_108(12)_2464-2469.nxml.txt.nlp	23695016	SENT16	13	13	9	9	paclitaxel	NACT	PA450761	284111	0.668
NULL	Open_Cardiovasc_Med_J_2011_Jun_20_5_136-147.nxml.txt.nlp	21760856	SENT41	20	20	18	18	rosiglitazone	adiponectin	PA451283	9370	0.668
NULL	Aging_(Albany_NY)_2013_Apr_14_5(4)_288-303.nxml.txt.nlp	23596277	SENT247	13	13	15	15	formaldehyde	EMD	PA449703	2010	0.668
NULL	Adv_Biomed_Res_2014_Sep_8_3_189.nxml.txt.nlp	25298958	SENT75	6	6	30	30	amoxicillin	NAC	PA448406	22861	0.668
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT81	42	42	9	9	trastuzumab	IL-6	PA451743	3569	0.668
NULL	Br_J_Pharmacol_2013_Jun_27_169(4)_736-747.nxml.txt.nlp	23489111	SENT195	20	20	11	11	granisetron	5-HT3A	PA449809	3359	0.668
NULL	Exp_Diabetes_Res_2011_Jun_23_2011_898913.nxml.txt.nlp	21747834	SENT96	35	35	19	19	metformin	AMIGO	PA450395	57463	0.668
NULL	J_Inherit_Metab_Dis_2011_Apr_3_34(2)_391-398.nxml.txt.nlp	21290186	SENT27	13	13	25	25	galactose	GALT	PA449725	2592	0.668
NULL	J_Cell_Mol_Med_2014_Apr_20_18(4)_709-720.nxml.txt.nlp	24444314	SENT248	6	6	9	9	metformin	p53	PA450395	7157	0.668
NULL	Biomed_Res_Int_2013_Nov_28_2013_789184.nxml.txt.nlp	24369535	SENT13	0	0	12	12	imatinib	CML	PA10804	613	0.668
NULL	Clin_Mol_Allergy_2007_Jan_25_5_1.nxml.txt.nlp	17254346	SENT14	2	2	14	14	curcumin	CD80	PA151958596	941	0.668
NULL	Stroke_Res_Treat_2009_Dec_20_2010_386389.nxml.txt.nlp	20700422	SENT160	9	9	6	6	pioglitazone	NAC	PA450970	22861	0.668
NULL	J_Oncol_2009_Mar_24_2009_491985.nxml.txt.nlp	19325924	SENT79	12	12	3	3	genistein	CXCL12	PA165109660	6387	0.668
NULL	J_Cell_Biol_2000_Jun_12_149(6)_1167-1170.nxml.txt.nlp	10851014	SENT49	12	12	5	5	collagenase	MT1-MMP	PA449107	4323	0.668
NULL	J_Gen_Physiol_1975_May_1_65(5)_599-615.nxml.txt.nlp	1080796	SENT0	18	18	1	1	theophylline	Gen	PA451647	348654	0.668
NULL	Br_J_Cancer_2009_Jul_21_101(2)_238-243.nxml.txt.nlp	19568242	SENT108	29	29	31	31	bevacizumab	IFN	PA130232992	3439	0.668
NULL	Mol_Cells_2014_Oct_31_37(10)_759-765.nxml.txt.nlp	25256221	SENT110	15	15	22	22	celecoxib	NDRG2	PA448871	57447	0.668
NULL	Oncoscience_2014_Oct_24_1(10)_665-673.nxml.txt.nlp	25593995	SENT76	2	2	22	22	doxorubicin	NANOG	PA449412	79923	0.668
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT194	3	3	12	12	tacrolimus	IL-6	PA451578	3569	0.668
NULL	Oxid_Med_Cell_Longev_2013_Apr_21_2013_412576.nxml.txt.nlp	23710286	SENT31	7	7	11	11	curcumin	NRF2	PA151958596	2551;4780	0.668
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT49	14	14	11	11	curcumin	TRAIL	PA151958596	8743	0.668
NULL	Pharmaceuticals_(Basel)_2012_Sep_12_5(9)_1008-1020.nxml.txt.nlp	24280702	SENT93	0	0	13	13	geldanamycin	Hsp90	PA152031327	3320	0.668
NULL	Oncol_Rep_2012_Sep_15_28(3)_763-767.nxml.txt.nlp	22710607	SENT116	4	4	23	23	erlotinib	PS2	PA134687924	5664	0.668
NULL	Curr_Clin_Pharmacol_2008_Sep_3(3)_198-203.nxml.txt.nlp	18781906	SENT5	23	23	0	0	levetiracetam	CYP3A4	PA450206	1576	0.668
NULL	Mol_Cancer_2008_May_16_7_38.nxml.txt.nlp	18485224	SENT206	7	7	9	9	celecoxib	DMC	PA448871	284340;54808	0.668
NULL	Anal_Chem_Insights_2013_Apr_16_8_9-20.nxml.txt.nlp	23700362	SENT12	0	0	2	2	tobramycin	TOB	PA451704	10140	0.668
NULL	Pak_J_Med_Sci_2013_Sep-Oct_29(5)_1278-1279.nxml.txt.nlp	24353736	SENT16	17	17	25	25	erlotinib	p27	PA134687924	5715;10534	0.668
NULL	J_Cell_Biol_1998_Jul_13_142(1)_271-284.nxml.txt.nlp	9660880	SENT100	2	2	18	18	galactose	BP180	PA449725	1308	0.668
NULL	Eur_J_Clin_Pharmacol_2012_Sep_15_68(9)_1267-1274.nxml.txt.nlp	22418828	SENT219	12	12	23	23	lansoprazole	CYP2C19	PA450180	1557	0.668
NULL	Diabetes_2009_Apr_9_58(4)_965-974.nxml.txt.nlp	19136651	SENT124	6	6	13	13	nadh	NQO1	PA164755085	1728	0.668
NULL	Indian_J_Pharmacol_2014_Nov-Dec_46(6)_627-632.nxml.txt.nlp	25538335	SENT118	10	10	8	8	metformin	Q10	PA450395	27161	0.668
NULL	J_Invest_Dermatol_2014_Feb_5_134(2)_452-460.nxml.txt.nlp	24008424	SENT31	26	26	30	30	vemurafenib	BRAF	PA165946873	673	0.668
NULL	Indian_J_Nephrol_2009_Oct_19(4)_175a.nxml.txt.nlp	20535260	SENT18	9	9	19	19	nevirapine	CD4	PA450616	920	0.668
NULL	J_Cell_Mol_Med_2014_Aug_1_18(8)_1599-1611.nxml.txt.nlp	24889822	SENT127	7	7	9	9	resveratrol	p62		8878;10657;23636	0.668
NULL	Clin_Ophthalmol_2012_Feb_20_6_277-282.nxml.txt.nlp	22375096	SENT88	32	32	27	27	triamcinolone	STA	PA451749	2010;2656	0.668
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT200	0	0	4	4	erlotinib	AKT	PA134687924	207	0.668
NULL	J_Autom_Methods_Manag_Chem_2007_Jun_19_2007_86857.nxml.txt.nlp	17671612	SENT198	10	10	27	27	tinidazole	mol	PA10813	90527	0.668
NULL	Front_Immunol_2013_Mar_27_4_76.nxml.txt.nlp	23543707	SENT74	26	26	22	22	cetuximab	EGFR	PA10040	1956	0.668
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Oct_4_64(Pt_11)_o2064.nxml.txt.nlp	21580930	SENT60	12	12	7	7	ethanol	mol	PA448073	90527	0.668
NULL	Arthritis_Res_Ther_2012_Jan_17_14(1)_R9.nxml.txt.nlp	22251404	SENT255	9	9	17	17	celecoxib	IL-6	PA448871	3569	0.668
NULL	J_Clin_Biochem_Nutr_2008_Mar_1_42(2)_158-166.nxml.txt.nlp	18385834	SENT120	23	23	40	40	ephedrine	DAI	PA449466	81030	0.668
NULL	Biochimie_2012_Sep_94(9)_1997-2005.nxml.txt.nlp	22659570	SENT178	10	10	22	22	pp2	LPA		4018	0.668
NULL	Indian_J_Pharmacol_2014_Nov-Dec_46(6)_627-632.nxml.txt.nlp	25538335	SENT106	11	11	4	4	metformin	Q10	PA450395	27161	0.668
NULL	Cancer_Inform_2014_Oct_14_13(Suppl_1)_103-111.nxml.txt.nlp	25392688	SENT212	7	7	11	11	carboplatin	APO-1	PA448803	355	0.668
NULL	Biochim_Biophys_Acta_2014_Apr_1841(4)_588-594.nxml.txt.nlp	24440819	SENT26	2	2	4	4	lipase	ATGL	PA450239	57104	0.668
NULL	J_Thorac_Oncol_2014_Feb_23_9(2)_231-238.nxml.txt.nlp	24419421	SENT188	19	19	39	39	gefitinib	NSCL	PA131301952	4807	0.668
NULL	Br_J_Cancer_2010_Jan_5_102(1)_80-86.nxml.txt.nlp	19920817	SENT79	13	13	17	17	sunitinib	IFN	PA162372840	3439	0.668
NULL	J_Inherit_Metab_Dis_2013_Mar_13_36(2)_363-371.nxml.txt.nlp	22971959	SENT11	7	7	13	13	gentamicin	ARSB	PA449753	411	0.668
NULL	Cent_European_J_Urol_2013_Aug_13_66(2)_150-151.nxml.txt.nlp	24579015	SENT25	2	2	10	10	resveratrol	PDCD4		27250	0.667
NULL	J_Thromb_Haemost_2011_Oct_9(10)_2050-2056.nxml.txt.nlp	21794076	SENT40	22	22	27	27	prasugrel	2-21	PA154410481	54097	0.667
NULL	EMBO_Mol_Med_2013_Jun_7_5(6)_858-869.nxml.txt.nlp	23653322	SENT227	10	10	26	26	paraformaldehyde	CD68	PA450790	968	0.667
NULL	J_Oncol_2011_Jul_7_2011_145617.nxml.txt.nlp	21776269	SENT108	12	12	0	0	bupropion	Yes	PA448687	7525	0.667
NULL	J_Korean_Med_Sci_2006_Dec_31_21(6)_973-978.nxml.txt.nlp	17179671	SENT167	22	22	8	8	ciprofloxacin	CTX	PA449009	1593	0.667
NULL	Hum_Genomics_2008_Sep_1_3(1)_7-16.nxml.txt.nlp	19129086	SENT10	21	21	40	40	rosiglitazone	CYP2C8	PA451283	1558	0.667
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT192	14	14	46	46	pertuzumab	Yes		7525	0.667
NULL	Br_J_Cancer_2013_Jun_25_108(12)_2464-2469.nxml.txt.nlp	23695016	SENT140	10	10	21	21	carboplatin	CRT	PA448803	811	0.667
NULL	Clin_Epidemiol_2010_Aug_9_2_145-151.nxml.txt.nlp	20865112	SENT69	24	24	4	4	raltegravir	CD4		920	0.667
NULL	Biochem_Res_Int_2011_Nov_30_2011_850924.nxml.txt.nlp	21151514	SENT160	14	14	22	22	l-cysteine	NifS	PA449173	9054	0.667
NULL	F1000_Med_Rep_2009_Feb_24_1_13.nxml.txt.nlp	20948769	SENT32	22	22	18	18	rituximab	CHOP	PA451261	1649	0.667
NULL	J_Am_Heart_Assoc_2013_Aug_23_2(4)_e000312.nxml.txt.nlp	23902639	SENT69	12	12	0	0	neomycin	ATRAP	PA450608	57085	0.667
NULL	J_Clin_Biochem_Nutr_2007_Sep_29_41(2)_84-91.nxml.txt.nlp	18193101	SENT12	7	7	13	13	lansoprazole	IL-8	PA450180	3576	0.667
NULL	Indian_J_Pharmacol_2014_Jan-Feb_46(1)_3-12.nxml.txt.nlp	24550577	SENT326	6	6	8	8	vismodegib	SMO		6608;54498	0.667
NULL	EMBO_Mol_Med_2013_Jul_6_5(7)_905-915.nxml.txt.nlp	23740690	SENT48	12	12	21	21	lipase	HSL	PA450239	3991	0.667
NULL	Curr_Neuropharmacol_2009_Jun_7(2)_83-95.nxml.txt.nlp	19949566	SENT445	6	6	32	32	felbamate	TGB	PA449590	5473	0.667
NULL	FEBS_Open_Bio_2014_Jan_6_4_77-89.nxml.txt.nlp	24490132	SENT179	7	7	37	37	ebselen	NAC	PA161660841	22861	0.667
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT39	35	35	37	37	capsaicin	p53	PA448776	7157	0.667
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT12	0	0	7	7	resveratrol	TRAIL		8743	0.667
NULL	J_Cell_Biol_2001_Nov_26_155(5)_787-796.nxml.txt.nlp	11724820	SENT283	17	17	6	6	ethanol	CO2	PA448073	4513	0.667
NULL	Atherosclerosis_2011_Nov_219(1)_109-115.nxml.txt.nlp	21820657	SENT148	0	0	3	3	probucol	CETP	PA451107	1071	0.667
NULL	Mol_Vis_2012_Oct_5_18_2454-2467.nxml.txt.nlp	23077404	SENT5	0	0	12	12	bevacizumab	VEGF-A	PA130232992	7422	0.667
NULL	Oncogene_2010_Nov_18_29(46)_6160-6171.nxml.txt.nlp	20729916	SENT88	10	10	0	0	cisplatin	YAP	PA449014	55249	0.667
NULL	Orphanet_J_Rare_Dis_2013_Apr_4_8_51.nxml.txt.nlp	23557332	SENT90	8	8	16	16	galsulfase	ARSB	PA164746235	411	0.667
NULL	J_Mol_Med_2011_Jul_23_89(7)_667-676.nxml.txt.nlp	21431325	SENT59	30	30	14	14	berberine	adiponectin	PA165860812	9370	0.667
NULL	Diabetes_Metab_Syndr_Obes_2014_Jun_24_7_229-239.nxml.txt.nlp	25018644	SENT104	11	11	16	16	exenatide	GLP-1	PA164749238	100125288	0.667
NULL	Colorectal_Dis_2012_Feb_14(2)_e31-e47.nxml.txt.nlp	21848897	SENT118	16	16	11	11	irinotecan	KRAS	PA450085	3845	0.667
NULL	Oncol_Lett_2014_Aug_19_8(2)_620-626.nxml.txt.nlp	25013476	SENT41	0	0	32	32	fluorescein	San	PA164746009	80218	0.667
NULL	Oxid_Med_Cell_Longev_2013_Apr_3_2013_781050.nxml.txt.nlp	23691267	SENT130	32	32	25	25	ethanol	CYP2E1	PA448073	1571	0.667
NULL	Eur_J_Clin_Pharmacol_2010_Nov_29_66(11)_1131-1136.nxml.txt.nlp	20669013	SENT32	9	9	22	22	erythromycin	CYP2C19	PA449493	1557	0.667
NULL	Kidney_Int_Suppl_(2011)_2012_Mar_29_2(1)_69-88.nxml.txt.nlp	25018920	SENT360	30	30	12	12	theophylline	NAC	PA451647	22861	0.667
NULL	Iran_J_Ped_Hematol_Oncol_2014_Mar_15_4(1)_32-38.nxml.txt.nlp	24734162	SENT109	5	5	8	8	mercaptopurine	TGN	PA450379	7038	0.667
NULL	Front_Neurol_2014_Sep_11_5_173.nxml.txt.nlp	25309501	SENT152	5	5	7	7	hyaluronan	RHAMM	PA165958431	3161	0.667
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Oct_9_66(Pt_11)_o2729-o2730.nxml.txt.nlp	21588939	SENT65	21	21	12	12	ethanol	mol	PA448073	90527	0.667
NULL	Biomed_Res_Int_2014_Jan_20_2014_948427.nxml.txt.nlp	24563867	SENT149	20	20	14	14	buspirone	STZ	PA448689	6484	0.667
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Apr_27_69(Pt_5)_o790-o791.nxml.txt.nlp	23723933	SENT76	22	22	10	10	ethanol	mol	PA448073	90527	0.667
NULL	Br_J_Haematol_2014_Feb_16_164(4)_586-596.nxml.txt.nlp	24236640	SENT161	27	27	31	31	carboplatin	EPO	PA448803	7076;8288;2056	0.667
NULL	Biomed_Res_Int_2014_Jan_12_2014_276918.nxml.txt.nlp	24524073	SENT106	20	20	15	15	paroxetine	CYP2D6	PA450801	1565	0.667
NULL	Int_J_Mol_Sci_2014_Oct_29_15(11)_19760-19776.nxml.txt.nlp	25356508	SENT99	7	7	11	11	metformin	A-FABP	PA450395	2167	0.667
NULL	Diabetes_2013_Sep_15_62(9)_3120-3131.nxml.txt.nlp	23670972	SENT361	22	22	8	8	daclizumab	CD56	PA164764446	4684	0.667
NULL	Int_J_Emerg_Med_2012_Jan_20_5_5.nxml.txt.nlp	22264348	SENT48	14	14	29	29	capsaicin	VR1	PA448776	56664	0.667
NULL	Front_Immunol_2012_Jan_24_3_3.nxml.txt.nlp	22566889	SENT109	9	9	12	12	rituximab	IL-2	PA451261	3558	0.667
NULL	Arthritis_Res_Ther_2011_Feb_16_13(1)_R25.nxml.txt.nlp	21324169	SENT150	40	40	18	18	tocilizumab	TNF	PA165292659	7124	0.667
NULL	Biomed_Res_Int_2014_Jun_4_2014_253243.nxml.txt.nlp	24995279	SENT45	23	23	7	7	fludarabine	CHOP	PA449655	1649	0.667
NULL	J_Skin_Cancer_2012_Dec_13_2012_147863.nxml.txt.nlp	23316365	SENT198	2	2	11	11	curcumin	IL-6	PA151958596	3569	0.667
NULL	Diabetes_Metab_J_2013_Aug_14_37(4)_240-248.nxml.txt.nlp	23991401	SENT114	9	9	6	6	ezetimibe	NPC1L1	PA10816	29881	0.667
NULL	Br_J_Cancer_1990_Jan_61(1)_61-64.nxml.txt.nlp	2297491	SENT5	15	15	17	17	cyclophosphamide	CTX	PA449165	1593	0.667
NULL	F1000Res_2013_Mar_5_2_74.nxml.txt.nlp	24358880	SENT179	11	11	0	0	benzaldehyde	TRPV1	PA448571	7442	0.667
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT156	0	0	16	16	curcumin	TRAIL	PA151958596	8743	0.667
NULL	Br_J_Ophthalmol_2012_Jul_26_96(7)_1023-1028.nxml.txt.nlp	22539748	SENT138	9	9	13	13	ranibizumab	REC	PA164746012	84515	0.667
NULL	EMBO_Mol_Med_2012_Jun_13_4(6)_515-527.nxml.txt.nlp	22416035	SENT6	32	32	12	12	olaparib	p53		7157	0.667
NULL	Cancers_(Basel)_2011_Mar_7_3(1)_1158-1181.nxml.txt.nlp	24212658	SENT257	15	15	2	2	cisplatin	HSF1	PA449014	3297	0.667
NULL	Cardiovasc_Diabetol_2011_Dec_21_10_114.nxml.txt.nlp	22189162	SENT152	17	17	2	2	indomethacin	CYP2C8	PA449982	1558	0.667
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT169	12	12	26	26	metformin	HIF-1	PA450395	29072	0.667
NULL	Emerg_Infect_Dis_2013_Jan_19(1)_133-136.nxml.txt.nlp	23260464	SENT37	11	11	29	29	imipenem	TOB	PA449968	10140	0.667
NULL	Exp_Ther_Med_2015_Feb_16_9(2)_289-293.nxml.txt.nlp	25574188	SENT51	11	11	18	18	curcumin	CD166	PA151958596	214	0.667
NULL	Clin_Dev_Immunol_2013_Sep_17_2013_791262.nxml.txt.nlp	24151519	SENT176	0	0	3	3	heparin	HMGB1	PA449855	3146	0.667
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Nov_21_65(Pt_12)_o3132-o3133.nxml.txt.nlp	21578855	SENT68	10	10	17	17	benzydamine	mol	PA134687812	90527	0.667
NULL	Indian_J_Med_Res_2012_Apr_135(4)_494-499.nxml.txt.nlp	22664496	SENT136	25	25	16	16	artemisinin	ACT	PA165111696	12;11332;9457;641455	0.667
NULL	FEBS_Open_Bio_2011_Dec_27_2_1-5.nxml.txt.nlp	23650573	SENT302	4	4	9	9	sunitinib	MDM2	PA162372840	4193	0.667
NULL	Br_J_Cancer_2004_May_17_90(10)_2032-2041.nxml.txt.nlp	15138490	SENT259	6	6	14	14	trastuzumab	HER-2	PA451743	2064	0.667
NULL	Cell_Death_Dis_2013_Jul_11_4(7)_e719.nxml.txt.nlp	23846221	SENT79	5	5	3	3	cisplatin	TRAIL	PA449014	8743	0.667
NULL	JAKSTAT_2014_Jun_12_3_e29554.nxml.txt.nlp	25105067	SENT105	27	27	20	20	propofol	p65	PA451141	5970	0.667
NULL	Diabetes_2013_Jun_17_62(6)_1843-1854.nxml.txt.nlp	23349486	SENT301	35	35	11	11	pioglitazone	CD68	PA450970	968	0.667
NULL	Biomed_Res_Int_2013_Jul_17_2013_549359.nxml.txt.nlp	23956990	SENT33	33	33	15	15	gefitinib	EGFR	PA131301952	1956	0.667
NULL	Hematol_Rep_2011_Nov_16_3(3)_e26.nxml.txt.nlp	22593817	SENT58	21	21	5	5	doxorubicin	CHOP	PA449412	1649	0.667
NULL	Indian_J_Pharm_Sci_2013_Jan-Feb_75(1)_45-52.nxml.txt.nlp	23901160	SENT73	5	5	1	1	gentamicin	FOR	PA449753	51741	0.667
NULL	Tumour_Biol_2012_Dec_14_33(6)_2209-2216.nxml.txt.nlp	22890830	SENT155	15	15	7	7	erlotinib	KRAS	PA134687924	3845	0.667
NULL	Niger_Med_J_2013_Mar-Apr_54(2)_100-106.nxml.txt.nlp	23798795	SENT5	20	20	9	9	indomethacin	PTEN	PA449982	5728	0.667
NULL	Oncologist_2010_Mar_9_15(3)_236-245.nxml.txt.nlp	20215359	SENT86	18	18	32	32	bevacizumab	IFN	PA130232992	3439	0.667
NULL	Oncotarget_2010_May_27_1(2)_89-103.nxml.txt.nlp	20671809	SENT211	0	0	14	14	perifosine	CD34	PA165291471	947	0.667
NULL	Front_Neurosci_2012_May_30_6_77.nxml.txt.nlp	22661925	SENT156	25	25	19	19	ethanol	DCX	PA448073	1641	0.667
NULL	Br_J_Cancer_2010_Feb_2_102(3)_513-519.nxml.txt.nlp	20051960	SENT41	4	4	9	9	trastuzumab	San	PA451743	80218	0.667
NULL	Emerg_Infect_Dis_2013_Jan_19(1)_133-136.nxml.txt.nlp	23260464	SENT37	3	3	29	29	tetracycline	TOB	PA451640	10140	0.667
NULL	Breast_Cancer_Res_2012_Jun_7_14(3)_R89.nxml.txt.nlp	22676470	SENT340	35	35	26	26	trastuzumab	HER2	PA451743	2064	0.667
NULL	J_Hematol_Oncol_2014_Aug_20_7_62.nxml.txt.nlp	25139395	SENT174	34	34	40	40	cisplatin	p53	PA449014	7157	0.667
NULL	Curr_Pain_Headache_Rep_2011_Aug_12_15(4)_271-279.nxml.txt.nlp	21479998	SENT39	0	0	3	3	tramadol	CYP2D6	PA451735	1565	0.667
NULL	J_Gen_Physiol_2008_Nov_132(5)_521-535.nxml.txt.nlp	18852303	SENT245	22	22	26	26	trypsin	CAP2	PA451806	5271;10486	0.667
NULL	J_Biol_Eng_2008_Mar_27_2_4.nxml.txt.nlp	18366808	SENT49	12	12	25	25	nadh	PHB	PA164755085	5245	0.667
NULL	Oncogenesis_2012_Apr_2_1(4)_e5.nxml.txt.nlp	23552603	SENT288	0	0	11	11	celecoxib	p65	PA448871	5970	0.667
NULL	Aging_(Albany_NY)_2012_Jul_22_4(7)_480-498.nxml.txt.nlp	22837425	SENT28	2	2	15	15	metformin	B12	PA450395	7126;4709	0.667
NULL	Br_J_Haematol_2014_Mar_28_164(6)_858-866.nxml.txt.nlp	24372446	SENT122	40	40	37	37	rituximab	PEX	PA451261	5251	0.667
NULL	J_Korean_Med_Sci_2010_Feb_19_25(2)_240-244.nxml.txt.nlp	20119577	SENT23	14	14	1	1	vincristine	NAC	PA451879	22861	0.667
NULL	J_Cell_Mol_Med_2014_Jul_13_18(7)_1300-1312.nxml.txt.nlp	24725889	SENT244	4	4	14	14	chloroquine	TLR9	PA448948	54106	0.667
NULL	Environ_Health_Perspect_2012_Jul_25_120(7)_984-989.nxml.txt.nlp	22763116	SENT13	11	11	5	5	ether	BPA	PA449525	667	0.667
NULL	Br_J_Cancer_2009_Oct_6_101(7)_1162-1167.nxml.txt.nlp	19724276	SENT8	21	21	16	16	axitinib	APC	PA164924493	324	0.667
NULL	Mol_Biol_Rep_2013_May_16_40(8)_4995-5004.nxml.txt.nlp	23677713	SENT140	17	17	5	5	camptothecin	TERT	PA153590860	7015	0.667
NULL	Br_J_Cancer_2010_Sep_7_103(6)_765-771.nxml.txt.nlp	20700120	SENT43	31	31	10	10	tamoxifen	CYP2D6	PA451581	1565	0.667
NULL	Exp_Neurol_2012_Jun_235(2)_528-538.nxml.txt.nlp	22417924	SENT269	4	4	20	20	pioglitazone	NFkappaB	PA450970	4790	0.667
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT123	33	33	8	8	vinorelbine	ASC	PA451881	29108	0.667
NULL	Oncotarget_2012_Dec_17_4(1)_48-63.nxml.txt.nlp	23295955	SENT188	22	22	8	8	methotrexate	MTHFD2	PA450428	10797	0.667
NULL	Cell_Cycle_2012_Oct_1_11(19)_3521-3522.nxml.txt.nlp	22935702	SENT32	1	1	12	12	metformin	spatial	PA450395	219793	0.667
NULL	Adv_Hematol_2012_Jul_11_2012_906247.nxml.txt.nlp	22829835	SENT161	24	24	32	32	lenalidomide	FGFR3	PA162363968	2261	0.667
NULL	Int_J_Biol_Sci_2014_May_14_10(5)_566-575.nxml.txt.nlp	24910535	SENT232	19	19	9	9	nadh	BRCA1	PA164755085	672	0.667
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jun_25_67(Pt_7)_o1809.nxml.txt.nlp	21837180	SENT64	12	12	38	38	ethanol	mol	PA448073	90527	0.667
NULL	Mol_Cancer_2012_Sep_25_11_73.nxml.txt.nlp	23009336	SENT143	5	5	24	24	gefitinib	PP2	PA131301952	4888	0.667
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT147	8	8	31	31	pp2	PP2		4888	0.667
NULL	Asian_J_Androl_2014_May_30_Sep-Oct_16(5)_669-674.nxml.txt.nlp	24923457	SENT16	10	10	8	8	protamine	PRM1	PA10366	5619	0.667
NULL	Ann_Oncol_2009_Nov_23_20(11)_1803-1812.nxml.txt.nlp	19549706	SENT243	3	3	23	23	sunitinib	IFN	PA162372840	3439	0.667
NULL	Ann_Rheum_Dis_2014_Jan_13_73(1)_48-55.nxml.txt.nlp	23942868	SENT253	10	10	22	22	infliximab	IMPACT	PA452639	55364	0.667
NULL	Ann_Clin_Microbiol_Antimicrob_2014_Jan_6_13_2.nxml.txt.nlp	24393536	SENT42	4	4	14	14	amikacin	TOB	PA164744372	10140	0.667
NULL	Ann_Hematol_2011_Feb_17_90(2)_173-183.nxml.txt.nlp	20714724	SENT166	4	4	12	12	resveratrol	CD5		921	0.667
NULL	Med_Sci_Monit_2012_Jan_1_18(1)_RA1-RA11.nxml.txt.nlp	22207127	SENT174	16	16	21	21	calcidiol	PTH	PA164745614	5741	0.667
NULL	Breast_Cancer_Res_2012_Jul_19_14(4)_R108.nxml.txt.nlp	22812534	SENT369	9	9	27	27	tamoxifen	PELP1	PA451581	27043	0.667
NULL	Clin_Dev_Immunol_2013_Sep_24_2013_413465.nxml.txt.nlp	24174969	SENT76	9	9	2	2	hyaluronan	TLR2	PA165958431	7097	0.667
NULL	Br_J_Cancer_1998_Oct_78(8)_1024-1029.nxml.txt.nlp	9792145	SENT15	19	19	4	4	amifostine	CD34	PA448365	947	0.667
NULL	Br_J_Cancer_2010_Jun_29_103(1)_61-72.nxml.txt.nlp	20588279	SENT247	5	5	29	29	trastuzumab	RhoB	PA451743	388	0.667
NULL	Ann_Lab_Med_2013_Sep_8_33(5)_383-385.nxml.txt.nlp	24003434	SENT83	16	16	6	6	ceftazidime	CTX	PA448861	1593	0.667
NULL	Arthritis_Res_Ther_2008_Mar_17_10(2)_R33.nxml.txt.nlp	18346273	SENT169	6	6	22	22	infliximab	HMGB1	PA452639	3146	0.667
NULL	Br_J_Haematol_2008_Jun_141(5)_659-671.nxml.txt.nlp	18410446	SENT155	30	30	36	36	cerulenin	IRE1	PA164764551	2081	0.667
NULL	J_Oncol_2013_Apr_29_2013_854121.nxml.txt.nlp	23737784	SENT108	29	29	19	19	lapatinib	HER2	PA152241907	2064	0.667
NULL	AIDS_Res_Ther_2013_May_1_10_10.nxml.txt.nlp	23634877	SENT156	12	12	5	5	lovastatin	CCL4	PA450272	6351	0.667
NULL	Indian_J_Pharmacol_2009_Aug_41(4)_167-172.nxml.txt.nlp	20523867	SENT40	42	42	13	13	acetaminophen	CYP2E1	PA448015	1571	0.667
NULL	Braz_J_Med_Biol_Res_2013_Jun_12_46(6)_546-554.nxml.txt.nlp	23780424	SENT202	4	4	16	16	paclitaxel	MSK1	PA450761	9252	0.667
NULL	Curr_Cardiol_Rev_2009_May_5(2)_87-104.nxml.txt.nlp	20436849	SENT263	38	38	23	23	nafcillin	San	PA450576	80218	0.667
NULL	Nucleic_Acids_Res_2013_Nov_26_41(21)_9779-9785.nxml.txt.nlp	23980031	SENT38	38	38	17	17	chloramphenicol	SOC	PA448927	91544	0.667
NULL	J_Hematop_2009_Mar_5_2(1)_50-61.nxml.txt.nlp	19669224	SENT433	20	20	2	2	rituximab	PIM1	PA451261	5292;9361	0.667
NULL	Biomed_Res_Int_2014_Jan_20_2014_948427.nxml.txt.nlp	24563867	SENT134	17	17	14	14	aripiprazole	5-HT1A	PA10026	3350	0.667
NULL	Nucleic_Acids_Res_2014_Jan_1_42(1)_583-598.nxml.txt.nlp	24049081	SENT83	10	10	27	27	trypsin	San	PA451806	80218	0.667
NULL	Front_Oncol_2014_Sep_22_4_258.nxml.txt.nlp	25295228	SENT211	16	16	33	33	afatinib	EGFR	PA165981154	1956	0.667
NULL	Protein_Cell_2014_Jul_2_5(7)_544-551.nxml.txt.nlp	24691905	SENT65	32	32	4	4	doxorubicin	p53	PA449412	7157	0.667
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Mar_12_64(Pt_4)_o685.nxml.txt.nlp	21202077	SENT3	18	18	25	25	paraformaldehyde	mol	PA450790	90527	0.667
NULL	J_Int_AIDS_Soc_2012_Jul_27_15(2)_17396.nxml.txt.nlp	22905358	SENT109	22	22	3	3	isoniazid	IPT	PA450112	54802	0.667
NULL	EMBO_Mol_Med_2012_Jun_13_4(6)_515-527.nxml.txt.nlp	22416035	SENT151	0	0	9	9	olaparib	p53		7157	0.667
NULL	Mol_Cancer_2014_Jun_20_13_155.nxml.txt.nlp	24950741	SENT162	18	18	5	5	bortezomib	p53	PA10252	7157	0.667
NULL	Front_Oncol_2014_May_30_4_128.nxml.txt.nlp	24910845	SENT132	22	22	1	1	glibenclamide	TRAIL	PA449782	8743	0.667
NULL	Oncol_Lett_2013_May_19_5(5)_1643-1648.nxml.txt.nlp	23760877	SENT73	9	9	13	13	vincristine	CHOP	PA451879	1649	0.667
NULL	Multidiscip_Respir_Med_2013_Feb_13_8(1)_13.nxml.txt.nlp	23406847	SENT22	23	23	16	16	pyrazinamide	EMB	PA451182	133418	0.667
NULL	Arthritis_Res_Ther_2006_Apr_12_8(Suppl_1)_S3.nxml.txt.nlp	16820042	SENT147	6	6	11	11	colchicine	NALP3	PA449092	114548	0.667
NULL	Br_J_Cancer_2010_Sep_7_103(6)_889-898.nxml.txt.nlp	20664599	SENT12	22	22	5	5	paclitaxel	HER-2	PA450761	2064	0.667
NULL	Oxid_Med_Cell_Longev_2013_Nov_28_2013_367040.nxml.txt.nlp	24381715	SENT61	25	25	14	14	glucose	TNF	PA449773	7124	0.667
NULL	Acta_Physiol_(Oxf)_2008_Oct_194(2)_123-140.nxml.txt.nlp	18419777	SENT18	14	14	20	20	isoproterenol	PES	PA450121	23481	0.667
NULL	Blood_Cancer_J_2013_Jul_19_3(7)_e126.nxml.txt.nlp	23872705	SENT105	8	8	20	20	daunorubicin	p53	PA449212	7157	0.667
NULL	Oncotarget_2013_Dec_28_5(6)_1475-1490.nxml.txt.nlp	24721996	SENT78	4	4	9	9	celecoxib	CD44	PA448871	960	0.667
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT131	20	20	17	17	trastuzumab	HER2	PA451743	2064	0.667
NULL	Contemp_Oncol_(Pozn)_2012_Nov_20_16(5)_401-406.nxml.txt.nlp	23788917	SENT30	29	29	25	25	gefitinib	EGFR	PA131301952	1956	0.667
NULL	J_Cancer_Prev_2014_Jun_19(2)_111-117.nxml.txt.nlp	25337579	SENT79	5	5	16	16	doxorubicin	ADM	PA449412	133	0.667
NULL	Cancer_Metastasis_Rev_2012_Jun_13_31(1-2)_397-414.nxml.txt.nlp	22527451	SENT86	4	4	6	6	hyaluronan	CD44	PA165958431	960	0.667
NULL	Cell_Biochem_Biophys_2013_May_28_67(1)_25-43.nxml.txt.nlp	23712866	SENT134	3	3	25	25	cisplatin	USP2	PA449014	9099	0.667
NULL	Acta_Pharmacol_Sin_2009_Nov_12_30(11)_1566-1572.nxml.txt.nlp	19820718	SENT150	33	33	27	27	omeprazole	P-gp	PA450704	5243	0.667
NULL	Exp_Ther_Med_2012_Oct_3_4(4)_594-604.nxml.txt.nlp	23170111	SENT163	5	5	17	17	propranolol	p38	PA451145	10598;1432;7965	0.667
NULL	Pharm_Pract_(Granada)_2011_Mar_15_Jan-Mar_9(1)_37-43.nxml.txt.nlp	25132888	SENT73	24	24	18	18	glibenclamide	GIT	PA449782	5034	0.667
NULL	Case_Rep_Crit_Care_2014_Jun_24_2014_650916.nxml.txt.nlp	25057417	SENT94	10	10	15	15	iron	MRI	PA450087	78996	0.667
NULL	Bioinformation_2010_Nov_27_5(6)_266-270.nxml.txt.nlp	21364830	SENT106	24	24	12	12	galactose	GAL	PA449725	51083	0.667
NULL	JAKSTAT_2013_Jan_1_2(1)_e23576.nxml.txt.nlp	24058797	SENT58	22	22	6	6	staurosporine	IFN	PA165109623	3439	0.667
NULL	Open_Access_J_Urol_2011_May_10_3_69-82.nxml.txt.nlp	24198638	SENT66	32	32	27	27	warfarin	CYP2C9	PA451906	1559	0.667
NULL	Front_Oncol_2014_Sep_23_4_263.nxml.txt.nlp	25295230	SENT406	16	16	12	12	plerixafor	CXCR4	PA165958410	7852	0.667
NULL	Int_J_Mol_Sci_2014_Oct_6_15(10)_17886-17900.nxml.txt.nlp	25290095	SENT109	5	5	11	11	resveratrol	p38		10598;1432;7965	0.667
NULL	Chemother_Res_Pract_2011_Sep_25_2011_730360.nxml.txt.nlp	22295205	SENT236	4	4	30	30	trastuzumab	DM1	PA451743	338023;1760;28509	0.667
NULL	J_Cell_Mol_Med_2014_Mar_10_18(3)_514-529.nxml.txt.nlp	24410795	SENT198	28	28	3	3	resveratrol	SIRT1		23411	0.667
NULL	Sci_Rep_2014_Dec_5_4_7157.nxml.txt.nlp	25475707	SENT201	25	25	32	32	paraformaldehyde	CD122	PA450790	3560	0.667
NULL	Mol_Cancer_2010_Nov_8_9_291.nxml.txt.nlp	21059223	SENT87	28	28	3	3	paclitaxel	ZNF217	PA450761	7764	0.667
NULL	Endocrinol_Metab_(Seoul)_2014_Sep_25_29(3)_379-387.nxml.txt.nlp	25309798	SENT176	11	11	9	9	resveratrol	BMAL1		406	0.667
NULL	Oncotarget_2013_Jun_8_4(5)_792-801.nxml.txt.nlp	23801022	SENT197	7	7	22	22	ethanol	Tech	PA448073	57449	0.667
NULL	Acta_Vet_Scand_2011_Feb_17_53(1)_11.nxml.txt.nlp	21324209	SENT75	10	10	16	16	gentamicin	OTC	PA449753	5009	0.667
NULL	AIDS_Res_Ther_2013_May_1_10_10.nxml.txt.nlp	23634877	SENT12	14	14	23	23	atorvastatin	CCL4	PA448500	6351	0.667
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1137-1144.nxml.txt.nlp	20234366	SENT171	7	7	14	14	cetuximab	BRAF	PA10040	673	0.667
NULL	Breast_Cancer_Res_Treat_2014_Dec_21_143(3)_459-467.nxml.txt.nlp	24362951	SENT247	11	11	34	34	exemestane	aromatase	PA449563	1588	0.667
NULL	Chin_J_Cancer_2012_Apr_31(4)_178-184.nxml.txt.nlp	22237038	SENT36	10	10	36	36	niclosamide	MTS1	PA165958408	1029	0.667
NULL	Int_J_Mol_Sci_2014_Oct_23_15(10)_19265-19280.nxml.txt.nlp	25342321	SENT241	3	3	13	13	cisplatin	KRT10	PA449014	3858	0.667
NULL	Nat_Med_2013_Feb_6_19(2)_217-226.nxml.txt.nlp	23291629	SENT355	18	18	13	13	lipase	ATGL	PA450239	57104	0.667
NULL	Br_J_Cancer_2012_Sep_4_107(6)_977-987.nxml.txt.nlp	22892389	SENT92	2	2	4	4	orlistat	VEGFA	PA164776864	7422	0.667
NULL	Cardiovasc_J_Afr_2013_Oct_24(8)_322-326.nxml.txt.nlp	24240384	SENT117	11	11	7	7	protamine	IL-6	PA10366	3569	0.667
NULL	Nat_Commun_2012_Dec_27_3_1316.nxml.txt.nlp	23271650	SENT518	12	12	33	33	tamoxifen	CA1	PA451581	759	0.667
NULL	Cell_Commun_Signal_2013_Jul_4_11_47.nxml.txt.nlp	23826796	SENT58	3	3	16	16	forskolin	CC2D1A	PA146096022	54862	0.667
NULL	Psychiatry_Investig_2010_Dec_30_7(4)_236-242.nxml.txt.nlp	21253406	SENT59	14	14	7	7	citalopram	BDNF	PA449015	627	0.667
NULL	Anal_Chem_Insights_2014_Mar_2_9_1-7.nxml.txt.nlp	24634579	SENT4	5	5	12	12	salbutamol	TRB	PA448068	6957	0.667
NULL	Ann_Oncol_2010_Jul_23_21(7)_1436-1441.nxml.txt.nlp	20032126	SENT207	23	23	9	9	paclitaxel	HER2	PA450761	2064	0.667
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Nov_4_9_31.nxml.txt.nlp	21050425	SENT126	17	17	11	11	kanamycin	Gen	PA450137	348654	0.667
NULL	J_Cell_Mol_Med_2013_Sep_11_17(9)_1160-1172.nxml.txt.nlp	23844832	SENT174	26	26	16	16	gefitinib	BMP9	PA131301952	2658	0.667
NULL	Parasit_Vectors_2011_Jan_7_4_4.nxml.txt.nlp	21214898	SENT277	27	27	11	11	galactose	SNA	PA449725	6615	0.667
NULL	Clin_Pharmacol_2013_Dec_9_5_185-192.nxml.txt.nlp	24353446	SENT80	11	11	23	23	clopidogrel	ARNT	PA449053	405	0.667
NULL	Subst_Abuse_Treat_Prev_Policy_2009_Apr_17_4_6.nxml.txt.nlp	19374740	SENT61	33	33	19	19	buprenorphine	OST	PA448685	1650;23263	0.667
NULL	Adv_Hematol_2012_Mar_25_2012_302570.nxml.txt.nlp	22536253	SENT336	8	8	5	5	nutlin-3	MDM2		4193	0.667
NULL	Brain_Sci_2013_Jun_3_3(2)_877-907.nxml.txt.nlp	24961429	SENT244	9	9	15	15	taurine	MELAS	PA451590	4219	0.667
NULL	Mol_Pain_2013_Jun_10_9_27.nxml.txt.nlp	23758830	SENT195	4	4	16	16	lidocaine	TRPV1	PA450226	7442	0.667
NULL	Curr_Clin_Pharmacol_2013_May_8(2)_135-155.nxml.txt.nlp	23062036	SENT197	5	5	11	11	raloxifene	AP-1	PA451221	2353;3727;2354;3725	0.667
NULL	Sensors_(Basel)_2013_Dec_27_14(1)_458-467.nxml.txt.nlp	24379050	SENT100	8	8	5	5	glucose	MTB	PA449773	54892;4498	0.667
NULL	Cell_Death_Dis_2014_Mar_13_5(3)_e1118.nxml.txt.nlp	24625977	SENT81	36	36	7	7	etoposide	mot-2	PA449552	3313	0.667
NULL	Clin_Kidney_J_2013_Jun_11_6(3)_287-294.nxml.txt.nlp	23717787	SENT16	14	14	27	27	cinacalcet	PTH	PA164776671	5741	0.667
NULL	Crit_Care_2011_Sep_19_15(5)_R217.nxml.txt.nlp	21929764	SENT122	18	18	20	20	vasopressin	AVP	PA451858	114548;551	0.667
NULL	J_Antimicrob_Chemother_2009_Feb_28_63(2)_389-395.nxml.txt.nlp	19042940	SENT87	25	25	14	14	trimethoprim	UTI	PA451788	259	0.667
NULL	J_Antimicrob_Chemother_2013_May_1_68(5)_1066-1070.nxml.txt.nlp	23378414	SENT71	14	14	31	31	erythromycin	NOV	PA449493	4856;5361;6134	0.667
NULL	Cancers_(Basel)_2010_Apr_9_2(2)_397-419.nxml.txt.nlp	24281076	SENT196	5	5	36	36	curcumin	PRL-3	PA151958596	11156	0.667
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT114	14	14	6	6	tenofovir	SLC22A8	PA10204	9376	0.667
NULL	J_Cell_Biol_2002_May_13_157(4)_565-570.nxml.txt.nlp	12011108	SENT324	11	11	2	2	choline	p75NTR	PA448976	4804	0.667
NULL	Acta_Pharmacol_Sin_2014_Oct_25_35(10)_1293-1301.nxml.txt.nlp	25152022	SENT188	2	2	8	8	enalapril	NLRP3	PA449456	114548	0.667
NULL	Adv_Hematol_2012_Feb_6_2012_485943.nxml.txt.nlp	22400030	SENT110	15	15	18	18	doxorubicin	CHOP	PA449412	1649	0.667
NULL	J_Cell_Biol_2001_Oct_1_155(1)_27-40.nxml.txt.nlp	11581284	SENT322	16	16	21	21	gentamicin	CO2	PA449753	4513	0.667
NULL	Infect_Drug_Resist_2011_Mar_2_4_77-86.nxml.txt.nlp	21694911	SENT74	13	13	3	3	tigecycline	CABP	PA164746412	6277	0.667
NULL	Psychiatry_Investig_2012_Dec_12_9(4)_422-424.nxml.txt.nlp	23251210	SENT14	20	20	15	15	terbinafine	CYP2D6	PA451614	1565	0.667
NULL	Exp_Ther_Med_2014_Apr_13_7(4)_799-803.nxml.txt.nlp	24669235	SENT87	5	5	13	13	metformin	PPG	PA450395	5552	0.667
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jun_18_67(Pt_7)_o1733.nxml.txt.nlp	21837122	SENT68	17	17	26	26	ethanol	mol	PA448073	90527	0.667
NULL	Br_J_Cancer_2014_Aug_12_111(4)_640-645.nxml.txt.nlp	24642617	SENT72	29	29	26	26	vemurafenib	CRAF	PA165946873	5894	0.667
NULL	Indian_J_Pharm_Sci_2013_Jan-Feb_75(1)_94-98.nxml.txt.nlp	23901167	SENT69	10	10	33	33	tolbutamide	CYP2C9	PA451718	1559	0.667
NULL	Exp_Anim_2014_Jul_22_63(4)_447-457.nxml.txt.nlp	25048263	SENT10	41	41	19	19	estradiol	LEP	PA449503	3952	0.667
NULL	Curr_Oncol_2006_Feb_13(1)_14-26.nxml.txt.nlp	17576437	SENT235	0	0	8	8	curcumin	MMP2	PA151958596	4313	0.667
NULL	Front_Endocrinol_(Lausanne)_2013_Mar_27_4_37.nxml.txt.nlp	23542897	SENT1047	0	0	5	5	pioglitazone	PPARgamma	PA450970	5468	0.667
NULL	Front_Immunol_2014_Aug_14_5_390.nxml.txt.nlp	25177322	SENT205	23	23	6	6	ribavirin	CD56	PA451241	4684	0.667
NULL	Case_Rep_Hematol_2013_Aug_31_2013_687260.nxml.txt.nlp	24073345	SENT32	12	12	17	17	vincristine	CHOP	PA451879	1649	0.667
NULL	Biomed_Res_Int_2013_Dec_30_2013_735835.nxml.txt.nlp	24490170	SENT173	38	38	40	40	fexofenadine	FEX	PA449621	8549	0.667
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT151	4	4	6	6	curcumin	TRAIL	PA151958596	8743	0.667
NULL	Acta_Pharmacol_Sin_2013_Feb_12_34(2)_255-261.nxml.txt.nlp	23147557	SENT86	19	19	15	15	pioglitazone	PTPRD	PA450970	5789	0.667
NULL	EMBO_Mol_Med_2013_Jun_30_5(6)_935-948.nxml.txt.nlp	23629957	SENT298	12	12	10	10	cisplatin	COL6A3	PA449014	1293	0.667
NULL	Biomed_Res_Int_2014_May_20_2014_291271.nxml.txt.nlp	24967346	SENT128	9	9	2	2	ethanol	flower	PA448073	11094	0.667
NULL	Basic_Res_Cardiol_2011_Sep_24_106(5)_829-847.nxml.txt.nlp	21516490	SENT376	4	4	2	2	tamoxifen	WT1	PA451581	7490	0.667
NULL	Clin_Med_Insights_Oncol_2011_Sep_21_5_315-323.nxml.txt.nlp	22084620	SENT229	14	14	20	20	gemcitabine	IFN	PA449748	3439	0.667
NULL	Br_J_Cancer_2009_Nov_3_101(9)_1549-1554.nxml.txt.nlp	19809436	SENT31	23	23	15	15	cyclophosphamide	ADM	PA449165	133	0.667
NULL	Indian_J_Pharmacol_2008_Oct_40(Suppl_2)_S112-S142.nxml.txt.nlp	21593965	SENT1760	0	0	11	11	diazepam	EPM	PA449283	2054	0.667
NULL	Iran_J_Microbiol_2013_Mar_5(1)_48-55.nxml.txt.nlp	23466743	SENT131	24	24	14	14	cefepime	CTX	PA164754876	1593	0.667
NULL	Clin_Transl_Allergy_2014_Feb_28_4(Suppl_1)_P35.nxml.txt.nlp	25045492	SENT15	0	0	31	31	atorvastatin	IL-18	PA448500	3606	0.667
NULL	Med_Sci_Monit_2013_May_1_19_317-326.nxml.txt.nlp	23632427	SENT277	24	24	14	14	cefuroxime	CTX	PA448868	1593	0.667
NULL	Cancer_Metastasis_Rev_2010_Dec_10_29(4)_581-594.nxml.txt.nlp	20830503	SENT341	11	11	28	28	tamoxifen	ATAC	PA451581	6375	0.667
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jun_25_67(Pt_7)_o1809.nxml.txt.nlp	21837180	SENT68	11	11	38	38	ethanol	mol	PA448073	90527	0.667
NULL	Arthritis_Res_Ther_2013_Dec_27_15(6)_R222.nxml.txt.nlp	24369907	SENT181	32	32	15	15	collagenase	p38	PA449107	10598;1432;7965	0.667
NULL	Int_J_Mol_Sci_2014_Nov_28_15(12)_21967-21979.nxml.txt.nlp	25464383	SENT62	10	10	12	12	ethanol	G17	PA448073	5089;10991	0.667
NULL	Clin_Pharmacol_2013_Nov_19_5_167-174.nxml.txt.nlp	24277991	SENT105	40	40	27	27	berberine	P-gp	PA165860812	5243	0.667
NULL	J_Int_AIDS_Soc_2011_Feb_9_14_7.nxml.txt.nlp	21306608	SENT74	17	17	23	23	didanosine	ATV	PA449301	4683	0.667
NULL	J_Hematol_Oncol_2009_Jan_21_2_2.nxml.txt.nlp	19159467	SENT57	26	26	31	31	cetuximab	EGFR	PA10040	1956	0.667
NULL	Oncotarget_2010_Jul_9_1(3)_185-197.nxml.txt.nlp	21037799	SENT99	6	6	0	0	choline	Hsp90	PA448976	3320	0.667
NULL	Clinics_(Sao_Paulo)_2014_Jan_69(1)_68-74.nxml.txt.nlp	24473562	SENT113	17	17	21	21	nutlin-3	SOCS-1		8651	0.667
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT164	0	0	8	8	atorvastatin	CD14	PA448500	929	0.667
NULL	JMIR_Res_Protoc_2014_Dec_10_3(4)_e73.nxml.txt.nlp	25500152	SENT176	10	10	3	3	phenytoin	CYP3A4	PA450947	1576	0.667
NULL	Theranostics_2013_Sep_4_3(9)_719-728.nxml.txt.nlp	24019856	SENT163	11	11	29	29	heparin	CD44	PA449855	960	0.667
NULL	J_Am_Heart_Assoc_2013_Dec_19_2(6)_e000355.nxml.txt.nlp	24190878	SENT26	44	44	35	35	isoproterenol	HK2	PA450121	3796;3099;29911;3741	0.667
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Apr_18_65(Pt_5)_o1066.nxml.txt.nlp	21583882	SENT55	22	22	33	33	ethanol	mol	PA448073	90527	0.667
NULL	Clin_Ophthalmol_2012_May_29_6_817-830.nxml.txt.nlp	22701083	SENT70	34	34	42	42	glucosamine	GFPT1	PA164747613	2673	0.667
NULL	Surg_Today_2015_Oct_14_45_221-226.nxml.txt.nlp	25734195	SENT122	23	23	17	17	doxorubicin	CRT	PA449412	811	0.667
NULL	Aging_(Albany_NY)_2012_Apr_16_4(4)_247-255.nxml.txt.nlp	22511639	SENT82	12	12	35	35	metformin	CH1	PA450395	51430	0.667
NULL	Acta_Pharmacol_Sin_2013_Apr_25_34(4)_522-530.nxml.txt.nlp	23524573	SENT11	6	6	8	8	cyclophosphamide	CTX	PA449165	1593	0.667
NULL	Clinics_(Sao_Paulo)_2014_Jan_69(1)_68-74.nxml.txt.nlp	24473562	SENT100	5	5	2	2	nutlin-3	SOCS-1		8651	0.667
NULL	Arthritis_Res_Ther_2011_Feb_4_13(1)_R14.nxml.txt.nlp	21294864	SENT121	4	4	6	6	indomethacin	IL-17	PA449982	3605	0.667
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Apr_13_69(Pt_5)_o718-o719.nxml.txt.nlp	23723871	SENT79	9	9	15	15	benzaldehyde	mol	PA448571	90527	0.667
NULL	Cancer_Imaging_2008_Mar_25_8(1)_57-69.nxml.txt.nlp	18390389	SENT209	26	26	31	31	thyroglobulin	WBS	PA164754910	2006	0.666
NULL	Front_Behav_Neurosci_2012_Mar_27_6_14.nxml.txt.nlp	22470324	SENT170	11	11	22	22	hydrocortisone	spatial	PA449905	219793	0.666
NULL	Arthritis_Res_2001_Sep_18_3(6)_381-388.nxml.txt.nlp	11714393	SENT138	34	34	17	17	collagenase	p38	PA449107	10598;1432;7965	0.666
NULL	Evid_Based_Complement_Alternat_Med_2014_May_8_2014_364819.nxml.txt.nlp	24899907	SENT148	6	6	20	20	tacrolimus	FKBP52	PA451578	2288	0.666
NULL	Eur_J_Med_Res_2014_Apr_9_19(1)_19.nxml.txt.nlp	24717101	SENT43	8	8	23	23	rituximab	CHOP	PA451261	1649	0.666
NULL	Mol_Biol_Cell_2013_Jul_15_24(14)_2186-2200.nxml.txt.nlp	23699397	SENT91	33	33	38	38	doxorubicin	TRAIL	PA449412	8743	0.666
NULL	Cell_Death_Dis_2014_Jul_17_5(7)_e1333.nxml.txt.nlp	25032856	SENT266	0	0	12	12	candesartan	TLR4	PA448765	7099	0.666
NULL	Diabetes_Care_2010_May_27_33(5)_951-957.nxml.txt.nlp	20107105	SENT19	0	0	9	9	exenatide	GLP-1	PA164749238	100125288	0.666
NULL	Diabetes_Care_2013_Mar_13_36(3)_656-661.nxml.txt.nlp	23093662	SENT155	36	36	13	13	lisinopril	NGAL	PA450242	3934	0.666
NULL	J_Exp_Med_2003_Dec_1_198(11)_1653-1663.nxml.txt.nlp	14657218	SENT53	22	22	2	2	gentamicin	CD19	PA449753	930	0.666
NULL	J_Biomed_Biotechnol_2008_Mar_18_2008_541678.nxml.txt.nlp	18382624	SENT39	34	34	8	8	bleomycin	CAF-1	PA448645	10036;8208	0.666
NULL	Exp_Ther_Med_2015_Feb_16_9(2)_289-293.nxml.txt.nlp	25574188	SENT99	13	13	3	3	metformin	AMPK	PA450395	5563	0.666
NULL	Mol_Cancer_2012_Sep_25_11_73.nxml.txt.nlp	23009336	SENT118	36	36	15	15	gefitinib	EGFR	PA131301952	1956	0.666
NULL	Open_Neurol_J_2009_Apr_2_3_27-44.nxml.txt.nlp	19461897	SENT363	10	10	1	1	donepezil	CYP2D6	PA449394	1565	0.666
NULL	Mucosal_Immunol_2011_Sep_2_4(5)_528-538.nxml.txt.nlp	21289616	SENT193	4	4	0	0	collagenase	CD11c	PA449107	3687	0.666
NULL	Eur_J_Pediatr_2012_Feb_17_171(2)_207-214.nxml.txt.nlp	21922352	SENT37	2	2	6	6	thrombin	FVIII	PA451674	2157	0.666
NULL	Int_J_Mol_Sci_2014_Oct_23_15(10)_19239-19252.nxml.txt.nlp	25342319	SENT43	20	20	24	24	heparin	SERS	PA449855	6301;54938	0.666
NULL	Breast_Cancer_Res_2011_Apr_15_13(2)_R44.nxml.txt.nlp	21496232	SENT246	30	30	21	21	erlotinib	HER2	PA134687924	2064	0.666
NULL	Exp_Anim_2013_Oct_31_62(4)_275-280.nxml.txt.nlp	24172191	SENT83	0	0	16	16	galactose	TRPV5	PA449725	56302	0.666
NULL	Mol_Cell_Proteomics_2014_Dec_9_13(12)_3435-3445.nxml.txt.nlp	25205226	SENT205	15	15	20	20	clopidogrel	P2Y12	PA449053	64805	0.666
NULL	Clin_Genet_2014_Jan_1_86(1)_21-28.nxml.txt.nlp	24684508	SENT58	17	17	28	28	warfarin	gamma	PA451906	9913	0.666
NULL	Br_J_Cancer_2009_Jul_21_101(2)_269-277.nxml.txt.nlp	19603033	SENT139	21	21	19	19	cisplatin	MLH1	PA449014	4292	0.666
NULL	Indian_Dermatol_Online_J_2013_Jul-Sep_4(3)_177-179.nxml.txt.nlp	23984227	SENT35	13	13	10	10	ustekinumab	IL-23	PA166048654	51561	0.666
NULL	Int_J_Environ_Res_Public_Health_2011_Dec_30_8(12)_4460-4476.nxml.txt.nlp	22408583	SENT172	13	13	7	7	ampicillin	S12	PA448419	3351;6206;5713;6268	0.666
NULL	Neuroscience_2009_Jun_30_161(2-3)_572-577.nxml.txt.nlp	19327387	SENT494	29	29	9	9	capsaicin	GAPDH	PA448776	2597	0.666
NULL	Br_J_Cancer_2013_Jul_23_109(2)_502-511.nxml.txt.nlp	23799850	SENT17	13	13	21	21	gemcitabine	SMARCC1	PA449748	6599	0.666
NULL	Cells_2014_Apr_8_3(2)_258-287.nxml.txt.nlp	24717323	SENT292	27	27	22	22	capsaicin	TRPV1	PA448776	7442	0.666
NULL	Am_J_Med_Sci_2014_Dec_20_348(6)_513-521.nxml.txt.nlp	25285512	SENT158	22	22	19	19	warfarin	VKORC1	PA451906	79001	0.666
NULL	Drug_Des_Devel_Ther_2014_Sep_18_8_1467-1479.nxml.txt.nlp	25258515	SENT256	42	42	16	16	cyclosporine	BCS	PA449167	617	0.666
NULL	Exp_Ther_Med_2013_Apr_5_5(4)_1259-1263.nxml.txt.nlp	23596498	SENT82	0	0	12	12	propofol	TRPV1	PA451141	7442	0.666
NULL	Cell_Regen_(Lond)_2012_Jun_28_1(1)_3.nxml.txt.nlp	25408866	SENT61	41	41	7	7	glucose	CO2	PA449773	4513	0.666
NULL	Case_Rep_Transplant_2011_Jan_5_2011_210178.nxml.txt.nlp	23213600	SENT110	3	3	23	23	tacrolimus	CYP3A4	PA451578	1576	0.666
NULL	Adv_Hematol_2012_Jun_19_2012_851674.nxml.txt.nlp	22778745	SENT240	7	7	15	15	indomethacin	AF9	PA449982	4300	0.666
NULL	Mol_Cancer_2008_Mar_26_7_27.nxml.txt.nlp	18366759	SENT288	13	13	18	18	etoposide	MCL1	PA449552	4170	0.666
NULL	Environ_Health_Perspect_2008_Apr_16_116(4)_426-433.nxml.txt.nlp	18414622	SENT151	0	0	2	2	resveratrol	NMU		10874	0.666
NULL	Exp_Ther_Med_2013_Oct_16_6(4)_873-882.nxml.txt.nlp	24137281	SENT175	2	2	39	39	diltiazem	IL-6	PA449334	3569	0.666
NULL	Cell_Commun_Signal_2014_Jan_10_12_3.nxml.txt.nlp	24410813	SENT88	4	4	21	21	tamoxifen	THOC1	PA451581	9984	0.666
NULL	Neural_Plast_2012_Oct_24_2012_832757.nxml.txt.nlp	23150836	SENT222	7	7	17	17	risperidone	spatial	PA451257	219793	0.666
NULL	Crit_Care_2004_Sep_29_8(2)_122-129.nxml.txt.nlp	15025773	SENT195	16	16	37	37	hydrocortisone	ACTH	PA449905	5443	0.666
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT165	26	26	23	23	rosiglitazone	CD36	PA451283	948	0.666
NULL	Case_Rep_Transplant_2013_Aug_1_2013_765230.nxml.txt.nlp	23984169	SENT37	8	8	13	13	vincristine	CHOP	PA451879	1649	0.666
NULL	Indian_J_Pharmacol_2014_Nov-Dec_46(6)_627-632.nxml.txt.nlp	25538335	SENT133	24	24	1	1	metformin	Q10	PA450395	27161	0.666
NULL	Case_Rep_Ophthalmol_2010_Dec_8_1(2)_110-113.nxml.txt.nlp	21373383	SENT4	28	28	11	11	ranibizumab	PED	PA164746012	8682	0.666
NULL	J_Lipid_Res_2013_Nov_54(11)_3085-3097.nxml.txt.nlp	23883581	SENT216	0	0	6	6	thrombin	PAR4	PA451674	9002;5074	0.666
NULL	Mol_Cancer_2010_Jun_25_9_166.nxml.txt.nlp	20579378	SENT65	15	15	21	21	gefitinib	EGF	PA131301952	1950	0.666
NULL	Mol_Biol_Rep_2013_May_16_40(8)_4995-5004.nxml.txt.nlp	23677713	SENT160	17	17	12	12	camptothecin	TERT	PA153590860	7015	0.666
NULL	Indian_J_Crit_Care_Med_2008_Oct-Dec_12(4)_181-189.nxml.txt.nlp	19742267	SENT202	25	25	14	14	anakinra	ACR	PA10799	49	0.666
NULL	Tuberc_Respir_Dis_(Seoul)_2014_Sep_30_77(3)_105-110.nxml.txt.nlp	25309604	SENT29	16	16	3	3	warfarin	CYP2C9	PA451906	1559	0.666
NULL	J_Antimicrob_Chemother_2009_Nov_18_64(5)_910-928.nxml.txt.nlp	19767318	SENT111	36	36	8	8	maraviroc	CD4	PA164768835	920	0.666
NULL	Arthritis_Res_Ther_2004_Mar_8_6(3)_R199-R207.nxml.txt.nlp	15142265	SENT4	6	6	3	3	collagenase	MMP1	PA449107	4312	0.666
NULL	New_Microbes_New_Infect_2014_May_4_2(3)_58-63.nxml.txt.nlp	25356345	SENT100	30	30	20	20	ciprofloxacin	GEM	PA449009	2669	0.666
NULL	F1000Res_2013_Oct_8_2_173.nxml.txt.nlp	24555085	SENT66	23	23	3	3	budesonide	BDP	PA448681	10620;152926	0.666
NULL	Biosci_Rep_2014_Dec_12_34(6)_e00160.nxml.txt.nlp	25495645	SENT99	4	4	19	19	rosiglitazone	ANGPTL3	PA451283	27329	0.666
NULL	Aging_(Albany_NY)_2011_Aug_21_3(8)_716-732.nxml.txt.nlp	21869457	SENT46	3	3	0	0	spermine	SSAT	PA164781199	6303	0.666
NULL	Diabetes_Metab_Syndr_Obes_2010_Jul_14_3_215-226.nxml.txt.nlp	21437090	SENT18	0	0	3	3	exenatide	GLP-1	PA164749238	100125288	0.666
NULL	Diabetes_Care_2009_Nov_32(Suppl_2)_S342-S348.nxml.txt.nlp	19875578	SENT114	29	29	24	24	liraglutide	GLP-1	PA165958364	100125288	0.666
NULL	Cancers_(Basel)_2014_Oct_24_6(4)_2187-2223.nxml.txt.nlp	25347122	SENT1236	10	10	4	4	olaparib	ADP		23038	0.666
NULL	Arthritis_Res_Ther_2010_Jul_7_12(4)_R131.nxml.txt.nlp	20609215	SENT211	23	23	10	10	iloprost	CXCL3	PA164746843	2921	0.666
NULL	Acta_Pharmacol_Sin_2013_Jun_8_34(6)_830-836.nxml.txt.nlp	23564080	SENT113	21	21	16	16	simvastatin	RAGE	PA451363	177	0.666
NULL	J_Biol_Chem_2012_Apr_20_287(17)_14122-14135.nxml.txt.nlp	22351750	SENT241	16	16	11	11	hyaluronan	TSG-6	PA165958431	7130	0.666
NULL	Vet_Res_2012_Dec_4_43(1)_81.nxml.txt.nlp	23210796	SENT80	3	3	21	21	cisplatin	p53	PA449014	7157	0.666
NULL	Br_J_Cancer_1996_Dec_74(12)_1908-1915.nxml.txt.nlp	8980389	SENT10	15	15	12	12	melphalan	TNF-alpha	PA450354	7124	0.666
NULL	Adv_Drug_Deliv_Rev_2014_Jun_30_73(100)_127-139.nxml.txt.nlp	24440429	SENT2034	0	0	5	5	alemtuzumab	CD54	PA164783958	3383	0.666
NULL	Mol_Cancer_2010_Jun_25_9_166.nxml.txt.nlp	20579378	SENT9	7	7	5	5	gefitinib	EGF	PA131301952	1950	0.666
NULL	Mol_Biol_Cell_2014_Mar_15_25(6)_791-799.nxml.txt.nlp	24451261	SENT227	10	10	14	14	nadh	ADP	PA164755085	23038	0.666
NULL	Breast_Cancer_2013_Mar_1_20(4)_302-309.nxml.txt.nlp	23456736	SENT29	13	13	15	15	tegafur	CDHP	PA452620	1001	0.666
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Mar_5_67(Pt_4)_o790.nxml.txt.nlp	21754081	SENT66	18	18	32	32	ethanol	mol	PA448073	90527	0.666
NULL	Mol_Pain_2014_Apr_9_10_24.nxml.txt.nlp	24716552	SENT43	2	2	10	10	capsaicin	NK1R	PA448776	6869	0.666
NULL	Br_J_Haematol_2014_Mar_13_164(1)_811-821.nxml.txt.nlp	24328678	SENT4	9	9	2	2	lenalidomide	CRBN	PA162363968	51185	0.666
NULL	Oncotarget_2014_Oct_16_5(22)_11442-11451.nxml.txt.nlp	25347345	SENT77	7	7	15	15	oxaliplatin	IL6	PA131285527	3569	0.666
NULL	Cancers_(Basel)_2012_Sep_25_4(4)_969-988.nxml.txt.nlp	24213497	SENT216	16	16	13	13	estradiol	aromatase	PA449503	1588	0.666
NULL	Biochem_Res_Int_2012_Feb_12_2012_346972.nxml.txt.nlp	22400115	SENT57	15	15	23	23	hyaluronidase	LYVE-1	PA164745713	10894	0.666
NULL	J_Neuroinflammation_2010_Nov_18_7_81.nxml.txt.nlp	21087489	SENT56	20	20	6	6	pilocarpine	GFAP	PA450962	2670	0.666
NULL	Mol_Cancer_2012_Dec_12_11_91.nxml.txt.nlp	23234355	SENT38	0	0	7	7	trastuzumab	HER2	PA451743	2064	0.666
NULL	ScientificWorldJournal_2012_May_15_2012_436039.nxml.txt.nlp	22666121	SENT92	20	20	22	22	lipase	HSL	PA450239	3991	0.666
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2014_Apr_30_70(Pt_5)_1321-1335.nxml.txt.nlp	24816101	SENT182	22	22	0	0	heparin	SGSH	PA449855	6448	0.666
NULL	Curr_Hypertens_Rep_2014_Feb_14_16(4)_423.nxml.txt.nlp	24522942	SENT56	24	24	18	18	cyclosporine	renalase	PA449167	55328	0.666
NULL	Behav_Brain_Funct_2010_Oct_29_6_67.nxml.txt.nlp	21029471	SENT241	22	22	16	16	estradiol	aromatase	PA449503	1588	0.666
NULL	Front_Neurosci_2014_Jan_31_8_6.nxml.txt.nlp	24550768	SENT221	20	20	27	27	vanillin	TRPV1	PA451852	7442	0.666
NULL	Indian_J_Pharm_Sci_2013_Jan-Feb_75(1)_94-98.nxml.txt.nlp	23901167	SENT75	13	13	25	25	tolbutamide	CYP2C9	PA451718	1559	0.666
NULL	Ann_Indian_Acad_Neurol_2011_Jul_14(Suppl1)_S40-S59.nxml.txt.nlp	21847329	SENT350	12	12	4	4	naproxen	PTH	PA450595	5741	0.666
NULL	Carcinogenesis_2014_May_13_35(5)_1055-1066.nxml.txt.nlp	24419232	SENT416	4	4	8	8	metformin	NF-kappaB	PA450395	4790	0.666
NULL	Drug_Target_Insights_2013_Aug_19_7_27-34.nxml.txt.nlp	24023511	SENT98	12	12	16	16	cyclosporine	P-gp	PA449167	5243	0.666
NULL	J_Oncol_2010_Jun_22_2010_939407.nxml.txt.nlp	20652010	SENT5	4	4	2	2	heparin	CXCL7	PA449855	5473	0.666
NULL	Orphanet_J_Rare_Dis_2007_Sep_11_2_37.nxml.txt.nlp	17848188	SENT190	16	16	13	13	imatinib	IFN	PA10804	3439	0.666
NULL	Stroke_Res_Treat_2009_Dec_20_2010_386389.nxml.txt.nlp	20700422	SENT161	3	3	14	14	ebselen	MCP-1	PA161660841	6347	0.666
NULL	Nucleic_Acids_Res_2013_May_20_41(9)_e104.nxml.txt.nlp	23519618	SENT9	14	14	10	10	camptothecin	SLFN11	PA153590860	91607	0.666
NULL	J_Immunol_Res_2014_Jun_2_2014_210241.nxml.txt.nlp	24987708	SENT360	13	13	21	21	estradiol	CD4	PA449503	920	0.666
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT170	39	39	24	24	heparin	FGF1	PA449855	2246	0.666
NULL	Mol_Cancer_2011_Sep_7_10_109.nxml.txt.nlp	21899742	SENT217	9	9	22	22	doxorubicin	TRAIL-R2	PA449412	8795	0.666
NULL	BMB_Rep_2014_May_47(5)_274-279.nxml.txt.nlp	24286313	SENT66	3	3	21	21	bortezomib	CD138	PA10252	6382	0.666
NULL	Int_J_Mol_Sci_2014_Nov_17_15(11)_21270-21285.nxml.txt.nlp	25407530	SENT353	33	33	16	16	collagenase	p38	PA449107	10598;1432;7965	0.666
NULL	Adipocyte_2012_Jul_1_1(3)_132-181.nxml.txt.nlp	23700522	SENT90	23	23	18	18	lipase	ATGL	PA450239	57104	0.666
NULL	Breast_Cancer_Res_2012_Jul_23_14(4)_R112.nxml.txt.nlp	22824341	SENT236	27	27	5	5	doxorubicin	RANKL	PA449412	8600	0.666
NULL	Cancer_Microenviron_2008_Dec_6_1(1)_141-151.nxml.txt.nlp	19308692	SENT241	24	24	10	10	fluorouracil	IMPACT	PA128406956	55364	0.666
NULL	Food_Dig_2012_Dec_7_3(1-3)_63-77.nxml.txt.nlp	23293684	SENT104	23	23	40	40	lipase	PLRP2	PA450239	5408	0.666
NULL	Case_Rep_Oncol_2010_Apr_8_3(1)_93-97.nxml.txt.nlp	20740166	SENT80	0	0	20	20	dasatinib	LCK	PA162372878	3932	0.666
NULL	COPD_2014_Dec_30_11(6)_705-717.nxml.txt.nlp	24787454	SENT173	12	12	23	23	theophylline	NAC	PA451647	22861	0.666
NULL	Acta_Pharmacol_Sin_2013_Sep_5_34(9)_1192-1200.nxml.txt.nlp	23685957	SENT178	3	3	9	9	curcumin	AP-2	PA151958596	7020	0.666
NULL	Br_J_Cancer_2009_Jul_21_101(2)_238-243.nxml.txt.nlp	19568242	SENT178	6	6	10	10	sunitinib	IFN	PA162372840	3439	0.666
NULL	Oncogene_2010_Sep_16_29(37)_5193-5203.nxml.txt.nlp	20581867	SENT21	8	8	12	12	lapatinib	p85	PA152241907	5296;5295;54776;23368	0.666
NULL	Indian_J_Pharmacol_2014_Nov-Dec_46(6)_590-595.nxml.txt.nlp	25538328	SENT81	8	8	15	15	colchicine	IL-6	PA449092	3569	0.666
NULL	Exp_Diabetes_Res_2012_Dec_12_2012_716404.nxml.txt.nlp	22194737	SENT120	8	8	24	24	metformin	AMPK	PA450395	5563	0.666
NULL	Cancer_Cell_Int_2013_Oct_11_13_97.nxml.txt.nlp	24119761	SENT11	9	9	11	11	trastuzumab	EGF	PA451743	1950	0.666
NULL	Breast_Cancer_Res_2008_Jan_25_10(1)_101.nxml.txt.nlp	18226190	SENT41	0	0	7	7	denosumab	RANKL	PA166048634	8600	0.666
NULL	Asian-Australas_J_Anim_Sci_2012_Jun_25(6)_852-860.nxml.txt.nlp	25049637	SENT101	13	13	0	0	trypsin	S27	PA451806	6232	0.666
NULL	Arthritis_Res_Ther_2014_Jul_24_16(4)_R157.nxml.txt.nlp	25059342	SENT117	7	7	0	0	bleomycin	IL-6	PA448645	3569	0.666
NULL	Gut_Liver_2013_Jul_20_7(4)_458-461.nxml.txt.nlp	23898387	SENT16	12	12	26	26	ribavirin	IFN	PA451241	3439	0.666
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_24_2013_482318.nxml.txt.nlp	23864891	SENT90	0	0	13	13	metoprolol	CHOP	PA450480	1649	0.666
NULL	Mol_Cells_2014_Dec_31_37(12)_899a-906.nxml.txt.nlp	25431425	SENT178	6	6	24	24	curcumin	p50	PA151958596	958;4790	0.666
NULL	Br_J_Cancer_2009_Sep_15_101(6)_875-878.nxml.txt.nlp	19672259	SENT35	13	13	1	1	anastrozole	ATAC	PA448432	6375	0.666
NULL	J_Biol_Chem_2010_Aug_20_285(34)_25928-25940.nxml.txt.nlp	20547488	SENT302	27	27	31	31	arsenite	MSK1	PA452638	9252	0.666
NULL	Clin_Med_Insights_Oncol_2012_Feb_28_6_125-135.nxml.txt.nlp	22408376	SENT276	10	10	28	28	cetuximab	BRAF	PA10040	673	0.666
NULL	Iran_J_Pharm_Res_2014_Autumn_13(4)_1241-1247.nxml.txt.nlp	25587313	SENT52	16	16	20	20	vancomycin	ANOVA	PA451850	4858	0.666
NULL	J_Exp_Bot_2012_May_15_63(8)_3157-3171.nxml.txt.nlp	22345641	SENT338	18	18	8	8	benzaldehyde	PAP1	PA448571	11333;5068	0.666
NULL	Int_J_Environ_Res_Public_Health_2013_Aug_2_10(8)_3263-3281.nxml.txt.nlp	23917813	SENT432	27	27	19	19	choline	B12	PA448976	7126;4709	0.666
NULL	Cardiovasc_Diabetol_2013_Mar_23_12_48.nxml.txt.nlp	23522121	SENT87	39	39	29	29	sitagliptin	Met	PA164748978	79811	0.666
NULL	Am_J_Physiol_Endocrinol_Metab_2013_Jul_15_305(2)_E263-E270.nxml.txt.nlp	23715727	SENT323	4	4	6	6	creatine	SLC6A8	PA164778930	6535	0.666
NULL	Eur_J_Clin_Pharmacol_2007_Apr_21_63(4)_335-343.nxml.txt.nlp	17318526	SENT162	19	19	13	13	sulfamethoxazole	CYP2C9	PA451544	1559	0.666
NULL	Ann_Surg_Treat_Res_2014_Feb_22_86(2)_68-75.nxml.txt.nlp	24761411	SENT146	3	3	9	9	resveratrol	survivin		332	0.666
NULL	Protein_Cell_2014_Jun_19_5(6)_469-479.nxml.txt.nlp	24748116	SENT168	7	7	5	5	paclitaxel	EB1	PA450761	9167;22919;10982	0.666
NULL	Oncotarget_2011_Dec_20_2(12)_1094-1108.nxml.txt.nlp	22190353	SENT77	15	15	11	11	doxorubicin	p53	PA449412	7157	0.666
NULL	Scientifica_(Cairo)_2013_Dec_12_2013_635203.nxml.txt.nlp	24416617	SENT460	38	38	27	27	dacarbazine	gp100	PA449197	6490	0.666
NULL	Cent_European_J_Urol_2011_Dec_9_64(4)_256-257.nxml.txt.nlp	24578906	SENT53	6	6	9	9	doxazosin	CD133	PA449407	8842	0.666
NULL	Cancers_(Basel)_2014_Sep_30_6(4)_2035-2048.nxml.txt.nlp	25271833	SENT140	23	23	16	16	gefitinib	IL-2	PA131301952	3558	0.666
NULL	Orphanet_J_Rare_Dis_2014_Nov_15_9(1)_161.nxml.txt.nlp	NULL	SENT205	28	28	37	37	s-adenosylmethionine	Met	PA164754994	79811	0.666
NULL	Chem_Cent_J_2012_Nov_2_6_128.nxml.txt.nlp	23122321	SENT27	19	19	6	6	l-phenylalanine	C10	PA450931	113246	0.666
NULL	J_Korean_Med_Sci_2007_Apr_30_22(2)_283-289.nxml.txt.nlp	17449938	SENT142	4	4	19	19	minoxidil	P21	PA450521	1026;9338	0.666
NULL	Evid_Based_Complement_Alternat_Med_2013_Mar_13_2013_685642.nxml.txt.nlp	23573144	SENT204	2	2	13	13	glimepiride	DAG	PA449761	1605	0.666
NULL	Eur_J_Med_Res_2011_May_12_16(5)_197-205.nxml.txt.nlp	21719392	SENT162	7	7	3	3	foscarnet	IL-2	PA449706	3558	0.666
NULL	Nat_Med_2013_Oct_8_19(10)_1313-1317.nxml.txt.nlp	24013700	SENT61	8	8	4	4	ribavirin	IFN	PA451241	3439	0.666
NULL	Curr_Genomics_2014_Jun_15(3)_217-230.nxml.txt.nlp	24955029	SENT129	18	18	26	26	oxygen	ROS	PA450744	6098	0.666
NULL	Crit_Care_2002_May_24_6(4)_298-305.nxml.txt.nlp	12225603	SENT173	12	12	16	16	chloroquine	IFN	PA448948	3439	0.666
NULL	Open_Med_Chem_J_2013_Oct_31_7_23-29.nxml.txt.nlp	24222802	SENT72	0	0	9	9	perifosine	AKT	PA165291471	207	0.666
NULL	Eur_J_Pediatr_2012_Feb_17_171(2)_207-214.nxml.txt.nlp	21922352	SENT37	2	2	9	9	thrombin	FXI	PA451674	2160	0.666
NULL	Child_Adolesc_Psychiatry_Ment_Health_2009_Mar_12_3_9.nxml.txt.nlp	19284622	SENT81	33	33	10	10	ziprasidone	BARS	PA451974	1487	0.666
NULL	Cardiol_Res_Pract_2013_Feb_21_2013_127270.nxml.txt.nlp	23509665	SENT41	3	3	27	27	prasugrel	IPA	PA154410481	3160	0.666
NULL	Cardiol_Ther_2013_Jun_7_2(1)_57-68.nxml.txt.nlp	25135289	SENT60	24	24	5	5	thrombin	PAR-1	PA451674	2011;2149	0.666
NULL	Am_J_Med_Sci_2014_Nov_27_348(5)_432-439.nxml.txt.nlp	25247759	SENT57	6	6	9	9	desmopressin	FOR	PA449237	51741	0.666
NULL	Oncol_Lett_2014_Mar_16_7(3)_827-833.nxml.txt.nlp	24527090	SENT93	8	8	5	5	cisplatin	IFN	PA449014	3439	0.666
NULL	J_Clin_Biochem_Nutr_2009_May_25_44(3)_205-211.nxml.txt.nlp	19430607	SENT111	7	7	20	20	lansoprazole	ESD	PA450180	2098	0.666
NULL	Acta_Pharmacol_Sin_2011_Jul_9_32(7)_879-887.nxml.txt.nlp	21552292	SENT109	2	2	13	13	metformin	AKT	PA450395	207	0.666
NULL	Int_Neurourol_J_2014_Sep_24_18(3)_115-125.nxml.txt.nlp	25279238	SENT128	31	31	38	38	berberine	PI3K	PA165860812	5290	0.666
NULL	Nat_Chem_Biol_2010_Apr_28_6(4)_291-299.nxml.txt.nlp	20190765	SENT144	6	6	11	11	dasatinib	EGFR	PA162372878	1956	0.666
NULL	Br_J_Cancer_2011_Jul_26_105(3)_372-381.nxml.txt.nlp	21730979	SENT163	10	10	2	2	cisplatin	ATR	PA449014	390502;84168;545	0.666
NULL	Biol_Open_2014_Nov_21_3(12)_1207-1216.nxml.txt.nlp	25416063	SENT72	6	6	14	14	zinc	NANOS2	PA451956	339345	0.666
NULL	Subst_Abuse_Rehabil_2011_Oct_28_2_181-188.nxml.txt.nlp	24474855	SENT157	17	17	13	13	naltrexone	Gen	PA450588	348654	0.666
NULL	Subst_Abuse_Treat_Prev_Policy_2009_Apr_17_4_6.nxml.txt.nlp	19374740	SENT242	0	0	12	12	buprenorphine	OST	PA448685	1650;23263	0.666
NULL	Exp_Diabetes_Res_2012_Oct_15_2012_465282.nxml.txt.nlp	23118742	SENT156	11	11	0	0	metformin	FGF21	PA450395	26291	0.666
NULL	Indian_J_Pharm_Sci_2008_Mar-Apr_70(2)_170-174.nxml.txt.nlp	20046707	SENT58	23	23	5	5	ethanol	ESD	PA448073	2098	0.666
NULL	Int_J_Med_Chem_2012_Dec_6_2012_316972.nxml.txt.nlp	25374685	SENT26	0	0	18	18	curcumin	PC-3	PA151958596	692094	0.666
NULL	Cancers_(Basel)_2014_Apr_30_6(2)_1031-1046.nxml.txt.nlp	24785146	SENT114	18	18	31	31	geldanamycin	HER2	PA152031327	2064	0.666
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT231	5	5	8	8	nutlin-3	p53		7157	0.666
NULL	Cell_Death_Dis_2014_Apr_17_5(4)_e1188.nxml.txt.nlp	24743743	SENT336	17	17	31	31	dantrolene	IRE1	PA449208	2081	0.666
NULL	Oncotarget_2014_Feb_25_5(5)_1304-1314.nxml.txt.nlp	24675421	SENT26	20	20	33	33	cisplatin	JNK	PA449014	5599	0.666
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_4_2013_378657.nxml.txt.nlp	23662132	SENT427	3	3	14	14	resveratrol	SIRT1		23411	0.666
NULL	Adv_Hematol_2014_Nov_24_2014_652395.nxml.txt.nlp	25525435	SENT848	5	5	24	24	lenalidomide	S14	PA162363968	5714;6208;7069	0.666
NULL	Cell_Commun_Signal_2013_Oct_1_11_73.nxml.txt.nlp	24083678	SENT119	26	26	5	5	sulindac	ICAM1	PA451565	3383	0.666
NULL	Acta_Pharmacol_Sin_2011_Jun_23_32(6)_711-715.nxml.txt.nlp	21602841	SENT25	7	7	9	9	capsaicin	TRPV1	PA448776	7442	0.666
NULL	Cancer_Cell_Int_2003_Jul_23_3_12.nxml.txt.nlp	12914669	SENT132	20	20	2	2	doxycycline	PP1	PA449415	5540;5464	0.666
NULL	Iran_J_Microbiol_2013_Mar_5(1)_48-55.nxml.txt.nlp	23466743	SENT131	36	36	14	14	amikacin	CTX	PA164744372	1593	0.666
NULL	Cell_Regen_(Lond)_2014_Jan_31_3(1)_2.nxml.txt.nlp	25408881	SENT256	7	7	15	15	heparin	Oct4	PA449855	5460	0.666
NULL	Int_J_Mol_Sci_2014_Nov_7_15(11)_20500-20517.nxml.txt.nlp	25387078	SENT588	5	5	17	17	vorinostat	c-Myc	PA164748224	4609	0.666
NULL	Ann_Oncol_2011_Jan_13_22(1)_215-223.nxml.txt.nlp	20627875	SENT306	7	7	11	11	vincristine	CHOP	PA451879	1649	0.666
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT151	23	23	27	27	perifosine	DR5	PA165291471	8795	0.666
NULL	J_Cereb_Blood_Flow_Metab_2012_Apr_4_32(4)_731-744.nxml.txt.nlp	22214903	SENT148	31	31	13	13	zolpidem	ANOVA	PA451976	4858	0.666
NULL	Oncotarget_2011_Aug_30_2(8)_610-626.nxml.txt.nlp	21881167	SENT70	6	6	17	17	doxorubicin	p53	PA449412	7157	0.666
NULL	Curr_Neuropharmacol_2009_Jun_7(2)_83-95.nxml.txt.nlp	19949566	SENT445	10	10	32	32	gabapentin	TGB	PA449720	5473	0.666
NULL	Front_Neural_Circuits_2014_Apr_8_8_33.nxml.txt.nlp	24782714	SENT1297	17	17	8	8	sulpiride	spatial	PA164745485	219793	0.666
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT39	22	22	13	13	metformin	AKT	PA450395	207	0.666
NULL	Biosci_Rep_2012_Dec_6_33(1)_e00006.nxml.txt.nlp	23050906	SENT250	33	33	19	19	lovastatin	DHCR24	PA450272	1718	0.666
NULL	Nucleic_Acids_Res_2012_Apr_18_40(8)_e59.nxml.txt.nlp	22259038	SENT218	31	31	27	27	erythromycin	L12	PA449493	26156;6136	0.666
NULL	Mol_Cancer_2010_Nov_2_9_289.nxml.txt.nlp	21044322	SENT166	24	24	6	6	cisplatin	RGS10	PA449014	6001	0.666
NULL	Br_J_Cancer_2010_Jun_29_103(1)_6-11.nxml.txt.nlp	20551960	SENT28	23	23	15	15	cyclophosphamide	ADM	PA449165	133	0.666
NULL	Mol_Brain_2013_Dec_16_6_56.nxml.txt.nlp	24330819	SENT201	4	4	20	20	dantrolene	GluN2D	PA449208	2906	0.666
NULL	Oncol_Rep_2014_Feb_13_31(2)_581-588.nxml.txt.nlp	24337105	SENT117	19	19	13	13	capsaicin	XBP1	PA448776	7494	0.666
NULL	Onco_Targets_Ther_2014_Jun_13_7_1033-1042.nxml.txt.nlp	24966685	SENT143	38	38	16	16	gemcitabine	PDK1	PA449748	5170;5163	0.666
NULL	Oncotarget_2012_Feb_22_3(2)_203-211.nxml.txt.nlp	22361516	SENT21	0	0	5	5	rituximab	San	PA451261	80218	0.666
NULL	Oncotarget_2014_Aug_29_5(19)_8947-8958.nxml.txt.nlp	25333254	SENT136	0	0	3	3	plerixafor	CXCR7	PA165958410	57007	0.666
NULL	J_Gen_Physiol_1984_Jun_1_83(6)_919-940.nxml.txt.nlp	6330283	SENT0	11	11	1	1	quinidine	Gen	PA451209	348654	0.666
NULL	Pharmacogn_Rev_2011_Jan-Jun_5(9)_1-12.nxml.txt.nlp	22096313	SENT211	0	0	30	30	flavopiridol	E2F1	PA452627	1869	0.666
NULL	Indian_J_Med_Res_2011_Sep_134(3)_253-255.nxml.txt.nlp	21985806	SENT42	36	36	14	14	phenytoin	CYP2C9	PA450947	1559	0.666
NULL	Cells_2014_May_23_3(2)_517-545.nxml.txt.nlp	24861977	SENT1073	3	3	7	7	gentamicin	TRPV4	PA449753	59341	0.666
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT201	24	24	2	2	metformin	p53	PA450395	7157	0.666
NULL	Behav_Brain_Funct_2008_Aug_15_4_37.nxml.txt.nlp	18702828	SENT7	23	23	19	19	methamphetamine	FZD3	PA450403	7976;8326	0.666
NULL	Indian_J_Med_Res_2014_Jun_139(6)_913-920.nxml.txt.nlp	25109726	SENT145	24	24	18	18	vancomycin	C23	PA451850	4691	0.666
NULL	Blood_Cancer_J_2012_Oct_19_2(10)_e95.nxml.txt.nlp	23085780	SENT11	7	7	34	34	imatinib	CML	PA10804	613	0.666
NULL	Oncotarget_2011_Apr_10_2(4)_321-328.nxml.txt.nlp	21487159	SENT78	4	4	8	8	estradiol	GREB1	PA449503	9687	0.666
NULL	J_Vet_Med_Sci_2014_Feb_21_76(2)_219-227.nxml.txt.nlp	24141321	SENT11	9	9	7	7	ns-398	SON		6651	0.666
NULL	Clin_Toxicol_(Phila)_2014_Nov_6_52(9)_926-944.nxml.txt.nlp	25283255	SENT392	9	9	26	26	lisinopril	San	PA450242	80218	0.666
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_29_2013_590393.nxml.txt.nlp	23737838	SENT301	0	0	5	5	resveratrol	p53		7157	0.666
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_11_2014_780385.nxml.txt.nlp	25435891	SENT27	30	30	19	19	lipase	ATGL	PA450239	57104	0.666
NULL	Br_J_Cancer_2002_Jan_21_86(2)_218-221.nxml.txt.nlp	11870509	SENT66	6	6	8	8	tamoxifen	BRCA2	PA451581	675	0.666
NULL	Oncogenesis_2012_Apr_2_1(4)_e5.nxml.txt.nlp	23552603	SENT568	35	35	6	6	ns-398	Bcl-2		596	0.666
NULL	Braz_J_Med_Biol_Res_2013_Aug_13_46(8)_650-658.nxml.txt.nlp	23969971	SENT13	9	9	23	23	cisplatin	survivin	PA449014	332	0.666
NULL	Hum_Genomics_Proteomics_2010_Sep_13_2010_754919.nxml.txt.nlp	20981234	SENT101	12	12	16	16	acenocoumarol	CYP2C9	PA452632	1559	0.666
NULL	Vet_Res_2013_Mar_11_44(1)_16.nxml.txt.nlp	23497076	SENT289	6	6	13	13	thrombin	PAR1	PA451674	79581;2149	0.666
NULL	Mol_Brain_2014_May_15_7_37.nxml.txt.nlp	24886748	SENT228	0	0	9	9	vorinostat	CD4	PA164748224	920	0.666
NULL	Acta_Histochem_Cytochem_2012_Apr_26_45(2)_139-146.nxml.txt.nlp	22685356	SENT82	16	16	6	6	forskolin	AQP2	PA146096022	359	0.666
NULL	Arch_Drug_Inf_2008_Jul_1(1)_14-22.nxml.txt.nlp	20157364	SENT71	31	31	23	23	pravastatin	MCP-1	PA451089	6347	0.666
NULL	Endocrine_2012_Dec_14_42(3)_622-636.nxml.txt.nlp	22695986	SENT58	7	7	5	5	forskolin	PTH	PA146096022	5741	0.666
NULL	Int_J_Mol_Sci_2013_Apr_26_14(5)_9126-9167.nxml.txt.nlp	23624605	SENT332	28	28	20	20	curcumin	HO-1	PA151958596	3162	0.666
NULL	Environ_Health_Perspect_2002_Oct_110(Suppl_5)_749-752.nxml.txt.nlp	12426125	SENT7	5	5	7	7	arsenite	p53	PA452638	7157	0.666
NULL	Semin_Immunopathol_2013_Jan_26_35(1)_39-52.nxml.txt.nlp	22829332	SENT197	7	7	30	30	dacarbazine	CHOP	PA449197	1649	0.666
NULL	Asia_Pac_Allergy_2014_Apr_29_4(2)_106-112.nxml.txt.nlp	24809016	SENT54	15	15	8	8	ampicillin	PPL	PA448419	5493	0.666
NULL	Breast_Cancer_Res_2012_Feb_21_14(1)_R35.nxml.txt.nlp	22353783	SENT352	14	14	0	0	glucose	AMPK	PA449773	5563	0.666
NULL	Cell_Cycle_2012_Nov_1_11(21)_4069-4078.nxml.txt.nlp	23095523	SENT101	37	37	11	11	imatinib	PERK	PA10804	9451	0.665
NULL	Br_J_Cancer_2010_Jul_13_103(2)_265-274.nxml.txt.nlp	20551953	SENT204	5	5	8	8	cisplatin	JNK	PA449014	5599	0.665
NULL	Open_Microbiol_J_2008_May_23_2_66-73.nxml.txt.nlp	19088913	SENT240	5	5	19	19	ketoconazole	HSCO	PA450146	23474	0.665
NULL	Cancer_Med_2014_Aug_14_3(4)_1010-1024.nxml.txt.nlp	24931821	SENT187	15	15	7	7	rituximab	IVL	PA451261	3713	0.665
NULL	Diabetes_Metab_J_2012_Oct_18_36(5)_328-335.nxml.txt.nlp	23130316	SENT24	6	6	26	26	nadh	ADP	PA164755085	23038	0.665
NULL	Front_Physiol_2010_Nov_2_1_145.nxml.txt.nlp	21423385	SENT46	11	11	5	5	heparin	CO2	PA449855	4513	0.665
NULL	Clin_Interv_Aging_2008_Sep_3(3)_431-444.nxml.txt.nlp	18982914	SENT119	20	20	0	0	mitomycin	WRN	PA450524	7486	0.665
NULL	Biosci_Rep_2014_Dec_12_34(6)_e00160.nxml.txt.nlp	25495645	SENT268	26	26	17	17	lipase	ANGPTL4	PA450239	51129	0.665
NULL	Oncotarget_2011_May_16_2(5)_378-392.nxml.txt.nlp	21623005	SENT162	15	15	7	7	oxaliplatin	p53	PA131285527	7157	0.665
NULL	Exp_Ther_Med_2013_Jul_29_6(1)_33-36.nxml.txt.nlp	23935714	SENT95	5	5	9	9	vincristine	CHOP	PA451879	1649	0.665
NULL	Br_J_Cancer_2010_Jan_5_102(1)_162-164.nxml.txt.nlp	19953097	SENT6	29	29	11	11	cetuximab	PTEN	PA10040	5728	0.665
NULL	Ann_Gastroenterol_2014_27(4)_380-386.nxml.txt.nlp	25331321	SENT27	31	31	10	10	telbivudine	IFN	PA164760861	3439	0.665
NULL	J_Exp_Med_2003_Feb_17_197(4)_537-542.nxml.txt.nlp	12591910	SENT161	29	29	26	26	collagenase	GM-CSF	PA449107	1437	0.665
NULL	Can_J_Psychiatry_2014_Jul_59(7)_349-357.nxml.txt.nlp	25007419	SENT232	6	6	13	13	citalopram	STAR	PA449015	6770;2984	0.665
NULL	J_Obes_2011_Apr_28_2011_587495.nxml.txt.nlp	21603273	SENT178	6	6	15	15	lipase	ATGL	PA450239	57104	0.665
NULL	Exp_Diabetes_Res_2011_Dec_27_2011_604989.nxml.txt.nlp	21253359	SENT180	16	16	9	9	clonidine	GLP-1	PA449051	100125288	0.665
NULL	Gut_Liver_2013_Sep_14_7(5)_585-593.nxml.txt.nlp	24073317	SENT111	22	22	11	11	ribavirin	IFN	PA451241	3439	0.665
NULL	Curr_Med_Chem_2014_Jul_21_663-688.nxml.txt.nlp	24251566	SENT136	12	12	5	5	pilocarpine	CA1	PA450962	759	0.665
NULL	Exp_Ther_Med_2013_May_15_5(5)_1327-1331.nxml.txt.nlp	23737873	SENT130	0	0	13	13	imidapril	AQP2	PA452640	359	0.665
NULL	Indian_J_Endocrinol_Metab_2011_Apr-Jun_15(2)_143-144.nxml.txt.nlp	21731879	SENT8	0	0	2	2	diethylstilbestrol	DES	PA449307	1674	0.665
NULL	J_Mol_Med_(Berl)_2013_Aug_17_91(11)_1257-1271.nxml.txt.nlp	23955016	SENT199	13	13	35	35	thrombin	p38	PA451674	10598;1432;7965	0.665
NULL	Oncol_Lett_2013_May_22_5(5)_1653-1655.nxml.txt.nlp	23760305	SENT36	13	13	9	9	thyroglobulin	CEA	PA164754910	5670;1087	0.665
NULL	J_Cell_Biol_1999_Jul_12_146(1)_149-164.nxml.txt.nlp	10402467	SENT741	1	1	4	4	urokinase	CD87	PA451836	5329	0.665
NULL	J_Neurovirol_2011_Feb_19_17(1)_63-69.nxml.txt.nlp	21246320	SENT11	28	28	17	17	memantine	IP-10	PA10364	3627	0.665
NULL	Mol_Syst_Biol_2010_Jan_19_6_344.nxml.txt.nlp	20087341	SENT240	23	23	12	12	ethanol	AMD1	PA448073	262	0.665
NULL	Cancer_Cell_Int_2009_Sep_10_9_25.nxml.txt.nlp	19744341	SENT38	3	3	10	10	glucosamine	STAT3	PA164747613	6774	0.665
NULL	Biomed_Res_Int_2014_Jun_30_2014_965348.nxml.txt.nlp	25101303	SENT202	17	17	29	29	ampicillin	GAPDH	PA448419	2597	0.665
NULL	Breast_Cancer_Res_2011_Aug_12_13(4)_311.nxml.txt.nlp	21884644	SENT4	38	38	13	13	tamoxifen	HSPB8	PA451581	26353	0.665
NULL	Cell_Mol_Neurobiol_2011_Jul_20_31(5)_715-727.nxml.txt.nlp	21424551	SENT58	38	38	17	17	l-glutamine	KSR	PA10090	10256	0.665
NULL	Curr_Cardiol_Rev_2008_Nov_4(4)_293-299.nxml.txt.nlp	20066137	SENT34	21	21	14	14	heparin	ACT	PA449855	12;11332;9457;641455	0.665
NULL	Ann_Oncol_2011_Jan_13_22(1)_215-223.nxml.txt.nlp	20627875	SENT76	25	25	27	27	dacarbazine	DAC	PA449197	13	0.665
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT44	0	0	3	3	chloroquine	BMPR-II	PA448948	659	0.665
NULL	EPMA_J_2012_Sep_27_3(1)_10.nxml.txt.nlp	23016735	SENT159	14	14	27	27	warfarin	CYP2C9	PA451906	1559	0.665
NULL	New_Microbes_New_Infect_2014_May_4_2(3)_58-63.nxml.txt.nlp	25356345	SENT100	14	14	8	8	ceftazidime	CTX	PA448861	1593	0.665
NULL	Ann_Lab_Med_2012_Jul_20_32(4)_298-303.nxml.txt.nlp	22779073	SENT117	20	20	10	10	ethionamide	EMB	PA164768738	133418	0.665
NULL	Arthritis_Res_Ther_2013_Aug_30_15(4)_R100.nxml.txt.nlp	24000795	SENT206	6	6	13	13	paraformaldehyde	CD4	PA450790	920	0.665
NULL	J_Pain_Res_2014_Jun_23_7_353-357.nxml.txt.nlp	25018649	SENT22	37	37	15	15	pregabalin	LNP	PA164754814	80856;51203	0.665
NULL	Acta_Pharmacol_Sin_2013_Mar_11_34(3)_403-413.nxml.txt.nlp	23396374	SENT314	8	8	36	36	triciribine	IL-6	PA165958661	3569	0.665
NULL	Breast_Cancer_Res_2014_May_30_16(3)_R55.nxml.txt.nlp	24886669	SENT244	31	31	24	24	doxorubicin	survivin	PA449412	332	0.665
NULL	Indian_J_Pharm_Sci_2008_Jul-Aug_70(4)_494-497.nxml.txt.nlp	20046778	SENT89	14	14	10	10	risperidone	RIS	PA451257	51285	0.665
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT185	2	2	22	22	perifosine	DR4	PA165291471	8797	0.665
NULL	Arthritis_Res_Ther_2011_Jul_30_13(4)_R126.nxml.txt.nlp	21801431	SENT33	9	9	20	20	etanercept	IL-6	PA449515	3569	0.665
NULL	Age_(Dordr)_2010_Mar_12_32(1)_109-121.nxml.txt.nlp	19908165	SENT82	19	19	32	32	fluorescein	CD61	PA164746009	3690	0.665
NULL	Mol_Cancer_2013_Oct_30_12_132.nxml.txt.nlp	24171719	SENT223	29	29	23	23	heparin	B27	PA449855	56246	0.665
NULL	Acta_Pharmacol_Sin_2013_Sep_5_34(9)_1237-1242.nxml.txt.nlp	23770984	SENT52	28	28	35	35	streptomycin	CO2	PA451512	4513	0.665
NULL	Exp_Ther_Med_2014_Apr_13_7(4)_799-803.nxml.txt.nlp	24669235	SENT87	3	3	13	13	vildagliptin	PPG	PA165958346	5552	0.665
NULL	Leukemia_2014_Apr_8_28(4)_894-903.nxml.txt.nlp	23925045	SENT93	12	12	24	24	tamoxifen	TMP	PA451581	2012	0.665
NULL	Cancers_(Basel)_2011_Apr_1_3(2)_1844-1860.nxml.txt.nlp	24212785	SENT89	12	12	33	33	cetuximab	BRAF	PA10040	673	0.665
NULL	Food_Dig_2012_Dec_7_3(1-3)_63-77.nxml.txt.nlp	23293684	SENT104	16	16	40	40	lipase	PLRP2	PA450239	5408	0.665
NULL	Front_Physiol_2011_Dec_19_2_104.nxml.txt.nlp	22194727	SENT46	0	0	3	3	triciribine	mol	PA165958661	90527	0.665
NULL	Front_Neuroenergetics_2014_Apr_3_6_1.nxml.txt.nlp	24765075	SENT584	3	3	10	10	isoflurane	IL-6	PA450106	3569	0.665
NULL	Clin_Infect_Dis_2011_Mar_15_52(6)_717-725.nxml.txt.nlp	21293047	SENT234	2	2	8	8	glibenclamide	MRP1	PA449782	4437	0.665
NULL	Oncotarget_2012_Dec_31_3(12)_1700-1710.nxml.txt.nlp	23482333	SENT12	33	33	37	37	vincristine	CHOP	PA451879	1649	0.665
NULL	Aging_(Albany_NY)_2012_Feb_21_4(2)_133-143.nxml.txt.nlp	22361433	SENT163	22	22	31	31	glucose	MEF2C	PA449773	4208	0.665
NULL	Arthritis_Res_Ther_2007_Oct_10_9(5)_R105.nxml.txt.nlp	17927818	SENT47	30	30	9	9	l-glutamine	F12	PA10090	2161	0.665
NULL	Br_J_Cancer_2009_Jul_21_101(2)_238-243.nxml.txt.nlp	19568242	SENT104	11	11	13	13	bevacizumab	IFN	PA130232992	3439	0.665
NULL	Br_J_Clin_Pharmacol_2013_Aug_23_76(2)_299-315.nxml.txt.nlp	23701319	SENT175	0	0	6	6	alemtuzumab	CD4	PA164783958	920	0.665
NULL	Oxid_Med_Cell_Longev_2012_Jun_3_2012_914273.nxml.txt.nlp	22701758	SENT151	3	3	12	12	resveratrol	IL-17		3605	0.665
NULL	Biomed_Res_Int_2013_Dec_5_2013_642848.nxml.txt.nlp	24381940	SENT138	4	4	16	16	telmisartan	IL-6	PA451605	3569	0.665
NULL	Nat_Genet_2014_Feb_15_46(2)_152-160.nxml.txt.nlp	24336168	SENT37	14	14	17	17	galactose	TDP-43	PA449725	23435	0.665
NULL	Springerplus_2013_Dec_7_2_659.nxml.txt.nlp	24353977	SENT210	25	25	9	9	ketotifen	MSU	PA450152	593	0.665
NULL	J_Gen_Physiol_2000_Jun_1_115(6)_685-696.nxml.txt.nlp	10828243	SENT158	9	9	14	14	genistein	OLF	PA165109660	83857	0.665
NULL	Br_J_Pharmacol_2008_Nov_11_155(6)_896-905.nxml.txt.nlp	18695641	SENT190	6	6	25	25	genistein	CTX	PA165109660	1593	0.665
NULL	J_Res_Med_Sci_2012_May_17(5)_487-490.nxml.txt.nlp	23626617	SENT83	15	15	20	20	doxorubicin	CHOP	PA449412	1649	0.665
NULL	Lab_Invest_2009_Nov_7_89(11)_1275-1290.nxml.txt.nlp	19736547	SENT302	5	5	11	11	curcumin	CD36	PA151958596	948	0.665
NULL	Front_Immunol_2013_Nov_18_4_382.nxml.txt.nlp	24302925	SENT175	2	2	14	14	imatinib	CD4	PA10804	920	0.665
NULL	Comp_Hepatol_2005_Dec_21_4_9.nxml.txt.nlp	16371151	SENT16	3	3	12	12	ribavirin	IFN	PA451241	3439	0.665
NULL	Curr_Neuropharmacol_2009_Jun_7(2)_83-95.nxml.txt.nlp	19949566	SENT515	22	22	32	32	oxcarbazepine	TGB	PA450732	5473	0.665
NULL	Breast_Cancer_Res_2014_Sep_9_16(5)_437.nxml.txt.nlp	25200860	SENT267	9	9	7	7	pha-665752	Met		79811	0.665
NULL	Arthritis_Res_Ther_2011_Mar_16_13(2)_R44.nxml.txt.nlp	21410959	SENT185	0	0	6	6	glucosamine	RANKL	PA164747613	8600	0.665
NULL	J_Biol_Chem_2013_Nov_15_288(46)_33049-33059.nxml.txt.nlp	24089524	SENT284	5	5	13	13	nicotine	GATA4	PA450626	2626	0.665
NULL	Clin_Transl_Allergy_2014_Feb_28_4(Suppl_1)_P11.nxml.txt.nlp	25045467	SENT15	13	13	8	8	omalizumab	ACT	PA164752253	12;11332;9457;641455	0.665
NULL	Mol_Cancer_2012_Dec_12_11_91.nxml.txt.nlp	23234355	SENT33	5	5	7	7	cetuximab	EGFR	PA10040	1956	0.665
NULL	Oncogene_2010_Sep_16_29(37)_5135-5145.nxml.txt.nlp	20622897	SENT101	22	22	6	6	cetuximab	HIF-1	PA10040	29072	0.665
NULL	Cell_Death_Differ_2010_Mar_16_17(3)_499-512.nxml.txt.nlp	19834490	SENT32	10	10	18	18	bevacizumab	VEGFR1	PA130232992	2321	0.665
NULL	Case_Rep_Rheumatol_2012_Apr_9_2012_517059.nxml.txt.nlp	22937453	SENT37	20	20	13	13	urea	ASAT	PA451831	22	0.665
NULL	Clin_Ophthalmol_2008_Dec_2(4)_919-930.nxml.txt.nlp	19668445	SENT250	0	0	6	6	ranibizumab	San	PA164746012	80218	0.665
NULL	Med_Sci_Monit_2013_Oct_21_19_875-882.nxml.txt.nlp	24145180	SENT34	19	19	11	11	bevacizumab	TRAIL	PA130232992	8743	0.665
NULL	Core_Evid_2008_Jun_3(1)_31-43.nxml.txt.nlp	20694082	SENT225	0	0	15	15	vasopressin	AVP	PA451858	114548;551	0.665
NULL	Acta_Pharmacol_Sin_2011_Nov_10_32(11)_1402-1410.nxml.txt.nlp	21986579	SENT235	8	8	41	41	curcumin	CDK4	PA151958596	1019	0.665
NULL	Ann_Lab_Med_2012_Jul_20_32(4)_298-303.nxml.txt.nlp	22779073	SENT117	28	28	10	10	clarithromycin	EMB	PA449028	133418	0.665
NULL	ScientificWorldJournal_2012_Apr_22_2012_643904.nxml.txt.nlp	22619632	SENT133	26	26	24	24	pp2	PP1		5540;5464	0.665
NULL	Cancer_Immunol_Immunother_2008_Jan_6_57(1)_135-142.nxml.txt.nlp	17922124	SENT146	9	9	14	14	l-arginine	IFN	PA448478	3439	0.665
NULL	Cells_2014_Jan_27_3(1)_53-78.nxml.txt.nlp	24709902	SENT1739	8	8	11	11	trastuzumab	HER2	PA451743	2064	0.665
NULL	Emerg_Infect_Dis_2012_Jun_18(6)_1019-1020.nxml.txt.nlp	22608263	SENT34	26	26	20	20	ciprofloxacin	TOB	PA449009	10140	0.665
NULL	Cell_Death_Dis_2014_Jul_10_5(7)_e1318.nxml.txt.nlp	25010984	SENT136	31	31	12	12	nutlin-3	p53		7157	0.665
NULL	Multidiscip_Respir_Med_2012_Nov_23_7(1)_48.nxml.txt.nlp	23174134	SENT50	13	13	10	10	imatinib	DLST	PA10804	1743	0.665
NULL	Cancer_Res_Treat_2012_Mar_31_44(1)_32-36.nxml.txt.nlp	22500158	SENT102	9	9	0	0	leucovorin	CEA	PA450198	5670;1087	0.665
NULL	Nutr_J_2014_Sep_4_13(1)_88.nxml.txt.nlp	NULL	SENT82	19	19	0	0	ethanol	Men	PA448073	8178	0.665
NULL	Cell_Death_Differ_2010_Nov_13_17(11)_1672-1683.nxml.txt.nlp	20706276	SENT190	20	20	6	6	trypsin	E14	PA451806	4863	0.665
NULL	Mol_Cancer_2011_Sep_24_10_120.nxml.txt.nlp	21943149	SENT134	25	25	8	8	creatine	EZH2	PA164778930	2146	0.665
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_May_15_66(Pt_6)_o1352.nxml.txt.nlp	21579438	SENT64	25	25	14	14	ethanol	mol	PA448073	90527	0.665
NULL	Anesthesiol_Res_Pract_2013_Sep_23_2013_297141.nxml.txt.nlp	24174934	SENT84	36	36	15	15	bupivacaine	mol	PA135057240	90527	0.665
NULL	Int_J_Endocrinol_2011_Dec_6_2011_350546.nxml.txt.nlp	22190926	SENT28	9	9	11	11	vasopressin	AVP	PA451858	114548;551	0.665
NULL	Indian_J_Endocrinol_Metab_2013_Jul-Aug_17(4)_636-646.nxml.txt.nlp	23961479	SENT138	14	14	16	16	fluvastatin	CYP2C9	PA449688	1559	0.665
NULL	Pharmaceuticals_(Basel)_2012_Aug_17_5(8)_837-852.nxml.txt.nlp	24280677	SENT790	2	2	0	0	capsaicin	TRPV1	PA448776	7442	0.665
NULL	Colorectal_Dis_2012_Feb_14(2)_e31-e47.nxml.txt.nlp	21848897	SENT147	10	10	28	28	panitumumab	KRAS	PA162373091	3845	0.665
NULL	Semin_Immunopathol_2009_Sep_26_31(3)_383-397.nxml.txt.nlp	19468733	SENT75	8	8	31	31	l-leucine	CD4	PA450197	920	0.665
NULL	Case_Rep_Oncol_2014_Jun_18_7(2)_393-400.nxml.txt.nlp	25076890	SENT92	25	25	18	18	thyroglobulin	FDG	PA164754910	23583	0.665
NULL	Clin_Med_Insights_Oncol_2013_Aug_12_7_181-197.nxml.txt.nlp	23997579	SENT157	25	25	11	11	cytarabine	CR1	PA449177	1378	0.665
NULL	Indian_J_Med_Res_2012_May_135(5)_672-674.nxml.txt.nlp	22771598	SENT6	23	23	30	30	kanamycin	ETO	PA450137	862	0.665
NULL	Croat_Med_J_2012_Aug_53(4)_294-297.nxml.txt.nlp	22911518	SENT26	24	24	6	6	crizotinib	EGFR	PA165946122	1956	0.665
NULL	Biomed_Res_Int_2013_Apr_15_2013_378380.nxml.txt.nlp	23691500	SENT43	0	0	2	2	chlorpromazine	CPZ	PA448964	8532	0.665
NULL	Hum_Genomics_2009_Jan_1_3(2)_121-127.nxml.txt.nlp	19164089	SENT76	28	28	19	19	ethanol	ALDH1A1	PA448073	216	0.665
NULL	Mar_Drugs_2014_Nov_24_12(11)_5677-5697.nxml.txt.nlp	25421323	SENT575	1	1	6	6	berberine	AMPK	PA165860812	5563	0.665
NULL	J_Oncol_2012_Oct_5_2012_794172.nxml.txt.nlp	22007215	SENT166	14	14	16	16	cyclophosphamide	LDM	PA449165	1595	0.665
NULL	Br_J_Cancer_2012_May_8_106(10)_1587-1590.nxml.txt.nlp	22568998	SENT97	20	20	10	10	sunitinib	IFN	PA162372840	3439	0.665
NULL	Pharmaceuticals_(Basel)_2013_Nov_25_6(12)_1475-1506.nxml.txt.nlp	24287492	SENT113	0	0	2	2	bortezomib	BTZ	PA10252	22794	0.665
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_127043.nxml.txt.nlp	23227093	SENT202	18	18	27	27	lovastatin	P-gp	PA450272	5243	0.665
NULL	Clin_Sci_(Lond)_2012_May_1_122(Pt_9)_421-428.nxml.txt.nlp	22092038	SENT33	5	5	15	15	doxycycline	AP-1	PA449415	2353;3727;2354;3725	0.665
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jun_18_67(Pt_7)_o1676.nxml.txt.nlp	21837075	SENT3	25	25	15	15	benzaldehyde	mol	PA448571	90527	0.665
NULL	Springerplus_2015_Jan_23_4_29.nxml.txt.nlp	25628986	SENT34	15	15	26	26	dapsone	G6PD	PA449211	2539	0.665
NULL	Drugs_Context_2013_Jan_3_2013_212245.nxml.txt.nlp	24432034	SENT105	18	18	39	39	duloxetine	TTR	PA10066	7276	0.665
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT49	2	2	12	12	nutlin-3	p53		7157	0.665
NULL	Mol_Cancer_2014_Feb_4_13_21.nxml.txt.nlp	24495750	SENT94	18	18	13	13	oxaliplatin	VEGFR	PA131285527	3791	0.665
NULL	Onco_Targets_Ther_2014_Nov_28_7_2183-2195.nxml.txt.nlp	25506223	SENT29	12	12	18	18	doxorubicin	MICA	PA449412	100507436	0.665
NULL	Clin_Cosmet_Investig_Dermatol_2013_Jan_14_6_29-36.nxml.txt.nlp	23355788	SENT185	37	37	22	22	desonide	CD68	PA164776996	968	0.665
NULL	Surg_Today_2012_Jan_6_42(1)_8-28.nxml.txt.nlp	22139128	SENT230	27	27	39	39	tegafur	PSK	PA452620	9344	0.665
NULL	J_Antimicrob_Chemother_2013_Mar_9_68(3)_697-707.nxml.txt.nlp	23143901	SENT146	11	11	23	23	oseltamivir	ZAN	PA450721	7455	0.665
NULL	Int_J_Mol_Sci_2010_Nov_17_11(11)_4660-4672.nxml.txt.nlp	21151462	SENT245	7	7	2	2	pioglitazone	gamma	PA450970	9913	0.665
NULL	Br_J_Cancer_2010_Dec_7_103(12)_1822-1830.nxml.txt.nlp	21063405	SENT272	30	30	25	25	cisplatin	FGF2	PA449014	2247;2258	0.665
NULL	Int_J_Biol_Sci_2012_Dec_22_9(1)_78-93.nxml.txt.nlp	23289019	SENT87	16	16	12	12	l-glutamine	B27	PA10090	56246	0.665
NULL	Biomed_Res_Int_2014_Apr_29_2014_186864.nxml.txt.nlp	24877064	SENT179	0	0	3	3	curcumin	AP-1	PA151958596	2353;3727;2354;3725	0.665
NULL	Biomed_Res_Int_2014_Apr_10_2014_580852.nxml.txt.nlp	24812624	SENT129	0	0	2	2	resveratrol	PTEN		5728	0.665
NULL	Br_J_Cancer_2009_Mar_24_100(6)_870-873.nxml.txt.nlp	19293806	SENT21	6	6	10	10	gemcitabine	CDA	PA449748	978	0.665
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT33	17	17	13	13	lapatinib	HER2	PA152241907	2064	0.665
NULL	An_Bras_Dermatol_2014_Mar-Apr_89(2)_266-273.nxml.txt.nlp	24770503	SENT147	11	11	6	6	thalidomide	ENL	PA451644	4298	0.665
NULL	Cancer_Imaging_2008_Sep_10_8(1)_159-162.nxml.txt.nlp	18818134	SENT41	15	15	23	23	thyroglobulin	WBS	PA164754910	2006	0.665
NULL	Front_Cell_Neurosci_2014_Dec_4_8_413.nxml.txt.nlp	25538563	SENT296	32	32	28	28	vasopressin	SON	PA451858	6651	0.665
NULL	Biomed_Res_Int_2013_Dec_10_2013_783698.nxml.txt.nlp	24386640	SENT63	28	28	12	12	rifampin	DST	PA451250	667	0.665
NULL	Cancer_Immunol_Immunother_2015_Oct_7_64_61-73.nxml.txt.nlp	25287778	SENT220	34	34	19	19	lenalidomide	CD56	PA162363968	4684	0.665
NULL	Cancers_(Basel)_2014_Aug_29_6(3)_1753-1768.nxml.txt.nlp	25256831	SENT526	18	18	0	0	bevacizumab	CEA	PA130232992	5670;1087	0.665
NULL	Eur_J_Endocrinol_2009_Nov_161(5)_655-662.nxml.txt.nlp	19729432	SENT119	35	35	31	31	lipase	FAAH	PA450239	79152;2166	0.665
NULL	Front_Genet_2012_Nov_19_3_242.nxml.txt.nlp	23181069	SENT48	14	14	0	0	spermine	ODC	PA164781199	4953;89874	0.665
NULL	Am_J_Rhinol_Allergy_2012_Jan-Feb_26(1)_e20-e22.nxml.txt.nlp	22391072	SENT58	3	3	19	19	aspirin	CRS	PA448497	1403	0.665
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT302	11	11	23	23	paliperidone	PRL	PA163518919	5617	0.665
NULL	Arch_Drug_Inf_2008_Sep_1(2)_43-49.nxml.txt.nlp	19915713	SENT59	5	5	25	25	fentanyl	API	PA449599	5345	0.665
NULL	J_Cheminform_2012_Mar_8_4_6.nxml.txt.nlp	22401035	SENT68	6	6	8	8	troglitazone	PPARG	PA451799	5468	0.665
NULL	Diabetes_2011_Jun_21_60(6)_1705-1715.nxml.txt.nlp	21521872	SENT136	7	7	4	4	doxycycline	STZ	PA449415	6484	0.665
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT148	27	27	7	7	tenofovir	SLC22A8	PA10204	9376	0.665
NULL	Cancer_Cell_2008_Apr_8_13(4)_355-364.nxml.txt.nlp	18394558	SENT244	17	17	7	7	temozolomide	MSH6	PA451609	2956	0.665
NULL	Viruses_2013_Mar_21_5(3)_902-927.nxml.txt.nlp	23518577	SENT1559	1	1	9	9	disulfiram	CD4	PA449376	920	0.665
NULL	Oncotarget_2012_May_18_3(5)_525-534.nxml.txt.nlp	22619113	SENT45	12	12	20	20	fludarabine	IL-4	PA449655	3565	0.665
NULL	Cell_Death_Dis_2010_Jan_21_1(1)_e16.nxml.txt.nlp	21364617	SENT161	29	29	37	37	imatinib	p63	PA10804	8626	0.665
NULL	Inflammation_2014_Sep_5_37(1)_1-9.nxml.txt.nlp	24005897	SENT148	39	39	41	41	diclofenac	COX	PA449293	1351	0.665
NULL	Breast_Cancer_(Auckl)_2009_Sep_2_3_61-75.nxml.txt.nlp	19809577	SENT89	3	3	11	11	curcumin	BRCA1	PA151958596	672	0.665
NULL	Breast_Cancer_Res_2011_Jan_17_13(1)_R5.nxml.txt.nlp	21241485	SENT239	14	14	6	6	estradiol	Brn-3b	PA449503	5458	0.665
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT252	17	17	10	10	heparin	FGF1	PA449855	2246	0.665
NULL	Diabetes_2011_Jul_20_60(7)_1973-1980.nxml.txt.nlp	21617182	SENT52	25	25	14	14	heparin	perlecan	PA449855	3339	0.665
NULL	Br_J_Cancer_2011_Apr_12_104(8)_1278-1287.nxml.txt.nlp	21487429	SENT35	23	23	31	31	cisplatin	p53	PA449014	7157	0.665
NULL	Environ_Health_Perspect_2004_Aug_1_112(12)_1236-1248.nxml.txt.nlp	15345370	SENT477	4	4	10	10	indomethacin	PHB	PA449982	5245	0.665
NULL	Mol_Cancer_2009_Nov_24_8_109.nxml.txt.nlp	19930708	SENT183	26	26	29	29	exemestane	aromatase	PA449563	1588	0.665
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT170	16	16	28	28	l-leucine	p27	PA450197	5715;10534	0.665
NULL	Front_Aging_Neurosci_2014_Sep_11_6_218.nxml.txt.nlp	25309423	SENT207	7	7	19	19	resveratrol	JNK		5599	0.665
NULL	Acta_Pharmacol_Sin_2012_Feb_3_33(2)_145-147.nxml.txt.nlp	22301854	SENT31	9	9	6	6	exenatide	GLP-1	PA164749238	100125288	0.665
NULL	Hematol_Rep_2011_Jan_21_3(1)_e2.nxml.txt.nlp	22184524	SENT44	2	2	16	16	rifampin	MOF	PA451250	84148	0.665
NULL	Cells_2014_May_23_3(2)_517-545.nxml.txt.nlp	24861977	SENT140	4	4	0	0	cisplatin	TRPV1	PA449014	7442	0.665
NULL	J_Antimicrob_Chemother_2009_Jun_28_63(6)_1233-1243.nxml.txt.nlp	19329800	SENT87	28	28	14	14	tenofovir	ATV	PA10204	4683	0.665
NULL	Indian_J_Pharm_Sci_2013_May-Jun_75(3)_302-309.nxml.txt.nlp	24082346	SENT57	14	14	17	17	diclofenac	SRMS	PA449293	6725	0.665
NULL	FASEB_J_2011_Apr_25(4)_1133-1144.nxml.txt.nlp	21163859	SENT508	4	4	6	6	ethanol	AMPK	PA448073	5563	0.665
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2007_Dec_21_64(Pt_1)_o313.nxml.txt.nlp	21200875	SENT59	13	13	7	7	acetone	mol	PA448025	90527	0.665
NULL	Mol_Brain_2013_May_4_6_22.nxml.txt.nlp	23641686	SENT10	4	4	16	16	memantine	GLAST	PA10364	6507	0.665
NULL	Clinics_(Sao_Paulo)_2013_May_68(5)_694-701.nxml.txt.nlp	23778405	SENT40	25	25	22	22	fluorouracil	DDP	PA128406956	1678	0.665
NULL	J_Int_Soc_Sports_Nutr_2014_May_12_11_20.nxml.txt.nlp	24864135	SENT323	9	9	13	13	creatine	CEE	PA164778930	51608	0.665
NULL	Mol_Biol_Cell_2013_Aug_1_24(15)_2328-2339.nxml.txt.nlp	23783029	SENT18	18	18	6	6	glucose	spatial	PA449773	219793	0.665
NULL	J_Breast_Cancer_2012_Dec_31_15(4)_427-433.nxml.txt.nlp	23346172	SENT39	8	8	13	13	docetaxel	NAC	PA449383	22861	0.665
NULL	J_Cereb_Blood_Flow_Metab_2011_Oct_20_31(10)_2030-2040.nxml.txt.nlp	21505475	SENT196	42	42	44	44	cilostazol	Bcl-2	PA164746334	596	0.665
NULL	Indian_J_Orthop_2010_Jul-Sep_44(3)_246-251.nxml.txt.nlp	20697475	SENT171	18	18	0	0	vancomycin	DBM	PA451850	1621	0.665
NULL	J_Cell_Mol_Med_2014_Aug_6_18(8)_1519-1539.nxml.txt.nlp	25100284	SENT178	9	9	16	16	afatinib	EGFR	PA165981154	1956	0.665
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT192	14	14	33	33	pertuzumab	Yes		7525	0.665
NULL	Cardiovasc_Ultrasound_2005_Jan_28_3_2.nxml.txt.nlp	15679889	SENT72	13	13	6	6	dobutamine	TDI	PA449381	100038246	0.665
NULL	Mol_Cancer_2008_Oct_23_7_82.nxml.txt.nlp	18947424	SENT468	0	0	10	10	metformin	AMPK	PA450395	5563	0.665
NULL	Clin_Med_Insights_Oncol_2011_Sep_21_5_315-323.nxml.txt.nlp	22084620	SENT8	32	32	19	19	gemcitabine	IFN	PA449748	3439	0.665
NULL	Breast_Cancer_Res_2011_Jun_14_13(3)_R63.nxml.txt.nlp	21679465	SENT141	7	7	17	17	formaldehyde	SDS	PA449703	51119;10993	0.665
NULL	Endocr_Relat_Cancer_2014_Jun_21(3)_R209-R225.nxml.txt.nlp	24500760	SENT128	0	0	2	2	resveratrol	COX2		4513;5743	0.665
NULL	Med_Sci_Monit_2012_Jan_1_18(1)_RA1-RA11.nxml.txt.nlp	22207127	SENT217	8	8	13	13	raloxifene	OPG	PA451221	690	0.665
NULL	Acta_Pharmacol_Sin_2011_Oct_19_32(10)_1294-1302.nxml.txt.nlp	21927013	SENT121	8	8	5	5	tacrolimus	SRM	PA451578	6723;6725	0.665
NULL	Cardiol_Ther_2013_Jun_1_2(1)_111-124.nxml.txt.nlp	25135294	SENT90	13	13	11	11	dabigatran	ACT		12;11332;9457;641455	0.665
NULL	Int_J_Emerg_Med_2010_Mar_25_3(2)_105-113.nxml.txt.nlp	20606819	SENT161	3	3	8	8	midazolam	gamma	PA450496	9913	0.665
NULL	Pharmaceutics_2012_Feb_16_4(1)_179-196.nxml.txt.nlp	24300187	SENT371	18	18	13	13	indomethacin	BCS	PA449982	617	0.665
NULL	Onco_Targets_Ther_2014_Jul_1_7_1177-1184.nxml.txt.nlp	25061319	SENT46	41	41	10	10	capecitabine	IFL	PA448771	3439	0.665
NULL	J_Cardiothorac_Surg_2012_Sep_29_7_98.nxml.txt.nlp	23020939	SENT35	1	1	14	14	flurbiprofen	IL-6	PA449683	3569	0.665
NULL	Cancers_(Basel)_2014_Jul_17_6(3)_1500-1521.nxml.txt.nlp	25037020	SENT262	0	0	9	9	montelukast	5-LOX	PA450546	240	0.665
NULL	Front_Neurosci_2011_Jan_14_4_207.nxml.txt.nlp	21258618	SENT173	8	8	13	13	ethanol	CRF1	PA448073	1394	0.665
NULL	Oncoimmunology_2012_Sep_1_1(6)_810-821.nxml.txt.nlp	23162748	SENT148	0	0	5	5	trastuzumab	CD16	PA451743	2215;2214	0.665
NULL	Oncol_Lett_2014_Jan_6_7(1)_255-259.nxml.txt.nlp	24348859	SENT93	23	23	27	27	cisplatin	DCX	PA449014	1641	0.665
NULL	J_Lipid_Res_2014_Dec_55(12)_2562-2575.nxml.txt.nlp	25316883	SENT196	31	31	3	3	lipase	CGI-58	PA450239	51099	0.665
NULL	Cell_Death_Dis_2011_Apr_28_2(4)_e152.nxml.txt.nlp	21525939	SENT5	0	0	2	2	gemcitabine	GEM	PA449748	2669	0.665
NULL	Chin_J_Cancer_2012_Jul_31(7)_348-353.nxml.txt.nlp	22704490	SENT109	1	1	5	5	rituximab	CHOP	PA451261	1649	0.665
NULL	Case_Rep_Med_2014_Nov_12_2014_231651.nxml.txt.nlp	25477968	SENT43	1	1	8	8	thyroglobulin	IL-6	PA164754910	3569	0.665
NULL	Arch_Orthop_Trauma_Surg_2009_Nov_7_129(11)_1495-1504.nxml.txt.nlp	18989686	SENT101	5	5	8	8	daptomycin	VISA	PA164768820	57506	0.665
NULL	Mol_Cancer_2009_Dec_23_8_129.nxml.txt.nlp	20030852	SENT181	1	1	10	10	curcumin	ABCA1	PA151958596	19	0.665
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R91.nxml.txt.nlp	22541814	SENT206	0	0	2	2	thrombin	HO-1	PA451674	3162	0.665
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT95	17	17	20	20	pemetrexed	UNG	PA10810	7374	0.665
NULL	Cell_Res_2013_Jul_21_23(7)_915-930.nxml.txt.nlp	23689279	SENT358	0	0	7	7	ethanol	ALDH2	PA448073	217	0.665
NULL	J_Cell_Biol_2005_May_23_169(4)_681-691.nxml.txt.nlp	15911882	SENT80	14	14	16	16	heparin	TIMP3	PA449855	7078	0.665
NULL	J_Headache_Pain_2008_Feb_24_9(1)_13-18.nxml.txt.nlp	18217199	SENT105	4	4	0	0	propranolol	CYP1A2	PA451145	1544	0.665
NULL	Cell_Biol_Int_Rep_(2010)_2012_Jun_21_19(1)_e00017.nxml.txt.nlp	23124518	SENT149	6	6	9	9	etoposide	TRAIL	PA449552	8743	0.665
NULL	J_Vet_Med_Sci_2014_Jul_18_76(7)_937-945.nxml.txt.nlp	24646457	SENT123	34	34	40	40	kanamycin	OTC	PA450137	5009	0.665
NULL	J_Nutr_Sci_2014_May_13_3_e13.nxml.txt.nlp	25191605	SENT209	5	5	2	2	alendronate	CT40	PA448082	54457	0.665
NULL	Bone_Joint_Res_2014_Apr_1_3(4)_108-116.nxml.txt.nlp	24740649	SENT73	8	8	16	16	fluorescein	CD14	PA164746009	929	0.665
NULL	Front_Endocrinol_(Lausanne)_2013_Jan_7_3_180.nxml.txt.nlp	23316185	SENT268	9	9	15	15	glucose	CRF2	PA449773	1395	0.665
NULL	Indian_J_Endocrinol_Metab_2013_May-Jun_17(3)_402-412.nxml.txt.nlp	23869295	SENT165	7	7	9	9	fenofibrate	PON1	PA449594	5444	0.665
NULL	Acta_Pharmacol_Sin_2010_Oct_13_31(10)_1243-1257.nxml.txt.nlp	20835267	SENT236	20	20	38	38	lipase	ACAT	PA450239	6646	0.665
NULL	Evid_Based_Complement_Alternat_Med_2011_Mar_14_2011_635058.nxml.txt.nlp	21437195	SENT228	6	6	4	4	cilomilast	PDE4B	PA165948031	5142	0.665
NULL	Clin_Ophthalmol_2010_Apr_26_4_369-374.nxml.txt.nlp	20463807	SENT64	8	8	19	19	bevacizumab	PED	PA130232992	8682	0.665
NULL	Sci_Rep_2015_Jan_19_5_7851.nxml.txt.nlp	25597762	SENT57	9	9	20	20	ethanol	NIR	PA448073	26155	0.665
NULL	Emerg_Infect_Dis_2014_Jul_20(7)_1252-1253.nxml.txt.nlp	24959839	SENT36	3	3	9	9	isoniazid	EMB	PA450112	133418	0.665
NULL	Oncol_Lett_2013_Oct_24_6(4)_970-976.nxml.txt.nlp	24137447	SENT159	15	15	6	6	tamoxifen	ADM	PA451581	133	0.664
NULL	Anesth_Essays_Res_2011_Jul-Dec_5(2)_204-206.nxml.txt.nlp	NULL	SENT66	30	30	10	10	fentanyl	CEA	PA449599	5670;1087	0.664
NULL	Crit_Care_2000_Mar_21_4(Suppl_1)_P28.nxml.txt.nlp	NULL	SENT10	32	32	20	20	thrombin	IL-6	PA451674	3569	0.664
NULL	J_Oncol_2010_Jan_3_2010_149362.nxml.txt.nlp	20069122	SENT115	25	25	20	20	pertuzumab	HER3		2065	0.664
NULL	Blood_Res_2014_Jun_25_49(2)_127-129.nxml.txt.nlp	25025015	SENT43	2	2	14	14	hydroxyurea	JAK2	PA449942	3717	0.664
NULL	Cancers_(Basel)_2014_Jul_22_6(3)_1540-1552.nxml.txt.nlp	25055117	SENT431	19	19	9	9	erlotinib	EGFR	PA134687924	1956	0.664
NULL	J_Asthma_Allergy_2008_Sep_19_1_19-29.nxml.txt.nlp	21436982	SENT110	15	15	21	21	fexofenadine	I-TAC	PA449621	6373	0.664
NULL	Open_Biochem_J_2011_Sep_23_5_45-51.nxml.txt.nlp	21966325	SENT119	19	19	7	7	indomethacin	IRE1	PA449982	2081	0.664
NULL	Indian_J_Plast_Surg_2012_Sep-Dec_45(3)_453-458.nxml.txt.nlp	23450460	SENT63	9	9	6	6	acetylcysteine	NAC	PA448033	22861	0.664
NULL	Neuropsychologia_2012_Nov_50(13)_3156-3168.nxml.txt.nlp	22884957	SENT867	17	17	6	6	scopolamine	CA1	PA451308	759	0.664
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_P64.nxml.txt.nlp	NULL	SENT16	32	32	16	16	ceftriaxone	PPL	PA448866	5493	0.664
NULL	Comp_Hepatol_2005_May_4_4_4.nxml.txt.nlp	15871734	SENT114	7	7	3	3	nadh	DTD	PA164755085	1728	0.664
NULL	Acta_Pharmacol_Sin_2010_May_12_31(5)_578-584.nxml.txt.nlp	20383171	SENT119	2	2	8	8	berberine	PERK	PA165860812	9451	0.664
NULL	Clinicoecon_Outcomes_Res_2014_Oct_17_6_451-461.nxml.txt.nlp	25378939	SENT126	12	12	23	23	linezolid	HAP	PA450233	5915;10313	0.664
NULL	Glia_2012_Sep_25_60(9)_1406-1416.nxml.txt.nlp	22639011	SENT35	24	24	36	36	l-glutamine	CO2	PA10090	4513	0.664
NULL	Crit_Care_2011_Oct_27_15(Suppl_3)_P22.nxml.txt.nlp	NULL	SENT26	4	4	6	6	hyaluronan	syndecan	PA165958431	6382	0.664
NULL	Cardiovasc_J_Afr_2008_Apr_19(2)_77-83.nxml.txt.nlp	18516352	SENT129	8	8	5	5	glucose	GLP-1	PA449773	100125288	0.664
NULL	Br_J_Cancer_2013_Sep_17_109(6)_1625-1635.nxml.txt.nlp	23969726	SENT90	14	14	9	9	imatinib	KIT	PA10804	3815	0.664
NULL	Front_Genet_2014_Jun_4_5_167.nxml.txt.nlp	24926315	SENT185	45	45	42	42	methotrexate	DHFR	PA450428	1719	0.664
NULL	Breast_Cancer_Res_2006_Oct_2_8(5)_R56.nxml.txt.nlp	17014703	SENT213	26	26	20	20	tamoxifen	POSTN	PA451581	10631	0.664
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT260	31	31	4	4	warfarin	CYP2C9	PA451906	1559	0.664
NULL	Ann_Hematol_2015_Aug_3_94_35-43.nxml.txt.nlp	25085377	SENT235	3	3	9	9	bortezomib	TRAIL	PA10252	8743	0.664
NULL	Fibrogenesis_Tissue_Repair_2012_Jul_23_5_11.nxml.txt.nlp	22824096	SENT371	2	2	4	4	thrombin	PAR-1	PA451674	2011;2149	0.664
NULL	Int_J_Med_Sci_2014_May_7_11(7)_697-706.nxml.txt.nlp	24843319	SENT150	17	17	7	7	temozolomide	NIR	PA451609	26155	0.664
NULL	Br_J_Cancer_2012_Feb_28_106(5)_858-866.nxml.txt.nlp	22343622	SENT160	2	2	11	11	paclitaxel	AKT	PA450761	207	0.664
NULL	Oncotarget_2013_Feb_17_4(1)_7-8.nxml.txt.nlp	23448894	SENT2	7	7	4	4	ponatinib	ABL1	PA165980594	25	0.664
NULL	Support_Care_Cancer_2012_Jul_27_20(7)_1353-1360.nxml.txt.nlp	22539050	SENT258	17	17	31	31	denosumab	NNT	PA166048634	23530	0.664
NULL	Cell_Death_Dis_2013_Jul_11_4(7)_e719.nxml.txt.nlp	23846221	SENT220	10	10	8	8	cisplatin	TRAIL	PA449014	8743	0.664
NULL	Nat_Commun_2013_4_2720.nxml.txt.nlp	24193139	SENT226	14	14	24	24	methamphetamine	AMPH	PA450403	273	0.664
NULL	Front_Neurosci_2013_Feb_22_7_19.nxml.txt.nlp	23440036	SENT102	15	15	24	24	doxycycline	NPY	PA449415	4852	0.664
NULL	Br_J_Ophthalmol_2008_Sep_22_92(9)_1275-1282.nxml.txt.nlp	18723745	SENT118	26	26	43	43	tafluprost	BAK	PA165958432	578	0.664
NULL	Cardiovasc_Diabetol_2011_Feb_11_10_18.nxml.txt.nlp	21314919	SENT31	20	20	22	22	metformin	Met	PA450395	79811	0.664
NULL	Clin_Epigenetics_2011_Dec_5_3(1)_8.nxml.txt.nlp	22414275	SENT34	8	8	14	14	ribavirin	ESR1	PA451241	2099	0.664
NULL	Breast_Cancer_Res_2011_Feb_23_13(1)_203.nxml.txt.nlp	21392408	SENT13	11	11	13	13	tamoxifen	aromatase	PA451581	1588	0.664
NULL	Am_J_Physiol_Endocrinol_Metab_2011_Feb_30_300(2)_E402-E409.nxml.txt.nlp	21119028	SENT321	15	15	13	13	pioglitazone	PPARgamma	PA450970	5468	0.664
NULL	Acta_Vet_Scand_2011_Feb_17_53(1)_11.nxml.txt.nlp	21324209	SENT82	26	26	20	20	chloramphenicol	OTC	PA448927	5009	0.664
NULL	Breast_Cancer_Res_2014_Dec_19_16(6)_499.nxml.txt.nlp	25522654	SENT237	22	22	10	10	estradiol	CYP19A1	PA449503	1588	0.664
NULL	Breast_Cancer_Res_2011_May_26_13(3)_209.nxml.txt.nlp	21635709	SENT157	26	26	34	34	tamoxifen	HER2	PA451581	2064	0.664
NULL	Breast_Cancer_(Auckl)_2009_Apr_7_3_23-34.nxml.txt.nlp	21556247	SENT102	16	16	12	12	celecoxib	AKT	PA448871	207	0.664
NULL	Oncoimmunology_2012_Oct_1_1(7)_1038-1047.nxml.txt.nlp	23170252	SENT61	35	35	5	5	cyclophosphamide	CT26	PA449165	168400	0.664
NULL	Oncogenesis_2012_Apr_16_1(4)_e7.nxml.txt.nlp	23552604	SENT259	20	20	18	18	etoposide	CTRL	PA449552	1506	0.664
NULL	Theranostics_2014_Jan_29_4(4)_336-365.nxml.txt.nlp	24578720	SENT183	20	20	24	24	triciribine	PTEN	PA165958661	5728	0.664
NULL	Case_Rep_Oncol_2012_Apr_18_5(1)_181-186.nxml.txt.nlp	22666210	SENT19	43	43	32	32	docetaxel	PC-3	PA449383	692094	0.664
NULL	J_Res_Med_Sci_2010_Nov-Dec_15(6)_331-343.nxml.txt.nlp	21526106	SENT27	21	21	26	26	l-arginine	HDEL	PA448478	10945	0.664
NULL	J_Biomed_Sci_2013_May_20_20(1)_30.nxml.txt.nlp	23687991	SENT158	25	25	33	33	ethanol	PGD2	PA448073	27306	0.664
NULL	Breast_Cancer_(Auckl)_2012_Nov_19_6_191-207.nxml.txt.nlp	23226023	SENT278	23	23	44	44	docetaxel	HER-2	PA449383	2064	0.664
NULL	N_Am_J_Med_Sci_2013_Dec_5(12)_721-723.nxml.txt.nlp	24404557	SENT62	12	12	7	7	vincristine	CHOP	PA451879	1649	0.664
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT276	17	17	1	1	cisplatin	ABCC2	PA449014	1244	0.664
NULL	Int_J_Ion_Mobil_Spectrom_2009_Aug_1_12(3)_91-102.nxml.txt.nlp	20835390	SENT154	29	29	17	17	glucosamine	mol	PA164747613	90527	0.664
NULL	J_Hematol_Oncol_2010_Oct_27_3_42.nxml.txt.nlp	20979652	SENT177	7	7	5	5	panitumumab	EGFR	PA162373091	1956	0.664
NULL	Acta_Histochem_Cytochem_2009_Apr_28_42(2)_23-28.nxml.txt.nlp	19492024	SENT4	22	22	29	29	estradiol	DES	PA449503	1674	0.664
NULL	Arthritis_Res_Ther_2004_Jun_21_6(4)_169-173.nxml.txt.nlp	15225361	SENT76	13	13	0	0	collagenase	RUNX2	PA449107	860	0.664
NULL	Croat_Med_J_2012_Jun_53(3)_224-233.nxml.txt.nlp	22661135	SENT68	26	26	17	17	bromocriptine	PRL	PA448671	5617	0.664
NULL	Front_Behav_Neurosci_2009_Sep_30_3_31.nxml.txt.nlp	19862348	SENT147	19	19	15	15	naloxone	PAG	PA450586	55824	0.664
NULL	J_Exp_Med_2000_May_15_191(10)_1745-1754.nxml.txt.nlp	10811867	SENT45	34	34	44	44	l-glutamine	CO2	PA10090	4513	0.664
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Feb_27_64(Pt_3)_o629.nxml.txt.nlp	21201960	SENT55	25	25	16	16	ethanol	mol	PA448073	90527	0.664
NULL	J_Thromb_Thrombolysis_2012_Feb_20_33(2)_143-153.nxml.txt.nlp	22183178	SENT250	16	16	5	5	clopidogrel	ABCB1	PA449053	5243	0.664
NULL	Biochemistry_2009_Mar_10_48(9)_2053-2062.nxml.txt.nlp	19220002	SENT105	5	5	15	15	nadh	mol	PA164755085	90527	0.664
NULL	Breast_Cancer_(Auckl)_2011_Sep_25_5_201-208.nxml.txt.nlp	22084573	SENT86	1	1	12	12	cisplatin	Bcl-2	PA449014	596	0.664
NULL	Cancer_Res_Treat_2015_Jan_21_47(1)_72-77.nxml.txt.nlp	25143051	SENT121	13	13	21	21	capecitabine	B12	PA448771	7126;4709	0.664
NULL	Cancer_Med_2013_Jun_23_2(3)_296-304.nxml.txt.nlp	23930206	SENT183	33	33	25	25	erlotinib	KRAS	PA134687924	3845	0.664
NULL	J_Mol_Med_(Berl)_2013_Aug_17_91(11)_1257-1271.nxml.txt.nlp	23955016	SENT58	6	6	10	10	thrombin	C5a	PA451674	727	0.664
NULL	Indian_J_Nephrol_2012_Jul-Aug_22(4)_275-279.nxml.txt.nlp	23162271	SENT57	4	4	0	0	daclizumab	IL-2	PA164764446	3558	0.664
NULL	J_Korean_Med_Sci_2013_Feb_29_28(2)_308-314.nxml.txt.nlp	23399960	SENT87	2	2	25	25	gabapentin	IL-6	PA449720	3569	0.664
NULL	Cases_J_2009_Mar_10_2_6464.nxml.txt.nlp	20181162	SENT6	26	26	24	24	ribavirin	IFN	PA451241	3439	0.664
NULL	Orphanet_J_Rare_Dis_2011_Nov_15_6_76.nxml.txt.nlp	22085750	SENT96	46	46	29	29	streptokinase	gamma	PA164754919	9913	0.664
NULL	Cancer_Cell_Int_2008_Apr_29_8_4.nxml.txt.nlp	18442416	SENT224	0	0	9	9	trypsin	Ku86	PA451806	7520	0.664
NULL	Ann_Hematol_2014_Apr_1_93(8)_1371-1380.nxml.txt.nlp	24687382	SENT30	0	0	4	4	lenalidomide	IKZF1	PA162363968	10320	0.664
NULL	Diabetes_Care_2011_Jul_17_34(7)_1678-1680.nxml.txt.nlp	21709302	SENT83	16	16	7	7	rosiglitazone	DREAM	PA451283	30818	0.664
NULL	Cell_Commun_Signal_2013_Nov_11_11_86.nxml.txt.nlp	24215724	SENT273	30	30	13	13	thrombin	PAR1	PA451674	79581;2149	0.664
NULL	J_Vet_Med_Sci_2014_Feb_8_76(2)_173-182.nxml.txt.nlp	24107430	SENT126	30	30	10	10	yohimbine	AVP	PA451946	114548;551	0.664
NULL	Breast_Cancer_Res_2009_May_29_11(3)_206.nxml.txt.nlp	19519952	SENT49	16	16	10	10	tamoxifen	DES	PA451581	1674	0.664
NULL	Front_Physiol_2013_Jul_30_4_195.nxml.txt.nlp	23908632	SENT444	0	0	10	10	atorvastatin	RhoA	PA448500	387	0.664
NULL	Patient_Prefer_Adherence_2008_Feb_2_2_387-392.nxml.txt.nlp	19920986	SENT8	4	4	11	11	azathioprine	gamma	PA448515	9913	0.664
NULL	Dermatoendocrinol_2012_Jul_1_4(3)_253-258.nxml.txt.nlp	23467280	SENT149	40	40	35	35	hyaluronan	p38	PA165958431	10598;1432;7965	0.664
NULL	Bioinformation_2012_Jan_6_8(1)_13-19.nxml.txt.nlp	22359429	SENT33	2	2	4	4	curcumin	MRP1	PA151958596	4437	0.664
NULL	Cell_Death_Dis_2013_Sep_19_4(9)_e804.nxml.txt.nlp	24052072	SENT148	6	6	12	12	paclitaxel	EGF	PA450761	1950	0.664
NULL	EMBO_Mol_Med_2012_Sep_7_4(9)_896-909.nxml.txt.nlp	22887866	SENT137	17	17	14	14	lovastatin	c-Myc	PA450272	4609	0.664
NULL	Alcohol_Res_2012_34(3)_293-305.nxml.txt.nlp	23134045	SENT95	4	4	20	20	ethanol	NPY	PA448073	4852	0.664
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_24_2012_673132.nxml.txt.nlp	23133498	SENT116	0	0	3	3	berberine	P-gp	PA165860812	5243	0.664
NULL	J_Neuroinflammation_2010_Nov_22_7_82.nxml.txt.nlp	21092194	SENT73	24	24	12	12	paraformaldehyde	CO2	PA450790	4513	0.664
NULL	Indian_J_Med_Res_2011_Sep_134(3)_295-301.nxml.txt.nlp	21985811	SENT111	9	9	28	28	carbamazepine	CYP3A4	PA448785	1576	0.664
NULL	Oncogene_2010_Sep_16_29(37)_5135-5145.nxml.txt.nlp	20622897	SENT356	3	3	8	8	cetuximab	STAT3	PA10040	6774	0.664
NULL	Braz_J_Microbiol_2011_Dec_1_Oct-Dec_42(4)_1434-1436.nxml.txt.nlp	24031774	SENT34	10	10	20	20	norfloxacin	TOB	PA450654	10140	0.664
NULL	Orphanet_J_Rare_Dis_2008_Mar_26_3_8.nxml.txt.nlp	18366757	SENT441	36	36	28	28	azathioprine	NAC	PA448515	22861	0.664
NULL	J_Hematol_Oncol_2013_Jan_15_6_5.nxml.txt.nlp	23320987	SENT135	9	9	2	2	heparin	PI-PLC	PA449855	2923	0.664
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Aug_4_6_123-133.nxml.txt.nlp	25177151	SENT50	35	35	26	26	tamoxifen	aromatase	PA451581	1588	0.664
NULL	Cancer_Med_2012_Oct_13_1(2)_218-229.nxml.txt.nlp	23342271	SENT211	15	15	25	25	paclitaxel	p53	PA450761	7157	0.664
NULL	Br_J_Cancer_2011_Jul_12_105(2)_255-262.nxml.txt.nlp	21694725	SENT167	6	6	12	12	panitumumab	KRAS	PA162373091	3845	0.664
NULL	Support_Care_Cancer_2009_Sep_10_17(9)_1187-1193.nxml.txt.nlp	19205754	SENT28	21	21	10	10	granisetron	CYP3A4	PA449809	1576	0.664
NULL	J_Cell_Mol_Med_2014_Apr_20_18(4)_709-720.nxml.txt.nlp	24444314	SENT247	6	6	12	12	metformin	SIRT1	PA450395	23411	0.664
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jun_5_66(Pt_7)_o1586.nxml.txt.nlp	21587826	SENT69	22	22	10	10	ethanol	mol	PA448073	90527	0.664
NULL	Front_Oncol_2014_Sep_23_4_264.nxml.txt.nlp	25295231	SENT109	9	9	11	11	lenalidomide	p53	PA162363968	7157	0.664
NULL	J_Cell_Biol_1998_May_4_141(3)_727-739.nxml.txt.nlp	9566972	SENT293	22	22	16	16	neomycin	NF-M	PA450608	4741	0.664
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT207	2	2	9	9	curcumin	PI3K	PA151958596	5290	0.664
NULL	Environ_Health_Perspect_2009_Jan_1_117(1)_93-98.nxml.txt.nlp	19165393	SENT39	8	8	19	19	estradiol	aromatase	PA449503	1588	0.664
NULL	Oxid_Med_Cell_Longev_2012_Jul_22_2012_785743.nxml.txt.nlp	22919441	SENT128	34	34	10	10	staurosporine	Bcl-2	PA165109623	596	0.664
NULL	Indian_J_Pharm_Sci_2014_Mar-Apr_76(2)_97-106.nxml.txt.nlp	24843182	SENT52	11	11	15	15	naringin	STZ	PA151958360	6484	0.664
NULL	Front_Endocrinol_(Lausanne)_2013_Jan_7_3_180.nxml.txt.nlp	23316185	SENT487	12	12	22	22	glucose	HPA	PA449773	10855	0.664
NULL	Breast_Cancer_Res_Treat_2012_Jun_18_133(3)_937-947.nxml.txt.nlp	22094936	SENT208	22	22	8	8	tamoxifen	CCNE1	PA451581	898	0.664
NULL	Oncogene_2010_Jul_8_29(27)_3896-3907.nxml.txt.nlp	20453888	SENT180	0	0	6	6	trastuzumab	San	PA451743	80218	0.664
NULL	J_Oncol_2013_Feb_17_2013_872957.nxml.txt.nlp	23476648	SENT154	15	15	8	8	cisplatin	SFN	PA449014	25996;2810	0.664
NULL	Cardiovasc_Res_2011_Feb_1_89(2)_282-289.nxml.txt.nlp	20884640	SENT45	16	16	24	24	l-glutamine	CO2	PA10090	4513	0.664
NULL	Br_J_Cancer_2011_Jun_7_104(12)_1805-1809.nxml.txt.nlp	21587260	SENT123	37	37	21	21	plerixafor	CXCR4	PA165958410	7852	0.664
NULL	Drug_Saf_2014_Feb_19_37(4)_201-211.nxml.txt.nlp	24550106	SENT132	0	0	10	10	esomeprazole	CYP2C19	PA10075	1557	0.664
NULL	Core_Evid_2009_Jun_15_4_25-36.nxml.txt.nlp	20694062	SENT325	11	11	13	13	cosyntropin	ACTH	PA164749052	5443	0.664
NULL	J_Korean_Neurosurg_Soc_2014_Sep_30_56(3)_175-187.nxml.txt.nlp	25368758	SENT137	1	1	27	27	mannitol	GOR	PA450320	254958	0.664
NULL	Neural_Regen_Res_2014_Sep_15_9(18)_1696-1702.nxml.txt.nlp	25374591	SENT15	27	27	21	21	forskolin	B27	PA146096022	56246	0.664
NULL	Toxins_(Basel)_2010_May_5_2(5)_954-962.nxml.txt.nlp	22069619	SENT68	9	9	0	0	l-tryptophan	IFN	PA10323	3439	0.664
NULL	Br_J_Cancer_2010_Jan_19_102(2)_383-391.nxml.txt.nlp	20010943	SENT187	38	38	18	18	cisplatin	P31	PA449014	529	0.664
NULL	Cardiovasc_Diabetol_2013_Mar_23_12_48.nxml.txt.nlp	23522121	SENT113	4	4	10	10	exenatide	NNT	PA164749238	23530	0.664
NULL	Breast_Cancer_Res_2003_Feb_5_5(2)_113-116.nxml.txt.nlp	12631392	SENT94	39	39	27	27	carboplatin	HER-2	PA448803	2064	0.664
NULL	Colomb_Med_(Cali)_43(4)_305-311.nxml.txt.nlp	24893304	SENT20	37	37	18	18	valganciclovir	CD4	PA10227	920	0.664
NULL	Evid_Based_Complement_Alternat_Med_2014_Jan_9_2014_506735.nxml.txt.nlp	24523822	SENT238	6	6	4	4	fluoxetine	GTS	PA449673	2973	0.664
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT157	31	31	8	8	pp2	PP2		4888	0.664
NULL	Oncol_Lett_2013_Dec_4_6(6)_1665-1672.nxml.txt.nlp	24273604	SENT181	42	42	10	10	chloroquine	TLR9	PA448948	54106	0.664
NULL	Int_J_Environ_Res_Public_Health_2013_Sep_12_10(9)_4274-4305.nxml.txt.nlp	24036486	SENT71	21	21	25	25	imipenem	HCAP	PA449968	117159;9126	0.664
NULL	Environ_Health_Perspect_2004_Nov_112(15)_A896b-A897.nxml.txt.nlp	NULL	SENT19	24	24	26	26	diethylstilbestrol	DES	PA449307	1674	0.664
NULL	Biochemistry_2014_Sep_16_53(36)_5804-5809.nxml.txt.nlp	25153692	SENT54	15	15	6	6	heparin	K19	PA449855	3880	0.664
NULL	Front_Physiol_2013_May_15_4_103.nxml.txt.nlp	23720630	SENT2	19	19	22	22	l-carnitine	Q10	PA450154	27161	0.664
NULL	J_Korean_Med_Sci_1992_Jun_7(2)_122-127.nxml.txt.nlp	1326284	SENT10	13	13	24	24	methacholine	TDI	PA165958382	100038246	0.664
NULL	Front_Neuroanat_2014_Dec_22_8_151.nxml.txt.nlp	25565976	SENT43	36	36	11	11	fluorescein	FAF	PA164746009	8239;2188	0.664
NULL	Appl_Microbiol_Biotechnol_2014_Feb_18_98(8)_3829-3840.nxml.txt.nlp	24535257	SENT28	14	14	9	9	ethanol	SHF	PA448073	90525	0.664
NULL	Asian-Australas_J_Anim_Sci_2012_Jan_25(1)_1-16.nxml.txt.nlp	25049471	SENT112	0	0	13	13	estradiol	PGF	PA449503	5228	0.664
NULL	Front_Neurosci_2014_Nov_10_8_364.nxml.txt.nlp	25426018	SENT271	13	13	5	5	dextran	ANOVA	PA449261	4858	0.664
NULL	Clin_Interv_Aging_2009_Jun_29_4_289-303.nxml.txt.nlp	19750231	SENT72	27	27	24	24	pamidronate	NNT	PA450767	23530	0.664
NULL	Clinicoecon_Outcomes_Res_2014_Oct_17_6_451-461.nxml.txt.nlp	25378939	SENT8	8	8	3	3	linezolid	HAP	PA450233	5915;10313	0.664
NULL	Daru_2012_Sep_3_20(1)_24.nxml.txt.nlp	23351176	SENT194	2	2	8	8	itopride	EPO	PA152432599	7076;8288;2056	0.664
NULL	Acta_Pharmacol_Sin_2011_Jun_30_32(6)_853-860.nxml.txt.nlp	21623392	SENT28	0	0	22	22	capsaicin	TRPV1	PA448776	7442	0.664
NULL	Cancers_(Basel)_2010_Apr_21_2(2)_653-669.nxml.txt.nlp	24281087	SENT76	14	14	0	0	doxorubicin	Boo	PA449412	10017	0.664
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT122	12	12	8	8	capsaicin	p53	PA448776	7157	0.664
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jun_23_68(Pt_7)_o2163.nxml.txt.nlp	22798835	SENT74	38	38	19	19	ethanol	mol	PA448073	90527	0.664
NULL	Mol_Cancer_2014_Jun_24_13_157.nxml.txt.nlp	24958351	SENT24	0	0	5	5	trastuzumab	HER2	PA451743	2064	0.664
NULL	Arthritis_Res_Ther_2003_Jan_20_5(2)_68-75.nxml.txt.nlp	12718746	SENT92	30	30	5	5	imiquimod	TLR1	PA449972	7096	0.664
NULL	BMJ_Open_2014_Oct_31_4(10)_e005762.nxml.txt.nlp	25361836	SENT207	4	4	7	7	capecitabine	HER2	PA448771	2064	0.664
NULL	Indian_J_Med_Res_2013_Apr_137(4)_785-790.nxml.txt.nlp	23703348	SENT86	18	18	38	38	urea	AST	PA451831	26503	0.664
NULL	J_Exp_Med_1998_Jun_1_187(11)_1885-1892.nxml.txt.nlp	9607928	SENT205	10	10	25	25	thalidomide	IL-2	PA451644	3558	0.664
NULL	Pharmaceutics_2011_Jul_13_3(3)_425-439.nxml.txt.nlp	24310588	SENT15	19	19	32	32	diazepam	OTC	PA449283	5009	0.664
NULL	Curr_Oncol_2009_Jan_16(1)_27-48.nxml.txt.nlp	19229369	SENT264	13	13	22	22	erlotinib	KRAS	PA134687924	3845	0.664
NULL	Eur_J_Clin_Pharmacol_2014_Mar_22_70(6)_685-693.nxml.txt.nlp	24658827	SENT142	0	0	36	36	cyclosporine	POR	PA449167	5447	0.664
NULL	Clin_Ophthalmol_2012_Sep_21_6_1547-1552.nxml.txt.nlp	23055677	SENT97	22	22	17	17	bimatoprost	SPK	PA164748867	55872;8189	0.664
NULL	Mol_Cancer_2010_Nov_8_9_291.nxml.txt.nlp	21059223	SENT118	28	28	25	25	paclitaxel	ZNF217	PA450761	7764	0.664
NULL	ISRN_Allergy_2013_Feb_28_2013_735031.nxml.txt.nlp	23724247	SENT35	15	15	23	23	papain	IL-4	PA450778	3565	0.664
NULL	Front_Endocrinol_(Lausanne)_2011_Dec_21_2_84.nxml.txt.nlp	22654830	SENT37	12	12	21	21	lipase	MGL	PA450239	11343	0.664
NULL	Diabetes_2009_Dec_31_58(12)_2851-2862.nxml.txt.nlp	19720788	SENT202	3	3	5	5	forskolin	Bcl-2	PA146096022	596	0.664
NULL	Mol_Cancer_2013_Nov_22_12_147.nxml.txt.nlp	24261856	SENT78	14	14	6	6	sunitinib	PC-3	PA162372840	692094	0.664
NULL	Mol_Cancer_2010_Nov_25_9_305.nxml.txt.nlp	21108789	SENT284	4	4	7	7	decitabine	AQP5	PA164749631	362	0.664
NULL	Front_Immunol_2012_May_4_3_103.nxml.txt.nlp	22566975	SENT287	4	4	15	15	cyclophosphamide	CD4	PA449165	920	0.664
NULL	Mol_Biol_Int_2014_Sep_7_2014_852748.nxml.txt.nlp	25276427	SENT173	11	11	18	18	trastuzumab	DM1	PA451743	338023;1760;28509	0.664
NULL	Breast_Cancer_Res_2007_Dec_20_9(Suppl_2)_S11.nxml.txt.nlp	NULL	SENT19	28	28	24	24	tamoxifen	ATAC	PA451581	6375	0.664
NULL	Clinicoecon_Outcomes_Res_2014_Oct_17_6_451-461.nxml.txt.nlp	25378939	SENT109	11	11	15	15	vancomycin	HAP	PA451850	5915;10313	0.664
NULL	Pharmaceuticals_(Basel)_2013_Aug_6_6(8)_929-959.nxml.txt.nlp	24276377	SENT912	10	10	5	5	dextran	CXCR2	PA449261	3579	0.664
NULL	Front_Synaptic_Neurosci_2011_Nov_3_3_6.nxml.txt.nlp	22065958	SENT278	2	2	8	8	isoproterenol	CA1	PA450121	759	0.664
NULL	EPMA_J_2013_Jan_28_4(1)_3.nxml.txt.nlp	23356214	SENT210	30	30	12	12	panitumumab	EGFR	PA162373091	1956	0.664
NULL	J_Biol_Chem_2009_Dec_25_284(52)_36628-36637.nxml.txt.nlp	19858215	SENT51	7	7	5	5	nadh	ADP	PA164755085	23038	0.664
NULL	Breast_Cancer_Res_2014_May_23_16(3)_R50.nxml.txt.nlp	24887458	SENT127	13	13	0	0	docetaxel	HER2	PA449383	2064	0.664
NULL	CNS_Spectr_2014_Apr_1_19(2)_121-133.nxml.txt.nlp	23903233	SENT133	10	10	17	17	ondansetron	CA1	PA450705	759	0.664
NULL	Diabetes_Care_2010_Apr_12_33(4)_861-868.nxml.txt.nlp	20067962	SENT136	16	16	7	7	hyaluronan	TLR4	PA165958431	7099	0.664
NULL	Cancer_Med_2013_Feb_3_2(1)_40-49.nxml.txt.nlp	24133626	SENT384	5	5	10	10	cilostazol	PDE3B	PA164746334	5140	0.664
NULL	J_Cardiothorac_Surg_2011_Oct_12_6_135.nxml.txt.nlp	21992542	SENT67	29	29	21	21	cisplatin	CRT	PA449014	811	0.664
NULL	Case_Rep_Oncol_2013_Jan_29_6(1)_72-77.nxml.txt.nlp	23466899	SENT98	5	5	9	9	docetaxel	GTX	PA449383	84504	0.664
NULL	Indian_J_Pharmacol_2013_Jul-Aug_45(4)_359-364.nxml.txt.nlp	24014911	SENT57	12	12	28	28	carrageenan	FIB	PA448814	2091	0.664
NULL	Adipocyte_2014_Jul_1_3(3)_190-196.nxml.txt.nlp	25068085	SENT13	29	29	4	4	lipase	ADIPOR2	PA450239	79602	0.664
NULL	Front_Oncol_2014_Apr_9_4_75.nxml.txt.nlp	24782986	SENT16	9	9	19	19	paclitaxel	Oct4	PA450761	5460	0.664
NULL	Oncol_Lett_2014_Apr_7_7(4)_1313-1319.nxml.txt.nlp	24660038	SENT202	24	24	13	13	imatinib	SLC22A1	PA10804	6580	0.664
NULL	Front_Neurol_2013_May_15_4_53.nxml.txt.nlp	23720649	SENT266	11	11	28	28	geldanamycin	CHIP	PA152031327	10273	0.664
NULL	Arthritis_Res_2001_Sep_18_3(6)_381-388.nxml.txt.nlp	11714393	SENT138	31	31	17	17	collagenase	p38	PA449107	10598;1432;7965	0.664
NULL	Biochemistry_2012_Aug_7_51(31)_6127-6138.nxml.txt.nlp	22794279	SENT150	11	11	19	19	chymotrypsin	14-3-3	PA448994	10971	0.664
NULL	Clin_Exp_Metastasis_2014_Sep_17_31(1)_135-147.nxml.txt.nlp	24043563	SENT143	17	17	8	8	trypsin	KLK4	PA451806	9622	0.664
NULL	J_Skin_Cancer_2012_Dec_13_2012_147863.nxml.txt.nlp	23316365	SENT181	17	17	14	14	curcumin	IL-6	PA151958596	3569	0.664
NULL	J_Cell_Biol_2005_Nov_21_171(4)_651-661.nxml.txt.nlp	16301331	SENT7	15	15	12	12	flutamide	Bcl-2	PA449685	596	0.664
NULL	Cancer_Immunol_Immunother_2011_Jun_25_60(6)_793-808.nxml.txt.nlp	21350947	SENT287	21	21	19	19	sorafenib	IFN	PA7000	3439	0.664
NULL	Oncogene_2013_Sep_12_32(37)_4355-4365.nxml.txt.nlp	23108409	SENT194	2	2	6	6	hyaluronan	HAS2	PA165958431	3037	0.664
NULL	Mol_Cancer_2014_Jun_5_13_143.nxml.txt.nlp	24898067	SENT16	31	31	18	18	gefitinib	HER-2	PA131301952	2064	0.664
NULL	Eur_J_Clin_Pharmacol_2014_Oct_8_70(12)_1433-1441.nxml.txt.nlp	25291992	SENT141	38	38	6	6	risperidone	FES	PA451257	2242	0.664
NULL	Cent_European_J_Urol_2013_Nov_18_66(3)_344-349.nxml.txt.nlp	24707382	SENT46	11	11	5	5	tacrolimus	ABO	PA451578	28	0.664
NULL	Endocrinology_2014_Oct_22_155(10)_3732-3738.nxml.txt.nlp	25051442	SENT7	24	24	26	26	sibutramine	ARC	PA451344	8996;23237	0.664
NULL	Alcohol_Res_Health_2010_33(3)_203-218.nxml.txt.nlp	23584062	SENT237	12	12	19	19	ethanol	CD4	PA448073	920	0.664
NULL	Indian_J_Pharmacol_2012_Sep-Oct_44(5)_624-628.nxml.txt.nlp	23112426	SENT93	3	3	5	5	pravastatin	CYP3A4	PA451089	1576	0.664
NULL	Psychiatry_Investig_2012_Jun_30_9(2)_187-190.nxml.txt.nlp	22707971	SENT30	28	28	8	8	capsaicin	POMC	PA448776	5443	0.664
NULL	Mediators_Inflamm_2011_Feb_6_2011_971502.nxml.txt.nlp	21437210	SENT148	3	3	10	10	urokinase	COX2	PA451836	4513;5743	0.664
NULL	Ann_Hematol_2010_Sep_13_89(9)_861-871.nxml.txt.nlp	20387067	SENT196	18	18	14	14	dasatinib	TPO	PA162372878	7066;7173	0.664
NULL	Indian_J_Pharmacol_2012_Sep-Oct_44(5)_624-628.nxml.txt.nlp	23112426	SENT37	35	35	15	15	pravastatin	CYP3A4	PA451089	1576	0.664
NULL	Diabetes_2013_May_16_62(5)_1697-1708.nxml.txt.nlp	23364453	SENT263	4	4	2	2	fasudil	GLP-1	PA165946121	100125288	0.664
NULL	J_Cell_Mol_Med_2014_Dec_7_18(12)_2536-2552.nxml.txt.nlp	25287328	SENT141	8	8	0	0	estradiol	PKD1	PA449503	5310	0.664
NULL	Cell_Commun_Signal_2013_Jul_4_11_47.nxml.txt.nlp	23826796	SENT90	0	0	15	15	rolipram	CC2D1A	PA153906323	54862	0.664
NULL	Curr_Neuropharmacol_2009_Jun_7(2)_83-95.nxml.txt.nlp	19949566	SENT515	30	30	32	32	phenytoin	TGB	PA450947	5473	0.664
NULL	Diabetes_Metab_Syndr_Obes_2013_Sep_2_6_317-325.nxml.txt.nlp	24039439	SENT90	39	39	16	16	voglibose	GLP-1	PA164752433	100125288	0.664
NULL	Oncotarget_2012_Sep_28_3(10)_1169-1181.nxml.txt.nlp	23045411	SENT106	11	11	6	6	doxorubicin	JIP1	PA449412	9479	0.664
NULL	Front_Behav_Neurosci_2009_Nov_16_3_47.nxml.txt.nlp	19949457	SENT535	4	4	7	7	naloxone	CA3	PA450586	761	0.664
NULL	Neuropsychopharmacology_2009_Apr_2_34(5)_1135-1148.nxml.txt.nlp	18596687	SENT263	12	12	18	18	cocaine	CRF	PA449072	1392;10882	0.664
NULL	Gut_2013_Mar_22_62(3)_358-367.nxml.txt.nlp	22442164	SENT236	28	28	11	11	genistein	PI3K	PA165109660	5290	0.664
NULL	Eur_J_Med_Res_2014_Jun_24_19(1)_34.nxml.txt.nlp	24961604	SENT103	26	26	13	13	vincristine	BCL11A	PA451879	53335	0.664
NULL	J_Clin_Biochem_Nutr_2011_Jul_14_49(1)_57-61.nxml.txt.nlp	21765608	SENT187	26	26	4	4	choline	GBF	PA448976	1316	0.664
NULL	J_Physiol_2014_Aug_15_592(16)_3611-3624.nxml.txt.nlp	24879873	SENT223	2	2	4	4	yohimbine	5-HT1A	PA451946	3350	0.664
NULL	J_Ophthalmol_2011_Oct_20_2011_252549.nxml.txt.nlp	22046503	SENT33	12	12	23	23	lipase	TIMP3	PA450239	7078	0.664
NULL	Br_J_Pharmacol_2011_Apr_162(8)_1832-1842.nxml.txt.nlp	21232033	SENT253	9	9	33	33	resveratrol	SIRT1		23411	0.664
NULL	Exp_Neurol_2012_Jun_235(2)_528-538.nxml.txt.nlp	22417924	SENT263	11	11	18	18	troglitazone	gamma	PA451799	9913	0.664
NULL	Infect_Ecol_Epidemiol_2012_Mar_27_2_10_3402_iee_v2i0_7438.nxml.txt.nlp	22957135	SENT9	32	32	39	39	ampicillin	VAN	PA448419	10318	0.664
NULL	Nat_Med_2010_Nov_24_16(11)_1299-1304.nxml.txt.nlp	20972434	SENT203	19	19	3	3	chloroquine	ASM	PA448948	6609;283120	0.664
NULL	Biologics_2012_Dec_17_6_429-464.nxml.txt.nlp	23269860	SENT163	8	8	21	21	abatacept	ACR	PA164747080	49	0.663
NULL	Front_Chem_2014_Dec_23_2_113.nxml.txt.nlp	25566531	SENT246	0	0	14	14	curcumin	PC-3	PA151958596	692094	0.663
NULL	Clin_Mol_Allergy_2012_Feb_6_10_4.nxml.txt.nlp	22309677	SENT72	15	15	35	35	ethanol	Eos	PA448073	64375	0.663
NULL	Cancer_Immunol_Immunother_2011_Jun_25_60(6)_793-808.nxml.txt.nlp	21350947	SENT284	21	21	19	19	sorafenib	IFN	PA7000	3439	0.663
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT166	10	10	18	18	perifosine	DR4	PA165291471	8797	0.663
NULL	Oncol_Lett_2013_Jul_14_6(1)_69-74.nxml.txt.nlp	23946779	SENT190	9	9	21	21	axitinib	MMP9	PA164924493	4318	0.663
NULL	Iran_J_Pharm_Res_2015_Winter_14(1)_27-34.nxml.txt.nlp	25561909	SENT44	8	8	4	4	rifampin	MSN	PA451250	4478	0.663
NULL	Am_J_Rhinol_Allergy_2012_Jan-Feb_26(1)_1-6.nxml.txt.nlp	22391065	SENT245	3	3	1	1	isoproterenol	IL-8	PA450121	3576	0.663
NULL	Cancer_Manag_Res_2012_Nov_9_4_383-395.nxml.txt.nlp	23204869	SENT138	11	11	14	14	carmustine	Bcl-2	PA448810	596	0.663
NULL	Ann_Oncol_2009_Nov_23_20(11)_1803-1812.nxml.txt.nlp	19549706	SENT208	14	14	26	26	sunitinib	IFN	PA162372840	3439	0.663
NULL	Sci_Rep_2014_Sep_3_4_6268.nxml.txt.nlp	25183265	SENT286	0	0	3	3	urokinase	PON2	PA451836	5445	0.663
NULL	Oncoscience_2014_Mar_12_1(2)_167-179.nxml.txt.nlp	25126591	SENT228	35	35	38	38	everolimus	PI3K	PA164746311	5290	0.663
NULL	Int_J_Chron_Obstruct_Pulmon_Dis_2006_Dec_1(4)_373-379.nxml.txt.nlp	18044094	SENT43	0	0	11	11	roflumilast	PDE4D	PA165948052	5144	0.663
NULL	Clinics_(Sao_Paulo)_2013_May_68(5)_694-701.nxml.txt.nlp	23778405	SENT140	6	6	24	24	curcumin	survivin	PA151958596	332	0.663
NULL	Iran_J_Pharm_Res_2013_Summer_12(3)_457-469.nxml.txt.nlp	24250652	SENT204	17	17	28	28	indomethacin	ANOVA	PA449982	4858	0.663
NULL	Evid_Based_Complement_Alternat_Med_2013_Mar_24_2013_450840.nxml.txt.nlp	23634169	SENT54	3	3	5	5	omeprazole	DTNB	PA450704	1838	0.663
NULL	J_Oncol_2013_Apr_29_2013_854121.nxml.txt.nlp	23737784	SENT114	33	33	27	27	trastuzumab	PTEN	PA451743	5728	0.663
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Apr_7_9_12.nxml.txt.nlp	20374640	SENT110	4	4	6	6	ampicillin	CHL	PA448419	91851	0.663
NULL	Core_Evid_2010_Jul_27_5_1-10.nxml.txt.nlp	20694135	SENT219	2	2	8	8	levodopa	CLE	PA450213	51637	0.663
NULL	J_Aging_Res_2011_Sep_28_2011_251517.nxml.txt.nlp	21969914	SENT159	11	11	13	13	estradiol	aromatase	PA449503	1588	0.663
NULL	Arch_Osteoporos_2013_Oct_11_8(1-2)_136.nxml.txt.nlp	24113837	SENT2988	12	12	10	10	teriparatide	PTH	PA451620	5741	0.663
NULL	Mol_Cells_2014_Dec_31_37(12)_899a-906.nxml.txt.nlp	25431425	SENT479	0	0	11	11	curcumin	p65	PA151958596	5970	0.663
NULL	Emerg_Infect_Dis_2013_Nov_19(11)_1721-1730.nxml.txt.nlp	24207100	SENT134	32	32	26	26	doxycycline	VAN	PA449415	10318	0.663
NULL	Emerg_Infect_Dis_2013_Jan_19(1)_133-136.nxml.txt.nlp	23260464	SENT54	38	38	24	24	ceftazidime	TOB	PA448861	10140	0.663
NULL	Clin_Drug_Investig_2013_Jan_22_33(1)_25-34.nxml.txt.nlp	23179472	SENT30	33	33	36	36	ethanol	castor	PA448073	54897	0.663
NULL	Br_J_Cancer_2011_Jul_12_105(2)_255-262.nxml.txt.nlp	21694725	SENT190	23	23	6	6	oxaliplatin	EGFR	PA131285527	1956	0.663
NULL	Trials_2014_Oct_7_15(1)_391.nxml.txt.nlp	NULL	SENT195	18	18	32	32	varenicline	ANOVA	PA164781343	4858	0.663
NULL	Brain_Behav_2011_Sep_1(1)_44-54.nxml.txt.nlp	22398980	SENT24	16	16	25	25	phencyclidine	LSD	PA128406980	1776	0.663
NULL	Exp_Diabetes_Res_2012_Apr_11_2012_728325.nxml.txt.nlp	22566995	SENT67	0	0	7	7	bevacizumab	San	PA130232992	80218	0.663
NULL	J_Nutr_Metab_2011_Jul_28_2011_235389.nxml.txt.nlp	21811679	SENT50	43	43	30	30	rosiglitazone	CORT	PA451283	1325	0.663
NULL	Exp_Ther_Med_2013_Aug_20_6(2)_310-316.nxml.txt.nlp	24137180	SENT182	7	7	15	15	fasudil	MCP-1	PA165946121	6347	0.663
NULL	Cell_Regen_(Lond)_2012_Jun_28_1(1)_3.nxml.txt.nlp	25408866	SENT185	19	19	9	9	oxygen	MSC	PA450744	9242	0.663
NULL	Oxid_Med_Cell_Longev_2014_Apr_10_2014_823071.nxml.txt.nlp	24817993	SENT6	8	8	10	10	desipramine	DES	PA449233	1674	0.663
NULL	J_Gynecol_Oncol_2014_Oct_7_25(4)_355-356.nxml.txt.nlp	25310036	SENT39	12	12	4	4	doxorubicin	GEM	PA449412	2669	0.663
NULL	Braz_J_Microbiol_2008_Jun_1_Apr-Jun_39(2)_257-261.nxml.txt.nlp	24031212	SENT9	27	27	35	35	chloramphenicol	EMB	PA448927	133418	0.663
NULL	Anesth_Essays_Res_2012_Jul-Dec_6(2)_140-146.nxml.txt.nlp	NULL	SENT101	18	18	7	7	lidocaine	IL6	PA450226	3569	0.663
NULL	Cancer_Med_2013_Jun_2_2(3)_325-333.nxml.txt.nlp	23930209	SENT151	11	11	24	24	everolimus	HER2	PA164746311	2064	0.663
NULL	Endocrine_2012_Dec_14_42(3)_622-636.nxml.txt.nlp	22695986	SENT51	2	2	0	0	forskolin	PTH	PA146096022	5741	0.663
NULL	Indian_J_Pharm_Sci_2008_Sep-Oct_70(5)_649-651.nxml.txt.nlp	21394266	SENT5	41	41	24	24	pitavastatin	mol	PA142650384	90527	0.663
NULL	Oxid_Med_Cell_Longev_2013_Jul_9_2013_574029.nxml.txt.nlp	23936610	SENT209	5	5	20	20	resveratrol	p38		10598;1432;7965	0.663
NULL	Anesthesiol_Res_Pract_2011_Jul_27_2011_927421.nxml.txt.nlp	21808645	SENT52	21	21	13	13	dobutamine	CFI	PA449381	3426	0.663
NULL	Acta_Pharmacol_Sin_2009_Dec_4_30(12)_1674-1687.nxml.txt.nlp	19960012	SENT352	5	5	21	21	lipase	FBA	PA450239	26273	0.663
NULL	Front_Oncol_2014_Jun_4_4_140.nxml.txt.nlp	24926440	SENT218	21	21	14	14	genistein	p53	PA165109660	7157	0.663
NULL	Int_J_Surg_Oncol_2011_Aug_8_2011_374012.nxml.txt.nlp	22312502	SENT176	3	3	7	7	tamoxifen	STAR	PA451581	6770;2984	0.663
NULL	Case_Rep_Oncol_Med_2013_Nov_26_2013_862585.nxml.txt.nlp	24371535	SENT38	21	21	26	26	vincristine	CHOP	PA451879	1649	0.663
NULL	Acta_Pharmacol_Sin_2010_Jun_4_31(6)_741-745.nxml.txt.nlp	20523344	SENT74	3	3	12	12	gemcitabine	Bcl-2	PA449748	596	0.663
NULL	Leukemia_2014_Jun_17_28(6)_1216-1226.nxml.txt.nlp	24301524	SENT201	0	0	14	14	bortezomib	p50	PA10252	958;4790	0.663
NULL	Diabetes_2009_Dec_31_58(12)_2851-2862.nxml.txt.nlp	19720788	SENT13	7	7	19	19	forskolin	Bcl-2	PA146096022	596	0.663
NULL	Database_(Oxford)_2013_Oct_8_2013_bat071.nxml.txt.nlp	24107613	SENT180	23	23	33	33	nadh	EDH	PA164755085	10804	0.663
NULL	J_Cell_Mol_Med_2015_Jan_26_19(1)_21-30.nxml.txt.nlp	25425096	SENT146	15	15	5	5	collagenase	CAL	PA449107	54751;57120	0.663
NULL	Oncoimmunology_2012_May_1_1(3)_287-357.nxml.txt.nlp	22737604	SENT231	24	24	31	31	sargramostim	IL-4	PA164748631	3565	0.663
NULL	J_Biol_Chem_2009_Jan_2_284(1)_77-84.nxml.txt.nlp	18854318	SENT166	35	35	26	26	forskolin	MO25	PA146096022	51719	0.663
NULL	Endocrinol_Metab_(Seoul)_2014_Sep_25_29(3)_226-232.nxml.txt.nlp	25309779	SENT62	20	20	31	31	thyroglobulin	RAI	PA164754910	10848;6050	0.663
NULL	Nucleic_Acids_Res_2012_Jul_25_40(12)_5262-5270.nxml.txt.nlp	22367884	SENT35	16	16	24	24	l-glutamine	CO2	PA10090	4513	0.663
NULL	Diabetes_2011_Jun_21_60(6)_1797-1804.nxml.txt.nlp	21536946	SENT17	13	13	7	7	diazoxide	SUR1	PA449285	6833	0.663
NULL	J_Gastroenterol_2013_Jan_24_48(1)_13-21.nxml.txt.nlp	23090000	SENT146	32	32	6	6	tenofovir	IFN	PA10204	3439	0.663
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT17	28	28	10	10	phenprocoumon	GGCX	PA450921	2677	0.663
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2675-2684.nxml.txt.nlp	24129246	SENT194	11	11	9	9	etoposide	p53	PA449552	7157	0.663
NULL	Front_Immunol_2013_Oct_22_4_334.nxml.txt.nlp	24155745	SENT219	21	21	25	25	tamoxifen	CD7	PA451581	924	0.663
NULL	J_Hematol_Oncol_2013_Nov_22_6_88.nxml.txt.nlp	24261963	SENT184	7	7	15	15	fulvestrant	HER2	PA164747170	2064	0.663
NULL	Support_Care_Cancer_2012_Dec_26_20(12)_3241-3246.nxml.txt.nlp	22534864	SENT164	3	3	26	26	palonosetron	HEC	PA10352	10403	0.663
NULL	Int_J_Gen_Med_2012_Nov_9_5_935-942.nxml.txt.nlp	23204857	SENT9	4	4	19	19	isoflurane	CA3	PA450106	761	0.663
NULL	Front_Neurol_2011_Dec_16_2_72.nxml.txt.nlp	22203815	SENT158	9	9	5	5	protamine	VSOP	PA10366	84329	0.663
NULL	J_Antimicrob_Chemother_2014_Nov_17_69(11)_2920-2927.nxml.txt.nlp	25038069	SENT139	41	41	29	29	fosfomycin	TMP	PA164748039	2012	0.663
NULL	Clin_Ophthalmol_2009_Jun_2_3_189-194.nxml.txt.nlp	19668564	SENT19	7	7	37	37	brimonidine	BAK	PA448665	578	0.663
NULL	Int_J_Biomed_Sci_2008_Mar_4(1)_8-13.nxml.txt.nlp	23675060	SENT97	17	17	5	5	estradiol	IFN	PA449503	3439	0.663
NULL	J_Med_Life_2008_Aug_15_1(3)_275-286.nxml.txt.nlp	20108505	SENT27	23	23	29	29	trypsin	CO2	PA451806	4513	0.663
NULL	Biosci_Rep_2012_Apr_1_32(Pt_2)_105-112.nxml.txt.nlp	22115362	SENT557	3	3	17	17	collagenase	c-Jun	PA449107	3725	0.663
NULL	Front_Neural_Circuits_2014_Apr_8_8_33.nxml.txt.nlp	24782714	SENT1319	16	16	2	2	bromocriptine	spatial	PA448671	219793	0.663
NULL	Case_Rep_Oncol_Med_2013_Nov_26_2013_862585.nxml.txt.nlp	24371535	SENT57	26	26	31	31	vincristine	CHOP	PA451879	1649	0.663
NULL	Diabetes_2009_Apr_9_58(4)_829-839.nxml.txt.nlp	19136654	SENT43	16	16	8	8	creatine	AMPK	PA164778930	5563	0.663
NULL	J_Korean_Med_Sci_2004_Apr_30_19(2)_167-171.nxml.txt.nlp	15082886	SENT118	15	15	30	30	levofloxacin	EMB	PA450214	133418	0.663
NULL	Daru_2013_Jan_18_21(1)_10.nxml.txt.nlp	23351340	SENT140	4	4	15	15	tramadol	mol	PA451735	90527	0.663
NULL	Breast_Cancer_(Auckl)_2009_Apr_7_3_23-34.nxml.txt.nlp	21556247	SENT128	0	0	7	7	celecoxib	AKT	PA448871	207	0.663
NULL	Ann_Biomed_Eng_2011_Apr_7_39(4)_1328-1334.nxml.txt.nlp	21136165	SENT51	17	17	43	43	l-glutamine	CO2	PA10090	4513	0.663
NULL	Ecancermedicalscience_2009_Jun_4_3_136.nxml.txt.nlp	22276003	SENT101	14	14	6	6	idarubicin	MM1	PA449961	23654	0.663
NULL	Int_J_Pediatr_2010_Dec_23_2010_376287.nxml.txt.nlp	21234103	SENT92	18	18	28	28	azithromycin	gamma	PA448519	9913	0.663
NULL	Oncotarget_2014_Sep_10_5(20)_9877-9888.nxml.txt.nlp	25245676	SENT66	25	25	20	20	cetuximab	EGFR	PA10040	1956	0.663
NULL	Acta_Histochem_Cytochem_2006_Mar_2_39(1)_1-7.nxml.txt.nlp	17460766	SENT53	11	11	21	21	choline	FGF1	PA448976	2246	0.663
NULL	J_Cheminform_2012_Mar_8_4_6.nxml.txt.nlp	22401035	SENT245	1	1	8	8	troglitazone	PPARG	PA451799	5468	0.663
NULL	Curr_Rev_Musculoskelet_Med_2009_Mar_10_2(1)_56-64.nxml.txt.nlp	19468919	SENT86	5	5	0	0	heparin	OPG	PA449855	690	0.663
NULL	F1000_Med_Rep_2010_Jun_23_2_47.nxml.txt.nlp	20948837	SENT84	9	9	18	18	olanzapine	Gen	PA450688	348654	0.663
NULL	Crit_Care_2006_May_12_10(3)_R75.nxml.txt.nlp	16696866	SENT3	14	14	16	16	vasopressin	AVP	PA451858	114548;551	0.663
NULL	Aging_(Albany_NY)_2010_Dec_20_2(12)_959-968.nxml.txt.nlp	21191146	SENT76	0	0	7	7	cisplatin	LKB1	PA449014	6794	0.663
NULL	J_Nutr_Metab_2011_Oct_1_2011_525094.nxml.txt.nlp	21977315	SENT154	20	20	7	7	resveratrol	SIRT1		23411	0.663
NULL	Cancer_Cell_Int_2004_Mar_19_4_3.nxml.txt.nlp	15035672	SENT79	10	10	3	3	etoposide	PC3	PA449552	57332;7832;5122	0.663
NULL	Nat_Med_2010_Feb_24_16(2)_214-218.nxml.txt.nlp	20098429	SENT165	22	22	8	8	doxorubicin	YWHAZ	PA449412	7534	0.663
NULL	Br_J_Cancer_2010_Nov_9_103(10)_1554-1561.nxml.txt.nlp	20959830	SENT182	13	13	27	27	imatinib	AKT	PA10804	207	0.663
NULL	Small_GTPases_2012_Jan_1_3(1)_53-59.nxml.txt.nlp	22714418	SENT27	3	3	17	17	hyaluronan	CD44	PA165958431	960	0.663
NULL	Curr_Neuropharmacol_2009_Dec_7(4)_269-275.nxml.txt.nlp	20514206	SENT257	17	17	11	11	atorvastatin	JNK	PA448500	5599	0.663
NULL	Emerg_Infect_Dis_2014_Jul_20(7)_1252-1253.nxml.txt.nlp	24959839	SENT36	19	19	9	9	capreomycin	EMB	PA164746226	133418	0.663
NULL	Support_Care_Cancer_2011_Oct_8_19(10)_1505-1510.nxml.txt.nlp	20694798	SENT59	39	39	26	26	rituximab	CHOP	PA451261	1649	0.663
NULL	Cardiovasc_Diabetol_2010_Sep_23_9_57.nxml.txt.nlp	20863381	SENT14	10	10	2	2	pioglitazone	DM2	PA450970	28508	0.663
NULL	J_Biol_2006_Nov_30_5(7)_22.nxml.txt.nlp	17125495	SENT49	7	7	24	24	cisplatin	NRP	PA449014	8829;4673;10133	0.663
NULL	J_Hematol_Oncol_2010_Mar_23_3_11.nxml.txt.nlp	20331897	SENT146	26	26	15	15	cisplatin	ACT	PA449014	12;11332;9457;641455	0.663
NULL	Br_J_Cancer_2013_Jun_25_108(12)_2470-2477.nxml.txt.nlp	23695024	SENT87	25	25	27	27	sunitinib	IFN	PA162372840	3439	0.663
NULL	Indian_J_Pharm_Sci_2008_Mar-Apr_70(2)_208-215.nxml.txt.nlp	20046714	SENT39	24	24	29	29	ethanol	mol	PA448073	90527	0.663
NULL	Drugs_R_D_2014_Dec_18_14(4)_233-239.nxml.txt.nlp	25231707	SENT131	10	10	32	32	clopidogrel	PTX3	PA449053	5806	0.663
NULL	Diabetes_Care_2010_Jul_22_33(7)_1629-1634.nxml.txt.nlp	20413520	SENT199	23	23	9	9	rosiglitazone	adiponectin	PA451283	9370	0.663
NULL	Emerg_Infect_Dis_2014_Jul_20(7)_1252-1253.nxml.txt.nlp	24959839	SENT36	23	23	9	9	amikacin	EMB	PA164744372	133418	0.663
NULL	Biosci_Rep_2012_Dec_20_33(1)_e00011.nxml.txt.nlp	23137297	SENT265	31	31	33	33	heparin	RPSA	PA449855	3921	0.663
NULL	Food_Addit_Contam_Part_A_Chem_Anal_Control_Expo_Risk_Assess_2014_Oct_3_31(10)_176916-1782.nxml.txt.nlp	25105506	SENT193	5	5	14	14	ethanol	AF4	PA448073	4299	0.663
NULL	J_Cardiothorac_Surg_2010_Nov_30_5_121.nxml.txt.nlp	21118555	SENT132	18	18	8	8	amiodarone	ARCH	PA448383	339487	0.663
NULL	Neural_Regen_Res_2014_Nov_1_9(21)_1870-1873.nxml.txt.nlp	25558231	SENT94	14	14	12	12	liraglutide	GLP-1	PA165958364	100125288	0.663
NULL	Indian_J_Pharm_Sci_2008_Jan-Feb_70(1)_102-105.nxml.txt.nlp	20390092	SENT40	5	5	32	32	lansoprazole	DOM	PA450180	6663	0.663
NULL	Hum_Genomics_Proteomics_2010_Aug_3_2010_159761.nxml.txt.nlp	20981231	SENT234	20	20	9	9	lithium	PLCG1	PA450243	5335	0.663
NULL	Emerg_Infect_Dis_2013_Nov_19(11)_1721-1730.nxml.txt.nlp	24207100	SENT134	36	36	26	26	ofloxacin	VAN	PA450684	10318	0.663
NULL	Oncotarget_2013_Dec_28_5(6)_1475-1490.nxml.txt.nlp	24721996	SENT11	4	4	17	17	celecoxib	PTEN	PA448871	5728	0.663
NULL	Breast_Cancer_Res_2005_Dec_7_7(1)_R156-R163.nxml.txt.nlp	15642164	SENT104	3	3	5	5	letrozole	aromatase	PA450196	1588	0.663
NULL	J_Immunol_Res_2014_Sep_1_2014_246171.nxml.txt.nlp	25254222	SENT96	2	2	6	6	carbamazepine	HLA-A	PA448785	3105	0.663
NULL	Curr_Neuropharmacol_2009_Jun_7(2)_83-95.nxml.txt.nlp	19949566	SENT453	18	18	32	32	lamotrigine	TGB	PA450164	5473	0.663
NULL	Cancers_(Basel)_2014_Apr_9_6(2)_829-859.nxml.txt.nlp	24722453	SENT280	16	16	27	27	oxaliplatin	STAT3	PA131285527	6774	0.663
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_127043.nxml.txt.nlp	23227093	SENT231	24	24	21	21	ketoconazole	CYP2D6	PA450146	1565	0.663
NULL	Arthritis_Res_Ther_2009_Jan_26_11(1)_R12.nxml.txt.nlp	19171052	SENT244	7	7	27	27	dipyridamole	ACTH	PA449367	5443	0.663
NULL	Curr_Oncol_2009_Sep_16(5)_91-110.nxml.txt.nlp	NULL	SENT889	5	5	8	8	cisplatin	BRCA1	PA449014	672	0.663
NULL	Iran_J_Public_Health_2011_Dec_31_40(4)_99-104.nxml.txt.nlp	23113108	SENT26	9	9	18	18	galactose	GALE	PA449725	2582	0.663
NULL	Oncotarget_2013_Nov_26_4(12)_2502-2511.nxml.txt.nlp	24318446	SENT50	6	6	9	9	doxycycline	PHGDH	PA449415	26227	0.663
NULL	Oncotarget_2014_Oct_15_5(21)_10763-10777.nxml.txt.nlp	25333257	SENT72	21	21	1	1	sn-38	ABCB1		5243	0.663
NULL	J_Biomed_Biotechnol_2011_Jul_2_2011_981214.nxml.txt.nlp	21772792	SENT245	4	4	1	1	oxygen	GIT	PA450744	5034	0.663
NULL	NMR_Biomed_2013_Oct_7_26(10)_1258-1270.nxml.txt.nlp	23564602	SENT413	12	12	22	22	erythromycin	OATP	PA449493	6579	0.663
NULL	Indian_J_Pharmacol_2014_Nov-Dec_46(6)_627-632.nxml.txt.nlp	25538335	SENT125	11	11	9	9	metformin	Q10	PA450395	27161	0.663
NULL	Daru_2012_Sep_10_20(1)_30.nxml.txt.nlp	23351387	SENT135	6	6	4	4	indomethacin	IL-6	PA449982	3569	0.663
NULL	Crit_Care_2008_Aug_4_12(4)_R99.nxml.txt.nlp	18680591	SENT163	24	24	16	16	metoprolol	AVP	PA450480	114548;551	0.663
NULL	Clin_Ophthalmol_2014_Aug_18_8_1527-1534.nxml.txt.nlp	25170245	SENT4	12	12	40	40	travoprost	TIM	PA164781371	7984;8914	0.663
NULL	Br_J_Cancer_2006_Feb_13_94(3)_407-426.nxml.txt.nlp	16434996	SENT315	14	14	7	7	genistein	BRCA2	PA165109660	675	0.663
NULL	Mol_Cancer_2014_Jun_5_13_143.nxml.txt.nlp	24898067	SENT78	8	8	13	13	trastuzumab	HER-2	PA451743	2064	0.663
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT120	29	29	34	34	curcumin	TRAIL	PA151958596	8743	0.663
NULL	Lab_Invest_2013_Feb_19_93(2)_181-193.nxml.txt.nlp	23212100	SENT65	5	5	7	7	cyclophosphamide	CTX	PA449165	1593	0.663
NULL	Clin_Pediatr_Endocrinol_2013_Oct_26_22(4)_73-76.nxml.txt.nlp	24170964	SENT36	10	10	3	3	alfacalcidol	PTH	PA164746469	5741	0.663
NULL	J_Venom_Res_2011_Jun_8_2_17-23.nxml.txt.nlp	21677795	SENT43	0	0	7	7	tubocurarine	San	PA451811	80218	0.663
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT281	16	16	12	12	neratinib	HER2	PA165291472	2064	0.663
NULL	Oncotarget_2013_Oct_19_4(11)_2045-2056.nxml.txt.nlp	24185104	SENT5	20	20	2	2	cisplatin	14-3-3	PA449014	10971	0.663
NULL	Front_Genet_2013_Aug_30_4_166.nxml.txt.nlp	24009623	SENT175	23	23	13	13	everolimus	ZNF765	PA164746311	91661	0.663
NULL	J_Biol_Chem_2008_Aug_8_283(32)_21873-21880.nxml.txt.nlp	18539602	SENT190	26	26	30	30	s-adenosylmethionine	DNMT1	PA164754994	1786	0.663
NULL	Breast_Cancer_Res_Treat_2013_Aug_20_141(1)_43-53.nxml.txt.nlp	23959396	SENT20	9	9	23	23	trastuzumab	HER2	PA451743	2064	0.663
NULL	Clinics_(Sao_Paulo)_2011_Aug_66(8)_1457-1462.nxml.txt.nlp	21915500	SENT30	8	8	32	32	l-arginine	eNOS	PA448478	4846	0.663
NULL	Mol_Biol_Cell_2014_Jun_1_25(11)_1782-1792.nxml.txt.nlp	24719457	SENT108	0	0	2	2	nicotine	p53	PA450626	7157	0.663
NULL	Eur_J_Appl_Physiol_2014_Mar_13_114(6)_1281-1295.nxml.txt.nlp	24623065	SENT276	22	22	24	24	vasopressin	AVP	PA451858	114548;551	0.663
NULL	Front_Neurol_2014_Sep_11_5_173.nxml.txt.nlp	25309501	SENT160	2	2	11	11	hyaluronidase	HYAL2	PA164745713	8692	0.663
NULL	Mol_Vis_2012_Jul_18_18_1966-1972.nxml.txt.nlp	22876123	SENT148	5	5	23	23	curcumin	IL-4	PA151958596	3565	0.663
NULL	Cancer_Cell_Int_2010_Oct_1_10_36.nxml.txt.nlp	20920299	SENT17	14	14	20	20	colchicine	survivin	PA449092	332	0.663
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Sep_4_66(Pt_10)_o2479.nxml.txt.nlp	21587480	SENT70	27	27	22	22	ethanol	mol	PA448073	90527	0.663
NULL	Clin_Mol_Allergy_2008_Oct_16_6_12.nxml.txt.nlp	18925959	SENT215	13	13	6	6	amoxicillin	CD63	PA448406	967	0.663
NULL	J_Antimicrob_Chemother_2014_Nov_17_69(11)_2920-2927.nxml.txt.nlp	25038069	SENT139	23	23	29	29	ciprofloxacin	TMP	PA449009	2012	0.663
NULL	Biologics_2012_Dec_17_6_429-464.nxml.txt.nlp	23269860	SENT253	10	10	14	14	etanercept	NMA	PA449515	25805	0.663
NULL	Oncotarget_2014_Jun_26_5(14)_5559-5569.nxml.txt.nlp	24980819	SENT102	0	0	10	10	vemurafenib	p53	PA165946873	7157	0.663
NULL	J_Obes_2011_Apr_26_2011_250496.nxml.txt.nlp	21603262	SENT66	17	17	11	11	creatine	GAPDH	PA164778930	2597	0.663
NULL	Anc_Sci_Life_2012_Jan-Mar_31(3)_101-106.nxml.txt.nlp	23284215	SENT90	21	21	27	27	ethanol	mol	PA448073	90527	0.663
NULL	Br_J_Cancer_1996_Apr_73(8)_972-978.nxml.txt.nlp	8611434	SENT0	10	10	12	12	collagenase	MMP2	PA449107	4313	0.663
NULL	Acta_Pharmacol_Sin_2011_Jul_9_32(7)_879-887.nxml.txt.nlp	21552292	SENT98	11	11	19	19	metformin	AMPK	PA450395	5563	0.663
NULL	Am_J_Trop_Med_Hyg_2011_Sep_1_85(3)_579-580.nxml.txt.nlp	21896826	SENT13	16	16	29	29	mebendazole	STH	PA164776669	246744	0.663
NULL	Gut_Pathog_2013_Mar_22_5_6.nxml.txt.nlp	23522652	SENT238	4	4	11	11	ampicillin	CTX	PA448419	1593	0.663
NULL	J_Breast_Cancer_2012_Dec_31_15(4)_388-392.nxml.txt.nlp	23346166	SENT44	3	3	9	9	fluorescein	CD44	PA164746009	960	0.663
NULL	Int_J_Alzheimers_Dis_2012_Dec_3_2012_509529.nxml.txt.nlp	23251824	SENT82	6	6	28	28	resveratrol	p53		7157	0.663
NULL	Oncotarget_2013_Aug_14_4(10)_1606-1617.nxml.txt.nlp	24091475	SENT24	23	23	25	25	troglitazone	TRO	PA451799	7216	0.663
NULL	Emerg_Infect_Dis_2013_Jan_19(1)_133-136.nxml.txt.nlp	23260464	SENT37	47	47	29	29	aztreonam	TOB	PA448523	10140	0.663
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_33-43.nxml.txt.nlp	17912634	SENT152	34	34	38	38	letrozole	HER2	PA450196	2064	0.663
NULL	Zookeys_2013_Dec_18_(364)_47-91.nxml.txt.nlp	24453545	SENT56	11	11	33	33	ethanol	San	PA448073	80218	0.663
NULL	Emerg_Infect_Dis_2013_Jan_19(1)_133-136.nxml.txt.nlp	23260464	SENT37	7	7	29	29	amikacin	TOB	PA164744372	10140	0.663
NULL	An_Bras_Dermatol_2013_Jan-Feb_88(1)_117-120.nxml.txt.nlp	23539016	SENT41	41	41	43	43	cyclophosphamide	TNF-alpha	PA449165	7124	0.663
NULL	Acta_Pharmacol_Sin_2011_May_18_32(5)_591-600.nxml.txt.nlp	21499286	SENT162	2	2	13	13	bezafibrate	AMPK	PA162364313	5563	0.663
NULL	Oncotarget_2010_Oct_30_1(7)_639-650.nxml.txt.nlp	21317459	SENT56	2	2	7	7	nutlin-3	p53		7157	0.663
NULL	EMBO_J_2013_Aug_14_32(16)_2275-2286.nxml.txt.nlp	23881097	SENT359	3	3	17	17	diazepam	P14	PA449283	11102;;6280;56259	0.663
NULL	Acta_Pharmacol_Sin_2011_Jul_9_32(7)_879-887.nxml.txt.nlp	21552292	SENT97	2	2	4	4	metformin	AMPK	PA450395	5563	0.663
NULL	J_Biol_Inorg_Chem_2007_Jun_23_12(5)_645-654.nxml.txt.nlp	17318599	SENT124	26	26	8	8	dextromethorphan	CYP2D6	PA449273	1565	0.663
NULL	Oxid_Med_Cell_Longev_2012_Jan_19_2012_390678.nxml.txt.nlp	22315655	SENT179	2	2	4	4	gliclazide	NAC	PA10892	22861	0.663
NULL	Cancers_(Basel)_2014_Apr_30_6(2)_1031-1046.nxml.txt.nlp	24785146	SENT35	14	14	39	39	trypsin	LOXL2	PA451806	4017	0.663
NULL	Curr_Neuropharmacol_2013_Sep_11(5)_535-558.nxml.txt.nlp	24403877	SENT765	11	11	28	28	clozapine	GSK3B	PA449061	2932	0.663
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT272	3	3	13	13	glucose	EGFR	PA449773	1956	0.663
NULL	Allergy_Asthma_Clin_Immunol_2013_Aug_15_9(1)_30.nxml.txt.nlp	23947590	SENT422	21	21	38	38	metformin	GLP-1	PA450395	100125288	0.663
NULL	Cardiovasc_Diabetol_2013_Mar_23_12_48.nxml.txt.nlp	23522121	SENT87	35	35	29	29	pioglitazone	Met	PA450970	79811	0.663
NULL	J_Breast_Cancer_2013_Jun_28_16(2)_138-145.nxml.txt.nlp	23843844	SENT110	15	15	19	19	tamoxifen	STAT3	PA451581	6774	0.663
NULL	Int_J_Biol_Sci_2012_Sep_6_8(8)_1109-1120.nxml.txt.nlp	22991499	SENT162	9	9	6	6	l-arginine	IFN	PA448478	3439	0.663
NULL	Front_Endocrinol_(Lausanne)_2013_Jan_7_3_180.nxml.txt.nlp	23316185	SENT268	22	22	15	15	glucose	CRF2	PA449773	1395	0.663
NULL	J_Mol_Signal_2006_Dec_6_1_8.nxml.txt.nlp	17224083	SENT113	12	12	15	15	thrombin	Rho	PA451674	29984	0.663
NULL	Breast_Cancer_(Auckl)_2011_Jul_27_5_175-199.nxml.txt.nlp	21863131	SENT381	4	4	27	27	capecitabine	San	PA448771	80218	0.663
NULL	J_Mol_Signal_2011_May_16_6_4.nxml.txt.nlp	21575178	SENT169	11	11	6	6	arsenite	HSP27	PA452638	3315	0.663
NULL	Mol_Vis_2012_Jan_1_18_1-9.nxml.txt.nlp	22232563	SENT80	13	13	33	33	bevacizumab	HIF-1	PA130232992	29072	0.663
NULL	Nucleic_Acids_Res_2013_Nov_5_41(20)_e191.nxml.txt.nlp	24013564	SENT37	9	9	11	11	fluorescein	HEX	PA164746009	3087	0.663
NULL	Br_J_Cancer_2012_Jan_17_106(2)_284-289.nxml.txt.nlp	22215065	SENT15	13	13	3	3	atrasentan	IFN	PA143414738	3439	0.663
NULL	Curr_Neuropharmacol_2012_Jun_10(2)_97-123.nxml.txt.nlp	23204981	SENT716	15	15	3	3	duloxetine	IL-6	PA10066	3569	0.663
NULL	Exp_Ther_Med_2014_Nov_18_8(5)_1371-1374.nxml.txt.nlp	25289025	SENT104	22	22	0	0	methacholine	Yes	PA165958382	7525	0.663
NULL	Pharmaceutics_2012_Oct_26_4(4)_551-562.nxml.txt.nlp	24300370	SENT18	9	9	6	6	dimenhydrinate	ODF	PA449338	8600	0.663
NULL	Mol_Biol_Rep_2013_May_16_40(8)_4995-5004.nxml.txt.nlp	23677713	SENT140	17	17	4	4	camptothecin	TERT	PA153590860	7015	0.663
NULL	Oncol_Lett_2013_Feb_7_5(2)_440-446.nxml.txt.nlp	23420122	SENT247	7	7	16	16	sorafenib	Gem	PA7000	51053	0.663
NULL	Evid_Based_Complement_Alternat_Med_2011_Mar_6_2011_839720.nxml.txt.nlp	21423642	SENT242	7	7	21	21	galantamine	spatial	PA449726	219793	0.663
NULL	Front_Neurosci_2014_Feb_14_8_23.nxml.txt.nlp	24592205	SENT175	13	13	15	15	capsaicin	TRPV1	PA448776	7442	0.663
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT150	27	27	20	20	glucose	ERK	PA449773	5594	0.663
NULL	J_Oncol_2010_Oct_25_2010_394913.nxml.txt.nlp	19859581	SENT56	36	36	20	20	l-glutamine	CO2	PA10090	4513	0.663
NULL	Clin_Ophthalmol_2013_Sep_9_7_1797-1803.nxml.txt.nlp	24043929	SENT60	14	14	2	2	l-cysteine	NAC	PA449173	22861	0.663
NULL	Cancer_Metab_2013_Feb_4_1_7.nxml.txt.nlp	24280108	SENT130	28	28	5	5	glucose	MYC	PA449773	4609	0.663
NULL	Br_J_Haematol_2014_Feb_16_164(4)_586-596.nxml.txt.nlp	24236640	SENT161	27	27	33	33	carboplatin	CARB	PA448803	9482	0.663
NULL	Mol_Cancer_2007_Aug_21_6_53.nxml.txt.nlp	17711579	SENT153	6	6	16	16	cisplatin	BCL2L10	PA449014	10017	0.663
NULL	Oncotarget_2013_Jul_14_4(8)_1185-1198.nxml.txt.nlp	23852390	SENT5	36	36	26	26	tanespimycin	PI3	PA165291490	5266	0.663
NULL	Orphanet_J_Rare_Dis_2008_Sep_16_3_25.nxml.txt.nlp	18796155	SENT300	27	27	29	29	ribavirin	RIBA	PA451241	6014	0.663
NULL	Cell_Res_2013_Jun_21_23(6)_746-758.nxml.txt.nlp	23689277	SENT129	10	10	4	4	resveratrol	SIRT1		23411	0.663
NULL	Asian_Spine_J_2014_Feb_6_8(1)_97-111.nxml.txt.nlp	24596613	SENT397	10	10	16	16	pyrazinamide	EMB	PA451182	133418	0.663
NULL	Mol_Cancer_2009_Nov_19_8_108.nxml.txt.nlp	19925669	SENT151	18	18	9	9	doxorubicin	CTRL	PA449412	1506	0.663
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT183	4	4	6	6	cisplatin	p53	PA449014	7157	0.663
NULL	J_Ophthalmol_2012_Nov_3_2012_852183.nxml.txt.nlp	22132316	SENT15	0	0	6	6	ranibizumab	San	PA164746012	80218	0.663
NULL	Dermatoendocrinol_2013_Jun_1_5(3)_331-347.nxml.txt.nlp	24516687	SENT25	30	30	14	14	calcidiol	CYP2R1	PA164745614	120227	0.663
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT860	27	27	13	13	risperidone	San	PA451257	80218	0.663
NULL	Br_J_Cancer_1997_75(10)_1497-1500.nxml.txt.nlp	9166943	SENT0	22	22	14	14	melphalan	TNF-alpha	PA450354	7124	0.663
NULL	Clin_Ophthalmol_2010_May_14_4_437-445.nxml.txt.nlp	20505836	SENT12	16	16	19	19	latanoprost	BAK	PA164774763	578	0.663
NULL	Int_J_Surg_Oncol_2012_Jun_12_2012_862879.nxml.txt.nlp	22778941	SENT100	18	18	22	22	cisplatin	BIN1	PA449014	274	0.663
NULL	Cancer_Cell_Int_2011_Aug_19_11_29.nxml.txt.nlp	21854619	SENT219	17	17	8	8	platinum	BRCA1	PA150595617	672	0.663
NULL	Case_Rep_Oncol_2014_Mar_26_7(1)_204-209.nxml.txt.nlp	24803896	SENT25	4	4	22	22	trabectedin	MRCL	PA165958349	348174	0.663
NULL	J_Ginseng_Res_2011_Nov_35(4)_436-441.nxml.txt.nlp	23717089	SENT99	11	11	22	22	ginseng	CAGC	PA164781150	6283	0.663
NULL	Cancers_(Basel)_2010_Jul_12_2(3)_1453-1491.nxml.txt.nlp	24281168	SENT1856	25	25	2	2	methotrexate	IL-6	PA450428	3569	0.663
NULL	Acta_Myol_2010_Oct_29(2)_351-356.nxml.txt.nlp	21314018	SENT128	23	23	33	33	lipase	ABHD5	PA450239	51099	0.663
NULL	Breast_Cancer_Res_2014_Nov_8_16(6)_470.nxml.txt.nlp	25380620	SENT111	18	18	26	26	urokinase	ELF5	PA451836	2001	0.663
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Dec_10_3(12)_e151.nxml.txt.nlp	25494035	SENT33	15	15	22	22	pravastatin	OATP1B1	PA451089	10599	0.663
NULL	Cancer_Cell_Int_2011_Aug_19_11_29.nxml.txt.nlp	21854619	SENT220	18	18	30	30	cisplatin	BRCA1	PA449014	672	0.663
NULL	Breast_Cancer_Res_2012_Apr_19_14(2)_207.nxml.txt.nlp	22515594	SENT177	19	19	25	25	doxorubicin	NACT	PA449412	284111	0.663
NULL	Case_Rep_Rheumatol_2011_Dec_15_2011_185657.nxml.txt.nlp	22937439	SENT75	11	11	9	9	etanercept	TNF-alpha	PA449515	7124	0.663
NULL	New_Microbes_New_Infect_2014_May_4_2(3)_58-63.nxml.txt.nlp	25356345	SENT100	38	38	24	24	imipenem	ANK	PA449968	56172	0.663
NULL	Br_J_Cancer_2011_Apr_12_104(8)_1278-1287.nxml.txt.nlp	21487429	SENT194	6	6	8	8	cisplatin	DR5	PA449014	8795	0.663
NULL	Theranostics_2014_Aug_15_4(11)_1072-1084.nxml.txt.nlp	25250092	SENT172	21	21	23	23	cetuximab	EGFR	PA10040	1956	0.663
NULL	Aging_(Albany_NY)_2009_Mar_31_1(4)_412-424.nxml.txt.nlp	20195491	SENT85	12	12	5	5	resveratrol	TXNIP		10628	0.663
NULL	Cancer_Cell_Int_2010_Sep_9_10_32.nxml.txt.nlp	20828393	SENT5	18	18	9	9	cisplatin	ATF3	PA449014	467	0.663
NULL	Cancer_Immunol_Immunother_2011_Jun_25_60(6)_793-808.nxml.txt.nlp	21350947	SENT155	32	32	12	12	sorafenib	IFN	PA7000	3439	0.663
NULL	Diabetes_Care_2010_Apr_22_33(4)_706-713.nxml.txt.nlp	20097780	SENT193	12	12	1	1	nortriptyline	Gen	PA450657	348654	0.663
NULL	Chem_Cent_J_2013_Jul_31_7_133.nxml.txt.nlp	23899303	SENT0	20	20	31	31	ofloxacin	DSC	PA450684	1825	0.663
NULL	Front_Genet_2014_Oct_14_5_314.nxml.txt.nlp	25352860	SENT118	8	8	2	2	napqi	CYP1A2		1544	0.663
NULL	Oncotarget_2014_Jun_27_5(13)_4694-4708.nxml.txt.nlp	25051361	SENT152	6	6	3	3	fludarabine	p27	PA449655	5715;10534	0.663
NULL	J_Biol_2009_Apr_15_8(3)_30.nxml.txt.nlp	19435483	SENT40	0	0	15	15	imatinib	NQO2	PA10804	4835	0.663
NULL	J_Antimicrob_Chemother_2014_Nov_17_69(11)_2920-2927.nxml.txt.nlp	25038069	SENT139	6	6	29	29	erythromycin	TMP	PA449493	2012	0.662
NULL	Anesth_Pain_Med_2014_Sep_9_4(4)_e14221.nxml.txt.nlp	25599022	SENT129	14	14	6	6	cisplatin	LPO	PA449014	4025	0.662
NULL	Eur_J_Clin_Pharmacol_2012_Sep_15_68(9)_1267-1274.nxml.txt.nlp	22418828	SENT36	17	17	10	10	pantoprazole	CYP2C19	PA450774	1557	0.662
NULL	Indian_J_Endocrinol_Metab_2011_Jul_15(Suppl1)_S69-S70.nxml.txt.nlp	21847463	SENT15	18	18	27	27	saxagliptin	PPG	PA165958362	5552	0.662
NULL	J_Gen_Physiol_1990_Nov_1_96(5)_1105-1127.nxml.txt.nlp	2177771	SENT3	29	29	32	32	bupivacaine	RAC	PA135057240	207	0.662
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT332	4	4	7	7	clozapine	PRL	PA449061	5617	0.662
NULL	J_Immunol_Res_2014_Jun_2_2014_210241.nxml.txt.nlp	24987708	SENT360	13	13	23	23	estradiol	CD25	PA449503	3669;3559	0.662
NULL	Behav_Brain_Funct_2005_Apr_22_1_2.nxml.txt.nlp	15916700	SENT237	30	30	45	45	guanfacine	spatial	PA449825	219793	0.662
NULL	Exp_Cell_Res_2011_Apr_15_317(7)_1028-1039.nxml.txt.nlp	21237154	SENT755	4	4	1	1	staurosporine	JIP1	PA165109623	9479	0.662
NULL	Adv_Appl_Bioinforma_Chem_2009_Dec_3_2_125-138.nxml.txt.nlp	21918620	SENT160	7	7	3	3	camptothecin	NIK	PA153590860	9020;9448	0.662
NULL	Aging_(Albany_NY)_2009_Feb_18_1(3)_335-349.nxml.txt.nlp	20195489	SENT127	15	15	5	5	etoposide	p65	PA449552	5970	0.662
NULL	Ann_Hematol_2011_Feb_17_90(2)_173-183.nxml.txt.nlp	20714724	SENT151	3	3	17	17	resveratrol	CD19		930	0.662
NULL	Oncol_Lett_2014_Apr_22_7(4)_1191-1196.nxml.txt.nlp	24944691	SENT116	14	14	9	9	vinblastine	PC-3	PA451877	692094	0.662
NULL	Cancers_(Basel)_2010_Aug_18_2(3)_1617-1628.nxml.txt.nlp	24281177	SENT143	20	20	11	11	gemcitabine	ZEB1	PA449748	6935	0.662
NULL	Cell_Cycle_2012_Dec_15_11(24)_4661-4672.nxml.txt.nlp	23187802	SENT115	35	35	33	33	doxorubicin	DREAM	PA449412	30818	0.662
NULL	Pain_Res_Treat_2011_Aug_14_2011_864605.nxml.txt.nlp	22110933	SENT134	0	0	12	12	oxcarbazepine	PLP	PA450732	25824;5744	0.662
NULL	J_Biol_Chem_2009_Apr_3_284(14)_9558-9565.nxml.txt.nlp	19202191	SENT77	10	10	7	7	camptothecin	CtIP	PA153590860	5932	0.662
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT194	3	3	10	10	tacrolimus	SOCS3	PA451578	9021	0.662
NULL	Int_J_Biol_Sci_2015_Jan_1_11(1)_1-10.nxml.txt.nlp	25552924	SENT34	0	0	13	13	cisplatin	Oct4	PA449014	5460	0.662
NULL	J_Int_Soc_Sports_Nutr_2009_Feb_19_6_6.nxml.txt.nlp	19228401	SENT7	5	5	23	23	creatine	CEE	PA164778930	51608	0.662
NULL	Iran_J_Neurol_2014_13(1)_33-39.nxml.txt.nlp	24800045	SENT133	21	21	31	31	gentamicin	CDP	PA449753	1523	0.662
NULL	Infect_Dis_Obstet_Gynecol_2012_Nov_29_2012_543916.nxml.txt.nlp	23251074	SENT37	33	33	38	38	lopinavir	CD4	PA450264	920	0.662
NULL	Oncotarget_2010_Jun_7_1(2)_156-160.nxml.txt.nlp	21297225	SENT21	1	1	20	20	dasatinib	CD38	PA162372878	952	0.662
NULL	Front_Neurosci_2011_Jan_14_4_207.nxml.txt.nlp	21258618	SENT20	11	11	5	5	ethanol	AC7	PA448073	113	0.662
NULL	Exp_Ther_Med_2013_Nov_13_6(5)_1317-1321.nxml.txt.nlp	24223665	SENT24	9	9	36	36	cisplatin	ABCG2	PA449014	9429	0.662
NULL	Breast_Cancer_Res_2007_Jul_5_9(4)_R41.nxml.txt.nlp	17612393	SENT145	0	0	17	17	celecoxib	Bcl-2	PA448871	596	0.662
NULL	Diabetologia_2010_Jun_27_53(6)_1142-1150.nxml.txt.nlp	20349036	SENT188	8	8	13	13	spermine	AMPK	PA164781199	5563	0.662
NULL	Clin_Ophthalmol_2009_Aug_3_3_447-456.nxml.txt.nlp	19684868	SENT168	4	4	10	10	travoprost	BIM	PA164781371	10018	0.662
NULL	EMBO_Mol_Med_2011_Nov_3(11)_623-636.nxml.txt.nlp	21953712	SENT260	1	1	23	23	gefitinib	ERBB3	PA131301952	2065	0.662
NULL	Eukaryot_Cell_2014_Aug_13(8)_1077-1084.nxml.txt.nlp	24951438	SENT158	0	0	5	5	doxycycline	HSF1	PA449415	3297	0.662
NULL	Indian_J_Pharmacol_2012_Sep-Oct_44(5)_629-633.nxml.txt.nlp	23112427	SENT106	4	4	14	14	propranolol	ANOVA	PA451145	4858	0.662
NULL	Acta_Vet_Scand_2011_Feb_17_53(1)_11.nxml.txt.nlp	21324209	SENT61	6	6	24	24	cefazolin	OTC	PA448839	5009	0.662
NULL	Brain_Sci_2013_Apr_23_3(2)_615-626.nxml.txt.nlp	24961417	SENT151	34	34	16	16	ethanol	CO2	PA448073	4513	0.662
NULL	Braz_J_Med_Biol_Res_2012_Feb_17_45(3)_244-249.nxml.txt.nlp	22331137	SENT45	6	6	8	8	gentamicin	PAG	PA449753	55824	0.662
NULL	Basic_Clin_Pharmacol_Toxicol_2013_Feb_5_112(2)_132-137.nxml.txt.nlp	22900583	SENT54	26	26	34	34	midazolam	CYP2C19	PA450496	1557	0.662
NULL	Environ_Health_2013_Apr_16_12_33.nxml.txt.nlp	23590724	SENT24	12	12	14	14	diethylstilbestrol	DES	PA449307	1674	0.662
NULL	Front_Immunol_2013_Oct_8_4_289.nxml.txt.nlp	24115947	SENT46	9	9	25	25	dextran	IL-18	PA449261	3606	0.662
NULL	Cancers_(Basel)_2014_Mar_26_6(2)_708-722.nxml.txt.nlp	24675568	SENT107	27	27	24	24	afatinib	IL-6	PA165981154	3569	0.662
NULL	BMJ_2014_Apr_15_348_g2366.nxml.txt.nlp	24736555	SENT434	2	2	17	17	pioglitazone	AM2	PA450970	79924	0.662
NULL	Biomed_Res_Int_2013_Aug_7_2013_864012.nxml.txt.nlp	23991423	SENT74	13	13	6	6	alfacalcidol	PTH	PA164746469	5741	0.662
NULL	Arch_Med_Sci_2013_Apr_20_9(2)_191-200.nxml.txt.nlp	23671428	SENT191	5	5	3	3	lipase	IL-6	PA450239	3569	0.662
NULL	Br_J_Cancer_2013_Jun_25_108(12)_2464-2469.nxml.txt.nlp	23695016	SENT33	10	10	15	15	paclitaxel	CRT	PA450761	811	0.662
NULL	Indian_J_Pharmacol_2014_Nov-Dec_46(6)_627-632.nxml.txt.nlp	25538335	SENT112	13	13	11	11	metformin	Q10	PA450395	27161	0.662
NULL	Brain_Res_2011_Mar_25_1382(C)_29-36.nxml.txt.nlp	21276431	SENT128	18	18	24	24	ketanserin	5-HT2A	PA131053734	3356	0.662
NULL	Mol_Pain_2013_Jun_10_9_27.nxml.txt.nlp	23758830	SENT11	5	5	3	3	tetracaine	ASIC3	PA451638	9311	0.662
NULL	Cell_Microbiol_2010_Dec_3_12(12)_1718-1731.nxml.txt.nlp	20618342	SENT141	25	25	27	27	staurosporine	STS	PA165109623	412	0.662
NULL	Acta_Pharmacol_Sin_2011_Dec_7_32(12)_1433-1445.nxml.txt.nlp	22056617	SENT237	0	0	15	15	lamotrigine	CA3	PA450164	761	0.662
NULL	Diagn_Pathol_2014_Jan_20_9_11.nxml.txt.nlp	24443801	SENT9	23	23	11	11	chymotrypsin	MUC6	PA448994	4588	0.662
NULL	Acta_Pharmacol_Sin_2012_May_16_33(5)_682-690.nxml.txt.nlp	22504904	SENT166	3	3	18	18	celecoxib	STAT3	PA448871	6774	0.662
NULL	Oncotarget_2014_Oct_16_5(20)_9546-9563.nxml.txt.nlp	25337673	SENT206	2	2	10	10	cabozantinib	AXL	PA165906891	558	0.662
NULL	Crit_Care_2011_Oct_25_15(5)_R255.nxml.txt.nlp	22026977	SENT124	14	14	16	16	vasopressin	AVP	PA451858	114548;551	0.662
NULL	Carcinogenesis_2013_Mar_7_34(3)_703-712.nxml.txt.nlp	23222814	SENT104	15	15	8	8	curcumin	p53	PA151958596	7157	0.662
NULL	Int_J_Nanomedicine_2007_Jun_2(2)_265-274.nxml.txt.nlp	17722554	SENT176	11	11	38	38	collagenase	spatial	PA449107	219793	0.662
NULL	Front_Aging_Neurosci_2010_Apr_8_2_15.nxml.txt.nlp	20552051	SENT1399	3	3	8	8	estradiol	spatial	PA449503	219793	0.662
NULL	Sensors_(Basel)_2010_Oct_12_10(10)_9155-9162.nxml.txt.nlp	22163401	SENT31	29	29	20	20	pp2	MP1		10531;8649	0.662
NULL	Trials_2014_Aug_6_15(1)_312.nxml.txt.nlp	NULL	SENT267	3	3	21	21	estradiol	Gen	PA449503	348654	0.662
NULL	Breast_Cancer_Res_2012_May_3_14(3)_R71.nxml.txt.nlp	22554015	SENT259	27	27	30	30	trastuzumab	EGFR	PA451743	1956	0.662
NULL	Pharmaceuticals_(Basel)_2014_Mar_5_7(3)_311-338.nxml.txt.nlp	24603603	SENT283	7	7	4	4	cetuximab	EGFR	PA10040	1956	0.662
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Oct_31_68(Pt_11)_m1424.nxml.txt.nlp	23284386	SENT66	17	17	9	9	ethanol	NO3	PA448073	4681	0.662
NULL	Allergy_Asthma_Immunol_Res_2014_Nov_19_6(6)_548-557.nxml.txt.nlp	25374755	SENT203	0	0	20	20	lovastatin	IL-13	PA450272	3596	0.662
NULL	Front_Physiol_2012_Nov_27_3_454.nxml.txt.nlp	23205014	SENT72	21	21	6	6	iodine	TLC	PA450049	3933	0.662
NULL	EMBO_Mol_Med_2013_Mar_18_5(3)_344-352.nxml.txt.nlp	23417962	SENT212	17	17	14	14	resveratrol	SIRT1		23411	0.662
NULL	Int_J_Gen_Med_2011_Jul_20_4_539-545.nxml.txt.nlp	21845063	SENT28	5	5	14	14	miglitol	adiponectin	PA164776726	9370	0.662
NULL	J_Cell_Biol_2008_Jul_28_182(2)_327-340.nxml.txt.nlp	18644889	SENT35	23	23	32	32	estradiol	AKT	PA449503	207	0.662
NULL	Drugs_R_D_2010_Sep_27_10(3)_179-202.nxml.txt.nlp	20945948	SENT30	8	8	16	16	telaprevir	IFN	PA165958354	3439	0.662
NULL	Indian_J_Pharmacol_2009_Dec_41(6)_262-267.nxml.txt.nlp	20407557	SENT197	2	2	12	12	ezetimibe	STZ	PA10816	6484	0.662
NULL	Vet_Res_2014_Dec_16_45(1)_123.nxml.txt.nlp	25512064	SENT227	2	2	10	10	zinc	CD34	PA451956	947	0.662
NULL	Curr_Neuropharmacol_2009_Jun_7(2)_83-95.nxml.txt.nlp	19949566	SENT515	14	14	32	32	levetiracetam	TGB	PA450206	5473	0.662
NULL	Cereb_Cortex_2014_Jan_9_24(1)_174-185.nxml.txt.nlp	23048018	SENT19	2	2	11	11	methylphenidate	ATX	PA450464	5168;23049	0.662
NULL	Cases_J_2009_Jul_9_2_7466.nxml.txt.nlp	19829971	SENT24	24	24	11	11	atropine	DST	PA448505	667	0.662
NULL	Oncologist_2011_Jan_6_16(1)_5-24.nxml.txt.nlp	21212434	SENT165	4	4	2	2	aldesleukin	IL-2	PA448081	3558	0.662
NULL	Clin_Ophthalmol_2014_Jun_13_8_1105-1118.nxml.txt.nlp	24966664	SENT347	7	7	15	15	bevacizumab	San	PA130232992	80218	0.662
NULL	Anesth_Pain_Med_2013_Mar_26_Spring_2(4)_159-163.nxml.txt.nlp	24223353	SENT59	16	16	31	31	isoflurane	CO2	PA450106	4513	0.662
NULL	Front_Oncol_2013_Sep_11_3_228.nxml.txt.nlp	24062981	SENT189	21	21	24	24	camptothecin	PARP1	PA153590860	142	0.662
NULL	AIDS_Res_Treat_2011_Jul_25_2011_743597.nxml.txt.nlp	21804938	SENT29	32	32	8	8	efavirenz	CD4	PA449441	920	0.662
NULL	Case_Rep_Hematol_2013_Oct_10_2013_840253.nxml.txt.nlp	24224107	SENT56	13	13	18	18	vincristine	CHOP	PA451879	1649	0.662
NULL	Int_J_Environ_Res_Public_Health_2010_Dec_21_7(12)_4281-4304.nxml.txt.nlp	21318009	SENT249	5	5	16	16	ethanol	PEPT1	PA448073	6564	0.662
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R91.nxml.txt.nlp	22541814	SENT191	15	15	12	12	thrombin	HO-1	PA451674	3162	0.662
NULL	Emerg_Infect_Dis_2014_Mar_20(3)_400-408.nxml.txt.nlp	24565738	SENT128	16	16	22	22	isoniazid	EMB	PA450112	133418	0.662
NULL	Evid_Based_Complement_Alternat_Med_2014_Sep_2_2014_627181.nxml.txt.nlp	25258643	SENT250	4	4	2	2	losartan	TMP	PA450268	2012	0.662
NULL	Chem_Rev_2011_Oct_12_111(10)_5899-5921.nxml.txt.nlp	21923193	SENT374	22	22	19	19	lipase	FAAH	PA450239	79152;2166	0.662
NULL	Mol_Cancer_2009_Apr_22_8_26.nxml.txt.nlp	19386116	SENT129	8	8	6	6	ritonavir	AKT	PA451260	207	0.662
NULL	Lab_Invest_2011_Apr_14_91(4)_598-608.nxml.txt.nlp	21321535	SENT129	6	6	8	8	sorafenib	CD4	PA7000	920	0.662
NULL	Mucosal_Immunol_2013_Mar_29_6(2)_358-368.nxml.txt.nlp	22929561	SENT105	5	5	9	9	collagenase	San	PA449107	80218	0.662
NULL	Breast_Cancer_Res_2008_Dec_18_10(Suppl_4)_S26.nxml.txt.nlp	19128440	SENT17	25	25	20	20	anastrozole	IMPACT	PA448432	55364	0.662
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT132	18	18	6	6	perifosine	DR4	PA165291471	8797	0.662
NULL	FEBS_Open_Bio_2012_Aug_22_2_279-283.nxml.txt.nlp	23650611	SENT108	0	0	14	14	tamoxifen	IFN	PA451581	3439	0.662
NULL	J_Gastroenterol_2014_Sep_25_49(8)_1253-1263.nxml.txt.nlp	24065124	SENT213	18	18	25	25	eltrombopag	IFN	PA165981594	3439	0.662
NULL	Br_J_Cancer_2012_Jan_3_106(1)_18-24.nxml.txt.nlp	22108516	SENT110	22	22	34	34	camptothecin	TDP1	PA153590860	55775	0.662
NULL	Aging_(Albany_NY)_2014_Mar_26_6(3)_187-206.nxml.txt.nlp	24753144	SENT131	0	0	7	7	metformin	B12	PA450395	7126;4709	0.662
NULL	Clin_Dev_Immunol_2013_May_29_2013_296031.nxml.txt.nlp	23818913	SENT103	2	2	9	9	hydrocortisone	IFN	PA449905	3439	0.662
NULL	Sci_Rep_2014_Dec_10_4_7418.nxml.txt.nlp	25492109	SENT345	0	0	13	13	phenol	gamma	PA450913	9913	0.662
NULL	Diabetologia_2010_Jun_27_53(6)_1142-1150.nxml.txt.nlp	20349036	SENT213	16	16	9	9	spermine	AMPK	PA164781199	5563	0.662
NULL	Diabetes_2011_Jun_21_60(6)_1797-1804.nxml.txt.nlp	21536946	SENT186	6	6	9	9	diazoxide	SUR1	PA449285	6833	0.662
NULL	ScientificWorldJournal_2013_Oct_24_2013_726912.nxml.txt.nlp	24282387	SENT163	32	32	29	29	fluorescein	AVP	PA164746009	114548;551	0.662
NULL	Open_Ophthalmol_J_2011_Apr_28_5_27-31.nxml.txt.nlp	21633720	SENT12	34	34	9	9	guanabenz	ERG	PA164774903	2078	0.662
NULL	Cell_Death_Dis_2013_Jun_6_4(6)_e654.nxml.txt.nlp	23744354	SENT253	22	22	12	12	paclitaxel	B4GALT1	PA450761	2683	0.662
NULL	Gene_Ther_2010_Oct_20_17(10)_1244-1252.nxml.txt.nlp	20485382	SENT241	12	12	1	1	mitomycin	CD34	PA450524	947	0.662
NULL	Clin_Ophthalmol_2014_Jun_3_8_1057-1064.nxml.txt.nlp	24940042	SENT35	38	38	43	43	bevacizumab	CST	PA130232992	9514	0.662
NULL	Curr_Med_Chem_2014_Feb_21_1129-1145.nxml.txt.nlp	24304271	SENT182	3	3	5	5	diethylstilbestrol	DES	PA449307	1674	0.662
NULL	Evid_Based_Complement_Alternat_Med_2014_May_22_2014_601064.nxml.txt.nlp	25136372	SENT172	34	34	40	40	methotrexate	N10	PA450428	3164	0.662
NULL	Oncotarget_2011_Oct_17_2(10)_797-809.nxml.txt.nlp	22006582	SENT66	21	21	15	15	propranolol	U87	PA451145	677775;641648	0.662
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT131	3	3	23	23	metformin	CCL16	PA450395	6360	0.662
NULL	Cell_Commun_Signal_2013_Feb_20_11_13.nxml.txt.nlp	23425659	SENT35	24	24	8	8	bromazepam	MCAD	PA10035	34	0.662
NULL	Iran_J_Pharm_Res_2013_Winter_12(1)_141-146.nxml.txt.nlp	24250582	SENT104	8	8	3	3	rifampin	NAC	PA451250	22861	0.662
NULL	Mol_Cancer_2007_Sep_26_6_61.nxml.txt.nlp	17894897	SENT11	0	0	2	2	etoposide	p53	PA449552	7157	0.662
NULL	Curr_Neuropharmacol_2008_Jun_6(2)_151-163.nxml.txt.nlp	19305794	SENT52	5	5	0	0	capsaicin	TRPV1	PA448776	7442	0.662
NULL	J_Gastrointest_Cancer_2013_Aug_7_44(4)_385-392.nxml.txt.nlp	23921604	SENT174	16	16	10	10	imatinib	KIT	PA10804	3815	0.662
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Dec_2_5_30.nxml.txt.nlp	17140452	SENT38	8	8	15	15	vancomycin	VISA	PA451850	57506	0.662
NULL	Eur_J_Clin_Pharmacol_2010_Nov_29_66(11)_1131-1136.nxml.txt.nlp	20669013	SENT137	13	13	16	16	erythromycin	CYP3A4	PA449493	1576	0.662
NULL	Blood_Res_2014_Jun_25_49(2)_95-99.nxml.txt.nlp	25025010	SENT37	24	24	18	18	cytarabine	LIR	PA449177	10871	0.662
NULL	Cancers_(Basel)_2011_Apr_1_3(2)_1844-1860.nxml.txt.nlp	24212785	SENT65	38	38	4	4	irinotecan	ACRC	PA450085	93953	0.662
NULL	Arthritis_Res_Ther_2013_Dec_27_15(6)_R222.nxml.txt.nlp	24369907	SENT181	3	3	17	17	collagenase	c-Jun	PA449107	3725	0.662
NULL	J_Lipid_Res_2014_Feb_55(2)_190-200.nxml.txt.nlp	24273196	SENT143	13	13	36	36	lipase	HSL	PA450239	3991	0.662
NULL	Brain_Sci_2012_Nov_7_2(4)_589-604.nxml.txt.nlp	24349762	SENT19	24	24	31	31	vasopressin	OXT	PA451858	5020	0.662
NULL	Front_Oncol_2012_Oct_31_2_157.nxml.txt.nlp	23120745	SENT240	6	6	3	3	temozolomide	p53	PA451609	7157	0.662
NULL	Cell_Commun_Signal_2009_Feb_26_7(Suppl_1)_A63.nxml.txt.nlp	NULL	SENT20	9	9	11	11	pp2	PP2		4888	0.662
NULL	Sensors_(Basel)_2010_May_4_10(5)_4541-4557.nxml.txt.nlp	22399891	SENT442	6	6	19	19	thrombin	ITO	PA451674	3160	0.662
NULL	J_Antimicrob_Chemother_2010_Mar_18_65(3)_390-398.nxml.txt.nlp	20022938	SENT31	18	18	24	24	halofantrine	ATV	PA449839	4683	0.662
NULL	Case_Rep_Rheumatol_2014_Apr_15_2014_949317.nxml.txt.nlp	24839574	SENT45	2	2	8	8	ustekinumab	IL-23	PA166048654	51561	0.662
NULL	Trials_2013_Nov_13_14_385.nxml.txt.nlp	24220602	SENT285	10	10	47	47	ximelagatran	Gen	PA161748474	348654	0.662
NULL	Indian_J_Med_Paediatr_Oncol_2014_Oct-Dec_35(4)_281-287.nxml.txt.nlp	25538406	SENT8	5	5	13	13	methotrexate	CRT	PA450428	811	0.662
NULL	Oxid_Med_Cell_Longev_2012_Aug_22_2012_534705.nxml.txt.nlp	22966415	SENT321	21	21	9	9	riluzole	GLT-1	PA451251	6506	0.662
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT333	14	14	7	7	heparin	FGF1	PA449855	2246	0.662
NULL	Adipocyte_2014_Jul_1_3(3)_190-196.nxml.txt.nlp	25068085	SENT13	29	29	25	25	lipase	HMOX1	PA450239	3162	0.662
NULL	Oncol_Rep_2013_Oct_24_30(4)_1587-1592.nxml.txt.nlp	23900512	SENT83	35	35	24	24	tranylcypromine	NOXA	PA451741	5366	0.662
NULL	Cancers_(Basel)_2013_Nov_1_5(4)_1379-1412.nxml.txt.nlp	24202450	SENT243	7	7	20	20	cyclophosphamide	IL-2	PA449165	3558	0.662
NULL	Exp_Diabetes_Res_2012_Oct_15_2012_465282.nxml.txt.nlp	23118742	SENT91	6	6	26	26	metformin	FGF21	PA450395	26291	0.662
NULL	Cereb_Cortex_2014_May_10_24(5)_1351-1360.nxml.txt.nlp	23307638	SENT87	35	35	11	11	galantamine	ANOVA	PA449726	4858	0.662
NULL	Oncotarget_2014_Feb_16_5(3)_587-598.nxml.txt.nlp	24583822	SENT110	15	15	24	24	carboplatin	IFI27	PA448803	3429	0.662
NULL	Case_Rep_Ophthalmol_2010_Aug_18_1(1)_36-41.nxml.txt.nlp	21369348	SENT3	14	14	8	8	bevacizumab	hole	PA130232992	80757	0.662
NULL	Core_Evid_2007_Nov_30_2(2)_121-129.nxml.txt.nlp	21221180	SENT233	10	10	14	14	rituximab	EFS	PA451261	10278	0.662
NULL	Cell_Death_Dis_2014_Jul_3_5(7)_e1316.nxml.txt.nlp	24991768	SENT94	8	8	16	16	pemetrexed	ATF3	PA10810	467	0.662
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Oct_13_65(Pt_11)_o2724.nxml.txt.nlp	21578321	SENT57	33	33	28	28	ethanol	mol	PA448073	90527	0.662
NULL	Anemia_2012_Mar_29_2012_425814.nxml.txt.nlp	22737580	SENT82	14	14	20	20	hydroxyurea	FANCD2	PA449942	2177	0.662
NULL	Drug_Des_Devel_Ther_2014_Sep_23_8_1527-1538.nxml.txt.nlp	25284985	SENT183	2	2	0	0	celecoxib	IFN	PA448871	3439	0.662
NULL	Emerg_Infect_Dis_2012_Feb_18(2)_302-304.nxml.txt.nlp	22305387	SENT113	32	32	14	14	itraconazole	PYM	PA450132	84305	0.662
NULL	Br_J_Cancer_2010_Jan_19_102(2)_383-391.nxml.txt.nlp	20010943	SENT12	31	31	17	17	cisplatin	P31	PA449014	529	0.662
NULL	J_Gen_Physiol_2000_Jun_1_115(6)_685-696.nxml.txt.nlp	10828243	SENT8	18	18	26	26	genistein	OLF	PA165109660	83857	0.662
NULL	Case_Rep_Oncol_2011_Sep_16_4(3)_464-466.nxml.txt.nlp	22114570	SENT14	10	10	7	7	erlotinib	EGFR	PA134687924	1956	0.662
NULL	J_Cancer_Res_Clin_Oncol_2013_Aug_7_139(10)_1667-1672.nxml.txt.nlp	23918349	SENT138	5	5	1	1	doxycycline	STEPP	PA449415	222659	0.662
NULL	Arthritis_Res_Ther_2011_Dec_12_13(6)_R204.nxml.txt.nlp	22151924	SENT87	43	43	8	8	alefacept	CFB	PA164748040	629	0.662
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT200	9	9	4	4	metformin	AKT	PA450395	207	0.662
NULL	Biomed_Res_Int_2013_Dec_30_2013_735835.nxml.txt.nlp	24490170	SENT162	29	29	39	39	desloratadine	FEX	PA164776964	8549	0.662
NULL	Aging_(Albany_NY)_2011_Jan_18_3(1)_33-43.nxml.txt.nlp	21248371	SENT7	12	12	6	6	zinc	HIF-1	PA451956	29072	0.662
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Apr_13_67(Pt_5)_o1105.nxml.txt.nlp	21754423	SENT55	13	13	23	23	coumarin	C11	PA134521193	1109	0.662
NULL	Neural_Dev_2012_Jul_4_7_17.nxml.txt.nlp	22559903	SENT277	11	11	9	9	paraformaldehyde	PLP	PA450790	25824;5744	0.662
NULL	J_Cell_Biol_1998_Mar_9_140(5)_1199-1209.nxml.txt.nlp	9490732	SENT39	12	12	0	0	isoproterenol	LPA	PA450121	4018	0.662
NULL	Acta_Vet_Scand_2011_Feb_17_53(1)_11.nxml.txt.nlp	21324209	SENT55	30	30	24	24	chloramphenicol	OTC	PA448927	5009	0.662
NULL	Ann_Lab_Med_2012_Jul_20_32(4)_298-303.nxml.txt.nlp	22779073	SENT117	24	24	10	10	moxifloxacin	EMB	PA450555	133418	0.662
NULL	Drugs_R_D_2010_Sep_27_10(3)_179-202.nxml.txt.nlp	20945948	SENT292	5	5	11	11	telaprevir	IFN	PA165958354	3439	0.662
NULL	Int_J_Biol_Sci_2011_May_24_7(5)_673-684.nxml.txt.nlp	21647250	SENT47	6	6	9	9	berberine	AMPK	PA165860812	5563	0.662
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT115	12	12	22	22	celecoxib	survivin	PA448871	332	0.662
NULL	Int_J_Surg_Oncol_2012_Apr_8_2012_748196.nxml.txt.nlp	22577533	SENT64	19	19	23	23	tamoxifen	BCS	PA451581	617	0.662
NULL	EMBO_Mol_Med_2012_Feb_4(2)_93-108.nxml.txt.nlp	22246988	SENT59	21	21	24	24	tetracycline	NDRG1	PA451640	10397	0.662
NULL	Breast_Cancer_Res_2002_May_15_4(4)_133-136.nxml.txt.nlp	12100736	SENT9	9	9	39	39	tamoxifen	DES	PA451581	1674	0.662
NULL	Acta_Pharmacol_Sin_2013_Sep_5_34(9)_1192-1200.nxml.txt.nlp	23685957	SENT138	0	0	6	6	curcumin	AP-2	PA151958596	7020	0.662
NULL	Int_J_Pediatr_2010_Dec_23_2010_376287.nxml.txt.nlp	21234103	SENT92	16	16	28	28	clarithromycin	gamma	PA449028	9913	0.662
NULL	Curr_Pharm_Biotechnol_2012_May_13(6)_969-986.nxml.txt.nlp	22039792	SENT105	18	18	4	4	ivermectin	MDR1	PA450133	5243	0.662
NULL	Front_Genet_2013_Dec_12_4_277.nxml.txt.nlp	24376456	SENT402	0	0	9	9	ethanol	RANK	PA448073	8792	0.662
NULL	Front_Oncol_2013_Oct_9_3_261.nxml.txt.nlp	24130964	SENT370	29	29	31	31	gemcitabine	Gem	PA449748	51053	0.662
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R91.nxml.txt.nlp	22541814	SENT42	5	5	7	7	thrombin	HO-1	PA451674	3162	0.662
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jul_10_68(Pt_8)_o2402-o2403.nxml.txt.nlp	22904859	SENT72	8	8	23	23	benzaldehyde	mol	PA448571	90527	0.662
NULL	Curr_Neuropharmacol_2010_Sep_8(3)_287-304.nxml.txt.nlp	21358978	SENT101	5	5	14	14	agomelatine	5-HT2C	PA165958363	3358	0.662
NULL	Curr_Genomics_2014_Jun_15(3)_190-202.nxml.txt.nlp	24955027	SENT585	9	9	6	6	rosiglitazone	gamma	PA451283	9913	0.662
NULL	Cancers_(Basel)_2014_Mar_25_6(2)_625-645.nxml.txt.nlp	24670365	SENT321	19	19	7	7	collagenase	perlecan	PA449107	3339	0.662
NULL	J_Cardiovasc_Magn_Reson_2009_Jul_27_11(1)_24.nxml.txt.nlp	19635160	SENT168	11	11	0	0	metformin	ATV	PA450395	4683	0.662
NULL	Cancer_Metastasis_Rev_2013_Jun_6_32(1-2)_179-188.nxml.txt.nlp	23129208	SENT104	31	31	25	25	trastuzumab	HER2	PA451743	2064	0.662
NULL	Evid_Based_Complement_Alternat_Med_2014_Dec_25_2014_871720.nxml.txt.nlp	25610485	SENT87	8	8	14	14	berberine	G6PD	PA165860812	2539	0.662
NULL	Case_Rep_Oncol_2010_May_7_3(2)_154-159.nxml.txt.nlp	20740189	SENT27	23	23	36	36	panitumumab	KRAS	PA162373091	3845	0.662
NULL	Int_J_Endocrinol_Metab_2013_Jul_1_Summer_11(3)_184-190.nxml.txt.nlp	24348591	SENT7	5	5	10	10	liraglutide	INS-1	PA165958364	2305	0.662
NULL	Oncotarget_2012_Oct_20_3(10)_1068-1111.nxml.txt.nlp	23085539	SENT138	0	0	12	12	vemurafenib	Raf-1	PA165946873	5894	0.662
NULL	Breast_Cancer_Res_2002_Jun_21_4(5)_R9.nxml.txt.nlp	12223126	SENT145	21	21	9	9	tamoxifen	FasL	PA451581	356	0.662
NULL	Virol_J_2011_Nov_28_8_523.nxml.txt.nlp	22122911	SENT132	6	6	37	37	heparin	DARC	PA449855	2532	0.662
NULL	J_Gen_Physiol_1924_Jul_20_6(6)_723-729.nxml.txt.nlp	19872112	SENT0	12	12	1	1	trypsin	Gen	PA451806	348654	0.662
NULL	Biologics_2014_Jul_31_8_211-220.nxml.txt.nlp	25114503	SENT58	8	8	37	37	infliximab	CD95	PA452639	355	0.662
NULL	Front_Immunol_2012_Jun_4_3_129.nxml.txt.nlp	22675324	SENT71	16	16	8	8	ustekinumab	p40	PA166048654	3921;339541;10314	0.662
NULL	Cardiovasc_Diabetol_2013_Mar_18_12_46.nxml.txt.nlp	23497197	SENT35	16	16	25	25	metformin	adiponectin	PA450395	9370	0.662
NULL	Adv_Ther_2014_Feb_15_31(3)_289-317.nxml.txt.nlp	24535623	SENT210	0	0	5	5	liraglutide	PPG	PA165958364	5552	0.662
NULL	Allergy_Asthma_Immunol_Res_2014_Jul_27_6(4)_288-295.nxml.txt.nlp	24991451	SENT74	12	12	15	15	montelukast	IL-5	PA450546	3567	0.662
NULL	Oncotarget_2011_Dec_24_2(12)_896-917.nxml.txt.nlp	22203527	SENT154	8	8	24	24	metformin	p53	PA450395	7157	0.662
NULL	Emerg_Infect_Dis_2005_Jun_11(6)_873-882.nxml.txt.nlp	15963282	SENT89	10	10	16	16	gentamicin	TOB	PA449753	10140	0.662
NULL	Indian_J_Anaesth_2012_Mar-Apr_56(2)_129-134.nxml.txt.nlp	22701202	SENT3	23	23	14	14	bupivacaine	CEA	PA135057240	5670;1087	0.662
NULL	Exp_Neurobiol_2014_Dec_12_23(4)_365-371.nxml.txt.nlp	25548536	SENT85	13	13	4	4	dextran	ATP13A2	PA449261	23400	0.662
NULL	Oncol_Lett_2013_Aug_17_6(2)_295-305.nxml.txt.nlp	24137320	SENT306	12	12	29	29	tamoxifen	ATAC	PA451581	6375	0.662
NULL	Arthritis_Res_Ther_2011_Mar_30_13(2)_105.nxml.txt.nlp	21542897	SENT26	27	27	7	7	adalimumab	TLR4	PA10004	7099	0.662
NULL	EMBO_Mol_Med_2012_Feb_4(2)_93-108.nxml.txt.nlp	22246988	SENT282	1	1	11	11	chloramphenicol	ATF3	PA448927	467	0.662
NULL	Curr_Neuropharmacol_2009_Jun_7(2)_83-95.nxml.txt.nlp	19949566	SENT453	22	22	32	32	oxcarbazepine	TGB	PA450732	5473	0.662
NULL	Drug_Des_Devel_Ther_2014_Oct_6_8_1723-1731.nxml.txt.nlp	25336916	SENT134	33	33	40	40	valsartan	CLCR	PA451848	11330	0.662
NULL	Exp_Mol_Med_2012_Feb_29_44(2)_81-88.nxml.txt.nlp	22257883	SENT76	23	23	19	19	glucose	PERK	PA449773	9451	0.662
NULL	J_Int_Soc_Sports_Nutr_2014_Aug_13_11_38.nxml.txt.nlp	25132809	SENT42	19	19	9	9	creatine	MSTN	PA164778930	2660	0.662
NULL	J_Biomed_Sci_2013_Dec_20_20(1)_99.nxml.txt.nlp	24358977	SENT176	12	12	9	9	methotrexate	DHFR	PA450428	1719	0.662
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT114	3	3	5	5	curcumin	TRAIL	PA151958596	8743	0.662
NULL	Exp_Diabetes_Res_2012_Feb_23_2012_187018.nxml.txt.nlp	22474416	SENT147	31	31	19	19	glucosamine	GFAT	PA164747613	2673	0.662
NULL	Arthritis_Res_Ther_2009_Aug_6_11(4)_R118.nxml.txt.nlp	19660107	SENT211	13	13	20	20	fluorescein	STEAP4	PA164746009	79689	0.662
NULL	J_Gen_Intern_Med_2009_May_21_24(5)_656-664.nxml.txt.nlp	19306050	SENT359	2	2	7	7	warfarin	VKORC1	PA451906	79001	0.662
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_21-38.nxml.txt.nlp	19305786	SENT306	0	0	22	22	menthol	TRPM8	PA164776605	79054	0.662
NULL	Mol_Cancer_2012_Dec_12_11_91.nxml.txt.nlp	23234355	SENT171	35	35	1	1	gefitinib	EGFR	PA131301952	1956	0.662
NULL	J_Immunother_Cancer_2013_Jul_15_1_10.nxml.txt.nlp	24829747	SENT44	4	4	0	0	l-arginine	ARG1	PA448478	383;64129	0.662
NULL	Eur_J_Pharmacol_2012_May_5_682(1-3)_21-28.nxml.txt.nlp	22381066	SENT147	11	11	30	30	doxycycline	PARP-1	PA449415	25976	0.662
NULL	Cancers_(Basel)_2014_Oct_24_6(4)_2187-2223.nxml.txt.nlp	25347122	SENT355	8	8	15	15	everolimus	EGFR	PA164746311	1956	0.662
NULL	Biomed_Res_Int_2014_Feb_10_2014_305610.nxml.txt.nlp	24683545	SENT133	11	11	13	13	chlorpromazine	CPZ	PA448964	8532	0.662
NULL	Mol_Vis_2012_Mar_9_18_624-633.nxml.txt.nlp	22509094	SENT279	0	0	9	9	cyclosporine	IL-4	PA449167	3565	0.662
NULL	Arthritis_Res_Ther_2010_Oct_28_12(5)_219.nxml.txt.nlp	21062511	SENT60	11	11	23	23	etanercept	IFN	PA449515	3439	0.662
NULL	J_Cell_Mol_Med_2014_Feb_11_18(2)_231-241.nxml.txt.nlp	24330074	SENT207	13	13	11	11	losartan	AT1	PA450268	9197;185	0.662
NULL	Biomed_Res_Int_2013_Jul_10_2013_152163.nxml.txt.nlp	23936774	SENT152	16	16	18	18	hyaluronan	CD44	PA165958431	960	0.662
NULL	Onco_Targets_Ther_2014_Sep_9_7_1571-1582.nxml.txt.nlp	25228815	SENT185	9	9	6	6	sunitinib	VEGFA	PA162372840	7422	0.662
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT95	13	13	10	10	resveratrol	TRAIL		8743	0.662
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Nov_21_70(Pt_12)_562-565.nxml.txt.nlp	25552993	SENT4	28	28	1	1	benzaldehyde	mol	PA448571	90527	0.662
NULL	Adv_Hematol_2010_Dec_30_2010_627401.nxml.txt.nlp	21234094	SENT114	25	25	21	21	methotrexate	SMILE	PA450428	160418	0.662
NULL	Dev_Cell_2014_Mar_31_28(6)_659-669.nxml.txt.nlp	24656740	SENT526	14	14	31	31	colchicine	Sas-4	PA449092	55835	0.662
NULL	Adv_Hematol_2014_Nov_24_2014_652395.nxml.txt.nlp	25525435	SENT147	20	20	17	17	thalidomide	IFN	PA451644	3439	0.662
NULL	Int_J_Mol_Sci_2014_Oct_29_15(11)_19700-19728.nxml.txt.nlp	25356505	SENT191	10	10	12	12	pp2	EGFR		1956	0.662
NULL	Acta_Pharmacol_Sin_2014_Sep_25_35(9)_1199-1206.nxml.txt.nlp	25152024	SENT187	14	14	5	5	cisplatin	mig-2	PA449014	10979	0.662
NULL	Clin_Exp_Otorhinolaryngol_2013_Mar_1_6(1)_48-51.nxml.txt.nlp	23526700	SENT82	24	24	21	21	thyroglobulin	CK7	PA164754910	3855	0.662
NULL	Environ_Health_Perspect_2003_Feb_111(2)_179-183.nxml.txt.nlp	12573902	SENT6	7	7	9	9	lindane	gamma	PA164754914	9913	0.662
NULL	Alcohol_Res_Health_2007_30(1)_38-47.nxml.txt.nlp	17718399	SENT172	2	2	5	5	ethanol	CYP2E1	PA448073	1571	0.662
NULL	Oncotarget_2014_Jun_1_5(13)_4895-4908.nxml.txt.nlp	24970800	SENT293	33	33	9	9	oxaliplatin	CXCR4	PA131285527	7852	0.662
NULL	Endocr_Connect_2012_Jun_8_1(1)_1-12.nxml.txt.nlp	23781298	SENT233	4	4	7	7	fenofibrate	adiponectin	PA449594	9370	0.662
NULL	Acta_Orthop_2010_Apr_6_81(2)_234-236.nxml.txt.nlp	20367417	SENT20	6	6	8	8	teriparatide	PTH	PA451620	5741	0.662
NULL	FEBS_Open_Bio_2014_Jan_6_4_77-89.nxml.txt.nlp	24490132	SENT251	16	16	9	9	ebselen	GDH	PA161660841	51084;2746	0.662
NULL	Enzyme_Res_2009_Nov_1_2010_165878.nxml.txt.nlp	21048860	SENT205	18	18	25	25	asparaginase	NAC	PA448492	22861	0.662
NULL	Emerg_Infect_Dis_2013_Jan_19(1)_133-136.nxml.txt.nlp	23260464	SENT37	39	39	29	29	ciprofloxacin	TOB	PA449009	10140	0.662
NULL	Front_Oncol_2014_Oct_21_4_285.nxml.txt.nlp	25374842	SENT680	17	17	26	26	dasatinib	p53	PA162372878	7157	0.662
NULL	Front_Oncol_2014_Apr_2_4_70.nxml.txt.nlp	24765614	SENT71	22	22	7	7	bevacizumab	VEGF-A	PA130232992	7422	0.662
NULL	Arch_Plast_Surg_2012_Sep_12_39(5)_540-545.nxml.txt.nlp	23094252	SENT38	19	19	15	15	remifentanil	TCI	PA451232	6947	0.662
NULL	Exp_Diabetes_Res_2012_Dec_26_2012_230624.nxml.txt.nlp	23365557	SENT12	7	7	13	13	liraglutide	LIR1	PA165958364	10859	0.662
NULL	Acta_Pharmacol_Sin_2012_Jun_14_33(6)_832-838.nxml.txt.nlp	22580740	SENT13	25	25	32	32	methotrexate	DDP	PA450428	1678	0.662
NULL	Clin_Pharmacol_2011_Jun_22_3_13-25.nxml.txt.nlp	22287853	SENT181	30	30	28	28	diltiazem	CYP3A4	PA449334	1576	0.662
NULL	Anesth_Essays_Res_2013_Sep-Dec_7(3)_319-325.nxml.txt.nlp	NULL	SENT30	19	19	24	24	propofol	AVP	PA451141	114548;551	0.662
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT114	9	9	7	7	trastuzumab	MUC4	PA451743	4585	0.662
NULL	Acta_Pharmacol_Sin_2010_Mar_22_31(3)_329-340.nxml.txt.nlp	20173759	SENT27	23	23	25	25	ethanol	AMPK	PA448073	5563	0.662
NULL	Oncol_Lett_2014_Sep_11_8(3)_1222-1228.nxml.txt.nlp	25120693	SENT144	27	27	21	21	olaparib	DDP		1678	0.662
NULL	Case_Rep_Med_2009_Dec_23_2009_469343.nxml.txt.nlp	20069057	SENT89	33	33	16	16	methotrexate	FDG	PA450428	23583	0.661
NULL	Drug_Saf_2014_Feb_19_37(4)_201-211.nxml.txt.nlp	24550106	SENT27	4	4	23	23	omeprazole	CYP3A4	PA450704	1576	0.661
NULL	BMB_Rep_2013_Aug_46(8)_410-415.nxml.txt.nlp	23977989	SENT109	14	14	10	10	curcumin	HO-1	PA151958596	3162	0.661
NULL	Br_J_Cancer_2010_Feb_16_102(4)_629-638.nxml.txt.nlp	20104223	SENT174	0	0	9	9	bortezomib	p27	PA10252	5715;10534	0.661
NULL	Pharmaceutics_2011_Nov_18_3(4)_865-913.nxml.txt.nlp	24309312	SENT376	26	26	28	28	ivermectin	P-gp	PA450133	5243	0.661
NULL	Ann_Hematol_2010_Oct_22_89(10)_971-978.nxml.txt.nlp	20567823	SENT94	15	15	3	3	filgrastim	CD34	PA449626	947	0.661
NULL	Int_J_Mol_Sci_2014_Nov_7_15(11)_20500-20517.nxml.txt.nlp	25387078	SENT132	7	7	23	23	vorinostat	Mcl-1	PA164748224	4170	0.661
NULL	Endocr_Relat_Cancer_2014_Jun_21(3)_R209-R225.nxml.txt.nlp	24500760	SENT292	22	22	12	12	resveratrol	CD95		355	0.661
NULL	Oncotarget_2014_Jun_7_5(14)_5257-5271.nxml.txt.nlp	24913448	SENT113	8	8	19	19	nilotinib	LASP1	PA165958345	3927	0.661
NULL	J_Ind_Microbiol_Biotechnol_2013_Jul_30_40(10)_1153-1160.nxml.txt.nlp	23896974	SENT176	13	13	0	0	kanamycin	PGK1	PA450137	5230	0.661
NULL	Curr_Control_Trials_Cardiovasc_Med_2001_Jul_26_2(4)_171-179.nxml.txt.nlp	11806792	SENT212	8	8	16	16	eptifibatide	IMPACT	PA449483	55364	0.661
NULL	Breast_Cancer_Res_2010_Mar_5_12(2)_R16.nxml.txt.nlp	20205716	SENT337	11	11	21	21	lovastatin	PTEN	PA450272	5728	0.661
NULL	Oncol_Lett_2013_Mar_17_5(3)_777-782.nxml.txt.nlp	23426190	SENT32	14	14	33	33	l-glutamine	CO2	PA10090	4513	0.661
NULL	Case_Rep_Ophthalmol_2010_Dec_8_1(2)_110-113.nxml.txt.nlp	21373383	SENT30	0	0	11	11	fluorescein	PED	PA164746009	8682	0.661
NULL	Allergy_Asthma_Clin_Immunol_2009_Dec_17_5(1)_14.nxml.txt.nlp	20066054	SENT50	7	7	20	20	desloratadine	IL-8	PA164776964	3576	0.661
NULL	J_Immunother_Cancer_2013_Jul_15_1_10.nxml.txt.nlp	24829747	SENT192	0	0	15	15	gemcitabine	CD11b	PA449748	3684	0.661
NULL	Mol_Neurodegener_2011_Aug_8_6_57.nxml.txt.nlp	21819629	SENT250	6	6	9	9	arsenite	TDP-43	PA452638	23435	0.661
NULL	Acta_Pharmacol_Sin_2009_Sep_17_30(9)_1316-1322.nxml.txt.nlp	19684609	SENT165	16	16	4	4	rosiglitazone	PTEN	PA451283	5728	0.661
NULL	Int_J_Endocrinol_Metab_2013_Dec_21_Winter_11(1)_57-61.nxml.txt.nlp	23853622	SENT122	18	18	22	22	bromocriptine	PRL	PA448671	5617	0.661
NULL	Aging_(Albany_NY)_2009_Mar_31_1(4)_412-424.nxml.txt.nlp	20195491	SENT5	23	23	36	36	resveratrol	TXNIP		10628	0.661
NULL	Int_J_Mol_Sci_2010_Nov_19_11(11)_4741-4749.nxml.txt.nlp	21151468	SENT168	16	16	22	22	cisplatin	mol	PA449014	90527	0.661
NULL	Cancer_Cell_Int_2011_Aug_19_11_29.nxml.txt.nlp	21854619	SENT218	26	26	34	34	cisplatin	BRCA1	PA449014	672	0.661
NULL	Acta_Neuropathol_Commun_2014_Jun_16_2_65.nxml.txt.nlp	24934666	SENT74	24	24	14	14	thrombin	CD62P	PA451674	6403	0.661
NULL	Amino_Acids_2014_Jun_13_46(9)_2189-2203.nxml.txt.nlp	24923264	SENT193	0	0	2	2	rosuvastatin	AKT	PA134308647	207	0.661
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jul_9_67(Pt_8)_o1944.nxml.txt.nlp	22090987	SENT68	24	24	13	13	ethanol	mol	PA448073	90527	0.661
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2008_Jun_1_64(Pt_6)_611-619.nxml.txt.nlp	18560148	SENT161	9	9	14	14	heparin	PF4	PA449855	5196	0.661
NULL	Pharmacogn_Mag_2014_Jul-Sep_10(39)_374-383.nxml.txt.nlp	25210328	SENT155	28	28	39	39	evodiamine	PC2	PA165860788	5126;5311;8535	0.661
NULL	Calcif_Tissue_Int_2010_Dec_16_87(6)_485-492.nxml.txt.nlp	20953593	SENT2	0	0	23	23	teriparatide	PTH	PA451620	5741	0.661
NULL	Breast_Cancer_Res_Treat_2014_Apr_9_145(1)_73-82.nxml.txt.nlp	24715380	SENT117	5	5	12	12	tamoxifen	CXCL10	PA451581	3627	0.661
NULL	Diabetes_Care_2010_Jul_31_33(7)_1509-1515.nxml.txt.nlp	20357372	SENT130	35	35	16	16	metformin	GLP-1	PA450395	100125288	0.661
NULL	FEBS_Open_Bio_2013_May_10_3_225-230.nxml.txt.nlp	23772398	SENT162	7	7	10	10	cisplatin	CD9	PA449014	928	0.661
NULL	Ann_Rheum_Dis_2014_Jan_8_73(1)_6-16.nxml.txt.nlp	23749611	SENT418	11	11	32	32	infliximab	IMPACT	PA452639	55364	0.661
NULL	Autism_Res_Treat_2012_May_31_2012_104317.nxml.txt.nlp	22934167	SENT43	7	7	28	28	fluoxetine	5-HT1A	PA449673	3350	0.661
NULL	J_Immunol_Res_2014_May_12_2014_897249.nxml.txt.nlp	24901013	SENT182	28	28	39	39	natalizumab	PTEN	PA164747191	5728	0.661
NULL	J_Cancer_2013_Jan_11_4(2)_117-132.nxml.txt.nlp	23386910	SENT157	22	22	7	7	olaparib	BRCA1		672	0.661
NULL	Mol_Pain_2012_Sep_24_8_73.nxml.txt.nlp	23006841	SENT143	4	4	10	10	ketoconazole	TRPV1	PA450146	7442	0.661
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT104	14	14	20	20	metformin	MEK1	PA450395	5604	0.661
NULL	Ther_Clin_Risk_Manag_2007_Jun_3(3)_411-420.nxml.txt.nlp	18488075	SENT38	2	2	10	10	alefacept	CD19	PA164748040	930	0.661
NULL	Breast_Cancer_Res_2007_Dec_18_9(6)_216.nxml.txt.nlp	18190723	SENT196	0	0	13	13	sorafenib	VEGFR3	PA7000	2324	0.661
NULL	FASEB_J_2009_Feb_23(2)_575-585.nxml.txt.nlp	18957574	SENT127	34	34	22	22	streptomycin	FBS	PA451512	64319;26269	0.661
NULL	Cancer_Manag_Res_2012_Jul_26_4_195-205.nxml.txt.nlp	22904641	SENT12	1	1	15	15	amiloride	NHE	PA448368	285335	0.661
NULL	Indian_J_Orthop_2010_Jul-Sep_44(3)_246-251.nxml.txt.nlp	20697475	SENT8	8	8	12	12	vancomycin	DBM	PA451850	1621	0.661
NULL	J_Cell_Biol_2001_Aug_6_154(3)_599-610.nxml.txt.nlp	11481345	SENT80	24	24	14	14	doxycycline	ARNO	PA449415	9266	0.661
NULL	ScientificWorldJournal_2012_Dec_27_2012_740308.nxml.txt.nlp	23346021	SENT182	25	25	27	27	ethanol	NAC	PA448073	22861	0.661
NULL	Diabetes_Care_2013_Dec_13_36(12)_e213.nxml.txt.nlp	24265382	SENT40	12	12	10	10	liraglutide	GLP-1	PA165958364	100125288	0.661
NULL	Acta_Pharmacol_Sin_2009_Feb_5_30(2)_228-234.nxml.txt.nlp	19122672	SENT125	9	9	2	2	isoflurane	HO-1	PA450106	3162	0.661
NULL	Breast_Cancer_Res_2011_Sep_13_13(5)_R87.nxml.txt.nlp	21914172	SENT168	22	22	8	8	afatinib	EGFR	PA165981154	1956	0.661
NULL	Carcinogenesis_2014_May_13_35(5)_1055-1066.nxml.txt.nlp	24419232	SENT181	6	6	3	3	metformin	CYP1B1	PA450395	1545	0.661
NULL	Diabetes_2013_Jun_17_62(6)_2141-2150.nxml.txt.nlp	23378610	SENT102	31	31	3	3	betaine	RISC	PA448603	59342	0.661
NULL	Front_Hum_Neurosci_2013_Apr_8_7_117.nxml.txt.nlp	23580360	SENT803	17	17	8	8	sulpiride	spatial	PA164745485	219793	0.661
NULL	Arthritis_Res_Ther_2013_Jul_9_15(4)_R73.nxml.txt.nlp	23837669	SENT276	14	14	22	22	colchicine	MICL	PA449092	160364	0.661
NULL	Indian_J_Pharmacol_2014_Mar-Apr_46(2)_161-165.nxml.txt.nlp	24741186	SENT94	2	2	24	24	carvedilol	STZ	PA448817	6484	0.661
NULL	J_Oncol_2012_Oct_5_2012_794172.nxml.txt.nlp	22007215	SENT166	14	14	17	17	cyclophosphamide	CTX	PA449165	1593	0.661
NULL	J_Hematol_Oncol_2011_Aug_1_4_31.nxml.txt.nlp	21806788	SENT84	10	10	6	6	rituximab	STAT3	PA451261	6774	0.661
NULL	Allergy_Asthma_Immunol_Res_2014_Nov_28_6(6)_567-572.nxml.txt.nlp	25374757	SENT141	5	5	20	20	fexofenadine	JNK	PA449621	5599	0.661
NULL	Braz_J_Med_Biol_Res_2012_Mar_30_45(4)_292-298.nxml.txt.nlp	22450375	SENT28	24	24	26	26	vasopressin	AVP	PA451858	114548;551	0.661
NULL	Oncol_Lett_2014_Jan_6_7(1)_87-94.nxml.txt.nlp	24348827	SENT233	8	8	11	11	thrombin	ADP	PA451674	23038	0.661
NULL	Front_Oncol_2014_Nov_25_4_329.nxml.txt.nlp	25505733	SENT34	17	17	8	8	afatinib	EGFR	PA165981154	1956	0.661
NULL	J_Exp_Med_1998_Mar_16_187(6)_823-833.nxml.txt.nlp	9500785	SENT136	14	14	5	5	dextran	SEC3	PA449261	55763	0.661
NULL	Crit_Care_2010_Sep_1_14(Suppl_2)_P17.nxml.txt.nlp	NULL	SENT16	5	5	37	37	ethanol	RANTES	PA448073	6352	0.661
NULL	Clin_Interv_Aging_2010_Nov_19_5_345-354.nxml.txt.nlp	21228900	SENT124	12	12	6	6	denosumab	OPG	PA166048634	690	0.661
NULL	N_Am_J_Med_Sci_2013_Dec_5(12)_721-723.nxml.txt.nlp	24404557	SENT62	10	10	7	7	cyclophosphamide	CHOP	PA449165	1649	0.661
NULL	Cerebrospinal_Fluid_Res_2010_Aug_12_7_11.nxml.txt.nlp	20704740	SENT66	31	31	19	19	kanamycin	F12	PA450137	2161	0.661
NULL	Cell_Commun_Signal_2013_Apr_17_11_27.nxml.txt.nlp	23594441	SENT88	15	15	7	7	doxorubicin	p53	PA449412	7157	0.661
NULL	Nat_Med_2011_Oct_2_17(10)_1304-1309.nxml.txt.nlp	21963515	SENT7	6	6	23	23	tacrolimus	WNK3	PA451578	65267	0.661
NULL	Clin_Exp_Metastasis_2014_Jan_4_31(3)_339-349.nxml.txt.nlp	24390633	SENT74	26	26	17	17	l-glutamine	F12	PA10090	2161	0.661
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT289	23	23	26	26	paclitaxel	ABCB1	PA450761	5243	0.661
NULL	AIDS_Res_Treat_2012_Mar_26_2012_948059.nxml.txt.nlp	22536498	SENT228	20	20	7	7	ribavirin	RVR	PA451241	9975	0.661
NULL	Br_J_Cancer_2014_Apr_15_110(8)_2144-2158.nxml.txt.nlp	24667650	SENT417	21	21	11	11	tamoxifen	BCAS2	PA451581	10286	0.661
NULL	Arthritis_Res_Ther_2012_Jun_25_14(3)_215.nxml.txt.nlp	22731694	SENT43	11	11	13	13	ribavirin	RIBA	PA451241	6014	0.661
NULL	Oncotarget_2011_Mar_27_2(3)_209-221.nxml.txt.nlp	21444945	SENT138	3	3	10	10	bortezomib	p53	PA10252	7157	0.661
NULL	Front_Cell_Neurosci_2014_Feb_6_8_27.nxml.txt.nlp	24567703	SENT1743	3	3	6	6	bumetanide	p75NTR	PA448682	4804	0.661
NULL	Evid_Based_Complement_Alternat_Med_2012_Dec_20_2012_908601.nxml.txt.nlp	23326293	SENT24	14	14	35	35	daunorubicin	LRP	PA449212	5786;3921;4035;9961	0.661
NULL	Curr_Oncol_2008_Oct_15(5)_237-243.nxml.txt.nlp	19008999	SENT137	10	10	8	8	curcumin	p300	PA151958596	2033	0.661
NULL	Br_J_Cancer_2012_Jan_3_106(1)_18-24.nxml.txt.nlp	22108516	SENT48	29	29	21	21	camptothecin	TDP1	PA153590860	55775	0.661
NULL	Pharmaceutics_2011_Oct_12_3(4)_680-705.nxml.txt.nlp	24309303	SENT1028	12	12	2	2	pravastatin	OATP1B1	PA451089	10599	0.661
NULL	Toxins_(Basel)_2011_Jun_14_3(6)_566-590.nxml.txt.nlp	22069726	SENT1089	10	10	7	7	l-carnitine	Q10	PA450154	27161	0.661
NULL	ScientificWorldJournal_2012_Apr_1_2012_179782.nxml.txt.nlp	22545008	SENT155	17	17	14	14	pp2	PP1		5540;5464	0.661
NULL	Oncol_Rep_2014_Dec_17_32(6)_2319-2326.nxml.txt.nlp	25230742	SENT38	0	0	7	7	tegafur	CDHP	PA452620	1001	0.661
NULL	Oncoimmunology_2013_Nov_1_2(11)_e27010.nxml.txt.nlp	24498547	SENT27	32	32	11	11	tegafur	GEM	PA452620	2669	0.661
NULL	Arthritis_Res_Ther_2009_Jan_30_11(1)_205.nxml.txt.nlp	19232061	SENT45	15	15	0	0	infliximab	ACR	PA452639	49	0.661
NULL	Breast_Cancer_Res_2010_Jul_22_12(4)_R53.nxml.txt.nlp	20649975	SENT173	11	11	21	21	tamoxifen	BCS	PA451581	617	0.661
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT93	27	27	18	18	metformin	HIP	PA450395	6767;6159;64399;5068	0.661
NULL	Trials_2013_Aug_19_14_261.nxml.txt.nlp	23958221	SENT379	14	14	25	25	pertuzumab	HER2		2064	0.661
NULL	Oncotarget_2014_Aug_4_5(17)_7776-7787.nxml.txt.nlp	25277200	SENT85	28	28	10	10	cisplatin	ANXA4	PA449014	307	0.661
NULL	Anc_Sci_Life_2012_Oct-Dec_32(2)_93-98.nxml.txt.nlp	24167334	SENT120	21	21	14	14	cyclophosphamide	AR7	PA449165	7067	0.661
NULL	Br_J_Cancer_2012_Feb_14_106(4)_685-692.nxml.txt.nlp	22294184	SENT118	14	14	18	18	docetaxel	p27	PA449383	5715;10534	0.661
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT2379	16	16	14	14	midazolam	CYP3A4	PA450496	1576	0.661
NULL	J_Cell_Biol_1997_Jun_16_137(6)_1229-1241.nxml.txt.nlp	9182658	SENT89	12	12	32	32	glucosamine	MUC1	PA164747613	4582	0.661
NULL	J_Korean_Med_Sci_2007_Aug_31_22(4)_677-681.nxml.txt.nlp	17728509	SENT45	20	20	39	39	rifampin	EMB	PA451250	133418	0.661
NULL	Ann_Oncol_2011_Jun_25_22(6)_1392-1403.nxml.txt.nlp	21266519	SENT236	10	10	12	12	bleomycin	CHOP	PA448645	1649	0.661
NULL	Ann_Lab_Med_2014_May_8_34(3)_230-234.nxml.txt.nlp	24790911	SENT125	23	23	17	17	entecavir	LAM	PA164784025	7249;7248	0.661
NULL	Arthritis_Res_Ther_2007_May_14_9(3)_210.nxml.txt.nlp	17509159	SENT154	9	9	7	7	hydralazine	DNMT1	PA449894	1786	0.661
NULL	Mol_Brain_2013_Jan_22_6_5.nxml.txt.nlp	23339575	SENT156	24	24	7	7	spermine	GluA2	PA164781199	2891	0.661
NULL	Exp_Ther_Med_2013_Dec_9_6(6)_1507-1511.nxml.txt.nlp	24255682	SENT25	15	15	11	11	celecoxib	COX	PA448871	1351	0.661
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT35	27	27	11	11	heparin	FGF1	PA449855	2246	0.661
NULL	J_Cell_Mol_Med_2014_Aug_1_18(8)_1599-1611.nxml.txt.nlp	24889822	SENT283	0	0	2	2	resveratrol	p62		8878;10657;23636	0.661
NULL	J_Neurovirol_2013_Jun_4_19(4)_351-358.nxml.txt.nlp	23733308	SENT110	16	16	13	13	mefloquine	SOC	PA450348	91544	0.661
NULL	Brain_Sci_2013_Jun_14_3(2)_941-963.nxml.txt.nlp	24961432	SENT168	14	14	22	22	ethanol	NR2D	PA448073	2906	0.661
NULL	Breast_Cancer_Res_2010_Nov_16_12(6)_R96.nxml.txt.nlp	21080941	SENT159	23	23	19	19	lapatinib	HRG	PA152241907	3084;3273	0.661
NULL	Med_Sci_Monit_2013_May_1_19_317-326.nxml.txt.nlp	23632427	SENT277	32	32	14	14	imipenem	CTX	PA449968	1593	0.661
NULL	Gut_Liver_2013_Sep_14_7(5)_585-593.nxml.txt.nlp	24073317	SENT121	36	36	22	22	ribavirin	IFN	PA451241	3439	0.661
NULL	F1000_Med_Rep_2010_Apr_12_2_28.nxml.txt.nlp	20436921	SENT71	23	23	18	18	azathioprine	NAC	PA448515	22861	0.661
NULL	Chem_Cent_J_2014_Aug_23_8(1)_49.nxml.txt.nlp	NULL	SENT202	19	19	12	12	ethanol	flower	PA448073	11094	0.661
NULL	Indian_J_Pharm_Sci_2014_Nov-Dec_76(6)_510-518.nxml.txt.nlp	25593384	SENT44	18	18	7	7	ethanol	mol	PA448073	90527	0.661
NULL	Exp_Lung_Res_2013_Oct_1_39(8)_336-348.nxml.txt.nlp	23919450	SENT85	23	23	18	18	argatroban	PAR-1	PA164745516	2011;2149	0.661
NULL	Exp_Neurobiol_2014_Mar_27_23(1)_65-76.nxml.txt.nlp	24737941	SENT173	22	22	24	24	etoposide	ETO	PA449552	862	0.661
NULL	Cardiovasc_Ther_2012_Aug_17_30(4)_e174-e182.nxml.txt.nlp	21883999	SENT159	11	11	18	18	ticagrelor	PAR-1	PA165374673	2011;2149	0.661
NULL	J_Gen_Physiol_1943_Jan_20_26(3)_333-340.nxml.txt.nlp	19873347	SENT0	13	13	1	1	phospholipids	Gen	PA450952	348654	0.661
NULL	Ann_Surg_Treat_Res_2015_Jan_26_88(1)_15-20.nxml.txt.nlp	25553320	SENT10	8	8	3	3	leucovorin	CRT	PA450198	811	0.661
NULL	Neural_Develop_2007_Dec_3_2_26.nxml.txt.nlp	18053187	SENT82	3	3	19	19	tamoxifen	STOP	PA451581	4135	0.661
NULL	Int_J_Chron_Obstruct_Pulmon_Dis_2007_Dec_2(4)_493-515.nxml.txt.nlp	18268924	SENT143	29	29	40	40	diphenhydramine	CO2	PA449349	4513	0.661
NULL	Mol_Syst_Biol_2010_Jul_27_6_391.nxml.txt.nlp	20664637	SENT246	5	5	8	8	sugar	NADK	PA451529	65220	0.661
NULL	Cancer_Cell_Int_2009_Sep_10_9_25.nxml.txt.nlp	19744341	SENT40	0	0	2	2	glucosamine	STAT3	PA164747613	6774	0.661
NULL	Curr_Immunol_Rev_2013_Feb_9(1)_13-22.nxml.txt.nlp	23853604	SENT172	9	9	7	7	cyclophosphamide	CHOP	PA449165	1649	0.661
NULL	Oncogene_2010_Nov_18_29(46)_6160-6171.nxml.txt.nlp	20729916	SENT127	47	47	23	23	cisplatin	YAP	PA449014	55249	0.661
NULL	Int_J_Biomed_Sci_2014_Sep_10(3)_146-157.nxml.txt.nlp	25324695	SENT9	7	7	9	9	pravastatin	LFA-1	PA451089	3683;3689	0.661
NULL	Emerg_Infect_Dis_2012_Jan_18(1)_176-178.nxml.txt.nlp	22261434	SENT15	18	18	20	20	ethambutol	EMB	PA164784021	133418	0.661
NULL	Diabetes_Care_2010_Aug_33(8)_1905-1907.nxml.txt.nlp	20668158	SENT57	7	7	4	4	irbesartan	AT-1	PA450084	9197	0.661
NULL	Br_J_Cancer_1996_Oct_74(7)_1132-1136.nxml.txt.nlp	8855987	SENT13	10	10	14	14	doxorubicin	GM-CSF	PA449412	1437	0.661
NULL	Clin_Ophthalmol_2010_Oct_5_4_1137-1143.nxml.txt.nlp	20957061	SENT85	10	10	7	7	travoprost	BAK	PA164781371	578	0.661
NULL	Int_J_Mol_Sci_2007_May_11_8(5)_392-398.nxml.txt.nlp	NULL	SENT66	3	3	11	11	phenol	mol	PA450913	90527	0.661
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Jul_19_70(Pt_8)_77-79.nxml.txt.nlp	25249859	SENT12	21	21	1	1	nitrile	mol	PA450636	90527	0.661
NULL	Mol_Biol_Cell_2012_Sep_1_23(17)_3473-3484.nxml.txt.nlp	22787275	SENT228	9	9	20	20	doxorubicin	ABCG2	PA449412	9429	0.661
NULL	Br_J_Dermatol_2014_Feb_18_170(1)_342-351.nxml.txt.nlp	24547721	SENT76	38	38	11	11	lansoprazole	DIF	PA450180	7124	0.661
NULL	Breast_Cancer_Res_2010_Jun_24_12(3)_R41.nxml.txt.nlp	20576088	SENT247	31	31	39	39	paclitaxel	MT3	PA450761	4504	0.661
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Feb_9_69(Pt_3)_o365-o366.nxml.txt.nlp	23476555	SENT7	21	21	16	16	ethanol	mol	PA448073	90527	0.661
NULL	Int_Semin_Surg_Oncol_2008_Apr_28_5_9.nxml.txt.nlp	18442393	SENT72	15	15	18	18	tamoxifen	HER2	PA451581	2064	0.661
NULL	Ann_Gen_Psychiatry_2013_Jan_24_12_1.nxml.txt.nlp	23347694	SENT170	0	0	7	7	ziprasidone	5-HT2A	PA451974	3356	0.661
NULL	Protein_Cell_2014_Jun_19_5(6)_469-479.nxml.txt.nlp	24748116	SENT77	20	20	17	17	paclitaxel	EB1	PA450761	9167;22919;10982	0.661
NULL	New_Microbes_New_Infect_2014_May_4_2(3)_58-63.nxml.txt.nlp	25356345	SENT100	38	38	20	20	imipenem	GEM	PA449968	2669	0.661
NULL	J_Cardiothorac_Surg_2013_Apr_29_8_115.nxml.txt.nlp	23628179	SENT18	12	12	20	20	bivalirudin	ACT	PA10032	12;11332;9457;641455	0.661
NULL	J_Gen_Physiol_1986_Mar_1_87(3)_425-442.nxml.txt.nlp	2420917	SENT0	13	13	1	1	amiloride	Gen	PA448368	348654	0.661
NULL	Breast_Cancer_Res_2012_Jul_19_14(4)_R109.nxml.txt.nlp	22812567	SENT234	9	9	11	11	gemcitabine	CHK1	PA449748	1111	0.661
NULL	Pharmaceutics_2011_Nov_18_3(4)_865-913.nxml.txt.nlp	24309312	SENT175	24	24	38	38	zopiclone	CYP3A4	PA10236	1576	0.661
NULL	Arthritis_Res_Ther_2006_Feb_3_8(2)_R43.nxml.txt.nlp	16507142	SENT52	14	14	30	30	fluorescein	CXCL12	PA164746009	6387	0.661
NULL	ScientificWorldJournal_2012_Sep_17_2012_637953.nxml.txt.nlp	23028251	SENT656	15	15	10	10	ceftriaxone	C10	PA448866	113246	0.661
NULL	J_Neural_Transm_2014_Mar_27_121(10)_1221-1232.nxml.txt.nlp	24671607	SENT30	12	12	19	19	ethanol	CORT	PA448073	1325	0.661
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT191	10	10	6	6	cisplatin	IBP	PA449014	706;50619	0.661
NULL	Cancer_Microenviron_2009_Aug_15_2(Suppl_1)_205-214.nxml.txt.nlp	19685283	SENT192	0	0	4	4	imiquimod	IFN	PA449972	3439	0.661
NULL	Cancer_Metab_2014_Nov_3_2(1)_20.nxml.txt.nlp	NULL	SENT206	11	11	16	16	erlotinib	PDK4	PA134687924	5166	0.661
NULL	Oncotarget_2012_Oct_20_3(10)_1068-1111.nxml.txt.nlp	23085539	SENT620	0	0	14	14	perifosine	JNK	PA165291471	5599	0.661
NULL	Int_J_Mol_Sci_2012_Feb_24_13(3)_2590-2617.nxml.txt.nlp	22489113	SENT243	14	14	32	32	benzaldehyde	mol	PA448571	90527	0.661
NULL	Daru_2012_Sep_3_20(1)_24.nxml.txt.nlp	23351176	SENT197	3	3	7	7	itopride	EPO	PA152432599	7076;8288;2056	0.661
NULL	Ann_Saudi_Med_2011_May-Jun_31(3)_279-283.nxml.txt.nlp	21623058	SENT54	10	10	3	3	cyclosporine	IL-2	PA449167	3558	0.661
NULL	Front_Pharmacol_2014_Oct_31_5_231.nxml.txt.nlp	25400580	SENT2979	20	20	3	3	paclitaxel	SLC28A3	PA450761	64078	0.661
NULL	Indian_J_Nephrol_2009_Jan_19(1)_15-19.nxml.txt.nlp	20352006	SENT52	8	8	15	15	diatrizoate	CO2	PA449281	4513	0.661
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Apr_21_68(Pt_5)_o1447.nxml.txt.nlp	22590326	SENT70	21	21	15	15	ethanol	mol	PA448073	90527	0.661
NULL	Basic_Clin_Pharmacol_Toxicol_2013_Feb_5_112(2)_132-137.nxml.txt.nlp	22900583	SENT156	4	4	1	1	ritonavir	CYP2B6	PA451260	1555	0.661
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_29_2013_590393.nxml.txt.nlp	23737838	SENT310	4	4	1	1	resveratrol	p53		7157	0.661
NULL	Mol_Pain_2013_Jan_2_9_1.nxml.txt.nlp	23279936	SENT53	14	14	6	6	capsaicin	TRPV1	PA448776	7442	0.661
NULL	Int_J_Mol_Sci_2014_Mar_6_15(3)_4049-4059.nxml.txt.nlp	24663080	SENT8	23	23	9	9	dexmedetomidine	IL-6	PA449256	3569	0.661
NULL	ScientificWorldJournal_2014_Jul_23_2014_854093.nxml.txt.nlp	25147870	SENT219	7	7	2	2	phenol	gamma	PA450913	9913	0.661
NULL	Front_Oncol_2013_Nov_18_3_282.nxml.txt.nlp	24303367	SENT422	18	18	0	0	glucose	JAMA	PA449773	50848	0.661
NULL	Nat_Genet_2014_Feb_15_46(2)_152-160.nxml.txt.nlp	24336168	SENT244	6	6	35	35	galactose	TIS11	PA449725	7538	0.661
NULL	Nat_Neurosci_2012_Sep_5_15(9)_1245-1254.nxml.txt.nlp	22864611	SENT91	12	12	8	8	clozapine	HDAC2	PA449061	3066	0.661
NULL	Ther_Clin_Risk_Manag_2006_Sep_2(3)_235-249.nxml.txt.nlp	18360599	SENT321	24	24	14	14	alendronate	PTH	PA448082	5741	0.661
NULL	Diabetes_2013_Mar_14_62(3)_953-964.nxml.txt.nlp	23223176	SENT169	8	8	36	36	paroxetine	ROS	PA450801	6098	0.661
NULL	Clin_Exp_Gastroenterol_2014_Apr_11_7_83-92.nxml.txt.nlp	24748811	SENT55	32	32	18	18	adalimumab	CDAI	PA10004	146059	0.661
NULL	Br_J_Cancer_2003_Mar_24_88(6)_863-870.nxml.txt.nlp	12644823	SENT105	44	44	7	7	tamoxifen	maspin	PA451581	5268	0.661
NULL	Exp_Ther_Med_2015_Feb_10_9(2)_598-602.nxml.txt.nlp	25574241	SENT164	23	23	5	5	thrombin	PTR	PA451674	374308	0.661
NULL	Ann_Ib_Postgrad_Med_2011_Dec_9(2)_83-88.nxml.txt.nlp	25161489	SENT77	21	21	28	28	estradiol	PRL	PA449503	5617	0.661
NULL	J_Ophthalmic_Inflamm_Infect_2013_Apr_22_3_46.nxml.txt.nlp	23607574	SENT63	2	2	16	16	amikacin	Gen	PA164744372	348654	0.661
NULL	Oncol_Lett_2013_Mar_19_5(3)_923-928.nxml.txt.nlp	23426648	SENT180	2	2	8	8	sc-560	MVD		4597	0.661
NULL	Clin_Ophthalmol_2011_Jan_20_5_115-121.nxml.txt.nlp	21339804	SENT23	18	18	33	33	fluorescein	ERG	PA164746009	2078	0.661
NULL	J_Exp_Bot_2012_May_22_63(8)_3173-3184.nxml.txt.nlp	22357599	SENT224	9	9	11	11	asparaginase	ASPG	PA448492		0.661
NULL	Iran_Red_Crescent_Med_J_2013_Dec_5_15(12)_e16698.nxml.txt.nlp	24693404	SENT168	30	30	34	34	tamoxifen	STAR	PA451581	6770;2984	0.661
NULL	Springerplus_2013_Feb_11_2_44.nxml.txt.nlp	23503672	SENT150	22	22	4	4	mannitol	fru	PA450320	9278	0.661
NULL	Breast_Cancer_Res_Treat_2014_Jul_8_146(3)_557-566.nxml.txt.nlp	25001612	SENT353	9	9	6	6	bsi-201	PARP1		142	0.661
NULL	Mol_Neurobiol_2010_Jun_2_41(2-3)_392-409.nxml.txt.nlp	20437209	SENT211	11	11	5	5	nadh	G6PD	PA164755085	2539	0.661
NULL	Emerg_Infect_Dis_2013_Jan_19(1)_133-136.nxml.txt.nlp	23260464	SENT54	10	10	24	24	gentamicin	TOB	PA449753	10140	0.661
NULL	Calcif_Tissue_Int_2011_Aug_3_89(2)_140-150.nxml.txt.nlp	21633782	SENT244	5	5	20	20	heparin	p38	PA449855	10598;1432;7965	0.661
NULL	EMBO_Rep_2013_Jan_30_14(1)_49-56.nxml.txt.nlp	23196367	SENT194	27	27	35	35	granisetron	5-HT3R	PA449809	3359	0.661
NULL	Biol_Open_2012_Mar_27_1(5)_458-466.nxml.txt.nlp	23213437	SENT77	16	16	18	18	tamoxifen	TMX	PA451581	81542	0.661
NULL	Breast_Cancer_Res_2010_Mar_5_12(2)_R16.nxml.txt.nlp	20205716	SENT348	10	10	3	3	lovastatin	NDRG1	PA450272	10397	0.661
NULL	Acta_Pharmacol_Sin_2011_Nov_10_32(11)_1402-1410.nxml.txt.nlp	21986579	SENT164	8	8	21	21	curcumin	p27	PA151958596	5715;10534	0.661
NULL	J_Nutr_Biochem_2012_Apr_23(4-2)_332-340.nxml.txt.nlp	21543215	SENT155	20	20	22	22	lipase	HSL	PA450239	3991	0.661
NULL	Exp_Neurobiol_2014_Mar_27_23(1)_36-44.nxml.txt.nlp	24737938	SENT106	0	0	25	25	geldanamycin	HSF1	PA152031327	3297	0.661
NULL	Antimicrob_Agents_Chemother_2014_Nov_10_59(1)_490-497.nxml.txt.nlp	25385107	SENT80	6	6	0	0	primaquine	ATV	PA451103	4683	0.661
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_29_2013_590393.nxml.txt.nlp	23737838	SENT299	0	0	4	4	resveratrol	p53		7157	0.661
NULL	Cancer_Cell_Int_2011_Nov_17_11_40.nxml.txt.nlp	22088142	SENT42	26	26	35	35	gemcitabine	EGF	PA449748	1950	0.661
NULL	Mol_Breed_2012_Oct_8_30(3)_1237-1252.nxml.txt.nlp	23024595	SENT143	38	38	40	40	acetone	ANOVA	PA448025	4858	0.661
NULL	Front_Endocrinol_(Lausanne)_2014_Aug_27_5_140.nxml.txt.nlp	25221543	SENT36	0	0	6	6	liraglutide	GLP-1	PA165958364	100125288	0.661
NULL	Arthritis_Res_Ther_2011_Jul_28_13(4)_235.nxml.txt.nlp	21861862	SENT136	9	9	7	7	infliximab	OPG	PA452639	690	0.661
NULL	Cancers_(Basel)_2012_Sep_6_4(3)_873-903.nxml.txt.nlp	24213471	SENT1786	8	8	3	3	hyaluronan	CD44	PA165958431	960	0.661
NULL	Acta_Naturae_2013_Jul-Sep_5(3)_92-98.nxml.txt.nlp	24303205	SENT78	22	22	7	7	l-methionine	MGL	PA450423	11343	0.661
NULL	Clin_Ophthalmol_2012_Feb_20_6_277-282.nxml.txt.nlp	22375096	SENT95	31	31	26	26	triamcinolone	STA	PA451749	2010;2656	0.661
NULL	Indian_J_Med_Res_2013_Oct_138(4)_461-491.nxml.txt.nlp	24434254	SENT177	5	5	22	22	atorvastatin	CARP	PA448500	27063;80013;767	0.661
NULL	Nucleic_Acids_Res_2011_Mar_4_39(5)_1843-1854.nxml.txt.nlp	21051342	SENT40	38	38	35	35	carbenicillin	IFN	PA448788	3439	0.661
NULL	Int_J_Mol_Sci_2014_Jun_5_15(6)_10083-10100.nxml.txt.nlp	24905407	SENT2	48	48	32	32	tetracycline	TRB	PA451640	6957	0.661
NULL	Breast_Cancer_(Auckl)_2014_May_12_8_81-88.nxml.txt.nlp	24855372	SENT138	13	13	6	6	pertuzumab	HER2		2064	0.661
NULL	Mol_Med_Rep_2014_Oct_25_10(4)_1671-1678.nxml.txt.nlp	25069764	SENT108	0	0	13	13	isoflurane	SPHK1	PA450106	8877	0.661
NULL	J_Cell_Mol_Med_2014_Feb_8_18(2)_197-207.nxml.txt.nlp	24400890	SENT122	5	5	41	41	ethanol	DNMT3A	PA448073	1788	0.661
NULL	Environ_Health_Perspect_2005_Apr_14_113(4)_431-439.nxml.txt.nlp	15811834	SENT141	16	16	3	3	nifedipine	PRL	PA450631	5617	0.661
NULL	Acta_Pharmacol_Sin_2014_Oct_25_35(10)_1293-1301.nxml.txt.nlp	25152022	SENT180	8	8	20	20	enalapril	IL-18	PA449456	3606	0.661
NULL	Exp_Diabetes_Res_2012_Dec_12_2012_716404.nxml.txt.nlp	22194737	SENT273	8	8	3	3	metformin	AMPK	PA450395	5563	0.661
NULL	Cell_Cycle_2012_Dec_1_11(23)_4474-4483.nxml.txt.nlp	23159862	SENT109	2	2	20	20	cisplatin	GAPDH	PA449014	2597	0.661
NULL	Diabetes_Care_2012_Feb_16_35(2)_327-333.nxml.txt.nlp	22179958	SENT26	12	12	25	25	metformin	B12	PA450395	7126;4709	0.661
NULL	Arthritis_Res_2002_Nov_23_4(3)_157-164.nxml.txt.nlp	12010565	SENT147	6	6	20	20	collagenase	c-Jun	PA449107	3725	0.661
NULL	Gut_Liver_2011_Sep_18_5(3)_293-297.nxml.txt.nlp	21927656	SENT33	16	16	11	11	rabeprazole	ESD	PA451216	2098	0.661
NULL	Neuropsychopharmacology_2009_Apr_2_34(5)_1135-1148.nxml.txt.nlp	18596687	SENT3	7	7	21	21	betaxolol	CRF	PA448611	1392;10882	0.661
NULL	Indian_J_Endocrinol_Metab_2013_May-Jun_17(3)_413-421.nxml.txt.nlp	23869296	SENT166	11	11	6	6	exenatide	GLP-1	PA164749238	100125288	0.661
NULL	J_Bras_Pneumol_2013_Jan-Feb_39(1)_5-15.nxml.txt.nlp	23503480	SENT187	21	21	28	28	doxycycline	VEGF-D	PA449415	2277	0.661
NULL	Arch_Trauma_Res_2013_Aug_1_2(2)_97-98.nxml.txt.nlp	24396803	SENT18	24	24	9	9	meperidine	P-gp	PA450369	5243	0.661
NULL	Mediators_Inflamm_2010_Jun_29_2010_627803.nxml.txt.nlp	20671920	SENT5	21	21	13	13	estradiol	IL-6	PA449503	3569	0.661
NULL	Clin_Ophthalmol_2011_Jan_11_5_75-80.nxml.txt.nlp	21407799	SENT22	20	20	5	5	fluorescein	ERG	PA164746009	2078	0.661
NULL	J_Neurovirol_2011_Feb_19_17(1)_63-69.nxml.txt.nlp	21246320	SENT109	25	25	3	3	memantine	MCP-1	PA10364	6347	0.661
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT200	3	3	15	15	metformin	p53	PA450395	7157	0.661
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT377	18	18	16	16	pp2	PP1		5540;5464	0.661
NULL	J_Clin_Biochem_Nutr_2010_Mar_27_46(2)_177-185.nxml.txt.nlp	20216951	SENT105	17	17	28	28	l-lysine	CEA	PA450280	5670;1087	0.661
NULL	Dermatoendocrinol_2013_Apr_1_5(2)_252-263.nxml.txt.nlp	24194965	SENT149	0	0	4	4	metformin	AMPK	PA450395	5563	0.66
NULL	Int_J_Breast_Cancer_2011_Sep_6_2011_352182.nxml.txt.nlp	22295219	SENT277	13	13	19	19	trastuzumab	HER2	PA451743	2064	0.66
NULL	Small_GTPases_2012_Oct_1_3(4)_202-208.nxml.txt.nlp	22858691	SENT28	4	4	7	7	lipase	GEF	PA450239	56731	0.66
NULL	Behav_Brain_Funct_2010_Aug_30_6_50.nxml.txt.nlp	20799992	SENT59	7	7	15	15	cocaine	LSD	PA449072	1776	0.66
NULL	Mucosal_Immunol_2013_May_19_6(3)_474-484.nxml.txt.nlp	22990623	SENT62	26	26	34	34	budesonide	CCR5	PA448681	1234	0.66
NULL	J_Gen_Physiol_2010_Apr_135(4)_303-305.nxml.txt.nlp	20231371	SENT20	3	3	17	17	creatine	ADP	PA164778930	23038	0.66
NULL	Br_J_Ophthalmol_2008_Sep_22_92(9)_1275-1282.nxml.txt.nlp	18723745	SENT118	33	33	43	43	latanoprost	BAK	PA164774763	578	0.66
NULL	Evid_Based_Complement_Alternat_Med_2011_Jan_12_2011_690518.nxml.txt.nlp	19687188	SENT170	11	11	34	34	chloramphenicol	TIC	PA448927	23550	0.66
NULL	Environ_Health_Perspect_2008_Jan_5_116(1)_1-6.nxml.txt.nlp	18197291	SENT136	23	23	3	3	arsenite	p85	PA452638	5296;5295;54776;23368	0.66
NULL	Oncol_Lett_2013_Apr_28_5(4)_1149-1154.nxml.txt.nlp	23599754	SENT102	8	8	5	5	cisplatin	Dicer	PA449014	23405	0.66
NULL	Nucleic_Acids_Res_2011_Sep_11_39(17)_7455-7464.nxml.txt.nlp	21666254	SENT321	16	16	24	24	cisplatin	zeta	PA449014	9907	0.66
NULL	Curr_Neuropharmacol_2009_Jun_7(2)_83-95.nxml.txt.nlp	19949566	SENT445	22	22	32	32	oxcarbazepine	TGB	PA450732	5473	0.66
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Apr_29_67(Pt_5)_o1248-o1249.nxml.txt.nlp	21754540	SENT72	22	22	17	17	ethanol	mol	PA448073	90527	0.66
NULL	Clin_Med_Insights_Oncol_2012_Mar_12_6_153-164.nxml.txt.nlp	22550404	SENT81	34	34	28	28	temsirolimus	Raf-1	PA164746890	5894	0.66
NULL	Clin_Pharmacol_2011_Jun_22_3_13-25.nxml.txt.nlp	22287853	SENT181	42	42	19	19	ketoconazole	CYP3A4	PA450146	1576	0.66
NULL	EMBO_Mol_Med_2013_Jun_30_5(6)_935-948.nxml.txt.nlp	23629957	SENT125	9	9	6	6	cisplatin	COL6A3	PA449014	1293	0.66
NULL	Evid_Based_Complement_Alternat_Med_2013_May_27_2013_969032.nxml.txt.nlp	23781273	SENT233	2	2	0	0	chlorpromazine	CPZ	PA448964	8532	0.66
NULL	Clin_Ophthalmol_2009_Aug_3_3_447-456.nxml.txt.nlp	19684868	SENT168	8	8	10	10	latanoprost	BIM	PA164774763	10018	0.66
NULL	Arthritis_Res_Ther_2013_Sep_25_15(5)_118.nxml.txt.nlp	24063679	SENT22	5	5	15	15	colchicine	MICL	PA449092	160364	0.66
NULL	J_Infect_Dis_2014_Dec_15_210(12)_2001-2008.nxml.txt.nlp	24994911	SENT79	12	12	2	2	lumefantrine	ACT	PA165111722	12;11332;9457;641455	0.66
NULL	COPD_2009_Jun_27_6(3)_211-225.nxml.txt.nlp	19811377	SENT146	3	3	12	12	tiotropium	TDI	PA164769056	100038246	0.66
NULL	J_Cell_Mol_Med_2014_Jul_30_18(7)_1392-1406.nxml.txt.nlp	24779927	SENT306	13	13	22	22	curcumin	CD31	PA151958596	5175	0.66
NULL	Front_Hum_Neurosci_2013_Mar_26_7_97.nxml.txt.nlp	23532379	SENT151	4	4	7	7	choline	B12	PA448976	7126;4709	0.66
NULL	J_Oncol_2012_Jun_19_2012_521215.nxml.txt.nlp	22778735	SENT267	10	10	13	13	gefitinib	IGF1R	PA131301952	3480	0.66
NULL	J_Infect_Dis_2013_Sep_1_208(5)_801-812.nxml.txt.nlp	23766527	SENT121	16	16	4	4	amodiaquine	LUM	PA448404	4060	0.66
NULL	Ann_Thorac_Med_2013_Apr-Jun_8(2)_109-115.nxml.txt.nlp	23741274	SENT7	15	15	7	7	docetaxel	CRT	PA449383	811	0.66
NULL	Emerg_Infect_Dis_2005_Jun_11(6)_873-882.nxml.txt.nlp	15963282	SENT94	2	2	16	16	ceftazidime	TOB	PA448861	10140	0.66
NULL	Arthritis_Res_Ther_2008_Mar_17_10(2)_R33.nxml.txt.nlp	18346273	SENT122	9	9	24	24	infliximab	CD68	PA452639	968	0.66
NULL	Indian_J_Pharm_Sci_2013_May-Jun_75(3)_361-364.nxml.txt.nlp	24082354	SENT50	12	12	8	8	ziprasidone	FOR	PA451974	51741	0.66
NULL	Int_J_Mol_Sci_2014_Sep_30_15(10)_17686-17704.nxml.txt.nlp	25272226	SENT101	9	9	12	12	cetuximab	EGFR	PA10040	1956	0.66
NULL	Curr_Neuropharmacol_2007_Dec_5(4)_232-243.nxml.txt.nlp	19305740	SENT182	2	2	4	4	minocycline	IL-6	PA450519	3569	0.66
NULL	Front_Neurol_2013_Mar_8_4_21.nxml.txt.nlp	23482896	SENT581	3	3	6	6	methylprednisolone	CCR5	PA450466	1234	0.66
NULL	Int_J_Mol_Sci_2014_Nov_17_15(11)_21270-21285.nxml.txt.nlp	25407530	SENT353	30	30	16	16	collagenase	p38	PA449107	10598;1432;7965	0.66
NULL	Curr_Opin_Infect_Dis_2013_Dec_6_26(6)_538-544.nxml.txt.nlp	24126716	SENT135	22	22	24	24	fosfomycin	PARI	PA164748039	55010	0.66
NULL	Arch_Drug_Inf_2011_Mar_4(1)_1-9.nxml.txt.nlp	21572514	SENT167	14	14	9	9	indomethacin	MRP1	PA449982	4437	0.66
NULL	Front_Neurol_2011_Feb_14_1_160.nxml.txt.nlp	21359195	SENT142	11	11	2	2	paclitaxel	DES	PA450761	1674	0.66
NULL	Evid_Based_Complement_Alternat_Med_2011_Feb_14_2011_248231.nxml.txt.nlp	19233878	SENT5	5	5	0	0	rosiglitazone	DBT	PA451283	1629	0.66
NULL	Pharmaceuticals_(Basel)_2012_Jan_5_5(1)_79-93.nxml.txt.nlp	24288044	SENT13	0	0	7	7	trastuzumab	San	PA451743	80218	0.66
NULL	Cancer_Immunol_Immunother_2012_Jul_23_61(7)_1101-1111.nxml.txt.nlp	22193989	SENT11	2	2	5	5	oxaliplatin	STAT1	PA131285527	6772	0.66
NULL	Indian_J_Nucl_Med_2010_Jul-Sep_25(3)_78-87.nxml.txt.nlp	NULL	SENT374	13	13	16	16	salbutamol	gamma	PA448068	9913	0.66
NULL	Allergy_Asthma_Clin_Immunol_2010_May_12_6(Suppl_1)_P14.nxml.txt.nlp	NULL	SENT6	23	23	9	9	tranilast	CD34	PA131890628	947	0.66
NULL	Arthritis_Res_Ther_2014_Sep_24_16(5)_434.nxml.txt.nlp	25249397	SENT208	1	1	22	22	adalimumab	CXCL13	PA10004	10563	0.66
NULL	Eur_J_Appl_Physiol_2011_Feb_24_111(2)_275-283.nxml.txt.nlp	20865425	SENT102	4	4	20	20	glucose	APE	PA449773	55704;328	0.66
NULL	Front_Immunol_2012_Jan_24_3_3.nxml.txt.nlp	22566889	SENT685	18	18	7	7	rituximab	CD16	PA451261	2215;2214	0.66
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jun_6_65(Pt_7)_o1501.nxml.txt.nlp	21582800	SENT61	8	8	20	20	ethanol	mol	PA448073	90527	0.66
NULL	Eur_J_Pediatr_2012_Sep_29_171(9)_1339-1348.nxml.txt.nlp	22543566	SENT216	33	33	30	30	icatibant	C1-INH	PA164749185	710	0.66
NULL	J_Oncol_2009_Mar_24_2009_491985.nxml.txt.nlp	19325924	SENT93	19	19	6	6	genistein	CXCR4	PA165109660	7852	0.66
NULL	Ann_Oncol_2013_Aug_12_24(8)_1994-1999.nxml.txt.nlp	23670096	SENT104	6	6	18	18	tamoxifen	STEPP	PA451581	222659	0.66
NULL	Brain_Sci_2014_May_6_4(2)_356-375.nxml.txt.nlp	24961766	SENT224	33	33	17	17	propofol	CA3	PA451141	761	0.66
NULL	Biomed_Res_Int_2013_Dec_30_2013_735835.nxml.txt.nlp	24490170	SENT169	14	14	40	40	cetirizine	FEX	PA448905	8549	0.66
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT170	11	11	4	4	trastuzumab	HER3	PA451743	2065	0.66
NULL	Ecancermedicalscience_2010_Oct_7_4_192.nxml.txt.nlp	22276040	SENT32	6	6	13	13	trastuzumab	PTEN	PA451743	5728	0.66
NULL	Cancer_Cell_Int_2010_Jun_22_10_18.nxml.txt.nlp	20569458	SENT204	12	12	5	5	heparin	IL-2	PA449855	3558	0.66
NULL	Neuroimage_Clin_2013_Sep_6_3_290-300.nxml.txt.nlp	24273714	SENT292	5	5	14	14	pioglitazone	spatial	PA450970	219793	0.66
NULL	Acta_Histochem_Cytochem_2010_May_1_43(2)_61-68.nxml.txt.nlp	20514293	SENT323	6	6	8	8	hyaluronan	LYVE-1	PA165958431	10894	0.66
NULL	Braz_J_Microbiol_2011_Dec_1_Oct-Dec_42(4)_1434-1436.nxml.txt.nlp	24031774	SENT34	2	2	20	20	ciprofloxacin	TOB	PA449009	10140	0.66
NULL	Breast_Cancer_Res_2011_Mar_11_13(2)_R30.nxml.txt.nlp	21396117	SENT273	3	3	35	35	erlotinib	p53	PA134687924	7157	0.66
NULL	Ann_Hematol_2014_Sep_10_93(1)_1-11.nxml.txt.nlp	24018623	SENT142	0	0	8	8	lenalidomide	SPARC	PA162363968	6678	0.66
NULL	Nanoscale_Res_Lett_2014_Feb_15_9(1)_76.nxml.txt.nlp	24528570	SENT112	24	24	21	21	hydroquinone	mol	PA449924	90527	0.66
NULL	Indian_J_Pharmacol_2014_Mar-Apr_46(2)_201-206.nxml.txt.nlp	24741194	SENT162	4	4	12	12	bupivacaine	K13	PA135057240	3860;3755	0.66
NULL	Cardiovasc_Drugs_Ther_2011_Jun_5_25(3)_197-201.nxml.txt.nlp	21544523	SENT149	2	2	10	10	dronedarone	HCN	PA153619853	378938	0.66
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Dec_10_3(12)_e151.nxml.txt.nlp	25494035	SENT110	11	11	16	16	pravastatin	OATP1B1	PA451089	10599	0.66
NULL	J_Cell_Biol_2001_Oct_1_155(1)_133-144.nxml.txt.nlp	11581290	SENT196	34	34	16	16	pp2	PP2		4888	0.66
NULL	Med_Sci_Monit_2013_May_1_19_317-326.nxml.txt.nlp	23632427	SENT277	20	20	14	14	cefepime	CTX	PA164754876	1593	0.66
NULL	Mol_Cancer_2010_Dec_20_9_317.nxml.txt.nlp	21172025	SENT2	8	8	22	22	tamoxifen	HER2	PA451581	2064	0.66
NULL	Front_Genet_2012_Nov_12_3_235.nxml.txt.nlp	23162568	SENT179	13	13	4	4	methamphetamine	CYP2D6	PA450403	1565	0.66
NULL	J_Lipid_Res_2014_Aug_55(8)_1657-1667.nxml.txt.nlp	24879802	SENT9	14	14	6	6	rosiglitazone	ACSL4	PA451283	2182	0.66
NULL	Arthritis_Res_Ther_2003_Sep_3_5(6)_R317-R328.nxml.txt.nlp	14680506	SENT92	2	2	15	15	rolipram	IL-10	PA153906323	3586	0.66
NULL	Indian_Dermatol_Online_J_2014_Jul-Sep_5(3)_250-259.nxml.txt.nlp	25165639	SENT319	27	27	35	35	cyclophosphamide	CHOP	PA449165	1649	0.66
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1066.nxml.txt.nlp	24556681	SENT30	30	30	41	41	ethanol	TLR4	PA448073	7099	0.66
NULL	Diabetes_2009_Jan_58(1)_243-249.nxml.txt.nlp	18840785	SENT25	1	1	5	5	glucose	GLP-1	PA449773	100125288	0.66
NULL	J_Hum_Genet_2013_Jun_16_58(6)_353-361.nxml.txt.nlp	23677058	SENT96	7	7	10	10	cytarabine	NT5C2	PA449177	22978	0.66
NULL	Biologics_2012_Dec_17_6_429-464.nxml.txt.nlp	23269860	SENT163	24	24	21	21	rituximab	ACR	PA451261	49	0.66
NULL	F1000_Med_Rep_2010_Apr_27_2_29.nxml.txt.nlp	20948857	SENT44	17	17	30	30	trastuzumab	HER-2	PA451743	2064	0.66
NULL	Ann_Rheum_Dis_2008_Apr_20_67(4)_511-517.nxml.txt.nlp	17644552	SENT8	18	18	4	4	infliximab	IL-6	PA452639	3569	0.66
NULL	Toxins_(Basel)_2010_Oct_26_2(11)_2490-2518.nxml.txt.nlp	22069563	SENT265	15	15	5	5	cisplatin	CD4	PA449014	920	0.66
NULL	Orphanet_J_Rare_Dis_2012_Apr_19_7_21.nxml.txt.nlp	22515166	SENT6	0	0	19	19	bezafibrate	COX10	PA162364313	1352	0.66
NULL	Arch_Med_Sci_2013_Oct_31_9(5)_916-921.nxml.txt.nlp	24273579	SENT40	21	21	12	12	bleomycin	AQP5	PA448645	362	0.66
NULL	Mol_Cancer_2012_May_1_11_28.nxml.txt.nlp	22548705	SENT124	44	44	16	16	etoposide	p53	PA449552	7157	0.66
NULL	Arthritis_Res_Ther_2005_Oct_18_7(6)_R1412-R1420.nxml.txt.nlp	16277694	SENT49	6	6	4	4	fluorescein	CD14	PA164746009	929	0.66
NULL	Indian_J_Pharm_Sci_2008_May-Jun_70(3)_310-319.nxml.txt.nlp	20046738	SENT12	29	29	20	20	erythromycin	MS2	PA449493	101	0.66
NULL	Indian_J_Med_Res_2013_Oct_138(4)_549-556.nxml.txt.nlp	24434263	SENT127	23	23	31	31	vancomycin	Gen	PA451850	348654	0.66
NULL	Oncoimmunology_2012_Aug_1_1(5)_618-629.nxml.txt.nlp	22934254	SENT199	18	18	21	21	dasatinib	IFN	PA162372878	3439	0.66
NULL	Oncol_Lett_2013_Jul_14_6(1)_69-74.nxml.txt.nlp	23946779	SENT190	17	17	21	21	axitinib	MMP9	PA164924493	4318	0.66
NULL	Semin_Dial_2013_Sep_17_26(5)_546-567.nxml.txt.nlp	23859229	SENT588	10	10	24	24	cyanocobalamin	B12	PA451892	7126;4709	0.66
NULL	Br_J_Cancer_2013_Jun_25_108(12)_2464-2469.nxml.txt.nlp	23695016	SENT140	12	12	21	21	paclitaxel	CRT	PA450761	811	0.66
NULL	Lab_Anim_Res_2012_Sep_26_28(3)_205-208.nxml.txt.nlp	23091521	SENT24	11	11	13	13	streptozocin	STZ	PA451514	6484	0.66
NULL	Front_Physiol_2011_Jun_30_2_33.nxml.txt.nlp	21747769	SENT292	0	0	11	11	berberine	KCNQ1	PA165860812	3784	0.66
NULL	Nat_Commun_2014_Aug_22_5_4684.nxml.txt.nlp	25147954	SENT324	5	5	14	14	methotrexate	IL-6	PA450428	3569	0.66
NULL	Front_Oncol_2014_Jun_18_4_159.nxml.txt.nlp	24995161	SENT226	24	24	36	36	estradiol	AKR1C3	PA449503	8644	0.66
NULL	Br_J_Pharmacol_2012_Jan_165(2)_390-400.nxml.txt.nlp	21671897	SENT191	0	0	22	22	suramin	P2X1	PA10292	5023	0.66
NULL	Allergy_Asthma_Clin_Immunol_2010_Sep_16_6(1)_27.nxml.txt.nlp	20846390	SENT192	9	9	12	12	methacholine	BRI	PA165958382	9445	0.66
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT128	15	15	4	4	theophylline	CYP3A4	PA451647	1576	0.66
NULL	Emerg_Med_Int_2014_Apr_27_2014_638102.nxml.txt.nlp	24876968	SENT132	3	3	11	11	furosemide	Men	PA449719	8178	0.66
NULL	Indian_J_Pharmacol_2013_Sep-Oct_45(5)_458-463.nxml.txt.nlp	24130379	SENT11	3	3	16	16	carvedilol	TLR4	PA448817	7099	0.66
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1437-1448.nxml.txt.nlp	24056706	SENT111	27	27	24	24	ketoconazole	CYP2D6	PA450146	1565	0.66
NULL	Pharmaceuticals_(Basel)_2013_Aug_6_6(8)_929-959.nxml.txt.nlp	24276377	SENT99	15	15	7	7	oxaliplatin	CXCL8	PA131285527	3576	0.66
NULL	Child_Adolesc_Psychiatry_Ment_Health_2012_Jun_22_6_25.nxml.txt.nlp	22726236	SENT14	17	17	14	14	risperidone	B12	PA451257	7126;4709	0.66
NULL	Acta_Pharmacol_Sin_2011_Oct_12_32(10)_1259-1265.nxml.txt.nlp	21909126	SENT128	13	13	18	18	losartan	MCP-1	PA450268	6347	0.66
NULL	J_Immunother_Cancer_2014_Nov_6_2(Suppl_3)_P210.nxml.txt.nlp	NULL	SENT10	4	4	7	7	curcumin	IL6	PA151958596	3569	0.66
NULL	Acta_Pharmacol_Sin_2013_Sep_5_34(9)_1237-1242.nxml.txt.nlp	23770984	SENT98	29	29	17	17	warfarin	CYP2C9	PA451906	1559	0.66
NULL	Ther_Clin_Risk_Manag_2007_Dec_3(6)_1009-1020.nxml.txt.nlp	18516316	SENT155	0	0	12	12	aprepitant	NK-1	PA164747039	27087	0.66
NULL	Acta_Pharmacol_Sin_2011_Oct_15_32(10)_1233-1238.nxml.txt.nlp	21841815	SENT24	2	2	10	10	naloxone	CTX	PA450586	1593	0.66
NULL	Oncotarget_2013_Jul_7_4(7)_1065-1074.nxml.txt.nlp	23867252	SENT129	21	21	17	17	geldanamycin	Hsp90	PA152031327	3320	0.66
NULL	Nat_Med_2011_Oct_2_17(10)_1304-1309.nxml.txt.nlp	21963515	SENT7	6	6	28	28	tacrolimus	SPAK	PA451578	27347	0.66
NULL	Pharmaceuticals_(Basel)_2011_Oct_25_4(11)_1400-1422.nxml.txt.nlp	NULL	SENT1147	0	0	11	11	carbamazepine	HDAC6	PA448785	10013	0.66
NULL	Am_J_Case_Rep_2014_Nov_3_15_480-484.nxml.txt.nlp	25380070	SENT53	4	4	31	31	crizotinib	CEA	PA165946122	5670;1087	0.66
NULL	Pharmaceuticals_(Basel)_2011_Oct_27_4(11)_1450-1474.nxml.txt.nlp	NULL	SENT326	5	5	22	22	taurine	NFkappaB	PA451590	4790	0.66
NULL	Oncotarget_2012_Oct_27_3(10)_1052-1053.nxml.txt.nlp	23165648	SENT23	14	14	11	11	nutlin-3	IFN		3439	0.66
NULL	Open_Biol_2014_Nov_4(11)_140180.nxml.txt.nlp	25392452	SENT137	17	17	8	8	filgrastim	GM-CSF	PA449626	1437	0.66
NULL	Infect_Dis_Ther_2013_Dec_3_2(2)_111-122.nxml.txt.nlp	25134475	SENT52	9	9	14	14	desipramine	CYP2D6	PA449233	1565	0.66
NULL	Nat_Commun_2012_3_1147.nxml.txt.nlp	23093184	SENT132	28	28	9	9	tetracycline	ND5	PA451640	4540	0.66
NULL	Turk_J_Haematol_2012_Jun_15_29(2)_170-173.nxml.txt.nlp	24744649	SENT21	9	9	11	11	methylprednisolone	MPZ	PA450466	4359	0.66
NULL	Oxid_Med_Cell_Longev_2013_Apr_18_2013_239854.nxml.txt.nlp	23710284	SENT83	0	0	3	3	zonisamide	HRD1	PA451978	84447	0.66
NULL	Br_J_Cancer_2009_Sep_15_101(6)_957-966.nxml.txt.nlp	19738618	SENT184	14	14	8	8	heparin	CD47	PA449855	961	0.66
NULL	Blood_Cancer_J_2013_Jun_7_3(6)_e120.nxml.txt.nlp	23749045	SENT86	4	4	2	2	imatinib	IGF1R	PA10804	3480	0.66
NULL	Chem_Cent_J_2012_May_11_6_41.nxml.txt.nlp	22578215	SENT7	27	27	11	11	lipase	castor	PA450239	54897	0.66
NULL	J_Korean_Med_Sci_2005_Jun_30_20(3)_456-460.nxml.txt.nlp	15953869	SENT81	20	20	34	34	lipase	UPP1	PA450239	7378	0.66
NULL	Oncogene_2014_Aug_28_33(35)_4396-4406.nxml.txt.nlp	24531714	SENT57	26	26	12	12	nutlin-3	p53		7157	0.66
NULL	Cancer_Metab_2014_Nov_3_2(1)_20.nxml.txt.nlp	NULL	SENT207	4	4	6	6	erlotinib	PDK4	PA134687924	5166	0.66
NULL	Oncotarget_2014_Oct_21_5(22)_11252-11268.nxml.txt.nlp	25361004	SENT117	3	3	10	10	metformin	CLIC1	PA450395	1192	0.66
NULL	Hum_Psychopharmacol_2012_Sep_20_27(5)_492-498.nxml.txt.nlp	22996616	SENT27	0	0	13	13	quetiapine	AAP	PA451201	5345	0.66
NULL	Aging_(Albany_NY)_2009_Jun_3_1(6)_515-528.nxml.txt.nlp	20157535	SENT131	7	7	10	10	resveratrol	S6K1		6198	0.66
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT279	0	0	5	5	clozapine	PRL	PA449061	5617	0.66
NULL	Br_J_Haematol_2014_Mar_13_164(1)_811-821.nxml.txt.nlp	24328678	SENT151	10	10	16	16	lenalidomide	IL2	PA162363968	3558	0.66
NULL	Leukemia_2014_Jun_25_28(6)_1280-1288.nxml.txt.nlp	24270737	SENT210	17	17	11	11	decitabine	THP1	PA164749631	2736	0.66
NULL	J_Radiat_Res_2014_Mar_1_55(2)_359-363.nxml.txt.nlp	24187329	SENT14	18	18	22	22	vincristine	CHOP	PA451879	1649	0.66
NULL	Oxid_Med_Cell_Longev_2010_Nov-Dec_3(6)_434-441.nxml.txt.nlp	21307644	SENT157	12	12	6	6	resveratrol	ANOVA		4858	0.66
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT128	18	18	4	4	mexiletine	CYP3A4	PA450488	1576	0.66
NULL	Ther_Clin_Risk_Manag_2006_Mar_2(1)_45-57.nxml.txt.nlp	18360581	SENT50	10	10	7	7	etoricoxib	CYP3A	PA164776853	1574	0.66
NULL	Semin_Dial_2013_Sep_17_26(5)_546-567.nxml.txt.nlp	23859229	SENT588	10	10	28	28	cyanocobalamin	B12	PA451892	7126;4709	0.66
NULL	Arthritis_Res_Ther_2011_Feb_16_13(1)_R25.nxml.txt.nlp	21324169	SENT98	28	28	20	20	infliximab	TNF	PA452639	7124	0.66
NULL	Br_J_Pharmacol_2014_May_171(10)_2659-2670.nxml.txt.nlp	24116661	SENT199	12	12	2	2	naringenin	TRPP2	PA151958361	5311	0.66
NULL	Emerg_Infect_Dis_2012_Jun_18(6)_1019-1020.nxml.txt.nlp	22608263	SENT34	34	34	20	20	moxifloxacin	TOB	PA450555	10140	0.66
NULL	Br_J_Cancer_2013_Jul_23_109(2)_502-511.nxml.txt.nlp	23799850	SENT192	17	17	35	35	gemcitabine	SMARCC1	PA449748	6599	0.66
NULL	F1000_Biol_Rep_2012_Mar_1_4_5.nxml.txt.nlp	22403588	SENT115	4	4	9	9	boceprevir	IFN	PA165948902	3439	0.66
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jan_31_65(Pt_2)_o420-o421.nxml.txt.nlp	21582009	SENT68	21	21	12	12	ethanol	mol	PA448073	90527	0.66
NULL	Hematol_Rep_2011_Jan_21_3(1)_e2.nxml.txt.nlp	22184524	SENT44	6	6	16	16	isoniazid	MOF	PA450112	84148	0.66
NULL	JRSM_Cardiovasc_Dis_2012_Sep_24_1(6)_cvd_2012_012015.nxml.txt.nlp	24175073	SENT171	30	30	19	19	clopidogrel	ABCB1	PA449053	5243	0.66
NULL	Eur_J_Haematol_2009_May_82(5)_339-349.nxml.txt.nlp	19187276	SENT52	5	5	17	17	rivaroxaban	TKR	PA165958360	8277	0.66
NULL	J_Med_Case_Reports_2011_Mar_28_5_117.nxml.txt.nlp	21443773	SENT20	8	8	3	3	liraglutide	GLP-1	PA165958364	100125288	0.66
NULL	Mol_Cancer_2007_Jan_14_6_5.nxml.txt.nlp	17222355	SENT36	16	16	23	23	doxorubicin	HMGA2	PA449412	8091	0.66
NULL	Breast_Cancer_Res_2013_Nov_8_15(6)_R107.nxml.txt.nlp	24207099	SENT184	5	5	0	0	ethanol	CYP2E1	PA448073	1571	0.66
NULL	Biochem_Res_Int_2012_Aug_23_2012_135723.nxml.txt.nlp	21904679	SENT30	22	22	30	30	lipase	DAG	PA450239	1605	0.66
NULL	Anesthesiol_Res_Pract_2013_Sep_23_2013_297141.nxml.txt.nlp	24174934	SENT135	21	21	6	6	bupivacaine	mol	PA135057240	90527	0.66
NULL	Br_J_Cancer_2009_Mar_10_100(5)_680-683.nxml.txt.nlp	19223897	SENT7	24	24	28	28	trastuzumab	HER2	PA451743	2064	0.66
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT115	6	6	8	8	everolimus	PI3K	PA164746311	5290	0.66
NULL	J_Vet_Med_Sci_2014_Oct_16_76(10)_1383-1387.nxml.txt.nlp	24931645	SENT150	9	9	7	7	liraglutide	GLP-1	PA165958364	100125288	0.66
NULL	J_Oncol_2009_Mar_24_2009_491985.nxml.txt.nlp	19325924	SENT79	19	19	3	3	genistein	CXCL12	PA165109660	6387	0.66
NULL	Biosensors_(Basel)_2013_Nov_13_3(4)_374-384.nxml.txt.nlp	25586413	SENT31	8	8	29	29	capsaicin	SPR	PA448776	6697;6869	0.66
NULL	J_Thromb_Haemost_2011_Oct_9(10)_2103-2105.nxml.txt.nlp	21812912	SENT44	19	19	17	17	ticagrelor	ADP	PA165374673	23038	0.66
NULL	Toxins_(Basel)_2010_Oct_26_2(11)_2490-2518.nxml.txt.nlp	22069563	SENT265	15	15	7	7	cisplatin	CD25	PA449014	3669;3559	0.66
NULL	Autophagy_2012_May_1_8(5)_853-855.nxml.txt.nlp	22617440	SENT34	2	2	11	11	imatinib	ATG5	PA10804	9474	0.66
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Apr_25_65(Pt_5)_o1132.nxml.txt.nlp	21583942	SENT7	4	4	12	12	nitrile	mol	PA450636	90527	0.66
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT207	19	19	29	29	risperidone	PRL	PA451257	5617	0.66
NULL	Nucleic_Acids_Res_2005_Jun_8_33(10)_3283-3291.nxml.txt.nlp	15944449	SENT114	24	24	13	13	sjg-136	ERCC1		2067	0.66
NULL	Patient_Prefer_Adherence_2013_Apr_26_7_369-377.nxml.txt.nlp	23641151	SENT2	0	0	26	26	ustekinumab	IL-23	PA166048654	51561	0.66
NULL	Int_J_Med_Sci_2014_Sep_3_11(11)_1172-1184.nxml.txt.nlp	25249786	SENT195	12	12	17	17	glibenclamide	LPO	PA449782	4025	0.66
NULL	Cancer_Imaging_2012_Sep_28_12(1)_283-289.nxml.txt.nlp	23033440	SENT119	15	15	0	0	imatinib	FDG	PA10804	23583	0.66
NULL	Diabetes_2009_Dec_31_58(12)_2851-2862.nxml.txt.nlp	19720788	SENT280	3	3	6	6	forskolin	PERK	PA146096022	9451	0.66
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jun_11_67(Pt_7)_o1640.nxml.txt.nlp	21837045	SENT68	22	22	13	13	ethanol	mol	PA448073	90527	0.66
NULL	Ann_Oncol_2009_Nov_23_20(11)_1803-1812.nxml.txt.nlp	19549706	SENT201	15	15	19	19	sunitinib	IFN	PA162372840	3439	0.66
NULL	Mol_Pain_2013_Jul_31_9_38.nxml.txt.nlp	23898828	SENT149	23	23	34	34	losartan	p38	PA450268	10598;1432;7965	0.66
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT116	5	5	10	10	trastuzumab	MUC1	PA451743	4582	0.66
NULL	Front_Neurosci_2012_May_30_6_77.nxml.txt.nlp	22661925	SENT158	5	5	31	31	ethanol	HEC	PA448073	10403	0.66
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT358	5	5	3	3	pp2	PP1		5540;5464	0.66
NULL	Int_J_Biol_Sci_2011_May_9_7(5)_575-587.nxml.txt.nlp	21614150	SENT118	24	24	31	31	resveratrol	SIRT1		23411	0.66
NULL	Int_Clin_Psychopharmacol_2014_Jul_26_29(4)_206-211.nxml.txt.nlp	24374906	SENT78	7	7	9	9	doxepin	CYP2C9	PA449409	1559	0.66
NULL	Case_Rep_Obstet_Gynecol_2012_Sep_4_2012_485452.nxml.txt.nlp	22988533	SENT63	19	19	4	4	hydroxocobalamin	B12	PA164768689	7126;4709	0.66
NULL	Small_GTPases_2012_Oct_1_3(4)_199-200.nxml.txt.nlp	NULL	SENT8	15	15	3	3	lipase	PLD2	PA450239	5338	0.66
NULL	J_Cardiovasc_Dis_Res_2012_Oct-Dec_3(4)_319-322.nxml.txt.nlp	23233778	SENT44	34	34	5	5	azithromycin	CYP3A4	PA448519	1576	0.66
NULL	Clin_Psychopharmacol_Neurosci_2011_Apr_30_9(1)_9-16.nxml.txt.nlp	23431048	SENT59	2	2	20	20	clomipramine	5-HTT	PA449048	6532	0.66
NULL	Cancer_Inform_2008_Jun_10_6_315-355.nxml.txt.nlp	19259415	SENT279	20	20	11	11	cisplatin	GPX1	PA449014	2876	0.66
NULL	J_Biol_Chem_2013_Nov_15_288(46)_33049-33059.nxml.txt.nlp	24089524	SENT270	8	8	16	16	nicotine	GATA4	PA450626	2626	0.66
NULL	J_Inherit_Metab_Dis_2012_Jan_10_35(1)_141-149.nxml.txt.nlp	21556832	SENT185	32	32	36	36	creatine	CEE	PA164778930	51608	0.66
NULL	F1000_Med_Rep_2011_May_3_3_9.nxml.txt.nlp	21654924	SENT42	27	27	25	25	ribavirin	IFN	PA451241	3439	0.66
NULL	Eur_J_Clin_Microbiol_Infect_Dis_2010_Nov_1_29(11)_1361-1367.nxml.txt.nlp	20680368	SENT106	6	6	4	4	vancomycin	VAN	PA451850	10318	0.66
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_P64.nxml.txt.nlp	NULL	SENT16	40	40	30	30	cefuroxime	PPL	PA448868	5493	0.66
NULL	J_Ophthalmic_Inflamm_Infect_2013_Apr_22_3_46.nxml.txt.nlp	23607574	SENT63	30	30	16	16	ofloxacin	Gen	PA450684	348654	0.66
NULL	J_Korean_Med_Sci_2010_Aug_21_25(8)_1222-1227.nxml.txt.nlp	20676337	SENT152	21	21	18	18	aminophylline	LPA	PA164781029	4018	0.66
NULL	Anal_Bioanal_Chem_2008_Apr_31_390(8)_1987-1998.nxml.txt.nlp	18236033	SENT269	8	8	0	0	estradiol	DES	PA449503	1674	0.66
NULL	Br_J_Cancer_2006_Feb_13_94(3)_363-371.nxml.txt.nlp	16465172	SENT45	15	15	19	19	oxaliplatin	CRT	PA131285527	811	0.66
NULL	Cell_Death_Dis_2010_Feb_4_1(2)_e23.nxml.txt.nlp	21364631	SENT242	26	26	31	31	curcumin	c-Jun	PA151958596	3725	0.66
NULL	J_Physiol_2011_Mar_1_589(Pt_5)_1081-1093.nxml.txt.nlp	21224236	SENT140	5	5	7	7	diazoxide	GLP-1	PA449285	100125288	0.66
NULL	J_Inflamm_(Lond)_2006_Jul_12_3_10.nxml.txt.nlp	16834783	SENT105	5	5	10	10	mometasone	CXCR4	PA450541	7852	0.66
NULL	J_Cancer_Prev_2014_Mar_19(1)_39-46.nxml.txt.nlp	25337571	SENT85	6	6	8	8	ethanol	JNK	PA448073	5599	0.66
NULL	J_Cell_Mol_Med_2014_Jan_31_18(1)_27-37.nxml.txt.nlp	24373581	SENT173	0	0	38	38	alendronate	CD31	PA448082	5175	0.66
NULL	Br_J_Pharmacol_2014_Oct_26_171(20)_4785-4796.nxml.txt.nlp	25074741	SENT135	0	0	8	8	guanfacine	NK1R	PA449825	6869	0.66
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Sep_30_66(Pt_10)_o2696.nxml.txt.nlp	21587664	SENT56	8	8	11	11	benzaldehyde	mol	PA448571	90527	0.66
NULL	Case_Rep_Gastroenterol_2008_Nov_15_2(3)_456-460.nxml.txt.nlp	21897799	SENT69	20	20	4	4	imatinib	KIT	PA10804	3815	0.66
NULL	Br_J_Haematol_2006_Jun_133(6)_628-633.nxml.txt.nlp	16704437	SENT70	2	2	0	0	cyclophosphamide	CHOP	PA449165	1649	0.66
NULL	Turk_J_Haematol_2012_Dec_5_29(4)_413-419.nxml.txt.nlp	24385732	SENT55	32	32	8	8	methotrexate	CHOP	PA450428	1649	0.66
NULL	Eur_J_Clin_Pharmacol_2010_Sep_16_66(9)_955.nxml.txt.nlp	20552178	SENT6	15	15	22	22	zolpidem	CYP3A	PA451976	1574	0.66
NULL	J_Cell_Biol_1998_Mar_9_140(5)_1199-1209.nxml.txt.nlp	9490732	SENT183	4	4	2	2	thrombin	LPA	PA451674	4018	0.66
NULL	Front_Neurol_2014_Apr_29_5_63.nxml.txt.nlp	24808888	SENT209	5	5	12	12	pilocarpine	ghrelin	PA450962	51738	0.66
NULL	Cancer_Cell_Int_2013_Dec_23_13_123.nxml.txt.nlp	24365069	SENT27	39	39	24	24	imatinib	CD34	PA10804	947	0.66
NULL	Breast_Cancer_Res_2009_Jul_15_11(4)_207.nxml.txt.nlp	19664181	SENT172	34	34	14	14	triciribine	PTEN	PA165958661	5728	0.66
NULL	Infect_Dis_Rep_2013_Jun_6_5(Suppl_1)_e5.nxml.txt.nlp	24470969	SENT93	16	16	19	19	raltegravir	CCR5		1234	0.66
NULL	EMBO_Mol_Med_2012_Sep_7_4(9)_896-909.nxml.txt.nlp	22887866	SENT141	0	0	7	7	lovastatin	c-Myc	PA450272	4609	0.66
NULL	J_Biol_Chem_2009_Jan_2_284(1)_77-84.nxml.txt.nlp	18854318	SENT166	35	35	41	41	forskolin	AMPK	PA146096022	5563	0.66
NULL	J_Oncol_2012_Jul_14_2012_193436.nxml.txt.nlp	21804824	SENT160	20	20	37	37	bevacizumab	SNO	PA130232992	6498	0.66
NULL	Indian_J_Pharmacol_2008_Oct_40(Suppl_2)_S66-S91.nxml.txt.nlp	21593982	SENT811	0	0	4	4	proguanil	CYP2C19	PA451124	1557	0.66
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Feb_5_70(Pt_3)_m82.nxml.txt.nlp	24764947	SENT59	5	5	21	21	l-valine	PF6	PA451843	200162	0.66
NULL	F1000_Biol_Rep_2012_Mar_1_4_5.nxml.txt.nlp	22403588	SENT78	32	32	29	29	ribavirin	IFN	PA451241	3439	0.66
NULL	Mol_Cancer_2009_Nov_19_8_108.nxml.txt.nlp	19925669	SENT175	31	31	14	14	doxorubicin	CTRL	PA449412	1506	0.66
NULL	Arthritis_Res_Ther_2006_Nov_30_8(1)_R10.nxml.txt.nlp	16356198	SENT27	21	21	16	16	bleomycin	IL-13	PA448645	3596	0.66
NULL	Arthritis_Res_Ther_2003_Jan_20_5(2)_68-75.nxml.txt.nlp	12718746	SENT92	30	30	18	18	imiquimod	TLR3	PA449972	7098	0.659
NULL	Cancers_(Basel)_2011_Aug_19_3(3)_3370-3393.nxml.txt.nlp	24212958	SENT47	18	18	12	12	trastuzumab	DM1	PA451743	338023;1760;28509	0.659
NULL	J_Cell_Biol_1998_Jun_29_141(7)_1479-1487.nxml.txt.nlp	9647642	SENT246	35	35	33	33	staurosporine	STS	PA165109623	412	0.659
NULL	J_Antimicrob_Chemother_2008_Nov_27_62(5)_929-933.nxml.txt.nlp	18755696	SENT60	6	6	20	20	amikacin	CTX	PA164744372	1593	0.659
NULL	Apoptosis_2012_Sep_30_17(9)_989-997.nxml.txt.nlp	22460505	SENT208	1	1	9	9	cisplatin	p53	PA449014	7157	0.659
NULL	Blood_Res_2013_Jun_25_48(2)_115-120.nxml.txt.nlp	23826580	SENT12	23	23	25	25	rituximab	CHOP	PA451261	1649	0.659
NULL	Arthritis_Res_2001_Sep_18_3(6)_381-388.nxml.txt.nlp	11714393	SENT138	5	5	19	19	collagenase	c-Jun	PA449107	3725	0.659
NULL	Environ_Microbiol_2013_Jan_15_15(1)_297-304.nxml.txt.nlp	23157680	SENT66	6	6	16	16	sulfamethoxazole	TMP	PA451544	2012	0.659
NULL	Hematol_Rep_2011_Jan_21_3(1)_e2.nxml.txt.nlp	22184524	SENT44	2	2	12	12	rifampin	ETB	PA451250	1910	0.659
NULL	Cancer_Cell_2013_Jul_8_24(1)_15-29.nxml.txt.nlp	23845441	SENT177	18	18	6	6	gefitinib	BRAF	PA131301952	673	0.659
NULL	Iran_J_Pharm_Res_2014_Winter_13(1)_29-37.nxml.txt.nlp	24734054	SENT164	5	5	16	16	gliclazide	STZ	PA10892	6484	0.659
NULL	Front_Immunol_2012_Jul_18_3_198.nxml.txt.nlp	22826708	SENT1519	3	3	0	0	sirolimus	CD154	PA451365	959	0.659
NULL	Cancer_Cell_Int_2011_Aug_19_11_29.nxml.txt.nlp	21854619	SENT8	25	25	33	33	cisplatin	BRCA1	PA449014	672	0.659
NULL	Biol_Open_2013_Aug_14_2(10)_1013-1021.nxml.txt.nlp	24167711	SENT176	17	17	22	22	ethanol	EVL	PA448073	51466	0.659
NULL	Am_J_Med_Genet_B_Neuropsychiatr_Genet_2014_Jun_9_165(4)_373-380.nxml.txt.nlp	24817687	SENT174	19	19	14	14	aprepitant	BPAD	PA164747039	4095	0.659
NULL	Korean_J_Anesthesiol_2013_Dec_26_65(6)_552-558.nxml.txt.nlp	24427462	SENT73	10	10	3	3	rocuronium	ANOVA	PA164754992	4858	0.659
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2751-2762.nxml.txt.nlp	24169358	SENT181	0	0	8	8	fulvestrant	p53	PA164747170	7157	0.659
NULL	Oncol_Lett_2014_Mar_19_7(3)_674-678.nxml.txt.nlp	24527071	SENT8	23	23	2	2	cisplatin	AKR1C2	PA449014	1646	0.659
NULL	Pediatr_Cardiol_2010_Jan_14_31(1)_90-95.nxml.txt.nlp	19915892	SENT98	14	14	32	32	palivizumab	AAP	PA164748781	5345	0.659
NULL	Iran_J_Reprod_Med_2011_Winter_9(1)_31-36.nxml.txt.nlp	25356079	SENT102	10	10	6	6	letrozole	Casper	PA450196	8837	0.659
NULL	Front_Neurol_2014_Jun_27_5_109.nxml.txt.nlp	25018748	SENT62	11	11	14	14	levetiracetam	CD95	PA450206	355	0.659
NULL	Int_J_Endocrinol_2013_Sep_5_2013_895102.nxml.txt.nlp	24089613	SENT21	19	19	24	24	exenatide	GLP-1	PA164749238	100125288	0.659
NULL	Pharmaceuticals_(Basel)_2013_Aug_21_6(8)_988-1038.nxml.txt.nlp	24276379	SENT498	20	20	26	26	oxaliplatin	TRAIL	PA131285527	8743	0.659
NULL	Mol_Cancer_2009_Jun_15_8_38.nxml.txt.nlp	19527517	SENT5	10	10	17	17	everolimus	AKT	PA164746311	207	0.659
NULL	Cell_Cycle_2012_Nov_1_11(21)_3983-3996.nxml.txt.nlp	22987153	SENT204	18	18	44	44	mitomycin	FANCD2	PA450524	2177	0.659
NULL	Braz_J_Med_Biol_Res_2013_Dec_2_46(12)_1000-1006.nxml.txt.nlp	24345907	SENT106	22	22	17	17	vasopressin	SON	PA451858	6651	0.659
NULL	Indian_Dermatol_Online_J_2013_Jul-Sep_4(3)_246-249.nxml.txt.nlp	23984250	SENT38	15	15	26	26	vismodegib	EGFR		1956	0.659
NULL	Sensors_(Basel)_2013_Feb_28_13(3)_2895-2910.nxml.txt.nlp	23449119	SENT123	17	17	5	5	pp2	PP1		5540;5464	0.659
NULL	Oncotarget_2014_Aug_29_5(17)_7217-7259.nxml.txt.nlp	25277175	SENT321	10	10	27	27	bicalutamide	p53	PA164746255	7157	0.659
NULL	Blood_Res_2014_Sep_25_49(3)_200-203.nxml.txt.nlp	25325043	SENT27	9	9	14	14	vincristine	CHOP	PA451879	1649	0.659
NULL	Diabetes_Care_2013_Aug_17_36(Suppl_2)_S180-S189.nxml.txt.nlp	23882044	SENT80	9	9	4	4	liraglutide	GLP-1	PA165958364	100125288	0.659
NULL	Gut_2012_Aug_24_61(8)_1146-1153.nxml.txt.nlp	22115910	SENT227	11	11	0	0	fluorescein	CLE	PA164746009	51637	0.659
NULL	Cell_Death_Dis_2012_Jun_21_3(6)_e330.nxml.txt.nlp	22717585	SENT293	0	0	8	8	simvastatin	CHOP	PA451363	1649	0.659
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT197	11	11	18	18	nilotinib	ABCB1	PA165958345	5243	0.659
NULL	J_Invest_Dermatol_2013_Mar_25_133(3)_793-802.nxml.txt.nlp	23096711	SENT203	17	17	19	19	diethylstilbestrol	DES	PA449307	1674	0.659
NULL	Mol_Cancer_2009_Nov_24_8_109.nxml.txt.nlp	19930708	SENT51	6	6	12	12	exemestane	aromatase	PA449563	1588	0.659
NULL	J_Korean_Med_Sci_2010_Feb_21_25(2)_197-202.nxml.txt.nlp	20119570	SENT117	10	10	28	28	erythromycin	VAN	PA449493	10318	0.659
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_16_2012_395912.nxml.txt.nlp	23118789	SENT75	29	29	24	24	phenylbutazone	UGT2B7	PA450932	7364	0.659
NULL	Arthritis_Res_Ther_2013_Dec_27_15(6)_R222.nxml.txt.nlp	24369907	SENT181	29	29	15	15	collagenase	p38	PA449107	10598;1432;7965	0.659
NULL	Indian_J_Endocrinol_Metab_2011_Oct_15(Suppl4)_S313-S316.nxml.txt.nlp	22145133	SENT122	2	2	8	8	metyrapone	ACTH	PA450486	5443	0.659
NULL	Biomed_Res_Int_2013_Jul_28_2013_724763.nxml.txt.nlp	23984402	SENT146	21	21	9	9	carrageenan	AD3	PA448814	11138	0.659
NULL	Cancers_(Basel)_2011_Oct_26_3(4)_4024-4045.nxml.txt.nlp	24213123	SENT817	5	5	15	15	curcumin	PTEN	PA151958596	5728	0.659
NULL	Cardiovasc_Res_2010_Jul_1_87(1)_60-72.nxml.txt.nlp	20110334	SENT13	3	3	11	11	carbachol	LQT3	PA448784	6331	0.659
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1150.nxml.txt.nlp	24675468	SENT33	34	34	38	38	metformin	adiponectin	PA450395	9370	0.659
NULL	Int_J_Inflam_2011_Sep_20_2011_367284.nxml.txt.nlp	21941675	SENT509	1	1	4	4	warfarin	IL-6	PA451906	3569	0.659
NULL	Exp_Diabetes_Res_2011_Jun_23_2011_898913.nxml.txt.nlp	21747834	SENT96	41	41	19	19	metformin	AMIGO	PA450395	57463	0.659
NULL	Pharmaceuticals_(Basel)_2012_Dec_4_5(12)_1332-1345.nxml.txt.nlp	24281339	SENT220	18	18	3	3	thrombin	COX2	PA451674	4513;5743	0.659
NULL	Epilepsia_2014_Jun_6_55(6)_806-818.nxml.txt.nlp	24802699	SENT92	7	7	13	13	bumetanide	NKCC1	PA448682	6558	0.659
NULL	Clin_Transl_Allergy_2014_Jan_15_4_3.nxml.txt.nlp	24428928	SENT174	19	19	14	14	methacholine	IL-17	PA165958382	3605	0.659
NULL	J_Cell_Mol_Med_2014_Sep_3_18(9)_1840-1850.nxml.txt.nlp	24894955	SENT247	4	4	7	7	ethanol	TFR1	PA448073	7037	0.659
NULL	Indian_J_Med_Res_2013_Jul_138(1)_19-31.nxml.txt.nlp	24056553	SENT68	14	14	18	18	artemisinin	ACT	PA165111696	12;11332;9457;641455	0.659
NULL	Cancers_(Basel)_2012_Jun_18_4(2)_581-600.nxml.txt.nlp	24213326	SENT693	1	1	5	5	cyclophosphamide	CD4	PA449165	920	0.659
NULL	J_Gen_Physiol_1977_Mar_1_69(3)_293-323.nxml.txt.nlp	845593	SENT0	12	12	1	1	pancuronium	Gen	PA450771	348654	0.659
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT75	7	7	13	13	curcumin	PC-3	PA151958596	692094	0.659
NULL	J_Skin_Cancer_2012_Jun_13_2012_410925.nxml.txt.nlp	22745913	SENT100	24	24	14	14	lipase	IL5RA	PA450239	3568	0.659
NULL	Cancer_Cell_Int_2006_Jun_27_6_18.nxml.txt.nlp	16803625	SENT20	11	11	8	8	ribavirin	IFN	PA451241	3439	0.659
NULL	J_Carcinog_2013_Dec_31_12_22.nxml.txt.nlp	24574860	SENT51	16	16	6	6	panitumumab	EGFR	PA162373091	1956	0.659
NULL	Clinicoecon_Outcomes_Res_2014_Sep_23_6_409-414.nxml.txt.nlp	25285019	SENT139	4	4	6	6	lamivudine	ATV	PA450163	4683	0.659
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jan_18_68(Pt_2)_o448.nxml.txt.nlp	22347059	SENT71	23	23	29	29	phenol	mol	PA450913	90527	0.659
NULL	Arthritis_Res_Ther_2004_Jun_21_6(4)_R384-R392.nxml.txt.nlp	15225374	SENT79	12	12	16	16	gentamicin	M-CSF	PA449753	1435	0.659
NULL	Cell_Res_2014_Feb_12_24(2)_143-160.nxml.txt.nlp	24217768	SENT68	16	16	12	12	heparin	FGFR1	PA449855	2260	0.659
NULL	Ther_Clin_Risk_Manag_2006_Sep_2(3)_281-295.nxml.txt.nlp	18360603	SENT321	10	10	12	12	alendronate	PTH	PA448082	5741	0.659
NULL	Ann_Rheum_Dis_2014_Jun_30_73(6)_990-999.nxml.txt.nlp	24482301	SENT101	30	30	28	28	ustekinumab	UST	PA166048654	10090	0.659
NULL	Br_J_Cancer_2001_Aug_85(3)_317-324.nxml.txt.nlp	11487258	SENT3	13	13	1	1	anastrozole	ATAC	PA448432	6375	0.659
NULL	Oncotarget_2012_Dec_30_3(12)_1505-1521.nxml.txt.nlp	23455493	SENT254	2	2	22	22	metformin	CD7	PA450395	924	0.659
NULL	Oncoimmunology_2013_Sep_1_2(9)_e25595.nxml.txt.nlp	24319634	SENT215	10	10	31	31	aldesleukin	IL-2	PA448081	3558	0.659
NULL	Daru_2012_Sep_3_20(1)_24.nxml.txt.nlp	23351176	SENT85	8	8	12	12	itopride	EPO	PA152432599	7076;8288;2056	0.659
NULL	Arthritis_Res_Ther_2014_Jan_14_16(1)_R9.nxml.txt.nlp	24423102	SENT297	16	16	3	3	trastuzumab	EZH2	PA451743	2146	0.659
NULL	Environ_Health_Perspect_2010_Jul_3_118(7)_936-942.nxml.txt.nlp	20199942	SENT220	19	19	21	21	arsenite	mot-2	PA452638	3313	0.659
NULL	Open_Biol_2014_Feb_4(2)_130210.nxml.txt.nlp	24554596	SENT447	22	22	25	25	trastuzumab	HER2	PA451743	2064	0.659
NULL	J_Phys_Ther_Sci_2013_Oct_20_25(10)_1317-1319.nxml.txt.nlp	24259784	SENT15	22	22	36	36	oxygen	ADP	PA450744	23038	0.659
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT3	0	0	27	27	perifosine	TRAIL	PA165291471	8743	0.659
NULL	Indian_J_Pharmacol_2008_Oct_40(5)_221-226.nxml.txt.nlp	20040961	SENT58	0	0	36	36	haloperidol	VHP	PA449841	285193	0.659
NULL	Chemother_Res_Pract_2012_Aug_29_2012_817297.nxml.txt.nlp	22970367	SENT125	19	19	26	26	erlotinib	AXL	PA134687924	558	0.659
NULL	J_Physiol_2009_Feb_15_587(Pt_4)_731-744.nxml.txt.nlp	19074966	SENT7	0	0	16	16	taurine	PAT1	PA451590	10513;206358	0.659
NULL	Int_J_Mol_Sci_2014_Sep_15_15(9)_16257-16269.nxml.txt.nlp	25226535	SENT65	5	5	10	10	collagenase	EGF	PA449107	1950	0.659
NULL	J_Mol_Med_(Berl)_2014_May_10_92(7)_709-722.nxml.txt.nlp	24811491	SENT109	34	34	8	8	cetuximab	PIK3CA	PA10040	5290	0.659
NULL	Adv_Biol_Regul_2014_Jan_19_0_197-206.nxml.txt.nlp	24103483	SENT77	26	26	15	15	lipase	PLD1	PA450239	5337	0.659
NULL	Oncol_Lett_2013_Jul_29_6(1)_23-27.nxml.txt.nlp	23946772	SENT34	20	20	32	32	ifosfamide	DDP	PA449964	1678	0.659
NULL	J_Gen_Physiol_1987_May_1_89(5)_815-837.nxml.txt.nlp	3496424	SENT0	11	11	1	1	creatine	Gen	PA164778930	348654	0.659
NULL	Oncol_Lett_2014_Oct_22_8(4)_1603-1607.nxml.txt.nlp	25202376	SENT130	11	11	35	35	cisplatin	BRCA1	PA449014	672	0.659
NULL	Drugs_R_D_2010_Sep_27_10(3)_179-202.nxml.txt.nlp	20945948	SENT291	3	3	8	8	telaprevir	IFN	PA165958354	3439	0.659
NULL	Cell_Death_Differ_2010_Oct_19_17(10)_1566-1576.nxml.txt.nlp	20300112	SENT156	0	0	30	30	etoposide	NAC	PA449552	22861	0.659
NULL	Eur_Arch_Psychiatry_Clin_Neurosci_2006_Dec_7_256(8)_464-475.nxml.txt.nlp	16960655	SENT509	17	17	8	8	fluoxetine	Gen	PA449673	348654	0.659
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Jul_20_69(Pt_8)_o1276.nxml.txt.nlp	24109358	SENT72	10	10	13	13	benzaldehyde	mol	PA448571	90527	0.659
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Apr_7_9_12.nxml.txt.nlp	20374640	SENT110	12	12	6	6	tetracycline	CHL	PA451640	91851	0.659
NULL	Pain_2014_Nov_155(11)_2306-2322.nxml.txt.nlp	25168672	SENT977	2	2	4	4	bupivacaine	LAM	PA135057240	7249;7248	0.659
NULL	Int_J_Genomics_2014_Jan_29_2014_894296.nxml.txt.nlp	24616891	SENT159	13	13	0	0	ethanol	PC1	PA448073	5122	0.659
NULL	Lipids_Health_Dis_2011_Jan_18_10_8.nxml.txt.nlp	21241519	SENT160	10	10	21	21	simvastatin	ABCA1	PA451363	19	0.659
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Apr_7_9_12.nxml.txt.nlp	20374640	SENT48	16	16	41	41	ampicillin	BSAC	PA448419	57591	0.659
NULL	AIDS_Res_Treat_2012_Mar_26_2012_948059.nxml.txt.nlp	22536498	SENT155	8	8	23	23	tenofovir	CD4	PA10204	920	0.659
NULL	Chin_J_Cancer_2012_Jul_31(7)_319-326.nxml.txt.nlp	22257382	SENT105	2	2	7	7	erlotinib	EGFR	PA134687924	1956	0.659
NULL	Mol_Vis_2007_Jan_24_13_66-78.nxml.txt.nlp	17277740	SENT186	34	34	16	16	taurine	VIT	PA451590	5212	0.659
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Aug_28_66(Pt_9)_o2417.nxml.txt.nlp	21588743	SENT58	20	20	11	11	ethanol	mol	PA448073	90527	0.659
NULL	Cell_Cycle_2012_Dec_15_11(24)_4661-4672.nxml.txt.nlp	23187802	SENT134	5	5	12	12	doxorubicin	p130	PA449412	5934	0.659
NULL	Emerg_Infect_Dis_2014_Mar_20(3)_400-408.nxml.txt.nlp	24565738	SENT128	20	20	22	22	rifampin	EMB	PA451250	133418	0.659
NULL	Theranostics_2014_Jan_29_4(4)_336-365.nxml.txt.nlp	24578720	SENT445	3	3	11	11	everolimus	PI3K	PA164746311	5290	0.659
NULL	Indian_J_Endocrinol_Metab_2013_Jul-Aug_17(4)_611-619.nxml.txt.nlp	23961476	SENT194	2	2	14	14	sitagliptin	GLP-1	PA164748978	100125288	0.659
NULL	Contemp_Oncol_(Pozn)_2012_Nov_20_16(5)_401-406.nxml.txt.nlp	23788917	SENT150	16	16	27	27	gefitinib	HER2	PA131301952	2064	0.659
NULL	Breast_Cancer_Res_2008_Dec_5_10(6)_R104.nxml.txt.nlp	19061505	SENT230	26	26	6	6	estradiol	JNK	PA449503	5599	0.659
NULL	Arthritis_Res_2002_Mar_27_4(Suppl_2)_S22-S28.nxml.txt.nlp	12110154	SENT52	13	13	20	20	infliximab	IL-6	PA452639	3569	0.659
NULL	Core_Evid_2007_Nov_30_2(2)_81-88.nxml.txt.nlp	21221177	SENT68	32	32	18	18	leucovorin	IFL	PA450198	3439	0.659
NULL	Biochem_Res_Int_2011_Nov_30_2011_850924.nxml.txt.nlp	21151514	SENT161	3	3	13	13	l-cysteine	PLP	PA449173	25824;5744	0.659
NULL	BMB_Rep_2014_May_47(5)_268-273.nxml.txt.nlp	24286315	SENT90	22	22	3	3	trastuzumab	PTEN	PA451743	5728	0.659
NULL	Breast_Cancer_Res_2011_Jan_17_13(1)_R5.nxml.txt.nlp	21241485	SENT332	15	15	8	8	estradiol	NGF	PA449503	4803	0.659
NULL	Case_Rep_Genet_2014_Jan_22_2014_413743.nxml.txt.nlp	24627811	SENT85	18	18	7	7	warfarin	CYP2C9	PA451906	1559	0.659
NULL	Int_J_Endocrinol_2010_Jul_18_2010_205357.nxml.txt.nlp	20706540	SENT138	25	25	13	13	galactose	GLUT11	PA449725	66035	0.659
NULL	Oncotarget_2013_Jun_4_4(5)_772-784.nxml.txt.nlp	23800712	SENT11	26	26	15	15	bevacizumab	EGFR	PA130232992	1956	0.659
NULL	Front_Oncol_2014_Apr_14_4_64.nxml.txt.nlp	24782981	SENT244	21	21	9	9	hydroxychloroquine	ATG7	PA164777036	10533	0.659
NULL	Eur_J_Nucl_Med_Mol_Imaging_2006_Oct_23_33(10)_1185-1195.nxml.txt.nlp	16718515	SENT407	5	5	3	3	dextran	EGF	PA449261	1950	0.659
NULL	Biomed_Res_Int_2014_Apr_10_2014_292017.nxml.txt.nlp	24818137	SENT70	35	35	41	41	nadh	MT-CYB	PA164755085	4519	0.659
NULL	Br_J_Cancer_2004_May_4_90(9)_1733-1739.nxml.txt.nlp	15150604	SENT109	8	8	5	5	anastrozole	aromatase	PA448432	1588	0.659
NULL	Br_J_Cancer_2010_Jan_5_102(1)_80-86.nxml.txt.nlp	19920817	SENT69	11	11	13	13	bevacizumab	IFN	PA130232992	3439	0.659
NULL	J_Breast_Cancer_2013_Jun_28_16(2)_133-137.nxml.txt.nlp	23843843	SENT95	0	0	36	36	mitomycin	CDK4	PA450524	1019	0.659
NULL	Comp_Hepatol_2004_Jan_14_3(Suppl_1)_S31.nxml.txt.nlp	14960183	SENT106	14	14	6	6	ethanol	TNF-alpha	PA448073	7124	0.659
NULL	Ann_Rheum_Dis_2014_Jun_30_73(6)_990-999.nxml.txt.nlp	24482301	SENT83	22	22	39	39	methotrexate	UST	PA450428	10090	0.659
NULL	J_Biol_Chem_2008_Nov_14_283(46)_31679-31689.nxml.txt.nlp	18755684	SENT269	7	7	10	10	iron	FAC	PA450087	2176	0.659
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT57	3	3	36	36	tamoxifen	p27	PA451581	5715;10534	0.659
NULL	J_Lipid_Res_2014_Oct_55(10)_2103-2112.nxml.txt.nlp	25139399	SENT117	4	4	11	11	atorvastatin	LDLR	PA448500	3949	0.659
NULL	Clin_Interv_Aging_2008_Mar_3(1)_45-50.nxml.txt.nlp	18488877	SENT31	0	0	2	2	raloxifene	BMD	PA451221	1756;7439	0.659
NULL	Br_J_Cancer_2013_Mar_19_108(5)_1079-1091.nxml.txt.nlp	23449353	SENT232	26	26	13	13	docetaxel	MIC-1	PA449383	29919;9518	0.659
NULL	Sensors_(Basel)_2013_Dec_27_14(1)_458-467.nxml.txt.nlp	24379050	SENT75	17	17	11	11	glucose	SPR	PA449773	6697;6869	0.659
NULL	Iran_J_Pharm_Res_2014_Spring_13(2)_417-429.nxml.txt.nlp	25237337	SENT211	21	21	5	5	methocarbamol	NIP	PA164749506	90527;10755	0.659
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Feb_18_65(Pt_3)_o546.nxml.txt.nlp	21582205	SENT70	27	27	11	11	ethanol	mol	PA448073	90527	0.659
NULL	Clin_Drug_Investig_2013_Aug_23_33(10)_727-736.nxml.txt.nlp	23975654	SENT76	0	0	2	2	omeprazole	CYP2C19	PA450704	1557	0.659
NULL	Arch_Osteoporos_2009_Dec_18_4(1-2)_1-8.nxml.txt.nlp	20234790	SENT76	35	35	28	28	teriparatide	PTH	PA451620	5741	0.659
NULL	Exp_Ther_Med_2013_Mar_17_5(3)_797-802.nxml.txt.nlp	23403698	SENT110	10	10	0	0	triciribine	PI3K	PA165958661	5290	0.659
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Apr_30_65(Pt_5)_m594.nxml.txt.nlp	21583816	SENT52	21	21	36	36	ethanol	mol	PA448073	90527	0.659
NULL	J_Oncol_2013_Feb_17_2013_872957.nxml.txt.nlp	23476648	SENT212	16	16	14	14	cisplatin	SFN	PA449014	25996;2810	0.659
NULL	Indian_J_Psychiatry_2010_Jan_52(Suppl1)_S362-S365.nxml.txt.nlp	21836706	SENT94	18	18	9	9	imipramine	DST	PA449969	667	0.659
NULL	Case_Rep_Anesthesiol_2011_Jan_18_2011_841510.nxml.txt.nlp	22611502	SENT21	5	5	10	10	fenofibrate	B12	PA449594	7126;4709	0.659
NULL	Pharmaceuticals_(Basel)_2012_Nov_29_5(12)_1291-1331.nxml.txt.nlp	24281338	SENT307	17	17	22	22	forskolin	ZO-1	PA146096022	7082	0.659
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT49	3	3	5	5	curcumin	TRAIL	PA151958596	8743	0.659
NULL	Aging_Cell_2012_Aug_11(4)_579-587.nxml.txt.nlp	22435726	SENT94	23	23	14	14	etoposide	CD28	PA449552	1493;940	0.659
NULL	Cell_Death_Dis_2012_Mar_1_3(3)_e275.nxml.txt.nlp	22378068	SENT220	3	3	15	15	metformin	AMPK	PA450395	5563	0.659
NULL	Arthritis_Res_Ther_2005_Jan_10_7(2)_R250-R255.nxml.txt.nlp	15743471	SENT148	8	8	2	2	adalimumab	CD69	PA10004	969	0.659
NULL	Front_Endocrinol_(Lausanne)_2011_Dec_29_2_107.nxml.txt.nlp	22645515	SENT36	1	1	31	31	trypsin	Hua	PA451806	1994	0.659
NULL	Pharm_Pract_(Granada)_2011_Mar_15_Jan-Mar_9(1)_1-10.nxml.txt.nlp	25132883	SENT156	6	6	15	15	warfarin	SPAF	PA451906	166378	0.659
NULL	J_Immune_Based_Ther_Vaccines_2008_Jun_9_6_3.nxml.txt.nlp	18541039	SENT133	0	0	11	11	ribavirin	IFN	PA451241	3439	0.659
NULL	Biochemistry_2012_Apr_17_51(15)_3170-3177.nxml.txt.nlp	22452743	SENT193	16	16	12	12	l-serine	CDP	PA451330	1523	0.659
NULL	J_Am_Heart_Assoc_2013_Dec_19_2(6)_e000439.nxml.txt.nlp	24334905	SENT304	18	18	10	10	doxorubicin	p62	PA449412	8878;10657;23636	0.659
NULL	Pharmaceutics_2012_Jan_31_4(1)_104-129.nxml.txt.nlp	24300183	SENT334	11	11	36	36	lidocaine	SMO	PA450226	6608;54498	0.659
NULL	Front_Behav_Neurosci_2012_Apr_10_6_16.nxml.txt.nlp	22514524	SENT144	10	10	14	14	pentagastrin	ANOVA	PA450849	4858	0.659
NULL	Arch_Med_Sci_2014_Aug_29_10(4)_643-650.nxml.txt.nlp	25276146	SENT8	11	11	9	9	everolimus	DES	PA164746311	1674	0.659
NULL	Breast_Cancer_Res_2010_Jun_28_12(3)_R43.nxml.txt.nlp	20579400	SENT160	16	16	18	18	estradiol	MAPT	PA449503	4137	0.659
NULL	Mol_Vis_2011_Aug_11_17_2157-2170.nxml.txt.nlp	21850191	SENT209	16	16	13	13	tacrolimus	p50	PA451578	958;4790	0.659
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT292	26	26	16	16	resveratrol	PUMA		27113	0.659
NULL	Theranostics_2014_Aug_15_4(11)_1072-1084.nxml.txt.nlp	25250092	SENT171	2	2	10	10	urokinase	NIR	PA451836	26155	0.659
NULL	Diabetes_2011_Jun_21_60(6)_1770-1778.nxml.txt.nlp	21562078	SENT197	3	3	5	5	metformin	AMPK	PA450395	5563	0.659
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT403	25	25	2	2	cetuximab	HER2	PA10040	2064	0.659
NULL	Eur_J_Med_Res_2014_Jun_24_19(1)_34.nxml.txt.nlp	24961604	SENT98	26	26	13	13	vincristine	BCL11A	PA451879	53335	0.659
NULL	CNS_Spectr_2014_Oct_3_19(5)_391-402.nxml.txt.nlp	24698103	SENT100	17	17	25	25	risperidone	hang	PA451257	374879	0.659
NULL	Iran_J_Basic_Med_Sci_2012_Mar-Apr_15(2)_709-718.nxml.txt.nlp	23493500	SENT132	2	2	16	16	ns-398	spatial		219793	0.659
NULL	AIDS_Res_Ther_2011_Oct_6_8_36.nxml.txt.nlp	21978457	SENT206	14	14	18	18	zinc	TNF	PA451956	7124	0.659
NULL	Arthritis_Res_Ther_2010_Jun_2_12(3)_R107.nxml.txt.nlp	20525198	SENT222	42	42	13	13	rolipram	CIA	PA153906323	25842;57727	0.659
NULL	Oncotarget_2013_Nov_7_4(12)_2550-2566.nxml.txt.nlp	24334291	SENT220	25	25	23	23	cyclophosphamide	CHOP	PA449165	1649	0.659
NULL	Crit_Care_2010_Oct_13_14(5)_R181.nxml.txt.nlp	20942931	SENT218	12	12	1	1	cisplatin	IL-6	PA449014	3569	0.659
NULL	Mol_Cancer_2009_Nov_19_8_108.nxml.txt.nlp	19925669	SENT243	4	4	12	12	doxorubicin	MRP3	PA449412	8714	0.659
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jul_29_65(Pt_8)_o2022.nxml.txt.nlp	21583691	SENT72	12	12	18	18	benzaldehyde	mol	PA448571	90527	0.659
NULL	J_Hematol_Oncol_2009_Dec_23_2_50.nxml.txt.nlp	20030851	SENT268	23	23	10	10	rituximab	p53	PA451261	7157	0.659
NULL	Eur_J_Haematol_2014_Feb_25_92(2)_127-136.nxml.txt.nlp	24118452	SENT179	28	28	16	16	anagrelide	CRT	PA164742986	811	0.659
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT13	16	16	19	19	trastuzumab	HER2	PA451743	2064	0.659
NULL	Evid_Based_Complement_Alternat_Med_2013_Nov_26_2013_731370.nxml.txt.nlp	24376467	SENT179	7	7	17	17	oseltamivir	TLR7	PA450721	51284	0.659
NULL	Br_J_Cancer_2011_May_24_104(11)_1786-1790.nxml.txt.nlp	21559018	SENT110	17	17	19	19	cetuximab	EGFR	PA10040	1956	0.659
NULL	Case_Rep_Neurol_2012_Jan_17_4(1)_13-19.nxml.txt.nlp	22379480	SENT24	7	7	10	10	heparin	ICAD	PA449855	1676	0.659
NULL	Am_J_Physiol_Cell_Physiol_2009_Oct_5_297(4)_C898-C906.nxml.txt.nlp	19657054	SENT284	38	38	21	21	collagenase	p38	PA449107	10598;1432;7965	0.659
NULL	Int_J_Mol_Sci_2012_Sep_19_13(9)_11881-11894.nxml.txt.nlp	23109889	SENT60	30	30	13	13	fluconazole	FLR1	PA449653	26234	0.659
NULL	Biologics_2012_Jul_13_6_221-231.nxml.txt.nlp	22904614	SENT39	23	23	12	12	cetuximab	EGFR	PA10040	1956	0.659
NULL	Eur_J_Med_Res_2010_Feb_26_15(2)_81-83.nxml.txt.nlp	20452889	SENT9	12	12	26	26	emtricitabine	CD4	PA10069	920	0.659
NULL	Oncotarget_2012_Jan_28_3(1)_78-83.nxml.txt.nlp	22289679	SENT87	6	6	18	18	gefitinib	AKT	PA131301952	207	0.659
NULL	Breast_Cancer_Res_2012_Jun_19_14(3)_311.nxml.txt.nlp	22713135	SENT7	19	19	17	17	exemestane	aromatase	PA449563	1588	0.659
NULL	Chin_J_Cancer_2012_Feb_31(2)_100-109.nxml.txt.nlp	22237039	SENT74	6	6	23	23	tariquidar	P-gp		5243	0.659
NULL	Indian_J_Med_Res_2013_Jan_137(1)_203-209.nxml.txt.nlp	23481074	SENT23	27	27	6	6	coumarin	CYP2C9	PA134521193	1559	0.659
NULL	Indian_J_Med_Res_2014_Jul_140(1)_116-122.nxml.txt.nlp	25222786	SENT7	21	21	23	23	ethambutol	EMB	PA164784021	133418	0.659
NULL	Br_J_Cancer_2013_May_14_108(9)_1862-1869.nxml.txt.nlp	23579219	SENT28	29	29	25	25	bevacizumab	ISX	PA130232992	91464	0.659
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Jan_15_70(Pt_2)_o140.nxml.txt.nlp	24764866	SENT75	31	31	34	34	benzaldehyde	mol	PA448571	90527	0.659
NULL	Mol_Cancer_2010_Jun_3_9_137.nxml.txt.nlp	20525240	SENT40	8	8	25	25	curcumin	XIAP	PA151958596	331	0.659
NULL	Curr_Infect_Dis_Rep_2012_Jun_14_14(3)_227-237.nxml.txt.nlp	22415581	SENT228	8	8	1	1	primaquine	G6PD	PA451103	2539	0.659
NULL	Adv_Hematol_2012_Apr_3_2012_460801.nxml.txt.nlp	22548066	SENT112	23	23	15	15	rituximab	MYC	PA451261	4609	0.659
NULL	Chemother_Res_Pract_2011_Sep_25_2011_730360.nxml.txt.nlp	22295205	SENT176	10	10	21	21	anastrozole	HER2	PA448432	2064	0.659
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT72	43	43	37	37	vinorelbine	ASC	PA451881	29108	0.659
NULL	Oncogenesis_2012_Apr_16_1(4)_e7.nxml.txt.nlp	23552604	SENT259	16	16	18	18	etoposide	CTRL	PA449552	1506	0.659
NULL	Breast_Cancer_Res_2011_Jun_9_13(3)_R57.nxml.txt.nlp	21658222	SENT24	25	25	9	9	epirubicin	UGT1A3	PA449476	54659	0.659
NULL	Mar_Drugs_2011_Aug_10_9(8)_1346-1358.nxml.txt.nlp	21892349	SENT96	26	26	11	11	thrombin	ADP	PA451674	23038	0.659
NULL	Drugs_Context_2013_Jan_3_2013_212245.nxml.txt.nlp	24432034	SENT304	28	28	33	33	duloxetine	NNT	PA10066	23530	0.659
NULL	Arch_Med_Sci_2011_Dec_31_7(6)_977-983.nxml.txt.nlp	22328880	SENT138	2	2	24	24	heparin	PAPP-A	PA449855	5069	0.659
NULL	Oncotarget_2014_Dec_1_5(22)_10965-10966.nxml.txt.nlp	25473898	SENT13	30	30	12	12	vincristine	STAT6	PA451879	6778	0.659
NULL	Front_Mol_Neurosci_2013_Apr_10_6_7.nxml.txt.nlp	23596389	SENT542	1	1	10	10	creatine	KCC2	PA164778930	57468	0.659
NULL	Exp_Ther_Med_2013_Jul_25_6(1)_109-114.nxml.txt.nlp	23935730	SENT104	16	16	6	6	lamivudine	CHOP	PA450163	1649	0.659
NULL	Br_J_Pharmacol_2011_Jul_163(6)_1263-1275.nxml.txt.nlp	21391977	SENT100	26	26	12	12	ketoconazole	CYP2C9	PA450146	1559	0.659
NULL	Evid_Based_Complement_Alternat_Med_2015_Jan_6_2015_736431.nxml.txt.nlp	25632290	SENT121	3	3	14	14	curcumin	CYP3A4	PA151958596	1576	0.659
NULL	Breast_Cancer_Res_2011_Nov_4_13(6)_R111.nxml.txt.nlp	22053985	SENT57	8	8	12	12	doxorubicin	IFN	PA449412	3439	0.659
NULL	J_Cell_Biol_1997_Jun_16_137(6)_1229-1241.nxml.txt.nlp	9182658	SENT89	12	12	23	23	glucosamine	CT1	PA164747613	1489;6535	0.659
NULL	Crit_Care_2008_Aug_29_12(4)_R111.nxml.txt.nlp	18759963	SENT141	8	8	15	15	tirofiban	PAC-1	PA451698	1844	0.659
NULL	Oncoimmunology_2013_Jul_1_2(7)_e24882.nxml.txt.nlp	24073370	SENT7	24	24	33	33	cisplatin	BTC	PA449014	685	0.659
NULL	Cancers_(Basel)_2012_Jul_25_4(3)_743-762.nxml.txt.nlp	24213464	SENT91	8	8	21	21	paraformaldehyde	San	PA450790	80218	0.659
NULL	Front_Neurosci_2012_May_30_6_77.nxml.txt.nlp	22661925	SENT228	7	7	12	12	ethanol	HEC	PA448073	10403	0.659
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT117	12	12	22	22	celecoxib	survivin	PA448871	332	0.659
NULL	FEBS_Open_Bio_2011_Dec_27_2_1-5.nxml.txt.nlp	23650573	SENT14	4	4	11	11	sunitinib	MDM2	PA162372840	4193	0.659
NULL	Oncogene_2014_Sep_18_33(38)_4685-4696.nxml.txt.nlp	24121268	SENT155	13	13	27	27	bortezomib	p53	PA10252	7157	0.658
NULL	Exp_Neurobiol_2014_Mar_27_23(1)_36-44.nxml.txt.nlp	24737938	SENT106	0	0	21	21	geldanamycin	HSF1	PA152031327	3297	0.658
NULL	Br_J_Cancer_2011_Apr_12_104(8)_1256-1261.nxml.txt.nlp	21448165	SENT131	25	25	27	27	bevacizumab	IFN	PA130232992	3439	0.658
NULL	J_Cell_Biol_1999_Feb_8_144(3)_413-425.nxml.txt.nlp	9971737	SENT64	29	29	37	37	l-glutamine	CO2	PA10090	4513	0.658
NULL	Br_J_Cancer_2012_Nov_20_107(11)_1853-1863.nxml.txt.nlp	23169338	SENT153	2	2	12	12	cisplatin	DNAJB11	PA449014	51726	0.658
NULL	Oncoimmunology_2012_Dec_1_1(9)_1661-1663.nxml.txt.nlp	23264929	SENT43	19	19	22	22	imiquimod	IFN	PA449972	3439	0.658
NULL	Cell_Death_Dis_2010_Oct_21_1(10)_e86.nxml.txt.nlp	21368859	SENT61	7	7	5	5	doxorubicin	TRAIL	PA449412	8743	0.658
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT23	26	26	32	32	pemetrexed	UNG	PA10810	7374	0.658
NULL	Evid_Based_Complement_Alternat_Med_2013_Jul_8_2013_636194.nxml.txt.nlp	23935670	SENT153	21	21	23	23	lipase	PPL	PA450239	5493	0.658
NULL	Br_J_Cancer_2012_May_8_106(10)_1598-1604.nxml.txt.nlp	22516948	SENT147	29	29	23	23	sunitinib	FGFR1	PA162372840	2260	0.658
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT275	26	26	6	6	glucose	EGFR	PA449773	1956	0.658
NULL	Cancer_Metastasis_Rev_2010_Sep_24_29(3)_465-482.nxml.txt.nlp	20730632	SENT317	2	2	7	7	genistein	p38	PA165109660	10598;1432;7965	0.658
NULL	Cells_2014_Apr_29_3(2)_331-362.nxml.txt.nlp	24785347	SENT189	11	11	16	16	capsaicin	TRPA1	PA448776	8989	0.658
NULL	Sci_Rep_2014_Dec_4_4_7315.nxml.txt.nlp	25472865	SENT26	26	26	28	28	thrombin	GT24	PA451674	1501	0.658
NULL	Br_J_Cancer_2006_Feb_13_94(3)_407-426.nxml.txt.nlp	16434996	SENT315	14	14	5	5	genistein	BRCA1	PA165109660	672	0.658
NULL	Mol_Cancer_2006_Sep_5_5_34.nxml.txt.nlp	16953886	SENT97	13	13	10	10	doxorubicin	TRAIL	PA449412	8743	0.658
NULL	Acta_Pharmacol_Sin_2011_Feb_4_32(2)_259-269.nxml.txt.nlp	21293479	SENT175	25	25	29	29	irinotecan	IL-3	PA450085	3562	0.658
NULL	Basic_Clin_Neurosci_2014_Summer_5(3)_182-190.nxml.txt.nlp	25337378	SENT153	8	8	5	5	bupropion	mol	PA448687	90527	0.658
NULL	New_Microbes_New_Infect_2014_May_4_2(3)_58-63.nxml.txt.nlp	25356345	SENT100	34	34	8	8	colistin	CTX	PA164760862	1593	0.658
NULL	Nucleic_Acids_Res_2013_May_12_41(9)_e101.nxml.txt.nlp	23482392	SENT381	6	6	15	15	bortezomib	AKR1B10	PA10252	57016	0.658
NULL	Aging_(Albany_NY)_2009_Mar_31_1(4)_412-424.nxml.txt.nlp	20195491	SENT106	6	6	8	8	resveratrol	TXNIP		10628	0.658
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT141	35	35	18	18	gefitinib	PI3K	PA131301952	5290	0.658
NULL	Ann_Hematol_2011_May_12_90(5)_557-568.nxml.txt.nlp	20938660	SENT149	14	14	25	25	plerixafor	CD34	PA165958410	947	0.658
NULL	Cell_Death_Differ_2010_May_13_17(5)_774-786.nxml.txt.nlp	19911006	SENT309	14	14	11	11	doxycycline	AATF	PA449415	26574	0.658
NULL	Pharmaceutics_2011_Oct_12_3(4)_680-705.nxml.txt.nlp	24309303	SENT140	20	20	14	14	trimethoprim	MATE1	PA451788	55244	0.658
NULL	Bone_Marrow_Transplant_2014_Feb_7_49(2)_219-222.nxml.txt.nlp	24096822	SENT84	21	21	11	11	plerixafor	CD34	PA165958410	947	0.658
NULL	J_Korean_Med_Sci_2004_Apr_30_19(2)_167-171.nxml.txt.nlp	15082886	SENT118	48	48	30	30	ofloxacin	EMB	PA450684	133418	0.658
NULL	Mol_Cancer_2010_Aug_20_9_220.nxml.txt.nlp	20727180	SENT109	5	5	7	7	nicotine	p53	PA450626	7157	0.658
NULL	Cancers_(Basel)_2014_Jun_27_6(3)_1328-1350.nxml.txt.nlp	24978436	SENT1532	15	15	12	12	melphalan	gamma	PA450354	9913	0.658
NULL	Crit_Care_2012_Jun_26_16(3)_R110.nxml.txt.nlp	22731930	SENT143	23	23	6	6	gentamicin	TMC	PA449753	3703	0.658
NULL	Mol_Cell_Proteomics_2012_Mar_2_11(3)_M111_013730.nxml.txt.nlp	22213832	SENT866	6	6	13	13	bortezomib	TRAIL	PA10252	8743	0.658
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT357	27	27	22	22	pp2	PP1		5540;5464	0.658
NULL	Biomed_Res_Int_2013_Nov_28_2013_789184.nxml.txt.nlp	24369535	SENT116	0	0	9	9	imatinib	CYP2D6	PA10804	1565	0.658
NULL	Biologics_2013_Apr_15_7_77-90.nxml.txt.nlp	23723688	SENT81	0	0	4	4	cetuximab	CRT	PA10040	811	0.658
NULL	Arch_Med_Sci_2012_Nov_9_8(5)_899-906.nxml.txt.nlp	23185202	SENT129	5	5	13	13	acarbose	ADN	PA448010	1675	0.658
NULL	J_Oncol_2013_Feb_17_2013_872957.nxml.txt.nlp	23476648	SENT33	28	28	13	13	cisplatin	SFN	PA449014	25996;2810	0.658
NULL	Oxid_Med_Cell_Longev_2010_Jan-Feb_3(1)_53-60.nxml.txt.nlp	20716928	SENT77	17	17	9	9	l-cysteine	NAC	PA449173	22861	0.658
NULL	Ann_Surg_Oncol_2014_Sep_5_21(2)_553-559.nxml.txt.nlp	24006094	SENT10	11	11	4	4	cisplatin	CO2	PA449014	4513	0.658
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT102	14	14	28	28	imatinib	ABCB1	PA10804	5243	0.658
NULL	Cancer_Cell_Int_2011_Mar_10_11_6.nxml.txt.nlp	21392380	SENT112	5	5	10	10	imipramine	HERG	PA449969	3757	0.658
NULL	Br_J_Cancer_2010_Jul_13_103(2)_265-274.nxml.txt.nlp	20551953	SENT327	3	3	8	8	cisplatin	JNK	PA449014	5599	0.658
NULL	Basic_Clin_Neurosci_2014_Summer_5(3)_182-190.nxml.txt.nlp	25337378	SENT176	5	5	2	2	bupropion	mol	PA448687	90527	0.658
NULL	J_Exp_Med_1998_Jun_1_187(11)_1885-1892.nxml.txt.nlp	9607928	SENT112	5	5	13	13	thalidomide	CD4	PA451644	920	0.658
NULL	Breast_Cancer_Res_2007_Dec_20_9(Suppl_2)_S11.nxml.txt.nlp	NULL	SENT19	16	16	24	24	anastrozole	ATAC	PA448432	6375	0.658
NULL	Clin_Transl_Allergy_2013_Sep_2_3_29.nxml.txt.nlp	24004581	SENT91	5	5	14	14	omalizumab	IL-4	PA164752253	3565	0.658
NULL	Br_J_Cancer_2011_Jun_28_105(1)_118-123.nxml.txt.nlp	21654685	SENT91	0	0	13	13	dasatinib	HOXC11	PA162372878	3227	0.658
NULL	Cardiovasc_Diabetol_2008_Jun_22_7_20.nxml.txt.nlp	18570678	SENT111	3	3	18	18	rosiglitazone	CD11b	PA451283	3684	0.658
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jun_20_68(Pt_7)_o2146-o2147.nxml.txt.nlp	22798820	SENT73	39	39	20	20	ethanol	mol	PA448073	90527	0.658
NULL	Nucleic_Acids_Res_2013_Nov_22_41(21)_9825-9838.nxml.txt.nlp	23969415	SENT70	15	15	22	22	l-valine	Met	PA451843	79811	0.658
NULL	F1000_Med_Rep_2011_May_3_3_9.nxml.txt.nlp	21654924	SENT118	13	13	32	32	cisplatin	NKG2D	PA449014	22914	0.658
NULL	J_Hematol_Oncol_2013_Jul_18_6_53.nxml.txt.nlp	23866964	SENT91	6	6	11	11	temsirolimus	AKT	PA164746890	207	0.658
NULL	Breast_Cancer_Res_2007_Jul_5_9(4)_R41.nxml.txt.nlp	17612393	SENT145	15	15	17	17	celecoxib	Bcl-2	PA448871	596	0.658
NULL	Nat_Med_2013_Dec_10_19(12)_10_1038_nm_3385.nxml.txt.nlp	24216752	SENT17	39	39	31	31	thrombin	PAR1	PA451674	79581;2149	0.658
NULL	Nat_Neurosci_2012_Sep_5_15(9)_1245-1254.nxml.txt.nlp	22864611	SENT173	33	33	12	12	clozapine	mGlu2	PA449061	2912	0.658
NULL	Daru_2012_Sep_3_20(1)_24.nxml.txt.nlp	23351176	SENT194	2	2	27	27	itopride	EPO	PA152432599	7076;8288;2056	0.658
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Apr_24_66(Pt_5)_o1139.nxml.txt.nlp	21579187	SENT73	30	30	25	25	ethanol	mol	PA448073	90527	0.658
NULL	Hum_Mol_Genet_2011_Jan_1_20(1)_80-89.nxml.txt.nlp	20926450	SENT8	25	25	7	7	oxygen	PTEN	PA450744	5728	0.658
NULL	Br_J_Cancer_2010_Jan_5_102(1)_80-86.nxml.txt.nlp	19920817	SENT88	0	0	4	4	sunitinib	IFN	PA162372840	3439	0.658
NULL	Cell_Commun_Signal_2014_May_15_12_34.nxml.txt.nlp	24885272	SENT179	9	9	21	21	heparin	FGF2	PA449855	2247;2258	0.658
NULL	Pain_Res_Treat_2012_Apr_23_2012_295926.nxml.txt.nlp	22577544	SENT139	26	26	20	20	dicyclomine	ARC	PA164744928	8996;23237	0.658
NULL	Clin_Ophthalmol_2012_Mar_13_6_397-401.nxml.txt.nlp	22457590	SENT27	32	32	7	7	lidocaine	Gen	PA450226	348654	0.658
NULL	Braz_J_Microbiol_2010_Mar_1_Jan-Mar_41(1)_59-65.nxml.txt.nlp	24031464	SENT45	30	30	7	7	novobiocin	API	PA164768819	5345	0.658
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Aug_16_70(Pt_9)_o1015-o1016.nxml.txt.nlp	25309199	SENT102	9	9	3	3	ethanol	mol	PA448073	90527	0.658
NULL	ScientificWorldJournal_2013_Jun_6_2013_943539.nxml.txt.nlp	23843741	SENT38	13	13	37	37	taurine	MEG3	PA451590	55384	0.658
NULL	Leukemia_2014_Jun_17_28(6)_1216-1226.nxml.txt.nlp	24301524	SENT106	12	12	17	17	bortezomib	NFKB1	PA10252	4790	0.658
NULL	Nat_Neurosci_2014_Jun_4_17(6)_813-821.nxml.txt.nlp	24793032	SENT157	18	18	20	20	topotecan	TPT	PA451729	23590;6469	0.658
NULL	Aging_(Albany_NY)_2012_Mar_12_4(3)_146-158.nxml.txt.nlp	22436213	SENT60	4	4	14	14	resveratrol	AMPK		5563	0.658
NULL	Mol_Cancer_2009_Apr_22_8_26.nxml.txt.nlp	19386116	SENT12	5	5	11	11	ritonavir	AKT	PA451260	207	0.658
NULL	Chem_Cent_J_2012_Jul_27_6_73.nxml.txt.nlp	22839208	SENT136	13	13	7	7	cefotaxime	CTX	PA448852	1593	0.658
NULL	Cell_Commun_Signal_2010_Sep_22_8_27.nxml.txt.nlp	20860841	SENT211	14	14	11	11	doxorubicin	CHK2	PA449412	11200	0.658
NULL	Biologics_2012_Dec_17_6_429-464.nxml.txt.nlp	23269860	SENT217	20	20	30	30	infliximab	ACR	PA452639	49	0.658
NULL	Cell_Microbiol_2014_Apr_6_16(4)_519-534.nxml.txt.nlp	24152255	SENT82	33	33	26	26	glucosamine	DC-SIGN	PA164747613	30835	0.658
NULL	Clinics_(Sao_Paulo)_2013_May_68(5)_592-598.nxml.txt.nlp	23778413	SENT84	33	33	26	26	epirubicin	NACT	PA449476	284111	0.658
NULL	J_Cell_Mol_Med_2014_Apr_20_18(4)_709-720.nxml.txt.nlp	24444314	SENT235	4	4	6	6	losartan	AMPK	PA450268	5563	0.658
NULL	Cell_Death_Dis_2012_Jun_21_3(6)_e330.nxml.txt.nlp	22717585	SENT109	3	3	14	14	simvastatin	LC3	PA451363	84557	0.658
NULL	J_Hum_Genet_2013_Jun_16_58(6)_353-361.nxml.txt.nlp	23677058	SENT128	39	39	26	26	etoposide	ABCC3	PA449552	8714	0.658
NULL	FEBS_Open_Bio_2014_Jan_6_4_77-89.nxml.txt.nlp	24490132	SENT749	9	9	7	7	ebselen	NAC	PA161660841	22861	0.658
NULL	Oncotarget_2013_Nov_22_5(4)_933-943.nxml.txt.nlp	24659749	SENT53	10	10	7	7	nutlin-3	AML3		860	0.658
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1063.nxml.txt.nlp	24556678	SENT36	0	0	3	3	thioridazine	c-FLIP	PA451666	8837	0.658
NULL	Mol_Cancer_2012_Dec_12_11_91.nxml.txt.nlp	23234355	SENT199	9	9	19	19	erlotinib	EGFR	PA134687924	1956	0.658
NULL	Lipids_Health_Dis_2011_Jan_24_10_20.nxml.txt.nlp	21261970	SENT79	9	9	19	19	lipase	ATGL	PA450239	57104	0.658
NULL	Br_J_Cancer_2011_May_24_104(11)_1786-1790.nxml.txt.nlp	21559018	SENT101	12	12	29	29	decitabine	EGFR	PA164749631	1956	0.658
NULL	Nat_Commun_2013_Oct_1_4_2516.nxml.txt.nlp	24084631	SENT123	6	6	15	15	losartan	AK4	PA450268	205	0.658
NULL	Indian_J_Med_Paediatr_Oncol_2013_Oct-Dec_34(4)_299-304.nxml.txt.nlp	24604961	SENT85	8	8	12	12	vincristine	CHOP	PA451879	1649	0.658
NULL	Front_Syst_Neurosci_2010_Jul_15_4_33.nxml.txt.nlp	20700385	SENT179	16	16	30	30	creatine	ANOVA	PA164778930	4858	0.658
NULL	Eur_J_Clin_Pharmacol_2011_Dec_23_67(12)_1231-1241.nxml.txt.nlp	21698374	SENT43	25	25	16	16	tacrolimus	CYP3A5	PA451578	1577	0.658
NULL	J_Adv_Pract_Oncol_2013_Sep_1_Sep-Oct_4(5)_307-321.nxml.txt.nlp	25032010	SENT49	27	27	0	0	melphalan	San	PA450354	80218	0.658
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT81	16	16	12	12	trastuzumab	STAT3	PA451743	6774	0.658
NULL	Support_Care_Cancer_2012_Jun_19_20(6)_1121-1133.nxml.txt.nlp	22258414	SENT274	3	3	15	15	lipase	Trad	PA450239	5892	0.658
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Feb_10_68(Pt_3)_o645.nxml.txt.nlp	22412548	SENT65	15	15	6	6	ethanol	mol	PA448073	90527	0.658
NULL	Cancer_Med_2013_Aug_10_2(4)_488-495.nxml.txt.nlp	24156021	SENT57	5	5	2	2	mitomycin	GEM	PA450524	2669	0.658
NULL	Acta_Neuropathol_2015_Oct_17_129_115-131.nxml.txt.nlp	25322816	SENT278	9	9	5	5	bevacizumab	LDHA	PA130232992	3939	0.658
NULL	Front_Neurosci_2012_May_30_6_77.nxml.txt.nlp	22661925	SENT257	12	12	7	7	ethanol	DCX	PA448073	1641	0.658
NULL	Mol_Cell_Neurosci_2013_Jul_55(100)_62-76.nxml.txt.nlp	22960139	SENT940	8	8	4	4	nadh	MELAS	PA164755085	4219	0.658
NULL	Diabetes_Metab_J_2014_Jun_17_38(3)_230-239.nxml.txt.nlp	25003077	SENT178	8	8	6	6	metformin	Met	PA450395	79811	0.658
NULL	Eur_J_Nutr_2014_Jul_12_53(2)_521-532.nxml.txt.nlp	23846557	SENT100	2	2	0	0	cyanocobalamin	B12	PA451892	7126;4709	0.658
NULL	Int_J_Gen_Med_2012_Nov_23_5_983-990.nxml.txt.nlp	23226071	SENT45	19	19	7	7	lamivudine	ART	PA450163	181	0.658
NULL	J_Mol_Signal_2010_Dec_13_5_20.nxml.txt.nlp	21144036	SENT5	20	20	22	22	troglitazone	TRG	PA451799	6965	0.658
NULL	Subst_Abuse_Treat_Prev_Policy_2008_Jun_20_3_17.nxml.txt.nlp	18570665	SENT129	8	8	15	15	buprenorphine	solo	PA448685	55701	0.658
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jun_25_67(Pt_7)_m978.nxml.txt.nlp	21836952	SENT61	11	11	37	37	ethanol	mol	PA448073	90527	0.658
NULL	J_Appl_Crystallogr_2010_Oct_1_43(Pt_5)_1189-1207.nxml.txt.nlp	22184476	SENT282	6	6	21	21	creatine	ADP	PA164778930	23038	0.658
NULL	J_Mol_Med_2008_Jul_2_86(7)_747-759.nxml.txt.nlp	18246321	SENT197	13	13	22	22	creatine	IKK2	PA164778930	3551	0.658
NULL	Infect_Dis_Ther_2013_Dec_8_2(2)_95-110.nxml.txt.nlp	25134474	SENT145	9	9	13	13	vancomycin	CABP	PA451850	6277	0.658
NULL	Evid_Based_Complement_Alternat_Med_2013_May_28_2013_629750.nxml.txt.nlp	23781265	SENT166	11	11	37	37	capsaicin	GADD153	PA448776	1649	0.658
NULL	Breast_Cancer_Res_2011_Dec_16_13(6)_R131.nxml.txt.nlp	22177475	SENT24	43	43	35	35	trastuzumab	HER2	PA451743	2064	0.658
NULL	ScientificWorldJournal_2014_May_19_2014_567148.nxml.txt.nlp	24971383	SENT181	11	11	3	3	epirubicin	MRP-1	PA449476	928	0.658
NULL	J_Parasitol_Res_2012_Aug_13_2012_296856.nxml.txt.nlp	22934153	SENT140	25	25	3	3	praziquantel	IL-5	PA164764583	3567	0.658
NULL	Br_J_Pharmacol_2008_Nov_11_155(6)_896-905.nxml.txt.nlp	18695641	SENT195	6	6	13	13	genistein	OPG	PA165109660	690	0.658
NULL	Int_J_Biol_Sci_2012_Oct_24_8(9)_1237-1247.nxml.txt.nlp	23136552	SENT168	4	4	12	12	tocilizumab	IL-6	PA165292659	3569	0.658
NULL	Oncol_Lett_2014_Mar_27_7(3)_820-826.nxml.txt.nlp	24520300	SENT7	40	40	42	42	cyclophosphamide	CTX	PA449165	1593	0.658
NULL	J_Hematol_Oncol_2012_Jul_2_5_35.nxml.txt.nlp	22747660	SENT17	15	15	10	10	crizotinib	HER-2	PA165946122	2064	0.658
NULL	J_Young_Pharm_2011_Apr-Jun_3(2)_97-104.nxml.txt.nlp	21731353	SENT164	17	17	10	10	glipizide	CS1	PA449762	57823	0.658
NULL	J_Exp_Clin_Cancer_Res_2009_Aug_19_28(1)_116.nxml.txt.nlp	19689822	SENT22	28	28	34	34	doxorubicin	CHOP	PA449412	1649	0.658
NULL	Int_Neurourol_J_2012_Mar_31_16(1)_37-40.nxml.txt.nlp	22500252	SENT60	19	19	21	21	vasopressin	AVP	PA451858	114548;551	0.658
NULL	Indian_J_Pharm_Sci_2008_Sep-Oct_70(5)_649-651.nxml.txt.nlp	21394266	SENT5	41	41	32	32	pitavastatin	mol	PA142650384	90527	0.658
NULL	Oncol_Lett_2014_May_11_7(5)_1401-1408.nxml.txt.nlp	24765145	SENT107	14	14	19	19	paclitaxel	PI3K	PA450761	5290	0.658
NULL	Arch_Med_Sci_2012_Nov_9_8(5)_899-906.nxml.txt.nlp	23185202	SENT147	41	41	25	25	pioglitazone	ADN	PA450970	1675	0.658
NULL	Acta_Ortop_Bras_2012_20(5)_258-261.nxml.txt.nlp	24453613	SENT2	16	16	22	22	bupivacaine	ACL	PA135057240	47	0.658
NULL	J_Headache_Pain_2010_Jun_22_11(3)_255-258.nxml.txt.nlp	20411294	SENT95	8	8	3	3	rizatriptan	5-HT1B	PA451264	3351	0.658
NULL	Mol_Cancer_2013_May_19_12_43.nxml.txt.nlp	23683438	SENT188	3	3	11	11	paclitaxel	PC3	PA450761	57332;7832;5122	0.658
NULL	Acta_Pharmacol_Sin_2011_Aug_18_32(8)_991-998.nxml.txt.nlp	21765445	SENT61	34	34	48	48	streptomycin	CO2	PA451512	4513	0.658
NULL	Int_J_Mol_Sci_2014_Oct_29_15(11)_19700-19728.nxml.txt.nlp	25356505	SENT108	24	24	34	34	thrombin	EGFR	PA451674	1956	0.658
NULL	Int_J_Biol_Sci_2013_Apr_22_9(4)_350-360.nxml.txt.nlp	23630447	SENT165	13	13	23	23	doxorubicin	STARS	PA449412	137735	0.658
NULL	N_Am_J_Med_Sci_2013_Jan_5(1)_71.nxml.txt.nlp	23378962	SENT24	17	17	36	36	estradiol	AMH	PA449503	268	0.658
NULL	Br_J_Cancer_2009_Mar_10_100(5)_732-738.nxml.txt.nlp	19259093	SENT20	18	18	36	36	cisplatin	ERCC1	PA449014	2067	0.658
NULL	Oncol_Lett_2014_Apr_4_7(4)_1011-1014.nxml.txt.nlp	24944660	SENT56	25	25	14	14	thyroglobulin	CK19	PA164754910	3880	0.658
NULL	Colomb_Med_(Cali)_44(1)_42-45.nxml.txt.nlp	24892321	SENT99	19	19	22	22	cyanocobalamin	B12	PA451892	7126;4709	0.658
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT69	6	6	4	4	methotrexate	MSH2	PA450428	4436	0.658
NULL	J_Gen_Physiol_1992_Apr_1_99(4)_531-544.nxml.txt.nlp	1597677	SENT9	19	19	9	9	tetracaine	gamma	PA451638	9913	0.658
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Sep_30_64(Pt_10)_o2048.nxml.txt.nlp	21201240	SENT60	25	25	20	20	ethanol	mol	PA448073	90527	0.658
NULL	J_Breast_Cancer_2011_Mar_31_14(1)_20-27.nxml.txt.nlp	21847390	SENT106	27	27	12	12	estradiol	CLDN6	PA449503	9074	0.658
NULL	Exp_Ther_Med_2013_Apr_5_5(4)_1259-1263.nxml.txt.nlp	23596498	SENT4	10	10	37	37	capsaicin	TRPV1	PA448776	7442	0.658
NULL	Oncotarget_2014_Aug_29_5(19)_8947-8958.nxml.txt.nlp	25333254	SENT32	21	21	15	15	plerixafor	CXCR4	PA165958410	7852	0.658
NULL	Br_J_Cancer_2012_Apr_24_106(9)_1543-1550.nxml.txt.nlp	22531721	SENT135	15	15	21	21	trastuzumab	CD55	PA451743	1604	0.658
NULL	Curr_Neuropharmacol_2009_Jun_7(2)_83-95.nxml.txt.nlp	19949566	SENT453	10	10	32	32	gabapentin	TGB	PA449720	5473	0.658
NULL	Cardiovasc_Res_2012_Dec_1_96(3)_466-475.nxml.txt.nlp	22915766	SENT220	20	20	29	29	creatine	HL-1	PA164778930	55600	0.658
NULL	Oncol_Rep_2013_Apr_23_29(4)_1268-1274.nxml.txt.nlp	23354756	SENT149	2	2	16	16	trastuzumab	SLC25A43	PA451743	203427	0.658
NULL	Indian_J_Pharmacol_2008_Mar-Apr_40(2)_84-86.nxml.txt.nlp	21279172	SENT77	12	12	9	9	erythromycin	CYP3A4	PA449493	1576	0.658
NULL	J_Gen_Physiol_1923_May_20_5(5)_647-659.nxml.txt.nlp	19872026	SENT4	12	12	1	1	trypsin	PDF	PA451806	64146;9518	0.658
NULL	CNS_Drugs_2013_Aug_23_27(11)_943-953.nxml.txt.nlp	23975660	SENT208	15	15	21	21	clonidine	ATX	PA449051	5168;23049	0.658
NULL	Mol_Cancer_2014_Jun_26_13_158.nxml.txt.nlp	24965046	SENT97	8	8	35	35	sorafenib	ANOVA	PA7000	4858	0.658
NULL	Adv_Biomed_Res_2014_Jan_27_3_53.nxml.txt.nlp	24627861	SENT58	7	7	12	12	heparin	ACT	PA449855	12;11332;9457;641455	0.658
NULL	Diabetes_2009_Dec_9_58(12)_2828-2834.nxml.txt.nlp	19741164	SENT239	11	11	19	19	glucose	SIRT1	PA449773	23411	0.658
NULL	Oncotarget_2014_Feb_7_5(3)_775-787.nxml.txt.nlp	24519956	SENT121	29	29	35	35	dasatinib	PC3	PA162372878	57332;7832;5122	0.658
NULL	J_Biomed_Sci_2014_Apr_29_21(1)_35.nxml.txt.nlp	24780003	SENT34	0	0	4	4	bevacizumab	VEGF-A	PA130232992	7422	0.658
NULL	Exp_Ther_Med_2013_Feb_13_5(2)_581-585.nxml.txt.nlp	23403473	SENT93	5	5	10	10	etanercept	p38	PA449515	10598;1432;7965	0.658
NULL	Br_J_Pharmacol_2014_Jun_15_171(11)_2705-2725.nxml.txt.nlp	24467436	SENT24	0	0	18	18	isoniazid	NAT	PA450112	6046	0.658
NULL	Sci_Rep_2014_Dec_12_4_7405.nxml.txt.nlp	25502009	SENT391	33	33	18	18	l-leucine	p38	PA450197	10598;1432;7965	0.658
NULL	Theranostics_2013_Jan_15_3(1)_47-75.nxml.txt.nlp	23382786	SENT89	36	36	29	29	bleomycin	CXCR4	PA448645	7852	0.658
NULL	Braz_J_Med_Biol_Res_2013_Sep_6_46(9)_746-751.nxml.txt.nlp	24036910	SENT23	10	10	12	12	genistein	PP1	PA165109660	5540;5464	0.658
NULL	J_Invest_Dermatol_2012_Sep_19_132(9)_2198-2205.nxml.txt.nlp	22513780	SENT80	26	26	17	17	isotretinoin	IL-6	PA450128	3569	0.658
NULL	Diabetol_Metab_Syndr_2014_Mar_31_6_47.nxml.txt.nlp	24684779	SENT100	21	21	11	11	pioglitazone	MCP-1	PA450970	6347	0.658
NULL	Sci_Rep_2014_Dec_19_4_7571.nxml.txt.nlp	25524368	SENT54	30	30	11	11	estradiol	mer	PA449503	10461	0.658
NULL	Biosci_Rep_2014_Dec_12_34(6)_e00160.nxml.txt.nlp	25495645	SENT268	26	26	11	11	lipase	ANGPTL3	PA450239	27329	0.658
NULL	Reprod_Biol_Endocrinol_2003_Dec_2_1_122.nxml.txt.nlp	14651749	SENT67	20	20	0	0	collagenase	IL-8	PA449107	3576	0.658
NULL	Arthritis_Res_Ther_2011_Feb_4_13(1)_R14.nxml.txt.nlp	21294864	SENT115	4	4	6	6	indomethacin	IL-17	PA449982	3605	0.658
NULL	Genome_Biol_2007_Sep_26_8(9)_227.nxml.txt.nlp	17903313	SENT31	2	2	29	29	protamine	PRM2	PA10366	5620	0.658
NULL	Adv_Hematol_2011_Jan_18_2011_439456.nxml.txt.nlp	21318045	SENT285	1	1	13	13	bortezomib	NF-kappaB	PA10252	4790	0.658
NULL	Diabetologia_2010_Oct_26_53(10)_2209-2219.nxml.txt.nlp	20582536	SENT198	15	15	20	20	indinavir	VAMP5	PA449977	10791	0.658
NULL	Mol_Cancer_2007_Aug_21_6_53.nxml.txt.nlp	17711579	SENT225	14	14	8	8	cisplatin	LATS2	PA449014	26524	0.658
NULL	J_Mater_Sci_Mater_Med_2010_Sep_19_21(9)_2683-2690.nxml.txt.nlp	20563626	SENT237	4	4	12	12	topotecan	U87	PA451729	677775;641648	0.658
NULL	Acta_Pharmacol_Sin_2014_Jun_4_35(6)_792-805.nxml.txt.nlp	24902787	SENT192	4	4	9	9	pravastatin	INS-1	PA451089	2305	0.658
NULL	Sensors_(Basel)_2010_Oct_12_10(10)_9155-9162.nxml.txt.nlp	22163401	SENT31	29	29	27	27	pp2	PP1		5540;5464	0.658
NULL	Sci_Rep_2014_Dec_3_4_7201.nxml.txt.nlp	25467193	SENT105	48	48	4	4	doxorubicin	NRF2	PA449412	2551;4780	0.658
NULL	J_Young_Pharm_2010_Oct-Dec_2(4)_428-429.nxml.txt.nlp	21264109	SENT36	11	11	5	5	metformin	B12	PA450395	7126;4709	0.658
NULL	Cancer_Immunol_Immunother_2011_Jul_24_60(7)_943-951.nxml.txt.nlp	21431918	SENT162	13	13	16	16	doxorubicin	CD34	PA449412	947	0.658
NULL	Biochem_Biophys_Res_Commun_2011_Nov_4_414(4)_820-825.nxml.txt.nlp	22020103	SENT341	14	14	25	25	paraformaldehyde	KAP1	PA450790	10155	0.658
NULL	Nat_Commun_2014_Aug_5_5_4408.nxml.txt.nlp	25093291	SENT373	13	13	6	6	cimetidine	HRH1	PA449001	3269;1659	0.658
NULL	Blood_Cancer_J_2013_May_17_3(5)_e115.nxml.txt.nlp	23686003	SENT21	6	6	3	3	thalidomide	CRBN	PA451644	51185	0.658
NULL	Bioinform_Biol_Insights_2013_Sep_18_7_289-306.nxml.txt.nlp	24092970	SENT209	24	24	10	10	carboplatin	PRAME	PA448803	23532	0.658
NULL	Case_Rep_Dermatol_2012_Jul_12_4(2)_158-162.nxml.txt.nlp	22807901	SENT44	0	0	21	21	tacrolimus	IL-4	PA451578	3565	0.658
NULL	Calcif_Tissue_Int_2010_Dec_16_87(6)_485-492.nxml.txt.nlp	20953593	SENT54	14	14	11	11	teriparatide	PTH	PA451620	5741	0.658
NULL	Indian_J_Ophthalmol_2010_Jul-Aug_58(4)_291-296.nxml.txt.nlp	20534918	SENT31	0	0	6	6	bevacizumab	San	PA130232992	80218	0.658
NULL	J_Adv_Pract_Oncol_2012_May_1_May-Jun_3(3)_161-169.nxml.txt.nlp	25031942	SENT309	13	13	15	15	carboplatin	TIC	PA448803	23550	0.658
NULL	Mol_Cancer_2008_Oct_23_7_82.nxml.txt.nlp	18947424	SENT680	45	45	32	32	verapamil	P-gp	PA451868	5243	0.658
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT230	7	7	14	14	curcumin	TRAIL	PA151958596	8743	0.658
NULL	Infect_Drug_Resist_2011_Mar_2_4_77-86.nxml.txt.nlp	21694911	SENT94	5	5	28	28	tigecycline	HAP	PA164746412	5915;10313	0.658
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_11_2013_987612.nxml.txt.nlp	23840275	SENT236	21	21	9	9	geldanamycin	Bcl-2	PA152031327	596	0.658
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT166	34	34	32	32	trastuzumab	MUC4	PA451743	4585	0.658
NULL	Emerg_Infect_Dis_2011_Jun_17(6)_1091-1094.nxml.txt.nlp	21749778	SENT133	16	16	26	26	ciprofloxacin	Mal	PA449009	114609	0.658
NULL	Front_Neurosci_2011_Mar_3_5_23.nxml.txt.nlp	21519398	SENT246	32	32	25	25	liraglutide	GLP-1	PA165958364	100125288	0.658
NULL	Front_Immunol_2013_May_15_4_116.nxml.txt.nlp	23720663	SENT243	10	10	18	18	temozolomide	CTX	PA451609	1593	0.658
NULL	J_Hematol_Oncol_2013_Apr_27_6_31.nxml.txt.nlp	23622716	SENT96	17	17	3	3	sunitinib	CD31	PA162372840	5175	0.658
NULL	Indian_J_Pharm_Sci_2014_Nov-Dec_76(6)_483-494.nxml.txt.nlp	25593381	SENT115	16	16	27	27	atorvastatin	ANOVA	PA448500	4858	0.658
NULL	Cancer_Cell_Int_2009_Sep_10_9_25.nxml.txt.nlp	19744341	SENT118	33	33	22	22	glucosamine	STAT3	PA164747613	6774	0.658
NULL	Cell_Death_Dis_2014_Feb_13_5(2)_e1055.nxml.txt.nlp	24525731	SENT310	12	12	17	17	cisplatin	XRCC1	PA449014	7515	0.658
NULL	Oncotarget_2014_Oct_21_5(22)_11252-11268.nxml.txt.nlp	25361004	SENT178	2	2	5	5	metformin	CLIC1	PA450395	1192	0.658
NULL	J_Hematol_Oncol_2010_Apr_7_3_13.nxml.txt.nlp	20374647	SENT174	21	21	14	14	flavopiridol	PSMB5	PA452627	5693	0.658
NULL	J_Gen_Physiol_1987_Nov_1_90(5)_651-669.nxml.txt.nlp	2826642	SENT0	12	12	1	1	amiloride	Gen	PA448368	348654	0.658
NULL	Mol_Cancer_2010_Aug_20_9_220.nxml.txt.nlp	20727180	SENT228	7	7	11	11	cisplatin	p53	PA449014	7157	0.658
NULL	Indian_J_Pharm_Sci_2013_Nov-Dec_75(6)_680-687.nxml.txt.nlp	24591743	SENT40	10	10	15	15	gemfibrozil	CYP2C8	PA449750	1558	0.658
NULL	Evid_Based_Complement_Alternat_Med_2011_Feb_13_2011_248481.nxml.txt.nlp	19861508	SENT154	24	24	5	5	cisplatin	ghrelin	PA449014	51738	0.658
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT361	7	7	5	5	pp2	PP1		5540;5464	0.658
NULL	Oncol_Lett_2013_Oct_1_6(4)_921-926.nxml.txt.nlp	24137437	SENT131	9	9	21	21	docetaxel	ID1	PA449383	3397	0.658
NULL	Mol_Cancer_2012_Jul_25_11_47.nxml.txt.nlp	22830443	SENT158	24	24	39	39	panitumumab	EGFR	PA162373091	1956	0.658
NULL	Int_J_Endocrinol_2010_May_26_2010_906163.nxml.txt.nlp	20585352	SENT52	5	5	11	11	cinacalcet	PTH	PA164776671	5741	0.658
NULL	Exp_Mol_Med_2012_Sep_30_44(9)_545-553.nxml.txt.nlp	22809901	SENT70	42	42	40	40	clozapine	PRDM16	PA449061	63976	0.658
NULL	Orphanet_J_Rare_Dis_2014_Dec_5_9(1)_194.nxml.txt.nlp	NULL	SENT383	18	18	37	37	desogestrel	CO2	PA449238	4513	0.658
NULL	J_Signal_Transduct_2011_Jul_26_2011_718609.nxml.txt.nlp	21808734	SENT16	16	16	23	23	heparin	perlecan	PA449855	3339	0.658
NULL	Infect_Drug_Resist_2014_Aug_19_7_223-228.nxml.txt.nlp	25187730	SENT138	21	21	15	15	ofloxacin	CPX	PA450684	1371;10682;1377	0.658
NULL	Arthritis_Res_Ther_2004_Jun_21_6(4)_R384-R392.nxml.txt.nlp	15225374	SENT71	25	25	29	29	gentamicin	M-CSF	PA449753	1435	0.658
NULL	Cent_European_J_Urol_2011_Dec_9_64(4)_256-257.nxml.txt.nlp	24578906	SENT16	6	6	14	14	doxazosin	CD133	PA449407	8842	0.658
NULL	Oncotarget_2014_Dec_4_5(22)_11365-11380.nxml.txt.nlp	25426548	SENT35	22	22	9	9	nutlin-3	p53		7157	0.658
NULL	J_Ophthalmol_2012_Dec_18_2012_483034.nxml.txt.nlp	22220269	SENT325	17	17	30	30	ranibizumab	PLGF	PA164746012	5228	0.658
NULL	Ann_Pediatr_Cardiol_2009_Jan-Jun_2(1)_65-73.nxml.txt.nlp	20300273	SENT134	8	8	20	20	vasopressin	AVP	PA451858	114548;551	0.658
NULL	Clin_Mol_Hepatol_2014_Dec_24_20(4)_338-344.nxml.txt.nlp	25548738	SENT135	17	17	23	23	ribavirin	BOC	PA451241	91653	0.658
NULL	J_Exp_Clin_Cancer_Res_2009_Aug_26_28(1)_119.nxml.txt.nlp	19709417	SENT52	17	17	28	28	epirubicin	CTX	PA449476	1593	0.658
NULL	Front_Immunol_2012_Feb_27_3_23.nxml.txt.nlp	22566907	SENT367	6	6	14	14	hyaluronan	CD25	PA165958431	3669;3559	0.658
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Sep_9_65(Pt_10)_o2403-o2404.nxml.txt.nlp	21577866	SENT83	0	0	6	6	haloperidol	mol	PA449841	90527	0.658
NULL	Indian_J_Pharm_Sci_2013_Jan-Feb_75(1)_94-98.nxml.txt.nlp	23901167	SENT87	36	36	17	17	bupropion	CYP1A2	PA448687	1544	0.658
NULL	Eur_J_Clin_Pharmacol_2012_Sep_15_68(9)_1267-1274.nxml.txt.nlp	22418828	SENT188	16	16	23	23	pantoprazole	CYP2C19	PA450774	1557	0.658
NULL	Int_J_Med_Sci_2014_Sep_3_11(11)_1172-1184.nxml.txt.nlp	25249786	SENT225	5	5	9	9	glibenclamide	STZ	PA449782	6484	0.658
NULL	Chin_J_Cancer_2012_Feb_31(2)_73-99.nxml.txt.nlp	22098950	SENT268	4	4	13	13	flavopiridol	MRP1	PA452627	4437	0.658
NULL	Arthritis_Res_Ther_2012_Jun_25_14(3)_215.nxml.txt.nlp	22731694	SENT99	16	16	10	10	rituximab	RIBA	PA451261	6014	0.657
NULL	Environ_Health_Perspect_2009_Feb_8_117(2)_175-180.nxml.txt.nlp	19270784	SENT141	13	13	11	11	doxorubicin	BPA	PA449412	667	0.657
NULL	Indian_J_Med_Res_2014_Jul_140(1)_130-137.nxml.txt.nlp	25222788	SENT56	14	14	21	21	cefotaxime	CTX	PA448852	1593	0.657
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT138	18	18	11	11	efavirenz	CYP3A	PA449441	1574	0.657
NULL	Orphanet_J_Rare_Dis_2014_Jan_9_9_4.nxml.txt.nlp	24405637	SENT21	12	12	9	9	celecoxib	p38	PA448871	10598;1432;7965	0.657
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT141	21	21	19	19	pp2	PP1		5540;5464	0.657
NULL	Oncotarget_2014_Feb_7_5(3)_775-787.nxml.txt.nlp	24519956	SENT106	9	9	17	17	docetaxel	PC3	PA449383	57332;7832;5122	0.657
NULL	Environ_Health_Perspect_2009_Feb_8_117(2)_175-180.nxml.txt.nlp	19270784	SENT214	14	14	7	7	doxorubicin	BPA	PA449412	667	0.657
NULL	Pharm_Pract_(Granada)_2011_Mar_15_Jan-Mar_9(1)_1-10.nxml.txt.nlp	25132883	SENT61	1	1	9	9	rivaroxaban	SPAF	PA165958360	166378	0.657
NULL	Acta_Pharmacol_Sin_2010_May_12_31(5)_578-584.nxml.txt.nlp	20383171	SENT157	11	11	13	13	berberine	JNK	PA165860812	5599	0.657
NULL	Aging_(Albany_NY)_2011_Jan_18_3(1)_33-43.nxml.txt.nlp	21248371	SENT213	14	14	17	17	zinc	p53	PA451956	7157	0.657
NULL	Curr_Neuropharmacol_2009_Jun_7(2)_83-95.nxml.txt.nlp	19949566	SENT474	10	10	32	32	gabapentin	TGB	PA449720	5473	0.657
NULL	J_Anim_Sci_Biotechnol_2013_Dec_18_4(1)_51.nxml.txt.nlp	24344643	SENT80	0	0	9	9	oxygen	CO2	PA450744	4513	0.657
NULL	Int_J_Mol_Sci_2014_Oct_27_15(11)_19487-19498.nxml.txt.nlp	25350112	SENT318	1	1	21	21	valsartan	AMPK	PA451848	5563	0.657
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Mar_26_3(3)_e107.nxml.txt.nlp	24670388	SENT5	8	8	15	15	warfarin	CYP3A	PA451906	1574	0.657
NULL	Parasit_Vectors_2009_Sep_25_2(Suppl_2)_S2.nxml.txt.nlp	19778463	SENT141	22	22	29	29	ivermectin	MOX	PA450133	26002	0.657
NULL	Vet_Res_2014_Jan_16_45(1)_5.nxml.txt.nlp	24428881	SENT69	26	26	31	31	heparin	IFN	PA449855	3439	0.657
NULL	Mol_Cancer_2012_Mar_21_11_13.nxml.txt.nlp	22436134	SENT253	0	0	19	19	doxorubicin	HuR	PA449412	1994	0.657
NULL	Curr_Opin_Lipidol_2014_Oct_4_25(5)_387-393.nxml.txt.nlp	25110901	SENT101	16	16	19	19	berberine	HNF1	PA165860812	6927	0.657
NULL	AIDS_Res_Treat_2012_Mar_5_2012_703604.nxml.txt.nlp	22500218	SENT112	38	38	9	9	artemether	CYP2A6	PA165111698	1548	0.657
NULL	J_Headache_Pain_2009_Apr_27_10(2)_105-110.nxml.txt.nlp	19172228	SENT99	31	31	27	27	capsaicin	c-fos	PA448776	2353	0.657
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jan_8_67(Pt_2)_o313-o314.nxml.txt.nlp	21523001	SENT73	27	27	22	22	ethanol	mol	PA448073	90527	0.657
NULL	J_Hematol_Oncol_2012_Mar_27_5_13.nxml.txt.nlp	22453030	SENT151	45	45	34	34	hyaluronan	ROCK1	PA165958431	6093	0.657
NULL	Acta_Pharmacol_Sin_2014_Aug_21_35(8)_1082-1092.nxml.txt.nlp	25047514	SENT224	4	4	9	9	estradiol	aromatase	PA449503	1588	0.657
NULL	J_Headache_Pain_2011_Aug_29_12(4)_411-417.nxml.txt.nlp	21626018	SENT86	24	24	27	27	capsaicin	mol	PA448776	90527	0.657
NULL	Curr_Neuropharmacol_2014_Jan_12(1)_2-36.nxml.txt.nlp	24533013	SENT208	8	8	20	20	rivastigmine	CB1	PA451262	1268	0.657
NULL	Oncotarget_2013_Nov_24_4(12)_2430-2438.nxml.txt.nlp	24280348	SENT112	9	9	13	13	gefitinib	SOCS3	PA131301952	9021	0.657
NULL	Diabetol_Metab_Syndr_2014_Mar_4_6_31.nxml.txt.nlp	24594121	SENT228	18	18	36	36	ramipril	DM2	PA451223	28508	0.657
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT268	6	6	9	9	glucose	TMS	PA449773	7298	0.657
NULL	J_Korean_Med_Sci_2009_Jan_29_24(Suppl_1)_S170-S175.nxml.txt.nlp	19194548	SENT127	16	16	18	18	cisplatin	EPO	PA449014	7076;8288;2056	0.657
NULL	AIDS_Res_Ther_2011_Oct_6_8_36.nxml.txt.nlp	21978457	SENT218	11	11	7	7	zinc	TNF	PA451956	7124	0.657
NULL	Indian_J_Med_Res_2014_Aug_140(2)_209-215.nxml.txt.nlp	25297352	SENT28	32	32	10	10	clobazam	CLB	PA10888	171425	0.657
NULL	Pharmaceutics_2011_Nov_18_3(4)_865-913.nxml.txt.nlp	24309312	SENT126	6	6	13	13	simvastatin	CYP3A4	PA451363	1576	0.657
NULL	Br_J_Cancer_2004_Mar_5_90(Suppl_1)_S7-S10.nxml.txt.nlp	15094758	SENT88	23	23	17	17	fulvestrant	CYP3A4	PA164747170	1576	0.657
NULL	Oncogene_2010_Sep_16_29(37)_5193-5203.nxml.txt.nlp	20581867	SENT21	8	8	10	10	lapatinib	HER3	PA152241907	2065	0.657
NULL	Breast_Cancer_Res_2008_Jul_24_10(4)_211.nxml.txt.nlp	18671839	SENT221	26	26	14	14	trastuzumab	CD40	PA451743	958	0.657
NULL	Iran_J_Basic_Med_Sci_2012_Sep-Oct_15(5)_1102-1105.nxml.txt.nlp	23492757	SENT3	14	14	18	18	celecoxib	IL-10	PA448871	3586	0.657
NULL	F1000_Med_Rep_2009_Apr_29_1_33.nxml.txt.nlp	20948747	SENT98	5	5	0	0	nicardipine	NEU	PA450620	2064	0.657
NULL	Scientifica_(Cairo)_2014_Apr_6_2014_394270.nxml.txt.nlp	24808974	SENT264	0	0	8	8	halothane	TASK	PA449845	3777	0.657
NULL	Chem_Cent_J_2012_Dec_10_6_152.nxml.txt.nlp	23228056	SENT24	28	28	26	26	thrombin	ADP	PA451674	23038	0.657
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT267	7	7	3	3	adalimumab	CD36	PA10004	948	0.657
NULL	Diabetes_Care_2011_Sep_19_34(9)_e140-e145.nxml.txt.nlp	21868769	SENT218	16	16	18	18	lipase	LIPG	PA450239	9388	0.657
NULL	Oncol_Lett_2014_Nov_14_8(5)_2086-2092.nxml.txt.nlp	25295095	SENT136	39	39	16	16	gemcitabine	CHK2	PA449748	11200	0.657
NULL	Environ_Microbiol_2013_Jan_15_15(1)_297-304.nxml.txt.nlp	23157680	SENT66	14	14	16	16	tetracycline	TMP	PA451640	2012	0.657
NULL	Cell_Death_Dis_2014_Feb_13_5(2)_e1055.nxml.txt.nlp	24525731	SENT6	18	18	9	9	cisplatin	XRCC1	PA449014	7515	0.657
NULL	J_Young_Pharm_2010_Jul-Sep_2(3)_311-314.nxml.txt.nlp	21042492	SENT42	9	9	5	5	gliclazide	PRG	PA10892	5544	0.657
NULL	Clin_Med_Insights_Case_Rep_2012_Nov_26_5_155-162.nxml.txt.nlp	23236259	SENT65	22	22	27	27	thyroglobulin	CEA	PA164754910	5670;1087	0.657
NULL	Mol_Vis_2012_Oct_5_18_2454-2467.nxml.txt.nlp	23077404	SENT134	10	10	26	26	bevacizumab	VEGF-A	PA130232992	7422	0.657
NULL	Diabetes_2013_Mar_14_62(3)_953-964.nxml.txt.nlp	23223176	SENT169	8	8	12	12	paroxetine	ROS	PA450801	6098	0.657
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT243	2	2	12	12	simvastatin	RANKL	PA451363	8600	0.657
NULL	J_Hum_Genet_2013_Jun_16_58(6)_353-361.nxml.txt.nlp	23677058	SENT173	27	27	3	3	etoposide	ABCC3	PA449552	8714	0.657
NULL	Exp_Ther_Med_2014_Jun_28_7(6)_1539-1544.nxml.txt.nlp	24926340	SENT24	8	8	0	0	geldanamycin	Hsp90	PA152031327	3320	0.657
NULL	EMBO_Mol_Med_2012_Jun_15_4(6)_472-485.nxml.txt.nlp	22419550	SENT141	26	26	11	11	thyroglobulin	IGFBP1	PA164754910	3484	0.657
NULL	Nat_Neurosci_2012_Sep_5_15(9)_1245-1254.nxml.txt.nlp	22864611	SENT173	33	33	14	14	clozapine	mGlu3	PA449061	2913	0.657
NULL	Cancer_Manag_Res_2012_Nov_9_4_383-395.nxml.txt.nlp	23204869	SENT142	8	8	19	19	carmustine	PC-3	PA448810	692094	0.657
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_29_2013_590393.nxml.txt.nlp	23737838	SENT187	0	0	5	5	resveratrol	p53		7157	0.657
NULL	Front_Endocrinol_(Lausanne)_2014_Feb_26_5_17.nxml.txt.nlp	24616713	SENT203	31	31	0	0	vasopressin	Gen	PA451858	348654	0.657
NULL	J_Korean_Med_Sci_2014_Jul_11_29(7)_965-972.nxml.txt.nlp	25045229	SENT78	12	12	36	36	metformin	B12	PA450395	7126;4709	0.657
NULL	Cancer_Cell_Int_2005_Aug_24_5_28.nxml.txt.nlp	16120219	SENT157	12	12	18	18	etoposide	MDM2	PA449552	4193	0.657
NULL	Mol_Med_Rep_2014_Nov_5_10(5)_2334-2340.nxml.txt.nlp	25189202	SENT6	12	12	14	14	cefoperazone	CFP	PA448849	5199	0.657
NULL	Cancer_Cell_2007_Dec_11_12(6)_514-527.nxml.txt.nlp	18068629	SENT124	9	9	14	14	paclitaxel	Rho	PA450761	29984	0.657
NULL	J_Korean_Med_Sci_2014_Jul_11_29(7)_965-972.nxml.txt.nlp	25045229	SENT167	13	13	18	18	metformin	B12	PA450395	7126;4709	0.657
NULL	Clin_Interv_Aging_2011_Dec_22_6_27-35.nxml.txt.nlp	21472089	SENT95	14	14	11	11	rosuvastatin	NNT	PA134308647	23530	0.657
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_P137.nxml.txt.nlp	NULL	SENT9	28	28	30	30	thiopental	COX2	PA451664	4513;5743	0.657
NULL	Indian_J_Med_Paediatr_Oncol_2013_Oct-Dec_34(4)_336-337.nxml.txt.nlp	24604973	SENT16	14	14	24	24	heparin	PF4	PA449855	5196	0.657
NULL	Pharmaceuticals_(Basel)_2013_Aug_6_6(8)_929-959.nxml.txt.nlp	24276377	SENT248	19	19	21	21	paclitaxel	HER-2	PA450761	2064	0.657
NULL	Mol_Cancer_2009_Nov_19_8_108.nxml.txt.nlp	19925669	SENT246	24	24	20	20	doxorubicin	MRP3	PA449412	8714	0.657
NULL	Indian_J_Endocrinol_Metab_2011_Jan-Mar_15(1)_9-17.nxml.txt.nlp	21584160	SENT172	8	8	24	24	liraglutide	PPG	PA165958364	5552	0.657
NULL	J_Gastroenterol_2013_Feb_22_48(2)_222-237.nxml.txt.nlp	22722906	SENT147	5	5	18	18	ethanol	ANOVA	PA448073	4858	0.657
NULL	Pharmaceutics_2011_Jan_13_3(1)_34-52.nxml.txt.nlp	21949900	SENT913	15	15	0	0	cisplatin	EGF	PA449014	1950	0.657
NULL	Oncol_Lett_2013_Mar_19_5(3)_923-928.nxml.txt.nlp	23426648	SENT9	8	8	1	1	sc-560	MVD		4597	0.657
NULL	Arthritis_Res_Ther_2014_Apr_3_16(2)_R86.nxml.txt.nlp	24708674	SENT245	2	2	8	8	bosentan	Fli1	PA10034	2314	0.657
NULL	Case_Rep_Med_2013_Dec_12_2013_834164.nxml.txt.nlp	24416042	SENT31	13	13	10	10	gefitinib	B12	PA131301952	7126;4709	0.657
NULL	Breast_Cancer_Res_2012_May_2_14(3)_R70.nxml.txt.nlp	22551440	SENT258	32	32	27	27	docetaxel	p53	PA449383	7157	0.657
NULL	J_Cancer_Prev_2014_Mar_19(1)_39-46.nxml.txt.nlp	25337571	SENT98	6	6	3	3	ethanol	JNK	PA448073	5599	0.657
NULL	J_Am_Heart_Assoc_2013_Dec_19_2(6)_e000355.nxml.txt.nlp	24190878	SENT28	5	5	0	0	isoproterenol	HK2	PA450121	3796;3099;29911;3741	0.657
NULL	Oncoscience_2014_Jun_3_1(6)_434-445.nxml.txt.nlp	25594042	SENT260	10	10	28	28	collagenase	CD44	PA449107	960	0.657
NULL	Iran_J_Microbiol_2013_Mar_5(1)_48-55.nxml.txt.nlp	23466743	SENT131	8	8	14	14	meropenem	CTX	PA164764445	1593	0.657
NULL	Front_Immunol_2012_Jan_2_2_82.nxml.txt.nlp	22566871	SENT643	0	0	5	5	resveratrol	fractalkine		6376	0.657
NULL	J_Ophthalmic_Inflamm_Infect_2013_Apr_22_3_46.nxml.txt.nlp	23607574	SENT63	10	10	16	16	ceftazidime	Gen	PA448861	348654	0.657
NULL	Gut_Liver_2011_Jun_24_5(2)_117-132.nxml.txt.nlp	21814590	SENT159	43	43	33	33	ribavirin	IFN	PA451241	3439	0.657
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT163	0	0	10	10	perifosine	DR5	PA165291471	8795	0.657
NULL	Am_J_Trop_Med_Hyg_2012_Mar_1_86(3)_489-495.nxml.txt.nlp	22403324	SENT179	25	25	23	23	ritonavir	P-gp	PA451260	5243	0.657
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_55-78.nxml.txt.nlp	19305788	SENT79	11	11	22	22	memantine	NR1	PA10364	27158	0.657
NULL	Indian_J_Anaesth_2014_Sep-Oct_58(5)_565-572.nxml.txt.nlp	25535418	SENT125	4	4	7	7	aprotinin	ACT	PA448472	12;11332;9457;641455	0.657
NULL	Biomed_Res_Int_2014_Apr_10_2014_580852.nxml.txt.nlp	24812624	SENT53	0	0	6	6	resveratrol	PTEN		5728	0.657
NULL	Diabetes_Care_2010_Sep_2_33(9)_1976-1982.nxml.txt.nlp	20519661	SENT110	29	29	27	27	sirolimus	DES	PA451365	1674	0.657
NULL	J_Breast_Cancer_2012_Dec_31_15(4)_427-433.nxml.txt.nlp	23346172	SENT39	10	10	13	13	doxorubicin	NAC	PA449412	22861	0.657
NULL	J_Med_Case_Rep_2014_Apr_3_8_113.nxml.txt.nlp	24708915	SENT55	13	13	17	17	vincristine	CHOP	PA451879	1649	0.657
NULL	BMJ_Open_2013_Dec_3_3(12)_e004025.nxml.txt.nlp	24302508	SENT195	7	7	15	15	fenofibrate	AMPK	PA449594	5563	0.657
NULL	J_Lipids_2011_Jan_13_2011_565316.nxml.txt.nlp	21490804	SENT199	13	13	20	20	doxorubicin	CD95	PA449412	355	0.657
NULL	Cell_Death_Dis_2012_Jun_21_3(6)_e330.nxml.txt.nlp	22717585	SENT93	4	4	7	7	simvastatin	XBP1	PA451363	7494	0.657
NULL	EMBO_J_2013_Mar_6_32(5)_629-644.nxml.txt.nlp	23299940	SENT128	16	16	18	18	hyaluronan	LYVE-1	PA165958431	10894	0.657
NULL	J_Korean_Med_Sci_2007_Dec_20_22(6)_1055-1059.nxml.txt.nlp	18162722	SENT31	12	12	7	7	famotidine	ESD	PA449586	2098	0.657
NULL	Acta_Pharmacol_Sin_2009_Nov_12_30(11)_1566-1572.nxml.txt.nlp	19820718	SENT36	14	14	22	22	omeprazole	CYP3A4	PA450704	1576	0.657
NULL	Proteins_2013_Aug_1_81(8)_1457-1465.nxml.txt.nlp	23589421	SENT56	12	12	6	6	l-alanine	PLP	PA448055	25824;5744	0.657
NULL	Structure_2013_Jan_8_21(1)_143-153.nxml.txt.nlp	23245851	SENT100	3	3	5	5	glucosamine	NAG	PA164747613	51594;4669	0.657
NULL	J_Int_Soc_Sports_Nutr_2010_Feb_3_7_8.nxml.txt.nlp	20181080	SENT111	2	2	4	4	vasopressin	AVP	PA451858	114548;551	0.657
NULL	Cells_2012_Aug_2_1(3)_428-448.nxml.txt.nlp	24710484	SENT251	40	40	21	21	resveratrol	p53		7157	0.657
NULL	J_Radiat_Res_2014_Nov_16_55(6)_1171-1177.nxml.txt.nlp	25129557	SENT48	23	23	17	17	capecitabine	CRT	PA448771	811	0.657
NULL	Carcinogenesis_2014_Sep_1_35(9)_1983-1992.nxml.txt.nlp	24692066	SENT173	3	3	37	37	tetracycline	CXCR4	PA451640	7852	0.657
NULL	J_Mol_Med_2008_Sep_4_86(9)_1045-1056.nxml.txt.nlp	18600309	SENT116	0	0	8	8	salmeterol	IL-8	PA451300	3576	0.657
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT242	16	16	5	5	doxorubicin	SLK	PA449412	9748;2534	0.657
NULL	Braz_J_Microbiol_2014_Mar_10_44(4)_1049-1057.nxml.txt.nlp	24688492	SENT152	18	18	4	4	lipase	ANOVA	PA450239	4858	0.657
NULL	Reprod_Biol_Endocrinol_2004_Aug_4_2_59.nxml.txt.nlp	15294019	SENT125	3	3	5	5	forskolin	EGF	PA146096022	1950	0.657
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_May_23_65(Pt_6)_o1371.nxml.txt.nlp	21583220	SENT76	16	16	19	19	benzaldehyde	mol	PA448571	90527	0.657
NULL	Brain_Res_2012_Feb_3_1436(C)_111-121.nxml.txt.nlp	22200378	SENT127	22	22	11	11	indomethacin	OAT	PA449982	4942	0.657
NULL	Fibrogenesis_Tissue_Repair_2012_Apr_28_5_6.nxml.txt.nlp	22541002	SENT97	36	36	32	32	cisplatin	CGI-59	PA449014	51631	0.657
NULL	Br_J_Cancer_2001_Jun_84(11)_1571-1576.nxml.txt.nlp	11384110	SENT7	6	6	10	10	docetaxel	Bcl-2	PA449383	596	0.657
NULL	Front_Neurol_2014_Jun_16_5_97.nxml.txt.nlp	24982649	SENT305	14	14	11	11	propofol	San	PA451141	80218	0.657
NULL	Pharmaceuticals_(Basel)_2012_Sep_12_5(9)_1008-1020.nxml.txt.nlp	24280702	SENT630	1	1	10	10	geldanamycin	Hsp90	PA152031327	3320	0.657
NULL	Int_J_Med_Sci_2012_Jun_8_9(4)_311-315.nxml.txt.nlp	22701339	SENT61	26	26	10	10	remifentanil	SAP	PA451232	4068;325	0.657
NULL	Aging_(Albany_NY)_2009_Mar_31_1(4)_412-424.nxml.txt.nlp	20195491	SENT104	11	11	27	27	resveratrol	G6PD		2539	0.657
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT128	19	19	4	4	amiodarone	CYP3A4	PA448383	1576	0.657
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT63	28	28	30	30	erlotinib	CYP3A	PA134687924	1574	0.657
NULL	Emerg_Infect_Dis_2013_Nov_19(11)_1803-1810.nxml.txt.nlp	24188126	SENT144	3	3	5	5	cefotaxime	CTX	PA448852	1593	0.657
NULL	Exp_Lung_Res_2013_Oct_1_39(8)_336-348.nxml.txt.nlp	23919450	SENT90	9	9	13	13	argatroban	PAR-1	PA164745516	2011;2149	0.657
NULL	J_Young_Pharm_2011_Apr-Jun_3(2)_97-104.nxml.txt.nlp	21731353	SENT194	3	3	15	15	glipizide	CS2	PA449762	64084	0.657
NULL	Front_Endocrinol_(Lausanne)_2013_Jul_8_4_80.nxml.txt.nlp	23847592	SENT36	6	6	12	12	diclofenac	UGT2B15	PA449293	7366	0.657
NULL	Crit_Care_2007_Sep_26_11(Suppl_4)_P19.nxml.txt.nlp	NULL	SENT2	6	6	8	8	vasopressin	AVP	PA451858	114548;551	0.657
NULL	AIDS_Res_Ther_2011_Oct_6_8_36.nxml.txt.nlp	21978457	SENT109	3	3	11	11	zinc	TNF	PA451956	7124	0.657
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT131	5	5	23	23	phenformin	CCL16	PA1000	6360	0.657
NULL	Cells_2014_Sep_12_3(3)_914-938.nxml.txt.nlp	25222270	SENT132	27	27	38	38	lipase	DAG	PA450239	1605	0.657
NULL	Nat_Commun_2010_Jun_1_1(3)_1-9.nxml.txt.nlp	20975695	SENT391	4	4	11	11	tamoxifen	E12	PA451581	64100	0.657
NULL	Cancer_Res_Treat_2014_Jan_15_46(1)_2-18.nxml.txt.nlp	24520218	SENT203	7	7	15	15	curcumin	DR5	PA151958596	8795	0.657
NULL	Diabetes_Care_2013_Jul_12_36(7)_2126-2132.nxml.txt.nlp	23645884	SENT113	12	12	10	10	exenatide	GLP-1	PA164749238	100125288	0.657
NULL	J_Viral_Hepat_2012_Feb_19(2)_e134-e142.nxml.txt.nlp	22239511	SENT19	10	10	5	5	ribavirin	SOC	PA451241	91544	0.657
NULL	Exp_Diabetes_Res_2012_Dec_26_2012_230624.nxml.txt.nlp	23365557	SENT185	31	31	36	36	liraglutide	LIR1	PA165958364	10859	0.657
NULL	J_Cell_Biol_1998_Mar_9_140(5)_1091-1099.nxml.txt.nlp	9490722	SENT41	16	16	2	2	taurine	ADP	PA451590	23038	0.657
NULL	DNA_Res_2012_Feb_30_19(1)_91-102.nxml.txt.nlp	22210603	SENT23	22	22	29	29	galactose	DAG	PA449725	1605	0.657
NULL	Front_Oncol_2014_Apr_9_4_75.nxml.txt.nlp	24782986	SENT231	28	28	10	10	paclitaxel	Oct4	PA450761	5460	0.657
NULL	Environ_Health_Perspect_2007_Dec_14_115(12)_1711-1716.nxml.txt.nlp	18087588	SENT61	29	29	31	31	diethylstilbestrol	DES	PA449307	1674	0.657
NULL	Aging_(Albany_NY)_2011_Jan_18_3(1)_33-43.nxml.txt.nlp	21248371	SENT111	0	0	3	3	zinc	HIF-1	PA451956	29072	0.657
NULL	Oxid_Med_Cell_Longev_2013_Sep_11_2013_639541.nxml.txt.nlp	24101950	SENT130	7	7	5	5	hemin	HO-1	PA449849	3162	0.657
NULL	Int_J_Crit_Illn_Inj_Sci_2013_Oct-Dec_3(4)_279-281.nxml.txt.nlp	24459628	SENT26	12	12	10	10	sargramostim	GM-CSF	PA164748631	1437	0.657
NULL	J_Biomed_Sci_2013_Nov_19_20(1)_86.nxml.txt.nlp	24251870	SENT254	32	32	15	15	isoflurane	spatial	PA450106	219793	0.657
NULL	Interdiscip_Perspect_Infect_Dis_2014_May_7_2014_849432.nxml.txt.nlp	24895495	SENT54	22	22	8	8	ritonavir	CD4	PA451260	920	0.657
NULL	Ann_Oncol_2010_Mar_18_21(3)_655-661.nxml.txt.nlp	19767314	SENT149	21	21	15	15	paclitaxel	GEM	PA450761	2669	0.657
NULL	Front_Neurol_2014_Dec_4_5_243.nxml.txt.nlp	25538673	SENT106	0	0	21	21	apomorphine	PPN	PA164781163	64840	0.657
NULL	Front_Mol_Neurosci_2012_Nov_26_5_100.nxml.txt.nlp	23189038	SENT222	18	18	25	25	furosemide	NKCC1	PA449719	6558	0.657
NULL	Case_Rep_Infect_Dis_2013_Oct_8_2013_693480.nxml.txt.nlp	24223316	SENT82	7	7	15	15	caspofungin	gamma	PA164743013	9913	0.657
NULL	Clin_Med_Insights_Oncol_2013_Jul_4_7_159-163.nxml.txt.nlp	23885182	SENT88	17	17	19	19	rituximab	CHOP	PA451261	1649	0.657
NULL	Oncol_Lett_2014_Jan_11_7(1)_156-158.nxml.txt.nlp	24348840	SENT38	11	11	7	7	cyclophosphamide	CHOP	PA449165	1649	0.657
NULL	Br_J_Cancer_2011_Jun_28_105(1)_1-8.nxml.txt.nlp	21654681	SENT85	20	20	36	36	cetuximab	EGFR	PA10040	1956	0.657
NULL	Oncotarget_2013_Nov_23_5(1)_196-210.nxml.txt.nlp	24344116	SENT191	20	20	18	18	doxorubicin	TNFAIP3	PA449412	7128	0.657
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT268	6	6	14	14	glucose	EGFR	PA449773	1956	0.657
NULL	Neural_Plast_2007_Oct_10_2007_23250.nxml.txt.nlp	NULL	SENT191	25	25	27	27	vasopressin	AVP	PA451858	114548;551	0.657
NULL	Evid_Based_Complement_Alternat_Med_2013_May_28_2013_629750.nxml.txt.nlp	23781265	SENT280	0	0	17	17	capsaicin	ATF4	PA448776	468	0.657
NULL	Brain_Sci_2012_Nov_27_2(4)_667-683.nxml.txt.nlp	24371520	SENT144	6	6	0	0	estradiol	OXT	PA449503	5020	0.657
NULL	Cardiovasc_Psychiatry_Neurol_2014_Feb_16_2014_631380.nxml.txt.nlp	24701348	SENT70	17	17	19	19	sugar	FBS	PA451529	64319;26269	0.657
NULL	Breast_Cancer_Res_2011_Mar_24_13(2)_R32.nxml.txt.nlp	21435239	SENT51	7	7	2	2	phenol	PC3	PA450913	57332;7832;5122	0.657
NULL	Br_J_Pharmacol_2014_Oct_26_171(20)_4785-4796.nxml.txt.nlp	25074741	SENT5	13	13	33	33	guanfacine	EPM	PA449825	2054	0.657
NULL	Curr_Oncol_2009_Jan_16(1)_16-26.nxml.txt.nlp	19229368	SENT46	11	11	4	4	panitumumab	KRAS	PA162373091	3845	0.657
NULL	J_Ophthalmol_2012_Aug_27_2012_285851.nxml.txt.nlp	23050121	SENT126	22	22	19	19	timolol	BAK	PA451690	578	0.657
NULL	Springerplus_2014_Sep_17_3_535.nxml.txt.nlp	25279326	SENT156	20	20	34	34	tamoxifen	AGO	PA451581	55294	0.657
NULL	Breast_Cancer_Res_2009_Jan_27_11(1)_R5.nxml.txt.nlp	19173736	SENT159	11	11	33	33	tamoxifen	San	PA451581	80218	0.657
NULL	Cell_Death_Dis_2014_Jan_9_5(1)_e982.nxml.txt.nlp	24407235	SENT143	23	23	27	27	l-glutamine	BDNF	PA10090	627	0.657
NULL	Front_Physiol_2013_Jan_3_3_484.nxml.txt.nlp	23316164	SENT165	11	11	13	13	vasopressin	AVP	PA451858	114548;551	0.657
NULL	J_Cell_Mol_Med_2013_Jan_10_17(1)_30-54.nxml.txt.nlp	23301832	SENT222	16	16	11	11	doxorubicin	PC3	PA449412	57332;7832;5122	0.657
NULL	Int_J_Mol_Sci_2014_Nov_17_15(11)_21270-21285.nxml.txt.nlp	25407530	SENT353	33	33	18	18	collagenase	c-Jun	PA449107	3725	0.657
NULL	Eur_J_Haematol_2014_Feb_25_92(2)_127-136.nxml.txt.nlp	24118452	SENT30	1	1	16	16	anagrelide	ELN	PA164742986	2006	0.657
NULL	Indian_J_Pharm_Sci_2014_Sep-Oct_76(5)_415-422.nxml.txt.nlp	25425755	SENT199	5	5	11	11	curcumin	MICE	PA151958596	4280;23581	0.657
NULL	Environ_Health_Perspect_2008_Apr_16_116(4)_426-433.nxml.txt.nlp	18414622	SENT84	3	3	5	5	genistein	aromatase	PA165109660	1588	0.657
NULL	Oncotarget_2012_Nov_8_3(11)_1472-1482.nxml.txt.nlp	23178531	SENT86	43	43	46	46	iron	IRP1	PA450087	48	0.657
NULL	Hematol_Rep_2013_Apr_4_5(1)_21-25.nxml.txt.nlp	23888242	SENT105	24	24	31	31	melphalan	HCST	PA450354	10870	0.657
NULL	Oncogene_2013_Sep_26_32(39)_10_1038_onc_2012_491.nxml.txt.nlp	23108394	SENT6	16	16	3	3	epirubicin	FOXM1	PA449476	2305	0.657
NULL	Case_Rep_Hematol_2014_Dec_11_2014_743856.nxml.txt.nlp	25580315	SENT38	5	5	14	14	cyclophosphamide	CHOP	PA449165	1649	0.657
NULL	Exp_Diabetes_Res_2008_Jan_4_2008_704045.nxml.txt.nlp	19132099	SENT41	8	8	31	31	berberine	STZ	PA165860812	6484	0.657
NULL	J_Thromb_Thrombolysis_2009_Nov_6_28(4)_410-417.nxml.txt.nlp	19504052	SENT33	29	29	36	36	clopidogrel	DES	PA449053	1674	0.657
NULL	Breast_Cancer_Res_2014_Sep_9_16(5)_433.nxml.txt.nlp	25212966	SENT305	19	19	21	21	aprotinin	ILEI	PA448472	10447	0.657
NULL	Aging_(Albany_NY)_2010_Dec_30_2(12)_897-899.nxml.txt.nlp	21212463	SENT6	12	12	6	6	metformin	HER-2	PA450395	2064	0.657
NULL	J_Cell_Biol_2003_Dec_22_163(6)_1385-1395.nxml.txt.nlp	14676308	SENT164	3	3	7	7	thrombin	RhoA	PA451674	387	0.657
NULL	Open_Biol_2014_Jan_4(1)_130138.nxml.txt.nlp	24403013	SENT280	12	12	21	21	etoposide	PP1	PA449552	5540;5464	0.657
NULL	Acta_Pharmacol_Sin_2010_Nov_18_31(11)_1447-1453.nxml.txt.nlp	20953204	SENT131	0	0	4	4	rimonabant	CB1	PA152407999	1268	0.657
NULL	Biomed_Res_Int_2014_Jan_23_2014_312647.nxml.txt.nlp	24587984	SENT164	0	0	10	10	infliximab	ABCA1	PA452639	19	0.657
NULL	J_Inherit_Metab_Dis_2010_Oct_2_33(5)_469-477.nxml.txt.nlp	20195903	SENT157	18	18	13	13	nadh	PDH	PA164755085	54704	0.657
NULL	Clin_Interv_Aging_2010_Nov_19_5_355-362.nxml.txt.nlp	21228901	SENT42	14	14	19	19	raloxifene	PTH	PA451221	5741	0.657
NULL	Oncol_Lett_2014_Sep_11_8(3)_1222-1228.nxml.txt.nlp	25120693	SENT140	27	27	21	21	olaparib	DDP		1678	0.657
NULL	An_Bras_Dermatol_2013_Nov-Dec_88(6)_945-953.nxml.txt.nlp	24474104	SENT99	19	19	42	42	calcidiol	PTH	PA164745614	5741	0.657
NULL	Mol_Cancer_2009_Aug_28_8_68.nxml.txt.nlp	19715609	SENT13	21	21	7	7	docetaxel	p75	PA449383	7133;11168	0.657
NULL	J_Biol_Eng_2009_Oct_16_3_18.nxml.txt.nlp	19835592	SENT138	6	6	39	39	kanamycin	CPZ	PA450137	8532	0.657
NULL	An_Bras_Dermatol_2014_Mar-Apr_89(2)_301-310.nxml.txt.nlp	24770508	SENT109	32	32	34	34	vinblastine	IFN	PA451877	3439	0.657
NULL	Cancer_Cell_Int_2009_Jan_8_9_3.nxml.txt.nlp	19128511	SENT32	8	8	3	3	oxaliplatin	PI3K	PA131285527	5290	0.657
NULL	Crit_Care_2010_Oct_13_14(5)_R181.nxml.txt.nlp	20942931	SENT14	35	35	5	5	cisplatin	IL-6	PA449014	3569	0.657
NULL	Nat_Commun_2013_Oct_15_4_2602.nxml.txt.nlp	24129506	SENT155	2	2	27	27	coumarin	S24	PA134521193	6229	0.657
NULL	Cancer_Res_Treat_2014_Jul_15_46(3)_234-242.nxml.txt.nlp	25038758	SENT28	12	12	5	5	paclitaxel	P-gp	PA450761	5243	0.657
NULL	Diabetes_2011_Nov_17_60(11)_2691-2700.nxml.txt.nlp	21896928	SENT237	13	13	7	7	resveratrol	SIRT1		23411	0.657
NULL	J_Cell_Mol_Med_2014_Jul_30_18(7)_1392-1406.nxml.txt.nlp	24779927	SENT304	2	2	4	4	curcumin	HIF-1	PA151958596	29072	0.657
NULL	Exp_Mol_Med_2012_Oct_31_44(10)_603-614.nxml.txt.nlp	22859500	SENT23	10	10	19	19	lipase	ATGL	PA450239	57104	0.657
NULL	Front_Endocrinol_(Lausanne)_2011_Apr_25_2_9.nxml.txt.nlp	22649361	SENT362	11	11	7	7	estradiol	aromatase	PA449503	1588	0.657
NULL	Evid_Based_Complement_Alternat_Med_2014_May_22_2014_601064.nxml.txt.nlp	25136372	SENT172	11	11	40	40	methotrexate	N10	PA450428	3164	0.657
NULL	Clinicoecon_Outcomes_Res_2014_Sep_23_6_409-414.nxml.txt.nlp	25285019	SENT139	20	20	6	6	ritonavir	ATV	PA451260	4683	0.657
NULL	Oncoimmunology_2013_Feb_1_2(2)_e23080.nxml.txt.nlp	23525357	SENT46	7	7	17	17	imatinib	IL-2	PA10804	3558	0.657
NULL	Br_J_Cancer_2010_Jan_5_102(1)_80-86.nxml.txt.nlp	19920817	SENT97	28	28	33	33	sunitinib	IFN	PA162372840	3439	0.657
NULL	Int_J_Biol_Sci_2013_Aug_14_9(8)_766-777.nxml.txt.nlp	23983610	SENT243	17	17	19	19	curcumin	B19	PA151958596	59271	0.657
NULL	Ann_Saudi_Med_2011_May-Jun_31(3)_279-283.nxml.txt.nlp	21623058	SENT61	10	10	3	3	cyclosporine	IL-2	PA449167	3558	0.657
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT149	5	5	26	26	doxorubicin	ABCB1	PA449412	5243	0.657
NULL	Cell_Death_Dis_2013_Jul_11_4(7)_e719.nxml.txt.nlp	23846221	SENT56	7	7	4	4	cisplatin	TRAIL	PA449014	8743	0.657
NULL	Oncoscience_2014_Oct_24_1(10)_665-673.nxml.txt.nlp	25593995	SENT79	15	15	5	5	doxorubicin	MDR1	PA449412	5243	0.657
NULL	Br_J_Cancer_2012_Feb_14_106(4)_685-692.nxml.txt.nlp	22294184	SENT247	17	17	8	8	docetaxel	L12	PA449383	26156;6136	0.657
NULL	Eur_J_Clin_Pharmacol_2011_Dec_23_67(12)_1231-1241.nxml.txt.nlp	21698374	SENT5	5	5	12	12	tacrolimus	ABCB1	PA451578	5243	0.657
NULL	J_Korean_Med_Sci_2014_Jul_11_29(7)_965-972.nxml.txt.nlp	25045229	SENT165	11	11	4	4	metformin	B12	PA450395	7126;4709	0.657
NULL	Pharmaceuticals_(Basel)_2013_Aug_21_6(8)_988-1038.nxml.txt.nlp	24276379	SENT486	13	13	3	3	vemurafenib	EGFR	PA165946873	1956	0.657
NULL	Br_J_Cancer_2009_Mar_10_100(5)_758-763.nxml.txt.nlp	19259094	SENT70	0	0	8	8	belinostat	MLH1		4292	0.657
NULL	Environ_Health_Perspect_2010_Jul_3_118(7)_936-942.nxml.txt.nlp	20199942	SENT136	16	16	21	21	arsenite	CBP	PA452638	55824;1387	0.657
NULL	Toxins_(Basel)_2010_Oct_26_2(11)_2490-2518.nxml.txt.nlp	22069563	SENT238	5	5	15	15	cisplatin	TLR4	PA449014	7099	0.657
NULL	Int_J_Environ_Res_Public_Health_2010_Aug_24_7(8)_3298-3312.nxml.txt.nlp	20948961	SENT147	22	22	7	7	malathion	LPO	PA164748092	4025	0.657
NULL	Front_Pharmacol_2014_May_8_5_85.nxml.txt.nlp	24847263	SENT153	12	12	8	8	resveratrol	STEP		84867	0.657
NULL	Cardiovasc_Res_2011_Apr_1_90(1)_140-147.nxml.txt.nlp	21071431	SENT94	0	0	30	30	resveratrol	EGF		1950	0.657
NULL	Environ_Health_Perspect_2008_Jan_5_116(1)_1-6.nxml.txt.nlp	18197291	SENT85	14	14	9	9	l-glutamine	FBS	PA10090	64319;26269	0.657
NULL	J_Immunother_2014_Sep_13_37(7)_360-365.nxml.txt.nlp	25075565	SENT163	7	7	10	10	aldesleukin	IL-2	PA448081	3558	0.656
NULL	J_Oncol_2010_Nov_19_2010_568938.nxml.txt.nlp	20037743	SENT298	23	23	29	29	carboplatin	EGFR	PA448803	1956	0.656
NULL	Braz_J_Med_Biol_Res_2014_Oct_14_47(12)_1068-1074.nxml.txt.nlp	25387674	SENT99	12	12	27	27	taurine	HCS	PA451590	3141;54205	0.656
NULL	Front_Oncol_2014_Jun_11_4_145.nxml.txt.nlp	24967214	SENT412	5	5	9	9	doxorubicin	B7-H1	PA449412	29126	0.656
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Sep_9_65(Pt_10)_o2409.nxml.txt.nlp	21577869	SENT58	23	23	19	19	ethanol	mol	PA448073	90527	0.656
NULL	Anticancer_Agents_Med_Chem_2012_Feb_12(2)_163-171.nxml.txt.nlp	22043994	SENT188	26	26	7	7	cetuximab	BRAF	PA10040	673	0.656
NULL	J_Gen_Intern_Med_2009_May_21_24(5)_656-664.nxml.txt.nlp	19306050	SENT360	2	2	7	7	warfarin	VKORC1	PA451906	79001	0.656
NULL	Cell_Death_Dis_2013_Jul_11_4(7)_e719.nxml.txt.nlp	23846221	SENT96	25	25	23	23	cisplatin	TRAIL	PA449014	8743	0.656
NULL	J_Allergy_(Cairo)_2011_Oct_24_2011_457169.nxml.txt.nlp	22121382	SENT99	1	1	5	5	salmeterol	IL-6	PA451300	3569	0.656
NULL	J_Cancer_2013_Jun_21_4(5)_391-401.nxml.txt.nlp	23833684	SENT148	21	21	17	17	trastuzumab	EEA1	PA451743	8411	0.656
NULL	Front_Oncol_2014_Oct_21_4_285.nxml.txt.nlp	25374842	SENT692	11	11	9	9	nutlin-3	p53		7157	0.656
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT82	35	35	17	17	metformin	p53	PA450395	7157	0.656
NULL	Breast_Cancer_Res_2002_Jan_14_4(2)_65-69.nxml.txt.nlp	11879566	SENT2	6	6	4	4	estradiol	aromatase	PA449503	1588	0.656
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Oct_31_65(Pt_11)_o2968-o2969.nxml.txt.nlp	21578539	SENT70	26	26	9	9	ethanol	mol	PA448073	90527	0.656
NULL	Front_Oncol_2013_Sep_24_3_251.nxml.txt.nlp	24069583	SENT166	4	4	30	30	carboplatin	GCG	PA448803	2641	0.656
NULL	Biosci_Rep_2013_Sep_17_33(5)_e00068.nxml.txt.nlp	23919527	SENT255	6	6	10	10	guanidine	CXCL8	PA164781028	3576	0.656
NULL	Mol_Cancer_2012_Jul_29_11_48.nxml.txt.nlp	22839996	SENT76	9	9	22	22	epirubicin	DDP	PA449476	1678	0.656
NULL	Exp_Neurobiol_2014_Mar_27_23(1)_65-76.nxml.txt.nlp	24737941	SENT173	12	12	24	24	staurosporine	ETO	PA165109623	862	0.656
NULL	Int_J_Environ_Res_Public_Health_2013_Sep_17_10(9)_4352-4389.nxml.txt.nlp	24048206	SENT287	19	19	14	14	choline	B12	PA448976	7126;4709	0.656
NULL	J_Inherit_Metab_Dis_2012_Jan_10_35(1)_141-149.nxml.txt.nlp	21556832	SENT185	3	3	36	36	creatine	CEE	PA164778930	51608	0.656
NULL	Iran_J_Public_Health_2012_Jan_31_41(1)_59-65.nxml.txt.nlp	23113123	SENT148	4	4	21	21	lipase	LIPC	PA450239	3990	0.656
NULL	Int_J_Hypertens_2013_Dec_11_2013_876865.nxml.txt.nlp	24396591	SENT124	19	19	11	11	simvastatin	SHARP	PA451363	23013	0.656
NULL	Curr_Neuropharmacol_2014_Jul_12(4)_308-323.nxml.txt.nlp	25342939	SENT2	11	11	13	13	vasopressin	AVP	PA451858	114548;551	0.656
NULL	Int_J_Nanomedicine_2012_May_7_7_2307-2314.nxml.txt.nlp	22661887	SENT103	25	25	18	18	gemcitabine	zeta	PA449748	9907	0.656
NULL	Acta_Pharmacol_Sin_2011_Apr_14_32(4)_449-455.nxml.txt.nlp	21399654	SENT3	3	3	18	18	telmisartan	PIR	PA451605	8544	0.656
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT17	13	13	24	24	l-leucine	ATP5A	PA450197	498	0.656
NULL	Genome_Biol_2011_Mar_17_12(3)_218.nxml.txt.nlp	21401968	SENT151	26	26	22	22	capsaicin	TRPV1	PA448776	7442	0.656
NULL	Nat_Commun_2014_Dec_8_5_5736.nxml.txt.nlp	25484020	SENT19	4	4	30	30	exemestane	aromatase	PA449563	1588	0.656
NULL	Eur_J_Clin_Pharmacol_2014_Mar_22_70(6)_685-693.nxml.txt.nlp	24658827	SENT142	0	0	18	18	cyclosporine	CYP3A4	PA449167	1576	0.656
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2008_Sep_1_64(Pt_9)_977-984.nxml.txt.nlp	18703847	SENT15	15	15	4	4	sulfamethoxazole	TMP	PA451544	2012	0.656
NULL	Indian_J_Pharmacol_2013_Sep-Oct_45(5)_439-446.nxml.txt.nlp	24130376	SENT98	18	18	10	10	clozapine	FGA	PA449061	2243	0.656
NULL	Int_J_Mol_Sci_2014_Oct_20_15(10)_18856-18891.nxml.txt.nlp	25334061	SENT1601	7	7	3	3	cisplatin	AKT	PA449014	207	0.656
NULL	Clin_Psychopharmacol_Neurosci_2011_Aug_31_9(2)_78-85.nxml.txt.nlp	23429185	SENT133	9	9	36	36	clozapine	PPL	PA449061	5493	0.656
NULL	Antibiotics_(Basel)_2014_Jul_1_3(3)_285-316.nxml.txt.nlp	25364574	SENT280	18	18	8	8	imipenem	IMP-1	PA449968	10642	0.656
NULL	Mol_Vis_2012_Oct_5_18_2454-2467.nxml.txt.nlp	23077404	SENT156	7	7	2	2	bevacizumab	HIF-1	PA130232992	29072	0.656
NULL	J_Korean_Med_Sci_2010_Nov_26_25(11)_1553-1559.nxml.txt.nlp	21060742	SENT158	20	20	34	34	heparin	TKR	PA449855	8277	0.656
NULL	Iran_J_Public_Health_2011_Sep_30_40(3)_63-70.nxml.txt.nlp	23113087	SENT167	13	13	9	9	sugar	FBS	PA451529	64319;26269	0.656
NULL	Arthritis_Res_Ther_2005_Nov_10_7(1)_R30-R37.nxml.txt.nlp	15642140	SENT44	10	10	27	27	paraformaldehyde	San	PA450790	80218	0.656
NULL	Mol_Cancer_2010_Dec_20_9_317.nxml.txt.nlp	21172025	SENT158	14	14	10	10	tamoxifen	HER2	PA451581	2064	0.656
NULL	Infect_Drug_Resist_2014_Aug_19_7_223-228.nxml.txt.nlp	25187730	SENT138	25	25	15	15	moxifloxacin	CPX	PA450555	1371;10682;1377	0.656
NULL	Ecancermedicalscience_2011_Apr_28_5_211.nxml.txt.nlp	22276054	SENT34	10	10	8	8	aprepitant	NK-1	PA164747039	27087	0.656
NULL	Leukemia_2013_Jan_11_27(1)_32-40.nxml.txt.nlp	22781593	SENT158	0	0	17	17	ponatinib	FGFR1	PA165980594	2260	0.656
NULL	Eur_J_Endocrinol_2014_Mar_170(3)_451-459.nxml.txt.nlp	24362411	SENT172	10	10	20	20	liraglutide	GLP-1	PA165958364	100125288	0.656
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT153	20	20	6	6	perifosine	DR5	PA165291471	8795	0.656
NULL	Ann_Rheum_Dis_2009_Dec_4_68(12)_1870-1877.nxml.txt.nlp	19124524	SENT160	34	34	16	16	abatacept	ACR	PA164747080	49	0.656
NULL	Cell_Death_Dis_2010_Nov_18_1(11)_e102.nxml.txt.nlp	21368867	SENT156	8	8	3	3	gentamicin	CLIMP-63	PA449753	10970	0.656
NULL	Mol_Cancer_2009_Oct_8_8_83.nxml.txt.nlp	19814803	SENT167	2	2	12	12	triciribine	CTRL	PA165958661	1506	0.656
NULL	J_Geriatr_Cardiol_2014_Jun_11(2)_151-157.nxml.txt.nlp	25009566	SENT124	19	19	16	16	cilostazol	CDP	PA164746334	1523	0.656
NULL	Cancer_Metab_2014_Aug_18_2_13.nxml.txt.nlp	25225614	SENT271	43	43	31	31	lipase	DAGLA	PA450239	747	0.656
NULL	Carcinogenesis_2008_Sep_9_29(9)_1734-1741.nxml.txt.nlp	18544564	SENT15	4	4	39	39	bortezomib	TRAIL	PA10252	8743	0.656
NULL	Evid_Based_Complement_Alternat_Med_2012_May_7_2012_242810.nxml.txt.nlp	22645625	SENT142	13	13	17	17	rifampin	CYP3A4	PA451250	1576	0.656
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R93.nxml.txt.nlp	22541888	SENT151	3	3	8	8	ustekinumab	IL-23	PA166048654	51561	0.656
NULL	Evid_Based_Complement_Alternat_Med_2013_Oct_24_2013_817826.nxml.txt.nlp	24282438	SENT9	26	26	15	15	flutamide	PI3K	PA449685	5290	0.656
NULL	Int_J_Mol_Cell_Med_2014_Summer_3(3)_183-189.nxml.txt.nlp	25317405	SENT35	0	0	8	8	estradiol	ARC	PA449503	8996;23237	0.656
NULL	J_Exp_Bot_2008_Oct_59(13)_3721-3728.nxml.txt.nlp	18820260	SENT25	14	14	21	21	pp2	14-3-3		10971	0.656
NULL	Arthritis_Res_Ther_2011_Apr_4_13(2)_R56.nxml.txt.nlp	21463515	SENT20	23	23	6	6	alefacept	IL-23	PA164748040	51561	0.656
NULL	Evid_Based_Complement_Alternat_Med_2011_Jan_9_2011_619650.nxml.txt.nlp	21799685	SENT147	24	24	12	12	ketanserin	5-HT1A	PA131053734	3350	0.656
NULL	J_Mol_Signal_2006_Dec_6_1_8.nxml.txt.nlp	17224083	SENT57	8	8	11	11	thrombin	Rho	PA451674	29984	0.656
NULL	Semin_Arthritis_Rheum_2014_Oct_44(2)_131-144.nxml.txt.nlp	24925692	SENT138	5	5	37	37	methotrexate	ERAS	PA450428	3266	0.656
NULL	Chromatographia_2009_Jun_26_69(Suppl_2)_167-173.nxml.txt.nlp	19554204	SENT133	2	2	0	0	hesperetin	MS2	PA164742902	101	0.656
NULL	J_Ind_Microbiol_Biotechnol_2014_Feb_26_41(4)_733-739.nxml.txt.nlp	24570325	SENT139	10	10	13	13	nadh	XDH	PA164755085	7498	0.656
NULL	Indian_J_Pharmacol_2013_Mar-Apr_45(2)_195-196.nxml.txt.nlp	23716902	SENT55	25	25	28	28	aripiprazole	EOS	PA10026	260429	0.656
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Dec_9_6_191-203.nxml.txt.nlp	25525387	SENT163	13	13	21	21	cetuximab	EGFR	PA10040	1956	0.656
NULL	Oncotarget_2013_Oct_19_4(11)_2045-2056.nxml.txt.nlp	24185104	SENT109	11	11	21	21	cisplatin	14-3-3	PA449014	10971	0.656
NULL	Pharmaceutics_2011_Nov_18_3(4)_865-913.nxml.txt.nlp	24309312	SENT292	30	30	12	12	lansoprazole	CYP2C19	PA450180	1557	0.656
NULL	Biologics_2012_Dec_17_6_429-464.nxml.txt.nlp	23269860	SENT163	8	8	27	27	abatacept	ACR	PA164747080	49	0.656
NULL	Oncotarget_2010_Nov_19_1(7)_472-482.nxml.txt.nlp	21317446	SENT37	6	6	26	26	fludarabine	TP53	PA449655	7157	0.656
NULL	Int_J_Ion_Mobil_Spectrom_2009_Aug_1_12(3)_91-102.nxml.txt.nlp	20835390	SENT142	6	6	15	15	loratadine	mol	PA450266	90527	0.656
NULL	J_Brachial_Plex_Peripher_Nerve_Inj_2008_Mar_19_3_8.nxml.txt.nlp	18353188	SENT205	3	3	17	17	capsaicin	SSeCKS	PA448776	9590	0.656
NULL	AMB_Express_2014_May_1_4_41.nxml.txt.nlp	24949274	SENT141	11	11	7	7	ethanol	CO2	PA448073	4513	0.656
NULL	Br_J_Cancer_2013_Dec_10_109(12)_2954-2958.nxml.txt.nlp	24231949	SENT95	17	17	29	29	gemcitabine	p53	PA449748	7157	0.656
NULL	Ann_Thorac_Med_2014_Apr-Jun_9(2)_124-126.nxml.txt.nlp	24791177	SENT82	28	28	10	10	sirolimus	LAM	PA451365	7249;7248	0.656
NULL	Diabetes_Care_2010_Feb_33(2)_428-433.nxml.txt.nlp	20103558	SENT80	13	13	20	20	sitagliptin	HIP	PA164748978	6767;6159;64399;5068	0.656
NULL	Oncotarget_2014_Jun_18_5(14)_5453-5471.nxml.txt.nlp	24977961	SENT74	5	5	7	7	bortezomib	Vel	PA10252	388588	0.656
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1033-1038.nxml.txt.nlp	22374460	SENT137	7	7	16	16	gemcitabine	HER2	PA449748	2064	0.656
NULL	Chin_J_Cancer_2012_Feb_31(2)_73-99.nxml.txt.nlp	22098950	SENT84	14	14	12	12	topotecan	TPT	PA451729	23590;6469	0.656
NULL	J_Cell_Mol_Med_2014_Oct_11_18(10)_2031-2043.nxml.txt.nlp	25109475	SENT12	0	0	2	2	valsartan	AMPK	PA451848	5563	0.656
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_May_11_67(Pt_6)_o1372-o1373.nxml.txt.nlp	21754763	SENT78	22	22	17	17	ethanol	mol	PA448073	90527	0.656
NULL	Cell_J_2014_May_25_Summer_16(2)_163-170.nxml.txt.nlp	24567946	SENT114	5	5	2	2	naloxone	CA1	PA450586	759	0.656
NULL	Int_J_Mol_Sci_2014_Oct_6_15(10)_17886-17900.nxml.txt.nlp	25290095	SENT9	0	0	12	12	resveratrol	p38		10598;1432;7965	0.656
NULL	Cancer_Inform_2011_Oct_27_10_259-271.nxml.txt.nlp	22084566	SENT171	14	14	25	25	acetanilide	Tech	PA448016	57449	0.656
NULL	Curr_Neuropharmacol_2014_Jul_12(4)_365-379.nxml.txt.nlp	25342944	SENT129	23	23	7	7	fluoxetine	cPLA2	PA449673	10524	0.656
NULL	Breast_Cancer_Res_2005_Mar_4_7(3)_R345-R352.nxml.txt.nlp	15987429	SENT231	23	23	25	25	pirenzepine	PIR	PA10159	8544	0.656
NULL	Cell_Death_Dis_2012_Jul_19_3(7)_e353.nxml.txt.nlp	22825471	SENT124	22	22	16	16	camptothecin	DR5	PA153590860	8795	0.656
NULL	Cardiovasc_Diabetol_2010_Sep_23_9_57.nxml.txt.nlp	20863381	SENT189	17	17	34	34	pioglitazone	DM2	PA450970	28508	0.656
NULL	Oncotarget_2010_Nov_25_1(7)_662-673.nxml.txt.nlp	21317461	SENT50	5	5	16	16	protamine	kallistatin	PA10366	5267	0.656
NULL	Emerg_Infect_Dis_2012_Feb_18(2)_302-304.nxml.txt.nlp	22305387	SENT113	20	20	14	14	clindamycin	PYM	PA449035	84305	0.656
NULL	Int_J_Mol_Sci_2012_Feb_24_13(3)_2590-2617.nxml.txt.nlp	22489113	SENT250	14	14	32	32	benzaldehyde	mol	PA448571	90527	0.656
NULL	Pan_Afr_Med_J_2013_May_18_15_26.nxml.txt.nlp	24009802	SENT86	21	21	3	3	lorazepam	Gen	PA450267	348654	0.656
NULL	Allergy_Asthma_Immunol_Res_2009_Oct_25_1(1)_30-35.nxml.txt.nlp	20224667	SENT65	6	6	0	0	aspirin	PPARG	PA448497	5468	0.656
NULL	Biomed_Res_Int_2013_Sep_8_2013_723680.nxml.txt.nlp	24083236	SENT21	35	35	26	26	phenol	TOM	PA450913	24148	0.656
NULL	Med_Sci_Monit_2013_May_1_19_317-326.nxml.txt.nlp	23632427	SENT277	36	36	14	14	gentamicin	CTX	PA449753	1593	0.656
NULL	Oxid_Med_Cell_Longev_2013_Apr_18_2013_239854.nxml.txt.nlp	23710284	SENT6	9	9	4	4	zonisamide	HRD1	PA451978	84447	0.656
NULL	Acta_Pharmacol_Sin_2009_Nov_12_30(11)_1566-1572.nxml.txt.nlp	19820718	SENT155	26	26	29	29	verapamil	CYP3A4	PA451868	1576	0.656
NULL	Eur_J_Endocrinol_2014_Mar_170(3)_451-459.nxml.txt.nlp	24362411	SENT172	23	23	7	7	exenatide	GLP1	PA164749238	100125288;2641	0.656
NULL	Crit_Care_2003_Dec_20_7(1)_23-38.nxml.txt.nlp	12617738	SENT157	28	28	17	17	thrombin	VIII	PA451674	1351	0.656
NULL	Behav_Brain_Res_2011_Sep_12_222(1)_274-278.nxml.txt.nlp	21440571	SENT8	5	5	7	7	glucosamine	GSN	PA164747613	2934	0.656
NULL	Eur_J_Clin_Pharmacol_2010_Jun_31_66(6)_579-590.nxml.txt.nlp	20354687	SENT316	4	4	14	14	methylprednisolone	CYP3A	PA450466	1574	0.656
NULL	J_Korean_Med_Sci_2011_Jan_22_26(1)_33-41.nxml.txt.nlp	21218027	SENT169	22	22	8	8	kanamycin	EMB	PA450137	133418	0.656
NULL	Diabetes_Metab_Syndr_Obes_2009_May_5_2_11-21.nxml.txt.nlp	21437115	SENT34	13	13	42	42	cholestyramine	B18	PA448974	59271;4713	0.656
NULL	J_Immunol_Res_2014_Jul_16_2014_696812.nxml.txt.nlp	25133198	SENT140	3	3	9	9	rifaximin	CD103	PA164752443	3682	0.656
NULL	Mol_Imaging_Biol_2011_Apr_3_13(2)_275-283.nxml.txt.nlp	20521132	SENT140	29	29	1	1	fluorescein	spatial	PA164746009	219793	0.656
NULL	J_Immunother_Cancer_2014_Aug_19_2_27.nxml.txt.nlp	25324973	SENT58	33	33	20	20	sorafenib	IFN	PA7000	3439	0.656
NULL	Indian_J_Pharm_Sci_2009_Nov-Dec_71(6)_622-629.nxml.txt.nlp	20376214	SENT217	19	19	10	10	captopril	B10	PA448780	5169	0.656
NULL	Breast_Cancer_Res_2010_Nov_16_12(6)_R96.nxml.txt.nlp	21080941	SENT117	10	10	22	22	lapatinib	HRG	PA152241907	3084;3273	0.656
NULL	Blood_Res_2014_Dec_23_49(4)_253-258.nxml.txt.nlp	25548759	SENT78	10	10	12	12	rituximab	CHOP	PA451261	1649	0.656
NULL	Cell_Death_Dis_2014_Mar_6_5(3)_e1108.nxml.txt.nlp	24603336	SENT61	12	12	20	20	cetuximab	CYP3A4	PA10040	1576	0.656
NULL	J_Headache_Pain_2013_Aug_13_14(1)_71.nxml.txt.nlp	23941062	SENT120	19	19	14	14	napqi	TRPA1		8989	0.656
NULL	Evid_Based_Complement_Alternat_Med_2012_Aug_28_2012_373219.nxml.txt.nlp	22969826	SENT68	11	11	0	0	cisplatin	CKI	PA449014	1119	0.656
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT182	0	0	2	2	metformin	HIF-1	PA450395	29072	0.656
NULL	Pan_Afr_Med_J_2012_Jul_9_12_67.nxml.txt.nlp	23024826	SENT63	10	10	8	8	cyclophosphamide	CHOP	PA449165	1649	0.656
NULL	Cancer_Med_2013_Jun_25_2(3)_277-285.nxml.txt.nlp	23930204	SENT195	27	27	5	5	mitomycin	BRAF	PA450524	673	0.656
NULL	Clin_Exp_Gastroenterol_2012_Sep_17_5_151-157.nxml.txt.nlp	23028235	SENT105	15	15	0	0	tetracycline	Mal	PA451640	114609	0.656
NULL	Open_Access_J_Urol_2011_May_10_3_69-82.nxml.txt.nlp	24198638	SENT66	32	32	5	5	warfarin	CYP2B6	PA451906	1555	0.656
NULL	Biomed_Res_Int_2014_Aug_6_2014_310194.nxml.txt.nlp	25165698	SENT50	26	26	28	28	ethambutol	EMB	PA164784021	133418	0.656
NULL	Oncotarget_2014_Mar_12_5(5)_1363-1381.nxml.txt.nlp	24658058	SENT454	6	6	14	14	imiquimod	TLR7	PA449972	51284	0.656
NULL	Diabetes_2009_Dec_9_58(12)_2828-2834.nxml.txt.nlp	19741164	SENT22	12	12	0	0	glucose	SIRT1	PA449773	23411	0.656
NULL	Clin_Med_Insights_Oncol_2011_Nov_7_5_349-364.nxml.txt.nlp	22174596	SENT155	15	15	17	17	bevacizumab	IFN	PA130232992	3439	0.656
NULL	Chemother_Res_Pract_2011_Dec_18_2011_965826.nxml.txt.nlp	22295208	SENT278	14	14	10	10	azacitidine	ACT	PA451996	12;11332;9457;641455	0.656
NULL	EMBO_Mol_Med_2013_Jul_6_5(7)_905-915.nxml.txt.nlp	23740690	SENT48	19	19	14	14	lipase	ATGL	PA450239	57104	0.656
NULL	Amino_Acids_2014_Jul_19_46(1)_7-20.nxml.txt.nlp	22810731	SENT96	0	0	14	14	taurine	IL-6	PA451590	3569	0.656
NULL	Bonekey_Rep_2014_Feb_5_3_495.nxml.txt.nlp	24605212	SENT131	11	11	38	38	alfacalcidol	PTH	PA164746469	5741	0.656
NULL	Neural_Plast_2009_Dec_2_2009_625469.nxml.txt.nlp	19096514	SENT35	19	19	14	14	lipase	FAAH	PA450239	79152;2166	0.656
NULL	Cardiovasc_Diabetol_2006_Sep_26_5_20.nxml.txt.nlp	17002798	SENT101	4	4	26	26	niacin	CDP	PA450617	1523	0.656
NULL	Acta_Pharmacol_Sin_2013_Sep_5_34(9)_1192-1200.nxml.txt.nlp	23685957	SENT129	0	0	5	5	curcumin	AP-2	PA151958596	7020	0.656
NULL	Mol_Cancer_2009_Nov_24_8_109.nxml.txt.nlp	19930708	SENT12	0	0	2	2	exemestane	EGFR	PA449563	1956	0.656
NULL	Arthritis_Res_Ther_2010_Jul_7_12(4)_R131.nxml.txt.nlp	20609215	SENT213	28	28	19	19	iloprost	TLR5	PA164746843	7100	0.656
NULL	Chem_Cent_J_2012_May_11_6_41.nxml.txt.nlp	22578215	SENT136	3	3	5	5	naringin	castor	PA151958360	54897	0.656
NULL	Cent_European_J_Urol_2013_Apr_26_66(1)_39-44.nxml.txt.nlp	24578986	SENT87	16	16	23	23	vincristine	ADM	PA451879	133	0.656
NULL	Cardiovasc_Diabetol_2006_Sep_26_5_20.nxml.txt.nlp	17002798	SENT95	0	0	8	8	niacin	DGAT2	PA450617	84649	0.656
NULL	Pharmaceutics_2011_Oct_12_3(4)_680-705.nxml.txt.nlp	24309303	SENT132	34	34	28	28	metformin	MATE1	PA450395	55244	0.656
NULL	Cancer_Cell_Int_2012_Jul_4_12_19.nxml.txt.nlp	22631225	SENT192	10	10	6	6	heparin	PPIA	PA449855	5478	0.656
NULL	Arthritis_Res_Ther_2010_Jun_2_12(3)_R107.nxml.txt.nlp	20525198	SENT200	7	7	22	22	rolipram	CIA	PA153906323	25842;57727	0.656
NULL	Front_Pharmacol_2014_Dec_22_5_281.nxml.txt.nlp	25566077	SENT40	9	9	0	0	l-arginine	Cocoa	PA448478	57658	0.656
NULL	Mol_Cancer_2014_Feb_5_13_24.nxml.txt.nlp	24495306	SENT297	32	32	28	28	collagenase	EGFR	PA449107	1956	0.656
NULL	Hum_Genomics_2009_Jan_1_3(2)_121-127.nxml.txt.nlp	19164089	SENT76	28	28	22	22	ethanol	ALDH2	PA448073	217	0.656
NULL	Adv_Hematol_2012_Sep_23_2012_727683.nxml.txt.nlp	23049558	SENT68	23	23	41	41	l-glutamine	IL-3	PA10090	3562	0.656
NULL	Iran_J_Pharm_Res_2014_Winter_13(1)_67-80.nxml.txt.nlp	24734057	SENT356	9	9	0	0	propranolol	Tech	PA451145	57449	0.656
NULL	Emerg_Infect_Dis_2013_Jan_19(1)_21-28.nxml.txt.nlp	23260763	SENT79	23	23	0	0	sulfamethoxazole	DHPS	PA451544	1725	0.656
NULL	Breast_Cancer_Res_2007_Dec_18_9(6)_R88.nxml.txt.nlp	18088411	SENT244	15	15	21	21	oxygen	NIR	PA450744	26155	0.656
NULL	Front_Endocrinol_(Lausanne)_2011_Dec_21_2_84.nxml.txt.nlp	22654830	SENT61	9	9	21	21	rosiglitazone	DGAT	PA451283	8694	0.656
NULL	Indian_J_Nephrol_2009_Oct_19(4)_175a.nxml.txt.nlp	20535260	SENT18	9	9	27	27	nevirapine	CD4	PA450616	920	0.656
NULL	Aging_(Albany_NY)_2009_Jun_29_1(6)_511-514.nxml.txt.nlp	20157534	SENT14	3	3	10	10	resveratrol	AMPK		5563	0.656
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Apr_15_9_13.nxml.txt.nlp	20398300	SENT97	13	13	7	7	moxifloxacin	LAM	PA450555	7249;7248	0.656
NULL	Atherosclerosis_2011_Apr_215(2)_421-427.nxml.txt.nlp	21292264	SENT163	15	15	12	12	lipase	LIPC	PA450239	3990	0.656
NULL	Acta_Histochem_Cytochem_2010_May_1_43(2)_61-68.nxml.txt.nlp	20514293	SENT13	19	19	11	11	hyaluronan	PROX1	PA165958431	5629	0.656
NULL	J_Immunother_Cancer_2014_Nov_6_2(Suppl_3)_P199.nxml.txt.nlp	NULL	SENT8	36	36	25	25	cetuximab	JAK2	PA10040	3717	0.656
NULL	Breast_Cancer_Res_2010_Oct_14_12(5)_R84.nxml.txt.nlp	20946630	SENT300	16	16	27	27	choline	Hsp90	PA448976	3320	0.656
NULL	Br_J_Pharmacol_2013_Jun_27_169(4)_736-747.nxml.txt.nlp	23489111	SENT111	21	21	10	10	granisetron	5-HT3A	PA449809	3359	0.656
NULL	Nucleic_Acids_Res_2008_Feb_20_36(3)_998-1008.nxml.txt.nlp	18096616	SENT19	23	23	28	28	heparin	PACT	PA449855	8575;5930	0.656
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Feb_22_64(Pt_3)_o619.nxml.txt.nlp	21201953	SENT66	1	1	12	12	hydroquinidine	mol	PA133888889	90527	0.656
NULL	Cell_Death_Dis_2013_Jun_13_4(6)_e665.nxml.txt.nlp	23764846	SENT12	14	14	16	16	bleomycin	BLM	PA448645	641	0.656
NULL	Cancer_Med_2014_Jun_8_3(3)_681-692.nxml.txt.nlp	24711160	SENT151	31	31	1	1	paclitaxel	San	PA450761	80218	0.656
NULL	Breast_Cancer_Res_2012_May_14_14(3)_R77.nxml.txt.nlp	22583478	SENT52	15	15	30	30	estradiol	E2F2	PA449503	1870	0.656
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT228	23	23	20	20	perifosine	DR5	PA165291471	8795	0.656
NULL	Nucleic_Acids_Res_2005_Oct_19_33(18)_5819-5828.nxml.txt.nlp	16237123	SENT98	33	33	20	20	cisplatin	HMGB1	PA449014	3146	0.656
NULL	J_Biol_Chem_2013_Mar_8_288(10)_7024-7036.nxml.txt.nlp	23303190	SENT64	24	24	33	33	paromomycin	mol	PA164784023	90527	0.656
NULL	J_Exerc_Rehabil_2013_Jun_30_9(3)_389-393.nxml.txt.nlp	24278889	SENT45	24	24	26	26	ethambutol	EMB	PA164784021	133418	0.656
NULL	Breast_Cancer_Res_2011_Apr_15_13(2)_R44.nxml.txt.nlp	21496232	SENT315	0	0	17	17	pertuzumab	HER2		2064	0.656
NULL	Clin_Dev_Immunol_2013_May_29_2013_296031.nxml.txt.nlp	23818913	SENT103	2	2	16	16	hydrocortisone	IL-10	PA449905	3586	0.656
NULL	J_Breast_Cancer_2013_Mar_31_16(1)_23-31.nxml.txt.nlp	23593078	SENT114	9	9	11	11	decitabine	DNMT1	PA164749631	1786	0.656
NULL	Emerg_Infect_Dis_2013_Jan_19(1)_133-136.nxml.txt.nlp	23260464	SENT54	22	22	24	24	ceftriaxone	TOB	PA448866	10140	0.656
NULL	Arthritis_Res_Ther_2005_Feb_17_7(Suppl_1)_P4.nxml.txt.nlp	NULL	SENT4	0	0	12	12	abatacept	CD28	PA164747080	1493;940	0.656
NULL	Br_J_Cancer_2013_Oct_1_109(7)_1717-1724.nxml.txt.nlp	24022187	SENT102	11	11	30	30	trabectedin	CXCL8	PA165958349	3576	0.656
NULL	Exp_Diabetes_Res_2012_Oct_15_2012_465282.nxml.txt.nlp	23118742	SENT85	0	0	3	3	metformin	FGF21	PA450395	26291	0.656
NULL	Osteoporos_Int_2013_Jan_14_24(1)_383-388.nxml.txt.nlp	22349912	SENT87	8	8	12	12	ns-398	ANOVA		4858	0.656
NULL	Indian_J_Pharmacol_2012_Nov-Dec_44(6)_759-764.nxml.txt.nlp	23248408	SENT135	4	4	8	8	sitagliptin	GLP	PA164748978	342096	0.656
NULL	Eur_J_Clin_Microbiol_Infect_Dis_2010_May_13_29(5)_543-550.nxml.txt.nlp	20229224	SENT73	33	33	47	47	linezolid	VAN	PA450233	10318	0.656
NULL	Case_Rep_Endocrinol_2011_Jul_18_2011_520516.nxml.txt.nlp	22937284	SENT89	26	26	39	39	estradiol	PTH	PA449503	5741	0.656
NULL	Cells_2014_Apr_9_3(2)_288-303.nxml.txt.nlp	24722470	SENT812	1	1	20	20	hyperforin	TRPC6	PA165985514	7225	0.656
NULL	Breast_Cancer_Res_2014_May_23_16(3)_R50.nxml.txt.nlp	24887458	SENT82	26	26	15	15	trastuzumab	HER2	PA451743	2064	0.656
NULL	Curr_Neuropharmacol_2011_Dec_9(4)_530-552.nxml.txt.nlp	22654714	SENT906	10	10	24	24	olanzapine	BDNF	PA450688	627	0.656
NULL	Diabetes_Care_2013_Dec_13_36(12)_3930-3937.nxml.txt.nlp	23990523	SENT67	12	12	3	3	glucose	adiponectin	PA449773	9370	0.656
NULL	Clin_Pharmacol_2011_Jun_22_3_13-25.nxml.txt.nlp	22287853	SENT203	11	11	13	13	saxagliptin	CYP3A4	PA165958362	1576	0.656
NULL	J_Cachexia_Sarcopenia_Muscle_2011_Dec_8_2(4)_209-261.nxml.txt.nlp	22476871	SENT1317	11	11	20	20	lipase	CGI-58	PA450239	51099	0.656
NULL	Clin_Microbiol_Infect_2014_Jun_21_20(6)_536-541.nxml.txt.nlp	24107197	SENT137	34	34	19	19	isoniazid	DST	PA450112	667	0.656
NULL	Support_Care_Cancer_2009_Sep_10_17(9)_1187-1193.nxml.txt.nlp	19205754	SENT200	4	4	38	38	aprepitant	CYP2D6	PA164747039	1565	0.656
NULL	Exp_Ther_Med_2014_Feb_25_7(2)_397-400.nxml.txt.nlp	24396413	SENT38	9	9	19	19	isoniazid	LOX	PA450112	4015	0.656
NULL	Breast_Cancer_Res_2010_Oct_22_12(Suppl_2)_S1.nxml.txt.nlp	21050422	SENT128	15	15	19	19	irinotecan	TRN	PA450085	3842	0.656
NULL	F1000_Med_Rep_2012_Jun_1_4_12.nxml.txt.nlp	22719795	SENT58	14	14	11	11	rifampin	CYP3A	PA451250	1574	0.656
NULL	EPMA_J_2010_Sep_20_1(3)_421-437.nxml.txt.nlp	23199086	SENT21	14	14	30	30	trastuzumab	HER2	PA451743	2064	0.656
NULL	Int_Clin_Psychopharmacol_2014_Jul_26_29(4)_229-234.nxml.txt.nlp	24419004	SENT130	23	23	1	1	sertindole	Gen	PA164784002	348654	0.656
NULL	Oxid_Med_Cell_Longev_2012_Sep_16_2012_740849.nxml.txt.nlp	23029600	SENT218	17	17	4	4	doxycycline	INS-1	PA449415	2305	0.656
NULL	AIDS_Res_Treat_2012_Mar_5_2012_703604.nxml.txt.nlp	22500218	SENT112	7	7	14	14	artesunate	CYP3A4	PA165111697	1576	0.656
NULL	ScientificWorldJournal_2012_Apr_1_2012_159456.nxml.txt.nlp	22547977	SENT264	10	10	19	19	tetracycline	OTC	PA451640	5009	0.656
NULL	J_Vet_Med_Sci_2014_Aug_1_76(8)_1105-1110.nxml.txt.nlp	24784441	SENT64	2	2	4	4	estradiol	GDN	PA449503	5270;55534	0.656
NULL	Cancer_Immunol_Immunother_2013_May_16_62(5)_897-908.nxml.txt.nlp	23589107	SENT259	3	3	7	7	cyclophosphamide	CD4	PA449165	920	0.656
NULL	Front_Genet_2011_Nov_22_2_84.nxml.txt.nlp	22303378	SENT118	10	10	12	12	diethylstilbestrol	DES	PA449307	1674	0.656
NULL	Int_J_Nanomedicine_2008_Mar_3(1)_1-19.nxml.txt.nlp	18488412	SENT336	7	7	13	13	salbutamol	Stella	PA448068	359787	0.656
NULL	Structure_2012_May_9_20-540(5-7)_841-849.nxml.txt.nlp	22579251	SENT232	3	3	10	10	alprenolol	EGFR	PA164750541	1956	0.656
NULL	J_Oncol_2010_Jun_10_2010_652320.nxml.txt.nlp	20628530	SENT57	7	7	24	24	heparin	VEGFR1	PA449855	2321	0.656
NULL	Croat_Med_J_2012_Jun_53(3)_214-223.nxml.txt.nlp	22661134	SENT11	12	12	18	18	yohimbine	ACTH	PA451946	5443	0.656
NULL	J_Cell_Biol_1998_Aug_10_142(3)_723-733.nxml.txt.nlp	9700161	SENT326	28	28	21	21	galactose	TWF1	PA449725	5756	0.656
NULL	Iran_J_Microbiol_2013_Mar_5(1)_48-55.nxml.txt.nlp	23466743	SENT131	32	32	14	14	gentamicin	CTX	PA449753	1593	0.656
NULL	Mol_Biol_Cell_2013_Sep_1_24(17)_2678-2688.nxml.txt.nlp	23864716	SENT64	0	0	16	16	thrombin	Rho	PA451674	29984	0.656
NULL	Scientifica_(Cairo)_2012_Nov_25_2012_473829.nxml.txt.nlp	24278698	SENT341	4	4	8	8	cisplatin	OCTN2	PA449014	6584	0.656
NULL	Emerg_Infect_Dis_2011_Mar_17(3)_372-378.nxml.txt.nlp	21392426	SENT29	3	3	1	1	isoniazid	DST	PA450112	667	0.656
NULL	Breast_Cancer_(Auckl)_2009_Sep_2_3_61-75.nxml.txt.nlp	19809577	SENT129	0	0	4	4	curcumin	PARP	PA151958596	142	0.656
NULL	BMJ_2011_Aug_4_343_d4588.nxml.txt.nlp	21816733	SENT438	15	15	9	9	clopidogrel	CYP2C19	PA449053	1557	0.656
NULL	Br_J_Cancer_1998_Apr_77(8)_1311-1317.nxml.txt.nlp	9579838	SENT12	29	29	24	24	tamoxifen	IL-2	PA451581	3558	0.656
NULL	Environ_Health_Perspect_2008_Mar_26_116(3)_322-328.nxml.txt.nlp	18335098	SENT99	16	16	35	35	genistein	PMI	PA165109660	8834;5373	0.656
NULL	Anal_Bioanal_Chem_2012_Apr_12_403(1)_151-155.nxml.txt.nlp	22327967	SENT71	9	9	14	14	fluorescein	mol	PA164746009	90527	0.656
NULL	Cancers_(Basel)_2014_Jan_27_6(1)_240-296.nxml.txt.nlp	24473089	SENT1416	8	8	12	12	collagenase	AP-1	PA449107	2353;3727;2354;3725	0.656
NULL	Ann_Lab_Med_2013_Jan_17_33(1)_86-88.nxml.txt.nlp	23301230	SENT52	18	18	12	12	ceftazidime	CTX	PA448861	1593	0.656
NULL	Br_J_Cancer_2011_Jul_12_105(2)_212-220.nxml.txt.nlp	21694723	SENT138	0	0	13	13	curcumin	CD133	PA151958596	8842	0.656
NULL	Breast_Cancer_Res_2008_Dec_18_10(Suppl_4)_S26.nxml.txt.nlp	19128440	SENT14	10	10	2	2	anastrozole	IMPACT	PA448432	55364	0.656
NULL	Eur_J_Med_Res_2010_Feb_26_15(2)_59-65.nxml.txt.nlp	20452885	SENT99	15	15	9	9	thrombin	ADP	PA451674	23038	0.656
NULL	Cell_Host_Microbe_2013_Mar_13_13(3)_324-335.nxml.txt.nlp	23498957	SENT384	3	3	23	23	bortezomib	TRAIL	PA10252	8743	0.656
NULL	Br_J_Cancer_2012_Oct_9_107(8)_1233-1238.nxml.txt.nlp	22955852	SENT170	24	24	13	13	docetaxel	RPN2	PA449383	6185	0.656
NULL	Cardiovasc_Diabetol_2013_Jan_9_12_10.nxml.txt.nlp	23302697	SENT249	2	2	34	34	fenofibrate	NDR	PA449594	11329;55363	0.656
NULL	BMB_Rep_2013_Jan_46(1)_25-30.nxml.txt.nlp	23351380	SENT387	0	0	16	16	tolbutamide	p27	PA451718	5715;10534	0.656
NULL	Oncotarget_2014_Aug_19_5(18)_8737-8749.nxml.txt.nlp	25228590	SENT75	28	28	22	22	crizotinib	MYCN	PA165946122	4613	0.656
NULL	Indian_J_Anaesth_2010_Jul-Aug_54(4)_296-301.nxml.txt.nlp	20882170	SENT109	18	18	33	33	midazolam	sit	PA450496	55733	0.656
NULL	Oncol_Lett_2013_Jun_29_5(6)_1943-1947.nxml.txt.nlp	23833672	SENT10	0	0	12	12	celecoxib	AKT	PA448871	207	0.655
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1018.nxml.txt.nlp	24457962	SENT74	0	0	3	3	afatinib	EGFR	PA165981154	1956	0.655
NULL	Brain_Sci_2013_Apr_26_3(2)_670-703.nxml.txt.nlp	24961420	SENT159	3	3	36	36	ethanol	P21	PA448073	1026;9338	0.655
NULL	Cell_Death_Dis_2012_Mar_1_3(3)_e275.nxml.txt.nlp	22378068	SENT84	7	7	17	17	metformin	AMPK	PA450395	5563	0.655
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2010_Aug_3_3_43-51.nxml.txt.nlp	22879786	SENT169	4	4	1	1	rosiglitazone	gamma	PA451283	9913	0.655
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT9	9	9	17	17	chloroquine	BMPR-II	PA448948	659	0.655
NULL	Oncotarget_2013_Nov_24_4(12)_2430-2438.nxml.txt.nlp	24280348	SENT20	8	8	14	14	afatinib	EGFR	PA165981154	1956	0.655
NULL	Mol_Vis_2012_Nov_29_18_2839-2846.nxml.txt.nlp	23233786	SENT195	12	12	5	5	geldanamycin	Hsp90	PA152031327	3320	0.655
NULL	Nat_Commun_2011_Feb_8_2_190.nxml.txt.nlp	21304519	SENT142	14	14	31	31	indomethacin	IL-10	PA449982	3586	0.655
NULL	Lab_Invest_2009_Nov_7_89(11)_1275-1290.nxml.txt.nlp	19736547	SENT287	21	21	27	27	curcumin	LOX-1	PA151958596	4973	0.655
NULL	Emerg_Microbes_Infect_2012_Aug_22_1(8)_e19.nxml.txt.nlp	NULL	SENT114	15	15	7	7	efavirenz	CYP2D6	PA449441	1565	0.655
NULL	Bone_Joint_Res_2014_Mar_1_3(3)_51-59.nxml.txt.nlp	24615710	SENT166	19	19	9	9	resveratrol	SIRT1		23411	0.655
NULL	Cancer_Cell_Int_2011_Nov_17_11_40.nxml.txt.nlp	22088142	SENT153	16	16	11	11	gefitinib	MRP3	PA131301952	8714	0.655
NULL	Cancer_Cell_Int_2010_May_11_10_16.nxml.txt.nlp	20459793	SENT91	5	5	2	2	cisplatin	CDKN1A	PA449014	1026	0.655
NULL	Breast_Cancer_Res_2014_May_23_16(3)_R50.nxml.txt.nlp	24887458	SENT3	39	39	19	19	trastuzumab	HER2	PA451743	2064	0.655
NULL	Curr_Neuropharmacol_2009_Jun_7(2)_83-95.nxml.txt.nlp	19949566	SENT453	14	14	32	32	levetiracetam	TGB	PA450206	5473	0.655
NULL	Int_J_Gen_Med_2014_Nov_11_7_491-504.nxml.txt.nlp	25419156	SENT157	12	12	27	27	oxymetazoline	END	PA164748840	2022	0.655
NULL	Ann_Rheum_Dis_2008_Apr_20_67(4)_511-517.nxml.txt.nlp	17644552	SENT95	23	23	4	4	infliximab	IL-6	PA452639	3569	0.655
NULL	Diabetol_Metab_Syndr_2014_Mar_31_6_48.nxml.txt.nlp	24684803	SENT111	13	13	8	8	miglitol	STEP	PA164776726	84867	0.655
NULL	Nat_Med_2013_Oct_8_19(10)_1313-1317.nxml.txt.nlp	24013700	SENT10	17	17	13	13	ribavirin	IFN	PA451241	3439	0.655
NULL	BMB_Rep_2013_Aug_46(8)_410-415.nxml.txt.nlp	23977989	SENT34	31	31	33	33	curcumin	HO-1	PA151958596	3162	0.655
NULL	J_Geriatr_Cardiol_2014_Jun_11(2)_151-157.nxml.txt.nlp	25009566	SENT126	20	20	17	17	cilostazol	CDP	PA164746334	1523	0.655
NULL	J_Hematol_Oncol_2009_Apr_22_2_18.nxml.txt.nlp	19386128	SENT150	10	10	18	18	cetuximab	KRAS	PA10040	3845	0.655
NULL	J_Am_Heart_Assoc_2013_Dec_19_2(6)_e000433.nxml.txt.nlp	24275630	SENT633	5	5	12	12	ranolazine	ATX	PA164746007	5168;23049	0.655
NULL	Breast_Cancer_Res_2010_Jun_24_12(3)_R41.nxml.txt.nlp	20576088	SENT253	7	7	2	2	paclitaxel	PPM1D	PA450761	8493	0.655
NULL	J_Cell_Biol_1998_Jul_13_142(1)_101-115.nxml.txt.nlp	9660866	SENT3	20	20	5	5	tetracycline	RhoA	PA451640	387	0.655
NULL	Clin_Infect_Dis_2013_May_1_56(9)_1330-1339.nxml.txt.nlp	23362284	SENT93	12	12	8	8	nevirapine	HLA-DQB1	PA450616	3119	0.655
NULL	J_Cell_Sci_2014_Jul_15_127(14)_3039-3051.nxml.txt.nlp	24928894	SENT196	36	36	40	40	heparin	entactin	PA449855	4811	0.655
NULL	Biosci_Rep_2014_Aug_6_34(4)_e00131.nxml.txt.nlp	24975826	SENT164	6	6	10	10	probenecid	TRPM8	PA451106	79054	0.655
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT371	14	14	10	10	resveratrol	pS2		7031	0.655
NULL	Cancer_Immunol_Immunother_2011_Jul_24_60(7)_953-963.nxml.txt.nlp	21431917	SENT55	12	12	10	10	aldesleukin	IL-2	PA448081	3558	0.655
NULL	Int_J_Mol_Sci_2014_Oct_22_15(10)_19183-19202.nxml.txt.nlp	25340982	SENT153	8	8	17	17	resveratrol	p53		7157	0.655
NULL	Cell_Microbiol_2013_Aug_14_15(8)_1385-1400.nxml.txt.nlp	23421931	SENT300	18	18	34	34	l-glutamine	IL-4	PA10090	3565	0.655
NULL	Cell_Death_Dis_2014_Apr_17_5(4)_e1182.nxml.txt.nlp	24743737	SENT51	3	3	15	15	capsaicin	TRPV1	PA448776	7442	0.655
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_May_24_70(Pt_6)_o713.nxml.txt.nlp	24940283	SENT75	0	0	3	3	benzaldehyde	mol	PA448571	90527	0.655
NULL	Biomed_Res_Int_2013_Dec_20_2013_162724.nxml.txt.nlp	23509685	SENT52	5	5	10	10	glibenclamide	STZ	PA449782	6484	0.655
NULL	Iran_Red_Crescent_Med_J_2013_Feb_5_15(2)_127-135.nxml.txt.nlp	23682324	SENT8	18	18	8	8	choline	NeuN	PA448976	146713	0.655
NULL	J_Gen_Intern_Med_2009_May_21_24(5)_656-664.nxml.txt.nlp	19306050	SENT287	18	18	4	4	acenocoumarol	CYP2C9	PA452632	1559	0.655
NULL	Int_J_Mol_Sci_2014_Jun_18_15(6)_11013-11029.nxml.txt.nlp	24945311	SENT141	5	5	26	26	celecoxib	STAT3	PA448871	6774	0.655
NULL	J_Korean_Med_Sci_2010_Jun_24_25(6)_829-834.nxml.txt.nlp	20514301	SENT69	15	15	11	11	papain	IL-17F	PA450778	112744	0.655
NULL	J_Cancer_Epidemiol_2012_Aug_27_2012_978391.nxml.txt.nlp	22969803	SENT85	19	19	23	23	rituximab	CHOP	PA451261	1649	0.655
NULL	Clin_Sci_(Lond)_2013_Aug_1_125(Pt_3)_121-130.nxml.txt.nlp	23577635	SENT130	20	20	15	15	lipase	HSL	PA450239	3991	0.655
NULL	Environ_Health_Perspect_2005_Sep_13_113(9)_1184-1189.nxml.txt.nlp	16140625	SENT13	29	29	11	11	malathion	spatial	PA164748092	219793	0.655
NULL	Oncotarget_2011_Dec_31_2(12)_1322-1328.nxml.txt.nlp	22249159	SENT7	13	13	7	7	metformin	AMPK	PA450395	5563	0.655
NULL	J_Lipid_Res_2014_Feb_55(2)_190-200.nxml.txt.nlp	24273196	SENT10	12	12	14	14	lipase	HSL	PA450239	3991	0.655
NULL	Oncoscience_2014_Oct_5_1(10)_624-633.nxml.txt.nlp	25593992	SENT52	23	23	14	14	tetracycline	PCTAIRE1	PA451640	5127	0.655
NULL	N_Am_J_Med_Sci_2014_Dec_6(12)_625-632.nxml.txt.nlp	25599050	SENT36	3	3	1	1	ramipril	STZ	PA451223	6484	0.655
NULL	Mol_Cancer_2014_Jun_5_13_143.nxml.txt.nlp	24898067	SENT160	22	22	19	19	trastuzumab	CTRL	PA451743	1506	0.655
NULL	Mol_Cancer_2009_Nov_19_8_108.nxml.txt.nlp	19925669	SENT72	18	18	9	9	doxorubicin	CTRL	PA449412	1506	0.655
NULL	Blood_Res_2014_Jun_25_49(2)_107-114.nxml.txt.nlp	25025012	SENT137	25	25	18	18	rituximab	CHOP	PA451261	1649	0.655
NULL	Mol_Cancer_2013_May_4_12_37.nxml.txt.nlp	23642048	SENT32	2	2	19	19	curcumin	p53	PA151958596	7157	0.655
NULL	Bioinformation_2006_Apr_4_1(4)_121-126.nxml.txt.nlp	17597870	SENT184	20	20	3	3	trypsin	K15	PA451806	3866	0.655
NULL	Ann_Lab_Med_2012_Jul_20_32(4)_298-303.nxml.txt.nlp	22779073	SENT117	32	32	10	10	pyrazinamide	EMB	PA451182	133418	0.655
NULL	Br_J_Cancer_2013_Oct_15_109(8)_2096-2105.nxml.txt.nlp	24064970	SENT34	40	40	0	0	cisplatin	ERCC1	PA449014	2067	0.655
NULL	Front_Genet_2014_Feb_26_5_40.nxml.txt.nlp	24616734	SENT309	29	29	14	14	docetaxel	CCL20	PA449383	6364	0.655
NULL	Oncotarget_2012_May_18_3(5)_525-534.nxml.txt.nlp	22619113	SENT7	3	3	11	11	fludarabine	BIRC5	PA449655	332	0.655
NULL	Autophagy_2012_May_1_8(5)_853-855.nxml.txt.nlp	22617440	SENT58	16	16	34	34	imatinib	BAX	PA10804	581	0.655
NULL	J_Korean_Med_Sci_2010_Jun_24_25(6)_829-834.nxml.txt.nlp	20514301	SENT9	2	2	31	31	papain	IL-25	PA450778	64806;56005	0.655
NULL	Arq_Bras_Cardiol_2014_Mar_102(3)_211-218.nxml.txt.nlp	24676223	SENT70	23	23	35	35	indomethacin	COX	PA449982	1351	0.655
NULL	Nucleic_Acids_Res_2011_Nov_25_39(20)_e139.nxml.txt.nlp	21873270	SENT89	28	28	20	20	streptomycin	FBS	PA451512	64319;26269	0.655
NULL	Aquat_Biosyst_2012_Apr_17_8_9.nxml.txt.nlp	22510370	SENT192	8	8	4	4	nadh	PHB	PA164755085	5245	0.655
NULL	Front_Immunol_2013_Sep_17_4_281.nxml.txt.nlp	24062747	SENT389	12	12	41	41	atorvastatin	STAT2	PA448500	6773	0.655
NULL	Exp_Mol_Med_2012_Oct_31_44(10)_603-614.nxml.txt.nlp	22859500	SENT23	10	10	12	12	lipase	HSL	PA450239	3991	0.655
NULL	Exp_Ther_Med_2014_Mar_10_7(3)_640-648.nxml.txt.nlp	24520260	SENT153	5	5	13	13	resveratrol	JNK		5599	0.655
NULL	J_Korean_Med_Sci_2007_Aug_31_22(4)_677-681.nxml.txt.nlp	17728509	SENT135	10	10	16	16	pyrazinamide	EMB	PA451182	133418	0.655
NULL	Diabetes_2009_Feb_58(2)_352-359.nxml.txt.nlp	19011168	SENT234	28	28	35	35	exenatide	adiponectin	PA164749238	9370	0.655
NULL	Behav_Genet_2008_Jul_7_38(4)_396-406.nxml.txt.nlp	18461434	SENT0	8	8	10	10	glucose	GLUT8	PA449773	29988;154091	0.655
NULL	Pharm_Pract_(Granada)_2011_Mar_15_Jan-Mar_9(1)_1-10.nxml.txt.nlp	25132883	SENT121	30	30	34	34	enoxaparin	SPAF	PA449463	166378	0.655
NULL	Front_Genet_2014_Jul_22_5_228.nxml.txt.nlp	25101113	SENT406	11	11	23	23	trypsin	Met	PA451806	79811	0.655
NULL	Clin_Infect_Dis_2013_May_1_56(9)_1330-1339.nxml.txt.nlp	23362284	SENT115	15	15	8	8	nevirapine	HLA-B	PA450616	3106	0.655
NULL	J_Korean_Med_Sci_2007_Aug_31_22(4)_677-681.nxml.txt.nlp	17728509	SENT135	2	2	16	16	isoniazid	EMB	PA450112	133418	0.655
NULL	Nucleic_Acids_Res_2013_May_5_41(10)_5210-5222.nxml.txt.nlp	23563151	SENT212	24	24	27	27	arsenite	GADD45	PA452638	1647	0.655
NULL	Oncol_Lett_2013_Feb_7_5(2)_440-446.nxml.txt.nlp	23420122	SENT212	7	7	20	20	paclitaxel	BRAF	PA450761	673	0.655
NULL	Breast_Cancer_(Auckl)_2009_Apr_7_3_23-34.nxml.txt.nlp	21556247	SENT10	4	4	15	15	celecoxib	AKT	PA448871	207	0.655
NULL	Virchows_Arch_2010_Dec_3_457(6)_677-692.nxml.txt.nlp	20890764	SENT387	5	5	7	7	hyaluronan	LYVE-1	PA165958431	10894	0.655
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT109	11	11	14	14	glucose	EGFR	PA449773	1956	0.655
NULL	Oncotarget_2013_Nov_24_4(12)_2186-2207.nxml.txt.nlp	24327604	SENT238	19	19	28	28	melphalan	FasL	PA450354	356	0.655
NULL	Summit_on_Translat_Bioinforma_2009_Mar_1_2009_124-128.nxml.txt.nlp	21347183	SENT69	11	11	13	13	thioguanine	TPMT	PA451663	7172	0.655
NULL	ScientificWorldJournal_2012_Apr_19_2012_804730.nxml.txt.nlp	22606063	SENT162	17	17	27	27	tafluprost	BAK	PA165958432	578	0.655
NULL	Case_Rep_Otolaryngol_2013_Feb_14_2013_875607.nxml.txt.nlp	23476859	SENT17	32	32	17	17	bevacizumab	gamma	PA130232992	9913	0.655
NULL	J_Cell_Biol_1999_Jul_12_146(1)_233-242.nxml.txt.nlp	10402473	SENT76	31	31	13	13	paraformaldehyde	NRP1	PA450790	8829	0.655
NULL	Pharmaceuticals_(Basel)_2014_Mar_5_7(3)_311-338.nxml.txt.nlp	24603603	SENT1398	3	3	1	1	cetuximab	EGFR	PA10040	1956	0.655
NULL	Front_Behav_Neurosci_2009_Jun_29_3_10.nxml.txt.nlp	19587848	SENT76	25	25	27	27	diethylstilbestrol	DES	PA449307	1674	0.655
NULL	Endocr_Connect_2012_Jul_21_1(1)_37-47.nxml.txt.nlp	23781302	SENT26	0	0	9	9	mitotane	CYP11A1	PA164746157	1583	0.655
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT342	7	7	10	10	heparin	FGF1	PA449855	2246	0.655
NULL	Aging_(Albany_NY)_2013_Feb_21_5(2)_94-95.nxml.txt.nlp	23518473	SENT16	0	0	21	21	resveratrol	HGPS		4000;10269;64221	0.655
NULL	J_Gen_Physiol_1972_May_1_59(5)_519-533.nxml.txt.nlp	4623851	SENT0	12	12	1	1	vasopressin	Gen	PA451858	348654	0.655
NULL	Biomed_Res_Int_2014_Jan_2_2014_526301.nxml.txt.nlp	24524079	SENT61	0	0	2	2	sevoflurane	GOX	PA451341	54363	0.655
NULL	Front_Oncol_2014_Oct_22_4_288.nxml.txt.nlp	25374843	SENT213	13	13	17	17	cyclophosphamide	CD4	PA449165	920	0.655
NULL	Acta_Pharmacol_Sin_2013_Jan_23_34(1)_33-38.nxml.txt.nlp	22820909	SENT135	17	17	14	14	tetracaine	ASIC3	PA451638	9311	0.655
NULL	Curr_Cardiol_Rev_2008_Nov_4(4)_309-322.nxml.txt.nlp	20066139	SENT85	11	11	14	14	estradiol	CEE	PA449503	51608	0.655
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2008_Aug_1_64(Pt_8)_843-850.nxml.txt.nlp	18645233	SENT45	33	33	21	21	thrombin	VASP	PA451674	7408	0.655
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT154	16	16	18	18	resveratrol	TRAIL		8743	0.655
NULL	Iran_J_Pharm_Res_2014_Spring_13(2)_417-429.nxml.txt.nlp	25237337	SENT211	26	26	5	5	clenbuterol	NIP	PA164745640	90527;10755	0.655
NULL	Int_J_Mol_Sci_2014_Oct_13_15(10)_18407-18421.nxml.txt.nlp	25314301	SENT492	24	24	7	7	amifostine	p38	PA448365	10598;1432;7965	0.655
NULL	Oncotarget_2011_Nov_9_2(11)_850-861.nxml.txt.nlp	22081665	SENT140	6	6	43	43	idarubicin	DNMT3A	PA449961	1788	0.655
NULL	Parasit_Vectors_2009_Sep_25_2(Suppl_2)_S2.nxml.txt.nlp	19778463	SENT4	25	25	32	32	ivermectin	MOX	PA450133	26002	0.655
NULL	Mol_Biol_Rep_2013_May_11_40(8)_5013-5026.nxml.txt.nlp	23666059	SENT118	7	7	26	26	resveratrol	MDM2		4193	0.655
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT11	1	1	11	11	metformin	AMPK	PA450395	5563	0.655
NULL	Oncotarget_2013_Dec_18_5(2)_375-385.nxml.txt.nlp	24495868	SENT157	3	3	10	10	fludarabine	MCL1	PA449655	4170	0.655
NULL	J_Korean_Med_Sci_2005_Oct_31_20(5)_883-885.nxml.txt.nlp	16224167	SENT38	12	12	15	15	azathioprine	gamma	PA448515	9913	0.655
NULL	Mol_Cancer_2009_Nov_24_8_109.nxml.txt.nlp	19930708	SENT41	16	16	8	8	estradiol	aromatase	PA449503	1588	0.655
NULL	Biol_Open_2013_Aug_14_2(10)_1013-1021.nxml.txt.nlp	24167711	SENT62	0	0	9	9	ethanol	EVL	PA448073	51466	0.655
NULL	Daru_2012_Sep_3_20(1)_24.nxml.txt.nlp	23351176	SENT201	13	13	3	3	itopride	EPO	PA152432599	7076;8288;2056	0.655
NULL	Hum_Genomics_Proteomics_2010_Aug_3_2010_159761.nxml.txt.nlp	20981231	SENT196	3	3	24	24	lithium	IMPA1	PA450243	3612	0.655
NULL	Oncotarget_2013_Aug_8_4(8)_1130-1142.nxml.txt.nlp	24029073	SENT173	4	4	11	11	glucose	G6PD	PA449773	2539	0.655
NULL	Trials_2014_Dec_3_15(1)_474.nxml.txt.nlp	NULL	SENT35	3	3	8	8	sorafenib	SHARP	PA7000	23013	0.655
NULL	Biomed_Res_Int_2014_May_4_2014_351252.nxml.txt.nlp	24877084	SENT45	6	6	16	16	lomustine	FTM	PA164749407	23322	0.655
NULL	Exp_Ther_Med_2013_Jul_25_6(1)_109-114.nxml.txt.nlp	23935730	SENT142	41	41	29	29	rituximab	CHOP	PA451261	1649	0.655
NULL	Indian_J_Pharmacol_2008_Oct_40(Suppl_2)_S97-S112.nxml.txt.nlp	21593984	SENT80	3	3	15	15	minocycline	STZ	PA450519	6484	0.655
NULL	Front_Neurol_2014_Sep_11_5_173.nxml.txt.nlp	25309501	SENT238	19	19	16	16	hyaluronan	HYAL2	PA165958431	8692	0.655
NULL	J_Antimicrob_Chemother_2012_Feb_17_67(2)_404-414.nxml.txt.nlp	22101217	SENT129	27	27	17	17	levofloxacin	EMB	PA450214	133418	0.655
NULL	Biosci_Rep_2013_Sep_17_33(5)_e00068.nxml.txt.nlp	23919527	SENT255	6	6	28	28	guanidine	CXCL8	PA164781028	3576	0.655
NULL	Core_Evid_2007_Nov_30_2(2)_121-129.nxml.txt.nlp	21221180	SENT99	29	29	12	12	rituximab	NHL	PA451261	51750	0.655
NULL	Mol_Cancer_2009_Aug_25_8_66.nxml.txt.nlp	19706164	SENT72	8	8	17	17	celecoxib	p53	PA448871	7157	0.655
NULL	Mol_Biol_Cell_2012_May_15_23(10)_1928-1942.nxml.txt.nlp	22438580	SENT180	25	25	28	28	galactose	GAL	PA449725	51083	0.655
NULL	Acta_Pharmacol_Sin_2013_Sep_5_34(9)_1237-1242.nxml.txt.nlp	23770984	SENT98	31	31	17	17	phenytoin	CYP2C9	PA450947	1559	0.655
NULL	Biochem_Biophys_Res_Commun_2009_May_22_383(1)_63-67.nxml.txt.nlp	19332024	SENT17	24	24	26	26	lipase	HSL	PA450239	3991	0.655
NULL	J_Adv_Pharm_Technol_Res_2010_Apr-Jun_1(2)_180-189.nxml.txt.nlp	22247844	SENT0	18	18	25	25	furosemide	FOR	PA449719	51741	0.655
NULL	Mol_Cancer_2007_Aug_21_6_53.nxml.txt.nlp	17711579	SENT153	6	6	40	40	cisplatin	STK17B	PA449014	9262	0.655
NULL	Oncol_Rep_2014_Aug_12_32(2)_469-474.nxml.txt.nlp	24926795	SENT31	12	12	15	15	carboplatin	CTR1	PA448803	1317	0.655
NULL	Diabetologia_2010_Jan_6_53(1)_1-6.nxml.txt.nlp	19894028	SENT16	17	17	14	14	exenatide	GLP-1	PA164749238	100125288	0.655
NULL	Core_Evid_2009_Jun_15_4_171-179.nxml.txt.nlp	20694073	SENT209	28	28	17	17	agomelatine	STAR	PA165958363	6770;2984	0.655
NULL	Apoptosis_2012_Sep_30_17(9)_989-997.nxml.txt.nlp	22460505	SENT118	11	11	16	16	thioridazine	p27	PA451666	5715;10534	0.655
NULL	Genetics_2014_Jun_20_197(2)_611-623.nxml.txt.nlp	24653001	SENT250	26	26	15	15	camptothecin	TEL1	PA153590860	472	0.655
NULL	Br_J_Cancer_2014_Nov_25_111(11)_2091-2102.nxml.txt.nlp	25349971	SENT18	10	10	13	13	imatinib	PTPN18	PA10804	26469	0.655
NULL	Eur_J_Endocrinol_2011_Jan_164(1)_69-74.nxml.txt.nlp	20961967	SENT99	6	6	13	13	pioglitazone	adiponectin	PA450970	9370	0.655
NULL	Curr_Gerontol_Geriatr_Res_2010_Mar_3_2010_927503.nxml.txt.nlp	20204184	SENT60	28	28	18	18	cyclophosphamide	FVIII	PA449165	2157	0.655
NULL	Viruses_2014_Feb_18_6(2)_875-892.nxml.txt.nlp	24553110	SENT189	10	10	31	31	erlotinib	IFN	PA134687924	3439	0.655
NULL	Int_J_Inflam_2011_Sep_20_2011_367284.nxml.txt.nlp	21941675	SENT422	0	0	4	4	heparin	PAR-1	PA449855	2011;2149	0.655
NULL	Evid_Based_Complement_Alternat_Med_2012_May_7_2012_242810.nxml.txt.nlp	22645625	SENT209	0	0	8	8	rifampin	HNF4	PA451250	3172	0.655
NULL	Evid_Based_Complement_Alternat_Med_2011_Apr_26_2011_965095.nxml.txt.nlp	21584198	SENT25	8	8	21	21	oxygen	mol	PA450744	90527	0.655
NULL	Breast_Cancer_Res_2010_Oct_14_12(5)_R84.nxml.txt.nlp	20946630	SENT14	22	22	12	12	choline	Hsp90	PA448976	3320	0.655
NULL	J_Cancer_2013_Nov_23_4(9)_736-754.nxml.txt.nlp	24312144	SENT276	6	6	3	3	bevacizumab	EGFR	PA130232992	1956	0.655
NULL	Br_J_Cancer_2009_Mar_24_100(6)_941-949.nxml.txt.nlp	19240716	SENT145	8	8	5	5	gefitinib	Met	PA131301952	79811	0.655
NULL	Br_J_Ophthalmol_2014_Sep_7_98(9)_1186-1191.nxml.txt.nlp	24711658	SENT152	18	18	30	30	verteporfin	TAP	PA451871	8615;2317;10482;23541	0.655
NULL	Clin_Exp_Otorhinolaryngol_2011_Mar_17_4(1)_18-23.nxml.txt.nlp	21461058	SENT78	14	14	8	8	furosemide	NKCC1	PA449719	6558	0.655
NULL	Cancer_Cell_Int_2010_Oct_1_10_36.nxml.txt.nlp	20920299	SENT17	12	12	20	20	vincristine	survivin	PA451879	332	0.655
NULL	Mol_Clin_Oncol_2013_Jul_30_1(4)_655-660.nxml.txt.nlp	24649224	SENT199	26	26	22	22	doxorubicin	CHOP	PA449412	1649	0.655
NULL	Cancer_Microenviron_2009_Mar_18_2(1)_9-21.nxml.txt.nlp	19308679	SENT237	6	6	17	17	urokinase	PLAT	PA451836	5327	0.655
NULL	Mol_Clin_Oncol_2013_Sep_24_1(5)_918-924.nxml.txt.nlp	24649271	SENT92	16	16	18	18	gemcitabine	EGFR	PA449748	1956	0.655
NULL	Biochemistry_2011_May_3_50(17)_3408-3410.nxml.txt.nlp	21425834	SENT158	5	5	15	15	nadh	ADP	PA164755085	23038	0.655
NULL	Oncoscience_2013_Dec_11_1(1)_21-29.nxml.txt.nlp	25593981	SENT124	22	22	10	10	disulfiram	HSP27	PA449376	3315	0.655
NULL	AoB_Plants_2013_Apr_26_5_plt016.nxml.txt.nlp	NULL	SENT121	14	14	37	37	ethanol	mol	PA448073	90527	0.655
NULL	Diabetes_2011_May_23_60(5)_1458-1466.nxml.txt.nlp	21464445	SENT115	15	15	7	7	lipase	HSL	PA450239	3991	0.655
NULL	Br_J_Cancer_2013_Dec_10_109(12)_2959-2964.nxml.txt.nlp	24157828	SENT25	7	7	13	13	tamoxifen	HER2	PA451581	2064	0.655
NULL	J_Cell_Mol_Med_2014_Mar_22_18(3)_480-491.nxml.txt.nlp	24450440	SENT62	25	25	9	9	sorafenib	EDD	PA7000	51366	0.655
NULL	Adv_Hematol_2012_May_28_2012_945138.nxml.txt.nlp	22693514	SENT30	20	20	13	13	vincristine	CHOP	PA451879	1649	0.655
NULL	J_Biol_Eng_2010_Jan_29_4_2.nxml.txt.nlp	20205817	SENT9	26	26	18	18	hydralazine	zeta	PA449894	9907	0.655
NULL	Adv_Hematol_2009_Jul_7_2009_495863.nxml.txt.nlp	19960059	SENT122	24	24	29	29	heparin	PF4	PA449855	5196	0.655
NULL	Brain_Sci_2013_Jul_19_3(3)_1076-1094.nxml.txt.nlp	24961522	SENT588	1	1	19	19	ethanol	CA1	PA448073	759	0.655
NULL	J_Korean_Med_Sci_2014_Jan_26_29(1)_53-60.nxml.txt.nlp	24431906	SENT169	33	33	21	21	rituximab	CHOP	PA451261	1649	0.655
NULL	Cancers_(Basel)_2011_Apr_19_3(2)_2050-2079.nxml.txt.nlp	24212796	SENT1824	1	1	4	4	sulindac	beta-catenin	PA451565	1499	0.655
NULL	Front_Genet_2012_Nov_22_3_249.nxml.txt.nlp	23189085	SENT759	7	7	2	2	doxorubicin	ABCB1	PA449412	5243	0.655
NULL	Sensors_(Basel)_2013_Dec_27_14(1)_458-467.nxml.txt.nlp	24379050	SENT108	9	9	14	14	glucose	MTB	PA449773	54892;4498	0.655
NULL	Environ_Health_Perspect_2005_Apr_14_113(4)_431-439.nxml.txt.nlp	15811834	SENT143	0	0	21	21	nifedipine	PRL	PA450631	5617	0.655
NULL	Case_Rep_Oncol_2009_Jan_17_2(1)_1-6.nxml.txt.nlp	20844570	SENT36	7	7	12	12	cytarabine	LAM	PA449177	7249;7248	0.655
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT795	0	0	18	18	imatinib	ABCC10	PA10804	89845	0.655
NULL	Br_J_Ophthalmol_2012_Jul_26_96(7)_1023-1028.nxml.txt.nlp	22539748	SENT138	22	22	13	13	bevacizumab	REC	PA130232992	84515	0.655
NULL	Core_Evid_2010_Oct_21_5_61-76.nxml.txt.nlp	21042543	SENT158	14	14	35	35	panitumumab	EGFR	PA162373091	1956	0.655
NULL	J_Clin_Biochem_Nutr_2011_Jul_17_49(1)_50-56.nxml.txt.nlp	21765607	SENT170	27	27	35	35	arsenite	p38	PA452638	10598;1432;7965	0.655
NULL	Oncotarget_2014_Oct_15_5(19)_8853-8868.nxml.txt.nlp	25326682	SENT226	3	3	10	10	saracatinib	RCC4		84925	0.655
NULL	Exp_Ther_Med_2012_Sep_13_4(3)_409-414.nxml.txt.nlp	23181109	SENT139	5	5	10	10	ethanol	flower	PA448073	11094	0.655
NULL	Environ_Health_Perspect_2010_Dec_12_118(12)_1707-1713.nxml.txt.nlp	20705543	SENT132	18	18	3	3	paclitaxel	XRCC1	PA450761	7515	0.655
NULL	Indian_J_Pharmacol_2012_Sep-Oct_44(5)_629-633.nxml.txt.nlp	23112427	SENT115	4	4	14	14	propranolol	ANOVA	PA451145	4858	0.655
NULL	Biomed_Res_Int_2014_Apr_15_2014_175721.nxml.txt.nlp	24822180	SENT168	7	7	12	12	nutlin-3	p53		7157	0.655
NULL	Mult_Scler_Int_2014_Jul_22_2014_436764.nxml.txt.nlp	25152817	SENT23	34	34	15	15	natalizumab	IFN	PA164747191	3439	0.655
NULL	Gut_Pathog_2013_Mar_22_5_6.nxml.txt.nlp	23522652	SENT238	29	29	11	11	tetracycline	CTX	PA451640	1593	0.655
NULL	J_Gen_Physiol_1993_Mar_1_101(3)_337-353.nxml.txt.nlp	8386216	SENT4	30	30	24	24	forskolin	gamma	PA146096022	9913	0.655
NULL	J_Cell_Biol_2003_Aug_18_162(4)_613-622.nxml.txt.nlp	12913110	SENT207	38	38	21	21	dextran	c-Jun	PA449261	3725	0.655
NULL	Endocrinol_Metab_(Seoul)_2014_Sep_25_29(3)_226-232.nxml.txt.nlp	25309779	SENT62	20	20	38	38	thyroglobulin	WBS	PA164754910	2006	0.655
NULL	Contemp_Clin_Dent_2013_Jan-Mar_4(1)_1.nxml.txt.nlp	23853443	SENT17	0	0	4	4	vemurafenib	BRAF	PA165946873	673	0.655
NULL	CNS_Spectr_2014_Oct_3_19(5)_391-402.nxml.txt.nlp	24698103	SENT100	0	0	25	25	aripiprazole	hang	PA10026	374879	0.655
NULL	J_Headache_Pain_2013_Apr_10_14(1)_33.nxml.txt.nlp	23574808	SENT141	11	11	15	15	capsaicin	CO2	PA448776	4513	0.655
NULL	Onco_Targets_Ther_2014_Nov_21_7_2143-2146.nxml.txt.nlp	25473295	SENT58	38	38	40	40	irinotecan	UGT1A1	PA450085	54658	0.655
NULL	ScientificWorldJournal_2012_Apr_22_2012_643904.nxml.txt.nlp	22619632	SENT305	25	25	23	23	pp2	PP1		5540;5464	0.655
NULL	Arthritis_Res_Ther_2007_Oct_9_9(5)_R104.nxml.txt.nlp	17925024	SENT214	9	9	18	18	glucosamine	AP-1	PA164747613	2353;3727;2354;3725	0.655
NULL	Cell_Death_Dis_2013_Jun_13_4(6)_e665.nxml.txt.nlp	23764846	SENT107	1	1	12	12	sorafenib	VEGFR	PA7000	3791	0.655
NULL	Clin_Exp_Otorhinolaryngol_2013_Mar_1_6(1)_48-51.nxml.txt.nlp	23526700	SENT82	24	24	19	19	thyroglobulin	TTF-1	PA164754910	7080	0.655
NULL	Breast_Cancer_Res_Treat_2014_Apr_6_145(1)_33-44.nxml.txt.nlp	24706169	SENT149	26	26	19	19	trastuzumab	HER2	PA451743	2064	0.655
NULL	Mol_Cell_2014_May_8_54(3)_445-459.nxml.txt.nlp	24746700	SENT36	30	30	6	6	etoposide	BRCA1	PA449552	672	0.655
NULL	J_Hematol_Oncol_2010_Apr_7_3_13.nxml.txt.nlp	20374647	SENT174	16	16	25	25	bortezomib	RRM2	PA10252	6241	0.655
NULL	Oncotarget_2011_Sep_9_2(9)_658-668.nxml.txt.nlp	21911919	SENT30	22	22	8	8	daunorubicin	HO-1	PA449212	3162	0.655
NULL	Oxid_Med_Cell_Longev_2013_Apr_30_2013_796891.nxml.txt.nlp	23738041	SENT249	7	7	14	14	resveratrol	SIRT1		23411	0.655
NULL	Acta_Pharmacol_Sin_2012_Jul_4_33(7)_897-908.nxml.txt.nlp	22659625	SENT205	33	33	35	35	bleomycin	BLM	PA448645	641	0.655
NULL	Toxins_(Basel)_2010_Oct_26_2(11)_2490-2518.nxml.txt.nlp	22069563	SENT305	3	3	7	7	cimetidine	OCT2	PA449001	6582;5452	0.655
NULL	J_Oncol_2010_Nov_19_2010_568938.nxml.txt.nlp	20037743	SENT298	21	21	29	29	paclitaxel	EGFR	PA450761	1956	0.655
NULL	Mol_Biol_Cell_2012_Mar_15_23(6)_996-1009.nxml.txt.nlp	22278744	SENT82	3	3	13	13	forskolin	14-3-3	PA146096022	10971	0.655
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT117	14	14	21	21	doxorubicin	B7-H1	PA449412	29126	0.655
NULL	Int_J_Med_Sci_2013_Mar_15_10(5)_567-574.nxml.txt.nlp	23533048	SENT172	2	2	4	4	entecavir	LAM	PA164784025	7249;7248	0.655
NULL	Arthritis_Rheumatol_2014_Jun_27_66(6)_1574-1582.nxml.txt.nlp	24577881	SENT111	0	0	17	17	hydralazine	CD4	PA449894	920	0.655
NULL	J_Cell_Mol_Med_2014_Apr_20_18(4)_709-720.nxml.txt.nlp	24444314	SENT238	13	13	8	8	losartan	AMPK	PA450268	5563	0.655
NULL	Exp_Diabetes_Res_2011_Dec_27_2011_604989.nxml.txt.nlp	21253359	SENT50	42	42	44	44	clonidine	GLP-1	PA449051	100125288	0.655
NULL	Emerg_Infect_Dis_2013_Jan_19(1)_133-136.nxml.txt.nlp	23260464	SENT54	30	30	24	24	ciprofloxacin	TOB	PA449009	10140	0.655
NULL	Clin_Psychopharmacol_Neurosci_2011_Aug_31_9(2)_78-85.nxml.txt.nlp	23429185	SENT133	30	30	36	36	zolpidem	PPL	PA451976	5493	0.655
NULL	Mol_Cancer_2009_Aug_25_8_66.nxml.txt.nlp	19706164	SENT72	41	41	30	30	celecoxib	p53	PA448871	7157	0.655
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_16_2012_395912.nxml.txt.nlp	23118789	SENT75	29	29	15	15	phenylbutazone	UGT1A7	PA450932	54577	0.655
NULL	Diabetes_Metab_J_2014_Apr_18_38(2)_100-106.nxml.txt.nlp	24851203	SENT36	44	44	28	28	glucose	MET	PA449773	4233	0.655
NULL	Adv_Biomed_Res_2014_Nov_29_3_232.nxml.txt.nlp	25538918	SENT32	7	7	21	21	ropivacaine	ACL	PA451271	47	0.655
NULL	Case_Rep_Nephrol_2013_Nov_20_2013_801575.nxml.txt.nlp	24558627	SENT33	20	20	22	22	vasopressin	AVP	PA451858	114548;551	0.655
NULL	J_Cell_Biol_2008_Jul_28_182(2)_327-340.nxml.txt.nlp	18644889	SENT94	30	30	19	19	estradiol	p85	PA449503	5296;5295;54776;23368	0.655
NULL	Nature_2012_Jan_25_482(7384)_232-236.nxml.txt.nlp	22278056	SENT36	11	11	8	8	melarsoprol	AT1	PA10136	9197;185	0.655
NULL	Br_J_Cancer_2012_Jul_10_107(2)_360-369.nxml.txt.nlp	22713663	SENT52	0	0	2	2	cisplatin	DDP	PA449014	1678	0.655
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT180	25	25	12	12	curcumin	TRAIL	PA151958596	8743	0.655
NULL	Acta_Pharmacol_Sin_2009_Jul_3_30(7)_889-898.nxml.txt.nlp	19574994	SENT150	0	0	23	23	pp2	EGFR		1956	0.655
NULL	Front_Cell_Neurosci_2014_Feb_6_8_27.nxml.txt.nlp	24567703	SENT319	16	16	27	27	taurine	WNK1	PA451590	65125	0.655
NULL	Kidney_Int_Suppl_(2011)_2012_Dec_15_2(5)_347-356.nxml.txt.nlp	25018961	SENT238	26	26	15	15	losartan	ACR	PA450268	49	0.655
NULL	Int_J_Mol_Sci_2014_Sep_23_15(9)_16911-16935.nxml.txt.nlp	25250910	SENT162	25	25	19	19	ethanol	mol	PA448073	90527	0.655
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT119	9	9	11	11	curcumin	TRAIL	PA151958596	8743	0.655
NULL	Cell_Death_Dis_2014_Jan_16_5(1)_e1000.nxml.txt.nlp	24434508	SENT292	7	7	25	25	etoposide	p53	PA449552	7157	0.654
NULL	Exp_Ther_Med_2014_Jun_3_7(6)_1762-1766.nxml.txt.nlp	24926381	SENT181	22	22	6	6	resveratrol	GCLC		2729	0.654
NULL	Emerg_Infect_Dis_2011_Mar_17(3)_510-513.nxml.txt.nlp	21392446	SENT53	34	34	36	36	capreomycin	ETO	PA164746226	862	0.654
NULL	J_Cell_Biol_1998_Jan_26_140(2)_335-345.nxml.txt.nlp	9442109	SENT20	14	14	21	21	chloroquine	NHE	PA448948	285335	0.654
NULL	Arch_Drug_Inf_2008_Jul_1(1)_14-22.nxml.txt.nlp	20157364	SENT148	0	0	5	5	pravastatin	MCP-1	PA451089	6347	0.654
NULL	Acta_Pharmacol_Sin_2013_Sep_5_34(9)_1208-1216.nxml.txt.nlp	23852087	SENT99	2	2	15	15	disulfiram	HIF-1	PA449376	29072	0.654
NULL	ScientificWorldJournal_2014_Dec_29_2014_396304.nxml.txt.nlp	25614886	SENT67	31	31	0	0	mannitol	MYP	PA450320	8996	0.654
NULL	J_Korean_Med_Sci_2001_Oct_16(5)_677-682.nxml.txt.nlp	11641544	SENT18	2	2	4	4	vasopressin	AVP	PA451858	114548;551	0.654
NULL	Emerg_Infect_Dis_2012_Jun_18(6)_1019-1020.nxml.txt.nlp	22608263	SENT34	38	38	20	20	norfloxacin	TOB	PA450654	10140	0.654
NULL	Environ_Microbiol_2013_Jan_15_15(1)_297-304.nxml.txt.nlp	23157680	SENT66	18	18	16	16	trimethoprim	TMP	PA451788	2012	0.654
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_P108.nxml.txt.nlp	NULL	SENT15	30	30	17	17	piperacillin	IL22	PA450975	50616	0.654
NULL	Evid_Based_Complement_Alternat_Med_2011_Mar_9_2011_750230.nxml.txt.nlp	21423639	SENT250	15	15	2	2	curcumin	HS7	PA151958596	349198	0.654
NULL	Br_J_Cancer_2000_Nov_26_83(10)_1360-1366.nxml.txt.nlp	11044362	SENT5	0	0	5	5	paclitaxel	p53	PA450761	7157	0.654
NULL	J_Med_Chem_2014_Jan_23_57(2)_449-461.nxml.txt.nlp	24387105	SENT133	5	5	12	12	benzaldehyde	ALDH3A1	PA448571	218	0.654
NULL	J_Korean_Med_Sci_2007_Dec_20_22(6)_1055-1059.nxml.txt.nlp	18162722	SENT137	8	8	16	16	famotidine	ESD	PA449586	2098	0.654
NULL	Oncologist_2010_Aug_29_15(8)_799-809.nxml.txt.nlp	20671105	SENT169	10	10	12	12	trastuzumab	HER-2	PA451743	2064	0.654
NULL	Alcohol_Res_Health_2007_30(1)_5-13.nxml.txt.nlp	17718394	SENT8	24	24	4	4	ethanol	ADH1B	PA448073	125	0.654
NULL	Semin_Immunopathol_2013_Jan_26_35(1)_39-52.nxml.txt.nlp	22829332	SENT197	37	37	30	30	mitoxantrone	CHOP	PA450526	1649	0.654
NULL	Comp_Hepatol_2004_Jan_14_3(Suppl_1)_S25.nxml.txt.nlp	14960177	SENT59	15	15	5	5	ethanol	TNF-alpha	PA448073	7124	0.654
NULL	Pain_2014_Nov_155(11)_2306-2322.nxml.txt.nlp	25168672	SENT973	14	14	8	8	bepridil	LOX	PA164754755	4015	0.654
NULL	J_Phys_Ther_Sci_2014_Nov_13_26(11)_1723-1727.nxml.txt.nlp	25435686	SENT73	11	11	23	23	dextran	DTD	PA449261	1728	0.654
NULL	Cell_Commun_Signal_2013_Nov_5_11_83.nxml.txt.nlp	24192293	SENT166	14	14	23	23	doxycycline	IL-6	PA449415	3569	0.654
NULL	J_Biol_Chem_2012_Dec_14_287(51)_43094-43107.nxml.txt.nlp	23118219	SENT516	3	3	9	9	hyaluronan	CD4	PA165958431	920	0.654
NULL	Breast_Cancer_Res_2009_Nov_18_11(6)_R85.nxml.txt.nlp	19922614	SENT27	25	25	16	16	tamoxifen	BCS	PA451581	617	0.654
NULL	Ann_Oncol_2010_Mar_28_21(3)_498-505.nxml.txt.nlp	19717534	SENT230	7	7	1	1	tamoxifen	ATAC	PA451581	6375	0.654
NULL	Mol_Cell_Proteomics_2012_Feb_6_11(2)_M111_015222.nxml.txt.nlp	22147731	SENT295	7	7	23	23	gefitinib	EGF	PA131301952	1950	0.654
NULL	Cancers_(Basel)_2010_Dec_23_3(1)_17-42.nxml.txt.nlp	24212604	SENT926	14	14	12	12	paclitaxel	PPX	PA450761	5531	0.654
NULL	Adv_Hematol_2012_Jun_16_2012_435342.nxml.txt.nlp	21822434	SENT82	13	13	20	20	doxorubicin	LBH	PA449412	81606;221491	0.654
NULL	Int_J_Nanomedicine_2012_May_7_7_2307-2314.nxml.txt.nlp	22661887	SENT128	9	9	26	26	gemcitabine	zeta	PA449748	9907	0.654
NULL	Breast_Cancer_Res_2014_Sep_9_16(5)_437.nxml.txt.nlp	25200860	SENT267	9	9	11	11	pha-665752	Met		79811	0.654
NULL	Br_J_Cancer_1959_Jun_13(2)_282-287.nxml.txt.nlp	13845398	SENT0	16	16	8	8	l-histidine	RD3	PA449882	343035	0.654
NULL	Scientifica_(Cairo)_2012_Dec_16_2012_402783.nxml.txt.nlp	24278688	SENT153	10	10	2	2	thrombin	MASP1	PA451674	5648	0.654
NULL	J_Gen_Physiol_2012_Nov_140(5)_541-555.nxml.txt.nlp	23109716	SENT548	2	2	11	11	capsaicin	TRPV1	PA448776	7442	0.654
NULL	Eur_J_Clin_Pharmacol_2010_Feb_17_66(2)_165-170.nxml.txt.nlp	19838691	SENT100	10	10	23	23	midazolam	CYP3A	PA450496	1574	0.654
NULL	Evid_Based_Complement_Alternat_Med_2013_Aug_12_2013_982689.nxml.txt.nlp	23997806	SENT40	7	7	3	3	tolbutamide	APE	PA451718	55704;328	0.654
NULL	Int_J_Endocrinol_2013_Sep_5_2013_895102.nxml.txt.nlp	24089613	SENT21	21	21	24	24	liraglutide	GLP-1	PA165958364	100125288	0.654
NULL	Emerg_Infect_Dis_2013_Jan_19(1)_133-136.nxml.txt.nlp	23260464	SENT42	30	30	20	20	cefepime	TOB	PA164754876	10140	0.654
NULL	Clinics_(Sao_Paulo)_2012_Apr_67(Suppl_1)_125-129.nxml.txt.nlp	22584717	SENT61	38	38	28	28	axitinib	VEGFR	PA164924493	3791	0.654
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT270	4	4	10	10	tenofovir	ABCC2	PA10204	1244	0.654
NULL	Oxid_Med_Cell_Longev_2013_Jun_2_2013_793525.nxml.txt.nlp	23819014	SENT256	21	21	5	5	resveratrol	ROS		6098	0.654
NULL	J_Oncol_2009_Mar_24_2009_491985.nxml.txt.nlp	19325924	SENT122	7	7	14	14	genistein	CXCL12	PA165109660	6387	0.654
NULL	Clin_Epigenetics_2011_Dec_5_3(1)_8.nxml.txt.nlp	22414275	SENT111	3	3	13	13	ribavirin	ESR1	PA451241	2099	0.654
NULL	Mol_Clin_Oncol_2013_Sep_18_1(5)_839-844.nxml.txt.nlp	24649257	SENT30	7	7	29	29	docetaxel	NAC	PA449383	22861	0.654
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1051.nxml.txt.nlp	24503543	SENT144	12	12	23	23	sunitinib	Yes	PA162372840	7525	0.654
NULL	J_Gastroenterol_2014_Jun_19_49(6)_1001-1010.nxml.txt.nlp	23780559	SENT192	13	13	4	4	genistein	HCN	PA165109660	378938	0.654
NULL	Emerg_Infect_Dis_2005_Jun_11(6)_873-882.nxml.txt.nlp	15963282	SENT94	14	14	16	16	ciprofloxacin	TOB	PA449009	10140	0.654
NULL	Biomed_Res_Int_2013_Sep_4_2013_419176.nxml.txt.nlp	24093097	SENT184	20	20	28	28	everolimus	IFN	PA164746311	3439	0.654
NULL	BMJ_Open_2014_Aug_19_4(8)_e006005.nxml.txt.nlp	25138814	SENT29	8	8	20	20	chloroquine	ACT	PA448948	12;11332;9457;641455	0.654
NULL	Indian_J_Pharmacol_2014_Mar-Apr_46(2)_161-165.nxml.txt.nlp	24741186	SENT23	18	18	25	25	carvedilol	STZ	PA448817	6484	0.654
NULL	Oncoimmunology_2013_Dec_1_2(12)_e26663.nxml.txt.nlp	24498552	SENT15	13	13	32	32	melphalan	DNAM-1	PA450354	10666	0.654
NULL	Nucleic_Acids_Res_2011_Dec_31_39(22)_9536-9548.nxml.txt.nlp	21880590	SENT170	12	12	5	5	etoposide	BRCA1	PA449552	672	0.654
NULL	Acta_Pharmacol_Sin_2011_Feb_4_32(2)_223-229.nxml.txt.nlp	21293474	SENT3	31	31	14	14	l-arginine	FKBP12	PA448478	2280	0.654
NULL	Int_J_Environ_Res_Public_Health_2010_Dec_21_7(12)_4281-4304.nxml.txt.nlp	21318009	SENT106	3	3	8	8	ethanol	spatial	PA448073	219793	0.654
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT128	12	12	1	1	diazepam	CYP2C9	PA449283	1559	0.654
NULL	Br_J_Pharmacol_2012_Apr_165(7)_2191-2202.nxml.txt.nlp	21958009	SENT219	14	14	16	16	phenylephrine	5-HT2A	PA450935	3356	0.654
NULL	Diabetes_2011_Nov_17_60(11)_2691-2700.nxml.txt.nlp	21896928	SENT117	1	1	5	5	resveratrol	SIRT1		23411	0.654
NULL	Oncol_Lett_2014_May_11_7(5)_1401-1408.nxml.txt.nlp	24765145	SENT173	2	2	11	11	paclitaxel	HIF-1	PA450761	29072	0.654
NULL	J_Korean_Med_Sci_2007_Apr_30_22(2)_283-289.nxml.txt.nlp	17449938	SENT9	3	3	16	16	minoxidil	Bcl-2	PA450521	596	0.654
NULL	Nucleic_Acids_Res_2005_May_19_33(9)_2859-2867.nxml.txt.nlp	15905475	SENT156	41	41	6	6	cisplatin	MPG	PA449014	4350	0.654
NULL	J_Cell_Mol_Med_2014_Mar_22_18(3)_480-491.nxml.txt.nlp	24450440	SENT62	33	33	9	9	sunitinib	EDD	PA162372840	51366	0.654
NULL	Daru_2012_Sep_3_20(1)_24.nxml.txt.nlp	23351176	SENT188	3	3	7	7	itopride	EPO	PA152432599	7076;8288;2056	0.654
NULL	Indian_J_Med_Res_2013_Jan_137(1)_203-209.nxml.txt.nlp	23481074	SENT23	27	27	12	12	coumarin	VKORC1	PA134521193	79001	0.654
NULL	Indian_J_Endocrinol_Metab_2012_Dec_16(Suppl_2)_S408-S410.nxml.txt.nlp	23565445	SENT69	14	14	26	26	paricalcitol	PTH	PA450798	5741	0.654
NULL	Oncotarget_2012_Jul_13_3(6)_601-607.nxml.txt.nlp	22802145	SENT18	22	22	6	6	doxorubicin	p53	PA449412	7157	0.654
NULL	Front_Cell_Neurosci_2014_Jan_22_8_2.nxml.txt.nlp	24478627	SENT86	23	23	5	5	isoflurane	BIM	PA450106	10018	0.654
NULL	J_Neurosci_Methods_2009_Oct_15_183(2)_107-113.nxml.txt.nlp	19524611	SENT95	14	14	5	5	carbachol	DSI	PA448784	5034	0.654
NULL	J_Int_Soc_Sports_Nutr_2015_Jan_21_12(1)_5.nxml.txt.nlp	NULL	SENT193	25	25	12	12	curcumin	IL-6	PA151958596	3569	0.654
NULL	Pharmaceuticals_(Basel)_2011_Nov_11_4(11)_1503-1517.nxml.txt.nlp	NULL	SENT140	26	26	28	28	capsaicin	TRPV1	PA448776	7442	0.654
NULL	Neuroscience_2012_Mar_15_205(C)_154-166.nxml.txt.nlp	22244974	SENT14	1	1	7	7	ethanol	MCP-1	PA448073	6347	0.654
NULL	Cancer_Immunol_Immunother_2015_Oct_7_64_61-73.nxml.txt.nlp	25287778	SENT224	6	6	16	16	lenalidomide	IL-2	PA162363968	3558	0.654
NULL	Acta_Pharmacol_Sin_2013_Oct_7_34(10)_1359-1366.nxml.txt.nlp	23933653	SENT36	21	21	6	6	retigabine	KCNQ2	PA144997862	3785	0.654
NULL	Mol_Cells_2014_Sep_30_37(9)_664-671.nxml.txt.nlp	25234467	SENT205	26	26	10	10	cisplatin	miR-217	PA449014	406999	0.654
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT299	10	10	17	17	resveratrol	IL-6		3569	0.654
NULL	Adv_Hematol_2012_Aug_2_2012_842945.nxml.txt.nlp	22919394	SENT180	13	13	22	22	lenalidomide	CRBN	PA162363968	51185	0.654
NULL	Oncotarget_2011_Jun_15_2(6)_518-524.nxml.txt.nlp	21680956	SENT90	9	9	3	3	imatinib	STAT3	PA10804	6774	0.654
NULL	J_Hematol_Oncol_2013_Nov_5_6_83.nxml.txt.nlp	24283248	SENT88	29	29	25	25	nutlin-3	CDKN1A		1026	0.654
NULL	Diabetes_Obes_Metab_2010_May_12(5)_437-441.nxml.txt.nlp	20415692	SENT32	17	17	9	9	metformin	GLA	PA450395	9027;2717	0.654
NULL	Breast_Cancer_Res_2010_Jul_19_12(4)_R51.nxml.txt.nlp	20642837	SENT330	5	5	21	21	etoposide	NR4A1	PA449552	3164	0.654
NULL	J_Immunother_Cancer_2014_Jan_27_2_2.nxml.txt.nlp	24829759	SENT138	8	8	3	3	sorafenib	IL-21	PA7000	59067;50616;27189	0.654
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT270	26	26	6	6	glucose	EGFR	PA449773	1956	0.654
NULL	Breast_Cancer_Res_2009_Jul_30_11(4)_R56.nxml.txt.nlp	19643025	SENT270	9	9	12	12	celecoxib	IL-17	PA448871	3605	0.654
NULL	Br_J_Pharmacol_2013_Jun_27_169(4)_736-747.nxml.txt.nlp	23489111	SENT103	35	35	13	13	granisetron	5-HT3A	PA449809	3359	0.654
NULL	Arthritis_Res_Ther_2009_May_19_11(3)_229.nxml.txt.nlp	19519924	SENT320	43	43	37	37	methotrexate	TNF	PA450428	7124	0.654
NULL	Protein_Cell_2014_Jun_19_5(6)_469-479.nxml.txt.nlp	24748116	SENT6	14	14	12	12	paclitaxel	EB1	PA450761	9167;22919;10982	0.654
NULL	Hematol_Rep_2011_Oct_28_3(3_Suppl)_e1.nxml.txt.nlp	22586509	SENT11	5	5	10	10	vincristine	CHOP	PA451879	1649	0.654
NULL	Oncol_Lett_2014_Mar_2_7(3)_791-796.nxml.txt.nlp	24527087	SENT101	2	2	8	8	imatinib	CDK1	PA10804	983	0.654
NULL	Ther_Clin_Risk_Manag_2006_Mar_2(1)_3-18.nxml.txt.nlp	18360577	SENT271	1	1	8	8	ibandronate	CTX	PA10270	1593	0.654
NULL	J_Vet_Med_Sci_2014_Jul_18_76(7)_937-945.nxml.txt.nlp	24646457	SENT123	6	6	40	40	amoxicillin	OTC	PA448406	5009	0.654
NULL	Pharmaceuticals_(Basel)_2014_Jan_9_7(1)_46-57.nxml.txt.nlp	24451403	SENT216	1	1	3	3	ritonavir	AKT	PA451260	207	0.654
NULL	J_Exp_Clin_Cancer_Res_2009_Apr_28_28(1)_57.nxml.txt.nlp	19397830	SENT47	9	9	31	31	paraformaldehyde	CK19	PA450790	3880	0.654
NULL	Chem_Rev_2011_Oct_12_111(10)_5899-5921.nxml.txt.nlp	21923193	SENT78	10	10	3	3	oxygen	LOX	PA450744	4015	0.654
NULL	Oncotarget_2014_Feb_25_5(5)_1304-1314.nxml.txt.nlp	24675421	SENT66	35	35	22	22	cisplatin	JNK	PA449014	5599	0.654
NULL	Biologics_2012_Aug_3_6_249-256.nxml.txt.nlp	22904616	SENT4	17	17	14	14	telaprevir	BOC	PA165958354	91653	0.654
NULL	J_Korean_Med_Sci_2014_Aug_30_29(8)_1042-1053.nxml.txt.nlp	25120312	SENT13	11	11	26	26	triciribine	p53	PA165958661	7157	0.654
NULL	J_Nat_Med_2014_Feb_19_68(2)_253-266.nxml.txt.nlp	24550097	SENT156	31	31	12	12	ethanol	SREBP-1c	PA448073	6720	0.654
NULL	Pharmaceutics_2011_Jul_13_3(3)_425-439.nxml.txt.nlp	24310588	SENT355	41	41	0	0	oxycodone	SERS	PA450741	6301;54938	0.654
NULL	Ann_Oncol_2011_May_3_22(5)_1078-1087.nxml.txt.nlp	21048039	SENT24	12	12	6	6	cetuximab	EGFR	PA10040	1956	0.654
NULL	Arthritis_Rheum_2013_Sep_26_65(9)_2290-2300.nxml.txt.nlp	23740547	SENT221	14	14	26	26	doxycycline	S100A9	PA449415	6280	0.654
NULL	J_Adv_Pract_Oncol_2013_Sep_1_Sep-Oct_4(5)_348-352.nxml.txt.nlp	25032013	SENT103	20	20	11	11	bevacizumab	EGFR	PA130232992	1956	0.654
NULL	Braz_J_Med_Biol_Res_2014_Sep_5_47(11)_929-939.nxml.txt.nlp	25296354	SENT114	19	19	21	21	erlotinib	EGFR	PA134687924	1956	0.654
NULL	Mol_Pain_2014_Apr_9_10_24.nxml.txt.nlp	24716552	SENT162	9	9	17	17	capsaicin	NK1R	PA448776	6869	0.654
NULL	Drugs_R_D_2013_Jun_5_13(2)_145-151.nxml.txt.nlp	23737453	SENT25	21	21	27	27	simvastatin	CYP3A4	PA451363	1576	0.654
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Mar_14_64(Pt_4)_m537.nxml.txt.nlp	21201997	SENT55	17	17	8	8	ethanol	NO3	PA448073	4681	0.654
NULL	Cell_Commun_Signal_2013_Oct_1_11_73.nxml.txt.nlp	24083678	SENT83	1	1	9	9	sulindac	p65	PA451565	5970	0.654
NULL	Emerg_Infect_Dis_2013_Jan_19(1)_133-136.nxml.txt.nlp	23260464	SENT54	6	6	24	24	amikacin	TOB	PA164744372	10140	0.654
NULL	Pharmaceutics_2011_Jun_22_3(2)_326-337.nxml.txt.nlp	24310499	SENT278	15	15	1	1	tenofovir	Ray	PA10204	26751	0.654
NULL	Ann_Thorac_Med_2014_Apr-Jun_9(2)_124-126.nxml.txt.nlp	24791177	SENT80	3	3	10	10	sirolimus	LAM	PA451365	7249;7248	0.654
NULL	Indian_J_Psychiatry_2014_Jan_56(Suppl_1)_S63-S96.nxml.txt.nlp	NULL	SENT808	13	13	10	10	clozapine	OGC	PA449061	8402	0.654
NULL	J_Vet_Med_Sci_2014_Jul_18_76(7)_937-945.nxml.txt.nlp	24646457	SENT123	14	14	40	40	chloramphenicol	OTC	PA448927	5009	0.654
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_17_2012_250584.nxml.txt.nlp	23118786	SENT299	16	16	21	21	nicotine	MAR	PA450626	3659	0.654
NULL	Int_Arch_Med_2011_Feb_4_4_6.nxml.txt.nlp	21294887	SENT100	21	21	28	28	methylphenidate	PB1	PA450464	55193	0.654
NULL	Cell_Commun_Signal_2009_Oct_27_7_25.nxml.txt.nlp	19860902	SENT155	3	3	15	15	thiopental	IFN	PA451664	3439	0.654
NULL	Breast_Cancer_Res_2014_May_23_16(3)_R50.nxml.txt.nlp	24887458	SENT123	13	13	0	0	docetaxel	HER2	PA449383	2064	0.654
NULL	Mol_Cytogenet_2014_Aug_19_7_52.nxml.txt.nlp	25295072	SENT126	15	15	3	3	s-adenosylmethionine	MAT2A	PA164754994	4144	0.654
NULL	Diabetes_2011_Jun_21_60(6)_1797-1804.nxml.txt.nlp	21536946	SENT73	24	24	20	20	diazoxide	ADP	PA449285	23038	0.654
NULL	Chem_Cent_J_2012_Nov_2_6_128.nxml.txt.nlp	23122321	SENT5	21	21	8	8	l-phenylalanine	C10	PA450931	113246	0.654
NULL	Mol_Vis_2012_Nov_29_18_2839-2846.nxml.txt.nlp	23233786	SENT167	39	39	17	17	geldanamycin	CB2	PA152031327	1269	0.654
NULL	J_Exp_Med_2003_Feb_17_197(4)_537-542.nxml.txt.nlp	12591910	SENT161	29	29	24	24	collagenase	IL-6	PA449107	3569	0.654
NULL	J_Biomed_Biotechnol_2008_Jul_8_2008_597913.nxml.txt.nlp	18629230	SENT206	29	29	31	31	ethanol	CO2	PA448073	4513	0.654
NULL	J_Hematol_Oncol_2013_Jul_18_6_53.nxml.txt.nlp	23866964	SENT79	22	22	16	16	temsirolimus	CDKN1A	PA164746890	1026	0.654
NULL	Br_J_Cancer_2010_Feb_2_102(3)_457-461.nxml.txt.nlp	20010942	SENT60	16	16	14	14	cetuximab	ERBB2	PA10040	2064	0.654
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Apr_28_68(Pt_5)_o1566.nxml.txt.nlp	22590424	SENT70	4	4	7	7	coumarin	mol	PA134521193	90527	0.654
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_127043.nxml.txt.nlp	23227093	SENT231	24	24	26	26	ketoconazole	CYP3A4	PA450146	1576	0.654
NULL	Behav_Brain_Funct_2009_Jun_4_5_23.nxml.txt.nlp	19497110	SENT54	3	3	16	16	ethanol	P29	PA448073	5657	0.654
NULL	J_Exp_Clin_Cancer_Res_2009_Sep_1_28(1)_123.nxml.txt.nlp	19723324	SENT0	19	19	21	21	gefitinib	PTEN	PA131301952	5728	0.654
NULL	Acta_Pharmacol_Sin_2010_Apr_15_31(4)_493-500.nxml.txt.nlp	20228829	SENT148	19	19	13	13	bupivacaine	JNK	PA135057240	5599	0.654
NULL	Mol_Cancer_2009_Jul_3_8_43.nxml.txt.nlp	19575780	SENT292	18	18	7	7	cisplatin	survivin	PA449014	332	0.654
NULL	Diabetes_Care_2011_Oct_15_34(10)_2323-2328.nxml.txt.nlp	21949223	SENT119	19	19	5	5	metformin	LKB1	PA450395	6794	0.654
NULL	Mol_Cancer_2009_Mar_5_8_14.nxml.txt.nlp	19265551	SENT78	7	7	13	13	camptothecin	p53	PA153590860	7157	0.654
NULL	Drugs_R_D_2010_May_27_10(1)_9-24.nxml.txt.nlp	20509711	SENT377	5	5	21	21	repaglinide	CYP2C8	PA451234	1558	0.654
NULL	Ann_Clin_Microbiol_Antimicrob_2014_Jan_6_13_2.nxml.txt.nlp	24393536	SENT42	38	38	14	14	ciprofloxacin	TOB	PA449009	10140	0.654
NULL	ScientificWorldJournal_2013_Dec_14_2013_732340.nxml.txt.nlp	24396306	SENT190	9	9	6	6	gatifloxacin	DPT	PA449738	1805	0.654
NULL	Int_J_Med_Sci_2015_Jan_1_12(1)_63-71.nxml.txt.nlp	25552920	SENT22	5	5	10	10	berberine	NODAL	PA165860812	4838	0.654
NULL	Exp_Ther_Med_2013_Feb_29_5(2)_527-532.nxml.txt.nlp	23404385	SENT108	8	8	6	6	tacrolimus	CYP3A5	PA451578	1577	0.654
NULL	Front_Cell_Neurosci_2014_Jul_30_8_203.nxml.txt.nlp	25126056	SENT673	11	11	4	4	allopregnanolone	FMR1	PA142320763	2332	0.654
NULL	J_Thromb_Thrombolysis_2011_Nov_26_32(4)_459-466.nxml.txt.nlp	21706290	SENT110	16	16	18	18	clopidogrel	CYP2C19	PA449053	1557	0.654
NULL	Clin_Epigenetics_2011_Dec_5_3(1)_8.nxml.txt.nlp	22414275	SENT36	6	6	30	30	ribavirin	ESR1	PA451241	2099	0.654
NULL	Emerg_Med_Int_2012_Sep_20_2012_637171.nxml.txt.nlp	23050154	SENT167	4	4	21	21	etomidate	RAI	PA164743987	10848;6050	0.654
NULL	Front_Neurosci_2014_Jun_3_8_128.nxml.txt.nlp	24917782	SENT144	22	22	29	29	ethanol	MC3R	PA448073	4159	0.654
NULL	Oncol_Lett_2014_Nov_14_8(5)_2086-2092.nxml.txt.nlp	25295095	SENT136	39	39	10	10	gemcitabine	CHK1	PA449748	1111	0.654
NULL	Bioimpacts_2014_May_17_4(3)_123-132.nxml.txt.nlp	25337465	SENT195	14	14	6	6	zinc	TRAIL	PA451956	8743	0.654
NULL	Biomed_Res_Int_2014_Aug_7_2014_310215.nxml.txt.nlp	25177687	SENT37	28	28	33	33	forskolin	NRG1	PA146096022	3084	0.654
NULL	Oncoimmunology_2013_Dec_1_2(12)_e26689.nxml.txt.nlp	24527364	SENT16	17	17	6	6	lapatinib	CD4	PA152241907	920	0.654
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2012_Feb_20_5_13-30.nxml.txt.nlp	22879796	SENT165	1	1	11	11	pravastatin	adiponectin	PA451089	9370	0.654
NULL	Br_J_Cancer_1997_75(1)_101-105.nxml.txt.nlp	9000605	SENT0	13	13	19	19	leucovorin	LCF	PA450198	3603	0.654
NULL	J_Oncol_2013_Mar_12_2013_975908.nxml.txt.nlp	23577029	SENT102	17	17	23	23	cisplatin	HLA-G	PA449014	3135	0.654
NULL	Biomed_Res_Int_2013_Jun_17_2013_247152.nxml.txt.nlp	23844359	SENT105	20	20	29	29	cyclophosphamide	CHOP	PA449165	1649	0.654
NULL	J_Cell_Biol_2003_Dec_22_163(6)_1385-1395.nxml.txt.nlp	14676308	SENT12	10	10	12	12	thrombin	Rho	PA451674	29984	0.654
NULL	Exp_Diabetes_Res_2012_Sep_20_2012_936518.nxml.txt.nlp	23049542	SENT35	7	7	11	11	glucose	SGK1	PA449773	6446	0.654
NULL	Int_J_Womens_Health_2012_Aug_3_4_395-404.nxml.txt.nlp	22927770	SENT123	7	7	11	11	bevacizumab	VEGF-A	PA130232992	7422	0.654
NULL	Breast_Cancer_Res_2011_Mar_30_13(2)_R34.nxml.txt.nlp	21450081	SENT67	25	25	18	18	estradiol	adiponectin	PA449503	9370	0.654
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT336	29	29	9	9	resveratrol	p53		7157	0.654
NULL	J_Biol_Chem_2013_Nov_22_288(47)_34217-34229.nxml.txt.nlp	24106270	SENT262	11	11	19	19	thrombin	RhoG	PA451674	391	0.654
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R91.nxml.txt.nlp	22541814	SENT162	26	26	36	36	thrombin	PP2	PA451674	4888	0.654
NULL	Trials_2013_Nov_26_14_404.nxml.txt.nlp	24279904	SENT79	15	15	31	31	choline	spatial	PA448976	219793	0.654
NULL	Open_Biochem_J_2014_Nov_1_8_74-82.nxml.txt.nlp	25400709	SENT440	6	6	16	16	curcumin	PTEN	PA151958596	5728	0.654
NULL	Front_Immunol_2012_Jun_12_3_150.nxml.txt.nlp	22701456	SENT864	10	10	0	0	capsaicin	TRPV1	PA448776	7442	0.654
NULL	J_Cell_Biol_1998_Jul_13_142(1)_101-115.nxml.txt.nlp	9660866	SENT345	18	18	0	0	dextran	RhoA	PA449261	387	0.654
NULL	Endocrinology_2011_Feb_5_152(2)_405-413.nxml.txt.nlp	21209017	SENT142	31	31	18	18	diazoxide	GLP-1	PA449285	100125288	0.654
NULL	J_Nutr_Metab_2011_Jun_1_2011_708183.nxml.txt.nlp	21773024	SENT128	27	27	5	5	metformin	DM2	PA450395	28508	0.654
NULL	Oncotarget_2014_Mar_13_5(4)_1101-1110.nxml.txt.nlp	24658355	SENT84	7	7	0	0	tamoxifen	MKP-1	PA451581	1843	0.654
NULL	Bioinformation_2012_Jan_6_8(1)_13-19.nxml.txt.nlp	22359429	SENT120	0	0	12	12	curcumin	MRP1	PA151958596	4437	0.654
NULL	Cell_Death_Dis_2011_Aug_11_2(8)_e191.nxml.txt.nlp	21833029	SENT271	14	14	17	17	oxaliplatin	CT26	PA131285527	168400	0.654
NULL	Int_J_Mol_Sci_2014_Mar_24_15(3)_5140-5162.nxml.txt.nlp	24663085	SENT116	22	22	25	25	galactose	LP1	PA449725	6176	0.654
NULL	J_Gen_Physiol_2000_Mar_1_115(3)_229-240.nxml.txt.nlp	10694252	SENT285	4	4	7	7	dofetilide	HERG	PA449389	3757	0.654
NULL	J_Parasitol_Res_2012_Aug_13_2012_296856.nxml.txt.nlp	22934153	SENT143	29	29	10	10	praziquantel	IL-10	PA164764583	3586	0.654
NULL	J_Immunother_Cancer_2013_May_29_1_4.nxml.txt.nlp	NULL	SENT257	14	14	12	12	vemurafenib	ACT	PA165946873	12;11332;9457;641455	0.654
NULL	Contemp_Oncol_(Pozn)_2013_Apr_29_17(2)_128-133.nxml.txt.nlp	23788978	SENT44	19	19	11	11	oxymorphone	CYP3A4	PA450748	1576	0.654
NULL	Anticancer_Agents_Med_Chem_2010_Dec_10(10)_753-768.nxml.txt.nlp	21269250	SENT612	4	4	13	13	temozolomide	PCB	PA451609	5091	0.654
NULL	Neural_Regen_Res_2013_Nov_25_8(33)_3095-3106.nxml.txt.nlp	25206630	SENT231	29	29	44	44	l-glutamine	CO2	PA10090	4513	0.654
NULL	Mol_Biol_Rep_2013_May_16_40(8)_4995-5004.nxml.txt.nlp	23677713	SENT155	17	17	12	12	camptothecin	TERT	PA153590860	7015	0.654
NULL	Front_Aging_Neurosci_2014_Sep_10_6_243.nxml.txt.nlp	25309427	SENT373	0	0	13	13	estradiol	beta-catenin	PA449503	1499	0.654
NULL	ScientificWorldJournal_2013_Aug_19_2013_157527.nxml.txt.nlp	24089600	SENT31	18	18	3	3	ethanol	TPC	PA448073	8030;60386	0.654
NULL	Indian_J_Pharmacol_2014_Mar-Apr_46(2)_161-165.nxml.txt.nlp	24741186	SENT104	2	2	12	12	carvedilol	STZ	PA448817	6484	0.654
NULL	J_Cell_Biol_1998_Jan_26_140(2)_335-345.nxml.txt.nlp	9442109	SENT202	21	21	12	12	tetracycline	NHE	PA451640	285335	0.654
NULL	Arthritis_Res_Ther_2014_Nov_30_16(6)_497.nxml.txt.nlp	25433812	SENT64	9	9	26	26	fluorescein	CD279	PA164746009	5133	0.654
NULL	Iran_J_Pediatr_2012_Mar_22(1)_117-120.nxml.txt.nlp	23056870	SENT62	25	25	18	18	thrombin	C-ANCA	PA451674	5657	0.654
NULL	Emerg_Infect_Dis_2011_Apr_17(4)_653-660.nxml.txt.nlp	21470455	SENT331	21	21	0	0	zanamivir	Baz	PA164740891	56288	0.654
NULL	Iran_J_Microbiol_2013_Mar_5(1)_56-62.nxml.txt.nlp	23467268	SENT14	1	1	9	9	vancomycin	VISA	PA451850	57506	0.654
NULL	J_Gen_Physiol_2003_Nov_122(5)_621-639.nxml.txt.nlp	14581586	SENT46	30	30	7	7	streptomycin	CO2	PA451512	4513	0.654
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_321-328.nxml.txt.nlp	21372824	SENT189	23	23	19	19	nitroprusside	STZ	PA451406	6484	0.654
NULL	J_Cardiothorac_Surg_2012_Nov_15_7_123.nxml.txt.nlp	23151309	SENT170	2	2	9	9	heparin	ACT	PA449855	12;11332;9457;641455	0.654
NULL	Front_Hum_Neurosci_2013_Mar_26_7_97.nxml.txt.nlp	23532379	SENT183	11	11	7	7	choline	B12	PA448976	7126;4709	0.654
NULL	J_Immunol_Res_2014_May_8_2014_565320.nxml.txt.nlp	24901010	SENT92	27	27	22	22	allopurinol	HLA-B	PA448320	3106	0.654
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT120	13	13	6	6	tenofovir	SLC28A2	PA10204	9153	0.654
NULL	Mol_Biol_Cell_2012_Nov_1_23(21)_4212-4225.nxml.txt.nlp	22956765	SENT87	15	15	12	12	thrombin	SHP2	PA451674	5781	0.654
NULL	Iran_J_Pharm_Res_2014_Autumn_13(4)_1393-1401.nxml.txt.nlp	25587329	SENT35	11	11	41	41	l-glutamine	CO2	PA10090	4513	0.654
NULL	J_Physiol_2011_Nov_1_589(Pt_21)_5153-5165.nxml.txt.nlp	21930604	SENT68	27	27	23	23	phenylephrine	mol	PA450935	90527	0.654
NULL	Emerg_Infect_Dis_2013_Jan_19(1)_133-136.nxml.txt.nlp	23260464	SENT49	35	35	9	9	cefepime	TOB	PA164754876	10140	0.654
NULL	Eur_J_Pharmacol_2012_Jul_5_686(1-3)_22-31.nxml.txt.nlp	22564863	SENT131	14	14	6	6	memantine	GluN3B	PA10364	116444	0.654
NULL	Emerg_Infect_Dis_2013_Jan_19(1)_133-136.nxml.txt.nlp	23260464	SENT49	7	7	9	9	gentamicin	TOB	PA449753	10140	0.654
NULL	Nat_Commun_2013_4_2720.nxml.txt.nlp	24193139	SENT223	10	10	7	7	methamphetamine	AMPH	PA450403	273	0.654
NULL	F1000Res_2014_Aug_21_3_201.nxml.txt.nlp	25520779	SENT75	23	23	19	19	estradiol	MRP2	PA449503	100130958;57626;1244	0.654
NULL	Clinicoecon_Outcomes_Res_2014_Sep_23_6_409-414.nxml.txt.nlp	25285019	SENT139	12	12	6	6	darunavir	ATV	PA163522472	4683	0.654
NULL	Cell_Res_2012_Aug_22_22(8)_1227-1245.nxml.txt.nlp	22613949	SENT168	38	38	32	32	doxorubicin	KRAS	PA449412	3845	0.654
NULL	Int_Cardiovasc_Res_J_2014_Jan_1_8(1)_9-14.nxml.txt.nlp	24757645	SENT172	23	23	25	25	pravastatin	Men	PA451089	8178	0.654
NULL	J_Ophthalmol_2012_Mar_18_2012_898207.nxml.txt.nlp	22523655	SENT2	0	0	6	6	ranibizumab	San	PA164746012	80218	0.654
NULL	Oncotarget_2014_Dec_4_5(22)_11365-11380.nxml.txt.nlp	25426548	SENT212	14	14	16	16	nutlin-3	p53		7157	0.654
NULL	Oxid_Med_Cell_Longev_2013_Feb_24_2013_375893.nxml.txt.nlp	23533689	SENT59	27	27	43	43	l-glutamine	CO2	PA10090	4513	0.654
NULL	Front_Behav_Neurosci_2012_Jun_13_6_24.nxml.txt.nlp	22707936	SENT460	0	0	16	16	choline	CA1	PA448976	759	0.654
NULL	Oncogene_2010_Mar_11_29(10)_1509-1518.nxml.txt.nlp	19946334	SENT99	6	6	8	8	bortezomib	pS2	PA10252	7031	0.654
NULL	Environ_Microbiol_2013_Jan_15_15(1)_297-304.nxml.txt.nlp	23157680	SENT51	6	6	45	45	ciprofloxacin	TMP	PA449009	2012	0.654
NULL	Evid_Based_Complement_Alternat_Med_2014_Dec_25_2014_605914.nxml.txt.nlp	25610478	SENT89	35	35	39	39	glutaraldehyde	mol	PA449777	90527	0.654
NULL	Acta_Pharmacol_Sin_2011_Jun_3_32(6)_845-852.nxml.txt.nlp	21642952	SENT127	9	9	6	6	capsaicin	TRPV1	PA448776	7442	0.654
NULL	Multidiscip_Respir_Med_2014_May_26_9(1)_29.nxml.txt.nlp	24917931	SENT138	17	17	23	23	terbutaline	AQP5	PA451616	362	0.654
NULL	Front_Genet_2013_Aug_29_4_163.nxml.txt.nlp	24009622	SENT119	2	2	38	38	ethanol	ABCG2	PA448073	9429	0.654
NULL	Evid_Based_Complement_Alternat_Med_2013_May_16_2013_379536.nxml.txt.nlp	23762128	SENT40	12	12	24	24	fluorescein	CD71	PA164746009	7037	0.654
NULL	Case_Rep_Dent_2013_Jun_13_2013_852932.nxml.txt.nlp	23840974	SENT60	19	19	9	9	vincristine	CHOP	PA451879	1649	0.654
NULL	Clin_Ophthalmol_2008_Jun_2(2)_425-433.nxml.txt.nlp	19668733	SENT146	33	33	35	35	ranibizumab	VEGF-A	PA164746012	7422	0.654
NULL	Int_J_Nanomedicine_2008_Sep_3(3)_359-372.nxml.txt.nlp	18990945	SENT14	1	1	8	8	methylprednisolone	CDP	PA450466	1523	0.654
NULL	Pharmaceuticals_(Basel)_2013_Mar_26_6(4)_469-479.nxml.txt.nlp	24276118	SENT147	12	12	6	6	ethanol	DARPP-32	PA448073	84152	0.654
NULL	J_Int_AIDS_Soc_2011_Feb_9_14_7.nxml.txt.nlp	21306608	SENT74	38	38	23	23	nelfinavir	ATV	PA450606	4683	0.654
NULL	Cardiol_Res_Pract_2011_Jul_2_2011_615087.nxml.txt.nlp	21747989	SENT22	5	5	12	12	heparin	ACT	PA449855	12;11332;9457;641455	0.654
NULL	Clin_Ophthalmol_2008_Jun_2(2)_355-368.nxml.txt.nlp	19668727	SENT81	30	30	26	26	amfenac	COX1	PA166049186	4512;5742	0.654
NULL	Cancers_(Basel)_2014_Nov_14_6(4)_2275-2295.nxml.txt.nlp	25405526	SENT82	18	18	7	7	cisplatin	CHOP	PA449014	1649	0.654
NULL	Case_Rep_Ophthalmol_2010_Aug_18_1(1)_36-41.nxml.txt.nlp	21369348	SENT21	22	22	8	8	bevacizumab	PED	PA130232992	8682	0.654
NULL	J_Membr_Biol_2009_Jul_5_230(2)_93-99.nxml.txt.nlp	19652898	SENT36	21	21	36	36	l-glutamine	CO2	PA10090	4513	0.653
NULL	Front_Endocrinol_(Lausanne)_2013_Jan_7_3_180.nxml.txt.nlp	23316185	SENT292	31	31	17	17	glucose	CRF2	PA449773	1395	0.653
NULL	Nanoscale_Res_Lett_2012_Jun_11_7(1)_302.nxml.txt.nlp	22687246	SENT28	24	24	8	8	ethanol	NO3	PA448073	4681	0.653
NULL	Mol_Cancer_2010_Nov_2_9_289.nxml.txt.nlp	21044322	SENT223	28	28	17	17	cisplatin	RGS10	PA449014	6001	0.653
NULL	Biochem_Res_Int_2012_Feb_12_2012_346972.nxml.txt.nlp	22400115	SENT241	6	6	30	30	hyaluronan	TLR4	PA165958431	7099	0.653
NULL	Cancers_(Basel)_2011_Oct_19_3(4)_3909-3920.nxml.txt.nlp	24213117	SENT221	15	15	7	7	cisplatin	YB-1	PA449014	4904	0.653
NULL	Breast_Cancer_Res_2010_Oct_28_12(5)_212.nxml.txt.nlp	21067532	SENT109	24	24	29	29	cyclophosphamide	ACT	PA449165	12;11332;9457;641455	0.653
NULL	Endocrinology_2012_Jan_15_153(1)_200-211.nxml.txt.nlp	22087024	SENT241	2	2	15	15	methylprednisolone	c-fos	PA450466	2353	0.653
NULL	Oncotarget_2012_Dec_18_3(12)_1615-1628.nxml.txt.nlp	23271044	SENT80	7	7	9	9	clofarabine	TOR	PA164754863	6097	0.653
NULL	Breast_Cancer_(Auckl)_2011_Sep_25_5_201-208.nxml.txt.nlp	22084573	SENT53	16	16	9	9	cisplatin	BRCA1	PA449014	672	0.653
NULL	Cancer_Cell_Int_2004_Aug_17_4_5.nxml.txt.nlp	15315711	SENT100	9	9	21	21	genistein	PC3	PA165109660	57332;7832;5122	0.653
NULL	Case_Rep_Anesthesiol_2011_Jan_18_2011_841510.nxml.txt.nlp	22611502	SENT21	7	7	10	10	citalopram	B12	PA449015	7126;4709	0.653
NULL	J_Invest_Dermatol_2014_Jun_17_134(6)_1589-1598.nxml.txt.nlp	24499735	SENT75	1	1	3	3	lipase	HSL	PA450239	3991	0.653
NULL	Br_J_Cancer_2012_Feb_14_106(4)_685-692.nxml.txt.nlp	22294184	SENT235	6	6	8	8	lovastatin	L12	PA450272	26156;6136	0.653
NULL	Mol_Biotechnol_2013_Jan_28_53(1)_9-18.nxml.txt.nlp	23104232	SENT78	23	23	18	18	l-glutamine	F12	PA10090	2161	0.653
NULL	Oncogenesis_2012_Apr_2_1(4)_e5.nxml.txt.nlp	23552603	SENT568	33	33	8	8	celecoxib	BAX	PA448871	581	0.653
NULL	Curr_Neuropharmacol_2013_Jul_11(4)_338-378.nxml.txt.nlp	24381528	SENT326	6	6	14	14	curcumin	BACE1	PA151958596	23621	0.653
NULL	Br_J_Pharmacol_2010_Sep_161(2)_308-320.nxml.txt.nlp	20735417	SENT118	3	3	1	1	rimonabant	GPR55	PA152407999	9290	0.653
NULL	Diabetes_2011_May_23_60(5)_1519-1527.nxml.txt.nlp	21430087	SENT11	3	3	11	11	lipase	CGI-58	PA450239	51099	0.653
NULL	J_Hepatol_2010_Sep_53(3-2)_519-527.nxml.txt.nlp	20579762	SENT283	3	3	17	17	collagenase	c-Jun	PA449107	3725	0.653
NULL	Virol_J_2011_Nov_28_8_523.nxml.txt.nlp	22122911	SENT184	11	11	5	5	heparin	gamma	PA449855	9913	0.653
NULL	Biochem_Res_Int_2012_Feb_9_2012_592806.nxml.txt.nlp	22400117	SENT145	3	3	19	19	nadh	HIF-1	PA164755085	29072	0.653
NULL	J_Mol_Med_(Berl)_2013_Aug_17_91(11)_1257-1271.nxml.txt.nlp	23955016	SENT213	6	6	8	8	thrombin	spatial	PA451674	219793	0.653
NULL	Arthritis_Res_Ther_2003_Jan_14_5(2)_54-67.nxml.txt.nlp	12718745	SENT318	14	14	11	11	hyaluronan	p75	PA165958431	7133;11168	0.653
NULL	Dis_Markers_2010_Jun_29_28(5)_307-313.nxml.txt.nlp	20592455	SENT4	23	23	9	9	atorvastatin	ABCG8	PA448500	64241	0.653
NULL	Oncotarget_2011_Dec_21_2(12)_1134-1144.nxml.txt.nlp	22193779	SENT167	36	36	28	28	gefitinib	EGF	PA131301952	1950	0.653
NULL	J_Cancer_2011_May_25_2_317-323.nxml.txt.nlp	21716848	SENT33	6	6	12	12	trastuzumab	HER2	PA451743	2064	0.653
NULL	Blood_Cancer_J_2013_Oct_18_3(10)_e153.nxml.txt.nlp	24141622	SENT89	3	3	17	17	chloroquine	XIAP	PA448948	331	0.653
NULL	Mol_Cancer_2009_Mar_5_8_14.nxml.txt.nlp	19265551	SENT61	9	9	15	15	camptothecin	p53	PA153590860	7157	0.653
NULL	Oncotarget_2014_Oct_21_5(22)_11252-11268.nxml.txt.nlp	25361004	SENT51	8	8	12	12	metformin	U87	PA450395	677775;641648	0.653
NULL	Adipocyte_2014_Jul_1_3(3)_190-196.nxml.txt.nlp	25068085	SENT10	11	11	14	14	estradiol	CCL2	PA449503	6347	0.653
NULL	Neural_Regen_Res_2013_Jul_15_8(20)_1853-1862.nxml.txt.nlp	25206494	SENT113	8	8	5	5	ethanol	JNK	PA448073	5599	0.653
NULL	J_Biol_Eng_2009_Oct_16_3_18.nxml.txt.nlp	19835592	SENT138	11	11	39	39	ciprofloxacin	CPZ	PA449009	8532	0.653
NULL	Clinics_(Sao_Paulo)_2012_Apr_67(Suppl_1)_125-129.nxml.txt.nlp	22584717	SENT61	40	40	28	28	pazopanib	VEGFR	PA165291492	3791	0.653
NULL	Arthritis_Res_Ther_2010_Dec_17_12(6)_221.nxml.txt.nlp	21205283	SENT189	0	0	6	6	ustekinumab	IL-23	PA166048654	51561	0.653
NULL	Biol_Open_2014_Nov_13_3(12)_1164-1172.nxml.txt.nlp	25395667	SENT218	10	10	8	8	capsaicin	TRPV1	PA448776	7442	0.653
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT419	12	12	7	7	heparin	FGF1	PA449855	2246	0.653
NULL	Oncotarget_2014_Jun_8_5(13)_5065-5075.nxml.txt.nlp	24970810	SENT144	3	3	6	6	lenalidomide	IRF4	PA162363968	3662	0.653
NULL	J_Infect_Dis_2013_Sep_1_208(5)_801-812.nxml.txt.nlp	23766527	SENT121	28	28	4	4	piperaquine	LUM	PA166104279	4060	0.653
NULL	J_Carcinog_2013_Aug_8_12_16.nxml.txt.nlp	24082825	SENT101	7	7	9	9	phenformin	LKB1	PA1000	6794	0.653
NULL	Br_J_Cancer_2010_Jan_5_102(1)_151-161.nxml.txt.nlp	19935791	SENT9	21	21	26	26	panitumumab	BRAF	PA162373091	673	0.653
NULL	Front_Endocrinol_(Lausanne)_2013_Nov_11_4_166.nxml.txt.nlp	24273531	SENT168	19	19	10	10	vasopressin	ANG	PA451858	283	0.653
NULL	J_Exp_Clin_Cancer_Res_2010_Apr_28_29(1)_39.nxml.txt.nlp	20426817	SENT155	8	8	10	10	cisplatin	BRCA1	PA449014	672	0.653
NULL	Case_Rep_Dent_2013_Jul_10_2013_812323.nxml.txt.nlp	23936686	SENT96	34	34	29	29	hyaluronan	LYVE-1	PA165958431	10894	0.653
NULL	Int_J_Environ_Res_Public_Health_2013_Sep_17_10(9)_4352-4389.nxml.txt.nlp	24048206	SENT287	21	21	14	14	betaine	B12	PA448603	7126;4709	0.653
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Nov_10_68(Pt_12)_o3314.nxml.txt.nlp	23476159	SENT69	27	27	23	23	ethanol	mol	PA448073	90527	0.653
NULL	Diabetes_Care_2011_Sep_19_34(9)_2072-2077.nxml.txt.nlp	21788633	SENT177	2	2	10	10	acarbose	GLP-1	PA448010	100125288	0.653
NULL	Br_J_Ophthalmol_2013_Aug_6_97(8)_989-993.nxml.txt.nlp	23743437	SENT191	20	20	17	17	latanoprost	BAK	PA164774763	578	0.653
NULL	Diabetes_Obes_Metab_2011_Nov_13(11)_982-989.nxml.txt.nlp	21615670	SENT22	19	19	10	10	liraglutide	GLP-1	PA165958364	100125288	0.653
NULL	Acta_Pharmacol_Sin_2011_Feb_4_32(2)_230-238.nxml.txt.nlp	21293475	SENT22	17	17	28	28	lipase	aP2	PA450239	2167	0.653
NULL	Diabetes_Care_2008_Dec_31(12)_2344-2348.nxml.txt.nlp	18796622	SENT14	11	11	27	27	metformin	ACR	PA450395	49	0.653
NULL	Ann_Rheum_Dis_2014_Sep_19_73(9)_1689-1694.nxml.txt.nlp	24748630	SENT150	4	4	25	25	infliximab	IMPACT	PA452639	55364	0.653
NULL	Chemother_Res_Pract_2011_Dec_1_2011_715469.nxml.txt.nlp	22312557	SENT150	18	18	2	2	cisplatin	p53	PA449014	7157	0.653
NULL	Breast_Cancer_Res_2012_Jan_6_14(1)_R2.nxml.txt.nlp	22225778	SENT174	4	4	12	12	docetaxel	p50	PA449383	958;4790	0.653
NULL	JRSM_Cardiovasc_Dis_2012_Apr_5_1(1)_cvd_2012_012001.nxml.txt.nlp	24175062	SENT268	19	19	34	34	tamoxifen	CYP3A	PA451581	1574	0.653
NULL	Case_Rep_Transplant_2012_Sep_27_2012_493758.nxml.txt.nlp	23259133	SENT73	39	39	30	30	micafungin	IFN	PA164781026	3439	0.653
NULL	Biochemistry_2013_Oct_15_52(41)_7167-7169.nxml.txt.nlp	24083983	SENT29	5	5	14	14	cyclosporine	P-gp	PA449167	5243	0.653
NULL	Breast_Cancer_Res_2010_Nov_16_12(6)_R96.nxml.txt.nlp	21080941	SENT63	38	38	21	21	lapatinib	HRG	PA152241907	3084;3273	0.653
NULL	Eur_J_Med_Res_2011_May_12_16(5)_197-205.nxml.txt.nlp	21719392	SENT103	13	13	7	7	foscarnet	IL-2	PA449706	3558	0.653
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2010_Aug_3_3_43-51.nxml.txt.nlp	22879786	SENT172	1	1	14	14	pioglitazone	gamma	PA450970	9913	0.653
NULL	Br_J_Cancer_2011_Mar_15_104(6)_899-902.nxml.txt.nlp	21343938	SENT51	16	16	3	3	tamoxifen	ATAC	PA451581	6375	0.653
NULL	Nat_Chem_Biol_2009_Jun_5(6)_421-427.nxml.txt.nlp	19430488	SENT142	17	17	26	26	ethanol	gamma	PA448073	9913	0.653
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jul_17_66(Pt_8)_o2039.nxml.txt.nlp	21588348	SENT64	12	12	6	6	ethanol	mol	PA448073	90527	0.653
NULL	Oncogene_2014_Oct_9_33(41)_4941-4951.nxml.txt.nlp	24681952	SENT81	13	13	6	6	metformin	WNT5A	PA450395	7474	0.653
NULL	Mol_Biol_Int_2011_Jun_8_2011_571242.nxml.txt.nlp	22091408	SENT299	14	14	3	3	arsenite	ODC	PA452638	4953;89874	0.653
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Dec_10_3(12)_e151.nxml.txt.nlp	25494035	SENT252	8	8	21	21	fluvastatin	OATP1B1	PA449688	10599	0.653
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT44	7	7	19	19	metformin	HIP	PA450395	6767;6159;64399;5068	0.653
NULL	J_Biol_2008_Nov_7_7(9)_33.nxml.txt.nlp	19014407	SENT90	26	26	31	31	arsenite	NIP	PA452638	90527;10755	0.653
NULL	J_Antimicrob_Chemother_2014_Mar_13_69(3)_651-663.nxml.txt.nlp	24235095	SENT124	33	33	7	7	pentamidine	AQP2	PA450850	359	0.653
NULL	J_Biol_Chem_2008_Oct_24_283(43)_29166-29174.nxml.txt.nlp	18694939	SENT64	31	31	41	41	l-glutamine	CO2	PA10090	4513	0.653
NULL	J_Med_Case_Reports_2011_Feb_14_5_60.nxml.txt.nlp	21320326	SENT124	13	13	11	11	cyclophosphamide	CHOP	PA449165	1649	0.653
NULL	Cell_Death_Dis_2012_Jun_21_3(6)_e330.nxml.txt.nlp	22717585	SENT297	0	0	8	8	simvastatin	XBP1	PA451363	7494	0.653
NULL	Curr_Microbiol_2010_Jun_20_60(6)_419-427.nxml.txt.nlp	20024656	SENT147	13	13	7	7	betaine	bet	PA448603	92737	0.653
NULL	F1000_Med_Rep_2012_Feb_1_4_4.nxml.txt.nlp	22312414	SENT277	19	19	7	7	vancomycin	VISA	PA451850	57506	0.653
NULL	Mucosal_Immunol_2013_Nov_10_6(6)_1179-1190.nxml.txt.nlp	23571504	SENT111	32	32	27	27	dextran	TRX	PA449261	7295	0.653
NULL	Mol_Biol_Cell_2012_Jun_1_23(11)_2017-2027.nxml.txt.nlp	22496424	SENT114	43	43	41	41	warfarin	PRDX4	PA451906	10549	0.653
NULL	Clin_Genet_2014_Feb_9_86(1)_1-11.nxml.txt.nlp	24665880	SENT126	36	36	13	13	losartan	TFG	PA450268	10342	0.653
NULL	Cancer_Immunol_Immunother_2011_Jun_25_60(6)_793-808.nxml.txt.nlp	21350947	SENT61	25	25	23	23	sorafenib	IFN	PA7000	3439	0.653
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_P43.nxml.txt.nlp	NULL	SENT7	21	21	23	23	abacavir	HLA-B	PA448004	3106	0.653
NULL	Virol_J_2011_May_17_8_234.nxml.txt.nlp	21575275	SENT101	22	22	19	19	ribavirin	IFN	PA451241	3439	0.653
NULL	J_Biol_Chem_2013_Dec_13_288(50)_35877-35885.nxml.txt.nlp	24155236	SENT194	14	14	9	9	heparin	DR5	PA449855	8795	0.653
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Sep_26_68(Pt_10)_o3003.nxml.txt.nlp	23125775	SENT72	26	26	11	11	ethanol	mol	PA448073	90527	0.653
NULL	Oncotarget_2012_Dec_31_3(12)_1700-1710.nxml.txt.nlp	23482333	SENT12	17	17	37	37	rituximab	CHOP	PA451261	1649	0.653
NULL	Oncotarget_2013_Aug_26_4(10)_1662-1672.nxml.txt.nlp	24091566	SENT101	11	11	16	16	trastuzumab	HER2	PA451743	2064	0.653
NULL	J_Immunol_Res_2014_May_12_2014_897249.nxml.txt.nlp	24901013	SENT129	11	11	16	16	natalizumab	BIM	PA164747191	10018	0.653
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT144	6	6	14	14	perifosine	DR4	PA165291471	8797	0.653
NULL	Biomed_Res_Int_2014_Jun_2_2014_946492.nxml.txt.nlp	24991574	SENT82	7	7	24	24	olmesartan	p40phox	PA164742950	4689	0.653
NULL	Epigenetics_Chromatin_2014_Dec_20_7(1)_38.nxml.txt.nlp	NULL	SENT64	10	10	2	2	tetracycline	MC1R	PA451640	4157	0.653
NULL	Biomed_Res_Int_2013_Oct_28_2013_161396.nxml.txt.nlp	24288663	SENT130	6	6	12	12	losartan	CYP11B2	PA450268	1585	0.653
NULL	Oncol_Rep_2014_Apr_28_31(4)_1605-1612.nxml.txt.nlp	24481648	SENT11	0	0	14	14	ponatinib	MRP7	PA165980594	89845;1080	0.653
NULL	Diabetes_Care_2011_Jun_20_34(6)_1424-1430.nxml.txt.nlp	21602431	SENT141	7	7	4	4	metformin	GLP-1	PA450395	100125288	0.653
NULL	Mucosal_Immunol_2014_Jan_12_7(1)_10_1038_mi_2013_36.nxml.txt.nlp	23757303	SENT64	12	12	7	7	mitomycin	CD4	PA450524	920	0.653
NULL	Diabetes_Metab_Syndr_Obes_2009_Jul_30_2_127-134.nxml.txt.nlp	21437126	SENT58	15	15	10	10	liraglutide	GLP-1	PA165958364	100125288	0.653
NULL	Biomed_Res_Int_2014_Aug_4_2014_459452.nxml.txt.nlp	25162013	SENT241	1	1	16	16	podophyllum	mol	PA10162	90527	0.653
NULL	Braz_J_Microbiol_2011_Jan-Mar_42(1)_310-320.nxml.txt.nlp	24031637	SENT71	38	38	14	14	l-glutamine	CO2	PA10090	4513	0.653
NULL	ASN_Neuro_2012_Feb_8_4(1)_e00074.nxml.txt.nlp	22220511	SENT259	5	5	12	12	l-cystine	xCT	PA449176	23657	0.653
NULL	Cancer_Med_2013_Feb_3_2(1)_11-20.nxml.txt.nlp	24133623	SENT291	0	0	26	26	cetuximab	BRAF	PA10040	673	0.653
NULL	Cell_Commun_Signal_2013_Oct_1_11_73.nxml.txt.nlp	24083678	SENT100	14	14	26	26	sulindac	A20	PA451565	7128;28935	0.653
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT29	7	7	16	16	cisplatin	MDM2	PA449014	4193	0.653
NULL	Br_J_Cancer_2013_Jan_15_108(1)_82-90.nxml.txt.nlp	23321512	SENT156	11	11	30	30	paclitaxel	TUBB3	PA450761	10381	0.653
NULL	Drug_Target_Insights_2007_Feb_16_2_39-54.nxml.txt.nlp	21901061	SENT162	20	20	22	22	vasopressin	AVP	PA451858	114548;551	0.653
NULL	Acta_Pharmacol_Sin_2010_Mar_22_31(3)_329-340.nxml.txt.nlp	20173759	SENT143	6	6	23	23	ethanol	MEF2D	PA448073	4209	0.653
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Apr_13_67(Pt_5)_o1105.nxml.txt.nlp	21754423	SENT55	13	13	21	21	coumarin	C10	PA134521193	113246	0.653
NULL	Cancer_Microenviron_2009_May_6_2(1)_59-67.nxml.txt.nlp	19418243	SENT92	25	25	20	20	tetracycline	CCL21	PA451640	6366	0.653
NULL	Front_Oncol_2014_Jun_18_4_153.nxml.txt.nlp	24995158	SENT175	6	6	19	19	vinblastine	p53	PA451877	7157	0.653
NULL	J_Cell_Mol_Med_2014_Dec_7_18(12)_2536-2552.nxml.txt.nlp	25287328	SENT279	45	45	1	1	tamoxifen	PKD1	PA451581	5310	0.653
NULL	Mol_Cancer_2012_Jun_21_11_42.nxml.txt.nlp	22721004	SENT207	23	23	32	32	l-glutamine	IL-3	PA10090	3562	0.653
NULL	Support_Care_Cancer_2010_May_27_18(5)_529-541.nxml.txt.nlp	20191292	SENT62	1	1	10	10	cyclophosphamide	gamma	PA449165	9913	0.653
NULL	Acta_Pharmacol_Sin_2009_Feb_5_30(2)_228-234.nxml.txt.nlp	19122672	SENT108	44	44	4	4	isoflurane	HO-1	PA450106	3162	0.653
NULL	Emerg_Infect_Dis_2014_Jul_20(7)_1252-1253.nxml.txt.nlp	24959839	SENT36	36	36	9	9	ofloxacin	EMB	PA450684	133418	0.653
NULL	Breast_Cancer_Res_2011_May_25_13(3)_309.nxml.txt.nlp	21672285	SENT20	16	16	23	23	sorafenib	CD44	PA7000	960	0.653
NULL	J_Korean_Med_Sci_2014_Jul_11_29(7)_965-972.nxml.txt.nlp	25045229	SENT94	16	16	4	4	metformin	B12	PA450395	7126;4709	0.653
NULL	Cancer_Cell_Int_2006_Mar_23_6_6.nxml.txt.nlp	16556298	SENT116	0	0	12	12	doxorubicin	FDG	PA449412	23583	0.653
NULL	Cancers_(Basel)_2010_Dec_23_3(1)_17-42.nxml.txt.nlp	24212604	SENT734	15	15	10	10	carboplatin	PPX	PA448803	5531	0.653
NULL	Int_J_Biol_Sci_2014_Sep_21_10(10)_1108-1115.nxml.txt.nlp	25332685	SENT171	7	7	9	9	dexmedetomidine	DMT	PA449256	2039	0.653
NULL	Pain_2013_Sep_154(9)_1680-1690.nxml.txt.nlp	23707289	SENT165	20	20	7	7	yohimbine	c-fos	PA451946	2353	0.653
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1126-1134.nxml.txt.nlp	21364592	SENT132	44	44	31	31	platinum	CYP2A6	PA150595617	1548	0.653
NULL	Diabetol_Metab_Syndr_2014_Mar_31_6_47.nxml.txt.nlp	24684779	SENT101	2	2	7	7	simvastatin	IL-6	PA451363	3569	0.653
NULL	Mol_Cancer_2007_Aug_21_6_53.nxml.txt.nlp	17711579	SENT153	6	6	26	26	cisplatin	IL2	PA449014	3558	0.653
NULL	Environ_Microbiol_2013_Jan_15_15(1)_297-304.nxml.txt.nlp	23157680	SENT66	34	34	16	16	cefotaxime	TMP	PA448852	2012	0.653
NULL	Cells_2014_Apr_8_3(2)_258-287.nxml.txt.nlp	24717323	SENT283	40	40	28	28	forskolin	TRPV1	PA146096022	7442	0.653
NULL	Acta_Naturae_2011_Apr-Jun_3(2)_22-33.nxml.txt.nlp	22649682	SENT72	14	14	26	26	s-adenosylmethionine	L11	PA164754994	90861;6135	0.653
NULL	Arthritis_Res_2002_Nov_23_4(3)_157-164.nxml.txt.nlp	12010565	SENT147	35	35	20	20	collagenase	c-Jun	PA449107	3725	0.653
NULL	Int_J_Endocrinol_2014_Mar_12_2014_847827.nxml.txt.nlp	24744784	SENT157	0	0	3	3	metformin	NLRP3	PA450395	114548	0.653
NULL	Scientifica_(Cairo)_2012_Oct_9_2012_821549.nxml.txt.nlp	24278743	SENT337	12	12	25	25	buspirone	5-HT1A	PA448689	3350	0.653
NULL	ISRN_Oxidative_Med_2013_2013_831596.nxml.txt.nlp	25506596	SENT38	3	3	10	10	hemin	TLR4	PA449849	7099	0.653
NULL	Evid_Based_Complement_Alternat_Med_2013_May_26_2013_349790.nxml.txt.nlp	23762123	SENT170	19	19	11	11	rosiglitazone	LSP1	PA451283	4046	0.653
NULL	Sensors_(Basel)_2011_Jan_25_11(2)_1328-1344.nxml.txt.nlp	22319354	SENT426	20	20	23	23	ethanol	mol	PA448073	90527	0.653
NULL	J_Cell_Biol_2001_Nov_26_155(5)_845-858.nxml.txt.nlp	11724824	SENT63	15	15	23	23	heparin	FGF4	PA449855	2249	0.653
NULL	Oxid_Med_Cell_Longev_2012_Feb_26_2012_681367.nxml.txt.nlp	22530076	SENT29	39	39	19	19	doxorubicin	SERCA2	PA449412	488	0.653
NULL	Cancer_Cell_Int_2013_Mar_4_13_21.nxml.txt.nlp	23497288	SENT62	10	10	12	12	doxorubicin	EWS	PA449412	2130	0.653
NULL	Endocrine_2012_Dec_14_42(3)_622-636.nxml.txt.nlp	22695986	SENT215	4	4	6	6	forskolin	PTH	PA146096022	5741	0.653
NULL	Adv_Biomed_Res_2014_Jan_9_3_19.nxml.txt.nlp	24592369	SENT76	11	11	25	25	paraformaldehyde	San	PA450790	80218	0.653
NULL	Int_J_Impot_Res_2012_Mar_6_24(2)_69-76.nxml.txt.nlp	21975567	SENT72	11	11	13	13	streptozocin	STZ	PA451514	6484	0.653
NULL	Br_J_Cancer_2010_Sep_7_103(6)_889-898.nxml.txt.nlp	20664599	SENT237	9	9	2	2	paclitaxel	AKT	PA450761	207	0.653
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_28_2012_937605.nxml.txt.nlp	23304227	SENT164	14	14	5	5	resveratrol	GDNF		2668	0.653
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT100	8	8	12	12	trastuzumab	HER3	PA451743	2065	0.653
NULL	Evid_Based_Complement_Alternat_Med_2014_Mar_26_2014_158987.nxml.txt.nlp	24795763	SENT25	5	5	10	10	fluoxetine	NR1	PA449673	27158	0.653
NULL	Exp_Ther_Med_2013_Apr_5_5(4)_1259-1263.nxml.txt.nlp	23596498	SENT23	9	9	0	0	capsaicin	TRPV1	PA448776	7442	0.653
NULL	Br_J_Cancer_2011_May_24_104(11)_1786-1790.nxml.txt.nlp	21559018	SENT108	17	17	19	19	cetuximab	EGFR	PA10040	1956	0.653
NULL	Korean_J_Anesthesiol_2013_Dec_26_65(6)_501-507.nxml.txt.nlp	24427455	SENT41	34	34	47	47	rocuronium	NMB	PA164754992	10457;4828	0.653
NULL	Biomed_Res_Int_2013_Dec_30_2013_735835.nxml.txt.nlp	24490170	SENT162	37	37	39	39	fexofenadine	FEX	PA449621	8549	0.653
NULL	Arthritis_Res_Ther_2005_Feb_18_7(3)_R476-R484.nxml.txt.nlp	15899034	SENT234	0	0	2	2	thrombin	IL-6	PA451674	3569	0.653
NULL	Osteoporos_Int_2011_Jun_12_22(6)_1935-1946.nxml.txt.nlp	20938767	SENT276	6	6	17	17	raloxifene	PTH	PA451221	5741	0.653
NULL	Ann_Oncol_2009_Aug_17_20(8)_1319-1329.nxml.txt.nlp	19535820	SENT349	13	13	43	43	cyclophosphamide	San	PA449165	80218	0.653
NULL	CNS_Neurosci_Ther_2010_Oct_16(5)_e138-e156.nxml.txt.nlp	20626426	SENT163	7	7	9	9	vasopressin	AVP	PA451858	114548;551	0.653
NULL	Int_J_Med_Sci_2013_Mar_15_10(5)_567-574.nxml.txt.nlp	23533048	SENT185	6	6	4	4	lamivudine	LAM	PA450163	7249;7248	0.653
NULL	Cancer_Metastasis_Rev_2010_Dec_10_29(4)_581-594.nxml.txt.nlp	20830503	SENT352	19	19	37	37	anastrozole	ATAC	PA448432	6375	0.653
NULL	Oncol_Rep_2013_Apr_23_29(4)_1268-1274.nxml.txt.nlp	23354756	SENT180	30	30	37	37	epirubicin	SLC25A43	PA449476	203427	0.653
NULL	Int_J_Mol_Sci_2012_Sep_19_13(9)_11881-11894.nxml.txt.nlp	23109889	SENT60	30	30	8	8	fluconazole	ATR1	PA449653	6519	0.653
NULL	Niger_Med_J_2014_Jul-Aug_55(4)_327-332.nxml.txt.nlp	25114369	SENT15	19	19	21	21	ethambutol	EMB	PA164784021	133418	0.653
NULL	Cancer_Cell_Int_2005_Jul_24_5_22.nxml.txt.nlp	16042792	SENT87	2	2	4	4	vincristine	NAC	PA451879	22861	0.653
NULL	Indian_J_Pharmacol_2014_Nov-Dec_46(6)_627-632.nxml.txt.nlp	25538335	SENT132	14	14	12	12	metformin	Q10	PA450395	27161	0.653
NULL	Clin_Med_Insights_Cardiol_2010_Oct_11_4_89-93.nxml.txt.nlp	20981132	SENT65	20	20	10	10	benazepril	TLR4	PA448561	7099	0.653
NULL	Mol_Cancer_2007_May_11_6_33.nxml.txt.nlp	17498302	SENT110	23	23	7	7	cytarabine	p53	PA449177	7157	0.653
NULL	Front_Neurosci_2013_Dec_17_7_244.nxml.txt.nlp	24381537	SENT206	30	30	9	9	naloxone	ANOVA	PA450586	4858	0.653
NULL	J_Korean_Med_Sci_2010_Feb_19_25(2)_304-308.nxml.txt.nlp	20119588	SENT87	23	23	29	29	isoniazid	EMB	PA450112	133418	0.653
NULL	Front_Behav_Neurosci_2011_Sep_8_5_56.nxml.txt.nlp	21927600	SENT218	10	10	12	12	morphine	DARPP-32	PA450550	84152	0.653
NULL	Cancer_Cell_Int_2005_Jul_24_5_22.nxml.txt.nlp	16042792	SENT105	23	23	5	5	vincristine	NAC	PA451879	22861	0.653
NULL	Br_J_Pharmacol_2014_Aug_17_171(15)_3680-3692.nxml.txt.nlp	24758567	SENT47	21	21	39	39	streptomycin	CO2	PA451512	4513	0.653
NULL	Diabetes_Metab_J_2012_Aug_20_36(4)_293-299.nxml.txt.nlp	22950061	SENT143	6	6	19	19	metformin	NPY	PA450395	4852	0.653
NULL	Arthritis_Res_Ther_2003_Sep_12_5(Suppl_3)_65.nxml.txt.nlp	NULL	SENT18	25	25	4	4	rofecoxib	EP2	PA451268	5732;10407	0.653
NULL	Diabetes_Care_2013_Jul_12_36(7)_1974-1980.nxml.txt.nlp	23340889	SENT101	9	9	30	30	lipase	adiponectin	PA450239	9370	0.653
NULL	Arch_Virol_2014_Dec_24_159(6)_1365-1371.nxml.txt.nlp	24366548	SENT54	14	14	31	31	ribavirin	SOCS3	PA451241	9021	0.653
NULL	Tumour_Biol_2012_Dec_14_33(6)_2209-2216.nxml.txt.nlp	22890830	SENT155	15	15	5	5	erlotinib	EGFR	PA134687924	1956	0.653
NULL	Case_Rep_Med_2012_May_9_2012_698513.nxml.txt.nlp	22649458	SENT98	8	8	16	16	saquinavir	CYP3A4	PA451305	1576	0.653
NULL	Oncol_Lett_2014_Mar_19_7(3)_674-678.nxml.txt.nlp	24527071	SENT144	5	5	2	2	cisplatin	AKR1C2	PA449014	1646	0.653
NULL	Int_J_Appl_Basic_Med_Res_2012_Jul-Dec_2(2)_77-83.nxml.txt.nlp	23776817	SENT119	22	22	11	11	ritonavir	CYP3A4	PA451260	1576	0.653
NULL	J_Int_AIDS_Soc_2010_Nov_8_13(Suppl_4)_P95.nxml.txt.nlp	NULL	SENT23	24	24	1	1	tenofovir	CD4	PA10204	920	0.653
NULL	Alzheimers_Res_Ther_2013_Oct_24_5(5)_50.nxml.txt.nlp	24401551	SENT221	19	19	10	10	donepezil	spatial	PA449394	219793	0.653
NULL	Adv_Pharmacol_Sci_2014_Apr_17_2014_354264.nxml.txt.nlp	24822061	SENT328	26	26	13	13	ethanol	CYP1A2	PA448073	1544	0.653
NULL	J_Korean_Med_Sci_2010_Nov_26_25(11)_1553-1559.nxml.txt.nlp	21060742	SENT71	14	14	5	5	warfarin	TKR	PA451906	8277	0.653
NULL	Exp_Ther_Med_2014_Jun_2_7(6)_1687-1690.nxml.txt.nlp	24926367	SENT7	0	0	7	7	estradiol	IL-6	PA449503	3569	0.653
NULL	Ann_Gen_Psychiatry_2009_Jul_27_8_16.nxml.txt.nlp	19635147	SENT185	9	9	25	25	aripiprazole	NNT	PA10026	23530	0.653
NULL	Anesthesiol_Res_Pract_2014_Feb_11_2014_848051.nxml.txt.nlp	24672542	SENT111	10	10	18	18	rocuronium	NMB	PA164754992	10457;4828	0.653
NULL	Orphanet_J_Rare_Dis_2013_Sep_13_8_142.nxml.txt.nlp	24034279	SENT141	19	19	17	17	metoclopramide	AVP	PA450475	114548;551	0.653
NULL	Arch_Osteoporos_2013_Sep_13_8(1-2)_144.nxml.txt.nlp	24030479	SENT1004	39	39	30	30	alfacalcidol	PTH	PA164746469	5741	0.653
NULL	Front_Immunol_2012_Jun_19_3_169.nxml.txt.nlp	22723800	SENT31	3	3	0	0	estradiol	MAST	PA449503	51324	0.653
NULL	Diabetol_Metab_Syndr_2014_Sep_23_6(1)_102.nxml.txt.nlp	NULL	SENT36	12	12	24	24	atorvastatin	RAGE	PA448500	177	0.653
NULL	Ann_Gastroenterol_2012_25(2)_100-105.nxml.txt.nlp	24714229	SENT99	27	27	35	35	metronidazole	BID	PA450484	637	0.653
NULL	J_Occup_Med_Toxicol_2008_Feb_27_3(Suppl_1)_S6.nxml.txt.nlp	18315837	SENT105	11	11	18	18	formoterol	IL-4	PA134687907	3565	0.653
NULL	J_Carcinog_2014_Feb_20_13_4.nxml.txt.nlp	24737952	SENT40	21	21	7	7	oxaliplatin	EGFR	PA131285527	1956	0.653
NULL	eLife_2014_May_27_3_e02200.nxml.txt.nlp	24867637	SENT670	14	14	7	7	nutlin-3	p53		7157	0.653
NULL	Autophagy_2012_May_1_8(5)_853-855.nxml.txt.nlp	22617440	SENT58	16	16	11	11	imatinib	BECN1	PA10804	8678	0.653
NULL	Mol_Cancer_2012_Mar_21_11_13.nxml.txt.nlp	22436134	SENT14	4	4	28	28	doxorubicin	HuR	PA449412	1994	0.652
NULL	Arthritis_2012_Nov_18_2012_864907.nxml.txt.nlp	23209899	SENT61	30	30	21	21	thyroglobulin	CTLA4	PA164754910	1493	0.652
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT82	35	35	8	8	metformin	p53	PA450395	7157	0.652
NULL	Nat_Commun_2013_Oct_7_4_2564.nxml.txt.nlp	24096827	SENT39	16	16	30	30	thrombin	ADP	PA451674	23038	0.652
NULL	Oxid_Med_Cell_Longev_2014_Apr_29_2014_572491.nxml.txt.nlp	24868314	SENT151	32	32	12	12	creatine	CNTF	PA164778930	1270	0.652
NULL	Chem_Cent_J_2012_May_11_6_41.nxml.txt.nlp	22578215	SENT7	9	9	17	17	naringin	castor	PA151958360	54897	0.652
NULL	Oncogenesis_2012_Apr_16_1(4)_e7.nxml.txt.nlp	23552604	SENT259	8	8	18	18	etoposide	CTRL	PA449552	1506	0.652
NULL	Br_J_Cancer_2013_Jan_15_108(1)_115-120.nxml.txt.nlp	23175150	SENT106	27	27	3	3	bevacizumab	KRAS	PA130232992	3845	0.652
NULL	Clin_Exp_Gastroenterol_2012_Jul_19_5_139-150.nxml.txt.nlp	22888267	SENT113	11	11	14	14	indomethacin	I-FABP	PA449982	2169	0.652
NULL	Diabetes_Care_2012_Feb_16_35(2)_327-333.nxml.txt.nlp	22179958	SENT161	24	24	16	16	choline	B12	PA448976	7126;4709	0.652
NULL	Mol_Med_Rep_2015_Jan_16_11(1)_91-98.nxml.txt.nlp	25322694	SENT11	7	7	23	23	cisplatin	LC3	PA449014	84557	0.652
NULL	Cell_J_2013_Aug_24_Autumn_15(3)_206-211.nxml.txt.nlp	24027660	SENT130	10	10	0	0	estradiol	CYP1A2	PA449503	1544	0.652
NULL	Arthritis_Res_Ther_2004_Sep_23_6(6)_R535-R543.nxml.txt.nlp	15535831	SENT141	18	18	3	3	infliximab	TPO	PA452639	7066;7173	0.652
NULL	Diagn_Pathol_2013_Jan_21_8_10.nxml.txt.nlp	23337059	SENT152	25	25	34	34	oxaliplatin	beta-catenin	PA131285527	1499	0.652
NULL	Br_J_Cancer_2004_Mar_22_90(6)_1285-1292.nxml.txt.nlp	15026814	SENT206	14	14	21	21	doxorubicin	p53	PA449412	7157	0.652
NULL	Environ_Health_Perspect_2006_Sep_23_114(9)_1401-1406.nxml.txt.nlp	16966095	SENT193	35	35	20	20	arsenite	p53	PA452638	7157	0.652
NULL	Clin_Pharmacol_2012_Feb_20_4_13-20.nxml.txt.nlp	22427735	SENT84	26	26	7	7	clopidogrel	PON1	PA449053	5444	0.652
NULL	Case_Rep_Endocrinol_2011_Oct_9_2011_584930.nxml.txt.nlp	22937287	SENT11	16	16	24	24	thyroglobulin	TPO	PA164754910	7066;7173	0.652
NULL	Oncotarget_2013_Nov_24_4(12)_2430-2438.nxml.txt.nlp	24280348	SENT41	3	3	18	18	gefitinib	c-Jun	PA131301952	3725	0.652
NULL	Nat_Commun_2014_Jun_25_5_4182.nxml.txt.nlp	24964370	SENT26	8	8	20	20	oxaliplatin	NO3	PA131285527	4681	0.652
NULL	J_Biol_Chem_2008_Nov_14_283(46)_31679-31689.nxml.txt.nlp	18755684	SENT233	12	12	5	5	iron	FTL	PA450087	2512	0.652
NULL	Mol_Vis_2011_Dec_15_17_3254-3261.nxml.txt.nlp	22194651	SENT91	6	6	8	8	vasopressin	AVP	PA451858	114548;551	0.652
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2008_Sep_1_64(Pt_9)_977-984.nxml.txt.nlp	18703847	SENT15	2	2	4	4	trimethoprim	TMP	PA451788	2012	0.652
NULL	Cancer_Microenviron_2008_Dec_20_1(1)_103-111.nxml.txt.nlp	19308689	SENT32	7	7	12	12	thrombin	PAR-1	PA451674	2011;2149	0.652
NULL	Dis_Markers_2012_Feb_1_32(1)_43-50.nxml.txt.nlp	22297601	SENT4	21	21	6	6	nevirapine	MDR1	PA450616	5243	0.652
NULL	Adv_Pharmacol_Sci_2012_Sep_13_2012_182671.nxml.txt.nlp	23008702	SENT214	9	9	2	2	ethanol	DA1	PA448073	28495;7169	0.652
NULL	Mol_Imaging_Biol_2009_Sep_27_11(5)_364-368.nxml.txt.nlp	19326174	SENT139	37	37	30	30	propranolol	FDG	PA451145	23583	0.652
NULL	Clin_Med_Insights_Oncol_2011_Oct_31_5_333-342.nxml.txt.nlp	22084622	SENT204	21	21	3	3	sunitinib	VEGFR	PA162372840	3791	0.652
NULL	Nat_Commun_2012_Dec_27_3_1316.nxml.txt.nlp	23271650	SENT531	20	20	41	41	tamoxifen	CA1	PA451581	759	0.652
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT187	18	18	3	3	tacrolimus	OPG	PA451578	690	0.652
NULL	Indian_J_Pharmacol_2009_Dec_41(6)_262-267.nxml.txt.nlp	20407557	SENT208	2	2	12	12	ezetimibe	STZ	PA10816	6484	0.652
NULL	J_Cell_Mol_Med_2014_Aug_15_18(8)_1680-1693.nxml.txt.nlp	23947793	SENT31	13	13	31	31	ethanol	CD44	PA448073	960	0.652
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1150.nxml.txt.nlp	24675468	SENT89	20	20	25	25	ethanol	adiponectin	PA448073	9370	0.652
NULL	Dermatol_Pract_Concept_2012_Apr_30_2(2)_0202a03.nxml.txt.nlp	23785591	SENT54	11	11	15	15	vincristine	CHOP	PA451879	1649	0.652
NULL	Oncotarget_2014_Jun_6_5(13)_4935-4944.nxml.txt.nlp	24952732	SENT33	0	0	14	14	doxazosin	PI3K	PA449407	5290	0.652
NULL	Eur_J_Med_Res_2009_Nov_3_14(11)_461-479.nxml.txt.nlp	19948442	SENT296	40	40	12	12	efavirenz	CD4	PA449441	920	0.652
NULL	Mol_Cancer_2012_May_28_11_36.nxml.txt.nlp	22640878	SENT43	19	19	29	29	paclitaxel	TGFBI	PA450761	7045	0.652
NULL	Breast_Cancer_(Auckl)_2009_Sep_2_3_61-75.nxml.txt.nlp	19809577	SENT23	0	0	2	2	curcumin	EMD	PA151958596	2010	0.652
NULL	Adv_Ther_2014_Jul_2_31(7)_762-775.nxml.txt.nlp	24985411	SENT260	2	2	17	17	valsartan	Xin	PA451848	165904	0.652
NULL	Ann_Rheum_Dis_2008_Oct_16_68(8)_1277-1284.nxml.txt.nlp	18930987	SENT12	8	8	44	44	infliximab	CAP	PA452639	23476;9200;4012;5269;10580;10487	0.652
NULL	Br_J_Cancer_2009_Jul_21_101(2)_238-243.nxml.txt.nlp	19568242	SENT145	31	31	33	33	bevacizumab	IFN	PA130232992	3439	0.652
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT12	20	20	14	14	pemetrexed	UNG	PA10810	7374	0.652
NULL	Breast_Cancer_Res_2011_Nov_24_13(6)_R120.nxml.txt.nlp	22115051	SENT99	2	2	18	18	tamoxifen	HER-2	PA451581	2064	0.652
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT110	34	34	17	17	phenformin	p53	PA1000	7157	0.652
NULL	Int_J_Mol_Sci_2014_Oct_20_15(10)_18840-18855.nxml.txt.nlp	25334060	SENT182	18	18	16	16	naphthol	TRAP	PA154081779	959;54;57410	0.652
NULL	Hum_Genomics_2004_May_1_1(4)_300-306.nxml.txt.nlp	15588489	SENT156	48	48	40	40	midazolam	CYP3A4	PA450496	1576	0.652
NULL	Oncotarget_2014_Feb_14_5(3)_841-852.nxml.txt.nlp	24553354	SENT221	37	37	17	17	l-glutamine	CO2	PA10090	4513	0.652
NULL	Cancer_Inform_2013_Feb_13_12_31-51.nxml.txt.nlp	23470717	SENT335	26	26	6	6	tamoxifen	E2F1	PA451581	1869	0.652
NULL	Cancer_Immunol_Immunother_2008_Jul_7_57(7)_931-950.nxml.txt.nlp	18256831	SENT435	17	17	20	20	doxorubicin	IL-2	PA449412	3558	0.652
NULL	J_Exp_Med_1961_Oct_31_114(5)_761-778.nxml.txt.nlp	19867206	SENT7	8	8	28	28	nitrogen	ACTH	PA450643	5443	0.652
NULL	Clin_Med_Insights_Oncol_2013_Jun_3_7_103-122.nxml.txt.nlp	23843721	SENT137	5	5	3	3	trastuzumab	PTEN	PA451743	5728	0.652
NULL	J_Ophthalmic_Inflamm_Infect_2013_Apr_22_3_46.nxml.txt.nlp	23607574	SENT63	34	34	16	16	vancomycin	Gen	PA451850	348654	0.652
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT128	12	12	0	0	diazepam	CYP1A2	PA449283	1544	0.652
NULL	J_Clin_Gastroenterol_2014_Sep_24_48(8)_679-686.nxml.txt.nlp	24921215	SENT136	5	5	13	13	telaprevir	BOC	PA165958354	91653	0.652
NULL	Clinics_(Sao_Paulo)_2012_Jul_67(7)_821-826.nxml.txt.nlp	22892929	SENT96	22	22	45	45	phenylephrine	S100B	PA450935	6285	0.652
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT87	40	40	34	34	pemetrexed	UNG	PA10810	7374	0.652
NULL	Chin_J_Cancer_2012_Feb_31(2)_51-57.nxml.txt.nlp	22257384	SENT67	7	7	19	19	cyclosporine	MRP1	PA449167	4437	0.652
NULL	Front_Neurosci_2014_Nov_10_8_364.nxml.txt.nlp	25426018	SENT271	18	18	5	5	dextran	ANOVA	PA449261	4858	0.652
NULL	Int_J_Mol_Sci_2014_Sep_5_15(9)_15754-15765.nxml.txt.nlp	25198898	SENT67	0	0	3	3	curcumin	JNK	PA151958596	5599	0.652
NULL	ScientificWorldJournal_2012_Jan_29_2012_454059.nxml.txt.nlp	22666124	SENT79	19	19	16	16	amoxicillin	TMP	PA448406	2012	0.652
NULL	J_Antimicrob_Chemother_2012_May_8_67(5)_1217-1223.nxml.txt.nlp	22316571	SENT29	19	19	7	7	artemether	ACT	PA165111698	12;11332;9457;641455	0.652
NULL	Cancer_Cell_Int_2006_Mar_30_6_9.nxml.txt.nlp	16573823	SENT132	13	13	9	9	lovastatin	CT50	PA450272	93273	0.652
NULL	Breast_Cancer_Res_Treat_2013_Apr_12_138(2)_427-435.nxml.txt.nlp	23479422	SENT282	15	15	17	17	paclitaxel	HER2	PA450761	2064	0.652
NULL	Indian_J_Med_Paediatr_Oncol_2013_Oct-Dec_34(4)_292-298.nxml.txt.nlp	24604960	SENT20	10	10	14	14	vincristine	CHOP	PA451879	1649	0.652
NULL	Oncogenesis_2014_Mar_24_3(3)_e95.nxml.txt.nlp	24662924	SENT70	38	38	19	19	fluorescein	ORCA	PA164746009	222229	0.652
NULL	F1000Res_2014_Aug_19_3_198.nxml.txt.nlp	25400908	SENT282	44	44	25	25	paclitaxel	HER2	PA450761	2064	0.652
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT142	3	3	23	23	dasatinib	JNK	PA162372878	5599	0.652
NULL	J_Hum_Genet_2013_Jun_23_58(6)_339-345.nxml.txt.nlp	23697979	SENT91	12	12	8	8	ticagrelor	CYP2C19	PA165374673	1557	0.652
NULL	Cancer_Inform_2007_Jan_12_3_275-284.nxml.txt.nlp	19455247	SENT220	14	14	5	5	gefitinib	EGFR	PA131301952	1956	0.652
NULL	Nucleic_Acids_Res_2013_May_5_41(10)_5210-5222.nxml.txt.nlp	23563151	SENT264	19	19	11	11	arsenite	MDM2	PA452638	4193	0.652
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Apr_15_9_13.nxml.txt.nlp	20398300	SENT108	25	25	7	7	moxifloxacin	LAM	PA450555	7249;7248	0.652
NULL	Front_Oncol_2013_Sep_9_3_235.nxml.txt.nlp	24058902	SENT63	10	10	27	27	vorinostat	BIM	PA164748224	10018	0.652
NULL	Aging_(Albany_NY)_2014_Jan_14_6(1)_70-81.nxml.txt.nlp	24429382	SENT201	22	22	6	6	etoposide	WRN	PA449552	7486	0.652
NULL	Cells_2014_Apr_9_3(2)_288-303.nxml.txt.nlp	24722470	SENT83	24	24	13	13	hyperforin	TRPC6	PA165985514	7225	0.652
NULL	Cells_2014_Apr_29_3(2)_331-362.nxml.txt.nlp	24785347	SENT1170	2	2	6	6	capsaicin	TRPV1	PA448776	7442	0.652
NULL	Mucosal_Immunol_2014_Jan_12_7(1)_10_1038_mi_2013_36.nxml.txt.nlp	23757303	SENT243	14	14	3	3	mitomycin	CD4	PA450524	920	0.652
NULL	Chin_J_Cancer_2012_Feb_31(2)_73-99.nxml.txt.nlp	22098950	SENT268	4	4	8	8	flavopiridol	ABCG2	PA452627	9429	0.652
NULL	Cardiovasc_Res_2013_Jul_1_99(1)_24-34.nxml.txt.nlp	23519266	SENT218	15	15	0	0	estradiol	CYP1B1	PA449503	1545	0.652
NULL	J_Ophthalmic_Inflamm_Infect_2013_Apr_22_3_46.nxml.txt.nlp	23607574	SENT63	26	26	16	16	gatifloxacin	Gen	PA449738	348654	0.652
NULL	Br_J_Cancer_2010_Jan_5_102(1)_80-86.nxml.txt.nlp	19920817	SENT83	21	21	23	23	bevacizumab	IFN	PA130232992	3439	0.652
NULL	J_Am_Heart_Assoc_2013_Dec_19_2(6)_e000355.nxml.txt.nlp	24190878	SENT35	4	4	0	0	isoproterenol	HK2	PA450121	3796;3099;29911;3741	0.652
NULL	Croat_Med_J_2012_Jun_53(3)_214-223.nxml.txt.nlp	22661134	SENT59	3	3	22	22	yohimbine	ACTH	PA451946	5443	0.652
NULL	Support_Care_Cancer_2012_May_1_20(5)_941-949.nxml.txt.nlp	21533811	SENT138	20	20	11	11	palonosetron	HEC	PA10352	10403	0.652
NULL	Int_J_Gen_Med_2011_Jul_20_4_539-545.nxml.txt.nlp	21845063	SENT6	5	5	17	17	miglitol	adiponectin	PA164776726	9370	0.652
NULL	Chin_J_Cancer_2013_Aug_32(8)_419-426.nxml.txt.nlp	23668930	SENT47	13	13	27	27	doxorubicin	SOCS1	PA449412	8651	0.652
NULL	J_Biol_Chem_2013_Mar_1_288(9)_6248-6258.nxml.txt.nlp	23344959	SENT741	23	23	9	9	quinidine	Slo3	PA451209	157855	0.652
NULL	Front_Aging_Neurosci_2010_Feb_3_2_2.nxml.txt.nlp	20552042	SENT613	15	15	7	7	nimodipine	spatial	PA450633	219793	0.652
NULL	Diabetes_2013_Mar_14_62(3)_669-671.nxml.txt.nlp	23431005	SENT18	0	0	5	5	ticagrelor	P2Y12	PA165374673	64805	0.652
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1224-1233.nxml.txt.nlp	22353810	SENT153	0	0	7	7	doxorubicin	MRP-1	PA449412	928	0.652
NULL	Stroke_Res_Treat_2011_Nov_10_2011_212485.nxml.txt.nlp	22135769	SENT111	24	24	9	9	warfarin	CYP2C9	PA451906	1559	0.652
NULL	Surg_Today_2015_Oct_14_45_221-226.nxml.txt.nlp	25734195	SENT38	27	27	15	15	doxorubicin	CRT	PA449412	811	0.652
NULL	Mol_Vis_2012_Mar_1_18_519-527.nxml.txt.nlp	22419845	SENT53	17	17	12	12	trypsin	CO2	PA451806	4513	0.652
NULL	Cell_Death_Differ_2010_Sep_5_17(9)_1511-1523.nxml.txt.nlp	20203690	SENT350	16	16	8	8	ethanol	c-fos	PA448073	2353	0.652
NULL	Virol_J_2009_Jun_3_6_70.nxml.txt.nlp	19493343	SENT229	18	18	30	30	chloramphenicol	MxA	PA448927	4599	0.652
NULL	Curr_Neuropharmacol_2014_Jan_12(1)_2-36.nxml.txt.nlp	24533013	SENT900	12	12	15	15	s-adenosylmethionine	PS1	PA164754994	5663	0.652
NULL	Eur_J_Immunol_2014_Jun_10_44(6)_1759-1769.nxml.txt.nlp	24595810	SENT43	0	0	6	6	fludrocortisone	CD62L	PA164743961	6402	0.652
NULL	Front_Cell_Neurosci_2014_Jul_8_8_188.nxml.txt.nlp	25071448	SENT243	0	0	3	3	estradiol	SEX	PA449503	55558	0.652
NULL	Oncotarget_2014_Oct_21_5(22)_11252-11268.nxml.txt.nlp	25361004	SENT269	11	11	5	5	metformin	CLIC1	PA450395	1192	0.652
NULL	Evid_Based_Complement_Alternat_Med_2013_Nov_5_2013_715040.nxml.txt.nlp	24302969	SENT82	22	22	19	19	gentamicin	OPG	PA449753	690	0.652
NULL	J_Med_Internet_Res_2003_Mar_31_5(1)_e6.nxml.txt.nlp	12746211	SENT37	5	5	3	3	diethylstilbestrol	DES	PA449307	1674	0.652
NULL	Neural_Plast_2007_Dec_11_2007_73079.nxml.txt.nlp	NULL	SENT1137	10	10	15	15	clozapine	NOT	PA449061	4929	0.652
NULL	Bioinformation_2012_Jan_6_8(1)_13-19.nxml.txt.nlp	22359429	SENT25	26	26	28	28	curcumin	MRP1	PA151958596	4437	0.652
NULL	Clinics_(Sao_Paulo)_2013_May_68(5)_694-701.nxml.txt.nlp	23778405	SENT126	10	10	16	16	curcumin	MDR1	PA151958596	5243	0.652
NULL	Apoptosis_2012_Sep_30_17(9)_989-997.nxml.txt.nlp	22460505	SENT4	4	4	23	23	thioridazine	p27	PA451666	5715;10534	0.652
NULL	Int_J_Breast_Cancer_2011_Sep_6_2011_352182.nxml.txt.nlp	22295219	SENT132	24	24	15	15	trastuzumab	PTEN	PA451743	5728	0.652
NULL	Braz_J_Microbiol_2014_Mar_10_44(4)_1279-1283.nxml.txt.nlp	24688523	SENT123	19	19	4	4	chloramphenicol	TMP	PA448927	2012	0.652
NULL	Cell_Commun_Signal_2013_Jul_31_11_52.nxml.txt.nlp	23902637	SENT123	10	10	46	46	geldanamycin	Raf-1	PA152031327	5894	0.652
NULL	Front_Physiol_2013_Dec_24_4_386.nxml.txt.nlp	24399968	SENT359	6	6	30	30	glibenclamide	SUR1	PA449782	6833	0.652
NULL	J_Immunother_Cancer_2013_Nov_7_1(Suppl_1)_P25.nxml.txt.nlp	NULL	SENT12	16	16	26	26	fludarabine	IL-2	PA449655	3558	0.652
NULL	J_Int_AIDS_Soc_2013_Apr_30_16(1)_18059.nxml.txt.nlp	23639243	SENT0	30	30	37	37	emtricitabine	CD4	PA10069	920	0.652
NULL	Arthritis_Res_Ther_2005_Apr_4_7(4)_R756-R768.nxml.txt.nlp	15987477	SENT273	8	8	5	5	hyaluronidase	PH-20	PA164745713	6677	0.652
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jun_26_66(Pt_7)_o1788-o1789.nxml.txt.nlp	21587999	SENT7	19	19	12	12	coumarin	mol	PA134521193	90527	0.652
NULL	Diabetes_2011_Nov_17_60(11)_2691-2700.nxml.txt.nlp	21896928	SENT4	5	5	14	14	resveratrol	SIRT1		23411	0.652
NULL	Cancers_(Basel)_2011_Apr_1_3(2)_1844-1860.nxml.txt.nlp	24212785	SENT65	36	36	4	4	oxaliplatin	ACRC	PA131285527	93953	0.652
NULL	Adv_Urol_2010_Jul_20_2010_687043.nxml.txt.nlp	20721275	SENT107	4	4	19	19	bevacizumab	IFN	PA130232992	3439	0.652
NULL	Breast_Cancer_Res_2010_May_10_12(3)_R26.nxml.txt.nlp	20459744	SENT99	6	6	19	19	fluorouracil	HDC	PA128406956	3067;51696	0.652
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_24_2013_482318.nxml.txt.nlp	23864891	SENT116	5	5	12	12	metoprolol	CHOP	PA450480	1649	0.652
NULL	J_Biomed_Sci_2014_Nov_18_21(1)_99.nxml.txt.nlp	25407417	SENT221	19	19	10	10	oseltamivir	CCR2	PA450721	729230	0.652
NULL	Ann_Clin_Microbiol_Antimicrob_2014_Jan_6_13_2.nxml.txt.nlp	24393536	SENT42	12	12	14	14	kanamycin	TOB	PA450137	10140	0.652
NULL	Indian_J_Endocrinol_Metab_2013_Jan-Feb_17(1)_91-94.nxml.txt.nlp	23776858	SENT31	21	21	16	16	liraglutide	GLP-1	PA165958364	100125288	0.652
NULL	Front_Endocrinol_(Lausanne)_2014_Feb_26_5_17.nxml.txt.nlp	24616713	SENT96	12	12	14	14	vasopressin	AVP	PA451858	114548;551	0.652
NULL	Gene_Ther_2011_Dec_12_18(12)_1150-1156.nxml.txt.nlp	21562591	SENT135	15	15	30	30	l-glutamine	CO2	PA10090	4513	0.652
NULL	Ann_Surg_Oncol_2012_Feb_12_19(2)_527-535.nxml.txt.nlp	21748247	SENT54	33	33	43	43	hydrocortisone	CO2	PA449905	4513	0.652
NULL	Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.nxml.txt.nlp	24736980	SENT176	3	3	5	5	rosuvastatin	OATP1B1	PA134308647	10599	0.652
NULL	Breast_Cancer_Res_2007_Aug_8_9(4)_R50.nxml.txt.nlp	17686159	SENT257	33	33	22	22	gefitinib	HRG	PA131301952	3084;3273	0.652
NULL	Trials_2014_Nov_27_15(1)_466.nxml.txt.nlp	NULL	SENT223	13	13	3	3	remifentanil	COX	PA451232	1351	0.652
NULL	Anal_Bioanal_Chem_2012_Apr_12_403(1)_151-155.nxml.txt.nlp	22327967	SENT62	6	6	12	12	fluorescein	mol	PA164746009	90527	0.652
NULL	Indian_J_Ophthalmol_2007_Nov-Dec_55(6)_445-450.nxml.txt.nlp	17951902	SENT34	0	0	16	16	pegaptanib	VEGF-A	PA164771236	7422	0.652
NULL	Br_J_Pharmacol_2008_Oct_18_155(4)_596-605.nxml.txt.nlp	18852694	SENT149	2	2	8	8	fenofibrate	SREBP2	PA449594	6721	0.652
NULL	Ann_Surg_Treat_Res_2014_Feb_22_86(2)_68-75.nxml.txt.nlp	24761411	SENT18	6	6	12	12	resveratrol	Bcl-2		596	0.652
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT13	3	3	10	10	pemetrexed	UNG	PA10810	7374	0.652
NULL	Diabetes_Care_2011_Sep_19_34(9)_2072-2077.nxml.txt.nlp	21788633	SENT223	22	22	9	9	glimepiride	GLP-1	PA449761	100125288	0.652
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_May_11_67(Pt_6)_o1379.nxml.txt.nlp	21754769	SENT68	4	4	20	20	benzaldehyde	mol	PA448571	90527	0.652
NULL	Diabetes_Metab_Syndr_Obes_2011_Apr_29_4_167-174.nxml.txt.nlp	21779148	SENT190	2	2	13	13	pioglitazone	adiponectin	PA450970	9370	0.652
NULL	Cancers_(Basel)_2010_May_7_2(2)_794-808.nxml.txt.nlp	24281094	SENT123	6	6	10	10	melphalan	IFN	PA450354	3439	0.652
NULL	Cell_Mol_Life_Sci_2011_Aug_24_68(16)_2797-2809.nxml.txt.nlp	21104292	SENT349	22	22	13	13	vasopressin	SON	PA451858	6651	0.652
NULL	Med_Sci_Monit_2013_Nov_29_19_1080-1088.nxml.txt.nlp	24287619	SENT135	9	9	17	17	estradiol	ACL	PA449503	47	0.652
NULL	Cost_Eff_Resour_Alloc_2005_Jan_25_3_2.nxml.txt.nlp	15670330	SENT130	20	20	15	15	terazosin	NNT	PA451612	23530	0.652
NULL	Mol_Cancer_2009_Nov_19_8_108.nxml.txt.nlp	19925669	SENT37	15	15	23	23	doxorubicin	MRP3	PA449412	8714	0.652
NULL	Evid_Based_Complement_Alternat_Med_2013_May_28_2013_629750.nxml.txt.nlp	23781265	SENT144	2	2	10	10	capsaicin	GADD153	PA448776	1649	0.652
NULL	Allergy_Asthma_Immunol_Res_2014_Nov_19_6(6)_548-557.nxml.txt.nlp	25374755	SENT88	6	6	15	15	lovastatin	CCL11	PA450272	6356	0.652
NULL	Plant_Methods_2013_Feb_5_9_4.nxml.txt.nlp	23379342	SENT135	33	33	24	24	aluminium	hole	PA164760864	80757	0.652
NULL	Breast_Cancer_Res_2000_Aug_11_2(6)_417-422.nxml.txt.nlp	11250735	SENT45	14	14	17	17	thrombin	TIE2	PA451674	7010	0.652
NULL	Int_J_Mol_Sci_2007_Jun_8_8(6)_492-504.nxml.txt.nlp	NULL	SENT63	4	4	0	0	fluorescein	CD16	PA164746009	2215;2214	0.652
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT128	13	13	1	1	encainide	CYP2C9	PA449459	1559	0.652
NULL	Iran_J_Pediatr_2010_Sep_20(3)_269-176.nxml.txt.nlp	23056716	SENT22	14	14	27	27	carbamazepine	PHB	PA448785	5245	0.652
NULL	Acta_Pharmacol_Sin_2009_Sep_24_30(9)_1323-1329.nxml.txt.nlp	19701237	SENT200	6	6	10	10	midazolam	CYP3A	PA450496	1574	0.652
NULL	Clin_Interv_Aging_2012_Jul_12_7_235-247.nxml.txt.nlp	22866001	SENT18	3	3	17	17	denosumab	RANKL	PA166048634	8600	0.652
NULL	Lab_Invest_2010_Oct_28_90(10)_1415-1424.nxml.txt.nlp	20585313	SENT145	9	9	3	3	celecoxib	HRG	PA448871	3084;3273	0.652
NULL	J_Immunother_Cancer_2014_Aug_19_2_27.nxml.txt.nlp	25324973	SENT58	3	3	20	20	cisplatin	IFN	PA449014	3439	0.652
NULL	J_Gen_Physiol_1981_Feb_1_77(2)_137-153.nxml.txt.nlp	6267160	SENT0	14	14	1	1	benzocaine	Gen	PA448576	348654	0.652
NULL	Diagn_Pathol_2013_May_15_8_81.nxml.txt.nlp	23675804	SENT21	24	24	19	19	cyclophosphamide	CD5	PA449165	921	0.652
NULL	Breast_Cancer_Res_2012_Jul_19_14(4)_R109.nxml.txt.nlp	22812567	SENT234	9	9	23	23	gemcitabine	CHK1	PA449748	1111	0.652
NULL	Eur_J_Clin_Pharmacol_2011_May_8_67(5)_493-506.nxml.txt.nlp	21140139	SENT231	29	29	25	25	oxycodone	CYP3A4	PA450741	1576	0.652
NULL	J_Korean_Med_Sci_2005_Oct_31_20(5)_883-885.nxml.txt.nlp	16224167	SENT23	21	21	24	24	cyclosporine	gamma	PA449167	9913	0.652
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Nov_8_64(Pt_12)_o2286-o2287.nxml.txt.nlp	21581265	SENT83	25	25	11	11	ethanol	mol	PA448073	90527	0.652
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT102	4	4	30	30	imatinib	ABCG2	PA10804	9429	0.652
NULL	Basic_Res_Cardiol_2010_Nov_20_105(6)_771-785.nxml.txt.nlp	20960209	SENT155	2	2	24	24	cyclosporine	ADP	PA449167	23038	0.652
NULL	Cholesterol_2014_Nov_18_2014_720507.nxml.txt.nlp	25478215	SENT114	42	42	21	21	atorvastatin	AT1	PA448500	9197;185	0.652
NULL	Diabetes_Metab_J_2013_Dec_12_37(6)_415-422.nxml.txt.nlp	24404512	SENT66	14	14	29	29	simvastatin	adiponectin	PA451363	9370	0.652
NULL	Clin_Mol_Hepatol_2014_Sep_25_20(3)_283-290.nxml.txt.nlp	25320732	SENT106	12	12	17	17	propranolol	EVL	PA451145	51466	0.652
NULL	Front_Neurosci_2012_May_30_6_77.nxml.txt.nlp	22661925	SENT257	12	12	3	3	ethanol	HEC	PA448073	10403	0.652
NULL	Eur_J_Nutr_2009_Jun_24_48(4)_229-234.nxml.txt.nlp	19238310	SENT6	9	9	17	17	capsaicin	ghrelin	PA448776	51738	0.652
NULL	Angew_Chem_Int_Ed_Engl_2012_Feb_13_51(7)_1572-1575.nxml.txt.nlp	22213572	SENT34	31	31	38	38	ethanol	CO2	PA448073	4513	0.652
NULL	J_Cell_Mol_Med_2014_Apr_20_18(4)_709-720.nxml.txt.nlp	24444314	SENT205	7	7	9	9	metformin	Met	PA450395	79811	0.652
NULL	Oncogene_2014_Jan_23_33(4)_421-428.nxml.txt.nlp	23318437	SENT322	21	21	9	9	etoposide	RNF2	PA449552	6045	0.652
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT157	27	27	40	40	l-leucine	SIRT3	PA450197	23410	0.652
NULL	Environ_Health_Perspect_2008_Mar_26_116(3)_322-328.nxml.txt.nlp	18335098	SENT20	20	20	7	7	estradiol	PMI	PA449503	8834;5373	0.652
NULL	EPMA_J_2012_Sep_27_3(1)_10.nxml.txt.nlp	23016735	SENT214	39	39	23	23	warfarin	GGCX	PA451906	2677	0.652
NULL	Chin_J_Cancer_2011_Oct_30(10)_690-700.nxml.txt.nlp	21959046	SENT125	3	3	12	12	chloroquine	TPT	PA448948	23590;6469	0.652
NULL	J_Gen_Physiol_1960_Mar_1_43(4)_753-758.nxml.txt.nlp	14433991	SENT0	12	12	1	1	dextran	Gen	PA449261	348654	0.652
NULL	Drug_Des_Devel_Ther_2014_Sep_23_8_1527-1538.nxml.txt.nlp	25284985	SENT107	2	2	0	0	celecoxib	IFN	PA448871	3439	0.652
NULL	Mol_Cancer_2013_Nov_20_12_144.nxml.txt.nlp	24257371	SENT211	8	8	22	22	cisplatin	PRL	PA449014	5617	0.652
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_21-38.nxml.txt.nlp	19305786	SENT498	2	2	13	13	capsaicin	TRPV3	PA448776	162514	0.652
NULL	J_Cancer_2013_Sep_27_4(8)_662-670.nxml.txt.nlp	24155778	SENT126	14	14	33	33	cisplatin	UCHL1	PA449014	7345	0.652
NULL	J_Biol_Chem_2012_Dec_14_287(51)_43094-43107.nxml.txt.nlp	23118219	SENT343	12	12	6	6	hyaluronan	CD44	PA165958431	960	0.652
NULL	Cancer_Cell_Int_2011_Aug_19_11_29.nxml.txt.nlp	21854619	SENT220	41	41	37	37	platinum	HDAC	PA150595617	9734	0.652
NULL	EMBO_J_2010_Sep_15_29(18)_3170-3183.nxml.txt.nlp	20676059	SENT427	27	27	31	31	fluoxetine	P15	PA449673	1030;29107	0.652
NULL	Cells_2012_Aug_3_1(3)_492-519.nxml.txt.nlp	24710487	SENT200	21	21	5	5	dextran	STAT1	PA449261	6772	0.652
NULL	Brain_Behav_2013_Mar_6_3(2)_114-133.nxml.txt.nlp	23533150	SENT14	5	5	19	19	ethanol	HSF1	PA448073	3297	0.652
NULL	Arthritis_Res_Ther_2010_Feb_9_12(1)_R21.nxml.txt.nlp	20144213	SENT252	7	7	5	5	naproxen	COX	PA450595	1351	0.652
NULL	Cancer_Res_Treat_2011_Dec_27_43(4)_255-259.nxml.txt.nlp	22247712	SENT85	19	19	7	7	cyclosporine	CHOP	PA449167	1649	0.652
NULL	Ann_Hematol_2010_Mar_2_89(3)_283-289.nxml.txt.nlp	19727725	SENT123	5	5	3	3	etoposide	CHOP	PA449552	1649	0.652
NULL	Breast_Cancer_Res_2007_Nov_26_9(6)_R82.nxml.txt.nlp	18036263	SENT174	7	7	21	21	trypsin	BRCA1	PA451806	672	0.652
NULL	Cardiovasc_Ultrasound_2007_Jan_25_5_4.nxml.txt.nlp	17254324	SENT145	22	22	20	20	cyclophosphamide	CHOP	PA449165	1649	0.652
NULL	Exp_Diabetes_Res_2012_Dec_26_2012_230624.nxml.txt.nlp	23365557	SENT63	2	2	19	19	liraglutide	LIR1	PA165958364	10859	0.652
NULL	Exp_Diabetes_Res_2012_Nov_1_2012_892706.nxml.txt.nlp	23197976	SENT200	6	6	0	0	vildagliptin	CD31	PA165958346	5175	0.652
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jul_24_66(Pt_8)_o2099.nxml.txt.nlp	21588392	SENT62	16	16	22	22	benzaldehyde	mol	PA448571	90527	0.652
NULL	J_Adv_Pharm_Technol_Res_2014_Oct-Dec_5(4)_185-190.nxml.txt.nlp	25364697	SENT155	17	17	8	8	talinolol	P-gp	PA146123005	5243	0.652
NULL	Clin_Med_Insights_Oncol_2013_Aug_12_7_181-197.nxml.txt.nlp	23997579	SENT157	25	25	18	18	cytarabine	CR1	PA449177	1378	0.652
NULL	J_Anim_Sci_Biotechnol_2014_Nov_14_5(1)_52.nxml.txt.nlp	25478164	SENT278	5	5	7	7	genistein	activin	PA165109660	83729	0.652
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1224-1233.nxml.txt.nlp	22353810	SENT153	2	2	7	7	etoposide	MRP-1	PA449552	928	0.652
NULL	J_Biol_Chem_2010_Apr_9_285(15)_11652-11666.nxml.txt.nlp	20150425	SENT71	19	19	14	14	l-glutamine	B27	PA10090	56246	0.652
NULL	Biosci_Rep_2012_Dec_1_32(Pt_6)_559-566.nxml.txt.nlp	NULL	SENT40	7	7	0	0	vinblastine	ADM	PA451877	133	0.652
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Nov_4_9_31.nxml.txt.nlp	21050425	SENT90	18	18	32	32	tetracycline	Gen	PA451640	348654	0.652
NULL	Arthritis_Res_Ther_2009_Jul_23_11(4)_236.nxml.txt.nlp	19664185	SENT69	25	25	4	4	probenecid	GLUT9	PA451106	11182	0.652
NULL	J_Oncol_2009_Mar_24_2009_491985.nxml.txt.nlp	19325924	SENT90	31	31	20	20	genistein	CXCR4	PA165109660	7852	0.652
NULL	J_Gen_Intern_Med_2009_May_21_24(5)_656-664.nxml.txt.nlp	19306050	SENT521	11	11	6	6	warfarin	VKORC1	PA451906	79001	0.652
NULL	Clin_Ophthalmol_2012_Sep_7_6_1471-1476.nxml.txt.nlp	23055666	SENT22	7	7	13	13	betaxolol	NAC	PA448611	22861	0.652
NULL	Pharmaceuticals_(Basel)_2012_Aug_30_5(9)_890-898.nxml.txt.nlp	24280696	SENT247	1	1	6	6	geldanamycin	alpha-synuclein	PA152031327	6622	0.652
NULL	Acta_Naturae_2013_Oct-Dec_5(4)_83-93.nxml.txt.nlp	24455187	SENT201	18	18	9	9	tamoxifen	7SL	PA451581	6029	0.652
NULL	Oncotarget_2013_Jun_3_4(6)_875-883.nxml.txt.nlp	23900261	SENT46	18	18	12	12	estradiol	RB1	PA449503	5925	0.652
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_4_2013_378657.nxml.txt.nlp	23662132	SENT495	9	9	15	15	liraglutide	GLP-1	PA165958364	100125288	0.652
NULL	Int_J_Med_Sci_2015_Jan_1_12(1)_63-71.nxml.txt.nlp	25552920	SENT115	2	2	33	33	berberine	COL1A2	PA165860812	1278	0.652
NULL	Indian_J_Crit_Care_Med_2008_Oct-Dec_12(4)_181-189.nxml.txt.nlp	19742267	SENT204	14	14	8	8	anakinra	ACR	PA10799	49	0.652
NULL	Cells_2014_May_23_3(2)_517-545.nxml.txt.nlp	24861977	SENT59	1	1	17	17	spermine	TRPV1	PA164781199	7442	0.652
NULL	Braz_J_Microbiol_2014_Mar_10_44(4)_1121-1131.nxml.txt.nlp	24688501	SENT122	44	44	29	29	ethanol	CO2	PA448073	4513	0.652
NULL	Virol_J_2009_Dec_1_6_213.nxml.txt.nlp	19951438	SENT147	3	3	16	16	mitomycin	TRAIL	PA450524	8743	0.652
NULL	Avicenna_J_Med_2014_Apr-Jun_4(2)_29-33.nxml.txt.nlp	24761380	SENT96	27	27	10	10	saxagliptin	GLP-1	PA165958362	100125288	0.652
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_24_2012_408187.nxml.txt.nlp	23193421	SENT227	22	22	19	19	vasopressin	AVP	PA451858	114548;551	0.652
NULL	J_Korean_Med_Sci_2010_Nov_26_25(11)_1626-1632.nxml.txt.nlp	21060752	SENT116	25	25	21	21	forskolin	NAC	PA146096022	22861	0.652
NULL	Aging_(Albany_NY)_2009_Mar_31_1(4)_412-424.nxml.txt.nlp	20195491	SENT125	12	12	27	27	resveratrol	AMPK		5563	0.652
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1150.nxml.txt.nlp	24675468	SENT14	10	10	2	2	metformin	AMPK	PA450395	5563	0.652
NULL	Drugs_Context_2012_Nov_26_2012_212243.nxml.txt.nlp	24432032	SENT398	2	2	11	11	theophylline	IL-6	PA451647	3569	0.652
NULL	J_Vis_Exp_2014_Feb_21_(84)_51285.nxml.txt.nlp	24637950	SENT89	6	6	12	12	phenol	F12	PA450913	2161	0.652
NULL	Evid_Based_Complement_Alternat_Med_2012_Aug_30_2012_517965.nxml.txt.nlp	22969827	SENT177	4	4	1	1	resveratrol	SIRT1		23411	0.652
NULL	JRSM_Cardiovasc_Dis_2012_Sep_24_1(6)_cvd_2012_012015.nxml.txt.nlp	24175073	SENT43	16	16	8	8	clopidogrel	ADP	PA449053	23038	0.652
NULL	Clinics_(Sao_Paulo)_2013_Jun_68(6)_766-771.nxml.txt.nlp	23778483	SENT22	37	37	28	28	hydroxychloroquine	IL-6	PA164777036	3569	0.651
NULL	Cell_Death_Dis_2012_Jun_21_3(6)_e330.nxml.txt.nlp	22717585	SENT293	0	0	16	16	simvastatin	XBP1	PA451363	7494	0.651
NULL	Exp_Ther_Med_2013_Nov_23_6(5)_1233-1236.nxml.txt.nlp	24223650	SENT12	14	14	36	36	creatine	LAMA2	PA164778930	3908	0.651
NULL	Endocr_Connect_2012_Aug_30_1(2)_62-67.nxml.txt.nlp	23781306	SENT65	5	5	10	10	efavirenz	CYP3A4	PA449441	1576	0.651
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT170	0	0	4	4	methotrexate	MSH2	PA450428	4436	0.651
NULL	Acta_Pharmacol_Sin_2011_Nov_10_32(11)_1402-1410.nxml.txt.nlp	21986579	SENT159	7	7	26	26	curcumin	CDK2	PA151958596	1017	0.651
NULL	Oncotarget_2014_Sep_29_5(20)_10084-10099.nxml.txt.nlp	25275296	SENT70	6	6	32	32	bortezomib	cIAP2	PA10252	330	0.651
NULL	Biosci_Rep_2011_Feb_1_31(Pt_1)_45-55.nxml.txt.nlp	20426768	SENT40	24	24	17	17	trypsin	CO2	PA451806	4513	0.651
NULL	Oncogene_2014_Feb_6_33(6)_713-723.nxml.txt.nlp	23435429	SENT105	26	26	5	5	etoposide	BRCA1	PA449552	672	0.651
NULL	Nat_Med_2010_Feb_24_16(2)_214-218.nxml.txt.nlp	20098429	SENT164	4	4	0	0	doxorubicin	LAPTM4B	PA449412	55353	0.651
NULL	Cancers_(Basel)_2011_Apr_1_3(2)_1844-1860.nxml.txt.nlp	24212785	SENT631	13	13	6	6	cetuximab	KRAS	PA10040	3845	0.651
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT193	0	0	9	9	metformin	p53	PA450395	7157	0.651
NULL	J_Infect_Dis_2014_Sep_15_210(6)_954-963.nxml.txt.nlp	24625807	SENT59	27	27	21	21	l-glutamine	F12	PA10090	2161	0.651
NULL	Emerg_Med_Int_2012_Apr_1_2012_852051.nxml.txt.nlp	22545217	SENT81	11	11	5	5	atropine	ACLS	PA448505	46;2737	0.651
NULL	Mol_Pain_2014_Apr_18_10_27.nxml.txt.nlp	24742127	SENT304	18	18	28	28	paclitaxel	CB2	PA450761	1269	0.651
NULL	Nat_Med_2013_Feb_6_19(2)_217-226.nxml.txt.nlp	23291629	SENT14	19	19	21	21	lipase	HSL	PA450239	3991	0.651
NULL	ACS_Nano_2014_Mar_25_8(3)_2018-2032.nxml.txt.nlp	24555414	SENT254	7	7	13	13	ethanol	mol	PA448073	90527	0.651
NULL	Cancer_Cell_Int_2011_Nov_17_11_40.nxml.txt.nlp	22088142	SENT147	29	29	33	33	gemcitabine	EGFR	PA449748	1956	0.651
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2012_Sep_13_68(Pt_10)_1311-1319.nxml.txt.nlp	22993085	SENT52	24	24	37	37	guanidine	ADP	PA164781028	23038	0.651
NULL	Environ_Health_Perspect_2008_Mar_3_116(3)_308-314.nxml.txt.nlp	18335096	SENT189	19	19	13	13	estradiol	aromatase	PA449503	1588	0.651
NULL	Acta_Neuropathol_2012_Mar_16_123(3)_369-380.nxml.txt.nlp	22083253	SENT57	34	34	43	43	lovastatin	NF1	PA450272	4763	0.651
NULL	Clin_Med_Insights_Oncol_2013_Feb_28_7_53-73.nxml.txt.nlp	23492937	SENT137	17	17	22	22	thalidomide	BTD	PA451644	686	0.651
NULL	Oncologist_2010_Apr_15(4)_350-359.nxml.txt.nlp	20413640	SENT202	13	13	2	2	bleomycin	HER-2	PA448645	2064	0.651
NULL	Evid_Based_Complement_Alternat_Med_2006_Sep_20_3(3)_365-372.nxml.txt.nlp	16951721	SENT198	5	5	24	24	ginseng	Bcl-2	PA164781150	596	0.651
NULL	Int_J_Endocrinol_2013_Mar_12_2013_578693.nxml.txt.nlp	23573088	SENT82	6	6	20	20	glucose	AST	PA449773	26503	0.651
NULL	Br_J_Ophthalmol_2014_Jun_98(Suppl_1)_i11-i16.nxml.txt.nlp	24836865	SENT23	0	0	6	6	ranibizumab	San	PA164746012	80218	0.651
NULL	Biomed_Res_Int_2013_Dec_17_2013_865197.nxml.txt.nlp	24455734	SENT47	19	19	21	21	ethambutol	EMB	PA164784021	133418	0.651
NULL	Gut_Microbes_2014_Jan_1_5(1)_5-10.nxml.txt.nlp	24247281	SENT125	24	24	16	16	choline	B12	PA448976	7126;4709	0.651
NULL	J_Biol_Chem_2009_Jul_3_284(27)_18537-18544.nxml.txt.nlp	19419970	SENT15	13	13	6	6	galactose	DC-SIGN	PA449725	30835	0.651
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT110	34	34	8	8	phenformin	p53	PA1000	7157	0.651
NULL	Cancer_Immunol_Immunother_2011_Jun_25_60(6)_793-808.nxml.txt.nlp	21350947	SENT161	21	21	19	19	sorafenib	IFN	PA7000	3439	0.651
NULL	Int_J_Genomics_2014_Jan_29_2014_894296.nxml.txt.nlp	24616891	SENT186	23	23	15	15	ethanol	PC2	PA448073	5126;5311;8535	0.651
NULL	Mol_Cancer_2008_Jun_30_7_60.nxml.txt.nlp	18590557	SENT73	13	13	34	34	doxorubicin	TRAIL	PA449412	8743	0.651
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT376	0	0	7	7	resveratrol	SMRT		9612	0.651
NULL	Diabetes_2009_Apr_9_58(4)_803-812.nxml.txt.nlp	19136652	SENT40	11	11	2	2	estradiol	adiponectin	PA449503	9370	0.651
NULL	Cent_European_J_Urol_2013_Aug_13_66(2)_150-151.nxml.txt.nlp	24579015	SENT9	12	12	4	4	resveratrol	ski		55733	0.651
NULL	Orphanet_J_Rare_Dis_2007_Jan_4_2_1.nxml.txt.nlp	17204147	SENT162	12	12	3	3	trypsin	SPINK1	PA451806	6690	0.651
NULL	Arthritis_Res_Ther_2010_Jul_7_12(4)_R131.nxml.txt.nlp	20609215	SENT213	28	28	9	9	iloprost	TLR2	PA164746843	7097	0.651
NULL	Case_Rep_Oncol_Med_2012_Nov_6_2012_164082.nxml.txt.nlp	23198199	SENT64	10	10	26	26	cyclophosphamide	ACTH	PA449165	5443	0.651
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_May_7_67(Pt_6)_o1313-o1314.nxml.txt.nlp	21754713	SENT75	22	22	17	17	ethanol	mol	PA448073	90527	0.651
NULL	Infect_Dis_Rep_2010_Feb_2_2(1)_e1.nxml.txt.nlp	24470884	SENT14	27	27	33	33	tigecycline	HAP	PA164746412	5915;10313	0.651
NULL	Cells_2012_Jun_29_1(3)_248-262.nxml.txt.nlp	24710475	SENT590	1	1	30	30	starch	GABARAPL1	PA451492	23710	0.651
NULL	Breast_Cancer_(Auckl)_2009_Sep_2_3_61-75.nxml.txt.nlp	19809577	SENT23	11	11	2	2	ethanol	EMD	PA448073	2010	0.651
NULL	Arthritis_Res_Ther_2004_Jun_21_6(4)_R384-R392.nxml.txt.nlp	15225374	SENT55	20	20	24	24	gentamicin	M-CSF	PA449753	1435	0.651
NULL	Br_J_Haematol_2008_Mar_3_144(5)_677-685.nxml.txt.nlp	19055662	SENT20	11	11	15	15	vincristine	CHOP	PA451879	1649	0.651
NULL	Biomed_Res_Int_2014_Jan_29_2014_876712.nxml.txt.nlp	24605339	SENT214	31	31	39	39	diazepam	GIV	PA449283	55704	0.651
NULL	Can_J_Infect_Dis_Med_Microbiol_2014_May-Jun_25(3)_155-158.nxml.txt.nlp	25285112	SENT80	27	27	29	29	levofloxacin	TMP	PA450214	2012	0.651
NULL	Indian_J_Endocrinol_Metab_2012_Mar-Apr_16(2)_324-325.nxml.txt.nlp	22470884	SENT11	31	31	37	37	sitagliptin	GLP-1	PA164748978	100125288	0.651
NULL	Diabetes_Care_2010_Apr_12_33(4)_861-868.nxml.txt.nlp	20067962	SENT133	34	34	27	27	hyaluronan	HMGB1	PA165958431	3146	0.651
NULL	Oncotarget_2010_Oct_9_1(6)_387-395.nxml.txt.nlp	21311095	SENT99	12	12	19	19	oxaliplatin	CD133	PA131285527	8842	0.651
NULL	Diabetes_Care_2011_Aug_16_34(8)_1778-1784.nxml.txt.nlp	21700918	SENT200	17	17	14	14	lipase	PCB	PA450239	5091	0.651
NULL	Front_Oncol_2014_Mar_6_4_40.nxml.txt.nlp	24639951	SENT47	14	14	20	20	cyclophosphamide	ETO	PA449165	862	0.651
NULL	Stroke_Res_Treat_2011_Nov_10_2011_212485.nxml.txt.nlp	22135769	SENT125	14	14	26	26	acenocoumarol	CYP2C18	PA452632	1562	0.651
NULL	Nat_Commun_2013_4_10_1038_ncomms2884.nxml.txt.nlp	23673639	SENT131	38	38	15	15	nadh	RNF	PA164755085	11074	0.651
NULL	Acta_Pharmacol_Sin_2013_Jun_8_34(6)_830-836.nxml.txt.nlp	23564080	SENT141	2	2	24	24	simvastatin	RAGE	PA451363	177	0.651
NULL	J_Oncol_2012_Nov_10_2012_358472.nxml.txt.nlp	22131994	SENT71	11	11	22	22	bevacizumab	EGFR	PA130232992	1956	0.651
NULL	Indian_J_Endocrinol_Metab_2013_Nov-Dec_17(6)_1046-1052.nxml.txt.nlp	24381882	SENT55	10	10	22	22	cosyntropin	ACTH	PA164749052	5443	0.651
NULL	Adv_Hematol_2010_Dec_2_2010_424786.nxml.txt.nlp	21188274	SENT22	5	5	15	15	cyclophosphamide	CHOP	PA449165	1649	0.651
NULL	Mol_Cancer_2010_Oct_12_9_269.nxml.txt.nlp	20939893	SENT127	35	35	15	15	isoproterenol	c-Jun	PA450121	3725	0.651
NULL	Clin_Epidemiol_2014_May_12_6_155-168.nxml.txt.nlp	24872722	SENT109	24	24	38	38	naproxen	OTC	PA450595	5009	0.651
NULL	Oncotarget_2013_Nov_22_5(4)_933-943.nxml.txt.nlp	24659749	SENT32	6	6	22	22	nutlin-3	AML2		864	0.651
NULL	Contemp_Clin_Dent_2012_Sep_3(Suppl_2)_S167-S171.nxml.txt.nlp	23230355	SENT94	25	25	20	20	ethanol	HEMA	PA448073	2157	0.651
NULL	J_Int_Soc_Sports_Nutr_2012_Apr_3_9_11.nxml.txt.nlp	22472466	SENT207	21	21	23	23	vasopressin	AVP	PA451858	114548;551	0.651
NULL	Emerg_Infect_Dis_2012_Jul_18(7)_1072-1080.nxml.txt.nlp	22709685	SENT147	8	8	24	24	linezolid	VISA	PA450233	57506	0.651
NULL	Oncotarget_2011_Sep_9_2(9)_658-668.nxml.txt.nlp	21911919	SENT117	16	16	9	9	cytarabine	HO-1	PA449177	3162	0.651
NULL	Curr_Neuropharmacol_2009_Jun_7(2)_83-95.nxml.txt.nlp	19949566	SENT445	46	46	32	32	zonisamide	TGB	PA451978	5473	0.651
NULL	Front_Endocrinol_(Lausanne)_2014_Oct_27_5_163.nxml.txt.nlp	25386163	SENT208	10	10	18	18	mecamylamine	ghrelin	PA450334	51738	0.651
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT9	11	11	6	6	atorvastatin	IL-6	PA448500	3569	0.651
NULL	J_Obes_2011_Apr_28_2011_587495.nxml.txt.nlp	21603273	SENT178	6	6	8	8	lipase	HSL	PA450239	3991	0.651
NULL	Cilia_2012_Sep_3_1_17.nxml.txt.nlp	23308345	SENT250	28	28	8	8	vasopressin	TRPV4	PA451858	59341	0.651
NULL	Database_(Oxford)_2013_Jul_18_2013_bat049.nxml.txt.nlp	23868908	SENT83	24	24	36	36	imatinib	NQO2	PA10804	4835	0.651
NULL	BMJ_2010_Feb_8_340_c693.nxml.txt.nlp	20142325	SENT187	3	3	20	20	tamoxifen	CYP2D6	PA451581	1565	0.651
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jul_17_66(Pt_8)_o2039.nxml.txt.nlp	21588348	SENT64	12	12	23	23	ethanol	mol	PA448073	90527	0.651
NULL	Mol_Cancer_2014_Jun_3_13_137.nxml.txt.nlp	24889938	SENT281	44	44	27	27	heparin	EGF	PA449855	1950	0.651
NULL	Oncotarget_2010_Oct_30_1(7)_639-650.nxml.txt.nlp	21317459	SENT3	25	25	20	20	nutlin-3	p53		7157	0.651
NULL	Oncogene_2014_Aug_28_33(35)_4396-4406.nxml.txt.nlp	24531714	SENT57	26	26	7	7	nutlin-3	MDM2		4193	0.651
NULL	J_Exerc_Nutrition_Biochem_2014_Sep_17_18(3)_267-275.nxml.txt.nlp	25566463	SENT29	25	25	13	13	creatine	ADP	PA164778930	23038	0.651
NULL	J_Hematol_Oncol_2009_Aug_12_2_36.nxml.txt.nlp	19674465	SENT78	0	0	32	32	lenalidomide	CTLA4	PA162363968	1493	0.651
NULL	Curr_Neuropharmacol_2008_Sep_6(3)_215-234.nxml.txt.nlp	19506722	SENT251	9	9	4	4	fluoxetine	NK-1	PA449673	27087	0.651
NULL	Braz_J_Med_Biol_Res_2012_Mar_30_45(4)_314-320.nxml.txt.nlp	22450372	SENT12	10	10	23	23	allopregnanolone	PAG	PA142320763	55824	0.651
NULL	Diabetes_2013_May_16_62(5)_1519-1526.nxml.txt.nlp	23274898	SENT31	20	20	2	2	nifedipine	ADP	PA450631	23038	0.651
NULL	Crit_Care_2012_Mar_2_16(2)_R37.nxml.txt.nlp	22386062	SENT12	13	13	0	0	oxygen	CENPV	PA450744	201161	0.651
NULL	Front_Neurol_2014_Sep_11_5_173.nxml.txt.nlp	25309501	SENT160	5	5	9	9	hyaluronan	HYAL1	PA165958431	3373	0.651
NULL	Nat_Med_2011_Apr_3_17(4)_454-460.nxml.txt.nlp	21460849	SENT161	7	7	18	18	paraformaldehyde	CT40	PA450790	54457	0.651
NULL	J_Cheminform_2012_Mar_8_4_6.nxml.txt.nlp	22401035	SENT247	19	19	21	21	troglitazone	PPARG	PA451799	5468	0.651
NULL	Pak_J_Med_Sci_2013_May-Jun_29(3)_788-792.nxml.txt.nlp	24353629	SENT78	12	12	20	20	cefdinir	CTX	PA164768739	1593	0.651
NULL	Oncoimmunology_2014_Jun_3_3_e29030.nxml.txt.nlp	25083328	SENT74	35	35	37	37	imiquimod	IFN	PA449972	3439	0.651
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_112-117.nxml.txt.nlp	23864844	SENT25	3	3	14	14	rituximab	CHOP	PA451261	1649	0.651
NULL	Int_J_Biol_Sci_2005_Apr_1_1(2)_51-66.nxml.txt.nlp	15951850	SENT83	8	8	5	5	thrombin	LARG	PA451674	23365	0.651
NULL	Eur_J_Histochem_2011_Mar_24_55(1)_e6.nxml.txt.nlp	21556121	SENT130	15	15	23	23	heparin	HRG	PA449855	3084;3273	0.651
NULL	Acta_Pharmacol_Sin_2014_Jun_4_35(6)_752-757.nxml.txt.nlp	24902786	SENT96	12	12	25	25	flutamide	STL2	PA449685	1301	0.651
NULL	Oncotarget_2013_Dec_15_4(12)_2577-2590.nxml.txt.nlp	24342878	SENT108	4	4	18	18	auranofin	KEAP1	PA448510	9817	0.651
NULL	Curr_Neuropharmacol_2014_Jul_12(4)_365-379.nxml.txt.nlp	25342944	SENT293	4	4	6	6	ethanol	5-HT1A	PA448073	3350	0.651
NULL	Genet_Mol_Biol_2009_Mar_1_Jan-Mar_32(1)_144-150.nxml.txt.nlp	21637660	SENT81	0	0	24	24	etoposide	ANOVA	PA449552	4858	0.651
NULL	Indian_Dermatol_Online_J_2014_Dec_5(Suppl_2)_S76-S86.nxml.txt.nlp	25593813	SENT285	23	23	13	13	carbamazepine	HLA-B	PA448785	3106	0.651
NULL	Eur_J_Clin_Pharmacol_2012_Jan_8_68(1)_29-37.nxml.txt.nlp	21739267	SENT0	21	21	23	23	aripiprazole	CYP2D6	PA10026	1565	0.651
NULL	Br_J_Cancer_2012_Aug_7_107(4)_639-645.nxml.txt.nlp	22805326	SENT175	5	5	2	2	pazopanib	VEGFR	PA165291492	3791	0.651
NULL	Diabetes_2011_Jun_21_60(6)_1770-1778.nxml.txt.nlp	21562078	SENT131	7	7	9	9	metformin	AMPK	PA450395	5563	0.651
NULL	Mol_Cancer_2012_Mar_21_11_13.nxml.txt.nlp	22436134	SENT372	10	10	5	5	doxorubicin	HuR	PA449412	1994	0.651
NULL	AMB_Express_2014_May_1_4_41.nxml.txt.nlp	24949274	SENT181	11	11	7	7	ethanol	CO2	PA448073	4513	0.651
NULL	Oncotarget_2010_Nov_22_1(7)_606-619.nxml.txt.nlp	21317456	SENT144	9	9	21	21	doxorubicin	RAD51	PA449412	5888	0.651
NULL	Biomed_Res_Int_2013_Nov_28_2013_789184.nxml.txt.nlp	24369535	SENT116	0	0	5	5	imatinib	CYP3A4	PA10804	1576	0.651
NULL	J_Infect_Dis_2014_Dec_15_210(12)_2001-2008.nxml.txt.nlp	24994911	SENT24	10	10	31	31	artemisinin	ACT	PA165111696	12;11332;9457;641455	0.651
NULL	Breast_Cancer_Res_2012_Jan_20_14(1)_R16.nxml.txt.nlp	22264274	SENT117	20	20	9	9	hyaluronidase	STAT1	PA164745713	6772	0.651
NULL	Diabetes_2013_Jun_17_62(6)_1816-1817.nxml.txt.nlp	23704523	SENT62	16	16	18	18	hyaluronan	CD44	PA165958431	960	0.651
NULL	J_Cancer_2013_Sep_27_4(8)_662-670.nxml.txt.nlp	24155778	SENT142	10	10	4	4	cisplatin	UCHL1	PA449014	7345	0.651
NULL	F1000Res_2013_Oct_8_2_173.nxml.txt.nlp	24555085	SENT238	9	9	31	31	ketoconazole	BDP	PA450146	10620;152926	0.651
NULL	Int_J_Mol_Sci_2010_Nov_17_11(11)_4660-4672.nxml.txt.nlp	21151462	SENT245	5	5	2	2	troglitazone	gamma	PA451799	9913	0.651
NULL	Breast_Cancer_Res_2008_Dec_5_10(6)_R104.nxml.txt.nlp	19061505	SENT191	14	14	17	17	estradiol	Bcl-2	PA449503	596	0.651
NULL	Eur_J_Clin_Pharmacol_2014_Oct_8_70(12)_1433-1441.nxml.txt.nlp	25291992	SENT127	7	7	11	11	risperidone	OCM	PA451257	654231	0.651
NULL	J_Korean_Med_Sci_2008_Aug_25_23(4)_657-661.nxml.txt.nlp	18756053	SENT72	23	23	18	18	estradiol	AMH	PA449503	268	0.651
NULL	Mol_Biol_Cell_2014_May_15_25(10)_1641-1652.nxml.txt.nlp	24648491	SENT15	41	41	14	14	cisplatin	NPM1	PA449014	4869	0.651
NULL	Eur_J_Med_Chem_2011_Nov_46(11)_5456-5464.nxml.txt.nlp	21940073	SENT93	7	7	11	11	cisplatin	CH1	PA449014	51430	0.651
NULL	Breast_Cancer_Res_2010_Nov_16_12(6)_R96.nxml.txt.nlp	21080941	SENT307	18	18	10	10	lapatinib	HRG	PA152241907	3084;3273	0.651
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT166	31	31	8	8	pp2	PP2		4888	0.651
NULL	Mol_Microbiol_2013_Aug_27_89(3)_420-432.nxml.txt.nlp	23750752	SENT59	2	2	6	6	lipase	MCOLN1	PA450239	57192	0.651
NULL	Lipids_Health_Dis_2011_Feb_28_10_38.nxml.txt.nlp	21352602	SENT92	5	5	8	8	atorvastatin	PCSK9	PA448500	255738	0.651
NULL	Breast_Cancer_Res_2008_Dec_18_10(Suppl_4)_S18.nxml.txt.nlp	19128431	SENT39	40	40	33	33	tamoxifen	LBA	PA451581	987	0.651
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT277	28	28	3	3	neratinib	EGFR	PA165291472	1956	0.651
NULL	Cancers_(Basel)_2012_Jun_18_4(2)_581-600.nxml.txt.nlp	24213326	SENT362	1	1	5	5	cyclophosphamide	CD4	PA449165	920	0.651
NULL	Evid_Based_Complement_Alternat_Med_2011_Jan_20_2011_751671.nxml.txt.nlp	21318106	SENT8	25	25	14	14	tacrolimus	P-gp	PA451578	5243	0.651
NULL	Cell_Commun_Signal_2009_Sep_8_7_23.nxml.txt.nlp	19737400	SENT76	32	32	30	30	coumarin	CPTIC	PA134521193	126129	0.651
NULL	Oncoimmunology_2012_Sep_1_1(6)_957-958.nxml.txt.nlp	23162770	SENT21	17	17	11	11	trastuzumab	CD137	PA451743	3604	0.651
NULL	Ann_Med_2014_Nov_21_46(7)_475-489.nxml.txt.nlp	25045928	SENT452	17	17	7	7	clopidogrel	CYP2C19	PA449053	1557	0.651
NULL	Ann_Saudi_Med_2011_Jul-Aug_31(4)_402-406.nxml.txt.nlp	21727749	SENT26	12	12	8	8	sitagliptin	GLP-1	PA164748978	100125288	0.651
NULL	Biomed_Res_Int_2014_May_13_2014_348647.nxml.txt.nlp	24949436	SENT62	16	16	9	9	chlorhexidine	PV1	PA164776863	83483	0.651
NULL	Eur_J_Med_Res_2009_Jul_22_14(7)_309-314.nxml.txt.nlp	19661014	SENT178	6	6	19	19	clarithromycin	IL-8	PA449028	3576	0.651
NULL	Oncotarget_2014_Oct_18_5(22)_11588-11603.nxml.txt.nlp	25473890	SENT181	21	21	34	34	imatinib	AMACR	PA10804	23600	0.651
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Apr_13_67(Pt_5)_o1081.nxml.txt.nlp	21754403	SENT52	8	8	18	18	ethanol	mol	PA448073	90527	0.651
NULL	J_Cancer_Res_Clin_Oncol_2012_Sep_3_138(9)_1569-1577.nxml.txt.nlp	22552718	SENT135	5	5	1	1	tamoxifen	ATAC	PA451581	6375	0.651
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1196-1204.nxml.txt.nlp	22315058	SENT18	20	20	1	1	cetuximab	EGFR	PA10040	1956	0.651
NULL	Mol_Cancer_2013_May_24_12_47.nxml.txt.nlp	23705854	SENT224	0	0	5	5	celecoxib	P-gp	PA448871	5243	0.651
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT2379	2	2	6	6	phenacetin	CYP2C9	PA450897	1559	0.651
NULL	Org_Med_Chem_Lett_2012_Oct_24_2_33.nxml.txt.nlp	23095284	SENT57	9	9	45	45	ethanol	flower	PA448073	11094	0.651
NULL	Cancer_Immunol_Immunother_2012_May_28_61(5)_655-665.nxml.txt.nlp	22033581	SENT75	30	30	18	18	cyclosporine	IL-4	PA449167	3565	0.651
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_11_2013_987612.nxml.txt.nlp	23840275	SENT236	21	21	3	3	geldanamycin	Bcl-2	PA152031327	596	0.651
NULL	Emerg_Infect_Dis_2012_Sep_18(9)_1515-1518.nxml.txt.nlp	22932671	SENT35	12	12	29	29	tetracycline	PROC	PA451640	5624	0.651
NULL	Mol_Cancer_2009_Aug_25_8_66.nxml.txt.nlp	19706164	SENT234	12	12	6	6	celecoxib	p53	PA448871	7157	0.651
NULL	Behav_Brain_Funct_2005_Aug_9_1_14.nxml.txt.nlp	16091141	SENT298	5	5	8	8	chlorpromazine	CPZ	PA448964	8532	0.651
NULL	Emerg_Infect_Dis_2011_Mar_17(3)_510-513.nxml.txt.nlp	21392446	SENT53	14	14	36	36	rifampin	ETO	PA451250	862	0.651
NULL	Arthritis_Res_Ther_2010_Apr_29_12(2)_R73.nxml.txt.nlp	20429888	SENT13	0	0	7	7	bortezomib	COL1A1	PA10252	1277	0.651
NULL	Crit_Care_2011_Jan_17_15(1)_R23.nxml.txt.nlp	21241489	SENT12	25	25	18	18	enoxaparin	PPIC	PA449463	5480	0.651
NULL	Mol_Pain_2013_Jun_10_9_27.nxml.txt.nlp	23758830	SENT60	21	21	18	18	tetracaine	ASIC3	PA451638	9311	0.651
NULL	J_Cardiothorac_Surg_2013_Apr_29_8_115.nxml.txt.nlp	23628179	SENT67	15	15	2	2	bivalirudin	ACT	PA10032	12;11332;9457;641455	0.651
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Apr_7_9_12.nxml.txt.nlp	20374640	SENT102	12	12	6	6	tetracycline	CHL	PA451640	91851	0.651
NULL	Arthritis_Res_Ther_2007_Oct_9_9(5)_R104.nxml.txt.nlp	17925024	SENT147	9	9	20	20	glucosamine	p38	PA164747613	10598;1432;7965	0.651
NULL	Int_J_Alzheimers_Dis_2012_Apr_4_2012_258454.nxml.txt.nlp	22548198	SENT229	3	3	7	7	estradiol	alpha-synuclein	PA449503	6622	0.651
NULL	Biochem_Res_Int_2012_Feb_12_2012_346972.nxml.txt.nlp	22400115	SENT267	4	4	11	11	hyaluronan	CD44	PA165958431	960	0.651
NULL	Bone_2014_Sep_66(100)_240-250.nxml.txt.nlp	24971713	SENT397	4	4	26	26	clodronate	OCN	PA10239	632	0.651
NULL	Indian_J_Dermatol_2014_Nov-Dec_59(6)_630b.nxml.txt.nlp	25484410	SENT114	12	12	19	19	isotretinoin	B12	PA450128	7126;4709	0.651
NULL	J_Gen_Physiol_1958_Sep_20_42(1)_29-37.nxml.txt.nlp	13575772	SENT0	11	11	1	1	meprobamate	Gen	PA450377	348654	0.651
NULL	J_Oncol_2013_Apr_29_2013_854121.nxml.txt.nlp	23737784	SENT79	23	23	26	26	trastuzumab	BCS	PA451743	617	0.651
NULL	Front_Neurol_2014_Sep_11_5_173.nxml.txt.nlp	25309501	SENT254	22	22	24	24	hyaluronan	RHAMM	PA165958431	3161	0.651
NULL	Angiogenesis_2010_Dec_7_13(4)_305-315.nxml.txt.nlp	20927579	SENT202	9	9	19	19	resveratrol	HIF-1		29072	0.651
NULL	Biosci_Rep_2012_Dec_20_33(1)_e00011.nxml.txt.nlp	23137297	SENT135	18	18	5	5	heparin	RPSA	PA449855	3921	0.651
NULL	Adv_Hematol_2012_Mar_8_2012_856341.nxml.txt.nlp	22496694	SENT111	10	10	20	20	rivaroxaban	TKR	PA165958360	8277	0.651
NULL	Diabetes_2011_Jun_21_60(6)_1797-1804.nxml.txt.nlp	21536946	SENT139	10	10	16	16	diazoxide	SUR1	PA449285	6833	0.651
NULL	ScientificWorldJournal_2014_Mar_12_2014_731462.nxml.txt.nlp	24715817	SENT167	3	3	13	13	diclofenac	IL-6	PA449293	3569	0.651
NULL	Bioinformation_2012_Jan_6_8(1)_13-19.nxml.txt.nlp	22359429	SENT138	14	14	6	6	calcein	MRP1	PA132595336	4437	0.651
NULL	Crit_Care_2009_Jun_23_13(3)_R98.nxml.txt.nlp	19549333	SENT24	21	21	23	23	vasopressin	AVP	PA451858	114548;551	0.651
NULL	Cancer_Med_2013_Jun_25_2(3)_277-285.nxml.txt.nlp	23930204	SENT110	8	8	16	16	bevacizumab	PTEN	PA130232992	5728	0.651
NULL	Front_Genet_2012_Nov_5_3_236.nxml.txt.nlp	23133441	SENT10	12	12	6	6	efavirenz	ABCB1	PA449441	5243	0.651
NULL	Mol_Cancer_2008_Jun_3_7_47.nxml.txt.nlp	18519000	SENT230	33	33	29	29	gefitinib	EGF	PA131301952	1950	0.651
NULL	Virol_J_2010_May_26_7_107.nxml.txt.nlp	20504321	SENT184	21	21	0	0	nadh	NDUFS1	PA164755085	4719	0.651
NULL	Curr_Neuropharmacol_2009_Jun_7(2)_83-95.nxml.txt.nlp	19949566	SENT515	2	2	32	32	carbamazepine	TGB	PA448785	5473	0.651
NULL	Biomed_Res_Int_2014_Jun_3_2014_732516.nxml.txt.nlp	24995326	SENT97	5	5	22	22	trypsin	San	PA451806	80218	0.651
NULL	Br_J_Cancer_2011_Jul_26_105(3)_407-412.nxml.txt.nlp	21730976	SENT69	2	2	7	7	pha-665752	STAT3		6774	0.651
NULL	Chemother_Res_Pract_2011_Dec_18_2011_965826.nxml.txt.nlp	22295208	SENT278	8	8	10	10	azacitidine	ACT	PA451996	12;11332;9457;641455	0.651
NULL	Clin_Med_Insights_Case_Rep_2014_Oct_1_7_117-121.nxml.txt.nlp	25336995	SENT88	4	4	11	11	cyclophosphamide	CHOP	PA449165	1649	0.651
NULL	Int_J_Mol_Sci_2014_Mar_5_15(3)_3970-3988.nxml.txt.nlp	24603537	SENT365	0	0	5	5	curcumin	HO-1	PA151958596	3162	0.651
NULL	Int_J_Mol_Sci_2014_Oct_22_15(10)_19183-19202.nxml.txt.nlp	25340982	SENT153	6	6	17	17	curcumin	p53	PA151958596	7157	0.651
NULL	Neural_Comput_Appl_2010_Jul_9_19(5)_667-676.nxml.txt.nlp	20651904	SENT248	17	17	4	4	oxygen	BOD	PA450744	10018	0.651
NULL	Oncotarget_2012_Nov_17_4(1)_18-28.nxml.txt.nlp	23248157	SENT100	18	18	13	13	pargyline	CD133	PA450797	8842	0.651
NULL	Eur_J_Immunol_2014_Jun_10_44(6)_1759-1769.nxml.txt.nlp	24595810	SENT34	14	14	6	6	fludrocortisone	CD4	PA164743961	920	0.651
NULL	J_Orthop_Traumatol_2013_Jun_23_14(2)_143-145.nxml.txt.nlp	22358780	SENT27	23	23	33	33	pyrazinamide	ETB	PA451182	1910	0.651
NULL	Int_J_Environ_Res_Public_Health_2010_May_27_7(5)_1872-1888.nxml.txt.nlp	20622998	SENT259	19	19	13	13	naltrexone	OPRM1	PA450588	4988	0.651
NULL	Leukemia_2013_Apr_14_27(4)_803-812.nxml.txt.nlp	23238589	SENT153	31	31	38	38	nilotinib	IFN	PA165958345	3439	0.651
NULL	Oncol_Lett_2014_Sep_11_8(3)_1222-1228.nxml.txt.nlp	25120693	SENT156	11	11	5	5	olaparib	DDP		1678	0.651
NULL	Front_Immunol_2012_May_4_3_103.nxml.txt.nlp	22566975	SENT637	1	1	5	5	cyclophosphamide	CD4	PA449165	920	0.651
NULL	Aging_(Albany_NY)_2014_Oct_30_6(10)_788-819.nxml.txt.nlp	25411230	SENT242	2	2	11	11	entacapone	COMT	PA164748726	1312	0.651
NULL	Nat_Commun_2014_Dec_8_5_5736.nxml.txt.nlp	25484020	SENT612	2	2	37	37	anastrozole	ATAC	PA448432	6375	0.651
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1063.nxml.txt.nlp	24556678	SENT36	0	0	8	8	thioridazine	Mcl-1	PA451666	4170	0.651
NULL	Arthritis_Res_Ther_2013_Jul_9_15(4)_R73.nxml.txt.nlp	23837669	SENT302	3	3	15	15	colchicine	MICL	PA449092	160364	0.651
NULL	J_Biol_Chem_2008_Oct_31_283(44)_29841-29846.nxml.txt.nlp	18765669	SENT40	8	8	30	30	suramin	HEK	PA10292	2042	0.651
NULL	Case_Rep_Transplant_2013_Jun_13_2013_375263.nxml.txt.nlp	23844312	SENT92	6	6	4	4	phenytoin	CYP3A4	PA450947	1576	0.651
NULL	Eur_J_Epidemiol_2009_Sep_2_24(9)_553-572.nxml.txt.nlp	19728115	SENT1527	10	10	25	25	coumarin	PAGM	PA134521193	5238	0.651
NULL	Crit_Rev_Toxicol_2013_Mar_13_43(3)_200-219.nxml.txt.nlp	23405971	SENT378	6	6	10	10	estradiol	aromatase	PA449503	1588	0.651
NULL	J_Antimicrob_Chemother_2014_Mar_29_69(3)_643-650.nxml.txt.nlp	24169580	SENT151	10	10	0	0	norfloxacin	CPZ	PA450654	8532	0.651
NULL	Oncotarget_2014_Feb_7_5(3)_775-787.nxml.txt.nlp	24519956	SENT122	23	23	26	26	docetaxel	PC3	PA449383	57332;7832;5122	0.651
NULL	ScientificWorldJournal_2012_Apr_29_2012_718791.nxml.txt.nlp	22649316	SENT4	18	18	25	25	sulfamethoxazole	TMP	PA451544	2012	0.651
NULL	Oncotarget_2014_Jun_19_5(15)_6540-6551.nxml.txt.nlp	25153728	SENT96	13	13	21	21	paclitaxel	p16	PA450761	1029	0.651
NULL	J_Immunother_Cancer_2013_Nov_7_1(Suppl_1)_P183.nxml.txt.nlp	NULL	SENT9	2	2	26	26	sunitinib	CEA	PA162372840	5670;1087	0.651
NULL	Exp_Diabetes_Res_2009_Jul_7_2009_910783.nxml.txt.nlp	19609456	SENT174	22	22	33	33	rosiglitazone	AMPK	PA451283	5563	0.651
NULL	Front_Oncol_2013_Oct_31_3_273.nxml.txt.nlp	24199173	SENT845	17	17	15	15	docetaxel	p53	PA449383	7157	0.651
NULL	Oncotarget_2013_Nov_24_4(12)_2430-2438.nxml.txt.nlp	24280348	SENT4	2	2	14	14	gefitinib	SOCS3	PA131301952	9021	0.651
NULL	Ecancermedicalscience_2008_Aug_15_2_91.nxml.txt.nlp	22275974	SENT263	1	1	5	5	cyclophosphamide	CD4	PA449165	920	0.651
NULL	Cancers_(Basel)_2010_Apr_21_2(2)_653-669.nxml.txt.nlp	24281087	SENT76	14	14	8	8	doxorubicin	HMGA2	PA449412	8091	0.651
NULL	Mol_Cancer_2012_Jul_12_11_45.nxml.txt.nlp	22788833	SENT96	2	2	8	8	cisplatin	EGFR	PA449014	1956	0.651
NULL	Front_Oncol_2014_Jun_3_4_132.nxml.txt.nlp	24918087	SENT376	30	30	21	21	leucovorin	TP53	PA450198	7157	0.651
NULL	Clin_Med_Insights_Case_Rep_2012_Feb_16_5_13-17.nxml.txt.nlp	22399868	SENT30	4	4	6	6	adalimumab	CD4	PA10004	920	0.651
NULL	Indian_J_Med_Res_2011_Sep_134(3)_295-301.nxml.txt.nlp	21985811	SENT111	6	6	28	28	phenytoin	CYP3A4	PA450947	1576	0.651
NULL	Arthritis_Res_Ther_2014_Apr_11_16(2)_R93.nxml.txt.nlp	24725461	SENT6	20	20	5	5	estradiol	CYP19A1	PA449503	1588	0.651
NULL	J_Invest_Dermatol_2014_Jun_17_134(6)_1589-1598.nxml.txt.nlp	24499735	SENT75	1	1	10	10	lipase	ATGL	PA450239	57104	0.651
NULL	Front_Immunol_2013_Nov_7_4_360.nxml.txt.nlp	24223576	SENT207	7	7	0	0	imiquimod	CCR7	PA449972	1236	0.651
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Nov_11_65(Pt_12)_o3062.nxml.txt.nlp	21578792	SENT85	29	29	25	25	ethanol	mol	PA448073	90527	0.651
NULL	Br_J_Ophthalmol_2008_Sep_22_92(9)_1275-1282.nxml.txt.nlp	18723745	SENT22	20	20	24	24	latanoprost	BAK	PA164774763	578	0.651
NULL	Cancer_Cell_Int_2014_Jul_2_14_59.nxml.txt.nlp	25120382	SENT159	12	12	14	14	metformin	Met	PA450395	79811	0.651
NULL	Brain_Sci_2012_Nov_7_2(4)_589-604.nxml.txt.nlp	24349762	SENT22	1	1	3	3	vasopressin	AVP	PA451858	114548;551	0.65
NULL	Biomed_Res_Int_2014_May_4_2014_351252.nxml.txt.nlp	24877084	SENT119	12	12	14	14	bevacizumab	FTM	PA130232992	23322	0.65
NULL	J_Neurol_Sci_2012_Nov_15_322(1-2)_92-95.nxml.txt.nlp	22819352	SENT139	12	12	14	14	ethanol	spatial	PA448073	219793	0.65
NULL	J_Biol_Chem_2008_Nov_14_283(46)_31679-31689.nxml.txt.nlp	18755684	SENT30	6	6	20	20	iron	FTL	PA450087	2512	0.65
NULL	Arthritis_Res_Ther_2008_Mar_18_10(2)_R35.nxml.txt.nlp	18348730	SENT98	7	7	14	14	fluorescein	HEX	PA164746009	3087	0.65
NULL	Open_AIDS_J_2011_Apr_22_5_44-50.nxml.txt.nlp	21643422	SENT39	20	20	22	22	atazanavir	ATV	PA10251	4683	0.65
NULL	Breast_Cancer_Res_2011_Nov_30_13(6)_R123.nxml.txt.nlp	22129105	SENT192	10	10	42	42	trastuzumab	HER2	PA451743	2064	0.65
NULL	Cancer_Med_2014_Oct_10_3(5)_1275-1283.nxml.txt.nlp	24913924	SENT280	23	23	8	8	vemurafenib	BRAF	PA165946873	673	0.65
NULL	Front_Neurol_2014_Sep_11_5_173.nxml.txt.nlp	25309501	SENT27	39	39	44	44	hyaluronan	HAS2	PA165958431	3037	0.65
NULL	Arthritis_Res_Ther_2014_Jul_18_16(4)_R153.nxml.txt.nlp	25037855	SENT13	6	6	25	25	adalimumab	CD14	PA10004	929	0.65
NULL	Diabetes_2011_Jul_20_60(7)_1861-1871.nxml.txt.nlp	21593203	SENT351	9	9	27	27	colesevelam	GLP-1	PA449095	100125288	0.65
NULL	Acta_Pharmacol_Sin_2011_Jun_30_32(6)_853-860.nxml.txt.nlp	21623392	SENT148	12	12	22	22	capsaicin	TRPV1	PA448776	7442	0.65
NULL	Cell_Oncol_(Dordr)_2011_Oct_4_34(5)_489-494.nxml.txt.nlp	21541733	SENT223	8	8	2	2	tamoxifen	ESR1	PA451581	2099	0.65
NULL	Evid_Based_Complement_Alternat_Med_2013_Aug_22_2013_423164.nxml.txt.nlp	24027594	SENT196	19	19	24	24	berberine	AP-1	PA165860812	2353;3727;2354;3725	0.65
NULL	Indian_J_Pharmacol_2009_Aug_41(4)_167-172.nxml.txt.nlp	20523867	SENT40	42	42	19	19	acetaminophen	CYP2A6	PA448015	1548	0.65
NULL	Breast_Cancer_(Auckl)_2009_Aug_17_3_47-60.nxml.txt.nlp	21556249	SENT281	22	22	26	26	tamoxifen	STAR	PA451581	6770;2984	0.65
NULL	Oncotarget_2011_May_16_2(5)_418-421.nxml.txt.nlp	21789791	SENT18	13	13	11	11	bortezomib	TRAIL	PA10252	8743	0.65
NULL	Org_Biomol_Chem_2014_Oct_7_12(37)_7261-7269.nxml.txt.nlp	25103319	SENT154	6	6	12	12	trastuzumab	HER2	PA451743	2064	0.65
NULL	Chin_J_Cancer_2012_Feb_31(2)_51-57.nxml.txt.nlp	22257384	SENT67	0	0	11	11	verapamil	P-gp	PA451868	5243	0.65
NULL	Arthritis_Res_Ther_2012_Dec_13_14(6)_R269.nxml.txt.nlp	23237573	SENT43	16	16	25	25	thrombin	C5a	PA451674	727	0.65
NULL	Arthritis_Rheumatol_2014_Jun_27_66(6)_1574-1582.nxml.txt.nlp	24577881	SENT151	16	16	23	23	hydralazine	CD4	PA449894	920	0.65
NULL	Breast_Cancer_Res_Treat_2012_Jul_8_134(2)_617-624.nxml.txt.nlp	22678156	SENT195	19	19	11	11	trastuzumab	San	PA451743	80218	0.65
NULL	Indian_J_Pharm_Sci_2008_Jul-Aug_70(4)_431-439.nxml.txt.nlp	20046766	SENT85	8	8	14	14	propranolol	P-gp	PA451145	5243	0.65
NULL	Int_J_Mol_Sci_2014_Nov_10_15(11)_20607-20637.nxml.txt.nlp	25391045	SENT40	27	27	24	24	fluvastatin	CYP3A4	PA449688	1576	0.65
NULL	J_Adv_Pract_Oncol_2012_May_1_May-Jun_3(3)_161-169.nxml.txt.nlp	25031942	SENT309	10	10	15	15	ifosfamide	TIC	PA449964	23550	0.65
NULL	Arthritis_Res_Ther_2007_May_30_9(3)_212.nxml.txt.nlp	17561993	SENT161	6	6	13	13	capsaicin	TRPV1	PA448776	7442	0.65
NULL	J_Cell_Biol_2007_Apr_23_177(2)_265-275.nxml.txt.nlp	17452530	SENT348	37	37	34	34	imiquimod	TLR4	PA449972	7099	0.65
NULL	eLife_2014_May_7_3_e02536.nxml.txt.nlp	24843004	SENT371	14	14	16	16	genistein	TRPC3	PA165109660	7222	0.65
NULL	Indian_J_Dermatol_2010_Apr-Jun_55(2)_161-170.nxml.txt.nlp	20606887	SENT51	1	1	7	7	ustekinumab	p40	PA166048654	3921;339541;10314	0.65
NULL	Diabetes_2009_Dec_31_58(12)_2851-2862.nxml.txt.nlp	19720788	SENT212	39	39	7	7	forskolin	XIAP	PA146096022	331	0.65
NULL	N_Z_Vet_J_2010_Jun_7_58(3)_121-129.nxml.txt.nlp	20514085	SENT42	19	19	36	36	levamisole	MOX	PA450205	26002	0.65
NULL	Database_(Oxford)_2013_Jul_18_2013_bat049.nxml.txt.nlp	23868908	SENT244	6	6	14	14	imatinib	NQO2	PA10804	4835	0.65
NULL	Core_Evid_2007_Nov_30_2(2)_81-88.nxml.txt.nlp	21221177	SENT201	29	29	12	12	oxaliplatin	EGFR	PA131285527	1956	0.65
NULL	Nat_Med_2011_Jun_26_17(7)_875-882.nxml.txt.nlp	21706030	SENT70	4	4	6	6	doxycycline	BRCA1	PA449415	672	0.65
NULL	Int_J_Biol_Sci_2012_Jan_6_8(2)_249-257.nxml.txt.nlp	22253568	SENT200	7	7	3	3	lipase	IL-22	PA450239	50616;53342	0.65
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT207	9	9	4	4	midazolam	CYP3A	PA450496	1574	0.65
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_May_7_65(Pt_6)_o1229.nxml.txt.nlp	21583097	SENT72	30	30	21	21	ethanol	mol	PA448073	90527	0.65
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Jun_18_70(Pt_7)_o788.nxml.txt.nlp	25161573	SENT71	14	14	9	9	ethanol	mol	PA448073	90527	0.65
NULL	Breast_Cancer_Res_2011_Jan_24_13(1)_401.nxml.txt.nlp	21349137	SENT39	37	37	20	20	lapatinib	HER2	PA152241907	2064	0.65
NULL	Oncoimmunology_2012_Nov_1_1(8)_1248-1257.nxml.txt.nlp	23243588	SENT216	6	6	26	26	clodronate	MCP-1	PA10239	6347	0.65
NULL	Ann_Rheum_Dis_2014_Jan_5_73(1)_238-242.nxml.txt.nlp	23740234	SENT144	14	14	10	10	infliximab	IMPACT	PA452639	55364	0.65
NULL	Case_Rep_Endocrinol_2014_Nov_6_2014_693294.nxml.txt.nlp	25431697	SENT36	27	27	29	29	vasopressin	AVP	PA451858	114548;551	0.65
NULL	Cancer_Immunol_Immunother_2012_Jul_23_61(7)_1101-1111.nxml.txt.nlp	22193989	SENT155	7	7	5	5	oxaliplatin	IL-4	PA131285527	3565	0.65
NULL	Indian_J_Endocrinol_Metab_2012_May-Jun_16(3)_343-348.nxml.txt.nlp	22629497	SENT6	34	34	8	8	teriparatide	PTH	PA451620	5741	0.65
NULL	Arch_Med_Sci_2012_Jul_4_8(3)_471-476.nxml.txt.nlp	22852002	SENT115	15	15	25	25	rosiglitazone	IL-6	PA451283	3569	0.65
NULL	J_Gen_Physiol_1979_Jul_1_74(1)_71-84.nxml.txt.nlp	479822	SENT0	17	17	1	1	picrotoxin	Gen	PA164777007	348654	0.65
NULL	Br_J_Cancer_2010_Jun_29_103(1)_6-11.nxml.txt.nlp	20551960	SENT28	13	13	15	15	doxorubicin	ADM	PA449412	133	0.65
NULL	Leukemia_2013_Apr_14_27(4)_803-812.nxml.txt.nlp	23238589	SENT3	32	32	21	21	imatinib	IFN	PA10804	3439	0.65
NULL	J_Cell_Biol_2000_Feb_21_148(4)_811-824.nxml.txt.nlp	10684261	SENT163	10	10	3	3	thrombin	syndecan	PA451674	6382	0.65
NULL	Mol_Cancer_2014_Jun_16_13_152.nxml.txt.nlp	24935000	SENT65	7	7	39	39	everolimus	p27	PA164746311	5715;10534	0.65
NULL	Oncogenesis_2012_Apr_16_1(4)_e7.nxml.txt.nlp	23552604	SENT259	8	8	6	6	etoposide	CTRL	PA449552	1506	0.65
NULL	J_Cell_Biol_2004_Jun_21_165(6)_893-902.nxml.txt.nlp	15197174	SENT15	33	33	31	31	trifluoperazine	TFP	PA451771	7034	0.65
NULL	Indian_J_Nephrol_2008_Jul_18(3)_95-100.nxml.txt.nlp	20142913	SENT102	10	10	4	4	vasopressin	AQP2	PA451858	359	0.65
NULL	Acta_Pharmacol_Sin_2010_Mar_22_31(3)_329-340.nxml.txt.nlp	20173759	SENT29	12	12	15	15	ethanol	AMPK	PA448073	5563	0.65
NULL	Eur_J_Neurosci_2012_Apr_35(8)_1368-1380.nxml.txt.nlp	22512261	SENT427	23	23	13	13	ethanol	gamma	PA448073	9913	0.65
NULL	Emerg_Infect_Dis_2013_Jan_19(1)_133-136.nxml.txt.nlp	23260464	SENT42	38	38	20	20	imipenem	TOB	PA449968	10140	0.65
NULL	Cell_Cycle_2012_Aug_15_11(16)_3067-3078.nxml.txt.nlp	22871739	SENT258	12	12	3	3	epirubicin	p53	PA449476	7157	0.65
NULL	Int_J_Endocrinol_2010_May_26_2010_906163.nxml.txt.nlp	20585352	SENT91	40	40	44	44	cinacalcet	MEN1	PA164776671	4221	0.65
NULL	New_Microbes_New_Infect_2014_May_4_2(3)_58-63.nxml.txt.nlp	25356345	SENT100	38	38	8	8	imipenem	CTX	PA449968	1593	0.65
NULL	Arthritis_Res_Ther_2007_Nov_12_9(6)_R118.nxml.txt.nlp	17997858	SENT236	10	10	6	6	hyaluronan	LYVE-1	PA165958431	10894	0.65
NULL	Orphanet_J_Rare_Dis_2014_Dec_24_9(1)_213.nxml.txt.nlp	NULL	SENT72	30	30	14	14	thrombin	ADP	PA451674	23038	0.65
NULL	Curr_Hepat_Rep_2010_May_21_9(2)_75-90.nxml.txt.nlp	20461127	SENT375	5	5	13	13	entecavir	LAM	PA164784025	7249;7248	0.65
NULL	Breast_Cancer_Res_2002_Aug_27_4(6)_213-217.nxml.txt.nlp	12473165	SENT5	6	6	28	28	tamoxifen	ATAC	PA451581	6375	0.65
NULL	Mar_Drugs_2011_Feb_8_9(2)_196-223.nxml.txt.nlp	21566795	SENT242	19	19	25	25	carrageenan	TLR4	PA448814	7099	0.65
NULL	J_Cancer_2012_Nov_30_4(1)_3-11.nxml.txt.nlp	23386900	SENT93	7	7	26	26	paclitaxel	CD11b	PA450761	3684	0.65
NULL	Exp_Ther_Med_2014_Oct_24_8(4)_1092-1096.nxml.txt.nlp	25187802	SENT124	2	2	12	12	carvedilol	TLR4	PA448817	7099	0.65
NULL	Cases_J_2009_Jul_9_2_7466.nxml.txt.nlp	19829971	SENT24	17	17	11	11	dobutamine	DST	PA449381	667	0.65
NULL	Cancers_(Basel)_2010_Dec_23_3(1)_17-42.nxml.txt.nlp	24212604	SENT928	14	14	12	12	paclitaxel	PPX	PA450761	5531	0.65
NULL	Apoptosis_2014_Aug_26_19(11)_1603-1615.nxml.txt.nlp	25156145	SENT160	2	2	0	0	mitomycin	TRAIL	PA450524	8743	0.65
NULL	Front_Genet_2013_Aug_29_4_163.nxml.txt.nlp	24009622	SENT205	19	19	27	27	ethanol	DDP	PA448073	1678	0.65
NULL	J_Korean_Med_Sci_2005_Jun_30_20(3)_456-460.nxml.txt.nlp	15953869	SENT13	2	2	20	20	lipase	UPP2	PA450239	151531	0.65
NULL	Arthritis_Res_2002_Nov_23_4(3)_157-164.nxml.txt.nlp	12010565	SENT147	32	32	18	18	collagenase	p38	PA449107	10598;1432;7965	0.65
NULL	Mol_Cell_Endocrinol_2013_Jan_30_365(2)_303-308.nxml.txt.nlp	23178796	SENT155	0	0	7	7	rimonabant	ghrelin	PA152407999	51738	0.65
NULL	J_Viral_Hepat_2009_May_16(5)_315-324.nxml.txt.nlp	19243499	SENT95	30	30	34	34	imiquimod	IFN	PA449972	3439	0.65
NULL	Arch_Med_Sci_2011_Feb_8_7(1)_27-33.nxml.txt.nlp	22291729	SENT141	18	18	8	8	doxorubicin	CHOP	PA449412	1649	0.65
NULL	Curr_Opin_Oncol_2014_Jul_6_26(4)_428-433.nxml.txt.nlp	24840521	SENT158	32	32	26	26	temozolomide	PARP	PA451609	142	0.65
NULL	Diagn_Pathol_2013_Jul_31_8_123.nxml.txt.nlp	23902646	SENT206	19	19	12	12	pioglitazone	B12	PA450970	7126;4709	0.65
NULL	Crit_Care_2011_Jun_10_15(3)_R146.nxml.txt.nlp	21663616	SENT296	3	3	25	25	aprotinin	IL-18	PA448472	3606	0.65
NULL	EMBO_Mol_Med_2012_Jun_13_4(6)_515-527.nxml.txt.nlp	22416035	SENT224	14	14	6	6	olaparib	p53		7157	0.65
NULL	Target_Oncol_2013_Jun_27_8(2)_127-136.nxml.txt.nlp	23625191	SENT105	12	12	16	16	panitumumab	KRAS	PA162373091	3845	0.65
NULL	Tuberc_Respir_Dis_(Seoul)_2013_Jan_31_74(1)_1-6.nxml.txt.nlp	23390446	SENT71	21	21	32	32	azathioprine	NAC	PA448515	22861	0.65
NULL	Acta_Neuropathol_Commun_2014_Jan_2_2_3.nxml.txt.nlp	24383546	SENT270	13	13	16	16	resveratrol	SIRT1		23411	0.65
NULL	Onco_Targets_Ther_2014_Nov_21_7_2143-2146.nxml.txt.nlp	25473295	SENT11	6	6	9	9	irinotecan	UGT1A1	PA450085	54658	0.65
NULL	Br_J_Cancer_1998_Apr_77(8)_1311-1317.nxml.txt.nlp	9579838	SENT12	36	36	24	24	tamoxifen	IL-2	PA451581	3558	0.65
NULL	Cancers_(Basel)_2011_Aug_2_3(3)_3104-3113.nxml.txt.nlp	24212947	SENT115	24	24	14	14	dextran	TLR4	PA449261	7099	0.65
NULL	Breast_Cancer_Res_2005_Jan_28_7(3)_R284-R290.nxml.txt.nlp	15987423	SENT36	37	37	14	14	tamoxifen	SULT1A1	PA451581	6817	0.65
NULL	J_Ophthalmic_Inflamm_Infect_2013_Apr_22_3_46.nxml.txt.nlp	23607574	SENT63	6	6	16	16	cefazolin	Gen	PA448839	348654	0.65
NULL	Biochimie_2014_Jan_96(100)_106-112.nxml.txt.nlp	23827855	SENT99	5	5	31	31	fenofibrate	ATGL	PA449594	57104	0.65
NULL	J_Gynecol_Oncol_2014_Oct_7_25(4)_355-356.nxml.txt.nlp	25310036	SENT39	6	6	4	4	gemcitabine	GEM	PA449748	2669	0.65
NULL	Front_Genet_2014_Dec_19_5_438.nxml.txt.nlp	25566322	SENT334	14	14	22	22	betaine	B12	PA448603	7126;4709	0.65
NULL	J_Korean_Med_Sci_2006_Jun_21_21(3)_418-424.nxml.txt.nlp	16778382	SENT157	19	19	23	23	hemin	INS-1	PA449849	2305	0.65
NULL	Int_J_Gen_Med_2014_Jan_7_7_49-58.nxml.txt.nlp	24470767	SENT112	29	29	48	48	fentanyl	PTEN	PA449599	5728	0.65
NULL	Brain_Sci_2013_Jun_14_3(2)_941-963.nxml.txt.nlp	24961432	SENT34	4	4	12	12	ethanol	CA1	PA448073	759	0.65
NULL	Cancer_Med_2014_Jun_8_3(3)_681-692.nxml.txt.nlp	24711160	SENT151	25	25	1	1	carboplatin	San	PA448803	80218	0.65
NULL	Nat_Chem_2011_Nov_20_4(2)_99-104.nxml.txt.nlp	22270625	SENT143	9	9	11	11	fluorescein	COPA	PA164746009	1314	0.65
NULL	Br_J_Cancer_2012_Apr_10_106(8)_1395-1405.nxml.txt.nlp	22460269	SENT162	6	6	12	12	sulindac	ABCB1	PA451565	5243	0.65
NULL	Int_J_Gen_Med_2012_Jun_18_5_535-540.nxml.txt.nlp	22807641	SENT86	6	6	12	12	pitavastatin	adiponectin	PA142650384	9370	0.65
NULL	Front_Neurosci_2014_May_27_8_129.nxml.txt.nlp	24904269	SENT154	8	8	5	5	ethanol	AC5	PA448073	111	0.65
NULL	Int_J_Chron_Obstruct_Pulmon_Dis_2006_Dec_1(4)_409-423.nxml.txt.nlp	18044097	SENT242	0	0	18	18	cilomilast	CD68	PA165948031	968	0.65
NULL	Anal_Bioanal_Chem_2008_Apr_31_390(8)_1987-1998.nxml.txt.nlp	18236033	SENT44	23	23	25	25	diethylstilbestrol	DES	PA449307	1674	0.65
NULL	Breast_Cancer_Res_2008_Mar_27_10(2)_R26.nxml.txt.nlp	18371194	SENT113	23	23	40	40	cisplatin	BRCA2	PA449014	675	0.65
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Apr_13_67(Pt_5)_o1090.nxml.txt.nlp	21754410	SENT69	27	27	22	22	ethanol	mol	PA448073	90527	0.65
NULL	Pharmaceuticals_(Basel)_2011_May_24_4(5)_770-781.nxml.txt.nlp	NULL	SENT104	20	20	29	29	carvedilol	IL-6	PA448817	3569	0.65
NULL	Clin_Genet_2014_Jan_1_86(1)_21-28.nxml.txt.nlp	24684508	SENT56	23	23	8	8	warfarin	CYP2C9	PA451906	1559	0.65
NULL	Oncoimmunology_2012_Oct_1_1(7)_1004-1016.nxml.txt.nlp	23170249	SENT29	16	16	9	9	paclitaxel	HER-2	PA450761	2064	0.65
NULL	Enzyme_Res_2009_Nov_1_2010_165878.nxml.txt.nlp	21048860	SENT5	11	11	18	18	l-cystine	Met	PA449176	79811	0.65
NULL	Cancers_(Basel)_2010_Dec_30_3(1)_106-125.nxml.txt.nlp	24212609	SENT529	21	21	1	1	gemcitabine	Bog	PA449748	10741	0.65
NULL	Mol_Cells_2014_Sep_30_37(9)_664-671.nxml.txt.nlp	25234467	SENT172	7	7	2	2	cisplatin	miR-217	PA449014	406999	0.65
NULL	Ann_Oncol_2009_Aug_20(Suppl_6)_vi41-vi50.nxml.txt.nlp	19617297	SENT51	10	10	23	23	vinblastine	IFN	PA451877	3439	0.65
NULL	Br_J_Cancer_2010_May_11_102(10)_1495-1502.nxml.txt.nlp	20461092	SENT238	33	33	2	2	gefitinib	HER2	PA131301952	2064	0.65
NULL	Breast_Cancer_Res_2008_Jul_15_10(4)_R58.nxml.txt.nlp	18627608	SENT229	21	21	8	8	paclitaxel	ISG15	PA450761	9636	0.65
NULL	Pediatr_Infect_Dis_J_2013_Sep_26_32(Suppl_1_Innovative_Treatment_Regimens_for_Severe_Infections_in_Young_Infants)_S33-S38.nxml.txt.nlp	23945574	SENT270	19	19	25	25	amoxicillin	MASS	PA448406	2200	0.65
NULL	Front_Endocrinol_(Lausanne)_2013_Sep_4_4_116.nxml.txt.nlp	24027559	SENT203	27	27	23	23	tamoxifen	SULT1A1	PA451581	6817	0.65
NULL	Br_J_Cancer_2010_Jun_29_103(1)_1-5.nxml.txt.nlp	20461086	SENT14	4	4	7	7	oxygen	HIF-1	PA450744	29072	0.65
NULL	Acta_Pharmacol_Sin_2012_Mar_27_33(3)_342-350.nxml.txt.nlp	22367283	SENT193	27	27	31	31	thrombin	PAR2	PA451674	2150;55065;8856	0.65
NULL	Tuberc_Respir_Dis_(Seoul)_2012_Apr_30_72(4)_343-351.nxml.txt.nlp	23227075	SENT118	8	8	11	11	temsirolimus	LC3	PA164746890	84557	0.65
NULL	Environ_Health_Perspect_2008_Jan_5_116(1)_1-6.nxml.txt.nlp	18197291	SENT71	12	12	7	7	l-glutamine	FBS	PA10090	64319;26269	0.65
NULL	Colomb_Med_(Cali)_44(1)_57-63.nxml.txt.nlp	24892324	SENT40	14	14	4	4	lipase	LYPLAL1	PA450239	127018	0.65
NULL	Ann_Indian_Acad_Neurol_2009_Oct-Dec_12(4)_254-263.nxml.txt.nlp	20182573	SENT177	8	8	21	21	daclizumab	CD25	PA164764446	3669;3559	0.65
NULL	Iran_Red_Crescent_Med_J_2014_Aug_5_16(8)_e6915.nxml.txt.nlp	25389496	SENT120	18	18	28	28	simvastatin	adiponectin	PA451363	9370	0.65
NULL	J_Antimicrob_Chemother_2010_Mar_18_65(3)_390-398.nxml.txt.nlp	20022938	SENT31	2	2	24	24	chloroquine	ATV	PA448948	4683	0.65
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT115	9	9	22	22	docetaxel	B7-H1	PA449383	29126	0.65
NULL	Acta_Diabetol_2011_Mar_21_48(1)_71-77.nxml.txt.nlp	20963449	SENT178	7	7	9	9	miglitol	PPG	PA164776726	5552	0.65
NULL	Indian_J_Ophthalmol_2014_Apr_62(4)_468-471.nxml.txt.nlp	23619494	SENT18	0	0	6	6	bevacizumab	San	PA130232992	80218	0.65
NULL	Breast_Cancer_Res_2010_Nov_16_12(6)_R96.nxml.txt.nlp	21080941	SENT125	0	0	10	10	lapatinib	Hsp90	PA152241907	3320	0.65
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT213	15	15	27	27	l-leucine	ATP5A	PA450197	498	0.65
NULL	J_Gastroenterol_2013_Jan_27_48(1)_22-30.nxml.txt.nlp	23104468	SENT84	7	7	3	3	ribavirin	IFN	PA451241	3439	0.65
NULL	Acta_Pharmacol_Sin_2011_Jul_13_32(7)_967-972.nxml.txt.nlp	21666702	SENT131	11	11	13	13	ticlopidine	P-gp	PA451686	5243	0.65
NULL	Oncotarget_2014_Sep_3_5(19)_9362-9381.nxml.txt.nlp	25313139	SENT127	7	7	22	22	orlistat	HMGCR	PA164776864	3156	0.65
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT29	4	4	23	23	gefitinib	KRAS	PA131301952	3845	0.65
NULL	Onco_Targets_Ther_2014_May_28_7_841-852.nxml.txt.nlp	24920926	SENT53	25	25	39	39	gefitinib	EGFR	PA131301952	1956	0.65
NULL	Ann_Rheum_Dis_2011_Aug_22_70(12)_2119-2125.nxml.txt.nlp	21859685	SENT108	9	9	0	0	ofatumumab	ACR	PA165291493	49	0.65
NULL	J_Hematol_Oncol_2010_Sep_9_3_31.nxml.txt.nlp	20828403	SENT43	2	2	14	14	trastuzumab	HER2	PA451743	2064	0.65
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT273	7	7	3	3	acenocoumarol	CYP2C9	PA452632	1559	0.65
NULL	Pharmacogn_Rev_2013_Jul-Dec_7(14)_157-169.nxml.txt.nlp	24347924	SENT262	8	8	18	18	ethanol	flower	PA448073	11094	0.65
NULL	J_Med_Case_Reports_2011_Sep_28_5_485.nxml.txt.nlp	21955859	SENT37	44	44	14	14	lipase	gamma	PA450239	9913	0.65
NULL	Int_J_Surg_Oncol_2012_Jun_24_2012_868645.nxml.txt.nlp	22778942	SENT77	1	1	4	4	trastuzumab	HER2	PA451743	2064	0.65
NULL	Biosci_Rep_2013_Dec_12_33(6)_e00085.nxml.txt.nlp	24229053	SENT136	9	9	7	7	collagenase	MMP13	PA449107	4322	0.65
NULL	J_Korean_Med_Sci_2006_Apr_20_21(2)_188-192.nxml.txt.nlp	16614499	SENT109	10	10	4	4	rifampin	VAN	PA451250	10318	0.65
NULL	Arthritis_Res_Ther_2012_Jun_25_14(3)_215.nxml.txt.nlp	22731694	SENT142	6	6	8	8	ribavirin	RIBA	PA451241	6014	0.65
NULL	Reprod_Biol_Endocrinol_2004_Mar_24_2_13.nxml.txt.nlp	15040802	SENT181	27	27	36	36	baclofen	PCNA	PA448533	5111	0.65
NULL	Cell_Regen_(Lond)_2012_Jun_28_1(1)_3.nxml.txt.nlp	25408866	SENT185	17	17	9	9	glucose	MSC	PA449773	9242	0.65
NULL	Breast_Cancer_Res_Treat_2012_Jun_18_133(3)_937-947.nxml.txt.nlp	22094936	SENT206	30	30	14	14	tamoxifen	EZH2	PA451581	2146	0.65
NULL	J_Med_Genet_2014_Aug_51(8)_537-544.nxml.txt.nlp	24987033	SENT262	13	13	21	21	lipase	CH25H	PA450239	9023	0.65
NULL	Diabetes_Care_2013_Jun_15_36(6)_1654-1659.nxml.txt.nlp	23250803	SENT8	10	10	24	24	repaglinide	ET3	PA451234	1908	0.65
NULL	Comp_Hepatol_2003_Jan_31_2_3.nxml.txt.nlp	12622871	SENT221	0	0	28	28	troglitazone	Bcl-2	PA451799	596	0.65
NULL	Stroke_Res_Treat_2012_Nov_4_2012_391538.nxml.txt.nlp	23213626	SENT207	10	10	22	22	ticlopidine	ADP	PA451686	23038	0.65
NULL	J_Clin_Biochem_Nutr_2010_Jul_17_47(1)_53-58.nxml.txt.nlp	20664731	SENT395	4	4	0	0	amoxicillin	RAC	PA448406	207	0.65
NULL	Ind_Psychiatry_J_2011_Jan-Jun_20(1)_4-10.nxml.txt.nlp	22969173	SENT30	19	19	23	23	vasopressin	ACTH	PA451858	5443	0.65
NULL	Cardiovasc_Intervent_Radiol_2014_Jan_9_37(3)_763-769.nxml.txt.nlp	24402644	SENT50	23	23	8	8	heparin	ACT	PA449855	12;11332;9457;641455	0.65
NULL	Biomed_Res_Int_2014_Jun_3_2014_656370.nxml.txt.nlp	24995318	SENT117	6	6	4	4	perphenazine	FGA	PA450882	2243	0.65
NULL	Breast_Cancer_Res_2014_Sep_28_16(5)_446.nxml.txt.nlp	25467785	SENT464	21	21	25	25	tamoxifen	STAR	PA451581	6770;2984	0.65
NULL	Br_J_Cancer_2010_Jun_8_102(12)_1707-1716.nxml.txt.nlp	20461078	SENT180	8	8	6	6	bortezomib	TRAIL	PA10252	8743	0.65
NULL	Semin_Immunopathol_2012_Jan_4_34(1)_93-106.nxml.txt.nlp	21845431	SENT62	9	9	22	22	thrombin	PAR-1	PA451674	2011;2149	0.65
NULL	Mol_Clin_Oncol_2013_Jul_15_1(4)_661-667.nxml.txt.nlp	24649225	SENT187	22	22	7	7	leucovorin	RFC1	PA450198	5981	0.65
NULL	Mol_Cancer_2010_Oct_12_9_269.nxml.txt.nlp	20939893	SENT7	10	10	13	13	isoproterenol	AP-1	PA450121	2353;3727;2354;3725	0.65
NULL	Hum_Genomics_2010_Apr_1_4(4)_238-249.nxml.txt.nlp	20511137	SENT225	4	4	6	6	irinotecan	UGT1A1	PA450085	54658	0.65
NULL	Cardiovasc_Ther_2009_27(4)_259-274.nxml.txt.nlp	19604248	SENT132	21	21	5	5	ticagrelor	ADP	PA165374673	23038	0.65
NULL	Oncotarget_2013_Dec_7_5(2)_363-374.nxml.txt.nlp	24495907	SENT264	17	17	7	7	temozolomide	MSH6	PA451609	2956	0.65
NULL	Exp_Hematol_2014_Dec_42(12)_1053-1058_e1.nxml.txt.nlp	25127743	SENT17	5	5	15	15	potassium	KCNQ1	PA451047	3784	0.65
NULL	J_Cardiothorac_Surg_2014_May_9_9_81.nxml.txt.nlp	24885948	SENT132	0	0	18	18	sorafenib	c-fos	PA7000	2353	0.65
NULL	Acta_Neuropathol_Commun_2014_May_30_2_57.nxml.txt.nlp	24887326	SENT186	4	4	13	13	etoposide	MED1	PA449552	5469;8930	0.65
NULL	Clin_Mol_Hepatol_2014_Sep_25_20(3)_283-290.nxml.txt.nlp	25320732	SENT106	19	19	17	17	propranolol	EVL	PA451145	51466	0.65
NULL	Breast_Cancer_Res_2008_Jul_24_10(4)_211.nxml.txt.nlp	18671839	SENT231	16	16	6	6	lapatinib	HER2	PA152241907	2064	0.65
NULL	J_Immune_Based_Ther_Vaccines_2008_Aug_12_6_4.nxml.txt.nlp	18700037	SENT64	24	24	38	38	fluorescein	PC5	PA164746009	5125	0.65
NULL	Case_Rep_Oncol_2011_Oct_26_4(3)_526-530.nxml.txt.nlp	22125524	SENT20	14	14	6	6	paclitaxel	castor	PA450761	54897	0.65
NULL	Behav_Neurol_2014_Aug_7_2014_294149.nxml.txt.nlp	25177106	SENT122	5	5	13	13	memantine	ACTH	PA10364	5443	0.65
NULL	Reprod_Biol_Endocrinol_2003_Oct_7_1_66.nxml.txt.nlp	14609433	SENT257	6	6	13	13	cisplatin	p53	PA449014	7157	0.65
NULL	Oncol_Lett_2013_Mar_19_5(3)_923-928.nxml.txt.nlp	23426648	SENT148	12	12	4	4	sc-560	MVD		4597	0.65
NULL	Neural_Dev_2013_Mar_7_8_4.nxml.txt.nlp	23497494	SENT230	3	3	21	21	chlorpheniramine	FOXP2	PA448960	93986	0.65
NULL	Glycobiology_2013_Apr_12_23(4)_398-411.nxml.txt.nlp	23315448	SENT267	25	25	28	28	hyaluronan	LYVE-1	PA165958431	10894	0.65
NULL	Int_J_Tryptophan_Res_2012_Sep_17_5_27-32.nxml.txt.nlp	23032646	SENT49	24	24	9	9	l-carnitine	B12	PA450154	7126;4709	0.65
NULL	J_Immunotoxicol_2013_Jan_11_10(1)_75-82.nxml.txt.nlp	22967038	SENT99	20	20	1	1	muromonab	IFN	PA164743097	3439	0.65
NULL	Br_J_Cancer_2009_Mar_24_100(6)_870-873.nxml.txt.nlp	19293806	SENT64	18	18	10	10	gemcitabine	CDA	PA449748	978	0.65
NULL	Cancers_(Basel)_2010_Dec_22_2(4)_2153-2170.nxml.txt.nlp	21390244	SENT144	22	22	8	8	gefitinib	EGFR	PA131301952	1956	0.65
NULL	Anal_Bioanal_Chem_2008_Apr_31_390(8)_1987-1998.nxml.txt.nlp	18236033	SENT44	5	5	25	25	estradiol	DES	PA449503	1674	0.65
NULL	Iran_J_Microbiol_2013_Mar_5(1)_48-55.nxml.txt.nlp	23466743	SENT131	16	16	14	14	cefotaxime	CTX	PA448852	1593	0.65
NULL	Oncotarget_2014_Feb_7_5(3)_775-787.nxml.txt.nlp	24519956	SENT121	9	9	35	35	dasatinib	PC3	PA162372878	57332;7832;5122	0.65
NULL	Europace_2012_Dec_6_14(12)_1700-1707.nxml.txt.nlp	22772054	SENT88	8	8	13	13	heparin	ACT	PA449855	12;11332;9457;641455	0.65
NULL	Breast_Cancer_Res_2014_May_23_16(3)_R50.nxml.txt.nlp	24887458	SENT112	13	13	0	0	docetaxel	HER2	PA449383	2064	0.65
NULL	J_Gen_Physiol_2000_Jun_1_115(6)_685-696.nxml.txt.nlp	10828243	SENT120	7	7	28	28	genistein	OLF	PA165109660	83857	0.65
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1437-1448.nxml.txt.nlp	24056706	SENT111	27	27	29	29	ketoconazole	CYP3A4	PA450146	1576	0.65
NULL	Front_Immunol_2013_Oct_22_4_334.nxml.txt.nlp	24155745	SENT227	2	2	8	8	tamoxifen	NOTCH1	PA451581	4851	0.65
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT199	0	0	12	12	methotrexate	MSH2	PA450428	4436	0.65
NULL	BMB_Rep_2013_Sep_46(9)_448-453.nxml.txt.nlp	24064059	SENT74	19	19	16	16	dextran	CD83	PA449261	9308	0.65
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_11_2014_780385.nxml.txt.nlp	25435891	SENT27	17	17	32	32	lipase	MGL	PA450239	11343	0.65
NULL	Open_Biol_2014_May_4(5)_140065.nxml.txt.nlp	24850914	SENT188	21	21	30	30	bortezomib	ALK3	PA10252	657	0.65
NULL	Acta_Pharmacol_Sin_2010_Jun_4_31(6)_709-717.nxml.txt.nlp	20523342	SENT53	33	33	25	25	repaglinide	OATP1B1	PA451234	10599	0.65
NULL	Front_Oncol_2014_May_16_4_107.nxml.txt.nlp	24904823	SENT398	5	5	18	18	metformin	REDD1	PA450395	54541	0.65
NULL	J_Korean_Med_Sci_2011_Jan_22_26(1)_33-41.nxml.txt.nlp	21218027	SENT169	41	41	8	8	cycloserine	EMB	PA164764600	133418	0.65
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT85	9	9	11	11	perifosine	TRAIL	PA165291471	8743	0.65
NULL	EMBO_Mol_Med_2012_Sep_7_4(9)_896-909.nxml.txt.nlp	22887866	SENT131	13	13	9	9	lovastatin	MYC	PA450272	4609	0.65
NULL	Soc_Cogn_Affect_Neurosci_2014_Apr_14_9(4)_436-444.nxml.txt.nlp	22977201	SENT115	7	7	25	25	chlorpromazine	SAPS	PA448964	8935	0.65
NULL	Diabetes_2009_Jan_58(1)_243-249.nxml.txt.nlp	18840785	SENT5	33	33	24	24	glucose	GLP-1	PA449773	100125288	0.65
NULL	Pak_J_Med_Sci_2013_Nov-Dec_29(6)_1459-1461.nxml.txt.nlp	24550976	SENT67	15	15	11	11	thrombin	ACT	PA451674	12;11332;9457;641455	0.65
NULL	Daru_2011_19(5)_356-366.nxml.txt.nlp	22615682	SENT182	6	6	0	0	diclofenac	Tech	PA449293	57449	0.65
NULL	Front_Neurosci_2015_Jan_12_8_445.nxml.txt.nlp	25628526	SENT1025	0	0	5	5	methamphetamine	IL-8	PA450403	3576	0.649
NULL	Nucleic_Acids_Res_2005_Apr_22_33(7)_2310-2317.nxml.txt.nlp	15849317	SENT45	28	28	24	24	geldanamycin	Hsp90	PA152031327	3320	0.649
NULL	J_Gynecol_Oncol_2013_Jul_4_24(3)_265-272.nxml.txt.nlp	23875077	SENT142	26	26	6	6	thrombin	SMAD2	PA451674	4087	0.649
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT112	3	3	10	10	capsaicin	p53	PA448776	7157	0.649
NULL	J_Exp_Med_1977_Dec_1_146(6)_1484-1499.nxml.txt.nlp	925610	SENT6	26	26	22	22	trypsin	C42	PA451806	51654	0.649
NULL	Front_Neurol_2011_Dec_16_2_72.nxml.txt.nlp	22203815	SENT225	7	7	9	9	protamine	VSOP	PA10366	84329	0.649
NULL	Mol_Cancer_2013_May_19_12_43.nxml.txt.nlp	23683438	SENT188	3	3	15	15	paclitaxel	MSK1	PA450761	9252	0.649
NULL	Diabetes_Care_2010_Sep_23_33(9)_2104-2109.nxml.txt.nlp	20573754	SENT202	23	23	1	1	metformin	Gen	PA450395	348654	0.649
NULL	J_Breast_Cancer_2014_Mar_28_17(1)_61-68.nxml.txt.nlp	24744799	SENT166	22	22	12	12	docetaxel	GEM	PA449383	2669	0.649
NULL	J_Vet_Med_Sci_2014_Feb_21_76(2)_219-227.nxml.txt.nlp	24141321	SENT142	12	12	10	10	ns-398	SON		6651	0.649
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT5	14	14	5	5	trastuzumab	STAT3	PA451743	6774	0.649
NULL	J_Korean_Med_Sci_2010_Dec_24_25(12)_1792-1797.nxml.txt.nlp	21165296	SENT26	7	7	9	9	vasopressin	AVP	PA451858	114548;551	0.649
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2012_Oct_10_1(10)_e10.nxml.txt.nlp	23887362	SENT29	5	5	11	11	zidovudine	UGT2B7	PA451954	7364	0.649
NULL	Calcif_Tissue_Int_2010_Dec_16_87(6)_485-492.nxml.txt.nlp	20953593	SENT106	3	3	26	26	teriparatide	PTH	PA451620	5741	0.649
NULL	J_Cancer_Res_Clin_Oncol_2015_Aug_3_141_61-68.nxml.txt.nlp	25086987	SENT21	0	0	15	15	erlotinib	EGFR	PA134687924	1956	0.649
NULL	Indian_J_Pharm_Sci_2008_Mar-Apr_70(2)_208-215.nxml.txt.nlp	20046714	SENT45	10	10	3	3	guanidine	mol	PA164781028	90527	0.649
NULL	Indian_J_Pharm_Sci_2013_Jan-Feb_75(1)_16-22.nxml.txt.nlp	23901156	SENT53	13	13	19	19	ethanol	mol	PA448073	90527	0.649
NULL	New_Microbes_New_Infect_2014_May_4_2(3)_58-63.nxml.txt.nlp	25356345	SENT100	42	42	20	20	meropenem	GEM	PA164764445	2669	0.649
NULL	Front_Behav_Neurosci_2014_Nov_7_8_371.nxml.txt.nlp	25426037	SENT135	6	6	8	8	chlorpromazine	CPZ	PA448964	8532	0.649
NULL	Oncotarget_2012_Jan_28_3(1)_78-83.nxml.txt.nlp	22289679	SENT87	6	6	11	11	gefitinib	TNF-alpha	PA131301952	7124	0.649
NULL	Acta_Vet_Scand_2011_Feb_17_53(1)_11.nxml.txt.nlp	21324209	SENT82	2	2	20	20	ampicillin	OTC	PA448419	5009	0.649
NULL	Mol_Biol_Cell_2012_Oct_15_23(20)_4109-4117.nxml.txt.nlp	22918949	SENT84	6	6	20	20	fluorescein	PTEN	PA164746009	5728	0.649
NULL	Curr_Neuropharmacol_2013_Mar_11(2)_160-170.nxml.txt.nlp	23997751	SENT123	25	25	8	8	haloperidol	5-HT2C	PA449841	3358	0.649
NULL	Fibrogenesis_Tissue_Repair_2008_Dec_11_1_8.nxml.txt.nlp	19077226	SENT41	6	6	16	16	urokinase	CD44	PA451836	960	0.649
NULL	Ann_Rheum_Dis_2010_Feb_7_69(2)_394-399.nxml.txt.nlp	19815494	SENT152	8	8	29	29	infliximab	IMPACT	PA452639	55364	0.649
NULL	Mol_Biol_Rep_2013_May_16_40(8)_4995-5004.nxml.txt.nlp	23677713	SENT160	17	17	11	11	camptothecin	TERT	PA153590860	7015	0.649
NULL	Crit_Care_2009_Mar_13_13(Suppl_1)_P383.nxml.txt.nlp	NULL	SENT2	6	6	8	8	vasopressin	AVP	PA451858	114548;551	0.649
NULL	Oncotarget_2014_Jun_19_5(15)_6540-6551.nxml.txt.nlp	25153728	SENT96	9	9	23	23	paclitaxel	p27	PA450761	5715;10534	0.649
NULL	Br_J_Cancer_2011_Apr_12_104(8)_1278-1287.nxml.txt.nlp	21487429	SENT102	0	0	4	4	cisplatin	DR4	PA449014	8797	0.649
NULL	ISRN_Obes_2014_Jan_23_2014_540582.nxml.txt.nlp	24587943	SENT157	20	20	16	16	lipase	ATGL	PA450239	57104	0.649
NULL	Arch_Gynecol_Obstet_2014_May_13_290(4)_757-762.nxml.txt.nlp	24818590	SENT78	10	10	23	23	fluorescein	CD16	PA164746009	2215;2214	0.649
NULL	Neural_Regen_Res_2013_Jul_15_8(20)_1853-1862.nxml.txt.nlp	25206494	SENT179	21	21	8	8	ethanol	p53	PA448073	7157	0.649
NULL	J_Hematol_Oncol_2012_Sep_18_5_57.nxml.txt.nlp	22989009	SENT90	11	11	22	22	nutlin-3	HDM2		4193	0.649
NULL	Antibodies_(Basel)_2012_Jul_4_1(2)_149-171.nxml.txt.nlp	24634778	SENT160	25	25	33	33	rituximab	IL2	PA451261	3558	0.649
NULL	Cell_Death_Dis_2012_Jun_21_3(6)_e327.nxml.txt.nlp	22717582	SENT218	21	21	8	8	vincristine	p53	PA451879	7157	0.649
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1676-1682.nxml.txt.nlp	19844234	SENT148	12	12	5	5	lapatinib	PIK3CA	PA152241907	5290	0.649
NULL	Acta_Pharmacol_Sin_2009_Jun_5_30(6)_859-867.nxml.txt.nlp	19498425	SENT27	0	0	12	12	carbachol	CA3	PA448784	761	0.649
NULL	J_Korean_Med_Sci_2004_Apr_30_19(2)_167-171.nxml.txt.nlp	15082886	SENT118	44	44	30	30	pyrazinamide	EMB	PA451182	133418	0.649
NULL	Int_J_Environ_Res_Public_Health_2011_Oct_29_8(10)_3889-3921.nxml.txt.nlp	22073019	SENT378	23	23	1	1	temozolomide	p50	PA451609	958;4790	0.649
NULL	Breast_Cancer_Res_2002_Jul_24_4(6)_R12.nxml.txt.nlp	12473173	SENT120	18	18	25	25	estradiol	PCB	PA449503	5091	0.649
NULL	Int_J_Mol_Imaging_2011_Oct_12_2011_694179.nxml.txt.nlp	22013519	SENT29	18	18	22	22	zolmitriptan	5-HT1B	PA451975	3351	0.649
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT147	42	42	8	8	pp2	PP2		4888	0.649
NULL	Genet_Mol_Biol_2010_Dec_1_Oct-Dec_33(4)_703-713.nxml.txt.nlp	21637580	SENT224	14	14	12	12	naringenin	CHS	PA151958361	1130	0.649
NULL	Breast_Cancer_Res_2004_Aug_5_6(5)_R601-R607.nxml.txt.nlp	15318941	SENT40	28	28	8	8	docetaxel	p27	PA449383	5715;10534	0.649
NULL	Mol_Cancer_2009_Nov_19_8_108.nxml.txt.nlp	19925669	SENT259	0	0	2	2	doxorubicin	CRT	PA449412	811	0.649
NULL	J_Clin_Exp_Pathol_2012_May_17_Suppl_4_7327.nxml.txt.nlp	25379357	SENT92	25	25	35	35	resveratrol	AMPK		5563	0.649
NULL	Eur_Respir_J_2013_Dec_30_42(6)_1484-1494.nxml.txt.nlp	23722616	SENT167	30	30	16	16	tiotropium	TDI	PA164769056	100038246	0.649
NULL	Indian_J_Pharmacol_2014_Nov-Dec_46(6)_627-632.nxml.txt.nlp	25538335	SENT134	5	5	3	3	metformin	Q10	PA450395	27161	0.649
NULL	Diabetes_Metab_Syndr_Obes_2014_Jun_24_7_229-239.nxml.txt.nlp	25018644	SENT32	9	9	5	5	exenatide	GLP-1	PA164749238	100125288	0.649
NULL	Pharmaceutics_2011_Nov_18_3(4)_865-913.nxml.txt.nlp	24309312	SENT2064	6	6	9	9	rabeprazole	CYP2C19	PA451216	1557	0.649
NULL	J_Hematol_Oncol_2010_Mar_23_3_11.nxml.txt.nlp	20331897	SENT158	12	12	19	19	oxaliplatin	CRT	PA131285527	811	0.649
NULL	Eur_J_Clin_Microbiol_Infect_Dis_2010_May_13_29(5)_543-550.nxml.txt.nlp	20229224	SENT73	45	45	47	47	tetracycline	VAN	PA451640	10318	0.649
NULL	Mol_Cancer_2010_Dec_7_9_311.nxml.txt.nlp	21138557	SENT200	10	10	12	12	etoposide	ETO	PA449552	862	0.649
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT208	37	37	21	21	phenprocoumon	VKORC1	PA450921	79001	0.649
NULL	Orphanet_J_Rare_Dis_2013_Sep_13_8_142.nxml.txt.nlp	24034279	SENT47	13	13	19	19	vasopressin	AVP	PA451858	114548;551	0.649
NULL	Autophagy_2012_May_1_8(5)_853-855.nxml.txt.nlp	22617440	SENT51	8	8	0	0	imatinib	MIR30A	PA10804	407029	0.649
NULL	Oncotarget_2014_Aug_4_5(16)_6867-6884.nxml.txt.nlp	25149539	SENT306	10	10	23	23	curcumin	PKD1	PA151958596	5310	0.649
NULL	Breast_Cancer_Res_2012_Mar_15_14(2)_R47.nxml.txt.nlp	22420423	SENT133	9	9	20	20	mitomycin	CHEK2	PA450524	11200	0.649
NULL	Case_Rep_Pathol_2012_Sep_29_2012_948352.nxml.txt.nlp	23056979	SENT47	5	5	3	3	cyclophosphamide	CHOP	PA449165	1649	0.649
NULL	Br_J_Cancer_2011_Apr_12_104(8)_1278-1287.nxml.txt.nlp	21487429	SENT14	27	27	23	23	cisplatin	DR5	PA449014	8795	0.649
NULL	Amino_Acids_2012_Oct_10_43(4)_1751-1759.nxml.txt.nlp	22407485	SENT154	21	21	0	0	carrageenan	DAG	PA448814	1605	0.649
NULL	J_Cell_Biol_2000_Feb_21_148(4)_811-824.nxml.txt.nlp	10684261	SENT160	10	10	4	4	thrombin	syndecan	PA451674	6382	0.649
NULL	Int_J_Mol_Sci_2014_Sep_29_15(10)_17577-17600.nxml.txt.nlp	25268624	SENT55	26	26	8	8	methacholine	IFN	PA165958382	3439	0.649
NULL	Nat_Commun_2013_4_1494.nxml.txt.nlp	23422662	SENT146	29	29	11	11	pp2	PI3K		5290	0.649
NULL	Clin_Mol_Hepatol_2013_Mar_25_19(1)_29-35.nxml.txt.nlp	23593607	SENT6	15	15	17	17	lamivudine	LAM	PA450163	7249;7248	0.649
NULL	Arthritis_Res_Ther_2009_Oct_14_11(5)_251.nxml.txt.nlp	19849819	SENT292	8	8	0	0	teriparatide	PTH	PA451620	5741	0.649
NULL	J_Oncol_2009_Mar_24_2009_491985.nxml.txt.nlp	19325924	SENT187	18	18	7	7	genistein	CXCL12	PA165109660	6387	0.649
NULL	Mol_Cancer_2014_Feb_4_13_21.nxml.txt.nlp	24495750	SENT144	22	22	7	7	oxaliplatin	p53	PA131285527	7157	0.649
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT90	0	0	10	10	nevirapine	UGT	PA450616	7361;7355	0.649
NULL	Diabetes_2009_Dec_31_58(12)_2851-2862.nxml.txt.nlp	19720788	SENT176	0	0	4	4	forskolin	BiP	PA146096022	3309	0.649
NULL	Breast_Cancer_Res_2014_May_5_16(3)_R45.nxml.txt.nlp	24887236	SENT220	6	6	8	8	lapatinib	EGFR	PA152241907	1956	0.649
NULL	Front_Neurosci_2014_Jun_3_8_128.nxml.txt.nlp	24917782	SENT162	22	22	7	7	ethanol	MC4R	PA448073	4160	0.649
NULL	Br_J_Cancer_2013_Jan_15_108(1)_82-90.nxml.txt.nlp	23321512	SENT219	10	10	27	27	doxorubicin	TUBB3	PA449412	10381	0.649
NULL	F1000Res_2014_Sep_29_3_161.nxml.txt.nlp	25485093	SENT211	9	9	3	3	tamoxifen	IL-6	PA451581	3569	0.649
NULL	Acta_Pharmacol_Sin_2014_Jun_4_35(6)_792-805.nxml.txt.nlp	24902787	SENT194	15	15	30	30	pravastatin	INS-1	PA451089	2305	0.649
NULL	Gut_Liver_2014_Sep_18_8(5)_471-479.nxml.txt.nlp	25228970	SENT17	21	21	23	23	boceprevir	BOC	PA165948902	91653	0.649
NULL	Arthritis_Res_2002_May_9_4(Suppl_3)_S91-S97.nxml.txt.nlp	12110127	SENT28	13	13	10	10	thrombin	C5a	PA451674	727	0.649
NULL	Ann_Gen_Psychiatry_2014_Apr_1_13_10.nxml.txt.nlp	24690136	SENT189	37	37	33	33	levomepromazine	FGA	PA134687942	2243	0.649
NULL	Indian_J_Nucl_Med_2012_Jan-Mar_27(1)_24-29.nxml.txt.nlp	23599594	SENT110	9	9	14	14	diazepam	FDG	PA449283	23583	0.649
NULL	Cardiovasc_Diabetol_2010_Nov_25_9_78.nxml.txt.nlp	21106105	SENT267	19	19	23	23	phenylephrine	STZ	PA450935	6484	0.649
NULL	Theranostics_2014_Aug_15_4(11)_1072-1084.nxml.txt.nlp	25250092	SENT172	21	21	28	28	cetuximab	HER2	PA10040	2064	0.649
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2705-2713.nxml.txt.nlp	24129232	SENT194	17	17	8	8	doxorubicin	ACT	PA449412	12;11332;9457;641455	0.649
NULL	J_Antimicrob_Chemother_2013_May_1_68(5)_1066-1070.nxml.txt.nlp	23378414	SENT71	33	33	31	31	novobiocin	NOV	PA164768819	4856;5361;6134	0.649
NULL	Nat_Genet_2011_Feb_26_43(2)_153-158.nxml.txt.nlp	21186352	SENT151	12	12	2	2	geldanamycin	Hsp90	PA152031327	3320	0.649
NULL	Eur_J_Epidemiol_2011_Aug_30_26(8)_657-686.nxml.txt.nlp	21877163	SENT961	3	3	14	14	phenprocoumon	CYP4F2	PA450921	8529	0.649
NULL	Indian_J_Med_Res_2013_Dec_138(6)_1022-1024.nxml.txt.nlp	24521652	SENT9	34	34	31	31	vancomycin	VISA	PA451850	57506	0.649
NULL	Front_Neurosci_2014_Feb_14_8_23.nxml.txt.nlp	24592205	SENT1288	0	0	2	2	capsaicin	VR1	PA448776	56664	0.649
NULL	ScientificWorldJournal_2012_Aug_13_2012_496453.nxml.txt.nlp	22927782	SENT31	0	0	5	5	liraglutide	GLP-1	PA165958364	100125288	0.649
NULL	Mol_Pain_2014_Feb_6_10_10.nxml.txt.nlp	24499354	SENT7	28	28	23	23	naloxone	CTX	PA450586	1593	0.649
NULL	J_Biomed_Biotechnol_2011_Jul_3_2011_343791.nxml.txt.nlp	21799660	SENT95	32	32	21	21	ethanol	mol	PA448073	90527	0.649
NULL	Oncoscience_2014_Mar_12_1(2)_167-179.nxml.txt.nlp	25126591	SENT201	14	14	11	11	gemcitabine	TLE3	PA449748	7090	0.649
NULL	Curr_Oncol_2009_May_16(Suppl_1)_S52-S59.nxml.txt.nlp	19478903	SENT281	8	8	11	11	amlodipine	CYP3A4	PA448388	1576	0.649
NULL	Acta_Histochem_Cytochem_2012_Oct_31_45(5)_251-259.nxml.txt.nlp	23209334	SENT120	10	10	18	18	vasopressin	AQP3	PA451858	360	0.649
NULL	Evid_Based_Complement_Alternat_Med_2006_Sep_5_3(3)_385-391.nxml.txt.nlp	NULL	SENT142	7	7	5	5	l-carnitine	Q10	PA450154	27161	0.649
NULL	Oxid_Med_Cell_Longev_2012_May_28_2012_632959.nxml.txt.nlp	22690272	SENT125	0	0	37	37	oxygen	TP53	PA450744	7157	0.649
NULL	J_Immunother_Cancer_2014_Jan_27_2_2.nxml.txt.nlp	24829759	SENT40	11	11	19	19	sorafenib	VEGFR	PA7000	3791	0.649
NULL	Mol_Cancer_2010_Aug_20_9_220.nxml.txt.nlp	20727180	SENT234	3	3	15	15	nicotine	p53	PA450626	7157	0.649
NULL	Acta_Pharmacol_Sin_2011_Oct_15_32(10)_1303-1308.nxml.txt.nlp	21841812	SENT59	2	2	0	0	losartan	CYP2C9	PA450268	1559	0.649
NULL	Exp_Diabetes_Res_2012_Mar_28_2012_386831.nxml.txt.nlp	22536214	SENT36	7	7	9	9	streptozocin	STZ	PA451514	6484	0.649
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1437-1448.nxml.txt.nlp	24056706	SENT253	3	3	14	14	irinotecan	C10	PA450085	113246	0.649
NULL	J_Immune_Based_Ther_Vaccines_2008_Jun_9_6_3.nxml.txt.nlp	18541039	SENT186	2	2	12	12	ribavirin	IL-10	PA451241	3586	0.649
NULL	Eur_J_Med_Res_2014_Jun_24_19(1)_34.nxml.txt.nlp	24961604	SENT103	18	18	30	30	vincristine	BCL11A	PA451879	53335	0.649
NULL	J_Cell_Biol_1994_Feb_1_124(3)_273-287.nxml.txt.nlp	8294512	SENT4	21	21	19	19	choline	CDP	PA448976	1523	0.649
NULL	Nat_Commun_2012_Jan_10_3_614.nxml.txt.nlp	22233624	SENT128	17	17	36	36	l-glutamine	CO2	PA10090	4513	0.649
NULL	Diabetes_Care_2011_Jul_17_34(7)_1601-1604.nxml.txt.nlp	21709296	SENT87	15	15	6	6	rosiglitazone	DREAM	PA451283	30818	0.649
NULL	Case_Rep_Oncol_2010_Nov_8_3(3)_397-405.nxml.txt.nlp	21113350	SENT69	5	5	13	13	cyclophosphamide	CHOP	PA449165	1649	0.649
NULL	Crit_Care_2012_Oct_15_16(5)_R193.nxml.txt.nlp	23068293	SENT129	13	13	21	21	pentobarbital	NMB	PA450859	10457;4828	0.649
NULL	AIDS_Res_Ther_2011_Oct_6_8_36.nxml.txt.nlp	21978457	SENT218	4	4	7	7	zinc	TNF	PA451956	7124	0.649
NULL	Asian-Australas_J_Anim_Sci_2013_Feb_26(2)_178-188.nxml.txt.nlp	25049774	SENT194	28	28	44	44	heparin	CO2	PA449855	4513	0.649
NULL	Int_Arch_Med_2008_May_12_1_6.nxml.txt.nlp	18474088	SENT40	13	13	18	18	lipase	HLP	PA450239	6499;9001;3002	0.649
NULL	Acta_Pharmacol_Sin_2011_Jan_29_32(1)_38-44.nxml.txt.nlp	21113177	SENT96	24	24	11	11	chloroquine	LC3	PA448948	84557	0.649
NULL	Nat_Commun_2013_Sep_20_4_2443.nxml.txt.nlp	24051437	SENT161	23	23	9	9	tamoxifen	BIG3	PA451581	57221	0.649
NULL	Viruses_2014_Aug_19_6(8)_3181-3227.nxml.txt.nlp	25196285	SENT196	23	23	25	25	acetylcysteine	NAC	PA448033	22861	0.649
NULL	Biomed_Res_Int_2013_Jul_18_2013_909045.nxml.txt.nlp	23971048	SENT25	26	26	24	24	nitrendipine	Q10	PA146096020	27161	0.649
NULL	J_Infect_Dis_2013_Sep_1_208(5)_801-812.nxml.txt.nlp	23766527	SENT113	29	29	4	4	piperaquine	LUM	PA166104279	4060	0.649
NULL	Br_J_Cancer_2012_May_8_106(10)_1587-1590.nxml.txt.nlp	22568998	SENT120	12	12	5	5	sunitinib	IFN	PA162372840	3439	0.649
NULL	Clin_Psychopharmacol_Neurosci_2011_Aug_31_9(2)_78-85.nxml.txt.nlp	23429185	SENT133	38	38	36	36	propranolol	PPL	PA451145	5493	0.649
NULL	Arthritis_Res_Ther_2014_Sep_18_16(5)_427.nxml.txt.nlp	25230745	SENT146	16	16	24	24	bevacizumab	MMP3	PA130232992	4314	0.649
NULL	Clin_Mol_Allergy_2007_Jan_25_5_1.nxml.txt.nlp	17254346	SENT188	0	0	12	12	curcumin	IL-4	PA151958596	3565	0.649
NULL	Asian_Spine_J_2014_Feb_6_8(1)_97-111.nxml.txt.nlp	24596613	SENT397	14	14	16	16	rifampin	EMB	PA451250	133418	0.649
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_39-54.nxml.txt.nlp	19305787	SENT215	28	28	11	11	ethanol	NR1	PA448073	27158	0.649
NULL	Indian_Dermatol_Online_J_2013_Jul-Sep_4(3)_246-249.nxml.txt.nlp	23984250	SENT38	32	32	35	35	erlotinib	EGFR	PA134687924	1956	0.649
NULL	Clin_Kidney_J_2013_Jun_11_6(3)_287-294.nxml.txt.nlp	23717787	SENT79	10	10	23	23	cinacalcet	PTH	PA164776671	5741	0.649
NULL	Acta_Pharmacol_Sin_2010_Aug_5_31(8)_938-943.nxml.txt.nlp	20686519	SENT201	23	23	10	10	reserpine	GML	PA451236	2765	0.649
NULL	Gut_Liver_2013_Sep_14_7(5)_552-559.nxml.txt.nlp	24073313	SENT30	6	6	20	20	celecoxib	EGFR	PA448871	1956	0.649
NULL	Mol_Vis_2011_Apr_27_17_1044-1055.nxml.txt.nlp	21552499	SENT2	12	12	25	25	bevacizumab	apelin	PA130232992	8862	0.649
NULL	Oncol_Lett_2014_Nov_14_8(5)_2086-2092.nxml.txt.nlp	25295095	SENT9	21	21	6	6	gemcitabine	LKB1	PA449748	6794	0.649
NULL	Crit_Care_2010_Nov_5_14(6)_R200.nxml.txt.nlp	21054850	SENT109	31	31	33	33	vasopressin	AVP	PA451858	114548;551	0.649
NULL	Int_J_Nephrol_2011_Apr_26_2011_245823.nxml.txt.nlp	21603155	SENT132	9	9	6	6	ribavirin	IFN	PA451241	3439	0.649
NULL	Ann_Nucl_Med_2013_Apr_5_27(7)_592-599.nxml.txt.nlp	23558450	SENT3	13	13	20	20	amiodarone	BLM	PA448383	641	0.649
NULL	J_Skin_Cancer_2014_Jul_21_2014_284582.nxml.txt.nlp	25136458	SENT37	3	3	7	7	cetuximab	CRT	PA10040	811	0.649
NULL	Eur_J_Pharmacol_2008_Feb_12_580(3-3)_291-297.nxml.txt.nlp	18082160	SENT335	7	7	10	10	granisetron	5-HT3A	PA449809	3359	0.649
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_13_2012_636848.nxml.txt.nlp	23258994	SENT28	18	18	2	2	carrageenan	TRPV4	PA448814	59341	0.649
NULL	Ann_Oncol_2014_Sep_25_25(9)_1762-1769.nxml.txt.nlp	25122671	SENT75	14	14	22	22	imatinib	KIT	PA10804	3815	0.649
NULL	Front_Physiol_2011_Jun_14_2_26.nxml.txt.nlp	21716655	SENT224	4	4	21	21	lipase	SCAD	PA450239	35	0.649
NULL	J_Int_AIDS_Soc_2011_Feb_9_14_7.nxml.txt.nlp	21306608	SENT74	46	46	23	23	saquinavir	ATV	PA451305	4683	0.649
NULL	Genome_Med_2010_Nov_30_2(11)_85.nxml.txt.nlp	21122163	SENT177	9	9	3	3	imatinib	CYP3A5	PA10804	1577	0.649
NULL	J_Exp_Med_1964_May_1_119(5)_851-868.nxml.txt.nlp	14157034	SENT4	42	42	13	13	cyclophosphamide	gamma	PA449165	9913	0.649
NULL	Protein_Cell_2014_Jun_19_5(6)_469-479.nxml.txt.nlp	24748116	SENT147	7	7	5	5	paclitaxel	EB1	PA450761	9167;22919;10982	0.649
NULL	J_Biomed_Opt_2013_Jun_7_18(6)_060501.nxml.txt.nlp	23748699	SENT60	28	28	1	1	nadh	ANOVA	PA164755085	4858	0.649
NULL	Braz_J_Med_Biol_Res_2014_Feb_17_47(2)_101-109.nxml.txt.nlp	24519125	SENT129	6	6	10	10	propranolol	IL-6	PA451145	3569	0.649
NULL	ScientificWorldJournal_2012_Aug_2_2012_940613.nxml.txt.nlp	22919361	SENT53	1	1	14	14	naloxone	PAG	PA450586	55824	0.649
NULL	J_Korean_Med_Sci_2008_Aug_25_23(4)_657-661.nxml.txt.nlp	18756053	SENT105	16	16	9	9	estradiol	AMH	PA449503	268	0.649
NULL	Diabetol_Metab_Syndr_2014_Mar_31_6_48.nxml.txt.nlp	24684803	SENT113	16	16	9	9	miglitol	STEP	PA164776726	84867	0.649
NULL	J_Clin_Biochem_Nutr_2009_Jul_30_45(1)_9-13.nxml.txt.nlp	19590701	SENT312	16	16	9	9	lansoprazole	HO-1	PA450180	3162	0.649
NULL	Open_Access_J_Urol_2010_Feb_10_2_25-30.nxml.txt.nlp	24198610	SENT114	4	4	6	6	cyclophosphamide	ETO	PA449165	862	0.649
NULL	Cancer_Cell_Int_2010_Apr_30_10_13.nxml.txt.nlp	20433758	SENT216	24	24	11	11	l-glutamine	F12	PA10090	2161	0.649
NULL	Exp_Hematol_2012_Feb_40(2)_97-106.nxml.txt.nlp	22085453	SENT184	3	3	30	30	busulfan	CD40	PA448691	958	0.649
NULL	Emerg_Infect_Dis_2013_Jan_19(1)_133-136.nxml.txt.nlp	23260464	SENT42	2	2	20	20	aztreonam	TOB	PA448523	10140	0.649
NULL	Biol_Open_2014_Sep_12_3(10)_937-946.nxml.txt.nlp	25217618	SENT538	17	17	0	0	trastuzumab	TP53	PA451743	7157	0.649
NULL	Mar_Drugs_2014_May_27_12(6)_3231-3244.nxml.txt.nlp	24879546	SENT411	3	3	17	17	curcumin	p300	PA151958596	2033	0.649
NULL	Ann_Gastroenterol_2014_27(2)_105-112.nxml.txt.nlp	24733569	SENT181	4	4	8	8	entecavir	IFN	PA164784025	3439	0.649
NULL	J_Skin_Cancer_2012_Dec_13_2012_147863.nxml.txt.nlp	23316365	SENT135	11	11	19	19	curcumin	IL6	PA151958596	3569	0.649
NULL	Clin_Transl_Allergy_2014_Feb_28_4(Suppl_1)_P35.nxml.txt.nlp	25045492	SENT16	0	0	20	20	atorvastatin	IL-4	PA448500	3565	0.649
NULL	J_Gen_Intern_Med_2009_May_21_24(5)_656-664.nxml.txt.nlp	19306050	SENT296	18	18	5	5	warfarin	VKORC1	PA451906	79001	0.649
NULL	Clin_Infect_Dis_2012_Aug_1_55(Suppl_2)_S154-S161.nxml.txt.nlp	22752865	SENT98	20	20	18	18	vancomycin	VAN	PA451850	10318	0.649
NULL	J_Carcinog_2012_Sep_13_11_15.nxml.txt.nlp	23230392	SENT127	32	32	40	40	bevacizumab	VEGFR	PA130232992	3791	0.649
NULL	Oncotarget_2013_Oct_19_4(11)_2045-2056.nxml.txt.nlp	24185104	SENT51	9	9	6	6	cisplatin	14-3-3	PA449014	10971	0.649
NULL	J_Neurosci_Rural_Pract_2014_Jul-Sep_5(3)_218-224.nxml.txt.nlp	25002759	SENT204	31	31	34	34	warfarin	B12	PA451906	7126;4709	0.649
NULL	Nat_Med_2012_Jul_18(7)_1118-1122.nxml.txt.nlp	22683780	SENT125	31	31	33	33	crizotinib	FGFR1	PA165946122	2260	0.649
NULL	Environ_Health_Perspect_2006_Sep_23_114(9)_1401-1406.nxml.txt.nlp	16966095	SENT118	9	9	5	5	tetracycline	p53	PA451640	7157	0.649
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2007_Dec_6_64(Pt_1)_o213.nxml.txt.nlp	21200779	SENT60	14	14	7	7	ethanol	mol	PA448073	90527	0.649
NULL	Diabetes_2013_Nov_18_62(11)_3909-3919.nxml.txt.nlp	23835339	SENT202	30	30	21	21	gliclazide	SUR1	PA10892	6833	0.649
NULL	Eur_J_Epidemiol_2007_Nov_23_22(11)_819-829.nxml.txt.nlp	17955331	SENT686	9	9	29	29	coumarin	PAGM	PA134521193	5238	0.649
NULL	Mol_Cancer_2013_May_24_12_47.nxml.txt.nlp	23705854	SENT224	0	0	9	9	celecoxib	MRP1	PA448871	4437	0.649
NULL	Ann_Gen_Psychiatry_2007_Jan_29_6_3.nxml.txt.nlp	17261186	SENT212	16	16	5	5	ziprasidone	Gen	PA451974	348654	0.649
NULL	Ann_Rheum_Dis_2008_Aug_20_67(8)_1121-1126.nxml.txt.nlp	18029384	SENT125	32	32	18	18	bosentan	LFA-1	PA10034	3683;3689	0.649
NULL	Bioinform_Biol_Insights_2009_Oct_5_3_109-127.nxml.txt.nlp	20140064	SENT389	12	12	16	16	zidovudine	P65	PA451954	64689;6857	0.649
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1051.nxml.txt.nlp	24503543	SENT144	12	12	31	31	sunitinib	Yes	PA162372840	7525	0.649
NULL	Osteopath_Med_Prim_Care_2009_Jan_6_3_1.nxml.txt.nlp	19126235	SENT57	6	6	0	0	naproxen	OTC	PA450595	5009	0.649
NULL	Drugs_2013_Sep_25_73(14)_1569-1586.nxml.txt.nlp	24065301	SENT130	21	21	2	2	amlodipine	TED	PA448388	27112	0.649
NULL	Arch_Med_Sci_2011_Feb_8_7(1)_27-33.nxml.txt.nlp	22291729	SENT141	10	10	8	8	cyclophosphamide	CHOP	PA449165	1649	0.649
NULL	Diabetes_Metab_Syndr_Obes_2014_Jan_18_7_15-24.nxml.txt.nlp	24465132	SENT20	27	27	41	41	metformin	GLP-1	PA450395	100125288	0.649
NULL	Emerg_Infect_Dis_2011_Mar_17(3)_510-513.nxml.txt.nlp	21392446	SENT53	34	34	16	16	capreomycin	EMB	PA164746226	133418	0.649
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Apr_2_65(Pt_5)_o953.nxml.txt.nlp	21583996	SENT65	3	3	31	31	nitrogen	AMPH	PA450643	273	0.649
NULL	Crit_Care_2006_May_12_10(3)_R75.nxml.txt.nlp	16696866	SENT153	25	25	27	27	vasopressin	AVP	PA451858	114548;551	0.649
NULL	Biofouling_2012_Sep_9_28(8)_835-842.nxml.txt.nlp	22877233	SENT125	13	13	17	17	ethanol	hole	PA448073	80757	0.649
NULL	Open_AIDS_J_2010_May_14_4_103-104.nxml.txt.nlp	20648218	SENT10	28	28	37	37	methamphetamine	CD4	PA450403	920	0.649
NULL	Exp_Ther_Med_2013_Apr_29_5(4)_1093-1096.nxml.txt.nlp	23596475	SENT75	2	2	7	7	ketamine	IL-6	PA450144	3569	0.649
NULL	J_Clin_Biochem_Nutr_2008_May_29_42(3)_197-203.nxml.txt.nlp	18545641	SENT46	0	0	5	5	paclitaxel	HO-1	PA450761	3162	0.649
NULL	Mol_Cancer_2007_Sep_18_6_56.nxml.txt.nlp	17877814	SENT166	14	14	25	25	erlotinib	EGFR	PA134687924	1956	0.649
NULL	Cancer_Med_2014_Apr_7_3(2)_349-361.nxml.txt.nlp	24515895	SENT177	13	13	33	33	doxycycline	HSC3	PA449415	150353	0.649
NULL	Br_J_Cancer_2014_Jan_7_110(1)_267-268.nxml.txt.nlp	24300975	SENT21	19	19	17	17	docetaxel	DES	PA449383	1674	0.649
NULL	J_Korean_Med_Sci_2011_Jan_22_26(1)_33-41.nxml.txt.nlp	21218027	SENT169	14	14	8	8	pyrazinamide	EMB	PA451182	133418	0.649
NULL	Front_Oncol_2013_Oct_1_3_259.nxml.txt.nlp	24102047	SENT105	4	4	29	29	paclitaxel	VEGFR2	PA450761	3791	0.649
NULL	Mol_Pain_2014_Feb_21_10_15.nxml.txt.nlp	24555569	SENT165	0	0	10	10	retigabine	KCNQ1	PA144997862	3784	0.649
NULL	Front_Behav_Neurosci_2009_Aug_27_3_17.nxml.txt.nlp	19753327	SENT38	1	1	3	3	vasopressin	AVP	PA451858	114548;551	0.649
NULL	J_Anaesthesiol_Clin_Pharmacol_2012_Apr-Jun_28(2)_190-193.nxml.txt.nlp	22557741	SENT30	17	17	22	22	sumatriptan	ACTH	PA451566	5443	0.648
NULL	Exp_Ther_Med_2015_Feb_16_9(2)_289-293.nxml.txt.nlp	25574188	SENT51	11	11	16	16	curcumin	CD44	PA151958596	960	0.648
NULL	Mol_Cancer_2010_May_19_9_112.nxml.txt.nlp	20482842	SENT216	26	26	33	33	paraformaldehyde	p65	PA450790	5970	0.648
NULL	Arthritis_Res_Ther_2013_Jul_24_15(Suppl_3)_S5.nxml.txt.nlp	24267413	SENT114	18	18	12	12	naproxen	COX	PA450595	1351	0.648
NULL	J_Clin_Biochem_Nutr_2007_May_25_40(3)_234-241.nxml.txt.nlp	18398502	SENT438	7	7	5	5	pioglitazone	gamma	PA450970	9913	0.648
NULL	Breast_Cancer_Res_2007_Dec_18_9(6)_216.nxml.txt.nlp	18190723	SENT196	0	0	11	11	sorafenib	VEGFR2	PA7000	3791	0.648
NULL	Diabetes_Care_2013_Aug_17_36(Suppl_2)_S245-S252.nxml.txt.nlp	23882053	SENT72	15	15	20	20	exenatide	GLP-1	PA164749238	100125288	0.648
NULL	Hum_Reprod_Update_2009_Jan_27_May-Jun_15(3)_323-339.nxml.txt.nlp	19174449	SENT197	10	10	15	15	estradiol	AMH	PA449503	268	0.648
NULL	BMJ_2010_Feb_8_340_c693.nxml.txt.nlp	20142325	SENT187	3	3	18	18	tamoxifen	CYP3A	PA451581	1574	0.648
NULL	Arch_Med_Sci_2013_Apr_20_9(2)_361-367.nxml.txt.nlp	23671450	SENT125	0	0	2	2	budesonide	HIF-1	PA448681	29072	0.648
NULL	Biotechnol_Res_Int_2013_Dec_1_2013_253286.nxml.txt.nlp	24363937	SENT62	30	30	32	32	urea	DAP	PA451831	23549;3375;1611	0.648
NULL	Mol_Med_Rep_2014_Nov_5_10(5)_2334-2340.nxml.txt.nlp	25189202	SENT168	20	20	18	18	cefoperazone	CFP	PA448849	5199	0.648
NULL	J_Mol_Signal_2010_May_10_5_4.nxml.txt.nlp	20459745	SENT68	7	7	9	9	cisplatin	p53	PA449014	7157	0.648
NULL	Cancer_Cell_Int_2010_Aug_13_10_26.nxml.txt.nlp	20707917	SENT9	4	4	35	35	doxorubicin	RhoA	PA449412	387	0.648
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Dec_9_6_191-203.nxml.txt.nlp	25525387	SENT196	48	48	0	0	tamoxifen	EGF	PA451581	1950	0.648
NULL	Curr_Pharm_Des_2011_Feb_17(6)_578-590.nxml.txt.nlp	21391908	SENT224	4	4	33	33	lenalidomide	CD154	PA162363968	959	0.648
NULL	J_Oncol_2012_Apr_10_2012_931071.nxml.txt.nlp	22570654	SENT52	16	16	7	7	plerixafor	CD34	PA165958410	947	0.648
NULL	JAKSTAT_2013_Jul_1_2(3)_e24812.nxml.txt.nlp	24069562	SENT10	22	22	7	7	pp2	HL-1		55600	0.648
NULL	Arch_Plast_Surg_2012_Sep_12_39(5)_540-545.nxml.txt.nlp	23094252	SENT121	24	24	17	17	remifentanil	TCI	PA451232	6947	0.648
NULL	Case_Rep_Transplant_2011_Jan_5_2011_210178.nxml.txt.nlp	23213600	SENT39	31	31	21	21	nevirapine	CYP3A	PA450616	1574	0.648
NULL	Adv_Hematol_2012_Sep_24_2012_596925.nxml.txt.nlp	23049557	SENT76	10	10	24	24	paraformaldehyde	San	PA450790	80218	0.648
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT111	26	26	19	19	celecoxib	IL-6	PA448871	3569	0.648
NULL	Arthritis_Res_Ther_2007_Jul_5_9(4)_R64.nxml.txt.nlp	17612394	SENT205	12	12	18	18	indomethacin	PGD2	PA449982	27306	0.648
NULL	Blood_Res_2014_Jun_25_49(2)_85-94.nxml.txt.nlp	25025009	SENT98	17	17	42	42	thrombin	VIII	PA451674	1351	0.648
NULL	EPMA_J_2010_Mar_24_1(1)_19-31.nxml.txt.nlp	23199038	SENT214	8	8	4	4	heparin	INS-1	PA449855	2305	0.648
NULL	J_Hepatol_2013_Aug_59(2)_318-326.nxml.txt.nlp	23624001	SENT155	9	9	21	21	oxaliplatin	MMP9	PA131285527	4318	0.648
NULL	Ann_Indian_Acad_Neurol_2012_Oct-Dec_15(4)_332-335.nxml.txt.nlp	23349609	SENT15	9	9	2	2	l-carnitine	PCD	PA450154	27019;5092;352909;1767	0.648
NULL	Nanoscale_Res_Lett_2014_Aug_25_9(1)_429.nxml.txt.nlp	25221458	SENT29	9	9	16	16	ethanol	IPA	PA448073	3160	0.648
NULL	Brain_Behav_2012_Mar_2(2)_155-177.nxml.txt.nlp	22574283	SENT460	15	15	3	3	vincristine	CB1	PA451879	1268	0.648
NULL	J_Carcinog_2011_Aug_23_10_20.nxml.txt.nlp	21886458	SENT175	27	27	8	8	docetaxel	IL-8	PA449383	3576	0.648
NULL	Br_J_Cancer_2013_Feb_19_108(3)_557-563.nxml.txt.nlp	23361053	SENT138	25	25	4	4	tamoxifen	PAK1	PA451581	5585;5058	0.648
NULL	Ann_Oncol_2013_Apr_31_24(4)_1067-1073.nxml.txt.nlp	23117073	SENT42	18	18	24	24	cisplatin	CYP3A4	PA449014	1576	0.648
NULL	Arthritis_Res_Ther_2012_Mar_5_14(2)_R45.nxml.txt.nlp	22390640	SENT69	0	0	16	16	fluorescein	CD61	PA164746009	3690	0.648
NULL	J_Cancer_2013_Sep_27_4(8)_662-670.nxml.txt.nlp	24155778	SENT170	15	15	13	13	cisplatin	UCHL1	PA449014	7345	0.648
NULL	Ann_Oncol_2010_Oct_19_21(10)_1952-1960.nxml.txt.nlp	20305037	SENT135	33	33	17	17	panitumumab	p16	PA162373091	1029	0.648
NULL	Cancer_Med_2014_Apr_12_3(2)_390-396.nxml.txt.nlp	24519810	SENT108	23	23	10	10	ethanol	LAM	PA448073	7249;7248	0.648
NULL	Arthritis_Res_Ther_2013_Oct_24_15(5)_R161.nxml.txt.nlp	24286516	SENT56	0	0	12	12	fluorescein	San	PA164746009	80218	0.648
NULL	Oncotarget_2012_Dec_18_3(12)_1615-1628.nxml.txt.nlp	23271044	SENT67	19	19	28	28	clofarabine	TOR	PA164754863	6097	0.648
NULL	Nucleic_Acids_Res_2012_Apr_16_40(8)_3511-3523.nxml.txt.nlp	22180533	SENT224	21	21	3	3	doxycycline	E2F7	PA449415	144455	0.648
NULL	Case_Rep_Hematol_2013_Sep_5_2013_708489.nxml.txt.nlp	24083040	SENT1	15	15	18	18	iron	B12	PA450087	7126;4709	0.648
NULL	Br_J_Cancer_2010_Jun_8_102(12)_1699-1706.nxml.txt.nlp	20485286	SENT17	0	0	8	8	ifosfamide	CYP3A	PA449964	1574	0.648
NULL	Exp_Ther_Med_2012_Sep_12_4(3)_475-480.nxml.txt.nlp	23181121	SENT159	12	12	0	0	rituximab	CHOP	PA451261	1649	0.648
NULL	Cancer_Metab_2014_Aug_18_2_13.nxml.txt.nlp	25225614	SENT271	22	22	45	45	lipase	HSL	PA450239	3991	0.648
NULL	Nanoscale_Res_Lett_2010_Aug_18_6(1)_1.nxml.txt.nlp	21711573	SENT27	38	38	10	10	ethanol	NO3	PA448073	4681	0.648
NULL	Cancer_Immunol_Immunother_2015_Oct_7_64_61-73.nxml.txt.nlp	25287778	SENT136	0	0	6	6	lenalidomide	CD25	PA162363968	3669;3559	0.648
NULL	Cell_Tissue_Res_2013_May_17_354(1)_259-271.nxml.txt.nlp	23681253	SENT115	29	29	23	23	bupropion	AMPH	PA448687	273	0.648
NULL	Exp_Mol_Med_2012_Sep_30_44(9)_536-544.nxml.txt.nlp	22771771	SENT56	23	23	32	32	celecoxib	p16	PA448871	1029	0.648
NULL	Diabetes_2011_Jun_21_60(6)_1734-1742.nxml.txt.nlp	21498783	SENT4	22	22	24	24	lipase	HSL	PA450239	3991	0.648
NULL	Ann_Rheum_Dis_2010_Jun_1_69(6)_1029-1035.nxml.txt.nlp	20444755	SENT151	26	26	20	20	acenocoumarol	VKORC1	PA452632	79001	0.648
NULL	Curr_HIV_Res_2014_May_12(3)_174-188.nxml.txt.nlp	24862327	SENT147	14	14	19	19	hemin	HO-1	PA449849	3162	0.648
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT152	14	14	22	22	capsaicin	p53	PA448776	7157	0.648
NULL	J_Cardiothorac_Surg_2009_Jun_18_4_25.nxml.txt.nlp	19538741	SENT55	9	9	23	23	protamine	ACT	PA10366	12;11332;9457;641455	0.648
NULL	Gut_2012_May_7_61(5)_673-684.nxml.txt.nlp	22315472	SENT39	6	6	11	11	trastuzumab	ERBB2	PA451743	2064	0.648
NULL	Mol_Pain_2014_Apr_9_10_24.nxml.txt.nlp	24716552	SENT205	12	12	20	20	capsaicin	NK1R	PA448776	6869	0.648
NULL	Int_J_Environ_Res_Public_Health_2010_May_28_7(5)_1996-2007.nxml.txt.nlp	20632473	SENT130	9	9	24	24	arsenite	JNK3	PA452638	5602	0.648
NULL	Front_Physiol_2011_Jun_14_2_26.nxml.txt.nlp	21716655	SENT224	4	4	28	28	lipase	NEFA	PA450239	4925	0.648
NULL	Mol_Med_Rep_2014_Nov_5_10(5)_2334-2340.nxml.txt.nlp	25189202	SENT25	4	4	11	11	ceftazidime	CFP	PA448861	5199	0.648
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R91.nxml.txt.nlp	22541814	SENT193	15	15	11	11	thrombin	HO-1	PA451674	3162	0.648
NULL	Br_J_Cancer_2010_Oct_26_103(9)_1380-1390.nxml.txt.nlp	20877355	SENT14	7	7	11	11	etoposide	FasL	PA449552	356	0.648
NULL	Subst_Abuse_Treat_Prev_Policy_2008_Nov_18_3_22.nxml.txt.nlp	19017405	SENT26	17	17	2	2	methamphetamine	MTF	PA450403	4500	0.648
NULL	J_Thyroid_Res_2010_Apr_13_2010_279468.nxml.txt.nlp	21048836	SENT118	22	22	19	19	thyroglobulin	RAI	PA164754910	10848;6050	0.648
NULL	Biomed_Res_Int_2014_Apr_27_2014_180428.nxml.txt.nlp	24877063	SENT259	26	26	21	21	cisplatin	TRPV1	PA449014	7442	0.648
NULL	EMBO_Mol_Med_2012_Feb_4(2)_125-141.nxml.txt.nlp	22253197	SENT388	5	5	10	10	paraformaldehyde	APO	PA450790	84909	0.648
NULL	Cell_Death_Dis_2010_Oct_21_1(10)_e86.nxml.txt.nlp	21368859	SENT193	22	22	11	11	irinotecan	TRAIL	PA450085	8743	0.648
NULL	Acta_Pharmacol_Sin_2010_Jul_28_31(7)_867-873.nxml.txt.nlp	20581857	SENT17	13	13	15	15	docetaxel	PC3	PA449383	57332;7832;5122	0.648
NULL	Summit_on_Translat_Bioinforma_2009_Mar_1_2009_124-128.nxml.txt.nlp	21347183	SENT69	38	38	40	40	thioguanine	TPMT	PA451663	7172	0.648
NULL	Ann_Saudi_Med_2011_Jul-Aug_31(4)_402-406.nxml.txt.nlp	21727749	SENT26	4	4	8	8	exenatide	GLP-1	PA164749238	100125288	0.648
NULL	Cell_Regen_(Lond)_2012_Jun_28_1(1)_3.nxml.txt.nlp	25408866	SENT28	9	9	18	18	oxygen	MSC	PA450744	9242	0.648
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jun_24_65(Pt_7)_o1668.nxml.txt.nlp	21582928	SENT60	34	34	30	30	ethanol	mol	PA448073	90527	0.648
NULL	Br_J_Cancer_2011_Jul_26_105(3)_372-381.nxml.txt.nlp	21730979	SENT104	6	6	17	17	temozolomide	p53	PA451609	7157	0.648
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT128	16	16	1	1	propafenone	CYP2C9	PA451131	1559	0.648
NULL	Indian_J_Endocrinol_Metab_2014_Jan-Feb_18(1)_77-82.nxml.txt.nlp	24701434	SENT36	11	11	14	14	liraglutide	GLP-1	PA165958364	100125288	0.648
NULL	J_Biol_Chem_2012_Apr_6_287(15)_12433-12444.nxml.txt.nlp	22351758	SENT980	3	3	23	23	hyaluronan	TSG-6	PA165958431	7130	0.648
NULL	J_Adv_Pract_Oncol_2012_Nov_1_Nov-Dec_3(6)_391-394.nxml.txt.nlp	25031970	SENT16	4	4	24	24	pertuzumab	PI3K		5290	0.648
NULL	Front_Oncol_2013_Nov_18_3_282.nxml.txt.nlp	24303367	SENT627	13	13	21	21	glucose	RET	PA449773	5979	0.648
NULL	Arthritis_Res_Ther_2013_Dec_23_15(6)_R220.nxml.txt.nlp	24360580	SENT198	8	8	6	6	hydrochlorothiazide	OAT4	PA449899	114571;55867	0.648
NULL	J_Exp_Bot_2008_Oct_59(13)_3721-3728.nxml.txt.nlp	18820260	SENT184	31	31	14	14	pp2	14-3-3		10971	0.648
NULL	Arthritis_Res_Ther_2012_Jun_25_14(3)_215.nxml.txt.nlp	22731694	SENT46	8	8	6	6	cyclophosphamide	CPX	PA449165	1371;10682;1377	0.648
NULL	Biosci_Rep_2012_Apr_1_32(Pt_2)_105-112.nxml.txt.nlp	22115362	SENT557	29	29	15	15	collagenase	p38	PA449107	10598;1432;7965	0.648
NULL	Arthritis_Res_Ther_2008_Mar_17_10(2)_R33.nxml.txt.nlp	18346273	SENT164	43	43	26	26	infliximab	HMGB1	PA452639	3146	0.648
NULL	Diabetes_Metab_Syndr_Obes_2010_Jul_20_3_263-273.nxml.txt.nlp	21437094	SENT184	9	9	7	7	metformin	Met	PA450395	79811	0.648
NULL	Braz_J_Med_Biol_Res_2012_Jul_20_45(10)_935-941.nxml.txt.nlp	22801415	SENT46	19	19	30	30	pioglitazone	adiponectin	PA450970	9370	0.648
NULL	Mar_Drugs_2012_Aug_22_10(8)_1852-1872.nxml.txt.nlp	23015777	SENT18	17	17	9	9	melphalan	TNF	PA450354	7124	0.648
NULL	Mol_Vis_2011_Mar_16_17_745-755.nxml.txt.nlp	21437201	SENT274	6	6	2	2	olopatadine	Gen	PA450698	348654	0.648
NULL	EMBO_Mol_Med_2012_Jul_11_4(7)_577-593.nxml.txt.nlp	22496117	SENT235	24	24	20	20	clofazimine	PAP-1	PA164748759	6100	0.648
NULL	Arch_Med_Sci_2012_Nov_9_8(5)_899-906.nxml.txt.nlp	23185202	SENT147	41	41	20	20	pioglitazone	ADN	PA450970	1675	0.648
NULL	Braz_J_Microbiol_2011_Dec_1_Oct-Dec_42(4)_1434-1436.nxml.txt.nlp	24031774	SENT34	14	14	20	20	gentamicin	TOB	PA449753	10140	0.648
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Sep_15_68(Pt_10)_o2941.nxml.txt.nlp	23125726	SENT66	12	12	6	6	ethanol	mol	PA448073	90527	0.648
NULL	J_Carcinog_2011_Dec_22_10_36.nxml.txt.nlp	22279421	SENT112	27	27	9	9	doxorubicin	RANKL	PA449412	8600	0.648
NULL	Genome_Announc_2013_Mar_7_1(2)_e00063-13.nxml.txt.nlp	23516198	SENT6	21	21	23	23	oxytetracycline	OTC	PA450757	5009	0.648
NULL	Allergy_Asthma_Immunol_Res_2009_Oct_25_1(1)_30-35.nxml.txt.nlp	20224667	SENT98	18	18	15	15	aspirin	PPARG	PA448497	5468	0.648
NULL	Arthritis_2012_Nov_18_2012_864907.nxml.txt.nlp	23209899	SENT61	30	30	19	19	thyroglobulin	CD40	PA164754910	958	0.648
NULL	Gut_2013_Sep_7_62(9)_1340-1346.nxml.txt.nlp	23135762	SENT161	18	18	34	34	ribavirin	IL28B	PA451241	282617	0.648
NULL	Leukemia_2013_Apr_14_27(4)_803-812.nxml.txt.nlp	23238589	SENT183	23	23	17	17	imatinib	IFN	PA10804	3439	0.648
NULL	Biomed_Res_Int_2013_Dec_30_2013_735835.nxml.txt.nlp	24490170	SENT177	38	38	40	40	fexofenadine	FEX	PA449621	8549	0.648
NULL	EMBO_J_2009_May_6_28(9)_1197-1207.nxml.txt.nlp	19322195	SENT294	19	19	11	11	dextran	EGF	PA449261	1950	0.648
NULL	Anesth_Essays_Res_2014_Sep-Dec_8(3)_319-323.nxml.txt.nlp	NULL	SENT51	8	8	24	24	sevoflurane	RGM	PA451341	56963	0.648
NULL	Cancers_(Basel)_2014_Apr_9_6(2)_829-859.nxml.txt.nlp	24722453	SENT1429	1	1	17	17	curcumin	IkappaBalpha	PA151958596	4792	0.648
NULL	J_Invest_Dermatol_2011_Nov_14_131(11)_2281-2288.nxml.txt.nlp	21753781	SENT22	12	12	0	0	chymotrypsin	KLK6	PA448994	5653	0.648
NULL	Crit_Care_2011_Sep_19_15(5)_R217.nxml.txt.nlp	21929764	SENT2	20	20	31	31	terlipressin	AVP	PA164781020	114548;551	0.648
NULL	Arthritis_Res_Ther_2009_Feb_3_11(1)_R15.nxml.txt.nlp	19192274	SENT212	34	34	9	9	diclofenac	IL-6	PA449293	3569	0.648
NULL	Cardiol_Ther_2013_Jun_1_2(1)_111-124.nxml.txt.nlp	25135294	SENT121	6	6	2	2	rifampin	P-gp	PA451250	5243	0.648
NULL	J_Cell_Mol_Med_2014_Apr_20_18(4)_709-720.nxml.txt.nlp	24444314	SENT267	16	16	5	5	losartan	AMPK	PA450268	5563	0.648
NULL	Front_Pharmacol_2014_May_30_5_132.nxml.txt.nlp	24910615	SENT102	24	24	0	0	estradiol	PDE7B	PA449503	27115	0.648
NULL	Oncotarget_2012_Dec_31_3(12)_1653-1668.nxml.txt.nlp	23391506	SENT175	13	13	8	8	carmustine	U87	PA448810	677775;641648	0.648
NULL	Mol_Cancer_2012_Jul_12_11_45.nxml.txt.nlp	22788833	SENT85	2	2	12	12	cisplatin	HER2	PA449014	2064	0.648
NULL	Support_Care_Cancer_2012_Dec_26_20(12)_3241-3246.nxml.txt.nlp	22534864	SENT34	9	9	18	18	palonosetron	HEC	PA10352	10403	0.648
NULL	Cell_Cycle_2013_Sep_1_12(17)_2899-2913.nxml.txt.nlp	23966157	SENT122	10	10	7	7	hyaluronan	EMMPRIN	PA165958431	682	0.648
NULL	Br_J_Cancer_2010_Jan_5_102(1)_234-235.nxml.txt.nlp	NULL	SENT8	25	25	27	27	bevacizumab	IFN	PA130232992	3439	0.648
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT222	5	5	35	35	curcumin	IL-8	PA151958596	3576	0.648
NULL	Aging_(Albany_NY)_2009_May_22_1(6)_557-572.nxml.txt.nlp	20195383	SENT16	14	14	7	7	creatine	gamma	PA164778930	9913	0.648
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT166	10	10	5	5	perifosine	NAC	PA165291471	22861	0.648
NULL	Cell_Mol_Life_Sci_2011_Apr_5_68(7)_1215-1225.nxml.txt.nlp	20820848	SENT63	6	6	18	18	ethanol	Tech	PA448073	57449	0.648
NULL	Int_J_Med_Sci_2013_Mar_19_10(5)_599-606.nxml.txt.nlp	23569422	SENT55	0	0	5	5	propofol	HO-1	PA451141	3162	0.648
NULL	Cancers_(Basel)_2014_Mar_25_6(2)_684-707.nxml.txt.nlp	24670368	SENT162	37	37	17	17	trastuzumab	HER2	PA451743	2064	0.648
NULL	J_Med_Case_Reports_2011_Aug_16_5_386.nxml.txt.nlp	21846347	SENT96	30	30	19	19	octreotide	SSTR1	PA450678	6751	0.648
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT28	10	10	19	19	atorvastatin	IL-6	PA448500	3569	0.648
NULL	Case_Rep_Endocrinol_2014_Oct_7_2014_584513.nxml.txt.nlp	25400957	SENT44	11	11	18	18	thyroglobulin	TTF-1	PA164754910	7080	0.648
NULL	J_Parasitol_Res_2012_Jun_27_2012_275436.nxml.txt.nlp	22792440	SENT247	26	26	3	3	l-arginine	IL-4	PA448478	3565	0.648
NULL	J_Nutr_Metab_2011_Jul_28_2011_235389.nxml.txt.nlp	21811679	SENT50	43	43	35	35	rosiglitazone	CORT	PA451283	1325	0.648
NULL	Br_J_Cancer_2009_Mar_10_100(5)_758-763.nxml.txt.nlp	19259094	SENT71	9	9	21	21	decitabine	MLH1	PA164749631	4292	0.648
NULL	Crit_Care_2009_Jul_10_13(4)_R113.nxml.txt.nlp	19591694	SENT166	10	10	8	8	terlipressin	AVP	PA164781020	114548;551	0.648
NULL	Oxid_Med_Cell_Longev_2013_Apr_3_2013_781050.nxml.txt.nlp	23691267	SENT190	30	30	12	12	ethanol	CYP2E1	PA448073	1571	0.648
NULL	Breast_Cancer_Res_2006_Nov_6_8(6)_215.nxml.txt.nlp	17096862	SENT175	16	16	19	19	trastuzumab	MUC4	PA451743	4585	0.648
NULL	Cent_European_J_Urol_2013_Dec_19_66(4)_394-404.nxml.txt.nlp	24757527	SENT263	10	10	12	12	bevacizumab	IFN	PA130232992	3439	0.648
NULL	Mol_Biol_Cell_2013_Dec_15_24(24)_3939-3944.nxml.txt.nlp	24152728	SENT141	8	8	16	16	tamoxifen	CCN2	PA451581	1490	0.648
NULL	Ann_Saudi_Med_2010_Jan-Feb_30(1)_38-49.nxml.txt.nlp	20103957	SENT165	0	0	7	7	rifampin	NOT	PA451250	4929	0.648
NULL	Drugs_R_D_2010_Nov_25_10(4)_219-224.nxml.txt.nlp	21171668	SENT4	23	23	9	9	clopidogrel	LTA	PA449053	4049	0.648
NULL	Biologics_2009_Oct_12_3_443-457.nxml.txt.nlp	19851470	SENT219	7	7	4	4	denosumab	RANKL	PA166048634	8600	0.648
NULL	Breast_Cancer_(Auckl)_2010_Feb_16_4_1-3.nxml.txt.nlp	20697527	SENT19	5	5	12	12	curcumin	CTX	PA151958596	1593	0.648
NULL	Biomed_Res_Int_2013_Jun_17_2013_459196.nxml.txt.nlp	23844362	SENT38	28	28	35	35	l-glutamine	CO2	PA10090	4513	0.648
NULL	Cancer_Res_Treat_2012_Mar_31_44(1)_37-42.nxml.txt.nlp	22500159	SENT166	17	17	11	11	docetaxel	GEM	PA449383	2669	0.648
NULL	Anal_Bioanal_Chem_2010_Aug_14_397(7)_2977-2986.nxml.txt.nlp	20549493	SENT46	24	24	9	9	estradiol	TRIM	PA449503	50852	0.648
NULL	Cell_Biol_Int_Rep_(2010)_2012_Jun_21_19(1)_e00017.nxml.txt.nlp	23124518	SENT83	25	25	11	11	etoposide	TRAIL	PA449552	8743	0.648
NULL	Am_J_Trop_Med_Hyg_2012_Nov_7_87(5_Suppl)_137-143.nxml.txt.nlp	23136289	SENT141	7	7	17	17	amoxicillin	PKR	PA448406	5610	0.648
NULL	Front_Neurosci_2014_Nov_24_8_380.nxml.txt.nlp	25505380	SENT311	26	26	23	23	estradiol	COMT	PA449503	1312	0.648
NULL	Infect_Agent_Cancer_2009_Jun_17_4(Suppl_2)_O9.nxml.txt.nlp	NULL	SENT3	3	3	5	5	rituximab	CHOP	PA451261	1649	0.648
NULL	Allergy_Asthma_Immunol_Res_2012_May_14_4(3)_137-142.nxml.txt.nlp	22548206	SENT134	23	23	25	25	naproxen	PRX	PA450595	9588;57716	0.648
NULL	Mol_Biol_Cell_2012_Nov_1_23(21)_4212-4225.nxml.txt.nlp	22956765	SENT263	13	13	4	4	thrombin	SHP2	PA451674	5781	0.648
NULL	Ann_N_Y_Acad_Sci_2013_Mar_28_1280(1)_19-23.nxml.txt.nlp	23551097	SENT86	15	15	20	20	letrozole	HER2	PA450196	2064	0.648
NULL	Clin_Ophthalmol_2014_Jun_28_8_1241-1252.nxml.txt.nlp	25061271	SENT136	5	5	11	11	timolol	BAK	PA451690	578	0.648
NULL	BMB_Rep_2013_Aug_46(8)_410-415.nxml.txt.nlp	23977989	SENT224	10	10	5	5	curcumin	AP-1	PA151958596	2353;3727;2354;3725	0.648
NULL	Ecancermedicalscience_2009_Aug_5_3_144.nxml.txt.nlp	22276009	SENT22	11	11	15	15	vincristine	CHOP	PA451879	1649	0.648
NULL	Mol_Vis_2012_Nov_29_18_2839-2846.nxml.txt.nlp	23233786	SENT167	6	6	17	17	geldanamycin	CB2	PA152031327	1269	0.648
NULL	Indian_J_Pharmacol_2014_Nov-Dec_46(6)_627-632.nxml.txt.nlp	25538335	SENT156	15	15	13	13	metformin	Q10	PA450395	27161	0.648
NULL	Acta_Vet_Scand_2011_Feb_17_53(1)_11.nxml.txt.nlp	21324209	SENT61	26	26	24	24	oxytetracycline	OTC	PA450757	5009	0.648
NULL	Cardiovasc_Diabetol_2010_Sep_23_9_57.nxml.txt.nlp	20863381	SENT24	31	31	15	15	pioglitazone	DM2	PA450970	28508	0.648
NULL	ScientificWorldJournal_2012_Aug_13_2012_496453.nxml.txt.nlp	22927782	SENT31	0	0	17	17	liraglutide	GLP-1	PA165958364	100125288	0.648
NULL	Eur_J_Clin_Pharmacol_2011_May_8_67(5)_493-506.nxml.txt.nlp	21140139	SENT286	15	15	10	10	oxycodone	CYP3A4	PA450741	1576	0.648
NULL	Cancer_Inform_2014_Oct_14_13(Suppl_1)_103-111.nxml.txt.nlp	25392688	SENT213	7	7	28	28	curcumin	Bcl-2	PA151958596	596	0.648
NULL	Orphanet_J_Rare_Dis_2013_Apr_4_8_51.nxml.txt.nlp	23557332	SENT178	20	20	23	23	galsulfase	ARSB	PA164746235	411	0.648
NULL	Arthritis_Res_Ther_2013_Oct_28_15(5)_R168.nxml.txt.nlp	24289101	SENT26	12	12	16	16	bleomycin	CD19	PA448645	930	0.648
NULL	Aging_(Albany_NY)_2009_Apr_21_1(4)_402-411.nxml.txt.nlp	20148189	SENT149	24	24	13	13	bleomycin	HCA2	PA448645	139081;55811;338442	0.648
NULL	Arthritis_Res_Ther_2004_Feb_24_6(Suppl_1)_24.nxml.txt.nlp	NULL	SENT14	1	1	5	5	infliximab	OPGL	PA452639	8600	0.648
NULL	J_Headache_Pain_2012_Mar_14_13(2)_159-166.nxml.txt.nlp	22246026	SENT143	8	8	0	0	sumatriptan	ANOVA	PA451566	4858	0.648
NULL	Eur_J_Clin_Microbiol_Infect_Dis_2010_May_13_29(5)_543-550.nxml.txt.nlp	20229224	SENT73	13	13	47	47	ciprofloxacin	VAN	PA449009	10318	0.648
NULL	Mol_Cancer_2007_Aug_21_6_53.nxml.txt.nlp	17711579	SENT262	7	7	24	24	cisplatin	SOX7	PA449014	83595	0.648
NULL	Chem_Cent_J_2013_Mar_27_7_57.nxml.txt.nlp	23537428	SENT7	11	11	25	25	exemestane	aromatase	PA449563	1588	0.648
NULL	Croat_Med_J_2014_Jun_55(3)_206-217.nxml.txt.nlp	24891279	SENT80	24	24	34	34	doxorubicin	p53	PA449412	7157	0.648
NULL	Cardiovasc_Diabetol_2013_Oct_17_12_150.nxml.txt.nlp	24134550	SENT34	43	43	24	24	metformin	activin	PA450395	83729	0.648
NULL	J_Immunother_Cancer_2014_Nov_6_2(Suppl_3)_P199.nxml.txt.nlp	NULL	SENT8	36	36	32	32	cetuximab	PD-L1	PA10040	29126	0.648
NULL	Mol_Biol_Cell_2014_Jun_1_25(11)_1782-1792.nxml.txt.nlp	24719457	SENT171	6	6	10	10	nicotine	BDNF	PA450626	627	0.648
NULL	Cancer_Res_Treat_2012_Sep_30_44(3)_195-201.nxml.txt.nlp	23091446	SENT161	12	12	3	3	etoposide	c-Jun	PA449552	3725	0.648
NULL	Biomed_Res_Int_2013_Sep_5_2013_929531.nxml.txt.nlp	24083250	SENT177	9	9	2	2	hyaluronan	RHAMM	PA165958431	3161	0.648
NULL	Br_J_Pharmacol_2014_Dec_24_171(23)_5431-5445.nxml.txt.nlp	25052258	SENT134	16	16	0	0	propranolol	SPAP	PA451145	10158	0.648
NULL	J_Gen_Physiol_2012_Nov_140(5)_541-555.nxml.txt.nlp	23109716	SENT323	33	33	12	12	capsaicin	TRPV1	PA448776	7442	0.648
NULL	Arthritis_Res_Ther_2011_Feb_16_13(1)_R25.nxml.txt.nlp	21324169	SENT150	38	38	18	18	infliximab	TNF	PA452639	7124	0.648
NULL	Bone_Marrow_Transplant_2011_Jul_11_46(7)_943-949.nxml.txt.nlp	20935680	SENT105	5	5	7	7	plerixafor	CD34	PA165958410	947	0.648
NULL	Mol_Cells_2014_Sep_30_37(9)_664-671.nxml.txt.nlp	25234467	SENT201	12	12	8	8	cisplatin	miR-217	PA449014	406999	0.648
NULL	Ann_Surg_Oncol_2012_Dec_6_19(13)_4287-4299.nxml.txt.nlp	22766981	SENT20	27	27	25	25	bevacizumab	VEGF-A	PA130232992	7422	0.648
NULL	Breast_Cancer_Res_2010_May_18_12(Suppl_1)_P2.nxml.txt.nlp	NULL	SENT11	19	19	8	8	tamoxifen	FOXM1	PA451581	2305	0.648
NULL	Mol_Med_Rep_2014_Oct_23_10(4)_1717-1724.nxml.txt.nlp	25069516	SENT170	0	0	10	10	resveratrol	PC-3		692094	0.648
NULL	Breast_Cancer_Res_2003_Feb_5_5(2)_113-116.nxml.txt.nlp	12631392	SENT94	37	37	27	27	paclitaxel	HER-2	PA450761	2064	0.648
NULL	Oncogene_2013_Nov_28_32(48)_5439-5448.nxml.txt.nlp	23563182	SENT174	21	21	23	23	vincristine	TRAIL	PA451879	8743	0.648
NULL	Int_J_Gen_Med_2012_Nov_9_5_935-942.nxml.txt.nlp	23204857	SENT77	6	6	10	10	isoflurane	AIDA	PA450106	64853	0.648
NULL	Emerg_Infect_Dis_2011_Mar_17(3)_510-513.nxml.txt.nlp	21392446	SENT53	18	18	16	16	ethambutol	EMB	PA164784021	133418	0.648
NULL	J_Mol_Med_2008_Sep_4_86(9)_1045-1056.nxml.txt.nlp	18600309	SENT35	10	10	27	27	salmeterol	IL-8	PA451300	3576	0.648
NULL	Oncol_Rep_2012_Apr_30_27(4)_954-958.nxml.txt.nlp	22209887	SENT132	7	7	11	11	collagenase	HSC3	PA449107	150353	0.648
NULL	Oxid_Med_Cell_Longev_2013_Jul_9_2013_574029.nxml.txt.nlp	23936610	SENT204	4	4	14	14	resveratrol	RAGE		177	0.648
NULL	Cancer_Med_2014_Jun_27_3(3)_462-471.nxml.txt.nlp	24573979	SENT273	7	7	16	16	brivanib	VEGFR	PA164924492	3791	0.648
NULL	Environ_Health_Perspect_2002_Dec_110(Suppl_6)_1031-1036.nxml.txt.nlp	12634135	SENT7	20	20	0	0	pyridostigmine	PTN	PA451185	5764	0.648
NULL	Aquat_Biosyst_2012_Apr_17_8_9.nxml.txt.nlp	22510370	SENT191	22	22	39	39	nadh	PHB	PA164755085	5245	0.648
NULL	Exp_Mol_Med_2012_May_31_44(5)_319-329.nxml.txt.nlp	22314196	SENT13	15	15	22	22	methacholine	VDBP	PA165958382	2638	0.648
NULL	Clin_Mol_Hepatol_2012_Jun_26_18(2)_109-162.nxml.txt.nlp	22893865	SENT688	17	17	19	19	lamivudine	IFN	PA450163	3439	0.648
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_May_11_67(Pt_6)_o1379.nxml.txt.nlp	21754769	SENT68	26	26	10	10	ethanol	mol	PA448073	90527	0.648
NULL	Breast_Cancer_Res_2012_Feb_14_14(1)_R30.nxml.txt.nlp	22333315	SENT168	12	12	17	17	celecoxib	IFN	PA448871	3439	0.648
NULL	Br_J_Cancer_2006_Dec_4_95(11)_1483-1489.nxml.txt.nlp	17106442	SENT145	16	16	1	1	gefitinib	EGFR	PA131301952	1956	0.648
NULL	Acta_Pharmacol_Sin_2010_Nov_18_31(11)_1447-1453.nxml.txt.nlp	20953204	SENT109	5	5	17	17	rimonabant	MCP-1	PA152407999	6347	0.648
NULL	Br_J_Cancer_1995_Feb_71(2)_294-299.nxml.txt.nlp	7841043	SENT9	17	17	9	9	vinblastine	P-gp	PA451877	5243	0.648
NULL	Patient_Prefer_Adherence_2011_Dec_23_6_1-9.nxml.txt.nlp	22272064	SENT11	0	0	2	2	telmisartan	ACE	PA451605	1636	0.648
NULL	Mol_Pain_2014_Apr_9_10_24.nxml.txt.nlp	24716552	SENT165	13	13	22	22	capsaicin	NK1R	PA448776	6869	0.648
NULL	Br_J_Cancer_1994_Mar_69(3)_537-540.nxml.txt.nlp	8123484	SENT8	15	15	21	21	cyclophosphamide	GM-CSF	PA449165	1437	0.648
NULL	Eur_J_Clin_Microbiol_Infect_Dis_2010_Nov_1_29(11)_1361-1367.nxml.txt.nlp	20680368	SENT80	2	2	4	4	linezolid	VAN	PA450233	10318	0.648
NULL	Eur_Respir_J_2012_Nov_26_40(5)_1106-1114.nxml.txt.nlp	23060624	SENT186	10	10	20	20	tiotropium	TDI	PA164769056	100038246	0.648
NULL	Asian-Australas_J_Anim_Sci_2014_Dec_27(12)_1783-1793.nxml.txt.nlp	25358373	SENT135	0	0	2	2	capsaicin	BAX	PA448776	581	0.648
NULL	Breast_Cancer_Res_2009_Jul_15_11(4)_207.nxml.txt.nlp	19664181	SENT226	6	6	20	20	bevacizumab	HER2	PA130232992	2064	0.648
NULL	Breast_Cancer_Res_2004_Mar_18_6(3)_119-127.nxml.txt.nlp	15084232	SENT136	0	0	18	18	resveratrol	pS2		7031	0.648
NULL	Crit_Care_2014_Mar_17_18(Suppl_1)_P488.nxml.txt.nlp	NULL	SENT5	12	12	19	19	heparin	ACT	PA449855	12;11332;9457;641455	0.647
NULL	Diabetol_Metab_Syndr_2014_Mar_31_6_48.nxml.txt.nlp	24684803	SENT117	28	28	8	8	mitiglinide	STEP	PA164748124	84867	0.647
NULL	Oncologist_2010_Mar_9_15(3)_236-245.nxml.txt.nlp	20215359	SENT11	7	7	12	12	bevacizumab	IFN	PA130232992	3439	0.647
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jul_23_67(Pt_8)_m1132.nxml.txt.nlp	22090894	SENT62	11	11	38	38	ethanol	mol	PA448073	90527	0.647
NULL	Front_Neurol_2013_Oct_7_4_139.nxml.txt.nlp	24109471	SENT203	0	0	6	6	modafinil	TAAR1	PA450530	134864	0.647
NULL	Curr_Med_Chem_2013_Jun_20(19)_2415-2437.nxml.txt.nlp	23394552	SENT735	8	8	5	5	naproxen	OTC	PA450595	5009	0.647
NULL	Cancer_Cell_Int_2010_Sep_9_10_32.nxml.txt.nlp	20828393	SENT120	7	7	3	3	cisplatin	ATF3	PA449014	467	0.647
NULL	BMB_Rep_2014_Apr_47(4)_215-220.nxml.txt.nlp	24286311	SENT404	9	9	13	13	auranofin	STAT3	PA448510	6774	0.647
NULL	Aging_(Albany_NY)_2009_Jan_15_1(1)_109-121.nxml.txt.nlp	20157594	SENT104	13	13	20	20	bleomycin	SIRT6	PA448645	51548	0.647
NULL	Bioinorg_Chem_Appl_2012_Nov_26_2012_984291.nxml.txt.nlp	23226992	SENT35	5	5	12	12	piperazine	NO3	PA450977	4681	0.647
NULL	Mol_Cancer_2014_Jul_5_13_165.nxml.txt.nlp	24996221	SENT248	8	8	6	6	docetaxel	HMGB1	PA449383	3146	0.647
NULL	Oncotarget_2014_Feb_25_5(5)_1304-1314.nxml.txt.nlp	24675421	SENT132	14	14	10	10	cisplatin	MKK4	PA449014	6416	0.647
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT376	0	0	11	11	resveratrol	NMNAT1		64802	0.647
NULL	Acta_Pharmacol_Sin_2011_Jul_13_32(7)_967-972.nxml.txt.nlp	21666702	SENT68	5	5	11	11	sulfaphenazole	CYP2C9	PA130231310	1559	0.647
NULL	Oncol_Rep_2013_Apr_5_29(4)_1671-1677.nxml.txt.nlp	23404329	SENT6	16	16	23	23	curcumin	SFN	PA151958596	25996;2810	0.647
NULL	J_Med_Life_2011_Feb_15_4(1)_11-20.nxml.txt.nlp	21505570	SENT192	10	10	21	21	diclofenac	FAAH	PA449293	79152;2166	0.647
NULL	Semin_Nephrol_2013_Nov_33(6)_508-530.nxml.txt.nlp	24161037	SENT1159	0	0	10	10	eculizumab	CFI	PA164776637	3426	0.647
NULL	Oxid_Med_Cell_Longev_2013_Dec_5_2013_963520.nxml.txt.nlp	24381719	SENT18	6	6	19	19	oxygen	ROS	PA450744	6098	0.647
NULL	Mol_Microbiol_2014_May_28_92(3)_453-470.nxml.txt.nlp	24533860	SENT158	5	5	28	28	tetracycline	C40	PA451640	55571	0.647
NULL	Breast_Cancer_Res_2006_Nov_6_8(6)_215.nxml.txt.nlp	17096862	SENT180	4	4	12	12	trastuzumab	PTEN	PA451743	5728	0.647
NULL	Neuro_Oncol_2010_Apr_27_12(4)_389-400.nxml.txt.nlp	20308316	SENT134	4	4	6	6	chloroquine	p53	PA448948	7157	0.647
NULL	Acta_Pharmacol_Sin_2011_Jul_9_32(7)_879-887.nxml.txt.nlp	21552292	SENT98	11	11	5	5	metformin	AMPK	PA450395	5563	0.647
NULL	Clin_Pharmacokinet_2014_Sep_3_53(1)_1-16.nxml.txt.nlp	23999929	SENT275	8	8	16	16	rivaroxaban	P-gp	PA165958360	5243	0.647
NULL	Int_J_Biol_Sci_2013_Dec_6_10(1)_25-32.nxml.txt.nlp	24391448	SENT29	4	4	12	12	trastuzumab	HER2	PA451743	2064	0.647
NULL	J_Headache_Pain_2014_Sep_18_15(Suppl_1)_F28.nxml.txt.nlp	NULL	SENT14	21	21	24	24	verapamil	MDR1	PA451868	5243	0.647
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT131	28	28	18	18	trastuzumab	HER2	PA451743	2064	0.647
NULL	Libyan_J_Med_2008_Jun_1_3(2)_78-83.nxml.txt.nlp	21499463	SENT129	11	11	2	2	clonidine	CA1	PA449051	759	0.647
NULL	Cardiovasc_Diabetol_2013_Jan_31_12_28.nxml.txt.nlp	23368770	SENT110	13	13	6	6	glucose	DIA	PA449773	1730;3976	0.647
NULL	Cancer_Med_2013_Dec_27_2(6)_751-762.nxml.txt.nlp	24403249	SENT174	0	0	10	10	paclitaxel	CD44	PA450761	960	0.647
NULL	J_Vet_Med_Sci_2014_May_13_76(5)_629-636.nxml.txt.nlp	24419976	SENT154	28	28	30	30	indomethacin	EP2	PA449982	5732;10407	0.647
NULL	J_Antimicrob_Chemother_2011_Jun_25_66(6)_1332-1339.nxml.txt.nlp	21441248	SENT33	29	29	7	7	nevirapine	CYP2B6	PA450616	1555	0.647
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT128	11	11	3	3	warfarin	CYP2D6	PA451906	1565	0.647
NULL	Drugs_2014_Jul_18_74(11)_1209-1231.nxml.txt.nlp	25034361	SENT231	26	26	1	1	enoxaparin	STARS	PA449463	137735	0.647
NULL	BMJ_Open_2014_May_5_4(5)_e005268.nxml.txt.nlp	24801283	SENT89	14	14	24	24	clopidogrel	SAS	PA449053	54187	0.647
NULL	Cancer_Cell_Int_2006_Aug_9_6_20.nxml.txt.nlp	16899133	SENT104	25	25	17	17	genistein	p27	PA165109660	5715;10534	0.647
NULL	Biomed_Res_Int_2013_Dec_30_2013_735835.nxml.txt.nlp	24490170	SENT169	38	38	40	40	fexofenadine	FEX	PA449621	8549	0.647
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Nov_13_64(Pt_12)_o2319.nxml.txt.nlp	21581295	SENT58	20	20	11	11	ethanol	mol	PA448073	90527	0.647
NULL	J_Am_Heart_Assoc_2013_Aug_23_2(4)_e000264.nxml.txt.nlp	23896681	SENT158	26	26	11	11	thrombin	FVIII	PA451674	2157	0.647
NULL	Indian_J_Pharmacol_2014_Mar-Apr_46(2)_211-215.nxml.txt.nlp	24741196	SENT2	14	14	11	11	carbamazepine	NAC	PA448785	22861	0.647
NULL	Curr_Oncol_2009_Jul_16(Suppl_2)_S1-S13.nxml.txt.nlp	19672416	SENT135	33	33	5	5	anastrozole	ARNO	PA448432	9266	0.647
NULL	Adv_Hematol_2012_Aug_2_2012_842945.nxml.txt.nlp	22919394	SENT97	2	2	14	14	lenalidomide	IL-6	PA162363968	3569	0.647
NULL	Cancer_Res_Treat_2011_Dec_27_43(4)_255-259.nxml.txt.nlp	22247712	SENT20	7	7	11	11	vincristine	CHOP	PA451879	1649	0.647
NULL	Curr_Neuropharmacol_2013_Dec_11(6)_592-597.nxml.txt.nlp	24396335	SENT79	2	2	15	15	capsaicin	TRPV1	PA448776	7442	0.647
NULL	Gut_2013_Sep_7_62(9)_1340-1346.nxml.txt.nlp	23135762	SENT5	27	27	23	23	ribavirin	IFN	PA451241	3439	0.647
NULL	Int_J_Biol_Sci_2014_Sep_21_10(10)_1108-1115.nxml.txt.nlp	25332685	SENT15	28	28	30	30	dexmedetomidine	DMT	PA449256	2039	0.647
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT321	16	16	11	11	cisplatin	DR5	PA449014	8795	0.647
NULL	Front_Oncol_2014_Apr_10_4_76.nxml.txt.nlp	24782987	SENT63	20	20	17	17	gemcitabine	MTD	PA449748	4493	0.647
NULL	Curr_Rheumatol_Rep_2010_Oct_30_12(5)_370-378.nxml.txt.nlp	20676807	SENT129	2	2	31	31	etanercept	p38	PA449515	10598;1432;7965	0.647
NULL	Core_Evid_2010_Oct_21_5_61-76.nxml.txt.nlp	21042543	SENT390	20	20	15	15	panitumumab	KRAS	PA162373091	3845	0.647
NULL	Acta_Pharmacol_Sin_2011_Feb_4_32(2)_223-229.nxml.txt.nlp	21293474	SENT147	16	16	26	26	l-arginine	FKBP12	PA448478	2280	0.647
NULL	Emerg_Infect_Dis_2012_Feb_18(2)_302-304.nxml.txt.nlp	22305387	SENT113	20	20	10	10	clindamycin	CTX	PA449035	1593	0.647
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT357	6	6	28	28	aripiprazole	PRL	PA10026	5617	0.647
NULL	Arthritis_Res_Ther_2010_Apr_29_12(2)_R73.nxml.txt.nlp	20429888	SENT13	0	0	13	13	bortezomib	SP1	PA10252	6667	0.647
NULL	Am_J_Physiol_Cell_Physiol_2009_Oct_5_297(4)_C898-C906.nxml.txt.nlp	19657054	SENT284	35	35	21	21	collagenase	p38	PA449107	10598;1432;7965	0.647
NULL	J_Immunol_Res_2014_May_8_2014_565320.nxml.txt.nlp	24901010	SENT143	26	26	23	23	carbamazepine	HLA-B	PA448785	3106	0.647
NULL	Acta_Histochem_Cytochem_2011_Apr_28_44(2)_51-60.nxml.txt.nlp	21614166	SENT460	35	35	27	27	thalidomide	CD31	PA451644	5175	0.647
NULL	Scientifica_(Cairo)_2012_May_29_2012_607427.nxml.txt.nlp	24278720	SENT228	6	6	8	8	hyaluronidase	PH-20	PA164745713	6677	0.647
NULL	Crit_Care_2010_Nov_5_14(6)_R200.nxml.txt.nlp	21054850	SENT124	1	1	3	3	vasopressin	AVP	PA451858	114548;551	0.647
NULL	Arthritis_Res_Ther_2009_Aug_24_11(4)_R127.nxml.txt.nlp	19703304	SENT148	3	3	1	1	adalimumab	OASIS	PA10004	90993	0.647
NULL	Case_Rep_Dent_2013_Jun_13_2013_852932.nxml.txt.nlp	23840974	SENT60	15	15	9	9	doxorubicin	CHOP	PA449412	1649	0.647
NULL	Arthritis_Res_Ther_2008_Oct_15_10(Suppl_1)_S4.nxml.txt.nlp	19007424	SENT34	25	25	33	33	rituximab	ACR	PA451261	49	0.647
NULL	Emerg_Infect_Dis_2013_Jan_19(1)_133-136.nxml.txt.nlp	23260464	SENT42	14	14	20	20	ciprofloxacin	TOB	PA449009	10140	0.647
NULL	Front_Physiol_2011_Apr_12_2_13.nxml.txt.nlp	21559063	SENT261	17	17	23	23	creatine	ADP	PA164778930	23038	0.647
NULL	Niger_Med_J_2014_Jul-Aug_55(4)_327-332.nxml.txt.nlp	25114369	SENT15	4	4	11	11	isoniazid	RIF	PA450112	54509;80196	0.647
NULL	Am_J_Physiol_Cell_Physiol_2009_Oct_5_297(4)_C898-C906.nxml.txt.nlp	19657054	SENT284	35	35	23	23	collagenase	c-Jun	PA449107	3725	0.647
NULL	Arthritis_Res_Ther_2014_Dec_3_16(6)_484.nxml.txt.nlp	25465897	SENT181	38	38	32	32	hyaluronan	UGDH	PA165958431	7358	0.647
NULL	Mol_Biol_Evol_2012_Jan_8_29(1)_367-379.nxml.txt.nlp	21903677	SENT133	29	29	21	21	nadh	TIM	PA164755085	7984;8914	0.647
NULL	Mediators_Inflamm_2010_Jun_21_2010_194896.nxml.txt.nlp	20652055	SENT48	28	28	17	17	olmesartan	mol	PA164742950	90527	0.647
NULL	Clin_Epigenetics_2011_Dec_5_3(1)_8.nxml.txt.nlp	22414275	SENT163	8	8	16	16	ribavirin	ESR1	PA451241	2099	0.647
NULL	Breast_Cancer_Res_2007_Jun_4_9(3)_207.nxml.txt.nlp	17561991	SENT60	32	32	37	37	trastuzumab	HER-2	PA451743	2064	0.647
NULL	Croat_Med_J_2012_Jun_53(3)_214-223.nxml.txt.nlp	22661134	SENT73	3	3	17	17	yohimbine	ACTH	PA451946	5443	0.647
NULL	J_Oncol_2009_Mar_24_2009_491985.nxml.txt.nlp	19325924	SENT7	2	2	15	15	genistein	CXCL12	PA165109660	6387	0.647
NULL	J_Hematol_Oncol_2011_Jan_21_4_5.nxml.txt.nlp	21255411	SENT15	0	0	3	3	paclitaxel	EGFR	PA450761	1956	0.647
NULL	J_Headache_Pain_2013_Mar_12_14(1)_25.nxml.txt.nlp	23566208	SENT76	19	19	35	35	topiramate	LEP	PA451728	3952	0.647
NULL	Int_J_Cell_Biol_2013_Nov_13_2013_674751.nxml.txt.nlp	24324498	SENT154	10	10	29	29	bacitracin	SOD1	PA448531	6647	0.647
NULL	New_Microbes_New_Infect_2014_May_4_2(3)_58-63.nxml.txt.nlp	25356345	SENT100	42	42	24	24	meropenem	ANK	PA164764445	56172	0.647
NULL	Mediators_Inflamm_2010_Jun_2_2010_682879.nxml.txt.nlp	20592757	SENT15	10	10	26	26	l-arginine	NOS1	PA448478	340719;4842	0.647
NULL	Oncotarget_2013_Dec_28_5(6)_1475-1490.nxml.txt.nlp	24721996	SENT3	2	2	4	4	celecoxib	CD44	PA448871	960	0.647
NULL	Bioinformation_2012_Jan_6_8(1)_13-19.nxml.txt.nlp	22359429	SENT142	11	11	16	16	curcumin	MRP2	PA151958596	100130958;57626;1244	0.647
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Feb_17_6_29-36.nxml.txt.nlp	24648767	SENT53	29	29	9	9	tamoxifen	BRCA1	PA451581	672	0.647
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT140	21	21	23	23	lovastatin	AKT	PA450272	207	0.647
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT119	44	44	46	46	perifosine	TRAIL	PA165291471	8743	0.647
NULL	Ann_Rheum_Dis_2009_Oct_17_68(10)_1580-1584.nxml.txt.nlp	19019888	SENT20	10	10	13	13	tocilizumab	IL-6	PA165292659	3569	0.647
NULL	Mol_Biol_Cell_2014_Jun_1_25(11)_1782-1792.nxml.txt.nlp	24719457	SENT99	22	22	9	9	nicotine	ASCL1	PA450626	429	0.647
NULL	Chemother_Res_Pract_2011_Sep_25_2011_730360.nxml.txt.nlp	22295205	SENT176	12	12	21	21	trastuzumab	HER2	PA451743	2064	0.647
NULL	Curr_Neuropharmacol_2010_Sep_8(3)_254-267.nxml.txt.nlp	21358975	SENT151	0	0	8	8	felbamate	CYP3A4	PA449590	1576	0.647
NULL	Curr_Neuropharmacol_2010_Jun_8(2)_122-127.nxml.txt.nlp	21119883	SENT97	11	11	13	13	vasopressin	AVP	PA451858	114548;551	0.647
NULL	Chem_Cent_J_2014_Sep_17_8(1)_59.nxml.txt.nlp	NULL	SENT16	0	0	2	2	moxifloxacin	MOX	PA450555	26002	0.647
NULL	Crit_Care_2006_Jan_13_10(1)_R16.nxml.txt.nlp	16420659	SENT77	26	26	40	40	fluorescein	San	PA164746009	80218	0.647
NULL	Oncotarget_2014_Jun_6_5(13)_4935-4944.nxml.txt.nlp	24952732	SENT72	5	5	10	10	doxazosin	PI3K	PA449407	5290	0.647
NULL	Emerg_Infect_Dis_2013_Jul_19(7)_1151-1152.nxml.txt.nlp	23763791	SENT19	31	31	19	19	ethambutol	DST	PA164784021	667	0.647
NULL	Environ_Health_Perspect_2007_Apr_4_115(4)_548-555.nxml.txt.nlp	17450223	SENT102	20	20	22	22	paraformaldehyde	PLP	PA450790	25824;5744	0.647
NULL	Ther_Clin_Risk_Manag_2007_Jun_3(2)_333-339.nxml.txt.nlp	18360642	SENT136	5	5	17	17	metoclopramide	NK1	PA450475	11126	0.647
NULL	Eur_J_Clin_Pharmacol_2014_Sep_27_70(1)_65-77.nxml.txt.nlp	24071959	SENT360	6	6	12	12	tacrolimus	CYP3A5	PA451578	1577	0.647
NULL	Cancer_Cell_Int_2014_Jan_27_14_8.nxml.txt.nlp	24467885	SENT110	20	20	16	16	fluorouracil	IFN	PA128406956	3439	0.647
NULL	Biomed_Res_Int_2014_Feb_10_2014_708593.nxml.txt.nlp	24689050	SENT268	7	7	0	0	dextran	TEM	PA449261	64102	0.647
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT124	18	18	7	7	curcumin	TRAIL	PA151958596	8743	0.647
NULL	Int_J_Mol_Sci_2014_Mar_5_15(3)_4007-4018.nxml.txt.nlp	24603539	SENT251	1	1	3	3	cisplatin	MSH2	PA449014	4436	0.647
NULL	Br_J_Cancer_2009_Jun_2_100(11)_1697-1703.nxml.txt.nlp	19384299	SENT96	25	25	20	20	indomethacin	IL-10	PA449982	3586	0.647
NULL	Nat_Methods_2011_Feb_16_8(2)_165-170.nxml.txt.nlp	21240280	SENT177	16	16	34	34	trypsin	OMI	PA451806	27429	0.647
NULL	Ann_Clin_Microbiol_Antimicrob_2014_Jan_6_13_2.nxml.txt.nlp	24393536	SENT42	20	20	14	14	azithromycin	TOB	PA448519	10140	0.647
NULL	Gut_2012_Nov_15_61(11)_1589-1599.nxml.txt.nlp	NULL	SENT67	24	24	17	17	ribavirin	IFN	PA451241	3439	0.647
NULL	Front_Genet_2013_Aug_29_4_163.nxml.txt.nlp	24009622	SENT14	5	5	9	9	ethanol	ABCG2	PA448073	9429	0.647
NULL	Breast_Cancer_Res_2010_Dec_16_12(6)_215.nxml.txt.nlp	21176175	SENT194	15	15	18	18	indomethacin	EP4	PA449982	5734	0.647
NULL	Oncotarget_2013_Dec_18_5(2)_375-385.nxml.txt.nlp	24495868	SENT116	3	3	7	7	fludarabine	BCL2	PA449655	596	0.647
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT286	10	10	4	4	warfarin	VKORC1	PA451906	79001	0.647
NULL	J_Korean_Med_Sci_2006_Dec_31_21(6)_973-978.nxml.txt.nlp	17179671	SENT167	2	2	8	8	piperacillin	CTX	PA450975	1593	0.647
NULL	Cancers_(Basel)_2014_Apr_9_6(2)_829-859.nxml.txt.nlp	24722453	SENT1429	1	1	19	19	curcumin	c-Jun	PA151958596	3725	0.647
NULL	Oncotarget_2011_Dec_17_2(12)_1011-1027.nxml.txt.nlp	22184288	SENT354	20	20	22	22	doxorubicin	AurB	PA449412	9212	0.647
NULL	Neural_Regen_Res_2013_May_25_8(15)_1368-1375.nxml.txt.nlp	25206431	SENT23	3	3	17	17	curcumin	Bcl-2	PA151958596	596	0.647
NULL	Emerg_Infect_Dis_2005_Jun_11(6)_873-882.nxml.txt.nlp	15963282	SENT89	22	22	16	16	cefepime	TOB	PA164754876	10140	0.647
NULL	Pharmaceuticals_(Basel)_2012_Feb_2_5(2)_114-132.nxml.txt.nlp	24288084	SENT166	39	39	42	42	capsaicin	TRPV1	PA448776	7442	0.647
NULL	J_Invest_Dermatol_2011_Dec_22_131(12)_2467-2476.nxml.txt.nlp	21938011	SENT237	14	14	3	3	everolimus	MVD	PA164746311	4597	0.647
NULL	J_Med_Chem_2014_Jan_23_57(2)_449-461.nxml.txt.nlp	24387105	SENT260	27	27	32	32	benzaldehyde	ALDH3A1	PA448571	218	0.647
NULL	Biomed_Res_Int_2013_Dec_17_2013_696317.nxml.txt.nlp	24455716	SENT171	6	6	4	4	l-arginine	NAC	PA448478	22861	0.647
NULL	Ann_Gen_Psychiatry_2008_Aug_18_7_11.nxml.txt.nlp	18706108	SENT70	21	21	30	30	bupropion	CD50	PA448687	3385	0.647
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT143	34	34	39	39	perifosine	DR5	PA165291471	8795	0.647
NULL	Indian_J_Crit_Care_Med_2008_Oct-Dec_12(4)_181-189.nxml.txt.nlp	19742267	SENT204	14	14	5	5	anakinra	ACR	PA10799	49	0.647
NULL	Br_J_Cancer_2002_Jan_21_86(2)_218-221.nxml.txt.nlp	11870509	SENT20	14	14	23	23	tamoxifen	BRCA2	PA451581	675	0.647
NULL	Virol_J_2012_Aug_3_9_143.nxml.txt.nlp	22863531	SENT24	9	9	6	6	ribavirin	IFN	PA451241	3439	0.647
NULL	J_Lipid_Res_2014_Feb_55(2)_190-200.nxml.txt.nlp	24273196	SENT22	17	17	19	19	lipase	ATGL	PA450239	57104	0.647
NULL	Curr_Med_Chem_2014_Jul_21_663-688.nxml.txt.nlp	24251566	SENT355	12	12	31	31	pilocarpine	CA1	PA450962	759	0.647
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Aug_6_64(Pt_9)_o1694.nxml.txt.nlp	21201683	SENT61	23	23	14	14	ethanol	mol	PA448073	90527	0.647
NULL	Bone_2012_Jan_50(1)_218-225.nxml.txt.nlp	22023931	SENT20	24	24	30	30	iron	FGF23	PA450087	8074	0.647
NULL	Ther_Clin_Risk_Manag_2007_Mar_3(1)_59-69.nxml.txt.nlp	18360616	SENT123	25	25	23	23	paroxetine	PRX	PA450801	9588;57716	0.647
NULL	J_Korean_Med_Sci_2013_Jun_3_28(6)_939-945.nxml.txt.nlp	23772162	SENT133	0	0	14	14	resveratrol	IL-8		3576	0.647
NULL	J_Korean_Med_Sci_2009_Jan_29_24(Suppl_1)_S170-S175.nxml.txt.nlp	19194548	SENT81	7	7	9	9	cisplatin	EPO	PA449014	7076;8288;2056	0.647
NULL	Cell_Death_Dis_2010_Nov_18_1(11)_e102.nxml.txt.nlp	21368867	SENT68	0	0	5	5	gentamicin	CLIMP-63	PA449753	10970	0.647
NULL	Front_Neurosci_2012_May_30_6_77.nxml.txt.nlp	22661925	SENT176	9	9	4	4	ethanol	DCX	PA448073	1641	0.647
NULL	Eur_J_Clin_Pharmacol_2014_Mar_22_70(6)_685-693.nxml.txt.nlp	24658827	SENT248	16	16	8	8	midazolam	CYP3A	PA450496	1574	0.647
NULL	J_Mol_Signal_2006_Dec_6_1_8.nxml.txt.nlp	17224083	SENT29	27	27	34	34	thrombin	Rho	PA451674	29984	0.647
NULL	Pharmaceuticals_(Basel)_2013_Nov_4_6(11)_1361-1380.nxml.txt.nlp	24287462	SENT733	13	13	16	16	cisplatin	HER2	PA449014	2064	0.647
NULL	Front_Oncol_2013_Apr_12_3_85.nxml.txt.nlp	23596569	SENT422	0	0	20	20	resveratrol	AKT		207	0.647
NULL	J_Neural_Transm_2014_Mar_27_121(10)_1221-1232.nxml.txt.nlp	24671607	SENT59	0	0	7	7	sertraline	CORT	PA451333	1325	0.647
NULL	Mol_Vis_2012_Apr_11_18_901-908.nxml.txt.nlp	22539869	SENT155	28	28	13	13	curcumin	HO-1	PA151958596	3162	0.647
NULL	Acta_Pharmacol_Sin_2009_Sep_24_30(9)_1262-1275.nxml.txt.nlp	19701231	SENT226	20	20	27	27	lovastatin	RTN3	PA450272	10313	0.647
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Nov_4_9_31.nxml.txt.nlp	21050425	SENT90	9	9	32	32	kanamycin	Gen	PA450137	348654	0.647
NULL	Exp_Ther_Med_2013_Dec_14_6(6)_1499-1503.nxml.txt.nlp	24255681	SENT99	14	14	3	3	fluorouracil	S100A3	PA128406956	6274	0.647
NULL	Ann_Oncol_2013_Apr_31_24(4)_1067-1073.nxml.txt.nlp	23117073	SENT140	12	12	33	33	fosaprepitant	CYP3A4	PA165958390	1576	0.647
NULL	Breast_Cancer_Res_2008_Jan_25_10(1)_101.nxml.txt.nlp	18226190	SENT40	10	10	8	8	denosumab	RANKL	PA166048634	8600	0.647
NULL	Clin_Transl_Allergy_2013_May_3_3(Suppl_1)_P1.nxml.txt.nlp	NULL	SENT5	21	21	18	18	omalizumab	SAA	PA164752253	6287	0.647
NULL	Biochem_Res_Int_2010_Aug_4_2010_549572.nxml.txt.nlp	21188077	SENT30	13	13	2	2	l-tyrosine	TAT	PA451822	6898	0.647
NULL	Asian-Australas_J_Anim_Sci_2014_Dec_27(12)_1783-1793.nxml.txt.nlp	25358373	SENT130	30	30	8	8	capsaicin	CEBPA	PA448776	1050	0.647
NULL	Genetics_2013_Jan_193(1)_1-50.nxml.txt.nlp	23275493	SENT211	30	30	19	19	lipase	DAG	PA450239	1605	0.647
NULL	Eur_J_Clin_Pharmacol_2012_Apr_8_68(4)_363-370.nxml.txt.nlp	21984116	SENT121	13	13	5	5	omeprazole	CYP2C19	PA450704	1557	0.647
NULL	Clin_Med_Insights_Arthritis_Musculoskelet_Disord_2012_Mar_5_5_27-42.nxml.txt.nlp	22438671	SENT65	8	8	27	27	tocilizumab	ACR	PA165292659	49	0.647
NULL	Biomed_Res_Int_2014_May_4_2014_351252.nxml.txt.nlp	24877084	SENT188	3	3	5	5	bevacizumab	FTM	PA130232992	23322	0.647
NULL	Biosci_Rep_2010_Mar_25_30(Pt_4)_277-283.nxml.txt.nlp	20100173	SENT133	15	15	8	8	sulfasalazine	SLC7A11	PA451547	23657	0.647
NULL	Biochem_Biophys_Res_Commun_2009_May_22_383(1)_63-67.nxml.txt.nlp	19332024	SENT17	24	24	33	33	lipase	ATGL	PA450239	57104	0.647
NULL	Br_J_Cancer_2011_Apr_12_104(8)_1256-1261.nxml.txt.nlp	21448165	SENT161	39	39	21	21	sorafenib	IL2	PA7000	3558	0.647
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1137-1144.nxml.txt.nlp	20234366	SENT31	4	4	12	12	cetuximab	KRAS	PA10040	3845	0.647
NULL	Indian_Dermatol_Online_J_2014_Dec_5(Suppl_2)_S92-S94.nxml.txt.nlp	25593815	SENT42	14	14	25	25	phenol	CO2	PA450913	4513	0.647
NULL	Oncotarget_2014_Aug_4_5(17)_7776-7787.nxml.txt.nlp	25277200	SENT180	6	6	3	3	paclitaxel	ANXA4	PA450761	307	0.647
NULL	Mol_Vis_2012_May_1_18_1115-1122.nxml.txt.nlp	22605923	SENT41	17	17	21	21	ethanol	EGF	PA448073	1950	0.647
NULL	Curr_Pharm_Des_2011_Dec_17(35)_3846-3853.nxml.txt.nlp	21933140	SENT146	26	26	29	29	liraglutide	GLP-1	PA165958364	100125288	0.647
NULL	J_Korean_Med_Sci_2013_Feb_29_28(2)_308-314.nxml.txt.nlp	23399960	SENT148	7	7	9	9	gabapentin	IL-10	PA449720	3586	0.647
NULL	Cancer_Med_2014_Apr_12_3(2)_390-396.nxml.txt.nlp	24519810	SENT108	42	42	10	10	telbivudine	LAM	PA164760861	7249;7248	0.647
NULL	Br_J_Cancer_2012_Jan_17_106(2)_324-332.nxml.txt.nlp	22134507	SENT46	0	0	7	7	topotecan	San	PA451729	80218	0.647
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT10	0	0	12	12	sitagliptin	HIP	PA164748978	6767;6159;64399;5068	0.647
NULL	Cell_Death_Dis_2014_Jul_17_5(7)_e1333.nxml.txt.nlp	25032856	SENT78	7	7	21	21	candesartan	EAAC1	PA448765	6505	0.647
NULL	Tob_Induc_Dis_2004_Mar_15_2(1)_1.nxml.txt.nlp	NULL	SENT262	34	34	16	16	oxygen	SP-D	PA450744	6441	0.647
NULL	Acta_Pharmacol_Sin_2012_Jun_14_33(6)_832-838.nxml.txt.nlp	22580740	SENT23	5	5	7	7	doxorubicin	ADM	PA449412	133	0.647
NULL	Indian_J_Anaesth_2014_Jul-Aug_58(4)_423-429.nxml.txt.nlp	25197110	SENT131	8	8	3	3	ondansetron	ODF	PA450705	8600	0.647
NULL	Leukemia_2013_Jan_11_27(1)_32-40.nxml.txt.nlp	22781593	SENT133	27	27	6	6	ponatinib	FGFR1	PA165980594	2260	0.647
NULL	Acta_Pharmacol_Sin_2012_Jan_28_33(1)_75-81.nxml.txt.nlp	22120969	SENT13	2	2	4	4	exenatide	GLP-1	PA164749238	100125288	0.647
NULL	Nat_Commun_2013_Sep_3_4_2394.nxml.txt.nlp	23999152	SENT477	8	8	0	0	dextran	BDNF	PA449261	627	0.647
NULL	Case_Rep_Oncol_2013_Feb_28_6(1)_119-126.nxml.txt.nlp	23569446	SENT78	6	6	8	8	medroxyprogesterone	aromatase	PA450344	1588	0.647
NULL	Clin_Dev_Immunol_2013_Sep_30_2013_238035.nxml.txt.nlp	24194771	SENT153	12	12	21	21	methotrexate	CTX	PA450428	1593	0.647
NULL	Cancer_Med_2014_Feb_26_3(1)_81-90.nxml.txt.nlp	24402778	SENT213	3	3	10	10	bleomycin	WISP1	PA448645	8840	0.647
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_21-38.nxml.txt.nlp	19305786	SENT453	22	22	33	33	capsaicin	TRPV4	PA448776	59341	0.647
NULL	Avicenna_J_Med_Biotechnol_2009_Apr-Jun_1(1)_41-46.nxml.txt.nlp	23407674	SENT23	11	11	19	19	thyroglobulin	TPO	PA164754910	7066;7173	0.647
NULL	Mol_Cancer_2009_Nov_24_8_109.nxml.txt.nlp	19930708	SENT192	3	3	5	5	exemestane	EGFR	PA449563	1956	0.647
NULL	Cancers_(Basel)_2012_Oct_29_4(4)_1146-1160.nxml.txt.nlp	24213502	SENT53	12	12	16	16	tamoxifen	STAR	PA451581	6770;2984	0.647
NULL	Aging_(Albany_NY)_2014_Oct_30_6(10)_788-819.nxml.txt.nlp	25411230	SENT242	28	28	11	11	carbidopa	COMT	PA448794	1312	0.647
NULL	Oncol_Lett_2013_Feb_3_5(2)_505-510.nxml.txt.nlp	23420812	SENT114	13	13	7	7	cisplatin	AEG-1	PA449014	92140	0.647
NULL	Indian_J_Pharmacol_2013_May-Jun_45(3)_286-288.nxml.txt.nlp	23833375	SENT55	2	2	0	0	montelukast	NMU	PA450546	10874	0.647
NULL	Indian_J_Psychiatry_2011_Apr-Jun_53(2)_111-120.nxml.txt.nlp	21772642	SENT209	34	34	18	18	imipramine	CYP1A2	PA449969	1544	0.647
NULL	Evid_Based_Complement_Alternat_Med_2014_Oct_19_2014_628712.nxml.txt.nlp	25389442	SENT168	5	5	20	20	erlotinib	PTEN	PA134687924	5728	0.647
NULL	J_Korean_Med_Sci_2005_Oct_31_20(5)_883-885.nxml.txt.nlp	16224167	SENT8	21	21	24	24	cyclosporine	gamma	PA449167	9913	0.647
NULL	Acta_Pharmacol_Sin_2012_Feb_3_33(2)_194-200.nxml.txt.nlp	22301859	SENT10	21	21	19	19	liraglutide	GLP-1	PA165958364	100125288	0.647
NULL	Ther_Clin_Risk_Manag_2007_Aug_3(4)_665-673.nxml.txt.nlp	18472989	SENT175	11	11	34	34	lapatinib	CYP3A4	PA152241907	1576	0.647
NULL	Contemp_Clin_Dent_2013_Apr-Jun_4(2)_156-161.nxml.txt.nlp	24015002	SENT133	22	22	28	28	chlorhexidine	SRP	PA164776863	90226	0.647
NULL	Biomed_Res_Int_2014_Feb_27_2014_827415.nxml.txt.nlp	24719890	SENT47	13	13	6	6	bortezomib	EGFR	PA10252	1956	0.647
NULL	Indian_J_Pharmacol_2008_Oct_40(Suppl_2)_S66-S91.nxml.txt.nlp	21593982	SENT1473	11	11	3	3	furosemide	HARC	PA449719	55664	0.647
NULL	Exp_Lung_Res_2013_Oct_1_39(8)_336-348.nxml.txt.nlp	23919450	SENT246	13	13	15	15	thrombin	PAR-1	PA451674	2011;2149	0.647
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT13	0	0	5	5	tacrolimus	IL-6	PA451578	3569	0.647
NULL	Indian_J_Endocrinol_Metab_2012_Sep-Oct_16(5)_728-739.nxml.txt.nlp	23087856	SENT226	11	11	20	20	hydrocortisone	ACTH	PA449905	5443	0.647
NULL	Ann_Clin_Transl_Neurol_2014_Dec_21_1(12)_996-1005.nxml.txt.nlp	25574474	SENT24	10	10	16	16	riluzole	P-gp	PA451251	5243	0.647
NULL	J_Hematol_Oncol_2014_Apr_4_7_30.nxml.txt.nlp	24708874	SENT15	17	17	22	22	vincristine	CHOP	PA451879	1649	0.647
NULL	J_Nat_Sci_Biol_Med_2011_Jan-Jun_2(1)_13-25.nxml.txt.nlp	22470230	SENT248	16	16	13	13	capsaicin	TRPV1	PA448776	7442	0.647
NULL	Oncogene_2013_Sep_12_32(37)_4355-4365.nxml.txt.nlp	23108409	SENT91	3	3	9	9	hyaluronan	HAS2	PA165958431	3037	0.647
NULL	Cardiovasc_Diabetol_2013_May_30_12(Suppl_1)_S2.nxml.txt.nlp	23819752	SENT129	12	12	10	10	fluvastatin	CYP3A4	PA449688	1576	0.647
NULL	Biomed_Res_Int_2013_Dec_30_2013_187204.nxml.txt.nlp	23533994	SENT289	12	12	21	21	bevacizumab	EGFR	PA130232992	1956	0.647
NULL	Autoimmune_Dis_2013_Aug_28_2013_613086.nxml.txt.nlp	24069534	SENT22	29	29	22	22	ustekinumab	p40	PA166048654	3921;339541;10314	0.647
NULL	J_Korean_Med_Sci_2009_Jan_29_24(Suppl_1)_S170-S175.nxml.txt.nlp	19194548	SENT92	23	23	25	25	cisplatin	EPO	PA449014	7076;8288;2056	0.647
NULL	Diabetes_Care_2010_Apr_12_33(4)_861-868.nxml.txt.nlp	20067962	SENT133	34	34	29	29	hyaluronan	HSP60	PA165958431	3329	0.647
NULL	Braz_J_Med_Biol_Res_2014_Mar_3_47(3)_192-205.nxml.txt.nlp	24676492	SENT207	8	8	10	10	lipase	MGL	PA450239	11343	0.647
NULL	Breast_Cancer_(Auckl)_2010_Feb_16_4_1-3.nxml.txt.nlp	20697527	SENT19	10	10	12	12	cyclophosphamide	CTX	PA449165	1593	0.647
NULL	J_Invest_Dermatol_2012_Sep_10_132(9)_2255-2262.nxml.txt.nlp	22572817	SENT9	15	15	6	6	forskolin	HBD3	PA146096022	414325	0.647
NULL	Reprod_Biol_Endocrinol_2013_May_8_11_34.nxml.txt.nlp	23656912	SENT92	9	9	3	3	nifedipine	CYP3A	PA450631	1574	0.647
NULL	Environ_Health_Perspect_1993_Oct_101(Suppl_3)_109-112.nxml.txt.nlp	7908263	SENT2	6	6	2	2	debrisoquine	CYP2D6	PA452616	1565	0.647
NULL	Int_J_Gen_Med_2011_Jul_20_4_539-545.nxml.txt.nlp	21845063	SENT91	7	7	5	5	miglitol	adiponectin	PA164776726	9370	0.647
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT84	4	4	7	7	perifosine	TRAIL	PA165291471	8743	0.647
NULL	J_Invest_Dermatol_2012_Sep_10_132(9)_2255-2262.nxml.txt.nlp	22572817	SENT157	11	11	23	23	forskolin	HBD3	PA146096022	414325	0.647
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_79-96.nxml.txt.nlp	19305789	SENT169	16	16	3	3	capsaicin	TRPV1	PA448776	7442	0.647
NULL	Brain_Behav_2013_Mar_11_3(2)_67-74.nxml.txt.nlp	23532860	SENT37	11	11	6	6	l-glutamine	B27	PA10090	56246	0.647
NULL	Br_J_Cancer_2012_Feb_14_106(4)_685-692.nxml.txt.nlp	22294184	SENT252	17	17	8	8	docetaxel	L12	PA449383	26156;6136	0.647
NULL	Acta_Pharmacol_Sin_2012_May_4_33(5)_644-651.nxml.txt.nlp	22555371	SENT162	6	6	23	23	sulodexide	eNOS	PA164746343	4846	0.647
NULL	Clin_Ophthalmol_2010_Apr_26_4_369-374.nxml.txt.nlp	20463807	SENT41	13	13	6	6	pegaptanib	PED	PA164771236	8682	0.647
NULL	J_Geriatr_Cardiol_2012_Jun_9(2)_209-210.nxml.txt.nlp	23097648	SENT34	39	39	5	5	warfarin	CYP4F2	PA451906	8529	0.647
NULL	J_Mol_Med_(Berl)_2014_Jan_10_92(5)_497-507.nxml.txt.nlp	24408111	SENT185	0	0	6	6	pioglitazone	HIF-1	PA450970	29072	0.647
NULL	Environ_Health_Perspect_2012_Aug_8_120(8)_1100-1106.nxml.txt.nlp	22571927	SENT112	1	1	45	45	erythromycin	STP	PA449493	9322	0.647
NULL	Mycobiology_2009_Dec_31_37(4)_272-276.nxml.txt.nlp	23983547	SENT14	9	9	2	2	potassium	AMF	PA451047	2821	0.647
NULL	Cerebrospinal_Fluid_Res_2006_Dec_21_3(Suppl_1)_S41.nxml.txt.nlp	NULL	SENT12	8	8	6	6	heparin	OTS	PA449855	5012	0.647
NULL	Korean_J_Anesthesiol_2013_Feb_15_64(2)_105-111.nxml.txt.nlp	23459312	SENT81	15	15	11	11	heparin	ACT	PA449855	12;11332;9457;641455	0.647
NULL	Br_J_Cancer_2013_Jun_25_108(12)_2549-2556.nxml.txt.nlp	23703247	SENT75	19	19	6	6	bevacizumab	TRG	PA130232992	6965	0.647
NULL	Mol_Cancer_2012_Mar_21_11_13.nxml.txt.nlp	22436134	SENT7	24	24	9	9	doxorubicin	HuR	PA449412	1994	0.647
NULL	Cases_J_2009_Mar_10_2_6464.nxml.txt.nlp	20181162	SENT6	26	26	16	16	ribavirin	IFN	PA451241	3439	0.647
NULL	Croat_Med_J_2014_Jun_55(3)_206-217.nxml.txt.nlp	24891279	SENT264	10	10	12	12	cisplatin	p53	PA449014	7157	0.647
NULL	Environ_Health_Perspect_1983_Apr_50_163-168.nxml.txt.nlp	6135607	SENT5	4	4	11	11	amobarbital	PTB	PA448401	58155	0.647
NULL	Int_J_Mol_Sci_2014_Nov_21_15(11)_21505-21537.nxml.txt.nlp	25421245	SENT279	6	6	15	15	lipase	CD36	PA450239	948	0.647
NULL	Front_Cell_Neurosci_2013_Dec_26_7_281.nxml.txt.nlp	24421757	SENT305	10	10	12	12	resveratrol	p38		10598;1432;7965	0.647
NULL	Int_J_Mol_Sci_2014_Sep_2_15(9)_15512-15529.nxml.txt.nlp	25184950	SENT123	12	12	24	24	resveratrol	IL-10		3586	0.647
NULL	Cancer_Med_2013_Jun_25_2(3)_277-285.nxml.txt.nlp	23930204	SENT195	19	19	5	5	capecitabine	BRAF	PA448771	673	0.647
NULL	ASN_Neuro_2012_Sep_24_4(6)_e00098.nxml.txt.nlp	22909302	SENT43	0	0	10	10	bromocriptine	MDC	PA448671	6367	0.647
NULL	J_Int_Soc_Sports_Nutr_2010_May_26_7_21.nxml.txt.nlp	20500899	SENT221	14	14	6	6	ethanol	flower	PA448073	11094	0.647
NULL	Patient_Prefer_Adherence_2010_Mar_24_4_51-60.nxml.txt.nlp	20361065	SENT192	2	2	14	14	warfarin	Gen	PA451906	348654	0.646
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT35	9	9	11	11	heparin	FGF1	PA449855	2246	0.646
NULL	Biologics_2012_Dec_17_6_429-464.nxml.txt.nlp	23269860	SENT238	5	5	12	12	tocilizumab	ACR	PA165292659	49	0.646
NULL	Oncol_Lett_2013_Oct_24_6(4)_970-976.nxml.txt.nlp	24137447	SENT180	6	6	4	4	doxorubicin	ADM	PA449412	133	0.646
NULL	Front_Neurol_2011_Aug_5_2_48.nxml.txt.nlp	21886636	SENT245	19	19	2	2	sildenafil	AQP2	PA451346	359	0.646
NULL	Biomed_Res_Int_2014_Aug_6_2014_967826.nxml.txt.nlp	25165721	SENT277	25	25	32	32	cisplatin	FasL	PA449014	356	0.646
NULL	Curr_Pharm_Des_2012_Apr_18(11)_1519-1530.nxml.txt.nlp	22364136	SENT82	3	3	14	14	atorvastatin	TNF-alpha	PA448500	7124	0.646
NULL	Cancers_(Basel)_2014_Jun_27_6(3)_1363-1381.nxml.txt.nlp	24978438	SENT106	10	10	4	4	hyaluronan	IL-6	PA165958431	3569	0.646
NULL	Mol_Brain_2014_Aug_21_7_59.nxml.txt.nlp	25139109	SENT202	22	22	30	30	l-glutamine	CO2	PA10090	4513	0.646
NULL	Br_J_Haematol_2008_Jun_141(5)_659-671.nxml.txt.nlp	18410446	SENT154	0	0	10	10	cerulenin	IRE1	PA164764551	2081	0.646
NULL	Case_Rep_Oncol_Med_2011_Nov_22_2011_326815.nxml.txt.nlp	22606443	SENT45	34	34	27	27	thyroglobulin	CD10	PA164754910	4311	0.646
NULL	Cardiovasc_Diabetol_2011_Dec_22_10_115.nxml.txt.nlp	22189184	SENT15	0	0	27	27	miglitol	GLP-1	PA164776726	100125288	0.646
NULL	Stroke_Res_Treat_2009_Dec_20_2010_386389.nxml.txt.nlp	20700422	SENT157	14	14	11	11	pioglitazone	NAC	PA450970	22861	0.646
NULL	Arthritis_Res_2001_Sep_18_3(6)_381-388.nxml.txt.nlp	11714393	SENT138	34	34	19	19	collagenase	c-Jun	PA449107	3725	0.646
NULL	Front_Neurosci_2012_Feb_21_6_26.nxml.txt.nlp	22363256	SENT47	14	14	11	11	estradiol	aromatase	PA449503	1588	0.646
NULL	Oncol_Lett_2013_May_22_5(5)_1541-1545.nxml.txt.nlp	23760395	SENT184	8	8	5	5	mefloquine	NAC	PA450348	22861	0.646
NULL	Acta_Vet_Scand_2011_Feb_17_53(1)_11.nxml.txt.nlp	21324209	SENT55	22	22	24	24	kanamycin	OTC	PA450137	5009	0.646
NULL	J_Hematol_Oncol_2012_May_15_5_23.nxml.txt.nlp	22587422	SENT87	6	6	19	19	dasatinib	ALL	PA162372878	613	0.646
NULL	Cancer_Immunol_Immunother_2013_Jan_3_62(1)_137-147.nxml.txt.nlp	22865266	SENT58	20	20	16	16	sargramostim	GM-CSF	PA164748631	1437	0.646
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT325	13	13	3	3	cisplatin	p53	PA449014	7157	0.646
NULL	Diabetes_Care_2013_Jul_12_36(7)_2126-2132.nxml.txt.nlp	23645884	SENT67	19	19	14	14	exenatide	GLP-1	PA164749238	100125288	0.646
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT53	22	22	9	9	nutlin-3	p53		7157	0.646
NULL	Autophagy_2013_Sep_1_9(9)_1418-1430.nxml.txt.nlp	23748697	SENT294	40	40	38	38	glucose	STS	PA449773	412	0.646
NULL	Mucosal_Immunol_2014_Mar_24_7(2)_335-347.nxml.txt.nlp	23881354	SENT299	0	0	2	2	galantamine	GAL	PA449726	51083	0.646
NULL	Clin_Mol_Hepatol_2014_Sep_25_20(3)_283-290.nxml.txt.nlp	25320732	SENT138	19	19	0	0	propranolol	PPN	PA451145	64840	0.646
NULL	Virol_J_2011_May_17_8_234.nxml.txt.nlp	21575275	SENT82	26	26	11	11	ribavirin	IFN	PA451241	3439	0.646
NULL	Environ_Health_Perspect_2005_Nov_29_113(11)_1479-1484.nxml.txt.nlp	16263499	SENT73	9	9	18	18	thyroglobulin	TPO	PA164754910	7066;7173	0.646
NULL	Int_J_Nanomedicine_2009_Apr_1_4_27-35.nxml.txt.nlp	19421368	SENT130	20	20	13	13	genistein	IL-10	PA165109660	3586	0.646
NULL	Diabetes_2009_Jan_58(1)_243-249.nxml.txt.nlp	18840785	SENT20	27	27	15	15	glucose	GLP-1	PA449773	100125288	0.646
NULL	Arthritis_Res_Ther_2004_Jun_21_6(4)_169-173.nxml.txt.nlp	15225361	SENT103	8	8	15	15	estradiol	RUNX2	PA449503	860	0.646
NULL	Cancer_Med_2013_Dec_27_2(6)_751-762.nxml.txt.nlp	24403249	SENT161	0	0	3	3	paclitaxel	CD44	PA450761	960	0.646
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT136	0	0	3	3	chloroquine	BMPR-II	PA448948	659	0.646
NULL	Oncotarget_2011_Mar_23_2(3)_165-177.nxml.txt.nlp	21444946	SENT172	20	20	0	0	erlotinib	KRAS	PA134687924	3845	0.646
NULL	Chem_Rev_2011_Oct_12_111(10)_5899-5921.nxml.txt.nlp	21923193	SENT125	29	29	2	2	taurine	15-LOX-2	PA451590	247	0.646
NULL	Int_J_Environ_Res_Public_Health_2010_Mar_15_7(3)_1076-1092.nxml.txt.nlp	20617019	SENT375	21	21	13	13	ethanol	ADH4	PA448073	127	0.646
NULL	J_Cell_Mol_Med_2013_Sep_24_17(9)_1065-1087.nxml.txt.nlp	24151975	SENT435	24	24	26	26	l-cysteine	TFEC	PA449173	22797	0.646
NULL	Ann_Gen_Psychiatry_2014_Jul_9_13_19.nxml.txt.nlp	25089150	SENT0	17	17	3	3	fluvoxamine	Gen	PA449690	348654	0.646
NULL	Can_J_Infect_Dis_Med_Microbiol_2014_May-Jun_25(3)_155-158.nxml.txt.nlp	25285112	SENT87	15	15	17	17	levofloxacin	TMP	PA450214	2012	0.646
NULL	Oncol_Lett_2013_Sep_1_6(3)_840-844.nxml.txt.nlp	24137422	SENT122	8	8	22	22	berberine	p65	PA165860812	5970	0.646
NULL	Acta_Pharmacol_Sin_2013_Jan_3_34(1)_119-128.nxml.txt.nlp	23202804	SENT168	1	1	13	13	rimonabant	NG2	PA152407999	1464;6048	0.646
NULL	J_Korean_Med_Sci_2004_Apr_30_19(2)_167-171.nxml.txt.nlp	15082886	SENT118	36	36	30	30	isoniazid	EMB	PA450112	133418	0.646
NULL	Clin_Ophthalmol_2009_Jun_29_3_381-390.nxml.txt.nlp	19668594	SENT155	0	0	6	6	difluprednate	BAK	PA165958405	578	0.646
NULL	Cent_European_J_Urol_2013_Apr_26_66(1)_56-59.nxml.txt.nlp	24578992	SENT105	12	12	19	19	estradiol	PRL	PA449503	5617	0.646
NULL	Bioinorg_Chem_Appl_2014_Feb_23_2014_276598.nxml.txt.nlp	24707242	SENT89	19	19	31	31	ethanol	mol	PA448073	90527	0.646
NULL	Biomed_Rep_2014_May_5_2(3)_303-308.nxml.txt.nlp	24748964	SENT116	7	7	9	9	trifluoperazine	TFP	PA451771	7034	0.646
NULL	Acta_Pharmacol_Sin_2011_Feb_4_32(2)_230-238.nxml.txt.nlp	21293475	SENT124	0	0	9	9	troglitazone	aP2	PA451799	2167	0.646
NULL	Case_Rep_Transplant_2012_Aug_30_2012_672923.nxml.txt.nlp	23259137	SENT73	10	10	15	15	caspofungin	IPA	PA164743013	3160	0.646
NULL	Br_J_Cancer_2010_Sep_28_103(7)_1001-1007.nxml.txt.nlp	20842117	SENT220	28	28	30	30	everolimus	PI3K	PA164746311	5290	0.646
NULL	Cancer_Manag_Res_2011_Sep_9_3_301-309.nxml.txt.nlp	21931504	SENT126	6	6	8	8	spermine	CXCR4	PA164781199	7852	0.646
NULL	Breast_Cancer_Res_2004_Jul_29_6(5)_204-210.nxml.txt.nlp	15318926	SENT101	23	23	18	18	tamoxifen	EGFR	PA451581	1956	0.646
NULL	Ther_Clin_Risk_Manag_2006_Dec_2(4)_389-400.nxml.txt.nlp	18360651	SENT136	3	3	24	24	infliximab	IMPACT	PA452639	55364	0.646
NULL	Emerg_Infect_Dis_2012_Jun_18(6)_1019-1020.nxml.txt.nlp	22608263	SENT34	34	34	36	36	moxifloxacin	NXN	PA450555	64359	0.646
NULL	Biosci_Rep_2012_Apr_1_32(Pt_2)_105-112.nxml.txt.nlp	22115362	SENT557	32	32	15	15	collagenase	p38	PA449107	10598;1432;7965	0.646
NULL	Bioinform_Biol_Insights_2012_Dec_3_6_287-302.nxml.txt.nlp	23236254	SENT107	9	9	15	15	chloroquine	DHPS	PA448948	1725	0.646
NULL	Int_J_Mol_Imaging_2013_May_9_2013_278607.nxml.txt.nlp	23762549	SENT225	26	26	19	19	ethanol	FES	PA448073	2242	0.646
NULL	Eur_J_Histochem_2011_Mar_24_55(1)_e6.nxml.txt.nlp	21556121	SENT21	14	14	0	0	heparin	HRG	PA449855	3084;3273	0.646
NULL	J_Headache_Pain_2006_Sep_11_7(4)_174-184.nxml.txt.nlp	16897620	SENT336	7	7	2	2	rizatriptan	5-HT1B	PA451264	3351	0.646
NULL	Clin_Interv_Aging_2010_Dec_3_5_403-416.nxml.txt.nlp	21152242	SENT158	8	8	2	2	telmisartan	ACE	PA451605	1636	0.646
NULL	J_Cardiothorac_Surg_2014_Dec_18_9(1)_196.nxml.txt.nlp	NULL	SENT145	5	5	11	11	heparin	ACT	PA449855	12;11332;9457;641455	0.646
NULL	EMBO_Mol_Med_2013_Jul_30_5(7)_932-948.nxml.txt.nlp	23723167	SENT291	2	2	5	5	pilocarpine	MMP13	PA450962	4322	0.646
NULL	Br_J_Cancer_2011_Oct_25_105(9)_1273-1278.nxml.txt.nlp	21959871	SENT26	20	20	35	35	trastuzumab	HER2	PA451743	2064	0.646
NULL	J_Clin_Biochem_Nutr_2011_Mar_26_48(2)_126-133.nxml.txt.nlp	21373265	SENT119	1	1	3	3	lansoprazole	HO-1	PA450180	3162	0.646
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Apr_7_9_12.nxml.txt.nlp	20374640	SENT110	16	16	6	6	trimethoprim	CHL	PA451788	91851	0.646
NULL	Clin_Ophthalmol_2008_Dec_2(4)_821-828.nxml.txt.nlp	19668436	SENT93	12	12	3	3	nilvadipine	Rho	PA165958385	29984	0.646
NULL	J_Gen_Physiol_1924_Mar_20_6(4)_429-437.nxml.txt.nlp	19872084	SENT0	12	12	1	1	trypsin	Gen	PA451806	348654	0.646
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Nov_4_65(Pt_12)_o2986.nxml.txt.nlp	21578726	SENT57	8	8	4	4	ethanol	mol	PA448073	90527	0.646
NULL	EMBO_J_2009_Feb_18_28(4)_313-314.nxml.txt.nlp	19225445	SENT39	13	13	15	15	cisplatin	POLH	PA449014	5429;10721	0.646
NULL	Cells_2012_Sep_28_1(4)_699-710.nxml.txt.nlp	24710526	SENT41	18	18	25	25	heparin	HMGB1	PA449855	3146	0.646
NULL	Arthritis_Res_Ther_2013_Sep_9_15(5)_R108.nxml.txt.nlp	24016860	SENT108	44	44	28	28	fluorescein	CD148	PA164746009	5795	0.646
NULL	Diabetes_2011_Nov_17_60(11)_2691-2700.nxml.txt.nlp	21896928	SENT128	21	21	28	28	resveratrol	SIRT1		23411	0.646
NULL	Front_Pharmacol_2014_Sep_2_5_204.nxml.txt.nlp	25228881	SENT97	5	5	13	13	methamphetamine	IL-6	PA450403	3569	0.646
NULL	J_Oncol_2009_Mar_24_2009_491985.nxml.txt.nlp	19325924	SENT93	11	11	6	6	genistein	CXCR4	PA165109660	7852	0.646
NULL	Oncoimmunology_2014_Apr_25_3_e28518.nxml.txt.nlp	25071979	SENT183	26	26	28	28	paclitaxel	CRT	PA450761	811	0.646
NULL	Avicenna_J_Phytomed_2013_Summer_3(3)_201-204.nxml.txt.nlp	25050275	SENT40	2	2	4	4	ketoconazole	CYP3A4	PA450146	1576	0.646
NULL	Int_J_Environ_Res_Public_Health_2012_Aug_27_9(8)_2636-2657.nxml.txt.nlp	23066388	SENT1047	0	0	9	9	fludarabine	ERCC1	PA449655	2067	0.646
NULL	J_Biol_Chem_2008_Nov_14_283(46)_31679-31689.nxml.txt.nlp	18755684	SENT328	35	35	6	6	iron	FTL	PA450087	2512	0.646
NULL	Nucleic_Acids_Res_2012_Jun_10_40(11)_4804-4815.nxml.txt.nlp	22328728	SENT283	27	27	5	5	resveratrol	SATB1		6304	0.646
NULL	Contemp_Clin_Dent_2011_Oct-Dec_2(4)_278-282.nxml.txt.nlp	22346152	SENT135	1	1	43	43	potassium	GCF	PA451047	6936	0.646
NULL	Endocrinol_Metab_(Seoul)_2014_Sep_25_29(3)_379-387.nxml.txt.nlp	25309798	SENT113	25	25	17	17	resveratrol	CLOCK		9575	0.646
NULL	Arthritis_Rheumatol_2014_Jun_27_66(6)_1574-1582.nxml.txt.nlp	24577881	SENT131	22	22	11	11	procainamide	CD4	PA451108	920	0.646
NULL	Chem_Cent_J_2013_Sep_4_7_147.nxml.txt.nlp	24006941	SENT94	7	7	13	13	lipase	LOX	PA450239	4015	0.646
NULL	Cancer_Cell_Int_2006_Oct_2_6_22.nxml.txt.nlp	17014709	SENT179	20	20	9	9	cisplatin	IB2	PA449014	23542	0.646
NULL	Cells_2014_Jan_27_3(1)_53-78.nxml.txt.nlp	24709902	SENT1462	15	15	13	13	trastuzumab	PTEN	PA451743	5728	0.646
NULL	Biosci_Rep_2011_Feb_1_31(Pt_1)_45-55.nxml.txt.nlp	20426768	SENT19	15	15	13	13	gemcitabine	GEM	PA449748	2669	0.646
NULL	Indian_J_Anaesth_2011_May-Jun_55(3)_228-234.nxml.txt.nlp	21808393	SENT198	15	15	7	7	midazolam	hole	PA450496	80757	0.646
NULL	Case_Rep_Rheumatol_2011_Dec_15_2011_185657.nxml.txt.nlp	22937439	SENT43	1	1	6	6	etanercept	IL-6	PA449515	3569	0.646
NULL	J_Thorac_Oncol_2015_Jan_29_10(1)_156-163.nxml.txt.nlp	25247337	SENT263	39	39	23	23	erlotinib	BSC	PA134687924	6558	0.646
NULL	Br_J_Cancer_2012_Aug_7_107(4)_739-747.nxml.txt.nlp	22782350	SENT9	4	4	13	13	lipase	PEX5	PA450239	5830	0.646
NULL	Br_J_Ophthalmol_2008_Sep_22_92(9)_1275-1282.nxml.txt.nlp	18723745	SENT54	0	0	19	19	tafluprost	BAK	PA165958432	578	0.646
NULL	Croat_Med_J_2013_Apr_54(2)_171-179.nxml.txt.nlp	23630144	SENT7	30	30	28	28	taurine	STZ	PA451590	6484	0.646
NULL	Br_J_Cancer_2012_Jan_3_106(1)_18-24.nxml.txt.nlp	22108516	SENT40	14	14	8	8	irinotecan	p38	PA450085	10598;1432;7965	0.646
NULL	Chem_Rev_2011_Oct_12_111(10)_5899-5921.nxml.txt.nlp	21923193	SENT402	5	5	2	2	lipase	FAAH	PA450239	79152;2166	0.646
NULL	Exp_Lung_Res_2013_Oct_1_39(8)_336-348.nxml.txt.nlp	23919450	SENT196	17	17	14	14	argatroban	PAR-1	PA164745516	2011;2149	0.646
NULL	Endocrinol_Diabetes_Metab_Case_Rep_2014_Sep_1_2014_140047.nxml.txt.nlp	25298880	SENT18	0	0	11	11	everolimus	MTOR	PA164746311	2475	0.646
NULL	Breast_Cancer_Res_2014_May_23_16(3)_R50.nxml.txt.nlp	24887458	SENT119	18	18	0	0	docetaxel	HER2	PA449383	2064	0.646
NULL	Oncogene_2014_Feb_6_33(6)_713-723.nxml.txt.nlp	23435429	SENT105	28	28	5	5	camptothecin	BRCA1	PA153590860	672	0.646
NULL	J_Gen_Physiol_2013_Aug_142(2)_137-155.nxml.txt.nlp	23858003	SENT302	17	17	14	14	forskolin	TREK-1	PA146096022	3776	0.646
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Nov_18_65(Pt_12)_o3113.nxml.txt.nlp	21578839	SENT66	22	22	18	18	ethanol	mol	PA448073	90527	0.646
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT109	11	11	16	16	doxorubicin	p53	PA449412	7157	0.646
NULL	Oncoimmunology_2012_Oct_1_1(7)_1004-1016.nxml.txt.nlp	23170249	SENT183	9	9	11	11	paclitaxel	HER-2	PA450761	2064	0.646
NULL	Behav_Brain_Funct_2010_May_28_6_27.nxml.txt.nlp	20507645	SENT194	2	2	0	0	amiloride	ABP1	PA448368	26	0.646
NULL	Ann_Gastroenterol_2014_27(4)_313-319.nxml.txt.nlp	25331779	SENT66	30	30	10	10	mercaptopurine	POR	PA450379	5447	0.646
NULL	J_Viral_Hepat_2007_Nov_14(11)_751-766.nxml.txt.nlp	17927611	SENT94	23	23	21	21	lamivudine	LAM	PA450163	7249;7248	0.646
NULL	J_Psychopharmacol_2010_Jan_24(1)_27-38.nxml.txt.nlp	19204064	SENT363	20	20	32	32	cocaine	NK1	PA449072	11126	0.646
NULL	Cell_Cycle_2013_May_15_12(10)_1492-1500.nxml.txt.nlp	23598717	SENT58	10	10	2	2	doxorubicin	ROCK1	PA449412	6093	0.646
NULL	Clin_Epigenetics_2011_Dec_5_3(1)_8.nxml.txt.nlp	22414275	SENT7	0	0	16	16	ribavirin	ESR1	PA451241	2099	0.646
NULL	Mol_Biol_Cell_2012_Nov_1_23(21)_4212-4225.nxml.txt.nlp	22956765	SENT13	15	15	0	0	thrombin	SHP2	PA451674	5781	0.646
NULL	Front_Aging_Neurosci_2010_Aug_6_2_26.nxml.txt.nlp	20802800	SENT1379	15	15	7	7	nimodipine	spatial	PA450633	219793	0.646
NULL	Gut_Pathog_2014_Jul_29_6_33.nxml.txt.nlp	25110521	SENT268	0	0	7	7	fluorescein	CD69	PA164746009	969	0.646
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT114	3	3	11	11	nutlin-3	p53		7157	0.646
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT57	18	18	12	12	vinblastine	MVP	PA451877	9961	0.646
NULL	Breast_Cancer_Res_2002_Jul_29_4(5)_202-204.nxml.txt.nlp	12223125	SENT97	7	7	40	40	tamoxifen	ATAC	PA451581	6375	0.646
NULL	Oncol_Lett_2013_Mar_28_5(3)_983-991.nxml.txt.nlp	23426861	SENT169	21	21	15	15	gemcitabine	DDP	PA449748	1678	0.646
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT394	2	2	20	20	risperidone	PRL	PA451257	5617	0.646
NULL	J_Headache_Pain_2008_Feb_23_9(1)_37-41.nxml.txt.nlp	18231713	SENT35	19	19	24	24	creatine	B12	PA164778930	7126;4709	0.646
NULL	J_Cancer_Prev_2014_Mar_19(1)_39-46.nxml.txt.nlp	25337571	SENT83	0	0	5	5	ethanol	JNK	PA448073	5599	0.646
NULL	Br_J_Cancer_2013_Jul_23_109(2)_351-359.nxml.txt.nlp	23799854	SENT163	17	17	22	22	paclitaxel	BLT2	PA450761	56413	0.646
NULL	Front_Immunol_2012_Feb_27_3_23.nxml.txt.nlp	22566907	SENT475	6	6	3	3	hyaluronan	CD44	PA165958431	960	0.646
NULL	J_Cell_Mol_Med_2014_Apr_20_18(4)_709-720.nxml.txt.nlp	24444314	SENT246	16	16	38	38	nadh	p53	PA164755085	7157	0.646
NULL	Croat_Med_J_2012_Jun_53(3)_224-233.nxml.txt.nlp	22661135	SENT65	16	16	22	22	bromocriptine	PRL	PA448671	5617	0.646
NULL	Curr_Neuropharmacol_2013_Dec_11(6)_641-651.nxml.txt.nlp	24396339	SENT186	17	17	22	22	capsaicin	TRPV1	PA448776	7442	0.646
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT292	8	8	14	14	tacrolimus	RANKL	PA451578	8600	0.646
NULL	Nat_Commun_2011_Jul_5_2_376.nxml.txt.nlp	21730957	SENT1472	16	16	9	9	zolpidem	GAD65	PA451976	2572	0.646
NULL	Am_J_Trop_Med_Hyg_2012_Nov_7_87(5_Suppl)_92-96.nxml.txt.nlp	23136283	SENT84	27	27	14	14	chloroquine	ACT	PA448948	12;11332;9457;641455	0.646
NULL	Med_Sci_Monit_2012_Jun_1_18(6)_BR247-BR252.nxml.txt.nlp	22648246	SENT22	20	20	17	17	indomethacin	IBP	PA449982	706;50619	0.646
NULL	EMBO_Mol_Med_2010_Sep_2(9)_349-370.nxml.txt.nlp	20665636	SENT442	20	20	34	34	paraformaldehyde	c-Myc	PA450790	4609	0.646
NULL	J_Antimicrob_Chemother_2009_Jun_28_63(6)_1233-1243.nxml.txt.nlp	19329800	SENT87	16	16	14	14	atazanavir	ATV	PA10251	4683	0.646
NULL	Int_J_Biol_Sci_2014_Jun_5_10(6)_620-626.nxml.txt.nlp	24948875	SENT86	3	3	24	24	saracatinib	PC-3		692094	0.646
NULL	Neurobiol_Aging_2013_Dec_34(12)_2889_e5-2889_e9.nxml.txt.nlp	23664753	SENT94	17	17	5	5	levodopa	LRRK2	PA450213	120892	0.646
NULL	Drug_Healthc_Patient_Saf_2012_Jun_6_4_39-54.nxml.txt.nlp	22792008	SENT206	3	3	11	11	tiagabine	UGT	PA451682	7361;7355	0.646
NULL	Front_Oncol_2014_Jun_11_4_145.nxml.txt.nlp	24967214	SENT380	13	13	17	17	cyclophosphamide	CD4	PA449165	920	0.646
NULL	Breast_Cancer_Res_2004_Mar_11_6(3)_109-118.nxml.txt.nlp	15084231	SENT90	18	18	15	15	tamoxifen	SRC-3	PA451581	8202	0.646
NULL	Eur_J_Neurosci_2007_Mar_1_25(6)_1619-1630.nxml.txt.nlp	17408433	SENT281	25	25	30	30	lipase	Stella	PA450239	359787	0.646
NULL	Acta_Pharmacol_Sin_2011_Aug_18_32(8)_1031-1037.nxml.txt.nlp	21765446	SENT189	18	18	7	7	raloxifene	MCP-1	PA451221	6347	0.646
NULL	J_Clin_Exp_Pathol_2012_May_17_Suppl_4_7327.nxml.txt.nlp	25379357	SENT129	11	11	7	7	metformin	AMPK	PA450395	5563	0.646
NULL	Cancer_Metab_2013_Feb_4_1_7.nxml.txt.nlp	24280108	SENT165	13	13	0	0	doxycycline	DMK	PA449415	1760	0.646
NULL	J_Cell_Biol_1990_Mar_1_110(3)_777-787.nxml.txt.nlp	2307707	SENT16	23	23	28	28	heparin	CS1	PA449855	57823	0.646
NULL	Br_J_Cancer_1974_Jan_29(1)_11-20.nxml.txt.nlp	4820942	SENT4	5	5	27	27	methylcholanthrene	SIII	PA165816878	6924;6921;6923	0.646
NULL	Mol_Imaging_Biol_2009_Sep_27_11(5)_364-368.nxml.txt.nlp	19326174	SENT139	37	37	2	2	propranolol	FDG	PA451145	23583	0.646
NULL	Front_Neurol_2015_Jan_13_5_289.nxml.txt.nlp	25628599	SENT276	0	0	10	10	nadh	BMAL1	PA164755085	406	0.646
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Nov_3_68(Pt_12)_o3272-o3273.nxml.txt.nlp	23468786	SENT90	22	22	10	10	ethanol	mol	PA448073	90527	0.646
NULL	Pan_Afr_Med_J_2014_Feb_3_17_85.nxml.txt.nlp	25452831	SENT87	3	3	23	23	tenofovir	Dakar	PA10204	22900	0.646
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT93	27	27	38	38	metformin	HIP	PA450395	6767;6159;64399;5068	0.646
NULL	Patient_Prefer_Adherence_2010_Nov_3_4_397-406.nxml.txt.nlp	21206515	SENT4	39	39	26	26	sitagliptin	GLP-1	PA164748978	100125288	0.646
NULL	Int_J_Nanomedicine_2008_Jun_3(2)_181-199.nxml.txt.nlp	18686778	SENT180	16	16	14	14	hyaluronidase	ECM	PA164745713	22915	0.646
NULL	Oncotarget_2014_Nov_2_5(21)_10222-10236.nxml.txt.nlp	25400118	SENT217	13	13	17	17	trastuzumab	HE2	PA451743	653423;10407	0.646
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_24_2012_408187.nxml.txt.nlp	23193421	SENT4	20	20	22	22	vasopressin	AVP	PA451858	114548;551	0.646
NULL	Nat_Genet_2011_Jun_5_43(7)_621-629.nxml.txt.nlp	21642992	SENT13	23	23	6	6	doxorubicin	NF-YA	PA449412	4800	0.646
NULL	Mol_Vis_2011_Dec_15_17_3254-3261.nxml.txt.nlp	22194651	SENT2	3	3	5	5	vasopressin	AVP	PA451858	114548;551	0.646
NULL	Chem_Cent_J_2012_Jan_21_6_6.nxml.txt.nlp	22264225	SENT160	34	34	38	38	duloxetine	mol	PA10066	90527	0.646
NULL	Int_J_Endocrinol_2013_Nov_19_2013_959487.nxml.txt.nlp	24348558	SENT102	11	11	17	17	estradiol	AMH	PA449503	268	0.646
NULL	Diabetes_Care_2009_Oct_8_32(10)_1873-1879.nxml.txt.nlp	19587362	SENT107	11	11	16	16	aliskiren	ANG	PA143487910	283	0.646
NULL	Allergy_Asthma_Clin_Immunol_2013_Oct_17_9(1)_41.nxml.txt.nlp	24499258	SENT168	8	8	20	20	omalizumab	IL-6	PA164752253	3569	0.646
NULL	Front_Endocrinol_(Lausanne)_2014_Oct_9_5_166.nxml.txt.nlp	25346724	SENT142	21	21	23	23	vasopressin	AVP	PA451858	114548;551	0.646
NULL	J_Korean_Med_Sci_2011_Dec_29_26(12)_1563-1568.nxml.txt.nlp	22147992	SENT128	0	0	5	5	ekb-569	AKT		207	0.646
NULL	Curr_Pharm_Des_2011_Apr_17(10)_985-989.nxml.txt.nlp	21524255	SENT58	8	8	14	14	vasopressin	PAC1	PA451858	8624;1316;117	0.646
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_39-54.nxml.txt.nlp	19305787	SENT148	18	18	29	29	ethanol	NR1	PA448073	27158	0.646
NULL	Leukemia_2014_Mar_13_28(3)_600-608.nxml.txt.nlp	24240203	SENT224	10	10	12	12	nutlin-3	p53		7157	0.646
NULL	Protein_J_2012_Aug_5_31(6)_511-518.nxml.txt.nlp	22763563	SENT179	40	40	32	32	atorvastatin	MSR1	PA448500	4481	0.646
NULL	Clin_Psychopharmacol_Neurosci_2012_Aug_31_10(2)_71-77.nxml.txt.nlp	23431082	SENT75	23	23	10	10	clozapine	PRKAR2B	PA449061	5577	0.646
NULL	J_Invest_Dermatol_2012_Sep_10_132(9)_2255-2262.nxml.txt.nlp	22572817	SENT139	26	26	31	31	forskolin	HBD3	PA146096022	414325	0.646
NULL	Acta_Pharmacol_Sin_2011_Oct_15_32(10)_1233-1238.nxml.txt.nlp	21841815	SENT104	3	3	15	15	atropine	CTX	PA448505	1593	0.646
NULL	Pain_Ther_2014_Jun_13_3(1)_59-69.nxml.txt.nlp	25135388	SENT151	3	3	9	9	curcumin	HSD1	PA151958596	26871	0.646
NULL	J_Headache_Pain_2009_Apr_27_10(2)_105-110.nxml.txt.nlp	19172228	SENT102	39	39	26	26	capsaicin	c-fos	PA448776	2353	0.646
NULL	Mol_Cancer_2008_Mar_26_7_27.nxml.txt.nlp	18366759	SENT288	13	13	20	20	etoposide	CLK1	PA449552	1195	0.646
NULL	Int_J_Med_Chem_2013_Apr_4_2013_203606.nxml.txt.nlp	24729874	SENT121	40	40	9	9	estradiol	C17	PA449503	54360	0.646
NULL	J_Carcinog_2011_Nov_30_10_27.nxml.txt.nlp	22190869	SENT54	17	17	11	11	genistein	TRAMP	PA165109660	8718;23471;9189	0.646
NULL	Acta_Pharmacol_Sin_2010_Mar_22_31(3)_329-340.nxml.txt.nlp	20173759	SENT78	39	39	13	13	ethanol	AMPK	PA448073	5563	0.645
NULL	Diabetes_2013_Nov_18_62(11)_3909-3919.nxml.txt.nlp	23835339	SENT108	8	8	15	15	gliclazide	SUR1	PA10892	6833	0.645
NULL	Indian_J_Pharmacol_2013_May-Jun_45(3)_286-288.nxml.txt.nlp	23833375	SENT28	5	5	24	24	tamoxifen	NMU	PA451581	10874	0.645
NULL	Int_J_Med_Sci_2012_Dec_28_10(2)_110-118.nxml.txt.nlp	23329881	SENT55	26	26	3	3	epirubicin	NACT	PA449476	284111	0.645
NULL	Ann_Dermatol_2011_Aug_6_23(3)_329-337.nxml.txt.nlp	21909203	SENT81	13	13	18	18	vincristine	CHOP	PA451879	1649	0.645
NULL	J_Gen_Intern_Med_2009_May_21_24(5)_656-664.nxml.txt.nlp	19306050	SENT521	11	11	4	4	warfarin	CYP2C9	PA451906	1559	0.645
NULL	Carcinogenesis_2010_Dec_27_31(12)_2049-2057.nxml.txt.nlp	20876285	SENT207	12	12	8	8	tamoxifen	HER2	PA451581	2064	0.645
NULL	Mol_Cancer_2004_Jul_12_3_19.nxml.txt.nlp	15248896	SENT243	19	19	5	5	oxygen	ROS	PA450744	6098	0.645
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT147	8	8	42	42	pp2	PP2		4888	0.645
NULL	Clin_Ophthalmol_2012_May_29_6_817-830.nxml.txt.nlp	22701083	SENT70	34	34	18	18	glucosamine	SP1	PA164747613	6667	0.645
NULL	Diabetol_Metab_Syndr_2014_Mar_31_6_48.nxml.txt.nlp	24684803	SENT162	3	3	9	9	miglitol	GLP-1	PA164776726	100125288	0.645
NULL	Cancer_Metastasis_Rev_2011_Jun_23_30(2)_185-197.nxml.txt.nlp	21340664	SENT144	21	21	6	6	topotecan	CHK2	PA451729	11200	0.645
NULL	Diabetes_Care_2010_Apr_12_33(4)_861-868.nxml.txt.nlp	20067962	SENT14	17	17	8	8	hyaluronan	HSP60	PA165958431	3329	0.645
NULL	Front_Endocrinol_(Lausanne)_2014_Dec_1_5_206.nxml.txt.nlp	25520704	SENT269	0	0	9	9	geldanamycin	HSF1	PA152031327	3297	0.645
NULL	J_Antimicrob_Chemother_2008_Nov_27_62(5)_929-933.nxml.txt.nlp	18755696	SENT60	30	30	20	20	gentamicin	CTX	PA449753	1593	0.645
NULL	Front_Aging_Neurosci_2010_Apr_8_2_15.nxml.txt.nlp	20552051	SENT1099	4	4	7	7	flutamide	CA1	PA449685	759	0.645
NULL	Allergy_Asthma_Immunol_Res_2010_Jul_15_2(3)_155-164.nxml.txt.nlp	20592913	SENT106	14	14	6	6	tiotropium	ADRB2	PA164769056	154	0.645
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT309	42	42	47	47	galactose	CCL16	PA449725	6360	0.645
NULL	J_Biomed_Sci_2013_Jan_25_20(1)_5.nxml.txt.nlp	23350714	SENT79	30	30	14	14	pemetrexed	B12	PA10810	7126;4709	0.645
NULL	J_Korean_Med_Sci_2004_Apr_30_19(2)_167-171.nxml.txt.nlp	15082886	SENT118	24	24	30	30	clarithromycin	EMB	PA449028	133418	0.645
NULL	J_Inflamm_(Lond)_2006_May_4_3_8.nxml.txt.nlp	16674821	SENT205	26	26	28	28	pp2	SKI-1		8720	0.645
NULL	Oncol_Lett_2013_Aug_25_6(2)_480-486.nxml.txt.nlp	24137351	SENT186	21	21	32	32	sorafenib	RAI	PA7000	10848;6050	0.645
NULL	Br_J_Pharmacol_2011_Jul_163(6)_1263-1275.nxml.txt.nlp	21391977	SENT100	4	4	2	2	gemfibrozil	CYP2C8	PA449750	1558	0.645
NULL	J_Cell_Mol_Med_2014_Mar_22_18(3)_422-433.nxml.txt.nlp	24450475	SENT407	6	6	8	8	hyaluronan	CD44	PA165958431	960	0.645
NULL	Eur_J_Clin_Pharmacol_2010_Nov_29_66(11)_1131-1136.nxml.txt.nlp	20669013	SENT119	28	28	31	31	voriconazole	CYP2C19	PA10233	1557	0.645
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1013.nxml.txt.nlp	24457957	SENT80	14	14	5	5	orlistat	NOXA	PA164776864	5366	0.645
NULL	Alcohol_Res_2012_34(4)_441-447.nxml.txt.nlp	23584110	SENT146	32	32	20	20	vasopressin	ACTH	PA451858	5443	0.645
NULL	J_Korean_Med_Sci_2006_Jun_21_21(3)_418-424.nxml.txt.nlp	16778382	SENT161	10	10	14	14	hemin	INS-1	PA449849	2305	0.645
NULL	New_Microbes_New_Infect_2014_May_4_2(3)_58-63.nxml.txt.nlp	25356345	SENT100	6	6	24	24	cefoxitin	ANK	PA448856	56172	0.645
NULL	Hematol_Rep_2011_Jan_21_3(1)_e2.nxml.txt.nlp	22184524	SENT44	14	14	12	12	ethambutol	ETB	PA164784021	1910	0.645
NULL	Alcohol_Res_2013_35(1)_25-35.nxml.txt.nlp	24313162	SENT143	22	22	8	8	ethanol	MTR	PA448073	4548	0.645
NULL	Clin_Exp_Otorhinolaryngol_2011_Jun_31_4(2)_77-82.nxml.txt.nlp	21716954	SENT122	2	2	8	8	minocycline	JNK	PA450519	5599	0.645
NULL	Antimicrob_Agents_Chemother_2014_Oct_58(10)_5900-5908.nxml.txt.nlp	25070091	SENT308	13	13	35	35	metoprolol	CYP2D6	PA450480	1565	0.645
NULL	Lipids_Health_Dis_2011_Aug_26_10_152.nxml.txt.nlp	21871076	SENT133	23	23	34	34	atorvastatin	AMN	PA448500	215;81693	0.645
NULL	Sensors_(Basel)_2011_May_4_11(5)_4990-5004.nxml.txt.nlp	22163886	SENT269	6	6	16	16	oxygen	CFD	PA450744	1675	0.645
NULL	Curr_Neuropharmacol_2009_Jun_7(2)_83-95.nxml.txt.nlp	19949566	SENT515	46	46	32	32	zonisamide	TGB	PA451978	5473	0.645
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT126	6	6	13	13	sitagliptin	HIP	PA164748978	6767;6159;64399;5068	0.645
NULL	Clin_Ophthalmol_2012_Apr_27_6_637-644.nxml.txt.nlp	22570544	SENT1	1	1	11	11	bromfenac	COX	PA448670	1351	0.645
NULL	Arthritis_Res_Ther_2009_Aug_24_11(4)_R127.nxml.txt.nlp	19703304	SENT90	13	13	11	11	adalimumab	OASIS	PA10004	90993	0.645
NULL	Ann_Pediatr_Cardiol_2009_Jan-Jun_2(1)_65-73.nxml.txt.nlp	20300273	SENT130	19	19	0	0	vasopressin	AVP	PA451858	114548;551	0.645
NULL	Int_J_Genomics_2014_Jan_29_2014_894296.nxml.txt.nlp	24616891	SENT232	15	15	7	7	ethanol	PC2	PA448073	5126;5311;8535	0.645
NULL	J_Gen_Physiol_1933_Nov_20_17(2)_151-157.nxml.txt.nlp	19872771	SENT0	12	12	1	1	trypsin	Gen	PA451806	348654	0.645
NULL	Emerg_Infect_Dis_2013_Jan_19(1)_133-136.nxml.txt.nlp	23260464	SENT54	2	2	24	24	tetracycline	TOB	PA451640	10140	0.645
NULL	Can_J_Infect_Dis_Med_Microbiol_2014_Nov-Dec_25(6)_311-320.nxml.txt.nlp	25587293	SENT371	7	7	30	30	ribavirin	BOC	PA451241	91653	0.645
NULL	Oncol_Lett_2014_May_11_7(5)_1401-1408.nxml.txt.nlp	24765145	SENT119	2	2	11	11	paclitaxel	HIF-1	PA450761	29072	0.645
NULL	Daru_2012_Oct_15_20(1)_55.nxml.txt.nlp	23352178	SENT48	29	29	13	13	olanzapine	CYP1A2	PA450688	1544	0.645
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT67	2	2	0	0	pp2	PP1		5540;5464	0.645
NULL	Br_J_Haematol_2014_Sep_17_166(6)_818-829.nxml.txt.nlp	24935654	SENT113	36	36	8	8	fludarabine	IL2	PA449655	3558	0.645
NULL	Mucosal_Immunol_2013_Nov_10_6(6)_1179-1190.nxml.txt.nlp	23571504	SENT95	18	18	9	9	auranofin	TRX	PA448510	7295	0.645
NULL	Endocr_Relat_Cancer_2013_Aug_20(5)_677-689.nxml.txt.nlp	23913484	SENT193	15	15	8	8	paclitaxel	IRF9	PA450761	10379	0.645
NULL	Curr_Neuropharmacol_2014_May_12(3)_219-238.nxml.txt.nlp	24851087	SENT128	22	22	8	8	ziprasidone	PSD-95	PA451974	1742	0.645
NULL	Indian_J_Pharmacol_2014_Nov-Dec_46(6)_627-632.nxml.txt.nlp	25538335	SENT110	5	5	3	3	metformin	Q10	PA450395	27161	0.645
NULL	Ann_Rheum_Dis_2008_Sep_11_68(7)_1146-1152.nxml.txt.nlp	18794178	SENT160	3	3	13	13	etanercept	ACR	PA449515	49	0.645
NULL	Virol_J_2010_Nov_17_7_323.nxml.txt.nlp	21083916	SENT38	6	6	11	11	telbivudine	POLG1	PA164760861	5428	0.645
NULL	Braz_J_Med_Biol_Res_2012_Mar_2_45(3)_250-255.nxml.txt.nlp	22370705	SENT30	10	10	12	12	vasopressin	AVP	PA451858	114548;551	0.645
NULL	J_Cell_Biol_1992_Feb_2_116(4)_1055-1062.nxml.txt.nlp	1370836	SENT2	8	8	11	11	hyaluronan	CD44	PA165958431	960	0.645
NULL	Ecancermedicalscience_2009_Sep_24_3_153.nxml.txt.nlp	22276017	SENT132	5	5	3	3	oxaliplatin	PI3K	PA131285527	5290	0.645
NULL	Eur_J_Med_Res_2011_May_12_16(5)_197-205.nxml.txt.nlp	21719392	SENT135	13	13	7	7	foscarnet	IL-2	PA449706	3558	0.645
NULL	Eur_J_Clin_Pharmacol_2014_Oct_8_70(1)_37-45.nxml.txt.nlp	24100471	SENT54	25	25	22	22	rosuvastatin	CYP2C19	PA134308647	1557	0.645
NULL	Front_Mol_Neurosci_2015_Jan_9_7_103.nxml.txt.nlp	25620909	SENT122	9	9	27	27	choline	B12	PA448976	7126;4709	0.645
NULL	Arch_Microbiol_2012_Apr_24_194(4)_255-268.nxml.txt.nlp	21947170	SENT9	39	39	8	8	colistin	MN1	PA164760862	4330	0.645
NULL	Clin_Med_Insights_Oncol_2012_Feb_28_6_125-135.nxml.txt.nlp	22408376	SENT29	0	0	3	3	panitumumab	EGFR	PA162373091	1956	0.645
NULL	Environ_Health_Perspect_2012_Mar_2_120(3)_406-412.nxml.txt.nlp	22049383	SENT30	15	15	17	17	diethylstilbestrol	DES	PA449307	1674	0.645
NULL	Diabetes_2009_Apr_23_58(4)_917-925.nxml.txt.nlp	19168598	SENT74	11	11	30	30	paraformaldehyde	AKT	PA450790	207	0.645
NULL	Int_J_Gen_Med_2011_Feb_15_4_131-139.nxml.txt.nlp	21475627	SENT153	3	3	10	10	atorvastatin	IL-6	PA448500	3569	0.645
NULL	Oxid_Med_Cell_Longev_2011_Aug_15_2011_824597.nxml.txt.nlp	21904648	SENT220	19	19	21	21	topotecan	TPT	PA451729	23590;6469	0.645
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Oct_17_65(Pt_11)_o2775.nxml.txt.nlp	21578368	SENT83	29	29	25	25	ethanol	mol	PA448073	90527	0.645
NULL	Br_J_Cancer_2001_Apr_84(8)_1016-1022.nxml.txt.nlp	11308247	SENT9	22	22	18	18	choline	NACT	PA448976	284111	0.645
NULL	Antiviral_Res_2009_May_82(2)_A99-A109.nxml.txt.nlp	19176219	SENT283	19	19	14	14	nelfinavir	P-gp	PA450606	5243	0.645
NULL	Front_Psychol_2014_May_13_5_434.nxml.txt.nlp	24860541	SENT145	1	1	3	3	vasopressin	AVP	PA451858	114548;551	0.645
NULL	An_Bras_Dermatol_2014_Mar-Apr_89(2)_365-367.nxml.txt.nlp	24770527	SENT20	28	28	13	13	adalimumab	IL-23	PA10004	51561	0.645
NULL	J_Ginseng_Res_2011_Nov_35(4)_436-441.nxml.txt.nlp	23717089	SENT107	13	13	32	32	ginseng	CAGC	PA164781150	6283	0.645
NULL	Chem_Res_Toxicol_2012_Aug_20_25(8)_1708-1719.nxml.txt.nlp	22793666	SENT341	11	11	2	2	imiquimod	Cbl-b	PA449972	868	0.645
NULL	Cardiovasc_Drugs_Ther_2011_Jun_12_25(3)_223-232.nxml.txt.nlp	21562974	SENT89	13	13	6	6	milrinone	AKT	PA164749171	207	0.645
NULL	Child_Adolesc_Psychiatry_Ment_Health_2009_Mar_12_3_9.nxml.txt.nlp	19284622	SENT44	11	11	21	21	ziprasidone	PES	PA451974	23481	0.645
NULL	J_Cell_Biol_1998_Aug_24_142(4)_923-936.nxml.txt.nlp	9722606	SENT288	31	31	24	24	fluorescein	TGN	PA164746009	7038	0.645
NULL	Hum_Mol_Genet_2013_Nov_15_22(22)_4616-4626.nxml.txt.nlp	23814041	SENT45	29	29	36	36	doxycycline	neuroserpin	PA449415	5274	0.645
NULL	Ann_Oncol_2011_Jan_13_22(1)_215-223.nxml.txt.nlp	20627875	SENT306	18	18	11	11	rituximab	CHOP	PA451261	1649	0.645
NULL	J_Cell_Mol_Med_2013_Oct_16_17(10)_1261-1270.nxml.txt.nlp	23855452	SENT175	2	2	4	4	gemcitabine	GEM	PA449748	2669	0.645
NULL	Front_Neurosci_2013_Dec_20_7_256.nxml.txt.nlp	24391536	SENT29	37	37	33	33	lipase	FAAH	PA450239	79152;2166	0.645
NULL	Exp_Neurol_2011_May_229(1)_2-9.nxml.txt.nlp	20816825	SENT449	4	4	19	19	heparin	FGFR1	PA449855	2260	0.645
NULL	Breast_Cancer_Res_2000_Dec_17_2(1)_10-12.nxml.txt.nlp	11250686	SENT49	12	12	16	16	tamoxifen	STAR	PA451581	6770;2984	0.645
NULL	J_Adv_Pharm_Technol_Res_2014_Apr-Jun_5(2)_90-95.nxml.txt.nlp	24959418	SENT36	5	5	22	22	benzaldehyde	mol	PA448571	90527	0.645
NULL	Blood_Cancer_J_2013_Sep_13_3(9)_e146.nxml.txt.nlp	24036945	SENT10	2	2	5	5	ribavirin	AKT	PA451241	207	0.645
NULL	Cancers_(Basel)_2014_Feb_13_6(1)_396-415.nxml.txt.nlp	24531055	SENT136	21	21	19	19	heparin	entactin	PA449855	4811	0.645
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1699-1708.nxml.txt.nlp	19861960	SENT165	9	9	5	5	dasatinib	mol	PA162372878	90527	0.645
NULL	J_Clin_Biochem_Nutr_2010_Jan_29_46(1)_87-92.nxml.txt.nlp	20104270	SENT315	15	15	13	13	hesperidin	STZ	PA449867	6484	0.645
NULL	Front_Oncol_2014_Oct_21_4_285.nxml.txt.nlp	25374842	SENT682	10	10	14	14	cisplatin	TP53	PA449014	7157	0.645
NULL	Mol_Cancer_2007_Jan_14_6_5.nxml.txt.nlp	17222355	SENT204	26	26	9	9	doxorubicin	HMGA2	PA449412	8091	0.645
NULL	Nucleic_Acids_Res_2010_Oct_28_38(19)_6418-6432.nxml.txt.nlp	20511593	SENT90	14	14	8	8	collagenase	AP-1	PA449107	2353;3727;2354;3725	0.645
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT157	8	8	42	42	pp2	PP2		4888	0.645
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT120	13	13	8	8	tenofovir	SLC22A7	PA10204	10864	0.645
NULL	Environ_Health_Perspect_2006_Aug_10_114(8)_1193-1198.nxml.txt.nlp	16882524	SENT173	13	13	17	17	arsenite	ERCC1	PA452638	2067	0.645
NULL	Diabetes_Care_2012_Feb_16_35(2)_327-333.nxml.txt.nlp	22179958	SENT122	24	24	17	17	metformin	B12	PA450395	7126;4709	0.645
NULL	Case_Rep_Oncol_Med_2013_Sep_26_2013_234391.nxml.txt.nlp	24191208	SENT68	32	32	26	26	trastuzumab	HER2	PA451743	2064	0.645
NULL	J_Epilepsy_Res_2014_Jun_30_4(1)_7-13.nxml.txt.nlp	24977124	SENT55	2	2	19	19	pilocarpine	CA1	PA450962	759	0.645
NULL	Braz_J_Med_Biol_Res_2014_Mar_21_47(4)_273-278.nxml.txt.nlp	24676475	SENT93	14	14	18	18	doxorubicin	ADM	PA449412	133	0.645
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jul_29_65(Pt_8)_o2022.nxml.txt.nlp	21583691	SENT72	12	12	32	32	benzaldehyde	mol	PA448571	90527	0.645
NULL	Oncol_Lett_2014_Jan_6_7(1)_255-259.nxml.txt.nlp	24348859	SENT93	21	21	27	27	docetaxel	DCX	PA449383	1641	0.645
NULL	Genet_Mol_Biol_2009_Sep_1_Jul-Sep_32(3)_516-520.nxml.txt.nlp	21637514	SENT7	8	8	5	5	estradiol	FGF2	PA449503	2247;2258	0.645
NULL	Arthritis_Res_Ther_2013_Sep_12_15(5)_R117.nxml.txt.nlp	24028544	SENT169	17	17	12	12	cyclophosphamide	VDI	PA449165	7420	0.645
NULL	Patient_Prefer_Adherence_2009_Nov_3_3_189-193.nxml.txt.nlp	19936161	SENT40	4	4	29	29	alendronate	CTX	PA448082	1593	0.645
NULL	Evid_Based_Complement_Alternat_Med_2011_Jun_8_2011_950461.nxml.txt.nlp	21799696	SENT191	3	3	23	23	vasopressin	ACTH	PA451858	5443	0.645
NULL	Adv_Hematol_2012_Jun_14_2012_523842.nxml.txt.nlp	22761620	SENT39	0	0	6	6	lenalidomide	CD28	PA162363968	1493;940	0.645
NULL	Br_J_Pharmacol_2011_Aug_163(8)_1679-1690.nxml.txt.nlp	21371008	SENT123	10	10	4	4	indomethacin	COX	PA449982	1351	0.645
NULL	Br_J_Pharmacol_2014_May_171(10)_2659-2670.nxml.txt.nlp	24116661	SENT186	10	10	24	24	naringenin	TRPP2	PA151958361	5311	0.645
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT40	9	9	12	12	raltitrexed	UNG	PA131625240	7374	0.645
NULL	Evid_Based_Complement_Alternat_Med_2014_Oct_29_2014_402126.nxml.txt.nlp	25530781	SENT84	19	19	4	4	nitrogen	ESI	PA450643	5266	0.645
NULL	Eur_J_Hum_Genet_2011_Oct_25_19(10)_1066-1073.nxml.txt.nlp	21610753	SENT4	9	9	1	1	trypsin	SPINK1	PA451806	6690	0.645
NULL	Clin_Med_Insights_Oncol_2013_Jun_3_7_103-122.nxml.txt.nlp	23843721	SENT129	2	2	0	0	trastuzumab	PTEN	PA451743	5728	0.645
NULL	Arthritis_Res_Ther_2009_Jun_29_11(3)_R100.nxml.txt.nlp	19563672	SENT149	2	2	9	9	infliximab	IFN	PA452639	3439	0.645
NULL	J_Korean_Neurosurg_Soc_2013_Oct_31_54(4)_280-288.nxml.txt.nlp	24294450	SENT219	13	13	15	15	acetazolamide	ACZ	PA448018	27445	0.645
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_21-38.nxml.txt.nlp	19305786	SENT650	24	24	14	14	capsaicin	TRPM8	PA448776	79054	0.645
NULL	Pharmaceuticals_(Basel)_2014_Mar_5_7(3)_311-338.nxml.txt.nlp	24603603	SENT735	11	11	4	4	cisplatin	p53	PA449014	7157	0.645
NULL	Mar_Drugs_2011_Aug_10_9(8)_1359-1367.nxml.txt.nlp	21892350	SENT6	8	8	10	10	lipase	HSL	PA450239	3991	0.645
NULL	Int_Ophthalmol_2012_Dec_31_32(6)_577-582.nxml.txt.nlp	22847248	SENT68	9	9	3	3	acetazolamide	ALPI	PA448018	248	0.645
NULL	Diabetes_Care_2013_Dec_13_36(12)_e214.nxml.txt.nlp	24265383	SENT31	17	17	15	15	liraglutide	GLP-1	PA165958364	100125288	0.645
NULL	Case_Rep_Med_2010_Jun_17_2010_472389.nxml.txt.nlp	20589221	SENT67	13	13	25	25	succinylcholine	TOF	PA451522	55079	0.645
NULL	Arch_Med_Sci_2011_Feb_8_7(1)_67-72.nxml.txt.nlp	22291735	SENT90	13	13	18	18	atorvastatin	PMI	PA448500	8834;5373	0.645
NULL	Cell_Logist_2014_Jan_9_4_e27732.nxml.txt.nlp	24843827	SENT7	23	23	7	7	perifosine	PI3K	PA165291471	5290	0.645
NULL	Environ_Health_Perspect_2012_Aug_2_120(8)_1177-1182.nxml.txt.nlp	22552965	SENT213	13	13	8	8	estradiol	c-fos	PA449503	2353	0.645
NULL	Diabetes_Metab_J_2013_Apr_16_37(2)_113-116.nxml.txt.nlp	23641351	SENT64	0	0	23	23	metformin	PI3K	PA450395	5290	0.645
NULL	Anesthesiol_Res_Pract_2013_Sep_23_2013_297141.nxml.txt.nlp	24174934	SENT105	0	0	10	10	lidocaine	mol	PA450226	90527	0.645
NULL	Oncotarget_2013_Jan_14_4(1)_118-127.nxml.txt.nlp	23435217	SENT185	32	32	40	40	erlotinib	EGFR	PA134687924	1956	0.645
NULL	Cell_Death_Dis_2013_Jun_27_4(6)_e692.nxml.txt.nlp	23807221	SENT257	23	23	31	31	collagenase	CO2	PA449107	4513	0.645
NULL	Acta_Pharmacol_Sin_2011_Apr_28_32(4)_441-448.nxml.txt.nlp	21441944	SENT3	24	24	7	7	sildenafil	FKBP12	PA451346	2280	0.645
NULL	Cancer_Immunol_Immunother_2015_Oct_7_64_61-73.nxml.txt.nlp	25287778	SENT224	6	6	29	29	lenalidomide	IL-2	PA162363968	3558	0.645
NULL	Genome_Biol_2008_May_13_9(5)_R80.nxml.txt.nlp	18477406	SENT96	2	2	0	0	l-arginine	ARG1	PA448478	383;64129	0.645
NULL	Curr_Colorectal_Cancer_Rep_2012_Jun_17_8(2)_130-137.nxml.txt.nlp	22611343	SENT166	4	4	19	19	panitumumab	KRAS	PA162373091	3845	0.645
NULL	Bull_Math_Biol_2014_Dec_14_76(2)_401-430.nxml.txt.nlp	24338592	SENT26	34	34	39	39	vincristine	CHOP	PA451879	1649	0.645
NULL	Nat_Commun_2014_Aug_4_5_4535.nxml.txt.nlp	25088745	SENT572	15	15	3	3	phenformin	LKB1	PA1000	6794	0.645
NULL	Br_J_Cancer_2010_Jun_29_103(1)_61-72.nxml.txt.nlp	20588279	SENT257	25	25	10	10	trastuzumab	RhoB	PA451743	388	0.645
NULL	Avicenna_J_Med_2014_Apr-Jun_4(2)_29-33.nxml.txt.nlp	24761380	SENT103	18	18	12	12	metformin	GLP-1	PA450395	100125288	0.645
NULL	Breast_Cancer_Res_2011_Nov_1_13(6)_225.nxml.txt.nlp	22078060	SENT97	0	0	12	12	novobiocin	SMYD3	PA164768819	64754	0.645
NULL	Indian_J_Plast_Surg_2014_Jan-Apr_47(1)_102-108.nxml.txt.nlp	24987213	SENT137	3	3	12	12	heparin	ATIII	PA449855	462	0.645
NULL	Emerg_Infect_Dis_2011_Mar_17(3)_510-513.nxml.txt.nlp	21392446	SENT53	38	38	36	36	ethionamide	ETO	PA164768738	862	0.645
NULL	J_Immunother_Cancer_2014_Nov_6_2(Suppl_3)_P199.nxml.txt.nlp	NULL	SENT10	26	26	21	21	cetuximab	PD-L1	PA10040	29126	0.645
NULL	Breast_Cancer_Res_Treat_2012_Jul_5_134(2)_693-700.nxml.txt.nlp	22562123	SENT196	3	3	18	18	tamoxifen	CYP3A	PA451581	1574	0.645
NULL	HSR_Proc_Intensive_Care_Cardiovasc_Anesth_2009_1(3)_33-45.nxml.txt.nlp	23439998	SENT75	11	11	17	17	heparin	ACT	PA449855	12;11332;9457;641455	0.645
NULL	Oncol_Lett_2013_Oct_29_6(4)_1031-1038.nxml.txt.nlp	24137459	SENT224	19	19	17	17	cisplatin	DDP	PA449014	1678	0.645
NULL	Ann_N_Y_Acad_Sci_2012_Aug_30_1264(1)_49-63.nxml.txt.nlp	22548651	SENT145	14	14	4	4	glucose	BDNF	PA449773	627	0.645
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT110	17	17	33	33	curcumin	PC-3	PA151958596	692094	0.645
NULL	Br_J_Cancer_2011_Jul_26_105(3)_366-371.nxml.txt.nlp	21750556	SENT26	30	30	16	16	trastuzumab	T-bet	PA451743	30009	0.645
NULL	Arthritis_Res_Ther_2013_Nov_7_15(6)_R183.nxml.txt.nlp	24286535	SENT72	27	27	20	20	paraformaldehyde	IL-4	PA450790	3565	0.645
NULL	Indian_J_Pharmacol_2014_Mar-Apr_46(2)_161-165.nxml.txt.nlp	24741186	SENT82	2	2	9	9	carvedilol	STZ	PA448817	6484	0.645
NULL	ScientificWorldJournal_2013_Oct_29_2013_274570.nxml.txt.nlp	24288475	SENT210	2	2	4	4	ciprofloxacin	CPX	PA449009	1371;10682;1377	0.645
NULL	J_Korean_Med_Sci_2004_Apr_30_19(2)_167-171.nxml.txt.nlp	15082886	SENT118	28	28	30	30	kanamycin	EMB	PA450137	133418	0.645
NULL	Core_Evid_2010_Jul_27_5_1-10.nxml.txt.nlp	20694135	SENT202	15	15	20	20	levodopa	CLE	PA450213	51637	0.645
NULL	Breast_Cancer_Res_2010_Mar_5_12(2)_R16.nxml.txt.nlp	20205716	SENT185	0	0	21	21	lovastatin	G3BP1	PA450272	10146	0.645
NULL	J_Immunother_2014_Feb_21_37(2)_105-114.nxml.txt.nlp	24509173	SENT201	11	11	6	6	gemcitabine	WT1	PA449748	7490	0.645
NULL	Lancet_2011_Aug_27_378(9793)_771-784.nxml.txt.nlp	21802721	SENT155	20	20	17	17	tamoxifen	p53	PA451581	7157	0.645
NULL	Int_J_Environ_Res_Public_Health_2011_Mar_1_8(3)_683-697.nxml.txt.nlp	21556173	SENT267	2	2	6	6	cyclophosphamide	CD4	PA449165	920	0.645
NULL	Leukemia_2014_Apr_14_28(4)_961-964.nxml.txt.nlp	24418991	SENT39	11	11	15	15	nilotinib	P-gp	PA165958345	5243	0.645
NULL	Target_Oncol_2013_Jun_27_8(2)_127-136.nxml.txt.nlp	23625191	SENT42	10	10	4	4	panitumumab	KRAS	PA162373091	3845	0.645
NULL	Cell_Commun_Signal_2003_Nov_24_1_5.nxml.txt.nlp	14636425	SENT76	4	4	1	1	heparin	CCN5	PA449855	8839	0.645
NULL	Clin_Ophthalmol_2012_Sep_7_6_1471-1476.nxml.txt.nlp	23055666	SENT3	16	16	22	22	betaxolol	NAC	PA448611	22861	0.645
NULL	Indian_J_Dermatol_2010_Apr-Jun_55(2)_171-175.nxml.txt.nlp	20606888	SENT91	7	7	11	11	ustekinumab	p40	PA166048654	3921;339541;10314	0.645
NULL	Cancers_(Basel)_2012_May_29_4(2)_531-548.nxml.txt.nlp	24213323	SENT117	2	2	9	9	hyaluronan	VCAN	PA165958431	1462	0.645
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Jul_23_3(7)_e126.nxml.txt.nlp	25054314	SENT329	24	24	33	33	docetaxel	SLCO1B3	PA449383	28234	0.645
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT128	16	16	2	2	propafenone	CYP2C19	PA451131	1557	0.645
NULL	Acta_Naturae_2013_Jan-Mar_5(1)_73-84.nxml.txt.nlp	23556132	SENT152	18	18	25	25	l-glutamine	CO2	PA10090	4513	0.645
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT115	5	5	10	10	cisplatin	p53	PA449014	7157	0.645
NULL	Ann_Hematol_2010_Nov_25_89(11)_1115-1124.nxml.txt.nlp	20499237	SENT108	8	8	23	23	simvastatin	CD19	PA451363	930	0.645
NULL	J_Gastroenterol_2013_May_20_48(5)_574-594.nxml.txt.nlp	23512346	SENT332	5	5	10	10	hesperidin	ghrelin	PA449867	51738	0.645
NULL	J_Hum_Genet_2013_Jun_16_58(6)_353-361.nxml.txt.nlp	23677058	SENT160	6	6	4	4	cytarabine	SLC28A3	PA449177	64078	0.645
NULL	Arch_Gynecol_Obstet_2011_Aug_24_284(2)_343-355.nxml.txt.nlp	21431845	SENT174	26	26	34	34	medroxyprogesterone	CEE	PA450344	51608	0.645
NULL	J_Antimicrob_Chemother_2008_Nov_27_62(5)_929-933.nxml.txt.nlp	18755696	SENT60	18	18	20	20	ceftriaxone	CTX	PA448866	1593	0.645
NULL	Protein_Eng_Des_Sel_2011_Apr_14_24(4)_351-360.nxml.txt.nlp	21159620	SENT73	28	28	6	6	ampicillin	SOC	PA448419	91544	0.645
NULL	Mol_Cancer_2012_Jul_29_11_48.nxml.txt.nlp	22839996	SENT88	9	9	30	30	epirubicin	DDP	PA449476	1678	0.645
NULL	Oxid_Med_Cell_Longev_2012_Jan_19_2012_390678.nxml.txt.nlp	22315655	SENT115	3	3	5	5	gliclazide	NAC	PA10892	22861	0.645
NULL	Evid_Based_Complement_Alternat_Med_2011_Mar_20_2011_571479.nxml.txt.nlp	21792361	SENT119	23	23	19	19	indomethacin	HIF-1	PA449982	29072	0.645
NULL	J_Invest_Dermatol_2012_Sep_10_132(9)_2255-2262.nxml.txt.nlp	22572817	SENT217	19	19	13	13	forskolin	HBD3	PA146096022	414325	0.645
NULL	Chin_J_Cancer_2011_Sep_30(9)_645-654.nxml.txt.nlp	21880186	SENT141	5	5	3	3	bleomycin	DDP	PA448645	1678	0.645
NULL	Br_J_Cancer_2010_Oct_26_103(9)_1380-1390.nxml.txt.nlp	20877355	SENT168	32	32	24	24	vincristine	p75NTR	PA451879	4804	0.645
NULL	Indian_Dermatol_Online_J_2014_Apr-Jun_5(2)_236-237.nxml.txt.nlp	24860779	SENT21	19	19	27	27	isotretinoin	CO2	PA450128	4513	0.645
NULL	Chemother_Res_Pract_2011_Dec_1_2011_715469.nxml.txt.nlp	22312557	SENT100	10	10	6	6	cisplatin	p53	PA449014	7157	0.645
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_11_2014_780385.nxml.txt.nlp	25435891	SENT27	17	17	25	25	lipase	HSL	PA450239	3991	0.645
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT128	16	16	4	4	propafenone	CYP3A4	PA451131	1576	0.645
NULL	Ann_Oncol_2009_Aug_20(Suppl_6)_vi35-vi40.nxml.txt.nlp	19617296	SENT10	21	21	33	33	tanespimycin	VEGFR	PA165291490	3791	0.645
NULL	Case_Rep_Oncol_2013_Oct_24_6(3)_526-530.nxml.txt.nlp	24348388	SENT44	9	9	17	17	tegafur	CDHP	PA452620	1001	0.645
NULL	Osteoarthritis_Cartilage_2013_Sep_21(9)_1336-1345.nxml.txt.nlp	23973148	SENT163	3	3	11	11	triamcinolone	MIA	PA451749	8190	0.645
NULL	Int_J_Mol_Sci_2014_Oct_13_15(10)_18381-18406.nxml.txt.nlp	25314300	SENT192	22	22	15	15	vildagliptin	IL-18	PA165958346	3606	0.645
NULL	J_Vet_Med_Sci_2014_Mar_1_76(3)_323-330.nxml.txt.nlp	24189582	SENT12	4	4	6	6	atovaquone	ATV	PA448502	4683	0.645
NULL	Ann_Neurol_2013_Feb_31_73(2)_246-258.nxml.txt.nlp	23281025	SENT12	0	0	11	11	riluzole	NRF2	PA451251	2551;4780	0.645
NULL	Exp_Diabetes_Res_2011_Dec_27_2011_604989.nxml.txt.nlp	21253359	SENT53	27	27	29	29	clonidine	GLP-1	PA449051	100125288	0.645
NULL	J_Oral_Pathol_Med_2013_Jul_18_42(6)_499-506.nxml.txt.nlp	23331485	SENT56	21	21	7	7	kanamycin	F12	PA450137	2161	0.645
NULL	Oncol_Lett_2014_Jul_12_8(1)_117-122.nxml.txt.nlp	24959230	SENT19	7	7	9	9	decitabine	DAC	PA164749631	13	0.645
NULL	Int_J_Environ_Res_Public_Health_2011_Jul_30_8(7)_2747-2757.nxml.txt.nlp	21845156	SENT139	9	9	3	3	trypsin	PRSS1	PA451806	5644	0.645
NULL	Diabetes_Care_2011_Mar_17_34(3)_782-784.nxml.txt.nlp	21357366	SENT27	16	16	1	1	aspirin	ADA	PA448497	100	0.645
NULL	J_Antimicrob_Chemother_2010_Jul_30_65(7)_1441-1447.nxml.txt.nlp	20435780	SENT65	18	18	20	20	azithromycin	TOB	PA448519	10140	0.645
NULL	Front_Oncol_2014_May_30_4_128.nxml.txt.nlp	24910845	SENT381	36	36	22	22	doxorubicin	TRAIL-R2	PA449412	8795	0.645
NULL	Neural_Plast_2014_Feb_18_2014_938235.nxml.txt.nlp	24693454	SENT93	30	30	26	26	capsaicin	TRPV1	PA448776	7442	0.645
NULL	Biochem_Res_Int_2012_Feb_12_2012_346972.nxml.txt.nlp	22400115	SENT5	1	1	11	11	hyaluronan	LYVE-1	PA165958431	10894	0.645
NULL	Front_Immunol_2012_Feb_27_3_23.nxml.txt.nlp	22566907	SENT367	6	6	12	12	hyaluronan	CD4	PA165958431	920	0.645
NULL	Crit_Care_2010_Nov_5_14(6)_R200.nxml.txt.nlp	21054850	SENT149	6	6	17	17	vasopressin	AVP	PA451858	114548;551	0.645
NULL	Adv_Hematol_2012_Feb_26_2012_529572.nxml.txt.nlp	22474449	SENT76	11	11	20	20	cyclophosphamide	CHOP	PA449165	1649	0.645
NULL	Exp_Lung_Res_2013_Oct_1_39(8)_336-348.nxml.txt.nlp	23919450	SENT176	6	6	2	2	thrombin	PAR-1	PA451674	2011;2149	0.645
NULL	Oncotarget_2011_Sep_9_2(9)_658-668.nxml.txt.nlp	21911919	SENT4	30	30	8	8	daunorubicin	HO-1	PA449212	3162	0.645
NULL	Curr_Neuropharmacol_2008_Jun_6(2)_151-163.nxml.txt.nlp	19305794	SENT78	6	6	10	10	capsaicin	TRPV1	PA448776	7442	0.645
NULL	Anal_Chem_Insights_2007_Nov_11_2_111-118.nxml.txt.nlp	19662185	SENT47	33	33	38	38	naphthol	mol	PA154081779	90527	0.645
NULL	Eur_J_Clin_Pharmacol_2014_Oct_8_70(12)_1433-1441.nxml.txt.nlp	25291992	SENT173	15	15	22	22	olanzapine	CPZ	PA450688	8532	0.645
NULL	Arthritis_Res_Ther_2014_Jul_24_16(4)_R157.nxml.txt.nlp	25059342	SENT232	9	9	19	19	bleomycin	IL-6	PA448645	3569	0.645
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Apr_18_65(Pt_5)_o1065.nxml.txt.nlp	21583881	SENT57	22	22	33	33	ethanol	mol	PA448073	90527	0.645
NULL	Pharmaceuticals_(Basel)_2013_Oct_11_6(10)_1304-1321.nxml.txt.nlp	24275851	SENT222	31	31	29	29	liraglutide	GLP-1	PA165958364	100125288	0.645
NULL	Oncologist_2011_Feb_1_16(2)_136-145.nxml.txt.nlp	21285392	SENT100	5	5	3	3	denosumab	OPG	PA166048634	690	0.645
NULL	Biomed_Res_Int_2014_Jun_26_2014_161346.nxml.txt.nlp	25054130	SENT26	6	6	20	20	curcumin	IL-6	PA151958596	3569	0.645
NULL	Oncotarget_2013_Nov_7_4(12)_2550-2566.nxml.txt.nlp	24334291	SENT220	5	5	23	23	fludarabine	CHOP	PA449655	1649	0.645
NULL	J_Res_Med_Sci_2012_Jul_17(7)_642-648.nxml.txt.nlp	23798924	SENT9	16	16	19	19	potassium	CRP	PA451047	1401;140913	0.645
NULL	Nucleic_Acids_Res_2012_Apr_16_40(8)_3641-3652.nxml.txt.nlp	22180534	SENT87	6	6	13	13	tobramycin	MS2	PA451704	101	0.645
NULL	Crit_Care_2008_Nov_26_12(Suppl_6)_S3.nxml.txt.nlp	19105796	SENT117	15	15	4	4	thrombin	PAR1	PA451674	79581;2149	0.645
NULL	Front_Pharmacol_2014_Oct_27_5_233.nxml.txt.nlp	25386143	SENT274	0	0	2	2	erythromycin	CD4	PA449493	920	0.644
NULL	Br_J_Pharmacol_2008_Oct_18_155(4)_596-605.nxml.txt.nlp	18852694	SENT215	2	2	6	6	fenofibrate	SREBP1	PA449594	6720	0.644
NULL	Eur_J_Clin_Pharmacol_2011_May_9_67(5)_477-482.nxml.txt.nlp	21305273	SENT103	32	32	20	20	atropine	DBP	PA448505	3295;1628;2638	0.644
NULL	J_Korean_Med_Sci_2013_Jun_3_28(6)_939-945.nxml.txt.nlp	23772162	SENT133	0	0	12	12	resveratrol	IL-6		3569	0.644
NULL	Biomed_Res_Int_2014_Jan_27_2014_683123.nxml.txt.nlp	24592395	SENT58	23	23	42	42	l-glutamine	CO2	PA10090	4513	0.644
NULL	J_Immunol_Methods_2009_Jan_1_340(1)_11-24.nxml.txt.nlp	18929568	SENT11	13	13	24	24	dasatinib	CD4	PA162372878	920	0.644
NULL	Arthritis_Res_Ther_2012_Jun_25_14(3)_215.nxml.txt.nlp	22731694	SENT70	19	19	17	17	ribavirin	RIBA	PA451241	6014	0.644
NULL	ScientificWorldJournal_2014_Dec_29_2014_396304.nxml.txt.nlp	25614886	SENT67	2	2	0	0	mannitol	MYP	PA450320	8996	0.644
NULL	Clin_Exp_Pharmacol_Physiol_2014_Mar_18_41(3)_227-237.nxml.txt.nlp	24471737	SENT295	5	5	26	26	losartan	ANG	PA450268	283	0.644
NULL	Bone_Marrow_Res_2012_Oct_18_2012_180391.nxml.txt.nlp	23119165	SENT229	22	22	26	26	alemtuzumab	CD34	PA164783958	947	0.644
NULL	Nat_Biotechnol_2011_May_29_29(6)_542-546.nxml.txt.nlp	21623355	SENT267	26	26	20	20	imatinib	PTPN12	PA10804	5782	0.644
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT17	28	28	15	15	phenprocoumon	PROC	PA450921	5624	0.644
NULL	Breast_Cancer_Res_2011_Mar_24_13(2)_R32.nxml.txt.nlp	21435239	SENT259	0	0	4	4	curcumin	ARNT	PA151958596	405	0.644
NULL	Diabetes_2011_Jul_20_60(7)_1990-1999.nxml.txt.nlp	21617181	SENT283	25	25	14	14	troglitazone	PPARgamma	PA451799	5468	0.644
NULL	Eur_J_Pediatr_2011_Dec_6_170(12)_1495-1505.nxml.txt.nlp	21465122	SENT198	17	17	11	11	budesonide	IL-8	PA448681	3576	0.644
NULL	Clin_Exp_Gastroenterol_2011_Jul_15_4_163-172.nxml.txt.nlp	21904462	SENT83	12	12	3	3	adalimumab	CDAI	PA10004	146059	0.644
NULL	Case_Rep_Surg_2012_Sep_17_2012_230538.nxml.txt.nlp	23024879	SENT30	21	21	25	25	vincristine	CHOP	PA451879	1649	0.644
NULL	Cancer_Cell_Int_2013_Mar_4_13_21.nxml.txt.nlp	23497288	SENT160	13	13	8	8	vincristine	EWS	PA451879	2130	0.644
NULL	Infect_Drug_Resist_2014_Oct_24_7_273-280.nxml.txt.nlp	25368526	SENT149	31	31	29	29	vancomycin	VAN	PA451850	10318	0.644
NULL	J_Korean_Med_Sci_2009_Jan_29_24(Suppl_1)_S170-S175.nxml.txt.nlp	19194548	SENT86	10	10	12	12	cisplatin	EPO	PA449014	7076;8288;2056	0.644
NULL	J_Cardiothorac_Surg_2010_Apr_19_5_26.nxml.txt.nlp	20403156	SENT143	39	39	9	9	etomidate	RAI	PA164743987	10848;6050	0.644
NULL	Cancer_Res_Treat_2014_Jan_15_46(1)_55-64.nxml.txt.nlp	24520224	SENT31	24	24	7	7	oxaliplatin	ERCC1	PA131285527	2067	0.644
NULL	Case_Rep_Neurol_2013_Jun_29_5(2)_116-124.nxml.txt.nlp	23898283	SENT107	34	34	28	28	gabapentin	LZP	PA449720	170392	0.644
NULL	J_Cell_Mol_Med_2014_Apr_20_18(4)_709-720.nxml.txt.nlp	24444314	SENT238	13	13	16	16	losartan	AMPK	PA450268	5563	0.644
NULL	Int_J_Biol_Sci_2007_Aug_29_3(6)_365-374.nxml.txt.nlp	17848981	SENT89	19	19	11	11	ethanol	GMP	PA448073	22978	0.644
NULL	Nat_Commun_2010_Nov_23_1_127.nxml.txt.nlp	21119640	SENT272	11	11	5	5	doxycycline	INS-1	PA449415	2305	0.644
NULL	Int_J_Biol_Sci_2015_Jan_1_11(1)_1-10.nxml.txt.nlp	25552924	SENT34	0	0	17	17	cisplatin	CD117	PA449014	3815	0.644
NULL	Oxid_Med_Cell_Longev_2013_Jun_2_2013_793525.nxml.txt.nlp	23819014	SENT209	15	15	34	34	resveratrol	PI3K		5290	0.644
NULL	Br_J_Pharmacol_2011_Jul_163(6)_1263-1275.nxml.txt.nlp	21391977	SENT100	14	14	24	24	fluconazole	CYP3A4	PA449653	1576	0.644
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT152	29	29	1	1	phenprocoumon	VKORC1	PA450921	79001	0.644
NULL	Semin_Immunopathol_2013_Jan_26_35(1)_39-52.nxml.txt.nlp	22829332	SENT197	33	33	30	30	rituximab	CHOP	PA451261	1649	0.644
NULL	Chin_J_Cancer_2011_Sep_30(9)_645-654.nxml.txt.nlp	21880186	SENT141	7	7	3	3	ifosfamide	DDP	PA449964	1678	0.644
NULL	Biochem_Res_Int_2012_Feb_12_2012_346972.nxml.txt.nlp	22400115	SENT5	1	1	13	13	hyaluronan	HARE	PA165958431	55576	0.644
NULL	J_Ophthalmic_Inflamm_Infect_2013_Apr_22_3_46.nxml.txt.nlp	23607574	SENT63	14	14	16	16	chloramphenicol	Gen	PA448927	348654	0.644
NULL	Biomed_Res_Int_2013_Jul_16_2013_687658.nxml.txt.nlp	23956997	SENT3	6	6	20	20	l-alanine	PLP	PA448055	25824;5744	0.644
NULL	Emerg_Infect_Dis_2013_Jan_19(1)_133-136.nxml.txt.nlp	23260464	SENT42	22	22	20	20	tobramycin	TOB	PA451704	10140	0.644
NULL	Virol_J_2010_Oct_27_7_285.nxml.txt.nlp	20979618	SENT170	18	18	13	13	isoproterenol	c-fos	PA450121	2353	0.644
NULL	Int_J_Hypertens_2012_Mar_7_2012_842632.nxml.txt.nlp	22506100	SENT155	5	5	3	3	hemin	HO-1	PA449849	3162	0.644
NULL	Evid_Based_Complement_Alternat_Med_2014_Mar_6_2014_627342.nxml.txt.nlp	24734109	SENT113	28	28	0	0	bupivacaine	B12	PA135057240	7126;4709	0.644
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Apr_21_68(Pt_5)_o1466.nxml.txt.nlp	22590340	SENT66	16	16	12	12	ethanol	mol	PA448073	90527	0.644
NULL	Breast_Cancer_Res_Treat_2014_Apr_6_145(3)_725-734.nxml.txt.nlp	24706168	SENT78	3	3	11	11	cyclophosphamide	HER2	PA449165	2064	0.644
NULL	Acta_Pharmacol_Sin_2009_Apr_3_30(4)_478-484.nxml.txt.nlp	19343062	SENT99	0	0	18	18	ketoconazole	CYP3A4	PA450146	1576	0.644
NULL	Libyan_J_Med_2007_Dec_1_2(4)_169-175.nxml.txt.nlp	21503240	SENT239	13	13	33	33	imipramine	CA1	PA449969	759	0.644
NULL	Oxid_Med_Cell_Longev_2013_Sep_24_2013_102741.nxml.txt.nlp	24205431	SENT7	9	9	34	34	hesperidin	Bcl-2	PA449867	596	0.644
NULL	Open_Cardiovasc_Med_J_2010_Feb_23_4_51-56.nxml.txt.nlp	20360981	SENT75	0	0	5	5	colchicine	MEFV	PA449092	4210	0.644
NULL	Acta_Pharmacol_Sin_2012_May_4_33(5)_625-634.nxml.txt.nlp	22555370	SENT172	21	21	14	14	nifedipine	APO	PA450631	84909	0.644
NULL	Oncotarget_2010_Jul_9_1(3)_185-197.nxml.txt.nlp	21037799	SENT100	5	5	9	9	choline	Hsp90	PA448976	3320	0.644
NULL	Acta_Pharmacol_Sin_2012_Aug_23_33(8)_1023-1029.nxml.txt.nlp	22820911	SENT88	11	11	5	5	glibenclamide	PAG	PA449782	55824	0.644
NULL	Asian_Spine_J_2014_Feb_6_8(1)_97-111.nxml.txt.nlp	24596613	SENT397	22	22	16	16	amikacin	EMB	PA164744372	133418	0.644
NULL	Leukemia_2013_Apr_14_27(4)_803-812.nxml.txt.nlp	23238589	SENT57	18	18	2	2	imatinib	IFN	PA10804	3439	0.644
NULL	Sci_Rep_2015_Jan_6_5_7641.nxml.txt.nlp	25560734	SENT91	9	9	21	21	tamoxifen	CLTC	PA451581	1213	0.644
NULL	Infect_Drug_Resist_2014_Aug_19_7_223-228.nxml.txt.nlp	25187730	SENT138	17	17	15	15	ciprofloxacin	CPX	PA449009	1371;10682;1377	0.644
NULL	Blood_Res_2013_Mar_25_48(1)_35-39.nxml.txt.nlp	23589793	SENT89	6	6	11	11	cyclophosphamide	CD25	PA449165	3669;3559	0.644
NULL	Mol_Cancer_2008_Jan_25_7_14.nxml.txt.nlp	18221502	SENT207	15	15	20	20	oxaliplatin	PSAT1	PA131285527	29968	0.644
NULL	Infect_Ecol_Epidemiol_2012_Mar_27_2_10_3402_iee_v2i0_7438.nxml.txt.nlp	22957135	SENT9	22	22	39	39	imipenem	VAN	PA449968	10318	0.644
NULL	AIDS_Res_Ther_2012_Feb_1_9_3.nxml.txt.nlp	22296672	SENT175	6	6	10	10	indinavir	RALDH1	PA449977	216	0.644
NULL	Mol_Biol_Cell_2014_Mar_15_25(6)_791-799.nxml.txt.nlp	24451261	SENT89	16	16	21	21	nadh	ADP	PA164755085	23038	0.644
NULL	Inflammation_2014_Apr_6_37(5)_1476-1485.nxml.txt.nlp	24706026	SENT9	0	0	17	17	curcumin	GATA3	PA151958596	2625	0.644
NULL	Front_Oncol_2014_Apr_9_4_75.nxml.txt.nlp	24782986	SENT240	22	22	9	9	paclitaxel	CA125	PA450761	4077;94025	0.644
NULL	Mar_Drugs_2012_Dec_12_10(12)_2795-2816.nxml.txt.nlp	23235364	SENT623	8	8	4	4	heparin	MCP-1	PA449855	6347	0.644
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1449-1456.nxml.txt.nlp	24077631	SENT123	34	34	10	10	tolbutamide	CYP2C9	PA451718	1559	0.644
NULL	Diabetes_Care_2013_Aug_17_36(Suppl_2)_S127-S138.nxml.txt.nlp	23882037	SENT465	8	8	14	14	pioglitazone	adiponectin	PA450970	9370	0.644
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_55-78.nxml.txt.nlp	19305788	SENT525	0	0	37	37	memantine	STZ	PA10364	6484	0.644
NULL	Cholesterol_2010_Oct_31_2010_271504.nxml.txt.nlp	21490912	SENT111	38	38	9	9	fenofibrate	adiponectin	PA449594	9370	0.644
NULL	Front_Endocrinol_(Lausanne)_2011_Dec_21_2_84.nxml.txt.nlp	22654830	SENT37	19	19	14	14	lipase	HSL	PA450239	3991	0.644
NULL	Front_Behav_Neurosci_2011_Sep_8_5_56.nxml.txt.nlp	21927600	SENT484	15	15	11	11	nicotine	PPP1R1B	PA450626	84152	0.644
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT126	27	27	29	29	perifosine	TRAIL	PA165291471	8743	0.644
NULL	Evid_Based_Complement_Alternat_Med_2014_Mar_26_2014_158987.nxml.txt.nlp	24795763	SENT207	6	6	26	26	fluoxetine	EPM	PA449673	2054	0.644
NULL	J_Korean_Med_Sci_2004_Apr_30_19(2)_167-171.nxml.txt.nlp	15082886	SENT118	6	6	30	30	cycloserine	EMB	PA164764600	133418	0.644
NULL	Cancer_Med_2014_Aug_18_3(4)_1025-1034.nxml.txt.nlp	24944108	SENT30	5	5	25	25	metformin	HER2	PA450395	2064	0.644
NULL	Osteoporos_Int_2013_Oct_19_24(1)_23-57.nxml.txt.nlp	23079689	SENT973	22	22	26	26	tamoxifen	STAR	PA451581	6770;2984	0.644
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT160	5	5	7	7	curcumin	TRAIL	PA151958596	8743	0.644
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Apr_23_64(Pt_5)_o895.nxml.txt.nlp	21202378	SENT3	25	25	21	21	phenol	mol	PA450913	90527	0.644
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2007_Dec_6_64(Pt_1)_o191.nxml.txt.nlp	21200756	SENT59	23	23	6	6	ethanol	mol	PA448073	90527	0.644
NULL	Acta_Orthop_2010_Apr_6_81(2)_263-267.nxml.txt.nlp	20148646	SENT11	1	1	29	29	taurine	ATF4	PA451590	468	0.644
NULL	New_Microbes_New_Infect_2014_May_4_2(3)_58-63.nxml.txt.nlp	25356345	SENT100	22	22	24	24	gentamicin	ANK	PA449753	56172	0.644
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT13	23	23	12	12	doxorubicin	SLK	PA449412	9748;2534	0.644
NULL	J_Hematol_Oncol_2014_Aug_12_7_57.nxml.txt.nlp	25112836	SENT167	3	3	8	8	imiquimod	TLR7	PA449972	51284	0.644
NULL	J_Neurosci_Rural_Pract_2012_Jan-Apr_3(1)_105-106.nxml.txt.nlp	22346220	SENT14	4	4	20	20	curcumin	p65	PA151958596	5970	0.644
NULL	Clin_Ophthalmol_2008_Jun_2(2)_355-368.nxml.txt.nlp	19668727	SENT43	7	7	10	10	nepafenac	COX	PA165958407	1351	0.644
NULL	Front_Physiol_2013_Jun_4_4_128.nxml.txt.nlp	23760815	SENT75	18	18	20	20	lipase	ATGL	PA450239	57104	0.644
NULL	J_Cell_Mol_Med_2014_Apr_20_18(4)_709-720.nxml.txt.nlp	24444314	SENT102	0	0	29	29	metformin	Bcl-2	PA450395	596	0.644
NULL	Breast_Cancer_Res_2007_Jan_23_9(1)_R7.nxml.txt.nlp	17244352	SENT116	8	8	19	19	tamoxifen	CYP3A5	PA451581	1577	0.644
NULL	Case_Rep_Ophthalmol_2012_Jun_12_3(2)_196-199.nxml.txt.nlp	22740830	SENT18	11	11	3	3	fluorescein	OCT3	PA164746009	5460;6581	0.644
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT115	3	3	5	5	resveratrol	TRAIL		8743	0.644
NULL	Diabetol_Metab_Syndr_2014_Mar_31_6_47.nxml.txt.nlp	24684779	SENT100	0	0	24	24	simvastatin	IL-6	PA451363	3569	0.644
NULL	Clin_Ophthalmol_2009_Jun_2_3_189-194.nxml.txt.nlp	19668564	SENT95	41	41	33	33	travoprost	BAK	PA164781371	578	0.644
NULL	Ann_Oncol_2010_Jul_23_21(7)_1436-1441.nxml.txt.nlp	20032126	SENT207	25	25	9	9	paclitaxel	HER2	PA450761	2064	0.644
NULL	Evid_Based_Complement_Alternat_Med_2013_Aug_12_2013_982689.nxml.txt.nlp	23997806	SENT4	39	39	13	13	tolbutamide	APE	PA451718	55704;328	0.644
NULL	J_Ophthalmic_Inflamm_Infect_2013_Apr_22_3_46.nxml.txt.nlp	23607574	SENT63	18	18	16	16	gentamicin	Gen	PA449753	348654	0.644
NULL	J_Korean_Med_Sci_2010_Feb_21_25(2)_197-202.nxml.txt.nlp	20119570	SENT117	6	6	28	28	clindamycin	VAN	PA449035	10318	0.644
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2011_Mar_14_4_13-24.nxml.txt.nlp	22879790	SENT243	13	13	11	11	liraglutide	GLP-1	PA165958364	100125288	0.644
NULL	J_Antimicrob_Chemother_2014_Apr_27_69(4)_907-910.nxml.txt.nlp	24284779	SENT24	24	24	27	27	cefoxitin	BSAC	PA448856	57591	0.644
NULL	Basic_Res_Cardiol_2012_Jul_24_107(4)_273.nxml.txt.nlp	22622703	SENT229	25	25	7	7	nadh	AMPK	PA164755085	5563	0.644
NULL	Mol_Syst_Biol_2010_Jan_19_6_344.nxml.txt.nlp	20087341	SENT37	25	25	12	12	ethanol	AMD1	PA448073	262	0.644
NULL	New_Microbes_New_Infect_2014_May_4_2(3)_58-63.nxml.txt.nlp	25356345	SENT100	46	46	24	24	tigecycline	ANK	PA164746412	56172	0.644
NULL	Diabetes_2013_Oct_17_62(10)_3547-3552.nxml.txt.nlp	23863812	SENT70	0	0	11	11	pravastatin	adiponectin	PA451089	9370	0.644
NULL	Cell_Death_Differ_2010_Apr_23_17(4)_699-709.nxml.txt.nlp	19851330	SENT299	16	16	25	25	tetracycline	PUMA	PA451640	27113	0.644
NULL	J_Clin_Exp_Pathol_2012_May_17_Suppl_4_7327.nxml.txt.nlp	25379357	SENT192	7	7	9	9	resveratrol	SIRT1		23411	0.644
NULL	Front_Genet_2012_Nov_5_3_236.nxml.txt.nlp	23133441	SENT132	14	14	24	24	efavirenz	ABCB1	PA449441	5243	0.644
NULL	Int_J_Endocrinol_Metab_2014_Apr_1_12(2)_e14098.nxml.txt.nlp	24803942	SENT38	17	17	19	19	vasopressin	AVP	PA451858	114548;551	0.644
NULL	Int_J_Vasc_Med_2013_Mar_31_2013_543141.nxml.txt.nlp	23606968	SENT242	0	0	10	10	etanercept	IL-13	PA449515	3596	0.644
NULL	Int_J_Biol_Sci_2014_Jan_20_10(2)_171-180.nxml.txt.nlp	24520215	SENT47	12	12	25	25	cerulenin	L-FABP	PA164764551	2168	0.644
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Nov_4_9_31.nxml.txt.nlp	21050425	SENT126	13	13	11	11	gentamicin	Gen	PA449753	348654	0.644
NULL	Scientifica_(Cairo)_2012_Oct_14_2012_428139.nxml.txt.nlp	24278693	SENT117	18	18	7	7	paclitaxel	OCT1	PA450761	5451;6580	0.644
NULL	Curr_Neuropharmacol_2013_Jan_11(1)_114-127.nxml.txt.nlp	23814544	SENT258	19	19	15	15	pilocarpine	EP2	PA450962	5732;10407	0.644
NULL	Br_J_Cancer_2010_Oct_26_103(9)_1325-1330.nxml.txt.nlp	20940720	SENT157	24	24	20	20	vinorelbine	CRT	PA451881	811	0.644
NULL	Br_J_Cancer_2010_Sep_7_103(6)_759-764.nxml.txt.nlp	20700118	SENT82	8	8	5	5	tamoxifen	aromatase	PA451581	1588	0.644
NULL	Mol_Cancer_2014_Feb_5_13_24.nxml.txt.nlp	24495306	SENT297	32	32	37	37	collagenase	ADAM17	PA449107	6868	0.644
NULL	Br_J_Cancer_2009_May_5_100(9)_1415-1424.nxml.txt.nlp	19352384	SENT187	25	25	19	19	cisplatin	JNK1	PA449014	5599	0.644
NULL	Autophagy_2012_May_1_8(5)_853-855.nxml.txt.nlp	22617440	SENT51	17	17	32	32	nilotinib	MIR30A	PA165958345	407029	0.644
NULL	Eur_J_Clin_Pharmacol_2014_Mar_22_70(6)_685-693.nxml.txt.nlp	24658827	SENT117	0	0	36	36	tacrolimus	POR	PA451578	5447	0.644
NULL	Nat_Commun_2014_Dec_15_5_5340.nxml.txt.nlp	25500532	SENT161	43	43	41	41	galactose	NAG	PA449725	51594;4669	0.644
NULL	Breast_Cancer_(Auckl)_2012_Nov_19_6_191-207.nxml.txt.nlp	23226023	SENT278	14	14	44	44	docetaxel	HER-2	PA449383	2064	0.644
NULL	Croat_Med_J_2012_Aug_53(4)_343-349.nxml.txt.nlp	22911527	SENT54	9	9	7	7	nifedipine	NIF	PA450631	6280	0.644
NULL	Enzyme_Res_2009_Nov_1_2010_165878.nxml.txt.nlp	21048860	SENT5	11	11	24	24	l-cystine	NAC	PA449176	22861	0.644
NULL	Mol_Cancer_2007_Aug_21_6_53.nxml.txt.nlp	17711579	SENT153	6	6	18	18	cisplatin	BCL2L13	PA449014	23786	0.644
NULL	Ann_Dermatol_2013_May_10_25(2)_261-263.nxml.txt.nlp	23717030	SENT37	6	6	15	15	imiquimod	IL-6	PA449972	3569	0.644
NULL	Arthritis_Res_Ther_2013_Apr_17_15(2)_R51.nxml.txt.nlp	23594962	SENT254	0	0	6	6	muraglitazar	IL-6	PA162356187	3569	0.644
NULL	J_Biol_Chem_2009_Feb_27_284(9)_5645-5653.nxml.txt.nlp	19095655	SENT195	23	23	1	1	forskolin	AMPK	PA146096022	5563	0.644
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Mar_5_67(Pt_4)_o795.nxml.txt.nlp	21754085	SENT62	24	24	19	19	ethanol	mol	PA448073	90527	0.644
NULL	Arthritis_Res_Ther_2009_Aug_24_11(4)_R127.nxml.txt.nlp	19703304	SENT12	8	8	12	12	adalimumab	OASIS	PA10004	90993	0.644
NULL	EPMA_J_2011_Sep_14_2(3)_271-276.nxml.txt.nlp	23199162	SENT88	20	20	16	16	zinc	B12	PA451956	7126;4709	0.644
NULL	Sci_Rep_2014_Dec_3_4_7294.nxml.txt.nlp	25465236	SENT502	27	27	23	23	axitinib	TYK2	PA164924493	7297	0.644
NULL	Case_Rep_Pathol_2013_Jul_14_2013_198643.nxml.txt.nlp	23936709	SENT44	19	19	10	10	thyroglobulin	PTH	PA164754910	5741	0.644
NULL	Clin_Mol_Hepatol_2013_Sep_30_19(3)_195-209.nxml.txt.nlp	24133659	SENT296	10	10	0	0	telbivudine	LAM	PA164760861	7249;7248	0.644
NULL	Drug_Des_Devel_Ther_2014_Sep_23_8_1527-1538.nxml.txt.nlp	25284985	SENT193	2	2	0	0	celecoxib	IFN	PA448871	3439	0.644
NULL	New_Microbes_New_Infect_2014_May_4_2(3)_58-63.nxml.txt.nlp	25356345	SENT100	22	22	8	8	gentamicin	CTX	PA449753	1593	0.644
NULL	Behav_Brain_Funct_2007_Jun_13_3_28.nxml.txt.nlp	17567902	SENT444	1	1	3	3	vasopressin	AVP	PA451858	114548;551	0.644
NULL	Endocrinology_2014_Oct_22_155(10)_3732-3738.nxml.txt.nlp	25051442	SENT7	24	24	4	4	sibutramine	POMC	PA451344	5443	0.644
NULL	Aging_(Albany_NY)_2009_Jun_3_1(6)_515-528.nxml.txt.nlp	20157535	SENT8	4	4	6	6	resveratrol	S6K1		6198	0.644
NULL	Int_J_Environ_Res_Public_Health_2010_May_28_7(5)_1913-1936.nxml.txt.nlp	20623001	SENT16	30	30	32	32	diethylstilbestrol	DES	PA449307	1674	0.644
NULL	Osteoarthritis_Cartilage_2013_Sep_21(9)_1336-1345.nxml.txt.nlp	23973148	SENT471	1	1	10	10	triamcinolone	MNX	PA451749	3892	0.644
NULL	Cardiol_Ther_2013_Jun_7_2(1)_57-68.nxml.txt.nlp	25135289	SENT66	16	16	2	2	thrombin	PAR-1	PA451674	2011;2149	0.644
NULL	ASN_Neuro_2009_Apr_14_1(1)_e00005.nxml.txt.nlp	19570022	SENT35	11	11	21	21	mefloquine	CBX	PA450348	10951	0.644
NULL	Eur_J_Clin_Pharmacol_2011_Dec_23_67(12)_1231-1241.nxml.txt.nlp	21698374	SENT274	7	7	2	2	tacrolimus	ABCB1	PA451578	5243	0.644
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT109	11	11	20	20	glucose	EGFR	PA449773	1956	0.644
NULL	Inflammation_2012_Feb_24_35(1)_206-213.nxml.txt.nlp	21347606	SENT134	13	13	21	21	dobutamine	IL-6	PA449381	3569	0.644
NULL	Child_Adolesc_Psychiatry_Ment_Health_2008_Nov_17_2_33.nxml.txt.nlp	19014633	SENT34	28	28	23	23	lipase	NAAA	PA450239	27163	0.644
NULL	J_Antimicrob_Chemother_2010_Jul_30_65(7)_1441-1447.nxml.txt.nlp	20435780	SENT65	10	10	20	20	gatifloxacin	TOB	PA449738	10140	0.644
NULL	Ital_J_Pediatr_2010_Sep_3_36_57.nxml.txt.nlp	20813071	SENT208	17	17	30	30	canakinumab	PAPA	PA165958358	2737;5069	0.644
NULL	Front_Behav_Neurosci_2009_Jan_27_3_1.nxml.txt.nlp	19194528	SENT384	14	14	2	2	amitriptyline	spatial	PA448385	219793	0.644
NULL	Int_J_Cell_Biol_2013_Sep_12_2013_153634.nxml.txt.nlp	24159334	SENT40	11	11	16	16	cisplatin	MDM2	PA449014	4193	0.644
NULL	Acta_Neuropathol_2014_Dec_8_127(1)_109-135.nxml.txt.nlp	24318124	SENT118	1	1	3	3	vasopressin	AVP	PA451858	114548;551	0.644
NULL	Alzheimers_Res_Ther_2011_Jun_29_3(3)_21.nxml.txt.nlp	21722346	SENT120	19	19	14	14	creatine	Q10	PA164778930	27161	0.644
NULL	Diabetol_Metab_Syndr_2014_Mar_31_6_48.nxml.txt.nlp	24684803	SENT117	13	13	23	23	mitiglinide	STEP	PA164748124	84867	0.644
NULL	Cancers_(Basel)_2011_Apr_1_3(2)_1844-1860.nxml.txt.nlp	24212785	SENT65	36	36	18	18	oxaliplatin	KRAS	PA131285527	3845	0.644
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1449-1456.nxml.txt.nlp	24077631	SENT123	34	34	19	19	tolbutamide	CYP2C9	PA451718	1559	0.644
NULL	Diabetes_2009_Dec_31_58(12)_2851-2862.nxml.txt.nlp	19720788	SENT190	11	11	1	1	forskolin	BiP	PA146096022	3309	0.644
NULL	J_Korean_Med_Sci_2004_Apr_30_19(2)_167-171.nxml.txt.nlp	15082886	SENT118	32	32	30	30	ethambutol	EMB	PA164784021	133418	0.644
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1126-1134.nxml.txt.nlp	21364592	SENT32	25	25	13	13	cisplatin	XRCC1	PA449014	7515	0.644
NULL	Surf_Sci_2012_Aug_606(15-16)_L55-L58.nxml.txt.nlp	23470898	SENT39	22	22	5	5	potassium	AES	PA451047	166	0.644
NULL	Case_Rep_Oncol_2012_May_10_5(2)_233-237.nxml.txt.nlp	22679429	SENT82	19	19	26	26	paclitaxel	GEM	PA450761	2669	0.644
NULL	Indian_Dermatol_Online_J_2012_May-Aug_3(2)_122-124.nxml.txt.nlp	23130286	SENT73	23	23	5	5	methotrexate	CHOP	PA450428	1649	0.644
NULL	Blood_Res_2013_Sep_25_48(3)_171-177.nxml.txt.nlp	24086936	SENT136	9	9	11	11	bortezomib	CHOP	PA10252	1649	0.644
NULL	Bone_Marrow_Transplant_2014_Feb_4_49(2)_201-205.nxml.txt.nlp	24185588	SENT99	8	8	2	2	lenalidomide	CD34	PA162363968	947	0.644
NULL	J_Gen_Physiol_1997_Jan_1_109(1)_3-14.nxml.txt.nlp	8997661	SENT0	11	11	1	1	tetracaine	Gen	PA451638	348654	0.644
NULL	J_Biol_2008_Dec_15_7(10)_38.nxml.txt.nlp	19090980	SENT96	18	18	11	11	artemisinin	ACT	PA165111696	12;11332;9457;641455	0.644
NULL	Acta_Pharmacol_Sin_2009_Oct_21_30(10)_1392-1398.nxml.txt.nlp	19767766	SENT55	20	20	22	22	atorvastatin	DPI	PA448500	1832	0.644
NULL	Crit_Care_2011_Sep_19_15(5)_R217.nxml.txt.nlp	21929764	SENT122	12	12	20	20	terlipressin	AVP	PA164781020	114548;551	0.644
NULL	Front_Physiol_2012_Nov_21_3_418.nxml.txt.nlp	23181020	SENT83	27	27	25	25	nadh	ADP	PA164755085	23038	0.644
NULL	Case_Rep_Endocrinol_2014_Jan_8_2014_807054.nxml.txt.nlp	24511399	SENT51	1	1	3	3	vasopressin	AVP	PA451858	114548;551	0.644
NULL	EMBO_Mol_Med_2012_Oct_30_4(10)_1087-1096.nxml.txt.nlp	22933245	SENT65	5	5	10	10	olaparib	NAMPT		10135	0.644
NULL	J_Int_Soc_Sports_Nutr_2010_Feb_3_7_8.nxml.txt.nlp	20181080	SENT12	44	44	39	39	creatine	ACTH	PA164778930	5443	0.644
NULL	J_Hematol_Oncol_2013_Jun_11_6_39.nxml.txt.nlp	23759001	SENT58	14	14	6	6	cytarabine	CR1	PA449177	1378	0.644
NULL	Clin_Psychopharmacol_Neurosci_2011_Apr_30_9(1)_36-43.nxml.txt.nlp	23431025	SENT108	12	12	15	15	haloperidol	FLI	PA449841	2314	0.644
NULL	Clinics_(Sao_Paulo)_2011_Dec_66(12)_2121-2124.nxml.txt.nlp	22189739	SENT27	0	0	20	20	curcumin	p53	PA151958596	7157	0.644
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Apr_18_68(Pt_5)_o1402.nxml.txt.nlp	22590290	SENT73	27	27	23	23	ethanol	mol	PA448073	90527	0.644
NULL	Neuropsychopharmacology_2009_May_1_34(6)_1443-1453.nxml.txt.nlp	18830237	SENT334	9	9	2	2	ethanol	AP-5	PA448073	91056	0.644
NULL	J_Antimicrob_Chemother_2010_Mar_18_65(3)_390-398.nxml.txt.nlp	20022938	SENT31	14	14	24	24	pyrimethamine	ATV	PA451193	4683	0.644
NULL	Acta_Vet_Scand_2011_Feb_17_53(1)_11.nxml.txt.nlp	21324209	SENT61	2	2	24	24	ampicillin	OTC	PA448419	5009	0.644
NULL	Ann_Lab_Med_2013_Jan_17_33(1)_86-88.nxml.txt.nlp	23301230	SENT52	38	38	12	12	amikacin	CTX	PA164744372	1593	0.644
NULL	Open_Cardiovasc_Med_J_2011_Jun_20_5_136-147.nxml.txt.nlp	21760856	SENT41	12	12	18	18	rosiglitazone	adiponectin	PA451283	9370	0.644
NULL	Br_J_Cancer_2009_May_19_100(10)_1589-1602.nxml.txt.nlp	19436306	SENT6	10	10	18	18	urokinase	TLR-4	PA451836	7099	0.644
NULL	Clin_Pharmacol_2011_Jun_22_3_13-25.nxml.txt.nlp	22287853	SENT188	20	20	10	10	simvastatin	OATP1B1	PA451363	10599	0.644
NULL	J_Antimicrob_Chemother_2012_Feb_17_67(2)_404-414.nxml.txt.nlp	22101217	SENT180	22	22	12	12	levofloxacin	EMB	PA450214	133418	0.644
NULL	Braz_J_Med_Biol_Res_2014_Nov_4_48(1)_13-24.nxml.txt.nlp	25493378	SENT291	17	17	14	14	cyclophosphamide	TPC	PA449165	8030;60386	0.644
NULL	Clinics_(Sao_Paulo)_2011_Jun_66(6)_1109-1111.nxml.txt.nlp	21808885	SENT31	37	37	19	19	imiquimod	CO2	PA449972	4513	0.644
NULL	EJC_Suppl_2013_Sep_5_11(2)_3-22.nxml.txt.nlp	NULL	SENT1178	3	3	29	29	anastrozole	p53	PA448432	7157	0.644
NULL	Evid_Based_Complement_Alternat_Med_2013_Nov_5_2013_715040.nxml.txt.nlp	24302969	SENT10	23	23	20	20	gentamicin	OPG	PA449753	690	0.644
NULL	Mol_Biol_Cell_2012_Oct_1_23(19)_3851-3862.nxml.txt.nlp	22875990	SENT12	31	31	3	3	l-leucine	GDH	PA450197	51084;2746	0.644
NULL	Arthritis_Res_Ther_2005_Jan_21_7(2)_55-61.nxml.txt.nlp	15743490	SENT102	0	0	15	15	lovastatin	LFA-1	PA450272	3683;3689	0.644
NULL	Croat_Med_J_2013_Apr_54(2)_171-179.nxml.txt.nlp	23630144	SENT45	21	21	19	19	taurine	STZ	PA451590	6484	0.644
NULL	Int_J_Biomed_Sci_2008_Dec_4(4)_260-265.nxml.txt.nlp	19568323	SENT81	8	8	11	11	forskolin	BRCA1	PA146096022	672	0.643
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT193	7	7	4	4	cisplatin	IBP	PA449014	706;50619	0.643
NULL	Oncotarget_2014_Aug_19_5(18)_8703-8715.nxml.txt.nlp	25237928	SENT92	15	15	0	0	glucose	CD44	PA449773	960	0.643
NULL	Support_Care_Cancer_2014_Dec_14_22(3)_837-846.nxml.txt.nlp	24337717	SENT19	21	21	5	5	clarithromycin	CYP3A4	PA449028	1576	0.643
NULL	Acta_Pharmacol_Sin_2012_Apr_12_33(4)_542-550.nxml.txt.nlp	22407228	SENT97	3	3	10	10	perifosine	JNK	PA165291471	5599	0.643
NULL	J_Int_Soc_Sports_Nutr_2009_Feb_19_6_6.nxml.txt.nlp	19228401	SENT80	22	22	15	15	creatine	CEE	PA164778930	51608	0.643
NULL	Cancer_Cell_Int_2005_Jul_24_5_22.nxml.txt.nlp	16042792	SENT58	14	14	9	9	vincristine	NAC	PA451879	22861	0.643
NULL	Indian_J_Pharmacol_2008_Oct_40(Suppl_2)_S37-S56.nxml.txt.nlp	21593978	SENT1133	16	16	20	20	pregabalin	gamma	PA164754814	9913	0.643
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1150.nxml.txt.nlp	24675468	SENT100	15	15	12	12	metformin	adiponectin	PA450395	9370	0.643
NULL	Mol_Biol_Cell_2012_Jul_1_23(13)_2583-2592.nxml.txt.nlp	22593214	SENT113	23	23	6	6	paclitaxel	GEF-H1	PA450761	9181	0.643
NULL	Bone_2014_Sep_66(100)_240-250.nxml.txt.nlp	24971713	SENT397	2	2	26	26	ibandronate	OCN	PA10270	632	0.643
NULL	Clin_Ophthalmol_2007_Mar_1(1)_61-64.nxml.txt.nlp	19668467	SENT85	11	11	8	8	ethanol	castor	PA448073	54897	0.643
NULL	Support_Care_Cancer_2009_Sep_10_17(9)_1187-1193.nxml.txt.nlp	19205754	SENT200	33	33	9	9	aprepitant	CYP2D6	PA164747039	1565	0.643
NULL	Oncol_Rep_2013_Mar_8_29(3)_917-924.nxml.txt.nlp	23314174	SENT153	0	0	12	12	sorafenib	CD24	PA7000	100133941	0.643
NULL	Acta_Histochem_Cytochem_2012_Apr_26_45(2)_139-146.nxml.txt.nlp	22685356	SENT90	5	5	11	11	forskolin	AQP2	PA146096022	359	0.643
NULL	Front_Microbiol_2013_Dec_17_4_377.nxml.txt.nlp	24381568	SENT87	29	29	13	13	phenol	TGC	PA450913	7052	0.643
NULL	Clin_Ophthalmol_2014_Nov_19_8_2301-2305.nxml.txt.nlp	25429200	SENT110	20	20	11	11	bevacizumab	CRT	PA130232992	811	0.643
NULL	Breast_Cancer_(Auckl)_2012_Oct_25_6_159-171.nxml.txt.nlp	23133315	SENT79	8	8	10	10	trastuzumab	HER2	PA451743	2064	0.643
NULL	Emerg_Infect_Dis_2012_Mar_18(3)_515-516.nxml.txt.nlp	22377354	SENT33	10	10	0	0	cefepime	CTX	PA164754876	1593	0.643
NULL	Front_Oncol_2013_Oct_1_3_237.nxml.txt.nlp	24098868	SENT404	30	30	27	27	bsi-201	PARP-1		25976	0.643
NULL	Acta_Pharmacol_Sin_2013_Jan_3_34(1)_119-128.nxml.txt.nlp	23202804	SENT168	1	1	7	7	rimonabant	NG2	PA152407999	1464;6048	0.643
NULL	Cell_Death_Dis_2012_Jun_21_3(6)_e330.nxml.txt.nlp	22717585	SENT293	0	0	13	13	simvastatin	ATF6	PA451363	22926	0.643
NULL	Int_J_Endocrinol_2014_Apr_3_2014_794943.nxml.txt.nlp	24803929	SENT104	7	7	5	5	carbimazole	ATD	PA164742970	465	0.643
NULL	Emerg_Infect_Dis_2011_Mar_17(3)_510-513.nxml.txt.nlp	21392446	SENT53	38	38	16	16	ethionamide	EMB	PA164768738	133418	0.643
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1067-1070.nxml.txt.nlp	21386841	SENT81	18	18	24	24	capecitabine	STZ	PA448771	6484	0.643
NULL	Hematol_Rep_2011_Oct_28_3(3_Suppl)_e3.nxml.txt.nlp	22586511	SENT10	6	6	11	11	vincristine	CHOP	PA451879	1649	0.643
NULL	Exp_Ther_Med_2013_Jul_25_6(1)_109-114.nxml.txt.nlp	23935730	SENT150	25	25	13	13	rituximab	CHOP	PA451261	1649	0.643
NULL	FEBS_Open_Bio_2014_Oct_22_4_905-914.nxml.txt.nlp	25383314	SENT6	0	0	6	6	physostigmine	L-FABP	PA450957	2168	0.643
NULL	Breast_Cancer_Res_2007_Mar_2_9(2)_205.nxml.txt.nlp	NULL	SENT128	22	22	12	12	trastuzumab	HER-2	PA451743	2064	0.643
NULL	Br_J_Pharmacol_2011_Apr_162(8)_1832-1842.nxml.txt.nlp	21232033	SENT161	8	8	6	6	resveratrol	SIRT1		23411	0.643
NULL	Int_J_Breast_Cancer_2012_May_9_2012_415170.nxml.txt.nlp	22649737	SENT99	18	18	33	33	trastuzumab	HER2	PA451743	2064	0.643
NULL	Pharmaceutics_2012_May_14_4(2)_252-275.nxml.txt.nlp	24300231	SENT513	17	17	13	13	etoposide	LDE	PA449552	7957	0.643
NULL	Mol_Cancer_2014_Jun_12_13_148.nxml.txt.nlp	24924916	SENT145	3	3	24	24	oxygen	S5B	PA450744	5711	0.643
NULL	Oncol_Lett_2014_Mar_11_7(3)_685-692.nxml.txt.nlp	24527073	SENT197	8	8	6	6	cisplatin	DDP	PA449014	1678	0.643
NULL	Cell_Commun_Signal_2009_Sep_8_7_23.nxml.txt.nlp	19737400	SENT74	10	10	34	34	paraformaldehyde	IQGAP1	PA450790	8826	0.643
NULL	Curr_Med_Chem_2013_Jun_20(19)_2415-2437.nxml.txt.nlp	23394552	SENT492	18	18	23	23	piroxicam	HRG	PA450985	3084;3273	0.643
NULL	Cancer_Med_2013_Aug_28_2(4)_468-477.nxml.txt.nlp	24156019	SENT179	17	17	30	30	gemcitabine	CLU	PA449748	1191	0.643
NULL	Mol_Vis_2012_Aug_10_18_2255-2264.nxml.txt.nlp	22933838	SENT138	12	12	4	4	dextran	CD80	PA449261	941	0.643
NULL	Trials_2013_Apr_23_14_105.nxml.txt.nlp	23782520	SENT241	11	11	2	2	fluoxetine	JAB	PA449673	8651	0.643
NULL	Cells_2014_Apr_29_3(2)_331-362.nxml.txt.nlp	24785347	SENT65	11	11	13	13	capsaicin	TRPV1	PA448776	7442	0.643
NULL	Ann_Lab_Med_2012_Jul_20_32(4)_298-303.nxml.txt.nlp	22779073	SENT117	16	16	10	10	amikacin	EMB	PA164744372	133418	0.643
NULL	J_Physiol_2011_Dec_15_589(Pt_24)_5965-5986.nxml.txt.nlp	22041182	SENT22	20	20	22	22	vasopressin	AVP	PA451858	114548;551	0.643
NULL	Clin_Dev_Immunol_2011_Dec_27_2011_814943.nxml.txt.nlp	21234341	SENT143	29	29	37	37	nitrogen	iNOS	PA450643	4843	0.643
NULL	Arch_Med_Sci_2010_Dec_29_6(6)_829-836.nxml.txt.nlp	22427753	SENT41	9	9	5	5	neomycin	RANTES	PA450608	6352	0.643
NULL	Br_J_Cancer_2010_Jan_19_102(2)_268-275.nxml.txt.nlp	20010948	SENT22	36	36	13	13	bevacizumab	EGFR	PA130232992	1956	0.643
NULL	Cardiovasc_Res_2011_Apr_1_90(1)_105-112.nxml.txt.nlp	21123217	SENT146	6	6	28	28	mibefradil	AMN	PA450492	215;81693	0.643
NULL	Case_Rep_Pathol_2013_Jul_14_2013_198643.nxml.txt.nlp	23936709	SENT44	19	19	16	16	thyroglobulin	TTF-1	PA164754910	7080	0.643
NULL	Exp_Diabetes_Res_2012_Jan_29_2012_159874.nxml.txt.nlp	22319521	SENT230	25	25	33	33	candesartan	Hes1	PA448765	3280	0.643
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT9	13	13	8	8	celecoxib	survivin	PA448871	332	0.643
NULL	Front_Immunol_2012_Mar_19_3_47.nxml.txt.nlp	22566929	SENT118	3	3	17	17	abatacept	B7-2	PA164747080	942	0.643
NULL	Int_J_Nanomedicine_2008_Jun_3(2)_181-199.nxml.txt.nlp	18686778	SENT162	20	20	10	10	hyaluronan	ECM	PA165958431	22915	0.643
NULL	Br_J_Cancer_1999_Aug_80(12)_1884-1891.nxml.txt.nlp	10471035	SENT7	1	1	27	27	urokinase	c-Jun	PA451836	3725	0.643
NULL	AIDS_Res_Ther_2013_Dec_13_10_32.nxml.txt.nlp	24330597	SENT64	27	27	42	42	urokinase	TNF	PA451836	7124	0.643
NULL	Br_J_Cancer_2014_Jan_21_110(2)_421-429.nxml.txt.nlp	24300973	SENT246	11	11	20	20	oxaliplatin	DAP3	PA131285527	58512;7818	0.643
NULL	Mol_Cancer_2008_Jun_5_7_50.nxml.txt.nlp	18534018	SENT110	33	33	19	19	bortezomib	p38	PA10252	10598;1432;7965	0.643
NULL	Exp_Ther_Med_2013_Jan_10_5(1)_11-16.nxml.txt.nlp	23251234	SENT50	34	34	12	12	cetuximab	CNTRL	PA10040	11064	0.643
NULL	Carcinogenesis_2010_Dec_27_31(12)_2049-2057.nxml.txt.nlp	20876285	SENT210	15	15	11	11	tamoxifen	HER2	PA451581	2064	0.643
NULL	Semin_Dial_2013_Sep_17_26(5)_546-567.nxml.txt.nlp	23859229	SENT581	41	41	33	33	choline	B12	PA448976	7126;4709	0.643
NULL	J_Geriatr_Cardiol_2012_Jun_9(2)_209-210.nxml.txt.nlp	23097648	SENT34	39	39	29	29	warfarin	CYP4F2	PA451906	8529	0.643
NULL	Diabetes_2013_Jun_17_62(6)_1843-1854.nxml.txt.nlp	23349486	SENT178	0	0	9	9	fluorescein	CCR2	PA164746009	729230	0.643
NULL	Acta_Pharmacol_Sin_2010_Sep_16_31(9)_1075-1084.nxml.txt.nlp	20711221	SENT110	20	20	25	25	nitrogen	PI3K	PA450643	5290	0.643
NULL	Int_J_Genomics_2014_Jan_29_2014_894296.nxml.txt.nlp	24616891	SENT171	9	9	0	0	ethanol	PC1	PA448073	5122	0.643
NULL	Eur_J_Med_Res_2014_Apr_9_19(1)_19.nxml.txt.nlp	24717101	SENT80	25	25	11	11	cyclophosphamide	FDG	PA449165	23583	0.643
NULL	Oncotarget_2014_Oct_21_5(22)_11709-11722.nxml.txt.nlp	25365944	SENT161	20	20	10	10	metformin	JNK	PA450395	5599	0.643
NULL	Case_Rep_Gastrointest_Med_2012_Dec_31_2012_698404.nxml.txt.nlp	23346428	SENT60	42	42	19	19	azathioprine	IL-2	PA448515	3558	0.643
NULL	Mol_Cancer_2007_Aug_21_6_53.nxml.txt.nlp	17711579	SENT15	9	9	13	13	cisplatin	ESR1	PA449014	2099	0.643
NULL	Cancer_Microenviron_2010_Feb_5_3(1)_15-28.nxml.txt.nlp	21209772	SENT484	14	14	24	24	urokinase	p38	PA451836	10598;1432;7965	0.643
NULL	Eur_J_Clin_Pharmacol_2012_Jan_7_68(1)_55-64.nxml.txt.nlp	21735164	SENT290	3	3	15	15	debrisoquine	CYP2D6	PA452616	1565	0.643
NULL	Breast_Cancer_Res_2004_Aug_5_6(5)_R601-R607.nxml.txt.nlp	15318941	SENT115	9	9	2	2	docetaxel	p27	PA449383	5715;10534	0.643
NULL	Breast_Cancer_Res_Treat_2013_Aug_20_141(1)_43-53.nxml.txt.nlp	23959396	SENT5	27	27	7	7	trastuzumab	HER3	PA451743	2065	0.643
NULL	Mol_Cancer_2007_May_11_6_33.nxml.txt.nlp	17498302	SENT93	0	0	11	11	daunorubicin	FLT3	PA449212	2322	0.643
NULL	Mol_Vis_2011_Apr_26_17_1024-1033.nxml.txt.nlp	21541269	SENT135	22	22	24	24	brimonidine	BRI	PA448665	9445	0.643
NULL	Core_Evid_2010_Jul_27_5_1-10.nxml.txt.nlp	20694135	SENT214	16	16	20	20	levodopa	CLE	PA450213	51637	0.643
NULL	Clin_Ophthalmol_2014_Feb_10_8_389-399.nxml.txt.nlp	24550667	SENT183	4	4	20	20	brinzolamide	TIM	PA164744929	7984;8914	0.643
NULL	Int_J_Endocrinol_2011_Mar_6_2011_415719.nxml.txt.nlp	21461394	SENT69	0	0	12	12	cinacalcet	PTH	PA164776671	5741	0.643
NULL	Breast_Cancer_Res_2003_Jul_29_5(5)_235-238.nxml.txt.nlp	12927031	SENT26	9	9	6	6	thyroglobulin	TPO	PA164754910	7066;7173	0.643
NULL	Arthritis_Res_Ther_2005_Oct_18_7(6)_R1412-R1420.nxml.txt.nlp	16277694	SENT49	6	6	12	12	fluorescein	TLR2	PA164746009	7097	0.643
NULL	Front_Genet_2013_Aug_29_4_163.nxml.txt.nlp	24009622	SENT27	6	6	8	8	cisplatin	DDP	PA449014	1678	0.643
NULL	Pharmacogn_Mag_2014_Jul-Sep_10(39)_374-383.nxml.txt.nlp	25210328	SENT155	28	28	21	21	evodiamine	PC2	PA165860788	5126;5311;8535	0.643
NULL	Crit_Care_2010_Sep_1_14(Suppl_2)_P17.nxml.txt.nlp	NULL	SENT16	5	5	19	19	ethanol	IL-17	PA448073	3605	0.643
NULL	Cancer_Immunol_Immunother_2015_Oct_7_64_61-73.nxml.txt.nlp	25287778	SENT174	2	2	6	6	lenalidomide	IFN	PA162363968	3439	0.643
NULL	Case_Rep_Nephrol_Urol_2012_Oct_24_2(2)_145-151.nxml.txt.nlp	23197970	SENT131	22	22	12	12	tetracycline	CTX	PA451640	1593	0.643
NULL	Br_J_Cancer_2013_Jun_25_108(12)_2505-2515.nxml.txt.nlp	23736036	SENT90	23	23	32	32	capecitabine	DPYD	PA448771	1806	0.643
NULL	J_Adv_Pharm_Technol_Res_2014_Jul-Sep_5(3)_129-133.nxml.txt.nlp	25126534	SENT175	5	5	44	44	perindopril	COX	PA450877	1351	0.643
NULL	Ann_Lab_Med_2012_Jul_20_32(4)_298-303.nxml.txt.nlp	22779073	SENT117	20	20	22	22	ethionamide	MOX	PA164768738	26002	0.643
NULL	Arthritis_Res_Ther_2008_Mar_18_10(2)_R35.nxml.txt.nlp	18348730	SENT93	2	2	9	9	fluorescein	HEX	PA164746009	3087	0.643
NULL	Mol_Syst_Biol_2011_Apr_26_7_486.nxml.txt.nlp	21525872	SENT337	18	18	20	20	gefitinib	EGF	PA131301952	1950	0.643
NULL	Int_J_Mol_Sci_2014_Oct_27_15(11)_19458-19471.nxml.txt.nlp	25350111	SENT163	33	33	21	21	formaldehyde	CAT	PA449703	847	0.643
NULL	Crit_Care_2008_Nov_18_12(Suppl_5)_P34.nxml.txt.nlp	NULL	SENT3	11	11	13	13	vasopressin	AVP	PA451858	114548;551	0.643
NULL	Infect_Ecol_Epidemiol_2012_Mar_27_2_10_3402_iee_v2i0_7438.nxml.txt.nlp	22957135	SENT59	9	9	16	16	ampicillin	VAN	PA448419	10318	0.643
NULL	J_Obes_2013_Jun_4_2013_874981.nxml.txt.nlp	23862058	SENT140	6	6	9	9	betaine	BSP	PA448603	3381	0.643
NULL	Ann_Rheum_Dis_2011_Aug_22_70(12)_2119-2125.nxml.txt.nlp	21859685	SENT53	9	9	26	26	ofatumumab	ACR	PA165291493	49	0.643
NULL	Breast_Cancer_Res_2005_Nov_11_7(6)_255-257.nxml.txt.nlp	16457700	SENT39	38	38	24	24	anastrozole	ATAC	PA448432	6375	0.643
NULL	ACS_Catal_2014_Feb_7_4(2)_546-552.nxml.txt.nlp	24634794	SENT78	44	44	47	47	hemin	TTN	PA449849	7273	0.643
NULL	Kidney_Int_Suppl_(2011)_2012_Dec_15_2(5)_405-414.nxml.txt.nlp	25018969	SENT1248	0	0	15	15	candesartan	SECRET	PA448765	10590	0.643
NULL	Mol_Vis_2012_Feb_11_18_439-448.nxml.txt.nlp	22355255	SENT216	14	14	10	10	nadh	SDH	PA164755085	1757;10993	0.643
NULL	Gut_Liver_2013_Sep_14_7(5)_552-559.nxml.txt.nlp	24073313	SENT19	1	1	16	16	celecoxib	EGFR	PA448871	1956	0.643
NULL	Core_Evid_2009_Jun_15_4_131-147.nxml.txt.nlp	20694070	SENT220	4	4	14	14	raltegravir	CD4		920	0.643
NULL	J_Invest_Dermatol_2013_Sep_31_133(9)_2247-2254.nxml.txt.nlp	23370537	SENT8	7	7	11	11	chloroquine	PUMA	PA448948	27113	0.643
NULL	Br_J_Cancer_2009_May_19_100(10)_1608-1616.nxml.txt.nlp	19401687	SENT50	31	31	33	33	bicalutamide	BIC	PA164746255	114614	0.643
NULL	Environ_Microbiol_2013_Jan_15_15(1)_297-304.nxml.txt.nlp	23157680	SENT51	39	39	45	45	sulfamethoxazole	TMP	PA451544	2012	0.643
NULL	Clin_Psychopharmacol_Neurosci_2012_Dec_20_10(3)_185-189.nxml.txt.nlp	23431037	SENT92	10	10	20	20	olanzapine	HPD	PA450688	3242	0.643
NULL	Exp_Ther_Med_2014_Feb_25_7(2)_417-422.nxml.txt.nlp	24396417	SENT176	8	8	12	12	estradiol	IL-4	PA449503	3565	0.643
NULL	Biomed_Res_Int_2013_Feb_28_2013_793502.nxml.txt.nlp	23555096	SENT55	18	18	6	6	ampicillin	FVIII	PA448419	2157	0.643
NULL	J_Breast_Cancer_2014_Dec_26_17(4)_308-313.nxml.txt.nlp	25548577	SENT53	39	39	28	28	trastuzumab	HER2	PA451743	2064	0.643
NULL	Oxid_Med_Cell_Longev_2013_Jun_6_2013_891748.nxml.txt.nlp	23840922	SENT279	2	2	17	17	resveratrol	NQO1		1728	0.643
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1676-1682.nxml.txt.nlp	19844234	SENT147	15	15	8	8	lapatinib	PIK3CA	PA152241907	5290	0.643
NULL	Nat_Med_2012_Mar_4_18(4)_547-554.nxml.txt.nlp	22388091	SENT76	0	0	12	12	atropine	IL-17A	PA448505	3605	0.643
NULL	Clin_Dev_Immunol_2013_Nov_26_2013_325481.nxml.txt.nlp	24371447	SENT24	3	3	12	12	propofol	IL-6	PA451141	3569	0.643
NULL	Hum_Reprod_2008_Oct_16_23(10)_2273-2281.nxml.txt.nlp	18635530	SENT148	13	13	21	21	etoposide	p53	PA449552	7157	0.643
NULL	Evid_Based_Complement_Alternat_Med_2014_Oct_29_2014_594354.nxml.txt.nlp	25530784	SENT6	3	3	12	12	4-methylumbelliferone	TFP	PA154081778	7034	0.643
NULL	Acta_Naturae_2012_Jan-Mar_4(1)_78-81.nxml.txt.nlp	22708066	SENT61	22	22	3	3	l-lysine	zeta	PA450280	9907	0.643
NULL	Acta_Pharmacol_Sin_2013_Sep_5_34(9)_1229-1236.nxml.txt.nlp	23892269	SENT108	5	5	18	18	sulfaphenazole	CYP2E1	PA130231310	1571	0.643
NULL	Oncogene_2010_Nov_18_29(46)_6115-6124.nxml.txt.nlp	20729912	SENT81	16	16	18	18	verapamil	ABCB5	PA451868	340273	0.643
NULL	Acta_Pharmacol_Sin_2014_Jun_5_35(6)_758-769.nxml.txt.nlp	24793309	SENT65	8	8	5	5	sevoflurane	CO2	PA451341	4513	0.643
NULL	Indian_J_Endocrinol_Metab_2013_Jul-Aug_17(4)_636-646.nxml.txt.nlp	23961479	SENT138	11	11	16	16	rosuvastatin	CYP2C9	PA134308647	1559	0.643
NULL	JAKSTAT_2012_Oct_1_1(4)_292-299.nxml.txt.nlp	24058786	SENT157	5	5	18	18	pyrimethamine	STAT3	PA451193	6774	0.643
NULL	Clin_Toxicol_(Phila)_2014_Nov_6_52(9)_926-944.nxml.txt.nlp	25283255	SENT392	7	7	26	26	amlodipine	San	PA448388	80218	0.643
NULL	Int_J_Nanomedicine_2009_Dec_29_4_299-319.nxml.txt.nlp	20054434	SENT266	4	4	32	32	doxorubicin	AP-1	PA449412	2353;3727;2354;3725	0.643
NULL	Cancer_Med_2013_Aug_2_2(4)_571-582.nxml.txt.nlp	24156030	SENT161	7	7	12	12	curcumin	IL-6	PA151958596	3569	0.643
NULL	J_Mol_Signal_2011_Oct_5_6_13.nxml.txt.nlp	21975218	SENT208	9	9	31	31	l-glutamine	FBS	PA10090	64319;26269	0.643
NULL	J_Int_Soc_Sports_Nutr_2009_Feb_19_6_6.nxml.txt.nlp	19228401	SENT240	8	8	12	12	creatine	CRT	PA164778930	811	0.643
NULL	Angew_Chem_Int_Ed_Engl_2012_Feb_13_51(7)_1572-1575.nxml.txt.nlp	22213572	SENT33	23	23	30	30	ethanol	CO2	PA448073	4513	0.643
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT1195	12	12	23	23	iron	ROS	PA450087	6098	0.643
NULL	J_Gen_Physiol_1937_Mar_20_20(4)_561-563.nxml.txt.nlp	19873010	SENT0	12	12	1	1	papain	Gen	PA450778	348654	0.643
NULL	J_Antimicrob_Chemother_2014_Nov_5_69(11)_2901-2912.nxml.txt.nlp	25096079	SENT48	6	6	4	4	vancomycin	VAN	PA451850	10318	0.643
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S31-S40.nxml.txt.nlp	20680106	SENT45	13	13	27	27	cetuximab	KRAS	PA10040	3845	0.643
NULL	Int_J_Med_Sci_2013_Mar_15_10(5)_567-574.nxml.txt.nlp	23533048	SENT172	6	6	4	4	lamivudine	LAM	PA450163	7249;7248	0.643
NULL	Ann_Gen_Psychiatry_2010_Mar_6_9_11.nxml.txt.nlp	20205742	SENT25	31	31	6	6	risperidone	STAR	PA451257	6770;2984	0.643
NULL	Oncotarget_2014_Jun_6_5(13)_4935-4944.nxml.txt.nlp	24952732	SENT81	0	0	2	2	doxazosin	PI3K	PA449407	5290	0.643
NULL	Br_J_Cancer_2012_Jul_10_107(2)_230-233.nxml.txt.nlp	22735900	SENT49	22	22	10	10	tamoxifen	CYP2D6	PA451581	1565	0.643
NULL	Mol_Vis_2012_Aug_10_18_2255-2264.nxml.txt.nlp	22933838	SENT138	12	12	6	6	dextran	CD86	PA449261	942	0.643
NULL	Mol_Immunol_2009_Apr_46(7)_1424-1431.nxml.txt.nlp	19185921	SENT10	5	5	1	1	taurine	CD1D	PA451590	912	0.643
NULL	Nucleic_Acids_Res_2014_Jan_2_42(Database_issue)_D178-D183.nxml.txt.nlp	24302579	SENT142	5	5	19	19	imatinib	TAL1	PA10804	6886	0.643
NULL	Cancers_(Basel)_2014_Apr_9_6(2)_829-859.nxml.txt.nlp	24722453	SENT221	3	3	12	12	evodiamine	SHP-1	PA165860788	5777	0.643
NULL	Cardiovasc_Drugs_Ther_2012_Aug_24_26(4)_349-358.nxml.txt.nlp	22622962	SENT148	22	22	17	17	atorvastatin	ANOVA	PA448500	4858	0.643
NULL	Diabetes_2011_Mar_21_60(3)_757-765.nxml.txt.nlp	21282370	SENT24	24	24	26	26	lipase	ATGL	PA450239	57104	0.643
NULL	Iran_J_Neurol_2014_Apr_3_13(2)_108-109.nxml.txt.nlp	25295156	SENT15	14	14	21	21	creatine	SLC6A8	PA164778930	6535	0.643
NULL	Environ_Health_Perspect_2006_Apr_2_114(4)_527-531.nxml.txt.nlp	16581540	SENT14	44	44	20	20	arsenite	AQP9	PA452638	366;364	0.643
NULL	Am_J_Physiol_Cell_Physiol_2009_Oct_5_297(4)_C898-C906.nxml.txt.nlp	19657054	SENT284	38	38	23	23	collagenase	c-Jun	PA449107	3725	0.643
NULL	J_Cell_Mol_Med_2014_Apr_20_18(4)_709-720.nxml.txt.nlp	24444314	SENT247	6	6	23	23	metformin	p53	PA450395	7157	0.643
NULL	Br_J_Pharmacol_2008_Nov_11_155(6)_896-905.nxml.txt.nlp	18695641	SENT16	2	2	20	20	genistein	OPG	PA165109660	690	0.643
NULL	J_Antimicrob_Chemother_2010_Mar_18_65(3)_390-398.nxml.txt.nlp	20022938	SENT31	34	34	24	24	azithromycin	ATV	PA448519	4683	0.643
NULL	J_Young_Pharm_2011_Apr-Jun_3(2)_132-137.nxml.txt.nlp	21731359	SENT80	21	21	6	6	pioglitazone	DM1	PA450970	338023;1760;28509	0.643
NULL	Lab_Invest_2009_Dec_19_89(12)_1397-1409.nxml.txt.nlp	19841616	SENT214	0	0	24	24	curcumin	PI3K	PA151958596	5290	0.643
NULL	Blood_Res_2014_Sep_25_49(3)_162-169.nxml.txt.nlp	25325035	SENT21	24	24	33	33	cyclophosphamide	CHOP	PA449165	1649	0.643
NULL	Mol_Microbiol_2014_Mar_23_91(5)_918-934.nxml.txt.nlp	24372851	SENT58	23	23	34	34	pyrimethamine	LUM	PA451193	4060	0.643
NULL	Front_Oncol_2014_Apr_8_4_71.nxml.txt.nlp	24782983	SENT497	24	24	21	21	cisplatin	KEAP1	PA449014	9817	0.643
NULL	J_Adv_Pract_Oncol_2013_Mar_1_Mar-Apr_4(2)_89-100.nxml.txt.nlp	25031987	SENT3	3	3	14	14	palifermin	OCN	PA164744014	632	0.643
NULL	Cardiovasc_Ultrasound_2010_May_16_8_18.nxml.txt.nlp	20470437	SENT87	3	3	31	31	heparin	PAP	PA449855	11333;10884;10914;11334;8853;50807	0.643
NULL	Int_J_Womens_Health_2012_Aug_31_4_437-443.nxml.txt.nlp	23071413	SENT114	41	41	7	7	heparin	VIII	PA449855	1351	0.643
NULL	Clin_Exp_Gastroenterol_2012_Jul_19_5_139-150.nxml.txt.nlp	22888267	SENT124	13	13	2	2	indomethacin	I-FABP	PA449982	2169	0.643
NULL	Int_J_Mol_Sci_2014_Oct_29_15(11)_19700-19728.nxml.txt.nlp	25356505	SENT117	10	10	12	12	pp2	EGFR		1956	0.643
NULL	Front_Aging_Neurosci_2014_Sep_11_6_218.nxml.txt.nlp	25309423	SENT226	3	3	28	28	resveratrol	AMPK		5563	0.643
NULL	Breast_Cancer_Res_2006_Oct_24_8(5)_R59.nxml.txt.nlp	17062128	SENT258	12	12	10	10	urokinase	UPA	PA451836	118471;5328	0.643
NULL	AIDS_Res_Ther_2013_May_1_10_10.nxml.txt.nlp	23634877	SENT156	12	12	9	9	lovastatin	CXCL12	PA450272	6387	0.643
NULL	J_Hematol_Oncol_2012_Sep_18_5_57.nxml.txt.nlp	22989009	SENT229	24	24	19	19	nutlin-3	HDM2		4193	0.643
NULL	Front_Genet_2012_Nov_22_3_249.nxml.txt.nlp	23189085	SENT612	14	14	7	7	ifosfamide	CYP2B6	PA449964	1555	0.643
NULL	Clinics_(Sao_Paulo)_2013_Oct_68(10)_1350-1357.nxml.txt.nlp	24212843	SENT119	16	16	23	23	bleomycin	COL1A1	PA448645	1277	0.643
NULL	J_Ophthalmic_Inflamm_Infect_2013_Jan_3_3_2.nxml.txt.nlp	23514612	SENT133	16	16	7	7	ganciclovir	CD4	PA449733	920	0.643
NULL	Int_J_Mol_Sci_2014_Sep_19_15(9)_16698-16718.nxml.txt.nlp	25244018	SENT73	10	10	16	16	estradiol	LKB1	PA449503	6794	0.643
NULL	J_Emerg_Trauma_Shock_2012_Oct-Dec_5(4)_285-295.nxml.txt.nlp	23248495	SENT116	14	14	16	16	vasopressin	AVP	PA451858	114548;551	0.643
NULL	Int_J_Mol_Sci_2012_Feb_24_13(3)_2590-2617.nxml.txt.nlp	22489113	SENT237	14	14	32	32	benzaldehyde	mol	PA448571	90527	0.643
NULL	Cancers_(Basel)_2010_Apr_9_2(2)_397-419.nxml.txt.nlp	24281076	SENT208	11	11	22	22	cisplatin	Bcl-2	PA449014	596	0.643
NULL	Front_Neurol_2013_Nov_6_4_176.nxml.txt.nlp	24223570	SENT182	5	5	24	24	carbachol	PIR	PA448784	8544	0.643
NULL	Front_Cell_Neurosci_2015_Jan_14_8_460.nxml.txt.nlp	25642167	SENT53	28	28	20	20	l-glutamine	B27	PA10090	56246	0.643
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_79-96.nxml.txt.nlp	19305789	SENT169	16	16	10	10	capsaicin	TRPV1	PA448776	7442	0.643
NULL	Nat_Med_2013_Mar_3_19(3)_295-304.nxml.txt.nlp	23377280	SENT206	27	27	20	20	paraformaldehyde	EGF	PA450790	1950	0.643
NULL	J_Breast_Cancer_2011_Jun_18_14(2)_129-134.nxml.txt.nlp	21847408	SENT128	10	10	18	18	cyclophosphamide	B27	PA449165	56246	0.643
NULL	FEBS_Open_Bio_2014_Jan_6_4_77-89.nxml.txt.nlp	24490132	SENT198	28	28	3	3	ebselen	GDH	PA161660841	51084;2746	0.643
NULL	Br_J_Cancer_2011_Mar_15_104(6)_893-898.nxml.txt.nlp	21364594	SENT114	24	24	35	35	capecitabine	miR-137	PA448771	406928	0.643
NULL	Oncoscience_2014_Mar_12_1(2)_158-166.nxml.txt.nlp	25594008	SENT64	20	20	12	12	dasatinib	PTRF	PA162372878	284119	0.643
NULL	Oncol_Lett_2013_Oct_24_6(4)_970-976.nxml.txt.nlp	24137447	SENT180	2	2	4	4	tamoxifen	ADM	PA451581	133	0.643
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT55	39	39	41	41	curcumin	TRAIL	PA151958596	8743	0.643
NULL	Arch_Med_Sci_2011_Feb_8_7(1)_27-33.nxml.txt.nlp	22291729	SENT141	26	26	8	8	vincristine	CHOP	PA451879	1649	0.643
NULL	Clin_Exp_Otorhinolaryngol_2013_Mar_1_6(1)_48-51.nxml.txt.nlp	23526700	SENT56	24	24	18	18	thyroglobulin	CK7	PA164754910	3855	0.643
NULL	Cell_Commun_Signal_2013_Apr_22_11_30.nxml.txt.nlp	23607741	SENT44	14	14	16	16	dasatinib	DST	PA162372878	667	0.643
NULL	J_Res_Med_Sci_2011_Jun_16(6)_814-820.nxml.txt.nlp	22091312	SENT66	12	12	4	4	doxorubicin	CTX	PA449412	1593	0.643
NULL	Front_Oncol_2014_Jun_10_4_134.nxml.txt.nlp	24959420	SENT100	25	25	27	27	maytansine	DM1	PA165291473	338023;1760;28509	0.643
NULL	Breast_Cancer_Res_2012_May_18_14(3)_R78.nxml.txt.nlp	22608253	SENT180	14	14	6	6	estradiol	ANOVA	PA449503	4858	0.643
NULL	Endocrinology_2015_Jan_6_156(1)_24-31.nxml.txt.nlp	25375036	SENT30	27	27	29	29	diethylstilbestrol	DES	PA449307	1674	0.643
NULL	Biochemistry_2009_Mar_10_48(9)_2053-2062.nxml.txt.nlp	19220002	SENT224	15	15	25	25	nadh	Q10	PA164755085	27161	0.643
NULL	Ann_Oncol_2014_Sep_13_25(9)_1813-1820.nxml.txt.nlp	24928832	SENT132	5	5	24	24	afatinib	p16	PA165981154	1029	0.643
NULL	Ann_Oncol_2009_Aug_20(Suppl_6)_vi35-vi40.nxml.txt.nlp	19617296	SENT10	26	26	33	33	everolimus	VEGFR	PA164746311	3791	0.643
NULL	J_Gen_Physiol_1947_Sep_20_31(1)_51-74.nxml.txt.nlp	19873519	SENT0	13	13	1	1	galactose	Gen	PA449725	348654	0.643
NULL	Mol_Cancer_2009_Nov_10_8_99.nxml.txt.nlp	19903356	SENT80	7	7	4	4	imatinib	IGFBP3	PA10804	3486	0.643
NULL	J_Korean_Med_Sci_2010_Feb_19_25(2)_304-308.nxml.txt.nlp	20119588	SENT35	43	43	46	46	cefoxitin	EMB	PA448856	133418	0.643
NULL	Curr_Neuropharmacol_2010_Jun_8(2)_122-127.nxml.txt.nlp	21119883	SENT43	24	24	5	5	capsaicin	AQP1	PA448776	358	0.643
NULL	Nat_Med_2010_Jun_23_16(6)_671-677.nxml.txt.nlp	20495567	SENT243	25	25	10	10	sorafenib	MCL1	PA7000	4170	0.643
NULL	Cardiovasc_Diabetol_2013_May_31_12_82.nxml.txt.nlp	23721199	SENT164	6	6	0	0	bezafibrate	ATV	PA162364313	4683	0.643
NULL	AIDS_Res_Treat_2012_Feb_20_2012_105980.nxml.txt.nlp	22454762	SENT136	30	30	7	7	efavirenz	CYP2B6	PA449441	1555	0.643
NULL	Nat_Med_2011_Dec_4_18(1)_111-119.nxml.txt.nlp	22138751	SENT72	7	7	17	17	doxycycline	WT1	PA449415	7490	0.643
NULL	J_Cell_Biol_1998_Jan_26_140(2)_335-345.nxml.txt.nlp	9442109	SENT214	1	1	6	6	chloroquine	NHE	PA448948	285335	0.643
NULL	Crit_Care_2008_Feb_2_12(1)_R11.nxml.txt.nlp	18252006	SENT172	24	24	19	19	vasopressin	ACTH	PA451858	5443	0.643
NULL	Int_J_Vasc_Med_2011_Jun_30_2011_250518.nxml.txt.nlp	21761004	SENT56	11	11	22	22	ticlopidine	ADP	PA451686	23038	0.642
NULL	Int_J_Mol_Sci_2012_Feb_24_13(3)_2590-2617.nxml.txt.nlp	22489113	SENT209	15	15	33	33	benzaldehyde	mol	PA448571	90527	0.642
NULL	BMJ_2013_Jun_13_346_f2865.nxml.txt.nlp	23766480	SENT377	28	28	1	1	paroxetine	Gen	PA450801	348654	0.642
NULL	Arthritis_Res_Ther_2013_Jul_9_15(4)_R73.nxml.txt.nlp	23837669	SENT20	6	6	12	12	colchicine	MICL	PA449092	160364	0.642
NULL	Curr_Neuropharmacol_2013_Jul_11(4)_338-378.nxml.txt.nlp	24381528	SENT687	21	21	16	16	curcumin	AP-1	PA151958596	2353;3727;2354;3725	0.642
NULL	Osteoporos_Int_2010_Oct_18_21(10)_1657-1680.nxml.txt.nlp	20480148	SENT107	35	35	25	25	medroxyprogesterone	CEE	PA450344	51608	0.642
NULL	Diabetes_2009_Dec_31_58(12)_2851-2862.nxml.txt.nlp	19720788	SENT149	8	8	5	5	forskolin	CHOP	PA146096022	1649	0.642
NULL	Arthritis_Res_Ther_2004_Nov_4_6(1)_R39-R45.nxml.txt.nlp	14979936	SENT7	12	12	0	0	collagenase	IL-18	PA449107	3606	0.642
NULL	Arthritis_Res_Ther_2003_Sep_3_5(6)_R317-R328.nxml.txt.nlp	14680506	SENT105	2	2	15	15	rolipram	IL-10	PA153906323	3586	0.642
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT57	0	0	14	14	pemetrexed	UNG	PA10810	7374	0.642
NULL	Drug_Des_Devel_Ther_2014_Sep_23_8_1527-1538.nxml.txt.nlp	25284985	SENT105	16	16	14	14	celecoxib	IFN	PA448871	3439	0.642
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_2_2013_482428.nxml.txt.nlp	23818926	SENT50	22	22	14	14	streptomycin	FBS	PA451512	64319;26269	0.642
NULL	Adv_Hematol_2009_Apr_14_2009_704928.nxml.txt.nlp	19960052	SENT4	5	5	1	1	mannitol	BTZ	PA450320	22794	0.642
NULL	Mol_Cancer_2007_Aug_21_6_53.nxml.txt.nlp	17711579	SENT153	6	6	28	28	cisplatin	CARD6	PA449014	84674	0.642
NULL	Ann_Gen_Psychiatry_2011_Nov_3_10_30.nxml.txt.nlp	22053728	SENT2	22	22	13	13	dibucaine	BCHE	PA449286	590	0.642
NULL	Leukemia_2013_Apr_14_27(4)_803-812.nxml.txt.nlp	23238589	SENT159	24	24	26	26	nilotinib	IFN	PA165958345	3439	0.642
NULL	Acta_Pharmacol_Sin_2009_Sep_24_30(9)_1330-1336.nxml.txt.nlp	19701234	SENT21	22	22	11	11	ilaprazole	CYP2C9	PA165947499	1559	0.642
NULL	J_Oncol_2009_Mar_24_2009_491985.nxml.txt.nlp	19325924	SENT83	11	11	27	27	genistein	CXCR4	PA165109660	7852	0.642
NULL	Case_Rep_Hematol_2014_Dec_11_2014_743856.nxml.txt.nlp	25580315	SENT38	28	28	14	14	etoposide	CHOP	PA449552	1649	0.642
NULL	ScientificWorldJournal_2013_Oct_24_2013_726912.nxml.txt.nlp	24282387	SENT40	9	9	6	6	fluorescein	AVP	PA164746009	114548;551	0.642
NULL	Emerg_Infect_Dis_2005_Jun_11(6)_873-882.nxml.txt.nlp	15963282	SENT94	10	10	16	16	gentamicin	TOB	PA449753	10140	0.642
NULL	Oncotarget_2012_Jul_22_3(7)_678-685.nxml.txt.nlp	22824673	SENT85	6	6	2	2	trypsin	rTS	PA451806	55556	0.642
NULL	J_Infect_Dis_2014_May_1_209(9)_1469-1478.nxml.txt.nlp	24286983	SENT136	4	4	10	10	daptomycin	VAN	PA164768820	10318	0.642
NULL	J_Gen_Physiol_2010_Feb_135(2)_149-167.nxml.txt.nlp	20100894	SENT71	2	2	15	15	spermine	CNGA1	PA164781199	1259	0.642
NULL	Exp_Ther_Med_2014_Apr_13_7(4)_799-803.nxml.txt.nlp	24669235	SENT10	2	2	11	11	vildagliptin	PPG	PA165958346	5552	0.642
NULL	J_Hematol_Oncol_2009_Aug_12_2_36.nxml.txt.nlp	19674465	SENT101	17	17	38	38	rituximab	EGFR	PA451261	1956	0.642
NULL	Breast_Cancer_Res_2011_Mar_1_13(2)_R21.nxml.txt.nlp	21362200	SENT156	1	1	17	17	estradiol	PI3K	PA449503	5290	0.642
NULL	Int_J_Biol_Sci_2013_Nov_21_9(10)_1089-1098.nxml.txt.nlp	24339730	SENT183	25	25	13	13	genistein	COL14A1	PA165109660	7373	0.642
NULL	Clin_Interv_Aging_2013_Jan_31_8_103-110.nxml.txt.nlp	23386786	SENT172	0	0	2	2	atorvastatin	IL-6	PA448500	3569	0.642
NULL	Front_Behav_Neurosci_2013_Dec_27_7_216.nxml.txt.nlp	24409129	SENT243	11	11	4	4	methamphetamine	CRMP1	PA450403	1400	0.642
NULL	Mol_Cancer_2011_Sep_30_10_125.nxml.txt.nlp	21962244	SENT106	31	31	36	36	gefitinib	AXL	PA131301952	558	0.642
NULL	Allergy_Asthma_Immunol_Res_2014_Nov_19_6(6)_548-557.nxml.txt.nlp	25374755	SENT117	9	9	14	14	lovastatin	IL-5	PA450272	3567	0.642
NULL	J_Int_AIDS_Soc_2011_Feb_9_14_7.nxml.txt.nlp	21306608	SENT74	29	29	23	23	indinavir	ATV	PA449977	4683	0.642
NULL	F1000_Med_Rep_2009_May_28_1_41.nxml.txt.nlp	20052398	SENT25	12	12	25	25	ribavirin	IFN	PA451241	3439	0.642
NULL	Int_J_Biol_Sci_2014_Jun_10_10(7)_654-663.nxml.txt.nlp	25013375	SENT115	6	6	12	12	nelfinavir	AKT	PA450606	207	0.642
NULL	Oncol_Lett_2013_Feb_27_5(2)_435-439.nxml.txt.nlp	23420613	SENT21	26	26	6	6	paclitaxel	EGFR	PA450761	1956	0.642
NULL	J_Lipid_Res_2014_Oct_55(10)_2103-2112.nxml.txt.nlp	25139399	SENT95	2	2	13	13	atorvastatin	APOE	PA448500	348	0.642
NULL	Cancer_Med_2014_Apr_12_3(2)_390-396.nxml.txt.nlp	24519810	SENT108	12	12	10	10	lamivudine	LAM	PA450163	7249;7248	0.642
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT251	0	0	3	3	nutlin-3	MDM2		4193	0.642
NULL	Diabetes_2013_Mar_14_62(3)_811-824.nxml.txt.nlp	23209186	SENT325	0	0	13	13	bortezomib	CHOP	PA10252	1649	0.642
NULL	Nat_Commun_2013_4_2598.nxml.txt.nlp	24121673	SENT19	11	11	16	16	vincristine	CHOP	PA451879	1649	0.642
NULL	Ther_Clin_Risk_Manag_2006_Sep_2(3)_281-295.nxml.txt.nlp	18360603	SENT323	18	18	26	26	alendronate	PTH	PA448082	5741	0.642
NULL	Oncogene_2010_Jul_8_29(27)_3953-3963.nxml.txt.nlp	20440263	SENT275	18	18	11	11	thioguanine	c-fos	PA451663	2353	0.642
NULL	Front_Oncol_2014_Apr_10_4_76.nxml.txt.nlp	24782987	SENT110	19	19	23	23	cyclophosphamide	CD4	PA449165	920	0.642
NULL	EMBO_Mol_Med_2012_Sep_7_4(9)_896-909.nxml.txt.nlp	22887866	SENT252	28	28	17	17	metformin	c-Myc	PA450395	4609	0.642
NULL	Breast_Cancer_Res_2008_Mar_27_10(2)_R27.nxml.txt.nlp	18371219	SENT41	20	20	30	30	paclitaxel	TFEC	PA450761	22797	0.642
NULL	Oncotarget_2012_Jul_13_3(6)_601-607.nxml.txt.nlp	22802145	SENT59	19	19	21	21	paclitaxel	TRAIL	PA450761	8743	0.642
NULL	Biomed_Res_Int_2014_Feb_6_2014_323594.nxml.txt.nlp	24689036	SENT229	21	21	9	9	raloxifene	PC3	PA451221	57332;7832;5122	0.642
NULL	Acta_Pharmacol_Sin_2013_Jan_17_34(1)_157-166.nxml.txt.nlp	23247593	SENT19	4	4	24	24	berberine	Bcl-2	PA165860812	596	0.642
NULL	Mediators_Inflamm_2010_Jun_9_2010_704202.nxml.txt.nlp	20628516	SENT91	9	9	17	17	hyaluronan	TLR2	PA165958431	7097	0.642
NULL	Nucleic_Acids_Res_2012_Jul_30_40(13)_6319-6337.nxml.txt.nlp	22467215	SENT266	33	33	10	10	cisplatin	HER2	PA449014	2064	0.642
NULL	Stroke_Res_Treat_2010_Dec_29_2010_427418.nxml.txt.nlp	21234304	SENT150	10	10	15	15	clopidogrel	ADP	PA449053	23038	0.642
NULL	Insights_Imaging_2013_Jan_29_4(2)_163-175.nxml.txt.nlp	23359240	SENT144	10	10	6	6	bevacizumab	HER2	PA130232992	2064	0.642
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Jul_23_6_103-113.nxml.txt.nlp	25114588	SENT180	19	19	25	25	lapatinib	PIK3CA	PA152241907	5290	0.642
NULL	Ther_Clin_Risk_Manag_2007_Dec_3(6)_1077-1086.nxml.txt.nlp	18516259	SENT118	10	10	12	12	entecavir	LAM	PA164784025	7249;7248	0.642
NULL	Aging_(Albany_NY)_2013_Jan_26_4(12)_894-898.nxml.txt.nlp	23525940	SENT1	2	2	22	22	metformin	AMPK	PA450395	5563	0.642
NULL	Cancer_Immunol_Immunother_2011_Jul_24_60(7)_943-951.nxml.txt.nlp	21431918	SENT123	10	10	32	32	doxorubicin	Langerin	PA449412	50489	0.642
NULL	Angew_Chem_Int_Ed_Engl_2012_Feb_13_51(7)_1572-1575.nxml.txt.nlp	22213572	SENT22	9	9	22	22	ethanol	CO2	PA448073	4513	0.642
NULL	Scientifica_(Cairo)_2012_Dec_16_2012_402783.nxml.txt.nlp	24278688	SENT153	29	29	2	2	thrombin	MASP1	PA451674	5648	0.642
NULL	Nucleic_Acids_Res_2005_Aug_12_33(14)_4584-4592.nxml.txt.nlp	16100380	SENT116	14	14	0	0	paromomycin	GCN2	PA164784023	440275	0.642
NULL	Nat_Chem_Biol_2010_Apr_28_6(4)_291-299.nxml.txt.nlp	20190765	SENT120	14	14	27	27	dasatinib	AKT	PA162372878	207	0.642
NULL	Springerplus_2014_Sep_9_3_510.nxml.txt.nlp	25279302	SENT256	15	15	10	10	creatine	ADP	PA164778930	23038	0.642
NULL	J_Biol_Chem_2012_Dec_14_287(51)_43094-43107.nxml.txt.nlp	23118219	SENT603	3	3	8	8	hyaluronan	CD44	PA165958431	960	0.642
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_11_2014_780385.nxml.txt.nlp	25435891	SENT27	23	23	32	32	lipase	MGL	PA450239	11343	0.642
NULL	Cancer_Inform_2013_Feb_13_12_31-51.nxml.txt.nlp	23470717	SENT335	11	11	8	8	epirubicin	FOXM1	PA449476	2305	0.642
NULL	Arch_Immunol_Ther_Exp_(Warsz)_2007_Aug_23_55(4)_267-279.nxml.txt.nlp	17659374	SENT518	10	10	8	8	melphalan	TNF-alpha	PA450354	7124	0.642
NULL	Nat_Commun_2011_May_24_2_326.nxml.txt.nlp	21610729	SENT140	11	11	19	19	l-tyrosine	TYR	PA451822	7299	0.642
NULL	Curr_Neuropharmacol_2009_Jun_7(2)_83-95.nxml.txt.nlp	19949566	SENT453	2	2	32	32	carbamazepine	TGB	PA448785	5473	0.642
NULL	Endocrinol_Metab_(Seoul)_2014_Sep_25_29(3)_379-387.nxml.txt.nlp	25309798	SENT176	11	11	4	4	resveratrol	SIRT1		23411	0.642
NULL	New_Phytol_2014_Apr_18_202(1)_322-335.nxml.txt.nlp	24350948	SENT74	8	8	24	24	ethanol	CO2	PA448073	4513	0.642
NULL	Breast_Cancer_Res_2010_Jul_1_12(4)_R45.nxml.txt.nlp	20594311	SENT198	3	3	6	6	nelfinavir	AKT	PA450606	207	0.642
NULL	J_Biol_Chem_2012_Apr_6_287(15)_12433-12444.nxml.txt.nlp	22351758	SENT45	1	1	14	14	hyaluronidase	HABP	PA164745713	3026	0.642
NULL	EMBO_Mol_Med_2013_Aug_5_5(8)_1149-1150.nxml.txt.nlp	23918227	SENT15	19	19	17	17	cyclophosphamide	CHOP	PA449165	1649	0.642
NULL	J_Oncol_2013_Feb_17_2013_872957.nxml.txt.nlp	23476648	SENT110	34	34	31	31	cisplatin	SFN	PA449014	25996;2810	0.642
NULL	Biochimie_2011_Oct_93(10)_1747-1754.nxml.txt.nlp	21703329	SENT154	23	23	10	10	galactose	GALE	PA449725	2582	0.642
NULL	Protein_Cell_2014_Feb_11_5(2)_124-140.nxml.txt.nlp	24515614	SENT42	40	40	3	3	bortezomib	DSS1	PA10252	7979	0.642
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_13_2012_636848.nxml.txt.nlp	23258994	SENT177	22	22	15	15	carrageenan	TRPV1	PA448814	7442	0.642
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT378	34	34	39	39	resveratrol	IL-6		3569	0.642
NULL	Case_Rep_Med_2014_Dec_17_2014_804917.nxml.txt.nlp	25580133	SENT45	13	13	18	18	cyclophosphamide	CHOP	PA449165	1649	0.642
NULL	Harm_Reduct_J_2012_Jan_20_9_6.nxml.txt.nlp	22264343	SENT141	22	22	4	4	buprenorphine	OST	PA448685	1650;23263	0.642
NULL	Front_Behav_Neurosci_2014_Oct_30_8_366.nxml.txt.nlp	25400560	SENT141	13	13	1	1	ethanol	ANOVA	PA448073	4858	0.642
NULL	Pharmaceutics_2011_Oct_12_3(4)_680-705.nxml.txt.nlp	24309303	SENT60	18	18	21	21	pravastatin	OATP1B1	PA451089	10599	0.642
NULL	Int_J_Endocrinol_2014_Jul_16_2014_690783.nxml.txt.nlp	25140176	SENT313	11	11	9	9	exenatide	GLP-1	PA164749238	100125288	0.642
NULL	Acta_Pharmacol_Sin_2010_Feb_5_31(2)_137-144.nxml.txt.nlp	20139896	SENT99	16	16	20	20	zileuton	ROS	PA451955	6098	0.642
NULL	Br_J_Cancer_2013_Mar_19_108(5)_1071-1078.nxml.txt.nlp	23412102	SENT141	16	16	10	10	itraconazole	CYP3A4	PA450132	1576	0.642
NULL	Chem_Cent_J_2013_Jul_31_7_133.nxml.txt.nlp	23899303	SENT19	10	10	7	7	norfloxacin	MOX	PA450654	26002	0.642
NULL	Oxid_Med_Cell_Longev_2013_Jul_9_2013_574029.nxml.txt.nlp	23936610	SENT209	5	5	8	8	resveratrol	RAGE		177	0.642
NULL	Mol_Clin_Oncol_2013_Jul_15_1(4)_661-667.nxml.txt.nlp	24649225	SENT181	22	22	7	7	leucovorin	RFC1	PA450198	5981	0.642
NULL	Comp_Hepatol_2004_Jan_14_3(Suppl_1)_S31.nxml.txt.nlp	14960183	SENT94	5	5	20	20	ethanol	p38	PA448073	10598;1432;7965	0.642
NULL	Antonie_Van_Leeuwenhoek_2014_Aug_5_106_693-706.nxml.txt.nlp	25090957	SENT138	36	36	7	7	glucosamine	LTA	PA164747613	4049	0.642
NULL	J_Antimicrob_Chemother_2008_Nov_27_62(5)_929-933.nxml.txt.nlp	18755696	SENT60	43	43	20	20	cefuroxime	CTX	PA448868	1593	0.642
NULL	Int_J_Environ_Res_Public_Health_2010_Mar_15_7(3)_1076-1092.nxml.txt.nlp	20617019	SENT142	18	18	20	20	ethanol	CYP2E1	PA448073	1571	0.642
NULL	Cancer_Manag_Res_2012_Nov_9_4_383-395.nxml.txt.nlp	23204869	SENT216	16	16	12	12	carmustine	PC-3	PA448810	692094	0.642
NULL	Med_Sci_Monit_2013_Nov_29_19_1080-1088.nxml.txt.nlp	24287619	SENT141	3	3	11	11	estradiol	ACL	PA449503	47	0.642
NULL	Indian_J_Med_Res_2014_Feb_139(2)_205-215.nxml.txt.nlp	24718394	SENT122	12	12	5	5	lumefantrine	ACT	PA165111722	12;11332;9457;641455	0.642
NULL	Curr_Med_Chem_2014_Feb_21_1129-1145.nxml.txt.nlp	24304271	SENT301	0	0	10	10	genistein	H11	PA165109660	26353	0.642
NULL	Nature_2012_Jan_25_482(7384)_232-236.nxml.txt.nlp	22278056	SENT56	5	5	2	2	suramin	ODC	PA10292	4953;89874	0.642
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1224-1233.nxml.txt.nlp	22353810	SENT202	20	20	8	8	doxorubicin	MRP-1	PA449412	928	0.642
NULL	Curr_Neuropharmacol_2013_Mar_11(2)_141-159.nxml.txt.nlp	23997750	SENT294	21	21	33	33	vasopressin	ACTH	PA451858	5443	0.642
NULL	Nucleic_Acids_Res_2012_Jul_30_40(13)_6319-6337.nxml.txt.nlp	22467215	SENT266	33	33	3	3	cisplatin	Bcl-2	PA449014	596	0.642
NULL	Pharmaceuticals_(Basel)_2011_Jul_14_4(7)_1032-1051.nxml.txt.nlp	NULL	SENT188	27	27	16	16	ethanol	mol	PA448073	90527	0.642
NULL	Bioinformation_2013_Nov_11_9(18)_908-911.nxml.txt.nlp	24307768	SENT16	19	19	12	12	glucose	BDNF	PA449773	627	0.642
NULL	J_Cell_Biol_2006_Sep_25_174(7)_1047-1058.nxml.txt.nlp	17000881	SENT37	15	15	13	13	hydrocortisone	EGF	PA449905	1950	0.642
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jun_20_68(Pt_7)_o2146-o2147.nxml.txt.nlp	22798820	SENT73	23	23	14	14	ethanol	mol	PA448073	90527	0.642
NULL	J_Geriatr_Cardiol_2012_Sep_9(3)_305-317.nxml.txt.nlp	23097661	SENT239	3	3	19	19	darapladib	CCL5	PA165884699	6352	0.642
NULL	Iran_Red_Crescent_Med_J_2014_Mar_5_16(3)_e15344.nxml.txt.nlp	24829782	SENT10	14	14	28	28	bumetanide	slim	PA448682	23008	0.642
NULL	Diabetes_2013_Jul_14_62(7)_2559-2568.nxml.txt.nlp	23423566	SENT302	17	17	21	21	collagenase	AP-1	PA449107	2353;3727;2354;3725	0.642
NULL	Evid_Based_Complement_Alternat_Med_2014_Oct_19_2014_628712.nxml.txt.nlp	25389442	SENT120	15	15	4	4	erlotinib	EGFR	PA134687924	1956	0.642
NULL	Nucleic_Acids_Res_2012_Jul_27_40(13)_6109-6121.nxml.txt.nlp	22453275	SENT313	24	24	7	7	iodixanol	SSBP1	PA164783998	6742	0.642
NULL	Int_J_Mol_Sci_2014_May_9_15(5)_8256-8279.nxml.txt.nlp	24821544	SENT184	8	8	12	12	choline	THP1	PA448976	2736	0.642
NULL	Autoimmun_Rev_2014_Sep_13(9)_909-916.nxml.txt.nlp	24833504	SENT564	16	16	11	11	daclizumab	IL-2	PA164764446	3558	0.642
NULL	J_Gastroenterol_2013_Jan_28_48(1)_1-12.nxml.txt.nlp	23188091	SENT147	27	27	8	8	telaprevir	IL28B	PA165958354	282617	0.642
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Aug_26_65(Pt_9)_m1136.nxml.txt.nlp	21577473	SENT54	19	19	21	21	phenol	HL1	PA450913	1767	0.642
NULL	Acta_Histochem_Cytochem_2007_May_12_40(2)_35-41.nxml.txt.nlp	17576431	SENT65	13	13	11	11	nifedipine	DHPR	PA450631	5860	0.642
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_May_14_3(5)_e114.nxml.txt.nlp	24827872	SENT122	20	20	22	22	sorafenib	PSMB5	PA7000	5693	0.642
NULL	J_Exp_Med_2000_Mar_6_191(5)_859-870.nxml.txt.nlp	10704466	SENT169	9	9	0	0	arsenite	p38	PA452638	10598;1432;7965	0.642
NULL	Arthritis_Res_Ther_2013_Dec_27_15(6)_R222.nxml.txt.nlp	24369907	SENT181	32	32	17	17	collagenase	c-Jun	PA449107	3725	0.642
NULL	Curr_Neuropharmacol_2008_Jun_6(2)_151-163.nxml.txt.nlp	19305794	SENT372	9	9	18	18	cyclophosphamide	VR1	PA449165	56664	0.642
NULL	J_Korean_Neurosurg_Soc_2014_Sep_30_56(3)_175-187.nxml.txt.nlp	25368758	SENT165	33	33	12	12	glucose	CPP	PA449773	340451	0.642
NULL	Front_Oncol_2014_Mar_6_4_40.nxml.txt.nlp	24639951	SENT545	29	29	12	12	lapatinib	mol	PA152241907	90527	0.642
NULL	Mol_Cancer_2012_Mar_21_11_13.nxml.txt.nlp	22436134	SENT97	19	19	34	34	doxorubicin	HuR	PA449412	1994	0.642
NULL	Cancer_Res_Treat_2014_Jan_15_46(1)_2-18.nxml.txt.nlp	24520218	SENT167	4	4	11	11	curcumin	TMC	PA151958596	3703	0.642
NULL	J_Biol_2009_Apr_15_8(3)_30.nxml.txt.nlp	19435483	SENT36	5	5	24	24	imatinib	NQO2	PA10804	4835	0.642
NULL	Oncotarget_2014_Oct_18_5(21)_10206-10221.nxml.txt.nlp	25344914	SENT42	19	19	7	7	vemurafenib	BRAF	PA165946873	673	0.642
NULL	Cell_Res_2012_Aug_22_22(8)_1227-1245.nxml.txt.nlp	22613949	SENT398	8	8	27	27	doxorubicin	KRAS	PA449412	3845	0.642
NULL	J_Korean_Med_Sci_2013_Apr_27_28(4)_527-533.nxml.txt.nlp	23580227	SENT17	6	6	8	8	genistein	TRAIL	PA165109660	8743	0.642
NULL	Eur_J_Dent_2012_Apr_6(2)_133-140.nxml.txt.nlp	22509115	SENT199	36	36	32	32	ethanol	HEMA	PA448073	2157	0.642
NULL	Arthritis_Rheum_2013_Sep_26_65(9)_2290-2300.nxml.txt.nlp	23740547	SENT221	14	14	9	9	doxycycline	S100A9	PA449415	6280	0.642
NULL	Ann_Surg_Oncol_2012_Feb_31_19(2)_627-635.nxml.txt.nlp	21879272	SENT199	10	10	8	8	melphalan	TNF-alpha	PA450354	7124	0.642
NULL	Diabetes_2009_Apr_16_58(4)_975-983.nxml.txt.nlp	19151200	SENT17	0	0	26	26	liraglutide	HO-1	PA165958364	3162	0.642
NULL	Indian_J_Pharm_Sci_2011_Sep-Oct_73(5)_569-572.nxml.txt.nlp	22923871	SENT24	12	12	6	6	hydrochlorothiazide	EPM	PA449899	2054	0.642
NULL	Exp_Ther_Med_2014_Oct_11_8(4)_1115-1122.nxml.txt.nlp	25187807	SENT38	0	0	24	24	fluorescein	San	PA164746009	80218	0.642
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT49	26	26	3	3	paclitaxel	CYP3A	PA450761	1574	0.642
NULL	Br_J_Cancer_2012_Jan_17_106(2)_284-289.nxml.txt.nlp	22215065	SENT115	36	36	15	15	atrasentan	IFN	PA143414738	3439	0.642
NULL	Br_J_Cancer_2013_Feb_5_108(2)_319-326.nxml.txt.nlp	23322198	SENT23	0	0	3	3	axitinib	VEGFR	PA164924493	3791	0.642
NULL	AAPS_J_2014_Jun_11_16(5)_1029-1037.nxml.txt.nlp	24917180	SENT190	43	43	38	38	quinidine	P-gp	PA451209	5243	0.642
NULL	Breast_Cancer_Res_2010_Oct_14_12(5)_R84.nxml.txt.nlp	20946630	SENT282	14	14	9	9	choline	Hsp90	PA448976	3320	0.642
NULL	Curr_Pharm_Des_2012_Apr_18(11)_1519-1530.nxml.txt.nlp	22364136	SENT106	8	8	20	20	lovastatin	IFN	PA450272	3439	0.642
NULL	Emerg_Infect_Dis_2011_Mar_17(3)_457-463.nxml.txt.nlp	21392437	SENT252	12	12	17	17	adalimumab	IFN	PA10004	3439	0.642
NULL	Arthritis_Rheum_2013_Sep_26_65(9)_2346-2355.nxml.txt.nlp	23740825	SENT260	10	10	4	4	hyaluronan	TSG-6	PA165958431	7130	0.642
NULL	Croat_Med_J_2013_Apr_54(2)_171-179.nxml.txt.nlp	23630144	SENT113	15	15	19	19	taurine	STZ	PA451590	6484	0.642
NULL	Nucleic_Acids_Res_2013_Nov_27_41(21)_9786-9799.nxml.txt.nlp	23982513	SENT265	4	4	13	13	arsenite	TIAR	PA452638	7073	0.642
NULL	Cell_Cycle_2012_Nov_1_11(21)_4069-4078.nxml.txt.nlp	23095523	SENT101	37	37	9	9	imatinib	PERK	PA10804	9451	0.642
NULL	Eur_J_Epidemiol_2007_Nov_23_22(11)_819-829.nxml.txt.nlp	17955331	SENT690	11	11	25	25	phenprocoumon	PAGM	PA450921	5238	0.642
NULL	Front_Aging_Neurosci_2014_Sep_18_6_245.nxml.txt.nlp	25278877	SENT210	7	7	13	13	tetracycline	ADAM12	PA451640	8038	0.642
NULL	Alcohol_Res_Health_2008_31(4)_310-339.nxml.txt.nlp	20729980	SENT123	12	12	7	7	ethanol	5-HT1B	PA448073	3351	0.642
NULL	Int_J_Womens_Health_2013_Dec_4_5_811-818.nxml.txt.nlp	24348074	SENT198	24	24	17	17	levonorgestrel	LAM	PA450218	7249;7248	0.642
NULL	Am_J_Trop_Med_Hyg_2012_Nov_7_87(5)_783-784.nxml.txt.nlp	23136171	SENT23	8	8	30	30	artesunate	ACT	PA165111697	12;11332;9457;641455	0.642
NULL	Exp_Neurobiol_2013_Sep_30_22(3)_214-223.nxml.txt.nlp	24167416	SENT195	27	27	19	19	ethanol	LPO	PA448073	4025	0.642
NULL	Arthritis_Res_Ther_2003_Sep_3_5(6)_R317-R328.nxml.txt.nlp	14680506	SENT152	2	2	4	4	forskolin	IL-10	PA146096022	3586	0.642
NULL	Biochem_Res_Int_2011_Oct_28_2011_191670.nxml.txt.nlp	21152183	SENT176	35	35	23	23	urokinase	ADAMTS-4	PA451836	9508	0.642
NULL	Indian_J_Pharmacol_2014_Nov-Dec_46(6)_627-632.nxml.txt.nlp	25538335	SENT104	5	5	3	3	metformin	Q10	PA450395	27161	0.642
NULL	J_Invest_Dermatol_2012_Nov_21_132(11)_2642-2651.nxml.txt.nlp	22718118	SENT251	8	8	13	13	collagenase	CCR2	PA449107	729230	0.642
NULL	Indian_J_Nucl_Med_2013_Dec_28(Suppl_1)_S25-S28.nxml.txt.nlp	NULL	SENT71	17	17	8	8	thyroglobulin	FDG	PA164754910	23583	0.642
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT460	16	16	2	2	olanzapine	PRL	PA450688	5617	0.642
NULL	Mol_Med_Rep_2014_Nov_5_10(5)_2334-2340.nxml.txt.nlp	25189202	SENT162	10	10	12	12	ceftazidime	CFP	PA448861	5199	0.642
NULL	Oncotarget_2014_Jun_19_5(15)_6540-6551.nxml.txt.nlp	25153728	SENT96	9	9	28	28	paclitaxel	CDK4	PA450761	1019	0.642
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Apr_15_9_13.nxml.txt.nlp	20398300	SENT97	25	25	18	18	moxifloxacin	LAM	PA450555	7249;7248	0.642
NULL	Angew_Chem_Int_Ed_Engl_2013_Jan_2_52(1)_325-330.nxml.txt.nlp	23080482	SENT30	1	1	4	4	thrombin	ACPP	PA451674	55	0.642
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT1758	7	7	2	2	doxorubicin	ABCB1	PA449412	5243	0.642
NULL	Breast_Cancer_(Auckl)_2009_Sep_2_3_61-75.nxml.txt.nlp	19809577	SENT91	13	13	6	6	curcumin	ATM	PA151958596	472	0.642
NULL	Case_Rep_Oncol_Med_2013_Jan_16_2013_292301.nxml.txt.nlp	23401819	SENT131	6	6	2	2	doxorubicin	CHOP	PA449412	1649	0.642
NULL	J_Clin_Biochem_Nutr_2009_Jan_27_44(1)_79-84.nxml.txt.nlp	19177192	SENT274	4	4	13	13	curcumin	HO-1	PA151958596	3162	0.642
NULL	Cancers_(Basel)_2014_Jun_27_6(3)_1363-1381.nxml.txt.nlp	24978438	SENT106	10	10	8	8	hyaluronan	IL-4	PA165958431	3565	0.642
NULL	Clin_Mol_Hepatol_2013_Sep_30_19(3)_195-209.nxml.txt.nlp	24133659	SENT288	10	10	0	0	telbivudine	LAM	PA164760861	7249;7248	0.642
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Apr_30_66(Pt_5)_o1233-o1234.nxml.txt.nlp	21579255	SENT78	19	19	7	7	ethanol	mol	PA448073	90527	0.642
NULL	Endocrine_2013_Feb_15_43(1)_230-232.nxml.txt.nlp	22983830	SENT103	23	23	9	9	methimazole	CXCL10	PA450422	3627	0.642
NULL	Br_J_Cancer_2010_Jan_5_102(1)_80-86.nxml.txt.nlp	19920817	SENT10	7	7	12	12	sunitinib	IFN	PA162372840	3439	0.642
NULL	AAPS_J_2014_Jun_11_16(5)_1029-1037.nxml.txt.nlp	24917180	SENT126	17	17	36	36	quinidine	ANOVA	PA451209	4858	0.642
NULL	HSR_Proc_Intensive_Care_Cardiovasc_Anesth_2010_2(2)_81-91.nxml.txt.nlp	23440622	SENT135	4	4	11	11	ticagrelor	ADP	PA165374673	23038	0.642
NULL	Diabetes_Care_2010_Apr_12_33(4)_861-868.nxml.txt.nlp	20067962	SENT136	16	16	24	24	hyaluronan	TLR4	PA165958431	7099	0.642
NULL	Diabetes_Care_2012_Dec_14_35(12)_e84.nxml.txt.nlp	23173145	SENT21	15	15	18	18	metformin	B12	PA450395	7126;4709	0.642
NULL	N_Am_J_Med_Sci_2014_Jun_6(6)_250-259.nxml.txt.nlp	25006559	SENT57	1	1	11	11	ethanol	gamma	PA448073	9913	0.642
NULL	Mol_Pain_2014_Apr_9_10_24.nxml.txt.nlp	24716552	SENT245	24	24	34	34	capsaicin	NK1R	PA448776	6869	0.642
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Aug_11_66(Pt_9)_o2228.nxml.txt.nlp	21588598	SENT70	20	20	16	16	ethanol	mol	PA448073	90527	0.642
NULL	Open_Biol_2014_May_4(5)_140051.nxml.txt.nlp	24806840	SENT89	8	8	21	21	nadh	PINK1	PA164755085	65018	0.642
NULL	Cell_Cycle_2013_Aug_15_12(16)_2580-2597.nxml.txt.nlp	23860378	SENT295	21	21	12	12	ethanol	BRCA1	PA448073	672	0.642
NULL	J_Hematol_Oncol_2009_Nov_22_2_49.nxml.txt.nlp	19930611	SENT50	17	17	29	29	vincristine	CHOP	PA451879	1649	0.642
NULL	Curr_Neuropharmacol_2009_Jun_7(2)_83-95.nxml.txt.nlp	19949566	SENT474	14	14	32	32	levetiracetam	TGB	PA450206	5473	0.642
NULL	Cardiovasc_Diabetol_2013_Jun_19_12_92.nxml.txt.nlp	23777506	SENT200	10	10	3	3	miglitol	GLP-1	PA164776726	100125288	0.642
NULL	Oncol_Lett_2013_Jul_8_6(1)_75-80.nxml.txt.nlp	23946780	SENT47	18	18	32	32	ampicillin	CO2	PA448419	4513	0.642
NULL	Mycobact_Dis_2014_May_5_4_145.nxml.txt.nlp	25525563	SENT29	0	0	7	7	isoniazid	EMB	PA450112	133418	0.642
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1075.nxml.txt.nlp	24556690	SENT263	2	2	11	11	spermine	SSAT	PA164781199	6303	0.642
NULL	Drug_Des_Devel_Ther_2014_Dec_12_8_2517-2529.nxml.txt.nlp	25548514	SENT210	10	10	16	16	cisplatin	STAT3	PA449014	6774	0.642
NULL	Int_J_Gen_Med_2013_Jun_7_6_453-464.nxml.txt.nlp	23785241	SENT205	37	37	31	31	nedocromil	GM-CSF	PA450601	1437	0.642
NULL	Eur_J_Clin_Microbiol_Infect_Dis_2013_Jun_13_32(6)_745-754.nxml.txt.nlp	23314745	SENT263	16	16	7	7	ribavirin	IL28B	PA451241	282617	0.642
NULL	Indian_J_Med_Res_2011_Apr_133(4)_434-441.nxml.txt.nlp	21537099	SENT33	29	29	22	22	lansoprazole	EGF	PA450180	1950	0.642
NULL	Ther_Clin_Risk_Manag_2006_Dec_2(4)_389-400.nxml.txt.nlp	18360651	SENT124	3	3	24	24	infliximab	IMPACT	PA452639	55364	0.642
NULL	Diabetes_Metab_J_2013_Oct_17_37(5)_315-325.nxml.txt.nlp	24199159	SENT193	1	1	12	12	resveratrol	AMPK		5563	0.642
NULL	Cancers_(Basel)_2011_Aug_5_3(3)_3114-3142.nxml.txt.nlp	24212948	SENT723	1	1	7	7	cyclophosphamide	CD25	PA449165	3669;3559	0.642
NULL	Int_J_Environ_Res_Public_Health_2013_Sep_12_10(9)_4274-4305.nxml.txt.nlp	24036486	SENT55	19	19	17	17	ertapenem	EPM	PA164777032	2054	0.642
NULL	Virol_J_2010_Oct_20_7_279.nxml.txt.nlp	20961433	SENT166	0	0	13	13	trypsin	GP2	PA451806	2813	0.642
NULL	Onco_Targets_Ther_2014_Nov_28_7_2183-2195.nxml.txt.nlp	25506223	SENT17	16	16	28	28	doxorubicin	MICA	PA449412	100507436	0.642
NULL	Arch_Plast_Surg_2013_Mar_11_40(2)_141-153.nxml.txt.nlp	23529264	SENT125	31	31	25	25	daclizumab	IL-2	PA164764446	3558	0.642
NULL	Breast_Cancer_Res_Treat_2014_Apr_6_145(1)_33-44.nxml.txt.nlp	24706169	SENT53	9	9	7	7	trastuzumab	HER2	PA451743	2064	0.642
NULL	J_Gynecol_Oncol_2014_Oct_7_25(4)_355-356.nxml.txt.nlp	25310036	SENT39	16	16	4	4	paclitaxel	GEM	PA450761	2669	0.642
NULL	J_Cell_Biol_1998_Jul_27_142(2)_595-607.nxml.txt.nlp	9679155	SENT473	0	0	3	3	urokinase	CD87	PA451836	5329	0.642
NULL	Oncol_Lett_2014_Nov_14_8(5)_2086-2092.nxml.txt.nlp	25295095	SENT117	15	15	6	6	gemcitabine	LKB1	PA449748	6794	0.642
NULL	J_Cell_Biol_2004_Jul_19_166(2)_261-272.nxml.txt.nlp	15263021	SENT551	3	3	5	5	hyaluronan	RHAMM	PA165958431	3161	0.642
NULL	Genome_Biol_2011_Jun_22_12(6)_R57.nxml.txt.nlp	21696594	SENT148	12	12	5	5	risperidone	PRL	PA451257	5617	0.641
NULL	Acta_Pharmacol_Sin_2010_Dec_29_31(12)_1583-1592.nxml.txt.nlp	21113175	SENT172	25	25	29	29	dextran	TLR9	PA449261	54106	0.641
NULL	Endocr_Connect_2012_Jul_21_1(1)_37-47.nxml.txt.nlp	23781302	SENT26	0	0	16	16	mitotane	CYP11B1	PA164746157	1584	0.641
NULL	Case_Rep_Nephrol_2013_Nov_20_2013_801575.nxml.txt.nlp	24558627	SENT83	1	1	3	3	vasopressin	AVP	PA451858	114548;551	0.641
NULL	Clin_Psychopharmacol_Neurosci_2011_Apr_30_9(1)_36-43.nxml.txt.nlp	23431025	SENT36	36	36	15	15	haloperidol	FLI	PA449841	2314	0.641
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT8	7	7	9	9	heparin	FGF1	PA449855	2246	0.641
NULL	Iran_J_Pharm_Res_2015_Winter_14(1)_77-87.nxml.txt.nlp	25561914	SENT227	32	32	26	26	carbamazepine	BIC	PA448785	114614	0.641
NULL	Biologics_2012_Dec_17_6_429-464.nxml.txt.nlp	23269860	SENT238	5	5	9	9	tocilizumab	ACR	PA165292659	49	0.641
NULL	New_Microbes_New_Infect_2014_May_4_2(3)_58-63.nxml.txt.nlp	25356345	SENT100	26	26	8	8	amikacin	CTX	PA164744372	1593	0.641
NULL	J_Antimicrob_Chemother_2008_Nov_27_62(5)_929-933.nxml.txt.nlp	18755696	SENT60	26	26	20	20	chloramphenicol	CTX	PA448927	1593	0.641
NULL	Mol_Cancer_2012_Oct_22_11_80.nxml.txt.nlp	23088607	SENT67	14	14	39	39	fulvestrant	HIF-1	PA164747170	29072	0.641
NULL	J_Physiol_2011_Dec_15_589(Pt_24)_5965-5986.nxml.txt.nlp	22041182	SENT13	10	10	12	12	vasopressin	AVP	PA451858	114548;551	0.641
NULL	Exp_Diabetes_Res_2012_Jan_29_2012_159874.nxml.txt.nlp	22319521	SENT158	13	13	10	10	telmisartan	VEGF-A	PA451605	7422	0.641
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT166	6	6	25	25	atorvastatin	p38	PA448500	10598;1432;7965	0.641
NULL	Oncotarget_2013_Nov_24_4(12)_2430-2438.nxml.txt.nlp	24280348	SENT6	11	11	5	5	gefitinib	STAT3	PA131301952	6774	0.641
NULL	Mol_Cancer_2010_Nov_8_9_291.nxml.txt.nlp	21059223	SENT269	2	2	24	24	zinc	BTAK	PA451956	6790	0.641
NULL	Mol_Cancer_2014_Jun_30_13_160.nxml.txt.nlp	24976026	SENT160	17	17	15	15	bortezomib	GADD153	PA10252	1649	0.641
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT254	23	23	15	15	doxorubicin	SLK	PA449412	9748;2534	0.641
NULL	Clin_Ophthalmol_2012_Dec_13_6_1-4.nxml.txt.nlp	22259229	SENT70	32	32	30	30	travoprost	BAK	PA164781371	578	0.641
NULL	Breast_Cancer_Res_2005_Jan_28_7(3)_R284-R290.nxml.txt.nlp	15987423	SENT36	22	22	14	14	tamoxifen	SULT1A1	PA451581	6817	0.641
NULL	Gut_Liver_2011_Jun_24_5(2)_160-164.nxml.txt.nlp	21814595	SENT26	2	2	15	15	midazolam	ESD	PA450496	2098	0.641
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Jul_23_3(7)_e126.nxml.txt.nlp	25054314	SENT23	23	23	14	14	docetaxel	MRP2	PA449383	100130958;57626;1244	0.641
NULL	Cases_J_2009_Jun_12_2_7429.nxml.txt.nlp	19829962	SENT11	16	16	13	13	ribavirin	IFN	PA451241	3439	0.641
NULL	J_Adv_Pharm_Technol_Res_2014_Apr-Jun_5(2)_90-95.nxml.txt.nlp	24959418	SENT36	5	5	8	8	benzaldehyde	mol	PA448571	90527	0.641
NULL	Biomed_Res_Int_2013_Jul_17_2013_549359.nxml.txt.nlp	23956990	SENT33	33	33	20	20	gefitinib	EGFR	PA131301952	1956	0.641
NULL	Evid_Based_Complement_Alternat_Med_2014_Dec_29_2014_609594.nxml.txt.nlp	25614752	SENT326	0	0	3	3	capsaicin	TRPV1	PA448776	7442	0.641
NULL	ISRN_Cardiol_2013_Mar_14_2013_617943.nxml.txt.nlp	23577267	SENT82	10	10	41	41	amiodarone	AIC	PA448383	192	0.641
NULL	Br_J_Cancer_2011_Jul_12_105(2)_255-262.nxml.txt.nlp	21694725	SENT184	19	19	12	12	irinotecan	KRAS	PA450085	3845	0.641
NULL	Arthritis_Res_2002_May_9_4(Suppl_3)_S3-S15.nxml.txt.nlp	12110118	SENT362	4	4	26	26	cyclophosphamide	p40	PA449165	3921;339541;10314	0.641
NULL	Front_Neurosci_2014_Jun_24_8_171.nxml.txt.nlp	25009457	SENT1027	3	3	5	5	vasopressin	AVP	PA451858	114548;551	0.641
NULL	Evid_Based_Complement_Alternat_Med_2011_Jan_12_2011_690518.nxml.txt.nlp	19687188	SENT170	19	19	34	34	sulfisoxazole	TIC	PA164748964	23550	0.641
NULL	Breast_Cancer_Res_2012_Jul_12_14(4)_R106.nxml.txt.nlp	22789011	SENT59	36	36	27	27	hydrocortisone	EGF	PA449905	1950	0.641
NULL	J_Obes_2013_Jun_4_2013_874981.nxml.txt.nlp	23862058	SENT8	2	2	36	36	l-proline	C17	PA451125	54360	0.641
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT182	5	5	15	15	curcumin	p53	PA151958596	7157	0.641
NULL	Front_Microbiol_2015_Jan_15_5_772.nxml.txt.nlp	25642214	SENT106	5	5	24	24	kanamycin	CO2	PA450137	4513	0.641
NULL	Asian_Spine_J_2014_Feb_6_8(1)_97-111.nxml.txt.nlp	24596613	SENT397	30	30	16	16	ciprofloxacin	EMB	PA449009	133418	0.641
NULL	Biol_Open_2014_Jul_25_3(8)_741-758.nxml.txt.nlp	25063196	SENT1194	13	13	0	0	ethanol	CD24	PA448073	100133941	0.641
NULL	Front_Immunol_2014_Apr_23_5_188.nxml.txt.nlp	24795730	SENT139	15	15	8	8	oxygen	TNF	PA450744	7124	0.641
NULL	ScientificWorldJournal_2012_Apr_19_2012_804730.nxml.txt.nlp	22606063	SENT162	0	0	27	27	tafluprost	BAK	PA165958432	578	0.641
NULL	Allergy_Asthma_Clin_Immunol_2014_Jul_7_10(1)_35.nxml.txt.nlp	25050125	SENT61	8	8	11	11	chloroquine	gamma	PA448948	9913	0.641
NULL	Clin_Sci_(Lond)_2011_Nov_1_121(Pt_10)_449-458.nxml.txt.nlp	21671887	SENT12	0	0	4	4	simvastatin	AMPK	PA451363	5563	0.641
NULL	Case_Rep_Genet_2014_Jan_22_2014_413743.nxml.txt.nlp	24627811	SENT19	28	28	19	19	warfarin	CYP2C9	PA451906	1559	0.641
NULL	Sensors_(Basel)_2013_Apr_9_13(4)_4674-4693.nxml.txt.nlp	23571670	SENT126	23	23	18	18	fluorescein	CD4	PA164746009	920	0.641
NULL	Clin_Cosmet_Investig_Dermatol_2011_Apr_26_4_41-53.nxml.txt.nlp	21691566	SENT259	4	4	6	6	tretinoin	CDP	PA451746	1523	0.641
NULL	Diabetes_Care_2013_Aug_17_36(Suppl_2)_S245-S252.nxml.txt.nlp	23882053	SENT163	14	14	12	12	liraglutide	GLP-1	PA165958364	100125288	0.641
NULL	Emerg_Infect_Dis_2013_Jan_19(1)_133-136.nxml.txt.nlp	23260464	SENT49	11	11	9	9	tobramycin	TOB	PA451704	10140	0.641
NULL	J_Korean_Med_Sci_2011_Jan_22_26(1)_33-41.nxml.txt.nlp	21218027	SENT169	10	10	8	8	ethambutol	EMB	PA164784021	133418	0.641
NULL	Ann_Clin_Transl_Neurol_2014_Dec_21_1(12)_996-1005.nxml.txt.nlp	25574474	SENT199	6	6	18	18	riluzole	P-gp	PA451251	5243	0.641
NULL	Ann_Clin_Microbiol_Antimicrob_2009_Jan_15_8_2.nxml.txt.nlp	19146672	SENT3	0	0	2	2	ethambutol	EMB	PA164784021	133418	0.641
NULL	Fibrogenesis_Tissue_Repair_2011_Aug_2_4_18.nxml.txt.nlp	21810214	SENT389	12	12	6	6	bleomycin	TLR9	PA448645	54106	0.641
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT196	0	0	36	36	metformin	p53	PA450395	7157	0.641
NULL	J_Nat_Sci_Biol_Med_2011_Jan-Jun_2(1)_13-25.nxml.txt.nlp	22470230	SENT121	9	9	15	15	fluorescein	TRPV1	PA164746009	7442	0.641
NULL	Cancer_Med_2012_Oct_6_1(2)_198-206.nxml.txt.nlp	23342269	SENT84	4	4	21	21	oxaliplatin	CD10	PA131285527	4311	0.641
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT144	6	6	12	12	perifosine	DR5	PA165291471	8795	0.641
NULL	Arthritis_Res_Ther_2006_Feb_3_8(2)_R43.nxml.txt.nlp	16507142	SENT115	5	5	18	18	heparin	CXCL12	PA449855	6387	0.641
NULL	Arthritis_Res_Ther_2013_Jul_24_15(4)_R76.nxml.txt.nlp	23883591	SENT90	2	2	9	9	fluorescein	HEX	PA164746009	3087	0.641
NULL	Diabetes_2013_Mar_14_62(3)_953-964.nxml.txt.nlp	23223176	SENT174	13	13	28	28	paroxetine	ROS	PA450801	6098	0.641
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT256	17	17	11	11	warfarin	CYP4F2	PA451906	8529	0.641
NULL	Int_J_Breast_Cancer_2013_Jun_24_2013_137414.nxml.txt.nlp	23864953	SENT254	11	11	36	36	bevacizumab	HER-2	PA130232992	2064	0.641
NULL	Braz_J_Microbiol_2011_Dec_1_Oct-Dec_42(4)_1434-1436.nxml.txt.nlp	24031774	SENT34	22	22	20	20	tobramycin	TOB	PA451704	10140	0.641
NULL	Mol_Biotechnol_2013_Jan_28_53(1)_9-18.nxml.txt.nlp	23104232	SENT77	16	16	11	11	l-glutamine	F12	PA10090	2161	0.641
NULL	Cancer_Metab_2014_Aug_18_2_13.nxml.txt.nlp	25225614	SENT271	43	43	38	38	lipase	ACSL1	PA450239	2180	0.641
NULL	Oxid_Med_Cell_Longev_2011_Aug_17_2011_450317.nxml.txt.nlp	21904643	SENT195	7	7	4	4	l-leucine	DTNB	PA450197	1838	0.641
NULL	Eur_J_Clin_Pharmacol_2011_Dec_23_67(12)_1231-1241.nxml.txt.nlp	21698374	SENT190	19	19	12	12	tacrolimus	CYP3A4	PA451578	1576	0.641
NULL	J_Immunother_2014_Apr_12_37(3)_180-186.nxml.txt.nlp	24598448	SENT4	19	19	15	15	sorafenib	IL-2	PA7000	3558	0.641
NULL	Exp_Neurobiol_2014_Jun_13_23(2)_138-147.nxml.txt.nlp	24963278	SENT153	16	16	7	7	hemin	TLR2	PA449849	7097	0.641
NULL	Iran_Red_Crescent_Med_J_2013_Aug_5_15(8)_649-654.nxml.txt.nlp	24578830	SENT178	21	21	0	0	atorvastatin	ATV	PA448500	4683	0.641
NULL	Diabetes_2009_Jan_58(1)_104-115.nxml.txt.nlp	18835938	SENT170	2	2	8	8	rosiglitazone	MRP-1	PA451283	928	0.641
NULL	Mycobact_Dis_2014_May_5_4_145.nxml.txt.nlp	25525563	SENT29	5	5	7	7	ethambutol	EMB	PA164784021	133418	0.641
NULL	Cancer_Imaging_2013_Mar_5_13(1)_53-62.nxml.txt.nlp	23466737	SENT50	12	12	8	8	rituximab	CHOP	PA451261	1649	0.641
NULL	Med_Sci_Monit_2013_May_1_19_317-326.nxml.txt.nlp	23632427	SENT261	3	3	13	13	ampicillin	CTX	PA448419	1593	0.641
NULL	Oncogene_2013_Sep_26_32(39)_10_1038_onc_2012_491.nxml.txt.nlp	23108394	SENT221	21	21	12	12	epirubicin	p53	PA449476	7157	0.641
NULL	Clin_Med_Cardiol_2009_Sep_3_3_77-91.nxml.txt.nlp	20508768	SENT91	29	29	27	27	thrombin	ADP	PA451674	23038	0.641
NULL	Int_J_Nephrol_2010_Dec_28_2011_920195.nxml.txt.nlp	21253529	SENT220	1	1	3	3	vasopressin	AVP	PA451858	114548;551	0.641
NULL	Virol_J_2010_Dec_3_7_354.nxml.txt.nlp	21129188	SENT53	30	30	11	11	raltegravir	p24		11261;140767	0.641
NULL	Daru_2011_19(3)_224-230.nxml.txt.nlp	22615661	SENT78	5	5	0	0	sumatriptan	DSC	PA451566	1825	0.641
NULL	J_Biol_Chem_2013_Nov_15_288(46)_33049-33059.nxml.txt.nlp	24089524	SENT202	12	12	6	6	nicotine	CAM	PA450626	889	0.641
NULL	Curr_Pharm_Biotechnol_2012_May_13(6)_969-986.nxml.txt.nlp	22039792	SENT216	14	14	10	10	ivermectin	P-gp	PA450133	5243	0.641
NULL	Ann_Rheum_Dis_2014_Jan_8_73(1)_6-16.nxml.txt.nlp	23749611	SENT342	10	10	31	31	infliximab	IMPACT	PA452639	55364	0.641
NULL	Chonnam_Med_J_2013_Apr_25_49(1)_31-37.nxml.txt.nlp	23678475	SENT5	11	11	16	16	rosuvastatin	adiponectin	PA134308647	9370	0.641
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT286	10	10	5	5	nutlin-3	DcR2		8793	0.641
NULL	Arthritis_2012_Nov_18_2012_864907.nxml.txt.nlp	23209899	SENT61	30	30	23	23	thyroglobulin	PTPN22	PA164754910	26191	0.641
NULL	Avicenna_J_Med_2013_Apr-Jun_3(2)_37-47.nxml.txt.nlp	23930241	SENT202	25	25	22	22	azathioprine	CD4	PA448515	920	0.641
NULL	Contemp_Oncol_(Pozn)_2013_Apr_29_17(2)_137-143.nxml.txt.nlp	23788980	SENT179	17	17	24	24	cabergoline	PRL	PA448708	5617	0.641
NULL	Nanoscale_Res_Lett_2012_Jun_11_7(1)_302.nxml.txt.nlp	22687246	SENT28	24	24	16	16	ethanol	NO3	PA448073	4681	0.641
NULL	Front_Cell_Neurosci_2014_Dec_11_8_422.nxml.txt.nlp	25565957	SENT249	0	0	6	6	pravastatin	RhoA	PA451089	387	0.641
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Oct_31_70(Pt_11)_o1214-o1215.nxml.txt.nlp	25484836	SENT93	26	26	22	22	ethanol	mol	PA448073	90527	0.641
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2675-2684.nxml.txt.nlp	24129246	SENT173	33	33	26	26	etoposide	p53	PA449552	7157	0.641
NULL	Cells_2012_May_10_1(2)_100-110.nxml.txt.nlp	24710417	SENT79	36	36	22	22	alemtuzumab	IL-2	PA164783958	3558	0.641
NULL	Mol_Med_Rep_2015_Jan_16_11(1)_91-98.nxml.txt.nlp	25322694	SENT94	11	11	23	23	cisplatin	LC3	PA449014	84557	0.641
NULL	Asian_Spine_J_2014_Feb_6_8(1)_97-111.nxml.txt.nlp	24596613	SENT397	18	18	16	16	ethambutol	EMB	PA164784021	133418	0.641
NULL	Gut_Liver_2012_Jul_12_6(3)_339-343.nxml.txt.nlp	22844562	SENT98	0	0	3	3	tegaserod	5-HT4	PA130413154	3360	0.641
NULL	Front_Physiol_2013_May_15_4_103.nxml.txt.nlp	23720630	SENT110	11	11	17	17	simvastatin	ADP	PA451363	23038	0.641
NULL	Indian_J_Endocrinol_Metab_2013_Jan-Feb_17(1)_91-94.nxml.txt.nlp	23776858	SENT125	6	6	4	4	exenatide	GLP-1	PA164749238	100125288	0.641
NULL	Clin_Pediatr_Endocrinol_2014_Oct_6_23(4)_115-117.nxml.txt.nlp	25374441	SENT3	1	1	3	3	vasopressin	AVP	PA451858	114548;551	0.641
NULL	Breast_Cancer_Res_2006_Oct_24_8(5)_R59.nxml.txt.nlp	17062128	SENT15	13	13	10	10	urokinase	IL-8	PA451836	3576	0.641
NULL	Patient_Prefer_Adherence_2010_Dec_2_4_415-424.nxml.txt.nlp	21206517	SENT218	9	9	7	7	pamidronate	PAM	PA450767	5066;23077	0.641
NULL	Evid_Based_Complement_Alternat_Med_2013_May_16_2013_857929.nxml.txt.nlp	23762164	SENT153	19	19	32	32	doxorubicin	p53	PA449412	7157	0.641
NULL	Br_J_Pharmacol_2014_Sep_28_171(18)_4255-4272.nxml.txt.nlp	24846338	SENT50	2	2	14	14	fluvoxamine	gamma	PA449690	9913	0.641
NULL	BMJ_2011_Feb_24_342_d813.nxml.txt.nlp	21349898	SENT229	10	10	3	3	warfarin	VIII	PA451906	1351	0.641
NULL	Evid_Based_Complement_Alternat_Med_2013_May_16_2013_857929.nxml.txt.nlp	23762164	SENT126	22	22	24	24	doxorubicin	p53	PA449412	7157	0.641
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT192	14	14	47	47	pertuzumab	Yes		7525	0.641
NULL	J_Oncol_2009_Mar_24_2009_491985.nxml.txt.nlp	19325924	SENT185	28	28	10	10	genistein	CXCL12	PA165109660	6387	0.641
NULL	Mol_Vis_2011_Apr_24_17_1011-1015.nxml.txt.nlp	21541272	SENT37	9	9	15	15	iron	FTL	PA450087	2512	0.641
NULL	Curr_HIV_Res_2011_Jan_9(1)_40-53.nxml.txt.nlp	21198432	SENT212	4	4	9	9	raltegravir	ART		181	0.641
NULL	Oncotarget_2014_Oct_21_5(22)_11252-11268.nxml.txt.nlp	25361004	SENT61	6	6	4	4	metformin	CLIC1	PA450395	1192	0.641
NULL	Int_J_Hypertens_2012_Nov_30_2012_192567.nxml.txt.nlp	22187625	SENT155	14	14	22	22	candesartan	ANOVA	PA448765	4858	0.641
NULL	FASEB_J_2014_Feb_28(2)_923-934.nxml.txt.nlp	24249636	SENT214	14	14	8	8	chymotrypsin	KLKB1	PA448994	3818	0.641
NULL	J_Viral_Hepat_2010_Feb_17(2)_139-147.nxml.txt.nlp	19674282	SENT58	9	9	18	18	ribavirin	RVR	PA451241	9975	0.641
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT175	11	11	18	18	chloroquine	BMP9	PA448948	2658	0.641
NULL	Exp_Ther_Med_2013_Feb_20_5(2)_443-447.nxml.txt.nlp	23407364	SENT174	11	11	9	9	cyclophosphamide	CTX	PA449165	1593	0.641
NULL	J_Korean_Med_Sci_2011_Dec_29_26(12)_1563-1568.nxml.txt.nlp	22147992	SENT78	0	0	5	5	ekb-569	AKT		207	0.641
NULL	J_Clin_Biochem_Nutr_2009_Jul_30_45(1)_74-81.nxml.txt.nlp	19590710	SENT68	0	0	21	21	fluorescein	San	PA164746009	80218	0.641
NULL	Clin_Exp_Reprod_Med_2011_Jun_30_38(2)_98-102.nxml.txt.nlp	22384426	SENT28	6	6	14	14	pioglitazone	IL-6	PA450970	3569	0.641
NULL	J_Biol_Chem_2009_Apr_3_284(14)_9558-9565.nxml.txt.nlp	19202191	SENT92	26	26	16	16	camptothecin	CtIP	PA153590860	5932	0.641
NULL	Cancer_Immunol_Immunother_2012_Jul_23_61(7)_1101-1111.nxml.txt.nlp	22193989	SENT101	1	1	6	6	oxaliplatin	IP-10	PA131285527	3627	0.641
NULL	Indian_J_Endocrinol_Metab_2012_May-Jun_16(3)_343-348.nxml.txt.nlp	22629497	SENT28	33	33	31	31	teriparatide	PTH	PA451620	5741	0.641
NULL	Clin_Psychopharmacol_Neurosci_2012_Aug_31_10(2)_78-87.nxml.txt.nlp	23430971	SENT34	25	25	18	18	risperidone	FES	PA451257	2242	0.641
NULL	J_Oncol_2012_Dec_7_2012_192464.nxml.txt.nlp	22187555	SENT402	0	0	3	3	genistein	SFN	PA165109660	25996;2810	0.641
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT84	12	12	19	19	curcumin	TRAIL	PA151958596	8743	0.641
NULL	Nat_Med_2013_Apr_17_19(4)_437-445.nxml.txt.nlp	23502961	SENT173	14	14	18	18	clodronate	EPO	PA10239	7076;8288;2056	0.641
NULL	Eur_J_Endocrinol_2014_Mar_170(3)_451-459.nxml.txt.nlp	24362411	SENT202	3	3	10	10	exenatide	GLP1	PA164749238	100125288;2641	0.641
NULL	Br_J_Cancer_2009_Nov_3_101(9)_1620-1629.nxml.txt.nlp	19809428	SENT3	25	25	21	21	geldanamycin	Hsp90	PA152031327	3320	0.641
NULL	Eur_J_Med_Res_2011_May_12_16(5)_197-205.nxml.txt.nlp	21719392	SENT137	8	8	6	6	foscarnet	IL-2	PA449706	3558	0.641
NULL	Cancer_Manag_Res_2013_Jun_27_5_133-146.nxml.txt.nlp	23869177	SENT126	21	21	8	8	everolimus	EGFR	PA164746311	1956	0.641
NULL	Eur_J_Clin_Microbiol_Infect_Dis_2010_May_13_29(5)_543-550.nxml.txt.nlp	20229224	SENT73	21	21	47	47	clindamycin	VAN	PA449035	10318	0.641
NULL	New_Microbes_New_Infect_2014_May_4_2(3)_58-63.nxml.txt.nlp	25356345	SENT100	18	18	24	24	cefepime	ANK	PA164754876	56172	0.641
NULL	Drugs_Aging_2012_Nov_5_29(11)_863-869.nxml.txt.nlp	23038608	SENT129	14	14	23	23	capsaicin	NNT	PA448776	23530	0.641
NULL	Cardiovasc_Diabetol_2011_Dec_22_10_115.nxml.txt.nlp	22189184	SENT96	5	5	11	11	miglitol	GLP-1	PA164776726	100125288	0.641
NULL	Adolesc_Health_Med_Ther_2010_May_27_1_21-30.nxml.txt.nlp	24600258	SENT224	21	21	8	8	ergotamine	OTC	PA164747651	5009	0.641
NULL	J_Mol_Med_(Berl)_2014_Jan_10_92(5)_497-507.nxml.txt.nlp	24408111	SENT293	5	5	2	2	rosiglitazone	gamma	PA451283	9913	0.641
NULL	J_Infect_Dis_2013_Sep_1_208(5)_801-812.nxml.txt.nlp	23766527	SENT113	8	8	4	4	lumefantrine	LUM	PA165111722	4060	0.641
NULL	Clinics_(Sao_Paulo)_2013_May_68(5)_694-701.nxml.txt.nlp	23778405	SENT41	0	0	5	5	curcumin	P-gp	PA151958596	5243	0.641
NULL	Cancer_Cell_Int_2014_Jan_14_14_4.nxml.txt.nlp	24423208	SENT60	22	22	8	8	cisplatin	IL-2	PA449014	3558	0.641
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT6	3	3	5	5	perifosine	TRAIL	PA165291471	8743	0.641
NULL	Cancer_Cell_Int_2013_Oct_11_13_97.nxml.txt.nlp	24119761	SENT192	12	12	30	30	trastuzumab	RDP	PA451743	7936	0.641
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jul_28_68(Pt_8)_o2598-o2599.nxml.txt.nlp	22905021	SENT61	12	12	40	40	ethanol	spatial	PA448073	219793	0.641
NULL	J_Obes_2011_Sep_22_2011_528401.nxml.txt.nlp	21949903	SENT133	6	6	14	14	exenatide	GLP-1	PA164749238	100125288	0.641
NULL	J_Ophthalmol_2012_Aug_27_2012_285851.nxml.txt.nlp	23050121	SENT126	22	22	12	12	timolol	BAK	PA451690	578	0.641
NULL	Cancer_Res_Treat_2014_Jan_15_46(1)_33-40.nxml.txt.nlp	24520221	SENT66	33	33	22	22	mitoxantrone	CHOP	PA450526	1649	0.641
NULL	J_Hematol_Oncol_2013_Jun_3_6_38.nxml.txt.nlp	23731980	SENT192	19	19	13	13	neratinib	San	PA165291472	80218	0.641
NULL	Brain_Sci_2012_Nov_7_2(4)_589-604.nxml.txt.nlp	24349762	SENT19	24	24	36	36	vasopressin	PRL	PA451858	5617	0.641
NULL	Enzyme_Res_2009_Nov_1_2010_165878.nxml.txt.nlp	21048860	SENT189	5	5	10	10	asparaginase	NAC	PA448492	22861	0.641
NULL	Biomed_Res_Int_2013_Dec_30_2013_735835.nxml.txt.nlp	24490170	SENT177	30	30	40	40	desloratadine	FEX	PA164776964	8549	0.641
NULL	Diabetes_Obes_Metab_2011_Nov_13(11)_982-989.nxml.txt.nlp	21615670	SENT26	16	16	36	36	exenatide	PPG	PA164749238	5552	0.641
NULL	Acta_Pharmacol_Sin_2011_Aug_18_32(8)_991-998.nxml.txt.nlp	21765445	SENT61	34	34	25	25	streptomycin	FBS	PA451512	64319;26269	0.641
NULL	Evid_Based_Complement_Alternat_Med_2012_Dec_13_2012_515901.nxml.txt.nlp	22194772	SENT65	0	0	16	16	fluorescein	San	PA164746009	80218	0.641
NULL	Clin_Exp_Otorhinolaryngol_2012_Sep_27_5(3)_132-138.nxml.txt.nlp	22977709	SENT191	16	16	27	27	fluorescein	P21	PA164746009	1026;9338	0.641
NULL	Drugs_R_D_2012_Mar_27_12(1)_9-14.nxml.txt.nlp	22329608	SENT49	26	26	9	9	formoterol	DPI	PA134687907	1832	0.641
NULL	Breast_Cancer_Res_2002_May_15_4(4)_133-136.nxml.txt.nlp	12100736	SENT83	11	11	5	5	estradiol	DES	PA449503	1674	0.641
NULL	Pharmaceutics_2011_Oct_12_3(4)_680-705.nxml.txt.nlp	24309303	SENT140	27	27	14	14	chloroquine	MATE1	PA448948	55244	0.641
NULL	Biosci_Rep_2014_Sep_17_34(5)_e00138.nxml.txt.nlp	25137483	SENT143	17	17	13	13	fluorescein	SNA	PA164746009	6615	0.641
NULL	BMJ_2010_Feb_8_340_c693.nxml.txt.nlp	20142325	SENT260	4	4	11	11	fluoxetine	CYP2D6	PA449673	1565	0.641
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT167	22	22	24	24	rosiglitazone	CD36	PA451283	948	0.641
NULL	Eur_J_Pediatr_2012_Sep_7_171(9)_1285-1300.nxml.txt.nlp	21898032	SENT102	3	3	18	18	vasopressin	EGFR	PA451858	1956	0.641
NULL	Genetics_2013_Mar_193(3)_853-864.nxml.txt.nlp	23267056	SENT110	16	16	3	3	hydroxyurea	GPN2	PA449942	54707	0.641
NULL	Oncotarget_2013_Aug_30_4(10)_1698-1711.nxml.txt.nlp	24091605	SENT86	0	0	7	7	gefitinib	EGFR	PA131301952	1956	0.641
NULL	Oncotarget_2013_Jul_15_4(8)_1230-1240.nxml.txt.nlp	23985559	SENT213	21	21	5	5	bortezomib	CD138	PA10252	6382	0.641
NULL	Acta_Pharmacol_Sin_2014_Oct_25_35(10)_1293-1301.nxml.txt.nlp	25152022	SENT179	2	2	7	7	enalapril	NLRP3	PA449456	114548	0.641
NULL	Clin_Interv_Aging_2015_Jan_6_10_157-174.nxml.txt.nlp	25609933	SENT251	30	30	24	24	tamoxifen	IMPACT	PA451581	55364	0.641
NULL	Channels_(Austin)_2010_Jan_1_4(1)_22-41.nxml.txt.nlp	19934650	SENT39	11	11	8	8	quinidine	Slo3	PA451209	157855	0.641
NULL	Emerg_Microbes_Infect_2014_Mar_12_3(3)_e19.nxml.txt.nlp	NULL	SENT89	8	8	6	6	moxifloxacin	MOX	PA450555	26002	0.641
NULL	Acta_Pharmacol_Sin_2012_Mar_27_33(3)_342-350.nxml.txt.nlp	22367283	SENT196	3	3	15	15	thrombin	RhoA	PA451674	387	0.641
NULL	Indian_J_Pharm_Sci_2013_Nov-Dec_75(6)_726-729.nxml.txt.nlp	24591749	SENT35	6	6	1	1	griseofulvin	FOR	PA449814	51741	0.641
NULL	J_Hematol_Oncol_2011_Jan_21_4_5.nxml.txt.nlp	21255411	SENT150	20	20	22	22	paclitaxel	EGFR	PA450761	1956	0.641
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT205	21	21	12	12	simvastatin	AKT	PA451363	207	0.641
NULL	Eur_J_Clin_Pharmacol_2012_Sep_15_68(9)_1267-1274.nxml.txt.nlp	22418828	SENT30	7	7	5	5	pantoprazole	CYP2C19	PA450774	1557	0.641
NULL	Br_J_Cancer_1998_Apr_77(8)_1311-1317.nxml.txt.nlp	9579838	SENT30	21	21	32	32	tamoxifen	IL-2	PA451581	3558	0.641
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2012_Jan_1_68(Pt_1)_82-92.nxml.txt.nlp	22194336	SENT29	22	22	12	12	l-alanine	PLP	PA448055	25824;5744	0.641
NULL	Indian_J_Endocrinol_Metab_2013_May-Jun_17(3)_413-421.nxml.txt.nlp	23869296	SENT6	30	30	28	28	liraglutide	GLP-1	PA165958364	100125288	0.641
NULL	EMBO_Mol_Med_2011_May_3(5)_266-278.nxml.txt.nlp	21438154	SENT178	10	10	2	2	oxaliplatin	HCN	PA131285527	378938	0.641
NULL	Mol_Cancer_2014_Jul_17_13_174.nxml.txt.nlp	25033833	SENT75	20	20	4	4	paclitaxel	SFRP1	PA450761	6422	0.641
NULL	Int_J_Fertil_Steril_2014_Jul_8_Jul-Sep_8(2)_119-128.nxml.txt.nlp	25083175	SENT8	6	6	8	8	metformin	MTF	PA450395	4500	0.641
NULL	Braz_J_Med_Biol_Res_2013_Aug_13_46(8)_650-658.nxml.txt.nlp	23969971	SENT131	2	2	9	9	oxaliplatin	STAT3	PA131285527	6774	0.641
NULL	Chromatographia_2014_Jun_1_77(13-14)_941-950.nxml.txt.nlp	25067847	SENT190	19	19	4	4	ethanol	zeta	PA448073	9907	0.641
NULL	Clin_Pharmacokinet_2014_Jul_24_53(1)_73-87.nxml.txt.nlp	23881596	SENT240	11	11	25	25	rosuvastatin	OATP1B1	PA134308647	10599	0.641
NULL	Breast_Cancer_Res_2012_Feb_7_14(1)_R23.nxml.txt.nlp	22314082	SENT330	35	35	38	38	hyaluronan	LYVE-1	PA165958431	10894	0.641
NULL	Braz_J_Microbiol_2011_Dec_1_Oct-Dec_42(4)_1434-1436.nxml.txt.nlp	24031774	SENT34	26	26	20	20	amikacin	TOB	PA164744372	10140	0.641
NULL	Front_Neurosci_2013_Feb_13_7_13.nxml.txt.nlp	23407595	SENT136	26	26	15	15	estradiol	ACTH	PA449503	5443	0.641
NULL	Iran_J_Neurol_2014_Apr_3_13(2)_108-109.nxml.txt.nlp	25295156	SENT15	34	34	17	17	creatine	AGAT	PA164778930	2628	0.641
NULL	Mol_Vis_2007_Jul_9_13_1083-1093.nxml.txt.nlp	17653053	SENT152	0	0	16	16	minocycline	MCP-3	PA450519	6354	0.641
NULL	Oncoimmunology_2012_Oct_1_1(7)_1004-1016.nxml.txt.nlp	23170249	SENT5	15	15	6	6	paclitaxel	HER-2	PA450761	2064	0.641
NULL	Diabetes_Care_2010_Apr_12_33(4)_861-868.nxml.txt.nlp	20067962	SENT133	34	34	23	23	hyaluronan	TLR4	PA165958431	7099	0.641
NULL	Ann_Lab_Med_2013_Sep_8_33(5)_383-385.nxml.txt.nlp	24003434	SENT83	30	30	6	6	imipenem	CTX	PA449968	1593	0.641
NULL	Neural_Develop_2008_Jun_23_3_15.nxml.txt.nlp	18573216	SENT251	9	9	27	27	paraformaldehyde	MAP2	PA450790	4133;10988	0.641
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Mar_25_65(Pt_4)_o836.nxml.txt.nlp	21582555	SENT63	33	33	18	18	ethanol	mol	PA448073	90527	0.641
NULL	J_Biomed_Biotechnol_2010_Nov_1_2010_617521.nxml.txt.nlp	19888437	SENT85	12	12	8	8	lovastatin	MRP1	PA450272	4437	0.641
NULL	Curr_Genomics_2014_Feb_15(1)_52-65.nxml.txt.nlp	24653663	SENT547	2	2	12	12	estradiol	TLR9	PA449503	54106	0.641
NULL	J_Vet_Med_Sci_2014_Jul_18_76(7)_937-945.nxml.txt.nlp	24646457	SENT123	2	2	40	40	ampicillin	OTC	PA448419	5009	0.64
NULL	J_Breast_Cancer_2012_Dec_31_15(4)_388-392.nxml.txt.nlp	23346166	SENT44	3	3	16	16	fluorescein	CD24	PA164746009	100133941	0.64
NULL	J_Vet_Med_Sci_2014_Jan_4_76(1)_113-117.nxml.txt.nlp	24004933	SENT37	25	25	28	28	sevoflurane	BAR	PA451341	154;51283	0.64
NULL	Nano_Rev_2010_Feb_22_1_10_3402_nano_v1i0_4883.nxml.txt.nlp	22110854	SENT221	23	23	27	27	iron	CD34	PA450087	947	0.64
NULL	BMB_Rep_2013_Mar_46(3)_157-162.nxml.txt.nlp	23527859	SENT111	16	16	8	8	galactose	mol	PA449725	90527	0.64
NULL	Br_J_Cancer_2014_Nov_25_111(11)_2091-2102.nxml.txt.nlp	25349971	SENT313	5	5	2	2	imatinib	PTPN18	PA10804	26469	0.64
NULL	J_Invest_Dermatol_2012_Dec_12_132(12)_2828-2837.nxml.txt.nlp	22785133	SENT170	17	17	5	5	hydrocortisone	EGF	PA449905	1950	0.64
NULL	Front_Immunol_2013_Sep_17_4_281.nxml.txt.nlp	24062747	SENT389	12	12	39	39	atorvastatin	STAT1	PA448500	6772	0.64
NULL	Crit_Care_2008_Mar_13_12(Suppl_2)_P438.nxml.txt.nlp	NULL	SENT2	1	1	3	3	vasopressin	AVP	PA451858	114548;551	0.64
NULL	Front_Microbiol_2015_Jan_6_5_751.nxml.txt.nlp	25610435	SENT34	21	21	19	19	cyanocobalamin	B12	PA451892	7126;4709	0.64
NULL	Acta_Pharmacol_Sin_2011_Oct_15_32(10)_1233-1238.nxml.txt.nlp	21841815	SENT105	4	4	10	10	mecamylamine	CTX	PA450334	1593	0.64
NULL	Braz_J_Med_Biol_Res_2013_Mar_15_46(3)_299-305.nxml.txt.nlp	23532269	SENT183	7	7	30	30	propofol	TLR4	PA451141	7099	0.64
NULL	Mol_Vis_2012_Nov_29_18_2839-2846.nxml.txt.nlp	23233786	SENT120	7	7	12	12	geldanamycin	Hsp90	PA152031327	3320	0.64
NULL	Cell_Biol_Int_Rep_(2010)_2012_Jun_21_19(1)_e00017.nxml.txt.nlp	23124518	SENT111	11	11	8	8	etoposide	TRAIL	PA449552	8743	0.64
NULL	Eur_J_Epidemiol_2009_Sep_2_24(9)_553-572.nxml.txt.nlp	19728115	SENT1556	15	15	34	34	coumarin	PAGM	PA134521193	5238	0.64
NULL	Cardiovasc_Ther_2009_27(4)_259-274.nxml.txt.nlp	19604248	SENT162	18	18	8	8	ticagrelor	ADP	PA165374673	23038	0.64
NULL	Ann_Dermatol_2011_Dec_27_23(Suppl_3)_S360-S363.nxml.txt.nlp	22346278	SENT19	21	21	29	29	imatinib	CML	PA10804	613	0.64
NULL	J_Gen_Physiol_2009_Jun_133(6)_623-625.nxml.txt.nlp	19468076	SENT150	1	1	4	4	caffeine	TRPA1	PA448710	8989	0.64
NULL	Int_J_Trichology_2014_Apr-Jun_6(2)_50-53.nxml.txt.nlp	25191037	SENT45	2	2	4	4	sugar	FBS	PA451529	64319;26269	0.64
NULL	Mol_Cancer_2009_Nov_24_8_109.nxml.txt.nlp	19930708	SENT154	14	14	16	16	exemestane	aromatase	PA449563	1588	0.64
NULL	ScientificWorldJournal_2014_Mar_12_2014_731462.nxml.txt.nlp	24715817	SENT133	7	7	24	24	carrageenan	IL-6	PA448814	3569	0.64
NULL	Mar_Drugs_2014_Dec_18_12(12)_6125-6141.nxml.txt.nlp	25528957	SENT388	0	0	6	6	curcumin	HO-1	PA151958596	3162	0.64
NULL	Oncol_Rep_2014_Apr_28_31(4)_1605-1612.nxml.txt.nlp	24481648	SENT39	3	3	16	16	ponatinib	MRP1	PA165980594	4437	0.64
NULL	J_Gen_Physiol_1947_Mar_20_30(4)_355-365.nxml.txt.nlp	19873500	SENT0	15	15	1	1	galactose	Gen	PA449725	348654	0.64
NULL	Front_Endocrinol_(Lausanne)_2013_Jul_3_4_79.nxml.txt.nlp	23840193	SENT122	15	15	21	21	estradiol	Pref-1	PA449503	8788	0.64
NULL	Case_Rep_Endocrinol_2011_Oct_9_2011_584930.nxml.txt.nlp	22937287	SENT31	16	16	24	24	thyroglobulin	TPO	PA164754910	7066;7173	0.64
NULL	Interdiscip_Perspect_Infect_Dis_2014_May_7_2014_849432.nxml.txt.nlp	24895495	SENT54	22	22	35	35	ritonavir	CD4	PA451260	920	0.64
NULL	Hum_Genomics_Proteomics_2010_Sep_13_2010_754919.nxml.txt.nlp	20981234	SENT38	17	17	12	12	warfarin	CYP2C9	PA451906	1559	0.64
NULL	Diabetes_Metab_J_2012_Oct_18_36(5)_328-335.nxml.txt.nlp	23130316	SENT8	14	14	20	20	rosiglitazone	PDK4	PA451283	5166	0.64
NULL	J_Korean_Med_Sci_2005_Jun_30_20(3)_456-460.nxml.txt.nlp	15953869	SENT13	2	2	4	4	lipase	HSL	PA450239	3991	0.64
NULL	Indian_J_Pharm_Sci_2008_Mar-Apr_70(2)_208-215.nxml.txt.nlp	20046714	SENT45	10	10	14	14	guanidine	mol	PA164781028	90527	0.64
NULL	Ann_Lab_Med_2012_Jul_20_32(4)_298-303.nxml.txt.nlp	22779073	SENT117	8	8	10	10	rifampin	EMB	PA451250	133418	0.64
NULL	Front_Neurol_2014_Sep_11_5_173.nxml.txt.nlp	25309501	SENT289	26	26	13	13	hyaluronidase	HYAL2	PA164745713	8692	0.64
NULL	J_Inherit_Metab_Dis_2012_May_2_35(3)_399-405.nxml.txt.nlp	22134542	SENT35	18	18	28	28	thyroglobulin	PMM2	PA164754910	5373	0.64
NULL	J_Antimicrob_Chemother_2012_Feb_17_67(2)_404-414.nxml.txt.nlp	22101217	SENT180	14	14	12	12	ethambutol	EMB	PA164784021	133418	0.64
NULL	Cells_2014_Jun_11_3(2)_616-626.nxml.txt.nlp	24921186	SENT62	40	40	45	45	capsaicin	TRPV1	PA448776	7442	0.64
NULL	Braz_J_Med_Biol_Res_2013_Mar_15_46(3)_299-305.nxml.txt.nlp	23532269	SENT175	12	12	35	35	propofol	TLR4	PA451141	7099	0.64
NULL	Sensors_(Basel)_2013_Aug_13_13(8)_10539-10549.nxml.txt.nlp	23945741	SENT220	7	7	1	1	ethanol	NIR	PA448073	26155	0.64
NULL	Clin_Interv_Aging_2013_Apr_29_8_467-483.nxml.txt.nlp	23766636	SENT189	8	8	3	3	ranibizumab	CRT	PA164746012	811	0.64
NULL	Lab_Anim_Res_2014_Dec_24_30(4)_143-150.nxml.txt.nlp	25628724	SENT78	4	4	9	9	genistein	TRAMP	PA165109660	8718;23471;9189	0.64
NULL	Front_Behav_Neurosci_2013_Apr_17_7_29.nxml.txt.nlp	23616753	SENT117	18	18	12	12	ethanol	CO2	PA448073	4513	0.64
NULL	Springerplus_2014_Sep_11_3_516.nxml.txt.nlp	25279308	SENT155	17	17	25	25	ethanol	CS-1	PA448073	6744;51778	0.64
NULL	J_Biol_Chem_2012_Apr_13_287(16)_12952-12965.nxml.txt.nlp	22371491	SENT63	18	18	12	12	terazosin	MCP-1	PA451612	6347	0.64
NULL	Springerplus_2013_Dec_6_2_658.nxml.txt.nlp	24349960	SENT88	8	8	4	4	heparin	OPG	PA449855	690	0.64
NULL	Int_J_Biomed_Sci_2014_Sep_10(3)_146-157.nxml.txt.nlp	25324695	SENT6	36	36	11	11	hyaluronan	LFA-1	PA165958431	3683;3689	0.64
NULL	J_Lipid_Res_2014_Oct_55(10)_2103-2112.nxml.txt.nlp	25139399	SENT51	4	4	6	6	atorvastatin	APOE	PA448500	348	0.64
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Nov_4_9_31.nxml.txt.nlp	21050425	SENT126	4	4	11	11	erythromycin	Gen	PA449493	348654	0.64
NULL	Aging_(Albany_NY)_2010_Dec_31_2(12)_924-935.nxml.txt.nlp	21212465	SENT73	0	0	2	2	etoposide	p53	PA449552	7157	0.64
NULL	CNS_Neurosci_Ther_2010_Oct_16(5)_e138-e156.nxml.txt.nlp	20626426	SENT97	5	5	9	9	vasopressin	ACTH	PA451858	5443	0.64
NULL	Br_J_Cancer_2013_Oct_15_109(8)_2096-2105.nxml.txt.nlp	24064970	SENT35	28	28	20	20	cisplatin	ERCC1	PA449014	2067	0.64
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_75-89.nxml.txt.nlp	17912638	SENT377	26	26	7	7	tamoxifen	ATAC	PA451581	6375	0.64
NULL	Curr_Neuropharmacol_2014_Jul_12(4)_342-352.nxml.txt.nlp	25342942	SENT264	17	17	25	25	ethanol	CCL2	PA448073	6347	0.64
NULL	Iran_J_Basic_Med_Sci_2012_May-Jun_15(3)_820-832.nxml.txt.nlp	23493157	SENT204	37	37	5	5	itraconazole	SP1	PA450132	6667	0.64
NULL	Mol_Cancer_2012_Jul_29_11_48.nxml.txt.nlp	22839996	SENT76	14	14	22	22	cyclophosphamide	DDP	PA449165	1678	0.64
NULL	Biosci_Rep_2014_Sep_17_34(5)_e00138.nxml.txt.nlp	25137483	SENT143	17	17	28	28	fluorescein	MPL	PA164746009	4352	0.64
NULL	Emerg_Infect_Dis_2012_Jun_18(6)_1019-1020.nxml.txt.nlp	22608263	SENT34	14	14	36	36	amikacin	NXN	PA164744372	64359	0.64
NULL	Clin_Pharmacokinet_2014_Jul_24_53(1)_73-87.nxml.txt.nlp	23881596	SENT31	8	8	14	14	rosuvastatin	OATP2B1	PA134308647	11309	0.64
NULL	J_Exp_Clin_Cancer_Res_2009_Aug_26_28(1)_119.nxml.txt.nlp	19709417	SENT52	9	9	28	28	vincristine	CTX	PA451879	1593	0.64
NULL	Evid_Based_Complement_Alternat_Med_2015_Jan_6_2015_736431.nxml.txt.nlp	25632290	SENT251	0	0	13	13	saquinavir	CD4	PA451305	920	0.64
NULL	Diabetes_2011_Mar_21_60(3)_757-765.nxml.txt.nlp	21282370	SENT23	16	16	18	18	lipase	HSL	PA450239	3991	0.64
NULL	Oncotarget_2014_Mar_15_5(8)_2096-2106.nxml.txt.nlp	24758762	SENT20	16	16	4	4	galactose	C1GALT1	PA449725	56913	0.64
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Jan_10_6_1-13.nxml.txt.nlp	24648765	SENT57	16	16	33	33	trastuzumab	HER2	PA451743	2064	0.64
NULL	Comp_Hepatol_2010_Feb_18_9_4.nxml.txt.nlp	20167095	SENT31	13	13	6	6	heparin	glypican	PA449855	2817	0.64
NULL	Br_J_Cancer_2000_Jul_24_83(4)_544-549.nxml.txt.nlp	10945505	SENT1	26	26	11	11	docetaxel	MAP2	PA449383	4133;10988	0.64
NULL	Cancer_Metab_2013_Jan_23_1_3.nxml.txt.nlp	24280005	SENT396	17	17	20	20	doxycycline	U87	PA449415	677775;641648	0.64
NULL	Front_Neural_Circuits_2013_Oct_2_7_155.nxml.txt.nlp	24106462	SENT138	20	20	11	11	haloperidol	gamma	PA449841	9913	0.64
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jun_24_65(Pt_7)_o1668.nxml.txt.nlp	21582928	SENT60	13	13	9	9	ethanol	mol	PA448073	90527	0.64
NULL	Int_J_Trop_Dis_Health_2014_4(5)_582-594.nxml.txt.nlp	25414840	SENT171	26	26	14	14	praziquantel	IPT	PA164764583	54802	0.64
NULL	Front_Neurol_2014_Apr_29_5_63.nxml.txt.nlp	24808888	SENT567	28	28	22	22	oxcarbazepine	ghrelin	PA450732	51738	0.64
NULL	Clin_Ophthalmol_2014_Jun_26_8_1213-1219.nxml.txt.nlp	25061267	SENT178	16	16	9	9	proparacaine	PRK	PA164776849	1263	0.64
NULL	Acta_Naturae_2011_Oct-Dec_3(4)_12-29.nxml.txt.nlp	22649701	SENT323	13	13	9	9	doxorubicin	A10	PA449412	28870	0.64
NULL	Br_J_Cancer_1988_Jul_58(1)_42-45.nxml.txt.nlp	3166892	SENT10	43	43	24	24	mitomycin	MTR	PA450524	4548	0.64
NULL	Leukemia_2013_Apr_14_27(4)_803-812.nxml.txt.nlp	23238589	SENT88	3	3	16	16	imatinib	IFN	PA10804	3439	0.64
NULL	J_Cell_Mol_Med_2014_Apr_20_18(4)_709-720.nxml.txt.nlp	24444314	SENT36	13	13	7	7	metformin	AMPK	PA450395	5563	0.64
NULL	Int_J_Mol_Sci_2013_Apr_29_14(5)_9487-9496.nxml.txt.nlp	23629677	SENT107	0	0	9	9	celecoxib	Mcl-1	PA448871	4170	0.64
NULL	Br_J_Cancer_2010_Feb_16_102(4)_658-664.nxml.txt.nlp	20104222	SENT98	2	2	11	11	sunitinib	IFN	PA162372840	3439	0.64
NULL	Br_J_Cancer_2012_Sep_4_107(6)_977-987.nxml.txt.nlp	22892389	SENT102	0	0	6	6	orlistat	VEGFA	PA164776864	7422	0.64
NULL	J_Breast_Cancer_2013_Jun_28_16(2)_164-170.nxml.txt.nlp	23843848	SENT12	22	22	33	33	doxorubicin	PTEN	PA449412	5728	0.64
NULL	Cancers_(Basel)_2014_Apr_9_6(2)_829-859.nxml.txt.nlp	24722453	SENT219	3	3	9	9	paclitaxel	STAT3	PA450761	6774	0.64
NULL	Aging_Cell_2009_Apr_8(2)_113-127.nxml.txt.nlp	19239417	SENT314	3	3	16	16	metformin	HER-2	PA450395	2064	0.64
NULL	Curr_Cardiol_Rev_2009_May_5(2)_125-132.nxml.txt.nlp	20436853	SENT20	15	15	3	3	clopidogrel	ADP	PA449053	23038	0.64
NULL	Oncotarget_2013_Dec_18_5(3)_634-648.nxml.txt.nlp	24504138	SENT189	18	18	8	8	bortezomib	IL-6	PA10252	3569	0.64
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jul_10_68(Pt_8)_o2402-o2403.nxml.txt.nlp	22904859	SENT72	27	27	23	23	ethanol	mol	PA448073	90527	0.64
NULL	Arthritis_Res_Ther_2011_Feb_16_13(1)_R25.nxml.txt.nlp	21324169	SENT150	26	26	18	18	infliximab	TNF	PA452639	7124	0.64
NULL	Front_Endocrinol_(Lausanne)_2014_Feb_28_5_23.nxml.txt.nlp	24592256	SENT112	7	7	4	4	vasopressin	ANG	PA451858	283	0.64
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Apr_7_9_12.nxml.txt.nlp	20374640	SENT83	21	21	23	23	ciprofloxacin	CHL	PA449009	91851	0.64
NULL	Cancer_Imaging_2008_Nov_25_8(1)_206-215.nxml.txt.nlp	19028613	SENT145	23	23	30	30	trastuzumab	NIR	PA451743	26155	0.64
NULL	Breast_Cancer_Res_2009_Nov_18_11(6)_R85.nxml.txt.nlp	19922614	SENT103	35	35	8	8	tamoxifen	BCS	PA451581	617	0.64
NULL	Cancer_Immunol_Immunother_2012_Jul_23_61(7)_1101-1111.nxml.txt.nlp	22193989	SENT166	13	13	15	15	oxaliplatin	IL-4	PA131285527	3565	0.64
NULL	J_Cell_Biol_2000_Dec_11_151(6)_1281-1294.nxml.txt.nlp	11121442	SENT208	17	17	3	3	glutaraldehyde	CCR5	PA449777	1234	0.64
NULL	Oxid_Med_Cell_Longev_2012_Jul_5_2012_718976.nxml.txt.nlp	22829960	SENT90	1	1	3	3	vasopressin	AVP	PA451858	114548;551	0.64
NULL	Acta_Physiol_(Oxf)_2007_Sep_191(1)_43-57.nxml.txt.nlp	17524066	SENT227	31	31	46	46	nifedipine	PES	PA450631	23481	0.64
NULL	Breast_Cancer_Res_2006_Nov_6_8(6)_215.nxml.txt.nlp	17096862	SENT93	0	0	5	5	pertuzumab	HER2		2064	0.64
NULL	Acta_Pharmacol_Sin_2010_Oct_27_31(10)_1389-1394.nxml.txt.nlp	20871620	SENT178	9	9	18	18	carbachol	JNK	PA448784	5599	0.64
NULL	Diabetologia_2009_Sep_17_52(9)_1866-1870.nxml.txt.nlp	19533084	SENT0	23	23	17	17	glucose	G6PC2	PA449773	57818	0.64
NULL	Front_Immunol_2013_Nov_7_4_360.nxml.txt.nlp	24223576	SENT190	0	0	3	3	imiquimod	IRF5	PA449972	3663	0.64
NULL	Clin_Dev_Immunol_2013_Sep_17_2013_791262.nxml.txt.nlp	24151519	SENT202	0	0	12	12	heparin	TLR7	PA449855	51284	0.64
NULL	Biosci_Rep_2012_Apr_1_32(Pt_2)_105-112.nxml.txt.nlp	22115362	SENT557	32	32	17	17	collagenase	c-Jun	PA449107	3725	0.64
NULL	Breast_Cancer_Res_Treat_2014_Apr_6_145(1)_33-44.nxml.txt.nlp	24706169	SENT2	27	27	7	7	trastuzumab	HER2	PA451743	2064	0.64
NULL	Breast_Cancer_Res_2008_Jan_25_10(1)_101.nxml.txt.nlp	18226190	SENT41	0	0	12	12	denosumab	OPG	PA166048634	690	0.64
NULL	Cardiol_Res_Pract_2011_Aug_15_2011_156146.nxml.txt.nlp	21876822	SENT195	31	31	26	26	potassium	KIR	PA451047	2669	0.64
NULL	Arthritis_Res_Ther_2005_Mar_16_7(Suppl_2)_S21-S25.nxml.txt.nlp	15833145	SENT59	27	27	9	9	abatacept	ACR	PA164747080	49	0.64
NULL	Cell_Death_Dis_2010_Nov_18_1(11)_e102.nxml.txt.nlp	21368867	SENT292	15	15	0	0	gentamicin	CLIMP-63	PA449753	10970	0.64
NULL	Cancers_(Basel)_2011_May_24_3(2)_2478-2500.nxml.txt.nlp	24212820	SENT127	3	3	9	9	metformin	REDD1	PA450395	54541	0.64
NULL	Cancer_Cell_Int_2010_Sep_1_10_30.nxml.txt.nlp	20809984	SENT19	2	2	14	14	estradiol	EGF	PA449503	1950	0.64
NULL	BMB_Rep_2013_Jan_46(1)_59-64.nxml.txt.nlp	23351386	SENT61	19	19	21	21	auranofin	STAT3	PA448510	6774	0.64
NULL	Clin_Drug_Investig_2014_Nov_9_34(2)_107-115.nxml.txt.nlp	24214232	SENT37	25	25	12	12	cinacalcet	IMPACT	PA164776671	55364	0.64
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R91.nxml.txt.nlp	22541814	SENT229	9	9	14	14	thrombin	HO-1	PA451674	3162	0.64
NULL	Mol_Syst_Biol_2010_Apr_13_6_359.nxml.txt.nlp	20393579	SENT183	22	22	14	14	cyclosporine	NFAT1	PA449167	4773	0.64
NULL	Stroke_Res_Treat_2009_Dec_20_2010_386389.nxml.txt.nlp	20700422	SENT188	13	13	24	24	resveratrol	MCP-1		6347	0.64
NULL	Cardiol_Ther_2013_Jun_1_2(1)_111-124.nxml.txt.nlp	25135294	SENT108	31	31	23	23	dabigatran	P-gp		5243	0.64
NULL	Pancreas_2014_Oct_12_43(7)_1060-1065.nxml.txt.nlp	25121413	SENT128	18	18	20	20	erlotinib	EGFR	PA134687924	1956	0.64
NULL	Cancers_(Basel)_2010_May_11_2(2)_842-858.nxml.txt.nlp	24281097	SENT163	17	17	25	25	thrombin	PAR-1	PA451674	2011;2149	0.64
NULL	Eur_J_Pediatr_2012_Feb_17_171(2)_207-214.nxml.txt.nlp	21922352	SENT47	5	5	9	9	thrombin	FVIII	PA451674	2157	0.64
NULL	Curr_Chem_Genomics_2008_Feb_25_1_34-42.nxml.txt.nlp	20161826	SENT31	25	25	15	15	fluorescein	AMPK	PA164746009	5563	0.64
NULL	Eur_J_Endocrinol_2011_Jan_164(1)_69-74.nxml.txt.nlp	20961967	SENT33	23	23	11	11	metformin	OPG	PA450395	690	0.64
NULL	Mol_Imaging_Biol_2010_Oct_1_12(5)_539-546.nxml.txt.nlp	19949980	SENT73	5	5	3	3	aldesleukin	IL2	PA448081	3558	0.64
NULL	Eur_J_Clin_Pharmacol_2007_Apr_21_63(4)_335-343.nxml.txt.nlp	17318526	SENT23	25	25	6	6	acenocoumarol	CYP2C9	PA452632	1559	0.64
NULL	J_Antimicrob_Chemother_2010_Mar_18_65(3)_390-398.nxml.txt.nlp	20022938	SENT31	26	26	24	24	atovaquone	ATV	PA448502	4683	0.64
NULL	Environ_Health_Perspect_2010_Jul_3_118(7)_936-942.nxml.txt.nlp	20199942	SENT135	0	0	7	7	arsenite	p53	PA452638	7157	0.64
NULL	Virchows_Arch_2010_Sep_28_457(3)_299-307.nxml.txt.nlp	20665045	SENT226	21	21	7	7	trastuzumab	HER2	PA451743	2064	0.64
NULL	Exp_Ther_Med_2013_Mar_21_5(3)_987-991.nxml.txt.nlp	23407636	SENT10	2	2	5	5	losartan	IL-8	PA450268	3576	0.64
NULL	Br_J_Anaesth_2014_Jul_22_113(1)_157-167.nxml.txt.nlp	24154701	SENT186	14	14	6	6	sevoflurane	TREK-1	PA451341	3776	0.64
NULL	Mol_Cancer_2007_Sep_26_6_61.nxml.txt.nlp	17894897	SENT125	0	0	2	2	etoposide	p53	PA449552	7157	0.64
NULL	Environ_Microbiol_2013_Jan_15_15(1)_297-304.nxml.txt.nlp	23157680	SENT51	22	22	45	45	gentamicin	TMP	PA449753	2012	0.64
NULL	Diabetes_Metab_Syndr_Obes_2009_May_18_2_37-49.nxml.txt.nlp	20148188	SENT170	5	5	3	3	exenatide	GLP-1	PA164749238	100125288	0.64
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT98	28	28	16	16	resveratrol	TNF		7124	0.64
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT43	19	19	26	26	docetaxel	HER2	PA449383	2064	0.64
NULL	Clinics_(Sao_Paulo)_2010_Sep_65(9)_885-894.nxml.txt.nlp	21049217	SENT243	19	19	25	25	clozapine	spatial	PA449061	219793	0.64
NULL	Br_J_Cancer_2013_May_14_108(9)_1862-1869.nxml.txt.nlp	23579219	SENT109	10	10	5	5	bevacizumab	KRAS	PA130232992	3845	0.64
NULL	Cancer_Res_Treat_2012_Mar_31_44(1)_37-42.nxml.txt.nlp	22500159	SENT166	9	9	11	11	vinorelbine	GEM	PA451881	2669	0.64
NULL	Pharmaceuticals_(Basel)_2012_Jan_5_5(1)_79-93.nxml.txt.nlp	24288044	SENT191	9	9	15	15	trastuzumab	HER2	PA451743	2064	0.64
NULL	Am_J_Transplant_2013_Mar_21_13(3)_760-769.nxml.txt.nlp	23279614	SENT20	16	16	2	2	tacrolimus	OPTN	PA451578	10133	0.64
NULL	J_Oncol_2012_Aug_24_2012_281261.nxml.txt.nlp	21876693	SENT223	10	10	19	19	sunitinib	IFN	PA162372840	3439	0.64
NULL	Oxid_Med_Cell_Longev_2012_Aug_9_2012_794237.nxml.txt.nlp	22928087	SENT234	8	8	5	5	hemin	HO-1	PA449849	3162	0.64
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jul_10_68(Pt_8)_o2416-o2417.nxml.txt.nlp	22904868	SENT72	17	17	13	13	ethanol	mol	PA448073	90527	0.64
NULL	J_Antimicrob_Chemother_2011_Feb_9_66(2)_363-370.nxml.txt.nlp	21148235	SENT72	10	10	0	0	ritonavir	ATV	PA451260	4683	0.64
NULL	Indian_J_Pharmacol_2014_Nov-Dec_46(6)_627-632.nxml.txt.nlp	25538335	SENT137	7	7	5	5	metformin	Q10	PA450395	27161	0.64
NULL	Acta_Pharmacol_Sin_2012_Jan_3_33(1)_49-56.nxml.txt.nlp	22212430	SENT172	12	12	9	9	thrombin	PAR-1	PA451674	2011;2149	0.64
NULL	J_Gen_Physiol_2004_Aug_124(2)_115-124.nxml.txt.nlp	15277573	SENT309	24	24	20	20	creatine	ADP	PA164778930	23038	0.64
NULL	Br_J_Cancer_2013_Mar_5_108(4)_983-992.nxml.txt.nlp	23361057	SENT121	35	35	15	15	cytarabine	MLH1	PA449177	4292	0.64
NULL	BMB_Rep_2013_Nov_46(11)_544-549.nxml.txt.nlp	24152910	SENT79	0	0	14	14	thrombin	HMGB1	PA451674	3146	0.64
NULL	Blood_Res_2014_Sep_25_49(3)_148-153.nxml.txt.nlp	25325033	SENT60	8	8	15	15	tositumomab	B2M	PA164748364	567	0.64
NULL	Cancer_Immunol_Immunother_2015_Oct_7_64_61-73.nxml.txt.nlp	25287778	SENT193	14	14	6	6	lenalidomide	CD56	PA162363968	4684	0.64
NULL	J_Gen_Intern_Med_2009_May_21_24(5)_656-664.nxml.txt.nlp	19306050	SENT449	12	12	8	8	warfarin	CYP2C9	PA451906	1559	0.64
NULL	Oncogenesis_2012_Apr_16_1(4)_e7.nxml.txt.nlp	23552604	SENT259	4	4	6	6	etoposide	CTRL	PA449552	1506	0.64
NULL	Carcinogenesis_2014_May_13_35(5)_1055-1066.nxml.txt.nlp	24419232	SENT191	0	0	3	3	metformin	CYP1B1	PA450395	1545	0.64
NULL	Indian_J_Anaesth_2010_Mar-Apr_54(2)_127-131.nxml.txt.nlp	20661350	SENT101	20	20	11	11	nimodipine	ANOVA	PA450633	4858	0.64
NULL	Br_J_Haematol_2014_Mar_13_164(1)_811-821.nxml.txt.nlp	24328678	SENT114	8	8	2	2	thalidomide	Aiolos	PA451644	22806	0.64
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_P108.nxml.txt.nlp	NULL	SENT18	16	16	9	9	piperacillin	IL22	PA450975	50616	0.64
NULL	Ann_Rheum_Dis_2014_Jun_19_73(6)_1000-1006.nxml.txt.nlp	24553909	SENT109	7	7	5	5	ustekinumab	UST	PA166048654	10090	0.64
NULL	Pain_2014_Nov_155(11)_2306-2322.nxml.txt.nlp	25168672	SENT977	10	10	4	4	doxapram	LAM	PA164784026	7249;7248	0.64
NULL	Clin_Ophthalmol_2007_Sep_1(3)_297-303.nxml.txt.nlp	19668484	SENT121	10	10	3	3	cyclosporine	MDR1	PA449167	5243	0.64
NULL	Environ_Health_Perspect_2013_Apr_5_121(4)_459-466.nxml.txt.nlp	23384675	SENT37	18	18	0	0	trypsin	GREB1	PA451806	9687	0.64
NULL	Curr_Neuropharmacol_2009_Jun_7(2)_83-95.nxml.txt.nlp	19949566	SENT474	30	30	32	32	phenytoin	TGB	PA450947	5473	0.64
NULL	Patient_Prefer_Adherence_2013_Apr_26_7_369-377.nxml.txt.nlp	23641151	SENT193	0	0	7	7	ustekinumab	IL-23	PA166048654	51561	0.64
NULL	J_Cell_Mol_Med_2014_Oct_11_18(10)_2031-2043.nxml.txt.nlp	25109475	SENT39	12	12	29	29	valsartan	STZ	PA451848	6484	0.64
NULL	J_Lipid_Res_2013_May_54(5)_1410-1420.nxml.txt.nlp	23419260	SENT150	12	12	21	21	tetracycline	IDOL	PA451640	29116	0.64
NULL	Aging_(Albany_NY)_2009_Sep_25_1(10)_845-854.nxml.txt.nlp	20157557	SENT166	20	20	3	3	doxorubicin	p53	PA449412	7157	0.64
NULL	Nucl_Recept_Signal_2009_Dec_31_7_e012.nxml.txt.nlp	20087433	SENT194	0	0	22	22	indomethacin	IL-6	PA449982	3569	0.64
NULL	Breast_Cancer_(Auckl)_2012_Mar_7_6_67-77.nxml.txt.nlp	22438669	SENT85	20	20	22	22	trastuzumab	HER2	PA451743	2064	0.64
NULL	Cancer_Cell_Int_2014_Jan_27_14_8.nxml.txt.nlp	24467885	SENT101	6	6	2	2	fluorouracil	IFN	PA128406956	3439	0.64
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT285	33	33	28	28	nutlin-3	DR5		8795	0.64
NULL	Curr_Cardiol_Rev_2011_Aug_7(3)_163-183.nxml.txt.nlp	22758615	SENT347	0	0	2	2	vasopressin	AVP	PA451858	114548;551	0.64
NULL	Exp_Diabetes_Res_2012_Dec_26_2012_230624.nxml.txt.nlp	23365557	SENT63	2	2	29	29	liraglutide	LIR1	PA165958364	10859	0.64
NULL	Mol_Cancer_2014_Feb_5_13_24.nxml.txt.nlp	24495306	SENT250	16	16	27	27	collagenase	ADAM17	PA449107	6868	0.64
NULL	Front_Neurol_2011_Nov_21_2_68.nxml.txt.nlp	22125548	SENT499	0	0	5	5	isradipine	CA1	PA450131	759	0.64
NULL	Braz_J_Med_Biol_Res_2014_Aug_1_47(9)_789-798.nxml.txt.nlp	25098618	SENT17	8	8	5	5	phenylephrine	ANG	PA450935	283	0.64
NULL	Arthritis_Res_Ther_2004_Mar_8_6(2)_60-72.nxml.txt.nlp	15059266	SENT181	8	8	17	17	infliximab	CD31	PA452639	5175	0.64
NULL	Bone_Marrow_Res_2013_Dec_12_2013_269107.nxml.txt.nlp	24416592	SENT69	8	8	21	21	imatinib	CML	PA10804	613	0.64
NULL	Diabetes_2009_Apr_58(4)_773-795.nxml.txt.nlp	19336687	SENT744	10	10	18	18	metformin	p110	PA450395	9733	0.64
NULL	Nucleic_Acids_Res_2012_Jan_9_40(1)_181-195.nxml.txt.nlp	21908405	SENT259	2	2	16	16	bleomycin	53BP1	PA448645	7158	0.64
NULL	Korean_J_Anesthesiol_2013_Feb_15_64(2)_105-111.nxml.txt.nlp	23459312	SENT81	15	15	36	36	heparin	ACT	PA449855	12;11332;9457;641455	0.64
NULL	F1000_Biol_Rep_2009_Nov_16_1_84.nxml.txt.nlp	20948605	SENT69	14	14	17	17	doxycycline	Oct4	PA449415	5460	0.64
NULL	Hematol_Rep_2011_Jan_21_3(1)_e2.nxml.txt.nlp	22184524	SENT44	10	10	12	12	pyrazinamide	ETB	PA451182	1910	0.64
NULL	Med_Sci_Monit_2013_Nov_29_19_1080-1088.nxml.txt.nlp	24287619	SENT77	29	29	5	5	estradiol	ACL	PA449503	47	0.64
NULL	Iran_J_Pharm_Res_2014_Summer_13(3)_975-985.nxml.txt.nlp	25276199	SENT149	4	4	6	6	vasopressin	AVP	PA451858	114548;551	0.64
NULL	Cancer_Metab_2013_Jan_23_1_3.nxml.txt.nlp	24280005	SENT402	24	24	20	20	doxycycline	SREBP1	PA449415	6720	0.64
NULL	Ann_Indian_Acad_Neurol_2008_Apr-Jun_11(2)_119-122.nxml.txt.nlp	19893652	SENT124	12	12	21	21	thalidomide	BMP4	PA451644	652	0.64
NULL	Indian_J_Endocrinol_Metab_2013_Jul-Aug_17(4)_636-646.nxml.txt.nlp	23961479	SENT251	7	7	4	4	rosuvastatin	TGS	PA134308647	286826	0.64
NULL	Korean_J_Radiol_2011_Apr_25_May-Jun_12(3)_319-326.nxml.txt.nlp	21603291	SENT56	28	28	22	22	propranolol	DBP	PA451145	3295;1628;2638	0.64
NULL	F1000Prime_Rep_2013_Sep_2_5_37.nxml.txt.nlp	24049641	SENT35	34	34	42	42	tamoxifen	spatial	PA451581	219793	0.64
NULL	Diabetes_2013_Oct_17_62(10)_3404-3417.nxml.txt.nlp	23835326	SENT300	15	15	23	23	nadh	PDH	PA164755085	54704	0.64
NULL	Biomed_Res_Int_2013_Dec_23_2013_287696.nxml.txt.nlp	23509704	SENT121	39	39	18	18	ramipril	DREAM	PA451223	30818	0.64
NULL	Breast_Cancer_Res_2010_Oct_22_12(Suppl_2)_S1.nxml.txt.nlp	21050422	SENT184	10	10	26	26	neratinib	HER2	PA165291472	2064	0.64
NULL	Pain_Res_Manag_2014_Nov-Dec_19(6)_e172-e178.nxml.txt.nlp	24992453	SENT101	11	11	7	7	carrageenan	IPL	PA448814	7262	0.64
NULL	Front_Neuroenergetics_2010_Jun_18_2_11.nxml.txt.nlp	20616881	SENT316	18	18	15	15	isoflurane	CO2	PA450106	4513	0.64
NULL	Cancer_Manag_Res_2011_Aug_10_3_273-285.nxml.txt.nlp	21931501	SENT145	29	29	31	31	bevacizumab	IFN	PA130232992	3439	0.64
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT133	12	12	19	19	heparin	FGF1	PA449855	2246	0.64
NULL	Pediatr_Cardiol_2010_Jan_14_31(1)_90-95.nxml.txt.nlp	19915892	SENT152	32	32	26	26	palivizumab	Era	PA164748781	2099	0.64
NULL	Physiol_Rep_2014_Aug_28_2(8)_e12143.nxml.txt.nlp	25168879	SENT20	0	0	9	9	staurosporine	p38	PA165109623	10598;1432;7965	0.64
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_21-38.nxml.txt.nlp	19305786	SENT123	11	11	4	4	capsaicin	TRPV1	PA448776	7442	0.64
NULL	Ann_Hematol_2014_Sep_10_93(1)_1-11.nxml.txt.nlp	24018623	SENT291	9	9	13	13	lenalidomide	GFM	PA162363968	85476	0.64
NULL	Cardiovasc_Diabetol_2011_Dec_22_10_115.nxml.txt.nlp	22189184	SENT120	5	5	24	24	miglitol	GLP-1	PA164776726	100125288	0.64
NULL	J_Vet_Med_Sci_2014_Mar_1_76(3)_323-330.nxml.txt.nlp	24189582	SENT25	16	16	5	5	leflunomide	ATV	PA450192	4683	0.64
NULL	Lab_Anim_Res_2011_Sep_30_27(3)_245-250.nxml.txt.nlp	21998614	SENT83	12	12	8	8	mannitol	EPOR	PA450320	2057	0.64
NULL	Biomed_Res_Int_2013_Jan_31_2013_503047.nxml.txt.nlp	23484127	SENT232	0	0	7	7	imatinib	CD140b	PA10804	5159	0.64
NULL	Int_J_Mol_Sci_2014_Nov_7_15(11)_20500-20517.nxml.txt.nlp	25387078	SENT135	16	16	35	35	vorinostat	ADP	PA164748224	23038	0.64
NULL	J_Res_Med_Sci_2010_Nov-Dec_15(6)_348-358.nxml.txt.nlp	21526108	SENT4	5	5	30	30	thrombin	PAR-1	PA451674	2011;2149	0.64
NULL	Acta_Pharmacol_Sin_2009_Oct_21_30(10)_1392-1398.nxml.txt.nlp	19767766	SENT28	5	5	30	30	oxygen	p67	PA450744	945;10988	0.64
NULL	J_Cell_Biol_1997_Mar_10_136(5)_995-1005.nxml.txt.nlp	9060465	SENT46	0	0	7	7	chlorpromazine	TFP	PA448964	7034	0.64
NULL	Diabetes_Care_2010_Oct_13_33(10)_2250-2253.nxml.txt.nlp	20628086	SENT112	33	33	6	6	glucose	DREAM	PA449773	30818	0.64
NULL	Ther_Clin_Risk_Manag_2007_Dec_3(6)_1077-1086.nxml.txt.nlp	18516259	SENT176	8	8	6	6	lamivudine	LAM	PA450163	7249;7248	0.64
NULL	Indian_J_Palliat_Care_2010_Sep-Dec_16(3)_129-137.nxml.txt.nlp	21218002	SENT7	28	28	20	20	olanzapine	ghrelin	PA450688	51738	0.64
NULL	Int_J_Environ_Res_Public_Health_2006_Jun_30_3(2)_141-173.nxml.txt.nlp	16823088	SENT641	5	5	8	8	cisplatin	CRA	PA449014	51747;10903	0.639
NULL	Acta_Pharmacol_Sin_2012_Mar_30_33(3)_401-406.nxml.txt.nlp	22286916	SENT131	6	6	28	28	paclitaxel	DDP	PA450761	1678	0.639
NULL	J_Cell_Mol_Med_2013_Nov_9_17(11)_1484-1493.nxml.txt.nlp	24015932	SENT10	0	0	22	22	berberine	c-Myc	PA165860812	4609	0.639
NULL	J_Biomed_Opt_2013_Dec_20_18(12)_126017.nxml.txt.nlp	24362926	SENT264	9	9	6	6	proflavine	spatial	PA164748742	219793	0.639
NULL	J_Med_Chem_2014_Jan_23_57(2)_449-461.nxml.txt.nlp	24387105	SENT260	27	27	21	21	benzaldehyde	ALDH1B1	PA448571	219	0.639
NULL	Curr_Pain_Headache_Rep_2011_Aug_12_15(4)_271-279.nxml.txt.nlp	21479998	SENT161	6	6	0	0	oxycodone	CYP2D6	PA450741	1565	0.639
NULL	Ann_Lab_Med_2013_Sep_8_33(5)_383-385.nxml.txt.nlp	24003434	SENT83	34	34	6	6	meropenem	CTX	PA164764445	1593	0.639
NULL	Front_Endocrinol_(Lausanne)_2011_Dec_21_2_84.nxml.txt.nlp	22654830	SENT37	12	12	14	14	lipase	HSL	PA450239	3991	0.639
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT287	17	17	11	11	glucose	EGFR	PA449773	1956	0.639
NULL	J_Cell_Mol_Med_2014_Nov_11_18(11)_2275-2286.nxml.txt.nlp	25208472	SENT135	28	28	13	13	chloroquine	p53	PA448948	7157	0.639
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1051.nxml.txt.nlp	24503543	SENT144	16	16	27	27	sorafenib	Yes	PA7000	7525	0.639
NULL	Basic_Clin_Neurosci_2014_Winter_5(1)_66-73.nxml.txt.nlp	25436086	SENT130	19	19	5	5	lidocaine	OX1R	PA450226	3061	0.639
NULL	Mucosal_Immunol_2014_Mar_24_7(2)_335-347.nxml.txt.nlp	23881354	SENT111	2	2	6	6	atropine	AMN	PA448505	215;81693	0.639
NULL	Anticancer_Agents_Med_Chem_2010_Oct_10(8)_617-624.nxml.txt.nlp	21182469	SENT54	3	3	8	8	estradiol	ABCC11	PA449503	85320	0.639
NULL	J_Cell_Biol_2008_Jul_28_182(2)_381-393.nxml.txt.nlp	18663145	SENT358	39	39	44	44	l-glutamine	CO2	PA10090	4513	0.639
NULL	Cell_Cycle_2012_Dec_15_11(24)_4661-4672.nxml.txt.nlp	23187802	SENT101	12	12	10	10	doxorubicin	DREAM	PA449412	30818	0.639
NULL	Emerg_Infect_Dis_2005_Jun_11(6)_873-882.nxml.txt.nlp	15963282	SENT89	18	18	16	16	tobramycin	TOB	PA451704	10140	0.639
NULL	Diagn_Pathol_2014_Jan_20_9_11.nxml.txt.nlp	24443801	SENT26	15	15	11	11	trypsin	MUC6	PA451806	4588	0.639
NULL	Eur_J_Neurosci_2014_Feb_4_39(3)_419-434.nxml.txt.nlp	24494682	SENT286	4	4	6	6	lipase	MGL	PA450239	11343	0.639
NULL	Mol_Biol_Cell_2014_Jul_1_25(13)_1995-2005.nxml.txt.nlp	24807907	SENT10	19	19	10	10	guanidine	RhoA	PA164781028	387	0.639
NULL	Can_J_Infect_Dis_Med_Microbiol_2014_Sep-Oct_25(5)_271-276.nxml.txt.nlp	25371690	SENT159	10	10	15	15	voriconazole	gamma	PA10233	9913	0.639
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT191	10	10	14	14	cisplatin	p53	PA449014	7157	0.639
NULL	J_Clin_Biochem_Nutr_2010_Mar_24_46(2)_105-110.nxml.txt.nlp	20216942	SENT167	17	17	32	32	dextran	NK1	PA449261	11126	0.639
NULL	Cardiovasc_J_Afr_2008_Apr_19(2)_77-83.nxml.txt.nlp	18516352	SENT171	6	6	3	3	glucose	GLP-1	PA449773	100125288	0.639
NULL	Diabetologia_2010_Jul_2_53(7)_1270-1287.nxml.txt.nlp	20361178	SENT273	0	0	23	23	pioglitazone	adiponectin	PA450970	9370	0.639
NULL	Braz_J_Microbiol_2008_Mar_1_Jan-Mar_39(1)_16-20.nxml.txt.nlp	24031169	SENT21	23	23	25	25	ethambutol	EMB	PA164784021	133418	0.639
NULL	Neuro_Oncol_2010_Nov_20_12(11)_1167-1172.nxml.txt.nlp	20729242	SENT42	17	17	15	15	isotretinoin	CRA	PA450128	51747;10903	0.639
NULL	J_Biol_Chem_2010_Apr_23_285(17)_13285-13293.nxml.txt.nlp	20181944	SENT128	20	20	0	0	galactose	Langerin	PA449725	50489	0.639
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT64	3	3	27	27	metformin	p53	PA450395	7157	0.639
NULL	Daru_2012_Nov_30_20(1)_82.nxml.txt.nlp	23351311	SENT153	3	3	17	17	sn-38	p53		7157	0.639
NULL	J_Biol_Eng_2009_Oct_16_3_18.nxml.txt.nlp	19835592	SENT48	21	21	25	25	tetracycline	CPZ	PA451640	8532	0.639
NULL	Mol_Cancer_2014_Jan_13_13_7.nxml.txt.nlp	24418169	SENT204	5	5	21	21	sorafenib	survivin	PA7000	332	0.639
NULL	J_Physiol_2014_Nov_15_592(22)_5093-5107.nxml.txt.nlp	25239460	SENT225	20	20	18	18	sc-560	PAG		55824	0.639
NULL	Iran_J_Microbiol_2013_Mar_5(1)_48-55.nxml.txt.nlp	23466743	SENT131	40	40	14	14	aztreonam	CTX	PA448523	1593	0.639
NULL	ScientificWorldJournal_2013_Oct_1_2013_654829.nxml.txt.nlp	24198725	SENT300	9	9	21	21	naproxen	NF2	PA450595	4771	0.639
NULL	Br_J_Cancer_2014_May_27_110(11)_2716-2727.nxml.txt.nlp	24800946	SENT153	11	11	18	18	gefitinib	PI3K	PA131301952	5290	0.639
NULL	Asian_Spine_J_2014_Feb_6_8(1)_97-111.nxml.txt.nlp	24596613	SENT397	26	26	16	16	ofloxacin	EMB	PA450684	133418	0.639
NULL	Cancer_Immunol_Immunother_2011_Jun_25_60(6)_793-808.nxml.txt.nlp	21350947	SENT285	41	41	39	39	sorafenib	IFN	PA7000	3439	0.639
NULL	J_Med_Case_Reports_2011_Jun_17_5_221.nxml.txt.nlp	21682857	SENT66	0	0	4	4	bevacizumab	San	PA130232992	80218	0.639
NULL	Arthritis_Res_Ther_2009_Aug_24_11(4)_R127.nxml.txt.nlp	19703304	SENT127	14	14	18	18	adalimumab	OASIS	PA10004	90993	0.639
NULL	J_Hematol_Oncol_2012_May_17_5_24.nxml.txt.nlp	22594538	SENT149	32	32	11	11	vorinostat	p65	PA164748224	5970	0.639
NULL	Indian_J_Med_Res_2012_Sep_136(3)_391-403.nxml.txt.nlp	23041732	SENT190	12	12	19	19	sorafenib	HCC	PA7000	84668	0.639
NULL	Ann_Gen_Psychiatry_2013_Jan_24_12_1.nxml.txt.nlp	23347694	SENT149	24	24	33	33	haloperidol	MRS	PA449841	8011	0.639
NULL	Clin_Med_Insights_Case_Rep_2012_Feb_16_5_13-17.nxml.txt.nlp	22399868	SENT30	4	4	13	13	adalimumab	CD25	PA10004	3669;3559	0.639
NULL	Exp_Diabetes_Res_2012_Feb_26_2012_548732.nxml.txt.nlp	22474425	SENT85	0	0	9	9	bevacizumab	San	PA130232992	80218	0.639
NULL	Int_J_Biomed_Sci_2008_Mar_4(1)_8-13.nxml.txt.nlp	23675060	SENT56	17	17	19	19	estradiol	IL-4	PA449503	3565	0.639
NULL	J_Nat_Sci_Biol_Med_2011_Jan-Jun_2(1)_119-124.nxml.txt.nlp	22470245	SENT143	10	10	15	15	ondansetron	NNT	PA450705	23530	0.639
NULL	Oncotarget_2013_Mar_26_4(3)_397-412.nxml.txt.nlp	23651630	SENT162	10	10	14	14	lapatinib	PI3K	PA152241907	5290	0.639
NULL	Br_J_Cancer_2003_Mar_24_88(6)_848-854.nxml.txt.nlp	12644821	SENT10	13	13	19	19	cisplatin	TP53	PA449014	7157	0.639
NULL	Cell_Commun_Signal_2011_May_15_9_13.nxml.txt.nlp	21569639	SENT232	24	24	26	26	quinacrine	P-gp	PA164745551	5243	0.639
NULL	J_Immunother_Cancer_2013_Nov_7_1(Suppl_1)_P183.nxml.txt.nlp	NULL	SENT9	4	4	26	26	sorafenib	CEA	PA7000	5670;1087	0.639
NULL	Oncotarget_2013_Nov_23_5(1)_196-210.nxml.txt.nlp	24344116	SENT35	13	13	19	19	doxorubicin	p65	PA449412	5970	0.639
NULL	J_Antimicrob_Chemother_2013_May_1_68(5)_1066-1070.nxml.txt.nlp	23378414	SENT71	10	10	31	31	nafcillin	NOV	PA450576	4856;5361;6134	0.639
NULL	J_Med_Life_2011_Feb_15_4(1)_11-20.nxml.txt.nlp	21505570	SENT195	8	8	2	2	rofecoxib	COX2	PA451268	4513;5743	0.639
NULL	Front_Immunol_2012_Jan_2_2_82.nxml.txt.nlp	22566871	SENT916	0	0	5	5	rosiglitazone	fractalkine	PA451283	6376	0.639
NULL	Breast_Cancer_Res_2004_Jun_29_6(5)_R488-R498.nxml.txt.nlp	15318931	SENT129	26	26	16	16	estradiol	SULT	PA449503	6816	0.639
NULL	Exp_Diabetes_Res_2009_Jul_7_2009_910783.nxml.txt.nlp	19609456	SENT141	0	0	5	5	rosiglitazone	AMPK	PA451283	5563	0.639
NULL	Int_J_Environ_Res_Public_Health_2010_May_27_7(5)_1872-1888.nxml.txt.nlp	20622998	SENT347	1	1	25	25	ethanol	TNF-alpha	PA448073	7124	0.639
NULL	J_Biol_Chem_2008_Apr_4_283(14)_8837-8845.nxml.txt.nlp	18250166	SENT185	0	0	7	7	methotrexate	DHFR	PA450428	1719	0.639
NULL	Curr_Cardiol_Rev_2008_Nov_4(4)_275-286.nxml.txt.nlp	20066135	SENT274	0	0	21	21	losartan	p47phox	PA450268	653361	0.639
NULL	Biomed_Res_Int_2014_Feb_13_2014_309151.nxml.txt.nlp	24683546	SENT219	33	33	29	29	rosiglitazone	STZ	PA451283	6484	0.639
NULL	Nat_Commun_2011_Dec_20_2_592.nxml.txt.nlp	22186888	SENT307	27	27	25	25	amisulpride	DRD2	PA162565877	1813	0.639
NULL	Blood_Cancer_J_2013_Sep_13_3(9)_e146.nxml.txt.nlp	24036945	SENT13	23	23	27	27	ribavirin	AKT	PA451241	207	0.639
NULL	Oncogene_2010_Sep_16_29(37)_5193-5203.nxml.txt.nlp	20581867	SENT123	3	3	5	5	trastuzumab	HRG	PA451743	3084;3273	0.639
NULL	J_Asthma_Allergy_2008_Sep_19_1_19-29.nxml.txt.nlp	21436982	SENT110	15	15	26	26	fexofenadine	TARC	PA449621	6361	0.639
NULL	Behav_Sci_(Basel)_2013_Jun_7_3(2)_273-297.nxml.txt.nlp	25379239	SENT65	10	10	12	12	chlorpromazine	CPZ	PA448964	8532	0.639
NULL	Ann_Rheum_Dis_2014_Jan_5_73(1)_238-242.nxml.txt.nlp	23740234	SENT144	14	14	37	37	infliximab	IMPACT	PA452639	55364	0.639
NULL	Open_Ophthalmol_J_2012_Dec_14_6_125-128.nxml.txt.nlp	23264840	SENT18	18	18	14	14	fluorescein	FAF	PA164746009	8239;2188	0.639
NULL	Breast_Cancer_Res_2014_Sep_11_16(5)_430.nxml.txt.nlp	25212826	SENT201	21	21	31	31	fulvestrant	PTEN	PA164747170	5728	0.639
NULL	Evid_Based_Complement_Alternat_Med_2015_Jan_6_2015_736431.nxml.txt.nlp	25632290	SENT275	9	9	18	18	ritonavir	CYP3A4	PA451260	1576	0.639
NULL	Reprod_Biol_Endocrinol_2004_Jul_5_2_49.nxml.txt.nlp	15236653	SENT222	10	10	21	21	vasopressin	PGF	PA451858	5228	0.639
NULL	J_Hematol_Oncol_2008_Oct_1_1_16.nxml.txt.nlp	18828924	SENT246	11	11	30	30	pazopanib	HER2	PA165291492	2064	0.639
NULL	Int_J_Nanomedicine_2012_Oct_18_7_5475-5489.nxml.txt.nlp	23093903	SENT2	0	0	9	9	itraconazole	DPI	PA450132	1832	0.639
NULL	Int_J_Hypertens_2013_Mar_19_2013_175428.nxml.txt.nlp	23573410	SENT293	17	17	26	26	vasopressin	SON	PA451858	6651	0.639
NULL	J_Int_AIDS_Soc_2011_Feb_9_14_7.nxml.txt.nlp	21306608	SENT74	25	25	23	23	atazanavir	ATV	PA10251	4683	0.639
NULL	Ann_Lab_Med_2013_Sep_8_33(5)_349-352.nxml.txt.nlp	24003425	SENT83	31	31	29	29	ethambutol	EMB	PA164784021	133418	0.639
NULL	J_Hematol_Oncol_2009_Feb_23_2_10.nxml.txt.nlp	19236716	SENT113	12	12	6	6	dasatinib	CYP3A4	PA162372878	1576	0.639
NULL	Cancer_Res_Treat_2015_Jan_25_47(1)_115-119.nxml.txt.nlp	25152191	SENT56	7	7	12	12	vincristine	POMP	PA451879	51371;51251	0.639
NULL	Arch_Trauma_Res_2013_Aug_1_2(2)_63-70.nxml.txt.nlp	24396796	SENT232	6	6	14	14	nilotinib	JNK	PA165958345	5599	0.639
NULL	J_Infect_Dis_2014_Dec_15_210(12)_2001-2008.nxml.txt.nlp	24994911	SENT79	10	10	2	2	artemether	ACT	PA165111698	12;11332;9457;641455	0.639
NULL	Cell_Death_Differ_2010_Mar_16_17(3)_499-512.nxml.txt.nlp	19834490	SENT118	0	0	26	26	bevacizumab	Bcl-2	PA130232992	596	0.639
NULL	Cell_Cycle_2012_Dec_1_11(23)_4474-4483.nxml.txt.nlp	23159862	SENT87	2	2	12	12	cisplatin	GAPDH	PA449014	2597	0.639
NULL	Environ_Health_Perspect_1976_Dec_18_167-179.nxml.txt.nlp	1037611	SENT6	0	0	2	2	diethylstilbestrol	DES	PA449307	1674	0.639
NULL	Int_J_Endocrinol_2014_Mar_12_2014_847827.nxml.txt.nlp	24744784	SENT157	0	0	9	9	metformin	AMPK	PA450395	5563	0.639
NULL	Clin_Mol_Hepatol_2014_Jun_30_20(2)_168-176.nxml.txt.nlp	25032183	SENT156	12	12	10	10	lamivudine	LAM	PA450163	7249;7248	0.639
NULL	Case_Rep_Hematol_2014_May_14_2014_484563.nxml.txt.nlp	24955264	SENT103	20	20	15	15	cyclophosphamide	VIII	PA449165	1351	0.639
NULL	Br_J_Cancer_2004_May_4_90(9)_1710-1714.nxml.txt.nlp	15150625	SENT91	11	11	9	9	oxaliplatin	GEM	PA131285527	2669	0.639
NULL	J_Carcinog_2011_Nov_30_10_25.nxml.txt.nlp	22190867	SENT242	15	15	6	6	tamoxifen	SMRT	PA451581	9612	0.639
NULL	N_Z_Vet_J_2010_Jun_7_58(3)_121-129.nxml.txt.nlp	20514085	SENT42	30	30	36	36	ivermectin	MOX	PA450133	26002	0.639
NULL	Emerg_Infect_Dis_2012_Jun_18(6)_1019-1020.nxml.txt.nlp	22608263	SENT34	22	22	20	20	tobramycin	TOB	PA451704	10140	0.639
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT33	7	7	12	12	metformin	AMPK	PA450395	5563	0.639
NULL	New_Microbes_New_Infect_2014_May_4_2(3)_58-63.nxml.txt.nlp	25356345	SENT100	26	26	20	20	amikacin	GEM	PA164744372	2669	0.639
NULL	Arch_Gynecol_Obstet_2013_Jul_7_288(1)_41-48.nxml.txt.nlp	23389246	SENT5	35	35	12	12	heparin	APO	PA449855	84909	0.639
NULL	Cancer_Manag_Res_2011_Mar_3_3_57-64.nxml.txt.nlp	21556317	SENT120	0	0	4	4	lapatinib	HER-2	PA152241907	2064	0.639
NULL	Open_Neurol_J_2013_May_31_7_23-31.nxml.txt.nlp	23894259	SENT116	12	12	18	18	olanzapine	adiponectin	PA450688	9370	0.639
NULL	Ann_Gastroenterol_2014_27(4)_313-319.nxml.txt.nlp	25331779	SENT66	28	28	10	10	azathioprine	POR	PA448515	5447	0.639
NULL	Biomed_Res_Int_2013_Aug_6_2013_909613.nxml.txt.nlp	24027765	SENT334	36	36	33	33	metronidazole	EEN	PA450484	6455	0.639
NULL	J_Cardiothorac_Surg_2012_Sep_27_7_97.nxml.txt.nlp	23013706	SENT194	17	17	11	11	warfarin	CYP4F2	PA451906	8529	0.639
NULL	Am_J_Physiol_Endocrinol_Metab_2013_Nov_1_305(9)_E1134-E1144.nxml.txt.nlp	24022868	SENT206	4	4	16	16	rosiglitazone	FASN	PA451283	2194	0.639
NULL	Case_Rep_Oncol_Med_2013_Aug_12_2013_267389.nxml.txt.nlp	23997969	SENT62	19	19	13	13	methotrexate	CHOP	PA450428	1649	0.639
NULL	EMBO_Mol_Med_2012_Dec_15_4(12)_1276-1293.nxml.txt.nlp	23065753	SENT155	14	14	5	5	cisplatin	NLRP3	PA449014	114548	0.639
NULL	Biologics_2012_Jul_13_6_221-231.nxml.txt.nlp	22904614	SENT40	16	16	33	33	paclitaxel	EGFR	PA450761	1956	0.639
NULL	Br_J_Cancer_2001_Jan_1_84(1)_126-133.nxml.txt.nlp	11139327	SENT1	6	6	8	8	diethylstilbestrol	DES	PA449307	1674	0.639
NULL	Emerg_Microbes_Infect_2014_Mar_12_3(3)_e19.nxml.txt.nlp	NULL	SENT89	4	4	6	6	gatifloxacin	MOX	PA449738	26002	0.639
NULL	Biol_Proced_Online_2004_Jun_8_6_113-119.nxml.txt.nlp	15192754	SENT0	18	18	47	47	ethanol	San	PA448073	80218	0.639
NULL	Pharmaceuticals_(Basel)_2014_Jan_9_7(1)_46-57.nxml.txt.nlp	24451403	SENT149	39	39	29	29	ritonavir	CDK4	PA451260	1019	0.639
NULL	Exp_Ther_Med_2015_Feb_15_9(2)_384-388.nxml.txt.nlp	25574202	SENT132	31	31	24	24	pentoxifylline	HLP	PA450864	6499;9001;3002	0.639
NULL	Croat_Med_J_2012_Jun_53(3)_214-223.nxml.txt.nlp	22661134	SENT67	3	3	17	17	clonidine	ACTH	PA449051	5443	0.639
NULL	Oncol_Lett_2014_Nov_10_8(5)_2333-2339.nxml.txt.nlp	25295120	SENT8	5	5	8	8	sorafenib	ADM	PA7000	133	0.639
NULL	Exp_Ther_Med_2012_Nov_6_4(5)_949-953.nxml.txt.nlp	23226754	SENT4	25	25	27	27	ethambutol	EMB	PA164784021	133418	0.639
NULL	Cancer_Cell_Int_2013_Mar_4_13_21.nxml.txt.nlp	23497288	SENT68	10	10	12	12	doxorubicin	EWS	PA449412	2130	0.639
NULL	Vet_Res_2013_Dec_21_44(1)_124.nxml.txt.nlp	24359443	SENT82	31	31	40	40	tetracycline	CO2	PA451640	4513	0.639
NULL	Community_Ment_Health_J_2011_Apr_25_47(2)_123-135.nxml.txt.nlp	20658320	SENT366	18	18	3	3	clozapine	CAGE	PA449061	168400	0.639
NULL	J_Int_Soc_Sports_Nutr_2014_Aug_13_11_38.nxml.txt.nlp	25132809	SENT87	14	14	2	2	creatine	MSTN	PA164778930	2660	0.639
NULL	Adv_Ther_2014_Mar_18_31(4)_375-391.nxml.txt.nlp	24639005	SENT261	6	6	18	18	etanercept	TNF-alpha	PA449515	7124	0.639
NULL	Br_J_Cancer_2013_Sep_3_109(5)_1214-1222.nxml.txt.nlp	23922104	SENT168	9	9	14	14	doxorubicin	TP53	PA449412	7157	0.639
NULL	Aging_(Albany_NY)_2012_Mar_12_4(3)_146-158.nxml.txt.nlp	22436213	SENT2	14	14	18	18	resveratrol	SIRT1		23411	0.639
NULL	Clin_Dev_Immunol_2013_Nov_26_2013_325481.nxml.txt.nlp	24371447	SENT11	0	0	11	11	propofol	p47phox	PA451141	653361	0.639
NULL	J_Young_Pharm_2012_Apr-Jun_4(2)_82-87.nxml.txt.nlp	22754259	SENT45	13	13	7	7	ethanol	mol	PA448073	90527	0.639
NULL	J_Cell_Biol_1997_May_5_137(3)_609-618.nxml.txt.nlp	9151668	SENT259	20	20	7	7	thyroglobulin	API	PA164754910	5345	0.639
NULL	Chin_J_Cancer_2012_Apr_31(4)_178-184.nxml.txt.nlp	22237038	SENT36	10	10	24	24	niclosamide	S100A4	PA165958408	6275	0.639
NULL	Cancer_Cell_Int_2009_Sep_10_9_25.nxml.txt.nlp	19744341	SENT287	21	21	23	23	glucosamine	PC-3	PA164747613	692094	0.639
NULL	Ann_Surg_Treat_Res_2014_Feb_22_86(2)_68-75.nxml.txt.nlp	24761411	SENT172	1	1	14	14	resveratrol	survivin		332	0.639
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jan_11_68(Pt_2)_o314.nxml.txt.nlp	22346949	SENT58	19	19	15	15	ethanol	mol	PA448073	90527	0.639
NULL	J_Nat_Sci_Biol_Med_2012_Jul-Dec_3(2)_168-176.nxml.txt.nlp	23225980	SENT261	24	24	16	16	lipase	B12	PA450239	7126;4709	0.639
NULL	Br_J_Cancer_2012_Jul_24_107(3)_516-526.nxml.txt.nlp	22782351	SENT332	15	15	17	17	tamoxifen	TIGAR	PA451581	57103	0.639
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R91.nxml.txt.nlp	22541814	SENT146	37	37	25	25	thrombin	HO-1	PA451674	3162	0.639
NULL	Evid_Based_Complement_Alternat_Med_2012_Dec_20_2012_893426.nxml.txt.nlp	22235232	SENT64	5	5	10	10	metformin	AMPK	PA450395	5563	0.639
NULL	Crit_Care_2011_Sep_19_15(5)_R217.nxml.txt.nlp	21929764	SENT122	18	18	25	25	vasopressin	CTRL	PA451858	1506	0.639
NULL	Cell_Commun_Signal_2013_Nov_11_11_86.nxml.txt.nlp	24215724	SENT59	16	16	30	30	thrombin	PAR1	PA451674	79581;2149	0.639
NULL	Arthritis_Res_Ther_2005_Mar_16_7(Suppl_2)_S1-S3.nxml.txt.nlp	NULL	SENT17	8	8	5	5	tocilizumab	IL-6	PA165292659	3569	0.639
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT11	5	5	0	0	glucose	PP2	PA449773	4888	0.639
NULL	Case_Rep_Hematol_2014_Feb_10_2014_641483.nxml.txt.nlp	24660077	SENT77	14	14	19	19	vincristine	CHOP	PA451879	1649	0.639
NULL	Eur_J_Clin_Pharmacol_2014_Aug_23_70(10)_1173-1179.nxml.txt.nlp	25146692	SENT186	10	10	5	5	ritonavir	CYP3A4	PA451260	1576	0.639
NULL	Pharm_Pract_(Granada)_2011_Mar_15_Jan-Mar_9(1)_1-10.nxml.txt.nlp	25132883	SENT161	7	7	13	13	warfarin	SPAF	PA451906	166378	0.639
NULL	Aging_(Albany_NY)_2013_Jul_20_5(7)_495-506.nxml.txt.nlp	24073437	SENT31	20	20	15	15	resveratrol	IL-6		3569	0.639
NULL	Br_J_Cancer_2012_Sep_25_107(7)_1059-1068.nxml.txt.nlp	22935581	SENT74	6	6	8	8	sunitinib	IFN	PA162372840	3439	0.639
NULL	Biologics_2012_Jul_12_6_201-206.nxml.txt.nlp	22904612	SENT132	3	3	24	24	infliximab	IMPACT	PA452639	55364	0.639
NULL	Ecancermedicalscience_2011_Apr_28_5_211.nxml.txt.nlp	22276054	SENT34	28	28	13	13	palonosetron	HEC	PA10352	10403	0.639
NULL	Osteoporos_Int_2010_Oct_18_21(10)_1657-1680.nxml.txt.nlp	20480148	SENT590	24	24	28	28	tamoxifen	STAR	PA451581	6770;2984	0.639
NULL	Acta_Pharmacol_Sin_2010_Feb_5_31(2)_202-210.nxml.txt.nlp	20139903	SENT42	25	25	35	35	l-glutamine	CO2	PA10090	4513	0.639
NULL	Arthritis_Res_Ther_2005_Mar_16_7(Suppl_2)_S4-S14.nxml.txt.nlp	15833146	SENT224	0	0	6	6	methotrexate	IFN	PA450428	3439	0.639
NULL	Oncotarget_2014_Sep_16_5(20)_9966-9979.nxml.txt.nlp	25294818	SENT68	3	3	9	9	glipizide	MVD	PA449762	4597	0.639
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Apr_15_9_13.nxml.txt.nlp	20398300	SENT97	25	25	7	7	moxifloxacin	LAM	PA450555	7249;7248	0.639
NULL	Mol_Cancer_2008_Jun_3_7_47.nxml.txt.nlp	18519000	SENT170	12	12	2	2	gefitinib	EGFR	PA131301952	1956	0.639
NULL	Cardiovasc_Diabetol_2005_Oct_5_4_16.nxml.txt.nlp	16207378	SENT163	4	4	6	6	glucosamine	perlecan	PA164747613	3339	0.639
NULL	Acta_Oncol_2014_Oct_9_53(10)_1347-1355.nxml.txt.nlp	24909504	SENT187	19	19	10	10	mitomycin	CHEK2	PA450524	11200	0.639
NULL	Nat_Med_2013_Feb_6_19(2)_217-226.nxml.txt.nlp	23291629	SENT355	11	11	20	20	lipase	HSL	PA450239	3991	0.639
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2705-2713.nxml.txt.nlp	24129232	SENT194	19	19	8	8	docetaxel	ACT	PA449383	12;11332;9457;641455	0.639
NULL	Front_Immunol_2013_Mar_27_4_76.nxml.txt.nlp	23543707	SENT218	31	31	10	10	irinotecan	gamma	PA450085	9913	0.639
NULL	Brain_Behav_2013_Mar_6_3(2)_114-133.nxml.txt.nlp	23533150	SENT189	14	14	5	5	ethanol	HSF1	PA448073	3297	0.639
NULL	EMBO_Mol_Med_2013_Aug_4_5(8)_1180-1195.nxml.txt.nlp	23828858	SENT151	4	4	9	9	rituximab	MYC	PA451261	4609	0.639
NULL	J_Exp_Clin_Cancer_Res_2009_Jun_22_28(1)_87.nxml.txt.nlp	19545438	SENT25	7	7	11	11	vincristine	CHOP	PA451879	1649	0.639
NULL	J_Korean_Med_Sci_2006_Dec_31_21(6)_973-978.nxml.txt.nlp	17179671	SENT167	18	18	8	8	imipenem	CTX	PA449968	1593	0.639
NULL	Hum_Reprod_Update_2008_Sep_23_Nov-Dec_14(6)_571-582.nxml.txt.nlp	18812422	SENT107	21	21	23	23	letrozole	aromatase	PA450196	1588	0.639
NULL	Int_J_Mol_Sci_2012_Sep_25_13(10)_12153-12168.nxml.txt.nlp	23202889	SENT497	0	0	26	26	cetuximab	BRAF	PA10040	673	0.639
NULL	Orphanet_J_Rare_Dis_2014_Oct_29_9(1)_162.nxml.txt.nlp	NULL	SENT186	25	25	5	5	sirolimus	CYP3A4	PA451365	1576	0.639
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Aug_6_64(Pt_9)_o1707.nxml.txt.nlp	21201695	SENT74	15	15	18	18	benzaldehyde	mol	PA448571	90527	0.639
NULL	J_Korean_Med_Sci_2010_Jun_24_25(6)_829-834.nxml.txt.nlp	20514301	SENT89	17	17	24	24	papain	TIRAP	PA450778	114609	0.639
NULL	Gastric_Cancer_2013_Jul_12_16(3)_345-354.nxml.txt.nlp	22968820	SENT208	34	34	7	7	oxaliplatin	FANCJ	PA131285527	83990	0.639
NULL	Osteoporos_Int_2012_Jan_28_23(1)_213-221.nxml.txt.nlp	21953472	SENT31	3	3	39	39	alendronate	PTH	PA448082	5741	0.639
NULL	Br_J_Cancer_2012_Jan_3_106(1)_18-24.nxml.txt.nlp	22108516	SENT167	16	16	23	23	irinotecan	TDP1	PA450085	55775	0.639
NULL	Bone_2012_Jan_50(1)_218-225.nxml.txt.nlp	22023931	SENT219	17	17	8	8	iron	FGF23	PA450087	8074	0.639
NULL	J_Young_Pharm_2010_Oct-Dec_2(4)_428-429.nxml.txt.nlp	21264109	SENT4	17	17	10	10	metformin	B12	PA450395	7126;4709	0.639
NULL	Diabetes_Obes_Metab_2010_May_12(5)_437-441.nxml.txt.nlp	20415692	SENT74	6	6	1	1	metformin	GLA	PA450395	9027;2717	0.639
NULL	Oxid_Med_Cell_Longev_2011_Aug_15_2011_824597.nxml.txt.nlp	21904648	SENT215	13	13	15	15	topotecan	TPT	PA451729	23590;6469	0.639
NULL	Tuberc_Respir_Dis_(Seoul)_2013_Aug_30_75(2)_47-51.nxml.txt.nlp	24023556	SENT56	28	28	37	37	azathioprine	NAC	PA448515	22861	0.639
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Apr_15_9_13.nxml.txt.nlp	20398300	SENT134	6	6	11	11	moxifloxacin	LAM	PA450555	7249;7248	0.639
NULL	J_Exp_Clin_Cancer_Res_2009_Jan_6_28(1)_1.nxml.txt.nlp	19126230	SENT150	0	0	8	8	thalidomide	FGF2	PA451644	2247;2258	0.639
NULL	Asia_Pac_Allergy_2014_Apr_29_4(2)_106-112.nxml.txt.nlp	24809016	SENT94	24	24	28	28	ampicillin	PPL	PA448419	5493	0.639
NULL	Arthritis_Res_Ther_2013_Aug_21_15(4)_R93.nxml.txt.nlp	23965253	SENT19	4	4	12	12	collagenase	MMP9	PA449107	4318	0.639
NULL	J_Mammary_Gland_Biol_Neoplasia_2010_Mar_27_15(1)_5-17.nxml.txt.nlp	20101446	SENT179	17	17	15	15	tamoxifen	HuR	PA451581	1994	0.639
NULL	J_Headache_Pain_2013_Mar_12_14(1)_25.nxml.txt.nlp	23566208	SENT76	19	19	43	43	topiramate	LEP	PA451728	3952	0.639
NULL	Drugs_2009_Mar_17_69(5)_549-565.nxml.txt.nlp	19368417	SENT148	12	12	4	4	formoterol	DPI	PA134687907	1832	0.639
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1224-1233.nxml.txt.nlp	22353810	SENT193	5	5	19	19	doxorubicin	MRP-1	PA449412	928	0.639
NULL	Eur_J_Dent_2009_Apr_3(2)_114-119.nxml.txt.nlp	19421391	SENT55	7	7	26	26	trypsin	CO2	PA451806	4513	0.639
NULL	Mol_Biol_Cell_2013_Jul_15_24(14)_2186-2200.nxml.txt.nlp	23699397	SENT91	8	8	38	38	staurosporine	TRAIL	PA165109623	8743	0.639
NULL	Biomed_Res_Int_2014_May_29_2014_645762.nxml.txt.nlp	24971341	SENT163	11	11	27	27	estradiol	A-FABP	PA449503	2167	0.639
NULL	J_Inherit_Metab_Dis_2012_Jan_10_35(1)_141-149.nxml.txt.nlp	21556832	SENT20	17	17	1	1	creatine	AGAT	PA164778930	2628	0.639
NULL	Cell_Cycle_2013_Dec_15_12(24)_3791-3803.nxml.txt.nlp	24107631	SENT116	16	16	5	5	doxorubicin	YB-1	PA449412	4904	0.639
NULL	Neural_Plast_2014_Mar_20_2014_675128.nxml.txt.nlp	24778885	SENT4	28	28	12	12	pilocarpine	CA1	PA450962	759	0.639
NULL	Emerg_Infect_Dis_2011_Mar_17(3)_432-440.nxml.txt.nlp	21392434	SENT145	6	6	14	14	rifampin	DST	PA451250	667	0.639
NULL	Pharmacogn_Mag_2014_Oct-Dec_10(40)_536-540.nxml.txt.nlp	25422558	SENT121	10	10	6	6	ethanol	SLB	PA448073	26160	0.639
NULL	Pediatr_Cardiol_2010_Jan_14_31(1)_90-95.nxml.txt.nlp	19915892	SENT62	35	35	28	28	palivizumab	Era	PA164748781	2099	0.639
NULL	Aging_(Albany_NY)_2011_Feb_20_3(2)_85-93.nxml.txt.nlp	21386133	SENT148	6	6	8	8	metformin	HER-2	PA450395	2064	0.639
NULL	F1000Res_2013_Jul_9_2_150.nxml.txt.nlp	24627787	SENT18	21	21	28	28	clozapine	DIP	PA449061	23151;1831	0.639
NULL	Carcinogenesis_2013_Mar_7_34(3)_703-712.nxml.txt.nlp	23222814	SENT89	0	0	29	29	curcumin	BAX	PA151958596	581	0.639
NULL	Front_Neurol_2013_Nov_6_4_176.nxml.txt.nlp	24223570	SENT182	18	18	24	24	mecamylamine	PIR	PA450334	8544	0.639
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT272	25	25	7	7	cisplatin	UNG	PA449014	7374	0.639
NULL	Br_J_Cancer_2014_Dec_9_111(12)_2379-2380.nxml.txt.nlp	24619075	SENT8	35	35	15	15	irinotecan	BRAF	PA450085	673	0.639
NULL	Front_Behav_Neurosci_2014_Nov_12_8_384.nxml.txt.nlp	25429263	SENT157	43	43	18	18	carbachol	IP3R2	PA448784	3709	0.639
NULL	Open_Access_J_Sports_Med_2013_Jul_10_4_175-182.nxml.txt.nlp	24379723	SENT18	21	21	15	15	oxygen	CO2	PA450744	4513	0.639
NULL	Breast_Cancer_Res_2003_Jul_28_5(5)_276-279.nxml.txt.nlp	12927039	SENT18	3	3	7	7	tamoxifen	STAR	PA451581	6770;2984	0.639
NULL	Pharmaceuticals_(Basel)_2011_Jan_12_4(1)_187-201.nxml.txt.nlp	NULL	SENT139	9	9	5	5	l-arginine	ANOVA	PA448478	4858	0.639
NULL	Ann_Surg_Oncol_2010_Feb_20_17(2)_354-355.nxml.txt.nlp	19936842	SENT37	20	20	15	15	panitumumab	KRAS	PA162373091	3845	0.638
NULL	Front_Neurosci_2014_Nov_10_8_364.nxml.txt.nlp	25426018	SENT236	10	10	20	20	fluorescein	Casper	PA164746009	8837	0.638
NULL	Eur_J_Med_Res_2009_Dec_7_14(Suppl_4)_170-176.nxml.txt.nlp	20156751	SENT6	7	7	9	9	methacholine	MCH	PA165958382	5367	0.638
NULL	Oxid_Med_Cell_Longev_2013_Nov_28_2013_568093.nxml.txt.nlp	24379901	SENT56	14	14	44	44	resveratrol	SIRT1		23411	0.638
NULL	Nat_Commun_2014_Apr_3_5_3546.nxml.txt.nlp	24699423	SENT13	9	9	3	3	gentamicin	spatial	PA449753	219793	0.638
NULL	Indian_J_Pharmacol_2013_Sep-Oct_45(5)_439-446.nxml.txt.nlp	24130376	SENT60	34	34	29	29	clozapine	FGA	PA449061	2243	0.638
NULL	Indian_J_Nucl_Med_2012_Jul-Sep_27(3)_145-150.nxml.txt.nlp	23919066	SENT102	20	20	27	27	furosemide	FDG	PA449719	23583	0.638
NULL	Front_Neurosci_2012_May_30_6_77.nxml.txt.nlp	22661925	SENT322	2	2	15	15	ethanol	NALP3	PA448073	114548	0.638
NULL	Oncotarget_2014_Jun_19_5(15)_6540-6551.nxml.txt.nlp	25153728	SENT105	34	34	17	17	paclitaxel	p16	PA450761	1029	0.638
NULL	Angew_Chem_Int_Ed_Engl_2013_Jan_2_52(1)_325-330.nxml.txt.nlp	23080482	SENT39	17	17	19	19	thrombin	PAR-1	PA451674	2011;2149	0.638
NULL	Evid_Based_Complement_Alternat_Med_2011_Mar_14_2011_635058.nxml.txt.nlp	21437195	SENT228	6	6	2	2	cilomilast	PDE4A	PA165948031	5141	0.638
NULL	Curr_Neuropharmacol_2009_Jun_7(2)_83-95.nxml.txt.nlp	19949566	SENT453	30	30	32	32	phenytoin	TGB	PA450947	5473	0.638
NULL	Front_Hum_Neurosci_2014_Oct_2_8_784.nxml.txt.nlp	25324767	SENT456	16	16	2	2	bromocriptine	spatial	PA448671	219793	0.638
NULL	Oncotarget_2011_Jun_15_2(6)_518-524.nxml.txt.nlp	21680956	SENT100	0	0	2	2	pimozide	STAT3	PA450965	6774	0.638
NULL	Diabetes_Care_2010_Feb_33(2)_428-433.nxml.txt.nlp	20103558	SENT163	16	16	12	12	liraglutide	GLP	PA165958364	342096	0.638
NULL	Diabetologia_2010_Jul_2_53(7)_1270-1287.nxml.txt.nlp	20361178	SENT266	0	0	8	8	pioglitazone	adiponectin	PA450970	9370	0.638
NULL	Chemother_Res_Pract_2011_Dec_1_2011_715469.nxml.txt.nlp	22312557	SENT13	12	12	19	19	cisplatin	p53	PA449014	7157	0.638
NULL	Mol_Cancer_2010_Apr_23_9_87.nxml.txt.nlp	20416058	SENT182	7	7	5	5	doxorubicin	TRAIL	PA449412	8743	0.638
NULL	J_Gen_Physiol_1929_Jan_20_12(3)_435-461.nxml.txt.nlp	19872472	SENT4	8	8	3	3	phenol	CO2	PA450913	4513	0.638
NULL	Structure_2014_Apr_8_22(4)_549-559.nxml.txt.nlp	24613487	SENT591	25	25	7	7	thrombin	TIP49	PA451674	8607	0.638
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1021.nxml.txt.nlp	24457965	SENT286	20	20	13	13	cisplatin	p65	PA449014	5970	0.638
NULL	Int_J_Endocrinol_2014_Aug_11_2014_312452.nxml.txt.nlp	25183970	SENT142	21	21	8	8	liraglutide	PI3K	PA165958364	5290	0.638
NULL	Ann_Lab_Med_2012_Jul_20_32(4)_298-303.nxml.txt.nlp	22779073	SENT117	36	36	10	10	ciprofloxacin	EMB	PA449009	133418	0.638
NULL	Exp_Diabetes_Res_2012_Oct_26_2012_820989.nxml.txt.nlp	22110480	SENT26	17	17	31	31	rosiglitazone	LYRM1	PA451283	57149	0.638
NULL	Arthritis_Res_Ther_2010_Feb_24_12(1)_R32.nxml.txt.nlp	20181277	SENT203	8	8	4	4	imatinib	M-CSF	PA10804	1435	0.638
NULL	Biologics_2009_Jul_13_3_225-232.nxml.txt.nlp	19707411	SENT114	8	8	18	18	rituximab	CTX	PA451261	1593	0.638
NULL	Diabetes_2011_May_23_60(5)_1458-1466.nxml.txt.nlp	21464445	SENT4	20	20	22	22	lipase	ATGL	PA450239	57104	0.638
NULL	Front_Neurosci_2011_Jan_14_4_207.nxml.txt.nlp	21258618	SENT172	12	12	2	2	ethanol	AC7	PA448073	113	0.638
NULL	J_Gen_Physiol_1975_Apr_1_65(4)_515-526.nxml.txt.nlp	1151324	SENT0	16	16	1	1	nystatin	Gen	PA450666	348654	0.638
NULL	J_Young_Pharm_2011_Apr-Jun_3(2)_97-104.nxml.txt.nlp	21731353	SENT142	17	17	10	10	glipizide	CS1	PA449762	57823	0.638
NULL	Front_Endocrinol_(Lausanne)_2011_Nov_10_2_72.nxml.txt.nlp	22649383	SENT82	6	6	9	9	ethanol	StAR	PA448073	6770	0.638
NULL	Indian_J_Med_Res_2012_Dec_136(6)_926-941.nxml.txt.nlp	23391788	SENT114	11	11	9	9	clopidogrel	DES	PA449053	1674	0.638
NULL	Support_Care_Cancer_2011_Oct_12_19(10)_1609-1617.nxml.txt.nlp	20835873	SENT43	13	13	18	18	granisetron	MEC	PA449809	56477	0.638
NULL	Can_J_Infect_Dis_Med_Microbiol_2014_Nov-Dec_25(6)_311-320.nxml.txt.nlp	25587293	SENT371	23	23	30	30	telaprevir	BOC	PA165958354	91653	0.638
NULL	Br_J_Cancer_2011_Jul_12_105(2)_212-220.nxml.txt.nlp	21694723	SENT3	17	17	11	11	curcumin	STAT3	PA151958596	6774	0.638
NULL	Arthritis_Res_Ther_2012_May_1_14(3)_R99.nxml.txt.nlp	22546542	SENT112	5	5	18	18	infliximab	IL-6	PA452639	3569	0.638
NULL	Crit_Care_2010_Nov_5_14(6)_R200.nxml.txt.nlp	21054850	SENT140	11	11	13	13	vasopressin	AVP	PA451858	114548;551	0.638
NULL	J_Vet_Med_Sci_2014_Aug_1_76(8)_1153-1156.nxml.txt.nlp	24784438	SENT41	19	19	17	17	oxytetracycline	OTC	PA450757	5009	0.638
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT128	14	14	3	3	disopyramide	CYP2D6	PA449373	1565	0.638
NULL	Environ_Health_Perspect_2012_Apr_6_120(4)_547-553.nxml.txt.nlp	22472290	SENT270	20	20	8	8	arsenite	GADD45	PA452638	1647	0.638
NULL	Mol_Cancer_2012_Mar_21_11_13.nxml.txt.nlp	22436134	SENT183	25	25	20	20	doxorubicin	HuR	PA449412	1994	0.638
NULL	J_Cell_Biol_2003_Dec_8_163(5)_1099-1109.nxml.txt.nlp	14662748	SENT15	19	19	12	12	vasopressin	AQP2	PA451858	359	0.638
NULL	J_Hematol_Oncol_2009_Mar_16_2_13.nxml.txt.nlp	19291303	SENT181	8	8	1	1	gemcitabine	Gem	PA449748	51053	0.638
NULL	Int_J_Cell_Biol_2012_Sep_9_2012_683897.nxml.txt.nlp	22991514	SENT48	28	28	19	19	nadh	ROS	PA164755085	6098	0.638
NULL	Alcohol_Res_2013_35(1)_6-16.nxml.txt.nlp	24313160	SENT125	14	14	25	25	ethanol	CYP2E1	PA448073	1571	0.638
NULL	FEBS_Open_Bio_2012_Aug_22_2_279-283.nxml.txt.nlp	23650611	SENT110	8	8	14	14	tamoxifen	IFN	PA451581	3439	0.638
NULL	Evid_Based_Complement_Alternat_Med_2011_Jan_12_2011_690518.nxml.txt.nlp	19687188	SENT170	2	2	34	34	ampicillin	TIC	PA448419	23550	0.638
NULL	Indian_J_Anaesth_2010_Jul-Aug_54(4)_324-326.nxml.txt.nlp	20882175	SENT48	22	22	16	16	bupivacaine	SGB	PA135057240	2719	0.638
NULL	Diabetes_Metab_Syndr_Obes_2014_Jun_24_7_229-239.nxml.txt.nlp	25018644	SENT103	13	13	10	10	liraglutide	GLP-1	PA165958364	100125288	0.638
NULL	Br_J_Cancer_2006_Dec_4_95(11)_1483-1489.nxml.txt.nlp	17106442	SENT155	31	31	24	24	gefitinib	EGFR	PA131301952	1956	0.638
NULL	Front_Oncol_2014_Apr_10_4_76.nxml.txt.nlp	24782987	SENT110	19	19	25	25	cyclophosphamide	CD25	PA449165	3669;3559	0.638
NULL	Braz_J_Microbiol_2014_Mar_10_44(4)_1067-1074.nxml.txt.nlp	24688494	SENT92	7	7	27	27	ethanol	mol	PA448073	90527	0.638
NULL	Int_J_Mol_Sci_2013_Apr_29_14(5)_9338-9364.nxml.txt.nlp	23629668	SENT694	18	18	24	24	bevacizumab	HER2	PA130232992	2064	0.638
NULL	Case_Rep_Med_2014_May_4_2014_964082.nxml.txt.nlp	24876846	SENT26	10	10	12	12	bortezomib	BOR	PA10252	55143	0.638
NULL	Acta_Pharmacol_Sin_2010_Sep_23_31(9)_1213-1222.nxml.txt.nlp	20729877	SENT40	8	8	5	5	suramin	LPA	PA10292	4018	0.638
NULL	Br_J_Cancer_2010_Jan_5_102(1)_80-86.nxml.txt.nlp	19920817	SENT123	12	12	14	14	bevacizumab	IFN	PA130232992	3439	0.638
NULL	Ann_Pediatr_Cardiol_2009_Jan-Jun_2(1)_65-73.nxml.txt.nlp	20300273	SENT50	15	15	17	17	vasopressin	AVP	PA451858	114548;551	0.638
NULL	Arthritis_Res_Ther_2013_Apr_4_15(Suppl_1)_S4.nxml.txt.nlp	23566679	SENT522	2	2	23	23	rituximab	ICOS	PA451261	29851;1493	0.638
NULL	Breast_Cancer_Res_2012_Feb_14_14(1)_R30.nxml.txt.nlp	22333315	SENT162	24	24	10	10	celecoxib	CXCL9	PA448871	4283	0.638
NULL	Br_J_Cancer_2012_May_22_106(11)_1779-1789.nxml.txt.nlp	22549178	SENT31	15	15	11	11	pertuzumab	HER2		2064	0.638
NULL	J_Cell_Mol_Med_2014_Jan_19_18(1)_156-169.nxml.txt.nlp	24251962	SENT242	20	20	28	28	bleomycin	BLM	PA448645	641	0.638
NULL	EPMA_J_2010_Jun_10_1(2)_229-235.nxml.txt.nlp	23199061	SENT90	13	13	25	25	dorzolamide	OBF	PA164748765	284359	0.638
NULL	Mol_Clin_Oncol_2013_Jul_15_1(4)_661-667.nxml.txt.nlp	24649225	SENT197	22	22	7	7	leucovorin	RFC1	PA450198	5981	0.638
NULL	Diabetes_Care_2009_Sep_28_32(9)_1649-1655.nxml.txt.nlp	19478198	SENT139	10	10	0	0	saxagliptin	MET	PA165958362	4233	0.638
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT247	9	9	21	21	vardenafil	CYP3A4	PA10229	1576	0.638
NULL	J_Am_Heart_Assoc_2013_Aug_23_2(4)_e000264.nxml.txt.nlp	23896681	SENT157	34	34	12	12	thrombin	FVIII	PA451674	2157	0.638
NULL	J_Korean_Med_Sci_1999_Oct_14(5)_565-570.nxml.txt.nlp	10576154	SENT9	14	14	18	18	vincristine	CHOP	PA451879	1649	0.638
NULL	Pediatr_Nephrol_2009_Jul_20_24(7)_1355-1361.nxml.txt.nlp	19301038	SENT7	4	4	9	9	sevelamer	PTH	PA164781197	5741	0.638
NULL	Br_J_Cancer_2010_Sep_7_103(6)_796-801.nxml.txt.nlp	20823888	SENT130	5	5	12	12	gefitinib	EGFR	PA131301952	1956	0.638
NULL	Front_Neurosci_2014_Jun_3_8_128.nxml.txt.nlp	24917782	SENT144	22	22	26	26	ethanol	MC3R	PA448073	4159	0.638
NULL	Cancers_(Basel)_2014_Apr_9_6(2)_829-859.nxml.txt.nlp	24722453	SENT1954	9	9	13	13	auranofin	STAT3	PA448510	6774	0.638
NULL	Iran_J_Basic_Med_Sci_2012_Nov-Dec_15(6)_1162-1167.nxml.txt.nlp	23653845	SENT107	0	0	7	7	curcumin	IL-8	PA151958596	3576	0.638
NULL	Indian_J_Nephrol_2012_Sep-Oct_22(5)_374-376.nxml.txt.nlp	23326050	SENT61	18	18	33	33	meropenem	ISPD	PA164764445	729920	0.638
NULL	Int_J_Mol_Cell_Med_2014_Autumn_3(4)_272-278.nxml.txt.nlp	25635254	SENT53	14	14	29	29	paraformaldehyde	San	PA450790	80218	0.638
NULL	J_Vet_Med_Sci_2013_Nov_18_75(11)_1497-1502.nxml.txt.nlp	23774039	SENT352	2	2	7	7	furazolidone	CYP2E1	PA164746760	1571	0.638
NULL	Mol_Cell_2014_May_8_54(3)_445-459.nxml.txt.nlp	24746700	SENT90	22	22	11	11	etoposide	ATRIP	PA449552	84126	0.638
NULL	Br_J_Cancer_1998_May_77(9)_1474-1479.nxml.txt.nlp	9652764	SENT0	17	17	24	24	doxorubicin	FAC	PA449412	2176	0.638
NULL	Tuberc_Respir_Dis_(Seoul)_2013_Aug_30_75(2)_47-51.nxml.txt.nlp	24023556	SENT56	28	28	31	31	azathioprine	NAC	PA448515	22861	0.638
NULL	Amino_Acids_2011_May_22_40(5)_1369-1383.nxml.txt.nlp	21424716	SENT246	12	12	4	4	creatine	CEE	PA164778930	51608	0.638
NULL	J_Oncol_2012_Mar_11_2012_359246.nxml.txt.nlp	22481925	SENT9	0	0	8	8	thyroglobulin	TPO	PA164754910	7066;7173	0.638
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT236	0	0	4	4	adalimumab	CD36	PA10004	948	0.638
NULL	Sensors_(Basel)_2012_Dec_28_13(1)_484-499.nxml.txt.nlp	23275084	SENT317	13	13	8	8	fluorescein	HEMA	PA164746009	2157	0.638
NULL	Biologics_2012_Jan_1_6_21-29.nxml.txt.nlp	22291464	SENT163	8	8	19	19	capecitabine	HER2	PA448771	2064	0.638
NULL	Diabetes_2009_Apr_58(4)_773-795.nxml.txt.nlp	19336687	SENT744	7	7	18	18	troglitazone	p110	PA451799	9733	0.638
NULL	Ann_Oncol_2012_Dec_2_23(12)_3007-3016.nxml.txt.nlp	22865781	SENT170	41	41	16	16	trastuzumab	IGF1R	PA451743	3480	0.638
NULL	Ann_Gen_Psychiatry_2008_Aug_18_7_11.nxml.txt.nlp	18706108	SENT15	4	4	16	16	bupropion	CD50	PA448687	3385	0.638
NULL	Oncogene_2010_Nov_18_29(46)_6160-6171.nxml.txt.nlp	20729916	SENT127	47	47	18	18	cisplatin	YAP	PA449014	55249	0.638
NULL	FEBS_Open_Bio_2012_Jul_20_2_179-186.nxml.txt.nlp	23650597	SENT142	10	10	17	17	imiquimod	MxA	PA449972	4599	0.638
NULL	Clin_Med_Insights_Oncol_2013_Feb_21_7_41-51.nxml.txt.nlp	23471238	SENT25	38	38	25	25	trastuzumab	HER2	PA451743	2064	0.638
NULL	J_Headache_Pain_2011_Apr_5_12(2)_127-133.nxml.txt.nlp	21298314	SENT135	11	11	9	9	amitriptyline	CSMT	PA448385	1442	0.638
NULL	Chin_J_Cancer_2011_May_30(5)_351-356.nxml.txt.nlp	21527068	SENT108	15	15	13	13	cyclophosphamide	CHOP	PA449165	1649	0.638
NULL	Ann_Rheum_Dis_2014_Jun_30_73(6)_990-999.nxml.txt.nlp	24482301	SENT101	2	2	28	28	methotrexate	UST	PA450428	10090	0.638
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT731	0	0	9	9	etravirine	DUET	PA166014703	8997	0.638
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Apr_2_65(Pt_5)_o953.nxml.txt.nlp	21583996	SENT65	19	19	31	31	nitrogen	AMPH	PA450643	273	0.638
NULL	J_Oncol_2009_Mar_24_2009_491985.nxml.txt.nlp	19325924	SENT152	25	25	32	32	genistein	CXCL12	PA165109660	6387	0.638
NULL	Front_Genet_2012_Nov_22_3_249.nxml.txt.nlp	23189085	SENT146	2	2	8	8	s-adenosylmethionine	TPMT	PA164754994	7172	0.638
NULL	Croat_Med_J_2012_Aug_53(4)_343-349.nxml.txt.nlp	22911527	SENT65	5	5	11	11	isoproterenol	NIF	PA450121	6280	0.638
NULL	Int_J_Mol_Sci_2014_Mar_20_15(3)_4965-4976.nxml.txt.nlp	24658440	SENT72	41	41	14	14	infliximab	CD4	PA452639	920	0.638
NULL	Int_J_Nanomedicine_2007_Mar_2(1)_39-47.nxml.txt.nlp	17722511	SENT58	4	4	14	14	methotrexate	NNT	PA450428	23530	0.638
NULL	Nucleic_Acids_Res_2013_May_5_41(10)_5210-5222.nxml.txt.nlp	23563151	SENT241	29	29	20	20	arsenite	GADD45	PA452638	1647	0.638
NULL	Ann_Thorac_Med_2013_Apr-Jun_8(2)_109-115.nxml.txt.nlp	23741274	SENT7	19	19	7	7	cisplatin	CRT	PA449014	811	0.638
NULL	Int_J_Surg_Oncol_2012_Jun_24_2012_868645.nxml.txt.nlp	22778942	SENT75	8	8	6	6	lapatinib	HER2	PA152241907	2064	0.638
NULL	Toxins_(Basel)_2010_Oct_28_2(11)_2584-2592.nxml.txt.nlp	22069565	SENT316	0	0	6	6	warfarin	CYP3A5	PA451906	1577	0.638
NULL	J_Cell_Biol_1998_Apr_20_141(2)_493-501.nxml.txt.nlp	9548726	SENT79	22	22	31	31	forskolin	GGF	PA146096022	3084	0.638
NULL	Leukemia_2013_Feb_10_27(2)_507-510.nxml.txt.nlp	22810506	SENT65	5	5	1	1	fludarabine	TRAC	PA449655	28755	0.638
NULL	Cell_Death_Dis_2014_Mar_13_5(3)_e1118.nxml.txt.nlp	24625977	SENT91	30	30	22	22	etoposide	p53	PA449552	7157	0.638
NULL	Nucleic_Acids_Res_2012_Jul_19_40(13)_5910-5925.nxml.txt.nlp	22434882	SENT344	14	14	11	11	etoposide	p53	PA449552	7157	0.638
NULL	Br_J_Cancer_2010_Sep_7_103(6)_837-844.nxml.txt.nlp	20717115	SENT147	13	13	16	16	sorafenib	SHARP	PA7000	23013	0.638
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_33-43.nxml.txt.nlp	17912634	SENT145	21	21	14	14	letrozole	HER2	PA450196	2064	0.638
NULL	Br_J_Pharmacol_2011_Jul_163(6)_1263-1275.nxml.txt.nlp	21391977	SENT100	4	4	24	24	gemfibrozil	CYP3A4	PA449750	1576	0.638
NULL	Inflamm_Res_2010_Oct_20_59(10)_879-887.nxml.txt.nlp	20490892	SENT235	9	9	4	4	dextran	IL-25	PA449261	64806;56005	0.638
NULL	Theranostics_2013_Jun_24_3(7)_448-466.nxml.txt.nlp	23843893	SENT251	22	22	29	29	choline	VAP-1	PA448976	8639	0.638
NULL	Nature_2012_Dec_20_492(7429)_387-392.nxml.txt.nlp	23222541	SENT14	3	3	9	9	thrombin	PAR1	PA451674	79581;2149	0.638
NULL	Br_J_Pharmacol_2008_Oct_18_155(4)_596-605.nxml.txt.nlp	18852694	SENT176	8	8	14	14	fenofibrate	SREBP2	PA449594	6721	0.638
NULL	Adv_Bioinformatics_2012_Oct_13_2012_159423.nxml.txt.nlp	23097667	SENT407	8	8	6	6	nadh	ADP	PA164755085	23038	0.638
NULL	Case_Rep_Anesthesiol_2014_Feb_5_2014_853243.nxml.txt.nlp	24653844	SENT93	9	9	1	1	bupivacaine	PPG	PA135057240	5552	0.638
NULL	Adv_Hematol_2012_Aug_2_2012_842945.nxml.txt.nlp	22919394	SENT126	4	4	9	9	lenalidomide	AP-1	PA162363968	2353;3727;2354;3725	0.638
NULL	Cell_Cycle_2013_Sep_15_12(18)_3013-3024.nxml.txt.nlp	23974104	SENT67	19	19	14	14	disulfiram	MYH9	PA449376	4627	0.638
NULL	Breast_Cancer_(Auckl)_2014_Oct_12_8_135-144.nxml.txt.nlp	25368520	SENT192	25	25	5	5	bleomycin	RAD51B	PA448645	5890	0.638
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1224-1233.nxml.txt.nlp	22353810	SENT197	15	15	21	21	doxorubicin	MRP-1	PA449412	928	0.638
NULL	Eur_J_Clin_Microbiol_Infect_Dis_2010_May_13_29(5)_543-550.nxml.txt.nlp	20229224	SENT73	17	17	7	7	erythromycin	PEN	PA449493	9933	0.638
NULL	Front_Oncol_2014_Mar_6_4_40.nxml.txt.nlp	24639951	SENT47	42	42	20	20	vincristine	ETO	PA451879	862	0.638
NULL	Exp_Ther_Med_2013_Jan_10_5(1)_287-291.nxml.txt.nlp	23251285	SENT8	27	27	19	19	aspirin	APS	PA448497	10603	0.638
NULL	Emerg_Infect_Dis_2013_Jan_19(1)_133-136.nxml.txt.nlp	23260464	SENT49	43	43	9	9	ciprofloxacin	TOB	PA449009	10140	0.638
NULL	J_Korean_Med_Sci_2009_Jan_29_24(Suppl_1)_S170-S175.nxml.txt.nlp	19194548	SENT128	15	15	17	17	cisplatin	EPO	PA449014	7076;8288;2056	0.638
NULL	Scientifica_(Cairo)_2013_Jan_17_2013_795964.nxml.txt.nlp	24278786	SENT112	9	9	29	29	xanthophyll	NPQ	PA164748318	80763	0.638
NULL	Cell_Commun_Signal_2013_Apr_5_11_22.nxml.txt.nlp	23561540	SENT162	9	9	12	12	isoproterenol	GLP	PA450121	342096	0.638
NULL	Clin_Med_Insights_Oncol_2012_Feb_28_6_125-135.nxml.txt.nlp	22408376	SENT28	17	17	25	25	panitumumab	EGFR	PA162373091	1956	0.638
NULL	Front_Neurol_2015_Jan_13_5_289.nxml.txt.nlp	25628599	SENT384	8	8	2	2	nadh	p53	PA164755085	7157	0.638
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jun_24_65(Pt_7)_o1670.nxml.txt.nlp	21582930	SENT63	12	12	24	24	ethanol	mol	PA448073	90527	0.638
NULL	Hematol_Rep_2011_Jan_21_3(1)_e2.nxml.txt.nlp	22184524	SENT44	18	18	12	12	moxifloxacin	ETB	PA450555	1910	0.638
NULL	Biomed_Res_Int_2014_May_19_2014_616025.nxml.txt.nlp	24967384	SENT33	0	0	7	7	methotrexate	NAC	PA450428	22861	0.638
NULL	Br_J_Cancer_2009_Sep_15_101(6)_957-966.nxml.txt.nlp	19738618	SENT184	14	14	10	10	heparin	CD36	PA449855	948	0.638
NULL	Breast_Cancer_Res_2011_Mar_10_13(2)_R28.nxml.txt.nlp	21392397	SENT222	33	33	28	28	erlotinib	API	PA134687924	5345	0.638
NULL	Int_J_Med_Sci_2012_Aug_10_9(6)_472-479.nxml.txt.nlp	22927772	SENT13	16	16	6	6	warfarin	CYP2C9	PA451906	1559	0.638
NULL	Oncotarget_2011_Dec_31_2(12)_1322-1328.nxml.txt.nlp	22249159	SENT49	21	21	13	13	metformin	AMPK	PA450395	5563	0.638
NULL	Front_Endocrinol_(Lausanne)_2013_Sep_13_4_122.nxml.txt.nlp	24062725	SENT66	4	4	7	7	forskolin	PRL	PA146096022	5617	0.638
NULL	Arthritis_Res_Ther_2011_Mar_16_13(2)_R44.nxml.txt.nlp	21410959	SENT267	20	20	27	27	glucosamine	RANKL	PA164747613	8600	0.638
NULL	J_Hepatol_2010_Sep_53(3-2)_519-527.nxml.txt.nlp	20579762	SENT283	32	32	17	17	collagenase	c-Jun	PA449107	3725	0.638
NULL	Exp_Ther_Med_2013_Jul_25_6(1)_172-176.nxml.txt.nlp	23935741	SENT197	7	7	9	9	resveratrol	TPT		23590;6469	0.638
NULL	Int_J_Surg_Oncol_2012_Jun_12_2012_862879.nxml.txt.nlp	22778941	SENT15	8	8	14	14	cisplatin	BIN1	PA449014	274	0.638
NULL	Allergy_Asthma_Immunol_Res_2010_Jan_30_2(1)_48-54.nxml.txt.nlp	20224678	SENT24	37	37	43	43	zafirlukast	CYSLTR2	PA451949	57105	0.638
NULL	J_Lipid_Res_2014_Aug_55(8)_1657-1667.nxml.txt.nlp	24879802	SENT36	37	37	31	31	gemfibrozil	CYP2C	PA449750	1562	0.638
NULL	Environ_Health_Perspect_2008_Feb_8_116(2)_149-157.nxml.txt.nlp	18288311	SENT29	4	4	6	6	diethylstilbestrol	DES	PA449307	1674	0.638
NULL	J_Immunother_Cancer_2014_Mar_11_2_5.nxml.txt.nlp	24829762	SENT220	5	5	7	7	l-arginine	ARG1	PA448478	383;64129	0.638
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT168	5	5	7	7	curcumin	TRAIL	PA151958596	8743	0.638
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Aug_11_66(Pt_9)_o2276.nxml.txt.nlp	21588631	SENT69	10	10	6	6	ethanol	mol	PA448073	90527	0.638
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT128	15	15	2	2	theophylline	CYP2C19	PA451647	1557	0.638
NULL	J_Immunol_Res_2014_May_21_2014_371087.nxml.txt.nlp	24963497	SENT322	21	21	17	17	decitabine	DAC	PA164749631	13	0.638
NULL	Amino_Acids_2012_Oct_10_43(4)_1751-1759.nxml.txt.nlp	22407485	SENT132	22	22	5	5	carrageenan	DAG	PA448814	1605	0.638
NULL	Basic_Res_Cardiol_2014_Oct_31_109(6)_451.nxml.txt.nlp	25358972	SENT214	3	3	14	14	phenylephrine	FHL2	PA450935	2274	0.638
NULL	Int_J_Mol_Sci_2013_Apr_29_14(5)_9338-9364.nxml.txt.nlp	23629668	SENT770	3	3	25	25	bevacizumab	MAX	PA130232992	4149	0.638
NULL	J_Mol_Med_(Berl)_2014_Jan_10_92(5)_497-507.nxml.txt.nlp	24408111	SENT181	0	0	4	4	pioglitazone	HIF-1	PA450970	29072	0.638
NULL	J_Biol_Chem_2009_Jan_2_284(1)_77-84.nxml.txt.nlp	18854318	SENT107	7	7	17	17	forskolin	AMPK	PA146096022	5563	0.638
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_33-43.nxml.txt.nlp	17912634	SENT126	10	10	4	4	letrozole	TFF1	PA450196	7031	0.638
NULL	Antimicrob_Agents_Chemother_2014_Nov_10_59(1)_490-497.nxml.txt.nlp	25385107	SENT80	16	16	0	0	sulfadiazine	ATV	PA451539	4683	0.638
NULL	Arthritis_Res_Ther_2013_Feb_27_15(1)_R35.nxml.txt.nlp	23446139	SENT22	9	9	11	11	cyclophosphamide	CTX	PA449165	1593	0.638
NULL	Crit_Care_2011_Nov_30_15(6)_235.nxml.txt.nlp	22216838	SENT118	18	18	5	5	hyaluronidase	CD44	PA164745713	960	0.638
NULL	Breast_Cancer_Res_2000_Aug_11_2(6)_417-422.nxml.txt.nlp	11250735	SENT45	14	14	19	19	thrombin	CD31	PA451674	5175	0.638
NULL	Acta_Pharmacol_Sin_2010_Sep_16_31(9)_1085-1094.nxml.txt.nlp	20711226	SENT39	29	29	41	41	thrombin	HIF-1	PA451674	29072	0.638
NULL	J_Breast_Cancer_2014_Dec_26_17(4)_308-313.nxml.txt.nlp	25548577	SENT137	21	21	10	10	doxorubicin	HER2	PA449412	2064	0.638
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Feb_26_67(Pt_3)_m384-m385.nxml.txt.nlp	21522303	SENT66	28	28	11	11	ethanol	mol	PA448073	90527	0.638
NULL	Crit_Care_2010_Jan_11_14(1)_R3.nxml.txt.nlp	20064232	SENT53	10	10	19	19	fluorescein	CD4	PA164746009	920	0.638
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Jul_23_3(7)_e126.nxml.txt.nlp	25054314	SENT278	16	16	4	4	pitavastatin	OATP1B1	PA142650384	10599	0.638
NULL	Cells_2014_May_23_3(2)_517-545.nxml.txt.nlp	24861977	SENT1146	0	0	2	2	capsaicin	VR1	PA448776	56664	0.638
NULL	Curr_Neuropharmacol_2008_Dec_6(4)_311-321.nxml.txt.nlp	19587852	SENT312	13	13	8	8	memantine	spatial	PA10364	219793	0.638
NULL	ScientificWorldJournal_2014_Mar_12_2014_731462.nxml.txt.nlp	24715817	SENT169	18	18	9	9	diclofenac	IL-6	PA449293	3569	0.638
NULL	J_Gen_Physiol_2013_Dec_142(6)_641-653.nxml.txt.nlp	24277604	SENT34	29	29	40	40	l-glutamine	CO2	PA10090	4513	0.638
NULL	Biomed_Res_Int_2013_Apr_27_2013_780145.nxml.txt.nlp	23710459	SENT110	36	36	25	25	erythromycin	BAP1	PA449493	8314;9223;6045	0.638
NULL	Nucleic_Acids_Res_2011_Dec_31_39(22)_9536-9548.nxml.txt.nlp	21880590	SENT228	20	20	27	27	etoposide	BRCA1	PA449552	672	0.638
NULL	Front_Physiol_2013_Dec_24_4_386.nxml.txt.nlp	24399968	SENT61	6	6	14	14	diazoxide	SUR1	PA449285	6833	0.638
NULL	Biomed_Res_Int_2013_Sep_4_2013_419176.nxml.txt.nlp	24093097	SENT184	4	4	28	28	sorafenib	IFN	PA7000	3439	0.638
NULL	BMJ_Open_2013_Nov_4_3(11)_e003995.nxml.txt.nlp	24189085	SENT6	0	0	10	10	liraglutide	GLP-1	PA165958364	100125288	0.638
NULL	J_Breast_Cancer_2011_Jun_18_14(2)_135-139.nxml.txt.nlp	21847409	SENT21	19	19	36	36	tamoxifen	aromatase	PA451581	1588	0.638
NULL	J_Infect_Dis_2011_May_1_203(9)_1204-1214.nxml.txt.nlp	21459813	SENT144	24	24	4	4	nevirapine	INI	PA450616	84844	0.638
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT332	4	4	18	18	clozapine	PRL	PA449061	5617	0.638
NULL	Nat_Chem_Biol_2013_Oct_25_9(10)_10_1038_nchembio_1333.nxml.txt.nlp	23974117	SENT182	17	17	15	15	forskolin	CNTF	PA146096022	1270	0.638
NULL	Nanoscale_Res_Lett_2014_Feb_10_9(1)_69.nxml.txt.nlp	24512605	SENT54	14	14	6	6	ethanol	Se2	PA448073	2524	0.638
NULL	Crit_Care_2008_Feb_21_12(1)_R20.nxml.txt.nlp	18291025	SENT22	2	2	4	4	vasopressin	AVP	PA451858	114548;551	0.638
NULL	Breast_Cancer_Res_2009_Jul_27_11(4)_R51.nxml.txt.nlp	19630952	SENT25	23	23	15	15	estradiol	CYP1A1	PA449503	1543	0.638
NULL	AAPS_J_2014_Jun_11_16(5)_1029-1037.nxml.txt.nlp	24917180	SENT190	43	43	8	8	quinidine	P-gp	PA451209	5243	0.638
NULL	Gut_Liver_2011_Jun_24_5(2)_117-132.nxml.txt.nlp	21814590	SENT159	36	36	40	40	ribavirin	IFN	PA451241	3439	0.638
NULL	Cardiovasc_Diabetol_2013_May_4_12_73.nxml.txt.nlp	23642288	SENT6	10	10	13	13	acarbose	GLP-1	PA448010	100125288	0.638
NULL	Front_Behav_Neurosci_2014_Dec_18_8_438.nxml.txt.nlp	25566006	SENT998	0	0	13	13	methamphetamine	spatial	PA450403	219793	0.637
NULL	Eur_J_Clin_Pharmacol_2014_Mar_22_70(6)_685-693.nxml.txt.nlp	24658827	SENT244	17	17	14	14	midazolam	CYP3A	PA450496	1574	0.637
NULL	Mediators_Inflamm_2010_Jun_21_2010_194896.nxml.txt.nlp	20652055	SENT48	13	13	27	27	rosuvastatin	mol	PA134308647	90527	0.637
NULL	Iran_Red_Crescent_Med_J_2013_Jul_5_15(7)_554-559.nxml.txt.nlp	24396573	SENT201	9	9	6	6	troglitazone	gamma	PA451799	9913	0.637
NULL	Gut_2012_Nov_15_61(11)_1589-1599.nxml.txt.nlp	NULL	SENT213	9	9	7	7	ribavirin	IFN	PA451241	3439	0.637
NULL	Onco_Targets_Ther_2014_Dec_4_7_2249-2255.nxml.txt.nlp	25587220	SENT6	8	8	17	17	doxorubicin	P-gp	PA449412	5243	0.637
NULL	Diabetes_Metab_J_2014_Dec_15_38(6)_456-463.nxml.txt.nlp	25541609	SENT103	7	7	11	11	glucose	ACR	PA449773	49	0.637
NULL	Oxid_Med_Cell_Longev_2013_Nov_28_2013_568093.nxml.txt.nlp	24379901	SENT22	2	2	15	15	resveratrol	SIRT1		23411	0.637
NULL	Curr_Opin_Allergy_Clin_Immunol_2013_Dec_6_13(6)_669-676.nxml.txt.nlp	24169433	SENT79	4	4	6	6	galactose	MGL	PA449725	11343	0.637
NULL	Exp_Ther_Med_2014_Dec_24_8(6)_1677-1682.nxml.txt.nlp	25371714	SENT139	8	8	10	10	sirolimus	HIF-1	PA451365	29072	0.637
NULL	J_Psychopharmacol_2014_Sep_28(9)_837-846.nxml.txt.nlp	25035246	SENT27	22	22	19	19	methylphenidate	ATX	PA450464	5168;23049	0.637
NULL	Cases_J_2009_Mar_10_2_6464.nxml.txt.nlp	20181162	SENT54	7	7	4	4	ribavirin	IFN	PA451241	3439	0.637
NULL	Emerg_Infect_Dis_2011_Mar_17(3)_510-513.nxml.txt.nlp	21392446	SENT53	30	30	36	36	kanamycin	ETO	PA450137	862	0.637
NULL	J_Lipids_2011_Jan_13_2011_565316.nxml.txt.nlp	21490804	SENT49	28	28	25	25	staurosporine	p53	PA165109623	7157	0.637
NULL	Iran_J_Microbiol_2013_Mar_5(1)_48-55.nxml.txt.nlp	23466743	SENT131	20	20	14	14	ceftriaxone	CTX	PA448866	1593	0.637
NULL	Cardiovasc_Diabetol_2011_Dec_22_10_115.nxml.txt.nlp	22189184	SENT48	15	15	13	13	metformin	Met	PA450395	79811	0.637
NULL	Ann_Lab_Med_2014_May_8_34(3)_230-234.nxml.txt.nlp	24790911	SENT125	19	19	17	17	lamivudine	LAM	PA450163	7249;7248	0.637
NULL	Chem_Commun_(Camb)_2013_Jun_21_49(76)_8441-8443.nxml.txt.nlp	23770604	SENT22	4	4	13	13	geldanamycin	Hsp90	PA152031327	3320	0.637
NULL	Int_J_Mol_Cell_Med_2012_Summer_1(3)_145-152.nxml.txt.nlp	24551770	SENT106	2	2	11	11	memantine	mol	PA10364	90527	0.637
NULL	Ital_J_Pediatr_2012_Mar_26_38_10.nxml.txt.nlp	22449104	SENT15	18	18	10	10	thyroglobulin	AIT	PA164754910	160728	0.637
NULL	Br_J_Cancer_2012_May_8_106(10)_1587-1590.nxml.txt.nlp	22568998	SENT81	18	18	37	37	sunitinib	IFN	PA162372840	3439	0.637
NULL	Ann_Hematol_2010_Nov_25_89(11)_1115-1124.nxml.txt.nlp	20499237	SENT108	8	8	26	26	simvastatin	CD5	PA451363	921	0.637
NULL	ScientificWorldJournal_2014_Mar_24_2014_694326.nxml.txt.nlp	24782665	SENT162	29	29	5	5	metformin	FDG	PA450395	23583	0.637
NULL	J_Korean_Med_Sci_2007_Apr_30_22(2)_283-289.nxml.txt.nlp	17449938	SENT9	3	3	27	27	minoxidil	P21	PA450521	1026;9338	0.637
NULL	Multidiscip_Respir_Med_2012_Jun_11_7(1)_4.nxml.txt.nlp	22958344	SENT134	24	24	2	2	rituximab	GM-CSF	PA451261	1437	0.637
NULL	Reprod_Biol_Endocrinol_2004_Mar_24_2_13.nxml.txt.nlp	15040802	SENT185	7	7	17	17	baclofen	PCNA	PA448533	5111	0.637
NULL	Oncol_Rep_2013_Apr_23_29(4)_1268-1274.nxml.txt.nlp	23354756	SENT117	38	38	30	30	trastuzumab	SLC25A43	PA451743	203427	0.637
NULL	Front_Psychol_2013_Oct_17_4_712.nxml.txt.nlp	24151474	SENT29	37	37	39	39	vasopressin	AVP	PA451858	114548;551	0.637
NULL	Multidiscip_Respir_Med_2013_Feb_6_8(1)_11.nxml.txt.nlp	23388501	SENT54	28	28	21	21	thrombin	ASM	PA451674	6609;283120	0.637
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT37	35	35	40	40	vinblastine	MVP	PA451877	9961	0.637
NULL	Curr_Hepat_Rep_2010_May_21_9(2)_75-90.nxml.txt.nlp	20461127	SENT244	27	27	45	45	lamivudine	LAM	PA450163	7249;7248	0.637
NULL	J_Am_Heart_Assoc_2013_Apr_24_2(2)_e000131.nxml.txt.nlp	23537811	SENT88	7	7	22	22	clopidogrel	ABCB1	PA449053	5243	0.637
NULL	BMJ_2009_Jul_14_339_b2538.nxml.txt.nlp	19602530	SENT179	4	4	12	12	esomeprazole	COX	PA10075	1351	0.637
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT132	18	18	24	24	perifosine	DR4	PA165291471	8797	0.637
NULL	Cancer_Med_2012_Aug_8_1(1)_5-16.nxml.txt.nlp	23342249	SENT45	20	20	35	35	fluorescein	San	PA164746009	80218	0.637
NULL	J_Biomed_Biotechnol_2011_Jun_16_2011_807929.nxml.txt.nlp	21738405	SENT202	11	11	6	6	choline	FDG	PA448976	23583	0.637
NULL	Evid_Based_Complement_Alternat_Med_2013_Aug_12_2013_982689.nxml.txt.nlp	23997806	SENT287	20	20	8	8	tolbutamide	APE	PA451718	55704;328	0.637
NULL	Exp_Diabetes_Res_2012_Nov_12_2012_618923.nxml.txt.nlp	23197974	SENT160	11	11	13	13	telmisartan	STZ	PA451605	6484	0.637
NULL	J_Cardiovasc_Dis_Res_2012_Oct-Dec_3(4)_319-322.nxml.txt.nlp	23233778	SENT64	8	8	2	2	ezetimibe	SHARP	PA10816	23013	0.637
NULL	J_Gen_Physiol_2003_Nov_122(5)_621-639.nxml.txt.nlp	14581586	SENT306	3	3	24	24	glucose	ADP	PA449773	23038	0.637
NULL	Neuropsychopharmacology_2009_Apr_2_34(5)_1135-1148.nxml.txt.nlp	18596687	SENT179	17	17	24	24	cocaine	CRF	PA449072	1392;10882	0.637
NULL	Br_J_Cancer_2013_Aug_6_109(3)_686-693.nxml.txt.nlp	23839492	SENT142	7	7	19	19	sorafenib	IL-8	PA7000	3576	0.637
NULL	Oncotarget_2013_Dec_24_5(9)_2418-2427.nxml.txt.nlp	24810714	SENT58	9	9	14	14	cisplatin	NAC	PA449014	22861	0.637
NULL	Br_J_Cancer_2012_Sep_25_107(7)_1009-1016.nxml.txt.nlp	22948724	SENT133	3	3	7	7	sunitinib	FDG	PA162372840	23583	0.637
NULL	Contemp_Clin_Dent_2013_Apr-Jun_4(2)_156-161.nxml.txt.nlp	24015002	SENT119	20	20	18	18	chlorhexidine	SRP	PA164776863	90226	0.637
NULL	Curr_Neuropharmacol_2009_Jun_7(2)_83-95.nxml.txt.nlp	19949566	SENT515	34	34	32	32	tiagabine	TGB	PA451682	5473	0.637
NULL	Indian_J_Anaesth_2011_Nov-Dec_55(6)_618-620.nxml.txt.nlp	22223910	SENT73	19	19	21	21	vasopressin	AVP	PA451858	114548;551	0.637
NULL	Oncotarget_2014_Jun_4_5(18)_8284-8305.nxml.txt.nlp	25268740	SENT254	42	42	9	9	streptomycin	STR	PA451512	6779	0.637
NULL	Oncoimmunology_2013_Sep_1_2(9)_e25789.nxml.txt.nlp	24244905	SENT22	4	4	16	16	cyclophosphamide	CXCL10	PA449165	3627	0.637
NULL	Mol_Vis_2011_Aug_18_17_2221-2227.nxml.txt.nlp	21897744	SENT8	4	4	6	6	l-arginine	NAC	PA448478	22861	0.637
NULL	J_Antimicrob_Chemother_2014_Nov_17_69(11)_2920-2927.nxml.txt.nlp	25038069	SENT139	31	31	29	29	trimethoprim	TMP	PA451788	2012	0.637
NULL	Cancer_Cell_Int_2011_Jun_1_11_15.nxml.txt.nlp	21631944	SENT150	22	22	15	15	etoposide	MICB	PA449552	4277	0.637
NULL	Exp_Lung_Res_2013_Oct_1_39(8)_336-348.nxml.txt.nlp	23919450	SENT176	11	11	2	2	thrombin	PAR-1	PA451674	2011;2149	0.637
NULL	Breast_Cancer_Res_2005_Aug_5_7(5)_212-214.nxml.txt.nlp	16168140	SENT39	10	10	25	25	celecoxib	PI3K	PA448871	5290	0.637
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Sep_18_69(Pt_10)_o1545.nxml.txt.nlp	24098230	SENT70	32	32	20	20	ethanol	mol	PA448073	90527	0.637
NULL	Indian_J_Pharm_Sci_2013_Jan-Feb_75(1)_94-98.nxml.txt.nlp	23901167	SENT87	34	34	15	15	omeprazole	CYP2C9	PA450704	1559	0.637
NULL	Front_Synaptic_Neurosci_2013_Sep_18_5_6.nxml.txt.nlp	24065916	SENT103	10	10	3	3	amphetamine	DCC	PA448408	1630	0.637
NULL	Sensors_(Basel)_2010_Jun_9_10(6)_5859-5871.nxml.txt.nlp	22219691	SENT319	6	6	19	19	thrombin	ITO	PA451674	3160	0.637
NULL	Br_J_Cancer_2011_Apr_12_104(8)_1256-1261.nxml.txt.nlp	21448165	SENT137	6	6	8	8	sunitinib	IFN	PA162372840	3439	0.637
NULL	J_Thromb_Haemost_2013_Jan_11(1)_132-141.nxml.txt.nlp	23205847	SENT209	0	0	42	42	thrombin	FVIII	PA451674	2157	0.637
NULL	J_Gen_Physiol_2013_Feb_141(2)_165-178.nxml.txt.nlp	23359281	SENT37	0	0	33	33	thrombin	CPI-17	PA451674	94274	0.637
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Nov_20_64(Pt_12)_o2387.nxml.txt.nlp	21581358	SENT60	30	30	15	15	ethanol	mol	PA448073	90527	0.637
NULL	J_Cell_Mol_Med_2014_Oct_11_18(10)_2031-2043.nxml.txt.nlp	25109475	SENT16	2	2	10	10	valsartan	IL-6	PA451848	3569	0.637
NULL	Evid_Based_Complement_Alternat_Med_2013_May_2_2013_507091.nxml.txt.nlp	23737833	SENT126	12	12	0	0	nimodipine	NeuN	PA450633	146713	0.637
NULL	J_Gen_Physiol_1984_Jun_1_83(6)_901-918.nxml.txt.nlp	6330282	SENT0	15	15	1	1	guanidine	Gen	PA164781028	348654	0.637
NULL	Adv_Hematol_2012_Mar_8_2012_856341.nxml.txt.nlp	22496694	SENT92	9	9	14	14	ritonavir	CYP3A4	PA451260	1576	0.637
NULL	Diabetes_Care_2010_Jun_23_33(6)_1294-1296.nxml.txt.nlp	20332358	SENT53	9	9	15	15	exenatide	GLP-1	PA164749238	100125288	0.637
NULL	Bioinorg_Chem_Appl_2014_Feb_27_2014_142828.nxml.txt.nlp	24715822	SENT111	9	9	34	34	ethanol	San	PA448073	80218	0.637
NULL	Int_J_Gen_Med_2012_Nov_9_5_935-942.nxml.txt.nlp	23204857	SENT52	6	6	10	10	isoflurane	AIDA	PA450106	64853	0.637
NULL	J_Cell_Biol_2001_Aug_6_154(3)_599-610.nxml.txt.nlp	11481345	SENT75	17	17	10	10	doxycycline	ARNO	PA449415	9266	0.637
NULL	Eur_J_Haematol_2014_Feb_25_92(2)_127-136.nxml.txt.nlp	24118452	SENT163	3	3	8	8	anagrelide	ELN	PA164742986	2006	0.637
NULL	Evid_Based_Complement_Alternat_Med_2011_Feb_14_2011_429843.nxml.txt.nlp	21869897	SENT176	6	6	20	20	ethanol	PC6	PA448073	5125	0.637
NULL	J_Exp_Med_2000_Mar_6_191(5)_761-770.nxml.txt.nlp	10704458	SENT141	9	9	28	28	neomycin	PLP	PA450608	25824;5744	0.637
NULL	ScientificWorldJournal_2013_Feb_3_2013_593267.nxml.txt.nlp	23431256	SENT149	2	2	6	6	chloramphenicol	c-Myc	PA448927	4609	0.637
NULL	JRSM_Cardiovasc_Dis_2012_Jun_30_1(3)_cvd_2012_012010.nxml.txt.nlp	24175065	SENT13	14	14	8	8	sugar	CAD	PA451529	1677;790	0.637
NULL	J_RNAi_Gene_Silencing_2009_Mar_9_5(1)_321-330.nxml.txt.nlp	19771229	SENT214	19	19	28	28	hydroxyurea	RRM2	PA449942	6241	0.637
NULL	Front_Genet_2012_Nov_22_3_249.nxml.txt.nlp	23189085	SENT42	6	6	12	12	methotrexate	CFD	PA450428	1675	0.637
NULL	Ann_Rheum_Dis_2011_Mar_6_70(6)_909-920.nxml.txt.nlp	21378402	SENT351	15	15	0	0	rituximab	San	PA451261	80218	0.637
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Apr_15_9_13.nxml.txt.nlp	20398300	SENT134	6	6	0	0	moxifloxacin	LAM	PA450555	7249;7248	0.637
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT128	13	13	4	4	encainide	CYP3A4	PA449459	1576	0.637
NULL	Genome_Med_2010_Mar_1_2(3)_17.nxml.txt.nlp	20487506	SENT283	22	22	10	10	nevirapine	CCL3	PA450616	6348	0.637
NULL	J_Cancer_Prev_2014_Mar_19(1)_39-46.nxml.txt.nlp	25337571	SENT8	0	0	18	18	ethanol	JNK	PA448073	5599	0.637
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT157	31	31	42	42	pp2	PP2		4888	0.637
NULL	Mol_Biol_Cell_2012_Sep_1_23(17)_3473-3484.nxml.txt.nlp	22787275	SENT191	10	10	13	13	doxorubicin	ABCC1	PA449412	4363	0.637
NULL	Cells_2012_Jun_20_1(2)_168-203.nxml.txt.nlp	24710422	SENT212	25	25	6	6	lipase	HSL	PA450239	3991	0.637
NULL	Adipocyte_2012_Jul_1_1(3)_132-181.nxml.txt.nlp	23700522	SENT90	16	16	25	25	lipase	HSL	PA450239	3991	0.637
NULL	Case_Rep_Oncol_2012_Dec_20_5(3)_676-681.nxml.txt.nlp	23341811	SENT39	25	25	14	14	cetuximab	EGFR	PA10040	1956	0.637
NULL	ScientificWorldJournal_2013_Oct_1_2013_523480.nxml.txt.nlp	24198723	SENT109	4	4	25	25	sertraline	Bcl-2	PA451333	596	0.637
NULL	J_Biol_Chem_2012_Dec_14_287(51)_43094-43107.nxml.txt.nlp	23118219	SENT350	9	9	19	19	hyaluronan	CD44	PA165958431	960	0.637
NULL	Int_J_Med_Chem_2012_Dec_13_2012_530392.nxml.txt.nlp	25379286	SENT255	14	14	33	33	ethanol	mol	PA448073	90527	0.637
NULL	Indian_J_Pharmacol_2009_Dec_41(6)_262-267.nxml.txt.nlp	20407557	SENT179	2	2	12	12	ezetimibe	STZ	PA10816	6484	0.637
NULL	Oncotarget_2014_Nov_8_5(21)_10280-10292.nxml.txt.nlp	25373733	SENT200	19	19	11	11	temsirolimus	HIF-1	PA164746890	29072	0.637
NULL	Diabetes_Care_2008_Jul_31(7)_1461-1466.nxml.txt.nlp	18594064	SENT122	6	6	32	32	salsalate	adiponectin	PA164745462	9370	0.637
NULL	Lab_Anim_Res_2014_Dec_24_30(4)_143-150.nxml.txt.nlp	25628724	SENT91	8	8	21	21	genistein	BPA	PA165109660	667	0.637
NULL	Cell_Cycle_2013_Dec_15_12(24)_3759-3769.nxml.txt.nlp	24107633	SENT205	9	9	29	29	metformin	CO2	PA450395	4513	0.637
NULL	Front_Neurosci_2014_Jun_3_8_128.nxml.txt.nlp	24917782	SENT166	12	12	16	16	ethanol	POMC	PA448073	5443	0.637
NULL	Indian_J_Psychiatry_2007_Oct-Dec_49(4)_271-276.nxml.txt.nlp	20680140	SENT66	16	16	19	19	clozapine	spatial	PA449061	219793	0.637
NULL	J_Cardiothorac_Surg_2012_Jun_28_7_61.nxml.txt.nlp	22741616	SENT109	7	7	16	16	amiodarone	NAC	PA448383	22861	0.637
NULL	Cell_Death_Dis_2014_Mar_13_5(3)_e1126.nxml.txt.nlp	24625985	SENT68	11	11	4	4	bortezomib	URI	PA10252	8725	0.637
NULL	J_Midlife_Health_2014_Jan-Mar_5(1)_3-5.nxml.txt.nlp	24672198	SENT54	17	17	9	9	estradiol	ANM	PA449503	7138	0.637
NULL	Int_J_Biomed_Sci_2014_Mar_10(1)_1-7.nxml.txt.nlp	24711742	SENT140	10	10	6	6	thrombin	PAR-1	PA451674	2011;2149	0.637
NULL	Diabetes_2013_Sep_15_62(9)_3019-3021.nxml.txt.nlp	23970522	SENT32	19	19	9	9	chymotrypsin	CTRB2	PA448994	440387	0.637
NULL	Croat_Med_J_2012_Aug_53(4)_343-349.nxml.txt.nlp	22911527	SENT65	13	13	11	11	nifedipine	NIF	PA450631	6280	0.637
NULL	Clin_Med_Insights_Oncol_2012_Oct_31_6_355-362.nxml.txt.nlp	23133319	SENT50	21	21	17	17	rifampin	CYP3A4	PA451250	1576	0.637
NULL	Acta_Pharmacol_Sin_2012_Oct_3_33(10)_1311-1318.nxml.txt.nlp	22941289	SENT135	0	0	5	5	sorafenib	VEGFR	PA7000	3791	0.637
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jun_11_67(Pt_7)_o1618.nxml.txt.nlp	21837024	SENT3	23	23	18	18	naphthol	mol	PA154081779	90527	0.637
NULL	Int_J_Biomed_Sci_2008_Mar_4(1)_8-13.nxml.txt.nlp	23675060	SENT97	17	17	19	19	estradiol	IL-4	PA449503	3565	0.637
NULL	Biomed_Res_Int_2014_Apr_10_2014_615363.nxml.txt.nlp	24818147	SENT52	16	16	11	11	thrombin	ADP	PA451674	23038	0.637
NULL	Proteins_2013_Sep_13_81(9)_1593-1609.nxml.txt.nlp	23671031	SENT80	21	21	26	26	nadh	PLP	PA164755085	25824;5744	0.637
NULL	Int_J_Mol_Sci_2014_Jun_3_15(6)_9924-9944.nxml.txt.nlp	24897026	SENT180	5	5	17	17	ethanol	AMPK	PA448073	5563	0.637
NULL	J_Psychopharmacol_2014_Sep_28(9)_837-846.nxml.txt.nlp	25035246	SENT27	17	17	19	19	atomoxetine	ATX	PA134688071	5168;23049	0.637
NULL	Environ_Health_Perspect_2005_Apr_14_113(4)_431-439.nxml.txt.nlp	15811834	SENT22	6	6	16	16	nifedipine	PRL	PA450631	5617	0.637
NULL	Breast_Cancer_Res_2011_Jun_9_13(3)_R57.nxml.txt.nlp	21658222	SENT24	25	25	19	19	epirubicin	UGT2B15	PA449476	7366	0.637
NULL	Pak_J_Med_Sci_2013_Jan-Mar_29(1)_140-143.nxml.txt.nlp	24353526	SENT78	7	7	25	25	captopril	NEFA	PA448780	4925	0.637
NULL	Cell_J_2011_Aug_24_Summer_13(2)_97-102.nxml.txt.nlp	23508230	SENT67	13	13	15	15	ethambutol	ETB	PA164784021	1910	0.637
NULL	Emerg_Infect_Dis_2014_Mar_20(3)_400-408.nxml.txt.nlp	24565738	SENT128	24	24	22	22	ethambutol	EMB	PA164784021	133418	0.637
NULL	Gut_Liver_2013_Sep_14_7(5)_585-593.nxml.txt.nlp	24073317	SENT74	15	15	13	13	ribavirin	IFN	PA451241	3439	0.637
NULL	Acta_Pharmacol_Sin_2012_Nov_30_33(11)_1372-1378.nxml.txt.nlp	22842736	SENT22	5	5	11	11	diclofenac	COX	PA449293	1351	0.637
NULL	Curr_Neuropharmacol_2009_Jun_7(2)_83-95.nxml.txt.nlp	19949566	SENT445	2	2	32	32	carbamazepine	TGB	PA448785	5473	0.637
NULL	Braz_J_Med_Biol_Res_2012_Jul_20_45(10)_935-941.nxml.txt.nlp	22801415	SENT3	25	25	35	35	pioglitazone	ghrelin	PA450970	51738	0.637
NULL	Nucleic_Acids_Res_2010_Oct_28_38(19)_6418-6432.nxml.txt.nlp	20511593	SENT231	43	43	38	38	collagenase	AP-1	PA449107	2353;3727;2354;3725	0.637
NULL	ScientificWorldJournal_2012_Dec_27_2012_740308.nxml.txt.nlp	23346021	SENT182	30	30	27	27	ethanol	NAC	PA448073	22861	0.637
NULL	J_Korean_Med_Sci_2010_Feb_21_25(2)_197-202.nxml.txt.nlp	20119570	SENT117	2	2	28	28	ciprofloxacin	VAN	PA449009	10318	0.637
NULL	Eur_J_Med_Res_2014_Jun_24_19(1)_34.nxml.txt.nlp	24961604	SENT95	10	10	7	7	vincristine	BCL11A	PA451879	53335	0.637
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_2_2013_482428.nxml.txt.nlp	23818926	SENT50	27	27	14	14	l-glutamine	FBS	PA10090	64319;26269	0.637
NULL	Brain_2014_May_12_137(5)_1454-1469.nxml.txt.nlp	24625696	SENT212	7	7	23	23	dextran	DARC	PA449261	2532	0.637
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Apr_7_9_12.nxml.txt.nlp	20374640	SENT102	4	4	6	6	ampicillin	CHL	PA448419	91851	0.637
NULL	J_Biol_Chem_2013_Dec_27_288(52)_36762-36771.nxml.txt.nlp	24217250	SENT30	6	6	0	0	galactose	Langerin	PA449725	50489	0.637
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT198	4	4	10	10	resveratrol	p53		7157	0.637
NULL	J_Antimicrob_Chemother_2013_May_1_68(5)_1066-1070.nxml.txt.nlp	23378414	SENT93	21	21	19	19	novobiocin	NOV	PA164768819	4856;5361;6134	0.637
NULL	Aging_(Albany_NY)_2012_Jul_31_4(7)_499-508.nxml.txt.nlp	22868943	SENT57	5	5	15	15	resveratrol	ANOVA		4858	0.637
NULL	Cell_Mol_Life_Sci_2011_May_26_68(10)_1785-1798.nxml.txt.nlp	20976523	SENT214	34	34	29	29	collagenase	AP-1	PA449107	2353;3727;2354;3725	0.637
NULL	Acta_Pharmacol_Sin_2010_Jul_28_31(7)_867-873.nxml.txt.nlp	20581857	SENT212	5	5	7	7	docetaxel	PC3	PA449383	57332;7832;5122	0.637
NULL	Biosci_Rep_2013_Aug_2_33(4)_e00055.nxml.txt.nlp	23802190	SENT29	24	24	22	22	nebivolol	p47phox	PA151958426	653361	0.637
NULL	Libyan_J_Med_2007_Dec_1_2(4)_169-175.nxml.txt.nlp	21503240	SENT239	6	6	33	33	picrotoxin	CA1	PA164777007	759	0.637
NULL	Cancer_Med_2013_Aug_10_2(4)_488-495.nxml.txt.nlp	24156021	SENT121	14	14	20	20	cisplatin	GEM	PA449014	2669	0.637
NULL	Evid_Based_Complement_Alternat_Med_2014_May_12_2014_804746.nxml.txt.nlp	24899911	SENT179	5	5	17	17	atropine	B12	PA448505	7126;4709	0.637
NULL	Pharmaceutics_2011_Nov_18_3(4)_865-913.nxml.txt.nlp	24309312	SENT1995	4	4	7	7	lansoprazole	CYP2C19	PA450180	1557	0.637
NULL	Exp_Ther_Med_2014_Feb_4_7(2)_478-482.nxml.txt.nlp	24396429	SENT30	20	20	9	9	glucose	HO-1	PA449773	3162	0.637
NULL	Nat_Commun_2013_4_2720.nxml.txt.nlp	24193139	SENT231	22	22	24	24	methylphenidate	AMPH	PA450464	273	0.637
NULL	Arthritis_Res_Ther_2012_Jun_25_14(3)_215.nxml.txt.nlp	22731694	SENT70	2	2	17	17	cyclophosphamide	RIBA	PA449165	6014	0.637
NULL	Br_J_Cancer_2013_Oct_1_109(7)_1717-1724.nxml.txt.nlp	24022187	SENT102	11	11	28	28	trabectedin	CCL2	PA165958349	6347	0.637
NULL	Indian_J_Urol_2008_Jul-Sep_24(3)_289-294.nxml.txt.nlp	19468456	SENT73	17	17	19	19	vasopressin	AVP	PA451858	114548;551	0.637
NULL	Mol_Cancer_2012_Mar_23_11_15.nxml.txt.nlp	22439866	SENT214	3	3	0	0	collagenase	MMP1	PA449107	4312	0.637
NULL	Front_Cell_Neurosci_2014_Jul_8_8_188.nxml.txt.nlp	25071448	SENT24	13	13	17	17	estradiol	aromatase	PA449503	1588	0.637
NULL	J_Immunotoxicol_2013_Jan_11_10(1)_75-82.nxml.txt.nlp	22967038	SENT101	10	10	2	2	rituximab	IFN	PA451261	3439	0.637
NULL	Front_Genet_2012_Nov_5_3_236.nxml.txt.nlp	23133441	SENT335	0	0	4	4	amlodipine	MDR1	PA448388	5243	0.637
NULL	Environ_Health_Perspect_1995_Jul-Aug_103(7-8)_708-713.nxml.txt.nlp	7588483	SENT5	10	10	8	8	genistein	DES	PA165109660	1674	0.637
NULL	Case_Rep_Oncol_2013_Jan_8_6(1)_1-5.nxml.txt.nlp	23466482	SENT67	2	2	5	5	capecitabine	CEA	PA448771	5670;1087	0.637
NULL	Nat_Biotechnol_2013_Jan_16_31(1)_63-70.nxml.txt.nlp	23242163	SENT256	15	15	18	18	marimastat	ANOVA	PA164748329	4858	0.637
NULL	Br_J_Cancer_1998_Jun_77(12)_2104-2111.nxml.txt.nlp	9649121	SENT12	18	18	20	20	bleomycin	BLM	PA448645	641	0.637
NULL	Int_J_Mol_Sci_2014_Nov_17_15(11)_21179-21201.nxml.txt.nlp	25407525	SENT46	36	36	30	30	kanamycin	G6PD	PA450137	2539	0.637
NULL	Curr_Oncol_2006_Feb_13(1)_2-7.nxml.txt.nlp	17576435	SENT15	13	13	19	19	trastuzumab	HER2	PA451743	2064	0.637
NULL	J_Clin_Biochem_Nutr_2010_Mar_27_46(2)_177-185.nxml.txt.nlp	20216951	SENT37	11	11	16	16	l-arginine	CEA	PA448478	5670;1087	0.637
NULL	Front_Neurol_2011_Dec_16_2_72.nxml.txt.nlp	22203815	SENT218	29	29	8	8	dextran	VSOP	PA449261	84329	0.637
NULL	Front_Immunol_2013_Nov_8_4_363.nxml.txt.nlp	24265631	SENT255	13	13	26	26	temozolomide	CXCL10	PA451609	3627	0.637
NULL	Biotechnol_Res_Int_2014_Jul_24_2014_319397.nxml.txt.nlp	25170426	SENT212	30	30	14	14	fluoxetine	mol	PA449673	90527	0.637
NULL	Oncol_Rep_2013_Apr_23_29(4)_1268-1274.nxml.txt.nlp	23354756	SENT99	6	6	10	10	trastuzumab	SLC25A43	PA451743	203427	0.637
NULL	Oncologist_2010_May_28_15(5)_436-446.nxml.txt.nlp	20427383	SENT69	18	18	34	34	paclitaxel	San	PA450761	80218	0.637
NULL	Osteopath_Med_Prim_Care_2007_Apr_20_1_9.nxml.txt.nlp	17448241	SENT144	5	5	3	3	exenatide	GLP-1	PA164749238	100125288	0.637
NULL	Cell_Death_Dis_2011_Apr_14_2(4)_e146.nxml.txt.nlp	21490678	SENT42	36	36	19	19	staurosporine	NIK	PA165109623	9020;9448	0.637
NULL	Acta_Vet_Scand_2011_Feb_17_53(1)_11.nxml.txt.nlp	21324209	SENT82	22	22	20	20	oxytetracycline	OTC	PA450757	5009	0.637
NULL	Emerg_Infect_Dis_2011_Mar_17(3)_510-513.nxml.txt.nlp	21392446	SENT53	18	18	36	36	ethambutol	ETO	PA164784021	862	0.637
NULL	Oncoscience_2014_Aug_7_1(8)_540-549.nxml.txt.nlp	25594061	SENT28	28	28	15	15	bevacizumab	EGFR	PA130232992	1956	0.637
NULL	Diabetes_Metab_Syndr_Obes_2014_Aug_1_7_381-389.nxml.txt.nlp	25120374	SENT105	10	10	4	4	salsalate	adiponectin	PA164745462	9370	0.637
NULL	Case_Rep_Oncol_2010_Jul_31_3(2)_282-286.nxml.txt.nlp	21347194	SENT41	34	34	25	25	oxaliplatin	KRAS	PA131285527	3845	0.637
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT203	26	26	28	28	perifosine	TRAIL	PA165291471	8743	0.637
NULL	Mol_Med_Rep_2014_Nov_5_10(5)_2334-2340.nxml.txt.nlp	25189202	SENT157	2	2	4	4	ceftazidime	CFP	PA448861	5199	0.637
NULL	Diabetes_2013_Nov_18_62(11)_3851-3862.nxml.txt.nlp	23884890	SENT212	29	29	20	20	metformin	Met	PA450395	79811	0.637
NULL	Indian_J_Nephrol_2009_Jan_19(1)_23-26.nxml.txt.nlp	20352008	SENT54	15	15	25	25	potassium	KCNJ1	PA451047	3758	0.637
NULL	Clinicoecon_Outcomes_Res_2014_Oct_17_6_451-461.nxml.txt.nlp	25378939	SENT28	32	32	34	34	linezolid	HAP	PA450233	5915;10313	0.637
NULL	Curr_Respir_Care_Rep_2014_Jul_6_3(3)_121-132.nxml.txt.nlp	25089228	SENT444	8	8	11	11	budesonide	p38	PA448681	10598;1432;7965	0.637
NULL	Breast_Cancer_Res_2012_Aug_8_14(4)_R116.nxml.txt.nlp	22873525	SENT314	17	17	15	15	trastuzumab	PTEN	PA451743	5728	0.637
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_112-117.nxml.txt.nlp	23864844	SENT28	7	7	9	9	rituximab	CHOP	PA451261	1649	0.637
NULL	Breast_Cancer_Res_2000_Aug_11_2(6)_417-422.nxml.txt.nlp	11250735	SENT41	6	6	11	11	thrombin	CD31	PA451674	5175	0.637
NULL	Diabetes_Care_2013_Jul_12_36(7)_2118-2125.nxml.txt.nlp	23645885	SENT186	11	11	9	9	liraglutide	GLP-1	PA165958364	100125288	0.637
NULL	Diabetologia_2010_Jun_27_53(6)_1142-1150.nxml.txt.nlp	20349036	SENT226	21	21	23	23	nitroprusside	AMPK	PA451406	5563	0.637
NULL	Acta_Pharmacol_Sin_2011_Jul_9_32(7)_879-887.nxml.txt.nlp	21552292	SENT84	0	0	10	10	metformin	AMPK	PA450395	5563	0.637
NULL	Curr_Dermatol_Rep_2014_Jan_22_3(1)_46-53.nxml.txt.nlp	24587977	SENT198	0	0	3	3	pazopanib	VEGFR	PA165291492	3791	0.637
NULL	Oncologist_2011_Jan_6_16(1)_5-24.nxml.txt.nlp	21212434	SENT189	9	9	14	14	dacarbazine	IL-2	PA449197	3558	0.637
NULL	Emerg_Infect_Dis_2005_Jun_11(6)_873-882.nxml.txt.nlp	15963282	SENT94	18	18	16	16	tobramycin	TOB	PA451704	10140	0.637
NULL	Breast_Cancer_Res_Treat_2012_Jul_5_134(2)_693-700.nxml.txt.nlp	22562123	SENT210	3	3	13	13	tamoxifen	FMO3	PA451581	2328	0.637
NULL	Indian_J_Pharmacol_2014_Nov-Dec_46(6)_627-632.nxml.txt.nlp	25538335	SENT170	37	37	35	35	metformin	Q10	PA450395	27161	0.637
NULL	Int_J_Mol_Sci_2014_Nov_18_15(11)_21401-21418.nxml.txt.nlp	25411802	SENT594	14	14	9	9	troglitazone	adiponectin	PA451799	9370	0.637
NULL	J_Invest_Dermatol_2013_Jul_13_133(7)_1742-1751.nxml.txt.nlp	23407402	SENT255	37	37	26	26	etanercept	IL-17	PA449515	3605	0.637
NULL	Mutagenesis_2013_Nov_21_28(6)_699-707.nxml.txt.nlp	24136994	SENT62	20	20	10	10	l-glutamine	F12	PA10090	2161	0.637
NULL	Physiol_Rep_2014_Nov_20_2(11)_e12202.nxml.txt.nlp	25413322	SENT123	29	29	35	35	propranolol	ANOVA	PA451145	4858	0.637
NULL	Br_J_Cancer_2013_May_28_108(10)_2021-2032.nxml.txt.nlp	23632475	SENT253	0	0	6	6	metformin	AMPK	PA450395	5563	0.637
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_May_17_70(Pt_6)_o666-o667.nxml.txt.nlp	24940248	SENT77	12	12	34	34	sulfur	hole	PA451558	80757	0.637
NULL	Acta_Pharmacol_Sin_2013_Dec_18_34(12)_1508-1514.nxml.txt.nlp	24241347	SENT207	7	7	5	5	ketanserin	KET	PA131053734	8626	0.636
NULL	J_Clin_Biochem_Nutr_2011_Mar_26_48(2)_126-133.nxml.txt.nlp	21373265	SENT119	15	15	28	28	lansoprazole	HO-1	PA450180	3162	0.636
NULL	J_Viral_Hepat_2007_Nov_14(11)_751-766.nxml.txt.nlp	17927611	SENT106	12	12	10	10	lamivudine	LAM	PA450163	7249;7248	0.636
NULL	AIDS_Res_Ther_2009_Apr_9_6_3.nxml.txt.nlp	19358725	SENT56	24	24	22	22	tenofovir	BID	PA10204	637	0.636
NULL	Viruses_2014_Jul_22_6(7)_2858-2879.nxml.txt.nlp	25054884	SENT149	7	7	17	17	raltegravir	ESD		2098	0.636
NULL	Mol_Med_Rep_2014_Nov_5_10(5)_2334-2340.nxml.txt.nlp	25189202	SENT157	6	6	4	4	cefoperazone	CFP	PA448849	5199	0.636
NULL	Acta_Vet_Scand_2003_Dec_31_44(4)_171-180.nxml.txt.nlp	15074630	SENT110	39	39	26	26	ivermectin	MSD	PA450133	4434	0.636
NULL	Cent_European_J_Urol_2013_Apr_26_66(1)_39-44.nxml.txt.nlp	24578986	SENT87	26	26	23	23	cyclophosphamide	ADM	PA449165	133	0.636
NULL	Arthritis_Res_Ther_2010_Jul_7_12(4)_R131.nxml.txt.nlp	20609215	SENT211	23	23	8	8	iloprost	CXCL12	PA164746843	6387	0.636
NULL	Diabetes_Care_2013_Aug_11_36(8)_2311-2316.nxml.txt.nlp	23462667	SENT10	7	7	23	23	glibenclamide	KCNJ11	PA449782	3767	0.636
NULL	Acta_Pharmacol_Sin_2010_Jun_4_31(6)_709-717.nxml.txt.nlp	20523342	SENT3	33	33	12	12	repaglinide	IGF2BP2	PA451234	10644	0.636
NULL	Br_J_Clin_Pharmacol_2011_Oct_72(4)_647-657.nxml.txt.nlp	21518389	SENT161	21	21	24	24	thrombin	ADP	PA451674	23038	0.636
NULL	Anesth_Pain_Med_2014_Aug_2_4(3)_e17620.nxml.txt.nlp	25237638	SENT137	16	16	6	6	levobupivacaine	AAP	PA164754741	5345	0.636
NULL	Oxid_Med_Cell_Longev_2013_Apr_30_2013_796891.nxml.txt.nlp	23738041	SENT249	7	7	12	12	resveratrol	AMPK		5563	0.636
NULL	Aging_(Albany_NY)_2011_Apr_4_3(4)_348-362.nxml.txt.nlp	21483040	SENT19	0	0	4	4	metformin	S6K1	PA450395	6198	0.636
NULL	J_Adv_Pract_Oncol_2014_Jan_1_Jan-Feb_5(1)_24-29.nxml.txt.nlp	25032030	SENT103	0	0	9	9	carbamazepine	CYP1A2	PA448785	1544	0.636
NULL	Med_Sci_Monit_2013_May_1_19_317-326.nxml.txt.nlp	23632427	SENT261	27	27	13	13	aztreonam	CTX	PA448523	1593	0.636
NULL	Biol_Proced_Online_2007_Dec_24_9_73-83.nxml.txt.nlp	18385809	SENT80	15	15	24	24	paraformaldehyde	CD19	PA450790	930	0.636
NULL	Front_Neurosci_2014_Nov_10_8_364.nxml.txt.nlp	25426018	SENT234	10	10	20	20	fluorescein	Casper	PA164746009	8837	0.636
NULL	Front_Immunol_2013_Mar_27_4_76.nxml.txt.nlp	23543707	SENT1025	21	21	2	2	cetuximab	FCGR3A	PA10040	2214	0.636
NULL	Oxid_Med_Cell_Longev_2013_Mar_18_2013_640673.nxml.txt.nlp	23577225	SENT66	10	10	12	12	diethylstilbestrol	DES	PA449307	1674	0.636
NULL	Biosci_Rep_2014_Sep_17_34(5)_e00138.nxml.txt.nlp	25137483	SENT54	20	20	7	7	fluorescein	SNA	PA164746009	6615	0.636
NULL	Int_J_Endocrinol_2014_Mar_12_2014_847827.nxml.txt.nlp	24744784	SENT152	4	4	20	20	anakinra	IL-6	PA10799	3569	0.636
NULL	J_Cell_Biol_2005_Jul_4_170(1)_49-59.nxml.txt.nlp	15983061	SENT156	19	19	23	23	fluorescein	HIF1	PA164746009	3091	0.636
NULL	Curr_Neuropharmacol_2009_Jun_7(2)_83-95.nxml.txt.nlp	19949566	SENT474	34	34	32	32	tiagabine	TGB	PA451682	5473	0.636
NULL	Ind_Psychiatry_J_2014_Jan-Jun_23(1)_27-35.nxml.txt.nlp	25535442	SENT109	18	18	3	3	amisulpride	SAPS	PA162565877	8935	0.636
NULL	Mol_Cancer_2010_Mar_2_9_46.nxml.txt.nlp	20196838	SENT202	15	15	13	13	ketoconazole	CYP3A4	PA450146	1576	0.636
NULL	Int_J_Environ_Res_Public_Health_2011_Jul_30_8(7)_2747-2757.nxml.txt.nlp	21845156	SENT139	9	9	27	27	trypsin	SPINK1	PA451806	6690	0.636
NULL	Front_Cell_Neurosci_2014_Jul_8_8_188.nxml.txt.nlp	25071448	SENT228	0	0	9	9	estradiol	NOT	PA449503	4929	0.636
NULL	Acta_Pharmacol_Sin_2013_Jan_17_34(1)_157-166.nxml.txt.nlp	23247593	SENT13	2	2	24	24	berberine	Bcl-2	PA165860812	596	0.636
NULL	Iran_J_Reprod_Med_2013_Jul_11(7)_565-576.nxml.txt.nlp	24639792	SENT172	21	21	34	34	berberine	SLPI	PA165860812	6590	0.636
NULL	Front_Neurosci_2015_Jan_6_8_420.nxml.txt.nlp	25610363	SENT880	7	7	17	17	estradiol	CA1	PA449503	759	0.636
NULL	Acta_Pharmacol_Sin_2012_Jan_3_33(1)_49-56.nxml.txt.nlp	22212430	SENT124	8	8	4	4	thrombin	PAR-1	PA451674	2011;2149	0.636
NULL	Mol_Pain_2013_Feb_28_9_7.nxml.txt.nlp	23448290	SENT86	10	10	27	27	capsaicin	TRPA1	PA448776	8989	0.636
NULL	Front_Chem_2014_Aug_26_2_72.nxml.txt.nlp	25207271	SENT109	0	0	7	7	ethanol	mol	PA448073	90527	0.636
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT15	5	5	13	13	cisplatin	DR5	PA449014	8795	0.636
NULL	Emerg_Infect_Dis_2011_Mar_17(3)_510-513.nxml.txt.nlp	21392446	SENT53	14	14	16	16	rifampin	EMB	PA451250	133418	0.636
NULL	Int_J_Vasc_Med_2012_Sep_11_2012_524235.nxml.txt.nlp	21915378	SENT135	26	26	14	14	thrombin	IL-17	PA451674	3605	0.636
NULL	Cell_Commun_Signal_2011_May_15_9_13.nxml.txt.nlp	21569639	SENT264	0	0	5	5	quinacrine	p53	PA164745551	7157	0.636
NULL	Int_J_Mol_Sci_2014_Oct_13_15(10)_18362-18380.nxml.txt.nlp	25314299	SENT187	0	0	7	7	capsaicin	CPZ	PA448776	8532	0.636
NULL	Mol_Cancer_2009_Jul_14_8_48.nxml.txt.nlp	19602291	SENT213	4	4	0	0	cisplatin	FANCF	PA449014	2188	0.636
NULL	J_Oncol_2012_Jun_19_2012_521215.nxml.txt.nlp	22778735	SENT258	18	18	20	20	gefitinib	ERBB3	PA131301952	2065	0.636
NULL	Curr_Neuropharmacol_2009_Dec_7(4)_296-301.nxml.txt.nlp	20514209	SENT111	17	17	11	11	vasopressin	ACTH	PA451858	5443	0.636
NULL	J_Cardiothorac_Surg_2012_Jun_28_7_61.nxml.txt.nlp	22741616	SENT110	10	10	8	8	amiodarone	NAC	PA448383	22861	0.636
NULL	Oncol_Lett_2014_Jun_28_7(6)_2093-2098.nxml.txt.nlp	24932295	SENT120	0	0	5	5	resveratrol	PI3K		5290	0.636
NULL	Arthritis_Res_Ther_2008_Aug_29_10(4)_213.nxml.txt.nlp	18828865	SENT126	26	26	23	23	lipase	PLTP	PA450239	5360	0.636
NULL	Gene_Ther_2010_Aug_1_17(8)_1042-1051.nxml.txt.nlp	20596059	SENT19	0	0	25	25	bevacizumab	KDR	PA130232992	3791	0.636
NULL	Open_Biochem_J_2014_Nov_1_8_74-82.nxml.txt.nlp	25400709	SENT440	8	8	16	16	resveratrol	PTEN		5728	0.636
NULL	J_Exp_Med_1977_Dec_1_146(6)_1484-1499.nxml.txt.nlp	925610	SENT6	26	26	18	18	trypsin	C42	PA451806	51654	0.636
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Sep_30_67(Pt_10)_o2720.nxml.txt.nlp	22065500	SENT68	13	13	9	9	ethanol	mol	PA448073	90527	0.636
NULL	Sensors_(Basel)_2013_Feb_28_13(3)_2895-2910.nxml.txt.nlp	23449119	SENT123	17	17	30	30	pp2	PP1		5540;5464	0.636
NULL	Int_J_Mol_Sci_2014_Nov_17_15(11)_21270-21285.nxml.txt.nlp	25407530	SENT353	30	30	18	18	collagenase	c-Jun	PA449107	3725	0.636
NULL	J_Exp_Med_1998_Mar_16_187(6)_949-959.nxml.txt.nlp	9500797	SENT41	10	10	22	22	zalcitabine	CD4	PA451950	920	0.636
NULL	Leukemia_2013_Feb_3_27(2)_315-324.nxml.txt.nlp	22751450	SENT215	5	5	7	7	sorafenib	Mcl-1	PA7000	4170	0.636
NULL	Semin_Immunopathol_2012_Jan_30_34(1)_167-179.nxml.txt.nlp	21805225	SENT52	26	26	21	21	thrombin	IL-6	PA451674	3569	0.636
NULL	J_Carcinog_2011_Nov_30_10_25.nxml.txt.nlp	22190867	SENT245	10	10	6	6	tamoxifen	N-CoR	PA451581	9611	0.636
NULL	Oncol_Rep_2013_Jan_26_29(1)_297-305.nxml.txt.nlp	23129017	SENT131	19	19	21	21	doxycycline	TR2	PA449415	80834;114112;8764	0.636
NULL	Case_Rep_Infect_Dis_2014_Aug_14_2014_370286.nxml.txt.nlp	25197584	SENT50	7	7	11	11	raltegravir	CD4		920	0.636
NULL	Cancers_(Basel)_2014_Oct_24_6(4)_2187-2223.nxml.txt.nlp	25347122	SENT699	8	8	35	35	fluorouracil	MA5	PA128406956	29944	0.636
NULL	eLife_2014_May_27_3_e02200.nxml.txt.nlp	24867637	SENT5	5	5	10	10	nutlin-3	p53		7157	0.636
NULL	Cases_J_2009_Jun_26_2_6384.nxml.txt.nlp	19829800	SENT16	27	27	10	10	rituximab	CHOP	PA451261	1649	0.636
NULL	Virulence_2013_Jan_1_4(1)_3-66.nxml.txt.nlp	23076359	SENT1454	5	5	12	12	nadh	NOX2	PA164755085	1536	0.636
NULL	Ann_Hematol_2014_Apr_1_93(8)_1371-1380.nxml.txt.nlp	24687382	SENT29	6	6	11	11	thalidomide	CRBN	PA451644	51185	0.636
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jul_10_68(Pt_8)_o2421.nxml.txt.nlp	22904872	SENT65	44	44	36	36	ethanol	mol	PA448073	90527	0.636
NULL	Exp_Diabetes_Res_2012_Oct_15_2012_465282.nxml.txt.nlp	23118742	SENT9	27	27	18	18	metformin	FGF21	PA450395	26291	0.636
NULL	Chem_Cent_J_2012_May_11_6_41.nxml.txt.nlp	22578215	SENT7	9	9	11	11	naringin	castor	PA151958360	54897	0.636
NULL	Oncotarget_2013_Nov_22_5(4)_933-943.nxml.txt.nlp	24659749	SENT42	10	10	18	18	nutlin-3	p53		7157	0.636
NULL	Int_J_Trop_Dis_Health_2014_4(5)_582-594.nxml.txt.nlp	25414840	SENT171	7	7	14	14	mefloquine	IPT	PA450348	54802	0.636
NULL	J_Headache_Pain_2011_Aug_25_12(4)_399-403.nxml.txt.nlp	21437713	SENT94	1	1	6	6	naratriptan	OTC	PA450597	5009	0.636
NULL	Iran_Red_Crescent_Med_J_2012_Dec_6_14(12)_782-786.nxml.txt.nlp	23483042	SENT37	5	5	20	20	teicoplanin	VISA	PA164746244	57506	0.636
NULL	Acta_Pharmacol_Sin_2013_Sep_5_34(9)_1192-1200.nxml.txt.nlp	23685957	SENT178	3	3	18	18	curcumin	AP-2	PA151958596	7020	0.636
NULL	Antibodies_(Basel)_2012_Jul_4_1(2)_149-171.nxml.txt.nlp	24634778	SENT34	24	24	15	15	rituximab	CD59	PA451261	966	0.636
NULL	Int_J_Environ_Res_Public_Health_2010_May_28_7(5)_1970-1983.nxml.txt.nlp	20623005	SENT36	13	13	3	3	arsenite	AS3MT	PA452638	57412	0.636
NULL	Cell_Death_Dis_2013_Jun_13_4(6)_e666.nxml.txt.nlp	23764847	SENT150	23	23	19	19	gentamicin	B27	PA449753	56246	0.636
NULL	Anticancer_Agents_Med_Chem_2012_Feb_12(2)_163-171.nxml.txt.nlp	22043994	SENT295	5	5	33	33	cetuximab	BRAF	PA10040	673	0.636
NULL	Theranostics_2014_Jan_14_4(2)_215-228.nxml.txt.nlp	24465277	SENT289	9	9	0	0	s-adenosylmethionine	COMT	PA164754994	1312	0.636
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1449-1456.nxml.txt.nlp	24077631	SENT153	3	3	10	10	tolbutamide	CYP2C9	PA451718	1559	0.636
NULL	Breast_Cancer_Res_2014_Sep_28_16(5)_446.nxml.txt.nlp	25467785	SENT155	13	13	16	16	raloxifene	STAR	PA451221	6770;2984	0.636
NULL	Cancer_Manag_Res_2012_Nov_9_4_383-395.nxml.txt.nlp	23204869	SENT137	0	0	8	8	carmustine	Bcl-2	PA448810	596	0.636
NULL	Diabetes_Care_2011_Jun_20_34(6)_1406-1411.nxml.txt.nlp	21515837	SENT144	23	23	30	30	glucose	LVM	PA449773	23209	0.636
NULL	Open_Biol_2014_Dec_4(12)_140178.nxml.txt.nlp	25520185	SENT47	27	27	37	37	geldanamycin	NOD1	PA152031327	10392	0.636
NULL	Clin_Transl_Allergy_2014_Feb_28_4(Suppl_1)_P35.nxml.txt.nlp	25045492	SENT15	0	0	38	38	atorvastatin	IL-10	PA448500	3586	0.636
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Oct_29_67(Pt_11)_o3099.nxml.txt.nlp	22220103	SENT4	19	19	21	21	ethanol	mol	PA448073	90527	0.636
NULL	Hum_Genomics_2009_Dec_1_4(2)_91-106.nxml.txt.nlp	20038497	SENT120	30	30	33	33	galantamine	CYP2D6	PA449726	1565	0.636
NULL	Curr_Oncol_2009_Jul_16(Suppl_2)_S14-S23.nxml.txt.nlp	19672417	SENT183	25	25	23	23	tamoxifen	aromatase	PA451581	1588	0.636
NULL	Front_Oncol_2014_Jun_23_4_162.nxml.txt.nlp	25003082	SENT9	18	18	11	11	estradiol	AKR1C3	PA449503	8644	0.636
NULL	J_Antimicrob_Chemother_2014_Feb_29_69(2)_368-374.nxml.txt.nlp	24080503	SENT134	34	34	36	36	sulfamethoxazole	DHPS	PA451544	1725	0.636
NULL	Diabetes_Metab_Syndr_Obes_2010_May_17_3_165-172.nxml.txt.nlp	21437086	SENT122	8	8	1	1	exenatide	GLP-1	PA164749238	100125288	0.636
NULL	J_Mol_Med_(Berl)_2013_Aug_17_91(11)_1257-1271.nxml.txt.nlp	23955016	SENT199	44	44	35	35	thrombin	p38	PA451674	10598;1432;7965	0.636
NULL	J_Breast_Cancer_2011_Mar_31_14(1)_20-27.nxml.txt.nlp	21847390	SENT148	10	10	13	13	estradiol	CLDN6	PA449503	9074	0.636
NULL	Front_Oncol_2014_Mar_6_4_40.nxml.txt.nlp	24639951	SENT47	18	18	20	20	doxorubicin	ETO	PA449412	862	0.636
NULL	Contemp_Clin_Dent_2013_Apr-Jun_4(2)_156-161.nxml.txt.nlp	24015002	SENT133	22	22	20	20	chlorhexidine	SRP	PA164776863	90226	0.636
NULL	J_Adv_Pract_Oncol_2013_Jul_1_Jul-Aug_4(4)_263-268.nxml.txt.nlp	25032007	SENT124	13	13	28	28	tamoxifen	CYP3A	PA451581	1574	0.636
NULL	Biomed_Res_Int_2014_Jun_3_2014_656370.nxml.txt.nlp	24995318	SENT87	31	31	29	29	chlorpromazine	FGA	PA448964	2243	0.636
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT40	9	9	25	25	raltitrexed	UNG	PA131625240	7374	0.636
NULL	Dement_Geriatr_Cogn_Dis_Extra_2012_Aug_16_2(1)_304-311.nxml.txt.nlp	22962554	SENT11	11	11	22	22	naproxen	APOE	PA450595	348	0.636
NULL	Exp_Ther_Med_2012_Sep_12_4(3)_475-480.nxml.txt.nlp	23181121	SENT156	12	12	0	0	rituximab	CHOP	PA451261	1649	0.636
NULL	J_Invest_Dermatol_2012_Sep_10_132(9)_2255-2262.nxml.txt.nlp	22572817	SENT148	10	10	2	2	forskolin	MC1R	PA146096022	4157	0.636
NULL	Biomed_Res_Int_2014_May_4_2014_351252.nxml.txt.nlp	24877084	SENT54	10	10	30	30	bevacizumab	FTM	PA130232992	23322	0.636
NULL	Ann_Neurosci_2011_Jan_18(1)_8-13.nxml.txt.nlp	25205911	SENT184	3	3	7	7	scopolamine	spatial	PA451308	219793	0.636
NULL	Anesth_Essays_Res_2013_Sep-Dec_7(3)_319-325.nxml.txt.nlp	NULL	SENT30	22	22	24	24	vasopressin	AVP	PA451858	114548;551	0.636
NULL	Front_Genet_2012_Nov_22_3_249.nxml.txt.nlp	23189085	SENT345	9	9	3	3	asparaginase	GRIA1	PA448492	2890	0.636
NULL	Expert_Rev_Endocrinol_Metab_2014_Jul_9_9(4)_397-409.nxml.txt.nlp	25264451	SENT240	25	25	40	40	estradiol	aromatase	PA449503	1588	0.636
NULL	Cancer_Metab_2014_Aug_18_2_13.nxml.txt.nlp	25225614	SENT271	43	43	45	45	lipase	HSL	PA450239	3991	0.636
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT12	0	0	12	12	atorvastatin	AKT	PA448500	207	0.636
NULL	Croat_Med_J_2012_Jun_53(3)_214-223.nxml.txt.nlp	22661134	SENT85	8	8	24	24	yohimbine	ACTH	PA451946	5443	0.636
NULL	Br_J_Cancer_1993_Aug_68(2)_352-356.nxml.txt.nlp	8347490	SENT4	8	8	5	5	tamoxifen	IFN	PA451581	3439	0.636
NULL	Med_Sci_Monit_2013_Dec_23_19_1195-1210.nxml.txt.nlp	24362017	SENT422	23	23	11	11	desmopressin	AVP	PA449237	114548;551	0.636
NULL	J_Gen_Intern_Med_2009_May_21_24(5)_656-664.nxml.txt.nlp	19306050	SENT93	21	21	18	18	amiodarone	CYP2C9	PA448383	1559	0.636
NULL	ScientificWorldJournal_2013_Oct_24_2013_726912.nxml.txt.nlp	24282387	SENT101	11	11	23	23	fluorescein	AVP	PA164746009	114548;551	0.636
NULL	Int_J_Environ_Res_Public_Health_2013_Sep_12_10(9)_4274-4305.nxml.txt.nlp	24036486	SENT71	23	23	11	11	meropenem	HCAP	PA164764445	117159;9126	0.636
NULL	Biomed_Res_Int_2013_Jul_14_2013_437613.nxml.txt.nlp	23936799	SENT262	18	18	24	24	l-carnitine	Q10	PA450154	27161	0.636
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT243	36	36	31	31	heparin	FGF1	PA449855	2246	0.636
NULL	Diabetes_Care_2009_Nov_32(Suppl_2)_S342-S348.nxml.txt.nlp	19875578	SENT114	29	29	44	44	liraglutide	GLP-1	PA165958364	100125288	0.636
NULL	Cancers_(Basel)_2010_Mar_12_2(1)_153-164.nxml.txt.nlp	24281038	SENT140	25	25	33	33	l-glutamine	CO2	PA10090	4513	0.636
NULL	Acta_Pharmacol_Sin_2010_Feb_5_31(2)_137-144.nxml.txt.nlp	20139896	SENT99	16	16	6	6	zileuton	ROS	PA451955	6098	0.636
NULL	J_Antimicrob_Chemother_2011_Jun_25_66(6)_1332-1339.nxml.txt.nlp	21441248	SENT141	29	29	7	7	nevirapine	CYP2B6	PA450616	1555	0.636
NULL	Acta_Neuropathol_Commun_2014_May_30_2_57.nxml.txt.nlp	24887326	SENT185	42	42	21	21	vardenafil	MED1	PA10229	5469;8930	0.636
NULL	J_Viral_Hepat_2010_Feb_17(2)_139-147.nxml.txt.nlp	19674282	SENT137	10	10	16	16	ribavirin	RVR	PA451241	9975	0.636
NULL	Mol_Biol_Cell_2013_Sep_1_24(17)_2678-2688.nxml.txt.nlp	23864716	SENT106	16	16	2	2	thrombin	Rho	PA451674	29984	0.636
NULL	Cardiovasc_Psychiatry_Neurol_2010_Jun_10_2010_480707.nxml.txt.nlp	20631894	SENT151	14	14	32	32	clozapine	S100B	PA449061	6285	0.636
NULL	Clin_Sci_(Lond)_2013_Aug_1_125(Pt_3)_121-130.nxml.txt.nlp	23577635	SENT158	36	36	33	33	lipase	MGL	PA450239	11343	0.636
NULL	J_Thromb_Haemost_2014_May_22_12(5)_748-760.nxml.txt.nlp	24612393	SENT119	13	13	16	16	thrombin	TSC2	PA451674	7249	0.636
NULL	Daru_2012_Dec_26_20(1)_100.nxml.txt.nlp	23351304	SENT20	12	12	27	27	staurosporine	PP2	PA165109623	4888	0.636
NULL	Oncoimmunology_2014_Jan_17_3_e27574.nxml.txt.nlp	24800167	SENT22	48	48	32	32	vancomycin	IL-23	PA451850	51561	0.636
NULL	Front_Synaptic_Neurosci_2013_Jul_30_5_2.nxml.txt.nlp	23908628	SENT277	0	0	16	16	choline	CA1	PA448976	759	0.636
NULL	Vet_Res_2012_Dec_4_43(1)_81.nxml.txt.nlp	23210796	SENT164	21	21	10	10	imiquimod	Tech	PA449972	57449	0.636
NULL	Gut_2009_Jun_10_58(6)_846-858.nxml.txt.nlp	19074178	SENT270	22	22	18	18	ribavirin	IFN	PA451241	3439	0.636
NULL	Acta_Pharmacol_Sin_2011_Apr_28_32(4)_441-448.nxml.txt.nlp	21441944	SENT3	24	24	5	5	sildenafil	CASQ2	PA451346	845	0.636
NULL	Mol_Vis_2007_Jun_8_13_823-832.nxml.txt.nlp	17615543	SENT260	20	20	22	22	etoposide	CD133	PA449552	8842	0.636
NULL	Curr_Chem_Genomics_2010_Mar_1_4_1-8.nxml.txt.nlp	20448812	SENT142	3	3	30	30	methotrexate	OATP1B1	PA450428	10599	0.636
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jul_3_66(Pt_8)_o1911.nxml.txt.nlp	21588243	SENT56	18	18	13	13	ethanol	mol	PA448073	90527	0.636
NULL	J_Inflamm_(Lond)_2008_Dec_5_5_23.nxml.txt.nlp	19061493	SENT175	19	19	15	15	hemin	HO-1	PA449849	3162	0.636
NULL	Nat_Commun_2013_4_2720.nxml.txt.nlp	24193139	SENT237	8	8	10	10	methylphenidate	AMPH	PA450464	273	0.636
NULL	Mar_Drugs_2011_Nov_2_9(11)_2188-2200.nxml.txt.nlp	22163181	SENT464	8	8	5	5	glibenclamide	PAG	PA449782	55824	0.636
NULL	J_Cell_Mol_Med_2013_Sep_24_17(9)_1065-1087.nxml.txt.nlp	24151975	SENT193	2	2	10	10	palifermin	Bcl-2	PA164744014	596	0.636
NULL	Br_J_Cancer_1996_May_73(9)_1063-1068.nxml.txt.nlp	8624264	SENT16	20	20	28	28	vinblastine	P-gp	PA451877	5243	0.636
NULL	Breast_Cancer_Res_2004_May_7_6(4)_R338-R351.nxml.txt.nlp	15217501	SENT5	33	33	20	20	estradiol	CYP1A2	PA449503	1544	0.636
NULL	Cardiovasc_Diabetol_2013_Mar_23_12_48.nxml.txt.nlp	23522121	SENT87	31	31	29	29	metformin	Met	PA450395	79811	0.636
NULL	Br_J_Cancer_2011_Jun_7_104(12)_1848-1853.nxml.txt.nlp	21610704	SENT167	12	12	9	9	panitumumab	KRAS	PA162373091	3845	0.636
NULL	Case_Rep_Gastroenterol_2010_Jul_28_4(2)_261-266.nxml.txt.nlp	20805953	SENT16	0	0	6	6	ribavirin	IFN	PA451241	3439	0.636
NULL	Mol_Microbiol_2012_Oct_86(1)_212-224.nxml.txt.nlp	22857388	SENT186	28	28	31	31	s-adenosylmethionine	B12	PA164754994	7126;4709	0.636
NULL	Biomed_Res_Int_2013_Aug_7_2013_864012.nxml.txt.nlp	23991423	SENT160	11	11	20	20	paricalcitol	IMPACT	PA450798	55364	0.636
NULL	J_Hematol_Oncol_2012_Sep_16_5_55.nxml.txt.nlp	22980425	SENT49	12	12	8	8	alemtuzumab	CD52	PA164783958	1043	0.636
NULL	Fibrogenesis_Tissue_Repair_2012_Jul_23_5_11.nxml.txt.nlp	22824096	SENT351	6	6	8	8	thrombin	PAR-1	PA451674	2011;2149	0.636
NULL	Sci_Rep_2015_Jan_6_5_7642.nxml.txt.nlp	25560837	SENT21	21	21	32	32	lipase	FAAH	PA450239	79152;2166	0.636
NULL	Breast_Cancer_Res_2014_May_23_16(3)_R50.nxml.txt.nlp	24887458	SENT3	32	32	19	19	trastuzumab	HER2	PA451743	2064	0.636
NULL	Breast_Cancer_Res_Treat_2013_Oct_8_141(3)_437-446.nxml.txt.nlp	24101324	SENT27	14	14	12	12	trastuzumab	PTEN	PA451743	5728	0.636
NULL	Ann_Hematol_2014_Sep_10_93(1)_1-11.nxml.txt.nlp	24018623	SENT170	20	20	9	9	lenalidomide	CD34	PA162363968	947	0.636
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT1911	14	14	11	11	phenacetin	CYP1A2	PA450897	1544	0.636
NULL	Ann_Hematol_2015_Aug_3_94_35-43.nxml.txt.nlp	25085377	SENT233	15	15	13	13	nutlin-3	p53		7157	0.636
NULL	Nat_Commun_2013_4_2720.nxml.txt.nlp	24193139	SENT242	10	10	12	12	methylphenidate	AMPH	PA450464	273	0.636
NULL	Nucleic_Acids_Res_2014_Jan_2_42(Database_issue)_D178-D183.nxml.txt.nlp	24302579	SENT142	5	5	15	15	imatinib	GATA1	PA10804	2623	0.636
NULL	Cilia_2012_Sep_3_1_17.nxml.txt.nlp	23308345	SENT250	28	28	6	6	vasopressin	TRPC1	PA451858	7220	0.636
NULL	J_Antimicrob_Chemother_2008_Nov_27_62(5)_929-933.nxml.txt.nlp	18755696	SENT60	22	22	20	20	cefotaxime	CTX	PA448852	1593	0.636
NULL	Iran_J_Basic_Med_Sci_2012_Nov-Dec_15(6)_1202-1209.nxml.txt.nlp	23653852	SENT128	6	6	14	14	metformin	VEGF-A	PA450395	7422	0.636
NULL	Epilepsia_2012_Jun_21_53(Suppl_1)_18-25.nxml.txt.nlp	22612805	SENT33	15	15	30	30	furosemide	KCC2	PA449719	57468	0.636
NULL	Oncotarget_2012_Dec_31_3(12)_1653-1668.nxml.txt.nlp	23391506	SENT175	15	15	8	8	temozolomide	U87	PA451609	677775;641648	0.636
NULL	ScientificWorldJournal_2013_Dec_23_2013_123974.nxml.txt.nlp	24453787	SENT96	6	6	21	21	ethanol	CO2	PA448073	4513	0.636
NULL	Adv_Hematol_2010_Dec_5_2010_595934.nxml.txt.nlp	21151515	SENT16	7	7	28	28	prasugrel	ADP	PA154410481	23038	0.636
NULL	Cases_J_2008_Dec_30_1_426.nxml.txt.nlp	19116013	SENT115	15	15	13	13	rituximab	CHOP	PA451261	1649	0.636
NULL	eLife_2014_Apr_15_3_e02238.nxml.txt.nlp	24737865	SENT460	19	19	39	39	paraformaldehyde	OCT	PA450790	5362	0.636
NULL	ASN_Neuro_2012_Sep_7_4(5)_e00096.nxml.txt.nlp	22867428	SENT328	3	3	0	0	guanidine	Gem	PA164781028	51053	0.636
NULL	Iran_Red_Crescent_Med_J_2014_Jun_5_16(6)_e18022.nxml.txt.nlp	25068053	SENT121	10	10	12	12	pamidronate	BMD	PA450767	1756;7439	0.636
NULL	Viruses_2014_Feb_18_6(2)_875-892.nxml.txt.nlp	24553110	SENT190	14	14	16	16	erlotinib	IFN	PA134687924	3439	0.636
NULL	FEBS_Open_Bio_2014_Jul_5_4_659-671.nxml.txt.nlp	25161875	SENT597	14	14	19	19	bortezomib	MCL1	PA10252	4170	0.636
NULL	Cancer_Imaging_2010_Jan_20_10(1)_1a-7.nxml.txt.nlp	20159663	SENT16	30	30	13	13	octreotide	FDG	PA450678	23583	0.636
NULL	AIDS_Res_Ther_2013_Jul_10_10_18.nxml.txt.nlp	23842109	SENT162	19	19	33	33	isoniazid	IL-2	PA450112	3558	0.636
NULL	Br_J_Cancer_2010_Oct_12_103(8)_1309-1310.nxml.txt.nlp	NULL	SENT38	28	28	26	26	sunitinib	IFN	PA162372840	3439	0.636
NULL	Cardiovasc_Diabetol_2007_Oct_24_6_32.nxml.txt.nlp	17958881	SENT25	35	35	24	24	glucose	ADA	PA449773	100	0.636
NULL	Cancer_Cell_Int_2011_Nov_17_11_40.nxml.txt.nlp	22088142	SENT155	2	2	11	11	gefitinib	MRP2	PA131301952	100130958;57626;1244	0.636
NULL	Br_J_Pharmacol_2011_Jul_163(6)_1263-1275.nxml.txt.nlp	21391977	SENT227	11	11	9	9	fluconazole	CYP2C9	PA449653	1559	0.636
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT189	26	26	41	41	metformin	HIF-1	PA450395	29072	0.636
NULL	Cell_Res_2014_Jul_9_24(7)_820-841.nxml.txt.nlp	24810299	SENT305	15	15	39	39	collagenase	KDR	PA449107	3791	0.636
NULL	Int_J_Surg_Oncol_2012_Aug_13_2012_891067.nxml.txt.nlp	22934164	SENT168	18	18	15	15	capecitabine	CRT	PA448771	811	0.636
NULL	Pharmaceutics_2012_May_14_4(2)_252-275.nxml.txt.nlp	24300231	SENT522	27	27	30	30	etoposide	LDE	PA449552	7957	0.636
NULL	Anesthesiol_Res_Pract_2013_Sep_23_2013_297141.nxml.txt.nlp	24174934	SENT236	2	2	20	20	lidocaine	mol	PA450226	90527	0.636
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_33-43.nxml.txt.nlp	17912634	SENT134	3	3	8	8	tamoxifen	HER2	PA451581	2064	0.636
NULL	Cancer_Cell_Int_2012_Jul_18_12_34.nxml.txt.nlp	22809533	SENT95	5	5	14	14	cisplatin	HK1	PA449014	3098;51361;3739	0.636
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_13_2012_978127.nxml.txt.nlp	23304234	SENT7	0	0	23	23	fosinopril	ACE2	PA449710	59272	0.636
NULL	Patient_Prefer_Adherence_2008_Feb_2_2_387-392.nxml.txt.nlp	19920986	SENT20	0	0	13	13	cyclosporine	IFN	PA449167	3439	0.636
NULL	Infect_Dis_Obstet_Gynecol_2012_Feb_28_2012_137192.nxml.txt.nlp	22536010	SENT128	10	10	16	16	phenytoin	CYP3A	PA450947	1574	0.636
NULL	Emerg_Microbes_Infect_2012_Nov_7_1(11)_e39.nxml.txt.nlp	NULL	SENT159	23	23	5	5	ciprofloxacin	Gen	PA449009	348654	0.636
NULL	Int_J_Biomed_Sci_2014_Sep_10(3)_146-157.nxml.txt.nlp	25324695	SENT217	39	39	16	16	bleomycin	LFA-1	PA448645	3683;3689	0.636
NULL	BMB_Rep_2013_Nov_46(11)_555-560.nxml.txt.nlp	24152914	SENT39	7	7	4	4	penicillamine	DDC	PA450840	1644	0.636
NULL	J_Geriatr_Cardiol_2013_Sep_10(3)_211-212.nxml.txt.nlp	24133505	SENT6	27	27	25	25	sirolimus	DES	PA451365	1674	0.635
NULL	Front_Chem_2013_Dec_31_1_40.nxml.txt.nlp	24790967	SENT1441	3	3	5	5	echinacea	flower	PA131550706	11094	0.635
NULL	Br_J_Pharmacol_2011_Jul_163(6)_1263-1275.nxml.txt.nlp	21391977	SENT100	4	4	12	12	gemfibrozil	CYP2C9	PA449750	1559	0.635
NULL	Int_J_Mol_Sci_2007_Apr_16_8(4)_295-303.nxml.txt.nlp	NULL	SENT204	20	20	18	18	diethylstilbestrol	DES	PA449307	1674	0.635
NULL	Ther_Clin_Risk_Manag_2005_Jun_1(2)_93-106.nxml.txt.nlp	18360549	SENT106	30	30	19	19	hydrochlorothiazide	AT2	PA449899	186	0.635
NULL	Cancers_(Basel)_2012_Jul_16_4(3)_673-700.nxml.txt.nlp	24213461	SENT277	4	4	13	13	bezafibrate	HIF-1	PA162364313	29072	0.635
NULL	Arthritis_Res_Ther_2012_Jun_29_14(3)_216.nxml.txt.nlp	22747923	SENT117	15	15	13	13	metformin	AMPK	PA450395	5563	0.635
NULL	Antimicrob_Agents_Chemother_2014_Aug_58(8)_4971-4973.nxml.txt.nlp	24913169	SENT13	30	30	2	2	primaquine	G6PD	PA451103	2539	0.635
NULL	Front_Neurosci_2012_May_30_6_77.nxml.txt.nlp	22661925	SENT177	10	10	6	6	ethanol	DCX	PA448073	1641	0.635
NULL	ScientificWorldJournal_2013_Apr_24_2013_928197.nxml.txt.nlp	23737732	SENT55	0	0	23	23	candesartan	RAGE	PA448765	177	0.635
NULL	Clin_Ophthalmol_2008_Mar_2(1)_1-14.nxml.txt.nlp	19668384	SENT241	8	8	10	10	ranibizumab	VEGF-A	PA164746012	7422	0.635
NULL	Mol_Biol_Cell_2012_Nov_1_23(21)_4212-4225.nxml.txt.nlp	22956765	SENT87	5	5	12	12	pp2	SHP2		5781	0.635
NULL	Ther_Clin_Risk_Manag_2007_Jun_3(3)_411-420.nxml.txt.nlp	18488075	SENT5	7	7	20	20	alefacept	CD2	PA164748040	914	0.635
NULL	Exp_Ther_Med_2014_Nov_17_8(5)_1484-1488.nxml.txt.nlp	25289046	SENT144	9	9	7	7	cisplatin	DDP	PA449014	1678	0.635
NULL	Oncogene_2013_Sep_26_32(39)_10_1038_onc_2012_491.nxml.txt.nlp	23108394	SENT61	33	33	6	6	epirubicin	FOXM1	PA449476	2305	0.635
NULL	Cancers_(Basel)_2010_Dec_23_3(1)_17-42.nxml.txt.nlp	24212604	SENT697	16	16	12	12	gemcitabine	PPX	PA449748	5531	0.635
NULL	Mol_Cancer_2014_Apr_29_13_96.nxml.txt.nlp	24779681	SENT212	15	15	18	18	tamoxifen	HER-2	PA451581	2064	0.635
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT46	0	0	26	26	trastuzumab	EGFR	PA451743	1956	0.635
NULL	J_Indian_Assoc_Pediatr_Surg_2013_Apr-Jun_18(2)_74-78.nxml.txt.nlp	23798811	SENT37	1	1	10	10	potassium	SRF	PA451047	6722	0.635
NULL	Diabetes_Care_2013_Dec_13_36(12)_e214.nxml.txt.nlp	24265383	SENT17	5	5	22	22	exenatide	GLP-1	PA164749238	100125288	0.635
NULL	Mol_Vis_2010_Oct_5_16_1958-1981.nxml.txt.nlp	21031019	SENT211	8	8	1	1	trypsin	HTRA1	PA451806	5654	0.635
NULL	AAPS_J_2014_Jun_19_16(5)_1056-1063.nxml.txt.nlp	24942210	SENT22	0	0	8	8	bevacizumab	VEGF-A	PA130232992	7422	0.635
NULL	Nat_Med_2014_Mar_16_20(3)_255-264.nxml.txt.nlp	24531378	SENT289	27	27	3	3	trypsin	p38	PA451806	10598;1432;7965	0.635
NULL	Oncotarget_2011_May_16_2(5)_418-421.nxml.txt.nlp	21789791	SENT32	2	2	8	8	bortezomib	TRAIL	PA10252	8743	0.635
NULL	Front_Mol_Neurosci_2014_Dec_2_7_92.nxml.txt.nlp	25520614	SENT80	20	20	22	22	paraformaldehyde	PF4	PA450790	5196	0.635
NULL	Acta_Pharmacol_Sin_2009_Jan_8_30(1)_25-30.nxml.txt.nlp	19060918	SENT58	7	7	4	4	ribavirin	IFN	PA451241	3439	0.635
NULL	Clin_Ophthalmol_2014_Feb_10_8_389-399.nxml.txt.nlp	24550667	SENT203	10	10	31	31	brinzolamide	TIM	PA164744929	7984;8914	0.635
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT128	17	17	2	2	lidocaine	CYP2C19	PA450226	1557	0.635
NULL	Cancer_Med_2013_Oct_21_2(5)_662-673.nxml.txt.nlp	24403232	SENT256	6	6	11	11	bevacizumab	IFN	PA130232992	3439	0.635
NULL	Arthritis_Res_Ther_2014_Apr_3_16(2)_R86.nxml.txt.nlp	24708674	SENT14	5	5	23	23	bosentan	Fli1	PA10034	2314	0.635
NULL	Bioinformation_2013_Nov_11_9(18)_908-911.nxml.txt.nlp	24307768	SENT13	6	6	3	3	glucose	BDNF	PA449773	627	0.635
NULL	Acta_Pharmacol_Sin_2011_Apr_14_32(4)_449-455.nxml.txt.nlp	21399654	SENT3	9	9	18	18	isoproterenol	PIR	PA450121	8544	0.635
NULL	J_Cell_Biol_1998_May_4_141(3)_553-566.nxml.txt.nlp	9566959	SENT270	6	6	9	9	zinc	TFIIIA	PA451956	2971	0.635
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Sep_8_5_21.nxml.txt.nlp	16961922	SENT125	28	28	9	9	voriconazole	Gen	PA10233	348654	0.635
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_P64.nxml.txt.nlp	NULL	SENT16	42	42	16	16	ceftriaxone	PPL	PA448866	5493	0.635
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1676-1682.nxml.txt.nlp	19844234	SENT149	14	14	9	9	lapatinib	IGF1R	PA152241907	3480	0.635
NULL	Glycobiology_2013_Jul_18_23(7)_853-864.nxml.txt.nlp	23507965	SENT130	15	15	5	5	galactose	MGL	PA449725	11343	0.635
NULL	Acta_Pharmacol_Sin_2012_Dec_27_33(12)_1469-1476.nxml.txt.nlp	22922343	SENT102	23	23	44	44	flunitrazepam	ANOVA	PA164781320	4858	0.635
NULL	Diabetes_Obes_Metab_2010_Aug_12(8)_700-708.nxml.txt.nlp	20590747	SENT181	0	0	10	10	vildagliptin	PPG	PA165958346	5552	0.635
NULL	Eur_Radiol_2011_Jun_3_21(6)_1188-1199.nxml.txt.nlp	21127880	SENT65	11	11	0	0	epirubicin	NAC	PA449476	22861	0.635
NULL	Int_J_Environ_Res_Public_Health_2013_Sep_12_10(9)_4274-4305.nxml.txt.nlp	24036486	SENT55	11	11	17	17	ceftazidime	EPM	PA448861	2054	0.635
NULL	Brain_Behav_2012_Mar_2(2)_155-177.nxml.txt.nlp	22574283	SENT265	1	1	11	11	lipase	FAAH	PA450239	79152;2166	0.635
NULL	Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.nxml.txt.nlp	24736980	SENT181	38	38	40	40	rosuvastatin	OATP1B1	PA134308647	10599	0.635
NULL	Clin_Pharmacokinet_2014_Jul_24_53(1)_73-87.nxml.txt.nlp	23881596	SENT39	15	15	24	24	rosuvastatin	OATP1B1	PA134308647	10599	0.635
NULL	Oncotarget_2014_Jun_1_5(13)_4881-4894.nxml.txt.nlp	24952679	SENT97	3	3	5	5	bortezomib	B10	PA10252	5169	0.635
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Apr_7_9_12.nxml.txt.nlp	20374640	SENT102	8	8	6	6	chloramphenicol	CHL	PA448927	91851	0.635
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Nov_4_9_31.nxml.txt.nlp	21050425	SENT90	30	30	32	32	trimethoprim	Gen	PA451788	348654	0.635
NULL	Osteoporos_Int_2014_Aug_15_25(10)_2359-2381.nxml.txt.nlp	25182228	SENT809	33	33	37	37	tamoxifen	STAR	PA451581	6770;2984	0.635
NULL	Indian_J_Med_Res_2012_Jul_136(1)_46-53.nxml.txt.nlp	22885263	SENT46	12	12	32	32	glucose	ACR	PA449773	49	0.635
NULL	Curr_Opin_Obstet_Gynecol_2014_Aug_3_26(4)_226-236.nxml.txt.nlp	24978853	SENT147	5	5	14	14	methotrexate	AMH	PA450428	268	0.635
NULL	Br_J_Haematol_2014_Jan_28_164(2)_233-244.nxml.txt.nlp	24206017	SENT177	15	15	1	1	lenalidomide	CRBN	PA162363968	51185	0.635
NULL	Aging_(Albany_NY)_2010_Oct_20_2(10)_637-638.nxml.txt.nlp	NULL	SENT16	0	0	30	30	doxorubicin	p53	PA449412	7157	0.635
NULL	J_Neurovirol_2013_Jun_4_19(4)_351-358.nxml.txt.nlp	23733308	SENT163	31	31	45	45	mefloquine	SOC	PA450348	91544	0.635
NULL	Asian-Australas_J_Anim_Sci_2014_Jul_27(7)_1057-1068.nxml.txt.nlp	25050050	SENT61	31	31	33	33	lipase	HSL	PA450239	3991	0.635
NULL	Arthritis_Res_Ther_2010_Feb_24_12(1)_R32.nxml.txt.nlp	20181277	SENT213	48	48	39	39	imatinib	RANKL	PA10804	8600	0.635
NULL	EMBO_Mol_Med_2013_Jun_4_5(6)_802-804.nxml.txt.nlp	23737442	SENT25	3	3	0	0	oxygen	PHD2	PA450744	54583	0.635
NULL	J_Med_Case_Rep_2013_Oct_29_7_247.nxml.txt.nlp	24168730	SENT59	32	32	34	34	iodine	RAI	PA450049	10848;6050	0.635
NULL	Mol_Cancer_2007_Aug_21_6_53.nxml.txt.nlp	17711579	SENT153	6	6	14	14	cisplatin	IL1A	PA449014	3552	0.635
NULL	Gut_Liver_2013_Sep_14_7(5)_585-593.nxml.txt.nlp	24073317	SENT111	15	15	11	11	ribavirin	IFN	PA451241	3439	0.635
NULL	Crit_Care_2003_Mar_3_7(Suppl_2)_P047.nxml.txt.nlp	NULL	SENT25	12	12	26	26	vasopressin	CO2	PA451858	4513	0.635
NULL	Environ_Health_Perspect_2008_Mar_11_116(3)_297-302.nxml.txt.nlp	18335094	SENT251	3	3	5	5	permethrin	OTC	PA164743137	5009	0.635
NULL	Clin_Pharmacokinet_2014_Sep_3_53(1)_1-16.nxml.txt.nlp	23999929	SENT268	4	4	16	16	rivaroxaban	CYP3A4	PA165958360	1576	0.635
NULL	Front_Oncol_2014_Sep_29_4_251.nxml.txt.nlp	25325012	SENT235	5	5	24	24	pemetrexed	TYMS	PA10810	7298	0.635
NULL	Ann_Surg_Oncol_2010_Apr_11_17(4)_950-952.nxml.txt.nlp	20012500	SENT55	17	17	13	13	gemcitabine	CRT	PA449748	811	0.635
NULL	Int_J_Med_Chem_2013_Apr_4_2013_203606.nxml.txt.nlp	24729874	SENT121	31	31	9	9	estradiol	C17	PA449503	54360	0.635
NULL	Diabetologia_2010_Jun_27_53(6)_1142-1150.nxml.txt.nlp	20349036	SENT212	16	16	28	28	spermine	AMPK	PA164781199	5563	0.635
NULL	Br_J_Cancer_1997_75(10)_1447-1453.nxml.txt.nlp	9166936	SENT0	19	19	15	15	melphalan	TNF-alpha	PA450354	7124	0.635
NULL	J_Clin_Biochem_Nutr_2010_Jan_29_46(1)_43-51.nxml.txt.nlp	20104264	SENT118	8	8	19	19	napqi	CYP2A6		1548	0.635
NULL	Biomed_Res_Int_2014_Jan_27_2014_696107.nxml.txt.nlp	24587987	SENT222	14	14	5	5	ebselen	NAC	PA161660841	22861	0.635
NULL	Avicenna_J_Phytomed_2014_Jul-Aug_4(4)_260-266.nxml.txt.nlp	25068140	SENT140	16	16	19	19	hesperetin	flower	PA164742902	11094	0.635
NULL	Korean_Circ_J_2013_Jul_31_43(7)_443-452.nxml.txt.nlp	23964290	SENT156	3	3	5	5	clopidogrel	DES	PA449053	1674	0.635
NULL	Clin_Pharmacol_2013_Dec_9_5_185-192.nxml.txt.nlp	24353446	SENT76	8	8	24	24	clopidogrel	CYP1A2	PA449053	1544	0.635
NULL	Arthritis_Res_Ther_2014_Apr_3_16(2)_R86.nxml.txt.nlp	24708674	SENT274	16	16	3	3	bosentan	Fli1	PA10034	2314	0.635
NULL	J_Oncol_2012_Feb_6_2012_737981.nxml.txt.nlp	22481932	SENT83	8	8	11	11	cisplatin	MUC16	PA449014	94025	0.635
NULL	Asian-Australas_J_Anim_Sci_2012_May_1_25(5)_635-641.nxml.txt.nlp	25049607	SENT104	33	33	1	1	estradiol	activin	PA449503	83729	0.635
NULL	Mol_Cancer_2007_Aug_21_6_53.nxml.txt.nlp	17711579	SENT153	6	6	24	24	cisplatin	CASP8	PA449014	841	0.635
NULL	Diabetes_2008_Sep_57(9)_2527-2533.nxml.txt.nlp	18591397	SENT92	21	21	31	31	l-glutamine	CO2	PA10090	4513	0.635
NULL	Int_J_Med_Sci_2013_Mar_15_10(5)_567-574.nxml.txt.nlp	23533048	SENT169	2	2	4	4	entecavir	LAM	PA164784025	7249;7248	0.635
NULL	Breast_Cancer_Res_2007_Dec_17_9(6)_R87.nxml.txt.nlp	18086299	SENT185	15	15	13	13	trastuzumab	PTEN	PA451743	5728	0.635
NULL	Biol_Proced_Online_2003_Feb_17_5_43-52.nxml.txt.nlp	12734557	SENT135	12	12	9	9	bupivacaine	IFNA6	PA135057240	3443	0.635
NULL	J_Physiol_2008_Jul_1_586(Pt_13)_3087-3095.nxml.txt.nlp	18467363	SENT156	18	18	12	12	lipase	DAG	PA450239	1605	0.635
NULL	Arq_Bras_Cardiol_2014_Nov_103(5)_403-409.nxml.txt.nlp	25229355	SENT125	33	33	31	31	diltiazem	PZP	PA449334	5858	0.635
NULL	Exp_Ther_Med_2013_Feb_20_5(2)_443-447.nxml.txt.nlp	23407364	SENT186	11	11	9	9	cyclophosphamide	CTX	PA449165	1593	0.635
NULL	Oncol_Lett_2013_Jul_29_6(1)_23-27.nxml.txt.nlp	23946772	SENT34	11	11	32	32	doxorubicin	DDP	PA449412	1678	0.635
NULL	Acta_Pharmacol_Sin_2013_Sep_5_34(9)_1192-1200.nxml.txt.nlp	23685957	SENT240	3	3	12	12	curcumin	Bcl-2	PA151958596	596	0.635
NULL	Oncotarget_2014_Aug_19_5(18)_8703-8715.nxml.txt.nlp	25237928	SENT52	13	13	5	5	glucose	CD44	PA449773	960	0.635
NULL	Front_Genet_2012_Nov_5_3_236.nxml.txt.nlp	23133441	SENT79	7	7	3	3	efavirenz	ABCB1	PA449441	5243	0.635
NULL	Biochem_Res_Int_2012_Feb_9_2012_592806.nxml.txt.nlp	22400117	SENT31	9	9	25	25	nadh	EGF	PA164755085	1950	0.635
NULL	Biomed_Res_Int_2014_Apr_10_2014_292017.nxml.txt.nlp	24818137	SENT70	35	35	24	24	nadh	MT-ND5	PA164755085	4540	0.635
NULL	Ann_Rheum_Dis_2014_Jan_13_73(1)_48-55.nxml.txt.nlp	23942868	SENT229	10	10	31	31	infliximab	IMPACT	PA452639	55364	0.635
NULL	J_Clin_Biochem_Nutr_2010_Mar_27_46(2)_126-134.nxml.txt.nlp	20216945	SENT66	31	31	21	21	taurine	Met	PA451590	79811	0.635
NULL	Clin_Mol_Hepatol_2014_Dec_24_20(4)_338-344.nxml.txt.nlp	25548738	SENT135	29	29	23	23	telaprevir	BOC	PA165958354	91653	0.635
NULL	Scientifica_(Cairo)_2012_Nov_25_2012_473829.nxml.txt.nlp	24278698	SENT336	10	10	22	22	cisplatin	OCT3	PA449014	5460;6581	0.635
NULL	Mol_Cancer_2007_Oct_22_6_66.nxml.txt.nlp	17953743	SENT160	9	9	2	2	cisplatin	NAC	PA449014	22861	0.635
NULL	Trials_2014_Sep_7_15(1)_352.nxml.txt.nlp	NULL	SENT73	16	16	35	35	atorvastatin	PMI	PA448500	8834;5373	0.635
NULL	Cancer_Res_Treat_2014_Jul_15_46(3)_243-249.nxml.txt.nlp	25038759	SENT106	5	5	26	26	capecitabine	CRT	PA448771	811	0.635
NULL	Oncotarget_2014_Mar_15_5(9)_2529-2541.nxml.txt.nlp	24796733	SENT324	3	3	7	7	tamoxifen	Bcl-2	PA451581	596	0.635
NULL	J_Korean_Med_Sci_2010_Jan_26_25(1)_110-116.nxml.txt.nlp	20054409	SENT149	27	27	0	0	doxorubicin	BCS	PA449412	617	0.635
NULL	Oncotarget_2014_Sep_8_5(19)_9498-9513.nxml.txt.nlp	25237769	SENT89	11	11	13	13	cisplatin	DDP	PA449014	1678	0.635
NULL	Breast_Cancer_Res_2007_Aug_8_9(4)_R50.nxml.txt.nlp	17686159	SENT167	5	5	2	2	gefitinib	HRG	PA131301952	3084;3273	0.635
NULL	Drugs_Context_2013_May_22_2013_212255.nxml.txt.nlp	24432042	SENT250	3	3	8	8	metformin	GLP-1	PA450395	100125288	0.635
NULL	J_Appl_Oral_Sci_2010_Nov-Dec_18(6)_630-634.nxml.txt.nlp	21308296	SENT61	39	39	41	41	etoricoxib	ETO	PA164776853	862	0.635
NULL	Drug_Des_Devel_Ther_2014_Sep_23_8_1527-1538.nxml.txt.nlp	25284985	SENT76	2	2	0	0	celecoxib	IFN	PA448871	3439	0.635
NULL	Pharmaceutics_2011_Oct_12_3(4)_680-705.nxml.txt.nlp	24309303	SENT76	19	19	9	9	glibenclamide	OATP2B1	PA449782	11309	0.635
NULL	Cell_Death_Dis_2012_Jun_28_3(6)_e336.nxml.txt.nlp	22739988	SENT94	8	8	5	5	perifosine	AKT	PA165291471	207	0.635
NULL	Exp_Diabetes_Res_2012_Sep_12_2012_183535.nxml.txt.nlp	23008698	SENT159	3	3	6	6	forskolin	MMP2	PA146096022	4313	0.635
NULL	Lab_Invest_2014_May_10_94(5)_503-516.nxml.txt.nlp	24614199	SENT175	6	6	27	27	curcumin	RAGE	PA151958596	177	0.635
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_13_2014_478653.nxml.txt.nlp	25477992	SENT192	0	0	15	15	gemcitabine	IL-6	PA449748	3569	0.635
NULL	Nat_Commun_2013_4_1449.nxml.txt.nlp	23385593	SENT104	16	16	18	18	nadh	BRCA1	PA164755085	672	0.635
NULL	Arthritis_Res_Ther_2006_Apr_12_8(Suppl_1)_S3.nxml.txt.nlp	16820042	SENT124	3	3	5	5	indomethacin	ACTH	PA449982	5443	0.635
NULL	Exp_Ther_Med_2013_Dec_15_6(6)_1565-1569.nxml.txt.nlp	24255692	SENT21	3	3	18	18	atorvastatin	adiponectin	PA448500	9370	0.635
NULL	Kidney_Int_Suppl_(2011)_2012_Dec_15_2(5)_347-356.nxml.txt.nlp	25018961	SENT238	8	8	15	15	aliskiren	ACR	PA143487910	49	0.635
NULL	J_Org_Chem_2008_Jun_6_73(11)_3975-3984.nxml.txt.nlp	18459734	SENT114	32	32	14	14	paclitaxel	PC3	PA450761	57332;7832;5122	0.635
NULL	Mol_Vis_2011_Jun_9_17_1564-1576.nxml.txt.nlp	21738386	SENT220	0	0	2	2	ethambutol	EMB	PA164784021	133418	0.635
NULL	Oncol_Lett_2013_Mar_28_5(3)_983-991.nxml.txt.nlp	23426861	SENT159	6	6	4	4	cisplatin	DDP	PA449014	1678	0.635
NULL	Case_Rep_Infect_Dis_2014_Apr_30_2014_914042.nxml.txt.nlp	24876978	SENT25	17	17	24	24	vancomycin	Tech	PA451850	57449	0.635
NULL	Oncotarget_2013_Jul_14_4(8)_1185-1198.nxml.txt.nlp	23852390	SENT5	36	36	22	22	tanespimycin	TRAIL	PA165291490	8743	0.635
NULL	Curr_Neuropharmacol_2009_Jun_7(2)_83-95.nxml.txt.nlp	19949566	SENT474	46	46	32	32	zonisamide	TGB	PA451978	5473	0.635
NULL	Ann_Clin_Transl_Neurol_2014_Dec_21_1(12)_996-1005.nxml.txt.nlp	25574474	SENT124	40	40	34	34	riluzole	P-gp	PA451251	5243	0.635
NULL	Indian_J_Pharmacol_2008_Oct_40(Suppl_2)_S66-S91.nxml.txt.nlp	21593982	SENT1608	10	10	7	7	resveratrol	adiponectin		9370	0.635
NULL	BMB_Rep_2013_Nov_46(11)_544-549.nxml.txt.nlp	24152910	SENT98	23	23	11	11	thrombin	TLR4	PA451674	7099	0.635
NULL	Environ_Health_Perspect_2008_Mar_11_116(3)_297-302.nxml.txt.nlp	18335094	SENT40	0	0	3	3	lindane	gamma	PA164754914	9913	0.635
NULL	Biomed_Res_Int_2013_Feb_18_2013_389792.nxml.txt.nlp	23555084	SENT62	0	0	2	2	streptozocin	STZ	PA451514	6484	0.635
NULL	Br_J_Cancer_2012_Feb_14_106(4)_673-677.nxml.txt.nlp	22240778	SENT143	32	32	14	14	trastuzumab	San	PA451743	80218	0.635
NULL	Acta_Pharmacol_Sin_2010_Jul_28_31(7)_867-873.nxml.txt.nlp	20581857	SENT105	26	26	28	28	docetaxel	PC3	PA449383	57332;7832;5122	0.635
NULL	Cell_Commun_Signal_2013_Oct_1_11_73.nxml.txt.nlp	24083678	SENT119	26	26	3	3	sulindac	A20	PA451565	7128;28935	0.635
NULL	Front_Neurol_2014_Nov_3_5_215.nxml.txt.nlp	25404927	SENT222	29	29	31	31	streptokinase	ASK	PA164754919	10926	0.635
NULL	Br_J_Cancer_2010_Sep_28_103(7)_1019-1024.nxml.txt.nlp	20842128	SENT22	19	19	21	21	cetuximab	LARC	PA10040	6364	0.635
NULL	Emerg_Infect_Dis_2012_Jan_18(1)_176-178.nxml.txt.nlp	22261434	SENT15	13	13	20	20	rifampin	EMB	PA451250	133418	0.635
NULL	Front_Microbiol_2014_Oct_9_5_503.nxml.txt.nlp	25346725	SENT141	4	4	30	30	estradiol	PRL	PA449503	5617	0.635
NULL	Anal_Chem_2012_Aug_7_84(15)_6595-6602.nxml.txt.nlp	22793869	SENT105	22	22	6	6	gentamicin	LGA	PA449753	27165	0.635
NULL	Oncotarget_2011_Dec_21_2(12)_1134-1144.nxml.txt.nlp	22193779	SENT165	16	16	23	23	gefitinib	PC3	PA131301952	57332;7832;5122	0.635
NULL	Arthritis_Res_Ther_2014_Sep_24_16(5)_434.nxml.txt.nlp	25249397	SENT149	3	3	9	9	triamcinolone	CXCL13	PA451749	10563	0.635
NULL	Drugs_R_D_2014_Jun_6_14(2)_113-123.nxml.txt.nlp	24797400	SENT6	6	6	20	20	dabigatran	CES1		1066	0.635
NULL	J_Int_Soc_Sports_Nutr_2009_Feb_19_6_6.nxml.txt.nlp	19228401	SENT237	30	30	33	33	creatine	CEE	PA164778930	51608	0.635
NULL	Case_Rep_Oncol_Med_2012_Nov_6_2012_164082.nxml.txt.nlp	23198199	SENT64	30	30	26	26	rituximab	ACTH	PA451261	5443	0.635
NULL	Nat_Methods_2011_Jun_24_8(6)_487-493.nxml.txt.nlp	21516115	SENT158	6	6	36	36	gefitinib	EGF	PA131301952	1950	0.635
NULL	Br_J_Pharmacol_2011_Apr_162(7)_1509-1520.nxml.txt.nlp	21108630	SENT143	6	6	15	15	allopregnanolone	TRPC5	PA142320763	7224	0.635
NULL	F1000_Biol_Rep_2010_Feb_11_2_12.nxml.txt.nlp	20948820	SENT62	10	10	26	26	nifedipine	TRPV4	PA450631	59341	0.635
NULL	Acta_Neuropathol_Commun_2014_Dec_20_2(1)_179.nxml.txt.nlp	NULL	SENT46	33	33	23	23	l-glutamine	B27	PA10090	56246	0.635
NULL	Front_Chem_2014_Dec_23_2_113.nxml.txt.nlp	25566531	SENT158	5	5	18	18	curcumin	AREG	PA151958596	374	0.635
NULL	Carcinogenesis_2011_Nov_1_32(11)_1724-1733.nxml.txt.nlp	21890461	SENT242	37	37	42	42	glucose	ROS	PA449773	6098	0.635
NULL	Ann_Rheum_Dis_2014_Jun_19_73(6)_1000-1006.nxml.txt.nlp	24553909	SENT106	17	17	15	15	ustekinumab	UST	PA166048654	10090	0.635
NULL	Mol_Cancer_2009_Nov_24_8_109.nxml.txt.nlp	19930708	SENT60	0	0	9	9	exemestane	aromatase	PA449563	1588	0.635
NULL	Case_Rep_Oncol_Med_2011_Nov_22_2011_326815.nxml.txt.nlp	22606443	SENT45	34	34	20	20	thyroglobulin	CK20	PA164754910	54474	0.635
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1063.nxml.txt.nlp	24556678	SENT79	23	23	9	9	thioridazine	c-FLIP	PA451666	8837	0.635
NULL	Clin_Psychopharmacol_Neurosci_2012_Dec_20_10(3)_185-189.nxml.txt.nlp	23431037	SENT92	14	14	20	20	perospirone	HPD	PA165291546	3242	0.635
NULL	Clin_Interv_Aging_2013_Jan_31_8_103-110.nxml.txt.nlp	23386786	SENT156	0	0	3	3	atorvastatin	spatial	PA448500	219793	0.635
NULL	Tech_Coloproctol_2010_Dec_29_14(4)_301-310.nxml.txt.nlp	20585822	SENT0	10	10	0	0	gentamicin	Tech	PA449753	57449	0.635
NULL	Diabetes_2013_Jun_17_62(6)_1843-1854.nxml.txt.nlp	23349486	SENT194	6	6	12	12	pioglitazone	IL-10	PA450970	3586	0.635
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Apr_18_68(Pt_5)_o1402.nxml.txt.nlp	22590290	SENT73	8	8	4	4	ethanol	mol	PA448073	90527	0.635
NULL	Cell_Commun_Signal_2013_Aug_27_11_63.nxml.txt.nlp	24103640	SENT447	16	16	8	8	cisplatin	YB-1	PA449014	4904	0.635
NULL	ACS_Med_Chem_Lett_2014_Mar_13_5(3)_214-220.nxml.txt.nlp	24672647	SENT22	19	19	4	4	ribavirin	IFN	PA451241	3439	0.635
NULL	Cholesterol_2011_Feb_22_2011_503028.nxml.txt.nlp	21490773	SENT110	0	0	18	18	methotrexate	IFN	PA450428	3439	0.635
NULL	Oxid_Med_Cell_Longev_2013_Apr_18_2013_239854.nxml.txt.nlp	23710284	SENT79	31	31	19	19	zonisamide	HRD1	PA451978	84447	0.635
NULL	Cancers_(Basel)_2011_Aug_5_3(3)_3114-3142.nxml.txt.nlp	24212948	SENT671	5	5	16	16	cyclophosphamide	CD4	PA449165	920	0.635
NULL	J_Gen_Physiol_1992_Jun_1_99(6)_985-1016.nxml.txt.nlp	1640223	SENT7	9	9	12	12	tetracaine	gamma	PA451638	9913	0.635
NULL	Oncol_Lett_2013_Oct_24_6(4)_970-976.nxml.txt.nlp	24137447	SENT168	6	6	4	4	doxorubicin	ADM	PA449412	133	0.635
NULL	eLife_2014_Aug_1_3_e02725.nxml.txt.nlp	25085081	SENT388	15	15	7	7	olaparib	BRCA1		672	0.635
NULL	J_Thromb_Haemost_2007_May_5(5)_1010-1018.nxml.txt.nlp	17355572	SENT164	24	24	10	10	thrombin	VWF	PA451674	7450	0.635
NULL	J_Cell_Biol_1999_Feb_22_144(4)_631-643.nxml.txt.nlp	10037786	SENT42	28	28	36	36	streptomycin	BRL	PA451512	23774	0.635
NULL	Comp_Hepatol_2004_Jan_14_3(Suppl_1)_S21.nxml.txt.nlp	14960173	SENT49	17	17	19	19	simvastatin	GGTI	PA451363	5229	0.635
NULL	Pharmaceutics_2011_Nov_18_3(4)_865-913.nxml.txt.nlp	24309312	SENT220	6	6	2	2	imatinib	CYP3A	PA10804	1574	0.635
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT324	0	0	2	2	cisplatin	p53	PA449014	7157	0.635
NULL	Drugs_2009_Mar_17_69(5)_549-565.nxml.txt.nlp	19368417	SENT139	12	12	4	4	formoterol	DPI	PA134687907	1832	0.635
NULL	Curr_Med_Chem_2014_May_21(14)_1595-1606.nxml.txt.nlp	23992330	SENT260	22	22	20	20	trastuzumab	PTEN	PA451743	5728	0.635
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Nov_8_64(Pt_12)_o2274-o2275.nxml.txt.nlp	21581255	SENT73	1	1	4	4	benzaldehyde	mol	PA448571	90527	0.635
NULL	Neuro_Oncol_2011_Jan_25_13(1)_70-83.nxml.txt.nlp	20978004	SENT259	26	26	30	30	etoposide	ABCB1	PA449552	5243	0.635
NULL	Cardiovasc_Psychiatry_Neurol_2009_Aug_31_2009_904836.nxml.txt.nlp	20037727	SENT12	21	21	3	3	collagenase	MMP9	PA449107	4318	0.635
NULL	Acta_Vet_Scand_2011_Feb_17_53(1)_11.nxml.txt.nlp	21324209	SENT61	18	18	24	24	gentamicin	OTC	PA449753	5009	0.635
NULL	Mol_Cancer_2004_Jul_12_3_19.nxml.txt.nlp	15248896	SENT68	35	35	32	32	nadh	ND6	PA164755085	4541	0.635
NULL	Case_Rep_Gastrointest_Med_2012_Dec_31_2012_698404.nxml.txt.nlp	23346428	SENT60	42	42	24	24	azathioprine	IFN	PA448515	3439	0.635
NULL	Indian_J_Med_Res_2012_Jul_136(1)_46-53.nxml.txt.nlp	22885263	SENT46	12	12	14	14	glucose	PPG	PA449773	5552	0.635
NULL	Br_J_Cancer_2012_May_22_106(11)_1718-1721.nxml.txt.nlp	22531628	SENT98	8	8	2	2	leucovorin	IFL	PA450198	3439	0.635
NULL	Drugs_2013_Sep_25_73(14)_1569-1586.nxml.txt.nlp	24065301	SENT125	21	21	2	2	atenolol	TED	PA448499	27112	0.635
NULL	Br_J_Cancer_2010_Jan_5_102(1)_80-86.nxml.txt.nlp	19920817	SENT64	35	35	27	27	sunitinib	IFN	PA162372840	3439	0.635
NULL	Br_J_Cancer_1995_Jan_71(1)_48-51.nxml.txt.nlp	7819047	SENT9	5	5	7	7	procarbazine	PCB	PA451112	5091	0.635
NULL	Case_Rep_Dermatol_2014_Feb_12_6(1)_37-42.nxml.txt.nlp	24707248	SENT11	15	15	6	6	methylprednisolone	CHOP	PA450466	1649	0.635
NULL	Bioinform_Biol_Insights_2009_Oct_5_3_109-127.nxml.txt.nlp	20140064	SENT361	20	20	24	24	tenofovir	P65	PA10204	64689;6857	0.635
NULL	J_Lipid_Res_2014_Dec_55(12)_2562-2575.nxml.txt.nlp	25316883	SENT488	6	6	8	8	lipase	PNPLA2	PA450239	57104	0.634
NULL	Breast_Cancer_Res_2013_Oct_1_15(5)_R92.nxml.txt.nlp	24286369	SENT390	13	13	17	17	lapatinib	HER2	PA152241907	2064	0.634
NULL	Front_Pharmacol_2014_May_9_5_103.nxml.txt.nlp	24847272	SENT660	15	15	7	7	midazolam	CYP3A	PA450496	1574	0.634
NULL	Neuropsychopharmacology_2009_May_8_34(6)_1454-1466.nxml.txt.nlp	18843265	SENT306	20	20	7	7	haloperidol	EAAT1	PA449841	6507	0.634
NULL	J_Bras_Pneumol_2013_Jan-Feb_39(1)_5-15.nxml.txt.nlp	23503480	SENT193	10	10	16	16	doxycycline	LAM	PA449415	7249;7248	0.634
NULL	Biomed_Res_Int_2014_Feb_6_2014_323594.nxml.txt.nlp	24689036	SENT31	12	12	14	14	diethylstilbestrol	DES	PA449307	1674	0.634
NULL	Mol_Biol_Cell_2014_Jul_1_25(13)_2116-2127.nxml.txt.nlp	24807908	SENT116	17	17	24	24	hemin	GAPDH	PA449849	2597	0.634
NULL	J_Lipid_Res_2015_Jan_56(1)_109-121.nxml.txt.nlp	25421061	SENT149	19	19	15	15	forskolin	CGI-58	PA146096022	51099	0.634
NULL	Cell_Commun_Signal_2009_Nov_23_7_26.nxml.txt.nlp	19930650	SENT46	18	18	41	41	mitomycin	EGF	PA450524	1950	0.634
NULL	Ital_J_Pediatr_2011_Aug_22_37_39.nxml.txt.nlp	21859484	SENT31	20	20	14	14	salbutamol	BDP	PA448068	10620;152926	0.634
NULL	Diabetes_Care_2011_Jun_20_34(6)_e61-e99.nxml.txt.nlp	21617108	SENT646	24	24	9	9	nadh	HBA	PA164755085	85340	0.634
NULL	J_Korean_Med_Sci_2010_Feb_21_25(2)_197-202.nxml.txt.nlp	20119570	SENT117	30	30	28	28	vancomycin	VAN	PA451850	10318	0.634
NULL	Int_J_Vasc_Med_2014_Jul_22_2014_659617.nxml.txt.nlp	25140254	SENT3	15	15	17	17	vasopressin	AVP	PA451858	114548;551	0.634
NULL	Int_J_Biol_Sci_2012_Sep_6_8(8)_1109-1120.nxml.txt.nlp	22991499	SENT37	6	6	1	1	l-arginine	ARG	PA448478	473;27	0.634
NULL	Environ_Health_Perspect_2005_Oct_14_113(10)_1330-1335.nxml.txt.nlp	16203242	SENT194	2	2	4	4	arsenite	MLC	PA452638	23209	0.634
NULL	Nat_Commun_2012_Jun_12_3_902.nxml.txt.nlp	22692545	SENT59	38	38	40	40	lipase	HSL	PA450239	3991	0.634
NULL	Ind_Psychiatry_J_2012_Jul-Dec_21(2)_148-151.nxml.txt.nlp	24250049	SENT89	8	8	20	20	sirolimus	VEGF-D	PA451365	2277	0.634
NULL	Biotechnol_Res_Int_2013_Dec_1_2013_253286.nxml.txt.nlp	24363937	SENT163	4	4	7	7	urea	DAP	PA451831	23549;3375;1611	0.634
NULL	Arthritis_Res_Ther_2013_Nov_28_15(6)_R202.nxml.txt.nlp	24283517	SENT182	7	7	15	15	curcumin	p65	PA151958596	5970	0.634
NULL	Breast_Cancer_Res_2013_Nov_29_15(6)_R114.nxml.txt.nlp	24289103	SENT358	7	7	21	21	tamoxifen	EGF	PA451581	1950	0.634
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Oct_7_65(Pt_11)_o2667.nxml.txt.nlp	21578277	SENT83	29	29	25	25	ethanol	mol	PA448073	90527	0.634
NULL	Int_J_Biol_Sci_2011_May_24_7(5)_673-684.nxml.txt.nlp	21647250	SENT211	13	13	3	3	berberine	AMPK	PA165860812	5563	0.634
NULL	J_Hematol_Oncol_2009_Oct_27_2_45.nxml.txt.nlp	19860903	SENT114	22	22	24	24	temsirolimus	IFN	PA164746890	3439	0.634
NULL	Indian_J_Med_Res_2014_Aug_140(2)_163-164.nxml.txt.nlp	25297347	SENT52	20	20	22	22	carbamazepine	CLB	PA448785	171425	0.634
NULL	Oncotarget_2014_Jun_5_5(18)_8306-8316.nxml.txt.nlp	25246709	SENT169	15	15	19	19	hydrocortisone	B27	PA449905	56246	0.634
NULL	Comput_Math_Methods_Med_2012_Jan_26_2012_613465.nxml.txt.nlp	22319550	SENT117	18	18	15	15	lidocaine	spatial	PA450226	219793	0.634
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Sep_12_69(Pt_10)_o1529.nxml.txt.nlp	24098217	SENT70	15	15	10	10	ethanol	mol	PA448073	90527	0.634
NULL	Cancer_Res_Treat_2014_Jul_15_46(3)_243-249.nxml.txt.nlp	25038759	SENT80	8	8	11	11	capecitabine	CRT	PA448771	811	0.634
NULL	Gastric_Cancer_2011_Mar_23_14(1)_72-80.nxml.txt.nlp	21340666	SENT235	9	9	4	4	irinotecan	UGT1A1	PA450085	54658	0.634
NULL	Cases_J_2009_Aug_11_2_8875.nxml.txt.nlp	20184702	SENT83	4	4	8	8	rituximab	CHOP	PA451261	1649	0.634
NULL	J_Hematol_Oncol_2010_Mar_23_3_11.nxml.txt.nlp	20331897	SENT143	21	21	24	24	cisplatin	CRT	PA449014	811	0.634
NULL	J_Vet_Med_Sci_2014_Mar_1_76(3)_323-330.nxml.txt.nlp	24189582	SENT140	21	21	15	15	leflunomide	ATV	PA450192	4683	0.634
NULL	Endocrinology_2015_Jan_6_156(1)_24-31.nxml.txt.nlp	25375036	SENT159	7	7	9	9	flutamide	DES	PA449685	1674	0.634
NULL	Clin_Interv_Aging_2013_Feb_5_8_131-137.nxml.txt.nlp	23403474	SENT33	6	6	4	4	choline	CDP	PA448976	1523	0.634
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT138	28	28	19	19	trastuzumab	HER3	PA451743	2065	0.634
NULL	Case_Rep_Oncol_Med_2013_Jul_1_2013_793927.nxml.txt.nlp	23936700	SENT56	9	9	15	15	ifosfamide	FDG	PA449964	23583	0.634
NULL	Breast_Cancer_Res_2008_Mar_29_10(2)_R28.nxml.txt.nlp	18373870	SENT135	19	19	9	9	estradiol	c-Myc	PA449503	4609	0.634
NULL	Reprod_Biol_Endocrinol_2013_Feb_26_11_15.nxml.txt.nlp	23442442	SENT149	18	18	8	8	l-arginine	BAX	PA448478	581	0.634
NULL	Basic_Res_Cardiol_2011_Jan_20_106(1)_51-63.nxml.txt.nlp	20725733	SENT35	19	19	0	0	rolipram	ET1	PA153906323	1906	0.634
NULL	Chin_J_Cancer_2012_Mar_31(3)_150-158.nxml.txt.nlp	22360854	SENT6	25	25	10	10	cisplatin	ABCG2	PA449014	9429	0.634
NULL	J_Clin_Biochem_Nutr_2010_Mar_27_46(2)_126-134.nxml.txt.nlp	20216945	SENT66	31	31	23	23	taurine	NAC	PA451590	22861	0.634
NULL	FEBS_Open_Bio_2012_Aug_22_2_279-283.nxml.txt.nlp	23650611	SENT310	12	12	16	16	tamoxifen	STAR	PA451581	6770;2984	0.634
NULL	Oncogene_2014_Sep_4_33(36)_4521-4530.nxml.txt.nlp	24662833	SENT6	23	23	13	13	bicalutamide	ARSI	PA164746255	340075	0.634
NULL	Eur_J_Endocrinol_2011_Jan_164(1)_69-74.nxml.txt.nlp	20961967	SENT77	23	23	3	3	pioglitazone	OPG	PA450970	690	0.634
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Sep_3_3(9)_e134.nxml.txt.nlp	25184734	SENT339	18	18	12	12	adalimumab	DRB1	PA10004	129831	0.634
NULL	J_Gen_Physiol_1948_Nov_20_32(2)_265-269.nxml.txt.nlp	18891150	SENT0	14	14	1	1	chymotrypsin	Gen	PA448994	348654	0.634
NULL	Eur_J_Clin_Pharmacol_2013_Mar_5_69(3)_467-475.nxml.txt.nlp	22864379	SENT40	29	29	12	12	warfarin	CYP4F2	PA451906	8529	0.634
NULL	Osteoporos_Int_2012_Feb_4_23(Suppl_1)_S1-S23.nxml.txt.nlp	22311111	SENT732	12	12	16	16	tamoxifen	STAR	PA451581	6770;2984	0.634
NULL	Arthritis_Res_Ther_2014_Jul_18_16(4)_R153.nxml.txt.nlp	25037855	SENT106	32	32	11	11	adalimumab	CD14	PA10004	929	0.634
NULL	J_Korean_Med_Sci_1989_Jun_4(2)_71-76.nxml.txt.nlp	2597363	SENT8	6	6	8	8	vasopressin	AVP	PA451858	114548;551	0.634
NULL	Indian_J_Nucl_Med_2011_Oct-Dec_26(4)_192-193.nxml.txt.nlp	23559715	SENT10	19	19	17	17	cyclophosphamide	CHOP	PA449165	1649	0.634
NULL	J_Exp_Clin_Cancer_Res_2009_Mar_2_28(1)_30.nxml.txt.nlp	19254383	SENT151	42	42	40	40	thrombin	IL-6	PA451674	3569	0.634
NULL	J_Viral_Hepat_2008_Dec_15(12)_849-854.nxml.txt.nlp	19087224	SENT22	21	21	30	30	heparin	DC-SIGN	PA449855	30835	0.634
NULL	Gynecol_Oncol_Case_Rep_2013_Dec_28_8_4-6.nxml.txt.nlp	24567884	SENT17	21	21	17	17	cisplatin	NAC	PA449014	22861	0.634
NULL	Acta_Pharmacol_Sin_2010_Dec_3_31(12)_1635-1642.nxml.txt.nlp	21127497	SENT84	0	0	35	35	phenylbutazone	UGT	PA450932	7361;7355	0.634
NULL	Oncotarget_2014_Aug_19_5(18)_8737-8749.nxml.txt.nlp	25228590	SENT201	34	34	43	43	crizotinib	PI3K	PA165946122	5290	0.634
NULL	Cardiovasc_Res_2011_Apr_1_90(1)_105-112.nxml.txt.nlp	21123217	SENT146	26	26	28	28	nifedipine	AMN	PA450631	215;81693	0.634
NULL	Br_J_Cancer_2014_Nov_25_111(11)_2091-2102.nxml.txt.nlp	25349971	SENT180	10	10	18	18	imatinib	PTPN18	PA10804	26469	0.634
NULL	Lab_Invest_2011_Jun_14_91(6)_852-858.nxml.txt.nlp	21403643	SENT6	31	31	16	16	tenofovir	OAT1	PA10204	9356	0.634
NULL	Nucleic_Acids_Res_2011_Sep_11_39(17)_7455-7464.nxml.txt.nlp	21666254	SENT321	16	16	4	4	cisplatin	zeta	PA449014	9907	0.634
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT16	5	5	2	2	sulindac	survivin	PA451565	332	0.634
NULL	Nat_Med_2013_Mar_10_19(3)_313-321.nxml.txt.nlp	23396211	SENT133	0	0	6	6	amlexanox	HSL	PA164745310	3991	0.634
NULL	ISRN_Nutr_2013_Aug_28_2013_403792.nxml.txt.nlp	24967258	SENT424	0	0	17	17	thiabendazole	p53	PA164746466	7157	0.634
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT30	9	9	16	16	atorvastatin	RANKL	PA448500	8600	0.634
NULL	Mol_Cancer_2007_Mar_7_6_18.nxml.txt.nlp	17343740	SENT312	12	12	18	18	pamidronate	CD44	PA450767	960	0.634
NULL	Pediatr_Nephrol_2007_Dec_7_22(12)_1983-1990.nxml.txt.nlp	17554565	SENT55	0	0	2	2	vasopressin	AVP	PA451858	114548;551	0.634
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT314	5	5	9	9	resveratrol	p53		7157	0.634
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT66	29	29	14	14	cetuximab	EGFR	PA10040	1956	0.634
NULL	Cancer_Metastasis_Rev_2010_Dec_10_29(4)_581-594.nxml.txt.nlp	20830503	SENT313	15	15	9	9	anastrozole	ATAC	PA448432	6375	0.634
NULL	Front_Oncol_2014_Oct_22_4_288.nxml.txt.nlp	25374843	SENT213	13	13	19	19	cyclophosphamide	CD25	PA449165	3669;3559	0.634
NULL	Acta_Pharmacol_Sin_2011_Dec_10_32(12)_1513-1521.nxml.txt.nlp	21986574	SENT157	8	8	12	12	hyaluronan	EMT	PA165958431	3702;6581	0.634
NULL	Orphanet_J_Rare_Dis_2014_Jan_16_9_8.nxml.txt.nlp	24433488	SENT94	17	17	9	9	halothane	mol	PA449845	90527	0.634
NULL	J_Korean_Assoc_Oral_Maxillofac_Surg_2014_Dec_26_40(6)_291-296.nxml.txt.nlp	25551094	SENT86	4	4	0	0	alendronate	OPG	PA448082	690	0.634
NULL	Indian_J_Pharmacol_2013_Sep-Oct_45(5)_458-463.nxml.txt.nlp	24130379	SENT120	29	29	24	24	carvedilol	Bcl-2	PA448817	596	0.634
NULL	Case_Rep_Hematol_2013_Jun_11_2013_680459.nxml.txt.nlp	23840983	SENT12	13	13	47	47	cyanocobalamin	B12	PA451892	7126;4709	0.634
NULL	Indian_J_Pharm_Sci_2014_Nov-Dec_76(6)_557-559.nxml.txt.nlp	25593392	SENT40	9	9	6	6	raltegravir	FOR		51741	0.634
NULL	Breast_Cancer_Res_2010_Dec_17_12(6)_R107.nxml.txt.nlp	21167057	SENT212	13	13	2	2	ethanol	CXCR4	PA448073	7852	0.634
NULL	Breast_Cancer_Res_2001_Mar_28_3(3)_150-153.nxml.txt.nlp	11305949	SENT57	16	16	6	6	paclitaxel	JNK	PA450761	5599	0.634
NULL	Acta_Pharmacol_Sin_2012_Mar_30_33(3)_401-406.nxml.txt.nlp	22286916	SENT131	26	26	13	13	cisplatin	ADM	PA449014	133	0.634
NULL	Acta_Pharmacol_Sin_2009_May_5_30(5)_545-552.nxml.txt.nlp	19417733	SENT164	20	20	5	5	lovastatin	Rho	PA450272	29984	0.634
NULL	J_Biol_Eng_2009_Oct_16_3_18.nxml.txt.nlp	19835592	SENT138	16	16	39	39	ofloxacin	CPZ	PA450684	8532	0.634
NULL	Acta_Vet_Scand_2011_Feb_17_53(1)_11.nxml.txt.nlp	21324209	SENT82	18	18	20	20	gentamicin	OTC	PA449753	5009	0.634
NULL	Nat_Med_2010_Jun_23_16(6)_671-677.nxml.txt.nlp	20495567	SENT192	32	32	2	2	sorafenib	ANOVA	PA7000	4858	0.634
NULL	Ann_Surg_Oncol_2010_Apr_20_17(4)_1168-1176.nxml.txt.nlp	19936839	SENT88	12	12	9	9	cetuximab	KRAS	PA10040	3845	0.634
NULL	Front_Microbiol_2012_May_28_3_180.nxml.txt.nlp	22783233	SENT59	22	22	20	20	spermine	Spn	PA164781199	84687	0.634
NULL	Eur_J_Med_Res_2014_Apr_9_19(1)_19.nxml.txt.nlp	24717101	SENT80	35	35	11	11	cyclophosphamide	FDG	PA449165	23583	0.634
NULL	Clin_Dev_Immunol_2011_Dec_27_2011_814943.nxml.txt.nlp	21234341	SENT143	29	29	10	10	nitrogen	IFN	PA450643	3439	0.634
NULL	Int_J_Environ_Res_Public_Health_2010_Apr_30_7(4)_1448-1466.nxml.txt.nlp	20617039	SENT73	13	13	10	10	ethanol	NR1	PA448073	27158	0.634
NULL	Cell_Death_Dis_2010_Nov_18_1(11)_e102.nxml.txt.nlp	21368867	SENT309	19	19	25	25	gentamicin	CLIMP-63	PA449753	10970	0.634
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1145.nxml.txt.nlp	24675463	SENT116	4	4	11	11	erlotinib	EGFR	PA134687924	1956	0.634
NULL	Cancer_Res_Treat_2012_Mar_31_44(1)_37-42.nxml.txt.nlp	22500159	SENT91	26	26	13	13	docetaxel	EGFR	PA449383	1956	0.634
NULL	Breast_Cancer_Res_2011_Nov_28_13(6)_R121.nxml.txt.nlp	22123186	SENT295	10	10	2	2	lapatinib	HER2	PA152241907	2064	0.634
NULL	Acta_Pharmacol_Sin_2011_Aug_18_32(8)_1078-1084.nxml.txt.nlp	21765448	SENT5	9	9	11	11	iptakalim	KCNJ11	PA165949694	3767	0.634
NULL	Cancer_2014_Apr_8_120(8)_1145-1154.nxml.txt.nlp	24501009	SENT8	14	14	16	16	erlotinib	KRAS	PA134687924	3845	0.634
NULL	Nucleic_Acids_Res_2011_Dec_31_39(22)_9536-9548.nxml.txt.nlp	21880590	SENT224	16	16	36	36	etoposide	STAT1	PA449552	6772	0.634
NULL	Gastroenterol_Hepatol_Bed_Bench_2011_Spring_4(2)_43-52.nxml.txt.nlp	24834156	SENT102	27	27	23	23	trypsin	TATI	PA451806	6690	0.634
NULL	Oncotarget_2013_Feb_25_4(2)_269-276.nxml.txt.nlp	23563166	SENT5	11	11	6	6	gemcitabine	GEM	PA449748	2669	0.634
NULL	Oncol_Lett_2014_Jun_3_7(6)_2083-2088.nxml.txt.nlp	24932293	SENT120	7	7	5	5	cyclophosphamide	CTX	PA449165	1593	0.634
NULL	J_Exp_Med_1977_Dec_1_146(6)_1484-1499.nxml.txt.nlp	925610	SENT6	31	31	22	22	trypsin	C42	PA451806	51654	0.634
NULL	Br_J_Cancer_2004_Mar_22_90(6)_1285-1292.nxml.txt.nlp	15026814	SENT131	0	0	7	7	doxorubicin	p53	PA449412	7157	0.634
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT142	1	1	9	9	pp2	LYN		4067	0.634
NULL	Nucleic_Acids_Res_2014_Jan_1_42(1)_553-566.nxml.txt.nlp	24097443	SENT315	4	4	2	2	cisplatin	ALKBH2	PA449014	121642	0.634
NULL	J_Antimicrob_Chemother_2014_Apr_27_69(4)_907-910.nxml.txt.nlp	24284779	SENT24	22	22	27	27	oxacillin	BSAC	PA450725	57591	0.634
NULL	Cell_Death_Dis_2010_May_13_1(5)_e41.nxml.txt.nlp	21364648	SENT307	22	22	26	26	etoposide	p65	PA449552	5970	0.634
NULL	ACS_Med_Chem_Lett_2012_Oct_22_3(12)_1034-1038.nxml.txt.nlp	23256033	SENT91	3	3	13	13	fasudil	STK33	PA165946121	65975	0.634
NULL	Br_J_Cancer_2010_Jan_19_102(2)_361-368.nxml.txt.nlp	20010949	SENT149	2	2	4	4	doxorubicin	L15	PA449412	6138;91057	0.634
NULL	J_Autom_Methods_Manag_Chem_2007_Apr_23_2007_71943.nxml.txt.nlp	18528514	SENT592	12	12	9	9	olsalazine	FOR	PA450700	51741	0.634
NULL	Mol_Biol_Int_2012_Apr_10_2012_154283.nxml.txt.nlp	22577551	SENT75	4	4	16	16	phenylephrine	Raf-1	PA450935	5894	0.634
NULL	J_Biol_2006_Apr_27_5(3)_7.nxml.txt.nlp	16643674	SENT116	18	18	21	21	cyclosporine	GDA	PA449167	8034;9615	0.634
NULL	Eur_J_Clin_Pharmacol_2010_Nov_29_66(11)_1131-1136.nxml.txt.nlp	20669013	SENT105	4	4	19	19	voriconazole	CYP2C19	PA10233	1557	0.634
NULL	Case_Rep_Oncol_2009_Feb_28_2(1)_36-43.nxml.txt.nlp	20740143	SENT21	15	15	13	13	cyclophosphamide	CHOP	PA449165	1649	0.634
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Apr_29_67(Pt_5)_o1262-o1263.nxml.txt.nlp	21754550	SENT68	17	17	36	36	ethanol	mol	PA448073	90527	0.634
NULL	Drugs_Context_2012_Dec_11_2012_212244.nxml.txt.nlp	24432033	SENT72	9	9	7	7	urokinase	EGFR	PA451836	1956	0.634
NULL	Ann_Oncol_2014_Apr_26_25(4)_801-807.nxml.txt.nlp	24577117	SENT12	11	11	27	27	cetuximab	p16	PA10040	1029	0.634
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Oct_26_69(Pt_11)_o1706.nxml.txt.nlp	24454132	SENT77	33	33	10	10	piperazine	mol	PA450977	90527	0.634
NULL	Clin_Pharmacol_2010_Apr_27_2_77-82.nxml.txt.nlp	22291489	SENT67	8	8	6	6	cosyntropin	ACTH	PA164749052	5443	0.634
NULL	Genome_Biol_2004_Jun_24_5(7)_332.nxml.txt.nlp	15239827	SENT45	4	4	21	21	celecoxib	LKB1	PA448871	6794	0.634
NULL	Mol_Cancer_2007_Mar_7_6_18.nxml.txt.nlp	17343740	SENT315	0	0	9	9	alendronate	PC3	PA448082	57332;7832;5122	0.634
NULL	Mucosal_Immunol_2014_Mar_24_7(2)_335-347.nxml.txt.nlp	23881354	SENT329	7	7	37	37	galantamine	NRX	PA449726	64359	0.634
NULL	Eur_J_Immunol_2014_Jun_10_44(6)_1759-1769.nxml.txt.nlp	24595810	SENT117	20	20	7	7	fludrocortisone	CD62L	PA164743961	6402	0.634
NULL	Acta_Pharmacol_Sin_2010_Feb_5_31(2)_150-159.nxml.txt.nlp	20139897	SENT197	13	13	9	9	thrombin	ADP	PA451674	23038	0.634
NULL	J_Clin_Biochem_Nutr_2011_Jul_17_49(1)_1-7.nxml.txt.nlp	21765599	SENT213	10	10	6	6	lipase	HSL	PA450239	3991	0.634
NULL	Crit_Care_2009_Jul_10_13(4)_R113.nxml.txt.nlp	19591694	SENT128	1	1	3	3	vasopressin	AVP	PA451858	114548;551	0.634
NULL	J_Nat_Sci_Biol_Med_2012_Jul-Dec_3(2)_189-191.nxml.txt.nlp	23225984	SENT74	12	12	21	21	cyclophosphamide	CHOP	PA449165	1649	0.634
NULL	J_Cell_Biol_1999_Feb_22_144(4)_789-801.nxml.txt.nlp	10037799	SENT343	15	15	33	33	hyaluronan	CD44	PA165958431	960	0.634
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_75-89.nxml.txt.nlp	17912638	SENT370	30	30	7	7	tamoxifen	ATAC	PA451581	6375	0.634
NULL	Cell_Res_2013_Jun_21_23(6)_746-758.nxml.txt.nlp	23689277	SENT52	3	3	6	6	resveratrol	SIRT1		23411	0.634
NULL	Leukemia_2013_Apr_14_27(4)_803-812.nxml.txt.nlp	23238589	SENT10	9	9	11	11	imatinib	IFN	PA10804	3439	0.634
NULL	Ann_Surg_Treat_Res_2014_Feb_22_86(2)_68-75.nxml.txt.nlp	24761411	SENT179	29	29	12	12	oxaliplatin	survivin	PA131285527	332	0.634
NULL	Crit_Care_2011_Oct_25_15(5)_R255.nxml.txt.nlp	22026977	SENT93	9	9	6	6	vasopressin	AVP	PA451858	114548;551	0.634
NULL	Cent_European_J_Urol_2011_Dec_9_64(4)_256-257.nxml.txt.nlp	24578906	SENT53	6	6	14	14	doxazosin	CD133	PA449407	8842	0.634
NULL	Asia_Pac_Allergy_2013_Apr_26_3(2)_100-105.nxml.txt.nlp	23667833	SENT35	6	6	28	28	thrombin	PAR1	PA451674	79581;2149	0.634
NULL	Glycobiology_2012_Jan_26_22(1)_134-145.nxml.txt.nlp	21873605	SENT39	10	10	8	8	heparin	IL-8	PA449855	3576	0.634
NULL	Case_Rep_Oncol_2013_Aug_24_6(2)_441-449.nxml.txt.nlp	24019785	SENT118	2	2	21	21	cisplatin	STZ	PA449014	6484	0.634
NULL	Diabetes_Care_2012_Feb_16_35(2)_196-197.nxml.txt.nlp	22228743	SENT29	19	19	28	28	fluorescein	CD62	PA164746009	6403	0.634
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT148	7	7	5	5	pp2	PP1		5540;5464	0.634
NULL	Exp_Ther_Med_2014_Mar_24_7(3)_663-668.nxml.txt.nlp	24520264	SENT97	6	6	11	11	curcumin	IL-6	PA151958596	3569	0.634
NULL	Br_J_Cancer_2010_Nov_9_103(11)_1692-1697.nxml.txt.nlp	21063402	SENT95	17	17	9	9	mitoxantrone	TRAIL	PA450526	8743	0.634
NULL	Oxid_Med_Cell_Longev_2012_May_28_2012_386527.nxml.txt.nlp	22690271	SENT90	11	11	16	16	curcumin	spatial	PA151958596	219793	0.634
NULL	Exp_Ther_Med_2013_Feb_29_5(2)_527-532.nxml.txt.nlp	23404385	SENT102	2	2	15	15	cyclosporine	CYP3A4	PA449167	1576	0.634
NULL	Diabetes_2013_Oct_17_62(10)_3316-3323.nxml.txt.nlp	23818527	SENT232	14	14	12	12	liraglutide	GLP-1	PA165958364	100125288	0.634
NULL	J_Allergy_(Cairo)_2011_Oct_24_2011_457169.nxml.txt.nlp	22121382	SENT100	0	0	7	7	salmeterol	IL-6	PA451300	3569	0.634
NULL	J_Prev_Med_Public_Health_2013_Jan_30_46(Suppl_1)_S3-S11.nxml.txt.nlp	23412842	SENT118	20	20	2	2	lipase	NEFA	PA450239	4925	0.634
NULL	Br_J_Cancer_2010_Jan_5_102(1)_80-86.nxml.txt.nlp	19920817	SENT79	15	15	17	17	bevacizumab	IFN	PA130232992	3439	0.634
NULL	ScientificWorldJournal_2013_Nov_5_2013_383574.nxml.txt.nlp	24298214	SENT131	21	21	5	5	phenol	gamma	PA450913	9913	0.634
NULL	Cancer_Manag_Res_2011_Aug_10_3_273-285.nxml.txt.nlp	21931501	SENT47	28	28	19	19	pazopanib	VEGFR	PA165291492	3791	0.634
NULL	Biomed_Res_Int_2013_Dec_30_2013_735835.nxml.txt.nlp	24490170	SENT162	13	13	39	39	cetirizine	FEX	PA448905	8549	0.634
NULL	Arthritis_Rheum_2010_Dec_62(12)_3666-3676.nxml.txt.nlp	20722027	SENT168	30	30	25	25	lipase	FAAH	PA450239	79152;2166	0.634
NULL	Case_Rep_Genet_2011_Jul_6_2011_913020.nxml.txt.nlp	23074682	SENT61	17	17	29	29	hydroxyprogesterone	ACTH	PA449932	5443	0.634
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Oct_14_6_159-168.nxml.txt.nlp	25339848	SENT126	13	13	20	20	trastuzumab	GM-CSF	PA451743	1437	0.634
NULL	J_Gen_Physiol_2000_Jun_1_115(6)_799-814.nxml.txt.nlp	10828252	SENT97	29	29	23	23	spermine	IRK1	PA164781199	3759	0.634
NULL	Cardiovasc_Toxicol_2013_May_1_13(4)_307-315.nxml.txt.nlp	23632742	SENT8	5	5	15	15	rosiglitazone	SOD2	PA451283	6648	0.634
NULL	Arthritis_Res_Ther_2008_Jul_28_10(4)_R83.nxml.txt.nlp	18662393	SENT93	25	25	16	16	lipase	GAPDH	PA450239	2597	0.634
NULL	J_Int_Soc_Sports_Nutr_2014_Feb_10_11_3.nxml.txt.nlp	24512517	SENT324	17	17	19	19	vasopressin	AVP	PA451858	114548;551	0.634
NULL	Biomed_Res_Int_2014_Apr_29_2014_186864.nxml.txt.nlp	24877064	SENT65	0	0	19	19	curcumin	IL-8	PA151958596	3576	0.634
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_24_2013_482318.nxml.txt.nlp	23864891	SENT8	4	4	24	24	metoprolol	CHOP	PA450480	1649	0.634
NULL	Amino_Acids_2012_Oct_10_43(4)_1751-1759.nxml.txt.nlp	22407485	SENT6	46	46	26	26	carrageenan	DAG	PA448814	1605	0.634
NULL	Mol_Cancer_2009_Jul_31_8_54.nxml.txt.nlp	19646236	SENT159	5	5	8	8	nadh	MDH1	PA164755085	4190	0.634
NULL	Oncotarget_2012_Dec_18_3(12)_1615-1628.nxml.txt.nlp	23271044	SENT55	15	15	17	17	clofarabine	TOR	PA164754863	6097	0.634
NULL	Br_J_Cancer_2013_Sep_17_109(6)_1625-1635.nxml.txt.nlp	23969726	SENT91	24	24	32	32	imatinib	CO2	PA10804	4513	0.634
NULL	J_Gen_Physiol_2000_Jun_1_115(6)_685-696.nxml.txt.nlp	10828243	SENT438	10	10	12	12	genistein	OLF	PA165109660	83857	0.634
NULL	Biochemistry_2013_Aug_6_52(31)_5236-5246.nxml.txt.nlp	23837592	SENT418	9	9	4	4	creatine	ASB9	PA164778930	140462	0.634
NULL	Drug_Des_Devel_Ther_2014_Dec_12_8_2517-2529.nxml.txt.nlp	25548514	SENT198	10	10	21	21	cisplatin	STAT3	PA449014	6774	0.634
NULL	Int_J_Mol_Sci_2012_Feb_24_13(3)_2590-2617.nxml.txt.nlp	22489113	SENT209	15	15	12	12	benzaldehyde	mol	PA448571	90527	0.634
NULL	Reprod_Biol_Endocrinol_2004_Aug_4_2_59.nxml.txt.nlp	15294019	SENT179	7	7	3	3	forskolin	EGF	PA146096022	1950	0.634
NULL	Curr_Dermatol_Rep_2014_Nov_28_3(1)_13-22.nxml.txt.nlp	24587975	SENT156	32	32	4	4	calcipotriol	IL-13	PA448714	3596	0.634
NULL	Mol_Cancer_2009_Jul_31_8_57.nxml.txt.nlp	19646263	SENT221	14	14	19	19	docetaxel	PC-3	PA449383	692094	0.634
NULL	Hematol_Rep_2011_Jan_21_3(1)_e2.nxml.txt.nlp	22184524	SENT15	15	15	31	31	isoniazid	ETB	PA450112	1910	0.634
NULL	J_Neural_Transm_2014_Mar_27_121(10)_1221-1232.nxml.txt.nlp	24671607	SENT237	5	5	8	8	ethanol	CORT	PA448073	1325	0.634
NULL	Oxid_Med_Cell_Longev_2013_Dec_9_2013_218145.nxml.txt.nlp	24386502	SENT271	33	33	41	41	nadh	ADP	PA164755085	23038	0.634
NULL	Mol_Cancer_2007_Apr_3_6_27.nxml.txt.nlp	17407586	SENT37	17	17	29	29	gemcitabine	p53	PA449748	7157	0.634
NULL	Inflamm_Res_2010_Oct_20_59(10)_879-887.nxml.txt.nlp	20490892	SENT0	20	20	15	15	dextran	IL-25	PA449261	64806;56005	0.634
NULL	Blood_Cancer_J_2013_Sep_13_3(9)_e146.nxml.txt.nlp	24036945	SENT13	1	1	27	27	ribavirin	AKT	PA451241	207	0.634
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jun_23_66(Pt_7)_o1753.nxml.txt.nlp	21587969	SENT74	30	30	26	26	ethanol	mol	PA448073	90527	0.634
NULL	Acta_Pharmacol_Sin_2013_Apr_11_34(4)_570-580.nxml.txt.nlp	23396375	SENT164	11	11	6	6	tegafur	CDHP	PA452620	1001	0.634
NULL	Open_Orthop_J_2009_Dec_24_3_115-120.nxml.txt.nlp	20111694	SENT71	26	26	23	23	phenol	HPAO	PA450913	8639	0.634
NULL	Br_J_Cancer_2009_Oct_6_101(7)_1155-1161.nxml.txt.nlp	19738614	SENT168	28	28	34	34	gemcitabine	MUC4	PA449748	4585	0.634
NULL	Cell_Death_Dis_2013_Oct_3_4(10)_e828.nxml.txt.nlp	24091671	SENT75	42	42	29	29	oxaliplatin	CD54	PA131285527	3383	0.634
NULL	Mar_Drugs_2011_Nov_2_9(11)_2188-2200.nxml.txt.nlp	22163181	SENT469	5	5	18	18	ethanol	ANOVA	PA448073	4858	0.634
NULL	Mol_Syst_Biol_2010_Apr_13_6_356.nxml.txt.nlp	20393576	SENT167	19	19	14	14	ethanol	GCR2	PA448073	11319	0.634
NULL	Front_Immunol_2012_May_4_3_103.nxml.txt.nlp	22566975	SENT637	1	1	7	7	cyclophosphamide	CD25	PA449165	3669;3559	0.634
NULL	Biosci_Rep_2012_Dec_20_33(1)_e00011.nxml.txt.nlp	23137297	SENT265	31	31	14	14	heparin	RPSA	PA449855	3921	0.634
NULL	Clin_Ophthalmol_2014_May_14_8_927-935.nxml.txt.nlp	24868144	SENT114	24	24	15	15	travoprost	BAK	PA164781371	578	0.634
NULL	Cell_Death_Dis_2013_Oct_3_4(10)_e827.nxml.txt.nlp	24091670	SENT11	3	3	0	0	nilotinib	PI3K	PA165958345	5290	0.634
NULL	Int_J_Med_Sci_2013_Mar_15_10(5)_567-574.nxml.txt.nlp	23533048	SENT185	2	2	4	4	entecavir	LAM	PA164784025	7249;7248	0.634
NULL	Int_J_Endocrinol_2009_Nov_3_2009_687259.nxml.txt.nlp	20011060	SENT89	21	21	14	14	estradiol	TRH	PA449503	7200	0.634
NULL	Br_J_Pharmacol_2011_Oct_164(3)_866-883.nxml.txt.nlp	21323893	SENT320	17	17	14	14	thrombin	ROS	PA451674	6098	0.634
NULL	Bioinformatics_2013_Feb_1_29(3)_338-346.nxml.txt.nlp	23271269	SENT300	14	14	24	24	galactose	GAL	PA449725	51083	0.634
NULL	Eur_J_Epidemiol_2009_Sep_2_24(9)_553-572.nxml.txt.nlp	19728115	SENT1541	10	10	32	32	coumarin	PAGM	PA134521193	5238	0.634
NULL	Clin_Exp_Reprod_Med_2013_Sep_30_40(3)_126-130.nxml.txt.nlp	24179870	SENT92	9	9	5	5	levonorgestrel	UPA	PA450218	118471;5328	0.634
NULL	Front_Hum_Neurosci_2013_Oct_30_7_727.nxml.txt.nlp	24198777	SENT109	9	9	11	11	chlorpromazine	CPZ	PA448964	8532	0.634
NULL	Cell_J_2012_Dec_22_Winter_13(4)_281-289.nxml.txt.nlp	23507624	SENT171	20	20	12	12	isoproterenol	IL-17	PA450121	3605	0.634
NULL	Cell_Death_Dis_2014_Jul_3_5(7)_e1316.nxml.txt.nlp	24991768	SENT90	12	12	5	5	pemetrexed	Mcl-1	PA10810	4170	0.634
NULL	Breast_Cancer_Res_2003_Oct_31_5(Suppl_1)_62.nxml.txt.nlp	NULL	SENT10	24	24	21	21	tamoxifen	ATAC	PA451581	6375	0.634
NULL	Mol_Vis_2014_Dec_19_20_1680-1694.nxml.txt.nlp	25558172	SENT229	19	19	8	8	bevacizumab	LOC387715	PA130232992	387715	0.634
NULL	Evid_Based_Complement_Alternat_Med_2012_Feb_12_2012_743075.nxml.txt.nlp	22454682	SENT186	4	4	19	19	forskolin	IFN	PA146096022	3439	0.634
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jun_6_65(Pt_7)_o1475.nxml.txt.nlp	21582777	SENT65	16	16	19	19	benzaldehyde	mol	PA448571	90527	0.634
NULL	Br_J_Cancer_2013_Mar_19_108(5)_1052-1060.nxml.txt.nlp	23422754	SENT122	29	29	24	24	bevacizumab	VEGF-A	PA130232992	7422	0.634
NULL	EMBO_Mol_Med_2011_Apr_3(4)_235-245.nxml.txt.nlp	21374818	SENT155	19	19	4	4	sunitinib	CLDN5	PA162372840	7122	0.634
NULL	Cardiovasc_Diabetol_2013_May_30_12(Suppl_1)_S2.nxml.txt.nlp	23819752	SENT129	20	20	18	18	pitavastatin	CYP2C9	PA142650384	1559	0.634
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT202	17	17	10	10	heparin	FGF1	PA449855	2246	0.634
NULL	Pharmaceutics_2011_Oct_12_3(4)_680-705.nxml.txt.nlp	24309303	SENT59	9	9	11	11	rosiglitazone	OATP1B1	PA451283	10599	0.634
NULL	Environ_Health_Perspect_1982_Feb_43_81-88.nxml.txt.nlp	7060548	SENT3	8	8	10	10	diethylstilbestrol	DES	PA449307	1674	0.634
NULL	Arthritis_Res_Ther_2011_Sep_21_13(5)_239.nxml.txt.nlp	21955617	SENT246	10	10	7	7	celecoxib	RANKL	PA448871	8600	0.634
NULL	Emerg_Infect_Dis_2013_Jan_19(1)_133-136.nxml.txt.nlp	23260464	SENT49	3	3	9	9	amikacin	TOB	PA164744372	10140	0.634
NULL	J_Cancer_2013_Jun_21_4(5)_383-390.nxml.txt.nlp	23833683	SENT36	31	31	47	47	gentamicin	CO2	PA449753	4513	0.634
NULL	Clin_Pediatr_Endocrinol_2011_Apr_7_20(2)_25-32.nxml.txt.nlp	23926391	SENT101	9	9	11	11	lipase	HSL	PA450239	3991	0.634
NULL	Chem_Res_Toxicol_2010_Mar_15_23(3)_568-577.nxml.txt.nlp	20112989	SENT446	7	7	17	17	cisplatin	ASK1	PA449014	4217	0.633
NULL	Curr_Med_Chem_2012_Sep_19(26)_4399-4413.nxml.txt.nlp	22830345	SENT237	28	28	26	26	rifampin	CYP3A4	PA451250	1576	0.633
NULL	Mol_Cell_Proteomics_2012_Feb_6_11(2)_M111_015222.nxml.txt.nlp	22147731	SENT291	33	33	30	30	cetuximab	EGF	PA10040	1950	0.633
NULL	Br_J_Cancer_2012_Oct_9_107(8)_1257-1267.nxml.txt.nlp	23047592	SENT205	20	20	2	2	cyclophosphamide	BCS	PA449165	617	0.633
NULL	F1000_Biol_Rep_2012_Mar_1_4_5.nxml.txt.nlp	22403588	SENT107	17	17	14	14	ribavirin	IFN	PA451241	3439	0.633
NULL	Bioessays_2013_Mar_8_35(3)_281-298.nxml.txt.nlp	22886688	SENT120	8	8	6	6	verapamil	HERG	PA451868	3757	0.633
NULL	Case_Rep_Gastroenterol_2010_Oct_21_4(3)_465-468.nxml.txt.nlp	21103206	SENT7	13	13	11	11	rituximab	CHOP	PA451261	1649	0.633
NULL	Clin_Dev_Immunol_2011_Dec_26_2011_890758.nxml.txt.nlp	22235224	SENT146	22	22	16	16	trastuzumab	HER2	PA451743	2064	0.633
NULL	Breast_Cancer_Res_2009_Jul_15_11(4)_207.nxml.txt.nlp	19664181	SENT48	23	23	11	11	trastuzumab	HER2	PA451743	2064	0.633
NULL	Cent_European_J_Urol_2013_Dec_19_66(4)_394-404.nxml.txt.nlp	24757527	SENT123	5	5	3	3	semaxanib	IFN	PA131887911	3439	0.633
NULL	Front_Behav_Neurosci_2014_Oct_30_8_366.nxml.txt.nlp	25400560	SENT121	29	29	7	7	ethanol	ANOVA	PA448073	4858	0.633
NULL	Eur_J_Clin_Pharmacol_2007_Apr_21_63(4)_335-343.nxml.txt.nlp	17318526	SENT23	31	31	6	6	phenprocoumon	CYP2C9	PA450921	1559	0.633
NULL	Nat_Chem_Biol_2013_Nov_22_9(11)_715-720.nxml.txt.nlp	24056400	SENT82	32	32	5	5	propofol	MS2	PA451141	101	0.633
NULL	Indian_J_Pharmacol_2014_Nov-Dec_46(6)_627-632.nxml.txt.nlp	25538335	SENT167	18	18	11	11	metformin	Q10	PA450395	27161	0.633
NULL	Br_J_Cancer_2012_Jan_3_106(1)_18-24.nxml.txt.nlp	22108516	SENT167	16	16	34	34	irinotecan	Yes	PA450085	7525	0.633
NULL	Brief_Bioinform_2014_Jul_31_15(4)_648-659.nxml.txt.nlp	23376192	SENT266	28	28	11	11	estradiol	ESR1	PA449503	2099	0.633
NULL	Oncoimmunology_2013_Nov_1_2(11)_e27010.nxml.txt.nlp	24498547	SENT32	4	4	6	6	cisplatin	GEM	PA449014	2669	0.633
NULL	J_Cardiovasc_Electrophysiol_2010_Oct_21(10)_1153-1159.nxml.txt.nlp	20384647	SENT16	31	31	5	5	quinidine	spatial	PA451209	219793	0.633
NULL	Oncotarget_2014_Jun_7_5(14)_5257-5271.nxml.txt.nlp	24913448	SENT55	8	8	12	12	ponatinib	CRKL	PA165980594	1399	0.633
NULL	Int_J_Environ_Res_Public_Health_2013_Sep_6_10(9)_4143-4160.nxml.txt.nlp	24018837	SENT57	5	5	3	3	copper	PEX	PA449114	5251	0.633
NULL	J_Int_Soc_Sports_Nutr_2010_Feb_4_7_9.nxml.txt.nlp	20205771	SENT163	30	30	33	33	creatine	ADP	PA164778930	23038	0.633
NULL	Biomed_Res_Int_2014_Feb_6_2014_323594.nxml.txt.nlp	24689036	SENT258	8	8	18	18	raloxifene	PC3	PA451221	57332;7832;5122	0.633
NULL	Oncotarget_2010_Nov_25_1(7)_662-673.nxml.txt.nlp	21317461	SENT89	12	12	8	8	fenofibrate	TSP-1	PA449594	7057	0.633
NULL	Mol_Vis_2007_Jul_9_13_1083-1093.nxml.txt.nlp	17653053	SENT152	0	0	22	22	minocycline	eotaxin	PA450519	6356	0.633
NULL	Nucleic_Acids_Res_2013_Nov_16_41(20)_9349-9360.nxml.txt.nlp	23956219	SENT166	27	27	6	6	cisplatin	RMI1	PA449014	80010	0.633
NULL	Br_J_Cancer_2010_Sep_7_103(6)_889-898.nxml.txt.nlp	20664599	SENT237	9	9	7	7	paclitaxel	HER-2	PA450761	2064	0.633
NULL	Indian_J_Pharmacol_2008_Oct_40(Suppl_2)_S112-S142.nxml.txt.nlp	21593965	SENT1761	8	8	12	12	diazepam	EPM	PA449283	2054	0.633
NULL	Emerg_Infect_Dis_2013_Jul_19(7)_1151-1152.nxml.txt.nlp	23763791	SENT19	39	39	19	19	kanamycin	DST	PA450137	667	0.633
NULL	Core_Evid_2012_Sep_27_7_105-114.nxml.txt.nlp	23055948	SENT216	23	23	20	20	icatibant	C1-INH	PA164749185	710	0.633
NULL	Mol_Biol_Cell_2014_Jan_1_25(1)_118-132.nxml.txt.nlp	24173715	SENT260	5	5	22	22	lipase	EGFR	PA450239	1956	0.633
NULL	J_Clin_Biochem_Nutr_2007_Sep_29_41(2)_84-91.nxml.txt.nlp	18193101	SENT136	3	3	18	18	lansoprazole	IL-6	PA450180	3569	0.633
NULL	Int_J_Tryptophan_Res_2013_Sep_22_6_67-71.nxml.txt.nlp	24092987	SENT11	4	4	25	25	tranilast	TDO	PA131890628	6999	0.633
NULL	Chem_Rev_2011_Oct_12_111(10)_5899-5921.nxml.txt.nlp	21923193	SENT542	23	23	5	5	ibuprofen	FAAH	PA449957	79152;2166	0.633
NULL	Biomed_Imaging_Interv_J_2010_Jul_1_6(3)_e23.nxml.txt.nlp	21611042	SENT158	14	14	19	19	ifosfamide	TIC	PA449964	23550	0.633
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_13_2014_849783.nxml.txt.nlp	25477998	SENT132	13	13	16	16	berberine	HMGB1	PA165860812	3146	0.633
NULL	Amino_Acids_2014_Jul_19_46(1)_7-20.nxml.txt.nlp	22810731	SENT280	10	10	18	18	taurine	IL-8	PA451590	3576	0.633
NULL	Allergy_Asthma_Immunol_Res_2013_Jul_27_5(4)_216-223.nxml.txt.nlp	23814675	SENT36	15	15	4	4	l-glutamine	F12	PA10090	2161	0.633
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_May_5_68(Pt_6)_o1607.nxml.txt.nlp	22719413	SENT70	20	20	16	16	ethanol	mol	PA448073	90527	0.633
NULL	J_Oncol_2009_Mar_24_2009_491985.nxml.txt.nlp	19325924	SENT174	20	20	3	3	genistein	CXCL12	PA165109660	6387	0.633
NULL	Acta_Pharmacol_Sin_2010_Jul_28_31(7)_867-873.nxml.txt.nlp	20581857	SENT141	12	12	14	14	docetaxel	PC3	PA449383	57332;7832;5122	0.633
NULL	Leukemia_2014_Jun_17_28(6)_1216-1226.nxml.txt.nlp	24301524	SENT96	0	0	11	11	bortezomib	p65	PA10252	5970	0.633
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT116	13	13	8	8	metformin	HIP	PA450395	6767;6159;64399;5068	0.633
NULL	Mol_Vis_2014_Dec_19_20_1680-1694.nxml.txt.nlp	25558172	SENT234	15	15	6	6	ranibizumab	HTRA1	PA164746012	5654	0.633
NULL	Indian_J_Pharm_Sci_2013_May-Jun_75(3)_302-309.nxml.txt.nlp	24082346	SENT124	23	23	10	10	diclofenac	SRMS	PA449293	6725	0.633
NULL	Cell_Death_Dis_2014_Jul_17_5(7)_e1339.nxml.txt.nlp	25032862	SENT10	41	41	37	37	etoposide	ATG5	PA449552	9474	0.633
NULL	Patient_Prefer_Adherence_2010_Mar_24_4_61-68.nxml.txt.nlp	20361006	SENT67	4	4	2	2	liraglutide	GLP-1	PA165958364	100125288	0.633
NULL	Mol_Vis_2012_Nov_30_18_2847-2859.nxml.txt.nlp	23233787	SENT178	34	34	5	5	fluorescein	15-LOX-1	PA164746009	246	0.633
NULL	Cell_Tissue_Res_2013_May_17_354(1)_259-271.nxml.txt.nlp	23681253	SENT25	37	37	39	39	atomoxetine	ATX	PA134688071	5168;23049	0.633
NULL	J_Cell_Biol_2004_Jul_5_166(1)_97-109.nxml.txt.nlp	15240572	SENT342	2	2	12	12	heparin	RhoA	PA449855	387	0.633
NULL	Mol_Med_Rep_2015_Jan_17_11(1)_43-52.nxml.txt.nlp	25333456	SENT266	21	21	45	45	vincristine	ADM	PA451879	133	0.633
NULL	Front_Aging_Neurosci_2010_Feb_3_2_2.nxml.txt.nlp	20552042	SENT129	4	4	9	9	isoproterenol	CA1	PA450121	759	0.633
NULL	Open_Biol_2014_Jan_4(1)_130138.nxml.txt.nlp	24403013	SENT222	19	19	21	21	etoposide	ETO	PA449552	862	0.633
NULL	Eur_J_Clin_Pharmacol_2012_Jan_8_68(1)_29-37.nxml.txt.nlp	21739267	SENT93	23	23	16	16	paroxetine	CYP2D6	PA450801	1565	0.633
NULL	F1000_Biol_Rep_2011_Nov_1_3_24.nxml.txt.nlp	22076126	SENT76	19	19	30	30	primaquine	G6PD	PA451103	2539	0.633
NULL	Case_Rep_Med_2011_Jul_31_2011_145856.nxml.txt.nlp	21811505	SENT40	16	16	18	18	vasopressin	AVP	PA451858	114548;551	0.633
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2008_Jun_1_64(Pt_6)_611-619.nxml.txt.nlp	18560148	SENT208	3	3	12	12	heparin	IP-10	PA449855	3627	0.633
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_16_2013_146142.nxml.txt.nlp	23843863	SENT128	12	12	19	19	aspirin	COX2	PA448497	4513;5743	0.633
NULL	J_Gastroenterol_2013_Jan_28_48(1)_1-12.nxml.txt.nlp	23188091	SENT122	21	21	15	15	ribavirin	ITPA	PA451241	3704	0.633
NULL	Cancer_Cell_Int_2009_Sep_10_9_25.nxml.txt.nlp	19744341	SENT134	8	8	16	16	glucosamine	survivin	PA164747613	332	0.633
NULL	Case_Rep_Ophthalmol_2014_Jan_8_5(1)_11-15.nxml.txt.nlp	24575033	SENT70	12	12	9	9	fluorescein	AMN	PA164746009	215;81693	0.633
NULL	Br_J_Cancer_2010_Jan_5_102(1)_80-86.nxml.txt.nlp	19920817	SENT94	11	11	13	13	bevacizumab	IFN	PA130232992	3439	0.633
NULL	Front_Immunol_2013_Sep_11_4_272.nxml.txt.nlp	24062740	SENT179	15	15	13	13	dextran	HIF-1	PA449261	29072	0.633
NULL	Int_Clin_Psychopharmacol_2014_Nov_3_29(6)_322-331.nxml.txt.nlp	24850228	SENT284	9	9	1	1	risperidone	Gen	PA451257	348654	0.633
NULL	J_Ginseng_Res_2011_Nov_35(4)_436-441.nxml.txt.nlp	23717089	SENT99	5	5	22	22	ginseng	CAGC	PA164781150	6283	0.633
NULL	Arthritis_Res_Ther_2010_Apr_29_12(2)_R73.nxml.txt.nlp	20429888	SENT13	0	0	9	9	bortezomib	COL1A2	PA10252	1278	0.633
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2014_Nov_22_70(Pt_12)_3177-3186.nxml.txt.nlp	25478836	SENT227	5	5	3	3	l-serine	SHMT	PA451330	6470	0.633
NULL	Paediatr_Drugs_2013_Apr_20_15(2)_119-131.nxml.txt.nlp	23512128	SENT162	20	20	14	14	omeprazole	CYP3A4	PA450704	1576	0.633
NULL	J_Cell_Mol_Med_2014_Nov_11_18(11)_2311-2320.nxml.txt.nlp	25210949	SENT65	30	30	16	16	paraformaldehyde	HMGB1	PA450790	3146	0.633
NULL	J_Gen_Physiol_1966_Mar_1_49(4)_793-806.nxml.txt.nlp	5943615	SENT0	22	22	1	1	procaine	Gen	PA451110	348654	0.633
NULL	Oxid_Med_Cell_Longev_2012_May_28_2012_386527.nxml.txt.nlp	22690271	SENT78	18	18	30	30	phenol	IL-6	PA450913	3569	0.633
NULL	Lab_Invest_2014_May_10_94(5)_503-516.nxml.txt.nlp	24614199	SENT241	13	13	11	11	curcumin	NAC	PA151958596	22861	0.633
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT117	3	3	11	11	l-leucine	4E-BP1	PA450197	1978	0.633
NULL	Pak_J_Med_Sci_2013_May-Jun_29(3)_788-792.nxml.txt.nlp	24353629	SENT29	38	38	19	19	glucose	MAST	PA449773	51324	0.633
NULL	J_Cell_Mol_Med_2014_Jan_4_18(1)_38-48.nxml.txt.nlp	24188742	SENT137	16	16	32	32	cisplatin	PAX3	PA449014	5077	0.633
NULL	J_Cell_Mol_Med_2013_Feb_10_17(2)_265-276.nxml.txt.nlp	23301855	SENT41	14	14	6	6	sunitinib	San	PA162372840	80218	0.633
NULL	J_Hematol_Oncol_2008_Aug_11_1_11.nxml.txt.nlp	18694493	SENT94	19	19	21	21	temsirolimus	IFN	PA164746890	3439	0.633
NULL	Acta_Pharmacol_Sin_2010_Jul_28_31(7)_867-873.nxml.txt.nlp	20581857	SENT112	14	14	16	16	docetaxel	PC3	PA449383	57332;7832;5122	0.633
NULL	Mol_Cells_2014_Nov_30_37(11)_804-811.nxml.txt.nlp	25410909	SENT221	6	6	9	9	thrombin	PAR-1	PA451674	2011;2149	0.633
NULL	Nat_Commun_2013_Nov_28_4_2852.nxml.txt.nlp	24284943	SENT281	6	6	11	11	pentobarbital	mol	PA450859	90527	0.633
NULL	Indian_J_Endocrinol_Metab_2012_Mar-Apr_16(2)_183-191.nxml.txt.nlp	22470853	SENT43	35	35	37	37	vasopressin	AVP	PA451858	114548;551	0.633
NULL	Front_Endocrinol_(Lausanne)_2013_Mar_12_4_26.nxml.txt.nlp	23486926	SENT830	1	1	3	3	vasopressin	AVP	PA451858	114548;551	0.633
NULL	Neural_Regen_Res_2014_Feb_15_9(4)_430-435.nxml.txt.nlp	25206831	SENT85	0	0	19	19	creatine	ADP	PA164778930	23038	0.633
NULL	Biotechnol_Res_Int_2013_Dec_1_2013_253286.nxml.txt.nlp	24363937	SENT62	47	47	32	32	ethanol	DAP	PA448073	23549;3375;1611	0.633
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT16	4	4	12	12	tacrolimus	IL-6	PA451578	3569	0.633
NULL	Arthritis_Res_Ther_2014_Oct_29_16(5)_469.nxml.txt.nlp	25606596	SENT233	6	6	4	4	cyclophosphamide	CTX	PA449165	1593	0.633
NULL	Biologics_2009_Sep_15_3_429-441.nxml.txt.nlp	19774210	SENT24	47	47	40	40	bevacizumab	IFL	PA130232992	3439	0.633
NULL	An_Bras_Dermatol_2013_Sep-Oct_88(5)_844-846.nxml.txt.nlp	24173202	SENT3	40	40	36	36	imiquimod	CO2	PA449972	4513	0.633
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT142	3	3	9	9	dasatinib	LYN	PA162372878	4067	0.633
NULL	Curr_Oncol_2009_May_16(3)_8-20.nxml.txt.nlp	19526080	SENT464	8	8	12	12	paclitaxel	castor	PA450761	54897	0.633
NULL	Front_Neurosci_2010_Nov_19_4_192.nxml.txt.nlp	21151361	SENT474	25	25	40	40	pindolol	5-HT1A	PA450966	3350	0.633
NULL	Indian_J_Pharmacol_2009_Aug_41(4)_167-172.nxml.txt.nlp	20523867	SENT40	42	42	17	17	acetaminophen	CYP1A2	PA448015	1544	0.633
NULL	Crit_Care_2008_Mar_13_12(Suppl_2)_P56.nxml.txt.nlp	NULL	SENT6	19	19	28	28	tobramycin	VAN	PA451704	10318	0.633
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_23_2013_185158.nxml.txt.nlp	23864881	SENT197	1	1	10	10	vorinostat	Bcl-2	PA164748224	596	0.633
NULL	Crit_Care_2006_May_12_10(3)_R76.nxml.txt.nlp	16696867	SENT160	20	20	27	27	oxygen	TNF	PA450744	7124	0.633
NULL	Behav_Brain_Funct_2012_Feb_28_8_11.nxml.txt.nlp	22369141	SENT29	21	21	8	8	quetiapine	AAP	PA451201	5345	0.633
NULL	Cell_Mol_Immunol_2008_Dec_5(6)_425-431.nxml.txt.nlp	19118508	SENT4	38	38	6	6	dextran	IL-25	PA449261	64806;56005	0.633
NULL	Clin_Mol_Hepatol_2013_Sep_30_19(3)_195-209.nxml.txt.nlp	24133659	SENT296	14	14	0	0	entecavir	LAM	PA164784025	7249;7248	0.633
NULL	Biochemistry_2013_Dec_23_52(51)_9269-9274.nxml.txt.nlp	24358934	SENT39	8	8	16	16	saquinavir	p24	PA451305	11261;140767	0.633
NULL	J_Mol_Med_2010_Nov_24_88(11)_1095-1100.nxml.txt.nlp	20574808	SENT102	22	22	19	19	trastuzumab	HER2	PA451743	2064	0.633
NULL	Case_Rep_Oncol_2013_Aug_24_6(2)_441-449.nxml.txt.nlp	24019785	SENT118	31	31	21	21	etoposide	STZ	PA449552	6484	0.633
NULL	Ecancermedicalscience_2008_Aug_15_2_91.nxml.txt.nlp	22275974	SENT263	1	1	7	7	cyclophosphamide	CD25	PA449165	3669;3559	0.633
NULL	Indian_J_Nephrol_2012_Nov-Dec_22(6)_462-465.nxml.txt.nlp	23439779	SENT55	8	8	21	21	flucytosine	API	PA449654	5345	0.633
NULL	Cancer_Metab_2013_Feb_4_1_7.nxml.txt.nlp	24280108	SENT139	0	0	7	7	glucose	MYC	PA449773	4609	0.633
NULL	J_Gen_Physiol_1989_Mar_1_93(3)_565-584.nxml.txt.nlp	2784827	SENT12	11	11	16	16	tetracaine	gamma	PA451638	9913	0.633
NULL	J_Oncol_2009_Mar_24_2009_491985.nxml.txt.nlp	19325924	SENT25	11	11	19	19	genistein	CXCL12	PA165109660	6387	0.633
NULL	Arthritis_Res_Ther_2011_Sep_21_13(5)_239.nxml.txt.nlp	21955617	SENT137	7	7	9	9	celecoxib	CBX	PA448871	10951	0.633
NULL	J_Clin_Biochem_Nutr_2009_Jul_30_45(1)_9-13.nxml.txt.nlp	19590701	SENT60	3	3	5	5	lansoprazole	HO-1	PA450180	3162	0.633
NULL	Eur_J_Contracept_Reprod_Health_Care_2011_Aug_20_16(4)_258-269.nxml.txt.nlp	21774563	SENT159	23	23	5	5	iron	MBL	PA450087	50639	0.633
NULL	Oncol_Lett_2013_Mar_14_5(3)_756-760.nxml.txt.nlp	23426872	SENT141	2	2	16	16	cisplatin	STAT3	PA449014	6774	0.633
NULL	Mar_Drugs_2014_Oct_17_12(10)_5240-5257.nxml.txt.nlp	25329706	SENT227	25	25	12	12	calcein	TES	PA132595336	26136	0.633
NULL	Int_J_Hypertens_2014_Oct_23_2014_641587.nxml.txt.nlp	25405024	SENT18	6	6	8	8	vasopressin	AVP	PA451858	114548;551	0.633
NULL	Pain_2014_Nov_155(11)_2306-2322.nxml.txt.nlp	25168672	SENT977	6	6	4	4	lamotrigine	LAM	PA450164	7249;7248	0.633
NULL	Front_Immunol_2013_Nov_7_4_360.nxml.txt.nlp	24223576	SENT168	0	0	13	13	imiquimod	NOXA	PA449972	5366	0.633
NULL	Cells_2012_Nov_12_1(4)_1061-1088.nxml.txt.nlp	24710543	SENT93	31	31	37	37	lipase	aP2	PA450239	2167	0.633
NULL	Clin_Dev_Immunol_2013_May_22_2013_701305.nxml.txt.nlp	23762095	SENT149	13	13	5	5	vinblastine	IL-17A	PA451877	3605	0.633
NULL	Int_J_Gen_Med_2012_Nov_12_5_943-951.nxml.txt.nlp	23204858	SENT112	37	37	21	21	fesoterodine	CYP2D6	PA165958376	1565	0.633
NULL	Int_J_Endocrinol_2010_Jun_27_2010_206801.nxml.txt.nlp	20652073	SENT14	16	16	21	21	alfacalcidol	PTH	PA164746469	5741	0.633
NULL	Semin_Immunopathol_2014_Nov_27_36(1)_3-12.nxml.txt.nlp	24281248	SENT52	15	15	17	17	lipase	HSL	PA450239	3991	0.633
NULL	Theranostics_2013_Mar_21_3(4)_267-274.nxml.txt.nlp	23606913	SENT103	35	35	8	8	l-glutamine	CO2	PA10090	4513	0.633
NULL	Cancer_Cell_Int_2013_Feb_8_13_11.nxml.txt.nlp	23394616	SENT169	30	30	22	22	geldanamycin	Hsp90	PA152031327	3320	0.633
NULL	Br_J_Cancer_2012_May_8_106(10)_1587-1590.nxml.txt.nlp	22568998	SENT45	3	3	6	6	sunitinib	IFN	PA162372840	3439	0.633
NULL	Breast_Cancer_Res_2011_Nov_7_13(6)_R112.nxml.txt.nlp	22060274	SENT118	12	12	30	30	fluorescein	ARTN	PA164746009	9048	0.633
NULL	J_Cell_Biol_2002_Jun_24_157(7)_1151-1160.nxml.txt.nlp	12082077	SENT185	4	4	7	7	trypsin	COX	PA451806	1351	0.633
NULL	Mol_Cancer_2014_Aug_16_13(1)_193.nxml.txt.nlp	NULL	SENT245	8	8	5	5	cisplatin	KEAP1	PA449014	9817	0.633
NULL	Br_J_Cancer_2000_Jun_18_82(12)_2000-2006.nxml.txt.nlp	10864209	SENT4	16	16	23	23	flurbiprofen	c-fos	PA449683	2353	0.633
NULL	Carcinogenesis_2014_May_13_35(5)_1055-1066.nxml.txt.nlp	24419232	SENT198	24	24	33	33	metformin	CYP1B1	PA450395	1545	0.633
NULL	Case_Rep_Oncol_2014_Mar_26_7(1)_204-209.nxml.txt.nlp	24803896	SENT24	6	6	8	8	trabectedin	MRCL	PA165958349	348174	0.633
NULL	Oncotarget_2014_Oct_21_5(22)_11252-11268.nxml.txt.nlp	25361004	SENT208	9	9	13	13	metformin	CLIC1	PA450395	1192	0.633
NULL	Oncol_Lett_2014_Apr_22_7(4)_1191-1196.nxml.txt.nlp	24944691	SENT115	22	22	17	17	vinblastine	PC-3	PA451877	692094	0.633
NULL	Basic_Clin_Pharmacol_Toxicol_2013_Feb_5_112(2)_132-137.nxml.txt.nlp	22900583	SENT54	22	22	30	30	omeprazole	CYP2B6	PA450704	1555	0.633
NULL	Oncotarget_2014_Nov_8_5(21)_10280-10292.nxml.txt.nlp	25373733	SENT200	24	24	11	11	doxorubicin	HIF-1	PA449412	29072	0.633
NULL	Diabetes_2013_Jun_17_62(6)_1843-1854.nxml.txt.nlp	23349486	SENT235	22	22	39	39	hyaluronan	CCR2	PA165958431	729230	0.633
NULL	Oncotarget_2014_Sep_10_5(19)_8924-8936.nxml.txt.nlp	25238040	SENT125	7	7	23	23	decitabine	p53	PA164749631	7157	0.633
NULL	J_Cancer_Res_Clin_Oncol_2010_May_11_136(5)_737-743.nxml.txt.nlp	19904559	SENT40	13	13	15	15	irinotecan	IFL	PA450085	3439	0.633
NULL	Clin_Med_Cardiol_2009_Sep_3_3_77-91.nxml.txt.nlp	20508768	SENT119	22	22	3	3	thrombin	P2Y12	PA451674	64805	0.633
NULL	J_Cancer_Epidemiol_2012_Apr_12_2012_529357.nxml.txt.nlp	22570656	SENT126	22	22	13	13	aprepitant	HEC	PA164747039	10403	0.633
NULL	Exp_Cell_Res_2013_Aug_1_319(13)_2037-2048.nxml.txt.nlp	23562655	SENT15	26	26	28	28	urokinase	PLAU	PA451836	5328	0.633
NULL	Int_J_Mol_Sci_2013_Aug_14_14(8)_16719-16731.nxml.txt.nlp	23949634	SENT369	3	3	5	5	thrombin	PAR-1	PA451674	2011;2149	0.633
NULL	Antibiotics_(Basel)_2014_Jul_1_3(3)_285-316.nxml.txt.nlp	25364574	SENT223	13	13	7	7	ceftazidime	IMP-1	PA448861	10642	0.633
NULL	EMBO_Mol_Med_2013_Aug_4_5(8)_1247-1262.nxml.txt.nlp	23737459	SENT152	0	0	4	4	nilotinib	parkin	PA165958345	5071	0.633
NULL	Iran_J_Basic_Med_Sci_2013_Jul_16(7)_865-872.nxml.txt.nlp	23997918	SENT30	0	0	3	3	cyanocobalamin	B12	PA451892	7126;4709	0.633
NULL	Clin_Infect_Dis_2013_Aug_15_57(Suppl_2)_S39-S45.nxml.txt.nlp	23884064	SENT102	23	23	11	11	ribavirin	OST	PA451241	1650;23263	0.633
NULL	Arthritis_Res_Ther_2006_May_5_8(3)_R83.nxml.txt.nlp	16677395	SENT111	21	21	16	16	rituximab	CD28	PA451261	1493;940	0.633
NULL	Biomed_Res_Int_2013_Dec_10_2013_783698.nxml.txt.nlp	24386640	SENT62	7	7	4	4	isoniazid	DST	PA450112	667	0.633
NULL	Mol_Cancer_2014_Jun_5_13_143.nxml.txt.nlp	24898067	SENT60	35	35	19	19	vinorelbine	HER-2	PA451881	2064	0.633
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Oct_14_6_159-168.nxml.txt.nlp	25339848	SENT139	20	20	26	26	lapatinib	HER2	PA152241907	2064	0.633
NULL	Oncotarget_2014_Oct_18_5(20)_10058-10069.nxml.txt.nlp	25375203	SENT219	15	15	11	11	hydrocortisone	EGF	PA449905	1950	0.633
NULL	Biomed_Res_Int_2013_Oct_27_2013_467869.nxml.txt.nlp	24282816	SENT139	13	13	7	7	ribavirin	IFN	PA451241	3439	0.633
NULL	Breast_Cancer_Res_2008_Dec_4_10(6)_R103.nxml.txt.nlp	19055788	SENT220	23	23	11	11	tamoxifen	EGFR	PA451581	1956	0.633
NULL	Br_J_Cancer_2013_May_14_108(9)_1862-1869.nxml.txt.nlp	23579219	SENT10	1	1	14	14	bevacizumab	ANXA11	PA130232992	311	0.633
NULL	Mol_Vis_2007_Jul_9_13_1083-1093.nxml.txt.nlp	17653053	SENT152	0	0	24	24	minocycline	RANTES	PA450519	6352	0.633
NULL	Niger_Med_J_2013_Mar-Apr_54(2)_96-99.nxml.txt.nlp	23798794	SENT70	26	26	11	11	chloroquine	ACT	PA448948	12;11332;9457;641455	0.633
NULL	BMB_Rep_2014_Jan_47(1)_33-38.nxml.txt.nlp	24209634	SENT57	3	3	6	6	cisplatin	CXCR4	PA449014	7852	0.633
NULL	J_Mol_Signal_2009_May_14_4_3.nxml.txt.nlp	19442290	SENT37	22	22	30	30	l-glutamine	CO2	PA10090	4513	0.633
NULL	Int_J_Environ_Res_Public_Health_2012_Mar_24_9(3)_698-711.nxml.txt.nlp	22690157	SENT14	7	7	9	9	diethylstilbestrol	DES	PA449307	1674	0.633
NULL	Diabetes_2013_Jun_17_62(6)_1843-1854.nxml.txt.nlp	23349486	SENT235	26	26	28	28	hyaluronan	CD44	PA165958431	960	0.633
NULL	Oncol_Lett_2013_Feb_7_5(2)_440-446.nxml.txt.nlp	23420122	SENT119	3	3	14	14	sorafenib	Bcl-2	PA7000	596	0.633
NULL	F1000Prime_Rep_2014_Apr_1_6_21.nxml.txt.nlp	24765526	SENT72	13	13	11	11	tocilizumab	IL-6	PA165292659	3569	0.633
NULL	Breast_Cancer_Res_Treat_2013_Oct_8_141(3)_437-446.nxml.txt.nlp	24101324	SENT277	15	15	13	13	trastuzumab	PTEN	PA451743	5728	0.633
NULL	J_Oncol_2010_May_24_2010_729725.nxml.txt.nlp	20508816	SENT106	0	0	30	30	vatalanib	VEGFR	PA7001	3791	0.633
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jan_28_65(Pt_2)_o409.nxml.txt.nlp	21582001	SENT55	25	25	21	21	ethanol	mol	PA448073	90527	0.633
NULL	Diabetes_2013_Nov_18_62(11)_3851-3862.nxml.txt.nlp	23884890	SENT353	7	7	21	21	rosiglitazone	AMPK	PA451283	5563	0.633
NULL	Core_Evid_2009_Jun_15_4_83-92.nxml.txt.nlp	20694067	SENT31	1	1	3	3	vasopressin	AVP	PA451858	114548;551	0.633
NULL	Chonnam_Med_J_2013_Apr_25_49(1)_31-37.nxml.txt.nlp	23678475	SENT20	11	11	16	16	rosuvastatin	adiponectin	PA134308647	9370	0.633
NULL	Ther_Clin_Risk_Manag_2006_Sep_2(3)_235-249.nxml.txt.nlp	18360599	SENT325	26	26	20	20	alendronate	PTH	PA448082	5741	0.633
NULL	Acta_Pharmacol_Sin_2012_Jul_18_33(7)_918-923.nxml.txt.nlp	22705728	SENT27	7	7	17	17	genistein	COX	PA165109660	1351	0.633
NULL	Acta_Histochem_Cytochem_2013_Dec_28_46(6)_187-197.nxml.txt.nlp	24610966	SENT20	14	14	22	22	pilocarpine	AQP5	PA450962	362	0.633
NULL	Virol_J_2011_May_17_8_234.nxml.txt.nlp	21575275	SENT23	33	33	14	14	ribavirin	IFN	PA451241	3439	0.633
NULL	Int_J_Nanomedicine_2010_Aug_9_5_517-523.nxml.txt.nlp	20957114	SENT119	2	2	16	16	nadh	ADP	PA164755085	23038	0.633
NULL	Int_J_Nephrol_2010_Dec_21_2011_490795.nxml.txt.nlp	21234092	SENT252	33	33	3	3	vasopressin	AVP	PA451858	114548;551	0.633
NULL	Asia_Pac_Allergy_2013_Oct_31_3(4)_231-240.nxml.txt.nlp	24260728	SENT88	1	1	9	9	theophylline	CYP1A2	PA451647	1544	0.633
NULL	J_Biomed_Biotechnol_2010_Jun_30_2010_485468.nxml.txt.nlp	20671927	SENT7	3	3	26	26	hyaluronan	MMP9	PA165958431	4318	0.633
NULL	Oncol_Rep_2014_Apr_28_31(4)_1605-1612.nxml.txt.nlp	24481648	SENT14	8	8	11	11	ponatinib	MRP7	PA165980594	89845;1080	0.633
NULL	Arthritis_Res_Ther_2013_Nov_1_15(6)_R176.nxml.txt.nlp	24456929	SENT101	11	11	31	31	colchicine	PP2	PA449092	4888	0.633
NULL	Acta_Pharmacol_Sin_2012_Jun_30_33(6)_743-751.nxml.txt.nlp	22543707	SENT81	20	20	13	13	l-glutamine	B27	PA10090	56246	0.633
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT150	23	23	26	26	chloroquine	BMPR-II	PA448948	659	0.633
NULL	Environ_Health_Perspect_2004_Nov_28_112(15)_1512-1518.nxml.txt.nlp	15531436	SENT41	19	19	3	3	letrozole	CYP2A6	PA450196	1548	0.633
NULL	J_Immunother_Cancer_2013_Jul_15_1_10.nxml.txt.nlp	24829747	SENT80	0	0	11	11	celecoxib	CD11b	PA448871	3684	0.633
NULL	Cancers_(Basel)_2013_May_24_5(2)_569-590.nxml.txt.nlp	24216992	SENT218	3	3	12	12	gemcitabine	CD11b	PA449748	3684	0.633
NULL	Arthritis_Res_Ther_2005_Apr_28_7(4)_R844-R851.nxml.txt.nlp	15987486	SENT192	8	8	6	6	nadh	ND2	PA164755085	4536	0.633
NULL	Multidiscip_Respir_Med_2013_Jun_21_8(1)_40.nxml.txt.nlp	23800154	SENT33	3	3	6	6	creatine	Q10	PA164778930	27161	0.633
NULL	Indian_J_Endocrinol_Metab_2013_May-Jun_17(3)_413-421.nxml.txt.nlp	23869296	SENT170	14	14	9	9	liraglutide	GLP-1	PA165958364	100125288	0.633
NULL	Exp_Ther_Med_2013_Dec_15_6(6)_1565-1569.nxml.txt.nlp	24255692	SENT112	3	3	15	15	atorvastatin	adiponectin	PA448500	9370	0.633
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT245	18	18	12	12	warfarin	VKORC1	PA451906	79001	0.633
NULL	Ann_Oncol_2011_Jan_13_22(1)_215-223.nxml.txt.nlp	20627875	SENT92	13	13	15	15	etoposide	ETO	PA449552	862	0.633
NULL	J_Immunol_Res_2014_Jul_16_2014_696812.nxml.txt.nlp	25133198	SENT261	19	19	9	9	rifaximin	TLR4	PA164752443	7099	0.633
NULL	Eur_J_Med_Res_2014_Jun_24_19(1)_34.nxml.txt.nlp	24961604	SENT98	33	33	13	13	vincristine	BCL11A	PA451879	53335	0.633
NULL	Mol_Cancer_2010_Apr_15_9_77.nxml.txt.nlp	20398291	SENT85	2	2	6	6	geldanamycin	p53	PA152031327	7157	0.633
NULL	Breast_Cancer_Res_2006_Nov_6_8(6)_215.nxml.txt.nlp	17096862	SENT47	18	18	27	27	trastuzumab	MUC4	PA451743	4585	0.633
NULL	J_Cell_Mol_Med_2014_Feb_28_18(2)_283-292.nxml.txt.nlp	24286347	SENT117	19	19	15	15	berberine	PI3K	PA165860812	5290	0.633
NULL	Mol_Syst_Biol_2009_Jul_28_5_288.nxml.txt.nlp	19638969	SENT451	20	20	26	26	resveratrol	HuR		1994	0.633
NULL	Evid_Based_Complement_Alternat_Med_2013_May_26_2013_349790.nxml.txt.nlp	23762123	SENT173	12	12	8	8	rosiglitazone	LSP1	PA451283	4046	0.633
NULL	Evid_Based_Complement_Alternat_Med_2011_Jan_20_2011_713523.nxml.txt.nlp	21318104	SENT19	13	13	27	27	imipramine	P-gp	PA449969	5243	0.633
NULL	Case_Rep_Oncol_2011_Sep_16_4(3)_464-466.nxml.txt.nlp	22114570	SENT6	10	10	7	7	erlotinib	EGFR	PA134687924	1956	0.633
NULL	Br_J_Cancer_2009_Nov_3_101(9)_1549-1554.nxml.txt.nlp	19809436	SENT31	18	18	15	15	etoposide	ADM	PA449552	133	0.633
NULL	Environ_Health_Perspect_2008_Jun_116(6)_A240a.nxml.txt.nlp	NULL	SENT28	29	29	16	16	aspartame	ERF	PA448493	2077	0.633
NULL	Ann_Hematol_2011_Feb_17_90(2)_173-183.nxml.txt.nlp	20714724	SENT151	3	3	20	20	resveratrol	CD5		921	0.633
NULL	J_Inherit_Metab_Dis_2012_May_2_35(3)_399-405.nxml.txt.nlp	22134542	SENT35	18	18	33	33	thyroglobulin	PMI	PA164754910	8834;5373	0.633
NULL	Gut_Pathog_2013_Mar_22_5_6.nxml.txt.nlp	23522652	SENT238	17	17	11	11	ceftriaxone	CTX	PA448866	1593	0.633
NULL	Clinics_(Sao_Paulo)_2013_May_68(5)_592-598.nxml.txt.nlp	23778413	SENT220	31	31	7	7	docetaxel	HIF2A	PA449383	2034	0.633
NULL	J_Cell_Biol_2001_Mar_19_152(6)_1145-1158.nxml.txt.nlp	11257116	SENT659	0	0	3	3	urokinase	CD87	PA451836	5329	0.632
NULL	Acta_Naturae_2013_Jul-Sep_5(3)_92-98.nxml.txt.nlp	24303205	SENT78	20	20	7	7	l-methionine	MGL	PA450423	11343	0.632
NULL	Ann_Indian_Acad_Neurol_2010_Jul-Sep_13(3)_207-210.nxml.txt.nlp	21085534	SENT108	0	0	12	12	infliximab	MRI	PA452639	78996	0.632
NULL	Arch_Gynecol_Obstet_2012_May_30_285(5)_1447-1453.nxml.txt.nlp	22127553	SENT40	7	7	1	1	paclitaxel	TEC	PA450761	7006	0.632
NULL	Open_Biol_2014_Oct_4(10)_140106.nxml.txt.nlp	25320096	SENT183	10	10	27	27	isoniazid	BTZ	PA450112	22794	0.632
NULL	Clin_Epidemiol_2010_Aug_9_2_145-151.nxml.txt.nlp	20865112	SENT67	24	24	2	2	raltegravir	CD4		920	0.632
NULL	Gut_Liver_2013_Sep_14_7(5)_585-593.nxml.txt.nlp	24073317	SENT26	35	35	31	31	ribavirin	IFN	PA451241	3439	0.632
NULL	Cancer_Immunol_Immunother_2011_Jun_25_60(6)_793-808.nxml.txt.nlp	21350947	SENT146	14	14	11	11	sorafenib	IFN	PA7000	3439	0.632
NULL	Drug_Des_Devel_Ther_2014_Dec_12_8_2517-2529.nxml.txt.nlp	25548514	SENT184	4	4	15	15	cisplatin	STAT3	PA449014	6774	0.632
NULL	J_Korean_Med_Sci_2009_Jan_29_24(Suppl_1)_S170-S175.nxml.txt.nlp	19194548	SENT76	4	4	6	6	cisplatin	EPO	PA449014	7076;8288;2056	0.632
NULL	Emerg_Infect_Dis_2012_Jun_18(6)_1019-1020.nxml.txt.nlp	22608263	SENT34	38	38	36	36	norfloxacin	NXN	PA450654	64359	0.632
NULL	Br_J_Cancer_2013_Feb_19_108(3)_570-578.nxml.txt.nlp	23299527	SENT141	0	0	10	10	acetohexamide	MLC2	PA164777011	10398	0.632
NULL	Evid_Based_Complement_Alternat_Med_2013_May_16_2013_379536.nxml.txt.nlp	23762128	SENT40	12	12	18	18	fluorescein	CD25	PA164746009	3669;3559	0.632
NULL	Diabetes_Metab_J_2014_Jun_17_38(3)_230-239.nxml.txt.nlp	25003077	SENT175	8	8	6	6	metformin	Met	PA450395	79811	0.632
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_127043.nxml.txt.nlp	23227093	SENT218	9	9	24	24	lovastatin	RYR	PA450272	6261	0.632
NULL	J_Korean_Med_Sci_1996_Jun_11(3)_250-257.nxml.txt.nlp	8843008	SENT7	5	5	2	2	verapamil	NIF	PA451868	6280	0.632
NULL	J_Vet_Med_Sci_2014_Jul_18_76(7)_937-945.nxml.txt.nlp	24646457	SENT123	38	38	40	40	cephalexin	OTC	PA448883	5009	0.632
NULL	Br_J_Cancer_2010_Jan_5_102(1)_80-86.nxml.txt.nlp	19920817	SENT94	15	15	13	13	sunitinib	IFN	PA162372840	3439	0.632
NULL	Viruses_2014_Mar_14_6(3)_1294-1316.nxml.txt.nlp	24638204	SENT177	27	27	9	9	galactose	SP-D	PA449725	6441	0.632
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT38	16	16	10	10	vinblastine	MVP	PA451877	9961	0.632
NULL	Clin_Exp_Gastroenterol_2013_Aug_5_6_139-148.nxml.txt.nlp	23950655	SENT146	9	9	11	11	thrombin	PAR-1	PA451674	2011;2149	0.632
NULL	Arch_Med_Sci_2012_May_9_8(2)_347-356.nxml.txt.nlp	22662010	SENT57	14	14	24	24	urokinase	IL-6	PA451836	3569	0.632
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT307	19	19	2	2	cisplatin	p38	PA449014	10598;1432;7965	0.632
NULL	Braz_J_Med_Biol_Res_2012_Jan_27_45(3)_264-272.nxml.txt.nlp	22267006	SENT29	18	18	13	13	heparin	CHI3L1	PA449855	1116	0.632
NULL	Clin_Interv_Aging_2009_May_14_4_179-186.nxml.txt.nlp	19503779	SENT54	17	17	2	2	levodopa	COMT	PA450213	1312	0.632
NULL	Patient_Prefer_Adherence_2010_Feb_4_4_11-16.nxml.txt.nlp	20165594	SENT38	14	14	36	36	duloxetine	BPI	PA10066	671	0.632
NULL	Lab_Invest_2009_Nov_7_89(11)_1275-1290.nxml.txt.nlp	19736547	SENT244	4	4	16	16	curcumin	LOX-1	PA151958596	4973	0.632
NULL	Hum_Genomics_2010_Aug_1_4(6)_371-374.nxml.txt.nlp	20846925	SENT20	40	40	26	26	warfarin	VKORC1	PA451906	79001	0.632
NULL	Biomed_Res_Int_2014_Feb_19_2014_162314.nxml.txt.nlp	24701564	SENT146	4	4	1	1	amiloride	NHE	PA448368	285335	0.632
NULL	Can_J_Infect_Dis_Med_Microbiol_2014_Nov-Dec_25(6)_327-343.nxml.txt.nlp	25587296	SENT190	0	0	5	5	posaconazole	CYP3A4	PA151958574	1576	0.632
NULL	Breast_Cancer_Res_2014_May_23_16(3)_R50.nxml.txt.nlp	24887458	SENT82	37	37	15	15	trastuzumab	HER2	PA451743	2064	0.632
NULL	Osteoporos_Int_2013_Jun_6_24(12)_2971-2981.nxml.txt.nlp	23740422	SENT264	5	5	16	16	raloxifene	PTH	PA451221	5741	0.632
NULL	Ann_Lab_Med_2012_Jul_20_32(4)_298-303.nxml.txt.nlp	22779073	SENT117	4	4	22	22	isoniazid	MOX	PA450112	26002	0.632
NULL	Curr_Neuropharmacol_2007_Dec_5(4)_278-288.nxml.txt.nlp	19305744	SENT499	10	10	2	2	ketamine	spatial	PA450144	219793	0.632
NULL	Front_Oncol_2014_Jun_18_4_159.nxml.txt.nlp	24995161	SENT224	8	8	20	20	estradiol	AKR1C3	PA449503	8644	0.632
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Sep_6_64(Pt_10)_m1225.nxml.txt.nlp	21200986	SENT61	16	16	23	23	zinc	mol	PA451956	90527	0.632
NULL	Br_J_Anaesth_2014_Jul_22_113(1)_157-167.nxml.txt.nlp	24154701	SENT219	6	6	2	2	sevoflurane	TREK-1	PA451341	3776	0.632
NULL	Indian_J_Nucl_Med_2013_Dec_28(Suppl_1)_S25-S28.nxml.txt.nlp	NULL	SENT74	10	10	14	14	thyroglobulin	FDG	PA164754910	23583	0.632
NULL	Br_J_Cancer_2010_May_11_102(10)_1456-1460.nxml.txt.nlp	20461090	SENT88	11	11	15	15	temsirolimus	IFN	PA164746890	3439	0.632
NULL	Mol_Cancer_2006_Sep_5_5_34.nxml.txt.nlp	16953886	SENT77	5	5	2	2	doxorubicin	XIAP	PA449412	331	0.632
NULL	Oncoimmunology_2012_Oct_1_1(7)_1004-1016.nxml.txt.nlp	23170249	SENT87	20	20	12	12	paclitaxel	HER-2	PA450761	2064	0.632
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT375	0	0	7	7	resveratrol	SRC3		8202	0.632
NULL	Oncogene_2014_Mar_6_33(10)_1316-1324.nxml.txt.nlp	23474758	SENT90	9	9	13	13	paclitaxel	AXL	PA450761	558	0.632
NULL	Acta_Pharmacol_Sin_2013_Jan_3_34(1)_119-128.nxml.txt.nlp	23202804	SENT238	8	8	14	14	rimonabant	NG2	PA152407999	1464;6048	0.632
NULL	Cardiol_Res_Pract_2011_Aug_15_2011_156146.nxml.txt.nlp	21876822	SENT182	22	22	3	3	oxygen	eNOS	PA450744	4846	0.632
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT39	7	7	26	26	gefitinib	KRAS	PA131301952	3845	0.632
NULL	Mol_Cancer_2008_May_16_7_38.nxml.txt.nlp	18485224	SENT6	17	17	22	22	celecoxib	DMC	PA448871	284340;54808	0.632
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT105	0	0	2	2	capsaicin	p53	PA448776	7157	0.632
NULL	Cerebrospinal_Fluid_Res_2004_Dec_10_1_3.nxml.txt.nlp	15679944	SENT42	1	1	3	3	vasopressin	AVP	PA451858	114548;551	0.632
NULL	J_Adv_Pharm_Technol_Res_2014_Apr-Jun_5(2)_70-77.nxml.txt.nlp	24959415	SENT148	10	10	0	0	theophylline	NIR	PA451647	26155	0.632
NULL	Cancers_(Basel)_2014_May_16_6(2)_1180-1194.nxml.txt.nlp	24840048	SENT62	17	17	4	4	imatinib	KIT	PA10804	3815	0.632
NULL	Nucleic_Acids_Res_2012_Jun_22_40(11)_4861-4878.nxml.txt.nlp	22362753	SENT501	1	1	6	6	trypsin	NPM3	PA451806	10360	0.632
NULL	J_Vis_Exp_2009_Jun_5_(28)_1278.nxml.txt.nlp	19578330	SENT102	2	2	20	20	isoflurane	hole	PA450106	80757	0.632
NULL	J_Int_Soc_Sports_Nutr_2010_Feb_3_7_8.nxml.txt.nlp	20181080	SENT12	14	14	16	16	vasopressin	AVP	PA451858	114548;551	0.632
NULL	Exp_Diabetes_Res_2012_Dec_26_2012_230624.nxml.txt.nlp	23365557	SENT185	31	31	40	40	liraglutide	LIR1	PA165958364	10859	0.632
NULL	Int_J_Nanomedicine_2009_Apr_20_4_107-114.nxml.txt.nlp	19516889	SENT8	3	3	14	14	cisplatin	DDP	PA449014	1678	0.632
NULL	Lab_Invest_2013_Feb_19_93(2)_181-193.nxml.txt.nlp	23212100	SENT256	9	9	18	18	cyclophosphamide	CTX	PA449165	1593	0.632
NULL	Alcohol_Res_2012_34(3)_355-361.nxml.txt.nlp	23134052	SENT94	12	12	15	15	ethanol	CYP2E1	PA448073	1571	0.632
NULL	Ther_Clin_Risk_Manag_2007_Jun_3(3)_449-459.nxml.txt.nlp	18488069	SENT196	17	17	14	14	almotriptan	RIZ	PA10246	7799	0.632
NULL	Int_J_Biol_Sci_2015_Jan_1_11(2)_144-155.nxml.txt.nlp	25561897	SENT183	37	37	7	7	cisplatin	POLB	PA449014	5423	0.632
NULL	Exp_Mol_Med_2012_Oct_31_44(10)_603-614.nxml.txt.nlp	22859500	SENT23	17	17	19	19	lipase	ATGL	PA450239	57104	0.632
NULL	Braz_J_Med_Biol_Res_2013_Jun_12_46(6)_546-554.nxml.txt.nlp	23780424	SENT202	4	4	12	12	paclitaxel	PC3	PA450761	57332;7832;5122	0.632
NULL	J_Exp_Clin_Cancer_Res_2008_Sep_24_27(1)_44.nxml.txt.nlp	18811981	SENT286	3	3	5	5	cisplatin	p53	PA449014	7157	0.632
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT842	16	16	22	22	resveratrol	SIRT1		23411	0.632
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2013_Nov_1_69(Pt_11)_2276-2286.nxml.txt.nlp	24189240	SENT557	3	3	15	15	trypsin	CPU	PA451806	1361	0.632
NULL	Acta_Pharmacol_Sin_2010_Oct_13_31(10)_1324-1328.nxml.txt.nlp	20835265	SENT99	5	5	21	21	l-arginine	iNOS	PA448478	4843	0.632
NULL	Neural_Regen_Res_2014_Mar_15_9(6)_622-629.nxml.txt.nlp	25206865	SENT35	11	11	21	21	vasopressin	p38	PA451858	10598;1432;7965	0.632
NULL	Breast_Cancer_Res_Treat_2013_Aug_20_141(1)_43-53.nxml.txt.nlp	23959396	SENT23	27	27	36	36	trastuzumab	HER2	PA451743	2064	0.632
NULL	Cancers_(Basel)_2013_May_27_5(2)_617-638.nxml.txt.nlp	24216994	SENT159	13	13	18	18	curcumin	PC3	PA151958596	57332;7832;5122	0.632
NULL	Biomed_Res_Int_2014_Feb_19_2014_162314.nxml.txt.nlp	24701564	SENT144	4	4	1	1	amiloride	NHE	PA448368	285335	0.632
NULL	Drug_Target_Insights_2007_Feb_7_2_19-27.nxml.txt.nlp	21901059	SENT139	28	28	11	11	ribavirin	IL-10	PA451241	3586	0.632
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Apr_7_9_12.nxml.txt.nlp	20374640	SENT83	21	21	10	10	ciprofloxacin	APR	PA449009	5366	0.632
NULL	Br_J_Cancer_1995_Feb_71(2)_294-299.nxml.txt.nlp	7841043	SENT9	12	12	9	9	tamoxifen	P-gp	PA451581	5243	0.632
NULL	J_Cell_Biol_2002_Jun_24_157(7)_1267-1278.nxml.txt.nlp	12082084	SENT688	8	8	11	11	thrombin	PAR-1	PA451674	2011;2149	0.632
NULL	Anal_Bioanal_Chem_2008_Apr_31_390(8)_1987-1998.nxml.txt.nlp	18236033	SENT44	18	18	25	25	estradiol	DES	PA449503	1674	0.632
NULL	Nat_Med_2010_Sep_29_16(9)_1042-1047.nxml.txt.nlp	20802500	SENT143	9	9	17	17	dextran	CO2	PA449261	4513	0.632
NULL	Oncol_Lett_2013_Feb_7_5(2)_440-446.nxml.txt.nlp	23420122	SENT247	2	2	16	16	gemcitabine	Gem	PA449748	51053	0.632
NULL	Indian_J_Endocrinol_Metab_2013_Sep-Oct_17(5)_946-947.nxml.txt.nlp	24083193	SENT19	1	1	3	3	vasopressin	AVP	PA451858	114548;551	0.632
NULL	Acta_Pharmacol_Sin_2010_Mar_22_31(3)_329-340.nxml.txt.nlp	20173759	SENT30	6	6	9	9	ethanol	AMPK	PA448073	5563	0.632
NULL	Blood_Cancer_J_2013_Sep_13_3(9)_e146.nxml.txt.nlp	24036945	SENT13	23	23	9	9	ribavirin	AKT	PA451241	207	0.632
NULL	Int_J_Antimicrob_Agents_2012_Feb_39(2)_124-129.nxml.txt.nlp	22079533	SENT30	4	4	10	10	fosfomycin	NAG	PA164748039	51594;4669	0.632
NULL	Oncol_Lett_2014_Nov_14_8(5)_2086-2092.nxml.txt.nlp	25295095	SENT118	8	8	6	6	gemcitabine	LKB1	PA449748	6794	0.632
NULL	Crit_Care_2006_Mar_7_10(2)_R40.nxml.txt.nlp	16542484	SENT27	9	9	11	11	vasopressin	AVP	PA451858	114548;551	0.632
NULL	Asian-Australas_J_Anim_Sci_2014_Dec_27(12)_1783-1793.nxml.txt.nlp	25358373	SENT135	0	0	4	4	capsaicin	CASP3	PA448776	836	0.632
NULL	Ann_Dermatol_2011_Oct_31_23(Suppl_2)_S169-S174.nxml.txt.nlp	22148042	SENT54	14	14	7	7	vincristine	CHOP	PA451879	1649	0.632
NULL	Br_J_Cancer_2012_Feb_14_106(4)_685-692.nxml.txt.nlp	22294184	SENT235	17	17	8	8	docetaxel	L12	PA449383	26156;6136	0.632
NULL	JAKSTAT_2013_Jan_1_2(1)_e24134.nxml.txt.nlp	24058800	SENT63	29	29	22	22	mitoxantrone	IFN	PA450526	3439	0.632
NULL	Exp_Lung_Res_2013_Oct_1_39(8)_336-348.nxml.txt.nlp	23919450	SENT177	16	16	6	6	argatroban	PAR-1	PA164745516	2011;2149	0.632
NULL	J_Inflamm_(Lond)_2008_Jul_24_5_10.nxml.txt.nlp	18652680	SENT120	12	12	36	36	estradiol	IL-10	PA449503	3586	0.632
NULL	Breast_Cancer_Res_2010_Jul_1_12(4)_R45.nxml.txt.nlp	20594311	SENT135	34	34	11	11	nelfinavir	AKT	PA450606	207	0.632
NULL	Gut_Liver_2013_Sep_14_7(5)_585-593.nxml.txt.nlp	24073317	SENT120	30	30	28	28	ribavirin	IFN	PA451241	3439	0.632
NULL	Mol_Cancer_2012_Jul_12_11_45.nxml.txt.nlp	22788833	SENT138	9	9	14	14	cisplatin	EGFR	PA449014	1956	0.632
NULL	Biosci_Rep_2014_Dec_12_34(6)_e00162.nxml.txt.nlp	25385088	SENT174	6	6	9	9	chymotrypsin	XPA	PA448994	7507	0.632
NULL	Case_Rep_Oncol_Med_2011_Nov_22_2011_326815.nxml.txt.nlp	22606443	SENT45	34	34	10	10	thyroglobulin	CK7	PA164754910	3855	0.632
NULL	J_Oncol_2010_Nov_19_2010_568938.nxml.txt.nlp	20037743	SENT51	21	21	9	9	urokinase	EGF	PA451836	1950	0.632
NULL	Mol_Cancer_2010_Nov_8_9_291.nxml.txt.nlp	21059223	SENT153	17	17	14	14	paclitaxel	ZNF217	PA450761	7764	0.632
NULL	J_Gen_Physiol_2012_Jun_139(6)_407-414.nxml.txt.nlp	22641635	SENT12	28	28	25	25	nadh	ADP	PA164755085	23038	0.632
NULL	Diabetes_2011_May_23_60(5)_1458-1466.nxml.txt.nlp	21464445	SENT320	19	19	21	21	lipase	ATGL	PA450239	57104	0.632
NULL	Curr_Hepat_Rep_2010_May_21_9(2)_75-90.nxml.txt.nlp	20461127	SENT375	5	5	0	0	entecavir	LAM	PA164784025	7249;7248	0.632
NULL	J_Cell_Mol_Med_2014_Dec_7_18(12)_2536-2552.nxml.txt.nlp	25287328	SENT307	13	13	0	0	estradiol	PKD1	PA449503	5310	0.632
NULL	Acta_Naturae_2011_Oct-Dec_3(4)_12-29.nxml.txt.nlp	22649701	SENT257	14	14	5	5	fluorescein	PTK7	PA164746009	5754	0.632
NULL	Cancers_(Basel)_2012_Apr_5_4(2)_354-378.nxml.txt.nlp	24213315	SENT880	1	1	13	13	sorafenib	STAT3	PA7000	6774	0.632
NULL	Br_J_Cancer_2001_Aug_85(3)_317-324.nxml.txt.nlp	11487258	SENT6	9	9	13	13	tamoxifen	DMT	PA451581	2039	0.632
NULL	Biomed_Res_Int_2014_Jun_26_2014_249780.nxml.txt.nlp	25054134	SENT214	15	15	18	18	ethanol	VIII	PA448073	1351	0.632
NULL	Int_J_Surg_Case_Rep_2014_Sep_22_5(11)_783-786.nxml.txt.nlp	25290381	SENT20	28	28	5	5	denosumab	RANKL	PA166048634	8600	0.632
NULL	J_Korean_Med_Sci_2006_Dec_31_21(6)_1037-1040.nxml.txt.nlp	17179683	SENT96	15	15	8	8	metronidazole	BAM	PA450484	9126	0.632
NULL	Front_Neurosci_2012_Feb_22_6_27.nxml.txt.nlp	22371696	SENT99	16	16	6	6	isoflurane	E12	PA450106	64100	0.632
NULL	Exp_Neurobiol_2014_Jun_13_23(2)_124-129.nxml.txt.nlp	24963276	SENT75	3	3	8	8	naringin	GDNF	PA151958360	2668	0.632
NULL	Curr_Neuropharmacol_2012_Jun_10(2)_139-158.nxml.txt.nlp	23204984	SENT662	0	0	28	28	imipramine	IL-10	PA449969	3586	0.632
NULL	Emerg_Infect_Dis_2012_Aug_18(8)_1290-1297.nxml.txt.nlp	22840274	SENT122	6	6	9	9	ciprofloxacin	GISP	PA449009	83998	0.632
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT157	19	19	30	30	perifosine	JNK	PA165291471	5599	0.632
NULL	Diabetes_Care_2009_Sep_28_32(9)_1649-1655.nxml.txt.nlp	19478198	SENT139	2	2	12	12	metformin	URI	PA450395	8725	0.632
NULL	Nat_Methods_2011_Feb_16_8(2)_165-170.nxml.txt.nlp	21240280	SENT177	37	37	34	34	trypsin	OMI	PA451806	27429	0.632
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT147	31	31	42	42	pp2	PP2		4888	0.632
NULL	AIDS_2014_Jun_1_28(9)_1333-1339.nxml.txt.nlp	24583670	SENT64	10	10	14	14	nevirapine	CD4	PA450616	920	0.632
NULL	Breast_Cancer_Res_2014_May_30_16(3)_R55.nxml.txt.nlp	24886669	SENT234	16	16	1	1	doxorubicin	survivin	PA449412	332	0.632
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1063.nxml.txt.nlp	24556678	SENT218	8	8	10	10	thioridazine	TRAIL	PA451666	8743	0.632
NULL	Arthritis_Res_Ther_2006_Jul_21_8(4)_R130.nxml.txt.nlp	16859540	SENT180	22	22	17	17	simvastatin	HIF-1	PA451363	29072	0.632
NULL	Diabetes_2009_Jun_16_58(6)_1382-1390.nxml.txt.nlp	19289456	SENT218	28	28	20	20	losartan	IPL	PA450268	7262	0.632
NULL	Arthritis_Res_2000_Sep_20_2(6)_504-512.nxml.txt.nlp	11056680	SENT64	7	7	12	12	thrombin	PAR1	PA451674	79581;2149	0.632
NULL	J_Korean_Med_Sci_2013_Aug_31_28(8)_1213-1219.nxml.txt.nlp	23960450	SENT178	25	25	11	11	ribavirin	RVR	PA451241	9975	0.632
NULL	Environ_Microbiol_2013_Jan_15_15(1)_297-304.nxml.txt.nlp	23157680	SENT66	22	22	16	16	chloramphenicol	TMP	PA448927	2012	0.632
NULL	Pharmaceutics_2012_May_23_4(2)_276-295.nxml.txt.nlp	24300232	SENT41	13	13	4	4	hyaluronan	NIR	PA165958431	26155	0.632
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT119	0	0	2	2	nutlin-3	p53		7157	0.632
NULL	Br_J_Cancer_2011_Aug_23_105(5)_649-657.nxml.txt.nlp	21811251	SENT7	22	22	20	20	gefitinib	EGFR	PA131301952	1956	0.632
NULL	F1000_Biol_Rep_2009_Sep_8_1_70.nxml.txt.nlp	20948617	SENT8	10	10	6	6	tocilizumab	IL-6	PA165292659	3569	0.632
NULL	Blood_Res_2013_Mar_25_48(1)_58-62.nxml.txt.nlp	23589798	SENT61	20	20	15	15	thrombin	FVIII	PA451674	2157	0.632
NULL	Front_Neurosci_2013_Jun_17_7_109.nxml.txt.nlp	23785312	SENT144	9	9	11	11	vasopressin	AVP	PA451858	114548;551	0.632
NULL	Diabetes_2013_Jun_17_62(6)_1843-1854.nxml.txt.nlp	23349486	SENT235	26	26	20	20	hyaluronan	MCP-1	PA165958431	6347	0.632
NULL	Diabetes_Care_2013_Aug_17_36(Suppl_2)_S245-S252.nxml.txt.nlp	23882053	SENT28	30	30	22	22	metformin	HIP	PA450395	6767;6159;64399;5068	0.632
NULL	J_Parasitol_Res_2012_Aug_13_2012_296856.nxml.txt.nlp	22934153	SENT142	9	9	19	19	praziquantel	SWAP	PA164764583	6433;50618	0.632
NULL	Crit_Care_2008_Feb_2_12(1)_R11.nxml.txt.nlp	18252006	SENT21	1	1	3	3	vasopressin	AVP	PA451858	114548;551	0.632
NULL	Cell_Death_Dis_2010_Nov_18_1(11)_e102.nxml.txt.nlp	21368867	SENT10	0	0	6	6	gentamicin	CLIMP-63	PA449753	10970	0.632
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1051.nxml.txt.nlp	24503543	SENT144	16	16	31	31	sorafenib	Yes	PA7000	7525	0.632
NULL	Clin_Med_Pathol_2008_Mar_1_1_17-34.nxml.txt.nlp	21876648	SENT147	0	0	9	9	tamoxifen	c-fos	PA451581	2353	0.632
NULL	Oncol_Lett_2014_Jun_8_7(6)_1761-1766.nxml.txt.nlp	24932229	SENT101	12	12	23	23	palifermin	KDR	PA164744014	3791	0.632
NULL	Biomed_Res_Int_2013_Aug_27_2013_960126.nxml.txt.nlp	24069608	SENT14	2	2	19	19	fluoxetine	CA3	PA449673	761	0.632
NULL	Mol_Pain_2012_Sep_22_8_71.nxml.txt.nlp	22998838	SENT148	0	0	11	11	paclitaxel	GLT-1	PA450761	6506	0.632
NULL	Oncotarget_2013_Dec_12_5(1)_249-257.nxml.txt.nlp	24371149	SENT156	14	14	8	8	tamoxifen	HER2	PA451581	2064	0.632
NULL	Front_Physiol_2012_Oct_29_3_409.nxml.txt.nlp	23112775	SENT16	3	3	20	20	forskolin	AMPK	PA146096022	5563	0.632
NULL	J_Lipid_Res_2014_Dec_55(12)_2606-2619.nxml.txt.nlp	25339683	SENT296	27	27	20	20	desipramine	ASM	PA449233	6609;283120	0.632
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT180	9	9	7	7	capsaicin	MDM2	PA448776	4193	0.632
NULL	Br_J_Ophthalmol_2008_Sep_22_92(9)_1275-1282.nxml.txt.nlp	18723745	SENT22	38	38	31	31	latanoprost	BAK	PA164774763	578	0.632
NULL	Br_J_Cancer_2014_May_27_110(11)_2716-2727.nxml.txt.nlp	24800946	SENT158	15	15	20	20	panitumumab	KRAS	PA162373091	3845	0.632
NULL	Br_J_Cancer_1999_May_1_80(3-4)_536-545.nxml.txt.nlp	10408864	SENT3	14	14	21	21	urokinase	p53	PA451836	7157	0.632
NULL	Int_J_Endocrinol_2014_Jun_3_2014_435481.nxml.txt.nlp	24995016	SENT23	2	2	9	9	exenatide	GLP-1	PA164749238	100125288	0.632
NULL	Surg_Today_2012_Jan_6_42(1)_8-28.nxml.txt.nlp	22139128	SENT230	21	21	39	39	tegafur	PSK	PA452620	9344	0.632
NULL	J_Cell_Biol_2005_Jul_4_170(1)_49-59.nxml.txt.nlp	15983061	SENT156	19	19	16	16	fluorescein	MITF	PA164746009	4286	0.632
NULL	Mol_Clin_Oncol_2013_Sep_26_1(5)_799-804.nxml.txt.nlp	24649249	SENT117	6	6	4	4	trastuzumab	HER2	PA451743	2064	0.632
NULL	Cardiovasc_Res_2012_Dec_1_96(3)_552-560.nxml.txt.nlp	22918977	SENT19	19	19	3	3	hydralazine	ANG	PA449894	283	0.632
NULL	BMJ_2014_Apr_15_348_g2366.nxml.txt.nlp	24736555	SENT331	4	4	2	2	liraglutide	GLP-1	PA165958364	100125288	0.632
NULL	Pain_Ther_2013_Jun_18_2(1)_65-71.nxml.txt.nlp	25135038	SENT85	12	12	19	19	duloxetine	Gen	PA10066	348654	0.632
NULL	Exp_Diabetes_Res_2011_Apr_26_2011_215764.nxml.txt.nlp	21584276	SENT137	8	8	4	4	exenatide	Yes	PA164749238	7525	0.632
NULL	Sci_Rep_2014_Dec_4_4_7315.nxml.txt.nlp	25472865	SENT74	15	15	3	3	thrombin	GT24	PA451674	1501	0.632
NULL	Cereb_Cortex_2014_May_10_24(5)_1351-1360.nxml.txt.nlp	23307638	SENT87	32	32	11	11	levodopa	ANOVA	PA450213	4858	0.632
NULL	F1000Res_2014_Mar_18_3_74.nxml.txt.nlp	25580222	SENT114	6	6	2	2	ciprofloxacin	TOX	PA449009	9760	0.632
NULL	Nat_Commun_2013_Nov_28_4_2852.nxml.txt.nlp	24284943	SENT290	26	26	12	12	fluorescein	NeuN	PA164746009	146713	0.632
NULL	Indian_J_Psychiatry_2014_Jan_56(Suppl_1)_S63-S96.nxml.txt.nlp	NULL	SENT816	16	16	6	6	clozapine	OGC	PA449061	8402	0.632
NULL	J_Cancer_2012_Jun_1_3_241-245.nxml.txt.nlp	22670158	SENT39	9	9	13	13	pemetrexed	FDG	PA10810	23583	0.632
NULL	Indian_J_Pharmacol_2014_Nov-Dec_46(6)_627-632.nxml.txt.nlp	25538335	SENT121	5	5	3	3	metformin	Q10	PA450395	27161	0.632
NULL	Acta_Vet_Scand_2011_Feb_17_53(1)_11.nxml.txt.nlp	21324209	SENT55	26	26	24	24	oxytetracycline	OTC	PA450757	5009	0.632
NULL	Arthritis_Res_Ther_2005_May_18_7(Suppl_3)_S2-S8.nxml.txt.nlp	15960819	SENT63	17	17	0	0	methotrexate	ACR	PA450428	49	0.632
NULL	Drug_Des_Devel_Ther_2014_Sep_23_8_1527-1538.nxml.txt.nlp	25284985	SENT194	30	30	34	34	celecoxib	IFN	PA448871	3439	0.632
NULL	Indian_J_Pharmacol_2014_Nov-Dec_46(6)_627-632.nxml.txt.nlp	25538335	SENT112	13	13	6	6	metformin	Q10	PA450395	27161	0.632
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Jul_20_69(Pt_8)_o1276.nxml.txt.nlp	24109358	SENT74	22	22	9	9	ethanol	mol	PA448073	90527	0.632
NULL	Croat_Med_J_2014_Jun_55(3)_206-217.nxml.txt.nlp	24891279	SENT150	16	16	21	21	doxorubicin	SDH	PA449412	1757;10993	0.632
NULL	Clin_Ophthalmol_2013_Aug_22_7_1669-1682.nxml.txt.nlp	24003303	SENT174	3	3	19	19	dacarbazine	IL-2	PA449197	3558	0.632
NULL	J_Oncol_2010_May_24_2010_729725.nxml.txt.nlp	20508816	SENT106	0	0	5	5	vatalanib	VEGFR	PA7001	3791	0.632
NULL	Neuropsychopharmacology_2009_Jun_25_34(7)_1854-1864.nxml.txt.nlp	19242406	SENT119	18	18	0	0	memantine	ANOVA	PA10364	4858	0.632
NULL	Acta_Pharmacol_Sin_2014_Aug_21_35(8)_1082-1092.nxml.txt.nlp	25047514	SENT101	9	9	13	13	estradiol	aromatase	PA449503	1588	0.632
NULL	Br_J_Cancer_2012_Sep_4_107(6)_947-955.nxml.txt.nlp	22892392	SENT14	0	0	10	10	lapatinib	AKT	PA152241907	207	0.632
NULL	J_Gen_Physiol_2000_Jun_1_115(6)_685-696.nxml.txt.nlp	10828243	SENT120	17	17	23	23	genistein	OLF	PA165109660	83857	0.632
NULL	Br_J_Pharmacol_2014_Oct_26_171(20)_4785-4796.nxml.txt.nlp	25074741	SENT230	0	0	7	7	guanfacine	NK1R	PA449825	6869	0.632
NULL	Arch_Med_Sci_2013_Apr_20_9(2)_332-339.nxml.txt.nlp	23671446	SENT129	5	5	25	25	midazolam	p38	PA450496	10598;1432;7965	0.632
NULL	J_Biol_Eng_2010_Nov_29_4_15.nxml.txt.nlp	21114841	SENT100	10	10	15	15	doxorubicin	P105	PA449412	57410	0.632
NULL	Oxid_Med_Cell_Longev_2013_Jun_2_2013_793525.nxml.txt.nlp	23819014	SENT156	4	4	19	19	resveratrol	SGBS		2719	0.632
NULL	Evid_Based_Complement_Alternat_Med_2012_Dec_20_2012_908601.nxml.txt.nlp	23326293	SENT24	14	14	37	37	daunorubicin	MRP	PA449212	79971	0.632
NULL	J_Antimicrob_Chemother_2014_Nov_17_69(11)_2920-2927.nxml.txt.nlp	25038069	SENT139	2	2	29	29	gentamicin	TMP	PA449753	2012	0.632
NULL	Indian_J_Nephrol_2013_Nov-Dec_23(6)_413-414.nxml.txt.nlp	24339517	SENT36	24	24	9	9	tacrolimus	IL2RA	PA451578	3559	0.632
NULL	Nat_Commun_2010_Nov_23_1_127.nxml.txt.nlp	21119640	SENT129	25	25	20	20	doxycycline	INS-1	PA449415	2305	0.632
NULL	Acta_Physiol_(Oxf)_2008_Apr_192(4)_505-517.nxml.txt.nlp	17973950	SENT113	17	17	1	1	propranolol	PES	PA451145	23481	0.632
NULL	Ann_Rheum_Dis_2011_Apr_22_70(8)_1395-1400.nxml.txt.nlp	21515602	SENT190	21	21	14	14	methotrexate	ATIC	PA450428	471	0.632
NULL	J_Thromb_Haemost_2007_May_5(5)_1010-1018.nxml.txt.nlp	17355572	SENT14	4	4	13	13	thrombin	VWF	PA451674	7450	0.631
NULL	Clin_Immunol_2010_Oct_137(1-3)_1-4.nxml.txt.nlp	20570568	SENT146	25	25	23	23	trimethoprim	TMP	PA451788	2012	0.631
NULL	Yale_J_Biol_Med_1976_Sep_49(4)_317-325.nxml.txt.nlp	997592	SENT10	27	27	14	14	methacholine	MEFV	PA165958382	4210	0.631
NULL	J_Antimicrob_Chemother_2010_Mar_18_65(3)_390-398.nxml.txt.nlp	20022938	SENT31	22	22	24	24	mefloquine	ATV	PA450348	4683	0.631
NULL	J_Int_Soc_Sports_Nutr_2009_Feb_19_6_6.nxml.txt.nlp	19228401	SENT253	8	8	2	2	creatine	CRT	PA164778930	811	0.631
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT106	8	8	11	11	neratinib	HER2	PA165291472	2064	0.631
NULL	EMBO_Mol_Med_2012_Oct_30_4(10)_1087-1096.nxml.txt.nlp	22933245	SENT64	19	19	7	7	olaparib	NAMPT		10135	0.631
NULL	Cardiol_Res_Pract_2010_Jun_29_2010_824938.nxml.txt.nlp	20671994	SENT180	31	31	42	42	l-arginine	B12	PA448478	7126;4709	0.631
NULL	Ann_Oncol_2013_Aug_12_24(8)_1994-1999.nxml.txt.nlp	23670096	SENT34	31	31	22	22	tamoxifen	AIB1	PA451581	8202	0.631
NULL	Protein_Cell_2014_Mar_22_5(3)_235-247.nxml.txt.nlp	24563216	SENT268	20	20	14	14	paraformaldehyde	CO2	PA450790	4513	0.631
NULL	J_Mol_Signal_2008_Dec_1_3_18.nxml.txt.nlp	19046439	SENT84	14	14	7	7	metformin	Met	PA450395	79811	0.631
NULL	Nucleic_Acids_Res_2012_Apr_19_40(8)_e60.nxml.txt.nlp	22262732	SENT131	24	24	26	26	lipase	MGLL	PA450239	11343	0.631
NULL	Ann_Surg_Treat_Res_2014_Feb_22_86(2)_68-75.nxml.txt.nlp	24761411	SENT199	0	0	6	6	resveratrol	survivin		332	0.631
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT194	14	14	16	16	methotrexate	MSH2	PA450428	4436	0.631
NULL	Oncoscience_2014_Mar_12_1(2)_158-166.nxml.txt.nlp	25594008	SENT47	20	20	14	14	dasatinib	IGFBP2	PA162372878	3485	0.631
NULL	Breast_Cancer_Res_Treat_2013_Jan_6_137(1)_167-174.nxml.txt.nlp	23129173	SENT162	10	10	15	15	letrozole	aromatase	PA450196	1588	0.631
NULL	Curr_Genomics_2013_Nov_14(7)_477-484.nxml.txt.nlp	24396279	SENT96	15	15	4	4	doxorubicin	MYH9	PA449412	4627	0.631
NULL	J_Mol_Med_(Berl)_2014_May_10_92(7)_709-722.nxml.txt.nlp	24811491	SENT68	43	43	27	27	cetuximab	EGFR	PA10040	1956	0.631
NULL	Ann_Lab_Med_2012_Jul_20_32(4)_298-303.nxml.txt.nlp	22779073	SENT117	28	28	22	22	clarithromycin	MOX	PA449028	26002	0.631
NULL	Br_J_Cancer_1996_Dec_74(11)_1719-1729.nxml.txt.nlp	8956784	SENT10	19	19	16	16	doxorubicin	EPI	PA449412	7035	0.631
NULL	Eur_J_Histochem_2011_Mar_24_55(1)_e6.nxml.txt.nlp	21556121	SENT113	16	16	10	10	paraformaldehyde	HRG	PA450790	3084;3273	0.631
NULL	J_Headache_Pain_2009_Dec_3_10(6)_407-417.nxml.txt.nlp	19802522	SENT195	8	8	16	16	ergotamine	MIDAS	PA164747651	64083	0.631
NULL	BioData_Min_2013_Jan_8_6_1.nxml.txt.nlp	23294634	SENT223	25	25	8	8	methotrexate	ATIC	PA450428	471	0.631
NULL	Oncotarget_2012_Dec_18_3(12)_1615-1628.nxml.txt.nlp	23271044	SENT55	19	19	17	17	temsirolimus	TOR	PA164746890	6097	0.631
NULL	Iran_J_Basic_Med_Sci_2012_Nov-Dec_15(6)_1162-1167.nxml.txt.nlp	23653845	SENT107	0	0	14	14	curcumin	MCP-1	PA151958596	6347	0.631
NULL	Crit_Care_2008_Aug_4_12(4)_R99.nxml.txt.nlp	18680591	SENT104	10	10	7	7	milrinone	AVP	PA164749171	114548;551	0.631
NULL	Arthritis_Res_Ther_2004_Jun_21_6(4)_R384-R392.nxml.txt.nlp	15225374	SENT63	6	6	10	10	gentamicin	M-CSF	PA449753	1435	0.631
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT122	0	0	15	15	nutlin-3	p53		7157	0.631
NULL	Braz_J_Med_Biol_Res_2014_Sep_5_47(11)_1008-1015.nxml.txt.nlp	25296365	SENT27	38	38	12	12	tamoxifen	CYP2D6	PA451581	1565	0.631
NULL	Front_Physiol_2013_May_20_4_101.nxml.txt.nlp	23730288	SENT134	0	0	8	8	allopurinol	XOR	PA448320	7498	0.631
NULL	Core_Evid_2010_Oct_21_5_77-90.nxml.txt.nlp	21042544	SENT22	0	0	8	8	aprepitant	NK1	PA164747039	11126	0.631
NULL	Oncotarget_2013_Jun_26_4(7)_1008-1018.nxml.txt.nlp	23900284	SENT156	4	4	14	14	bortezomib	SLAMF7	PA10252	57823	0.631
NULL	Pain_2011_Aug_152(8)_1899-1908.nxml.txt.nlp	21600693	SENT492	37	37	22	22	capsaicin	ADP	PA448776	23038	0.631
NULL	Blood_Res_2014_Dec_23_49(4)_253-258.nxml.txt.nlp	25548759	SENT145	8	8	10	10	rituximab	CHOP	PA451261	1649	0.631
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Apr_7_9_12.nxml.txt.nlp	20374640	SENT83	25	25	23	23	chloramphenicol	CHL	PA448927	91851	0.631
NULL	Curr_Neuropharmacol_2010_Dec_8(4)_409-421.nxml.txt.nlp	21629447	SENT193	13	13	9	9	allopurinol	LGS	PA448320	51557	0.631
NULL	Ann_Gen_Psychiatry_2008_Aug_18_7_11.nxml.txt.nlp	18706108	SENT15	23	23	16	16	bupropion	CD50	PA448687	3385	0.631
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1063.nxml.txt.nlp	24556678	SENT6	5	5	13	13	thioridazine	TRAIL	PA451666	8743	0.631
NULL	Gut_Pathog_2010_Dec_7_2_17.nxml.txt.nlp	21138594	SENT39	26	26	32	32	gentamicin	OTC	PA449753	5009	0.631
NULL	Mol_Cancer_2008_Sep_12_7_69.nxml.txt.nlp	18789131	SENT58	22	22	11	11	ethanol	PP2	PA448073	4888	0.631
NULL	Core_Evid_2011_Feb_8_6_23-29.nxml.txt.nlp	21468240	SENT32	2	2	19	19	plerixafor	CD34	PA165958410	947	0.631
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1051.nxml.txt.nlp	24503543	SENT144	36	36	11	11	hexachlorophene	Yes	PA449871	7525	0.631
NULL	J_Antimicrob_Chemother_2011_Feb_9_66(2)_363-370.nxml.txt.nlp	21148235	SENT115	10	10	0	0	ritonavir	ATV	PA451260	4683	0.631
NULL	Diabetes_Metab_Syndr_Obes_2014_Jul_17_7_313-319.nxml.txt.nlp	25092992	SENT107	21	21	24	24	glucose	adiponectin	PA449773	9370	0.631
NULL	J_Cell_Biol_1998_Nov_30_143(5)_1329-1339.nxml.txt.nlp	9832560	SENT210	9	9	19	19	hydrocortisone	PC3	PA449905	57332;7832;5122	0.631
NULL	Oncol_Lett_2013_Aug_29_6(2)_317-322.nxml.txt.nlp	24137323	SENT170	5	5	17	17	vorinostat	c-Myc	PA164748224	4609	0.631
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT147	31	31	8	8	pp2	PP2		4888	0.631
NULL	Case_Rep_Hematol_2012_Jul_2_2012_458716.nxml.txt.nlp	22937329	SENT27	15	15	41	41	imatinib	ABL1	PA10804	25	0.631
NULL	J_Infect_Dis_2013_Sep_1_208(5)_801-812.nxml.txt.nlp	23766527	SENT113	20	20	4	4	chloroquine	LUM	PA448948	4060	0.631
NULL	Reprod_Biol_Endocrinol_2003_Oct_7_1_66.nxml.txt.nlp	14609433	SENT93	10	10	12	12	cisplatin	p53	PA449014	7157	0.631
NULL	Cardiovasc_Res_2009_May_1_82(2)_296-302.nxml.txt.nlp	19088082	SENT90	14	14	18	18	desipramine	nSMase	PA449233	6610	0.631
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT103	1	1	4	4	glucose	EGFR	PA449773	1956	0.631
NULL	Curr_Hepat_Rep_2010_May_21_9(2)_75-90.nxml.txt.nlp	20461127	SENT288	18	18	24	24	telbivudine	LAM	PA164760861	7249;7248	0.631
NULL	Breast_Cancer_Res_2004_Nov_11_6(1)_R31-R37.nxml.txt.nlp	14680498	SENT130	1	1	7	7	estradiol	RbAp46	PA449503	5931	0.631
NULL	J_Antimicrob_Chemother_2010_Jul_30_65(7)_1441-1447.nxml.txt.nlp	20435780	SENT65	14	14	20	20	ciprofloxacin	TOB	PA449009	10140	0.631
NULL	Neuropsychopharmacology_2009_Jul_11_34(8)_1946-1957.nxml.txt.nlp	19279569	SENT204	18	18	8	8	naltrexone	DOR	PA450588	58476	0.631
NULL	Oxid_Med_Cell_Longev_2012_Jul_8_2012_624925.nxml.txt.nlp	22829959	SENT69	28	28	7	7	levodopa	PINK1	PA450213	65018	0.631
NULL	Front_Hum_Neurosci_2010_Oct_14_4_169.nxml.txt.nlp	21048900	SENT594	13	13	2	2	bromocriptine	spatial	PA448671	219793	0.631
NULL	Biomed_Res_Int_2013_Sep_8_2013_843748.nxml.txt.nlp	24083244	SENT173	2	2	4	4	colchicine	CN2	PA449092	55748	0.631
NULL	J_Gen_Physiol_1997_Dec_1_110(6)_727-740.nxml.txt.nlp	9382899	SENT307	10	10	19	19	trypsin	uvomorulin	PA451806	999	0.631
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Apr_15_9_13.nxml.txt.nlp	20398300	SENT108	25	25	18	18	moxifloxacin	LAM	PA450555	7249;7248	0.631
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT243	17	17	10	10	pp2	AKT		207	0.631
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Jun_22_69(Pt_7)_o1137.nxml.txt.nlp	24046688	SENT69	19	19	12	12	ethanol	mol	PA448073	90527	0.631
NULL	J_Viral_Hepat_2007_Nov_14(11)_751-766.nxml.txt.nlp	17927611	SENT139	23	23	21	21	lamivudine	LAM	PA450163	7249;7248	0.631
NULL	J_Allergy_(Cairo)_2011_Oct_24_2011_457169.nxml.txt.nlp	22121382	SENT100	0	0	13	13	salmeterol	IL-8	PA451300	3576	0.631
NULL	Mol_Cancer_2008_May_19_7_40.nxml.txt.nlp	18489772	SENT200	6	6	13	13	bortezomib	PIR	PA10252	8544	0.631
NULL	Clinics_(Sao_Paulo)_2013_Oct_68(10)_1305-1311.nxml.txt.nlp	24212836	SENT110	20	20	4	4	desflurane	CO2	PA164749136	4513	0.631
NULL	Ann_Gen_Psychiatry_2010_Apr_22_9(Suppl_1)_S118.nxml.txt.nlp	NULL	SENT0	20	20	1	1	galantamine	Gen	PA449726	348654	0.631
NULL	Crit_Care_2008_Apr_14_12(2)_415.nxml.txt.nlp	18423070	SENT4	13	13	15	15	vasopressin	AVP	PA451858	114548;551	0.631
NULL	Eur_J_Clin_Microbiol_Infect_Dis_2010_May_13_29(5)_543-550.nxml.txt.nlp	20229224	SENT73	5	5	47	47	oxacillin	VAN	PA450725	10318	0.631
NULL	Cancer_Manag_Res_2014_May_23_6_225-252.nxml.txt.nlp	24904222	SENT482	4	4	11	11	diethylstilbestrol	gamma	PA449307	9913	0.631
NULL	Cancer_Cell_Int_2005_Aug_24_5_28.nxml.txt.nlp	16120219	SENT69	15	15	11	11	etoposide	p53	PA449552	7157	0.631
NULL	J_Biol_Chem_2012_Apr_6_287(15)_12433-12444.nxml.txt.nlp	22351758	SENT514	27	27	9	9	hyaluronan	TSG-6	PA165958431	7130	0.631
NULL	Cough_2007_Oct_31_3_9.nxml.txt.nlp	17971242	SENT35	20	20	29	29	capsaicin	TRPV1	PA448776	7442	0.631
NULL	Front_Genet_2013_Aug_29_4_163.nxml.txt.nlp	24009622	SENT105	19	19	14	14	ethanol	DDP	PA448073	1678	0.631
NULL	Mol_Vis_2012_Oct_5_18_2454-2467.nxml.txt.nlp	23077404	SENT86	2	2	18	18	bevacizumab	HIF-1	PA130232992	29072	0.631
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT211	19	19	24	24	doxorubicin	ABCB1	PA449412	5243	0.631
NULL	Ann_Oncol_2009_Aug_17_20(8)_1319-1329.nxml.txt.nlp	19535820	SENT349	20	20	43	43	cyclophosphamide	San	PA449165	80218	0.631
NULL	BMJ_Open_2013_Feb_12_3(2)_e002242.nxml.txt.nlp	23408078	SENT200	13	13	1	1	phenelzine	Gen	PA450903	348654	0.631
NULL	Clinics_(Sao_Paulo)_2014_Jun_69(6)_438-446.nxml.txt.nlp	24964310	SENT47	2	2	6	6	alendronate	IL-6	PA448082	3569	0.631
NULL	Brain_Sci_2014_May_6_4(2)_356-375.nxml.txt.nlp	24961766	SENT345	18	18	20	20	propofol	G18	PA451141	1154;63940	0.631
NULL	Mol_Pain_2012_Sep_22_8_71.nxml.txt.nlp	22998838	SENT155	12	12	25	25	cisplatin	CB2	PA449014	1269	0.631
NULL	Br_J_Clin_Pharmacol_2010_Jan_69(1)_23-26.nxml.txt.nlp	20078609	SENT86	25	25	17	17	sildenafil	CYP3A4	PA451346	1576	0.631
NULL	Indian_J_Anaesth_2009_Aug_53(4)_399-400.nxml.txt.nlp	20640200	SENT4	23	23	12	12	rocuronium	NMB	PA164754992	10457;4828	0.631
NULL	Springerplus_2013_Jan_23_2_22.nxml.txt.nlp	23420789	SENT103	12	12	19	19	cetuximab	EGFR	PA10040	1956	0.631
NULL	Acta_Pharmacol_Sin_2012_May_16_33(5)_682-690.nxml.txt.nlp	22504904	SENT229	0	0	13	13	celecoxib	Bcl-2	PA448871	596	0.631
NULL	J_Vet_Med_Sci_2014_Jul_18_76(7)_937-945.nxml.txt.nlp	24646457	SENT123	10	10	40	40	cefazolin	OTC	PA448839	5009	0.631
NULL	Bone_Marrow_Res_2011_Mar_2_2011_924058.nxml.txt.nlp	22046572	SENT55	0	0	3	3	tocilizumab	IL-6	PA165292659	3569	0.631
NULL	Arthritis_Res_Ther_2010_Apr_1_12(2)_R60.nxml.txt.nlp	20359365	SENT168	14	14	25	25	bleomycin	SPARC	PA448645	6678	0.631
NULL	Mol_Cancer_2008_Jun_3_7_47.nxml.txt.nlp	18519000	SENT223	25	25	21	21	gefitinib	EGF	PA131301952	1950	0.631
NULL	Iran_J_Public_Health_2012_Jan_31_41(1)_59-65.nxml.txt.nlp	23113123	SENT127	4	4	21	21	lipase	LIPC	PA450239	3990	0.631
NULL	Dermatoendocrinol_2013_Jun_1_5(3)_331-347.nxml.txt.nlp	24516687	SENT25	30	30	12	12	calcidiol	CYP27A1	PA164745614	1593	0.631
NULL	Breast_Cancer_Res_Treat_2013_Aug_20_141(1)_43-53.nxml.txt.nlp	23959396	SENT25	44	44	33	33	trastuzumab	HER3	PA451743	2065	0.631
NULL	Allergy_Asthma_Immunol_Res_2011_Jul_17_3(3)_186-193.nxml.txt.nlp	21738884	SENT72	13	13	15	15	paraformaldehyde	PLP	PA450790	25824;5744	0.631
NULL	Alcohol_Res_2012_34(3)_306-317.nxml.txt.nlp	23134046	SENT191	11	11	16	16	ethanol	HAP	PA448073	5915;10313	0.631
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT128	15	15	1	1	theophylline	CYP2C9	PA451647	1559	0.631
NULL	Acta_Pharmacol_Sin_2010_Mar_22_31(3)_329-340.nxml.txt.nlp	20173759	SENT207	30	30	19	19	ethanol	AMPK	PA448073	5563	0.631
NULL	J_Immunol_Res_2014_Jul_16_2014_696812.nxml.txt.nlp	25133198	SENT266	13	13	3	3	rifaximin	CTR	PA164752443	799	0.631
NULL	Evid_Based_Complement_Alternat_Med_2012_May_7_2012_242810.nxml.txt.nlp	22645625	SENT230	15	15	19	19	rifampin	UGT1A1	PA451250	54658	0.631
NULL	Oncotarget_2014_Oct_10_5(20)_10151-10169.nxml.txt.nlp	25294814	SENT76	6	6	8	8	lipase	LIPE	PA450239	3991	0.631
NULL	Oncotarget_2014_Feb_7_5(3)_775-787.nxml.txt.nlp	24519956	SENT113	20	20	8	8	docetaxel	PC3	PA449383	57332;7832;5122	0.631
NULL	Oncotarget_2011_Dec_24_2(12)_896-917.nxml.txt.nlp	22203527	SENT109	0	0	19	19	metformin	AMPK	PA450395	5563	0.631
NULL	J_Biomed_Biotechnol_2010_Oct_27_2010_948543.nxml.txt.nlp	21048930	SENT48	9	9	27	27	amiloride	MDC	PA448368	6367	0.631
NULL	Oncotarget_2013_Jul_14_4(8)_1212-1229.nxml.txt.nlp	23902736	SENT321	6	6	8	8	bortezomib	BTZ	PA10252	22794	0.631
NULL	Cardiovasc_Diabetol_2013_Jun_18_12_90.nxml.txt.nlp	23777457	SENT114	13	13	10	10	exenatide	GLP-1	PA164749238	100125288	0.631
NULL	Cell_Death_Dis_2014_Jan_30_5(1)_e1038.nxml.txt.nlp	24481452	SENT231	3	3	8	8	raloxifene	CYP1A1	PA451221	1543	0.631
NULL	Indian_J_Pharmacol_2009_Aug_41(4)_167-172.nxml.txt.nlp	20523867	SENT31	3	3	10	10	imatinib	AST	PA10804	26503	0.631
NULL	Cancer_Res_Treat_2012_Mar_31_44(1)_50-56.nxml.txt.nlp	22500161	SENT119	11	11	9	9	heparin	EGF	PA449855	1950	0.631
NULL	Leukemia_2014_Mar_13_28(3)_629-641.nxml.txt.nlp	24263804	SENT207	32	32	25	25	imatinib	PAK2	PA10804	5062	0.631
NULL	Neural_Plast_2012_Jul_8_2012_710943.nxml.txt.nlp	22830052	SENT234	22	22	39	39	betaine	UBE3A	PA448603	7337	0.631
NULL	Crit_Care_2010_Nov_5_14(6)_R200.nxml.txt.nlp	21054850	SENT181	1	1	3	3	vasopressin	AVP	PA451858	114548;551	0.631
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT780	29	29	0	0	paclitaxel	OATP1B3	PA450761	28234	0.631
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_24_2012_203732.nxml.txt.nlp	23150739	SENT257	12	12	24	24	raloxifene	DPD	PA451221	1806	0.631
NULL	J_Int_Soc_Sports_Nutr_2014_Aug_13_11_38.nxml.txt.nlp	25132809	SENT42	19	19	13	13	creatine	MSTN	PA164778930	2660	0.631
NULL	Mol_Cancer_2010_Jun_23_9_162.nxml.txt.nlp	20573255	SENT33	29	29	23	23	paclitaxel	PC3	PA450761	57332;7832;5122	0.631
NULL	Nucleic_Acids_Res_2008_Jan_13_36(1)_121-132.nxml.txt.nlp	17999998	SENT56	43	43	18	18	hydrocortisone	F12	PA449905	2161	0.631
NULL	Evid_Based_Complement_Alternat_Med_2011_Feb_14_2011_429843.nxml.txt.nlp	21869897	SENT181	6	6	20	20	ethanol	PC6	PA448073	5125	0.631
NULL	J_Oncol_2009_Mar_24_2009_491985.nxml.txt.nlp	19325924	SENT164	18	18	5	5	genistein	CXCL12	PA165109660	6387	0.631
NULL	J_Biol_Chem_2012_Apr_20_287(17)_14122-14135.nxml.txt.nlp	22351750	SENT623	9	9	14	14	hyaluronan	TSG-6	PA165958431	7130	0.631
NULL	Mol_Vis_2012_May_1_18_1115-1122.nxml.txt.nlp	22605923	SENT100	20	20	4	4	estradiol	IL-6	PA449503	3569	0.631
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Apr_15_9_13.nxml.txt.nlp	20398300	SENT134	4	4	11	11	amoxicillin	LAM	PA448406	7249;7248	0.631
NULL	J_Int_Soc_Sports_Nutr_2007_Oct_19_4_13.nxml.txt.nlp	17949492	SENT35	39	39	32	32	estradiol	aromatase	PA449503	1588	0.631
NULL	Contemp_Oncol_(Pozn)_2012_Jul_6_16(3)_223-229.nxml.txt.nlp	23788884	SENT78	0	0	15	15	metformin	TSC2	PA450395	7249	0.631
NULL	Gut_Pathog_2013_Mar_22_5_6.nxml.txt.nlp	23522652	SENT238	13	13	11	11	cefotaxime	CTX	PA448852	1593	0.631
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT307	19	19	17	17	cisplatin	JNK	PA449014	5599	0.631
NULL	Acta_Otorhinolaryngol_Ital_2014_Apr_34(2)_146-149.nxml.txt.nlp	24843227	SENT49	23	23	19	19	doxorubicin	CHOP	PA449412	1649	0.631
NULL	Osong_Public_Health_Res_Perspect_2013_Dec_12_4(6)_316-322.nxml.txt.nlp	24524020	SENT206	22	22	33	33	cefotaxime	PEN	PA448852	9933	0.631
NULL	Diabetes_Care_2013_Jul_12_36(7)_2015-2019.nxml.txt.nlp	23340883	SENT54	28	28	13	13	glucose	SII	PA449773	6917	0.631
NULL	J_Neural_Transm_2014_Mar_27_121(10)_1221-1232.nxml.txt.nlp	24671607	SENT77	22	22	18	18	l-glutamine	B27	PA10090	56246	0.631
NULL	Environ_Health_Insights_2008_Nov_6_2_105-109.nxml.txt.nlp	21572836	SENT20	9	9	11	11	diethylstilbestrol	DES	PA449307	1674	0.631
NULL	J_Biol_Chem_2012_Apr_13_287(16)_13382-13395.nxml.txt.nlp	22367194	SENT91	19	19	16	16	marimastat	TIMP4	PA164748329	7079	0.631
NULL	Hum_Mol_Genet_2009_Oct_15_18(20)_3955-3968.nxml.txt.nlp	19625296	SENT244	25	25	34	34	l-glutamine	B27	PA10090	56246	0.631
NULL	Indian_J_Pharm_Sci_2008_Jan-Feb_70(1)_128-131.nxml.txt.nlp	20390100	SENT30	8	8	10	10	domperidone	DOM	PA134711056	6663	0.631
NULL	Environ_Sci_Technol_2013_Dec_3_47(23)_13781-13790.nxml.txt.nlp	24144340	SENT135	0	0	13	13	genistein	FOR	PA165109660	51741	0.631
NULL	J_Cancer_Prev_2014_Mar_19(1)_39-46.nxml.txt.nlp	25337571	SENT86	4	4	7	7	ethanol	JNK	PA448073	5599	0.631
NULL	Br_J_Cancer_2012_Feb_14_106(4)_685-692.nxml.txt.nlp	22294184	SENT156	3	3	6	6	lovastatin	p27	PA450272	5715;10534	0.631
NULL	Int_J_Mol_Sci_2014_Mar_5_15(3)_3970-3988.nxml.txt.nlp	24603537	SENT121	5	5	3	3	curcumin	MCH	PA151958596	5367	0.631
NULL	Oncotarget_2012_May_18_3(5)_525-534.nxml.txt.nlp	22619113	SENT28	22	22	8	8	fludarabine	Hsp90	PA449655	3320	0.631
NULL	Europace_2011_Feb_7_13(2)_161-173.nxml.txt.nlp	21138930	SENT155	28	28	3	3	flecainide	CAST	PA449646	10849;26059;831	0.631
NULL	Am_J_Trop_Med_Hyg_2013_Nov_6_89(5)_857-865.nxml.txt.nlp	24019436	SENT233	13	13	17	17	artemisinin	ACT	PA165111696	12;11332;9457;641455	0.631
NULL	Ann_Neurol_2013_Oct_24_74(4)_527-536.nxml.txt.nlp	23794460	SENT100	19	19	26	26	metyrapone	ACTH	PA450486	5443	0.631
NULL	Cancer_Biol_Med_2012_Mar_9(1)_18-22.nxml.txt.nlp	23691449	SENT170	16	16	7	7	gefitinib	PTEN	PA131301952	5728	0.631
NULL	J_Adv_Pract_Oncol_2013_Sep_1_Sep-Oct_4(5)_307-321.nxml.txt.nlp	25032010	SENT49	19	19	0	0	melphalan	San	PA450354	80218	0.631
NULL	Cancer_Immunol_Immunother_2013_Aug_27_62(10)_1637-1648.nxml.txt.nlp	23982484	SENT7	21	21	15	15	lenalidomide	IL-6	PA162363968	3569	0.631
NULL	J_Gen_Physiol_2005_Jul_126(1)_1.nxml.txt.nlp	NULL	SENT1038	21	21	16	16	fluorescein	SERCA1	PA164746009	487	0.631
NULL	J_Gen_Physiol_2009_Apr_133(4)_421-438.nxml.txt.nlp	19289574	SENT486	35	35	6	6	forskolin	SLC26A9	PA146096022	115019	0.631
NULL	Nat_Commun_2014_Nov_19_5_5479.nxml.txt.nlp	25407222	SENT69	24	24	8	8	dextran	YTS	PA449261	8565	0.631
NULL	Addict_Sci_Clin_Pract_2013_Apr_8_8(1)_8.nxml.txt.nlp	23566363	SENT107	18	18	13	13	methamphetamine	San	PA450403	80218	0.631
NULL	Oncogene_2010_May_20_29(20)_2962-2972.nxml.txt.nlp	20228846	SENT35	23	23	9	9	imatinib	HIF-1	PA10804	29072	0.631
NULL	J_Radiat_Res_2014_Mar_8_55(2)_257-264.nxml.txt.nlp	24105712	SENT162	7	7	16	16	simvastatin	HGB	PA451363	114757	0.631
NULL	Acta_Pharmacol_Sin_2011_Mar_31_32(3)_295-302.nxml.txt.nlp	21278785	SENT111	1	1	20	20	evodiamine	spatial	PA165860788	219793	0.631
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT359	2	2	15	15	pp2	PP1		5540;5464	0.631
NULL	Genome_Announc_2014_Jul_24_2(4)_e00449-14.nxml.txt.nlp	25059856	SENT9	13	13	24	24	vancomycin	VISA	PA451850	57506	0.631
NULL	J_Korean_Neurosurg_Soc_2013_Oct_31_54(4)_280-288.nxml.txt.nlp	24294450	SENT195	13	13	15	15	acetazolamide	ACZ	PA448018	27445	0.631
NULL	Nucleic_Acids_Res_2012_Jun_10_40(11)_4804-4815.nxml.txt.nlp	22328728	SENT231	3	3	9	9	hemin	SIRT1	PA449849	23411	0.631
NULL	Br_J_Cancer_1995_Aug_72(2)_399-404.nxml.txt.nlp	7640225	SENT6	0	0	2	2	topotecan	TPT	PA451729	23590;6469	0.631
NULL	Clin_Ophthalmol_2011_Feb_11_5_167-170.nxml.txt.nlp	21383944	SENT19	17	17	21	21	ranibizumab	San	PA164746012	80218	0.631
NULL	Int_J_Mol_Sci_2014_Oct_23_15(10)_19265-19280.nxml.txt.nlp	25342321	SENT132	21	21	4	4	cisplatin	MVD	PA449014	4597	0.631
NULL	Br_J_Cancer_2010_Jan_5_102(1)_162-164.nxml.txt.nlp	19953097	SENT12	10	10	4	4	cetuximab	PTEN	PA10040	5728	0.631
NULL	J_Hematol_Oncol_2008_Oct_1_1_16.nxml.txt.nlp	18828924	SENT22	5	5	7	7	trastuzumab	HER2	PA451743	2064	0.631
NULL	Pharmaceuticals_(Basel)_2014_May_28_7(6)_676-694.nxml.txt.nlp	24878537	SENT248	0	0	2	2	bupropion	BUP	PA448687	23412	0.631
NULL	Exp_Lung_Res_2013_Oct_1_39(8)_336-348.nxml.txt.nlp	23919450	SENT108	7	7	18	18	thrombin	PAR-1	PA451674	2011;2149	0.631
NULL	Crit_Care_2006_May_25_10(3)_144.nxml.txt.nlp	16732898	SENT38	7	7	4	4	vasopressin	AVP	PA451858	114548;551	0.631
NULL	Crit_Care_2006_Mar_21_10(Suppl_1)_P360.nxml.txt.nlp	NULL	SENT2	1	1	3	3	vasopressin	AVP	PA451858	114548;551	0.631
NULL	Int_J_Alzheimers_Dis_2010_Sep_2_2010_716453.nxml.txt.nlp	20862344	SENT39	10	10	12	12	vasopressin	AVP	PA451858	114548;551	0.631
NULL	Mol_Cell_Biochem_2014_Oct_9_385(1-2)_265-275.nxml.txt.nlp	24104452	SENT175	15	15	11	11	bortezomib	U87	PA10252	677775;641648	0.631
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT337	3	3	12	12	resveratrol	IL-6		3569	0.631
NULL	Diabetes_Care_2011_Jun_20_34(6)_1424-1430.nxml.txt.nlp	21602431	SENT278	12	12	9	9	pioglitazone	ACT	PA450970	12;11332;9457;641455	0.631
NULL	Cell_Mol_Life_Sci_2012_Apr_22_69(8)_1353-1375.nxml.txt.nlp	22105709	SENT286	2	2	4	4	chlorpromazine	CPZ	PA448964	8532	0.631
NULL	Br_J_Cancer_2011_Apr_12_104(8)_1256-1261.nxml.txt.nlp	21448165	SENT29	21	21	23	23	sorafenib	IL-2	PA7000	3558	0.631
NULL	Acta_Pharmacol_Sin_2010_Jun_4_31(6)_709-717.nxml.txt.nlp	20523342	SENT148	12	12	25	25	repaglinide	CYP2C8	PA451234	1558	0.631
NULL	J_Korean_Med_Sci_2006_Dec_31_21(6)_973-978.nxml.txt.nlp	17179671	SENT167	14	14	8	8	cefepime	CTX	PA164754876	1593	0.631
NULL	Breast_Cancer_Res_2011_Mar_11_13(2)_R30.nxml.txt.nlp	21396117	SENT320	5	5	18	18	erlotinib	EGFR	PA134687924	1956	0.631
NULL	Oncol_Rep_2013_Apr_23_29(4)_1268-1274.nxml.txt.nlp	23354756	SENT117	16	16	30	30	trastuzumab	SLC25A43	PA451743	203427	0.631
NULL	Arthritis_Res_Ther_2014_Apr_3_16(2)_R86.nxml.txt.nlp	24708674	SENT195	19	19	10	10	bosentan	Fli1	PA10034	2314	0.631
NULL	Ther_Clin_Risk_Manag_2007_Aug_3(4)_569-578.nxml.txt.nlp	18472978	SENT240	23	23	5	5	bisoprolol	MDC	PA448641	6367	0.631
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2012_Feb_20_5_13-30.nxml.txt.nlp	22879796	SENT164	6	6	17	17	simvastatin	adiponectin	PA451363	9370	0.631
NULL	Environ_Health_Perspect_2006_Apr_21_114(Suppl_1)_142-146.nxml.txt.nlp	16818260	SENT32	7	7	9	9	diethylstilbestrol	DES	PA449307	1674	0.631
NULL	Chemother_Res_Pract_2011_Feb_6_2011_249867.nxml.txt.nlp	22312550	SENT51	16	16	21	21	moxifloxacin	CAP	PA450555	23476;9200;4012;5269;10580;10487	0.631
NULL	Exp_Diabetes_Res_2009_Jul_7_2009_910783.nxml.txt.nlp	19609456	SENT178	3	3	8	8	rosiglitazone	AMPK	PA451283	5563	0.631
NULL	F1000_Med_Rep_2009_Dec_15_1_96.nxml.txt.nlp	20948681	SENT29	0	0	14	14	teriparatide	PTH	PA451620	5741	0.631
NULL	Breast_Cancer_Res_Treat_2014_Dec_21_143(3)_459-467.nxml.txt.nlp	24362951	SENT1	11	11	19	19	exemestane	HER2	PA449563	2064	0.631
NULL	Nucleic_Acids_Res_2012_Sep_8_40(16)_8059-8071.nxml.txt.nlp	22684629	SENT240	8	8	19	19	forskolin	U2AF65	PA146096022	11338	0.631
NULL	Cancers_(Basel)_2011_Sep_30_3(4)_3799-3823.nxml.txt.nlp	24213112	SENT165	12	12	0	0	urokinase	HIF-1	PA451836	29072	0.631
NULL	Curr_Neuropharmacol_2009_Jun_7(2)_83-95.nxml.txt.nlp	19949566	SENT445	30	30	32	32	phenytoin	TGB	PA450947	5473	0.631
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Apr_15_9_13.nxml.txt.nlp	20398300	SENT97	11	11	18	18	amoxicillin	LAM	PA448406	7249;7248	0.631
NULL	Eur_J_Pediatr_2012_Feb_17_171(2)_207-214.nxml.txt.nlp	21922352	SENT47	5	5	11	11	thrombin	FXI	PA451674	2160	0.631
NULL	Croat_Med_J_2013_Apr_54(2)_171-179.nxml.txt.nlp	23630144	SENT9	13	13	11	11	taurine	STZ	PA451590	6484	0.631
NULL	J_Oncol_2010_Feb_22_2010_891059.nxml.txt.nlp	20182637	SENT134	15	15	5	5	cisplatin	ERCC1	PA449014	2067	0.631
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT180	25	25	16	16	perifosine	DR4	PA165291471	8797	0.631
NULL	ScientificWorldJournal_2013_Oct_29_2013_274570.nxml.txt.nlp	24288475	SENT210	7	7	4	4	isoniazid	CPX	PA450112	1371;10682;1377	0.631
NULL	Front_Microbiol_2015_Jan_15_5_798.nxml.txt.nlp	25642226	SENT50	2	2	6	6	oxygen	HIF1	PA450744	3091	0.631
NULL	Int_J_Mol_Sci_2012_Feb_24_13(3)_2590-2617.nxml.txt.nlp	22489113	SENT237	14	14	11	11	benzaldehyde	mol	PA448571	90527	0.63
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Apr_15_9_13.nxml.txt.nlp	20398300	SENT108	13	13	7	7	moxifloxacin	LAM	PA450555	7249;7248	0.63
NULL	J_Cell_Biol_1998_May_18_141(4)_1061-1071.nxml.txt.nlp	9585423	SENT47	35	35	9	9	streptomycin	BRL	PA451512	23774	0.63
NULL	Orphanet_J_Rare_Dis_2007_Jan_23_2_6.nxml.txt.nlp	17244349	SENT101	8	8	15	15	methotrexate	CDP	PA450428	1523	0.63
NULL	Iran_J_Pharm_Res_2014_Winter_13(1)_29-37.nxml.txt.nlp	24734054	SENT159	5	5	17	17	gliclazide	STZ	PA10892	6484	0.63
NULL	Oncol_Lett_2013_Apr_22_5(4)_1093-1100.nxml.txt.nlp	23599746	SENT145	12	12	7	7	vinblastine	PC-3	PA451877	692094	0.63
NULL	Cancers_(Basel)_2011_Nov_10_3(4)_4139-4150.nxml.txt.nlp	24213130	SENT472	1	1	7	7	cyclophosphamide	CD25	PA449165	3669;3559	0.63
NULL	Semin_Immunol_2011_Feb_23(1)_28-41.nxml.txt.nlp	21295490	SENT235	2	2	9	9	etanercept	IL-23	PA449515	51561	0.63
NULL	J_Biom_Biostat_2013_Jan_4_4(1)_1000158.nxml.txt.nlp	24851193	SENT324	3	3	5	5	lipase	LIPE	PA450239	3991	0.63
NULL	Clin_Med_Insights_Case_Rep_2014_Oct_1_7_117-121.nxml.txt.nlp	25336995	SENT88	6	6	11	11	etoposide	CHOP	PA449552	1649	0.63
NULL	Nat_Commun_2013_4_1911.nxml.txt.nlp	23715270	SENT88	10	10	12	12	tubocurarine	TBC	PA451811	23216	0.63
NULL	Cardiol_Res_Pract_2012_Feb_22_2012_845698.nxml.txt.nlp	22462028	SENT170	7	7	30	30	valsartan	EPO	PA451848	7076;8288;2056	0.63
NULL	Viruses_2014_Oct_24_6(10)_4095-4139.nxml.txt.nlp	25341668	SENT224	12	12	37	37	nevirapine	TMC	PA450616	3703	0.63
NULL	Arthritis_Res_Ther_2005_May_18_7(Suppl_3)_S13-S18.nxml.txt.nlp	15960817	SENT77	6	6	0	0	methotrexate	CTX	PA450428	1593	0.63
NULL	Acta_Vet_Scand_2008_Jul_4_50(1)_27.nxml.txt.nlp	18601734	SENT18	27	27	17	17	doxorubicin	CLPTM1	PA449412	1209	0.63
NULL	Oncol_Rep_2013_Apr_5_29(4)_1671-1677.nxml.txt.nlp	23404329	SENT6	16	16	13	13	curcumin	ASP	PA151958596	259266;443;9474;29974;434;83853	0.63
NULL	Clin_Pharmacol_2013_Dec_10_5_193-199.nxml.txt.nlp	24353447	SENT29	25	25	43	43	midazolam	CYP2D6	PA450496	1565	0.63
NULL	Clin_Ophthalmol_2009_Jun_2_3_291-295.nxml.txt.nlp	19668581	SENT12	25	25	31	31	latanoprost	BAK	PA164774763	578	0.63
NULL	eLife_2014_May_7_3_e02536.nxml.txt.nlp	24843004	SENT250	4	4	2	2	genistein	TRPC3	PA165109660	7222	0.63
NULL	Indian_J_Med_Res_2013_Jan_137(1)_191-196.nxml.txt.nlp	23481072	SENT95	22	22	12	12	vancomycin	VISA	PA451850	57506	0.63
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT263	6	6	1	1	pertuzumab	HER2		2064	0.63
NULL	Arthritis_Res_Ther_2008_Jun_30_10(3)_209.nxml.txt.nlp	18598385	SENT242	13	13	20	20	oxaliplatin	HMGB1	PA131285527	3146	0.63
NULL	Mol_Cancer_2010_Aug_20_9_220.nxml.txt.nlp	20727180	SENT171	20	20	11	11	nicotine	p53	PA450626	7157	0.63
NULL	Biochimie_2014_Jan_96(100)_106-112.nxml.txt.nlp	23827855	SENT29	21	21	23	23	lipase	ATGL	PA450239	57104	0.63
NULL	Appl_Microbiol_Biotechnol_2012_Sep_31_95(6)_1427-1436.nxml.txt.nlp	22846902	SENT134	13	13	0	0	oxygen	FAD	PA450744	5663;675;2177	0.63
NULL	Arthritis_Res_Ther_2009_Sep_21_11(5)_241.nxml.txt.nlp	19804619	SENT174	37	37	31	31	collagenase	AP-1	PA449107	2353;3727;2354;3725	0.63
NULL	J_Gen_Physiol_1968_Apr_1_51(4)_497-516.nxml.txt.nlp	5651769	SENT0	12	12	1	1	choline	Gen	PA448976	348654	0.63
NULL	Crit_Care_2005_Oct_27_9(6)_R725-R728.nxml.txt.nlp	16280070	SENT103	1	1	20	20	pentobarbital	B19	PA450859	59271	0.63
NULL	J_Inflamm_(Lond)_2006_Jul_12_3_10.nxml.txt.nlp	16834783	SENT190	5	5	11	11	mometasone	MCP-1	PA450541	6347	0.63
NULL	J_Cell_Biol_2000_Feb_21_148(4)_811-824.nxml.txt.nlp	10684261	SENT268	19	19	17	17	thrombin	EGF	PA451674	1950	0.63
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Nov_14_65(Pt_12)_o3083.nxml.txt.nlp	21578813	SENT69	32	32	28	28	ethanol	mol	PA448073	90527	0.63
NULL	Clin_Mol_Hepatol_2014_Sep_25_20(3)_283-290.nxml.txt.nlp	25320732	SENT120	10	10	8	8	propranolol	EVL	PA451145	51466	0.63
NULL	Gut_2009_Jul_4_58(7)_964-973.nxml.txt.nlp	19193669	SENT39	35	35	31	31	ribavirin	IFN	PA451241	3439	0.63
NULL	Cases_J_2009_Apr_28_2_7081.nxml.txt.nlp	19829905	SENT116	19	19	27	27	cyclophosphamide	CHOP	PA449165	1649	0.63
NULL	J_Int_Soc_Sports_Nutr_2014_Aug_13_11_38.nxml.txt.nlp	25132809	SENT107	14	14	2	2	creatine	MSTN	PA164778930	2660	0.63
NULL	Diabetes_2009_Dec_31_58(12)_2813-2819.nxml.txt.nlp	19720793	SENT266	25	25	17	17	diazoxide	SUR1	PA449285	6833	0.63
NULL	Clin_Med_Insights_Circ_Respir_Pulm_Med_2013_Nov_13_7_61-77.nxml.txt.nlp	24324354	SENT298	5	5	11	11	tobramycin	TIP	PA451704	81533;79828	0.63
NULL	J_Clin_Biochem_Nutr_2010_Jan_29_46(1)_43-51.nxml.txt.nlp	20104264	SENT118	8	8	15	15	napqi	CYP1A2		1544	0.63
NULL	Indian_J_Endocrinol_Metab_2013_Oct_17(Suppl1)_S259-S261.nxml.txt.nlp	24251180	SENT73	16	16	18	18	letrozole	CDP	PA450196	1523	0.63
NULL	J_Med_Case_Reports_2011_Dec_21_5_593.nxml.txt.nlp	22188652	SENT52	18	18	26	26	gefitinib	CYP1A2	PA131301952	1544	0.63
NULL	Indian_J_Endocrinol_Metab_2012_Mar_16(Suppl1)_S47-S56.nxml.txt.nlp	22701844	SENT111	12	12	9	9	exenatide	GLP-1	PA164749238	100125288	0.63
NULL	Evid_Based_Complement_Alternat_Med_2013_Aug_7_2013_641480.nxml.txt.nlp	23997797	SENT155	6	6	20	20	estradiol	castor	PA449503	54897	0.63
NULL	Oncol_Lett_2013_Oct_24_6(4)_970-976.nxml.txt.nlp	24137447	SENT168	2	2	4	4	tamoxifen	ADM	PA451581	133	0.63
NULL	Am_J_Physiol_Endocrinol_Metab_2013_Jul_15_305(2)_E263-E270.nxml.txt.nlp	23715727	SENT331	11	11	6	6	creatine	SGK1	PA164778930	6446	0.63
NULL	Support_Care_Cancer_2014_Oct_19_22(2)_469-477.nxml.txt.nlp	24141698	SENT155	7	7	25	25	palonosetron	NK1	PA10352	11126	0.63
NULL	Croat_Med_J_2012_Aug_53(4)_343-349.nxml.txt.nlp	22911527	SENT105	31	31	29	29	nifedipine	NIF	PA450631	6280	0.63
NULL	Indian_J_Pharmacol_2009_Dec_41(6)_262-267.nxml.txt.nlp	20407557	SENT153	6	6	4	4	ezetimibe	STZ	PA10816	6484	0.63
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Aug_4_6_123-133.nxml.txt.nlp	25177151	SENT50	42	42	26	26	fulvestrant	aromatase	PA164747170	1588	0.63
NULL	Cardiovasc_Res_2011_Feb_15_89(3)_560-565.nxml.txt.nlp	20889759	SENT60	14	14	24	24	phenylephrine	CO2	PA450935	4513	0.63
NULL	Arthritis_Res_Ther_2011_Jun_20_13(3)_R97.nxml.txt.nlp	21689431	SENT177	30	30	21	21	ambrisentan	ETB	PA165860521	1910	0.63
NULL	Int_J_Mol_Sci_2010_Nov_30_11(12)_4905-4915.nxml.txt.nlp	21614181	SENT182	5	5	3	3	oxaliplatin	PI3K	PA131285527	5290	0.63
NULL	Cancer_Cell_Int_2009_Sep_10_9_25.nxml.txt.nlp	19744341	SENT15	3	3	8	8	glucosamine	STAT3	PA164747613	6774	0.63
NULL	J_Intensive_Care_2014_Mar_25_2(1)_23.nxml.txt.nlp	25520835	SENT233	3	3	14	14	starch	NF-kappaB	PA451492	4790	0.63
NULL	Arthritis_Res_Ther_2014_Apr_3_16(2)_R86.nxml.txt.nlp	24708674	SENT219	0	0	5	5	bosentan	Fli1	PA10034	2314	0.63
NULL	Child_Adolesc_Psychiatry_Ment_Health_2008_Sep_15_2_25.nxml.txt.nlp	18793405	SENT33	0	0	2	2	atomoxetine	ATX	PA134688071	5168;23049	0.63
NULL	Arthritis_Res_Ther_2009_Nov_13_11(6)_R172.nxml.txt.nlp	19912653	SENT2	8	8	20	20	simvastatin	IVD	PA451363	3712	0.63
NULL	J_Viral_Hepat_2010_Feb_17(2)_139-147.nxml.txt.nlp	19674282	SENT24	13	13	22	22	ribavirin	RVR	PA451241	9975	0.63
NULL	J_Parasitol_Res_2012_Jun_27_2012_275436.nxml.txt.nlp	22792440	SENT247	17	17	5	5	l-arginine	IL-13	PA448478	3596	0.63
NULL	Int_J_Chron_Obstruct_Pulmon_Dis_2007_Dec_2(4)_493-515.nxml.txt.nlp	18268924	SENT143	11	11	40	40	droperidol	CO2	PA449422	4513	0.63
NULL	Front_Oncol_2012_Sep_12_2_114.nxml.txt.nlp	22988546	SENT59	42	42	9	9	vincristine	CTX	PA451879	1593	0.63
NULL	J_Mol_Signal_2011_May_9_6_3.nxml.txt.nlp	21554706	SENT77	17	17	31	31	isoproterenol	AKAP12	PA450121	9590	0.63
NULL	J_Korean_Med_Sci_2008_Apr_20_23(2)_324-327.nxml.txt.nlp	18437020	SENT27	5	5	40	40	busulfan	CD34	PA448691	947	0.63
NULL	Breast_Cancer_Res_2010_Nov_16_12(6)_R96.nxml.txt.nlp	21080941	SENT63	27	27	21	21	lapatinib	HRG	PA152241907	3084;3273	0.63
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT54	0	0	23	23	resveratrol	DR5		8795	0.63
NULL	Aging_(Albany_NY)_2009_Mar_31_1(4)_412-424.nxml.txt.nlp	20195491	SENT8	19	19	17	17	resveratrol	G6PD		2539	0.63
NULL	Mol_Vis_2011_Jun_9_17_1564-1576.nxml.txt.nlp	21738386	SENT226	0	0	2	2	ethambutol	EMB	PA164784021	133418	0.63
NULL	Infect_Dis_Ther_2014_Jun_18_3(1)_35-43.nxml.txt.nlp	25134810	SENT120	25	25	7	7	oxacillin	VAN	PA450725	10318	0.63
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT37	21	21	7	7	lapatinib	PTEN	PA152241907	5728	0.63
NULL	Int_J_Endocrinol_2010_May_26_2010_906163.nxml.txt.nlp	20585352	SENT103	23	23	9	9	cinacalcet	MEN1	PA164776671	4221	0.63
NULL	Patient_Prefer_Adherence_2010_Dec_2_4_415-424.nxml.txt.nlp	21206517	SENT218	13	13	7	7	ibandronate	PAM	PA10270	5066;23077	0.63
NULL	Brain_Behav_2011_Sep_1(1)_44-54.nxml.txt.nlp	22398980	SENT195	0	0	4	4	phencyclidine	PCP	PA128406980	5547	0.63
NULL	Breast_Cancer_Res_2011_Jun_14_13(3)_R63.nxml.txt.nlp	21679465	SENT124	9	9	19	19	formaldehyde	SDS	PA449703	51119;10993	0.63
NULL	Ecancermedicalscience_2010_Oct_7_4_192.nxml.txt.nlp	22276040	SENT61	14	14	12	12	trastuzumab	PTEN	PA451743	5728	0.63
NULL	J_Biol_Chem_2012_Apr_20_287(17)_14122-14135.nxml.txt.nlp	22351750	SENT7	12	12	10	10	hyaluronan	TSG-6	PA165958431	7130	0.63
NULL	J_Histochem_Cytochem_2012_Dec_60(12)_908-915.nxml.txt.nlp	22899865	SENT24	25	25	27	27	hyaluronan	CD44	PA165958431	960	0.63
NULL	J_Med_Life_2011_Feb_15_4(1)_11-20.nxml.txt.nlp	21505570	SENT41	18	18	12	12	capsaicin	TRPV1	PA448776	7442	0.63
NULL	Int_J_Med_Chem_2012_Sep_25_2012_196921.nxml.txt.nlp	25374683	SENT155	26	26	13	13	streptomycin	FBS	PA451512	64319;26269	0.63
NULL	Oncoimmunology_2013_Jun_1_2(6)_e24677.nxml.txt.nlp	23894722	SENT12	2	2	13	13	cetuximab	CD86	PA10040	942	0.63
NULL	Mol_Neurodegener_2011_Nov_25_6_81.nxml.txt.nlp	22118545	SENT216	29	29	25	25	l-glutamine	B27	PA10090	56246	0.63
NULL	Case_Rep_Oncol_Med_2013_Nov_26_2013_862585.nxml.txt.nlp	24371535	SENT9	11	11	16	16	vincristine	CHOP	PA451879	1649	0.63
NULL	N_Am_J_Med_Sci_2014_Dec_6(12)_625-632.nxml.txt.nlp	25599050	SENT13	8	8	11	11	ramipril	AT1	PA451223	9197;185	0.63
NULL	J_Immunother_Cancer_2013_May_29_1_5.nxml.txt.nlp	24764535	SENT167	24	24	8	8	sargramostim	IL-2	PA164748631	3558	0.63
NULL	Front_Neurol_2011_Nov_21_2_68.nxml.txt.nlp	22125548	SENT1833	4	4	2	2	liraglutide	GLP-1	PA165958364	100125288	0.63
NULL	Mar_Drugs_2008_May_28_6(2)_180-219.nxml.txt.nlp	18728725	SENT331	29	29	23	23	terfenadine	NT3	PA451619	4877;6272	0.63
NULL	Breast_Cancer_Res_2004_May_7_6(4)_R352-R365.nxml.txt.nlp	15217502	SENT229	18	18	4	4	estradiol	CYP1A2	PA449503	1544	0.63
NULL	Br_J_Cancer_2010_Jan_5_102(1)_115-123.nxml.txt.nlp	19997099	SENT227	17	17	24	24	oxaliplatin	GEM	PA131285527	2669	0.63
NULL	Breast_Cancer_(Dove_Med_Press)_2014_May_2_6_59-71.nxml.txt.nlp	24833917	SENT83	3	3	7	7	tamoxifen	STAR	PA451581	6770;2984	0.63
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Aug_30_64(Pt_9)_o1863.nxml.txt.nlp	21201832	SENT3	15	15	20	20	benzaldehyde	mol	PA448571	90527	0.63
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT99	0	0	6	6	chloroquine	BMPR-II	PA448948	659	0.63
NULL	Br_J_Cancer_2011_Aug_9_105(4)_469-474.nxml.txt.nlp	21712825	SENT167	10	10	22	22	nadh	NQO1	PA164755085	1728	0.63
NULL	JAKSTAT_2014_Jun_12_3_e29554.nxml.txt.nlp	25105067	SENT14	3	3	7	7	propofol	p65	PA451141	5970	0.63
NULL	Curr_Neuropharmacol_2009_Jun_7(2)_83-95.nxml.txt.nlp	19949566	SENT453	34	34	32	32	tiagabine	TGB	PA451682	5473	0.63
NULL	Oncotarget_2014_Feb_7_5(3)_775-787.nxml.txt.nlp	24519956	SENT112	20	20	8	8	docetaxel	PC3	PA449383	57332;7832;5122	0.63
NULL	Exp_Hematol_2008_Sep_36(9-2)_1167-1175.nxml.txt.nlp	18550257	SENT41	19	19	11	11	mitomycin	CO2	PA450524	4513	0.63
NULL	Virol_J_2012_Aug_3_9_143.nxml.txt.nlp	22863531	SENT20	31	31	16	16	boceprevir	IFN	PA165948902	3439	0.63
NULL	Arq_Bras_Cardiol_2014_Nov_103(5)_403-409.nxml.txt.nlp	25229355	SENT9	0	0	2	2	pazopanib	PZP	PA165291492	5858	0.63
NULL	Mar_Drugs_2009_Jul_17_7(3)_331-340.nxml.txt.nlp	19841717	SENT3	41	41	20	20	trabectedin	FDG	PA165958349	23583	0.63
NULL	Sci_Rep_2014_Dec_3_4_7294.nxml.txt.nlp	25465236	SENT105	6	6	10	10	erlotinib	EGFR	PA134687924	1956	0.63
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT302	19	19	23	23	paliperidone	PRL	PA163518919	5617	0.63
NULL	Brain_Sci_2014_May_6_4(2)_356-375.nxml.txt.nlp	24961766	SENT19	3	3	20	20	isoflurane	spatial	PA450106	219793	0.63
NULL	Int_J_Biol_Sci_2011_May_24_7(5)_673-684.nxml.txt.nlp	21647250	SENT197	26	26	23	23	berberine	AMPK	PA165860812	5563	0.63
NULL	Oncotarget_2010_Nov_25_1(7)_662-673.nxml.txt.nlp	21317461	SENT138	23	23	0	0	heparin	TSP-1	PA449855	7057	0.63
NULL	Br_J_Cancer_1996_Dec_74(11)_1821-1827.nxml.txt.nlp	8956800	SENT15	1	1	33	33	filgrastim	CD34	PA449626	947	0.63
NULL	ScientificWorldJournal_2013_Oct_1_2013_654829.nxml.txt.nlp	24198725	SENT312	8	8	13	13	naproxen	NF2	PA450595	4771	0.63
NULL	Breast_Cancer_Res_Treat_2014_Apr_6_145(3)_725-734.nxml.txt.nlp	24706168	SENT78	1	1	5	5	doxorubicin	ACT	PA449412	12;11332;9457;641455	0.63
NULL	Nucleic_Acids_Res_2012_Jul_30_40(13)_6319-6337.nxml.txt.nlp	22467215	SENT416	33	33	25	25	trastuzumab	HER2	PA451743	2064	0.63
NULL	Tuberc_Respir_Dis_(Seoul)_2013_Aug_30_75(2)_75-78.nxml.txt.nlp	24023561	SENT57	7	7	5	5	ceftriaxone	CAP	PA448866	23476;9200;4012;5269;10580;10487	0.63
NULL	N_Am_J_Med_Sci_2014_Sep_6(9)_481-483.nxml.txt.nlp	25317395	SENT40	22	22	16	16	heparin	ACT	PA449855	12;11332;9457;641455	0.63
NULL	ScientificWorldJournal_2013_Feb_3_2013_593267.nxml.txt.nlp	23431256	SENT167	0	0	14	14	chloramphenicol	p43	PA448927	9255	0.63
NULL	Cancers_(Basel)_2011_Aug_5_3(3)_3114-3142.nxml.txt.nlp	24212948	SENT723	1	1	5	5	cyclophosphamide	CD4	PA449165	920	0.63
NULL	Oncol_Lett_2014_Jun_8_7(6)_1761-1766.nxml.txt.nlp	24932229	SENT101	16	16	14	14	pazopanib	FGFR2	PA165291492	2263	0.63
NULL	Arthritis_Res_Ther_2005_Nov_16_7(1)_R93-R100.nxml.txt.nlp	15642147	SENT196	0	0	17	17	nifedipine	CAL	PA450631	54751;57120	0.63
NULL	Indian_J_Med_Res_2012_Jul_136(1)_46-53.nxml.txt.nlp	22885263	SENT46	5	5	14	14	glucose	PPG	PA449773	5552	0.63
NULL	Braz_J_Microbiol_2012_Jun_1_Apr-Jun_43(2)_482-489.nxml.txt.nlp	24031855	SENT258	4	4	17	17	ethanol	GPD1	PA448073	2819	0.63
NULL	Clin_Med_Insights_Oncol_2012_Feb_20_6_117-124.nxml.txt.nlp	22412303	SENT27	4	4	15	15	pemetrexed	DHFR	PA10810	1719	0.63
NULL	J_Infect_Dis_2014_Jul_15_210(2)_306-310.nxml.txt.nlp	24511100	SENT102	19	19	37	37	pentamidine	SOD1	PA450850	6647	0.63
NULL	Br_J_Cancer_2004_Mar_22_90(6)_1285-1292.nxml.txt.nlp	15026814	SENT33	4	4	1	1	doxorubicin	p53	PA449412	7157	0.63
NULL	Indian_J_Med_Res_2014_Jul_140(1)_130-137.nxml.txt.nlp	25222788	SENT56	29	29	21	21	ciprofloxacin	CTX	PA449009	1593	0.63
NULL	J_Antimicrob_Chemother_2009_Feb_28_63(2)_389-395.nxml.txt.nlp	19042940	SENT16	22	22	11	11	trimethoprim	UTI	PA451788	259	0.63
NULL	Mol_Cancer_2007_Aug_21_6_53.nxml.txt.nlp	17711579	SENT153	6	6	42	42	cisplatin	GML	PA449014	2765	0.63
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2014_Jun_29_70(Pt_7)_1922-1933.nxml.txt.nlp	25004969	SENT229	18	18	22	22	cycloserine	PLP	PA164764600	25824;5744	0.63
NULL	Front_Pharmacol_2014_Mar_3_5_28.nxml.txt.nlp	24624084	SENT41	19	19	12	12	lipase	FAAH	PA450239	79152;2166	0.63
NULL	Patient_Prefer_Adherence_2013_Apr_26_7_369-377.nxml.txt.nlp	23641151	SENT43	0	0	7	7	ustekinumab	IL-23	PA166048654	51561	0.63
NULL	Case_Rep_Rheumatol_2012_Dec_24_2012_270315.nxml.txt.nlp	23424706	SENT58	11	11	7	7	tocilizumab	IL-6	PA165292659	3569	0.63
NULL	J_Cell_Mol_Med_2014_Apr_20_18(4)_709-720.nxml.txt.nlp	24444314	SENT235	4	4	18	18	losartan	AMPK	PA450268	5563	0.63
NULL	Diabetes_2009_Jan_58(1)_243-249.nxml.txt.nlp	18840785	SENT191	19	19	22	22	glucose	GLP-1	PA449773	100125288	0.63
NULL	J_Cell_Biol_2002_Jun_10_157(6)_1017-1028.nxml.txt.nlp	12058017	SENT166	16	16	25	25	lovastatin	COD1	PA450272	25839	0.63
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Dec_21_68(Pt_1)_o193.nxml.txt.nlp	22259476	SENT6	27	27	34	34	phenol	mol	PA450913	90527	0.63
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT6	4	4	10	10	nutlin-3	p53		7157	0.63
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Aug_28_66(Pt_9)_o2421.nxml.txt.nlp	21588746	SENT63	22	22	7	7	ethanol	mol	PA448073	90527	0.63
NULL	Indian_J_Plast_Surg_2014_Jan-Apr_47(1)_102-108.nxml.txt.nlp	24987213	SENT130	0	0	11	11	thrombin	VIII	PA451674	1351	0.63
NULL	Open_Dent_J_2010_Jul_20_4_147-152.nxml.txt.nlp	21339893	SENT147	25	25	11	11	chlorhexidine	Solo	PA164776863	91404	0.63
NULL	ScientificWorldJournal_2013_Apr_18_2013_808460.nxml.txt.nlp	23710149	SENT124	7	7	4	4	indomethacin	BOR	PA449982	55143	0.63
NULL	Case_Rep_Med_2011_Jul_31_2011_145856.nxml.txt.nlp	21811505	SENT7	3	3	5	5	vasopressin	AVP	PA451858	114548;551	0.63
NULL	Anat_Cell_Biol_2012_Jun_30_45(2)_114-120.nxml.txt.nlp	22822466	SENT131	3	3	5	5	vasopressin	AVP	PA451858	114548;551	0.63
NULL	Case_Rep_Dermatol_2012_Mar_17_4(1)_56-60.nxml.txt.nlp	22548037	SENT57	19	19	24	24	vincristine	CHOP	PA451879	1649	0.63
NULL	Diabetes_Metab_Syndr_Obes_2014_Jul_17_7_313-319.nxml.txt.nlp	25092992	SENT17	14	14	4	4	pioglitazone	adiponectin	PA450970	9370	0.63
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT132	18	18	26	26	perifosine	DR5	PA165291471	8795	0.63
NULL	Br_J_Cancer_1985_Apr_51(4)_485-492.nxml.txt.nlp	3978028	SENT7	1	1	8	8	aminoglutethimide	NAG	PA448375	51594;4669	0.63
NULL	J_Korean_Med_Sci_2010_Jun_24_25(6)_829-834.nxml.txt.nlp	20514301	SENT107	20	20	8	8	papain	JNK	PA450778	5599	0.63
NULL	Mol_Biol_Cell_2012_Jul_1_23(13)_2583-2592.nxml.txt.nlp	22593214	SENT113	23	23	25	25	paclitaxel	GEF-H1	PA450761	9181	0.63
NULL	Anat_Cell_Biol_2012_Jun_30_45(2)_114-120.nxml.txt.nlp	22822466	SENT140	3	3	5	5	vasopressin	AVP	PA451858	114548;551	0.63
NULL	Diabetes_Care_2010_Apr_12_33(4)_861-868.nxml.txt.nlp	20067962	SENT14	17	17	12	12	hyaluronan	HMGB1	PA165958431	3146	0.63
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT72	13	13	5	5	curcumin	TRAIL	PA151958596	8743	0.63
NULL	Cancers_(Basel)_2011_Sep_2_3(3)_3461-3495.nxml.txt.nlp	24212964	SENT993	10	10	2	2	cyclophosphamide	FOXP3	PA449165	50943	0.63
NULL	Breast_Cancer_Res_Treat_2013_Aug_20_141(1)_43-53.nxml.txt.nlp	23959396	SENT27	44	44	38	38	pertuzumab	HER2		2064	0.63
NULL	J_Cell_Biol_2003_Aug_18_162(4)_587-597.nxml.txt.nlp	12913114	SENT148	21	21	29	29	etoposide	p53	PA449552	7157	0.63
NULL	Oxid_Med_Cell_Longev_2012_May_28_2012_632959.nxml.txt.nlp	22690272	SENT63	5	5	20	20	curcumin	PC-3	PA151958596	692094	0.63
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT83	13	13	6	6	celecoxib	IL-6	PA448871	3569	0.63
NULL	Cancers_(Basel)_2012_Sep_6_4(3)_873-903.nxml.txt.nlp	24213471	SENT1019	4	4	6	6	hyaluronan	RHAMM	PA165958431	3161	0.63
NULL	Biomed_Res_Int_2014_Aug_6_2014_967826.nxml.txt.nlp	25165721	SENT287	42	42	37	37	cisplatin	CD25	PA449014	3669;3559	0.63
NULL	Oncol_Lett_2014_Nov_12_8(5)_2203-2208.nxml.txt.nlp	25295109	SENT84	4	4	13	13	celecoxib	GLI1	PA448871	2735	0.63
NULL	Cell_Res_2012_Dec_4_22(12)_1696-1706.nxml.txt.nlp	22945357	SENT211	19	19	23	23	glutaraldehyde	CD4	PA449777	920	0.63
NULL	J_Thromb_Haemost_2013_Jan_11(1)_132-141.nxml.txt.nlp	23205847	SENT209	0	0	5	5	thrombin	FVIII	PA451674	2157	0.63
NULL	Oxid_Med_Cell_Longev_2013_Dec_5_2013_963520.nxml.txt.nlp	24381719	SENT245	15	15	8	8	l-arginine	NOS	PA448478	4843	0.63
NULL	Clin_Pharmacokinet_2013_Jun_26_52(6)_453-462.nxml.txt.nlp	23529813	SENT247	12	12	19	19	dabigatran	CLCR		11330	0.63
NULL	Front_Oncol_2014_Mar_6_4_40.nxml.txt.nlp	24639951	SENT62	6	6	24	24	cisplatin	UNK	PA449014	85451	0.63
NULL	Chem_Rev_2011_Oct_12_111(10)_5899-5921.nxml.txt.nlp	21923193	SENT373	17	17	14	14	lipase	FAAH	PA450239	79152;2166	0.63
NULL	Cell_Res_2013_Sep_25_23(9)_1106-1118.nxml.txt.nlp	23797855	SENT53	8	8	0	0	retigabine	KCNQ2	PA144997862	3785	0.63
NULL	Br_J_Cancer_2010_Jun_8_102(12)_1707-1716.nxml.txt.nlp	20461078	SENT15	11	11	9	9	bortezomib	TRAIL	PA10252	8743	0.63
NULL	Acta_Pharmacol_Sin_2013_Jan_17_34(1)_157-166.nxml.txt.nlp	23247593	SENT252	0	0	4	4	berberine	Set9	PA165860812	80854	0.63
NULL	Oncotarget_2012_May_18_3(5)_525-534.nxml.txt.nlp	22619113	SENT7	3	3	9	9	fludarabine	MCL1	PA449655	4170	0.63
NULL	Int_J_Endocrinol_2011_Aug_21_2011_742719.nxml.txt.nlp	21869886	SENT139	35	35	12	12	cilostazol	DES	PA164746334	1674	0.63
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT632	11	11	17	17	letrozole	ERBB2	PA450196	2064	0.63
NULL	FEBS_Open_Bio_2014_Sep_2_4_755-762.nxml.txt.nlp	25349780	SENT139	19	19	42	42	simvastatin	PCSK9	PA451363	255738	0.63
NULL	J_Cell_Mol_Med_2014_Feb_11_18(2)_231-241.nxml.txt.nlp	24330074	SENT43	2	2	6	6	mannitol	STZ	PA450320	6484	0.63
NULL	Allergy_Asthma_Immunol_Res_2014_Nov_19_6(6)_548-557.nxml.txt.nlp	25374755	SENT88	6	6	23	23	lovastatin	IL-4	PA450272	3565	0.63
NULL	Indian_J_Pharmacol_2014_Nov-Dec_46(6)_627-632.nxml.txt.nlp	25538335	SENT115	5	5	3	3	metformin	Q10	PA450395	27161	0.63
NULL	Eur_J_Clin_Pharmacol_2011_Dec_23_67(12)_1231-1241.nxml.txt.nlp	21698374	SENT262	7	7	3	3	tacrolimus	CYP3A5	PA451578	1577	0.63
NULL	Biomed_Res_Int_2013_Jan_16_2013_572609.nxml.txt.nlp	23484132	SENT38	20	20	8	8	erlotinib	EGFR	PA134687924	1956	0.63
NULL	Exp_Hematol_Oncol_2013_Apr_10_2_11.nxml.txt.nlp	23574711	SENT41	26	26	15	15	l-arginine	OTC	PA448478	5009	0.63
NULL	Glycobiology_2013_Jul_18_23(7)_853-864.nxml.txt.nlp	23507965	SENT166	26	26	38	38	trypsin	MGL	PA451806	11343	0.63
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT192	21	21	19	19	cetuximab	Yes	PA10040	7525	0.63
NULL	Hum_Genomics_2013_Oct_30_7(1)_22.nxml.txt.nlp	24172014	SENT189	3	3	0	0	trypsin	SERPINB12	PA451806	89777	0.63
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT155	3	3	11	11	heparin	VEGF-A	PA449855	7422	0.63
NULL	Oxid_Med_Cell_Longev_2013_Sep_11_2013_639541.nxml.txt.nlp	24101950	SENT171	16	16	8	8	hemin	HO-1	PA449849	3162	0.63
NULL	Ann_Clin_Transl_Neurol_2014_May_29_1(5)_307-318.nxml.txt.nlp	25215310	SENT50	32	32	42	42	l-glutamine	CO2	PA10090	4513	0.63
NULL	Arch_Microbiol_2013_Jun_10_195(6)_439-445.nxml.txt.nlp	23661196	SENT119	20	20	28	28	ethanol	CO2	PA448073	4513	0.63
NULL	Environ_Health_Perspect_2008_Sep_116(9)_A402a.nxml.txt.nlp	NULL	SENT17	10	10	3	3	iron	HFE	PA450087	3077	0.63
NULL	Iran_J_Basic_Med_Sci_2012_Jan-Feb_15(1)_678-682.nxml.txt.nlp	23493931	SENT41	17	17	14	14	cefepime	CTX	PA164754876	1593	0.63
NULL	Med_Sci_Monit_2013_May_1_19_317-326.nxml.txt.nlp	23632427	SENT277	12	12	14	14	ceftazidime	CTX	PA448861	1593	0.63
NULL	Cardiovasc_Ther_2009_27(4)_259-274.nxml.txt.nlp	19604248	SENT51	20	20	7	7	ticagrelor	P2Y12	PA165374673	64805	0.63
NULL	Pharmaceuticals_(Basel)_2011_May_31_4(6)_794-803.nxml.txt.nlp	NULL	SENT1	16	16	6	6	amiodarone	NIF	PA448383	6280	0.63
NULL	J_Antimicrob_Chemother_2010_Jul_30_65(7)_1441-1447.nxml.txt.nlp	20435780	SENT65	22	22	20	20	tobramycin	TOB	PA451704	10140	0.63
NULL	Br_J_Cancer_1996_Nov_74(9)_1466-1468.nxml.txt.nlp	8912546	SENT10	16	16	18	18	tamoxifen	TMX	PA451581	81542	0.63
NULL	Indian_J_Dermatol_2014_Nov-Dec_59(6)_632a.nxml.txt.nlp	25484418	SENT29	42	42	39	39	methotrexate	IFN	PA450428	3439	0.63
NULL	Oxid_Med_Cell_Longev_2013_Jun_6_2013_891748.nxml.txt.nlp	23840922	SENT279	0	0	17	17	curcumin	NQO1	PA151958596	1728	0.63
NULL	J_Radiat_Res_2013_Sep_13_54(5)_789-797.nxml.txt.nlp	23764456	SENT6	32	32	19	19	mitomycin	gamma	PA450524	9913	0.63
NULL	Clinics_(Sao_Paulo)_2013_May_68(5)_694-701.nxml.txt.nlp	23778405	SENT162	0	0	13	13	curcumin	DDP	PA151958596	1678	0.63
NULL	J_Gen_Physiol_1981_Mar_1_77(3)_273-293.nxml.txt.nlp	6973006	SENT0	13	13	1	1	guanidine	Gen	PA164781028	348654	0.63
NULL	Osteopath_Med_Prim_Care_2008_Feb_7_2_2.nxml.txt.nlp	18257920	SENT21	20	20	4	4	naproxen	OTC	PA450595	5009	0.63
NULL	Acta_Pharmacol_Sin_2009_Jun_5_30(6)_859-867.nxml.txt.nlp	19498425	SENT26	34	34	26	26	carbachol	CA3	PA448784	761	0.63
NULL	Ann_Clin_Microbiol_Antimicrob_2008_Jan_28_7_3.nxml.txt.nlp	18226256	SENT63	15	15	5	5	ritonavir	SXR	PA451260	8856	0.63
NULL	Breast_Cancer_Res_2008_May_13_10(Suppl_2)_P5.nxml.txt.nlp	NULL	SENT9	16	16	23	23	mitoxantrone	MX2	PA450526	4600	0.63
NULL	Oncol_Lett_2013_Feb_7_5(2)_440-446.nxml.txt.nlp	23420122	SENT247	18	18	16	16	sorafenib	Gem	PA7000	51053	0.63
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT325	4	4	7	7	risperidone	PRL	PA451257	5617	0.63
NULL	Curr_Neuropharmacol_2009_Jun_7(2)_83-95.nxml.txt.nlp	19949566	SENT445	14	14	32	32	levetiracetam	TGB	PA450206	5473	0.63
NULL	Breast_Cancer_Res_2001_Jan_17_3(2)_99-103.nxml.txt.nlp	11250754	SENT53	11	11	15	15	tamoxifen	STAR	PA451581	6770;2984	0.63
NULL	Arthritis_Rheum_2010_Dec_62(12)_3666-3676.nxml.txt.nlp	20722027	SENT168	30	30	11	11	lipase	NAPE-PLD	PA450239	222236	0.63
NULL	J_Cell_Biol_1993_Nov_1_123(3)_749-758.nxml.txt.nlp	7693717	SENT0	17	17	19	19	hyaluronan	RHAMM	PA165958431	3161	0.63
NULL	Br_J_Cancer_2012_Feb_14_106(4)_685-692.nxml.txt.nlp	22294184	SENT128	2	2	5	5	docetaxel	survivin	PA449383	332	0.63
NULL	Int_J_Biol_Sci_2012_Feb_22_8(3)_363-374.nxml.txt.nlp	22393308	SENT206	21	21	17	17	capsaicin	Bcl-2	PA448776	596	0.63
NULL	Arthritis_Res_Ther_2014_Sep_27_16(5)_439.nxml.txt.nlp	25261100	SENT181	20	20	14	14	colchicine	MEFV	PA449092	4210	0.629
NULL	AIDS_Res_Ther_2014_Jul_2_11_17.nxml.txt.nlp	25013451	SENT10	6	6	12	12	naloxone	NAC	PA450586	22861	0.629
NULL	Curr_Neuropharmacol_2012_Jun_10(2)_167-178.nxml.txt.nlp	23204986	SENT218	9	9	11	11	capsaicin	c-fos	PA448776	2353	0.629
NULL	Arthritis_Res_Ther_2007_Nov_20_9(6)_R120.nxml.txt.nlp	18028548	SENT38	5	5	39	39	fluorescein	San	PA164746009	80218	0.629
NULL	Breast_Cancer_Res_2004_Nov_7_6(1)_39-52.nxml.txt.nlp	14680484	SENT158	14	14	28	28	tamoxifen	N-CoR	PA451581	9611	0.629
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Jan_30_64(Pt_2)_o530.nxml.txt.nlp	21201549	SENT62	1	1	12	12	hydroquinidine	mol	PA133888889	90527	0.629
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT208	0	0	7	7	tacrolimus	IL-6	PA451578	3569	0.629
NULL	Breast_Cancer_Res_2010_Sep_29_12(5)_209.nxml.txt.nlp	21067536	SENT53	34	34	20	20	bevacizumab	HER2	PA130232992	2064	0.629
NULL	Mol_Cancer_2012_Mar_21_11_13.nxml.txt.nlp	22436134	SENT65	43	43	2	2	doxorubicin	HuR	PA449412	1994	0.629
NULL	Oncogene_2013_Sep_12_32(37)_4355-4365.nxml.txt.nlp	23108409	SENT154	2	2	14	14	hyaluronan	p38	PA165958431	10598;1432;7965	0.629
NULL	Appl_Plant_Sci_2015_Jan_5_3(1)_apps_1400086.nxml.txt.nlp	25606353	SENT65	21	21	38	38	vancomycin	BAM	PA451850	9126	0.629
NULL	Environ_Monit_Assess_2014_Mar_28_186(7)_4569-4580.nxml.txt.nlp	24671617	SENT100	10	10	6	6	benzaldehyde	C10	PA448571	113246	0.629
NULL	Breast_Cancer_Res_2011_Jan_17_13(1)_R5.nxml.txt.nlp	21241485	SENT332	15	15	10	10	estradiol	EGF	PA449503	1950	0.629
NULL	Br_J_Cancer_1996_Oct_74(7)_1109-1113.nxml.txt.nlp	8855983	SENT13	10	10	17	17	levamisole	IL-2	PA450205	3558	0.629
NULL	Indian_J_Med_Res_2012_Sep_136(3)_391-403.nxml.txt.nlp	23041732	SENT190	14	14	19	19	doxorubicin	HCC	PA449412	84668	0.629
NULL	J_Gen_Intern_Med_2013_Jul_27_28(Suppl_2)_542-548.nxml.txt.nlp	23807063	SENT182	14	14	30	30	prazosin	Gen	PA451093	348654	0.629
NULL	Tumour_Biol_2013_Jun_5_34(3)_1371-1380.nxml.txt.nlp	23558965	SENT116	10	10	18	18	gefitinib	TERT	PA131301952	7015	0.629
NULL	Acta_Crystallogr_F_Struct_Biol_Commun_2014_Mar_25_70(Pt_4)_444-449.nxml.txt.nlp	24699735	SENT39	9	9	37	37	thrombin	TSH2B	PA451674	255626	0.629
NULL	Oncotarget_2013_Nov_24_4(12)_2430-2438.nxml.txt.nlp	24280348	SENT4	2	2	20	20	gefitinib	STAT3	PA131301952	6774	0.629
NULL	J_Thromb_Thrombolysis_2010_Nov_23_30(4)_446-451.nxml.txt.nlp	20571920	SENT148	9	9	28	28	protamine	ARNO	PA10366	9266	0.629
NULL	Oncoimmunology_2013_Nov_1_2(11)_e27010.nxml.txt.nlp	24498547	SENT32	22	22	6	6	tegafur	GEM	PA452620	2669	0.629
NULL	Front_Endocrinol_(Lausanne)_2015_Jan_9_5_235.nxml.txt.nlp	25620956	SENT34	21	21	12	12	glucosamine	OGA	PA164747613	10724	0.629
NULL	Mol_Vis_2010_Oct_8_16_2033-2042.nxml.txt.nlp	21042558	SENT254	10	10	23	23	genistein	p38	PA165109660	10598;1432;7965	0.629
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Feb_5_67(Pt_3)_o560-o561.nxml.txt.nlp	21522325	SENT6	32	32	34	34	ethanol	mol	PA448073	90527	0.629
NULL	Cell_Mol_Life_Sci_2012_Jan_11_69(1)_149-163.nxml.txt.nlp	21667063	SENT311	15	15	5	5	curcumin	ATP8B1	PA151958596	5205	0.629
NULL	Mol_Vis_2012_Nov_29_18_2839-2846.nxml.txt.nlp	23233786	SENT167	39	39	13	13	geldanamycin	Hsp90	PA152031327	3320	0.629
NULL	Blood_Res_2014_Sep_25_49(3)_162-169.nxml.txt.nlp	25325035	SENT21	28	28	33	33	doxorubicin	CHOP	PA449412	1649	0.629
NULL	Indian_J_Pharmacol_2014_Nov-Dec_46(6)_627-632.nxml.txt.nlp	25538335	SENT127	5	5	3	3	metformin	Q10	PA450395	27161	0.629
NULL	Mar_Drugs_2014_Nov_13_12(11)_5408-5424.nxml.txt.nlp	25402829	SENT112	29	29	10	10	cisplatin	HMGN5	PA449014	79366	0.629
NULL	Oncotarget_2012_May_19_3(5)_535-545.nxml.txt.nlp	22619121	SENT108	11	11	13	13	topotecan	TPT	PA451729	23590;6469	0.629
NULL	Clin_Psychopharmacol_Neurosci_2012_Dec_20_10(3)_185-189.nxml.txt.nlp	23431037	SENT92	18	18	20	20	quetiapine	HPD	PA451201	3242	0.629
NULL	Nat_Commun_2013_Aug_15_4_2130.nxml.txt.nlp	23945651	SENT56	6	6	3	3	etoposide	ATG5	PA449552	9474	0.629
NULL	Chin_J_Cancer_2012_Jul_31(7)_335-341.nxml.txt.nlp	22640629	SENT35	10	10	3	3	vincristine	CHOP	PA451879	1649	0.629
NULL	J_Skin_Cancer_2012_Jun_13_2012_410925.nxml.txt.nlp	22745913	SENT100	24	24	16	16	lipase	IL-5	PA450239	3567	0.629
NULL	Allergy_Asthma_Immunol_Res_2014_Nov_19_6(6)_548-557.nxml.txt.nlp	25374755	SENT89	16	16	23	23	lovastatin	IFN	PA450272	3439	0.629
NULL	Allergy_Asthma_Immunol_Res_2014_Mar_15_6(2)_126-130.nxml.txt.nlp	24587948	SENT93	13	13	21	21	salbutamol	TTN	PA448068	7273	0.629
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Mar_5_67(Pt_4)_o790.nxml.txt.nlp	21754081	SENT66	18	18	21	21	ethanol	mol	PA448073	90527	0.629
NULL	J_Cardiothorac_Surg_2011_Oct_14_6_138.nxml.txt.nlp	21999189	SENT132	29	29	3	3	creatine	IL-6	PA164778930	3569	0.629
NULL	Cancer_Med_2013_Jun_25_2(3)_277-285.nxml.txt.nlp	23930204	SENT110	14	14	16	16	mitomycin	PTEN	PA450524	5728	0.629
NULL	Br_J_Cancer_2009_Jun_2_100(11)_1697-1703.nxml.txt.nlp	19384299	SENT58	0	0	2	2	cyclophosphamide	CD4	PA449165	920	0.629
NULL	Physiol_Rep_2014_Oct_10_2(10)_e12177.nxml.txt.nlp	25303952	SENT529	2	2	9	9	estradiol	CD16	PA449503	2215;2214	0.629
NULL	J_Int_Soc_Sports_Nutr_2010_Feb_3_7_8.nxml.txt.nlp	20181080	SENT12	14	14	27	27	vasopressin	IL-6	PA451858	3569	0.629
NULL	Int_J_Mol_Sci_2014_Nov_7_15(11)_20500-20517.nxml.txt.nlp	25387078	SENT115	5	5	39	39	sorafenib	AKT	PA7000	207	0.629
NULL	Mol_Cancer_2014_Mar_2_13_43.nxml.txt.nlp	24580730	SENT294	17	17	32	32	fluorescein	San	PA164746009	80218	0.629
NULL	Diabetes_2013_Jun_17_62(6)_1981-1989.nxml.txt.nlp	23382450	SENT303	7	7	10	10	metformin	AMPK	PA450395	5563	0.629
NULL	Exp_Ther_Med_2013_Jul_25_6(1)_109-114.nxml.txt.nlp	23935730	SENT27	5	5	10	10	vincristine	CHOP	PA451879	1649	0.629
NULL	Cancers_(Basel)_2013_Feb_28_5(1)_234-254.nxml.txt.nlp	24216706	SENT231	20	20	16	16	melphalan	IFN	PA450354	3439	0.629
NULL	Breast_Cancer_Res_2010_Jun_4_12(3)_R32.nxml.txt.nlp	20525379	SENT222	4	4	30	30	tamoxifen	c-Myc	PA451581	4609	0.629
NULL	J_Immunol_Res_2014_May_21_2014_371087.nxml.txt.nlp	24963497	SENT309	21	21	17	17	decitabine	DAC	PA164749631	13	0.629
NULL	Mol_Cancer_2008_Jul_24_7_64.nxml.txt.nlp	18652674	SENT93	29	29	3	3	urokinase	TRAF2	PA451836	7186	0.629
NULL	Diabetes_Care_2009_Oct_8_32(10)_1873-1879.nxml.txt.nlp	19587362	SENT107	11	11	20	20	aliskiren	ANG	PA143487910	283	0.629
NULL	Clin_Exp_Otorhinolaryngol_2012_Sep_27_5(3)_117-121.nxml.txt.nlp	22977707	SENT12	21	21	28	28	kanamycin	KCC2	PA450137	57468	0.629
NULL	Breast_Cancer_Res_2009_Nov_18_11(6)_R85.nxml.txt.nlp	19922614	SENT181	39	39	32	32	tamoxifen	BCS	PA451581	617	0.629
NULL	Environ_Microbiol_2013_Jan_15_15(1)_297-304.nxml.txt.nlp	23157680	SENT51	2	2	45	45	ampicillin	TMP	PA448419	2012	0.629
NULL	Mol_Cell_Proteomics_2012_Feb_6_11(2)_M111_015222.nxml.txt.nlp	22147731	SENT295	7	7	9	9	gefitinib	JAG1	PA131301952	182	0.629
NULL	Mol_Biol_Cell_2014_Mar_1_25(5)_620-632.nxml.txt.nlp	24371086	SENT323	32	32	24	24	paraformaldehyde	ILK	PA450790	3611	0.629
NULL	Arthritis_Res_Ther_2013_Oct_24_15(5)_R161.nxml.txt.nlp	24286516	SENT61	13	13	24	24	phenol	San	PA450913	80218	0.629
NULL	Patient_Prefer_Adherence_2009_Nov_3_3_131-143.nxml.txt.nlp	19936155	SENT334	18	18	28	28	drospirenone	MGA	PA164749409	8972;23269	0.629
NULL	Nucl_Recept_Signal_2007_Nov_30_5_e009.nxml.txt.nlp	18174917	SENT70	28	28	30	30	diethylstilbestrol	DES	PA449307	1674	0.629
NULL	Nat_Neurosci_2012_Sep_5_15(9)_1245-1254.nxml.txt.nlp	22864611	SENT448	4	4	16	16	clozapine	mGlu2	PA449061	2912	0.629
NULL	J_Oncol_2009_Mar_24_2009_491985.nxml.txt.nlp	19325924	SENT92	13	13	8	8	genistein	CXCR4	PA165109660	7852	0.629
NULL	Evid_Based_Complement_Alternat_Med_2011_Mar_13_2011_913898.nxml.txt.nlp	21785639	SENT187	0	0	6	6	curcumin	CYP3A4	PA151958596	1576	0.629
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT118	3	3	28	28	l-methionine	4E-BP1	PA450423	1978	0.629
NULL	Front_Oncol_2013_Nov_15_3_281.nxml.txt.nlp	24298448	SENT85	29	29	22	22	oxaliplatin	KRAS	PA131285527	3845	0.629
NULL	J_Hematol_Oncol_2009_Aug_12_2_36.nxml.txt.nlp	19674465	SENT22	0	0	6	6	thalidomide	IL-6	PA451644	3569	0.629
NULL	Oncol_Lett_2013_Aug_17_6(2)_295-305.nxml.txt.nlp	24137320	SENT306	4	4	29	29	anastrozole	ATAC	PA448432	6375	0.629
NULL	Mol_Brain_2013_Feb_12_6_8.nxml.txt.nlp	23402298	SENT288	19	19	27	27	fentanyl	OPRM1	PA449599	4988	0.629
NULL	Indian_J_Pharmacol_2013_Sep-Oct_45(5)_458-463.nxml.txt.nlp	24130379	SENT11	3	3	11	11	carvedilol	Bcl-2	PA448817	596	0.629
NULL	Nanoscale_Res_Lett_2014_Jul_15_9(1)_353.nxml.txt.nlp	25114645	SENT2	23	23	20	20	dienestrol	DES	PA164745534	1674	0.629
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_May_24_70(Pt_6)_o713.nxml.txt.nlp	24940283	SENT77	27	27	14	14	ethanol	mol	PA448073	90527	0.629
NULL	Cases_J_2008_Oct_29_1_283.nxml.txt.nlp	18959805	SENT32	18	18	27	27	nevirapine	CD4	PA450616	920	0.629
NULL	Antimicrob_Agents_Chemother_2014_Nov_10_59(1)_490-497.nxml.txt.nlp	25385107	SENT182	6	6	0	0	primaquine	ATV	PA451103	4683	0.629
NULL	New_Microbes_New_Infect_2014_May_4_2(3)_58-63.nxml.txt.nlp	25356345	SENT100	10	10	8	8	cefotaxime	CTX	PA448852	1593	0.629
NULL	Nat_Commun_2013_Aug_15_4_2130.nxml.txt.nlp	23945651	SENT43	20	20	17	17	etoposide	ATG5	PA449552	9474	0.629
NULL	Arthritis_Res_Ther_2014_Apr_3_16(2)_R86.nxml.txt.nlp	24708674	SENT203	0	0	19	19	bosentan	Fli1	PA10034	2314	0.629
NULL	Ann_Rheum_Dis_2014_Jan_13_73(1)_233-237.nxml.txt.nlp	23942869	SENT144	7	7	19	19	infliximab	IMPACT	PA452639	55364	0.629
NULL	Biochem_Biophys_Res_Commun_2009_May_22_383(1)_63-67.nxml.txt.nlp	19332024	SENT17	31	31	33	33	lipase	ATGL	PA450239	57104	0.629
NULL	Mediators_Inflamm_2010_Jun_2_2010_682879.nxml.txt.nlp	20592757	SENT124	9	9	20	20	l-arginine	MCP-1	PA448478	6347	0.629
NULL	Front_Physiol_2011_Jul_27_2_41.nxml.txt.nlp	21845181	SENT235	19	19	39	39	glucosamine	TLR4	PA164747613	7099	0.629
NULL	Cancer_Manag_Res_2012_Mar_29_4_105-111.nxml.txt.nlp	22570564	SENT117	11	11	4	4	letrozole	aromatase	PA450196	1588	0.629
NULL	Cancer_Med_2014_Jun_14_3(3)_580-591.nxml.txt.nlp	24574330	SENT245	7	7	2	2	bevacizumab	VEGF-D	PA130232992	2277	0.629
NULL	Nanoscale_Res_Lett_2014_Jul_15_9(1)_353.nxml.txt.nlp	25114645	SENT2	18	18	31	31	diethylstilbestrol	HEX	PA449307	3087	0.629
NULL	Sensors_(Basel)_2013_Dec_27_14(1)_458-467.nxml.txt.nlp	24379050	SENT231	4	4	0	0	glucose	SPR	PA449773	6697;6869	0.629
NULL	Front_Immunol_2014_Aug_22_5_406.nxml.txt.nlp	25202312	SENT229	10	10	12	12	eculizumab	C1-INH	PA164776637	710	0.629
NULL	Arthritis_Res_Ther_2010_Apr_1_12(2)_R60.nxml.txt.nlp	20359365	SENT155	14	14	25	25	bleomycin	SPARC	PA448645	6678	0.629
NULL	Oncotarget_2014_Aug_29_5(18)_8052-8082.nxml.txt.nlp	25211298	SENT438	4	4	21	21	sertraline	Bcl-2	PA451333	596	0.629
NULL	Indian_J_Dermatol_2012_May-Jun_57(3)_219-221.nxml.txt.nlp	22707777	SENT27	22	22	19	19	cyclophosphamide	CHOP	PA449165	1649	0.629
NULL	Breast_Cancer_Res_2011_Jun_29_13(3)_R70.nxml.txt.nlp	21707964	SENT175	19	19	21	21	raloxifene	14-3-3	PA451221	10971	0.629
NULL	Comput_Struct_Biotechnol_J_2012_Nov_12_3_e201210011.nxml.txt.nlp	24688671	SENT259	23	23	13	13	nadh	San	PA164755085	80218	0.629
NULL	Bioinorg_Chem_Appl_2014_Sep_15_2014_718175.nxml.txt.nlp	25332694	SENT44	14	14	9	9	ethanol	mol	PA448073	90527	0.629
NULL	Nanoscale_Res_Lett_2012_Jan_16_7(1)_77.nxml.txt.nlp	22247975	SENT58	39	39	35	35	l-glutamine	FBS	PA10090	64319;26269	0.629
NULL	Sci_Rep_2015_Jan_6_5_7647.nxml.txt.nlp	25558795	SENT377	14	14	24	24	cyclophosphamide	CHOP	PA449165	1649	0.629
NULL	Oncoimmunology_2014_Apr_25_3_e28497.nxml.txt.nlp	25050215	SENT136	32	32	24	24	epirubicin	MICA	PA449476	100507436	0.629
NULL	Mol_Cells_2014_Mar_31_37(3)_234-240.nxml.txt.nlp	24642709	SENT158	16	16	5	5	cisplatin	HO-1	PA449014	3162	0.629
NULL	J_Appl_Genet_2011_Aug_17_52(3)_305-311.nxml.txt.nlp	21584731	SENT35	12	12	17	17	colchicine	ski	PA449092	55733	0.629
NULL	Mol_Cancer_2004_Jul_12_3_19.nxml.txt.nlp	15248896	SENT246	14	14	29	29	oxygen	HIF-1	PA450744	29072	0.629
NULL	Acta_Pharmacol_Sin_2012_Jul_18_33(7)_861-872.nxml.txt.nlp	22705730	SENT122	19	19	13	13	atorvastatin	PDK1	PA448500	5170;5163	0.629
NULL	Front_Physiol_2013_Dec_24_4_386.nxml.txt.nlp	24399968	SENT177	9	9	15	15	diazoxide	SUR1	PA449285	6833	0.629
NULL	Indian_J_Anaesth_2009_Oct_53(5)_582-591.nxml.txt.nlp	20640109	SENT140	5	5	3	3	clopidogrel	DES	PA449053	1674	0.629
NULL	Springerplus_2013_Jan_30_2_31.nxml.txt.nlp	23450269	SENT43	33	33	28	28	clavulanate	CTX	PA164742987	1593	0.629
NULL	Int_J_Med_Chem_2012_Dec_13_2012_530392.nxml.txt.nlp	25379286	SENT165	24	24	20	20	ethanol	mol	PA448073	90527	0.629
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT236	9	9	15	15	amisulpride	PRL	PA162565877	5617	0.629
NULL	J_Korean_Med_Sci_2010_Feb_21_25(2)_197-202.nxml.txt.nlp	20119570	SENT117	18	18	28	28	rifampin	VAN	PA451250	10318	0.629
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1106-1112.nxml.txt.nlp	20234360	SENT128	26	26	17	17	streptozocin	TTR	PA451514	7276	0.629
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT85	11	11	16	16	resveratrol	IL-6		3569	0.629
NULL	Cell_Commun_Signal_2013_Dec_20_11_97.nxml.txt.nlp	24359404	SENT66	36	36	38	38	hyaluronan	CD44	PA165958431	960	0.629
NULL	Diabetes_2013_Jul_14_62(7)_2625-2626.nxml.txt.nlp	NULL	SENT8	11	11	13	13	lipase	HSL	PA450239	3991	0.629
NULL	J_Med_Case_Rep_2014_Apr_30_8_132.nxml.txt.nlp	24886030	SENT93	14	14	10	10	rivaroxaban	VIII	PA165958360	1351	0.629
NULL	Diabetes_Care_2009_Sep_28_32(9)_1649-1655.nxml.txt.nlp	19478198	SENT139	10	10	19	19	saxagliptin	UTI	PA165958362	259	0.629
NULL	Emerg_Infect_Dis_2014_Jul_20(7)_1252-1253.nxml.txt.nlp	24959839	SENT36	11	11	9	9	ethambutol	EMB	PA164784021	133418	0.629
NULL	Arch_Med_Sci_2013_Apr_20_9(2)_368-371.nxml.txt.nlp	23671451	SENT67	2	2	12	12	malathion	EPM	PA164748092	2054	0.629
NULL	Curr_Neuropharmacol_2009_Jun_7(2)_83-95.nxml.txt.nlp	19949566	SENT474	6	6	32	32	felbamate	TGB	PA449590	5473	0.629
NULL	Mol_Cell_Proteomics_2012_Mar_27_11(3)_M111_014126.nxml.txt.nlp	22286754	SENT136	38	38	30	30	trypsin	TIC	PA451806	23550	0.629
NULL	Arthritis_Res_Ther_2009_Aug_24_11(4)_R127.nxml.txt.nlp	19703304	SENT78	9	9	13	13	adalimumab	OASIS	PA10004	90993	0.629
NULL	AMB_Express_2014_Apr_1_4_20.nxml.txt.nlp	24949255	SENT90	30	30	21	21	kanamycin	GP2	PA450137	2813	0.629
NULL	Indian_J_Pharmacol_2014_Sep-Oct_46(5)_549-550.nxml.txt.nlp	25298588	SENT64	21	21	12	12	warfarin	Xin	PA451906	165904	0.629
NULL	Front_Endocrinol_(Lausanne)_2014_Oct_27_5_163.nxml.txt.nlp	25386163	SENT461	13	13	26	26	maprotiline	adiponectin	PA450322	9370	0.629
NULL	Mol_Cancer_2009_Jun_23_8_39.nxml.txt.nlp	19549337	SENT7	7	7	5	5	etoposide	TRAIL	PA449552	8743	0.629
NULL	Int_J_Fertil_Steril_2014_Jul_8_Jul-Sep_8(2)_193-206.nxml.txt.nlp	25083185	SENT184	9	9	3	3	estradiol	PRL	PA449503	5617	0.629
NULL	Indian_J_Endocrinol_Metab_2012_May-Jun_16(3)_343-348.nxml.txt.nlp	22629497	SENT6	34	34	32	32	teriparatide	PTH	PA451620	5741	0.629
NULL	Blood_Res_2013_Jun_25_48(2)_160-163.nxml.txt.nlp	23826591	SENT18	12	12	22	22	heparin	PF4	PA449855	5196	0.629
NULL	Crit_Care_2003_Feb_18_7(Suppl_1)_5.nxml.txt.nlp	NULL	SENT15	4	4	11	11	hydrocortisone	IL-6	PA449905	3569	0.629
NULL	Indian_J_Pharmacol_2012_Sep-Oct_44(5)_624-628.nxml.txt.nlp	23112426	SENT37	23	23	15	15	nimodipine	CYP3A4	PA450633	1576	0.629
NULL	Nucleic_Acids_Res_2010_Oct_22_38(19)_6502-6512.nxml.txt.nlp	20571088	SENT243	8	8	21	21	galactose	SMC6	PA449725	79677	0.629
NULL	Case_Rep_Transplant_2013_Jun_13_2013_375263.nxml.txt.nlp	23844312	SENT103	41	41	25	25	tacrolimus	CYP3A	PA451578	1574	0.629
NULL	Breast_Cancer_Res_2004_Mar_26_6(3)_R252-R263.nxml.txt.nlp	15084249	SENT110	40	40	18	18	tamoxifen	ABCC11	PA451581	85320	0.629
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT232	20	20	9	9	doxorubicin	SLK	PA449412	9748;2534	0.629
NULL	Clin_Interv_Aging_2013_Jul_16_8_889-897.nxml.txt.nlp	23898224	SENT10	7	7	5	5	gemcitabine	SIRT1	PA449748	23411	0.629
NULL	Arthritis_Res_Ther_2009_Jun_29_11(3)_R100.nxml.txt.nlp	19563672	SENT160	0	0	11	11	infliximab	IFN	PA452639	3439	0.629
NULL	J_Int_Soc_Sports_Nutr_2014_Aug_13_11_38.nxml.txt.nlp	25132809	SENT3	9	9	36	36	l-leucine	MSTN	PA450197	2660	0.629
NULL	Int_J_Med_Chem_2012_Dec_13_2012_530392.nxml.txt.nlp	25379286	SENT195	21	21	17	17	ethanol	mol	PA448073	90527	0.629
NULL	J_Infect_Dis_2014_May_1_209(9)_1469-1478.nxml.txt.nlp	24286983	SENT108	19	19	26	26	oxacillin	VAN	PA450725	10318	0.629
NULL	Arch_Med_Sci_2013_Feb_21_9(1)_151-158.nxml.txt.nlp	23515030	SENT126	6	6	19	19	lipase	SN2	PA450239	92745	0.629
NULL	Br_J_Pharmacol_2014_Oct_26_171(20)_4785-4796.nxml.txt.nlp	25074741	SENT4	9	9	18	18	guanfacine	NK1R	PA449825	6869	0.629
NULL	J_Korean_Med_Sci_2013_Apr_27_28(4)_527-533.nxml.txt.nlp	23580227	SENT90	4	4	6	6	genistein	TRAIL	PA165109660	8743	0.629
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1126-1134.nxml.txt.nlp	21364592	SENT134	22	22	10	10	cisplatin	ERCC1	PA449014	2067	0.629
NULL	Ann_Lab_Med_2014_Nov_28_34(6)_439-445.nxml.txt.nlp	25368819	SENT31	26	26	28	28	vancomycin	VAN	PA451850	10318	0.629
NULL	Oncotarget_2011_Mar_28_2(3)_109-112.nxml.txt.nlp	21487160	SENT15	5	5	26	26	metformin	p53	PA450395	7157	0.629
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT11	8	8	14	14	gefitinib	AKT	PA131301952	207	0.629
NULL	Autophagy_2012_Jul_1_8(7)_1045-1057.nxml.txt.nlp	22647547	SENT172	3	3	17	17	gentamicin	BECN1	PA449753	8678	0.629
NULL	Cancer_Manag_Res_2012_Oct_11_4_357-365.nxml.txt.nlp	23091399	SENT77	11	11	37	37	lucanthone	p53	PA164748783	7157	0.629
NULL	BMJ_2011_Jul_26_343_d4366.nxml.txt.nlp	21791491	SENT33	24	24	18	18	lisinopril	ACE	PA450242	1636	0.629
NULL	Int_J_Biol_Sci_2012_Sep_6_8(8)_1109-1120.nxml.txt.nlp	22991499	SENT44	12	12	9	9	l-arginine	IFN	PA448478	3439	0.629
NULL	F1000Res_2014_Aug_19_3_198.nxml.txt.nlp	25400908	SENT289	6	6	9	9	lapatinib	ACT	PA152241907	12;11332;9457;641455	0.629
NULL	J_Hematol_Oncol_2009_Aug_12_2_36.nxml.txt.nlp	19674465	SENT60	14	14	4	4	lenalidomide	IL-6	PA162363968	3569	0.629
NULL	Front_Pharmacol_2015_Jan_13_5_291.nxml.txt.nlp	25628565	SENT91	8	8	14	14	estradiol	HO-1	PA449503	3162	0.629
NULL	Ann_Surg_Treat_Res_2014_Feb_22_86(2)_68-75.nxml.txt.nlp	24761411	SENT199	3	3	6	6	oxaliplatin	survivin	PA131285527	332	0.629
NULL	Biomed_Res_Int_2014_Feb_17_2014_172913.nxml.txt.nlp	24696843	SENT64	12	12	41	41	phenol	CO2	PA450913	4513	0.629
NULL	J_Neuroinflammation_2011_Aug_5_8_91.nxml.txt.nlp	21819568	SENT202	6	6	13	13	pioglitazone	CD68	PA450970	968	0.629
NULL	Exp_Neurobiol_2013_Mar_31_22(1)_51-57.nxml.txt.nlp	23585723	SENT131	0	0	21	21	capsaicin	TRPV1	PA448776	7442	0.629
NULL	Onco_Targets_Ther_2014_Jun_11_7_969-983.nxml.txt.nlp	24959084	SENT115	23	23	20	20	phenytoin	CYP3A4	PA450947	1576	0.629
NULL	Bone_2012_Jan_50(1)_218-225.nxml.txt.nlp	22023931	SENT25	0	0	6	6	iron	FGF23	PA450087	8074	0.629
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Nov_8_64(Pt_12)_o2276.nxml.txt.nlp	21581256	SENT68	8	8	11	11	benzaldehyde	mol	PA448571	90527	0.629
NULL	ScientificWorldJournal_2012_Apr_1_2012_159456.nxml.txt.nlp	22547977	SENT19	11	11	13	13	oxytetracycline	OTC	PA450757	5009	0.629
NULL	Gut_2008_Jul_4_57(7)_923-929.nxml.txt.nlp	18252749	SENT226	7	7	14	14	capsaicin	P2X3	PA448776	5024	0.629
NULL	Mol_Microbiol_2014_Mar_23_91(5)_918-934.nxml.txt.nlp	24372851	SENT6	4	4	19	19	artemisinin	ACT	PA165111696	12;11332;9457;641455	0.629
NULL	Gut_Liver_2015_Jan_15_9(1)_103-108.nxml.txt.nlp	NULL	SENT127	8	8	6	6	lamivudine	LAM	PA450163	7249;7248	0.629
NULL	J_Invest_Dermatol_2012_Sep_10_132(9)_2255-2262.nxml.txt.nlp	22572817	SENT45	8	8	18	18	forskolin	HBD3	PA146096022	414325	0.629
NULL	eLife_2014_May_23_3_e01964.nxml.txt.nlp	24859754	SENT431	19	19	15	15	l-glutamine	TPO	PA10090	7066;7173	0.629
NULL	Ann_Gen_Psychiatry_2008_Aug_18_7_11.nxml.txt.nlp	18706108	SENT64	7	7	19	19	bupropion	CD50	PA448687	3385	0.629
NULL	Braz_J_Med_Biol_Res_2014_Oct_14_47(12)_1062-1067.nxml.txt.nlp	25387673	SENT81	2	2	18	18	propofol	IL-6	PA451141	3569	0.629
NULL	New_Microbes_New_Infect_2014_May_4_2(3)_58-63.nxml.txt.nlp	25356345	SENT100	18	18	20	20	cefepime	GEM	PA164754876	2669	0.629
NULL	Nat_Commun_2010_Nov_30_1_130.nxml.txt.nlp	21119643	SENT104	25	25	39	39	flurbiprofen	PS1	PA449683	5663	0.629
NULL	Anal_Bioanal_Chem_2013_Jul_23_405(23)_7337-7345.nxml.txt.nlp	23877175	SENT144	5	5	13	13	creatine	CA3	PA164778930	761	0.629
NULL	Cell_Commun_Signal_2013_Nov_5_11_83.nxml.txt.nlp	24192293	SENT62	12	12	21	21	doxycycline	IL-6	PA449415	3569	0.629
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT74	14	14	16	16	perifosine	TRAIL	PA165291471	8743	0.629
NULL	J_Lipid_Res_2014_Dec_55(12)_2606-2619.nxml.txt.nlp	25339683	SENT296	27	27	9	9	desipramine	ASM	PA449233	6609;283120	0.629
NULL	Oncol_Lett_2014_Jun_8_7(6)_2035-2040.nxml.txt.nlp	24932285	SENT168	22	22	7	7	cisplatin	ABCG2	PA449014	9429	0.629
NULL	Oxid_Med_Cell_Longev_2012_Apr_5_2012_983427.nxml.txt.nlp	22550557	SENT167	11	11	24	24	ethanol	MOF	PA448073	84148	0.629
NULL	Clin_Psychopharmacol_Neurosci_2011_Apr_30_9(1)_36-43.nxml.txt.nlp	23431025	SENT125	12	12	15	15	haloperidol	FLI	PA449841	2314	0.629
NULL	Arthritis_Res_Ther_2012_Apr_30_14(2)_R96.nxml.txt.nlp	22546471	SENT134	7	7	4	4	methotrexate	IL-6	PA450428	3569	0.629
NULL	Front_Oncol_2014_Sep_23_4_264.nxml.txt.nlp	25295231	SENT20	7	7	9	9	lenalidomide	MDM2	PA162363968	4193	0.629
NULL	Arthritis_Res_Ther_2010_May_28_12(3)_R105.nxml.txt.nlp	20509880	SENT239	11	11	13	13	celecoxib	p38	PA448871	10598;1432;7965	0.629
NULL	J_Cancer_2011_May_16_2_280-291.nxml.txt.nlp	21611109	SENT237	33	33	9	9	kanamycin	IL2	PA450137	3558	0.629
NULL	Adv_Hematol_2009_Jul_7_2009_495863.nxml.txt.nlp	19960059	SENT119	10	10	16	16	heparin	PF4	PA449855	5196	0.629
NULL	Oxid_Med_Cell_Longev_2013_Mar_5_2013_264935.nxml.txt.nlp	23533686	SENT122	22	22	20	20	hemin	HO-1	PA449849	3162	0.629
NULL	Patient_Prefer_Adherence_2010_Nov_3_4_397-406.nxml.txt.nlp	21206515	SENT27	28	28	18	18	sitagliptin	GLP-1	PA164748978	100125288	0.628
NULL	Nature_2012_Apr_25_484(7395)_524-528.nxml.txt.nlp	22538616	SENT115	9	9	15	15	ciprofloxacin	PD1	PA449009	9825;6622;5133	0.628
NULL	Sci_Rep_2014_Dec_12_4_7467.nxml.txt.nlp	25502280	SENT259	0	0	3	3	taurine	spatial	PA451590	219793	0.628
NULL	Diabetes_Care_2013_Aug_17_36(Suppl_2)_S162-S174.nxml.txt.nlp	23882042	SENT427	8	8	14	14	pioglitazone	adiponectin	PA450970	9370	0.628
NULL	Cell_Death_Differ_2010_Oct_30_17(10)_1624-1635.nxml.txt.nlp	20431602	SENT51	24	24	15	15	paclitaxel	Bcl-2	PA450761	596	0.628
NULL	Adv_Hematol_2011_Oct_15_2011_196135.nxml.txt.nlp	22013445	SENT191	0	0	12	12	thrombin	VIII	PA451674	1351	0.628
NULL	Evid_Based_Complement_Alternat_Med_2014_May_12_2014_804746.nxml.txt.nlp	24899911	SENT157	11	11	15	15	diazepam	PC6	PA449283	5125	0.628
NULL	Cell_Death_Dis_2010_Sep_23_1(9)_e78.nxml.txt.nlp	21364680	SENT65	5	5	13	13	cisplatin	XIAP	PA449014	331	0.628
NULL	Cancers_(Basel)_2012_Jun_18_4(2)_581-600.nxml.txt.nlp	24213326	SENT693	1	1	7	7	cyclophosphamide	CD25	PA449165	3669;3559	0.628
NULL	Curr_Neuropharmacol_2008_Jun_6(2)_151-163.nxml.txt.nlp	19305794	SENT450	7	7	10	10	capsaicin	VR1	PA448776	56664	0.628
NULL	Breast_Cancer_Res_2010_Aug_23_12(4)_R64.nxml.txt.nlp	20731819	SENT226	28	28	11	11	tamoxifen	CYP2D6	PA451581	1565	0.628
NULL	EMBO_Mol_Med_2013_Aug_5_5(8)_1149-1150.nxml.txt.nlp	23918227	SENT15	21	21	17	17	doxorubicin	CHOP	PA449412	1649	0.628
NULL	Osteoporos_Int_2014_Oct_10_25(3)_1173-1180.nxml.txt.nlp	24108429	SENT147	14	14	37	37	teriparatide	DPD	PA451620	1806	0.628
NULL	Carcinogenesis_2011_Apr_27_32(4)_516-521.nxml.txt.nlp	21273643	SENT33	30	30	13	13	l-glutamine	CO2	PA10090	4513	0.628
NULL	Cell_Commun_Signal_2013_Jan_11_11_2.nxml.txt.nlp	23305203	SENT240	8	8	6	6	forskolin	RACK1	PA146096022	10399	0.628
NULL	Breast_Cancer_Res_2008_Dec_16_10(6)_R105.nxml.txt.nlp	19087274	SENT193	3	3	19	19	fulvestrant	ZEB1	PA164747170	6935	0.628
NULL	J_Phys_Ther_Sci_2014_May_29_26(5)_789-792.nxml.txt.nlp	24926154	SENT86	13	13	16	16	capsaicin	TRPV1	PA448776	7442	0.628
NULL	J_Breast_Cancer_2013_Jun_28_16(2)_164-170.nxml.txt.nlp	23843848	SENT47	12	12	4	4	doxorubicin	p53	PA449412	7157	0.628
NULL	Cell_Commun_Signal_2013_Nov_11_11_86.nxml.txt.nlp	24215724	SENT477	21	21	13	13	losartan	PAR1	PA450268	79581;2149	0.628
NULL	Br_J_Pharmacol_2014_Oct_26_171(20)_4785-4796.nxml.txt.nlp	25074741	SENT35	9	9	15	15	guanfacine	NK1R	PA449825	6869	0.628
NULL	Crit_Care_2003_Mar_3_7(Suppl_2)_P001.nxml.txt.nlp	NULL	SENT4	28	28	37	37	estradiol	PRL	PA449503	5617	0.628
NULL	Anal_Bioanal_Chem_2012_Feb_16_402(4)_1611-1623.nxml.txt.nlp	22173207	SENT207	14	14	0	0	ribavirin	SRM	PA451241	6723;6725	0.628
NULL	Cancers_(Basel)_2014_Aug_12_6(3)_1631-1669.nxml.txt.nlp	25119536	SENT374	11	11	7	7	crizotinib	FGFR1	PA165946122	2260	0.628
NULL	Med_Sci_Monit_2013_May_1_19_317-326.nxml.txt.nlp	23632427	SENT277	40	40	14	14	ciprofloxacin	CTX	PA449009	1593	0.628
NULL	Arthritis_Res_Ther_2011_Feb_11_13(1)_R21.nxml.txt.nlp	21314928	SENT171	25	25	16	16	tocilizumab	CD64	PA165292659	2209	0.628
NULL	Indian_J_Nephrol_2009_Jan_19(1)_15-19.nxml.txt.nlp	20352006	SENT52	8	8	17	17	diatrizoate	CO2	PA449281	4513	0.628
NULL	Mol_Neurobiol_2007_Oct_10_36(2)_137-151.nxml.txt.nlp	17952658	SENT388	15	15	47	47	vasopressin	CXCR4	PA451858	7852	0.628
NULL	Curr_Neuropharmacol_2014_Jan_12(1)_57-70.nxml.txt.nlp	24533016	SENT143	7	7	15	15	ketamine	CN1	PA450144	84618;84735	0.628
NULL	Biomed_Res_Int_2013_Oct_27_2013_467869.nxml.txt.nlp	24282816	SENT60	12	12	6	6	ribavirin	SOC	PA451241	91544	0.628
NULL	Hum_Genomics_2009_Jan_1_3(2)_128-142.nxml.txt.nlp	19164090	SENT196	3	3	10	10	carboplatin	CD44	PA448803	960	0.628
NULL	Biomed_Res_Int_2014_Jan_29_2014_831845.nxml.txt.nlp	24605337	SENT207	29	29	17	17	bupivacaine	S6K1	PA135057240	6198	0.628
NULL	Cancer_Med_2013_Dec_31_2(6)_950-963.nxml.txt.nlp	24403269	SENT19	12	12	4	4	cisplatin	RAB25	PA449014	57111	0.628
NULL	Iran_J_Reprod_Med_2013_Jul_11(7)_565-576.nxml.txt.nlp	24639792	SENT93	9	9	20	20	berberine	SP-D	PA165860812	6441	0.628
NULL	Front_Genet_2014_Aug_25_5_290.nxml.txt.nlp	25202324	SENT76	27	27	23	23	iron	NAP	PA450087	56259	0.628
NULL	Oncotarget_2013_Nov_4_5(1)_161-172.nxml.txt.nlp	24389287	SENT115	0	0	2	2	propranolol	p53	PA451145	7157	0.628
NULL	J_Cell_Biol_2007_Apr_23_177(2)_329-341.nxml.txt.nlp	17438075	SENT382	26	26	40	40	glutaraldehyde	p17	PA449777	54107	0.628
NULL	Biosci_Rep_2012_Aug_1_32(Pt_4)_361-374.nxml.txt.nlp	22762204	SENT1062	17	17	3	3	mitomycin	p27	PA450524	5715;10534	0.628
NULL	Emerg_Infect_Dis_2011_Mar_17(3)_432-440.nxml.txt.nlp	21392434	SENT145	2	2	14	14	isoniazid	DST	PA450112	667	0.628
NULL	J_Int_AIDS_Soc_2011_Mar_26_14_14.nxml.txt.nlp	21439074	SENT114	23	23	30	30	nelfinavir	ATV	PA450606	4683	0.628
NULL	Patient_Prefer_Adherence_2014_Apr_8_8_463-471.nxml.txt.nlp	24748775	SENT34	25	25	21	21	denosumab	RANKL	PA166048634	8600	0.628
NULL	Saudi_J_Anaesth_2014_Apr-Jun_8(2)_209-214.nxml.txt.nlp	24843334	SENT38	37	37	14	14	bupivacaine	C15	PA135057240	51316	0.628
NULL	Curr_Neuropharmacol_2010_Jun_8(2)_92-96.nxml.txt.nlp	21119879	SENT107	13	13	23	23	mannitol	p38	PA450320	10598;1432;7965	0.628
NULL	Br_J_Cancer_2010_Feb_16_102(4)_629-638.nxml.txt.nlp	20104223	SENT174	0	0	11	11	bortezomib	p53	PA10252	7157	0.628
NULL	Case_Rep_Oncol_Med_2011_Dec_8_2011_805893.nxml.txt.nlp	22606447	SENT11	9	9	7	7	cyclophosphamide	CHOP	PA449165	1649	0.628
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Nov_21_65(Pt_12)_o3132-o3133.nxml.txt.nlp	21578855	SENT68	10	10	7	7	benzydamine	mol	PA134687812	90527	0.628
NULL	Asian-Australas_J_Anim_Sci_2014_May_27(5)_757-766.nxml.txt.nlp	25050012	SENT205	31	31	28	28	lipase	HSL	PA450239	3991	0.628
NULL	Arthritis_Res_Ther_2011_Jun_20_13(3)_R97.nxml.txt.nlp	21689431	SENT144	18	18	9	9	ambrisentan	ETB	PA165860521	1910	0.628
NULL	Trials_2012_Dec_13_13_239.nxml.txt.nlp	23237631	SENT8	14	14	32	32	acenocoumarol	CYP2C9	PA452632	1559	0.628
NULL	Crit_Care_2010_Nov_5_14(6)_R200.nxml.txt.nlp	21054850	SENT71	22	22	24	24	vasopressin	AVP	PA451858	114548;551	0.628
NULL	Oncol_Lett_2013_Oct_26_6(4)_947-949.nxml.txt.nlp	24137442	SENT48	37	37	11	11	creatine	CD34	PA164778930	947	0.628
NULL	Front_Oncol_2014_Mar_6_4_40.nxml.txt.nlp	24639951	SENT47	26	26	20	20	fluorouracil	ETO	PA128406956	862	0.628
NULL	J_Hepatobiliary_Pancreat_Surg_2007_Jan_30_14(1)_83-90.nxml.txt.nlp	17252301	SENT81	2	2	4	4	ampicillin	TOB	PA448419	10140	0.628
NULL	Br_J_Cancer_2000_Jul_3_83(3)_366-374.nxml.txt.nlp	10917553	SENT5	5	5	14	14	daunorubicin	MRP2	PA449212	100130958;57626;1244	0.628
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT17	7	7	3	3	sulindac	survivin	PA451565	332	0.628
NULL	Front_Neurosci_2014_Jun_24_8_171.nxml.txt.nlp	25009457	SENT13	17	17	19	19	vasopressin	AVP	PA451858	114548;551	0.628
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Nov_12_3(11)_e147.nxml.txt.nlp	25390686	SENT195	2	2	6	6	tenofovir	CD4	PA10204	920	0.628
NULL	Eur_J_Med_Res_2011_Jul_25_16(7)_303-314.nxml.txt.nlp	21813371	SENT179	15	15	8	8	ribavirin	IFN	PA451241	3439	0.628
NULL	Breast_Cancer_Res_2010_May_18_12(Suppl_1)_P20.nxml.txt.nlp	NULL	SENT15	8	8	20	20	vinblastine	PLU-1	PA451877	10765	0.628
NULL	Oncologist_2010_Nov_4_15(11)_1135-1146.nxml.txt.nlp	21051659	SENT178	5	5	8	8	temsirolimus	IFN	PA164746890	3439	0.628
NULL	Int_J_Endocrinol_2010_Nov_14_2010_515136.nxml.txt.nlp	21113299	SENT143	18	18	6	6	lipase	adiponectin	PA450239	9370	0.628
NULL	J_Oncol_2010_Nov_19_2010_568938.nxml.txt.nlp	20037743	SENT304	16	16	24	24	trastuzumab	HER2	PA451743	2064	0.628
NULL	Mol_Cancer_2009_Aug_25_8_66.nxml.txt.nlp	19706164	SENT33	0	0	8	8	celecoxib	PARP	PA448871	142	0.628
NULL	Am_J_Cardiovasc_Drugs_2014_Oct_31_14(2)_79-87.nxml.txt.nlp	24174174	SENT203	4	4	11	11	pravastatin	adiponectin	PA451089	9370	0.628
NULL	Exp_Ther_Med_2013_Mar_21_5(3)_987-991.nxml.txt.nlp	23407636	SENT104	0	0	14	14	losartan	CXCR1	PA450268	3577	0.628
NULL	Aging_(Albany_NY)_2013_Jan_26_4(12)_894-898.nxml.txt.nlp	23525940	SENT39	22	22	31	31	metformin	AMPK	PA450395	5563	0.628
NULL	Insights_Imaging_2014_May_3_5(3)_365-374.nxml.txt.nlp	24792779	SENT62	18	18	8	8	icatibant	C1-INH	PA164749185	710	0.628
NULL	J_Oncol_2012_Feb_6_2012_737981.nxml.txt.nlp	22481932	SENT83	28	28	11	11	etoposide	MUC16	PA449552	94025	0.628
NULL	Biomed_Res_Int_2014_Jan_19_2014_215872.nxml.txt.nlp	24575401	SENT85	26	26	35	35	artemisinin	TC2	PA165111696	6948	0.628
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT244	6	6	8	8	resveratrol	ROS		6098	0.628
NULL	Breast_Cancer_Res_2012_Jun_7_14(3)_R89.nxml.txt.nlp	22676470	SENT330	7	7	14	14	geldanamycin	HER2	PA152031327	2064	0.628
NULL	Adipocyte_2012_Jan_1_1(1)_25-37.nxml.txt.nlp	23700508	SENT177	22	22	24	24	lipase	ATGL	PA450239	57104	0.628
NULL	Viruses_2013_Mar_22_5(3)_998-1022.nxml.txt.nlp	23524390	SENT253	29	29	14	14	oxygen	PCD	PA450744	27019;5092;352909;1767	0.628
NULL	Crit_Care_2008_Feb_15_12(1)_R14.nxml.txt.nlp	18279513	SENT21	3	3	11	11	thrombin	VIII	PA451674	1351	0.628
NULL	J_Breast_Cancer_2013_Mar_31_16(1)_122-126.nxml.txt.nlp	23593093	SENT83	43	43	34	34	letrozole	HER2	PA450196	2064	0.628
NULL	Anal_Bioanal_Chem_2011_Jul_15_401(1)_305-313.nxml.txt.nlp	21573846	SENT166	14	14	8	8	genistein	Gen	PA165109660	348654	0.628
NULL	Angiogenesis_2012_Dec_28_15(4)_623-641.nxml.txt.nlp	22843200	SENT323	20	20	7	7	sunitinib	CD11b	PA162372840	3684	0.628
NULL	Avicenna_J_Med_Biotechnol_2009_Jul-Sep_1(2)_125-131.nxml.txt.nlp	23407681	SENT26	12	12	20	20	lipase	NT3	PA450239	4877;6272	0.628
NULL	Int_J_Mol_Sci_2014_Mar_18_15(3)_4747-4779.nxml.txt.nlp	24646914	SENT1953	4	4	14	14	sorafenib	CXCR4	PA7000	7852	0.628
NULL	Cardiol_Ther_2013_Jun_26_2(1)_69-84.nxml.txt.nlp	25135290	SENT104	3	3	1	1	sirolimus	DES	PA451365	1674	0.628
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Jun_14_70(Pt_7)_o766-o767.nxml.txt.nlp	25161557	SENT78	23	23	9	9	ethanol	mol	PA448073	90527	0.628
NULL	Eur_J_Endocrinol_2012_Feb_166(2)_159-170.nxml.txt.nlp	21930715	SENT212	30	30	28	28	metformin	Met	PA450395	79811	0.628
NULL	Emerg_Infect_Dis_2011_Mar_17(3)_510-513.nxml.txt.nlp	21392446	SENT53	10	10	36	36	isoniazid	ETO	PA450112	862	0.628
NULL	Amino_Acids_2011_Mar_8_40(3)_885-893.nxml.txt.nlp	20824293	SENT226	5	5	13	13	glucosamine	Bcl-2	PA164747613	596	0.628
NULL	Virol_J_2010_Dec_31_7_377.nxml.txt.nlp	21194456	SENT53	20	20	17	17	ribavirin	IFN	PA451241	3439	0.628
NULL	Int_J_Environ_Res_Public_Health_2013_Sep_12_10(9)_4274-4305.nxml.txt.nlp	24036486	SENT55	15	15	17	17	ceftriaxone	EPM	PA448866	2054	0.628
NULL	Nucleic_Acids_Res_2013_May_12_41(10)_5533-5541.nxml.txt.nlp	23585281	SENT188	6	6	26	26	fluorescein	NRAS	PA164746009	4893	0.628
NULL	Hum_Genomics_2005_Jun_1_2(2)_138-143.nxml.txt.nlp	16004729	SENT37	43	43	27	27	nadh	ALDH3A1	PA164755085	218	0.628
NULL	Int_J_Nephrol_2010_Dec_15_2011_194910.nxml.txt.nlp	21197109	SENT207	1	1	3	3	vasopressin	AVP	PA451858	114548;551	0.628
NULL	Hum_Mol_Genet_2012_Mar_15_21(6)_1299-1311.nxml.txt.nlp	22131369	SENT303	44	44	28	28	l-glutamine	B27	PA10090	56246	0.628
NULL	Genet_Vaccines_Ther_2004_Oct_27_2_16.nxml.txt.nlp	15509303	SENT97	9	9	14	14	chloroquine	IL-3	PA448948	3562	0.628
NULL	Mol_Cancer_2012_Apr_26_11_24.nxml.txt.nlp	22537161	SENT139	15	15	9	9	pp2	IFN		3439	0.628
NULL	Breast_Cancer_Res_2007_Oct_19_9(5)_111.nxml.txt.nlp	17983482	SENT49	20	20	35	35	lapatinib	HER2	PA152241907	2064	0.628
NULL	Diabetologia_2010_Jun_27_53(6)_1142-1150.nxml.txt.nlp	20349036	SENT189	1	1	23	23	spermine	AMPK	PA164781199	5563	0.628
NULL	Br_J_Cancer_1982_Aug_46(2)_236-248.nxml.txt.nlp	6758828	SENT4	14	14	16	16	cyclophosphamide	CTX	PA449165	1593	0.628
NULL	Tuberc_Respir_Dis_(Seoul)_2013_Aug_30_75(2)_59-66.nxml.txt.nlp	24023558	SENT168	4	4	15	15	docetaxel	FOXO1	PA449383	2308	0.628
NULL	Breast_Cancer_Res_2009_May_18_11(3)_303.nxml.txt.nlp	19519950	SENT10	18	18	11	11	paclitaxel	ACT	PA450761	12;11332;9457;641455	0.628
NULL	Cancers_(Basel)_2014_Apr_29_6(2)_1020-1030.nxml.txt.nlp	24784954	SENT43	10	10	0	0	octreotide	FDG	PA450678	23583	0.628
NULL	Int_J_Environ_Res_Public_Health_2010_Apr_30_7(4)_1448-1466.nxml.txt.nlp	20617039	SENT157	0	0	4	4	ethanol	L1CAM	PA448073	3897	0.628
NULL	Eur_J_Clin_Microbiol_Infect_Dis_2010_May_13_29(5)_543-550.nxml.txt.nlp	20229224	SENT73	17	17	47	47	erythromycin	VAN	PA449493	10318	0.628
NULL	Front_Neurosci_2013_Jan_10_6_191.nxml.txt.nlp	23335875	SENT240	7	7	4	4	vasopressin	AT1	PA451858	9197;185	0.628
NULL	Mol_Pain_2014_Apr_9_10_24.nxml.txt.nlp	24716552	SENT39	16	16	30	30	capsaicin	NK1R	PA448776	6869	0.628
NULL	Mar_Drugs_2014_Sep_12_12(9)_4783-4798.nxml.txt.nlp	25222667	SENT366	19	19	17	17	urokinase	NF-kappaB	PA451836	4790	0.628
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S18-S30.nxml.txt.nlp	20680104	SENT194	12	12	5	5	leucovorin	IFL	PA450198	3439	0.628
NULL	AIDS_Res_Ther_2009_Dec_23_6_30.nxml.txt.nlp	20030841	SENT93	9	9	16	16	lopinavir	CD4	PA450264	920	0.628
NULL	J_Cell_Biol_1977_Oct_1_75(1)_277-289.nxml.txt.nlp	410816	SENT9	0	0	14	14	hydrocortisone	C5a	PA449905	727	0.628
NULL	J_Res_Med_Sci_2010_Nov-Dec_15(6)_348-358.nxml.txt.nlp	21526108	SENT90	12	12	15	15	thrombin	PAR-1	PA451674	2011;2149	0.628
NULL	J_Cell_Mol_Med_2013_Oct_16_17(10)_1261-1270.nxml.txt.nlp	23855452	SENT268	4	4	6	6	gemcitabine	GEM	PA449748	2669	0.628
NULL	J_Cachexia_Sarcopenia_Muscle_2011_Dec_8_2(4)_209-261.nxml.txt.nlp	22476871	SENT1317	11	11	13	13	lipase	ATGL	PA450239	57104	0.628
NULL	Crit_Care_2008_Aug_29_12(4)_R111.nxml.txt.nlp	18759963	SENT134	17	17	7	7	heparin	SAPS	PA449855	8935	0.628
NULL	Eur_J_Med_Res_2011_Jul_25_16(7)_303-314.nxml.txt.nlp	21813371	SENT59	27	27	29	29	telaprevir	SOC	PA165958354	91544	0.628
NULL	J_Clin_Biochem_Nutr_2010_Jan_29_46(1)_36-42.nxml.txt.nlp	20104263	SENT9	25	25	21	21	ribavirin	IFN	PA451241	3439	0.628
NULL	Mol_Cancer_2008_Aug_7_7_65.nxml.txt.nlp	18687124	SENT108	13	13	5	5	thrombin	parafibromin	PA451674	79577	0.628
NULL	Cardiol_Res_Pract_2012_Feb_22_2012_845698.nxml.txt.nlp	22462028	SENT170	7	7	17	17	valsartan	AT1	PA451848	9197;185	0.628
NULL	Acta_Pharmacol_Sin_2010_Jul_28_31(7)_867-873.nxml.txt.nlp	20581857	SENT159	17	17	19	19	docetaxel	PC3	PA449383	57332;7832;5122	0.628
NULL	Diabetes_2013_Jun_17_62(6)_1843-1854.nxml.txt.nlp	23349486	SENT195	2	2	19	19	pioglitazone	CD68	PA450970	968	0.628
NULL	Br_J_Haematol_2014_Jan_28_164(2)_233-244.nxml.txt.nlp	24206017	SENT186	22	22	3	3	lenalidomide	CRBN	PA162363968	51185	0.628
NULL	Ann_Oncol_2013_Apr_31_24(4)_1067-1073.nxml.txt.nlp	23117073	SENT42	13	13	24	24	fosaprepitant	CYP3A4	PA165958390	1576	0.628
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT265	4	4	17	17	sitagliptin	HIP	PA164748978	6767;6159;64399;5068	0.628
NULL	Endocrinol_Diabetes_Metab_Case_Rep_2014_Feb_1_2014_130079.nxml.txt.nlp	24683483	SENT60	22	22	4	4	glucose	PRL	PA449773	5617	0.628
NULL	J_Mol_Signal_2008_May_22_3_11.nxml.txt.nlp	18498628	SENT296	16	16	10	10	isoproterenol	IL-6	PA450121	3569	0.628
NULL	Exp_Anim_2013_Oct_31_62(4)_275-280.nxml.txt.nlp	24172191	SENT83	0	0	18	18	galactose	ROMK1	PA449725	3758	0.628
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT212	10	10	12	12	metformin	AMPK	PA450395	5563	0.628
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_23_2013_941093.nxml.txt.nlp	23864901	SENT234	0	0	3	3	fluvoxamine	CYP1A2	PA449690	1544	0.628
NULL	Biomed_Res_Int_2014_Apr_15_2014_175721.nxml.txt.nlp	24822180	SENT83	19	19	2	2	doxorubicin	WWP1	PA449412	11059	0.628
NULL	Environ_Health_Perspect_2011_Aug_22_119(8)_1053-1061.nxml.txt.nlp	21697028	SENT246	30	30	28	28	genistein	DES	PA165109660	1674	0.628
NULL	Cancer_Manag_Res_2012_Nov_9_4_383-395.nxml.txt.nlp	23204869	SENT204	11	11	7	7	carmustine	PC-3	PA448810	692094	0.628
NULL	Ann_Clin_Transl_Neurol_2014_Sep_29_1(9)_650-658.nxml.txt.nlp	25493279	SENT45	6	6	16	16	mitoxantrone	IFN	PA450526	3439	0.628
NULL	Oncol_Lett_2013_Mar_28_5(3)_935-942.nxml.txt.nlp	23426424	SENT43	0	0	7	7	oxaliplatin	DDP	PA131285527	1678	0.628
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT2379	2	2	14	14	phenacetin	CYP3A4	PA450897	1576	0.628
NULL	J_Antimicrob_Chemother_2014_Apr_2_69(4)_911-918.nxml.txt.nlp	24302651	SENT39	2	2	12	12	oxacillin	PEN	PA450725	9933	0.628
NULL	Allergy_Asthma_Clin_Immunol_2010_Jul_28_6(1)_21.nxml.txt.nlp	20667124	SENT28	36	36	26	26	icatibant	C1-INH	PA164749185	710	0.628
NULL	Alcohol_Res_2012_34(4)_468-483.nxml.txt.nlp	23584113	SENT45	18	18	20	20	vasopressin	AVP	PA451858	114548;551	0.628
NULL	Acta_Pharmacol_Sin_2012_Jun_14_33(6)_832-838.nxml.txt.nlp	22580740	SENT23	10	10	12	12	cisplatin	DDP	PA449014	1678	0.628
NULL	Breast_Cancer_Res_2011_Apr_14_13(2)_R43.nxml.txt.nlp	21492444	SENT133	10	10	17	17	doxycycline	HER3	PA449415	2065	0.628
NULL	Oncoimmunology_2013_Sep_1_2(9)_e25595.nxml.txt.nlp	24319634	SENT215	10	10	12	12	aldesleukin	IL-2	PA448081	3558	0.628
NULL	Bone_2009_Jul_45(1)_91-97.nxml.txt.nlp	19332164	SENT314	19	19	24	24	pamidronate	LTBR	PA450767	4055	0.628
NULL	Cancers_(Basel)_2014_Aug_12_6(3)_1631-1669.nxml.txt.nlp	25119536	SENT1888	2	2	7	7	curcumin	SOCS1	PA151958596	8651	0.628
NULL	Indian_J_Med_Res_2011_Sep_134(3)_295-301.nxml.txt.nlp	21985811	SENT122	27	27	20	20	carbamazepine	ABCB1	PA448785	5243	0.628
NULL	Oncogenesis_2014_Mar_3_3(3)_e90.nxml.txt.nlp	24590311	SENT95	31	31	35	35	imatinib	CD34	PA10804	947	0.628
NULL	J_Clin_Biochem_Nutr_2007_Jul_27_41(1)_32-42.nxml.txt.nlp	18392098	SENT146	28	28	24	24	curcumin	ROS	PA151958596	6098	0.628
NULL	Eur_J_Clin_Pharmacol_2008_Feb_26_64(2)_133-157.nxml.txt.nlp	18224312	SENT544	11	11	6	6	trimipramine	CYP2C9	PA451791	1559	0.628
NULL	Diabetes_Care_2011_Mar_17_34(3)_669-674.nxml.txt.nlp	21285389	SENT48	9	9	7	7	metformin	Met	PA450395	79811	0.628
NULL	Arch_Med_Sci_2013_Dec_30_9(6)_990-998.nxml.txt.nlp	24482641	SENT55	19	19	26	26	l-glutamine	CO2	PA10090	4513	0.628
NULL	Adv_Prev_Med_2012_Dec_5_2012_316871.nxml.txt.nlp	23304535	SENT34	20	20	24	24	buprenorphine	OST	PA448685	1650;23263	0.628
NULL	Case_Rep_Oncol_2009_Mar_14_2(1)_53-56.nxml.txt.nlp	20740145	SENT16	11	11	9	9	cyclophosphamide	CHOP	PA449165	1649	0.628
NULL	Org_Med_Chem_Lett_2014_Feb_28_4_1.nxml.txt.nlp	24576663	SENT65	10	10	6	6	ethanol	mol	PA448073	90527	0.628
NULL	Front_Physiol_2013_May_20_4_101.nxml.txt.nlp	23730288	SENT145	38	38	46	46	allopurinol	Met	PA448320	79811	0.628
NULL	Cell_Death_Dis_2010_Nov_4_1(11)_e95.nxml.txt.nlp	21368871	SENT80	5	5	8	8	nadh	NDUFA4	PA164755085	4697	0.628
NULL	Oncol_Rep_2012_Oct_26_28(4)_1139-1145.nxml.txt.nlp	22842551	SENT112	0	0	6	6	urokinase	PLAU	PA451836	5328	0.628
NULL	Breast_Cancer_(Auckl)_2011_Apr_13_5_53-65.nxml.txt.nlp	21603258	SENT254	6	6	10	10	paclitaxel	castor	PA450761	54897	0.628
NULL	Mol_Cancer_2012_Apr_26_11_26.nxml.txt.nlp	22537224	SENT137	25	25	43	43	cisplatin	FANCF	PA449014	2188	0.628
NULL	J_Parasitol_Res_2012_Aug_13_2012_296856.nxml.txt.nlp	22934153	SENT142	9	9	15	15	praziquantel	IL-10	PA164764583	3586	0.628
NULL	ScientificWorldJournal_2014_Feb_6_2014_328513.nxml.txt.nlp	24683330	SENT79	0	0	4	4	midazolam	IL-8	PA450496	3576	0.628
NULL	Sci_Rep_2015_Jan_6_5_7642.nxml.txt.nlp	25560837	SENT902	9	9	6	6	rimonabant	CB1	PA152407999	1268	0.628
NULL	Front_Genet_2012_Nov_5_3_236.nxml.txt.nlp	23133441	SENT131	19	19	12	12	efavirenz	CYP2B6	PA449441	1555	0.628
NULL	J_Appl_Oral_Sci_2010_Nov-Dec_18(6)_630-634.nxml.txt.nlp	21308296	SENT61	39	39	36	36	etoricoxib	KET	PA164776853	8626	0.628
NULL	Inflammation_2014_Apr_6_37(5)_1476-1485.nxml.txt.nlp	24706026	SENT132	1	1	29	29	curcumin	GATA3	PA151958596	2625	0.628
NULL	Oncol_Lett_2013_Mar_11_5(3)_1010-1016.nxml.txt.nlp	23426784	SENT23	12	12	35	35	midazolam	TRPM7	PA450496	54822	0.628
NULL	Clin_Med_Insights_Blood_Disord_2013_Nov_14_6_23-27.nxml.txt.nlp	25512717	SENT21	25	25	30	30	vincristine	CHOP	PA451879	1649	0.628
NULL	Br_J_Pharmacol_2011_Apr_162(8)_1832-1842.nxml.txt.nlp	21232033	SENT253	9	9	6	6	resveratrol	SIRT1		23411	0.628
NULL	Neural_Regen_Res_2014_Mar_1_9(5)_540-548.nxml.txt.nlp	25206852	SENT36	5	5	2	2	choline	HSP27	PA448976	3315	0.628
NULL	Apoptosis_2014_Apr_23_19(7)_1055-1068.nxml.txt.nlp	24756955	SENT13	2	2	26	26	imatinib	EGFR	PA10804	1956	0.628
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT103	11	11	13	13	curcumin	TRAIL	PA151958596	8743	0.628
NULL	J_Cardiothorac_Surg_2012_Sep_27_7_97.nxml.txt.nlp	23013706	SENT117	13	13	3	3	warfarin	CYP4F2	PA451906	8529	0.628
NULL	Oncotarget_2014_Jun_26_5(14)_5559-5569.nxml.txt.nlp	24980819	SENT14	5	5	0	0	vemurafenib	BRAF	PA165946873	673	0.628
NULL	Oncol_Lett_2014_Apr_13_7(4)_1057-1062.nxml.txt.nlp	24944668	SENT157	28	28	7	7	hydroxychloroquine	LC3	PA164777036	84557	0.628
NULL	Mol_Cell_Biochem_2014_Jul_26_396(1-2)_221-228.nxml.txt.nlp	25063218	SENT128	5	5	19	19	resveratrol	c-Myc		4609	0.628
NULL	Oncol_Lett_2015_Jan_4_9(1)_91-95.nxml.txt.nlp	25435939	SENT116	4	4	2	2	paclitaxel	DDP	PA450761	1678	0.628
NULL	Br_J_Cancer_2002_Feb_1_86(3)_490-496.nxml.txt.nlp	11875720	SENT164	7	7	3	3	collagenase	BAI1	PA449107	575	0.628
NULL	Surg_Neurol_Int_2013_Feb_20_4_18.nxml.txt.nlp	23493431	SENT39	6	6	11	11	heparin	ACT	PA449855	12;11332;9457;641455	0.628
NULL	Cerebrospinal_Fluid_Res_2008_May_14_5_10.nxml.txt.nlp	18479516	SENT291	2	2	4	4	vasopressin	AVP	PA451858	114548;551	0.628
NULL	Scientifica_(Cairo)_2012_Dec_17_2012_502378.nxml.txt.nlp	24278706	SENT103	15	15	10	10	dabigatran	P-gp		5243	0.628
NULL	Case_Rep_Nephrol_Urol_2012_May_31_2(1)_38-45.nxml.txt.nlp	23197954	SENT86	11	11	22	22	eculizumab	C5a	PA164776637	727	0.628
NULL	New_Microbes_New_Infect_2014_May_4_2(3)_58-63.nxml.txt.nlp	25356345	SENT100	6	6	8	8	cefoxitin	CTX	PA448856	1593	0.628
NULL	Environ_Health_Perspect_2011_Aug_22_119(8)_1053-1061.nxml.txt.nlp	21697028	SENT432	15	15	19	19	tamoxifen	STAR	PA451581	6770;2984	0.628
NULL	Breast_Cancer_Res_2011_Mar_11_13(2)_R30.nxml.txt.nlp	21396117	SENT272	0	0	9	9	erlotinib	BRCA1	PA134687924	672	0.628
NULL	Diabetes_Metab_Syndr_Obes_2014_Jun_24_7_229-239.nxml.txt.nlp	25018644	SENT9	0	0	7	7	exenatide	GLP-1	PA164749238	100125288	0.628
NULL	Ann_Indian_Acad_Neurol_2009_Apr-Jun_12(2)_89-98.nxml.txt.nlp	20142853	SENT30	26	26	32	32	mitoxantrone	ABCG2	PA450526	9429	0.628
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT202	4	4	39	39	curcumin	CD31	PA151958596	5175	0.628
NULL	Br_J_Cancer_2013_Mar_5_108(4)_887-900.nxml.txt.nlp	23462807	SENT108	39	39	32	32	sunitinib	FGFR2	PA162372840	2263	0.628
NULL	Cancer_Cell_Int_2010_Feb_19_10_3.nxml.txt.nlp	20170512	SENT125	8	8	31	31	tamoxifen	p27	PA451581	5715;10534	0.628
NULL	ScientificWorldJournal_2012_Jan_4_2012_578616.nxml.txt.nlp	22262955	SENT35	1	1	3	3	vasopressin	AVP	PA451858	114548;551	0.628
NULL	Br_J_Cancer_2013_Dec_10_109(12)_2954-2958.nxml.txt.nlp	24231949	SENT59	21	21	26	26	paclitaxel	p53	PA450761	7157	0.627
NULL	J_Am_Heart_Assoc_2013_Dec_19_2(6)_e000355.nxml.txt.nlp	24190878	SENT176	0	0	25	25	isoproterenol	HK2	PA450121	3796;3099;29911;3741	0.627
NULL	Ann_Gen_Psychiatry_2008_Aug_18_7_11.nxml.txt.nlp	18706108	SENT164	7	7	5	5	bupropion	CD50	PA448687	3385	0.627
NULL	Clin_Exp_Reprod_Med_2011_Jun_30_38(2)_98-102.nxml.txt.nlp	22384426	SENT12	24	24	12	12	pioglitazone	IL-6	PA450970	3569	0.627
NULL	Ann_Dermatol_2014_Apr_30_26(2)_221-230.nxml.txt.nlp	24882978	SENT171	8	8	3	3	imiquimod	IL-4	PA449972	3565	0.627
NULL	Genetics_2012_Jul_191(3)_765-780.nxml.txt.nlp	22505622	SENT155	18	18	5	5	ethanol	Tra1	PA448073	8295	0.627
NULL	Cells_2012_Jun_20_1(2)_168-203.nxml.txt.nlp	24710422	SENT212	10	10	21	21	lipase	ATGL	PA450239	57104	0.627
NULL	Mol_Cancer_2007_Mar_7_6_18.nxml.txt.nlp	17343740	SENT245	37	37	16	16	pamidronate	PC3	PA450767	57332;7832;5122	0.627
NULL	Mol_Cancer_2009_Aug_25_8_66.nxml.txt.nlp	19706164	SENT33	0	0	4	4	celecoxib	BAD	PA448871	572	0.627
NULL	Cancer_Med_2014_Jun_8_3(3)_681-692.nxml.txt.nlp	24711160	SENT151	27	27	1	1	paclitaxel	San	PA450761	80218	0.627
NULL	Diabetes_Care_2010_Apr_12_33(4)_861-868.nxml.txt.nlp	20067962	SENT14	17	17	4	4	hyaluronan	TLR4	PA165958431	7099	0.627
NULL	Oncogene_2014_Mar_20_33(12)_1495-1505.nxml.txt.nlp	23604115	SENT339	12	12	18	18	nilotinib	RAD51	PA165958345	5888	0.627
NULL	Int_J_Biomed_Sci_2008_Jun_4(2)_147-154.nxml.txt.nlp	23675082	SENT224	4	4	6	6	captopril	DTNB	PA448780	1838	0.627
NULL	Cancer_Med_2013_Jun_25_2(3)_277-285.nxml.txt.nlp	23930204	SENT195	19	19	16	16	capecitabine	MAX	PA448771	4149	0.627
NULL	Adv_Hematol_2012_Jun_24_2012_857058.nxml.txt.nlp	22778746	SENT46	7	7	9	9	thrombin	PAR-1	PA451674	2011;2149	0.627
NULL	J_Virol_2013_Aug_87(16)_9353-9364.nxml.txt.nlp	23785211	SENT121	27	27	10	10	paraformaldehyde	San	PA450790	80218	0.627
NULL	Calcif_Tissue_Int_2011_Aug_3_89(2)_91-104.nxml.txt.nlp	21637997	SENT181	14	14	18	18	tamoxifen	STAR	PA451581	6770;2984	0.627
NULL	J_Nutr_Metab_2011_Oct_1_2011_525094.nxml.txt.nlp	21977315	SENT145	3	3	5	5	resveratrol	SIRT4		23409	0.627
NULL	Nucleic_Acids_Res_2011_Dec_31_39(22)_9536-9548.nxml.txt.nlp	21880590	SENT168	10	10	16	16	etoposide	BRCA1	PA449552	672	0.627
NULL	Hematol_Rep_2011_Jan_21_3(1)_e2.nxml.txt.nlp	22184524	SENT44	18	18	16	16	moxifloxacin	MOF	PA450555	84148	0.627
NULL	Animal_2010_Jul_21_4(7)_1227-1239.nxml.txt.nlp	20582145	SENT140	12	12	19	19	diethylstilbestrol	PCB	PA449307	5091	0.627
NULL	Front_Oncol_2014_Jun_12_4_144.nxml.txt.nlp	24971229	SENT59	2	2	27	27	cisplatin	MLH1	PA449014	4292	0.627
NULL	Braz_J_Med_Biol_Res_2012_Apr_27_45(6)_510-516.nxml.txt.nlp	22527124	SENT69	0	0	2	2	doxorubicin	ADM	PA449412	133	0.627
NULL	Br_J_Cancer_2004_Mar_22_90(6)_1285-1292.nxml.txt.nlp	15026814	SENT142	20	20	27	27	doxorubicin	p53	PA449412	7157	0.627
NULL	Cardiovasc_Diabetol_2006_Sep_26_5_20.nxml.txt.nlp	17002798	SENT210	24	24	0	0	simvastatin	mol	PA451363	90527	0.627
NULL	J_Hematol_Oncol_2013_Dec_17_6_93.nxml.txt.nlp	24341609	SENT149	25	25	21	21	gefitinib	EGFR	PA131301952	1956	0.627
NULL	Crit_Care_2010_Jul_9_14(4)_R131.nxml.txt.nlp	20615266	SENT67	7	7	9	9	vasopressin	AVP	PA451858	114548;551	0.627
NULL	Br_J_Cancer_2010_Jun_29_103(1)_61-72.nxml.txt.nlp	20588279	SENT257	25	25	21	21	trastuzumab	RhoB	PA451743	388	0.627
NULL	Cent_European_J_Urol_2011_Dec_9_64(4)_256-257.nxml.txt.nlp	24578906	SENT62	20	20	14	14	doxazosin	CD133	PA449407	8842	0.627
NULL	J_Adv_Pract_Oncol_2013_Sep_1_Sep-Oct_4(5)_307-321.nxml.txt.nlp	25032010	SENT49	14	14	0	0	bortezomib	San	PA10252	80218	0.627
NULL	J_Infect_Dis_2013_Sep_1_208(5)_801-812.nxml.txt.nlp	23766527	SENT113	16	16	4	4	amodiaquine	LUM	PA448404	4060	0.627
NULL	Mol_Cancer_2014_Jun_12_13_148.nxml.txt.nlp	24924916	SENT145	3	3	16	16	oxygen	CHOP	PA450744	1649	0.627
NULL	Int_J_Biol_Sci_2014_Apr_8_10(4)_457-465.nxml.txt.nlp	24719563	SENT133	6	6	12	12	genistein	Bcl-2	PA165109660	596	0.627
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT31	33	33	15	15	atorvastatin	survivin	PA448500	332	0.627
NULL	Curr_Pharm_Des_2011_Feb_17(6)_578-590.nxml.txt.nlp	21391908	SENT181	2	2	26	26	nutlin-3	E2F1		1869	0.627
NULL	Lab_Invest_2009_Dec_19_89(12)_1397-1409.nxml.txt.nlp	19841616	SENT214	0	0	22	22	curcumin	JNK	PA151958596	5599	0.627
NULL	J_Hematol_Oncol_2009_Oct_27_2_45.nxml.txt.nlp	19860903	SENT116	6	6	2	2	temsirolimus	IFN	PA164746890	3439	0.627
NULL	Diabetes_Care_2010_Jul_31_33(7)_1509-1515.nxml.txt.nlp	20357372	SENT130	28	28	16	16	metformin	GLP-1	PA450395	100125288	0.627
NULL	Clinics_(Sao_Paulo)_2009_May_64(5)_409-414.nxml.txt.nlp	19488606	SENT22	24	24	21	21	vasopressin	AVP	PA451858	114548;551	0.627
NULL	Aging_(Albany_NY)_2012_Aug_31_4(8)_567-577.nxml.txt.nlp	22948034	SENT82	23	23	41	41	l-glutamine	CO2	PA10090	4513	0.627
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT166	6	6	28	28	atorvastatin	JNK	PA448500	5599	0.627
NULL	Indian_J_Endocrinol_Metab_2013_Jul-Aug_17(4)_636-646.nxml.txt.nlp	23961479	SENT76	21	21	16	16	cyclosporine	CYP3A4	PA449167	1576	0.627
NULL	Int_J_Chron_Obstruct_Pulmon_Dis_2007_Dec_2(4)_409-428.nxml.txt.nlp	18268916	SENT132	11	11	5	5	thrombin	SERPINE2	PA451674	5270	0.627
NULL	Summit_on_Translat_Bioinforma_2009_Mar_1_2009_124-128.nxml.txt.nlp	21347183	SENT69	24	24	26	26	mercaptopurine	TPMT	PA450379	7172	0.627
NULL	Case_Rep_Oncol_Med_2014_May_15_2014_608585.nxml.txt.nlp	24959365	SENT67	0	0	4	4	letrozole	aromatase	PA450196	1588	0.627
NULL	J_Inflamm_(Lond)_2008_Feb_27_5_3.nxml.txt.nlp	18304343	SENT50	35	35	13	13	l-glutamine	F12	PA10090	2161	0.627
NULL	Case_Rep_Dent_2013_Jun_13_2013_852932.nxml.txt.nlp	23840974	SENT60	11	11	9	9	cyclophosphamide	CHOP	PA449165	1649	0.627
NULL	Front_Immunol_2013_May_13_4_111.nxml.txt.nlp	23717309	SENT88	35	35	15	15	thrombin	IL-4	PA451674	3565	0.627
NULL	J_Mol_Signal_2006_Dec_6_1_8.nxml.txt.nlp	17224083	SENT128	31	31	34	34	thrombin	Rho	PA451674	29984	0.627
NULL	Clinics_(Sao_Paulo)_2012_Aug_67(8)_885-890.nxml.txt.nlp	22948454	SENT126	23	23	31	31	creatine	ADM	PA164778930	133	0.627
NULL	Aging_Cell_2007_Aug_6(4)_577-591.nxml.txt.nlp	17578512	SENT76	20	20	9	9	tetracycline	HDAC1	PA451640	3065	0.627
NULL	F1000Res_2014_Mar_31_3_81.nxml.txt.nlp	24795809	SENT38	21	21	24	24	clindamycin	TDI	PA449035	100038246	0.627
NULL	Can_J_Infect_Dis_Med_Microbiol_2014_May-Jun_25(3)_163-169.nxml.txt.nlp	25285114	SENT221	14	14	26	26	levofloxacin	TOB	PA450214	10140	0.627
NULL	Environ_Health_Perspect_2010_Oct_118(10)_A452a.nxml.txt.nlp	NULL	SENT13	10	10	12	12	diethylstilbestrol	DES	PA449307	1674	0.627
NULL	Pak_J_Med_Sci_2013_May-Jun_29(3)_768-772.nxml.txt.nlp	24353625	SENT38	19	19	9	9	cefotaxime	hole	PA448852	80757	0.627
NULL	Indian_J_Pharmacol_2014_Nov-Dec_46(6)_627-632.nxml.txt.nlp	25538335	SENT170	37	37	30	30	metformin	Q10	PA450395	27161	0.627
NULL	Br_J_Anaesth_2014_Jul_22_113(1)_157-167.nxml.txt.nlp	24154701	SENT208	0	0	5	5	sevoflurane	TREK-1	PA451341	3776	0.627
NULL	Gut_Pathog_2014_Jul_29_6_33.nxml.txt.nlp	25110521	SENT268	0	0	29	29	fluorescein	CD103	PA164746009	3682	0.627
NULL	Int_J_Chron_Obstruct_Pulmon_Dis_2006_Dec_1(4)_373-379.nxml.txt.nlp	18044094	SENT109	6	6	14	14	cilomilast	PDE4D	PA165948031	5144	0.627
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT435	21	21	24	24	risperidone	PRL	PA451257	5617	0.627
NULL	Diabetes_Care_2013_Jul_12_36(7)_1941-1946.nxml.txt.nlp	23393209	SENT211	25	25	14	14	metformin	SLC22A3	PA450395	6581	0.627
NULL	Oncotarget_2014_Aug_29_5(19)_8947-8958.nxml.txt.nlp	25333254	SENT54	0	0	9	9	plerixafor	CXCR4	PA165958410	7852	0.627
NULL	Open_Ophthalmol_J_2011_Dec_19_5_59-62.nxml.txt.nlp	22216076	SENT10	0	0	6	6	ranibizumab	San	PA164746012	80218	0.627
NULL	Mol_Clin_Oncol_2013_Sep_24_1(5)_918-924.nxml.txt.nlp	24649271	SENT58	42	42	22	22	cetuximab	CO2	PA10040	4513	0.627
NULL	Indian_J_Psychiatry_2010_Jan_52(Suppl1)_S317-S340.nxml.txt.nlp	21836703	SENT119	26	26	15	15	triflupromazine	TFP	PA451773	7034	0.627
NULL	Environ_Health_Perspect_2009_Jan_22_117(1)_112-116.nxml.txt.nlp	19165396	SENT16	29	29	31	31	vasopressin	AVP	PA451858	114548;551	0.627
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1676-1682.nxml.txt.nlp	19844234	SENT14	17	17	12	12	lapatinib	PTEN	PA152241907	5728	0.627
NULL	Oncotarget_2014_Jun_1_5(13)_4868-4880.nxml.txt.nlp	24947902	SENT336	7	7	24	24	fluorouracil	ERBB2	PA128406956	2064	0.627
NULL	Arthritis_Res_Ther_2003_Dec_2_5(Suppl_4)_S12-S16.nxml.txt.nlp	15180892	SENT78	11	11	13	13	rituximab	CHOP	PA451261	1649	0.627
NULL	Crit_Care_2011_Aug_11_15(4)_226.nxml.txt.nlp	21892977	SENT71	20	20	17	17	vasopressin	SPC3	PA451858	60559;5122	0.627
NULL	Cancer_Cell_Int_2011_Nov_17_11_40.nxml.txt.nlp	22088142	SENT155	0	0	11	11	doxorubicin	MRP2	PA449412	100130958;57626;1244	0.627
NULL	Gut_2013_Feb_28_62(2)_259-271.nxml.txt.nlp	22543158	SENT503	7	7	19	19	pazopanib	HER2	PA165291492	2064	0.627
NULL	Biochemistry_2013_Oct_15_52(41)_7167-7169.nxml.txt.nlp	24083983	SENT34	20	20	6	6	cyclosporine	P-gp	PA449167	5243	0.627
NULL	Breast_Cancer_Res_2012_Mar_15_14(2)_R47.nxml.txt.nlp	22420423	SENT133	9	9	18	18	mitomycin	TP53	PA450524	7157	0.627
NULL	Nucleic_Acids_Res_2013_Nov_22_41(21)_9825-9838.nxml.txt.nlp	23969415	SENT70	25	25	22	22	l-serine	Met	PA451330	79811	0.627
NULL	Mol_Vis_2011_Dec_15_17_3254-3261.nxml.txt.nlp	22194651	SENT19	1	1	3	3	vasopressin	AVP	PA451858	114548;551	0.627
NULL	Br_J_Cancer_2006_Feb_13_94(3)_407-426.nxml.txt.nlp	16434996	SENT313	16	16	7	7	genistein	BRCA2	PA165109660	675	0.627
NULL	Environ_Health_Perspect_2008_Mar_11_116(3)_297-302.nxml.txt.nlp	18335094	SENT133	25	25	34	34	permethrin	OTC	PA164743137	5009	0.627
NULL	J_Korean_Med_Sci_2014_Jul_11_29(7)_965-972.nxml.txt.nlp	25045229	SENT169	15	15	4	4	metformin	B12	PA450395	7126;4709	0.627
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT245	8	8	10	10	pertuzumab	HER3		2065	0.627
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT83	30	30	6	6	celecoxib	IL-6	PA448871	3569	0.627
NULL	Cancer_Manag_Res_2014_Oct_4_6_397-404.nxml.txt.nlp	25328417	SENT77	0	0	9	9	erlotinib	KRAS	PA134687924	3845	0.627
NULL	Indian_J_Anaesth_2014_Jul-Aug_58(4)_423-429.nxml.txt.nlp	25197110	SENT43	27	27	7	7	ondansetron	ODF	PA450705	8600	0.627
NULL	Exp_Lung_Res_2013_Oct_1_39(8)_336-348.nxml.txt.nlp	23919450	SENT108	23	23	18	18	argatroban	PAR-1	PA164745516	2011;2149	0.627
NULL	Oxid_Med_Cell_Longev_2012_Nov_28_2012_162934.nxml.txt.nlp	23251719	SENT71	9	9	4	4	diazepam	TSPO	PA449283	706	0.627
NULL	Biomed_Res_Int_2013_Jul_18_2013_487610.nxml.txt.nlp	23971039	SENT167	9	9	1	1	indomethacin	ANOVA	PA449982	4858	0.627
NULL	Acta_Pharmacol_Sin_2010_Jul_28_31(7)_867-873.nxml.txt.nlp	20581857	SENT40	21	21	23	23	docetaxel	PC3	PA449383	57332;7832;5122	0.627
NULL	Ann_Thorac_Med_2014_Apr-Jun_9(2)_124-126.nxml.txt.nlp	24791177	SENT80	3	3	14	14	sirolimus	LAM	PA451365	7249;7248	0.627
NULL	Exp_Ther_Med_2014_Nov_17_8(5)_1484-1488.nxml.txt.nlp	25289046	SENT152	9	9	7	7	cisplatin	DDP	PA449014	1678	0.627
NULL	Int_J_Breast_Cancer_2013_Jun_24_2013_137414.nxml.txt.nlp	23864953	SENT254	34	34	36	36	bevacizumab	HER-2	PA130232992	2064	0.627
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jan_28_65(Pt_2)_o410.nxml.txt.nlp	21582002	SENT55	25	25	21	21	ethanol	mol	PA448073	90527	0.627
NULL	Stroke_Res_Treat_2011_Nov_10_2011_212485.nxml.txt.nlp	22135769	SENT146	35	35	28	28	clopidogrel	ABCB1	PA449053	5243	0.627
NULL	Eur_J_Clin_Microbiol_Infect_Dis_2010_Nov_1_29(11)_1361-1367.nxml.txt.nlp	20680368	SENT106	2	2	4	4	linezolid	VAN	PA450233	10318	0.627
NULL	Breast_Cancer_Res_2012_Mar_16_14(2)_206.nxml.txt.nlp	22423895	SENT181	15	15	17	17	estradiol	FES	PA449503	2242	0.627
NULL	J_Mol_Signal_2010_May_10_5_4.nxml.txt.nlp	20459745	SENT117	15	15	10	10	cisplatin	p53	PA449014	7157	0.627
NULL	Mol_Vis_2007_Jul_9_13_1073-1082.nxml.txt.nlp	17653052	SENT209	10	10	21	21	minocycline	P14	PA450519	11102;;6280;56259	0.627
NULL	Curr_Control_Trials_Cardiovasc_Med_2001_Nov_3_2(6)_257-259.nxml.txt.nlp	11806808	SENT33	11	11	13	13	vasopressin	AVP	PA451858	114548;551	0.627
NULL	J_Community_Hosp_Intern_Med_Perspect_2012_Oct_15_2(3)_10_3402_jchimp_v2i3_19081.nxml.txt.nlp	23882374	SENT65	0	0	4	4	exenatide	GLP-1	PA164749238	100125288	0.627
NULL	Infect_Dis_Obstet_Gynecol_2012_Nov_29_2012_543916.nxml.txt.nlp	23251074	SENT80	30	30	22	22	lopinavir	CD4	PA450264	920	0.627
NULL	Front_Neurosci_2014_Jun_24_8_176.nxml.txt.nlp	25009459	SENT337	7	7	13	13	ethanol	P2X2	PA448073	22953	0.627
NULL	J_Antimicrob_Chemother_2013_May_1_68(5)_1066-1070.nxml.txt.nlp	23378414	SENT71	2	2	31	31	oxacillin	NOV	PA450725	4856;5361;6134	0.627
NULL	Clin_Med_Insights_Oncol_2013_May_20_7_87-102.nxml.txt.nlp	23761989	SENT146	0	0	6	6	bevacizumab	San	PA130232992	80218	0.627
NULL	F1000Prime_Rep_2014_Dec_1_6_112.nxml.txt.nlp	25580266	SENT185	7	7	26	26	anakinra	IL-23	PA10799	51561	0.627
NULL	Mol_Cancer_2010_Mar_9_9_54.nxml.txt.nlp	20214788	SENT270	3	3	18	18	tetracycline	LAP	PA451640	1051;51056;55835	0.627
NULL	J_Antimicrob_Chemother_2009_Jun_28_63(6)_1233-1243.nxml.txt.nlp	19329800	SENT87	20	20	14	14	ritonavir	ATV	PA451260	4683	0.627
NULL	Emerg_Infect_Dis_2013_Jan_19(1)_133-136.nxml.txt.nlp	23260464	SENT49	47	47	9	9	tetracycline	TOB	PA451640	10140	0.627
NULL	Comput_Math_Methods_Med_2014_May_8_2014_203871.nxml.txt.nlp	24899916	SENT104	18	18	16	16	nadh	ND6	PA164755085	4541	0.627
NULL	Med_Sci_Monit_2012_Jun_1_18(6)_BR208-BR214.nxml.txt.nlp	22648241	SENT216	26	26	12	12	nitrile	NAC	PA450636	22861	0.627
NULL	Crit_Care_2010_Nov_5_14(6)_R200.nxml.txt.nlp	21054850	SENT21	1	1	3	3	vasopressin	AVP	PA451858	114548;551	0.627
NULL	Br_J_Cancer_2012_Jan_17_106(2)_284-289.nxml.txt.nlp	22215065	SENT115	36	36	41	41	atrasentan	IFN	PA143414738	3439	0.627
NULL	Int_J_Cell_Biol_2013_Sep_12_2013_153634.nxml.txt.nlp	24159334	SENT40	11	11	18	18	cisplatin	MDM4	PA449014	4194	0.627
NULL	Springerplus_2014_Sep_9_3_510.nxml.txt.nlp	25279302	SENT212	6	6	27	27	creatine	SLC6A8	PA164778930	6535	0.627
NULL	Mol_Vis_2012_Jul_18_18_1966-1972.nxml.txt.nlp	22876123	SENT148	5	5	25	25	curcumin	IL-5	PA151958596	3567	0.627
NULL	Clin_Interv_Aging_2013_Feb_5_8_131-137.nxml.txt.nlp	23403474	SENT49	43	43	21	21	thyroglobulin	B12	PA164754910	7126;4709	0.627
NULL	J_Immunol_Res_2014_Feb_9_2014_897487.nxml.txt.nlp	24741630	SENT20	8	8	16	16	heparin	TLR7	PA449855	51284	0.627
NULL	Oncotarget_2014_Feb_25_5(5)_1304-1314.nxml.txt.nlp	24675421	SENT53	1	1	9	9	cisplatin	JNK	PA449014	5599	0.627
NULL	Nat_Med_2011_Dec_11_18(1)_74-82.nxml.txt.nlp	22157681	SENT237	19	19	15	15	gefitinib	APAF-1	PA131301952	317	0.627
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT170	14	14	4	4	trastuzumab	HER3	PA451743	2065	0.627
NULL	Diabetes_Metab_J_2014_Jun_17_38(3)_230-239.nxml.txt.nlp	25003077	SENT175	8	8	20	20	metformin	GLP-1	PA450395	100125288	0.627
NULL	Blood_Res_2014_Dec_23_49(4)_279-280.nxml.txt.nlp	25548764	SENT24	18	18	10	10	lenalidomide	CD86	PA162363968	942	0.627
NULL	EMBO_Rep_2013_Dec_18_14(12)_1113-1119.nxml.txt.nlp	24136413	SENT249	17	17	8	8	spermine	TPO1	PA164781199	256987	0.627
NULL	Pharm_Pract_(Granada)_2011_Mar_15_Jan-Mar_9(1)_1-10.nxml.txt.nlp	25132883	SENT125	11	11	23	23	dabigatran	SPAF		166378	0.627
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT102	9	9	15	15	nutlin-3	MDM2		4193	0.627
NULL	Comp_Hepatol_2004_Jan_14_3(Suppl_1)_S37.nxml.txt.nlp	14960189	SENT111	36	36	5	5	ethanol	TNF-alpha	PA448073	7124	0.627
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Mar_26_3(3)_e107.nxml.txt.nlp	24670388	SENT28	27	27	11	11	midazolam	CYP3A	PA450496	1574	0.627
NULL	Int_J_Mol_Sci_2012_Apr_23_13(4)_5060-5073.nxml.txt.nlp	22606030	SENT7	21	21	5	5	artemisinin	ANOVA	PA165111696	4858	0.627
NULL	J_Carcinog_2012_Feb_17_11_4.nxml.txt.nlp	22438770	SENT182	9	9	22	22	estradiol	MMP2	PA449503	4313	0.627
NULL	Nat_Commun_2014_Aug_4_5_4535.nxml.txt.nlp	25088745	SENT28	17	17	14	14	metformin	AMPK	PA450395	5563	0.627
NULL	Colorectal_Dis_2012_Feb_14(2)_e31-e47.nxml.txt.nlp	21848897	SENT121	21	21	27	27	cetuximab	KRAS	PA10040	3845	0.627
NULL	Onco_Targets_Ther_2014_Sep_9_7_1571-1582.nxml.txt.nlp	25228815	SENT143	7	7	12	12	sunitinib	VEGFR2	PA162372840	3791	0.627
NULL	Iran_J_Basic_Med_Sci_2013_Apr_16(4)_610-614.nxml.txt.nlp	24250937	SENT32	31	31	40	40	coumarin	CYP2A6	PA134521193	1548	0.627
NULL	EMBO_Mol_Med_2012_Apr_4(4)_298-312.nxml.txt.nlp	22331558	SENT164	24	24	13	13	etoposide	p53	PA449552	7157	0.627
NULL	Front_Oncol_2014_Apr_8_4_71.nxml.txt.nlp	24782983	SENT253	28	28	18	18	paclitaxel	MDR1	PA450761	5243	0.627
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1051.nxml.txt.nlp	24503543	SENT144	12	12	27	27	sunitinib	Yes	PA162372840	7525	0.627
NULL	Osong_Public_Health_Res_Perspect_2014_Dec_13_5(6)_333-338.nxml.txt.nlp	25562041	SENT207	22	22	8	8	imipenem	CTX	PA449968	1593	0.627
NULL	Biochemistry_2013_Aug_13_52(32)_5403-5414.nxml.txt.nlp	23865508	SENT108	27	27	24	24	vasopressin	GPR35	PA451858	2859	0.627
NULL	Aging_(Albany_NY)_2009_Apr_21_1(4)_402-411.nxml.txt.nlp	20148189	SENT115	30	30	9	9	bleomycin	IL-6	PA448645	3569	0.627
NULL	Clin_Ophthalmol_2012_Oct_30_6_1749-1753.nxml.txt.nlp	23152652	SENT58	19	19	27	27	travoprost	ANOVA	PA164781371	4858	0.627
NULL	Anesth_Essays_Res_2012_Jan-Jun_6(1)_62-69.nxml.txt.nlp	NULL	SENT150	21	21	17	17	rocuronium	TOF	PA164754992	55079	0.627
NULL	Int_J_Hypertens_2012_Feb_1_2012_859235.nxml.txt.nlp	22518295	SENT293	25	25	22	22	cisplatin	HO-1	PA449014	3162	0.627
NULL	Case_Rep_Nephrol_2013_Nov_20_2013_801575.nxml.txt.nlp	24558627	SENT6	9	9	11	11	vasopressin	AVP	PA451858	114548;551	0.627
NULL	Pak_J_Med_Sci_2013_Nov-Dec_29(6)_1459-1461.nxml.txt.nlp	24550976	SENT67	8	8	11	11	heparin	ACT	PA449855	12;11332;9457;641455	0.627
NULL	Ann_Rehabil_Med_2012_Oct_31_36(5)_633-639.nxml.txt.nlp	23185727	SENT46	33	33	11	11	lidocaine	SGB	PA450226	2719	0.627
NULL	Exp_Hematol_Oncol_2013_Jul_1_2_17.nxml.txt.nlp	23815814	SENT70	17	17	3	3	camptothecin	CD133	PA153590860	8842	0.627
NULL	Case_Rep_Pathol_2014_Jul_15_2014_313974.nxml.txt.nlp	25133003	SENT184	33	33	20	20	thyroglobulin	CK7	PA164754910	3855	0.627
NULL	Br_J_Cancer_2011_Nov_22_105(11)_1635-1639.nxml.txt.nlp	22033275	SENT123	4	4	13	13	bevacizumab	IFN	PA130232992	3439	0.627
NULL	Cells_2014_Apr_8_3(2)_258-287.nxml.txt.nlp	24717323	SENT299	2	2	8	8	capsaicin	TRPV1	PA448776	7442	0.627
NULL	Int_J_Mol_Sci_2012_Apr_16_13(4)_4831-4838.nxml.txt.nlp	22606012	SENT33	0	0	12	12	curcumin	p65	PA151958596	5970	0.627
NULL	J_Adv_Pharm_Technol_Res_2011_Oct-Dec_2(4)_215-222.nxml.txt.nlp	22247888	SENT157	10	10	16	16	ciprofloxacin	HEC	PA449009	10403	0.627
NULL	Acta_Pharmacol_Sin_2010_Jul_28_31(7)_867-873.nxml.txt.nlp	20581857	SENT113	17	17	19	19	docetaxel	PC3	PA449383	57332;7832;5122	0.627
NULL	Front_Psychol_2013_Oct_17_4_712.nxml.txt.nlp	24151474	SENT10	20	20	22	22	vasopressin	AVP	PA451858	114548;551	0.627
NULL	ACS_Med_Chem_Lett_2014_Mar_13_5(3)_214-220.nxml.txt.nlp	24672647	SENT60	40	40	14	14	ribavirin	IFN	PA451241	3439	0.627
NULL	J_Int_Soc_Sports_Nutr_2010_Oct_27_7_34.nxml.txt.nlp	20979623	SENT37	15	15	17	17	lipase	HTGL	PA450239	3990	0.627
NULL	Crit_Care_2007_Jun_28_11(3)_145.nxml.txt.nlp	17610749	SENT8	43	43	7	7	etomidate	Ray	PA164743987	26751	0.627
NULL	Biologics_2012_Dec_17_6_429-464.nxml.txt.nlp	23269860	SENT183	2	2	31	31	etanercept	ACR	PA449515	49	0.627
NULL	Curr_Neuropharmacol_2009_Jun_7(2)_83-95.nxml.txt.nlp	19949566	SENT474	22	22	32	32	oxcarbazepine	TGB	PA450732	5473	0.627
NULL	Cell_Death_Differ_2010_Mar_16_17(3)_499-512.nxml.txt.nlp	19834490	SENT156	11	11	17	17	bevacizumab	VEGFR1	PA130232992	2321	0.627
NULL	Orthop_J_Sports_Med_2014_May_1_2(5)_http_ojs_sagepub_com_content_2_5_2325967114529537_full.nxml.txt.nlp	25401118	SENT89	25	25	21	21	ketorolac	ACL	PA450150	47	0.627
NULL	Front_Physiol_2013_May_15_4_103.nxml.txt.nlp	23720630	SENT99	12	12	15	15	simvastatin	ADP	PA451363	23038	0.627
NULL	Int_J_Environ_Res_Public_Health_2014_Aug_6_11(8)_7918-7930.nxml.txt.nlp	25101772	SENT286	0	0	7	7	lidocaine	spatial	PA450226	219793	0.627
NULL	Arthritis_Res_Ther_2011_Mar_16_13(2)_R44.nxml.txt.nlp	21410959	SENT201	0	0	3	3	glucosamine	RANKL	PA164747613	8600	0.627
NULL	J_Gen_Physiol_2010_Jul_136(1)_117.nxml.txt.nlp	NULL	SENT49	5	5	7	7	trimethoprim	TMP	PA451788	2012	0.627
NULL	Curr_Med_Chem_2013_Apr_20(10)_1241-1285.nxml.txt.nlp	23409712	SENT1006	14	14	6	6	amiloride	TRPC1	PA448368	7220	0.627
NULL	Biologics_2014_Dec_4_8_281-291.nxml.txt.nlp	25506209	SENT58	34	34	21	21	sorafenib	FLT3	PA7000	2322	0.627
NULL	Bioinformatics_2014_Jan_1_30(1)_50-60.nxml.txt.nlp	24177718	SENT391	7	7	38	38	temozolomide	PDGFRA	PA451609	5156	0.627
NULL	NDT_Plus_2009_Nov_2(Suppl_3)_iii5-iii11.nxml.txt.nlp	19881934	SENT151	9	9	6	6	vasopressin	AVP	PA451858	114548;551	0.627
NULL	Exp_Ther_Med_2013_Jun_9_5(6)_1765-1769.nxml.txt.nlp	23837070	SENT137	20	20	12	12	fluvastatin	GAPDH	PA449688	2597	0.627
NULL	Behav_Brain_Res_2010_Dec_1_213(2)_269-277.nxml.txt.nlp	20570596	SENT254	3	3	5	5	midazolam	c-fos	PA450496	2353	0.627
NULL	Br_J_Cancer_2003_Mar_10_88(5)_648-653.nxml.txt.nlp	12659110	SENT156	11	11	29	29	capecitabine	A-2	PA448771	27239	0.627
NULL	Oncotarget_2010_Oct_15_1(7)_515-529.nxml.txt.nlp	21317448	SENT88	8	8	18	18	gemcitabine	EGFR	PA449748	1956	0.627
NULL	Int_J_Vasc_Med_2012_Feb_14_2012_569654.nxml.txt.nlp	22489274	SENT93	43	43	28	28	l-arginine	adiponectin	PA448478	9370	0.627
NULL	Cardiovasc_Drugs_Ther_2012_Oct_12_26(5)_417-426.nxml.txt.nlp	22968678	SENT59	6	6	4	4	metformin	AMPK	PA450395	5563	0.627
NULL	Crit_Care_2009_Jul_10_13(4)_R113.nxml.txt.nlp	19591694	SENT155	17	17	7	7	vasopressin	AVP	PA451858	114548;551	0.627
NULL	Breast_Cancer_Res_2010_May_18_12(Suppl_1)_P58.nxml.txt.nlp	NULL	SENT11	14	14	4	4	doxorubicin	TRAIL-R2	PA449412	8795	0.627
NULL	Pharmaceuticals_(Basel)_2011_May_24_4(5)_770-781.nxml.txt.nlp	NULL	SENT113	5	5	20	20	carvedilol	IL-10	PA448817	3586	0.627
NULL	J_Cell_Biol_1997_Mar_10_136(5)_995-1005.nxml.txt.nlp	9060465	SENT46	5	5	2	2	trifluoperazine	CPZ	PA451771	8532	0.627
NULL	Breast_Cancer_Res_Treat_2013_Oct_12_142(1)_69-80.nxml.txt.nlp	24122389	SENT149	11	11	0	0	docetaxel	STEPP	PA449383	222659	0.627
NULL	Chem_Cent_J_2012_May_11_6_41.nxml.txt.nlp	22578215	SENT47	6	6	8	8	naringin	castor	PA151958360	54897	0.627
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1067-1070.nxml.txt.nlp	21386841	SENT81	26	26	20	20	cisplatin	STZ	PA449014	6484	0.627
NULL	J_Thromb_Haemost_2014_Jul_19_12(7)_1054-1065.nxml.txt.nlp	24766850	SENT207	1	1	16	16	thrombin	FVIII	PA451674	2157	0.627
NULL	Acta_Pharmacol_Sin_2011_Oct_5_32(10)_1276-1284.nxml.txt.nlp	21970838	SENT35	5	5	2	2	troleandomycin	KET	PA127840611	8626	0.627
NULL	J_Exp_Med_1977_Dec_1_146(6)_1484-1499.nxml.txt.nlp	925610	SENT6	7	7	18	18	trypsin	C42	PA451806	51654	0.627
NULL	Cancer_Manag_Res_2011_Aug_10_3_273-285.nxml.txt.nlp	21931501	SENT211	12	12	14	14	bevacizumab	IFN	PA130232992	3439	0.627
NULL	Gut_2011_Sep_8_60(9)_1284-1293.nxml.txt.nlp	21303914	SENT86	16	16	4	4	ribavirin	IFN	PA451241	3439	0.627
NULL	Int_J_Environ_Res_Public_Health_2011_Mar_1_8(3)_683-697.nxml.txt.nlp	21556173	SENT267	2	2	8	8	cyclophosphamide	CD25	PA449165	3669;3559	0.627
NULL	Mol_Cancer_2013_Mar_2_12_16.nxml.txt.nlp	23452820	SENT107	40	40	20	20	chloroquine	NOXA	PA448948	5366	0.627
NULL	Autoimmun_Rev_2014_Sep_13(9)_909-916.nxml.txt.nlp	24833504	SENT229	15	15	22	22	abatacept	CD86	PA164747080	942	0.627
NULL	Aging_(Albany_NY)_2009_May_22_1(6)_557-572.nxml.txt.nlp	20195383	SENT2	19	19	8	8	creatine	gamma	PA164778930	9913	0.627
NULL	Diabetes_Metab_Syndr_Obes_2014_Jun_24_7_229-239.nxml.txt.nlp	25018644	SENT147	5	5	1	1	exenatide	GLP-1	PA164749238	100125288	0.627
NULL	Arthritis_Res_Ther_2005_May_18_7(Suppl_3)_S13-S18.nxml.txt.nlp	15960817	SENT92	6	6	0	0	methotrexate	CTX	PA450428	1593	0.627
NULL	Extremophiles_2009_Nov_23_13(6)_885-894.nxml.txt.nlp	19701714	SENT136	23	23	31	31	ethanol	mol	PA448073	90527	0.627
NULL	Pain_2014_Nov_155(11)_2306-2322.nxml.txt.nlp	25168672	SENT973	6	6	8	8	retigabine	LOX	PA144997862	4015	0.627
NULL	Anc_Sci_Life_2012_Jul-Sep_32(1)_11-15.nxml.txt.nlp	23929987	SENT150	22	22	24	24	scopolamine	spatial	PA451308	219793	0.627
NULL	J_Cell_Biol_2003_Dec_22_163(6)_1219-1230.nxml.txt.nlp	14676306	SENT82	16	16	39	39	lipase	cPLA2	PA450239	10524	0.627
NULL	Exp_Ther_Med_2014_Sep_23_8(3)_935-942.nxml.txt.nlp	25120627	SENT26	14	14	34	34	mitomycin	CO2	PA450524	4513	0.627
NULL	Gene_Ther_2011_Jul_17_18(7)_637-645.nxml.txt.nlp	21412286	SENT130	33	33	44	44	diazepam	ERG	PA449283	2078	0.627
NULL	Expert_Rev_Mol_Med_2009_May_11_e16.nxml.txt.nlp	19467172	SENT449	14	14	34	34	artesunate	NAC	PA165111697	22861	0.627
NULL	Basic_Clin_Pharmacol_Toxicol_2013_Feb_5_112(2)_132-137.nxml.txt.nlp	22900583	SENT54	26	26	32	32	midazolam	CYP2C9	PA450496	1559	0.627
NULL	Angiogenesis_2010_Dec_7_13(4)_305-315.nxml.txt.nlp	20927579	SENT242	19	19	14	14	resveratrol	TSP1		7057	0.627
NULL	Br_J_Cancer_2012_Aug_7_107(4)_739-747.nxml.txt.nlp	22782350	SENT98	16	16	22	22	lipase	PEX5	PA450239	5830	0.627
NULL	Int_J_Biol_Sci_2012_Feb_9_8(3)_310-327.nxml.txt.nlp	22355267	SENT143	6	6	11	11	simvastatin	PCSK9	PA451363	255738	0.627
NULL	New_Microbes_New_Infect_2014_May_4_2(3)_58-63.nxml.txt.nlp	25356345	SENT100	22	22	20	20	gentamicin	GEM	PA449753	2669	0.627
NULL	Clin_Interv_Aging_2011_Mar_28_6_89-99.nxml.txt.nlp	21594000	SENT290	10	10	3	3	denosumab	RANKL	PA166048634	8600	0.627
NULL	Oncogene_2010_Jul_22_29(29)_4170-4182.nxml.txt.nlp	20498638	SENT122	14	14	10	10	cetuximab	EGFR	PA10040	1956	0.627
NULL	Arch_Med_Sci_2011_Dec_31_7(6)_977-983.nxml.txt.nlp	22328880	SENT138	2	2	20	20	heparin	PAPP-A	PA449855	5069	0.627
NULL	Cell_Cycle_2012_Dec_1_11(23)_4474-4483.nxml.txt.nlp	23159862	SENT109	6	6	20	20	etoposide	GAPDH	PA449552	2597	0.627
NULL	Apoptosis_2014_Aug_26_19(11)_1603-1615.nxml.txt.nlp	25156145	SENT159	2	2	0	0	mitomycin	TRAIL	PA450524	8743	0.627
NULL	Br_J_Cancer_2012_Sep_4_107(6)_977-987.nxml.txt.nlp	22892389	SENT31	11	11	28	28	cerulenin	HIF-1	PA164764551	29072	0.627
NULL	Biosci_Rep_2012_Apr_1_32(Pt_2)_105-112.nxml.txt.nlp	22115362	SENT129	2	2	9	9	infliximab	p65	PA452639	5970	0.627
NULL	Arthritis_Res_Ther_2006_Apr_13_8(3)_R69.nxml.txt.nlp	16613612	SENT197	27	27	33	33	methylprednisolone	S100A8	PA450466	6279	0.626
NULL	Curr_Neuropharmacol_2008_Jun_6(2)_151-163.nxml.txt.nlp	19305794	SENT355	9	9	12	12	capsaicin	VR1	PA448776	56664	0.626
NULL	Front_Neurol_2014_Sep_11_5_173.nxml.txt.nlp	25309501	SENT160	5	5	14	14	hyaluronan	HYAL3	PA165958431	8372	0.626
NULL	Evid_Based_Complement_Alternat_Med_2014_May_21_2014_375986.nxml.txt.nlp	24963322	SENT236	0	0	4	4	ethanol	flower	PA448073	11094	0.626
NULL	Exp_Diabetes_Res_2012_Nov_12_2012_618923.nxml.txt.nlp	23197974	SENT4	40	40	37	37	telmisartan	STZ	PA451605	6484	0.626
NULL	Breast_Cancer_Res_2010_Jul_1_12(4)_R45.nxml.txt.nlp	20594311	SENT141	7	7	0	0	tamoxifen	BiP	PA451581	3309	0.626
NULL	Mucosal_Immunol_2012_May_8_5(3)_288-298.nxml.txt.nlp	22318495	SENT5	6	6	25	25	dextran	NLRC4	PA449261	58484	0.626
NULL	Cancers_(Basel)_2012_Apr_25_4(2)_442-473.nxml.txt.nlp	24213319	SENT496	23	23	6	6	arsenite	MRP1	PA452638	4437	0.626
NULL	F1000Res_2014_Mar_18_3_74.nxml.txt.nlp	25580222	SENT107	6	6	2	2	ciprofloxacin	TOX	PA449009	9760	0.626
NULL	Biochimie_2014_Jan_96(100)_106-112.nxml.txt.nlp	23827855	SENT29	21	21	39	39	lipase	iPLA2	PA450239	8398	0.626
NULL	Crit_Care_2009_Jul_10_13(4)_R113.nxml.txt.nlp	19591694	SENT85	1	1	3	3	vasopressin	AVP	PA451858	114548;551	0.626
NULL	Nucleic_Acids_Res_2010_Oct_28_38(19)_6418-6432.nxml.txt.nlp	20511593	SENT175	41	41	36	36	collagenase	AP-1	PA449107	2353;3727;2354;3725	0.626
NULL	J_Clin_Biochem_Nutr_2010_Jan_29_46(1)_43-51.nxml.txt.nlp	20104264	SENT118	8	8	13	13	napqi	CYP2E1		1571	0.626
NULL	Br_J_Cancer_2009_Jan_27_100(2)_366-369.nxml.txt.nlp	19165200	SENT53	13	13	16	16	bortezomib	Apo2	PA10252	8797	0.626
NULL	Front_Genet_2014_Aug_26_5_285.nxml.txt.nlp	25206361	SENT287	5	5	25	25	ethanol	PKR	PA448073	5610	0.626
NULL	Cancers_(Basel)_2012_Jun_27_4(3)_618-657.nxml.txt.nlp	22946011	SENT2026	0	0	5	5	urokinase	CD87	PA451836	5329	0.626
NULL	Oncotarget_2011_Sep_9_2(9)_658-668.nxml.txt.nlp	21911919	SENT4	28	28	8	8	cytarabine	HO-1	PA449177	3162	0.626
NULL	Anal_Biochem_2014_Jun_1_454(100)_17-22.nxml.txt.nlp	24637157	SENT339	10	10	22	22	camptothecin	TDP1	PA153590860	55775	0.626
NULL	Ann_Rheum_Dis_2009_Jan_5_68(6)_1051-1058.nxml.txt.nlp	18662930	SENT217	13	13	19	19	hyaluronan	CD54	PA165958431	3383	0.626
NULL	Mol_Biol_Cell_2012_Nov_1_23(21)_4212-4225.nxml.txt.nlp	22956765	SENT274	11	11	20	20	thrombin	SHP2	PA451674	5781	0.626
NULL	Breast_Cancer_Res_2006_Oct_16_8(5)_111.nxml.txt.nlp	17049068	SENT57	23	23	27	27	tamoxifen	STAR	PA451581	6770;2984	0.626
NULL	Mol_Cell_Proteomics_2012_Jan_3_11(1)_M111_011445.nxml.txt.nlp	22338125	SENT230	0	0	23	23	chymotrypsin	Met	PA448994	79811	0.626
NULL	Ann_Lab_Med_2012_Jul_20_32(4)_298-303.nxml.txt.nlp	22779073	SENT117	24	24	22	22	moxifloxacin	MOX	PA450555	26002	0.626
NULL	Sci_Rep_2014_Dec_12_4_7465.nxml.txt.nlp	25501874	SENT174	23	23	43	43	l-glutamine	CO2	PA10090	4513	0.626
NULL	Exp_Ther_Med_2012_Nov_6_4(5)_949-953.nxml.txt.nlp	23226754	SENT164	23	23	21	21	ethambutol	EMB	PA164784021	133418	0.626
NULL	Breast_Cancer_Res_2005_Mar_4_7(3)_R345-R352.nxml.txt.nlp	15987429	SENT124	15	15	33	33	indomethacin	COX	PA449982	1351	0.626
NULL	Algorithms_Mol_Biol_2010_Jul_15_5_29.nxml.txt.nlp	20633297	SENT243	18	18	20	20	sildenafil	PDE4B	PA451346	5142	0.626
NULL	Mol_Cancer_2008_Dec_15_7_91.nxml.txt.nlp	19077306	SENT54	0	0	4	4	trastuzumab	San	PA451743	80218	0.626
NULL	Cardiovasc_Ther_2009_27(4)_259-274.nxml.txt.nlp	19604248	SENT136	28	28	41	41	ticagrelor	IPA	PA165374673	3160	0.626
NULL	Front_Oncol_2014_Sep_23_4_264.nxml.txt.nlp	25295231	SENT99	18	18	20	20	lenalidomide	MDM2	PA162363968	4193	0.626
NULL	Clin_Dev_Immunol_2013_Nov_26_2013_325481.nxml.txt.nlp	24371447	SENT158	17	17	37	37	propofol	IL-6	PA451141	3569	0.626
NULL	J_Cell_Sci_2012_Jun_15_125(12)_2940-2953.nxml.txt.nlp	22366451	SENT294	21	21	17	17	imatinib	PP2	PA10804	4888	0.626
NULL	Mol_Cancer_2009_Jun_8_8_34.nxml.txt.nlp	19500427	SENT175	16	16	19	19	gemcitabine	FBXO5	PA449748	26271	0.626
NULL	J_Cell_Mol_Med_2014_Apr_20_18(4)_709-720.nxml.txt.nlp	24444314	SENT162	3	3	5	5	losartan	p53	PA450268	7157	0.626
NULL	CNS_Drugs_2013_May_27_27(5)_335-343.nxml.txt.nlp	23533009	SENT26	4	4	11	11	vasopressin	OXT	PA451858	5020	0.626
NULL	Acta_Pharmacol_Sin_2011_Feb_4_32(2)_182-187.nxml.txt.nlp	21293470	SENT104	20	20	11	11	riluzole	TREK-1	PA451251	3776	0.626
NULL	Am_J_Trop_Med_Hyg_2011_Jan_5_84(1)_152-157.nxml.txt.nlp	21212219	SENT26	20	20	25	25	artemisinin	ACT	PA165111696	12;11332;9457;641455	0.626
NULL	Oncoimmunology_2013_Sep_1_2(9)_e25773.nxml.txt.nlp	24319639	SENT28	35	35	30	30	cetuximab	EGFR	PA10040	1956	0.626
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_May_22_66(Pt_6)_o1394-o1395.nxml.txt.nlp	21579474	SENT79	20	20	16	16	ethanol	mol	PA448073	90527	0.626
NULL	Breast_Cancer_Res_2011_Nov_23_13(6)_R116.nxml.txt.nlp	22113133	SENT332	22	22	6	6	tamoxifen	DES	PA451581	1674	0.626
NULL	J_Int_Soc_Sports_Nutr_2013_Aug_6_10_36.nxml.txt.nlp	23919405	SENT162	8	8	30	30	creatine	FFM	PA164778930	24	0.626
NULL	Oncoimmunology_2013_Nov_1_2(11)_e27010.nxml.txt.nlp	24498547	SENT32	32	32	6	6	tegafur	GEM	PA452620	2669	0.626
NULL	Oxid_Med_Cell_Longev_2013_Nov_28_2013_568093.nxml.txt.nlp	24379901	SENT114	0	0	15	15	resveratrol	AMPK		5563	0.626
NULL	Arthritis_Rheum_2013_Sep_26_65(9)_2290-2300.nxml.txt.nlp	23740547	SENT240	24	24	12	12	doxycycline	DIP	PA449415	23151;1831	0.626
NULL	Int_J_Biomed_Sci_2006_Dec_2(4)_333-336.nxml.txt.nlp	23675001	SENT48	5	5	17	17	telmisartan	NEFA	PA451605	4925	0.626
NULL	EMBO_Mol_Med_2012_Jun_13_4(6)_515-527.nxml.txt.nlp	22416035	SENT230	10	10	15	15	olaparib	p53		7157	0.626
NULL	Acta_Histochem_Cytochem_2012_Apr_26_45(2)_139-146.nxml.txt.nlp	22685356	SENT363	7	7	15	15	forskolin	AQP2	PA146096022	359	0.626
NULL	Anal_Bioanal_Chem_2009_Oct_30_395(4)_893-905.nxml.txt.nlp	19484227	SENT67	29	29	31	31	oxytetracycline	OTC	PA450757	5009	0.626
NULL	J_Oncol_2012_Aug_8_2012_635614.nxml.txt.nlp	22927847	SENT34	22	22	30	30	thyroglobulin	TPO	PA164754910	7066;7173	0.626
NULL	Mol_Cell_2014_May_8_54(3)_445-459.nxml.txt.nlp	24746700	SENT90	22	22	16	16	etoposide	EXO1	PA449552	9156	0.626
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1066.nxml.txt.nlp	24556681	SENT216	24	24	7	7	ethanol	LC3	PA448073	84557	0.626
NULL	Cell_Commun_Signal_2013_Nov_11_11_86.nxml.txt.nlp	24215724	SENT548	3	3	30	30	thrombin	PAR2	PA451674	2150;55065;8856	0.626
NULL	J_Hepatol_2010_Sep_53(3-2)_519-527.nxml.txt.nlp	20579762	SENT283	29	29	17	17	collagenase	c-Jun	PA449107	3725	0.626
NULL	J_Gen_Physiol_2009_Sep_134(3)_243-258.nxml.txt.nlp	19720962	SENT455	8	8	10	10	capsaicin	TRPV1	PA448776	7442	0.626
NULL	Stroke_Res_Treat_2009_Dec_20_2010_386389.nxml.txt.nlp	20700422	SENT156	12	12	9	9	pioglitazone	NAC	PA450970	22861	0.626
NULL	J_Mol_Signal_2010_May_10_5_4.nxml.txt.nlp	20459745	SENT66	6	6	27	27	cisplatin	p53	PA449014	7157	0.626
NULL	Nat_Commun_2014_Jun_2_5_3983.nxml.txt.nlp	24886709	SENT10	4	4	12	12	lipase	APOA5	PA450239	116519	0.626
NULL	Adv_Hematol_2012_Mar_8_2012_856341.nxml.txt.nlp	22496694	SENT22	32	32	25	25	thrombin	VIII	PA451674	1351	0.626
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT38	12	12	10	10	mitomycin	MVP	PA450524	9961	0.626
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Jul_11_70(Pt_8)_m298-m299.nxml.txt.nlp	25249881	SENT75	2	2	25	25	ethanol	NO3	PA448073	4681	0.626
NULL	Front_Endocrinol_(Lausanne)_2015_Jan_9_5_235.nxml.txt.nlp	25620956	SENT154	25	25	17	17	glucosamine	p65	PA164747613	5970	0.626
NULL	Oncotarget_2013_Jul_21_4(8)_1253-1265.nxml.txt.nlp	23896512	SENT108	12	12	7	7	gefitinib	EGFR	PA131301952	1956	0.626
NULL	Breast_Cancer_Res_2008_Mar_7_10(2)_R22.nxml.txt.nlp	18328103	SENT50	34	34	14	14	hydrocortisone	F12	PA449905	2161	0.626
NULL	Evid_Based_Complement_Alternat_Med_2013_May_26_2013_161628.nxml.txt.nlp	23781255	SENT253	4	4	15	15	sunitinib	ERK1	PA162372840	5595	0.626
NULL	J_Lipid_Res_2013_Feb_54(2)_425-435.nxml.txt.nlp	23220585	SENT28	15	15	31	31	lipase	ATGL	PA450239	57104	0.626
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT616	13	13	8	8	risperidone	PRL	PA451257	5617	0.626
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_6_2014_270930.nxml.txt.nlp	25431606	SENT268	0	0	11	11	curcumin	c-Jun	PA151958596	3725	0.626
NULL	Crit_Care_2011_Dec_5_15(6)_236.nxml.txt.nlp	22146601	SENT33	16	16	18	18	vasopressin	AVP	PA451858	114548;551	0.626
NULL	Ann_Neurosci_2012_Jul_19(3)_125-132.nxml.txt.nlp	25205985	SENT207	11	11	13	13	gabapentin	NCX	PA449720	3196	0.626
NULL	Adipocyte_2013_Jul_1_2(3)_135-142.nxml.txt.nlp	23991359	SENT54	16	16	18	18	lipase	HSL	PA450239	3991	0.626
NULL	Mol_Vis_2011_Jun_9_17_1564-1576.nxml.txt.nlp	21738386	SENT158	15	15	17	17	ethambutol	EMB	PA164784021	133418	0.626
NULL	Open_Allergy_J_2010_3_91-101.nxml.txt.nlp	25018787	SENT14	6	6	28	28	omalizumab	IL-8	PA164752253	3576	0.626
NULL	Indian_J_Endocrinol_Metab_2013_Jul-Aug_17(4)_611-619.nxml.txt.nlp	23961476	SENT194	0	0	14	14	vildagliptin	GLP-1	PA165958346	100125288	0.626
NULL	Cell_Death_Dis_2014_Jul_10_5(7)_e1322.nxml.txt.nlp	25010988	SENT125	19	19	35	35	temozolomide	PHD2	PA451609	54583	0.626
NULL	Front_Endocrinol_(Lausanne)_2013_Mar_12_4_26.nxml.txt.nlp	23486926	SENT1923	3	3	8	8	vasopressin	ACTH	PA451858	5443	0.626
NULL	Front_Microbiol_2014_Oct_9_5_503.nxml.txt.nlp	25346725	SENT114	4	4	14	14	estradiol	DES	PA449503	1674	0.626
NULL	Breast_Cancer_Res_2001_Mar_28_3(3)_150-153.nxml.txt.nlp	11305949	SENT60	8	8	13	13	paclitaxel	JNK	PA450761	5599	0.626
NULL	Br_J_Cancer_2011_Aug_9_105(4)_469-474.nxml.txt.nlp	21712825	SENT167	10	10	7	7	nadh	UCP2	PA164755085	7351	0.626
NULL	Mol_Cancer_2014_Apr_29_13_96.nxml.txt.nlp	24779681	SENT230	15	15	8	8	trastuzumab	IGFIR	PA451743	3480	0.626
NULL	Diabetes_Care_2013_Jul_12_36(7)_2126-2132.nxml.txt.nlp	23645884	SENT161	12	12	10	10	liraglutide	GLP-1	PA165958364	100125288	0.626
NULL	Curr_Hepat_Rep_2010_May_21_9(2)_75-90.nxml.txt.nlp	20461127	SENT244	34	34	45	45	telbivudine	LAM	PA164760861	7249;7248	0.626
NULL	Mol_Pain_2014_Apr_18_10_27.nxml.txt.nlp	24742127	SENT254	43	43	41	41	sr144528	CB2		1269	0.626
NULL	Mol_Cancer_2012_Sep_25_11_73.nxml.txt.nlp	23009336	SENT143	24	24	30	30	pp2	Oct4		5460	0.626
NULL	Breast_Cancer_Res_2010_Aug_9_12(4)_R62.nxml.txt.nlp	20696059	SENT238	1	1	14	14	trastuzumab	HER2	PA451743	2064	0.626
NULL	Indian_J_Endocrinol_Metab_2012_Mar-Apr_16(2)_158-163.nxml.txt.nlp	22470850	SENT62	23	23	15	15	calcidiol	CYP27A1	PA164745614	1593	0.626
NULL	Breast_Cancer_Res_2010_Mar_5_12(2)_R16.nxml.txt.nlp	20205716	SENT185	0	0	40	40	lovastatin	CDC42	PA450272	998	0.626
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT90	21	21	5	5	methotrexate	MSH2	PA450428	4436	0.626
NULL	Int_J_Mol_Sci_2012_Feb_24_13(3)_2590-2617.nxml.txt.nlp	22489113	SENT221	15	15	12	12	benzaldehyde	mol	PA448571	90527	0.626
NULL	Evol_Med_Public_Health_2013_Apr_9_2013(1)_46-64.nxml.txt.nlp	24481186	SENT121	17	17	22	22	infliximab	IL-6	PA452639	3569	0.626
NULL	Ann_Surg_Oncol_2011_Apr_16_18(4)_1006-1014.nxml.txt.nlp	21080086	SENT225	3	3	18	18	fluorouracil	IMPACT	PA128406956	55364	0.626
NULL	Genome_Biol_2008_Oct_13_9(10)_R150.nxml.txt.nlp	18851746	SENT78	13	13	24	24	tetracycline	MYCN	PA451640	4613	0.626
NULL	Clinics_(Sao_Paulo)_2013_Oct_68(10)_1325-1332.nxml.txt.nlp	24212839	SENT45	40	40	22	22	ribavirin	MxA	PA451241	4599	0.626
NULL	Cell_Death_Dis_2013_Oct_3_4(10)_e830.nxml.txt.nlp	24091673	SENT23	33	33	15	15	doxorubicin	JNK	PA449412	5599	0.626
NULL	Oncotarget_2013_Oct_19_4(11)_2045-2056.nxml.txt.nlp	24185104	SENT5	20	20	14	14	cisplatin	14-3-3	PA449014	10971	0.626
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT167	28	28	24	24	trastuzumab	MUC4	PA451743	4585	0.626
NULL	Viruses_2014_Jul_22_6(7)_2858-2879.nxml.txt.nlp	25054884	SENT149	11	11	27	27	elvitegravir	vRNA	PA165291498	56664	0.626
NULL	Oncotarget_2014_Sep_26_5(21)_10237-10250.nxml.txt.nlp	25296978	SENT170	2	2	22	22	bortezomib	Mcl-1	PA10252	4170	0.626
NULL	J_Oncol_2009_Mar_24_2009_491985.nxml.txt.nlp	19325924	SENT185	36	36	10	10	genistein	CXCL12	PA165109660	6387	0.626
NULL	J_Oncol_2014_Feb_10_2014_808012.nxml.txt.nlp	24659999	SENT50	11	11	26	26	paraformaldehyde	San	PA450790	80218	0.626
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT156	2	2	6	6	atorvastatin	OPG	PA448500	690	0.626
NULL	Oncotarget_2013_Nov_24_4(12)_2430-2438.nxml.txt.nlp	24280348	SENT65	7	7	9	9	gefitinib	EGFR	PA131301952	1956	0.626
NULL	Diabetes_Metab_Syndr_Obes_2010_Jul_20_3_263-273.nxml.txt.nlp	21437094	SENT196	9	9	7	7	metformin	Met	PA450395	79811	0.626
NULL	Drugs_Aging_2014_May_6_31(6)_413-424.nxml.txt.nlp	24797286	SENT146	0	0	3	3	denosumab	CTX	PA166048634	1593	0.626
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_24_2012_673132.nxml.txt.nlp	23133498	SENT132	14	14	16	16	tamoxifen	P-gp	PA451581	5243	0.626
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT270	26	26	19	19	glucose	EGFR	PA449773	1956	0.626
NULL	J_Biomed_Sci_2013_Jan_25_20(1)_4.nxml.txt.nlp	23350663	SENT188	16	16	7	7	thrombin	PAR1	PA451674	79581;2149	0.626
NULL	Endocrinol_Diabetes_Metab_Case_Rep_2013_Jul_15_2013_130021.nxml.txt.nlp	24616764	SENT43	4	4	11	11	octreotide	FDG	PA450678	23583	0.626
NULL	Ann_Surg_Oncol_2009_Aug_10_16(8)_2086-2088.nxml.txt.nlp	19513600	SENT72	31	31	4	4	irinotecan	gamma	PA450085	9913	0.626
NULL	Indian_J_Med_Res_2012_May_135(5)_672-674.nxml.txt.nlp	22771598	SENT6	28	28	30	30	ethionamide	ETO	PA164768738	862	0.626
NULL	Biomed_Res_Int_2013_May_27_2013_526367.nxml.txt.nlp	23762850	SENT63	15	15	27	27	fluorescein	CD90	PA164746009	7070	0.626
NULL	Proteome_Sci_2010_Mar_26_8_18.nxml.txt.nlp	20346146	SENT113	21	21	13	13	hyaluronan	CD29	PA165958431	3688	0.626
NULL	Acta_Pharmacol_Sin_2012_Mar_30_33(3)_401-406.nxml.txt.nlp	22286916	SENT131	6	6	13	13	paclitaxel	ADM	PA450761	133	0.626
NULL	Front_Oncol_2014_May_26_4_123.nxml.txt.nlp	24904834	SENT371	22	22	11	11	resveratrol	AMPK		5563	0.626
NULL	Mol_Med_Rep_2014_Nov_5_10(5)_2334-2340.nxml.txt.nlp	25189202	SENT83	11	11	15	15	ceftriaxone	CFP	PA448866	5199	0.626
NULL	Front_Behav_Neurosci_2012_Jan_13_5_92.nxml.txt.nlp	22347852	SENT720	11	11	7	7	forskolin	5-HT1A	PA146096022	3350	0.626
NULL	Int_J_Biomed_Sci_2014_Dec_10(4)_229-235.nxml.txt.nlp	25598752	SENT105	2	2	13	13	abatacept	CX3CL1	PA164747080	6376	0.626
NULL	Oncotarget_2013_Aug_26_4(10)_1662-1672.nxml.txt.nlp	24091566	SENT110	11	11	16	16	trastuzumab	HER2	PA451743	2064	0.626
NULL	Diabetes_Metab_Syndr_Obes_2010_Mar_26_3_43-48.nxml.txt.nlp	21437075	SENT77	16	16	3	3	bromocriptine	CYP3A4	PA448671	1576	0.626
NULL	Adv_Hematol_2014_Nov_9_2014_369084.nxml.txt.nlp	25431593	SENT26	27	27	19	19	warfarin	VKORC1	PA451906	79001	0.626
NULL	Cardiol_Res_Pract_2011_Mar_3_2011_394740.nxml.txt.nlp	21403876	SENT46	24	24	16	16	thrombin	ADP	PA451674	23038	0.626
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Dec_17_3(12)_e152.nxml.txt.nlp	25518025	SENT50	39	39	36	36	oxycodone	CYP2D6	PA450741	1565	0.626
NULL	Br_J_Cancer_2012_Sep_4_107(6)_967-976.nxml.txt.nlp	22892391	SENT143	11	11	16	16	cisplatin	BCL2	PA449014	596	0.626
NULL	Cancers_(Basel)_2010_Aug_18_2(3)_1576-1596.nxml.txt.nlp	24281174	SENT224	18	18	1	1	doxorubicin	CD133	PA449412	8842	0.626
NULL	Environ_Health_Perspect_1985_Oct_62_73-79.nxml.txt.nlp	4085450	SENT4	7	7	18	18	guanidine	TSK	PA164781028	25987	0.626
NULL	Allergy_Asthma_Immunol_Res_2014_Nov_19_6(6)_548-557.nxml.txt.nlp	25374755	SENT136	0	0	2	2	lovastatin	IFN	PA450272	3439	0.626
NULL	Cell_Commun_Signal_2003_Nov_24_1_5.nxml.txt.nlp	14636425	SENT87	3	3	0	0	heparin	CCN5	PA449855	8839	0.626
NULL	J_Gen_Physiol_1997_Dec_1_110(6)_643-654.nxml.txt.nlp	9382893	SENT207	20	20	25	25	diazoxide	ADP	PA449285	23038	0.626
NULL	J_Cell_Biol_2003_Sep_29_162(7)_1197-1209.nxml.txt.nlp	14517203	SENT374	17	17	6	6	mimosine	NBS1	PA164752445	55655	0.626
NULL	Diabetes_2011_Nov_17_60(11)_2691-2700.nxml.txt.nlp	21896928	SENT166	9	9	18	18	resveratrol	POMC		5443	0.626
NULL	Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.nxml.txt.nlp	24736980	SENT178	4	4	6	6	rosuvastatin	OATP1B1	PA134308647	10599	0.626
NULL	EMBO_J_2009_Apr_22_28(8)_1043-1054.nxml.txt.nlp	19300439	SENT149	5	5	20	20	pp2	p38		10598;1432;7965	0.626
NULL	Breast_Cancer_Res_2004_Jun_18_6(4)_179-180.nxml.txt.nlp	NULL	SENT41	0	0	2	2	anastrozole	aromatase	PA448432	1588	0.626
NULL	Open_Dent_J_2014_May_30_8_109-124.nxml.txt.nlp	24976875	SENT193	5	5	15	15	doxycycline	IL-6	PA449415	3569	0.626
NULL	Int_J_Biol_Sci_2014_Feb_20_10(3)_268-277.nxml.txt.nlp	24644425	SENT256	31	31	33	33	metformin	Met	PA450395	79811	0.626
NULL	Clin_Ophthalmol_2008_Jun_2(2)_355-368.nxml.txt.nlp	19668727	SENT215	9	9	17	17	nepafenac	PRK	PA165958407	1263	0.626
NULL	Environ_Microbiol_2013_Jan_15_15(1)_297-304.nxml.txt.nlp	23157680	SENT51	10	10	45	45	chloramphenicol	TMP	PA448927	2012	0.626
NULL	Ann_Rheum_Dis_2014_Aug_30_73(8)_1558-1565.nxml.txt.nlp	23723320	SENT184	11	11	7	7	zoledronate	OPG	PA10235	690	0.626
NULL	J_Viral_Hepat_2010_Feb_17(2)_139-147.nxml.txt.nlp	19674282	SENT28	30	30	8	8	ribavirin	RVR	PA451241	9975	0.626
NULL	J_Nucl_Cardiol_2009_Apr_22_16(2)_321-324.nxml.txt.nlp	19156479	SENT87	17	17	32	32	dobutamine	Sara	PA449381	56681	0.626
NULL	Iran_J_Neurol_2013_12(4)_157-165.nxml.txt.nlp	24250926	SENT208	18	18	11	11	felbamate	LGS	PA449590	51557	0.626
NULL	Clin_Mol_Hepatol_2014_Dec_24_20(4)_338-344.nxml.txt.nlp	25548738	SENT135	29	29	11	11	telaprevir	IFN	PA165958354	3439	0.626
NULL	Patient_Prefer_Adherence_2010_Mar_24_4_61-68.nxml.txt.nlp	20361006	SENT168	19	19	17	17	liraglutide	GLP-1	PA165958364	100125288	0.626
NULL	J_Korean_Med_Sci_1990_Dec_5(4)_185-188.nxml.txt.nlp	1966034	SENT0	18	18	27	27	methacholine	TDI	PA165958382	100038246	0.626
NULL	Br_J_Pharmacol_2008_Oct_18_155(4)_596-605.nxml.txt.nlp	18852694	SENT287	0	0	10	10	fenofibrate	SREBP2	PA449594	6721	0.626
NULL	Acta_Pharmacol_Sin_2014_Aug_7_35(8)_1015-1022.nxml.txt.nlp	24998256	SENT5	16	16	9	9	ethanol	ALDH2	PA448073	217	0.626
NULL	Springerplus_2014_Sep_9_3_510.nxml.txt.nlp	25279302	SENT8	13	13	23	23	creatine	spatial	PA164778930	219793	0.626
NULL	Front_Cell_Neurosci_2014_Jul_28_8_205.nxml.txt.nlp	25120431	SENT128	19	19	1	1	choline	ISL1	PA448976	3670	0.626
NULL	Br_J_Cancer_2010_Jan_5_102(1)_80-86.nxml.txt.nlp	19920817	SENT12	15	15	31	31	sunitinib	IFN	PA162372840	3439	0.626
NULL	Ther_Clin_Risk_Manag_2006_Sep_2(3)_235-249.nxml.txt.nlp	18360599	SENT343	26	26	16	16	alendronate	PTH	PA448082	5741	0.626
NULL	Epigenetics_Chromatin_2014_Aug_3_7_17.nxml.txt.nlp	25170345	SENT317	14	14	39	39	formaldehyde	P14	PA449703	11102;;6280;56259	0.626
NULL	Br_J_Cancer_2011_Apr_12_104(8)_1256-1261.nxml.txt.nlp	21448165	SENT126	16	16	28	28	sorafenib	IL-2	PA7000	3558	0.626
NULL	Indian_J_Med_Res_2013_Jan_137(1)_191-196.nxml.txt.nlp	23481072	SENT95	24	24	12	12	daptomycin	VISA	PA164768820	57506	0.626
NULL	J_Cancer_Res_Clin_Oncol_2011_Feb_11_137(2)_183-192.nxml.txt.nlp	21069385	SENT151	3	3	15	15	trastuzumab	HER2	PA451743	2064	0.626
NULL	J_Cell_Biol_2005_Jul_4_170(1)_49-59.nxml.txt.nlp	15983061	SENT191	9	9	11	11	forskolin	HIF1	PA146096022	3091	0.626
NULL	Int_J_Mol_Sci_2012_Aug_10_13(8)_9971-9979.nxml.txt.nlp	22949842	SENT212	2	2	4	4	lipase	PPL	PA450239	5493	0.626
NULL	Adv_Hematol_2012_Feb_26_2012_529572.nxml.txt.nlp	22474449	SENT76	15	15	20	20	vincristine	CHOP	PA451879	1649	0.626
NULL	Iran_J_Microbiol_2013_Mar_5(1)_48-55.nxml.txt.nlp	23466743	SENT131	12	12	14	14	ceftazidime	CTX	PA448861	1593	0.626
NULL	Acta_Pharmacol_Sin_2014_Aug_7_35(8)_1015-1022.nxml.txt.nlp	24998256	SENT122	20	20	9	9	ethanol	ALDH2	PA448073	217	0.626
NULL	Arthritis_Res_Ther_2012_Apr_26_14(2)_R90.nxml.txt.nlp	22537858	SENT182	0	0	6	6	atorvastatin	IFN	PA448500	3439	0.626
NULL	Oncol_Lett_2015_Jan_4_9(1)_91-95.nxml.txt.nlp	25435939	SENT116	6	6	2	2	etoposide	DDP	PA449552	1678	0.626
NULL	Neural_Regen_Res_2014_Mar_15_9(6)_622-629.nxml.txt.nlp	25206865	SENT112	3	3	5	5	vasopressin	c-Jun	PA451858	3725	0.626
NULL	Trials_2013_May_4_14_125.nxml.txt.nlp	23782591	SENT208	21	21	17	17	galantamine	CYP2D6	PA449726	1565	0.626
NULL	Cancers_(Basel)_2013_Dec_4_5(4)_1655-1675.nxml.txt.nlp	24305655	SENT127	18	18	11	11	doxorubicin	p53	PA449412	7157	0.626
NULL	J_Vet_Med_Sci_2014_Feb_8_76(2)_173-182.nxml.txt.nlp	24107430	SENT10	11	11	13	13	vasopressin	AVP	PA451858	114548;551	0.626
NULL	Indian_J_Med_Res_2011_Nov_134(5)_704-708.nxml.txt.nlp	22199111	SENT54	20	20	13	13	vancomycin	VISA	PA451850	57506	0.626
NULL	Eur_J_Med_Res_2010_Aug_20_15(8)_337-344.nxml.txt.nlp	20947470	SENT33	39	39	36	36	vincristine	BLM	PA451879	641	0.626
NULL	Exp_Ther_Med_2014_Apr_13_7(4)_799-803.nxml.txt.nlp	24669235	SENT69	0	0	3	3	metformin	GLP-1	PA450395	100125288	0.626
NULL	Int_J_Vasc_Med_2013_Mar_31_2013_543141.nxml.txt.nlp	23606968	SENT132	0	0	7	7	etanercept	IL-13	PA449515	3596	0.626
NULL	Clin_Endosc_2013_Jul_31_46(4)_311-312.nxml.txt.nlp	23964324	SENT0	23	23	35	35	propofol	CHA	PA451141	10732	0.626
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2587-2596.nxml.txt.nlp	24129237	SENT39	7	7	33	33	l-glutamine	CO2	PA10090	4513	0.626
NULL	Environ_Health_Perspect_2010_Jan_10_118(1)_108-115.nxml.txt.nlp	20056578	SENT132	5	5	14	14	arsenite	PTEN	PA452638	5728	0.626
NULL	Hum_Genomics_2009_Jan_1_3(2)_128-142.nxml.txt.nlp	19164090	SENT236	40	40	36	36	carboplatin	CD44	PA448803	960	0.626
NULL	Carcinogenesis_2010_Dec_27_31(12)_2049-2057.nxml.txt.nlp	20876285	SENT169	14	14	10	10	tamoxifen	HER2	PA451581	2064	0.626
NULL	Orthop_Rev_(Pavia)_2010_Mar_20_2(1)_e9.nxml.txt.nlp	21808704	SENT30	13	13	11	11	fentanyl	EDA	PA449599	1896	0.626
NULL	Oncol_Lett_2014_Nov_10_8(5)_2333-2339.nxml.txt.nlp	25295120	SENT9	6	6	19	19	cyclosporine	ADM	PA449167	133	0.626
NULL	Bioinform_Biol_Insights_2009_Oct_5_3_109-127.nxml.txt.nlp	20140064	SENT463	13	13	17	17	zidovudine	P200	PA451954	5035	0.626
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT132	39	39	41	41	procainamide	NAPA	PA451108	9476;8775	0.626
NULL	Acta_Pharmacol_Sin_2009_Jan_8_30(1)_25-30.nxml.txt.nlp	19060918	SENT55	8	8	5	5	ribavirin	IFN	PA451241	3439	0.626
NULL	Front_Physiol_2013_May_15_4_103.nxml.txt.nlp	23720630	SENT150	20	20	3	3	l-carnitine	Q10	PA450154	27161	0.626
NULL	Mol_Cancer_2013_Nov_13_12_137.nxml.txt.nlp	24225025	SENT201	19	19	8	8	doxorubicin	MRP1	PA449412	4437	0.626
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT226	17	17	22	22	perifosine	DR4	PA165291471	8797	0.626
NULL	Br_J_Cancer_2002_Jan_21_86(2)_179-184.nxml.txt.nlp	11870502	SENT59	14	14	21	21	tamoxifen	IFN	PA451581	3439	0.626
NULL	AIDS_Res_Treat_2012_Mar_5_2012_703604.nxml.txt.nlp	22500218	SENT106	24	24	14	14	artesunate	UGT	PA165111697	7361;7355	0.626
NULL	Diabetes_2011_Nov_17_60(11)_2691-2700.nxml.txt.nlp	21896928	SENT227	9	9	18	18	resveratrol	SIRT1		23411	0.626
NULL	Mol_Med_Rep_2015_Jan_17_11(1)_43-52.nxml.txt.nlp	25333456	SENT266	35	35	45	45	cisplatin	ADM	PA449014	133	0.626
NULL	Mol_Cancer_2012_Apr_26_11_24.nxml.txt.nlp	22537161	SENT222	34	34	28	28	pp2	MUC4		4585	0.626
NULL	Arthritis_Res_Ther_2009_Jun_5_11(3)_R85.nxml.txt.nlp	19500336	SENT35	1	1	4	4	hyaluronan	CD44	PA165958431	960	0.626
NULL	Diabetes_Care_2009_Sep_29_32(9)_1620-1625.nxml.txt.nlp	19564453	SENT18	7	7	20	20	metformin	AMPK	PA450395	5563	0.626
NULL	ScientificWorldJournal_2012_Apr_1_2012_159456.nxml.txt.nlp	22547977	SENT264	17	17	19	19	oxytetracycline	OTC	PA450757	5009	0.626
NULL	Oncol_Rep_2013_Apr_5_29(4)_1671-1677.nxml.txt.nlp	23404329	SENT165	19	19	16	16	curcumin	ASP	PA151958596	259266;443;9474;29974;434;83853	0.626
NULL	J_Mol_Med_(Berl)_2013_Aug_17_91(11)_1257-1271.nxml.txt.nlp	23955016	SENT186	38	38	30	30	thrombin	p38	PA451674	10598;1432;7965	0.626
NULL	Cancer_Manag_Res_2012_Nov_9_4_383-395.nxml.txt.nlp	23204869	SENT263	25	25	21	21	carmustine	PC-3	PA448810	692094	0.625
NULL	Cancer_Med_2013_Jun_25_2(3)_277-285.nxml.txt.nlp	23930204	SENT193	5	5	27	27	bevacizumab	MAX	PA130232992	4149	0.625
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT96	21	21	23	23	perifosine	TRAIL	PA165291471	8743	0.625
NULL	Environ_Health_Perspect_2011_Aug_22_119(8)_1053-1061.nxml.txt.nlp	21697028	SENT404	12	12	14	14	diethylstilbestrol	DES	PA449307	1674	0.625
NULL	Cancer_Cell_Int_2014_Jan_18_14_5.nxml.txt.nlp	24438119	SENT3	0	0	2	2	rituximab	CHOP	PA451261	1649	0.625
NULL	Antiviral_Res_2009_May_82(2)_A99-A109.nxml.txt.nlp	19176219	SENT78	9	9	1	1	nevirapine	P-gp	PA450616	5243	0.625
NULL	J_Cell_Biol_2001_Apr_16_153(2)_367-380.nxml.txt.nlp	11309417	SENT203	0	0	3	3	etoposide	BLM	PA449552	641	0.625
NULL	Indian_J_Dermatol_2013_Mar-Apr_58(2)_101-106.nxml.txt.nlp	23716797	SENT132	11	11	9	9	heparin	EGF	PA449855	1950	0.625
NULL	Cancer_Res_Treat_2012_Jun_30_44(2)_133-141.nxml.txt.nlp	22802752	SENT190	5	5	13	13	oxaliplatin	GM-CSF	PA131285527	1437	0.625
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT137	20	20	28	28	trastuzumab	HER2	PA451743	2064	0.625
NULL	Mol_Cancer_2010_Oct_12_9_269.nxml.txt.nlp	20939893	SENT59	0	0	9	9	isoproterenol	AP-1	PA450121	2353;3727;2354;3725	0.625
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT607	1	1	8	8	clozapine	PRL	PA449061	5617	0.625
NULL	Emerg_Infect_Dis_2012_Jan_18(1)_29-37.nxml.txt.nlp	22260950	SENT55	15	15	0	0	ethambutol	DST	PA164784021	667	0.625
NULL	Front_Physiol_2010_Nov_2_1_145.nxml.txt.nlp	21423385	SENT17	3	3	0	0	indomethacin	COX	PA449982	1351	0.625
NULL	Clin_Transl_Allergy_2014_Mar_14_4(Suppl_1)_O19.nxml.txt.nlp	NULL	SENT10	20	20	36	36	fluorescein	CD19	PA164746009	930	0.625
NULL	Exp_Mol_Med_2012_Sep_30_44(9)_562-570.nxml.txt.nlp	22809900	SENT58	16	16	18	18	rosiglitazone	adiponectin	PA451283	9370	0.625
NULL	Pharmacogn_Mag_2014_Jul-Sep_10(39)_374-383.nxml.txt.nlp	25210328	SENT156	12	12	23	23	evodiamine	PC2	PA165860788	5126;5311;8535	0.625
NULL	Emerg_Infect_Dis_2005_Jun_11(6)_873-882.nxml.txt.nlp	15963282	SENT89	2	2	16	16	ceftazidime	TOB	PA448861	10140	0.625
NULL	Cancer_Biol_Med_2012_Jun_9(2)_141-143.nxml.txt.nlp	23691471	SENT32	15	15	12	12	dacarbazine	ADM	PA449197	133	0.625
NULL	Chin_J_Cancer_2012_Aug_31(8)_373-380.nxml.txt.nlp	22739266	SENT11	21	21	8	8	gemcitabine	XRCC3	PA449748	7517	0.625
NULL	Open_Access_J_Urol_2010_Feb_10_2_25-30.nxml.txt.nlp	24198610	SENT114	8	8	6	6	etoposide	ETO	PA449552	862	0.625
NULL	Front_Behav_Neurosci_2009_Sep_7_3_19.nxml.txt.nlp	19826624	SENT139	24	24	26	26	vasopressin	AVP	PA451858	114548;551	0.625
NULL	Indian_J_Pharm_Sci_2014_Nov-Dec_76(6)_557-559.nxml.txt.nlp	25593392	SENT48	9	9	6	6	raltegravir	FOR		51741	0.625
NULL	Front_Neurosci_2010_Mar_19_4_22.nxml.txt.nlp	20582262	SENT132	0	0	38	38	mecamylamine	P2X3	PA450334	5024	0.625
NULL	J_Gen_Physiol_1989_Mar_1_93(3)_565-584.nxml.txt.nlp	2784827	SENT10	13	13	26	26	tetracaine	gamma	PA451638	9913	0.625
NULL	Arthritis_Rheumatol_2014_Jun_27_66(6)_1574-1582.nxml.txt.nlp	24577881	SENT203	15	15	4	4	oxygen	NAC	PA450744	22861	0.625
NULL	J_Lipid_Res_2013_Feb_54(2)_425-435.nxml.txt.nlp	23220585	SENT28	15	15	10	10	lipase	HSL	PA450239	3991	0.625
NULL	Cancers_(Basel)_2010_Dec_23_3(1)_17-42.nxml.txt.nlp	24212604	SENT930	14	14	12	12	paclitaxel	PPX	PA450761	5531	0.625
NULL	Biologics_2012_Oct_25_6_371-378.nxml.txt.nlp	23118526	SENT234	10	10	16	16	rituximab	CD59	PA451261	966	0.625
NULL	Nat_Commun_2013_Oct_15_4_2602.nxml.txt.nlp	24129506	SENT155	2	2	28	28	coumarin	S26	PA134521193	6231	0.625
NULL	J_Cell_Mol_Med_2013_Jan_20_17(1)_1-11.nxml.txt.nlp	23279634	SENT33	3	3	5	5	diethylstilbestrol	DES	PA449307	1674	0.625
NULL	Biochem_Res_Int_2012_Feb_12_2012_346972.nxml.txt.nlp	22400115	SENT5	1	1	18	18	hyaluronan	RHAMM	PA165958431	3161	0.625
NULL	Breast_Cancer_Res_2011_Apr_21_13(2)_R46.nxml.txt.nlp	21510863	SENT57	10	10	2	2	trastuzumab	HER2	PA451743	2064	0.625
NULL	Exp_Ther_Med_2013_Feb_20_5(2)_443-447.nxml.txt.nlp	23407364	SENT180	11	11	9	9	cyclophosphamide	CTX	PA449165	1593	0.625
NULL	Clin_Exp_Metastasis_2013_Apr_27_30(4)_447-455.nxml.txt.nlp	23187934	SENT40	9	9	7	7	cetuximab	HAI	PA10040	6692;6768	0.625
NULL	Acta_Pharmacol_Sin_2012_Mar_27_33(3)_342-350.nxml.txt.nlp	22367283	SENT132	4	4	7	7	thrombin	PAR1	PA451674	79581;2149	0.625
NULL	Breast_Cancer_Res_2012_Mar_19_14(2)_R50.nxml.txt.nlp	22429397	SENT225	16	16	23	23	choline	DAG	PA448976	1605	0.625
NULL	J_Cancer_Epidemiol_2012_Oct_24_2012_294730.nxml.txt.nlp	23150730	SENT244	23	23	7	7	cetuximab	KRAS	PA10040	3845	0.625
NULL	Ann_Hematol_2010_Sep_13_89(9)_861-871.nxml.txt.nlp	20387067	SENT112	0	0	13	13	dasatinib	CD34	PA162372878	947	0.625
NULL	Case_Rep_Hematol_2015_Jan_5_2015_321602.nxml.txt.nlp	25628902	SENT4	21	21	7	7	methotrexate	CTX	PA450428	1593	0.625
NULL	Arthritis_Res_Ther_2012_Mar_12_14(2)_R57.nxml.txt.nlp	22409963	SENT24	9	9	14	14	rituximab	ACPA	PA451261	5657	0.625
NULL	Cancers_(Basel)_2013_Jul_26_5(3)_959-984.nxml.txt.nlp	24202329	SENT119	24	24	41	41	mitomycin	CO2	PA450524	4513	0.625
NULL	Mediators_Inflamm_2010_Jun_21_2010_194896.nxml.txt.nlp	20652055	SENT48	13	13	32	32	rosuvastatin	mol	PA134308647	90527	0.625
NULL	Indian_J_Pharmacol_2014_Nov-Dec_46(6)_627-632.nxml.txt.nlp	25538335	SENT114	11	11	4	4	metformin	Q10	PA450395	27161	0.625
NULL	Acta_Pharmacol_Sin_2014_Aug_21_35(8)_1082-1092.nxml.txt.nlp	25047514	SENT148	5	5	20	20	letrozole	Met	PA450196	79811	0.625
NULL	Front_Endocrinol_(Lausanne)_2013_Jun_10_4_69.nxml.txt.nlp	23772224	SENT1211	4	4	15	15	rosiglitazone	JNK	PA451283	5599	0.625
NULL	Breast_Cancer_Res_2009_Nov_18_11(6)_R85.nxml.txt.nlp	19922614	SENT27	25	25	21	21	tamoxifen	BCS	PA451581	617	0.625
NULL	Front_Genet_2013_Aug_30_4_166.nxml.txt.nlp	24009623	SENT120	15	15	12	12	everolimus	FBXW7	PA164746311	55294	0.625
NULL	Oncol_Rep_2012_Apr_30_27(4)_923-928.nxml.txt.nlp	22209766	SENT46	37	37	42	42	hydrocortisone	EGF	PA449905	1950	0.625
NULL	Biologics_2011_Aug_9_5_87-94.nxml.txt.nlp	21847344	SENT156	14	14	31	31	trastuzumab	San	PA451743	80218	0.625
NULL	Br_J_Cancer_2010_May_11_102(10)_1483-1490.nxml.txt.nlp	20407444	SENT223	8	8	19	19	cisplatin	IFN	PA449014	3439	0.625
NULL	Int_J_Environ_Res_Public_Health_2013_Sep_17_10(9)_4352-4389.nxml.txt.nlp	24048206	SENT165	14	14	12	12	choline	B12	PA448976	7126;4709	0.625
NULL	J_Gen_Intern_Med_2009_May_21_24(5)_656-664.nxml.txt.nlp	19306050	SENT190	13	13	6	6	warfarin	CYP2C9	PA451906	1559	0.625
NULL	Case_Rep_Nephrol_Urol_2012_Oct_24_2(2)_145-151.nxml.txt.nlp	23197970	SENT131	30	30	12	12	clindamycin	CTX	PA449035	1593	0.625
NULL	Mol_Cancer_2010_Apr_23_9_87.nxml.txt.nlp	20416058	SENT197	28	28	26	26	doxorubicin	TRAIL	PA449412	8743	0.625
NULL	Chem_Rev_2013_Jul_10_113(7)_4633-4679.nxml.txt.nlp	23514336	SENT551	4	4	19	19	l-arginine	CAT-1	PA448478	6541	0.625
NULL	Mol_Cancer_2009_Nov_14_8_102.nxml.txt.nlp	19912656	SENT121	33	33	8	8	urokinase	PDCD4	PA451836	27250	0.625
NULL	Breast_Cancer_Res_Treat_2014_Apr_6_145(3)_725-734.nxml.txt.nlp	24706168	SENT78	1	1	11	11	doxorubicin	HER2	PA449412	2064	0.625
NULL	Oncotarget_2014_Nov_6_5(22)_11038-11053.nxml.txt.nlp	25402820	SENT176	7	7	13	13	gemcitabine	RRM2	PA449748	6241	0.625
NULL	Cancers_(Basel)_2010_Dec_23_3(1)_17-42.nxml.txt.nlp	24212604	SENT902	12	12	10	10	paclitaxel	PPX	PA450761	5531	0.625
NULL	Reprod_Biol_Endocrinol_2004_Jul_5_2_47.nxml.txt.nlp	15236655	SENT156	22	22	20	20	estradiol	HLA-G	PA449503	3135	0.625
NULL	Clin_Drug_Investig_2013_Jun_20_33(6)_419-427.nxml.txt.nlp	23605507	SENT6	27	27	12	12	ciprofloxacin	DPI	PA449009	1832	0.625
NULL	JRSM_Cardiovasc_Dis_2012_Sep_24_1(6)_cvd_2012_012015.nxml.txt.nlp	24175073	SENT90	21	21	18	18	clopidogrel	HPR	PA449053	3250	0.625
NULL	Hum_Mol_Genet_2013_Nov_15_22(22)_4616-4626.nxml.txt.nlp	23814041	SENT46	33	33	40	40	doxycycline	neuroserpin	PA449415	5274	0.625
NULL	Case_Rep_Nephrol_Urol_2014_Apr_12_4(1)_75-81.nxml.txt.nlp	24847349	SENT24	17	17	7	7	everolimus	APT	PA164746311	653639	0.625
NULL	Clin_Ophthalmol_2009_Jun_2_3_117-122.nxml.txt.nlp	19668554	SENT85	35	35	27	27	brimonidine	BAK	PA448665	578	0.625
NULL	Nat_Med_2013_Feb_6_19(2)_217-226.nxml.txt.nlp	23291629	SENT245	3	3	5	5	lipase	HSL	PA450239	3991	0.625
NULL	J_Cell_Mol_Med_2013_Sep_24_17(9)_1065-1087.nxml.txt.nlp	24151975	SENT319	2	2	31	31	palifermin	IL-6	PA164744014	3569	0.625
NULL	Cancers_(Basel)_2011_Apr_1_3(2)_1844-1860.nxml.txt.nlp	24212785	SENT552	0	0	28	28	cetuximab	BRAF	PA10040	673	0.625
NULL	Cell_Commun_Signal_2014_Mar_11_12_16.nxml.txt.nlp	24618498	SENT240	43	43	32	32	niclosamide	STAT1	PA165958408	6772	0.625
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT36	21	21	35	35	saquinavir	ABCB1	PA451305	5243	0.625
NULL	Acta_Ortop_Bras_2012_20(5)_258-261.nxml.txt.nlp	24453613	SENT24	25	25	15	15	bupivacaine	ACL	PA135057240	47	0.625
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Mar_29_70(Pt_4)_o500.nxml.txt.nlp	24826188	SENT78	25	25	11	11	piperazine	mol	PA450977	90527	0.625
NULL	Oncogene_2014_Aug_28_33(35)_4418-4423.nxml.txt.nlp	24469055	SENT173	25	25	15	15	erlotinib	RIT1	PA134687924	6016	0.625
NULL	Int_J_Mol_Sci_2012_Feb_24_13(3)_2590-2617.nxml.txt.nlp	22489113	SENT221	15	15	33	33	benzaldehyde	mol	PA448571	90527	0.625
NULL	N_Am_J_Med_Sci_2011_Jan_3(1)_13-19.nxml.txt.nlp	22540057	SENT69	1	1	17	17	capsaicin	TRPV1	PA448776	7442	0.625
NULL	Diabetes_Care_2010_Jul_31_33(7)_1544-1548.nxml.txt.nlp	20357370	SENT25	6	6	0	0	metformin	STK11	PA450395	6794	0.625
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1150.nxml.txt.nlp	24675468	SENT112	6	6	21	21	ethanol	adiponectin	PA448073	9370	0.625
NULL	J_Gen_Physiol_1997_Dec_1_110(6)_693-715.nxml.txt.nlp	9382897	SENT228	7	7	5	5	choline	EAOH	PA448976	54840	0.625
NULL	Mol_Cancer_2007_Oct_25_6_67.nxml.txt.nlp	17958915	SENT212	21	21	11	11	imatinib	GM-CSF	PA10804	1437	0.625
NULL	Cancers_(Basel)_2014_Apr_3_6(2)_771-795.nxml.txt.nlp	24704793	SENT1499	16	16	9	9	camptothecin	MLH1	PA153590860	4292	0.625
NULL	Crit_Care_2009_Jul_10_13(4)_R113.nxml.txt.nlp	19591694	SENT122	1	1	3	3	vasopressin	AVP	PA451858	114548;551	0.625
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT120	29	29	27	27	curcumin	TRAIL	PA151958596	8743	0.625
NULL	Ann_Biomed_Eng_2011_Apr_2_39(4)_1296-1305.nxml.txt.nlp	21287275	SENT66	0	0	9	9	heparin	C3a	PA449855	718	0.625
NULL	Core_Evid_2009_Jun_15_4_83-92.nxml.txt.nlp	20694067	SENT172	0	0	19	19	conivaptan	AVP	PA164742939	114548;551	0.625
NULL	Leukemia_2014_Jan_12_28(1)_15-33.nxml.txt.nlp	23778311	SENT397	8	8	25	25	dasatinib	ATF5	PA162372878	22809	0.625
NULL	Adv_Biomed_Res_2014_Mar_25_3_98.nxml.txt.nlp	24800187	SENT42	0	0	38	38	clarithromycin	MART	PA449028	5414	0.625
NULL	Diabetes_Care_2009_Sep_28_32(9)_1649-1655.nxml.txt.nlp	19478198	SENT88	14	14	0	0	saxagliptin	MET	PA165958362	4233	0.625
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT196	0	0	29	29	metformin	p53	PA450395	7157	0.625
NULL	J_Gen_Physiol_1997_Dec_1_110(6)_643-654.nxml.txt.nlp	9382893	SENT148	21	21	36	36	trypsin	SUR1	PA451806	6833	0.625
NULL	Eur_J_Clin_Pharmacol_2011_May_8_67(5)_493-506.nxml.txt.nlp	21140139	SENT27	23	23	14	14	oxymorphone	CYP2D6	PA450748	1565	0.625
NULL	Oncoimmunology_2013_Feb_1_2(2)_e22730.nxml.txt.nlp	23524978	SENT38	3	3	10	10	dasatinib	FOXP3	PA162372878	50943	0.625
NULL	J_Carcinog_2011_Dec_31_10_37.nxml.txt.nlp	22279422	SENT123	21	21	11	11	urokinase	MMP1	PA451836	4312	0.625
NULL	Indian_J_Pharmacol_2013_Mar-Apr_45(2)_121-125.nxml.txt.nlp	23716885	SENT140	22	22	33	33	aripiprazole	CYP3A4	PA10026	1576	0.625
NULL	Core_Evid_2012_Dec_11_7_131-143.nxml.txt.nlp	23271985	SENT112	11	11	39	39	rifampin	hole	PA451250	80757	0.625
NULL	Ecancermedicalscience_2009_Oct_12_3_161.nxml.txt.nlp	22276022	SENT106	7	7	4	4	trastuzumab	HER-2	PA451743	2064	0.625
NULL	Indian_Dermatol_Online_J_2013_Oct-Dec_4(4)_365-368.nxml.txt.nlp	24350028	SENT76	30	30	11	11	azithromycin	P-gp	PA448519	5243	0.625
NULL	Pain_2014_Nov_155(11)_2306-2322.nxml.txt.nlp	25168672	SENT1007	10	10	12	12	retigabine	LOX	PA144997862	4015	0.625
NULL	Breast_Cancer_Res_2005_Aug_5_7(5)_212-214.nxml.txt.nlp	16168140	SENT71	14	14	12	12	trastuzumab	PTEN	PA451743	5728	0.625
NULL	Mol_Vis_2012_Sep_6_18_2323-2337.nxml.txt.nlp	22977300	SENT91	5	5	28	28	fluorescein	CO2	PA164746009	4513	0.625
NULL	Clin_Ophthalmol_2010_May_14_4_437-445.nxml.txt.nlp	20505836	SENT11	17	17	23	23	latanoprost	BAK	PA164774763	578	0.625
NULL	Biomed_Res_Int_2013_Aug_6_2013_687575.nxml.txt.nlp	23986909	SENT39	11	11	13	13	vasopressin	AVP	PA451858	114548;551	0.625
NULL	Curr_Genomics_2013_Nov_14(7)_453-467.nxml.txt.nlp	24396277	SENT118	13	13	8	8	lipase	PCSK5	PA450239	5125	0.625
NULL	Cardiovasc_Diabetol_2013_Mar_23_12_48.nxml.txt.nlp	23522121	SENT87	14	14	29	29	exenatide	Met	PA164749238	79811	0.625
NULL	Br_J_Cancer_2004_Mar_22_90(6)_1285-1292.nxml.txt.nlp	15026814	SENT144	9	9	7	7	doxorubicin	p53	PA449412	7157	0.625
NULL	Basic_Clin_Neurosci_2014_Summer_5(3)_182-190.nxml.txt.nlp	25337378	SENT197	12	12	9	9	bupropion	mol	PA448687	90527	0.625
NULL	Exp_Mol_Med_2012_Sep_30_44(9)_521-528.nxml.txt.nlp	22684244	SENT96	6	6	22	22	staurosporine	RhoA	PA165109623	387	0.625
NULL	J_Gen_Physiol_1941_Sep_20_25(1)_75-88.nxml.txt.nlp	19873260	SENT0	14	14	1	1	choline	Gen	PA448976	348654	0.625
NULL	Br_J_Cancer_2011_Aug_23_105(5)_618-627.nxml.txt.nlp	21829197	SENT13	2	2	8	8	lapatinib	EGFR	PA152241907	1956	0.625
NULL	Indian_J_Endocrinol_Metab_2012_Jan-Feb_16(1)_33-43.nxml.txt.nlp	22276251	SENT143	20	20	10	10	rosiglitazone	DREAM	PA451283	30818	0.625
NULL	Am_J_Trop_Med_Hyg_2014_Aug_6_91(2)_424-434.nxml.txt.nlp	24799369	SENT308	12	12	10	10	chloroquine	ACT	PA448948	12;11332;9457;641455	0.625
NULL	Br_J_Cancer_2011_Jul_26_105(3)_372-381.nxml.txt.nlp	21730979	SENT197	11	11	28	28	hydroxyurea	CHK1	PA449942	1111	0.625
NULL	Emerg_Med_J_2014_Feb_22_31(2)_163-168.nxml.txt.nlp	23435652	SENT82	15	15	27	27	thrombin	VIII	PA451674	1351	0.625
NULL	J_Biol_Chem_2013_Nov_22_288(47)_34217-34229.nxml.txt.nlp	24106270	SENT261	14	14	5	5	thrombin	RhoG	PA451674	391	0.625
NULL	Breast_Cancer_Res_2009_Jul_15_11(4)_207.nxml.txt.nlp	19664181	SENT172	17	17	14	14	trastuzumab	PTEN	PA451743	5728	0.625
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT166	3	3	8	8	capsaicin	p53	PA448776	7157	0.625
NULL	Biologics_2009_Jul_13_3_77-97.nxml.txt.nlp	19707398	SENT466	7	7	4	4	etanercept	CDP	PA449515	1523	0.625
NULL	Oncotarget_2014_Oct_21_5(22)_11709-11722.nxml.txt.nlp	25365944	SENT29	38	38	9	9	metformin	Rho	PA450395	29984	0.625
NULL	Orphanet_J_Rare_Dis_2014_Dec_24_9(1)_213.nxml.txt.nlp	NULL	SENT72	30	30	3	3	thrombin	LTA	PA451674	4049	0.625
NULL	Eur_J_Clin_Microbiol_Infect_Dis_2012_May_7_31(5)_739-745.nxml.txt.nlp	21822974	SENT63	21	21	19	19	vancomycin	VAN	PA451850	10318	0.625
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT120	29	29	6	6	curcumin	p65	PA151958596	5970	0.625
NULL	Drug_Des_Devel_Ther_2014_Sep_23_8_1527-1538.nxml.txt.nlp	25284985	SENT214	35	35	39	39	celecoxib	IFN	PA448871	3439	0.625
NULL	Gastroenterol_Hepatol_Bed_Bench_2011_Summer_4(3)_127-132.nxml.txt.nlp	24834170	SENT21	11	11	19	19	bevacizumab	EGFR	PA130232992	1956	0.625
NULL	Allergy_Asthma_Immunol_Res_2014_Sep_18_6(5)_376-388.nxml.txt.nlp	25228994	SENT133	24	24	17	17	formoterol	DPI	PA134687907	1832	0.625
NULL	Mol_Cancer_2012_Sep_6_11_63.nxml.txt.nlp	22954255	SENT79	3	3	5	5	lipase	HSL	PA450239	3991	0.625
NULL	Front_Genet_2012_Nov_12_3_235.nxml.txt.nlp	23162568	SENT365	6	6	3	3	methamphetamine	CYP2D6	PA450403	1565	0.625
NULL	Front_Pharmacol_2014_Nov_25_5_256.nxml.txt.nlp	25505414	SENT110	3	3	6	6	allopregnanolone	KCC2	PA142320763	57468	0.625
NULL	Pain_2012_Apr_153(4)_775-783.nxml.txt.nlp	22325744	SENT158	12	12	20	20	naloxone	P28	PA450586	9446;7802;9527	0.625
NULL	Diabetes_Care_2012_Feb_16_35(2)_327-333.nxml.txt.nlp	22179958	SENT26	12	12	3	3	metformin	B12	PA450395	7126;4709	0.625
NULL	J_Carcinog_2013_Dec_31_12_22.nxml.txt.nlp	24574860	SENT281	12	12	8	8	cabozantinib	AXL	PA165906891	558	0.625
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1437-1448.nxml.txt.nlp	24056706	SENT111	10	10	16	16	furafylline	CYP2C9	PA452614	1559	0.625
NULL	J_Antimicrob_Chemother_2013_May_1_68(5)_1066-1070.nxml.txt.nlp	23378414	SENT71	6	6	31	31	cloxacillin	NOV	PA449059	4856;5361;6134	0.625
NULL	J_Clin_Biochem_Nutr_2011_May_13_48(3)_214-221.nxml.txt.nlp	21562641	SENT210	11	11	7	7	ethanol	flower	PA448073	11094	0.625
NULL	N_Am_J_Med_Sci_2014_Aug_6(8)_422-424.nxml.txt.nlp	25210678	SENT50	4	4	15	15	rituximab	CHOP	PA451261	1649	0.625
NULL	Int_J_Anal_Chem_2014_Nov_18_2014_536823.nxml.txt.nlp	25484901	SENT74	17	17	23	23	glutaraldehyde	DTNB	PA449777	1838	0.625
NULL	Cell_Death_Dis_2013_Oct_3_4(10)_e830.nxml.txt.nlp	24091673	SENT23	33	33	10	10	doxorubicin	APO-1	PA449412	355	0.625
NULL	Trials_2013_Dec_10_14_424.nxml.txt.nlp	24325953	SENT94	5	5	8	8	hydromorphone	PCA	PA449918	28982	0.625
NULL	Nat_Methods_2011_Jun_24_8(6)_487-493.nxml.txt.nlp	21516115	SENT74	16	16	10	10	gefitinib	EGF	PA131301952	1950	0.625
NULL	Arch_Med_Sci_2013_Apr_20_9(2)_332-339.nxml.txt.nlp	23671446	SENT159	9	9	6	6	midazolam	p38	PA450496	10598;1432;7965	0.625
NULL	Ann_Surg_Treat_Res_2014_Feb_22_86(2)_68-75.nxml.txt.nlp	24761411	SENT114	0	0	6	6	resveratrol	survivin		332	0.625
NULL	Psychiatr_Genet_2013_Aug_28_23(4)_153-162.nxml.txt.nlp	23811784	SENT157	13	13	8	8	clozapine	ARRB2	PA449061	409	0.625
NULL	Cancer_Metab_2013_Feb_4_1_7.nxml.txt.nlp	24280108	SENT95	8	8	4	4	oxygen	MYC	PA450744	4609	0.625
NULL	Exp_Lung_Res_2013_Oct_1_39(8)_336-348.nxml.txt.nlp	23919450	SENT118	7	7	18	18	thrombin	PAR-1	PA451674	2011;2149	0.625
NULL	Blood_Res_2014_Sep_25_49(3)_154-161.nxml.txt.nlp	25325034	SENT66	0	0	16	16	fluorescein	San	PA164746009	80218	0.625
NULL	Oncologist_2010_Nov_4_15(11)_1135-1146.nxml.txt.nlp	21051659	SENT136	6	6	14	14	sorafenib	IFN	PA7000	3439	0.625
NULL	Cancer_2014_Apr_8_120(8)_1145-1154.nxml.txt.nlp	24501009	SENT8	14	14	21	21	erlotinib	EGFR	PA134687924	1956	0.625
NULL	Food_Dig_2012_Dec_7_3(1-3)_63-77.nxml.txt.nlp	23293684	SENT105	8	8	10	10	lipase	BSSL	PA450239	1056	0.625
NULL	Diabetes_Care_2012_Feb_16_35(2)_196-197.nxml.txt.nlp	22228743	SENT29	19	19	21	21	fluorescein	CD41	PA164746009	3674	0.625
NULL	Brain_Struct_Funct_2015_Oct_16_220_193-203.nxml.txt.nlp	24129767	SENT155	9	9	5	5	probenecid	OATP1C1	PA451106	53919	0.625
NULL	Oncotarget_2013_Nov_7_4(12)_2550-2566.nxml.txt.nlp	24334291	SENT123	12	12	8	8	dasatinib	TIGAR	PA162372878	57103	0.625
NULL	Mol_Cell_Endocrinol_2013_Mar_10_367(1-2)_98-108.nxml.txt.nlp	23291342	SENT207	9	9	11	11	diethylstilbestrol	DES	PA449307	1674	0.625
NULL	Cancers_(Basel)_2014_Aug_12_6(3)_1631-1669.nxml.txt.nlp	25119536	SENT1938	4	4	16	16	imatinib	NF-kappaB	PA10804	4790	0.625
NULL	Cases_J_2009_Mar_10_2_6464.nxml.txt.nlp	20181162	SENT58	25	25	22	22	ribavirin	IFN	PA451241	3439	0.625
NULL	Int_J_Mol_Sci_2014_Sep_29_15(10)_17411-17441.nxml.txt.nlp	25268615	SENT240	30	30	12	12	docetaxel	MRP2	PA449383	100130958;57626;1244	0.625
NULL	Breast_Cancer_Res_2002_Jul_24_4(6)_R12.nxml.txt.nlp	12473173	SENT188	20	20	13	13	ethanol	PCB	PA448073	5091	0.625
NULL	Int_J_Mol_Sci_2014_Nov_25_15(12)_21703-21722.nxml.txt.nlp	25429431	SENT147	0	0	10	10	curcumin	p38	PA151958596	10598;1432;7965	0.625
NULL	Exp_Ther_Med_2014_Jun_3_7(6)_1762-1766.nxml.txt.nlp	24926381	SENT169	15	15	6	6	resveratrol	GCLM		2730	0.625
NULL	Ann_Surg_Treat_Res_2014_Feb_22_86(2)_68-75.nxml.txt.nlp	24761411	SENT174	3	3	15	15	resveratrol	survivin		332	0.625
NULL	Oncotarget_2011_Sep_9_2(9)_658-668.nxml.txt.nlp	21911919	SENT117	18	18	9	9	daunorubicin	HO-1	PA449212	3162	0.625
NULL	Lipids_Health_Dis_2011_Feb_28_10_38.nxml.txt.nlp	21352602	SENT105	10	10	33	33	ezetimibe	NPC1L1	PA10816	29881	0.625
NULL	Oncoimmunology_2013_Sep_1_2(9)_e25789.nxml.txt.nlp	24244905	SENT25	8	8	31	31	cyclophosphamide	OX40	PA449165	7293	0.625
NULL	Tob_Induc_Dis_2002_Jan_15_1(1)_3.nxml.txt.nlp	NULL	SENT260	16	16	22	22	hyaluronan	CD44	PA165958431	960	0.625
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT105	0	0	12	12	phenformin	p53	PA1000	7157	0.625
NULL	Exp_Ther_Med_2014_Dec_24_8(6)_1677-1682.nxml.txt.nlp	25371714	SENT139	2	2	10	10	isoproterenol	HIF-1	PA450121	29072	0.625
NULL	DNA_Res_2010_Feb_4_17(1)_37-50.nxml.txt.nlp	20047946	SENT305	13	13	11	11	hemin	B12	PA449849	7126;4709	0.625
NULL	Drug_Target_Insights_2007_Sep_18_2_221-228.nxml.txt.nlp	21901076	SENT187	16	16	20	20	dextran	CD4	PA449261	920	0.625
NULL	Oncoscience_2014_Apr_30_1(4)_272-282.nxml.txt.nlp	25594019	SENT25	30	30	18	18	lipase	NAAA	PA450239	27163	0.625
NULL	Oncol_Rep_2014_Feb_13_31(2)_581-588.nxml.txt.nlp	24337105	SENT117	19	19	9	9	capsaicin	ATF4	PA448776	468	0.625
NULL	Mol_Cancer_2009_Nov_19_8_108.nxml.txt.nlp	19925669	SENT40	26	26	31	31	doxorubicin	CRT	PA449412	811	0.625
NULL	Mol_Vis_2012_Nov_12_18_2673-2686.nxml.txt.nlp	23170060	SENT46	11	11	5	5	l-cysteine	CDO	PA449173	50937	0.625
NULL	Arthritis_Res_Ther_2012_Jun_12_14(3)_R142.nxml.txt.nlp	22691272	SENT14	5	5	15	15	mianserin	IL-17	PA134687937	3605	0.625
NULL	Mol_Cancer_2014_Jul_2_13_163.nxml.txt.nlp	24990559	SENT17	2	2	12	12	tamoxifen	LSR	PA451581	51599	0.625
NULL	J_Gen_Physiol_2012_Nov_140(5)_557-566.nxml.txt.nlp	23109717	SENT51	7	7	2	2	tetracycline	HCN	PA451640	378938	0.625
NULL	Biomed_Res_Int_2014_Jan_29_2014_831845.nxml.txt.nlp	24605337	SENT94	9	9	11	11	bupivacaine	S6K1	PA135057240	6198	0.625
NULL	Front_Oncol_2014_Apr_21_4_82.nxml.txt.nlp	24795859	SENT190	16	16	10	10	maytansine	CD19	PA165291473	930	0.625
NULL	Int_J_Endocrinol_2014_Aug_11_2014_312452.nxml.txt.nlp	25183970	SENT25	0	0	16	16	liraglutide	GLP-1	PA165958364	100125288	0.625
NULL	Brain_Sci_2012_Nov_27_2(4)_667-683.nxml.txt.nlp	24371520	SENT144	6	6	2	2	estradiol	AVP	PA449503	114548;551	0.625
NULL	Breast_Cancer_(Auckl)_2011_Jul_27_5_175-199.nxml.txt.nlp	21863131	SENT381	2	2	27	27	capecitabine	San	PA448771	80218	0.625
NULL	Protein_Cell_2014_Jul_2_5(7)_544-551.nxml.txt.nlp	24691905	SENT142	7	7	2	2	neomycin	p53	PA450608	7157	0.625
NULL	Pharmaceuticals_(Basel)_2011_Jan_12_4(1)_187-201.nxml.txt.nlp	NULL	SENT155	2	2	23	23	l-arginine	ARG	PA448478	473;27	0.625
NULL	J_Orthop_Traumatol_2013_Jun_23_14(2)_143-145.nxml.txt.nlp	22358780	SENT27	16	16	33	33	isoniazid	ETB	PA450112	1910	0.625
NULL	Oncol_Lett_2014_Jun_28_7(6)_2093-2098.nxml.txt.nlp	24932295	SENT4	10	10	19	19	resveratrol	PI3K		5290	0.625
NULL	Oncotarget_2011_Sep_9_2(9)_658-668.nxml.txt.nlp	21911919	SENT109	21	21	9	9	daunorubicin	HO-1	PA449212	3162	0.625
NULL	Oncoimmunology_2012_Dec_1_1(9)_1577-1583.nxml.txt.nlp	23264903	SENT44	6	6	4	4	cyclophosphamide	CTX	PA449165	1593	0.625
NULL	Eur_J_Med_Res_2014_Jun_24_19(1)_34.nxml.txt.nlp	24961604	SENT98	33	33	30	30	vincristine	BCL11A	PA451879	53335	0.625
NULL	Mol_Clin_Oncol_2013_Sep_24_1(5)_918-924.nxml.txt.nlp	24649271	SENT91	2	2	4	4	gemcitabine	EGFR	PA449748	1956	0.625
NULL	Pharmaceuticals_(Basel)_2012_Aug_30_5(9)_890-898.nxml.txt.nlp	24280696	SENT299	29	29	21	21	fludarabine	TP53	PA449655	7157	0.625
NULL	Bioinformation_2012_Jan_6_8(1)_13-19.nxml.txt.nlp	22359429	SENT138	14	14	28	28	calcein	MRP1	PA132595336	4437	0.625
NULL	Clin_Exp_Otorhinolaryngol_2014_Sep_1_7(3)_175-180.nxml.txt.nlp	25177432	SENT96	8	8	2	2	heparin	entactin	PA449855	4811	0.625
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1986-2011.nxml.txt.nlp	25268165	SENT166	26	26	33	33	cisplatin	CD133	PA449014	8842	0.625
NULL	Chiropr_Osteopat_2006_Apr_6_14_6.nxml.txt.nlp	16597343	SENT38	10	10	19	19	halothane	CO2	PA449845	4513	0.625
NULL	Breast_Cancer_Res_2007_Mar_2_9(2)_205.nxml.txt.nlp	NULL	SENT26	11	11	20	20	canertinib	EGFR	PA134687925	1956	0.625
NULL	Cancer_Cell_Int_2013_Jan_15_13_3.nxml.txt.nlp	23320839	SENT142	16	16	9	9	doxorubicin	ABCC3	PA449412	8714	0.625
NULL	Cancer_Med_2012_Aug_31_1(1)_89-95.nxml.txt.nlp	23342258	SENT34	21	21	18	18	etoposide	CTX	PA449552	1593	0.625
NULL	J_Hum_Genet_2013_Jun_2_58(6)_306-312.nxml.txt.nlp	23635953	SENT156	10	10	19	19	estradiol	TSPYL5	PA449503	85453	0.625
NULL	Biol_Open_2014_Sep_12_3(10)_937-946.nxml.txt.nlp	25217618	SENT170	18	18	33	33	niclosamide	p110	PA165958408	9733	0.625
NULL	Diabetes_Care_2012_Feb_16_35(2)_327-333.nxml.txt.nlp	22179958	SENT143	47	47	38	38	metformin	B12	PA450395	7126;4709	0.625
NULL	Br_J_Cancer_2010_Aug_24_103(5)_649-655.nxml.txt.nlp	20664591	SENT244	8	8	20	20	irinotecan	GEM	PA450085	2669	0.625
NULL	Mol_Biol_Int_2012_Jun_25_2012_643856.nxml.txt.nlp	22792463	SENT20	25	25	33	33	proguanil	CYP2C19	PA451124	1557	0.625
NULL	Arthritis_Res_Ther_2009_Jun_29_11(3)_R100.nxml.txt.nlp	19563672	SENT219	22	22	28	28	infliximab	IFN	PA452639	3439	0.625
NULL	Asian-Australas_J_Anim_Sci_2015_Jan_28(1)_127-134.nxml.txt.nlp	25557684	SENT172	15	15	5	5	lipase	FATP5	PA450239	10998	0.625
NULL	Acta_Pharmacol_Sin_2009_Apr_9_30(4)_467-477.nxml.txt.nlp	19270721	SENT168	14	14	17	17	cisplatin	IL-24	PA449014	11009	0.625
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Dec_17_3(12)_e152.nxml.txt.nlp	25518025	SENT17	43	43	35	35	ketoconazole	CYP3A	PA450146	1574	0.625
NULL	Interdiscip_Toxicol_2011_Jun_4(2)_78-84.nxml.txt.nlp	21753903	SENT4	34	34	14	14	estradiol	CYP2E1	PA449503	1571	0.625
NULL	Arthritis_Res_Ther_2013_Apr_17_15(2)_R51.nxml.txt.nlp	23594962	SENT300	26	26	33	33	muraglitazar	IL-6	PA162356187	3569	0.625
NULL	J_Int_AIDS_Soc_2011_Feb_9_14_7.nxml.txt.nlp	21306608	SENT74	21	21	23	23	tenofovir	ATV	PA10204	4683	0.625
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT6	1	1	3	3	trastuzumab	STAT3	PA451743	6774	0.625
NULL	J_Hematol_Oncol_2013_Aug_2_6_55.nxml.txt.nlp	23915913	SENT49	17	17	9	9	lenalidomide	CRBN	PA162363968	51185	0.625
NULL	J_Inflamm_(Lond)_2006_May_4_3_8.nxml.txt.nlp	16674821	SENT40	13	13	21	21	pp2	SKI-1		8720	0.624
NULL	Front_Neurosci_2014_Dec_5_8_398.nxml.txt.nlp	25538552	SENT218	13	13	2	2	glucose	gamma	PA449773	9913	0.624
NULL	J_Gen_Intern_Med_2007_Feb_17_22(2)_171-176.nxml.txt.nlp	17356982	SENT42	24	24	8	8	buprenorphine	NCM	PA448685	57703	0.624
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT138	10	10	30	30	nadh	AMPK	PA164755085	5563	0.624
NULL	J_Cell_Mol_Med_2014_Aug_1_18(8)_1599-1611.nxml.txt.nlp	24889822	SENT238	0	0	11	11	resveratrol	SIRT1		23411	0.624
NULL	Int_J_Biomed_Sci_2014_Dec_10(4)_229-235.nxml.txt.nlp	25598752	SENT105	2	2	4	4	abatacept	ADAM17	PA164747080	6868	0.624
NULL	Ann_Hematol_2014_Mar_18_93(8)_1335-1344.nxml.txt.nlp	24638841	SENT92	8	8	19	19	rituximab	CHOP	PA451261	1649	0.624
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jun_23_68(Pt_7)_o2163.nxml.txt.nlp	22798835	SENT74	22	22	13	13	ethanol	mol	PA448073	90527	0.624
NULL	J_Korean_Med_Sci_2010_Aug_21_25(8)_1222-1227.nxml.txt.nlp	20676337	SENT157	24	24	21	21	aminophylline	LPA	PA164781029	4018	0.624
NULL	Mol_Cancer_2007_May_11_6_33.nxml.txt.nlp	17498302	SENT93	0	0	6	6	daunorubicin	Mcl-1	PA449212	4170	0.624
NULL	Mol_Cancer_2009_Aug_28_8_68.nxml.txt.nlp	19715609	SENT119	0	0	8	8	docetaxel	PC3	PA449383	57332;7832;5122	0.624
NULL	Acta_Pharmacol_Sin_2014_Jul_9_35(7)_853-861.nxml.txt.nlp	24909512	SENT125	22	22	2	2	ethanol	ANOVA	PA448073	4858	0.624
NULL	J_Med_Chem_2014_Jul_24_57(14)_5995-6007.nxml.txt.nlp	24960438	SENT7	14	14	8	8	estradiol	HSD2	PA449503	6060	0.624
NULL	Indian_J_Crit_Care_Med_2012_Jul-Sep_16(3)_136-140.nxml.txt.nlp	23188953	SENT57	6	6	8	8	cefoxitin	CTX	PA448856	1593	0.624
NULL	Mol_Cancer_2012_Aug_6_11_52.nxml.txt.nlp	22867098	SENT90	16	16	31	31	tranylcypromine	KDM1A	PA451741	23028	0.624
NULL	J_Cell_Mol_Med_2014_Dec_9_18(12)_2425-2436.nxml.txt.nlp	25297942	SENT184	9	9	6	6	cisplatin	HOTAIR	PA449014	100124700	0.624
NULL	Arch_Osteoporos_2009_Dec_18_4(1-2)_1-8.nxml.txt.nlp	20234790	SENT76	20	20	28	28	ibandronate	PTH	PA10270	5741	0.624
NULL	Oncotarget_2014_Jun_26_5(14)_5559-5569.nxml.txt.nlp	24980819	SENT199	23	23	12	12	vemurafenib	p53	PA165946873	7157	0.624
NULL	Antiviral_Res_2009_May_82(2)_A99-A109.nxml.txt.nlp	19176219	SENT1108	23	23	31	31	efavirenz	P-gp	PA449441	5243	0.624
NULL	Arthritis_Res_Ther_2012_Jun_12_14(3)_R142.nxml.txt.nlp	22691272	SENT117	0	0	11	11	mianserin	IL-17	PA134687937	3605	0.624
NULL	Front_Oncol_2012_Sep_12_2_114.nxml.txt.nlp	22988546	SENT59	11	11	9	9	cyclophosphamide	CTX	PA449165	1593	0.624
NULL	Food_Chem_2014_Mar_1_146(100)_479-484.nxml.txt.nlp	24176371	SENT106	9	9	18	18	lipase	ANOVA	PA450239	4858	0.624
NULL	Clinics_(Sao_Paulo)_2010_Oct_65(10)_941-946.nxml.txt.nlp	21120291	SENT135	13	13	9	9	bupivacaine	sit	PA135057240	55733	0.624
NULL	Neural_Dev_2011_Feb_1_6_6.nxml.txt.nlp	21284846	SENT366	32	32	12	12	paraformaldehyde	HET	PA450790	6294	0.624
NULL	Mol_Biol_Cell_2014_May_1_25(9)_1411-1420.nxml.txt.nlp	24623724	SENT116	21	21	30	30	doxycycline	ATF6	PA449415	22926	0.624
NULL	Braz_J_Med_Biol_Res_2012_Sep_21_45(12)_1240-1243.nxml.txt.nlp	22983178	SENT81	13	13	9	9	lipase	FAAH	PA450239	79152;2166	0.624
NULL	Nat_Med_2012_Jul_18(7)_1118-1122.nxml.txt.nlp	22683780	SENT118	26	26	36	36	crizotinib	HGF	PA165946122	3569;6654;3082	0.624
NULL	Curr_Cardiol_Rev_2009_Aug_5(3)_216-222.nxml.txt.nlp	20676280	SENT139	24	24	32	32	lipase	HSL	PA450239	3991	0.624
NULL	Adolesc_Health_Med_Ther_2014_Nov_27_5_211-221.nxml.txt.nlp	25473324	SENT43	0	0	7	7	aripiprazole	5-HT1A	PA10026	3350	0.624
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Jun_25_3(6)_e120.nxml.txt.nlp	24964282	SENT19	17	17	32	32	itraconazole	CYP3A4	PA450132	1576	0.624
NULL	Crit_Care_2011_Sep_19_15(5)_R217.nxml.txt.nlp	21929764	SENT122	12	12	25	25	terlipressin	CTRL	PA164781020	1506	0.624
NULL	Clin_Pharmacol_2010_Jun_22_2_105-110.nxml.txt.nlp	22291493	SENT14	11	11	17	17	sibutramine	UCP2	PA451344	7351	0.624
NULL	Breast_Cancer_Res_2004_Jun_18_6(4)_179-180.nxml.txt.nlp	NULL	SENT41	5	5	2	2	trastuzumab	aromatase	PA451743	1588	0.624
NULL	Breast_Cancer_Res_2014_May_28_16(3)_R53.nxml.txt.nlp	24886537	SENT343	22	22	20	20	tamoxifen	VAV3	PA451581	10451	0.624
NULL	Cancer_Cell_Int_2013_Oct_11_13_97.nxml.txt.nlp	24119761	SENT180	14	14	16	16	trastuzumab	EGF	PA451743	1950	0.624
NULL	J_Immunol_Res_2014_May_25_2014_608930.nxml.txt.nlp	24971371	SENT103	5	5	12	12	montelukast	CysLT1	PA450546	10800	0.624
NULL	Biologics_2013_Apr_15_7_77-90.nxml.txt.nlp	23723688	SENT82	3	3	6	6	cetuximab	CRT	PA10040	811	0.624
NULL	Clin_Psychopharmacol_Neurosci_2011_Apr_30_9(1)_36-43.nxml.txt.nlp	23431025	SENT18	3	3	5	5	haloperidol	FLI	PA449841	2314	0.624
NULL	Oxid_Med_Cell_Longev_2010_Nov-Dec_3(6)_404-413.nxml.txt.nlp	21311213	SENT255	10	10	15	15	doxorubicin	ANOVA	PA449412	4858	0.624
NULL	Antimicrob_Agents_Chemother_2014_Oct_58(10)_5900-5908.nxml.txt.nlp	25070091	SENT117	5	5	28	28	metoprolol	CYP2D6	PA450480	1565	0.624
NULL	Breast_Cancer_Res_2012_Feb_14_14(1)_R30.nxml.txt.nlp	22333315	SENT170	9	9	11	11	celecoxib	CXCL9	PA448871	4283	0.624
NULL	Endocrinol_Diabetes_Metab_Case_Rep_2014_Feb_1_2014_130079.nxml.txt.nlp	24683483	SENT60	22	22	10	10	glucose	IGF1	PA449773	3479	0.624
NULL	Eur_J_Endocrinol_2011_Jan_164(1)_69-74.nxml.txt.nlp	20961967	SENT4	23	23	5	5	metformin	OPG	PA450395	690	0.624
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT254	0	0	10	10	pemetrexed	UNG	PA10810	7374	0.624
NULL	Br_J_Cancer_2010_Jan_5_102(1)_80-86.nxml.txt.nlp	19920817	SENT67	38	38	30	30	sunitinib	IFN	PA162372840	3439	0.624
NULL	Arthritis_Res_Ther_2013_Jan_25_15(1)_R20.nxml.txt.nlp	23351360	SENT168	11	11	20	20	rituximab	C3b	PA451261	718	0.624
NULL	Crit_Care_2010_Nov_5_14(6)_R200.nxml.txt.nlp	21054850	SENT132	11	11	13	13	vasopressin	AVP	PA451858	114548;551	0.624
NULL	Cases_J_2009_Dec_10_2_9303.nxml.txt.nlp	20062627	SENT90	26	26	40	40	clopidogrel	DES	PA449053	1674	0.624
NULL	Cancers_(Basel)_2011_Mar_29_3(2)_1732-1743.nxml.txt.nlp	21738852	SENT87	10	10	18	18	thyroglobulin	TSHR	PA164754910	7253	0.624
NULL	Open_Orthop_J_2008_Jul_14_2_115-120.nxml.txt.nlp	19478935	SENT7	9	9	16	16	dexrazoxane	AMF	PA449259	2821	0.624
NULL	Mol_Cancer_2014_Feb_4_13_21.nxml.txt.nlp	24495750	SENT121	0	0	7	7	oxaliplatin	AKT	PA131285527	207	0.624
NULL	Int_J_Endocrinol_2013_Jul_28_2013_517239.nxml.txt.nlp	23983687	SENT30	2	2	4	4	estradiol	AMH	PA449503	268	0.624
NULL	Oxid_Med_Cell_Longev_2012_Jan_19_2012_390678.nxml.txt.nlp	22315655	SENT8	16	16	13	13	gliclazide	NAC	PA10892	22861	0.624
NULL	Evid_Based_Complement_Alternat_Med_2012_Aug_25_2012_946867.nxml.txt.nlp	21876716	SENT118	23	23	12	12	oseltamivir	TRAIL	PA450721	8743	0.624
NULL	Biologics_2014_Feb_15_8_67-81.nxml.txt.nlp	24600203	SENT119	0	0	9	9	daclizumab	San	PA164764446	80218	0.624
NULL	Acta_Pharmacol_Sin_2014_Jul_9_35(7)_889-898.nxml.txt.nlp	24909515	SENT214	36	36	25	25	methamphetamine	SULT2A1	PA450403	6822	0.624
NULL	Oncogene_2014_May_8_33(19)_2478-2486.nxml.txt.nlp	23752180	SENT127	12	12	21	21	phenol	FBS	PA450913	64319;26269	0.624
NULL	Cardiol_Res_Pract_2012_Apr_22_2012_181394.nxml.txt.nlp	22577589	SENT218	2	2	11	11	atorvastatin	TLR4	PA448500	7099	0.624
NULL	Clin_Mol_Hepatol_2014_Dec_24_20(4)_338-344.nxml.txt.nlp	25548738	SENT135	25	25	23	23	boceprevir	BOC	PA165948902	91653	0.624
NULL	Chin_J_Cancer_2012_Feb_31(2)_73-99.nxml.txt.nlp	22098950	SENT99	17	17	12	12	mitoxantrone	CD38	PA450526	952	0.624
NULL	Cancers_(Basel)_2013_Oct_22_5(4)_1271-1305.nxml.txt.nlp	24202446	SENT287	31	31	15	15	temozolomide	IL-24	PA451609	11009	0.624
NULL	J_Asthma_Allergy_2013_Jul_1_6_93-101.nxml.txt.nlp	23843695	SENT199	19	19	12	12	formoterol	BDP	PA134687907	10620;152926	0.624
NULL	Acta_Pharmacol_Sin_2011_Aug_18_32(8)_991-998.nxml.txt.nlp	21765445	SENT61	34	34	12	12	streptomycin	F12	PA451512	2161	0.624
NULL	J_Cancer_2013_Aug_16_4(7)_557-565.nxml.txt.nlp	23983820	SENT34	28	28	22	22	lapatinib	HER2	PA152241907	2064	0.624
NULL	J_Lipid_Res_2013_Feb_54(2)_425-435.nxml.txt.nlp	23220585	SENT28	8	8	31	31	lipase	ATGL	PA450239	57104	0.624
NULL	Crit_Care_2009_Jul_22_13(4)_169.nxml.txt.nlp	19664189	SENT1	6	6	8	8	vasopressin	AVP	PA451858	114548;551	0.624
NULL	FEBS_Open_Bio_2012_Mar_5_2_32-36.nxml.txt.nlp	23650578	SENT13	0	0	3	3	isoproterenol	PDK4	PA450121	5166	0.624
NULL	Br_J_Cancer_2002_Jan_21_86(2)_218-221.nxml.txt.nlp	11870509	SENT11	6	6	8	8	tamoxifen	BRCA1	PA451581	672	0.624
NULL	Front_Cell_Neurosci_2014_Jul_30_8_203.nxml.txt.nlp	25126056	SENT1746	10	10	3	3	allopregnanolone	NPC1	PA142320763	4864	0.624
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT165	3	3	5	5	curcumin	TRAIL	PA151958596	8743	0.624
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT193	0	0	16	16	metformin	p53	PA450395	7157	0.624
NULL	Alzheimers_Res_Ther_2013_Nov_26_5(6)_59.nxml.txt.nlp	24280255	SENT4	8	8	26	26	choline	B12	PA448976	7126;4709	0.624
NULL	Braz_J_Med_Biol_Res_2013_Aug_13_46(8)_650-658.nxml.txt.nlp	23969971	SENT189	0	0	7	7	cisplatin	STAT3	PA449014	6774	0.624
NULL	Mol_Cancer_2010_Jun_25_9_166.nxml.txt.nlp	20579378	SENT224	32	32	26	26	gefitinib	EGR1	PA131301952	1958	0.624
NULL	Mol_Biol_Cell_2014_Jun_1_25(11)_1782-1792.nxml.txt.nlp	24719457	SENT210	10	10	6	6	nicotine	p53	PA450626	7157	0.624
NULL	Indian_J_Anaesth_2010_Mar-Apr_54(2)_127-131.nxml.txt.nlp	20661350	SENT67	9	9	15	15	nimodipine	VIII	PA450633	1351	0.624
NULL	Br_J_Cancer_2011_Jul_12_105(2)_212-220.nxml.txt.nlp	21694723	SENT40	2	2	40	40	curcumin	CD133	PA151958596	8842	0.624
NULL	J_Neurochem_2008_Jan_104(1)_74-88.nxml.txt.nlp	17995938	SENT146	14	14	39	39	forskolin	Bcl-2	PA146096022	596	0.624
NULL	Pharm_Methods_2011_Jan-Mar_2(1)_3-8.nxml.txt.nlp	23781422	SENT168	24	24	14	14	codeine	FAD	PA449088	5663;675;2177	0.624
NULL	Subst_Abuse_Rehabil_2013_Feb_8_4_29-43.nxml.txt.nlp	24648786	SENT11	29	29	26	26	methamphetamine	AMPH	PA450403	273	0.624
NULL	Biomed_Res_Int_2014_Feb_6_2014_323594.nxml.txt.nlp	24689036	SENT380	10	10	3	3	raloxifene	EGFR	PA451221	1956	0.624
NULL	AIDS_Res_Ther_2011_Oct_6_8_36.nxml.txt.nlp	21978457	SENT142	6	6	18	18	zinc	ZIP4	PA451956	55630	0.624
NULL	Toxins_(Basel)_2010_Mar_31_2(4)_517-551.nxml.txt.nlp	22069598	SENT110	19	19	32	32	curcumin	IL-8	PA151958596	3576	0.624
NULL	J_Korean_Med_Sci_2007_Apr_30_22(2)_283-289.nxml.txt.nlp	17449938	SENT111	2	2	7	7	minoxidil	P21	PA450521	1026;9338	0.624
NULL	Cancer_Cell_Int_2012_Feb_21_12_5.nxml.txt.nlp	22353776	SENT131	10	10	16	16	sorafenib	Mcl-1	PA7000	4170	0.624
NULL	Clin_Psychopharmacol_Neurosci_2013_Dec_24_11(3)_144-151.nxml.txt.nlp	24465251	SENT40	0	0	8	8	haloperidol	IFN	PA449841	3439	0.624
NULL	Mol_Cell_Proteomics_2012_Feb_6_11(2)_M111_015222.nxml.txt.nlp	22147731	SENT295	18	18	9	9	cetuximab	JAG1	PA10040	182	0.624
NULL	Emerg_Infect_Dis_2012_Jun_18(6)_1019-1020.nxml.txt.nlp	22608263	SENT34	14	14	20	20	amikacin	TOB	PA164744372	10140	0.624
NULL	Allergy_Asthma_Immunol_Res_2014_Nov_19_6(6)_548-557.nxml.txt.nlp	25374755	SENT88	6	6	17	17	lovastatin	CCL24	PA450272	6369	0.624
NULL	Arthritis_Res_Ther_2005_Feb_18_7(3)_R476-R484.nxml.txt.nlp	15899034	SENT135	20	20	25	25	thrombin	Rho	PA451674	29984	0.624
NULL	Crit_Care_2006_Feb_3_10(1)_R24.nxml.txt.nlp	16469128	SENT149	13	13	21	21	heparin	TP2	PA449855	7015;7142	0.624
NULL	Case_Rep_Ophthalmol_Med_2011_Jan_31_2011_679751.nxml.txt.nlp	22606470	SENT38	14	14	22	22	bevacizumab	hole	PA130232992	80757	0.624
NULL	Sci_Rep_2014_Dec_19_4_7571.nxml.txt.nlp	25524368	SENT59	22	22	32	32	estradiol	mer	PA449503	10461	0.624
NULL	J_Mol_Signal_2014_Aug_8_9_8.nxml.txt.nlp	25237386	SENT84	12	12	5	5	ns-398	PTGS1		5742	0.624
NULL	Nat_Med_2012_Jul_18(7)_1118-1122.nxml.txt.nlp	22683780	SENT57	41	41	36	36	crizotinib	HGF	PA165946122	3569;6654;3082	0.624
NULL	Cancer_Res_Treat_2014_Jan_15_46(1)_55-64.nxml.txt.nlp	24520224	SENT205	18	18	7	7	oxaliplatin	CEA	PA131285527	5670;1087	0.624
NULL	Br_J_Cancer_2011_Jul_12_105(2)_212-220.nxml.txt.nlp	21694723	SENT6	15	15	9	9	curcumin	STAT3	PA151958596	6774	0.624
NULL	J_Biol_Chem_2013_Nov_1_288(44)_31715-31727.nxml.txt.nlp	24025329	SENT173	27	27	24	24	lamivudine	IFN	PA450163	3439	0.624
NULL	Hematol_Rep_2011_Jan_21_3(1)_e2.nxml.txt.nlp	22184524	SENT44	10	10	16	16	pyrazinamide	MOF	PA451182	84148	0.624
NULL	Acta_Myol_2012_Dec_31(3)_184-195.nxml.txt.nlp	23620650	SENT90	5	5	0	0	collagenase	IL6	PA449107	3569	0.624
NULL	J_Parasitol_Res_2012_Sep_28_2012_921715.nxml.txt.nlp	21966590	SENT25	13	13	11	11	artemisinin	ACT	PA165111696	12;11332;9457;641455	0.624
NULL	Breast_Cancer_Res_Treat_2013_Sep_1_141(2)_243-248.nxml.txt.nlp	23996142	SENT150	13	13	8	8	tamoxifen	SULT1A1	PA451581	6817	0.624
NULL	Adv_Hematol_2012_Jan_18_2012_195484.nxml.txt.nlp	22312366	SENT22	9	9	14	14	vincristine	CHOP	PA451879	1649	0.624
NULL	Drug_Target_Insights_2007_Aug_17_2_197-207.nxml.txt.nlp	21901074	SENT74	0	0	32	32	suramin	IGF1	PA10292	3479	0.624
NULL	J_Anaesthesiol_Clin_Pharmacol_2011_Jul-Sep_27(3)_344-348.nxml.txt.nlp	21897505	SENT123	10	10	0	0	clonidine	Ray	PA449051	26751	0.624
NULL	J_Obes_2010_Jul_28_2010_748048.nxml.txt.nlp	20798882	SENT109	29	29	31	31	vasopressin	AVP	PA451858	114548;551	0.624
NULL	J_Mol_Signal_2012_May_31_7_6.nxml.txt.nlp	22651859	SENT162	10	10	23	23	neomycin	14-3-3	PA450608	10971	0.624
NULL	Breast_Cancer_Res_2009_Jun_23_11(Suppl_1)_S15.nxml.txt.nlp	NULL	SENT9	11	11	23	23	tamoxifen	HER2	PA451581	2064	0.624
NULL	Int_J_Nanomedicine_2012_May_8_7_2373-2388.nxml.txt.nlp	22661891	SENT264	17	17	19	19	atazanavir	ATV	PA10251	4683	0.624
NULL	J_Cell_Biol_1998_Jun_29_141(7)_1529-1537.nxml.txt.nlp	9647646	SENT148	1	1	17	17	genistein	PI3	PA165109660	5266	0.624
NULL	Crit_Care_2009_Jul_10_13(4)_R113.nxml.txt.nlp	19591694	SENT108	1	1	3	3	vasopressin	AVP	PA451858	114548;551	0.624
NULL	Evid_Based_Complement_Alternat_Med_2011_Jan_20_2011_713523.nxml.txt.nlp	21318104	SENT103	21	21	27	27	verapamil	P-gp	PA451868	5243	0.624
NULL	JAKSTAT_2014_Jun_12_3_e29554.nxml.txt.nlp	25105067	SENT58	13	13	18	18	propofol	AKT	PA451141	207	0.624
NULL	Arch_Plast_Surg_2012_Sep_12_39(5)_540-545.nxml.txt.nlp	23094252	SENT12	11	11	22	22	remifentanil	TCI	PA451232	6947	0.624
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT128	14	14	0	0	disopyramide	CYP1A2	PA449373	1544	0.624
NULL	Arch_Med_Sci_2013_Oct_31_9(5)_837-842.nxml.txt.nlp	24273566	SENT122	11	11	13	13	vasopressin	AVP	PA451858	114548;551	0.624
NULL	Clin_Mol_Hepatol_2013_Sep_30_19(3)_195-209.nxml.txt.nlp	24133659	SENT288	14	14	0	0	entecavir	LAM	PA164784025	7249;7248	0.624
NULL	Environ_Health_Perspect_2013_May_22_121(5)_551-557.nxml.txt.nlp	23434795	SENT176	3	3	13	13	hyaluronan	AHR	PA165958431	196	0.624
NULL	Oncol_Lett_2014_Nov_10_8(5)_2333-2339.nxml.txt.nlp	25295120	SENT90	5	5	8	8	sorafenib	ADM	PA7000	133	0.624
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Apr_21_68(Pt_5)_o1479.nxml.txt.nlp	22590351	SENT60	17	17	26	26	ethanol	mol	PA448073	90527	0.624
NULL	Breast_Cancer_Res_2014_May_5_16(3)_R45.nxml.txt.nlp	24887236	SENT219	8	8	5	5	lapatinib	EGFR	PA152241907	1956	0.624
NULL	Mol_Vis_2014_Sep_20_20_1328-1356.nxml.txt.nlp	25352741	SENT90	11	11	23	23	l-lysine	PLP	PA450280	25824;5744	0.624
NULL	Nat_Commun_2014_Nov_25_5_5548.nxml.txt.nlp	25420520	SENT67	14	14	16	16	cabazitaxel	ERG	PA165958401	2078	0.624
NULL	Clin_Ophthalmol_2012_Jan_12_6_111-116.nxml.txt.nlp	22275815	SENT18	0	0	13	13	latanoprost	PGF	PA164774763	5228	0.624
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_75-89.nxml.txt.nlp	17912638	SENT370	16	16	37	37	anastrozole	ATAC	PA448432	6375	0.624
NULL	Reprod_Biol_Endocrinol_2013_Feb_25_11_14.nxml.txt.nlp	23442383	SENT14	17	17	30	30	metoclopramide	DOM	PA450475	6663	0.624
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT72	3	3	5	5	curcumin	TRAIL	PA151958596	8743	0.624
NULL	J_Biomed_Biotechnol_2010_Jun_7_2010_150960.nxml.txt.nlp	20617134	SENT204	28	28	2	2	imatinib	KRAS	PA10804	3845	0.624
NULL	Emerg_Infect_Dis_2013_Nov_19(11)_1721-1730.nxml.txt.nlp	24207100	SENT134	2	2	26	26	amoxicillin	VAN	PA448406	10318	0.624
NULL	Front_Oncol_2011_Jun_17_1_10.nxml.txt.nlp	22655230	SENT60	15	15	7	7	oxaliplatin	BMP4	PA131285527	652	0.624
NULL	Ann_Oncol_2010_Mar_18_21(3)_655-661.nxml.txt.nlp	19767314	SENT149	17	17	15	15	gemcitabine	GEM	PA449748	2669	0.624
NULL	Clin_Med_Insights_Oncol_2011_Jul_20_5_213-221.nxml.txt.nlp	21836817	SENT116	21	21	27	27	cabozantinib	VEGFR2	PA165906891	3791	0.624
NULL	Mol_Cancer_2010_Apr_30_9_98.nxml.txt.nlp	20433755	SENT40	13	13	31	31	doxorubicin	TRAIL	PA449412	8743	0.624
NULL	Med_Sci_Monit_2013_May_1_19_317-326.nxml.txt.nlp	23632427	SENT277	16	16	14	14	cefotaxime	CTX	PA448852	1593	0.624
NULL	Eur_J_Clin_Microbiol_Infect_Dis_2010_May_13_29(5)_543-550.nxml.txt.nlp	20229224	SENT73	21	21	7	7	clindamycin	PEN	PA449035	9933	0.624
NULL	Oncol_Lett_2014_Jan_11_7(1)_156-158.nxml.txt.nlp	24348840	SENT4	5	5	13	13	cyclophosphamide	CHOP	PA449165	1649	0.624
NULL	Clin_Med_Case_Rep_2008_Aug_29_1_119-122.nxml.txt.nlp	24179360	SENT89	0	0	3	3	teriparatide	PTH	PA451620	5741	0.624
NULL	J_Cancer_2013_Jun_21_4(5)_391-401.nxml.txt.nlp	23833684	SENT148	8	8	17	17	trastuzumab	EEA1	PA451743	8411	0.624
NULL	J_Hematol_Oncol_2012_Sep_18_5_57.nxml.txt.nlp	22989009	SENT15	4	4	12	12	nutlin-3	HDM2		4193	0.624
NULL	Oncotarget_2014_Sep_3_5(19)_9362-9381.nxml.txt.nlp	25313139	SENT269	22	22	19	19	orlistat	HMGCR	PA164776864	3156	0.624
NULL	Biosci_Rep_2012_Aug_1_32(Pt_4)_361-374.nxml.txt.nlp	22762204	SENT1100	15	15	13	13	trastuzumab	PTEN	PA451743	5728	0.624
NULL	J_Basic_Clin_Pharm_2012_Dec_4(1)_20-24.nxml.txt.nlp	24808665	SENT109	9	9	12	12	diazepam	hole	PA449283	80757	0.624
NULL	Indian_J_Ophthalmol_2014_Jul_62(7)_761-767.nxml.txt.nlp	25116765	SENT97	4	4	23	23	bevacizumab	CRT	PA130232992	811	0.624
NULL	Ann_Oncol_2013_Aug_12_24(8)_1994-1999.nxml.txt.nlp	23670096	SENT137	4	4	11	11	tamoxifen	AIB1	PA451581	8202	0.624
NULL	Cancer_Manag_Res_2014_Jan_28_6_39-51.nxml.txt.nlp	24501545	SENT138	27	27	12	12	ketoconazole	CYP3A4	PA450146	1576	0.624
NULL	BMB_Rep_2014_Aug_47(8)_424-432.nxml.txt.nlp	24874851	SENT92	8	8	39	39	temozolomide	PARP1	PA451609	142	0.624
NULL	Nucleic_Acids_Res_2011_Mar_20_39(4)_1565-1575.nxml.txt.nlp	20961956	SENT120	1	1	6	6	zinc	CTD	PA451956	1283	0.624
NULL	Nucleic_Acids_Res_2011_Jun_1_39(11)_e74.nxml.txt.nlp	21459849	SENT249	5	5	11	11	glucosamine	GANAB	PA164747613	23193	0.624
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT107	5	5	7	7	curcumin	TRAIL	PA151958596	8743	0.624
NULL	Pharmaceuticals_(Basel)_2011_Oct_25_4(11)_1400-1422.nxml.txt.nlp	NULL	SENT79	17	17	7	7	hydroquinone	NQO1	PA449924	1728	0.624
NULL	Int_J_Med_Sci_2013_Mar_15_10(5)_567-574.nxml.txt.nlp	23533048	SENT194	2	2	4	4	entecavir	LAM	PA164784025	7249;7248	0.624
NULL	Clin_Interv_Aging_2008_Sep_3(3)_453-472.nxml.txt.nlp	18982916	SENT513	30	30	20	20	tipranavir	ATV	PA163522473	4683	0.624
NULL	Oncogenesis_2012_Apr_2_1(4)_e5.nxml.txt.nlp	23552603	SENT240	0	0	8	8	celecoxib	IEX-1	PA448871	8870	0.624
NULL	Mol_Cell_Biochem_2013_Jul_10_383(1-2)_29-37.nxml.txt.nlp	23839109	SENT228	5	5	9	9	probucol	PDGF-A	PA451107	5154	0.624
NULL	Case_Rep_Dermatol_2013_Jun_29_5(2)_186-191.nxml.txt.nlp	23898268	SENT100	8	8	6	6	cyanocobalamin	B12	PA451892	7126;4709	0.624
NULL	Int_J_Med_Sci_2013_Jan_3_10(2)_141-147.nxml.txt.nlp	23329885	SENT139	25	25	28	28	creatine	AGAT	PA164778930	2628	0.624
NULL	Environ_Health_Perspect_2005_Aug_20_113(8)_1022-1026.nxml.txt.nlp	16079073	SENT126	14	14	23	23	estradiol	DES	PA449503	1674	0.624
NULL	Exp_Neurobiol_2014_Sep_18_23(3)_224-230.nxml.txt.nlp	25258569	SENT106	3	3	7	7	duloxetine	EPM	PA10066	2054	0.624
NULL	Cancers_(Basel)_2010_Jan_14_2(1)_1-19.nxml.txt.nlp	24281029	SENT1081	14	14	32	32	cisplatin	San	PA449014	80218	0.624
NULL	Biomed_Res_Int_2013_Jul_16_2013_687658.nxml.txt.nlp	23956997	SENT13	12	12	26	26	l-alanine	PLP	PA448055	25824;5744	0.624
NULL	Mol_Cancer_2009_Jul_3_8_43.nxml.txt.nlp	19575780	SENT292	18	18	2	2	cisplatin	survivin	PA449014	332	0.624
NULL	Clin_Drug_Investig_2013_Jun_20_33(6)_419-427.nxml.txt.nlp	23605507	SENT6	11	11	30	30	ciprofloxacin	DPI	PA449009	1832	0.624
NULL	Indian_J_Pharmacol_2012_Sep-Oct_44(5)_629-633.nxml.txt.nlp	23112427	SENT129	4	4	14	14	propranolol	ANOVA	PA451145	4858	0.624
NULL	J_Cancer_2013_Jul_1_4(5)_433-446.nxml.txt.nlp	23833688	SENT234	9	9	4	4	tamoxifen	STAR	PA451581	6770;2984	0.624
NULL	Front_Behav_Neurosci_2014_Oct_1_8_306.nxml.txt.nlp	25324743	SENT833	9	9	1	1	risperidone	5-HT7	PA451257	3363	0.624
NULL	F1000_Med_Rep_2009_Dec_9_1_93.nxml.txt.nlp	20948684	SENT89	26	26	28	28	doxycycline	LAM	PA449415	7249;7248	0.624
NULL	J_Korean_Med_Sci_2010_Feb_19_25(2)_304-308.nxml.txt.nlp	20119588	SENT39	26	26	17	17	cycloserine	EMB	PA164764600	133418	0.624
NULL	Appl_Microbiol_Biotechnol_2013_Aug_16_97(18)_7999-8009.nxml.txt.nlp	23948723	SENT96	16	16	9	9	nadh	GAP	PA164755085	5921	0.624
NULL	Turk_J_Haematol_2012_Dec_5_29(4)_413-419.nxml.txt.nlp	24385732	SENT80	30	30	9	9	cytarabine	CD56	PA449177	4684	0.624
NULL	Pharmaceuticals_(Basel)_2014_Jan_27_7(2)_169-191.nxml.txt.nlp	24473270	SENT203	8	8	26	26	gemcitabine	PEPT1	PA449748	6564	0.624
NULL	J_Obes_2011_Sep_22_2011_528401.nxml.txt.nlp	21949903	SENT133	17	17	14	14	liraglutide	GLP-1	PA165958364	100125288	0.624
NULL	Environ_Health_Perspect_2009_Feb_8_117(2)_175-180.nxml.txt.nlp	19270784	SENT137	3	3	9	9	doxorubicin	Bcl-2	PA449412	596	0.624
NULL	Clin_Mol_Hepatol_2014_Sep_25_20(3)_283-290.nxml.txt.nlp	25320732	SENT138	19	19	4	4	propranolol	EVL	PA451145	51466	0.624
NULL	Appl_Biochem_Biotechnol_2012_Nov_16_168(6)_1584-1593.nxml.txt.nlp	22983742	SENT151	15	15	40	40	nitrogen	CYP2D6	PA450643	1565	0.624
NULL	Cancer_Immunol_Immunother_2011_Jan_22_60(1)_37-47.nxml.txt.nlp	20859626	SENT66	24	24	28	28	streptomycin	GM-CSF	PA451512	1437	0.624
NULL	J_Cell_Biol_1997_May_5_137(3)_609-618.nxml.txt.nlp	9151668	SENT312	20	20	7	7	thyroglobulin	API	PA164754910	5345	0.624
NULL	Cancer_Cell_Int_2013_Aug_27_13_87.nxml.txt.nlp	23977838	SENT45	25	25	30	30	colchicine	CAIX	PA449092	768	0.624
NULL	Ann_Rheum_Dis_2011_Oct_12_71(4)_541-548.nxml.txt.nlp	21994233	SENT219	9	9	21	21	infliximab	IMPACT	PA452639	55364	0.624
NULL	Ann_Surg_Treat_Res_2014_Feb_22_86(2)_55-60.nxml.txt.nlp	24761409	SENT95	2	2	21	21	levothyroxine	CTX	PA450221	1593	0.624
NULL	Cell_Cycle_2014_Feb_1_13(3)_471-481.nxml.txt.nlp	24280901	SENT64	7	7	9	9	l-cysteine	NAC	PA449173	22861	0.624
NULL	Breast_Cancer_(Dove_Med_Press)_2013_Aug_22_5_73-78.nxml.txt.nlp	24648760	SENT133	4	4	6	6	tamoxifen	END	PA451581	2022	0.624
NULL	Psychiatry_Investig_2012_Jun_30_9(2)_187-190.nxml.txt.nlp	22707971	SENT64	12	12	14	14	capsaicin	POMC	PA448776	5443	0.623
NULL	Front_Bioeng_Biotechnol_2014_Nov_26_2_53.nxml.txt.nlp	25505786	SENT272	26	26	28	28	nadh	CO2	PA164755085	4513	0.623
NULL	Am_J_Physiol_Endocrinol_Metab_2013_Nov_1_305(9)_E1134-E1144.nxml.txt.nlp	24022868	SENT91	9	9	11	11	lipase	LPL	PA450239	4023	0.623
NULL	EMBO_Mol_Med_2012_Sep_7_4(9)_896-909.nxml.txt.nlp	22887866	SENT145	0	0	11	11	lovastatin	ODC	PA450272	4953;89874	0.623
NULL	Front_Physiol_2013_Jul_15_4_179.nxml.txt.nlp	23874304	SENT80	26	26	11	11	nadh	GPD	PA164755085	2532	0.623
NULL	Br_J_Cancer_1995_Feb_71(2)_294-299.nxml.txt.nlp	7841043	SENT9	0	0	9	9	tamoxifen	P-gp	PA451581	5243	0.623
NULL	J_Immunol_Res_2014_Jul_16_2014_696812.nxml.txt.nlp	25133198	SENT263	18	18	9	9	rifaximin	TLR4	PA164752443	7099	0.623
NULL	Cell_Commun_Signal_2013_Jan_11_11_2.nxml.txt.nlp	23305203	SENT155	19	19	12	12	forskolin	TIMAP	PA146096022	26051	0.623
NULL	J_Carcinog_2012_Sep_13_11_15.nxml.txt.nlp	23230392	SENT127	44	44	40	40	axitinib	VEGFR	PA164924493	3791	0.623
NULL	Br_J_Cancer_2009_Oct_6_101(7)_1155-1161.nxml.txt.nlp	19738614	SENT152	13	13	7	7	gemcitabine	MUC4	PA449748	4585	0.623
NULL	Bone_2014_Sep_66(100)_240-250.nxml.txt.nlp	24971713	SENT397	2	2	28	28	ibandronate	MSX1	PA10270	4487	0.623
NULL	Evid_Based_Complement_Alternat_Med_2012_Dec_25_2012_818451.nxml.txt.nlp	23365600	SENT277	4	4	9	9	naloxone	GAT1	PA450586	6529	0.623
NULL	J_Korean_Med_Sci_2005_Dec_31_20(6)_1076-1078.nxml.txt.nlp	16361827	SENT6	14	14	32	32	vasopressin	AQP2	PA451858	359	0.623
NULL	Diabetes_2011_May_23_60(5)_1458-1466.nxml.txt.nlp	21464445	SENT248	36	36	29	29	lipase	ATGL	PA450239	57104	0.623
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT270	4	4	0	0	tenofovir	ABCC2	PA10204	1244	0.623
NULL	Clin_Ophthalmol_2011_Sep_13_5_1309-1313.nxml.txt.nlp	21966207	SENT86	15	15	42	42	methotrexate	TNF-alpha	PA450428	7124	0.623
NULL	Ann_Oncol_2009_Aug_20(Suppl_6)_vi22-vi29.nxml.txt.nlp	19617294	SENT334	9	9	7	7	melphalan	TNF-alpha	PA450354	7124	0.623
NULL	Allergy_Asthma_Immunol_Res_2012_May_14_4(3)_137-142.nxml.txt.nlp	22548206	SENT134	27	27	25	25	piroxicam	PRX	PA450985	9588;57716	0.623
NULL	J_Carcinog_2014_Feb_20_13_4.nxml.txt.nlp	24737952	SENT40	23	23	7	7	irinotecan	EGFR	PA450085	1956	0.623
NULL	Arthritis_Res_Ther_2012_Jun_25_14(3)_215.nxml.txt.nlp	22731694	SENT99	12	12	0	0	ribavirin	CPX	PA451241	1371;10682;1377	0.623
NULL	Ann_Rheum_Dis_2011_Oct_12_71(4)_541-548.nxml.txt.nlp	21994233	SENT220	11	11	32	32	infliximab	IMPACT	PA452639	55364	0.623
NULL	Front_Neurosci_2012_May_30_6_77.nxml.txt.nlp	22661925	SENT304	3	3	36	36	ethanol	HEC	PA448073	10403	0.623
NULL	J_Cell_Biol_1998_May_4_141(3)_727-739.nxml.txt.nlp	9566972	SENT297	22	22	16	16	neomycin	NF-M	PA450608	4741	0.623
NULL	Cancer_Med_2013_Jun_25_2(3)_277-285.nxml.txt.nlp	23930204	SENT121	2	2	19	19	capecitabine	PTEN	PA448771	5728	0.623
NULL	Crit_Care_2014_Mar_17_18(Suppl_1)_P488.nxml.txt.nlp	NULL	SENT17	20	20	23	23	heparin	ACT	PA449855	12;11332;9457;641455	0.623
NULL	Exp_Diabetes_Res_2012_Nov_12_2012_618923.nxml.txt.nlp	23197974	SENT4	40	40	27	27	telmisartan	STZ	PA451605	6484	0.623
NULL	Oncogene_2014_Oct_9_33(41)_4941-4951.nxml.txt.nlp	24681952	SENT121	8	8	12	12	metformin	WNT5A	PA450395	7474	0.623
NULL	Pharmaceutics_2011_Nov_18_3(4)_865-913.nxml.txt.nlp	24309312	SENT198	2	2	20	20	talinolol	P-gp	PA146123005	5243	0.623
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_May_5_68(Pt_6)_o1637.nxml.txt.nlp	22719438	SENT4	29	29	1	1	piperazine	mol	PA450977	90527	0.623
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Apr_30_65(Pt_5)_m595.nxml.txt.nlp	21583817	SENT56	21	21	36	36	ethanol	mol	PA448073	90527	0.623
NULL	Endocrinol_Metab_(Seoul)_2014_Sep_25_29(3)_280-292.nxml.txt.nlp	25309786	SENT242	20	20	8	8	cabergoline	PRL	PA448708	5617	0.623
NULL	Eur_J_Med_Res_2012_May_18_17(1)_12.nxml.txt.nlp	22608095	SENT112	44	44	35	35	estradiol	aromatase	PA449503	1588	0.623
NULL	Cells_2012_Aug_21_1(3)_535-557.nxml.txt.nlp	24710489	SENT268	23	23	12	12	irinotecan	p38	PA450085	10598;1432;7965	0.623
NULL	Clin_Transl_Allergy_2011_Aug_12_1(Suppl_1)_O16.nxml.txt.nlp	NULL	SENT7	27	27	30	30	glutaraldehyde	RAGA	PA449777	10670	0.623
NULL	Chiropr_Osteopat_2006_Oct_18_14_25.nxml.txt.nlp	17044942	SENT112	30	30	32	32	vasopressin	AVP	PA451858	114548;551	0.623
NULL	Cell_Commun_Signal_2013_Oct_1_11_73.nxml.txt.nlp	24083678	SENT194	3	3	15	15	sulindac	A20	PA451565	7128;28935	0.623
NULL	Int_J_Surg_Oncol_2012_Jun_12_2012_862879.nxml.txt.nlp	22778941	SENT38	0	0	8	8	cisplatin	p53	PA449014	7157	0.623
NULL	Breast_Cancer_Res_2010_Nov_16_12(6)_R96.nxml.txt.nlp	21080941	SENT94	47	47	36	36	lapatinib	HRG	PA152241907	3084;3273	0.623
NULL	Cell_Death_Dis_2013_Jun_13_4(6)_e665.nxml.txt.nlp	23764846	SENT12	12	12	16	16	sorafenib	BLM	PA7000	641	0.623
NULL	Acta_Pharmacol_Sin_2011_Jun_3_32(6)_845-852.nxml.txt.nlp	21642952	SENT98	12	12	15	15	prazosin	TRPV1	PA451093	7442	0.623
NULL	Hum_Genomics_2009_Jan_1_3(2)_128-142.nxml.txt.nlp	19164090	SENT180	36	36	11	11	carboplatin	CD44	PA448803	960	0.623
NULL	EMBO_Mol_Med_2012_Jul_11_4(7)_577-593.nxml.txt.nlp	22496117	SENT226	17	17	13	13	clofazimine	PAP-1	PA164748759	6100	0.623
NULL	Cell_Death_Differ_2009_Aug_20_16(8)_1135-1145.nxml.txt.nlp	19300452	SENT165	24	24	28	28	doxycycline	PUMA	PA449415	27113	0.623
NULL	Int_J_Emerg_Med_2012_Jan_20_5_5.nxml.txt.nlp	22264348	SENT46	11	11	22	22	capsaicin	TRPV1	PA448776	7442	0.623
NULL	Cell_Cycle_2013_Aug_15_12(16)_2580-2597.nxml.txt.nlp	23860378	SENT294	17	17	10	10	ethanol	BRCA1	PA448073	672	0.623
NULL	Drugs_R_D_2010_May_27_10(1)_9-24.nxml.txt.nlp	20509711	SENT385	4	4	9	9	saquinavir	CD4	PA451305	920	0.623
NULL	J_Korean_Med_Sci_2010_Sep_14_25(9)_1277-1283.nxml.txt.nlp	20808669	SENT143	4	4	11	11	pamidronate	IFN	PA450767	3439	0.623
NULL	Breast_Cancer_Res_2001_May_23_3(4)_209-212.nxml.txt.nlp	11434870	SENT24	8	8	13	13	tetracycline	c-Myc	PA451640	4609	0.623
NULL	Clin_Interv_Aging_2009_Jun_9_4_251-258.nxml.txt.nlp	19554096	SENT141	16	16	11	11	ketoconazole	CYP2D6	PA450146	1565	0.623
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1051.nxml.txt.nlp	24503543	SENT144	20	20	31	31	mitoxantrone	Yes	PA450526	7525	0.623
NULL	J_Cell_Biol_1999_Jan_11_144(1)_125-138.nxml.txt.nlp	9885249	SENT103	16	16	31	31	copper	TEM	PA449114	64102	0.623
NULL	Nat_Neurosci_2012_Sep_5_15(9)_1245-1254.nxml.txt.nlp	22864611	SENT448	6	6	16	16	risperidone	mGlu2	PA451257	2912	0.623
NULL	Biomed_Res_Int_2013_Dec_10_2013_159786.nxml.txt.nlp	24386633	SENT26	0	0	2	2	gemifloxacin	GMF	PA10088	2764	0.623
NULL	Oncotarget_2013_Nov_23_5(1)_196-210.nxml.txt.nlp	24344116	SENT31	2	2	7	7	daunorubicin	bcl-xL	PA449212	598	0.623
NULL	Mol_Cancer_2007_Oct_22_6_66.nxml.txt.nlp	17953743	SENT144	0	0	6	6	cisplatin	BAX	PA449014	581	0.623
NULL	Case_Rep_Endocrinol_2014_Aug_10_2014_680876.nxml.txt.nlp	25177504	SENT90	9	9	24	24	thyroglobulin	PTH	PA164754910	5741	0.623
NULL	J_Int_Soc_Sports_Nutr_2012_Apr_17_9_17.nxml.txt.nlp	22510253	SENT28	11	11	14	14	l-arginine	AAKG	PA448478	51422	0.623
NULL	J_Skin_Cancer_2012_Dec_13_2012_147863.nxml.txt.nlp	23316365	SENT182	25	25	30	30	curcumin	IL-6	PA151958596	3569	0.623
NULL	Oxid_Med_Cell_Longev_2013_Jun_2_2013_793525.nxml.txt.nlp	23819014	SENT167	3	3	27	27	resveratrol	ROS		6098	0.623
NULL	Case_Rep_Oncol_2010_Jul_16_3(2)_252-254.nxml.txt.nlp	20740206	SENT44	3	3	16	16	quetiapine	5-HT2A	PA451201	3356	0.623
NULL	Biomed_Res_Int_2014_Apr_10_2014_580852.nxml.txt.nlp	24812624	SENT170	0	0	7	7	resveratrol	PTEN		5728	0.623
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT169	20	20	26	26	metformin	HIF-1	PA450395	29072	0.623
NULL	Angiogenesis_2013_Apr_10_16(2)_373-386.nxml.txt.nlp	23143659	SENT223	7	7	24	24	cyclophosphamide	LDM	PA449165	1595	0.623
NULL	Emerg_Infect_Dis_2011_Mar_17(3)_495-497.nxml.txt.nlp	21392442	SENT32	2	2	9	9	isoniazid	EMB	PA450112	133418	0.623
NULL	Nat_Med_2011_Aug_7_17(9)_1116-1120.nxml.txt.nlp	21822287	SENT37	32	32	8	8	doxycycline	p110	PA449415	9733	0.623
NULL	Exp_Diabetes_Res_2011_Dec_27_2011_604989.nxml.txt.nlp	21253359	SENT105	14	14	7	7	clonidine	GLP-1	PA449051	100125288	0.623
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT371	14	14	19	19	resveratrol	SIRT1		23411	0.623
NULL	Brain_Sci_2013_Apr_26_3(2)_670-703.nxml.txt.nlp	24961420	SENT1527	4	4	6	6	ethanol	AMPK	PA448073	5563	0.623
NULL	Hum_Genomics_2008_Sep_1_3(1)_7-16.nxml.txt.nlp	19129086	SENT146	0	0	9	9	rosiglitazone	CYP2C8	PA451283	1558	0.623
NULL	Exp_Ther_Med_2014_Mar_24_7(3)_663-668.nxml.txt.nlp	24520264	SENT138	3	3	12	12	curcumin	IL-6	PA151958596	3569	0.623
NULL	Mol_Vis_2007_Jul_9_13_1083-1093.nxml.txt.nlp	17653053	SENT163	0	0	23	23	minocycline	RANTES	PA450519	6352	0.623
NULL	J_Cell_Biol_2002_Jun_24_157(7)_1151-1160.nxml.txt.nlp	12082077	SENT149	0	0	3	3	trypsin	COX	PA451806	1351	0.623
NULL	Lab_Invest_2009_Nov_7_89(11)_1275-1290.nxml.txt.nlp	19736547	SENT182	17	17	27	27	curcumin	LOX-1	PA151958596	4973	0.623
NULL	Front_Oncol_2013_Apr_23_3_86.nxml.txt.nlp	23630663	SENT611	8	8	3	3	lapatinib	ERBB2	PA152241907	2064	0.623
NULL	Ann_Gen_Psychiatry_2011_Mar_24_10_8.nxml.txt.nlp	21435226	SENT192	11	11	18	18	imipramine	Gen	PA449969	348654	0.623
NULL	Cancer_Manag_Res_2011_Aug_10_3_273-285.nxml.txt.nlp	21931501	SENT142	18	18	20	20	bevacizumab	IFN	PA130232992	3439	0.623
NULL	Mol_Biol_Cell_2012_Sep_1_23(17)_3473-3484.nxml.txt.nlp	22787275	SENT151	11	11	14	14	doxorubicin	ABCC1	PA449412	4363	0.623
NULL	Nat_Commun_2014_Mar_17_5_3479.nxml.txt.nlp	24632940	SENT120	26	26	20	20	streptomycin	FBS	PA451512	64319;26269	0.623
NULL	Breast_Cancer_Res_2011_Jun_29_13(3)_R70.nxml.txt.nlp	21707964	SENT26	39	39	32	32	tamoxifen	14-3-3	PA451581	10971	0.623
NULL	Leukemia_2014_Apr_8_28(4)_894-903.nxml.txt.nlp	23925045	SENT296	11	11	13	13	tamoxifen	TMX	PA451581	81542	0.623
NULL	Biosci_Rep_2014_Dec_12_34(6)_e00159.nxml.txt.nlp	25327961	SENT464	8	8	21	21	curcumin	CDK4	PA151958596	1019	0.623
NULL	Br_J_Cancer_2010_Dec_7_103(12)_1815-1821.nxml.txt.nlp	21063408	SENT98	5	5	13	13	zoledronate	6-16	PA10235	2537	0.623
NULL	Front_Oncol_2013_Sep_24_3_251.nxml.txt.nlp	24069583	SENT166	2	2	30	30	gemcitabine	GCG	PA449748	2641	0.623
NULL	AMB_Express_2011_Jul_13_1_16.nxml.txt.nlp	21906371	SENT10	13	13	25	25	sugar	PHB	PA451529	5245	0.623
NULL	Nat_Med_2013_Apr_17_19(4)_429-436.nxml.txt.nlp	23502962	SENT77	4	4	14	14	dextran	CD169	PA449261	6614	0.623
NULL	J_Int_Soc_Sports_Nutr_2009_Feb_19_6_6.nxml.txt.nlp	19228401	SENT80	22	22	1	1	creatine	CRT	PA164778930	811	0.623
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT2379	8	8	6	6	diclofenac	CYP2C9	PA449293	1559	0.623
NULL	Emerg_Infect_Dis_2012_Mar_18(3)_515-516.nxml.txt.nlp	22377354	SENT33	22	22	0	0	tetracycline	CTX	PA451640	1593	0.623
NULL	J_Gen_Physiol_1994_Dec_1_104(6)_1039-1055.nxml.txt.nlp	7535344	SENT0	15	15	1	1	quinidine	Gen	PA451209	348654	0.623
NULL	Cell_Death_Differ_2010_Apr_16_17(4)_666-676.nxml.txt.nlp	19834494	SENT251	37	37	4	4	gemcitabine	RAGE	PA449748	177	0.623
NULL	Front_Oncol_2014_Jun_18_4_153.nxml.txt.nlp	24995158	SENT554	21	21	25	25	vinorelbine	ERK2	PA451881	5594	0.623
NULL	Front_Physiol_2013_May_20_4_101.nxml.txt.nlp	23730288	SENT142	37	37	45	45	allopurinol	Met	PA448320	79811	0.623
NULL	Curr_Clin_Pharmacol_2013_May_8(2)_135-155.nxml.txt.nlp	23062036	SENT348	36	36	8	8	raloxifene	PTH	PA451221	5741	0.623
NULL	Mol_Cell_2014_May_8_54(3)_445-459.nxml.txt.nlp	24746700	SENT39	13	13	7	7	etoposide	BCLAF1	PA449552	9774	0.623
NULL	BMB_Rep_2014_Jul_47(7)_376-381.nxml.txt.nlp	24286332	SENT41	14	14	5	5	thrombin	PPG	PA451674	5552	0.623
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT149	5	5	11	11	doxorubicin	SLK	PA449412	9748;2534	0.623
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1522-1532.nxml.txt.nlp	21997136	SENT248	3	3	15	15	lapatinib	p53	PA152241907	7157	0.623
NULL	Adv_Bioinformatics_2012_Oct_13_2012_159423.nxml.txt.nlp	23097667	SENT405	18	18	16	16	nadh	ADP	PA164755085	23038	0.623
NULL	Apoptosis_2009_Dec_23_14(12)_1451-1458.nxml.txt.nlp	19466552	SENT95	10	10	21	21	thrombin	PAR-1	PA451674	2011;2149	0.623
NULL	Mol_Brain_2014_Mar_5_7_15.nxml.txt.nlp	24594013	SENT235	40	40	42	42	physostigmine	A-2	PA450957	27239	0.623
NULL	Arthritis_Res_Ther_2005_Dec_1_7(1)_R149-R155.nxml.txt.nlp	15642135	SENT74	6	6	11	11	infliximab	IL-6	PA452639	3569	0.623
NULL	Neuroscience_2008_Aug_13_155(2)_556-564.nxml.txt.nlp	18619738	SENT11	2	2	0	0	choline	CDP	PA448976	1523	0.623
NULL	Cells_2014_Apr_4_3(2)_199-235.nxml.txt.nlp	24709958	SENT331	16	16	19	19	cetuximab	EGFR	PA10040	1956	0.623
NULL	Pharmaceuticals_(Basel)_2013_Nov_11_6(11)_1429-1450.nxml.txt.nlp	24287465	SENT319	7	7	0	0	dacarbazine	Bcl-2	PA449197	596	0.623
NULL	Front_Microbiol_2013_Dec_6_4_367.nxml.txt.nlp	24367357	SENT297	19	19	9	9	ethanol	CO2	PA448073	4513	0.623
NULL	Br_J_Cancer_2013_Feb_5_108(2)_469-476.nxml.txt.nlp	23169292	SENT174	12	12	25	25	gemcitabine	TTF1	PA449748	7080;7270	0.623
NULL	Daru_2011_19(3)_224-230.nxml.txt.nlp	22615661	SENT76	20	20	0	0	sumatriptan	DSC	PA451566	1825	0.623
NULL	Breast_Cancer_Res_2010_May_18_12(Suppl_1)_P20.nxml.txt.nlp	NULL	SENT15	8	8	18	18	vinblastine	AP-2	PA451877	7020	0.623
NULL	Int_J_Breast_Cancer_2011_Jul_12_2011_232435.nxml.txt.nlp	22295213	SENT50	0	0	21	21	estradiol	H11	PA449503	26353	0.623
NULL	Cardiol_Res_Pract_2011_Aug_15_2011_156146.nxml.txt.nlp	21876822	SENT195	15	15	26	26	potassium	KIR	PA451047	2669	0.623
NULL	Oncol_Lett_2014_Sep_11_8(3)_1222-1228.nxml.txt.nlp	25120693	SENT137	6	6	0	0	olaparib	DDP		1678	0.623
NULL	Nat_Med_2013_Mar_10_19(3)_313-321.nxml.txt.nlp	23396211	SENT302	2	2	9	9	amlexanox	TBK1	PA164745310	29110	0.623
NULL	Infect_Dis_Ther_2014_Dec_5_3(2)_69-81.nxml.txt.nlp	25475412	SENT80	22	22	24	24	daptomycin	DAP	PA164768820	23549;3375;1611	0.623
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Jun_27_5_15.nxml.txt.nlp	16803618	SENT178	14	14	30	30	erythromycin	CIP1	PA449493	1026;56996	0.623
NULL	Cancer_Med_2013_Feb_3_2(1)_11-20.nxml.txt.nlp	24133623	SENT277	13	13	0	0	irinotecan	KRAS	PA450085	3845	0.623
NULL	J_Lipid_Res_2014_Dec_55(12)_2562-2575.nxml.txt.nlp	25316883	SENT9	9	9	11	11	lipase	ATGL	PA450239	57104	0.623
NULL	Biochim_Biophys_Acta_2013_Oct_1830(10)_4813-4819.nxml.txt.nlp	23811337	SENT79	25	25	30	30	streptomycin	FBS	PA451512	64319;26269	0.623
NULL	Oncol_Lett_2014_Nov_14_8(5)_2086-2092.nxml.txt.nlp	25295095	SENT77	8	8	6	6	gemcitabine	LKB1	PA449748	6794	0.623
NULL	Int_J_Biol_Sci_2013_Nov_21_9(10)_1089-1098.nxml.txt.nlp	24339730	SENT183	25	25	11	11	genistein	COL1A1	PA165109660	1277	0.623
NULL	Indian_J_Pharm_Sci_2013_Sep-Oct_75(5)_545-556.nxml.txt.nlp	24403655	SENT209	31	31	27	27	ethanol	mol	PA448073	90527	0.623
NULL	Oncol_Lett_2013_Apr_7_5(4)_1382-1384.nxml.txt.nlp	23599798	SENT37	10	10	12	12	vinblastine	IFN	PA451877	3439	0.623
NULL	Biomed_Res_Int_2013_Mar_27_2013_561410.nxml.txt.nlp	23607091	SENT73	6	6	23	23	trypsin	VIII	PA451806	1351	0.623
NULL	Indian_J_Med_Res_2013_Jan_137(1)_191-196.nxml.txt.nlp	23481072	SENT97	12	12	8	8	daptomycin	VISA	PA164768820	57506	0.623
NULL	Br_J_Haematol_2014_Mar_13_164(1)_811-821.nxml.txt.nlp	24328678	SENT44	22	22	11	11	lenalidomide	San	PA162363968	80218	0.623
NULL	Leukemia_2014_Mar_13_28(3)_600-608.nxml.txt.nlp	24240203	SENT122	7	7	10	10	nutlin-3	p53		7157	0.623
NULL	Int_J_Mol_Sci_2014_Mar_5_15(3)_3970-3988.nxml.txt.nlp	24603537	SENT514	3	3	20	20	curcumin	MCH	PA151958596	5367	0.623
NULL	Front_Neurosci_2011_Jan_14_4_207.nxml.txt.nlp	21258618	SENT107	1	1	12	12	ethanol	HET	PA448073	6294	0.623
NULL	Cancers_(Basel)_2011_Oct_26_3(4)_4024-4045.nxml.txt.nlp	24213123	SENT179	5	5	15	15	curcumin	PTEN	PA151958596	5728	0.623
NULL	Inflammation_2012_Feb_1_35(1)_214-220.nxml.txt.nlp	21360048	SENT174	23	23	20	20	choline	TNF	PA448976	7124	0.623
NULL	Br_J_Pharmacol_2014_Aug_17_171(15)_3680-3692.nxml.txt.nlp	24758567	SENT47	21	21	9	9	streptomycin	FBS	PA451512	64319;26269	0.623
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT253	2	2	18	18	nutlin-3	E2F1		1869	0.623
NULL	J_Orthop_Traumatol_2011_Mar_19_12(1)_69-76.nxml.txt.nlp	21246392	SENT55	6	6	13	13	heparin	FON	PA449855	741	0.623
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT106	41	41	13	13	methotrexate	MSH2	PA450428	4436	0.623
NULL	Diabetes_2013_Nov_18_62(11)_3751-3759.nxml.txt.nlp	23897951	SENT116	0	0	11	11	rosiglitazone	FRS2	PA451283	10818	0.623
NULL	Cell_Death_Dis_2014_Jul_17_5(7)_e1333.nxml.txt.nlp	25032856	SENT8	5	5	7	7	candesartan	TLR4	PA448765	7099	0.623
NULL	Gut_Pathog_2012_Jul_16_4_7.nxml.txt.nlp	22800501	SENT75	14	14	8	8	ceftazidime	CTX	PA448861	1593	0.623
NULL	Mol_Imaging_Radionucl_Ther_2013_Aug_1_22(2)_49-55.nxml.txt.nlp	24003397	SENT145	25	25	14	14	octreotide	ACTH	PA450678	5443	0.623
NULL	Breast_Cancer_Res_2011_Jul_26_13(4)_214.nxml.txt.nlp	21867572	SENT97	30	30	18	18	medroxyprogesterone	RANK	PA450344	8792	0.623
NULL	J_Oncol_2012_Mar_8_2012_723541.nxml.txt.nlp	22481931	SENT185	34	34	40	40	heparin	HBEGF	PA449855	1839	0.623
NULL	J_Gen_Physiol_1924_Mar_20_6(4)_417-428.nxml.txt.nlp	19872083	SENT0	12	12	1	1	trypsin	Gen	PA451806	348654	0.623
NULL	Biomed_Res_Int_2014_Feb_6_2014_323594.nxml.txt.nlp	24689036	SENT249	6	6	10	10	raloxifene	PC3	PA451221	57332;7832;5122	0.623
NULL	Breast_Cancer_Res_2010_Jul_22_12(4)_R53.nxml.txt.nlp	20649975	SENT8	22	22	8	8	tamoxifen	HOXB13	PA451581	10481	0.623
NULL	Iran_J_Public_Health_2012_Nov_1_41(11)_1-9.nxml.txt.nlp	23304670	SENT202	0	0	2	2	diethylstilbestrol	DES	PA449307	1674	0.623
NULL	Nat_Chem_Biol_2010_Apr_28_6(4)_291-299.nxml.txt.nlp	20190765	SENT77	30	30	16	16	dasatinib	EGFR	PA162372878	1956	0.623
NULL	Mol_Cancer_2010_Apr_15_9_77.nxml.txt.nlp	20398291	SENT27	11	11	8	8	tamoxifen	survivin	PA451581	332	0.623
NULL	Biologics_2012_Jul_13_6_221-231.nxml.txt.nlp	22904614	SENT40	18	18	33	33	carboplatin	EGFR	PA448803	1956	0.623
NULL	J_Cell_Biol_2005_Jan_3_168(1)_117-126.nxml.txt.nlp	15631993	SENT445	0	0	7	7	minocycline	p38	PA450519	10598;1432;7965	0.623
NULL	Clin_Interv_Aging_2008_Mar_3(1)_45-50.nxml.txt.nlp	18488877	SENT148	4	4	8	8	tamoxifen	STAR	PA451581	6770;2984	0.623
NULL	Endocrinol_Metab_(Seoul)_2014_Sep_25_29(3)_379-387.nxml.txt.nlp	25309798	SENT111	9	9	11	11	resveratrol	SIRT1		23411	0.623
NULL	Front_Neurosci_2011_Mar_9_5_31.nxml.txt.nlp	21441985	SENT46	11	11	9	9	l-arginine	SNO	PA448478	6498	0.623
NULL	Cases_J_2009_Apr_28_2_7081.nxml.txt.nlp	19829905	SENT116	5	5	27	27	cyclophosphamide	CHOP	PA449165	1649	0.623
NULL	Ann_Hematol_2014_Sep_10_93(1)_1-11.nxml.txt.nlp	24018623	SENT170	20	20	15	15	lenalidomide	CD48	PA162363968	962	0.623
NULL	Clin_Ophthalmol_2013_Aug_22_7_1669-1682.nxml.txt.nlp	24003303	SENT174	22	22	19	19	dacarbazine	IL-2	PA449197	3558	0.623
NULL	Hum_Genomics_2009_Jan_1_3(2)_103-105.nxml.txt.nlp	19164087	SENT40	16	16	10	10	ethanol	ALDH2	PA448073	217	0.623
NULL	Eur_J_Clin_Pharmacol_2012_Jan_8_68(1)_29-37.nxml.txt.nlp	21739267	SENT109	5	5	9	9	aripiprazole	CYP2D6	PA10026	1565	0.623
NULL	ISRN_Cardiol_2013_Apr_4_2013_518968.nxml.txt.nlp	23762606	SENT108	27	27	29	29	clopidogrel	DES	PA449053	1674	0.623
NULL	Diabetes_2009_Jan_58(1)_243-249.nxml.txt.nlp	18840785	SENT29	7	7	4	4	glucose	GLP-1	PA449773	100125288	0.623
NULL	Cardiovasc_Diabetol_2013_Oct_17_12_150.nxml.txt.nlp	24134550	SENT15	9	9	13	13	pioglitazone	activin	PA450970	83729	0.623
NULL	Ther_Clin_Risk_Manag_2007_Jun_3(2)_341-348.nxml.txt.nlp	18360643	SENT115	10	10	14	14	imatinib	KIT	PA10804	3815	0.623
NULL	Breast_Cancer_Res_2010_May_10_12(3)_R26.nxml.txt.nlp	20459744	SENT110	6	6	19	19	fluorouracil	HDC	PA128406956	3067;51696	0.623
NULL	Br_J_Cancer_2010_Jan_5_102(1)_80-86.nxml.txt.nlp	19920817	SENT23	8	8	11	11	bevacizumab	IFN	PA130232992	3439	0.623
NULL	Breast_Cancer_Res_2011_Jun_27_13(3)_212.nxml.txt.nlp	21787441	SENT209	19	19	10	10	tamoxifen	SET	PA451581	6418	0.623
NULL	Front_Immunol_2013_Mar_6_4_59.nxml.txt.nlp	23508732	SENT68	3	3	5	5	imiquimod	TLR7	PA449972	51284	0.623
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2705-2713.nxml.txt.nlp	24129232	SENT194	6	6	8	8	cyclophosphamide	ACT	PA449165	12;11332;9457;641455	0.623
NULL	Infect_Dis_Ther_2014_Dec_5_3(2)_69-81.nxml.txt.nlp	25475412	SENT80	11	11	24	24	teicoplanin	DAP	PA164746244	23549;3375;1611	0.623
NULL	EMBO_Mol_Med_2012_Oct_30_4(10)_1087-1096.nxml.txt.nlp	22933245	SENT99	9	9	23	23	olaparib	BRCA2		675	0.623
NULL	Aging_(Albany_NY)_2009_Mar_28_1(3)_281-288.nxml.txt.nlp	20157517	SENT80	6	6	11	11	metformin	AMPK	PA450395	5563	0.623
NULL	Alcohol_Res_Health_2007_30(1)_38-47.nxml.txt.nlp	17718399	SENT229	11	11	30	30	oxygen	ROS	PA450744	6098	0.623
NULL	J_Mol_Signal_2011_Jul_20_6_7.nxml.txt.nlp	21774804	SENT257	15	15	33	33	curcumin	CD166	PA151958596	214	0.623
NULL	Diabetes_Care_2011_Jul_17_34(7)_1678-1680.nxml.txt.nlp	21709302	SENT73	10	10	7	7	pioglitazone	ACT	PA450970	12;11332;9457;641455	0.623
NULL	Breast_Cancer_Res_Treat_2013_Aug_20_141(1)_43-53.nxml.txt.nlp	23959396	SENT23	9	9	36	36	trastuzumab	HER2	PA451743	2064	0.623
NULL	Croat_Med_J_2013_Apr_54(2)_171-179.nxml.txt.nlp	23630144	SENT91	10	10	14	14	taurine	STZ	PA451590	6484	0.623
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT102	3	3	8	8	tenofovir	ABCG2	PA10204	9429	0.623
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT6	45	45	24	24	tacrolimus	IL-6	PA451578	3569	0.623
NULL	Cardiovasc_Res_2013_May_1_98(2)_286-296.nxml.txt.nlp	23334259	SENT218	13	13	16	16	flecainide	NCX	PA449646	3196	0.623
NULL	Reprod_Biol_Endocrinol_2013_Jul_16_11_65.nxml.txt.nlp	23855623	SENT17	9	9	3	3	estradiol	activin	PA449503	83729	0.623
NULL	Front_Neurol_2015_Jan_13_5_289.nxml.txt.nlp	25628599	SENT276	0	0	6	6	nadh	CLOCK	PA164755085	9575	0.623
NULL	J_Ophthalmol_2011_Nov_1_2011_743670.nxml.txt.nlp	22132313	SENT94	12	12	10	10	fluorescein	FAF	PA164746009	8239;2188	0.623
NULL	JAKSTAT_2012_Apr_1_1(2)_55-64.nxml.txt.nlp	24058751	SENT139	3	3	8	8	flavopiridol	Mcl-1	PA452627	4170	0.623
NULL	Front_Neurol_2014_Feb_18_5_17.nxml.txt.nlp	24600432	SENT21	5	5	11	11	levetiracetam	C17	PA450206	54360	0.623
NULL	J_Neurovirol_2013_Jun_4_19(4)_351-358.nxml.txt.nlp	23733308	SENT111	15	15	23	23	mefloquine	SOC	PA450348	91544	0.623
NULL	Oncol_Lett_2013_Mar_28_5(3)_983-991.nxml.txt.nlp	23426861	SENT159	2	2	4	4	epirubicin	DDP	PA449476	1678	0.623
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1563-1573.nxml.txt.nlp	22015557	SENT260	18	18	8	8	sunitinib	c-Myc	PA162372840	4609	0.623
NULL	Mol_Pain_2013_Jan_2_9_1.nxml.txt.nlp	23279936	SENT112	23	23	19	19	capsaicin	TRPV1	PA448776	7442	0.623
NULL	EMBO_Mol_Med_2011_Jul_3(7)_370-384.nxml.txt.nlp	21591259	SENT26	0	0	4	4	thrombin	PAR1	PA451674	79581;2149	0.623
NULL	Int_J_Vasc_Med_2013_Mar_31_2013_543141.nxml.txt.nlp	23606968	SENT132	0	0	25	25	etanercept	IL-13	PA449515	3596	0.622
NULL	Mol_Pain_2012_Sep_22_8_71.nxml.txt.nlp	22998838	SENT120	9	9	17	17	paclitaxel	CB2	PA450761	1269	0.622
NULL	Eur_J_Clin_Pharmacol_2012_Jan_8_68(1)_29-37.nxml.txt.nlp	21739267	SENT101	5	5	18	18	aripiprazole	PRX	PA10026	9588;57716	0.622
NULL	Open_Dent_J_2014_May_30_8_109-124.nxml.txt.nlp	24976875	SENT627	13	13	20	20	doxycycline	MIDAS	PA449415	64083	0.622
NULL	Front_Behav_Neurosci_2010_Jun_10_4_32.nxml.txt.nlp	20589092	SENT410	15	15	20	20	perospirone	5-HT1A	PA165291546	3350	0.622
NULL	Crit_Care_2004_Mar_15_8(Suppl_1)_P246.nxml.txt.nlp	NULL	SENT12	28	28	30	30	vasopressin	AVP	PA451858	114548;551	0.622
NULL	Ann_Clin_Microbiol_Antimicrob_2014_Jan_6_13_2.nxml.txt.nlp	24393536	SENT42	16	16	14	14	tobramycin	TOB	PA451704	10140	0.622
NULL	Calcif_Tissue_Int_2010_Aug_23_87(2)_130-136.nxml.txt.nlp	20571786	SENT14	10	10	20	20	teriparatide	BMD	PA451620	1756;7439	0.622
NULL	Biochemistry_2012_Aug_7_51(31)_6127-6138.nxml.txt.nlp	22794279	SENT150	11	11	32	32	chymotrypsin	14-3-3	PA448994	10971	0.622
NULL	Acta_Pharmacol_Sin_2011_May_18_32(5)_601-610.nxml.txt.nlp	21499285	SENT229	35	35	37	37	bleomycin	BLM	PA448645	641	0.622
NULL	Arthritis_Res_Ther_2013_Nov_28_15(6)_R202.nxml.txt.nlp	24283517	SENT178	9	9	24	24	curcumin	p65	PA151958596	5970	0.622
NULL	Arthritis_Res_Ther_2013_Aug_16_15(4)_R88.nxml.txt.nlp	23953493	SENT46	31	31	7	7	milnacipran	ACR	PA164752812	49	0.622
NULL	Subst_Abuse_Rehabil_2011_May_15_2_89-102.nxml.txt.nlp	21743792	SENT352	43	43	28	28	methamphetamine	CRK	PA450403	1398	0.622
NULL	Arthritis_Res_Ther_2009_Aug_24_11(4)_R127.nxml.txt.nlp	19703304	SENT144	6	6	10	10	adalimumab	OASIS	PA10004	90993	0.622
NULL	Ther_Clin_Risk_Manag_2006_Mar_2(1)_3-18.nxml.txt.nlp	18360577	SENT232	1	1	9	9	ibandronate	CTX	PA10270	1593	0.622
NULL	J_Vet_Med_Sci_2014_Feb_8_76(2)_173-182.nxml.txt.nlp	24107430	SENT59	19	19	21	21	vasopressin	AVP	PA451858	114548;551	0.622
NULL	Diabetes_Care_2010_Apr_12_33(4)_861-868.nxml.txt.nlp	20067962	SENT155	11	11	9	9	hyaluronan	HMGB1	PA165958431	3146	0.622
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT406	4	4	8	8	heparin	FGF1	PA449855	2246	0.622
NULL	Mol_Imaging_Radionucl_Ther_2012_Apr_1_21(1)_38-41.nxml.txt.nlp	23487501	SENT69	11	11	13	13	thyroglobulin	TTF1	PA164754910	7080;7270	0.622
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jun_13_68(Pt_7)_o2086.nxml.txt.nlp	22798767	SENT66	12	12	28	28	ethanol	mol	PA448073	90527	0.622
NULL	Cancer_Metab_2014_Aug_18_2_13.nxml.txt.nlp	25225614	SENT271	22	22	31	31	lipase	DAGLA	PA450239	747	0.622
NULL	Mar_Drugs_2011_Nov_28_9(12)_2488-2498.nxml.txt.nlp	22363235	SENT27	19	19	26	26	glucosamine	NAG	PA164747613	51594;4669	0.622
NULL	J_Ophthalmol_2012_Feb_28_2012_786870.nxml.txt.nlp	22523653	SENT36	20	20	39	39	bevacizumab	PED	PA130232992	8682	0.622
NULL	Infect_Dis_Ther_2014_Jun_18_3(1)_35-43.nxml.txt.nlp	25134810	SENT118	20	20	2	2	oxacillin	VAN	PA450725	10318	0.622
NULL	Child_Adolesc_Psychiatry_Ment_Health_2008_Nov_17_2_33.nxml.txt.nlp	19014633	SENT34	28	28	13	13	lipase	FAAH	PA450239	79152;2166	0.622
NULL	Adv_Virol_2012_Jul_19_2012_267483.nxml.txt.nlp	22851970	SENT140	35	35	33	33	ribavirin	IFN	PA451241	3439	0.622
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT61	10	10	6	6	dasatinib	PP1	PA162372878	5540;5464	0.622
NULL	Trials_2013_Sep_24_14_311.nxml.txt.nlp	24063608	SENT63	0	0	6	6	pyrimethamine	DHFR	PA451193	1719	0.622
NULL	Breast_Cancer_Res_2011_Jun_9_13(3)_R57.nxml.txt.nlp	21658222	SENT24	25	25	11	11	epirubicin	UGT1A4	PA449476	54657	0.622
NULL	Exp_Ther_Med_2013_Oct_19_6(4)_1070-1076.nxml.txt.nlp	24137319	SENT227	7	7	5	5	cyclophosphamide	CTX	PA449165	1593	0.622
NULL	Mol_Cell_Proteomics_2012_Mar_6_11(3)_M111_014035.nxml.txt.nlp	22311637	SENT307	7	7	4	4	etoposide	EEF1G	PA449552	1937	0.622
NULL	J_Cardiothorac_Surg_2014_May_9_9_81.nxml.txt.nlp	24885948	SENT132	0	0	24	24	sorafenib	GATA4	PA7000	2626	0.622
NULL	J_Asthma_Allergy_2014_Apr_11_7_53-65.nxml.txt.nlp	24748808	SENT90	17	17	12	12	omalizumab	GM-CSF	PA164752253	1437	0.622
NULL	Ann_Rheum_Dis_2014_Jun_30_73(6)_990-999.nxml.txt.nlp	24482301	SENT86	29	29	27	27	ustekinumab	UST	PA166048654	10090	0.622
NULL	J_Korean_Med_Sci_2006_Apr_20_21(2)_188-192.nxml.txt.nlp	16614499	SENT109	2	2	4	4	arbekacin	VAN	PA165958370	10318	0.622
NULL	Breast_Cancer_Res_2005_Jul_18_7(5)_187-189.nxml.txt.nlp	16168136	SENT41	18	18	23	23	gefitinib	HER2	PA131301952	2064	0.622
NULL	Br_J_Cancer_2014_Apr_15_110(8)_2144-2158.nxml.txt.nlp	24667650	SENT20	0	0	2	2	diethylstilbestrol	DES	PA449307	1674	0.622
NULL	J_Cell_Mol_Med_2014_Apr_20_18(4)_709-720.nxml.txt.nlp	24444314	SENT144	0	0	8	8	metformin	p53	PA450395	7157	0.622
NULL	Pharmaceutics_2011_Oct_12_3(4)_680-705.nxml.txt.nlp	24309303	SENT727	1	1	4	4	sitagliptin	AMPK	PA164748978	5563	0.622
NULL	BMJ_2010_Feb_8_340_c693.nxml.txt.nlp	20142325	SENT3	14	14	26	26	tamoxifen	CYP2D6	PA451581	1565	0.622
NULL	Contemp_Oncol_(Pozn)_2012_Feb_29_16(1)_86-89.nxml.txt.nlp	23788860	SENT83	18	18	16	16	capecitabine	DDP	PA448771	1678	0.622
NULL	Oncogene_2010_May_20_29(20)_2962-2972.nxml.txt.nlp	20228846	SENT89	8	8	5	5	imatinib	HIF-1	PA10804	29072	0.622
NULL	J_Obes_2011_Sep_19_2011_984245.nxml.txt.nlp	20885921	SENT124	3	3	0	0	exenatide	GLP-1	PA164749238	100125288	0.622
NULL	Biochimie_2015_Jan_108_40-47.nxml.txt.nlp	25447146	SENT194	8	8	12	12	chymotrypsin	CPZ	PA448994	8532	0.622
NULL	F1000_Med_Rep_2009_Feb_24_1_13.nxml.txt.nlp	20948769	SENT79	31	31	27	27	mitoxantrone	CHOP	PA450526	1649	0.622
NULL	Neural_Regen_Res_2014_Mar_15_9(6)_622-629.nxml.txt.nlp	25206865	SENT15	8	8	20	20	vasopressin	c-Jun	PA451858	3725	0.622
NULL	Int_J_Mol_Sci_2014_Sep_25_15(9)_17065-17076.nxml.txt.nlp	25257528	SENT68	17	17	23	23	decitabine	DAC	PA164749631	13	0.622
NULL	Nat_Commun_2011_Jul_5_2_376.nxml.txt.nlp	21730957	SENT1467	14	14	2	2	zolpidem	GAD65	PA451976	2572	0.622
NULL	Cell_Regen_(Lond)_2012_Jun_28_1(1)_3.nxml.txt.nlp	25408866	SENT147	0	0	12	12	glucose	MSC	PA449773	9242	0.622
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Apr_18_68(Pt_5)_o1407.nxml.txt.nlp	22590295	SENT62	18	18	14	14	ethanol	mol	PA448073	90527	0.622
NULL	Curr_Pharm_Des_2011_Dec_17(35)_3846-3853.nxml.txt.nlp	21933140	SENT146	34	34	17	17	exenatide	GLP-1	PA164749238	100125288	0.622
NULL	Eur_J_Immunol_2014_Jun_10_44(6)_1759-1769.nxml.txt.nlp	24595810	SENT9	6	6	10	10	fludrocortisone	CD62L	PA164743961	6402	0.622
NULL	J_Korean_Med_Sci_2010_Aug_21_25(8)_1222-1227.nxml.txt.nlp	20676337	SENT126	0	0	5	5	propofol	LPA	PA451141	4018	0.622
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Apr_13_69(Pt_5)_o697.nxml.txt.nlp	23723853	SENT73	23	23	9	9	ethanol	mol	PA448073	90527	0.622
NULL	Amino_Acids_2012_Apr_6_42(4)_1317-1327.nxml.txt.nlp	21210163	SENT33	4	4	20	20	taurine	SLC6A6	PA451590	6533	0.622
NULL	Sensors_(Basel)_2010_Jun_8_10(6)_5758-5773.nxml.txt.nlp	22219685	SENT139	5	5	9	9	lipase	GPD	PA450239	2532	0.622
NULL	Emerg_Microbes_Infect_2012_Nov_7_1(11)_e39.nxml.txt.nlp	NULL	SENT159	19	19	5	5	tetracycline	Gen	PA451640	348654	0.622
NULL	Biologics_2012_Sep_25_6_337-345.nxml.txt.nlp	23055691	SENT52	26	26	17	17	docetaxel	EGFR	PA449383	1956	0.622
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1437-1448.nxml.txt.nlp	24056706	SENT111	14	14	20	20	sulfaphenazole	CYP2C19	PA130231310	1557	0.622
NULL	Front_Comput_Neurosci_2013_Apr_5_7_22.nxml.txt.nlp	23576979	SENT12	3	3	27	27	ketamine	HCN1	PA450144	348980	0.622
NULL	Exp_Cell_Res_2013_Aug_1_319(13)_2037-2048.nxml.txt.nlp	23562655	SENT15	33	33	9	9	urokinase	PRKD2	PA451836	25865	0.622
NULL	Mol_Pain_2013_Aug_8_9_39.nxml.txt.nlp	23924059	SENT92	6	6	10	10	vasopressin	SON	PA451858	6651	0.622
NULL	J_Cell_Biol_2002_Jun_24_157(7)_1267-1278.nxml.txt.nlp	12082084	SENT164	0	0	17	17	thrombin	AC6	PA451674	112	0.622
NULL	J_Young_Pharm_2012_Jan-Mar_4(1)_42-48.nxml.txt.nlp	22523460	SENT142	29	29	19	19	ethanol	TPC	PA448073	8030;60386	0.622
NULL	Arthritis_Res_Ther_2004_Feb_5_6(1)_28-38.nxml.txt.nlp	14979930	SENT42	41	41	25	25	paraformaldehyde	San	PA450790	80218	0.622
NULL	Cancer_Manag_Res_2012_Nov_9_4_383-395.nxml.txt.nlp	23204869	SENT224	14	14	10	10	carmustine	PC-3	PA448810	692094	0.622
NULL	J_Cachexia_Sarcopenia_Muscle_2011_Dec_20_2(4)_191-200.nxml.txt.nlp	22207907	SENT158	0	0	8	8	rosiglitazone	IL-6	PA451283	3569	0.622
NULL	Br_J_Cancer_2000_Sep_16_83(5)_588-593.nxml.txt.nlp	10944597	SENT1	23	23	25	25	procarbazine	PCB	PA451112	5091	0.622
NULL	Clin_Ophthalmol_2014_Dec_30_9_43-49.nxml.txt.nlp	25565767	SENT63	1	1	9	9	fluorescein	RPE	PA164746009	6120	0.622
NULL	Cell_Death_Dis_2010_Oct_21_1(10)_e86.nxml.txt.nlp	21368859	SENT175	6	6	8	8	doxorubicin	TRAIL	PA449412	8743	0.622
NULL	Oncoscience_2014_Apr_30_1(4)_272-282.nxml.txt.nlp	25594019	SENT25	30	30	26	26	lipase	FAAH	PA450239	79152;2166	0.622
NULL	Br_J_Cancer_2011_Jun_7_104(12)_1805-1809.nxml.txt.nlp	21587260	SENT123	37	37	14	14	plerixafor	HIF-1	PA165958410	29072	0.622
NULL	Viruses_2014_Oct_23_6(10)_3925-3943.nxml.txt.nlp	25341660	SENT214	26	26	7	7	etoposide	TRAF6	PA449552	7189	0.622
NULL	Acta_Pharmacol_Sin_2013_Feb_12_34(2)_255-261.nxml.txt.nlp	23147557	SENT93	7	7	15	15	pioglitazone	PPG	PA450970	5552	0.622
NULL	Arq_Bras_Cardiol_2014_Nov_103(5)_403-409.nxml.txt.nlp	25229355	SENT124	7	7	5	5	diltiazem	PZP	PA449334	5858	0.622
NULL	Comp_Funct_Genomics_2012_Feb_6_2012_876893.nxml.txt.nlp	22400011	SENT297	17	17	3	3	zinc	CTD	PA451956	1283	0.622
NULL	Eur_J_Clin_Pharmacol_2008_Feb_26_64(2)_133-157.nxml.txt.nlp	18224312	SENT66	15	15	0	0	voriconazole	CYP2C19	PA10233	1557	0.622
NULL	Exp_Ther_Med_2014_Nov_29_8(5)_1473-1478.nxml.txt.nlp	25289044	SENT109	12	12	19	19	heparin	AZU	PA449855	566	0.622
NULL	Comp_Hepatol_2005_Feb_8_4_2.nxml.txt.nlp	15701172	SENT261	24	24	26	26	ketoconazole	CYP3A	PA450146	1574	0.622
NULL	Brain_Struct_Funct_2013_Jan_14_218(1)_59-72.nxml.txt.nlp	22246100	SENT223	15	15	30	30	pilocarpine	c-fos	PA450962	2353	0.622
NULL	Can_J_Infect_Dis_Med_Microbiol_2014_May-Jun_25(3)_163-169.nxml.txt.nlp	25285114	SENT225	18	18	30	30	levofloxacin	TOB	PA450214	10140	0.622
NULL	Cell_Death_Dis_2014_Feb_27_5(2)_e1088.nxml.txt.nlp	24577086	SENT16	3	3	8	8	metformin	Bcl-2	PA450395	596	0.622
NULL	Mol_Med_Rep_2015_Feb_3_11(2)_968-974.nxml.txt.nlp	25371265	SENT186	25	25	23	23	cyclophosphamide	CTX	PA449165	1593	0.622
NULL	Ann_Lab_Med_2012_Jul_20_32(4)_298-303.nxml.txt.nlp	22779073	SENT117	12	12	10	10	ethambutol	EMB	PA164784021	133418	0.622
NULL	J_Appl_Crystallogr_2014_Sep_4_47(Pt_5)_1606-1613.nxml.txt.nlp	25294980	SENT44	12	12	24	24	ethanol	mol	PA448073	90527	0.622
NULL	Breast_Cancer_Res_2005_Nov_14_7(6)_R1122-R1131.nxml.txt.nlp	16457692	SENT36	30	30	34	34	tamoxifen	STAR	PA451581	6770;2984	0.622
NULL	Braz_J_Med_Biol_Res_2013_May_10_46(5)_433-439.nxml.txt.nlp	23681290	SENT156	11	11	15	15	bezafibrate	BAFF	PA162364313	10673	0.622
NULL	Biomed_Res_Int_2014_Aug_6_2014_310194.nxml.txt.nlp	25165698	SENT50	21	21	16	16	isoniazid	DST	PA450112	667	0.622
NULL	Depress_Res_Treat_2011_Oct_4_2011_650450.nxml.txt.nlp	21197097	SENT100	25	25	14	14	creatine	ADP	PA164778930	23038	0.622
NULL	J_Korean_Med_Sci_2006_Apr_20_21(2)_188-192.nxml.txt.nlp	16614499	SENT109	6	6	4	4	vancomycin	VAN	PA451850	10318	0.622
NULL	J_Korean_Med_Sci_2011_Jul_20_26(7)_914-918.nxml.txt.nlp	21738345	SENT17	22	22	24	24	lipase	HSL	PA450239	3991	0.622
NULL	Oncotarget_2014_Oct_16_5(20)_9546-9563.nxml.txt.nlp	25337673	SENT184	17	17	11	11	lapatinib	VEGFR2	PA152241907	3791	0.622
NULL	Oncol_Lett_2014_Sep_11_8(3)_1222-1228.nxml.txt.nlp	25120693	SENT140	23	23	21	21	cisplatin	DDP	PA449014	1678	0.622
NULL	Oncotarget_2010_Oct_25_1(7)_497-514.nxml.txt.nlp	21165163	SENT197	20	20	8	8	imatinib	EGFR	PA10804	1956	0.622
NULL	Breast_Cancer_Res_Treat_2013_Feb_4_137(3)_721-731.nxml.txt.nlp	23288344	SENT208	16	16	12	12	tamoxifen	HER-2	PA451581	2064	0.622
NULL	Chem_Cent_J_2012_Jun_20_6_58.nxml.txt.nlp	22716299	SENT18	2	2	4	4	genistein	Gen	PA165109660	348654	0.622
NULL	Front_Oncol_2013_Sep_23_3_250.nxml.txt.nlp	24069582	SENT359	24	24	28	28	tamoxifen	STAR	PA451581	6770;2984	0.622
NULL	Int_J_Fertil_Steril_2013_Mar_3_Jan-Mar_6(4)_304-309.nxml.txt.nlp	24520455	SENT132	22	22	27	27	estradiol	RFRP	PA449503	64111	0.622
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT254	3	3	22	22	methotrexate	MSH2	PA450428	4436	0.622
NULL	Mol_Biol_Cell_2012_May_15_23(10)_1812-1825.nxml.txt.nlp	22438585	SENT203	21	21	13	13	dextran	EGF	PA449261	1950	0.622
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Aug_27_67(Pt_9)_m1269.nxml.txt.nlp	22058871	SENT67	19	19	15	15	ethanol	mol	PA448073	90527	0.622
NULL	Eur_J_Clin_Pharmacol_2011_May_8_67(5)_493-506.nxml.txt.nlp	21140139	SENT8	14	14	2	2	oxycodone	CYP3A4	PA450741	1576	0.622
NULL	J_Gen_Physiol_1939_Jan_20_22(3)_293-310.nxml.txt.nlp	19873105	SENT0	24	24	1	1	trypsin	Gen	PA451806	348654	0.622
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT128	14	14	2	2	disopyramide	CYP2C19	PA449373	1557	0.622
NULL	Br_J_Cancer_2011_Apr_12_104(8)_1256-1261.nxml.txt.nlp	21448165	SENT161	39	39	35	35	sorafenib	IL2	PA7000	3558	0.622
NULL	Genome_Biol_2008_May_16_9(5)_222.nxml.txt.nlp	18495049	SENT15	7	7	20	20	paraformaldehyde	NUP93	PA450790	9688	0.622
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jun_16_68(Pt_7)_o2121.nxml.txt.nlp	22798797	SENT68	22	22	13	13	ethanol	mol	PA448073	90527	0.622
NULL	Mol_Cancer_2010_Mar_31_9_70.nxml.txt.nlp	20356374	SENT140	25	25	37	37	vanillin	DNA-PKcs	PA451852	5591	0.622
NULL	Front_Endocrinol_(Lausanne)_2013_Oct_29_4_161.nxml.txt.nlp	24194732	SENT146	6	6	13	13	estradiol	ACE2	PA449503	59272	0.622
NULL	Ann_Oncol_2010_Mar_28_21(3)_498-505.nxml.txt.nlp	19717534	SENT219	3	3	31	31	tamoxifen	ATAC	PA451581	6375	0.622
NULL	Exp_Ther_Med_2013_Mar_8_5(3)_707-710.nxml.txt.nlp	23404433	SENT148	14	14	16	16	cisplatin	DDP	PA449014	1678	0.622
NULL	Contemp_Oncol_(Pozn)_2012_Feb_29_16(1)_86-89.nxml.txt.nlp	23788860	SENT45	21	21	18	18	etoposide	ADM	PA449552	133	0.622
NULL	Arthritis_2012_Oct_11_2012_713618.nxml.txt.nlp	23133751	SENT157	25	25	8	8	tocilizumab	CDAI	PA165292659	146059	0.622
NULL	Exp_Ther_Med_2012_Oct_16_4(4)_611-614.nxml.txt.nlp	23170113	SENT39	2	2	15	15	heparin	EGF	PA449855	1950	0.622
NULL	J_Gen_Physiol_1985_Sep_1_86(3)_353-379.nxml.txt.nlp	2414392	SENT0	12	12	1	1	nifedipine	Gen	PA450631	348654	0.622
NULL	Emerg_Infect_Dis_2012_Aug_18(8)_1290-1297.nxml.txt.nlp	22840274	SENT155	25	25	28	28	ciprofloxacin	GISP	PA449009	83998	0.622
NULL	J_Anaesthesiol_Clin_Pharmacol_2012_Oct-Dec_28(4)_548-549.nxml.txt.nlp	23225959	SENT32	29	29	5	5	diphenhydramine	Gen	PA449349	348654	0.622
NULL	Breast_Cancer_Res_2009_Mar_19_11(2)_204.nxml.txt.nlp	19344489	SENT241	10	10	5	5	paclitaxel	HER2	PA450761	2064	0.622
NULL	Environ_Health_Perspect_2011_Apr_2_119(4)_547-552.nxml.txt.nlp	21126938	SENT46	22	22	24	24	diethylstilbestrol	DES	PA449307	1674	0.622
NULL	Arch_Drug_Inf_2011_Mar_4(1)_1-9.nxml.txt.nlp	21572514	SENT206	11	11	16	16	ciprofloxacin	P-gp	PA449009	5243	0.622
NULL	Oncotarget_2010_Oct_25_1(7)_497-514.nxml.txt.nlp	21165163	SENT236	43	43	34	34	gefitinib	EGFR	PA131301952	1956	0.622
NULL	Case_Rep_Med_2011_Jul_31_2011_145856.nxml.txt.nlp	21811505	SENT17	9	9	11	11	vasopressin	AVP	PA451858	114548;551	0.622
NULL	Cell_Death_Dis_2012_Jun_21_3(6)_e330.nxml.txt.nlp	22717585	SENT297	0	0	2	2	simvastatin	ATF4	PA451363	468	0.622
NULL	Autoimmune_Dis_2012_Jul_25_2012_834291.nxml.txt.nlp	22888407	SENT122	19	19	23	23	hydroxychloroquine	CLE	PA164777036	51637	0.622
NULL	Mol_Cancer_2010_Jun_25_9_166.nxml.txt.nlp	20579378	SENT162	13	13	9	9	gefitinib	EGF	PA131301952	1950	0.622
NULL	J_Cell_Biol_2003_Dec_22_163(6)_1385-1395.nxml.txt.nlp	14676308	SENT15	34	34	20	20	thrombin	PSGL-1	PA451674	6404	0.622
NULL	Cells_2012_Nov_12_1(4)_1061-1088.nxml.txt.nlp	24710543	SENT93	31	31	26	26	lipase	PPARgamma	PA450239	5468	0.622
NULL	Adv_Synth_Catal_2012_May_7_354(7)_1327-1336.nxml.txt.nlp	23396482	SENT49	9	9	6	6	ethanol	mol	PA448073	90527	0.622
NULL	J_Vet_Med_Sci_2014_Aug_1_76(8)_1153-1156.nxml.txt.nlp	24784438	SENT41	23	23	17	17	kanamycin	OTC	PA450137	5009	0.622
NULL	Mar_Drugs_2011_Aug_10_9(8)_1359-1367.nxml.txt.nlp	21892350	SENT4	10	10	12	12	lipase	HSL	PA450239	3991	0.622
NULL	Cancer_Res_Treat_2014_Jan_15_46(1)_33-40.nxml.txt.nlp	24520221	SENT66	17	17	22	22	vincristine	CHOP	PA451879	1649	0.622
NULL	Mol_Cancer_2014_Jun_5_13_143.nxml.txt.nlp	24898067	SENT103	11	11	3	3	trastuzumab	HER-2	PA451743	2064	0.622
NULL	NDT_Plus_2009_Nov_2(Suppl_3)_iii1-iii4.nxml.txt.nlp	19881931	SENT32	23	23	25	25	vasopressin	AVP	PA451858	114548;551	0.622
NULL	J_Int_Soc_Sports_Nutr_2009_Feb_19_6_6.nxml.txt.nlp	19228401	SENT80	9	9	15	15	creatine	CEE	PA164778930	51608	0.622
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_21-38.nxml.txt.nlp	19305786	SENT498	28	28	4	4	menthol	TRPV1	PA164776605	7442	0.622
NULL	Eur_J_Nucl_Med_Mol_Imaging_2006_Mar_29_33(3)_281-291.nxml.txt.nlp	16317537	SENT178	13	13	23	23	indomethacin	DDC	PA449982	1644	0.622
NULL	Acta_Pharmacol_Sin_2009_Oct_5_30(10)_1369-1384.nxml.txt.nlp	19801995	SENT76	8	8	19	19	hyaluronidase	cadherin	PA164745713	1015	0.622
NULL	Arthritis_Rheum_2011_Nov_63(11)_3512-3521.nxml.txt.nlp	21739425	SENT134	10	10	27	27	thrombin	FIX	PA451674	2158	0.622
NULL	Front_Endocrinol_(Lausanne)_2014_Oct_9_5_166.nxml.txt.nlp	25346724	SENT266	14	14	24	24	resveratrol	SIRT1		23411	0.622
NULL	Nat_Genet_2013_Sep_28_45(9)_1004-1012.nxml.txt.nlp	23892607	SENT309	47	47	6	6	doxycycline	PC2	PA449415	5126;5311;8535	0.622
NULL	Br_J_Cancer_2010_Feb_16_102(4)_774-782.nxml.txt.nlp	20087350	SENT7	8	8	12	12	tetracycline	ERM	PA451640	2119	0.622
NULL	Chem_Cent_J_2012_May_11_6_41.nxml.txt.nlp	22578215	SENT47	18	18	8	8	naringin	castor	PA151958360	54897	0.622
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Nov_21_70(Pt_12)_562-565.nxml.txt.nlp	25552993	SENT8	17	17	13	13	phenol	spatial	PA450913	219793	0.622
NULL	Ann_Indian_Acad_Neurol_2008_Jan-Mar_11(1)_47-48.nxml.txt.nlp	19966979	SENT11	18	18	20	20	vasopressin	AVP	PA451858	114548;551	0.622
NULL	Cancer_Med_2013_Feb_3_2(1)_108-115.nxml.txt.nlp	24279005	SENT145	23	23	27	27	tamoxifen	STAR	PA451581	6770;2984	0.622
NULL	JAKSTAT_2012_Jul_1_1(3)_197-199.nxml.txt.nlp	24058771	SENT33	12	12	24	24	fulvestrant	STAT1	PA164747170	6772	0.622
NULL	BMJ_2011_Jul_26_343_d4366.nxml.txt.nlp	21791491	SENT37	18	18	12	12	lisinopril	ACE	PA450242	1636	0.622
NULL	Anesth_Essays_Res_2013_May-Aug_7(2)_178-182.nxml.txt.nlp	NULL	SENT111	7	7	30	30	fentanyl	CO2	PA449599	4513	0.622
NULL	Eur_J_Cancer_2014_Sep_50(14)_2367-2374.nxml.txt.nlp	25027307	SENT125	24	24	34	34	estradiol	AMH	PA449503	268	0.622
NULL	Mol_Biol_Cell_2013_Aug_1_24(15)_2477-2490.nxml.txt.nlp	23761072	SENT143	31	31	19	19	arsenite	CHOP	PA452638	1649	0.622
NULL	Nat_Prod_Bioprospect_2014_Jun_21_4(3)_181-188.nxml.txt.nlp	24955300	SENT54	2	2	4	4	cisplatin	DDP	PA449014	1678	0.622
NULL	Aging_(Albany_NY)_2012_Dec_6_4(11)_823-842.nxml.txt.nlp	23235539	SENT87	8	8	11	11	bleomycin	HCA2	PA448645	139081;55811;338442	0.622
NULL	Fibrogenesis_Tissue_Repair_2012_Jul_9_5_10.nxml.txt.nlp	22776437	SENT165	28	28	30	30	ethanol	TRAIL	PA448073	8743	0.622
NULL	ScientificWorldJournal_2013_Apr_9_2013_825375.nxml.txt.nlp	23710151	SENT73	0	0	2	2	boceprevir	BOC	PA165948902	91653	0.622
NULL	Eur_J_Med_Res_2014_Jun_24_19(1)_34.nxml.txt.nlp	24961604	SENT103	33	33	13	13	vincristine	BCL11A	PA451879	53335	0.622
NULL	Pharmaceuticals_(Basel)_2013_Aug_6_6(8)_929-959.nxml.txt.nlp	24276377	SENT105	25	25	2	2	oxaliplatin	CXCL8	PA131285527	3576	0.622
NULL	Diabetes_2013_Mar_14_62(3)_783-788.nxml.txt.nlp	23274886	SENT12	24	24	26	26	lipase	LPL	PA450239	4023	0.622
NULL	N_Z_Vet_J_2010_Jun_7_58(3)_121-129.nxml.txt.nlp	20514085	SENT111	7	7	20	20	levamisole	MOX	PA450205	26002	0.622
NULL	J_Gen_Physiol_2009_Jun_133(6)_603-622.nxml.txt.nlp	19468075	SENT288	7	7	27	27	amiloride	CO2	PA448368	4513	0.622
NULL	Mol_Brain_2013_Dec_13_6_55.nxml.txt.nlp	24330808	SENT203	36	36	14	14	l-glutamine	San	PA10090	80218	0.622
NULL	Aging_(Albany_NY)_2010_Nov_15_2(11)_823-842.nxml.txt.nlp	21084727	SENT76	26	26	24	24	nadh	NDUFB4	PA164755085	4710	0.622
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_21-38.nxml.txt.nlp	19305786	SENT435	8	8	11	11	capsaicin	VR1	PA448776	56664	0.622
NULL	Biomed_Res_Int_2014_Jan_29_2014_876712.nxml.txt.nlp	24605339	SENT128	22	22	29	29	diazepam	ANOVA	PA449283	4858	0.622
NULL	F1000Res_2014_Oct_16_3_245.nxml.txt.nlp	25383189	SENT236	18	18	15	15	ranolazine	ATX	PA164746007	5168;23049	0.622
NULL	Case_Rep_Dermatol_2010_Dec_29_2(3)_207-213.nxml.txt.nlp	21537372	SENT29	18	18	21	21	imiquimod	CO2	PA449972	4513	0.622
NULL	Front_Neurosci_2012_Apr_9_6_44.nxml.txt.nlp	22509146	SENT466	4	4	11	11	ethanol	gamma	PA448073	9913	0.622
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT91	0	0	7	7	delavirdine	CYP3A4	PA449223	1576	0.622
NULL	Nat_Commun_2011_Dec_20_2_593.nxml.txt.nlp	22186889	SENT163	0	0	4	4	doxorubicin	BRCA1	PA449412	672	0.622
NULL	Ann_Surg_Treat_Res_2014_Feb_22_86(2)_68-75.nxml.txt.nlp	24761411	SENT114	3	3	6	6	oxaliplatin	survivin	PA131285527	332	0.622
NULL	Mol_Cancer_2009_Dec_31_8_133.nxml.txt.nlp	20043851	SENT190	18	18	2	2	curcumin	DDN	PA151958596	23109	0.622
NULL	J_Cell_Biol_2008_Jul_14_182(1)_197-213.nxml.txt.nlp	18625847	SENT140	11	11	9	9	nutlin-3	p53		7157	0.622
NULL	Ann_Oncol_2010_Mar_28_21(3)_498-505.nxml.txt.nlp	19717534	SENT219	16	16	10	10	anastrozole	ATAC	PA448432	6375	0.622
NULL	Br_J_Cancer_2012_Sep_4_107(6)_977-987.nxml.txt.nlp	22892389	SENT16	2	2	8	8	orlistat	VEGFA	PA164776864	7422	0.622
NULL	Arthritis_Res_Ther_2005_Feb_17_7(Suppl_1)_P81.nxml.txt.nlp	NULL	SENT14	1	1	5	5	infliximab	RANKL	PA452639	8600	0.622
NULL	Front_Synaptic_Neurosci_2010_Dec_22_2_152.nxml.txt.nlp	21423538	SENT301	12	12	6	6	forskolin	CA1	PA146096022	759	0.622
NULL	AoB_Plants_2013_Feb_20_5_plt003.nxml.txt.nlp	23429357	SENT219	13	13	17	17	ethanol	CO2	PA448073	4513	0.622
NULL	Balkan_J_Med_Genet_2011_Dec_8_14(2)_35-40.nxml.txt.nlp	24052710	SENT24	18	18	3	3	guanidine	APOB	PA164781028	338	0.622
NULL	Pharmaceutics_2010_Oct_14_2(4)_321-338.nxml.txt.nlp	NULL	SENT117	13	13	21	21	creatine	ADP	PA164778930	23038	0.622
NULL	Arthritis_Res_Ther_2009_Mar_30_11(2)_R49.nxml.txt.nlp	19327174	SENT25	39	39	28	28	rofecoxib	COX	PA451268	1351	0.622
NULL	Breast_Cancer_Res_2011_Nov_23_13(6)_R117.nxml.txt.nlp	22112244	SENT24	11	11	20	20	trastuzumab	HER2	PA451743	2064	0.622
NULL	Indian_J_Endocrinol_Metab_2013_May-Jun_17(3)_413-421.nxml.txt.nlp	23869296	SENT170	12	12	9	9	exenatide	GLP-1	PA164749238	100125288	0.622
NULL	Indian_J_Pharm_Sci_2014_Sep-Oct_76(5)_437-444.nxml.txt.nlp	25425758	SENT158	21	21	6	6	glimepiride	N10	PA449761	3164	0.621
NULL	Osteoporos_Int_2008_Apr_12_19(4)_399-428.nxml.txt.nlp	18266020	SENT879	23	23	27	27	tamoxifen	STAR	PA451581	6770;2984	0.621
NULL	Breast_Cancer_Res_2012_Feb_14_14(1)_R30.nxml.txt.nlp	22333315	SENT38	31	31	11	11	indomethacin	CXCL10	PA449982	3627	0.621
NULL	Am_J_Physiol_Cell_Physiol_2014_Jan_15_306(2)_C89-C97.nxml.txt.nlp	24133067	SENT53	0	0	6	6	hyaluronan	HAS2	PA165958431	3037	0.621
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R91.nxml.txt.nlp	22541814	SENT146	37	37	40	40	thrombin	HO-1	PA451674	3162	0.621
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT57	14	14	12	12	mitomycin	MVP	PA450524	9961	0.621
NULL	Onco_Targets_Ther_2014_Jan_9_7_111-116.nxml.txt.nlp	24470762	SENT3	25	25	27	27	diethylstilbestrol	DES	PA449307	1674	0.621
NULL	J_Korean_Med_Sci_2006_Dec_31_21(6)_1037-1040.nxml.txt.nlp	17179683	SENT86	15	15	8	8	metronidazole	BAM	PA450484	9126	0.621
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1224-1233.nxml.txt.nlp	22353810	SENT198	26	26	31	31	vincristine	MRP-1	PA451879	928	0.621
NULL	Genome_Biol_2003_Jun_30_4(7)_221.nxml.txt.nlp	12844352	SENT22	17	17	2	2	nicotine	GOX	PA450626	54363	0.621
NULL	Acta_Pharmacol_Sin_2010_Aug_19_31(8)_963-969.nxml.txt.nlp	20644547	SENT103	12	12	7	7	fenofibrate	PDX-1	PA449594	3651	0.621
NULL	Mol_Cancer_2010_Nov_2_9_289.nxml.txt.nlp	21044322	SENT139	30	30	4	4	cisplatin	RGS17	PA449014	26575	0.621
NULL	Angiogenesis_2011_Sep_31_14(3)_245-253.nxml.txt.nlp	21452059	SENT113	13	13	17	17	topotecan	HIF-1	PA451729	29072	0.621
NULL	J_Epilepsy_Res_2011_Dec_30_1(2)_52-56.nxml.txt.nlp	24649446	SENT20	14	14	16	16	lorazepam	LZP	PA450267	170392	0.621
NULL	Yale_J_Biol_Med_1985_Nov-Dec_58(6)_561-570.nxml.txt.nlp	3008450	SENT5	40	40	16	16	vasopressin	gamma	PA451858	9913	0.621
NULL	Gut_Liver_2011_Jun_24_5(2)_117-132.nxml.txt.nlp	21814590	SENT159	36	36	33	33	ribavirin	IFN	PA451241	3439	0.621
NULL	Arthritis_Res_Ther_2012_May_1_14(3)_R99.nxml.txt.nlp	22546542	SENT60	8	8	23	23	infliximab	IL-6	PA452639	3569	0.621
NULL	Facts_Views_Vis_Obgyn_2011_3(3)_189-202.nxml.txt.nlp	24753865	SENT99	35	35	23	23	paclitaxel	p53	PA450761	7157	0.621
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT122	12	12	26	26	capsaicin	p53	PA448776	7157	0.621
NULL	Evid_Based_Complement_Alternat_Med_2013_Mar_28_2013_845172.nxml.txt.nlp	23606892	SENT177	0	0	7	7	masoprocol	HSL	PA164746493	3991	0.621
NULL	Oncol_Lett_2014_Nov_12_8(5)_2203-2208.nxml.txt.nlp	25295109	SENT174	4	4	13	13	celecoxib	GLI1	PA448871	2735	0.621
NULL	Cell_Cycle_2012_Dec_1_11(23)_4474-4483.nxml.txt.nlp	23159862	SENT94	6	6	20	20	etoposide	GAPDH	PA449552	2597	0.621
NULL	Diabetes_2011_Mar_21_60(3)_947-959.nxml.txt.nlp	21300842	SENT129	36	36	28	28	isoproterenol	STZ	PA450121	6484	0.621
NULL	Br_J_Cancer_2010_Feb_2_102(3)_520-529.nxml.txt.nlp	20029417	SENT170	29	29	26	26	trastuzumab	IL-21	PA451743	59067;50616;27189	0.621
NULL	Oncol_Lett_2013_Feb_7_5(2)_440-446.nxml.txt.nlp	23420122	SENT247	32	32	24	24	sorafenib	Gem	PA7000	51053	0.621
NULL	Chem_Cent_J_2013_Jul_31_7_133.nxml.txt.nlp	23899303	SENT19	0	0	7	7	ciprofloxacin	MOX	PA449009	26002	0.621
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Oct_14_6_159-168.nxml.txt.nlp	25339848	SENT135	17	17	14	14	trastuzumab	IL-2	PA451743	3558	0.621
NULL	Cancer_Med_2014_Oct_4_3(5)_1396-1403.nxml.txt.nlp	24995699	SENT150	27	27	25	25	thyroglobulin	TTF-1	PA164754910	7080	0.621
NULL	Arthritis_Res_Ther_2010_Jul_8_12(4)_R135.nxml.txt.nlp	20615213	SENT240	0	0	13	13	hyaluronan	TLR4	PA165958431	7099	0.621
NULL	Open_Cardiovasc_Med_J_2011_Jun_20_5_136-147.nxml.txt.nlp	21760856	SENT41	25	25	31	31	pioglitazone	ghrelin	PA450970	51738	0.621
NULL	J_Clin_Exp_Pathol_2012_May_17_Suppl_4_7327.nxml.txt.nlp	25379357	SENT195	0	0	8	8	resveratrol	S6K1		6198	0.621
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT345	13	13	9	9	dasatinib	PP1	PA162372878	5540;5464	0.621
NULL	Brain_Sci_2013_Jun_3_3(2)_877-907.nxml.txt.nlp	24961429	SENT159	6	6	31	31	taurine	SON	PA451590	6651	0.621
NULL	Diabetes_2009_Dec_31_58(12)_2851-2862.nxml.txt.nlp	19720788	SENT172	2	2	4	4	forskolin	BiP	PA146096022	3309	0.621
NULL	Front_Neurosci_2012_May_30_6_77.nxml.txt.nlp	22661925	SENT257	12	12	15	15	ethanol	DCX	PA448073	1641	0.621
NULL	Pain_2014_Nov_155(11)_2306-2322.nxml.txt.nlp	25168672	SENT977	10	10	0	0	doxapram	BUP	PA164784026	23412	0.621
NULL	Eur_J_Nutr_2009_Jun_24_48(4)_229-234.nxml.txt.nlp	19238310	SENT43	7	7	27	27	capsaicin	GLP-1	PA448776	100125288	0.621
NULL	Mol_Cancer_2013_Oct_8_12_119.nxml.txt.nlp	24103454	SENT29	10	10	6	6	etoposide	TOP2A	PA449552	7153	0.621
NULL	Exp_Ther_Med_2013_Aug_20_6(2)_310-316.nxml.txt.nlp	24137180	SENT183	6	6	14	14	fasudil	MCP-1	PA165946121	6347	0.621
NULL	Bone_Marrow_Res_2012_Oct_18_2012_180391.nxml.txt.nlp	23119165	SENT176	23	23	26	26	alemtuzumab	CD34	PA164783958	947	0.621
NULL	Hematol_Rep_2011_Oct_10_3(2)_e16.nxml.txt.nlp	22184537	SENT23	0	0	11	11	bosentan	CYP2C9	PA10034	1559	0.621
NULL	Front_Physiol_2013_Feb_27_4_30.nxml.txt.nlp	23450717	SENT109	33	33	22	22	collagenase	TLR4	PA449107	7099	0.621
NULL	Environ_Health_2009_Aug_18_8_37.nxml.txt.nlp	19689815	SENT17	0	0	2	2	diethylstilbestrol	DES	PA449307	1674	0.621
NULL	J_Cell_Biol_2003_Dec_22_163(6)_1385-1395.nxml.txt.nlp	14676308	SENT11	11	11	7	7	thrombin	Rho	PA451674	29984	0.621
NULL	Acta_Pharmacol_Sin_2010_Aug_19_31(8)_963-969.nxml.txt.nlp	20644547	SENT95	8	8	22	22	fenofibrate	PDX-1	PA449594	3651	0.621
NULL	J_Ophthalmic_Inflamm_Infect_2011_Nov_6_2(1)_21-28.nxml.txt.nlp	22057810	SENT101	1	1	13	13	methotrexate	CTX	PA450428	1593	0.621
NULL	J_Antimicrob_Chemother_2011_Feb_9_66(2)_363-370.nxml.txt.nlp	21148235	SENT126	10	10	0	0	ritonavir	ATV	PA451260	4683	0.621
NULL	Int_J_Med_Sci_2012_Aug_10_9(6)_472-479.nxml.txt.nlp	22927772	SENT113	21	21	8	8	warfarin	VKORC1	PA451906	79001	0.621
NULL	Biomed_Res_Int_2014_Feb_24_2014_480921.nxml.txt.nlp	24707486	SENT41	25	25	19	19	nitroprusside	PAG	PA451406	55824	0.621
NULL	Int_J_Gen_Med_2011_Jul_20_4_539-545.nxml.txt.nlp	21845063	SENT161	15	15	28	28	miglitol	adiponectin	PA164776726	9370	0.621
NULL	Int_J_Biomed_Sci_2008_Mar_4(1)_8-13.nxml.txt.nlp	23675060	SENT97	17	17	9	9	estradiol	CD4	PA449503	920	0.621
NULL	Br_J_Pharmacol_2011_Apr_162(8)_1832-1842.nxml.txt.nlp	21232033	SENT253	9	9	42	42	resveratrol	SAP97		1739	0.621
NULL	Angiogenesis_2012_Jun_2_15(2)_275-286.nxml.txt.nlp	22382585	SENT24	3	3	5	5	cyclophosphamide	CTX	PA449165	1593	0.621
NULL	Hum_Genomics_2009_Jan_1_3(2)_128-142.nxml.txt.nlp	19164090	SENT241	18	18	12	12	carboplatin	CD44	PA448803	960	0.621
NULL	Mol_Cancer_2014_Jun_4_13_141.nxml.txt.nlp	24894453	SENT130	13	13	15	15	cetuximab	EGFR	PA10040	1956	0.621
NULL	Br_J_Cancer_2012_Feb_28_106(5)_876-882.nxml.txt.nlp	22333597	SENT183	30	30	8	8	everolimus	4E-BP1	PA164746311	1978	0.621
NULL	Iran_J_Pediatr_2011_Dec_21(4)_441-448.nxml.txt.nlp	23056829	SENT139	27	27	4	4	ampicillin	Dakar	PA448419	22900	0.621
NULL	J_Neurol_2012_Oct_26_259(10)_2031-2040.nxml.txt.nlp	22535255	SENT291	14	14	6	6	apomorphine	Ray	PA164781163	26751	0.621
NULL	Oxid_Med_Cell_Longev_2013_Apr_18_2013_239854.nxml.txt.nlp	23710284	SENT83	0	0	15	15	zonisamide	SEL1L	PA451978	6400	0.621
NULL	N_Am_J_Med_Sci_2011_Oct_3(10)_441-450.nxml.txt.nlp	22363081	SENT104	3	3	8	8	gemcitabine	EGFR	PA449748	1956	0.621
NULL	J_Korean_Med_Sci_2009_Oct_23_24(5)_867-873.nxml.txt.nlp	19794985	SENT168	18	18	10	10	estradiol	DPD	PA449503	1806	0.621
NULL	Indian_J_Anaesth_2012_Jul-Aug_56(4)_430-431.nxml.txt.nlp	23087482	SENT17	11	11	16	16	heparin	ACT	PA449855	12;11332;9457;641455	0.621
NULL	Carcinogenesis_2013_Feb_3_34(2)_351-360.nxml.txt.nlp	23125222	SENT168	0	0	3	3	curcumin	CDC25C	PA151958596	995	0.621
NULL	Nat_Commun_2013_Apr_23_4_1758.nxml.txt.nlp	23612299	SENT537	14	14	7	7	isoproterenol	SOD1	PA450121	6647	0.621
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT128	14	14	1	1	disopyramide	CYP2C9	PA449373	1559	0.621
NULL	Exp_Lung_Res_2013_Oct_1_39(8)_336-348.nxml.txt.nlp	23919450	SENT149	7	7	18	18	thrombin	PAR-1	PA451674	2011;2149	0.621
NULL	Arthritis_Res_Ther_2009_May_19_11(3)_223.nxml.txt.nlp	19490599	SENT119	22	22	20	20	debrisoquine	CYP2D6	PA452616	1565	0.621
NULL	J_Korean_Med_Sci_1990_Dec_5(4)_185-188.nxml.txt.nlp	1966034	SENT14	19	19	16	16	methacholine	TDI	PA165958382	100038246	0.621
NULL	Allergy_Asthma_Immunol_Res_2014_Nov_19_6(6)_548-557.nxml.txt.nlp	25374755	SENT88	6	6	25	25	lovastatin	IL-5	PA450272	3567	0.621
NULL	Oxid_Med_Cell_Longev_2013_May_14_2013_957947.nxml.txt.nlp	23766864	SENT221	13	13	23	23	napqi	GCLC		2729	0.621
NULL	Oncol_Rep_2012_Sep_15_28(3)_763-767.nxml.txt.nlp	22710607	SENT116	18	18	23	23	gemcitabine	PS2	PA449748	5664	0.621
NULL	Cancer_Immunol_Immunother_2012_Jun_10_61(6)_941-947.nxml.txt.nlp	22402907	SENT51	24	24	11	11	paraformaldehyde	IFN	PA450790	3439	0.621
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT229	8	8	0	0	panitumumab	STEPP	PA162373091	222659	0.621
NULL	Evid_Based_Complement_Alternat_Med_2014_Oct_19_2014_628712.nxml.txt.nlp	25389442	SENT8	6	6	30	30	erlotinib	PTEN	PA134687924	5728	0.621
NULL	Emerg_Infect_Dis_2014_Apr_20(4)_612-619.nxml.txt.nlp	24655615	SENT50	32	32	34	34	ciprofloxacin	GISP	PA449009	83998	0.621
NULL	Front_Immunol_2013_Mar_27_4_76.nxml.txt.nlp	23543707	SENT1025	21	21	0	0	cetuximab	FCGR2A	PA10040	2212	0.621
NULL	J_Int_Soc_Sports_Nutr_2012_Nov_15_9_49.nxml.txt.nlp	23153110	SENT44	24	24	9	9	creatine	SHOT	PA164778930	6474	0.621
NULL	Breast_Cancer_Res_Treat_2013_Apr_12_138(2)_427-435.nxml.txt.nlp	23479422	SENT27	8	8	20	20	trastuzumab	HER2	PA451743	2064	0.621
NULL	Acta_Pharmacol_Sin_2012_Aug_23_33(8)_1095-1100.nxml.txt.nlp	22820908	SENT115	6	6	4	4	ilaprazole	CYP3A	PA165947499	1574	0.621
NULL	Open_AIDS_J_2007_Oct_22_1_5-10.nxml.txt.nlp	18923691	SENT53	21	21	38	38	methamphetamine	gamma	PA450403	9913	0.621
NULL	Clin_Dev_Immunol_2011_Oct_20_2011_947858.nxml.txt.nlp	22046194	SENT159	0	0	11	11	lenalidomide	IL-10	PA162363968	3586	0.621
NULL	Infect_Drug_Resist_2011_Feb_22_4_65-76.nxml.txt.nlp	21694910	SENT97	27	27	20	20	raltegravir	CD4		920	0.621
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT126	6	6	8	8	curcumin	TRAIL	PA151958596	8743	0.621
NULL	Case_Rep_Pathol_2013_Jul_14_2013_198643.nxml.txt.nlp	23936709	SENT73	18	18	37	37	thyroglobulin	PTH	PA164754910	5741	0.621
NULL	Br_J_Cancer_2010_Jan_5_102(1)_80-86.nxml.txt.nlp	19920817	SENT116	21	21	23	23	bevacizumab	IFN	PA130232992	3439	0.621
NULL	Int_J_Biol_Sci_2013_Jun_28_9(6)_598-612.nxml.txt.nlp	23847442	SENT132	11	11	6	6	l-arginine	CO2	PA448478	4513	0.621
NULL	Arthritis_Res_Ther_2008_Nov_19_10(6)_R136.nxml.txt.nlp	19019215	SENT198	20	20	5	5	methotrexate	IFN	PA450428	3439	0.621
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT309	21	21	16	16	heparin	FGF1	PA449855	2246	0.621
NULL	Arthritis_Res_Ther_2011_Sep_13_13(5)_R145.nxml.txt.nlp	21914170	SENT90	2	2	9	9	fluorescein	HEX	PA164746009	3087	0.621
NULL	Front_Comput_Neurosci_2011_Nov_14_5_44.nxml.txt.nlp	22171217	SENT45	41	41	5	5	halothane	CA1	PA449845	759	0.621
NULL	Cell_Commun_Signal_2011_Sep_22_9_20.nxml.txt.nlp	21939515	SENT27	38	38	48	48	l-glutamine	CO2	PA10090	4513	0.621
NULL	Acta_Orthop_2012_Feb_8_83(1)_87-92.nxml.txt.nlp	22313369	SENT156	8	8	24	24	lovastatin	aP2	PA450272	2167	0.621
NULL	Breast_Cancer_Res_Treat_2012_Jul_8_134(2)_617-624.nxml.txt.nlp	22678156	SENT195	19	19	5	5	trastuzumab	San	PA451743	80218	0.621
NULL	Case_Rep_Neurol_2013_Jun_29_5(2)_116-124.nxml.txt.nlp	23898283	SENT107	18	18	28	28	phenytoin	LZP	PA450947	170392	0.621
NULL	N_Am_J_Med_Sci_2012_Dec_4(12)_638-640.nxml.txt.nlp	23272306	SENT6	12	12	5	5	exenatide	GLP-1	PA164749238	100125288	0.621
NULL	Theranostics_2013_Mar_21_3(4)_267-274.nxml.txt.nlp	23606913	SENT38	16	16	11	11	fluorescein	NIR	PA164746009	26155	0.621
NULL	Ann_Lab_Med_2013_Sep_8_33(5)_383-385.nxml.txt.nlp	24003434	SENT83	8	8	6	6	cefotaxime	CTX	PA448852	1593	0.621
NULL	Acta_Histochem_Cytochem_2010_May_1_43(2)_61-68.nxml.txt.nlp	20514293	SENT67	32	32	15	15	hyaluronan	LYVE-1	PA165958431	10894	0.621
NULL	Eur_Heart_J_2012_Mar_33(6)_705-713.nxml.txt.nlp	22422912	SENT161	15	15	8	8	clopidogrel	ARCH	PA449053	339487	0.621
NULL	Diabetologia_2010_Jun_27_53(6)_1142-1150.nxml.txt.nlp	20349036	SENT176	0	0	6	6	spermine	AMPK	PA164781199	5563	0.621
NULL	Oncotarget_2014_Oct_21_5(22)_11252-11268.nxml.txt.nlp	25361004	SENT177	0	0	3	3	metformin	CLIC1	PA450395	1192	0.621
NULL	J_Hematol_Oncol_2013_Sep_5_6_66.nxml.txt.nlp	24010946	SENT301	19	19	26	26	panitumumab	HER2	PA162373091	2064	0.621
NULL	Anesthesiol_Res_Pract_2012_Nov_24_2012_921405.nxml.txt.nlp	22162685	SENT99	2	2	5	5	lidocaine	NPY	PA450226	4852	0.621
NULL	Br_J_Cancer_2012_Sep_25_107(7)_1009-1016.nxml.txt.nlp	22948724	SENT93	13	13	38	38	temsirolimus	CAIX	PA164746890	768	0.621
NULL	Mol_Biol_Rep_2012_May_20_39(5)_5253-5267.nxml.txt.nlp	22183301	SENT92	14	14	18	18	gliclazide	NAC	PA10892	22861	0.621
NULL	Breast_Cancer_Res_2003_Feb_5_5(2)_113-116.nxml.txt.nlp	12631392	SENT94	39	39	33	33	carboplatin	TPC	PA448803	8030;60386	0.621
NULL	Mol_Cancer_2008_Mar_26_7_27.nxml.txt.nlp	18366759	SENT83	30	30	21	21	etoposide	E2F5	PA449552	1875	0.621
NULL	Front_Neurol_2011_Nov_21_2_68.nxml.txt.nlp	22125548	SENT155	0	0	41	41	rasagiline	GAPDH	PA164764584	2597	0.621
NULL	BMJ_2010_Feb_8_340_c693.nxml.txt.nlp	20142325	SENT220	15	15	5	5	quinidine	CYP2D6	PA451209	1565	0.621
NULL	Cancer_Med_2014_Oct_2_3(5)_1246-1255.nxml.txt.nlp	24890221	SENT123	12	12	18	18	fluorescein	LAT2	PA164746009	7462;23428	0.621
NULL	Clin_J_Gastroenterol_2013_Oct_8_6(5)_378-382.nxml.txt.nlp	24273612	SENT52	10	10	6	6	tacrolimus	CRP	PA451578	1401;140913	0.621
NULL	ScientificWorldJournal_2012_Nov_4_2012_897178.nxml.txt.nlp	23213304	SENT25	6	6	10	10	rituximab	CHOP	PA451261	1649	0.621
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT212	18	18	14	14	adalimumab	CD36	PA10004	948	0.621
NULL	J_Immunother_Cancer_2014_Jan_27_2_2.nxml.txt.nlp	24829759	SENT191	32	32	24	24	sorafenib	IL-21	PA7000	59067;50616;27189	0.621
NULL	J_Mol_Signal_2010_Jul_12_5_8.nxml.txt.nlp	20624308	SENT50	12	12	22	22	gefitinib	Met	PA131301952	79811	0.621
NULL	J_Asthma_Allergy_2013_Feb_22_6_31-39.nxml.txt.nlp	23459334	SENT103	16	16	9	9	desloratadine	ANOVA	PA164776964	4858	0.621
NULL	J_Cell_Biol_2002_Nov_25_159(4)_625-635.nxml.txt.nlp	12438417	SENT11	4	4	2	2	dextran	CD63	PA449261	967	0.621
NULL	Cancers_(Basel)_2014_May_9_6(2)_1128-1137.nxml.txt.nlp	24821131	SENT105	18	18	39	39	octreotide	CD56	PA450678	4684	0.621
NULL	Clin_Dev_Immunol_2004_Mar_11(1)_13-21.nxml.txt.nlp	15154607	SENT5	1	1	7	7	zileuton	5-LOX	PA451955	240	0.621
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT98	18	18	11	11	vinorelbine	MVP	PA451881	9961	0.621
NULL	Cancers_(Basel)_2009_Dec_15_1(1)_23-28.nxml.txt.nlp	20535236	SENT126	37	37	28	28	cisplatin	SOD1	PA449014	6647	0.621
NULL	Indian_J_Psychiatry_2010_Jan_52(Suppl1)_S317-S340.nxml.txt.nlp	21836703	SENT117	20	20	16	16	thioproperazine	TFP	PA164754875	7034	0.621
NULL	Oncol_Lett_2014_Jun_8_7(6)_1761-1766.nxml.txt.nlp	24932229	SENT101	16	16	23	23	pazopanib	KDR	PA165291492	3791	0.621
NULL	Br_J_Cancer_1995_Feb_71(2)_366-370.nxml.txt.nlp	7530988	SENT0	11	11	9	9	mitomycin	MVP	PA450524	9961	0.621
NULL	Braz_J_Med_Biol_Res_2014_Mar_3_47(3)_245-251.nxml.txt.nlp	24554037	SENT150	11	11	27	27	rosuvastatin	IFN	PA134308647	3439	0.621
NULL	Diabetes_Care_2012_Feb_16_35(2)_327-333.nxml.txt.nlp	22179958	SENT23	13	13	16	16	metformin	B12	PA450395	7126;4709	0.621
NULL	Braz_J_Med_Biol_Res_2011_Nov_18_45(1)_86-92.nxml.txt.nlp	22086466	SENT147	7	7	2	2	thrombin	PAR-1	PA451674	2011;2149	0.621
NULL	Braz_J_Med_Biol_Res_2014_Feb_17_47(2)_101-109.nxml.txt.nlp	24519125	SENT137	17	17	5	5	forskolin	IL-6	PA146096022	3569	0.621
NULL	Front_Immunol_2012_Jan_12_2_98.nxml.txt.nlp	22566887	SENT1893	0	0	11	11	celecoxib	NF-kappaB	PA448871	4790	0.621
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT128	11	11	1	1	warfarin	CYP2C9	PA451906	1559	0.621
NULL	Mol_Cell_Proteomics_2012_Nov_3_11(11)_1489-1499.nxml.txt.nlp	22865923	SENT159	0	0	7	7	trypsin	CD4	PA451806	920	0.621
NULL	Exp_Diabetes_Res_2011_Apr_6_2011_928523.nxml.txt.nlp	21603181	SENT172	2	2	7	7	haloperidol	ghrelin	PA449841	51738	0.621
NULL	J_Mol_Signal_2011_Jul_20_6_7.nxml.txt.nlp	21774804	SENT9	13	13	31	31	curcumin	CD166	PA151958596	214	0.621
NULL	Emerg_Infect_Dis_2012_Mar_18(3)_515-516.nxml.txt.nlp	22377354	SENT33	14	14	0	0	ciprofloxacin	CTX	PA449009	1593	0.621
NULL	Clin_Nutr_Res_2014_Jan_27_3(1)_1-8.nxml.txt.nlp	24527414	SENT104	23	23	21	21	choline	B12	PA448976	7126;4709	0.621
NULL	AMB_Express_2011_Jul_13_1_16.nxml.txt.nlp	21906371	SENT10	13	13	4	4	sugar	PTS	PA451529	5805	0.621
NULL	Front_Physiol_2011_Jun_30_2_33.nxml.txt.nlp	21747769	SENT261	6	6	8	8	berberine	EGF	PA165860812	1950	0.621
NULL	Cell_Cycle_2012_Dec_1_11(23)_4474-4483.nxml.txt.nlp	23159862	SENT94	2	2	20	20	cisplatin	GAPDH	PA449014	2597	0.621
NULL	Emerg_Infect_Dis_2014_Jul_20(7)_1252-1253.nxml.txt.nlp	24959839	SENT36	7	7	9	9	rifampin	EMB	PA451250	133418	0.621
NULL	Int_J_Mol_Sci_2012_Feb_24_13(3)_2590-2617.nxml.txt.nlp	22489113	SENT243	14	14	11	11	benzaldehyde	mol	PA448571	90527	0.621
NULL	Mol_Cancer_2012_Jun_18_11_41.nxml.txt.nlp	22709873	SENT328	3	3	10	10	lapatinib	CDKN1B	PA152241907	1027	0.621
NULL	Acta_Pharmacol_Sin_2010_Aug_19_31(8)_963-969.nxml.txt.nlp	20644547	SENT94	14	14	5	5	fenofibrate	PDX-1	PA449594	3651	0.621
NULL	J_Oncol_2011_Jun_12_2011_542358.nxml.txt.nlp	21772843	SENT166	15	15	36	36	imatinib	San	PA10804	80218	0.621
NULL	Breast_Cancer_Res_2014_Dec_19_16(6)_499.nxml.txt.nlp	25522654	SENT0	22	22	17	17	estradiol	CYP19A1	PA449503	1588	0.621
NULL	BMJ_2014_Jul_10_349_g4164.nxml.txt.nlp	25011450	SENT316	1	1	17	17	ethanol	ALDH2	PA448073	217	0.621
NULL	Infect_Dis_Ther_2014_Jun_18_3(1)_35-43.nxml.txt.nlp	25134810	SENT27	22	22	19	19	teicoplanin	VAN	PA164746244	10318	0.621
NULL	Br_J_Cancer_2012_Sep_4_107(6)_947-955.nxml.txt.nlp	22892392	SENT95	6	6	9	9	lapatinib	BCAR1	PA152241907	9564	0.621
NULL	Environ_Health_Perspect_2007_Sep_28_115(9)_1314-1319.nxml.txt.nlp	17805421	SENT13	0	0	2	2	diethylstilbestrol	DES	PA449307	1674	0.621
NULL	Evid_Based_Complement_Alternat_Med_2011_Aug_11_2011_237941.nxml.txt.nlp	19887507	SENT179	26	26	11	11	ethanol	STZ	PA448073	6484	0.621
NULL	J_Hematol_Oncol_2008_Oct_23_1_19.nxml.txt.nlp	18947412	SENT129	12	12	5	5	alemtuzumab	CD52	PA164783958	1043	0.621
NULL	Mol_Vis_2014_Dec_31_20_1796-1805.nxml.txt.nlp	25593507	SENT36	1	1	20	20	papain	CD172a	PA450778	140885	0.621
NULL	N_Am_J_Med_Sci_2010_Oct_2(10)_491-495.nxml.txt.nlp	22558553	SENT105	4	4	0	0	napqi	CYP2D6		1565	0.621
NULL	Cancer_Res_Treat_2012_Mar_31_44(1)_37-42.nxml.txt.nlp	22500159	SENT166	13	13	11	11	gemcitabine	GEM	PA449748	2669	0.621
NULL	Oncol_Lett_2013_Feb_7_5(2)_440-446.nxml.txt.nlp	23420122	SENT212	7	7	18	18	paclitaxel	KRAS	PA450761	3845	0.621
NULL	Bioinformation_2012_Jan_6_8(1)_13-19.nxml.txt.nlp	22359429	SENT87	25	25	29	29	curcumin	MRP1	PA151958596	4437	0.621
NULL	Int_J_Mol_Sci_2012_Feb_24_13(3)_2590-2617.nxml.txt.nlp	22489113	SENT237	14	14	21	21	benzaldehyde	mol	PA448571	90527	0.621
NULL	J_Ophthalmic_Inflamm_Infect_2011_Nov_6_2(1)_21-28.nxml.txt.nlp	22057810	SENT81	1	1	13	13	methotrexate	CTX	PA450428	1593	0.621
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Jun_27_5_15.nxml.txt.nlp	16803618	SENT284	6	6	16	16	erythromycin	LTA	PA449493	4049	0.621
NULL	Clin_Sci_(Lond)_2012_May_1_122(Pt_9)_421-428.nxml.txt.nlp	22092038	SENT32	15	15	30	30	doxycycline	AP-1	PA449415	2353;3727;2354;3725	0.621
NULL	Oncotarget_2012_May_18_3(5)_525-534.nxml.txt.nlp	22619113	SENT167	15	15	25	25	fludarabine	IL-4	PA449655	3565	0.621
NULL	Iran_J_Basic_Med_Sci_2013_Jan_16(1)_56-63.nxml.txt.nlp	23638293	SENT103	26	26	5	5	isoproterenol	ANOVA	PA450121	4858	0.621
NULL	Nucleic_Acids_Res_2006_Jun_27_34(10)_3181-3188.nxml.txt.nlp	16772402	SENT349	25	25	16	16	galactose	mol	PA449725	90527	0.621
NULL	Clinics_(Sao_Paulo)_2013_Apr_68(4)_531-536.nxml.txt.nlp	23778350	SENT107	23	23	12	12	thrombin	VWF	PA451674	7450	0.621
NULL	Breast_Cancer_Res_2011_Nov_24_13(6)_R120.nxml.txt.nlp	22115051	SENT171	41	41	21	21	tamoxifen	HER-2	PA451581	2064	0.621
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT128	12	12	3	3	diazepam	CYP2D6	PA449283	1565	0.621
NULL	Crit_Care_2010_Jan_11_14(1)_R3.nxml.txt.nlp	20064232	SENT53	10	10	3	3	fluorescein	CD25	PA164746009	3669;3559	0.621
NULL	Biogerontology_2008_Feb_11_9(1)_49-55.nxml.txt.nlp	17929190	SENT40	31	31	21	21	nadh	GAPDH	PA164755085	2597	0.621
NULL	Anal_Bioanal_Chem_2009_Oct_30_395(4)_893-905.nxml.txt.nlp	19484227	SENT142	12	12	18	18	amoxicillin	OTC	PA448406	5009	0.621
NULL	AIDS_Res_Treat_2014_Nov_9_2014_724958.nxml.txt.nlp	25431661	SENT18	17	17	19	19	atazanavir	ATV	PA10251	4683	0.621
NULL	Breast_Cancer_Res_2002_Jul_24_4(6)_R12.nxml.txt.nlp	12473173	SENT180	20	20	13	13	ethanol	PCB	PA448073	5091	0.621
NULL	ACS_Med_Chem_Lett_2014_Mar_13_5(3)_214-220.nxml.txt.nlp	24672647	SENT60	24	24	14	14	ribavirin	IFN	PA451241	3439	0.621
NULL	F1000_Med_Rep_2009_May_28_1_41.nxml.txt.nlp	20052398	SENT20	3	3	5	5	ribavirin	IFN	PA451241	3439	0.621
NULL	Case_Rep_Hematol_2013_Aug_27_2013_258028.nxml.txt.nlp	24066245	SENT6	17	17	22	22	cytarabine	DAC	PA449177	13	0.621
NULL	J_Antimicrob_Chemother_2011_Feb_9_66(2)_363-370.nxml.txt.nlp	21148235	SENT115	6	6	0	0	lopinavir	ATV	PA450264	4683	0.621
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jun_27_65(Pt_7)_o1689.nxml.txt.nlp	21582945	SENT3	12	12	2	2	phenol	mol	PA450913	90527	0.621
NULL	Antimicrob_Agents_Chemother_2014_Nov_10_59(1)_490-497.nxml.txt.nlp	25385107	SENT182	14	14	0	0	sulfadiazine	ATV	PA451539	4683	0.621
NULL	Hematol_Rep_2011_Oct_28_3(3_Suppl)_e3.nxml.txt.nlp	22586511	SENT24	8	8	13	13	vincristine	CHOP	PA451879	1649	0.621
NULL	Diabetes_Obes_Metab_2011_Nov_13(11)_982-989.nxml.txt.nlp	21615670	SENT26	26	26	36	36	exenatide	PPG	PA164749238	5552	0.621
NULL	Acta_Pharmacol_Sin_2014_Sep_25_35(9)_1199-1206.nxml.txt.nlp	25152024	SENT132	9	9	7	7	cisplatin	mig-2	PA449014	10979	0.621
NULL	J_Mol_Signal_2013_Aug_7_8_8.nxml.txt.nlp	23924390	SENT58	20	20	18	18	pp2	PP1		5540;5464	0.621
NULL	Biologics_2014_Dec_4_8_281-291.nxml.txt.nlp	25506209	SENT58	34	34	11	11	sorafenib	RET	PA7000	5979	0.621
NULL	Front_Neurol_2014_May_20_5_72.nxml.txt.nlp	24904517	SENT270	7	7	0	0	nicardipine	NEU	PA450620	2064	0.621
NULL	Oxid_Med_Cell_Longev_2011_May_23_2011_213286.nxml.txt.nlp	NULL	SENT115	15	15	11	11	ethanol	GAPDH	PA448073	2597	0.621
NULL	Clin_Epigenetics_2011_Dec_5_3(1)_8.nxml.txt.nlp	22414275	SENT94	3	3	5	5	ribavirin	ESR1	PA451241	2099	0.621
NULL	Cell_Death_Dis_2012_Mar_8_3(3)_e278.nxml.txt.nlp	22402602	SENT265	12	12	37	37	nifedipine	COL2A1	PA450631	1280	0.621
NULL	Br_J_Cancer_2010_Jun_8_102(12)_1707-1716.nxml.txt.nlp	20461078	SENT170	34	34	12	12	bortezomib	XIAP	PA10252	331	0.62
NULL	Evid_Based_Complement_Alternat_Med_2011_Feb_14_2011_429843.nxml.txt.nlp	21869897	SENT97	5	5	2	2	ethanol	CORT	PA448073	1325	0.62
NULL	J_Biol_Chem_2013_Dec_6_288(49)_35387-35395.nxml.txt.nlp	24142790	SENT157	39	39	24	24	meclizine	mol	PA450338	90527	0.62
NULL	Genet_Mol_Biol_2009_Mar_1_Jan-Mar_32(1)_75-82.nxml.txt.nlp	21637649	SENT6	26	26	23	23	thyroglobulin	LEP	PA164754910	3952	0.62
NULL	Contemp_Oncol_(Pozn)_2012_Nov_20_16(5)_416-419.nxml.txt.nlp	23788920	SENT18	16	16	18	18	enoxaparin	CRT	PA449463	811	0.62
NULL	J_Hematol_Oncol_2013_Apr_27_6_31.nxml.txt.nlp	23622716	SENT207	10	10	26	26	suramin	gamma	PA10292	9913	0.62
NULL	Cancer_Cell_Int_2010_Sep_9_10_32.nxml.txt.nlp	20828393	SENT187	24	24	19	19	cisplatin	ATF3	PA449014	467	0.62
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Apr_23_64(Pt_5)_o895.nxml.txt.nlp	21202378	SENT3	25	25	29	29	phenol	mol	PA450913	90527	0.62
NULL	Nanoscale_Res_Lett_2011_Apr_4_6(1)_289.nxml.txt.nlp	21711824	SENT113	10	10	12	12	ethanol	HEG	PA448073	57493	0.62
NULL	Acta_Pharmacol_Sin_2009_Jul_22_30(7)_956-964.nxml.txt.nlp	19543298	SENT137	0	0	2	2	simvastatin	SLCO2B1	PA451363	11309	0.62
NULL	Oncotarget_2012_Nov_14_3(12)_1557-1565.nxml.txt.nlp	23238683	SENT104	26	26	23	23	ponatinib	CRKL	PA165980594	1399	0.62
NULL	Mol_Cancer_2010_Nov_23_9_300.nxml.txt.nlp	21092249	SENT30	23	23	8	8	tamoxifen	IL-6	PA451581	3569	0.62
NULL	ScientificWorldJournal_2012_Jun_18_2012_373709.nxml.txt.nlp	22761550	SENT37	11	11	27	27	halothane	NALCN	PA449845	259232	0.62
NULL	J_Biol_2003_Sep_24_2(4)_28.nxml.txt.nlp	14511394	SENT355	11	11	13	13	phenformin	LKB1	PA1000	6794	0.62
NULL	Environ_Health_Perspect_2007_Dec_8_115(Suppl_1)_84-90.nxml.txt.nlp	18174955	SENT91	41	41	43	43	diethylstilbestrol	DES	PA449307	1674	0.62
NULL	Exp_Biol_Med_(Maywood)_2012_May_237(5)_540-547.nxml.txt.nlp	22569032	SENT32	37	37	11	11	hemin	CO2	PA449849	4513	0.62
NULL	Pharmaceuticals_(Basel)_2013_Nov_25_6(12)_1475-1506.nxml.txt.nlp	24287492	SENT716	7	7	4	4	temozolomide	p53	PA451609	7157	0.62
NULL	Arthritis_Res_Ther_2012_Jan_31_14(1)_R24.nxml.txt.nlp	22293286	SENT136	20	20	11	11	methotrexate	ACPA	PA450428	5657	0.62
NULL	Br_J_Cancer_1991_Dec_64(6)_1069-1075.nxml.txt.nlp	1764369	SENT10	16	16	33	33	melphalan	HAI	PA450354	6692;6768	0.62
NULL	Oncotarget_2012_Nov_17_3(12)_1600-1614.nxml.txt.nlp	23307622	SENT41	0	0	26	26	trastuzumab	DAPK1	PA451743	1612	0.62
NULL	Environ_Health_Perspect_2010_Dec_12_118(12)_1707-1713.nxml.txt.nlp	20705543	SENT134	18	18	3	3	paclitaxel	XRCC1	PA450761	7515	0.62
NULL	Cell_Cycle_2012_Aug_15_11(16)_3097-3108.nxml.txt.nlp	22871741	SENT125	22	22	26	26	hyaluronan	HAS2	PA165958431	3037	0.62
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT260	9	9	14	14	ranibizumab	VEGF-A	PA164746012	7422	0.62
NULL	Oncoimmunology_2014_Jun_25_3_e29080.nxml.txt.nlp	25101222	SENT103	26	26	30	30	hyaluronan	VEGFR	PA165958431	3791	0.62
NULL	Cell_Commun_Signal_2013_Nov_11_11_86.nxml.txt.nlp	24215724	SENT274	9	9	11	11	thrombin	PAR3	PA451674	56288;2151	0.62
NULL	Exp_Diabetes_Res_2011_Dec_27_2011_604989.nxml.txt.nlp	21253359	SENT139	15	15	7	7	clonidine	INS-1	PA449051	2305	0.62
NULL	Arch_Med_Sci_2010_Jun_30_6(3)_316-320.nxml.txt.nlp	22371765	SENT21	10	10	27	27	naltrexone	A10	PA450588	28870	0.62
NULL	Drug_Des_Devel_Ther_2014_Oct_20_8_1993-2007.nxml.txt.nlp	25349474	SENT44	4	4	12	12	phenol	San	PA450913	80218	0.62
NULL	J_Cell_Biol_2005_Nov_21_171(4)_729-738.nxml.txt.nlp	16286510	SENT87	28	28	17	17	trypsin	FGF2	PA451806	2247;2258	0.62
NULL	J_Obes_2013_Jun_4_2013_874981.nxml.txt.nlp	23862058	SENT8	2	2	30	30	l-proline	C15	PA451125	51316	0.62
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jul_14_66(Pt_8)_o1995.nxml.txt.nlp	21588309	SENT74	25	25	16	16	ethanol	mol	PA448073	90527	0.62
NULL	Case_Rep_Med_2014_Mar_4_2014_923496.nxml.txt.nlp	24715926	SENT137	20	20	17	17	tocilizumab	IL-6	PA165292659	3569	0.62
NULL	Clinics_(Sao_Paulo)_2013_Jun_68(6)_785-791.nxml.txt.nlp	23778474	SENT38	3	3	21	21	glucose	IGF1	PA449773	3479	0.62
NULL	Nat_Commun_2010_Sep_1(6)_1-8.nxml.txt.nlp	20842194	SENT40	21	21	23	23	vasopressin	AVP	PA451858	114548;551	0.62
NULL	Carcinogenesis_2014_May_13_35(5)_1055-1066.nxml.txt.nlp	24419232	SENT39	26	26	28	28	metformin	AMPK	PA450395	5563	0.62
NULL	Int_J_Endocrinol_2010_Jan_26_2010_820876.nxml.txt.nlp	21318184	SENT121	6	6	19	19	choline	CD36	PA448976	948	0.62
NULL	Arch_Virol_2014_Dec_24_159(6)_1365-1371.nxml.txt.nlp	24366548	SENT160	21	21	19	19	ribavirin	IFN	PA451241	3439	0.62
NULL	Alcohol_Res_Health_2007_30(1)_38-47.nxml.txt.nlp	17718399	SENT173	8	8	6	6	ethanol	ADH	PA448073	551	0.62
NULL	Sci_Rep_2014_Dec_8_4_7357.nxml.txt.nlp	25483805	SENT306	10	10	35	35	collagenase	NCM	PA449107	57703	0.62
NULL	JRSM_Cardiovasc_Dis_2012_Apr_5_1(1)_cvd_2012_012001.nxml.txt.nlp	24175062	SENT268	19	19	36	36	tamoxifen	CYP2D6	PA451581	1565	0.62
NULL	Clin_Pharmacokinet_2014_Jul_24_53(1)_73-87.nxml.txt.nlp	23881596	SENT39	15	15	26	26	rosuvastatin	OATP1B3	PA134308647	28234	0.62
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Oct_13_68(Pt_11)_o3116.nxml.txt.nlp	23284441	SENT63	15	15	11	11	ethanol	mol	PA448073	90527	0.62
NULL	Acta_Pharmacol_Sin_2010_Aug_5_31(8)_970-976.nxml.txt.nlp	20686521	SENT44	16	16	23	23	methotrexate	ADM	PA450428	133	0.62
NULL	Clin_Pharmacokinet_2014_Sep_3_53(1)_1-16.nxml.txt.nlp	23999929	SENT203	19	19	37	37	rivaroxaban	CLCR	PA165958360	11330	0.62
NULL	Chin_J_Cancer_2011_Jul_30(7)_490-496.nxml.txt.nlp	21718595	SENT88	18	18	27	27	oxaliplatin	LC3	PA131285527	84557	0.62
NULL	Arthritis_Res_Ther_2008_Jan_16_10(1)_R6.nxml.txt.nlp	18199331	SENT17	4	4	14	14	pioglitazone	adiponectin	PA450970	9370	0.62
NULL	Cancers_(Basel)_2011_Oct_14_3(4)_3894-3908.nxml.txt.nlp	24213116	SENT83	16	16	19	19	heparin	EGF	PA449855	1950	0.62
NULL	Biomed_Res_Int_2013_Aug_13_2013_659254.nxml.txt.nlp	24000324	SENT125	11	11	18	18	ethanol	DAC	PA448073	13	0.62
NULL	Front_Immunol_2013_Sep_17_4_281.nxml.txt.nlp	24062747	SENT389	12	12	19	19	atorvastatin	IFN	PA448500	3439	0.62
NULL	Amino_Acids_2012_May_25_42(5)_1529-1539.nxml.txt.nlp	21437784	SENT144	2	2	8	8	taurine	Bcl-2	PA451590	596	0.62
NULL	Clin_Ophthalmol_2014_Feb_10_8_389-399.nxml.txt.nlp	24550667	SENT167	4	4	24	24	brinzolamide	TIM	PA164744929	7984;8914	0.62
NULL	Acta_Vet_Scand_2011_Feb_17_53(1)_11.nxml.txt.nlp	21324209	SENT61	22	22	24	24	kanamycin	OTC	PA450137	5009	0.62
NULL	Emerg_Infect_Dis_2013_Jan_19(1)_133-136.nxml.txt.nlp	23260464	SENT37	31	31	29	29	tobramycin	TOB	PA451704	10140	0.62
NULL	Cancers_(Basel)_2011_Aug_5_3(3)_3114-3142.nxml.txt.nlp	24212948	SENT912	1	1	10	10	paclitaxel	TLR4	PA450761	7099	0.62
NULL	J_Breast_Cancer_2012_Sep_28_15(3)_273-282.nxml.txt.nlp	23091539	SENT130	33	33	26	26	doxycycline	TRAIL	PA449415	8743	0.62
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_May_31_70(Pt_6)_o720.nxml.txt.nlp	24940289	SENT64	14	14	10	10	ethanol	mol	PA448073	90527	0.62
NULL	Arthritis_Res_Ther_2010_Jun_2_12(3)_R107.nxml.txt.nlp	20525198	SENT130	20	20	40	40	rolipram	IL-10	PA153906323	3586	0.62
NULL	Br_J_Cancer_2013_Jan_15_108(1)_115-120.nxml.txt.nlp	23175150	SENT105	31	31	4	4	bevacizumab	KRAS	PA130232992	3845	0.62
NULL	Br_J_Cancer_1988_Nov_58(5)_640-643.nxml.txt.nlp	3064798	SENT0	19	19	14	14	chlorambucil	JM8	PA448926	778	0.62
NULL	Niger_Med_J_2014_Mar-Apr_55(2)_93-98.nxml.txt.nlp	24791039	SENT129	12	12	14	14	vasopressin	AVP	PA451858	114548;551	0.62
NULL	Exp_Neurobiol_2014_Dec_12_23(4)_365-371.nxml.txt.nlp	25548536	SENT8	36	36	21	21	dextran	p62	PA449261	8878;10657;23636	0.62
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT154	10	10	42	42	nutlin-3	p53		7157	0.62
NULL	Biomed_Res_Int_2014_Jun_26_2014_161346.nxml.txt.nlp	25054130	SENT146	3	3	7	7	curcumin	NOX2	PA151958596	1536	0.62
NULL	An_Bras_Dermatol_2013_Nov-Dec_88(6_Suppl_1)_158-161.nxml.txt.nlp	24346907	SENT50	5	5	3	3	cyclophosphamide	CHOP	PA449165	1649	0.62
NULL	Curr_Pharm_Des_2012_Apr_18(11)_1519-1530.nxml.txt.nlp	22364136	SENT131	8	8	14	14	atorvastatin	IFN	PA448500	3439	0.62
NULL	Breast_Cancer_(Auckl)_2014_Mar_23_8_51-56.nxml.txt.nlp	24678242	SENT5	13	13	28	28	carboplatin	BRCA1	PA448803	672	0.62
NULL	Int_J_Mol_Sci_2012_Feb_24_13(3)_2590-2617.nxml.txt.nlp	22489113	SENT214	15	15	12	12	benzaldehyde	mol	PA448571	90527	0.62
NULL	Arthritis_Res_2002_May_24_4(Suppl_2)_S34-S40.nxml.txt.nlp	12110156	SENT106	4	4	7	7	infliximab	IL-18	PA452639	3606	0.62
NULL	Mol_Cancer_2008_Jun_30_7_60.nxml.txt.nlp	18590557	SENT73	10	10	34	34	paclitaxel	TRAIL	PA450761	8743	0.62
NULL	Mol_Biol_Cell_2012_Nov_1_23(21)_4212-4225.nxml.txt.nlp	22956765	SENT261	8	8	5	5	thrombin	SHP2	PA451674	5781	0.62
NULL	Support_Care_Cancer_2009_Sep_10_17(9)_1177-1185.nxml.txt.nlp	19205755	SENT93	28	28	41	41	ondansetron	HEC	PA450705	10403	0.62
NULL	Pharmaceuticals_(Basel)_2011_Jan_11_4(1)_169-186.nxml.txt.nlp	NULL	SENT208	11	11	9	9	fluconazole	CDR2	PA449653	1039	0.62
NULL	Biomed_Res_Int_2013_Sep_5_2013_929531.nxml.txt.nlp	24083250	SENT56	25	25	17	17	hyaluronan	HAS2	PA165958431	3037	0.62
NULL	Nat_Commun_2013_4_2720.nxml.txt.nlp	24193139	SENT226	22	22	24	24	methylphenidate	AMPH	PA450464	273	0.62
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT247	27	27	15	15	doxorubicin	SLK	PA449412	9748;2534	0.62
NULL	Eukaryot_Cell_2014_Aug_13(8)_1077-1084.nxml.txt.nlp	24951438	SENT185	8	8	10	10	doxycycline	RSP5	PA449415	23327	0.62
NULL	Oxid_Med_Cell_Longev_2012_Aug_23_2012_139327.nxml.txt.nlp	22966413	SENT237	0	0	6	6	methimazole	METL	PA450422	55798	0.62
NULL	Oncol_Rep_2012_Aug_25_28(2)_409-417.nxml.txt.nlp	22641253	SENT230	7	7	3	3	trypsin	SPINK1	PA451806	6690	0.62
NULL	Comp_Hepatol_2005_Feb_8_4_2.nxml.txt.nlp	15701172	SENT178	13	13	25	25	estradiol	CYP3A4	PA449503	1576	0.62
NULL	Cell_Commun_Signal_2013_Oct_1_11_73.nxml.txt.nlp	24083678	SENT221	15	15	7	7	sulindac	AP-1	PA451565	2353;3727;2354;3725	0.62
NULL	J_Korean_Med_Sci_2009_Jan_29_24(Suppl_1)_S170-S175.nxml.txt.nlp	19194548	SENT41	30	30	32	32	cisplatin	EPO	PA449014	7076;8288;2056	0.62
NULL	Oncol_Lett_2014_Sep_11_8(3)_1222-1228.nxml.txt.nlp	25120693	SENT156	7	7	5	5	cisplatin	DDP	PA449014	1678	0.62
NULL	Chem_Cent_J_2012_Dec_20_6_160.nxml.txt.nlp	23256754	SENT44	17	17	30	30	cisplatin	HH1	PA449014	6331	0.62
NULL	Clin_Mol_Hepatol_2013_Sep_30_19(3)_195-209.nxml.txt.nlp	24133659	SENT288	22	22	0	0	tenofovir	LAM	PA10204	7249;7248	0.62
NULL	Exp_Diabetes_Res_2010_Feb_17_2010_686734.nxml.txt.nlp	21403818	SENT6	15	15	17	17	pimozide	5-HT7	PA450965	3363	0.62
NULL	J_Cell_Biol_1972_Aug_1_54(2)_266-278.nxml.txt.nlp	4557309	SENT1	24	24	12	12	colchicine	HGL	PA449092	3993;8513	0.62
NULL	Curr_Pharm_Des_2012_Apr_18(11)_1519-1530.nxml.txt.nlp	22364136	SENT109	0	0	9	9	simvastatin	IL-6	PA451363	3569	0.62
NULL	Cent_European_J_Urol_2013_Apr_26_66(1)_39-44.nxml.txt.nlp	24578986	SENT87	16	16	13	13	vincristine	ACT	PA451879	12;11332;9457;641455	0.62
NULL	Lipids_Health_Dis_2011_Dec_30_10_246.nxml.txt.nlp	22208561	SENT67	11	11	27	27	ethanol	PI3K	PA448073	5290	0.62
NULL	J_Cachexia_Sarcopenia_Muscle_2011_Dec_8_2(4)_209-261.nxml.txt.nlp	22476871	SENT1316	10	10	12	12	lipase	HSL	PA450239	3991	0.62
NULL	Am_J_Physiol_Cell_Physiol_2009_Oct_5_297(4)_C898-C906.nxml.txt.nlp	19657054	SENT284	9	9	23	23	collagenase	c-Jun	PA449107	3725	0.62
NULL	Ann_Lab_Med_2012_Jul_20_32(4)_264-269.nxml.txt.nlp	22779067	SENT43	9	9	7	7	isoniazid	DST	PA450112	667	0.62
NULL	Int_Neurourol_J_2014_Sep_24_18(3)_115-125.nxml.txt.nlp	25279238	SENT7	10	10	23	23	berberine	PI3K	PA165860812	5290	0.62
NULL	J_Invest_Dermatol_2012_Sep_19_132(9)_2198-2205.nxml.txt.nlp	22513780	SENT78	2	2	7	7	isotretinoin	IL-10	PA450128	3586	0.62
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1224-1233.nxml.txt.nlp	22353810	SENT194	6	6	10	10	doxorubicin	MRP-1	PA449412	928	0.62
NULL	Biochemistry_2014_Feb_11_53(5)_836-845.nxml.txt.nlp	24483367	SENT699	12	12	8	8	phenol	S12	PA450913	3351;6206;5713;6268	0.62
NULL	Int_J_Biol_Sci_2011_Nov_5_8(1)_1-14.nxml.txt.nlp	22211100	SENT169	2	2	15	15	evodiamine	Bcl-2	PA165860788	596	0.62
NULL	J_Immunol_Res_2014_May_21_2014_371087.nxml.txt.nlp	24963497	SENT317	21	21	17	17	decitabine	DAC	PA164749631	13	0.62
NULL	Libyan_J_Med_2006_Jul_28_1(1)_42-59.nxml.txt.nlp	21526020	SENT204	3	3	1	1	bevacizumab	IFL	PA130232992	3439	0.62
NULL	Acta_Pharmacol_Sin_2014_Aug_30_35(8)_1045-1054.nxml.txt.nlp	24976155	SENT92	0	0	19	19	resveratrol	STAT3		6774	0.62
NULL	Patient_Prefer_Adherence_2009_Nov_3_3_195-203.nxml.txt.nlp	19936162	SENT291	9	9	5	5	palivizumab	NOT	PA164748781	4929	0.62
NULL	Br_J_Cancer_2010_Nov_9_103(10)_1606-1616.nxml.txt.nlp	20959824	SENT30	24	24	0	0	heparin	IGFBP7	PA449855	3490	0.62
NULL	J_Gen_Physiol_2003_Jul_122(1)_5-16.nxml.txt.nlp	12810851	SENT246	11	11	1	1	betaine	p38	PA448603	10598;1432;7965	0.62
NULL	J_Hepatobiliary_Pancreat_Surg_2007_Jan_30_14(1)_83-90.nxml.txt.nlp	17252301	SENT81	6	6	4	4	tobramycin	TOB	PA451704	10140	0.62
NULL	Int_J_Mol_Sci_2012_Feb_24_13(3)_2590-2617.nxml.txt.nlp	22489113	SENT250	14	14	11	11	benzaldehyde	mol	PA448571	90527	0.62
NULL	ScientificWorldJournal_2012_Mar_12_2012_793823.nxml.txt.nlp	22500143	SENT174	19	19	9	9	lipase	ADD1	PA450239	118	0.62
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT208	0	0	2	2	capsaicin	p53	PA448776	7157	0.62
NULL	Curr_Pharm_Des_2011_Feb_17(6)_578-590.nxml.txt.nlp	21391908	SENT181	15	15	11	11	doxorubicin	MDM2	PA449412	4193	0.62
NULL	Carcinogenesis_2010_Dec_27_31(12)_2049-2057.nxml.txt.nlp	20876285	SENT127	2	2	23	23	tamoxifen	HER2	PA451581	2064	0.62
NULL	Acta_Pharmacol_Sin_2010_Oct_13_31(10)_1350-1358.nxml.txt.nlp	20835264	SENT138	0	0	9	9	simvastatin	gamma	PA451363	9913	0.62
NULL	Cell_Commun_Signal_2013_Oct_1_11_73.nxml.txt.nlp	24083678	SENT15	0	0	21	21	sulindac	IL-8	PA451565	3576	0.62
NULL	Anat_Cell_Biol_2010_Sep_30_43(3)_185-193.nxml.txt.nlp	21212858	SENT99	19	19	30	30	methimazole	DCX	PA450422	1641	0.62
NULL	Breast_Cancer_Res_2012_Jun_7_14(3)_R89.nxml.txt.nlp	22676470	SENT330	7	7	10	10	geldanamycin	HER2	PA152031327	2064	0.62
NULL	Arthritis_Res_Ther_2010_Sep_8_12(5)_R167.nxml.txt.nlp	20825639	SENT169	23	23	12	12	resveratrol	p38		10598;1432;7965	0.62
NULL	Front_Neurosci_2014_Nov_24_8_380.nxml.txt.nlp	25505380	SENT189	34	34	31	31	estradiol	COMT	PA449503	1312	0.62
NULL	Mar_Drugs_2014_Mar_24_12(3)_1641-1675.nxml.txt.nlp	24663117	SENT169	8	8	6	6	cyanocobalamin	B12	PA451892	7126;4709	0.62
NULL	J_Skin_Cancer_2012_Dec_13_2012_147863.nxml.txt.nlp	23316365	SENT135	15	15	19	19	curcumin	IL6	PA151958596	3569	0.62
NULL	Neural_Dev_2010_Aug_24_5_21.nxml.txt.nlp	20735826	SENT492	26	26	14	14	l-glutamine	B27	PA10090	56246	0.62
NULL	Front_Behav_Neurosci_2014_Dec_16_8_437.nxml.txt.nlp	25566005	SENT436	6	6	8	8	menthol	TRPM8	PA164776605	79054	0.62
NULL	Front_Aging_Neurosci_2011_May_20_3_7.nxml.txt.nlp	21647396	SENT2789	0	0	5	5	nimodipine	CA1	PA450633	759	0.62
NULL	Oxid_Med_Cell_Longev_2011_Oct_15_2011_703676.nxml.txt.nlp	22013498	SENT35	13	13	28	28	resveratrol	IL-6		3569	0.62
NULL	J_Int_Soc_Sports_Nutr_2009_Feb_19_6_6.nxml.txt.nlp	19228401	SENT80	9	9	1	1	creatine	CRT	PA164778930	811	0.62
NULL	Br_J_Cancer_2010_Jan_5_102(1)_80-86.nxml.txt.nlp	19920817	SENT105	13	13	15	15	bevacizumab	IFN	PA130232992	3439	0.62
NULL	Braz_J_Med_Biol_Res_2014_Mar_3_47(3)_245-251.nxml.txt.nlp	24554037	SENT103	4	4	8	8	atorvastatin	IL-6	PA448500	3569	0.62
NULL	Exp_Mol_Med_2012_Dec_17_44(12)_749-755.nxml.txt.nlp	23178275	SENT104	6	6	3	3	phenylephrine	CAL	PA450935	54751;57120	0.62
NULL	Breast_Cancer_Res_2012_Feb_9_14(1)_R27.nxml.txt.nlp	22321971	SENT69	24	24	19	19	phenol	F12	PA450913	2161	0.62
NULL	Eur_J_Clin_Pharmacol_2010_Feb_17_66(2)_165-170.nxml.txt.nlp	19838691	SENT99	26	26	21	21	midazolam	CYP3A	PA450496	1574	0.62
NULL	J_Invest_Dermatol_2013_Jun_14_133(6)_1541-1549.nxml.txt.nlp	23407395	SENT121	30	30	25	25	imiquimod	CXCL2	PA449972	2920	0.62
NULL	Front_Neural_Circuits_2014_Apr_8_8_33.nxml.txt.nlp	24782714	SENT572	15	15	2	2	clonidine	spatial	PA449051	219793	0.62
NULL	Anesthesiol_Res_Pract_2012_Nov_24_2012_921405.nxml.txt.nlp	22162685	SENT3	6	6	22	22	lidocaine	NPY	PA450226	4852	0.62
NULL	Semin_Dial_2013_Sep_17_26(5)_546-567.nxml.txt.nlp	23859229	SENT587	39	39	37	37	cyanocobalamin	B12	PA451892	7126;4709	0.62
NULL	Aging_(Albany_NY)_2011_Apr_6_3(4)_444-449.nxml.txt.nlp	21483037	SENT71	3	3	8	8	resveratrol	AMPK		5563	0.62
NULL	Br_J_Cancer_2013_Feb_19_108(3)_570-578.nxml.txt.nlp	23299527	SENT128	0	0	14	14	acetohexamide	MLC2	PA164777011	10398	0.62
NULL	Front_Neural_Circuits_2015_Jan_12_8_150.nxml.txt.nlp	25628540	SENT326	0	0	9	9	midazolam	CA1	PA450496	759	0.62
NULL	J_Korean_Med_Sci_2007_Apr_30_22(2)_283-289.nxml.txt.nlp	17449938	SENT98	17	17	8	8	minoxidil	Bcl-2	PA450521	596	0.62
NULL	Blood_Res_2014_Dec_23_49(4)_253-258.nxml.txt.nlp	25548759	SENT114	23	23	25	25	rituximab	CHOP	PA451261	1649	0.62
NULL	Cancer_Med_2013_Dec_31_2(6)_950-963.nxml.txt.nlp	24403269	SENT71	8	8	0	0	cisplatin	CRT	PA449014	811	0.62
NULL	Hum_Genomics_2010_Feb_1_4(3)_194-201.nxml.txt.nlp	20368140	SENT15	6	6	8	8	collagenase	MMP1	PA449107	4312	0.62
NULL	Nat_Genet_2013_Nov_15_45(11)_1366-1370.nxml.txt.nlp	24036952	SENT307	10	10	8	8	heparin	C3b	PA449855	718	0.62
NULL	J_Ophthalmol_2011_Aug_8_2011_706849.nxml.txt.nlp	21845214	SENT4	32	32	6	6	fluorescein	FAF	PA164746009	8239;2188	0.62
NULL	Cell_J_2012_Dec_22_Winter_13(4)_281-289.nxml.txt.nlp	23507624	SENT171	25	25	12	12	propranolol	IL-17	PA451145	3605	0.62
NULL	Clin_Med_Insights_Womens_Health_2013_Jan_23_6_13-24.nxml.txt.nlp	24665210	SENT172	43	43	28	28	estradiol	CEE	PA449503	51608	0.62
NULL	Emerg_Infect_Dis_2013_Jan_19(1)_133-136.nxml.txt.nlp	23260464	SENT49	31	31	9	9	ceftriaxone	TOB	PA448866	10140	0.62
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT128	11	11	2	2	warfarin	CYP2C19	PA451906	1557	0.62
NULL	Cancers_(Basel)_2011_Apr_1_3(2)_1844-1860.nxml.txt.nlp	24212785	SENT125	34	34	21	21	bevacizumab	ACRC	PA130232992	93953	0.62
NULL	Int_J_Chron_Obstruct_Pulmon_Dis_2008_Jun_3(2)_253-268.nxml.txt.nlp	18686734	SENT126	0	0	11	11	thrombin	PAR-1	PA451674	2011;2149	0.62
NULL	Arthritis_Res_Ther_2008_Jan_7_10(1)_R1.nxml.txt.nlp	18179697	SENT53	21	21	27	27	cisplatin	HMGB1	PA449014	3146	0.62
NULL	Nat_Genet_2011_Oct_23_43(12)_1232-1236.nxml.txt.nlp	22019782	SENT83	28	28	26	26	heparin	C3b	PA449855	718	0.62
NULL	Curr_Neuropharmacol_2013_Jan_11(1)_102-108.nxml.txt.nlp	23814542	SENT224	42	42	22	22	curcumin	Yes	PA151958596	7525	0.62
NULL	Mol_Biol_Evol_2011_Aug_4_28(8)_2379-2391.nxml.txt.nlp	21378103	SENT256	12	12	10	10	nadh	CO2	PA164755085	4513	0.62
NULL	Mediators_Inflamm_2011_Jun_7_2011_432080.nxml.txt.nlp	21772662	SENT119	3	3	5	5	thrombin	PAR-1	PA451674	2011;2149	0.62
NULL	Biologics_2009_Oct_12_3_443-457.nxml.txt.nlp	19851470	SENT283	4	4	0	0	tocilizumab	IL-6	PA165292659	3569	0.62
NULL	Br_J_Cancer_2010_Feb_16_102(4)_658-664.nxml.txt.nlp	20104222	SENT6	8	8	28	28	sunitinib	IFN	PA162372840	3439	0.62
NULL	J_Lipid_Res_2014_Jul_55(7)_1465-1477.nxml.txt.nlp	24868093	SENT170	27	27	9	9	choline	LPA	PA448976	4018	0.62
NULL	Front_Genet_2012_Nov_5_3_236.nxml.txt.nlp	23133441	SENT36	14	14	7	7	efavirenz	ABCB1	PA449441	5243	0.62
NULL	Crit_Care_2010_Aug_11_14(4)_R153.nxml.txt.nlp	20701787	SENT182	3	3	5	5	exenatide	GLP-1	PA164749238	100125288	0.62
NULL	Biomed_Res_Int_2014_May_20_2014_418975.nxml.txt.nlp	24967364	SENT205	14	14	12	12	resveratrol	AMPK		5563	0.62
NULL	J_Biomed_Sci_2013_Oct_21_20(1)_76.nxml.txt.nlp	24143895	SENT95	34	34	17	17	tranilast	CO2	PA131890628	4513	0.62
NULL	Case_Rep_Transplant_2012_Nov_4_2012_305920.nxml.txt.nlp	23213610	SENT44	14	14	16	16	everolimus	EVL	PA164746311	51466	0.62
NULL	Cancer_Inform_2013_Feb_13_12_31-51.nxml.txt.nlp	23470717	SENT335	11	11	18	18	epirubicin	E2F1	PA449476	1869	0.62
NULL	Clin_Mol_Hepatol_2013_Sep_30_19(3)_195-209.nxml.txt.nlp	24133659	SENT296	22	22	0	0	tenofovir	LAM	PA10204	7249;7248	0.62
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT46	18	18	45	45	l-leucine	SIRT3	PA450197	23410	0.62
NULL	Mol_Cancer_2012_Jul_12_11_45.nxml.txt.nlp	22788833	SENT96	2	2	6	6	cisplatin	HER2	PA449014	2064	0.62
NULL	Drugs_2009_Mar_17_69(5)_549-565.nxml.txt.nlp	19368417	SENT104	22	22	14	14	formoterol	DPI	PA134687907	1832	0.62
NULL	Br_J_Cancer_2012_Jan_17_106(2)_284-289.nxml.txt.nlp	22215065	SENT180	27	27	22	22	atrasentan	IFN	PA143414738	3439	0.62
NULL	Nucleic_Acids_Res_2005_Jun_9_33(10)_3323-3330.nxml.txt.nlp	15947132	SENT241	14	14	9	9	cisplatin	MSH2	PA449014	4436	0.62
NULL	Biomed_Res_Int_2013_Aug_6_2013_602987.nxml.txt.nlp	24027759	SENT191	17	17	21	21	camptothecin	SMF	PA153590860	22993	0.62
NULL	Brain_Behav_2014_Jul_14_4(4)_468-483.nxml.txt.nlp	25161814	SENT131	12	12	6	6	duloxetine	ANOVA	PA10066	4858	0.62
NULL	Anal_Chem_Insights_2014_Mar_10_9_9-16.nxml.txt.nlp	24653644	SENT11	0	0	2	2	buprenorphine	BUP	PA448685	23412	0.62
NULL	Nat_Commun_2013_Sep_20_4_2444.nxml.txt.nlp	24051492	SENT48	6	6	3	3	nutlin-3	PER2		8864	0.62
NULL	Cell_Death_Dis_2014_Jul_17_5(7)_e1333.nxml.txt.nlp	25032856	SENT224	2	2	10	10	candesartan	EAAC1	PA448765	6505	0.62
NULL	Am_J_Trop_Med_Hyg_2012_Aug_1_87(2)_231-241.nxml.txt.nlp	22855752	SENT148	8	8	3	3	artemisinin	TRAC	PA165111696	28755	0.62
NULL	Arthritis_Res_Ther_2014_Apr_11_16(2)_R93.nxml.txt.nlp	24725461	SENT146	16	16	9	9	letrozole	CYP1A1	PA450196	1543	0.62
NULL	Acta_Pharmacol_Sin_2012_Jul_4_33(7)_897-908.nxml.txt.nlp	22659625	SENT188	13	13	15	15	bleomycin	BLM	PA448645	641	0.62
NULL	Mol_Clin_Oncol_2013_Sep_23_1(5)_869-874.nxml.txt.nlp	24649263	SENT140	10	10	8	8	gemcitabine	GEM	PA449748	2669	0.619
NULL	Emerg_Infect_Dis_2005_Jun_11(6)_873-882.nxml.txt.nlp	15963282	SENT94	22	22	16	16	cefepime	TOB	PA164754876	10140	0.619
NULL	J_Neurol_Sci_2012_Nov_15_322(1-2)_92-95.nxml.txt.nlp	22819352	SENT213	26	26	12	12	ethanol	spatial	PA448073	219793	0.619
NULL	Protein_Cell_2014_Jun_19_5(6)_469-479.nxml.txt.nlp	24748116	SENT109	12	12	24	24	paclitaxel	EB1	PA450761	9167;22919;10982	0.619
NULL	Arthritis_Res_Ther_2013_Dec_3_15(6)_R205.nxml.txt.nlp	24295447	SENT138	0	0	7	7	methotrexate	RANKL	PA450428	8600	0.619
NULL	Oncol_Lett_2013_Apr_22_5(4)_1140-1148.nxml.txt.nlp	23599753	SENT142	14	14	20	20	docetaxel	ANOVA	PA449383	4858	0.619
NULL	Adv_Pharmacol_Sci_2014_Apr_17_2014_354264.nxml.txt.nlp	24822061	SENT328	26	26	15	15	ethanol	CYP3A	PA448073	1574	0.619
NULL	Cancers_(Basel)_2010_Apr_9_2(2)_397-419.nxml.txt.nlp	24281076	SENT606	7	7	0	0	dacarbazine	Bcl-2	PA449197	596	0.619
NULL	Br_J_Cancer_2011_Apr_12_104(8)_1278-1287.nxml.txt.nlp	21487429	SENT102	0	0	6	6	cisplatin	DcR1	PA449014	8794	0.619
NULL	Ann_Lab_Med_2013_Sep_8_33(5)_349-352.nxml.txt.nlp	24003425	SENT83	27	27	29	29	rifampin	EMB	PA451250	133418	0.619
NULL	Gut_Liver_2013_Jan_13_7(1)_82-88.nxml.txt.nlp	23424009	SENT107	9	9	7	7	ribavirin	IFN	PA451241	3439	0.619
NULL	Breast_Cancer_Res_2011_Nov_23_13(6)_R116.nxml.txt.nlp	22113133	SENT327	28	28	12	12	tamoxifen	DES	PA451581	1674	0.619
NULL	Mol_Syst_Biol_2011_Apr_26_7_486.nxml.txt.nlp	21525872	SENT137	29	29	18	18	gefitinib	EGF	PA131301952	1950	0.619
NULL	Int_J_Biol_Macromol_2012_Mar_1_50(2)_362-368.nxml.txt.nlp	22210486	SENT34	0	0	2	2	lamivudine	LAM	PA450163	7249;7248	0.619
NULL	J_Hematol_Oncol_2013_Dec_5_6_90.nxml.txt.nlp	24308725	SENT99	0	0	8	8	curcumin	PC-3	PA151958596	692094	0.619
NULL	J_Thyroid_Res_2011_Apr_10_2011_895923.nxml.txt.nlp	21603172	SENT82	14	14	31	31	thyroglobulin	San	PA164754910	80218	0.619
NULL	Oncotarget_2013_Apr_23_4(6)_816-829.nxml.txt.nlp	23615731	SENT59	6	6	9	9	doxycycline	HSF1	PA449415	3297	0.619
NULL	Cardiovasc_Diabetol_2013_Jun_18_12_90.nxml.txt.nlp	23777457	SENT159	14	14	12	12	liraglutide	GLP-1	PA165958364	100125288	0.619
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Sep_25_66(Pt_10)_o2642.nxml.txt.nlp	21587613	SENT71	25	25	15	15	ethanol	mol	PA448073	90527	0.619
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT102	22	22	30	30	imatinib	ABCG2	PA10804	9429	0.619
NULL	Semin_Nephrol_2013_Nov_33(6)_508-530.nxml.txt.nlp	24161037	SENT1122	11	11	9	9	heparin	C3b	PA449855	718	0.619
NULL	Oncotarget_2014_Oct_21_5(22)_11252-11268.nxml.txt.nlp	25361004	SENT36	0	0	6	6	metformin	U87	PA450395	677775;641648	0.619
NULL	Indian_J_Endocrinol_Metab_2012_Sep-Oct_16(5)_867-868.nxml.txt.nlp	23087894	SENT18	43	43	19	19	bromocriptine	PRL	PA448671	5617	0.619
NULL	Tanaffos_2013_12(1)_6-15.nxml.txt.nlp	25191444	SENT60	11	11	17	17	pyrazinamide	PTH	PA451182	5741	0.619
NULL	Br_J_Pharmacol_2012_Jan_165(2)_380-389.nxml.txt.nlp	21585347	SENT34	2	2	4	4	lipase	ATGL	PA450239	57104	0.619
NULL	Exp_Diabetes_Res_2007_Jun_28_2007_52487.nxml.txt.nlp	17713597	SENT63	0	0	9	9	bevacizumab	San	PA130232992	80218	0.619
NULL	Iran_J_Neurol_2012_11(2)_70-73.nxml.txt.nlp	24250865	SENT54	14	14	16	16	doxycycline	IFN	PA449415	3439	0.619
NULL	Mediators_Inflamm_2011_Jul_3_2011_296069.nxml.txt.nlp	21765615	SENT24	5	5	1	1	heparin	TSP-1	PA449855	7057	0.619
NULL	Front_Endocrinol_(Lausanne)_2011_Aug_11_2_21.nxml.txt.nlp	22654797	SENT54	8	8	13	13	estradiol	Hes1	PA449503	3280	0.619
NULL	J_Headache_Pain_2014_Feb_8_15(1)_7.nxml.txt.nlp	24506953	SENT194	17	17	19	19	capsaicin	TRPV1	PA448776	7442	0.619
NULL	Biomed_Res_Int_2013_Dec_31_2013_795103.nxml.txt.nlp	23710462	SENT212	24	24	6	6	fenofibrate	p65	PA449594	5970	0.619
NULL	J_Oncol_2010_Nov_19_2010_568938.nxml.txt.nlp	20037743	SENT315	21	21	37	37	carboplatin	HER2	PA448803	2064	0.619
NULL	Eur_J_Med_Res_2010_Aug_20_15(8)_337-344.nxml.txt.nlp	20947470	SENT33	29	29	36	36	methotrexate	BLM	PA450428	641	0.619
NULL	Case_Rep_Hematol_2013_Feb_6_2013_541783.nxml.txt.nlp	23476834	SENT36	13	13	18	18	vincristine	CHOP	PA451879	1649	0.619
NULL	Front_Neurosci_2012_May_30_6_77.nxml.txt.nlp	22661925	SENT312	9	9	5	5	ethanol	MCP-1	PA448073	6347	0.619
NULL	Diabetes_Care_2011_Jul_17_34(7)_1601-1604.nxml.txt.nlp	21709296	SENT79	13	13	7	7	acarbose	STOP	PA448010	4135	0.619
NULL	Org_Med_Chem_Lett_2014_Feb_28_4_1.nxml.txt.nlp	24576663	SENT65	29	29	25	25	ethanol	mol	PA448073	90527	0.619
NULL	Front_Neurosci_2010_May_15_4_13.nxml.txt.nlp	20859447	SENT114	8	8	0	0	ketamine	PCP	PA450144	5547	0.619
NULL	Ann_Clin_Microbiol_Antimicrob_2005_Apr_1_4_6.nxml.txt.nlp	15804353	SENT82	8	8	5	5	rifampin	Met	PA451250	79811	0.619
NULL	Exp_Diabetes_Res_2011_Jun_21_2011_853501.nxml.txt.nlp	21754919	SENT52	4	4	6	6	vasopressin	AVP	PA451858	114548;551	0.619
NULL	Case_Rep_Oncol_2014_Apr_17_7(1)_266-272.nxml.txt.nlp	24847253	SENT114	11	11	13	13	octreotide	IFN	PA450678	3439	0.619
NULL	Support_Care_Cancer_2009_Sep_10_17(9)_1187-1193.nxml.txt.nlp	19205754	SENT200	33	33	38	38	aprepitant	CYP2D6	PA164747039	1565	0.619
NULL	Indian_J_Endocrinol_Metab_2013_Jan-Feb_17(1)_91-94.nxml.txt.nlp	23776858	SENT31	19	19	16	16	exenatide	GLP-1	PA164749238	100125288	0.619
NULL	Exp_Ther_Med_2013_Mar_24_5(3)_902-906.nxml.txt.nlp	23408108	SENT20	9	9	21	21	estradiol	aromatase	PA449503	1588	0.619
NULL	Braz_J_Med_Biol_Res_2013_Aug_13_46(8)_650-658.nxml.txt.nlp	23969971	SENT13	9	9	19	19	cisplatin	STAT3	PA449014	6774	0.619
NULL	Front_Physiol_2011_Jul_19_2_40.nxml.txt.nlp	21811470	SENT13	0	0	39	39	candesartan	RVR	PA448765	9975	0.619
NULL	Br_J_Pharmacol_2014_Dec_24_171(23)_5431-5445.nxml.txt.nlp	25052258	SENT126	26	26	0	0	propranolol	SPAP	PA451145	10158	0.619
NULL	Diabetes_Obes_Metab_2010_Aug_12(8)_700-708.nxml.txt.nlp	20590747	SENT13	0	0	31	31	vildagliptin	PPG	PA165958346	5552	0.619
NULL	Afr_J_Infect_Dis_2010_4(2)_29-42.nxml.txt.nlp	23878698	SENT7	24	24	26	26	chloroquine	ACT	PA448948	12;11332;9457;641455	0.619
NULL	Breast_Cancer_Res_2003_Feb_5_5(2)_113-116.nxml.txt.nlp	12631392	SENT100	7	7	33	33	tamoxifen	ATAC	PA451581	6375	0.619
NULL	Case_Rep_Dermatol_2012_Sep_16_4(3)_256-260.nxml.txt.nlp	23275770	SENT67	15	15	22	22	isotretinoin	OMG	PA450128	4974	0.619
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_21-38.nxml.txt.nlp	19305786	SENT488	6	6	15	15	capsaicin	TRPV4	PA448776	59341	0.619
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT102	22	22	28	28	imatinib	ABCB1	PA10804	5243	0.619
NULL	Breast_Cancer_Res_2008_May_13_10(Suppl_2)_P33.nxml.txt.nlp	NULL	SENT9	2	2	12	12	tetracycline	CD44	PA451640	960	0.619
NULL	Indian_J_Dermatol_2014_Nov-Dec_59(6)_630b.nxml.txt.nlp	25484410	SENT27	18	18	16	16	cyanocobalamin	B12	PA451892	7126;4709	0.619
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Apr_17_6_43-57.nxml.txt.nlp	24833916	SENT333	9	9	11	11	everolimus	HER2	PA164746311	2064	0.619
NULL	Nat_Commun_2012_Feb_14_3_672.nxml.txt.nlp	22334075	SENT507	5	5	9	9	pioglitazone	PTEN	PA450970	5728	0.619
NULL	Mol_Cancer_2010_May_18_9_110.nxml.txt.nlp	20482802	SENT136	10	10	19	19	bortezomib	CHOP	PA10252	1649	0.619
NULL	Mol_Med_Rep_2015_Jan_17_11(1)_43-52.nxml.txt.nlp	25333456	SENT266	21	21	11	11	vincristine	ADM	PA451879	133	0.619
NULL	Cardiovasc_J_Afr_2008_Apr_19(2)_77-83.nxml.txt.nlp	18516352	SENT166	13	13	26	26	glucose	GLP-1	PA449773	100125288	0.619
NULL	Acta_Neuropathol_2012_Mar_16_123(3)_369-380.nxml.txt.nlp	22083253	SENT60	23	23	25	25	lovastatin	NF1	PA450272	4763	0.619
NULL	Front_Aging_Neurosci_2010_Oct_14_2_140.nxml.txt.nlp	21048902	SENT634	11	11	5	5	choline	spatial	PA448976	219793	0.619
NULL	Arthritis_Res_Ther_2011_Mar_16_13(2)_R44.nxml.txt.nlp	21410959	SENT144	0	0	12	12	glucosamine	RANTES	PA164747613	6352	0.619
NULL	Front_Oncol_2013_Apr_29_3_99.nxml.txt.nlp	23641363	SENT273	12	12	4	4	methotrexate	FPGS	PA450428	2356	0.619
NULL	Clin_Interv_Aging_2013_Jul_16_8_889-897.nxml.txt.nlp	23898224	SENT7	40	40	38	38	gemcitabine	SIRT1	PA449748	23411	0.619
NULL	Mol_Cancer_2010_Nov_13_9_293.nxml.txt.nlp	21073737	SENT56	14	14	11	11	lipase	MGLL	PA450239	11343	0.619
NULL	Drugs_Context_2014_Jun_11_3_212262.nxml.txt.nlp	24991224	SENT388	28	28	25	25	glucose	PPG	PA449773	5552	0.619
NULL	Brain_Sci_2014_Mar_14_4(1)_136-149.nxml.txt.nlp	24961704	SENT134	2	2	4	4	pramipexole	PPX	PA164742949	5531	0.619
NULL	Iran_J_Pharm_Res_2014_Summer_13(3)_975-985.nxml.txt.nlp	25276199	SENT10	14	14	16	16	vasopressin	AVP	PA451858	114548;551	0.619
NULL	Cells_2014_Sep_12_3(3)_914-938.nxml.txt.nlp	25222270	SENT85	38	38	32	32	capsaicin	TRPM1	PA448776	4308	0.619
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Apr_15_9_13.nxml.txt.nlp	20398300	SENT108	13	13	18	18	moxifloxacin	LAM	PA450555	7249;7248	0.619
NULL	Br_J_Cancer_2004_Mar_8_90(5)_944-949.nxml.txt.nlp	14997187	SENT146	10	10	6	6	genistein	DES	PA165109660	1674	0.619
NULL	Exp_Ther_Med_2014_Mar_10_7(3)_640-648.nxml.txt.nlp	24520260	SENT153	5	5	11	11	resveratrol	p38		10598;1432;7965	0.619
NULL	Cancers_(Basel)_2011_Aug_5_3(3)_3114-3142.nxml.txt.nlp	24212948	SENT140	21	21	13	13	paclitaxel	GEM	PA450761	2669	0.619
NULL	Exp_Cell_Res_2011_Apr_15_317(7)_1028-1039.nxml.txt.nlp	21237154	SENT133	6	6	4	4	staurosporine	TRAIL	PA165109623	8743	0.619
NULL	Hum_Reprod_Update_2010_May_28_Nov-Dec_16(6)_745-760.nxml.txt.nlp	20511398	SENT89	26	26	6	6	genistein	Yes	PA165109660	7525	0.619
NULL	Front_Neurosci_2014_Jun_3_8_128.nxml.txt.nlp	24917782	SENT136	34	34	13	13	ethanol	MC4R	PA448073	4160	0.619
NULL	Exp_Ther_Med_2013_Mar_21_5(3)_987-991.nxml.txt.nlp	23407636	SENT9	10	10	15	15	losartan	IL-8	PA450268	3576	0.619
NULL	Open_Ophthalmol_J_2014_May_16_8_3-6.nxml.txt.nlp	24949110	SENT103	11	11	2	2	ranibizumab	HTRA1	PA164746012	5654	0.619
NULL	Emerg_Infect_Dis_2013_Nov_19(11)_1721-1730.nxml.txt.nlp	24207100	SENT134	28	28	26	26	vancomycin	VAN	PA451850	10318	0.619
NULL	Cell_Commun_Signal_2013_Nov_11_11_86.nxml.txt.nlp	24215724	SENT273	30	30	27	27	thrombin	PAR4	PA451674	9002;5074	0.619
NULL	Cancer_Manag_Res_2014_Jan_28_6_39-51.nxml.txt.nlp	24501545	SENT135	43	43	12	12	tolterodine	CYP2D6	PA164746757	1565	0.619
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT276	16	16	18	18	resveratrol	TRAIL		8743	0.619
NULL	Lab_Invest_2011_Sep_23_91(9)_1396-1409.nxml.txt.nlp	21606925	SENT335	21	21	28	28	pp2	EGF		1950	0.619
NULL	Adv_Hematol_2012_Feb_6_2012_485943.nxml.txt.nlp	22400030	SENT90	25	25	23	23	rituximab	CHOP	PA451261	1649	0.619
NULL	J_Immunol_Res_2014_Oct_12_2014_570685.nxml.txt.nlp	25371908	SENT96	25	25	20	20	levofloxacin	IFN	PA450214	3439	0.619
NULL	J_Neurol_2011_Jul_2_258(7)_1207-1222.nxml.txt.nlp	21461686	SENT260	15	15	12	12	gabapentin	OPT	PA449720	51430	0.619
NULL	Clin_Epigenetics_2011_Dec_5_3(1)_8.nxml.txt.nlp	22414275	SENT200	4	4	6	6	ribavirin	ESR1	PA451241	2099	0.619
NULL	Mol_Med_Rep_2015_Jan_17_11(1)_43-52.nxml.txt.nlp	25333456	SENT266	25	25	33	33	mitomycin	DDP	PA450524	1678	0.619
NULL	Mol_Cancer_2009_Nov_17_8_104.nxml.txt.nlp	19919690	SENT201	26	26	11	11	urokinase	HIF-1	PA451836	29072	0.619
NULL	J_Mol_Signal_2013_Jan_26_8_1.nxml.txt.nlp	23351368	SENT110	0	0	15	15	estradiol	TRAF6	PA449503	7189	0.619
NULL	Clin_Ophthalmol_2012_Sep_21_6_1547-1552.nxml.txt.nlp	23055677	SENT97	3	3	0	0	latanoprost	SPK	PA164774763	55872;8189	0.619
NULL	Ann_Oncol_2009_Nov_23_20(11)_1803-1812.nxml.txt.nlp	19549706	SENT238	33	33	37	37	sunitinib	IFN	PA162372840	3439	0.619
NULL	J_Biol_Chem_2013_Feb_8_288(6)_3918-3928.nxml.txt.nlp	23239877	SENT174	34	34	37	37	thrombin	ADP	PA451674	23038	0.619
NULL	Cost_Eff_Resour_Alloc_2004_Apr_15_2_2.nxml.txt.nlp	15086954	SENT120	7	7	11	11	nateglinide	PPG	PA450600	5552	0.619
NULL	Cancer_Immunol_Immunother_2013_May_16_62(5)_897-908.nxml.txt.nlp	23589107	SENT259	3	3	9	9	cyclophosphamide	CD25	PA449165	3669;3559	0.619
NULL	Cancers_(Basel)_2013_Mar_21_5(1)_296-319.nxml.txt.nlp	24216709	SENT344	9	9	4	4	gemcitabine	EGFR	PA449748	1956	0.619
NULL	Basic_Res_Cardiol_2015_Jan_20_110_4.nxml.txt.nlp	25600226	SENT341	20	20	7	7	ezetimibe	PCSK9	PA10816	255738	0.619
NULL	J_Biol_Chem_2012_Dec_14_287(51)_43094-43107.nxml.txt.nlp	23118219	SENT516	3	3	11	11	hyaluronan	CD25	PA165958431	3669;3559	0.619
NULL	J_Adv_Pharm_Technol_Res_2012_Apr-Jun_3(2)_83-91.nxml.txt.nlp	22837955	SENT147	12	12	14	14	cyclophosphamide	CTX	PA449165	1593	0.619
NULL	J_Biol_Inorg_Chem_2007_Nov_8_12(8)_1181-1196.nxml.txt.nlp	17828423	SENT435	16	16	26	26	benzaldehyde	CO2	PA448571	4513	0.619
NULL	Acta_Physiol_(Oxf)_2007_Sep_191(1)_43-57.nxml.txt.nlp	17524066	SENT229	19	19	2	2	nifedipine	PES	PA450631	23481	0.619
NULL	Cancers_(Basel)_2012_Oct_29_4(4)_1146-1160.nxml.txt.nlp	24213502	SENT403	14	14	18	18	tamoxifen	STAR	PA451581	6770;2984	0.619
NULL	Exp_Lung_Res_2013_Oct_1_39(8)_336-348.nxml.txt.nlp	23919450	SENT118	23	23	18	18	argatroban	PAR-1	PA164745516	2011;2149	0.619
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT220	6	6	17	17	simvastatin	GAPDH	PA451363	2597	0.619
NULL	Environ_Health_Perspect_2005_Nov_113(11)_A740.nxml.txt.nlp	NULL	SENT19	0	0	2	2	diethylstilbestrol	DES	PA449307	1674	0.619
NULL	J_Oncol_2010_May_4_2010_373491.nxml.txt.nlp	20454582	SENT161	20	20	15	15	doxorubicin	TRG	PA449412	6965	0.619
NULL	Infect_Dis_Ther_2014_Jun_18_3(1)_35-43.nxml.txt.nlp	25134810	SENT2	0	0	2	2	vancomycin	VAN	PA451850	10318	0.619
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT17	33	33	22	22	vinorelbine	ASC	PA451881	29108	0.619
NULL	Blood_Cancer_J_2014_Jan_10_4(1)_e171.nxml.txt.nlp	24413065	SENT3	4	4	6	6	gemcitabine	Gem	PA449748	51053	0.619
NULL	Anal_Bioanal_Chem_2014_Sep_12_406(28)_7049-7057.nxml.txt.nlp	25213215	SENT188	17	17	14	14	hemin	spatial	PA449849	219793	0.619
NULL	Br_J_Cancer_2003_Mar_10_88(5)_775-781.nxml.txt.nlp	12618889	SENT184	11	11	33	33	cytarabine	GM-CSF	PA449177	1437	0.619
NULL	ISRN_Obes_2014_Jan_23_2014_540582.nxml.txt.nlp	24587943	SENT157	26	26	23	23	lipase	HSL	PA450239	3991	0.619
NULL	Eur_J_Med_Res_2010_Feb_26_15(2)_59-65.nxml.txt.nlp	20452885	SENT11	11	11	9	9	thrombin	ADP	PA451674	23038	0.619
NULL	Exp_Ther_Med_2013_Mar_8_5(3)_707-710.nxml.txt.nlp	23404433	SENT80	5	5	10	10	cisplatin	Bcl-2	PA449014	596	0.619
NULL	Br_J_Cancer_2011_Apr_12_104(8)_1256-1261.nxml.txt.nlp	21448165	SENT16	12	12	5	5	sorafenib	IL-2	PA7000	3558	0.619
NULL	Br_J_Clin_Pharmacol_2014_Sep_26_78(3)_610-618.nxml.txt.nlp	24666324	SENT30	19	19	21	21	acetylcysteine	NAC	PA448033	22861	0.619
NULL	Pain_2014_Nov_155(11)_2306-2322.nxml.txt.nlp	25168672	SENT977	6	6	0	0	lamotrigine	BUP	PA450164	23412	0.619
NULL	Front_Oncol_2013_Nov_15_3_281.nxml.txt.nlp	24298448	SENT86	8	8	15	15	fluorouracil	BRAF	PA128406956	673	0.619
NULL	F1000Res_2013_Oct_10_2_134.nxml.txt.nlp	24358901	SENT318	19	19	29	29	cisplatin	TP53	PA449014	7157	0.619
NULL	Acta_Pharmacol_Sin_2013_Aug_5_34(8)_1061-1069.nxml.txt.nlp	23770982	SENT33	11	11	13	13	metformin	Met	PA450395	79811	0.619
NULL	Curr_Neuropharmacol_2014_May_12(3)_219-238.nxml.txt.nlp	24851087	SENT128	20	20	8	8	haloperidol	PSD-95	PA449841	1742	0.619
NULL	Emerg_Med_Int_2012_Nov_20_2012_815857.nxml.txt.nlp	22145080	SENT69	1	1	3	3	vasopressin	AVP	PA451858	114548;551	0.619
NULL	Exp_Mol_Med_2012_May_31_44(5)_319-329.nxml.txt.nlp	22314196	SENT49	33	33	25	25	methacholine	VDBP	PA165958382	2638	0.619
NULL	J_Biol_Chem_2013_Nov_15_288(46)_33049-33059.nxml.txt.nlp	24089524	SENT81	30	30	35	35	streptomycin	FBS	PA451512	64319;26269	0.619
NULL	Arthritis_Res_2002_Nov_23_4(3)_157-164.nxml.txt.nlp	12010565	SENT147	32	32	20	20	collagenase	c-Jun	PA449107	3725	0.619
NULL	Indian_J_Endocrinol_Metab_2012_Nov-Dec_16(6)_1051-1052.nxml.txt.nlp	23226668	SENT29	1	1	3	3	vasopressin	AVP	PA451858	114548;551	0.619
NULL	Mol_Vis_2012_Jul_18_18_1966-1972.nxml.txt.nlp	22876123	SENT105	22	22	6	6	curcumin	IL-5	PA151958596	3567	0.619
NULL	Anticancer_Agents_Med_Chem_2013_Jun_13(5)_681-688.nxml.txt.nlp	23092289	SENT223	13	13	19	19	rituximab	CD59	PA451261	966	0.619
NULL	J_Cell_Biol_1999_Feb_22_144(4)_789-801.nxml.txt.nlp	10037799	SENT276	36	36	22	22	heparin	LYVE-1	PA449855	10894	0.619
NULL	J_Cell_Biol_1998_May_4_141(3)_715-726.nxml.txt.nlp	9566971	SENT41	16	16	8	8	creatine	HER2	PA164778930	2064	0.619
NULL	Cancers_(Basel)_2010_May_26_2(2)_955-969.nxml.txt.nlp	24281101	SENT967	8	8	1	1	dacarbazine	Bcl-2	PA449197	596	0.619
NULL	Int_J_Gen_Med_2013_Jun_7_6_453-464.nxml.txt.nlp	23785241	SENT205	5	5	31	31	nedocromil	GM-CSF	PA450601	1437	0.619
NULL	Brain_Res_2012_Feb_3_1436(C)_111-121.nxml.txt.nlp	22200378	SENT127	16	16	11	11	probenecid	OAT	PA451106	4942	0.619
NULL	Nat_Neurosci_2012_Sep_5_15(9)_1245-1254.nxml.txt.nlp	22864611	SENT90	7	7	14	14	clozapine	HDAC2	PA449061	3066	0.619
NULL	Gastric_Cancer_2013_Jul_12_16(3)_345-354.nxml.txt.nlp	22968820	SENT106	30	30	36	36	oxaliplatin	FANCJ	PA131285527	83990	0.619
NULL	Carcinogenesis_2010_Dec_27_31(12)_2049-2057.nxml.txt.nlp	20876285	SENT218	3	3	20	20	tamoxifen	HER2	PA451581	2064	0.619
NULL	Oncol_Lett_2014_Nov_14_8(5)_2086-2092.nxml.txt.nlp	25295095	SENT177	8	8	11	11	gemcitabine	LKB1	PA449748	6794	0.619
NULL	Oncotarget_2013_Dec_21_5(9)_2404-2417.nxml.txt.nlp	24811221	SENT278	0	0	2	2	bleomycin	BLM	PA448645	641	0.619
NULL	Cancers_(Basel)_2011_Apr_26_3(2)_2195-2213.nxml.txt.nlp	24212804	SENT190	21	21	12	12	cyclophosphamide	IL-2	PA449165	3558	0.619
NULL	Drugs_Context_2012_Dec_11_2012_212244.nxml.txt.nlp	24432033	SENT72	9	9	22	22	urokinase	CA125	PA451836	4077;94025	0.619
NULL	Emerg_Infect_Dis_2012_Feb_18(2)_302-304.nxml.txt.nlp	22305387	SENT113	16	16	14	14	pyrimethamine	PYM	PA451193	84305	0.619
NULL	Breast_Cancer_Res_2011_Nov_28_13(6)_317.nxml.txt.nlp	22189202	SENT29	5	5	18	18	nadh	PSPH	PA164755085	5723	0.619
NULL	Oncotarget_2014_Jun_18_5(14)_5428-5438.nxml.txt.nlp	24980817	SENT94	8	8	21	21	cetuximab	EGFR	PA10040	1956	0.619
NULL	Diabetes_Care_2009_Sep_28_32(9)_1649-1655.nxml.txt.nlp	19478198	SENT103	25	25	7	7	metformin	PPG	PA450395	5552	0.619
NULL	Mol_Cell_Proteomics_2013_Jan_22_12(1)_158-171.nxml.txt.nlp	23090970	SENT255	28	28	26	26	tamoxifen	FGFR1	PA451581	2260	0.619
NULL	Oncogene_2013_Nov_28_32(48)_5439-5448.nxml.txt.nlp	23563182	SENT137	31	31	41	41	vincristine	TRAIL	PA451879	8743	0.619
NULL	Patient_Prefer_Adherence_2013_May_7_7_391-400.nxml.txt.nlp	23687442	SENT26	39	39	44	44	fosaprepitant	HEC	PA165958390	10403	0.619
NULL	Clin_Dev_Immunol_2011_Dec_8_2011_439053.nxml.txt.nlp	22190971	SENT291	20	20	34	34	cisplatin	TC-1	PA449014	56892	0.619
NULL	Case_Rep_Oncol_2010_Nov_29_3(3)_439-444.nxml.txt.nlp	21151639	SENT35	4	4	13	13	thyroglobulin	CK20	PA164754910	54474	0.619
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1437-1448.nxml.txt.nlp	24056706	SENT111	10	10	24	24	furafylline	CYP2D6	PA452614	1565	0.619
NULL	Clin_Pediatr_Endocrinol_2005_Feb_14_14(1)_27-33.nxml.txt.nlp	24790307	SENT40	6	6	8	8	vasopressin	AVP	PA451858	114548;551	0.619
NULL	Neural_Plast_2014_Sep_9_2014_360481.nxml.txt.nlp	25313338	SENT147	37	37	33	33	celecoxib	COX	PA448871	1351	0.619
NULL	FEBS_Open_Bio_2014_Jan_6_4_77-89.nxml.txt.nlp	24490132	SENT115	3	3	6	6	ebselen	GDH	PA161660841	51084;2746	0.619
NULL	Front_Behav_Neurosci_2010_Apr_5_4_14.nxml.txt.nlp	20407577	SENT550	10	10	2	2	cocaine	BDNF	PA449072	627	0.619
NULL	J_Adv_Pharm_Technol_Res_2014_Oct-Dec_5(4)_171-178.nxml.txt.nlp	25364695	SENT144	15	15	20	20	curcumin	ARG	PA151958596	473;27	0.619
NULL	J_Cell_Biol_1999_Feb_8_144(3)_447-458.nxml.txt.nlp	9971740	SENT173	21	21	18	18	dextran	mol	PA449261	90527	0.619
NULL	Clin_Interv_Aging_2012_Jul_12_7_235-247.nxml.txt.nlp	22866001	SENT133	11	11	9	9	alendronate	PTH	PA448082	5741	0.619
NULL	Br_J_Cancer_2010_Feb_16_102(4)_658-664.nxml.txt.nlp	20104222	SENT130	30	30	26	26	sunitinib	IFN	PA162372840	3439	0.619
NULL	Clinics_(Sao_Paulo)_2010_Feb_65(2)_175-179.nxml.txt.nlp	20186301	SENT21	7	7	24	24	phenol	PON1	PA450913	5444	0.619
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jul_31_66(Pt_8)_o2178-o2179.nxml.txt.nlp	21588457	SENT73	16	16	12	12	ethanol	mol	PA448073	90527	0.619
NULL	Front_Oncol_2013_Nov_18_3_282.nxml.txt.nlp	24303367	SENT245	5	5	11	11	glucose	RET	PA449773	5979	0.619
NULL	Clin_Interv_Aging_2008_Mar_3(1)_45-50.nxml.txt.nlp	18488877	SENT52	25	25	15	15	raloxifene	STAR	PA451221	6770;2984	0.619
NULL	Br_J_Pharmacol_2013_Jun_27_169(4)_736-747.nxml.txt.nlp	23489111	SENT139	3	3	5	5	topotecan	5-HT3A	PA451729	3359	0.619
NULL	Acta_Pharmacol_Sin_2010_Mar_22_31(3)_329-340.nxml.txt.nlp	20173759	SENT207	6	6	24	24	ethanol	AMPK	PA448073	5563	0.619
NULL	J_Immunol_Res_2014_Mar_31_2014_301376.nxml.txt.nlp	24741584	SENT32	7	7	28	28	cisplatin	XIAP	PA449014	331	0.619
NULL	J_Anaesthesiol_Clin_Pharmacol_2011_Oct-Dec_27(4)_489-494.nxml.txt.nlp	22096282	SENT115	3	3	12	12	dextromethorphan	ACTH	PA449273	5443	0.619
NULL	Cardiovasc_Ther_2012_Jun_19_30(3)_e146-e155.nxml.txt.nlp	21167014	SENT36	0	0	4	4	liraglutide	GLP-1	PA165958364	100125288	0.619
NULL	J_Hematol_Oncol_2010_May_2_3_18.nxml.txt.nlp	20433767	SENT189	14	14	8	8	paclitaxel	EGFR	PA450761	1956	0.619
NULL	Biologics_2010_Feb_4_4_19-31.nxml.txt.nlp	20161982	SENT309	2	2	10	10	imatinib	PDGFA	PA10804	5154	0.619
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT190	0	0	2	2	chloroquine	BMPR-II	PA448948	659	0.619
NULL	Curr_Pharm_Des_2012_Apr_18(11)_1519-1530.nxml.txt.nlp	22364136	SENT109	0	0	11	11	simvastatin	IL-8	PA451363	3576	0.619
NULL	Front_Neurosci_2014_Nov_10_8_364.nxml.txt.nlp	25426018	SENT242	16	16	11	11	fluorescein	Casper	PA164746009	8837	0.619
NULL	Clin_Interv_Aging_2011_Jun_21_6_151-160.nxml.txt.nlp	21753870	SENT177	22	22	26	26	tamoxifen	STAR	PA451581	6770;2984	0.619
NULL	Acta_Pharmacol_Sin_2012_Oct_3_33(10)_1311-1318.nxml.txt.nlp	22941289	SENT153	22	22	15	15	sorafenib	VEGFR2	PA7000	3791	0.619
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jun_23_66(Pt_7)_o1753.nxml.txt.nlp	21587969	SENT74	10	10	13	13	benzaldehyde	mol	PA448571	90527	0.619
NULL	J_Nutr_Metab_2011_Oct_1_2011_525094.nxml.txt.nlp	21977315	SENT184	25	25	9	9	resveratrol	SIRT3		23410	0.619
NULL	Int_J_Nanomedicine_2009_Apr_1_4_27-35.nxml.txt.nlp	19421368	SENT130	20	20	27	27	genistein	IL-4	PA165109660	3565	0.619
NULL	Epilepsia_2014_Jun_6_55(6)_806-818.nxml.txt.nlp	24802699	SENT92	7	7	19	19	bumetanide	NKCC2	PA448682	6557	0.619
NULL	J_Oncol_2012_Mar_11_2012_359246.nxml.txt.nlp	22481925	SENT103	13	13	21	21	thyroglobulin	TPO	PA164754910	7066;7173	0.619
NULL	Arch_Med_Sci_2013_Apr_20_9(2)_332-339.nxml.txt.nlp	23671446	SENT129	5	5	28	28	midazolam	JNK	PA450496	5599	0.619
NULL	AIDS_Res_Ther_2006_Apr_24_3_12.nxml.txt.nlp	16635263	SENT102	9	9	1	1	fluorescein	PEG10	PA164746009	23089	0.619
NULL	Sci_Rep_2015_Jan_15_5_7817.nxml.txt.nlp	25588710	SENT31	7	7	1	1	trastuzumab	MPL	PA451743	4352	0.619
NULL	J_Bras_Pneumol_2014_May-Jun_40(3)_238-243.nxml.txt.nlp	25029646	SENT6	10	10	22	22	methylprednisolone	LPO	PA450466	4025	0.619
NULL	Acta_Pharmacol_Sin_2012_Jul_4_33(7)_873-878.nxml.txt.nlp	22659623	SENT20	2	2	13	13	eplerenone	IL-6	PA164749044	3569	0.619
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_May_7_65(Pt_6)_o1229.nxml.txt.nlp	21583097	SENT72	30	30	14	14	ethanol	mol	PA448073	90527	0.619
NULL	Surg_Today_2012_Jan_6_42(1)_8-28.nxml.txt.nlp	22139128	SENT230	17	17	39	39	tegafur	PSK	PA452620	9344	0.619
NULL	Ann_Lab_Med_2012_Jul_20_32(4)_264-269.nxml.txt.nlp	22779067	SENT117	8	8	6	6	isoniazid	DST	PA450112	667	0.619
NULL	Oncol_Lett_2013_Mar_14_5(3)_756-760.nxml.txt.nlp	23426872	SENT141	2	2	8	8	cisplatin	JAK2	PA449014	3717	0.619
NULL	Oxid_Med_Cell_Longev_2013_Jun_2_2013_793525.nxml.txt.nlp	23819014	SENT244	3	3	9	9	resveratrol	SGBS		2719	0.618
NULL	J_Exp_Med_2000_Mar_6_191(5)_859-870.nxml.txt.nlp	10704466	SENT150	17	17	8	8	arsenite	p38	PA452638	10598;1432;7965	0.618
NULL	Neuroimage_Clin_2013_Sep_6_3_290-300.nxml.txt.nlp	24273714	SENT165	9	9	16	16	pioglitazone	spatial	PA450970	219793	0.618
NULL	Chem_Senses_2008_Sep_5_33(7)_665-680.nxml.txt.nlp	18603652	SENT38	7	7	19	19	amiloride	TRPV1	PA448368	7442	0.618
NULL	Diabetes_Care_2012_Jan_9_35(1)_131-136.nxml.txt.nlp	22040838	SENT167	8	8	14	14	metformin	NEFA	PA450395	4925	0.618
NULL	AIDS_2014_Jun_1_28(9)_1333-1339.nxml.txt.nlp	24583670	SENT151	12	12	19	19	emtricitabine	CD4	PA10069	920	0.618
NULL	Biosci_Rep_2012_Apr_1_32(Pt_2)_105-112.nxml.txt.nlp	22115362	SENT557	29	29	17	17	collagenase	c-Jun	PA449107	3725	0.618
NULL	J_Korean_Med_Sci_2010_Feb_19_25(2)_304-308.nxml.txt.nlp	20119588	SENT34	31	31	27	27	pyrazinamide	EMB	PA451182	133418	0.618
NULL	Arch_Drug_Inf_2009_Mar_2(1)_8-16.nxml.txt.nlp	19381336	SENT30	16	16	23	23	ritonavir	CYP3A4	PA451260	1576	0.618
NULL	Front_Genet_2014_Aug_26_5_280.nxml.txt.nlp	25206360	SENT447	14	14	3	3	iloperidone	NPAS3	PA161199368	64067	0.618
NULL	Protein_Eng_Des_Sel_2014_Apr_28_27(4)_97-109.nxml.txt.nlp	24586053	SENT368	10	10	21	21	trastuzumab	CEA	PA451743	5670;1087	0.618
NULL	Br_J_Cancer_2009_Mar_10_100(5)_789-794.nxml.txt.nlp	19223899	SENT80	15	15	4	4	taurine	p38	PA451590	10598;1432;7965	0.618
NULL	Eur_J_Neurosci_2014_Feb_4_39(3)_419-434.nxml.txt.nlp	24494682	SENT313	4	4	6	6	lipase	MGL	PA450239	11343	0.618
NULL	Biomed_Res_Int_2013_Dec_23_2013_931028.nxml.txt.nlp	24455740	SENT187	19	19	9	9	capecitabine	TYMP	PA448771	1890	0.618
NULL	Gastroenterol_Hepatol_Bed_Bench_2012_Winter_5(1)_3-6.nxml.txt.nlp	24834191	SENT75	15	15	13	13	cyanocobalamin	B12	PA451892	7126;4709	0.618
NULL	Emerg_Infect_Dis_2013_Jul_19(7)_1138-1141.nxml.txt.nlp	23764343	SENT68	43	43	41	41	ethambutol	ETB	PA164784021	1910	0.618
NULL	J_Breast_Cancer_2012_Jun_28_15(2)_203-210.nxml.txt.nlp	22807938	SENT94	16	16	21	21	trastuzumab	NACT	PA451743	284111	0.618
NULL	Biomed_Res_Int_2014_Apr_27_2014_180428.nxml.txt.nlp	24877063	SENT258	8	8	16	16	cisplatin	TRPV1	PA449014	7442	0.618
NULL	Curr_Neuropharmacol_2013_Dec_11(6)_652-663.nxml.txt.nlp	24396340	SENT253	24	24	16	16	capsaicin	PKR1	PA448776	10887	0.618
NULL	Cancers_(Basel)_2010_Dec_30_3(1)_106-125.nxml.txt.nlp	24212609	SENT26	12	12	29	29	gemcitabine	DCK	PA449748	1633	0.618
NULL	Mol_Cancer_2014_Feb_20_13_31.nxml.txt.nlp	24555568	SENT4	1	1	19	19	bumetanide	NKCC1	PA448682	6558	0.618
NULL	Diabetes_2013_Oct_17_62(10)_3547-3552.nxml.txt.nlp	23863812	SENT139	7	7	13	13	simvastatin	adiponectin	PA451363	9370	0.618
NULL	Front_Physiol_2011_Jul_27_2_41.nxml.txt.nlp	21845181	SENT209	30	30	20	20	glucosamine	MD-2	PA164747613	23643	0.618
NULL	Int_J_Nanomedicine_2009_Oct_19_4_209-216.nxml.txt.nlp	19918367	SENT166	8	8	17	17	daunorubicin	P-gp	PA449212	5243	0.618
NULL	Eur_J_Haematol_2011_Oct_87(4)_349-354.nxml.txt.nlp	21668501	SENT86	7	7	9	9	deferoxamine	EOS	PA164746490	260429	0.618
NULL	Case_Rep_Med_2010_Feb_27_2010_691563.nxml.txt.nlp	21461374	SENT20	3	3	1	1	cyanocobalamin	B12	PA451892	7126;4709	0.618
NULL	Br_J_Cancer_2009_Jun_2_100(11)_1739-1745.nxml.txt.nlp	19436299	SENT6	18	18	5	5	everolimus	FDG	PA164746311	23583	0.618
NULL	Carcinogenesis_2010_Dec_27_31(12)_2049-2057.nxml.txt.nlp	20876285	SENT246	14	14	19	19	tamoxifen	HER2	PA451581	2064	0.618
NULL	F1000Res_2014_Aug_19_3_198.nxml.txt.nlp	25400908	SENT289	20	20	22	22	trastuzumab	ACT	PA451743	12;11332;9457;641455	0.618
NULL	Case_Rep_Oncol_2014_Jun_18_7(2)_393-400.nxml.txt.nlp	25076890	SENT87	35	35	7	7	erlotinib	RAI	PA134687924	10848;6050	0.618
NULL	J_Nucl_Cardiol_2011_Aug_26_18(4)_741-743.nxml.txt.nlp	21519975	SENT25	10	10	5	5	heparin	FDG	PA449855	23583	0.618
NULL	Crit_Care_2012_Oct_15_16(5)_R193.nxml.txt.nlp	23068293	SENT129	9	9	21	21	mannitol	NMB	PA450320	10457;4828	0.618
NULL	Oncotarget_2014_Jun_30_5(14)_5637-5650.nxml.txt.nlp	25026298	SENT79	4	4	6	6	vorinostat	BRCA1	PA164748224	672	0.618
NULL	Oncol_Lett_2013_Mar_28_5(3)_983-991.nxml.txt.nlp	23426861	SENT169	13	13	15	15	vinblastine	DDP	PA451877	1678	0.618
NULL	J_Korean_Med_Sci_2009_Oct_24_24(5)_910-917.nxml.txt.nlp	19794992	SENT24	3	3	23	23	paclitaxel	HER2	PA450761	2064	0.618
NULL	J_Vet_Med_Sci_2014_Jan_4_76(1)_113-117.nxml.txt.nlp	24004933	SENT71	11	11	25	25	sevoflurane	BAR	PA451341	154;51283	0.618
NULL	Eur_J_Neurosci_2008_Jun_27(12)_3151-3160.nxml.txt.nlp	18598259	SENT99	21	21	33	33	paraformaldehyde	TRPA1	PA450790	8989	0.618
NULL	ISRN_Oxidative_Med_2013_2013_831596.nxml.txt.nlp	25506596	SENT46	2	2	5	5	hemin	TLR4	PA449849	7099	0.618
NULL	Br_J_Cancer_2010_Sep_7_103(6)_765-771.nxml.txt.nlp	20700120	SENT4	15	15	4	4	tamoxifen	CYP2D6	PA451581	1565	0.618
NULL	Cardiovasc_Diabetol_2013_Mar_4_12_42.nxml.txt.nlp	23452502	SENT228	29	29	8	8	isoflurane	GLP1	PA450106	100125288;2641	0.618
NULL	EJC_Suppl_2013_Sep_5_11(2)_307-309.nxml.txt.nlp	NULL	SENT50	16	16	20	20	gefitinib	EGFR	PA131301952	1956	0.618
NULL	Br_J_Cancer_2013_Mar_5_108(4)_748-754.nxml.txt.nlp	23361058	SENT55	0	0	13	13	vorinostat	RAD50	PA164748224	10111	0.618
NULL	Acta_Physiol_(Oxf)_2007_Sep_191(1)_43-57.nxml.txt.nlp	17524066	SENT226	11	11	24	24	nifedipine	LQT3	PA450631	6331	0.618
NULL	Osong_Public_Health_Res_Perspect_2013_Dec_12_4(6)_316-322.nxml.txt.nlp	24524020	SENT206	10	10	20	20	cefaclor	CTX	PA164749137	1593	0.618
NULL	Arthritis_Res_Ther_2003_Sep_23_5(6)_251-265.nxml.txt.nlp	14680500	SENT29	1	1	3	3	vasopressin	AVP	PA451858	114548;551	0.618
NULL	Oncotarget_2013_Nov_22_5(4)_933-943.nxml.txt.nlp	24659749	SENT51	29	29	19	19	nutlin-3	AML2		864	0.618
NULL	J_Thromb_Thrombolysis_2011_May_13_31(4)_478-492.nxml.txt.nlp	21318583	SENT101	25	25	17	17	thrombin	ADP	PA451674	23038	0.618
NULL	Br_J_Clin_Pharmacol_2011_Oct_72(4)_647-657.nxml.txt.nlp	21518389	SENT192	31	31	18	18	iloprost	PGD2	PA164746843	27306	0.618
NULL	Eur_J_Clin_Pharmacol_2012_Jan_7_68(1)_55-64.nxml.txt.nlp	21735164	SENT184	23	23	30	30	oxycodone	CYP3A4	PA450741	1576	0.618
NULL	Oxid_Med_Cell_Longev_2013_Apr_18_2013_239854.nxml.txt.nlp	23710284	SENT79	31	31	36	36	zonisamide	HRD1	PA451978	84447	0.618
NULL	Clin_Transl_Allergy_2013_Sep_2_3_29.nxml.txt.nlp	24004581	SENT157	26	26	17	17	omalizumab	IL-4	PA164752253	3565	0.618
NULL	Physiol_Rep_2014_Nov_26_2(11)_e12231.nxml.txt.nlp	25428953	SENT655	2	2	18	18	phenylephrine	AMPK	PA450935	5563	0.618
NULL	Breast_Cancer_Res_2014_Sep_11_16(5)_430.nxml.txt.nlp	25212826	SENT201	7	7	31	31	estradiol	PTEN	PA449503	5728	0.618
NULL	Cell_Tissue_Res_2013_May_17_354(1)_259-271.nxml.txt.nlp	23681253	SENT25	23	23	30	30	methylphenidate	AMPH	PA450464	273	0.618
NULL	Biomed_Res_Int_2013_Nov_26_2013_843657.nxml.txt.nlp	24371833	SENT219	18	18	25	25	exenatide	GLP-1	PA164749238	100125288	0.618
NULL	Diabetes_2013_Jun_20_62(6)_2122-2129.nxml.txt.nlp	23378607	SENT244	14	14	17	17	oxygen	CO2	PA450744	4513	0.618
NULL	Indian_J_Med_Res_2013_Dec_138(6)_1022-1024.nxml.txt.nlp	24521652	SENT47	7	7	24	24	vancomycin	VISA	PA451850	57506	0.618
NULL	J_Invest_Dermatol_2012_Nov_21_132(11)_2642-2651.nxml.txt.nlp	22718118	SENT72	3	3	7	7	collagenase	CD11b	PA449107	3684	0.618
NULL	Mol_Cancer_2010_Aug_23_9_222.nxml.txt.nlp	20731837	SENT156	7	7	19	19	gefitinib	COX2	PA131301952	4513;5743	0.618
NULL	Acta_Pharmacol_Sin_2012_Jan_28_33(1)_66-74.nxml.txt.nlp	22120966	SENT165	6	6	36	36	genistein	OPG	PA165109660	690	0.618
NULL	J_Thyroid_Res_2010_Dec_14_2011_675703.nxml.txt.nlp	21209713	SENT78	8	8	16	16	thyroglobulin	TPO	PA164754910	7066;7173	0.618
NULL	Front_Immunol_2013_Oct_29_4_338.nxml.txt.nlp	24194738	SENT209	11	11	26	26	estradiol	TLR3	PA449503	7098	0.618
NULL	J_Cardiothorac_Surg_2011_Feb_8_6_14.nxml.txt.nlp	21303502	SENT137	14	14	25	25	mesna	CO2	PA450385	4513	0.618
NULL	Adv_Hematol_2012_Sep_19_2012_879368.nxml.txt.nlp	21941554	SENT89	40	40	42	42	curcumin	STAT3	PA151958596	6774	0.618
NULL	J_Viral_Hepat_2007_Nov_14(11)_751-766.nxml.txt.nlp	17927611	SENT131	2	2	0	0	lamivudine	LAM	PA450163	7249;7248	0.618
NULL	Alzheimers_Res_Ther_2012_Oct_29_4(5)_43.nxml.txt.nlp	23107780	SENT49	25	25	38	38	heparin	Q10	PA449855	27161	0.618
NULL	J_Cell_Biol_2001_Apr_16_153(2)_367-380.nxml.txt.nlp	11309417	SENT202	0	0	2	2	bleomycin	BLM	PA448645	641	0.618
NULL	Oncologist_2010_Mar_9_15(3)_236-245.nxml.txt.nlp	20215359	SENT95	39	39	41	41	bevacizumab	IFN	PA130232992	3439	0.618
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT161	26	26	24	24	vinorelbine	MVP	PA451881	9961	0.618
NULL	Int_J_Biomed_Sci_2014_Sep_10(3)_146-157.nxml.txt.nlp	25324695	SENT217	29	29	16	16	lovastatin	LFA-1	PA450272	3683;3689	0.618
NULL	BMJ_Open_2014_Aug_19_4(8)_e006005.nxml.txt.nlp	25138814	SENT9	6	6	3	3	chloroquine	ACT	PA448948	12;11332;9457;641455	0.618
NULL	Osong_Public_Health_Res_Perspect_2013_Dec_12_4(6)_316-322.nxml.txt.nlp	24524020	SENT206	44	44	20	20	tetracycline	CTX	PA451640	1593	0.618
NULL	Neural_Regen_Res_2014_Jun_1_9(11)_1117-1121.nxml.txt.nlp	25206770	SENT124	27	27	31	31	collagenase	VIII	PA449107	1351	0.618
NULL	Oncogene_2013_Sep_26_32(39)_10_1038_onc_2012_491.nxml.txt.nlp	23108394	SENT245	17	17	24	24	epirubicin	FOXM1	PA449476	2305	0.618
NULL	Ann_Hematol_2010_Mar_2_89(3)_283-289.nxml.txt.nlp	19727725	SENT157	12	12	20	20	rituximab	IL-2	PA451261	3558	0.618
NULL	Int_J_Environ_Res_Public_Health_2010_Jul_12_7(7)_2845-2852.nxml.txt.nlp	20717544	SENT15	22	22	24	24	diethylstilbestrol	DES	PA449307	1674	0.618
NULL	Curr_Health_Sci_J_2010_Mar_24_Jan-Mar_36(1)_42-49.nxml.txt.nlp	24778826	SENT4	10	10	7	7	nimesulide	BCS	PA137179528	617	0.618
NULL	Cancer_Causes_Control_2012_Oct_21_23(10)_1739-1744.nxml.txt.nlp	22907422	SENT115	17	17	9	9	sulindac	CRA	PA451565	51747;10903	0.618
NULL	Mol_Cell_Proteomics_2013_Mar_12_12(3)_638-650.nxml.txt.nlp	23242552	SENT40	21	21	37	37	l-glutamine	CO2	PA10090	4513	0.618
NULL	J_Cell_Biol_2002_Nov_25_159(4)_625-635.nxml.txt.nlp	12438417	SENT11	4	4	6	6	dextran	VAMP7	PA449261	6845	0.618
NULL	Nucleic_Acids_Res_2013_Nov_22_41(21)_9825-9838.nxml.txt.nlp	23969415	SENT70	0	0	22	22	l-leucine	Met	PA450197	79811	0.618
NULL	Cardiovasc_Ther_2012_Jun_19_30(3)_e146-e155.nxml.txt.nlp	21167014	SENT68	9	9	11	11	exenatide	GLP-1	PA164749238	100125288	0.618
NULL	Cancers_(Basel)_2012_Oct_26_4(4)_1106-1146.nxml.txt.nlp	24213501	SENT358	8	8	2	2	doxazosin	PC-3	PA449407	692094	0.618
NULL	Crit_Care_2004_Sep_29_8(2)_122-129.nxml.txt.nlp	15025773	SENT190	8	8	5	5	vasopressin	AVP	PA451858	114548;551	0.618
NULL	Cardiovasc_Diabetol_2008_Aug_11_7_24.nxml.txt.nlp	18694484	SENT207	17	17	5	5	exenatide	Ray	PA164749238	26751	0.618
NULL	AIDS_Res_Treat_2012_Sep_17_2012_940580.nxml.txt.nlp	23019521	SENT90	12	12	6	6	ritonavir	ART	PA451260	181	0.618
NULL	Braz_J_Med_Biol_Res_2013_Aug_13_46(8)_650-658.nxml.txt.nlp	23969971	SENT195	20	20	23	23	cisplatin	survivin	PA449014	332	0.618
NULL	J_Am_Heart_Assoc_2013_Aug_23_2(4)_e000170.nxml.txt.nlp	23832325	SENT4	16	16	26	26	warfarin	LEP	PA451906	3952	0.618
NULL	Case_Rep_Med_2014_Dec_8_2014_516549.nxml.txt.nlp	25544844	SENT19	17	17	21	21	thyroglobulin	CK7	PA164754910	3855	0.618
NULL	Clin_Med_Insights_Cardiol_2014_Jul_14_8_57-62.nxml.txt.nlp	25089090	SENT8	30	30	32	32	nitroprusside	NIP	PA451406	90527;10755	0.618
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT148	2	2	28	28	tamoxifen	SIRT3	PA451581	23410	0.618
NULL	Evid_Based_Complement_Alternat_Med_2013_May_21_2013_472704.nxml.txt.nlp	23762141	SENT10	4	4	6	6	hyaluronan	LYVE-1	PA165958431	10894	0.618
NULL	Cancer_Biol_Med_2012_Mar_9(1)_1-8.nxml.txt.nlp	23691447	SENT171	5	5	10	10	lipase	OTP	PA450239	23440	0.618
NULL	Clin_Ophthalmol_2009_Aug_3_3_447-456.nxml.txt.nlp	19684868	SENT168	12	12	10	10	bimatoprost	BIM	PA164748867	10018	0.618
NULL	Protein_Cell_2014_Jun_19_5(6)_469-479.nxml.txt.nlp	24748116	SENT171	28	28	4	4	paclitaxel	EB1	PA450761	9167;22919;10982	0.618
NULL	Anemia_2012_Nov_8_2012_607436.nxml.txt.nlp	23198140	SENT163	16	16	7	7	capsaicin	TRPV1	PA448776	7442	0.618
NULL	Biologics_2013_Apr_15_7_77-90.nxml.txt.nlp	23723688	SENT138	23	23	7	7	cisplatin	CRT	PA449014	811	0.618
NULL	Arch_Med_Sci_2013_Apr_20_9(2)_332-339.nxml.txt.nlp	23671446	SENT161	7	7	12	12	midazolam	p38	PA450496	10598;1432;7965	0.618
NULL	Cancers_(Basel)_2013_May_27_5(2)_617-638.nxml.txt.nlp	24216994	SENT219	0	0	4	4	curcumin	MMP9	PA151958596	4318	0.618
NULL	Cancer_Metab_2014_May_28_2(Suppl_1)_P65.nxml.txt.nlp	NULL	SENT26	4	4	18	18	resveratrol	SIRT1		23411	0.618
NULL	Curr_Neuropharmacol_2009_Jun_7(2)_83-95.nxml.txt.nlp	19949566	SENT445	34	34	32	32	tiagabine	TGB	PA451682	5473	0.618
NULL	F1000_Med_Rep_2012_Feb_1_4_4.nxml.txt.nlp	22312414	SENT57	31	31	13	13	vancomycin	VISA	PA451850	57506	0.618
NULL	J_Vet_Med_Sci_2014_Sep_30_76(9)_1225-1229.nxml.txt.nlp	24881651	SENT271	3	3	10	10	trypsin	IL-8	PA451806	3576	0.618
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT113	10	10	8	8	capsaicin	p53	PA448776	7157	0.618
NULL	Cancer_Metab_2014_May_28_2(Suppl_1)_P14.nxml.txt.nlp	NULL	SENT17	14	14	18	18	vemurafenib	PFKFB3	PA165946873	5209	0.618
NULL	Oncotarget_2012_Dec_17_4(1)_48-63.nxml.txt.nlp	23295955	SENT188	5	5	8	8	methotrexate	MTHFD2	PA450428	10797	0.618
NULL	J_Korean_Assoc_Oral_Maxillofac_Surg_2014_Dec_26_40(6)_291-296.nxml.txt.nlp	25551094	SENT99	2	2	8	8	alendronate	M-CSF	PA448082	1435	0.618
NULL	Case_Rep_Med_2009_Aug_31_2009_420152.nxml.txt.nlp	19730751	SENT45	11	11	26	26	thrombin	VIII	PA451674	1351	0.618
NULL	Lab_Invest_2014_May_10_94(5)_503-516.nxml.txt.nlp	24614199	SENT472	15	15	13	13	curcumin	NAC	PA151958596	22861	0.618
NULL	Pharmaceutics_2011_Apr_14_3(2)_171-185.nxml.txt.nlp	24310494	SENT410	6	6	10	10	paclitaxel	castor	PA450761	54897	0.618
NULL	Case_Rep_Oncol_Med_2012_Sep_11_2012_726424.nxml.txt.nlp	22997596	SENT84	9	9	7	7	rituximab	CHOP	PA451261	1649	0.618
NULL	Sensors_(Basel)_2013_Feb_28_13(3)_2895-2910.nxml.txt.nlp	23449119	SENT123	17	17	23	23	pp2	PP1		5540;5464	0.618
NULL	Exp_Ther_Med_2014_Dec_24_8(6)_1677-1682.nxml.txt.nlp	25371714	SENT146	17	17	19	19	sirolimus	HIF-1	PA451365	29072	0.618
NULL	Open_AIDS_J_2010_May_14_4_105-115.nxml.txt.nlp	20657829	SENT75	10	10	5	5	methamphetamine	San	PA450403	80218	0.618
NULL	Arthritis_Res_Ther_2005_May_18_7(Suppl_3)_S13-S18.nxml.txt.nlp	15960817	SENT92	10	10	0	0	rituximab	CTX	PA451261	1593	0.618
NULL	J_Young_Pharm_2011_Jul-Sep_3(3)_216-220.nxml.txt.nlp	21897661	SENT78	7	7	10	10	ramipril	SLN	PA451223	6588	0.618
NULL	Sci_Rep_2015_Jan_6_5_7641.nxml.txt.nlp	25560734	SENT94	18	18	4	4	tamoxifen	CLTC	PA451581	1213	0.618
NULL	Cancer_Med_2013_Aug_28_2(4)_468-477.nxml.txt.nlp	24156019	SENT39	24	24	28	28	docetaxel	CLU	PA449383	1191	0.618
NULL	Arthritis_Res_2000_Sep_20_2(6)_504-512.nxml.txt.nlp	11056680	SENT61	28	28	37	37	thrombin	PAR-1	PA451674	2011;2149	0.618
NULL	Breast_Cancer_Res_2003_Jun_3_5(4)_208-215.nxml.txt.nlp	12817994	SENT146	15	15	17	17	estradiol	EGF	PA449503	1950	0.618
NULL	J_Clin_Biochem_Nutr_2010_Jan_29_46(1)_87-92.nxml.txt.nlp	20104270	SENT3	5	5	36	36	hesperidin	STZ	PA449867	6484	0.618
NULL	Crit_Care_2008_Mar_13_12(Suppl_2)_P56.nxml.txt.nlp	NULL	SENT6	33	33	21	21	erythromycin	TOB	PA449493	10140	0.618
NULL	J_Vet_Med_Sci_2014_Nov_24_76(11)_1471-1478.nxml.txt.nlp	25056673	SENT34	9	9	6	6	nystatin	CPZ	PA450666	8532	0.618
NULL	Cancer_Cell_Int_2013_Sep_3_13_89.nxml.txt.nlp	24004445	SENT130	8	8	10	10	topotecan	TPT	PA451729	23590;6469	0.618
NULL	Mol_Clin_Oncol_2013_Sep_23_1(5)_869-874.nxml.txt.nlp	24649263	SENT140	10	10	31	31	gemcitabine	HAI	PA449748	6692;6768	0.618
NULL	J_Nat_Med_2009_Jul_4_63(3)_274-282.nxml.txt.nlp	19343477	SENT229	7	7	19	19	memantine	spatial	PA10364	219793	0.618
NULL	Front_Genet_2014_Sep_5_5_279.nxml.txt.nlp	25250042	SENT2875	10	10	2	2	thyroglobulin	gp330	PA164754910	4036	0.618
NULL	Mol_Cancer_2006_Oct_17_5_45.nxml.txt.nlp	17044934	SENT11	0	0	12	12	resveratrol	AKT		207	0.618
NULL	Exp_Ther_Med_2014_Nov_17_8(5)_1484-1488.nxml.txt.nlp	25289046	SENT18	0	0	2	2	cisplatin	DDP	PA449014	1678	0.618
NULL	J_Cancer_Prev_2013_Jun_18(2)_169-176.nxml.txt.nlp	25337543	SENT31	36	36	29	29	gentamicin	CO2	PA449753	4513	0.618
NULL	Acta_Pharmacol_Sin_2010_Jul_28_31(7)_867-873.nxml.txt.nlp	20581857	SENT140	14	14	16	16	docetaxel	PC3	PA449383	57332;7832;5122	0.618
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_11_2014_780385.nxml.txt.nlp	25435891	SENT27	23	23	25	25	lipase	HSL	PA450239	3991	0.618
NULL	Aging_(Albany_NY)_2012_Jul_22_4(7)_480-498.nxml.txt.nlp	22837425	SENT84	2	2	8	8	metformin	HPX	PA450395	3263	0.618
NULL	Cancer_Cell_Int_2010_Apr_30_10_13.nxml.txt.nlp	20433758	SENT216	41	41	11	11	hydrocortisone	F12	PA449905	2161	0.618
NULL	Mol_Cancer_2014_Jun_26_13_158.nxml.txt.nlp	24965046	SENT117	0	0	21	21	sorafenib	NK1	PA7000	11126	0.618
NULL	Anal_Bioanal_Chem_2009_Oct_30_395(4)_893-905.nxml.txt.nlp	19484227	SENT194	30	30	22	22	sulfamethazine	FAST	PA451542	10922	0.618
NULL	Oncotarget_2013_Jul_21_4(8)_1253-1265.nxml.txt.nlp	23896512	SENT196	9	9	11	11	gefitinib	EGFR	PA131301952	1956	0.618
NULL	Asian_J_Androl_2014_Dec_16_Jan-Feb_16(1)_60-70.nxml.txt.nlp	24369134	SENT210	3	3	5	5	diethylstilbestrol	DES	PA449307	1674	0.618
NULL	Biomed_Res_Int_2013_Oct_27_2013_467869.nxml.txt.nlp	24282816	SENT59	26	26	20	20	ribavirin	SOC	PA451241	91544	0.618
NULL	Toxins_(Basel)_2010_Jun_9_2(6)_1381-1398.nxml.txt.nlp	22069643	SENT215	2	2	12	12	piroxicam	OAT4	PA450985	114571;55867	0.618
NULL	Arch_Med_Sci_2012_Feb_29_8(1)_154-161.nxml.txt.nlp	22457689	SENT43	4	4	12	12	ranitidine	IFN	PA451224	3439	0.618
NULL	Int_J_Fertil_Steril_2014_Jul_8_Jul-Sep_8(2)_193-206.nxml.txt.nlp	25083185	SENT245	33	33	10	10	estradiol	PRL	PA449503	5617	0.618
NULL	Adipocyte_2014_Jul_1_3(3)_224-229.nxml.txt.nlp	25068091	SENT77	41	41	23	23	oxygen	HNE	PA450744	1991	0.618
NULL	Cancer_Res_Treat_2012_Jun_30_44(2)_133-141.nxml.txt.nlp	22802752	SENT190	5	5	18	18	oxaliplatin	IL-2	PA131285527	3558	0.618
NULL	Int_J_Mol_Sci_2014_Nov_21_15(11)_21433-21454.nxml.txt.nlp	25421240	SENT148	0	0	2	2	heparin	EGF	PA449855	1950	0.618
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Apr_29_67(Pt_5)_o1256.nxml.txt.nlp	21754546	SENT68	14	14	9	9	acetone	mol	PA448025	90527	0.618
NULL	Mol_Cancer_2010_Mar_2_9_47.nxml.txt.nlp	20196847	SENT89	1	1	7	7	paclitaxel	SFN	PA450761	25996;2810	0.618
NULL	Ann_Gen_Psychiatry_2010_Apr_22_9(Suppl_1)_S227.nxml.txt.nlp	NULL	SENT6	22	22	28	28	oxcarbazepine	B12	PA450732	7126;4709	0.618
NULL	Onco_Targets_Ther_2014_Oct_4_7_1817-1828.nxml.txt.nlp	25336973	SENT71	23	23	18	18	irinotecan	UGT	PA450085	7361;7355	0.618
NULL	Ther_Clin_Risk_Manag_2006_Sep_2(3)_297-301.nxml.txt.nlp	18360604	SENT75	3	3	8	8	paricalcitol	PTH	PA450798	5741	0.618
NULL	Biomed_Res_Int_2014_Aug_6_2014_967826.nxml.txt.nlp	25165721	SENT72	26	26	34	34	taurine	SIRT1	PA451590	23411	0.618
NULL	Mol_Vis_2011_Dec_2_17_3137-3146.nxml.txt.nlp	22171160	SENT38	0	0	7	7	capsaicin	CPZ	PA448776	8532	0.618
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Jun_27_5_15.nxml.txt.nlp	16803618	SENT253	6	6	15	15	trovafloxacin	LTA	PA164749184	4049	0.618
NULL	Oxid_Med_Cell_Longev_2011_May_23_2011_213286.nxml.txt.nlp	NULL	SENT73	16	16	25	25	ethanol	ALDH2	PA448073	217	0.618
NULL	J_Biomed_Biotechnol_2010_May_23_2010_798467.nxml.txt.nlp	20508851	SENT28	7	7	9	9	cyclophosphamide	CTX	PA449165	1593	0.618
NULL	Iran_J_Pharm_Res_2014_Winter_13(1)_29-37.nxml.txt.nlp	24734054	SENT217	0	0	19	19	gliclazide	BCS	PA10892	617	0.618
NULL	Emerg_Infect_Dis_2013_Jan_19(1)_133-136.nxml.txt.nlp	23260464	SENT54	26	26	24	24	tobramycin	TOB	PA451704	10140	0.618
NULL	Diabetes_Care_2010_Jul_31_33(7)_1607-1609.nxml.txt.nlp	20357375	SENT49	2	2	20	20	sitagliptin	MCP-1	PA164748978	6347	0.618
NULL	Breast_Cancer_Res_2008_Dec_5_10(6)_R104.nxml.txt.nlp	19061505	SENT296	9	9	22	22	estradiol	Bcl-2	PA449503	596	0.618
NULL	Drug_Des_Devel_Ther_2014_Sep_23_8_1527-1538.nxml.txt.nlp	25284985	SENT176	19	19	23	23	celecoxib	IFN	PA448871	3439	0.618
NULL	Mol_Cancer_2009_Nov_10_8_99.nxml.txt.nlp	19903356	SENT101	1	1	4	4	imatinib	IGFBP3	PA10804	3486	0.618
NULL	Front_Behav_Neurosci_2013_Dec_23_7_211.nxml.txt.nlp	24391566	SENT143	3	3	14	14	propranolol	CA1	PA451145	759	0.618
NULL	Gut_Liver_2012_Oct_18_6(4)_505-511.nxml.txt.nlp	23170158	SENT74	35	35	25	25	lipase	gamma	PA450239	9913	0.618
NULL	Front_Psychol_2014_Aug_22_5_900.nxml.txt.nlp	25202287	SENT72	25	25	23	23	chlorpromazine	CPZ	PA448964	8532	0.618
NULL	Indian_J_Pharm_Sci_2014_Nov-Dec_76(6)_557-559.nxml.txt.nlp	25593392	SENT46	9	9	6	6	raltegravir	FOR		51741	0.618
NULL	Chem_Res_Toxicol_2012_Aug_20_25(8)_1708-1719.nxml.txt.nlp	22793666	SENT436	15	15	8	8	budesonide	CYP3A4	PA448681	1576	0.618
NULL	J_Antimicrob_Chemother_2014_Dec_20_69(12)_3329-3334.nxml.txt.nlp	25147095	SENT38	24	24	19	19	nevirapine	CYP2B6	PA450616	1555	0.618
NULL	Diabetes_Care_2012_Dec_14_35(12)_e84.nxml.txt.nlp	23173145	SENT34	7	7	15	15	omeprazole	B12	PA450704	7126;4709	0.618
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Apr_8_65(Pt_5)_o970-o971.nxml.txt.nlp	21584012	SENT7	5	5	2	2	torasemide	mol	PA451733	90527	0.618
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT58	6	6	14	14	trastuzumab	STAT3	PA451743	6774	0.618
NULL	J_Oncol_2010_Feb_17_2010_514310.nxml.txt.nlp	20182531	SENT246	0	0	19	19	metformin	HER-2	PA450395	2064	0.618
NULL	Iran_J_Reprod_Med_2013_Jul_11(7)_565-576.nxml.txt.nlp	24639792	SENT0	19	19	30	30	berberine	SP-D	PA165860812	6441	0.618
NULL	Core_Evid_2007_Nov_30_2(2)_121-129.nxml.txt.nlp	21221180	SENT19	8	8	0	0	doxorubicin	CHOP	PA449412	1649	0.618
NULL	J_Cancer_2013_Aug_28_4(7)_585-596.nxml.txt.nlp	24069069	SENT158	9	9	5	5	verteporfin	LC3	PA451871	84557	0.618
NULL	Case_Rep_Oncol_2010_Jun_30_4(2)_327-335.nxml.txt.nlp	21738504	SENT50	36	36	43	43	cisplatin	HCC	PA449014	84668	0.618
NULL	EMBO_Mol_Med_2009_Jul_1(4)_211-222.nxml.txt.nlp	20049723	SENT294	13	13	22	22	l-glutamine	IL-4	PA10090	3565	0.618
NULL	Endocrinology_2013_Dec_30_154(12)_4536-4547.nxml.txt.nlp	24080367	SENT198	18	18	23	23	lipase	IRS2	PA450239	8660	0.618
NULL	ACS_Med_Chem_Lett_2012_Jan_30_3(3)_232-237.nxml.txt.nlp	22408714	SENT220	12	12	15	15	thrombin	PAR-1	PA451674	2011;2149	0.618
NULL	Indian_J_Pharmacol_2013_May-Jun_45(3)_274-277.nxml.txt.nlp	23833372	SENT31	12	12	20	20	colchicine	CA1	PA449092	759	0.618
NULL	Genome_Med_2010_Nov_12_2(11)_81.nxml.txt.nlp	21092148	SENT112	27	27	12	12	letrozole	HER2	PA450196	2064	0.618
NULL	Neuropsychopharmacology_2011_May_23_36(6)_1237-1247.nxml.txt.nlp	21346736	SENT212	19	19	21	21	atomoxetine	ATX	PA134688071	5168;23049	0.618
NULL	Biosci_Microflora_2011_Nov_17_30(4)_135-140.nxml.txt.nlp	25045319	SENT159	9	9	5	5	ethanol	flower	PA448073	11094	0.618
NULL	Int_J_Mol_Sci_2014_Oct_8_15(10)_17974-17999.nxml.txt.nlp	25299695	SENT8	7	7	18	18	curcumin	HO-2	PA151958596	3163	0.618
NULL	Mol_Cancer_2010_Aug_23_9_222.nxml.txt.nlp	20731837	SENT161	6	6	18	18	gefitinib	COX2	PA131301952	4513;5743	0.618
NULL	Acta_Pharmacol_Sin_2010_Feb_5_31(2)_150-159.nxml.txt.nlp	20139897	SENT214	25	25	21	21	thrombin	ADP	PA451674	23038	0.618
NULL	J_Biol_Chem_2013_Nov_29_288(48)_34502-34513.nxml.txt.nlp	24133206	SENT131	42	42	16	16	paraformaldehyde	HCS	PA450790	3141;54205	0.618
NULL	Biomed_Res_Int_2013_Jun_18_2013_104315.nxml.txt.nlp	23853765	SENT108	5	5	25	25	pitrakinra	IL-13R	PA165983754	3598	0.618
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Apr_15_9_13.nxml.txt.nlp	20398300	SENT108	11	11	18	18	amoxicillin	LAM	PA448406	7249;7248	0.618
NULL	Br_J_Cancer_2010_Jan_5_102(1)_80-86.nxml.txt.nlp	19920817	SENT88	2	2	4	4	bevacizumab	IFN	PA130232992	3439	0.618
NULL	Pain_2014_Nov_155(11)_2306-2322.nxml.txt.nlp	25168672	SENT1007	14	14	12	12	loxapine	LOX	PA450273	4015	0.618
NULL	Mol_Biol_Cell_2014_May_15_25(10)_1641-1652.nxml.txt.nlp	24648491	SENT15	8	8	14	14	cisplatin	NPM1	PA449014	4869	0.617
NULL	J_Korean_Med_Sci_2010_Apr_19_25(4)_557-563.nxml.txt.nlp	20357998	SENT87	4	4	1	1	rosiglitazone	IL-10	PA451283	3586	0.617
NULL	Oncotarget_2013_Dec_18_5(2)_375-385.nxml.txt.nlp	24495868	SENT158	5	5	11	11	fludarabine	MCL1	PA449655	4170	0.617
NULL	Carcinogenesis_2010_Dec_27_31(12)_2049-2057.nxml.txt.nlp	20876285	SENT174	25	25	21	21	tamoxifen	HER2	PA451581	2064	0.617
NULL	Patient_Prefer_Adherence_2013_Sep_11_7_891-895.nxml.txt.nlp	24049440	SENT52	16	16	20	20	nevirapine	ART	PA450616	181	0.617
NULL	Ann_Med_Health_Sci_Res_2013_Oct-Dec_3(4)_498-503.nxml.txt.nlp	24379998	SENT104	16	16	20	20	epirubicin	CD4	PA449476	920	0.617
NULL	AIDS_Res_Ther_2006_Mar_31_3_8.nxml.txt.nlp	16573838	SENT52	0	0	9	9	etanercept	CD4	PA449515	920	0.617
NULL	Acta_Naturae_2013_Oct-Dec_5(4)_83-93.nxml.txt.nlp	24455187	SENT147	22	22	14	14	tamoxifen	7SL	PA451581	6029	0.617
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT169	6	6	14	14	ranibizumab	PlGF-2	PA164746012	5228	0.617
NULL	Diabetologia_2010_Jun_27_53(6)_1142-1150.nxml.txt.nlp	20349036	SENT45	10	10	17	17	nitroprusside	SLC2A4	PA451406	6517	0.617
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Jul_26_64(Pt_8)_o1594-o1595.nxml.txt.nlp	21203289	SENT71	22	22	25	25	benzaldehyde	mol	PA448571	90527	0.617
NULL	Anat_Cell_Biol_2012_Jun_30_45(2)_114-120.nxml.txt.nlp	22822466	SENT6	1	1	3	3	vasopressin	AVP	PA451858	114548;551	0.617
NULL	Anc_Sci_Life_2012_Oct-Dec_32(2)_93-98.nxml.txt.nlp	24167334	SENT16	5	5	18	18	cyclophosphamide	ANOVA	PA449165	4858	0.617
NULL	Cell_Commun_Signal_2012_Jul_11_10_13.nxml.txt.nlp	22607136	SENT30	38	38	48	48	l-glutamine	CO2	PA10090	4513	0.617
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT157	29	29	21	21	metformin	p53	PA450395	7157	0.617
NULL	ScientificWorldJournal_2013_Sep_21_2013_208309.nxml.txt.nlp	24170980	SENT91	13	13	22	22	lenalidomide	MRP8	PA162363968	6833;6279;85320	0.617
NULL	Diabetes_Care_2010_Apr_12_33(4)_861-868.nxml.txt.nlp	20067962	SENT136	16	16	13	13	hyaluronan	HSP60	PA165958431	3329	0.617
NULL	Diabetes_2013_Nov_18_62(11)_3751-3759.nxml.txt.nlp	23897951	SENT128	2	2	9	9	rosiglitazone	FRS2	PA451283	10818	0.617
NULL	Oxid_Med_Cell_Longev_2012_Apr_22_2012_479348.nxml.txt.nlp	22577490	SENT142	17	17	28	28	ethanol	IL-6	PA448073	3569	0.617
NULL	Cell_Death_Dis_2010_Jul_1_1(7)_e51.nxml.txt.nlp	21364656	SENT61	23	23	6	6	gentamicin	survivin	PA449753	332	0.617
NULL	Curr_Cardiol_Rev_2009_Aug_5(3)_216-222.nxml.txt.nlp	20676280	SENT50	16	16	18	18	lipase	HSL	PA450239	3991	0.617
NULL	Osong_Public_Health_Res_Perspect_2014_Dec_13_5(6)_333-338.nxml.txt.nlp	25562041	SENT207	2	2	8	8	ceftazidime	CTX	PA448861	1593	0.617
NULL	Acta_Pharmacol_Sin_2012_Apr_5_33(4)_429-430.nxml.txt.nlp	22476059	SENT34	14	14	16	16	iptakalim	KCNJ11	PA165949694	3767	0.617
NULL	Neuro_Oncol_2010_Apr_27_12(4)_389-400.nxml.txt.nlp	20308316	SENT186	7	7	17	17	chloroquine	p53	PA448948	7157	0.617
NULL	Crit_Care_2011_Aug_11_15(4)_226.nxml.txt.nlp	21892977	SENT59	20	20	39	39	vasopressin	P2Y1	PA451858	5028	0.617
NULL	Cardiovasc_Diabetol_2013_Nov_11_12_168.nxml.txt.nlp	24215469	SENT18	3	3	0	0	vasopressin	AVP	PA451858	114548;551	0.617
NULL	J_Cancer_2013_Aug_28_4(7)_585-596.nxml.txt.nlp	24069069	SENT130	20	20	2	2	verteporfin	LC3	PA451871	84557	0.617
NULL	Turk_J_Haematol_2012_Dec_5_29(4)_413-419.nxml.txt.nlp	24385732	SENT80	33	33	9	9	cisplatin	CD56	PA449014	4684	0.617
NULL	Exp_Ther_Med_2013_Oct_19_6(4)_1070-1076.nxml.txt.nlp	24137319	SENT216	7	7	5	5	cyclophosphamide	CTX	PA449165	1593	0.617
NULL	Breast_Cancer_Res_Treat_2013_Aug_20_141(1)_43-53.nxml.txt.nlp	23959396	SENT192	14	14	21	21	trastuzumab	HER3	PA451743	2065	0.617
NULL	Ann_Clin_Transl_Neurol_2014_Sep_29_1(9)_650-658.nxml.txt.nlp	25493279	SENT45	10	10	16	16	natalizumab	IFN	PA164747191	3439	0.617
NULL	J_Cell_Biol_1998_Aug_10_142(3)_625-633.nxml.txt.nlp	9700154	SENT96	11	11	24	24	estradiol	JNK	PA449503	5599	0.617
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT110	13	13	6	6	nifedipine	CYP3A	PA450631	1574	0.617
NULL	Comput_Struct_Biotechnol_J_2013_Feb_22_3_e201210020.nxml.txt.nlp	24688680	SENT64	32	32	22	22	resveratrol	CHS		1130	0.617
NULL	Nat_Commun_2013_Apr_23_4_1758.nxml.txt.nlp	23612299	SENT541	13	13	7	7	isoproterenol	SOD1	PA450121	6647	0.617
NULL	J_Am_Heart_Assoc_2013_Aug_23_2(4)_e000271.nxml.txt.nlp	23842280	SENT98	26	26	18	18	flutamide	PGF	PA449685	5228	0.617
NULL	Cancer_Manag_Res_2011_Mar_3_3_57-64.nxml.txt.nlp	21556317	SENT64	2	2	13	13	trastuzumab	HER-2	PA451743	2064	0.617
NULL	Crit_Care_2010_Jul_19_14(4)_179.nxml.txt.nlp	20670385	SENT17	5	5	7	7	vasopressin	AVP	PA451858	114548;551	0.617
NULL	Br_J_Pharmacol_2012_Jan_165(2)_390-400.nxml.txt.nlp	21671897	SENT183	18	18	12	12	suramin	P2X1	PA10292	5023	0.617
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1676-1682.nxml.txt.nlp	19844234	SENT147	15	15	6	6	lapatinib	PTEN	PA152241907	5728	0.617
NULL	Biomed_Res_Int_2013_Sep_4_2013_419176.nxml.txt.nlp	24093097	SENT184	33	33	28	28	pazopanib	IFN	PA165291492	3439	0.617
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT273	16	16	21	21	adalimumab	CD36	PA10004	948	0.617
NULL	Cancer_Metab_2014_Aug_18_2_13.nxml.txt.nlp	25225614	SENT271	22	22	38	38	lipase	ACSL1	PA450239	2180	0.617
NULL	J_Cell_Biol_1998_Jun_29_141(7)_1479-1487.nxml.txt.nlp	9647642	SENT25	19	19	22	22	zinc	A20	PA451956	7128;28935	0.617
NULL	Oncogene_2014_Feb_6_33(6)_713-723.nxml.txt.nlp	23435429	SENT84	39	39	37	37	etoposide	p65	PA449552	5970	0.617
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Sep_8_68(Pt_10)_o2873.nxml.txt.nlp	23125672	SENT66	5	5	8	8	benzaldehyde	mol	PA448571	90527	0.617
NULL	Biochem_Res_Int_2011_Sep_22_2011_285618.nxml.txt.nlp	21949907	SENT119	8	8	10	10	resveratrol	adiponectin		9370	0.617
NULL	Breast_Cancer_Res_2007_Jul_5_9(4)_R41.nxml.txt.nlp	17612393	SENT216	4	4	7	7	celecoxib	Bcl-2	PA448871	596	0.617
NULL	Curr_Neuropharmacol_2013_Dec_11(6)_606-620.nxml.txt.nlp	24396337	SENT267	0	0	2	2	diltiazem	BTZ	PA449334	22794	0.617
NULL	Nat_Commun_2013_Apr_9_4_1684.nxml.txt.nlp	23575688	SENT104	5	5	12	12	rolipram	CYLD	PA153906323	1540	0.617
NULL	Thorax_2013_Sep_24_68(9)_835-845.nxml.txt.nlp	23709760	SENT204	5	5	14	14	metformin	AMPK	PA450395	5563	0.617
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT115	20	20	16	16	doxorubicin	B7-H1	PA449412	29126	0.617
NULL	J_Biomed_Sci_2014_Feb_3_21(1)_10.nxml.txt.nlp	24490900	SENT165	26	26	31	31	alendronate	RANKL	PA448082	8600	0.617
NULL	Ann_Surg_Oncol_2014_Feb_13_21(5)_1575-1582.nxml.txt.nlp	24522992	SENT187	4	4	10	10	letrozole	ERBB2	PA450196	2064	0.617
NULL	Infect_Drug_Resist_2012_Aug_8_5_121-127.nxml.txt.nlp	22893749	SENT5	3	3	8	8	ribavirin	gamma	PA451241	9913	0.617
NULL	Mol_Cancer_2012_Jun_18_11_41.nxml.txt.nlp	22709873	SENT328	3	3	22	22	lapatinib	RB1CC1	PA152241907	9821	0.617
NULL	J_Korean_Med_Sci_2007_Apr_30_22(2)_283-289.nxml.txt.nlp	17449938	SENT188	0	0	7	7	minoxidil	P21	PA450521	1026;9338	0.617
NULL	Cancer_Microenviron_2009_Sep_26_2(Suppl_1)_19-204.nxml.txt.nlp	NULL	SENT6583	12	12	0	0	hyaluronan	CD147	PA165958431	682	0.617
NULL	BMB_Rep_2014_Apr_47(4)_221-226.nxml.txt.nlp	24286312	SENT104	3	3	10	10	nutlin-3	p53		7157	0.617
NULL	Ther_Clin_Risk_Manag_2007_Dec_3(6)_1077-1086.nxml.txt.nlp	18516259	SENT176	4	4	6	6	entecavir	LAM	PA164784025	7249;7248	0.617
NULL	Evid_Based_Complement_Alternat_Med_2014_May_8_2014_404505.nxml.txt.nlp	24899908	SENT117	7	7	11	11	warfarin	CYP2C9	PA451906	1559	0.617
NULL	Nat_Commun_2014_Jun_30_5_4209.nxml.txt.nlp	24979243	SENT256	26	26	30	30	paraformaldehyde	CSK	PA450790	1445	0.617
NULL	Ther_Clin_Risk_Manag_2007_Dec_3(6)_1077-1086.nxml.txt.nlp	18516259	SENT118	14	14	12	12	lamivudine	LAM	PA450163	7249;7248	0.617
NULL	Biochim_Biophys_Acta_2014_Jun_1841(6)_906-917.nxml.txt.nlp	24657704	SENT444	5	5	7	7	lipase	PNPLA2	PA450239	57104	0.617
NULL	Breast_Cancer_Res_2011_Jan_21_13(1)_R9.nxml.txt.nlp	21255398	SENT15	18	18	2	2	etoposide	RAD21	PA449552	5885	0.617
NULL	Indian_J_Med_Res_2011_Sep_134(3)_362-368.nxml.txt.nlp	21985820	SENT41	36	36	38	38	ethambutol	EMB	PA164784021	133418	0.617
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_9_2013_486047.nxml.txt.nlp	23662138	SENT125	46	46	40	40	glibenclamide	GDH	PA449782	51084;2746	0.617
NULL	Front_Immunol_2013_Nov_12_4_370.nxml.txt.nlp	24273542	SENT196	6	6	8	8	gemcitabine	Gem	PA449748	51053	0.617
NULL	Br_J_Pharmacol_2014_Aug_17_171(15)_3651-3665.nxml.txt.nlp	24712679	SENT291	24	24	22	22	exenatide	GLP-1	PA164749238	100125288	0.617
NULL	J_Carcinog_2014_Mar_5_13_5.nxml.txt.nlp	24799832	SENT46	11	11	24	24	bicalutamide	DES	PA164746255	1674	0.617
NULL	Mol_Cancer_2010_Apr_23_9_87.nxml.txt.nlp	20416058	SENT44	25	25	23	23	doxorubicin	TRAIL	PA449412	8743	0.617
NULL	Mol_Cancer_2009_Dec_31_8_133.nxml.txt.nlp	20043851	SENT30	13	13	6	6	curcumin	FANCD2	PA151958596	2177	0.617
NULL	J_Cell_Mol_Med_2014_Jul_24_18(7)_1358-1371.nxml.txt.nlp	24758741	SENT287	2	2	5	5	bevacizumab	MVD	PA130232992	4597	0.617
NULL	Breast_Cancer_Res_2003_May_30_5(4)_206-207.nxml.txt.nlp	12817993	SENT3	11	11	7	7	trastuzumab	HER2	PA451743	2064	0.617
NULL	Oncotarget_2014_Sep_10_5(19)_8924-8936.nxml.txt.nlp	25238040	SENT99	12	12	5	5	decitabine	p53	PA164749631	7157	0.617
NULL	J_Immunol_Res_2014_May_12_2014_897249.nxml.txt.nlp	24901013	SENT269	19	19	10	10	natalizumab	CD4	PA164747191	920	0.617
NULL	Biomed_Res_Int_2013_Apr_15_2013_378380.nxml.txt.nlp	23691500	SENT137	0	0	2	2	chlorpromazine	CPZ	PA448964	8532	0.617
NULL	Cancer_Biol_Med_2012_Jun_9(2)_99-104.nxml.txt.nlp	23691462	SENT154	11	11	7	7	hyaluronan	CD44	PA165958431	960	0.617
NULL	Ann_Surg_Treat_Res_2014_Feb_22_86(2)_55-60.nxml.txt.nlp	24761409	SENT103	13	13	27	27	levothyroxine	CTX	PA450221	1593	0.617
NULL	Clin_Med_Insights_Oncol_2011_Sep_21_5_315-323.nxml.txt.nlp	22084620	SENT136	6	6	8	8	gemcitabine	IFN	PA449748	3439	0.617
NULL	Mol_Med_Rep_2014_Nov_5_10(5)_2334-2340.nxml.txt.nlp	25189202	SENT168	16	16	18	18	ceftazidime	CFP	PA448861	5199	0.617
NULL	J_Hematol_Oncol_2013_Jan_15_6_5.nxml.txt.nlp	23320987	SENT117	0	0	23	23	heparin	PI-PLC	PA449855	2923	0.617
NULL	Mol_Cancer_2014_Jan_28_13_17.nxml.txt.nlp	24472312	SENT124	0	0	5	5	ponatinib	Mcl-1	PA165980594	4170	0.617
NULL	Int_J_Inflam_2010_Aug_9_2010_151097.nxml.txt.nlp	21152121	SENT88	3	3	12	12	thrombin	CD141	PA451674	7056	0.617
NULL	Cell_Death_Dis_2010_Nov_18_1(11)_e102.nxml.txt.nlp	21368867	SENT86	14	14	2	2	gentamicin	CLIMP-63	PA449753	10970	0.617
NULL	Emerg_Microbes_Infect_2014_Mar_12_3(3)_e19.nxml.txt.nlp	NULL	SENT89	12	12	6	6	ofloxacin	MOX	PA450684	26002	0.617
NULL	Nat_Med_2014_Jun_18_20(6)_624-632.nxml.txt.nlp	24836577	SENT320	24	24	31	31	isoproterenol	ANOVA	PA450121	4858	0.617
NULL	FEBS_Open_Bio_2011_Dec_27_2_1-5.nxml.txt.nlp	23650573	SENT104	20	20	17	17	sunitinib	MDM2	PA162372840	4193	0.617
NULL	Pharm_Pract_(Granada)_2011_Mar_15_Jan-Mar_9(1)_1-10.nxml.txt.nlp	25132883	SENT60	1	1	8	8	dabigatran	SPAF		166378	0.617
NULL	Int_Semin_Surg_Oncol_2007_Jul_23_4_18.nxml.txt.nlp	17645796	SENT88	35	35	39	39	tamoxifen	STAR	PA451581	6770;2984	0.617
NULL	Clin_Mol_Hepatol_2014_Jun_30_20(2)_168-176.nxml.txt.nlp	25032183	SENT152	2	2	0	0	lamivudine	LAM	PA450163	7249;7248	0.617
NULL	Adv_Biol_Regul_2014_Jan_19_0_197-206.nxml.txt.nlp	24103483	SENT190	23	23	7	7	lipase	PLD2	PA450239	5338	0.617
NULL	Adv_Hematol_2010_Aug_25_2010_268921.nxml.txt.nlp	20862197	SENT147	7	7	5	5	cytarabine	IFN	PA449177	3439	0.617
NULL	J_Korean_Med_Sci_2006_Dec_31_21(6)_1037-1040.nxml.txt.nlp	17179683	SENT86	6	6	8	8	clarithromycin	BAM	PA449028	9126	0.617
NULL	Ann_Rheum_Dis_2014_Jun_30_73(6)_990-999.nxml.txt.nlp	24482301	SENT117	37	37	35	35	ustekinumab	UST	PA166048654	10090	0.617
NULL	Cell_Death_Dis_2010_Nov_18_1(11)_e102.nxml.txt.nlp	21368867	SENT69	3	3	5	5	gentamicin	CLIMP-63	PA449753	10970	0.617
NULL	Cell_Regen_(Lond)_2012_Jun_28_1(1)_3.nxml.txt.nlp	25408866	SENT91	7	7	11	11	oxygen	ADP	PA450744	23038	0.617
NULL	Adv_Ther_2013_Jun_29_30(6)_607-622.nxml.txt.nlp	23812875	SENT281	13	13	30	30	glucose	U100	PA449773	692149	0.617
NULL	J_Gastroenterol_2013_Jan_28_48(1)_1-12.nxml.txt.nlp	23188091	SENT221	21	21	38	38	ribavirin	IFN	PA451241	3439	0.617
NULL	Front_Hum_Neurosci_2015_Jan_13_8_1047.nxml.txt.nlp	25628553	SENT206	2	2	7	7	ketamine	spatial	PA450144	219793	0.617
NULL	eLife_2013_Nov_5_2_e00969.nxml.txt.nlp	24192036	SENT537	4	4	11	11	oxygen	JNK	PA450744	5599	0.617
NULL	J_Histochem_Cytochem_2012_Oct_60(10)_749-760.nxml.txt.nlp	22821669	SENT262	9	9	14	14	hyaluronan	TSG-6	PA165958431	7130	0.617
NULL	Int_J_Environ_Res_Public_Health_2011_Jul_30_8(7)_2747-2757.nxml.txt.nlp	21845156	SENT134	14	14	16	16	trypsin	PRSS1	PA451806	5644	0.617
NULL	Biologics_2009_Oct_12_3_469-474.nxml.txt.nlp	19851472	SENT71	15	15	27	27	desloratadine	IL-5	PA164776964	3567	0.617
NULL	Breast_Cancer_Res_2014_Jul_29_16(4)_412.nxml.txt.nlp	25410383	SENT102	6	6	8	8	vorinostat	TRAIL	PA164748224	8743	0.617
NULL	Clin_Pract_2012_Mar_30_2(2)_e44.nxml.txt.nlp	24765443	SENT74	22	22	18	18	ifosfamide	PRSS	PA449964	3003	0.617
NULL	Cancer_Immunol_Immunother_2012_Jul_23_61(7)_1101-1111.nxml.txt.nlp	22193989	SENT171	0	0	5	5	oxaliplatin	STAT3	PA131285527	6774	0.617
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT225	10	10	2	2	atorvastatin	p38	PA448500	10598;1432;7965	0.617
NULL	Int_J_Mol_Sci_2014_Jun_3_15(6)_9924-9944.nxml.txt.nlp	24897026	SENT181	28	28	32	32	ethanol	SREBP-1c	PA448073	6720	0.617
NULL	Curr_Neuropharmacol_2013_Jul_11(4)_338-378.nxml.txt.nlp	24381528	SENT371	3	3	20	20	curcumin	HO-1	PA151958596	3162	0.617
NULL	Bone_Marrow_Transplant_2011_Mar_24_46(3)_430-435.nxml.txt.nlp	20498647	SENT25	16	16	10	10	daclizumab	IL-2	PA164764446	3558	0.617
NULL	Oncol_Lett_2014_Jul_22_8(1)_295-300.nxml.txt.nlp	24959264	SENT152	28	28	7	7	genistein	FOXM1	PA165109660	2305	0.617
NULL	Niger_Med_J_2014_Jul-Aug_55(4)_327-332.nxml.txt.nlp	25114369	SENT15	14	14	11	11	pyrazinamide	RIF	PA451182	54509;80196	0.617
NULL	J_Radiat_Res_2014_May_5_55(3)_443-450.nxml.txt.nlp	24309719	SENT168	15	15	10	10	nitroprusside	p53	PA451406	7157	0.617
NULL	Mol_Cancer_2010_Dec_7_9_311.nxml.txt.nlp	21138557	SENT160	4	4	6	6	etoposide	ETO	PA449552	862	0.617
NULL	Indian_J_Dermatol_2009_Jul-Sep_54(3)_211-220.nxml.txt.nlp	20161849	SENT162	2	2	4	4	efalizumab	LFA-1	PA164748817	3683;3689	0.617
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT207	23	23	25	25	adalimumab	DPI	PA10004	1832	0.617
NULL	Aging_(Albany_NY)_2012_Apr_16_4(4)_247-255.nxml.txt.nlp	22511639	SENT82	12	12	43	43	metformin	CH1	PA450395	51430	0.617
NULL	Br_J_Pharmacol_2014_Oct_26_171(20)_4785-4796.nxml.txt.nlp	25074741	SENT39	10	10	26	26	guanfacine	EPM	PA449825	2054	0.617
NULL	Clin_Interv_Aging_2014_Apr_8_9_603-612.nxml.txt.nlp	24748778	SENT161	11	11	9	9	chlorpromazine	CPZ	PA448964	8532	0.617
NULL	Arthritis_Res_2002_Mar_27_4(Suppl_2)_S22-S28.nxml.txt.nlp	12110154	SENT61	29	29	4	4	infliximab	IL-6	PA452639	3569	0.617
NULL	Mol_Cancer_2010_Nov_8_9_291.nxml.txt.nlp	21059223	SENT176	4	4	43	43	paclitaxel	ZNF217	PA450761	7764	0.617
NULL	Oncotarget_2013_Aug_9_4(9)_1332-1333.nxml.txt.nlp	23934763	SENT15	3	3	9	9	ponatinib	ABL1	PA165980594	25	0.617
NULL	Curr_Oncol_2006_Feb_13(1)_2-7.nxml.txt.nlp	17576435	SENT102	14	14	16	16	tamoxifen	HER2	PA451581	2064	0.617
NULL	J_Invest_Dermatol_2012_Apr_15_132(4)_1103-1110.nxml.txt.nlp	22170488	SENT122	14	14	26	26	trypsin	CO2	PA451806	4513	0.617
NULL	Br_J_Cancer_2012_Sep_4_107(6)_947-955.nxml.txt.nlp	22892392	SENT143	5	5	27	27	ifosfamide	BCAR4	PA449964	400500	0.617
NULL	Anesth_Essays_Res_2012_Jan-Jun_6(1)_62-69.nxml.txt.nlp	NULL	SENT108	19	19	15	15	rocuronium	TOF	PA164754992	55079	0.617
NULL	Front_Oncol_2014_Mar_6_4_40.nxml.txt.nlp	24639951	SENT47	22	22	20	20	etoposide	ETO	PA449552	862	0.617
NULL	Oncol_Lett_2014_Nov_14_8(5)_2086-2092.nxml.txt.nlp	25295095	SENT114	31	31	16	16	gemcitabine	LKB1	PA449748	6794	0.617
NULL	J_Am_Heart_Assoc_2013_Dec_19_2(6)_e000355.nxml.txt.nlp	24190878	SENT223	23	23	13	13	phenylephrine	HK2	PA450935	3796;3099;29911;3741	0.617
NULL	Springerplus_2014_Sep_11_3_516.nxml.txt.nlp	25279308	SENT176	12	12	20	20	ethanol	CS-1	PA448073	6744;51778	0.617
NULL	Arthritis_Res_Ther_2009_Jan_7_11(1)_101.nxml.txt.nlp	19183433	SENT26	33	33	18	18	adalimumab	MMP3	PA10004	4314	0.617
NULL	Diabetes_Metab_Syndr_Obes_2010_Sep_22_3_325-335.nxml.txt.nlp	21437102	SENT87	4	4	30	30	saxagliptin	PPG	PA165958362	5552	0.617
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_75-81.nxml.txt.nlp	25568841	SENT49	10	10	13	13	denosumab	RANKL	PA166048634	8600	0.617
NULL	Clin_Med_Insights_Womens_Health_2013_Jan_23_6_13-24.nxml.txt.nlp	24665210	SENT172	37	37	28	28	estradiol	CEE	PA449503	51608	0.617
NULL	Clin_Mol_Hepatol_2014_Sep_25_20(3)_267-273.nxml.txt.nlp	25320730	SENT156	10	10	0	0	entecavir	LAM	PA164784025	7249;7248	0.617
NULL	J_Asthma_Allergy_2010_Dec_30_4_1-12.nxml.txt.nlp	21701574	SENT240	2	2	6	6	formoterol	GM-CSF	PA134687907	1437	0.617
NULL	Enzyme_Res_2010_Jun_28_2010_734182.nxml.txt.nlp	21048869	SENT60	6	6	10	10	ethanol	SSF	PA448073	56342	0.617
NULL	Subst_Abuse_Rehabil_2011_May_15_2_89-102.nxml.txt.nlp	21743792	SENT344	43	43	28	28	methamphetamine	CRK	PA450403	1398	0.617
NULL	J_Headache_Pain_2013_Jan_30_14(1)_7.nxml.txt.nlp	23565873	SENT91	3	3	1	1	naratriptan	NNT	PA450597	23530	0.617
NULL	Ann_Hematol_2010_Nov_25_89(11)_1115-1124.nxml.txt.nlp	20499237	SENT108	36	36	23	23	fludarabine	CD19	PA449655	930	0.617
NULL	Indian_J_Med_Res_2014_Jun_139(6)_822-834.nxml.txt.nlp	25109716	SENT67	15	15	0	0	lipase	IL-6	PA450239	3569	0.617
NULL	Biomed_Res_Int_2014_Feb_27_2014_802539.nxml.txt.nlp	24719888	SENT178	18	18	33	33	isoflurane	ANOVA	PA450106	4858	0.617
NULL	Biomed_Res_Int_2013_May_28_2013_197398.nxml.txt.nlp	23781498	SENT26	6	6	8	8	loratadine	LOR	PA450266	4014	0.617
NULL	J_Biomed_Biotechnol_2008_Jul_8_2008_597913.nxml.txt.nlp	18629230	SENT550	23	23	21	21	tetracycline	GAL	PA451640	51083	0.617
NULL	Nat_Commun_2013_Aug_13_4_2316.nxml.txt.nlp	23939267	SENT36	7	7	9	9	lipase	HSL	PA450239	3991	0.617
NULL	Hum_Reprod_Update_2008_Sep_23_Nov-Dec_14(6)_571-582.nxml.txt.nlp	18812422	SENT183	27	27	2	2	letrozole	Casper	PA450196	8837	0.617
NULL	Cancers_(Basel)_2014_Apr_16_6(2)_926-957.nxml.txt.nlp	24743778	SENT1220	0	0	8	8	arsenite	STAT3	PA452638	6774	0.617
NULL	Int_J_Med_Sci_2013_Mar_15_10(5)_567-574.nxml.txt.nlp	23533048	SENT194	6	6	4	4	lamivudine	LAM	PA450163	7249;7248	0.617
NULL	Environ_Health_Perspect_1997_May_105(5)_528-533.nxml.txt.nlp	9222139	SENT8	3	3	17	17	tamoxifen	aromatase	PA451581	1588	0.617
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2013_Jul_31_6_15-24.nxml.txt.nlp	23966808	SENT1	8	8	31	31	metformin	Tech	PA450395	57449	0.617
NULL	Genome_Biol_2008_May_15_9(5)_309.nxml.txt.nlp	18492227	SENT27	44	44	30	30	erlotinib	EGFR	PA134687924	1956	0.617
NULL	Int_J_Alzheimers_Dis_2010_Dec_27_2011_231595.nxml.txt.nlp	21234401	SENT21	38	38	16	16	iron	HFE	PA450087	3077	0.617
NULL	Diabetes_2013_Sep_15_62(9)_3232-3240.nxml.txt.nlp	23835329	SENT152	0	0	8	8	olanzapine	GLP-1	PA450688	100125288	0.617
NULL	Environ_Health_Perspect_2005_Oct_14_113(10)_1330-1335.nxml.txt.nlp	16203242	SENT221	0	0	5	5	arsenite	SMC	PA452638	54808	0.617
NULL	Oncotarget_2014_Nov_2_5(21)_10222-10236.nxml.txt.nlp	25400118	SENT99	3	3	14	14	neratinib	HER3	PA165291472	2065	0.617
NULL	J_Gen_Physiol_1990_Jun_1_95(6)_1061-1075.nxml.txt.nlp	2115574	SENT8	5	5	17	17	choline	CO2	PA448976	4513	0.617
NULL	Oncol_Lett_2013_Oct_24_6(4)_970-976.nxml.txt.nlp	24137447	SENT180	2	2	10	10	tamoxifen	ADM	PA451581	133	0.617
NULL	Oncogene_2010_Sep_23_29(38)_5299-5310.nxml.txt.nlp	20622903	SENT290	6	6	8	8	paclitaxel	HMGB1	PA450761	3146	0.617
NULL	Arthritis_Res_Ther_2012_Jun_25_14(3)_215.nxml.txt.nlp	22731694	SENT70	23	23	0	0	rituximab	CPX	PA451261	1371;10682;1377	0.617
NULL	Indian_J_Ophthalmol_2012_Nov-Dec_60(6)_503-509.nxml.txt.nlp	23202387	SENT128	19	19	1	1	cyclopentolate	ANOVA	PA164743019	4858	0.617
NULL	Emerg_Infect_Dis_2014_Jul_20(7)_1252-1253.nxml.txt.nlp	24959839	SENT36	40	40	9	9	levofloxacin	EMB	PA450214	133418	0.617
NULL	Ann_Indian_Acad_Neurol_2014_Mar_17(Suppl_1)_S27-S31.nxml.txt.nlp	24791084	SENT117	19	19	15	15	diazepam	LOR	PA449283	4014	0.617
NULL	Protein_Eng_Des_Sel_2011_Jul_3_24(7)_565-578.nxml.txt.nlp	21642284	SENT214	25	25	27	27	trimethoprim	TMP	PA451788	2012	0.616
NULL	J_Lipid_Res_2014_Apr_55(4)_645-658.nxml.txt.nlp	24493834	SENT353	4	4	6	6	lipase	HSL	PA450239	3991	0.616
NULL	Br_J_Cancer_2004_May_17_90(10)_2032-2041.nxml.txt.nlp	15138490	SENT135	14	14	34	34	trastuzumab	CEA	PA451743	5670;1087	0.616
NULL	Ann_N_Y_Acad_Sci_2012_Aug_30_1264(1)_49-63.nxml.txt.nlp	22548651	SENT48	8	8	1	1	glucose	BDNF	PA449773	627	0.616
NULL	Pak_J_Med_Sci_2014_May-Jun_30(3)_488-492.nxml.txt.nlp	24948964	SENT104	18	18	1	1	docetaxel	BRCA1	PA449383	672	0.616
NULL	Mol_Cancer_2009_Nov_10_8_99.nxml.txt.nlp	19903356	SENT83	21	21	9	9	imatinib	IGFBP3	PA10804	3486	0.616
NULL	Br_J_Pharmacol_2014_Jan_23_171(2)_523-535.nxml.txt.nlp	24372553	SENT227	3	3	10	10	metformin	SIRT1	PA450395	23411	0.616
NULL	Curr_Neuropharmacol_2013_Jul_11(4)_338-378.nxml.txt.nlp	24381528	SENT431	10	10	15	15	curcumin	spatial	PA151958596	219793	0.616
NULL	Front_Neurosci_2013_Feb_13_7_13.nxml.txt.nlp	23407595	SENT136	4	4	13	13	estradiol	CORT	PA449503	1325	0.616
NULL	Cancers_(Basel)_2011_Apr_1_3(2)_1844-1860.nxml.txt.nlp	24212785	SENT579	25	25	2	2	irinotecan	PTEN	PA450085	5728	0.616
NULL	Cell_Death_Dis_2014_Jul_3_5(7)_e1316.nxml.txt.nlp	24991768	SENT40	0	0	2	2	pemetrexed	Mcl-1	PA10810	4170	0.616
NULL	Clin_Med_Insights_Oncol_2011_Sep_21_5_265-314.nxml.txt.nlp	22084619	SENT411	2	2	5	5	temozolomide	CD41	PA451609	3674	0.616
NULL	FEBS_Open_Bio_2014_Sep_6_4_777-787.nxml.txt.nlp	25349782	SENT142	29	29	32	32	napqi	RIPK1		8737	0.616
NULL	Environ_Health_Perspect_2006_Nov_17_114(11)_1636-1642.nxml.txt.nlp	17107846	SENT127	38	38	40	40	cyanocobalamin	B12	PA451892	7126;4709	0.616
NULL	Eur_J_Med_Res_2014_Jun_24_19(1)_34.nxml.txt.nlp	24961604	SENT98	18	18	30	30	vincristine	BCL11A	PA451879	53335	0.616
NULL	Tob_Induc_Dis_2002_Jan_15_1(1)_7-25.nxml.txt.nlp	19570245	SENT260	16	16	22	22	hyaluronan	CD44	PA165958431	960	0.616
NULL	J_Hematop_2009_Mar_5_2(1)_50-61.nxml.txt.nlp	19669224	SENT35	18	18	21	21	mi-63	p53		7157	0.616
NULL	J_Vet_Med_Sci_2014_Feb_9_76(2)_277-280.nxml.txt.nlp	24107464	SENT123	11	11	14	14	phenacetin	p53	PA450897	7157	0.616
NULL	J_Physiol_2009_Feb_15_587(Pt_4)_731-744.nxml.txt.nlp	19074966	SENT10	11	11	19	19	taurine	PAT1	PA451590	10513;206358	0.616
NULL	Mol_Cancer_2013_Oct_26_12_129.nxml.txt.nlp	24160469	SENT93	18	18	26	26	paraformaldehyde	Oct4	PA450790	5460	0.616
NULL	J_Oncol_2012_Nov_1_2012_707156.nxml.txt.nlp	23193402	SENT3	1	1	3	3	iodine	RAI	PA450049	10848;6050	0.616
NULL	Cancers_(Basel)_2010_Jan_14_2(1)_1-19.nxml.txt.nlp	24281029	SENT373	9	9	28	28	trastuzumab	San	PA451743	80218	0.616
NULL	Mol_Cancer_2010_Nov_2_9_289.nxml.txt.nlp	21044322	SENT131	0	0	8	8	cisplatin	RGS17	PA449014	26575	0.616
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Jun_19_69(Pt_7)_o1121.nxml.txt.nlp	24046676	SENT63	26	26	6	6	ethanol	mol	PA448073	90527	0.616
NULL	Oncotarget_2013_Nov_19_5(2)_309-325.nxml.txt.nlp	24525395	SENT335	7	7	10	10	flavopiridol	Mcl-1	PA452627	4170	0.616
NULL	Diabetes_Care_2012_Apr_13_35(4)_868-872.nxml.txt.nlp	22357182	SENT118	10	10	7	7	pioglitazone	ACT	PA450970	12;11332;9457;641455	0.616
NULL	Br_J_Cancer_2010_Jun_29_103(1)_52-60.nxml.txt.nlp	20531411	SENT102	3	3	9	9	gemcitabine	MTD	PA449748	4493	0.616
NULL	Evid_Based_Complement_Alternat_Med_2011_Jan_12_2011_690518.nxml.txt.nlp	19687188	SENT170	36	36	34	34	ticarcillin	TIC	PA451684	23550	0.616
NULL	Acta_Pharmacol_Sin_2012_Mar_27_33(3)_342-350.nxml.txt.nlp	22367283	SENT196	3	3	6	6	thrombin	PAR1	PA451674	79581;2149	0.616
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1542-1553.nxml.txt.nlp	21970874	SENT224	18	18	22	22	erlotinib	EGFR	PA134687924	1956	0.616
NULL	Blood_Res_2014_Dec_23_49(4)_279-280.nxml.txt.nlp	25548764	SENT24	18	18	8	8	lenalidomide	CD40	PA162363968	958	0.616
NULL	Int_J_Appl_Basic_Med_Res_2013_Jul-Dec_3(2)_134.nxml.txt.nlp	24083153	SENT13	17	17	8	8	curcumin	mol	PA151958596	90527	0.616
NULL	Pain_2014_Nov_155(11)_2243-2252.nxml.txt.nlp	24978826	SENT280	3	3	10	10	propofol	TRPA1	PA451141	8989	0.616
NULL	Diabetologia_2010_Jun_27_53(6)_1142-1150.nxml.txt.nlp	20349036	SENT196	8	8	13	13	spermine	AMPK	PA164781199	5563	0.616
NULL	G3_(Bethesda)_2014_Feb_20_4(4)_761-767.nxml.txt.nlp	24558266	SENT38	29	29	20	20	galactose	PIS1	PA449725	10423	0.616
NULL	Protein_Cell_2014_Jun_19_5(6)_469-479.nxml.txt.nlp	24748116	SENT76	9	9	7	7	paclitaxel	EB1	PA450761	9167;22919;10982	0.616
NULL	Cancer_Cell_Int_2010_Sep_1_10_30.nxml.txt.nlp	20809984	SENT37	22	22	19	19	phenol	EGF	PA450913	1950	0.616
NULL	Oncotarget_2014_Oct_16_5(22)_11442-11451.nxml.txt.nlp	25347345	SENT71	2	2	26	26	oxaliplatin	CT26	PA131285527	168400	0.616
NULL	Cancer_Manag_Res_2013_Nov_21_5_387-400.nxml.txt.nlp	24294007	SENT124	18	18	15	15	cetuximab	HER2	PA10040	2064	0.616
NULL	Crit_Care_2006_Mar_21_10(Suppl_1)_P93.nxml.txt.nlp	NULL	SENT10	0	0	16	16	ketamine	IL-6	PA450144	3569	0.616
NULL	Diabetes_Care_2009_Apr_8_32(4)_720-725.nxml.txt.nlp	19131464	SENT77	29	29	2	2	metformin	ACR	PA450395	49	0.616
NULL	Acta_Pharmacol_Sin_2009_Apr_9_30(4)_467-477.nxml.txt.nlp	19270721	SENT124	3	3	5	5	cisplatin	IL-24	PA449014	11009	0.616
NULL	Arthritis_Res_Ther_2012_Sep_20_14(5)_R199.nxml.txt.nlp	22995428	SENT89	35	35	10	10	collagenase	GM-CSF	PA449107	1437	0.616
NULL	Aging_(Albany_NY)_2011_Jan_18_3(1)_33-43.nxml.txt.nlp	21248371	SENT133	5	5	0	0	oxygen	HIF-1	PA450744	29072	0.616
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT121	3	3	5	5	curcumin	TRAIL	PA151958596	8743	0.616
NULL	J_Hematol_Oncol_2010_Mar_23_3_11.nxml.txt.nlp	20331897	SENT143	21	21	10	10	cisplatin	CRT	PA449014	811	0.616
NULL	Protein_Cell_2014_Jul_2_5(7)_544-551.nxml.txt.nlp	24691905	SENT72	24	24	6	6	nutlin-3	p53		7157	0.616
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT157	29	29	12	12	metformin	p53	PA450395	7157	0.616
NULL	Evid_Based_Complement_Alternat_Med_2013_Nov_26_2013_731370.nxml.txt.nlp	24376467	SENT210	3	3	20	20	resveratrol	EGFR		1956	0.616
NULL	Animal_2010_Jul_21_4(7)_1227-1239.nxml.txt.nlp	20582145	SENT140	17	17	10	10	estradiol	DES	PA449503	1674	0.616
NULL	Mol_Cancer_2012_Sep_25_11_73.nxml.txt.nlp	23009336	SENT143	20	20	24	24	dasatinib	PP2	PA162372878	4888	0.616
NULL	Biosensors_(Basel)_2013_Sep_13_3(3)_312-326.nxml.txt.nlp	25586261	SENT234	3	3	0	0	thrombin	SERS	PA451674	6301;54938	0.616
NULL	Br_J_Haematol_2014_Mar_13_164(1)_811-821.nxml.txt.nlp	24328678	SENT134	24	24	13	13	lenalidomide	Aiolos	PA162363968	22806	0.616
NULL	Indian_J_Pharmacol_2014_Nov-Dec_46(6)_627-632.nxml.txt.nlp	25538335	SENT133	6	6	1	1	metformin	Q10	PA450395	27161	0.616
NULL	Cardiol_Res_Pract_2012_Feb_22_2012_845698.nxml.txt.nlp	22462028	SENT170	9	9	30	30	losartan	EPO	PA450268	7076;8288;2056	0.616
NULL	Drugs_2012_Sep_6_72(9)_e1-e25.nxml.txt.nlp	22686620	SENT1068	6	6	8	8	atazanavir	ATV	PA10251	4683	0.616
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_3-5.nxml.txt.nlp	17912632	SENT42	35	35	14	14	letrozole	aromatase	PA450196	1588	0.616
NULL	J_Clin_Biochem_Nutr_2009_Jul_30_45(1)_9-13.nxml.txt.nlp	19590701	SENT54	13	13	18	18	lansoprazole	HO-1	PA450180	3162	0.616
NULL	Oncotarget_2013_Nov_24_4(12)_2430-2438.nxml.txt.nlp	24280348	SENT4	2	2	12	12	gefitinib	STAT3	PA131301952	6774	0.616
NULL	ScientificWorldJournal_2013_Mar_25_2013_720858.nxml.txt.nlp	23589707	SENT109	4	4	14	14	paclitaxel	castor	PA450761	54897	0.616
NULL	Environ_Microbiol_2013_Jan_15_15(1)_297-304.nxml.txt.nlp	23157680	SENT51	47	47	45	45	trimethoprim	TMP	PA451788	2012	0.616
NULL	Curr_Health_Sci_J_2010_Mar_24_Jan-Mar_36(1)_42-49.nxml.txt.nlp	24778826	SENT33	10	10	7	7	nimesulide	BCS	PA137179528	617	0.616
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT116	0	0	2	2	cisplatin	IBP	PA449014	706;50619	0.616
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S31-S40.nxml.txt.nlp	20680106	SENT191	14	14	17	17	irinotecan	KRAS	PA450085	3845	0.616
NULL	Hum_Genomics_Proteomics_2010_Sep_13_2010_754919.nxml.txt.nlp	20981234	SENT98	4	4	15	15	acenocoumarol	CYP2C9	PA452632	1559	0.616
NULL	Acta_Pharmacol_Sin_2009_Jul_22_30(7)_956-964.nxml.txt.nlp	19543298	SENT5	9	9	29	29	simvastatin	SLC22A1	PA451363	6580	0.616
NULL	Cell_Death_Dis_2013_Jun_13_4(6)_e665.nxml.txt.nlp	23764846	SENT228	2	2	4	4	bleomycin	BLM	PA448645	641	0.616
NULL	Nat_Med_2013_Feb_6_19(2)_217-226.nxml.txt.nlp	23291629	SENT150	22	22	24	24	lipase	HSL	PA450239	3991	0.616
NULL	Evid_Based_Complement_Alternat_Med_2011_Feb_20_2011_541209.nxml.txt.nlp	21799681	SENT83	34	34	30	30	curcumin	CDC2	PA151958596	5424	0.616
NULL	Clin_Med_Insights_Case_Rep_2013_Jun_12_6_101-106.nxml.txt.nlp	23843716	SENT12	0	0	2	2	adalimumab	ADA	PA10004	100	0.616
NULL	Acta_Histochem_Cytochem_2012_Apr_26_45(2)_139-146.nxml.txt.nlp	22685356	SENT100	13	13	9	9	forskolin	AQP2	PA146096022	359	0.616
NULL	Neuropsychopharmacology_2009_Jun_25_34(7)_1854-1864.nxml.txt.nlp	19242406	SENT0	18	18	30	30	memantine	San	PA10364	80218	0.616
NULL	Oxid_Med_Cell_Longev_2011_May_23_2011_213286.nxml.txt.nlp	NULL	SENT115	15	15	20	20	ethanol	GAPDH	PA448073	2597	0.616
NULL	Alcohol_Res_2012_34(4)_459-467.nxml.txt.nlp	23584112	SENT107	28	28	24	24	cosyntropin	ACTH	PA164749052	5443	0.616
NULL	Breast_Cancer_Res_2007_Jul_5_9(4)_R41.nxml.txt.nlp	17612393	SENT146	18	18	27	27	celecoxib	Bcl-2	PA448871	596	0.616
NULL	Curr_Control_Trials_Cardiovasc_Med_2000_Dec_4_1(3)_166-171.nxml.txt.nlp	11714434	SENT192	26	26	8	8	heparin	EDA	PA449855	1896	0.616
NULL	J_Appl_Oral_Sci_2010_Nov-Dec_18(6)_591-598.nxml.txt.nlp	21308290	SENT52	16	16	4	4	ethanol	HEMA	PA448073	2157	0.616
NULL	Emerg_Infect_Dis_2014_May_20(5)_910-911.nxml.txt.nlp	24751334	SENT31	20	20	14	14	sulfisoxazole	COT	PA164748964	54677	0.616
NULL	Adv_Hematol_2012_Feb_6_2012_485943.nxml.txt.nlp	22400030	SENT110	11	11	18	18	doxorubicin	CHOP	PA449412	1649	0.616
NULL	Clin_Exp_Vaccine_Res_2014_Jul_20_3(2)_227-234.nxml.txt.nlp	25003097	SENT48	10	10	20	20	collagenase	CD11c	PA449107	3687	0.616
NULL	Front_Genet_2014_Dec_4_5_419.nxml.txt.nlp	25538730	SENT1170	0	0	5	5	nimodipine	CA1	PA450633	759	0.616
NULL	Breast_Cancer_Res_2010_Jun_18_12(3)_110.nxml.txt.nlp	20584345	SENT56	13	13	38	38	risedronate	aromatase	PA451255	1588	0.616
NULL	Diabetes_2013_Sep_15_62(9)_3232-3240.nxml.txt.nlp	23835329	SENT162	0	0	3	3	olanzapine	GLP-1	PA450688	100125288	0.616
NULL	BMB_Rep_2013_Jan_46(1)_59-64.nxml.txt.nlp	23351386	SENT65	13	13	15	15	auranofin	STAT3	PA448510	6774	0.616
NULL	J_Physiol_2012_Apr_20_590(7)_1517-1534.nxml.txt.nlp	22351636	SENT261	41	41	15	15	zolpidem	ANOVA	PA451976	4858	0.616
NULL	Cerebrospinal_Fluid_Res_2006_Dec_21_3(Suppl_1)_S41.nxml.txt.nlp	NULL	SENT13	27	27	21	21	heparin	OTS	PA449855	5012	0.616
NULL	Pharmaceuticals_(Basel)_2013_May_27_6(6)_759-776.nxml.txt.nlp	24276260	SENT1166	1	1	9	9	topiramate	CA1	PA451728	759	0.616
NULL	Oncoimmunology_2013_Nov_1_2(11)_e27010.nxml.txt.nlp	24498547	SENT32	8	8	6	6	gemcitabine	GEM	PA449748	2669	0.616
NULL	Br_J_Cancer_2012_Jan_3_106(1)_148-156.nxml.txt.nlp	22045191	SENT198	12	12	24	24	erlotinib	ZEB1	PA134687924	6935	0.616
NULL	J_Oncol_2012_Jul_14_2012_193436.nxml.txt.nlp	21804824	SENT160	22	22	37	37	temozolomide	SNO	PA451609	6498	0.616
NULL	Br_J_Cancer_2014_Jan_21_110(2)_384-391.nxml.txt.nlp	24346286	SENT126	19	19	15	15	trastuzumab	PTEN	PA451743	5728	0.616
NULL	Nat_Med_2013_Feb_6_19(2)_217-226.nxml.txt.nlp	23291629	SENT392	25	25	7	7	isoproterenol	TRIP-Br2	PA450121	9792	0.616
NULL	Ann_Oncol_2013_Nov_12_24(11)_2892-2897.nxml.txt.nlp	24030098	SENT73	42	42	7	7	rituximab	CHOP	PA451261	1649	0.616
NULL	Neural_Regen_Res_2013_May_5_8(13)_1180-1189.nxml.txt.nlp	25206412	SENT95	42	42	7	7	fasudil	RhoA	PA165946121	387	0.616
NULL	Front_Oncol_2014_Mar_6_4_40.nxml.txt.nlp	24639951	SENT47	46	46	20	20	vindesine	ETO	PA10232	862	0.616
NULL	Br_J_Cancer_2013_Sep_3_109(5)_1079-1084.nxml.txt.nlp	23928659	SENT39	27	27	25	25	docetaxel	DES	PA449383	1674	0.616
NULL	Eur_J_Clin_Pharmacol_2014_Mar_22_70(6)_685-693.nxml.txt.nlp	24658827	SENT231	13	13	3	3	tacrolimus	CYP3A5	PA451578	1577	0.616
NULL	Indian_J_Pharm_Sci_2008_Jul-Aug_70(4)_494-497.nxml.txt.nlp	20046778	SENT19	0	0	2	2	risperidone	RIS	PA451257	51285	0.616
NULL	Ann_Rheum_Dis_2014_Jun_30_73(6)_990-999.nxml.txt.nlp	24482301	SENT132	7	7	5	5	ustekinumab	UST	PA166048654	10090	0.616
NULL	Int_J_Endocrinol_2011_Mar_6_2011_415719.nxml.txt.nlp	21461394	SENT62	15	15	28	28	cinacalcet	PTH	PA164776671	5741	0.616
NULL	Extremophiles_2009_Jul_21_13(4)_567-581.nxml.txt.nlp	19544040	SENT171	9	9	11	11	lipase	HSL	PA450239	3991	0.616
NULL	Braz_J_Microbiol_2011_Dec_1_Oct-Dec_42(4)_1434-1436.nxml.txt.nlp	24031774	SENT34	18	18	20	20	neomycin	TOB	PA450608	10140	0.616
NULL	Insights_Imaging_2013_Jan_29_4(2)_163-175.nxml.txt.nlp	23359240	SENT144	4	4	6	6	trastuzumab	HER2	PA451743	2064	0.616
NULL	Infect_Dis_Obstet_Gynecol_2012_Aug_14_2012_890160.nxml.txt.nlp	22927715	SENT151	12	12	14	14	etonogestrel	ENG	PA164771231	2022	0.616
NULL	Lancet_2011_May_21_377(9779)_1749-1759.nxml.txt.nlp	21570111	SENT186	34	34	7	7	capecitabine	MAX	PA448771	4149	0.616
NULL	Neural_Plast_2013_Jun_26_2013_605079.nxml.txt.nlp	23936678	SENT118	6	6	38	38	fluoxetine	GABRA4	PA449673	2557	0.616
NULL	Cancers_(Basel)_2011_Sep_13_3(3)_3506-3524.nxml.txt.nlp	24212966	SENT162	7	7	16	16	docetaxel	EGFR	PA449383	1956	0.616
NULL	Mol_Biol_Cell_2014_Mar_15_25(6)_791-799.nxml.txt.nlp	24451261	SENT70	28	28	38	38	nadh	ADP	PA164755085	23038	0.616
NULL	Oncotarget_2011_Sep_9_2(9)_658-668.nxml.txt.nlp	21911919	SENT106	19	19	15	15	daunorubicin	NAC	PA449212	22861	0.616
NULL	Exp_Lung_Res_2013_Oct_1_39(8)_336-348.nxml.txt.nlp	23919450	SENT85	7	7	18	18	thrombin	PAR-1	PA451674	2011;2149	0.616
NULL	Acta_Pharmacol_Sin_2009_Feb_26_30(2)_175-183.nxml.txt.nlp	19169269	SENT140	4	4	27	27	iptakalim	NUP54	PA165949694	53371	0.616
NULL	Cancers_(Basel)_2014_Aug_12_6(3)_1631-1669.nxml.txt.nlp	25119536	SENT102	3	3	6	6	imatinib	IFN	PA10804	3439	0.616
NULL	Crit_Care_2003_Jun_26_7(6)_427-434.nxml.txt.nlp	14624682	SENT186	4	4	6	6	vasopressin	AVP	PA451858	114548;551	0.616
NULL	Vet_Res_Forum_2013_Winter_4(1)_19-24.nxml.txt.nlp	25593681	SENT80	0	0	44	44	diclofenac	ANOVA	PA449293	4858	0.616
NULL	Nanoscale_Res_Lett_2014_Jul_15_9(1)_353.nxml.txt.nlp	25114645	SENT2	18	18	20	20	diethylstilbestrol	DES	PA449307	1674	0.616
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT169	8	8	14	14	bevacizumab	PlGF-2	PA130232992	5228	0.616
NULL	Brain_Sci_2014_May_6_4(2)_356-375.nxml.txt.nlp	24961766	SENT254	2	2	14	14	propofol	P28	PA451141	9446;7802;9527	0.616
NULL	Ann_Oncol_2009_Aug_17_20(8)_1319-1329.nxml.txt.nlp	19535820	SENT349	16	16	43	43	docetaxel	San	PA449383	80218	0.616
NULL	Toxins_(Basel)_2011_Jul_14_3(7)_848-883.nxml.txt.nlp	22069744	SENT269	11	11	25	25	l-alanine	DM1	PA448055	338023;1760;28509	0.616
NULL	New_Microbes_New_Infect_2014_May_4_2(3)_58-63.nxml.txt.nlp	25356345	SENT100	42	42	8	8	meropenem	CTX	PA164764445	1593	0.616
NULL	Ann_Lab_Med_2013_Jan_17_33(1)_86-88.nxml.txt.nlp	23301230	SENT52	10	10	12	12	piperacillin	CTX	PA450975	1593	0.616
NULL	Cancer_Med_2014_Apr_12_3(2)_390-396.nxml.txt.nlp	24519810	SENT108	16	16	10	10	tenofovir	LAM	PA10204	7249;7248	0.616
NULL	Diabetes_2011_Nov_17_60(11)_2691-2700.nxml.txt.nlp	21896928	SENT11	19	19	4	4	resveratrol	SIRT1		23411	0.616
NULL	Apoptosis_2014_Apr_23_19(7)_1055-1068.nxml.txt.nlp	24756955	SENT166	16	16	11	11	nutlin-3	MDMX		4194	0.616
NULL	Braz_J_Med_Biol_Res_2012_Jun_8_45(10)_988-994.nxml.txt.nlp	22666778	SENT130	27	27	24	24	lipase	HSL	PA450239	3991	0.616
NULL	J_Headache_Pain_2001_Jun_2(1)_3-11.nxml.txt.nlp	NULL	SENT1	0	0	25	25	sumatriptan	5-HT1B	PA451566	3351	0.616
NULL	Cell_Commun_Signal_2013_Jul_4_11_47.nxml.txt.nlp	23826796	SENT61	4	4	19	19	forskolin	CC2D1A	PA146096022	54862	0.616
NULL	Clin_Dev_Immunol_2013_Oct_10_2013_746068.nxml.txt.nlp	24223607	SENT219	3	3	11	11	thrombin	MMP9	PA451674	4318	0.616
NULL	Adv_Ther_2013_Nov_30_30(12)_1086-1099.nxml.txt.nlp	24293132	SENT105	16	16	3	3	olmesartan	CSBP	PA164742950	3190	0.616
NULL	Clin_Exp_Gastroenterol_2011_May_4_4_55-73.nxml.txt.nlp	21753892	SENT383	2	2	4	4	lipase	RGL	PA450239	23179	0.616
NULL	Arthritis_Res_2002_Jul_26_4(5)_R9.nxml.txt.nlp	12223112	SENT62	0	0	19	19	fluorescein	San	PA164746009	80218	0.616
NULL	Iran_J_Pharm_Res_2014_Spring_13(2)_635-639.nxml.txt.nlp	25237359	SENT18	5	5	7	7	chlorzoxazone	CYP2E1	PA448971	1571	0.616
NULL	Front_Genet_2014_Jul_14_5_220.nxml.txt.nlp	25071843	SENT294	10	10	14	14	s-adenosylmethionine	PS1	PA164754994	5663	0.616
NULL	Environ_Health_Perspect_2005_Jan_30_113(1)_17-24.nxml.txt.nlp	15626642	SENT145	9	9	5	5	quinidine	P-gp	PA451209	5243	0.616
NULL	Sensors_(Basel)_2010_May_19_10(5)_5031-5053.nxml.txt.nlp	22399922	SENT68	0	0	2	2	rosiglitazone	SLC2A2	PA451283	6514	0.616
NULL	Exp_Diabetes_Res_2011_Apr_6_2011_928523.nxml.txt.nlp	21603181	SENT229	32	32	9	9	haloperidol	NEFA	PA449841	4925	0.616
NULL	Breast_Cancer_Res_2010_Mar_5_12(2)_R16.nxml.txt.nlp	20205716	SENT341	2	2	9	9	lovastatin	PTEN	PA450272	5728	0.616
NULL	Oncol_Lett_2013_Sep_28_6(3)_795-800.nxml.txt.nlp	24137413	SENT120	19	19	3	3	paclitaxel	HIF-1	PA450761	29072	0.616
NULL	J_Korean_Assoc_Oral_Maxillofac_Surg_2014_Dec_26_40(6)_291-296.nxml.txt.nlp	25551094	SENT87	2	2	8	8	alendronate	OPG	PA448082	690	0.616
NULL	Front_Oncol_2014_Mar_3_4_34.nxml.txt.nlp	24624361	SENT252	24	24	26	26	pertuzumab	ERBB2		2064	0.616
NULL	Int_J_Environ_Res_Public_Health_2011_Jul_21_8(7)_3019-3031.nxml.txt.nlp	21845171	SENT82	2	2	10	10	ethanol	IL-10	PA448073	3586	0.616
NULL	Arthritis_Res_Ther_2006_Apr_12_8(Suppl_1)_S3.nxml.txt.nlp	16820042	SENT147	6	6	9	9	colchicine	MSU	PA449092	593	0.616
NULL	Breast_Cancer_Res_2002_Oct_25_4(1)_1-4.nxml.txt.nlp	11879551	SENT112	6	6	4	4	genistein	Gen	PA165109660	348654	0.616
NULL	Emerg_Infect_Dis_2014_Mar_20(3)_400-408.nxml.txt.nlp	24565738	SENT66	16	16	4	4	rifampin	DST	PA451250	667	0.616
NULL	Indian_J_Pharmacol_2014_Nov-Dec_46(6)_627-632.nxml.txt.nlp	25538335	SENT126	10	10	3	3	metformin	Q10	PA450395	27161	0.616
NULL	Pharmaceuticals_(Basel)_2013_Aug_2_6(8)_915-928.nxml.txt.nlp	24276376	SENT12	33	33	35	35	aspirin	P2Y12	PA448497	64805	0.616
NULL	J_Cardiothorac_Surg_2013_Sep_11_8(Suppl_1)_O209.nxml.txt.nlp	NULL	SENT5	18	18	7	7	creatine	EPO	PA164778930	7076;8288;2056	0.616
NULL	Cell_Death_Dis_2013_Jul_11_4(7)_e719.nxml.txt.nlp	23846221	SENT76	2	2	0	0	cisplatin	TRAIL	PA449014	8743	0.616
NULL	Oncol_Lett_2014_Jun_3_7(6)_2083-2088.nxml.txt.nlp	24932293	SENT7	6	6	8	8	cyclophosphamide	CTX	PA449165	1593	0.616
NULL	Mol_Vis_2012_Nov_30_18_2847-2859.nxml.txt.nlp	23233787	SENT178	34	34	18	18	fluorescein	15-LOX-1	PA164746009	246	0.616
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT172	0	0	5	5	heparin	FGF1	PA449855	2246	0.616
NULL	Eur_Heart_J_2013_Dec_1_34(45)_3515-3524.nxml.txt.nlp	23594590	SENT55	3	3	19	19	eplerenone	CD68	PA164749044	968	0.616
NULL	Indian_J_Med_Res_2014_Feb_139(2)_205-215.nxml.txt.nlp	24718394	SENT39	17	17	8	8	artemether	ACT	PA165111698	12;11332;9457;641455	0.616
NULL	Br_J_Cancer_2010_Oct_26_103(9)_1380-1390.nxml.txt.nlp	20877355	SENT14	7	7	4	4	etoposide	TRAIL	PA449552	8743	0.616
NULL	Breast_Cancer_Res_2009_Mar_19_11(2)_R16.nxml.txt.nlp	19298655	SENT118	26	26	22	22	lipase	HSL	PA450239	3991	0.616
NULL	Mol_Pain_2014_Aug_15_10_53.nxml.txt.nlp	25127716	SENT76	12	12	10	10	paclitaxel	SDH	PA450761	1757;10993	0.616
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1123-1128.nxml.txt.nlp	20354531	SENT143	34	34	11	11	cisplatin	ACT	PA449014	12;11332;9457;641455	0.616
NULL	Iran_J_Pharm_Res_2014_Spring_13(2)_651-658.nxml.txt.nlp	25237361	SENT138	18	18	15	15	lipase	castor	PA450239	54897	0.616
NULL	Clin_Ophthalmol_2010_Apr_26_4_331-341.nxml.txt.nlp	20463802	SENT85	13	13	27	27	gatifloxacin	API	PA449738	5345	0.616
NULL	Mol_Pain_2012_Sep_22_8_71.nxml.txt.nlp	22998838	SENT102	10	10	3	3	cisplatin	CB2	PA449014	1269	0.616
NULL	Environ_Health_Perspect_2002_Dec_110(Suppl_6)_1031-1036.nxml.txt.nlp	12634135	SENT5	33	33	30	30	permethrin	PTN	PA164743137	5764	0.616
NULL	Mol_Cancer_2012_Jul_29_11_48.nxml.txt.nlp	22839996	SENT88	28	28	30	30	cisplatin	DDP	PA449014	1678	0.616
NULL	J_Immunother_Cancer_2014_Nov_6_2(Suppl_3)_P199.nxml.txt.nlp	NULL	SENT8	36	36	30	30	cetuximab	IFN	PA10040	3439	0.616
NULL	Iran_J_Pharm_Res_2014_Summer_13(3)_919-926.nxml.txt.nlp	25276192	SENT124	3	3	5	5	doxorubicin	Bcl-2	PA449412	596	0.616
NULL	Angiogenesis_2011_Mar_4_14(1)_17-27.nxml.txt.nlp	21049284	SENT141	23	23	18	18	thrombin	CD146	PA451674	4162	0.616
NULL	Br_J_Anaesth_2011_Oct_17_107(4)_490-502.nxml.txt.nlp	21852280	SENT12	14	14	16	16	capsaicin	TRPV1	PA448776	7442	0.616
NULL	Oncotarget_2013_Jul_22_4(8)_1309-1316.nxml.txt.nlp	23896568	SENT50	2	2	0	0	nadh	COX	PA164755085	1351	0.616
NULL	Osong_Public_Health_Res_Perspect_2013_Dec_12_4(6)_316-322.nxml.txt.nlp	24524020	SENT206	26	26	33	33	erythromycin	PEN	PA449493	9933	0.616
NULL	Diabetes_Care_2013_Jul_12_36(7)_2126-2132.nxml.txt.nlp	23645884	SENT113	16	16	10	10	sitagliptin	GLP-1	PA164748978	100125288	0.616
NULL	Front_Oncol_2013_Nov_15_3_281.nxml.txt.nlp	24298448	SENT86	12	12	15	15	oxaliplatin	BRAF	PA131285527	673	0.616
NULL	Cancer_Cell_Int_2003_Jul_23_3_12.nxml.txt.nlp	12914669	SENT45	4	4	15	15	tetracycline	PP1	PA451640	5540;5464	0.616
NULL	Int_Ophthalmol_2012_Dec_31_32(6)_577-582.nxml.txt.nlp	22847248	SENT29	12	12	9	9	acetazolamide	ALPI	PA448018	248	0.616
NULL	Mol_Vis_2012_May_11_18_1260-1270.nxml.txt.nlp	22665973	SENT226	0	0	2	2	topotecan	TPT	PA451729	23590;6469	0.616
NULL	J_Korean_Med_Sci_2010_May_16_25(5)_738-745.nxml.txt.nlp	20436711	SENT12	22	22	10	10	entecavir	NUC	PA164784025	4924	0.616
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Apr_17_6_43-57.nxml.txt.nlp	24833916	SENT328	9	9	11	11	everolimus	HER2	PA164746311	2064	0.616
NULL	J_Ginseng_Res_2011_Nov_35(4)_436-441.nxml.txt.nlp	23717089	SENT141	17	17	7	7	ginseng	CAGC	PA164781150	6283	0.616
NULL	Arthritis_Res_Ther_2008_Jan_18_10(1)_R8.nxml.txt.nlp	18205921	SENT34	1	1	4	4	hyaluronan	MRP5	PA165958431	10057	0.616
NULL	Mol_Vis_2011_May_25_17_1350-1354.nxml.txt.nlp	21647273	SENT85	8	8	16	16	creatine	GCG	PA164778930	2641	0.616
NULL	F1000Res_2013_Feb_28_2_65.nxml.txt.nlp	24358861	SENT69	19	19	24	24	minocycline	TLR4	PA450519	7099	0.616
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT49	14	14	16	16	curcumin	TRAIL	PA151958596	8743	0.616
NULL	Nature_2012_Dec_20_492(7429)_387-392.nxml.txt.nlp	23222541	SENT18	17	17	12	12	thrombin	PAR1	PA451674	79581;2149	0.616
NULL	Br_J_Cancer_2009_Jun_2_100(11)_1739-1745.nxml.txt.nlp	19436299	SENT111	7	7	10	10	everolimus	FDG	PA164746311	23583	0.616
NULL	Evid_Based_Complement_Alternat_Med_2013_Aug_13_2013_569160.nxml.txt.nlp	23997795	SENT326	22	22	34	34	forskolin	ADP	PA146096022	23038	0.616
NULL	Arthritis_Res_Ther_2012_May_1_14(3)_R99.nxml.txt.nlp	22546542	SENT11	34	34	25	25	infliximab	IL-6	PA452639	3569	0.616
NULL	Clin_Drug_Investig_2015_Dec_16_35_141-147.nxml.txt.nlp	25511640	SENT70	23	23	18	18	miglitol	GLP-1	PA164776726	100125288	0.616
NULL	Int_J_Hypertens_2014_Jan_12_2014_381082.nxml.txt.nlp	24678415	SENT172	2	2	20	20	cinacalcet	PTH	PA164776671	5741	0.616
NULL	Arthritis_Res_Ther_2013_Dec_27_15(6)_R222.nxml.txt.nlp	24369907	SENT181	29	29	17	17	collagenase	c-Jun	PA449107	3725	0.616
NULL	Pharmaceutics_2011_Oct_12_3(4)_680-705.nxml.txt.nlp	24309303	SENT73	30	30	17	17	glibenclamide	CYP3A4	PA449782	1576	0.616
NULL	J_Cell_Mol_Med_2013_Jun_4_17(6)_713-722.nxml.txt.nlp	23551576	SENT131	6	6	2	2	cblb502	TLR5		7100	0.616
NULL	Int_J_Mol_Sci_2012_Aug_13_13(8)_10091-10112.nxml.txt.nlp	22949849	SENT12	5	5	7	7	lipase	PPL	PA450239	5493	0.616
NULL	Breast_Cancer_Res_2012_Mar_9_14(2)_R41.nxml.txt.nlp	22405131	SENT152	35	35	7	7	estradiol	TCL1A	PA449503	8115	0.615
NULL	Open_AIDS_J_2010_May_14_4_105-115.nxml.txt.nlp	20657829	SENT77	5	5	15	15	methamphetamine	San	PA450403	80218	0.615
NULL	AIDS_Res_Treat_2011_Jun_7_2011_354908.nxml.txt.nlp	21716719	SENT218	1	1	4	4	tenofovir	OAT1	PA10204	9356	0.615
NULL	Br_J_Dermatol_2014_Feb_18_170(1)_342-351.nxml.txt.nlp	24547721	SENT76	6	6	11	11	lansoprazole	DIF	PA450180	7124	0.615
NULL	JAKSTAT_2012_Jul_1_1(3)_219-221.nxml.txt.nlp	NULL	SENT61	4	4	9	9	dasatinib	CD40	PA162372878	958	0.615
NULL	J_Hematol_Oncol_2010_May_28_3_19.nxml.txt.nlp	20509866	SENT13	30	30	34	34	zinc	RBCC	PA451956	51127	0.615
NULL	Int_J_Nanomedicine_2012_May_8_7_2373-2388.nxml.txt.nlp	22661891	SENT76	9	9	33	33	paraformaldehyde	San	PA450790	80218	0.615
NULL	Arthritis_Res_Ther_2010_Oct_14_12(5)_R190.nxml.txt.nlp	20942979	SENT72	4	4	0	0	fluorescein	CD49b	PA164746009	3673	0.615
NULL	Pain_2014_Nov_155(11)_2306-2322.nxml.txt.nlp	25168672	SENT973	10	10	8	8	loxapine	LOX	PA450273	4015	0.615
NULL	Oncotarget_2013_Apr_13_4(4)_502-530.nxml.txt.nlp	23594434	SENT426	1	1	16	16	artesunate	HIF-1	PA165111697	29072	0.615
NULL	Exp_Ther_Med_2014_May_20_7(5)_1354-1358.nxml.txt.nlp	24940438	SENT29	0	0	40	40	fluorescein	San	PA164746009	80218	0.615
NULL	Front_Neurol_2011_Nov_21_2_68.nxml.txt.nlp	22125548	SENT155	0	0	30	30	rasagiline	PARP-1	PA164764584	25976	0.615
NULL	Indian_J_Pharm_Sci_2014_Nov-Dec_76(6)_510-518.nxml.txt.nlp	25593384	SENT177	22	22	36	36	ethanol	mol	PA448073	90527	0.615
NULL	Ann_Oncol_2014_Sep_13_25(9)_1813-1820.nxml.txt.nlp	24928832	SENT132	30	30	24	24	cetuximab	p16	PA10040	1029	0.615
NULL	Diabetes_2013_Mar_14_62(3)_953-964.nxml.txt.nlp	23223176	SENT226	24	24	13	13	paroxetine	ROS	PA450801	6098	0.615
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT128	13	13	0	0	encainide	CYP1A2	PA449459	1544	0.615
NULL	Cell_Commun_Signal_2014_Oct_5_12(1)_54.nxml.txt.nlp	NULL	SENT119	8	8	14	14	doxycycline	MRCK	PA449415	8476	0.615
NULL	J_Int_Soc_Sports_Nutr_2014_Aug_13_11_38.nxml.txt.nlp	25132809	SENT42	19	19	17	17	creatine	MSTN	PA164778930	2660	0.615
NULL	Brain_Behav_2011_Sep_1(1)_44-54.nxml.txt.nlp	22398980	SENT49	2	2	15	15	cocaine	AIS	PA449072	367	0.615
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT221	28	28	16	16	heparin	FGF1	PA449855	2246	0.615
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Apr_15_9_13.nxml.txt.nlp	20398300	SENT108	23	23	18	18	amoxicillin	LAM	PA448406	7249;7248	0.615
NULL	Virol_J_2008_Sep_26_5_109.nxml.txt.nlp	18822145	SENT135	13	13	17	17	amantadine	CPE	PA448360	1363	0.615
NULL	Exp_Ther_Med_2014_Jun_10_7(6)_1605-1610.nxml.txt.nlp	24926352	SENT171	24	24	30	30	methylprednisolone	Bcl-2	PA450466	596	0.615
NULL	Surg_Neurol_Int_2013_Feb_20_4_18.nxml.txt.nlp	23493431	SENT39	6	6	20	20	heparin	ACT	PA449855	12;11332;9457;641455	0.615
NULL	Br_J_Cancer_1987_Oct_56(4)_413-417.nxml.txt.nlp	3479994	SENT9	0	0	48	48	dipyridamole	ML-1	PA449367	112744;51761	0.615
NULL	Br_J_Cancer_2013_Sep_3_109(5)_1117-1122.nxml.txt.nlp	23942070	SENT135	7	7	11	11	cetuximab	CRT	PA10040	811	0.615
NULL	Eur_Arch_Psychiatry_Clin_Neurosci_2012_Aug_9_262(5)_415-423.nxml.txt.nlp	22318337	SENT95	9	9	11	11	chlorpromazine	CPZ	PA448964	8532	0.615
NULL	J_Vet_Med_Sci_2013_Dec_25_75(12)_1637-1642.nxml.txt.nlp	23884081	SENT8	10	10	21	21	dextran	p38	PA449261	10598;1432;7965	0.615
NULL	Cardiovasc_J_Afr_2014_Feb_25(1)_27-33.nxml.txt.nlp	24626517	SENT78	11	11	6	6	glucose	DBP	PA449773	3295;1628;2638	0.615
NULL	Mol_Cancer_2012_Sep_21_11_72.nxml.txt.nlp	22995644	SENT47	23	23	7	7	imatinib	PRL-3	PA10804	11156	0.615
NULL	J_Neuroinflammation_2010_Nov_18_7_81.nxml.txt.nlp	21087489	SENT56	34	34	6	6	pilocarpine	GFAP	PA450962	2670	0.615
NULL	Mol_Vis_2012_Jul_18_18_1966-1972.nxml.txt.nlp	22876123	SENT117	0	0	10	10	curcumin	IL-4	PA151958596	3565	0.615
NULL	Cardiovasc_J_Afr_2014_Feb_25(1)_27-33.nxml.txt.nlp	24626517	SENT78	11	11	8	8	glucose	MBP	PA449773	5553;4155	0.615
NULL	Surg_Neurol_Int_2010_Dec_22_1_84.nxml.txt.nlp	21206536	SENT112	5	5	14	14	heparin	PED	PA449855	8682	0.615
NULL	Ann_Rheum_Dis_2008_Oct_25_68(10)_1644-1650.nxml.txt.nlp	18957484	SENT143	22	22	18	18	leflunomide	IL-15	PA450192	3600	0.615
NULL	Arthritis_Res_Ther_2004_Jun_21_6(4)_169-173.nxml.txt.nlp	15225361	SENT103	8	8	11	11	estradiol	RUNX2	PA449503	860	0.615
NULL	Front_Behav_Neurosci_2013_Dec_16_7_200.nxml.txt.nlp	24379768	SENT11	11	11	13	13	l-tyrosine	TYR	PA451822	7299	0.615
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT417	14	14	17	17	irinotecan	KRAS	PA450085	3845	0.615
NULL	Oncotarget_2014_Aug_27_5(17)_7328-7341.nxml.txt.nlp	25193862	SENT27	30	30	16	16	erlotinib	EGFR	PA134687924	1956	0.615
NULL	Clinicoecon_Outcomes_Res_2014_Sep_23_6_409-414.nxml.txt.nlp	25285019	SENT139	8	8	6	6	atazanavir	ATV	PA10251	4683	0.615
NULL	Indian_J_Endocrinol_Metab_2011_Apr-Jun_15(2)_137-139.nxml.txt.nlp	21731877	SENT32	0	0	13	13	cabergoline	HTR2B	PA448708	3357	0.615
NULL	Br_J_Cancer_2011_Apr_26_104(9)_1418-1425.nxml.txt.nlp	21468050	SENT138	48	48	40	40	tamoxifen	PTEN	PA451581	5728	0.615
NULL	Acta_Pharmacol_Sin_2013_Dec_18_34(12)_1508-1514.nxml.txt.nlp	24241347	SENT215	7	7	5	5	ketanserin	KET	PA131053734	8626	0.615
NULL	Asian-Australas_J_Anim_Sci_2012_Aug_25(8)_1145-1152.nxml.txt.nlp	25049674	SENT35	2	2	5	5	choline	B12	PA448976	7126;4709	0.615
NULL	Mol_Biol_Cell_2014_Jul_1_25(13)_1995-2005.nxml.txt.nlp	24807907	SENT10	19	19	5	5	guanidine	paracingulin	PA164781028	84952	0.615
NULL	Mol_Cancer_2012_Apr_26_11_26.nxml.txt.nlp	22537224	SENT146	0	0	25	25	geldanamycin	FANCF	PA152031327	2188	0.615
NULL	ISRN_Otolaryngol_2012_Nov_14_2012_797619.nxml.txt.nlp	23762619	SENT143	3	3	11	11	gefitinib	BMAC	PA131301952	9547	0.615
NULL	Eur_J_Neurosci_2014_Sep_19_40(6)_2922-2940.nxml.txt.nlp	24945075	SENT6	9	9	12	12	choline	p75	PA448976	7133;11168	0.615
NULL	Biotechnol_Res_Int_2013_Dec_1_2013_253286.nxml.txt.nlp	24363937	SENT108	4	4	7	7	urea	DAP	PA451831	23549;3375;1611	0.615
NULL	Case_Rep_Gastroenterol_2010_May_12_4(2)_144-152.nxml.txt.nlp	20805936	SENT40	5	5	7	7	gemcitabine	GEM	PA449748	2669	0.615
NULL	Orphanet_J_Rare_Dis_2007_Jan_8_2_3.nxml.txt.nlp	17210076	SENT321	35	35	29	29	anagrelide	AIT	PA164742986	160728	0.615
NULL	Ther_Clin_Risk_Manag_2006_Sep_2(3)_297-301.nxml.txt.nlp	18360604	SENT67	7	7	20	20	paricalcitol	PTH	PA450798	5741	0.615
NULL	Arthritis_Res_Ther_2013_Mar_4_15(2)_R39.nxml.txt.nlp	23497717	SENT202	16	16	10	10	imiquimod	TLR7	PA449972	51284	0.615
NULL	Anal_Bioanal_Chem_2014_Nov_8_406(1)_213-224.nxml.txt.nlp	24202195	SENT193	0	0	2	2	genistein	Gen	PA165109660	348654	0.615
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT166	31	31	42	42	pp2	PP2		4888	0.615
NULL	J_Cell_Biol_2004_Jan_19_164(2)_169-174.nxml.txt.nlp	14718521	SENT69	4	4	0	0	dextran	MARCKS	PA449261	4082	0.615
NULL	Carcinogenesis_2013_Mar_7_34(3)_703-712.nxml.txt.nlp	23222814	SENT120	0	0	9	9	curcumin	CDK6	PA151958596	1021	0.615
NULL	J_Immunol_Res_2014_Jul_16_2014_696812.nxml.txt.nlp	25133198	SENT252	13	13	3	3	rifaximin	CTR	PA164752443	799	0.615
NULL	Ann_Surg_Treat_Res_2014_Feb_22_86(2)_55-60.nxml.txt.nlp	24761409	SENT99	14	14	27	27	levothyroxine	CTX	PA450221	1593	0.615
NULL	Eur_J_Clin_Pharmacol_2011_Dec_23_67(12)_1231-1241.nxml.txt.nlp	21698374	SENT297	12	12	8	8	cyclosporine	ABCB1	PA449167	5243	0.615
NULL	EPMA_J_2013_Jun_7_4(1)_14.nxml.txt.nlp	23742177	SENT1059	9	9	18	18	acetazolamide	OBF	PA448018	284359	0.615
NULL	Diabetes_2013_Oct_17_62(10)_3350-3361.nxml.txt.nlp	23835334	SENT7	11	11	13	13	lipase	ATGL	PA450239	57104	0.615
NULL	Exp_Hematol_2012_Feb_40(2)_97-106.nxml.txt.nlp	22085453	SENT146	7	7	25	25	sitagliptin	DPPIV	PA164748978	2191;1803	0.615
NULL	Osong_Public_Health_Res_Perspect_2013_Dec_12_4(6)_316-322.nxml.txt.nlp	24524020	SENT206	14	14	20	20	chloramphenicol	CTX	PA448927	1593	0.615
NULL	Emerg_Infect_Dis_2012_Nov_18(11)_1729-1737.nxml.txt.nlp	23092683	SENT334	23	23	20	20	amoxicillin	19A	PA448406	57823	0.615
NULL	J_Med_Life_2011_Feb_15_4(1)_11-20.nxml.txt.nlp	21505570	SENT196	21	21	26	26	nimesulide	CB1	PA137179528	1268	0.615
NULL	Br_J_Cancer_1996_Jul_74(2)_187-193.nxml.txt.nlp	8688320	SENT13	26	26	7	7	doxorubicin	P-gp	PA449412	5243	0.615
NULL	Biology_(Basel)_2012_Dec_31_2(1)_40-63.nxml.txt.nlp	24832651	SENT241	15	15	31	31	cisplatin	BRCA1	PA449014	672	0.615
NULL	EMBO_Rep_2013_Dec_18_14(12)_1113-1119.nxml.txt.nlp	24136413	SENT206	21	21	8	8	spermine	TPO1	PA164781199	256987	0.615
NULL	Cardiovasc_Drugs_Ther_2010_Dec_13_24(5-6)_391-399.nxml.txt.nlp	20640495	SENT25	0	0	2	2	dipyridamole	DIP	PA449367	23151;1831	0.615
NULL	Curr_Clin_Pharmacol_2013_May_8(2)_135-155.nxml.txt.nlp	23062036	SENT348	36	36	25	25	raloxifene	PTH	PA451221	5741	0.615
NULL	Breast_Cancer_Res_2011_Nov_28_13(6)_317.nxml.txt.nlp	22189202	SENT29	5	5	12	12	nadh	PSAT1	PA164755085	29968	0.615
NULL	South_Asian_J_Cancer_2014_Jul-Sep_3(3)_186.nxml.txt.nlp	25136531	SENT14	8	8	13	13	vincristine	CHOP	PA451879	1649	0.615
NULL	Sensors_(Basel)_2012_Apr_20_12(4)_5170-5194.nxml.txt.nlp	22666081	SENT104	46	46	32	32	ethanol	LTA	PA448073	4049	0.615
NULL	Mol_Biol_Int_2011_Feb_24_2011_137459.nxml.txt.nlp	22091395	SENT201	8	8	37	37	arsenite	PRMT5	PA452638	10419	0.615
NULL	Front_Oncol_2014_Nov_10_4_318.nxml.txt.nlp	25426449	SENT238	17	17	22	22	ethanol	PTEN	PA448073	5728	0.615
NULL	Biologics_2014_Dec_4_8_281-291.nxml.txt.nlp	25506209	SENT44	5	5	7	7	iodine	RAI	PA450049	10848;6050	0.615
NULL	Biologics_2013_Apr_15_7_77-90.nxml.txt.nlp	23723688	SENT161	3	3	7	7	cetuximab	CRT	PA10040	811	0.615
NULL	J_Cancer_2013_Sep_27_4(8)_662-670.nxml.txt.nlp	24155778	SENT44	8	8	6	6	cisplatin	UCHL1	PA449014	7345	0.615
NULL	ScientificWorldJournal_2013_Apr_3_2013_460215.nxml.txt.nlp	23690744	SENT139	16	16	22	22	hydroquinone	CYP2E1	PA449924	1571	0.615
NULL	Curr_Genomics_2014_Jun_15(3)_217-230.nxml.txt.nlp	24955029	SENT348	18	18	14	14	oxygen	ROS	PA450744	6098	0.615
NULL	J_Korean_Med_Sci_2010_Apr_19_25(4)_557-563.nxml.txt.nlp	20357998	SENT140	15	15	12	12	rosiglitazone	IL-10	PA451283	3586	0.615
NULL	Support_Care_Cancer_2012_Jul_27_20(7)_1353-1360.nxml.txt.nlp	22539050	SENT261	16	16	32	32	denosumab	NNT	PA166048634	23530	0.615
NULL	J_Infect_2013_Jan_66(1)_75-79.nxml.txt.nlp	23046967	SENT88	14	14	17	17	fluconazole	CD4	PA449653	920	0.615
NULL	Biomed_Res_Int_2013_Dec_11_2013_167954.nxml.txt.nlp	24392447	SENT16	0	0	2	2	ethambutol	EMB	PA164784021	133418	0.615
NULL	Eur_J_Clin_Pharmacol_2012_Jan_8_68(1)_29-37.nxml.txt.nlp	21739267	SENT101	5	5	9	9	aripiprazole	CYP2D6	PA10026	1565	0.615
NULL	Oncogene_2013_Sep_26_32(39)_10_1038_onc_2012_491.nxml.txt.nlp	23108394	SENT52	27	27	17	17	epirubicin	FOXM1	PA449476	2305	0.615
NULL	Exp_Ther_Med_2013_Jun_9_5(6)_1770-1774.nxml.txt.nlp	23837071	SENT26	7	7	21	21	coumarin	Mcl-1	PA134521193	4170	0.615
NULL	Eur_Respir_J_2014_Jul_23_44(1)_23-63.nxml.txt.nlp	24659544	SENT368	17	17	13	13	isoniazid	DST	PA450112	667	0.615
NULL	J_Anim_Sci_Biotechnol_2013_Jun_26_4(1)_23.nxml.txt.nlp	23800120	SENT120	16	16	23	23	estradiol	IFNG	PA449503	3458	0.615
NULL	Pharmaceuticals_(Basel)_2012_Mar_8_5(3)_297-316.nxml.txt.nlp	24281380	SENT511	14	14	0	0	coumarin	BACE1	PA134521193	23621	0.615
NULL	Crit_Care_2008_Jun_30_12(3)_158.nxml.txt.nlp	18620549	SENT10	0	0	8	8	heparin	PF4	PA449855	5196	0.615
NULL	J_Cell_Biol_2001_Mar_19_152(6)_1135-1144.nxml.txt.nlp	11257115	SENT166	9	9	14	14	lipase	DAG	PA450239	1605	0.615
NULL	Oncotarget_2011_Dec_24_2(12)_896-917.nxml.txt.nlp	22203527	SENT339	25	25	17	17	metformin	p27	PA450395	5715;10534	0.615
NULL	Crit_Care_2000_Mar_21_4(Suppl_1)_P27.nxml.txt.nlp	NULL	SENT5	15	15	42	42	thrombin	ATIII	PA451674	462	0.615
NULL	Int_J_Mol_Sci_2012_Sep_26_13(10)_12268-12286.nxml.txt.nlp	23202898	SENT856	27	27	21	21	heparin	BTC	PA449855	685	0.615
NULL	Acta_Histochem_Cytochem_2008_Feb_28_41(1)_1-5.nxml.txt.nlp	18320021	SENT81	14	14	31	31	colchicine	B10	PA449092	5169	0.615
NULL	Int_J_Surg_Oncol_2012_Dec_12_2012_417086.nxml.txt.nlp	23304478	SENT115	1	1	3	3	thyroglobulin	TGB	PA164754910	5473	0.615
NULL	J_Headache_Pain_2010_Feb_10_11(1)_5-12.nxml.txt.nlp	20012125	SENT50	9	9	13	13	sumatriptan	c-fos	PA451566	2353	0.615
NULL	J_Oncol_2009_Mar_24_2009_491985.nxml.txt.nlp	19325924	SENT94	12	12	7	7	genistein	CXCL12	PA165109660	6387	0.615
NULL	Eur_J_Clin_Pharmacol_2009_Sep_3_65(9)_957.nxml.txt.nlp	19415250	SENT2	9	9	11	11	pramipexole	PRX	PA164742949	9588;57716	0.615
NULL	J_Cell_Mol_Med_2014_May_14_18(5)_811-823.nxml.txt.nlp	24628949	SENT156	16	16	13	13	docetaxel	FOXM1	PA449383	2305	0.615
NULL	J_Oncol_2009_May_6_2009_567486.nxml.txt.nlp	19424511	SENT157	8	8	17	17	sunitinib	IFN	PA162372840	3439	0.615
NULL	Eur_J_Med_Res_2009_Jan_28_14(1)_1-6.nxml.txt.nlp	19258203	SENT64	1	1	3	3	vasopressin	AVP	PA451858	114548;551	0.615
NULL	J_Cell_Biol_2005_Jul_18_170(2)_305-316.nxml.txt.nlp	16009726	SENT399	21	21	12	12	heparin	B27	PA449855	56246	0.615
NULL	J_Cell_Biol_1999_Feb_22_144(4)_789-801.nxml.txt.nlp	10037799	SENT343	15	15	11	11	hyaluronan	CD44	PA165958431	960	0.615
NULL	Mol_Cancer_2014_Jan_15_13_9.nxml.txt.nlp	24428911	SENT118	6	6	16	16	gefitinib	EGFR	PA131301952	1956	0.615
NULL	J_Exp_Med_2000_Mar_6_191(5)_859-870.nxml.txt.nlp	10704466	SENT165	20	20	12	12	arsenite	p38	PA452638	10598;1432;7965	0.615
NULL	Cancer_Med_2014_Oct_25_3(5)_1099-1111.nxml.txt.nlp	24961511	SENT337	19	19	8	8	cisplatin	DUSP1	PA449014	1843;11266	0.615
NULL	Arch_Sex_Behav_2011_Apr_28_40(2)_273-279.nxml.txt.nlp	19330436	SENT187	3	3	17	17	methamphetamine	San	PA450403	80218	0.615
NULL	EMBO_Mol_Med_2013_Dec_8_5(12)_1821-1834.nxml.txt.nlp	24293316	SENT175	1	1	7	7	doxorubicin	p53	PA449412	7157	0.615
NULL	Curr_Neuropharmacol_2008_Dec_6(4)_311-321.nxml.txt.nlp	19587852	SENT95	10	10	19	19	propranolol	spatial	PA451145	219793	0.615
NULL	Diabetes_2013_Mar_14_62(3)_953-964.nxml.txt.nlp	23223176	SENT101	30	30	24	24	glucose	ROS	PA449773	6098	0.615
NULL	Brain_Sci_2014_May_6_4(2)_356-375.nxml.txt.nlp	24961766	SENT138	14	14	30	30	propofol	P28	PA451141	9446;7802;9527	0.615
NULL	Mol_Cancer_2009_Jul_30_8_52.nxml.txt.nlp	19642973	SENT42	13	13	29	29	diazepam	TRC8	PA449283	11236	0.615
NULL	Ann_Pediatr_Cardiol_2009_Jan-Jun_2(1)_65-73.nxml.txt.nlp	20300273	SENT71	3	3	17	17	vasopressin	GMP	PA451858	22978	0.615
NULL	ScientificWorldJournal_2012_Aug_1_2012_625867.nxml.txt.nlp	22919343	SENT92	7	7	9	9	fluorescein	CLE	PA164746009	51637	0.615
NULL	Front_Oncol_2014_Mar_3_4_41.nxml.txt.nlp	24624364	SENT601	47	47	38	38	curcumin	ABCC1	PA151958596	4363	0.615
NULL	Clin_Med_Insights_Oncol_2013_Aug_21_7_221-234.nxml.txt.nlp	24179413	SENT198	24	24	14	14	bevacizumab	VEGF-A	PA130232992	7422	0.615
NULL	Harm_Reduct_J_2010_Dec_1_7_29.nxml.txt.nlp	21122129	SENT3	14	14	10	10	buprenorphine	OST	PA448685	1650;23263	0.615
NULL	J_Hematol_Oncol_2013_Jul_10_6_50.nxml.txt.nlp	23841999	SENT142	30	30	32	32	erlotinib	EGFR	PA134687924	1956	0.615
NULL	Chiropr_Osteopat_2006_Oct_18_14_25.nxml.txt.nlp	17044942	SENT34	9	9	6	6	vasopressin	AVP	PA451858	114548;551	0.615
NULL	Oncoscience_2014_Mar_16_1(2)_132-157.nxml.txt.nlp	25594007	SENT31	0	0	3	3	cetuximab	EGFR	PA10040	1956	0.615
NULL	Breast_Cancer_Res_2003_Jul_28_5(5)_228-231.nxml.txt.nlp	12927029	SENT18	27	27	4	4	anastrozole	ATAC	PA448432	6375	0.615
NULL	Blood_Res_2014_Sep_25_49(3)_162-169.nxml.txt.nlp	25325035	SENT143	5	5	14	14	rituximab	CD16	PA451261	2215;2214	0.615
NULL	Mol_Clin_Oncol_2013_Sep_24_1(5)_918-924.nxml.txt.nlp	24649271	SENT92	9	9	18	18	cetuximab	EGFR	PA10040	1956	0.615
NULL	Allergy_Asthma_Immunol_Res_2014_Nov_19_6(6)_548-557.nxml.txt.nlp	25374755	SENT203	0	0	9	9	lovastatin	IL-4	PA450272	3565	0.615
NULL	Indian_J_Endocrinol_Metab_2015_Jan-Feb_19(1)_30-38.nxml.txt.nlp	25593823	SENT103	37	37	34	34	sitagliptin	adiponectin	PA164748978	9370	0.615
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT86	11	11	17	17	methotrexate	MSH2	PA450428	4436	0.615
NULL	Oncoimmunology_2013_Sep_1_2(9)_e25789.nxml.txt.nlp	24244905	SENT25	8	8	26	26	cyclophosphamide	CD69	PA449165	969	0.615
NULL	Ecancermedicalscience_2010_Nov_3_4_178.nxml.txt.nlp	22276032	SENT201	3	3	11	11	gefitinib	HER2	PA131301952	2064	0.615
NULL	J_Immunol_Res_2014_May_21_2014_371087.nxml.txt.nlp	24963497	SENT327	21	21	17	17	decitabine	DAC	PA164749631	13	0.615
NULL	Gene_Ther_2010_Jul_27_17(7)_922-929.nxml.txt.nlp	20508601	SENT41	17	17	12	12	bevacizumab	VEGFR2	PA130232992	3791	0.615
NULL	Core_Evid_2007_Nov_30_2(2)_81-88.nxml.txt.nlp	21221177	SENT220	3	3	10	10	irinotecan	IFL	PA450085	3439	0.615
NULL	Clin_Ophthalmol_2014_Aug_18_8_1527-1534.nxml.txt.nlp	25170245	SENT142	18	18	7	7	travoprost	TIM	PA164781371	7984;8914	0.615
NULL	Infect_Dis_Ther_2013_Jun_30_2(1)_47-58.nxml.txt.nlp	25135823	SENT60	16	16	5	5	artemether	RDT	PA165111698	6598	0.615
NULL	Nat_Commun_2010_Nov_30_1_130.nxml.txt.nlp	21119643	SENT45	22	22	36	36	fenofibrate	PS1	PA449594	5663	0.615
NULL	Emerg_Infect_Dis_2011_Oct_17(10)_1917-1920.nxml.txt.nlp	22000371	SENT68	7	7	9	9	bacitracin	B10	PA448531	5169	0.615
NULL	New_Microbes_New_Infect_2014_May_4_2(3)_58-63.nxml.txt.nlp	25356345	SENT100	46	46	8	8	tigecycline	CTX	PA164746412	1593	0.615
NULL	Exp_Ther_Med_2013_Feb_7_5(2)_467-470.nxml.txt.nlp	23407763	SENT17	1	1	3	3	vasopressin	AVP	PA451858	114548;551	0.615
NULL	Front_Immunol_2013_Nov_8_4_363.nxml.txt.nlp	24265631	SENT255	11	11	26	26	dacarbazine	CXCL10	PA449197	3627	0.615
NULL	Acta_Histochem_Cytochem_2013_Dec_28_46(6)_187-197.nxml.txt.nlp	24610966	SENT5	31	31	20	20	pilocarpine	AQP5	PA450962	362	0.615
NULL	J_Cell_Mol_Med_2014_Nov_11_18(11)_2275-2286.nxml.txt.nlp	25208472	SENT228	3	3	10	10	cisplatin	p53	PA449014	7157	0.615
NULL	Br_J_Cancer_2011_Aug_23_105(5)_649-657.nxml.txt.nlp	21811251	SENT7	22	22	25	25	gefitinib	IGF1R	PA131301952	3480	0.615
NULL	Biosci_Rep_2014_Jan_31_34(1)_e00092.nxml.txt.nlp	24393046	SENT50	21	21	36	36	l-glutamine	CO2	PA10090	4513	0.615
NULL	Reprod_Biol_Endocrinol_2013_May_10_11_36.nxml.txt.nlp	23663257	SENT31	43	43	27	27	estradiol	ghrelin	PA449503	51738	0.615
NULL	Clin_Dev_Immunol_2007_Jan_20_2007_76396.nxml.txt.nlp	18317531	SENT129	14	14	2	2	sertraline	IL-4	PA451333	3565	0.615
NULL	Int_J_Mol_Sci_2014_Nov_7_15(11)_20500-20517.nxml.txt.nlp	25387078	SENT127	5	5	9	9	sorafenib	Mcl-1	PA7000	4170	0.615
NULL	Hum_Mol_Genet_2013_Jul_1_22(13)_2705-2722.nxml.txt.nlp	23492669	SENT202	37	37	6	6	galactose	SLC5A1	PA449725	6523	0.615
NULL	Diabetes_2009_Jun_31_58(6)_1434-1439.nxml.txt.nlp	19336679	SENT151	41	41	38	38	metformin	SLC22A1	PA450395	6580	0.615
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1437-1448.nxml.txt.nlp	24056706	SENT111	22	22	12	12	quinidine	CYP1A2	PA451209	1544	0.615
NULL	Ann_Clin_Microbiol_Antimicrob_2005_Jan_7_4_2.nxml.txt.nlp	15638934	SENT35	0	0	2	2	vancomycin	VAN	PA451850	10318	0.615
NULL	BMJ_Open_2014_Feb_27_4(2)_e004071.nxml.txt.nlp	24578536	SENT90	37	37	8	8	warfarin	TTR	PA451906	7276	0.615
NULL	Cell_Death_Dis_2014_Apr_17_5(4)_e1188.nxml.txt.nlp	24743743	SENT79	19	19	8	8	dantrolene	IRE1	PA449208	2081	0.615
NULL	Biochemistry_2009_Jun_9_48(22)_4871-4880.nxml.txt.nlp	19364131	SENT128	22	22	32	32	papain	p54	PA450778	9295	0.615
NULL	Mol_Cells_2014_May_22_37(5)_426-434.nxml.txt.nlp	24850148	SENT165	29	29	19	19	tamoxifen	TRAIL	PA451581	8743	0.615
NULL	Mol_Med_Rep_2014_Nov_5_10(5)_2334-2340.nxml.txt.nlp	25189202	SENT162	14	14	12	12	cefoperazone	CFP	PA448849	5199	0.615
NULL	Brain_Sci_2013_Jun_14_3(2)_941-963.nxml.txt.nlp	24961432	SENT34	4	4	22	22	ethanol	CA4	PA448073	762	0.615
NULL	J_Gen_Physiol_1979_Aug_1_74(2)_237-259.nxml.txt.nlp	314969	SENT0	12	12	1	1	taurine	Gen	PA451590	348654	0.615
NULL	J_Gastroenterol_2013_Feb_22_48(2)_222-237.nxml.txt.nlp	22722906	SENT232	6	6	12	12	ethanol	JNK	PA448073	5599	0.615
NULL	Behav_Neurol_2014_Nov_16_2014_360978.nxml.txt.nlp	25477708	SENT99	7	7	19	19	nicotine	P56	PA450626	8999	0.615
NULL	Arthritis_Res_Ther_2012_Jun_25_14(3)_215.nxml.txt.nlp	22731694	SENT99	12	12	10	10	ribavirin	RIBA	PA451241	6014	0.615
NULL	Arch_Med_Sci_2013_Aug_30_9(4)_739-744.nxml.txt.nlp	24049538	SENT9	18	18	28	28	candesartan	PC-3	PA448765	692094	0.615
NULL	Genome_Biol_2004_Apr_27_5(5)_R34.nxml.txt.nlp	15128448	SENT121	10	10	13	13	urokinase	PLAUR	PA451836	5329	0.615
NULL	JAKSTAT_2012_Oct_1_1(4)_292-299.nxml.txt.nlp	24058786	SENT190	24	24	5	5	paclitaxel	STAT3	PA450761	6774	0.615
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2013_Sep_1_6_25-37.nxml.txt.nlp	24031162	SENT226	12	12	6	6	pioglitazone	Met	PA450970	79811	0.615
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Nov_21_65(Pt_12)_o3125.nxml.txt.nlp	21578848	SENT59	4	4	7	7	isoniazid	mol	PA450112	90527	0.615
NULL	Comp_Hepatol_2004_Jan_14_3(Suppl_1)_S31.nxml.txt.nlp	14960183	SENT35	6	6	16	16	ethanol	TNF-alpha	PA448073	7124	0.615
NULL	Arthritis_Res_Ther_2009_Jul_23_11(4)_236.nxml.txt.nlp	19664185	SENT69	25	25	2	2	probenecid	URAT1	PA451106	116085	0.614
NULL	Croat_Med_J_2013_Apr_54(2)_171-179.nxml.txt.nlp	23630144	SENT70	10	10	8	8	taurine	STZ	PA451590	6484	0.614
NULL	Acta_Pharmacol_Sin_2009_Sep_24_30(9)_1262-1275.nxml.txt.nlp	19701231	SENT226	20	20	23	23	lovastatin	MOSPD1	PA450272	56180	0.614
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT312	4	4	12	12	quetiapine	PRL	PA451201	5617	0.614
NULL	Infect_Drug_Resist_2009_Apr_24_2_13-26.nxml.txt.nlp	21694884	SENT312	2	2	22	22	tenofovir	TDF	PA10204	6736	0.614
NULL	Drug_Des_Devel_Ther_2014_Dec_12_8_2517-2529.nxml.txt.nlp	25548514	SENT194	4	4	22	22	cisplatin	STAT3	PA449014	6774	0.614
NULL	Cell_Death_Dis_2010_Oct_21_1(10)_e86.nxml.txt.nlp	21368859	SENT102	35	35	33	33	doxorubicin	TRAIL	PA449412	8743	0.614
NULL	J_Med_Case_Reports_2008_May_29_2_181.nxml.txt.nlp	18510736	SENT49	11	11	6	6	chymotrypsin	CD68	PA448994	968	0.614
NULL	Neuro_Oncol_2010_Nov_20_12(11)_1167-1172.nxml.txt.nlp	20729242	SENT42	13	13	15	15	thalidomide	CRA	PA451644	51747;10903	0.614
NULL	J_Biol_Chem_2009_Oct_16_284(42)_28885-28895.nxml.txt.nlp	19687008	SENT136	23	23	8	8	simvastatin	PCSK9	PA451363	255738	0.614
NULL	J_Clin_Biochem_Nutr_2010_Mar_27_46(2)_126-134.nxml.txt.nlp	20216945	SENT68	16	16	7	7	taurine	NAC	PA451590	22861	0.614
NULL	Curr_Neuropharmacol_2014_Mar_12(2)_120-139.nxml.txt.nlp	24669207	SENT936	3	3	18	18	vasopressin	EPM	PA451858	2054	0.614
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Apr_29_67(Pt_5)_o1232.nxml.txt.nlp	21754528	SENT4	20	20	23	23	febuxostat	mol	PA165958521	90527	0.614
NULL	Int_J_Biomed_Sci_2014_Dec_10(4)_236-242.nxml.txt.nlp	25598753	SENT149	22	22	15	15	chlorpropamide	NUT	PA448966	256646	0.614
NULL	Int_J_Mol_Sci_2013_Apr_10_14(4)_7742-7756.nxml.txt.nlp	23574936	SENT159	4	4	14	14	paclitaxel	CERT	PA450761	10087	0.614
NULL	Emerg_Infect_Dis_2012_Mar_18(3)_515-516.nxml.txt.nlp	22377354	SENT33	6	6	0	0	cefoxitin	CTX	PA448856	1593	0.614
NULL	Mol_Med_Rep_2015_Jan_23_11(1)_151-158.nxml.txt.nlp	25352008	SENT268	20	20	7	7	resveratrol	PI3K		5290	0.614
NULL	Indian_J_Med_Res_2014_Apr_139(4)_572-578.nxml.txt.nlp	24927344	SENT21	23	23	9	9	warfarin	CYP4F2	PA451906	8529	0.614
NULL	Genome_Biol_2011_Sep_14_12(9)_228.nxml.txt.nlp	21920049	SENT135	9	9	0	0	lipase	ANGPTL3	PA450239	27329	0.614
NULL	Drug_Healthc_Patient_Saf_2013_Mar_28_5_79-99.nxml.txt.nlp	23569399	SENT327	11	11	7	7	imipenem	TMP	PA449968	2012	0.614
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT166	6	6	11	11	atorvastatin	TNF	PA448500	7124	0.614
NULL	Ital_J_Pediatr_2013_Dec_20_39_79.nxml.txt.nlp	24355069	SENT35	15	15	22	22	thyroglobulin	TPO	PA164754910	7066;7173	0.614
NULL	Osteoporos_Int_2010_Oct_18_21(10)_1657-1680.nxml.txt.nlp	20480148	SENT523	7	7	9	9	alendronate	PTH	PA448082	5741	0.614
NULL	Cell_Cycle_2013_Jul_1_12(13)_1987-1988.nxml.txt.nlp	23759579	SENT32	16	16	20	20	glucose	G6PD	PA449773	2539	0.614
NULL	J_Biomater_Appl_2015_Jan_29(6)_824-836.nxml.txt.nlp	25145989	SENT47	12	12	37	37	ethanol	CO2	PA448073	4513	0.614
NULL	Br_J_Cancer_2013_Sep_3_109(5)_1157-1164.nxml.txt.nlp	23942075	SENT152	37	37	33	33	trastuzumab	NAT	PA451743	6046	0.614
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Apr_30_65(Pt_5)_m595.nxml.txt.nlp	21583817	SENT56	40	40	36	36	ethanol	mol	PA448073	90527	0.614
NULL	Iran_J_Psychiatry_2012_Winter_7(1)_1-10.nxml.txt.nlp	23056111	SENT39	8	8	6	6	topiramate	BD1	PA451728	1672	0.614
NULL	Br_J_Pharmacol_2014_Apr_28_171(8)_1798-1817.nxml.txt.nlp	24116962	SENT37	9	9	24	24	nadh	Q10	PA164755085	27161	0.614
NULL	Br_J_Cancer_2011_Apr_12_104(8)_1256-1261.nxml.txt.nlp	21448165	SENT28	12	12	14	14	sorafenib	IL-2	PA7000	3558	0.614
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_21-38.nxml.txt.nlp	19305786	SENT321	7	7	3	3	menthol	TRPM8	PA164776605	79054	0.614
NULL	Exp_Ther_Med_2013_Feb_20_5(2)_443-447.nxml.txt.nlp	23407364	SENT168	11	11	9	9	cyclophosphamide	CTX	PA449165	1593	0.614
NULL	J_Adv_Pract_Oncol_2013_Jul_1_Jul-Aug_4(4)_263-268.nxml.txt.nlp	25032007	SENT124	13	13	30	30	tamoxifen	CYP2D6	PA451581	1565	0.614
NULL	J_Biol_Chem_2008_Nov_14_283(46)_31679-31689.nxml.txt.nlp	18755684	SENT29	24	24	18	18	iron	FTL	PA450087	2512	0.614
NULL	J_Hematol_Oncol_2013_Jul_1_6_44.nxml.txt.nlp	23816178	SENT80	32	32	10	10	vincristine	CHOP	PA451879	1649	0.614
NULL	Iran_J_Neurol_2013_12(3)_114-116.nxml.txt.nlp	24250917	SENT56	11	11	0	0	alteplase	C3a	PA164776730	718	0.614
NULL	Mol_Cancer_2010_Aug_20_9_220.nxml.txt.nlp	20727180	SENT12	20	20	16	16	curcumin	p53	PA151958596	7157	0.614
NULL	Pharmaceuticals_(Basel)_2011_May_31_4(6)_794-803.nxml.txt.nlp	NULL	SENT274	2	2	4	4	amiodarone	NIF	PA448383	6280	0.614
NULL	J_Invest_Dermatol_2014_Feb_10_134(2)_319-325.nxml.txt.nlp	24108405	SENT232	7	7	9	9	vemurafenib	VIII	PA165946873	1351	0.614
NULL	Ann_Rheum_Dis_2014_Jun_30_73(6)_990-999.nxml.txt.nlp	24482301	SENT83	41	41	39	39	ustekinumab	UST	PA166048654	10090	0.614
NULL	Curr_Neuropharmacol_2009_Jun_7(2)_83-95.nxml.txt.nlp	19949566	SENT515	6	6	32	32	felbamate	TGB	PA449590	5473	0.614
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Jul_3_6_81-91.nxml.txt.nlp	25114586	SENT169	32	32	17	17	urokinase	HER2	PA451836	2064	0.614
NULL	Nucleic_Acids_Res_2012_Jun_10_40(11)_4804-4815.nxml.txt.nlp	22328728	SENT285	20	20	7	7	hemin	SIRT1	PA449849	23411	0.614
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1150.nxml.txt.nlp	24675468	SENT14	10	10	7	7	metformin	adiponectin	PA450395	9370	0.614
NULL	BMB_Rep_2013_Mar_46(3)_157-162.nxml.txt.nlp	23527859	SENT110	42	42	34	34	galactose	mol	PA449725	90527	0.614
NULL	Mol_Cancer_2006_Oct_17_5_45.nxml.txt.nlp	17044934	SENT54	0	0	3	3	resveratrol	AKT		207	0.614
NULL	Diabetes_Obes_Metab_2011_Nov_13(11)_982-989.nxml.txt.nlp	21615670	SENT177	28	28	26	26	sitagliptin	GLP-1	PA164748978	100125288	0.614
NULL	Crit_Care_2010_Sep_1_14(Suppl_2)_P15.nxml.txt.nlp	NULL	SENT3	29	29	31	31	vasopressin	AVP	PA451858	114548;551	0.614
NULL	Gastric_Cancer_2014_Jan_12_17(4)_638-647.nxml.txt.nlp	24414131	SENT26	12	12	7	7	trastuzumab	HER2	PA451743	2064	0.614
NULL	Curr_Oncol_2006_Feb_13(1)_14-26.nxml.txt.nlp	17576437	SENT235	0	0	10	10	curcumin	MMP9	PA151958596	4318	0.614
NULL	EMBO_J_2008_Jan_23_27(2)_350-360.nxml.txt.nlp	18157088	SENT250	41	41	46	46	pamidronate	LTBR	PA450767	4055	0.614
NULL	Glycobiology_2012_Jan_26_22(1)_134-145.nxml.txt.nlp	21873605	SENT137	11	11	14	14	heparin	IL-8	PA449855	3576	0.614
NULL	Int_J_Mol_Sci_2014_Sep_5_15(9)_15754-15765.nxml.txt.nlp	25198898	SENT387	0	0	13	13	curcumin	PAK1	PA151958596	5585;5058	0.614
NULL	J_Inflamm_(Lond)_2006_May_4_3_8.nxml.txt.nlp	16674821	SENT151	10	10	12	12	pp2	SKI-1		8720	0.614
NULL	Nucleic_Acids_Res_2013_Dec_2_41(22)_10110-10123.nxml.txt.nlp	23999093	SENT56	11	11	13	13	topotecan	TPT	PA451729	23590;6469	0.614
NULL	J_Korean_Med_Sci_2010_May_16_25(5)_738-745.nxml.txt.nlp	20436711	SENT22	26	26	24	24	lamivudine	NUC	PA450163	4924	0.614
NULL	Evid_Based_Complement_Alternat_Med_2012_Aug_7_2012_863101.nxml.txt.nlp	21837249	SENT88	26	26	41	41	l-glutamine	CO2	PA10090	4513	0.614
NULL	Osteoporos_Int_2013_May_4_24(10)_2659-2670.nxml.txt.nlp	23644877	SENT225	18	18	32	32	metformin	AMPK	PA450395	5563	0.614
NULL	Soc_Cogn_Affect_Neurosci_2014_Apr_14_9(4)_436-444.nxml.txt.nlp	22977201	SENT183	8	8	16	16	chlorpromazine	SAPS	PA448964	8935	0.614
NULL	Cancers_(Basel)_2010_Aug_19_2(3)_1629-1641.nxml.txt.nlp	24281178	SENT119	4	4	29	29	gemcitabine	CD24	PA449748	100133941	0.614
NULL	Support_Care_Cancer_2012_Nov_2_20(11)_2661-2668.nxml.txt.nlp	22382588	SENT217	6	6	10	10	paclitaxel	castor	PA450761	54897	0.614
NULL	Int_J_Anal_Chem_2012_Mar_22_2012_592650.nxml.txt.nlp	22536244	SENT24	18	18	16	16	cyanocobalamin	B12	PA451892	7126;4709	0.614
NULL	Curr_Neuropharmacol_2008_Jun_6(2)_151-163.nxml.txt.nlp	19305794	SENT183	18	18	24	24	capsaicin	TRPV1	PA448776	7442	0.614
NULL	J_Breast_Cancer_2014_Mar_28_17(1)_61-68.nxml.txt.nlp	24744799	SENT166	14	14	12	12	gemcitabine	GEM	PA449748	2669	0.614
NULL	Neural_Plast_2014_May_12_2014_563160.nxml.txt.nlp	24900924	SENT259	12	12	5	5	curcumin	spatial	PA151958596	219793	0.614
NULL	Aging_(Albany_NY)_2010_Sep_18_2(9)_535-537.nxml.txt.nlp	20876940	SENT16	6	6	11	11	doxorubicin	TP53	PA449412	7157	0.614
NULL	Nucleic_Acids_Res_2013_Nov_16_41(20)_9349-9360.nxml.txt.nlp	23956219	SENT166	27	27	10	10	cisplatin	OB1	PA449014	84525	0.614
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT200	9	9	11	11	perifosine	TRAIL	PA165291471	8743	0.614
NULL	Ther_Clin_Risk_Manag_2006_Mar_2(1)_77-86.nxml.txt.nlp	18360583	SENT110	10	10	8	8	alendronate	PTH	PA448082	5741	0.614
NULL	J_Antimicrob_Chemother_2014_Nov_17_69(11)_2920-2927.nxml.txt.nlp	25038069	SENT139	2	2	12	12	gentamicin	FUS	PA449753	2521	0.614
NULL	Indian_J_Psychol_Med_2014_Jan-Mar_36(1)_33-39.nxml.txt.nlp	24701007	SENT89	16	16	19	19	olanzapine	FGA	PA450688	2243	0.614
NULL	Mol_Cancer_2009_Nov_19_8_108.nxml.txt.nlp	19925669	SENT133	13	13	6	6	doxorubicin	CTRL	PA449412	1506	0.614
NULL	Ann_Lab_Med_2014_Nov_28_34(6)_439-445.nxml.txt.nlp	25368819	SENT31	16	16	28	28	metronidazole	VAN	PA450484	10318	0.614
NULL	Arthritis_Res_Ther_2005_Dec_1_7(1)_R149-R155.nxml.txt.nlp	15642135	SENT27	22	22	11	11	infliximab	OPG	PA452639	690	0.614
NULL	Br_J_Haematol_2009_Nov_2_147(3)_396-410.nxml.txt.nlp	19758122	SENT26	6	6	4	4	chlorambucil	CLB	PA448926	171425	0.614
NULL	Oxid_Med_Cell_Longev_2013_Apr_21_2013_412576.nxml.txt.nlp	23710286	SENT102	0	0	2	2	curcumin	NRF2	PA151958596	2551;4780	0.614
NULL	Braz_J_Microbiol_2010_Jun_1_Apr-Jun_41(2)_452-460.nxml.txt.nlp	24031516	SENT121	0	0	27	27	tetracycline	STX	PA451640	8128	0.614
NULL	Arch_Med_Sci_2014_Aug_29_10(4)_684-691.nxml.txt.nlp	25276151	SENT112	17	17	26	26	dobutamine	CRT	PA449381	811	0.614
NULL	Sensors_(Basel)_2010_Mar_29_10(4)_2869-2884.nxml.txt.nlp	22319277	SENT427	5	5	2	2	spermine	SERS	PA164781199	6301;54938	0.614
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_28_2012_937605.nxml.txt.nlp	23304227	SENT104	4	4	9	9	resveratrol	GDNF		2668	0.614
NULL	Reprod_Biol_Endocrinol_2003_Oct_7_1_66.nxml.txt.nlp	14609433	SENT257	6	6	8	8	cisplatin	p53	PA449014	7157	0.614
NULL	Virol_J_2012_Aug_3_9_143.nxml.txt.nlp	22863531	SENT20	29	29	16	16	telaprevir	IFN	PA165958354	3439	0.614
NULL	Mar_Drugs_2014_Mar_24_12(3)_1641-1675.nxml.txt.nlp	24663117	SENT48	44	44	11	11	ethanol	CO2	PA448073	4513	0.614
NULL	Mol_Vis_2011_Jun_9_17_1564-1576.nxml.txt.nlp	21738386	SENT121	0	0	2	2	ethambutol	EMB	PA164784021	133418	0.614
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT271	30	30	19	19	phenprocoumon	EPHX1	PA450921	2052	0.614
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Aug_6_64(Pt_9)_o1707.nxml.txt.nlp	21201695	SENT74	21	21	11	11	ethanol	mol	PA448073	90527	0.614
NULL	Br_J_Cancer_2010_Sep_7_103(6)_765-771.nxml.txt.nlp	20700120	SENT149	23	23	5	5	tamoxifen	CYP2D6	PA451581	1565	0.614
NULL	Clin_Ophthalmol_2014_Feb_10_8_389-399.nxml.txt.nlp	24550667	SENT151	4	4	14	14	brinzolamide	TIM	PA164744929	7984;8914	0.614
NULL	Br_J_Cancer_2010_Jan_19_102(2)_456.nxml.txt.nlp	NULL	SENT1	11	11	7	7	paclitaxel	MAD2	PA450761	4085;4601	0.614
NULL	Acta_Pharmacol_Sin_2009_Dec_4_30(12)_1601-1606.nxml.txt.nlp	19960006	SENT5	12	12	17	17	suramin	DPI	PA10292	1832	0.614
NULL	Clin_Transl_Allergy_2014_Mar_14_4(Suppl_1)_O19.nxml.txt.nlp	NULL	SENT10	20	20	34	34	fluorescein	CD16	PA164746009	2215;2214	0.614
NULL	AAPS_J_2014_Jun_11_16(5)_1029-1037.nxml.txt.nlp	24917180	SENT190	13	13	38	38	quinidine	P-gp	PA451209	5243	0.614
NULL	J_Cancer_Epidemiol_2012_Apr_12_2012_529357.nxml.txt.nlp	22570656	SENT126	22	22	26	26	aprepitant	IMPACT	PA164747039	55364	0.614
NULL	Eur_J_Pediatr_2012_May_28_171(5)_833-841.nxml.txt.nlp	22203430	SENT199	32	32	39	39	palivizumab	AAP	PA164748781	5345	0.614
NULL	Iran_J_Pharm_Res_2014_Summer_13(3)_919-926.nxml.txt.nlp	25276192	SENT111	5	5	2	2	doxorubicin	p53	PA449412	7157	0.614
NULL	Indian_J_Endocrinol_Metab_2013_Nov-Dec_17(6)_1046-1052.nxml.txt.nlp	24381882	SENT55	20	20	22	22	cosyntropin	ACTH	PA164749052	5443	0.614
NULL	Br_J_Cancer_2009_Jul_21_101(2)_238-243.nxml.txt.nlp	19568242	SENT103	8	8	10	10	bevacizumab	IFN	PA130232992	3439	0.614
NULL	Biomed_Res_Int_2013_Dec_30_2013_735835.nxml.txt.nlp	24490170	SENT8	20	20	27	27	desloratadine	FEX	PA164776964	8549	0.614
NULL	Clin_Pediatr_Endocrinol_2005_Feb_14_14(1)_27-33.nxml.txt.nlp	24790307	SENT13	29	29	14	14	vasopressin	AVPR2	PA451858	554	0.614
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_11_2013_910451.nxml.txt.nlp	23840269	SENT273	11	11	8	8	gefitinib	EGFR	PA131301952	1956	0.614
NULL	Arq_Bras_Cardiol_2014_Nov_103(5)_403-409.nxml.txt.nlp	25229355	SENT26	0	0	30	30	sunitinib	GDNF	PA162372840	2668	0.614
NULL	Cancer_Cell_Int_2005_Aug_24_5_28.nxml.txt.nlp	16120219	SENT155	34	34	18	18	etoposide	p53	PA449552	7157	0.614
NULL	Angiogenesis_2010_Mar_11_13(1)_1-14.nxml.txt.nlp	20012482	SENT156	0	0	7	7	sorafenib	CYP3A4	PA7000	1576	0.614
NULL	Crit_Care_2011_Feb_10_15(1)_R58.nxml.txt.nlp	21310070	SENT85	11	11	26	26	filgrastim	GM-CSF	PA449626	1437	0.614
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Sep_26_68(Pt_10)_o3003.nxml.txt.nlp	23125775	SENT72	26	26	40	40	ethanol	mol	PA448073	90527	0.614
NULL	Viruses_2014_Apr_14_6(4)_1715-1758.nxml.txt.nlp	24736215	SENT2150	1	1	9	9	disulfiram	CD4	PA449376	920	0.614
NULL	Mol_Vis_2012_Oct_5_18_2454-2467.nxml.txt.nlp	23077404	SENT14	6	6	15	15	bevacizumab	HIF-1	PA130232992	29072	0.614
NULL	Behav_Sci_(Basel)_2012_Aug_30_2(3)_186-194.nxml.txt.nlp	25379220	SENT96	19	19	1	1	methamphetamine	San	PA450403	80218	0.614
NULL	Eur_J_Clin_Pharmacol_2011_May_8_67(5)_493-506.nxml.txt.nlp	21140139	SENT207	20	20	14	14	oxycodone	CYP3A4	PA450741	1576	0.614
NULL	BMB_Rep_2013_Sep_46(9)_429-438.nxml.txt.nlp	24064057	SENT1102	3	3	1	1	paclitaxel	SIRT6	PA450761	51548	0.614
NULL	J_Occup_Med_Toxicol_2008_Feb_27_3(Suppl_1)_S6.nxml.txt.nlp	18315837	SENT93	5	5	11	11	montelukast	IL-13	PA450546	3596	0.614
NULL	Br_J_Cancer_2012_Nov_20_107(11)_1844-1852.nxml.txt.nlp	23169337	SENT320	20	20	18	18	bortezomib	Brt	PA10252	7301	0.614
NULL	Environ_Health_Perspect_2008_Mar_3_116(3)_308-314.nxml.txt.nlp	18335096	SENT138	10	10	5	5	estradiol	aromatase	PA449503	1588	0.614
NULL	Anal_Chem_2014_Jan_7_86(1)_443-452.nxml.txt.nlp	24313826	SENT85	35	35	33	33	diazepam	COX5A	PA449283	9377	0.614
NULL	Br_J_Cancer_2012_Jul_24_107(3)_516-526.nxml.txt.nlp	22782351	SENT333	0	0	7	7	tamoxifen	TIGAR	PA451581	57103	0.614
NULL	An_Bras_Dermatol_2014_Mar-Apr_89(2)_301-310.nxml.txt.nlp	24770508	SENT109	30	30	38	38	cisplatin	IL-2	PA449014	3558	0.614
NULL	J_Gastroenterol_2013_Feb_23_48(12)_1373-1383.nxml.txt.nlp	23435670	SENT73	6	6	8	8	lamivudine	LAM	PA450163	7249;7248	0.614
NULL	Acta_Pharmacol_Sin_2010_Jul_28_31(7)_867-873.nxml.txt.nlp	20581857	SENT94	8	8	13	13	docetaxel	PC3	PA449383	57332;7832;5122	0.614
NULL	Crit_Care_2011_Aug_11_15(4)_R195.nxml.txt.nlp	21834973	SENT188	1	1	17	17	thrombin	PAR1	PA451674	79581;2149	0.614
NULL	Br_J_Pharmacol_2013_Jun_27_169(4)_736-747.nxml.txt.nlp	23489111	SENT111	5	5	10	10	granisetron	5-HT3A	PA449809	3359	0.614
NULL	Ann_Intensive_Care_2011_May_25_1_14.nxml.txt.nlp	21906345	SENT23	34	34	17	17	colistimethate	SAPS	PA164749509	8935	0.614
NULL	Oncol_Lett_2013_Mar_14_5(3)_756-760.nxml.txt.nlp	23426872	SENT9	20	20	17	17	cisplatin	AKT	PA449014	207	0.614
NULL	Nucleic_Acids_Res_2012_Jul_30_40(13)_6319-6337.nxml.txt.nlp	22467215	SENT416	33	33	2	2	trastuzumab	HER2	PA451743	2064	0.614
NULL	J_Cancer_Epidemiol_2012_Apr_12_2012_529357.nxml.txt.nlp	22570656	SENT4	44	44	13	13	aprepitant	HEC	PA164747039	10403	0.614
NULL	Virol_J_2010_Oct_27_7_285.nxml.txt.nlp	20979618	SENT21	18	18	7	7	isoproterenol	c-fos	PA450121	2353	0.614
NULL	Emerg_Infect_Dis_2012_Jun_18(6)_1019-1020.nxml.txt.nlp	22608263	SENT34	18	18	20	20	gentamicin	TOB	PA449753	10140	0.614
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT161	6	6	8	8	curcumin	TRAIL	PA151958596	8743	0.614
NULL	Int_J_Biol_Sci_2011_Nov_5_8(1)_1-14.nxml.txt.nlp	22211100	SENT131	0	0	6	6	evodiamine	Bcl-2	PA165860788	596	0.614
NULL	Eur_J_Med_Res_2010_Sep_24_15(9)_383-389.nxml.txt.nlp	20952347	SENT69	33	33	19	19	thrombin	ADP	PA451674	23038	0.614
NULL	Breast_Cancer_Res_2008_May_2_10(3)_R39.nxml.txt.nlp	18454852	SENT303	10	10	18	18	genistein	CYP1A1	PA165109660	1543	0.614
NULL	Int_J_Mol_Sci_2014_Oct_29_15(11)_19700-19728.nxml.txt.nlp	25356505	SENT244	6	6	11	11	thrombin	PAR1	PA451674	79581;2149	0.614
NULL	Oncotarget_2011_Nov_9_2(11)_850-861.nxml.txt.nlp	22081665	SENT161	22	22	11	11	idarubicin	FLT3	PA449961	2322	0.614
NULL	Acta_Neuropathol_Commun_2013_Jul_11_1_34.nxml.txt.nlp	24252661	SENT299	19	19	11	11	zolpidem	CA1	PA451976	759	0.614
NULL	Scientifica_(Cairo)_2012_Sep_3_2012_757890.nxml.txt.nlp	24278738	SENT125	7	7	32	32	curcumin	p38	PA151958596	10598;1432;7965	0.614
NULL	Int_J_Biomed_Sci_2014_Mar_10(1)_1-7.nxml.txt.nlp	24711742	SENT186	3	3	22	22	thrombin	PAR1	PA451674	79581;2149	0.614
NULL	Breast_Cancer_Res_Treat_2013_Jun_5_139(3)_649-655.nxml.txt.nlp	23736997	SENT188	3	3	18	18	tamoxifen	CYP3A	PA451581	1574	0.614
NULL	Clin_Interv_Aging_2010_Nov_19_5_345-354.nxml.txt.nlp	21228900	SENT121	9	9	19	19	denosumab	RANKL	PA166048634	8600	0.614
NULL	Br_J_Cancer_2010_Sep_7_103(6)_889-898.nxml.txt.nlp	20664599	SENT14	19	19	22	22	paclitaxel	HER-2	PA450761	2064	0.614
NULL	ScientificWorldJournal_2014_Jan_29_2014_265953.nxml.txt.nlp	24688374	SENT158	3	3	14	14	resveratrol	CMC1		152100	0.614
NULL	Oncotarget_2014_Aug_16_5(17)_7342-7356.nxml.txt.nlp	25277177	SENT186	28	28	22	22	gefitinib	IDH1	PA131301952	3417	0.614
NULL	Evid_Based_Complement_Alternat_Med_2014_May_8_2014_364819.nxml.txt.nlp	24899907	SENT181	20	20	16	16	tacrolimus	FKBP52	PA451578	2288	0.614
NULL	Front_Behav_Neurosci_2011_Sep_13_5_57.nxml.txt.nlp	21949506	SENT1738	4	4	6	6	donepezil	spatial	PA449394	219793	0.614
NULL	Clin_Exp_Otorhinolaryngol_2008_Jun_20_1(2)_110-112.nxml.txt.nlp	19434282	SENT48	25	25	27	27	vasopressin	AVP	PA451858	114548;551	0.614
NULL	Arthritis_Res_Ther_2008_Mar_6_10(2)_R29.nxml.txt.nlp	18321389	SENT276	17	17	25	25	hydroxychloroquine	IFN	PA164777036	3439	0.614
NULL	Scientifica_(Cairo)_2013_Jan_17_2013_795964.nxml.txt.nlp	24278786	SENT189	44	44	42	42	lipase	SDP1	PA450239	51429;51282	0.614
NULL	Osong_Public_Health_Res_Perspect_2014_Dec_13_5(6)_333-338.nxml.txt.nlp	25562041	SENT207	10	10	8	8	cefotaxime	CTX	PA448852	1593	0.614
NULL	Case_Rep_Hematol_2013_Jun_11_2013_680459.nxml.txt.nlp	23840983	SENT12	13	13	40	40	cyanocobalamin	B12	PA451892	7126;4709	0.614
NULL	Front_Genet_2012_May_16_3_77.nxml.txt.nlp	22623924	SENT36	0	0	17	17	ethanol	ABCG2	PA448073	9429	0.614
NULL	AIDS_Res_Treat_2011_Jun_7_2011_354908.nxml.txt.nlp	21716719	SENT221	6	6	14	14	tenofovir	OAT1	PA10204	9356	0.614
NULL	Cell_Cycle_2012_Nov_1_11(21)_3983-3996.nxml.txt.nlp	22987153	SENT233	11	11	2	2	cisplatin	DNA2	PA449014	1763	0.614
NULL	Front_Oncol_2014_Jun_23_4_162.nxml.txt.nlp	25003082	SENT46	32	32	25	25	estradiol	AKR1C3	PA449503	8644	0.614
NULL	Brain_Sci_2014_May_6_4(2)_356-375.nxml.txt.nlp	24961766	SENT224	33	33	40	40	propofol	P28	PA451141	9446;7802;9527	0.614
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Jun_25_3(6)_e120.nxml.txt.nlp	24964282	SENT19	28	28	32	32	carbamazepine	CYP3A4	PA448785	1576	0.614
NULL	Arch_Med_Sci_2014_Feb_24_10(1)_1-9.nxml.txt.nlp	24701207	SENT20	29	29	15	15	panitumumab	EGFR	PA162373091	1956	0.614
NULL	Breast_Cancer_Res_2011_Jan_24_13(1)_401.nxml.txt.nlp	21349137	SENT39	3	3	20	20	lapatinib	HER2	PA152241907	2064	0.614
NULL	Cell_Death_Dis_2014_Jan_30_5(1)_e1038.nxml.txt.nlp	24481452	SENT229	3	3	8	8	raloxifene	CYP1A1	PA451221	1543	0.614
NULL	Biomed_Res_Int_2014_Mar_6_2014_712893.nxml.txt.nlp	24734240	SENT9	0	0	2	2	ethanol	HIF-1alpha	PA448073	3091	0.614
NULL	Pharmaceuticals_(Basel)_2012_Sep_4_5(9)_899-924.nxml.txt.nlp	24280697	SENT131	14	14	21	21	raloxifene	LAS	PA451221	11019	0.614
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1013.nxml.txt.nlp	24457957	SENT79	17	17	28	28	orlistat	NOXA	PA164776864	5366	0.614
NULL	Crit_Care_2009_Jul_10_13(4)_R113.nxml.txt.nlp	19591694	SENT115	1	1	3	3	vasopressin	AVP	PA451858	114548;551	0.614
NULL	Brain_Behav_2012_Mar_2(2)_155-177.nxml.txt.nlp	22574283	SENT8	21	21	15	15	lipase	IL-10	PA450239	3586	0.614
NULL	Oxid_Med_Cell_Longev_2013_Jun_2_2013_793525.nxml.txt.nlp	23819014	SENT104	25	25	9	9	resveratrol	SGBS		2719	0.614
NULL	Br_J_Cancer_2011_Apr_12_104(8)_1256-1261.nxml.txt.nlp	21448165	SENT138	11	11	13	13	sorafenib	IL-2	PA7000	3558	0.614
NULL	Ecancermedicalscience_2008_May_2_2_64.nxml.txt.nlp	22275961	SENT486	3	3	11	11	gefitinib	HER2	PA131301952	2064	0.613
NULL	J_Geriatr_Cardiol_2014_Sep_11(3)_253-258.nxml.txt.nlp	25278975	SENT107	19	19	5	5	creatine	ghrelin	PA164778930	51738	0.613
NULL	Nucleic_Acids_Res_2011_Mar_4_39(5)_1843-1854.nxml.txt.nlp	21051342	SENT9	29	29	20	20	carbenicillin	IFN	PA448788	3439	0.613
NULL	Front_Oncol_2013_Sep_23_3_250.nxml.txt.nlp	24069582	SENT142	4	4	2	2	trastuzumab	HER2	PA451743	2064	0.613
NULL	Nat_Neurosci_2012_Sep_5_15(9)_1245-1254.nxml.txt.nlp	22864611	SENT104	3	3	6	6	clozapine	HDAC2	PA449061	3066	0.613
NULL	Clin_Interv_Aging_2010_Feb_2_5_19-29.nxml.txt.nlp	20169039	SENT145	35	35	4	4	raloxifene	LAS	PA451221	11019	0.613
NULL	Iran_J_Basic_Med_Sci_2012_May-Jun_15(3)_795-802.nxml.txt.nlp	23493622	SENT127	8	8	11	11	capsaicin	EPM	PA448776	2054	0.613
NULL	Indian_J_Pharmacol_2014_Nov-Dec_46(6)_627-632.nxml.txt.nlp	25538335	SENT132	14	14	7	7	metformin	Q10	PA450395	27161	0.613
NULL	Cancer_Cell_Int_2005_Oct_4_5_30.nxml.txt.nlp	16202168	SENT27	29	29	33	33	mitoxantrone	MXR	PA450526	9429	0.613
NULL	Indian_J_Nephrol_2013_Mar-Apr_23(2)_143-145.nxml.txt.nlp	23716924	SENT70	10	10	8	8	ribavirin	IFN	PA451241	3439	0.613
NULL	Adv_Hematol_2012_May_28_2012_945138.nxml.txt.nlp	22693514	SENT32	4	4	7	7	rituximab	CHOP	PA451261	1649	0.613
NULL	J_Gen_Physiol_1941_Sep_20_25(1)_53-73.nxml.txt.nlp	19873258	SENT0	21	21	1	1	trypsin	Gen	PA451806	348654	0.613
NULL	Exp_Neurobiol_2013_Sep_30_22(3)_200-207.nxml.txt.nlp	24167414	SENT195	0	0	2	2	ciclopirox	CPX	PA164747060	1371;10682;1377	0.613
NULL	J_Med_Case_Reports_2011_Feb_21_5_71.nxml.txt.nlp	21338490	SENT96	6	6	23	23	pamidronate	IFN	PA450767	3439	0.613
NULL	Semin_Immunol_2014_Aug_26(4)_329-340.nxml.txt.nlp	25028340	SENT489	9	9	4	4	dextran	IL-25	PA449261	64806;56005	0.613
NULL	Front_Oncol_2012_Sep_12_2_114.nxml.txt.nlp	22988546	SENT59	46	46	9	9	etoposide	CTX	PA449552	1593	0.613
NULL	J_Cell_Biol_2001_Oct_29_155(3)_447-458.nxml.txt.nlp	11684709	SENT79	15	15	13	13	pp2	PP1		5540;5464	0.613
NULL	Braz_J_Med_Biol_Res_2013_May_10_46(5)_433-439.nxml.txt.nlp	23681290	SENT151	18	18	14	14	bezafibrate	BAFF	PA162364313	10673	0.613
NULL	Int_J_Mol_Imaging_2011_Oct_26_2011_874585.nxml.txt.nlp	21490735	SENT15	23	23	11	11	docetaxel	FDG	PA449383	23583	0.613
NULL	J_Int_Soc_Prev_Community_Dent_2014_Nov_4(Suppl_1)_S68-S71.nxml.txt.nlp	25452932	SENT110	14	14	12	12	cyclophosphamide	CHOP	PA449165	1649	0.613
NULL	Tanaffos_2013_12(1)_6-15.nxml.txt.nlp	25191444	SENT60	7	7	17	17	ethambutol	PTH	PA164784021	5741	0.613
NULL	Br_J_Pharmacol_2012_Oct_167(3)_505-514.nxml.txt.nlp	22506619	SENT248	14	14	37	37	indomethacin	COX	PA449982	1351	0.613
NULL	Breast_Cancer_Res_2010_May_18_12(Suppl_1)_O5.nxml.txt.nlp	NULL	SENT9	0	0	22	22	vorinostat	CD24	PA164748224	100133941	0.613
NULL	Indian_J_Med_Paediatr_Oncol_2013_Apr-Jun_34(2)_136-137.nxml.txt.nlp	24049309	SENT8	9	9	7	7	cyclophosphamide	CHOP	PA449165	1649	0.613
NULL	Biomed_Res_Int_2013_Dec_11_2013_167954.nxml.txt.nlp	24392447	SENT3	0	0	2	2	ethambutol	EMB	PA164784021	133418	0.613
NULL	Cell_Cycle_2012_Nov_1_11(21)_3983-3996.nxml.txt.nlp	22987153	SENT213	4	4	14	14	cisplatin	DNA2	PA449014	1763	0.613
NULL	J_Biol_Chem_2009_Apr_3_284(14)_9558-9565.nxml.txt.nlp	19202191	SENT152	10	10	18	18	camptothecin	CtIP	PA153590860	5932	0.613
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_24_2012_408187.nxml.txt.nlp	23193421	SENT27	3	3	5	5	vasopressin	AVP	PA451858	114548;551	0.613
NULL	Environ_Health_Perspect_2006_Jun_2_114(6)_898-904.nxml.txt.nlp	16759992	SENT13	10	10	12	12	diethylstilbestrol	DES	PA449307	1674	0.613
NULL	Mol_Cell_Proteomics_2014_Jan_18_13(1)_145-156.nxml.txt.nlp	24142993	SENT55	11	11	18	18	trastuzumab	San	PA451743	80218	0.613
NULL	Diabetes_2011_Nov_17_60(11)_2691-2700.nxml.txt.nlp	21896928	SENT13	13	13	9	9	resveratrol	AMPK		5563	0.613
NULL	Int_J_Nephrol_2011_Jun_16_2011_436856.nxml.txt.nlp	21716699	SENT3	0	0	2	2	vancomycin	VAN	PA451850	10318	0.613
NULL	Exp_Diabetes_Res_2011_Apr_26_2011_215764.nxml.txt.nlp	21584276	SENT146	8	8	4	4	exenatide	Yes	PA164749238	7525	0.613
NULL	Cell_Death_Dis_2014_Apr_24_5(4)_e1193.nxml.txt.nlp	24763050	SENT320	12	12	18	18	chloroquine	p62	PA448948	8878;10657;23636	0.613
NULL	J_Vet_Med_Sci_2014_Jan_4_76(1)_113-117.nxml.txt.nlp	24004933	SENT77	38	38	29	29	sevoflurane	CO2	PA451341	4513	0.613
NULL	J_Korean_Med_Sci_2007_Sep_30_22(Suppl)_S98-S103.nxml.txt.nlp	17923763	SENT107	14	14	20	20	cetuximab	EGFR	PA10040	1956	0.613
NULL	Acta_Pharmacol_Sin_2014_Oct_15_35(10)_1302-1310.nxml.txt.nlp	25220642	SENT37	0	0	2	2	cyclophosphamide	CTX	PA449165	1593	0.613
NULL	J_Cell_Biol_2000_Jul_10_150(1)_155-164.nxml.txt.nlp	10893264	SENT182	4	4	2	2	choline	CDP	PA448976	1523	0.613
NULL	Anc_Sci_Life_2012_Oct-Dec_32(2)_93-98.nxml.txt.nlp	24167334	SENT16	10	10	18	18	cyclophosphamide	ANOVA	PA449165	4858	0.613
NULL	Br_J_Cancer_2009_Jun_2_100(11)_1704-1719.nxml.txt.nlp	19436303	SENT343	2	2	17	17	leucovorin	IFL	PA450198	3439	0.613
NULL	Environ_Health_Perspect_2000_Aug_108(8)_769-776.nxml.txt.nlp	10964798	SENT5	7	7	28	28	lindane	StAR	PA164754914	6770	0.613
NULL	Mol_Cancer_2006_Oct_17_5_45.nxml.txt.nlp	17044934	SENT86	3	3	14	14	resveratrol	COX		1351	0.613
NULL	Ann_Oncol_2014_Sep_13_25(9)_1813-1820.nxml.txt.nlp	24928832	SENT132	8	8	24	24	cetuximab	p16	PA10040	1029	0.613
NULL	Br_J_Cancer_2014_Dec_9_111(12)_2379-2380.nxml.txt.nlp	24619075	SENT10	23	23	19	19	irinotecan	BRAF	PA450085	673	0.613
NULL	Breast_Cancer_Res_2004_Nov_7_6(1)_39-52.nxml.txt.nlp	14680484	SENT90	13	13	9	9	raloxifene	DES	PA451221	1674	0.613
NULL	J_Cancer_Prev_2014_Mar_19(1)_39-46.nxml.txt.nlp	25337571	SENT19	35	35	17	17	ethanol	c-Jun	PA448073	3725	0.613
NULL	Int_J_Med_Chem_2012_Dec_13_2012_530392.nxml.txt.nlp	25379286	SENT301	27	27	20	20	ethanol	mol	PA448073	90527	0.613
NULL	Mol_Cell_2014_May_8_54(3)_445-459.nxml.txt.nlp	24746700	SENT39	13	13	25	25	etoposide	BCLAF1	PA449552	9774	0.613
NULL	Br_J_Cancer_2009_Sep_15_101(6)_957-966.nxml.txt.nlp	19738618	SENT251	22	22	16	16	dexrazoxane	THBS-1	PA449259	7057	0.613
NULL	Indian_J_Nucl_Med_2013_Dec_28(Suppl_1)_S16-S20.nxml.txt.nlp	NULL	SENT161	8	8	4	4	curcumin	gamma	PA151958596	9913	0.613
NULL	Crit_Care_2014_Mar_17_18(Suppl_1)_P383.nxml.txt.nlp	NULL	SENT18	0	0	12	12	resveratrol	survivin		332	0.613
NULL	Drugs_R_D_2014_Jun_6_14(2)_113-123.nxml.txt.nlp	24797400	SENT28	8	8	16	16	amiodarone	ABCB1	PA448383	5243	0.613
NULL	Int_J_Fertil_Steril_2011_Dec_22_Oct-Dec_5(3)_142-147.nxml.txt.nlp	25101157	SENT14	27	27	35	35	collagenase	F12	PA449107	2161	0.613
NULL	Antimicrob_Agents_Chemother_2013_Oct_57(10)_4872-4876.nxml.txt.nlp	23877700	SENT38	3	3	21	21	metronidazole	San	PA450484	80218	0.613
NULL	Pain_Res_Treat_2011_Jun_15_2011_738645.nxml.txt.nlp	22110931	SENT278	20	20	17	17	bumetanide	NKCC1	PA448682	6558	0.613
NULL	Braz_J_Med_Biol_Res_2012_Sep_21_45(12)_1240-1243.nxml.txt.nlp	22983178	SENT36	30	30	17	17	diclofenac	CB2	PA449293	1269	0.613
NULL	Br_J_Haematol_2014_Jan_28_164(2)_233-244.nxml.txt.nlp	24206017	SENT176	20	20	4	4	thalidomide	DDB1	PA451644	1642	0.613
NULL	Cancer_Immunol_Immunother_2012_Jul_23_61(7)_1101-1111.nxml.txt.nlp	22193989	SENT168	26	26	28	28	oxaliplatin	IL-4	PA131285527	3565	0.613
NULL	Exp_Ther_Med_2014_May_20_7(5)_1354-1358.nxml.txt.nlp	24940438	SENT29	6	6	27	27	dextran	CD40	PA449261	958	0.613
NULL	Front_Cell_Neurosci_2014_Jan_30_8_14.nxml.txt.nlp	24523673	SENT80	10	10	18	18	isoflurane	CO2	PA450106	4513	0.613
NULL	Glycobiology_2009_Nov_14_19(11)_1155-1162.nxml.txt.nlp	19528664	SENT104	26	26	22	22	galactose	DC-SIGN	PA449725	30835	0.613
NULL	ScientificWorldJournal_2012_Mar_12_2012_793823.nxml.txt.nlp	22500143	SENT332	29	29	8	8	lipase	ADD1	PA450239	118	0.613
NULL	Int_J_Nanomedicine_2009_Apr_1_4_27-35.nxml.txt.nlp	19421368	SENT130	20	20	29	29	genistein	IL-10	PA165109660	3586	0.613
NULL	J_Vet_Med_Sci_2014_Jan_10_76(1)_51-56.nxml.txt.nlp	24025432	SENT11	34	34	6	6	etoposide	XRCC6	PA449552	2547	0.613
NULL	Chin_J_Cancer_2011_Jan_30(1)_41-53.nxml.txt.nlp	21192843	SENT17	0	0	2	2	cisplatin	DDP	PA449014	1678	0.613
NULL	Br_J_Cancer_2009_Sep_15_101(6)_957-966.nxml.txt.nlp	19738618	SENT245	18	18	12	12	dexrazoxane	THBS-1	PA449259	7057	0.613
NULL	Br_J_Cancer_2006_Feb_13_94(3)_407-426.nxml.txt.nlp	16434996	SENT121	19	19	31	31	genistein	BRCA2	PA165109660	675	0.613
NULL	Diabetes_2008_Sep_57(9)_2272-2279.nxml.txt.nlp	18519799	SENT205	0	0	4	4	rosiglitazone	PDK4	PA451283	5166	0.613
NULL	Cancer_Metastasis_Rev_2010_Dec_9_29(4)_777-784.nxml.txt.nlp	20936327	SENT180	8	8	17	17	thrombin	PAR-1	PA451674	2011;2149	0.613
NULL	Br_J_Cancer_2011_Nov_22_105(11)_1759-1767.nxml.txt.nlp	22045189	SENT32	19	19	35	35	oxaliplatin	XRCC1	PA131285527	7515	0.613
NULL	Eur_J_Clin_Pharmacol_2014_Oct_8_70(1)_37-45.nxml.txt.nlp	24100471	SENT54	16	16	22	22	pioglitazone	CYP2C19	PA450970	1557	0.613
NULL	Diabetes_Care_2011_Jul_17_34(7)_e115-e120.nxml.txt.nlp	21709286	SENT98	0	0	4	4	metformin	AMPK	PA450395	5563	0.613
NULL	Endocrinol_Metab_(Seoul)_2014_Mar_14_29(1)_33-39.nxml.txt.nlp	24741452	SENT125	9	9	25	25	thyroglobulin	WBS	PA164754910	2006	0.613
NULL	Front_Pharmacol_2014_May_9_5_103.nxml.txt.nlp	24847272	SENT233	7	7	15	15	tacrolimus	CYP3A5	PA451578	1577	0.613
NULL	Curr_Opin_Endocrinol_Diabetes_Obes_2014_Oct_28_21(5)_394-404.nxml.txt.nlp	25122493	SENT25	26	26	43	43	thyroglobulin	RAI	PA164754910	10848;6050	0.613
NULL	Diabetes_2013_Nov_18_62(11)_3663-3665.nxml.txt.nlp	24158994	SENT75	4	4	6	6	pioglitazone	ACT	PA450970	12;11332;9457;641455	0.613
NULL	J_Ayurveda_Integr_Med_2014_Jul-Sep_5(3)_154-161.nxml.txt.nlp	25336846	SENT229	27	27	35	35	colchicine	Trad	PA449092	5892	0.613
NULL	Fibrogenesis_Tissue_Repair_2010_Oct_11_3_20.nxml.txt.nlp	20937083	SENT30	2	2	4	4	bleomycin	BLM	PA448645	641	0.613
NULL	Eur_J_Dent_2012_Apr_6(2)_169-177.nxml.txt.nlp	22509120	SENT200	31	31	27	27	ethanol	HEMA	PA448073	2157	0.613
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT106	9	9	12	12	chloroquine	BMPR-II	PA448948	659	0.613
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Apr_7_9_12.nxml.txt.nlp	20374640	SENT110	8	8	6	6	chloramphenicol	CHL	PA448927	91851	0.613
NULL	Mediators_Inflamm_2010_Jun_21_2010_194896.nxml.txt.nlp	20652055	SENT48	18	18	32	32	fluvastatin	mol	PA449688	90527	0.613
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Nov_4_9_31.nxml.txt.nlp	21050425	SENT90	34	34	32	32	gentamicin	Gen	PA449753	348654	0.613
NULL	Cardiol_Ther_2013_Jun_28_2(1)_47-56.nxml.txt.nlp	25135288	SENT158	15	15	4	4	prasugrel	ABCB1	PA154410481	5243	0.613
NULL	Int_J_Nanomedicine_2012_Nov_20_7_5781-5792.nxml.txt.nlp	23185118	SENT168	0	0	14	14	etoposide	p53	PA449552	7157	0.613
NULL	Arthritis_Res_Ther_2009_Sep_21_11(5)_241.nxml.txt.nlp	19804619	SENT175	13	13	9	9	collagenase	AP-1	PA449107	2353;3727;2354;3725	0.613
NULL	Sci_Rep_2014_Dec_3_4_7294.nxml.txt.nlp	25465236	SENT502	27	27	19	19	axitinib	TYK2	PA164924493	7297	0.613
NULL	Braz_J_Microbiol_2009_Sep_1_Jul-Sep_40(3)_550-562.nxml.txt.nlp	24031399	SENT70	9	9	15	15	spectinomycin	CO2	PA164781342	4513	0.613
NULL	Acta_Pharmacol_Sin_2009_Jul_22_30(7)_956-964.nxml.txt.nlp	19543298	SENT5	9	9	16	16	simvastatin	ABCB1	PA451363	5243	0.613
NULL	Allergy_Asthma_Immunol_Res_2014_Sep_18_6(5)_376-388.nxml.txt.nlp	25228994	SENT133	7	7	17	17	budesonide	DPI	PA448681	1832	0.613
NULL	Cancers_(Basel)_2014_May_7_6(2)_1098-1110.nxml.txt.nlp	24810425	SENT142	30	30	28	28	cisplatin	CCL21	PA449014	6366	0.613
NULL	Br_J_Cancer_2012_Jan_31_106(3)_482-489.nxml.txt.nlp	22233925	SENT243	42	42	18	18	carboplatin	PEO1	PA448803	56652	0.613
NULL	Bone_Joint_Res_2014_Mar_1_3(3)_51-59.nxml.txt.nlp	24615710	SENT36	0	0	15	15	resveratrol	RUNX2		860	0.613
NULL	Breast_Cancer_Res_2001_Oct_1_3(6)_395-398.nxml.txt.nlp	11737892	SENT79	11	11	34	34	zinc	ZONAB	PA451956	8531	0.613
NULL	Int_J_Surg_Oncol_2011_May_26_2011_951260.nxml.txt.nlp	22312534	SENT127	30	30	8	8	estradiol	aromatase	PA449503	1588	0.613
NULL	Breast_Cancer_Res_Treat_2012_Jul_8_134(2)_603-615.nxml.txt.nlp	22678159	SENT42	0	0	10	10	phenytoin	IL-6	PA450947	3569	0.613
NULL	Br_J_Cancer_1999_Jul_80(10)_1595-1598.nxml.txt.nlp	10408405	SENT2	6	6	8	8	gemcitabine	GEM	PA449748	2669	0.613
NULL	Oncotarget_2011_Mar_19_2(3)_239-244.nxml.txt.nlp	21608150	SENT61	11	11	17	17	sorafenib	Mcl-1	PA7000	4170	0.613
NULL	Exp_Cell_Res_2013_Apr_1_319(6)_800-809.nxml.txt.nlp	23247073	SENT206	4	4	9	9	curcumin	AKT	PA151958596	207	0.613
NULL	Oncotarget_2011_Aug_23_2(8)_599-609.nxml.txt.nlp	21865609	SENT89	13	13	25	25	cetuximab	EGFR	PA10040	1956	0.613
NULL	Environ_Health_Perspect_1990_Aug_88_217-223.nxml.txt.nlp	2125558	SENT2	0	0	2	2	diethylstilbestrol	DES	PA449307	1674	0.613
NULL	Biochemistry_2009_Jun_9_48(22)_4871-4880.nxml.txt.nlp	19364131	SENT240	20	20	27	27	papain	p54	PA450778	9295	0.613
NULL	Front_Oncol_2013_Aug_19_3_209.nxml.txt.nlp	23967401	SENT94	4	4	22	22	resveratrol	IL-6		3569	0.613
NULL	Evid_Based_Complement_Alternat_Med_2011_Feb_14_2011_429843.nxml.txt.nlp	21869897	SENT192	18	18	32	32	ethanol	PC6	PA448073	5125	0.613
NULL	Clinics_(Sao_Paulo)_2013_Jun_68(6)_766-771.nxml.txt.nlp	23778483	SENT22	37	37	30	30	hydroxychloroquine	IL-17	PA164777036	3605	0.613
NULL	Cancer_Res_Treat_2014_Jan_15_46(1)_55-64.nxml.txt.nlp	24520224	SENT205	24	24	7	7	oxaliplatin	CEA	PA131285527	5670;1087	0.613
NULL	Cell_Mol_Life_Sci_2011_May_26_68(10)_1785-1798.nxml.txt.nlp	20976523	SENT223	10	10	5	5	collagenase	AP-1	PA449107	2353;3727;2354;3725	0.613
NULL	Curr_Cardiol_Rev_2009_Aug_5(3)_216-222.nxml.txt.nlp	20676280	SENT139	35	35	26	26	lipase	ATGL	PA450239	57104	0.613
NULL	Br_J_Cancer_2010_Jan_19_102(2)_268-275.nxml.txt.nlp	20010948	SENT187	20	20	10	10	sorafenib	CD133	PA7000	8842	0.613
NULL	Acta_Histochem_Cytochem_2012_Apr_26_45(2)_139-146.nxml.txt.nlp	22685356	SENT85	5	5	10	10	forskolin	AQP2	PA146096022	359	0.613
NULL	J_Antimicrob_Chemother_2014_Nov_17_69(11)_2920-2927.nxml.txt.nlp	25038069	SENT139	23	23	12	12	ciprofloxacin	FUS	PA449009	2521	0.613
NULL	Int_J_Med_Sci_2015_Jan_1_12(1)_23-31.nxml.txt.nlp	25552915	SENT148	10	10	26	26	oxygen	CAT	PA450744	847	0.613
NULL	Biomed_Opt_Express_2014_Jul_14_5(8)_2614-2619.nxml.txt.nlp	25136489	SENT112	7	7	14	14	fluorescein	LTA	PA164746009	4049	0.613
NULL	Curr_Cardiol_Rev_2012_Aug_8(3)_239-249.nxml.txt.nlp	22935021	SENT257	12	12	15	15	clopidogrel	P2Y12	PA449053	64805	0.613
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT453	8	8	18	18	phenol	FBS	PA450913	64319;26269	0.613
NULL	J_Korean_Neurosurg_Soc_2013_Oct_31_54(4)_280-288.nxml.txt.nlp	24294450	SENT178	34	34	20	20	acetazolamide	ACZ	PA448018	27445	0.613
NULL	Semin_Immunopathol_2012_Jan_4_34(1)_93-106.nxml.txt.nlp	21845431	SENT269	10	10	13	13	urokinase	UPAR	PA451836	5329	0.613
NULL	Front_Oncol_2013_Aug_30_3_222.nxml.txt.nlp	24010121	SENT119	25	25	35	35	docetaxel	PC3	PA449383	57332;7832;5122	0.613
NULL	Curr_Dermatol_Rep_2014_Nov_28_3(1)_13-22.nxml.txt.nlp	24587975	SENT156	32	32	9	9	calcipotriol	IL-5	PA448714	3567	0.613
NULL	AAPS_J_2011_Jun_1_13(3)_405-416.nxml.txt.nlp	21630127	SENT335	2	2	4	4	bevacizumab	CHOP	PA130232992	1649	0.613
NULL	J_Med_Case_Reports_2011_Feb_17_5_70.nxml.txt.nlp	21329500	SENT16	18	18	20	20	atazanavir	ATV	PA10251	4683	0.613
NULL	J_Gen_Physiol_1938_Jan_20_21(3)_289-295.nxml.txt.nlp	19873051	SENT1	7	7	3	3	choline	FOR	PA448976	51741	0.613
NULL	Ann_Surg_Oncol_2011_Sep_23_18(9)_2442-2452.nxml.txt.nlp	21347782	SENT44	24	24	13	13	oxaliplatin	CEA	PA131285527	5670;1087	0.613
NULL	J_Inherit_Metab_Dis_2010_Oct_3_33(5)_625-632.nxml.txt.nlp	20814828	SENT69	2	2	4	4	simvastatin	RhoA	PA451363	387	0.613
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Nov_30_67(Pt_12)_o3513.nxml.txt.nlp	22199982	SENT73	34	34	30	30	ethanol	mol	PA448073	90527	0.613
NULL	Commun_Integr_Biol_2013_Jan_1_6(1)_e22278.nxml.txt.nlp	23802033	SENT42	24	24	12	12	nifedipine	Dicer	PA450631	23405	0.613
NULL	Breast_Cancer_Res_2013_Oct_1_15(5)_R92.nxml.txt.nlp	24286369	SENT390	15	15	17	17	pertuzumab	HER2		2064	0.613
NULL	Int_J_Gen_Med_2012_Nov_23_5_983-990.nxml.txt.nlp	23226071	SENT117	29	29	13	13	glucose	DBP	PA449773	3295;1628;2638	0.613
NULL	Drugs_Aging_2012_Nov_5_29(11)_863-869.nxml.txt.nlp	23038608	SENT93	20	20	13	13	desipramine	NNT	PA449233	23530	0.613
NULL	J_Cell_Mol_Med_2013_Dec_6_17(12)_1588-1597.nxml.txt.nlp	24199964	SENT277	3	3	18	18	doxycycline	APT	PA449415	653639	0.613
NULL	Lancet_2011_Jun_9_377(9784)_2181-2192.nxml.txt.nlp	21663949	SENT129	7	7	1	1	ezetimibe	SHARP	PA10816	23013	0.613
NULL	Case_Rep_Endocrinol_2013_Feb_20_2013_719304.nxml.txt.nlp	23509641	SENT44	1	1	7	7	thyroglobulin	THW	PA164754910	64065	0.613
NULL	Eur_J_Haematol_2009_May_82(5)_339-349.nxml.txt.nlp	19187276	SENT70	10	10	22	22	rivaroxaban	TKR	PA165958360	8277	0.613
NULL	Int_J_Inflam_2011_Aug_2_2011_364310.nxml.txt.nlp	21826258	SENT318	4	4	19	19	atorvastatin	LRP5	PA448500	4041	0.613
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Apr_30_65(Pt_5)_m579.nxml.txt.nlp	21583807	SENT5	24	24	32	32	theophylline	mol	PA451647	90527	0.613
NULL	Acta_Pharmacol_Sin_2009_Sep_24_30(9)_1330-1336.nxml.txt.nlp	19701234	SENT21	24	24	11	11	ilaprazole	CYP2C9	PA165947499	1559	0.613
NULL	Aging_(Albany_NY)_2011_Dec_12_3(11)_1063-1077.nxml.txt.nlp	22170748	SENT116	38	38	10	10	doxorubicin	p53	PA449412	7157	0.613
NULL	Braz_J_Med_Biol_Res_2014_Mar_3_47(3)_192-205.nxml.txt.nlp	24676492	SENT190	24	24	26	26	lipase	ATGL	PA450239	57104	0.613
NULL	Reprod_Biol_Endocrinol_2003_Aug_6_1_54.nxml.txt.nlp	12932297	SENT282	7	7	4	4	hyaluronidase	SPAM1	PA164745713	6677	0.613
NULL	Br_J_Cancer_1999_Nov_81(5)_783-789.nxml.txt.nlp	10555746	SENT6	9	9	12	12	vinblastine	P-gp	PA451877	5243	0.613
NULL	Diabetes_2009_Dec_18_58(12)_2880-2892.nxml.txt.nlp	19690065	SENT26	28	28	30	30	lipase	HSL	PA450239	3991	0.613
NULL	Case_Rep_Oncol_2014_Jul_5_7(2)_435-443.nxml.txt.nlp	25126073	SENT153	25	25	11	11	bevacizumab	Gem	PA130232992	51053	0.613
NULL	Acta_Pharmacol_Sin_2012_May_26_33(5)_675-681.nxml.txt.nlp	22447226	SENT103	7	7	16	16	gefitinib	survivin	PA131301952	332	0.613
NULL	Trials_2013_Sep_24_14_311.nxml.txt.nlp	24063608	SENT63	10	10	15	15	sulfadoxine	DHPS	PA451540	1725	0.613
NULL	Nucleic_Acids_Res_2005_Jun_9_33(10)_3323-3330.nxml.txt.nlp	15947132	SENT155	27	27	16	16	cisplatin	MSH2	PA449014	4436	0.613
NULL	Cancer_Manag_Res_2011_May_10_3_157-175.nxml.txt.nlp	21625399	SENT54	15	15	29	29	tolbutamide	CYP2C9	PA451718	1559	0.613
NULL	J_Med_Life_2011_Feb_15_4(1)_11-20.nxml.txt.nlp	21505570	SENT148	8	8	5	5	diclofenac	URB	PA449293	151887	0.613
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT74	18	18	6	6	nutlin-3	p53		7157	0.613
NULL	FEBS_Open_Bio_2012_May_30_2_119-128.nxml.txt.nlp	23650590	SENT243	16	16	23	23	docetaxel	PC3	PA449383	57332;7832;5122	0.613
NULL	Aging_(Albany_NY)_2009_Feb_5_1(2)_219-233.nxml.txt.nlp	20157511	SENT200	3	3	8	8	hydroxyurea	WRN	PA449942	7486	0.613
NULL	Chemother_Res_Pract_2011_Dec_1_2011_715469.nxml.txt.nlp	22312557	SENT106	30	30	4	4	cisplatin	p53	PA449014	7157	0.613
NULL	Case_Rep_Dent_2011_Jul_7_2011_357518.nxml.txt.nlp	22567436	SENT32	21	21	15	15	thyroglobulin	TTF1	PA164754910	7080;7270	0.613
NULL	Acta_Pharmacol_Sin_2012_May_2_33(5)_615-624.nxml.txt.nlp	22465948	SENT3	5	5	12	12	estradiol	PRG	PA449503	5544	0.613
NULL	Drugs_2009_Mar_17_69(5)_549-565.nxml.txt.nlp	19368417	SENT120	12	12	4	4	formoterol	DPI	PA134687907	1832	0.613
NULL	Acta_Crystallogr_Sect_F_Struct_Biol_Cryst_Commun_2010_Aug_4_66(Pt_10)_1287-1296.nxml.txt.nlp	20944224	SENT95	14	14	20	20	galactose	SCOP	PA449725	23239	0.613
NULL	Diabetes_2008_Sep_57(9)_2272-2279.nxml.txt.nlp	18519799	SENT43	11	11	23	23	rosiglitazone	PEPCK-C	PA451283	5105	0.613
NULL	Case_Rep_Oncol_Med_2011_Dec_8_2011_805893.nxml.txt.nlp	22606447	SENT47	19	19	17	17	cyclophosphamide	CHOP	PA449165	1649	0.613
NULL	Br_J_Cancer_1998_Aug_78(3)_312-320.nxml.txt.nlp	9703276	SENT9	26	26	22	22	hydroquinone	NQO1	PA449924	1728	0.613
NULL	Diabetes_2008_Sep_57(9)_2272-2279.nxml.txt.nlp	18519799	SENT304	0	0	5	5	rosiglitazone	PEPCK-C	PA451283	5105	0.613
NULL	J_Gen_Physiol_2009_Jun_133(6)_623-625.nxml.txt.nlp	19468076	SENT27	2	2	10	10	menthol	TRPA1	PA164776605	8989	0.613
NULL	Brain_2014_Jan_16_137(1)_172-182.nxml.txt.nlp	24253201	SENT164	15	15	17	17	chlorpromazine	CPZ	PA448964	8532	0.613
NULL	Mediators_Inflamm_2010_Jun_2_2010_682879.nxml.txt.nlp	20592757	SENT15	10	10	43	43	l-arginine	NOS3	PA448478	4846;342977	0.613
NULL	Mol_Med_Rep_2014_Nov_5_10(5)_2334-2340.nxml.txt.nlp	25189202	SENT174	14	14	12	12	cefoperazone	CFP	PA448849	5199	0.613
NULL	Biomed_Res_Int_2013_Oct_27_2013_798261.nxml.txt.nlp	24282821	SENT9	39	39	31	31	ethanol	DAI	PA448073	81030	0.613
NULL	Biochim_Biophys_Acta_2014_Apr_1841(4)_588-594.nxml.txt.nlp	24440819	SENT8	2	2	4	4	lipase	ATGL	PA450239	57104	0.613
NULL	Arthritis_Res_Ther_2014_Sep_18_16(5)_427.nxml.txt.nlp	25230745	SENT145	2	2	24	24	bevacizumab	MMP13	PA130232992	4322	0.613
NULL	Front_Genet_2013_Aug_29_4_163.nxml.txt.nlp	24009622	SENT37	8	8	13	13	ethanol	DDP	PA448073	1678	0.613
NULL	Virol_J_2010_Oct_27_7_285.nxml.txt.nlp	20979618	SENT159	14	14	24	24	isoproterenol	c-fos	PA450121	2353	0.613
NULL	Int_J_Mol_Sci_2007_Jan_29_8(1)_13-28.nxml.txt.nlp	NULL	SENT88	2	2	4	4	galactose	NAG	PA449725	51594;4669	0.613
NULL	Biochim_Biophys_Acta_2014_Jun_1841(6)_906-917.nxml.txt.nlp	24657704	SENT28	2	2	4	4	lipase	ATGL	PA450239	57104	0.613
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT142	10	10	12	12	perifosine	DR5	PA165291471	8795	0.613
NULL	Comput_Struct_Biotechnol_J_2013_Feb_22_3_e201210020.nxml.txt.nlp	24688680	SENT161	22	22	8	8	naringenin	PDH	PA151958361	54704	0.613
NULL	Chin_J_Cancer_2012_Feb_31(2)_73-99.nxml.txt.nlp	22098950	SENT235	0	0	2	2	erlotinib	P-gp	PA134687924	5243	0.612
NULL	Environ_Health_Perspect_2005_May_2_113(5)_527-531.nxml.txt.nlp	15866758	SENT192	23	23	5	5	ketanserin	ANOVA	PA131053734	4858	0.612
NULL	Mol_Cell_Proteomics_2013_Dec_16_12(12)_3851-3873.nxml.txt.nlp	24043423	SENT360	13	13	9	9	doxycycline	MORF4L1	PA449415	10933	0.612
NULL	Nat_Chem_Biol_2009_Jan_23_5(1)_37-44.nxml.txt.nlp	19029917	SENT57	3	3	30	30	piperazine	ABHD6	PA450977	57406	0.612
NULL	Iran_J_Reprod_Med_2013_Jul_11(7)_565-576.nxml.txt.nlp	24639792	SENT0	19	19	28	28	berberine	SLPI	PA165860812	6590	0.612
NULL	Mol_Brain_2013_Mar_12_6_12.nxml.txt.nlp	23497716	SENT9	30	30	20	20	fluoxetine	Schnurri-2	PA449673	3097	0.612
NULL	Cell_Biol_Toxicol_2012_Apr_19_28(2)_69-87.nxml.txt.nlp	22258563	SENT104	24	24	38	38	midazolam	CYP3A4	PA450496	1576	0.612
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_75-89.nxml.txt.nlp	17912638	SENT372	16	16	40	40	anastrozole	ATAC	PA448432	6375	0.612
NULL	Breast_Cancer_Res_2010_Jun_28_12(3)_R43.nxml.txt.nlp	20579400	SENT286	9	9	20	20	fulvestrant	MAPT	PA164747170	4137	0.612
NULL	Cancer_Immunol_Immunother_2012_Jul_23_61(7)_1101-1111.nxml.txt.nlp	22193989	SENT12	1	1	5	5	oxaliplatin	PD-L1	PA131285527	29126	0.612
NULL	Diabetes_Care_2013_Aug_17_36(Suppl_2)_S127-S138.nxml.txt.nlp	23882037	SENT204	11	11	5	5	metformin	GLP-1	PA450395	100125288	0.612
NULL	J_Antimicrob_Chemother_2011_Feb_9_66(2)_363-370.nxml.txt.nlp	21148235	SENT115	2	2	0	0	atazanavir	ATV	PA10251	4683	0.612
NULL	Mol_Immunol_2009_Mar_46(6)_1149-1162.nxml.txt.nlp	19100624	SENT212	22	22	15	15	chlorpromazine	C5L2	PA448964	27202	0.612
NULL	Indian_J_Endocrinol_Metab_2013_Jul-Aug_17(4)_636-646.nxml.txt.nlp	23961479	SENT159	28	28	24	24	warfarin	CYP2C9	PA451906	1559	0.612
NULL	Angiogenesis_2010_Mar_11_13(1)_1-14.nxml.txt.nlp	20012482	SENT156	0	0	16	16	sorafenib	UGT1A9	PA7000	54600	0.612
NULL	Diabetes_Care_2010_Jul_33(7)_1674-1685.nxml.txt.nlp	20587728	SENT287	8	8	22	22	exenatide	GLP-1	PA164749238	100125288	0.612
NULL	Oncol_Lett_2013_May_27_5(5)_1554-1558.nxml.txt.nlp	23761818	SENT160	7	7	5	5	cyclophosphamide	CTX	PA449165	1593	0.612
NULL	Crit_Care_2008_Feb_2_12(1)_R11.nxml.txt.nlp	18252006	SENT205	12	12	9	9	vasopressin	AVP	PA451858	114548;551	0.612
NULL	Front_Endocrinol_(Lausanne)_2013_Nov_11_4_165.nxml.txt.nlp	24273530	SENT548	39	39	18	18	taurine	gamma	PA451590	9913	0.612
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT183	5	5	7	7	doxorubicin	B7-H1	PA449412	29126	0.612
NULL	Mol_Microbiol_2014_Mar_23_91(5)_918-934.nxml.txt.nlp	24372851	SENT58	32	32	34	34	lumefantrine	LUM	PA165111722	4060	0.612
NULL	Mol_Cancer_2012_Apr_26_11_26.nxml.txt.nlp	22537224	SENT146	0	0	12	12	geldanamycin	FANCF	PA152031327	2188	0.612
NULL	Cancer_Metastasis_Rev_2010_Dec_9_29(4)_777-784.nxml.txt.nlp	20936327	SENT180	3	3	17	17	thrombin	PAR-1	PA451674	2011;2149	0.612
NULL	Front_Neurol_2014_Sep_11_5_173.nxml.txt.nlp	25309501	SENT160	2	2	14	14	hyaluronidase	HYAL3	PA164745713	8372	0.612
NULL	Biologics_2009_Oct_12_3_443-457.nxml.txt.nlp	19851470	SENT218	12	12	10	10	tocilizumab	IL-6	PA165292659	3569	0.612
NULL	Cell_Death_Dis_2014_Jul_3_5(7)_e1316.nxml.txt.nlp	24991768	SENT100	15	15	4	4	pemetrexed	Mcl-1	PA10810	4170	0.612
NULL	Eur_J_Neurosci_2012_Apr_35(8)_1368-1380.nxml.txt.nlp	22512261	SENT427	19	19	13	13	baclofen	gamma	PA448533	9913	0.612
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Apr_6_5_8.nxml.txt.nlp	16600049	SENT7	6	6	8	8	lamivudine	LAM	PA450163	7249;7248	0.612
NULL	Cell_Commun_Signal_2013_Nov_4_11_82.nxml.txt.nlp	24188565	SENT353	26	26	18	18	paraformaldehyde	CO2	PA450790	4513	0.612
NULL	Mol_Cancer_2010_Nov_2_9_289.nxml.txt.nlp	21044322	SENT171	20	20	33	33	docetaxel	RGS17	PA449383	26575	0.612
NULL	Br_J_Pharmacol_2012_Jan_165(2)_380-389.nxml.txt.nlp	21585347	SENT7	2	2	4	4	lipase	ATGL	PA450239	57104	0.612
NULL	EMBO_Mol_Med_2013_Jul_30_5(7)_932-948.nxml.txt.nlp	23723167	SENT78	25	25	12	12	pilocarpine	MMP13	PA450962	4322	0.612
NULL	Cancers_(Basel)_2014_Apr_4_6(2)_796-812.nxml.txt.nlp	24713998	SENT812	7	7	5	5	doxorubicin	NGAL	PA449412	3934	0.612
NULL	Mol_Cancer_2014_Apr_17_13_85.nxml.txt.nlp	24741998	SENT147	25	25	22	22	rituximab	CD40L	PA451261	959	0.612
NULL	Environ_Health_Perspect_2006_Nov_114(11)_A644-A649.nxml.txt.nlp	17107842	SENT38	18	18	20	20	diethylstilbestrol	DES	PA449307	1674	0.612
NULL	Iran_J_Basic_Med_Sci_2012_Sep-Oct_15(5)_1102-1105.nxml.txt.nlp	23492757	SENT28	14	14	27	27	celecoxib	IL-10	PA448871	3586	0.612
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT192	10	10	8	8	lapatinib	Yes	PA152241907	7525	0.612
NULL	J_Oncol_2012_Jun_19_2012_521215.nxml.txt.nlp	22778735	SENT113	5	5	13	13	cetuximab	EGFR	PA10040	1956	0.612
NULL	Cancer_Med_2014_Feb_10_3(1)_134-142.nxml.txt.nlp	24407937	SENT249	1	1	7	7	letrozole	ERBB2	PA450196	2064	0.612
NULL	Mediators_Inflamm_1995_Sep_4(5)_331-338.nxml.txt.nlp	18475660	SENT12	21	21	4	4	dextran	IL-5	PA449261	3567	0.612
NULL	ASN_Neuro_2010_Aug_11_2(4)_e00040.nxml.txt.nlp	20711301	SENT281	13	13	10	10	paclitaxel	p35	PA450761	3592;80761	0.612
NULL	J_Gen_Physiol_1939_Mar_20_22(4)_429-446.nxml.txt.nlp	19873112	SENT0	11	11	1	1	trypsin	Gen	PA451806	348654	0.612
NULL	Aging_(Albany_NY)_2009_Oct_13_1(10)_842-844.nxml.txt.nlp	20157556	SENT26	6	6	17	17	nutlin-3	p53		7157	0.612
NULL	J_Res_Med_Sci_2012_Jul_17(7)_694-709.nxml.txt.nlp	23798934	SENT136	25	25	27	27	sugar	FBS	PA451529	64319;26269	0.612
NULL	Clin_Psychopharmacol_Neurosci_2012_Aug_31_10(2)_94-98.nxml.txt.nlp	23430731	SENT91	7	7	4	4	phencyclidine	SFN	PA128406980	25996;2810	0.612
NULL	Breast_Cancer_Res_2011_Jun_9_13(3)_R57.nxml.txt.nlp	21658222	SENT105	30	30	22	22	epirubicin	UGT	PA449476	7361;7355	0.612
NULL	Acta_Pharmacol_Sin_2012_Jun_14_33(6)_832-838.nxml.txt.nlp	22580740	SENT23	10	10	7	7	cisplatin	ADM	PA449014	133	0.612
NULL	Environ_Health_Perspect_2006_May_2_114(5)_746-751.nxml.txt.nlp	16675431	SENT174	9	9	3	3	choline	HC3	PA448976	5683;360177	0.612
NULL	Cancer_Causes_Control_2012_Oct_21_23(10)_1739-1744.nxml.txt.nlp	22907422	SENT39	18	18	24	24	sulindac	CRA	PA451565	51747;10903	0.612
NULL	Leukemia_2014_Apr_14_28(4)_961-964.nxml.txt.nlp	24418991	SENT39	13	13	15	15	imatinib	P-gp	PA10804	5243	0.612
NULL	EMBO_J_2014_Jul_17_33(14)_1514-1526.nxml.txt.nlp	24872509	SENT113	21	21	9	9	zinc	S5A	PA451956	5710	0.612
NULL	Diabetologia_2010_Jan_6_53(1)_1-6.nxml.txt.nlp	19894028	SENT53	38	38	20	20	sitagliptin	HIP	PA164748978	6767;6159;64399;5068	0.612
NULL	AIDS_Res_Ther_2014_Aug_4_11_25.nxml.txt.nlp	25120580	SENT29	4	4	8	8	omeprazole	CYP2C19	PA450704	1557	0.612
NULL	Arch_Pharm_Res_2014_May_26_37(2)_175-185.nxml.txt.nlp	23709168	SENT105	20	20	16	16	hydrocortisone	EGFR	PA449905	1956	0.612
NULL	Clin_Dev_Immunol_2011_Sep_14_2011_267539.nxml.txt.nlp	21922022	SENT212	2	2	4	4	gemcitabine	WT1	PA449748	7490	0.612
NULL	Int_J_Nanomedicine_2012_Sep_17_7_5039-5049.nxml.txt.nlp	23055722	SENT230	4	4	17	17	fluorescein	PTEN	PA164746009	5728	0.612
NULL	J_Biol_Chem_2013_Nov_15_288(46)_33049-33059.nxml.txt.nlp	24089524	SENT232	5	5	25	25	nicotine	GATA4	PA450626	2626	0.612
NULL	Oncol_Rep_2013_Apr_23_29(4)_1268-1274.nxml.txt.nlp	23354756	SENT90	17	17	5	5	paclitaxel	SLC25A43	PA450761	203427	0.612
NULL	Int_J_Nephrol_2010_Dec_21_2011_490795.nxml.txt.nlp	21234092	SENT251	1	1	3	3	vasopressin	AVP	PA451858	114548;551	0.612
NULL	Curr_Neuropharmacol_2009_Jun_7(2)_83-95.nxml.txt.nlp	19949566	SENT453	6	6	32	32	felbamate	TGB	PA449590	5473	0.612
NULL	J_Cell_Mol_Med_2014_Oct_11_18(10)_2031-2043.nxml.txt.nlp	25109475	SENT137	0	0	4	4	valsartan	AMPK	PA451848	5563	0.612
NULL	Indian_J_Pharm_Sci_2013_Nov-Dec_75(6)_680-687.nxml.txt.nlp	24591743	SENT35	38	38	17	17	gemfibrozil	CYP2C9	PA449750	1559	0.612
NULL	Drug_Des_Devel_Ther_2014_Sep_23_8_1527-1538.nxml.txt.nlp	25284985	SENT204	30	30	34	34	celecoxib	IFN	PA448871	3439	0.612
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1495-1502.nxml.txt.nlp	21989186	SENT189	18	18	9	9	panitumumab	HSI	PA162373091	57016	0.612
NULL	Oncogene_2013_Sep_12_32(37)_4355-4365.nxml.txt.nlp	23108409	SENT47	3	3	5	5	hyaluronan	CD44	PA165958431	960	0.612
NULL	Cell_Death_Dis_2013_Jun_13_4(6)_e665.nxml.txt.nlp	23764846	SENT265	7	7	9	9	bleomycin	BLM	PA448645	641	0.612
NULL	J_Adv_Pharm_Technol_Res_2012_Oct-Dec_3(4)_202-209.nxml.txt.nlp	23378940	SENT164	7	7	5	5	fosaprepitant	CYP3A4	PA165958390	1576	0.612
NULL	Evid_Based_Complement_Alternat_Med_2013_May_26_2013_349790.nxml.txt.nlp	23762123	SENT170	19	19	9	9	rosiglitazone	TLSP	PA451283	11012	0.612
NULL	Evid_Based_Complement_Alternat_Med_2011_Feb_14_2011_429843.nxml.txt.nlp	21869897	SENT192	18	18	27	27	ethanol	PC6	PA448073	5125	0.612
NULL	Acta_Pharmacol_Sin_2011_Feb_4_32(2)_259-269.nxml.txt.nlp	21293479	SENT123	24	24	28	28	irinotecan	IL-3	PA450085	3562	0.612
NULL	Behav_Sci_(Basel)_2012_Jun_21_2(2)_135-171.nxml.txt.nlp	23077729	SENT28	1	1	3	3	vasopressin	AVP	PA451858	114548;551	0.612
NULL	Nat_Chem_Biol_2010_Apr_28_6(4)_291-299.nxml.txt.nlp	20190765	SENT118	4	4	6	6	dasatinib	EGFR	PA162372878	1956	0.612
NULL	Oncotarget_2014_Aug_29_5(18)_8052-8082.nxml.txt.nlp	25211298	SENT404	9	9	17	17	ritonavir	P-gp	PA451260	5243	0.612
NULL	Carcinogenesis_2010_Dec_27_31(12)_2049-2057.nxml.txt.nlp	20876285	SENT138	21	21	13	13	fulvestrant	HER2	PA164747170	2064	0.612
NULL	Breast_Cancer_Res_Treat_2013_Apr_12_138(2)_427-435.nxml.txt.nlp	23479422	SENT26	37	37	17	17	letrozole	HER2	PA450196	2064	0.612
NULL	Br_J_Haematol_2014_Mar_13_164(1)_811-821.nxml.txt.nlp	24328678	SENT257	16	16	14	14	lenalidomide	Aiolos	PA162363968	22806	0.612
NULL	Crit_Care_2008_Feb_21_12(1)_R20.nxml.txt.nlp	18291025	SENT3	1	1	3	3	vasopressin	AVP	PA451858	114548;551	0.612
NULL	Clin_Interv_Aging_2010_Nov_19_5_345-354.nxml.txt.nlp	21228900	SENT126	10	10	8	8	denosumab	RANKL	PA166048634	8600	0.612
NULL	Diabetes_Metab_Syndr_Obes_2010_Sep_22_3_325-335.nxml.txt.nlp	21437102	SENT27	2	2	11	11	saxagliptin	GLP-1	PA165958362	100125288	0.612
NULL	Arthritis_Res_Ther_2003_Mar_19_5(3)_131-135.nxml.txt.nlp	12723978	SENT144	17	17	15	15	rituximab	CHOP	PA451261	1649	0.612
NULL	Mediators_Inflamm_1998_7(6)_391-396.nxml.txt.nlp	9927231	SENT4	35	35	33	33	forskolin	GM-CSF	PA146096022	1437	0.612
NULL	Int_J_Nanomedicine_2009_Apr_1_4_1-7.nxml.txt.nlp	19421366	SENT146	14	14	10	10	paclitaxel	castor	PA450761	54897	0.612
NULL	AIDS_2014_Mar_13_28(5)_717-725.nxml.txt.nlp	24983542	SENT3	34	34	8	8	efavirenz	CCR5	PA449441	1234	0.612
NULL	Diabetes_Metab_J_2014_Jun_17_38(3)_211-219.nxml.txt.nlp	25003075	SENT139	6	6	24	24	vildagliptin	PPG	PA165958346	5552	0.612
NULL	Front_Endocrinol_(Lausanne)_2011_Dec_21_2_84.nxml.txt.nlp	22654830	SENT61	9	9	19	19	rosiglitazone	GPAT	PA451283	5471	0.612
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Jul_23_6_103-113.nxml.txt.nlp	25114588	SENT219	17	17	6	6	trastuzumab	HER2	PA451743	2064	0.612
NULL	J_Gynecol_Oncol_2011_Mar_31_22(1)_9-17.nxml.txt.nlp	21607090	SENT161	17	17	26	26	carboplatin	PCFT	PA448803	113235	0.612
NULL	Hum_Genomics_2004_Nov_1_1(6)_444-455.nxml.txt.nlp	15606999	SENT88	38	38	40	40	lipase	LIPG	PA450239	9388	0.612
NULL	Environ_Health_Perspect_1976_Dec_18_25-34.nxml.txt.nlp	829487	SENT10	3	3	5	5	diethylstilbestrol	DES	PA449307	1674	0.612
NULL	J_Cell_Biol_1998_Jun_29_141(7)_1479-1487.nxml.txt.nlp	9647642	SENT246	35	35	20	20	staurosporine	NAC	PA165109623	22861	0.612
NULL	Indian_J_Psychiatry_2011_Apr-Jun_53(2)_111-120.nxml.txt.nlp	21772642	SENT209	32	32	18	18	diazepam	CYP1A2	PA449283	1544	0.612
NULL	Front_Endocrinol_(Lausanne)_2011_Dec_21_2_84.nxml.txt.nlp	22654830	SENT37	19	19	21	21	lipase	MGL	PA450239	11343	0.612
NULL	Nat_Commun_2014_Jun_2_5_3983.nxml.txt.nlp	24886709	SENT70	7	7	9	9	lipase	LIPC	PA450239	3990	0.612
NULL	Int_J_Nanomedicine_2010_Dec_2_5_1079-1084.nxml.txt.nlp	21170355	SENT138	10	10	16	16	daunorubicin	CTX	PA449212	1593	0.612
NULL	J_Thromb_Thrombolysis_2011_Nov_26_32(4)_459-466.nxml.txt.nlp	21706290	SENT229	14	14	3	3	prasugrel	ABCB1	PA154410481	5243	0.612
NULL	Br_J_Cancer_2013_Jan_15_108(1)_72-81.nxml.txt.nlp	23257894	SENT219	11	11	7	7	sorafenib	HK2	PA7000	3796;3099;29911;3741	0.612
NULL	Acta_Myol_2010_Oct_29(2)_351-356.nxml.txt.nlp	21314018	SENT194	5	5	7	7	lipase	PNPLA2	PA450239	57104	0.612
NULL	Crit_Care_2008_Mar_13_12(Suppl_2)_P56.nxml.txt.nlp	NULL	SENT6	33	33	28	28	erythromycin	VAN	PA449493	10318	0.612
NULL	Biologics_2013_Apr_15_7_77-90.nxml.txt.nlp	23723688	SENT8	3	3	8	8	cetuximab	CRT	PA10040	811	0.612
NULL	J_Invest_Dermatol_2012_May_16_132(5)_1435-1442.nxml.txt.nlp	22336948	SENT231	0	0	9	9	doxycycline	TLSP	PA449415	11012	0.612
NULL	Acta_Pharmacol_Sin_2012_Jul_4_33(7)_897-908.nxml.txt.nlp	22659625	SENT182	16	16	18	18	bleomycin	BLM	PA448645	641	0.612
NULL	Br_J_Cancer_2010_Nov_9_103(10)_1597-1605.nxml.txt.nlp	20978501	SENT68	27	27	41	41	fluorescein	San	PA164746009	80218	0.612
NULL	Am_J_Rhinol_Allergy_2012_Jan-Feb_26(1)_e20-e22.nxml.txt.nlp	22391072	SENT58	7	7	19	19	aspirin	CRS	PA448497	1403	0.612
NULL	Cardiovasc_Res_2012_Mar_15_93(4)_674-681.nxml.txt.nlp	22166712	SENT192	7	7	3	3	clopidogrel	CYP3A	PA449053	1574	0.612
NULL	Gastric_Cancer_2013_Jul_12_16(3)_345-354.nxml.txt.nlp	22968820	SENT18	41	41	8	8	oxaliplatin	FANCJ	PA131285527	83990	0.612
NULL	Breast_Cancer_Res_2010_Nov_16_12(6)_R96.nxml.txt.nlp	21080941	SENT94	30	30	43	43	lapatinib	HRG	PA152241907	3084;3273	0.612
NULL	Eur_J_Clin_Pharmacol_2011_Dec_23_67(12)_1231-1241.nxml.txt.nlp	21698374	SENT266	11	11	6	6	tacrolimus	MDR1	PA451578	5243	0.612
NULL	Breast_Cancer_Res_2011_Apr_15_13(2)_R44.nxml.txt.nlp	21496232	SENT246	5	5	10	10	erlotinib	HER2	PA134687924	2064	0.612
NULL	Br_J_Cancer_2003_Mar_10_88(5)_754-759.nxml.txt.nlp	12618886	SENT68	5	5	2	2	amifostine	p53	PA448365	7157	0.612
NULL	Biologics_2012_Dec_17_6_429-464.nxml.txt.nlp	23269860	SENT217	18	18	30	30	adalimumab	ACR	PA10004	49	0.612
NULL	AIDS_Res_Ther_2013_May_1_10_10.nxml.txt.nlp	23634877	SENT187	34	34	25	25	atorvastatin	CCL3	PA448500	6348	0.612
NULL	Drug_Des_Devel_Ther_2014_Sep_23_8_1527-1538.nxml.txt.nlp	25284985	SENT184	30	30	34	34	celecoxib	IFN	PA448871	3439	0.612
NULL	Arthritis_Res_Ther_2005_Jun_16_7(4)_155-156.nxml.txt.nlp	15987498	SENT30	30	30	28	28	collagenase	MMP13	PA449107	4322	0.612
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1149.nxml.txt.nlp	24675467	SENT83	16	16	7	7	trastuzumab	HER2	PA451743	2064	0.612
NULL	Gut_Liver_2013_May_9_7(3)_329-334.nxml.txt.nlp	23710315	SENT137	2	2	0	0	lamivudine	LAM	PA450163	7249;7248	0.612
NULL	J_Vet_Sci_2007_Dec_31_8(4)_341-351.nxml.txt.nlp	17993747	SENT157	6	6	8	8	echinacea	gamma	PA131550706	9913	0.612
NULL	Mol_Cell_Proteomics_2012_Feb_6_11(2)_M111_015222.nxml.txt.nlp	22147731	SENT369	13	13	11	11	gefitinib	EGF	PA131301952	1950	0.612
NULL	FEMS_Microbiol_Ecol_2014_Sep_31_89(3)_542-552.nxml.txt.nlp	24909965	SENT110	14	14	29	29	ethanol	CO2	PA448073	4513	0.612
NULL	J_Brachial_Plex_Peripher_Nerve_Inj_2008_Oct_25_3_22.nxml.txt.nlp	18950516	SENT46	12	12	8	8	ketamine	SGB	PA450144	2719	0.612
NULL	Br_J_Cancer_2010_Jun_29_103(1)_6-11.nxml.txt.nlp	20551960	SENT28	18	18	15	15	etoposide	ADM	PA449552	133	0.612
NULL	Drug_Des_Devel_Ther_2014_Sep_9_8_1307-1314.nxml.txt.nlp	25246772	SENT148	14	14	7	7	tacrolimus	HTX	PA451578	7547	0.612
NULL	Int_J_Mol_Sci_2012_Feb_24_13(3)_2590-2617.nxml.txt.nlp	22489113	SENT214	15	15	22	22	benzaldehyde	mol	PA448571	90527	0.612
NULL	Comp_Hepatol_2005_Feb_8_4_2.nxml.txt.nlp	15701172	SENT185	0	0	9	9	ketoconazole	CYP3A	PA450146	1574	0.612
NULL	Clin_Interv_Aging_2013_Aug_19_8_1089-1095.nxml.txt.nlp	23983461	SENT117	39	39	25	25	minocycline	MT4	PA450519	84560	0.612
NULL	Front_Oncol_2014_Apr_21_4_82.nxml.txt.nlp	24795859	SENT198	16	16	24	24	vincristine	CD19	PA451879	930	0.612
NULL	J_Gen_Physiol_2012_Oct_140(4)_403-419.nxml.txt.nlp	23008434	SENT109	11	11	14	14	phenol	TMX	PA450913	81542	0.612
NULL	Clin_Interv_Aging_2014_Apr_8_9_593-601.nxml.txt.nlp	24748777	SENT143	5	5	16	16	denosumab	RANKL	PA166048634	8600	0.612
NULL	Aging_(Albany_NY)_2013_Apr_14_5(4)_288-303.nxml.txt.nlp	23596277	SENT195	37	37	12	12	indomethacin	KSR	PA449982	10256	0.612
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1149.nxml.txt.nlp	24675467	SENT312	18	18	4	4	trastuzumab	CD24	PA451743	100133941	0.612
NULL	Exp_Diabetes_Res_2011_Dec_27_2011_604989.nxml.txt.nlp	21253359	SENT113	13	13	6	6	clonidine	GLP-1	PA449051	100125288	0.612
NULL	J_Clin_Biochem_Nutr_2011_Jul_17_49(1)_1-7.nxml.txt.nlp	21765599	SENT213	16	16	6	6	lipase	HSL	PA450239	3991	0.612
NULL	Infect_Dis_Ther_2014_Dec_5_3(2)_69-81.nxml.txt.nlp	25475412	SENT80	11	11	8	8	teicoplanin	VAN	PA164746244	10318	0.612
NULL	Biomed_Res_Int_2014_Feb_17_2014_429198.nxml.txt.nlp	24696850	SENT316	15	15	6	6	cyclophosphamide	p53	PA449165	7157	0.612
NULL	Diabetes_Care_2010_Mar_23_33(3)_645-651.nxml.txt.nlp	20032281	SENT128	2	2	0	0	metformin	Met	PA450395	79811	0.612
NULL	Curr_Pharm_Des_2011_Aug_17(24)_2528-2541.nxml.txt.nlp	21774770	SENT226	7	7	20	20	urea	OTC	PA451831	5009	0.612
NULL	Mol_Cancer_2008_Jun_30_7_60.nxml.txt.nlp	18590557	SENT4	28	28	39	39	paclitaxel	TRAIL	PA450761	8743	0.612
NULL	J_Cancer_2013_Jul_1_4(5)_433-446.nxml.txt.nlp	23833688	SENT234	20	20	4	4	raloxifene	STAR	PA451221	6770;2984	0.612
NULL	Ann_Gastroenterol_2013_26(1)_29-36.nxml.txt.nlp	24714698	SENT75	0	0	7	7	doxorubicin	STZ	PA449412	6484	0.612
NULL	Pharmaceuticals_(Basel)_2013_Aug_6_6(8)_929-959.nxml.txt.nlp	24276377	SENT1196	4	4	11	11	bortezomib	p53	PA10252	7157	0.612
NULL	J_Mol_Med_2011_Apr_16_89(4)_321-329.nxml.txt.nlp	21079906	SENT190	7	7	10	10	capsaicin	VR1	PA448776	56664	0.612
NULL	Chin_J_Cancer_2012_Feb_31(2)_100-109.nxml.txt.nlp	22237039	SENT94	43	43	31	31	paclitaxel	Bcl-2	PA450761	596	0.612
NULL	Sci_Rep_2015_Jan_6_5_7641.nxml.txt.nlp	25560734	SENT90	4	4	0	0	tamoxifen	CLTC	PA451581	1213	0.612
NULL	Indian_J_Endocrinol_Metab_2012_Mar_16(Suppl1)_S47-S56.nxml.txt.nlp	22701844	SENT111	14	14	9	9	liraglutide	GLP-1	PA165958364	100125288	0.612
NULL	Orthop_Rev_(Pavia)_2010_Mar_20_2(1)_e9.nxml.txt.nlp	21808704	SENT30	13	13	29	29	fentanyl	EDA	PA449599	1896	0.612
NULL	J_Neurol_2011_Jul_2_258(7)_1207-1222.nxml.txt.nlp	21461686	SENT263	5	5	7	7	baclofen	OPT	PA448533	51430	0.612
NULL	Mol_Cancer_2007_Aug_21_6_53.nxml.txt.nlp	17711579	SENT153	6	6	32	32	cisplatin	BAG5	PA449014	9529	0.612
NULL	Cells_2014_Apr_8_3(2)_258-287.nxml.txt.nlp	24717323	SENT101	25	25	39	39	capsaicin	TRPV1	PA448776	7442	0.612
NULL	Cancer_Med_2014_Dec_11_3(6)_1502-1511.nxml.txt.nlp	25111859	SENT25	11	11	6	6	gemcitabine	BTC	PA449748	685	0.612
NULL	Mar_Drugs_2011_Aug_10_9(8)_1359-1367.nxml.txt.nlp	21892350	SENT29	13	13	15	15	lipase	HSL	PA450239	3991	0.612
NULL	Neural_Regen_Res_2012_Oct_5_7(28)_2227-2239.nxml.txt.nlp	25538744	SENT174	25	25	16	16	estradiol	aromatase	PA449503	1588	0.612
NULL	Ann_Gen_Psychiatry_2008_Aug_18_7_11.nxml.txt.nlp	18706108	SENT108	13	13	1	1	bupropion	CD50	PA448687	3385	0.612
NULL	Case_Rep_Med_2014_Mar_4_2014_923496.nxml.txt.nlp	24715926	SENT83	16	16	21	21	tocilizumab	ACR	PA165292659	49	0.612
NULL	Breast_Cancer_Res_2006_Nov_1_8(Suppl_2)_P18.nxml.txt.nlp	NULL	SENT9	2	2	12	12	tetracycline	CD44	PA451640	960	0.612
NULL	Arthritis_Res_Ther_2012_Jun_25_14(3)_215.nxml.txt.nlp	22731694	SENT70	19	19	0	0	ribavirin	CPX	PA451241	1371;10682;1377	0.612
NULL	J_Phys_Ther_Sci_2013_Oct_20_25(10)_1317-1319.nxml.txt.nlp	24259784	SENT15	11	11	36	36	oxygen	ADP	PA450744	23038	0.612
NULL	Pharmaceutics_2011_Mar_9_3(1)_73-87.nxml.txt.nlp	24310426	SENT21	22	22	19	19	hydrocodone	API	PA449900	5345	0.612
NULL	Drug_Target_Insights_2012_Aug_6_6_19-39.nxml.txt.nlp	22915839	SENT205	13	13	9	9	doxorubicin	Hsp90	PA449412	3320	0.612
NULL	Cardiovasc_Diabetol_2013_Nov_4_12_159.nxml.txt.nlp	24180232	SENT132	2	2	17	17	olmesartan	URAT1	PA164742950	116085	0.612
NULL	Tanaffos_2013_12(1)_6-15.nxml.txt.nlp	25191444	SENT60	11	11	5	5	pyrazinamide	EMB	PA451182	133418	0.612
NULL	Diabetes_Care_2012_Feb_16_35(2)_327-333.nxml.txt.nlp	22179958	SENT112	35	35	23	23	metformin	B12	PA450395	7126;4709	0.612
NULL	Cell_Commun_Signal_2009_Aug_27_7_20.nxml.txt.nlp	19712465	SENT307	5	5	9	9	carbachol	ERK1	PA448784	5595	0.612
NULL	Aging_(Albany_NY)_2012_Jul_22_4(7)_480-498.nxml.txt.nlp	22837425	SENT62	22	22	9	9	s-adenosylmethionine	SAHH	PA164754994	191	0.612
NULL	Brain_Sci_2013_Jun_14_3(2)_941-963.nxml.txt.nlp	24961432	SENT747	1	1	9	9	ethanol	GDNF	PA448073	2668	0.612
NULL	Mol_Cancer_2008_Mar_26_7_27.nxml.txt.nlp	18366759	SENT83	12	12	21	21	etoposide	E2F5	PA449552	1875	0.612
NULL	Oncol_Lett_2013_Oct_24_6(4)_970-976.nxml.txt.nlp	24137447	SENT159	8	8	6	6	doxorubicin	ADM	PA449412	133	0.612
NULL	ScientificWorldJournal_2014_Dec_21_2014_586270.nxml.txt.nlp	25587567	SENT776	6	6	23	23	estradiol	JNK3	PA449503	5602	0.612
NULL	Crit_Care_2007_Dec_6_11(6)_235.nxml.txt.nlp	18177512	SENT128	39	39	30	30	amiodarone	CASH	PA448383	8837	0.612
NULL	Int_J_Mol_Sci_2014_Oct_23_15(10)_19265-19280.nxml.txt.nlp	25342321	SENT132	21	21	27	27	cisplatin	MVD	PA449014	4597	0.612
NULL	Crit_Care_2005_Sep_3_9(1)_23-24.nxml.txt.nlp	15693976	SENT23	14	14	1	1	dantrolene	CHS	PA449208	1130	0.612
NULL	Neuro_Oncol_2010_Nov_20_12(11)_1167-1172.nxml.txt.nlp	20729242	SENT42	9	9	15	15	temozolomide	CRA	PA451609	51747;10903	0.612
NULL	Cancer_Cell_2007_Dec_11_12(6)_514-527.nxml.txt.nlp	18068629	SENT99	8	8	5	5	paclitaxel	TGFBI	PA450761	7045	0.612
NULL	J_Gastroenterol_2013_Jan_28_48(1)_1-12.nxml.txt.nlp	23188091	SENT221	21	21	42	42	ribavirin	IFN	PA451241	3439	0.612
NULL	Diabetes_Metab_Syndr_Obes_2014_Jul_3_7_277-288.nxml.txt.nlp	25050071	SENT203	0	0	6	6	pioglitazone	gamma	PA450970	9913	0.612
NULL	Pharmacogn_Rev_2012_Jul-Dec_6(12)_100-106.nxml.txt.nlp	23055635	SENT188	9	9	27	27	ethanol	castor	PA448073	54897	0.612
NULL	Onco_Targets_Ther_2014_May_16_7_761-770.nxml.txt.nlp	24876785	SENT64	27	27	30	30	gefitinib	EGFR	PA131301952	1956	0.612
NULL	Genome_Biol_2004_Jun_11_5(7)_230.nxml.txt.nlp	15239821	SENT54	30	30	32	32	lipase	LIP	PA450239	23049	0.612
NULL	Diagn_Pathol_2013_Feb_16_8_26.nxml.txt.nlp	23414265	SENT23	16	16	24	24	thyroglobulin	CK19	PA164754910	3880	0.612
NULL	Hum_Genomics_2009_Jan_1_3(2)_128-142.nxml.txt.nlp	19164090	SENT29	25	25	14	14	carboplatin	XRCC1	PA448803	7515	0.612
NULL	Br_J_Cancer_1998_Nov_78(9)_1170-1174.nxml.txt.nlp	9820175	SENT13	24	24	26	26	coumarin	CYP2A6	PA134521193	1548	0.611
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT170	18	18	20	20	metformin	HIF-1	PA450395	29072	0.611
NULL	Arthritis_Res_Ther_2009_Nov_13_11(6)_R172.nxml.txt.nlp	19912653	SENT180	6	6	18	18	simvastatin	IVD	PA451363	3712	0.611
NULL	Cases_J_2009_Mar_10_2_6458.nxml.txt.nlp	20181159	SENT47	8	8	10	10	heparin	PF4	PA449855	5196	0.611
NULL	Arch_Toxicol_2014_Nov_5_88(12)_2135-2190.nxml.txt.nlp	25370008	SENT739	7	7	15	15	erythromycin	CYP3A	PA449493	1574	0.611
NULL	Oncotarget_2011_Aug_30_2(8)_610-626.nxml.txt.nlp	21881167	SENT116	26	26	5	5	doxorubicin	Raf-1	PA449412	5894	0.611
NULL	Exp_Ther_Med_2014_May_20_7(5)_1354-1358.nxml.txt.nlp	24940438	SENT29	6	6	17	17	dextran	CD80	PA449261	941	0.611
NULL	Neural_Plast_2012_Jul_8_2012_710943.nxml.txt.nlp	22830052	SENT234	22	22	17	17	betaine	B12	PA448603	7126;4709	0.611
NULL	Curr_Opin_Endocrinol_Diabetes_Obes_2014_Oct_28_21(5)_394-404.nxml.txt.nlp	25122493	SENT125	11	11	5	5	thyroglobulin	RAI	PA164754910	10848;6050	0.611
NULL	Indian_J_Endocrinol_Metab_2013_Jul-Aug_17(4)_665-671.nxml.txt.nlp	23961483	SENT166	7	7	9	9	lipase	ATGL	PA450239	57104	0.611
NULL	Int_J_Mol_Sci_2012_Feb_24_13(3)_2590-2617.nxml.txt.nlp	22489113	SENT231	14	14	11	11	benzaldehyde	mol	PA448571	90527	0.611
NULL	Oncoimmunology_2012_Mar_1_1(2)_189-194.nxml.txt.nlp	22720240	SENT23	7	7	4	4	imiquimod	TLR7	PA449972	51284	0.611
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT277	20	20	22	22	resveratrol	TRAIL		8743	0.611
NULL	Cancer_Med_2012_Oct_6_1(2)_198-206.nxml.txt.nlp	23342269	SENT226	28	28	30	30	leucovorin	ROX	PA450198	4335	0.611
NULL	Oncotarget_2012_Nov_14_3(12)_1557-1565.nxml.txt.nlp	23238683	SENT86	8	8	12	12	imatinib	CD34	PA10804	947	0.611
NULL	J_Biomed_Sci_2012_Nov_21_19(1)_99.nxml.txt.nlp	23170833	SENT173	24	24	33	33	atorvastatin	CXCR4	PA448500	7852	0.611
NULL	Int_J_Biomed_Imaging_2013_Feb_26_2013_230487.nxml.txt.nlp	23533377	SENT113	2	2	4	4	tamoxifen	FTX	PA451581	100302692	0.611
NULL	Biosci_Rep_2013_Feb_1_33(2)_e00020.nxml.txt.nlp	23176403	SENT394	9	9	4	4	gemcitabine	EGFR	PA449748	1956	0.611
NULL	J_Midlife_Health_2014_Jan-Mar_5(1)_38-40.nxml.txt.nlp	24672205	SENT33	6	6	0	0	estradiol	CEE	PA449503	51608	0.611
NULL	Diabetes_2013_Mar_14_62(3)_953-964.nxml.txt.nlp	23223176	SENT5	0	0	4	4	paroxetine	ROS	PA450801	6098	0.611
NULL	Pharmaceuticals_(Basel)_2012_Jun_28_5(7)_690-718.nxml.txt.nlp	24281707	SENT77	0	0	2	2	ethambutol	EMB	PA164784021	133418	0.611
NULL	Br_J_Cancer_2010_Jun_29_103(1)_61-72.nxml.txt.nlp	20588279	SENT247	5	5	7	7	trastuzumab	RhoB	PA451743	388	0.611
NULL	Br_J_Cancer_2013_Mar_19_108(5)_1052-1060.nxml.txt.nlp	23422754	SENT146	13	13	4	4	bevacizumab	VEGF-A	PA130232992	7422	0.611
NULL	Sci_Rep_2015_Jan_6_5_7641.nxml.txt.nlp	25560734	SENT395	3	3	8	8	tamoxifen	CLTC	PA451581	1213	0.611
NULL	Oncoimmunology_2013_May_1_2(5)_e23850.nxml.txt.nlp	23762785	SENT36	3	3	6	6	denosumab	RANK	PA166048634	8792	0.611
NULL	Oncol_Lett_2014_Jun_20_7(6)_1997-2002.nxml.txt.nlp	24932278	SENT122	4	4	2	2	denosumab	RANKL	PA166048634	8600	0.611
NULL	Ann_Lab_Med_2012_Mar_23_32(2)_105-112.nxml.txt.nlp	22389876	SENT160	31	31	14	14	alendronate	CTX	PA448082	1593	0.611
NULL	J_Adv_Pract_Oncol_2013_Jul_1_Jul-Aug_4(4)_238-250.nxml.txt.nlp	25032004	SENT3	5	5	17	17	imatinib	BSN	PA10804	8927	0.611
NULL	Gut_Pathog_2013_Mar_22_5_6.nxml.txt.nlp	23522652	SENT238	33	33	11	11	azithromycin	CTX	PA448519	1593	0.611
NULL	Open_Biol_2014_Nov_4(11)_140180.nxml.txt.nlp	25392452	SENT137	10	10	8	8	sargramostim	GM-CSF	PA164748631	1437	0.611
NULL	Ann_Surg_Oncol_2011_Feb_4_18(2)_321-327.nxml.txt.nlp	21049306	SENT171	15	15	13	13	melphalan	TNF-alpha	PA450354	7124	0.611
NULL	Oncotarget_2011_May_16_2(5)_418-421.nxml.txt.nlp	21789791	SENT19	21	21	23	23	bortezomib	TRAIL	PA10252	8743	0.611
NULL	J_Thromb_Haemost_2010_Mar_8(3)_577-587.nxml.txt.nlp	20040043	SENT207	44	44	26	26	rosiglitazone	PGD2	PA451283	27306	0.611
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT90	16	16	18	18	curcumin	TRAIL	PA151958596	8743	0.611
NULL	J_Exp_Clin_Cancer_Res_2008_Oct_11_27(1)_50.nxml.txt.nlp	18847500	SENT251	17	17	9	9	collagenase	SAPK	PA449107	5601	0.611
NULL	AIDS_Res_Treat_2012_May_14_2012_246280.nxml.txt.nlp	22675613	SENT17	1	1	8	8	tenofovir	ATV	PA10204	4683	0.611
NULL	Cancer_Metab_2013_Feb_4_1_7.nxml.txt.nlp	24280108	SENT72	29	29	19	19	l-glutamine	FBS	PA10090	64319;26269	0.611
NULL	Breast_Cancer_Res_2010_Jun_24_12(3)_R41.nxml.txt.nlp	20576088	SENT273	21	21	30	30	paclitaxel	THBS1	PA450761	7057	0.611
NULL	Indian_J_Dermatol_2008_53(3)_149-153.nxml.txt.nlp	19882018	SENT64	20	20	22	22	ethambutol	EMB	PA164784021	133418	0.611
NULL	Indian_J_Endocrinol_Metab_2013_Sep-Oct_17(5)_819-834.nxml.txt.nlp	24083163	SENT316	19	19	14	14	liraglutide	GLP-1	PA165958364	100125288	0.611
NULL	Crit_Care_2008_Jan_24_12(1)_R27.nxml.txt.nlp	18304335	SENT235	38	38	18	18	thrombin	Rho	PA451674	29984	0.611
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Jul_9_3(7)_e124.nxml.txt.nlp	25006781	SENT13	18	18	37	37	rosuvastatin	OATP1B1	PA134308647	10599	0.611
NULL	Autophagy_2012_May_1_8(5)_853-855.nxml.txt.nlp	22617440	SENT70	18	18	20	20	imatinib	MIR30A	PA10804	407029	0.611
NULL	Cell_Microbiol_2014_Jun_21_16(6)_797-815.nxml.txt.nlp	24552180	SENT24	17	17	19	19	lipase	HSL	PA450239	3991	0.611
NULL	Inflamm_Res_2010_Sep_26_59(9)_699-709.nxml.txt.nlp	20339899	SENT29	23	23	26	26	thrombin	PAR4	PA451674	9002;5074	0.611
NULL	Indian_J_Endocrinol_Metab_2013_Oct_17(Suppl1)_S35-S44.nxml.txt.nlp	24251212	SENT236	34	34	20	20	calcidiol	PTH	PA164745614	5741	0.611
NULL	Nat_Commun_2013_Oct_28_4_2610.nxml.txt.nlp	24162018	SENT64	7	7	23	23	doxycycline	AXIN2	PA449415	8313	0.611
NULL	Breast_Cancer_Res_2010_Jun_24_12(3)_R41.nxml.txt.nlp	20576088	SENT138	27	27	2	2	paclitaxel	TUBG1	PA450761	7283	0.611
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1437-1448.nxml.txt.nlp	24056706	SENT111	10	10	20	20	furafylline	CYP2C19	PA452614	1557	0.611
NULL	Exp_Diabetes_Res_2012_Jun_14_2012_859395.nxml.txt.nlp	22778716	SENT136	27	27	30	30	estradiol	adiponectin	PA449503	9370	0.611
NULL	N_Am_J_Med_Sci_2011_Jan_3(1)_1-12.nxml.txt.nlp	22540056	SENT213	18	18	20	20	gemcitabine	GEM	PA449748	2669	0.611
NULL	Front_Oncol_2013_Sep_23_3_250.nxml.txt.nlp	24069582	SENT407	4	4	9	9	metformin	HER-2	PA450395	2064	0.611
NULL	Br_J_Ophthalmol_2014_Sep_7_98(9)_1186-1191.nxml.txt.nlp	24711658	SENT81	29	29	20	20	ranibizumab	CRT	PA164746012	811	0.611
NULL	J_Hypertens_2014_Jun_30_32(6)_1178-1188.nxml.txt.nlp	24621808	SENT83	0	0	4	4	phentermine	FOR	PA164748099	51741	0.611
NULL	Oncotarget_2014_Mar_14_5(5)_1149-1156.nxml.txt.nlp	24658419	SENT47	4	4	9	9	doxorubicin	p53	PA449412	7157	0.611
NULL	Environ_Health_Perspect_2008_Mar_26_116(3)_322-328.nxml.txt.nlp	18335098	SENT99	16	16	10	10	genistein	PMI	PA165109660	8834;5373	0.611
NULL	Mol_Vis_2012_Nov_29_18_2839-2846.nxml.txt.nlp	23233786	SENT167	39	39	29	29	geldanamycin	Hsp90	PA152031327	3320	0.611
NULL	Biologics_2014_Feb_15_8_67-81.nxml.txt.nlp	24600203	SENT235	25	25	14	14	natalizumab	IL-23	PA164747191	51561	0.611
NULL	Carcinogenesis_2008_Sep_9_29(9)_1734-1741.nxml.txt.nlp	18544564	SENT15	4	4	29	29	bortezomib	DR5	PA10252	8795	0.611
NULL	Cancers_(Basel)_2013_Apr_11_5(2)_418-429.nxml.txt.nlp	24216984	SENT251	5	5	17	17	sirolimus	VEGF-D	PA451365	2277	0.611
NULL	Oncol_Lett_2013_Oct_24_6(4)_970-976.nxml.txt.nlp	24137447	SENT15	13	13	15	15	doxorubicin	ADM	PA449412	133	0.611
NULL	Drug_Des_Devel_Ther_2014_Sep_23_8_1527-1538.nxml.txt.nlp	25284985	SENT127	6	6	4	4	celecoxib	IFN	PA448871	3439	0.611
NULL	Int_J_Chron_Obstruct_Pulmon_Dis_2007_Dec_2(4)_517-533.nxml.txt.nlp	18268925	SENT206	8	8	38	38	roflumilast	IL-8	PA165948052	3576	0.611
NULL	Anal_Biochem_2014_Jun_1_454(100)_17-22.nxml.txt.nlp	24637157	SENT190	12	12	1	1	camptothecin	SCAN1	PA153590860	55775	0.611
NULL	Brain_Sci_2013_Jun_3_3(2)_877-907.nxml.txt.nlp	24961429	SENT1905	1	1	18	18	taurine	p53	PA451590	7157	0.611
NULL	Cancer_Imaging_2010_Sep_29_10(1A)_S83-S91.nxml.txt.nlp	20880795	SENT95	22	22	1	1	octreotide	FDG	PA450678	23583	0.611
NULL	Drugs_2012_Dec_25_72(16)_2043-2050.nxml.txt.nlp	23039281	SENT79	7	7	4	4	hydroxyprogesterone	API	PA449932	5345	0.611
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT359	10	10	1	1	heparin	FGF1	PA449855	2246	0.611
NULL	Crit_Care_2008_Aug_29_12(4)_R111.nxml.txt.nlp	18759963	SENT98	36	36	21	21	heparin	SAPS	PA449855	8935	0.611
NULL	Breast_Cancer_Res_2014_May_23_16(3)_R50.nxml.txt.nlp	24887458	SENT112	11	11	0	0	trastuzumab	HER2	PA451743	2064	0.611
NULL	Evid_Based_Complement_Alternat_Med_2011_Apr_26_2011_965095.nxml.txt.nlp	21584198	SENT25	23	23	21	21	iron	mol	PA450087	90527	0.611
NULL	Tanaffos_2012_11(1)_67-70.nxml.txt.nlp	25191405	SENT38	4	4	14	14	thyroglobulin	CK20	PA164754910	54474	0.611
NULL	Hum_Mol_Genet_2012_Jan_15_21(2)_300-310.nxml.txt.nlp	21979946	SENT422	8	8	2	2	nadh	p53	PA164755085	7157	0.611
NULL	Neural_Develop_2007_Dec_3_2_26.nxml.txt.nlp	18053187	SENT202	37	37	8	8	tamoxifen	Math1	PA451581	474	0.611
NULL	Int_J_Mol_Sci_2014_Jun_25_15(7)_11234-11244.nxml.txt.nlp	24968266	SENT34	30	30	38	38	docetaxel	PC-3	PA449383	692094	0.611
NULL	Clin_Ophthalmol_2014_Nov_19_8_2301-2305.nxml.txt.nlp	25429200	SENT103	5	5	13	13	bevacizumab	CRT	PA130232992	811	0.611
NULL	J_Gen_Physiol_2012_Mar_139(3)_219-234.nxml.txt.nlp	22371363	SENT656	2	2	10	10	topiramate	CA1	PA451728	759	0.611
NULL	Biosci_Rep_2012_Aug_1_32(Pt_4)_361-374.nxml.txt.nlp	22762204	SENT1620	17	17	4	4	topotecan	p16	PA451729	1029	0.611
NULL	Mol_Biol_Cell_2012_Sep_1_23(17)_3461-3472.nxml.txt.nlp	22767580	SENT270	32	32	4	4	paraformaldehyde	ILK	PA450790	3611	0.611
NULL	Front_Behav_Neurosci_2010_Apr_5_4_14.nxml.txt.nlp	20407577	SENT327	0	0	3	3	cocaine	BDNF	PA449072	627	0.611
NULL	Int_J_Hypertens_2013_Jun_17_2013_627938.nxml.txt.nlp	23844279	SENT37	26	26	15	15	telmisartan	A10	PA451605	28870	0.611
NULL	Drug_Target_Insights_2013_Aug_19_7_27-34.nxml.txt.nlp	24023511	SENT104	36	36	24	24	doxorubicin	P-gp	PA449412	5243	0.611
NULL	Eur_J_Clin_Pharmacol_2010_Nov_29_66(11)_1131-1136.nxml.txt.nlp	20669013	SENT21	0	0	13	13	voriconazole	CYP2C19	PA10233	1557	0.611
NULL	J_Ayurveda_Integr_Med_2013_Apr-Jun_4(2)_99-106.nxml.txt.nlp	23930042	SENT41	22	22	2	2	glipizide	STZ	PA449762	6484	0.611
NULL	Biomed_Res_Int_2013_Jul_30_2013_754946.nxml.txt.nlp	23984405	SENT166	22	22	34	34	mannitol	B2M	PA450320	567	0.611
NULL	Oncotarget_2014_Aug_25_5(17)_7945-7959.nxml.txt.nlp	25277206	SENT28	19	19	16	16	cabozantinib	EGFR	PA165906891	1956	0.611
NULL	Can_J_Infect_Dis_Med_Microbiol_2014_May-Jun_25(3)_163-169.nxml.txt.nlp	25285114	SENT221	11	11	26	26	gentamicin	TOB	PA449753	10140	0.611
NULL	Mol_Cancer_2012_Mar_8_11_10.nxml.txt.nlp	22401567	SENT253	2	2	25	25	cisplatin	MSH5	PA449014	4439	0.611
NULL	Crit_Care_2007_Dec_18_11(6)_178.nxml.txt.nlp	18177510	SENT42	7	7	0	0	vasopressin	AVP	PA451858	114548;551	0.611
NULL	Br_J_Cancer_2010_Jan_5_102(1)_80-86.nxml.txt.nlp	19920817	SENT124	24	24	26	26	bevacizumab	IFN	PA130232992	3439	0.611
NULL	Exp_Ther_Med_2013_Mar_8_5(3)_707-710.nxml.txt.nlp	23404433	SENT97	13	13	28	28	cisplatin	Bcl-2	PA449014	596	0.611
NULL	Asia_Pac_Allergy_2014_Jul_29_4(3)_156-163.nxml.txt.nlp	25097851	SENT16	22	22	19	19	pyrazinamide	EMB	PA451182	133418	0.611
NULL	Br_J_Cancer_2012_Apr_24_106(9)_1486-1494.nxml.txt.nlp	22472882	SENT118	11	11	24	24	rosiglitazone	HPSE	PA451283	10855	0.611
NULL	Lab_Invest_2013_Dec_14_93(12)_1265-1275.nxml.txt.nlp	24126890	SENT183	5	5	14	14	celecoxib	JAM-A	PA448871	50848	0.611
NULL	Scientifica_(Cairo)_2012_Sep_3_2012_757890.nxml.txt.nlp	24278738	SENT124	19	19	22	22	curcumin	p38	PA151958596	10598;1432;7965	0.611
NULL	Environ_Health_Perspect_2007_Sep_21_115(9)_1264-1270.nxml.txt.nlp	17805414	SENT95	14	14	16	16	diethylstilbestrol	DES	PA449307	1674	0.611
NULL	Oncol_Lett_2014_May_24_7(5)_1594-1598.nxml.txt.nlp	24765183	SENT22	5	5	7	7	gemcitabine	Gem	PA449748	51053	0.611
NULL	J_Brachial_Plex_Peripher_Nerve_Inj_2010_Dec_7_5_18.nxml.txt.nlp	21138588	SENT78	10	10	29	29	trypsin	B27	PA451806	56246	0.611
NULL	Br_J_Cancer_2006_Dec_4_95(11)_1504-1513.nxml.txt.nlp	17088902	SENT198	47	47	14	14	gefitinib	EGFR	PA131301952	1956	0.611
NULL	Acta_Neuropathol_Commun_2014_Sep_16_2(1)_138.nxml.txt.nlp	NULL	SENT64	32	32	21	21	natalizumab	IFN	PA164747191	3439	0.611
NULL	Oncogene_2013_Oct_17_32(42)_5089-5100.nxml.txt.nlp	23178492	SENT291	19	19	8	8	vorinostat	TGFBR2	PA164748224	7048	0.611
NULL	AIDS_Res_Ther_2013_May_1_10_10.nxml.txt.nlp	23634877	SENT152	8	8	5	5	lovastatin	CCR5	PA450272	1234	0.611
NULL	Diabetes_2009_Dec_31_58(12)_2813-2819.nxml.txt.nlp	19720793	SENT103	34	34	24	24	diazoxide	INS-1	PA449285	2305	0.611
NULL	Clin_Infect_Dis_2012_Aug_1_55(Suppl_2)_S132-S142.nxml.txt.nlp	22752862	SENT129	8	8	6	6	vancomycin	VAN	PA451850	10318	0.611
NULL	Mucosal_Immunol_2014_Jan_1_7(1)_68-77.nxml.txt.nlp	23632327	SENT150	13	13	34	34	collagenase	CD11c	PA449107	3687	0.611
NULL	Diabetes_Metab_J_2012_Oct_18_36(5)_328-335.nxml.txt.nlp	23130316	SENT144	11	11	6	6	rosiglitazone	PDK4	PA451283	5166	0.611
NULL	Biomed_Res_Int_2013_Sep_5_2013_929531.nxml.txt.nlp	24083250	SENT56	25	25	29	29	hyaluronan	HAS1	PA165958431	3036	0.611
NULL	Diabetologia_2010_Jun_27_53(6)_1142-1150.nxml.txt.nlp	20349036	SENT189	1	1	5	5	spermine	AMPK	PA164781199	5563	0.611
NULL	Cancer_Cell_Int_2010_Aug_24_10_29.nxml.txt.nlp	20735832	SENT228	7	7	14	14	celecoxib	mda-7	PA448871	11009	0.611
NULL	Acta_Pharmacol_Sin_2010_Mar_5_31(3)_307-312.nxml.txt.nlp	20140003	SENT6	9	9	2	2	creatine	H-FABP	PA164778930	2170	0.611
NULL	J_Hematol_Oncol_2009_Oct_27_2_45.nxml.txt.nlp	19860903	SENT124	14	14	11	11	bevacizumab	IFN	PA130232992	3439	0.611
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT105	10	10	12	12	perifosine	TRAIL	PA165291471	8743	0.611
NULL	J_Korean_Med_Sci_2010_Jan_29_25(1)_35-41.nxml.txt.nlp	20052345	SENT38	34	34	15	15	pioglitazone	PMI	PA450970	8834;5373	0.611
NULL	Ann_Rehabil_Med_2012_Dec_28_36(6)_857-860.nxml.txt.nlp	23342320	SENT13	37	37	32	32	warfarin	VKORC1	PA451906	79001	0.611
NULL	Arthritis_Res_Ther_2011_Feb_28_13(1)_205.nxml.txt.nlp	21371351	SENT62	9	9	5	5	etanercept	TNF	PA449515	7124	0.611
NULL	Mol_Med_Rep_2015_Jan_17_11(1)_43-52.nxml.txt.nlp	25333456	SENT266	35	35	33	33	cisplatin	DDP	PA449014	1678	0.611
NULL	J_Thromb_Thrombolysis_2011_Nov_26_32(4)_459-466.nxml.txt.nlp	21706290	SENT30	14	14	5	5	clopidogrel	CYP2C19	PA449053	1557	0.611
NULL	Support_Care_Cancer_2009_Sep_10_17(9)_1187-1193.nxml.txt.nlp	19205754	SENT65	2	2	6	6	dolasetron	ANOVA	PA449390	4858	0.611
NULL	Nanoscale_Res_Lett_2014_Feb_15_9(1)_76.nxml.txt.nlp	24528570	SENT133	17	17	14	14	hydroquinone	mol	PA449924	90527	0.611
NULL	Surg_Today_2012_Jan_6_42(1)_8-28.nxml.txt.nlp	22139128	SENT271	6	6	16	16	tegafur	PSK	PA452620	9344	0.611
NULL	J_Cell_Mol_Med_2014_Jan_31_18(1)_27-37.nxml.txt.nlp	24373581	SENT173	0	0	44	44	alendronate	VEGFR2	PA448082	3791	0.611
NULL	Ann_Lab_Med_2013_Jan_17_33(1)_86-88.nxml.txt.nlp	23301230	SENT52	14	14	12	12	cefotaxime	CTX	PA448852	1593	0.611
NULL	Mol_Cell_Biochem_2014_Oct_9_385(1-2)_265-275.nxml.txt.nlp	24104452	SENT100	6	6	12	12	bortezomib	U87	PA10252	677775;641648	0.611
NULL	Br_J_Cancer_2013_May_28_108(10)_2063-2069.nxml.txt.nlp	23591198	SENT73	25	25	13	13	axitinib	GEM	PA164924493	2669	0.611
NULL	Cancer_Med_2014_Apr_27_3(2)_310-321.nxml.txt.nlp	24464839	SENT224	5	5	8	8	everolimus	MVD	PA164746311	4597	0.611
NULL	Curr_Genomics_2014_Jun_15(3)_217-230.nxml.txt.nlp	24955029	SENT650	16	16	4	4	oxygen	ROS	PA450744	6098	0.611
NULL	Ann_Nucl_Med_2013_Apr_5_27(7)_592-599.nxml.txt.nlp	23558450	SENT34	0	0	2	2	bleomycin	BLM	PA448645	641	0.611
NULL	J_Oncol_2011_Jun_12_2011_542358.nxml.txt.nlp	21772843	SENT368	6	6	0	0	cetuximab	EGFR	PA10040	1956	0.611
NULL	J_Int_Soc_Sports_Nutr_2007_Oct_19_4_13.nxml.txt.nlp	17949492	SENT23	7	7	16	16	estradiol	aromatase	PA449503	1588	0.611
NULL	Arthritis_Res_Ther_2014_Sep_18_16(5)_427.nxml.txt.nlp	25230745	SENT271	1	1	15	15	bevacizumab	MMP13	PA130232992	4322	0.611
NULL	Cancer_Cell_Int_2013_Jun_26_13_63.nxml.txt.nlp	23800022	SENT115	0	0	7	7	genistein	MCL1	PA165109660	4170	0.611
NULL	J_Hematol_Oncol_2008_Aug_11_1_11.nxml.txt.nlp	18694493	SENT134	10	10	15	15	bevacizumab	IFN	PA130232992	3439	0.611
NULL	Curr_Pharm_Des_2014_Dec_20(42)_6584-6643.nxml.txt.nlp	25341935	SENT868	8	8	17	17	rituximab	CD19	PA451261	930	0.611
NULL	Br_J_Cancer_2011_Jul_12_105(2)_255-262.nxml.txt.nlp	21694725	SENT22	16	16	1	1	cetuximab	KRAS	PA10040	3845	0.611
NULL	Biol_Proced_Online_2003_Oct_24_5_197-203.nxml.txt.nlp	14615816	SENT133	20	20	10	10	dextran	GM-CSF	PA449261	1437	0.611
NULL	J_Biol_Chem_2013_Nov_22_288(47)_34217-34229.nxml.txt.nlp	24106270	SENT305	16	16	11	11	thrombin	RhoG	PA451674	391	0.611
NULL	Arthritis_Res_Ther_2013_Mar_4_15(2)_R39.nxml.txt.nlp	23497717	SENT15	3	3	22	22	imiquimod	IL-18	PA449972	3606	0.611
NULL	Int_Cardiovasc_Res_J_2012_Dec_15_6(4)_113-117.nxml.txt.nlp	24757604	SENT30	16	16	12	12	sirolimus	DES	PA451365	1674	0.611
NULL	Cancers_(Basel)_2011_Apr_1_3(2)_1844-1860.nxml.txt.nlp	24212785	SENT129	13	13	4	4	bevacizumab	ACRC	PA130232992	93953	0.611
NULL	Ann_Hematol_2010_Nov_25_89(11)_1115-1124.nxml.txt.nlp	20499237	SENT108	36	36	26	26	fludarabine	CD5	PA449655	921	0.611
NULL	Gut_Pathog_2012_Jul_16_4_7.nxml.txt.nlp	22800501	SENT75	26	26	8	8	gentamicin	CTX	PA449753	1593	0.611
NULL	Sci_Rep_2014_Nov_28_4_7237.nxml.txt.nlp	25429875	SENT86	34	34	20	20	hesperidin	p38	PA449867	10598;1432;7965	0.611
NULL	Int_J_Environ_Res_Public_Health_2014_Jul_22_11(7)_7537-7561.nxml.txt.nlp	25054232	SENT18	9	9	11	11	diethylstilbestrol	DES	PA449307	1674	0.611
NULL	Acta_Naturae_2013_Jan-Mar_5(1)_73-84.nxml.txt.nlp	23556132	SENT68	22	22	32	32	l-glutamine	CO2	PA10090	4513	0.611
NULL	Int_J_Mol_Sci_2014_Oct_14_15(10)_18557-18573.nxml.txt.nlp	25318057	SENT993	6	6	26	26	bortezomib	survivin	PA10252	332	0.611
NULL	J_Young_Pharm_2011_Apr-Jun_3(2)_97-104.nxml.txt.nlp	21731353	SENT164	5	5	10	10	glipizide	CS1	PA449762	57823	0.611
NULL	J_Aquat_Anim_Health_2012_Sep_16_24(3)_185-194.nxml.txt.nlp	22897202	SENT116	12	12	14	14	lipase	HSL	PA450239	3991	0.611
NULL	Proteome_Sci_2010_Jul_9_8_38.nxml.txt.nlp	20618950	SENT163	2	2	6	6	trypsin	PDH	PA451806	54704	0.611
NULL	Sensors_(Basel)_2013_Feb_28_13(3)_2895-2910.nxml.txt.nlp	23449119	SENT123	17	17	11	11	pp2	PP1		5540;5464	0.611
NULL	Int_J_Mol_Sci_2014_Sep_19_15(9)_16698-16718.nxml.txt.nlp	25244018	SENT68	8	8	17	17	estradiol	LKB1	PA449503	6794	0.611
NULL	Eur_J_Immunol_2014_Jun_10_44(6)_1759-1769.nxml.txt.nlp	24595810	SENT82	17	17	2	2	fludrocortisone	CXCR4	PA164743961	7852	0.611
NULL	Diabetes_2009_Jan_58(1)_243-249.nxml.txt.nlp	18840785	SENT20	30	30	15	15	glucose	GLP-1	PA449773	100125288	0.611
NULL	Springerplus_2014_Sep_11_3_516.nxml.txt.nlp	25279308	SENT179	2	2	10	10	ethanol	CS-3	PA448073	91977	0.611
NULL	Mol_Cancer_2012_Apr_26_11_24.nxml.txt.nlp	22537161	SENT222	21	21	8	8	pp2	IFN		3439	0.611
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Jul_20_9_19.nxml.txt.nlp	20646305	SENT64	20	20	27	27	ceftazidime	CTX	PA448861	1593	0.611
NULL	J_Clin_Biochem_Nutr_2010_Jul_17_47(1)_53-58.nxml.txt.nlp	20664731	SENT395	6	6	0	0	clarithromycin	RAC	PA449028	207	0.611
NULL	Clin_Pharmacokinet_2014_Oct_15_53(2)_155-164.nxml.txt.nlp	24127209	SENT229	11	11	3	3	clopidogrel	CYP2C19	PA449053	1557	0.611
NULL	Diabetes_2009_Jan_58(1)_243-249.nxml.txt.nlp	18840785	SENT119	3	3	6	6	glucose	GLP-1	PA449773	100125288	0.611
NULL	Mol_Cells_2014_Sep_30_37(9)_664-671.nxml.txt.nlp	25234467	SENT44	16	16	12	12	cisplatin	miR-217	PA449014	406999	0.611
NULL	Leukemia_2014_Apr_14_28(4)_961-964.nxml.txt.nlp	24418991	SENT46	26	26	15	15	nilotinib	P-gp	PA165958345	5243	0.611
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1013.nxml.txt.nlp	24457957	SENT305	7	7	3	3	bortezomib	NOXA	PA10252	5366	0.611
NULL	Pediatr_Cardiol_2010_Jan_14_31(1)_90-95.nxml.txt.nlp	19915892	SENT2	21	21	9	9	palivizumab	AAP	PA164748781	5345	0.611
NULL	Front_Oncol_2014_Mar_25_4_54.nxml.txt.nlp	24724051	SENT346	9	9	13	13	imatinib	BCL6	PA10804	604	0.611
NULL	J_Cardiovasc_Dis_Res_2010_Jan-Mar_1(1)_29-36.nxml.txt.nlp	21188088	SENT170	11	11	4	4	amiloride	TNF	PA448368	7124	0.611
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_408-414.nxml.txt.nlp	21372831	SENT29	7	7	12	12	vincristine	CHOP	PA451879	1649	0.611
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT371	0	0	14	14	pp2	PP1		5540;5464	0.611
NULL	Front_Oncol_2013_Sep_23_3_250.nxml.txt.nlp	24069582	SENT338	34	34	38	38	tamoxifen	STAR	PA451581	6770;2984	0.611
NULL	Diabetes_Care_2013_Jul_12_36(7)_2015-2019.nxml.txt.nlp	23340883	SENT123	31	31	18	18	glucose	SII	PA449773	6917	0.611
NULL	Oncol_Rep_2014_Apr_28_31(4)_1605-1612.nxml.txt.nlp	24481648	SENT138	0	0	15	15	bortezomib	P-gp	PA10252	5243	0.611
NULL	J_Gen_Physiol_1924_Mar_20_6(4)_439-452.nxml.txt.nlp	19872085	SENT0	12	12	1	1	trypsin	Gen	PA451806	348654	0.611
NULL	An_Bras_Dermatol_2012_Nov-Dec_87(6)_857-861.nxml.txt.nlp	23197204	SENT92	8	8	5	5	tetracycline	PEN	PA451640	9933	0.611
NULL	Br_J_Cancer_2009_Sep_15_101(6)_957-966.nxml.txt.nlp	19738618	SENT148	21	21	5	5	dexrazoxane	THBS-1	PA449259	7057	0.611
NULL	J_Young_Pharm_2011_Apr-Jun_3(2)_97-104.nxml.txt.nlp	21731353	SENT142	5	5	10	10	glipizide	CS1	PA449762	57823	0.611
NULL	Biomed_Res_Int_2013_Aug_5_2013_462589.nxml.txt.nlp	23998124	SENT18	0	0	2	2	bleomycin	BLM	PA448645	641	0.611
NULL	Mol_Cancer_2012_Jul_12_11_45.nxml.txt.nlp	22788833	SENT135	8	8	10	10	cisplatin	EGFR	PA449014	1956	0.611
NULL	Eur_J_Clin_Microbiol_Infect_Dis_2012_May_7_31(5)_739-745.nxml.txt.nlp	21822974	SENT63	6	6	12	12	linezolid	SYN	PA450233	2534;23336	0.611
NULL	Cancer_2012_Mar_15_118(6)_1474-1485.nxml.txt.nlp	21837668	SENT61	8	8	31	31	doxorubicin	GM-CSF	PA449412	1437	0.611
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Jun_25_3(6)_e120.nxml.txt.nlp	24964282	SENT89	9	9	6	6	rifampin	CYP3A4	PA451250	1576	0.611
NULL	Br_J_Cancer_2002_Feb_1_86(3)_490-496.nxml.txt.nlp	11875720	SENT104	17	17	2	2	collagenase	BAI1	PA449107	575	0.611
NULL	Front_Behav_Neurosci_2014_Nov_7_8_371.nxml.txt.nlp	25426037	SENT251	8	8	24	24	fluphenazine	ANOVA	PA449676	4858	0.611
NULL	Mol_Neurobiol_2010_Jun_2_41(2-3)_392-409.nxml.txt.nlp	20437209	SENT394	6	6	0	0	selegiline	San	PA451316	80218	0.611
NULL	Br_J_Cancer_2012_Jul_24_107(3)_516-526.nxml.txt.nlp	22782351	SENT196	9	9	6	6	tamoxifen	TIGAR	PA451581	57103	0.611
NULL	Gynecol_Oncol_Case_Rep_2013_Dec_28_8_4-6.nxml.txt.nlp	24567884	SENT16	10	10	6	6	cisplatin	NAC	PA449014	22861	0.611
NULL	Front_Neurol_2011_Dec_16_2_72.nxml.txt.nlp	22203815	SENT191	9	9	16	16	protamine	CD4	PA10366	920	0.611
NULL	Br_J_Haematol_2014_Mar_13_164(1)_811-821.nxml.txt.nlp	24328678	SENT164	14	14	12	12	lenalidomide	Aiolos	PA162363968	22806	0.611
NULL	J_Korean_Med_Sci_2010_Dec_24_25(12)_1766-1770.nxml.txt.nlp	21165292	SENT131	28	28	18	18	glucose	DBP	PA449773	3295;1628;2638	0.611
NULL	J_Young_Pharm_2012_Jul-Sep_4(3)_171-176.nxml.txt.nlp	23112536	SENT145	10	10	12	12	lipase	HSL	PA450239	3991	0.611
NULL	Case_Rep_Dent_2013_Jul_10_2013_812323.nxml.txt.nlp	23936686	SENT96	18	18	13	13	hyaluronan	LYVE-1	PA165958431	10894	0.611
NULL	Pain_2013_Dec_154(12)_2606-2615.nxml.txt.nlp	23707280	SENT213	11	11	13	13	capsaicin	TRPV1	PA448776	7442	0.611
NULL	J_Int_Soc_Sports_Nutr_2014_May_12_11_20.nxml.txt.nlp	24864135	SENT325	18	18	10	10	creatine	CEE	PA164778930	51608	0.611
NULL	J_Insect_Sci_2002_Aug_21_2_17.nxml.txt.nlp	15455051	SENT2580	13	13	0	0	forskolin	PP1	PA146096022	5540;5464	0.611
NULL	Cancer_Microenviron_2013_Jan_22_6(3)_231-240.nxml.txt.nlp	23335094	SENT10	2	2	8	8	simvastatin	PC-3	PA451363	692094	0.611
NULL	Biochim_Biophys_Acta_2014_Jul_1842(7)_959-970.nxml.txt.nlp	24594481	SENT52	2	2	4	4	lipase	ATGL	PA450239	57104	0.611
NULL	J_Hematol_Oncol_2013_Aug_19_6_59.nxml.txt.nlp	23958373	SENT174	1	1	17	17	leflunomide	BTK	PA450192	695	0.611
NULL	Oncol_Lett_2014_Jul_22_8(1)_295-300.nxml.txt.nlp	24959264	SENT161	22	22	7	7	genistein	FOXM1	PA165109660	2305	0.611
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Aug_23_70(Pt_9)_142-144.nxml.txt.nlp	25309163	SENT4	7	7	9	9	ethanol	mol	PA448073	90527	0.611
NULL	Nat_Neurosci_2012_Jun_15(6)_845-852.nxml.txt.nlp	22522402	SENT108	17	17	4	4	primaquine	KAR	PA451103	51144	0.61
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT9	8	8	12	12	pp2	STZ		6484	0.61
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT259	24	24	6	6	bevacizumab	VEGF-A	PA130232992	7422	0.61
NULL	Clin_Ophthalmol_2008_Dec_2(4)_897-905.nxml.txt.nlp	19668444	SENT129	20	20	15	15	travoprost	BAK	PA164781371	578	0.61
NULL	Int_J_Surg_Oncol_2011_Aug_8_2011_374012.nxml.txt.nlp	22312502	SENT176	15	15	7	7	raloxifene	STAR	PA451221	6770;2984	0.61
NULL	Br_J_Cancer_2012_Apr_10_106(8)_1367-1373.nxml.txt.nlp	22454081	SENT12	3	3	6	6	trastuzumab	IGF1R	PA451743	3480	0.61
NULL	Hum_Mol_Genet_2012_Oct_1_21(19)_4201-4213.nxml.txt.nlp	22736029	SENT797	1	1	4	4	rasagiline	alpha-synuclein	PA164764584	6622	0.61
NULL	J_Clin_Biochem_Nutr_2007_Nov_30_41(3)_224-230.nxml.txt.nlp	18299720	SENT215	32	32	39	39	nitrogen	AST	PA450643	26503	0.61
NULL	Cancer_Cell_Int_2013_Sep_23_13_94.nxml.txt.nlp	24059699	SENT41	25	25	10	10	bevacizumab	VEGFA	PA130232992	7422	0.61
NULL	Diabetes_2009_Jun_31_58(6)_1434-1439.nxml.txt.nlp	19336679	SENT138	29	29	33	33	metformin	SLC22A1	PA450395	6580	0.61
NULL	Pharmaceuticals_(Basel)_2012_Oct_23_5(10)_1128-1146.nxml.txt.nlp	24281261	SENT360	0	0	9	9	taurine	GMP	PA451590	22978	0.61
NULL	J_Biol_Chem_2012_Apr_20_287(17)_13868-13876.nxml.txt.nlp	22389490	SENT280	11	11	14	14	capsaicin	VR1	PA448776	56664	0.61
NULL	Ecancermedicalscience_2010_Nov_3_4_178.nxml.txt.nlp	22276032	SENT172	3	3	11	11	gefitinib	HER2	PA131301952	2064	0.61
NULL	Arthritis_Rheum_2010_Dec_62(12)_3666-3676.nxml.txt.nlp	20722027	SENT168	15	15	25	25	lipase	FAAH	PA450239	79152;2166	0.61
NULL	Oncol_Lett_2013_Feb_7_5(2)_440-446.nxml.txt.nlp	23420122	SENT150	12	12	2	2	gemcitabine	AKT	PA449748	207	0.61
NULL	J_Infect_Dis_2013_Mar_1_207(5)_842-847.nxml.txt.nlp	23225895	SENT110	1	1	3	3	lumefantrine	LUM	PA165111722	4060	0.61
NULL	Int_J_Mol_Sci_2014_Mar_19_15(3)_4878-4902.nxml.txt.nlp	24651460	SENT30	26	26	29	29	arsenite	p38	PA452638	10598;1432;7965	0.61
NULL	Ann_Hematol_2014_Sep_10_93(1)_1-11.nxml.txt.nlp	24018623	SENT334	12	12	14	14	lenalidomide	CD34	PA162363968	947	0.61
NULL	Mol_Cancer_2008_Mar_6_7_24.nxml.txt.nlp	18325101	SENT149	1	1	6	6	cisplatin	FANCD2	PA449014	2177	0.61
NULL	Crit_Care_2010_Nov_5_14(6)_R200.nxml.txt.nlp	21054850	SENT101	13	13	10	10	vasopressin	AVP	PA451858	114548;551	0.61
NULL	Br_J_Cancer_2011_Jun_7_104(12)_1848-1853.nxml.txt.nlp	21610704	SENT169	10	10	23	23	panitumumab	TOX	PA162373091	9760	0.61
NULL	Diabetes_Care_2010_Jul_22_33(7)_1604-1606.nxml.txt.nlp	20413521	SENT19	17	17	7	7	vasopressin	AVP	PA451858	114548;551	0.61
NULL	Acta_Neuropathol_Commun_2014_May_30_2_57.nxml.txt.nlp	24887326	SENT186	4	4	10	10	etoposide	ABCB1	PA449552	5243	0.61
NULL	J_Mol_Signal_2011_Oct_5_6_13.nxml.txt.nlp	21975218	SENT139	24	24	12	12	ethanol	ID2	PA448073	3398	0.61
NULL	Emerg_Infect_Dis_2014_Mar_20(3)_400-408.nxml.txt.nlp	24565738	SENT139	2	2	16	16	rifampin	DST	PA451250	667	0.61
NULL	Cancer_Cell_Int_2004_Mar_19_4_3.nxml.txt.nlp	15035672	SENT78	21	21	5	5	camptothecin	PC3	PA153590860	57332;7832;5122	0.61
NULL	Br_J_Cancer_2010_Oct_26_103(9)_1325-1330.nxml.txt.nlp	20940720	SENT156	7	7	13	13	docetaxel	CRT	PA449383	811	0.61
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Jun_8_69(Pt_7)_o1056.nxml.txt.nlp	24046630	SENT69	8	8	11	11	phenol	mol	PA450913	90527	0.61
NULL	Cancer_2014_Feb_15_120(4)_513-520.nxml.txt.nlp	24258498	SENT38	18	18	14	14	hydroxyurea	ELN	PA449942	2006	0.61
NULL	Nat_Biotechnol_2012_Jul_1_30(7)_715-720.nxml.txt.nlp	22750882	SENT114	17	17	11	11	capsaicin	P2RX3	PA448776	5024	0.61
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT214	21	21	27	27	curcumin	TRAIL	PA151958596	8743	0.61
NULL	Eur_J_Med_Res_2014_Jun_24_19(1)_34.nxml.txt.nlp	24961604	SENT103	33	33	30	30	vincristine	BCL11A	PA451879	53335	0.61
NULL	N_Z_Vet_J_2010_Jun_7_58(3)_121-129.nxml.txt.nlp	20514085	SENT168	9	9	15	15	levamisole	MOX	PA450205	26002	0.61
NULL	Curr_Cardiol_Rev_2009_Aug_5(3)_216-222.nxml.txt.nlp	20676280	SENT139	30	30	26	26	lipase	ATGL	PA450239	57104	0.61
NULL	Breast_Cancer_Res_2011_Jun_27_13(3)_212.nxml.txt.nlp	21787441	SENT209	19	19	5	5	tamoxifen	NAC	PA451581	22861	0.61
NULL	Breast_Cancer_Res_2007_Aug_8_9(4)_R50.nxml.txt.nlp	17686159	SENT158	5	5	2	2	gefitinib	HRG	PA131301952	3084;3273	0.61
NULL	J_Gynecol_Oncol_2013_Jan_8_24(1)_66-82.nxml.txt.nlp	23346316	SENT249	23	23	9	9	trastuzumab	HER2	PA451743	2064	0.61
NULL	Exp_Ther_Med_2014_Dec_24_8(6)_1677-1682.nxml.txt.nlp	25371714	SENT7	16	16	7	7	isoproterenol	HIF-1	PA450121	29072	0.61
NULL	Arthritis_Res_Ther_2008_Jun_30_10(3)_209.nxml.txt.nlp	18598385	SENT242	13	13	17	17	oxaliplatin	HMGB1	PA131285527	3146	0.61
NULL	Arthritis_Res_Ther_2011_Jun_24_13(3)_115.nxml.txt.nlp	21722352	SENT37	17	17	42	42	imatinib	IL-17	PA10804	3605	0.61
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT190	3	3	5	5	resveratrol	TRAIL		8743	0.61
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT132	18	18	8	8	perifosine	DR5	PA165291471	8795	0.61
NULL	Curr_Gerontol_Geriatr_Res_2010_May_4_2010_420139.nxml.txt.nlp	20454643	SENT90	3	3	29	29	estradiol	AMPK	PA449503	5563	0.61
NULL	EPMA_J_2010_Sep_17_1(3)_369-375.nxml.txt.nlp	21151487	SENT191	10	10	1	1	tamoxifen	CYP2D6	PA451581	1565	0.61
NULL	J_Immunother_2014_Feb_21_37(2)_105-114.nxml.txt.nlp	24509173	SENT164	19	19	17	17	gemcitabine	GEM	PA449748	2669	0.61
NULL	Br_J_Cancer_2012_Oct_23_107(9)_1518-1524.nxml.txt.nlp	22996610	SENT174	4	4	6	6	capecitabine	CEA	PA448771	5670;1087	0.61
NULL	Biosci_Rep_2014_Dec_12_34(6)_e00160.nxml.txt.nlp	25495645	SENT8	12	12	17	17	rosiglitazone	ANGPTL3	PA451283	27329	0.61
NULL	Stroke_Res_Treat_2009_Dec_20_2010_386389.nxml.txt.nlp	20700422	SENT51	4	4	9	9	ebselen	NAC	PA161660841	22861	0.61
NULL	Cardiovasc_Toxicol_2013_May_1_13(4)_307-315.nxml.txt.nlp	23632742	SENT8	5	5	12	12	rosiglitazone	SOD1	PA451283	6647	0.61
NULL	Hum_Genet_2012_Oct_28_131(10)_1565-1589.nxml.txt.nlp	22740325	SENT244	0	0	2	2	diethylstilbestrol	DES	PA449307	1674	0.61
NULL	J_Int_Soc_Sports_Nutr_2009_Jan_28_6_4.nxml.txt.nlp	19175919	SENT39	12	12	14	14	lipase	HSL	PA450239	3991	0.61
NULL	Int_J_Nanomedicine_2012_Nov_2_7_5577-5591.nxml.txt.nlp	23144561	SENT200	26	26	16	16	verteporfin	VIII	PA451871	1351	0.61
NULL	Front_Behav_Neurosci_2011_Oct_5_5_63.nxml.txt.nlp	22007164	SENT1263	8	8	14	14	sr144528	CB2		1269	0.61
NULL	Adv_Hematol_2012_Aug_2_2012_842945.nxml.txt.nlp	22919394	SENT126	4	4	13	13	lenalidomide	IL-2	PA162363968	3558	0.61
NULL	Oncol_Lett_2013_Mar_11_5(3)_1010-1016.nxml.txt.nlp	23426784	SENT131	5	5	10	10	midazolam	p27	PA450496	5715;10534	0.61
NULL	Core_Evid_2009_Jun_15_4_25-36.nxml.txt.nlp	20694062	SENT325	26	26	13	13	febuxostat	ACTH	PA165958521	5443	0.61
NULL	Acta_Pharmacol_Sin_2010_Oct_13_31(10)_1243-1257.nxml.txt.nlp	20835267	SENT142	11	11	13	13	lipase	LPL	PA450239	4023	0.61
NULL	Exp_Diabetes_Res_2012_May_28_2012_924168.nxml.txt.nlp	22693487	SENT3	21	21	15	15	exenatide	GLP-1	PA164749238	100125288	0.61
NULL	Br_J_Pharmacol_2014_Jan_23_171(2)_523-535.nxml.txt.nlp	24372553	SENT35	0	0	27	27	metformin	AMPK	PA450395	5563	0.61
NULL	Acta_Pharmacol_Sin_2012_Nov_23_33(11)_1409-1416.nxml.txt.nlp	22820910	SENT136	16	16	10	10	clozapine	CYP1A2	PA449061	1544	0.61
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Nov_21_70(Pt_12)_562-565.nxml.txt.nlp	25552993	SENT34	12	12	8	8	phenol	spatial	PA450913	219793	0.61
NULL	Cell_Mol_Life_Sci_2012_Aug_22_69(16)_2751-2764.nxml.txt.nlp	22438059	SENT58	6	6	13	13	paraformaldehyde	CADM1	PA450790	23705	0.61
NULL	Front_Cell_Neurosci_2012_Oct_25_6_47.nxml.txt.nlp	23112761	SENT753	0	0	5	5	nimodipine	CA1	PA450633	759	0.61
NULL	Br_J_Cancer_2010_Jun_29_103(1)_61-72.nxml.txt.nlp	20588279	SENT18	4	4	15	15	trastuzumab	PTEN	PA451743	5728	0.61
NULL	Acta_Pharmacol_Sin_2013_Sep_5_34(9)_1208-1216.nxml.txt.nlp	23852087	SENT127	32	32	27	27	disulfiram	CA9	PA449376	768	0.61
NULL	Oncotarget_2011_Dec_31_2(12)_1314-1321.nxml.txt.nlp	22248929	SENT36	9	9	25	25	everolimus	PI3K	PA164746311	5290	0.61
NULL	J_Cell_Biol_2003_Dec_22_163(6)_1385-1395.nxml.txt.nlp	14676308	SENT396	0	0	11	11	thrombin	Rho	PA451674	29984	0.61
NULL	Biomed_Res_Int_2013_Dec_10_2013_159786.nxml.txt.nlp	24386633	SENT3	0	0	2	2	gemifloxacin	GMF	PA10088	2764	0.61
NULL	Aging_(Albany_NY)_2011_Jan_12_3(1)_3-4.nxml.txt.nlp	21248373	SENT12	32	32	34	34	doxorubicin	p53	PA449412	7157	0.61
NULL	Breast_Cancer_Res_2010_Aug_23_12(4)_R64.nxml.txt.nlp	20731819	SENT63	36	36	26	26	tamoxifen	MAF	PA451581	4094	0.61
NULL	J_Antimicrob_Chemother_2012_May_8_67(5)_1217-1223.nxml.txt.nlp	22316571	SENT31	13	13	8	8	lumefantrine	CYP3A4	PA165111722	1576	0.61
NULL	Int_J_Breast_Cancer_2011_Jan_20_2011_807380.nxml.txt.nlp	22332017	SENT75	0	0	11	11	clotrimazole	ABCC11	PA449057	85320	0.61
NULL	Mol_Vis_2007_Feb_27_13_273-286.nxml.txt.nlp	17356514	SENT56	17	17	4	4	glutaraldehyde	CO2	PA449777	4513	0.61
NULL	Indian_J_Pharmacol_2008_Oct_40(Suppl_2)_S160-S171.nxml.txt.nlp	21593969	SENT599	36	36	31	31	praziquantel	NAC	PA164764583	22861	0.61
NULL	J_Gen_Physiol_2003_Jul_122(1)_45-61.nxml.txt.nlp	12835470	SENT262	5	5	2	2	capsaicin	VR1	PA448776	56664	0.61
NULL	Anesth_Pain_Med_2013_Sep_1_3(2)_260-262.nxml.txt.nlp	24282779	SENT119	11	11	6	6	bupivacaine	AAP	PA135057240	5345	0.61
NULL	J_Lipid_Res_2015_Jan_56(1)_109-121.nxml.txt.nlp	25421061	SENT578	23	23	10	10	lipase	CGI-58	PA450239	51099	0.61
NULL	Environ_Health_Perspect_1987_Nov_75_25-27.nxml.txt.nlp	3319561	SENT4	14	14	16	16	diethylstilbestrol	DES	PA449307	1674	0.61
NULL	Protein_Cell_2014_Jun_19_5(6)_469-479.nxml.txt.nlp	24748116	SENT129	11	11	9	9	paclitaxel	EB1	PA450761	9167;22919;10982	0.61
NULL	Br_J_Cancer_2001_Aug_85(4)_509-517.nxml.txt.nlp	11506488	SENT8	9	9	16	16	oxaliplatin	ACRC	PA131285527	93953	0.61
NULL	Eur_J_Clin_Pharmacol_2014_Mar_22_70(6)_685-693.nxml.txt.nlp	24658827	SENT220	11	11	6	6	tacrolimus	MDR1	PA451578	5243	0.61
NULL	Int_J_Mol_Sci_2012_Feb_24_13(3)_2590-2617.nxml.txt.nlp	22489113	SENT231	14	14	21	21	benzaldehyde	mol	PA448571	90527	0.61
NULL	Int_J_Nanomedicine_2009_Apr_1_4_27-35.nxml.txt.nlp	19421368	SENT130	20	20	31	31	genistein	IFN	PA165109660	3439	0.61
NULL	Environ_Health_2009_Aug_18_8_37.nxml.txt.nlp	19689815	SENT2	0	0	2	2	diethylstilbestrol	DES	PA449307	1674	0.61
NULL	Drugs_R_D_2011_Mar_27_11(1)_37-51.nxml.txt.nlp	21410294	SENT203	36	36	25	25	itraconazole	CYP3A4	PA450132	1576	0.61
NULL	J_Ophthalmic_Inflamm_Infect_2010_Nov_17_1(1)_35-38.nxml.txt.nlp	21475657	SENT92	11	11	16	16	bevacizumab	TTF-1	PA130232992	7080	0.61
NULL	Case_Rep_Oncol_2014_Jul_5_7(2)_435-443.nxml.txt.nlp	25126073	SENT153	21	21	11	11	paclitaxel	Gem	PA450761	51053	0.61
NULL	Front_Neuroanat_2014_Nov_20_8_137.nxml.txt.nlp	25477790	SENT97	15	15	22	22	paraformaldehyde	NeuN	PA450790	146713	0.61
NULL	Infect_Drug_Resist_2011_Aug_4_4_149-154.nxml.txt.nlp	21904460	SENT5	6	6	25	25	cefepime	HAI	PA164754876	6692;6768	0.61
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Nov_8_64(Pt_12)_m1497.nxml.txt.nlp	21581118	SENT61	36	36	12	12	phenol	NO3	PA450913	4681	0.61
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Mar_19_67(Pt_4)_o912-o913.nxml.txt.nlp	21754185	SENT3	9	9	3	3	phenol	mol	PA450913	90527	0.61
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT94	5	5	7	7	curcumin	TRAIL	PA151958596	8743	0.61
NULL	Environ_Health_Perspect_2010_Sep_28_118(9)_1267-1272.nxml.txt.nlp	20427257	SENT69	7	7	3	3	estradiol	BPA	PA449503	667	0.61
NULL	Br_J_Cancer_2012_Aug_7_107(4)_707-712.nxml.txt.nlp	22828609	SENT127	23	23	33	33	celecoxib	MUC1	PA448871	4582	0.61
NULL	Carcinogenesis_2014_May_13_35(5)_1055-1066.nxml.txt.nlp	24419232	SENT25	3	3	5	5	metformin	p53	PA450395	7157	0.61
NULL	Nat_Chem_Biol_2010_Feb_6(2)_117-124.nxml.txt.nlp	20081827	SENT160	2	2	11	11	piperazine	p110	PA450977	9733	0.61
NULL	F1000_Med_Rep_2012_Feb_1_4_4.nxml.txt.nlp	22312414	SENT123	34	34	27	27	vancomycin	VISA	PA451850	57506	0.61
NULL	Oncol_Rep_2013_Apr_5_29(4)_1671-1677.nxml.txt.nlp	23404329	SENT35	19	19	16	16	curcumin	ASP	PA151958596	259266;443;9474;29974;434;83853	0.61
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT88	10	10	6	6	pp2	PP2		4888	0.61
NULL	Pak_J_Med_Sci_2014_May-Jun_30(3)_488-492.nxml.txt.nlp	24948964	SENT104	16	16	1	1	gemcitabine	BRCA1	PA449748	672	0.61
NULL	Nat_Commun_2011_Jul_5_2_376.nxml.txt.nlp	21730957	SENT1483	23	23	6	6	picrotoxin	GAD65	PA164777007	2572	0.61
NULL	Biomed_Res_Int_2014_Jan_19_2014_215872.nxml.txt.nlp	24575401	SENT85	43	43	47	47	artemisinin	TC1	PA165111696	6947	0.61
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT259	22	22	6	6	ranibizumab	VEGF-A	PA164746012	7422	0.61
NULL	Int_J_Mol_Sci_2014_Jun_26_15(7)_11416-11434.nxml.txt.nlp	24972137	SENT33	1	1	18	18	sitagliptin	GLP-1	PA164748978	100125288	0.61
NULL	Hum_Genomics_Proteomics_2010_Aug_3_2010_159761.nxml.txt.nlp	20981231	SENT256	24	24	20	20	lithium	FYN	PA450243	2534	0.61
NULL	ScientificWorldJournal_2013_Aug_19_2013_157527.nxml.txt.nlp	24089600	SENT30	16	16	7	7	ethanol	TPC	PA448073	8030;60386	0.61
NULL	Turk_J_Haematol_2013_Dec_5_30(4)_424-425.nxml.txt.nlp	24385839	SENT9	26	26	24	24	carbamazepine	IL-6	PA448785	3569	0.61
NULL	Oncotarget_2014_Aug_19_5(17)_7303-7315.nxml.txt.nlp	25229978	SENT236	14	14	10	10	rosiglitazone	CO2	PA451283	4513	0.61
NULL	Acta_Pharmacol_Sin_2013_Dec_14_34(12)_1575-1584.nxml.txt.nlp	24122013	SENT189	11	11	15	15	berberine	C10	PA165860812	113246	0.61
NULL	Am_J_Trop_Med_Hyg_2014_Oct_1_91(4)_854-861.nxml.txt.nlp	25071003	SENT159	5	5	16	16	fluorescein	G6PD	PA164746009	2539	0.61
NULL	Eur_J_Haematol_2014_Feb_25_92(2)_127-136.nxml.txt.nlp	24118452	SENT172	40	40	10	10	anagrelide	CRT	PA164742986	811	0.61
NULL	Arch_Sex_Behav_2011_Apr_28_40(2)_273-279.nxml.txt.nlp	19330436	SENT6	4	4	0	0	methamphetamine	Men	PA450403	8178	0.61
NULL	Int_J_Biomed_Sci_2007_Jun_3(2)_123-130.nxml.txt.nlp	23675034	SENT17	2	2	20	20	cimetidine	RAN	PA449001	5901	0.61
NULL	Diabetes_2011_Mar_21_60(3)_909-917.nxml.txt.nlp	21300843	SENT162	20	20	17	17	galactose	Sda	PA449725	124872	0.61
NULL	J_Cell_Biol_2001_Oct_29_155(3)_427-438.nxml.txt.nlp	11673478	SENT271	7	7	15	15	genistein	PP1	PA165109660	5540;5464	0.61
NULL	New_Microbes_New_Infect_2014_May_4_2(3)_58-63.nxml.txt.nlp	25356345	SENT100	26	26	24	24	amikacin	ANK	PA164744372	56172	0.61
NULL	J_Cell_Mol_Med_2015_Jan_8_19(1)_82-91.nxml.txt.nlp	25381905	SENT37	26	26	28	28	lipase	HSL	PA450239	3991	0.61
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT172	3	3	15	15	tacrolimus	OPG	PA451578	690	0.61
NULL	Oncol_Rep_2014_Apr_28_31(4)_1605-1612.nxml.txt.nlp	24481648	SENT101	27	27	12	12	ponatinib	MRP7	PA165980594	89845;1080	0.61
NULL	Ther_Clin_Risk_Manag_2005_Jun_1(2)_141-150.nxml.txt.nlp	18360553	SENT194	16	16	2	2	heparin	ACT	PA449855	12;11332;9457;641455	0.61
NULL	Eur_J_Clin_Pharmacol_2012_Jan_8_68(1)_29-37.nxml.txt.nlp	21739267	SENT101	16	16	9	9	paroxetine	CYP2D6	PA450801	1565	0.61
NULL	Case_Rep_Dermatol_2013_Dec_21_5(3)_379-381.nxml.txt.nlp	24516409	SENT56	9	9	5	5	ribavirin	IFN	PA451241	3439	0.61
NULL	J_Antimicrob_Chemother_2014_Mar_29_69(3)_643-650.nxml.txt.nlp	24169580	SENT151	6	6	0	0	ciprofloxacin	CPZ	PA449009	8532	0.61
NULL	Mar_Drugs_2014_Dec_18_12(12)_6125-6141.nxml.txt.nlp	25528957	SENT313	4	4	24	24	cyclophosphamide	p38	PA449165	10598;1432;7965	0.61
NULL	J_Cell_Biol_1998_Jan_26_140(2)_335-345.nxml.txt.nlp	9442109	SENT190	14	14	24	24	chloroquine	NHE	PA448948	285335	0.61
NULL	Iran_J_Public_Health_2011_Sep_30_40(3)_63-70.nxml.txt.nlp	23113087	SENT60	14	14	16	16	sugar	FBS	PA451529	64319;26269	0.61
NULL	Indian_J_Nucl_Med_2010_Jul-Sep_25(3)_78-87.nxml.txt.nlp	NULL	SENT311	11	11	16	16	diclofenac	gamma	PA449293	9913	0.61
NULL	Mol_Vis_2011_Apr_24_17_1011-1015.nxml.txt.nlp	21541272	SENT50	9	9	17	17	iron	FTL	PA450087	2512	0.61
NULL	Biomed_Res_Int_2014_Apr_10_2014_580852.nxml.txt.nlp	24812624	SENT147	6	6	18	18	resveratrol	PI3K		5290	0.61
NULL	Mol_Vis_2011_Dec_15_17_3254-3261.nxml.txt.nlp	22194651	SENT61	1	1	3	3	vasopressin	AVP	PA451858	114548;551	0.61
NULL	Scand_J_Prim_Health_Care_2013_Dec_31(4)_235-240.nxml.txt.nlp	24102498	SENT212	6	6	21	21	nitrofurantoin	Gen	PA450640	348654	0.61
NULL	Breast_Cancer_Res_2008_Feb_12_10(1)_R11.nxml.txt.nlp	18267033	SENT222	7	7	15	15	paraformaldehyde	IFN	PA450790	3439	0.61
NULL	J_Aquat_Anim_Health_2012_Sep_16_24(3)_185-194.nxml.txt.nlp	22897202	SENT73	2	2	4	4	lipase	HSL	PA450239	3991	0.61
NULL	Br_J_Pharmacol_2011_Aug_163(8)_1626-1638.nxml.txt.nlp	21410464	SENT46	4	4	21	21	forskolin	CA3	PA146096022	761	0.61
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Jul_23_3(7)_e126.nxml.txt.nlp	25054314	SENT61	9	9	7	7	docetaxel	OATP1B3	PA449383	28234	0.61
NULL	An_Bras_Dermatol_2014_Mar-Apr_89(2)_301-310.nxml.txt.nlp	24770508	SENT109	32	32	38	38	vinblastine	IL-2	PA451877	3558	0.61
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT72	16	16	10	10	resveratrol	TRAIL		8743	0.61
NULL	Cardiovasc_Diabetol_2006_Sep_26_5_20.nxml.txt.nlp	17002798	SENT101	22	22	26	26	niacin	CDP	PA450617	1523	0.61
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT216	8	8	14	14	chloroquine	BMP9	PA448948	2658	0.61
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT138	30	30	22	22	pertuzumab	HRG		3084;3273	0.61
NULL	Arthritis_Res_Ther_2007_Nov_12_9(6)_R118.nxml.txt.nlp	17997858	SENT304	4	4	0	0	hyaluronan	LYVE-1	PA165958431	10894	0.61
NULL	Cell_Biol_Int_Rep_(2010)_2012_Jun_21_19(1)_e00017.nxml.txt.nlp	23124518	SENT83	32	32	11	11	etoposide	TRAIL	PA449552	8743	0.61
NULL	Front_Endocrinol_(Lausanne)_2014_Oct_9_5_161.nxml.txt.nlp	25346723	SENT414	6	6	4	4	rosiglitazone	gamma	PA451283	9913	0.61
NULL	Emerg_Infect_Dis_2012_Jun_18(6)_1019-1020.nxml.txt.nlp	22608263	SENT34	30	30	36	36	levofloxacin	NXN	PA450214	64359	0.61
NULL	Bioinformation_2012_Jan_6_8(1)_13-19.nxml.txt.nlp	22359429	SENT8	26	26	9	9	curcumin	MRP1	PA151958596	4437	0.61
NULL	Crit_Care_2007_Nov_8_11(6)_R120.nxml.txt.nlp	17996049	SENT239	42	42	36	36	nadh	NOS2	PA164755085	339345;4843	0.61
NULL	J_Infect_Dis_2013_Mar_1_207(5)_842-847.nxml.txt.nlp	23225895	SENT128	8	8	10	10	lumefantrine	LUM	PA165111722	4060	0.61
NULL	Chin_J_Cancer_2012_Aug_31(8)_381-391.nxml.txt.nlp	22739263	SENT37	15	15	11	11	l-glutamine	FBS	PA10090	64319;26269	0.61
NULL	Cancer_Metastasis_Rev_2010_Dec_10_29(4)_581-594.nxml.txt.nlp	20830503	SENT93	11	11	4	4	anastrozole	TTR	PA448432	7276	0.61
NULL	Diabetes_Care_2013_Dec_13_36(12)_3930-3937.nxml.txt.nlp	23990523	SENT121	24	24	9	9	glucose	adiponectin	PA449773	9370	0.61
NULL	Iran_Red_Crescent_Med_J_2013_Dec_5_15(12)_e7788.nxml.txt.nlp	24693412	SENT5	33	33	35	35	lamivudine	LAM	PA450163	7249;7248	0.61
NULL	Mol_Imaging_Biol_2013_Apr_11_15(2)_136-147.nxml.txt.nlp	22886728	SENT80	8	8	31	31	orlistat	FDG	PA164776864	23583	0.61
NULL	Oncol_Lett_2013_Jul_8_6(1)_81-85.nxml.txt.nlp	23946781	SENT159	11	11	5	5	curcumin	CTR	PA151958596	799	0.61
NULL	Infect_Dis_Obstet_Gynecol_2012_Aug_14_2012_890160.nxml.txt.nlp	22927715	SENT183	14	14	20	20	etonogestrel	ENG	PA164771231	2022	0.61
NULL	Int_J_Gen_Med_2013_Jun_7_6_453-464.nxml.txt.nlp	23785241	SENT205	37	37	17	17	nedocromil	IL-8	PA450601	3576	0.61
NULL	Open_Biol_2014_Dec_4(12)_140178.nxml.txt.nlp	25520185	SENT47	27	27	5	5	geldanamycin	NOD2	PA152031327	64127	0.61
NULL	Oncol_Rep_2013_Apr_23_29(4)_1268-1274.nxml.txt.nlp	23354756	SENT137	13	13	6	6	epirubicin	SLC25A43	PA449476	203427	0.61
NULL	J_Korean_Med_Sci_2009_Jan_29_24(Suppl_1)_S183-S188.nxml.txt.nlp	19194550	SENT114	3	3	14	14	celecoxib	CD2AP	PA448871	23607	0.61
NULL	Arch_Med_Sci_2011_Dec_31_7(6)_977-983.nxml.txt.nlp	22328880	SENT117	25	25	3	3	heparin	PAPP-A	PA449855	5069	0.61
NULL	Oncoimmunology_2013_Oct_1_2(10)_e26333.nxml.txt.nlp	24251081	SENT71	0	0	5	5	denosumab	RANKL	PA166048634	8600	0.61
NULL	Emerg_Infect_Dis_2012_Mar_18(3)_515-516.nxml.txt.nlp	22377354	SENT33	18	18	0	0	gentamicin	CTX	PA449753	1593	0.61
NULL	Acta_Orthop_2010_Apr_6_81(2)_263-267.nxml.txt.nlp	20148646	SENT145	4	4	17	17	taurine	Men	PA451590	8178	0.61
NULL	Asian_J_Androl_2014_Dec_16_Jan-Feb_16(1)_39-49.nxml.txt.nlp	24369132	SENT191	16	16	10	10	estradiol	aromatase	PA449503	1588	0.61
NULL	Breast_Cancer_Res_2010_Oct_22_12(Suppl_2)_S2.nxml.txt.nlp	21050423	SENT70	14	14	0	0	methotrexate	MRP1	PA450428	4437	0.61
NULL	Crit_Care_2010_Sep_21_14(5)_R169.nxml.txt.nlp	20858239	SENT167	1	1	3	3	vasopressin	AVP	PA451858	114548;551	0.609
NULL	Dermatoendocrinol_2013_Apr_1_5(2)_252-263.nxml.txt.nlp	24194965	SENT328	24	24	9	9	metformin	AMPK	PA450395	5563	0.609
NULL	J_Immunol_Methods_2009_Jan_1_340(1)_11-24.nxml.txt.nlp	18929568	SENT144	6	6	26	26	dasatinib	CD4	PA162372878	920	0.609
NULL	Arthritis_Res_Ther_2009_Jul_9_11(4)_R106.nxml.txt.nlp	19589151	SENT110	25	25	5	5	methotrexate	ACPA	PA450428	5657	0.609
NULL	Curr_Genomics_2014_Jun_15(3)_217-230.nxml.txt.nlp	24955029	SENT192	20	20	25	25	oxygen	ROS	PA450744	6098	0.609
NULL	Biomed_Imaging_Interv_J_2007_Oct_1_3(4)_e52.nxml.txt.nlp	21614300	SENT98	7	7	12	12	vincristine	CHOP	PA451879	1649	0.609
NULL	Oncotarget_2011_Nov_9_2(11)_850-861.nxml.txt.nlp	22081665	SENT139	6	6	14	14	idarubicin	DNMT3A	PA449961	1788	0.609
NULL	Arch_Dis_Child_2008_Jul_1_93(7)_620-625.nxml.txt.nlp	18381346	SENT195	11	11	20	20	oxygen	PAP	PA450744	11333;10884;10914;11334;8853;50807	0.609
NULL	Oncotarget_2011_Dec_20_2(12)_1094-1108.nxml.txt.nlp	22190353	SENT56	22	22	24	24	gemcitabine	Gem	PA449748	51053	0.609
NULL	Hum_Mol_Genet_2013_Nov_15_22(22)_4616-4626.nxml.txt.nlp	23814041	SENT46	33	33	26	26	doxycycline	neuroserpin	PA449415	5274	0.609
NULL	Br_J_Cancer_2009_Sep_15_101(6)_875-878.nxml.txt.nlp	19672259	SENT34	19	19	26	26	anastrozole	ATAC	PA448432	6375	0.609
NULL	Mol_Vis_2011_Aug_18_17_2221-2227.nxml.txt.nlp	21897744	SENT6	30	30	27	27	penicillamine	GBA	PA450840	2629	0.609
NULL	J_Neuroinflammation_2011_Aug_30_8_109.nxml.txt.nlp	21878125	SENT305	2	2	12	12	galactose	MAC-2	PA449725	3958	0.609
NULL	Allergy_Asthma_Immunol_Res_2012_Jan_9_4(1)_24-30.nxml.txt.nlp	22211167	SENT50	14	14	16	16	paraformaldehyde	PLP	PA450790	25824;5744	0.609
NULL	Front_Physiol_2011_Jun_30_2_33.nxml.txt.nlp	21747769	SENT233	0	0	7	7	berberine	KCNQ1	PA165860812	3784	0.609
NULL	Cancers_(Basel)_2014_Jul_8_6(3)_1487-1499.nxml.txt.nlp	25006835	SENT308	8	8	5	5	cisplatin	Bcl-2	PA449014	596	0.609
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT281	5	5	25	25	bortezomib	survivin	PA10252	332	0.609
NULL	Breast_Cancer_Res_Treat_2012_Jun_3_133(2)_793-798.nxml.txt.nlp	22388692	SENT124	13	13	8	8	tamoxifen	SULT1A1	PA451581	6817	0.609
NULL	Biomed_Res_Int_2013_Aug_6_2013_687575.nxml.txt.nlp	23986909	SENT78	10	10	12	12	vasopressin	AVP	PA451858	114548;551	0.609
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT2379	8	8	14	14	diclofenac	CYP3A4	PA449293	1576	0.609
NULL	J_Korean_Med_Sci_2006_Oct_31_21(5)_827-832.nxml.txt.nlp	17043414	SENT62	29	29	15	15	mupirocin	Kua	PA164764568	387521	0.609
NULL	Ann_Intensive_Care_2011_Mar_21_1_3.nxml.txt.nlp	21906325	SENT111	27	27	30	30	cisplatin	EPO	PA449014	7076;8288;2056	0.609
NULL	Pharmacogn_Mag_2014_Oct-Dec_10(40)_536-540.nxml.txt.nlp	25422558	SENT110	18	18	5	5	ethanol	SLB	PA448073	26160	0.609
NULL	J_Cell_Biol_2002_Jun_10_157(6)_1017-1028.nxml.txt.nlp	12058017	SENT171	3	3	23	23	lovastatin	COD1	PA450272	25839	0.609
NULL	Breast_Cancer_Res_2008_Apr_1_10(2)_R30.nxml.txt.nlp	18380893	SENT117	5	5	18	18	doxorubicin	HER2	PA449412	2064	0.609
NULL	Neural_Plast_2007_Jun_19_2007_52908.nxml.txt.nlp	17641734	SENT45	22	22	31	31	lipase	DAG	PA450239	1605	0.609
NULL	Breast_Cancer_Res_2010_Oct_22_12(Suppl_2)_S3.nxml.txt.nlp	21050424	SENT199	17	17	21	21	paclitaxel	p63	PA450761	8626	0.609
NULL	J_Med_Case_Reports_2011_Mar_28_5_117.nxml.txt.nlp	21443773	SENT128	22	22	15	15	sitagliptin	GLP-1	PA164748978	100125288	0.609
NULL	Iran_J_Pharm_Res_2014_Autumn_13(4)_1393-1401.nxml.txt.nlp	25587329	SENT136	14	14	16	16	celecoxib	ABCG2	PA448871	9429	0.609
NULL	Environ_Health_Perspect_2013_Apr_5_121(4)_480-487.nxml.txt.nlp	23384616	SENT207	18	18	35	35	heparin	PC2	PA449855	5126;5311;8535	0.609
NULL	Pediatr_Cardiol_2010_Jan_14_31(1)_90-95.nxml.txt.nlp	19915892	SENT104	27	27	21	21	palivizumab	Era	PA164748781	2099	0.609
NULL	J_Antimicrob_Chemother_2012_Feb_17_67(2)_404-414.nxml.txt.nlp	22101217	SENT180	6	6	12	12	chloramphenicol	EMB	PA448927	133418	0.609
NULL	Nat_Med_2010_Nov_24_16(11)_1299-1304.nxml.txt.nlp	20972434	SENT204	3	3	6	6	chloroquine	ASM	PA448948	6609;283120	0.609
NULL	Emerg_Infect_Dis_2012_Feb_18(2)_302-304.nxml.txt.nlp	22305387	SENT113	16	16	10	10	pyrimethamine	CTX	PA451193	1593	0.609
NULL	Cerebrospinal_Fluid_Res_2010_Sep_22_7_15.nxml.txt.nlp	20860832	SENT255	24	24	26	26	acetazolamide	AQP1	PA448018	358	0.609
NULL	Cancers_(Basel)_2014_Mar_25_6(2)_684-707.nxml.txt.nlp	24670368	SENT1039	15	15	2	2	capecitabine	EGFR	PA448771	1956	0.609
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Aug_11_68(Pt_9)_o2694.nxml.txt.nlp	22969586	SENT61	45	45	35	35	ethanol	mol	PA448073	90527	0.609
NULL	Clin_Med_Insights_Blood_Disord_2013_Nov_14_6_23-27.nxml.txt.nlp	25512717	SENT112	47	47	28	28	rituximab	CHOP	PA451261	1649	0.609
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT3599	18	18	20	20	fluorescein	CLF	PA164746009	51340;9244	0.609
NULL	Biomed_Res_Int_2013_Sep_4_2013_486072.nxml.txt.nlp	24093099	SENT52	6	6	22	22	trypsin	NUC	PA451806	4924	0.609
NULL	Clin_Exp_Reprod_Med_2013_Dec_31_40(4)_148-154.nxml.txt.nlp	24505560	SENT110	40	40	28	28	paraformaldehyde	CO2	PA450790	4513	0.609
NULL	Int_J_Mol_Sci_2014_Nov_21_15(11)_21505-21537.nxml.txt.nlp	25421245	SENT222	3	3	28	28	capsaicin	UCP2	PA448776	7351	0.609
NULL	Ayu_2013_Oct-Dec_34(4)_339-345.nxml.txt.nlp	24696569	SENT47	2	2	4	4	sugar	FBS	PA451529	64319;26269	0.609
NULL	Tob_Control_2009_Feb_13_18(1)_34-42.nxml.txt.nlp	18845621	SENT274	41	41	44	44	primidone	CYP2B6	PA451105	1555	0.609
NULL	Oncotarget_2014_Jun_19_5(15)_6540-6551.nxml.txt.nlp	25153728	SENT305	16	16	3	3	gemcitabine	gamma	PA449748	9913	0.609
NULL	Orthop_Rev_(Pavia)_2014_Sep_18_6(3)_5405.nxml.txt.nlp	25317308	SENT102	6	6	2	2	acetaminophen	PRP	PA448015	7001;5621	0.609
NULL	Diabetes_2013_Nov_18_62(11)_3677-3686.nxml.txt.nlp	24158999	SENT359	10	10	12	12	capsaicin	TRPV1	PA448776	7442	0.609
NULL	Emerg_Infect_Dis_2013_Jan_19(1)_133-136.nxml.txt.nlp	23260464	SENT42	10	10	20	20	ceftazidime	TOB	PA448861	10140	0.609
NULL	Nat_Chem_Biol_2014_Jun_13_10(6)_431-436.nxml.txt.nlp	24727900	SENT278	26	26	34	34	sitagliptin	EGFR	PA164748978	1956	0.609
NULL	Emerg_Infect_Dis_2012_Feb_18(2)_302-304.nxml.txt.nlp	22305387	SENT113	24	24	10	10	albendazole	CTX	PA164746058	1593	0.609
NULL	Acta_Histochem_Cytochem_2014_Feb_27_47(1)_27-33.nxml.txt.nlp	24761047	SENT22	5	5	1	1	arsenite	AQP7	PA452638	364	0.609
NULL	Crit_Care_2008_Oct_14_12(5)_227.nxml.txt.nlp	18983707	SENT6	27	27	29	29	vasopressin	AVP	PA451858	114548;551	0.609
NULL	Oncotarget_2012_Dec_18_3(12)_1615-1628.nxml.txt.nlp	23271044	SENT109	11	11	13	13	temsirolimus	TOR	PA164746890	6097	0.609
NULL	Acta_Pharmacol_Sin_2011_May_18_32(5)_601-610.nxml.txt.nlp	21499285	SENT235	4	4	6	6	bleomycin	BLM	PA448645	641	0.609
NULL	Front_Genet_2012_Oct_26_3_213.nxml.txt.nlp	23112805	SENT608	25	25	19	19	diclofenac	CYP1A2	PA449293	1544	0.609
NULL	Cell_Death_Dis_2014_Jul_17_5(7)_e1333.nxml.txt.nlp	25032856	SENT26	10	10	12	12	candesartan	EAAC1	PA448765	6505	0.609
NULL	Indian_J_Pharm_Sci_2013_Jul-Aug_75(4)_420-426.nxml.txt.nlp	24302796	SENT113	11	11	2	2	paclitaxel	ANOVA	PA450761	4858	0.609
NULL	Drugs_R_D_2011_Jun_27_11(2)_101-111.nxml.txt.nlp	21679003	SENT37	13	13	25	25	irinotecan	IFL	PA450085	3439	0.609
NULL	Diabetes_2009_Jan_58(1)_243-249.nxml.txt.nlp	18840785	SENT197	34	34	47	47	glucose	GLP-1	PA449773	100125288	0.609
NULL	Exp_Ther_Med_2013_Oct_16_6(4)_873-882.nxml.txt.nlp	24137281	SENT288	19	19	7	7	diltiazem	IL-6	PA449334	3569	0.609
NULL	Sci_Rep_2015_Jan_6_5_7641.nxml.txt.nlp	25560734	SENT395	3	3	0	0	tamoxifen	CLTC	PA451581	1213	0.609
NULL	Diagn_Pathol_2013_May_15_8_81.nxml.txt.nlp	23675804	SENT21	24	24	33	33	cyclophosphamide	CHOP	PA449165	1649	0.609
NULL	Breast_Cancer_Res_2011_Nov_24_13(6)_R120.nxml.txt.nlp	22115051	SENT99	6	6	18	18	tamoxifen	HER-2	PA451581	2064	0.609
NULL	Oncotarget_2014_Oct_15_5(21)_10763-10777.nxml.txt.nlp	25333257	SENT57	19	19	29	29	leucovorin	FasL	PA450198	356	0.609
NULL	Exp_Ther_Med_2013_Nov_18_6(5)_1177-1183.nxml.txt.nlp	24223641	SENT162	10	10	15	15	propofol	BMP2	PA451141	650	0.609
NULL	Orphanet_J_Rare_Dis_2014_Dec_10_9(1)_180.nxml.txt.nlp	NULL	SENT108	13	13	26	26	glucosamine	HGSNAT	PA164747613	138050	0.609
NULL	J_Antimicrob_Chemother_2012_Feb_17_67(2)_404-414.nxml.txt.nlp	22101217	SENT129	19	19	17	17	ethambutol	EMB	PA164784021	133418	0.609
NULL	J_Hypertens_2014_Jun_30_32(6)_1178-1188.nxml.txt.nlp	24621808	SENT83	2	2	4	4	topiramate	FOR	PA451728	51741	0.609
NULL	Case_Rep_Oncol_2010_Dec_17_3(3)_480-488.nxml.txt.nlp	21611102	SENT21	0	0	2	2	cetuximab	CTX	PA10040	1593	0.609
NULL	Mol_Cancer_2010_Apr_23_9_87.nxml.txt.nlp	20416058	SENT198	22	22	12	12	doxorubicin	DR5	PA449412	8795	0.609
NULL	Exp_Ther_Med_2014_Aug_4_8(2)_657-661.nxml.txt.nlp	25009636	SENT92	0	0	16	16	propofol	CCL2	PA451141	6347	0.609
NULL	Support_Care_Cancer_2009_Sep_10_17(9)_1187-1193.nxml.txt.nlp	19205754	SENT66	2	2	6	6	granisetron	ANOVA	PA449809	4858	0.609
NULL	Orphanet_J_Rare_Dis_2013_Apr_4_8_51.nxml.txt.nlp	23557332	SENT174	6	6	27	27	galsulfase	ARSB	PA164746235	411	0.609
NULL	Nat_Neurosci_2013_Apr_17_16(4)_456-463.nxml.txt.nlp	23502535	SENT94	24	24	26	26	lipase	MGL	PA450239	11343	0.609
NULL	Cell_Death_Dis_2012_Oct_11_3(10)_e403.nxml.txt.nlp	23059822	SENT181	24	24	12	12	allopurinol	MSU	PA448320	593	0.609
NULL	Oncol_Lett_2015_Feb_3_9(2)_757-761.nxml.txt.nlp	25621047	SENT98	0	0	2	2	olaparib	PARP-1		25976	0.609
NULL	Acta_Orthop_2009_Jun_5_80(3)_363-367.nxml.txt.nlp	19421908	SENT8	0	0	35	35	triamcinolone	ANOVA	PA451749	4858	0.609
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1051.nxml.txt.nlp	24503543	SENT144	16	16	23	23	sorafenib	Yes	PA7000	7525	0.609
NULL	Clinicoecon_Outcomes_Res_2014_Oct_17_6_451-461.nxml.txt.nlp	25378939	SENT109	13	13	15	15	linezolid	HAP	PA450233	5915;10313	0.609
NULL	Eur_J_Med_Res_2011_Jun_21_16(6)_265-274.nxml.txt.nlp	21810561	SENT218	21	21	15	15	cisplatin	PLG	PA449014	5340	0.609
NULL	Exp_Ther_Med_2013_Feb_20_5(2)_443-447.nxml.txt.nlp	23407364	SENT162	11	11	9	9	cyclophosphamide	CTX	PA449165	1593	0.609
NULL	Ann_Rheum_Dis_2011_Nov_29_71(6)_891-898.nxml.txt.nlp	22128078	SENT9	3	3	15	15	adalimumab	HOA	PA10004	4148	0.609
NULL	Crit_Care_2010_Sep_1_14(Suppl_2)_P17.nxml.txt.nlp	NULL	SENT6	13	13	24	24	ethanol	TLR4	PA448073	7099	0.609
NULL	J_Biomed_Biotechnol_2003_Oct_29_2003(4)_249-255.nxml.txt.nlp	14615633	SENT42	18	18	12	12	trypsin	CO2	PA451806	4513	0.609
NULL	J_Cell_Biol_1997_Mar_10_136(5)_995-1005.nxml.txt.nlp	9060465	SENT46	0	0	2	2	chlorpromazine	CPZ	PA448964	8532	0.609
NULL	J_Gen_Physiol_1990_Sep_1_96(3)_493-516.nxml.txt.nlp	2230710	SENT0	16	16	1	1	phenol	Gen	PA450913	348654	0.609
NULL	J_Gen_Physiol_1997_Dec_1_110(6)_643-654.nxml.txt.nlp	9382893	SENT197	35	35	43	43	diazoxide	ADP	PA449285	23038	0.609
NULL	Biosci_Rep_2014_Mar_31_34(2)_e00101.nxml.txt.nlp	NULL	SENT123	19	19	16	16	lipase	LPL	PA450239	4023	0.609
NULL	Pharmaceuticals_(Basel)_2012_Dec_12_5(12)_1393-1408.nxml.txt.nlp	24281342	SENT161	35	35	29	29	imiglucerase	EPO	PA164742934	7076;8288;2056	0.609
NULL	Mol_Cancer_2009_Jul_31_8_54.nxml.txt.nlp	19646236	SENT264	23	23	29	29	nadh	NAMPT	PA164755085	10135	0.609
NULL	Biochem_Res_Int_2012_Aug_23_2012_135723.nxml.txt.nlp	21904679	SENT20	5	5	7	7	lipase	LIPA	PA450239	3988;10648	0.609
NULL	Front_Immunol_2012_May_31_3_124.nxml.txt.nlp	22666222	SENT396	0	0	4	4	resveratrol	CYP1A1		1543	0.609
NULL	Front_Endocrinol_(Lausanne)_2011_Aug_11_2_19.nxml.txt.nlp	22649366	SENT1206	9	9	2	2	allopregnanolone	spatial	PA142320763	219793	0.609
NULL	Ann_Indian_Acad_Neurol_2010_Oct-Dec_13(4)_313.nxml.txt.nlp	21264146	SENT7	0	0	28	28	mitoxantrone	IL-2	PA450526	3558	0.609
NULL	Curr_Control_Trials_Cardiovasc_Med_2001_May_11_2(3)_118-122.nxml.txt.nlp	11806784	SENT43	38	38	6	6	pravastatin	NNT	PA451089	23530	0.609
NULL	Eur_J_Neurosci_2014_Jun_26_39(12)_2151-2162.nxml.txt.nlp	24666402	SENT254	23	23	15	15	thrombin	EGF	PA451674	1950	0.609
NULL	Mol_Clin_Oncol_2013_Sep_24_1(5)_918-924.nxml.txt.nlp	24649271	SENT156	3	3	5	5	gemcitabine	EGFR	PA449748	1956	0.609
NULL	Arthritis_Res_Ther_2012_Feb_7_14(1)_R33.nxml.txt.nlp	22325903	SENT58	2	2	0	0	cyclophosphamide	CTX	PA449165	1593	0.609
NULL	J_Korean_Med_Sci_2011_Jan_22_26(1)_33-41.nxml.txt.nlp	21218027	SENT169	2	2	8	8	isoniazid	EMB	PA450112	133418	0.609
NULL	Br_J_Pharmacol_2008_Oct_18_155(4)_596-605.nxml.txt.nlp	18852694	SENT261	9	9	6	6	fenofibrate	aP2	PA449594	2167	0.609
NULL	Cancers_(Basel)_2014_Apr_30_6(2)_1031-1046.nxml.txt.nlp	24785146	SENT35	14	14	25	25	trypsin	G3BP	PA451806	10146	0.609
NULL	Emerg_Infect_Dis_2005_Jun_11(6)_873-882.nxml.txt.nlp	15963282	SENT89	14	14	16	16	ciprofloxacin	TOB	PA449009	10140	0.609
NULL	Indian_J_Pharmacol_2013_Jan-Feb_45(1)_54-60.nxml.txt.nlp	23543867	SENT145	25	25	8	8	bosentan	NAC	PA10034	22861	0.609
NULL	Br_J_Cancer_1999_Dec_81(8)_1285-1293.nxml.txt.nlp	10604724	SENT13	14	14	4	4	sn-38	p53		7157	0.609
NULL	Clin_Dev_Immunol_2007_Dec_13_2007_17315.nxml.txt.nlp	18320010	SENT118	23	23	33	33	gefitinib	EGFR	PA131301952	1956	0.609
NULL	Int_J_Mol_Cell_Med_2012_Summer_1(3)_145-152.nxml.txt.nlp	24551770	SENT120	2	2	11	11	memantine	mol	PA10364	90527	0.609
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT29	6	6	8	8	methotrexate	MSH2	PA450428	4436	0.609
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT116	34	34	26	26	resveratrol	TNF		7124	0.609
NULL	Exp_Cell_Res_2011_Apr_15_317(7)_1028-1039.nxml.txt.nlp	21237154	SENT96	8	8	3	3	staurosporine	JIP1	PA165109623	9479	0.609
NULL	Environ_Health_Perspect_1996_May_104(5)_544-548.nxml.txt.nlp	8743443	SENT6	20	20	22	22	diethylstilbestrol	DES	PA449307	1674	0.609
NULL	Diabetol_Metab_Syndr_2014_Sep_16_6(1)_99.nxml.txt.nlp	NULL	SENT184	5	5	8	8	metformin	adiponectin	PA450395	9370	0.609
NULL	J_Gynecol_Oncol_2013_Jul_4_24(3)_265-272.nxml.txt.nlp	23875077	SENT105	13	13	25	25	thrombin	IL-8	PA451674	3576	0.609
NULL	Biology_(Basel)_2012_Dec_31_2(1)_40-63.nxml.txt.nlp	24832651	SENT241	18	18	31	31	hydroxyurea	BRCA1	PA449942	672	0.609
NULL	Curr_Hypertens_Rep_2014_Jan_11_16(2)_416.nxml.txt.nlp	24414230	SENT145	33	33	25	25	olmesartan	C21	PA164742950	79718	0.609
NULL	Front_Microbiol_2013_Aug_19_4_241.nxml.txt.nlp	23966991	SENT226	6	6	17	17	ceftriaxone	GLT-1	PA448866	6506	0.609
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_75-89.nxml.txt.nlp	17912638	SENT372	30	30	7	7	anastrozole	ATAC	PA448432	6375	0.609
NULL	Biochemistry_2008_Aug_19_47(33)_8689-8696.nxml.txt.nlp	18642884	SENT88	21	21	15	15	nadh	GMP	PA164755085	22978	0.609
NULL	Cardiovasc_Ultrasound_2006_Aug_21_4_33.nxml.txt.nlp	16923191	SENT19	16	16	7	7	l-arginine	NOS3	PA448478	4846;342977	0.609
NULL	Breast_Cancer_Res_2007_Jun_4_9(3)_207.nxml.txt.nlp	17561991	SENT174	25	25	11	11	trastuzumab	HER-2	PA451743	2064	0.609
NULL	Cell_Commun_Signal_2014_Mar_11_12_16.nxml.txt.nlp	24618498	SENT240	34	34	32	32	fludarabine	STAT1	PA449655	6772	0.609
NULL	JRSM_Cardiovasc_Dis_2012_May_31_1(2)_cvd_2012_012007.nxml.txt.nlp	24175064	SENT59	22	22	19	19	thrombin	ADP	PA451674	23038	0.609
NULL	Mycobiology_2010_Mar_31_38(1)_17-25.nxml.txt.nlp	23956620	SENT180	10	10	20	20	galactose	Mal	PA449725	114609	0.609
NULL	Osteoarthritis_Cartilage_2014_Sep_22(9)_1241-1250.nxml.txt.nlp	25042552	SENT473	11	11	19	19	heparin	OKS	PA449855	9968	0.609
NULL	J_Parasitol_Res_2012_Mar_15_2012_930257.nxml.txt.nlp	22523644	SENT195	9	9	5	5	imiquimod	TLR7	PA449972	51284	0.609
NULL	Mol_Vis_2011_Feb_1_17_332-340.nxml.txt.nlp	21297899	SENT15	12	12	17	17	telmisartan	NAC	PA451605	22861	0.609
NULL	Mol_Vis_2013_Apr_17_19_894-903.nxml.txt.nlp	23687426	SENT22	5	5	11	11	adalimumab	CRALBP	PA10004	6017	0.609
NULL	J_Biomed_Sci_2014_Feb_3_21(1)_10.nxml.txt.nlp	24490900	SENT203	10	10	22	22	alendronate	M-CSF	PA448082	1435	0.609
NULL	Biomed_Res_Int_2014_Feb_6_2014_323594.nxml.txt.nlp	24689036	SENT381	9	9	2	2	raloxifene	EGFR	PA451221	1956	0.609
NULL	Am_J_Rhinol_Allergy_2012_Sep-Oct_26(5)_371-379.nxml.txt.nlp	23168151	SENT158	10	10	17	17	fluorescein	CD25	PA164746009	3669;3559	0.609
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT134	21	21	14	14	imatinib	ABCB1	PA10804	5243	0.609
NULL	Eur_J_Endocrinol_2009_Sep_161(3)_375-380.nxml.txt.nlp	19549748	SENT26	24	24	35	35	hydrocortisone	HSD1	PA449905	26871	0.609
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Sep_15_68(Pt_10)_o2943.nxml.txt.nlp	23125728	SENT3	23	23	18	18	naphthol	mol	PA154081779	90527	0.609
NULL	Front_Genet_2011_Nov_22_2_84.nxml.txt.nlp	22303378	SENT335	7	7	3	3	diethylstilbestrol	A10	PA449307	28870	0.609
NULL	Clin_Psychopharmacol_Neurosci_2011_Apr_30_9(1)_36-43.nxml.txt.nlp	23431025	SENT102	0	0	7	7	aripiprazole	FLI	PA10026	2314	0.609
NULL	Mol_Cancer_2008_May_16_7_38.nxml.txt.nlp	18485224	SENT194	30	30	42	42	streptomycin	CO2	PA451512	4513	0.609
NULL	J_Invest_Dermatol_2012_Sep_10_132(9)_2255-2262.nxml.txt.nlp	22572817	SENT49	28	28	34	34	forskolin	ASIP	PA146096022	434;56288	0.609
NULL	J_Lipid_Res_2013_Nov_54(11)_3085-3097.nxml.txt.nlp	23883581	SENT221	11	11	27	27	pp2	p38		10598;1432;7965	0.609
NULL	Oxid_Med_Cell_Longev_2013_Apr_21_2013_412576.nxml.txt.nlp	23710286	SENT161	4	4	9	9	curcumin	NRF1	PA151958596	4899;4779	0.609
NULL	Multidiscip_Respir_Med_2013_Feb_13_8(1)_13.nxml.txt.nlp	23406847	SENT5	8	8	10	10	ethambutol	EMB	PA164784021	133418	0.609
NULL	Front_Cell_Neurosci_2013_Aug_29_7_130.nxml.txt.nlp	24009554	SENT116	8	8	18	18	pilocarpine	NPY	PA450962	4852	0.609
NULL	Theranostics_2014_Aug_24_4(11)_1096-1111.nxml.txt.nlp	25285163	SENT314	2	2	4	4	paclitaxel	Bcl-2	PA450761	596	0.609
NULL	Comput_Math_Methods_Med_2012_Mar_15_2012_790281.nxml.txt.nlp	22474537	SENT25	24	24	26	26	vasopressin	AVP	PA451858	114548;551	0.609
NULL	J_Korean_Med_Sci_2011_Jan_22_26(1)_33-41.nxml.txt.nlp	21218027	SENT169	22	22	35	35	kanamycin	PTH	PA450137	5741	0.609
NULL	Eur_J_Epidemiol_2011_Aug_30_26(8)_657-686.nxml.txt.nlp	21877163	SENT495	12	12	22	22	phenprocoumon	CYP2C9	PA450921	1559	0.609
NULL	Mol_Cancer_2010_Nov_2_9_289.nxml.txt.nlp	21044322	SENT166	24	24	8	8	cisplatin	RGS17	PA449014	26575	0.609
NULL	Indian_J_Med_Res_2012_Jul_136(1)_54-59.nxml.txt.nlp	22885264	SENT6	4	4	11	11	cisplatin	IFN	PA449014	3439	0.609
NULL	J_Lipid_Res_2014_Feb_55(2)_307-312.nxml.txt.nlp	24262094	SENT4	2	2	4	4	lipase	PNLIP	PA450239	5406	0.609
NULL	Int_J_Biol_Sci_2015_Jan_1_11(1)_1-10.nxml.txt.nlp	25552924	SENT34	0	0	22	22	cisplatin	ABCG2	PA449014	9429	0.609
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S320-S324.nxml.txt.nlp	21525476	SENT68	11	11	3	3	rosiglitazone	DREAM	PA451283	30818	0.609
NULL	Case_Rep_Oncol_2011_Nov_22_4(3)_534-541.nxml.txt.nlp	22187539	SENT30	8	8	15	15	paclitaxel	GEM	PA450761	2669	0.609
NULL	Arthritis_Res_Ther_2005_Feb_18_7(3)_R476-R484.nxml.txt.nlp	15899034	SENT240	16	16	5	5	thrombin	Rho	PA451674	29984	0.609
NULL	Br_J_Cancer_2011_Apr_12_104(8)_1256-1261.nxml.txt.nlp	21448165	SENT84	27	27	29	29	sorafenib	IL-2	PA7000	3558	0.609
NULL	Iran_J_Pharm_Res_2013_Winter_12(Suppl)_57-63.nxml.txt.nlp	24250672	SENT14	0	0	2	2	azithromycin	AZI	PA448519	4946	0.609
NULL	Hum_Reprod_2013_Feb_30_28(2)_306-314.nxml.txt.nlp	23203216	SENT135	15	15	13	13	hyaluronan	HBA	PA165958431	85340	0.609
NULL	Case_Rep_Dermatol_2013_Mar_20_5(1)_79-83.nxml.txt.nlp	23626544	SENT12	14	14	23	23	tacrolimus	CD163	PA451578	9332	0.609
NULL	Leukemia_2013_Feb_3_27(2)_315-324.nxml.txt.nlp	22751450	SENT205	5	5	19	19	sorafenib	Mcl-1	PA7000	4170	0.609
NULL	Cell_Commun_Signal_2014_Oct_17_12(1)_67.nxml.txt.nlp	NULL	SENT250	36	36	13	13	protamine	PDE6G	PA10366	5148	0.609
NULL	Oxid_Med_Cell_Longev_2013_Jun_2_2013_793525.nxml.txt.nlp	23819014	SENT160	8	8	14	14	resveratrol	SGBS		2719	0.609
NULL	Exp_Ther_Med_2015_Feb_15_9(2)_384-388.nxml.txt.nlp	25574202	SENT132	29	29	24	24	iohexol	HLP	PA450061	6499;9001;3002	0.609
NULL	Curr_Chem_Genomics_2010_Mar_19_4_9-18.nxml.txt.nlp	20502647	SENT151	12	12	9	9	triciribine	DM1	PA165958661	338023;1760;28509	0.609
NULL	Exp_Ther_Med_2014_Jun_3_7(6)_1762-1766.nxml.txt.nlp	24926381	SENT175	15	15	6	6	resveratrol	GCLC		2729	0.609
NULL	Eur_J_Clin_Pharmacol_2011_May_2_67(Suppl_1)_87-107.nxml.txt.nlp	21287160	SENT338	24	24	7	7	flavopiridol	UGT1A9	PA452627	54600	0.609
NULL	Clin_Interv_Aging_2009_Dec_29_4_463-472.nxml.txt.nlp	20054411	SENT97	8	8	22	22	vardenafil	CYP3A	PA10229	1574	0.609
NULL	Indian_J_Pharm_Sci_2011_Nov-Dec_73(6)_615-620.nxml.txt.nlp	23112394	SENT121	44	44	32	32	azithromycin	HLP3	PA448519	7447	0.609
NULL	Breast_Cancer_Res_2007_Jul_5_9(4)_R41.nxml.txt.nlp	17612393	SENT139	32	32	21	21	celecoxib	Bcl-2	PA448871	596	0.609
NULL	Cancer_Inform_2013_Feb_13_12_31-51.nxml.txt.nlp	23470717	SENT335	11	11	6	6	epirubicin	E2F1	PA449476	1869	0.609
NULL	Ethiop_J_Health_Sci_2010_Mar_20(1)_41-48.nxml.txt.nlp	22434959	SENT115	16	16	26	26	tetracycline	Gen	PA451640	348654	0.609
NULL	Indian_J_Med_Res_2012_Dec_136(6)_979-984.nxml.txt.nlp	23391793	SENT135	11	11	18	18	pyrazinamide	EMB	PA451182	133418	0.609
NULL	Cancer_Res_Treat_2013_Sep_30_45(3)_178-185.nxml.txt.nlp	24155676	SENT32	6	6	8	8	gefitinib	EGFR	PA131301952	1956	0.609
NULL	Mol_Cancer_2010_Mar_4_9_49.nxml.txt.nlp	20202195	SENT126	27	27	12	12	vorinostat	HDAC1	PA164748224	3065	0.609
NULL	J_Biomed_Sci_2014_Aug_5_21(1)_67.nxml.txt.nlp	25091805	SENT99	8	8	15	15	tetracycline	DEPDC1B	PA451640	55789	0.609
NULL	Neural_Regen_Res_2013_May_5_8(13)_1180-1189.nxml.txt.nlp	25206412	SENT136	0	0	9	9	fasudil	PTEN	PA165946121	5728	0.609
NULL	J_Gen_Physiol_1924_Jan_20_6(3)_239-243.nxml.txt.nlp	19872065	SENT0	12	12	1	1	trypsin	Gen	PA451806	348654	0.609
NULL	eLife_2014_May_7_3_e02536.nxml.txt.nlp	24843004	SENT221	32	32	7	7	genistein	TRPC3	PA165109660	7222	0.609
NULL	J_Gen_Physiol_1992_Dec_1_100(6)_1003-1020.nxml.txt.nlp	1336539	SENT0	14	14	1	1	bupivacaine	Gen	PA135057240	348654	0.609
NULL	Oncotarget_2013_Dec_28_5(6)_1475-1490.nxml.txt.nlp	24721996	SENT188	0	0	5	5	celecoxib	PTEN	PA448871	5728	0.609
NULL	Mol_Neurodegener_2011_Aug_8_6_57.nxml.txt.nlp	21819629	SENT344	14	14	7	7	arsenite	TDP-43	PA452638	23435	0.609
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Jun_27_5_15.nxml.txt.nlp	16803618	SENT145	14	14	30	30	erythromycin	CIP1	PA449493	1026;56996	0.609
NULL	ACS_Nano_2014_Mar_25_8(3)_2018-2032.nxml.txt.nlp	24555414	SENT210	14	14	11	11	gemcitabine	mol	PA449748	90527	0.609
NULL	J_Int_Soc_Sports_Nutr_2015_Jan_21_12(1)_5.nxml.txt.nlp	NULL	SENT193	29	29	12	12	curcumin	IL-6	PA151958596	3569	0.609
NULL	Cardiovasc_Res_2012_Mar_15_93(4)_674-681.nxml.txt.nlp	22166712	SENT194	37	37	28	28	simvastatin	CYP3A	PA451363	1574	0.609
NULL	Crit_Care_2010_Nov_5_14(6)_R200.nxml.txt.nlp	21054850	SENT22	7	7	18	18	vasopressin	AVP	PA451858	114548;551	0.609
NULL	J_Cell_Biol_1998_Nov_2_143(3)_695-707.nxml.txt.nlp	9813091	SENT62	29	29	15	15	tetracycline	CO2	PA451640	4513	0.609
NULL	Indian_J_Pharmacol_2014_Sep-Oct_46(5)_549-550.nxml.txt.nlp	25298588	SENT46	30	30	20	20	warfarin	CYP2C9	PA451906	1559	0.609
NULL	Front_Genet_2012_Sep_6_3_173.nxml.txt.nlp	22973297	SENT181	21	21	19	19	gemcitabine	FKBP5	PA449748	2289	0.608
NULL	Oxid_Med_Cell_Longev_2013_Apr_3_2013_781050.nxml.txt.nlp	23691267	SENT131	9	9	21	21	ethanol	CYP2E1	PA448073	1571	0.608
NULL	Infect_Drug_Resist_2010_Apr_26_3_15-23.nxml.txt.nlp	21694890	SENT66	33	33	27	27	raltegravir	CD4		920	0.608
NULL	Mol_Pain_2013_Jun_10_9_27.nxml.txt.nlp	23758830	SENT108	2	2	4	4	tetracaine	ASIC1	PA451638	41	0.608
NULL	Arthritis_Res_Ther_2014_Apr_3_16(2)_R86.nxml.txt.nlp	24708674	SENT220	5	5	10	10	bosentan	Fli1	PA10034	2314	0.608
NULL	J_Korean_Med_Sci_2013_Apr_27_28(4)_527-533.nxml.txt.nlp	23580227	SENT26	20	20	28	28	genistein	TRAIL	PA165109660	8743	0.608
NULL	J_Appl_Oral_Sci_2011_Mar-Apr_19(2)_106-112.nxml.txt.nlp	21552710	SENT80	2	2	9	9	chlorhexidine	CHP	PA164776863	11261	0.608
NULL	Case_Rep_Nephrol_Urol_2012_Oct_24_2(2)_145-151.nxml.txt.nlp	23197970	SENT131	18	18	12	12	gentamicin	CTX	PA449753	1593	0.608
NULL	Core_Evid_2011_Sep_8_6_67-79.nxml.txt.nlp	22022289	SENT287	8	8	28	28	metformin	PPG	PA450395	5552	0.608
NULL	Acta_Pharmacol_Sin_2011_Jun_3_32(6)_845-852.nxml.txt.nlp	21642952	SENT99	2	2	19	19	prazosin	TRPV1	PA451093	7442	0.608
NULL	Br_J_Cancer_2011_Jun_7_104(12)_1848-1853.nxml.txt.nlp	21610704	SENT169	10	10	12	12	panitumumab	REL	PA162373091	5966	0.608
NULL	Ann_Rheum_Dis_2013_Aug_21_72(8)_1287-1294.nxml.txt.nlp	22915624	SENT187	8	8	32	32	abatacept	MRI	PA164747080	78996	0.608
NULL	Cell_Death_Dis_2013_Jul_11_4(7)_e719.nxml.txt.nlp	23846221	SENT58	10	10	8	8	cisplatin	TRAIL	PA449014	8743	0.608
NULL	Br_J_Pharmacol_2012_Jan_165(2)_390-400.nxml.txt.nlp	21671897	SENT185	22	22	13	13	suramin	P2X1	PA10292	5023	0.608
NULL	Oncotarget_2012_Mar_31_3(3)_236-260.nxml.txt.nlp	22470194	SENT275	23	23	2	2	sorafenib	SHARP	PA7000	23013	0.608
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT109	21	21	26	26	l-cysteine	S6K1	PA449173	6198	0.608
NULL	Oncotarget_2012_Dec_18_3(12)_1615-1628.nxml.txt.nlp	23271044	SENT80	11	11	9	9	temsirolimus	TOR	PA164746890	6097	0.608
NULL	Cell_Death_Dis_2014_Jul_3_5(7)_e1316.nxml.txt.nlp	24991768	SENT15	8	8	19	19	pemetrexed	Mcl-1	PA10810	4170	0.608
NULL	Acta_Vet_Scand_2008_Nov_27_50(1)_47.nxml.txt.nlp	19038035	SENT20	8	8	0	0	mephenytoin	CYP2C19	PA450373	1557	0.608
NULL	Oncol_Lett_2013_Oct_24_6(4)_970-976.nxml.txt.nlp	24137447	SENT168	2	2	10	10	tamoxifen	ADM	PA451581	133	0.608
NULL	Arthritis_Res_2001_Sep_18_3(6)_381-388.nxml.txt.nlp	11714393	SENT138	31	31	19	19	collagenase	c-Jun	PA449107	3725	0.608
NULL	Cancers_(Basel)_2011_Oct_26_3(4)_4024-4045.nxml.txt.nlp	24213123	SENT817	7	7	15	15	resveratrol	PTEN		5728	0.608
NULL	Environ_Health_Perspect_2005_Sep_13_113(9)_1184-1189.nxml.txt.nlp	16140625	SENT63	3	3	26	26	malathion	CARB	PA164748092	9482	0.608
NULL	Br_J_Haematol_2014_Feb_16_164(4)_586-596.nxml.txt.nlp	24236640	SENT159	6	6	4	4	carboplatin	EPO	PA448803	7076;8288;2056	0.608
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT166	10	10	20	20	perifosine	DR5	PA165291471	8795	0.608
NULL	Arthritis_Res_Ther_2012_May_17_14(3)_R118.nxml.txt.nlp	22594821	SENT54	16	16	4	4	leflunomide	ACPA	PA450192	5657	0.608
NULL	Br_J_Cancer_2012_Jan_17_106(2)_284-289.nxml.txt.nlp	22215065	SENT180	12	12	15	15	atrasentan	IFN	PA143414738	3439	0.608
NULL	Eur_J_Clin_Pharmacol_2010_Feb_17_66(2)_165-170.nxml.txt.nlp	19838691	SENT139	8	8	6	6	dextromethorphan	CYP2D6	PA449273	1565	0.608
NULL	Oncol_Lett_2014_Nov_14_8(5)_2086-2092.nxml.txt.nlp	25295095	SENT105	12	12	10	10	gemcitabine	LKB1	PA449748	6794	0.608
NULL	Nucleic_Acids_Res_2012_Apr_16_40(8)_3511-3523.nxml.txt.nlp	22180533	SENT185	25	25	33	33	doxycycline	E2F7	PA449415	144455	0.608
NULL	Mol_Vis_2012_Jul_18_18_1966-1972.nxml.txt.nlp	22876123	SENT14	5	5	10	10	curcumin	IL-4	PA151958596	3565	0.608
NULL	J_Cell_Biol_2000_Dec_25_151(7)_1561-1574.nxml.txt.nlp	11134083	SENT87	19	19	21	21	paraformaldehyde	CSK	PA450790	1445	0.608
NULL	Oncol_Lett_2014_Mar_27_7(3)_820-826.nxml.txt.nlp	24520300	SENT194	22	22	20	20	cyclophosphamide	CTX	PA449165	1593	0.608
NULL	Acta_Pharmacol_Sin_2013_Sep_5_34(9)_1208-1216.nxml.txt.nlp	23852087	SENT94	2	2	4	4	disulfiram	HIF-1	PA449376	29072	0.608
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT49	6	6	20	20	resveratrol	SIRT1		23411	0.608
NULL	Exp_Diabetes_Res_2012_Oct_15_2012_465282.nxml.txt.nlp	23118742	SENT160	35	35	3	3	metformin	FGF21	PA450395	26291	0.608
NULL	J_Korean_Med_Sci_2006_Dec_31_21(6)_1037-1040.nxml.txt.nlp	17179683	SENT93	6	6	8	8	clarithromycin	BAM	PA449028	9126	0.608
NULL	J_Cancer_Prev_2013_Sep_18(3)_227-234.nxml.txt.nlp	25337550	SENT95	13	13	26	26	belinostat	MLH1		4292	0.608
NULL	J_Exp_Bot_2008_Aug_7_59(11)_3009-3018.nxml.txt.nlp	18611912	SENT109	13	13	18	18	nadh	ADP	PA164755085	23038	0.608
NULL	Breast_Cancer_Res_2007_Mar_2_9(2)_205.nxml.txt.nlp	NULL	SENT26	11	11	29	29	canertinib	EGFR	PA134687925	1956	0.608
NULL	Cell_Commun_Signal_2013_Oct_1_11_73.nxml.txt.nlp	24083678	SENT197	0	0	6	6	sulindac	A20	PA451565	7128;28935	0.608
NULL	Chem_Res_Toxicol_2010_Mar_15_23(3)_568-577.nxml.txt.nlp	20112989	SENT446	7	7	21	21	cisplatin	AKT2	PA449014	208	0.608
NULL	Adv_Biomed_Res_2014_Mar_25_3_97.nxml.txt.nlp	24800186	SENT71	9	9	25	25	sertraline	MAP2	PA451333	4133;10988	0.608
NULL	Biomed_Res_Int_2014_Aug_6_2014_967826.nxml.txt.nlp	25165721	SENT140	1	1	5	5	arsenite	p27	PA452638	5715;10534	0.608
NULL	Acta_Diabetol_2012_Aug_11_49(4)_277-289.nxml.txt.nlp	21833779	SENT112	23	23	13	13	carbachol	ANOVA	PA448784	4858	0.608
NULL	Biomed_Res_Int_2014_May_4_2014_351252.nxml.txt.nlp	24877084	SENT161	7	7	9	9	bevacizumab	FTM	PA130232992	23322	0.608
NULL	Osong_Public_Health_Res_Perspect_2013_Dec_12_4(6)_316-322.nxml.txt.nlp	24524020	SENT206	14	14	33	33	chloramphenicol	PEN	PA448927	9933	0.608
NULL	Cancer_Med_2013_Dec_31_2(6)_826-835.nxml.txt.nlp	24403256	SENT218	16	16	18	18	nutlin-3	HDM2		4193	0.608
NULL	Asian_J_Androl_2014_May_30_Sep-Oct_16(5)_669-674.nxml.txt.nlp	24923457	SENT16	10	10	14	14	protamine	DAZL	PA10366	1618	0.608
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jul_4_65(Pt_8)_o1750.nxml.txt.nlp	21583461	SENT60	26	26	9	9	ethanol	mol	PA448073	90527	0.608
NULL	Carcinogenesis_2014_May_13_35(5)_1055-1066.nxml.txt.nlp	24419232	SENT249	25	25	6	6	metformin	VEGF-A	PA450395	7422	0.608
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1821-1889.nxml.txt.nlp	25268160	SENT305	3	3	7	7	imatinib	FDG	PA10804	23583	0.608
NULL	Inflammation_2013_Apr_26_36(2)_387-404.nxml.txt.nlp	23100032	SENT267	20	20	28	28	carrageenan	HGB	PA448814	114757	0.608
NULL	Acta_Orthop_2011_Feb_10_82(1)_6-12.nxml.txt.nlp	21189110	SENT157	11	11	25	25	chromium	CD4	PA448989	920	0.608
NULL	Acta_Vet_Scand_2011_Feb_17_53(1)_11.nxml.txt.nlp	21324209	SENT75	18	18	16	16	oxytetracycline	OTC	PA450757	5009	0.608
NULL	Clin_Ophthalmol_2007_Mar_1(1)_61-64.nxml.txt.nlp	19668467	SENT77	4	4	10	10	tacrolimus	castor	PA451578	54897	0.608
NULL	Front_Physiol_2013_May_15_4_103.nxml.txt.nlp	23720630	SENT151	15	15	33	33	simvastatin	Q10	PA451363	27161	0.608
NULL	Br_J_Pharmacol_2014_Dec_5_171(23)_5209-5224.nxml.txt.nlp	25041479	SENT160	11	11	37	37	choline	ANOVA	PA448976	4858	0.608
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Aug_4_66(Pt_9)_o2198-o2199.nxml.txt.nlp	21588573	SENT79	16	16	12	12	ethanol	mol	PA448073	90527	0.608
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_11_2014_780385.nxml.txt.nlp	25435891	SENT27	30	30	25	25	lipase	HSL	PA450239	3991	0.608
NULL	Clin_Pharmacokinet_2014_Sep_3_53(1)_1-16.nxml.txt.nlp	23999929	SENT287	12	12	8	8	erythromycin	CYP3A4	PA449493	1576	0.608
NULL	Diabetes_Metab_J_2014_Apr_18_38(2)_100-106.nxml.txt.nlp	24851203	SENT91	18	18	0	0	glucose	MET	PA449773	4233	0.608
NULL	Mol_Pain_2013_Mar_7_9_11.nxml.txt.nlp	23497285	SENT61	6	6	25	25	sevoflurane	ANOVA	PA451341	4858	0.608
NULL	Eur_J_Neurosci_2011_Mar_33(5)_914-922.nxml.txt.nlp	21255131	SENT112	0	0	8	8	pentobarbital	gamma	PA450859	9913	0.608
NULL	Carcinogenesis_2013_Mar_7_34(3)_703-712.nxml.txt.nlp	23222814	SENT104	15	15	10	10	curcumin	BAX	PA151958596	581	0.608
NULL	Oncogene_2010_Sep_2_29(35)_4925-4937.nxml.txt.nlp	20562914	SENT314	36	36	16	16	collagenase	c-fos	PA449107	2353	0.608
NULL	Appl_Microbiol_Biotechnol_2013_Aug_15_97(15)_7049-7059.nxml.txt.nlp	23771779	SENT31	21	21	8	8	ethanol	CO2	PA448073	4513	0.608
NULL	Crit_Care_2007_May_24_11(3)_R61.nxml.txt.nlp	17524133	SENT121	9	9	28	28	oxygen	SAPS	PA450744	8935	0.608
NULL	Int_J_Nanomedicine_2012_Oct_25_7_5565-5575.nxml.txt.nlp	23118538	SENT51	10	10	12	12	fenofibrate	CO2	PA449594	4513	0.608
NULL	Eur_J_Neurosci_2014_Feb_4_39(3)_419-434.nxml.txt.nlp	24494682	SENT27	1	1	3	3	lipase	MGL	PA450239	11343	0.608
NULL	Ann_Saudi_Med_2010_Jan-Feb_30(1)_33-37.nxml.txt.nlp	20103956	SENT15	8	8	19	19	l-arginine	NOS1	PA448478	340719;4842	0.608
NULL	Braz_J_Med_Biol_Res_2013_May_10_46(5)_433-439.nxml.txt.nlp	23681290	SENT152	18	18	14	14	bezafibrate	BAFF	PA162364313	10673	0.608
NULL	Acta_Pharmacol_Sin_2010_Apr_8_31(4)_461-469.nxml.txt.nlp	20208553	SENT177	13	13	16	16	ethanol	adiponectin	PA448073	9370	0.608
NULL	Diabetes_2013_Mar_14_62(3)_789-800.nxml.txt.nlp	22966074	SENT214	10	10	13	13	forskolin	AMPK	PA146096022	5563	0.608
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_3_2014_473213.nxml.txt.nlp	25538791	SENT22	12	12	17	17	ethanol	MDR1	PA448073	5243	0.608
NULL	Bioengineered_2013_Nov_1_4(6)_420-430.nxml.txt.nlp	23969939	SENT106	15	15	11	11	nadh	FBA	PA164755085	26273	0.608
NULL	Exp_Ther_Med_2013_Nov_6_6(5)_1089-1095.nxml.txt.nlp	24223627	SENT183	12	12	29	29	cyclophosphamide	HER2	PA449165	2064	0.608
NULL	Hum_Genomics_2012_Jul_5_6(1)_3.nxml.txt.nlp	23244780	SENT142	27	27	17	17	tamoxifen	CYP2D6	PA451581	1565	0.608
NULL	Int_J_Endocrinol_Metab_2013_Jul_1_Summer_11(3)_184-190.nxml.txt.nlp	24348591	SENT138	0	0	8	8	liraglutide	INS-1	PA165958364	2305	0.608
NULL	Nat_Genet_2014_Jun_20_46(6)_613-617.nxml.txt.nlp	24747643	SENT16	14	14	23	23	vasopressin	ACTH	PA451858	5443	0.608
NULL	Acta_Pharmacol_Sin_2010_Jul_28_31(7)_867-873.nxml.txt.nlp	20581857	SENT130	14	14	16	16	docetaxel	PC3	PA449383	57332;7832;5122	0.608
NULL	Genome_Med_2009_Oct_27_1(10)_99.nxml.txt.nlp	19863774	SENT181	14	14	24	24	cisplatin	TP53	PA449014	7157	0.608
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT104	0	0	5	5	pertuzumab	HER2		2064	0.608
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT35	8	8	31	31	gefitinib	KRAS	PA131301952	3845	0.608
NULL	Breast_Cancer_Res_2010_Nov_16_12(6)_R96.nxml.txt.nlp	21080941	SENT197	18	18	14	14	lapatinib	HRG	PA152241907	3084;3273	0.608
NULL	Clin_Exp_Reprod_Med_2014_Sep_30_41(3)_120-124.nxml.txt.nlp	25309856	SENT0	23	23	41	41	thyroglobulin	CHA	PA164754910	10732	0.608
NULL	Head_Face_Med_2012_Sep_28_8_25.nxml.txt.nlp	23021517	SENT37	20	20	17	17	l-glutamine	GEM	PA10090	2669	0.608
NULL	J_Cell_Mol_Med_2014_May_14_18(5)_811-823.nxml.txt.nlp	24628949	SENT152	3	3	12	12	docetaxel	MCAK	PA449383	11004	0.608
NULL	Br_J_Cancer_2013_Feb_5_108(2)_469-476.nxml.txt.nlp	23169292	SENT174	8	8	25	25	erlotinib	TTF1	PA134687924	7080;7270	0.608
NULL	Clin_Med_Insights_Case_Rep_2012_Feb_16_5_13-17.nxml.txt.nlp	22399868	SENT30	4	4	11	11	adalimumab	CD4	PA10004	920	0.608
NULL	Int_J_Endocrinol_2014_Apr_30_2014_674987.nxml.txt.nlp	24883061	SENT109	24	24	8	8	nadh	PARP	PA164755085	142	0.608
NULL	Antiviral_Res_2009_May_82(2)_A99-A109.nxml.txt.nlp	19176219	SENT1110	24	24	2	2	ritonavir	MRP-1	PA451260	928	0.608
NULL	J_Young_Pharm_2012_Oct-Dec_4(4)_235-244.nxml.txt.nlp	23493308	SENT59	0	0	18	18	fluoxetine	BUP	PA449673	23412	0.608
NULL	Clin_Ophthalmol_2014_Feb_10_8_389-399.nxml.txt.nlp	24550667	SENT161	4	4	29	29	brinzolamide	TIM	PA164744929	7984;8914	0.608
NULL	J_Korean_Neurosurg_Soc_2013_Oct_31_54(4)_280-288.nxml.txt.nlp	24294450	SENT184	21	21	23	23	acetazolamide	ACZ	PA448018	27445	0.608
NULL	Mult_Scler_Int_2014_May_6_2014_759808.nxml.txt.nlp	24891952	SENT108	16	16	9	9	nadh	Q10	PA164755085	27161	0.608
NULL	J_Gynecol_Oncol_2014_Apr_9_25(2)_130-135.nxml.txt.nlp	24761217	SENT32	6	6	14	14	paclitaxel	P-gp	PA450761	5243	0.608
NULL	Exp_Diabetes_Res_2007_Jun_28_2007_52487.nxml.txt.nlp	17713597	SENT72	0	0	9	9	ranibizumab	San	PA164746012	80218	0.608
NULL	Drug_Des_Devel_Ther_2014_Oct_31_8_2121-2128.nxml.txt.nlp	25382970	SENT129	8	8	14	14	curcumin	TTR	PA151958596	7276	0.608
NULL	Diabetes_2013_Jun_17_62(6)_1843-1854.nxml.txt.nlp	23349486	SENT178	0	0	2	2	fluorescein	CD14	PA164746009	929	0.608
NULL	Emerg_Infect_Dis_2012_Feb_18(2)_302-304.nxml.txt.nlp	22305387	SENT113	36	36	14	14	atovaquone	PYM	PA448502	84305	0.608
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT78	0	0	7	7	metformin	p53	PA450395	7157	0.608
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_21-38.nxml.txt.nlp	19305786	SENT307	0	0	2	2	menthol	TRPM8	PA164776605	79054	0.608
NULL	EMBO_Mol_Med_2013_May_22_5(5)_723-736.nxml.txt.nlp	23606532	SENT12	0	0	2	2	tamoxifen	TMX	PA451581	81542	0.608
NULL	Case_Rep_Oncol_2014_Jul_5_7(2)_435-443.nxml.txt.nlp	25126073	SENT153	17	17	11	11	carboplatin	Gem	PA448803	51053	0.608
NULL	Mol_Cancer_2014_Jul_5_13_165.nxml.txt.nlp	24996221	SENT80	0	0	2	2	docetaxel	HMGB1	PA449383	3146	0.608
NULL	Curr_Neuropharmacol_2013_Mar_11(2)_141-159.nxml.txt.nlp	23997750	SENT630	3	3	0	0	vasopressin	AVP	PA451858	114548;551	0.608
NULL	Amyloid_2014_Sep_11_21(3)_175-184.nxml.txt.nlp	24918964	SENT196	17	17	21	21	anakinra	TTR	PA10799	7276	0.608
NULL	Arthritis_Res_Ther_2011_Feb_15_13(1)_R24.nxml.txt.nlp	21324111	SENT134	15	15	6	6	methotrexate	M-CSF	PA450428	1435	0.608
NULL	Sci_Rep_2015_Jan_6_5_7641.nxml.txt.nlp	25560734	SENT246	1	1	6	6	tamoxifen	14-3-3	PA451581	10971	0.608
NULL	J_Adv_Pharm_Technol_Res_2012_Oct-Dec_3(4)_202-209.nxml.txt.nlp	23378940	SENT129	13	13	11	11	aprepitant	CYP3A4	PA164747039	1576	0.608
NULL	Br_J_Cancer_1988_Sep_58(3)_335-340.nxml.txt.nlp	3179186	SENT7	6	6	8	8	trifluoperazine	TFP	PA451771	7034	0.608
NULL	Eur_J_Med_Res_2011_Feb_24_16(2)_85-92.nxml.txt.nlp	21463988	SENT37	1	1	3	3	atazanavir	ATV	PA10251	4683	0.608
NULL	Orphanet_J_Rare_Dis_2010_Dec_1_5_33.nxml.txt.nlp	21122093	SENT32	16	16	18	18	lipase	ATGL	PA450239	57104	0.608
NULL	J_Hepatobiliary_Pancreat_Surg_2008_Jan_16_15(1)_55-62.nxml.txt.nlp	18274844	SENT65	26	26	10	10	hydroxyurea	IFN	PA449942	3439	0.608
NULL	Case_Rep_Ophthalmol_Med_2012_Nov_6_2012_968180.nxml.txt.nlp	23198204	SENT54	24	24	4	4	tocilizumab	IL-6	PA165292659	3569	0.608
NULL	Braz_J_Med_Biol_Res_2013_Aug_16_46(8)_708-714.nxml.txt.nlp	23969974	SENT173	12	12	16	16	alendronate	ANOVA	PA448082	4858	0.608
NULL	Front_Oncol_2013_Nov_14_3_279.nxml.txt.nlp	24294592	SENT111	27	27	16	16	carboplatin	PI3K	PA448803	5290	0.608
NULL	EMBO_Mol_Med_2013_Aug_5_5(8)_1213-1226.nxml.txt.nlp	23918228	SENT139	4	4	7	7	cetuximab	EGFR	PA10040	1956	0.608
NULL	J_Cardiothorac_Surg_2013_Jul_18_8_176.nxml.txt.nlp	23866777	SENT75	17	17	6	6	creatine	IL-6	PA164778930	3569	0.608
NULL	Adipocyte_2012_Jul_1_1(3)_132-181.nxml.txt.nlp	23700522	SENT90	23	23	25	25	lipase	HSL	PA450239	3991	0.608
NULL	J_Nat_Med_2009_Jul_4_63(3)_274-282.nxml.txt.nlp	19343477	SENT113	8	8	22	22	ethanol	spatial	PA448073	219793	0.608
NULL	BMB_Rep_2013_Jan_46(1)_59-64.nxml.txt.nlp	23351386	SENT5	4	4	15	15	auranofin	NAC	PA448510	22861	0.608
NULL	J_Biol_Chem_2011_Oct_7_286(40)_34998-35006.nxml.txt.nlp	21757733	SENT32	7	7	9	9	lipase	HSL	PA450239	3991	0.608
NULL	Mol_Cancer_2014_Jun_27_13_159.nxml.txt.nlp	24972933	SENT53	5	5	7	7	cytarabine	CTRL	PA449177	1506	0.608
NULL	Lancet_2009_May_23_373(9677)_1780-1788.nxml.txt.nlp	19465233	SENT108	11	11	8	8	fenofibrate	NNT	PA449594	23530	0.608
NULL	Oncotarget_2013_Oct_19_4(11)_2045-2056.nxml.txt.nlp	24185104	SENT5	8	8	14	14	cisplatin	14-3-3	PA449014	10971	0.608
NULL	EMBO_J_2014_Jul_17_33(14)_1514-1526.nxml.txt.nlp	24872509	SENT113	21	21	25	25	zinc	CYC1	PA451956	1537	0.608
NULL	Lancet_2010_Nov_6_376(9752)_1566-1578.nxml.txt.nlp	21035842	SENT277	29	29	16	16	primaquine	G6PD	PA451103	2539	0.608
NULL	J_Geriatr_Cardiol_2012_Sep_9(3)_292-304.nxml.txt.nlp	23097660	SENT283	1	1	3	3	vasopressin	AVP	PA451858	114548;551	0.608
NULL	Diabetes_Care_2009_Nov_32(Suppl_2)_S232-S236.nxml.txt.nlp	19875557	SENT46	5	5	15	15	glucose	IL-6	PA449773	3569	0.608
NULL	Oncol_Lett_2014_Jul_25_8(1)_367-373.nxml.txt.nlp	24959278	SENT11	0	0	7	7	cisplatin	DDP	PA449014	1678	0.608
NULL	Int_J_Mol_Sci_2012_Sep_25_13(10)_12213-12223.nxml.txt.nlp	23202893	SENT357	1	1	3	3	cyclophosphamide	CD4	PA449165	920	0.608
NULL	Br_J_Clin_Pharmacol_2011_Dec_72(6)_921-931.nxml.txt.nlp	21676011	SENT46	10	10	8	8	capsaicin	TRPV1	PA448776	7442	0.608
NULL	ScientificWorldJournal_2013_Apr_24_2013_928197.nxml.txt.nlp	23737732	SENT59	6	6	16	16	losartan	adiponectin	PA450268	9370	0.608
NULL	Int_J_Mol_Sci_2013_Aug_14_14(8)_16719-16731.nxml.txt.nlp	23949634	SENT109	24	24	17	17	thrombin	TPC	PA451674	8030;60386	0.608
NULL	Iran_J_Pharm_Res_2013_Winter_12(Suppl)_3-10.nxml.txt.nlp	24250666	SENT138	13	13	6	6	ethanol	zeta	PA448073	9907	0.608
NULL	Curr_Genomics_2014_Jun_15(3)_231-236.nxml.txt.nlp	24955030	SENT138	26	26	17	17	nadh	PGC1	PA164755085	10891	0.608
NULL	Autophagy_2013_Sep_1_9(9)_1418-1430.nxml.txt.nlp	23748697	SENT105	14	14	7	7	glucose	LC3	PA449773	84557	0.608
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT41	6	6	11	11	nutlin-3	p53		7157	0.608
NULL	Colomb_Med_(Cali)_43(4)_305-311.nxml.txt.nlp	24893304	SENT20	35	35	18	18	ganciclovir	CD4	PA449733	920	0.608
NULL	Diabetes_Care_2010_Jul_31_33(7)_1607-1609.nxml.txt.nlp	20357375	SENT55	11	11	34	34	sitagliptin	CXCR4	PA164748978	7852	0.608
NULL	Br_J_Cancer_1997_76(6)_797-804.nxml.txt.nlp	9310249	SENT16	4	4	6	6	mitoxantrone	NOV	PA450526	4856;5361;6134	0.608
NULL	J_RNAi_Gene_Silencing_2009_Mar_9_5(1)_321-330.nxml.txt.nlp	19771229	SENT215	6	6	38	38	gemcitabine	RRM2	PA449748	6241	0.608
NULL	Front_Genet_2012_Nov_22_3_249.nxml.txt.nlp	23189085	SENT42	14	14	12	12	cyclophosphamide	CFD	PA449165	1675	0.608
NULL	J_Cancer_2011_May_25_2_317-323.nxml.txt.nlp	21716848	SENT34	13	13	25	25	trastuzumab	HER2	PA451743	2064	0.608
NULL	Clin_Ophthalmol_2008_Dec_2(4)_897-905.nxml.txt.nlp	19668444	SENT130	7	7	5	5	travoprost	BAK	PA164781371	578	0.608
NULL	Arthritis_Res_Ther_2014_Jan_20_16(1)_R17.nxml.txt.nlp	24444433	SENT81	14	14	6	6	hydroxychloroquine	ANOVA	PA164777036	4858	0.608
NULL	J_Inherit_Metab_Dis_2012_Jan_10_35(1)_141-149.nxml.txt.nlp	21556832	SENT24	8	8	11	11	creatine	AGAT	PA164778930	2628	0.608
NULL	Lipids_Health_Dis_2011_Feb_28_10_38.nxml.txt.nlp	21352602	SENT198	29	29	33	33	ezetimibe	PCSK9	PA10816	255738	0.608
NULL	Clin_Exp_Otorhinolaryngol_2011_Dec_15_4(4)_177-183.nxml.txt.nlp	22232712	SENT119	19	19	6	6	doxycycline	MUC5B	PA449415	727897	0.608
NULL	Mol_Vis_2007_Dec_17_13_2282-2288.nxml.txt.nlp	18199969	SENT5	13	13	38	38	oxygen	IL-8	PA450744	3576	0.608
NULL	Br_J_Cancer_2010_Sep_7_103(6)_845-851.nxml.txt.nlp	20700125	SENT5	30	30	24	24	capecitabine	ERCC1	PA448771	2067	0.608
NULL	Arthritis_Res_Ther_2009_Feb_3_11(1)_R15.nxml.txt.nlp	19192274	SENT223	16	16	34	34	piroxicam	IL-8	PA450985	3576	0.608
NULL	Eur_J_Clin_Microbiol_Infect_Dis_2010_May_13_29(5)_543-550.nxml.txt.nlp	20229224	SENT73	41	41	47	47	teicoplanin	VAN	PA164746244	10318	0.608
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT259	24	24	32	32	bevacizumab	VEGF-A	PA130232992	7422	0.608
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1449-1456.nxml.txt.nlp	24077631	SENT27	42	42	38	38	tolbutamide	CYP2C9	PA451718	1559	0.608
NULL	Ann_Oncol_2009_Aug_20(Suppl_6)_vi41-vi50.nxml.txt.nlp	19617297	SENT51	10	10	27	27	vinblastine	IL-2	PA451877	3558	0.608
NULL	EMBO_Mol_Med_2012_Jun_13_4(6)_515-527.nxml.txt.nlp	22416035	SENT6	5	5	12	12	olaparib	p53		7157	0.608
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Aug_28_66(Pt_9)_m1165-m1166.nxml.txt.nlp	21588557	SENT76	15	15	18	18	ethanol	mol	PA448073	90527	0.608
NULL	Virol_J_2011_May_17_8_234.nxml.txt.nlp	21575275	SENT119	15	15	13	13	ribavirin	IFN	PA451241	3439	0.608
NULL	Int_J_Biomed_Sci_2014_Dec_10(4)_236-242.nxml.txt.nlp	25598753	SENT149	22	22	10	10	chlorpropamide	DUT	PA448966	1854	0.608
NULL	Case_Rep_Oncol_Med_2014_May_15_2014_874831.nxml.txt.nlp	24959367	SENT62	5	5	11	11	ketoconazole	ACTH	PA450146	5443	0.608
NULL	Int_J_Mol_Sci_2014_Oct_31_15(11)_19791-19815.nxml.txt.nlp	25365172	SENT1492	3	3	6	6	ciclopirox	HIF-1alpha	PA164747060	3091	0.608
NULL	Front_Endocrinol_(Lausanne)_2013_Jun_12_4_71.nxml.txt.nlp	23781214	SENT205	21	21	8	8	rosiglitazone	IL-6	PA451283	3569	0.608
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_May_15_66(Pt_6)_o1353.nxml.txt.nlp	21579439	SENT69	1	1	12	12	phenol	C17	PA450913	54360	0.608
NULL	Oncotarget_2014_Mar_26_5(21)_10342-10355.nxml.txt.nlp	25431950	SENT84	22	22	27	27	doxorubicin	EZH2	PA449412	2146	0.608
NULL	J_Hematol_Oncol_2008_Aug_11_1_11.nxml.txt.nlp	18694493	SENT133	13	13	18	18	bevacizumab	IFN	PA130232992	3439	0.608
NULL	J_Young_Pharm_2012_Jan-Mar_4(1)_42-48.nxml.txt.nlp	22523460	SENT10	0	0	2	2	tropicamide	TPC	PA164749389	8030;60386	0.608
NULL	Mol_Cancer_2012_Mar_21_11_13.nxml.txt.nlp	22436134	SENT253	0	0	11	11	doxorubicin	HuR	PA449412	1994	0.607
NULL	Clin_Ophthalmol_2007_Dec_1(4)_519-525.nxml.txt.nlp	19668531	SENT105	8	8	16	16	azithromycin	BAK	PA448519	578	0.607
NULL	Arthritis_Res_Ther_2012_Jun_8_14(3)_213.nxml.txt.nlp	22682420	SENT78	5	5	16	16	lipase	IL-6	PA450239	3569	0.607
NULL	Cancers_(Basel)_2010_Aug_18_2(3)_1576-1596.nxml.txt.nlp	24281174	SENT230	24	24	27	27	perifosine	ABCG2	PA165291471	9429	0.607
NULL	Int_J_Mol_Sci_2014_Mar_20_15(3)_4977-4993.nxml.txt.nlp	24658441	SENT297	1	1	6	6	resveratrol	AKT		207	0.607
NULL	Infect_Drug_Resist_2012_Jun_25_5_87-102.nxml.txt.nlp	22787406	SENT113	3	3	20	20	linezolid	HAP	PA450233	5915;10313	0.607
NULL	J_Inflamm_(Lond)_2007_Jun_13_4_13.nxml.txt.nlp	17567894	SENT136	0	0	8	8	pentobarbital	GM-CSF	PA450859	1437	0.607
NULL	Acta_Neuropathol_Commun_2013_May_20_1_17.nxml.txt.nlp	24252689	SENT6	33	33	25	25	fluvastatin	IQGAP1	PA449688	8826	0.607
NULL	Int_Arch_Med_2010_Dec_13_3_36.nxml.txt.nlp	21144047	SENT452	4	4	12	12	zinc	PRDM16	PA451956	63976	0.607
NULL	Behav_Ecol_Sociobiol_2011_May_12_65(5)_983-994.nxml.txt.nlp	21625648	SENT103	11	11	16	16	ethanol	hole	PA448073	80757	0.607
NULL	Oncogene_2014_Sep_18_33(38)_4685-4696.nxml.txt.nlp	24121268	SENT116	8	8	15	15	nutlin-3	p53		7157	0.607
NULL	Int_J_Biol_Sci_2012_Sep_6_8(8)_1109-1120.nxml.txt.nlp	22991499	SENT143	19	19	13	13	l-arginine	IFN	PA448478	3439	0.607
NULL	J_Mol_Signal_2011_May_16_6_4.nxml.txt.nlp	21575178	SENT138	6	6	14	14	arsenite	MSK1	PA452638	9252	0.607
NULL	Ann_Oncol_2009_Aug_20(Suppl_6)_vi35-vi40.nxml.txt.nlp	19617296	SENT10	30	30	33	33	temsirolimus	VEGFR	PA164746890	3791	0.607
NULL	Mediators_Inflamm_2010_Jun_21_2010_194896.nxml.txt.nlp	20652055	SENT48	18	18	27	27	fluvastatin	mol	PA449688	90527	0.607
NULL	J_Cell_Biol_1998_Jan_26_140(2)_335-345.nxml.txt.nlp	9442109	SENT168	24	24	22	22	chloroquine	NHE	PA448948	285335	0.607
NULL	J_Invest_Dermatol_2013_Sep_31_133(9)_2247-2254.nxml.txt.nlp	23370537	SENT136	26	26	28	28	chloroquine	PUMA	PA448948	27113	0.607
NULL	J_Vet_Med_Sci_2014_Feb_8_76(2)_173-182.nxml.txt.nlp	24107430	SENT177	9	9	1	1	vasopressin	AVP	PA451858	114548;551	0.607
NULL	Indian_J_Psychol_Med_2012_Jan-Mar_34(1)_85-86.nxml.txt.nlp	22661816	SENT15	35	35	17	17	topiramate	BPAD	PA451728	4095	0.607
NULL	J_Hematol_Oncol_2012_Aug_16_5_51.nxml.txt.nlp	22897949	SENT22	11	11	6	6	rituximab	CHOP	PA451261	1649	0.607
NULL	ISRN_Obes_2014_Jan_23_2014_540582.nxml.txt.nlp	24587943	SENT157	20	20	23	23	lipase	HSL	PA450239	3991	0.607
NULL	Core_Evid_2011_Sep_8_6_67-79.nxml.txt.nlp	22022289	SENT287	16	16	10	10	pioglitazone	PCB	PA450970	5091	0.607
NULL	Evid_Based_Complement_Alternat_Med_2014_May_14_2014_158018.nxml.txt.nlp	24963319	SENT18	17	17	19	19	lipase	HSL	PA450239	3991	0.607
NULL	Neural_Regen_Res_2013_Jul_5_8(19)_1803-1813.nxml.txt.nlp	25206477	SENT156	7	7	9	9	donepezil	spatial	PA449394	219793	0.607
NULL	Br_J_Cancer_2002_Jan_21_86(2)_179-184.nxml.txt.nlp	11870502	SENT59	10	10	19	19	cisplatin	IL-2	PA449014	3558	0.607
NULL	J_Clin_Biochem_Nutr_2009_Sep_28_45(2)_125-130.nxml.txt.nlp	19794918	SENT490	0	0	9	9	lansoprazole	HO-1	PA450180	3162	0.607
NULL	Breast_Cancer_Res_2012_May_2_14(3)_R70.nxml.txt.nlp	22551440	SENT256	14	14	19	19	cisplatin	TP53	PA449014	7157	0.607
NULL	Indian_J_Pharm_Sci_2008_Jan-Feb_70(1)_102-105.nxml.txt.nlp	20390092	SENT69	19	19	17	17	lansoprazole	LAN	PA450180	9993	0.607
NULL	Eur_J_Med_Res_2010_May_18_15(5)_220-224.nxml.txt.nlp	20562062	SENT53	22	22	34	34	rabeprazole	CYP2C19	PA451216	1557	0.607
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_P104.nxml.txt.nlp	NULL	SENT20	6	6	0	0	raltegravir	DPT		1805	0.607
NULL	Genome_Biol_2008_May_9_9(5)_221.nxml.txt.nlp	18492217	SENT46	31	31	44	44	cisplatin	p53	PA449014	7157	0.607
NULL	Br_J_Cancer_2010_Jun_29_103(1)_12-17.nxml.txt.nlp	20588278	SENT189	28	28	31	31	carboplatin	mol	PA448803	90527	0.607
NULL	Europace_2012_Aug_27_14(8)_1206-1214.nxml.txt.nlp	22454409	SENT102	34	34	4	4	olmesartan	MCP-1	PA164742950	6347	0.607
NULL	J_Mol_Med_(Berl)_2014_May_10_92(7)_709-722.nxml.txt.nlp	24811491	SENT109	34	34	29	29	cetuximab	PIK3CA	PA10040	5290	0.607
NULL	Mol_Vis_2007_Jul_9_13_1083-1093.nxml.txt.nlp	17653053	SENT152	0	0	26	26	minocycline	IL-10	PA450519	3586	0.607
NULL	J_Cardiovasc_Dis_Res_2011_Jan-Mar_2(1)_14-22.nxml.txt.nlp	21716747	SENT123	26	26	17	17	dextran	ADP	PA449261	23038	0.607
NULL	Daru_2013_Jan_5_21(1)_4.nxml.txt.nlp	23351476	SENT85	5	5	9	9	fluoxetine	ANOVA	PA449673	4858	0.607
NULL	Diabetologia_2007_Apr_15_50(4)_790-796.nxml.txt.nlp	17334651	SENT98	8	8	34	34	nadh	ADP	PA164755085	23038	0.607
NULL	Toxins_(Basel)_2010_May_28_2(6)_1207-1224.nxml.txt.nlp	22069634	SENT457	16	16	5	5	sulindac	A33	PA451565	10223	0.607
NULL	Mol_Cancer_2010_Aug_20_9_220.nxml.txt.nlp	20727180	SENT8	0	0	17	17	curcumin	p53	PA151958596	7157	0.607
NULL	J_Gynecol_Oncol_2013_Jul_4_24(3)_265-272.nxml.txt.nlp	23875077	SENT169	20	20	29	29	thrombin	GAPDH	PA451674	2597	0.607
NULL	Arthritis_Res_Ther_2014_Apr_11_16(2)_R93.nxml.txt.nlp	24725461	SENT156	21	21	30	30	letrozole	CYP1A1	PA450196	1543	0.607
NULL	J_Adv_Pract_Oncol_2013_Jul_1_Jul-Aug_4(4)_238-250.nxml.txt.nlp	25032004	SENT242	41	41	8	8	nilotinib	CML	PA165958345	613	0.607
NULL	Acta_Pharmacol_Sin_2012_Jul_4_33(7)_897-908.nxml.txt.nlp	22659625	SENT193	13	13	15	15	bleomycin	BLM	PA448645	641	0.607
NULL	Br_J_Cancer_2003_Mar_10_88(5)_788-795.nxml.txt.nlp	12618891	SENT147	18	18	20	20	bosentan	FasL	PA10034	356	0.607
NULL	Acta_Pharmacol_Sin_2014_Sep_25_35(9)_1199-1206.nxml.txt.nlp	25152024	SENT136	20	20	13	13	cisplatin	mig-2	PA449014	10979	0.607
NULL	J_Mammary_Gland_Biol_Neoplasia_2010_Mar_27_15(1)_5-17.nxml.txt.nlp	20101446	SENT200	15	15	30	30	cisplatin	TIAR	PA449014	7073	0.607
NULL	Front_Behav_Neurosci_2014_Oct_30_8_366.nxml.txt.nlp	25400560	SENT158	15	15	3	3	ethanol	ANOVA	PA448073	4858	0.607
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT105	15	15	26	26	imatinib	ABCB1	PA10804	5243	0.607
NULL	J_Autom_Methods_Manag_Chem_2011_Mar_30_2011_143416.nxml.txt.nlp	21584273	SENT61	0	0	2	2	chloramphenicol	CAP	PA448927	23476;9200;4012;5269;10580;10487	0.607
NULL	J_Parasitol_Res_2012_Jun_27_2012_275436.nxml.txt.nlp	22792440	SENT247	17	17	3	3	l-arginine	IL-4	PA448478	3565	0.607
NULL	J_Korean_Med_Sci_2006_Dec_31_21(6)_1037-1040.nxml.txt.nlp	17179683	SENT96	13	13	8	8	amoxicillin	BAM	PA448406	9126	0.607
NULL	Clin_Dev_Immunol_2013_Sep_22_2013_317682.nxml.txt.nlp	24171032	SENT11	24	24	20	20	hyaluronan	IFN	PA165958431	3439	0.607
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2705-2713.nxml.txt.nlp	24129232	SENT194	4	4	8	8	doxorubicin	ACT	PA449412	12;11332;9457;641455	0.607
NULL	J_Cardiothorac_Surg_2013_Apr_29_8_115.nxml.txt.nlp	23628179	SENT66	10	10	15	15	bivalirudin	ACT	PA10032	12;11332;9457;641455	0.607
NULL	Eur_J_Clin_Microbiol_Infect_Dis_2012_May_7_31(5)_739-745.nxml.txt.nlp	21822974	SENT63	21	21	12	12	vancomycin	SYN	PA451850	2534;23336	0.607
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Oct_23_65(Pt_11)_m1406-m1407.nxml.txt.nlp	21578146	SENT93	27	27	9	9	ethanol	NO3	PA448073	4681	0.607
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT253	25	25	27	27	perifosine	TRAIL	PA165291471	8743	0.607
NULL	Front_Bioeng_Biotechnol_2015_Jan_5_2_76.nxml.txt.nlp	25601910	SENT108	4	4	6	6	l-threonine	FBA	PA451673	26273	0.607
NULL	Diabetes_2008_Oct_57(10)_2801-2808.nxml.txt.nlp	18633115	SENT159	13	13	6	6	sulfasalazine	p65	PA451547	5970	0.607
NULL	Cancers_(Basel)_2014_Apr_9_6(2)_829-859.nxml.txt.nlp	24722453	SENT1476	1	1	6	6	capsaicin	STAT3	PA448776	6774	0.607
NULL	Oncol_Rep_2013_Apr_23_29(4)_1268-1274.nxml.txt.nlp	23354756	SENT106	14	14	2	2	paclitaxel	SLC25A43	PA450761	203427	0.607
NULL	Int_J_Mol_Imaging_2011_May_5_2011_413290.nxml.txt.nlp	21629849	SENT272	11	11	16	16	staurosporine	ANOVA	PA165109623	4858	0.607
NULL	Br_J_Cancer_2002_Jan_21_86(2)_218-221.nxml.txt.nlp	11870509	SENT20	14	14	21	21	tamoxifen	BRCA1	PA451581	672	0.607
NULL	Emerg_Infect_Dis_2012_Feb_18(2)_302-304.nxml.txt.nlp	22305387	SENT113	28	28	10	10	sulfadiazine	CTX	PA451539	1593	0.607
NULL	J_Radiat_Res_2012_Sep_10_53(5)_704-709.nxml.txt.nlp	22843360	SENT94	16	16	10	10	cisplatin	CRT	PA449014	811	0.607
NULL	Exp_Neurobiol_2013_Mar_31_22(1)_51-57.nxml.txt.nlp	23585723	SENT142	6	6	11	11	capsaicin	TRPV1	PA448776	7442	0.607
NULL	J_Cardiovasc_Thorac_Res_2014_Jun_30_6(2)_97-100.nxml.txt.nlp	25031824	SENT71	7	7	10	10	heparin	ACT	PA449855	12;11332;9457;641455	0.607
NULL	J_Korean_Med_Sci_2010_Feb_19_25(2)_240-244.nxml.txt.nlp	20119577	SENT15	7	7	3	3	cisplatin	NAC	PA449014	22861	0.607
NULL	J_Hematol_Oncol_2008_Aug_11_1_11.nxml.txt.nlp	18694493	SENT95	0	0	9	9	temsirolimus	IFN	PA164746890	3439	0.607
NULL	Acta_Pharmacol_Sin_2010_Feb_21_31(2)_145-149.nxml.txt.nlp	20023694	SENT6	11	11	13	13	vasopressin	AVP	PA451858	114548;551	0.607
NULL	Breast_Cancer_Res_Treat_2014_Nov_11_148(3)_563-570.nxml.txt.nlp	25385180	SENT24	5	5	11	11	pertuzumab	PTH		5741	0.607
NULL	Curr_Med_Chem_2013_Jun_20(19)_2415-2437.nxml.txt.nlp	23394552	SENT86	19	19	35	35	piroxicam	COX	PA450985	1351	0.607
NULL	Nucleic_Acids_Res_2013_Nov_22_41(21)_9825-9838.nxml.txt.nlp	23969415	SENT70	20	20	22	22	l-methionine	Met	PA450423	79811	0.607
NULL	Br_J_Cancer_2011_Apr_12_104(8)_1256-1261.nxml.txt.nlp	21448165	SENT40	25	25	27	27	sorafenib	IL-2	PA7000	3558	0.607
NULL	Gut_2008_Nov_2_57(11)_1509-1517.nxml.txt.nlp	18596194	SENT191	6	6	17	17	curcumin	p38	PA151958596	10598;1432;7965	0.607
NULL	J_Cell_Biol_2003_Dec_22_163(6)_1385-1395.nxml.txt.nlp	14676308	SENT265	16	16	7	7	thrombin	p38	PA451674	10598;1432;7965	0.607
NULL	J_Exp_Clin_Cancer_Res_2010_Apr_27_29(1)_38.nxml.txt.nlp	20423465	SENT5	16	16	44	44	pemetrexed	B12	PA10810	7126;4709	0.607
NULL	J_Oncol_2011_May_31_2011_561862.nxml.txt.nlp	21772844	SENT69	34	34	9	9	streptomycin	F12	PA451512	2161	0.607
NULL	Br_J_Cancer_2012_Sep_4_107(6)_947-955.nxml.txt.nlp	22892392	SENT95	6	6	11	11	lapatinib	BCAR3	PA152241907	8412	0.607
NULL	Arthritis_Res_Ther_2013_Oct_30_15(5)_R171.nxml.txt.nlp	24286269	SENT152	0	0	13	13	abatacept	CD28	PA164747080	1493;940	0.607
NULL	J_Headache_Pain_2012_Nov_16_13(8)_677-684.nxml.txt.nlp	23070400	SENT120	21	21	41	41	nabilone	DAI	PA164746998	81030	0.607
NULL	Braz_J_Med_Biol_Res_2014_Mar_3_47(3)_192-205.nxml.txt.nlp	24676492	SENT372	6	6	8	8	lipase	ATGL	PA450239	57104	0.607
NULL	Iran_Red_Crescent_Med_J_2012_Jul_30_14(7)_442-446.nxml.txt.nlp	22997561	SENT7	37	37	39	39	sugar	FBS	PA451529	64319;26269	0.607
NULL	Basic_Clin_Neurosci_2014_Winter_5(1)_66-73.nxml.txt.nlp	25436086	SENT16	14	14	10	10	lidocaine	OX1R	PA450226	3061	0.607
NULL	ScientificWorldJournal_2013_Nov_5_2013_383574.nxml.txt.nlp	24298214	SENT88	4	4	9	9	phenol	gamma	PA450913	9913	0.607
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1145.nxml.txt.nlp	24675463	SENT118	2	2	10	10	cetuximab	EGFR	PA10040	1956	0.607
NULL	Front_Physiol_2015_Jan_14_5_522.nxml.txt.nlp	25642192	SENT280	17	17	27	27	nadh	PDK1	PA164755085	5170;5163	0.607
NULL	J_Physiol_2009_Feb_15_587(Pt_4)_731-744.nxml.txt.nlp	19074966	SENT141	5	5	23	23	taurine	PAT1	PA451590	10513;206358	0.607
NULL	Mol_Cancer_2012_Jun_26_11_43.nxml.txt.nlp	22731636	SENT241	36	36	28	28	trypsin	CO2	PA451806	4513	0.607
NULL	Crit_Care_2008_Apr_30_12(2)_144.nxml.txt.nlp	18466641	SENT18	29	29	19	19	thrombin	IL-6	PA451674	3569	0.607
NULL	Exp_Ther_Med_2014_Jul_2_8(1)_38-48.nxml.txt.nlp	24944594	SENT154	0	0	18	18	lovastatin	IL-6	PA450272	3569	0.607
NULL	Br_J_Cancer_2013_Jun_11_108(11)_2304-2311.nxml.txt.nlp	23695020	SENT251	2	2	4	4	resveratrol	EEF1A2		1917	0.607
NULL	Mol_Clin_Oncol_2013_Jul_15_1(4)_661-667.nxml.txt.nlp	24649225	SENT181	22	22	0	0	leucovorin	OAT2	PA450198	10864	0.607
NULL	Osteopath_Med_Prim_Care_2007_Feb_8_1_7.nxml.txt.nlp	17371583	SENT115	6	6	8	8	diethylstilbestrol	DES	PA449307	1674	0.607
NULL	Clin_Pharmacol_2011_Jun_22_3_13-25.nxml.txt.nlp	22287853	SENT205	24	24	14	14	simvastatin	CYP3A4	PA451363	1576	0.607
NULL	Diabetes_Obes_Metab_2011_Nov_13(11)_982-989.nxml.txt.nlp	21615670	SENT23	9	9	12	12	sitagliptin	GLP-1	PA164748978	100125288	0.607
NULL	J_Nucleic_Acids_2009_Dec_15_2010_593408.nxml.txt.nlp	20814427	SENT273	11	11	8	8	berberine	PC-3	PA165860812	692094	0.607
NULL	Arch_Plast_Surg_2013_Mar_11_40(2)_141-153.nxml.txt.nlp	23529264	SENT125	33	33	25	25	basiliximab	IL-2	PA164747126	3558	0.607
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Feb_29_68(Pt_3)_m350.nxml.txt.nlp	22412477	SENT63	19	19	29	29	ethanol	NO3	PA448073	4681	0.607
NULL	Oxid_Med_Cell_Longev_2013_Jun_6_2013_462361.nxml.txt.nlp	23840917	SENT272	18	18	11	11	minocycline	p47phox	PA450519	653361	0.607
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT143	31	31	20	20	vinorelbine	ASC	PA451881	29108	0.607
NULL	Leukemia_2013_Apr_14_27(4)_803-812.nxml.txt.nlp	23238589	SENT127	13	13	22	22	imatinib	IFN	PA10804	3439	0.607
NULL	Nat_Commun_2014_Nov_25_5_5548.nxml.txt.nlp	25420520	SENT119	36	36	11	11	docetaxel	DTE	PA449383	199699	0.607
NULL	Br_J_Cancer_2013_Mar_5_108(4)_983-992.nxml.txt.nlp	23361057	SENT119	6	6	8	8	cytarabine	MLH1	PA449177	4292	0.607
NULL	Br_J_Pharmacol_2012_Apr_165(8)_2611-2619.nxml.txt.nlp	21718301	SENT58	17	17	10	10	rimonabant	GPR55	PA152407999	9290	0.607
NULL	Curr_Neuropharmacol_2014_Jul_12(4)_308-323.nxml.txt.nlp	25342939	SENT65	0	0	2	2	vasopressin	AVP	PA451858	114548;551	0.607
NULL	Breast_Cancer_Res_2010_May_18_12(Suppl_1)_P13.nxml.txt.nlp	NULL	SENT9	7	7	29	29	fulvestrant	EGFR	PA164747170	1956	0.607
NULL	Diagn_Pathol_2013_Jan_21_8_10.nxml.txt.nlp	23337059	SENT152	23	23	34	34	leucovorin	beta-catenin	PA450198	1499	0.607
NULL	Mol_Cancer_2007_Aug_21_6_53.nxml.txt.nlp	17711579	SENT153	6	6	36	36	cisplatin	CAPN1	PA449014	823	0.607
NULL	Br_J_Anaesth_2011_Oct_17_107(4)_490-502.nxml.txt.nlp	21852280	SENT110	20	20	12	12	capsaicin	TRPV1	PA448776	7442	0.607
NULL	Diabetes_Obes_Metab_2010_Aug_12(8)_700-708.nxml.txt.nlp	20590747	SENT190	21	21	24	24	vildagliptin	PPG	PA165958346	5552	0.607
NULL	Int_J_Biol_Sci_2012_Jan_1_8(2)_228-235.nxml.txt.nlp	22253566	SENT203	2	2	21	21	ustekinumab	IL-23	PA166048654	51561	0.607
NULL	J_Breast_Cancer_2013_Jun_28_16(2)_138-145.nxml.txt.nlp	23843844	SENT180	0	0	15	15	tamoxifen	STAT3	PA451581	6774	0.607
NULL	Onco_Targets_Ther_2014_May_21_7_779-787.nxml.txt.nlp	24899816	SENT236	4	4	14	14	fluorescein	DR5	PA164746009	8795	0.607
NULL	Diabetes_Metab_Syndr_Obes_2014_Aug_1_7_381-389.nxml.txt.nlp	25120374	SENT144	23	23	10	10	salsalate	AMPK	PA164745462	5563	0.607
NULL	Scientifica_(Cairo)_2012_Nov_25_2012_473829.nxml.txt.nlp	24278698	SENT393	5	5	17	17	oxaliplatin	OCTN1	PA131285527	6583	0.607
NULL	Neural_Plast_2007_Jan_1_2007_30585.nxml.txt.nlp	25148070	SENT3514	34	34	22	22	imipramine	PAC1	PA449969	8624;1316;117	0.607
NULL	Indian_J_Med_Res_2014_Jun_139(6)_892-902.nxml.txt.nlp	25109724	SENT7	30	30	32	32	ethambutol	EMB	PA164784021	133418	0.607
NULL	Biochim_Biophys_Acta_2014_Apr_1841(4)_588-594.nxml.txt.nlp	24440819	SENT13	22	22	24	24	lipase	HSL	PA450239	3991	0.607
NULL	Orphanet_J_Rare_Dis_2014_Jun_5_9_79.nxml.txt.nlp	24898617	SENT99	4	4	16	16	resveratrol	CPT2		1376	0.607
NULL	eLife_2014_Apr_29_3_e02407.nxml.txt.nlp	24843027	SENT53	20	20	22	22	estradiol	TNF-alpha	PA449503	7124	0.607
NULL	Arch_Dis_Child_2008_Jul_1_93(7)_620-625.nxml.txt.nlp	18381346	SENT182	0	0	12	12	bosentan	CYP2C9	PA10034	1559	0.607
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1051.nxml.txt.nlp	24503543	SENT144	20	20	27	27	mitoxantrone	Yes	PA450526	7525	0.607
NULL	Int_J_Mol_Sci_2013_Apr_11_14(4)_7923-7931.nxml.txt.nlp	23579955	SENT80	8	8	16	16	galactose	CGB	PA449725	1082	0.607
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT102	35	35	26	26	resveratrol	TNF		7124	0.607
NULL	Oncol_Lett_2013_Oct_24_6(4)_970-976.nxml.txt.nlp	24137447	SENT176	2	2	0	0	doxorubicin	ADM	PA449412	133	0.607
NULL	J_Mol_Signal_2006_Dec_6_1_8.nxml.txt.nlp	17224083	SENT4	18	18	15	15	thrombin	Rho	PA451674	29984	0.607
NULL	Asian-Australas_J_Anim_Sci_2013_Feb_26(2)_266-274.nxml.txt.nlp	25049786	SENT231	3	3	13	13	ginseng	FA3	PA164781150	2176	0.607
NULL	Oncol_Rep_2012_Dec_21_28(6)_1977-1983.nxml.txt.nlp	23007635	SENT61	13	13	11	11	fluorescein	HER-2	PA164746009	2064	0.607
NULL	Ann_Gastroenterol_2012_25(2)_100-105.nxml.txt.nlp	24714229	SENT99	32	32	35	35	ciprofloxacin	BID	PA449009	637	0.607
NULL	Int_J_Environ_Res_Public_Health_2013_Sep_6_10(9)_4143-4160.nxml.txt.nlp	24018837	SENT234	10	10	0	0	copper	PEX	PA449114	5251	0.607
NULL	Mol_Clin_Oncol_2013_Jul_26_1(4)_649-654.nxml.txt.nlp	24649223	SENT205	1	1	7	7	cyclophosphamide	CD25	PA449165	3669;3559	0.607
NULL	J_Korean_Med_Sci_2010_Feb_19_25(2)_304-308.nxml.txt.nlp	20119588	SENT87	27	27	29	29	rifampin	EMB	PA451250	133418	0.607
NULL	Biosci_Rep_2014_Apr_15_34(2)_e00105.nxml.txt.nlp	24617546	SENT95	7	7	18	18	metformin	AMPK	PA450395	5563	0.607
NULL	Mol_Cancer_2014_Jul_5_13_165.nxml.txt.nlp	24996221	SENT92	0	0	2	2	docetaxel	HMGB1	PA449383	3146	0.607
NULL	Cardiovasc_Res_2011_Apr_1_90(1)_140-147.nxml.txt.nlp	21071431	SENT228	19	19	35	35	resveratrol	EGF		1950	0.607
NULL	Allergy_Asthma_Immunol_Res_2011_Jan_29_3(1)_21-26.nxml.txt.nlp	21217921	SENT35	13	13	7	7	methacholine	CK19	PA165958382	3880	0.607
NULL	Acta_Pharmacol_Sin_2010_Apr_8_31(4)_461-469.nxml.txt.nlp	20208553	SENT190	6	6	13	13	ethanol	adiponectin	PA448073	9370	0.607
NULL	Int_J_Mol_Sci_2013_Aug_13_14(8)_16685-16705.nxml.txt.nlp	23945562	SENT821	8	8	14	14	oxygen	ROS	PA450744	6098	0.607
NULL	Int_J_Endocrinol_2014_Apr_30_2014_674987.nxml.txt.nlp	24883061	SENT122	34	34	15	15	collagenase	c-Jun	PA449107	3725	0.607
NULL	Oncol_Lett_2013_Mar_28_5(3)_983-991.nxml.txt.nlp	23426861	SENT169	8	8	15	15	mitomycin	DDP	PA450524	1678	0.607
NULL	J_Biol_Chem_2012_Dec_14_287(51)_42564-42573.nxml.txt.nlp	23055530	SENT239	6	6	4	4	fluorescein	RIG-I	PA164746009	23586	0.607
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Jun_14_70(Pt_7)_o766-o767.nxml.txt.nlp	25161557	SENT78	23	23	19	19	ethanol	mol	PA448073	90527	0.607
NULL	J_Cell_Biol_1998_Jun_15_141(6)_1449-1465.nxml.txt.nlp	9628900	SENT390	13	13	15	15	genistein	Gen	PA165109660	348654	0.607
NULL	J_Immunol_Res_2014_Jan_19_2014_103780.nxml.txt.nlp	24741572	SENT17	39	39	32	32	amantadine	COMT	PA448360	1312	0.607
NULL	Tanaffos_2013_12(1)_6-15.nxml.txt.nlp	25191444	SENT60	15	15	5	5	amikacin	EMB	PA164744372	133418	0.607
NULL	Acta_Vet_Scand_2008_Nov_27_50(1)_47.nxml.txt.nlp	19038035	SENT22	38	38	11	11	diazepam	CYP2C19	PA449283	1557	0.607
NULL	Mol_Cytogenet_2014_Jan_23_7_8.nxml.txt.nlp	24456987	SENT382	25	25	23	23	tamoxifen	MED1	PA451581	5469;8930	0.607
NULL	Nat_Chem_Biol_2014_Feb_22_10(2)_113-121.nxml.txt.nlp	24362705	SENT232	20	20	16	16	lipase	CES1	PA450239	1066	0.607
NULL	Oncoscience_2014_Mar_12_1(2)_158-166.nxml.txt.nlp	25594008	SENT155	33	33	10	10	dasatinib	ANXA1	PA162372878	301	0.607
NULL	Iran_Red_Crescent_Med_J_2014_Aug_5_16(8)_e6915.nxml.txt.nlp	25389496	SENT116	12	12	16	16	rosuvastatin	adiponectin	PA134308647	9370	0.607
NULL	J_Exp_Clin_Cancer_Res_2009_May_27_28(1)_68.nxml.txt.nlp	19470182	SENT172	11	11	17	17	cisplatin	p53	PA449014	7157	0.607
NULL	J_Hematol_Oncol_2012_May_15_5_23.nxml.txt.nlp	22587422	SENT53	7	7	5	5	dasatinib	ALL	PA162372878	613	0.607
NULL	Front_Cell_Neurosci_2013_Dec_19_7_256.nxml.txt.nlp	24391540	SENT2555	0	0	17	17	resveratrol	SIRT2		22933	0.607
NULL	Diabetes_Metab_J_2013_Apr_16_37(2)_113-116.nxml.txt.nlp	23641351	SENT42	4	4	16	16	metformin	PI3K	PA450395	5290	0.607
NULL	Breast_Cancer_Res_2011_Apr_15_13(2)_R44.nxml.txt.nlp	21496232	SENT323	3	3	9	9	lapatinib	HER2	PA152241907	2064	0.607
NULL	Springerplus_2015_Jan_23_4_29.nxml.txt.nlp	25628986	SENT68	32	32	35	35	dapsone	G6PD	PA449211	2539	0.607
NULL	J_Gynecol_Oncol_2014_Jan_8_25(1)_22-29.nxml.txt.nlp	24459577	SENT21	18	18	10	10	ifosfamide	NACT	PA449964	284111	0.607
NULL	Subst_Abuse_Treat_Prev_Policy_2010_Apr_29_5_7.nxml.txt.nlp	20429943	SENT74	19	19	9	9	diclofenac	OTC	PA449293	5009	0.607
NULL	Environ_Health_Perspect_2008_Jan_5_116(1)_1-6.nxml.txt.nlp	18197291	SENT53	23	23	14	14	arsenite	San	PA452638	80218	0.607
NULL	J_Asthma_Allergy_2010_Dec_30_4_1-12.nxml.txt.nlp	21701574	SENT240	4	4	8	8	budesonide	IL-8	PA448681	3576	0.607
NULL	Comput_Struct_Biotechnol_J_2012_Mar_19_1_e201204005.nxml.txt.nlp	22737296	SENT121	4	4	12	12	oxaliplatin	BRCA1	PA131285527	672	0.607
NULL	Cell_Commun_Signal_2013_Oct_1_11_73.nxml.txt.nlp	24083678	SENT205	0	0	8	8	sulindac	A20	PA451565	7128;28935	0.607
NULL	Exp_Ther_Med_2014_Nov_29_8(5)_1473-1478.nxml.txt.nlp	25289044	SENT8	10	10	8	8	heparin	AZU	PA449855	566	0.607
NULL	Biol_Open_2012_Jun_27_1(8)_761-774.nxml.txt.nlp	23213470	SENT454	8	8	13	13	phenol	B27	PA450913	56246	0.607
NULL	Mol_Cancer_2007_Jan_19_6_9.nxml.txt.nlp	17233922	SENT114	10	10	8	8	cisplatin	CROP	PA449014	51747	0.607
NULL	Mol_Brain_2014_May_15_7_37.nxml.txt.nlp	24886748	SENT97	0	0	2	2	vorinostat	HDAC2	PA164748224	3066	0.607
NULL	Biol_Proced_Online_2003_Oct_24_5_204-210.nxml.txt.nlp	14615817	SENT65	16	16	28	28	l-glutamine	IL-3	PA10090	3562	0.607
NULL	Oncol_Lett_2013_Mar_8_5(3)_805-812.nxml.txt.nlp	23426281	SENT146	10	10	7	7	gemcitabine	B7-H3	PA449748	80381	0.607
NULL	Case_Rep_Nephrol_Urol_2012_Oct_24_2(2)_145-151.nxml.txt.nlp	23197970	SENT131	2	2	12	12	ampicillin	CTX	PA448419	1593	0.607
NULL	J_Hematol_Oncol_2010_May_2_3_18.nxml.txt.nlp	20433767	SENT189	12	12	8	8	carboplatin	EGFR	PA448803	1956	0.607
NULL	AMB_Express_2014_Aug_23_4_66.nxml.txt.nlp	25177540	SENT160	30	30	3	3	glucose	GatA	PA449773	55278	0.607
NULL	Oncotarget_2014_Aug_29_5(18)_8052-8082.nxml.txt.nlp	25211298	SENT151	12	12	18	18	artesunate	U87	PA165111697	677775;641648	0.607
NULL	Curr_Respir_Care_Rep_2014_Jul_6_3(3)_121-132.nxml.txt.nlp	25089228	SENT407	6	6	0	0	tiotropium	Mal	PA164769056	114609	0.607
NULL	Eur_J_Clin_Pharmacol_2007_Apr_21_63(4)_335-343.nxml.txt.nlp	17318526	SENT234	35	35	9	9	trimethoprim	CYP2C9	PA451788	1559	0.607
NULL	Biosci_Rep_2013_Sep_17_33(5)_e00068.nxml.txt.nlp	23919527	SENT35	5	5	3	3	heparin	CXCL8	PA449855	3576	0.607
NULL	Oncotarget_2013_Dec_28_5(6)_1475-1490.nxml.txt.nlp	24721996	SENT206	1	1	11	11	celecoxib	CD133	PA448871	8842	0.607
NULL	JAKSTAT_2013_Jan_1_2(1)_e23576.nxml.txt.nlp	24058797	SENT48	25	25	17	17	staurosporine	STAT1	PA165109623	6772	0.607
NULL	Arthritis_Res_Ther_2011_Feb_4_13(1)_R14.nxml.txt.nlp	21294864	SENT125	27	27	20	20	indomethacin	IL-17	PA449982	3605	0.607
NULL	Iran_Red_Crescent_Med_J_2013_Mar_5_15(3)_207-211.nxml.txt.nlp	23983999	SENT53	21	21	16	16	vancomycin	MTM	PA451850	326343	0.607
NULL	Front_Physiol_2013_May_15_4_103.nxml.txt.nlp	23720630	SENT128	14	14	29	29	simvastatin	Q10	PA451363	27161	0.607
NULL	Diabetes_2013_Oct_17_62(10)_3307-3315.nxml.txt.nlp	24065788	SENT104	13	13	36	36	allopurinol	adiponectin	PA448320	9370	0.606
NULL	J_Korean_Med_Sci_2010_Mar_18_25(3)_496-500.nxml.txt.nlp	20191056	SENT43	15	15	20	20	vincristine	CHOP	PA451879	1649	0.606
NULL	Br_J_Cancer_2012_Oct_23_107(9)_1518-1524.nxml.txt.nlp	22996610	SENT174	18	18	6	6	fluorouracil	CEA	PA128406956	5670;1087	0.606
NULL	J_Antimicrob_Chemother_2011_Feb_9_66(2)_363-370.nxml.txt.nlp	21148235	SENT72	6	6	0	0	lopinavir	ATV	PA450264	4683	0.606
NULL	Ethiop_J_Health_Sci_2010_Mar_20(1)_41-48.nxml.txt.nlp	22434959	SENT115	40	40	26	26	kanamycin	Gen	PA450137	348654	0.606
NULL	Core_Evid_2008_Jun_3(1)_13-30.nxml.txt.nlp	20694081	SENT256	6	6	23	23	vildagliptin	GLP-1	PA165958346	100125288	0.606
NULL	Brain_Sci_2013_Apr_26_3(2)_670-703.nxml.txt.nlp	24961420	SENT154	3	3	7	7	ethanol	P19	PA448073	51561	0.606
NULL	Diabetes_Metab_Syndr_Obes_2014_Jun_24_7_229-239.nxml.txt.nlp	25018644	SENT106	0	0	4	4	exenatide	GLP-1	PA164749238	100125288	0.606
NULL	Breast_Cancer_Res_2003_Feb_5_5(2)_113-116.nxml.txt.nlp	12631392	SENT94	37	37	33	33	paclitaxel	TPC	PA450761	8030;60386	0.606
NULL	Cancer_Res_Treat_2014_Jan_15_46(1)_2-18.nxml.txt.nlp	24520218	SENT42	2	2	12	12	curcumin	COX	PA151958596	1351	0.606
NULL	Diabetes_2011_Jun_21_60(6)_1734-1742.nxml.txt.nlp	21498783	SENT24	13	13	15	15	lipase	HSL	PA450239	3991	0.606
NULL	FASEB_J_2012_Jan_26(1)_387-396.nxml.txt.nlp	21957127	SENT60	23	23	44	44	l-glutamine	CO2	PA10090	4513	0.606
NULL	Curr_Control_Trials_Cardiovasc_Med_2001_Nov_3_2(6)_257-259.nxml.txt.nlp	11806808	SENT53	8	8	5	5	vasopressin	AVP	PA451858	114548;551	0.606
NULL	Br_J_Cancer_2009_Jul_21_101(2)_269-277.nxml.txt.nlp	19603033	SENT142	18	18	15	15	cisplatin	MLH1	PA449014	4292	0.606
NULL	Clin_Ophthalmol_2014_Feb_10_8_389-399.nxml.txt.nlp	24550667	SENT195	9	9	29	29	brinzolamide	TIM	PA164744929	7984;8914	0.606
NULL	Cancer_Res_Treat_2014_Jan_15_46(1)_33-40.nxml.txt.nlp	24520221	SENT66	13	13	22	22	cyclophosphamide	CHOP	PA449165	1649	0.606
NULL	Mol_Cancer_2010_Nov_23_9_301.nxml.txt.nlp	21092273	SENT186	15	15	27	27	pentazocine	MCSP	PA164744326	1464;2879	0.606
NULL	Hum_Genomics_2008_Sep_1_3(1)_7-16.nxml.txt.nlp	19129086	SENT182	10	10	18	18	rosiglitazone	CYP2C8	PA451283	1558	0.606
NULL	Adv_Hematol_2013_Apr_16_2013_812605.nxml.txt.nlp	23690782	SENT20	6	6	17	17	lenalidomide	CRBN	PA162363968	51185	0.606
NULL	Breast_Cancer_Res_2011_Nov_24_13(6)_R120.nxml.txt.nlp	22115051	SENT129	27	27	39	39	tamoxifen	HER-2	PA451581	2064	0.606
NULL	ScientificWorldJournal_2012_Jan_29_2012_454059.nxml.txt.nlp	22666124	SENT79	14	14	16	16	trimethoprim	TMP	PA451788	2012	0.606
NULL	Cell_Death_Dis_2011_Apr_28_2(4)_e152.nxml.txt.nlp	21525939	SENT244	28	28	4	4	voacamine	p53	PA165958347	7157	0.606
NULL	Arch_Med_Sci_2012_May_9_8(2)_342-346.nxml.txt.nlp	22662009	SENT60	36	36	31	31	hydroxyprogesterone	PRL	PA449932	5617	0.606
NULL	Mol_Cancer_2007_Sep_26_6_61.nxml.txt.nlp	17894897	SENT88	24	24	9	9	etoposide	p53	PA449552	7157	0.606
NULL	Curr_Pharm_Biotechnol_2011_Jan_12(1)_35-41.nxml.txt.nlp	20932261	SENT101	0	0	14	14	hyperforin	TRPC6	PA165985514	7225	0.606
NULL	Acta_Otorhinolaryngol_Ital_2014_Apr_34(2)_146-149.nxml.txt.nlp	24843227	SENT49	25	25	19	19	vincristine	CHOP	PA451879	1649	0.606
NULL	CNS_Drugs_2014_Feb_7_28(3)_185-193.nxml.txt.nlp	24504829	SENT20	26	26	33	33	choline	CDP	PA448976	1523	0.606
NULL	J_Autom_Methods_Manag_Chem_2011_Mar_30_2011_143416.nxml.txt.nlp	21584273	SENT3	4	4	6	6	chloramphenicol	CAP	PA448927	23476;9200;4012;5269;10580;10487	0.606
NULL	J_Gen_Physiol_2009_Apr_133(4)_421-438.nxml.txt.nlp	19289574	SENT174	5	5	11	11	forskolin	SLC26A9	PA146096022	115019	0.606
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1051.nxml.txt.nlp	24503543	SENT144	28	28	15	15	erlotinib	Yes	PA134687924	7525	0.606
NULL	Epigenetics_Chromatin_2013_Mar_18_6(Suppl_1)_P33.nxml.txt.nlp	NULL	SENT23	31	31	27	27	diethylstilbestrol	A10	PA449307	28870	0.606
NULL	Int_J_Biomed_Sci_2014_Dec_10(4)_236-242.nxml.txt.nlp	25598753	SENT138	22	22	10	10	chlorpropamide	DUT	PA448966	1854	0.606
NULL	Biomed_Res_Int_2014_Aug_6_2014_967826.nxml.txt.nlp	25165721	SENT238	15	15	10	10	cisplatin	IL-10	PA449014	3586	0.606
NULL	Arthritis_Res_Ther_2006_Jul_21_8(4)_R130.nxml.txt.nlp	16859540	SENT256	0	0	2	2	atorvastatin	CD59	PA448500	966	0.606
NULL	Support_Care_Cancer_2012_Sep_17_20(9)_1991-1997.nxml.txt.nlp	22089428	SENT154	6	6	10	10	paclitaxel	castor	PA450761	54897	0.606
NULL	Neuropsychopharmacology_2009_Sep_13_34(10)_2197-2207.nxml.txt.nlp	19440190	SENT182	4	4	7	7	fluoxetine	EPM	PA449673	2054	0.606
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT126	7	7	12	12	doxorubicin	B7-H1	PA449412	29126	0.606
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT7	2	2	19	19	perifosine	DR5	PA165291471	8795	0.606
NULL	Mol_Cancer_2010_Oct_12_9_269.nxml.txt.nlp	20939893	SENT129	6	6	4	4	isoproterenol	AP-1	PA450121	2353;3727;2354;3725	0.606
NULL	Oncotarget_2014_Nov_6_5(22)_11038-11053.nxml.txt.nlp	25402820	SENT150	25	25	27	27	gemcitabine	GEM	PA449748	2669	0.606
NULL	J_Cachexia_Sarcopenia_Muscle_2010_Sep_26_1(1)_43-128.nxml.txt.nlp	22477519	SENT747	17	17	5	5	fenfluramine	NPY	PA449592	4852	0.606
NULL	Int_J_Mol_Sci_2012_Sep_26_13(10)_12268-12286.nxml.txt.nlp	23202898	SENT183	1	1	3	3	lapatinib	AMPK	PA152241907	5563	0.606
NULL	Case_Rep_Dermatol_2012_Sep_16_4(3)_256-260.nxml.txt.nlp	23275770	SENT103	11	11	18	18	isotretinoin	OMG	PA450128	4974	0.606
NULL	Cells_2014_May_23_3(2)_517-545.nxml.txt.nlp	24861977	SENT386	8	8	11	11	capsaicin	VR1	PA448776	56664	0.606
NULL	Eur_J_Neurosci_2014_Feb_4_39(3)_419-434.nxml.txt.nlp	24494682	SENT238	1	1	3	3	lipase	MGL	PA450239	11343	0.606
NULL	Clin_Med_Insights_Womens_Health_2013_Jan_23_6_13-24.nxml.txt.nlp	24665210	SENT176	30	30	20	20	estradiol	CEE	PA449503	51608	0.606
NULL	Int_J_Endocrinol_2013_Nov_27_2013_592576.nxml.txt.nlp	24369464	SENT31	29	29	31	31	streptozocin	STZ	PA451514	6484	0.606
NULL	Virol_J_2012_Feb_16_9_42.nxml.txt.nlp	22339884	SENT193	43	43	19	19	thrombin	CD4	PA451674	920	0.606
NULL	Clin_Med_Oncol_2008_Mar_27_2_275-287.nxml.txt.nlp	21892289	SENT55	8	8	15	15	rituximab	CD19	PA451261	930	0.606
NULL	Cholesterol_2011_Feb_22_2011_503028.nxml.txt.nlp	21490773	SENT109	29	29	24	24	methotrexate	IFN	PA450428	3439	0.606
NULL	Mol_Cancer_2010_Nov_13_9_293.nxml.txt.nlp	21073737	SENT56	14	14	5	5	lipase	LDHA	PA450239	3939	0.606
NULL	Ann_Surg_Oncol_2014_Feb_13_21(5)_1575-1582.nxml.txt.nlp	24522992	SENT10	24	24	16	16	exemestane	BCS	PA449563	617	0.606
NULL	Braz_J_Med_Biol_Res_2013_Dec_10_46(12)_1033-1039.nxml.txt.nlp	24345912	SENT187	0	0	11	11	ethanol	IL-6	PA448073	3569	0.606
NULL	Oncotarget_2013_Jul_14_4(8)_1212-1229.nxml.txt.nlp	23902736	SENT321	14	14	8	8	camptothecin	BTZ	PA153590860	22794	0.606
NULL	Oxid_Med_Cell_Longev_2013_Apr_21_2013_412576.nxml.txt.nlp	23710286	SENT30	18	18	8	8	curcumin	NRF2	PA151958596	2551;4780	0.606
NULL	Asian-Australas_J_Anim_Sci_2013_Feb_26(2)_233-240.nxml.txt.nlp	25049781	SENT113	28	28	10	10	l-carnitine	SDH	PA450154	1757;10993	0.606
NULL	Nucleic_Acids_Res_2013_Dec_5_41(22)_10298-10311.nxml.txt.nlp	24013561	SENT54	28	28	45	45	l-glutamine	CO2	PA10090	4513	0.606
NULL	Exp_Cell_Res_2011_Apr_15_317(7)_1028-1039.nxml.txt.nlp	21237154	SENT102	3	3	1	1	staurosporine	TRAIL	PA165109623	8743	0.606
NULL	Biomed_Res_Int_2013_Aug_19_2013_235194.nxml.txt.nlp	24024185	SENT228	37	37	39	39	dipyridamole	DIP	PA449367	23151;1831	0.606
NULL	Nanoscale_Res_Lett_2014_Aug_21_9(1)_409.nxml.txt.nlp	25221454	SENT118	36	36	25	25	glutaraldehyde	spatial	PA449777	219793	0.606
NULL	Am_J_Case_Rep_2012_Nov_19_13_271-275.nxml.txt.nlp	23569547	SENT73	6	6	8	8	diethylstilbestrol	DES	PA449307	1674	0.606
NULL	Mol_Biol_Cell_2014_Jun_1_25(11)_1782-1792.nxml.txt.nlp	24719457	SENT126	14	14	22	22	nicotine	CHRNA3	PA450626	1136	0.606
NULL	Front_Hum_Neurosci_2014_Dec_22_8_1022.nxml.txt.nlp	25566037	SENT915	10	10	13	13	oxygen	MRI	PA450744	78996	0.606
NULL	Breast_Cancer_Res_2006_Nov_27_8(6)_R66.nxml.txt.nlp	17129383	SENT220	14	14	18	18	paclitaxel	HER2	PA450761	2064	0.606
NULL	ScientificWorldJournal_2013_Mar_6_2013_303815.nxml.txt.nlp	23554568	SENT13	7	7	5	5	lindane	DDT	PA164754914	1652	0.606
NULL	Pharmaceuticals_(Basel)_2011_Oct_10_4(10)_1295-1314.nxml.txt.nlp	NULL	SENT655	17	17	1	1	nitrogen	CD40	PA450643	958	0.606
NULL	Oncologist_2013_Oct_18(Suppl_1)_S1-S7.nxml.txt.nlp	24157419	SENT5	21	21	34	34	afatinib	EGFR	PA165981154	1956	0.606
NULL	J_Lipid_Res_2014_Mar_55(3)_385-397.nxml.txt.nlp	24347527	SENT580	23	23	10	10	lipase	CGI-58	PA450239	51099	0.606
NULL	J_Korean_Med_Sci_2009_Oct_24_24(5)_910-917.nxml.txt.nlp	19794992	SENT24	17	17	23	23	paclitaxel	HER2	PA450761	2064	0.606
NULL	Indian_J_Pharm_Sci_2008_Jul-Aug_70(4)_415-422.nxml.txt.nlp	20046764	SENT97	8	8	12	12	sotalol	mol	PA451457	90527	0.606
NULL	Case_Rep_Hematol_2013_Jun_11_2013_680459.nxml.txt.nlp	23840983	SENT12	13	13	16	16	cyanocobalamin	B12	PA451892	7126;4709	0.606
NULL	Crit_Care_2010_Apr_19_14(2)_R70.nxml.txt.nlp	20403177	SENT260	13	13	8	8	thrombin	cPLA2	PA451674	10524	0.606
NULL	Oncogene_2013_Sep_26_32(39)_10_1038_onc_2012_491.nxml.txt.nlp	23108394	SENT10	22	22	5	5	epirubicin	FOXM1	PA449476	2305	0.606
NULL	J_Infect_Dis_2014_May_1_209(9)_1469-1478.nxml.txt.nlp	24286983	SENT136	12	12	10	10	vancomycin	VAN	PA451850	10318	0.606
NULL	Indian_J_Anaesth_2010_Mar-Apr_54(2)_137-141.nxml.txt.nlp	20661352	SENT130	7	7	26	26	clonidine	CO2	PA449051	4513	0.606
NULL	Int_J_Alzheimers_Dis_2011_May_2_2011_985085.nxml.txt.nlp	21629716	SENT53	9	9	24	24	hemin	p45	PA449849	5705;6502	0.606
NULL	Cancer_Cell_Int_2012_Feb_21_12_5.nxml.txt.nlp	22353776	SENT131	10	10	25	25	sorafenib	STAT3	PA7000	6774	0.606
NULL	Cancer_Metab_2013_Feb_4_1_7.nxml.txt.nlp	24280108	SENT188	13	13	2	2	doxycycline	GLS1	PA449415	2744	0.606
NULL	Nat_Neurosci_2011_May_17_14(5)_612-619.nxml.txt.nlp	21499254	SENT303	1	1	7	7	ethanol	ANOVA	PA448073	4858	0.606
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT92	3	3	5	5	perifosine	TRAIL	PA165291471	8743	0.606
NULL	Breast_Cancer_Res_2009_Mar_19_11(2)_R16.nxml.txt.nlp	19298655	SENT118	26	26	11	11	lipase	ATGL	PA450239	57104	0.606
NULL	Int_J_Microbiol_2014_May_11_2014_764046.nxml.txt.nlp	24949017	SENT5	45	45	27	27	mannitol	NO3	PA450320	4681	0.606
NULL	Curr_Neuropharmacol_2012_Sep_10(3)_272-285.nxml.txt.nlp	23450042	SENT357	5	5	16	16	cycloserine	spatial	PA164764600	219793	0.606
NULL	Cancer_Immunol_Immunother_2013_Aug_27_62(10)_1637-1648.nxml.txt.nlp	23982484	SENT132	21	21	0	0	lenalidomide	IL-6	PA162363968	3569	0.606
NULL	Brain_Res_2013_Jul_12_1521(100)_1-15.nxml.txt.nlp	22789905	SENT832	3	3	7	7	colchicine	P-gp	PA449092	5243	0.606
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1150.nxml.txt.nlp	24675468	SENT103	34	34	19	19	ethanol	PARP-1	PA448073	25976	0.606
NULL	J_Neuroinflammation_2011_Feb_4_8_10.nxml.txt.nlp	21294877	SENT22	30	30	22	22	capsaicin	NK1	PA448776	11126	0.606
NULL	Arthritis_Res_Ther_2011_Feb_16_13(1)_R25.nxml.txt.nlp	21324169	SENT120	37	37	8	8	tocilizumab	ANA	PA165292659	10950	0.606
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT131	2	2	8	8	atorvastatin	AKT	PA448500	207	0.606
NULL	Hematol_Rep_2011_Jan_21_3(1)_e2.nxml.txt.nlp	22184524	SENT44	14	14	16	16	ethambutol	MOF	PA164784021	84148	0.606
NULL	Comput_Struct_Biotechnol_J_2012_Mar_19_1_e201204005.nxml.txt.nlp	22737296	SENT121	2	2	12	12	carboplatin	BRCA1	PA448803	672	0.606
NULL	Cancers_(Basel)_2014_Aug_29_6(3)_1753-1768.nxml.txt.nlp	25256831	SENT566	17	17	10	10	bevacizumab	CEA	PA130232992	5670;1087	0.606
NULL	J_Biomed_Sci_2014_Apr_17_21(1)_30.nxml.txt.nlp	24742230	SENT164	7	7	33	33	lovastatin	OPG	PA450272	690	0.606
NULL	Curr_Pharm_Des_2011_Feb_17(6)_578-590.nxml.txt.nlp	21391908	SENT181	15	15	26	26	doxorubicin	E2F1	PA449412	1869	0.606
NULL	Evid_Based_Complement_Alternat_Med_2012_Dec_9_2012_329171.nxml.txt.nlp	23304197	SENT203	1	1	13	13	simvastatin	AST	PA451363	26503	0.606
NULL	J_Mov_Disord_2009_May_30_2(1)_48-49.nxml.txt.nlp	24868355	SENT32	6	6	13	13	disulfiram	OGC	PA449376	8402	0.606
NULL	Front_Cell_Neurosci_2015_Jan_15_8_459.nxml.txt.nlp	25642166	SENT70	0	0	2	2	hemin	HO-1	PA449849	3162	0.606
NULL	J_Neuroinflammation_2010_Sep_7_7_51.nxml.txt.nlp	20822529	SENT169	1	1	10	10	hemin	CXCL10	PA449849	3627	0.606
NULL	Breast_Cancer_Res_Treat_2012_Jun_18_133(3)_937-947.nxml.txt.nlp	22094936	SENT21	16	16	5	5	tamoxifen	CDC2	PA451581	5424	0.606
NULL	Breast_Cancer_Res_Treat_2014_Dec_21_143(3)_459-467.nxml.txt.nlp	24362951	SENT260	5	5	19	19	everolimus	HER2	PA164746311	2064	0.606
NULL	Exp_Ther_Med_2014_Nov_29_8(5)_1473-1478.nxml.txt.nlp	25289044	SENT128	6	6	10	10	heparin	AZU	PA449855	566	0.606
NULL	Front_Hum_Neurosci_2009_Dec_23_3_49.nxml.txt.nlp	20087437	SENT449	3	3	8	8	glucose	CBT	PA449773	611	0.606
NULL	J_Gen_Physiol_1962_Nov_1_46(2)_315-332.nxml.txt.nlp	13955884	SENT0	16	16	1	1	ethanol	Gen	PA448073	348654	0.606
NULL	Int_J_Breast_Cancer_2011_Feb_24_2011_967419.nxml.txt.nlp	22332018	SENT53	23	23	6	6	doxorubicin	MRP1	PA449412	4437	0.606
NULL	Stroke_Res_Treat_2012_Nov_4_2012_391538.nxml.txt.nlp	23213626	SENT207	12	12	22	22	clopidogrel	ADP	PA449053	23038	0.606
NULL	Iran_J_Microbiol_2013_Mar_5(1)_42-47.nxml.txt.nlp	23466523	SENT91	2	2	8	8	ampicillin	CTX	PA448419	1593	0.606
NULL	Crit_Care_2009_Jul_10_13(4)_R113.nxml.txt.nlp	19591694	SENT90	1	1	3	3	vasopressin	AVP	PA451858	114548;551	0.606
NULL	Int_J_Nanomedicine_2012_Sep_19_7_5053-5065.nxml.txt.nlp	23028227	SENT44	27	27	38	38	l-glutamine	CO2	PA10090	4513	0.606
NULL	Biomed_Res_Int_2013_Jul_14_2013_434561.nxml.txt.nlp	23936798	SENT48	4	4	11	11	heparin	entactin	PA449855	4811	0.606
NULL	J_Nutr_Metab_2010_Nov_23_2010_415075.nxml.txt.nlp	20721351	SENT131	26	26	7	7	lipase	PLB	PA450239	151056	0.606
NULL	Exp_Ther_Med_2012_Oct_16_4(4)_705-710.nxml.txt.nlp	23170130	SENT94	4	4	6	6	cyclophosphamide	CTX	PA449165	1593	0.606
NULL	Front_Endocrinol_(Lausanne)_2014_Feb_26_5_17.nxml.txt.nlp	24616713	SENT27	18	18	15	15	vasopressin	OXT	PA451858	5020	0.606
NULL	AIDS_Res_Ther_2007_May_1_4_8.nxml.txt.nlp	17472747	SENT94	9	9	31	31	ritonavir	adiponectin	PA451260	9370	0.606
NULL	ScientificWorldJournal_2013_Sep_25_2013_807284.nxml.txt.nlp	24187524	SENT17	25	25	22	22	cetuximab	HER2	PA10040	2064	0.606
NULL	Arthritis_Res_Ther_2005_Mar_16_7(Suppl_2)_S4-S14.nxml.txt.nlp	15833146	SENT236	42	42	27	27	alefacept	CD58	PA164748040	965	0.606
NULL	Front_Genet_2014_Aug_27_5_281.nxml.txt.nlp	25221567	SENT185	0	0	20	20	sildenafil	CYP2C9	PA451346	1559	0.606
NULL	Arthritis_Res_2002_Sep_16_4(6)_R12.nxml.txt.nlp	12453315	SENT8	2	2	12	12	methotrexate	CRP	PA450428	1401;140913	0.606
NULL	Support_Care_Cancer_2012_Sep_17_20(9)_1991-1997.nxml.txt.nlp	22089428	SENT135	9	9	19	19	paclitaxel	HER-2	PA450761	2064	0.606
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT72	43	43	39	39	vinorelbine	MVP	PA451881	9961	0.606
NULL	Nat_Genet_2013_Nov_15_45(11)_10_1038_ng_2758.nxml.txt.nlp	24036949	SENT18	12	12	8	8	heparin	C3b	PA449855	718	0.606
NULL	EMBO_Mol_Med_2012_Mar_4(3)_180-191.nxml.txt.nlp	22174035	SENT160	2	2	5	5	dantrolene	RYR2	PA449208	6262	0.606
NULL	J_Cell_Biol_2001_Dec_24_155(7)_1319-1332.nxml.txt.nlp	11756480	SENT174	27	27	11	11	staurosporine	LPA	PA165109623	4018	0.606
NULL	Acta_Orthop_2010_Apr_6_81(2)_263-267.nxml.txt.nlp	20148646	SENT121	0	0	8	8	taurine	ATF4	PA451590	468	0.606
NULL	Nat_Commun_2011_Aug_9_2_424.nxml.txt.nlp	21829186	SENT557	12	12	14	14	decitabine	DAC	PA164749631	13	0.606
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT18	4	4	11	11	tacrolimus	IL-6	PA451578	3569	0.606
NULL	Evid_Based_Complement_Alternat_Med_2013_Mar_14_2013_429706.nxml.txt.nlp	23573127	SENT115	33	33	7	7	indomethacin	ANOVA	PA449982	4858	0.606
NULL	Basic_Clin_Neurosci_2014_Summer_5(3)_218-224.nxml.txt.nlp	25337383	SENT7	28	28	35	35	prazosin	EPM	PA451093	2054	0.606
NULL	Apoptosis_2012_Jun_9_17(6)_566-578.nxml.txt.nlp	22402981	SENT166	18	18	39	39	pp2	PP2		4888	0.606
NULL	Arthritis_Res_Ther_2009_Jul_23_11(4)_236.nxml.txt.nlp	19664185	SENT69	27	27	7	7	benzbromarone	ABCG2	PA134852920	9429	0.606
NULL	AIDS_Res_Treat_2011_Jun_7_2011_354908.nxml.txt.nlp	21716719	SENT218	12	12	4	4	tenofovir	OAT1	PA10204	9356	0.606
NULL	Nanoscale_Res_Lett_2014_Jul_15_9(1)_353.nxml.txt.nlp	25114645	SENT30	0	0	2	2	diethylstilbestrol	DES	PA449307	1674	0.606
NULL	J_Hematol_Oncol_2010_Aug_2_3_26.nxml.txt.nlp	20678204	SENT197	4	4	26	26	thalidomide	IL-6	PA451644	3569	0.606
NULL	Int_J_Surg_Oncol_2012_Jun_12_2012_862879.nxml.txt.nlp	22778941	SENT100	18	18	32	32	cisplatin	ADP	PA449014	23038	0.606
NULL	Acta_Pharmacol_Sin_2013_Feb_12_34(2)_247-254.nxml.txt.nlp	23147558	SENT201	27	27	5	5	doxycycline	BOP	PA449415	611;150572	0.606
NULL	Case_Rep_Rheumatol_2012_Dec_24_2012_270315.nxml.txt.nlp	23424706	SENT7	0	0	7	7	tocilizumab	IL-6	PA165292659	3569	0.606
NULL	Front_Genet_2012_Nov_22_3_249.nxml.txt.nlp	23189085	SENT1190	11	11	4	4	ifosfamide	GSTP1	PA449964	2950	0.606
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT1121	8	8	20	20	oxygen	CO2	PA450744	4513	0.606
NULL	Breast_Cancer_Res_2010_Nov_16_12(6)_R96.nxml.txt.nlp	21080941	SENT307	18	18	14	14	lapatinib	HRG	PA152241907	3084;3273	0.606
NULL	Clin_Ophthalmol_2014_Jun_10_8_1097-1104.nxml.txt.nlp	24959067	SENT38	17	17	25	25	bimatoprost	BAK	PA164748867	578	0.606
NULL	Core_Evid_2009_Jun_15_4_113-129.nxml.txt.nlp	20694069	SENT385	27	27	12	12	raloxifene	LAS	PA451221	11019	0.606
NULL	AAPS_J_2014_Jun_11_16(5)_1029-1037.nxml.txt.nlp	24917180	SENT188	15	15	3	3	quinidine	P-gp	PA451209	5243	0.606
NULL	Eur_J_Haematol_2009_May_82(5)_339-349.nxml.txt.nlp	19187276	SENT9	13	13	22	22	enoxaparin	TKR	PA449463	8277	0.606
NULL	J_Cell_Biol_2001_May_28_153(5)_893-904.nxml.txt.nlp	11381077	SENT1	14	14	21	21	hyaluronan	MT1-MMP	PA165958431	4323	0.606
NULL	J_Gen_Physiol_2009_Sep_134(3)_243-258.nxml.txt.nlp	19720962	SENT273	7	7	10	10	capsaicin	TRPV1	PA448776	7442	0.606
NULL	Gynecol_Oncol_Case_Rep_2013_Sep_21_6_42-44.nxml.txt.nlp	24371718	SENT100	11	11	0	0	tamoxifen	ATAC	PA451581	6375	0.606
NULL	Diabetes_2013_May_16_62(5)_1409-1416.nxml.txt.nlp	23193189	SENT187	2	2	4	4	lipase	HSL	PA450239	3991	0.606
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1126-1134.nxml.txt.nlp	21364592	SENT32	25	25	8	8	cisplatin	CYP2A6	PA449014	1548	0.606
NULL	Cancer_Med_2013_Oct_19_2(5)_646-653.nxml.txt.nlp	24403230	SENT94	14	14	17	17	trastuzumab	MKK6	PA451743	5608	0.606
NULL	Pharmaceuticals_(Basel)_2012_Aug_10_5(8)_802-836.nxml.txt.nlp	24280676	SENT1761	3	3	13	13	methotrexate	ABCC4	PA450428	10257	0.606
NULL	Ann_Surg_Oncol_2009_Aug_10_16(8)_2086-2088.nxml.txt.nlp	19513600	SENT72	31	31	10	10	irinotecan	gamma	PA450085	9913	0.605
NULL	Breast_Cancer_Res_2008_Jan_25_10(1)_101.nxml.txt.nlp	18226190	SENT41	0	0	3	3	denosumab	RANK	PA166048634	8792	0.605
NULL	Croat_Med_J_2013_Apr_54(2)_171-179.nxml.txt.nlp	23630144	SENT138	21	21	24	24	taurine	STZ	PA451590	6484	0.605
NULL	J_Minim_Access_Surg_2006_Jun_2(2)_47-48.nxml.txt.nlp	21170234	SENT16	16	16	0	0	propofol	CO2	PA451141	4513	0.605
NULL	Braz_J_Med_Biol_Res_2012_Jul_20_45(9)_834-840.nxml.txt.nlp	22801417	SENT28	1	1	3	3	vasopressin	AVP	PA451858	114548;551	0.605
NULL	Br_J_Cancer_2014_Dec_9_111(12)_2379-2380.nxml.txt.nlp	24619075	SENT8	35	35	13	13	irinotecan	KRAS	PA450085	3845	0.605
NULL	Emerg_Infect_Dis_2014_May_20(5)_899-901.nxml.txt.nlp	24751149	SENT22	23	23	17	17	cefoxitin	PEN	PA448856	9933	0.605
NULL	Mol_Vis_2007_Jan_24_13_57-65.nxml.txt.nlp	17277739	SENT222	26	26	24	24	heparin	FGF2	PA449855	2247;2258	0.605
NULL	Acta_Pharmacol_Sin_2013_Feb_31_34(2)_231-238.nxml.txt.nlp	23274414	SENT137	0	0	8	8	amiloride	Bcl-2	PA448368	596	0.605
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT1628	8	8	4	4	tenofovir	ABCC10	PA10204	89845	0.605
NULL	Diabetes_2009_Aug_2_58(8)_1902-1913.nxml.txt.nlp	19491211	SENT99	23	23	2	2	tetracaine	ERG	PA451638	2078	0.605
NULL	J_Korean_Med_Sci_2011_Jul_20_26(7)_893-899.nxml.txt.nlp	21738342	SENT10	14	14	16	16	resveratrol	CD97		976	0.605
NULL	Oncoimmunology_2014_Jun_25_3_e29080.nxml.txt.nlp	25101222	SENT103	26	26	0	0	hyaluronan	DLEC	PA165958431	170482	0.605
NULL	Diabetes_2009_Dec_31_58(12)_2851-2862.nxml.txt.nlp	19720788	SENT190	5	5	1	1	forskolin	BiP	PA146096022	3309	0.605
NULL	J_Biomed_Sci_2014_Apr_29_21(1)_35.nxml.txt.nlp	24780003	SENT89	32	32	0	0	bevacizumab	NIRF	PA130232992	27190;115426	0.605
NULL	Sci_Rep_2015_Jan_6_5_7641.nxml.txt.nlp	25560734	SENT90	4	4	9	9	tamoxifen	CLTC	PA451581	1213	0.605
NULL	Mol_Cancer_2010_Dec_20_9_316.nxml.txt.nlp	21172016	SENT163	14	14	45	45	heparin	CCL21	PA449855	6366	0.605
NULL	Cancer_Microenviron_2009_Sep_26_2(Suppl_1)_19-204.nxml.txt.nlp	NULL	SENT6100	23	23	17	17	bortezomib	PC-3	PA10252	692094	0.605
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT180	10	10	12	12	curcumin	TRAIL	PA151958596	8743	0.605
NULL	Crit_Care_2003_Mar_12_7(3)_R17-R23.nxml.txt.nlp	12793886	SENT145	13	13	28	28	ranitidine	CO2	PA451224	4513	0.605
NULL	Clin_Interv_Aging_2009_May_14_4_109-113.nxml.txt.nlp	19503773	SENT56	48	48	40	40	levodopa	COMT	PA450213	1312	0.605
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT256	24	24	12	12	cisplatin	MDM2	PA449014	4193	0.605
NULL	Nat_Commun_2013_Sep_27_4_2519.nxml.txt.nlp	24071738	SENT273	10	10	21	21	tetracycline	SMAD3	PA451640	4088	0.605
NULL	Saudi_J_Anaesth_2014_Apr-Jun_8(2)_209-214.nxml.txt.nlp	24843334	SENT8	21	21	11	11	clonidine	C15	PA449051	51316	0.605
NULL	J_Biomed_Biotechnol_2011_Jan_24_2011_250860.nxml.txt.nlp	21318107	SENT161	0	0	6	6	lenalidomide	IFN	PA162363968	3439	0.605
NULL	J_Exp_Med_1952_Mar_31_95(4)_347-362.nxml.txt.nlp	14938505	SENT10	11	11	18	18	diethylstilbestrol	ACTH	PA449307	5443	0.605
NULL	Exp_Ther_Med_2013_Mar_21_5(3)_987-991.nxml.txt.nlp	23407636	SENT91	8	8	10	10	losartan	IL-8	PA450268	3576	0.605
NULL	Breast_Cancer_Res_2011_Nov_24_13(6)_R120.nxml.txt.nlp	22115051	SENT117	39	39	21	21	tamoxifen	HER-2	PA451581	2064	0.605
NULL	Arthritis_Res_Ther_2011_Apr_4_13(2)_R56.nxml.txt.nlp	21463515	SENT19	28	28	26	26	tocilizumab	IL-6	PA165292659	3569	0.605
NULL	Case_Rep_Rheumatol_2012_Dec_24_2012_270315.nxml.txt.nlp	23424706	SENT85	9	9	3	3	tocilizumab	IL-6	PA165292659	3569	0.605
NULL	Harm_Reduct_J_2010_Dec_1_7_29.nxml.txt.nlp	21122129	SENT147	28	28	4	4	buprenorphine	OST	PA448685	1650;23263	0.605
NULL	Oncoscience_2014_Oct_24_1(10)_665-673.nxml.txt.nlp	25593995	SENT73	8	8	22	22	doxorubicin	MDR1	PA449412	5243	0.605
NULL	Breast_Cancer_Res_2007_Aug_8_9(4)_R50.nxml.txt.nlp	17686159	SENT11	0	0	20	20	gefitinib	AKT	PA131301952	207	0.605
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT138	28	28	11	11	trastuzumab	HER2	PA451743	2064	0.605
NULL	Br_J_Cancer_2013_Jul_23_109(2)_351-359.nxml.txt.nlp	23799854	SENT125	10	10	7	7	paclitaxel	BLT2	PA450761	56413	0.605
NULL	Arthritis_Res_Ther_2012_Jan_23_14(1)_R17.nxml.txt.nlp	22269139	SENT27	0	0	2	2	diethylstilbestrol	DES	PA449307	1674	0.605
NULL	J_Invest_Dermatol_2013_Jan_26_133(1)_144-153.nxml.txt.nlp	22832495	SENT214	13	13	25	25	gentamicin	CO2	PA449753	4513	0.605
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT139	5	5	7	7	curcumin	TRAIL	PA151958596	8743	0.605
NULL	Drugs_R_D_2013_Jun_5_13(2)_145-151.nxml.txt.nlp	23737453	SENT179	8	8	11	11	simvastatin	CYP3A4	PA451363	1576	0.605
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT841	1	1	8	8	telatinib	ABCG2	PA165980595	9429	0.605
NULL	Biosci_Rep_2014_Oct_22_34(5)_e00146.nxml.txt.nlp	25188723	SENT755	11	11	9	9	heparin	C3b	PA449855	718	0.605
NULL	Acta_Pharmacol_Sin_2014_Jun_5_35(6)_716-726.nxml.txt.nlp	24793311	SENT165	0	0	17	17	atorvastatin	IL-6	PA448500	3569	0.605
NULL	Braz_J_Med_Biol_Res_2012_Jun_8_45(10)_988-994.nxml.txt.nlp	22666778	SENT79	28	28	25	25	lipase	HSL	PA450239	3991	0.605
NULL	Anesthesiol_Res_Pract_2011_Oct_25_2011_271539.nxml.txt.nlp	22110496	SENT44	25	25	14	14	sevoflurane	CO2	PA451341	4513	0.605
NULL	Brain_Sci_2012_Nov_7_2(4)_589-604.nxml.txt.nlp	24349762	SENT2	18	18	20	20	vasopressin	AVP	PA451858	114548;551	0.605
NULL	Hum_Genomics_Proteomics_2010_Aug_3_2010_159761.nxml.txt.nlp	20981231	SENT292	30	30	15	15	lithium	LIM	PA450243	10611	0.605
NULL	J_Gen_Physiol_1923_Jul_20_5(6)_751-755.nxml.txt.nlp	19872034	SENT0	12	12	1	1	trypsin	Gen	PA451806	348654	0.605
NULL	Clin_Ophthalmol_2007_Mar_1(1)_11-24.nxml.txt.nlp	19668462	SENT192	14	14	20	20	travoprost	BAK	PA164781371	578	0.605
NULL	Mar_Drugs_2012_Dec_11_10(12)_2782-2794.nxml.txt.nlp	23342393	SENT123	0	0	2	2	cyclophosphamide	CTX	PA449165	1593	0.605
NULL	Cancer_Manag_Res_2012_Oct_11_4_357-365.nxml.txt.nlp	23091399	SENT117	4	4	6	6	hydroxychloroquine	CTRC	PA164777036	11330	0.605
NULL	J_Neurochem_2008_Jan_104(1)_74-88.nxml.txt.nlp	17995938	SENT10	10	10	29	29	forskolin	Bcl-2	PA146096022	596	0.605
NULL	Br_J_Cancer_2010_Dec_7_103(12)_1765-1772.nxml.txt.nlp	21139621	SENT75	34	34	16	16	irinotecan	PTEN	PA450085	5728	0.605
NULL	Orphanet_J_Rare_Dis_2014_Sep_26_9(1)_145.nxml.txt.nlp	NULL	SENT141	0	0	3	3	denosumab	RANKL	PA166048634	8600	0.605
NULL	Exp_Ther_Med_2014_Apr_29_7(4)_958-962.nxml.txt.nlp	24669258	SENT149	3	3	28	28	thrombin	EGF	PA451674	1950	0.605
NULL	Int_J_Anal_Chem_2013_Jul_16_2013_419716.nxml.txt.nlp	23956748	SENT146	26	26	15	15	heparin	PF6	PA449855	200162	0.605
NULL	Clinicoecon_Outcomes_Res_2014_Oct_17_6_451-461.nxml.txt.nlp	25378939	SENT6	14	14	21	21	vancomycin	HAP	PA451850	5915;10313	0.605
NULL	Clin_Sci_(Lond)_2009_Apr_1_116(Pt_8)_607-620.nxml.txt.nlp	19275766	SENT115	24	24	17	17	cilostazol	AMPK	PA164746334	5563	0.605
NULL	Drugs_2012_Sep_6_72(9)_e1-e25.nxml.txt.nlp	22686620	SENT252	3	3	1	1	raltegravir	INI		84844	0.605
NULL	Cell_Commun_Signal_2011_May_15_9_13.nxml.txt.nlp	21569639	SENT264	0	0	14	14	quinacrine	AKT	PA164745551	207	0.605
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_P64.nxml.txt.nlp	NULL	SENT16	42	42	36	36	ceftriaxone	PPL	PA448866	5493	0.605
NULL	Viruses_2013_May_22_5(5)_1292-1324.nxml.txt.nlp	23698400	SENT225	36	36	23	23	ezetimibe	NPC1L1	PA10816	29881	0.605
NULL	Environ_Health_Perspect_2008_Mar_26_116(3)_322-328.nxml.txt.nlp	18335098	SENT177	31	31	24	24	estradiol	PMI	PA449503	8834;5373	0.605
NULL	Environ_Health_Perspect_1977_Dec_21_71-78.nxml.txt.nlp	612461	SENT11	38	38	40	40	cyclophosphamide	CTX	PA449165	1593	0.605
NULL	Eur_J_Epidemiol_2011_Aug_30_26(8)_657-686.nxml.txt.nlp	21877163	SENT495	12	12	24	24	phenprocoumon	4F2	PA450921	6520	0.605
NULL	Cells_2014_Jun_11_3(2)_616-626.nxml.txt.nlp	24921186	SENT306	1	1	3	3	capsaicin	TRPV1	PA448776	7442	0.605
NULL	Clin_Interv_Aging_2013_Jul_16_8_889-897.nxml.txt.nlp	23898224	SENT20	25	25	23	23	gemcitabine	SIRT1	PA449748	23411	0.605
NULL	J_Vis_Exp_2010_Dec_9_(46)_2460.nxml.txt.nlp	21178968	SENT239	30	30	32	32	atazanavir	ATV	PA10251	4683	0.605
NULL	Angew_Chem_Int_Ed_Engl_2013_Jan_2_52(1)_325-330.nxml.txt.nlp	23080482	SENT19	31	31	6	6	thrombin	ACPP	PA451674	55	0.605
NULL	Oncogene_2014_Oct_23_33(43)_5109-5120.nxml.txt.nlp	24858043	SENT281	3	3	9	9	pp2	MCT-1		28985	0.605
NULL	Clin_Cosmet_Investig_Dermatol_2014_Sep_2_7_243-249.nxml.txt.nlp	25214798	SENT65	6	6	11	11	ustekinumab	ACR	PA166048654	49	0.605
NULL	Arch_Toxicol_2012_Dec_8_86(12)_1841-1850.nxml.txt.nlp	22872140	SENT28	13	13	7	7	l-cysteine	NAC	PA449173	22861	0.605
NULL	Scientifica_(Cairo)_2013_Dec_12_2013_635203.nxml.txt.nlp	24416617	SENT460	18	18	13	13	dacarbazine	gp100	PA449197	6490	0.605
NULL	Cardiovasc_Diabetol_2013_May_30_12(Suppl_1)_S2.nxml.txt.nlp	23819752	SENT102	0	0	3	3	pitavastatin	adiponectin	PA142650384	9370	0.605
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT130	3	3	5	5	curcumin	TRAIL	PA151958596	8743	0.605
NULL	Hum_Genomics_2009_Jan_1_3(2)_121-127.nxml.txt.nlp	19164089	SENT78	2	2	5	5	ethanol	ADH1B	PA448073	125	0.605
NULL	Diabetes_Care_2010_Jul_31_33(7)_1607-1609.nxml.txt.nlp	20357375	SENT69	7	7	9	9	sitagliptin	CD34	PA164748978	947	0.605
NULL	J_Clin_Neonatol_2012_Oct-Dec_1(4)_171-175.nxml.txt.nlp	24027721	SENT34	12	12	34	34	sildenafil	GMP	PA451346	22978	0.605
NULL	Oncoimmunology_2012_Oct_1_1(7)_1038-1047.nxml.txt.nlp	23170252	SENT35	13	13	21	21	cyclophosphamide	CT26	PA449165	168400	0.605
NULL	Braz_J_Med_Biol_Res_2013_Jul_2_46(6)_465-485.nxml.txt.nlp	23828584	SENT222	25	25	23	23	lisinopril	GGH	PA450242	8836	0.605
NULL	Br_J_Cancer_2010_May_11_102(10)_1456-1460.nxml.txt.nlp	20461090	SENT84	14	14	19	19	temsirolimus	IFN	PA164746890	3439	0.605
NULL	Daru_2011_19(5)_322-325.nxml.txt.nlp	22615676	SENT7	15	15	24	24	atorvastatin	STZ	PA448500	6484	0.605
NULL	Front_Endocrinol_(Lausanne)_2013_Nov_1_4_164.nxml.txt.nlp	24198811	SENT168	18	18	20	20	lipase	ATGL	PA450239	57104	0.605
NULL	Nat_Commun_2014_Nov_19_5_5479.nxml.txt.nlp	25407222	SENT43	19	19	29	29	dextran	YTS	PA449261	8565	0.605
NULL	Clin_Interv_Aging_2013_May_22_8_565-572.nxml.txt.nlp	23723696	SENT153	24	24	22	22	chlorpromazine	CPZ	PA448964	8532	0.605
NULL	J_Mol_Signal_2010_May_10_5_4.nxml.txt.nlp	20459745	SENT10	10	10	19	19	cisplatin	p53	PA449014	7157	0.605
NULL	EPMA_J_2010_Jun_9_1(2)_317-327.nxml.txt.nlp	23199067	SENT180	7	7	25	25	cladribine	CD19	PA449027	930	0.605
NULL	ScientificWorldJournal_2013_Sep_19_2013_809891.nxml.txt.nlp	24170983	SENT133	2	2	9	9	dexketoprofen	CD86	PA166049175	942	0.605
NULL	Case_Rep_Dermatol_2014_Mar_7_6(1)_74-79.nxml.txt.nlp	24707255	SENT54	29	29	35	35	vincristine	IFN	PA451879	3439	0.605
NULL	Drugs_2014_Feb_25_74(4)_423-441.nxml.txt.nlp	24566842	SENT455	3	3	24	24	infliximab	IMPACT	PA452639	55364	0.605
NULL	Mol_Cancer_2008_Mar_6_7_24.nxml.txt.nlp	18325101	SENT14	14	14	31	31	cisplatin	BRCA1	PA449014	672	0.605
NULL	Contemp_Oncol_(Pozn)_2012_Feb_29_16(1)_86-89.nxml.txt.nlp	23788860	SENT45	11	11	18	18	methotrexate	ADM	PA450428	133	0.605
NULL	Br_J_Cancer_2002_Jan_21_86(2)_218-221.nxml.txt.nlp	11870509	SENT81	8	8	13	13	tamoxifen	BRCA1	PA451581	672	0.605
NULL	J_Am_Heart_Assoc_2013_Dec_19_2(6)_e000355.nxml.txt.nlp	24190878	SENT172	15	15	6	6	isoproterenol	HK2	PA450121	3796;3099;29911;3741	0.605
NULL	Asia_Pac_Allergy_2014_Apr_29_4(2)_106-112.nxml.txt.nlp	24809016	SENT94	22	22	28	28	amoxicillin	PPL	PA448406	5493	0.605
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1013.nxml.txt.nlp	24457957	SENT90	4	4	11	11	orlistat	NOXA	PA164776864	5366	0.605
NULL	Cancer_Cell_Int_2005_Aug_24_5_28.nxml.txt.nlp	16120219	SENT69	15	15	32	32	etoposide	p53	PA449552	7157	0.605
NULL	F1000Res_2013_Apr_19_2_114.nxml.txt.nlp	24555057	SENT45	45	45	29	29	salbutamol	FEV	PA448068	54738	0.605
NULL	Parasit_Vectors_2011_Aug_24_4_164.nxml.txt.nlp	21864384	SENT8	14	14	6	6	praziquantel	LAMP	PA164764583	4045;27074	0.605
NULL	ScientificWorldJournal_2012_Feb_14_2012_402919.nxml.txt.nlp	22448133	SENT326	14	14	16	16	ciprofloxacin	CPX	PA449009	1371;10682;1377	0.605
NULL	ScientificWorldJournal_2012_Aug_13_2012_496453.nxml.txt.nlp	22927782	SENT48	18	18	23	23	liraglutide	GLP-1	PA165958364	100125288	0.605
NULL	Crit_Care_2005_Nov_15_9(2)_134-135.nxml.txt.nlp	15774061	SENT14	16	16	18	18	vasopressin	AVP	PA451858	114548;551	0.605
NULL	Mol_Pain_2014_Aug_15_10_53.nxml.txt.nlp	25127716	SENT90	16	16	7	7	paclitaxel	SDH	PA450761	1757;10993	0.605
NULL	Cell_Death_Dis_2014_Jul_17_5(7)_e1333.nxml.txt.nlp	25032856	SENT263	7	7	9	9	candesartan	EAAC1	PA448765	6505	0.605
NULL	Arthritis_Res_Ther_2003_Jan_20_5(2)_68-75.nxml.txt.nlp	12718746	SENT92	30	30	33	33	imiquimod	IFN	PA449972	3439	0.605
NULL	Indian_J_Med_Res_2012_Jul_136(1)_46-53.nxml.txt.nlp	22885263	SENT46	5	5	32	32	glucose	ACR	PA449773	49	0.605
NULL	Clin_Mol_Hepatol_2013_Sep_30_19(3)_195-209.nxml.txt.nlp	24133659	SENT296	2	2	0	0	lamivudine	LAM	PA450163	7249;7248	0.605
NULL	Oncol_Lett_2014_Oct_30_8(4)_1628-1634.nxml.txt.nlp	25202381	SENT33	30	30	21	21	trypsin	CO2	PA451806	4513	0.605
NULL	Arthritis_Res_2000_Aug_3_2(5)_424-427.nxml.txt.nlp	11056677	SENT168	7	7	14	14	paraformaldehyde	mol	PA450790	90527	0.605
NULL	Ann_Oncol_2011_Aug_27_22(8)_1736-1747.nxml.txt.nlp	21709140	SENT316	26	26	10	10	lapatinib	EGF	PA152241907	1950	0.605
NULL	Angew_Chem_Int_Ed_Engl_2013_Dec_23_52(52)_13991-13996.nxml.txt.nlp	24214017	SENT74	16	16	10	10	nadh	ADP	PA164755085	23038	0.605
NULL	Crit_Care_2003_Dec_12_7(1)_63-71.nxml.txt.nlp	12617742	SENT249	18	18	41	41	oxygen	SAPS	PA450744	8935	0.605
NULL	Arthritis_Res_Ther_2013_Nov_6_15(6)_124.nxml.txt.nlp	24229459	SENT29	12	12	31	31	atorvastatin	IL-6	PA448500	3569	0.605
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2014_Jun_29_70(Pt_7)_1922-1933.nxml.txt.nlp	25004969	SENT193	5	5	11	11	cycloserine	PLP	PA164764600	25824;5744	0.605
NULL	Nature_2012_Apr_25_484(7395)_524-528.nxml.txt.nlp	22538616	SENT136	2	2	11	11	vancomycin	GM-CSF	PA451850	1437	0.605
NULL	Biomed_Res_Int_2013_Dec_10_2013_783698.nxml.txt.nlp	24386640	SENT63	26	26	12	12	isoniazid	DST	PA450112	667	0.605
NULL	Drugs_Context_2013_Sep_13_2013_212260.nxml.txt.nlp	24432046	SENT303	17	17	7	7	methylphenidate	ATX	PA450464	5168;23049	0.605
NULL	Cell_Res_2013_Jun_21_23(6)_746-758.nxml.txt.nlp	23689277	SENT44	7	7	5	5	resveratrol	SIRT1		23411	0.605
NULL	Mol_Cancer_2012_Jul_25_11_47.nxml.txt.nlp	22830443	SENT144	39	39	35	35	panitumumab	EGFR	PA162373091	1956	0.605
NULL	EMBO_Mol_Med_2009_Jul_1(4)_236-248.nxml.txt.nlp	20049725	SENT251	9	9	1	1	forskolin	NF1	PA146096022	4763	0.605
NULL	Clin_Dev_Immunol_2007_Dec_13_2007_17315.nxml.txt.nlp	18320010	SENT118	23	23	31	31	gefitinib	VEGFR	PA131301952	3791	0.605
NULL	Surg_Today_2015_Oct_14_45_221-226.nxml.txt.nlp	25734195	SENT38	23	23	15	15	cisplatin	CRT	PA449014	811	0.605
NULL	Mol_Vis_2011_Aug_18_17_2221-2227.nxml.txt.nlp	21897744	SENT6	30	30	37	37	penicillamine	NAC	PA450840	22861	0.605
NULL	Crit_Care_2010_Nov_5_14(6)_R200.nxml.txt.nlp	21054850	SENT76	18	18	20	20	vasopressin	AVP	PA451858	114548;551	0.605
NULL	J_Mol_Signal_2010_May_10_5_4.nxml.txt.nlp	20459745	SENT90	5	5	2	2	cisplatin	p53	PA449014	7157	0.605
NULL	Br_J_Cancer_2009_Oct_20_101(8)_1253-1260.nxml.txt.nlp	19755984	SENT131	19	19	5	5	tamoxifen	AIB1	PA451581	8202	0.605
NULL	Br_J_Cancer_2000_Oct_83(8)_980-985.nxml.txt.nlp	10993642	SENT1	20	20	16	16	fluorouracil	IL-2	PA128406956	3558	0.605
NULL	Breast_Cancer_Res_2012_Nov_5_14(6)_R143.nxml.txt.nlp	23127292	SENT152	5	5	8	8	goserelin	VIII	PA164747674	1351	0.605
NULL	Front_Neurosci_2014_Jun_3_8_128.nxml.txt.nlp	24917782	SENT137	25	25	35	35	ethanol	MC4R	PA448073	4160	0.605
NULL	Breast_Cancer_(Dove_Med_Press)_2013_Aug_22_5_73-78.nxml.txt.nlp	24648760	SENT133	4	4	10	10	tamoxifen	ANOVA	PA451581	4858	0.605
NULL	Pharm_Methods_2011_Jan-Mar_2(1)_42-46.nxml.txt.nlp	23781429	SENT17	3	3	5	5	lornoxicam	LOX	PA165958395	4015	0.605
NULL	Environ_Microbiol_2013_Jan_15_15(1)_297-304.nxml.txt.nlp	23157680	SENT66	10	10	16	16	ampicillin	TMP	PA448419	2012	0.605
NULL	Fibrogenesis_Tissue_Repair_2012_Jul_23_5_11.nxml.txt.nlp	22824096	SENT148	3	3	33	33	bleomycin	CD19	PA448645	930	0.605
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT38	40	40	21	21	glucose	FBS	PA449773	64319;26269	0.605
NULL	Cell_Cycle_2012_Nov_1_11(21)_3983-3996.nxml.txt.nlp	22987153	SENT220	41	41	29	29	cisplatin	EXO1	PA449014	9156	0.605
NULL	Clin_Interv_Aging_2009_May_14_4_121-136.nxml.txt.nlp	19503775	SENT375	22	22	26	26	tamoxifen	STAR	PA451581	6770;2984	0.605
NULL	Clin_Interv_Aging_2009_May_14_4_165-177.nxml.txt.nlp	19503778	SENT162	10	10	26	26	cholestyramine	CYP2C9	PA448974	1559	0.605
NULL	Cancers_(Basel)_2013_Jun_24_5(3)_762-785.nxml.txt.nlp	24202320	SENT330	6	6	0	0	clodronate	PF4	PA10239	5196	0.605
NULL	J_Mol_Signal_2012_Aug_16_7_12.nxml.txt.nlp	22898329	SENT314	13	13	15	15	bortezomib	TRAIL	PA10252	8743	0.605
NULL	Mol_Cancer_2012_Jul_29_11_48.nxml.txt.nlp	22839996	SENT88	18	18	30	30	cyclophosphamide	DDP	PA449165	1678	0.605
NULL	Breast_Cancer_Res_2011_Nov_23_13(6)_R116.nxml.txt.nlp	22113133	SENT336	15	15	6	6	tamoxifen	JAG1	PA451581	182	0.605
NULL	ISRN_AIDS_2012_Jul_12_2012_485307.nxml.txt.nlp	24052874	SENT103	16	16	30	30	tenofovir	PTH	PA10204	5741	0.605
NULL	Ecancermedicalscience_2011_Apr_28_5_211.nxml.txt.nlp	22276054	SENT34	10	10	13	13	aprepitant	HEC	PA164747039	10403	0.605
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Apr_7_9_12.nxml.txt.nlp	20374640	SENT95	2	2	7	7	ampicillin	TEM	PA448419	64102	0.605
NULL	Biomed_Res_Int_2013_Sep_2_2013_968518.nxml.txt.nlp	24078931	SENT47	1	1	3	3	oxytetracycline	OTC	PA450757	5009	0.605
NULL	F1000Res_2013_Feb_28_2_65.nxml.txt.nlp	24358861	SENT69	15	15	24	24	minocycline	TLR4	PA450519	7099	0.605
NULL	Biotechnol_Res_Int_2013_Dec_1_2013_253286.nxml.txt.nlp	24363937	SENT163	12	12	7	7	ethanol	DAP	PA448073	23549;3375;1611	0.605
NULL	Ann_Lab_Med_2012_Jul_20_32(4)_264-269.nxml.txt.nlp	22779067	SENT18	23	23	8	8	rifampin	DST	PA451250	667	0.605
NULL	Arthritis_Res_Ther_2006_Jul_19_8(4)_R124.nxml.txt.nlp	16859525	SENT155	8	8	3	3	collagenase	MMP13	PA449107	4322	0.605
NULL	Neuropsychologia_2012_Nov_50(13)_3156-3168.nxml.txt.nlp	22884957	SENT162	14	14	5	5	scopolamine	spatial	PA451308	219793	0.605
NULL	Cerebrospinal_Fluid_Res_2010_Aug_12_7_11.nxml.txt.nlp	20704740	SENT66	31	31	34	34	kanamycin	EGF	PA450137	1950	0.605
NULL	Cell_Death_Dis_2013_Oct_3_4(10)_e827.nxml.txt.nlp	24091670	SENT230	14	14	29	29	nilotinib	AKT	PA165958345	207	0.605
NULL	J_Cell_Mol_Med_2014_Apr_20_18(4)_709-720.nxml.txt.nlp	24444314	SENT267	16	16	21	21	losartan	AMPK	PA450268	5563	0.605
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT510	19	19	3	3	phenformin	LKB1	PA1000	6794	0.605
NULL	J_Ophthalmic_Inflamm_Infect_2013_Apr_22_3_46.nxml.txt.nlp	23607574	SENT63	22	22	16	16	ciprofloxacin	Gen	PA449009	348654	0.605
NULL	Mol_Cancer_2006_Sep_5_5_34.nxml.txt.nlp	16953886	SENT5	22	22	20	20	doxorubicin	TRAIL	PA449412	8743	0.605
NULL	Oxid_Med_Cell_Longev_2013_Jun_6_2013_891748.nxml.txt.nlp	23840922	SENT190	0	0	6	6	resveratrol	HO-1		3162	0.605
NULL	Breast_Cancer_Res_2002_Jul_24_4(6)_R12.nxml.txt.nlp	12473173	SENT172	25	25	18	18	ethanol	PCB	PA448073	5091	0.605
NULL	Iran_J_Basic_Med_Sci_2013_Apr_16(4)_610-614.nxml.txt.nlp	24250937	SENT110	5	5	11	11	coumarin	CYP2A6	PA134521193	1548	0.605
NULL	Chem_Cent_J_2013_Sep_23_7_159.nxml.txt.nlp	24059652	SENT143	36	36	46	46	neomycin	CO2	PA450608	4513	0.605
NULL	Eur_J_Neurosci_2014_Apr_8_39(7)_1068-1073.nxml.txt.nlp	24712987	SENT50	13	13	8	8	tamoxifen	DISC1	PA451581	27185	0.605
NULL	Clinics_(Sao_Paulo)_2011_Feb_66(2)_183-187.nxml.txt.nlp	21484031	SENT59	18	18	21	21	estradiol	ANOVA	PA449503	4858	0.605
NULL	Oncotarget_2014_Mar_15_5(8)_2096-2106.nxml.txt.nlp	24758762	SENT1	7	7	4	4	galactose	C1GALT1	PA449725	56913	0.605
NULL	J_Oral_Pathol_Med_2013_Jul_18_42(6)_499-506.nxml.txt.nlp	23331485	SENT188	3	3	11	11	indomethacin	IL-6	PA449982	3569	0.605
NULL	J_Radiat_Res_2014_Nov_16_55(6)_1171-1177.nxml.txt.nlp	25129557	SENT45	4	4	8	8	bevacizumab	CRT	PA130232992	811	0.605
NULL	J_Gen_Physiol_2005_Jul_126(1)_1.nxml.txt.nlp	NULL	SENT1038	21	21	26	26	fluorescein	FLASH	PA164746009	9994	0.604
NULL	Biosci_Rep_2012_Dec_6_33(1)_e00006.nxml.txt.nlp	23050906	SENT61	23	23	34	34	gentamicin	CO2	PA449753	4513	0.604
NULL	Clin_Ophthalmol_2014_Feb_10_8_389-399.nxml.txt.nlp	24550667	SENT156	4	4	29	29	brinzolamide	TIM	PA164744929	7984;8914	0.604
NULL	Mol_Cancer_2010_Aug_27_9_226.nxml.txt.nlp	20799951	SENT105	6	6	26	26	paraformaldehyde	PRAME	PA450790	23532	0.604
NULL	Front_Aging_Neurosci_2010_Aug_6_2_26.nxml.txt.nlp	20802800	SENT495	7	7	17	17	memantine	spatial	PA10364	219793	0.604
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_May_7_67(Pt_6)_m708-m709.nxml.txt.nlp	21754609	SENT63	12	12	24	24	ethanol	mol	PA448073	90527	0.604
NULL	Mol_Cancer_2012_Jul_12_11_45.nxml.txt.nlp	22788833	SENT139	15	15	11	11	cisplatin	EGFR	PA449014	1956	0.604
NULL	Am_J_Transplant_2014_Nov_2_14(11)_2595-2606.nxml.txt.nlp	25278159	SENT168	11	11	16	16	collagenase	NB1	PA449107	57126	0.604
NULL	Environ_Health_Perspect_2010_Mar_3_118(3)_375-381.nxml.txt.nlp	20194067	SENT22	2	2	4	4	diethylstilbestrol	DES	PA449307	1674	0.604
NULL	Evid_Based_Complement_Alternat_Med_2011_Feb_14_2011_429843.nxml.txt.nlp	21869897	SENT181	6	6	15	15	ethanol	PC6	PA448073	5125	0.604
NULL	BMJ_Open_2013_Aug_9_3(8)_e003268.nxml.txt.nlp	23943777	SENT136	18	18	32	32	creatine	ACR	PA164778930	49	0.604
NULL	Breast_Cancer_Res_2002_Aug_27_4(6)_213-217.nxml.txt.nlp	12473165	SENT141	14	14	4	4	tamoxifen	ATAC	PA451581	6375	0.604
NULL	Acta_Histochem_Cytochem_2012_Apr_26_45(2)_139-146.nxml.txt.nlp	22685356	SENT35	14	14	31	31	forskolin	CO2	PA146096022	4513	0.604
NULL	Anal_Bioanal_Chem_2011_Jun_22_400(8)_2475-2485.nxml.txt.nlp	21258785	SENT243	16	16	7	7	fluorescein	PBI	PA164746009	27350;26952	0.604
NULL	Indian_J_Pharm_Sci_2014_Jul-Aug_76(4)_315-322.nxml.txt.nlp	25284929	SENT144	14	14	19	19	ethanol	STZ	PA448073	6484	0.604
NULL	Cardiovasc_Diabetol_2013_May_20_12_77.nxml.txt.nlp	23688357	SENT66	11	11	25	25	glucose	DBP	PA449773	3295;1628;2638	0.604
NULL	Environ_Health_Perspect_2005_Aug_10_113(8)_1046-1051.nxml.txt.nlp	16079077	SENT169	22	22	14	14	malathion	p53	PA164748092	7157	0.604
NULL	Biosci_Rep_2012_Dec_1_32(Pt_6)_511-519.nxml.txt.nlp	NULL	SENT87	4	4	20	20	pitavastatin	Rho	PA142650384	29984	0.604
NULL	Cell_Tissue_Res_2014_Apr_26_357(1)_253-266.nxml.txt.nlp	24770893	SENT178	21	21	13	13	staurosporine	CXCL11	PA165109623	6373	0.604
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT306	23	23	15	15	neratinib	EGFR	PA165291472	1956	0.604
NULL	Ann_Hematol_2010_Nov_25_89(11)_1115-1124.nxml.txt.nlp	20499237	SENT108	38	38	23	23	simvastatin	CD19	PA451363	930	0.604
NULL	Clin_Interv_Aging_2008_Sep_3(3)_453-472.nxml.txt.nlp	18982916	SENT344	10	10	13	13	azithromycin	CD4	PA448519	920	0.604
NULL	Front_Oncol_2014_Jun_30_4_165.nxml.txt.nlp	25072020	SENT128	27	27	24	24	cisplatin	CRT	PA449014	811	0.604
NULL	Ann_Rheum_Dis_2008_Oct_25_68(10)_1644-1650.nxml.txt.nlp	18957484	SENT9	26	26	14	14	methotrexate	IL-15	PA450428	3600	0.604
NULL	Int_J_Surg_Oncol_2011_May_26_2011_951260.nxml.txt.nlp	22312534	SENT135	30	30	8	8	estradiol	aromatase	PA449503	1588	0.604
NULL	J_Korean_Med_Sci_2014_Jul_11_29(7)_965-972.nxml.txt.nlp	25045229	SENT121	16	16	4	4	metformin	B12	PA450395	7126;4709	0.604
NULL	Br_J_Pharmacol_2008_Nov_11_155(6)_896-905.nxml.txt.nlp	18695641	SENT135	23	23	13	13	raloxifene	CTX	PA451221	1593	0.604
NULL	Breast_Cancer_Res_2010_May_10_12(3)_R26.nxml.txt.nlp	20459744	SENT76	4	4	23	23	doxorubicin	HDC	PA449412	3067;51696	0.604
NULL	ISRN_Otolaryngol_2012_Oct_16_2012_706896.nxml.txt.nlp	23762616	SENT24	11	11	23	23	vasopressin	AQP5	PA451858	362	0.604
NULL	Case_Rep_Ophthalmol_2011_Mar_12_2(1)_105-110.nxml.txt.nlp	22110438	SENT59	7	7	25	25	ribavirin	IFN	PA451241	3439	0.604
NULL	Asian_J_Androl_2015_Aug_15_Jan-Feb_17(1)_143-148.nxml.txt.nlp	25155105	SENT130	23	23	31	31	udenafil	TNF	PA164776753	7124	0.604
NULL	Ann_Oncol_2010_Jan_21(1)_133-139.nxml.txt.nlp	20019090	SENT188	20	20	2	2	rituximab	PIM1	PA451261	5292;9361	0.604
NULL	Nat_Methods_2012_Feb_19_9(4)_396-402.nxml.txt.nlp	22343342	SENT21	3	3	5	5	capsaicin	TRPV1	PA448776	7442	0.604
NULL	Biologics_2013_Apr_15_7_77-90.nxml.txt.nlp	23723688	SENT55	11	11	16	16	cetuximab	CRT	PA10040	811	0.604
NULL	Diabetes_2009_Jun_10_58(6)_1342-1349.nxml.txt.nlp	19276444	SENT90	15	15	6	6	paraformaldehyde	TC1	PA450790	6947	0.604
NULL	Ther_Clin_Risk_Manag_2006_Dec_2(4)_389-400.nxml.txt.nlp	18360651	SENT149	19	19	24	24	infliximab	IMPACT	PA452639	55364	0.604
NULL	Pharmaceuticals_(Basel)_2011_Jun_17_4(6)_880-914.nxml.txt.nlp	21904468	SENT448	8	8	28	28	methamphetamine	BiP	PA450403	3309	0.604
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT48	32	32	14	14	pemetrexed	UNG	PA10810	7374	0.604
NULL	Acta_Pharmacol_Sin_2010_Mar_22_31(3)_329-340.nxml.txt.nlp	20173759	SENT209	22	22	17	17	ethanol	AMPK	PA448073	5563	0.604
NULL	Clin_Epigenetics_2011_Dec_5_3(1)_8.nxml.txt.nlp	22414275	SENT6	5	5	8	8	ribavirin	ESR1	PA451241	2099	0.604
NULL	Oncoimmunology_2012_Oct_1_1(7)_1004-1016.nxml.txt.nlp	23170249	SENT9	24	24	20	20	paclitaxel	HER-2	PA450761	2064	0.604
NULL	Front_Genet_2013_Aug_30_4_166.nxml.txt.nlp	24009623	SENT175	23	23	9	9	everolimus	MGLL	PA164746311	11343	0.604
NULL	Daru_2012_Oct_15_20(1)_55.nxml.txt.nlp	23352178	SENT48	31	31	13	13	clozapine	CYP1A2	PA449061	1544	0.604
NULL	Acta_Pharmacol_Sin_2010_Mar_22_31(3)_329-340.nxml.txt.nlp	20173759	SENT154	41	41	31	31	ethanol	AMPK	PA448073	5563	0.604
NULL	Front_Microbiol_2015_Jan_5_5_733.nxml.txt.nlp	25601858	SENT105	24	24	18	18	thrombin	ATIII	PA451674	462	0.604
NULL	J_Cell_Biol_2003_Dec_22_163(6)_1385-1395.nxml.txt.nlp	14676308	SENT396	0	0	7	7	thrombin	Rho	PA451674	29984	0.604
NULL	Oxid_Med_Cell_Longev_2012_Mar_13_2012_768101.nxml.txt.nlp	22530077	SENT309	22	22	26	26	paraformaldehyde	p67phox	PA450790	4688	0.604
NULL	Clin_Interv_Aging_2012_Jul_12_7_235-247.nxml.txt.nlp	22866001	SENT131	42	42	27	27	alendronate	PTH	PA448082	5741	0.604
NULL	Drug_Des_Devel_Ther_2014_Dec_5_8_2431-2438.nxml.txt.nlp	25525333	SENT155	9	9	15	15	verapamil	P-gp	PA451868	5243	0.604
NULL	Oncoimmunology_2013_Jul_1_2(7)_e24720.nxml.txt.nlp	24073365	SENT32	9	9	2	2	trastuzumab	HER2	PA451743	2064	0.604
NULL	Oncotarget_2011_Dec_20_2(12)_1094-1108.nxml.txt.nlp	22190353	SENT56	27	27	24	24	doxorubicin	Gem	PA449412	51053	0.604
NULL	Cerebrospinal_Fluid_Res_2008_Jan_11_5_1.nxml.txt.nlp	18186943	SENT85	7	7	5	5	doxycycline	EGFR	PA449415	1956	0.604
NULL	Acta_Pharmacol_Sin_2010_Aug_5_31(8)_970-976.nxml.txt.nlp	20686521	SENT44	16	16	29	29	methotrexate	CDP	PA450428	1523	0.604
NULL	Breast_Cancer_Res_Treat_2012_Jul_5_134(2)_693-700.nxml.txt.nlp	22562123	SENT219	13	13	8	8	tamoxifen	SULT1A1	PA451581	6817	0.604
NULL	Cancer_Cell_Int_2005_Aug_23_5_27.nxml.txt.nlp	16117829	SENT129	16	16	23	23	neomycin	p53	PA450608	7157	0.604
NULL	Exp_Ther_Med_2013_Nov_2_6(5)_1251-1258.nxml.txt.nlp	24223654	SENT242	2	2	0	0	methacholine	MCH	PA165958382	5367	0.604
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT227	8	8	16	16	sulindac	survivin	PA451565	332	0.604
NULL	Cancer_Med_2014_Oct_10_3(5)_1275-1283.nxml.txt.nlp	24913924	SENT280	23	23	28	28	vemurafenib	BRAF	PA165946873	673	0.604
NULL	Endocrinol_Metab_(Seoul)_2013_Sep_13_28(3)_226-230.nxml.txt.nlp	24396683	SENT65	41	41	27	27	carbimazole	TSHR	PA164742970	7253	0.604
NULL	Breast_Cancer_Res_2010_Nov_16_12(6)_R96.nxml.txt.nlp	21080941	SENT262	6	6	4	4	lapatinib	HRG	PA152241907	3084;3273	0.604
NULL	Br_J_Cancer_2009_Jun_2_100(11)_1784-1793.nxml.txt.nlp	19436293	SENT90	8	8	11	11	hyaluronan	LYVE-1	PA165958431	10894	0.604
NULL	Adipocyte_2014_Jul_1_3(3)_190-196.nxml.txt.nlp	25068085	SENT58	1	1	4	4	estradiol	ADIPOR2	PA449503	79602	0.604
NULL	Mol_Cancer_2008_Aug_7_7_65.nxml.txt.nlp	18687124	SENT255	8	8	3	3	thrombin	parafibromin	PA451674	79577	0.604
NULL	Mol_Cancer_2010_Apr_23_9_87.nxml.txt.nlp	20416058	SENT200	30	30	28	28	doxorubicin	TRAIL	PA449412	8743	0.604
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_May_17_64(Pt_6)_o1101.nxml.txt.nlp	21202615	SENT66	8	8	18	18	pseudoephedrine	Casper	PA451170	8837	0.604
NULL	Natl_J_Maxillofac_Surg_2013_Jan-Jun_4(1)_94-99.nxml.txt.nlp	24163562	SENT102	28	28	2	2	thrombin	PRP	PA451674	7001;5621	0.604
NULL	Pharmaceutics_2011_Jun_22_3(2)_326-337.nxml.txt.nlp	24310499	SENT249	16	16	5	5	tenofovir	MRP2	PA10204	100130958;57626;1244	0.604
NULL	Oncol_Lett_2013_Mar_14_5(3)_756-760.nxml.txt.nlp	23426872	SENT147	2	2	4	4	cisplatin	NAC	PA449014	22861	0.604
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Nov_14_68(Pt_12)_o3347.nxml.txt.nlp	23476184	SENT9	22	22	1	1	piperazine	mol	PA450977	90527	0.604
NULL	J_Epilepsy_Res_2014_Dec_31_4(2)_45-54.nxml.txt.nlp	25625088	SENT273	11	11	18	18	bezafibrate	ANOVA	PA162364313	4858	0.604
NULL	Biotechnol_Res_Int_2014_May_22_2014_705068.nxml.txt.nlp	24963410	SENT33	8	8	10	10	lipase	PPL	PA450239	5493	0.604
NULL	Summit_on_Translat_Bioinforma_2010_Mar_1_2010_71-75.nxml.txt.nlp	21347153	SENT57	27	27	10	10	tacrolimus	WIZ	PA451578	58525	0.604
NULL	Br_J_Cancer_2006_Dec_4_95(11)_1483-1489.nxml.txt.nlp	17106442	SENT145	6	6	1	1	gefitinib	EGFR	PA131301952	1956	0.604
NULL	Br_J_Cancer_2004_Mar_22_90(6)_1285-1292.nxml.txt.nlp	15026814	SENT134	0	0	4	4	doxorubicin	p53	PA449412	7157	0.604
NULL	J_Clin_Biochem_Nutr_2010_Jan_29_46(1)_36-42.nxml.txt.nlp	20104263	SENT121	27	27	23	23	ribavirin	IFN	PA451241	3439	0.604
NULL	Emerg_Infect_Dis_2012_Jul_18(7)_1166-1169.nxml.txt.nlp	22709586	SENT62	10	10	16	16	azithromycin	UNK	PA448519	85451	0.604
NULL	J_Cell_Biol_2005_Nov_7_171(3)_505-516.nxml.txt.nlp	16275754	SENT333	18	18	23	23	pp2	EGF		1950	0.604
NULL	Cancer_Immunol_Immunother_2012_Jul_23_61(7)_1101-1111.nxml.txt.nlp	22193989	SENT156	12	12	17	17	oxaliplatin	CD86	PA131285527	942	0.604
NULL	Crit_Care_2006_Mar_29_10(2)_135.nxml.txt.nlp	16594988	SENT8	1	1	3	3	vasopressin	AVP	PA451858	114548;551	0.604
NULL	Clin_Exp_Gastroenterol_2013_Aug_5_6_139-148.nxml.txt.nlp	23950655	SENT110	17	17	19	19	thrombin	ADP	PA451674	23038	0.604
NULL	Nat_Commun_2014_Nov_19_5_5479.nxml.txt.nlp	25407222	SENT94	4	4	27	27	dextran	YTS	PA449261	8565	0.604
NULL	Int_J_Nanomedicine_2012_Oct_18_7_5475-5489.nxml.txt.nlp	23093903	SENT308	23	23	8	8	itraconazole	DPI	PA450132	1832	0.604
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT119	0	0	6	6	nutlin-3	MDM2		4193	0.604
NULL	J_Young_Pharm_2012_Oct-Dec_4(4)_235-244.nxml.txt.nlp	23493308	SENT204	11	11	13	13	bupropion	BUP	PA448687	23412	0.604
NULL	Mol_Vis_2012_Feb_9_18_390-402.nxml.txt.nlp	22355250	SENT476	10	10	5	5	warfarin	Q10	PA451906	27161	0.604
NULL	Ann_Gastroenterol_2013_26(3)_233-238.nxml.txt.nlp	NULL	SENT26	0	0	2	2	natalizumab	NAT	PA164747191	6046	0.604
NULL	Chem_Cent_J_2012_Jul_27_6_73.nxml.txt.nlp	22839208	SENT136	9	9	7	7	chloramphenicol	CTX	PA448927	1593	0.604
NULL	Int_J_Nanomedicine_2012_Sep_21_7_5091-5106.nxml.txt.nlp	23049256	SENT339	7	7	9	9	protamine	SOD1	PA10366	6647	0.604
NULL	BMJ_Open_2013_Sep_25_3(9)_e003631.nxml.txt.nlp	24071463	SENT41	8	8	11	11	creatine	ACR	PA164778930	49	0.604
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Sep_13_70(Pt_10)_199-202.nxml.txt.nlp	25484651	SENT54	25	25	12	12	ethanol	mol	PA448073	90527	0.604
NULL	Front_Physiol_2011_Apr_12_2_13.nxml.txt.nlp	21559063	SENT197	8	8	18	18	creatine	ADP	PA164778930	23038	0.604
NULL	Crit_Care_2009_Jul_6_13(4)_R108.nxml.txt.nlp	19580651	SENT276	26	26	5	5	dalteparin	c-Jun	PA165958404	3725	0.604
NULL	Mol_Cancer_2014_Jun_5_13_143.nxml.txt.nlp	24898067	SENT42	35	35	18	18	gefitinib	HER-2	PA131301952	2064	0.604
NULL	Nucleic_Acids_Res_2013_May_5_41(10)_5210-5222.nxml.txt.nlp	23563151	SENT85	23	23	28	28	arsenite	GADD45	PA452638	1647	0.604
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R91.nxml.txt.nlp	22541814	SENT136	0	0	8	8	thrombin	PAR1	PA451674	79581;2149	0.604
NULL	Int_J_Nanomedicine_2012_Nov_8_7_5671-5682.nxml.txt.nlp	23152683	SENT32	26	26	11	11	l-glutamine	CO2	PA10090	4513	0.604
NULL	Front_Cell_Neurosci_2014_Jul_28_8_205.nxml.txt.nlp	25120431	SENT128	19	19	10	10	choline	LHX6	PA448976	26468	0.604
NULL	Stroke_Res_Treat_2011_Jun_22_2011_607852.nxml.txt.nlp	21822469	SENT499	27	27	13	13	dabigatran	CYP3A4		1576	0.604
NULL	Arthritis_Res_Ther_2011_Mar_30_13(2)_105.nxml.txt.nlp	21542897	SENT16	36	36	14	14	adalimumab	IFN	PA10004	3439	0.604
NULL	Cancer_Immunol_Immunother_2011_Jun_25_60(6)_793-808.nxml.txt.nlp	21350947	SENT139	12	12	9	9	sorafenib	IFN	PA7000	3439	0.604
NULL	J_Gen_Physiol_2009_Sep_134(3)_243-258.nxml.txt.nlp	19720962	SENT450	7	7	9	9	capsaicin	TRPV1	PA448776	7442	0.604
NULL	Hum_Genomics_Proteomics_2010_Aug_3_2010_159761.nxml.txt.nlp	20981231	SENT151	3	3	5	5	lithium	BDNF	PA450243	627	0.604
NULL	J_Immunol_Res_2014_May_8_2014_565320.nxml.txt.nlp	24901010	SENT68	36	36	9	9	fosphenytoin	HLA-B	PA164746820	3106	0.604
NULL	Int_J_Mol_Imaging_2011_Oct_26_2011_874585.nxml.txt.nlp	21490735	SENT206	0	0	12	12	glucose	OMG	PA449773	4974	0.604
NULL	Clinicoecon_Outcomes_Res_2014_Oct_17_6_451-461.nxml.txt.nlp	25378939	SENT142	8	8	33	33	linezolid	HAP	PA450233	5915;10313	0.604
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_May_7_65(Pt_6)_o1188-o1189.nxml.txt.nlp	21583061	SENT72	4	4	7	7	benzaldehyde	mol	PA448571	90527	0.604
NULL	Pediatr_Nephrol_2003_Aug_15_18(8)_805-809.nxml.txt.nlp	12750985	SENT236	24	24	21	21	l-carnitine	EPO	PA450154	7076;8288;2056	0.604
NULL	Eur_J_Neurosci_2014_Feb_4_39(3)_419-434.nxml.txt.nlp	24494682	SENT216	1	1	3	3	lipase	MGL	PA450239	11343	0.604
NULL	Int_J_Mol_Sci_2014_Nov_25_15(12)_21703-21722.nxml.txt.nlp	25429431	SENT1031	0	0	16	16	curcumin	p38	PA151958596	10598;1432;7965	0.604
NULL	J_Exp_Med_1994_May_1_179(5)_1737-1741.nxml.txt.nlp	8163952	SENT8	34	34	5	5	thrombin	gamma	PA451674	9913	0.604
NULL	Mol_Cancer_2012_Jul_25_11_47.nxml.txt.nlp	22830443	SENT158	37	37	39	39	panitumumab	EGFR	PA162373091	1956	0.604
NULL	J_Antimicrob_Chemother_2012_Feb_17_67(2)_404-414.nxml.txt.nlp	22101217	SENT129	11	11	17	17	chloramphenicol	EMB	PA448927	133418	0.604
NULL	Cell_Death_Dis_2014_Mar_13_5(3)_e1112.nxml.txt.nlp	24625971	SENT131	26	26	38	38	curcumin	CHOP	PA151958596	1649	0.604
NULL	Breast_Cancer_Res_2010_May_18_12(Suppl_1)_P58.nxml.txt.nlp	NULL	SENT16	12	12	32	32	doxorubicin	TRAIL	PA449412	8743	0.604
NULL	Open_Orthop_J_2008_Jul_14_2_121-125.nxml.txt.nlp	19572021	SENT66	38	38	21	21	pamidronate	PROC	PA450767	5624	0.604
NULL	Anat_Cell_Biol_2012_Jun_30_45(2)_114-120.nxml.txt.nlp	22822466	SENT16	1	1	3	3	vasopressin	AVP	PA451858	114548;551	0.604
NULL	J_Mammary_Gland_Biol_Neoplasia_2010_Sep_19_15(3)_279-290.nxml.txt.nlp	20717712	SENT328	14	14	5	5	lipase	PRL	PA450239	5617	0.604
NULL	Infect_Dis_Rep_2010_Feb_17_2(1)_e2.nxml.txt.nlp	24470885	SENT63	6	6	16	16	rifampin	COT	PA451250	54677	0.604
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT166	8	8	42	42	pp2	PP2		4888	0.604
NULL	Diabetes_Care_2013_Jul_12_36(7)_2126-2132.nxml.txt.nlp	23645884	SENT79	12	12	10	10	exenatide	GLP-1	PA164749238	100125288	0.604
NULL	Biomed_Res_Int_2013_Dec_31_2013_795103.nxml.txt.nlp	23710462	SENT9	1	1	17	17	fenofibrate	adiponectin	PA449594	9370	0.604
NULL	Clin_Ophthalmol_2010_Oct_28_4_1249-1252.nxml.txt.nlp	21151329	SENT63	10	10	27	27	bevacizumab	PED	PA130232992	8682	0.604
NULL	Aging_(Albany_NY)_2010_Dec_20_2(12)_959-968.nxml.txt.nlp	21191146	SENT24	6	6	19	19	cisplatin	LKB1	PA449014	6794	0.604
NULL	J_Cell_Biol_2008_Jan_28_180(2)_403-415.nxml.txt.nlp	18227282	SENT12	23	23	11	11	paromomycin	HPD	PA164784023	3242	0.604
NULL	Biologics_2012_Dec_17_6_429-464.nxml.txt.nlp	23269860	SENT163	8	8	11	11	abatacept	ACR	PA164747080	49	0.604
NULL	Br_J_Cancer_1987_May_55(5)_509-512.nxml.txt.nlp	3606944	SENT11	6	6	8	8	tamoxifen	TMX	PA451581	81542	0.604
NULL	Cancers_(Basel)_2014_Nov_14_6(4)_2275-2295.nxml.txt.nlp	25405526	SENT201	30	30	28	28	etoposide	CHOP	PA449552	1649	0.604
NULL	Biochemistry_2008_Jun_10_47(23)_6242-6250.nxml.txt.nlp	18470998	SENT45	17	17	6	6	coumarin	HDAC8	PA134521193	55869	0.604
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT32	14	14	23	23	heparin	FGF1	PA449855	2246	0.604
NULL	EMBO_Mol_Med_2011_Jul_3(7)_363-366.nxml.txt.nlp	21674807	SENT53	3	3	12	12	etoposide	SMAC	PA449552	56616	0.604
NULL	Oncotarget_2014_Nov_3_5(20)_10127-10139.nxml.txt.nlp	25333256	SENT148	10	10	18	18	vemurafenib	TRIM16	PA165946873	10626	0.604
NULL	Cell_Death_Dis_2013_Oct_3_4(10)_e830.nxml.txt.nlp	24091673	SENT23	33	33	20	20	doxorubicin	c-Jun	PA449412	3725	0.604
NULL	Clin_Interv_Aging_2014_Sep_4_9_1479-1487.nxml.txt.nlp	25214775	SENT137	26	26	19	19	saxagliptin	PPG	PA165958362	5552	0.604
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT102	14	14	9	9	imatinib	ABCB1	PA10804	5243	0.604
NULL	Daru_2011_19(6)_433-439.nxml.txt.nlp	23008689	SENT108	5	5	7	7	ethanol	IPA	PA448073	3160	0.604
NULL	Arthritis_Res_Ther_2009_Dec_11_11(6)_R187.nxml.txt.nlp	20003323	SENT271	17	17	6	6	indomethacin	RANKL	PA449982	8600	0.604
NULL	J_Thromb_Haemost_2007_May_5(5)_1010-1018.nxml.txt.nlp	17355572	SENT223	15	15	8	8	thrombin	VWF	PA451674	7450	0.604
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT148	14	14	20	20	glucose	ECM	PA449773	22915	0.604
NULL	Breast_Cancer_Res_2004_Apr_7_6(4)_R275-R283.nxml.txt.nlp	15217493	SENT199	29	29	19	19	paclitaxel	IFN	PA450761	3439	0.604
NULL	Environ_Health_Perspect_2010_Jul_3_118(7)_936-942.nxml.txt.nlp	20199942	SENT174	21	21	23	23	arsenite	CBP	PA452638	55824;1387	0.604
NULL	J_Oncol_2012_Oct_5_2012_794172.nxml.txt.nlp	22007215	SENT6	20	20	23	23	cyclophosphamide	CTX	PA449165	1593	0.604
NULL	Int_J_Biol_Sci_2012_Jul_7_8(6)_913-934.nxml.txt.nlp	22811614	SENT85	24	24	40	40	glibenclamide	STZ	PA449782	6484	0.604
NULL	J_Korean_Med_Sci_2009_Jan_29_24(Suppl_1)_S170-S175.nxml.txt.nlp	19194548	SENT11	18	18	20	20	cisplatin	EPO	PA449014	7076;8288;2056	0.604
NULL	Exp_Ther_Med_2013_Nov_13_6(5)_1317-1321.nxml.txt.nlp	24223665	SENT84	5	5	7	7	curcumin	CD133	PA151958596	8842	0.604
NULL	Br_J_Pharmacol_2011_Apr_162(8)_1832-1842.nxml.txt.nlp	21232033	SENT156	5	5	17	17	resveratrol	SAP97		1739	0.604
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Oct_28_65(Pt_11)_o2859.nxml.txt.nlp	21578446	SENT69	15	15	18	18	benzaldehyde	mol	PA448571	90527	0.604
NULL	Biomed_Res_Int_2014_Jun_3_2014_656370.nxml.txt.nlp	24995318	SENT99	0	0	4	4	haloperidol	FGA	PA449841	2243	0.604
NULL	J_Allergy_(Cairo)_2011_Apr_6_2011_479129.nxml.txt.nlp	21603171	SENT62	0	0	24	24	tacrolimus	IL-5	PA451578	3567	0.604
NULL	Eur_J_Med_Res_2011_Jul_25_16(7)_303-314.nxml.txt.nlp	21813371	SENT59	11	11	13	13	telaprevir	SOC	PA165958354	91544	0.604
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_11_2014_780385.nxml.txt.nlp	25435891	SENT27	17	17	19	19	lipase	ATGL	PA450239	57104	0.603
NULL	Case_Rep_Pediatr_2013_Dec_19_2013_897902.nxml.txt.nlp	24455378	SENT38	10	10	33	33	urea	AST	PA451831	26503	0.603
NULL	J_Gynecol_Oncol_2013_Jul_4_24(3)_265-272.nxml.txt.nlp	23875077	SENT177	23	23	32	32	thrombin	GAPDH	PA451674	2597	0.603
NULL	Arthritis_Res_Ther_2003_Nov_4_5(1)_R40-R48.nxml.txt.nlp	12716452	SENT45	32	32	35	35	l-glutamine	mol	PA10090	90527	0.603
NULL	Ann_Hematol_2010_Apr_13_89(4)_341-348.nxml.txt.nlp	19823823	SENT84	31	31	23	23	daunorubicin	LAK	PA449212	10123	0.603
NULL	J_Biomed_Biotechnol_2011_Dec_6_2011_286947.nxml.txt.nlp	21188170	SENT15	18	18	20	20	vasopressin	AVP	PA451858	114548;551	0.603
NULL	Clin_Dev_Immunol_2011_Dec_8_2011_439053.nxml.txt.nlp	22190971	SENT295	3	3	5	5	cyclophosphamide	CTX	PA449165	1593	0.603
NULL	Cell_Commun_Signal_2010_Jun_12_8_11.nxml.txt.nlp	20540792	SENT68	6	6	8	8	thalidomide	CRBN	PA451644	51185	0.603
NULL	Neural_Regen_Res_2014_Nov_1_9(21)_1897-1901.nxml.txt.nlp	25558239	SENT69	0	0	9	9	diazepam	CA1	PA449283	759	0.603
NULL	AIDS_Res_Ther_2014_Aug_4_11_25.nxml.txt.nlp	25120580	SENT18	20	20	13	13	voriconazole	CYP2C19	PA10233	1557	0.603
NULL	Front_Cell_Neurosci_2014_Jan_29_8_11.nxml.txt.nlp	24523671	SENT619	14	14	10	10	ethanol	NR1	PA448073	27158	0.603
NULL	Indian_J_Endocrinol_Metab_2011_Apr-Jun_15(2)_110-114.nxml.txt.nlp	21731868	SENT89	11	11	22	22	metformin	B12	PA450395	7126;4709	0.603
NULL	J_Antimicrob_Chemother_2014_Nov_17_69(11)_2920-2927.nxml.txt.nlp	25038069	SENT139	6	6	12	12	erythromycin	FUS	PA449493	2521	0.603
NULL	Anal_Bioanal_Chem_2012_Mar_29_402(7)_2267-2274.nxml.txt.nlp	22038587	SENT21	31	31	13	13	pilocarpine	CA3	PA450962	761	0.603
NULL	Int_J_Chron_Obstruct_Pulmon_Dis_2007_Dec_2(4)_517-533.nxml.txt.nlp	18268925	SENT160	0	0	20	20	cilomilast	IL-8	PA165948031	3576	0.603
NULL	Acta_Pharmacol_Sin_2011_Aug_18_32(8)_1078-1084.nxml.txt.nlp	21765448	SENT33	28	28	11	11	iptakalim	KCNJ11	PA165949694	3767	0.603
NULL	Breast_Cancer_Res_2014_May_30_16(3)_R55.nxml.txt.nlp	24886669	SENT196	6	6	2	2	doxorubicin	survivin	PA449412	332	0.603
NULL	Mol_Vis_2012_Jul_18_18_1966-1972.nxml.txt.nlp	22876123	SENT14	5	5	15	15	curcumin	IL-5	PA151958596	3567	0.603
NULL	Ital_J_Pediatr_2014_Feb_13_40_17.nxml.txt.nlp	24524345	SENT85	24	24	14	14	cyclosporine	CHP	PA449167	11261	0.603
NULL	Epigenetics_2012_Nov_1_7(11)_1225-1229.nxml.txt.nlp	23069641	SENT48	10	10	14	14	cisplatin	BRCA1	PA449014	672	0.603
NULL	Clin_Ophthalmol_2009_Jun_2_3_291-295.nxml.txt.nlp	19668581	SENT61	17	17	12	12	travoprost	BAK	PA164781371	578	0.603
NULL	Crit_Care_2008_Mar_13_12(Suppl_2)_P56.nxml.txt.nlp	NULL	SENT6	26	26	28	28	vancomycin	VAN	PA451850	10318	0.603
NULL	J_Asthma_Allergy_2013_Jul_1_6_93-101.nxml.txt.nlp	23843695	SENT199	28	28	12	12	salmeterol	BDP	PA451300	10620;152926	0.603
NULL	J_Adv_Pract_Oncol_2014_May_1_May-Jun_5(3)_205-210.nxml.txt.nlp	25089219	SENT92	9	9	4	4	capecitabine	DPD	PA448771	1806	0.603
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT121	3	3	5	5	perifosine	TRAIL	PA165291471	8743	0.603
NULL	Braz_J_Med_Biol_Res_2012_Apr_27_45(6)_510-516.nxml.txt.nlp	22527124	SENT84	0	0	2	2	doxorubicin	ADM	PA449412	133	0.603
NULL	J_Oncol_2013_Feb_17_2013_872957.nxml.txt.nlp	23476648	SENT202	28	28	13	13	cisplatin	SFN	PA449014	25996;2810	0.603
NULL	Diabetes_2008_Sep_57(9)_2332-2340.nxml.txt.nlp	18567824	SENT93	4	4	9	9	atropine	ghrelin	PA448505	51738	0.603
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Apr_15_9_13.nxml.txt.nlp	20398300	SENT108	23	23	7	7	amoxicillin	LAM	PA448406	7249;7248	0.603
NULL	Cancer_Immunol_Immunother_2011_Jun_25_60(6)_793-808.nxml.txt.nlp	21350947	SENT220	43	43	32	32	sorafenib	IFN	PA7000	3439	0.603
NULL	Interdiscip_Perspect_Infect_Dis_2014_May_7_2014_849432.nxml.txt.nlp	24895495	SENT54	18	18	8	8	triamcinolone	CD4	PA451749	920	0.603
NULL	Blood_Res_2013_Dec_24_48(4)_293-295.nxml.txt.nlp	24466556	SENT45	19	19	27	27	hydroxyurea	IFN	PA449942	3439	0.603
NULL	J_Korean_Med_Sci_2007_Apr_30_22(2)_283-289.nxml.txt.nlp	17449938	SENT9	32	32	27	27	minoxidil	P21	PA450521	1026;9338	0.603
NULL	Arch_Immunol_Ther_Exp_(Warsz)_2007_Aug_23_55(4)_267-279.nxml.txt.nlp	17659374	SENT521	37	37	35	35	melphalan	TNF-alpha	PA450354	7124	0.603
NULL	Cancer_Causes_Control_2012_Nov_15_23(11)_1747-1766.nxml.txt.nlp	22983399	SENT222	37	37	22	22	formaldehyde	NHL	PA449703	51750	0.603
NULL	Ann_Clin_Microbiol_Antimicrob_2009_Jan_15_8_2.nxml.txt.nlp	19146672	SENT25	0	0	2	2	ethambutol	EMB	PA164784021	133418	0.603
NULL	Diabetes_Metab_Syndr_Obes_2010_May_10_3_125-143.nxml.txt.nlp	21437083	SENT42	16	16	18	18	lipase	HGL	PA450239	3993;8513	0.603
NULL	Breast_Cancer_Res_Treat_2013_Jan_8_137(2)_457-464.nxml.txt.nlp	23224144	SENT215	6	6	10	10	paclitaxel	castor	PA450761	54897	0.603
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Apr_15_9_13.nxml.txt.nlp	20398300	SENT97	13	13	18	18	moxifloxacin	LAM	PA450555	7249;7248	0.603
NULL	Gut_Liver_2013_Sep_14_7(5)_552-559.nxml.txt.nlp	24073313	SENT8	22	22	15	15	celecoxib	EGFR	PA448871	1956	0.603
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT150	27	27	11	11	glucose	PP2	PA449773	4888	0.603
NULL	ScientificWorldJournal_2012_Apr_22_2012_643904.nxml.txt.nlp	22619632	SENT215	14	14	12	12	pp2	PP1		5540;5464	0.603
NULL	Oncotarget_2011_Mar_28_2(3)_109-112.nxml.txt.nlp	21487160	SENT57	15	15	28	28	metformin	AMPK	PA450395	5563	0.603
NULL	Bioinformatics_2014_Jan_1_30(1)_50-60.nxml.txt.nlp	24177718	SENT391	7	7	36	36	temozolomide	EGFR	PA451609	1956	0.603
NULL	J_Korean_Med_Sci_2013_Aug_31_28(8)_1145-1153.nxml.txt.nlp	23960440	SENT109	31	31	22	22	colchicine	ST2	PA449092	9173;6761	0.603
NULL	Diabetes_Care_2013_Jul_12_36(7)_2098-2106.nxml.txt.nlp	23695817	SENT295	42	42	7	7	liraglutide	GLP-1	PA165958364	100125288	0.603
NULL	Breast_Cancer_Res_2011_Aug_31_13(4)_R84.nxml.txt.nlp	21884573	SENT15	3	3	16	16	trastuzumab	HER2	PA451743	2064	0.603
NULL	Int_J_Gen_Med_2011_Apr_8_4_277-287.nxml.txt.nlp	21556314	SENT270	12	12	16	16	tamoxifen	STAR	PA451581	6770;2984	0.603
NULL	Ann_Rheum_Dis_2011_Oct_12_71(4)_541-548.nxml.txt.nlp	21994233	SENT108	19	19	0	0	methotrexate	ACR	PA450428	49	0.603
NULL	Braz_J_Med_Biol_Res_2013_Aug_16_46(8)_708-714.nxml.txt.nlp	23969974	SENT146	13	13	17	17	alendronate	ANOVA	PA448082	4858	0.603
NULL	Mol_Cell_Proteomics_2012_Jun_25_11(6)_M111_015073.nxml.txt.nlp	22278372	SENT677	14	14	3	3	hyaluronan	PTX3	PA165958431	5806	0.603
NULL	J_Antimicrob_Chemother_2014_Apr_2_69(4)_911-918.nxml.txt.nlp	24302651	SENT39	6	6	12	12	cefoxitin	PEN	PA448856	9933	0.603
NULL	Int_J_Mol_Sci_2014_Oct_8_15(10)_17974-17999.nxml.txt.nlp	25299695	SENT8	7	7	4	4	curcumin	HO-1	PA151958596	3162	0.603
NULL	Cell_Death_Dis_2011_Apr_28_2(4)_e152.nxml.txt.nlp	21525939	SENT244	28	28	6	6	voacamine	p16	PA165958347	1029	0.603
NULL	Int_J_Endocrinol_2014_Mar_12_2014_847827.nxml.txt.nlp	24744784	SENT162	6	6	9	9	fenofibrate	TLR4	PA449594	7099	0.603
NULL	Anat_Cell_Biol_2011_Sep_29_44(3)_169-175.nxml.txt.nlp	22025968	SENT66	25	25	11	11	ethanol	CLU	PA448073	1191	0.603
NULL	J_Mol_Med_(Berl)_2014_May_10_92(7)_709-722.nxml.txt.nlp	24811491	SENT96	33	33	20	20	vemurafenib	BRAF	PA165946873	673	0.603
NULL	Cancer_Manag_Res_2011_May_10_3_157-175.nxml.txt.nlp	21625399	SENT54	6	6	29	29	midazolam	CYP2C9	PA450496	1559	0.603
NULL	Int_J_Biol_Sci_2005_Dec_1_1(4)_146-151.nxml.txt.nlp	18167569	SENT66	15	15	11	11	zinc	IMAC	PA451956	10344	0.603
NULL	Front_Behav_Neurosci_2014_Oct_30_8_366.nxml.txt.nlp	25400560	SENT156	17	17	1	1	ethanol	ANOVA	PA448073	4858	0.603
NULL	J_Anaesthesiol_Clin_Pharmacol_2012_Oct-Dec_28(4)_486-490.nxml.txt.nlp	23225930	SENT28	23	23	33	33	fentanyl	TKR	PA449599	8277	0.603
NULL	Front_Oncol_2012_Oct_31_2_157.nxml.txt.nlp	23120745	SENT552	7	7	4	4	temozolomide	p53	PA451609	7157	0.603
NULL	J_Hematol_Oncol_2011_Apr_1_4_13.nxml.txt.nlp	21453545	SENT153	24	24	19	19	imatinib	CML	PA10804	613	0.603
NULL	Mol_Cancer_2007_Aug_21_6_53.nxml.txt.nlp	17711579	SENT153	6	6	38	38	cisplatin	CAPN2	PA449014	824	0.603
NULL	Crit_Care_2010_Mar_15_14(2)_R30.nxml.txt.nlp	20226064	SENT278	1	1	11	11	midazolam	IL-6	PA450496	3569	0.603
NULL	J_Mammary_Gland_Biol_Neoplasia_2010_Sep_19_15(3)_279-290.nxml.txt.nlp	20717712	SENT328	14	14	11	11	lipase	PRL	PA450239	5617	0.603
NULL	Arthritis_Res_Ther_2009_Feb_3_11(1)_R15.nxml.txt.nlp	19192274	SENT212	17	17	9	9	chloroquine	IL-6	PA448948	3569	0.603
NULL	Mol_Cancer_2004_May_4_3_14.nxml.txt.nlp	15125777	SENT50	6	6	15	15	cisplatin	CHK2	PA449014	11200	0.603
NULL	Int_J_Endocrinol_2014_Jul_16_2014_690783.nxml.txt.nlp	25140176	SENT599	21	21	35	35	metformin	CTX	PA450395	1593	0.603
NULL	Drugs_R_D_2011_Jun_27_11(2)_101-111.nxml.txt.nlp	21679003	SENT37	20	20	25	25	oxaliplatin	IFL	PA131285527	3439	0.603
NULL	J_Thromb_Haemost_2011_Oct_9(10)_2103-2105.nxml.txt.nlp	21812912	SENT18	33	33	16	16	ticagrelor	ADP	PA165374673	23038	0.603
NULL	Age_(Dordr)_2010_Mar_12_32(1)_109-121.nxml.txt.nlp	19908165	SENT82	19	19	34	34	fluorescein	CD41	PA164746009	3674	0.603
NULL	Arthritis_Res_Ther_2013_Nov_6_15(6)_124.nxml.txt.nlp	24229459	SENT25	23	23	3	3	pioglitazone	IL-6	PA450970	3569	0.603
NULL	Br_J_Cancer_2002_Feb_12_86(4)_612-618.nxml.txt.nlp	11870545	SENT20	19	19	21	21	lipase	HSL	PA450239	3991	0.603
NULL	J_Cell_Biol_1989_Aug_1_109(2)_577-584.nxml.txt.nlp	2547803	SENT8	28	28	26	26	thrombin	EGF	PA451674	1950	0.603
NULL	J_Biol_Chem_2012_Apr_20_287(17)_14122-14135.nxml.txt.nlp	22351750	SENT599	27	27	9	9	hyaluronan	TSG-6	PA165958431	7130	0.603
NULL	Crit_Care_2006_Mar_7_10(2)_R40.nxml.txt.nlp	16542484	SENT135	10	10	7	7	vasopressin	AVP	PA451858	114548;551	0.603
NULL	Front_Endocrinol_(Lausanne)_2013_Mar_28_4_22.nxml.txt.nlp	23543285	SENT247	3	3	11	11	estradiol	ARC	PA449503	8996;23237	0.603
NULL	BMB_Rep_2013_Jan_46(1)_59-64.nxml.txt.nlp	23351386	SENT64	8	8	21	21	auranofin	STAT3	PA448510	6774	0.603
NULL	J_Thorac_Oncol_2014_May_22_9(5)_710-716.nxml.txt.nlp	24722157	SENT224	25	25	20	20	cetuximab	CRT	PA10040	811	0.603
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1137-1144.nxml.txt.nlp	20234366	SENT171	7	7	12	12	cetuximab	KRAS	PA10040	3845	0.603
NULL	J_Inflamm_(Lond)_2008_Dec_5_5_23.nxml.txt.nlp	19061493	SENT188	11	11	3	3	hemin	HO-1	PA449849	3162	0.603
NULL	Behav_Brain_Funct_2012_Feb_28_8_11.nxml.txt.nlp	22369141	SENT29	24	24	8	8	risperidone	AAP	PA451257	5345	0.603
NULL	Arthritis_Res_Ther_2014_Jan_24_16(1)_R23.nxml.txt.nlp	24460726	SENT192	10	10	0	0	hydroxychloroquine	CCL2	PA164777036	6347	0.603
NULL	Exp_Ther_Med_2013_May_15_5(5)_1293-1300.nxml.txt.nlp	23737867	SENT241	10	10	16	16	finasteride	STAT3	PA449627	6774	0.603
NULL	Mol_Cancer_2012_Mar_8_11_9.nxml.txt.nlp	22401581	SENT141	18	18	29	29	calcein	IGFBP3	PA132595336	3486	0.603
NULL	Breast_Cancer_Res_2011_May_26_13(3)_209.nxml.txt.nlp	21635709	SENT141	14	14	4	4	tamoxifen	STEPP	PA451581	222659	0.603
NULL	Indian_J_Pharmacol_2014_Nov-Dec_46(6)_627-632.nxml.txt.nlp	25538335	SENT125	11	11	4	4	metformin	Q10	PA450395	27161	0.603
NULL	Acta_Vet_Scand_2008_Jul_4_50(1)_27.nxml.txt.nlp	18601734	SENT18	27	27	23	23	doxorubicin	SMYD2	PA449412	56950	0.603
NULL	Virulence_2013_Oct_1_4(7)_646-653.nxml.txt.nlp	24045422	SENT87	18	18	24	24	l-lysine	CD4	PA450280	920	0.603
NULL	Cancers_(Basel)_2012_Sep_6_4(3)_873-903.nxml.txt.nlp	24213471	SENT635	13	13	4	4	hyaluronan	HYAL3	PA165958431	8372	0.603
NULL	Biosci_Rep_2013_Sep_17_33(5)_e00068.nxml.txt.nlp	23919527	SENT255	6	6	34	34	guanidine	CXCL8	PA164781028	3576	0.603
NULL	Gut_Liver_2011_Jun_24_5(2)_117-132.nxml.txt.nlp	21814590	SENT159	43	43	40	40	ribavirin	IFN	PA451241	3439	0.603
NULL	Viruses_2014_Jul_22_6(7)_2858-2879.nxml.txt.nlp	25054884	SENT149	7	7	27	27	raltegravir	vRNA		56664	0.603
NULL	Cancer_Cell_Int_2011_Nov_17_11_40.nxml.txt.nlp	22088142	SENT153	16	16	7	7	gefitinib	MRP1	PA131301952	4437	0.603
NULL	Ann_Oncol_2009_Aug_20(Suppl_6)_vi41-vi50.nxml.txt.nlp	19617297	SENT51	21	21	27	27	tamoxifen	IL-2	PA451581	3558	0.603
NULL	Br_J_Cancer_2009_Jul_21_101(2)_238-243.nxml.txt.nlp	19568242	SENT102	15	15	28	28	sunitinib	IFN	PA162372840	3439	0.603
NULL	Crit_Care_2008_Mar_13_12(Suppl_2)_P22.nxml.txt.nlp	NULL	SENT2	0	0	2	2	micafungin	MICA	PA164781026	100507436	0.603
NULL	Br_J_Cancer_1997_75(10)_1497-1500.nxml.txt.nlp	9166943	SENT9	44	44	42	42	melphalan	TNF-alpha	PA450354	7124	0.603
NULL	J_Physiol_2009_Feb_15_587(Pt_4)_731-744.nxml.txt.nlp	19074966	SENT97	0	0	4	4	taurine	PAT1	PA451590	10513;206358	0.603
NULL	Front_Synaptic_Neurosci_2010_Jun_10_2_10.nxml.txt.nlp	21423496	SENT766	0	0	5	5	nimodipine	CA1	PA450633	759	0.603
NULL	Aging_Cell_2013_Oct_8_12(5)_784-793.nxml.txt.nlp	23755917	SENT291	22	22	17	17	kanamycin	PEX5	PA450137	5830	0.603
NULL	Biochem_Res_Int_2012_Mar_20_2012_951539.nxml.txt.nlp	22482055	SENT213	8	8	11	11	doxorubicin	p38	PA449412	10598;1432;7965	0.603
NULL	Cell_Death_Dis_2012_Jun_21_3(6)_e330.nxml.txt.nlp	22717585	SENT293	0	0	10	10	simvastatin	ATF4	PA451363	468	0.603
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Apr_30_65(Pt_5)_m594.nxml.txt.nlp	21583816	SENT52	40	40	36	36	ethanol	mol	PA448073	90527	0.603
NULL	Evid_Based_Complement_Alternat_Med_2014_Mar_4_2014_305149.nxml.txt.nlp	24723958	SENT70	10	10	26	26	paraformaldehyde	p65	PA450790	5970	0.603
NULL	Proteome_Sci_2010_Mar_26_8_18.nxml.txt.nlp	20346146	SENT113	21	21	11	11	hyaluronan	CD90	PA165958431	7070	0.603
NULL	Oncol_Lett_2013_May_22_5(5)_1653-1655.nxml.txt.nlp	23760305	SENT36	13	13	19	19	thyroglobulin	TTF-1	PA164754910	7080	0.603
NULL	Nat_Commun_2014_Mar_17_5_3438.nxml.txt.nlp	24633423	SENT628	24	24	13	13	spermine	DAO	PA164781199	26;1610	0.603
NULL	Diabetes_2011_Nov_17_60(11)_2691-2700.nxml.txt.nlp	21896928	SENT254	11	11	7	7	resveratrol	SIRT1		23411	0.603
NULL	ScientificWorldJournal_2012_Dec_17_2012_916381.nxml.txt.nlp	23319889	SENT27	12	12	20	20	ciprofloxacin	CTX	PA449009	1593	0.603
NULL	J_Korean_Med_Sci_2010_Feb_19_25(2)_304-308.nxml.txt.nlp	20119588	SENT87	31	31	29	29	ethambutol	EMB	PA164784021	133418	0.603
NULL	J_Korean_Med_Sci_2010_Nov_26_25(11)_1553-1559.nxml.txt.nlp	21060742	SENT158	26	26	34	34	heparin	TKR	PA449855	8277	0.603
NULL	Oncol_Lett_2014_Mar_2_7(3)_791-796.nxml.txt.nlp	24527087	SENT100	24	24	13	13	imatinib	CDK1	PA10804	983	0.603
NULL	Braz_J_Med_Biol_Res_2013_Mar_15_46(3)_299-305.nxml.txt.nlp	23532269	SENT135	19	19	7	7	propofol	TLR4	PA451141	7099	0.603
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Jun_27_5_15.nxml.txt.nlp	16803618	SENT145	20	20	30	30	erythromycin	CIP1	PA449493	1026;56996	0.603
NULL	Diabetes_2013_Oct_17_62(10)_3362-3372.nxml.txt.nlp	23801581	SENT78	29	29	34	34	nadh	ND1	PA164755085	4535;10625	0.603
NULL	Breast_Cancer_Res_2010_Dec_16_12(6)_215.nxml.txt.nlp	21176175	SENT194	15	15	30	30	indomethacin	RANKL	PA449982	8600	0.603
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT39	22	22	11	11	metformin	EGFR	PA450395	1956	0.603
NULL	J_Hematol_Oncol_2008_Aug_11_1_11.nxml.txt.nlp	18694493	SENT40	10	10	14	14	sorafenib	IFN	PA7000	3439	0.603
NULL	Biologics_2013_Apr_15_7_77-90.nxml.txt.nlp	23723688	SENT294	12	12	17	17	cetuximab	CRT	PA10040	811	0.603
NULL	J_Gen_Physiol_1955_Nov_20_39(2)_185-195.nxml.txt.nlp	13271719	SENT0	18	18	1	1	hyaluronidase	Gen	PA164745713	348654	0.603
NULL	J_Cell_Biol_1997_Mar_10_136(5)_995-1005.nxml.txt.nlp	9060465	SENT46	10	10	7	7	dibucaine	TFP	PA449286	7034	0.603
NULL	Nat_Biotechnol_2011_Oct_23_29(11)_1028-1033.nxml.txt.nlp	22020385	SENT248	7	7	1	1	thrombin	VIII	PA451674	1351	0.603
NULL	Drugs_R_D_2010_Nov_25_10(4)_219-224.nxml.txt.nlp	21171668	SENT98	10	10	20	20	clopidogrel	CYP2C19	PA449053	1557	0.603
NULL	Pharmaceuticals_(Basel)_2012_Sep_12_5(9)_963-990.nxml.txt.nlp	24280700	SENT1225	8	8	17	17	tranylcypromine	LSD2	PA451741	221656	0.603
NULL	Clin_Epigenetics_2011_Dec_5_3(1)_8.nxml.txt.nlp	22414275	SENT89	3	3	5	5	ribavirin	ESR1	PA451241	2099	0.603
NULL	Cell_J_2012_Dec_22_Winter_13(4)_265-274.nxml.txt.nlp	23507995	SENT29	2	2	9	9	ethanol	CA3	PA448073	761	0.603
NULL	Appl_Clin_Genet_2013_Oct_18_6_91-101.nxml.txt.nlp	24159262	SENT18	29	29	12	12	thrombin	FIX	PA451674	2158	0.603
NULL	Nucleic_Acids_Res_2012_Apr_16_40(8)_3511-3523.nxml.txt.nlp	22180533	SENT142	3	3	7	7	doxycycline	E2F7	PA449415	144455	0.603
NULL	Br_J_Cancer_2013_May_28_108(10)_2063-2069.nxml.txt.nlp	23591198	SENT73	25	25	6	6	axitinib	GEM	PA164924493	2669	0.603
NULL	Neural_Regen_Res_2013_May_5_8(13)_1180-1189.nxml.txt.nlp	25206412	SENT86	2	2	5	5	fasudil	RhoA	PA165946121	387	0.603
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2012_Feb_20_5_13-30.nxml.txt.nlp	22879796	SENT170	17	17	7	7	atorvastatin	adiponectin	PA448500	9370	0.603
NULL	Endocrinol_Metab_(Seoul)_2014_Dec_29_29(4)_553-560.nxml.txt.nlp	25325265	SENT134	7	7	9	9	lipase	HSL	PA450239	3991	0.603
NULL	Mol_Cancer_2012_Mar_21_11_13.nxml.txt.nlp	22436134	SENT385	9	9	18	18	doxorubicin	HuR	PA449412	1994	0.603
NULL	Appl_Microbiol_Biotechnol_2014_Apr_3_98(11)_4805-4816.nxml.txt.nlp	24695829	SENT18	21	21	8	8	ethanol	CO2	PA448073	4513	0.603
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT261	14	14	9	9	chloroquine	BMPR-II	PA448948	659	0.603
NULL	Crit_Care_2009_Jul_10_13(4)_R113.nxml.txt.nlp	19591694	SENT175	18	18	4	4	terlipressin	AVP	PA164781020	114548;551	0.603
NULL	Pharmaceuticals_(Basel)_2013_Aug_21_6(8)_988-1038.nxml.txt.nlp	24276379	SENT476	18	18	12	12	vemurafenib	PTEN	PA165946873	5728	0.603
NULL	Mol_Biol_Cell_2014_Apr_1_25(7)_965-976.nxml.txt.nlp	24478450	SENT39	7	7	20	20	chloramphenicol	COX	PA448927	1351	0.603
NULL	Br_J_Cancer_2010_Jan_19_102(2)_361-368.nxml.txt.nlp	20010949	SENT157	9	9	6	6	doxorubicin	PSMB7	PA449412	5695	0.603
NULL	Ther_Clin_Risk_Manag_2007_Mar_3(1)_181-196.nxml.txt.nlp	18360626	SENT250	0	0	9	9	dutasteride	BII	PA164749300	777	0.603
NULL	Chem_Cent_J_2014_Sep_17_8(1)_59.nxml.txt.nlp	NULL	SENT92	8	8	27	27	moxifloxacin	MOX	PA450555	26002	0.603
NULL	J_Carcinog_2014_Mar_5_13_5.nxml.txt.nlp	24799832	SENT28	0	0	2	2	diethylstilbestrol	DES	PA449307	1674	0.603
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Apr_8_65(Pt_5)_o981-o982.nxml.txt.nlp	21584020	SENT87	4	4	7	7	benzaldehyde	mol	PA448571	90527	0.603
NULL	Nanoscale_Res_Lett_2014_Feb_15_9(1)_76.nxml.txt.nlp	24528570	SENT130	17	17	14	14	hydroquinone	mol	PA449924	90527	0.603
NULL	Daru_2013_Jan_5_21(1)_4.nxml.txt.nlp	23351476	SENT18	5	5	9	9	fluoxetine	ANOVA	PA449673	4858	0.603
NULL	Br_J_Cancer_2012_May_8_106(10)_1587-1590.nxml.txt.nlp	22568998	SENT68	25	25	32	32	sunitinib	IFN	PA162372840	3439	0.603
NULL	Clin_Ophthalmol_2008_Jun_2(2)_355-368.nxml.txt.nlp	19668727	SENT81	30	30	34	34	amfenac	COX2	PA166049186	4513;5743	0.603
NULL	Oxid_Med_Cell_Longev_2011_Aug_15_2011_824597.nxml.txt.nlp	21904648	SENT18	15	15	17	17	topotecan	TPT	PA451729	23590;6469	0.603
NULL	J_Biol_Chem_2009_Sep_25_284(39)_26578-26590.nxml.txt.nlp	19635791	SENT131	27	27	13	13	nadh	INS-1	PA164755085	2305	0.603
NULL	Environ_Health_Perspect_2005_Aug_13_113(8)_926-933.nxml.txt.nlp	16079060	SENT59	25	25	27	27	diethylstilbestrol	DES	PA449307	1674	0.603
NULL	Indian_Dermatol_Online_J_2014_Oct-Dec_5(4)_539-540.nxml.txt.nlp	25396160	SENT33	8	8	5	5	methotrexate	gamma	PA450428	9913	0.603
NULL	Int_J_Mol_Sci_2012_Feb_1_13(2)_1512-1523.nxml.txt.nlp	22408405	SENT358	2	2	11	11	olmesartan	LOX-1	PA164742950	4973	0.603
NULL	Front_Oncol_2014_Sep_23_4_264.nxml.txt.nlp	25295231	SENT110	12	12	9	9	lenalidomide	MDM2	PA162363968	4193	0.603
NULL	Cancer_Immunol_Immunother_2013_Aug_27_62(10)_1637-1648.nxml.txt.nlp	23982484	SENT12	0	0	2	2	lenalidomide	IL-6	PA162363968	3569	0.603
NULL	Curr_Control_Trials_Cardiovasc_Med_2001_May_31_2(3)_129-140.nxml.txt.nlp	11806786	SENT316	4	4	8	8	heparin	ACT	PA449855	12;11332;9457;641455	0.603
NULL	Mol_Cancer_2010_Apr_23_9_87.nxml.txt.nlp	20416058	SENT192	13	13	11	11	doxorubicin	TRAIL	PA449412	8743	0.603
NULL	Clin_Psychopharmacol_Neurosci_2012_Dec_20_10(3)_185-189.nxml.txt.nlp	23431037	SENT92	22	22	20	20	haloperidol	HPD	PA449841	3242	0.603
NULL	J_Cancer_Res_Clin_Oncol_2015_Aug_3_141_61-68.nxml.txt.nlp	25086987	SENT21	0	0	6	6	erlotinib	EGFR	PA134687924	1956	0.603
NULL	Appl_Plant_Sci_2014_Apr_3_2(4)_apps_1400011.nxml.txt.nlp	25202621	SENT175	4	4	6	6	ethanol	IPA	PA448073	3160	0.603
NULL	Int_J_Mol_Sci_2014_Mar_20_15(3)_4977-4993.nxml.txt.nlp	24658441	SENT595	1	1	9	9	resveratrol	TLR4		7099	0.603
NULL	Front_Neurosci_2014_May_27_8_129.nxml.txt.nlp	24904269	SENT153	18	18	15	15	ethanol	AC8	PA448073	114	0.603
NULL	Biosci_Rep_2013_Nov_25_33(6)_e00081.nxml.txt.nlp	24070327	SENT113	28	28	17	17	imatinib	ABCB1	PA10804	5243	0.603
NULL	Case_Rep_Oncol_2012_May_24_5(2)_260-266.nxml.txt.nlp	22712014	SENT15	4	4	9	9	vincristine	CHOP	PA451879	1649	0.603
NULL	Infect_Drug_Resist_2009_Apr_24_2_13-26.nxml.txt.nlp	21694884	SENT36	40	40	9	9	telbivudine	IFN	PA164760861	3439	0.603
NULL	Breast_Cancer_Res_2012_Mar_15_14(2)_R47.nxml.txt.nlp	22420423	SENT0	30	30	21	21	mitomycin	CHEK2	PA450524	11200	0.603
NULL	J_Pregnancy_2014_Jun_2_2014_910751.nxml.txt.nlp	24991435	SENT104	33	33	22	22	urokinase	IL1A	PA451836	3552	0.603
NULL	J_Immunother_Cancer_2013_Nov_7_1(Suppl_1)_P66.nxml.txt.nlp	NULL	SENT8	18	18	20	20	trastuzumab	HER-2	PA451743	2064	0.603
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT143	6	6	24	24	phenol	HRG	PA450913	3084;3273	0.603
NULL	J_Infect_Dis_2013_Mar_1_207(5)_842-847.nxml.txt.nlp	23225895	SENT103	2	2	4	4	lumefantrine	LUM	PA165111722	4060	0.603
NULL	Curr_Cardiol_Rev_2009_Aug_5(3)_216-222.nxml.txt.nlp	20676280	SENT139	35	35	32	32	lipase	HSL	PA450239	3991	0.603
NULL	Int_J_Biomed_Sci_2008_Dec_4(4)_260-265.nxml.txt.nlp	19568323	SENT82	5	5	8	8	forskolin	aromatase	PA146096022	1588	0.603
NULL	Breast_Cancer_Res_2011_Apr_14_13(2)_R43.nxml.txt.nlp	21492444	SENT133	10	10	15	15	doxycycline	HER2	PA449415	2064	0.603
NULL	J_Cell_Biol_1998_Jan_12_140(1)_159-169.nxml.txt.nlp	9425164	SENT310	14	14	24	24	tetracycline	EGF	PA451640	1950	0.603
NULL	Cardiol_Res_Pract_2011_Apr_3_2011_320983.nxml.txt.nlp	21559260	SENT7	0	0	11	11	everolimus	DES	PA164746311	1674	0.603
NULL	Br_J_Cancer_2013_Jun_25_108(12)_2495-2504.nxml.txt.nlp	23736031	SENT225	32	32	28	28	paclitaxel	p28	PA450761	246778;5716	0.603
NULL	Behav_Brain_Funct_2008_Aug_15_4_37.nxml.txt.nlp	18702828	SENT7	30	30	19	19	methamphetamine	FZD3	PA450403	7976;8326	0.603
NULL	Front_Cell_Neurosci_2015_Jan_15_8_459.nxml.txt.nlp	25642166	SENT77	18	18	2	2	hemin	HO-1	PA449849	3162	0.603
NULL	Crit_Care_2009_Mar_13_13(Suppl_1)_P313.nxml.txt.nlp	NULL	SENT4	0	0	2	2	micafungin	MICA	PA164781026	100507436	0.603
NULL	Arthritis_Res_Ther_2004_Sep_13_6(Suppl_3)_65.nxml.txt.nlp	NULL	SENT4	13	13	15	15	troglitazone	TRO	PA451799	7216	0.603
NULL	Cancer_Cell_Int_2013_Aug_19_13_82.nxml.txt.nlp	23958424	SENT310	15	15	11	11	bortezomib	TMC	PA10252	3703	0.603
NULL	Acta_Pharmacol_Sin_2010_Sep_16_31(9)_1085-1094.nxml.txt.nlp	20711226	SENT39	20	20	41	41	thrombin	HIF-1	PA451674	29072	0.603
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2014_Sep_27_70(Pt_10)_2740-2753.nxml.txt.nlp	25286857	SENT272	21	21	14	14	bsi-201	TNKS2		80351	0.603
NULL	BMB_Rep_2014_Nov_47(11)_599-608.nxml.txt.nlp	25154720	SENT199	2	2	20	20	rosiglitazone	PRDM16	PA451283	63976	0.603
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Jul_21_9_20.nxml.txt.nlp	20663145	SENT108	3	3	12	12	gentamicin	LBH	PA449753	81606;221491	0.603
NULL	Mar_Drugs_2009_Aug_26_7(3)_401-434.nxml.txt.nlp	19841722	SENT312	17	17	0	0	spermine	SAMDC	PA164781199	262	0.603
NULL	Genome_Med_2010_Sep_13_2(9)_64.nxml.txt.nlp	20831840	SENT56	19	19	6	6	lipase	APOA5	PA450239	116519	0.603
NULL	Mol_Clin_Oncol_2013_Jul_23_1(4)_745-748.nxml.txt.nlp	24649239	SENT131	6	6	4	4	cyclophosphamide	CTX	PA449165	1593	0.603
NULL	Mol_Med_Rep_2015_Jan_23_11(1)_151-158.nxml.txt.nlp	25352008	SENT268	20	20	28	28	resveratrol	PI3K		5290	0.602
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jul_31_65(Pt_8)_o2055.nxml.txt.nlp	21583717	SENT76	34	34	17	17	ethanol	mol	PA448073	90527	0.602
NULL	Ann_Hematol_2014_Sep_12_93(1)_13-32.nxml.txt.nlp	24026426	SENT274	17	17	10	10	caspofungin	BII	PA164743013	777	0.602
NULL	Environ_Health_Perspect_2010_Jul_3_118(7)_936-942.nxml.txt.nlp	20199942	SENT178	5	5	7	7	arsenite	p53	PA452638	7157	0.602
NULL	Cancers_(Basel)_2010_Jun_14_2(2)_1288-1311.nxml.txt.nlp	24281116	SENT573	4	4	8	8	oxygen	EMT	PA450744	3702;6581	0.602
NULL	Iran_Red_Crescent_Med_J_2013_Feb_5_15(2)_147-151.nxml.txt.nlp	23682327	SENT5	11	11	29	29	methylprednisolone	IL-10	PA450466	3586	0.602
NULL	J_Mol_Signal_2011_Jul_20_6_7.nxml.txt.nlp	21774804	SENT257	15	15	31	31	curcumin	CD133	PA151958596	8842	0.602
NULL	J_Med_Chem_2014_Jul_24_57(14)_5995-6007.nxml.txt.nlp	24960438	SENT14	22	22	13	13	estradiol	HSD1	PA449503	26871	0.602
NULL	Exp_Cell_Res_2011_Apr_15_317(7)_1028-1039.nxml.txt.nlp	21237154	SENT201	4	4	10	10	staurosporine	JNK	PA165109623	5599	0.602
NULL	CNS_Drugs_2014_Feb_7_28(3)_185-193.nxml.txt.nlp	24504829	SENT190	5	5	3	3	choline	CDP	PA448976	1523	0.602
NULL	Indian_J_Med_Paediatr_Oncol_2013_Oct-Dec_34(4)_336-337.nxml.txt.nlp	24604973	SENT16	22	22	24	24	heparin	PF4	PA449855	5196	0.602
NULL	Amino_Acids_2012_Oct_10_43(4)_1751-1759.nxml.txt.nlp	22407485	SENT124	11	11	6	6	carrageenan	ghrelin	PA448814	51738	0.602
NULL	J_Exp_Med_2000_Mar_6_191(5)_859-870.nxml.txt.nlp	10704466	SENT4	15	15	0	0	neomycin	p38	PA450608	10598;1432;7965	0.602
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT187	19	19	11	11	acenocoumarol	VKORC1	PA452632	79001	0.602
NULL	Case_Rep_Med_2014_Nov_12_2014_231651.nxml.txt.nlp	25477968	SENT114	26	26	10	10	amiodarone	AIT	PA448383	160728	0.602
NULL	Viruses_2013_Oct_4_5(10)_2447-2468.nxml.txt.nlp	24100888	SENT217	8	8	10	10	staurosporine	STP	PA165109623	9322	0.602
NULL	Arthritis_Res_Ther_2012_May_1_14(3)_R99.nxml.txt.nlp	22546542	SENT11	34	34	17	17	infliximab	IFN	PA452639	3439	0.602
NULL	Protein_Cell_2014_Jun_19_5(6)_469-479.nxml.txt.nlp	24748116	SENT28	7	7	5	5	paclitaxel	EB1	PA450761	9167;22919;10982	0.602
NULL	Exp_Ther_Med_2014_Jul_8_8(1)_248-254.nxml.txt.nlp	24944630	SENT205	9	9	7	7	cyclophosphamide	CTX	PA449165	1593	0.602
NULL	Front_Oncol_2012_Oct_4_2_123.nxml.txt.nlp	23061041	SENT101	7	7	9	9	estradiol	aromatase	PA449503	1588	0.602
NULL	Breast_Cancer_(Auckl)_2010_Feb_16_4_1-3.nxml.txt.nlp	20697527	SENT20	6	6	8	8	curcumin	CTX	PA151958596	1593	0.602
NULL	J_Obes_2010_Oct_31_2010_892081.nxml.txt.nlp	21052532	SENT52	5	5	34	34	glucose	adiponectin	PA449773	9370	0.602
NULL	Can_J_Infect_Dis_Med_Microbiol_2014_May-Jun_25(3)_163-169.nxml.txt.nlp	25285114	SENT225	4	4	30	30	ciprofloxacin	TOB	PA449009	10140	0.602
NULL	Int_J_Biol_Sci_2012_Mar_28_8(4)_533-547.nxml.txt.nlp	22532787	SENT29	2	2	4	4	gemcitabine	Gem	PA449748	51053	0.602
NULL	J_Headache_Pain_2011_Apr_5_12(2)_127-133.nxml.txt.nlp	21298314	SENT97	27	27	20	20	amitriptyline	CSMT	PA448385	1442	0.602
NULL	Nat_Med_2013_Feb_6_19(2)_217-226.nxml.txt.nlp	23291629	SENT355	18	18	20	20	lipase	HSL	PA450239	3991	0.602
NULL	Oncotarget_2014_Feb_25_5(5)_1304-1314.nxml.txt.nlp	24675421	SENT70	11	11	14	14	cisplatin	JNK	PA449014	5599	0.602
NULL	Int_J_Biol_Sci_2013_Nov_16_9(10)_1070-1078.nxml.txt.nlp	24250252	SENT156	24	24	31	31	lipase	ADIPOQ	PA450239	9370	0.602
NULL	Mol_Biol_Cell_2012_Sep_15_23(18)_3499-3510.nxml.txt.nlp	22833567	SENT192	35	35	32	32	arsenite	HRI	PA452638	27102	0.602
NULL	Med_Sci_Monit_2013_May_1_19_317-326.nxml.txt.nlp	23632427	SENT261	39	39	13	13	ciprofloxacin	CTX	PA449009	1593	0.602
NULL	J_Hematol_Oncol_2009_Jan_21_2_2.nxml.txt.nlp	19159467	SENT4	41	41	28	28	bevacizumab	EGFR	PA130232992	1956	0.602
NULL	Ann_Gen_Psychiatry_2008_Aug_18_7_11.nxml.txt.nlp	18706108	SENT164	1	1	5	5	ethanol	CD50	PA448073	3385	0.602
NULL	Front_Oncol_2014_Mar_6_4_40.nxml.txt.nlp	24639951	SENT62	10	10	24	24	daunorubicin	UNK	PA449212	85451	0.602
NULL	Br_J_Clin_Pharmacol_2011_Oct_72(4)_647-657.nxml.txt.nlp	21518389	SENT95	19	19	5	5	clopidogrel	CYP2C9	PA449053	1559	0.602
NULL	J_Exp_Clin_Cancer_Res_2009_May_27_28(1)_68.nxml.txt.nlp	19470182	SENT172	24	24	17	17	cisplatin	p53	PA449014	7157	0.602
NULL	Clin_Ophthalmol_2014_Dec_30_9_43-49.nxml.txt.nlp	25565767	SENT88	12	12	10	10	acetazolamide	RPE	PA448018	6120	0.602
NULL	Allergy_Asthma_Immunol_Res_2012_May_14_4(3)_137-142.nxml.txt.nlp	22548206	SENT134	27	27	17	17	piroxicam	IPA	PA450985	3160	0.602
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Jun_27_5_15.nxml.txt.nlp	16803618	SENT251	9	9	16	16	ciprofloxacin	LTA	PA449009	4049	0.602
NULL	Breast_Cancer_Res_2014_Jun_18_16(3)_212.nxml.txt.nlp	NULL	SENT58	7	7	24	24	tamoxifen	LAS	PA451581	11019	0.602
NULL	Breast_Cancer_Res_2000_Feb_18_2(2)_E005.nxml.txt.nlp	NULL	SENT41	37	37	12	12	vinorelbine	San	PA451881	80218	0.602
NULL	J_Hematol_Oncol_2013_Jan_15_6_5.nxml.txt.nlp	23320987	SENT142	11	11	5	5	heparin	PI-PLC	PA449855	2923	0.602
NULL	Cancer_Cell_Int_2013_Jan_15_13_3.nxml.txt.nlp	23320839	SENT16	28	28	21	21	doxorubicin	MRP3	PA449412	8714	0.602
NULL	Breast_Cancer_Res_2008_Dec_18_10(Suppl_4)_S20.nxml.txt.nlp	19128434	SENT27	11	11	7	7	anastrozole	FACT	PA448432	11198	0.602
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R91.nxml.txt.nlp	22541814	SENT110	2	2	11	11	thrombin	HO-1	PA451674	3162	0.602
NULL	J_Biol_Chem_2013_Oct_11_288(41)_29642-29653.nxml.txt.nlp	24005673	SENT663	27	27	9	9	hyaluronan	TSG-6	PA165958431	7130	0.602
NULL	Clin_Pharmacokinet_2013_Jun_26_52(6)_453-462.nxml.txt.nlp	23529813	SENT40	10	10	18	18	dabigatran	P-gp		5243	0.602
NULL	J_Adv_Pharm_Technol_Res_2014_Oct-Dec_5(4)_185-190.nxml.txt.nlp	25364697	SENT155	17	17	21	21	talinolol	P-gp	PA146123005	5243	0.602
NULL	Ther_Clin_Risk_Manag_2006_Sep_2(3)_235-249.nxml.txt.nlp	18360599	SENT299	7	7	9	9	alendronate	PTH	PA448082	5741	0.602
NULL	Biol_Proced_Online_2003_Oct_24_5_204-210.nxml.txt.nlp	14615817	SENT67	16	16	12	12	imatinib	CO2	PA10804	4513	0.602
NULL	Oncol_Lett_2014_Apr_10_7(4)_1078-1082.nxml.txt.nlp	24944672	SENT37	0	0	2	2	bleomycin	BLM	PA448645	641	0.602
NULL	Arthritis_Res_Ther_2014_Apr_3_16(2)_R86.nxml.txt.nlp	24708674	SENT193	18	18	27	27	imatinib	Fli1	PA10804	2314	0.602
NULL	Orphanet_J_Rare_Dis_2010_Jan_29_5_2.nxml.txt.nlp	20113479	SENT375	21	21	29	29	doxorubicin	RECQL4	PA449412	9401	0.602
NULL	Breast_Cancer_Res_2011_May_26_13(3)_209.nxml.txt.nlp	21635709	SENT149	19	19	9	9	tamoxifen	STEPP	PA451581	222659	0.602
NULL	Iran_Red_Crescent_Med_J_2013_Feb_5_15(2)_136-141.nxml.txt.nlp	23682325	SENT192	20	20	0	0	tetracycline	Gen	PA451640	348654	0.602
NULL	Cancer_Res_Treat_2014_Jan_15_46(1)_55-64.nxml.txt.nlp	24520224	SENT205	22	22	7	7	capecitabine	CEA	PA448771	5670;1087	0.602
NULL	Clin_Exp_Metastasis_2014_Sep_17_31(1)_135-147.nxml.txt.nlp	24043563	SENT183	25	25	19	19	tamoxifen	NES1	PA451581	5655	0.602
NULL	Arthritis_Res_Ther_2004_Jul_19_6(5)_R422-R432.nxml.txt.nlp	15380042	SENT237	10	10	0	0	fluorescein	ALCAM	PA164746009	214	0.602
NULL	Crit_Care_2006_Aug_7_10(4)_313.nxml.txt.nlp	16934108	SENT33	16	16	22	22	etomidate	ACTH	PA164743987	5443	0.602
NULL	Breast_Cancer_Res_2010_Jun_28_12(3)_R43.nxml.txt.nlp	20579400	SENT189	0	0	4	4	fulvestrant	MAPT	PA164747170	4137	0.602
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT227	12	12	0	0	simvastatin	GAPDH	PA451363	2597	0.602
NULL	Oncologist_2011_Jan_6_16(1)_5-24.nxml.txt.nlp	21212434	SENT136	19	19	22	22	dacarbazine	IL-2	PA449197	3558	0.602
NULL	Behav_Brain_Funct_2011_Sep_7_7_39.nxml.txt.nlp	21899751	SENT79	1	1	6	6	lidocaine	KCNA1	PA450226	3736	0.602
NULL	Diabetes_2013_Oct_17_62(10)_3547-3552.nxml.txt.nlp	23863812	SENT77	40	40	3	3	valsartan	adiponectin	PA451848	9370	0.602
NULL	J_Vis_Exp_2009_Jun_9_(28)_1305.nxml.txt.nlp	19513018	SENT26	17	17	21	21	papain	sit	PA450778	55733	0.602
NULL	Eur_Spine_J_2012_Jun_9_21(6)_1033-1042.nxml.txt.nlp	22402844	SENT152	24	24	36	36	estradiol	BSP	PA449503	3381	0.602
NULL	Diabetes_2009_Mar_58(3)_536-542.nxml.txt.nlp	19066310	SENT51	24	24	12	12	paraformaldehyde	CO2	PA450790	4513	0.602
NULL	Asia_Pac_Allergy_2012_Oct_31_2(4)_248-255.nxml.txt.nlp	23130330	SENT38	4	4	34	34	methacholine	MAST	PA165958382	51324	0.602
NULL	Diabetes_2013_Oct_17_62(10)_3426-3436.nxml.txt.nlp	23733201	SENT308	29	29	14	14	metformin	AMPK	PA450395	5563	0.602
NULL	J_Adv_Pharm_Technol_Res_2013_Jul-Sep_4(3)_141-145.nxml.txt.nlp	24083201	SENT134	10	10	32	32	phenytoin	zeta	PA450947	9907	0.602
NULL	Mol_Neurodegener_2011_Aug_8_6_57.nxml.txt.nlp	21819629	SENT345	17	17	31	31	arsenite	TDP-43	PA452638	23435	0.602
NULL	Core_Evid_2007_Nov_30_2(2)_111-119.nxml.txt.nlp	21221179	SENT228	18	18	1	1	capecitabine	MB1	PA448771	5693	0.602
NULL	Oncogene_2014_Jul_24_33(30)_3980-3991.nxml.txt.nlp	24121271	SENT163	17	17	24	24	l-glutamine	CO2	PA10090	4513	0.602
NULL	Nat_Med_2012_Jan_22_18(2)_224-226.nxml.txt.nlp	22270723	SENT13	12	12	18	18	celecoxib	DNMT3B	PA448871	1789	0.602
NULL	Eur_J_Med_Res_2010_Oct_25_15(10)_422-427.nxml.txt.nlp	21156401	SENT41	24	24	34	34	temozolomide	IFN	PA451609	3439	0.602
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Oct_28_65(Pt_11)_o2878.nxml.txt.nlp	21578464	SENT3	12	12	2	2	penciclovir	mol	PA450839	90527	0.602
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT47	3	3	6	6	trastuzumab	HER-2	PA451743	2064	0.602
NULL	EPMA_J_2011_Mar_12_2(1)_9-14.nxml.txt.nlp	23199123	SENT129	2	2	19	19	probucol	FAST	PA451107	10922	0.602
NULL	Diabetes_2013_Oct_17_62(10)_3488-3499.nxml.txt.nlp	23863811	SENT64	5	5	36	36	collagenase	mol	PA449107	90527	0.602
NULL	Croat_Med_J_2013_Apr_54(2)_171-179.nxml.txt.nlp	23630144	SENT9	9	9	11	11	taurine	STZ	PA451590	6484	0.602
NULL	Crit_Care_2012_Oct_12_16(5)_R189.nxml.txt.nlp	23062226	SENT78	3	3	22	22	glucose	SAPS	PA449773	8935	0.602
NULL	Crit_Care_2008_Apr_10_12(2)_132.nxml.txt.nlp	18423065	SENT22	17	17	7	7	vasopressin	AVP	PA451858	114548;551	0.602
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1150.nxml.txt.nlp	24675468	SENT8	4	4	38	38	ethanol	Bcl-2	PA448073	596	0.602
NULL	Pharmaceutics_2010_Apr_27_2(2)_136-158.nxml.txt.nlp	NULL	SENT211	42	42	0	0	diclofenac	HSM	PA449293	94030	0.602
NULL	Cell_Death_Dis_2014_Jul_17_5(7)_e1333.nxml.txt.nlp	25032856	SENT43	4	4	11	11	candesartan	EAAC1	PA448765	6505	0.602
NULL	Contemp_Oncol_(Pozn)_2012_Nov_20_16(5)_401-406.nxml.txt.nlp	23788917	SENT95	29	29	25	25	neratinib	EGFR	PA165291472	1956	0.602
NULL	Case_Rep_Hematol_2012_Dec_12_2012_180204.nxml.txt.nlp	23304578	SENT38	8	8	3	3	cyclophosphamide	CHOP	PA449165	1649	0.602
NULL	Indian_J_Med_Res_2014_Aug_140(2)_209-215.nxml.txt.nlp	25297352	SENT19	0	0	2	2	clobazam	CLB	PA10888	171425	0.602
NULL	Biochim_Biophys_Acta_2013_Nov_1831(11)_1600-1608.nxml.txt.nlp	23867907	SENT38	7	7	9	9	lipase	ATGL	PA450239	57104	0.602
NULL	J_Inflamm_(Lond)_2004_Sep_30_1_3.nxml.txt.nlp	15813980	SENT90	11	11	16	16	tranilast	p53	PA131890628	7157	0.602
NULL	J_Adv_Pharm_Technol_Res_2012_Oct-Dec_3(4)_202-209.nxml.txt.nlp	23378940	SENT127	13	13	8	8	aprepitant	CYP3A4	PA164747039	1576	0.602
NULL	Curr_Opin_Microbiol_2014_Apr_18(100)_16-22.nxml.txt.nlp	24607989	SENT95	22	22	14	14	vancomycin	PTG	PA451850	5507	0.602
NULL	Crit_Care_2010_Aug_3_14(4)_R145.nxml.txt.nlp	20682036	SENT54	8	8	18	18	fluorescein	San	PA164746009	80218	0.602
NULL	Cell_Death_Dis_2013_Jul_11_4(7)_e719.nxml.txt.nlp	23846221	SENT71	19	19	17	17	cisplatin	TRAIL	PA449014	8743	0.602
NULL	J_Exp_Med_2003_Aug_4_198(3)_505-512.nxml.txt.nlp	12900524	SENT141	13	13	25	25	heparin	CCL21	PA449855	6366	0.602
NULL	J_Korean_Med_Sci_2006_Dec_31_21(6)_1037-1040.nxml.txt.nlp	17179683	SENT86	13	13	8	8	amoxicillin	BAM	PA448406	9126	0.602
NULL	Cancers_(Basel)_2012_Oct_12_4(4)_989-1035.nxml.txt.nlp	24213498	SENT450	1	1	9	9	gemcitabine	ABCG2	PA449748	9429	0.602
NULL	Case_Rep_Nephrol_Urol_2012_Oct_24_2(2)_145-151.nxml.txt.nlp	23197970	SENT131	6	6	12	12	cefazolin	CTX	PA448839	1593	0.602
NULL	Diabetes_2009_Jan_58(1)_243-249.nxml.txt.nlp	18840785	SENT193	35	35	31	31	glucose	GLP-1	PA449773	100125288	0.602
NULL	Brain_Behav_2013_Mar_6_3(2)_114-133.nxml.txt.nlp	23533150	SENT13	39	39	24	24	ethanol	HSF1	PA448073	3297	0.602
NULL	Front_Cell_Neurosci_2015_Jan_15_8_459.nxml.txt.nlp	25642166	SENT76	2	2	5	5	hemin	HO-1	PA449849	3162	0.602
NULL	ScientificWorldJournal_2013_Oct_1_2013_265234.nxml.txt.nlp	24235880	SENT43	20	20	40	40	doxazosin	PC-3	PA449407	692094	0.602
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT180	25	25	6	6	perifosine	NAC	PA165291471	22861	0.602
NULL	Drug_Saf_2014_Feb_19_37(4)_201-211.nxml.txt.nlp	24550106	SENT69	27	27	25	25	ritonavir	CYP3A4	PA451260	1576	0.602
NULL	Ann_Dermatol_2012_Nov_8_24(4)_482-484.nxml.txt.nlp	23197922	SENT23	3	3	9	9	imiquimod	IL-8	PA449972	3576	0.602
NULL	Br_J_Cancer_1999_Mar_79(9-10)_1356-1365.nxml.txt.nlp	10188876	SENT8	26	26	5	5	vincristine	KAR	PA451879	51144	0.602
NULL	Arch_Toxicol_2014_Nov_5_88(12)_2135-2190.nxml.txt.nlp	25370008	SENT1285	23	23	11	11	4-methylumbelliferone	FTM	PA154081778	23322	0.602
NULL	Behav_Brain_Funct_2014_Jun_16_10_21.nxml.txt.nlp	24934302	SENT168	0	0	8	8	rosiglitazone	p65	PA451283	5970	0.602
NULL	Emerg_Infect_Dis_2012_Feb_18(2)_302-304.nxml.txt.nlp	22305387	SENT113	36	36	10	10	atovaquone	CTX	PA448502	1593	0.602
NULL	Cell_Commun_Signal_2010_Jun_12_8_11.nxml.txt.nlp	20540792	SENT334	28	28	31	31	thalidomide	CRBN	PA451644	51185	0.602
NULL	Acta_Neuropathol_Commun_2014_Oct_21_2(1)_134.nxml.txt.nlp	NULL	SENT112	13	13	28	28	l-glutamine	CO2	PA10090	4513	0.602
NULL	Acta_Neuropathol_Commun_2014_Sep_2_2(1)_101.nxml.txt.nlp	NULL	SENT71	12	12	14	14	paraformaldehyde	PLP	PA450790	25824;5744	0.602
NULL	Diabetes_Metab_J_2013_Apr_16_37(2)_113-116.nxml.txt.nlp	23641351	SENT44	11	11	18	18	metformin	AMPK	PA450395	5563	0.602
NULL	Support_Care_Cancer_2009_Sep_10_17(9)_1187-1193.nxml.txt.nlp	19205754	SENT200	4	4	9	9	aprepitant	CYP2D6	PA164747039	1565	0.602
NULL	J_Invest_Dermatol_2014_Mar_13_134(3)_791-800.nxml.txt.nlp	24037342	SENT113	28	28	9	9	glutaraldehyde	p53	PA449777	7157	0.602
NULL	Eur_J_Clin_Pharmacol_2011_May_8_67(5)_493-506.nxml.txt.nlp	21140139	SENT230	21	21	11	11	oxycodone	CYP3A4	PA450741	1576	0.602
NULL	Exp_Ther_Med_2013_Mar_21_5(3)_987-991.nxml.txt.nlp	23407636	SENT11	0	0	12	12	losartan	CXCR1	PA450268	3577	0.602
NULL	Cell_Death_Dis_2014_Mar_13_5(3)_e1126.nxml.txt.nlp	24625985	SENT13	22	22	2	2	bortezomib	URI	PA10252	8725	0.602
NULL	ScientificWorldJournal_2012_Sep_17_2012_637953.nxml.txt.nlp	23028251	SENT503	34	34	6	6	midazolam	CYP3A4	PA450496	1576	0.602
NULL	Diabetes_2013_Sep_15_62(9)_3275-3281.nxml.txt.nlp	23674605	SENT28	15	15	5	5	chymotrypsin	CTRB1	PA448994	1504	0.602
NULL	Bioinformation_2012_Jan_6_8(1)_13-19.nxml.txt.nlp	22359429	SENT141	10	10	17	17	curcumin	MRP1	PA151958596	4437	0.602
NULL	Acta_Pharmacol_Sin_2012_Jan_3_33(1)_49-56.nxml.txt.nlp	22212430	SENT38	8	8	11	11	thrombin	PAR-1	PA451674	2011;2149	0.602
NULL	Adipocyte_2014_Jan_1_3(1)_1-3.nxml.txt.nlp	24575362	SENT20	22	22	27	27	glucose	ERK	PA449773	5594	0.602
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT251	29	29	23	23	pemetrexed	UNG	PA10810	7374	0.602
NULL	Comp_Hepatol_2004_Jan_14_3(Suppl_1)_S31.nxml.txt.nlp	14960183	SENT98	6	6	11	11	ethanol	TNF-alpha	PA448073	7124	0.602
NULL	Oncotarget_2013_Dec_21_5(9)_2404-2417.nxml.txt.nlp	24811221	SENT15	6	6	8	8	bleomycin	BLM	PA448645	641	0.602
NULL	Nat_Med_2011_Oct_23_17(11)_1490-1497.nxml.txt.nlp	22019885	SENT25	33	33	35	35	thrombin	PAR1	PA451674	79581;2149	0.602
NULL	Mol_Biol_Cell_2012_Jun_1_23(11)_2017-2027.nxml.txt.nlp	22496424	SENT114	43	43	17	17	warfarin	PRDX4	PA451906	10549	0.602
NULL	Int_J_Mol_Sci_2014_Jun_25_15(7)_11234-11244.nxml.txt.nlp	24968266	SENT63	2	2	5	5	docetaxel	PC-3	PA449383	692094	0.602
NULL	Anal_Chem_2014_Jan_7_86(1)_443-452.nxml.txt.nlp	24313826	SENT85	35	35	24	24	diazepam	N-myc	PA449283	4613	0.602
NULL	Oncogene_2010_Sep_9_29(36)_5048-5060.nxml.txt.nlp	20639907	SENT211	22	22	18	18	cisplatin	TRAIL	PA449014	8743	0.602
NULL	Arthritis_Res_Ther_2004_Mar_8_6(2)_60-72.nxml.txt.nlp	15059266	SENT286	7	7	31	31	heparin	PTX3	PA449855	5806	0.602
NULL	Orphanet_J_Rare_Dis_2014_Jun_5_9_79.nxml.txt.nlp	24898617	SENT171	9	9	14	14	resveratrol	CPT2		1376	0.602
NULL	Cancer_Res_Treat_2015_Jan_25_47(1)_46-54.nxml.txt.nlp	25327492	SENT123	25	25	22	22	cisplatin	CRT	PA449014	811	0.602
NULL	J_Hematol_Oncol_2008_Nov_7_1_22.nxml.txt.nlp	18992162	SENT56	34	34	23	23	carboplatin	pT1	PA448803	58492	0.602
NULL	Biol_Proced_Online_2001_Dec_3_3_35-42.nxml.txt.nlp	12734581	SENT76	16	16	26	26	collagenase	CO2	PA449107	4513	0.602
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_P64.nxml.txt.nlp	NULL	SENT16	40	40	16	16	cefuroxime	PPL	PA448868	5493	0.602
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT110	1	1	28	28	curcumin	cIAP1	PA151958596	329	0.602
NULL	Evid_Based_Complement_Alternat_Med_2013_Nov_26_2013_156574.nxml.txt.nlp	24379885	SENT55	11	11	13	13	nifedipine	NIF	PA450631	6280	0.602
NULL	Biochemistry_2008_Jun_10_47(23)_6242-6250.nxml.txt.nlp	18470998	SENT45	17	17	11	11	coumarin	p53	PA134521193	7157	0.602
NULL	Ann_Pediatr_Cardiol_2013_Jan-Jun_6(1)_101-104.nxml.txt.nlp	23626452	SENT129	0	0	8	8	warfarin	LARGE	PA451906	9215	0.602
NULL	Br_J_Cancer_2010_Aug_24_103(5)_649-655.nxml.txt.nlp	20664591	SENT244	4	4	20	20	cisplatin	GEM	PA449014	2669	0.602
NULL	Int_J_Biol_Sci_2011_May_24_7(5)_664-672.nxml.txt.nlp	21647249	SENT104	34	34	14	14	tamoxifen	HER2	PA451581	2064	0.602
NULL	J_Cell_Mol_Med_2013_Oct_16_17(10)_1261-1270.nxml.txt.nlp	23855452	SENT213	4	4	6	6	gemcitabine	GEM	PA449748	2669	0.602
NULL	Ann_Saudi_Med_2011_Jul-Aug_31(4)_402-406.nxml.txt.nlp	21727749	SENT26	14	14	8	8	vildagliptin	GLP-1	PA165958346	100125288	0.602
NULL	Braz_J_Med_Biol_Res_2013_Feb_1_46(2)_171-177.nxml.txt.nlp	23369979	SENT26	0	0	8	8	enalapril	IL-6	PA449456	3569	0.602
NULL	Front_Aging_Neurosci_2014_Sep_11_6_218.nxml.txt.nlp	25309423	SENT161	2	2	17	17	resveratrol	HO-1		3162	0.602
NULL	J_Lipid_Res_2014_Dec_55(12)_2562-2575.nxml.txt.nlp	25316883	SENT25	11	11	18	18	lipase	CGI-58	PA450239	51099	0.602
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Apr_15_9_13.nxml.txt.nlp	20398300	SENT97	23	23	18	18	amoxicillin	LAM	PA448406	7249;7248	0.602
NULL	Osteoarthritis_Cartilage_2013_Sep_21(9)_1336-1345.nxml.txt.nlp	23973148	SENT163	3	3	27	27	triamcinolone	MIA	PA451749	8190	0.602
NULL	Nat_Biotechnol_2010_Mar_14_28(3)_249-255.nxml.txt.nlp	20160716	SENT168	35	35	3	3	meclizine	HIF-1	PA450338	29072	0.602
NULL	Mediators_Inflamm_2010_Jun_21_2010_194896.nxml.txt.nlp	20652055	SENT194	0	0	4	4	berberine	mol	PA165860812	90527	0.602
NULL	Int_J_Mol_Sci_2012_Aug_10_13(8)_9971-9979.nxml.txt.nlp	22949842	SENT29	3	3	5	5	lipase	PPL	PA450239	5493	0.602
NULL	Evid_Based_Complement_Alternat_Med_2013_Mar_28_2013_845172.nxml.txt.nlp	23606892	SENT177	5	5	7	7	lipase	HSL	PA450239	3991	0.602
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT333	16	16	9	9	risperidone	PRL	PA451257	5617	0.602
NULL	Diabetes_Care_2009_Sep_28_32(9)_1649-1655.nxml.txt.nlp	19478198	SENT139	2	2	19	19	metformin	UTI	PA450395	259	0.602
NULL	Mucosal_Immunol_2014_May_16_7(3)_589-601.nxml.txt.nlp	24129165	SENT7	15	15	26	26	dextran	IL10	PA449261	3586	0.602
NULL	Expert_Rev_Anti_Infect_Ther_2013_Dec_11_11(12)_1303-1332.nxml.txt.nlp	24191955	SENT446	12	12	14	14	azithromycin	San	PA448519	80218	0.602
NULL	Mol_Cancer_2013_May_24_12_47.nxml.txt.nlp	23705854	SENT95	5	5	8	8	celecoxib	P-gp	PA448871	5243	0.602
NULL	Clin_Dev_Immunol_2011_Oct_20_2011_947858.nxml.txt.nlp	22046194	SENT134	23	23	32	32	dasatinib	IFN	PA162372878	3439	0.602
NULL	J_Lipid_Res_2013_Feb_54(2)_425-435.nxml.txt.nlp	23220585	SENT5	2	2	4	4	lipase	ATGL	PA450239	57104	0.602
NULL	Endocr_Connect_2012_Jun_8_1(1)_1-12.nxml.txt.nlp	23781298	SENT8	4	4	12	12	fenofibrate	adiponectin	PA449594	9370	0.602
NULL	Neuropsychopharmacology_2009_Jul_25_34(8)_1968-1978.nxml.txt.nlp	19322168	SENT31	13	13	19	19	clozapine	PI3K	PA449061	5290	0.602
NULL	Front_Aging_Neurosci_2009_Nov_27_1_2.nxml.txt.nlp	20552053	SENT1412	0	0	5	5	nimodipine	CA1	PA450633	759	0.602
NULL	Diabetes_Care_2011_Jun_20_34(6)_1406-1411.nxml.txt.nlp	21515837	SENT29	12	12	27	27	glucose	LVM	PA449773	23209	0.602
NULL	BMB_Rep_2013_Nov_46(11)_555-560.nxml.txt.nlp	24152914	SENT62	38	38	31	31	penicillamine	DDC	PA450840	1644	0.602
NULL	J_Carcinog_2012_Aug_30_11_11.nxml.txt.nlp	23230390	SENT149	25	25	23	23	gemcitabine	ACR	PA449748	49	0.602
NULL	Cell_Death_Dis_2010_Nov_18_1(11)_e102.nxml.txt.nlp	21368867	SENT95	3	3	0	0	gentamicin	CLIMP-63	PA449753	10970	0.602
NULL	Orphanet_J_Rare_Dis_2012_Apr_19_7_21.nxml.txt.nlp	22515166	SENT213	7	7	20	20	bezafibrate	OAT	PA162364313	4942	0.602
NULL	Osong_Public_Health_Res_Perspect_2014_Dec_13_5(6)_333-338.nxml.txt.nlp	25562041	SENT207	18	18	8	8	cefoxitin	CTX	PA448856	1593	0.602
NULL	Clin_Mol_Hepatol_2014_Sep_25_20(3)_283-290.nxml.txt.nlp	25320732	SENT138	12	12	0	0	propranolol	PPN	PA451145	64840	0.602
NULL	Exp_Diabetes_Res_2012_Dec_6_2012_386041.nxml.txt.nlp	23304116	SENT149	23	23	12	12	glucose	ROS	PA449773	6098	0.602
NULL	Amino_Acids_2012_Oct_10_43(4)_1751-1759.nxml.txt.nlp	22407485	SENT145	23	23	1	1	carrageenan	DAG	PA448814	1605	0.602
NULL	Pharmaceuticals_(Basel)_2012_Aug_17_5(8)_837-852.nxml.txt.nlp	24280677	SENT481	9	9	12	12	capsaicin	TRPV1	PA448776	7442	0.602
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT315	0	0	3	3	cisplatin	p53	PA449014	7157	0.602
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT69	12	12	14	14	curcumin	TRAIL	PA151958596	8743	0.602
NULL	Hum_Genomics_2013_Apr_5_7(1)_10.nxml.txt.nlp	23561625	SENT328	20	20	15	15	flavopiridol	CDK7	PA452627	1022	0.602
NULL	Aging_(Albany_NY)_2009_Jul_30_1(7)_669-673.nxml.txt.nlp	20157548	SENT61	0	0	20	20	resveratrol	TORC2		200186	0.601
NULL	Front_Endocrinol_(Lausanne)_2011_Nov_10_2_65.nxml.txt.nlp	22649380	SENT11	10	10	12	12	vasopressin	AVP	PA451858	114548;551	0.601
NULL	Oncoimmunology_2013_Feb_1_2(2)_e23079.nxml.txt.nlp	23525192	SENT159	11	11	13	13	cyclophosphamide	CTX	PA449165	1593	0.601
NULL	Indian_J_Med_Res_2012_Jul_136(1)_54-59.nxml.txt.nlp	22885264	SENT92	0	0	6	6	cisplatin	IFN	PA449014	3439	0.601
NULL	Infect_Drug_Resist_2013_Sep_18_6_99-114.nxml.txt.nlp	24082790	SENT237	10	10	8	8	vancomycin	MSRA	PA451850	4482	0.601
NULL	Acta_Oncol_2014_Oct_9_53(10)_1347-1355.nxml.txt.nlp	24909504	SENT11	3	3	42	42	doxorubicin	TP53	PA449412	7157	0.601
NULL	Diabetes_Care_2013_Dec_13_36(12)_3930-3937.nxml.txt.nlp	23990523	SENT72	15	15	10	10	glucose	adiponectin	PA449773	9370	0.601
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT220	2	2	17	17	sulindac	GAPDH	PA451565	2597	0.601
NULL	Int_J_Anal_Chem_2013_Jul_16_2013_419716.nxml.txt.nlp	23956748	SENT100	1	1	45	45	heparin	PF6	PA449855	200162	0.601
NULL	Int_J_Environ_Res_Public_Health_2014_Aug_31_11(8)_7725-7739.nxml.txt.nlp	25089777	SENT151	37	37	39	39	diethylstilbestrol	DES	PA449307	1674	0.601
NULL	J_Cell_Mol_Med_2014_Apr_20_18(4)_709-720.nxml.txt.nlp	24444314	SENT246	16	16	33	33	nadh	SIRT1	PA164755085	23411	0.601
NULL	Anal_Bioanal_Chem_2011_Jul_15_401(1)_305-313.nxml.txt.nlp	21573846	SENT166	6	6	8	8	estradiol	Gen	PA449503	348654	0.601
NULL	J_Gynecol_Oncol_2014_Oct_7_25(4)_355-356.nxml.txt.nlp	25310036	SENT39	2	2	4	4	carboplatin	GEM	PA448803	2669	0.601
NULL	J_Oncol_2012_Oct_5_2012_794172.nxml.txt.nlp	22007215	SENT13	0	0	2	2	cyclophosphamide	CTX	PA449165	1593	0.601
NULL	Nucleic_Acids_Res_2013_Nov_16_41(20)_9349-9360.nxml.txt.nlp	23956219	SENT165	20	20	7	7	cisplatin	RMI1	PA449014	80010	0.601
NULL	Adv_Appl_Bioinforma_Chem_2009_Dec_3_2_125-138.nxml.txt.nlp	21918620	SENT160	0	0	3	3	camptothecin	NIK	PA153590860	9020;9448	0.601
NULL	Cells_2014_May_23_3(2)_517-545.nxml.txt.nlp	24861977	SENT927	4	4	6	6	capsaicin	TRPV1	PA448776	7442	0.601
NULL	Cancer_Cell_Int_2010_May_11_10_16.nxml.txt.nlp	20459793	SENT88	2	2	4	4	cisplatin	ABCC6	PA449014	368	0.601
NULL	Clin_Infect_Dis_2012_Aug_1_55(Suppl_2)_S132-S142.nxml.txt.nlp	22752862	SENT152	27	27	25	25	vancomycin	VAN	PA451850	10318	0.601
NULL	Mar_Drugs_2009_Aug_26_7(3)_401-434.nxml.txt.nlp	19841722	SENT312	2	2	5	5	s-adenosylmethionine	ODC	PA164754994	4953;89874	0.601
NULL	Front_Neurosci_2013_Jun_13_7_108.nxml.txt.nlp	23781171	SENT91	0	0	10	10	allopregnanolone	PGRMC1	PA142320763	10857	0.601
NULL	Cough_2005_Oct_19_1_10.nxml.txt.nlp	16270907	SENT8	0	0	5	5	omeprazole	GOR	PA450704	254958	0.601
NULL	Indian_J_Endocrinol_Metab_2012_Dec_16(Suppl_2)_S239-S241.nxml.txt.nlp	23565388	SENT63	23	23	25	25	exenatide	CD25	PA164749238	3669;3559	0.601
NULL	Behav_Brain_Funct_2005_Aug_9_1_14.nxml.txt.nlp	16091141	SENT347	19	19	22	22	chlorpromazine	CPZ	PA448964	8532	0.601
NULL	Ann_Dermatol_2011_Nov_3_23(4)_529-535.nxml.txt.nlp	22148028	SENT29	9	9	7	7	cyclophosphamide	CHOP	PA449165	1649	0.601
NULL	J_Korean_Med_Sci_2014_Jul_11_29(7)_965-972.nxml.txt.nlp	25045229	SENT93	11	11	15	15	metformin	B12	PA450395	7126;4709	0.601
NULL	Evid_Based_Complement_Alternat_Med_2011_Feb_10_2011_815390.nxml.txt.nlp	19752167	SENT134	28	28	10	10	hydrocortisone	IL-2	PA449905	3558	0.601
NULL	Indian_J_Anaesth_2013_May-Jun_57(3)_248-252.nxml.txt.nlp	23983282	SENT53	12	12	26	26	halothane	CO2	PA449845	4513	0.601
NULL	Acta_Pharmacol_Sin_2009_Oct_21_30(10)_1392-1398.nxml.txt.nlp	19767766	SENT55	20	20	24	24	atorvastatin	NAC	PA448500	22861	0.601
NULL	Int_J_Environ_Res_Public_Health_2013_Sep_12_10(9)_4274-4305.nxml.txt.nlp	24036486	SENT55	23	23	17	17	imipenem	EPM	PA449968	2054	0.601
NULL	Clin_Pharmacokinet_2014_Nov_9_53(3)_283-293.nxml.txt.nlp	24214317	SENT192	4	4	8	8	probenecid	OAT1	PA451106	9356	0.601
NULL	Antimicrob_Agents_Chemother_2014_Oct_58(10)_5900-5908.nxml.txt.nlp	25070091	SENT238	21	21	13	13	metoprolol	CYP2D6	PA450480	1565	0.601
NULL	Acta_Pharmacol_Sin_2013_Jun_8_34(6)_830-836.nxml.txt.nlp	23564080	SENT141	2	2	6	6	simvastatin	HMGB1	PA451363	3146	0.601
NULL	Saudi_J_Anaesth_2013_Jan-Mar_7(1)_68-74.nxml.txt.nlp	23717236	SENT34	22	22	18	18	granisetron	5-HT4	PA449809	3360	0.601
NULL	J_Biomed_Biotechnol_2004_Apr_27_2004(1)_52-60.nxml.txt.nlp	15123888	SENT108	12	12	14	14	genistein	Gen	PA165109660	348654	0.601
NULL	Int_J_Environ_Res_Public_Health_2012_Sep_19_9(9)_3354-3364.nxml.txt.nlp	23202692	SENT113	8	8	12	12	resveratrol	CYP2E1		1571	0.601
NULL	Br_J_Cancer_2013_Jul_9_109(1)_1-7.nxml.txt.nlp	23736035	SENT98	27	27	31	31	tamoxifen	STAR	PA451581	6770;2984	0.601
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT59	18	18	14	14	adalimumab	CD36	PA10004	948	0.601
NULL	Onco_Targets_Ther_2014_Nov_27_7_2175-2181.nxml.txt.nlp	25473300	SENT24	3	3	32	32	bevacizumab	HER2	PA130232992	2064	0.601
NULL	Nucleic_Acids_Res_2005_Jun_8_33(10)_3283-3291.nxml.txt.nlp	15944449	SENT96	4	4	13	13	sjg-136	XPB		2071	0.601
NULL	Ann_Clin_Transl_Neurol_2014_Sep_29_1(9)_650-658.nxml.txt.nlp	25493279	SENT45	2	2	16	16	cyclophosphamide	IFN	PA449165	3439	0.601
NULL	J_Korean_Assoc_Oral_Maxillofac_Surg_2014_Dec_26_40(6)_291-296.nxml.txt.nlp	25551094	SENT121	1	1	12	12	alendronate	RANKL	PA448082	8600	0.601
NULL	EMBO_Mol_Med_2009_Jul_1(4)_236-248.nxml.txt.nlp	20049725	SENT252	7	7	1	1	forskolin	NF1	PA146096022	4763	0.601
NULL	AIDS_Res_Ther_2011_Oct_6_8_36.nxml.txt.nlp	21978457	SENT11	7	7	13	13	zinc	ZIP1	PA451956	27173	0.601
NULL	Cancer_Causes_Control_2013_Aug_18_24(8)_1605-1614.nxml.txt.nlp	23775025	SENT228	12	12	7	7	cyclophosphamide	CYP2C19	PA449165	1557	0.601
NULL	Front_Neurol_2014_Sep_11_5_173.nxml.txt.nlp	25309501	SENT233	22	22	24	24	hyaluronidase	HYAL-1	PA164745713	3373	0.601
NULL	Biologics_2012_Aug_24_6_277-287.nxml.txt.nlp	22956859	SENT283	18	18	33	33	hyaluronidase	PIDD	PA164745713	55367	0.601
NULL	Curr_Hematol_Malig_Rep_2014_Jun_27_9(3)_243-253.nxml.txt.nlp	24969265	SENT255	21	21	6	6	methotrexate	RFC1	PA450428	5981	0.601
NULL	J_Cancer_Prev_2014_Sep_19(3)_153-160.nxml.txt.nlp	25337584	SENT115	2	2	6	6	betaine	ROS	PA448603	6098	0.601
NULL	Cell_Death_Dis_2010_Feb_4_1(2)_e21.nxml.txt.nlp	21364629	SENT119	15	15	32	32	nadh	survivin	PA164755085	332	0.601
NULL	Antiviral_Res_2009_May_82(2)_A99-A109.nxml.txt.nlp	19176219	SENT1108	23	23	1	1	efavirenz	MRP-1	PA449441	928	0.601
NULL	Acta_Pharmacol_Sin_2010_Oct_13_31(10)_1324-1328.nxml.txt.nlp	20835265	SENT99	5	5	27	27	l-arginine	eNOS	PA448478	4846	0.601
NULL	Int_J_Mol_Sci_2012_Sep_26_13(10)_12336-12348.nxml.txt.nlp	23202901	SENT412	11	11	16	16	phenol	P90	PA450913	821	0.601
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT331	38	38	15	15	risperidone	PRL	PA451257	5617	0.601
NULL	Eur_J_Endocrinol_2011_Jan_164(1)_69-74.nxml.txt.nlp	20961967	SENT15	7	7	20	20	pioglitazone	adiponectin	PA450970	9370	0.601
NULL	Diagn_Pathol_2014_Jan_20_9_11.nxml.txt.nlp	24443801	SENT26	15	15	7	7	trypsin	CK19	PA451806	3880	0.601
NULL	Int_J_Mol_Sci_2014_Sep_5_15(9)_15754-15765.nxml.txt.nlp	25198898	SENT47	22	22	5	5	curcumin	NAC	PA151958596	22861	0.601
NULL	Lab_Invest_2012_Dec_8_92(12)_1749-1759.nxml.txt.nlp	23044923	SENT34	22	22	10	10	dextran	MMP10	PA449261	4319	0.601
NULL	Iran_J_Basic_Med_Sci_2012_Mar-Apr_15(2)_709-718.nxml.txt.nlp	23493500	SENT139	10	10	12	12	ns-398	spatial		219793	0.601
NULL	F1000_Biol_Rep_2010_May_24_2_40.nxml.txt.nlp	20948793	SENT45	6	6	3	3	ustekinumab	IL-23	PA166048654	51561	0.601
NULL	Front_Oncol_2014_Apr_9_4_75.nxml.txt.nlp	24782986	SENT231	28	28	8	8	paclitaxel	CA125	PA450761	4077;94025	0.601
NULL	Int_J_Endocrinol_2014_Mar_11_2014_927317.nxml.txt.nlp	24738001	SENT36	26	26	12	12	sitagliptin	GLP-1	PA164748978	100125288	0.601
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1051.nxml.txt.nlp	24503543	SENT144	36	36	15	15	hexachlorophene	Yes	PA449871	7525	0.601
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT74	11	11	13	13	curcumin	TRAIL	PA151958596	8743	0.601
NULL	Br_J_Cancer_2010_Mar_2_102(5)_815-826.nxml.txt.nlp	20145614	SENT289	4	4	28	28	anastrozole	HER2	PA448432	2064	0.601
NULL	Br_J_Cancer_1984_Jun_49(6)_779-786.nxml.txt.nlp	6203548	SENT2	10	10	7	7	bleomycin	ADM	PA448645	133	0.601
NULL	Diabetol_Metab_Syndr_2014_Sep_23_6(1)_102.nxml.txt.nlp	NULL	SENT188	0	0	6	6	atorvastatin	RAGE	PA448500	177	0.601
NULL	J_Cell_Biol_1998_May_18_141(4)_1061-1071.nxml.txt.nlp	9585423	SENT116	17	17	22	22	aprotinin	SDS	PA448472	51119;10993	0.601
NULL	Breast_Cancer_Res_2010_Jun_4_12(3)_R32.nxml.txt.nlp	20525379	SENT10	8	8	3	3	tamoxifen	AGR2	PA451581	10551	0.601
NULL	Cancer_Metab_2013_Feb_4_1_7.nxml.txt.nlp	24280108	SENT180	18	18	16	16	doxycycline	DMK	PA449415	1760	0.601
NULL	Am_J_Med_Genet_A_2012_May_29_158A(5)_1135-1144.nxml.txt.nlp	22473653	SENT195	14	14	3	3	choline	E16	PA448976	8140	0.601
NULL	Int_J_Cardiovasc_Imaging_2012_Apr_21_28(4)_843-853.nxml.txt.nlp	21509430	SENT166	9	9	17	17	iron	spatial	PA450087	219793	0.601
NULL	Asian-Australas_J_Anim_Sci_2013_Nov_26(11)_1518-1522.nxml.txt.nlp	25049736	SENT102	35	35	27	27	taurine	MITF	PA451590	4286	0.601
NULL	EMBO_J_2013_Feb_20_32(4)_511-523.nxml.txt.nlp	23241948	SENT129	3	3	5	5	kanamycin	FRP	PA450137	11167;6422	0.601
NULL	Asian-Australas_J_Anim_Sci_2012_Jan_25(1)_1-16.nxml.txt.nlp	25049471	SENT112	0	0	9	9	estradiol	OXT	PA449503	5020	0.601
NULL	J_Korean_Med_Sci_2006_Dec_31_21(6)_1037-1040.nxml.txt.nlp	17179683	SENT96	4	4	8	8	amoxicillin	BAM	PA448406	9126	0.601
NULL	Curr_Neuropharmacol_2008_Jun_6(2)_151-163.nxml.txt.nlp	19305794	SENT490	5	5	7	7	capsaicin	VR1	PA448776	56664	0.601
NULL	Evid_Based_Complement_Alternat_Med_2013_Aug_28_2013_516017.nxml.txt.nlp	24066014	SENT141	8	8	21	21	doxorubicin	p67phox	PA449412	4688	0.601
NULL	Ital_J_Pediatr_2011_May_14_37_21.nxml.txt.nlp	21569539	SENT39	43	43	31	31	phenol	NAG	PA450913	51594;4669	0.601
NULL	Indian_J_Pharm_Sci_2013_May-Jun_75(3)_270-276.nxml.txt.nlp	24082342	SENT169	9	9	25	25	primaquine	G6PD	PA451103	2539	0.601
NULL	NDT_Plus_2011_Jun_2_4(3)_158-163.nxml.txt.nlp	21629670	SENT11	18	18	20	20	vasopressin	AVP	PA451858	114548;551	0.601
NULL	Oncotarget_2014_Oct_21_5(22)_11709-11722.nxml.txt.nlp	25365944	SENT29	38	38	23	23	metformin	JNK	PA450395	5599	0.601
NULL	Oncogene_2010_Sep_16_29(37)_5193-5203.nxml.txt.nlp	20581867	SENT127	23	23	25	25	lapatinib	HRG	PA152241907	3084;3273	0.601
NULL	AIDS_2014_Mar_13_28(5)_717-725.nxml.txt.nlp	24983542	SENT3	32	32	8	8	maraviroc	CCR5	PA164768835	1234	0.601
NULL	Protein_Cell_2014_Jun_19_5(6)_469-479.nxml.txt.nlp	24748116	SENT162	19	19	5	5	paclitaxel	EB1	PA450761	9167;22919;10982	0.601
NULL	J_Thromb_Haemost_2014_Jul_19_12(7)_1054-1065.nxml.txt.nlp	24766850	SENT207	1	1	11	11	thrombin	FXI	PA451674	2160	0.601
NULL	Brain_Behav_2014_Jul_14_4(4)_468-483.nxml.txt.nlp	25161814	SENT140	1	1	20	20	ethanol	ANOVA	PA448073	4858	0.601
NULL	J_Am_Heart_Assoc_2013_Aug_23_2(4)_e000264.nxml.txt.nlp	23896681	SENT159	23	23	11	11	thrombin	FVIII	PA451674	2157	0.601
NULL	Eur_J_Neurosci_2007_Feb_25(3)_837-846.nxml.txt.nlp	17313573	SENT236	3	3	12	12	colchicine	spatial	PA449092	219793	0.601
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2013_Dec_25_70(Pt_1)_144-154.nxml.txt.nlp	24419387	SENT193	9	9	7	7	l-tyrosine	TYR	PA451822	7299	0.601
NULL	Psychiatry_Investig_2012_Jun_30_9(2)_187-190.nxml.txt.nlp	22707971	SENT65	0	0	2	2	capsaicin	POMC	PA448776	5443	0.601
NULL	J_Geriatr_Cardiol_2013_Jun_10(2)_151-158.nxml.txt.nlp	23888175	SENT222	3	3	8	8	rosuvastatin	AT1	PA134308647	9197;185	0.601
NULL	Cancer_Manag_Res_2012_Nov_9_4_383-395.nxml.txt.nlp	23204869	SENT243	15	15	11	11	carmustine	PC-3	PA448810	692094	0.601
NULL	J_Geriatr_Cardiol_2012_Sep_9(3)_305-317.nxml.txt.nlp	23097661	SENT154	26	26	12	12	lovastatin	FATS	PA450272	118611	0.601
NULL	Cancer_Immunol_Immunother_2012_Jul_23_61(7)_1101-1111.nxml.txt.nlp	22193989	SENT12	1	1	13	13	oxaliplatin	CD86	PA131285527	942	0.601
NULL	Breast_Cancer_Res_Treat_2012_Jul_31_134(1)_199-205.nxml.txt.nlp	22290080	SENT199	19	19	35	35	estradiol	c-fos	PA449503	2353	0.601
NULL	Oxid_Med_Cell_Longev_2013_Mar_21_2013_516051.nxml.txt.nlp	23577223	SENT51	0	0	17	17	fluorescein	San	PA164746009	80218	0.601
NULL	J_Mol_Med_(Berl)_2013_Aug_17_91(11)_1257-1271.nxml.txt.nlp	23955016	SENT131	2	2	7	7	thrombin	C5a	PA451674	727	0.601
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_39-54.nxml.txt.nlp	19305787	SENT123	6	6	14	14	ethanol	NR1	PA448073	27158	0.601
NULL	Clin_Ophthalmol_2011_Oct_31_5_1567-1574.nxml.txt.nlp	22125403	SENT43	16	16	10	10	fluorescein	San	PA164746009	80218	0.601
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT8	0	0	15	15	gefitinib	KRAS	PA131301952	3845	0.601
NULL	Oxid_Med_Cell_Longev_2013_Jun_2_2013_793525.nxml.txt.nlp	23819014	SENT209	15	15	32	32	resveratrol	AMPK		5563	0.601
NULL	Front_Immunol_2012_May_4_3_98.nxml.txt.nlp	22566974	SENT461	28	28	26	26	rituximab	CHOP	PA451261	1649	0.601
NULL	Case_Rep_Med_2013_Dec_4_2013_250716.nxml.txt.nlp	24368917	SENT4	1	1	19	19	ethanol	CYP1A2	PA448073	1544	0.601
NULL	Breast_Cancer_Res_2010_Jun_28_12(3)_R43.nxml.txt.nlp	20579400	SENT253	27	27	31	31	paclitaxel	MAPT	PA450761	4137	0.601
NULL	J_Antimicrob_Chemother_2014_Feb_3_69(2)_343-348.nxml.txt.nlp	24092655	SENT48	19	19	4	4	chloramphenicol	FUS	PA448927	2521	0.601
NULL	Cerebrospinal_Fluid_Res_2010_Aug_13_7_13.nxml.txt.nlp	20707896	SENT221	8	8	6	6	vasopressin	FGF2	PA451858	2247;2258	0.601
NULL	Hum_Genomics_2009_Jan_1_3(2)_169-190.nxml.txt.nlp	19164093	SENT225	9	9	2	2	warfarin	CYP2C9	PA451906	1559	0.601
NULL	Biomed_Res_Int_2014_May_20_2014_309307.nxml.txt.nlp	24967350	SENT125	32	32	42	42	gentamicin	CO2	PA449753	4513	0.601
NULL	Arthritis_Res_Ther_2005_Apr_4_7(4)_R756-R768.nxml.txt.nlp	15987477	SENT115	24	24	15	15	hyaluronidase	PH-20	PA164745713	6677	0.601
NULL	Clin_Microbiol_Infect_2014_Jun_21_20(6)_536-541.nxml.txt.nlp	24107197	SENT137	29	29	19	19	isoniazid	DST	PA450112	667	0.601
NULL	Indian_J_Psychiatry_2010_Jan_52(Suppl1)_S317-S340.nxml.txt.nlp	21836703	SENT115	19	19	24	24	thioproperazine	CPZ	PA164754875	8532	0.601
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT128	13	13	2	2	encainide	CYP2C19	PA449459	1557	0.601
NULL	Mol_Cancer_2013_May_24_12_46.nxml.txt.nlp	23705826	SENT114	18	18	29	29	imatinib	FLT3	PA10804	2322	0.601
NULL	Exp_Ther_Med_2012_Oct_20_4(4)_605-610.nxml.txt.nlp	23170112	SENT41	1	1	18	18	fluorescein	San	PA164746009	80218	0.601
NULL	Infect_Drug_Resist_2012_Aug_8_5_121-127.nxml.txt.nlp	22893749	SENT30	8	8	13	13	ribavirin	gamma	PA451241	9913	0.601
NULL	Infect_Dis_Ther_2014_Dec_5_3(2)_69-81.nxml.txt.nlp	25475412	SENT80	11	11	13	13	teicoplanin	TEC	PA164746244	7006	0.601
NULL	Cancer_Manag_Res_2012_Nov_9_4_383-395.nxml.txt.nlp	23204869	SENT154	11	11	18	18	carmustine	PC-3	PA448810	692094	0.601
NULL	Med_Sci_Monit_2013_May_1_19_317-326.nxml.txt.nlp	23632427	SENT277	48	48	14	14	nitrofurantoin	CTX	PA450640	1593	0.601
NULL	J_Invest_Dermatol_2012_Sep_19_132(9)_2198-2205.nxml.txt.nlp	22513780	SENT80	26	26	19	19	isotretinoin	IL-8	PA450128	3576	0.601
NULL	Br_J_Haematol_2014_Mar_6_164(6)_759-766.nxml.txt.nlp	24387053	SENT107	31	31	11	11	rituximab	PEX	PA451261	5251	0.601
NULL	Biomed_Res_Int_2013_May_27_2013_597282.nxml.txt.nlp	23781504	SENT95	4	4	1	1	cyanocobalamin	B12	PA451892	7126;4709	0.601
NULL	J_Skin_Cancer_2012_Jun_13_2012_410925.nxml.txt.nlp	22745913	SENT100	24	24	21	21	lipase	MGLL	PA450239	11343	0.601
NULL	J_Korean_Med_Sci_2010_Jun_24_25(6)_829-834.nxml.txt.nlp	20514301	SENT107	20	20	11	11	papain	p38	PA450778	10598;1432;7965	0.601
NULL	Leukemia_2013_Apr_14_27(4)_803-812.nxml.txt.nlp	23238589	SENT150	32	32	13	13	imatinib	IFN	PA10804	3439	0.601
NULL	ScientificWorldJournal_2012_Feb_14_2012_402919.nxml.txt.nlp	22448133	SENT341	2	2	0	0	ciprofloxacin	CPX	PA449009	1371;10682;1377	0.601
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT133	38	38	26	26	glucose	EGFR	PA449773	1956	0.601
NULL	Mol_Neurodegener_2011_Aug_8_6_57.nxml.txt.nlp	21819629	SENT241	8	8	13	13	arsenite	TDP-43	PA452638	23435	0.601
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT79	12	12	14	14	curcumin	TRAIL	PA151958596	8743	0.601
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Apr_13_68(Pt_5)_o1347.nxml.txt.nlp	22590243	SENT66	23	23	19	19	ethanol	mol	PA448073	90527	0.601
NULL	Breast_Cancer_Res_2014_Jul_24_16(4)_411.nxml.txt.nlp	25056669	SENT192	10	10	12	12	tamoxifen	CD29	PA451581	3688	0.601
NULL	Diabetes_2009_Apr_58(4)_773-795.nxml.txt.nlp	19336687	SENT693	12	12	14	14	pioglitazone	AMPK	PA450970	5563	0.601
NULL	Allergy_2014_Jul_29_69(7)_817-827.nxml.txt.nlp	24773466	SENT175	7	7	5	5	pitrakinra	IL-4	PA165983754	3565	0.601
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT145	0	0	32	32	dasatinib	LYN	PA162372878	4067	0.601
NULL	Case_Rep_Gastroenterol_2011_Oct_7_5(3)_610-616.nxml.txt.nlp	22110423	SENT50	5	5	1	1	mesalazine	DLST	PA450384	1743	0.601
NULL	Cancers_(Basel)_2009_Dec_15_1(1)_23-28.nxml.txt.nlp	20535236	SENT122	9	9	4	4	cisplatin	SOD1	PA449014	6647	0.601
NULL	Case_Rep_Endocrinol_2012_Oct_14_2012_503290.nxml.txt.nlp	23097726	SENT51	14	14	12	12	cosyntropin	ACTH	PA164749052	5443	0.601
NULL	Exp_Diabetes_Res_2011_Dec_27_2011_604989.nxml.txt.nlp	21253359	SENT72	6	6	35	35	clonidine	INS-1	PA449051	2305	0.601
NULL	Arthritis_Res_Ther_2012_May_17_14(3)_R118.nxml.txt.nlp	22594821	SENT54	20	20	4	4	methotrexate	ACPA	PA450428	5657	0.601
NULL	Int_J_Womens_Health_2012_Apr_12_4_175-183.nxml.txt.nlp	22532781	SENT102	11	11	25	25	levonorgestrel	aromatase	PA450218	1588	0.601
NULL	Oncotarget_2012_Nov_14_3(12)_1557-1565.nxml.txt.nlp	23238683	SENT86	10	10	12	12	ponatinib	CD34	PA165980594	947	0.601
NULL	Front_Physiol_2013_Dec_24_4_386.nxml.txt.nlp	24399968	SENT199	14	14	6	6	glibenclamide	SUR2	PA449782	10060	0.601
NULL	AIDS_Res_Ther_2013_May_1_10_10.nxml.txt.nlp	23634877	SENT187	30	30	11	11	lovastatin	CD4	PA450272	920	0.601
NULL	Protein_Cell_2014_Jun_19_5(6)_469-479.nxml.txt.nlp	24748116	SENT167	22	22	6	6	paclitaxel	EB1	PA450761	9167;22919;10982	0.601
NULL	Oncol_Rep_2013_May_27_29(5)_1707-1713.nxml.txt.nlp	23446822	SENT181	9	9	11	11	tamoxifen	HER2	PA451581	2064	0.601
NULL	Ann_Surg_Oncol_2011_Sep_23_18(9)_2442-2452.nxml.txt.nlp	21347782	SENT44	24	24	31	31	oxaliplatin	APE	PA131285527	55704;328	0.601
NULL	Allergy_Asthma_Clin_Immunol_2011_Nov_10_7(Suppl_1)_S11.nxml.txt.nlp	22165913	SENT139	30	30	25	25	azithromycin	TMP	PA448519	2012	0.601
NULL	Biomed_Res_Int_2014_Feb_6_2014_323594.nxml.txt.nlp	24689036	SENT41	10	10	25	25	raloxifene	PC3	PA451221	57332;7832;5122	0.601
NULL	Cell_Death_Dis_2013_Sep_19_4(9)_e807.nxml.txt.nlp	24052075	SENT72	39	39	10	10	doxorubicin	p63	PA449412	8626	0.601
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Apr_15_9_13.nxml.txt.nlp	20398300	SENT134	16	16	11	11	amoxicillin	LAM	PA448406	7249;7248	0.601
NULL	Ann_Neurol_2013_Feb_31_73(2)_246-258.nxml.txt.nlp	23281025	SENT174	11	11	13	13	riluzole	NRF2	PA451251	2551;4780	0.601
NULL	Breast_Cancer_Res_2012_Jun_7_14(3)_R89.nxml.txt.nlp	22676470	SENT328	7	7	26	26	geldanamycin	Hsp90	PA152031327	3320	0.601
NULL	Br_J_Cancer_2011_Apr_12_104(8)_1256-1261.nxml.txt.nlp	21448165	SENT120	38	38	40	40	sorafenib	IL-2	PA7000	3558	0.601
NULL	Carcinogenesis_2014_May_13_35(5)_1055-1066.nxml.txt.nlp	24419232	SENT158	31	31	23	23	metformin	CTR	PA450395	799	0.601
NULL	Crit_Care_2006_Feb_3_10(1)_R24.nxml.txt.nlp	16469128	SENT131	11	11	15	15	heparin	MARS	PA449855	4141	0.601
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT143	34	34	11	11	perifosine	DR5	PA165291471	8795	0.601
NULL	AIDS_Res_Ther_2013_May_9_10_11.nxml.txt.nlp	23659629	SENT27	15	15	29	29	maraviroc	CXCR4	PA164768835	7852	0.601
NULL	Cancer_Med_2013_Oct_19_2(5)_646-653.nxml.txt.nlp	24403230	SENT94	14	14	9	9	trastuzumab	SESN1	PA451743	27244	0.601
NULL	Exp_Hematol_Oncol_2013_Jan_10_2_2.nxml.txt.nlp	23305345	SENT191	0	0	2	2	bortezomib	BTZ	PA10252	22794	0.601
NULL	Exp_Ther_Med_2014_Mar_19_7(3)_573-578.nxml.txt.nlp	24520247	SENT130	2	2	11	11	dextran	DAI	PA449261	81030	0.601
NULL	Oncotarget_2011_Aug_30_2(8)_610-626.nxml.txt.nlp	21881167	SENT216	30	30	13	13	doxorubicin	Raf-1	PA449412	5894	0.601
NULL	J_Mol_Psychiatry_2013_Nov_4_1(1)_19.nxml.txt.nlp	25408910	SENT76	11	11	5	5	olanzapine	COMT	PA450688	1312	0.601
NULL	Cell_Commun_Signal_2013_Jul_4_11_47.nxml.txt.nlp	23826796	SENT107	9	9	33	33	rolipram	CC2D1A	PA153906323	54862	0.601
NULL	J_Korean_Med_Sci_2013_Dec_26_28(12)_1774-1780.nxml.txt.nlp	24339708	SENT197	32	32	30	30	octreotide	OST	PA450678	1650;23263	0.601
NULL	Br_J_Haematol_2014_Mar_13_164(1)_811-821.nxml.txt.nlp	24328678	SENT83	0	0	8	8	lenalidomide	Aiolos	PA162363968	22806	0.601
NULL	Br_J_Haematol_2011_Jun_153(5)_634-643.nxml.txt.nlp	21477209	SENT164	9	9	2	2	etoposide	TP53	PA449552	7157	0.601
NULL	Oncol_Rep_2013_May_27_29(5)_1785-1788.nxml.txt.nlp	23446853	SENT7	21	21	4	4	methotrexate	p53	PA450428	7157	0.601
NULL	Ann_Thorac_Med_2014_Apr-Jun_9(2)_55-76.nxml.txt.nlp	24791168	SENT724	12	12	30	30	salbutamol	CO2	PA448068	4513	0.601
NULL	Biologics_2009_Jul_13_3_225-232.nxml.txt.nlp	19707411	SENT114	16	16	18	18	rituximab	CTX	PA451261	1593	0.601
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Aug_23_70(Pt_9)_142-144.nxml.txt.nlp	25309163	SENT17	28	28	30	30	ethanol	mol	PA448073	90527	0.601
NULL	J_Cell_Biol_1999_Jan_11_144(1)_175-184.nxml.txt.nlp	9885253	SENT234	3	3	7	7	thrombin	RANTES	PA451674	6352	0.601
NULL	Basic_Res_Cardiol_2010_Nov_20_105(6)_771-785.nxml.txt.nlp	20960209	SENT12	15	15	0	0	cyclosporine	STAT3	PA449167	6774	0.601
NULL	Curr_Opin_Biotechnol_2011_Dec_22(6)_793-799.nxml.txt.nlp	21354781	SENT93	10	10	12	12	lipase	PPL	PA450239	5493	0.601
NULL	Oncol_Lett_2014_Sep_11_8(3)_1222-1228.nxml.txt.nlp	25120693	SENT140	23	23	8	8	cisplatin	XRCC2	PA449014	7516	0.601
NULL	Mult_Scler_Int_2013_Jun_25_2013_627870.nxml.txt.nlp	23878736	SENT350	0	0	10	10	natalizumab	IFN	PA164747191	3439	0.601
NULL	Breast_Cancer_Res_2012_May_18_14(3)_R78.nxml.txt.nlp	22608253	SENT212	0	0	12	12	nilotinib	AIB1	PA165958345	8202	0.601
NULL	Eur_J_Endocrinol_2014_Mar_170(3)_451-459.nxml.txt.nlp	24362411	SENT170	9	9	6	6	orlistat	GLP1	PA164776864	100125288;2641	0.6
NULL	Child_Adolesc_Psychiatry_Ment_Health_2008_Nov_17_2_33.nxml.txt.nlp	19014633	SENT34	28	28	30	30	lipase	MGLL	PA450239	11343	0.6
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_P64.nxml.txt.nlp	NULL	SENT19	16	16	7	7	cefuroxime	PPL	PA448868	5493	0.6
NULL	Clin_Sci_(Lond)_2013_Aug_1_125(Pt_3)_121-130.nxml.txt.nlp	23577635	SENT158	28	28	33	33	lipase	MGL	PA450239	11343	0.6
NULL	Int_J_Mol_Sci_2014_Sep_29_15(10)_17411-17441.nxml.txt.nlp	25268615	SENT337	27	27	0	0	hyaluronan	CD147	PA165958431	682	0.6
NULL	Oncoimmunology_2013_Jan_1_2(1)_e22664.nxml.txt.nlp	23482679	SENT191	16	16	26	26	bevacizumab	EOS	PA130232992	260429	0.6
NULL	Alzheimers_Res_Ther_2013_Jan_3_5(1)_2.nxml.txt.nlp	23286718	SENT53	35	35	14	14	galantamine	APOE	PA449726	348	0.6
NULL	Cell_J_2014_Feb_3_Spring_16(1)_1-10.nxml.txt.nlp	24511574	SENT119	29	29	10	10	ethanol	hole	PA448073	80757	0.6
NULL	Int_J_Endocrinol_2014_Jun_25_2014_534904.nxml.txt.nlp	25053942	SENT21	11	11	20	20	amiodarone	AIT	PA448383	160728	0.6
NULL	Arthritis_Res_Ther_2004_Jun_21_6(Suppl_2)_S12-S18.nxml.txt.nlp	15228616	SENT207	18	18	20	20	infliximab	ACR	PA452639	49	0.6
NULL	Oncol_Lett_2014_Jun_3_7(6)_2083-2088.nxml.txt.nlp	24932293	SENT124	7	7	5	5	cyclophosphamide	CTX	PA449165	1593	0.6
NULL	J_Cell_Mol_Med_2013_Oct_16_17(10)_1261-1270.nxml.txt.nlp	23855452	SENT231	11	11	23	23	doxorubicin	GEM	PA449412	2669	0.6
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Apr_13_69(Pt_5)_o697.nxml.txt.nlp	23723853	SENT73	23	23	19	19	ethanol	mol	PA448073	90527	0.6
NULL	J_Mol_Signal_2009_Apr_28_4_2.nxml.txt.nlp	19400946	SENT149	31	31	33	33	genistein	Gen	PA165109660	348654	0.6
NULL	J_Vet_Med_Sci_2014_Feb_8_76(2)_173-182.nxml.txt.nlp	24107430	SENT14	27	27	16	16	yohimbine	AVP	PA451946	114548;551	0.6
NULL	Cell_Death_Dis_2010_May_13_1(5)_e41.nxml.txt.nlp	21364648	SENT334	10	10	34	34	etoposide	A20	PA449552	7128;28935	0.6
NULL	Oncotarget_2014_Mar_13_5(4)_1101-1110.nxml.txt.nlp	24658355	SENT84	7	7	2	2	tamoxifen	MKP-2	PA451581	1846	0.6
NULL	Physiol_Rep_2014_Sep_11_2(9)_e12146.nxml.txt.nlp	25214523	SENT392	1	1	9	9	pioglitazone	adiponectin	PA450970	9370	0.6
NULL	J_Cell_Biol_1978_Jan_1_76(1)_191-206.nxml.txt.nlp	618892	SENT10	13	13	16	16	dextran	mol	PA449261	90527	0.6
NULL	Case_Rep_Oncol_2011_Nov_22_4(3)_534-541.nxml.txt.nlp	22187539	SENT5	0	0	2	2	gemcitabine	GEM	PA449748	2669	0.6
NULL	FEBS_Open_Bio_2012_Jul_20_2_179-186.nxml.txt.nlp	23650597	SENT142	10	10	8	8	imiquimod	IFN	PA449972	3439	0.6
NULL	Crit_Care_2010_Mar_15_14(2)_R30.nxml.txt.nlp	20226064	SENT286	23	23	12	12	midazolam	IL-6	PA450496	3569	0.6
NULL	Nature_2012_Apr_8_485(7396)_128-132.nxml.txt.nlp	22495310	SENT13	5	5	18	18	cyclosporine	CRTC2	PA449167	200186	0.6
NULL	Chem_Cent_J_2013_Jul_31_7_133.nxml.txt.nlp	23899303	SENT4	0	0	7	7	ciprofloxacin	MOX	PA449009	26002	0.6
NULL	Int_J_Biol_Sci_2005_Dec_1_1(4)_146-151.nxml.txt.nlp	18167569	SENT88	45	45	41	41	zinc	IMAC	PA451956	10344	0.6
NULL	Breast_Cancer_Res_2014_Sep_11_16(5)_430.nxml.txt.nlp	25212826	SENT278	17	17	0	0	fulvestrant	AKT	PA164747170	207	0.6
NULL	Arthritis_Res_Ther_2008_Jul_28_10(4)_R83.nxml.txt.nlp	18662393	SENT93	25	25	9	9	lipase	COL2A1	PA450239	1280	0.6
NULL	Cancer_Metastasis_Rev_2010_Dec_10_29(4)_581-594.nxml.txt.nlp	20830503	SENT313	17	17	9	9	tamoxifen	ATAC	PA451581	6375	0.6
NULL	Oncol_Lett_2013_Feb_30_5(2)_588-592.nxml.txt.nlp	23420263	SENT127	0	0	6	6	lenalidomide	NKX2-1	PA162363968	7080	0.6
NULL	Pak_J_Med_Sci_2013_May-Jun_29(3)_788-792.nxml.txt.nlp	24353629	SENT78	27	27	20	20	ceftazidime	CTX	PA448861	1593	0.6
NULL	Nat_Commun_2014_Nov_19_5_5479.nxml.txt.nlp	25407222	SENT86	5	5	17	17	dextran	YTS	PA449261	8565	0.6
NULL	Mol_Biol_Cell_2012_Sep_15_23(18)_3499-3510.nxml.txt.nlp	22833567	SENT148	13	13	23	23	arsenite	G3BP	PA452638	10146	0.6
NULL	Contemp_Oncol_(Pozn)_2012_Jan_4_16(6)_474-479.nxml.txt.nlp	23788932	SENT100	10	10	16	16	lipase	ADAM29	PA450239	11086	0.6
NULL	Evid_Based_Complement_Alternat_Med_2013_Mar_13_2013_685642.nxml.txt.nlp	23573144	SENT49	30	30	6	6	glimepiride	STZ	PA449761	6484	0.6
NULL	Clinics_(Sao_Paulo)_2013_May_68(5)_694-701.nxml.txt.nlp	23778405	SENT40	20	20	22	22	cisplatin	DDP	PA449014	1678	0.6
NULL	J_Mol_Signal_2008_Dec_1_3_18.nxml.txt.nlp	19046439	SENT23	6	6	21	21	metformin	p53	PA450395	7157	0.6
NULL	Cancer_Res_Treat_2014_Jul_15_46(3)_297-306.nxml.txt.nlp	25038765	SENT24	22	22	6	6	galactose	IL-10	PA449725	3586	0.6
NULL	Oncoimmunology_2013_Jun_1_2(6)_e24677.nxml.txt.nlp	23894722	SENT113	23	23	21	21	cetuximab	CD86	PA10040	942	0.6
NULL	Curr_Neuropharmacol_2013_Jul_11(4)_338-378.nxml.txt.nlp	24381528	SENT329	3	3	13	13	curcumin	BACE1	PA151958596	23621	0.6
NULL	Endocr_Connect_2012_Jun_8_1(1)_1-12.nxml.txt.nlp	23781298	SENT192	18	18	20	20	fenofibrate	adiponectin	PA449594	9370	0.6
NULL	J_Med_Internet_Res_2003_Mar_31_5(1)_e6.nxml.txt.nlp	12746211	SENT43	0	0	2	2	diethylstilbestrol	DES	PA449307	1674	0.6
NULL	Exp_Ther_Med_2014_May_20_7(5)_1354-1358.nxml.txt.nlp	24940438	SENT29	6	6	21	21	dextran	CD14	PA449261	929	0.6
NULL	Ann_Oncol_2009_Aug_20(Suppl_6)_vi41-vi50.nxml.txt.nlp	19617297	SENT51	33	33	23	23	temozolomide	IFN	PA451609	3439	0.6
NULL	Clin_Mol_Hepatol_2014_Dec_24_20(4)_338-344.nxml.txt.nlp	25548738	SENT135	25	25	11	11	boceprevir	IFN	PA165948902	3439	0.6
NULL	Reprod_Biol_Endocrinol_2004_Jul_5_2_49.nxml.txt.nlp	15236653	SENT256	0	0	22	22	estradiol	PGF	PA449503	5228	0.6
NULL	Int_J_Emerg_Med_2011_Aug_30_4_54.nxml.txt.nlp	21878099	SENT10	14	14	23	23	naloxone	NAC	PA450586	22861	0.6
NULL	Environ_Health_Perspect_2006_Apr_21_114(Suppl_1)_101-105.nxml.txt.nlp	16818254	SENT22	12	12	14	14	diethylstilbestrol	DES	PA449307	1674	0.6
NULL	Avicenna_J_Phytomed_2014_May-Jun_4(3)_215-224.nxml.txt.nlp	25050319	SENT115	28	28	0	0	diclofenac	MEPI	PA449293	5276	0.6
NULL	Int_J_Nephrol_2010_Dec_15_2011_194910.nxml.txt.nlp	21197109	SENT50	1	1	3	3	vasopressin	AVP	PA451858	114548;551	0.6
NULL	Environ_Health_Perspect_2005_Aug_10_113(8)_1046-1051.nxml.txt.nlp	16079077	SENT168	10	10	13	13	malathion	p53	PA164748092	7157	0.6
NULL	Ann_Clin_Transl_Neurol_2014_May_17_1(5)_348-360.nxml.txt.nlp	24883337	SENT147	0	0	9	9	betaxolol	ANOVA	PA448611	4858	0.6
NULL	Biomed_Res_Int_2013_Sep_8_2013_843748.nxml.txt.nlp	24083244	SENT99	25	25	27	27	colchicine	CN2	PA449092	55748	0.6
NULL	Cell_Cycle_2012_Nov_1_11(21)_3983-3996.nxml.txt.nlp	22987153	SENT220	41	41	20	20	cisplatin	CtIP	PA449014	5932	0.6
NULL	J_Mol_Signal_2014_Aug_8_9_8.nxml.txt.nlp	25237386	SENT84	7	7	10	10	sc-560	PTGS2		5743	0.6
NULL	Curr_Neuropharmacol_2010_Sep_8(3)_287-304.nxml.txt.nlp	21358978	SENT193	35	35	12	12	agomelatine	5-HT2B	PA165958363	3357	0.6
NULL	J_Korean_Med_Sci_2006_Dec_31_21(6)_1037-1040.nxml.txt.nlp	17179683	SENT86	4	4	8	8	amoxicillin	BAM	PA448406	9126	0.6
NULL	Orphanet_J_Rare_Dis_2006_Sep_14_1_35.nxml.txt.nlp	16972995	SENT122	6	6	11	11	quinidine	PES	PA451209	23481	0.6
NULL	J_Cell_Biol_1983_Jan_1_96(1)_282-285.nxml.txt.nlp	6826648	SENT6	4	4	23	23	thrombin	gamma	PA451674	9913	0.6
NULL	Mol_Cancer_2006_Oct_17_5_45.nxml.txt.nlp	17044934	SENT56	5	5	8	8	resveratrol	AKT		207	0.6
NULL	Exp_Ther_Med_2014_Feb_19_7(2)_389-392.nxml.txt.nlp	24396411	SENT77	2	2	4	4	metformin	AMPK	PA450395	5563	0.6
NULL	Breast_Cancer_Res_Treat_2014_Apr_6_145(1)_33-44.nxml.txt.nlp	24706169	SENT150	32	32	19	19	trastuzumab	HER2	PA451743	2064	0.6
NULL	J_Med_Case_Reports_2011_Mar_28_5_117.nxml.txt.nlp	21443773	SENT137	14	14	6	6	sitagliptin	GLP-1	PA164748978	100125288	0.6
NULL	J_Cell_Biol_2001_Aug_6_154(3)_599-610.nxml.txt.nlp	11481345	SENT318	22	22	24	24	doxycycline	ARF6	PA449415	382	0.6
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT211	36	36	13	13	curcumin	p53	PA151958596	7157	0.6
NULL	Braz_J_Med_Biol_Res_2013_Mar_15_46(3)_299-305.nxml.txt.nlp	23532269	SENT126	2	2	4	4	propofol	CD14	PA451141	929	0.6
NULL	J_Exp_Med_2000_Mar_6_191(5)_761-770.nxml.txt.nlp	10704458	SENT141	9	9	34	34	neomycin	PLP	PA450608	25824;5744	0.6
NULL	Diabetes_Care_2010_Jun_23_33(6)_1344-1346.nxml.txt.nlp	20332349	SENT26	32	32	29	29	celecoxib	COX2	PA448871	4513;5743	0.6
NULL	J_Radiat_Res_2012_Sep_22_53(5)_735-741.nxml.txt.nlp	22843374	SENT121	15	15	9	9	paclitaxel	CRT	PA450761	811	0.6
NULL	Mol_Cancer_2009_Apr_22_8_26.nxml.txt.nlp	19386116	SENT148	5	5	2	2	ritonavir	AKT	PA451260	207	0.6
NULL	Biochem_Res_Int_2012_May_7_2012_395974.nxml.txt.nlp	22611495	SENT236	6	6	13	13	sirolimus	MCP-1	PA451365	6347	0.6
NULL	Breast_Cancer_Res_2010_Nov_16_12(6)_R96.nxml.txt.nlp	21080941	SENT63	27	27	34	34	lapatinib	HRG	PA152241907	3084;3273	0.6
NULL	J_Inflamm_(Lond)_2006_May_4_3_8.nxml.txt.nlp	16674821	SENT14	15	15	23	23	pp2	SKI-1		8720	0.6
NULL	Br_J_Cancer_2010_Jun_29_103(1)_12-17.nxml.txt.nlp	20588278	SENT189	28	28	25	25	carboplatin	mol	PA448803	90527	0.6
NULL	Br_J_Cancer_2010_Jan_5_102(1)_232-233.nxml.txt.nlp	20051962	SENT32	21	21	28	28	bevacizumab	IFN	PA130232992	3439	0.6
NULL	Clin_Epigenetics_2011_May_7_2(2)_249-256.nxml.txt.nlp	22704340	SENT139	7	7	18	18	l-methionine	GAD1	PA450423	2571	0.6
NULL	Evid_Based_Complement_Alternat_Med_2005_Dec_17_2(4)_571.nxml.txt.nlp	NULL	SENT9	24	24	17	17	curcumin	gamma	PA151958596	9913	0.6
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT209	0	0	9	9	nelfinavir	CYP2C19	PA450606	1557	0.6
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Oct_13_68(Pt_11)_o3116.nxml.txt.nlp	23284441	SENT63	31	31	11	11	ethanol	mol	PA448073	90527	0.6
NULL	Cell_Biol_Int_Rep_(2010)_2012_Jun_21_19(1)_e00017.nxml.txt.nlp	23124518	SENT5	30	30	32	32	etoposide	TRAIL	PA449552	8743	0.6
NULL	Behav_Brain_Funct_2009_Feb_28_5_13.nxml.txt.nlp	19250550	SENT291	9	9	7	7	heparin	APOE	PA449855	348	0.6
NULL	Mol_Cancer_2008_Mar_6_7_24.nxml.txt.nlp	18325101	SENT77	18	18	21	21	cisplatin	FANCD2	PA449014	2177	0.6
NULL	Case_Rep_Med_2010_Dec_26_2010_403237.nxml.txt.nlp	21209804	SENT10	4	4	6	6	bortezomib	CHOP	PA10252	1649	0.6
NULL	Aging_(Albany_NY)_2010_Sep_18_2(9)_535-537.nxml.txt.nlp	20876940	SENT15	7	7	12	12	doxorubicin	TP53	PA449412	7157	0.6
NULL	Mol_Cancer_2008_Feb_14_7_20.nxml.txt.nlp	18275607	SENT241	5	5	12	12	rituximab	CHOP	PA451261	1649	0.6
NULL	J_Biol_Chem_2013_Nov_15_288(46)_33049-33059.nxml.txt.nlp	24089524	SENT232	5	5	27	27	nicotine	GATA6	PA450626	2627	0.6
NULL	Arthritis_Rheum_2013_Sep_26_65(9)_2290-2300.nxml.txt.nlp	23740547	SENT57	41	41	26	26	doxycycline	DIP	PA449415	23151;1831	0.6
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2654-2664.nxml.txt.nlp	24136149	SENT140	9	9	5	5	doxorubicin	DNA-PKcs	PA449412	5591	0.6
NULL	Adolesc_Health_Med_Ther_2012_Jun_20_3_85-93.nxml.txt.nlp	24600289	SENT67	20	20	14	14	methotrexate	ACR	PA450428	49	0.6
NULL	Genome_Biol_2011_May_25_12(5)_R46.nxml.txt.nlp	21609475	SENT134	15	15	46	46	etoposide	CCND1	PA449552	595	0.6
NULL	Int_J_Biol_Sci_2013_Dec_22_10(1)_90-102.nxml.txt.nlp	24391455	SENT197	31	31	14	14	mechlorethamine	JNK	PA450336	5599	0.6
NULL	Int_J_Gen_Med_2013_Jun_7_6_453-464.nxml.txt.nlp	23785241	SENT205	12	12	17	17	nedocromil	IL-8	PA450601	3576	0.6
NULL	Case_Rep_Oncol_2012_May_10_5(2)_233-237.nxml.txt.nlp	22679429	SENT82	24	24	26	26	gemcitabine	GEM	PA449748	2669	0.6
NULL	J_Cell_Biol_2005_Nov_21_171(4)_729-738.nxml.txt.nlp	16286510	SENT171	12	12	8	8	heparin	FGF2	PA449855	2247;2258	0.6
NULL	Diabetes_Care_2011_Jun_20_34(6)_1265-1269.nxml.txt.nlp	21515846	SENT156	13	13	7	7	acarbose	STOP	PA448010	4135	0.6
NULL	Biochimie_2014_Jan_96(100)_106-112.nxml.txt.nlp	23827855	SENT5	2	2	4	4	lipase	ATGL	PA450239	57104	0.6
NULL	Neuropsychopharmacology_2009_Apr_2_34(5)_1135-1148.nxml.txt.nlp	18596687	SENT7	7	7	13	13	cocaine	CRF	PA449072	1392;10882	0.6
NULL	J_Neurovirol_2013_Jun_4_19(4)_351-358.nxml.txt.nlp	23733308	SENT144	12	12	7	7	mefloquine	SOC	PA450348	91544	0.6
NULL	Int_J_Surg_Oncol_2012_May_17_2012_406830.nxml.txt.nlp	22675625	SENT196	27	27	23	23	cetuximab	CRT	PA10040	811	0.6
NULL	Cells_2014_May_23_3(2)_517-545.nxml.txt.nlp	24861977	SENT765	4	4	6	6	capsaicin	TRPV1	PA448776	7442	0.6
NULL	Front_Neural_Circuits_2014_Jul_10_8_76.nxml.txt.nlp	25071457	SENT92	0	0	2	2	trimethoprim	TMP	PA451788	2012	0.6
NULL	Cancer_Cell_Int_2013_Feb_8_13_11.nxml.txt.nlp	23394616	SENT129	38	38	11	11	geldanamycin	Hsp90	PA152031327	3320	0.6
NULL	EPMA_J_2013_Jan_28_4(1)_3.nxml.txt.nlp	23356214	SENT350	15	15	26	26	panitumumab	KRAS	PA162373091	3845	0.6
NULL	Breast_Cancer_Res_2014_Sep_12_16(5)_436.nxml.txt.nlp	25213081	SENT311	15	15	12	12	tamoxifen	FOXM1	PA451581	2305	0.6
NULL	Acta_Pharmacol_Sin_2011_Oct_19_32(10)_1294-1302.nxml.txt.nlp	21927013	SENT224	21	21	14	14	tacrolimus	CYP3A4	PA451578	1576	0.6
NULL	J_Korean_Med_Sci_2007_Aug_31_22(4)_677-681.nxml.txt.nlp	17728509	SENT135	18	18	16	16	ethambutol	EMB	PA164784021	133418	0.6
NULL	Ann_Oncol_2009_Nov_23_20(11)_1803-1812.nxml.txt.nlp	19549706	SENT195	6	6	37	37	sunitinib	IFN	PA162372840	3439	0.6
NULL	Clin_Epigenetics_2011_Dec_5_3(1)_8.nxml.txt.nlp	22414275	SENT196	3	3	5	5	ribavirin	ESR1	PA451241	2099	0.6
NULL	Front_Oncol_2013_Apr_17_3_90.nxml.txt.nlp	23616948	SENT175	2	2	4	4	cetuximab	IL-2	PA10040	3558	0.6
NULL	Arthritis_Res_Ther_2010_Apr_12_12(2)_R66.nxml.txt.nlp	20384988	SENT41	3	3	35	35	fluorescein	San	PA164746009	80218	0.6
NULL	Diabetes_2009_Dec_31_58(12)_2851-2862.nxml.txt.nlp	19720788	SENT221	4	4	6	6	forskolin	XIAP	PA146096022	331	0.6
NULL	Carcinogenesis_2012_Nov_8_33(11)_2007-2017.nxml.txt.nlp	22822097	SENT856	6	6	13	13	geldanamycin	p53	PA152031327	7157	0.6
NULL	Cancer_Immunol_Immunother_2008_Jul_7_57(7)_931-950.nxml.txt.nlp	18256831	SENT62	0	0	12	12	cyclophosphamide	IL-2	PA449165	3558	0.6
NULL	Br_J_Cancer_2012_Feb_14_106(4)_685-692.nxml.txt.nlp	22294184	SENT132	15	15	19	19	lovastatin	p38	PA450272	10598;1432;7965	0.6
NULL	Mol_Vis_2012_Jul_18_18_1966-1972.nxml.txt.nlp	22876123	SENT122	0	0	10	10	curcumin	IL-4	PA151958596	3565	0.6
NULL	Nat_Commun_2014_Jul_17_5_4421.nxml.txt.nlp	25030704	SENT37	25	25	27	27	lipase	MGL	PA450239	11343	0.6
NULL	J_Carcinog_2014_Jul_29_13_9.nxml.txt.nlp	25191137	SENT152	22	22	11	11	dextran	Bcl-2	PA449261	596	0.6
NULL	Cancer_Gene_Ther_2011_Oct_29_18(10)_695-706.nxml.txt.nlp	21799529	SENT281	4	4	23	23	chloroquine	TGD	PA448948	19	0.6
NULL	J_Ophthalmol_2012_Aug_27_2012_285851.nxml.txt.nlp	23050121	SENT126	16	16	25	25	latanoprost	BAK	PA164774763	578	0.6
NULL	Exp_Lung_Res_2013_Oct_1_39(8)_336-348.nxml.txt.nlp	23919450	SENT232	0	0	15	15	thrombin	c-Raf	PA451674	5894	0.6
NULL	J_Hematol_Oncol_2013_Nov_5_6_83.nxml.txt.nlp	24283248	SENT8	6	6	11	11	nutlin-3	TP53		7157	0.6
NULL	Nat_Commun_2013_Aug_14_4_2312.nxml.txt.nlp	23942241	SENT233	13	13	19	19	heparin	FGF2	PA449855	2247;2258	0.6
NULL	ScientificWorldJournal_2014_Mar_12_2014_731462.nxml.txt.nlp	24715817	SENT169	7	7	9	9	diclofenac	IL-6	PA449293	3569	0.6
NULL	AIDS_Res_Ther_2014_Oct_2_11(1)_32.nxml.txt.nlp	NULL	SENT38	19	19	4	4	zidovudine	CD4	PA451954	920	0.6
NULL	Br_J_Cancer_2003_Mar_10_88(5)_754-759.nxml.txt.nlp	12618886	SENT78	15	15	4	4	amifostine	p53	PA448365	7157	0.6
NULL	Oncol_Rep_2012_Oct_13_28(4)_1146-1152.nxml.txt.nlp	22797812	SENT102	0	0	7	7	cisplatin	ADM	PA449014	133	0.6
NULL	Iran_J_Microbiol_2013_Mar_5(1)_91-98.nxml.txt.nlp	23467065	SENT177	23	23	18	18	l-arginine	10C	PA448478	64333	0.6
NULL	Mol_Vis_2011_Oct_31_17_2824-2834.nxml.txt.nlp	22128230	SENT183	12	12	14	14	atropine	APO	PA448505	84909	0.6
NULL	Acta_Myol_2011_Jul_30(1)_9-15.nxml.txt.nlp	21842587	SENT193	29	29	12	12	l-arginine	MELAS	PA448478	4219	0.6
NULL	Interdiscip_Toxicol_2011_Mar_4(1)_33-39.nxml.txt.nlp	21577282	SENT194	14	14	17	17	methotrexate	Q10	PA450428	27161	0.6
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT315	25	25	10	10	nelfinavir	ABCG2	PA450606	9429	0.6
NULL	Breast_Cancer_(Auckl)_2011_Apr_13_5_53-65.nxml.txt.nlp	21603258	SENT239	11	11	19	19	docetaxel	HER2	PA449383	2064	0.6
NULL	J_Exp_Bot_2011_Oct_4_62(14)_4787-4803.nxml.txt.nlp	21821598	SENT291	8	8	4	4	mannitol	M6PR	PA450320	4074	0.6
NULL	Curr_Oncol_2009_May_16(3)_8-20.nxml.txt.nlp	19526080	SENT464	14	14	12	12	paclitaxel	castor	PA450761	54897	0.6
NULL	Crit_Care_2013_Mar_1_17(2)_R38.nxml.txt.nlp	23452669	SENT166	28	28	21	21	midazolam	IL-2	PA450496	3558	0.6
NULL	Cancers_(Basel)_2013_Jun_5_5(2)_676-713.nxml.txt.nlp	24216997	SENT278	29	29	10	10	decitabine	MLH1	PA164749631	4292	0.6
NULL	Acta_Vet_Scand_2013_Aug_28_55(1)_61.nxml.txt.nlp	23985065	SENT71	12	12	1	1	chloramphenicol	PEN	PA448927	9933	0.6
NULL	J_Gastroenterol_2014_Apr_17_49(1)_126-137.nxml.txt.nlp	23591768	SENT4	20	20	9	9	ribavirin	IFN	PA451241	3439	0.6
NULL	Case_Rep_Oncol_2012_Aug_9_5(2)_428-433.nxml.txt.nlp	22949905	SENT73	18	18	10	10	cetuximab	KRAS	PA10040	3845	0.6
NULL	Toxins_(Basel)_2011_Jul_15_3(7)_884-899.nxml.txt.nlp	22069745	SENT788	13	13	11	11	urokinase	CD14	PA451836	929	0.6
NULL	Exp_Mol_Med_2012_Nov_30_44(11)_665-673.nxml.txt.nlp	23114424	SENT10	0	0	8	8	taurine	adiponectin	PA451590	9370	0.6
NULL	Front_Genet_2012_Nov_12_3_235.nxml.txt.nlp	23162568	SENT13	0	0	11	11	methamphetamine	CYP2D6	PA450403	1565	0.6
NULL	Mediators_Inflamm_2010_Jun_21_2010_194896.nxml.txt.nlp	20652055	SENT110	12	12	17	17	berberine	CCL2	PA165860812	6347	0.6
NULL	Clin_Pharmacokinet_2014_Sep_3_53(1)_1-16.nxml.txt.nlp	23999929	SENT284	35	35	8	8	rivaroxaban	CYP3A4	PA165958360	1576	0.6
NULL	Cancer_Cell_Int_2012_Jun_6_12_22.nxml.txt.nlp	22672528	SENT119	3	3	9	9	epirubicin	DR4	PA449476	8797	0.6
NULL	Front_Neuroeng_2013_Aug_30_6_7.nxml.txt.nlp	24009582	SENT273	24	24	7	7	ethanol	CO2	PA448073	4513	0.6
NULL	Cell_Cycle_2013_Feb_15_12(4)_625-634.nxml.txt.nlp	23324396	SENT188	10	10	26	26	doxycycline	p53	PA449415	7157	0.6
NULL	Ann_Rehabil_Med_2012_Dec_28_36(6)_857-860.nxml.txt.nlp	23342320	SENT66	33	33	24	24	warfarin	CYP2C9	PA451906	1559	0.6
NULL	Chem_Cent_J_2013_Jul_31_7_133.nxml.txt.nlp	23899303	SENT4	10	10	7	7	norfloxacin	MOX	PA450654	26002	0.6
NULL	Clin_Interv_Aging_2013_Apr_29_8_467-483.nxml.txt.nlp	23766636	SENT191	13	13	27	27	ranibizumab	CRT	PA164746012	811	0.6
NULL	Core_Evid_2010_Oct_21_5_23-37.nxml.txt.nlp	21042540	SENT283	13	13	6	6	saxagliptin	PPG	PA165958362	5552	0.6
NULL	Front_Physiol_2011_Jul_27_2_41.nxml.txt.nlp	21845181	SENT235	19	19	4	4	glucosamine	MD-2	PA164747613	23643	0.6
NULL	Exp_Ther_Med_2013_Feb_20_5(2)_443-447.nxml.txt.nlp	23407364	SENT186	11	11	22	22	cyclophosphamide	ANOVA	PA449165	4858	0.6
NULL	J_Clin_Exp_Pathol_2012_May_17_Suppl_4_7327.nxml.txt.nlp	25379357	SENT204	19	19	9	9	metformin	TSC2	PA450395	7249	0.6
NULL	J_Biol_Chem_2013_Oct_11_288(41)_29642-29653.nxml.txt.nlp	24005673	SENT776	11	11	9	9	hyaluronan	TSG-6	PA165958431	7130	0.6
NULL	Exp_Diabetes_Res_2012_Oct_15_2012_465282.nxml.txt.nlp	23118742	SENT133	20	20	12	12	metformin	FGF21	PA450395	26291	0.6
NULL	Clin_Sci_(Lond)_2011_Nov_1_121(Pt_10)_449-458.nxml.txt.nlp	21671887	SENT202	24	24	28	28	simvastatin	AMPK	PA451363	5563	0.6
NULL	Oncotarget_2013_Aug_30_4(10)_1698-1711.nxml.txt.nlp	24091605	SENT175	18	18	10	10	cisplatin	TIC	PA449014	23550	0.6
NULL	J_Cheminform_2012_Mar_8_4_6.nxml.txt.nlp	22401035	SENT119	3	3	5	5	troglitazone	PPARG	PA451799	5468	0.6
NULL	Int_J_Endocrinol_2014_Mar_11_2014_927317.nxml.txt.nlp	24738001	SENT127	11	11	27	27	sitagliptin	GLP-1	PA164748978	100125288	0.6
NULL	Am_J_Physiol_Endocrinol_Metab_2013_Jul_15_305(2)_E263-E270.nxml.txt.nlp	23715727	SENT4	25	25	30	30	creatine	SLC6A8	PA164778930	6535	0.6
NULL	Oncotarget_2014_Sep_8_5(20)_9851-9863.nxml.txt.nlp	25375205	SENT283	40	40	27	27	l-glutamine	CO2	PA10090	4513	0.6
NULL	Clin_Transl_Allergy_2014_Mar_14_4(Suppl_1)_O19.nxml.txt.nlp	NULL	SENT10	20	20	32	32	fluorescein	CD14	PA164746009	929	0.6
NULL	Int_J_Lab_Hematol_2014_Aug_14_36(4)_431-438.nxml.txt.nlp	24237750	SENT85	23	23	1	1	clopidogrel	ADP	PA449053	23038	0.6
NULL	Acta_Histochem_Cytochem_2009_Apr_28_42(2)_23-28.nxml.txt.nlp	19492024	SENT18	7	7	9	9	diethylstilbestrol	DES	PA449307	1674	0.6
NULL	J_Korean_Med_Sci_2006_Apr_20_21(2)_199-207.nxml.txt.nlp	16614501	SENT33	9	9	13	13	methotrexate	IL-2	PA450428	3558	0.6
NULL	Eur_J_Immunol_2014_Jun_10_44(6)_1759-1769.nxml.txt.nlp	24595810	SENT82	17	17	5	5	fludrocortisone	CD4	PA164743961	920	0.6
NULL	Biologics_2009_Oct_12_3_469-474.nxml.txt.nlp	19851472	SENT5	42	42	18	18	mometasone	IFN	PA450541	3439	0.6
NULL	Front_Microbiol_2012_May_3_3_164.nxml.txt.nlp	22563326	SENT103	4	4	10	10	glucose	PEP	PA449773	5047	0.6
NULL	J_Korean_Med_Sci_2011_Jan_22_26(1)_33-41.nxml.txt.nlp	21218027	SENT169	26	26	35	35	ofloxacin	PTH	PA450684	5741	0.6
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jul_31_66(Pt_8)_o2162-o2163.nxml.txt.nlp	21588446	SENT74	16	16	12	12	ethanol	mol	PA448073	90527	0.6
NULL	Indian_J_Psychiatry_2013_Jul-Sep_55(3)_283-286.nxml.txt.nlp	24082251	SENT56	11	11	2	2	doxylamine	OTC	PA449419	5009	0.6
NULL	Crit_Care_2012_Mar_20_16(Suppl_1)_P516.nxml.txt.nlp	NULL	SENT4	29	29	0	0	ranitidine	SUP	PA451224	9709	0.6
NULL	Cardiovasc_Diabetol_2013_May_30_12(Suppl_1)_S2.nxml.txt.nlp	23819752	SENT169	6	6	12	12	pitavastatin	adiponectin	PA142650384	9370	0.6
NULL	Mol_Cancer_2010_Apr_23_9_87.nxml.txt.nlp	20416058	SENT194	8	8	6	6	doxorubicin	TRAIL	PA449412	8743	0.6
NULL	Biomed_Res_Int_2014_Feb_23_2014_358136.nxml.txt.nlp	24707482	SENT158	16	16	26	26	iodixanol	NGAL	PA164783998	3934	0.6
NULL	Breast_Cancer_Res_2008_Mar_27_10(2)_R27.nxml.txt.nlp	18371219	SENT41	32	32	30	30	paclitaxel	TFEC	PA450761	22797	0.6
NULL	Oncol_Lett_2013_May_15_5(5)_1567-1571.nxml.txt.nlp	23759954	SENT34	14	14	31	31	l-glutamine	CO2	PA10090	4513	0.6
NULL	Dev_Cell_2014_Mar_31_28(6)_659-669.nxml.txt.nlp	24656740	SENT526	8	8	31	31	colchicine	Sas-4	PA449092	55835	0.6
NULL	Soc_Sci_Med_2010_Mar_70(5)_744-753.nxml.txt.nlp	20022680	SENT238	20	20	15	15	l-arginine	B12	PA448478	7126;4709	0.6
NULL	Ann_Hematol_2012_May_11_91(5)_697-703.nxml.txt.nlp	22071570	SENT152	10	10	5	5	etoposide	CHOP	PA449552	1649	0.6
NULL	Adv_Virol_2012_Mar_5_2012_509296.nxml.txt.nlp	22500168	SENT193	12	12	6	6	rituximab	CD21	PA451261	1380	0.6
NULL	Nucleic_Acids_Res_2010_Oct_28_38(19)_6418-6432.nxml.txt.nlp	20511593	SENT231	43	43	21	21	collagenase	AP-1	PA449107	2353;3727;2354;3725	0.6
NULL	Case_Rep_Dermatol_2012_Sep_16_4(3)_256-260.nxml.txt.nlp	23275770	SENT16	11	11	18	18	isotretinoin	OMG	PA450128	4974	0.6
NULL	Nat_Med_2013_Mar_10_19(3)_313-321.nxml.txt.nlp	23396211	SENT132	9	9	11	11	lipase	HSL	PA450239	3991	0.6
NULL	Cell_Death_Dis_2012_Jun_21_3(6)_e330.nxml.txt.nlp	22717585	SENT297	0	0	5	5	simvastatin	ATF6	PA451363	22926	0.6
NULL	Cancer_Cell_Int_2010_Sep_9_10_32.nxml.txt.nlp	20828393	SENT51	1	1	6	6	cisplatin	ATF3	PA449014	467	0.6
NULL	Cancers_(Basel)_2012_Sep_6_4(3)_873-903.nxml.txt.nlp	24213471	SENT1594	8	8	10	10	hyaluronidase	HYAL1	PA164745713	3373	0.6
NULL	Biomed_Res_Int_2014_Jun_26_2014_161346.nxml.txt.nlp	25054130	SENT177	9	9	14	14	curcumin	NOX2	PA151958596	1536	0.6
NULL	Oncol_Rep_2013_Apr_23_29(4)_1268-1274.nxml.txt.nlp	23354756	SENT190	16	16	0	0	epirubicin	SLC25A43	PA449476	203427	0.6
NULL	Gut_Pathog_2012_Jul_16_4_7.nxml.txt.nlp	22800501	SENT75	2	2	8	8	imipenem	CTX	PA449968	1593	0.6
NULL	J_Physiol_2014_Nov_15_592(22)_5093-5107.nxml.txt.nlp	25239460	SENT228	11	11	17	17	sc-560	PAG		55824	0.6
NULL	Acta_Naturae_2013_Jul-Sep_5(3)_92-98.nxml.txt.nlp	24303205	SENT78	39	39	7	7	l-cysteine	MGL	PA449173	11343	0.6
NULL	Core_Evid_2008_Jun_3(1)_31-43.nxml.txt.nlp	20694082	SENT21	1	1	3	3	vasopressin	AVP	PA451858	114548;551	0.599
NULL	Biosci_Rep_2012_Dec_20_33(1)_e00011.nxml.txt.nlp	23137297	SENT141	27	27	6	6	heparin	RPSA	PA449855	3921	0.599
NULL	Int_J_Med_Sci_2013_Mar_1_10(4)_427-433.nxml.txt.nlp	23471472	SENT35	4	4	9	9	entecavir	LAM	PA164784025	7249;7248	0.599
NULL	Iran_J_Public_Health_2012_Jan_31_41(1)_59-65.nxml.txt.nlp	23113123	SENT145	2	2	4	4	lipase	LIPC	PA450239	3990	0.599
NULL	Core_Evid_2011_Sep_8_6_67-79.nxml.txt.nlp	22022289	SENT287	16	16	28	28	pioglitazone	PPG	PA450970	5552	0.599
NULL	Biomed_Res_Int_2013_Jul_18_2013_603782.nxml.txt.nlp	23971041	SENT176	14	14	11	11	travoprost	BAK	PA164781371	578	0.599
NULL	J_Asthma_Allergy_2014_Apr_11_7_53-65.nxml.txt.nlp	24748808	SENT90	17	17	9	9	omalizumab	IL-13	PA164752253	3596	0.599
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT100	21	21	26	26	l-cysteine	4E-BP1	PA449173	1978	0.599
NULL	Mol_Vis_2011_Dec_28_17_3458-3467.nxml.txt.nlp	22219641	SENT65	15	15	6	6	fluorescein	CD29	PA164746009	3688	0.599
NULL	Crit_Care_2009_Feb_6_13(1)_R11.nxml.txt.nlp	19196475	SENT161	39	39	5	5	clonidine	IL-6	PA449051	3569	0.599
NULL	Cancer_Cell_Int_2011_Nov_17_11_40.nxml.txt.nlp	22088142	SENT155	2	2	8	8	gefitinib	MRP1	PA131301952	4437	0.599
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Aug_3_69(Pt_9)_o1376.nxml.txt.nlp	24427020	SENT77	15	15	11	11	ethanol	mol	PA448073	90527	0.599
NULL	Oncol_Lett_2013_Dec_4_6(6)_1665-1672.nxml.txt.nlp	24273604	SENT195	2	2	14	14	chloroquine	TLR9	PA448948	54106	0.599
NULL	Breast_Cancer_Res_2002_Aug_27_4(6)_213-217.nxml.txt.nlp	12473165	SENT126	10	10	7	7	tamoxifen	STAR	PA451581	6770;2984	0.599
NULL	Emerg_Infect_Dis_2014_May_20(5)_910-911.nxml.txt.nlp	24751334	SENT31	32	32	14	14	kanamycin	COT	PA450137	54677	0.599
NULL	Biomed_Res_Int_2013_Jul_8_2013_507103.nxml.txt.nlp	23936812	SENT32	4	4	27	27	curcumin	AP-1	PA151958596	2353;3727;2354;3725	0.599
NULL	Oncol_Lett_2013_Mar_11_5(3)_1010-1016.nxml.txt.nlp	23426784	SENT126	15	15	22	22	midazolam	TRPM7	PA450496	54822	0.599
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT132	19	19	8	8	trastuzumab	HER2	PA451743	2064	0.599
NULL	J_Biomed_Sci_2014_Jul_22_21(1)_65.nxml.txt.nlp	25047949	SENT162	2	2	10	10	docetaxel	PC-3	PA449383	692094	0.599
NULL	J_Neurosci_Methods_2009_Oct_15_183(2)_107-113.nxml.txt.nlp	19524611	SENT327	4	4	11	11	zolpidem	CA1	PA451976	759	0.599
NULL	Mol_Cancer_2009_Jul_31_8_57.nxml.txt.nlp	19646263	SENT207	6	6	8	8	docetaxel	IL-8	PA449383	3576	0.599
NULL	Acta_Pharmacol_Sin_2013_Sep_5_34(9)_1192-1200.nxml.txt.nlp	23685957	SENT188	11	11	13	13	curcumin	AP-2	PA151958596	7020	0.599
NULL	J_Carcinog_2011_Dec_8_10_33.nxml.txt.nlp	22279418	SENT159	8	8	11	11	estradiol	aromatase	PA449503	1588	0.599
NULL	Oncogene_2010_Jul_8_29(27)_3953-3963.nxml.txt.nlp	20440263	SENT160	39	39	18	18	azathioprine	ROS	PA448515	6098	0.599
NULL	Infect_Dis_Rep_2010_Feb_17_2(1)_e2.nxml.txt.nlp	24470885	SENT63	10	10	16	16	ceftriaxone	COT	PA448866	54677	0.599
NULL	Arthritis_Res_Ther_2009_Jan_13_11(1)_R5.nxml.txt.nlp	19134200	SENT191	16	16	6	6	quinacrine	TLR9	PA164745551	54106	0.599
NULL	Cancer_Med_2014_Aug_16_3(4)_927-938.nxml.txt.nlp	24740968	SENT257	7	7	5	5	rituximab	CHOP	PA451261	1649	0.599
NULL	Exp_Ther_Med_2013_Mar_8_5(3)_707-710.nxml.txt.nlp	23404433	SENT97	26	26	28	28	cisplatin	Bcl-2	PA449014	596	0.599
NULL	Arthritis_Res_Ther_2007_Oct_26_9(5)_220.nxml.txt.nlp	18001488	SENT181	0	0	3	3	hyaluronan	CD44	PA165958431	960	0.599
NULL	Cell_Biol_Toxicol_2012_Apr_19_28(2)_69-87.nxml.txt.nlp	22258563	SENT104	20	20	35	35	bupropion	CYP2B6	PA448687	1555	0.599
NULL	Int_J_Mol_Sci_2014_Nov_25_15(12)_21703-21722.nxml.txt.nlp	25429431	SENT808	3	3	16	16	curcumin	STAT3	PA151958596	6774	0.599
NULL	Br_J_Cancer_2013_Jun_25_108(12)_2464-2469.nxml.txt.nlp	23695016	SENT56	11	11	13	13	cisplatin	CRT	PA449014	811	0.599
NULL	Exp_Diabetes_Res_2012_May_28_2012_924168.nxml.txt.nlp	22693487	SENT3	19	19	15	15	liraglutide	GLP-1	PA165958364	100125288	0.599
NULL	Cardiovasc_Diabetol_2011_Dec_22_10_115.nxml.txt.nlp	22189184	SENT15	25	25	6	6	sitagliptin	GLP-1	PA164748978	100125288	0.599
NULL	Mol_Cancer_2010_Dec_20_9_316.nxml.txt.nlp	21172016	SENT163	14	14	24	24	heparin	CCL21	PA449855	6366	0.599
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT54	32	32	25	25	metformin	ADP	PA450395	23038	0.599
NULL	Anal_Bioanal_Chem_2012_Dec_4_404(10)_3071-3080.nxml.txt.nlp	23052869	SENT135	8	8	17	17	pilocarpine	MAX	PA450962	4149	0.599
NULL	Front_Immunol_2012_Feb_27_3_23.nxml.txt.nlp	22566907	SENT475	6	6	10	10	hyaluronan	CD44	PA165958431	960	0.599
NULL	Mar_Drugs_2008_Nov_3_6(4)_595-606.nxml.txt.nlp	19172197	SENT181	14	14	7	7	epirubicin	HER2	PA449476	2064	0.599
NULL	Oncologist_2010_Mar_3_15(3)_216-235.nxml.txt.nlp	20200040	SENT226	0	0	2	2	pazopanib	VEGFR	PA165291492	3791	0.599
NULL	Acta_Pharmacol_Sin_2012_Jul_4_33(7)_897-908.nxml.txt.nlp	22659625	SENT170	39	39	41	41	bleomycin	BLM	PA448645	641	0.599
NULL	Biomed_Res_Int_2013_Jan_21_2013_581631.nxml.txt.nlp	23484133	SENT75	0	0	15	15	infliximab	IL-10	PA452639	3586	0.599
NULL	Int_J_Endocrinol_Metab_2013_Jul_1_Summer_11(3)_184-190.nxml.txt.nlp	24348591	SENT118	0	0	5	5	liraglutide	INS-1	PA165958364	2305	0.599
NULL	AIDS_Res_Ther_2011_Oct_6_8_36.nxml.txt.nlp	21978457	SENT125	32	32	22	22	zinc	TNF	PA451956	7124	0.599
NULL	Mol_Cancer_2013_Nov_13_12_137.nxml.txt.nlp	24225025	SENT199	12	12	31	31	doxorubicin	MRP1	PA449412	4437	0.599
NULL	Cardiovasc_Diabetol_2011_Aug_4_10_72.nxml.txt.nlp	21816063	SENT134	6	6	25	25	allopurinol	MCP-1	PA448320	6347	0.599
NULL	Case_Rep_Pathol_2014_Jul_15_2014_313974.nxml.txt.nlp	25133003	SENT184	33	33	28	28	thyroglobulin	TTF-1	PA164754910	7080	0.599
NULL	Physiol_Rep_2014_Sep_11_2(9)_e12133.nxml.txt.nlp	25214520	SENT121	19	19	40	40	bleomycin	GAPDH	PA448645	2597	0.599
NULL	Biomed_Res_Int_2013_Sep_4_2013_419176.nxml.txt.nlp	24093097	SENT184	22	22	28	28	bevacizumab	IFN	PA130232992	3439	0.599
NULL	Alcohol_Res_Health_2010_33(1-2)_109-117.nxml.txt.nlp	23579941	SENT169	3	3	31	31	estradiol	AVP	PA449503	114548;551	0.599
NULL	Br_J_Cancer_2010_Jan_5_102(1)_1-7.nxml.txt.nlp	19935796	SENT167	6	6	8	8	choline	DAG	PA448976	1605	0.599
NULL	Int_J_Gen_Med_2012_Sep_10_5_753-758.nxml.txt.nlp	23049268	SENT57	12	12	34	34	telmisartan	adiponectin	PA451605	9370	0.599
NULL	Diabetes_2009_Jan_58(1)_104-115.nxml.txt.nlp	18835938	SENT207	0	0	7	7	rosiglitazone	MCP-3	PA451283	6354	0.599
NULL	Blood_Cancer_J_2012_Oct_19_2(10)_e95.nxml.txt.nlp	23085780	SENT117	23	23	20	20	dasatinib	PAH	PA162372878	5053	0.599
NULL	Environ_Health_Perspect_2005_Jun_24_113(6)_680-687.nxml.txt.nlp	15929889	SENT269	7	7	28	28	phenol	SULT1A1	PA450913	6817	0.599
NULL	J_Cell_Biol_2002_Jun_24_157(7)_1151-1160.nxml.txt.nlp	12082077	SENT278	28	28	31	31	trypsin	COX	PA451806	1351	0.599
NULL	J_Korean_Med_Sci_2014_Jul_11_29(7)_965-972.nxml.txt.nlp	25045229	SENT32	5	5	9	9	metformin	B12	PA450395	7126;4709	0.599
NULL	Nat_Med_2011_Oct_23_17(11)_1490-1497.nxml.txt.nlp	22019885	SENT25	33	33	27	27	thrombin	PAR2	PA451674	2150;55065;8856	0.599
NULL	Iran_J_Pharm_Res_2014_Winter_13(1)_243-251.nxml.txt.nlp	24734077	SENT41	44	44	13	13	sulfadiazine	MOX	PA451539	26002	0.599
NULL	J_Mol_Signal_2006_Dec_6_1_8.nxml.txt.nlp	17224083	SENT203	13	13	41	41	thrombin	Rho	PA451674	29984	0.599
NULL	J_Cell_Biol_1997_Mar_10_136(5)_995-1005.nxml.txt.nlp	9060465	SENT46	5	5	7	7	trifluoperazine	TFP	PA451771	7034	0.599
NULL	Am_J_Trop_Med_Hyg_2012_Nov_7_87(5_Suppl)_137-143.nxml.txt.nlp	23136289	SENT141	7	7	1	1	amoxicillin	PKR	PA448406	5610	0.599
NULL	Front_Neurosci_2015_Jan_6_8_437.nxml.txt.nlp	25610366	SENT32	4	4	6	6	pramipexole	PPX	PA164742949	5531	0.599
NULL	Diabetes_Care_2012_Feb_16_35(2)_327-333.nxml.txt.nlp	22179958	SENT60	3	3	7	7	metformin	B12	PA450395	7126;4709	0.599
NULL	Mol_Cancer_2010_Nov_2_9_289.nxml.txt.nlp	21044322	SENT166	22	22	6	6	platinum	RGS10	PA150595617	6001	0.599
NULL	Br_J_Cancer_2009_Jul_21_101(2)_238-243.nxml.txt.nlp	19568242	SENT105	25	25	27	27	bevacizumab	IFN	PA130232992	3439	0.599
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT39	14	14	4	4	lapatinib	HRG	PA152241907	3084;3273	0.599
NULL	Int_J_Mol_Sci_2014_Nov_28_15(12)_21967-21979.nxml.txt.nlp	25464383	SENT41	28	28	19	19	ethanol	CTR	PA448073	799	0.599
NULL	J_Biol_Chem_2008_Nov_7_283(45)_30735-30744.nxml.txt.nlp	18786921	SENT96	23	23	37	37	nadh	ALDH2	PA164755085	217	0.599
NULL	Int_J_Endocrinol_Metab_2013_Jul_1_Summer_11(3)_184-190.nxml.txt.nlp	24348591	SENT144	12	12	5	5	liraglutide	LC3	PA165958364	84557	0.599
NULL	Amino_Acids_2012_Oct_10_43(4)_1751-1759.nxml.txt.nlp	22407485	SENT143	27	27	0	0	carrageenan	DAG	PA448814	1605	0.599
NULL	Front_Aging_Neurosci_2010_Feb_3_2_2.nxml.txt.nlp	20552042	SENT643	0	0	5	5	nimodipine	CA1	PA450633	759	0.599
NULL	Hum_Genomics_2011_Mar_1_5(3)_170-191.nxml.txt.nlp	21504868	SENT62	25	25	27	27	lipase	HSL	PA450239	3991	0.599
NULL	Diabetol_Metab_Syndr_2014_Sep_23_6(1)_102.nxml.txt.nlp	NULL	SENT37	11	11	27	27	atorvastatin	RAGE	PA448500	177	0.599
NULL	Sensors_(Basel)_2012_May_18_12(5)_6520-6537.nxml.txt.nlp	22778656	SENT165	11	11	13	13	etoposide	CYP3A4	PA449552	1576	0.599
NULL	Acta_Pharmacol_Sin_2014_Aug_30_35(8)_1045-1054.nxml.txt.nlp	24976155	SENT94	0	0	11	11	resveratrol	STAT3		6774	0.599
NULL	Indian_J_Endocrinol_Metab_2012_May-Jun_16(3)_406-408.nxml.txt.nlp	22629508	SENT40	14	14	23	23	octreotide	gamma	PA450678	9913	0.599
NULL	J_Hematol_Oncol_2013_Sep_5_6_66.nxml.txt.nlp	24010946	SENT301	12	12	26	26	cetuximab	HER2	PA10040	2064	0.599
NULL	J_Immunother_Cancer_2013_Nov_7_1(Suppl_1)_P123.nxml.txt.nlp	NULL	SENT23	4	4	22	22	chloroquine	HMGB1	PA448948	3146	0.599
NULL	J_Cell_Biol_2001_Apr_16_153(2)_367-380.nxml.txt.nlp	11309417	SENT226	0	0	7	7	etoposide	BLM	PA449552	641	0.599
NULL	Indian_J_Dermatol_2008_53(3)_125-128.nxml.txt.nlp	19882010	SENT73	25	25	35	35	terbinafine	ANOVA	PA451614	4858	0.599
NULL	Int_J_Appl_Basic_Med_Res_2012_Jul-Dec_2(2)_77-83.nxml.txt.nlp	23776817	SENT2	1	1	3	3	vasopressin	AVP	PA451858	114548;551	0.599
NULL	Int_J_Biol_Sci_2011_May_24_7(5)_673-684.nxml.txt.nlp	21647250	SENT139	8	8	5	5	berberine	AMPK	PA165860812	5563	0.599
NULL	Mar_Drugs_2014_May_13_12(5)_2840-2850.nxml.txt.nlp	24828291	SENT228	15	15	0	0	resveratrol	MG1		727897	0.599
NULL	Oncotarget_2013_Aug_14_4(10)_1606-1617.nxml.txt.nlp	24091475	SENT24	11	11	25	25	clotrimazole	TRO	PA449057	7216	0.599
NULL	J_Lipid_Res_2013_Feb_54(2)_425-435.nxml.txt.nlp	23220585	SENT28	29	29	10	10	lipase	HSL	PA450239	3991	0.599
NULL	Environ_Health_Perspect_2005_Oct_15_113(10)_1271-1276.nxml.txt.nlp	16203233	SENT232	28	28	30	30	diethylstilbestrol	DES	PA449307	1674	0.599
NULL	Clin_Endosc_2011_Dec_31_44(2)_65-75.nxml.txt.nlp	22741116	SENT155	9	9	6	6	fluorescein	CLE	PA164746009	51637	0.599
NULL	Oncol_Lett_2014_May_11_7(5)_1401-1408.nxml.txt.nlp	24765145	SENT175	0	0	5	5	paclitaxel	PI3K	PA450761	5290	0.599
NULL	Breast_Cancer_Res_2010_Jul_22_12(4)_R53.nxml.txt.nlp	20649975	SENT11	13	13	9	9	tamoxifen	HOXB13	PA451581	10481	0.599
NULL	J_Exp_Med_2000_May_15_191(10)_1675-1686.nxml.txt.nlp	10811861	SENT29	43	43	22	22	hydrocortisone	F12	PA449905	2161	0.599
NULL	Breast_Cancer_Res_2008_May_13_10(Suppl_2)_P5.nxml.txt.nlp	NULL	SENT9	16	16	21	21	mitoxantrone	MX1	PA450526	4599	0.599
NULL	AIDS_Res_Ther_2013_May_16_10_13.nxml.txt.nlp	23680529	SENT4	0	0	2	2	atazanavir	ATV	PA10251	4683	0.599
NULL	Amino_Acids_2012_Oct_10_43(4)_1751-1759.nxml.txt.nlp	22407485	SENT148	25	25	10	10	carrageenan	DAG	PA448814	1605	0.599
NULL	Exp_Ther_Med_2013_Oct_19_6(4)_1070-1076.nxml.txt.nlp	24137319	SENT40	0	0	2	2	cyclophosphamide	CTX	PA449165	1593	0.599
NULL	Nucl_Recept_Signal_2008_Nov_26_6_e010.nxml.txt.nlp	19079612	SENT503	4	4	19	19	bicalutamide	IL-8	PA164746255	3576	0.599
NULL	Iran_J_Pharm_Res_2014_Autumn_13(4)_1369-1378.nxml.txt.nlp	25587326	SENT4	11	11	18	18	ethanol	LCE	PA448073	79071	0.599
NULL	Acta_Pharmacol_Sin_2013_Jan_17_34(1)_157-166.nxml.txt.nlp	23247593	SENT45	27	27	44	44	l-glutamine	CO2	PA10090	4513	0.599
NULL	Breast_Cancer_Res_2014_Sep_12_16(5)_436.nxml.txt.nlp	25213081	SENT153	9	9	18	18	tamoxifen	FOXM1	PA451581	2305	0.599
NULL	Crit_Care_2008_Apr_10_12(2)_132.nxml.txt.nlp	18423065	SENT22	17	17	37	37	vasopressin	AVP	PA451858	114548;551	0.599
NULL	J_Cell_Biol_1993_May_1_121(3)_705-713.nxml.txt.nlp	8387532	SENT9	24	24	11	11	heparin	K-FGF	PA449855	2249	0.599
NULL	Indian_J_Med_Res_2011_Mar_133(3)_257-266.nxml.txt.nlp	21441678	SENT56	15	15	28	28	isoniazid	RIF	PA450112	54509;80196	0.599
NULL	Core_Evid_2011_Sep_8_6_67-79.nxml.txt.nlp	22022289	SENT287	4	4	28	28	exenatide	PPG	PA164749238	5552	0.599
NULL	Br_J_Cancer_2012_May_8_106(10)_1587-1590.nxml.txt.nlp	22568998	SENT64	15	15	20	20	sunitinib	IFN	PA162372840	3439	0.599
NULL	Ann_Rheum_Dis_2011_Jun_27_70(9)_1631-1640.nxml.txt.nlp	21708910	SENT220	33	33	20	20	methotrexate	San	PA450428	80218	0.599
NULL	Proteome_Sci_2010_Mar_26_8_18.nxml.txt.nlp	20346146	SENT113	21	21	15	15	hyaluronan	CD166	PA165958431	214	0.599
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT187	3	3	5	5	curcumin	TRAIL	PA151958596	8743	0.599
NULL	Indian_J_Endocrinol_Metab_2013_Oct_17(Suppl1)_S132-S134.nxml.txt.nlp	24251133	SENT59	13	13	19	19	cabergoline	ACTH	PA448708	5443	0.599
NULL	J_Ophthalmic_Inflamm_Infect_2011_Nov_6_2(1)_21-28.nxml.txt.nlp	22057810	SENT92	1	1	13	13	methotrexate	CTX	PA450428	1593	0.599
NULL	Anc_Sci_Life_1994_Jul-Dec_14(1-2)_35-38.nxml.txt.nlp	22556672	SENT0	19	19	14	14	caffeine	SIMPLE	PA448710	9516	0.599
NULL	J_Lipid_Res_2014_Feb_55(2)_307-312.nxml.txt.nlp	24262094	SENT12	21	21	28	28	lipase	CLPS	PA450239	1208	0.599
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Apr_15_9_13.nxml.txt.nlp	20398300	SENT97	11	11	7	7	amoxicillin	LAM	PA448406	7249;7248	0.599
NULL	Mol_Biol_Cell_2014_May_15_25(10)_1641-1652.nxml.txt.nlp	24648491	SENT10	0	0	5	5	cisplatin	NPM1	PA449014	4869	0.599
NULL	Chin_J_Cancer_2011_Sep_30(9)_645-654.nxml.txt.nlp	21880186	SENT51	0	0	2	2	cisplatin	DDP	PA449014	1678	0.599
NULL	Front_Oncol_2013_Nov_15_3_281.nxml.txt.nlp	24298448	SENT193	14	14	38	38	cetuximab	KRAS	PA10040	3845	0.599
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT148	0	0	7	7	dasatinib	EGR1	PA162372878	1958	0.599
NULL	Br_J_Cancer_2002_Jan_21_86(2)_218-221.nxml.txt.nlp	11870509	SENT5	11	11	26	26	tamoxifen	BRCA1	PA451581	672	0.599
NULL	Curr_Neuropharmacol_2010_Mar_8(1)_41-61.nxml.txt.nlp	20808545	SENT287	2	2	7	7	carbamazepine	EA2	PA448785	773	0.599
NULL	Case_Rep_Nephrol_Urol_2012_Oct_24_2(2)_145-151.nxml.txt.nlp	23197970	SENT131	26	26	12	12	erythromycin	CTX	PA449493	1593	0.599
NULL	Ann_Hematol_2014_Mar_18_93(8)_1335-1344.nxml.txt.nlp	24638841	SENT6	3	3	5	5	chlorambucil	CLB	PA448926	171425	0.599
NULL	BMB_Rep_2014_Jul_47(7)_388-392.nxml.txt.nlp	24286329	SENT35	4	4	10	10	berberine	AP-1	PA165860812	2353;3727;2354;3725	0.599
NULL	Acta_Pharmacol_Sin_2010_Jun_4_31(6)_709-717.nxml.txt.nlp	20523342	SENT53	33	33	23	23	repaglinide	CYP2C8	PA451234	1558	0.599
NULL	J_Oncol_2009_Mar_24_2009_491985.nxml.txt.nlp	19325924	SENT75	0	0	2	2	genistein	CXCR4	PA165109660	7852	0.599
NULL	Contemp_Oncol_(Pozn)_2012_Nov_20_16(5)_416-419.nxml.txt.nlp	23788920	SENT18	16	16	14	14	enoxaparin	CRT	PA449463	811	0.599
NULL	Clin_Dev_Immunol_2011_Dec_26_2011_890758.nxml.txt.nlp	22235224	SENT146	0	0	3	3	pertuzumab	HER2		2064	0.599
NULL	Oncotarget_2013_Dec_21_5(9)_2404-2417.nxml.txt.nlp	24811221	SENT15	6	6	4	4	bleomycin	FIR	PA448645	22827;9855	0.599
NULL	Br_J_Cancer_2013_Jun_25_108(12)_2549-2556.nxml.txt.nlp	23703247	SENT76	23	23	14	14	bevacizumab	TRG	PA130232992	6965	0.599
NULL	Int_J_Endocrinol_Metab_2013_Jul_1_Summer_11(3)_129-136.nxml.txt.nlp	24348584	SENT270	18	18	6	6	flutamide	spatial	PA449685	219793	0.599
NULL	Curr_Neuropharmacol_2013_Mar_11(2)_218-230.nxml.txt.nlp	23997756	SENT497	3	3	5	5	vasopressin	AVP	PA451858	114548;551	0.599
NULL	Trials_2013_Sep_24_14_311.nxml.txt.nlp	24063608	SENT63	10	10	6	6	sulfadoxine	DHFR	PA451540	1719	0.599
NULL	Pharmaceutics_2011_Oct_12_3(4)_680-705.nxml.txt.nlp	24309303	SENT782	4	4	13	13	atorvastatin	SLCO1B1	PA448500	10599	0.599
NULL	J_Int_AIDS_Soc_2012_Jul_10_15(2)_17393.nxml.txt.nlp	22789611	SENT172	2	2	18	18	abacavir	LTA	PA448004	4049	0.599
NULL	Scientifica_(Cairo)_2012_Nov_25_2012_473829.nxml.txt.nlp	24278698	SENT334	4	4	0	0	cisplatin	OCT3	PA449014	5460;6581	0.599
NULL	Eur_J_Endocrinol_2012_Aug_167(2)_287-294.nxml.txt.nlp	22660026	SENT181	13	13	11	11	metformin	Met	PA450395	79811	0.599
NULL	Indian_J_Dermatol_2014_Nov-Dec_59(6)_632a.nxml.txt.nlp	25484418	SENT29	25	25	39	39	bevacizumab	IFN	PA130232992	3439	0.599
NULL	Clin_Transl_Allergy_2013_Sep_2_3_29.nxml.txt.nlp	24004581	SENT179	17	17	19	19	omalizumab	CD23	PA164752253	2208	0.599
NULL	J_Lipids_2011_Jan_13_2011_565316.nxml.txt.nlp	21490804	SENT199	15	15	20	20	cisplatin	CD95	PA449014	355	0.599
NULL	Int_J_Gen_Med_2013_Dec_27_7_43-47.nxml.txt.nlp	24403843	SENT56	10	10	13	13	clarithromycin	ACR	PA449028	49	0.599
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT128	8	8	1	1	flecainide	CYP2C9	PA449646	1559	0.599
NULL	Eplasty_2013_Feb_28_13_e11.nxml.txt.nlp	23460929	SENT97	9	9	16	16	triamcinolone	DIP	PA451749	23151;1831	0.599
NULL	Cardiovasc_J_Afr_2010_Oct_21(5)_280-285.nxml.txt.nlp	20972517	SENT118	7	7	15	15	felodipine	CYP3A	PA449591	1574	0.599
NULL	Braz_J_Med_Biol_Res_2012_Jul_20_45(10)_935-941.nxml.txt.nlp	22801415	SENT176	15	15	23	23	pioglitazone	adiponectin	PA450970	9370	0.599
NULL	Exp_Ther_Med_2013_Nov_13_6(5)_1317-1321.nxml.txt.nlp	24223665	SENT110	13	13	18	18	curcumin	ABCG2	PA151958596	9429	0.599
NULL	J_Invest_Dermatol_2012_Apr_22_132(4)_1253-1262.nxml.txt.nlp	22189789	SENT279	9	9	11	11	capsaicin	TRPV1	PA448776	7442	0.599
NULL	Cancer_Metastasis_Rev_2014_Nov_7_33(4)_1095-1108.nxml.txt.nlp	25376898	SENT193	9	9	15	15	coumarin	CA9	PA134521193	768	0.599
NULL	Ann_Dermatol_2012_Feb_2_24(1)_103-106.nxml.txt.nlp	22363169	SENT70	4	4	0	0	isotretinoin	CO2	PA450128	4513	0.599
NULL	Eur_J_Nutr_2012_Aug_15_51(5)_513-528.nxml.txt.nlp	22584415	SENT459	5	5	13	13	infliximab	adiponectin	PA452639	9370	0.599
NULL	Case_Rep_Dermatol_2013_Jun_29_5(2)_186-191.nxml.txt.nlp	23898268	SENT103	22	22	20	20	cyanocobalamin	B12	PA451892	7126;4709	0.599
NULL	Front_Mol_Neurosci_2012_Nov_12_5_99.nxml.txt.nlp	23162427	SENT259	0	0	3	3	cocaine	HDAC5	PA449072	10014	0.598
NULL	Oncol_Lett_2013_Mar_28_5(3)_983-991.nxml.txt.nlp	23426861	SENT169	17	17	15	15	cisplatin	DDP	PA449014	1678	0.598
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT123	33	33	20	20	vinorelbine	MVP	PA451881	9961	0.598
NULL	Curr_Pain_Headache_Rep_2012_Oct_27_16(5)_439-444.nxml.txt.nlp	22836591	SENT81	16	16	10	10	creatine	ADP	PA164778930	23038	0.598
NULL	J_Biomed_Opt_2013_Jun_11_18(6)_060502.nxml.txt.nlp	23757007	SENT49	20	20	37	37	phenol	B27	PA450913	56246	0.598
NULL	Acta_Pharmacol_Sin_2014_Aug_7_35(8)_1023-1030.nxml.txt.nlp	24998255	SENT168	20	20	9	9	octreotide	Oct4	PA450678	5460	0.598
NULL	Diabetes_Care_2008_Jul_31(7)_1427-1432.nxml.txt.nlp	18390799	SENT162	11	11	18	18	pioglitazone	RBP4	PA450970	5433;5950	0.598
NULL	Case_Rep_Oncol_2013_Aug_24_6(2)_441-449.nxml.txt.nlp	24019785	SENT118	35	35	21	21	capecitabine	STZ	PA448771	6484	0.598
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1073.nxml.txt.nlp	24556688	SENT40	21	21	18	18	fluorescein	CTR	PA164746009	799	0.598
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jun_27_68(Pt_7)_o2237.nxml.txt.nlp	22798893	SENT75	19	19	28	28	ethanol	mol	PA448073	90527	0.598
NULL	Front_Neural_Circuits_2010_Mar_22_4_8.nxml.txt.nlp	20407636	SENT168	30	30	25	25	carbachol	gamma	PA448784	9913	0.598
NULL	Hum_Mol_Genet_2012_Jun_15_21(12)_2631-2645.nxml.txt.nlp	22407129	SENT228	18	18	16	16	protamine	PRM1	PA10366	5619	0.598
NULL	Interdiscip_Toxicol_2008_Dec_1(3-4)_218-224.nxml.txt.nlp	21218119	SENT112	37	37	39	39	ethanol	CYP2E1	PA448073	1571	0.598
NULL	Int_J_Mol_Sci_2012_Apr_23_13(4)_5074-5097.nxml.txt.nlp	22606031	SENT52	14	14	26	26	ethanol	ANOVA	PA448073	4858	0.598
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1051.nxml.txt.nlp	24503543	SENT144	20	20	11	11	mitoxantrone	Yes	PA450526	7525	0.598
NULL	Nat_Med_2011_Nov_6_17(12)_1685-1691.nxml.txt.nlp	22057348	SENT64	28	28	10	10	panitumumab	HER2	PA162373091	2064	0.598
NULL	Case_Rep_Oncol_2012_May_24_5(2)_260-266.nxml.txt.nlp	22712014	SENT15	0	0	9	9	cyclophosphamide	CHOP	PA449165	1649	0.598
NULL	J_Cardiothorac_Surg_2012_Sep_27_7_97.nxml.txt.nlp	23013706	SENT139	18	18	15	15	warfarin	CYP4F2	PA451906	8529	0.598
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2008_Sep_1_64(Pt_9)_933-940.nxml.txt.nlp	18703841	SENT182	29	29	22	22	nadh	MRF	PA164755085	745	0.598
NULL	Exp_Ther_Med_2013_May_15_5(5)_1293-1300.nxml.txt.nlp	23737867	SENT214	10	10	18	18	finasteride	EGFR	PA449627	1956	0.598
NULL	Interdiscip_Perspect_Infect_Dis_2014_May_7_2014_849432.nxml.txt.nlp	24895495	SENT54	18	18	35	35	triamcinolone	CD4	PA451749	920	0.598
NULL	Br_J_Cancer_2011_Apr_12_104(8)_1256-1261.nxml.txt.nlp	21448165	SENT126	30	30	14	14	sorafenib	IL-2	PA7000	3558	0.598
NULL	Eur_J_Clin_Pharmacol_2013_Mar_11_69(3)_327-339.nxml.txt.nlp	22782539	SENT81	1	1	4	4	clopidogrel	IPA	PA449053	3160	0.598
NULL	Front_Neurosci_2011_Jan_14_4_207.nxml.txt.nlp	21258618	SENT161	29	29	16	16	ethanol	HET	PA448073	6294	0.598
NULL	Cancers_(Basel)_2014_Mar_13_6(1)_595-624.nxml.txt.nlp	24633084	SENT1673	15	15	20	20	lapatinib	HER2	PA152241907	2064	0.598
NULL	Ther_Clin_Risk_Manag_2006_Mar_2(1)_87-98.nxml.txt.nlp	18360584	SENT143	5	5	3	3	sorafenib	RDT	PA7000	6598	0.598
NULL	Cell_Commun_Signal_2013_Oct_1_11_73.nxml.txt.nlp	24083678	SENT80	3	3	9	9	sulindac	p65	PA451565	5970	0.598
NULL	Oncol_Lett_2014_Jun_28_7(6)_2093-2098.nxml.txt.nlp	24932295	SENT122	11	11	18	18	resveratrol	PI3K		5290	0.598
NULL	Curr_Opin_Allergy_Clin_Immunol_2014_Oct_28_14(5)_397-403.nxml.txt.nlp	25115682	SENT121	33	33	19	19	montelukast	IL-5	PA450546	3567	0.598
NULL	Expert_Rev_Endocrinol_Metab_2014_Jul_9_9(4)_397-409.nxml.txt.nlp	25264451	SENT319	23	23	31	31	estradiol	aromatase	PA449503	1588	0.598
NULL	Cancer_Cell_Int_2013_May_1_13_39.nxml.txt.nlp	23631621	SENT206	15	15	4	4	hydrocortisone	EGF	PA449905	1950	0.598
NULL	J_Gastroenterol_2013_Feb_22_48(2)_222-237.nxml.txt.nlp	22722906	SENT257	4	4	13	13	ethanol	ANOVA	PA448073	4858	0.598
NULL	Eur_J_Neurosci_2011_Mar_33(5)_914-922.nxml.txt.nlp	21255131	SENT113	30	30	20	20	pentobarbital	gamma	PA450859	9913	0.598
NULL	Pain_Res_Treat_2011_Jun_12_2011_647967.nxml.txt.nlp	22110928	SENT43	23	23	26	26	capsaicin	TRPV1	PA448776	7442	0.598
NULL	FEBS_Open_Bio_2013_Aug_17_3_352-356.nxml.txt.nlp	24251095	SENT190	10	10	15	15	hyaluronan	CD44	PA165958431	960	0.598
NULL	Curr_Cardiol_Rev_2009_Aug_5(3)_216-222.nxml.txt.nlp	20676280	SENT139	30	30	32	32	lipase	HSL	PA450239	3991	0.598
NULL	Oncotarget_2013_Jul_15_4(8)_1241-1252.nxml.txt.nlp	23872733	SENT250	24	24	29	29	bortezomib	MCL1	PA10252	4170	0.598
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT253	7	7	2	2	doxorubicin	B7-H1	PA449412	29126	0.598
NULL	Arch_Med_Sci_2013_Apr_20_9(2)_332-339.nxml.txt.nlp	23671446	SENT129	5	5	10	10	midazolam	p38	PA450496	10598;1432;7965	0.598
NULL	Environ_Health_Perspect_2013_Apr_5_121(4)_459-466.nxml.txt.nlp	23384675	SENT37	18	18	12	12	trypsin	SPUVE	PA451806	11098	0.598
NULL	Mol_Cancer_2009_Nov_10_8_99.nxml.txt.nlp	19903356	SENT83	21	21	18	18	imatinib	IGFBP3	PA10804	3486	0.598
NULL	JMIR_Med_Inform_2014_Mar_18_2(1)_e5.nxml.txt.nlp	25601137	SENT230	21	21	36	36	warfarin	Gen	PA451906	348654	0.598
NULL	Int_J_Environ_Res_Public_Health_2010_Dec_21_7(12)_4281-4304.nxml.txt.nlp	21318009	SENT385	9	9	2	2	allopregnanolone	spatial	PA142320763	219793	0.598
NULL	Br_J_Cancer_2009_May_5_100(9)_1415-1424.nxml.txt.nlp	19352384	SENT187	25	25	22	22	cisplatin	JNK1	PA449014	5599	0.598
NULL	Exp_Ther_Med_2013_Jul_25_6(1)_109-114.nxml.txt.nlp	23935730	SENT28	14	14	16	16	rituximab	CHOP	PA451261	1649	0.598
NULL	J_Mol_Signal_2011_Jul_20_6_7.nxml.txt.nlp	21774804	SENT9	13	13	29	29	curcumin	CD133	PA151958596	8842	0.598
NULL	Oncol_Lett_2014_Jul_28_8(1)_404-408.nxml.txt.nlp	24959285	SENT100	7	7	35	35	tegafur	GEM	PA452620	2669	0.598
NULL	Mycobiology_2010_Jun_30_38(2)_89-96.nxml.txt.nlp	23956633	SENT155	10	10	20	20	galactose	Mal	PA449725	114609	0.598
NULL	Ann_Indian_Acad_Neurol_2009_Apr-Jun_12(2)_89-98.nxml.txt.nlp	20142853	SENT30	26	26	19	19	mitoxantrone	MRP1	PA450526	4437	0.598
NULL	Osong_Public_Health_Res_Perspect_2013_Dec_12_4(6)_316-322.nxml.txt.nlp	24524020	SENT206	6	6	20	20	azithromycin	CTX	PA448519	1593	0.598
NULL	Acta_Histochem_Cytochem_2012_Apr_26_45(2)_139-146.nxml.txt.nlp	22685356	SENT7	19	19	8	8	forskolin	AQP2	PA146096022	359	0.598
NULL	Curr_Med_Chem_2014_May_21(14)_1595-1606.nxml.txt.nlp	23992330	SENT41	6	6	4	4	gefitinib	Met	PA131301952	79811	0.598
NULL	Indian_J_Endocrinol_Metab_2011_Apr-Jun_15(2)_110-114.nxml.txt.nlp	21731868	SENT89	11	11	15	15	metformin	B12	PA450395	7126;4709	0.598
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT167	28	28	22	22	trastuzumab	MUC1	PA451743	4582	0.598
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Sep_19_65(Pt_10)_o2506-o2507.nxml.txt.nlp	21577955	SENT79	15	15	18	18	benzaldehyde	mol	PA448571	90527	0.598
NULL	Oncotarget_2013_Aug_24_4(10)_1618-1631.nxml.txt.nlp	24113128	SENT205	10	10	1	1	sorafenib	p53	PA7000	7157	0.598
NULL	Core_Evid_2010_Jul_27_5_1-10.nxml.txt.nlp	20694135	SENT202	30	30	33	33	levodopa	CLE	PA450213	51637	0.598
NULL	Diabetes_Metab_J_2012_Jun_14_36(3)_199-206.nxml.txt.nlp	22737659	SENT26	27	27	11	11	glucose	ADA	PA449773	100	0.598
NULL	Mol_Vis_2014_Nov_16_20_1629-1642.nxml.txt.nlp	25489234	SENT54	23	23	14	14	doxycycline	ESRP1	PA449415	54845	0.598
NULL	Eur_J_Clin_Pharmacol_2011_May_2_67(Suppl_1)_87-107.nxml.txt.nlp	21287160	SENT295	8	8	2	2	doxorubicin	CBR3	PA449412	874	0.598
NULL	J_Biol_Chem_2012_Apr_20_287(17)_14122-14135.nxml.txt.nlp	22351750	SENT1040	4	4	10	10	hyaluronan	TSG-6	PA165958431	7130	0.598
NULL	Anal_Chem_Insights_2008_Aug_13_3_91-101.nxml.txt.nlp	19609393	SENT23	9	9	11	11	desipramine	DES	PA449233	1674	0.598
NULL	Atherosclerosis_2011_Nov_219(1)_109-115.nxml.txt.nlp	21820657	SENT183	21	21	13	13	probucol	CETP	PA451107	1071	0.598
NULL	Cancer_Res_Treat_2013_Sep_30_45(3)_178-185.nxml.txt.nlp	24155676	SENT36	15	15	17	17	gefitinib	EGFR	PA131301952	1956	0.598
NULL	Int_J_Cell_Biol_2013_Mar_19_2013_834684.nxml.txt.nlp	23573093	SENT72	0	0	12	12	metformin	AMPK	PA450395	5563	0.598
NULL	Arthritis_Res_Ther_2013_Apr_17_15(2)_R51.nxml.txt.nlp	23594962	SENT214	8	8	15	15	muraglitazar	IL-6	PA162356187	3569	0.598
NULL	Front_Immunol_2014_Aug_13_5_387.nxml.txt.nlp	25165466	SENT176	9	9	17	17	l-arginine	zeta	PA448478	9907	0.598
NULL	Front_Immunol_2013_Oct_18_4_315.nxml.txt.nlp	24151492	SENT265	3	3	5	5	erythromycin	CD4	PA449493	920	0.598
NULL	Int_J_Mol_Sci_2014_Mar_5_15(3)_3970-3988.nxml.txt.nlp	24603537	SENT41	11	11	9	9	curcumin	MCH	PA151958596	5367	0.598
NULL	Indian_Dermatol_Online_J_2014_Jul-Sep_5(3)_276-281.nxml.txt.nlp	25165643	SENT60	23	23	25	25	sugar	FBS	PA451529	64319;26269	0.598
NULL	Mol_Pain_2013_Dec_9_9_64.nxml.txt.nlp	24313960	SENT65	17	17	34	34	bupivacaine	RAPA	PA135057240	55809	0.598
NULL	Nat_Commun_2013_4_2720.nxml.txt.nlp	24193139	SENT231	22	22	16	16	methylphenidate	CTRL	PA450464	1506	0.598
NULL	Cell_Death_Dis_2014_Jul_3_5(7)_e1311.nxml.txt.nlp	24991763	SENT349	14	14	16	16	ketamine	PSD95	PA450144	1742	0.598
NULL	Pharmaceuticals_(Basel)_2012_Jun_28_5(7)_674-689.nxml.txt.nlp	24281706	SENT145	6	6	14	14	trastuzumab	EEA1	PA451743	8411	0.598
NULL	Drug_Des_Devel_Ther_2014_Sep_9_8_1307-1314.nxml.txt.nlp	25246772	SENT154	23	23	7	7	tacrolimus	HTX	PA451578	7547	0.598
NULL	Ann_Oncol_2013_Aug_12_24(8)_1994-1999.nxml.txt.nlp	23670096	SENT99	0	0	5	5	tamoxifen	AIB1	PA451581	8202	0.598
NULL	Acta_Pharmacol_Sin_2013_Apr_11_34(4)_473-479.nxml.txt.nlp	23474709	SENT126	13	13	7	7	phenytoin	MRP1	PA450947	4437	0.598
NULL	Diabetes_Metab_Syndr_Obes_2014_Mar_18_7_107-120.nxml.txt.nlp	24672252	SENT39	3	3	12	12	liraglutide	GLP-1	PA165958364	100125288	0.598
NULL	J_Oncol_2012_Oct_5_2012_794172.nxml.txt.nlp	22007215	SENT39	0	0	2	2	cyclophosphamide	CTX	PA449165	1593	0.598
NULL	Cell_Death_Dis_2010_Nov_18_1(11)_e102.nxml.txt.nlp	21368867	SENT120	23	23	10	10	gentamicin	14-3-3	PA449753	10971	0.598
NULL	Acta_Pharmacol_Sin_2012_Jan_28_33(1)_66-74.nxml.txt.nlp	22120966	SENT14	11	11	21	21	genistein	OPG	PA165109660	690	0.598
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S31-S40.nxml.txt.nlp	20680106	SENT49	33	33	31	31	cetuximab	KRAS	PA10040	3845	0.598
NULL	Int_J_Mol_Cell_Med_2012_Summer_1(3)_145-152.nxml.txt.nlp	24551770	SENT115	2	2	11	11	memantine	mol	PA10364	90527	0.598
NULL	Clin_Ophthalmol_2014_Feb_10_8_389-399.nxml.txt.nlp	24550667	SENT172	34	34	32	32	timolol	TIM	PA451690	7984;8914	0.598
NULL	Orphanet_J_Rare_Dis_2013_Dec_21_8_197.nxml.txt.nlp	24360150	SENT30	2	2	4	4	lipase	ATGL	PA450239	57104	0.598
NULL	Int_J_Mol_Sci_2014_Sep_5_15(9)_15754-15765.nxml.txt.nlp	25198898	SENT479	0	0	16	16	curcumin	p38	PA151958596	10598;1432;7965	0.598
NULL	Front_Genet_2014_Aug_26_5_285.nxml.txt.nlp	25206361	SENT1066	0	0	7	7	ethanol	Oct4	PA448073	5460	0.598
NULL	Oncol_Lett_2013_Sep_12_6(3)_860-864.nxml.txt.nlp	24137426	SENT98	19	19	26	26	omeprazole	CYP1A2	PA450704	1544	0.598
NULL	Iran_J_Neurol_2012_11(2)_70-73.nxml.txt.nlp	24250865	SENT16	2	2	4	4	doxycycline	IFN	PA449415	3439	0.598
NULL	Clin_Pharmacol_2012_Feb_20_4_13-20.nxml.txt.nlp	22427735	SENT12	36	36	7	7	clopidogrel	PON1	PA449053	5444	0.598
NULL	Oncoscience_2014_Mar_12_1(2)_167-179.nxml.txt.nlp	25126591	SENT248	18	18	11	11	sorafenib	MYC	PA7000	4609	0.598
NULL	Drugs_Aging_2012_Nov_5_29(11)_863-869.nxml.txt.nlp	23038608	SENT93	18	18	13	13	nortriptyline	NNT	PA450657	23530	0.598
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1449-1456.nxml.txt.nlp	24077631	SENT123	34	34	22	22	tolbutamide	CYP2C9	PA451718	1559	0.598
NULL	Mar_Drugs_2011_Dec_13_9(12)_2605-2621.nxml.txt.nlp	22363242	SENT221	39	39	47	47	l-glutamine	CO2	PA10090	4513	0.598
NULL	Oncotarget_2014_Feb_8_5(6)_1609-1620.nxml.txt.nlp	24742492	SENT56	15	15	21	21	tetracycline	TBX2	PA451640	6909	0.598
NULL	Drug_Des_Devel_Ther_2014_Dec_5_8_2431-2438.nxml.txt.nlp	25525333	SENT155	13	13	15	15	doxorubicin	P-gp	PA449412	5243	0.598
NULL	Lab_Invest_2014_May_10_94(5)_503-516.nxml.txt.nlp	24614199	SENT56	0	0	23	23	curcumin	NAC	PA151958596	22861	0.598
NULL	Oncogene_2014_Aug_28_33(35)_4407-4417.nxml.txt.nlp	24469038	SENT123	33	33	24	24	cisplatin	p53	PA449014	7157	0.598
NULL	J_Radiat_Res_2014_Jul_11_55(4)_613-628.nxml.txt.nlp	24522270	SENT91	5	5	21	21	vorinostat	MM1	PA164748224	23654	0.598
NULL	Pharmaceutics_2010_Apr_27_2(2)_136-158.nxml.txt.nlp	NULL	SENT185	5	5	19	19	diclofenac	HSM	PA449293	94030	0.598
NULL	Cancer_Cell_Int_2004_Mar_19_4_3.nxml.txt.nlp	15035672	SENT92	23	23	12	12	etoposide	APO	PA449552	84909	0.598
NULL	Pharmaceutics_2011_Nov_18_3(4)_865-913.nxml.txt.nlp	24309312	SENT155	10	10	7	7	ritonavir	CYP3A4	PA451260	1576	0.598
NULL	Stroke_Res_Treat_2012_Nov_30_2012_382361.nxml.txt.nlp	22195291	SENT85	10	10	13	13	clopidogrel	CEA	PA449053	5670;1087	0.598
NULL	Aging_(Albany_NY)_2009_Feb_12_1(2)_245-253.nxml.txt.nlp	19946467	SENT92	13	13	15	15	vasopressin	AVP	PA451858	114548;551	0.598
NULL	Mol_Cancer_2007_Aug_21_6_53.nxml.txt.nlp	17711579	SENT153	6	6	22	22	cisplatin	CCL2	PA449014	6347	0.598
NULL	Front_Endocrinol_(Lausanne)_2011_Jan_14_1_12.nxml.txt.nlp	22654789	SENT41	26	26	28	28	vasopressin	AVP	PA451858	114548;551	0.598
NULL	Int_J_Med_Sci_2014_Jan_10_11(2)_192-198.nxml.txt.nlp	24465165	SENT178	12	12	14	14	vasopressin	AVP	PA451858	114548;551	0.598
NULL	Semin_Immunopathol_2014_Nov_27_36(1)_3-12.nxml.txt.nlp	24281248	SENT52	27	27	29	29	lipase	ATGL	PA450239	57104	0.598
NULL	AMB_Express_2014_Aug_30_4_63.nxml.txt.nlp	25401066	SENT271	3	3	10	10	ethanol	CO2	PA448073	4513	0.598
NULL	J_Mol_Signal_2009_Apr_28_4_2.nxml.txt.nlp	19400946	SENT101	37	37	39	39	genistein	Gen	PA165109660	348654	0.598
NULL	Acta_Pharmacol_Sin_2012_Jan_28_33(1)_75-81.nxml.txt.nlp	22120969	SENT103	1	1	3	3	exenatide	GLP-1	PA164749238	100125288	0.598
NULL	Amyloid_2014_Sep_11_21(3)_175-184.nxml.txt.nlp	24918964	SENT118	0	0	12	12	anakinra	p65	PA10799	5970	0.598
NULL	Biochim_Biophys_Acta_2014_Apr_1841(4)_588-594.nxml.txt.nlp	24440819	SENT430	6	6	8	8	lipase	ATGL	PA450239	57104	0.598
NULL	Biotechnol_Res_Int_2013_Dec_1_2013_253286.nxml.txt.nlp	24363937	SENT63	8	8	10	10	urea	DAP	PA451831	23549;3375;1611	0.598
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT116	6	6	11	11	neratinib	HER2	PA165291472	2064	0.598
NULL	Braz_J_Med_Biol_Res_2012_Mar_23_45(4)_366-375.nxml.txt.nlp	22437485	SENT183	43	43	45	45	fluoxetine	ETM	PA449673	2112	0.598
NULL	Diabetes_2013_Sep_15_62(9)_3275-3281.nxml.txt.nlp	23674605	SENT10	27	27	19	19	chymotrypsin	CTRB2	PA448994	440387	0.598
NULL	Trials_2012_Sep_8_13_160.nxml.txt.nlp	22958580	SENT44	28	28	12	12	vecuronium	LSR	PA164748865	51599	0.598
NULL	Clin_Ophthalmol_2014_Feb_10_8_389-399.nxml.txt.nlp	24550667	SENT147	4	4	14	14	brinzolamide	TIM	PA164744929	7984;8914	0.598
NULL	Acta_Pharmacol_Sin_2009_Jul_3_30(7)_1025-1032.nxml.txt.nlp	19575006	SENT189	2	2	12	12	vincristine	ADM	PA451879	133	0.598
NULL	Arthritis_Res_Ther_2014_Apr_11_16(2)_R93.nxml.txt.nlp	24725461	SENT203	15	15	20	20	letrozole	CYP1A1	PA450196	1543	0.598
NULL	Front_Microbiol_2014_Mar_27_5_124.nxml.txt.nlp	24723921	SENT358	12	12	31	31	nadh	CO2	PA164755085	4513	0.598
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT7	9	9	7	7	pp2	PP1		5540;5464	0.598
NULL	Front_Neural_Circuits_2014_Jun_11_8_58.nxml.txt.nlp	24966814	SENT735	17	17	12	12	scopolamine	spatial	PA451308	219793	0.598
NULL	Exp_Mol_Med_2012_Sep_30_44(9)_536-544.nxml.txt.nlp	22771771	SENT8	3	3	8	8	ns-398	p53		7157	0.598
NULL	Oncoimmunology_2014_Jan_1_3_e27358.nxml.txt.nlp	24701373	SENT28	30	30	7	7	glucosamine	TERF2	PA164747613	7014	0.598
NULL	Arthritis_Res_Ther_2013_Mar_20_15(2)_R44.nxml.txt.nlp	23514433	SENT9	25	25	27	27	methotrexate	MRI	PA450428	78996	0.598
NULL	Hum_Genomics_2009_Jan_1_3(2)_103-105.nxml.txt.nlp	19164087	SENT52	3	3	13	13	ethanol	ADH4	PA448073	127	0.598
NULL	Osteoporos_Int_2011_Aug_30_22(8)_2337-2345.nxml.txt.nlp	21116816	SENT171	28	28	9	9	fluvastatin	IL-6	PA449688	3569	0.598
NULL	Arthritis_Rheum_2010_Dec_62(12)_3666-3676.nxml.txt.nlp	20722027	SENT168	15	15	11	11	lipase	NAPE-PLD	PA450239	222236	0.598
NULL	Int_J_Biomed_Sci_2006_Jun_2(2)_121-134.nxml.txt.nlp	23674974	SENT178	2	2	7	7	lisinopril	CTR1	PA450242	1317	0.598
NULL	Mol_Cancer_2009_Dec_14_8_121.nxml.txt.nlp	20003443	SENT51	16	16	4	4	hydroxyprogesterone	AKR1C1	PA449932	1645	0.598
NULL	Endocrinology_2014_Nov_21_155(11)_4380-4390.nxml.txt.nlp	25144923	SENT14	35	35	37	37	vasopressin	AVP	PA451858	114548;551	0.598
NULL	Cancer_Cell_Int_2006_Aug_9_6_20.nxml.txt.nlp	16899133	SENT65	0	0	24	24	curcumin	p27	PA151958596	5715;10534	0.598
NULL	Acta_Pharmacol_Sin_2013_Oct_7_34(10)_1349-1358.nxml.txt.nlp	23892274	SENT192	17	17	12	12	fexofenadine	P-gp	PA449621	5243	0.598
NULL	Crit_Care_2011_Jun_29_15(3)_R160.nxml.txt.nlp	21714857	SENT16	4	4	23	23	fenoldopam	NGAL	PA164784034	3934	0.598
NULL	EPMA_J_2012_Sep_27_3(1)_10.nxml.txt.nlp	23016735	SENT216	36	36	4	4	warfarin	VKORC1	PA451906	79001	0.598
NULL	Chonnam_Med_J_2013_Dec_23_49(3)_118-124.nxml.txt.nlp	24400214	SENT130	11	11	16	16	paclitaxel	PES	PA450761	23481	0.598
NULL	Indian_J_Sex_Transm_Dis_2013_Jul-Dec_34(2)_148-149.nxml.txt.nlp	24339470	SENT18	16	16	28	28	lamivudine	AKT	PA450163	207	0.598
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT632	13	13	17	17	tamoxifen	ERBB2	PA451581	2064	0.598
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT137	41	41	45	45	doxorubicin	SLK	PA449412	9748;2534	0.598
NULL	J_Invest_Dermatol_2013_Jul_13_133(7)_1742-1751.nxml.txt.nlp	23407402	SENT109	13	13	22	22	ustekinumab	IL-17	PA166048654	3605	0.598
NULL	Cell_Death_Dis_2010_May_13_1(5)_e41.nxml.txt.nlp	21364648	SENT24	9	9	6	6	etoposide	p65	PA449552	5970	0.598
NULL	J_Med_Internet_Res_2013_Jul_12_15(7)_e138.nxml.txt.nlp	23853350	SENT185	13	13	6	6	warfarin	TTR	PA451906	7276	0.598
NULL	Sci_Rep_2014_Dec_19_4_7554.nxml.txt.nlp	25523081	SENT50	19	19	23	23	l-glutamine	B27	PA10090	56246	0.598
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1046.nxml.txt.nlp	24503538	SENT75	18	18	32	32	oxaliplatin	FGFR4	PA131285527	2264	0.598
NULL	Neural_Regen_Res_2014_Nov_1_9(21)_1897-1901.nxml.txt.nlp	25558239	SENT17	0	0	10	10	diazepam	CA1	PA449283	759	0.598
NULL	Crit_Care_2005_Oct_27_9(6)_R725-R728.nxml.txt.nlp	16280070	SENT69	22	22	10	10	lorazepam	San	PA450267	80218	0.598
NULL	Breast_Cancer_Res_2010_Nov_16_12(6)_R96.nxml.txt.nlp	21080941	SENT149	45	45	29	29	lapatinib	HRG	PA152241907	3084;3273	0.598
NULL	Endocrine_2012_Dec_14_42(3)_622-636.nxml.txt.nlp	22695986	SENT318	9	9	7	7	forskolin	PTH	PA146096022	5741	0.598
NULL	Front_Immunol_2013_May_13_4_111.nxml.txt.nlp	23717309	SENT88	35	35	11	11	thrombin	IL-13	PA451674	3596	0.598
NULL	Mol_Cancer_2013_Mar_2_12_16.nxml.txt.nlp	23452820	SENT107	40	40	25	25	chloroquine	Bcl-2	PA448948	596	0.598
NULL	Mol_Med_Rep_2015_Jan_17_11(1)_43-52.nxml.txt.nlp	25333456	SENT266	35	35	11	11	cisplatin	ADM	PA449014	133	0.598
NULL	Front_Comput_Neurosci_2013_Apr_5_7_22.nxml.txt.nlp	23576979	SENT12	5	5	27	27	propofol	HCN1	PA451141	348980	0.598
NULL	Eur_J_Med_Res_2011_Feb_24_16(2)_63-66.nxml.txt.nlp	21463983	SENT130	10	10	16	16	tobramycin	PARI	PA451704	55010	0.598
NULL	Arch_Med_Sci_2013_Apr_20_9(2)_361-367.nxml.txt.nlp	23671450	SENT163	5	5	7	7	budesonide	HIF-1	PA448681	29072	0.598
NULL	Eur_Heart_J_2013_Dec_1_34(45)_3515-3524.nxml.txt.nlp	23594590	SENT115	3	3	0	0	indomethacin	COX	PA449982	1351	0.598
NULL	Indian_J_Pharmacol_2012_Sep-Oct_44(5)_619-623.nxml.txt.nlp	23112425	SENT125	11	11	24	24	forskolin	CFTR	PA146096022	1080	0.598
NULL	FEBS_Open_Bio_2014_Aug_1_4_722-729.nxml.txt.nlp	25161880	SENT122	29	29	9	9	ethanol	TSK	PA448073	25987	0.598
NULL	Int_J_Nanomedicine_2009_Apr_1_4_27-35.nxml.txt.nlp	19421368	SENT101	21	21	14	14	genistein	IL-10	PA165109660	3586	0.598
NULL	J_Cardiovasc_Magn_Reson_2014_Sep_27_16(1)_80.nxml.txt.nlp	25270330	SENT13	23	23	17	17	iron	spatial	PA450087	219793	0.598
NULL	Acta_Neuropathol_Commun_2014_Sep_16_2(1)_137.nxml.txt.nlp	NULL	SENT29	30	30	33	33	nadh	SDH	PA164755085	1757;10993	0.598
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT128	17	17	3	3	lidocaine	CYP2D6	PA450226	1565	0.598
NULL	Oncotarget_2013_Nov_22_5(4)_933-943.nxml.txt.nlp	24659749	SENT118	24	24	19	19	nutlin-3	AML2		864	0.598
NULL	Gut_Liver_2015_Jan_9(1)_18-27.nxml.txt.nlp	NULL	SENT52	18	18	9	9	infliximab	ACT	PA452639	12;11332;9457;641455	0.598
NULL	Exp_Neurobiol_2013_Mar_31_22(1)_45-50.nxml.txt.nlp	23585722	SENT31	5	5	19	19	fluoxetine	EPO	PA449673	7076;8288;2056	0.598
NULL	Clin_Mol_Hepatol_2014_Sep_25_20(3)_283-290.nxml.txt.nlp	25320732	SENT150	2	2	0	0	propranolol	PPN	PA451145	64840	0.598
NULL	Mol_Clin_Oncol_2013_Jul_11_1(4)_763-767.nxml.txt.nlp	24649243	SENT152	35	35	18	18	leucovorin	CEA	PA450198	5670;1087	0.598
NULL	Nat_Commun_2012_3_990.nxml.txt.nlp	22871809	SENT203	24	24	12	12	dextran	LPC	PA449261	9159	0.598
NULL	Arch_Med_Sci_2013_Oct_31_9(5)_916-921.nxml.txt.nlp	24273579	SENT98	7	7	2	2	bleomycin	AQP1	PA448645	358	0.598
NULL	Arthritis_Res_Ther_2005_May_18_7(Suppl_3)_S19-S25.nxml.txt.nlp	15960818	SENT167	25	25	23	23	rituximab	CHOP	PA451261	1649	0.597
NULL	Gut_Pathog_2010_Dec_7_2_17.nxml.txt.nlp	21138594	SENT39	12	12	32	32	cefazolin	OTC	PA448839	5009	0.597
NULL	J_Breast_Cancer_2014_Mar_28_17(1)_61-68.nxml.txt.nlp	24744799	SENT166	18	18	12	12	capecitabine	GEM	PA448771	2669	0.597
NULL	Diabetes_Care_2008_Nov_31(11)_2222-2229.nxml.txt.nlp	18955719	SENT224	34	34	41	41	lipase	GLP-1	PA450239	100125288	0.597
NULL	Arthritis_Res_Ther_2009_May_19_11(3)_229.nxml.txt.nlp	19519924	SENT279	13	13	32	32	methotrexate	TNF	PA450428	7124	0.597
NULL	Genet_Mol_Biol_2010_Dec_1_Oct-Dec_33(4)_750-755.nxml.txt.nlp	21637586	SENT16	8	8	6	6	pp2	PP1		5540;5464	0.597
NULL	Breast_Cancer_Res_2014_Sep_11_16(5)_430.nxml.txt.nlp	25212826	SENT278	17	17	39	39	fulvestrant	PTEN	PA164747170	5728	0.597
NULL	Cancer_Imaging_2007_Dec_17_7(1)_202-209.nxml.txt.nlp	18083649	SENT17	32	32	25	25	guanidine	FDG	PA164781028	23583	0.597
NULL	Clin_Med_Insights_Cardiol_2010_Dec_1_4_117-128.nxml.txt.nlp	21151850	SENT278	14	14	3	3	prasugrel	ABCB1	PA154410481	5243	0.597
NULL	J_Cell_Mol_Med_2013_Oct_16_17(10)_1261-1270.nxml.txt.nlp	23855452	SENT192	10	10	12	12	gemcitabine	GEM	PA449748	2669	0.597
NULL	Islets_2012_Nov_1_4(6)_366-378.nxml.txt.nlp	23183538	SENT299	21	21	35	35	ciprofloxacin	CO2	PA449009	4513	0.597
NULL	Eur_J_Haematol_2009_Apr_82(4)_277-287.nxml.txt.nlp	19187270	SENT146	13	13	19	19	pha-665752	IL-6		3569	0.597
NULL	Gut_2011_Jun_7_60(6)_837-845.nxml.txt.nlp	21139063	SENT196	20	20	18	18	ribavirin	IFN	PA451241	3439	0.597
NULL	Mol_Cancer_2012_Jul_25_11_47.nxml.txt.nlp	22830443	SENT188	8	8	12	12	panitumumab	EGFR	PA162373091	1956	0.597
NULL	J_Res_Med_Sci_2012_Aug_17(8)_777-781.nxml.txt.nlp	23798946	SENT79	20	20	23	23	trypsin	IL8	PA451806	3576	0.597
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT151	15	15	31	31	glucose	ERK	PA449773	5594	0.597
NULL	Mol_Cancer_2010_Aug_23_9_222.nxml.txt.nlp	20731837	SENT7	0	0	9	9	gefitinib	ATM	PA131301952	472	0.597
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT89	8	8	10	10	perifosine	TRAIL	PA165291471	8743	0.597
NULL	Biology_(Basel)_2012_Aug_24_1(2)_339-369.nxml.txt.nlp	24832229	SENT216	37	37	15	15	s-adenosylmethionine	K20	PA164754994	54474	0.597
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT225	10	10	17	17	atorvastatin	TNF	PA448500	7124	0.597
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT128	8	8	0	0	flecainide	CYP1A2	PA449646	1544	0.597
NULL	Br_J_Haematol_2011_Apr_153(1)_83-91.nxml.txt.nlp	21332705	SENT17	12	12	20	20	thrombin	ADP	PA451674	23038	0.597
NULL	Fibrogenesis_Tissue_Repair_2010_Sep_3_3_18.nxml.txt.nlp	20815874	SENT4	15	15	17	17	bleomycin	BLM	PA448645	641	0.597
NULL	Gene_Ther_2011_Mar_4_18(3)_283-293.nxml.txt.nlp	21048796	SENT44	23	23	14	14	mitomycin	KLF4	PA450524	9314	0.597
NULL	Avicenna_J_Phytomed_2012_Autumn_2(4)_212-221.nxml.txt.nlp	25050251	SENT188	18	18	21	21	metformin	STZ	PA450395	6484	0.597
NULL	Nanoscale_Res_Lett_2014_Jul_15_9(1)_353.nxml.txt.nlp	25114645	SENT30	0	0	13	13	diethylstilbestrol	HEX	PA449307	3087	0.597
NULL	Exp_Ther_Med_2014_Dec_24_8(6)_1677-1682.nxml.txt.nlp	25371714	SENT135	8	8	10	10	sirolimus	HIF-1	PA451365	29072	0.597
NULL	Int_Semin_Surg_Oncol_2008_Apr_28_5_9.nxml.txt.nlp	18442393	SENT63	5	5	1	1	tamoxifen	HER2	PA451581	2064	0.597
NULL	Infect_Dis_Ther_2014_Jun_18_3(1)_35-43.nxml.txt.nlp	25134810	SENT118	20	20	7	7	oxacillin	VAN	PA450725	10318	0.597
NULL	Breast_Cancer_Res_2011_Sep_14_13(5)_R88.nxml.txt.nlp	21914219	SENT195	48	48	7	7	estradiol	c-FLIP	PA449503	8837	0.597
NULL	J_Inflamm_(Lond)_2005_Apr_20_2_3.nxml.txt.nlp	15840176	SENT221	13	13	6	6	collagenase	AP-1	PA449107	2353;3727;2354;3725	0.597
NULL	Infect_Dis_Ther_2014_Jun_18_3(1)_35-43.nxml.txt.nlp	25134810	SENT97	4	4	14	14	daptomycin	VAN	PA164768820	10318	0.597
NULL	Arch_Med_Sci_2012_May_9_8(2)_347-356.nxml.txt.nlp	22662010	SENT57	14	14	12	12	urokinase	Bcl-2	PA451836	596	0.597
NULL	Br_J_Cancer_1992_Jun_65(6)_865-869.nxml.txt.nlp	1616857	SENT10	5	5	22	22	tamoxifen	EGFR	PA451581	1956	0.597
NULL	Cerebrospinal_Fluid_Res_2010_Sep_22_7_15.nxml.txt.nlp	20860832	SENT257	23	23	25	25	acetazolamide	AQP1	PA448018	358	0.597
NULL	Core_Evid_2007_Nov_30_2(2)_121-129.nxml.txt.nlp	21221180	SENT230	37	37	32	32	rituximab	CHOP	PA451261	1649	0.597
NULL	Braz_J_Med_Biol_Res_2012_Mar_30_45(4)_314-320.nxml.txt.nlp	22450372	SENT102	2	2	29	29	fluoxetine	PAG	PA449673	55824	0.597
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT61	9	9	12	12	trastuzumab	STAT3	PA451743	6774	0.597
NULL	Oxid_Med_Cell_Longev_2013_Jun_2_2013_793525.nxml.txt.nlp	23819014	SENT199	3	3	19	19	resveratrol	TNF		7124	0.597
NULL	Int_J_Hypertens_2013_Feb_6_2013_382802.nxml.txt.nlp	23476746	SENT107	26	26	6	6	metoprolol	MDC	PA450480	6367	0.597
NULL	Oncogene_2014_Oct_23_33(43)_5109-5120.nxml.txt.nlp	24858043	SENT279	28	28	47	47	pp2	MCT-1		28985	0.597
NULL	Oncoimmunology_2012_Mar_1_1(2)_172-178.nxml.txt.nlp	22720238	SENT30	12	12	10	10	rituximab	IL-2	PA451261	3558	0.597
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT128	2	2	0	0	dasatinib	PP2	PA162372878	4888	0.597
NULL	Bull_Math_Biol_2012_Dec_14_74(12)_2875-2896.nxml.txt.nlp	23151957	SENT362	7	7	13	13	heparin	U87	PA449855	677775;641648	0.597
NULL	J_Antimicrob_Chemother_2014_Apr_2_69(4)_911-918.nxml.txt.nlp	24302651	SENT39	6	6	20	20	cefoxitin	FUS	PA448856	2521	0.597
NULL	Genet_Mol_Biol_2009_Sep_1_Jul-Sep_32(3)_516-520.nxml.txt.nlp	21637514	SENT109	7	7	26	26	estradiol	FGF2	PA449503	2247;2258	0.597
NULL	Cancer_Med_2013_Oct_18_2(5)_595-610.nxml.txt.nlp	24403226	SENT306	32	32	19	19	sunitinib	ZEB1	PA162372840	6935	0.597
NULL	Int_J_Environ_Res_Public_Health_2014_Apr_23_11(4)_4449-4527.nxml.txt.nlp	24762670	SENT478	39	39	37	37	lindane	gamma	PA164754914	9913	0.597
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jul_6_67(Pt_8)_o1933.nxml.txt.nlp	22090977	SENT73	27	27	14	14	ethanol	mol	PA448073	90527	0.597
NULL	Int_J_Endocrinol_2013_Mar_12_2013_578693.nxml.txt.nlp	23573088	SENT64	3	3	17	17	glucose	AST	PA449773	26503	0.597
NULL	J_Ginseng_Res_2011_Nov_35(4)_436-441.nxml.txt.nlp	23717089	SENT117	17	17	7	7	ginseng	CAGC	PA164781150	6283	0.597
NULL	Nucleic_Acids_Res_2006_Jun_6_34(10)_3095-3106.nxml.txt.nlp	16757575	SENT422	9	9	31	31	raloxifene	PS2	PA451221	5664	0.597
NULL	Blood_Res_2013_Sep_25_48(3)_171-177.nxml.txt.nlp	24086936	SENT137	18	18	20	20	bortezomib	CHOP	PA10252	1649	0.597
NULL	Oxid_Med_Cell_Longev_2013_Jun_6_2013_891748.nxml.txt.nlp	23840922	SENT190	0	0	26	26	resveratrol	HIF-1		29072	0.597
NULL	Ann_Rheum_Dis_2013_Aug_21_72(8)_1287-1294.nxml.txt.nlp	22915624	SENT132	10	10	4	4	methotrexate	MCP	PA450428	822	0.597
NULL	J_Ophthalmol_2011_Nov_1_2011_743670.nxml.txt.nlp	22132313	SENT33	31	31	37	37	fluorescein	FAF	PA164746009	8239;2188	0.597
NULL	Cell_Host_Microbe_2014_Dec_10_16(6)_778-786.nxml.txt.nlp	25498345	SENT75	10	10	8	8	choline	CDP	PA448976	1523	0.597
NULL	J_Lipid_Res_2014_Apr_55(4)_645-658.nxml.txt.nlp	24493834	SENT358	33	33	30	30	lipase	PLIN5	PA450239	440503	0.597
NULL	AIDS_Res_Ther_2007_May_1_4_8.nxml.txt.nlp	17472747	SENT13	0	0	5	5	ritonavir	adiponectin	PA451260	9370	0.597
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_17_2013_523484.nxml.txt.nlp	23843878	SENT7	2	2	10	10	curcumin	CYP2E1	PA151958596	1571	0.597
NULL	J_Cell_Biol_1981_Dec_1_91(3)_889-894.nxml.txt.nlp	6976966	SENT1	0	0	15	15	colchicine	T200	PA449092	5788	0.597
NULL	J_Hum_Genet_2013_Jun_2_58(6)_306-312.nxml.txt.nlp	23635953	SENT156	10	10	21	21	estradiol	CYP19A1	PA449503	1588	0.597
NULL	Ann_Gen_Psychiatry_2014_Sep_24_13_27.nxml.txt.nlp	25478001	SENT182	7	7	20	20	creatine	GAMT	PA164778930	2593	0.597
NULL	Arthritis_Res_Ther_2009_Jul_23_11(4)_236.nxml.txt.nlp	19664185	SENT69	25	25	7	7	probenecid	ABCG2	PA451106	9429	0.597
NULL	Arthritis_Res_2002_Feb_4_4(Suppl_1)_83.nxml.txt.nlp	NULL	SENT11	6	6	19	19	nadh	GAPDH	PA164755085	2597	0.597
NULL	Chemother_Res_Pract_2011_Sep_21_2011_839742.nxml.txt.nlp	22295206	SENT90	33	33	31	31	cetuximab	EGFR	PA10040	1956	0.597
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT128	9	9	0	0	quinidine	CYP1A2	PA451209	1544	0.597
NULL	Neural_Plast_2014_May_12_2014_563160.nxml.txt.nlp	24900924	SENT257	10	10	25	25	curcumin	spatial	PA151958596	219793	0.597
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT173	20	20	12	12	simvastatin	survivin	PA451363	332	0.597
NULL	Chin_J_Cancer_2012_Feb_31(2)_51-57.nxml.txt.nlp	22257384	SENT67	4	4	19	19	genistein	MRP1	PA165109660	4437	0.597
NULL	Curr_Osteoporos_Rep_2014_Jan_24_12(1)_127-134.nxml.txt.nlp	24458429	SENT101	6	6	27	27	pamidronate	ADAMTS-4	PA450767	9508	0.597
NULL	Ann_Rheum_Dis_2011_Oct_12_71(4)_541-548.nxml.txt.nlp	21994233	SENT108	9	9	0	0	infliximab	ACR	PA452639	49	0.597
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT128	16	16	3	3	propafenone	CYP2D6	PA451131	1565	0.597
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT128	8	8	4	4	flecainide	CYP3A4	PA449646	1576	0.597
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_315-322.nxml.txt.nlp	20049735	SENT59	14	14	6	6	cisplatin	PTEN	PA449014	5728	0.597
NULL	DNA_Res_2011_Aug_26_18(4)_291-303.nxml.txt.nlp	21791478	SENT44	21	21	11	11	paraformaldehyde	IFN	PA450790	3439	0.597
NULL	Leukemia_2013_Feb_10_27(2)_507-510.nxml.txt.nlp	22810506	SENT92	8	8	29	29	fludarabine	TRAC	PA449655	28755	0.597
NULL	Oncotarget_2013_Jan_27_4(1)_153-162.nxml.txt.nlp	23847722	SENT128	1	1	10	10	fluorouracil	HAI	PA128406956	6692;6768	0.597
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1449-1456.nxml.txt.nlp	24077631	SENT63	29	29	7	7	tolbutamide	CYP2C9	PA451718	1559	0.597
NULL	Acta_Pharmacol_Sin_2012_Jan_28_33(1)_66-74.nxml.txt.nlp	22120966	SENT250	24	24	14	14	genistein	OPG	PA165109660	690	0.597
NULL	Environ_Health_Perspect_2011_Mar_1_119(3)_371-376.nxml.txt.nlp	21041162	SENT14	0	0	2	2	diethylstilbestrol	DES	PA449307	1674	0.597
NULL	J_Infect_Dis_2013_Sep_1_208(5)_801-812.nxml.txt.nlp	23766527	SENT121	8	8	4	4	lumefantrine	LUM	PA165111722	4060	0.597
NULL	Int_J_Nanomedicine_2012_Oct_25_7_5565-5575.nxml.txt.nlp	23118538	SENT131	9	9	15	15	fenofibrate	CO2	PA449594	4513	0.597
NULL	Adv_Urol_2012_Apr_3_2012_248607.nxml.txt.nlp	22548055	SENT190	3	3	6	6	metformin	AMPK	PA450395	5563	0.597
NULL	Int_J_Nanomedicine_2009_Apr_20_4_99-105.nxml.txt.nlp	19516888	SENT177	13	13	11	11	paclitaxel	castor	PA450761	54897	0.597
NULL	Saudi_J_Anaesth_2014_Apr-Jun_8(2)_209-214.nxml.txt.nlp	24843334	SENT8	8	8	11	11	clonidine	C15	PA449051	51316	0.597
NULL	Front_Endocrinol_(Lausanne)_2014_Dec_18_5_218.nxml.txt.nlp	25566190	SENT34	9	9	1	1	glucose	GHR	PA449773	2690	0.597
NULL	Cancer_Med_2014_Oct_25_3(5)_1099-1111.nxml.txt.nlp	24961511	SENT337	19	19	13	13	cisplatin	VEGFC	PA449014	7424	0.597
NULL	Br_J_Cancer_2009_Jul_7_101(1)_139-144.nxml.txt.nlp	19568272	SENT76	38	38	6	6	trypsin	CO2	PA451806	4513	0.597
NULL	EMBO_Mol_Med_2012_Feb_4(2)_109-124.nxml.txt.nlp	22228679	SENT310	28	28	30	30	piroxicam	PIR	PA450985	8544	0.597
NULL	Mol_Biotechnol_2013_Jan_28_53(1)_9-18.nxml.txt.nlp	23104232	SENT51	41	41	32	32	l-glutamine	F12	PA10090	2161	0.597
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT211	2	2	4	4	capsaicin	p53	PA448776	7157	0.597
NULL	J_Carcinog_2011_Nov_30_10_27.nxml.txt.nlp	22190869	SENT77	3	3	19	19	resveratrol	TRAMP		8718;23471;9189	0.597
NULL	Mol_Vis_2011_Jun_9_17_1564-1576.nxml.txt.nlp	21738386	SENT128	11	11	13	13	ethambutol	EMB	PA164784021	133418	0.597
NULL	Clinics_(Sao_Paulo)_2013_May_68(5)_592-598.nxml.txt.nlp	23778413	SENT220	29	29	7	7	epirubicin	HIF2A	PA449476	2034	0.597
NULL	Diabetes_2011_Nov_17_60(11)_2928-2938.nxml.txt.nlp	21885868	SENT312	7	7	32	32	curcumin	MCP-1	PA151958596	6347	0.597
NULL	Crit_Care_2008_Nov_26_12(Suppl_6)_S2.nxml.txt.nlp	19105795	SENT4	33	33	21	21	oxygen	CAP	PA450744	23476;9200;4012;5269;10580;10487	0.597
NULL	Int_J_Environ_Res_Public_Health_2010_Dec_21_7(12)_4281-4304.nxml.txt.nlp	21318009	SENT149	7	7	3	3	ethanol	Bcl-2	PA448073	596	0.597
NULL	Front_Oncol_2014_Apr_21_4_82.nxml.txt.nlp	24795859	SENT306	16	16	13	13	rituximab	CHOP	PA451261	1649	0.597
NULL	Br_J_Pharmacol_2014_Aug_17_171(15)_3651-3665.nxml.txt.nlp	24712679	SENT256	19	19	11	11	exenatide	GLP-1	PA164749238	100125288	0.597
NULL	J_Cancer_2013_Aug_28_4(7)_585-596.nxml.txt.nlp	24069069	SENT158	9	9	2	2	verteporfin	LC3	PA451871	84557	0.597
NULL	Int_J_Inflam_2011_Sep_20_2011_367284.nxml.txt.nlp	21941675	SENT383	23	23	39	39	enoxaparin	MCP-1	PA449463	6347	0.597
NULL	Nucleic_Acids_Res_2005_Mar_14_33(5)_1581-1592.nxml.txt.nlp	15767283	SENT50	25	25	34	34	l-glutamine	CO2	PA10090	4513	0.597
NULL	Hum_Genomics_2008_Sep_1_3(1)_7-16.nxml.txt.nlp	19129086	SENT121	0	0	4	4	rosiglitazone	SLCO1B1	PA451283	10599	0.597
NULL	Orphanet_J_Rare_Dis_2014_Sep_2_9(1)_130.nxml.txt.nlp	NULL	SENT434	15	15	24	24	l-carnitine	B12	PA450154	7126;4709	0.597
NULL	Int_J_Nanomedicine_2012_Sep_21_7_5091-5106.nxml.txt.nlp	23049256	SENT336	7	7	22	22	protamine	ALP	PA10366	6590;10850;27295;80150;470;26033	0.597
NULL	Protein_Cell_2014_Jun_19_5(6)_469-479.nxml.txt.nlp	24748116	SENT171	18	18	26	26	paclitaxel	EB1	PA450761	9167;22919;10982	0.597
NULL	Patient_Prefer_Adherence_2013_Sep_11_7_891-895.nxml.txt.nlp	24049440	SENT52	14	14	20	20	efavirenz	ART	PA449441	181	0.597
NULL	Breast_Cancer_Res_2000_Jul_7_2(5)_353-359.nxml.txt.nlp	11250728	SENT100	13	13	15	15	diethylstilbestrol	DES	PA449307	1674	0.597
NULL	Mol_Cells_2014_Mar_31_37(3)_234-240.nxml.txt.nlp	24642709	SENT109	16	16	13	13	capsaicin	NOX4	PA448776	50507	0.597
NULL	Clin_Interv_Aging_2010_Dec_3_5_403-416.nxml.txt.nlp	21152242	SENT139	36	36	33	33	telmisartan	ACE	PA451605	1636	0.597
NULL	J_Korean_Med_Sci_2011_Jul_20_26(7)_893-899.nxml.txt.nlp	21738342	SENT10	14	14	9	9	resveratrol	CD97		976	0.597
NULL	Osteoarthritis_Cartilage_2013_Sep_21(9)_1336-1345.nxml.txt.nlp	23973148	SENT25	0	0	13	13	triamcinolone	MNX	PA451749	3892	0.597
NULL	Infect_Dis_Rep_2012_Apr_3_4(2)_e26.nxml.txt.nlp	24470940	SENT99	35	35	26	26	benzaldehyde	ETB	PA448571	1910	0.597
NULL	Exp_Ther_Med_2014_Dec_24_8(6)_1677-1682.nxml.txt.nlp	25371714	SENT146	11	11	19	19	isoproterenol	HIF-1	PA450121	29072	0.597
NULL	Braz_J_Microbiol_2009_Jun_1_Apr-Jun_40(2)_358-366.nxml.txt.nlp	24031373	SENT290	9	9	14	14	lipase	CCR11	PA450239	51554	0.597
NULL	Allergy_Asthma_Immunol_Res_2014_Jul_21_6(4)_341-349.nxml.txt.nlp	24991458	SENT214	17	17	14	14	methacholine	AHR	PA165958382	196	0.597
NULL	Behav_Brain_Funct_2011_Sep_7_7_39.nxml.txt.nlp	21899751	SENT79	1	1	11	11	lidocaine	KCNH2	PA450226	3757	0.597
NULL	J_Oncol_2010_Aug_24_2010_654348.nxml.txt.nlp	20871846	SENT53	17	17	10	10	exemestane	ATAC	PA449563	6375	0.597
NULL	Acta_Pharmacol_Sin_2010_Jul_28_31(7)_849-854.nxml.txt.nlp	20581858	SENT39	28	28	36	36	gentamicin	CO2	PA449753	4513	0.597
NULL	Anal_Bioanal_Chem_2011_Sep_14_401(4)_1109-1125.nxml.txt.nlp	21755271	SENT147	22	22	19	19	morphine	PEBP	PA450550	5037	0.597
NULL	Cancer_Med_2013_Oct_19_2(5)_646-653.nxml.txt.nlp	24403230	SENT94	14	14	21	21	trastuzumab	SESN1	PA451743	27244	0.597
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2014_May_24_70(Pt_6)_1614-1621.nxml.txt.nlp	24914972	SENT108	13	13	2	2	guanidine	CD27	PA164781028	939	0.597
NULL	J_Cancer_2013_Mar_15_4(3)_241-250.nxml.txt.nlp	23459666	SENT90	19	19	15	15	cetuximab	KRAS	PA10040	3845	0.597
NULL	Breast_Cancer_Res_2010_Dec_17_12(6)_R107.nxml.txt.nlp	21167057	SENT238	24	24	2	2	ethanol	CXCR4	PA448073	7852	0.597
NULL	J_Korean_Med_Sci_2007_Apr_30_22(2)_283-289.nxml.txt.nlp	17449938	SENT112	1	1	8	8	minoxidil	P21	PA450521	1026;9338	0.597
NULL	Biomed_Res_Int_2014_Feb_10_2014_708593.nxml.txt.nlp	24689050	SENT268	3	3	0	0	etoposide	TEM	PA449552	64102	0.597
NULL	J_Med_Case_Reports_2008_May_23_2_174.nxml.txt.nlp	18500979	SENT30	8	8	10	10	trimethoprim	TMP	PA451788	2012	0.597
NULL	Eur_J_Neurosci_2014_Feb_4_39(3)_419-434.nxml.txt.nlp	24494682	SENT4	1	1	3	3	lipase	MGL	PA450239	11343	0.597
NULL	Int_J_Mol_Sci_2014_Jun_18_15(6)_11013-11029.nxml.txt.nlp	24945311	SENT77	38	38	9	9	celecoxib	STAT3	PA448871	6774	0.597
NULL	Acta_Diabetol_2012_Aug_11_49(4)_277-289.nxml.txt.nlp	21833779	SENT138	27	27	23	23	carbachol	ANOVA	PA448784	4858	0.597
NULL	Breast_Cancer_Res_2004_Dec_15_6(2)_R63-R74.nxml.txt.nlp	14979919	SENT248	14	14	30	30	estradiol	CYP1A1	PA449503	1543	0.597
NULL	Curr_Pharm_Des_2011_Feb_17(6)_578-590.nxml.txt.nlp	21391908	SENT181	2	2	11	11	nutlin-3	MDM2		4193	0.597
NULL	Oncotarget_2012_Oct_20_3(10)_1236-1245.nxml.txt.nlp	23100449	SENT76	13	13	22	22	doxorubicin	NGAL	PA449412	3934	0.597
NULL	Lipids_Health_Dis_2011_Dec_6_10_229.nxml.txt.nlp	22146099	SENT165	32	32	28	28	rosiglitazone	IL-13	PA451283	3596	0.597
NULL	Mol_Cancer_2010_Dec_7_9_311.nxml.txt.nlp	21138557	SENT201	9	9	11	11	bleomycin	BLM	PA448645	641	0.597
NULL	Indian_J_Med_Res_2013_Nov_138(5)_577-590.nxml.txt.nlp	24434313	SENT153	21	21	23	23	staurosporine	gamma	PA165109623	9913	0.597
NULL	Evid_Based_Complement_Alternat_Med_2013_Dec_12_2013_324618.nxml.txt.nlp	24416065	SENT3	20	20	22	22	atazanavir	ATV	PA10251	4683	0.597
NULL	Autophagy_2012_May_1_8(5)_853-855.nxml.txt.nlp	22617440	SENT51	8	8	32	32	imatinib	MIR30A	PA10804	407029	0.597
NULL	J_Korean_Med_Sci_2014_Jan_26_29(1)_53-60.nxml.txt.nlp	24431906	SENT9	9	9	18	18	cyclophosphamide	CHOP	PA449165	1649	0.597
NULL	Neuroscience_2008_Aug_13_155(2)_556-564.nxml.txt.nlp	18619738	SENT184	16	16	14	14	choline	CDP	PA448976	1523	0.597
NULL	Cancer_Manag_Res_2012_Nov_9_4_383-395.nxml.txt.nlp	23204869	SENT112	2	2	6	6	carmustine	PC-3	PA448810	692094	0.597
NULL	Biol_Open_2014_Nov_21_3(12)_1207-1216.nxml.txt.nlp	25416063	SENT261	26	26	6	6	zinc	NANOS3	PA451956	342977	0.597
NULL	Curr_Nutr_Rep_2014_Dec_15_3(1)_22-34.nxml.txt.nlp	24563822	SENT71	27	27	42	42	estradiol	SHBG	PA449503	6462	0.597
NULL	Oncotarget_2013_Nov_7_4(12)_2550-2566.nxml.txt.nlp	24334291	SENT207	33	33	17	17	dasatinib	p53	PA162372878	7157	0.597
NULL	J_Gen_Physiol_2008_Nov_132(5)_521-535.nxml.txt.nlp	18852303	SENT128	10	10	3	3	aprotinin	CAP2	PA448472	5271;10486	0.597
NULL	Mol_Cancer_2014_Jan_28_13_17.nxml.txt.nlp	24472312	SENT232	5	5	3	3	ponatinib	Mcl-1	PA165980594	4170	0.597
NULL	EMBO_Rep_2010_Oct_3_11(10)_758-764.nxml.txt.nlp	20814424	SENT76	23	23	26	26	glucose	Grc3	PA449773	79707	0.597
NULL	Mol_Cancer_2014_Jan_15_13_8.nxml.txt.nlp	24423412	SENT102	16	16	3	3	cisplatin	CD44	PA449014	960	0.597
NULL	Int_J_Mol_Imaging_2011_Oct_26_2011_874585.nxml.txt.nlp	21490735	SENT15	1	1	11	11	glucose	FDG	PA449773	23583	0.597
NULL	Ann_Hematol_2015_Aug_3_94_35-43.nxml.txt.nlp	25085377	SENT233	15	15	6	6	nutlin-3	TRAIL		8743	0.597
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1100-1106.nxml.txt.nlp	22374459	SENT52	13	13	18	18	erlotinib	EGFR	PA134687924	1956	0.597
NULL	Acta_Pharmacol_Sin_2011_Jul_20_32(7)_956-966.nxml.txt.nlp	21685928	SENT40	0	0	2	2	streptozocin	STZ	PA451514	6484	0.597
NULL	Oncotarget_2012_Dec_17_4(1)_48-63.nxml.txt.nlp	23295955	SENT176	4	4	10	10	methotrexate	MTHFD2	PA450428	10797	0.597
NULL	Exp_Lung_Res_2013_Oct_1_39(8)_336-348.nxml.txt.nlp	23919450	SENT213	0	0	10	10	thrombin	PAR-1	PA451674	2011;2149	0.596
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jan_8_67(Pt_2)_o307.nxml.txt.nlp	21522996	SENT3	17	17	2	2	coumarin	mol	PA134521193	90527	0.596
NULL	Mol_Vis_2011_Dec_24_17_3384-3391.nxml.txt.nlp	22219634	SENT106	17	17	8	8	mannitol	TLR2	PA450320	7097	0.596
NULL	Cell_Death_Dis_2010_Mar_18_1(3)_e31.nxml.txt.nlp	21364639	SENT137	7	7	11	11	staurosporine	PDK1	PA165109623	5170;5163	0.596
NULL	Pharmaceuticals_(Basel)_2014_Jan_9_7(1)_46-57.nxml.txt.nlp	24451403	SENT127	14	14	16	16	ritonavir	AKT	PA451260	207	0.596
NULL	Int_J_Nanomedicine_2009_Apr_1_4_27-35.nxml.txt.nlp	19421368	SENT176	10	10	14	14	genistein	IL-2	PA165109660	3558	0.596
NULL	Emerg_Infect_Dis_2014_Sep_20(9)_1464-1471.nxml.txt.nlp	25148473	SENT52	3	3	11	11	fluorescein	CD69	PA164746009	969	0.596
NULL	Br_J_Cancer_2010_Jan_19_102(2)_383-391.nxml.txt.nlp	20010943	SENT103	19	19	21	21	cisplatin	P31	PA449014	529	0.596
NULL	Exp_Ther_Med_2014_Apr_13_7(4)_799-803.nxml.txt.nlp	24669235	SENT10	4	4	11	11	metformin	PPG	PA450395	5552	0.596
NULL	J_Cell_Biol_1983_May_1_96(5)_1234-1240.nxml.txt.nlp	6404909	SENT1	11	11	13	13	thrombin	ADP	PA451674	23038	0.596
NULL	Clin_Pharmacokinet_2013_Jun_26_52(6)_453-462.nxml.txt.nlp	23529813	SENT40	2	2	18	18	dabigatran	P-gp		5243	0.596
NULL	Int_Neurourol_J_2011_Jun_30_15(2)_64-73.nxml.txt.nlp	21811695	SENT93	4	4	6	6	vasopressin	AVP	PA451858	114548;551	0.596
NULL	Indian_J_Endocrinol_Metab_2013_Sep-Oct_17(5)_819-834.nxml.txt.nlp	24083163	SENT316	17	17	14	14	exenatide	GLP-1	PA164749238	100125288	0.596
NULL	Int_J_Med_Sci_2013_Mar_15_10(5)_567-574.nxml.txt.nlp	23533048	SENT26	0	0	2	2	lamivudine	LAM	PA450163	7249;7248	0.596
NULL	Br_J_Cancer_2009_Oct_20_101(8)_1253-1260.nxml.txt.nlp	19755984	SENT192	2	2	10	10	anastrozole	AIB1	PA448432	8202	0.596
NULL	J_Cell_Sci_2014_May_1_127(9)_2106-2119.nxml.txt.nlp	24569881	SENT207	22	22	13	13	isoproterenol	SUR1	PA450121	6833	0.596
NULL	J_Physiol_2014_Nov_15_592(22)_5093-5107.nxml.txt.nlp	25239460	SENT163	6	6	8	8	ketoprofen	PAG	PA450149	55824	0.596
NULL	J_Gen_Physiol_1997_Jan_1_109(1)_15-26.nxml.txt.nlp	8997662	SENT132	3	3	18	18	amiloride	STX	PA448368	8128	0.596
NULL	Pain_Res_Treat_2011_Jul_2_2011_650320.nxml.txt.nlp	22110929	SENT259	9	9	4	4	midazolam	SAS	PA450496	54187	0.596
NULL	Mol_Brain_2014_Mar_10_7_14.nxml.txt.nlp	24618249	SENT125	13	13	6	6	dextran	CST	PA449261	9514	0.596
NULL	Oncotarget_2014_Oct_21_5(22)_11709-11722.nxml.txt.nlp	25365944	SENT154	0	0	7	7	metformin	RhoA	PA450395	387	0.596
NULL	J_Antimicrob_Chemother_2014_Mar_11_69(3)_594-597.nxml.txt.nlp	24216768	SENT36	7	7	13	13	oxacillin	PEN	PA450725	9933	0.596
NULL	Crit_Care_2011_Apr_11_15(2)_R112.nxml.txt.nlp	21481266	SENT79	21	21	26	26	piperacillin	SAPS	PA450975	8935	0.596
NULL	Cells_2014_Nov_27_3(4)_1089-1101.nxml.txt.nlp	25437439	SENT71	1	1	4	4	spermine	TRPM7	PA164781199	54822	0.596
NULL	Int_J_Nanomedicine_2012_Oct_1_7_5159-5173.nxml.txt.nlp	23055728	SENT231	32	32	44	44	heparin	CO2	PA449855	4513	0.596
NULL	Crit_Care_2010_Nov_5_14(6)_R200.nxml.txt.nlp	21054850	SENT26	18	18	30	30	vasopressin	AVP	PA451858	114548;551	0.596
NULL	Front_Immunol_2013_May_15_4_116.nxml.txt.nlp	23720663	SENT15	6	6	37	37	temozolomide	GITR	PA451609	8784	0.596
NULL	Oncol_Lett_2013_Dec_4_6(6)_1665-1672.nxml.txt.nlp	24273604	SENT8	6	6	2	2	chloroquine	TLR9	PA448948	54106	0.596
NULL	Acta_Pharmacol_Sin_2012_Mar_30_33(3)_401-406.nxml.txt.nlp	22286916	SENT131	26	26	28	28	cisplatin	DDP	PA449014	1678	0.596
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Mar_27_66(Pt_4)_o942-o943.nxml.txt.nlp	21580748	SENT78	11	11	14	14	benzaldehyde	mol	PA448571	90527	0.596
NULL	Antimicrob_Agents_Chemother_2014_Feb_58(2)_706-712.nxml.txt.nlp	24217698	SENT169	0	0	15	15	nevirapine	CYP2B6	PA450616	1555	0.596
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT128	15	15	3	3	theophylline	CYP2D6	PA451647	1565	0.596
NULL	Breast_Cancer_Res_Treat_2012_Jun_18_133(3)_937-947.nxml.txt.nlp	22094936	SENT209	14	14	5	5	tamoxifen	CDC2	PA451581	5424	0.596
NULL	Adv_Hematol_2011_Apr_10_2011_960137.nxml.txt.nlp	21547266	SENT88	8	8	2	2	vincristine	CHOP	PA451879	1649	0.596
NULL	Front_Neurol_2011_Feb_22_2_7.nxml.txt.nlp	21373206	SENT355	13	13	15	15	streptokinase	ASK	PA164754919	10926	0.596
NULL	Ann_Surg_Treat_Res_2014_Feb_22_86(2)_55-60.nxml.txt.nlp	24761409	SENT95	18	18	21	21	thyroglobulin	CTX	PA164754910	1593	0.596
NULL	Breast_Cancer_Res_2005_Nov_21_7(6)_R1153-R1158.nxml.txt.nlp	16457695	SENT94	2	2	13	13	tamoxifen	EGFR	PA451581	1956	0.596
NULL	J_Cell_Biol_2008_Jul_28_182(2)_381-393.nxml.txt.nlp	18663145	SENT214	5	5	8	8	trypsin	GIV	PA451806	55704	0.596
NULL	Arthritis_Res_Ther_2005_Sep_15_7(Suppl_4)_S23-S29.nxml.txt.nlp	16168078	SENT19	12	12	18	18	misoprostol	COX	PA450523	1351	0.596
NULL	Oncogene_2013_Sep_12_32(37)_4355-4365.nxml.txt.nlp	23108409	SENT37	19	19	9	9	hyaluronan	HAS2	PA165958431	3037	0.596
NULL	Diabetes_2008_Sep_57(9)_2272-2279.nxml.txt.nlp	18519799	SENT149	8	8	20	20	rosiglitazone	PDK4	PA451283	5166	0.596
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT128	5	5	7	7	resveratrol	TRAIL		8743	0.596
NULL	Mol_Brain_2013_Apr_9_6_16.nxml.txt.nlp	23570271	SENT236	0	0	14	14	sulindac	cPLA2	PA451565	10524	0.596
NULL	Int_J_Hypertens_2012_Feb_8_2012_414128.nxml.txt.nlp	22518283	SENT35	34	34	11	11	estradiol	ACE2	PA449503	59272	0.596
NULL	Front_Genet_2014_Jun_2_5_162.nxml.txt.nlp	24917882	SENT997	13	13	0	0	irinotecan	KRAS	PA450085	3845	0.596
NULL	Oxid_Med_Cell_Longev_2011_Oct_15_2011_703676.nxml.txt.nlp	22013498	SENT8	19	19	27	27	resveratrol	IL-6		3569	0.596
NULL	Hum_Genomics_2010_Apr_1_4(4)_238-249.nxml.txt.nlp	20511137	SENT61	25	25	19	19	irinotecan	UGT1A1	PA450085	54658	0.596
NULL	Crit_Care_2006_May_25_10(3)_144.nxml.txt.nlp	16732898	SENT38	7	7	0	0	vasopressin	ANG	PA451858	283	0.596
NULL	Emerg_Infect_Dis_2014_Apr_20(4)_612-619.nxml.txt.nlp	24655615	SENT30	20	20	13	13	ciprofloxacin	GISP	PA449009	83998	0.596
NULL	Front_Neurosci_2014_Nov_10_8_364.nxml.txt.nlp	25426018	SENT261	7	7	2	2	fluorescein	ANOVA	PA164746009	4858	0.596
NULL	Oncogenesis_2014_Dec_15_3(12)_e133.nxml.txt.nlp	25500906	SENT118	25	25	28	28	trastuzumab	PIK3CA	PA451743	5290	0.596
NULL	Arthritis_Res_Ther_2011_Dec_12_13(6)_R204.nxml.txt.nlp	22151924	SENT131	16	16	4	4	abatacept	CFB	PA164747080	629	0.596
NULL	Exp_Ther_Med_2014_Sep_23_8(3)_935-942.nxml.txt.nlp	25120627	SENT31	26	26	13	13	mitomycin	CO2	PA450524	4513	0.596
NULL	Front_Genet_2012_Sep_6_3_173.nxml.txt.nlp	22973297	SENT42	25	25	19	19	gemcitabine	FKBP5	PA449748	2289	0.596
NULL	Infect_Drug_Resist_2010_Oct_13_3_103-114.nxml.txt.nlp	21694899	SENT46	13	13	7	7	raltegravir	UGT1A1		54658	0.596
NULL	Ann_Oncol_2009_Aug_20(Suppl_6)_vi35-vi40.nxml.txt.nlp	19617296	SENT73	0	0	13	13	tanespimycin	Hsp90	PA165291490	3320	0.596
NULL	Oncol_Rep_2014_Jan_8_31(1)_19-26.nxml.txt.nlp	24213840	SENT129	23	23	28	28	decitabine	p15	PA164749631	10923;10573	0.596
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT144	16	16	18	18	methotrexate	MSH2	PA450428	4436	0.596
NULL	Nucleic_Acids_Res_2012_Jul_27_40(13)_6109-6121.nxml.txt.nlp	22453275	SENT303	8	8	18	18	iodixanol	CRIF1	PA164783998	90480	0.596
NULL	Int_J_Environ_Res_Public_Health_2010_Mar_15_7(3)_1093-1104.nxml.txt.nlp	20617020	SENT79	0	0	11	11	resveratrol	IL-10		3586	0.596
NULL	Exp_Ther_Med_2014_Aug_6_8(2)_585-590.nxml.txt.nlp	25009624	SENT7	3	3	9	9	glucose	ROS	PA449773	6098	0.596
NULL	Nat_Commun_2014_Aug_5_5_4408.nxml.txt.nlp	25093291	SENT373	8	8	6	6	cetirizine	HRH1	PA448905	3269;1659	0.596
NULL	Front_Mol_Neurosci_2012_Nov_12_5_99.nxml.txt.nlp	23162427	SENT286	18	18	23	23	cocaine	CPP	PA449072	340451	0.596
NULL	Adv_Hematol_2012_Jan_18_2012_195484.nxml.txt.nlp	22312366	SENT22	3	3	14	14	rituximab	CHOP	PA451261	1649	0.596
NULL	Clin_Med_Insights_Oncol_2011_Feb_14_5_15-21.nxml.txt.nlp	21499558	SENT89	13	13	6	6	bevacizumab	OST	PA130232992	1650;23263	0.596
NULL	EMBO_Mol_Med_2012_May_4(5)_396-411.nxml.txt.nlp	22351606	SENT124	11	11	19	19	heparin	EGF	PA449855	1950	0.596
NULL	J_Clin_Exp_Pathol_2012_May_17_Suppl_4_7327.nxml.txt.nlp	25379357	SENT195	0	0	21	21	resveratrol	DEPTOR		64798	0.596
NULL	Br_J_Cancer_2014_Nov_25_111(11)_2091-2102.nxml.txt.nlp	25349971	SENT180	21	21	18	18	imatinib	PTPN18	PA10804	26469	0.596
NULL	Int_J_Med_Sci_2015_Jan_1_12(1)_63-71.nxml.txt.nlp	25552920	SENT22	5	5	8	8	berberine	BMP7	PA165860812	655	0.596
NULL	Diabetologia_2010_Jun_27_53(6)_1142-1150.nxml.txt.nlp	20349036	SENT226	21	21	30	30	nitroprusside	AMPK	PA451406	5563	0.596
NULL	Front_Neurosci_2012_May_30_6_77.nxml.txt.nlp	22661925	SENT252	43	43	30	30	ethanol	HEC	PA448073	10403	0.596
NULL	Mol_Vis_2011_May_4_17_1172-1181.nxml.txt.nlp	21617754	SENT202	14	14	0	0	staurosporine	FKBP51	PA165109623	2289	0.596
NULL	Nucleic_Acids_Res_2012_Jun_10_40(11)_4804-4815.nxml.txt.nlp	22328728	SENT226	12	12	5	5	hemin	SIRT1	PA449849	23411	0.596
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Jul_23_6_103-113.nxml.txt.nlp	25114588	SENT73	11	11	14	14	trastuzumab	DM1	PA451743	338023;1760;28509	0.596
NULL	Evid_Based_Complement_Alternat_Med_2013_Aug_12_2013_982689.nxml.txt.nlp	23997806	SENT230	45	45	7	7	tolbutamide	APE	PA451718	55704;328	0.596
NULL	Clin_Ophthalmol_2014_Feb_10_8_389-399.nxml.txt.nlp	24550667	SENT156	31	31	29	29	timolol	TIM	PA451690	7984;8914	0.596
NULL	J_Cancer_2013_Aug_28_4(7)_585-596.nxml.txt.nlp	24069069	SENT127	8	8	11	11	verteporfin	p62	PA451871	8878;10657;23636	0.596
NULL	Mol_Cell_Proteomics_2012_Feb_6_11(2)_M111_015222.nxml.txt.nlp	22147731	SENT256	22	22	24	24	cetuximab	PRIM1	PA10040	5557	0.596
NULL	Oncotarget_2012_Nov_17_4(1)_18-28.nxml.txt.nlp	23248157	SENT81	12	12	17	17	pargyline	U87	PA450797	677775;641648	0.596
NULL	J_Gen_Intern_Med_2009_May_3_24(5)_692-694.nxml.txt.nlp	19343457	SENT147	4	4	20	20	ezetimibe	ESG	PA10816	7089;7088;7090;7091	0.596
NULL	Comput_Math_Methods_Med_2012_Jan_16_2012_792375.nxml.txt.nlp	22291855	SENT82	26	26	32	32	estradiol	E2F2	PA449503	1870	0.596
NULL	Drug_Des_Devel_Ther_2014_Sep_23_8_1527-1538.nxml.txt.nlp	25284985	SENT110	22	22	20	20	celecoxib	IFN	PA448871	3439	0.596
NULL	Mol_Biol_Cell_2012_Jun_1_23(11)_2017-2027.nxml.txt.nlp	22496424	SENT201	7	7	5	5	warfarin	PRDX4	PA451906	10549	0.596
NULL	Cancer_Nanotechnol_2015_Jan_24_6_1.nxml.txt.nlp	25642297	SENT190	6	6	10	10	docetaxel	GM-CSF	PA449383	1437	0.596
NULL	Aging_(Albany_NY)_2014_Sep_2_6(9)_742-754.nxml.txt.nlp	25324470	SENT112	8	8	10	10	lipase	ATGL	PA450239	57104	0.596
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT166	0	0	3	3	tacrolimus	RANKL	PA451578	8600	0.596
NULL	Case_Rep_Neurol_2013_Mar_25_5(1)_56-61.nxml.txt.nlp	23626566	SENT24	18	18	26	26	thrombin	BCS	PA451674	617	0.596
NULL	Clin_Sarcoma_Res_2014_Jan_31_4_2.nxml.txt.nlp	24484617	SENT46	24	24	10	10	paclitaxel	SPARC	PA450761	6678	0.596
NULL	J_Korean_Med_Sci_2006_Dec_31_21(6)_1037-1040.nxml.txt.nlp	17179683	SENT96	2	2	8	8	omeprazole	BAM	PA450704	9126	0.596
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_127043.nxml.txt.nlp	23227093	SENT231	15	15	7	7	sulfaphenazole	CYP1A2	PA130231310	1544	0.596
NULL	Acta_Pharmacol_Sin_2011_Apr_28_32(4)_503-511.nxml.txt.nlp	21441948	SENT55	27	27	42	42	l-glutamine	CO2	PA10090	4513	0.596
NULL	Diabetes_Care_2010_Apr_12_33(4)_861-868.nxml.txt.nlp	20067962	SENT155	11	11	7	7	hyaluronan	TLR6	PA165958431	10333	0.596
NULL	Breast_Cancer_Res_2000_Aug_11_2(6)_417-422.nxml.txt.nlp	11250735	SENT41	6	6	9	9	thrombin	TIE2	PA451674	7010	0.596
NULL	Clinics_(Sao_Paulo)_2011_Aug_66(8)_1457-1462.nxml.txt.nlp	21915500	SENT121	3	3	9	9	rosuvastatin	IL-6	PA134308647	3569	0.596
NULL	Mol_Vis_2012_Oct_11_18_2509-2517.nxml.txt.nlp	23112566	SENT173	4	4	11	11	bevacizumab	RPE	PA130232992	6120	0.596
NULL	Indian_J_Orthop_2011_Sep-Oct_45(5)_450-453.nxml.txt.nlp	21886928	SENT35	25	25	17	17	heparin	ACL	PA449855	47	0.596
NULL	Cancer_Immunol_Immunother_2011_Jun_25_60(6)_793-808.nxml.txt.nlp	21350947	SENT155	32	32	16	16	sorafenib	IFN	PA7000	3439	0.596
NULL	Theranostics_2014_Apr_25_4(7)_708-720.nxml.txt.nlp	24883121	SENT233	17	17	3	3	trastuzumab	Ray	PA451743	26751	0.596
NULL	Clin_Pharmacol_2010_Sep_6_2_155-162.nxml.txt.nlp	22291500	SENT122	5	5	11	11	clopidogrel	SCAI	PA449053	286205	0.596
NULL	Oncol_Rep_2012_Apr_16_27(4)_971-978.nxml.txt.nlp	22266706	SENT192	8	8	10	10	cisplatin	Bcl-2	PA449014	596	0.596
NULL	J_Biol_Chem_2013_Jan_11_288(2)_1114-1124.nxml.txt.nlp	23172224	SENT182	7	7	19	19	calcein	7B2	PA132595336	6447	0.596
NULL	J_Hum_Hypertens_2011_Feb_13_25(2)_114-121.nxml.txt.nlp	20463748	SENT6	10	10	13	13	captopril	ACTH	PA448780	5443	0.596
NULL	Oncoscience_2014_Dec_15_1(12)_844-853.nxml.txt.nlp	25621299	SENT7	1	1	5	5	sunitinib	MVD	PA162372840	4597	0.596
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT23	16	16	11	11	imatinib	CML	PA10804	613	0.596
NULL	J_Hematol_Oncol_2013_Sep_5_6_66.nxml.txt.nlp	24010946	SENT301	30	30	26	26	trastuzumab	HER2	PA451743	2064	0.596
NULL	Int_J_Mol_Sci_2014_Jun_5_15(6)_10034-10051.nxml.txt.nlp	24905404	SENT142	21	21	19	19	trifluoperazine	TFP	PA451771	7034	0.596
NULL	Oncotarget_2013_Mar_26_4(3)_397-412.nxml.txt.nlp	23651630	SENT308	20	20	32	32	cyclophosphamide	CHOP	PA449165	1649	0.596
NULL	Clin_Endosc_2013_Jul_31_46(4)_311-312.nxml.txt.nlp	23964324	SENT0	21	21	17	17	midazolam	Solo	PA450496	91404	0.596
NULL	AIDS_Res_Ther_2013_Dec_13_10_33.nxml.txt.nlp	24330617	SENT147	8	8	38	38	raltegravir	ATV		4683	0.596
NULL	Basic_Clin_Neurosci_2014_Summer_5(3)_182-190.nxml.txt.nlp	25337378	SENT190	6	6	2	2	bupropion	mol	PA448687	90527	0.596
NULL	Jpn_Clin_Med_2013_Mar_6_4_7-13.nxml.txt.nlp	23966811	SENT127	10	10	13	13	esomeprazole	ESD	PA10075	2098	0.596
NULL	Carcinogenesis_2010_Dec_27_31(12)_2049-2057.nxml.txt.nlp	20876285	SENT242	8	8	25	25	tamoxifen	HER2	PA451581	2064	0.596
NULL	Pharmaceuticals_(Basel)_2012_Mar_21_5(3)_325-338.nxml.txt.nlp	24281382	SENT89	1	1	15	15	timolol	CRA	PA451690	51747;10903	0.596
NULL	Pharmaceuticals_(Basel)_2014_Jan_23_7(2)_113-135.nxml.txt.nlp	24463342	SENT79	8	8	12	12	memantine	sit	PA10364	55733	0.596
NULL	Indian_J_Endocrinol_Metab_2012_Dec_16(Suppl_2)_S245-S247.nxml.txt.nlp	23565390	SENT62	38	38	19	19	liraglutide	GLP	PA165958364	342096	0.596
NULL	Protein_Cell_2014_Jul_30_5(7)_552-562.nxml.txt.nlp	24870149	SENT101	23	23	40	40	kanamycin	PRK	PA450137	1263	0.596
NULL	Br_J_Cancer_2003_Mar_10_88(5)_754-759.nxml.txt.nlp	12618886	SENT70	5	5	2	2	amifostine	p53	PA448365	7157	0.596
NULL	Breast_Cancer_Res_2009_Mar_19_11(2)_R16.nxml.txt.nlp	19298655	SENT118	15	15	22	22	lipase	HSL	PA450239	3991	0.596
NULL	Ann_Gastroenterol_2013_26(1)_29-36.nxml.txt.nlp	24714698	SENT75	5	5	7	7	streptozocin	STZ	PA451514	6484	0.596
NULL	Ann_Surg_Oncol_2012_Dec_6_19(13)_4287-4299.nxml.txt.nlp	22766981	SENT20	27	27	30	30	bevacizumab	EGFR	PA130232992	1956	0.596
NULL	J_Autom_Methods_Manag_Chem_2007_Apr_23_2007_71943.nxml.txt.nlp	18528514	SENT1378	15	15	11	11	imipramine	FOR	PA449969	51741	0.596
NULL	Gut_Liver_2011_Jun_24_5(2)_160-164.nxml.txt.nlp	21814595	SENT107	41	41	43	43	meperidine	ESD	PA450369	2098	0.596
NULL	Chem_Cent_J_2013_Sep_4_7_147.nxml.txt.nlp	24006941	SENT93	7	7	9	9	lipase	LOX	PA450239	4015	0.596
NULL	Clin_Interv_Aging_2013_Feb_5_8_131-137.nxml.txt.nlp	23403474	SENT105	42	42	40	40	choline	CDP	PA448976	1523	0.596
NULL	Drug_Des_Devel_Ther_2014_Sep_23_8_1527-1538.nxml.txt.nlp	25284985	SENT194	36	36	26	26	celecoxib	IFN	PA448871	3439	0.596
NULL	Mol_Cancer_2007_Dec_28_6_83.nxml.txt.nlp	18163903	SENT21	18	18	4	4	coumarin	BGLAP	PA134521193	632	0.596
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT118	3	3	11	11	l-methionine	S6K1	PA450423	6198	0.596
NULL	Trials_2013_Sep_24_14_311.nxml.txt.nlp	24063608	SENT63	0	0	15	15	pyrimethamine	DHPS	PA451193	1725	0.596
NULL	Oncotarget_2013_Nov_24_4(12)_2430-2438.nxml.txt.nlp	24280348	SENT6	11	11	13	13	gefitinib	STAT3	PA131301952	6774	0.596
NULL	Br_J_Cancer_2013_Feb_5_108(2)_469-476.nxml.txt.nlp	23169292	SENT174	4	4	25	25	capecitabine	TTF1	PA448771	7080;7270	0.596
NULL	Acta_Pharmacol_Sin_2010_Feb_5_31(2)_137-144.nxml.txt.nlp	20139896	SENT117	26	26	17	17	zileuton	p38	PA451955	10598;1432;7965	0.596
NULL	Braz_J_Med_Biol_Res_2014_Jun_4_47(7)_567-575.nxml.txt.nlp	24919172	SENT205	24	24	26	26	bleomycin	BLM	PA448645	641	0.596
NULL	Target_Oncol_2013_Jun_27_8(2)_127-136.nxml.txt.nlp	23625191	SENT48	11	11	28	28	panitumumab	KRAS	PA162373091	3845	0.596
NULL	Biosci_Microbiota_Food_Health_2014_Jan_30_33(1)_31-40.nxml.txt.nlp	24936380	SENT241	12	12	1	1	nadh	Gen	PA164755085	348654	0.596
NULL	Mediators_Inflamm_2010_Jun_21_2010_194896.nxml.txt.nlp	20652055	SENT182	0	0	4	4	berberine	mol	PA165860812	90527	0.596
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1437-1448.nxml.txt.nlp	24056706	SENT111	10	10	29	29	furafylline	CYP3A4	PA452614	1576	0.596
NULL	Indian_J_Endocrinol_Metab_2011_Jan-Mar_15(1)_18-22.nxml.txt.nlp	21584161	SENT29	0	0	5	5	vasopressin	ACTH	PA451858	5443	0.596
NULL	Case_Rep_Ophthalmol_Med_2014_Oct_27_2014_326957.nxml.txt.nlp	25400961	SENT40	5	5	23	23	sulfacetamide	TMP	PA451536	2012	0.596
NULL	Dis_Markers_2010_Jun_29_28(5)_307-313.nxml.txt.nlp	20592455	SENT4	23	23	18	18	atorvastatin	CAD	PA448500	1677;790	0.596
NULL	Oncogene_2014_Aug_28_33(35)_4418-4423.nxml.txt.nlp	24469055	SENT173	25	25	12	12	erlotinib	RIT1	PA134687924	6016	0.596
NULL	J_Korean_Assoc_Oral_Maxillofac_Surg_2014_Dec_26_40(6)_291-296.nxml.txt.nlp	25551094	SENT98	2	2	5	5	alendronate	M-CSF	PA448082	1435	0.596
NULL	J_Nutr_Environ_Med_2007_Jan_10_Sep-Dec_16(3-4)_181-211.nxml.txt.nlp	18836533	SENT478	6	6	4	4	hydroxocobalamin	B12	PA164768689	7126;4709	0.596
NULL	Ann_Indian_Acad_Neurol_2012_Jul-Sep_15(3)_227-229.nxml.txt.nlp	22919202	SENT39	14	14	3	3	creatine	B12	PA164778930	7126;4709	0.596
NULL	Ann_Clin_Transl_Neurol_2014_Dec_21_1(12)_996-1005.nxml.txt.nlp	25574474	SENT10	15	15	27	27	riluzole	P-gp	PA451251	5243	0.596
NULL	Cancer_Metab_2013_Mar_21_1_12.nxml.txt.nlp	24280230	SENT168	3	3	26	26	urea	ASL	PA451831	435	0.596
NULL	J_Cell_Biol_2003_Aug_18_162(4)_599-612.nxml.txt.nlp	12925707	SENT385	36	36	3	3	dextran	mol	PA449261	90527	0.596
NULL	Int_J_Mol_Sci_2014_Oct_24_15(11)_19342-19354.nxml.txt.nlp	25347273	SENT3	11	11	8	8	cyclophosphamide	PAG	PA449165	55824	0.596
NULL	Pharmaceuticals_(Basel)_2011_Nov_10_4(11)_1488-1502.nxml.txt.nlp	NULL	SENT106	12	12	1	1	cisplatin	GRP94	PA449014	7184	0.596
NULL	Drug_Saf_2014_Feb_19_37(4)_201-211.nxml.txt.nlp	24550106	SENT116	19	19	39	39	proguanil	CYP2C19	PA451124	1557	0.596
NULL	Alcohol_Res_Health_2008_31(4)_310-339.nxml.txt.nlp	20729980	SENT471	2	2	13	13	ethanol	CRF2	PA448073	1395	0.596
NULL	Front_Genet_2014_Aug_26_5_289.nxml.txt.nlp	25206362	SENT102	38	38	32	32	betaine	B12	PA448603	7126;4709	0.596
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT132	21	21	24	24	bevacizumab	HER2	PA130232992	2064	0.596
NULL	Evid_Based_Complement_Alternat_Med_2013_Oct_29_2013_795365.nxml.txt.nlp	24319485	SENT88	32	32	27	27	thrombin	ADP	PA451674	23038	0.596
NULL	Oncotarget_2013_Dec_21_5(9)_2404-2417.nxml.txt.nlp	24811221	SENT30	0	0	2	2	bleomycin	BLM	PA448645	641	0.595
NULL	Front_Neuroanat_2014_Oct_9_8_112.nxml.txt.nlp	25346662	SENT207	16	16	14	14	levocabastine	NTR2	PA164742988	23620	0.595
NULL	Breast_Cancer_Res_Treat_2014_Dec_13_143(2)_373-384.nxml.txt.nlp	24337537	SENT40	8	8	10	10	tamoxifen	aromatase	PA451581	1588	0.595
NULL	Eur_J_Neurosci_2008_Jun_27(11)_2783-2802.nxml.txt.nlp	18588525	SENT578	11	11	7	7	potassium	TREK-1	PA451047	3776	0.595
NULL	Iran_J_Microbiol_2013_Mar_5(1)_42-47.nxml.txt.nlp	23466523	SENT91	18	18	8	8	tetracycline	CTX	PA451640	1593	0.595
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Sep_25_66(Pt_10)_o2642.nxml.txt.nlp	21587613	SENT71	25	25	10	10	ethanol	mol	PA448073	90527	0.595
NULL	Case_Rep_Hematol_2013_Sep_26_2013_521785.nxml.txt.nlp	24191205	SENT107	15	15	19	19	desmopressin	VIII	PA449237	1351	0.595
NULL	ScientificWorldJournal_2014_Jan_29_2014_265953.nxml.txt.nlp	24688374	SENT160	3	3	14	14	resveratrol	CMC1		152100	0.595
NULL	Mol_Cancer_2010_Aug_20_9_220.nxml.txt.nlp	20727180	SENT192	17	17	10	10	nicotine	p53	PA450626	7157	0.595
NULL	Curr_Neuropharmacol_2013_Jul_11(4)_338-378.nxml.txt.nlp	24381528	SENT407	8	8	21	21	curcumin	AP-1	PA151958596	2353;3727;2354;3725	0.595
NULL	Biomed_Res_Int_2014_Jan_22_2014_157987.nxml.txt.nlp	24579074	SENT110	22	22	34	34	collagenase	CO2	PA449107	4513	0.595
NULL	J_Am_Heart_Assoc_2013_Dec_19_2(6)_e000355.nxml.txt.nlp	24190878	SENT207	17	17	7	7	phenylephrine	HK2	PA450935	3796;3099;29911;3741	0.595
NULL	Cancer_Causes_Control_2013_Aug_18_24(8)_1605-1614.nxml.txt.nlp	23775025	SENT64	38	38	43	43	epirubicin	GSTP1	PA449476	2950	0.595
NULL	BMJ_2013_Apr_18_346_f2310.nxml.txt.nlp	23599320	SENT234	21	21	39	39	capsaicin	TRPV1	PA448776	7442	0.595
NULL	Arthritis_Res_Ther_2008_Sep_12_10(5)_R111.nxml.txt.nlp	18789153	SENT19	4	4	9	9	2-methoxyestradiol	HIF-1	PA134967247	29072	0.595
NULL	Mol_Cancer_2014_Jun_5_13_143.nxml.txt.nlp	24898067	SENT16	31	31	27	27	gefitinib	HER-2	PA131301952	2064	0.595
NULL	Oncogene_2014_Feb_6_33(6)_713-723.nxml.txt.nlp	23435429	SENT53	23	23	7	7	mitomycin	BRCA1	PA450524	672	0.595
NULL	Angew_Chem_Int_Ed_Engl_2013_Jan_2_52(1)_325-330.nxml.txt.nlp	23080482	SENT30	19	19	26	26	thrombin	ACPP	PA451674	55	0.595
NULL	Oncotarget_2011_Jan_25_2(1-2)_8-17.nxml.txt.nlp	21378407	SENT36	8	8	10	10	thrombin	PAR-1	PA451674	2011;2149	0.595
NULL	Mol_Med_Rep_2015_Feb_3_11(2)_968-974.nxml.txt.nlp	25371265	SENT186	25	25	5	5	cyclophosphamide	IL-2	PA449165	3558	0.595
NULL	Acta_Pharmacol_Sin_2010_Oct_13_31(10)_1243-1257.nxml.txt.nlp	20835267	SENT236	20	20	22	22	lipase	LPL	PA450239	4023	0.595
NULL	Cancers_(Basel)_2010_Dec_23_3(1)_17-42.nxml.txt.nlp	24212604	SENT904	27	27	29	29	estradiol	PPX	PA449503	5531	0.595
NULL	Ann_Rheum_Dis_2014_Jan_25_73(1)_56-61.nxml.txt.nlp	24067785	SENT42	24	24	17	17	vasopressin	IL-4	PA451858	3565	0.595
NULL	J_Hum_Genet_2013_Jun_16_58(6)_353-361.nxml.txt.nlp	23677058	SENT161	11	11	3	3	cytarabine	DCK	PA449177	1633	0.595
NULL	EMBO_Mol_Med_2011_May_3(5)_266-278.nxml.txt.nlp	21438154	SENT83	19	19	25	25	oxaliplatin	TRPM8	PA131285527	79054	0.595
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT166	45	45	12	12	glucose	EGFR	PA449773	1956	0.595
NULL	Lipids_Health_Dis_2011_Feb_28_10_38.nxml.txt.nlp	21352602	SENT125	4	4	6	6	fenofibrate	PCSK9	PA449594	255738	0.595
NULL	Exp_Ther_Med_2013_Jul_25_6(1)_172-176.nxml.txt.nlp	23935741	SENT215	15	15	17	17	resveratrol	TPT		23590;6469	0.595
NULL	Cancer_Med_2013_Feb_3_2(1)_76-85.nxml.txt.nlp	24133630	SENT346	25	25	5	5	vemurafenib	ABCB1	PA165946873	5243	0.595
NULL	J_Immunother_2014_Apr_12_37(3)_180-186.nxml.txt.nlp	24598448	SENT189	0	0	6	6	sorafenib	IL-2	PA7000	3558	0.595
NULL	Ann_Oncol_2009_Aug_17_20(8)_1319-1329.nxml.txt.nlp	19535820	SENT349	25	25	43	43	trastuzumab	San	PA451743	80218	0.595
NULL	Environ_Health_Perspect_2010_Jul_3_118(7)_936-942.nxml.txt.nlp	20199942	SENT174	21	21	26	26	arsenite	p53	PA452638	7157	0.595
NULL	J_Breast_Cancer_2014_Mar_28_17(1)_61-68.nxml.txt.nlp	24744799	SENT166	26	26	12	12	letrozole	GEM	PA450196	2669	0.595
NULL	Environ_Health_Perspect_2010_Jul_3_118(7)_936-942.nxml.txt.nlp	20199942	SENT220	13	13	21	21	arsenite	mot-2	PA452638	3313	0.595
NULL	Front_Synaptic_Neurosci_2010_Dec_22_2_152.nxml.txt.nlp	21423538	SENT78	4	4	10	10	forskolin	CA1	PA146096022	759	0.595
NULL	F1000_Biol_Rep_2012_Mar_1_4_5.nxml.txt.nlp	22403588	SENT22	40	40	37	37	ribavirin	IFN	PA451241	3439	0.595
NULL	Diabetes_Care_2013_Jul_12_36(7)_2126-2132.nxml.txt.nlp	23645884	SENT184	42	42	7	7	liraglutide	GLP-1	PA165958364	100125288	0.595
NULL	Mol_Cancer_2013_Mar_2_12_16.nxml.txt.nlp	23452820	SENT130	34	34	16	16	chloroquine	BECN1	PA448948	8678	0.595
NULL	Oncol_Lett_2013_Feb_30_5(2)_588-592.nxml.txt.nlp	23420263	SENT128	7	7	25	25	lenalidomide	NKX2-1	PA162363968	7080	0.595
NULL	Front_Oncol_2014_Apr_9_4_75.nxml.txt.nlp	24782986	SENT50	14	14	21	21	paclitaxel	CD117	PA450761	3815	0.595
NULL	Infect_Dis_Rep_2012_Mar_7_4(1)_e20.nxml.txt.nlp	24470927	SENT26	12	12	19	19	vancomycin	HAP	PA451850	5915;10313	0.595
NULL	Diabetes_Metab_J_2014_Aug_20_38(4)_274-277.nxml.txt.nlp	25215273	SENT32	3	3	5	5	lipase	LPL	PA450239	4023	0.595
NULL	Br_J_Pharmacol_2011_May_163(1)_141-172.nxml.txt.nlp	21265830	SENT263	7	7	19	19	fluorescein	IL-13	PA164746009	3596	0.595
NULL	Int_J_Gen_Med_2009_Nov_30_1_21-25.nxml.txt.nlp	20428402	SENT89	13	13	15	15	vasopressin	AVP	PA451858	114548;551	0.595
NULL	Nat_Neurosci_2013_Apr_17_16(4)_464-472.nxml.txt.nlp	23502536	SENT133	2	2	19	19	fluoxetine	GluA1	PA449673	2890	0.595
NULL	Child_Adolesc_Psychiatry_Ment_Health_2009_Mar_12_3_9.nxml.txt.nlp	19284622	SENT128	23	23	31	31	ziprasidone	BARS	PA451974	1487	0.595
NULL	Exp_Ther_Med_2014_Jun_3_7(6)_1762-1766.nxml.txt.nlp	24926381	SENT181	22	22	13	13	resveratrol	GCLM		2730	0.595
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT211	0	0	9	9	nutlin-3	p53		7157	0.595
NULL	Arthritis_Res_Ther_2012_Jul_27_14(4)_R176.nxml.txt.nlp	22838845	SENT244	5	5	10	10	acetazolamide	CA1	PA448018	759	0.595
NULL	Breast_Cancer_Res_2011_Dec_8_13(6)_R126.nxml.txt.nlp	22151962	SENT246	10	10	32	32	doxorubicin	TLR4	PA449412	7099	0.595
NULL	Acta_Pharmacol_Sin_2011_May_18_32(5)_601-610.nxml.txt.nlp	21499285	SENT31	7	7	9	9	bleomycin	BLM	PA448645	641	0.595
NULL	J_Adv_Pharm_Technol_Res_2012_Oct-Dec_3(4)_202-209.nxml.txt.nlp	23378940	SENT127	27	27	8	8	aprepitant	CYP3A4	PA164747039	1576	0.595
NULL	Front_Neurosci_2010_Nov_19_4_191.nxml.txt.nlp	21151372	SENT348	5	5	14	14	mefloquine	HERG	PA450348	3757	0.595
NULL	Animal_2010_Jul_21_4(7)_1227-1239.nxml.txt.nlp	20582145	SENT140	17	17	19	19	estradiol	PCB	PA449503	5091	0.595
NULL	Gut_Liver_2013_Sep_14_7(5)_585-593.nxml.txt.nlp	24073317	SENT33	32	32	28	28	ribavirin	IFN	PA451241	3439	0.595
NULL	Acta_Pharmacol_Sin_2011_May_18_32(5)_601-610.nxml.txt.nlp	21499285	SENT243	0	0	2	2	bleomycin	BLM	PA448645	641	0.595
NULL	J_Gen_Physiol_2000_Aug_1_116(2)_147-162.nxml.txt.nlp	10919863	SENT649	16	16	8	8	forskolin	AC8	PA146096022	114	0.595
NULL	Exp_Mol_Med_2012_Feb_29_44(2)_159-166.nxml.txt.nlp	22127053	SENT49	17	17	11	11	simvastatin	RhoA	PA451363	387	0.595
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1051.nxml.txt.nlp	24503543	SENT144	28	28	11	11	erlotinib	Yes	PA134687924	7525	0.595
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_29_2013_590393.nxml.txt.nlp	23737838	SENT9	2	2	10	10	resveratrol	p53		7157	0.595
NULL	Curr_Chem_Genomics_2010_Mar_19_4_9-18.nxml.txt.nlp	20502647	SENT209	19	19	24	24	triciribine	DM1	PA165958661	338023;1760;28509	0.595
NULL	Cancer_Med_2014_Dec_13_3(6)_1579-1594.nxml.txt.nlp	25124282	SENT292	22	22	17	17	cisplatin	FACT	PA449014	11198	0.595
NULL	J_Biomed_Biotechnol_2010_May_23_2010_798467.nxml.txt.nlp	20508851	SENT212	0	0	2	2	cyclophosphamide	CTX	PA449165	1593	0.595
NULL	Emerg_Microbes_Infect_2012_Nov_7_1(11)_e39.nxml.txt.nlp	NULL	SENT159	31	31	5	5	fosfomycin	Gen	PA164748039	348654	0.595
NULL	Crit_Care_2010_Jan_11_14(1)_R3.nxml.txt.nlp	20064232	SENT53	10	10	1	1	fluorescein	CD4	PA164746009	920	0.595
NULL	Front_Neurol_2013_Oct_29_4_168.nxml.txt.nlp	24194728	SENT279	21	21	19	19	ceftriaxone	GLT-1	PA448866	6506	0.595
NULL	Biol_Open_2012_Mar_27_1(5)_458-466.nxml.txt.nlp	23213437	SENT137	29	29	31	31	tamoxifen	TMX	PA451581	81542	0.595
NULL	J_Parasitol_Res_2012_Jun_27_2012_275436.nxml.txt.nlp	22792440	SENT247	26	26	5	5	l-arginine	IL-13	PA448478	3596	0.595
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT138	2	2	6	6	phenprocoumon	VKORC1	PA450921	79001	0.595
NULL	Acta_Pharmacol_Sin_2010_May_26_31(5)_554-559.nxml.txt.nlp	20418892	SENT31	0	0	2	2	bleomycin	BLM	PA448645	641	0.595
NULL	Oncol_Lett_2014_Sep_19_8(3)_1269-1274.nxml.txt.nlp	25120704	SENT162	2	2	30	30	metformin	p38	PA450395	10598;1432;7965	0.595
NULL	J_Oncol_2010_Jul_7_2010_645376.nxml.txt.nlp	20631908	SENT199	31	31	14	14	urokinase	TSP-1	PA451836	7057	0.595
NULL	J_Hum_Genet_2013_Jun_16_58(6)_353-361.nxml.txt.nlp	23677058	SENT163	25	25	29	29	cytarabine	DCK	PA449177	1633	0.595
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT39	7	7	14	14	gefitinib	p110	PA131301952	9733	0.595
NULL	Cardiovasc_Res_2015_Jan_1_105(1)_65-74.nxml.txt.nlp	25341894	SENT139	11	11	23	23	collagenase	TIMP1	PA449107	7076	0.595
NULL	BMJ_2010_Feb_8_340_c693.nxml.txt.nlp	20142325	SENT114	27	27	15	15	tamoxifen	CYP2D6	PA451581	1565	0.595
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT29	20	20	13	13	imatinib	ABCG2	PA10804	9429	0.595
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Mar_23_69(Pt_4)_o585.nxml.txt.nlp	23634117	SENT3	22	22	31	31	ethanol	mol	PA448073	90527	0.595
NULL	Diabetes_Care_2010_Feb_33(2)_453-455.nxml.txt.nlp	20103562	SENT91	16	16	12	12	liraglutide	GLP	PA165958364	342096	0.595
NULL	Cell_Death_Dis_2012_Mar_1_3(3)_e275.nxml.txt.nlp	22378068	SENT46	0	0	7	7	metformin	AKT	PA450395	207	0.595
NULL	Br_J_Cancer_2012_May_8_106(10)_1587-1590.nxml.txt.nlp	22568998	SENT27	13	13	18	18	sunitinib	IFN	PA162372840	3439	0.595
NULL	Clin_Ophthalmol_2011_Feb_28_5_269-274.nxml.txt.nlp	21468332	SENT59	13	13	34	34	ketorolac	BAK	PA450150	578	0.595
NULL	Acta_Pharmacol_Sin_2010_Oct_13_31(10)_1243-1257.nxml.txt.nlp	20835267	SENT192	25	25	27	27	lipase	LPL	PA450239	4023	0.595
NULL	JRSM_Cardiovasc_Dis_2012_May_31_1(2)_cvd_2012_012007.nxml.txt.nlp	24175064	SENT150	36	36	32	32	thrombin	ADP	PA451674	23038	0.595
NULL	Int_J_Mol_Cell_Med_2014_Summer_3(3)_183-189.nxml.txt.nlp	25317405	SENT35	0	0	2	2	estradiol	NPY	PA449503	4852	0.595
NULL	Crit_Care_2006_Jan_31_10(1)_R20.nxml.txt.nlp	16469127	SENT29	0	0	2	2	vasopressin	AVP	PA451858	114548;551	0.595
NULL	Hum_Mol_Genet_2013_Dec_20_22(25)_5229-5236.nxml.txt.nlp	23933735	SENT111	19	19	21	21	nadh	SDH	PA164755085	1757;10993	0.595
NULL	Mol_Cancer_2010_Apr_15_9_77.nxml.txt.nlp	20398291	SENT121	3	3	9	9	geldanamycin	survivin	PA152031327	332	0.595
NULL	BMB_Rep_2013_Jan_46(1)_59-64.nxml.txt.nlp	23351386	SENT90	24	24	17	17	auranofin	NAC	PA448510	22861	0.595
NULL	AIDS_Res_Ther_2006_Mar_31_3_8.nxml.txt.nlp	16573838	SENT48	11	11	1	1	etanercept	IL-6	PA449515	3569	0.595
NULL	J_Hematol_Oncol_2008_Oct_23_1_19.nxml.txt.nlp	18947412	SENT125	15	15	7	7	alemtuzumab	CD34	PA164783958	947	0.595
NULL	Case_Rep_Nephrol_Urol_2012_Oct_24_2(2)_145-151.nxml.txt.nlp	23197970	SENT131	14	14	12	12	ceftriaxone	CTX	PA448866	1593	0.595
NULL	Exp_Mol_Med_2012_Sep_30_44(9)_545-553.nxml.txt.nlp	22809901	SENT8	0	0	7	7	clozapine	PRDM16	PA449061	63976	0.595
NULL	Cell_Commun_Signal_2011_May_15_9_13.nxml.txt.nlp	21569639	SENT320	43	43	37	37	quinacrine	AKT	PA164745551	207	0.595
NULL	Clin_Ophthalmol_2014_May_23_8_1031-1038.nxml.txt.nlp	24920879	SENT106	17	17	20	20	travoprost	BAK	PA164781371	578	0.595
NULL	Chin_J_Cancer_2011_Oct_30(10)_690-700.nxml.txt.nlp	21959046	SENT102	0	0	2	2	topotecan	TPT	PA451729	23590;6469	0.595
NULL	Br_J_Cancer_2009_Jun_2_100(11)_1704-1719.nxml.txt.nlp	19436303	SENT343	11	11	17	17	bevacizumab	IFL	PA130232992	3439	0.595
NULL	CNS_Drugs_2014_May_1_28(6)_497-511.nxml.txt.nlp	24788672	SENT29	22	22	24	24	atomoxetine	ATX	PA134688071	5168;23049	0.595
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_13_2014_478653.nxml.txt.nlp	25477992	SENT202	4	4	30	30	gemcitabine	IL-10	PA449748	3586	0.595
NULL	J_Antimicrob_Chemother_2014_Nov_5_69(11)_2901-2912.nxml.txt.nlp	25096079	SENT42	12	12	10	10	vancomycin	VAN	PA451850	10318	0.595
NULL	Clin_Interv_Aging_2009_Dec_29_4_463-472.nxml.txt.nlp	20054411	SENT71	0	0	13	13	vardenafil	SEP2	PA10229	23176;23157	0.595
NULL	Ital_J_Pediatr_2014_Feb_13_40_17.nxml.txt.nlp	24524345	SENT99	19	19	6	6	cyclosporine	CHP	PA449167	11261	0.595
NULL	J_Clin_Biochem_Nutr_2010_Mar_27_46(2)_177-185.nxml.txt.nlp	20216951	SENT102	4	4	9	9	l-arginine	CEA	PA448478	5670;1087	0.595
NULL	Neuropsychopharmacology_2012_Feb_2_37(3)_641-650.nxml.txt.nlp	22048466	SENT127	9	9	16	16	bupropion	CHRNB2	PA448687	1141	0.595
NULL	J_Hematol_Oncol_2014_Apr_4_7_30.nxml.txt.nlp	24708874	SENT169	16	16	13	13	hyaluronan	LYVE-1	PA165958431	10894	0.595
NULL	Biomed_Res_Int_2014_Jan_20_2014_789765.nxml.txt.nlp	24575414	SENT172	20	20	22	22	piroxicam	PRX	PA450985	9588;57716	0.595
NULL	Int_J_Endocrinol_2011_Dec_20_2011_746482.nxml.txt.nlp	22216029	SENT227	37	37	18	18	nifedipine	K60	PA450631	3576	0.595
NULL	Acta_Pharmacol_Sin_2012_Oct_17_33(10)_1301-1310.nxml.txt.nlp	22983390	SENT98	18	18	5	5	cisplatin	migfilin	PA449014	54751	0.595
NULL	Lipids_Health_Dis_2011_Jan_18_10_8.nxml.txt.nlp	21241519	SENT12	7	7	15	15	simvastatin	ABCG5	PA451363	64240	0.595
NULL	J_Med_Case_Rep_2013_Jul_26_7_200.nxml.txt.nlp	23889916	SENT75	23	23	25	25	thyroglobulin	TTF-1	PA164754910	7080	0.595
NULL	Int_J_Mol_Sci_2014_Oct_20_15(10)_18856-18891.nxml.txt.nlp	25334061	SENT174	2	2	18	18	arsenite	HIF-1	PA452638	29072	0.595
NULL	Drugs_Context_2012_Dec_11_2012_212244.nxml.txt.nlp	24432033	SENT72	9	9	27	27	urokinase	MUC1	PA451836	4582	0.595
NULL	Cancer_Med_2013_Apr_21_2(2)_216-225.nxml.txt.nlp	23634289	SENT125	39	39	10	10	imatinib	ELN	PA10804	2006	0.595
NULL	Bioinorg_Chem_Appl_2014_Jul_21_2014_865407.nxml.txt.nlp	25140121	SENT70	22	22	27	27	phenol	mol	PA450913	90527	0.595
NULL	J_Orthop_Traumatol_2013_Jun_23_14(2)_143-145.nxml.txt.nlp	22358780	SENT27	9	9	33	33	rifampin	ETB	PA451250	1910	0.595
NULL	Exp_Lung_Res_2013_Oct_1_39(8)_336-348.nxml.txt.nlp	23919450	SENT90	9	9	0	0	argatroban	PAR-1	PA164745516	2011;2149	0.595
NULL	eLife_2013_Nov_5_2_e00969.nxml.txt.nlp	24192036	SENT233	0	0	2	2	vemurafenib	JNK	PA165946873	5599	0.595
NULL	Eur_J_Immunol_2012_Nov_18_42(11)_3049-3061.nxml.txt.nlp	22806397	SENT99	19	19	8	8	imiquimod	CD27	PA449972	939	0.595
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Apr_7_9_12.nxml.txt.nlp	20374640	SENT83	25	25	10	10	chloramphenicol	APR	PA448927	5366	0.595
NULL	Cell_Commun_Signal_2014_Nov_7_12(1)_73.nxml.txt.nlp	NULL	SENT207	25	25	7	7	tamoxifen	THOC5	PA451581	8563	0.595
NULL	Indian_J_Dermatol_2013_Jul-Aug_58(4)_325a.nxml.txt.nlp	23919014	SENT34	15	15	12	12	thyroglobulin	TPO	PA164754910	7066;7173	0.595
NULL	J_Cell_Biol_1998_Jan_12_140(1)_233-245.nxml.txt.nlp	9425170	SENT363	3	3	6	6	urokinase	CD87	PA451836	5329	0.595
NULL	Int_J_Hypertens_2014_Jan_12_2014_381082.nxml.txt.nlp	24678415	SENT172	16	16	20	20	cinacalcet	PTH	PA164776671	5741	0.595
NULL	Biologics_2011_Feb_14_5_21-31.nxml.txt.nlp	21383913	SENT168	22	22	30	30	clobetasol	CLE	PA164744375	51637	0.595
NULL	Front_Oncol_2014_Apr_8_4_71.nxml.txt.nlp	24782983	SENT208	1	1	22	22	decitabine	HOXA11	PA164749631	3207	0.595
NULL	J_Hum_Kinet_2013_Dec_31_39_137-145.nxml.txt.nlp	24511349	SENT12	12	12	47	47	creatine	ADP	PA164778930	23038	0.595
NULL	Acta_Pharmacol_Sin_2013_Sep_5_34(9)_1192-1200.nxml.txt.nlp	23685957	SENT148	2	2	12	12	curcumin	AKT	PA151958596	207	0.595
NULL	Indian_J_Med_Paediatr_Oncol_2013_Apr-Jun_34(2)_96-98.nxml.txt.nlp	24049295	SENT54	8	8	15	15	vincristine	CHOP	PA451879	1649	0.595
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Aug_20_64(Pt_9)_o1785.nxml.txt.nlp	21201765	SENT69	18	18	14	14	ethanol	mol	PA448073	90527	0.595
NULL	Arthritis_Rheumatol_2014_Aug_28_66(8)_2297-2307.nxml.txt.nlp	24756912	SENT119	4	4	12	12	methylprednisolone	CHOP	PA450466	1649	0.595
NULL	Niger_Med_J_2013_Mar-Apr_54(2)_100-106.nxml.txt.nlp	23798795	SENT73	3	3	12	12	indomethacin	HEC	PA449982	10403	0.595
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT120	24	24	12	12	vinorelbine	MVP	PA451881	9961	0.595
NULL	Cell_Death_Dis_2013_Jun_27_4(6)_e696.nxml.txt.nlp	23807225	SENT175	9	9	7	7	doxycycline	ACL	PA449415	47	0.595
NULL	Eur_J_Clin_Microbiol_Infect_Dis_2011_Jan_27_30(1)_1-6.nxml.txt.nlp	20978814	SENT200	2	2	26	26	oxygen	AID	PA450744	57379	0.595
NULL	Cancer_Med_2014_Aug_14_3(4)_1010-1024.nxml.txt.nlp	24931821	SENT251	21	21	18	18	methotrexate	IVL	PA450428	3713	0.595
NULL	Mol_Brain_2014_Nov_7_7(1)_77.nxml.txt.nlp	NULL	SENT359	16	16	8	8	ethanol	AC5	PA448073	111	0.595
NULL	Breast_Cancer_Res_2012_Jan_6_14(1)_R2.nxml.txt.nlp	22225778	SENT174	23	23	10	10	docetaxel	p65	PA449383	5970	0.595
NULL	Front_Endocrinol_(Lausanne)_2014_Aug_28_5_137.nxml.txt.nlp	25221541	SENT274	21	21	8	8	metformin	mol	PA450395	90527	0.595
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT275	3	3	5	5	resveratrol	TRAIL		8743	0.595
NULL	Nat_Chem_Biol_2010_Jun_9_6(6)_424-432.nxml.txt.nlp	20453863	SENT339	3	3	21	21	dantrolene	CHOP	PA449208	1649	0.595
NULL	Mol_Biol_Rep_2013_Sep_28_40(10)_5573-5585.nxml.txt.nlp	24078156	SENT43	32	32	19	19	iron	IRP1	PA450087	48	0.595
NULL	Hum_Mol_Genet_2013_Nov_15_22(22)_4616-4626.nxml.txt.nlp	23814041	SENT49	30	30	23	23	doxycycline	neuroserpin	PA449415	5274	0.595
NULL	Oncol_Lett_2014_Mar_11_7(3)_685-692.nxml.txt.nlp	24527073	SENT190	29	29	27	27	cisplatin	DDP	PA449014	1678	0.595
NULL	Arch_Drug_Inf_2008_Jul_1(1)_14-22.nxml.txt.nlp	20157364	SENT114	12	12	15	15	pravastatin	IL-6	PA451089	3569	0.595
NULL	Arthritis_Rheum_2013_Sep_26_65(9)_2290-2300.nxml.txt.nlp	23740547	SENT240	15	15	12	12	doxycycline	DIP	PA449415	23151;1831	0.595
NULL	Indian_J_Dermatol_2014_Jan-Feb_59(1)_94-95.nxml.txt.nlp	24470672	SENT37	15	15	23	23	ofloxacin	ENL	PA450684	4298	0.595
NULL	eLife_2013_Nov_5_2_e00969.nxml.txt.nlp	24192036	SENT104	6	6	8	8	vemurafenib	NOXA	PA165946873	5366	0.595
NULL	J_Korean_Med_Sci_2007_Apr_30_22(2)_283-289.nxml.txt.nlp	17449938	SENT187	6	6	12	12	minoxidil	P21	PA450521	1026;9338	0.595
NULL	Anal_Chem_Insights_2014_Mar_2_9_1-7.nxml.txt.nlp	24634579	SENT4	5	5	7	7	salbutamol	SLB	PA448068	26160	0.595
NULL	Case_Rep_Oncol_Med_2013_Nov_18_2013_901246.nxml.txt.nlp	24349811	SENT53	5	5	9	9	thyroglobulin	CD34	PA164754910	947	0.595
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Sep_18_69(Pt_10)_o1545.nxml.txt.nlp	24098230	SENT70	32	32	13	13	ethanol	mol	PA448073	90527	0.595
NULL	Int_J_Mol_Sci_2012_Aug_10_13(8)_9971-9979.nxml.txt.nlp	22949842	SENT196	22	22	24	24	lipase	PPL	PA450239	5493	0.595
NULL	Front_Neuroenergetics_2014_Apr_3_6_1.nxml.txt.nlp	24765075	SENT584	3	3	8	8	isoflurane	TNF-alpha	PA450106	7124	0.595
NULL	Br_J_Cancer_2013_Mar_5_108(4)_973-982.nxml.txt.nlp	23299537	SENT243	17	17	7	7	doxorubicin	BTG2	PA449412	7832	0.595
NULL	Int_J_Endocrinol_2013_Nov_27_2013_592576.nxml.txt.nlp	24369464	SENT5	12	12	14	14	streptozocin	STZ	PA451514	6484	0.595
NULL	Breast_Cancer_Res_2011_Nov_23_13(6)_R116.nxml.txt.nlp	22113133	SENT327	10	10	0	0	estradiol	CTRL	PA449503	1506	0.595
NULL	Int_J_Mol_Sci_2014_Mar_6_15(3)_4049-4059.nxml.txt.nlp	24663080	SENT6	0	0	7	7	dexmedetomidine	IL-6	PA449256	3569	0.595
NULL	Neural_Plast_2012_May_20_2012_569149.nxml.txt.nlp	22685677	SENT146	37	37	33	33	staurosporine	INS-1	PA165109623	2305	0.595
NULL	Oncotarget_2014_Nov_11_5(22)_11490-11500.nxml.txt.nlp	25359780	SENT79	9	9	7	7	docetaxel	CXCL12	PA449383	6387	0.595
NULL	Breast_Cancer_Res_Treat_2013_Aug_20_141(1)_43-53.nxml.txt.nlp	23959396	SENT19	17	17	23	23	trastuzumab	HER2	PA451743	2064	0.595
NULL	J_Int_Soc_Sports_Nutr_2015_Jan_21_12(1)_5.nxml.txt.nlp	NULL	SENT193	9	9	12	12	curcumin	IL-6	PA151958596	3569	0.595
NULL	Environ_Health_Perspect_1995_Oct_103(Suppl_7)_83-87.nxml.txt.nlp	8593881	SENT4	18	18	20	20	diethylstilbestrol	DES	PA449307	1674	0.595
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1051.nxml.txt.nlp	24503543	SENT144	36	36	23	23	hexachlorophene	Yes	PA449871	7525	0.595
NULL	J_Biol_2007_Apr_30_6(2)_4.nxml.txt.nlp	17439666	SENT235	27	27	29	29	ethanol	CO2	PA448073	4513	0.595
NULL	Diabetes_2013_Jun_20_62(6)_2122-2129.nxml.txt.nlp	23378607	SENT195	23	23	2	2	glucose	ANOVA	PA449773	4858	0.595
NULL	EMBO_Mol_Med_2013_Jul_6_5(7)_905-915.nxml.txt.nlp	23740690	SENT48	19	19	21	21	lipase	HSL	PA450239	3991	0.594
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Apr_15_9_13.nxml.txt.nlp	20398300	SENT108	11	11	7	7	amoxicillin	LAM	PA448406	7249;7248	0.594
NULL	Infect_Drug_Resist_2011_Feb_22_4_65-76.nxml.txt.nlp	21694910	SENT90	10	10	27	27	raltegravir	N155		9631	0.594
NULL	Hum_Mol_Genet_2008_Jun_1_17(11)_1527-1539.nxml.txt.nlp	18267959	SENT140	35	35	31	31	doxycycline	neuroserpin	PA449415	5274	0.594
NULL	J_Cell_Biol_1998_Aug_10_142(3)_697-710.nxml.txt.nlp	9700159	SENT76	28	28	15	15	paraformaldehyde	CO2	PA450790	4513	0.594
NULL	Front_Oncol_2014_Oct_21_4_285.nxml.txt.nlp	25374842	SENT680	19	19	29	29	nutlin-3	p53		7157	0.594
NULL	Arch_Osteoporos_2013_Oct_11_8(1-2)_136.nxml.txt.nlp	24113837	SENT1264	15	15	3	3	denosumab	San	PA166048634	80218	0.594
NULL	EPMA_J_2012_Sep_27_3(1)_10.nxml.txt.nlp	23016735	SENT214	39	39	7	7	warfarin	VKORC1	PA451906	79001	0.594
NULL	Nat_Med_2011_Dec_11_18(1)_74-82.nxml.txt.nlp	22157681	SENT268	31	31	26	26	gefitinib	Dicer	PA131301952	23405	0.594
NULL	Acta_Pharmacol_Sin_2010_Feb_5_31(2)_137-144.nxml.txt.nlp	20139896	SENT117	26	26	10	10	zileuton	ROS	PA451955	6098	0.594
NULL	Eur_J_Pediatr_2013_Aug_17_172(8)_997-1005.nxml.txt.nlp	22801769	SENT200	14	14	31	31	nebivolol	FBN1	PA151958426	2200	0.594
NULL	Eur_J_Histochem_2010_Mar_20_54(1)_e4.nxml.txt.nlp	20353911	SENT100	29	29	9	9	levamisole	H19	PA450205	283120	0.594
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT143	6	6	11	11	perifosine	DR5	PA165291471	8795	0.594
NULL	J_Antimicrob_Chemother_2010_Aug_11_65(8)_1646-1654.nxml.txt.nlp	20542901	SENT103	38	38	11	11	urea	IMAC	PA451831	10344	0.594
NULL	Int_J_Mol_Sci_2014_Oct_8_15(10)_17974-17999.nxml.txt.nlp	25299695	SENT122	26	26	18	18	curcumin	HO-2	PA151958596	3163	0.594
NULL	Mol_Biol_Rep_2013_Sep_28_40(10)_5573-5585.nxml.txt.nlp	24078156	SENT249	2	2	14	14	iron	ROS	PA450087	6098	0.594
NULL	BMB_Rep_2013_Nov_46(11)_544-549.nxml.txt.nlp	24152910	SENT19	14	14	4	4	thrombin	PAR-1	PA451674	2011;2149	0.594
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT616	11	11	8	8	amisulpride	PRL	PA162565877	5617	0.594
NULL	Mol_Vis_2012_Apr_11_18_901-908.nxml.txt.nlp	22539869	SENT153	12	12	10	10	curcumin	HO-1	PA151958596	3162	0.594
NULL	Front_Immunol_2013_May_15_4_116.nxml.txt.nlp	23720663	SENT15	6	6	32	32	temozolomide	CD25	PA451609	3669;3559	0.594
NULL	Int_J_Mol_Sci_2010_Sep_13_11(9)_3195-3208.nxml.txt.nlp	20957088	SENT42	22	22	11	11	lipase	AT2	PA450239	186	0.594
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT282	24	24	31	31	pertuzumab	HER2		2064	0.594
NULL	Acta_Neuropathol_Commun_2014_Sep_4_2(1)_93.nxml.txt.nlp	NULL	SENT340	29	29	19	19	tamoxifen	IKZF1	PA451581	10320	0.594
NULL	EJC_Suppl_2013_Sep_5_11(2)_278-280.nxml.txt.nlp	NULL	SENT105	6	6	11	11	dacarbazine	BRAF	PA449197	673	0.594
NULL	Mol_Biol_Rep_2014_Nov_10_41(1)_331-336.nxml.txt.nlp	24213830	SENT167	6	6	2	2	carbamazepine	ABCB1	PA448785	5243	0.594
NULL	Acta_Pharmacol_Sin_2012_May_16_33(5)_682-690.nxml.txt.nlp	22504904	SENT229	0	0	11	11	celecoxib	Mcl-1	PA448871	4170	0.594
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_May_11_69(Pt_6)_o863-o864.nxml.txt.nlp	23795045	SENT73	35	35	28	28	ethanol	mol	PA448073	90527	0.594
NULL	Arthritis_Res_Ther_2009_Nov_23_11(6)_R176.nxml.txt.nlp	19930661	SENT66	7	7	10	10	fluorescein	CD86	PA164746009	942	0.594
NULL	Diabetes_Care_2012_Feb_16_35(2)_327-333.nxml.txt.nlp	22179958	SENT3	15	15	6	6	metformin	B12	PA450395	7126;4709	0.594
NULL	Br_J_Cancer_2003_Mar_10_88(5)_754-759.nxml.txt.nlp	12618886	SENT121	12	12	6	6	amifostine	p53	PA448365	7157	0.594
NULL	Hum_Mol_Genet_2008_Jul_15_17(14)_2101-2107.nxml.txt.nlp	18413323	SENT112	1	1	3	3	ezetimibe	NPC1L1	PA10816	29881	0.594
NULL	Ann_Surg_Oncol_2010_Apr_11_17(4)_950-952.nxml.txt.nlp	20012500	SENT60	5	5	7	7	gemcitabine	GEM	PA449748	2669	0.594
NULL	Cancer_Res_Treat_2014_Jan_15_46(1)_48-54.nxml.txt.nlp	24520223	SENT129	12	12	22	22	bevacizumab	KRAS	PA130232992	3845	0.594
NULL	J_Carcinog_2011_Dec_31_10_37.nxml.txt.nlp	22279422	SENT123	21	21	15	15	urokinase	MMP9	PA451836	4318	0.594
NULL	J_Korean_Med_Sci_2013_Dec_26_28(12)_1774-1780.nxml.txt.nlp	24339708	SENT189	20	20	18	18	octreotide	OST	PA450678	1650;23263	0.594
NULL	Oncologist_2010_Apr_15(4)_372-381.nxml.txt.nlp	20413642	SENT148	0	0	5	5	gemcitabine	EGFR	PA449748	1956	0.594
NULL	Exp_Diabetes_Res_2012_Oct_15_2012_465282.nxml.txt.nlp	23118742	SENT96	3	3	5	5	metformin	FGF21	PA450395	26291	0.594
NULL	Breast_Cancer_Res_2004_Apr_7_6(4)_R275-R283.nxml.txt.nlp	15217493	SENT199	8	8	19	19	doxorubicin	IFN	PA449412	3439	0.594
NULL	Chin_J_Cancer_2012_Nov_31(11)_507-518.nxml.txt.nlp	22640626	SENT173	11	11	19	19	nilotinib	ABL2	PA165958345	27	0.594
NULL	Cancers_(Basel)_2011_Aug_9_3(3)_3189-3205.nxml.txt.nlp	24212952	SENT788	8	8	10	10	hyaluronidase	HYAL1	PA164745713	3373	0.594
NULL	Cancers_(Basel)_2011_May_25_3(2)_2501-2515.nxml.txt.nlp	24212821	SENT142	11	11	24	24	l-glutamine	CO2	PA10090	4513	0.594
NULL	Braz_J_Med_Biol_Res_2012_Feb_17_45(3)_244-249.nxml.txt.nlp	22331137	SENT109	33	33	26	26	gentamicin	PAG	PA449753	55824	0.594
NULL	BMB_Rep_2014_Jan_47(1)_33-38.nxml.txt.nlp	24209634	SENT101	11	11	6	6	cisplatin	CXCR4	PA449014	7852	0.594
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT54	46	46	36	36	vinorelbine	ASC	PA451881	29108	0.594
NULL	Front_Oncol_2013_Apr_23_3_86.nxml.txt.nlp	23630663	SENT104	15	15	6	6	maytansine	DM1	PA165291473	338023;1760;28509	0.594
NULL	Cancers_(Basel)_2012_Jul_16_4(3)_673-700.nxml.txt.nlp	24213461	SENT318	21	21	6	6	bezafibrate	survivin	PA162364313	332	0.594
NULL	Ann_Dermatol_2014_Aug_31_26(4)_517-520.nxml.txt.nlp	25143685	SENT16	13	13	29	29	tazarotene	TIG3	PA164746821	5920	0.594
NULL	J_Gastroenterol_2014_Jun_19_49(6)_1001-1010.nxml.txt.nlp	23780559	SENT10	6	6	8	8	clonidine	HCN	PA449051	378938	0.594
NULL	JAKSTAT_2012_Apr_1_1(2)_55-64.nxml.txt.nlp	24058751	SENT106	13	13	9	9	pimozide	FLT3	PA450965	2322	0.594
NULL	Iran_J_Reprod_Med_2012_Jul_10(4)_329-336.nxml.txt.nlp	25246894	SENT93	3	3	18	18	protamine	PRM2	PA10366	5620	0.594
NULL	Ann_Gen_Psychiatry_2013_Jan_24_12_1.nxml.txt.nlp	23347694	SENT172	26	26	35	35	quetiapine	5-HT1A	PA451201	3350	0.594
NULL	Cell_Death_Dis_2013_Jun_27_4(6)_e696.nxml.txt.nlp	23807225	SENT176	13	13	9	9	doxycycline	AKT1	PA449415	207	0.594
NULL	Onco_Targets_Ther_2014_Jul_12_7_1273-1284.nxml.txt.nlp	25050069	SENT36	34	34	18	18	trabectedin	CYP2C19	PA165958349	1557	0.594
NULL	Anticancer_Drugs_2015_Jan_28_26(1)_117-122.nxml.txt.nlp	25115342	SENT124	21	21	29	29	docetaxel	HER2	PA449383	2064	0.594
NULL	Diabetes_2011_Nov_17_60(11)_2730-2739.nxml.txt.nlp	21926273	SENT24	42	42	15	15	nadh	SIRT1	PA164755085	23411	0.594
NULL	Drugs_R_D_2010_Nov_25_10(4)_219-224.nxml.txt.nlp	21171668	SENT1	8	8	21	21	clopidogrel	DES	PA449053	1674	0.594
NULL	Sci_Rep_2014_Dec_19_4_7571.nxml.txt.nlp	25524368	SENT312	18	18	11	11	estradiol	mer	PA449503	10461	0.594
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1224-1233.nxml.txt.nlp	22353810	SENT164	15	15	21	21	etoposide	MRP-1	PA449552	928	0.594
NULL	Aging_(Albany_NY)_2011_Apr_4_3(4)_348-362.nxml.txt.nlp	21483040	SENT190	8	8	22	22	metformin	HGPS	PA450395	4000;10269;64221	0.594
NULL	Indian_J_Endocrinol_Metab_2012_Jul-Aug_16(4)_675-676.nxml.txt.nlp	22837952	SENT33	5	5	17	17	metformin	B12	PA450395	7126;4709	0.594
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_13_2012_636848.nxml.txt.nlp	23258994	SENT296	8	8	0	0	carrageenan	TRPV1	PA448814	7442	0.594
NULL	Enzyme_Res_2010_Jun_28_2010_734182.nxml.txt.nlp	21048869	SENT150	1	1	5	5	ethanol	SSF	PA448073	56342	0.594
NULL	Br_J_Cancer_2012_Oct_23_107(9)_1518-1524.nxml.txt.nlp	22996610	SENT174	22	22	6	6	irinotecan	CEA	PA450085	5670;1087	0.594
NULL	Diabetes_2008_Sep_57(9)_2288-2295.nxml.txt.nlp	18535187	SENT169	0	0	4	4	pioglitazone	adiponectin	PA450970	9370	0.594
NULL	Cell_Death_Dis_2010_Oct_21_1(10)_e86.nxml.txt.nlp	21368859	SENT80	27	27	25	25	doxorubicin	TRAIL	PA449412	8743	0.594
NULL	Clinics_(Sao_Paulo)_2013_May_68(5)_628-631.nxml.txt.nlp	23778422	SENT31	3	3	5	5	cyclophosphamide	CTX	PA449165	1593	0.594
NULL	Curr_Heart_Fail_Rep_2011_Dec_13_8(4)_242-251.nxml.txt.nlp	21842146	SENT142	5	5	1	1	exenatide	GLP-1	PA164749238	100125288	0.594
NULL	J_Gen_Physiol_1922_Jan_20_4(3)_245-260.nxml.txt.nlp	19871929	SENT0	12	12	1	1	trypsin	Gen	PA451806	348654	0.594
NULL	J_Cell_Mol_Med_2014_Nov_11_18(11)_2275-2286.nxml.txt.nlp	25208472	SENT228	26	26	20	20	cisplatin	p53	PA449014	7157	0.594
NULL	Front_Chem_2014_Aug_26_2_72.nxml.txt.nlp	25207271	SENT109	0	0	9	9	ethanol	mol	PA448073	90527	0.594
NULL	Br_J_Cancer_2002_Jan_21_86(2)_218-221.nxml.txt.nlp	11870509	SENT5	44	44	26	26	tamoxifen	BRCA1	PA451581	672	0.594
NULL	Arthritis_Res_Ther_2013_Apr_4_15(Suppl_1)_S4.nxml.txt.nlp	23566679	SENT522	2	2	25	25	rituximab	CD4	PA451261	920	0.594
NULL	Breast_Cancer_Res_2002_Jul_24_4(6)_R12.nxml.txt.nlp	12473173	SENT120	18	18	36	36	estradiol	POC	PA449503	5443	0.594
NULL	Arthritis_Res_Ther_2012_Apr_30_14(2)_R96.nxml.txt.nlp	22546471	SENT209	20	20	17	17	tocilizumab	SLC19A1	PA165292659	6573	0.594
NULL	Antimicrob_Agents_Chemother_2014_May_58(5)_2925-2928.nxml.txt.nlp	24550326	SENT31	16	16	12	12	suramin	AAT	PA10292	5265	0.594
NULL	BMB_Rep_2014_Oct_47(10)_575-580.nxml.txt.nlp	24499675	SENT49	11	11	18	18	arsenite	p53	PA452638	7157	0.594
NULL	Environ_Health_Perspect_2007_Sep_28_115(9)_1314-1319.nxml.txt.nlp	17805421	SENT27	0	0	2	2	diethylstilbestrol	DES	PA449307	1674	0.594
NULL	Breast_Cancer_Res_Treat_2012_Jun_15_133(3)_1057-1065.nxml.txt.nlp	22418700	SENT33	12	12	23	23	trastuzumab	HER2	PA451743	2064	0.594
NULL	J_Biol_Chem_2012_Dec_14_287(51)_43094-43107.nxml.txt.nlp	23118219	SENT820	7	7	9	9	hyaluronan	RHAMM	PA165958431	3161	0.594
NULL	Core_Evid_2007_Nov_30_2(2)_121-129.nxml.txt.nlp	21221180	SENT19	8	8	10	10	doxorubicin	EFS	PA449412	10278	0.594
NULL	J_Oncol_2012_Aug_24_2012_281261.nxml.txt.nlp	21876693	SENT233	5	5	3	3	temsirolimus	IFN	PA164746890	3439	0.594
NULL	Nat_Chem_Biol_2013_May_24_9(5)_326-332.nxml.txt.nlp	23524984	SENT141	10	10	36	36	tamoxifen	AF1	PA451581	1946	0.594
NULL	Toxins_(Basel)_2010_Mar_31_2(4)_517-551.nxml.txt.nlp	22069598	SENT173	13	13	23	23	genistein	AKT	PA165109660	207	0.594
NULL	Br_J_Cancer_2004_Mar_22_90(6)_1285-1292.nxml.txt.nlp	15026814	SENT132	32	32	19	19	doxorubicin	p53	PA449412	7157	0.594
NULL	Br_J_Cancer_2011_Jul_26_105(3)_372-381.nxml.txt.nlp	21730979	SENT163	26	26	29	29	temozolomide	ATR	PA451609	390502;84168;545	0.594
NULL	Breast_Cancer_(Auckl)_2014_Oct_8_8_125-133.nxml.txt.nlp	25336961	SENT125	15	15	23	23	trastuzumab	DM1	PA451743	338023;1760;28509	0.594
NULL	Am_J_Trop_Med_Hyg_2012_Jul_1_87(1)_192.nxml.txt.nlp	NULL	SENT14	12	12	21	21	primaquine	G6PD	PA451103	2539	0.594
NULL	Atherosclerosis_2011_Nov_219(1)_109-115.nxml.txt.nlp	21820657	SENT183	21	21	25	25	probucol	CETP	PA451107	1071	0.594
NULL	Br_J_Cancer_1999_Jun_80(8)_1150-1155.nxml.txt.nlp	10376965	SENT5	2	2	9	9	genistein	pS2	PA165109660	7031	0.594
NULL	Iran_J_Pharm_Res_2014_Autumn_13(4)_1393-1401.nxml.txt.nlp	25587329	SENT42	7	7	9	9	celecoxib	ABCG2	PA448871	9429	0.594
NULL	Cancer_Med_2013_Oct_19_2(5)_646-653.nxml.txt.nlp	24403230	SENT94	14	14	12	12	trastuzumab	DDIT3	PA451743	1649	0.594
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Apr_17_6_43-57.nxml.txt.nlp	24833916	SENT348	9	9	11	11	everolimus	HER2	PA164746311	2064	0.594
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT50	11	11	13	13	resveratrol	TRAIL		8743	0.594
NULL	J_Antimicrob_Chemother_2011_Feb_9_66(2)_363-370.nxml.txt.nlp	21148235	SENT72	2	2	0	0	atazanavir	ATV	PA10251	4683	0.594
NULL	Exp_Ther_Med_2013_Jun_3_5(6)_1631-1636.nxml.txt.nlp	23837045	SENT87	20	20	26	26	phentolamine	PI3K	PA450926	5290	0.594
NULL	Acta_Pharmacol_Sin_2010_Mar_22_31(3)_329-340.nxml.txt.nlp	20173759	SENT78	10	10	13	13	ethanol	AMPK	PA448073	5563	0.594
NULL	Cancers_(Basel)_2014_Oct_24_6(4)_2187-2223.nxml.txt.nlp	25347122	SENT355	19	19	15	15	everolimus	EGFR	PA164746311	1956	0.594
NULL	Cancer_Manag_Res_2011_Aug_10_3_273-285.nxml.txt.nlp	21931501	SENT318	19	19	15	15	pazopanib	IFN	PA165291492	3439	0.594
NULL	Adv_Ther_2014_Feb_18_31(3)_247-263.nxml.txt.nlp	24535624	SENT261	7	7	12	12	pioglitazone	GLP-1	PA450970	100125288	0.594
NULL	Breast_Cancer_Res_2009_Jun_23_11(Suppl_1)_P10.nxml.txt.nlp	NULL	SENT3	20	20	14	14	tamoxifen	p27	PA451581	5715;10534	0.594
NULL	Int_J_Nanomedicine_2009_Apr_1_4_27-35.nxml.txt.nlp	19421368	SENT101	21	21	25	25	genistein	IL-2	PA165109660	3558	0.594
NULL	Nucleic_Acids_Res_2005_Jun_8_33(10)_3283-3291.nxml.txt.nlp	15944449	SENT52	15	15	10	10	trypsin	CO2	PA451806	4513	0.594
NULL	J_Cheminform_2012_Mar_8_4_6.nxml.txt.nlp	22401035	SENT317	10	10	17	17	troglitazone	CYP2D6	PA451799	1565	0.594
NULL	J_Gen_Physiol_1934_Jan_20_17(3)_393-398.nxml.txt.nlp	19872789	SENT0	14	14	1	1	trypsin	Gen	PA451806	348654	0.594
NULL	Endocrinol_Metab_(Seoul)_2014_Sep_25_29(3)_379-387.nxml.txt.nlp	25309798	SENT141	7	7	5	5	resveratrol	SIRT1		23411	0.594
NULL	N_Am_J_Med_Sci_2011_Jan_3(1)_48-54.nxml.txt.nlp	22540065	SENT24	0	0	2	2	chlorpromazine	CPZ	PA448964	8532	0.594
NULL	Cent_European_J_Urol_2013_Aug_13_66(2)_150-151.nxml.txt.nlp	24579015	SENT25	2	2	12	12	resveratrol	maspin		5268	0.594
NULL	J_Cell_Biol_2005_Jul_4_170(1)_27-35.nxml.txt.nlp	15983062	SENT283	11	11	17	17	erythromycin	L22	PA449493	6146	0.594
NULL	Nat_Chem_Biol_2010_Apr_28_6(4)_291-299.nxml.txt.nlp	20190765	SENT120	14	14	25	25	dasatinib	EGFR	PA162372878	1956	0.594
NULL	J_Vis_Exp_2014_May_20_(87)_51655.nxml.txt.nlp	24893837	SENT53	27	27	38	38	hydrocortisone	CO2	PA449905	4513	0.594
NULL	Brain_Sci_2014_May_6_4(2)_356-375.nxml.txt.nlp	24961766	SENT236	3	3	19	19	propofol	P28	PA451141	9446;7802;9527	0.594
NULL	Br_J_Cancer_2009_Sep_15_101(6)_924-934.nxml.txt.nlp	19690550	SENT232	15	15	28	28	irinotecan	CRT	PA450085	811	0.594
NULL	Chemother_Res_Pract_2011_Nov_2_2011_878912.nxml.txt.nlp	22295207	SENT194	19	19	12	12	cilengitide	PCB	PA164924491	5091	0.594
NULL	Pharmaceuticals_(Basel)_2013_Aug_6_6(8)_929-959.nxml.txt.nlp	24276377	SENT99	15	15	21	21	oxaliplatin	TRAIL	PA131285527	8743	0.594
NULL	Ann_Rheum_Dis_2008_Nov_14_67(11)_1516-1523.nxml.txt.nlp	18625622	SENT178	14	14	23	23	tocilizumab	CRP	PA165292659	1401;140913	0.594
NULL	Scientifica_(Cairo)_2012_Nov_25_2012_478631.nxml.txt.nlp	24278700	SENT319	0	0	2	2	boceprevir	BOC	PA165948902	91653	0.594
NULL	Oncotarget_2014_Mar_13_5(4)_1101-1110.nxml.txt.nlp	24658355	SENT257	7	7	4	4	cisplatin	Bcl-2	PA449014	596	0.594
NULL	Clin_Ophthalmol_2010_Nov_23_4_1355-1359.nxml.txt.nlp	21179218	SENT2	25	25	16	16	latanoprost	BAK	PA164774763	578	0.594
NULL	Chemother_Res_Pract_2011_Sep_25_2011_730360.nxml.txt.nlp	22295205	SENT94	9	9	18	18	trastuzumab	HER2	PA451743	2064	0.594
NULL	Br_J_Cancer_2014_Jan_21_110(2)_384-391.nxml.txt.nlp	24346286	SENT108	14	14	5	5	trastuzumab	HER3	PA451743	2065	0.594
NULL	Indian_J_Psychiatry_2010_Jan_52(Suppl1)_S317-S340.nxml.txt.nlp	21836703	SENT115	19	19	8	8	thioproperazine	TFP	PA164754875	7034	0.594
NULL	Acta_Histochem_Cytochem_2010_May_1_43(2)_61-68.nxml.txt.nlp	20514293	SENT61	15	15	17	17	hyaluronan	LYVE-1	PA165958431	10894	0.594
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT123	5	5	9	9	nutlin-3	DR5		8795	0.594
NULL	Oncoimmunology_2012_Dec_1_1(9)_1661-1663.nxml.txt.nlp	23264929	SENT17	35	35	22	22	imiquimod	CCL2	PA449972	6347	0.594
NULL	Genome_Biol_2011_Mar_21_12(3)_R25.nxml.txt.nlp	21418647	SENT226	27	27	46	46	l-glutamine	CO2	PA10090	4513	0.594
NULL	Breast_Cancer_Res_Treat_2013_Apr_6_138(3)_829-837.nxml.txt.nlp	23563958	SENT200	13	13	11	11	paclitaxel	castor	PA450761	54897	0.594
NULL	Br_J_Cancer_2013_Mar_5_108(4)_983-992.nxml.txt.nlp	23361057	SENT112	29	29	9	9	cytarabine	MLH1	PA449177	4292	0.594
NULL	Front_Oncol_2013_Nov_15_3_281.nxml.txt.nlp	24298448	SENT82	15	15	3	3	cetuximab	KRAS	PA10040	3845	0.594
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT120	32	32	34	34	curcumin	TRAIL	PA151958596	8743	0.594
NULL	Int_J_Emerg_Med_2010_May_12_3(2)_133-134.nxml.txt.nlp	20606823	SENT4	15	15	9	9	atropine	PAM	PA448505	5066;23077	0.594
NULL	Symbiosis_2010_Jul_5_51(1)_55-65.nxml.txt.nlp	20730111	SENT146	23	23	13	13	hemin	ALAD	PA449849	210	0.594
NULL	Breast_Cancer_Res_2014_May_30_16(3)_R55.nxml.txt.nlp	24886669	SENT184	6	6	2	2	doxorubicin	survivin	PA449412	332	0.594
NULL	J_Cell_Biol_2003_Dec_8_163(5)_1157-1165.nxml.txt.nlp	14662753	SENT34	33	33	6	6	neomycin	PLIC-1	PA450608	29979	0.594
NULL	Front_Chem_2014_Dec_23_2_113.nxml.txt.nlp	25566531	SENT131	0	0	14	14	curcumin	STAT3	PA151958596	6774	0.594
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT229	20	20	9	9	nutlin-3	p53		7157	0.594
NULL	Nat_Commun_2013_Oct_15_4_2602.nxml.txt.nlp	24129506	SENT161	15	15	11	11	coumarin	CYP2A6	PA134521193	1548	0.594
NULL	Arch_Med_Sci_2012_Nov_9_8(5)_899-906.nxml.txt.nlp	23185202	SENT147	31	31	25	25	pioglitazone	ADN	PA450970	1675	0.594
NULL	Alcohol_Res_2012_34(4)_495-505.nxml.txt.nlp	23584115	SENT150	23	23	13	13	ethanol	RACK1	PA448073	10399	0.594
NULL	Breast_Cancer_Res_2009_Jul_15_11(4)_207.nxml.txt.nlp	19664181	SENT172	36	36	14	14	trastuzumab	PTEN	PA451743	5728	0.594
NULL	Carcinogenesis_2013_Mar_7_34(3)_703-712.nxml.txt.nlp	23222814	SENT12	10	10	30	30	curcumin	AKT1	PA151958596	207	0.594
NULL	Oncotarget_2012_Jan_28_3(1)_22-30.nxml.txt.nlp	22289880	SENT90	1	1	33	33	rituximab	IFN	PA451261	3439	0.594
NULL	Indian_J_Endocrinol_Metab_2013_Oct_17(Suppl1)_S259-S261.nxml.txt.nlp	24251180	SENT74	6	6	8	8	letrozole	CDP	PA450196	1523	0.594
NULL	J_Cell_Mol_Med_2013_Feb_10_17(2)_233-241.nxml.txt.nlp	23301673	SENT166	11	11	17	17	cisplatin	REN	PA449014	5972;147040	0.594
NULL	Clin_Sci_(Lond)_2011_Feb_1_120(Pt_4)_161-167.nxml.txt.nlp	20828371	SENT100	32	32	34	34	propranolol	CTRL	PA451145	1506	0.594
NULL	Breast_Cancer_Res_2011_Nov_24_13(6)_R120.nxml.txt.nlp	22115051	SENT129	23	23	39	39	tamoxifen	HER-2	PA451581	2064	0.594
NULL	Ann_Rheum_Dis_2008_Dec_9_68(6)_789-796.nxml.txt.nlp	19066176	SENT106	9	9	0	0	methotrexate	ACR	PA450428	49	0.594
NULL	Oxid_Med_Cell_Longev_2013_Mar_5_2013_264935.nxml.txt.nlp	23533686	SENT164	16	16	12	12	hemin	HO-1	PA449849	3162	0.594
NULL	Comp_Hepatol_2003_Jan_31_2_3.nxml.txt.nlp	12622871	SENT421	11	11	9	9	troglitazone	gamma	PA451799	9913	0.594
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_11_2014_780385.nxml.txt.nlp	25435891	SENT27	23	23	19	19	lipase	ATGL	PA450239	57104	0.594
NULL	Cases_J_2009_Jul_9_2_7466.nxml.txt.nlp	19829971	SENT54	16	16	5	5	atropine	DST	PA448505	667	0.594
NULL	J_Cell_Sci_2014_Feb_1_127(3)_497-508.nxml.txt.nlp	24284071	SENT381	25	25	6	6	aprotinin	p120	PA448472	4839;1500;55695;10902	0.594
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Feb_29_68(Pt_3)_o878-o879.nxml.txt.nlp	22412730	SENT84	20	20	7	7	potassium	mol	PA451047	90527	0.594
NULL	Br_J_Cancer_2006_Feb_13_94(3)_407-426.nxml.txt.nlp	16434996	SENT229	13	13	22	22	genistein	BRCA2	PA165109660	675	0.594
NULL	Curr_Med_Chem_2014_Feb_21_1129-1145.nxml.txt.nlp	24304271	SENT109	17	17	19	19	diethylstilbestrol	DES	PA449307	1674	0.594
NULL	Eur_J_Clin_Pharmacol_2008_Feb_26_64(2)_133-157.nxml.txt.nlp	18224312	SENT205	23	23	17	17	acenocoumarol	VKORC1	PA452632	79001	0.594
NULL	J_Vet_Med_Sci_2014_Aug_15_76(8)_1119-1127.nxml.txt.nlp	24829081	SENT121	23	23	10	10	trypsin	IL-8	PA451806	3576	0.594
NULL	J_Hematol_Oncol_2014_Feb_24_7_15.nxml.txt.nlp	24565018	SENT166	18	18	41	41	mitomycin	CD4	PA450524	920	0.593
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT247	27	27	29	29	doxorubicin	SLK	PA449412	9748;2534	0.593
NULL	Drug_Des_Devel_Ther_2014_Sep_9_8_1307-1314.nxml.txt.nlp	25246772	SENT151	14	14	7	7	tacrolimus	HTX	PA451578	7547	0.593
NULL	J_Int_AIDS_Soc_2012_Jul_27_15(2)_17396.nxml.txt.nlp	22905358	SENT175	11	11	9	9	isoniazid	IPT	PA450112	54802	0.593
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT280	1	1	4	4	cisplatin	GSTP1	PA449014	2950	0.593
NULL	Case_Rep_Obstet_Gynecol_2013_May_2_2013_492754.nxml.txt.nlp	23738169	SENT12	10	10	21	21	etoposide	EMA	PA449552	2108	0.593
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Jul_20_9_19.nxml.txt.nlp	20646305	SENT64	30	30	27	27	cefpodoxime	CTX	PA164746385	1593	0.593
NULL	J_Cell_Biol_2008_Jul_28_182(2)_327-340.nxml.txt.nlp	18644889	SENT94	30	30	22	22	estradiol	AKT	PA449503	207	0.593
NULL	Bioengineered_2014_Jan_1_5(1)_30-37.nxml.txt.nlp	24424156	SENT4	27	27	22	22	l-lysine	PPG	PA450280	5552	0.593
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT107	14	14	17	17	perifosine	TRAIL	PA165291471	8743	0.593
NULL	J_Biomed_Biotechnol_2011_Jan_18_2011_583929.nxml.txt.nlp	21331359	SENT148	23	23	7	7	cisplatin	TP53	PA449014	7157	0.593
NULL	J_Carcinog_2014_Mar_5_13_5.nxml.txt.nlp	24799832	SENT46	16	16	24	24	nilutamide	DES	PA450632	1674	0.593
NULL	Front_Oncol_2014_May_1_4_92.nxml.txt.nlp	24822170	SENT257	11	11	13	13	cisplatin	TRAIL	PA449014	8743	0.593
NULL	Cases_J_2009_Sep_10_2_8951.nxml.txt.nlp	20181215	SENT63	46	46	5	5	mitotane	ACTH	PA164746157	5443	0.593
NULL	J_Vet_Med_Sci_2014_Jul_18_76(7)_937-945.nxml.txt.nlp	24646457	SENT123	42	42	40	40	oxytetracycline	OTC	PA450757	5009	0.593
NULL	Indian_J_Endocrinol_Metab_2012_Mar_16(Suppl1)_S79-S82.nxml.txt.nlp	22701852	SENT104	6	6	10	10	metformin	B12	PA450395	7126;4709	0.593
NULL	Oncol_Lett_2014_Jun_9_7(6)_2053-2058.nxml.txt.nlp	24932288	SENT169	6	6	8	8	doxorubicin	MDR1	PA449412	5243	0.593
NULL	Indian_J_Pharm_Sci_2013_Mar-Apr_75(2)_230-233.nxml.txt.nlp	24019575	SENT85	14	14	32	32	tadalafil	API	PA10333	5345	0.593
NULL	Lipids_Health_Dis_2011_Aug_4_10_129.nxml.txt.nlp	21813022	SENT20	36	36	38	38	lipase	MGL	PA450239	11343	0.593
NULL	Cell_J_2012_Dec_12_Autumn_14(3)_161-170.nxml.txt.nlp	23508676	SENT205	15	15	27	27	arsenite	Bcl-2	PA452638	596	0.593
NULL	Clin_Interv_Aging_2013_Aug_19_8_1089-1095.nxml.txt.nlp	23983461	SENT109	40	40	26	26	minocycline	MT4	PA450519	84560	0.593
NULL	Subst_Abuse_Rehabil_2011_May_15_2_89-102.nxml.txt.nlp	21743792	SENT356	43	43	28	28	methamphetamine	CRK	PA450403	1398	0.593
NULL	Adipocyte_2012_Jul_1_1(3)_123-131.nxml.txt.nlp	23145367	SENT24	30	30	32	32	lipase	HSL	PA450239	3991	0.593
NULL	Pharmaceuticals_(Basel)_2013_Mar_26_6(4)_469-479.nxml.txt.nlp	24276118	SENT360	4	4	6	6	ethanol	DARPP-32	PA448073	84152	0.593
NULL	Mol_Biol_Cell_2012_Nov_1_23(21)_4212-4225.nxml.txt.nlp	22956765	SENT224	12	12	6	6	thrombin	RhoA	PA451674	387	0.593
NULL	Mol_Cancer_2009_Dec_10_8_118.nxml.txt.nlp	20003259	SENT187	0	0	2	2	imatinib	KIT	PA10804	3815	0.593
NULL	Mol_Cancer_2012_Sep_21_11_72.nxml.txt.nlp	22995644	SENT42	0	0	2	2	imatinib	PRL-3	PA10804	11156	0.593
NULL	Breast_Cancer_Res_2011_Nov_24_13(6)_R120.nxml.txt.nlp	22115051	SENT129	23	23	12	12	tamoxifen	HER-2	PA451581	2064	0.593
NULL	Springerplus_2013_Jan_30_2_31.nxml.txt.nlp	23450269	SENT43	21	21	28	28	ceftazidime	CTX	PA448861	1593	0.593
NULL	Neural_Plast_2014_May_4_2014_574159.nxml.txt.nlp	24883213	SENT50	17	17	19	19	vasopressin	AVP	PA451858	114548;551	0.593
NULL	Diabetes_2013_Mar_14_62(3)_811-824.nxml.txt.nlp	23209186	SENT325	0	0	11	11	bortezomib	BiP	PA10252	3309	0.593
NULL	Cancers_(Basel)_2012_Apr_25_4(2)_442-473.nxml.txt.nlp	24213319	SENT387	0	0	6	6	curcumin	Bcl-2	PA151958596	596	0.593
NULL	Nat_Neurosci_2012_Sep_5_15(9)_1245-1254.nxml.txt.nlp	22864611	SENT485	4	4	15	15	clozapine	HDAC4	PA449061	9759	0.593
NULL	J_Gen_Physiol_2009_Apr_133(4)_421-438.nxml.txt.nlp	19289574	SENT239	16	16	21	21	forskolin	SLC26A9	PA146096022	115019	0.593
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT6	4	4	17	17	nutlin-3	p53		7157	0.593
NULL	J_Radiat_Res_2012_Sep_10_53(5)_704-709.nxml.txt.nlp	22843360	SENT94	20	20	10	10	docetaxel	CRT	PA449383	811	0.593
NULL	Breast_Cancer_(Auckl)_2009_Sep_2_3_61-75.nxml.txt.nlp	19809577	SENT100	0	0	8	8	curcumin	BRCA1	PA151958596	672	0.593
NULL	Braz_J_Med_Biol_Res_2012_Feb_17_45(3)_244-249.nxml.txt.nlp	22331137	SENT92	15	15	8	8	gentamicin	PAG	PA449753	55824	0.593
NULL	Oncotarget_2012_Aug_31_3(9)_998-1010.nxml.txt.nlp	22948175	SENT169	7	7	0	0	hydroquinone	NQO1	PA449924	1728	0.593
NULL	Pharmaceutics_2010_Oct_14_2(4)_321-338.nxml.txt.nlp	NULL	SENT188	9	9	19	19	creatine	ADP	PA164778930	23038	0.593
NULL	Oncotarget_2014_Feb_25_5(5)_1304-1314.nxml.txt.nlp	24675421	SENT257	7	7	4	4	cisplatin	Bcl-2	PA449014	596	0.593
NULL	Pharmaceutics_2011_Nov_18_3(4)_865-913.nxml.txt.nlp	24309312	SENT531	13	13	15	15	nafcillin	CYP3A4	PA450576	1576	0.593
NULL	Biol_Open_2014_Nov_21_3(12)_1207-1216.nxml.txt.nlp	25416063	SENT3	14	14	0	0	zinc	NANOS2	PA451956	339345	0.593
NULL	Clin_Med_Insights_Oncol_2012_Nov_20_6_381-393.nxml.txt.nlp	23226079	SENT138	10	10	7	7	rifampin	CYP3A4	PA451250	1576	0.593
NULL	Biochim_Biophys_Acta_2014_Apr_1841(4)_588-594.nxml.txt.nlp	24440819	SENT291	5	5	7	7	lipase	PNPLA2	PA450239	57104	0.593
NULL	Support_Care_Cancer_2014_Oct_19_22(2)_469-477.nxml.txt.nlp	24141698	SENT181	4	4	15	15	prochlorperazine	URCC	PA451114	54894	0.593
NULL	Indian_J_Pharmacol_2008_Oct_40(Suppl_2)_S112-S142.nxml.txt.nlp	21593965	SENT455	12	12	23	23	perindopril	STZ	PA450877	6484	0.593
NULL	J_Int_Soc_Sports_Nutr_2014_Aug_13_11_38.nxml.txt.nlp	25132809	SENT127	14	14	22	22	creatine	MSTN	PA164778930	2660	0.593
NULL	Mol_Cancer_2014_Jul_5_13_165.nxml.txt.nlp	24996221	SENT325	0	0	2	2	docetaxel	HMGB1	PA449383	3146	0.593
NULL	Oncologist_2010_Mar_3_15(3)_216-235.nxml.txt.nlp	20200040	SENT76	14	14	11	11	erlotinib	HER-2	PA134687924	2064	0.593
NULL	Arthritis_Res_Ther_2009_Feb_3_11(1)_R15.nxml.txt.nlp	19192274	SENT218	26	26	4	4	diclofenac	TXNIP	PA449293	10628	0.593
NULL	Front_Oncol_2013_Apr_2_3_68.nxml.txt.nlp	23565504	SENT286	3	3	0	0	rituximab	CHOP	PA451261	1649	0.593
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Mar_17_68(Pt_4)_o1104-o1105.nxml.txt.nlp	22589963	SENT74	13	13	7	7	coumarin	mol	PA134521193	90527	0.593
NULL	Autophagy_2012_May_1_8(5)_853-855.nxml.txt.nlp	22617440	SENT51	19	19	32	32	dasatinib	MIR30A	PA162372878	407029	0.593
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT98	18	18	5	5	vinorelbine	ASC	PA451881	29108	0.593
NULL	Comp_Hepatol_2004_Jan_14_3(Suppl_1)_S50.nxml.txt.nlp	14960202	SENT22	38	38	47	47	l-glutamine	CO2	PA10090	4513	0.593
NULL	Comp_Hepatol_2004_Jan_14_3(Suppl_1)_S31.nxml.txt.nlp	14960183	SENT95	24	24	19	19	ethanol	TNF-alpha	PA448073	7124	0.593
NULL	Ann_Intensive_Care_2011_Apr_13_1_7.nxml.txt.nlp	21906332	SENT59	25	25	11	11	hydrocortisone	ACTH	PA449905	5443	0.593
NULL	Oncogene_2010_Sep_16_29(37)_5135-5145.nxml.txt.nlp	20622897	SENT77	1	1	3	3	cetuximab	STAT3	PA10040	6774	0.593
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT239	3	3	1	1	cisplatin	IBP	PA449014	706;50619	0.593
NULL	Cancer_2014_Jan_15_120(2)_229-237.nxml.txt.nlp	24122122	SENT168	14	14	11	11	sorafenib	VEGF-A	PA7000	7422	0.593
NULL	Scientifica_(Cairo)_2012_Nov_25_2012_473829.nxml.txt.nlp	24278698	SENT335	10	10	7	7	cisplatin	OCT3	PA449014	5460;6581	0.593
NULL	Mol_Cancer_2012_Jan_6_11_2.nxml.txt.nlp	22226043	SENT51	24	24	26	26	tamoxifen	Yes	PA451581	7525	0.593
NULL	Hematol_Rep_2011_Jan_21_3(1)_e2.nxml.txt.nlp	22184524	SENT44	6	6	12	12	isoniazid	ETB	PA450112	1910	0.593
NULL	Acta_Neuropathol_2014_Sep_24_128(5)_665-677.nxml.txt.nlp	25248508	SENT326	13	13	17	17	s-adenosylmethionine	PS1	PA164754994	5663	0.593
NULL	Med_Sci_Monit_2013_May_1_19_317-326.nxml.txt.nlp	23632427	SENT261	19	19	13	13	cefepime	CTX	PA164754876	1593	0.593
NULL	Protein_Cell_2014_Jun_19_5(6)_469-479.nxml.txt.nlp	24748116	SENT142	9	9	22	22	paclitaxel	EB1	PA450761	9167;22919;10982	0.593
NULL	Front_Physiol_2013_Jun_4_4_128.nxml.txt.nlp	23760815	SENT79	7	7	9	9	lipase	HSL	PA450239	3991	0.593
NULL	Case_Rep_Transplant_2012_Nov_4_2012_305920.nxml.txt.nlp	23213610	SENT44	8	8	10	10	everolimus	EVL	PA164746311	51466	0.593
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT73	39	39	32	32	vinorelbine	MVP	PA451881	9961	0.593
NULL	Curr_Med_Chem_2014_Feb_21_1129-1145.nxml.txt.nlp	24304271	SENT501	5	5	9	9	tamoxifen	STAR	PA451581	6770;2984	0.593
NULL	Crit_Care_2012_Oct_14_16(5)_R191.nxml.txt.nlp	23062276	SENT127	11	11	23	23	creatine	POD1	PA164778930	6943	0.593
NULL	Curr_Neuropharmacol_2008_Sep_6(3)_215-234.nxml.txt.nlp	19506722	SENT70	1	1	4	4	fluoxetine	5-HT1B	PA449673	3351	0.593
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_11_2014_780385.nxml.txt.nlp	25435891	SENT27	30	30	32	32	lipase	MGL	PA450239	11343	0.593
NULL	Front_Neurosci_2014_Jun_3_8_128.nxml.txt.nlp	24917782	SENT133	26	26	39	39	ethanol	MC3R	PA448073	4159	0.593
NULL	J_Thromb_Haemost_2010_Mar_8(3)_577-587.nxml.txt.nlp	20040043	SENT129	22	22	19	19	rosiglitazone	mol	PA451283	90527	0.593
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT91	0	0	9	9	delavirdine	CYP2C9	PA449223	1559	0.593
NULL	Leukemia_2013_Feb_3_27(2)_315-324.nxml.txt.nlp	22751450	SENT159	0	0	9	9	sorafenib	Mcl-1	PA7000	4170	0.593
NULL	Br_J_Cancer_2003_Mar_10_88(5)_754-759.nxml.txt.nlp	12618886	SENT107	19	19	3	3	paclitaxel	p53	PA450761	7157	0.593
NULL	Osong_Public_Health_Res_Perspect_2013_Dec_12_4(6)_316-322.nxml.txt.nlp	24524020	SENT206	26	26	20	20	erythromycin	CTX	PA449493	1593	0.593
NULL	Nanoscale_Res_Lett_2012_Nov_27_7(1)_652.nxml.txt.nlp	23181940	SENT54	12	12	6	6	ethanol	FTO	PA448073	79068	0.593
NULL	Cancers_(Basel)_2010_Jun_14_2(2)_1288-1311.nxml.txt.nlp	24281116	SENT714	2	2	8	8	oxygen	HIF-1alpha	PA450744	3091	0.593
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT61	8	8	6	6	pp2	PP1		5540;5464	0.593
NULL	Curr_Control_Trials_Cardiovasc_Med_2000_Aug_7_1(1)_48-54.nxml.txt.nlp	11714409	SENT69	21	21	29	29	ticlopidine	ARTS	PA451686	5414	0.593
NULL	AIDS_Res_Ther_2007_May_1_4_8.nxml.txt.nlp	17472747	SENT187	0	0	10	10	ritonavir	adiponectin	PA451260	9370	0.593
NULL	Br_J_Cancer_2010_Jan_5_102(1)_80-86.nxml.txt.nlp	19920817	SENT14	14	14	11	11	sunitinib	IFN	PA162372840	3439	0.593
NULL	Calcif_Tissue_Int_2011_Aug_3_89(2)_91-104.nxml.txt.nlp	21637997	SENT241	0	0	8	8	teriparatide	PTH	PA451620	5741	0.593
NULL	Neuroscience_2014_Dec_12_282_69-85.nxml.txt.nlp	24943715	SENT577	31	31	0	0	choline	AKT	PA448976	207	0.593
NULL	Hum_Genomics_2009_Jan_1_3(2)_128-142.nxml.txt.nlp	19164090	SENT176	8	8	1	1	carboplatin	CD44	PA448803	960	0.593
NULL	J_Cell_Mol_Med_2013_Oct_16_17(10)_1261-1270.nxml.txt.nlp	23855452	SENT149	2	2	4	4	gemcitabine	GEM	PA449748	2669	0.593
NULL	Oncotarget_2014_Aug_25_5(17)_7945-7959.nxml.txt.nlp	25277206	SENT332	6	6	19	19	hyaluronan	TPC1	PA165958431	53373	0.593
NULL	Fibrogenesis_Tissue_Repair_2011_Aug_2_4_18.nxml.txt.nlp	21810214	SENT241	5	5	11	11	bleomycin	IFN	PA448645	3439	0.593
NULL	Biochimie_2013_Jan_95(1)_59-65.nxml.txt.nlp	22771767	SENT47	0	0	8	8	ether	GPI	PA449525	10007;2821	0.593
NULL	Parasit_Vectors_2010_Sep_22_3_91.nxml.txt.nlp	20860829	SENT123	15	15	9	9	amodiaquine	ACT	PA448404	12;11332;9457;641455	0.593
NULL	Cell_Death_Dis_2013_Jul_18_4(7)_e733.nxml.txt.nlp	23868066	SENT234	37	37	21	21	cisplatin	REN	PA449014	5972;147040	0.593
NULL	G3_(Bethesda)_2014_Aug_27_4(11)_2079-2093.nxml.txt.nlp	25168010	SENT86	14	14	24	24	ethanol	HRC	PA448073	3270	0.593
NULL	Kidney_Int_Suppl_(2011)_2013_Jan_28_3(1)_19-62.nxml.txt.nlp	25018975	SENT635	42	42	31	31	iohexol	GFR	PA450061	9771	0.593
NULL	Allergy_Asthma_Clin_Immunol_2011_Nov_10_7(Suppl_1)_S8.nxml.txt.nlp	22165816	SENT128	30	30	3	3	omalizumab	IL-5	PA164752253	3567	0.593
NULL	Breast_Cancer_Res_2007_Oct_10_9(5)_R69.nxml.txt.nlp	17925034	SENT215	20	20	7	7	pp2	HC11		6347	0.593
NULL	Drugs_R_D_2011_Jun_27_11(2)_101-111.nxml.txt.nlp	21679003	SENT37	34	34	25	25	leucovorin	IFL	PA450198	3439	0.593
NULL	Genome_Biol_2008_Oct_13_9(10)_R150.nxml.txt.nlp	18851746	SENT71	5	5	2	2	tetracycline	MYCN	PA451640	4613	0.593
NULL	Breast_Cancer_Res_2005_Aug_1_7(5)_R796-R807.nxml.txt.nlp	16168126	SENT169	3	3	13	13	celecoxib	HER-2	PA448871	2064	0.593
NULL	J_Gen_Physiol_2003_Jul_122(1)_45-61.nxml.txt.nlp	12835470	SENT0	18	18	24	24	capsaicin	VR1	PA448776	56664	0.593
NULL	Reprod_Biol_Endocrinol_2013_Feb_26_11_15.nxml.txt.nlp	23442442	SENT138	2	2	4	4	l-arginine	BAX	PA448478	581	0.593
NULL	Mult_Scler_Int_2014_Dec_30_2014_926134.nxml.txt.nlp	25610650	SENT34	14	14	17	17	heparin	EGF	PA449855	1950	0.593
NULL	Acta_Neuropathol_Commun_2014_Oct_21_2(1)_149.nxml.txt.nlp	NULL	SENT11	24	24	8	8	riluzole	p38	PA451251	10598;1432;7965	0.593
NULL	Mol_Biol_Rep_2013_Sep_28_40(10)_5573-5585.nxml.txt.nlp	24078156	SENT58	30	30	18	18	iron	DMT1	PA450087	4891;1761	0.593
NULL	Chin_J_Cancer_2012_Feb_31(2)_110-118.nxml.txt.nlp	22098951	SENT30	19	19	14	14	imatinib	MRP1	PA10804	4437	0.593
NULL	Pharmacogn_Rev_2010_Jul-Dec_4(8)_153-160.nxml.txt.nlp	22228955	SENT162	16	16	39	39	ethanol	SHF	PA448073	90525	0.593
NULL	J_Hematol_Oncol_2010_Feb_10_3_7.nxml.txt.nlp	20146807	SENT182	15	15	6	6	carboplatin	GM-CSF	PA448803	1437	0.593
NULL	Breast_Cancer_Res_2011_May_26_13(3)_209.nxml.txt.nlp	21635709	SENT141	2	2	4	4	letrozole	STEPP	PA450196	222659	0.593
NULL	Front_Synaptic_Neurosci_2014_Oct_21_6_22.nxml.txt.nlp	25374536	SENT335	6	6	8	8	carbachol	MSN	PA448784	4478	0.593
NULL	BMJ_Open_2014_Feb_13_4(2)_e003960.nxml.txt.nlp	24525389	SENT235	12	12	1	1	warfarin	Gen	PA451906	348654	0.593
NULL	Lab_Invest_2011_Mar_15_91(3)_363-378.nxml.txt.nlp	21079581	SENT177	34	34	38	38	hyaluronan	HAS1	PA165958431	3036	0.593
NULL	J_Vis_Exp_2014_Jun_28_(88)_51278.nxml.txt.nlp	24998179	SENT183	21	21	2	2	cyclosporine	P-gp	PA449167	5243	0.593
NULL	Anc_Sci_Life_2012_Oct-Dec_32(2)_93-98.nxml.txt.nlp	24167334	SENT92	11	11	7	7	cyclophosphamide	AR7	PA449165	7067	0.593
NULL	J_Cell_Biol_2000_Feb_21_148(4)_791-800.nxml.txt.nlp	10684259	SENT199	7	7	3	3	estradiol	Raf-1	PA449503	5894	0.593
NULL	Biomed_Res_Int_2013_Oct_29_2013_495319.nxml.txt.nlp	24288681	SENT236	16	16	11	11	capecitabine	F10	PA448771	2159	0.593
NULL	Clin_Ophthalmol_2008_Jun_2(2)_355-368.nxml.txt.nlp	19668727	SENT81	13	13	18	18	ketorolac	COX	PA450150	1351	0.593
NULL	Cancers_(Basel)_2011_Apr_1_3(2)_1844-1860.nxml.txt.nlp	24212785	SENT631	13	13	4	4	cetuximab	BRAF	PA10040	673	0.593
NULL	J_Korean_Assoc_Oral_Maxillofac_Surg_2014_Dec_26_40(6)_291-296.nxml.txt.nlp	25551094	SENT93	2	2	7	7	alendronate	RANKL	PA448082	8600	0.593
NULL	Open_Biochem_J_2014_Feb_21_8_21-34.nxml.txt.nlp	24688608	SENT125	29	29	9	9	etanercept	KYNU	PA449515	8942	0.593
NULL	Exp_Mol_Med_2012_Nov_30_44(11)_665-673.nxml.txt.nlp	23114424	SENT73	0	0	6	6	taurine	adiponectin	PA451590	9370	0.593
NULL	Mol_Vis_2011_Apr_26_17_1024-1033.nxml.txt.nlp	21541269	SENT11	8	8	2	2	brimonidine	BRI	PA448665	9445	0.593
NULL	J_Invest_Dermatol_2012_Jan_18_132(1)_135-143.nxml.txt.nlp	21850017	SENT156	3	3	14	14	paraformaldehyde	TLR9	PA450790	54106	0.593
NULL	J_Ophthalmic_Inflamm_Infect_2011_Nov_6_2(1)_21-28.nxml.txt.nlp	22057810	SENT112	1	1	13	13	methotrexate	CTX	PA450428	1593	0.593
NULL	Biomed_Res_Int_2014_Feb_23_2014_358136.nxml.txt.nlp	24707482	SENT158	16	16	13	13	iodixanol	NGAL	PA164783998	3934	0.593
NULL	Clin_Pharmacol_2011_Jun_22_3_13-25.nxml.txt.nlp	22287853	SENT195	2	2	27	27	saxagliptin	CYP3A4	PA165958362	1576	0.593
NULL	J_Cell_Biol_1998_Apr_20_141(2)_539-551.nxml.txt.nlp	9548730	SENT67	41	41	18	18	hydrocortisone	F12	PA449905	2161	0.593
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1150.nxml.txt.nlp	24675468	SENT88	13	13	7	7	ethanol	adiponectin	PA448073	9370	0.593
NULL	Clin_Ophthalmol_2007_Dec_1(4)_441-453.nxml.txt.nlp	19668521	SENT371	8	8	15	15	ganciclovir	SPK	PA449733	55872;8189	0.593
NULL	Mol_Cancer_2010_May_18_9_110.nxml.txt.nlp	20482802	SENT165	24	24	11	11	bortezomib	PSMB5	PA10252	5693	0.593
NULL	Br_J_Cancer_2012_Nov_6_107(10)_1714-1721.nxml.txt.nlp	23073173	SENT95	2	2	4	4	bicalutamide	RUNX2	PA164746255	860	0.593
NULL	Biomed_Opt_Express_2014_Jul_14_5(8)_2614-2619.nxml.txt.nlp	25136489	SENT80	10	10	17	17	fluorescein	LTA	PA164746009	4049	0.593
NULL	Acta_Pharmacol_Sin_2012_Nov_23_33(11)_1409-1416.nxml.txt.nlp	22820910	SENT136	16	16	12	12	clozapine	CYP3A4	PA449061	1576	0.593
NULL	Front_Immunol_2013_Nov_12_4_370.nxml.txt.nlp	24273542	SENT160	3	3	5	5	gemcitabine	Gem	PA449748	51053	0.593
NULL	Crit_Care_2010_Oct_13_14(5)_R181.nxml.txt.nlp	20942931	SENT163	24	24	4	4	furosemide	IL-6	PA449719	3569	0.593
NULL	BMB_Rep_2014_Oct_47(10)_569-574.nxml.txt.nlp	24499676	SENT102	9	9	5	5	hemin	HO-1	PA449849	3162	0.593
NULL	Exp_Neurobiol_2014_Jun_13_23(2)_148-154.nxml.txt.nlp	24963279	SENT24	16	16	7	7	thrombin	IFN	PA451674	3439	0.593
NULL	Front_Neurosci_2013_Jan_10_6_191.nxml.txt.nlp	23335875	SENT18	8	8	5	5	vasopressin	AT1	PA451858	9197;185	0.593
NULL	Patient_Prefer_Adherence_2009_Nov_3_3_131-143.nxml.txt.nlp	19936155	SENT334	39	39	28	28	medroxyprogesterone	MGA	PA450344	8972;23269	0.593
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Apr_6_5_8.nxml.txt.nlp	16600049	SENT63	0	0	2	2	lamivudine	LAM	PA450163	7249;7248	0.593
NULL	Korean_Circ_J_2013_Oct_30_43(10)_699-701.nxml.txt.nlp	24255655	SENT35	13	13	10	10	amiodarone	APT	PA448383	653639	0.593
NULL	Cancer_Cell_Int_2005_Jul_24_5_22.nxml.txt.nlp	16042792	SENT129	19	19	17	17	vincristine	MRP1	PA451879	4437	0.593
NULL	Case_Rep_Dermatol_2012_Sep_16_4(3)_256-260.nxml.txt.nlp	23275770	SENT29	28	28	22	22	isotretinoin	OMG	PA450128	4974	0.593
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_May_24_70(Pt_6)_o713.nxml.txt.nlp	24940283	SENT75	22	22	18	18	ethanol	mol	PA448073	90527	0.593
NULL	Cell_Death_Differ_2010_Apr_23_17(4)_699-709.nxml.txt.nlp	19851330	SENT92	3	3	13	13	tetracycline	p53	PA451640	7157	0.593
NULL	Breast_Cancer_Res_2010_Mar_5_12(2)_R16.nxml.txt.nlp	20205716	SENT363	20	20	9	9	lovastatin	PTEN	PA450272	5728	0.593
NULL	Biomed_Res_Int_2013_Jan_21_2013_581631.nxml.txt.nlp	23484133	SENT75	0	0	7	7	infliximab	IFN	PA452639	3439	0.593
NULL	Mol_Cell_Proteomics_2014_Dec_3_13(12)_3396-3409.nxml.txt.nlp	25187573	SENT106	25	25	17	17	trypsin	MS2	PA451806	101	0.593
NULL	J_Hematol_Oncol_2012_Sep_18_5_57.nxml.txt.nlp	22989009	SENT159	4	4	18	18	nutlin-3	p53		7157	0.593
NULL	J_Korean_Med_Sci_2010_Nov_26_25(11)_1601-1608.nxml.txt.nlp	21060749	SENT80	25	25	22	22	thrombin	ADP	PA451674	23038	0.593
NULL	Ecancermedicalscience_2010_Nov_3_4_178.nxml.txt.nlp	22276032	SENT174	4	4	12	12	gefitinib	HER2	PA131301952	2064	0.593
NULL	Nucleic_Acids_Res_2011_Oct_6_39(19)_8651-8664.nxml.txt.nlp	21737428	SENT395	7	7	17	17	galactose	GAL	PA449725	51083	0.593
NULL	J_Korean_Med_Sci_2010_Apr_19_25(4)_557-563.nxml.txt.nlp	20357998	SENT99	3	3	8	8	rosiglitazone	IL-10	PA451283	3586	0.593
NULL	Clin_Sci_(Lond)_2011_Nov_1_121(Pt_10)_449-458.nxml.txt.nlp	21671887	SENT188	4	4	6	6	simvastatin	AMPK	PA451363	5563	0.593
NULL	Osong_Public_Health_Res_Perspect_2013_Dec_12_4(6)_316-322.nxml.txt.nlp	24524020	SENT206	18	18	20	20	clindamycin	CTX	PA449035	1593	0.593
NULL	Toxins_(Basel)_2010_Oct_28_2(11)_2584-2592.nxml.txt.nlp	22069565	SENT202	11	11	8	8	warfarin	CYP2C9	PA451906	1559	0.593
NULL	Oncotarget_2010_Aug_6_1(4)_252-264.nxml.txt.nlp	21304177	SENT282	7	7	5	5	quinacrine	CYP2E1	PA164745551	1571	0.593
NULL	Int_J_Cell_Biol_2014_Jan_22_2014_709828.nxml.txt.nlp	24578708	SENT104	14	14	30	30	choline	PEMT	PA448976	10400	0.593
NULL	Front_Neurosci_2014_Dec_5_8_398.nxml.txt.nlp	25538552	SENT215	30	30	4	4	oxygen	gamma	PA450744	9913	0.593
NULL	Oncoimmunology_2013_Sep_1_2(9)_e25737.nxml.txt.nlp	24327935	SENT28	0	0	2	2	bleomycin	BLM	PA448645	641	0.593
NULL	Mult_Scler_Int_2013_Jun_25_2013_627870.nxml.txt.nlp	23878736	SENT350	0	0	6	6	natalizumab	IFN	PA164747191	3439	0.593
NULL	Hum_Genomics_Proteomics_2010_Aug_3_2010_159761.nxml.txt.nlp	20981231	SENT130	3	3	23	23	lithium	c-Jun	PA450243	3725	0.593
NULL	Iran_J_Microbiol_2013_Mar_5(1)_42-47.nxml.txt.nlp	23466523	SENT91	26	26	8	8	chloramphenicol	CTX	PA448927	1593	0.593
NULL	Breast_Cancer_Res_2012_Mar_14_14(2)_R46.nxml.txt.nlp	22417870	SENT84	6	6	22	22	tamoxifen	HER2	PA451581	2064	0.593
NULL	Case_Rep_Ophthalmol_Med_2014_Dec_14_2014_403461.nxml.txt.nlp	25580329	SENT60	5	5	1	1	bevacizumab	hole	PA130232992	80757	0.593
NULL	J_Biol_Chem_2012_Apr_20_287(17)_14122-14135.nxml.txt.nlp	22351750	SENT7	23	23	10	10	trypsin	TSG-6	PA451806	7130	0.593
NULL	Breast_Cancer_Res_2004_Aug_5_6(5)_R601-R607.nxml.txt.nlp	15318941	SENT147	42	42	28	28	docetaxel	BIRC5	PA449383	332	0.593
NULL	Toxins_(Basel)_2011_Jul_14_3(7)_848-883.nxml.txt.nlp	22069744	SENT320	47	47	31	31	paclitaxel	MDR1	PA450761	5243	0.593
NULL	Clin_Genet_2014_Jan_1_86(1)_21-28.nxml.txt.nlp	24684508	SENT58	17	17	25	25	warfarin	CYP4F2	PA451906	8529	0.593
NULL	Front_Genet_2013_Aug_29_4_163.nxml.txt.nlp	24009622	SENT385	3	3	11	11	heparin	ABCG2	PA449855	9429	0.593
NULL	Br_J_Cancer_2013_Feb_5_108(2)_250-258.nxml.txt.nlp	23385789	SENT29	34	34	11	11	bevacizumab	CA125	PA130232992	4077;94025	0.593
NULL	J_Physiol_2009_Feb_15_587(Pt_4)_731-744.nxml.txt.nlp	19074966	SENT98	8	8	11	11	taurine	PAT1	PA451590	10513;206358	0.593
NULL	Clinicoecon_Outcomes_Res_2014_Oct_17_6_451-461.nxml.txt.nlp	25378939	SENT19	9	9	12	12	linezolid	HAP	PA450233	5915;10313	0.593
NULL	J_Korean_Med_Sci_2010_Nov_26_25(11)_1683-1687.nxml.txt.nlp	21060764	SENT8	18	18	20	20	thyroglobulin	TTF-1	PA164754910	7080	0.593
NULL	Pain_Res_Treat_2011_Dec_12_2011_507029.nxml.txt.nlp	22220274	SENT28	15	15	17	17	ceftriaxone	CTX	PA448866	1593	0.593
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT104	11	11	13	13	perifosine	TRAIL	PA165291471	8743	0.593
NULL	Curr_Nutr_Rep_2014_Dec_15_3(1)_22-34.nxml.txt.nlp	24563822	SENT67	5	5	21	21	estradiol	SHBG	PA449503	6462	0.593
NULL	Oncotarget_2014_Mar_26_5(21)_10342-10355.nxml.txt.nlp	25431950	SENT84	22	22	7	7	doxorubicin	EZH2	PA449412	2146	0.593
NULL	Facts_Views_Vis_Obgyn_2013_5(2)_149-159.nxml.txt.nlp	24753940	SENT299	9	9	0	0	levonorgestrel	UPA	PA450218	118471;5328	0.593
NULL	Exp_Mol_Med_2012_Sep_30_44(9)_536-544.nxml.txt.nlp	22771771	SENT8	3	3	10	10	ns-398	p16		1029	0.593
NULL	Front_Genet_2013_Aug_29_4_163.nxml.txt.nlp	24009622	SENT84	12	12	20	20	ethanol	DDP	PA448073	1678	0.593
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_13_2012_636848.nxml.txt.nlp	23258994	SENT177	22	22	17	17	carrageenan	TRPV4	PA448814	59341	0.593
NULL	Clin_Mol_Hepatol_2014_Sep_25_20(3)_267-273.nxml.txt.nlp	25320730	SENT163	2	2	0	0	lamivudine	LAM	PA450163	7249;7248	0.593
NULL	Emerg_Infect_Dis_2014_May_20(5)_910-911.nxml.txt.nlp	24751334	SENT31	24	24	14	14	cefoxitin	COT	PA448856	54677	0.593
NULL	J_Inflamm_(Lond)_2007_Sep_20_4_18.nxml.txt.nlp	17883846	SENT47	7	7	9	9	bleomycin	BLM	PA448645	641	0.593
NULL	Biomed_Res_Int_2014_May_4_2014_351252.nxml.txt.nlp	24877084	SENT160	12	12	14	14	bevacizumab	FTM	PA130232992	23322	0.593
NULL	Osteoporos_Int_2008_Apr_12_19(4)_399-428.nxml.txt.nlp	18266020	SENT255	2	2	0	0	teriparatide	PTH	PA451620	5741	0.593
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Feb_18_65(Pt_3)_o546.nxml.txt.nlp	21582205	SENT70	27	27	41	41	ethanol	mol	PA448073	90527	0.592
NULL	J_Gen_Physiol_1922_Jan_20_4(3)_261-274.nxml.txt.nlp	19871930	SENT0	12	12	1	1	trypsin	Gen	PA451806	348654	0.592
NULL	Case_Rep_Crit_Care_2014_Jun_24_2014_650916.nxml.txt.nlp	25057417	SENT72	34	34	29	29	iron	MRI	PA450087	78996	0.592
NULL	J_Obes_2010_Jan_14_2010_970865.nxml.txt.nlp	20798864	SENT148	30	30	32	32	metformin	AMPK	PA450395	5563	0.592
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT148	14	14	6	6	glucose	ERK	PA449773	5594	0.592
NULL	J_Am_Heart_Assoc_2013_Dec_19_2(6)_e000426.nxml.txt.nlp	24275629	SENT316	24	24	13	13	sirolimus	ARTS	PA451365	5414	0.592
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1495-1502.nxml.txt.nlp	21989186	SENT199	18	18	9	9	panitumumab	HSI	PA162373091	57016	0.592
NULL	AAPS_J_2014_Jun_19_16(5)_1056-1063.nxml.txt.nlp	24942210	SENT130	7	7	43	43	bevacizumab	HER2	PA130232992	2064	0.592
NULL	Arthritis_Res_Ther_2014_Dec_23_16(6)_506.nxml.txt.nlp	25587634	SENT189	0	0	2	2	ustekinumab	UST	PA166048654	10090	0.592
NULL	Korean_J_Anesthesiol_2013_Jan_21_64(1)_47-53.nxml.txt.nlp	23372886	SENT33	8	8	4	4	bupivacaine	IGK	PA135057240	50802	0.592
NULL	Cell_Death_Dis_2010_Nov_18_1(11)_e102.nxml.txt.nlp	21368867	SENT58	6	6	4	4	gentamicin	CLIMP-63	PA449753	10970	0.592
NULL	Acta_Pharmacol_Sin_2011_Dec_7_32(12)_1433-1445.nxml.txt.nlp	22056617	SENT262	3	3	6	6	lamotrigine	Bcl-2	PA450164	596	0.592
NULL	Iran_Red_Crescent_Med_J_2014_Aug_5_16(8)_e6915.nxml.txt.nlp	25389496	SENT165	12	12	16	16	simvastatin	adiponectin	PA451363	9370	0.592
NULL	Environ_Health_Perspect_2011_Mar_1_119(3)_371-376.nxml.txt.nlp	21041162	SENT79	0	0	10	10	fluorescein	CD4	PA164746009	920	0.592
NULL	BMB_Rep_2013_Apr_46(4)_230-235.nxml.txt.nlp	23615266	SENT18	21	21	14	14	protamine	PP1	PA10366	5540;5464	0.592
NULL	Anc_Sci_Life_2012_Oct-Dec_32(2)_93-98.nxml.txt.nlp	24167334	SENT81	5	5	19	19	cyclophosphamide	ANOVA	PA449165	4858	0.592
NULL	Int_J_Mol_Sci_2014_Oct_14_15(10)_18557-18573.nxml.txt.nlp	25318057	SENT993	6	6	9	9	bortezomib	DR5	PA10252	8795	0.592
NULL	J_Invest_Dermatol_2014_Apr_11_134(4)_984-991.nxml.txt.nlp	24352038	SENT77	31	31	12	12	adalimumab	P21	PA10004	1026;9338	0.592
NULL	Clin_Interv_Aging_2010_Nov_19_5_345-354.nxml.txt.nlp	21228900	SENT124	12	12	3	3	denosumab	RANKL	PA166048634	8600	0.592
NULL	Diabetes_Metab_Syndr_Obes_2011_Apr_28_4_155-166.nxml.txt.nlp	21779147	SENT67	22	22	8	8	atorvastatin	SLCO1B1	PA448500	10599	0.592
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT159	29	29	19	19	tacrolimus	SOCS3	PA451578	9021	0.592
NULL	Blood_Cancer_J_2013_Sep_13_3(9)_e146.nxml.txt.nlp	24036945	SENT13	1	1	9	9	ribavirin	AKT	PA451241	207	0.592
NULL	Theranostics_2013_Jun_24_3(7)_467-476.nxml.txt.nlp	23843894	SENT180	45	45	17	17	urokinase	Plg-RKT	PA451836	55848	0.592
NULL	Mol_Biol_Cell_2014_Mar_1_25(5)_712-727.nxml.txt.nlp	24403601	SENT542	36	36	0	0	lipase	DGAT	PA450239	8694	0.592
NULL	Breast_Cancer_Res_2014_May_23_16(3)_R50.nxml.txt.nlp	24887458	SENT127	11	11	0	0	trastuzumab	HER2	PA451743	2064	0.592
NULL	eLife_2013_Nov_5_2_e00969.nxml.txt.nlp	24192036	SENT163	14	14	25	25	vemurafenib	JNK	PA165946873	5599	0.592
NULL	Biomed_Res_Int_2014_Jun_26_2014_161346.nxml.txt.nlp	25054130	SENT182	9	9	36	36	curcumin	NOX2	PA151958596	1536	0.592
NULL	Drug_Saf_2014_Jul_31_37(11)_897-902.nxml.txt.nlp	25079141	SENT161	12	12	16	16	diclofenac	PRAC	PA449293	84366	0.592
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_39-54.nxml.txt.nlp	19305787	SENT503	3	3	5	5	ethanol	DARPP-32	PA448073	84152	0.592
NULL	Nat_Neurosci_2013_Apr_17_16(4)_464-472.nxml.txt.nlp	23502536	SENT78	17	17	26	26	fluoxetine	GluA1	PA449673	2890	0.592
NULL	Arthritis_Res_Ther_2012_May_17_14(3)_R118.nxml.txt.nlp	22594821	SENT54	12	12	4	4	hydroxychloroquine	ACPA	PA164777036	5657	0.592
NULL	Mol_Cancer_2014_Jun_9_13_146.nxml.txt.nlp	24913494	SENT141	24	24	8	8	bicalutamide	MID1	PA164746255	4281	0.592
NULL	J_Biol_Chem_2013_Feb_22_288(8)_5330-5341.nxml.txt.nlp	23288844	SENT103	28	28	13	13	kanamycin	CO2	PA450137	4513	0.592
NULL	Anal_Biochem_2014_Jun_1_454(100)_17-22.nxml.txt.nlp	24637157	SENT339	10	10	29	29	camptothecin	TOP1	PA153590860	7150	0.592
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT250	14	14	8	8	vinorelbine	ASC	PA451881	29108	0.592
NULL	EPMA_J_2012_Sep_27_3(1)_10.nxml.txt.nlp	23016735	SENT214	39	39	19	19	warfarin	EPHX1	PA451906	2052	0.592
NULL	Cell_Commun_Signal_2006_Oct_18_4_7.nxml.txt.nlp	17049074	SENT384	10	10	6	6	heparin	EGF	PA449855	1950	0.592
NULL	J_Am_Heart_Assoc_2013_Aug_23_2(4)_e000249.nxml.txt.nlp	23817469	SENT293	3	3	40	40	creatine	apelin	PA164778930	8862	0.592
NULL	Acta_Pharmacol_Sin_2010_Mar_22_31(3)_329-340.nxml.txt.nlp	20173759	SENT147	1	1	4	4	ethanol	AMPK	PA448073	5563	0.592
NULL	Biomed_Res_Int_2014_Jun_4_2014_253243.nxml.txt.nlp	24995279	SENT45	9	9	7	7	melphalan	CHOP	PA450354	1649	0.592
NULL	Oncotarget_2014_May_27_5(19)_9049-9064.nxml.txt.nlp	24979294	SENT135	30	30	44	44	fulvestrant	ANOVA	PA164747170	4858	0.592
NULL	Biomed_Res_Int_2013_Dec_10_2013_783698.nxml.txt.nlp	24386640	SENT63	26	26	29	29	isoniazid	DST	PA450112	667	0.592
NULL	Br_J_Cancer_2010_Feb_16_102(4)_658-664.nxml.txt.nlp	20104222	SENT191	4	4	6	6	sunitinib	IFN	PA162372840	3439	0.592
NULL	Oncol_Lett_2014_Sep_19_8(3)_1269-1274.nxml.txt.nlp	25120704	SENT156	2	2	0	0	metformin	Met	PA450395	79811	0.592
NULL	J_Epilepsy_Res_2014_Jun_30_4(1)_7-13.nxml.txt.nlp	24977124	SENT122	2	2	18	18	pilocarpine	CA3	PA450962	761	0.592
NULL	Arthritis_Res_Ther_2005_Dec_1_7(1)_R149-R155.nxml.txt.nlp	15642135	SENT193	18	18	4	4	infliximab	IL-6	PA452639	3569	0.592
NULL	Breast_Cancer_Res_2011_Apr_15_13(2)_R44.nxml.txt.nlp	21496232	SENT250	8	8	10	10	erlotinib	EGF	PA134687924	1950	0.592
NULL	Mol_Biol_Cell_2014_Mar_1_25(5)_583-593.nxml.txt.nlp	24403604	SENT124	6	6	11	11	collagenase	MMP2	PA449107	4313	0.592
NULL	Eur_J_Med_Chem_2014_Nov_24_87_722-734.nxml.txt.nlp	25305716	SENT29	0	0	8	8	ezetimibe	NPC1L1	PA10816	29881	0.592
NULL	Hum_Mol_Genet_2012_Jun_15_21(12)_2631-2645.nxml.txt.nlp	22407129	SENT228	18	18	22	22	protamine	TNP1	PA10366	7141	0.592
NULL	EPMA_J_2011_Jun_9_2(2)_197-210.nxml.txt.nlp	23199149	SENT350	17	17	20	20	deferoxamine	HIF-1alpha	PA164746490	3091	0.592
NULL	Ann_Rheum_Dis_2008_Sep_11_68(7)_1146-1152.nxml.txt.nlp	18794178	SENT160	8	8	13	13	sulfasalazine	ACR	PA451547	49	0.592
NULL	ScientificWorldJournal_2013_Apr_18_2013_808460.nxml.txt.nlp	23710149	SENT127	7	7	4	4	indomethacin	BOR	PA449982	55143	0.592
NULL	J_Hematol_Oncol_2009_Jan_21_2_2.nxml.txt.nlp	19159467	SENT102	7	7	3	3	panitumumab	EGFR	PA162373091	1956	0.592
NULL	J_Mol_Signal_2011_Jul_20_6_7.nxml.txt.nlp	21774804	SENT257	15	15	29	29	curcumin	CD44	PA151958596	960	0.592
NULL	J_Mol_Med_(Berl)_2014_May_10_92(7)_709-722.nxml.txt.nlp	24811491	SENT250	12	12	7	7	cetuximab	PTEN	PA10040	5728	0.592
NULL	Br_J_Ophthalmol_2008_Sep_22_92(9)_1275-1282.nxml.txt.nlp	18723745	SENT54	21	21	19	19	latanoprost	BAK	PA164774763	578	0.592
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT277	28	28	20	20	neratinib	EGFR	PA165291472	1956	0.592
NULL	Nature_2012_Aug_16_488(7411)_394-398.nxml.txt.nlp	22810587	SENT62	26	26	9	9	isoproterenol	apelin	PA450121	8862	0.592
NULL	Oncotarget_2014_Aug_29_5(19)_8947-8958.nxml.txt.nlp	25333254	SENT112	8	8	22	22	plerixafor	CXCR7	PA165958410	57007	0.592
NULL	Support_Care_Cancer_2010_May_27_18(5)_529-541.nxml.txt.nlp	20191292	SENT258	10	10	5	5	etoposide	CHOP	PA449552	1649	0.592
NULL	Clin_Endosc_2014_Mar_31_47(2)_141-150.nxml.txt.nlp	24765596	SENT178	45	45	29	29	propofol	ACLS	PA451141	46;2737	0.592
NULL	Case_Rep_Endocrinol_2015_Jan_5_2015_268714.nxml.txt.nlp	25628901	SENT68	14	14	20	20	thyroglobulin	CD10	PA164754910	4311	0.592
NULL	Acta_Pharmacol_Sin_2013_Oct_7_34(10)_1349-1358.nxml.txt.nlp	23892274	SENT19	5	5	7	7	ritonavir	P-gp	PA451260	5243	0.592
NULL	Mol_Cancer_2009_Nov_24_8_109.nxml.txt.nlp	19930708	SENT188	0	0	3	3	exemestane	EGFR	PA449563	1956	0.592
NULL	Arthritis_2012_Oct_11_2012_713618.nxml.txt.nlp	23133751	SENT155	25	25	8	8	tocilizumab	CDAI	PA165292659	146059	0.592
NULL	Biol_Open_2012_Mar_21_1(5)_446-457.nxml.txt.nlp	23213436	SENT579	18	18	15	15	protamine	TP1	PA10366	7011	0.592
NULL	Mol_Cell_Biochem_2014_Oct_9_385(1-2)_265-275.nxml.txt.nlp	24104452	SENT145	31	31	19	19	bortezomib	U87	PA10252	677775;641648	0.592
NULL	Int_J_Mol_Sci_2012_Aug_13_13(8)_10091-10112.nxml.txt.nlp	22949849	SENT46	17	17	19	19	lipase	PPL	PA450239	5493	0.592
NULL	Ther_Clin_Risk_Manag_2007_Jun_3(3)_411-420.nxml.txt.nlp	18488075	SENT38	2	2	18	18	alefacept	CD56	PA164748040	4684	0.592
NULL	Br_J_Cancer_2013_Dec_10_109(12)_2954-2958.nxml.txt.nlp	24231949	SENT59	21	21	10	10	paclitaxel	p53	PA450761	7157	0.592
NULL	Front_Immunol_2013_Nov_18_4_382.nxml.txt.nlp	24302925	SENT97	0	0	7	7	zoledronate	IL-10	PA10235	3586	0.592
NULL	J_Carcinog_2011_Nov_30_10_28.nxml.txt.nlp	22190870	SENT175	16	16	28	28	trastuzumab	CDK2	PA451743	1017	0.592
NULL	Int_J_Mol_Sci_2014_Mar_6_15(3)_4049-4059.nxml.txt.nlp	24663080	SENT33	9	9	16	16	dexmedetomidine	IL-6	PA449256	3569	0.592
NULL	Arch_Virol_2014_Jul_16_159(1)_29-37.nxml.txt.nlp	23857507	SENT19	0	0	2	2	lamivudine	LAM	PA450163	7249;7248	0.592
NULL	Biosci_Rep_2012_Dec_6_33(1)_e00006.nxml.txt.nlp	23050906	SENT297	13	13	15	15	lovastatin	DHCR24	PA450272	1718	0.592
NULL	Clin_Med_Insights_Oncol_2012_Dec_20_7_1-12.nxml.txt.nlp	23362372	SENT35	34	34	37	37	phenytoin	CYP3A	PA450947	1574	0.592
NULL	Support_Care_Cancer_2014_Oct_19_22(2)_469-477.nxml.txt.nlp	24141698	SENT60	27	27	33	33	palonosetron	HEC	PA10352	10403	0.592
NULL	Eur_J_Haematol_2008_Feb_80(2)_93-106.nxml.txt.nlp	18081719	SENT317	21	21	0	0	iron	MRI	PA450087	78996	0.592
NULL	Breast_Cancer_Res_2011_Nov_23_13(6)_R116.nxml.txt.nlp	22113133	SENT327	16	16	0	0	diethylstilbestrol	CTRL	PA449307	1506	0.592
NULL	Clin_Ophthalmol_2008_Jun_2(2)_355-368.nxml.txt.nlp	19668727	SENT248	1	1	18	18	amfenac	COX	PA166049186	1351	0.592
NULL	ScientificWorldJournal_2013_Jun_5_2013_704912.nxml.txt.nlp	23844410	SENT21	8	8	15	15	telaprevir	BOC	PA165958354	91653	0.592
NULL	Osteoporos_Int_2012_Apr_15_23(4)_1225-1234.nxml.txt.nlp	21573880	SENT246	14	14	6	6	alendronate	PTH	PA448082	5741	0.592
NULL	Case_Rep_Pediatr_2013_May_16_2013_207907.nxml.txt.nlp	23762715	SENT64	25	25	10	10	clonidine	ACTH	PA449051	5443	0.592
NULL	Environ_Health_Perspect_2008_Mar_26_116(3)_322-328.nxml.txt.nlp	18335098	SENT108	26	26	17	17	estradiol	PMI	PA449503	8834;5373	0.592
NULL	Open_Cardiovasc_Med_J_2007_Nov_14_1_22-26.nxml.txt.nlp	18949087	SENT8	0	0	41	41	eprosartan	PON1	PA449481	5444	0.592
NULL	Arthritis_Res_Ther_2010_Apr_1_12(2)_R60.nxml.txt.nlp	20359365	SENT176	18	18	11	11	bleomycin	SPARC	PA448645	6678	0.592
NULL	Breast_Cancer_Res_2011_Jan_17_13(1)_R5.nxml.txt.nlp	21241485	SENT202	18	18	3	3	estradiol	Brn-3b	PA449503	5458	0.592
NULL	J_Antimicrob_Chemother_2014_Apr_2_69(4)_911-918.nxml.txt.nlp	24302651	SENT39	18	18	12	12	tetracycline	PEN	PA451640	9933	0.592
NULL	Scientifica_(Cairo)_2012_Nov_25_2012_473829.nxml.txt.nlp	24278698	SENT238	27	27	18	18	cisplatin	ATP7B	PA449014	540	0.592
NULL	EPMA_J_2012_Sep_27_3(1)_10.nxml.txt.nlp	23016735	SENT216	36	36	17	17	warfarin	GGCX	PA451906	2677	0.592
NULL	Arch_Dis_Child_2008_Jul_1_93(7)_620-625.nxml.txt.nlp	18381346	SENT182	0	0	10	10	bosentan	CYP3A4	PA10034	1576	0.592
NULL	Biomed_Res_Int_2014_Jun_2_2014_525097.nxml.txt.nlp	24991560	SENT131	14	14	17	17	creatine	CNTF	PA164778930	1270	0.592
NULL	Acta_Pharmacol_Sin_2009_Feb_5_30(2)_228-234.nxml.txt.nlp	19122672	SENT119	18	18	11	11	isoflurane	HO-1	PA450106	3162	0.592
NULL	Proteome_Sci_2010_Mar_26_8_18.nxml.txt.nlp	20346146	SENT113	21	21	9	9	hyaluronan	CD73	PA165958431	4907	0.592
NULL	J_Korean_Med_Sci_2010_Jun_24_25(6)_829-834.nxml.txt.nlp	20514301	SENT107	4	4	11	11	papain	p38	PA450778	10598;1432;7965	0.592
NULL	Br_J_Cancer_2012_Nov_6_107(10)_1714-1721.nxml.txt.nlp	23073173	SENT213	15	15	10	10	bicalutamide	RUNX2	PA164746255	860	0.592
NULL	Curr_Neuropharmacol_2008_Jun_6(2)_151-163.nxml.txt.nlp	19305794	SENT479	18	18	29	29	capsaicin	TRPV1	PA448776	7442	0.592
NULL	FEBS_Open_Bio_2012_Jul_20_2_179-186.nxml.txt.nlp	23650597	SENT103	3	3	10	10	imiquimod	MxA	PA449972	4599	0.592
NULL	Nat_Neurosci_2012_Jun_15(6)_845-852.nxml.txt.nlp	22522402	SENT107	2	2	10	10	primaquine	KAR	PA451103	51144	0.592
NULL	Breast_Cancer_Res_2010_Aug_9_12(4)_R62.nxml.txt.nlp	20696059	SENT238	1	1	34	34	trastuzumab	HER2	PA451743	2064	0.592
NULL	Case_Rep_Med_2011_Mar_30_2011_515719.nxml.txt.nlp	21541234	SENT43	8	8	4	4	choline	gamma	PA448976	9913	0.592
NULL	Arthritis_Res_Ther_2009_Aug_24_11(4)_R127.nxml.txt.nlp	19703304	SENT52	11	11	9	9	adalimumab	OASIS	PA10004	90993	0.592
NULL	Head_Face_Med_2006_May_25_2_15.nxml.txt.nlp	16725028	SENT154	0	0	7	7	amitriptyline	LEP	PA448385	3952	0.592
NULL	Curr_Neuropharmacol_2013_Jul_11(4)_338-378.nxml.txt.nlp	24381528	SENT217	8	8	6	6	pp2	PP1		5540;5464	0.592
NULL	Cent_European_J_Urol_2013_Aug_13_66(2)_189-194.nxml.txt.nlp	24579025	SENT85	0	0	5	5	doxazosin	CD40	PA449407	958	0.592
NULL	J_Antimicrob_Chemother_2014_Nov_17_69(11)_2920-2927.nxml.txt.nlp	25038069	SENT139	31	31	12	12	trimethoprim	FUS	PA451788	2521	0.592
NULL	J_Neurochem_2012_Oct_123(1)_182-191.nxml.txt.nlp	22804756	SENT58	17	17	39	39	phenol	B27	PA450913	56246	0.592
NULL	Oncotarget_2012_Jul_22_3(7)_678-685.nxml.txt.nlp	22824673	SENT171	17	17	35	35	thrombin	rTS	PA451674	55556	0.592
NULL	Diabetologia_2010_Dec_25_53(12)_2646-2655.nxml.txt.nlp	20865240	SENT158	3	3	35	35	hyaluronan	DM2	PA165958431	28508	0.592
NULL	Arthritis_Res_Ther_2005_Mar_16_7(Suppl_2)_S21-S25.nxml.txt.nlp	15833145	SENT126	0	0	11	11	abatacept	CTLA4	PA164747080	1493	0.592
NULL	J_Cardiothorac_Surg_2014_May_9_9_81.nxml.txt.nlp	24885948	SENT117	23	23	8	8	sorafenib	c-Raf	PA7000	5894	0.592
NULL	Diabetes_2008_Sep_57(9)_2272-2279.nxml.txt.nlp	18519799	SENT14	2	2	4	4	rosiglitazone	PDK4	PA451283	5166	0.592
NULL	Lab_Anim_Res_2012_Dec_26_28(4)_265-271.nxml.txt.nlp	23326287	SENT113	24	24	26	26	lipase	HSL	PA450239	3991	0.592
NULL	Scientifica_(Cairo)_2013_Feb_7_2013_249101.nxml.txt.nlp	24278770	SENT126	0	0	24	24	mitoxantrone	IL-2	PA450526	3558	0.592
NULL	Nucleic_Acids_Res_2005_Mar_8_33(5)_1423-1434.nxml.txt.nlp	15755745	SENT401	13	13	3	3	lipase	IFN	PA450239	3439	0.592
NULL	Oncol_Lett_2014_Sep_19_8(3)_1269-1274.nxml.txt.nlp	25120704	SENT166	2	2	0	0	metformin	Met	PA450395	79811	0.592
NULL	Front_Genet_2015_Jan_14_5_469.nxml.txt.nlp	25642242	SENT242	38	38	12	12	paromomycin	MRPS12	PA164784023	6183	0.592
NULL	J_Res_Med_Sci_2012_May_17(5)_487-490.nxml.txt.nlp	23626617	SENT18	16	16	20	20	doxorubicin	CHOP	PA449412	1649	0.592
NULL	Diabetes_2013_Mar_14_62(3)_811-824.nxml.txt.nlp	23209186	SENT325	0	0	19	19	bortezomib	IRE1	PA10252	2081	0.592
NULL	J_Cell_Biol_2000_Feb_7_148(3)_505-518.nxml.txt.nlp	10662776	SENT44	42	42	13	13	kanamycin	CO2	PA450137	4513	0.592
NULL	J_Gen_Physiol_1978_Sep_1_72(3)_297-304.nxml.txt.nlp	702110	SENT0	21	21	1	1	vasopressin	Gen	PA451858	348654	0.592
NULL	Mol_Cancer_2010_Oct_12_9_269.nxml.txt.nlp	20939893	SENT7	10	10	19	19	isoproterenol	STAT3	PA450121	6774	0.592
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT1443	44	44	36	36	heparin	ECM	PA449855	22915	0.592
NULL	Br_J_Cancer_2011_Jul_12_105(2)_255-262.nxml.txt.nlp	21694725	SENT184	19	19	7	7	irinotecan	EGFR	PA450085	1956	0.592
NULL	Exp_Ther_Med_2014_Feb_4_7(2)_478-482.nxml.txt.nlp	24396429	SENT12	33	33	24	24	glucose	HO-1	PA449773	3162	0.592
NULL	Case_Rep_Oncol_2013_Aug_24_6(2)_441-449.nxml.txt.nlp	24019785	SENT118	14	14	21	21	paclitaxel	STZ	PA450761	6484	0.592
NULL	Open_Cardiovasc_Med_J_2012_Mar_22_6_28-32.nxml.txt.nlp	22481984	SENT82	3	3	12	12	atorvastatin	p53	PA448500	7157	0.592
NULL	Arq_Bras_Cardiol_2014_Nov_103(5)_403-409.nxml.txt.nlp	25229355	SENT124	3	3	5	5	metoprolol	PZP	PA450480	5858	0.592
NULL	Diabetes_2008_Sep_57(9)_2272-2279.nxml.txt.nlp	18519799	SENT155	7	7	23	23	rosiglitazone	PDK4	PA451283	5166	0.592
NULL	Pharmaceuticals_(Basel)_2013_Nov_7_6(11)_1381-1406.nxml.txt.nlp	24287463	SENT42	5	5	12	12	linezolid	PEN	PA450233	9933	0.592
NULL	J_Korean_Med_Sci_2014_Jul_11_29(7)_965-972.nxml.txt.nlp	25045229	SENT95	12	12	6	6	metformin	B12	PA450395	7126;4709	0.592
NULL	Breast_Cancer_Res_2009_Jun_23_11(Suppl_1)_P10.nxml.txt.nlp	NULL	SENT16	18	18	6	6	tamoxifen	p27	PA451581	5715;10534	0.592
NULL	Int_J_Nanomedicine_2012_Sep_13_7_4917-4926.nxml.txt.nlp	23028220	SENT139	12	12	4	4	calcein	mol	PA132595336	90527	0.592
NULL	Brain_Res_2013_Jul_12_1521(100)_1-15.nxml.txt.nlp	22789905	SENT70	21	21	37	37	colchicine	P-gp	PA449092	5243	0.592
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT190	13	13	19	19	pemetrexed	UNG	PA10810	7374	0.592
NULL	Arthritis_Res_Ther_2010_Oct_28_12(5)_219.nxml.txt.nlp	21062511	SENT60	11	11	25	25	etanercept	IFN	PA449515	3439	0.592
NULL	Curr_Med_Chem_2013_Jan_20(3)_438-447.nxml.txt.nlp	23157636	SENT115	6	6	4	4	haloperidol	FGA	PA449841	2243	0.592
NULL	Mol_Cancer_2010_Jun_25_9_166.nxml.txt.nlp	20579378	SENT172	12	12	8	8	gefitinib	EGF	PA131301952	1950	0.592
NULL	Clin_Kidney_J_2013_Jun_29_6(3)_266-271.nxml.txt.nlp	24596657	SENT80	8	8	10	10	heparin	PF4	PA449855	5196	0.592
NULL	Gene_Ther_2011_Mar_4_18(3)_283-293.nxml.txt.nlp	21048796	SENT44	23	23	12	12	mitomycin	SOX2	PA450524	6657	0.592
NULL	Oncologist_2010_Mar_3_15(3)_216-235.nxml.txt.nlp	20200040	SENT290	4	4	11	11	trastuzumab	HER-2	PA451743	2064	0.592
NULL	Curr_Infect_Dis_Rep_2012_Jun_14_14(3)_227-237.nxml.txt.nlp	22415581	SENT225	18	18	3	3	primaquine	G6PD	PA451103	2539	0.592
NULL	Oncotarget_2014_Jun_5_5(21)_10382-10392.nxml.txt.nlp	25071015	SENT114	25	25	7	7	trastuzumab	p53	PA451743	7157	0.592
NULL	Front_Physiol_2013_May_15_4_103.nxml.txt.nlp	23720630	SENT125	11	11	21	21	l-carnitine	ADP	PA450154	23038	0.592
NULL	Brain_Struct_Funct_2013_Jan_14_218(1)_59-72.nxml.txt.nlp	22246100	SENT12	20	20	10	10	pilocarpine	c-fos	PA450962	2353	0.592
NULL	Cancer_Metastasis_Rev_2010_Dec_10_29(4)_581-594.nxml.txt.nlp	20830503	SENT341	11	11	0	0	tamoxifen	ATAC	PA451581	6375	0.592
NULL	J_Cancer_2013_Sep_27_4(8)_662-670.nxml.txt.nlp	24155778	SENT21	17	17	6	6	cisplatin	UCHL1	PA449014	7345	0.592
NULL	J_Asthma_Allergy_2008_Sep_19_1_19-29.nxml.txt.nlp	21436982	SENT109	8	8	4	4	fexofenadine	IFN	PA449621	3439	0.592
NULL	Pharmaceuticals_(Basel)_2012_Jul_19_5(7)_758-778.nxml.txt.nlp	24281711	SENT157	14	14	16	16	lipase	HSL	PA450239	3991	0.592
NULL	Diagn_Pathol_2013_Feb_4_8_16.nxml.txt.nlp	23379953	SENT61	13	13	18	18	vincristine	CHOP	PA451879	1649	0.592
NULL	Diabetes_Metab_J_2013_Jun_14_37(3)_157-164.nxml.txt.nlp	23807917	SENT110	19	19	22	22	glibenclamide	SUR1	PA449782	6833	0.592
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT128	7	7	11	11	metformin	HIP	PA450395	6767;6159;64399;5068	0.592
NULL	Bioconjug_Chem_2010_Dec_15_21(12)_2327-2331.nxml.txt.nlp	21080622	SENT45	48	48	39	39	nitrogen	SDS	PA450643	51119;10993	0.592
NULL	Bioimpacts_2014_Jun_29_4(2)_55-67.nxml.txt.nlp	25035848	SENT161	21	21	24	24	bevacizumab	VEGFR2	PA130232992	3791	0.592
NULL	J_Immunol_Res_2014_Jul_16_2014_696812.nxml.txt.nlp	25133198	SENT280	13	13	3	3	rifaximin	CTR	PA164752443	799	0.592
NULL	Nat_Chem_Biol_2010_Apr_28_6(4)_291-299.nxml.txt.nlp	20190765	SENT112	7	7	14	14	dasatinib	EGFR	PA162372878	1956	0.592
NULL	Br_J_Cancer_2003_Mar_24_88(6)_822-827.nxml.txt.nlp	12644816	SENT117	6	6	9	9	thalidomide	PSA	PA451644	29968;9520;354	0.592
NULL	Mol_Cancer_2010_May_18_9_110.nxml.txt.nlp	20482802	SENT11	3	3	14	14	bortezomib	p53	PA10252	7157	0.592
NULL	Breast_Cancer_Res_Treat_2014_Apr_6_145(1)_33-44.nxml.txt.nlp	24706169	SENT9	32	32	19	19	trastuzumab	HER2	PA451743	2064	0.592
NULL	Nat_Commun_2013_Apr_23_4_1758.nxml.txt.nlp	23612299	SENT540	13	13	7	7	isoproterenol	SOD1	PA450121	6647	0.592
NULL	J_Anaesthesiol_Clin_Pharmacol_2011_Oct-Dec_27(4)_489-494.nxml.txt.nlp	22096282	SENT129	4	4	25	25	dextromethorphan	ACTH	PA449273	5443	0.592
NULL	Arch_Trauma_Res_2013_Aug_1_2(2)_76-80.nxml.txt.nlp	24396798	SENT33	22	22	27	27	creatine	14-3-3	PA164778930	10971	0.592
NULL	Diabetes_Metab_J_2012_Jun_14_36(3)_181-189.nxml.txt.nlp	22737657	SENT103	13	13	16	16	pioglitazone	adiponectin	PA450970	9370	0.592
NULL	J_Cell_Mol_Med_2014_Nov_11_18(11)_2275-2286.nxml.txt.nlp	25208472	SENT322	10	10	18	18	cisplatin	p53	PA449014	7157	0.592
NULL	Breast_Cancer_Res_2007_Apr_10_9(2)_R25.nxml.txt.nlp	17428314	SENT212	35	35	7	7	tetracycline	CDC6	PA451640	990	0.592
NULL	Oncologist_2010_Mar_3_15(3)_216-235.nxml.txt.nlp	20200040	SENT76	16	16	11	11	gefitinib	HER-2	PA131301952	2064	0.592
NULL	Arthritis_Res_Ther_2010_Oct_28_12(5)_219.nxml.txt.nlp	21062511	SENT141	7	7	16	16	etanercept	IFN	PA449515	3439	0.592
NULL	F1000Res_2013_Feb_28_2_65.nxml.txt.nlp	24358861	SENT69	39	39	24	24	naloxone	TLR4	PA450586	7099	0.592
NULL	Pharmaceuticals_(Basel)_2013_Aug_21_6(8)_988-1038.nxml.txt.nlp	24276379	SENT2584	21	21	2	2	cetuximab	KRAS	PA10040	3845	0.592
NULL	Exp_Ther_Med_2014_Dec_13_8(6)_1939-1945.nxml.txt.nlp	25371760	SENT248	6	6	0	0	cisplatin	NAC	PA449014	22861	0.592
NULL	Br_J_Cancer_2010_Mar_2_102(5)_815-826.nxml.txt.nlp	20145614	SENT24	17	17	29	29	lapatinib	CD24	PA152241907	100133941	0.592
NULL	Diabetes_Care_2013_Dec_13_36(12)_3930-3937.nxml.txt.nlp	23990523	SENT121	15	15	9	9	glucose	adiponectin	PA449773	9370	0.591
NULL	Brain_Res_2009_Jul_7_1279(C)_21-28.nxml.txt.nlp	19410564	SENT90	12	12	8	8	creatine	ADP	PA164778930	23038	0.591
NULL	Mol_Vis_2012_Sep_6_18_2323-2337.nxml.txt.nlp	22977300	SENT87	28	28	17	17	gentamicin	FBS	PA449753	64319;26269	0.591
NULL	Ann_Rehabil_Med_2012_Oct_31_36(5)_633-639.nxml.txt.nlp	23185727	SENT46	33	33	6	6	lidocaine	SGB	PA450226	2719	0.591
NULL	Anesthesiol_Res_Pract_2013_Sep_23_2013_297141.nxml.txt.nlp	24174934	SENT80	14	14	21	21	lidocaine	mol	PA450226	90527	0.591
NULL	Cell_Commun_Signal_2013_Jan_11_11_2.nxml.txt.nlp	23305203	SENT28	13	13	4	4	thrombin	TIMAP	PA451674	26051	0.591
NULL	Int_J_Mol_Sci_2014_Oct_29_15(11)_19700-19728.nxml.txt.nlp	25356505	SENT189	0	0	14	14	isoproterenol	EGFR	PA450121	1956	0.591
NULL	Nucleic_Acids_Res_2011_Sep_11_39(17)_7750-7763.nxml.txt.nlp	21666256	SENT235	30	30	19	19	doxycycline	PDE12	PA449415	201626	0.591
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT613	0	0	6	6	metformin	CA9	PA450395	768	0.591
NULL	J_Biol_Chem_2013_Jan_4_288(1)_552-560.nxml.txt.nlp	23135277	SENT108	18	18	25	25	deferoxamine	IRP2	PA164746490	3658	0.591
NULL	Environ_Health_Perspect_2010_Sep_28_118(9)_1267-1272.nxml.txt.nlp	20427257	SENT116	47	47	9	9	estradiol	BPA	PA449503	667	0.591
NULL	Acta_Pharmacol_Sin_2010_Mar_22_31(3)_329-340.nxml.txt.nlp	20173759	SENT193	9	9	12	12	ethanol	MEF2A	PA448073	4205	0.591
NULL	Cancer_Metastasis_Rev_2010_Dec_10_29(4)_581-594.nxml.txt.nlp	20830503	SENT93	16	16	4	4	tamoxifen	TTR	PA451581	7276	0.591
NULL	Acta_Pharmacol_Sin_2010_Mar_22_31(3)_329-340.nxml.txt.nlp	20173759	SENT210	2	2	17	17	ethanol	AMPK	PA448073	5563	0.591
NULL	Clin_Ophthalmol_2011_Feb_11_5_167-170.nxml.txt.nlp	21383944	SENT72	4	4	1	1	ranibizumab	hole	PA164746012	80757	0.591
NULL	J_Korean_Med_Sci_2007_Apr_30_22(2)_283-289.nxml.txt.nlp	17449938	SENT175	5	5	13	13	minoxidil	Bcl-2	PA450521	596	0.591
NULL	Acta_Pharmacol_Sin_2010_May_26_31(5)_554-559.nxml.txt.nlp	20418892	SENT39	0	0	2	2	bleomycin	BLM	PA448645	641	0.591
NULL	Mediators_Inflamm_2010_Jun_21_2010_194896.nxml.txt.nlp	20652055	SENT48	28	28	12	12	olmesartan	mol	PA164742950	90527	0.591
NULL	Mar_Drugs_2011_Apr_18_9(4)_615-624.nxml.txt.nlp	21731553	SENT44	20	20	40	40	mannitol	PHB	PA450320	5245	0.591
NULL	Open_Ophthalmol_J_2010_Oct_21_4_66-69.nxml.txt.nlp	21293730	SENT4	12	12	17	17	bevacizumab	VEGF-A	PA130232992	7422	0.591
NULL	Acta_Pharmacol_Sin_2011_Jul_13_32(7)_967-972.nxml.txt.nlp	21666702	SENT87	4	4	6	6	ticlopidine	CYP2C9	PA451686	1559	0.591
NULL	Nat_Med_2012_Mar_4_18(4)_547-554.nxml.txt.nlp	22388091	SENT249	28	28	21	21	atropine	IL-17A	PA448505	3605	0.591
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1437-1448.nxml.txt.nlp	24056706	SENT111	18	18	24	24	tranylcypromine	CYP2D6	PA451741	1565	0.591
NULL	Biomed_Res_Int_2014_Jun_26_2014_161346.nxml.txt.nlp	25054130	SENT26	6	6	31	31	curcumin	c-Jun	PA151958596	3725	0.591
NULL	Oncogene_2014_Sep_18_33(38)_4685-4696.nxml.txt.nlp	24121268	SENT69	27	27	6	6	nutlin-3	p53		7157	0.591
NULL	Br_J_Cancer_2010_Aug_24_103(5)_649-655.nxml.txt.nlp	20664591	SENT244	22	22	20	20	gemcitabine	GEM	PA449748	2669	0.591
NULL	J_Immunol_Res_2014_Jul_16_2014_696812.nxml.txt.nlp	25133198	SENT270	11	11	5	5	rifaximin	CD103	PA164752443	3682	0.591
NULL	Mar_Drugs_2011_Aug_10_9(8)_1359-1367.nxml.txt.nlp	21892350	SENT50	10	10	12	12	lipase	HSL	PA450239	3991	0.591
NULL	Can_J_Infect_Dis_Med_Microbiol_2014_May-Jun_25(3)_163-169.nxml.txt.nlp	25285114	SENT225	11	11	30	30	gentamicin	TOB	PA449753	10140	0.591
NULL	J_Med_Case_Reports_2011_Feb_21_5_71.nxml.txt.nlp	21338490	SENT96	6	6	10	10	pamidronate	B19	PA450767	59271	0.591
NULL	Environ_Health_Perspect_2010_Jul_3_118(7)_936-942.nxml.txt.nlp	20199942	SENT199	27	27	5	5	arsenite	NKRF	PA452638	55922	0.591
NULL	Br_J_Cancer_2013_Feb_5_108(2)_469-476.nxml.txt.nlp	23169292	SENT174	4	4	10	10	capecitabine	Gem	PA448771	51053	0.591
NULL	Evid_Based_Complement_Alternat_Med_2014_Oct_29_2014_594354.nxml.txt.nlp	25530784	SENT6	10	10	12	12	trifluoperazine	TFP	PA451771	7034	0.591
NULL	Eur_J_Med_Res_2014_Apr_9_19(1)_19.nxml.txt.nlp	24717101	SENT80	27	27	11	11	vincristine	FDG	PA451879	23583	0.591
NULL	Biomed_Res_Int_2013_Aug_29_2013_560141.nxml.txt.nlp	24073410	SENT161	23	23	31	31	estradiol	IL-8	PA449503	3576	0.591
NULL	Ann_Thorac_Med_2007_Jul-Sep_2(3)_128-142.nxml.txt.nlp	19727362	SENT503	11	11	9	9	doxycycline	TPC	PA449415	8030;60386	0.591
NULL	Ann_Coloproctol_2014_Aug_26_30(4)_201-204.nxml.txt.nlp	25210691	SENT48	3	3	8	8	sulindac	COX	PA451565	1351	0.591
NULL	Am_J_Rhinol_Allergy_2012_Sep-Oct_26(5)_371-379.nxml.txt.nlp	23168151	SENT158	10	10	7	7	fluorescein	CD4	PA164746009	920	0.591
NULL	Orphanet_J_Rare_Dis_2012_Apr_19_7_21.nxml.txt.nlp	22515166	SENT213	7	7	9	9	bezafibrate	COX	PA162364313	1351	0.591
NULL	Front_Oncol_2013_Nov_18_3_282.nxml.txt.nlp	24303367	SENT627	13	13	19	19	glucose	GDNF	PA449773	2668	0.591
NULL	Breast_Cancer_Res_2011_Jan_7_13(1)_R1.nxml.txt.nlp	21214929	SENT180	6	6	8	8	doxorubicin	GAPDH	PA449412	2597	0.591
NULL	Evid_Based_Complement_Alternat_Med_2011_Feb_14_2011_429843.nxml.txt.nlp	21869897	SENT176	6	6	15	15	ethanol	PC6	PA448073	5125	0.591
NULL	J_Biol_Chem_2013_Nov_15_288(46)_33049-33059.nxml.txt.nlp	24089524	SENT264	0	0	7	7	nicotine	GATA4	PA450626	2626	0.591
NULL	G3_(Bethesda)_2014_Nov_11_5(1)_35-44.nxml.txt.nlp	25387827	SENT65	9	9	5	5	neomycin	MTAP	PA450608	4507	0.591
NULL	Cell_Death_Dis_2013_Oct_3_4(10)_e827.nxml.txt.nlp	24091670	SENT87	3	3	15	15	nilotinib	CD34	PA165958345	947	0.591
NULL	Clin_Exp_Reprod_Med_2013_Jun_30_40(2)_67-75.nxml.txt.nlp	23875162	SENT209	6	6	27	27	rosiglitazone	COX	PA451283	1351	0.591
NULL	Sensors_(Basel)_2010_Mar_25_10(4)_2626-2637.nxml.txt.nlp	22319264	SENT130	39	39	31	31	ethanol	ADP	PA448073	23038	0.591
NULL	Cardiol_Res_Pract_2011_Aug_15_2011_156146.nxml.txt.nlp	21876822	SENT195	36	36	26	26	potassium	KIR	PA451047	2669	0.591
NULL	Br_J_Haematol_2014_Mar_13_164(1)_811-821.nxml.txt.nlp	24328678	SENT173	2	2	10	10	lenalidomide	Aiolos	PA162363968	22806	0.591
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1953-1985.nxml.txt.nlp	25268164	SENT690	7	7	4	4	temozolomide	p53	PA451609	7157	0.591
NULL	Pharmaceuticals_(Basel)_2014_Apr_10_7(4)_433-452.nxml.txt.nlp	24727459	SENT50	0	0	10	10	cyclosporine	P-gp	PA449167	5243	0.591
NULL	AIDS_Res_Ther_2009_Apr_9_6_3.nxml.txt.nlp	19358725	SENT115	13	13	10	10	lamivudine	ATV	PA450163	4683	0.591
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1699-1708.nxml.txt.nlp	19861960	SENT260	0	0	19	19	dasatinib	mol	PA162372878	90527	0.591
NULL	Case_Rep_Oncol_Med_2012_Nov_6_2012_164082.nxml.txt.nlp	23198199	SENT79	14	14	21	21	rituximab	BAFF	PA451261	10673	0.591
NULL	Clin_Ophthalmol_2007_Mar_1(1)_61-64.nxml.txt.nlp	19668467	SENT39	15	15	24	24	tacrolimus	castor	PA451578	54897	0.591
NULL	Biol_Proced_Online_2003_Feb_17_5_43-52.nxml.txt.nlp	12734557	SENT176	24	24	5	5	bupivacaine	IFNA6	PA135057240	3443	0.591
NULL	Pharmaceutics_2011_Nov_18_3(4)_865-913.nxml.txt.nlp	24309312	SENT112	9	9	26	26	repaglinide	CYP2C8	PA451234	1558	0.591
NULL	Br_J_Cancer_2003_Mar_10_88(5)_754-759.nxml.txt.nlp	12618886	SENT121	12	12	31	31	amifostine	p53	PA448365	7157	0.591
NULL	Oncotarget_2011_Mar_23_2(3)_165-177.nxml.txt.nlp	21444946	SENT143	28	28	4	4	erlotinib	EGFR	PA134687924	1956	0.591
NULL	Chem_Cent_J_2012_May_11_6_41.nxml.txt.nlp	22578215	SENT7	27	27	17	17	lipase	castor	PA450239	54897	0.591
NULL	Case_Rep_Hematol_2012_Sep_10_2012_517546.nxml.txt.nlp	22997594	SENT122	0	0	14	14	dasatinib	KIT	PA162372878	3815	0.591
NULL	Clin_Med_Insights_Oncol_2011_Sep_21_5_315-323.nxml.txt.nlp	22084620	SENT31	15	15	20	20	gemcitabine	IL-2	PA449748	3558	0.591
NULL	ScientificWorldJournal_2014_Mar_12_2014_731462.nxml.txt.nlp	24715817	SENT166	19	19	26	26	carrageenan	IL-6	PA448814	3569	0.591
NULL	Mol_Cancer_2013_Sep_27_12_111.nxml.txt.nlp	24070020	SENT169	7	7	4	4	indomethacin	COX	PA449982	1351	0.591
NULL	Front_Chem_2014_Apr_1_2_15.nxml.txt.nlp	24790983	SENT107	2	2	10	10	chloramphenicol	UPRT	PA448927	139596	0.591
NULL	J_Appl_Crystallogr_2014_Sep_4_47(Pt_5)_1606-1613.nxml.txt.nlp	25294980	SENT44	12	12	17	17	ethanol	mol	PA448073	90527	0.591
NULL	Acta_Pharmacol_Sin_2011_Jun_9_32(6)_725-733.nxml.txt.nlp	21552293	SENT148	25	25	33	33	nimodipine	TRPM7	PA450633	54822	0.591
NULL	Cancers_(Basel)_2013_May_10_5(2)_529-549.nxml.txt.nlp	24216990	SENT955	1	1	14	14	nelfinavir	ATF6	PA450606	22926	0.591
NULL	Acta_Pharmacol_Sin_2014_Jun_5_35(6)_727-737.nxml.txt.nlp	24793312	SENT127	15	15	2	2	telmisartan	B27	PA451605	56246	0.591
NULL	Nucleic_Acids_Res_2011_Mar_20_39(4)_1565-1575.nxml.txt.nlp	20961956	SENT120	1	1	5	5	zinc	RIG-I	PA451956	23586	0.591
NULL	Int_J_Mol_Sci_2007_Mar_13_8(3)_229-240.nxml.txt.nlp	NULL	SENT40	30	30	11	11	acetazolamide	AQP1	PA448018	358	0.591
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1063.nxml.txt.nlp	24556678	SENT26	5	5	3	3	thioridazine	TRAIL	PA451666	8743	0.591
NULL	Oncotarget_2014_Nov_6_5(22)_11038-11053.nxml.txt.nlp	25402820	SENT71	18	18	20	20	gemcitabine	GEM	PA449748	2669	0.591
NULL	Br_J_Cancer_2009_Jul_21_101(2)_238-243.nxml.txt.nlp	19568242	SENT122	13	13	15	15	bevacizumab	IFN	PA130232992	3439	0.591
NULL	Cells_2014_May_23_3(2)_517-545.nxml.txt.nlp	24861977	SENT927	4	4	11	11	capsaicin	TRPV3	PA448776	162514	0.591
NULL	Int_J_Mol_Sci_2014_Sep_29_15(10)_17411-17441.nxml.txt.nlp	25268615	SENT208	8	8	0	0	methotrexate	CD147	PA450428	682	0.591
NULL	Acta_Pharmacol_Sin_2014_Aug_30_35(8)_1045-1054.nxml.txt.nlp	24976155	SENT92	0	0	4	4	resveratrol	STAT3		6774	0.591
NULL	Biomed_Res_Int_2014_May_29_2014_349074.nxml.txt.nlp	24977149	SENT292	19	19	8	8	ethanol	ANOVA	PA448073	4858	0.591
NULL	Ann_Rheum_Dis_2008_Jun_2_68(5)_654-657.nxml.txt.nlp	18519424	SENT102	14	14	12	12	tocilizumab	IL6	PA165292659	3569	0.591
NULL	Nat_Commun_2013_4_10_1038_ncomms3834.nxml.txt.nlp	24280772	SENT76	5	5	8	8	troglitazone	IL-4	PA451799	3565	0.591
NULL	Cancers_(Basel)_2013_Dec_19_6(1)_1-27.nxml.txt.nlp	24378750	SENT123	9	9	25	25	erlotinib	BRCA1	PA134687924	672	0.591
NULL	Crit_Care_2008_Mar_13_12(Suppl_2)_P56.nxml.txt.nlp	NULL	SENT6	26	26	21	21	vancomycin	TOB	PA451850	10140	0.591
NULL	Med_Sci_Monit_2013_Feb_7_19_95-101.nxml.txt.nlp	23396358	SENT114	0	0	3	3	glucose	FDG	PA449773	23583	0.591
NULL	J_Cell_Biol_2001_Nov_12_155(4)_593-604.nxml.txt.nlp	11696560	SENT156	16	16	12	12	iodixanol	TGN	PA164783998	7038	0.591
NULL	Int_J_Environ_Res_Public_Health_2012_Sep_19_9(9)_3354-3364.nxml.txt.nlp	23202692	SENT110	0	0	5	5	resveratrol	CYP2E1		1571	0.591
NULL	Apoptosis_2013_Jan_7_18(1)_77-84.nxml.txt.nlp	23054081	SENT183	10	10	6	6	collagenase	EMMPRIN	PA449107	682	0.591
NULL	J_Immunother_Cancer_2014_Feb_24_2(Suppl_1)_O1.nxml.txt.nlp	NULL	SENT7	0	0	8	8	bortezomib	Hes1	PA10252	3280	0.591
NULL	Br_J_Haematol_2014_Mar_13_164(1)_811-821.nxml.txt.nlp	24328678	SENT174	3	3	6	6	lenalidomide	IL2	PA162363968	3558	0.591
NULL	Br_J_Haematol_2014_Feb_16_164(4)_469-480.nxml.txt.nlp	24372186	SENT265	4	4	6	6	primaquine	G6PD	PA451103	2539	0.591
NULL	Br_J_Cancer_2010_Nov_2_103(11)_1671-1679.nxml.txt.nlp	21045835	SENT238	22	22	7	7	gemcitabine	PI3K	PA449748	5290	0.591
NULL	Mol_Vis_2014_May_13_20_649-660.nxml.txt.nlp	24868139	SENT38	0	0	9	9	ranibizumab	San	PA164746012	80218	0.591
NULL	Bioinorg_Chem_Appl_2013_Sep_19_2013_541030.nxml.txt.nlp	24170995	SENT107	17	17	24	24	amoxicillin	SBF	PA448406	7702	0.591
NULL	Br_J_Cancer_2012_Oct_9_107(8)_1277-1285.nxml.txt.nlp	22990652	SENT190	6	6	8	8	cisplatin	Gem	PA449014	51053	0.591
NULL	J_Clin_Biochem_Nutr_2008_Jan_28_42(1)_64-69.nxml.txt.nlp	18231633	SENT3	12	12	14	14	troglitazone	TRO	PA451799	7216	0.591
NULL	Br_J_Cancer_2011_Jul_12_105(2)_212-220.nxml.txt.nlp	21694723	SENT6	15	15	3	3	curcumin	STAT3	PA151958596	6774	0.591
NULL	Mol_Cancer_2009_Jun_23_8_39.nxml.txt.nlp	19549337	SENT233	19	19	21	21	resveratrol	TRAIL		8743	0.591
NULL	J_Cell_Biol_2001_Aug_6_154(3)_485-490.nxml.txt.nlp	11489912	SENT296	12	12	10	10	glutaraldehyde	GAPDH	PA449777	2597	0.591
NULL	Front_Genet_2012_Oct_19_3_220.nxml.txt.nlp	23091481	SENT71	2	2	0	0	bleomycin	BLM	PA448645	641	0.591
NULL	Arthritis_Res_Ther_2011_Jun_20_13(3)_R97.nxml.txt.nlp	21689431	SENT156	28	28	8	8	ambrisentan	ETB	PA165860521	1910	0.591
NULL	Curr_Neuropharmacol_2013_Jul_11(4)_338-378.nxml.txt.nlp	24381528	SENT665	4	4	21	21	curcumin	Bcl-2	PA151958596	596	0.591
NULL	Clinics_(Sao_Paulo)_2011_Aug_66(8)_1457-1462.nxml.txt.nlp	21915500	SENT110	5	5	32	32	rosuvastatin	iNOS	PA134308647	4843	0.591
NULL	eLife_2014_Apr_22_3_e02053.nxml.txt.nlp	24755289	SENT102	20	20	27	27	baclofen	R7BP	PA448533	401190	0.591
NULL	Acta_Pharmacol_Sin_2014_Aug_7_35(8)_1015-1022.nxml.txt.nlp	24998256	SENT164	15	15	21	21	ethanol	ALDH2	PA448073	217	0.591
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT9	0	0	7	7	perifosine	JNK	PA165291471	5599	0.591
NULL	Crit_Care_2011_Nov_20_15(6)_R275.nxml.txt.nlp	22099212	SENT179	18	18	38	38	heparin	ACT	PA449855	12;11332;9457;641455	0.591
NULL	Environ_Health_Perspect_2005_Oct_15_113(10)_1271-1276.nxml.txt.nlp	16203233	SENT112	12	12	14	14	diethylstilbestrol	DES	PA449307	1674	0.591
NULL	Trials_2013_Dec_10_14_424.nxml.txt.nlp	24325953	SENT36	26	26	18	18	morphine	TAP	PA450550	8615;2317;10482;23541	0.591
NULL	Virol_J_2012_Dec_19_9_312.nxml.txt.nlp	23249700	SENT175	21	21	9	9	trypsin	CO2	PA451806	4513	0.591
NULL	Ann_Hematol_2014_Mar_18_93(8)_1335-1344.nxml.txt.nlp	24638841	SENT84	22	22	39	39	rituximab	CLB	PA451261	171425	0.591
NULL	Hum_Mol_Genet_2013_Jul_1_22(13)_2676-2688.nxml.txt.nlp	23474818	SENT206	22	22	10	10	l-glutamine	F12	PA10090	2161	0.591
NULL	Pharmaceuticals_(Basel)_2014_Apr_10_7(4)_433-452.nxml.txt.nlp	24727459	SENT50	0	0	17	17	cyclosporine	MRP2	PA449167	100130958;57626;1244	0.591
NULL	Cancer_Cell_Int_2014_Jul_2_14_59.nxml.txt.nlp	25120382	SENT167	9	9	11	11	metformin	AMPK	PA450395	5563	0.591
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT212	26	26	14	14	adalimumab	CD36	PA10004	948	0.591
NULL	Acta_Neuropathol_Commun_2014_Jul_12_2(1)_82.nxml.txt.nlp	NULL	SENT177	32	32	13	13	lapatinib	NF2	PA152241907	4771	0.591
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1013.nxml.txt.nlp	24457957	SENT90	2	2	11	11	bortezomib	NOXA	PA10252	5366	0.591
NULL	Ann_Oncol_2014_Jul_5_25(7)_1328-1333.nxml.txt.nlp	24603643	SENT129	30	30	33	33	cisplatin	HEC	PA449014	10403	0.591
NULL	Neural_Plast_2007_Sep_19_2007_26496.nxml.txt.nlp	18301726	SENT83	1	1	8	8	fluoxetine	TIEG1	PA449673	7071	0.591
NULL	Nat_Commun_2014_Jun_19_5_4037.nxml.txt.nlp	24941968	SENT104	31	31	17	17	vanillin	ADH6	PA451852	130	0.591
NULL	Nat_Commun_2011_Jul_5_2_376.nxml.txt.nlp	21730957	SENT135	0	0	6	6	zolpidem	GAD65	PA451976	2572	0.591
NULL	Mol_Pain_2013_Jun_10_9_27.nxml.txt.nlp	23758830	SENT117	2	2	4	4	tetracaine	ASIC1	PA451638	41	0.591
NULL	Crit_Care_2009_Mar_16_13(2)_R37.nxml.txt.nlp	19291300	SENT159	5	5	3	3	alemtuzumab	CD52	PA164783958	1043	0.591
NULL	Extremophiles_2009_Nov_23_13(6)_885-894.nxml.txt.nlp	19701714	SENT136	23	23	7	7	ethanol	mol	PA448073	90527	0.591
NULL	Fibrogenesis_Tissue_Repair_2011_Feb_2_4_5.nxml.txt.nlp	21288331	SENT15	29	29	3	3	l-tryptophan	LOX	PA10323	4015	0.591
NULL	J_Hepatobiliary_Pancreat_Surg_2008_Jan_16_15(1)_55-62.nxml.txt.nlp	18274844	SENT87	8	8	23	23	methotrexate	IFN	PA450428	3439	0.591
NULL	J_Oncol_2012_Oct_5_2012_794172.nxml.txt.nlp	22007215	SENT6	20	20	22	22	cyclophosphamide	LDM	PA449165	1595	0.591
NULL	Environ_Health_Perspect_2008_Mar_19_116(3)_315-321.nxml.txt.nlp	18335097	SENT212	11	11	20	20	betaine	BHMT	PA448603	635	0.591
NULL	J_Biol_Chem_2009_Oct_16_284(42)_28885-28895.nxml.txt.nlp	19687008	SENT136	20	20	8	8	lovastatin	PCSK9	PA450272	255738	0.591
NULL	Exp_Diabetes_Res_2011_Jun_20_2011_601047.nxml.txt.nlp	21747830	SENT88	8	8	20	20	sitagliptin	GLP-1	PA164748978	100125288	0.591
NULL	Acta_Naturae_2011_Jul-Sep_3(3)_12-28.nxml.txt.nlp	22649690	SENT34	9	9	18	18	maraviroc	CCR5	PA164768835	1234	0.591
NULL	J_Clin_Biochem_Nutr_2007_Jul_27_41(1)_32-42.nxml.txt.nlp	18392098	SENT186	0	0	14	14	curcumin	ROS	PA151958596	6098	0.591
NULL	J_Hematol_Oncol_2013_Jun_3_6_38.nxml.txt.nlp	23731980	SENT120	15	15	7	7	pertuzumab	San		80218	0.591
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT48	0	0	2	2	chloroquine	BMPR-II	PA448948	659	0.591
NULL	Onco_Targets_Ther_2014_May_28_7_841-852.nxml.txt.nlp	24920926	SENT85	0	0	3	3	gefitinib	EGFR	PA131301952	1956	0.591
NULL	J_Gen_Physiol_2004_Aug_124(2)_125-137.nxml.txt.nlp	15277574	SENT216	32	32	27	27	forskolin	CFTR	PA146096022	1080	0.591
NULL	Target_Oncol_2010_Jun_14_5(2)_95-112.nxml.txt.nlp	20625845	SENT498	22	22	8	8	sunitinib	Bex	PA162372840	27018	0.591
NULL	Mol_Vis_2011_Sep_1_17_2368-2379.nxml.txt.nlp	21921989	SENT227	24	24	26	26	diethylstilbestrol	DES	PA449307	1674	0.591
NULL	Ann_Rheum_Dis_2014_Oct_29_73(10)_1906-1908.nxml.txt.nlp	25074690	SENT49	9	9	22	22	rituximab	DREAM	PA451261	30818	0.591
NULL	Indian_J_Pharmacol_2009_Aug_41(4)_167-172.nxml.txt.nlp	20523867	SENT40	42	42	24	24	acetaminophen	CYP3A4	PA448015	1576	0.591
NULL	J_Carcinog_2014_Jul_29_13_9.nxml.txt.nlp	25191137	SENT159	22	22	11	11	dextran	p53	PA449261	7157	0.591
NULL	Oncotarget_2013_Jul_18_4(10)_1582-1591.nxml.txt.nlp	24123600	SENT135	15	15	9	9	imatinib	OCTN1	PA10804	6583	0.591
NULL	Cardiovasc_J_Afr_2013_Apr_24(3)_78-81.nxml.txt.nlp	23736131	SENT71	10	10	5	5	hemin	HO-1	PA449849	3162	0.591
NULL	J_Mol_Signal_2010_Jul_23_5_11.nxml.txt.nlp	20653955	SENT217	4	4	7	7	thrombin	PAR-1	PA451674	2011;2149	0.591
NULL	Biochem_Res_Int_2012_Jun_25_2012_518437.nxml.txt.nlp	22792465	SENT202	10	10	13	13	tetracycline	RGS5	PA451640	8490	0.591
NULL	Br_J_Haematol_2008_Jun_141(5)_659-671.nxml.txt.nlp	18410446	SENT163	0	0	6	6	cerulenin	JNK	PA164764551	5599	0.591
NULL	Nat_Commun_2014_Jun_19_5_4037.nxml.txt.nlp	24941968	SENT133	15	15	9	9	vanillin	UGT	PA451852	7361;7355	0.591
NULL	Hum_Genomics_Proteomics_2010_Aug_3_2010_159761.nxml.txt.nlp	20981231	SENT141	10	10	36	36	lithium	TPH2	PA450243	6999;121278	0.591
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jul_23_67(Pt_8)_o2099.nxml.txt.nlp	22091118	SENT61	4	4	12	12	ethanol	mol	PA448073	90527	0.591
NULL	J_Cancer_2012_Jun_21_3_269-284.nxml.txt.nlp	22773931	SENT24	32	32	22	22	urokinase	p53	PA451836	7157	0.591
NULL	Mol_Cell_Biochem_2014_Oct_9_385(1-2)_265-275.nxml.txt.nlp	24104452	SENT116	0	0	8	8	bortezomib	U87	PA10252	677775;641648	0.591
NULL	Exp_Ther_Med_2014_Apr_13_7(4)_923-928.nxml.txt.nlp	24669252	SENT192	12	12	4	4	resveratrol	GAPDH		2597	0.591
NULL	Nat_Neurosci_2012_Jun_15(6)_845-852.nxml.txt.nlp	22522402	SENT108	17	17	19	19	primaquine	KAR	PA451103	51144	0.591
NULL	Psychol_Res_Behav_Manag_2010_Mar_26_3_51-63.nxml.txt.nlp	22110329	SENT179	27	27	39	39	buspirone	flower	PA448689	11094	0.591
NULL	ISRN_Oxidative_Med_2013_2013_831596.nxml.txt.nlp	25506596	SENT36	2	2	7	7	hemin	TLR4	PA449849	7099	0.591
NULL	Nucleic_Acids_Res_2005_Jun_8_33(10)_3283-3291.nxml.txt.nlp	15944449	SENT96	2	2	28	28	melphalan	XRCC5	PA450354	7520	0.591
NULL	Front_Genet_2013_Aug_30_4_166.nxml.txt.nlp	24009623	SENT175	23	23	16	16	everolimus	MAN1B1	PA164746311	11253	0.591
NULL	Nat_Genet_2011_Jun_5_43(7)_621-629.nxml.txt.nlp	21642992	SENT337	3	3	11	11	doxorubicin	CDKN1A	PA449412	1026	0.59
NULL	Exp_Ther_Med_2013_Feb_20_5(2)_443-447.nxml.txt.nlp	23407364	SENT3	35	35	37	37	cyclophosphamide	CTX	PA449165	1593	0.59
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT291	12	12	15	15	glucose	EGFR	PA449773	1956	0.59
NULL	Oncoimmunology_2012_May_1_1(3)_383-384.nxml.txt.nlp	22737623	SENT26	4	4	15	15	dacarbazine	CXCL9	PA449197	4283	0.59
NULL	Pharmaceutics_2011_Oct_12_3(4)_680-705.nxml.txt.nlp	24309303	SENT22	34	34	2	2	atorvastatin	OATP1B1	PA448500	10599	0.59
NULL	J_Oncol_2009_Mar_24_2009_491985.nxml.txt.nlp	19325924	SENT26	7	7	20	20	genistein	CXCL12	PA165109660	6387	0.59
NULL	J_Cell_Biol_1998_Jul_13_142(1)_101-115.nxml.txt.nlp	9660866	SENT345	24	24	0	0	dextran	RhoA	PA449261	387	0.59
NULL	Int_J_Mol_Sci_2014_Mar_5_15(3)_3970-3988.nxml.txt.nlp	24603537	SENT560	29	29	17	17	curcumin	MCH	PA151958596	5367	0.59
NULL	EPMA_J_2010_Mar_13_1(1)_88-100.nxml.txt.nlp	21494317	SENT60	22	22	27	27	hyaluronan	CD44	PA165958431	960	0.59
NULL	Int_J_Mol_Sci_2010_Sep_13_11(9)_3195-3208.nxml.txt.nlp	20957088	SENT70	7	7	5	5	lipase	AT2	PA450239	186	0.59
NULL	Aging_(Albany_NY)_2009_Dec_29_2(1)_63-68.nxml.txt.nlp	20228936	SENT55	12	12	7	7	nadh	CYB5R3	PA164755085	1727	0.59
NULL	J_Korean_Med_Sci_2010_Aug_21_25(8)_1222-1227.nxml.txt.nlp	20676337	SENT145	6	6	8	8	propofol	LPA	PA451141	4018	0.59
NULL	J_Cardiovasc_Thorac_Res_2014_Jun_30_6(2)_97-100.nxml.txt.nlp	25031824	SENT22	25	25	8	8	heparin	ACT	PA449855	12;11332;9457;641455	0.59
NULL	Trials_2013_Sep_24_14_311.nxml.txt.nlp	24063608	SENT59	7	7	13	13	mefloquine	IPT	PA450348	54802	0.59
NULL	Int_J_Biol_Sci_2011_Nov_5_8(1)_1-14.nxml.txt.nlp	22211100	SENT131	0	0	8	8	evodiamine	survivin	PA165860788	332	0.59
NULL	Exp_Ther_Med_2013_Mar_20_5(3)_840-844.nxml.txt.nlp	23408173	SENT70	15	15	11	11	venlafaxine	SERS	PA451866	6301;54938	0.59
NULL	ScientificWorldJournal_2014_May_19_2014_567148.nxml.txt.nlp	24971383	SENT168	12	12	17	17	epirubicin	TLR4	PA449476	7099	0.59
NULL	Exp_Ther_Med_2013_Mar_19_5(3)_875-879.nxml.txt.nlp	23407611	SENT155	3	3	10	10	cevimeline	AQP5	PA164754754	362	0.59
NULL	Amino_Acids_2014_Jul_19_46(1)_7-20.nxml.txt.nlp	22810731	SENT274	25	25	9	9	taurine	TNF-alpha	PA451590	7124	0.59
NULL	JAKSTAT_2013_Oct_1_2(4)_e24911.nxml.txt.nlp	24416641	SENT63	9	9	1	1	estradiol	STAT3	PA449503	6774	0.59
NULL	Ann_Clin_Transl_Neurol_2014_Aug_8_1(8)_519-533.nxml.txt.nlp	25356424	SENT197	31	31	27	27	cilostazol	BACE1	PA164746334	23621	0.59
NULL	Oncotarget_2012_May_4_3(4)_395-398.nxml.txt.nlp	22565037	SENT25	15	15	23	23	metformin	CD24	PA450395	100133941	0.59
NULL	Endocrinol_Metab_(Seoul)_2014_Sep_25_29(3)_211-216.nxml.txt.nlp	25309777	SENT55	15	15	17	17	iodine	RAI	PA450049	10848;6050	0.59
NULL	Drugs_2014_Oct_25_74(17)_1993-2013.nxml.txt.nlp	25344022	SENT468	13	13	26	26	erlotinib	EGFR	PA134687924	1956	0.59
NULL	Arthritis_Res_Ther_2012_Jun_25_14(3)_215.nxml.txt.nlp	22731694	SENT99	2	2	0	0	cyclophosphamide	CPX	PA449165	1371;10682;1377	0.59
NULL	Nanoscale_Res_Lett_2014_Jul_15_9(1)_353.nxml.txt.nlp	25114645	SENT30	5	5	2	2	dienestrol	DES	PA164745534	1674	0.59
NULL	AIDS_Res_Treat_2012_Mar_5_2012_703604.nxml.txt.nlp	22500218	SENT112	32	32	9	9	artesunate	CYP2A6	PA165111697	1548	0.59
NULL	Environ_Health_Perspect_2010_Jul_3_118(7)_936-942.nxml.txt.nlp	20199942	SENT43	6	6	8	8	arsenite	p53	PA452638	7157	0.59
NULL	Gut_Liver_2012_Oct_18_6(4)_464-470.nxml.txt.nlp	23170151	SENT29	16	16	21	21	propofol	ESD	PA451141	2098	0.59
NULL	J_Ayurveda_Integr_Med_2012_Jul-Sep_3(3)_150-157.nxml.txt.nlp	23125512	SENT139	31	31	10	10	potassium	AST	PA451047	26503	0.59
NULL	Pharmaceuticals_(Basel)_2013_Oct_11_6(10)_1287-1303.nxml.txt.nlp	24275850	SENT386	1	1	8	8	glibenclamide	spatial	PA449782	219793	0.59
NULL	J_Biol_Eng_2009_Oct_16_3_18.nxml.txt.nlp	19835592	SENT50	15	15	17	17	erythromycin	CPZ	PA449493	8532	0.59
NULL	Oncogene_2014_Aug_28_33(35)_4396-4406.nxml.txt.nlp	24531714	SENT57	26	26	15	15	nutlin-3	IL-6		3569	0.59
NULL	Clin_Exp_Metastasis_2013_Jul_27_30(8)_1063-1071.nxml.txt.nlp	23892415	SENT218	7	7	12	12	erlotinib	EGFR	PA134687924	1956	0.59
NULL	Mol_Pain_2013_Jan_2_9_1.nxml.txt.nlp	23279936	SENT115	6	6	14	14	capsaicin	TRPV1	PA448776	7442	0.59
NULL	Nat_Med_2010_Feb_24_16(2)_214-218.nxml.txt.nlp	20098429	SENT72	16	16	7	7	cisplatin	LAPTM4A	PA449014	9741	0.59
NULL	Breast_Cancer_Res_2010_Nov_16_12(6)_R96.nxml.txt.nlp	21080941	SENT94	47	47	43	43	lapatinib	HRG	PA152241907	3084;3273	0.59
NULL	eLife_2014_Apr_1_3_e01808.nxml.txt.nlp	24692446	SENT231	18	18	3	3	dextran	PC3	PA449261	57332;7832;5122	0.59
NULL	Acta_Histochem_Cytochem_2010_May_1_43(2)_61-68.nxml.txt.nlp	20514293	SENT62	8	8	15	15	hyaluronan	LYVE-1	PA165958431	10894	0.59
NULL	Acta_Pharmacol_Sin_2012_Nov_22_33(11)_1395-1400.nxml.txt.nlp	23085738	SENT131	31	31	4	4	prasugrel	CYP2C9	PA154410481	1559	0.59
NULL	BioDrugs_2014_Aug_18_28(1)_27-39.nxml.txt.nlp	23955284	SENT250	15	15	13	13	doxorubicin	FasL	PA449412	356	0.59
NULL	Crit_Care_2006_Apr_7_10(2)_R57.nxml.txt.nlp	16606437	SENT178	25	25	27	27	estradiol	p38	PA449503	10598;1432;7965	0.59
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_21-38.nxml.txt.nlp	19305786	SENT488	6	6	8	8	capsaicin	TRPV1	PA448776	7442	0.59
NULL	Antibodies_(Basel)_2012_Jul_4_1(2)_149-171.nxml.txt.nlp	24634778	SENT160	31	31	33	33	rituximab	IL2	PA451261	3558	0.59
NULL	Indian_J_Pharm_Sci_2012_May-Jun_74(3)_211-216.nxml.txt.nlp	23440938	SENT121	18	18	4	4	ethanol	HO-1	PA448073	3162	0.59
NULL	Drug_Des_Devel_Ther_2014_Dec_5_8_2431-2438.nxml.txt.nlp	25525333	SENT158	9	9	15	15	verapamil	P-gp	PA451868	5243	0.59
NULL	Int_J_Endocrinol_2014_Apr_30_2014_674987.nxml.txt.nlp	24883061	SENT43	28	28	13	13	glucose	ROS	PA449773	6098	0.59
NULL	Exp_Diabetes_Res_2012_Dec_6_2012_386041.nxml.txt.nlp	23304116	SENT31	9	9	33	33	oxygen	ROS	PA450744	6098	0.59
NULL	Target_Oncol_2013_Mar_30_8(1)_27-33.nxml.txt.nlp	23361373	SENT26	19	19	16	16	gefitinib	EGFR	PA131301952	1956	0.59
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT145	13	13	15	15	methotrexate	MSH2	PA450428	4436	0.59
NULL	Oncotarget_2014_Mar_16_5(12)_4087-4102.nxml.txt.nlp	24961479	SENT64	2	2	7	7	hemin	PC3	PA449849	57332;7832;5122	0.59
NULL	Cancer_Inform_2009_Feb_9_8_1-17.nxml.txt.nlp	19458790	SENT173	23	23	27	27	tamoxifen	BRCA1	PA451581	672	0.59
NULL	Oncotarget_2012_Jan_28_3(1)_84-97.nxml.txt.nlp	22289741	SENT223	12	12	18	18	coumarin	CAIX	PA134521193	768	0.59
NULL	Oncotarget_2012_Jan_28_3(1)_22-30.nxml.txt.nlp	22289880	SENT90	27	27	33	33	rituximab	IFN	PA451261	3439	0.59
NULL	Eur_J_Neurosci_2011_Apr_33(8)_1471-1482.nxml.txt.nlp	21395866	SENT12	4	4	6	6	vigabatrin	SOC	PA10231	91544	0.59
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jan_11_68(Pt_2)_o315.nxml.txt.nlp	22346950	SENT63	19	19	15	15	ethanol	mol	PA448073	90527	0.59
NULL	CNS_Drugs_2014_Feb_7_28(3)_185-193.nxml.txt.nlp	24504829	SENT262	4	4	2	2	choline	CDP	PA448976	1523	0.59
NULL	Arthritis_Res_Ther_2010_Jul_7_12(4)_R131.nxml.txt.nlp	20609215	SENT211	23	23	6	6	iloprost	CXCL13	PA164746843	10563	0.59
NULL	Diabetes_2009_Jun_16_58(6)_1382-1390.nxml.txt.nlp	19289456	SENT143	28	28	20	20	losartan	IPL	PA450268	7262	0.59
NULL	Brain_Behav_2011_Sep_1(1)_44-54.nxml.txt.nlp	22398980	SENT194	0	0	2	2	phencyclidine	PCP	PA128406980	5547	0.59
NULL	Cancers_(Basel)_2013_May_27_5(2)_617-638.nxml.txt.nlp	24216994	SENT134	15	15	8	8	curcumin	PC3	PA151958596	57332;7832;5122	0.59
NULL	Med_Sci_Monit_2013_May_1_19_317-326.nxml.txt.nlp	23632427	SENT261	31	31	13	13	imipenem	CTX	PA449968	1593	0.59
NULL	Breast_Cancer_Res_2011_Nov_23_13(6)_R116.nxml.txt.nlp	22113133	SENT332	4	4	6	6	estradiol	DES	PA449503	1674	0.59
NULL	Amino_Acids_2012_Oct_10_43(4)_1751-1759.nxml.txt.nlp	22407485	SENT29	20	20	37	37	carrageenan	ghrelin	PA448814	51738	0.59
NULL	Br_J_Cancer_2013_Jan_15_108(1)_82-90.nxml.txt.nlp	23321512	SENT202	7	7	12	12	paclitaxel	TUBB3	PA450761	10381	0.59
NULL	Cancer_Res_Treat_2015_Jan_29_47(1)_26-33.nxml.txt.nlp	25327493	SENT167	11	11	19	19	cyclophosphamide	HER-2	PA449165	2064	0.59
NULL	Arthritis_Res_Ther_2010_Apr_29_12(2)_R73.nxml.txt.nlp	20429888	SENT15	5	5	19	19	bortezomib	c-Jun	PA10252	3725	0.59
NULL	J_Invest_Dermatol_2012_Sep_19_132(9)_2198-2205.nxml.txt.nlp	22513780	SENT116	1	1	3	3	isotretinoin	IL-10	PA450128	3586	0.59
NULL	Int_J_Mol_Sci_2013_Aug_14_14(8)_16719-16731.nxml.txt.nlp	23949634	SENT413	1	1	16	16	thrombin	RhoA	PA451674	387	0.59
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Jun_27_5_15.nxml.txt.nlp	16803618	SENT145	44	44	30	30	gentamicin	CIP1	PA449753	1026;56996	0.59
NULL	Oxid_Med_Cell_Longev_2012_Jan_19_2012_390678.nxml.txt.nlp	22315655	SENT4	12	12	23	23	gliclazide	NAC	PA10892	22861	0.59
NULL	J_Cell_Biol_2001_Nov_12_155(4)_637-648.nxml.txt.nlp	11696559	SENT548	9	9	17	17	coumarin	FADD	PA134521193	8772	0.59
NULL	Lab_Invest_2014_Jul_5_94(7)_716-725.nxml.txt.nlp	24791744	SENT249	22	22	9	9	aprotinin	GZMB	PA448472	3002	0.59
NULL	Cell_Death_Dis_2013_Jun_13_4(6)_e664.nxml.txt.nlp	23764845	SENT90	21	21	41	41	gentamicin	CO2	PA449753	4513	0.59
NULL	Mol_Cancer_2009_Nov_24_8_109.nxml.txt.nlp	19930708	SENT202	3	3	19	19	exemestane	aromatase	PA449563	1588	0.59
NULL	J_Appl_Oral_Sci_2011_Mar-Apr_19(2)_147-153.nxml.txt.nlp	21552716	SENT139	13	13	15	15	glutaraldehyde	HEMA	PA449777	2157	0.59
NULL	Mol_Cancer_2010_May_17_9_107.nxml.txt.nlp	20470445	SENT23	31	31	6	6	dexrazoxane	PTEN	PA449259	5728	0.59
NULL	Cell_Commun_Signal_2009_Aug_10_7_18.nxml.txt.nlp	19664273	SENT525	16	16	27	27	enoxacin	RISC	PA449462	59342	0.59
NULL	Saudi_J_Anaesth_2014_Apr-Jun_8(2)_209-214.nxml.txt.nlp	24843334	SENT38	22	22	14	14	bupivacaine	C15	PA135057240	51316	0.59
NULL	Oncogene_2014_Oct_23_33(43)_5109-5120.nxml.txt.nlp	24858043	SENT279	23	23	47	47	pp2	MCT-1		28985	0.59
NULL	Subst_Abuse_Rehabil_2011_May_15_2_89-102.nxml.txt.nlp	21743792	SENT348	43	43	28	28	methamphetamine	CRK	PA450403	1398	0.59
NULL	Biologics_2009_Sep_15_3_429-441.nxml.txt.nlp	19774210	SENT75	2	2	4	4	bevacizumab	EGFR	PA130232992	1956	0.59
NULL	Angew_Chem_Int_Ed_Engl_2012_Dec_21_51(52)_13140-13143.nxml.txt.nlp	23161730	SENT76	10	10	22	22	heparin	mol	PA449855	90527	0.59
NULL	Cells_2012_Nov_5_1(4)_976-993.nxml.txt.nlp	24710538	SENT782	0	0	5	5	sildenafil	PKG	PA451346	5592	0.59
NULL	Biosci_Rep_2012_Aug_1_32(Pt_4)_361-374.nxml.txt.nlp	22762204	SENT1320	11	11	0	0	paclitaxel	BRCA1	PA450761	672	0.59
NULL	Breast_Cancer_Res_Treat_2013_Jan_10_137(1)_1-12.nxml.txt.nlp	23143215	SENT209	8	8	10	10	trastuzumab	HER2	PA451743	2064	0.59
NULL	Gut_Liver_2013_May_9_7(3)_329-334.nxml.txt.nlp	23710315	SENT143	10	10	0	0	entecavir	LAM	PA164784025	7249;7248	0.59
NULL	Breast_Cancer_Res_2011_Nov_1_13(6)_224.nxml.txt.nlp	22114931	SENT91	37	37	40	40	tamoxifen	PTEN	PA451581	5728	0.59
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT154	0	0	2	2	chloroquine	BMPR-II	PA448948	659	0.59
NULL	Cardiovasc_Diabetol_2005_Aug_9_4_12.nxml.txt.nlp	16086844	SENT122	15	15	29	29	heparin	ANOVA	PA449855	4858	0.59
NULL	Front_Genet_2013_Aug_29_4_163.nxml.txt.nlp	24009622	SENT42	2	2	4	4	ethanol	NOT	PA448073	4929	0.59
NULL	J_Lipid_Res_2015_Jan_56(1)_109-121.nxml.txt.nlp	25421061	SENT10	6	6	2	2	lipase	ABHD5	PA450239	51099	0.59
NULL	Cancer_Metab_2013_Feb_4_1_7.nxml.txt.nlp	24280108	SENT159	20	20	18	18	glucose	NAC	PA449773	22861	0.59
NULL	Anticancer_Drugs_2015_Jan_28_26(1)_117-122.nxml.txt.nlp	25115342	SENT125	13	13	17	17	paclitaxel	castor	PA450761	54897	0.59
NULL	Int_J_Fertil_Steril_2012_Jun_19_Jul-Sep_6(2)_131-134.nxml.txt.nlp	25493171	SENT57	18	18	20	20	diethylstilbestrol	DES	PA449307	1674	0.59
NULL	Osteopath_Med_Prim_Care_2008_Feb_15_2_4.nxml.txt.nlp	18279520	SENT115	9	9	6	6	protamine	NPL	PA10366	80896	0.59
NULL	Acta_Pharmacol_Sin_2010_May_12_31(5)_531-539.nxml.txt.nlp	20383168	SENT98	13	13	18	18	trypsin	F12	PA451806	2161	0.59
NULL	Clin_Mol_Hepatol_2014_Dec_24_20(4)_338-344.nxml.txt.nlp	25548738	SENT135	17	17	11	11	ribavirin	IFN	PA451241	3439	0.59
NULL	Indian_J_Crit_Care_Med_2010_Oct-Dec_14(4)_188-195.nxml.txt.nlp	21572750	SENT68	32	32	35	35	thrombin	PAR-1	PA451674	2011;2149	0.59
NULL	J_Biol_Chem_2013_Dec_6_288(49)_35592-35603.nxml.txt.nlp	24165129	SENT61	14	14	43	43	l-glutamine	CO2	PA10090	4513	0.59
NULL	Int_J_Mol_Sci_2012_Feb_24_13(3)_2590-2617.nxml.txt.nlp	22489113	SENT209	15	15	22	22	benzaldehyde	mol	PA448571	90527	0.59
NULL	Mol_Cancer_2007_Aug_21_6_53.nxml.txt.nlp	17711579	SENT153	6	6	34	34	cisplatin	DOCK1	PA449014	1793	0.59
NULL	Drugs_R_D_2014_Jun_6_14(2)_113-123.nxml.txt.nlp	24797400	SENT28	8	8	21	21	amiodarone	P-gp	PA448383	5243	0.59
NULL	Int_J_Med_Sci_2012_Aug_10_9(6)_472-479.nxml.txt.nlp	22927772	SENT113	21	21	10	10	warfarin	CYP2C9	PA451906	1559	0.59
NULL	Pancreas_2014_Oct_12_43(7)_1060-1065.nxml.txt.nlp	25121413	SENT119	4	4	20	20	glucose	FDG	PA449773	23583	0.59
NULL	Arthritis_Res_Ther_2012_Mar_8_14(Suppl_2)_A2.nxml.txt.nlp	NULL	SENT2	19	19	13	13	denosumab	PTH	PA166048634	5741	0.59
NULL	Breast_Cancer_Res_2010_Nov_16_12(6)_R96.nxml.txt.nlp	21080941	SENT159	31	31	19	19	lapatinib	HRG	PA152241907	3084;3273	0.59
NULL	Diabetes_Metab_Syndr_Obes_2014_Feb_13_7_55-64.nxml.txt.nlp	24611020	SENT23	39	39	32	32	metformin	AMPK	PA450395	5563	0.59
NULL	Cell_Mol_Life_Sci_2011_Dec_2_68(23)_3933-3947.nxml.txt.nlp	21533980	SENT31	12	12	14	14	lipase	ATGL	PA450239	57104	0.59
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT128	13	13	3	3	encainide	CYP2D6	PA449459	1565	0.59
NULL	Arthritis_Res_Ther_2011_Feb_16_13(1)_R25.nxml.txt.nlp	21324169	SENT120	26	26	4	4	rituximab	ADA	PA451261	100	0.59
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT616	13	13	21	21	risperidone	PRL	PA451257	5617	0.59
NULL	AIDS_Res_Ther_2009_Apr_9_6_3.nxml.txt.nlp	19358725	SENT43	17	17	28	28	efavirenz	BID	PA449441	637	0.59
NULL	Pharmaceuticals_(Basel)_2011_May_31_4(6)_794-803.nxml.txt.nlp	NULL	SENT280	8	8	10	10	amiodarone	NIF	PA448383	6280	0.59
NULL	Crit_Care_2014_Mar_17_18(Suppl_1)_P488.nxml.txt.nlp	NULL	SENT7	5	5	8	8	heparin	ACT	PA449855	12;11332;9457;641455	0.59
NULL	Int_J_Mol_Sci_2014_Oct_22_15(10)_19183-19202.nxml.txt.nlp	25340982	SENT837	1	1	3	3	curcumin	AP-1	PA151958596	2353;3727;2354;3725	0.59
NULL	Chin_J_Cancer_2012_Feb_31(2)_73-99.nxml.txt.nlp	22098950	SENT99	28	28	12	12	mitoxantrone	CD38	PA450526	952	0.59
NULL	Nucl_Recept_Signal_2009_Jan_16_7_e001.nxml.txt.nlp	19240808	SENT183	9	9	20	20	hyperforin	SXR	PA165985514	8856	0.59
NULL	Open_Access_J_Urol_2010_Dec_30_3_7-17.nxml.txt.nlp	24198630	SENT83	20	20	17	17	tolterodine	CYP3A4	PA164746757	1576	0.59
NULL	Oncotarget_2014_Aug_27_5(19)_9227-9238.nxml.txt.nlp	25193861	SENT135	24	24	12	12	cisplatin	p53	PA449014	7157	0.59
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_91-103.nxml.txt.nlp	17912639	SENT497	32	32	13	13	estradiol	aromatase	PA449503	1588	0.59
NULL	J_Antimicrob_Chemother_2014_Mar_29_69(3)_643-650.nxml.txt.nlp	24169580	SENT151	2	2	0	0	chlorpromazine	CPZ	PA448964	8532	0.59
NULL	Exp_Ther_Med_2013_Mar_21_5(3)_987-991.nxml.txt.nlp	23407636	SENT10	2	2	20	20	losartan	IL-8	PA450268	3576	0.59
NULL	J_Indian_Soc_Periodontol_2014_May-Jun_18(3)_282-288.nxml.txt.nlp	25024538	SENT87	28	28	22	22	denosumab	RANKL	PA166048634	8600	0.59
NULL	Leukemia_2013_Feb_10_27(2)_507-510.nxml.txt.nlp	22810506	SENT92	4	4	29	29	chlorambucil	TRAC	PA448926	28755	0.59
NULL	Cell_Death_Dis_2010_Nov_18_1(11)_e102.nxml.txt.nlp	21368867	SENT134	12	12	0	0	gentamicin	CLIMP-63	PA449753	10970	0.59
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Jun_27_5_15.nxml.txt.nlp	16803618	SENT161	26	26	42	42	ciprofloxacin	GEN1	PA449009	348654	0.59
NULL	Oncotarget_2011_Mar_27_2(3)_209-221.nxml.txt.nlp	21444945	SENT221	5	5	7	7	bortezomib	p53	PA10252	7157	0.59
NULL	Exp_Mol_Med_2012_Apr_30_44(4)_251-259.nxml.txt.nlp	22198296	SENT217	27	27	18	18	hydrocortisone	F12	PA449905	2161	0.59
NULL	Front_Neurol_2010_Jul_12_1_11.nxml.txt.nlp	21206763	SENT82	5	5	7	7	riluzole	GDNF	PA451251	2668	0.59
NULL	Amino_Acids_2014_Feb_20_46(5)_1275-1283.nxml.txt.nlp	24553827	SENT87	9	9	21	21	taurine	CDO	PA451590	50937	0.59
NULL	Breast_Cancer_Res_2010_Oct_14_12(5)_R84.nxml.txt.nlp	20946630	SENT51	21	21	23	23	choline	SLC44A1	PA448976	23446	0.59
NULL	Cancer_Manag_Res_2012_Nov_9_4_383-395.nxml.txt.nlp	23204869	SENT122	14	14	0	0	carmustine	PC-3	PA448810	692094	0.59
NULL	Anat_Cell_Biol_2014_Jun_20_47(2)_83-90.nxml.txt.nlp	24987544	SENT183	10	10	29	29	lipase	GAPDH	PA450239	2597	0.59
NULL	Front_Neurol_2014_Sep_11_5_173.nxml.txt.nlp	25309501	SENT201	14	14	20	20	hyaluronan	MRP5	PA165958431	10057	0.59
NULL	Diabetes_Care_2009_Oct_8_32(10)_1873-1879.nxml.txt.nlp	19587362	SENT121	15	15	12	12	irbesartan	ANG	PA450084	283	0.59
NULL	Biochemistry_2013_Aug_6_52(31)_5161-5163.nxml.txt.nlp	23865422	SENT51	15	15	21	21	vasopressin	SUR1	PA451858	6833	0.589
NULL	Biochem_Res_Int_2012_Feb_12_2012_346972.nxml.txt.nlp	22400115	SENT238	4	4	17	17	hyaluronan	TLR4	PA165958431	7099	0.589
NULL	Oncol_Lett_2013_Aug_25_6(2)_480-486.nxml.txt.nlp	24137351	SENT186	30	30	32	32	iodine	RAI	PA450049	10848;6050	0.589
NULL	Arthritis_Rheumatol_2014_Jun_27_66(6)_1574-1582.nxml.txt.nlp	24577881	SENT111	0	0	19	19	hydralazine	CD28	PA449894	1493;940	0.589
NULL	Exp_Ther_Med_2014_Jun_31_7(6)_1647-1652.nxml.txt.nlp	24926360	SENT167	31	31	24	24	fluvastatin	ASC	PA449688	29108	0.589
NULL	Front_Endocrinol_(Lausanne)_2011_Dec_21_2_84.nxml.txt.nlp	22654830	SENT242	11	11	8	8	rosiglitazone	gamma	PA451283	9913	0.589
NULL	Biomed_Res_Int_2013_Jul_28_2013_724763.nxml.txt.nlp	23984402	SENT146	25	25	9	9	curcumin	AD3	PA151958596	11138	0.589
NULL	Environ_Health_Perspect_2008_Mar_26_116(3)_322-328.nxml.txt.nlp	18335098	SENT168	22	22	11	11	estradiol	PMI	PA449503	8834;5373	0.589
NULL	Oncotarget_2012_Nov_17_3(12)_1600-1614.nxml.txt.nlp	23307622	SENT58	7	7	3	3	trastuzumab	ATG12	PA451743	9140	0.589
NULL	BMB_Rep_2014_Oct_47(10)_575-580.nxml.txt.nlp	24499675	SENT8	3	3	9	9	arsenite	p53	PA452638	7157	0.589
NULL	Korean_J_Radiol_2011_Apr_25_May-Jun_12(3)_319-326.nxml.txt.nlp	21603291	SENT7	43	43	37	37	propranolol	DBP	PA451145	3295;1628;2638	0.589
NULL	Iran_J_Pharm_Res_2014_Autumn_13(4)_1393-1401.nxml.txt.nlp	25587329	SENT96	2	2	4	4	celecoxib	ABCG2	PA448871	9429	0.589
NULL	Mol_Cancer_2013_Sep_3_12_100.nxml.txt.nlp	24004603	SENT33	5	5	7	7	topotecan	TPT	PA451729	23590;6469	0.589
NULL	Clinics_(Sao_Paulo)_2010_Jul_65(7)_723-728.nxml.txt.nlp	20668631	SENT12	9	9	20	20	enalapril	AT1	PA449456	9197;185	0.589
NULL	J_Gen_Physiol_1938_May_20_21(5)_601-620.nxml.txt.nlp	19873069	SENT0	11	11	1	1	trypsin	Gen	PA451806	348654	0.589
NULL	Nat_Med_2013_Feb_6_19(2)_217-226.nxml.txt.nlp	23291629	SENT392	25	25	15	15	isoproterenol	HSL	PA450121	3991	0.589
NULL	Oncogenesis_2014_May_12_3(5)_e102.nxml.txt.nlp	24819061	SENT97	15	15	33	33	nadh	SIRT1	PA164755085	23411	0.589
NULL	Pediatr_Cardiol_2010_Jan_14_31(1)_90-95.nxml.txt.nlp	19915892	SENT105	15	15	20	20	palivizumab	Era	PA164748781	2099	0.589
NULL	Clin_Psychopharmacol_Neurosci_2012_Aug_31_10(2)_94-98.nxml.txt.nlp	23430731	SENT97	7	7	4	4	phencyclidine	SFN	PA128406980	25996;2810	0.589
NULL	Biomed_Res_Int_2013_Dec_30_2013_735835.nxml.txt.nlp	24490170	SENT8	25	25	27	27	fexofenadine	FEX	PA449621	8549	0.589
NULL	Korean_J_Urol_2010_Jun_21_51(6)_379-385.nxml.txt.nlp	20577603	SENT39	18	18	13	13	fluorouracil	IL-2	PA128406956	3558	0.589
NULL	Br_J_Cancer_2010_Oct_26_103(9)_1380-1390.nxml.txt.nlp	20877355	SENT183	7	7	5	5	vincristine	FasL	PA451879	356	0.589
NULL	J_Korean_Med_Sci_2014_Jul_11_29(7)_965-972.nxml.txt.nlp	25045229	SENT124	8	8	5	5	metformin	B12	PA450395	7126;4709	0.589
NULL	Indian_J_Anaesth_2010_Jul-Aug_54(4)_327-330.nxml.txt.nlp	20882176	SENT101	2	2	16	16	halothane	CO2	PA449845	4513	0.589
NULL	EMBO_J_2015_Jan_2_34(1)_97-114.nxml.txt.nlp	25385835	SENT382	7	7	13	13	paraformaldehyde	RBM14	PA450790	10432	0.589
NULL	Cell_Commun_Signal_2014_May_15_12_34.nxml.txt.nlp	24885272	SENT171	21	21	10	10	heparin	FGF2	PA449855	2247;2258	0.589
NULL	Front_Physiol_2013_Dec_24_4_386.nxml.txt.nlp	24399968	SENT195	34	34	23	23	tolbutamide	SUR2	PA451718	10060	0.589
NULL	Behav_Brain_Funct_2007_Apr_20_3_19.nxml.txt.nlp	17445278	SENT114	6	6	13	13	chlorpromazine	Rho	PA448964	29984	0.589
NULL	Brain_Struct_Funct_2013_Jan_14_218(1)_59-72.nxml.txt.nlp	22246100	SENT235	1	1	4	4	pilocarpine	c-fos	PA450962	2353	0.589
NULL	Oncoimmunology_2013_Oct_1_2(10)_e27025.nxml.txt.nlp	24353914	SENT142	33	33	9	9	sunitinib	CD4	PA162372840	920	0.589
NULL	Mol_Cancer_2014_Jan_13_13_7.nxml.txt.nlp	24418169	SENT251	4	4	17	17	sorafenib	CD31	PA7000	5175	0.589
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT1552	11	11	4	4	tariquidar	ABCC10		89845	0.589
NULL	Environ_Health_Perspect_2006_Sep_9_114(9)_1464-1470.nxml.txt.nlp	16966106	SENT63	7	7	9	9	gemfibrozil	GEM	PA449750	2669	0.589
NULL	Biosci_Rep_2012_Dec_20_33(1)_e00011.nxml.txt.nlp	23137297	SENT151	6	6	31	31	heparin	RPSA	PA449855	3921	0.589
NULL	J_Mol_Signal_2011_Jul_20_6_7.nxml.txt.nlp	21774804	SENT9	13	13	27	27	curcumin	CD44	PA151958596	960	0.589
NULL	Oncol_Lett_2014_Mar_16_7(3)_827-833.nxml.txt.nlp	24527090	SENT158	6	6	3	3	cisplatin	IFN	PA449014	3439	0.589
NULL	Indian_J_Med_Res_2014_Aug_140(2)_209-215.nxml.txt.nlp	25297352	SENT128	17	17	14	14	lamotrigine	CLB	PA450164	171425	0.589
NULL	Breast_Cancer_Res_2008_Dec_18_10(Suppl_4)_S20.nxml.txt.nlp	19128434	SENT27	9	9	7	7	fulvestrant	FACT	PA164747170	11198	0.589
NULL	Pain_2014_Jan_155(1)_168-178.nxml.txt.nlp	24076162	SENT25	20	20	22	22	naloxone	P21	PA450586	1026;9338	0.589
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_18_2012_372670.nxml.txt.nlp	23118787	SENT154	24	24	34	34	hyaluronan	EGF	PA165958431	1950	0.589
NULL	J_Cell_Biol_2008_Jul_14_182(1)_197-213.nxml.txt.nlp	18625847	SENT308	2	2	31	31	nutlin-3	p53		7157	0.589
NULL	Br_J_Cancer_2012_Oct_9_107(8)_1233-1238.nxml.txt.nlp	22955852	SENT175	4	4	9	9	docetaxel	RPN2	PA449383	6185	0.589
NULL	Cancer_Manag_Res_2011_Jul_13_3_257-266.nxml.txt.nlp	21792334	SENT145	33	33	30	30	docetaxel	HER2	PA449383	2064	0.589
NULL	Breast_Cancer_Res_2011_Mar_23_13(2)_R31.nxml.txt.nlp	21429211	SENT76	36	36	18	18	ethanol	CO2	PA448073	4513	0.589
NULL	Exp_Ther_Med_2014_Jun_31_7(6)_1647-1652.nxml.txt.nlp	24926360	SENT156	33	33	26	26	fluvastatin	ASC	PA449688	29108	0.589
NULL	Int_J_Mol_Sci_2014_Mar_5_15(3)_3970-3988.nxml.txt.nlp	24603537	SENT117	4	4	11	11	curcumin	HO-1	PA151958596	3162	0.589
NULL	Cancers_(Basel)_2012_Jul_16_4(3)_673-700.nxml.txt.nlp	24213461	SENT309	15	15	3	3	bezafibrate	HIF-1	PA162364313	29072	0.589
NULL	Oncol_Lett_2014_Jun_8_7(6)_2035-2040.nxml.txt.nlp	24932285	SENT157	2	2	22	22	irinotecan	AST	PA450085	26503	0.589
NULL	Br_J_Pharmacol_2011_Sep_164(2)_358-371.nxml.txt.nlp	21426317	SENT253	21	21	6	6	phenylephrine	COX	PA450935	1351	0.589
NULL	Crit_Care_2007_Dec_18_11(6)_178.nxml.txt.nlp	18177510	SENT42	3	3	0	0	vasopressin	AVP	PA451858	114548;551	0.589
NULL	Exp_Anim_2014_Apr_26_63(2)_257-267.nxml.txt.nlp	24770651	SENT83	2	2	4	4	perindopril	apelin	PA450877	8862	0.589
NULL	Diabetes_2011_May_23_60(5)_1519-1527.nxml.txt.nlp	21430087	SENT11	9	9	11	11	lipase	CGI-58	PA450239	51099	0.589
NULL	J_Exp_Bot_2011_Oct_4_62(14)_4787-4803.nxml.txt.nlp	21821598	SENT298	17	17	12	12	mannitol	M6PR	PA450320	4074	0.589
NULL	Clin_Epigenetics_2011_Dec_5_3(1)_8.nxml.txt.nlp	22414275	SENT132	3	3	5	5	ribavirin	ESR1	PA451241	2099	0.589
NULL	Breast_Cancer_Res_2007_Aug_10_9(4)_R52.nxml.txt.nlp	17692126	SENT4	11	11	9	9	exemestane	aromatase	PA449563	1588	0.589
NULL	Acta_Neuropathol_2013_Sep_5_126(5)_741-756.nxml.txt.nlp	24005891	SENT56	13	13	5	5	scopolamine	CTRL	PA451308	1506	0.589
NULL	FEBS_Open_Bio_2014_Feb_7_4_220-228.nxml.txt.nlp	24693490	SENT34	6	6	12	12	l-phenylalanine	PAO	PA450931	196743;54498	0.589
NULL	Ann_Dermatol_2014_Feb_17_26(1)_141-143.nxml.txt.nlp	24648711	SENT27	21	21	17	17	tacrolimus	LDE	PA451578	7957	0.589
NULL	Enzyme_Res_2009_Nov_1_2010_165878.nxml.txt.nlp	21048860	SENT190	24	24	12	12	asparaginase	NAC	PA448492	22861	0.589
NULL	Br_J_Cancer_2011_Jun_7_104(12)_1848-1853.nxml.txt.nlp	21610704	SENT125	6	6	13	13	panitumumab	REL	PA162373091	5966	0.589
NULL	Hum_Genomics_2009_Jan_1_3(2)_128-142.nxml.txt.nlp	19164090	SENT175	34	34	1	1	carboplatin	PAK1	PA448803	5585;5058	0.589
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Feb_15_5_3.nxml.txt.nlp	16480505	SENT188	0	0	2	2	warfarin	CYP2C9	PA451906	1559	0.589
NULL	Br_J_Cancer_2010_Mar_30_102(7)_1123-1128.nxml.txt.nlp	20354531	SENT143	32	32	11	11	mitomycin	ACT	PA450524	12;11332;9457;641455	0.589
NULL	Br_J_Cancer_2014_Nov_25_111(11)_2091-2102.nxml.txt.nlp	25349971	SENT180	10	10	8	8	imatinib	PTPN18	PA10804	26469	0.589
NULL	Acta_Pharmacol_Sin_2014_Sep_25_35(9)_1199-1206.nxml.txt.nlp	25152024	SENT133	31	31	4	4	cisplatin	mig-2	PA449014	10979	0.589
NULL	Daru_2012_Sep_10_20(1)_30.nxml.txt.nlp	23351387	SENT41	1	1	3	3	acetylcysteine	NAC	PA448033	22861	0.589
NULL	J_Vis_Exp_2010_Sep_2_(43)_2192.nxml.txt.nlp	20834222	SENT276	14	14	6	6	paraformaldehyde	PLP	PA450790	25824;5744	0.589
NULL	Breast_Cancer_Res_2005_Jan_12_7(2)_48-51.nxml.txt.nlp	15743510	SENT84	17	17	7	7	tamoxifen	ATAC	PA451581	6375	0.589
NULL	Eur_J_Pharmacol_2012_Jul_5_686(1-3)_22-31.nxml.txt.nlp	22564863	SENT33	18	18	40	40	memantine	GluN3B	PA10364	116444	0.589
NULL	Int_J_Endocrinol_2010_Feb_10_2010_625852.nxml.txt.nlp	20169119	SENT214	0	0	2	2	cinacalcet	PTH	PA164776671	5741	0.589
NULL	Oncotarget_2014_Dec_4_5(22)_11365-11380.nxml.txt.nlp	25426548	SENT34	0	0	2	2	nutlin-3	p53		7157	0.589
NULL	Mol_Cancer_2009_Nov_24_8_109.nxml.txt.nlp	19930708	SENT202	5	5	19	19	estradiol	aromatase	PA449503	1588	0.589
NULL	Br_J_Cancer_2013_Jun_25_108(12)_2464-2469.nxml.txt.nlp	23695016	SENT164	16	16	27	27	paclitaxel	CRT	PA450761	811	0.589
NULL	Indian_J_Med_Paediatr_Oncol_2013_Oct-Dec_34(4)_292-298.nxml.txt.nlp	24604960	SENT20	6	6	14	14	cyclophosphamide	CHOP	PA449165	1649	0.589
NULL	Breast_Cancer_Res_2003_Mar_14_5(3)_R77-R81.nxml.txt.nlp	12793904	SENT109	30	30	6	6	urokinase	LRP1	PA451836	10438;4035	0.589
NULL	Crit_Care_2007_Mar_22_11(Suppl_2)_P360.nxml.txt.nlp	NULL	SENT4	25	25	21	21	etomidate	RAI	PA164743987	10848;6050	0.589
NULL	Mol_Vis_2007_Jul_9_13_1073-1082.nxml.txt.nlp	17653052	SENT208	4	4	15	15	minocycline	P14	PA450519	11102;;6280;56259	0.589
NULL	Iran_Red_Crescent_Med_J_2012_Nov_15_14(11)_719-721.nxml.txt.nlp	23396650	SENT38	10	10	3	3	vincristine	CHOP	PA451879	1649	0.589
NULL	Bone_Marrow_Res_2011_Mar_2_2011_924058.nxml.txt.nlp	22046572	SENT96	13	13	15	15	maytansine	DM1	PA165291473	338023;1760;28509	0.589
NULL	Clin_Med_Insights_Oncol_2011_May_29_5_177-184.nxml.txt.nlp	21695043	SENT165	7	7	14	14	pemetrexed	B12	PA10810	7126;4709	0.589
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1224-1233.nxml.txt.nlp	22353810	SENT191	13	13	4	4	etoposide	MRP-1	PA449552	928	0.589
NULL	Drug_Des_Devel_Ther_2014_Sep_23_8_1527-1538.nxml.txt.nlp	25284985	SENT204	36	36	26	26	celecoxib	IFN	PA448871	3439	0.589
NULL	Arthritis_Res_Ther_2011_Jul_12_13(4)_R113.nxml.txt.nlp	21749686	SENT164	14	14	16	16	curcumin	RAGE	PA151958596	177	0.589
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_105-115.nxml.txt.nlp	17912640	SENT44	2	2	4	4	trastuzumab	HER2	PA451743	2064	0.589
NULL	Int_J_Appl_Basic_Med_Res_2011_Jan-Jun_1(1)_5-10.nxml.txt.nlp	23776764	SENT43	13	13	29	29	curcumin	Q10	PA151958596	27161	0.589
NULL	Front_Neurol_2014_Feb_18_5_17.nxml.txt.nlp	24600432	SENT98	34	34	21	21	levetiracetam	C17	PA450206	54360	0.589
NULL	J_Immunother_Cancer_2014_Nov_6_2(Suppl_3)_P181.nxml.txt.nlp	NULL	SENT6	2	2	19	19	bortezomib	Hes1	PA10252	3280	0.589
NULL	Br_J_Cancer_2014_Mar_18_110(6)_1497-1505.nxml.txt.nlp	24569463	SENT57	29	29	23	23	hydrocortisone	EGF	PA449905	1950	0.589
NULL	Gastric_Cancer_2011_Mar_23_14(1)_72-80.nxml.txt.nlp	21340666	SENT223	12	12	31	31	trastuzumab	HER2	PA451743	2064	0.589
NULL	Diabetes_Care_2010_Jul_33(7)_1674-1685.nxml.txt.nlp	20587728	SENT464	18	18	16	16	troglitazone	gamma	PA451799	9913	0.589
NULL	Reprod_Biol_Endocrinol_2003_Feb_11_1_18.nxml.txt.nlp	12694627	SENT89	19	19	31	31	galactose	STA	PA449725	2010;2656	0.589
NULL	Biologics_2009_Sep_15_3_429-441.nxml.txt.nlp	19774210	SENT300	37	37	47	47	irinotecan	IFL	PA450085	3439	0.589
NULL	Paediatr_Drugs_2014_Feb_27_16(3)_199-211.nxml.txt.nlp	24574047	SENT123	5	5	8	8	doxylamine	PLP	PA449419	25824;5744	0.589
NULL	Asian_J_Transfus_Sci_2014_8(Suppl1)_S26-S87.nxml.txt.nlp	NULL	SENT1576	5	5	10	10	busulfan	ABO	PA448691	28	0.589
NULL	Cell_Death_Dis_2010_Oct_21_1(10)_e86.nxml.txt.nlp	21368859	SENT39	7	7	5	5	doxorubicin	TRAIL	PA449412	8743	0.589
NULL	Arthritis_Res_Ther_2009_Jul_17_11(4)_R111.nxml.txt.nlp	19615053	SENT191	11	11	0	0	azathioprine	CTX	PA448515	1593	0.589
NULL	J_Breast_Cancer_2013_Mar_31_16(1)_122-126.nxml.txt.nlp	23593093	SENT115	2	2	14	14	carboplatin	gamma	PA448803	9913	0.589
NULL	Cell_Death_Dis_2010_Jul_1_1(7)_e51.nxml.txt.nlp	21364656	SENT217	0	0	4	4	gentamicin	survivin	PA449753	332	0.589
NULL	Br_J_Cancer_2010_Jul_13_103(2)_265-274.nxml.txt.nlp	20551953	SENT202	4	4	17	17	cisplatin	JNK	PA449014	5599	0.589
NULL	Br_J_Cancer_2013_Sep_3_109(5)_1157-1164.nxml.txt.nlp	23942075	SENT8	19	19	3	3	trastuzumab	NAT	PA451743	6046	0.589
NULL	eLife_2013_May_28_2_e00498.nxml.txt.nlp	23741617	SENT376	33	33	23	23	l-glutamine	CO2	PA10090	4513	0.589
NULL	Arch_Plast_Surg_2014_Nov_3_41(6)_620-629.nxml.txt.nlp	25396172	SENT113	20	20	9	9	triamcinolone	IFN	PA451749	3439	0.589
NULL	Oncol_Rep_2013_Apr_23_29(4)_1268-1274.nxml.txt.nlp	23354756	SENT170	14	14	5	5	paclitaxel	SLC25A43	PA450761	203427	0.589
NULL	Oncol_Lett_2014_Sep_19_8(3)_1269-1274.nxml.txt.nlp	25120704	SENT162	2	2	0	0	metformin	Met	PA450395	79811	0.589
NULL	EJNMMI_Res_2011_Aug_17_1_15.nxml.txt.nlp	22214307	SENT202	17	17	25	25	trastuzumab	HER2	PA451743	2064	0.589
NULL	Arthritis_Res_Ther_2008_Aug_15_10(4)_R91.nxml.txt.nlp	18706081	SENT51	2	2	0	0	cyclophosphamide	CTX	PA449165	1593	0.589
NULL	Gut_2008_Jul_4_57(7)_923-929.nxml.txt.nlp	18252749	SENT226	7	7	9	9	capsaicin	VR1	PA448776	56664	0.589
NULL	Ann_Indian_Acad_Neurol_2009_Apr-Jun_12(2)_89-98.nxml.txt.nlp	20142853	SENT174	15	15	23	23	cyclosporine	MDR1	PA449167	5243	0.589
NULL	Mol_Cancer_2013_Oct_30_12_132.nxml.txt.nlp	24171719	SENT223	29	29	25	25	heparin	EGF	PA449855	1950	0.589
NULL	Basic_Clin_Neurosci_2013_Autumn_4(4)_323-328.nxml.txt.nlp	25337364	SENT70	28	28	16	16	colchicine	CA1	PA449092	759	0.589
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT111	11	11	8	8	trastuzumab	MUC4	PA451743	4585	0.589
NULL	Mol_Cancer_2010_Apr_12_9_75.nxml.txt.nlp	20385023	SENT315	41	41	44	44	trastuzumab	HER2	PA451743	2064	0.589
NULL	Oxid_Med_Cell_Longev_2012_Apr_5_2012_983427.nxml.txt.nlp	22550557	SENT226	3	3	12	12	ethanol	Bcl-2	PA448073	596	0.589
NULL	Oncotarget_2014_Jun_7_5(13)_5017-5028.nxml.txt.nlp	24970809	SENT127	23	23	28	28	doxycycline	GCIP	PA449415	23582	0.589
NULL	Br_J_Cancer_2012_Oct_9_107(8)_1233-1238.nxml.txt.nlp	22955852	SENT70	7	7	5	5	docetaxel	RPN2	PA449383	6185	0.589
NULL	Osteoporos_Int_2009_Sep_16_20(9)_1631.nxml.txt.nlp	19085029	SENT4	12	12	20	20	teriparatide	PTH	PA451620	5741	0.589
NULL	Br_J_Clin_Pharmacol_2013_Aug_23_76(2)_299-315.nxml.txt.nlp	23701319	SENT71	8	8	16	16	basiliximab	IL-2	PA164747126	3558	0.589
NULL	Calcif_Tissue_Int_2011_Jul_28_89(1)_10-20.nxml.txt.nlp	21526395	SENT23	18	18	11	11	teriparatide	PTH1R	PA451620	5745	0.589
NULL	Br_J_Cancer_2011_Apr_12_104(8)_1256-1261.nxml.txt.nlp	21448165	SENT16	3	3	5	5	sorafenib	IL-2	PA7000	3558	0.589
NULL	Int_J_Mol_Sci_2014_Sep_16_15(9)_16381-16417.nxml.txt.nlp	25229821	SENT231	0	0	17	17	tacrolimus	IL-10	PA451578	3586	0.589
NULL	Braz_J_Med_Biol_Res_2013_May_10_46(5)_433-439.nxml.txt.nlp	23681290	SENT149	18	18	14	14	bezafibrate	BAFF	PA162364313	10673	0.589
NULL	Curr_Neuropharmacol_2013_Mar_11(2)_160-170.nxml.txt.nlp	23997751	SENT51	11	11	2	2	piperazine	5-HT2C	PA450977	3358	0.589
NULL	Crit_Care_2007_Aug_24_11(4)_222.nxml.txt.nlp	17764585	SENT10	2	2	4	4	vasopressin	AVP	PA451858	114548;551	0.589
NULL	F1000Res_2014_Aug_19_3_198.nxml.txt.nlp	25400908	SENT524	32	32	41	41	anastrozole	IMPACT	PA448432	55364	0.589
NULL	Nucleic_Acids_Res_2013_Apr_17_41(7)_4129-4143.nxml.txt.nlp	23420868	SENT42	14	14	23	23	hemin	GATA-1	PA449849	2623	0.589
NULL	Cancer_Cell_Int_2011_Nov_17_11_40.nxml.txt.nlp	22088142	SENT147	25	25	7	7	gemcitabine	EGFR	PA449748	1956	0.589
NULL	J_Infect_Dis_2013_Sep_1_208(5)_801-812.nxml.txt.nlp	23766527	SENT113	14	14	4	4	artesunate	LUM	PA165111697	4060	0.589
NULL	Cancer_Causes_Control_2010_Jul_4_21(7)_999-1007.nxml.txt.nlp	20204493	SENT20	0	0	2	2	diethylstilbestrol	DES	PA449307	1674	0.589
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT134	2	2	15	15	perifosine	DR4	PA165291471	8797	0.589
NULL	N_Z_Vet_J_2010_Jun_7_58(3)_121-129.nxml.txt.nlp	20514085	SENT160	2	2	4	4	ivermectin	MOX	PA450133	26002	0.589
NULL	J_Hematol_Oncol_2011_Jan_21_4_5.nxml.txt.nlp	21255411	SENT150	11	11	22	22	paclitaxel	EGFR	PA450761	1956	0.589
NULL	Cancer_Cell_2007_Dec_11_12(6)_514-527.nxml.txt.nlp	18068629	SENT13	27	27	31	31	paclitaxel	THBS1	PA450761	7057	0.589
NULL	Nucleic_Acids_Res_2005_Oct_6_33(18)_e154.nxml.txt.nlp	16214805	SENT116	38	38	30	30	kanamycin	SOC	PA450137	91544	0.589
NULL	Bull_Environ_Contam_Toxicol_2010_Sep_25_85(3)_251-255.nxml.txt.nlp	20577871	SENT26	35	35	6	6	ethanol	FAE	PA448073	2178	0.589
NULL	Evid_Based_Complement_Alternat_Med_2014_Dec_25_2014_871720.nxml.txt.nlp	25610485	SENT6	33	33	22	22	berberine	G6PD	PA165860812	2539	0.589
NULL	Cancers_(Basel)_2009_Dec_15_1(1)_23-28.nxml.txt.nlp	20535236	SENT102	18	18	5	5	cisplatin	NAC	PA449014	22861	0.589
NULL	Cancer_Med_2014_Apr_12_3(2)_390-396.nxml.txt.nlp	24519810	SENT96	2	2	0	0	lamivudine	LAM	PA450163	7249;7248	0.589
NULL	Crit_Rev_Toxicol_2013_Feb_25_43(2)_119-153.nxml.txt.nlp	23346981	SENT265	10	10	19	19	phenol	CYP2E1	PA450913	1571	0.589
NULL	Crit_Care_2012_Mar_2_16(2)_R37.nxml.txt.nlp	22386062	SENT170	16	16	31	31	oxygen	CENPV	PA450744	201161	0.589
NULL	Ann_N_Y_Acad_Sci_2014_Nov_5_1329(1)_93-106.nxml.txt.nlp	25377080	SENT193	25	25	15	15	warfarin	TTR	PA451906	7276	0.589
NULL	Mol_Neurobiol_2007_Oct_10_36(2)_137-151.nxml.txt.nlp	17952658	SENT388	44	44	47	47	vasopressin	CXCR4	PA451858	7852	0.589
NULL	Mol_Biol_Rep_2013_Sep_28_40(10)_5573-5585.nxml.txt.nlp	24078156	SENT275	22	22	4	4	iron	FPN1	PA450087	30061	0.589
NULL	Oral_Maxillofac_Surg_2010_Mar_29_14(1)_17-22.nxml.txt.nlp	19865836	SENT100	7	7	3	3	heparin	BMP2	PA449855	650	0.589
NULL	Biomed_Res_Int_2014_Aug_6_2014_310194.nxml.txt.nlp	25165698	SENT50	21	21	28	28	isoniazid	EMB	PA450112	133418	0.589
NULL	Exp_Neurol_2012_Jun_235(2)_528-538.nxml.txt.nlp	22417924	SENT153	5	5	7	7	rosiglitazone	SOD1	PA451283	6647	0.589
NULL	Acta_Pharmacol_Sin_2012_Jan_12_33(1)_27-33.nxml.txt.nlp	22158109	SENT37	15	15	36	36	propofol	AMPK	PA451141	5563	0.589
NULL	J_Anaesthesiol_Clin_Pharmacol_2011_Jan-Mar_27(1)_74-78.nxml.txt.nlp	21804711	SENT116	8	8	1	1	fentanyl	EWS	PA449599	2130	0.589
NULL	Oncotarget_2014_Jun_7_5(11)_3426-3427.nxml.txt.nlp	24913333	SENT16	25	25	32	32	melphalan	FANCD2	PA450354	2177	0.589
NULL	J_Biol_Chem_2012_Dec_14_287(51)_43094-43107.nxml.txt.nlp	23118219	SENT147	20	20	18	18	hyaluronan	CD44	PA165958431	960	0.589
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT108	0	0	11	11	sitagliptin	HIP	PA164748978	6767;6159;64399;5068	0.589
NULL	Arthritis_Res_Ther_2013_Nov_6_15(6)_124.nxml.txt.nlp	24229459	SENT26	15	15	17	17	pioglitazone	IL-6	PA450970	3569	0.589
NULL	Ann_N_Y_Acad_Sci_2012_Aug_30_1264(1)_49-63.nxml.txt.nlp	22548651	SENT145	7	7	4	4	glucose	BDNF	PA449773	627	0.589
NULL	Drug_Des_Devel_Ther_2014_Sep_23_8_1527-1538.nxml.txt.nlp	25284985	SENT214	41	41	10	10	celecoxib	VIII	PA448871	1351	0.589
NULL	J_Oncol_2012_Mar_26_2012_198412.nxml.txt.nlp	22536237	SENT6	14	14	7	7	trastuzumab	HER2	PA451743	2064	0.589
NULL	Arthritis_Res_Ther_2010_Jul_8_12(4)_R135.nxml.txt.nlp	20615213	SENT240	0	0	4	4	hyaluronan	TLR2	PA165958431	7097	0.589
NULL	Front_Oncol_2013_Oct_1_3_259.nxml.txt.nlp	24102047	SENT105	4	4	31	31	paclitaxel	FGFR2	PA450761	2263	0.589
NULL	AIDS_Res_Ther_2008_Aug_14_5_18.nxml.txt.nlp	18700986	SENT35	14	14	11	11	tenofovir	ATV	PA10204	4683	0.589
NULL	J_Immunotoxicol_2013_Jan_11_10(1)_75-82.nxml.txt.nlp	22967038	SENT75	18	18	23	23	rituximab	IL-8	PA451261	3576	0.589
NULL	J_Invest_Dermatol_2011_Dec_22_131(12)_2467-2476.nxml.txt.nlp	21938011	SENT129	22	22	6	6	urokinase	IL-6	PA451836	3569	0.589
NULL	Br_J_Clin_Pharmacol_2011_Oct_72(4)_647-657.nxml.txt.nlp	21518389	SENT110	3	3	16	16	ticagrelor	ADP	PA165374673	23038	0.589
NULL	Biologics_2012_Jul_13_6_221-231.nxml.txt.nlp	22904614	SENT198	10	10	12	12	cetuximab	EGFR	PA10040	1956	0.589
NULL	Biomed_Res_Int_2014_Jan_20_2014_789765.nxml.txt.nlp	24575414	SENT175	5	5	7	7	piroxicam	PRX	PA450985	9588;57716	0.589
NULL	Ann_Oncol_2009_Aug_20(Suppl_6)_vi41-vi50.nxml.txt.nlp	19617297	SENT51	2	2	23	23	dacarbazine	IFN	PA449197	3439	0.589
NULL	Biosci_Rep_2012_Dec_20_33(1)_e00011.nxml.txt.nlp	23137297	SENT135	18	18	11	11	heparin	RPSA	PA449855	3921	0.589
NULL	Chemother_Res_Pract_2012_Jul_15_2012_905796.nxml.txt.nlp	22844591	SENT246	14	14	17	17	oxaliplatin	MTD	PA131285527	4493	0.589
NULL	J_Immunol_Res_2014_Jul_16_2014_696812.nxml.txt.nlp	25133198	SENT248	16	16	7	7	rifaximin	TLR4	PA164752443	7099	0.589
NULL	Br_J_Ophthalmol_2014_Aug_10_98(8)_1036-1041.nxml.txt.nlp	24723616	SENT18	4	4	22	22	bevacizumab	CRT	PA130232992	811	0.589
NULL	J_Gastroenterol_2013_Feb_22_48(2)_222-237.nxml.txt.nlp	22722906	SENT186	4	4	13	13	ethanol	ANOVA	PA448073	4858	0.589
NULL	J_Exp_Clin_Cancer_Res_2009_Oct_7_28(1)_134.nxml.txt.nlp	19811659	SENT89	3	3	35	35	imatinib	QR2	PA10804	4835	0.589
NULL	J_Asthma_Allergy_2013_Feb_22_6_31-39.nxml.txt.nlp	23459334	SENT120	7	7	24	24	rupatadine	ANOVA		4858	0.589
NULL	Lab_Anim_Res_2012_Jun_26_28(2)_109-114.nxml.txt.nlp	22787484	SENT103	10	10	5	5	reserpine	MKP-1	PA451236	1843	0.589
NULL	Diabetes_2013_Jun_17_62(6)_2106-2111.nxml.txt.nlp	23378609	SENT37	9	9	6	6	collagenase	FFAR1	PA449107	2864	0.589
NULL	Front_Genet_2014_Aug_26_5_289.nxml.txt.nlp	25206362	SENT48	9	9	20	20	betaine	B12	PA448603	7126;4709	0.589
NULL	Indian_J_Med_Res_2014_Feb_139(2)_205-215.nxml.txt.nlp	24718394	SENT39	10	10	8	8	artemisinin	ACT	PA165111696	12;11332;9457;641455	0.589
NULL	Oncotarget_2013_Dec_4_5(2)_351-362.nxml.txt.nlp	24504051	SENT8	17	17	4	4	cytarabine	ERG	PA449177	2078	0.589
NULL	Ann_Oncol_2011_Mar_8_22(3)_503-514.nxml.txt.nlp	20616198	SENT330	3	3	39	39	exemestane	San	PA449563	80218	0.589
NULL	J_Oncol_2009_Mar_24_2009_491985.nxml.txt.nlp	19325924	SENT128	25	25	18	18	genistein	CXCR4	PA165109660	7852	0.589
NULL	Avicenna_J_Phytomed_2014_May-Jun_4(3)_215-224.nxml.txt.nlp	25050319	SENT120	17	17	0	0	indomethacin	MEPI	PA449982	5276	0.589
NULL	Br_J_Cancer_2013_Jun_11_108(11)_2304-2311.nxml.txt.nlp	23695020	SENT146	2	2	5	5	resveratrol	EEF1A2		1917	0.589
NULL	Front_Oncol_2014_Mar_6_4_40.nxml.txt.nlp	24639951	SENT62	14	14	24	24	docetaxel	UNK	PA449383	85451	0.589
NULL	J_Antimicrob_Chemother_2014_Apr_2_69(4)_911-918.nxml.txt.nlp	24302651	SENT39	10	10	20	20	chloramphenicol	FUS	PA448927	2521	0.589
NULL	ARYA_Atheroscler_2013_Jan_9(1)_112-114.nxml.txt.nlp	23690810	SENT70	8	8	1	1	heparin	Mal	PA449855	114609	0.589
NULL	Chemother_Res_Pract_2011_Nov_2_2011_878912.nxml.txt.nlp	22295207	SENT194	10	10	12	12	procarbazine	PCB	PA451112	5091	0.589
NULL	Mediators_Inflamm_2010_May_23_2010_513948.nxml.txt.nlp	20508843	SENT202	9	9	11	11	lipase	HSL	PA450239	3991	0.589
NULL	Angiogenesis_2010_Dec_7_13(4)_305-315.nxml.txt.nlp	20927579	SENT163	2	2	4	4	resveratrol	HIF-1		29072	0.588
NULL	Infect_Dis_Obstet_Gynecol_2008_May_29_2008_493508.nxml.txt.nlp	18528520	SENT179	8	8	4	4	tetracycline	CDR1	PA451640	1038	0.588
NULL	Orphanet_J_Rare_Dis_2007_Jan_4_2_1.nxml.txt.nlp	17204147	SENT96	24	24	7	7	trypsin	SPINK1	PA451806	6690	0.588
NULL	Cancer_Causes_Control_2009_Aug_11_20(6)_835-846.nxml.txt.nlp	19277880	SENT170	19	19	30	30	fructose	San	PA449716	80218	0.588
NULL	Mol_Biol_Cell_2012_Nov_1_23(21)_4212-4225.nxml.txt.nlp	22956765	SENT189	27	27	31	31	thrombin	SHP2	PA451674	5781	0.588
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT324	0	0	5	5	cisplatin	XIAP	PA449014	331	0.588
NULL	Indian_J_Anaesth_2014_May-Jun_58(3)_372-382.nxml.txt.nlp	NULL	SENT138	4	4	10	10	tramadol	P150	PA451735	10036	0.588
NULL	Clinics_(Sao_Paulo)_2013_May_68(5)_694-701.nxml.txt.nlp	23778405	SENT139	5	5	7	7	curcumin	P-gp	PA151958596	5243	0.588
NULL	J_Cell_Biol_2003_Dec_22_163(6)_1385-1395.nxml.txt.nlp	14676308	SENT14	7	7	9	9	thrombin	RhoA	PA451674	387	0.588
NULL	Front_Genet_2012_Oct_26_3_213.nxml.txt.nlp	23112805	SENT608	35	35	19	19	dextromethorphan	CYP1A2	PA449273	1544	0.588
NULL	EMBO_Mol_Med_2012_Jun_13_4(6)_515-527.nxml.txt.nlp	22416035	SENT100	12	12	23	23	olaparib	p53		7157	0.588
NULL	Hum_Reprod_Update_2010_May_28_Nov-Dec_16(6)_745-760.nxml.txt.nlp	20511398	SENT89	26	26	7	7	genistein	Yes	PA165109660	7525	0.588
NULL	Int_J_Mol_Sci_2012_Aug_13_13(8)_10091-10112.nxml.txt.nlp	22949849	SENT642	4	4	6	6	lipase	PPL	PA450239	5493	0.588
NULL	J_Cancer_2013_Sep_27_4(8)_662-670.nxml.txt.nlp	24155778	SENT205	11	11	16	16	cisplatin	UCHL1	PA449014	7345	0.588
NULL	Cancer_Causes_Control_2013_Aug_18_24(8)_1605-1614.nxml.txt.nlp	23775025	SENT64	38	38	12	12	epirubicin	CYP2C9	PA449476	1559	0.588
NULL	Addict_Health_2014_Winter-Spring_6(1-2)_54-64.nxml.txt.nlp	25140218	SENT84	11	11	16	16	naloxone	spatial	PA450586	219793	0.588
NULL	Biomed_Res_Int_2014_Jun_2_2014_946492.nxml.txt.nlp	24991574	SENT72	7	7	9	9	olmesartan	adiponectin	PA164742950	9370	0.588
NULL	ScientificWorldJournal_2013_Dec_30_2013_565813.nxml.txt.nlp	24489506	SENT148	2	2	7	7	resveratrol	Q10		27161	0.588
NULL	Breast_Cancer_Res_2008_Apr_1_10(2)_R30.nxml.txt.nlp	18380893	SENT174	5	5	18	18	doxorubicin	HER2	PA449412	2064	0.588
NULL	ScientificWorldJournal_2014_Jan_29_2014_265953.nxml.txt.nlp	24688374	SENT160	3	3	15	15	resveratrol	CMC2		56942	0.588
NULL	Blood_Cancer_J_2013_Jul_19_3(7)_e126.nxml.txt.nlp	23872705	SENT105	8	8	17	17	daunorubicin	p53	PA449212	7157	0.588
NULL	Diabetes_2013_Sep_15_62(9)_3275-3281.nxml.txt.nlp	23674605	SENT10	27	27	17	17	chymotrypsin	CTRB1	PA448994	1504	0.588
NULL	Mol_Cancer_2007_Nov_24_6_76.nxml.txt.nlp	18036246	SENT208	9	9	36	36	phenol	CO2	PA450913	4513	0.588
NULL	Crit_Care_2009_Jul_10_13(4)_R113.nxml.txt.nlp	19591694	SENT104	3	3	0	0	vasopressin	AVP	PA451858	114548;551	0.588
NULL	Oncoimmunology_2012_Mar_1_1(2)_179-188.nxml.txt.nlp	22720239	SENT111	4	4	15	15	oxaliplatin	PD-L2	PA131285527	80380	0.588
NULL	Br_J_Pharmacol_2011_May_163(2)_261-271.nxml.txt.nlp	21054345	SENT237	15	15	22	22	forskolin	GLP-1	PA146096022	100125288	0.588
NULL	J_Occup_Med_Toxicol_2008_Feb_27_3(Suppl_1)_S6.nxml.txt.nlp	18315837	SENT94	4	4	6	6	montelukast	IL-4	PA450546	3565	0.588
NULL	Behav_Brain_Funct_2012_Jun_11_8_30.nxml.txt.nlp	22686184	SENT199	11	11	5	5	diazepam	CORT	PA449283	1325	0.588
NULL	Arthritis_Res_2001_Aug_2_3(5)_311-318.nxml.txt.nlp	11549373	SENT235	11	11	13	13	camptothecin	GAPDH	PA153590860	2597	0.588
NULL	Pharmaceutics_2011_Oct_12_3(4)_680-705.nxml.txt.nlp	24309303	SENT91	31	31	15	15	cimetidine	OCT2	PA449001	6582;5452	0.588
NULL	Case_Rep_Genet_2012_Mar_26_2012_280813.nxml.txt.nlp	23074686	SENT78	0	0	12	12	minocycline	FMR1	PA450519	2332	0.588
NULL	J_Invest_Dermatol_2012_Sep_10_132(9)_2255-2262.nxml.txt.nlp	22572817	SENT202	25	25	31	31	forskolin	ASIP	PA146096022	434;56288	0.588
NULL	Epilepsia_2012_Jun_21_53(Suppl_1)_18-25.nxml.txt.nlp	22612805	SENT43	0	0	6	6	furosemide	NKCC1	PA449719	6558	0.588
NULL	AIDS_Res_Ther_2006_Apr_24_3_12.nxml.txt.nlp	16635263	SENT148	15	15	8	8	fluorescein	PEG10	PA164746009	23089	0.588
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S258-S263.nxml.txt.nlp	21525465	SENT205	14	14	12	12	liraglutide	GLP-1	PA165958364	100125288	0.588
NULL	F1000Res_2014_Aug_19_3_198.nxml.txt.nlp	25400908	SENT289	6	6	22	22	lapatinib	ACT	PA152241907	12;11332;9457;641455	0.588
NULL	Braz_J_Med_Biol_Res_2013_Aug_16_46(8)_708-714.nxml.txt.nlp	23969974	SENT136	13	13	17	17	alendronate	ANOVA	PA448082	4858	0.588
NULL	Indian_J_Pharmacol_2014_Jul-Aug_46(4)_416-419.nxml.txt.nlp	25097281	SENT50	0	0	2	2	diethylstilbestrol	DES	PA449307	1674	0.588
NULL	Drug_Target_Insights_2007_Oct_30_2_239-247.nxml.txt.nlp	21901078	SENT22	18	18	23	23	adalimumab	p75	PA10004	7133;11168	0.588
NULL	Case_Rep_Dermatol_2011_Feb_23_3(1)_42-48.nxml.txt.nlp	21487460	SENT60	8	8	10	10	tegafur	CDHP	PA452620	1001	0.588
NULL	J_Biol_Chem_2008_Nov_7_283(45)_31005-31011.nxml.txt.nlp	18765663	SENT167	12	12	16	16	baclofen	CA1	PA448533	759	0.588
NULL	Nanoscale_Res_Lett_2014_Jun_20_9(1)_311.nxml.txt.nlp	25024678	SENT44	17	17	26	26	fluorescein	CD86	PA164746009	942	0.588
NULL	Indian_J_Ophthalmol_2008_Sep-Oct_56(5)_439-440.nxml.txt.nlp	18711283	SENT13	7	7	17	17	azelastine	BAK	PA448517	578	0.588
NULL	Biol_Open_2014_Nov_21_3(12)_1207-1216.nxml.txt.nlp	25416063	SENT8	20	20	14	14	zinc	NANOS2	PA451956	339345	0.588
NULL	Acta_Neuropathol_2012_Jul_7_124(1)_99-110.nxml.txt.nlp	22311740	SENT56	11	11	34	34	ethanol	CD133	PA448073	8842	0.588
NULL	Exp_Ther_Med_2015_Feb_15_9(2)_384-388.nxml.txt.nlp	25574202	SENT23	17	17	11	11	cisplatin	ROS	PA449014	6098	0.588
NULL	Iran_J_Pediatr_2012_Mar_22(1)_43-51.nxml.txt.nlp	23056858	SENT55	6	6	15	15	fluorescein	CD19	PA164746009	930	0.588
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Sep_11_66(Pt_10)_o2523.nxml.txt.nlp	21587517	SENT4	16	16	2	2	benzaldehyde	mol	PA448571	90527	0.588
NULL	Mol_Vis_2012_Nov_29_18_2839-2846.nxml.txt.nlp	23233786	SENT167	6	6	29	29	geldanamycin	Hsp90	PA152031327	3320	0.588
NULL	J_Health_Popul_Nutr_2011_Jun_29(3)_183-190.nxml.txt.nlp	21766553	SENT139	19	19	4	4	l-isoleucine	HBD-3	PA164750430	414325	0.588
NULL	Amino_Acids_2010_Oct_16_39(4)_1055-1066.nxml.txt.nlp	20473773	SENT158	16	16	29	29	nadh	fumarase	PA164755085	2271	0.588
NULL	Crit_Care_2000_Mar_21_4(Suppl_1)_P84.nxml.txt.nlp	NULL	SENT11	7	7	18	18	mefloquine	GIT	PA450348	5034	0.588
NULL	J_Lipid_Res_2013_Feb_54(2)_425-435.nxml.txt.nlp	23220585	SENT28	8	8	10	10	lipase	HSL	PA450239	3991	0.588
NULL	Ann_Rheum_Dis_2008_Nov_14_67(11)_1516-1523.nxml.txt.nlp	18625622	SENT101	11	11	0	0	tocilizumab	CRP	PA165292659	1401;140913	0.588
NULL	Indian_J_Crit_Care_Med_2015_Jan_19(1)_42-46.nxml.txt.nlp	25624650	SENT82	27	27	41	41	dobutamine	APE	PA449381	55704;328	0.588
NULL	Cardiovasc_Diabetol_2013_May_30_12(Suppl_1)_S2.nxml.txt.nlp	23819752	SENT129	20	20	43	43	pitavastatin	CYP2C9	PA142650384	1559	0.588
NULL	Clin_Mol_Allergy_2010_Nov_1_8_14.nxml.txt.nlp	21040557	SENT20	16	16	21	21	amiloride	ABP1	PA448368	26	0.588
NULL	Arthritis_Res_Ther_2009_Aug_24_11(4)_R127.nxml.txt.nlp	19703304	SENT62	7	7	3	3	adalimumab	OASIS	PA10004	90993	0.588
NULL	Breast_Cancer_Res_2008_Dec_5_10(6)_R104.nxml.txt.nlp	19061505	SENT195	10	10	15	15	estradiol	Bcl-2	PA449503	596	0.588
NULL	ScientificWorldJournal_2012_Feb_14_2012_402919.nxml.txt.nlp	22448133	SENT313	25	25	27	27	ciprofloxacin	CPX	PA449009	1371;10682;1377	0.588
NULL	Oncotarget_2013_Nov_22_5(4)_933-943.nxml.txt.nlp	24659749	SENT50	12	12	14	14	nutlin-3	p53		7157	0.588
NULL	Scientifica_(Cairo)_2012_Nov_25_2012_473829.nxml.txt.nlp	24278698	SENT318	46	46	38	38	cisplatin	OCT1	PA449014	5451;6580	0.588
NULL	Cardiovasc_Diabetol_2008_Feb_26_7_3.nxml.txt.nlp	18302760	SENT340	4	4	27	27	troglitazone	gamma	PA451799	9913	0.588
NULL	J_Clin_Exp_Pathol_2012_May_17_Suppl_4_7327.nxml.txt.nlp	25379357	SENT92	25	25	37	37	resveratrol	SIRT1		23411	0.588
NULL	Drug_Des_Devel_Ther_2014_Sep_23_8_1527-1538.nxml.txt.nlp	25284985	SENT184	36	36	26	26	celecoxib	IFN	PA448871	3439	0.588
NULL	Oncol_Lett_2013_Mar_8_5(3)_805-812.nxml.txt.nlp	23426281	SENT138	7	7	14	14	gemcitabine	B7-H3	PA449748	80381	0.588
NULL	Core_Evid_2010_Oct_21_5_61-76.nxml.txt.nlp	21042543	SENT358	22	22	7	7	irinotecan	KRAS	PA450085	3845	0.588
NULL	Infect_Dis_Obstet_Gynecol_2014_Sep_25_2014_961375.nxml.txt.nlp	25328370	SENT198	14	14	0	0	ritonavir	ATV	PA451260	4683	0.588
NULL	Gut_Liver_2013_Nov_14_7(6)_696-703.nxml.txt.nlp	24312711	SENT126	14	14	0	0	sorafenib	SHARP	PA7000	23013	0.588
NULL	Br_J_Cancer_2003_Mar_10_88(5)_754-759.nxml.txt.nlp	12618886	SENT128	4	4	10	10	amifostine	p53	PA448365	7157	0.588
NULL	Environ_Health_Perspect_2013_Apr_5_121(4)_480-487.nxml.txt.nlp	23384616	SENT207	18	18	40	40	heparin	PC3	PA449855	57332;7832;5122	0.588
NULL	Gut_Pathog_2011_Sep_22_3_13.nxml.txt.nlp	21939552	SENT122	17	17	26	26	gentamicin	CO2	PA449753	4513	0.588
NULL	Ann_Gastroenterol_2013_26(4)_304-313.nxml.txt.nlp	24714603	SENT7	31	31	15	15	ribavirin	IL28B	PA451241	282617	0.588
NULL	Acta_Histochem_Cytochem_2010_May_1_43(2)_61-68.nxml.txt.nlp	20514293	SENT67	19	19	30	30	hyaluronan	LYVE-1	PA165958431	10894	0.588
NULL	J_Gen_Physiol_1938_Sep_20_22(1)_79-89.nxml.txt.nlp	19873094	SENT0	16	16	1	1	papain	Gen	PA450778	348654	0.588
NULL	Arthritis_Res_Ther_2009_Aug_24_11(4)_R127.nxml.txt.nlp	19703304	SENT13	19	19	13	13	adalimumab	OASIS	PA10004	90993	0.588
NULL	Facts_Views_Vis_Obgyn_2010_2(2)_74-87.nxml.txt.nlp	25302102	SENT222	6	6	0	0	doxorubicin	CHOP	PA449412	1649	0.588
NULL	Oncotarget_2014_Aug_19_5(18)_8703-8715.nxml.txt.nlp	25237928	SENT184	11	11	3	3	glucose	CD44	PA449773	960	0.588
NULL	Front_Oncol_2014_Oct_21_4_285.nxml.txt.nlp	25374842	SENT674	5	5	17	17	nutlin-3	FLT3		2322	0.588
NULL	J_Cell_Biol_1998_Jan_26_140(2)_335-345.nxml.txt.nlp	9442109	SENT92	39	39	37	37	chloroquine	NHE	PA448948	285335	0.588
NULL	Diabetes_2013_Nov_18_62(11)_3909-3919.nxml.txt.nlp	23835339	SENT298	23	23	15	15	diazoxide	SUR1	PA449285	6833	0.588
NULL	Mol_Biol_Cell_2013_Feb_1_24(3)_261-273.nxml.txt.nlp	23264468	SENT242	39	39	34	34	hydrocortisone	EGF	PA449905	1950	0.588
NULL	J_Exp_Med_1998_Mar_16_187(6)_949-959.nxml.txt.nlp	9500797	SENT41	5	5	22	22	zidovudine	CD4	PA451954	920	0.588
NULL	Clin_Dev_Immunol_2013_Sep_17_2013_791262.nxml.txt.nlp	24151519	SENT137	6	6	3	3	heparin	HMGB1	PA449855	3146	0.588
NULL	Eur_J_Haematol_2008_Feb_80(2)_93-106.nxml.txt.nlp	18081719	SENT326	15	15	18	18	iron	MRI	PA450087	78996	0.588
NULL	Evid_Based_Complement_Alternat_Med_2014_Mar_6_2014_627342.nxml.txt.nlp	24734109	SENT21	23	23	17	17	neostigmine	B12	PA450611	7126;4709	0.588
NULL	Arch_Virol_2014_Aug_2_159(12)_3231-3237.nxml.txt.nlp	25085624	SENT21	21	21	18	18	ribavirin	IFN	PA451241	3439	0.588
NULL	Infect_Dis_Ther_2014_Jun_20_3(1)_1-17.nxml.txt.nlp	25134808	SENT130	10	10	3	3	darunavir	ATV	PA163522472	4683	0.588
NULL	Cancer_Med_2014_Apr_12_3(2)_390-396.nxml.txt.nlp	24519810	SENT96	17	17	0	0	telbivudine	LAM	PA164760861	7249;7248	0.588
NULL	Environ_Health_Perspect_2011_Apr_16_119(4)_534-541.nxml.txt.nlp	21081300	SENT190	23	23	20	20	genistein	DES	PA165109660	1674	0.588
NULL	J_Neural_Transm_2014_Mar_27_121(10)_1221-1232.nxml.txt.nlp	24671607	SENT204	14	14	29	29	sertraline	PSD-95	PA451333	1742	0.588
NULL	Oncotarget_2011_Aug_30_2(8)_610-626.nxml.txt.nlp	21881167	SENT147	6	6	4	4	doxorubicin	p53	PA449412	7157	0.588
NULL	Cerebrospinal_Fluid_Res_2010_Aug_12_7_11.nxml.txt.nlp	20704740	SENT149	14	14	24	24	calcein	P-gp	PA132595336	5243	0.588
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT39	10	10	30	30	pp2	San		80218	0.588
NULL	Diabetes_Obes_Metab_2010_Aug_12(8)_700-708.nxml.txt.nlp	20590747	SENT26	0	0	5	5	voglibose	PPG	PA164752433	5552	0.588
NULL	Acta_Histochem_Cytochem_2014_Feb_27_47(1)_27-33.nxml.txt.nlp	24761047	SENT22	5	5	3	3	arsenite	AQP9	PA452638	366;364	0.588
NULL	Arthritis_Res_Ther_2011_Feb_16_13(1)_R25.nxml.txt.nlp	21324169	SENT120	14	14	8	8	etanercept	ANA	PA449515	10950	0.588
NULL	Allergy_Asthma_Clin_Immunol_2011_Nov_10_7(Suppl_1)_S11.nxml.txt.nlp	22165913	SENT139	21	21	25	25	amoxicillin	TMP	PA448406	2012	0.588
NULL	J_Immunother_Cancer_2013_Nov_7_1(Suppl_1)_P123.nxml.txt.nlp	NULL	SENT23	4	4	30	30	chloroquine	IL-2	PA448948	3558	0.588
NULL	J_Cell_Biol_2007_Apr_23_177(2)_265-275.nxml.txt.nlp	17452530	SENT348	37	37	39	39	imiquimod	TLR7	PA449972	51284	0.588
NULL	Exp_Hematol_Oncol_2012_Sep_11_1_27.nxml.txt.nlp	23210501	SENT64	0	0	11	11	lenalidomide	PI3K	PA162363968	5290	0.588
NULL	Adv_Hematol_2011_Oct_23_2011_829525.nxml.txt.nlp	22110506	SENT208	28	28	12	12	cisplatin	p53	PA449014	7157	0.588
NULL	Mediators_Inflamm_2010_Jun_21_2010_194896.nxml.txt.nlp	20652055	SENT48	33	33	17	17	telmisartan	mol	PA451605	90527	0.588
NULL	Exp_Cell_Res_2011_Apr_15_317(7)_1028-1039.nxml.txt.nlp	21237154	SENT255	14	14	12	12	staurosporine	TRAIL	PA165109623	8743	0.588
NULL	Br_J_Cancer_1999_Aug_80(12)_1884-1891.nxml.txt.nlp	10471035	SENT7	1	1	11	11	urokinase	AP-1	PA451836	2353;3727;2354;3725	0.588
NULL	Clin_Ophthalmol_2011_Apr_18_5_495-502.nxml.txt.nlp	21573098	SENT117	20	20	24	24	gatifloxacin	BAK	PA449738	578	0.588
NULL	J_Gen_Physiol_1925_Sep_20_9(1)_87-96.nxml.txt.nlp	19872235	SENT0	12	12	1	1	trypsin	Gen	PA451806	348654	0.588
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Apr_15_9_13.nxml.txt.nlp	20398300	SENT97	23	23	7	7	amoxicillin	LAM	PA448406	7249;7248	0.588
NULL	Mol_Cancer_2010_Jun_25_9_165.nxml.txt.nlp	20576164	SENT52	8	8	6	6	curcumin	STAT3	PA151958596	6774	0.588
NULL	Adv_Hematol_2012_Aug_2_2012_842945.nxml.txt.nlp	22919394	SENT7	6	6	17	17	lenalidomide	CRBN	PA162363968	51185	0.588
NULL	Br_J_Ophthalmol_2009_Dec_17_93(12)_1634-1638.nxml.txt.nlp	19889831	SENT4	12	12	9	9	mitomycin	PRK	PA450524	1263	0.588
NULL	Commun_Integr_Biol_2013_Nov_1_6(6)_e26794.nxml.txt.nlp	24563712	SENT54	2	2	40	40	amphetamine	mol	PA448408	90527	0.588
NULL	Gastric_Cancer_2013_Dec_14_16(4)_513-520.nxml.txt.nlp	23238856	SENT223	3	3	5	5	hyaluronan	LYVE-1	PA165958431	10894	0.588
NULL	Antimicrob_Agents_Chemother_2014_Aug_58(8)_4971-4973.nxml.txt.nlp	24913169	SENT2	21	21	3	3	primaquine	G6PD	PA451103	2539	0.588
NULL	Genome_Med_2010_Feb_22_2(2)_13.nxml.txt.nlp	20236491	SENT54	21	21	19	19	irinotecan	UGT1A1	PA450085	54658	0.588
NULL	Crit_Care_2004_May_14_8(4)_R163-R171.nxml.txt.nlp	15312214	SENT193	37	37	3	3	candesartan	ANG	PA448765	283	0.588
NULL	Cardiovasc_Diabetol_2013_Oct_17_12_150.nxml.txt.nlp	24134550	SENT102	10	10	18	18	metformin	activin	PA450395	83729	0.588
NULL	Cancers_(Basel)_2014_Jul_8_6(3)_1487-1499.nxml.txt.nlp	25006835	SENT112	10	10	13	13	cisplatin	HCC	PA449014	84668	0.588
NULL	Exp_Ther_Med_2014_Apr_13_7(4)_923-928.nxml.txt.nlp	24669252	SENT204	7	7	9	9	resveratrol	PRL		5617	0.588
NULL	Neural_Regen_Res_2013_Nov_15_8(32)_3047-3054.nxml.txt.nlp	25206625	SENT165	28	28	7	7	paraformaldehyde	NeuN	PA450790	146713	0.588
NULL	Br_J_Cancer_2010_Nov_9_103(10)_1580-1587.nxml.txt.nlp	20959823	SENT82	22	22	26	26	bortezomib	LAMP	PA10252	4045;27074	0.588
NULL	Oncotarget_2014_Feb_7_5(3)_775-787.nxml.txt.nlp	24519956	SENT109	0	0	5	5	dasatinib	PC3	PA162372878	57332;7832;5122	0.588
NULL	Environ_Health_Perspect_2008_Apr_16_116(4)_426-433.nxml.txt.nlp	18414622	SENT138	6	6	16	16	resveratrol	Bcl-2		596	0.588
NULL	J_Korean_Med_Sci_2010_Aug_21_25(8)_1222-1227.nxml.txt.nlp	20676337	SENT72	2	2	19	19	aminophylline	LPA	PA164781029	4018	0.588
NULL	J_Clin_Biochem_Nutr_2008_May_29_42(3)_197-203.nxml.txt.nlp	18545641	SENT44	3	3	8	8	curcumin	p38	PA151958596	10598;1432;7965	0.588
NULL	Amino_Acids_2011_May_22_40(5)_1369-1383.nxml.txt.nlp	21424716	SENT274	28	28	16	16	creatine	CEE	PA164778930	51608	0.588
NULL	Arthritis_Res_Ther_2003_Sep_3_5(6)_R317-R328.nxml.txt.nlp	14680506	SENT99	18	18	10	10	rolipram	IL-10	PA153906323	3586	0.588
NULL	J_Cardiothorac_Surg_2011_Aug_10_6_96.nxml.txt.nlp	21831274	SENT61	21	21	11	11	colchicine	COPE	PA449092	11316	0.588
NULL	Oxid_Med_Cell_Longev_2013_May_22_2013_791795.nxml.txt.nlp	23766861	SENT115	32	32	39	39	taurine	F12	PA451590	2161	0.588
NULL	Semin_Nephrol_2013_Nov_33(6)_479-492.nxml.txt.nlp	24161035	SENT399	10	10	8	8	heparin	C3b	PA449855	718	0.588
NULL	Cancer_Cell_Int_2013_Oct_29_13_107.nxml.txt.nlp	24168269	SENT18	5	5	3	3	methotrexate	FPGS	PA450428	2356	0.588
NULL	Cancer_Med_2012_Aug_8_1(1)_5-16.nxml.txt.nlp	23342249	SENT255	27	27	11	11	bevacizumab	CDH1	PA130232992	51343;999	0.588
NULL	Nat_Commun_2013_4_2720.nxml.txt.nlp	24193139	SENT217	10	10	16	16	methylphenidate	CTRL	PA450464	1506	0.588
NULL	Cancer_Med_2014_Aug_10_3(4)_759-774.nxml.txt.nlp	24723436	SENT429	11	11	25	25	pp2	PP2		4888	0.588
NULL	Indian_J_Med_Res_2012_Aug_136(2)_249-259.nxml.txt.nlp	22960892	SENT27	11	11	5	5	sn-38	UGT1A1		54658	0.588
NULL	Mol_Pain_2014_Aug_15_10_53.nxml.txt.nlp	25127716	SENT82	18	18	16	16	paclitaxel	SDH	PA450761	1757;10993	0.588
NULL	Breast_Cancer_Res_2014_May_23_16(3)_R50.nxml.txt.nlp	24887458	SENT119	16	16	0	0	trastuzumab	HER2	PA451743	2064	0.588
NULL	Org_Med_Chem_Lett_2012_Oct_24_2_33.nxml.txt.nlp	23095284	SENT169	18	18	15	15	galactose	flower	PA449725	11094	0.588
NULL	Ecancermedicalscience_2009_Oct_29_3_157.nxml.txt.nlp	22276018	SENT362	16	16	12	12	urokinase	HER2	PA451836	2064	0.588
NULL	Glia_2013_Aug_6_61(8)_1331-1346.nxml.txt.nlp	23832647	SENT76	25	25	4	4	plerixafor	DKK2	PA165958410	27123	0.588
NULL	Br_J_Cancer_2014_Nov_25_111(11)_2091-2102.nxml.txt.nlp	25349971	SENT245	10	10	18	18	imatinib	PTPN18	PA10804	26469	0.588
NULL	J_Cardiothorac_Surg_2013_Sep_11_8(Suppl_1)_P122.nxml.txt.nlp	NULL	SENT7	25	25	36	36	clopidogrel	APT	PA449053	653639	0.588
NULL	J_Immunother_Cancer_2014_Jan_27_2_2.nxml.txt.nlp	24829759	SENT16	2	2	0	0	sorafenib	IL-21	PA7000	59067;50616;27189	0.588
NULL	Biologics_2009_Oct_12_3_469-474.nxml.txt.nlp	19851472	SENT70	22	22	9	9	mometasone	IL-5	PA450541	3567	0.588
NULL	Carcinogenesis_2010_Dec_27_31(12)_2049-2057.nxml.txt.nlp	20876285	SENT305	15	15	11	11	tamoxifen	HER-2	PA451581	2064	0.588
NULL	J_Int_Soc_Sports_Nutr_2015_Jan_21_12(1)_5.nxml.txt.nlp	NULL	SENT165	10	10	1	1	curcumin	IL-6	PA151958596	3569	0.588
NULL	Diabetologia_2009_Sep_17_52(9)_1866-1870.nxml.txt.nlp	19533084	SENT0	23	23	19	19	glucose	MTNR1B	PA449773	4544	0.588
NULL	Chin_J_Cancer_2011_Dec_30(12)_815-820.nxml.txt.nlp	22059910	SENT91	12	12	24	24	cetuximab	KRAS	PA10040	3845	0.588
NULL	Semin_Dial_2013_Sep_17_26(5)_546-567.nxml.txt.nlp	23859229	SENT308	0	0	6	6	cyanocobalamin	B12	PA451892	7126;4709	0.588
NULL	Iran_J_Pharm_Res_2014_Winter_13(1)_253-262.nxml.txt.nlp	24734078	SENT159	9	9	4	4	propofol	LPO	PA451141	4025	0.588
NULL	Bioimpacts_2014_Aug_31_4(3)_141-148.nxml.txt.nlp	25337467	SENT28	0	0	2	2	piroxicam	PRX	PA450985	9588;57716	0.588
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_127043.nxml.txt.nlp	23227093	SENT231	19	19	7	7	quinidine	CYP1A2	PA451209	1544	0.588
NULL	Diagn_Pathol_2014_Jan_20_9_11.nxml.txt.nlp	24443801	SENT26	15	15	23	23	trypsin	p53	PA451806	7157	0.588
NULL	Alcohol_Res_Health_2007_30(1)_48-54.nxml.txt.nlp	17718401	SENT174	31	31	36	36	ethanol	GP2	PA448073	2813	0.588
NULL	J_Nutr_Metab_2011_Jul_26_2011_163631.nxml.txt.nlp	21808727	SENT216	8	8	10	10	troglitazone	TRO	PA451799	7216	0.588
NULL	BMB_Rep_2013_Jan_46(1)_59-64.nxml.txt.nlp	23351386	SENT34	12	12	14	14	auranofin	STAT3	PA448510	6774	0.588
NULL	Diabetes_Metab_Syndr_Obes_2013_Sep_2_6_317-325.nxml.txt.nlp	24039439	SENT90	3	3	16	16	voglibose	GLP-1	PA164752433	100125288	0.588
NULL	Curr_Pharm_Biotechnol_2012_May_13(6)_1004-1060.nxml.txt.nlp	22039795	SENT386	26	26	21	21	praziquantel	MOX	PA164764583	26002	0.588
NULL	Genome_Biol_2008_May_13_9(5)_R80.nxml.txt.nlp	18477406	SENT226	32	32	44	44	collagenase	CO2	PA449107	4513	0.588
NULL	Neuroscience_2011_Dec_1_197(1)_280-292.nxml.txt.nlp	21945033	SENT303	7	7	21	21	coumarin	CA1	PA134521193	759	0.588
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_127043.nxml.txt.nlp	23227093	SENT231	15	15	26	26	sulfaphenazole	CYP3A4	PA130231310	1576	0.588
NULL	Breast_Cancer_Res_2011_Jun_29_13(3)_R70.nxml.txt.nlp	21707964	SENT118	15	15	1	1	tamoxifen	14-3-3	PA451581	10971	0.588
NULL	J_Asthma_Allergy_2008_Sep_19_1_19-29.nxml.txt.nlp	21436982	SENT117	10	10	25	25	fexofenadine	eotaxin	PA449621	6356	0.588
NULL	Clin_Transl_Allergy_2013_Sep_2_3_29.nxml.txt.nlp	24004581	SENT192	2	2	10	10	omalizumab	IL-6	PA164752253	3569	0.588
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1709-1716.nxml.txt.nlp	19844235	SENT140	4	4	6	6	gemcitabine	B7-H3	PA449748	80381	0.588
NULL	Turk_J_Haematol_2012_Dec_5_29(4)_413-419.nxml.txt.nlp	24385732	SENT55	13	13	8	8	vincristine	CHOP	PA451879	1649	0.588
NULL	EMBO_Mol_Med_2009_Jul_1(4)_236-248.nxml.txt.nlp	20049725	SENT258	6	6	10	10	forskolin	NF1	PA146096022	4763	0.588
NULL	J_Korean_Med_Sci_2013_Dec_26_28(12)_1774-1780.nxml.txt.nlp	24339708	SENT179	20	20	18	18	octreotide	OST	PA450678	1650;23263	0.588
NULL	Cell_Commun_Signal_2013_Nov_11_11_86.nxml.txt.nlp	24215724	SENT81	29	29	32	32	heparin	EGF	PA449855	1950	0.588
NULL	J_Carcinog_2013_Jun_29_12_11.nxml.txt.nlp	23858299	SENT193	22	22	24	24	diethylstilbestrol	DES	PA449307	1674	0.588
NULL	Drugs_2012_Sep_6_72(9)_e1-e25.nxml.txt.nlp	22686620	SENT253	4	4	2	2	elvitegravir	INI	PA165291498	84844	0.588
NULL	Int_J_Biol_Sci_2013_Nov_21_9(10)_1089-1098.nxml.txt.nlp	24339730	SENT183	25	25	15	15	genistein	COL15A1	PA165109660	1306	0.588
NULL	Neuropsychopharmacology_2009_Jul_11_34(8)_1946-1957.nxml.txt.nlp	19279569	SENT166	14	14	4	4	cocaine	DOR	PA449072	58476	0.588
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1013.nxml.txt.nlp	24457957	SENT138	8	8	16	16	bortezomib	NOXA	PA10252	5366	0.588
NULL	Mol_Vis_2011_Dec_24_17_3384-3391.nxml.txt.nlp	22219634	SENT124	25	25	9	9	mannitol	TLR2	PA450320	7097	0.587
NULL	Evid_Based_Complement_Alternat_Med_2012_May_7_2012_242810.nxml.txt.nlp	22645625	SENT141	0	0	3	3	rifampin	CYP3A4	PA451250	1576	0.587
NULL	Ann_Rheum_Dis_2013_Aug_21_72(8)_1287-1294.nxml.txt.nlp	22915624	SENT98	16	16	10	10	methotrexate	MCP	PA450428	822	0.587
NULL	Case_Rep_Pathol_2011_Sep_22_2011_809567.nxml.txt.nlp	22937394	SENT35	18	18	32	32	fluconazole	B12	PA449653	7126;4709	0.587
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT272	20	20	6	6	acenocoumarol	CYP2C9	PA452632	1559	0.587
NULL	Br_J_Cancer_2004_May_17_90(10)_2032-2041.nxml.txt.nlp	15138490	SENT170	14	14	6	6	trastuzumab	HER-2	PA451743	2064	0.587
NULL	Cell_Death_Dis_2014_Mar_13_5(3)_e1112.nxml.txt.nlp	24625971	SENT121	26	26	29	29	curcumin	CHOP	PA151958596	1649	0.587
NULL	Am_J_Physiol_Cell_Physiol_2010_Nov_18_299(5)_C1180-C1194.nxml.txt.nlp	20720182	SENT96	2	2	0	0	hyaluronan	HAS2	PA165958431	3037	0.587
NULL	Front_Neurosci_2008_Dec_15_2(2)_155-167.nxml.txt.nlp	19225588	SENT94	12	12	8	8	choline	NPY	PA448976	4852	0.587
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1150.nxml.txt.nlp	24675468	SENT80	4	4	10	10	ethanol	PARP-1	PA448073	25976	0.587
NULL	Br_J_Pharmacol_2014_May_11_171(9)_2385-2398.nxml.txt.nlp	24467222	SENT199	10	10	18	18	rolipram	CXCL10	PA153906323	3627	0.587
NULL	Oncotarget_2012_Oct_20_3(10)_1236-1245.nxml.txt.nlp	23100449	SENT90	7	7	3	3	doxorubicin	NGAL	PA449412	3934	0.587
NULL	Br_J_Clin_Pharmacol_2013_Aug_23_76(2)_299-315.nxml.txt.nlp	23701319	SENT240	8	8	3	3	daclizumab	IL-2	PA164764446	3558	0.587
NULL	Open_Biochem_J_2009_Oct_13_3_55-65.nxml.txt.nlp	19911071	SENT361	3	3	37	37	l-arginine	COX	PA448478	1351	0.587
NULL	Int_J_Environ_Res_Public_Health_2011_Jul_30_8(7)_2747-2757.nxml.txt.nlp	21845156	SENT37	9	9	4	4	trypsin	PRSS1	PA451806	5644	0.587
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1051.nxml.txt.nlp	24503543	SENT144	24	24	11	11	tamoxifen	Yes	PA451581	7525	0.587
NULL	Front_Neurosci_2013_Oct_7_7_179.nxml.txt.nlp	24109427	SENT158	1	1	4	4	capsaicin	TRPV1	PA448776	7442	0.587
NULL	Int_J_Breast_Cancer_2013_Jun_24_2013_137414.nxml.txt.nlp	23864953	SENT254	9	9	36	36	trastuzumab	HER-2	PA451743	2064	0.587
NULL	Oxid_Med_Cell_Longev_2012_Jan_19_2012_390678.nxml.txt.nlp	22315655	SENT176	10	10	18	18	ethanol	ANOVA	PA448073	4858	0.587
NULL	Clinics_(Sao_Paulo)_2013_May_68(5)_694-701.nxml.txt.nlp	23778405	SENT41	0	0	7	7	curcumin	survivin	PA151958596	332	0.587
NULL	Front_Neural_Circuits_2013_Oct_2_7_155.nxml.txt.nlp	24106462	SENT141	38	38	17	17	apomorphine	gamma	PA164781163	9913	0.587
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT127	31	31	34	34	trastuzumab	HER2	PA451743	2064	0.587
NULL	Pharmaceuticals_(Basel)_2013_Aug_21_6(8)_988-1038.nxml.txt.nlp	24276379	SENT2621	1	1	3	3	dasatinib	KRAS	PA162372878	3845	0.587
NULL	Mol_Biol_Rep_2013_May_11_40(8)_5013-5026.nxml.txt.nlp	23666059	SENT266	13	13	10	10	resveratrol	p53		7157	0.587
NULL	Open_AIDS_J_2010_May_14_4_105-115.nxml.txt.nlp	20657829	SENT78	22	22	8	8	methamphetamine	San	PA450403	80218	0.587
NULL	ScientificWorldJournal_2013_Sep_22_2013_752184.nxml.txt.nlp	24174916	SENT130	11	11	17	17	vancomycin	hole	PA451850	80757	0.587
NULL	Oncotarget_2013_Dec_21_5(9)_2404-2417.nxml.txt.nlp	24811221	SENT8	0	0	2	2	bleomycin	BLM	PA448645	641	0.587
NULL	Br_J_Cancer_2010_Nov_9_103(10)_1588-1596.nxml.txt.nlp	20978505	SENT128	26	26	13	13	temozolomide	MSH3	PA451609	4437	0.587
NULL	Ann_Gen_Psychiatry_2008_Aug_18_7_11.nxml.txt.nlp	18706108	SENT84	7	7	0	0	ethanol	BUP	PA448073	23412	0.587
NULL	Exp_Ther_Med_2014_Mar_19_7(3)_669-674.nxml.txt.nlp	24520265	SENT43	23	23	25	25	bleomycin	BLM	PA448645	641	0.587
NULL	Front_Oncol_2014_Apr_10_4_74.nxml.txt.nlp	24782985	SENT300	10	10	20	20	hyaluronan	TLR2	PA165958431	7097	0.587
NULL	Arthritis_Res_Ther_2009_May_26_11(3)_R78.nxml.txt.nlp	19470154	SENT117	20	20	11	11	nitrogen	AST	PA450643	26503	0.587
NULL	J_Cell_Biol_1994_Apr_2_125(2)_495-509.nxml.txt.nlp	7512973	SENT7	8	8	4	4	hyaluronan	BEHAB	PA165958431	63827	0.587
NULL	Anticancer_Drugs_2015_Jan_28_26(1)_117-122.nxml.txt.nlp	25115342	SENT124	21	21	31	31	docetaxel	SPARC	PA449383	6678	0.587
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT31	3	3	6	6	cisplatin	p53	PA449014	7157	0.587
NULL	Chin_J_Cancer_2012_Jun_31(6)_266-280.nxml.txt.nlp	22313597	SENT222	30	30	14	14	lipase	IGFBP5	PA450239	3488	0.587
NULL	Clin_Dev_Immunol_2013_Sep_24_2013_814973.nxml.txt.nlp	24174972	SENT91	25	25	19	19	basiliximab	IL-2	PA164747126	3558	0.587
NULL	Arthritis_Res_Ther_2009_Aug_24_11(4)_R127.nxml.txt.nlp	19703304	SENT109	29	29	25	25	adalimumab	OASIS	PA10004	90993	0.587
NULL	Basic_Res_Cardiol_2014_Oct_31_109(6)_451.nxml.txt.nlp	25358972	SENT10	24	24	17	17	phenylephrine	FHL2	PA450935	2274	0.587
NULL	Neural_Regen_Res_2013_Nov_5_8(31)_2895-2903.nxml.txt.nlp	25206610	SENT76	2	2	9	9	fluorescein	CD31	PA164746009	5175	0.587
NULL	Biomed_Res_Int_2013_Sep_8_2013_808713.nxml.txt.nlp	24083242	SENT73	29	29	17	17	yohimbine	CYP2D6	PA451946	1565	0.587
NULL	Endocrinol_Diabetes_Metab_Case_Rep_2014_Jul_1_2014_140051.nxml.txt.nlp	25136449	SENT130	5	5	7	7	octreotide	ACTH	PA450678	5443	0.587
NULL	Stroke_Res_Treat_2011_Nov_10_2011_212485.nxml.txt.nlp	22135769	SENT146	15	15	28	28	clopidogrel	ABCB1	PA449053	5243	0.587
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT149	1	1	9	9	glucose	p38	PA449773	10598;1432;7965	0.587
NULL	Case_Rep_Gastroenterol_2012_Aug_9_6(2)_538-544.nxml.txt.nlp	22949894	SENT26	1	1	5	5	sitagliptin	GLP-1	PA164748978	100125288	0.587
NULL	J_Allergy_(Cairo)_2011_Apr_26_2011_736319.nxml.txt.nlp	21747870	SENT48	27	27	23	23	l-arginine	CAT-2	PA448478	6542	0.587
NULL	Ann_Indian_Acad_Neurol_2013_Apr-Jun_16(2)_137-143.nxml.txt.nlp	23956550	SENT187	9	9	11	11	clobazam	CLB	PA10888	171425	0.587
NULL	Clin_Med_Insights_Circ_Respir_Pulm_Med_2013_Apr_9_7_7-15.nxml.txt.nlp	23641160	SENT69	14	14	9	9	roflumilast	CYP3A4	PA165948052	1576	0.587
NULL	Clin_Interv_Aging_2008_Sep_3(3)_453-472.nxml.txt.nlp	18982916	SENT513	26	26	20	20	fosamprenavir	ATV	PA10084	4683	0.587
NULL	Chem_Cent_J_2014_Jul_1_8_43.nxml.txt.nlp	25050134	SENT122	5	5	13	13	hemin	Bcl-2	PA449849	596	0.587
NULL	Case_Rep_Med_2010_Dec_26_2010_403237.nxml.txt.nlp	21209804	SENT77	7	7	9	9	bortezomib	CHOP	PA10252	1649	0.587
NULL	Ann_Oncol_2011_Aug_27_22(8)_1736-1747.nxml.txt.nlp	21709140	SENT87	10	10	2	2	trastuzumab	STEPP	PA451743	222659	0.587
NULL	Cell_Commun_Signal_2014_Oct_25_12(1)_59.nxml.txt.nlp	NULL	SENT309	6	6	21	21	cisplatin	mol	PA449014	90527	0.587
NULL	Pharmaceuticals_(Basel)_2012_Jun_28_5(7)_690-718.nxml.txt.nlp	24281707	SENT396	6	6	24	24	moxifloxacin	EMB	PA450555	133418	0.587
NULL	Apoptosis_2013_Jul_31_18(12)_1447-1468.nxml.txt.nlp	23900974	SENT469	21	21	4	4	lapatinib	HER2	PA152241907	2064	0.587
NULL	Croat_Med_J_2013_Apr_54(2)_171-179.nxml.txt.nlp	23630144	SENT135	18	18	7	7	taurine	HO-1	PA451590	3162	0.587
NULL	Ann_Surg_Oncol_2007_Dec_25_14(12)_3283-3284.nxml.txt.nlp	17899294	SENT45	0	0	8	8	tamoxifen	BRCA2	PA451581	675	0.587
NULL	Semin_Dial_2013_Sep_17_26(5)_546-567.nxml.txt.nlp	23859229	SENT433	28	28	20	20	cyanocobalamin	B12	PA451892	7126;4709	0.587
NULL	Osteoporos_Int_2014_Aug_15_25(10)_2359-2381.nxml.txt.nlp	25182228	SENT809	13	13	37	37	tamoxifen	STAR	PA451581	6770;2984	0.587
NULL	Avicenna_J_Phytomed_2014_May-Jun_4(3)_215-224.nxml.txt.nlp	25050319	SENT118	15	15	13	13	carrageenan	MEPI	PA448814	5276	0.587
NULL	EMBO_Mol_Med_2011_Apr_3(4)_235-245.nxml.txt.nlp	21374818	SENT35	36	36	20	20	doxycycline	CLDN5	PA449415	7122	0.587
NULL	Indian_J_Pharmacol_2013_May-Jun_45(3)_286-288.nxml.txt.nlp	23833375	SENT2	12	12	26	26	montelukast	NMU	PA450546	10874	0.587
NULL	Front_Oncol_2014_Mar_6_4_40.nxml.txt.nlp	24639951	SENT547	22	22	33	33	lapatinib	HER2	PA152241907	2064	0.587
NULL	Cardiovasc_Diabetol_2006_Sep_26_5_20.nxml.txt.nlp	17002798	SENT41	34	34	25	25	fenofibrate	CAD	PA449594	1677;790	0.587
NULL	eLife_2013_Nov_5_2_e00969.nxml.txt.nlp	24192036	SENT363	19	19	14	14	doxorubicin	JNK	PA449412	5599	0.587
NULL	BMB_Rep_2013_Aug_46(8)_410-415.nxml.txt.nlp	23977989	SENT201	1	1	8	8	curcumin	IL-6	PA151958596	3569	0.587
NULL	Nucleic_Acids_Res_2011_Sep_17_39(16)_e107.nxml.txt.nlp	21685448	SENT249	25	25	29	29	neomycin	AAVS1	PA450608	17	0.587
NULL	Cancers_(Basel)_2013_May_27_5(2)_617-638.nxml.txt.nlp	24216994	SENT222	8	8	10	10	curcumin	MMP9	PA151958596	4318	0.587
NULL	HSR_Proc_Intensive_Care_Cardiovasc_Anesth_2009_1(3)_54-59.nxml.txt.nlp	23439887	SENT82	1	1	9	9	fenoldopam	DA1	PA164784034	28495;7169	0.587
NULL	Arthritis_Res_Ther_2011_Feb_3_13(1)_102.nxml.txt.nlp	21345249	SENT46	0	0	27	27	curcumin	JNK	PA151958596	5599	0.587
NULL	Int_J_Med_Sci_2015_Jan_1_12(1)_63-71.nxml.txt.nlp	25552920	SENT89	4	4	10	10	berberine	PC-3	PA165860812	692094	0.587
NULL	Clin_Sci_(Lond)_2013_May_1_124(Pt_9)_567-578.nxml.txt.nlp	23113760	SENT294	18	18	9	9	hydroxyurea	RNR4	PA449942	6055	0.587
NULL	Epilepsia_2014_Jun_6_55(6)_806-818.nxml.txt.nlp	24802699	SENT120	0	0	11	11	bumetanide	NKCC1	PA448682	6558	0.587
NULL	Diabetes_Care_2010_Apr_12_33(4)_861-868.nxml.txt.nlp	20067962	SENT31	26	26	2	2	hyaluronan	TLR2	PA165958431	7097	0.587
NULL	Int_J_Mol_Sci_2007_Jan_29_8(1)_13-28.nxml.txt.nlp	NULL	SENT85	19	19	21	21	galactose	NAG	PA449725	51594;4669	0.587
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT128	9	9	2	2	quinidine	CYP2C19	PA451209	1557	0.587
NULL	Clin_Med_Insights_Blood_Disord_2014_Apr_10_7_1-6.nxml.txt.nlp	25512718	SENT52	1	1	15	15	heparin	STA	PA449855	2010;2656	0.587
NULL	Cancer_Med_2014_Feb_10_3(1)_134-142.nxml.txt.nlp	24407937	SENT249	3	3	7	7	tamoxifen	ERBB2	PA451581	2064	0.587
NULL	Neural_Regen_Res_2014_Sep_15_9(18)_1723-1728.nxml.txt.nlp	25374596	SENT92	23	23	30	30	capsaicin	TRPV3	PA448776	162514	0.587
NULL	Breast_Cancer_Res_Treat_2013_Apr_12_138(2)_427-435.nxml.txt.nlp	23479422	SENT271	22	22	5	5	lapatinib	NCCT	PA152241907	6559	0.587
NULL	Support_Care_Cancer_2013_May_22_21(5)_1335-1340.nxml.txt.nlp	23262807	SENT24	9	9	3	3	iron	CIA	PA450087	25842;57727	0.587
NULL	J_Gastroenterol_2013_Feb_22_48(2)_222-237.nxml.txt.nlp	22722906	SENT209	4	4	13	13	ethanol	ANOVA	PA448073	4858	0.587
NULL	Child_Adolesc_Psychiatry_Ment_Health_2013_Jun_19_7_19.nxml.txt.nlp	23777626	SENT12	8	8	10	10	atomoxetine	ATX	PA134688071	5168;23049	0.587
NULL	Diabetes_2011_Jun_21_60(6)_1734-1742.nxml.txt.nlp	21498783	SENT26	7	7	9	9	lipase	ATGL	PA450239	57104	0.587
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1196-1204.nxml.txt.nlp	22315058	SENT116	20	20	16	16	gefitinib	HSC3	PA131301952	150353	0.587
NULL	Breast_Cancer_Res_2002_Jun_10_4(4)_148-154.nxml.txt.nlp	12100740	SENT207	10	10	8	8	tamoxifen	ATAC	PA451581	6375	0.587
NULL	Brain_Behav_2011_Sep_1(1)_44-54.nxml.txt.nlp	22398980	SENT89	0	0	13	13	cocaine	AIS	PA449072	367	0.587
NULL	Cancers_(Basel)_2012_Mar_27_4(2)_340-353.nxml.txt.nlp	24213314	SENT144	5	5	18	18	imatinib	FGF2	PA10804	2247;2258	0.587
NULL	Alzheimers_Res_Ther_2013_Jan_3_5(1)_2.nxml.txt.nlp	23286718	SENT173	4	4	0	0	galantamine	Men	PA449726	8178	0.587
NULL	Sensors_(Basel)_2010_Mar_25_10(4)_2626-2637.nxml.txt.nlp	22319264	SENT130	39	39	24	24	ethanol	mol	PA448073	90527	0.587
NULL	Int_J_Anal_Chem_2014_Nov_18_2014_536823.nxml.txt.nlp	25484901	SENT81	12	12	14	14	glutaraldehyde	DTNB	PA449777	1838	0.587
NULL	Breast_Cancer_Res_Treat_2012_Jun_18_133(3)_937-947.nxml.txt.nlp	22094936	SENT208	22	22	10	10	tamoxifen	CDC2	PA451581	5424	0.587
NULL	Br_J_Cancer_2011_Aug_23_105(5)_649-657.nxml.txt.nlp	21811251	SENT83	10	10	7	7	gefitinib	EGFR	PA131301952	1956	0.587
NULL	J_Gen_Intern_Med_2009_May_21_24(5)_656-664.nxml.txt.nlp	19306050	SENT286	18	18	4	4	acenocoumarol	CYP2C9	PA452632	1559	0.587
NULL	Allergy_Asthma_Immunol_Res_2014_Mar_5_6(2)_175-178.nxml.txt.nlp	24587956	SENT98	14	14	38	38	budesonide	ACT	PA448681	12;11332;9457;641455	0.587
NULL	Core_Evid_2011_Sep_8_6_67-79.nxml.txt.nlp	22022289	SENT287	4	4	10	10	exenatide	PCB	PA164749238	5091	0.587
NULL	Int_J_Mol_Sci_2014_Oct_6_15(10)_17886-17900.nxml.txt.nlp	25290095	SENT110	2	2	10	10	resveratrol	p38		10598;1432;7965	0.587
NULL	Ann_Thorac_Med_2013_Apr-Jun_8(2)_109-115.nxml.txt.nlp	23741274	SENT165	11	11	14	14	cisplatin	CRT	PA449014	811	0.587
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_24_2012_673132.nxml.txt.nlp	23133498	SENT132	6	6	16	16	tamoxifen	P-gp	PA451581	5243	0.587
NULL	Curr_Rheumatol_Rep_2011_Jun_2_13(3)_233-240.nxml.txt.nlp	21365209	SENT150	7	7	4	4	teriparatide	PTH	PA451620	5741	0.587
NULL	Drugs_2014_Apr_17_74(6)_659-674.nxml.txt.nlp	24740824	SENT430	21	21	1	1	daclizumab	IL-2	PA164764446	3558	0.587
NULL	Cell_Death_Dis_2010_Jul_1_1(7)_e51.nxml.txt.nlp	21364656	SENT9	4	4	16	16	gentamicin	survivin	PA449753	332	0.587
NULL	Oncotarget_2014_Jun_19_5(15)_6540-6551.nxml.txt.nlp	25153728	SENT96	13	13	23	23	paclitaxel	p27	PA450761	5715;10534	0.587
NULL	J_Lipid_Res_2013_May_54(5)_1410-1420.nxml.txt.nlp	23419260	SENT183	12	12	22	22	tetracycline	IDOL	PA451640	29116	0.587
NULL	Angiogenesis_2010_Mar_11_13(1)_1-14.nxml.txt.nlp	20012482	SENT272	3	3	6	6	sunitinib	KIT	PA162372840	3815	0.587
NULL	J_Korean_Med_Sci_2006_Dec_31_21(6)_1037-1040.nxml.txt.nlp	17179683	SENT93	4	4	8	8	amoxicillin	BAM	PA448406	9126	0.587
NULL	Br_J_Cancer_2010_Feb_16_102(4)_658-664.nxml.txt.nlp	20104222	SENT93	22	22	27	27	sunitinib	IFN	PA162372840	3439	0.587
NULL	Arthritis_Res_Ther_2011_Jun_17_13(3)_R93.nxml.txt.nlp	21682898	SENT297	16	16	27	27	collagenase	IL-6	PA449107	3569	0.587
NULL	Cancer_Med_2014_Oct_10_3(5)_1368-1376.nxml.txt.nlp	25045041	SENT42	15	15	10	10	docetaxel	CRT	PA449383	811	0.587
NULL	Hum_Reprod_Update_2008_Sep_23_Nov-Dec_14(6)_571-582.nxml.txt.nlp	18812422	SENT307	8	8	30	30	letrozole	Casper	PA450196	8837	0.587
NULL	Int_J_Mol_Sci_2010_Oct_25_11(10)_4165-4174.nxml.txt.nlp	21152328	SENT88	14	14	23	23	ethanol	mol	PA448073	90527	0.587
NULL	Ann_Thorac_Med_2012_Jul-Sep_7(3)_130-132.nxml.txt.nlp	22924069	SENT23	9	9	3	3	collagenase	MMP1	PA449107	4312	0.587
NULL	Neural_Regen_Res_2014_Mar_1_9(5)_540-548.nxml.txt.nlp	25206852	SENT41	18	18	13	13	choline	HSP27	PA448976	3315	0.587
NULL	Clin_Ophthalmol_2010_Oct_5_4_1137-1143.nxml.txt.nlp	20957061	SENT13	20	20	27	27	latanoprost	BAK	PA164774763	578	0.587
NULL	Avicenna_J_Med_2014_Apr-Jun_4(2)_29-33.nxml.txt.nlp	24761380	SENT96	33	33	10	10	vildagliptin	GLP-1	PA165958346	100125288	0.587
NULL	Arch_Med_Sci_2013_Oct_31_9(5)_916-921.nxml.txt.nlp	24273579	SENT98	7	7	29	29	bleomycin	AQP5	PA448645	362	0.587
NULL	Angiogenesis_2012_Sep_27_15(3)_361-376.nxml.txt.nlp	22451299	SENT339	2	2	20	20	oxygen	PI3	PA450744	5266	0.587
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Dec_10_3(12)_e151.nxml.txt.nlp	25494035	SENT67	20	20	16	16	fluvastatin	OATP1B1	PA449688	10599	0.587
NULL	Pain_2014_Jan_155(1)_168-178.nxml.txt.nlp	24076162	SENT25	20	20	24	24	naloxone	P28	PA450586	9446;7802;9527	0.587
NULL	Crit_Care_2010_Jul_9_14(4)_R131.nxml.txt.nlp	20615266	SENT72	3	3	0	0	vasopressin	AVP	PA451858	114548;551	0.587
NULL	Mol_Vis_2011_Aug_18_17_2221-2227.nxml.txt.nlp	21897744	SENT91	7	7	0	0	penicillamine	GBA	PA450840	2629	0.587
NULL	Br_J_Cancer_2009_Mar_24_100(6)_941-949.nxml.txt.nlp	19240716	SENT126	37	37	22	22	gefitinib	EGFR	PA131301952	1956	0.587
NULL	Oncotarget_2014_Aug_27_5(21)_10486-10502.nxml.txt.nlp	25401222	SENT132	24	24	22	22	gefitinib	EGFR	PA131301952	1956	0.587
NULL	Arthritis_2012_Oct_11_2012_713618.nxml.txt.nlp	23133751	SENT82	5	5	16	16	abatacept	CD28	PA164747080	1493;940	0.587
NULL	J_Ind_Microbiol_Biotechnol_2013_Jul_30_40(10)_1153-1160.nxml.txt.nlp	23896974	SENT140	3	3	7	7	nadh	GAS1	PA164755085	2619	0.587
NULL	J_Biol_Eng_2012_Jun_11_6_7.nxml.txt.nlp	22686441	SENT55	10	10	2	2	ganciclovir	EVA	PA449733	10205	0.587
NULL	F1000Res_2013_Mar_5_2_74.nxml.txt.nlp	24358880	SENT90	21	21	19	19	capsaicin	TRPV1	PA448776	7442	0.587
NULL	Acta_Pharmacol_Sin_2013_Jan_17_34(1)_157-166.nxml.txt.nlp	23247593	SENT252	0	0	25	25	berberine	Set9	PA165860812	80854	0.587
NULL	Genetics_2013_Mar_193(3)_853-864.nxml.txt.nlp	23267056	SENT110	16	16	5	5	hydroxyurea	GPN3	PA449942	51184	0.587
NULL	J_Biol_Chem_2009_Aug_7_284(32)_21347-21359.nxml.txt.nlp	19520849	SENT168	17	17	19	19	s-adenosylmethionine	PRMT5	PA164754994	10419	0.587
NULL	Eur_J_Med_Res_2011_Feb_24_16(2)_63-66.nxml.txt.nlp	21463983	SENT122	7	7	18	18	tobramycin	PARI	PA451704	55010	0.587
NULL	Br_J_Pharmacol_2008_Sep_9_155(1)_127-137.nxml.txt.nlp	18536750	SENT10	0	0	11	11	dextran	IL-10	PA449261	3586	0.587
NULL	EJNMMI_Res_2011_Jun_20_1_7.nxml.txt.nlp	22214546	SENT34	9	9	13	13	rituximab	CHOP	PA451261	1649	0.587
NULL	Cardiovasc_Diabetol_2005_Aug_9_4_12.nxml.txt.nlp	16086844	SENT155	17	17	32	32	heparin	ANOVA	PA449855	4858	0.587
NULL	J_Carcinog_2013_Aug_8_12_16.nxml.txt.nlp	24082825	SENT91	16	16	10	10	berberine	AMPK	PA165860812	5563	0.587
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Jun_27_5_15.nxml.txt.nlp	16803618	SENT145	26	26	42	42	ciprofloxacin	GEN1	PA449009	348654	0.587
NULL	Neural_Regen_Res_2013_Nov_5_8(31)_2932-2941.nxml.txt.nlp	25206614	SENT149	4	4	19	19	creatine	spatial	PA164778930	219793	0.587
NULL	J_Breast_Cancer_2011_Mar_31_14(1)_20-27.nxml.txt.nlp	21847390	SENT160	8	8	11	11	estradiol	CLDN6	PA449503	9074	0.587
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT137	7	7	19	19	sulindac	survivin	PA451565	332	0.587
NULL	Rare_Tumors_2010_Dec_31_2(4)_e58.nxml.txt.nlp	21234250	SENT60	9	9	7	7	imatinib	PDGFRA	PA10804	5156	0.587
NULL	Adv_Hematol_2012_Jun_24_2012_857058.nxml.txt.nlp	22778746	SENT76	0	0	2	2	thrombin	ADP	PA451674	23038	0.587
NULL	J_Breast_Cancer_2013_Mar_31_16(1)_122-126.nxml.txt.nlp	23593093	SENT115	31	31	14	14	lapatinib	gamma	PA152241907	9913	0.587
NULL	Biomed_Res_Int_2014_Mar_9_2014_687835.nxml.txt.nlp	24734239	SENT114	14	14	11	11	lidocaine	CTB	PA450226	9468	0.587
NULL	Biologics_2009_Sep_15_3_429-441.nxml.txt.nlp	19774210	SENT304	32	32	30	30	irinotecan	IFL	PA450085	3439	0.587
NULL	J_Biomed_Biotechnol_2011_Jul_6_2011_783528.nxml.txt.nlp	21785566	SENT230	2	2	7	7	sulfamethoxazole	NAT	PA451544	6046	0.587
NULL	AAPS_J_2011_Dec_22_14(1)_68-78.nxml.txt.nlp	22189899	SENT90	28	28	36	36	atorvastatin	OATP1B3	PA448500	28234	0.587
NULL	Mol_Cancer_2010_May_18_9_110.nxml.txt.nlp	20482802	SENT27	5	5	27	27	bortezomib	p53	PA10252	7157	0.587
NULL	Drugs_R_D_2011_Jun_27_11(2)_101-111.nxml.txt.nlp	21679003	SENT37	27	27	25	25	irinotecan	IFL	PA450085	3439	0.587
NULL	Europace_2014_Aug_19_16(8)_1145-1153.nxml.txt.nlp	24843051	SENT182	35	35	20	20	protamine	ACT	PA10366	12;11332;9457;641455	0.587
NULL	Environ_Health_Perspect_2012_Apr_24_120(4)_560-565.nxml.txt.nlp	22275727	SENT226	10	10	12	12	diethylstilbestrol	DES	PA449307	1674	0.587
NULL	J_Mol_Signal_2011_Oct_5_6_13.nxml.txt.nlp	21975218	SENT210	35	35	14	14	ethanol	FBS	PA448073	64319;26269	0.587
NULL	Cancer_Immunol_Immunother_2012_Jul_23_61(7)_1101-1111.nxml.txt.nlp	22193989	SENT205	10	10	6	6	oxaliplatin	STAT1	PA131285527	6772	0.587
NULL	Oncol_Lett_2014_Sep_11_8(3)_1222-1228.nxml.txt.nlp	25120693	SENT137	2	2	0	0	cisplatin	DDP	PA449014	1678	0.587
NULL	Arthritis_Res_Ther_2013_Mar_20_15(2)_R44.nxml.txt.nlp	23514433	SENT9	19	19	27	27	rituximab	MRI	PA451261	78996	0.586
NULL	Acta_Pharmacol_Sin_2013_Feb_12_34(2)_255-261.nxml.txt.nlp	23147557	SENT37	22	22	17	17	pioglitazone	PTPRD	PA450970	5789	0.586
NULL	Clin_Interv_Aging_2012_Dec_30_7_1-13.nxml.txt.nlp	22291468	SENT135	3	3	8	8	dronedarone	CYP2D6	PA153619853	1565	0.586
NULL	Cancer_Cell_Int_2011_Nov_17_11_40.nxml.txt.nlp	22088142	SENT104	0	0	11	11	doxorubicin	RAF1	PA449412	5894	0.586
NULL	Cell_Death_Dis_2011_Aug_11_2(8)_e190.nxml.txt.nlp	21833028	SENT59	0	0	6	6	doxorubicin	p38	PA449412	10598;1432;7965	0.586
NULL	J_Med_Life_2011_Feb_15_4(1)_11-20.nxml.txt.nlp	21505570	SENT192	10	10	14	14	diclofenac	URB	PA449293	151887	0.586
NULL	EMBO_Mol_Med_2011_May_3(5)_266-278.nxml.txt.nlp	21438154	SENT227	21	21	14	14	oxaliplatin	TRPA1	PA131285527	8989	0.586
NULL	Infect_Dis_Rep_2012_Apr_3_4(2)_e26.nxml.txt.nlp	24470940	SENT99	35	35	21	21	benzaldehyde	PTB	PA448571	58155	0.586
NULL	Cancer_Cell_Int_2007_Jun_8_7_11.nxml.txt.nlp	17559657	SENT47	30	30	14	14	estradiol	IL6	PA449503	3569	0.586
NULL	Cell_Commun_Signal_2014_May_15_12_34.nxml.txt.nlp	24885272	SENT167	3	3	12	12	heparin	FGF2	PA449855	2247;2258	0.586
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT229	16	16	9	9	nutlin-3	p53		7157	0.586
NULL	Hum_Psychopharmacol_2012_Sep_20_27(5)_492-498.nxml.txt.nlp	22996616	SENT150	13	13	6	6	quetiapine	AAP	PA451201	5345	0.586
NULL	Diabetes_Metab_Syndr_Obes_2014_Jul_17_7_313-319.nxml.txt.nlp	25092992	SENT17	1	1	4	4	pioglitazone	adiponectin	PA450970	9370	0.586
NULL	Cell_Death_Differ_2010_Mar_16_17(3)_499-512.nxml.txt.nlp	19834490	SENT117	5	5	10	10	bevacizumab	VEGFR1	PA130232992	2321	0.586
NULL	Oncoimmunology_2012_May_1_1(3)_326-333.nxml.txt.nlp	22737608	SENT66	0	0	2	2	cyclophosphamide	CTX	PA449165	1593	0.586
NULL	Cancer_Cell_Int_2013_Oct_11_13_97.nxml.txt.nlp	24119761	SENT120	17	17	6	6	trastuzumab	EGF	PA451743	1950	0.586
NULL	Cancers_(Basel)_2011_Apr_1_3(2)_1844-1860.nxml.txt.nlp	24212785	SENT42	11	11	15	15	cetuximab	ACRC	PA10040	93953	0.586
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2607-2618.nxml.txt.nlp	24129234	SENT126	41	41	28	28	ethanol	CO2	PA448073	4513	0.586
NULL	J_Int_Soc_Sports_Nutr_2013_Aug_22_10_39.nxml.txt.nlp	23967897	SENT260	2	2	10	10	betaine	IRS1	PA448603	3667	0.586
NULL	Gut_Liver_2013_Jul_20_7(4)_458-461.nxml.txt.nlp	23898387	SENT16	20	20	9	9	ribavirin	IFN	PA451241	3439	0.586
NULL	Alcohol_Res_Health_2007_30(1)_38-47.nxml.txt.nlp	17718399	SENT229	11	11	19	19	oxygen	CYP2E1	PA450744	1571	0.586
NULL	Mol_Cancer_2009_Aug_25_8_66.nxml.txt.nlp	19706164	SENT101	10	10	12	12	celecoxib	p53	PA448871	7157	0.586
NULL	Diabetes_2013_Oct_17_62(10)_3316-3323.nxml.txt.nlp	23818527	SENT268	42	42	7	7	liraglutide	GLP-1	PA165958364	100125288	0.586
NULL	Ann_Oncol_2009_Aug_20(Suppl_6)_vi41-vi50.nxml.txt.nlp	19617297	SENT51	33	33	27	27	temozolomide	IL-2	PA451609	3558	0.586
NULL	Pharmaceuticals_(Basel)_2013_Aug_2_6(8)_915-928.nxml.txt.nlp	24276376	SENT414	7	7	10	10	thrombin	PAR-1	PA451674	2011;2149	0.586
NULL	Head_Face_Med_2010_Jul_19_6_17.nxml.txt.nlp	20642842	SENT99	11	11	19	19	glutaraldehyde	mol	PA449777	90527	0.586
NULL	Acta_Pharmacol_Sin_2013_Apr_18_34(4)_555-560.nxml.txt.nlp	23503472	SENT38	25	25	18	18	cyclosporine	ABCB1	PA449167	5243	0.586
NULL	J_Cell_Biol_2003_Aug_18_162(4)_587-597.nxml.txt.nlp	12913114	SENT17	42	42	17	17	staurosporine	BiP	PA165109623	3309	0.586
NULL	Int_J_Nanomedicine_2012_Sep_21_7_5091-5106.nxml.txt.nlp	23049256	SENT288	7	7	9	9	protamine	SOD1	PA10366	6647	0.586
NULL	Exp_Diabetes_Res_2008_Jan_4_2008_704045.nxml.txt.nlp	19132099	SENT215	7	7	23	23	berberine	AMPK	PA165860812	5563	0.586
NULL	J_Clin_Biochem_Nutr_2010_Jan_29_46(1)_20-29.nxml.txt.nlp	20104261	SENT89	15	15	26	26	estradiol	PTH	PA449503	5741	0.586
NULL	Cardiol_Ther_2013_Jun_7_2(1)_57-68.nxml.txt.nlp	25135289	SENT60	2	2	5	5	thrombin	PAR-1	PA451674	2011;2149	0.586
NULL	Oncotarget_2013_Jun_4_4(5)_772-784.nxml.txt.nlp	23800712	SENT163	15	15	11	11	bortezomib	EGFR	PA10252	1956	0.586
NULL	Br_J_Cancer_2013_Mar_19_108(5)_1052-1060.nxml.txt.nlp	23422754	SENT181	13	13	7	7	paclitaxel	VEGF-A	PA450761	7422	0.586
NULL	Int_J_Emerg_Med_2010_May_12_3(2)_133-134.nxml.txt.nlp	20606823	SENT26	15	15	9	9	atropine	PAM	PA448505	5066;23077	0.586
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1075.nxml.txt.nlp	24556690	SENT263	13	13	11	11	spermine	SSAT	PA164781199	6303	0.586
NULL	J_Asthma_Allergy_2008_Sep_19_1_19-29.nxml.txt.nlp	21436982	SENT113	0	0	7	7	fexofenadine	IL-6	PA449621	3569	0.586
NULL	Br_J_Cancer_2001_Mar_84(5)_670-673.nxml.txt.nlp	11237388	SENT5	22	22	24	24	curcumin	JNK	PA151958596	5599	0.586
NULL	Gut_Pathog_2012_Jul_16_4_7.nxml.txt.nlp	22800501	SENT75	10	10	8	8	cefotaxime	CTX	PA448852	1593	0.586
NULL	Indian_J_Endocrinol_Metab_2013_Jul-Aug_17(4)_636-646.nxml.txt.nlp	23961479	SENT138	19	19	9	9	pravastatin	CYP3A4	PA451089	1576	0.586
NULL	Ethiop_J_Health_Sci_2010_Mar_20(1)_41-48.nxml.txt.nlp	22434959	SENT115	36	36	26	26	ampicillin	Gen	PA448419	348654	0.586
NULL	Cancers_(Basel)_2013_Aug_14_5(3)_1020-1048.nxml.txt.nlp	24202332	SENT291	2	2	16	16	estradiol	zeta	PA449503	9907	0.586
NULL	Exp_Lung_Res_2009_Jun_9_35(5)_411-426.nxml.txt.nlp	19842842	SENT217	0	0	15	15	simvastatin	Rho	PA451363	29984	0.586
NULL	Indian_J_Med_Res_2011_Jun_133(6)_581-593.nxml.txt.nlp	21727656	SENT75	15	15	17	17	diethylstilbestrol	DES	PA449307	1674	0.586
NULL	J_Biomed_Biotechnol_2004_Apr_27_2004(1)_52-60.nxml.txt.nlp	15123888	SENT97	12	12	14	14	genistein	Gen	PA165109660	348654	0.586
NULL	Biochimie_2010_Nov_92(11)_1546-1567.nxml.txt.nlp	20615447	SENT354	38	38	29	29	chymotrypsin	KLK3	PA448994	354	0.586
NULL	J_Korean_Med_Sci_2006_Dec_31_21(6)_973-978.nxml.txt.nlp	17179671	SENT167	10	10	8	8	cefotaxime	CTX	PA448852	1593	0.586
NULL	Cancer_Immunol_Immunother_2011_Jun_25_60(6)_793-808.nxml.txt.nlp	21350947	SENT220	43	43	40	40	sorafenib	IFN	PA7000	3439	0.586
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_127043.nxml.txt.nlp	23227093	SENT27	35	35	28	28	lovastatin	P-gp	PA450272	5243	0.586
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT168	32	32	34	34	methotrexate	MSH2	PA450428	4436	0.586
NULL	Diabetes_Care_2013_Jun_15_36(6)_1765-1771.nxml.txt.nlp	23704676	SENT181	10	10	22	22	metformin	B12	PA450395	7126;4709	0.586
NULL	J_Invest_Dermatol_2012_Apr_22_132(4)_1253-1262.nxml.txt.nlp	22189789	SENT279	9	9	16	16	capsaicin	TRPV3	PA448776	162514	0.586
NULL	Bioinformation_2012_Jan_6_8(1)_13-19.nxml.txt.nlp	22359429	SENT165	2	2	4	4	curcumin	MRP1	PA151958596	4437	0.586
NULL	Pharmaceuticals_(Basel)_2011_May_31_4(6)_794-803.nxml.txt.nlp	NULL	SENT286	13	13	15	15	amiodarone	NIF	PA448383	6280	0.586
NULL	Biosci_Rep_2014_Aug_6_34(4)_e00131.nxml.txt.nlp	24975826	SENT184	9	9	11	11	pp2	TRPA1		8989	0.586
NULL	Br_J_Cancer_1998_Sep_78(5)_625-630.nxml.txt.nlp	9744503	SENT10	23	23	26	26	tegafur	mol	PA452620	90527	0.586
NULL	Case_Rep_Oncol_2012_Jul_3_5(2)_339-346.nxml.txt.nlp	22807902	SENT53	14	14	22	22	doxorubicin	CHOP	PA449412	1649	0.586
NULL	Angiogenesis_2011_Dec_11_14(4)_481-489.nxml.txt.nlp	21833622	SENT157	27	27	7	7	sunitinib	LARC	PA162372840	6364	0.586
NULL	J_Antimicrob_Chemother_2014_Apr_2_69(4)_911-918.nxml.txt.nlp	24302651	SENT39	2	2	20	20	oxacillin	FUS	PA450725	2521	0.586
NULL	Breast_Cancer_Res_2000_Feb_21_2(2)_125-132.nxml.txt.nlp	11250702	SENT175	16	16	4	4	urokinase	SMAD4	PA451836	4089	0.586
NULL	Crit_Care_2006_Feb_3_10(1)_R24.nxml.txt.nlp	16469128	SENT149	13	13	19	19	heparin	TP1	PA449855	7011	0.586
NULL	FASEB_J_2011_Oct_25(10)_3465-3476.nxml.txt.nlp	21715680	SENT82	31	31	42	42	l-glutamine	CO2	PA10090	4513	0.586
NULL	J_Thromb_Haemost_2014_May_22_12(5)_748-760.nxml.txt.nlp	24612393	SENT17	0	0	32	32	thrombin	TSC2	PA451674	7249	0.586
NULL	Mol_Biol_Cell_2012_Jun_1_23(11)_2017-2027.nxml.txt.nlp	22496424	SENT114	43	43	37	37	warfarin	PRDX4	PA451906	10549	0.586
NULL	Ann_Rehabil_Med_2012_Aug_27_36(4)_561-564.nxml.txt.nlp	22977784	SENT65	19	19	11	11	clonazepam	LAS	PA449050	11019	0.586
NULL	J_Int_Soc_Sports_Nutr_2014_May_12_11_20.nxml.txt.nlp	24864135	SENT323	5	5	13	13	creatine	CEE	PA164778930	51608	0.586
NULL	Ther_Clin_Risk_Manag_2007_Jun_3(2)_259-268.nxml.txt.nlp	18360634	SENT60	14	14	11	11	natalizumab	IFN	PA164747191	3439	0.586
NULL	Harm_Reduct_J_2010_Jul_19_7_17.nxml.txt.nlp	20642849	SENT46	18	18	10	10	buprenorphine	OST	PA448685	1650;23263	0.586
NULL	Acta_Pharmacol_Sin_2012_May_26_33(5)_675-681.nxml.txt.nlp	22447226	SENT103	7	7	21	21	gefitinib	SKP2	PA131301952	6502	0.586
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT44	28	28	22	22	pertuzumab	HER-2		2064	0.586
NULL	Oncol_Lett_2013_Oct_24_6(4)_970-976.nxml.txt.nlp	24137447	SENT165	2	2	0	0	doxorubicin	ADM	PA449412	133	0.586
NULL	Nat_Med_2010_Nov_24_16(11)_1299-1304.nxml.txt.nlp	20972434	SENT32	9	9	7	7	colchicine	ASM	PA449092	6609;283120	0.586
NULL	Diabetes_Metab_J_2014_Dec_15_38(6)_449-455.nxml.txt.nlp	25541608	SENT86	24	24	38	38	metformin	DPP4	PA450395	1803	0.586
NULL	Ann_Surg_Oncol_2011_Feb_4_18(2)_321-327.nxml.txt.nlp	21049306	SENT191	19	19	17	17	melphalan	gamma	PA450354	9913	0.586
NULL	Ann_Neurosci_2011_Apr_18(2)_76-83.nxml.txt.nlp	25205926	SENT6	22	22	6	6	selegiline	COMT	PA451316	1312	0.586
NULL	Clin_Ophthalmol_2011_Apr_26_5_517-525.nxml.txt.nlp	21573041	SENT99	8	8	11	11	apraclonidine	BAK	PA164748866	578	0.586
NULL	Br_J_Pharmacol_2014_Sep_28_171(18)_4255-4272.nxml.txt.nlp	24846338	SENT49	0	0	15	15	fluoxetine	gamma	PA449673	9913	0.586
NULL	Int_J_Med_Sci_2015_Jan_1_12(1)_63-71.nxml.txt.nlp	25552920	SENT115	2	2	42	42	berberine	BMP7	PA165860812	655	0.586
NULL	Avicenna_J_Phytomed_2014_Jul-Aug_4(4)_287-296.nxml.txt.nlp	25068143	SENT63	5	5	2	2	carrageenan	castor	PA448814	54897	0.586
NULL	Nucleic_Acids_Res_2008_Jan_11_36(1)_e1.nxml.txt.nlp	18073192	SENT32	25	25	40	40	l-glutamine	CO2	PA10090	4513	0.586
NULL	Eur_J_Med_Res_2011_Apr_28_16(4)_139-144.nxml.txt.nlp	21486727	SENT157	22	22	6	6	fluconazole	NNT	PA449653	23530	0.586
NULL	Exp_Mol_Med_2012_May_31_44(5)_311-318.nxml.txt.nlp	22282402	SENT56	2	2	9	9	cilostazol	MCP-1	PA164746334	6347	0.586
NULL	Arthritis_Rheum_2013_Sep_26_65(9)_2290-2300.nxml.txt.nlp	23740547	SENT57	24	24	26	26	doxycycline	DIP	PA449415	23151;1831	0.586
NULL	Int_J_Mol_Sci_2012_Feb_24_13(3)_2590-2617.nxml.txt.nlp	22489113	SENT243	14	14	21	21	benzaldehyde	mol	PA448571	90527	0.586
NULL	Chin_J_Cancer_2012_Feb_31(2)_110-118.nxml.txt.nlp	22098951	SENT30	19	19	12	12	imatinib	P-gp	PA10804	5243	0.586
NULL	Diabetes_2013_Jun_17_62(6)_1800-1807.nxml.txt.nlp	23704521	SENT105	4	4	6	6	metformin	SIRT1	PA450395	23411	0.586
NULL	Arthritis_Res_Ther_2009_Feb_3_11(1)_R15.nxml.txt.nlp	19192274	SENT212	31	31	9	9	chloroquine	IL-6	PA448948	3569	0.586
NULL	J_Clin_Biochem_Nutr_2007_Nov_30_41(3)_224-230.nxml.txt.nlp	18299720	SENT215	32	32	12	12	nitrogen	DBP	PA450643	3295;1628;2638	0.586
NULL	Nat_Med_2013_Mar_10_19(3)_313-321.nxml.txt.nlp	23396211	SENT50	0	0	4	4	amlexanox	TBK1	PA164745310	29110	0.586
NULL	Addiction_2014_Aug_27_109(8)_1338-1352.nxml.txt.nlp	24861844	SENT154	14	14	8	8	methamphetamine	AMPH	PA450403	273	0.586
NULL	Indian_J_Dermatol_2012_Sep-Oct_57(5)_371-374.nxml.txt.nlp	23112357	SENT190	0	0	2	2	cyclophosphamide	CTX	PA449165	1593	0.586
NULL	Diabetes_2008_Sep_57(9)_2332-2340.nxml.txt.nlp	18567824	SENT39	9	9	14	14	atropine	ghrelin	PA448505	51738	0.586
NULL	Mol_Cancer_2009_Jul_3_8_43.nxml.txt.nlp	19575780	SENT130	45	45	18	18	colchicine	survivin	PA449092	332	0.586
NULL	Br_J_Cancer_2012_Feb_14_106(4)_685-692.nxml.txt.nlp	22294184	SENT194	5	5	8	8	docetaxel	survivin	PA449383	332	0.586
NULL	Oncogene_2014_Aug_28_33(35)_4396-4406.nxml.txt.nlp	24531714	SENT57	26	26	28	28	nutlin-3	p53		7157	0.586
NULL	Ann_Oncol_2010_Jan_21(1)_133-139.nxml.txt.nlp	20019090	SENT92	0	0	3	3	tositumomab	CHOP	PA164748364	1649	0.586
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT113	5	5	7	7	resveratrol	TRAIL		8743	0.586
NULL	Clin_Med_Insights_Oncol_2011_Sep_21_5_315-323.nxml.txt.nlp	22084620	SENT126	23	23	29	29	gemcitabine	TRAIL	PA449748	8743	0.586
NULL	Oncotarget_2013_Jul_7_4(7)_1065-1074.nxml.txt.nlp	23867252	SENT46	4	4	16	16	trypsin	Hsp90	PA451806	3320	0.586
NULL	Aging_(Albany_NY)_2013_Feb_21_5(2)_94-95.nxml.txt.nlp	23518473	SENT9	9	9	11	11	resveratrol	SIRT1		23411	0.586
NULL	Can_Geriatr_J_2013_Jun_3_16(2)_66-103.nxml.txt.nlp	NULL	SENT672	27	27	4	4	donepezil	NMA	PA449394	25805	0.586
NULL	Mol_Pain_2014_Feb_6_10_10.nxml.txt.nlp	24499354	SENT330	31	31	8	8	clodronate	CTX	PA10239	1593	0.586
NULL	Ann_Surg_Oncol_2014_Feb_13_21(5)_1575-1582.nxml.txt.nlp	24522992	SENT187	6	6	10	10	tamoxifen	ERBB2	PA451581	2064	0.586
NULL	Eur_J_Nutr_2015_Oct_9_54_1-24.nxml.txt.nlp	25296886	SENT368	1	1	3	3	lipase	MGLL	PA450239	11343	0.586
NULL	Mucosal_Immunol_2014_May_25_7(3)_549-557.nxml.txt.nlp	24064666	SENT8	0	0	3	3	indomethacin	COX	PA449982	1351	0.586
NULL	Br_J_Cancer_2000_Sep_16_83(5)_588-593.nxml.txt.nlp	10944597	SENT1	11	11	25	25	temozolomide	PCB	PA451609	5091	0.586
NULL	Open_Dent_J_2013_Apr_5_7_36-46.nxml.txt.nlp	23802022	SENT175	38	38	9	9	teriparatide	CAL	PA451620	54751;57120	0.586
NULL	J_Anaesthesiol_Clin_Pharmacol_2012_Jul-Sep_28(3)_339-343.nxml.txt.nlp	22869941	SENT105	5	5	0	0	fentanyl	STA	PA449599	2010;2656	0.586
NULL	Cancers_(Basel)_2014_Sep_30_6(4)_2035-2048.nxml.txt.nlp	25271833	SENT2	15	15	13	13	gefitinib	IL-2	PA131301952	3558	0.586
NULL	J_Korean_Med_Sci_2007_Dec_20_22(6)_963-967.nxml.txt.nlp	18162707	SENT52	28	28	7	7	pyrazinamide	DST	PA451182	667	0.586
NULL	Chonnam_Med_J_2013_Dec_23_49(3)_125-128.nxml.txt.nlp	24400215	SENT5	7	7	17	17	lipase	PTH	PA450239	5741	0.586
NULL	Breast_Cancer_Res_2010_Jun_28_12(3)_R43.nxml.txt.nlp	20579400	SENT235	26	26	6	6	tamoxifen	MAPT	PA451581	4137	0.586
NULL	Osteoporos_Int_2013_Oct_19_24(1)_23-57.nxml.txt.nlp	23079689	SENT516	2	2	0	0	teriparatide	PTH	PA451620	5741	0.586
NULL	Cancer_Med_2014_Dec_1_3(6)_1493-1501.nxml.txt.nlp	25081631	SENT33	12	12	2	2	erlotinib	FDG	PA134687924	23583	0.586
NULL	Acta_Pharmacol_Sin_2012_Jan_28_33(1)_66-74.nxml.txt.nlp	22120966	SENT154	3	3	20	20	genistein	RANKL	PA165109660	8600	0.586
NULL	J_Headache_Pain_2011_Aug_25_12(4)_399-403.nxml.txt.nlp	21437713	SENT94	1	1	17	17	naratriptan	OTC	PA450597	5009	0.586
NULL	Mol_Biol_Cell_2013_Sep_1_24(17)_2678-2688.nxml.txt.nlp	23864716	SENT251	19	19	11	11	thrombin	Rho	PA451674	29984	0.586
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Jun_27_5_15.nxml.txt.nlp	16803618	SENT284	14	14	16	16	gentamicin	LTA	PA449753	4049	0.586
NULL	Environ_Health_Perspect_2008_Mar_26_116(3)_322-328.nxml.txt.nlp	18335098	SENT186	18	18	8	8	estradiol	PMI	PA449503	8834;5373	0.586
NULL	J_Cell_Biol_1998_Aug_10_142(3)_625-633.nxml.txt.nlp	9700154	SENT96	11	11	26	26	estradiol	p38	PA449503	10598;1432;7965	0.586
NULL	Diabetes_2011_Mar_21_60(3)_1008-1018.nxml.txt.nlp	21282362	SENT319	7	7	34	34	lipase	EARS	PA450239	2058	0.586
NULL	Alcohol_Res_Health_2010_33(1-2)_109-117.nxml.txt.nlp	23579941	SENT52	29	29	31	31	vasopressin	AVP	PA451858	114548;551	0.586
NULL	BMB_Rep_2013_Oct_46(10)_484-489.nxml.txt.nlp	24148768	SENT19	0	0	14	14	thrombin	VIII	PA451674	1351	0.586
NULL	Crit_Care_2005_Sep_9_9(2)_212-222.nxml.txt.nlp	15774080	SENT252	12	12	6	6	phenylephrine	AVP	PA450935	114548;551	0.586
NULL	J_Clin_Biochem_Nutr_2009_Sep_28_45(2)_178-184.nxml.txt.nlp	19794926	SENT114	11	11	17	17	collagenase	AP-1	PA449107	2353;3727;2354;3725	0.586
NULL	Acta_Vet_Scand_2012_Feb_24_54(Suppl_1)_S13.nxml.txt.nlp	NULL	SENT10	4	4	6	6	diethylstilbestrol	DES	PA449307	1674	0.586
NULL	Breast_Cancer_Res_2007_Apr_10_9(2)_R25.nxml.txt.nlp	17428314	SENT212	35	35	14	14	tetracycline	CKS2	PA451640	1164	0.586
NULL	BMJ_Open_2013_Dec_18_3(12)_e003815.nxml.txt.nlp	24353255	SENT122	14	14	16	16	levonorgestrel	UPA	PA450218	118471;5328	0.586
NULL	Br_J_Cancer_2013_Sep_3_109(5)_1279-1286.nxml.txt.nlp	23949154	SENT133	4	4	13	13	flutamide	PC-3	PA449685	692094	0.586
NULL	Breast_Cancer_Res_2004_Jun_29_6(5)_R488-R498.nxml.txt.nlp	15318931	SENT155	7	7	14	14	estradiol	UGT2B4	PA449503	7363	0.586
NULL	Case_Rep_Dent_2013_Jul_10_2013_812323.nxml.txt.nlp	23936686	SENT96	18	18	10	10	hyaluronan	CD34	PA165958431	947	0.586
NULL	Tumour_Biol_2014_Aug_12_35(8)_7807-7819.nxml.txt.nlp	24817012	SENT271	25	25	13	13	cisplatin	ERCC1	PA449014	2067	0.586
NULL	Iran_J_Reprod_Med_2013_Aug_11(8)_611-618.nxml.txt.nlp	24639797	SENT35	0	0	2	2	metformin	MTF	PA450395	4500	0.586
NULL	Front_Genet_2012_Nov_5_3_236.nxml.txt.nlp	23133441	SENT88	32	32	0	0	efavirenz	ABCB1	PA449441	5243	0.586
NULL	Oxid_Med_Cell_Longev_2013_Nov_28_2013_568093.nxml.txt.nlp	24379901	SENT114	0	0	22	22	resveratrol	SIRT1		23411	0.586
NULL	Mol_Cancer_2009_Nov_24_8_109.nxml.txt.nlp	19930708	SENT73	12	12	19	19	exemestane	aromatase	PA449563	1588	0.586
NULL	Stroke_Res_Treat_2009_Dec_20_2010_386389.nxml.txt.nlp	20700422	SENT35	16	16	10	10	pioglitazone	NAC	PA450970	22861	0.586
NULL	Evid_Based_Complement_Alternat_Med_2013_Aug_28_2013_516017.nxml.txt.nlp	24066014	SENT141	8	8	19	19	doxorubicin	p47phox	PA449412	653361	0.586
NULL	Br_J_Cancer_2010_May_11_102(10)_1483-1490.nxml.txt.nlp	20407444	SENT223	12	12	19	19	doxorubicin	IFN	PA449412	3439	0.586
NULL	Nat_Genet_2010_Mar_31_42(3)_268-271.nxml.txt.nlp	20101240	SENT58	4	4	11	11	artesunate	ACT	PA165111697	12;11332;9457;641455	0.586
NULL	Indian_J_Dermatol_2013_Jul-Aug_58(4)_313-314.nxml.txt.nlp	23919006	SENT45	18	18	20	20	methotrexate	TNF-alpha	PA450428	7124	0.586
NULL	J_Vet_Med_Sci_2014_Oct_7_76(10)_1367-1374.nxml.txt.nlp	24998396	SENT328	0	0	12	12	resveratrol	XIAP		331	0.586
NULL	Exp_Ther_Med_2013_Oct_19_6(4)_1070-1076.nxml.txt.nlp	24137319	SENT201	2	2	0	0	cyclophosphamide	CTX	PA449165	1593	0.586
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1437-1448.nxml.txt.nlp	24056706	SENT111	22	22	16	16	quinidine	CYP2C9	PA451209	1559	0.586
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Jun_27_5_15.nxml.txt.nlp	16803618	SENT178	26	26	42	42	ciprofloxacin	GEN1	PA449009	348654	0.586
NULL	J_Cell_Biol_1998_Nov_2_143(3)_795-813.nxml.txt.nlp	9813098	SENT86	25	25	38	38	l-glutamine	CO2	PA10090	4513	0.586
NULL	Neural_Plast_2008_Nov_17_2008_401645.nxml.txt.nlp	19043593	SENT147	11	11	18	18	carbachol	gamma	PA448784	9913	0.586
NULL	Iran_Red_Crescent_Med_J_2014_Jun_5_16(6)_e18022.nxml.txt.nlp	25068053	SENT113	19	19	8	8	estradiol	BMD	PA449503	1756;7439	0.586
NULL	Acta_Orthop_2009_Feb_26_80(1)_46-50.nxml.txt.nlp	19234885	SENT113	27	27	24	24	celecoxib	TKR	PA448871	8277	0.586
NULL	Diabetologia_2010_Jun_27_53(6)_1142-1150.nxml.txt.nlp	20349036	SENT145	0	0	3	3	spermine	AMPK	PA164781199	5563	0.586
NULL	Int_J_Mol_Sci_2012_Dec_7_13(12)_16751-16768.nxml.txt.nlp	23222680	SENT170	28	28	37	37	rasagiline	LSD2	PA164764584	221656	0.586
NULL	Clin_Mol_Hepatol_2014_Sep_25_20(3)_267-273.nxml.txt.nlp	25320730	SENT156	2	2	0	0	lamivudine	LAM	PA450163	7249;7248	0.586
NULL	Br_J_Haematol_2014_Apr_30_165(2)_204-216.nxml.txt.nlp	24588354	SENT181	17	17	3	3	thrombin	PRKCD	PA451674	5580	0.586
NULL	Curr_Cardiol_Rev_2009_Aug_5(3)_243-250.nxml.txt.nlp	20676284	SENT108	18	18	26	26	nadh	ADP	PA164755085	23038	0.586
NULL	Cell_Commun_Signal_2014_Sep_10_12(1)_56.nxml.txt.nlp	NULL	SENT156	38	38	30	30	chloroquine	BAF	PA448948	8815	0.586
NULL	Core_Evid_2010_Jul_27_5_1-10.nxml.txt.nlp	20694135	SENT168	26	26	28	28	entacapone	CLE	PA164748726	51637	0.586
NULL	J_Med_Case_Reports_2008_Mar_31_2_94.nxml.txt.nlp	18373879	SENT80	2	2	4	4	tenofovir	CYP1A2	PA10204	1544	0.586
NULL	Drugs_R_D_2011_Jun_27_11(2)_113-126.nxml.txt.nlp	21679004	SENT94	0	0	23	23	axitinib	CYP2C19	PA164924493	1557	0.586
NULL	Afr_J_Infect_Dis_2010_4(2)_29-42.nxml.txt.nlp	23878698	SENT7	24	24	21	21	chloroquine	ACT	PA448948	12;11332;9457;641455	0.586
NULL	Cases_J_2008_Aug_19_1_112.nxml.txt.nlp	18713450	SENT120	15	15	5	5	phenytoin	CDP	PA450947	1523	0.586
NULL	Hum_Genomics_2004_Aug_1_1(5)_375-380.nxml.txt.nlp	15588498	SENT221	6	6	4	4	debrisoquine	CYP2D6	PA452616	1565	0.586
NULL	J_Cancer_Prev_2014_Mar_19(1)_39-46.nxml.txt.nlp	25337571	SENT84	8	8	14	14	ethanol	JNK	PA448073	5599	0.586
NULL	Mol_Cancer_2009_Jul_31_8_54.nxml.txt.nlp	19646236	SENT220	11	11	13	13	galactose	TBX2	PA449725	6909	0.586
NULL	Arthritis_Res_Ther_2006_Jul_21_8(4)_R130.nxml.txt.nlp	16859540	SENT271	0	0	2	2	atorvastatin	CD59	PA448500	966	0.586
NULL	Oxid_Med_Cell_Longev_2012_Jan_19_2012_390678.nxml.txt.nlp	22315655	SENT174	30	30	25	25	ethanol	NAC	PA448073	22861	0.586
NULL	Curr_Gerontol_Geriatr_Res_2011_May_11_2011_624156.nxml.txt.nlp	21765826	SENT285	23	23	29	29	midazolam	CYP3A4	PA450496	1576	0.586
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT77	12	12	19	19	l-cysteine	p27	PA449173	5715;10534	0.586
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT54	46	46	44	44	vinorelbine	ASC	PA451881	29108	0.586
NULL	Virol_J_2012_Feb_16_9_42.nxml.txt.nlp	22339884	SENT193	43	43	45	45	thrombin	PAR1	PA451674	79581;2149	0.586
NULL	Biologics_2012_Dec_17_6_429-464.nxml.txt.nlp	23269860	SENT199	6	6	9	9	sulfasalazine	ACR	PA451547	49	0.586
NULL	Acta_Orthop_2014_Apr_20_85(2)_141-146.nxml.txt.nlp	24650022	SENT21	22	22	28	28	ropivacaine	PAO	PA451271	196743;54498	0.586
NULL	J_Med_Genet_2014_Aug_51(8)_537-544.nxml.txt.nlp	24987033	SENT262	13	13	15	15	lipase	LIPA	PA450239	3988;10648	0.586
NULL	Oncoimmunology_2013_Mar_1_2(3)_e23336.nxml.txt.nlp	23802076	SENT39	22	22	32	32	mitomycin	LBH	PA450524	81606;221491	0.586
NULL	Cancer_Med_2014_Oct_18_3(5)_1294-1301.nxml.txt.nlp	24941936	SENT214	22	22	9	9	sunitinib	FDG	PA162372840	23583	0.586
NULL	Arthritis_Res_Ther_2014_Jul_24_16(4)_R157.nxml.txt.nlp	25059342	SENT267	8	8	18	18	bleomycin	IL-6	PA448645	3569	0.586
NULL	Pediatr_Infect_Dis_J_2013_Sep_26_32(Suppl_1_Innovative_Treatment_Regimens_for_Severe_Infections_in_Young_Infants)_S33-S38.nxml.txt.nlp	23945574	SENT270	3	3	25	25	amoxicillin	MASS	PA448406	2200	0.586
NULL	Crit_Care_2008_Apr_10_12(2)_132.nxml.txt.nlp	18423065	SENT12	22	22	14	14	phenylephrine	AVP	PA450935	114548;551	0.586
NULL	Ann_Rehabil_Med_2014_Aug_28_38(4)_433-442.nxml.txt.nlp	25229021	SENT231	11	11	29	29	tamsulosin	VIT	PA451583	5212	0.585
NULL	Br_J_Cancer_2012_Jan_17_106(2)_348-357.nxml.txt.nlp	22146521	SENT155	24	24	18	18	hyaluronan	LYVE-1	PA165958431	10894	0.585
NULL	Int_J_Mol_Sci_2012_Feb_24_13(3)_2590-2617.nxml.txt.nlp	22489113	SENT250	14	14	21	21	benzaldehyde	mol	PA448571	90527	0.585
NULL	J_Immunol_Res_2014_May_12_2014_897249.nxml.txt.nlp	24901013	SENT142	12	12	34	34	natalizumab	TGFBR2	PA164747191	7048	0.585
NULL	J_Vis_Exp_2011_Feb_15_(48)_2389.nxml.txt.nlp	21372783	SENT51	3	3	13	13	trypsin	L15	PA451806	6138;91057	0.585
NULL	Mol_Biol_Cell_2014_Jul_1_25(13)_2116-2127.nxml.txt.nlp	24807908	SENT48	12	12	20	20	hemin	GAPDH	PA449849	2597	0.585
NULL	Indian_J_Anaesth_2014_Nov-Dec_58(6)_778-779.nxml.txt.nlp	25624557	SENT5	22	22	26	26	glutaraldehyde	ETO	PA449777	862	0.585
NULL	Case_Rep_Gastroenterol_2009_Aug_28_3(2)_240-247.nxml.txt.nlp	21103282	SENT86	8	8	5	5	azathioprine	CTX	PA448515	1593	0.585
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1150.nxml.txt.nlp	24675468	SENT103	8	8	6	6	ethanol	adiponectin	PA448073	9370	0.585
NULL	Mol_Vis_2007_Jul_9_13_1083-1093.nxml.txt.nlp	17653053	SENT163	0	0	26	26	minocycline	IL-10	PA450519	3586	0.585
NULL	J_Adv_Pharm_Technol_Res_2011_Jan-Mar_2(1)_39-42.nxml.txt.nlp	22171290	SENT53	16	16	5	5	atropine	castor	PA448505	54897	0.585
NULL	Sensors_(Basel)_2013_Dec_27_14(1)_458-467.nxml.txt.nlp	24379050	SENT105	28	28	25	25	glucose	MTB	PA449773	54892;4498	0.585
NULL	Indian_J_Med_Res_2013_Jun_137(6)_1102-1110.nxml.txt.nlp	23852291	SENT61	12	12	21	21	fluorescein	HEX	PA164746009	3087	0.585
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT110	3	3	6	6	perifosine	TRAIL	PA165291471	8743	0.585
NULL	Calcif_Tissue_Int_2011_Aug_3_89(2)_140-150.nxml.txt.nlp	21633782	SENT34	6	6	10	10	heparin	FGF23	PA449855	8074	0.585
NULL	Int_J_Med_Sci_2013_Feb_11_10(3)_320-330.nxml.txt.nlp	23423768	SENT89	11	11	13	13	erlotinib	EGFR	PA134687924	1956	0.585
NULL	J_Breast_Cancer_2011_Sep_29_14(3)_185-190.nxml.txt.nlp	22031799	SENT105	26	26	18	18	fulvestrant	EGFR	PA164747170	1956	0.585
NULL	Mar_Drugs_2011_Nov_2_9(11)_2188-2200.nxml.txt.nlp	22163181	SENT469	15	15	18	18	ethanol	ANOVA	PA448073	4858	0.585
NULL	Parasit_Vectors_2010_Sep_22_3_91.nxml.txt.nlp	20860829	SENT123	13	13	9	9	artesunate	ACT	PA165111697	12;11332;9457;641455	0.585
NULL	Int_J_Biol_Sci_2011_Nov_16_8(1)_39-48.nxml.txt.nlp	22211103	SENT126	12	12	14	14	heparin	CHI3L2	PA449855	1117	0.585
NULL	J_Public_Health_Res_2014_Mar_26_3(1)_204.nxml.txt.nlp	25170509	SENT99	7	7	38	38	buprenorphine	OST	PA448685	1650;23263	0.585
NULL	Acta_Vet_Scand_2008_Jul_4_50(1)_27.nxml.txt.nlp	18601734	SENT18	27	27	21	21	doxorubicin	MTSS1	PA449412	9788	0.585
NULL	Oncol_Lett_2014_Sep_19_8(3)_1269-1274.nxml.txt.nlp	25120704	SENT142	2	2	0	0	metformin	Met	PA450395	79811	0.585
NULL	Eur_J_Neurosci_2014_Feb_4_39(3)_419-434.nxml.txt.nlp	24494682	SENT135	2	2	4	4	lipase	MGL	PA450239	11343	0.585
NULL	Exp_Ther_Med_2012_Sep_25_4(3)_391-396.nxml.txt.nlp	23181105	SENT91	20	20	33	33	estradiol	aromatase	PA449503	1588	0.585
NULL	Angiogenesis_2013_Apr_10_16(2)_373-386.nxml.txt.nlp	23143659	SENT142	33	33	30	30	vincristine	ABCC2	PA451879	1244	0.585
NULL	Neural_Regen_Res_2013_Jun_25_8(18)_1702-1713.nxml.txt.nlp	25206467	SENT144	2	2	9	9	ethanol	CA1	PA448073	759	0.585
NULL	Emerg_Infect_Dis_2012_Feb_18(2)_302-304.nxml.txt.nlp	22305387	SENT113	32	32	10	10	itraconazole	CTX	PA450132	1593	0.585
NULL	Cancer_Med_2012_Aug_31_1(1)_89-95.nxml.txt.nlp	23342258	SENT34	16	16	18	18	cyclophosphamide	CTX	PA449165	1593	0.585
NULL	Cell_Death_Dis_2014_Jul_3_5(7)_e1311.nxml.txt.nlp	24991763	SENT344	14	14	16	16	ketamine	GluN1	PA450144	2902	0.585
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT181	2	2	7	7	curcumin	Bcl-2	PA151958596	596	0.585
NULL	Cell_Death_Dis_2014_Jul_17_5(7)_e1333.nxml.txt.nlp	25032856	SENT33	3	3	5	5	candesartan	EAAC1	PA448765	6505	0.585
NULL	Biosci_Rep_2012_Aug_1_32(Pt_4)_361-374.nxml.txt.nlp	22762204	SENT184	17	17	5	5	doxorubicin	LATS2	PA449412	26524	0.585
NULL	Mol_Cell_Endocrinol_2013_Jan_30_365(2)_303-308.nxml.txt.nlp	23178796	SENT155	0	0	24	24	rimonabant	ghrelin	PA152407999	51738	0.585
NULL	Case_Rep_Oncol_2014_Apr_25_7(1)_277-284.nxml.txt.nlp	24926257	SENT23	31	31	24	24	lenalidomide	p53	PA162363968	7157	0.585
NULL	J_Invest_Dermatol_2012_Sep_10_132(9)_2255-2262.nxml.txt.nlp	22572817	SENT215	30	30	25	25	forskolin	HBD3	PA146096022	414325	0.585
NULL	Front_Neurosci_2014_Dec_5_8_398.nxml.txt.nlp	25538552	SENT17	32	32	7	7	glucose	gamma	PA449773	9913	0.585
NULL	Curr_Biol_2009_Feb_24_19(4)_297-304.nxml.txt.nlp	19217292	SENT72	29	29	31	31	vasopressin	AVP	PA451858	114548;551	0.585
NULL	Clin_Ophthalmol_2007_Sep_1(3)_273-284.nxml.txt.nlp	19668481	SENT208	5	5	7	7	bevacizumab	CRT	PA130232992	811	0.585
NULL	Nucleic_Acids_Res_2006_Jun_27_34(10)_3181-3188.nxml.txt.nlp	16772402	SENT48	25	25	16	16	galactose	mol	PA449725	90527	0.585
NULL	Br_J_Cancer_2003_Mar_10_88(5)_648-653.nxml.txt.nlp	12659110	SENT156	17	17	29	29	tegafur	A-2	PA452620	27239	0.585
NULL	Cancer_Causes_Control_2013_Aug_18_24(8)_1605-1614.nxml.txt.nlp	23775025	SENT64	38	38	28	28	epirubicin	DHFR	PA449476	1719	0.585
NULL	Arthritis_Res_Ther_2012_Apr_26_14(2)_R90.nxml.txt.nlp	22537858	SENT41	0	0	6	6	atorvastatin	IFN	PA448500	3439	0.585
NULL	Front_Neurosci_2013_Jul_15_7_122.nxml.txt.nlp	23874266	SENT87	28	28	11	11	ethanol	gamma	PA448073	9913	0.585
NULL	Cell_Cycle_2013_May_15_12(10)_1492-1500.nxml.txt.nlp	23598717	SENT143	28	28	7	7	doxorubicin	ROCK2	PA449412	9475	0.585
NULL	Ann_Thorac_Med_2013_Apr-Jun_8(2)_109-115.nxml.txt.nlp	23741274	SENT165	9	9	14	14	docetaxel	CRT	PA449383	811	0.585
NULL	Cardiovasc_Drugs_Ther_2010_Dec_13_24(5-6)_391-399.nxml.txt.nlp	20640495	SENT108	9	9	11	11	simvastatin	DIP	PA451363	23151;1831	0.585
NULL	Ann_Gen_Psychiatry_2008_Aug_18_7_11.nxml.txt.nlp	18706108	SENT130	7	7	0	0	ethanol	BUP	PA448073	23412	0.585
NULL	Theranostics_2013_Nov_30_3(12)_943-952.nxml.txt.nlp	24396505	SENT69	11	11	25	25	thyroglobulin	CA125	PA164754910	4077;94025	0.585
NULL	Clin_Mol_Hepatol_2014_Sep_25_20(3)_267-273.nxml.txt.nlp	25320730	SENT163	6	6	0	0	entecavir	LAM	PA164784025	7249;7248	0.585
NULL	Oncotarget_2011_Sep_9_2(9)_658-668.nxml.txt.nlp	21911919	SENT30	20	20	8	8	cytarabine	HO-1	PA449177	3162	0.585
NULL	J_Hematol_Oncol_2013_Oct_12_6_78.nxml.txt.nlp	24283803	SENT174	10	10	13	13	daunorubicin	STAT3	PA449212	6774	0.585
NULL	J_Biomed_Sci_2014_Apr_17_21(1)_30.nxml.txt.nlp	24742230	SENT164	7	7	15	15	lovastatin	RANKL	PA450272	8600	0.585
NULL	F1000Prime_Rep_2014_Aug_1_6_64.nxml.txt.nlp	25165563	SENT127	29	29	19	19	aztreonam	VIM	PA448523	7431	0.585
NULL	Indian_J_Pharmacol_2009_Aug_41(4)_167-172.nxml.txt.nlp	20523867	SENT40	38	38	21	21	napqi	CYP2D6		1565	0.585
NULL	Front_Neurosci_2008_Dec_15_2(2)_135-136.nxml.txt.nlp	19225584	SENT17	5	5	15	15	choline	spatial	PA448976	219793	0.585
NULL	Clin_Ophthalmol_2014_Jun_26_8_1213-1219.nxml.txt.nlp	25061267	SENT178	20	20	9	9	tetracaine	PRK	PA451638	1263	0.585
NULL	Bioinorg_Chem_Appl_2013_Sep_19_2013_541030.nxml.txt.nlp	24170995	SENT9	18	18	24	24	amoxicillin	SBF	PA448406	7702	0.585
NULL	Front_Neurosci_2014_Nov_25_8_366.nxml.txt.nlp	25505376	SENT86	15	15	11	11	creatine	ADP	PA164778930	23038	0.585
NULL	Hum_Genomics_2011_Oct_1_5(6)_577-622.nxml.txt.nlp	22155605	SENT630	42	42	19	19	ribavirin	IL28B	PA451241	282617	0.585
NULL	Infect_Dis_Rep_2010_Feb_17_2(1)_e2.nxml.txt.nlp	24470885	SENT63	14	14	16	16	ciprofloxacin	COT	PA449009	54677	0.585
NULL	Arthritis_Res_Ther_2005_May_18_7(Suppl_3)_S2-S8.nxml.txt.nlp	15960819	SENT63	9	9	0	0	methotrexate	ACR	PA450428	49	0.585
NULL	Int_J_Mol_Sci_2014_Oct_28_15(11)_19650-19661.nxml.txt.nlp	25353180	SENT78	21	21	5	5	dextran	SEMA7A	PA449261	8482	0.585
NULL	F1000Res_2014_Mar_21_3_40.nxml.txt.nlp	24715979	SENT108	21	21	12	12	chlorpromazine	mol	PA448964	90527	0.585
NULL	Mol_Vis_2012_Jul_18_18_1973-1982.nxml.txt.nlp	22876124	SENT119	30	30	37	37	streptomycin	CO2	PA451512	4513	0.585
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1051.nxml.txt.nlp	24503543	SENT144	24	24	31	31	tamoxifen	Yes	PA451581	7525	0.585
NULL	Br_J_Pharmacol_2014_Apr_28_171(8)_1798-1817.nxml.txt.nlp	24116962	SENT239	5	5	17	17	bezafibrate	CPT2	PA162364313	1376	0.585
NULL	Braz_J_Med_Biol_Res_2014_Jan_10_47(1)_60-69.nxml.txt.nlp	24519092	SENT170	21	21	18	18	doxorubicin	YWHAZ	PA449412	7534	0.585
NULL	Arthritis_Res_Ther_2011_Oct_12_13(5)_R163.nxml.txt.nlp	21992149	SENT28	18	18	14	14	pamidronate	NIR	PA450767	26155	0.585
NULL	Cell_Death_Dis_2013_Jul_11_4(7)_e719.nxml.txt.nlp	23846221	SENT22	11	11	18	18	cisplatin	TRAIL	PA449014	8743	0.585
NULL	Front_Genet_2012_Nov_5_3_236.nxml.txt.nlp	23133441	SENT177	10	10	0	0	efavirenz	ABCB1	PA449441	5243	0.585
NULL	Breast_Cancer_Res_2012_Jun_19_14(3)_209.nxml.txt.nlp	22713170	SENT29	24	24	35	35	trastuzumab	VEGFR	PA451743	3791	0.585
NULL	Drug_Des_Devel_Ther_2014_Sep_23_8_1527-1538.nxml.txt.nlp	25284985	SENT214	41	41	31	31	celecoxib	IFN	PA448871	3439	0.585
NULL	Arch_Med_Sci_2013_Apr_20_9(2)_361-367.nxml.txt.nlp	23671450	SENT36	7	7	9	9	budesonide	HIF-1	PA448681	29072	0.585
NULL	Mar_Drugs_2012_Dec_11_10(12)_2782-2794.nxml.txt.nlp	23342393	SENT85	0	0	2	2	cyclophosphamide	CTX	PA449165	1593	0.585
NULL	Breast_Cancer_Res_2004_Nov_7_6(1)_39-52.nxml.txt.nlp	14680484	SENT157	25	25	28	28	tamoxifen	N-CoR	PA451581	9611	0.585
NULL	Oncotarget_2012_May_23_3(5)_518-524.nxml.txt.nlp	22643838	SENT74	4	4	6	6	imatinib	MYL	PA10804	5371	0.585
NULL	J_Anaesthesiol_Clin_Pharmacol_2012_Jul-Sep_28(3)_339-343.nxml.txt.nlp	22869941	SENT10	18	18	0	0	fentanyl	STA	PA449599	2010;2656	0.585
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_5.nxml.txt.nlp	23422286	SENT20	30	30	26	26	hydroxyurea	IFN	PA449942	3439	0.585
NULL	Front_Neurosci_2012_May_30_6_77.nxml.txt.nlp	22661925	SENT173	13	13	19	19	ethanol	HEC	PA448073	10403	0.585
NULL	Mol_Cancer_2009_Aug_25_8_66.nxml.txt.nlp	19706164	SENT80	2	2	4	4	celecoxib	p53	PA448871	7157	0.585
NULL	Int_J_Genomics_2014_Jan_29_2014_894296.nxml.txt.nlp	24616891	SENT171	9	9	14	14	ethanol	PC2	PA448073	5126;5311;8535	0.585
NULL	J_Breast_Cancer_2014_Dec_26_17(4)_332-338.nxml.txt.nlp	25548580	SENT63	13	13	9	9	capsaicin	TRPV1	PA448776	7442	0.585
NULL	Cell_Commun_Signal_2013_Feb_20_11_13.nxml.txt.nlp	23425659	SENT35	20	20	8	8	flunitrazepam	MCAD	PA164781320	34	0.585
NULL	Br_J_Cancer_2009_Jul_21_101(2)_269-277.nxml.txt.nlp	19603033	SENT115	6	6	14	14	cisplatin	MLH1	PA449014	4292	0.585
NULL	Exp_Ther_Med_2014_Aug_26_8(2)_371-376.nxml.txt.nlp	25009585	SENT126	3	3	18	18	fluorescein	PED	PA164746009	8682	0.585
NULL	Curr_Neuropharmacol_2008_Sep_6(3)_215-234.nxml.txt.nlp	19506722	SENT344	18	18	13	13	clonidine	5-HT1A	PA449051	3350	0.585
NULL	Cell_Res_2014_Jan_24_24(1)_105-121.nxml.txt.nlp	24366341	SENT227	25	25	45	45	l-glutamine	CO2	PA10090	4513	0.585
NULL	Int_J_Inflam_2014_Dec_24_2014_690596.nxml.txt.nlp	25610704	SENT238	7	7	4	4	oxygen	ROS	PA450744	6098	0.585
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT157	19	19	8	8	perifosine	JNK	PA165291471	5599	0.585
NULL	Arch_Med_Sci_2011_Dec_31_7(6)_977-983.nxml.txt.nlp	22328880	SENT23	1	1	5	5	heparin	PAPP-A	PA449855	5069	0.585
NULL	Br_J_Cancer_2012_Oct_23_107(9)_1488-1497.nxml.txt.nlp	23033007	SENT175	0	0	5	5	disulfiram	p38	PA449376	10598;1432;7965	0.585
NULL	Endocrinol_Diabetes_Metab_Case_Rep_2013_Aug_30_2013_130026.nxml.txt.nlp	24616766	SENT61	25	25	5	5	octreotide	IGF1	PA450678	3479	0.585
NULL	Indian_J_Endocrinol_Metab_2015_Jan-Feb_19(1)_30-38.nxml.txt.nlp	25593823	SENT105	13	13	15	15	sitagliptin	adiponectin	PA164748978	9370	0.585
NULL	Front_Neuroanat_2011_Jul_12_5_38.nxml.txt.nlp	21808606	SENT151	7	7	3	3	haloperidol	c-fos	PA449841	2353	0.585
NULL	AIDS_Res_Treat_2011_Jun_7_2011_354908.nxml.txt.nlp	21716719	SENT243	27	27	21	21	tenofovir	ABCC2	PA10204	1244	0.585
NULL	Hum_Genomics_2008_Sep_1_3(1)_7-16.nxml.txt.nlp	19129086	SENT146	0	0	5	5	rosiglitazone	SLCO1B1	PA451283	10599	0.585
NULL	J_Exp_Med_2000_Nov_20_192(10)_1501-1508.nxml.txt.nlp	11085751	SENT93	3	3	17	17	trypsin	HCC-1	PA451806	6358	0.585
NULL	Br_J_Cancer_2010_Jan_5_102(1)_97-103.nxml.txt.nlp	19904270	SENT184	18	18	10	10	cisplatin	STA	PA449014	2010;2656	0.585
NULL	Arthritis_Res_Ther_2010_Jan_8_12(1)_R4.nxml.txt.nlp	20064200	SENT9	27	27	24	24	diclofenac	COX2	PA449293	4513;5743	0.585
NULL	Oncol_Lett_2014_Sep_11_8(3)_1222-1228.nxml.txt.nlp	25120693	SENT144	23	23	21	21	cisplatin	DDP	PA449014	1678	0.585
NULL	Mol_Cell_Proteomics_2012_Feb_6_11(2)_M111_015222.nxml.txt.nlp	22147731	SENT386	35	35	21	21	cetuximab	PRIM1	PA10040	5557	0.585
NULL	J_Oncol_2010_Nov_19_2010_568938.nxml.txt.nlp	20037743	SENT313	21	21	36	36	bevacizumab	VEGFR	PA130232992	3791	0.585
NULL	Clin_Ophthalmol_2010_Nov_3_4_1253-1261.nxml.txt.nlp	21151330	SENT6	18	18	8	8	travoprost	BAK	PA164781371	578	0.585
NULL	Clin_Mol_Hepatol_2014_Sep_25_20(3)_283-290.nxml.txt.nlp	25320732	SENT115	6	6	4	4	propranolol	EVL	PA451145	51466	0.585
NULL	Curr_Neuropharmacol_2010_Sep_8(3)_287-304.nxml.txt.nlp	21358978	SENT305	2	2	13	13	agomelatine	spatial	PA165958363	219793	0.585
NULL	Int_J_Nanomedicine_2007_Mar_2(1)_13-18.nxml.txt.nlp	17722507	SENT131	8	8	10	10	cyclophosphamide	NK1	PA449165	11126	0.585
NULL	Onco_Targets_Ther_2014_Oct_4_7_1817-1828.nxml.txt.nlp	25336973	SENT115	0	0	13	13	bevacizumab	IFL	PA130232992	3439	0.585
NULL	Ann_Rheum_Dis_2008_Apr_20_67(4)_511-517.nxml.txt.nlp	17644552	SENT10	38	38	12	12	infliximab	IL-6	PA452639	3569	0.585
NULL	J_Biol_Chem_2011_Sep_16_286(37)_32684-32696.nxml.txt.nlp	21768105	SENT24	33	33	8	8	lipase	GalNAc-T2	PA450239	2590	0.585
NULL	Indian_J_Psychol_Med_2012_Apr-Jun_34(2)_110-118.nxml.txt.nlp	23162184	SENT110	41	41	30	30	clozapine	BPAD	PA449061	4095	0.585
NULL	Ann_Oncol_2009_Nov_23_20(11)_1803-1812.nxml.txt.nlp	19549706	SENT13	24	24	28	28	sunitinib	IFN	PA162372840	3439	0.585
NULL	Genome_Med_2010_Sep_13_2(9)_64.nxml.txt.nlp	20831840	SENT56	19	19	21	21	lipase	PDE4D	PA450239	5144	0.585
NULL	Aging_(Albany_NY)_2010_Aug_5_2(8)_527-534.nxml.txt.nlp	20689156	SENT89	8	8	17	17	resveratrol	SIRT1		23411	0.585
NULL	Front_Genet_2013_Aug_30_4_166.nxml.txt.nlp	24009623	SENT175	23	23	11	11	everolimus	SLC39A9	PA164746311	55334	0.585
NULL	Genome_Biol_Evol_2010_Nov_11_2_888-896.nxml.txt.nlp	21071627	SENT112	18	18	6	6	galactose	mol	PA449725	90527	0.585
NULL	Clin_Drug_Investig_2015_Dec_16_35_141-147.nxml.txt.nlp	25511640	SENT75	0	0	11	11	miglitol	GLP-1	PA164776726	100125288	0.585
NULL	Basic_Clin_Pharmacol_Toxicol_2013_Feb_5_112(2)_132-137.nxml.txt.nlp	22900583	SENT54	14	14	34	34	bupropion	CYP2C19	PA448687	1557	0.585
NULL	South_Asian_J_Cancer_2014_Jan-Mar_3(1)_66-70.nxml.txt.nlp	24665451	SENT22	3	3	5	5	rituximab	CHOP	PA451261	1649	0.585
NULL	Int_J_Mol_Sci_2014_Oct_13_15(10)_18362-18380.nxml.txt.nlp	25314299	SENT635	12	12	9	9	capsaicin	TRPV1	PA448776	7442	0.585
NULL	J_Cell_Biol_2003_Dec_8_163(5)_1099-1109.nxml.txt.nlp	14662748	SENT15	19	19	16	16	vasopressin	AVP	PA451858	114548;551	0.585
NULL	Breast_Cancer_Res_2011_Jan_26_13(1)_R10.nxml.txt.nlp	21269472	SENT243	20	20	17	17	tamoxifen	NCOA1	PA451581	8648	0.585
NULL	Exp_Hematol_Oncol_2013_Nov_8_2_30.nxml.txt.nlp	24499550	SENT129	3	3	16	16	vemurafenib	BRAF	PA165946873	673	0.585
NULL	Open_Biol_2014_Jan_4(1)_130138.nxml.txt.nlp	24403013	SENT350	19	19	15	15	etoposide	PP1	PA449552	5540;5464	0.585
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_127043.nxml.txt.nlp	23227093	SENT231	19	19	13	13	quinidine	CYP2C19	PA451209	1557	0.585
NULL	J_Neurochem_2008_Jan_104(1)_74-88.nxml.txt.nlp	17995938	SENT12	2	2	27	27	forskolin	c-Jun	PA146096022	3725	0.585
NULL	Carcinogenesis_2014_May_13_35(5)_1055-1066.nxml.txt.nlp	24419232	SENT485	4	4	14	14	metformin	VEGF-A	PA450395	7422	0.585
NULL	Exp_Cell_Res_2011_Feb_1_317(3)_330-337.nxml.txt.nlp	21056556	SENT42	27	27	45	45	l-glutamine	CO2	PA10090	4513	0.585
NULL	Nat_Med_2013_Dec_3_19(12)_10_1038_nm_3384.nxml.txt.nlp	24185693	SENT176	19	19	7	7	hydrocortisone	F12	PA449905	2161	0.585
NULL	Virol_J_2009_Dec_1_6_213.nxml.txt.nlp	19951438	SENT189	35	35	38	38	mitomycin	TRAIL	PA450524	8743	0.585
NULL	Nat_Genet_2010_Nov_17_42(11)_1000-1004.nxml.txt.nlp	20953189	SENT68	15	15	7	7	heparin	SDC4	PA449855	6385	0.585
NULL	Oncol_Lett_2014_Sep_11_8(3)_1222-1228.nxml.txt.nlp	25120693	SENT144	27	27	8	8	olaparib	XRCC2		7516	0.585
NULL	Indian_J_Psychiatry_2010_Jan_52(Suppl1)_S317-S340.nxml.txt.nlp	21836703	SENT117	29	29	27	27	triflupromazine	CPZ	PA451773	8532	0.585
NULL	Mol_Cancer_2008_Mar_6_7_24.nxml.txt.nlp	18325101	SENT91	20	20	25	25	cisplatin	FANCD2	PA449014	2177	0.585
NULL	BMB_Rep_2013_Apr_46(4)_230-235.nxml.txt.nlp	23615266	SENT18	16	16	14	14	pp2	PP1		5540;5464	0.585
NULL	Clin_Med_Case_Rep_2008_Aug_29_1_119-122.nxml.txt.nlp	24179360	SENT57	5	5	11	11	teriparatide	RANKL	PA451620	8600	0.585
NULL	Acta_Pharmacol_Sin_2010_Sep_16_31(9)_1133-1140.nxml.txt.nlp	20711219	SENT48	0	0	16	16	adalimumab	p75	PA10004	7133;11168	0.585
NULL	Br_J_Cancer_2002_Jan_21_86(2)_159-160.nxml.txt.nlp	11870499	SENT21	28	28	15	15	cimetidine	CEA	PA449001	5670;1087	0.585
NULL	Evid_Based_Complement_Alternat_Med_2014_Jul_23_2014_784689.nxml.txt.nlp	25152763	SENT161	5	5	9	9	carrageenan	ANOVA	PA448814	4858	0.585
NULL	Antimicrob_Resist_Infect_Control_2012_Mar_16_1_12.nxml.txt.nlp	22958880	SENT107	18	18	28	28	gentamicin	CTX	PA449753	1593	0.585
NULL	Aging_(Albany_NY)_2010_Dec_20_2(12)_959-968.nxml.txt.nlp	21191146	SENT24	6	6	34	34	cisplatin	Rpn13	PA449014	11047	0.585
NULL	Asia_Pac_Allergy_2013_Oct_31_3(4)_231-240.nxml.txt.nlp	24260728	SENT158	0	0	13	13	theophylline	CYP1A2	PA451647	1544	0.585
NULL	Gut_Pathog_2012_Jul_16_4_7.nxml.txt.nlp	22800501	SENT75	30	30	8	8	amikacin	CTX	PA164744372	1593	0.585
NULL	J_Cell_Biol_2005_Nov_21_171(4)_663-673.nxml.txt.nlp	16301332	SENT292	26	26	4	4	ethanol	HC11	PA448073	6347	0.584
NULL	Cancer_Causes_Control_2013_Aug_18_24(8)_1605-1614.nxml.txt.nlp	23775025	SENT64	38	38	16	16	epirubicin	CYP3A4	PA449476	1576	0.584
NULL	J_Asthma_Allergy_2008_Sep_19_1_19-29.nxml.txt.nlp	21436982	SENT117	10	10	23	23	fexofenadine	IL-5	PA449621	3567	0.584
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT345	11	11	9	9	pp2	PP1		5540;5464	0.584
NULL	Br_J_Cancer_2012_May_22_106(11)_1718-1721.nxml.txt.nlp	22531628	SENT98	4	4	2	2	irinotecan	IFL	PA450085	3439	0.584
NULL	Front_Endocrinol_(Lausanne)_2013_Jan_7_3_180.nxml.txt.nlp	23316185	SENT244	18	18	8	8	glucose	CRF2	PA449773	1395	0.584
NULL	Curr_Oncol_2009_Jul_16(Suppl_2)_S1-S13.nxml.txt.nlp	19672416	SENT301	21	21	34	34	anastrozole	ARNO	PA448432	9266	0.584
NULL	Front_Immunol_2013_Oct_31_4_351.nxml.txt.nlp	24198817	SENT397	45	45	27	27	anakinra	PAPA	PA10799	2737;5069	0.584
NULL	Int_J_Gen_Med_2013_Jun_7_6_453-464.nxml.txt.nlp	23785241	SENT205	12	12	31	31	nedocromil	GM-CSF	PA450601	1437	0.584
NULL	Br_J_Cancer_2010_Sep_7_103(6)_796-801.nxml.txt.nlp	20823888	SENT34	15	15	32	32	everolimus	AST	PA164746311	26503	0.584
NULL	J_Cell_Mol_Med_2014_Apr_20_18(4)_709-720.nxml.txt.nlp	24444314	SENT246	16	16	9	9	nadh	AMPK	PA164755085	5563	0.584
NULL	Breast_Cancer_Res_Treat_2014_Nov_8_148(3)_553-561.nxml.txt.nlp	NULL	SENT74	17	17	15	15	capecitabine	TPC	PA448771	8030;60386	0.584
NULL	Crit_Care_2008_Apr_10_12(2)_132.nxml.txt.nlp	18423065	SENT14	9	9	7	7	terlipressin	AVP	PA164781020	114548;551	0.584
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT46	2	2	8	8	curcumin	TRAIL	PA151958596	8743	0.584
NULL	Cancer_Metastasis_Rev_2014_Dec_28_33(1)_161-171.nxml.txt.nlp	24375389	SENT163	15	15	17	17	paclitaxel	CHFR	PA450761	55743	0.584
NULL	Ann_Dermatol_2014_Jun_12_26(3)_363-373.nxml.txt.nlp	24966637	SENT222	24	24	4	4	imiquimod	MT1-MMP	PA449972	4323	0.584
NULL	Acta_Neuropathol_Commun_2013_Sep_6_1_57.nxml.txt.nlp	24252176	SENT8	20	20	14	14	creatine	AMPK	PA164778930	5563	0.584
NULL	Biosci_Rep_2014_Jun_25_34(3)_e00115.nxml.txt.nlp	24877606	SENT707	1	1	8	8	thrombin	CXCL8	PA451674	3576	0.584
NULL	J_Cancer_2014_Jan_5_5(2)_115-124.nxml.txt.nlp	24494029	SENT25	1	1	20	20	urokinase	CD87	PA451836	5329	0.584
NULL	Breast_Cancer_Res_2011_Aug_31_13(4)_R84.nxml.txt.nlp	21884573	SENT15	3	3	19	19	trastuzumab	HER3	PA451743	2065	0.584
NULL	J_Antimicrob_Chemother_2014_Apr_8_69(4)_924-931.nxml.txt.nlp	24324223	SENT110	18	18	0	0	erythromycin	PEN	PA449493	9933	0.584
NULL	Neural_Plast_2013_Jun_26_2013_605079.nxml.txt.nlp	23936678	SENT118	6	6	36	36	fluoxetine	VGAT	PA449673	140679	0.584
NULL	Hum_Genomics_2010_Oct_1_5(1)_61-72.nxml.txt.nlp	21106490	SENT141	4	4	14	14	gemfibrozil	CYP2C8	PA449750	1558	0.584
NULL	Nat_Chem_Biol_2010_Apr_28_6(4)_291-299.nxml.txt.nlp	20190765	SENT134	30	30	22	22	dasatinib	AKT	PA162372878	207	0.584
NULL	Arthritis_Res_Ther_2010_Jul_7_12(4)_R131.nxml.txt.nlp	20609215	SENT211	23	23	12	12	iloprost	CXCL11	PA164746843	6373	0.584
NULL	Int_J_Mol_Sci_2013_Apr_16_14(4)_8381-8392.nxml.txt.nlp	23591849	SENT209	8	8	1	1	bupropion	CYP2B6	PA448687	1555	0.584
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_24_2012_673132.nxml.txt.nlp	23133498	SENT125	4	4	10	10	berberine	CYP3A	PA165860812	1574	0.584
NULL	Crit_Care_2008_Aug_4_12(4)_R99.nxml.txt.nlp	18680591	SENT194	3	3	0	0	vasopressin	AVP	PA451858	114548;551	0.584
NULL	Gynecol_Oncol_Case_Rep_2013_Jul_1_6_10-12.nxml.txt.nlp	24371707	SENT17	20	20	13	13	imiquimod	CO2	PA449972	4513	0.584
NULL	Br_J_Haematol_2014_Mar_6_164(6)_759-766.nxml.txt.nlp	24387053	SENT107	20	20	23	23	rituximab	PEX	PA451261	5251	0.584
NULL	Osong_Public_Health_Res_Perspect_2013_Dec_12_4(6)_316-322.nxml.txt.nlp	24524020	SENT206	18	18	33	33	clindamycin	PEN	PA449035	9933	0.584
NULL	Exp_Ther_Med_2013_May_15_5(5)_1327-1331.nxml.txt.nlp	23737873	SENT193	3	3	5	5	vasopressin	AQP2	PA451858	359	0.584
NULL	Mol_Cell_Proteomics_2015_Jan_3_14(1)_243-250.nxml.txt.nlp	25368411	SENT155	8	8	2	2	guanidine	Car1	PA164781028	759	0.584
NULL	Exp_Ther_Med_2013_Feb_20_5(2)_443-447.nxml.txt.nlp	23407364	SENT14	0	0	2	2	cyclophosphamide	CTX	PA449165	1593	0.584
NULL	F1000_Biol_Rep_2009_Mar_24_1_23.nxml.txt.nlp	20948663	SENT44	39	39	32	32	citalopram	ABCB1	PA449015	5243	0.584
NULL	Mol_Cancer_2007_Aug_21_6_53.nxml.txt.nlp	17711579	SENT150	9	9	13	13	cisplatin	ESR1	PA449014	2099	0.584
NULL	Eur_J_Appl_Physiol_2011_Feb_24_111(2)_275-283.nxml.txt.nlp	20865425	SENT190	15	15	3	3	glucose	AS160	PA449773	9882	0.584
NULL	Cell_Mol_Life_Sci_2011_May_26_68(10)_1785-1798.nxml.txt.nlp	20976523	SENT223	10	10	17	17	collagenase	AP-1	PA449107	2353;3727;2354;3725	0.584
NULL	Breast_Cancer_Res_Treat_2013_Jun_30_139(2)_441-451.nxml.txt.nlp	23715630	SENT88	24	24	14	14	exemestane	EGFR	PA449563	1956	0.584
NULL	J_Exp_Med_2000_Mar_6_191(5)_761-770.nxml.txt.nlp	10704458	SENT141	9	9	20	20	neomycin	PLP	PA450608	25824;5744	0.584
NULL	Clin_Ophthalmol_2012_Feb_20_6_277-282.nxml.txt.nlp	22375096	SENT95	13	13	2	2	ranibizumab	CRT	PA164746012	811	0.584
NULL	Proteins_2013_Sep_13_81(9)_1593-1609.nxml.txt.nlp	23671031	SENT82	20	20	25	25	nadh	PLP	PA164755085	25824;5744	0.584
NULL	Braz_J_Microbiol_2014_Mar_10_44(4)_1279-1283.nxml.txt.nlp	24688523	SENT123	6	6	4	4	trimethoprim	TMP	PA451788	2012	0.584
NULL	Oncotarget_2011_Mar_23_2(3)_165-177.nxml.txt.nlp	21444946	SENT236	25	25	3	3	erlotinib	LBA1	PA134687924	9881	0.584
NULL	J_Korean_Med_Sci_2013_Dec_26_28(12)_1774-1780.nxml.txt.nlp	24339708	SENT192	26	26	24	24	octreotide	OST	PA450678	1650;23263	0.584
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT6	4	4	23	23	nutlin-3	MDM2		4193	0.584
NULL	Arthritis_Res_Ther_2005_May_18_7(Suppl_3)_S13-S18.nxml.txt.nlp	15960817	SENT77	2	2	0	0	cyclophosphamide	CTX	PA449165	1593	0.584
NULL	Oncol_Lett_2013_Aug_25_6(2)_480-486.nxml.txt.nlp	24137351	SENT21	25	25	27	27	iodine	RAI	PA450049	10848;6050	0.584
NULL	Evid_Based_Complement_Alternat_Med_2011_May_24_2011_841564.nxml.txt.nlp	21716682	SENT185	40	40	18	18	epirubicin	JNK	PA449476	5599	0.584
NULL	Viruses_2014_Apr_14_6(4)_1715-1758.nxml.txt.nlp	24736215	SENT468	9	9	18	18	indinavir	CD4	PA449977	920	0.584
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1224-1233.nxml.txt.nlp	22353810	SENT193	13	13	19	19	doxorubicin	MRP-1	PA449412	928	0.584
NULL	Breast_Cancer_Res_2010_Nov_16_12(6)_R96.nxml.txt.nlp	21080941	SENT94	30	30	36	36	lapatinib	HRG	PA152241907	3084;3273	0.584
NULL	Head_Face_Med_2010_Jul_19_6_17.nxml.txt.nlp	20642842	SENT90	6	6	21	21	glutaraldehyde	mol	PA449777	90527	0.584
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT79	4	4	15	15	celecoxib	survivin	PA448871	332	0.584
NULL	Patient_Prefer_Adherence_2008_Feb_2_2_387-392.nxml.txt.nlp	19920986	SENT20	4	4	13	13	azathioprine	IFN	PA448515	3439	0.584
NULL	J_Cell_Biol_2005_May_23_169(4)_681-691.nxml.txt.nlp	15911882	SENT79	22	22	6	6	aprotinin	MMP3	PA448472	4314	0.584
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT54	46	46	41	41	vinorelbine	MVP	PA451881	9961	0.584
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT261	21	21	16	16	trastuzumab	HRG	PA451743	3084;3273	0.584
NULL	Arthritis_Res_Ther_2012_Jun_25_14(3)_215.nxml.txt.nlp	22731694	SENT99	16	16	0	0	rituximab	CPX	PA451261	1371;10682;1377	0.584
NULL	Oncoscience_2014_Nov_15_1(11)_674-705.nxml.txt.nlp	25593996	SENT313	17	17	12	12	erlotinib	AXL	PA134687924	558	0.584
NULL	AIDS_Care_2013_Jun_23_25(6)_657-666.nxml.txt.nlp	23088551	SENT80	11	11	13	13	atazanavir	ATV	PA10251	4683	0.584
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT87	40	40	7	7	pemetrexed	UNG	PA10810	7374	0.584
NULL	Mol_Cancer_2014_Feb_24_13_35.nxml.txt.nlp	24565101	SENT127	10	10	7	7	doxorubicin	TAB3	PA449412	257397	0.584
NULL	Breast_Cancer_Res_2004_Nov_7_6(1)_39-52.nxml.txt.nlp	14680484	SENT86	14	14	16	16	diethylstilbestrol	DES	PA449307	1674	0.584
NULL	Clin_Endosc_2012_Jun_30_45(2)_128-131.nxml.txt.nlp	22866252	SENT45	13	13	9	9	lipase	CEA	PA450239	5670;1087	0.584
NULL	Biochim_Biophys_Acta_2014_Jul_1842(7)_959-970.nxml.txt.nlp	24594481	SENT53	11	11	13	13	lipase	HSL	PA450239	3991	0.584
NULL	Exp_Ther_Med_2013_May_15_5(5)_1327-1331.nxml.txt.nlp	23737873	SENT129	0	0	3	3	imidapril	AVP	PA452640	114548;551	0.584
NULL	J_Headache_Pain_2013_Apr_10_14(1)_33.nxml.txt.nlp	23574808	SENT11	33	33	22	22	capsaicin	CO2	PA448776	4513	0.584
NULL	J_Exp_Clin_Cancer_Res_2009_Sep_7_28(1)_124.nxml.txt.nlp	19735546	SENT43	20	20	31	31	gentamicin	CO2	PA449753	4513	0.584
NULL	Mol_Brain_2014_May_15_7_37.nxml.txt.nlp	24886748	SENT126	5	5	14	14	vorinostat	HOMER1	PA164748224	9456	0.584
NULL	Exp_Ther_Med_2014_Mar_10_7(3)_640-648.nxml.txt.nlp	24520260	SENT210	14	14	26	26	triciribine	PI3K	PA165958661	5290	0.584
NULL	Cancer_Cell_Int_2009_Sep_10_9_25.nxml.txt.nlp	19744341	SENT177	7	7	9	9	glucosamine	p27	PA164747613	5715;10534	0.584
NULL	Mol_Biol_Cell_2012_Nov_1_23(21)_4212-4225.nxml.txt.nlp	22956765	SENT80	3	3	9	9	thrombin	SHP2	PA451674	5781	0.584
NULL	Front_Endocrinol_(Lausanne)_2014_Jan_16_5_1.nxml.txt.nlp	24474947	SENT59	19	19	14	14	estradiol	ESR2	PA449503	2100	0.584
NULL	Facts_Views_Vis_Obgyn_2010_2(4)_278-286.nxml.txt.nlp	25009715	SENT134	19	19	10	10	docetaxel	CYP2C8	PA449383	1558	0.584
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Apr_6_5_8.nxml.txt.nlp	16600049	SENT64	0	0	2	2	lamivudine	LAM	PA450163	7249;7248	0.584
NULL	Diabetes_2013_Oct_17_62(10)_3500-3513.nxml.txt.nlp	23884882	SENT173	0	0	15	15	resveratrol	NKX2-2		4821	0.584
NULL	Mol_Cancer_2012_Apr_26_11_26.nxml.txt.nlp	22537224	SENT125	0	0	23	23	geldanamycin	FANCF	PA152031327	2188	0.584
NULL	Oncotarget_2012_Oct_20_3(10)_1236-1245.nxml.txt.nlp	23100449	SENT76	33	33	22	22	doxorubicin	NGAL	PA449412	3934	0.584
NULL	Breed_Sci_2012_Mar_20_62(1)_78-86.nxml.txt.nlp	23136517	SENT114	19	19	14	14	zinc	ARF	PA451956	1029	0.584
NULL	Cardiovasc_Ultrasound_2005_Sep_8_3_27.nxml.txt.nlp	16150150	SENT278	11	11	39	39	isoproterenol	FFR	PA450121	738	0.584
NULL	Basic_Clin_Neurosci_2014_Summer_5(3)_182-190.nxml.txt.nlp	25337378	SENT181	6	6	2	2	bupropion	mol	PA448687	90527	0.584
NULL	Ann_Surg_Oncol_2007_Jul_25_14(7)_2105-2112.nxml.txt.nlp	17457649	SENT260	16	16	14	14	melphalan	gamma	PA450354	9913	0.584
NULL	Mol_Cell_Biochem_2014_Jul_26_396(1-2)_221-228.nxml.txt.nlp	25063218	SENT7	5	5	20	20	resveratrol	EGFR		1956	0.584
NULL	Cardiovasc_Diabetol_2006_Aug_30_5_17.nxml.txt.nlp	16939660	SENT106	12	12	17	17	metformin	IL-6	PA450395	3569	0.584
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT171	9	9	13	13	phenprocoumon	CYP2C9	PA450921	1559	0.584
NULL	J_Radiat_Res_2014_Mar_8_55(2)_257-264.nxml.txt.nlp	24105712	SENT162	32	32	16	16	simvastatin	HGB	PA451363	114757	0.584
NULL	Br_J_Cancer_2012_Feb_14_106(4)_685-692.nxml.txt.nlp	22294184	SENT189	0	0	16	16	lovastatin	survivin	PA450272	332	0.584
NULL	J_Radiat_Res_2012_Sep_10_53(5)_704-709.nxml.txt.nlp	22843360	SENT94	4	4	10	10	doxorubicin	CRT	PA449412	811	0.584
NULL	Aging_(Albany_NY)_2012_Mar_4_4(3)_144-145.nxml.txt.nlp	22388573	SENT11	15	15	18	18	resveratrol	AMPK		5563	0.584
NULL	Structure_2012_May_9_20-540(5-7)_841-849.nxml.txt.nlp	22579251	SENT86	36	36	40	40	formoterol	EL2	PA134687907	6708	0.584
NULL	Mol_Cells_2014_Apr_30_37(4)_275-285.nxml.txt.nlp	24625576	SENT539	22	22	4	4	bleomycin	spatial	PA448645	219793	0.584
NULL	Cell_Death_Dis_2014_Mar_13_5(3)_e1118.nxml.txt.nlp	24625977	SENT296	10	10	4	4	etoposide	UBXN2A	PA449552	165324	0.584
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT188	9	9	7	7	phenprocoumon	CYP2C9	PA450921	1559	0.584
NULL	Oncol_Lett_2013_Dec_4_6(6)_1665-1672.nxml.txt.nlp	24273604	SENT170	26	26	32	32	chloroquine	TLR9	PA448948	54106	0.584
NULL	Indian_J_Med_Res_2014_Jul_140(1)_130-137.nxml.txt.nlp	25222788	SENT8	11	11	13	13	ceftriaxone	CTX	PA448866	1593	0.584
NULL	Crit_Care_2011_Aug_11_15(4)_226.nxml.txt.nlp	21892977	SENT271	0	0	6	6	vasopressin	ACTH	PA451858	5443	0.584
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_9_2013_486047.nxml.txt.nlp	23662138	SENT122	41	41	35	35	glibenclamide	SDH	PA449782	1757;10993	0.584
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT1340	7	7	3	3	tenofovir	ABCC10	PA10204	89845	0.584
NULL	Front_Behav_Neurosci_2011_Sep_8_5_56.nxml.txt.nlp	21927600	SENT210	25	25	20	20	cocaine	DARPP-32	PA449072	84152	0.584
NULL	BMB_Rep_2014_Aug_47(8)_424-432.nxml.txt.nlp	24874851	SENT92	19	19	22	22	dacarbazine	gamma	PA449197	9913	0.584
NULL	Curr_Neuropharmacol_2008_Sep_6(3)_215-234.nxml.txt.nlp	19506722	SENT450	15	15	19	19	fluvoxamine	5-HT1A	PA449690	3350	0.584
NULL	Emerg_Infect_Dis_2014_Mar_20(3)_400-408.nxml.txt.nlp	24565738	SENT128	16	16	30	30	isoniazid	DST	PA450112	667	0.584
NULL	Int_J_Mol_Sci_2012_Apr_16_13(4)_4831-4838.nxml.txt.nlp	22606012	SENT177	1	1	19	19	curcumin	EGFR	PA151958596	1956	0.584
NULL	Oncotarget_2012_Dec_18_3(12)_1615-1628.nxml.txt.nlp	23271044	SENT206	0	0	3	3	temsirolimus	ERK	PA164746890	5594	0.584
NULL	Braz_J_Microbiol_2014_Oct_9_45(3)_1007-1015.nxml.txt.nlp	25477937	SENT157	5	5	15	15	trypsin	AG1	PA451806	100132406	0.584
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_16_2012_395912.nxml.txt.nlp	23118789	SENT75	29	29	27	27	phenylbutazone	UGT2B15	PA450932	7366	0.584
NULL	Diabetes_Care_2012_Feb_16_35(2)_327-333.nxml.txt.nlp	22179958	SENT171	11	11	22	22	rosiglitazone	B12	PA451283	7126;4709	0.584
NULL	Reprod_Biol_Endocrinol_2013_Feb_22_11_12.nxml.txt.nlp	23433095	SENT53	15	15	28	28	estradiol	CD7	PA449503	924	0.584
NULL	Front_Immunol_2012_Feb_27_3_23.nxml.txt.nlp	22566907	SENT1205	8	8	3	3	hyaluronan	CD44	PA165958431	960	0.584
NULL	J_Nutr_Metab_2012_Apr_10_2012_431574.nxml.txt.nlp	22570769	SENT159	4	4	12	12	citalopram	TPH2	PA449015	6999;121278	0.584
NULL	Cerebrospinal_Fluid_Res_2010_Aug_13_7_13.nxml.txt.nlp	20707896	SENT23	9	9	11	11	vasopressin	AVP	PA451858	114548;551	0.584
NULL	ScientificWorldJournal_2012_Mar_12_2012_746412.nxml.txt.nlp	22489201	SENT59	36	36	23	23	ethanol	mol	PA448073	90527	0.584
NULL	Breast_Cancer_Res_2014_May_23_16(3)_R50.nxml.txt.nlp	24887458	SENT119	32	32	0	0	trastuzumab	HER2	PA451743	2064	0.584
NULL	Chemother_Res_Pract_2012_Dec_20_2012_743193.nxml.txt.nlp	23320171	SENT125	12	12	16	16	trastuzumab	HER2	PA451743	2064	0.584
NULL	Br_J_Cancer_2010_Oct_26_103(9)_1407-1414.nxml.txt.nlp	20924372	SENT228	38	38	10	10	capecitabine	MVD	PA448771	4597	0.584
NULL	J_Mol_Signal_2012_May_14_7_4.nxml.txt.nlp	22583680	SENT228	9	9	41	41	rolipram	AKAP5	PA153906323	9495	0.584
NULL	Eur_J_Immunol_2014_Jun_10_44(6)_1759-1769.nxml.txt.nlp	24595810	SENT41	5	5	11	11	fludrocortisone	CXCR4	PA164743961	7852	0.584
NULL	Clin_Ophthalmol_2014_May_14_8_927-935.nxml.txt.nlp	24868144	SENT114	24	24	29	29	travoprost	BAK	PA164781371	578	0.584
NULL	Br_J_Cancer_2010_Jan_5_102(1)_80-86.nxml.txt.nlp	19920817	SENT10	10	10	12	12	bevacizumab	IFN	PA130232992	3439	0.584
NULL	J_Infect_Dis_2013_Sep_1_208(5)_801-812.nxml.txt.nlp	23766527	SENT121	14	14	4	4	artesunate	LUM	PA165111697	4060	0.584
NULL	Front_Neural_Circuits_2014_Oct_2_8_123.nxml.txt.nlp	25324730	SENT170	16	16	18	18	diazepam	GAD65	PA449283	2572	0.584
NULL	J_Histochem_Cytochem_2012_Oct_60(10)_749-760.nxml.txt.nlp	22821669	SENT262	11	11	14	14	hyaluronan	TSG-6	PA165958431	7130	0.584
NULL	Cardiol_Ther_2013_Jun_27_2(1)_1-16.nxml.txt.nlp	25135285	SENT169	33	33	25	25	pioglitazone	GLP-1	PA450970	100125288	0.584
NULL	Ann_Gen_Hosp_Psychiatry_2004_Jan_7_3_1.nxml.txt.nlp	14711381	SENT108	22	22	4	4	apomorphine	mol	PA164781163	90527	0.584
NULL	Iran_J_Reprod_Med_2013_Jul_11(7)_565-576.nxml.txt.nlp	24639792	SENT172	21	21	38	38	berberine	SP-D	PA165860812	6441	0.584
NULL	Cancer_Microenviron_2009_May_6_2(1)_59-67.nxml.txt.nlp	19418243	SENT33	1	1	3	3	tetracycline	CCL21	PA451640	6366	0.584
NULL	Front_Plant_Sci_2011_Dec_26_2_101.nxml.txt.nlp	22639623	SENT78	7	7	0	0	methotrexate	DHFR	PA450428	1719	0.584
NULL	Mol_Biol_Cell_2012_Mar_15_23(6)_996-1009.nxml.txt.nlp	22278744	SENT107	18	18	10	10	forskolin	14-3-3	PA146096022	10971	0.584
NULL	Arthritis_Res_Ther_2011_Jan_11_13(1)_R3.nxml.txt.nlp	21223583	SENT51	27	27	43	43	l-glutamine	CO2	PA10090	4513	0.584
NULL	Brain_Sci_2012_Nov_27_2(4)_667-683.nxml.txt.nlp	24371520	SENT131	14	14	21	21	vasopressin	OXT	PA451858	5020	0.584
NULL	J_Korean_Med_Sci_2013_Aug_31_28(8)_1213-1219.nxml.txt.nlp	23960450	SENT178	25	25	32	32	ribavirin	IL28B	PA451241	282617	0.584
NULL	Front_Oncol_2013_Nov_15_3_281.nxml.txt.nlp	24298448	SENT229	8	8	14	14	vemurafenib	survivin	PA165946873	332	0.584
NULL	Neural_Regen_Res_2014_Sep_15_9(18)_1723-1728.nxml.txt.nlp	25374596	SENT92	23	23	25	25	capsaicin	TRPV1	PA448776	7442	0.584
NULL	Core_Evid_2009_Jun_15_4_83-92.nxml.txt.nlp	20694067	SENT11	7	7	4	4	vasopressin	AVP	PA451858	114548;551	0.584
NULL	Acta_Histochem_Cytochem_2012_Apr_26_45(2)_139-146.nxml.txt.nlp	22685356	SENT361	1	1	10	10	forskolin	AQP2	PA146096022	359	0.584
NULL	Apoptosis_2012_Jun_9_17(6)_566-578.nxml.txt.nlp	22402981	SENT166	35	35	22	22	pp2	PP2		4888	0.584
NULL	Int_J_Mol_Cell_Med_2012_Summer_1(3)_145-152.nxml.txt.nlp	24551770	SENT110	2	2	11	11	memantine	mol	PA10364	90527	0.584
NULL	Indian_J_Dermatol_2011_Jan-Feb_56(1)_87-91.nxml.txt.nlp	21572802	SENT81	30	30	12	12	cyclophosphamide	CHOP	PA449165	1649	0.584
NULL	Arthritis_Res_2001_Aug_2_3(5)_311-318.nxml.txt.nlp	11549373	SENT235	11	11	0	0	camptothecin	COL1A2	PA153590860	1278	0.584
NULL	Arthritis_Res_Ther_2013_Dec_3_15(6)_R205.nxml.txt.nlp	24295447	SENT113	0	0	6	6	methotrexate	RANKL	PA450428	8600	0.584
NULL	Oncotarget_2013_Apr_8_4(4)_584-599.nxml.txt.nlp	23603840	SENT122	33	33	18	18	doxycycline	AMPK	PA449415	5563	0.584
NULL	Br_J_Cancer_2010_May_11_102(10)_1456-1460.nxml.txt.nlp	20461090	SENT116	20	20	13	13	temsirolimus	IFN	PA164746890	3439	0.584
NULL	Oncoimmunology_2012_Oct_1_1(7)_1038-1047.nxml.txt.nlp	23170252	SENT35	7	7	21	21	cyclophosphamide	CT26	PA449165	168400	0.584
NULL	Breast_Cancer_Res_2007_Aug_8_9(4)_R50.nxml.txt.nlp	17686159	SENT256	28	28	17	17	gefitinib	HRG	PA131301952	3084;3273	0.584
NULL	Exp_Cell_Res_2011_Apr_15_317(7)_1028-1039.nxml.txt.nlp	21237154	SENT781	10	10	5	5	staurosporine	JNK	PA165109623	5599	0.584
NULL	Ann_Oncol_2009_Aug_20(Suppl_6)_vi41-vi50.nxml.txt.nlp	19617297	SENT51	6	6	23	23	cisplatin	IFN	PA449014	3439	0.584
NULL	Br_J_Pharmacol_2008_Nov_11_155(6)_896-905.nxml.txt.nlp	18695641	SENT110	2	2	12	12	raloxifene	CTX	PA451221	1593	0.584
NULL	Behav_Brain_Funct_2012_Jul_10_8_20.nxml.txt.nlp	22559224	SENT145	5	5	1	1	baclofen	ANOVA	PA448533	4858	0.584
NULL	Front_Cell_Neurosci_2015_Jan_15_8_459.nxml.txt.nlp	25642166	SENT89	16	16	3	3	hemin	HO-1	PA449849	3162	0.584
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT94	31	31	38	38	pertuzumab	PI3K		5290	0.584
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT3	35	35	7	7	erlotinib	CYP3A	PA134687924	1574	0.584
NULL	Gastric_Cancer_2014_Apr_7_17(1)_1-12.nxml.txt.nlp	23563986	SENT299	14	14	24	24	paclitaxel	HER2	PA450761	2064	0.584
NULL	Cancer_Cell_Int_2011_Jun_1_11_15.nxml.txt.nlp	21631944	SENT146	24	24	29	29	etoposide	MICA	PA449552	100507436	0.584
NULL	Clin_Ophthalmol_2009_Jun_2_3_291-295.nxml.txt.nlp	19668581	SENT3	38	38	35	35	travoprost	BAK	PA164781371	578	0.584
NULL	Mol_Vis_2011_Jun_9_17_1564-1576.nxml.txt.nlp	21738386	SENT206	9	9	11	11	ethambutol	EMB	PA164784021	133418	0.584
NULL	Lab_Invest_2009_Nov_7_89(11)_1275-1290.nxml.txt.nlp	19736547	SENT321	3	3	19	19	curcumin	LOX-1	PA151958596	4973	0.584
NULL	Oncotarget_2014_Feb_25_5(5)_1304-1314.nxml.txt.nlp	24675421	SENT142	25	25	21	21	cisplatin	MKK4	PA449014	6416	0.584
NULL	AIDS_Res_Ther_2011_Oct_6_8_36.nxml.txt.nlp	21978457	SENT12	3	3	13	13	zinc	TNF	PA451956	7124	0.584
NULL	Clin_Pharmacokinet_2014_Jan_16_53(3)_213-225.nxml.txt.nlp	24430725	SENT269	10	10	14	14	sitagliptin	GLP-1	PA164748978	100125288	0.584
NULL	J_Oncol_2010_Dec_28_2010_414676.nxml.txt.nlp	20066160	SENT169	12	12	7	7	fluorescein	EGF	PA164746009	1950	0.583
NULL	Mol_Pain_2012_Sep_22_8_71.nxml.txt.nlp	22998838	SENT10	16	16	4	4	paclitaxel	CXCR4	PA450761	7852	0.583
NULL	Hum_Reprod_Update_2010_May_28_Nov-Dec_16(6)_745-760.nxml.txt.nlp	20511398	SENT89	26	26	8	8	genistein	Yes	PA165109660	7525	0.583
NULL	Exp_Ther_Med_2015_Feb_16_9(2)_289-293.nxml.txt.nlp	25574188	SENT51	11	11	36	36	curcumin	ABCG2	PA151958596	9429	0.583
NULL	Int_J_Endocrinol_2010_Jun_27_2010_206801.nxml.txt.nlp	20652073	SENT56	11	11	13	13	cinacalcet	PTH	PA164776671	5741	0.583
NULL	Indian_J_Med_Res_2011_Sep_134(3)_295-301.nxml.txt.nlp	21985811	SENT122	29	29	20	20	phenytoin	ABCB1	PA450947	5243	0.583
NULL	Clinics_(Sao_Paulo)_2010_Jul_65(7)_703-708.nxml.txt.nlp	20668628	SENT108	2	2	4	4	hyaluronan	CD44	PA165958431	960	0.583
NULL	Breast_Cancer_Res_2011_Apr_15_13(2)_R44.nxml.txt.nlp	21496232	SENT326	7	7	9	9	erlotinib	EGF	PA134687924	1950	0.583
NULL	Clin_Ophthalmol_2010_Oct_21_4_1229-1236.nxml.txt.nlp	21060677	SENT88	25	25	17	17	tafluprost	BAK	PA165958432	578	0.583
NULL	Mol_Biol_Cell_2012_May_15_23(10)_1928-1942.nxml.txt.nlp	22438580	SENT258	21	21	24	24	galactose	GAL	PA449725	51083	0.583
NULL	Alcohol_Res_2013_35(1)_6-16.nxml.txt.nlp	24313160	SENT125	5	5	25	25	ethanol	CYP2E1	PA448073	1571	0.583
NULL	Indian_J_Anaesth_2009_Oct_53(5)_608-617.nxml.txt.nlp	20640111	SENT186	9	9	11	11	bupivacaine	CSE	PA135057240	1433	0.583
NULL	Arthritis_Res_Ther_2010_Mar_25_12(2)_R54.nxml.txt.nlp	20338043	SENT37	9	9	19	19	rituximab	IL-6	PA451261	3569	0.583
NULL	Pharmaceuticals_(Basel)_2013_Aug_21_6(8)_988-1038.nxml.txt.nlp	24276379	SENT2794	5	5	0	0	cetuximab	PTEN	PA10040	5728	0.583
NULL	Cell_Res_2011_Mar_11_21(3)_530-545.nxml.txt.nlp	21221130	SENT176	36	36	27	27	heparin	TPO	PA449855	7066;7173	0.583
NULL	Biol_Open_2014_Nov_21_3(12)_1207-1216.nxml.txt.nlp	25416063	SENT23	17	17	39	39	zinc	NANOS3	PA451956	342977	0.583
NULL	J_Biol_Chem_2013_Nov_15_288(46)_33049-33059.nxml.txt.nlp	24089524	SENT138	19	19	14	14	nicotine	FBS	PA450626	64319;26269	0.583
NULL	Cell_Death_Dis_2010_Nov_18_1(11)_e102.nxml.txt.nlp	21368867	SENT120	23	23	28	28	gentamicin	14-3-3	PA449753	10971	0.583
NULL	EMBO_Mol_Med_2011_May_3(5)_266-278.nxml.txt.nlp	21438154	SENT156	5	5	0	0	oxaliplatin	HCN	PA131285527	378938	0.583
NULL	Ann_Hematol_2011_Feb_17_90(2)_173-183.nxml.txt.nlp	20714724	SENT164	0	0	15	15	resveratrol	p53		7157	0.583
NULL	Braz_J_Med_Biol_Res_2014_Mar_3_47(3)_245-251.nxml.txt.nlp	24554037	SENT150	11	11	17	17	rosuvastatin	IFN	PA134308647	3439	0.583
NULL	Br_J_Clin_Pharmacol_2011_Oct_72(4)_647-657.nxml.txt.nlp	21518389	SENT92	5	5	26	26	prasugrel	ADP	PA154410481	23038	0.583
NULL	FASEB_J_2008_Sep_22(9)_3111-3119.nxml.txt.nlp	18509199	SENT42	21	21	42	42	l-glutamine	CO2	PA10090	4513	0.583
NULL	Cardiovasc_Drugs_Ther_2010_Dec_13_24(5-6)_391-399.nxml.txt.nlp	20640495	SENT4	0	0	2	2	dipyridamole	DIP	PA449367	23151;1831	0.583
NULL	Front_Neurosci_2013_Jul_15_7_122.nxml.txt.nlp	23874266	SENT87	4	4	11	11	ethanol	gamma	PA448073	9913	0.583
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT84	0	0	6	6	chloroquine	BMPR-II	PA448948	659	0.583
NULL	J_Ginseng_Res_2011_Nov_35(4)_436-441.nxml.txt.nlp	23717089	SENT118	14	14	29	29	sugar	CAGC	PA451529	6283	0.583
NULL	Oxid_Med_Cell_Longev_2012_Aug_22_2012_534705.nxml.txt.nlp	22966415	SENT220	2	2	4	4	riluzole	GLAST	PA451251	6507	0.583
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_33-43.nxml.txt.nlp	17912634	SENT164	19	19	29	29	tamoxifen	aromatase	PA451581	1588	0.583
NULL	Int_J_Tryptophan_Res_2010_Jun_10_3_113-120.nxml.txt.nlp	22084593	SENT30	29	29	16	16	l-tryptophan	IDO2	PA10323	169355	0.583
NULL	Diabetes_Care_2009_Sep_28_32(9)_1649-1655.nxml.txt.nlp	19478198	SENT139	10	10	12	12	saxagliptin	URI	PA165958362	8725	0.583
NULL	J_Korean_Med_Sci_2011_Jul_20_26(7)_893-899.nxml.txt.nlp	21738342	SENT78	0	0	10	10	resveratrol	CD97		976	0.583
NULL	Cancer_Metab_2014_May_28_2(Suppl_1)_P65.nxml.txt.nlp	NULL	SENT5	22	22	24	24	resveratrol	NAMPT		10135	0.583
NULL	J_Korean_Med_Sci_2011_Jul_20_26(7)_938-944.nxml.txt.nlp	21738349	SENT90	13	13	34	34	fluorescein	IL-17	PA164746009	3605	0.583
NULL	Indian_J_Endocrinol_Metab_2012_Dec_16(Suppl_2)_S242-S244.nxml.txt.nlp	23565389	SENT63	16	16	34	34	sitagliptin	RAGE	PA164748978	177	0.583
NULL	Allergy_Rhinol_(Providence)_2013_Fall_4(3)_e132-e139.nxml.txt.nlp	24498518	SENT167	8	8	10	10	collagenase	MMP8	PA449107	4317	0.583
NULL	J_Hematol_Oncol_2012_Sep_18_5_57.nxml.txt.nlp	22989009	SENT162	12	12	9	9	nutlin-3	p53		7157	0.583
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Jun_27_5_15.nxml.txt.nlp	16803618	SENT178	20	20	30	30	erythromycin	CIP1	PA449493	1026;56996	0.583
NULL	Br_J_Cancer_2011_Nov_22_105(11)_1697-1707.nxml.txt.nlp	22027709	SENT187	19	19	13	13	paclitaxel	U87	PA450761	677775;641648	0.583
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT144	6	6	4	4	vinorelbine	ASC	PA451881	29108	0.583
NULL	Int_J_Mol_Sci_2014_Jun_18_15(6)_11013-11029.nxml.txt.nlp	24945311	SENT622	0	0	32	32	rituximab	Bcl-2	PA451261	596	0.583
NULL	Acta_Pharmacol_Sin_2013_Sep_5_34(9)_1192-1200.nxml.txt.nlp	23685957	SENT139	17	17	22	22	curcumin	AP-2	PA151958596	7020	0.583
NULL	J_Cell_Biol_1997_Jul_28_138(2)_323-330.nxml.txt.nlp	9230074	SENT144	19	19	10	10	thrombin	ADP	PA451674	23038	0.583
NULL	Biosci_Rep_2013_Jun_5_33(3)_e00041.nxml.txt.nlp	23577625	SENT17	11	11	0	0	disulfiram	DDC	PA449376	1644	0.583
NULL	J_Cell_Biol_1984_Jun_1_98(6)_2192-2197.nxml.txt.nlp	6725411	SENT7	6	6	35	35	guanidine	mol	PA164781028	90527	0.583
NULL	Oncol_Lett_2014_Mar_16_7(3)_827-833.nxml.txt.nlp	24527090	SENT136	9	9	6	6	cisplatin	IFN	PA449014	3439	0.583
NULL	Breast_Cancer_Res_2011_Apr_21_13(2)_R46.nxml.txt.nlp	21510863	SENT118	1	1	9	9	trastuzumab	HER2	PA451743	2064	0.583
NULL	J_Cell_Biol_1982_Feb_1_92(2)_313-323.nxml.txt.nlp	6801061	SENT1	19	19	17	17	thrombin	ADP	PA451674	23038	0.583
NULL	Nat_Photonics_2011_Feb_5(2)_110-116.nxml.txt.nlp	25558274	SENT140	32	32	39	39	l-glutamine	CO2	PA10090	4513	0.583
NULL	Ann_Surg_Treat_Res_2014_Feb_22_86(2)_68-75.nxml.txt.nlp	24761411	SENT191	2	2	5	5	resveratrol	survivin		332	0.583
NULL	Am_J_Trop_Med_Hyg_2012_Nov_7_87(5_Suppl)_21-29.nxml.txt.nlp	23136274	SENT323	2	2	15	15	artemisinin	RDT	PA165111696	6598	0.583
NULL	Ann_Gen_Psychiatry_2010_Apr_22_9(Suppl_1)_S168.nxml.txt.nlp	NULL	SENT17	12	12	17	17	aripiprazole	San	PA10026	80218	0.583
NULL	CNS_Drugs_2014_May_1_28(6)_497-511.nxml.txt.nlp	24788672	SENT107	14	14	8	8	lisdexamfetamine	DBP	PA164748975	3295;1628;2638	0.583
NULL	Asian-Australas_J_Anim_Sci_2014_May_27(5)_757-766.nxml.txt.nlp	25050012	SENT205	31	31	5	5	lipase	ATGL	PA450239	57104	0.583
NULL	J_Neurovirol_2013_Jun_4_19(4)_351-358.nxml.txt.nlp	23733308	SENT39	16	16	14	14	mefloquine	SOC	PA450348	91544	0.583
NULL	J_Korean_Med_Sci_2010_Dec_24_25(12)_1766-1770.nxml.txt.nlp	21165292	SENT131	28	28	30	30	glucose	CRP	PA449773	1401;140913	0.583
NULL	Ann_Pediatr_Endocrinol_Metab_2013_Jun_30_18(2)_90-94.nxml.txt.nlp	24904859	SENT96	41	41	18	18	hydrocortisone	ACTH	PA449905	5443	0.583
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT84	12	12	21	21	curcumin	PC-3	PA151958596	692094	0.583
NULL	Cancers_(Basel)_2011_Aug_5_3(3)_3114-3142.nxml.txt.nlp	24212948	SENT140	23	23	13	13	oxaliplatin	GEM	PA131285527	2669	0.583
NULL	Breast_Cancer_Res_2008_Dec_18_10(Suppl_4)_S24.nxml.txt.nlp	19128438	SENT64	17	17	12	12	tamoxifen	IMPACT	PA451581	55364	0.583
NULL	Case_Rep_Oncol_2012_Apr_13_5(1)_173-180.nxml.txt.nlp	22666209	SENT34	24	24	18	18	carboplatin	OSC	PA448803	4047	0.583
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Jun_27_5_15.nxml.txt.nlp	16803618	SENT161	32	32	42	42	ciprofloxacin	GEN1	PA449009	348654	0.583
NULL	Breast_Cancer_Res_2006_Nov_6_8(6)_215.nxml.txt.nlp	17096862	SENT93	0	0	9	9	pertuzumab	HER3		2065	0.583
NULL	EMBO_Mol_Med_2011_Jul_3(7)_370-384.nxml.txt.nlp	21591259	SENT26	14	14	8	8	thrombin	PAR1	PA451674	79581;2149	0.583
NULL	Int_J_Chron_Obstruct_Pulmon_Dis_2006_Dec_1(4)_373-379.nxml.txt.nlp	18044094	SENT50	5	5	2	2	roflumilast	PDE4B	PA165948052	5142	0.583
NULL	AIDS_Res_Ther_2005_Sep_12_2_7.nxml.txt.nlp	16156891	SENT110	48	48	30	30	l-glutamine	BRL	PA10090	23774	0.583
NULL	Crit_Care_2012_Oct_14_16(5)_R191.nxml.txt.nlp	23062276	SENT127	16	16	23	23	creatine	POD1	PA164778930	6943	0.583
NULL	Arq_Bras_Cardiol_2014_Nov_103(5)_403-409.nxml.txt.nlp	25229355	SENT125	29	29	31	31	metoprolol	PZP	PA450480	5858	0.583
NULL	Diabetes_Care_2010_Mar_23_33(3)_645-651.nxml.txt.nlp	20032281	SENT138	6	6	4	4	metformin	Met	PA450395	79811	0.583
NULL	Indian_J_Nephrol_2009_Apr_19(2)_82.nxml.txt.nlp	20368932	SENT16	11	11	5	5	vincristine	CHOP	PA451879	1649	0.583
NULL	ScientificWorldJournal_2014_Mar_24_2014_694326.nxml.txt.nlp	24782665	SENT175	26	26	2	2	metformin	FDG	PA450395	23583	0.583
NULL	Mol_Cancer_2009_Nov_19_8_108.nxml.txt.nlp	19925669	SENT66	36	36	48	48	doxorubicin	GAPDH	PA449412	2597	0.583
NULL	AMB_Express_2014_Jul_22_4_56.nxml.txt.nlp	25147754	SENT210	15	15	4	4	ethanol	YAP1	PA448073	10413	0.583
NULL	Cancers_(Basel)_2011_Aug_5_3(3)_3114-3142.nxml.txt.nlp	24212948	SENT949	1	1	21	21	cyclophosphamide	HER-2	PA449165	2064	0.583
NULL	J_Cell_Biol_2008_Jul_28_182(2)_289-300.nxml.txt.nlp	18663142	SENT312	13	13	29	29	l-glutamine	CO2	PA10090	4513	0.583
NULL	Biosci_Rep_2012_Dec_20_33(1)_e00011.nxml.txt.nlp	23137297	SENT309	7	7	15	15	heparin	RPSA	PA449855	3921	0.583
NULL	J_Cell_Biol_1992_Apr_2_117(2)_383-393.nxml.txt.nlp	1313816	SENT9	22	22	12	12	forskolin	EGF	PA146096022	1950	0.583
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT536	8	8	13	13	haloperidol	PRL	PA449841	5617	0.583
NULL	Clinics_(Sao_Paulo)_2012_Jul_67(7)_711-717.nxml.txt.nlp	22892913	SENT209	1	1	6	6	metformin	TFI	PA450395	7035	0.583
NULL	BMB_Rep_2013_Sep_46(9)_448-453.nxml.txt.nlp	24064059	SENT70	38	38	5	5	dextran	CD83	PA449261	9308	0.583
NULL	Arch_Drug_Inf_2011_Mar_4(1)_1-9.nxml.txt.nlp	21572514	SENT143	18	18	25	25	ciprofloxacin	MDR1	PA449009	5243	0.583
NULL	Int_J_Endocrinol_2011_Aug_21_2011_742719.nxml.txt.nlp	21869886	SENT264	2	2	14	14	cilostazol	DES	PA164746334	1674	0.583
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT203	8	8	11	11	perifosine	TRAIL	PA165291471	8743	0.583
NULL	Oncotarget_2014_Jun_19_5(15)_6540-6551.nxml.txt.nlp	25153728	SENT131	10	10	14	14	paclitaxel	PI3K	PA450761	5290	0.583
NULL	Cancer_Cell_Int_2013_May_16_13_44.nxml.txt.nlp	23680357	SENT29	28	28	35	35	zinc	ZEB2	PA451956	9839	0.583
NULL	Br_J_Haematol_2014_Mar_13_164(1)_811-821.nxml.txt.nlp	24328678	SENT184	14	14	6	6	lenalidomide	IL2	PA162363968	3558	0.583
NULL	J_Mol_Signal_2010_Dec_13_5_20.nxml.txt.nlp	21144036	SENT26	3	3	5	5	troglitazone	TRG	PA451799	6965	0.583
NULL	Acta_Pharmacol_Sin_2013_Apr_25_34(4)_455-463.nxml.txt.nlp	23524568	SENT213	0	0	2	2	pioglitazone	RAGE	PA450970	177	0.583
NULL	Trop_Anim_Health_Prod_2012_Jan_27_44(1)_165-172.nxml.txt.nlp	21947959	SENT80	18	18	21	21	phenol	mol	PA450913	90527	0.583
NULL	Exp_Mol_Med_2012_Sep_30_44(9)_545-553.nxml.txt.nlp	22809901	SENT8	40	40	30	30	clozapine	PRDM16	PA449061	63976	0.583
NULL	Nucleic_Acids_Res_2012_Jul_30_40(13)_6319-6337.nxml.txt.nlp	22467215	SENT422	34	34	30	30	urokinase	HER2	PA451836	2064	0.583
NULL	Eur_J_Clin_Pharmacol_2011_Dec_23_67(12)_1231-1241.nxml.txt.nlp	21698374	SENT15	6	6	0	0	tacrolimus	CYP3A5	PA451578	1577	0.583
NULL	Br_J_Cancer_2012_Oct_9_107(8)_1277-1285.nxml.txt.nlp	22990652	SENT190	10	10	8	8	gemcitabine	Gem	PA449748	51053	0.583
NULL	Biomed_Res_Int_2014_Aug_6_2014_967826.nxml.txt.nlp	25165721	SENT204	0	0	8	8	cisplatin	TNF-alpha	PA449014	7124	0.583
NULL	Br_J_Cancer_2004_Mar_22_90(6)_1285-1292.nxml.txt.nlp	15026814	SENT148	21	21	19	19	doxorubicin	p53	PA449412	7157	0.583
NULL	Braz_J_Med_Biol_Res_2012_Jun_29_45(8)_777-783.nxml.txt.nlp	22735180	SENT100	23	23	25	25	lipase	PGC1	PA450239	10891	0.583
NULL	Ann_Clin_Microbiol_Antimicrob_2005_Sep_13_4_13.nxml.txt.nlp	16159399	SENT211	18	18	16	16	ribavirin	IFN	PA451241	3439	0.583
NULL	Clin_Mol_Hepatol_2014_Sep_25_20(3)_283-290.nxml.txt.nlp	25320732	SENT124	5	5	3	3	propranolol	EVL	PA451145	51466	0.583
NULL	Br_J_Cancer_2010_Sep_28_103(7)_1008-1018.nxml.txt.nlp	20736947	SENT240	38	38	2	2	docetaxel	CD147	PA449383	682	0.583
NULL	Mol_Cells_2014_Mar_31_37(3)_234-240.nxml.txt.nlp	24642709	SENT383	10	10	6	6	cisplatin	ANOVA	PA449014	4858	0.583
NULL	J_Headache_Pain_2011_Apr_25_12(2)_185-191.nxml.txt.nlp	21350791	SENT64	14	14	0	0	capsaicin	ANOVA	PA448776	4858	0.583
NULL	J_Antimicrob_Chemother_2014_Mar_11_69(3)_594-597.nxml.txt.nlp	24216768	SENT36	11	11	13	13	cefoxitin	PEN	PA448856	9933	0.583
NULL	Int_J_Mol_Sci_2014_Sep_22_15(9)_16800-16815.nxml.txt.nlp	25247578	SENT56	1	1	3	3	minoxidil	MNX	PA450521	3892	0.583
NULL	Oncol_Lett_2013_Apr_5_5(4)_1123-1128.nxml.txt.nlp	23599750	SENT5	16	16	12	12	docetaxel	LDM	PA449383	1595	0.583
NULL	Exp_Ther_Med_2013_Feb_20_5(2)_443-447.nxml.txt.nlp	23407364	SENT174	11	11	13	13	cyclophosphamide	ANOVA	PA449165	4858	0.583
NULL	Hum_Genomics_2009_Jan_1_3(2)_128-142.nxml.txt.nlp	19164090	SENT175	11	11	1	1	carboplatin	PAK1	PA448803	5585;5058	0.583
NULL	Case_Rep_Pediatr_2012_Aug_9_2012_323681.nxml.txt.nlp	22924145	SENT92	14	14	4	4	tocilizumab	IL-6	PA165292659	3569	0.583
NULL	Indian_J_Pharmacol_2013_May-Jun_45(3)_248-251.nxml.txt.nlp	23833367	SENT117	6	6	18	18	diazepam	EPM	PA449283	2054	0.583
NULL	Oncotarget_2014_Nov_2_5(21)_10222-10236.nxml.txt.nlp	25400118	SENT99	3	3	16	16	neratinib	AKT	PA165291472	207	0.583
NULL	Front_Mol_Neurosci_2014_Dec_2_7_92.nxml.txt.nlp	25520614	SENT283	1	1	11	11	mannitol	p38	PA450320	10598;1432;7965	0.583
NULL	Nat_Commun_2014_Jun_19_5_4037.nxml.txt.nlp	24941968	SENT108	13	13	9	9	vanillin	UGT	PA451852	7361;7355	0.583
NULL	Emerg_Microbes_Infect_2012_Nov_7_1(11)_e39.nxml.txt.nlp	NULL	SENT159	7	7	5	5	gentamicin	Gen	PA449753	348654	0.583
NULL	Case_Rep_Med_2010_Dec_26_2010_403237.nxml.txt.nlp	21209804	SENT53	0	0	28	28	bortezomib	Bcl-2	PA10252	596	0.583
NULL	Breast_Cancer_Res_2011_Nov_24_13(6)_R120.nxml.txt.nlp	22115051	SENT129	27	27	12	12	tamoxifen	HER-2	PA451581	2064	0.583
NULL	Acta_Pharmacol_Sin_2012_Oct_3_33(10)_1311-1318.nxml.txt.nlp	22941289	SENT204	3	3	12	12	sorafenib	VEGFR2	PA7000	3791	0.583
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Jun_29_69(Pt_7)_o1169.nxml.txt.nlp	24046713	SENT5	4	4	15	15	phenol	mol	PA450913	90527	0.583
NULL	J_Cardiothorac_Surg_2014_Sep_17_9(1)_129.nxml.txt.nlp	NULL	SENT167	10	10	4	4	heparin	ACT	PA449855	12;11332;9457;641455	0.583
NULL	Parasit_Vectors_2009_Sep_25_2(Suppl_2)_S5.nxml.txt.nlp	19778466	SENT130	22	22	17	17	praziquantel	MOX	PA164764583	26002	0.583
NULL	Arthritis_Res_Ther_2013_Feb_27_15(1)_R35.nxml.txt.nlp	23446139	SENT73	0	0	2	2	cyclophosphamide	CTX	PA449165	1593	0.583
NULL	J_Korean_Med_Sci_2006_Dec_31_21(6)_1037-1040.nxml.txt.nlp	17179683	SENT93	13	13	8	8	amoxicillin	BAM	PA448406	9126	0.583
NULL	Cell_Death_Dis_2012_Jun_21_3(6)_e330.nxml.txt.nlp	22717585	SENT10	0	0	15	15	simvastatin	c-Jun	PA451363	3725	0.583
NULL	J_Gen_Physiol_2000_Dec_1_116(6)_769-780.nxml.txt.nlp	11099346	SENT131	20	20	9	9	tetracaine	DAG	PA451638	1605	0.583
NULL	Oxid_Med_Cell_Longev_2013_Jun_11_2013_870472.nxml.txt.nlp	23840921	SENT237	43	43	19	19	chloroquine	HO-1	PA448948	3162	0.583
NULL	Drug_Des_Devel_Ther_2014_Sep_16_8_1391-1403.nxml.txt.nlp	25258509	SENT174	2	2	16	16	ethanol	ANOVA	PA448073	4858	0.583
NULL	Asian-Australas_J_Anim_Sci_2013_Feb_26(2)_266-274.nxml.txt.nlp	25049786	SENT215	7	7	17	17	ginseng	FA3	PA164781150	2176	0.583
NULL	Arthritis_Res_Ther_2006_Nov_27_8(6)_R176.nxml.txt.nlp	17129374	SENT232	31	31	14	14	pp2	p38		10598;1432;7965	0.583
NULL	J_Nat_Med_2014_Feb_19_68(2)_253-266.nxml.txt.nlp	24550097	SENT223	5	5	9	9	ethanol	AMPK	PA448073	5563	0.583
NULL	Mol_Cancer_2012_Mar_21_11_13.nxml.txt.nlp	22436134	SENT183	25	25	5	5	doxorubicin	HuR	PA449412	1994	0.583
NULL	Lipids_Health_Dis_2011_Dec_6_10_229.nxml.txt.nlp	22146099	SENT44	2	2	0	0	rosiglitazone	IL-13	PA451283	3596	0.583
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_11_2014_274786.nxml.txt.nlp	25505920	SENT484	5	5	17	17	cisplatin	ERCC1	PA449014	2067	0.583
NULL	EMBO_Mol_Med_2012_Jul_19_4(7)_647-659.nxml.txt.nlp	22514144	SENT121	7	7	9	9	trypsin	ADAM10	PA451806	102	0.583
NULL	Oncogene_2014_Sep_11_33(37)_4579-4588.nxml.txt.nlp	24662835	SENT49	32	32	1	1	tamoxifen	MAGEA2	PA451581	4101;266740	0.583
NULL	Surg_Today_2012_Jan_6_42(1)_8-28.nxml.txt.nlp	22139128	SENT271	6	6	10	10	tegafur	PSK	PA452620	9344	0.583
NULL	J_Mol_Med_(Berl)_2013_Aug_17_91(11)_1257-1271.nxml.txt.nlp	23955016	SENT61	2	2	24	24	thrombin	IL-6	PA451674	3569	0.583
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_3_2012_908562.nxml.txt.nlp	23082087	SENT28	3	3	0	0	hesperetin	Men	PA164742902	8178	0.583
NULL	Biochem_Res_Int_2012_Feb_12_2012_346972.nxml.txt.nlp	22400115	SENT178	19	19	15	15	hyaluronan	CD44	PA165958431	960	0.583
NULL	Ther_Clin_Risk_Manag_2007_Jun_3(3)_449-459.nxml.txt.nlp	18488069	SENT196	12	12	14	14	rizatriptan	RIZ	PA451264	7799	0.583
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT192	10	10	6	6	phenprocoumon	CYP2C9	PA450921	1559	0.583
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT195	0	0	4	4	resveratrol	p53		7157	0.583
NULL	Pharmaceutics_2011_Oct_12_3(4)_680-705.nxml.txt.nlp	24309303	SENT76	17	17	9	9	atorvastatin	OATP2B1	PA448500	11309	0.583
NULL	Biomed_Res_Int_2014_Feb_6_2014_323594.nxml.txt.nlp	24689036	SENT237	23	23	29	29	raloxifene	EGFR	PA451221	1956	0.583
NULL	J_Oncol_2010_Nov_19_2010_568938.nxml.txt.nlp	20037743	SENT315	19	19	37	37	lapatinib	HER2	PA152241907	2064	0.583
NULL	Br_J_Cancer_2010_Oct_26_103(9)_1335-1342.nxml.txt.nlp	20978512	SENT27	17	17	8	8	trastuzumab	HER-2	PA451743	2064	0.583
NULL	Eur_J_Cancer_2013_Oct_49(15)_3366-3375.nxml.txt.nlp	23790465	SENT85	5	5	16	16	sorafenib	HCC1	PA7000	9584	0.583
NULL	Evid_Based_Complement_Alternat_Med_2013_May_22_2013_921012.nxml.txt.nlp	23762167	SENT175	13	13	16	16	glucose	AMPK	PA449773	5563	0.583
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1145.nxml.txt.nlp	24675463	SENT193	11	11	0	0	omalizumab	EGFR	PA164752253	1956	0.583
NULL	Int_J_Nanomedicine_2009_Apr_20_4_99-105.nxml.txt.nlp	19516888	SENT177	7	7	11	11	paclitaxel	castor	PA450761	54897	0.583
NULL	J_Ginseng_Res_2011_Nov_35(4)_471-478.nxml.txt.nlp	23717094	SENT100	6	6	24	24	ethanol	CaCC	PA448073	1179	0.583
NULL	Clinics_(Sao_Paulo)_2013_Oct_68(10)_1318-1324.nxml.txt.nlp	24212838	SENT184	10	10	20	20	timolol	IL-6	PA451690	3569	0.583
NULL	Clin_Exp_Reprod_Med_2011_Jun_30_38(2)_98-102.nxml.txt.nlp	22384426	SENT114	10	10	7	7	pioglitazone	IL-6	PA450970	3569	0.583
NULL	Oncotarget_2013_Dec_28_5(6)_1475-1490.nxml.txt.nlp	24721996	SENT118	3	3	10	10	celecoxib	CD133	PA448871	8842	0.583
NULL	Br_J_Cancer_2011_Jul_26_105(3)_407-412.nxml.txt.nlp	21730976	SENT67	19	19	9	9	pha-665752	STAT3		6774	0.583
NULL	J_Cancer_2013_Nov_21_4(9)_727-735.nxml.txt.nlp	24312143	SENT117	3	3	19	19	temozolomide	DDP	PA451609	1678	0.583
NULL	Pain_Res_Treat_2011_Jul_2_2011_650320.nxml.txt.nlp	22110929	SENT197	12	12	22	22	remifentanil	SAS	PA451232	54187	0.583
NULL	Int_J_Mol_Sci_2014_Nov_25_15(12)_21703-21722.nxml.txt.nlp	25429431	SENT147	0	0	5	5	curcumin	p38	PA151958596	10598;1432;7965	0.583
NULL	J_Antimicrob_Chemother_2011_Feb_9_66(2)_363-370.nxml.txt.nlp	21148235	SENT126	6	6	0	0	lopinavir	ATV	PA450264	4683	0.583
NULL	Infect_Dis_Ther_2014_Jun_20_3(1)_1-17.nxml.txt.nlp	25134808	SENT130	16	16	3	3	efavirenz	ATV	PA449441	4683	0.583
NULL	Mol_Cancer_2014_Aug_16_13(1)_193.nxml.txt.nlp	NULL	SENT29	8	8	13	13	cisplatin	KEAP1	PA449014	9817	0.583
NULL	Acta_Pharmacol_Sin_2010_Aug_5_31(8)_970-976.nxml.txt.nlp	20686521	SENT27	10	10	12	12	cisplatin	CDP	PA449014	1523	0.583
NULL	Environ_Health_Perspect_2011_Mar_29_119(3)_326-331.nxml.txt.nlp	21036692	SENT189	18	18	4	4	medroxyprogesterone	CEE	PA450344	51608	0.583
NULL	Anal_Chem_Insights_2013_Apr_16_8_9-20.nxml.txt.nlp	23700362	SENT2	27	27	29	29	tobramycin	TOB	PA451704	10140	0.583
NULL	Int_J_Nanomedicine_2012_Sep_21_7_5091-5106.nxml.txt.nlp	23049256	SENT269	7	7	14	14	protamine	SMCC	PA10366	6876;1264	0.582
NULL	Arthritis_Res_Ther_2014_Oct_30_16(5)_467.nxml.txt.nlp	25359150	SENT162	0	0	3	3	adalimumab	CXCL13	PA10004	10563	0.582
NULL	Springerplus_2014_Sep_9_3_510.nxml.txt.nlp	25279302	SENT199	11	11	13	13	creatine	SLC6A8	PA164778930	6535	0.582
NULL	ScientificWorldJournal_2013_Dec_3_2013_260915.nxml.txt.nlp	24367239	SENT103	1	1	14	14	iron	ESA	PA450087	2319;4072;5444	0.582
NULL	Breast_Cancer_Res_2004_Mar_17_6(3)_R215-R231.nxml.txt.nlp	15084245	SENT68	33	33	29	29	hydrocortisone	EGF	PA449905	1950	0.582
NULL	Front_Neurol_2013_Nov_6_4_176.nxml.txt.nlp	24223570	SENT182	26	26	24	24	pirenzepine	PIR	PA10159	8544	0.582
NULL	Clin_Mol_Hepatol_2014_Sep_25_20(3)_267-273.nxml.txt.nlp	25320730	SENT160	2	2	0	0	lamivudine	LAM	PA450163	7249;7248	0.582
NULL	Mol_Brain_2014_Sep_4_7(1)_69.nxml.txt.nlp	NULL	SENT148	3	3	42	42	sevoflurane	CCL2	PA451341	6347	0.582
NULL	J_Biol_Chem_2013_Nov_22_288(47)_34217-34229.nxml.txt.nlp	24106270	SENT307	21	21	13	13	thrombin	RhoG	PA451674	391	0.582
NULL	J_Korean_Assoc_Oral_Maxillofac_Surg_2014_Dec_26_40(6)_291-296.nxml.txt.nlp	25551094	SENT92	2	2	5	5	alendronate	RANKL	PA448082	8600	0.582
NULL	Cardiovasc_Diabetol_2004_Feb_4_3_1.nxml.txt.nlp	14761253	SENT477	4	4	15	15	nadh	DAG	PA164755085	1605	0.582
NULL	Mol_Clin_Oncol_2013_Sep_23_1(5)_845-850.nxml.txt.nlp	24649258	SENT26	35	35	6	6	glucosamine	HS6ST2	PA164747613	90161	0.582
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1563-1573.nxml.txt.nlp	22015557	SENT255	8	8	20	20	sunitinib	c-Myc	PA162372840	4609	0.582
NULL	Indian_J_Pharmacol_2014_Nov-Dec_46(6)_627-632.nxml.txt.nlp	25538335	SENT38	12	12	10	10	metformin	Q10	PA450395	27161	0.582
NULL	J_Orthop_Sci_2014_Oct_13_19(6)_933-939.nxml.txt.nlp	25308211	SENT199	17	17	19	19	curcumin	TNF-alpha	PA151958596	7124	0.582
NULL	Acta_Pharmacol_Sin_2011_Feb_10_32(2)_217-222.nxml.txt.nlp	21217769	SENT12	0	0	34	34	fluoxetine	MCP-1	PA449673	6347	0.582
NULL	Front_Pharmacol_2014_May_9_5_103.nxml.txt.nlp	24847272	SENT235	15	15	10	10	tacrolimus	POR	PA451578	5447	0.582
NULL	Oxid_Med_Cell_Longev_2012_Jan_19_2012_390678.nxml.txt.nlp	22315655	SENT102	8	8	10	10	gliclazide	NAC	PA10892	22861	0.582
NULL	Mol_Neurodegener_2011_Nov_2_6_75.nxml.txt.nlp	22047141	SENT273	27	27	45	45	l-glutamine	CO2	PA10090	4513	0.582
NULL	Pain_2014_Nov_155(11)_2306-2322.nxml.txt.nlp	25168672	SENT977	2	2	0	0	bupivacaine	BUP	PA135057240	23412	0.582
NULL	Arch_Gynecol_Obstet_2012_May_25_285(5)_1331-1338.nxml.txt.nlp	22116314	SENT194	15	15	19	19	alendronate	JNK	PA448082	5599	0.582
NULL	Int_J_Vasc_Med_2012_Feb_14_2012_569654.nxml.txt.nlp	22489274	SENT144	5	5	3	3	ebselen	GP-1	PA161660841	9567	0.582
NULL	Acta_Pharmacol_Sin_2014_Aug_21_35(8)_994-1004.nxml.txt.nlp	25042549	SENT46	8	8	18	18	pravastatin	PCSK9	PA451089	255738	0.582
NULL	Ann_Oncol_2011_Aug_27_22(8)_1736-1747.nxml.txt.nlp	21709140	SENT316	28	28	10	10	trastuzumab	EGF	PA451743	1950	0.582
NULL	Structure_2012_May_9_20-540(5-7)_841-849.nxml.txt.nlp	22579251	SENT526	0	0	6	6	carvedilol	EL2	PA448817	6708	0.582
NULL	Ann_Oncol_2013_Aug_12_24(8)_1994-1999.nxml.txt.nlp	23670096	SENT154	35	35	20	20	tamoxifen	AIB1	PA451581	8202	0.582
NULL	Nat_Commun_2013_Oct_1_4_2516.nxml.txt.nlp	24084631	SENT694	3	3	26	26	losartan	AK4	PA450268	205	0.582
NULL	Int_J_Environ_Res_Public_Health_2013_Sep_27_10(9)_3843-3854.nxml.txt.nlp	23985770	SENT115	28	28	34	34	resveratrol	ACR		49	0.582
NULL	Mol_Cancer_2009_Nov_10_8_99.nxml.txt.nlp	19903356	SENT122	17	17	2	2	imatinib	IGFBP3	PA10804	3486	0.582
NULL	Brain_2014_Aug_18_137(8)_2312-2328.nxml.txt.nlp	24941947	SENT118	14	14	18	18	dextran	CA3	PA449261	761	0.582
NULL	Exp_Diabetes_Res_2011_Apr_26_2011_215764.nxml.txt.nlp	21584276	SENT144	12	12	4	4	metformin	Yes	PA450395	7525	0.582
NULL	Adolesc_Health_Med_Ther_2014_Nov_27_5_211-221.nxml.txt.nlp	25473324	SENT7	0	0	18	18	aripiprazole	5-HT1A	PA10026	3350	0.582
NULL	Cancers_(Basel)_2012_Sep_6_4(3)_873-903.nxml.txt.nlp	24213471	SENT1147	15	15	9	9	hyaluronan	RHAMM	PA165958431	3161	0.582
NULL	Nat_Med_2010_Nov_24_16(11)_1299-1304.nxml.txt.nlp	20972434	SENT191	1	1	5	5	chloroquine	VASP	PA448948	7408	0.582
NULL	Crit_Care_2008_Mar_13_12(Suppl_2)_P21.nxml.txt.nlp	NULL	SENT2	0	0	2	2	micafungin	MICA	PA164781026	100507436	0.582
NULL	Physiol_Rep_2014_Sep_28_2(9)_e12159.nxml.txt.nlp	25263208	SENT539	8	8	2	2	lipase	CD36	PA450239	948	0.582
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT248	11	11	18	18	doxorubicin	B7-H1	PA449412	29126	0.582
NULL	Acta_Vet_Scand_2012_Jun_29_54(1)_39.nxml.txt.nlp	22748116	SENT80	4	4	39	39	novobiocin	MRB	PA164768819	54538	0.582
NULL	J_Ayurveda_Integr_Med_2014_Jan-Mar_5(1)_33-37.nxml.txt.nlp	24812473	SENT76	10	10	14	14	diclofenac	INAC	PA449293	51802	0.582
NULL	Oncol_Lett_2014_Jun_9_7(6)_2053-2058.nxml.txt.nlp	24932288	SENT159	12	12	0	0	doxorubicin	ANOVA	PA449412	4858	0.582
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_6_2014_270930.nxml.txt.nlp	25431606	SENT258	0	0	8	8	curcumin	IL-8	PA151958596	3576	0.582
NULL	Korean_J_Anesthesiol_2013_Feb_15_64(2)_105-111.nxml.txt.nlp	23459312	SENT81	32	32	11	11	heparin	ACT	PA449855	12;11332;9457;641455	0.582
NULL	Arthritis_Res_Ther_2011_Mar_1_13(2)_R36.nxml.txt.nlp	21356124	SENT107	13	13	0	0	cyclophosphamide	ACR	PA449165	49	0.582
NULL	Cancer_Cell_Int_2013_Feb_8_13_11.nxml.txt.nlp	23394616	SENT129	38	38	32	32	geldanamycin	Hsp90	PA152031327	3320	0.582
NULL	Crit_Care_2008_Jan_24_12(1)_R27.nxml.txt.nlp	18304335	SENT204	44	44	15	15	thrombin	Rho	PA451674	29984	0.582
NULL	Diabetes_2011_Nov_17_60(11)_2691-2700.nxml.txt.nlp	21896928	SENT164	18	18	14	14	resveratrol	AMPK		5563	0.582
NULL	Mol_Syst_Biol_2009_Jul_28_5_288.nxml.txt.nlp	19638969	SENT443	4	4	1	1	resveratrol	HuR		1994	0.582
NULL	Open_Neurol_J_2013_May_31_7_23-31.nxml.txt.nlp	23894259	SENT72	0	0	14	14	aripiprazole	5-HT1A	PA10026	3350	0.582
NULL	Crit_Care_2011_Jun_10_15(3)_R146.nxml.txt.nlp	21663616	SENT296	17	17	25	25	aprotinin	IL-18	PA448472	3606	0.582
NULL	J_Hematol_Oncol_2013_Nov_5_6_83.nxml.txt.nlp	24283248	SENT55	25	25	13	13	nutlin-3	TP53		7157	0.582
NULL	Acta_Pharmacol_Sin_2010_Sep_16_31(9)_1075-1084.nxml.txt.nlp	20711221	SENT150	12	12	20	20	glucose	ROS	PA449773	6098	0.582
NULL	J_Gen_Physiol_2008_Nov_132(5)_547-562.nxml.txt.nlp	18955595	SENT439	9	9	12	12	capsaicin	VR1	PA448776	56664	0.582
NULL	Interdiscip_Perspect_Infect_Dis_2014_May_7_2014_849432.nxml.txt.nlp	24895495	SENT130	3	3	8	8	triamcinolone	CYP3A4	PA451749	1576	0.582
NULL	Br_J_Cancer_1999_Nov_81(6)_942-951.nxml.txt.nlp	10576649	SENT9	10	10	13	13	vinblastine	P-gp	PA451877	5243	0.582
NULL	Oncogene_2010_Sep_16_29(37)_5193-5203.nxml.txt.nlp	20581867	SENT364	28	28	14	14	lapatinib	PI3K	PA152241907	5290	0.582
NULL	J_Hematol_Oncol_2011_Jan_21_4_5.nxml.txt.nlp	21255411	SENT150	13	13	22	22	gefitinib	EGFR	PA131301952	1956	0.582
NULL	Diabetes_2009_Jan_58(1)_104-115.nxml.txt.nlp	18835938	SENT209	2	2	8	8	rosiglitazone	MRP-1	PA451283	928	0.582
NULL	Clin_Ophthalmol_2014_Feb_10_8_389-399.nxml.txt.nlp	24550667	SENT161	31	31	29	29	timolol	TIM	PA451690	7984;8914	0.582
NULL	Br_J_Haematol_2013_Sep_29_162(5)_684-692.nxml.txt.nlp	23808903	SENT165	24	24	35	35	thrombin	ADP	PA451674	23038	0.582
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_P64.nxml.txt.nlp	NULL	SENT16	32	32	36	36	ceftriaxone	PPL	PA448866	5493	0.582
NULL	Clin_Interv_Aging_2008_Sep_3(3)_421-430.nxml.txt.nlp	18982913	SENT81	6	6	12	12	buprenorphine	CYP3A4	PA448685	1576	0.582
NULL	J_Korean_Med_Sci_2010_Aug_21_25(8)_1222-1227.nxml.txt.nlp	20676337	SENT54	26	26	24	24	propofol	LPA	PA451141	4018	0.582
NULL	Osteoporos_Int_2013_Aug_31_24(8)_2365-2369.nxml.txt.nlp	23371327	SENT130	7	7	11	11	teriparatide	PTH	PA451620	5741	0.582
NULL	Cancers_(Basel)_2011_Oct_19_3(4)_3909-3920.nxml.txt.nlp	24213117	SENT221	17	17	7	7	mitomycin	YB-1	PA450524	4904	0.582
NULL	Front_Neurosci_2011_Dec_5_5_131.nxml.txt.nlp	22164129	SENT336	3	3	12	12	ethanol	CA1	PA448073	759	0.582
NULL	Br_J_Cancer_2010_Jun_8_102(12)_1707-1716.nxml.txt.nlp	20461078	SENT170	34	34	36	36	bortezomib	TRAIL	PA10252	8743	0.582
NULL	Neural_Regen_Res_2013_Jul_15_8(20)_1853-1862.nxml.txt.nlp	25206494	SENT113	8	8	15	15	ethanol	JNK	PA448073	5599	0.582
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT151	15	15	19	19	glucose	EGFR	PA449773	1956	0.582
NULL	Oncotarget_2014_Nov_3_5(20)_10127-10139.nxml.txt.nlp	25333256	SENT180	9	9	7	7	vemurafenib	IFN	PA165946873	3439	0.582
NULL	Breast_Cancer_Res_2012_Nov_5_14(6)_R143.nxml.txt.nlp	23127292	SENT152	10	10	8	8	tamoxifen	VIII	PA451581	1351	0.582
NULL	Evid_Based_Complement_Alternat_Med_2013_May_26_2013_349790.nxml.txt.nlp	23762123	SENT173	12	12	6	6	rosiglitazone	TLSP	PA451283	11012	0.582
NULL	Oncoimmunology_2012_May_1_1(3)_383-384.nxml.txt.nlp	22737623	SENT26	4	4	19	19	dacarbazine	CCL5	PA449197	6352	0.582
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jul_11_65(Pt_8)_o1842.nxml.txt.nlp	21583542	SENT3	21	21	1	1	phenol	mol	PA450913	90527	0.582
NULL	Mol_Pain_2014_Apr_18_10_27.nxml.txt.nlp	24742127	SENT39	20	20	4	4	paclitaxel	CB2	PA450761	1269	0.582
NULL	Iran_Red_Crescent_Med_J_2014_Jun_5_16(6)_e18026.nxml.txt.nlp	25068054	SENT80	13	13	8	8	paraformaldehyde	PLP	PA450790	25824;5744	0.582
NULL	Adv_Pharmacol_Sci_2013_Dec_26_2013_510298.nxml.txt.nlp	24454346	SENT210	14	14	10	10	lipase	flower	PA450239	11094	0.582
NULL	Int_J_Nanomedicine_2009_Apr_1_4_1-7.nxml.txt.nlp	19421366	SENT146	6	6	10	10	paclitaxel	castor	PA450761	54897	0.582
NULL	Eur_J_Clin_Microbiol_Infect_Dis_2012_May_7_31(5)_739-745.nxml.txt.nlp	21822974	SENT63	2	2	12	12	daptomycin	SYN	PA164768820	2534;23336	0.582
NULL	Mol_Cancer_2010_Jun_25_9_165.nxml.txt.nlp	20576164	SENT212	10	10	13	13	curcumin	STAT3	PA151958596	6774	0.582
NULL	Oncol_Rep_2013_Oct_24_30(4)_1587-1592.nxml.txt.nlp	23900512	SENT83	33	33	24	24	pargyline	NOXA	PA450797	5366	0.582
NULL	Exp_Hematol_Oncol_2013_Aug_8_2_21.nxml.txt.nlp	23927414	SENT95	4	4	6	6	enoxaparin	HARE	PA449463	55576	0.582
NULL	J_Int_Soc_Sports_Nutr_2015_Jan_21_12(1)_5.nxml.txt.nlp	NULL	SENT226	23	23	21	21	curcumin	IL-6	PA151958596	3569	0.582
NULL	Emerg_Med_J_2011_Apr_26_28(4)_313-315.nxml.txt.nlp	20581384	SENT101	8	8	18	18	atropine	PON1	PA448505	5444	0.582
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1449-1456.nxml.txt.nlp	24077631	SENT123	34	34	7	7	tolbutamide	CYP2C9	PA451718	1559	0.582
NULL	Pain_Ther_2014_Dec_29_3(2)_73-84.nxml.txt.nlp	25069571	SENT87	6	6	11	11	capsaicin	TRPV1	PA448776	7442	0.582
NULL	Cancers_(Basel)_2014_Jul_8_6(3)_1487-1499.nxml.txt.nlp	25006835	SENT106	14	14	11	11	cisplatin	AIF	PA449014	9131	0.582
NULL	Clinics_(Sao_Paulo)_2010_Dec_65(12)_1311-1314.nxml.txt.nlp	21340220	SENT96	3	3	7	7	tadalafil	BTC	PA10333	685	0.582
NULL	Breast_Cancer_Res_2010_Oct_26_12(5)_210.nxml.txt.nlp	21067538	SENT61	26	26	37	37	urokinase	MT1-MMP	PA451836	4323	0.582
NULL	Oncol_Lett_2014_Jun_3_7(6)_1796-1802.nxml.txt.nlp	24932236	SENT144	11	11	13	13	thyroglobulin	TTF-1	PA164754910	7080	0.582
NULL	Arch_Med_Sci_2011_Dec_31_7(6)_977-983.nxml.txt.nlp	22328880	SENT127	14	14	19	19	heparin	ACT	PA449855	12;11332;9457;641455	0.582
NULL	Cardiovasc_Diabetol_2013_Jun_7_12_84.nxml.txt.nlp	23759020	SENT62	38	38	29	29	dipyridamole	LSR	PA449367	51599	0.582
NULL	Nat_Commun_2014_Jun_25_5_4182.nxml.txt.nlp	24964370	SENT98	11	11	14	14	cisplatin	CT26	PA449014	168400	0.582
NULL	Curr_Neuropharmacol_2013_Jan_11(1)_102-108.nxml.txt.nlp	23814542	SENT224	42	42	34	34	curcumin	Yes	PA151958596	7525	0.582
NULL	Biomed_Res_Int_2014_Apr_27_2014_180428.nxml.txt.nlp	24877063	SENT27	0	0	2	2	bortezomib	BTZ	PA10252	22794	0.582
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Jul_20_9_19.nxml.txt.nlp	20646305	SENT64	25	25	27	27	cefotaxime	CTX	PA448852	1593	0.582
NULL	Behav_Brain_Funct_2010_May_28_6_27.nxml.txt.nlp	20507645	SENT194	2	2	20	20	amiloride	ATG9B	PA448368	285973	0.582
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Jun_27_5_15.nxml.txt.nlp	16803618	SENT145	38	38	30	30	gentamicin	CIP1	PA449753	1026;56996	0.582
NULL	Exp_Ther_Med_2015_Jan_4_9(1)_250-256.nxml.txt.nlp	25452811	SENT67	27	27	19	19	fluorescein	San	PA164746009	80218	0.582
NULL	Springerplus_2014_Sep_9_3_510.nxml.txt.nlp	25279302	SENT46	1	1	3	3	creatine	CT1	PA164778930	1489;6535	0.582
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Feb_10_68(Pt_3)_o656.nxml.txt.nlp	22412559	SENT77	23	23	19	19	ethanol	mol	PA448073	90527	0.582
NULL	Clin_Psychopharmacol_Neurosci_2011_Apr_30_9(1)_36-43.nxml.txt.nlp	23431025	SENT13	3	3	21	21	aripiprazole	FLI	PA10026	2314	0.582
NULL	Drugs_R_D_2014_Jun_6_14(2)_113-123.nxml.txt.nlp	24797400	SENT153	13	13	2	2	dabigatran	ABCB1		5243	0.582
NULL	J_Gen_Intern_Med_2009_May_24_24(5)_563-569.nxml.txt.nlp	19238488	SENT24	0	0	2	2	varenicline	AKA	PA164781343	4762	0.582
NULL	J_Physiol_2009_Feb_15_587(Pt_4)_731-744.nxml.txt.nlp	19074966	SENT177	9	9	4	4	taurine	PAT1	PA451590	10513;206358	0.582
NULL	Med_Sci_Monit_2013_Nov_29_19_1080-1088.nxml.txt.nlp	24287619	SENT182	31	31	12	12	estradiol	ACL	PA449503	47	0.582
NULL	Diabetes_Metab_Syndr_Obes_2010_Sep_22_3_325-335.nxml.txt.nlp	21437102	SENT149	19	19	21	21	metformin	PPG	PA450395	5552	0.582
NULL	Int_J_Environ_Res_Public_Health_2010_May_28_7(5)_2033-2044.nxml.txt.nlp	20623009	SENT70	17	17	35	35	taurine	CO2	PA451590	4513	0.582
NULL	Oncogene_2013_Sep_12_32(37)_4355-4365.nxml.txt.nlp	23108409	SENT27	13	13	18	18	hyaluronan	HAS2	PA165958431	3037	0.582
NULL	Cells_2014_May_23_3(2)_517-545.nxml.txt.nlp	24861977	SENT927	4	4	13	13	capsaicin	TRPV4	PA448776	59341	0.582
NULL	Curr_HIV_Res_2011_Jan_9(1)_40-53.nxml.txt.nlp	21198432	SENT150	7	7	9	9	raltegravir	BID		637	0.582
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1046.nxml.txt.nlp	24503538	SENT15	26	26	37	37	oxaliplatin	FGFR4	PA131285527	2264	0.582
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_3_2012_908562.nxml.txt.nlp	23082087	SENT180	12	12	17	17	hesperidin	IL-4	PA449867	3565	0.582
NULL	Clinicoecon_Outcomes_Res_2014_Oct_17_6_451-461.nxml.txt.nlp	25378939	SENT142	8	8	23	23	linezolid	HAP	PA450233	5915;10313	0.582
NULL	eLife_2013_Oct_29_2_e01236.nxml.txt.nlp	24171104	SENT539	9	9	15	15	bortezomib	MM1	PA10252	23654	0.582
NULL	Cell_Death_Differ_2010_Oct_19_17(10)_1566-1576.nxml.txt.nlp	20300112	SENT115	37	37	0	0	staurosporine	CAML	PA165109623	819	0.582
NULL	Arthritis_Res_Ther_2011_Mar_16_13(2)_R44.nxml.txt.nlp	21410959	SENT14	0	0	5	5	glucosamine	CD11b	PA164747613	3684	0.582
NULL	Case_Rep_Genet_2014_Mar_4_2014_423071.nxml.txt.nlp	24711935	SENT54	7	7	5	5	levothyroxine	Q10	PA450221	27161	0.582
NULL	Aging_(Albany_NY)_2010_Apr_30_2(4)_183-184.nxml.txt.nlp	20436227	SENT9	0	0	29	29	resveratrol	p53		7157	0.582
NULL	J_Breast_Cancer_2011_Mar_31_14(1)_46-51.nxml.txt.nlp	21847394	SENT137	12	12	0	0	methotrexate	HER2	PA450428	2064	0.582
NULL	Int_J_Endocrinol_2011_Dec_10_2011_903918.nxml.txt.nlp	22190929	SENT157	9	9	11	11	bicalutamide	ZEB1	PA164746255	6935	0.582
NULL	Exp_Mol_Med_2012_Nov_30_44(11)_653-664.nxml.txt.nlp	22932446	SENT189	14	14	34	34	l-glutamine	CO2	PA10090	4513	0.582
NULL	ScientificWorldJournal_2013_Oct_27_2013_549091.nxml.txt.nlp	24288493	SENT302	0	0	34	34	vancomycin	VISA	PA451850	57506	0.582
NULL	Case_Rep_Pathol_2013_Jul_14_2013_198643.nxml.txt.nlp	23936709	SENT73	18	18	30	30	thyroglobulin	TTF-1	PA164754910	7080	0.582
NULL	Exp_Ther_Med_2014_Apr_13_7(4)_923-928.nxml.txt.nlp	24669252	SENT210	7	7	9	9	resveratrol	PRL		5617	0.582
NULL	Carcinogenesis_2013_Mar_7_34(3)_703-712.nxml.txt.nlp	23222814	SENT89	0	0	7	7	curcumin	p53	PA151958596	7157	0.582
NULL	Glycobiology_2009_Nov_14_19(11)_1155-1162.nxml.txt.nlp	19528664	SENT70	11	11	7	7	galactose	DC-SIGN	PA449725	30835	0.582
NULL	Cancer_Metab_2014_May_28_2(Suppl_1)_P23.nxml.txt.nlp	NULL	SENT25	0	0	2	2	metformin	AMPK	PA450395	5563	0.582
NULL	Eur_J_Endocrinol_2011_Jan_164(1)_69-74.nxml.txt.nlp	20961967	SENT80	8	8	21	21	pioglitazone	adiponectin	PA450970	9370	0.582
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_P64.nxml.txt.nlp	NULL	SENT16	26	26	16	16	ceftriaxone	PPL	PA448866	5493	0.582
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_O2.nxml.txt.nlp	NULL	SENT6	15	15	27	27	flucloxacillin	PD-L1	PA164781042	29126	0.582
NULL	Arthritis_Res_Ther_2014_Jan_20_16(1)_R17.nxml.txt.nlp	24444433	SENT81	22	22	6	6	methotrexate	ANOVA	PA450428	4858	0.582
NULL	Exp_Diabetes_Res_2012_Nov_1_2012_892706.nxml.txt.nlp	23197976	SENT237	13	13	17	17	vildagliptin	HIF-1	PA165958346	29072	0.582
NULL	Ann_N_Y_Acad_Sci_2012_Oct_10_1271(1)_1-9.nxml.txt.nlp	23050958	SENT86	13	13	33	33	gefitinib	ERBB2	PA131301952	2064	0.582
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1437-1448.nxml.txt.nlp	24056706	SENT111	14	14	24	24	sulfaphenazole	CYP2D6	PA130231310	1565	0.582
NULL	J_Hematol_Oncol_2010_May_28_3_19.nxml.txt.nlp	20509866	SENT13	30	30	37	37	zinc	PML	PA451956	5371	0.582
NULL	Breast_Cancer_Res_2011_Dec_9_13(6)_R127.nxml.txt.nlp	22151997	SENT160	13	13	33	33	estradiol	SNAI2	PA449503	6591	0.582
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Jun_27_5_15.nxml.txt.nlp	16803618	SENT284	2	2	16	16	ciprofloxacin	LTA	PA449009	4049	0.582
NULL	FEBS_Open_Bio_2011_Dec_27_2_1-5.nxml.txt.nlp	23650573	SENT138	3	3	10	10	sunitinib	MDM2	PA162372840	4193	0.582
NULL	Biochemistry_2010_Feb_16_49(6)_1268-1280.nxml.txt.nlp	20052994	SENT25	13	13	31	31	amiloride	VAP-1	PA448368	8639	0.582
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT201	11	11	17	17	nutlin-3	TRAIL		8743	0.582
NULL	Ann_Saudi_Med_2010_Jan-Feb_30(1)_38-49.nxml.txt.nlp	20103957	SENT162	0	0	2	2	rifampin	RIF	PA451250	54509;80196	0.582
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT100	8	8	34	34	trastuzumab	p85	PA451743	5296;5295;54776;23368	0.582
NULL	Infect_Drug_Resist_2009_Apr_24_2_13-26.nxml.txt.nlp	21694884	SENT343	39	39	37	37	tenofovir	TDF	PA10204	6736	0.582
NULL	Allergy_Asthma_Immunol_Res_2014_Mar_15_6(2)_126-130.nxml.txt.nlp	24587948	SENT33	10	10	15	15	salbutamol	TTN	PA448068	7273	0.582
NULL	Cardiovasc_Diabetol_2006_Aug_30_5_17.nxml.txt.nlp	16939660	SENT101	0	0	4	4	metformin	IL-6	PA450395	3569	0.582
NULL	J_Asthma_Allergy_2013_Feb_22_6_31-39.nxml.txt.nlp	23459334	SENT116	10	10	25	25	desloratadine	ANOVA	PA164776964	4858	0.582
NULL	Curr_Genomics_2013_Nov_14(7)_441-452.nxml.txt.nlp	24396276	SENT295	17	17	7	7	cisplatin	p63	PA449014	8626	0.582
NULL	J_Hematol_Oncol_2009_Feb_23_2_9.nxml.txt.nlp	19236713	SENT36	9	9	6	6	cetuximab	KRAS	PA10040	3845	0.582
NULL	Case_Rep_Ophthalmol_2011_Aug_18_2(2)_283-286.nxml.txt.nlp	21941507	SENT57	0	0	6	6	fluorescein	hole	PA164746009	80757	0.582
NULL	Ann_Pediatr_Cardiol_2009_Jan-Jun_2(1)_65-73.nxml.txt.nlp	20300273	SENT174	3	3	0	0	vasopressin	AVP	PA451858	114548;551	0.582
NULL	Eur_J_Med_Res_2010_Jan_29_15(1)_1-12.nxml.txt.nlp	20159665	SENT251	8	8	11	11	abacavir	HLA-B	PA448004	3106	0.582
NULL	Oncol_Lett_2014_Jun_3_7(6)_2083-2088.nxml.txt.nlp	24932293	SENT116	2	2	0	0	cyclophosphamide	CTX	PA449165	1593	0.582
NULL	Diabetes_2013_Mar_14_62(3)_953-964.nxml.txt.nlp	23223176	SENT201	23	23	20	20	nitrogen	ROS	PA450643	6098	0.582
NULL	Environ_Health_Perspect_2009_Feb_8_117(2)_175-180.nxml.txt.nlp	19270784	SENT138	22	22	17	17	doxorubicin	BPA	PA449412	667	0.582
NULL	Emerg_Microbes_Infect_2013_Jul_10_2(7)_e42.nxml.txt.nlp	NULL	SENT27	14	14	27	27	l-glutamine	CO2	PA10090	4513	0.582
NULL	Front_Neurol_2015_Jan_7_5_274.nxml.txt.nlp	25620952	SENT346	3	3	5	5	streptozocin	STZ	PA451514	6484	0.582
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT235	22	22	10	10	panitumumab	KRAS	PA162373091	3845	0.582
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT229	15	15	0	0	irinotecan	STEPP	PA450085	222659	0.582
NULL	Iran_J_Public_Health_2010_Jun_30_39(2)_63-68.nxml.txt.nlp	23113008	SENT144	4	4	14	14	levofloxacin	TOB	PA450214	10140	0.582
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_16_2012_395912.nxml.txt.nlp	23118789	SENT75	29	29	13	13	phenylbutazone	UGT1A6	PA450932	54578	0.582
NULL	Breast_Cancer_Res_2012_Feb_9_14(1)_R27.nxml.txt.nlp	22321971	SENT91	11	11	6	6	phenol	F12	PA450913	2161	0.582
NULL	Core_Evid_2009_Jun_15_4_1-11.nxml.txt.nlp	20694060	SENT99	28	28	14	14	valsartan	AT2	PA451848	186	0.582
NULL	Arthritis_Care_Res_(Hoboken)_2014_Mar_24_66(3)_344-354.nxml.txt.nlp	23983039	SENT172	9	9	0	0	tocilizumab	SOC	PA165292659	91544	0.582
NULL	Clin_Ophthalmol_2014_Feb_10_8_389-399.nxml.txt.nlp	24550667	SENT183	22	22	20	20	timolol	TIM	PA451690	7984;8914	0.582
NULL	Int_J_Biol_Sci_2013_Jul_5_9(6)_649-655.nxml.txt.nlp	23847446	SENT33	28	28	23	23	collagenase	MMP13	PA449107	4322	0.582
NULL	Front_Aging_Neurosci_2015_Jan_6_6_337.nxml.txt.nlp	25610394	SENT642	0	0	5	5	nimodipine	CA1	PA450633	759	0.582
NULL	Cancer_Cell_Int_2011_Nov_17_11_40.nxml.txt.nlp	22088142	SENT147	16	16	7	7	gemcitabine	EGFR	PA449748	1956	0.581
NULL	J_Carcinog_Mutagen_2013_Aug_5_Suppl_7_4.nxml.txt.nlp	25587491	SENT153	26	26	23	23	gefitinib	EGFR	PA131301952	1956	0.581
NULL	Int_J_Biol_Sci_2011_May_24_7(5)_673-684.nxml.txt.nlp	21647250	SENT204	16	16	5	5	berberine	SREBP-1c	PA165860812	6720	0.581
NULL	Adolesc_Health_Med_Ther_2012_Jun_20_3_85-93.nxml.txt.nlp	24600289	SENT58	7	7	0	0	oxygen	TNF	PA450744	7124	0.581
NULL	Nat_Commun_2014_Nov_25_5_5548.nxml.txt.nlp	25420520	SENT43	19	19	3	3	cabazitaxel	ERG	PA165958401	2078	0.581
NULL	Exp_Mol_Med_2012_Sep_30_44(9)_545-553.nxml.txt.nlp	22809901	SENT8	28	28	30	30	quetiapine	PRDM16	PA451201	63976	0.581
NULL	Arthritis_Res_2002_May_9_4(Suppl_3)_S17-S24.nxml.txt.nlp	12110119	SENT108	6	6	9	9	infliximab	IL-18	PA452639	3606	0.581
NULL	Biosci_Rep_2012_Dec_13_33(1)_e00007.nxml.txt.nlp	23095119	SENT8	19	19	9	9	lipase	NEFA	PA450239	4925	0.581
NULL	Pak_J_Med_Sci_2013_May-Jun_29(3)_891-896.nxml.txt.nlp	24353652	SENT87	5	5	3	3	thrombin	ADP	PA451674	23038	0.581
NULL	Diabetes_2008_Sep_57(9)_2321-2331.nxml.txt.nlp	18599527	SENT333	28	28	34	34	cisplatin	TRAIL	PA449014	8743	0.581
NULL	Chem_Cent_J_2013_Jul_31_7_133.nxml.txt.nlp	23899303	SENT19	5	5	7	7	moxifloxacin	MOX	PA450555	26002	0.581
NULL	Front_Endocrinol_(Lausanne)_2014_Aug_18_5_129.nxml.txt.nlp	25183960	SENT257	13	13	20	20	octreotide	ghrelin	PA450678	51738	0.581
NULL	Clin_Kidney_J_2013_Jun_29_6(3)_266-271.nxml.txt.nlp	24596657	SENT80	25	25	10	10	thrombin	PF4	PA451674	5196	0.581
NULL	Int_J_Biomed_Sci_2008_Dec_4(4)_260-265.nxml.txt.nlp	19568323	SENT81	8	8	14	14	forskolin	aromatase	PA146096022	1588	0.581
NULL	Breast_Cancer_Res_2012_Feb_14_14(1)_R30.nxml.txt.nlp	22333315	SENT170	9	9	13	13	celecoxib	CXCL10	PA448871	3627	0.581
NULL	Basic_Clin_Pharmacol_Toxicol_2013_Feb_5_112(2)_132-137.nxml.txt.nlp	22900583	SENT54	18	18	34	34	flurbiprofen	CYP2C19	PA449683	1557	0.581
NULL	Oncotarget_2013_Nov_15_5(6)_1458-1474.nxml.txt.nlp	24681547	SENT245	2	2	6	6	celecoxib	CDH11	PA448871	1009	0.581
NULL	Arthritis_Res_Ther_2014_Apr_11_16(2)_R93.nxml.txt.nlp	24725461	SENT34	45	45	28	28	estradiol	aromatase	PA449503	1588	0.581
NULL	J_Prev_Med_Public_Health_2014_Jan_29_47(1)_36-46.nxml.txt.nlp	24570805	SENT174	12	12	0	0	liothyronine	HIRA	PA164778866	7290	0.581
NULL	Int_J_Biol_Sci_2014_Sep_21_10(10)_1108-1115.nxml.txt.nlp	25332685	SENT29	0	0	2	2	dexmedetomidine	DMT	PA449256	2039	0.581
NULL	Nat_Neurosci_2012_Jun_15(6)_845-852.nxml.txt.nlp	22522402	SENT108	2	2	4	4	primaquine	KAR	PA451103	51144	0.581
NULL	Biomed_Res_Int_2014_May_20_2014_418975.nxml.txt.nlp	24967364	SENT205	31	31	26	26	resveratrol	AMPK		5563	0.581
NULL	Open_Virol_J_2010_Jun_18_4_123-156.nxml.txt.nlp	20835362	SENT449	0	0	12	12	cisplatin	GADD34	PA449014	23645	0.581
NULL	Nucleic_Acids_Res_2012_Jul_20_40(13)_6270-6289.nxml.txt.nlp	22434888	SENT343	11	11	1	1	galactose	GAL	PA449725	51083	0.581
NULL	Cancer_Immunol_Immunother_2013_Aug_27_62(10)_1637-1648.nxml.txt.nlp	23982484	SENT132	21	21	18	18	lenalidomide	IL-6	PA162363968	3569	0.581
NULL	Indian_J_Pharm_Sci_2008_Jan-Feb_70(1)_102-105.nxml.txt.nlp	20390092	SENT13	0	0	2	2	lansoprazole	LAN	PA450180	9993	0.581
NULL	Cancers_(Basel)_2011_Mar_4_3(1)_1111-1128.nxml.txt.nlp	24212655	SENT925	3	3	12	12	etoposide	CD133	PA449552	8842	0.581
NULL	Diabetes_2009_Mar_58(3)_579-589.nxml.txt.nlp	19074989	SENT136	13	13	7	7	lipase	PNPLA2	PA450239	57104	0.581
NULL	Case_Rep_Ophthalmol_2011_Aug_18_2(2)_283-286.nxml.txt.nlp	21941507	SENT28	0	0	16	16	fluorescein	hole	PA164746009	80757	0.581
NULL	Cell_Commun_Signal_2011_May_15_9_13.nxml.txt.nlp	21569639	SENT3	3	3	12	12	quinacrine	p53	PA164745551	7157	0.581
NULL	J_Cardiothorac_Surg_2013_May_13_8_127.nxml.txt.nlp	23668669	SENT5	11	11	36	36	oxycodone	EDA	PA450741	1896	0.581
NULL	Breast_Cancer_Res_2012_Aug_8_14(4)_R116.nxml.txt.nlp	22873525	SENT20	45	45	11	11	trastuzumab	HER2	PA451743	2064	0.581
NULL	J_Mol_Signal_2009_Apr_28_4_2.nxml.txt.nlp	19400946	SENT124	37	37	39	39	genistein	Gen	PA165109660	348654	0.581
NULL	Drugs_R_D_2010_Nov_25_10(4)_219-224.nxml.txt.nlp	21171668	SENT98	10	10	3	3	clopidogrel	CYP2C19	PA449053	1557	0.581
NULL	ISRN_AIDS_2012_Jul_12_2012_485307.nxml.txt.nlp	24052874	SENT75	6	6	4	4	tenofovir	PTH	PA10204	5741	0.581
NULL	Cardiovasc_Diabetol_2010_Nov_5_9_72.nxml.txt.nlp	21054861	SENT110	22	22	14	14	isoproterenol	ANOVA	PA450121	4858	0.581
NULL	Br_J_Cancer_2012_Jan_17_106(2)_284-289.nxml.txt.nlp	22215065	SENT180	27	27	15	15	atrasentan	IFN	PA143414738	3439	0.581
NULL	Brain_2014_Aug_18_137(8)_2312-2328.nxml.txt.nlp	24941947	SENT275	14	14	18	18	dextran	CA3	PA449261	761	0.581
NULL	Breast_Cancer_Res_2010_Jun_28_12(3)_R43.nxml.txt.nlp	20579400	SENT280	0	0	27	27	fulvestrant	MAPT	PA164747170	4137	0.581
NULL	Pharmacogn_Rev_2011_Jul-Dec_5(10)_120-137.nxml.txt.nlp	22279370	SENT36	27	27	15	15	rofecoxib	COX2	PA451268	4513;5743	0.581
NULL	Front_Endocrinol_(Lausanne)_2014_Oct_20_5_175.nxml.txt.nlp	25368605	SENT73	13	13	11	11	estradiol	SDHA	PA449503	6389	0.581
NULL	Diabetes_Obes_Metab_2010_May_12(5)_437-441.nxml.txt.nlp	20415692	SENT84	1	1	17	17	glucose	GLA	PA449773	9027;2717	0.581
NULL	J_Cell_Biol_1998_Jul_13_142(1)_129-138.nxml.txt.nlp	9660868	SENT166	16	16	8	8	chymotrypsin	p55	PA448994	6624;2078;8503;5718	0.581
NULL	Nat_Biotechnol_2009_Jun_17_27(6)_567-571.nxml.txt.nlp	19448630	SENT124	33	33	42	42	l-glutamine	IL2	PA10090	3558	0.581
NULL	Oncotarget_2011_May_16_2(5)_418-421.nxml.txt.nlp	21789791	SENT28	36	36	34	34	bortezomib	TRAIL	PA10252	8743	0.581
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT272	25	25	15	15	cisplatin	UNG	PA449014	7374	0.581
NULL	Case_Rep_Oncol_2014_Sep_25_7(3)_669-672.nxml.txt.nlp	25408661	SENT9	0	0	15	15	aprepitant	CYP3A4	PA164747039	1576	0.581
NULL	EMBO_Mol_Med_2011_May_3(5)_266-278.nxml.txt.nlp	21438154	SENT280	7	7	10	10	oxaliplatin	TRPM8	PA131285527	79054	0.581
NULL	Clinicoecon_Outcomes_Res_2014_Dec_17_7_17-25.nxml.txt.nlp	25565871	SENT23	0	0	12	12	desmopressin	VWF	PA449237	7450	0.581
NULL	Acta_Histochem_Cytochem_2014_Jun_28_47(3)_103-112.nxml.txt.nlp	25320407	SENT209	22	22	18	18	estradiol	aromatase	PA449503	1588	0.581
NULL	Clin_Med_Insights_Oncol_2013_Jun_20_7_137-149.nxml.txt.nlp	23843723	SENT273	5	5	14	14	imatinib	KIT	PA10804	3815	0.581
NULL	Curr_Chem_Genomics_2008_May_23_1_54-64.nxml.txt.nlp	20161828	SENT149	9	9	11	11	staurosporine	PI3K	PA165109623	5290	0.581
NULL	Oncol_Lett_2014_Sep_11_8(3)_1222-1228.nxml.txt.nlp	25120693	SENT140	27	27	8	8	olaparib	XRCC2		7516	0.581
NULL	Br_J_Cancer_2010_Nov_2_103(11)_1680-1691.nxml.txt.nlp	21045833	SENT186	11	11	34	34	capecitabine	p53	PA448771	7157	0.581
NULL	Front_Behav_Neurosci_2012_Mar_14_6_9.nxml.txt.nlp	22457644	SENT272	0	0	9	9	echinacea	CB2	PA131550706	1269	0.581
NULL	Nat_Neurosci_2012_Mar_4_15(4)_565-573.nxml.txt.nlp	22388960	SENT446	19	19	12	12	isoflurane	Hv1	PA450106	84329	0.581
NULL	Biomed_Res_Int_2013_Aug_4_2013_315848.nxml.txt.nlp	23984340	SENT151	39	39	19	19	glucose	GLP	PA449773	342096	0.581
NULL	Curr_Oncol_2008_Oct_15(5)_229-233.nxml.txt.nlp	19008997	SENT136	21	21	13	13	chlorambucil	Yes	PA448926	7525	0.581
NULL	eLife_2013_Nov_5_2_e00969.nxml.txt.nlp	24192036	SENT363	19	19	16	16	doxorubicin	p38	PA449412	10598;1432;7965	0.581
NULL	Eur_J_Clin_Pharmacol_2014_Oct_8_70(1)_37-45.nxml.txt.nlp	24100471	SENT54	20	20	14	14	omeprazole	CYP3A4	PA450704	1576	0.581
NULL	Biosci_Microbiota_Food_Health_2014_Jan_30_33(1)_31-40.nxml.txt.nlp	24936380	SENT79	16	16	14	14	nadh	mol	PA164755085	90527	0.581
NULL	Br_J_Cancer_2013_Feb_5_108(2)_469-476.nxml.txt.nlp	23169292	SENT174	8	8	10	10	erlotinib	Gem	PA134687924	51053	0.581
NULL	Front_Cell_Neurosci_2015_Jan_6_8_426.nxml.txt.nlp	25610369	SENT651	4	4	9	9	lipase	AT1	PA450239	9197;185	0.581
NULL	Diabetes_Care_2009_Sep_28_32(9)_1649-1655.nxml.txt.nlp	19478198	SENT88	2	2	0	0	metformin	MET	PA450395	4233	0.581
NULL	Behav_Brain_Funct_2010_May_28_6_27.nxml.txt.nlp	20507645	SENT194	2	2	8	8	amiloride	NOS3	PA448368	4846;342977	0.581
NULL	Iran_Red_Crescent_Med_J_2013_Mar_5_15(3)_249-253.nxml.txt.nlp	23984007	SENT37	2	2	19	19	carbamazepine	B12	PA448785	7126;4709	0.581
NULL	Int_J_Mol_Sci_2014_Nov_7_15(11)_20500-20517.nxml.txt.nlp	25387078	SENT43	10	10	12	12	sorafenib	VEGFR1	PA7000	2321	0.581
NULL	Saudi_J_Anaesth_2014_Apr-Jun_8(2)_209-214.nxml.txt.nlp	24843334	SENT8	6	6	11	11	bupivacaine	C15	PA135057240	51316	0.581
NULL	Neural_Regen_Res_2013_Jul_15_8(20)_1853-1862.nxml.txt.nlp	25206494	SENT116	14	14	3	3	ethanol	JNK	PA448073	5599	0.581
NULL	Int_J_Mol_Sci_2012_Feb_24_13(3)_2590-2617.nxml.txt.nlp	22489113	SENT221	15	15	22	22	benzaldehyde	mol	PA448571	90527	0.581
NULL	Front_Genet_2012_Nov_5_3_236.nxml.txt.nlp	23133441	SENT64	6	6	10	10	efavirenz	ABCB1	PA449441	5243	0.581
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1821-1889.nxml.txt.nlp	25268160	SENT2835	19	19	7	7	erlotinib	FDG	PA134687924	23583	0.581
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_May_5_68(Pt_6)_o1638.nxml.txt.nlp	22719439	SENT3	12	12	2	2	piperazine	mol	PA450977	90527	0.581
NULL	Front_Physiol_2014_Dec_18_5_496.nxml.txt.nlp	25566092	SENT348	0	0	10	10	hyaluronan	TLR2	PA165958431	7097	0.581
NULL	Front_Neurol_2012_Dec_21_3_177.nxml.txt.nlp	23267342	SENT59	9	9	4	4	isoflurane	CO2	PA450106	4513	0.581
NULL	Osteoporos_Int_2008_Apr_12_19(4)_399-428.nxml.txt.nlp	18266020	SENT306	9	9	24	24	raloxifene	PTH	PA451221	5741	0.581
NULL	J_Vet_Med_Sci_2014_Jun_15_76(6)_813-817.nxml.txt.nlp	24531829	SENT115	17	17	8	8	primaquine	DPT	PA451103	1805	0.581
NULL	Arch_Med_Sci_2013_Aug_30_9(4)_724-730.nxml.txt.nlp	24049536	SENT35	0	0	2	2	genistein	PTH	PA165109660	5741	0.581
NULL	Br_J_Cancer_2012_Sep_4_107(6)_947-955.nxml.txt.nlp	22892392	SENT14	0	0	19	19	lapatinib	STAT6	PA152241907	6778	0.581
NULL	J_Neural_Transm_2014_Mar_27_121(10)_1221-1232.nxml.txt.nlp	24671607	SENT204	18	18	29	29	sertraline	PSD-95	PA451333	1742	0.581
NULL	Nanoscale_Res_Lett_2009_Aug_1_4(11)_1275-1285.nxml.txt.nlp	20628458	SENT85	6	6	20	20	glutaraldehyde	mol	PA449777	90527	0.581
NULL	Eur_J_Med_Res_2011_Mar_28_16(3)_115-126.nxml.txt.nlp	21486724	SENT84	23	23	36	36	metronidazole	Met	PA450484	79811	0.581
NULL	Cardiovasc_Diabetol_2007_Aug_22_6_21.nxml.txt.nlp	17714581	SENT46	17	17	36	36	l-glutamine	CO2	PA10090	4513	0.581
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT70	10	10	25	25	pemetrexed	UNG	PA10810	7374	0.581
NULL	J_Med_Genet_2013_Sep_24_50(9)_567-578.nxml.txt.nlp	23709754	SENT158	0	0	6	6	staurosporine	STAT1	PA165109623	6772	0.581
NULL	Mol_Cell_Biochem_2014_Jul_26_396(1-2)_221-228.nxml.txt.nlp	25063218	SENT217	14	14	21	21	resveratrol	CYP1A2		1544	0.581
NULL	Leukemia_2014_May_29_28(5)_1129-1131.nxml.txt.nlp	24166296	SENT58	20	20	6	6	lenalidomide	DDB1	PA162363968	1642	0.581
NULL	J_Mol_Signal_2011_Aug_10_6_8.nxml.txt.nlp	21831305	SENT163	18	18	28	28	isoproterenol	AKAP12	PA450121	9590	0.581
NULL	Chin_J_Cancer_2012_Feb_31(2)_73-99.nxml.txt.nlp	22098950	SENT131	5	5	9	9	mitoxantrone	MXR	PA450526	9429	0.581
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT78	0	0	15	15	metformin	p53	PA450395	7157	0.581
NULL	Acta_Pharmacol_Sin_2014_Jun_5_35(6)_758-769.nxml.txt.nlp	24793309	SENT25	0	0	28	28	sevoflurane	AMPK	PA451341	5563	0.581
NULL	Arthritis_Res_Ther_2012_May_1_14(3)_R99.nxml.txt.nlp	22546542	SENT234	7	7	13	13	infliximab	IL-6	PA452639	3569	0.581
NULL	Exp_Ther_Med_2014_May_20_7(5)_1354-1358.nxml.txt.nlp	24940438	SENT29	6	6	19	19	dextran	CD86	PA449261	942	0.581
NULL	J_Immunol_Res_2014_May_12_2014_897249.nxml.txt.nlp	24901013	SENT182	28	28	14	14	natalizumab	CD25	PA164747191	3669;3559	0.581
NULL	J_Oncol_2010_Nov_19_2010_568938.nxml.txt.nlp	20037743	SENT298	19	19	29	29	cetuximab	EGFR	PA10040	1956	0.581
NULL	Molecules_2013_Dec_16_18(12)_15662-15688.nxml.txt.nlp	24352021	SENT319	10	10	41	41	oxygen	TH1	PA450744	51497	0.581
NULL	J_Mol_Signal_2010_May_10_5_4.nxml.txt.nlp	20459745	SENT85	41	41	15	15	cisplatin	p53	PA449014	7157	0.581
NULL	Exp_Ther_Med_2013_Nov_13_6(5)_1317-1321.nxml.txt.nlp	24223665	SENT70	20	20	16	16	cisplatin	CD133	PA449014	8842	0.581
NULL	Braz_J_Med_Biol_Res_2014_Sep_5_47(11)_929-939.nxml.txt.nlp	25296354	SENT117	17	17	15	15	afatinib	EGFR	PA165981154	1956	0.581
NULL	Cancer_Cell_Int_2010_Sep_9_10_32.nxml.txt.nlp	20828393	SENT157	24	24	33	33	cisplatin	ATF3	PA449014	467	0.581
NULL	Nat_Med_2013_Feb_6_19(2)_217-226.nxml.txt.nlp	23291629	SENT380	23	23	18	18	isoproterenol	TRIP-Br2	PA450121	9792	0.581
NULL	Semin_Immunopathol_2013_Jul_7_35(4)_439-453.nxml.txt.nlp	23649713	SENT362	3	3	12	12	thrombin	TLR2	PA451674	7097	0.581
NULL	Exp_Ther_Med_2013_Mar_21_5(3)_987-991.nxml.txt.nlp	23407636	SENT64	0	0	6	6	losartan	IL-8	PA450268	3576	0.581
NULL	EMBO_J_2013_Feb_20_32(4)_511-523.nxml.txt.nlp	23241948	SENT127	10	10	12	12	kanamycin	FRP	PA450137	11167;6422	0.581
NULL	J_Korean_Neurosurg_Soc_2014_Jul_31_56(1)_1-4.nxml.txt.nlp	25289117	SENT19	10	10	4	4	curcumin	p38	PA151958596	10598;1432;7965	0.581
NULL	J_Hematol_Oncol_2011_Mar_26_4_11.nxml.txt.nlp	21439076	SENT138	8	8	21	21	cetuximab	Gem	PA10040	51053	0.581
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT137	0	0	8	8	curcumin	PC-3	PA151958596	692094	0.581
NULL	Front_Immunol_2012_Jun_4_3_129.nxml.txt.nlp	22675324	SENT71	16	16	14	14	ustekinumab	IL-23	PA166048654	51561	0.581
NULL	Environ_Health_Perspect_2008_Apr_16_116(4)_426-433.nxml.txt.nlp	18414622	SENT172	2	2	20	20	genistein	PC3	PA165109660	57332;7832;5122	0.581
NULL	Front_Hum_Neurosci_2013_Jul_30_7_428.nxml.txt.nlp	23908624	SENT1928	4	4	11	11	citalopram	STAR	PA449015	6770;2984	0.581
NULL	Biosci_Rep_2012_Dec_20_33(1)_e00011.nxml.txt.nlp	23137297	SENT47	23	23	15	15	heparin	RPSA	PA449855	3921	0.581
NULL	Front_Cell_Neurosci_2013_Dec_26_7_277.nxml.txt.nlp	24421756	SENT165	39	39	29	29	forskolin	B27	PA146096022	56246	0.581
NULL	Acta_Pharmacol_Sin_2011_May_18_32(5)_591-600.nxml.txt.nlp	21499286	SENT187	22	22	24	24	bezafibrate	AMPK	PA162364313	5563	0.581
NULL	Indian_J_Pharm_Sci_2013_Nov-Dec_75(6)_680-687.nxml.txt.nlp	24591743	SENT35	38	38	30	30	gemfibrozil	CYP2C8	PA449750	1558	0.581
NULL	Leukemia_2014_Mar_13_28(3)_600-608.nxml.txt.nlp	24240203	SENT215	0	0	2	2	nutlin-3	p53		7157	0.581
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Oct_13_68(Pt_11)_o3116.nxml.txt.nlp	23284441	SENT63	31	31	27	27	ethanol	mol	PA448073	90527	0.581
NULL	Indian_J_Med_Res_2013_Jan_137(1)_102-110.nxml.txt.nlp	23481058	SENT131	14	14	9	9	oxygen	EPO	PA450744	7076;8288;2056	0.581
NULL	Mol_Biol_Cell_2012_Nov_1_23(21)_4188-4202.nxml.txt.nlp	22973054	SENT117	19	19	4	4	forskolin	IL-8	PA146096022	3576	0.581
NULL	Exp_Hematol_Oncol_2014_Jan_11_3_2.nxml.txt.nlp	24410791	SENT29	9	9	20	20	afatinib	EGFR	PA165981154	1956	0.581
NULL	Acta_Pharmacol_Sin_2013_Feb_12_34(2)_247-254.nxml.txt.nlp	23147558	SENT201	27	27	11	11	doxycycline	CAL	PA449415	54751;57120	0.581
NULL	Ann_Hematol_2014_Sep_12_93(1)_13-32.nxml.txt.nlp	24026426	SENT274	17	17	31	31	caspofungin	BII	PA164743013	777	0.581
NULL	Int_J_Environ_Res_Public_Health_2011_Oct_24_8(10)_4102-4117.nxml.txt.nlp	22073031	SENT119	23	23	8	8	buprenorphine	OTP	PA448685	23440	0.581
NULL	Fibrogenesis_Tissue_Repair_2012_Jul_23_5_11.nxml.txt.nlp	22824096	SENT295	31	31	6	6	bleomycin	NAC	PA448645	22861	0.581
NULL	Diabetes_Care_2011_Jun_20_34(6)_1406-1411.nxml.txt.nlp	21515837	SENT29	22	22	27	27	glucose	LVM	PA449773	23209	0.581
NULL	Clin_Ophthalmol_2014_Sep_26_8_1967-1985.nxml.txt.nlp	25328381	SENT249	2	2	7	7	latanoprost	BAK	PA164774763	578	0.581
NULL	Crit_Care_2003_Jan_6_7(2)_130-138.nxml.txt.nlp	12720559	SENT284	21	21	0	0	thrombin	ATIII	PA451674	462	0.581
NULL	Breast_Cancer_Res_Treat_2013_Apr_6_138(3)_829-837.nxml.txt.nlp	23563958	SENT200	7	7	11	11	paclitaxel	castor	PA450761	54897	0.581
NULL	Ann_Lab_Med_2014_Jan_6_34(1)_43-50.nxml.txt.nlp	24422195	SENT66	30	30	40	40	l-glutamine	CO2	PA10090	4513	0.581
NULL	Nat_Neurosci_2012_Sep_5_15(9)_1245-1254.nxml.txt.nlp	22864611	SENT582	23	23	9	9	clozapine	mGlu2	PA449061	2912	0.581
NULL	J_Korean_Med_Sci_2013_Apr_27_28(4)_527-533.nxml.txt.nlp	23580227	SENT9	14	14	24	24	genistein	TRAIL	PA165109660	8743	0.581
NULL	J_Oncol_2012_Jun_19_2012_521215.nxml.txt.nlp	22778735	SENT76	22	22	30	30	paclitaxel	p16	PA450761	1029	0.581
NULL	J_Gen_Physiol_2000_Jun_1_115(6)_799-814.nxml.txt.nlp	10828252	SENT7	18	18	37	37	spermine	IRK1	PA164781199	3759	0.581
NULL	Endocrinology_2013_Aug_4_154(8)_2807-2820.nxml.txt.nlp	23736296	SENT468	1	1	7	7	estradiol	CA1	PA449503	759	0.581
NULL	Environ_Health_Perspect_2009_Apr_14_117(4)_645-652.nxml.txt.nlp	19440506	SENT88	7	7	17	17	diclofenac	UGT2B7	PA449293	7364	0.581
NULL	Front_Genet_2014_Jan_24_5_3.nxml.txt.nlp	24478792	SENT250	13	13	18	18	cisapride	eag	PA449011	3756	0.581
NULL	Pharmaceutics_2012_Oct_26_4(4)_551-562.nxml.txt.nlp	24300370	SENT10	8	8	6	6	dimenhydrinate	ODF	PA449338	8600	0.581
NULL	Mol_Cell_Biochem_2014_Oct_9_385(1-2)_265-275.nxml.txt.nlp	24104452	SENT137	0	0	6	6	bortezomib	U87	PA10252	677775;641648	0.581
NULL	J_Cell_Mol_Med_2014_Oct_11_18(10)_2031-2043.nxml.txt.nlp	25109475	SENT138	5	5	12	12	valsartan	AMPK	PA451848	5563	0.581
NULL	Cancers_(Basel)_2013_Jun_24_5(3)_762-785.nxml.txt.nlp	24202320	SENT331	6	6	2	2	suramin	PF4	PA10292	5196	0.581
NULL	Front_Endocrinol_(Lausanne)_2013_Jan_7_3_180.nxml.txt.nlp	23316185	SENT269	16	16	4	4	glucose	CRF2	PA449773	1395	0.581
NULL	J_Clin_Biochem_Nutr_2009_Sep_28_45(2)_125-130.nxml.txt.nlp	19794918	SENT9	8	8	18	18	omeprazole	HO-1	PA450704	3162	0.581
NULL	Front_Pharmacol_2014_Dec_10_5_274.nxml.txt.nlp	25540623	SENT789	10	10	14	14	sitagliptin	GLP-1	PA164748978	100125288	0.581
NULL	Front_Neural_Circuits_2013_Feb_12_7_14.nxml.txt.nlp	23407806	SENT759	3	3	10	10	zolpidem	CA1	PA451976	759	0.581
NULL	Cell_Regen_(Lond)_2012_Jun_28_1(1)_3.nxml.txt.nlp	25408866	SENT138	13	13	5	5	glucose	MSC	PA449773	9242	0.581
NULL	J_Cell_Biol_2005_Nov_7_171(3)_559-568.nxml.txt.nlp	16275757	SENT106	26	26	30	30	heparin	CCN1	PA449855	3491	0.581
NULL	Fibrogenesis_Tissue_Repair_2012_Jul_23_5_11.nxml.txt.nlp	22824096	SENT385	2	2	7	7	bleomycin	PAR-1	PA448645	2011;2149	0.581
NULL	J_Immunother_Cancer_2014_Jan_27_2_2.nxml.txt.nlp	24829759	SENT101	2	2	14	14	sorafenib	IL-21	PA7000	59067;50616;27189	0.581
NULL	Breast_Cancer_Res_2010_Oct_26_12(5)_210.nxml.txt.nlp	21067538	SENT61	26	26	24	24	urokinase	RhoC	PA451836	389	0.581
NULL	Curr_Neuropharmacol_2013_May_11(3)_263-275.nxml.txt.nlp	24179463	SENT296	19	19	6	6	fluoxetine	beta-catenin	PA449673	1499	0.581
NULL	Emerg_Infect_Dis_2011_Mar_17(3)_495-497.nxml.txt.nlp	21392442	SENT32	37	37	9	9	capreomycin	EMB	PA164746226	133418	0.581
NULL	J_Clin_Biochem_Nutr_2010_Jan_29_46(1)_43-51.nxml.txt.nlp	20104264	SENT118	8	8	17	17	napqi	CYP3A		1574	0.581
NULL	Oncotarget_2013_Jul_5_4(7)_984-994.nxml.txt.nlp	23846322	SENT148	16	16	12	12	resveratrol	SIRT1		23411	0.581
NULL	Front_Immunol_2012_Feb_27_3_23.nxml.txt.nlp	22566907	SENT752	0	0	4	4	hyaluronan	CD44	PA165958431	960	0.581
NULL	Oncol_Lett_2014_Mar_27_7(3)_820-826.nxml.txt.nlp	24520300	SENT53	14	14	16	16	cyclophosphamide	CTX	PA449165	1593	0.581
NULL	Evid_Based_Complement_Alternat_Med_2013_Mar_27_2013_352019.nxml.txt.nlp	23606878	SENT3	5	5	13	13	ethanol	flower	PA448073	11094	0.581
NULL	Br_J_Cancer_2012_Oct_23_107(9)_1518-1524.nxml.txt.nlp	22996610	SENT174	41	41	6	6	oxaliplatin	CEA	PA131285527	5670;1087	0.581
NULL	Arch_Med_Sci_2013_Aug_30_9(4)_724-730.nxml.txt.nlp	24049536	SENT89	15	15	6	6	genistein	PTH	PA165109660	5741	0.581
NULL	Acta_Histochem_Cytochem_2011_Apr_28_44(2)_51-60.nxml.txt.nlp	21614166	SENT113	3	3	14	14	thalidomide	PCNA	PA451644	5111	0.581
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Jun_14_70(Pt_7)_o778.nxml.txt.nlp	25161565	SENT59	28	28	24	24	ethanol	mol	PA448073	90527	0.581
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT307	19	19	31	31	cisplatin	FasL	PA449014	356	0.581
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT285	10	10	4	4	gefitinib	ATV	PA131301952	4683	0.581
NULL	Adv_Appl_Bioinforma_Chem_2008_Oct_30_1_85-98.nxml.txt.nlp	21918608	SENT72	26	26	6	6	bortezomib	SPARC	PA10252	6678	0.581
NULL	J_Cell_Biol_1997_May_5_137(3)_729-742.nxml.txt.nlp	9151677	SENT71	37	37	7	7	ethanol	CO2	PA448073	4513	0.581
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT171	2	2	0	0	dasatinib	PP2	PA162372878	4888	0.581
NULL	Mol_Clin_Oncol_2013_Sep_12_1(5)_911-917.nxml.txt.nlp	24649270	SENT117	6	6	4	4	cyclophosphamide	CHOP	PA449165	1649	0.581
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_21-38.nxml.txt.nlp	19305786	SENT350	3	3	17	17	menthol	TRPV3	PA164776605	162514	0.581
NULL	Exp_Ther_Med_2013_Jun_9_5(6)_1770-1774.nxml.txt.nlp	23837071	SENT22	1	1	18	18	coumarin	TRAIL	PA134521193	8743	0.581
NULL	Breast_Cancer_Res_2011_Nov_23_13(6)_R116.nxml.txt.nlp	22113133	SENT444	37	37	6	6	tamoxifen	p53	PA451581	7157	0.581
NULL	Adv_Biomed_Res_2013_Jul_30_2_66.nxml.txt.nlp	24223381	SENT49	32	32	22	22	doxepin	Ray	PA449409	26751	0.581
NULL	Drug_Target_Insights_2007_Oct_30_2_239-247.nxml.txt.nlp	21901078	SENT22	9	9	23	23	infliximab	p75	PA452639	7133;11168	0.581
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT88	19	19	21	21	perifosine	TRAIL	PA165291471	8743	0.581
NULL	Neural_Regen_Res_2014_Nov_1_9(21)_1897-1901.nxml.txt.nlp	25558239	SENT90	0	0	10	10	diazepam	CA1	PA449283	759	0.581
NULL	Patient_Prefer_Adherence_2010_Sep_7_4_313-324.nxml.txt.nlp	20859458	SENT256	17	17	8	8	exenatide	PPG	PA164749238	5552	0.581
NULL	Indian_J_Anaesth_2011_Nov-Dec_55(6)_567-572.nxml.txt.nlp	22223899	SENT46	17	17	23	23	isoflurane	NAC	PA450106	22861	0.581
NULL	Ann_Intensive_Care_2011_May_25_1_14.nxml.txt.nlp	21906345	SENT23	39	39	17	17	meropenem	SAPS	PA164764445	8935	0.58
NULL	Curr_Neuropharmacol_2010_Sep_8(3)_168-181.nxml.txt.nlp	21358968	SENT485	4	4	24	24	fluoxetine	AANAT	PA449673	15	0.58
NULL	Cell_J_2011_Aug_24_Summer_13(2)_117-126.nxml.txt.nlp	23508136	SENT42	6	6	33	33	heparin	BMP2	PA449855	650	0.58
NULL	FEBS_Open_Bio_2014_Oct_22_4_905-914.nxml.txt.nlp	25383314	SENT13	2	2	17	17	physostigmine	L-FABP	PA450957	2168	0.58
NULL	Cell_Cycle_2013_Jun_15_12(12)_1811-1812.nxml.txt.nlp	23708513	SENT5	11	11	24	24	rituximab	CHOP	PA451261	1649	0.58
NULL	Mol_Cancer_2010_Dec_20_9_316.nxml.txt.nlp	21172016	SENT351	15	15	10	10	heparin	CCL21	PA449855	6366	0.58
NULL	Iran_J_Basic_Med_Sci_2011_Jul-Aug_14(4)_308-317.nxml.txt.nlp	23492971	SENT86	14	14	23	23	doxorubicin	P-gp	PA449412	5243	0.58
NULL	Infect_Dis_Ther_2013_Dec_3_2(2)_111-122.nxml.txt.nlp	25134475	SENT173	7	7	12	12	ritonavir	CD36	PA451260	948	0.58
NULL	Br_J_Cancer_2009_Oct_6_101(7)_1044-1050.nxml.txt.nlp	19738609	SENT1	7	7	35	35	vorinostat	San	PA164748224	80218	0.58
NULL	J_Gen_Physiol_2010_Jul_136(1)_29-34.nxml.txt.nlp	20584890	SENT174	15	15	5	5	losartan	RYR	PA450268	6261	0.58
NULL	FASEB_J_2014_Jun_28(6)_2441-2454.nxml.txt.nlp	24577121	SENT35	27	27	22	22	neomycin	PGK	PA450608	5592	0.58
NULL	Nat_Med_2013_Dec_10_19(12)_10_1038_nm_3385.nxml.txt.nlp	24216752	SENT38	3	3	6	6	thrombin	PAR4	PA451674	9002;5074	0.58
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Nov_25_65(Pt_12)_o3216.nxml.txt.nlp	21578924	SENT4	20	20	2	2	coumarin	mol	PA134521193	90527	0.58
NULL	AMB_Express_2012_Jul_29_2_38.nxml.txt.nlp	22838397	SENT32	8	8	23	23	ethanol	EPG	PA448073	255324	0.58
NULL	Cardiovasc_Res_2011_Apr_1_90(1)_140-147.nxml.txt.nlp	21071431	SENT81	0	0	4	4	resveratrol	ROS		6098	0.58
NULL	Infect_Dis_Ther_2014_Jun_18_3(1)_35-43.nxml.txt.nlp	25134810	SENT167	7	7	16	16	oxacillin	VISA	PA450725	57506	0.58
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT434	26	26	20	20	forskolin	IL-6	PA146096022	3569	0.58
NULL	J_Biol_Chem_2013_Feb_8_288(6)_3918-3928.nxml.txt.nlp	23239877	SENT98	6	6	18	18	paraformaldehyde	LSR	PA450790	51599	0.58
NULL	J_Cell_Biol_2005_Nov_21_171(4)_729-738.nxml.txt.nlp	16286510	SENT171	12	12	26	26	heparin	MMP7	PA449855	4316	0.58
NULL	Iran_J_Pharm_Res_2014_Summer_13(3)_975-985.nxml.txt.nlp	25276199	SENT181	36	36	14	14	vasopressin	SON	PA451858	6651	0.58
NULL	J_Clin_Biochem_Nutr_2010_Jan_29_46(1)_36-42.nxml.txt.nlp	20104263	SENT62	10	10	6	6	ribavirin	IFN	PA451241	3439	0.58
NULL	Mol_Cancer_2013_Sep_11_12_104.nxml.txt.nlp	24025152	SENT218	5	5	2	2	gemcitabine	STAT3	PA449748	6774	0.58
NULL	J_Gen_Physiol_1923_Jan_20_5(3)_415.nxml.txt.nlp	19872006	SENT0	26	26	1	1	trypsin	Gen	PA451806	348654	0.58
NULL	Indian_J_Pharm_Sci_2013_May-Jun_75(3)_302-309.nxml.txt.nlp	24082346	SENT183	17	17	8	8	diclofenac	SRMS	PA449293	6725	0.58
NULL	J_Med_Case_Reports_2011_Feb_25_5_83.nxml.txt.nlp	21352527	SENT40	23	23	34	34	neostigmine	USP30	PA450611	84749	0.58
NULL	Pharmaceutics_2011_Aug_31_3(3)_582-600.nxml.txt.nlp	24310598	SENT248	14	14	28	28	theophylline	TC4	PA451647	5901	0.58
NULL	J_Cancer_2012_Aug_24_3_354-361.nxml.txt.nlp	22962562	SENT178	11	11	8	8	fludarabine	CLB	PA449655	171425	0.58
NULL	Mol_Cancer_2006_Oct_17_5_45.nxml.txt.nlp	17044934	SENT66	0	0	2	2	resveratrol	COX		1351	0.58
NULL	Oncoimmunology_2013_Mar_1_2(3)_e23403.nxml.txt.nlp	23802081	SENT88	15	15	11	11	cyclophosphamide	GM-CSF	PA449165	1437	0.58
NULL	Cell_J_2012_Dec_22_Winter_13(4)_265-274.nxml.txt.nlp	23507995	SENT29	2	2	7	7	ethanol	CA1	PA448073	759	0.58
NULL	Acta_Pharmacol_Sin_2013_Sep_5_34(9)_1192-1200.nxml.txt.nlp	23685957	SENT198	11	11	13	13	curcumin	AP-2	PA151958596	7020	0.58
NULL	Oncol_Lett_2014_Mar_19_7(3)_674-678.nxml.txt.nlp	24527071	SENT107	9	9	7	7	cisplatin	AKR1C2	PA449014	1646	0.58
NULL	Ann_Neurosci_2014_Jul_21(3)_97-103.nxml.txt.nlp	25206073	SENT51	14	14	23	23	bumetanide	WNK1	PA448682	65125	0.58
NULL	J_Thromb_Thrombolysis_2009_Nov_6_28(4)_410-417.nxml.txt.nlp	19504052	SENT96	15	15	0	0	clopidogrel	CD40L	PA449053	959	0.58
NULL	Mol_Vis_2012_Jan_18_18_121-127.nxml.txt.nlp	22275803	SENT93	38	38	8	8	ranibizumab	CD36	PA164746012	948	0.58
NULL	Ann_Hematol_2012_Sep_28_91(9)_1499-1500.nxml.txt.nlp	22281990	SENT22	9	9	11	11	rituximab	CHOP	PA451261	1649	0.58
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Nov_26_64(Pt_12)_o2446.nxml.txt.nlp	21581414	SENT9	16	16	6	6	piperazine	mol	PA450977	90527	0.58
NULL	J_Korean_Neurosurg_Soc_2013_Mar_31_53(3)_139-144.nxml.txt.nlp	23634262	SENT144	7	7	19	19	isoflurane	CA3	PA450106	761	0.58
NULL	Int_J_Fertil_Steril_2012_Dec_17_Oct-Dec_6(3)_165-174.nxml.txt.nlp	24520434	SENT195	10	10	18	18	protamine	HSPA2	PA10366	3306	0.58
NULL	Diabetes_2008_Oct_57(10)_2801-2808.nxml.txt.nlp	18633115	SENT10	16	16	27	27	sulfasalazine	p50	PA451547	958;4790	0.58
NULL	Acta_Neuropathol_2010_Nov_17_120(5)_567-584.nxml.txt.nlp	20714900	SENT311	17	17	7	7	temozolomide	MSH6	PA451609	2956	0.58
NULL	Clin_Ophthalmol_2007_Sep_1(3)_297-303.nxml.txt.nlp	19668484	SENT137	2	2	8	8	cyclosporine	MDR1	PA449167	5243	0.58
NULL	Front_Oncol_2014_Sep_23_4_252.nxml.txt.nlp	25295225	SENT151	7	7	2	2	doxycycline	PI3K	PA449415	5290	0.58
NULL	Amino_Acids_2012_Oct_10_43(4)_1751-1759.nxml.txt.nlp	22407485	SENT136	25	25	10	10	carrageenan	DAG	PA448814	1605	0.58
NULL	Breast_Cancer_Res_2014_Sep_9_16(5)_433.nxml.txt.nlp	25212966	SENT242	0	0	34	34	aprotinin	ILEI	PA448472	10447	0.58
NULL	Diabetes_2008_Sep_57(9)_2470-2479.nxml.txt.nlp	18511847	SENT127	0	0	18	18	pioglitazone	ANOVA	PA450970	4858	0.58
NULL	Exp_Ther_Med_2013_Jun_19_5(6)_1697-1700.nxml.txt.nlp	23837057	SENT78	18	18	26	26	heparin	HPSE	PA449855	10855	0.58
NULL	Br_J_Clin_Pharmacol_2014_Nov_20_78(5)_1050-1057.nxml.txt.nlp	24962564	SENT3	19	19	24	24	ketoconazole	CYP3A4	PA450146	1576	0.58
NULL	Br_J_Cancer_2013_Dec_10_109(12)_2954-2958.nxml.txt.nlp	24231949	SENT74	14	14	25	25	gemcitabine	p53	PA449748	7157	0.58
NULL	Environ_Health_Perspect_2011_Apr_16_119(4)_534-541.nxml.txt.nlp	21081300	SENT190	11	11	20	20	phenol	DES	PA450913	1674	0.58
NULL	J_Biomed_Biotechnol_2011_Dec_6_2011_856985.nxml.txt.nlp	21188173	SENT277	26	26	11	11	tamoxifen	EGFR	PA451581	1956	0.58
NULL	Thorax_2014_Jan_7_69(1)_14-23.nxml.txt.nlp	23925644	SENT83	13	13	1	1	salmeterol	ANOVA	PA451300	4858	0.58
NULL	J_Ophthalmol_2012_Aug_27_2012_285851.nxml.txt.nlp	23050121	SENT126	0	0	25	25	travoprost	BAK	PA164781371	578	0.58
NULL	J_Korean_Med_Sci_2011_Jan_22_26(1)_47-52.nxml.txt.nlp	21218029	SENT141	15	15	5	5	creatine	H-FABP	PA164778930	2170	0.58
NULL	Diabetes_Care_2010_Nov_33(11)_2399-2405.nxml.txt.nlp	20980427	SENT109	25	25	16	16	ranibizumab	CRT	PA164746012	811	0.58
NULL	Hum_Mol_Genet_2013_Nov_15_22(22)_4602-4615.nxml.txt.nlp	23814040	SENT144	31	31	24	24	l-cysteine	NDUFB8	PA449173	4714	0.58
NULL	Biologics_2013_Jun_19_7_149-159.nxml.txt.nlp	23818756	SENT38	3	3	1	1	sirolimus	DES	PA451365	1674	0.58
NULL	Brain_Behav_2012_Mar_2(2)_155-177.nxml.txt.nlp	22574283	SENT8	21	21	9	9	lipase	p38	PA450239	10598;1432;7965	0.58
NULL	J_Korean_Med_Sci_2014_Jul_11_29(7)_965-972.nxml.txt.nlp	25045229	SENT95	26	26	6	6	metformin	B12	PA450395	7126;4709	0.58
NULL	ScientificWorldJournal_2014_Feb_11_2014_898361.nxml.txt.nlp	24678280	SENT86	5	5	15	15	curcumin	IL-4	PA151958596	3565	0.58
NULL	J_Inflamm_(Lond)_2008_Jul_24_5_10.nxml.txt.nlp	18652680	SENT120	12	12	34	34	estradiol	IL-6	PA449503	3569	0.58
NULL	Biologics_2009_Sep_15_3_429-441.nxml.txt.nlp	19774210	SENT300	37	37	35	35	irinotecan	IFL	PA450085	3439	0.58
NULL	Mol_Cancer_2014_Jun_16_13_152.nxml.txt.nlp	24935000	SENT126	8	8	26	26	everolimus	PTEN	PA164746311	5728	0.58
NULL	Neural_Regen_Res_2013_Jul_15_8(20)_1853-1862.nxml.txt.nlp	25206494	SENT179	21	21	15	15	ethanol	p53	PA448073	7157	0.58
NULL	Semin_Immunopathol_2013_May_10_35(3)_351-373.nxml.txt.nlp	23572207	SENT366	0	0	12	12	bortezomib	JNK	PA10252	5599	0.58
NULL	Curr_Gerontol_Geriatr_Res_2011_May_11_2011_624156.nxml.txt.nlp	21765826	SENT285	21	21	29	29	verapamil	CYP3A4	PA451868	1576	0.58
NULL	Cardiovasc_Res_2012_Mar_15_93(4)_674-681.nxml.txt.nlp	22166712	SENT140	3	3	6	6	clopidogrel	CYP3A	PA449053	1574	0.58
NULL	J_Cell_Biol_2007_Apr_23_177(2)_329-341.nxml.txt.nlp	17438075	SENT382	26	26	19	19	glutaraldehyde	PAG	PA449777	55824	0.58
NULL	Arch_Med_Sci_2014_Oct_27_10(5)_1007-1018.nxml.txt.nlp	25395954	SENT178	17	17	23	23	idarubicin	CTX	PA449961	1593	0.58
NULL	Indian_Dermatol_Online_J_2011_Jul-Dec_2(2)_111-119.nxml.txt.nlp	23130241	SENT214	4	4	10	10	methotrexate	FAE	PA450428	2178	0.58
NULL	Neuroscience_2009_Jun_30_161(2-3)_572-577.nxml.txt.nlp	19327387	SENT499	26	26	4	4	capsaicin	NAPE-PLD	PA448776	222236	0.58
NULL	J_Cell_Mol_Med_2014_Jul_30_18(7)_1392-1406.nxml.txt.nlp	24779927	SENT322	0	0	5	5	curcumin	RhoA	PA151958596	387	0.58
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1051.nxml.txt.nlp	24503543	SENT144	12	12	19	19	sunitinib	Yes	PA162372840	7525	0.58
NULL	Diabetes_Care_2013_Jan_11_36(1)_e13.nxml.txt.nlp	23264296	SENT7	5	5	10	10	vildagliptin	GLP-1	PA165958346	100125288	0.58
NULL	J_Immunol_Res_2014_Feb_9_2014_897487.nxml.txt.nlp	24741630	SENT20	8	8	11	11	heparin	CCR2	PA449855	729230	0.58
NULL	EMBO_Mol_Med_2013_Jun_30_5(6)_935-948.nxml.txt.nlp	23629957	SENT260	10	10	15	15	cisplatin	ANOVA	PA449014	4858	0.58
NULL	Cancer_Causes_Control_2013_Aug_18_24(8)_1605-1614.nxml.txt.nlp	23775025	SENT64	38	38	30	30	epirubicin	MTHFR	PA449476	4524	0.58
NULL	Contemp_Oncol_(Pozn)_2012_Sep_29_16(4)_279-284.nxml.txt.nlp	23788895	SENT119	21	21	0	0	doxorubicin	MMP7	PA449412	4316	0.58
NULL	J_Immunother_Cancer_2013_Sep_23_1_16.nxml.txt.nlp	24829752	SENT19	23	23	7	7	methylcholanthrene	IFN	PA165816878	3439	0.58
NULL	Oxid_Med_Cell_Longev_2013_Apr_17_2013_737591.nxml.txt.nlp	23710289	SENT165	10	10	3	3	ethanol	NRF2	PA448073	2551;4780	0.58
NULL	Cancer_Causes_Control_2013_Aug_18_24(8)_1605-1614.nxml.txt.nlp	23775025	SENT64	38	38	22	22	epirubicin	GSTM2	PA449476	2946	0.58
NULL	Cell_J_2012_Jun_13_Spring_14(1)_7-18.nxml.txt.nlp	23626932	SENT282	38	38	35	35	lipase	castor	PA450239	54897	0.58
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT454	21	21	17	17	iloperidone	5-HT2A	PA161199368	3356	0.58
NULL	Psychiatry_Investig_2010_Dec_30_7(4)_236-242.nxml.txt.nlp	21253406	SENT78	29	29	7	7	citalopram	BDNF	PA449015	627	0.58
NULL	Anal_Bioanal_Chem_2013_Jul_23_405(23)_7337-7345.nxml.txt.nlp	23877175	SENT16	15	15	9	9	creatine	CA3	PA164778930	761	0.58
NULL	Int_J_Mol_Sci_2013_Apr_26_14(5)_9111-9125.nxml.txt.nlp	23624604	SENT92	3	3	15	15	iron	gamma	PA450087	9913	0.58
NULL	Aging_(Albany_NY)_2010_Dec_20_2(12)_959-968.nxml.txt.nlp	21191146	SENT82	25	25	19	19	cisplatin	LKB1	PA449014	6794	0.58
NULL	Endocrinol_Metab_(Seoul)_2014_Sep_25_29(3)_379-387.nxml.txt.nlp	25309798	SENT113	25	25	19	19	resveratrol	BMAL1		406	0.58
NULL	Allergy_Asthma_Immunol_Res_2014_Mar_5_6(2)_175-178.nxml.txt.nlp	24587956	SENT98	18	18	38	38	formoterol	ACT	PA134687907	12;11332;9457;641455	0.58
NULL	J_Cell_Biol_2004_Jul_5_166(1)_97-109.nxml.txt.nlp	15240572	SENT220	12	12	8	8	heparin	FGF2	PA449855	2247;2258	0.58
NULL	Acta_Pharmacol_Sin_2011_Oct_5_32(10)_1276-1284.nxml.txt.nlp	21970838	SENT35	17	17	2	2	sulfaphenazole	KET	PA130231310	8626	0.58
NULL	Cancers_(Basel)_2010_Jun_14_2(2)_1288-1311.nxml.txt.nlp	24281116	SENT2	7	7	17	17	oxygen	ROS	PA450744	6098	0.58
NULL	Acta_Neuropathol_Commun_2014_Oct_21_2(1)_149.nxml.txt.nlp	NULL	SENT186	9	9	20	20	riluzole	gamma	PA451251	9913	0.58
NULL	Autoimmune_Dis_2012_Feb_2_2012_374635.nxml.txt.nlp	22400102	SENT34	24	24	17	17	methimazole	IFN	PA450422	3439	0.58
NULL	Curr_Neuropharmacol_2013_Jul_11(4)_338-378.nxml.txt.nlp	24381528	SENT693	3	3	6	6	curcumin	CD105	PA151958596	2022	0.58
NULL	J_Mol_Signal_2014_Aug_8_9_8.nxml.txt.nlp	25237386	SENT84	12	12	10	10	ns-398	PTGS2		5743	0.58
NULL	Front_Immunol_2013_Oct_7_4_317.nxml.txt.nlp	24109482	SENT55	21	21	28	28	l-glutamine	CO2	PA10090	4513	0.58
NULL	Eur_J_Clin_Pharmacol_2011_May_8_67(5)_493-506.nxml.txt.nlp	21140139	SENT8	18	18	2	2	oxycodone	CYP3A4	PA450741	1576	0.58
NULL	Behav_Brain_Funct_2011_Dec_31_7_50.nxml.txt.nlp	22208616	SENT159	0	0	2	2	pp2	PP4		5531	0.58
NULL	Breast_Cancer_Res_2010_Oct_22_12(Suppl_2)_S1.nxml.txt.nlp	21050422	SENT464	34	34	10	10	cetuximab	San	PA10040	80218	0.58
NULL	Br_J_Cancer_2003_Mar_10_88(5)_754-759.nxml.txt.nlp	12618886	SENT137	14	14	26	26	amifostine	p53	PA448365	7157	0.58
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT66	0	0	9	9	bevacizumab	San	PA130232992	80218	0.58
NULL	Arthritis_Res_Ther_2005_May_18_7(Suppl_3)_S13-S18.nxml.txt.nlp	15960817	SENT77	15	15	0	0	rituximab	CTX	PA451261	1593	0.58
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_10_2014_838101.nxml.txt.nlp	25435894	SENT457	10	10	15	15	curcumin	PPARgamma	PA151958596	5468	0.58
NULL	Crit_Care_2008_Nov_26_12(Suppl_6)_S2.nxml.txt.nlp	19105795	SENT81	4	4	16	16	urea	DBP	PA451831	3295;1628;2638	0.58
NULL	Kidney_Int_Suppl_(2011)_2012_Mar_29_2(1)_69-88.nxml.txt.nlp	25018920	SENT129	22	22	14	14	iloprost	NAC	PA164746843	22861	0.58
NULL	Leukemia_2013_Jan_11_27(1)_32-40.nxml.txt.nlp	22781593	SENT237	0	0	4	4	ponatinib	ZNF112	PA165980594	7771	0.58
NULL	Mol_Cancer_2010_Nov_13_9_293.nxml.txt.nlp	21073737	SENT56	14	14	16	16	lipase	ANGPTL4	PA450239	51129	0.58
NULL	Acta_Pharmacol_Sin_2012_Jan_3_33(1)_49-56.nxml.txt.nlp	22212430	SENT154	2	2	8	8	thrombin	JNK	PA451674	5599	0.58
NULL	Oncol_Lett_2014_May_11_7(5)_1401-1408.nxml.txt.nlp	24765145	SENT121	0	0	5	5	paclitaxel	PI3K	PA450761	5290	0.58
NULL	Clin_Transl_Allergy_2014_Apr_15_4_14.nxml.txt.nlp	24735832	SENT532	19	19	12	12	itraconazole	NNT	PA450132	23530	0.58
NULL	Br_J_Cancer_2013_Oct_15_109(8)_2096-2105.nxml.txt.nlp	24064970	SENT143	19	19	29	29	erlotinib	ERCC1	PA134687924	2067	0.58
NULL	Cells_2014_May_23_3(2)_517-545.nxml.txt.nlp	24861977	SENT19	1	1	4	4	capsaicin	TRPV1	PA448776	7442	0.58
NULL	Cancers_(Basel)_2014_Aug_29_6(3)_1753-1768.nxml.txt.nlp	25256831	SENT547	1	1	22	22	bevacizumab	S17	PA130232992	6218	0.58
NULL	J_Radiat_Res_2012_Sep_22_53(5)_735-741.nxml.txt.nlp	22843374	SENT121	19	19	9	9	cisplatin	CRT	PA449014	811	0.58
NULL	J_Skin_Cancer_2012_Dec_13_2012_147863.nxml.txt.nlp	23316365	SENT134	13	13	10	10	curcumin	IL6	PA151958596	3569	0.58
NULL	Clin_Ophthalmol_2008_Mar_2(1)_159-166.nxml.txt.nlp	19668400	SENT162	22	22	14	14	fluorescein	CRT	PA164746009	811	0.58
NULL	Front_Physiol_2013_May_16_4_111.nxml.txt.nlp	23720634	SENT1792	17	17	10	10	curcumin	BACE1	PA151958596	23621	0.58
NULL	Environ_Health_Perspect_2009_May_7_117(5)_757-762.nxml.txt.nlp	19479018	SENT98	14	14	16	16	cetrorelix	CRX	PA164764506	1406	0.58
NULL	Front_Endocrinol_(Lausanne)_2013_Jan_2_3_174.nxml.txt.nlp	23293631	SENT175	17	17	22	22	creatine	UII	PA164778930	10911	0.58
NULL	Oncotarget_2014_Jun_26_5(12)_3996-4010.nxml.txt.nlp	24994118	SENT190	20	20	8	8	dasatinib	BRAF	PA162372878	673	0.58
NULL	BMJ_2014_Apr_24_348_g2780.nxml.txt.nlp	24764569	SENT33	33	33	19	19	vildagliptin	GLP-1	PA165958346	100125288	0.58
NULL	Cell_Death_Dis_2011_Aug_11_2(8)_e191.nxml.txt.nlp	21833029	SENT61	11	11	28	28	oxaliplatin	CT26	PA131285527	168400	0.58
NULL	Breast_Cancer_Res_2014_Sep_11_16(5)_430.nxml.txt.nlp	25212826	SENT201	2	2	31	31	doxycycline	PTEN	PA449415	5728	0.58
NULL	Oncotarget_2011_Dec_15_2(12)_984-996.nxml.txt.nlp	22184287	SENT187	35	35	23	23	olaparib	gamma		9913	0.58
NULL	Chemother_Res_Pract_2011_Sep_21_2011_839742.nxml.txt.nlp	22295206	SENT144	30	30	20	20	oxaliplatin	CRT	PA131285527	811	0.58
NULL	Cancer_Cell_Int_2011_Jun_1_11_15.nxml.txt.nlp	21631944	SENT146	24	24	31	31	etoposide	MICB	PA449552	4277	0.58
NULL	EJC_Suppl_2013_Sep_5_11(2)_278-280.nxml.txt.nlp	NULL	SENT105	2	2	11	11	dacarbazine	BRAF	PA449197	673	0.58
NULL	Cancers_(Basel)_2012_Oct_29_4(4)_1146-1160.nxml.txt.nlp	24213502	SENT620	1	1	6	6	metformin	HER-2	PA450395	2064	0.58
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Jun_27_5_15.nxml.txt.nlp	16803618	SENT178	32	32	42	42	ciprofloxacin	GEN1	PA449009	348654	0.58
NULL	J_Biol_Chem_2009_Aug_21_284(34)_22926-22937.nxml.txt.nlp	19520847	SENT340	2	2	15	15	amrinone	ADP	PA164746803	23038	0.58
NULL	Br_J_Ophthalmol_2013_Aug_6_97(8)_989-993.nxml.txt.nlp	23743437	SENT114	14	14	0	0	bimatoprost	BIM	PA164748867	10018	0.58
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT218	4	4	27	27	pp2	PP2		4888	0.58
NULL	Diabetes_2013_Sep_15_62(9)_3019-3021.nxml.txt.nlp	23970522	SENT20	7	7	1	1	chymotrypsin	CTRB1	PA448994	1504	0.58
NULL	Mol_Cancer_2009_Jul_31_8_57.nxml.txt.nlp	19646263	SENT207	6	6	15	15	docetaxel	PC-3	PA449383	692094	0.58
NULL	Neural_Dev_2011_Nov_15_6_36.nxml.txt.nlp	22085733	SENT418	6	6	18	18	forskolin	BMP7	PA146096022	655	0.58
NULL	Acta_Pharmacol_Sin_2011_Jan_6_32(1)_133-138.nxml.txt.nlp	21131997	SENT138	25	25	32	32	creatine	ACT	PA164778930	12;11332;9457;641455	0.58
NULL	Pharmaceuticals_(Basel)_2013_Aug_2_6(8)_915-928.nxml.txt.nlp	24276376	SENT54	0	0	10	10	thrombin	VIII	PA451674	1351	0.58
NULL	Endocrinol_Metab_(Seoul)_2014_Dec_29_29(4)_553-560.nxml.txt.nlp	25325265	SENT39	13	13	15	15	lipase	HSL	PA450239	3991	0.58
NULL	Exp_Ther_Med_2013_Dec_10_6(6)_1343-1349.nxml.txt.nlp	24255660	SENT152	13	13	18	18	lactulose	DAO	PA164748762	26;1610	0.58
NULL	Arthritis_Res_Ther_2011_Feb_3_13(1)_102.nxml.txt.nlp	21345249	SENT46	0	0	21	21	curcumin	IL-8	PA151958596	3576	0.58
NULL	Neural_Regen_Res_2014_May_1_9(9)_951-958.nxml.txt.nlp	25206917	SENT0	24	24	21	21	methamphetamine	alpha-synuclein	PA450403	6622	0.58
NULL	Indian_Dermatol_Online_J_2014_Apr-Jun_5(2)_236-237.nxml.txt.nlp	24860779	SENT21	21	21	27	27	imiquimod	CO2	PA449972	4513	0.58
NULL	Ann_Surg_Oncol_2014_Feb_13_21(5)_1575-1582.nxml.txt.nlp	24522992	SENT10	21	21	16	16	anastrozole	BCS	PA448432	617	0.58
NULL	J_Thromb_Thrombolysis_2012_Feb_20_33(2)_143-153.nxml.txt.nlp	22183178	SENT66	8	8	13	13	cangrelor	ADP	PA165945763	23038	0.58
NULL	Gut_Liver_2013_May_9_7(3)_329-334.nxml.txt.nlp	23710315	SENT143	2	2	0	0	lamivudine	LAM	PA450163	7249;7248	0.58
NULL	J_Am_Heart_Assoc_2013_Dec_19_2(6)_e000433.nxml.txt.nlp	24275630	SENT580	10	10	7	7	liraglutide	GLP	PA165958364	342096	0.58
NULL	Curr_Cardiol_Rev_2009_Aug_5(3)_216-222.nxml.txt.nlp	20676280	SENT139	24	24	26	26	lipase	ATGL	PA450239	57104	0.58
NULL	Diabetes_Care_2009_Oct_32(10)_1769-1782.nxml.txt.nlp	19794002	SENT243	7	7	9	9	daclizumab	EGF	PA164764446	1950	0.58
NULL	Cancer_Res_Treat_2015_Jan_25_47(1)_115-119.nxml.txt.nlp	25152191	SENT56	5	5	12	12	methotrexate	POMP	PA450428	51371;51251	0.58
NULL	J_Exp_Bot_2012_Apr_20_63(7)_2449-2464.nxml.txt.nlp	22268155	SENT87	14	14	11	11	phenol	mol	PA450913	90527	0.58
NULL	Lab_Invest_2013_Dec_14_93(12)_1265-1275.nxml.txt.nlp	24126890	SENT183	5	5	16	16	celecoxib	ZO-1	PA448871	7082	0.58
NULL	Am_J_Physiol_Cell_Physiol_2014_Jan_15_306(2)_C89-C97.nxml.txt.nlp	24133067	SENT53	25	25	6	6	hyaluronan	HAS2	PA165958431	3037	0.58
NULL	Ann_Indian_Acad_Neurol_2009_Apr-Jun_12(2)_89-98.nxml.txt.nlp	20142853	SENT30	26	26	21	21	mitoxantrone	ABCC1	PA450526	4363	0.58
NULL	Br_J_Cancer_2012_Sep_4_107(6)_977-987.nxml.txt.nlp	22892389	SENT16	0	0	8	8	cerulenin	VEGFA	PA164764551	7422	0.58
NULL	Front_Oncol_2014_Jun_23_4_162.nxml.txt.nlp	25003082	SENT30	20	20	14	14	estradiol	AKR1C3	PA449503	8644	0.58
NULL	Exp_Ther_Med_2014_Dec_24_8(6)_1677-1682.nxml.txt.nlp	25371714	SENT135	2	2	10	10	isoproterenol	HIF-1	PA450121	29072	0.58
NULL	Mol_Cancer_2012_Oct_22_11_80.nxml.txt.nlp	23088607	SENT67	14	14	20	20	fulvestrant	HIF-1	PA164747170	29072	0.58
NULL	EMBO_Mol_Med_2012_Sep_8_4(9)_939-951.nxml.txt.nlp	22684844	SENT186	6	6	13	13	bleomycin	IL-6	PA448645	3569	0.58
NULL	J_Gynecol_Oncol_2014_Apr_9_25(2)_130-135.nxml.txt.nlp	24761217	SENT26	41	41	15	15	paclitaxel	castor	PA450761	54897	0.58
NULL	Emerg_Microbes_Infect_2012_Nov_7_1(11)_e39.nxml.txt.nlp	NULL	SENT159	27	27	5	5	chloramphenicol	Gen	PA448927	348654	0.58
NULL	Clinics_(Sao_Paulo)_2014_Jan_69(1)_68-74.nxml.txt.nlp	24473562	SENT81	10	10	15	15	nutlin-3	SOCS-1		8651	0.579
NULL	Chem_Cent_J_2013_Sep_16_7_156.nxml.txt.nlp	24041151	SENT72	6	6	17	17	oxygen	LPP	PA450744	4026	0.579
NULL	EPMA_J_2012_Sep_27_3(1)_10.nxml.txt.nlp	23016735	SENT203	9	9	17	17	warfarin	ORM2	PA451906	5005	0.579
NULL	Emerg_Infect_Dis_2011_Mar_17(3)_495-497.nxml.txt.nlp	21392442	SENT32	11	11	9	9	ethambutol	EMB	PA164784021	133418	0.579
NULL	Arch_Med_Sci_2014_Oct_27_10(5)_1007-1018.nxml.txt.nlp	25395954	SENT178	9	9	23	23	mitoxantrone	CTX	PA450526	1593	0.579
NULL	Breast_Cancer_Res_Treat_2014_Nov_8_148(3)_553-561.nxml.txt.nlp	NULL	SENT98	12	12	22	22	capecitabine	HER2	PA448771	2064	0.579
NULL	Cardiovasc_Diabetol_2013_Oct_17_12_150.nxml.txt.nlp	24134550	SENT110	28	28	10	10	metformin	activin	PA450395	83729	0.579
NULL	Indian_J_Psychiatry_2012_Jul-Sep_54(3)_248-252.nxml.txt.nlp	23226849	SENT47	0	0	2	2	chlorpromazine	CPZ	PA448964	8532	0.579
NULL	Evid_Based_Complement_Alternat_Med_2013_Nov_4_2013_434823.nxml.txt.nlp	24302965	SENT55	35	35	41	41	l-glutamine	CO2	PA10090	4513	0.579
NULL	J_Asthma_Allergy_2008_Sep_19_1_19-29.nxml.txt.nlp	21436982	SENT110	15	15	10	10	fexofenadine	IL-8	PA449621	3576	0.579
NULL	Neuropsychopharmacology_2009_Jul_11_34(8)_1946-1957.nxml.txt.nlp	19279569	SENT124	25	25	29	29	cocaine	DOR	PA449072	58476	0.579
NULL	Indian_J_Med_Res_2012_Mar_135(3)_312-317.nxml.txt.nlp	22561616	SENT98	8	8	26	26	tamoxifen	HER2	PA451581	2064	0.579
NULL	Oxid_Med_Cell_Longev_2011_Oct_9_2011_756938.nxml.txt.nlp	22007271	SENT153	28	28	12	12	forskolin	PNMT	PA146096022	5409	0.579
NULL	Ann_Oncol_2011_Jun_25_22(6)_1392-1403.nxml.txt.nlp	21266519	SENT214	7	7	2	2	rituximab	CHOP	PA451261	1649	0.579
NULL	J_Cell_Mol_Med_2014_Oct_11_18(10)_2031-2043.nxml.txt.nlp	25109475	SENT140	0	0	7	7	valsartan	LKB1	PA451848	6794	0.579
NULL	Exp_Ther_Med_2014_Nov_17_8(5)_1484-1488.nxml.txt.nlp	25289046	SENT144	9	9	0	0	cisplatin	ECRG2	PA449014	84651	0.579
NULL	Biologics_2012_Aug_24_6_277-287.nxml.txt.nlp	22956859	SENT282	28	28	42	42	hyaluronidase	PIDD	PA164745713	55367	0.579
NULL	Indian_J_Nephrol_2009_Jan_19(1)_15-19.nxml.txt.nlp	20352006	SENT78	16	16	10	10	diatrizoate	CO2	PA449281	4513	0.579
NULL	Iran_J_Psychiatry_2010_Spring_5(2)_60-65.nxml.txt.nlp	22952493	SENT46	33	33	24	24	naltrexone	DBT	PA450588	1629	0.579
NULL	Oncotarget_2014_Jun_6_5(13)_4935-4944.nxml.txt.nlp	24952732	SENT110	0	0	5	5	doxazosin	PDK1	PA449407	5170;5163	0.579
NULL	Crit_Care_2011_Dec_5_15(6)_236.nxml.txt.nlp	22146601	SENT35	3	3	22	22	vasopressin	AVP	PA451858	114548;551	0.579
NULL	Exp_Neurobiol_2013_Mar_31_22(1)_45-50.nxml.txt.nlp	23585722	SENT113	11	11	16	16	fluoxetine	EPO	PA449673	7076;8288;2056	0.579
NULL	Osong_Public_Health_Res_Perspect_2013_Dec_12_4(6)_316-322.nxml.txt.nlp	24524020	SENT206	10	10	33	33	cefaclor	PEN	PA164749137	9933	0.579
NULL	Patient_Prefer_Adherence_2009_Nov_3_3_195-203.nxml.txt.nlp	19936162	SENT196	6	6	4	4	palivizumab	NOT	PA164748781	4929	0.579
NULL	Nat_Med_2014_Apr_16_20(4)_385-397.nxml.txt.nlp	24633305	SENT331	36	36	32	32	glibenclamide	GLP1	PA449782	100125288;2641	0.579
NULL	Parasit_Vectors_2010_Aug_4_3_67.nxml.txt.nlp	20684757	SENT124	7	7	14	14	permethrin	ANOVA	PA164743137	4858	0.579
NULL	Exp_Lung_Res_2013_Oct_1_39(8)_336-348.nxml.txt.nlp	23919450	SENT232	0	0	9	9	thrombin	CCL2	PA451674	6347	0.579
NULL	Breast_Cancer_Res_2004_Mar_18_6(3)_R239-R245.nxml.txt.nlp	15084247	SENT39	4	4	0	0	l-glutamine	EGF	PA10090	1950	0.579
NULL	Contemp_Oncol_(Pozn)_2012_Feb_29_16(1)_86-89.nxml.txt.nlp	23788860	SENT68	10	10	15	15	trastuzumab	HER2	PA451743	2064	0.579
NULL	Clin_Ophthalmol_2013_Aug_22_7_1669-1682.nxml.txt.nlp	24003303	SENT174	5	5	19	19	temozolomide	IL-2	PA451609	3558	0.579
NULL	Oncol_Lett_2014_Nov_12_8(5)_2203-2208.nxml.txt.nlp	25295109	SENT166	4	4	9	9	celecoxib	GLI1	PA448871	2735	0.579
NULL	Clin_Med_Insights_Womens_Health_2013_Jan_23_6_13-24.nxml.txt.nlp	24665210	SENT172	22	22	28	28	dydrogesterone	CEE	PA164745443	51608	0.579
NULL	Braz_J_Med_Biol_Res_2013_Mar_15_46(3)_270-277.nxml.txt.nlp	23532271	SENT9	5	5	7	7	lipase	ATGL	PA450239	57104	0.579
NULL	J_Mol_Med_(Berl)_2013_Aug_17_91(11)_1257-1271.nxml.txt.nlp	23955016	SENT186	12	12	6	6	thrombin	p38	PA451674	10598;1432;7965	0.579
NULL	Cardiovasc_Diabetol_2013_May_20_12_77.nxml.txt.nlp	23688357	SENT66	4	4	25	25	glucose	DBP	PA449773	3295;1628;2638	0.579
NULL	Biologics_2009_Oct_12_3_443-457.nxml.txt.nlp	19851470	SENT218	12	12	16	16	tocilizumab	IL-17A	PA165292659	3605	0.579
NULL	BMJ_2009_Feb_25_338_b509.nxml.txt.nlp	19244303	SENT89	3	3	8	8	trastuzumab	HER-2	PA451743	2064	0.579
NULL	Cell_Regen_(Lond)_2014_Jan_31_3(1)_2.nxml.txt.nlp	25408881	SENT59	24	24	12	12	l-glutamine	F12	PA10090	2161	0.579
NULL	Oncogene_2014_Feb_20_33(8)_977-985.nxml.txt.nlp	23455321	SENT211	11	11	29	29	calcein	ANOVA	PA132595336	4858	0.579
NULL	Clinics_(Sao_Paulo)_2011_Jan_66(1)_65-71.nxml.txt.nlp	21437438	SENT153	19	19	0	0	nortriptyline	BUP	PA450657	23412	0.579
NULL	Front_Neurosci_2014_Dec_5_8_398.nxml.txt.nlp	25538552	SENT152	28	28	18	18	glucose	PSD	PA449773	5662	0.579
NULL	Diabetes_Care_2013_May_13_36(5)_1074-1082.nxml.txt.nlp	23275352	SENT216	8	8	10	10	liraglutide	ZAG	PA165958364	563	0.579
NULL	Clin_Ophthalmol_2010_Apr_26_4_203-209.nxml.txt.nlp	20463785	SENT92	26	26	7	7	fluorescein	SPK	PA164746009	55872;8189	0.579
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT163	21	21	7	7	heparin	FGF1	PA449855	2246	0.579
NULL	Front_Behav_Neurosci_2012_Nov_22_6_78.nxml.txt.nlp	23189046	SENT75	14	14	8	8	ethanol	OX1R	PA448073	3061	0.579
NULL	Indian_J_Dermatol_2009_Jan-Mar_54(1)_7-12.nxml.txt.nlp	20049260	SENT35	0	0	12	12	alefacept	CD2	PA164748040	914	0.579
NULL	Indian_J_Pharmacol_2009_Aug_41(4)_167-172.nxml.txt.nlp	20523867	SENT30	13	13	25	25	imatinib	CML	PA10804	613	0.579
NULL	Mol_Pain_2014_Apr_18_10_27.nxml.txt.nlp	24742127	SENT304	18	18	26	26	paclitaxel	CB1	PA450761	1268	0.579
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT8	3	3	12	12	nutlin-3	TRAIL		8743	0.579
NULL	Front_Cell_Neurosci_2015_Jan_15_8_459.nxml.txt.nlp	25642166	SENT40	22	22	29	29	hemin	HO-1	PA449849	3162	0.579
NULL	Mol_Biol_Cell_2013_Aug_1_24(15)_2328-2339.nxml.txt.nlp	23783029	SENT282	43	43	38	38	glucose	GEF	PA449773	56731	0.579
NULL	Br_J_Cancer_2013_Feb_19_108(3)_557-563.nxml.txt.nlp	23361053	SENT5	8	8	4	4	tamoxifen	PAK1	PA451581	5585;5058	0.579
NULL	Nat_Commun_2013_Apr_23_4_1758.nxml.txt.nlp	23612299	SENT536	14	14	7	7	isoproterenol	SOD1	PA450121	6647	0.579
NULL	Front_Endocrinol_(Lausanne)_2011_Mar_29_2_8.nxml.txt.nlp	22654791	SENT68	34	34	48	48	l-glutamine	CO2	PA10090	4513	0.579
NULL	Br_J_Nutr_2013_May_14_109(9)_1678-1687.nxml.txt.nlp	22935250	SENT276	14	14	21	21	creatine	SGK1	PA164778930	6446	0.579
NULL	Mol_Vis_2007_Jul_9_13_1083-1093.nxml.txt.nlp	17653053	SENT163	0	0	13	13	minocycline	MCP-1	PA450519	6347	0.579
NULL	Pharmaceuticals_(Basel)_2011_Nov_10_4(11)_1488-1502.nxml.txt.nlp	NULL	SENT108	7	7	11	11	geldanamycin	HER2	PA152031327	2064	0.579
NULL	Biol_Proced_Online_2007_Dec_24_9_73-83.nxml.txt.nlp	18385809	SENT80	15	15	26	26	paraformaldehyde	CD21	PA450790	1380	0.579
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Apr_20_69(Pt_5)_o761.nxml.txt.nlp	23723907	SENT78	11	11	1	1	piperazine	C10	PA450977	113246	0.579
NULL	Br_J_Pharmacol_2014_Oct_26_171(20)_4785-4796.nxml.txt.nlp	25074741	SENT138	4	4	9	9	guanfacine	NK1R	PA449825	6869	0.579
NULL	Chem_Cent_J_2012_Jul_18_6_69.nxml.txt.nlp	22809083	SENT120	11	11	34	34	l-glutamine	CO2	PA10090	4513	0.579
NULL	BMB_Rep_2013_Nov_46(11)_544-549.nxml.txt.nlp	24152910	SENT39	0	0	5	5	thrombin	HMGB1	PA451674	3146	0.579
NULL	Drug_Saf_2014_Feb_19_37(4)_201-211.nxml.txt.nlp	24550106	SENT301	2	2	9	9	tacrolimus	CYP2C19	PA451578	1557	0.579
NULL	JMIR_Med_Inform_2014_Mar_18_2(1)_e5.nxml.txt.nlp	25601137	SENT228	19	19	27	27	warfarin	VKORC1	PA451906	79001	0.579
NULL	Front_Endocrinol_(Lausanne)_2014_Oct_27_5_163.nxml.txt.nlp	25386163	SENT133	17	17	13	13	ethanol	ghrelin	PA448073	51738	0.579
NULL	Exp_Ther_Med_2014_Oct_18_8(4)_1213-1218.nxml.txt.nlp	25187827	SENT141	5	5	7	7	heparin	ADM	PA449855	133	0.579
NULL	Cancer_Cell_Int_2014_Jul_2_14_59.nxml.txt.nlp	25120382	SENT125	5	5	16	16	metformin	N-myc	PA450395	4613	0.579
NULL	Arthritis_Res_Ther_2005_Feb_17_7(Suppl_1)_P88.nxml.txt.nlp	NULL	SENT31	0	0	7	7	etanercept	JNK	PA449515	5599	0.579
NULL	J_Med_Chem_2014_Jan_23_57(2)_449-461.nxml.txt.nlp	24387105	SENT80	10	10	21	21	benzaldehyde	ALDH3A1	PA448571	218	0.579
NULL	Exp_Ther_Med_2013_Nov_6_6(5)_1089-1095.nxml.txt.nlp	24223627	SENT183	12	12	24	24	cyclophosphamide	NAC	PA449165	22861	0.579
NULL	Allergy_Asthma_Immunol_Res_2014_Nov_28_6(6)_567-572.nxml.txt.nlp	25374757	SENT80	0	0	3	3	fexofenadine	IL-6	PA449621	3569	0.579
NULL	Cancer_Cell_Int_2013_Mar_4_13_21.nxml.txt.nlp	23497288	SENT59	34	34	3	3	vincristine	EWS	PA451879	2130	0.579
NULL	Blood_Res_2013_Dec_24_48(4)_274-281.nxml.txt.nlp	24466552	SENT46	27	27	33	33	vincristine	CHOP	PA451879	1649	0.579
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_P108.nxml.txt.nlp	NULL	SENT15	30	30	15	15	piperacillin	IL13	PA450975	3596	0.579
NULL	Curr_Neuropharmacol_2008_Jun_6(2)_125-150.nxml.txt.nlp	19305793	SENT959	9	9	4	4	heparin	EGF	PA449855	1950	0.579
NULL	Nat_Genet_2014_Feb_12_46(2)_166-170.nxml.txt.nlp	24413734	SENT278	7	7	10	10	dasatinib	FYN	PA162372878	2534	0.579
NULL	J_Invest_Dermatol_2012_Sep_10_132(9)_2255-2262.nxml.txt.nlp	22572817	SENT215	30	30	23	23	forskolin	ASIP	PA146096022	434;56288	0.579
NULL	Emerg_Microbes_Infect_2012_Nov_7_1(11)_e39.nxml.txt.nlp	NULL	SENT159	11	11	5	5	amikacin	Gen	PA164744372	348654	0.579
NULL	Oncol_Rep_2012_Apr_6_27(4)_1213-1218.nxml.txt.nlp	22159760	SENT49	26	26	45	45	l-glutamine	CO2	PA10090	4513	0.579
NULL	Allergy_Asthma_Immunol_Res_2012_May_14_4(3)_137-142.nxml.txt.nlp	22548206	SENT134	15	15	17	17	diclofenac	IPA	PA449293	3160	0.579
NULL	J_Cell_Biol_1982_Nov_1_95(2)_771-780.nxml.txt.nlp	NULL	SENT9	11	11	14	14	trifluoperazine	TFP	PA451771	7034	0.579
NULL	Breast_Cancer_Res_2014_Sep_11_16(5)_430.nxml.txt.nlp	25212826	SENT278	8	8	39	39	doxycycline	PTEN	PA449415	5728	0.579
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT271	23	23	34	34	methotrexate	MSH2	PA450428	4436	0.579
NULL	Br_J_Cancer_2010_Jun_29_103(1)_61-72.nxml.txt.nlp	20588279	SENT248	39	39	30	30	trastuzumab	RhoB	PA451743	388	0.579
NULL	J_Hematol_Oncol_2010_Apr_7_3_13.nxml.txt.nlp	20374647	SENT174	16	16	19	19	bortezomib	CDK2	PA10252	1017	0.579
NULL	Endocrinol_Metab_(Seoul)_2014_Dec_29_29(4)_450-456.nxml.txt.nlp	25325263	SENT161	45	45	43	43	octreotide	OST	PA450678	1650;23263	0.579
NULL	Amino_Acids_2014_Jul_19_46(1)_7-20.nxml.txt.nlp	22810731	SENT280	10	10	16	16	taurine	IL-6	PA451590	3569	0.579
NULL	Mol_Cells_2014_Apr_30_37(4)_330-336.nxml.txt.nlp	24732964	SENT52	21	21	25	25	hyaluronan	HAS2	PA165958431	3037	0.579
NULL	Adv_Virol_2012_Jul_19_2012_267483.nxml.txt.nlp	22851970	SENT64	24	24	20	20	ribavirin	IFN	PA451241	3439	0.579
NULL	J_Allergy_(Cairo)_2011_Apr_6_2011_479129.nxml.txt.nlp	21603171	SENT62	0	0	20	20	tacrolimus	IL-3	PA451578	3562	0.579
NULL	Nano_Rev_2010_Nov_8_1_10_3402_nano_v1i0_5705.nxml.txt.nlp	22110857	SENT14	18	18	0	0	doxorubicin	PK1	PA449412	84432	0.579
NULL	Cancer_Manag_Res_2012_Nov_9_4_383-395.nxml.txt.nlp	23204869	SENT97	2	2	11	11	carmustine	PC-3	PA448810	692094	0.579
NULL	Exp_Cell_Res_2011_Apr_15_317(7)_1028-1039.nxml.txt.nlp	21237154	SENT252	13	13	11	11	staurosporine	TRAIL	PA165109623	8743	0.579
NULL	Oncol_Lett_2013_Oct_24_6(4)_985-989.nxml.txt.nlp	24137450	SENT128	11	11	20	20	vincristine	ADM	PA451879	133	0.579
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT39	3	3	0	0	cisplatin	IBP	PA449014	706;50619	0.579
NULL	Arthritis_Res_Ther_2012_Jun_25_14(3)_215.nxml.txt.nlp	22731694	SENT123	5	5	3	3	ribavirin	IFN	PA451241	3439	0.579
NULL	Breast_Cancer_Res_Treat_2014_Nov_8_148(3)_553-561.nxml.txt.nlp	NULL	SENT114	9	9	19	19	capecitabine	HER2	PA448771	2064	0.579
NULL	Osong_Public_Health_Res_Perspect_2014_Dec_13_5(6)_333-338.nxml.txt.nlp	25562041	SENT207	14	14	8	8	cefepime	CTX	PA164754876	1593	0.579
NULL	Eur_J_Clin_Microbiol_Infect_Dis_2010_May_13_29(5)_543-550.nxml.txt.nlp	20229224	SENT73	45	45	7	7	tetracycline	PEN	PA451640	9933	0.579
NULL	Arthritis_Res_Ther_2009_Feb_3_11(1)_R15.nxml.txt.nlp	19192274	SENT212	34	34	27	27	diclofenac	MIP-3	PA449293	6368	0.579
NULL	Br_J_Cancer_2010_Jan_5_102(1)_80-86.nxml.txt.nlp	19920817	SENT151	18	18	20	20	bevacizumab	IFN	PA130232992	3439	0.579
NULL	Drug_Des_Devel_Ther_2014_Sep_23_8_1527-1538.nxml.txt.nlp	25284985	SENT176	25	25	15	15	celecoxib	IFN	PA448871	3439	0.579
NULL	J_Immunol_Res_2014_Jul_13_2014_964069.nxml.txt.nlp	25126586	SENT116	9	9	4	4	imiquimod	IL-6	PA449972	3569	0.579
NULL	BMJ_2009_Dec_3_339_b4731.nxml.txt.nlp	19959591	SENT279	9	9	6	6	pioglitazone	gamma	PA450970	9913	0.579
NULL	Front_Oncol_2014_May_13_4_101.nxml.txt.nlp	24860784	SENT116	15	15	31	31	loperamide	MDR1	PA450262	5243	0.579
NULL	J_Cancer_2013_Mar_25_4(4)_315-319.nxml.txt.nlp	23569464	SENT28	28	28	11	11	paclitaxel	S1PR1	PA450761	1901	0.579
NULL	Diabetes_2013_May_16_62(5)_1697-1708.nxml.txt.nlp	23364453	SENT308	7	7	5	5	fasudil	GLP-1	PA165946121	100125288	0.579
NULL	Chem_Commun_(Camb)_2013_Jun_21_49(76)_8441-8443.nxml.txt.nlp	23770604	SENT22	22	22	13	13	geldanamycin	Hsp90	PA152031327	3320	0.579
NULL	Int_J_Mol_Sci_2013_Aug_14_14(8)_16719-16731.nxml.txt.nlp	23949634	SENT68	12	12	5	5	thrombin	TPC	PA451674	8030;60386	0.579
NULL	Environ_Health_Perspect_2012_Sep_16_120(9)_1320-1326.nxml.txt.nlp	22591701	SENT31	4	4	42	42	l-arginine	NOS3	PA448478	4846;342977	0.579
NULL	Br_J_Cancer_2009_Jul_21_101(2)_238-243.nxml.txt.nlp	19568242	SENT79	37	37	39	39	sunitinib	IFN	PA162372840	3439	0.579
NULL	Front_Immunol_2013_Nov_20_4_385.nxml.txt.nlp	24312095	SENT272	14	14	22	22	heparin	gamma	PA449855	9913	0.579
NULL	Hum_Mol_Genet_2013_Nov_15_22(22)_4616-4626.nxml.txt.nlp	23814041	SENT45	29	29	22	22	doxycycline	neuroserpin	PA449415	5274	0.579
NULL	Cancers_(Basel)_2011_Aug_5_3(3)_3114-3142.nxml.txt.nlp	24212948	SENT949	6	6	21	21	paclitaxel	HER-2	PA450761	2064	0.579
NULL	Avicenna_J_Med_2014_Apr-Jun_4(2)_29-33.nxml.txt.nlp	24761380	SENT96	29	29	10	10	sitagliptin	GLP-1	PA164748978	100125288	0.579
NULL	Ann_Hematol_2014_Apr_30_93(9)_1515-1522.nxml.txt.nlp	24782121	SENT62	13	13	29	29	fluorescein	CD90	PA164746009	7070	0.579
NULL	J_Cell_Biol_2008_Jul_28_182(2)_327-340.nxml.txt.nlp	18644889	SENT253	0	0	3	3	estradiol	PI3K	PA449503	5290	0.579
NULL	Korean_J_Anesthesiol_2013_Feb_15_64(2)_105-111.nxml.txt.nlp	23459312	SENT81	32	32	36	36	heparin	ACT	PA449855	12;11332;9457;641455	0.579
NULL	Biol_Direct_2008_Aug_20_3_34.nxml.txt.nlp	18715501	SENT59	44	44	11	11	staurosporine	IL-2	PA165109623	3558	0.579
NULL	Oncotarget_2014_Feb_25_5(5)_1304-1314.nxml.txt.nlp	24675421	SENT66	35	35	31	31	cisplatin	JNK	PA449014	5599	0.579
NULL	Arthritis_Res_Ther_2014_Oct_30_16(5)_467.nxml.txt.nlp	25359150	SENT179	7	7	3	3	adalimumab	ACR	PA10004	49	0.579
NULL	Biosci_Rep_2012_Dec_20_33(1)_e00011.nxml.txt.nlp	23137297	SENT147	27	27	18	18	heparin	RPSA	PA449855	3921	0.579
NULL	Front_Oncol_2014_Jun_18_4_153.nxml.txt.nlp	24995158	SENT259	2	2	0	0	paclitaxel	CLIP170	PA450761	6249	0.579
NULL	Mol_Vis_2007_Jul_9_13_1083-1093.nxml.txt.nlp	17653053	SENT163	0	0	21	21	minocycline	eotaxin	PA450519	6356	0.579
NULL	Eur_J_Neurosci_2013_Oct_5_38(8)_3146-3158.nxml.txt.nlp	23909897	SENT393	12	12	19	19	zolpidem	CA1	PA451976	759	0.579
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT616	41	41	30	30	aripiprazole	PRL	PA10026	5617	0.579
NULL	Int_J_Nanomedicine_2009_Apr_1_4_27-35.nxml.txt.nlp	19421368	SENT101	21	21	31	31	genistein	IFN	PA165109660	3439	0.579
NULL	Case_Rep_Med_2014_Apr_9_2014_696725.nxml.txt.nlp	24812562	SENT79	22	22	12	12	thrombin	VWF	PA451674	7450	0.579
NULL	Diabetes_2013_Mar_14_62(3)_905-911.nxml.txt.nlp	23160528	SENT37	7	7	22	22	collagenase	CO2	PA449107	4513	0.579
NULL	Cancers_(Basel)_2010_Mar_30_2(2)_338-363.nxml.txt.nlp	24281073	SENT982	6	6	2	2	doxorubicin	RLIP76	PA449412	10928	0.579
NULL	Oncol_Lett_2014_Mar_16_7(3)_827-833.nxml.txt.nlp	24527090	SENT154	12	12	9	9	cisplatin	IFN	PA449014	3439	0.579
NULL	J_Cell_Biol_1999_Dec_27_147(7)_1533-1548.nxml.txt.nlp	10613910	SENT82	15	15	0	0	paraformaldehyde	CO2	PA450790	4513	0.579
NULL	J_Gen_Physiol_1997_Jun_1_109(6)_681-692.nxml.txt.nlp	9222895	SENT173	8	8	4	4	amiloride	CH1	PA448368	51430	0.579
NULL	Front_Oncol_2014_Jun_18_4_159.nxml.txt.nlp	24995161	SENT161	7	7	15	15	estradiol	AKR1C3	PA449503	8644	0.579
NULL	FASEB_J_2012_Mar_26(3)_1064-1076.nxml.txt.nlp	22090315	SENT190	21	21	6	6	carrageenan	JAM-C	PA448814	83700	0.579
NULL	Breast_Cancer_Res_2011_Nov_23_13(6)_R116.nxml.txt.nlp	22113133	SENT327	10	10	12	12	estradiol	DES	PA449503	1674	0.579
NULL	Eur_J_Clin_Pharmacol_2014_Oct_8_70(1)_37-45.nxml.txt.nlp	24100471	SENT54	20	20	29	29	omeprazole	OATP1B1	PA450704	10599	0.579
NULL	Diabetes_2011_Jun_21_60(6)_1813-1822.nxml.txt.nlp	21617188	SENT319	23	23	15	15	diazoxide	SUR1	PA449285	6833	0.579
NULL	Ann_Neurosci_2011_Oct_18(4)_151-155.nxml.txt.nlp	25205946	SENT0	16	16	26	26	naringenin	GFAP	PA151958361	2670	0.579
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Jun_27_5_15.nxml.txt.nlp	16803618	SENT178	44	44	30	30	gentamicin	CIP1	PA449753	1026;56996	0.579
NULL	Hum_Genomics_2004_Nov_1_1(6)_435-443.nxml.txt.nlp	15606998	SENT159	32	32	10	10	creatine	COX5B	PA164778930	1329	0.579
NULL	Alcohol_Res_2013_35(1)_6-16.nxml.txt.nlp	24313160	SENT148	3	3	9	9	nadh	PDH	PA164755085	54704	0.579
NULL	J_Breast_Cancer_2011_Mar_31_14(1)_46-51.nxml.txt.nlp	21847394	SENT137	10	10	0	0	cyclophosphamide	HER2	PA449165	2064	0.579
NULL	Cough_2009_Dec_16_5_11.nxml.txt.nlp	20015366	SENT125	11	11	22	22	tiotropium	URI	PA164769056	8725	0.579
NULL	Biomed_Res_Int_2013_Aug_13_2013_690491.nxml.txt.nlp	23998127	SENT39	32	32	34	34	cyclophosphamide	CTX	PA449165	1593	0.579
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT93	9	9	21	21	phenol	TNF	PA450913	7124	0.579
NULL	J_Hematol_Oncol_2013_Jan_15_6_5.nxml.txt.nlp	23320987	SENT199	24	24	26	26	heparin	PI-PLC	PA449855	2923	0.579
NULL	Epilepsia_2014_Jun_6_55(6)_806-818.nxml.txt.nlp	24802699	SENT92	27	27	23	23	bumetanide	NKCC1	PA448682	6558	0.579
NULL	Br_J_Cancer_2013_Jan_15_108(1)_82-90.nxml.txt.nlp	23321512	SENT163	19	19	2	2	paclitaxel	TUBB3	PA450761	10381	0.579
NULL	Theranostics_2013_Jun_24_3(7)_448-466.nxml.txt.nlp	23843893	SENT251	22	22	25	25	choline	TSPO	PA448976	706	0.579
NULL	Br_J_Cancer_2013_Feb_19_108(3)_557-563.nxml.txt.nlp	23361053	SENT113	29	29	7	7	tamoxifen	PAK1	PA451581	5585;5058	0.579
NULL	J_Neural_Transm_2014_Mar_27_121(10)_1221-1232.nxml.txt.nlp	24671607	SENT204	14	14	32	32	sertraline	PSD-95	PA451333	1742	0.579
NULL	Hum_Genomics_2008_Sep_1_3(1)_7-16.nxml.txt.nlp	19129086	SENT40	19	19	11	11	rosiglitazone	SLCO1B1	PA451283	10599	0.579
NULL	Int_J_Mol_Sci_2014_Oct_6_15(10)_17886-17900.nxml.txt.nlp	25290095	SENT109	5	5	33	33	resveratrol	p38		10598;1432;7965	0.579
NULL	Int_J_Endocrinol_2014_Aug_11_2014_312452.nxml.txt.nlp	25183970	SENT25	0	0	5	5	liraglutide	GLP-1	PA165958364	100125288	0.579
NULL	J_Ginseng_Res_2011_Nov_35(4)_436-441.nxml.txt.nlp	23717089	SENT131	3	3	7	7	ginseng	CAGC	PA164781150	6283	0.579
NULL	Front_Genet_2014_Oct_31_5_379.nxml.txt.nlp	25400658	SENT321	0	0	3	3	estradiol	H19	PA449503	283120	0.579
NULL	Patient_Prefer_Adherence_2008_Feb_2_2_167-175.nxml.txt.nlp	19920959	SENT181	15	15	17	17	clopidogrel	DES	PA449053	1674	0.579
NULL	Biologics_2009_Oct_12_3_469-474.nxml.txt.nlp	19851472	SENT5	47	47	18	18	desloratadine	IFN	PA164776964	3439	0.579
NULL	Cells_2014_Nov_27_3(4)_1116-1130.nxml.txt.nlp	25437441	SENT73	5	5	20	20	ethanol	IFN	PA448073	3439	0.579
NULL	Br_J_Ophthalmol_2013_Aug_6_97(8)_989-993.nxml.txt.nlp	23743437	SENT191	12	12	17	17	latanoprost	BAK	PA164774763	578	0.579
NULL	Oncotarget_2014_Oct_21_5(22)_11252-11268.nxml.txt.nlp	25361004	SENT266	24	24	8	8	metformin	CLIC1	PA450395	1192	0.579
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT128	7	7	4	4	phenytoin	CYP3A4	PA450947	1576	0.578
NULL	Int_J_Chron_Obstruct_Pulmon_Dis_2007_Jun_2(2)_95-105.nxml.txt.nlp	18044681	SENT159	3	3	12	12	tiotropium	TDI	PA164769056	100038246	0.578
NULL	Breast_Cancer_(Dove_Med_Press)_2013_Aug_22_5_73-78.nxml.txt.nlp	24648760	SENT142	4	4	6	6	tamoxifen	END	PA451581	2022	0.578
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Feb_29_68(Pt_3)_o878-o879.nxml.txt.nlp	22412730	SENT84	11	11	17	17	coumarin	mol	PA134521193	90527	0.578
NULL	Gut_Liver_2013_Sep_14_7(5)_585-593.nxml.txt.nlp	24073317	SENT194	28	28	22	22	ribavirin	IFN	PA451241	3439	0.578
NULL	J_Antimicrob_Chemother_2014_Apr_2_69(4)_911-918.nxml.txt.nlp	24302651	SENT39	10	10	12	12	chloramphenicol	PEN	PA448927	9933	0.578
NULL	Ecol_Evol_2014_Mar_11_4(5)_606-622.nxml.txt.nlp	25035802	SENT77	19	19	24	24	nadh	ND4	PA164755085	4538	0.578
NULL	Clinics_(Sao_Paulo)_2014_Jan_69(1)_68-74.nxml.txt.nlp	24473562	SENT117	14	14	5	5	nutlin-3	SOCS-1		8651	0.578
NULL	Acta_Pharmacol_Sin_2012_Dec_29_33(12)_1518-1524.nxml.txt.nlp	23103625	SENT198	2	2	4	4	telmisartan	ACE2	PA451605	59272	0.578
NULL	Br_J_Cancer_2012_Oct_9_107(8)_1399-1408.nxml.txt.nlp	22976800	SENT11	0	0	11	11	temozolomide	MLH1	PA451609	4292	0.578
NULL	Evid_Based_Complement_Alternat_Med_2013_Aug_12_2013_982689.nxml.txt.nlp	23997806	SENT151	7	7	2	2	tolbutamide	APE	PA451718	55704;328	0.578
NULL	Brain_Res_2008_Feb_15_1194(5)_110-117.nxml.txt.nlp	18177844	SENT350	7	7	0	0	citalopram	5-HTT	PA449015	6532	0.578
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT57	18	18	20	20	neratinib	HER2	PA165291472	2064	0.578
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_6_2014_270930.nxml.txt.nlp	25431606	SENT258	0	0	27	27	curcumin	MCP-1	PA151958596	6347	0.578
NULL	Nat_Commun_2013_Apr_3_4_1652.nxml.txt.nlp	23552067	SENT69	0	0	12	12	ketamine	ANOVA	PA450144	4858	0.578
NULL	Cancer_Causes_Control_2013_Aug_18_24(8)_1605-1614.nxml.txt.nlp	23775025	SENT64	38	38	24	24	epirubicin	GSTP1	PA449476	2950	0.578
NULL	Hum_Genomics_2010_Oct_1_5(1)_61-72.nxml.txt.nlp	21106490	SENT141	4	4	16	16	gemfibrozil	OATP1B1	PA449750	10599	0.578
NULL	Indian_J_Med_Res_2014_Aug_140(2)_163-164.nxml.txt.nlp	25297347	SENT4	0	0	2	2	clobazam	CLB	PA10888	171425	0.578
NULL	J_Int_AIDS_Soc_2011_Oct_11_14_48.nxml.txt.nlp	21988905	SENT34	18	18	21	21	fluconazole	ART	PA449653	181	0.578
NULL	Open_Biol_2014_Dec_4(12)_140178.nxml.txt.nlp	25520185	SENT47	27	27	39	39	geldanamycin	NOD2	PA152031327	64127	0.578
NULL	Neural_Regen_Res_2014_Sep_15_9(18)_1723-1728.nxml.txt.nlp	25374596	SENT92	23	23	32	32	capsaicin	TRPV4	PA448776	59341	0.578
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Jun_27_5_15.nxml.txt.nlp	16803618	SENT284	10	10	16	16	flucloxacillin	LTA	PA164781042	4049	0.578
NULL	Breast_Cancer_Res_2012_Mar_16_14(2)_206.nxml.txt.nlp	22423895	SENT190	10	10	12	12	estradiol	FES	PA449503	2242	0.578
NULL	Front_Immunol_2013_Nov_18_4_387.nxml.txt.nlp	24302927	SENT96	20	20	1	1	imiquimod	TLR7	PA449972	51284	0.578
NULL	Cardiovasc_Drugs_Ther_2011_Jun_12_25(3)_223-232.nxml.txt.nlp	21562974	SENT89	11	11	6	6	esmolol	AKT	PA449500	207	0.578
NULL	Breast_Cancer_Res_2000_Mar_25_2(3)_184-190.nxml.txt.nlp	11250708	SENT58	17	17	35	35	carbachol	EGFR	PA448784	1956	0.578
NULL	J_Cardiothorac_Surg_2012_Sep_27_7_97.nxml.txt.nlp	23013706	SENT27	5	5	3	3	warfarin	CYP4F2	PA451906	8529	0.578
NULL	J_Histochem_Cytochem_2014_Nov_62(11)_802-812.nxml.txt.nlp	25124006	SENT38	4	4	6	6	l-valine	ADP	PA451843	23038	0.578
NULL	Breast_Cancer_Res_2011_Oct_25_13(5)_216.nxml.txt.nlp	22067349	SENT128	27	27	45	45	tamoxifen	CDH1	PA451581	51343;999	0.578
NULL	J_Med_Life_2011_Feb_15_4(1)_11-20.nxml.txt.nlp	21505570	SENT141	0	0	7	7	indomethacin	CB1	PA449982	1268	0.578
NULL	Int_J_Mol_Sci_2014_Mar_20_15(3)_4977-4993.nxml.txt.nlp	24658441	SENT490	0	0	11	11	resveratrol	JNK		5599	0.578
NULL	J_Hematol_Oncol_2009_Dec_23_2_50.nxml.txt.nlp	20030851	SENT268	23	23	28	28	rituximab	TRAIL	PA451261	8743	0.578
NULL	Cell_Commun_Signal_2010_Jun_12_8_11.nxml.txt.nlp	20540792	SENT334	28	28	24	24	thalidomide	DDB1	PA451644	1642	0.578
NULL	J_Gen_Physiol_1938_Nov_20_22(2)_207-237.nxml.txt.nlp	19873101	SENT8	17	17	4	4	chymotrypsin	gamma	PA448994	9913	0.578
NULL	Exp_Ther_Med_2014_Nov_17_8(5)_1484-1488.nxml.txt.nlp	25289046	SENT152	9	9	0	0	cisplatin	ECRG2	PA449014	84651	0.578
NULL	J_Geriatr_Cardiol_2014_Mar_11(1)_63-73.nxml.txt.nlp	24748884	SENT104	2	2	16	16	levodopa	PKD	PA450213	5587	0.578
NULL	Am_J_Trop_Med_Hyg_2012_Nov_7_87(5)_785.nxml.txt.nlp	23136172	SENT18	7	7	16	16	artemisinin	ACT	PA165111696	12;11332;9457;641455	0.578
NULL	Cell_Death_Dis_2010_Nov_18_1(11)_e102.nxml.txt.nlp	21368867	SENT10	0	0	8	8	gentamicin	14-3-3	PA449753	10971	0.578
NULL	Br_J_Cancer_2010_Oct_26_103(9)_1331-1334.nxml.txt.nlp	20877352	SENT7	17	17	24	24	trastuzumab	GM-CSF	PA451743	1437	0.578
NULL	Mol_Vis_2011_Dec_15_17_3254-3261.nxml.txt.nlp	22194651	SENT170	2	2	4	4	vasopressin	AVP	PA451858	114548;551	0.578
NULL	Ann_Rheum_Dis_2009_Jan_5_68(6)_1051-1058.nxml.txt.nlp	18662930	SENT200	9	9	21	21	hyaluronan	p38	PA165958431	10598;1432;7965	0.578
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_127043.nxml.txt.nlp	23227093	SENT21	3	3	11	11	lovastatin	RYR	PA450272	6261	0.578
NULL	J_Exp_Med_2003_Aug_4_198(3)_505-512.nxml.txt.nlp	12900524	SENT130	6	6	22	22	dextran	CCL21	PA449261	6366	0.578
NULL	Oncotarget_2014_Sep_29_5(20)_10084-10099.nxml.txt.nlp	25275296	SENT70	6	6	15	15	bortezomib	cIAP2	PA10252	330	0.578
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT102	14	14	30	30	imatinib	ABCG2	PA10804	9429	0.578
NULL	Indian_J_Nephrol_2014_Nov-Dec_24(6)_349-355.nxml.txt.nlp	25484527	SENT57	3	3	13	13	fluorescein	CD4	PA164746009	920	0.578
NULL	Environ_Health_Perspect_2010_Jul_3_118(7)_936-942.nxml.txt.nlp	20199942	SENT135	0	0	5	5	arsenite	mot-2	PA452638	3313	0.578
NULL	Breast_Cancer_Res_2008_Apr_1_10(2)_R30.nxml.txt.nlp	18380893	SENT174	10	10	18	18	docetaxel	HER2	PA449383	2064	0.578
NULL	Br_J_Cancer_2010_Jan_5_102(1)_80-86.nxml.txt.nlp	19920817	SENT151	22	22	20	20	sunitinib	IFN	PA162372840	3439	0.578
NULL	Breast_Cancer_Res_Treat_2012_Apr_3_132(3)_895-915.nxml.txt.nlp	22048814	SENT354	20	20	29	29	anastrozole	IMPACT	PA448432	55364	0.578
NULL	Arthritis_Rheum_2011_Oct_63(10)_2854-2864.nxml.txt.nlp	21618201	SENT275	21	21	24	24	abatacept	ACR	PA164747080	49	0.578
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT142	1	1	23	23	pp2	JNK		5599	0.578
NULL	Cancer_Biol_Med_2012_Dec_9(4)_261-265.nxml.txt.nlp	23691487	SENT38	21	21	28	28	streptomycin	CO2	PA451512	4513	0.578
NULL	Mol_Neurodegener_2011_Jun_1_6_37.nxml.txt.nlp	21631942	SENT70	42	42	23	23	l-glutamine	B27	PA10090	56246	0.578
NULL	Ann_Rheum_Dis_2008_Oct_5_67(10)_1444-1447.nxml.txt.nlp	18535115	SENT52	13	13	0	0	methotrexate	ACR	PA450428	49	0.578
NULL	Case_Rep_Rheumatol_2012_Dec_24_2012_270315.nxml.txt.nlp	23424706	SENT48	13	13	7	7	tocilizumab	IL-6	PA165292659	3569	0.578
NULL	J_Hepatobiliary_Pancreat_Surg_2008_Jan_16_15(1)_55-62.nxml.txt.nlp	18274844	SENT87	12	12	23	23	mitomycin	IFN	PA450524	3439	0.578
NULL	Endocrinol_Metab_(Seoul)_2014_Mar_14_29(1)_20-29.nxml.txt.nlp	24741450	SENT152	30	30	13	13	thyroglobulin	TPO	PA164754910	7066;7173	0.578
NULL	Clin_Ophthalmol_2008_Dec_2(4)_897-905.nxml.txt.nlp	19668444	SENT133	32	32	23	23	travoprost	BAK	PA164781371	578	0.578
NULL	J_Hematol_Oncol_2011_Jan_21_4_5.nxml.txt.nlp	21255411	SENT175	0	0	2	2	paclitaxel	EGFR	PA450761	1956	0.578
NULL	Breast_Cancer_Res_2004_Oct_6_6(6)_269-274.nxml.txt.nlp	15535858	SENT82	13	13	10	10	tamoxifen	pS2	PA451581	7031	0.578
NULL	Semin_Immunopathol_2013_Jan_26_35(1)_39-52.nxml.txt.nlp	22829332	SENT197	23	23	18	18	vincristine	CHOP	PA451879	1649	0.578
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT149	3	3	18	18	curcumin	PC-3	PA151958596	692094	0.578
NULL	Curr_Med_Chem_2011_Jun_18(18)_2686-2714.nxml.txt.nlp	21649578	SENT340	19	19	34	34	erlotinib	EGFR	PA134687924	1956	0.578
NULL	J_Gen_Physiol_2003_Mar_121(3)_245-260.nxml.txt.nlp	12601087	SENT32	18	18	38	38	l-glutamine	CO2	PA10090	4513	0.578
NULL	Crit_Care_2010_Mar_1_14(Suppl_1)_P366.nxml.txt.nlp	NULL	SENT2	22	22	28	28	heparin	PF4	PA449855	5196	0.578
NULL	J_Lipid_Res_2014_Dec_55(12)_2562-2575.nxml.txt.nlp	25316883	SENT253	36	36	15	15	l-glutamine	CGI-58	PA10090	51099	0.578
NULL	GMS_Curr_Top_Otorhinolaryngol_Head_Neck_Surg_2004_Dec_28_3_Doc04.nxml.txt.nlp	22073046	SENT324	12	12	20	20	hydrocortisone	C17	PA449905	54360	0.578
NULL	Evid_Based_Complement_Alternat_Med_2013_Mar_26_2013_974313.nxml.txt.nlp	23589723	SENT143	7	7	28	28	metformin	HIF-1	PA450395	29072	0.578
NULL	Oncotarget_2014_Oct_18_5(21)_10206-10221.nxml.txt.nlp	25344914	SENT42	19	19	9	9	vemurafenib	CRAF	PA165946873	5894	0.578
NULL	J_Hum_Genet_2012_Jul_24_57(7)_459-464.nxml.txt.nlp	22622361	SENT10	15	15	13	13	heparin	C3b	PA449855	718	0.578
NULL	Endocrinol_Metab_(Seoul)_2014_Sep_25_29(3)_379-387.nxml.txt.nlp	25309798	SENT186	41	41	34	34	resveratrol	BMAL1		406	0.578
NULL	Cancer_Med_2013_Oct_18_2(5)_674-686.nxml.txt.nlp	24403233	SENT220	16	16	32	32	cabozantinib	RDT	PA165906891	6598	0.578
NULL	Diabetes_2009_Mar_58(3)_579-589.nxml.txt.nlp	19074989	SENT136	24	24	7	7	lipase	PNPLA2	PA450239	57104	0.578
NULL	Front_Neurol_2015_Jan_13_5_289.nxml.txt.nlp	25628599	SENT276	0	0	8	8	nadh	NPAS2	PA164755085	4862	0.578
NULL	Indian_J_Anaesth_2009_Apr_53(2)_226-229.nxml.txt.nlp	20640129	SENT41	22	22	14	14	midazolam	NIBP	PA450496	83696	0.578
NULL	Mol_Biol_Cell_2013_Sep_1_24(17)_2678-2688.nxml.txt.nlp	23864716	SENT85	12	12	14	14	thrombin	PP2	PA451674	4888	0.578
NULL	Eur_J_Pediatr_2011_Mar_17_170(3)_389-391.nxml.txt.nlp	20848129	SENT13	27	27	16	16	cyclosporine	WT1	PA449167	7490	0.578
NULL	Anticancer_Drugs_2015_Jan_28_26(1)_117-122.nxml.txt.nlp	25115342	SENT124	18	18	31	31	paclitaxel	SPARC	PA450761	6678	0.578
NULL	Mol_Vis_2011_Jun_9_17_1564-1576.nxml.txt.nlp	21738386	SENT17	0	0	2	2	ethambutol	EMB	PA164784021	133418	0.578
NULL	J_Radiat_Res_2014_Mar_8_55(2)_265-276.nxml.txt.nlp	24105709	SENT21	4	4	27	27	oxygen	ROS	PA450744	6098	0.578
NULL	Biologics_2009_Oct_12_3_469-474.nxml.txt.nlp	19851472	SENT83	19	19	12	12	montelukast	IL-13	PA450546	3596	0.578
NULL	Mol_Brain_2013_Dec_16_6_56.nxml.txt.nlp	24330819	SENT428	18	18	12	12	phencyclidine	GluN2D	PA128406980	2906	0.578
NULL	J_Gynecol_Oncol_2012_Oct_19_23(4)_226-234.nxml.txt.nlp	23094125	SENT61	10	10	6	6	cisplatin	CRT	PA449014	811	0.578
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1563-1573.nxml.txt.nlp	22015557	SENT144	3	3	12	12	sunitinib	c-Myc	PA162372840	4609	0.578
NULL	Oncotarget_2014_Sep_16_5(20)_10048-10057.nxml.txt.nlp	25301727	SENT165	34	34	45	45	l-glutamine	CO2	PA10090	4513	0.578
NULL	Mol_Med_Rep_2014_Nov_5_10(5)_2334-2340.nxml.txt.nlp	25189202	SENT25	9	9	11	11	cefoperazone	CFP	PA448849	5199	0.578
NULL	Int_J_Endocrinol_Metab_2013_Dec_21_Winter_11(1)_57-61.nxml.txt.nlp	23853622	SENT118	7	7	10	10	risperidone	PRL	PA451257	5617	0.578
NULL	J_Headache_Pain_2012_Mar_27_13(2)_103-111.nxml.txt.nlp	22200764	SENT70	6	6	0	0	capsaicin	TRPV1	PA448776	7442	0.578
NULL	Eur_J_Nutr_2009_Jun_24_48(4)_229-234.nxml.txt.nlp	19238310	SENT179	23	23	8	8	capsaicin	GLP-1	PA448776	100125288	0.578
NULL	Open_Biol_2014_May_4(5)_140045.nxml.txt.nlp	24850912	SENT179	11	11	4	4	azithromycin	L22	PA448519	6146	0.578
NULL	Nucleic_Acids_Res_2012_Jul_27_40(13)_6109-6121.nxml.txt.nlp	22453275	SENT313	24	24	34	34	iodixanol	PHB	PA164783998	5245	0.578
NULL	Brain_2014_Apr_27_137(4)_1145-1155.nxml.txt.nlp	24578545	SENT243	18	18	13	13	citalopram	ANOVA	PA449015	4858	0.578
NULL	J_Biol_Chem_2012_Apr_6_287(15)_12433-12444.nxml.txt.nlp	22351758	SENT334	13	13	3	3	trypsin	ITIH5	PA451806	80760	0.578
NULL	Environ_Health_2013_Jan_28_12_11.nxml.txt.nlp	23356966	SENT97	3	3	0	0	salbutamol	LHA	PA448068	1081	0.578
NULL	Tanaffos_2013_12(1)_6-15.nxml.txt.nlp	25191444	SENT60	15	15	17	17	amikacin	PTH	PA164744372	5741	0.578
NULL	Pharmaceutics_2011_Nov_18_3(4)_865-913.nxml.txt.nlp	24309312	SENT138	10	10	18	18	tacrolimus	P-gp	PA451578	5243	0.578
NULL	Br_J_Pharmacol_2011_Jul_163(6)_1263-1275.nxml.txt.nlp	21391977	SENT100	14	14	12	12	fluconazole	CYP2C9	PA449653	1559	0.578
NULL	Oxid_Med_Cell_Longev_2014_Apr_30_2014_149627.nxml.txt.nlp	24876909	SENT113	20	20	14	14	ethanol	NAC	PA448073	22861	0.578
NULL	Osteoporos_Int_2013_Jun_6_24(12)_2971-2981.nxml.txt.nlp	23740422	SENT264	5	5	10	10	raloxifene	PTH	PA451221	5741	0.578
NULL	Nucleic_Acids_Res_2013_Nov_16_41(20)_9349-9360.nxml.txt.nlp	23956219	SENT166	27	27	16	16	cisplatin	RMI1	PA449014	80010	0.578
NULL	Cancer_Med_2013_Feb_3_2(1)_76-85.nxml.txt.nlp	24133630	SENT180	8	8	0	0	vemurafenib	PI3K	PA165946873	5290	0.578
NULL	Nanoscale_Res_Lett_2010_Aug_31_5(12)_1908-1912.nxml.txt.nlp	21170411	SENT25	17	17	40	40	ethanol	PES	PA448073	23481	0.578
NULL	Br_J_Cancer_2010_Sep_7_103(6)_820-826.nxml.txt.nlp	20736948	SENT205	17	17	19	19	temozolomide	IFN	PA451609	3439	0.578
NULL	Mol_Cell_Proteomics_2013_Jan_22_12(1)_158-171.nxml.txt.nlp	23090970	SENT42	6	6	8	8	trastuzumab	VEGF-A	PA451743	7422	0.578
NULL	J_Mol_Signal_2012_May_14_7_4.nxml.txt.nlp	22583680	SENT66	19	19	3	3	isoproterenol	AKAP5	PA450121	9495	0.578
NULL	Biomed_Res_Int_2014_May_29_2014_349074.nxml.txt.nlp	24977149	SENT324	17	17	6	6	ethanol	ANOVA	PA448073	4858	0.578
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jan_7_68(Pt_2)_o289.nxml.txt.nlp	22346928	SENT50	15	15	23	23	ethanol	mol	PA448073	90527	0.578
NULL	Br_J_Anaesth_2014_Jul_22_113(1)_157-167.nxml.txt.nlp	24154701	SENT25	0	0	5	5	sevoflurane	TREK-1	PA451341	3776	0.578
NULL	ScientificWorldJournal_2014_Mar_12_2014_731462.nxml.txt.nlp	24715817	SENT172	24	24	30	30	diclofenac	IL-6	PA449293	3569	0.578
NULL	Int_J_Mol_Imaging_2011_Jul_14_2011_813028.nxml.txt.nlp	21785722	SENT184	3	3	0	0	glucose	FDG	PA449773	23583	0.578
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Apr_15_9_13.nxml.txt.nlp	20398300	SENT108	9	9	18	18	lansoprazole	LAM	PA450180	7249;7248	0.578
NULL	Case_Rep_Oncol_2013_Aug_24_6(2)_441-449.nxml.txt.nlp	24019785	SENT118	6	6	21	21	doxorubicin	STZ	PA449412	6484	0.578
NULL	Ann_Clin_Microbiol_Antimicrob_2005_Apr_1_4_6.nxml.txt.nlp	15804353	SENT104	4	4	6	6	ethambutol	EMB	PA164784021	133418	0.578
NULL	Br_J_Cancer_2011_Sep_6_105(6)_778-786.nxml.txt.nlp	21847128	SENT193	6	6	8	8	zoledronate	IL-2	PA10235	3558	0.578
NULL	Adv_Hematol_2011_Apr_10_2011_960137.nxml.txt.nlp	21547266	SENT63	29	29	14	14	rituximab	NHL	PA451261	51750	0.578
NULL	Aging_(Albany_NY)_2010_Dec_20_2(12)_959-968.nxml.txt.nlp	21191146	SENT134	15	15	33	33	cisplatin	LC3	PA449014	84557	0.578
NULL	Oncol_Lett_2014_Sep_11_8(3)_1222-1228.nxml.txt.nlp	25120693	SENT144	23	23	8	8	cisplatin	XRCC2	PA449014	7516	0.578
NULL	Mol_Pain_2013_Jun_10_9_27.nxml.txt.nlp	23758830	SENT109	17	17	19	19	tetracaine	ASIC1	PA451638	41	0.578
NULL	Gut_2012_May_3_61(5)_695-705.nxml.txt.nlp	21813473	SENT354	30	30	16	16	dextran	CCR5	PA449261	1234	0.578
NULL	Front_Behav_Neurosci_2014_Sep_3_8_291.nxml.txt.nlp	25232308	SENT702	1	1	5	5	phencyclidine	NR1	PA128406980	27158	0.578
NULL	Biologics_2012_Oct_25_6_371-378.nxml.txt.nlp	23118526	SENT234	10	10	14	14	rituximab	CD55	PA451261	1604	0.578
NULL	Front_Oncol_2014_Sep_23_4_264.nxml.txt.nlp	25295231	SENT119	0	0	22	22	lenalidomide	p53	PA162363968	7157	0.578
NULL	Iran_J_Public_Health_2010_Jun_30_39(2)_63-68.nxml.txt.nlp	23113008	SENT144	8	8	14	14	ceftazidime	TOB	PA448861	10140	0.578
NULL	J_Gastroenterol_2014_Dec_24_49(12)_1536-1547.nxml.txt.nlp	24366288	SENT213	3	3	11	11	lansoprazole	CYP2C19	PA450180	1557	0.578
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Feb_29_68(Pt_3)_o878-o879.nxml.txt.nlp	22412730	SENT84	11	11	7	7	coumarin	mol	PA134521193	90527	0.578
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Aug_21_66(Pt_9)_o2379-o2380.nxml.txt.nlp	21588717	SENT73	31	31	23	23	ethanol	mol	PA448073	90527	0.578
NULL	Arthritis_Res_2001_Sep_12_3(6)_362-367.nxml.txt.nlp	11714390	SENT147	18	18	10	10	creatine	B27	PA164778930	56246	0.578
NULL	Oncotarget_2013_Nov_24_4(12)_2430-2438.nxml.txt.nlp	24280348	SENT112	9	9	11	11	gefitinib	SOCS1	PA131301952	8651	0.578
NULL	Case_Rep_Oncol_2013_Aug_24_6(2)_441-449.nxml.txt.nlp	24019785	SENT118	23	23	21	21	streptozocin	STZ	PA451514	6484	0.578
NULL	Arthritis_Res_Ther_2010_Nov_17_12(6)_R211.nxml.txt.nlp	21083889	SENT103	20	20	0	0	methotrexate	ACR	PA450428	49	0.578
NULL	Indian_J_Endocrinol_Metab_2013_May-Jun_17(3)_524-528.nxml.txt.nlp	23869316	SENT38	15	15	26	26	thyroglobulin	AC1	PA164754910	107	0.578
NULL	Cancer_Metab_2014_May_28_2(Suppl_1)_P14.nxml.txt.nlp	NULL	SENT17	14	14	16	16	vemurafenib	HIF-1	PA165946873	29072	0.578
NULL	Clin_Ophthalmol_2010_Nov_23_4_1355-1359.nxml.txt.nlp	21179218	SENT65	19	19	33	33	latanoprost	BAK	PA164774763	578	0.578
NULL	Arthritis_Res_Ther_2014_Jan_24_16(1)_R23.nxml.txt.nlp	24460726	SENT192	10	10	12	12	hydroxychloroquine	IFN	PA164777036	3439	0.578
NULL	J_Biol_Chem_2013_Nov_15_288(46)_33049-33059.nxml.txt.nlp	24089524	SENT245	12	12	7	7	nicotine	GATA4	PA450626	2626	0.578
NULL	J_Oncol_2012_Dec_7_2012_192464.nxml.txt.nlp	22187555	SENT522	19	19	4	4	docetaxel	PC-3	PA449383	692094	0.578
NULL	Oxid_Med_Cell_Longev_2012_Jul_25_2012_472932.nxml.txt.nlp	22888398	SENT293	10	10	7	7	choline	B12	PA448976	7126;4709	0.578
NULL	Front_Neurosci_2011_Jul_26_5_92.nxml.txt.nlp	21845173	SENT75	9	9	17	17	ketorolac	NRM	PA450150	11270	0.578
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT609	0	0	5	5	aripiprazole	PRL	PA10026	5617	0.578
NULL	JRSM_Cardiovasc_Dis_2012_Sep_24_1(6)_cvd_2012_012015.nxml.txt.nlp	24175073	SENT23	30	30	38	38	clopidogrel	CYP2C19	PA449053	1557	0.578
NULL	Exp_Ther_Med_2014_Jun_28_7(6)_1659-1662.nxml.txt.nlp	24926362	SENT130	8	8	13	13	creatine	EPO	PA164778930	7076;8288;2056	0.578
NULL	Pak_J_Med_Sci_2013_May-Jun_29(3)_788-792.nxml.txt.nlp	24353629	SENT78	17	17	20	20	ceftizoxime	CTX	PA164748758	1593	0.578
NULL	Breast_Cancer_Res_2004_Feb_25_6(3)_R157-R169.nxml.txt.nlp	15084239	SENT56	16	16	8	8	collagenase	Met	PA449107	79811	0.578
NULL	Br_J_Cancer_2010_Dec_7_103(12)_1822-1830.nxml.txt.nlp	21063405	SENT152	6	6	4	4	cisplatin	NBS1	PA449014	55655	0.578
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT281	5	5	8	8	bortezomib	DR5	PA10252	8795	0.578
NULL	J_Biomed_Biotechnol_2004_Apr_27_2004(1)_52-60.nxml.txt.nlp	15123888	SENT118	22	22	24	24	genistein	Gen	PA165109660	348654	0.578
NULL	Clin_Transl_Allergy_2014_Mar_14_4(Suppl_1)_O19.nxml.txt.nlp	NULL	SENT10	20	20	40	40	fluorescein	CD56	PA164746009	4684	0.578
NULL	Cell_Death_Dis_2014_Jan_16_5(1)_e994.nxml.txt.nlp	24434517	SENT113	0	0	22	22	ivermectin	DD2	PA450133	1646	0.578
NULL	Eur_J_Clin_Microbiol_Infect_Dis_2010_May_13_29(5)_543-550.nxml.txt.nlp	20229224	SENT73	29	29	7	7	gentamicin	PEN	PA449753	9933	0.578
NULL	J_Cardiothorac_Surg_2013_Apr_4_8_63.nxml.txt.nlp	23557204	SENT50	7	7	30	30	glucose	FDG	PA449773	23583	0.578
NULL	Ther_Clin_Risk_Manag_2006_Sep_2(3)_297-301.nxml.txt.nlp	18360604	SENT77	6	6	9	9	paricalcitol	PTH	PA450798	5741	0.578
NULL	Ther_Clin_Risk_Manag_2007_Jun_3(3)_381-400.nxml.txt.nlp	18488078	SENT214	19	19	16	16	oxycodone	CYP2D6	PA450741	1565	0.578
NULL	Diabetes_2009_Jan_58(1)_61-70.nxml.txt.nlp	18931039	SENT144	2	2	10	10	forskolin	FHC	PA146096022	4607;2495	0.578
NULL	Mol_Cancer_2009_Nov_19_8_108.nxml.txt.nlp	19925669	SENT279	6	6	9	9	doxorubicin	CRT	PA449412	811	0.578
NULL	J_Korean_Med_Sci_2006_Dec_31_21(6)_1037-1040.nxml.txt.nlp	17179683	SENT93	2	2	8	8	omeprazole	BAM	PA450704	9126	0.578
NULL	Curr_Oncol_2006_Feb_13(1)_2-7.nxml.txt.nlp	17576435	SENT23	16	16	27	27	trastuzumab	HER2	PA451743	2064	0.578
NULL	Carcinogenesis_2014_May_13_35(5)_1055-1066.nxml.txt.nlp	24419232	SENT188	5	5	12	12	metformin	AMPK	PA450395	5563	0.577
NULL	Exp_Ther_Med_2013_Mar_16_5(3)_777-782.nxml.txt.nlp	23403801	SENT159	24	24	26	26	celecoxib	GAPDH	PA448871	2597	0.577
NULL	Case_Rep_Dermatol_2014_Jul_19_6(2)_180-184.nxml.txt.nlp	25202260	SENT49	5	5	12	12	itraconazole	GNS	PA450132	2799	0.577
NULL	Cost_Eff_Resour_Alloc_2005_Jan_25_3_2.nxml.txt.nlp	15670330	SENT130	18	18	15	15	enalapril	NNT	PA449456	23530	0.577
NULL	Int_J_Mol_Sci_2014_Mar_20_15(3)_4946-4964.nxml.txt.nlp	24658439	SENT100	6	6	17	17	capsaicin	GBF	PA448776	1316	0.577
NULL	Front_Oncol_2013_Sep_17_3_230.nxml.txt.nlp	24062983	SENT488	23	23	16	16	hyaluronan	PTH	PA165958431	5741	0.577
NULL	Proteome_Sci_2010_Mar_26_8_18.nxml.txt.nlp	20346146	SENT113	21	21	34	34	hyaluronan	CD14	PA165958431	929	0.577
NULL	Environ_Health_Perspect_1993_Oct_101(Suppl_3)_117-120.nxml.txt.nlp	8143602	SENT2	9	9	7	7	debrisoquine	CYP2D6	PA452616	1565	0.577
NULL	Pharmaceuticals_(Basel)_2014_May_7_7(5)_530-544.nxml.txt.nlp	24810947	SENT325	3	3	0	0	rituximab	CHOP	PA451261	1649	0.577
NULL	Pain_Res_Treat_2014_Apr_24_2014_850794.nxml.txt.nlp	24876957	SENT23	0	0	9	9	pregabalin	gamma	PA164754814	9913	0.577
NULL	Indian_J_Anaesth_2009_Aug_53(4)_399-400.nxml.txt.nlp	20640200	SENT4	23	23	4	4	rocuronium	gamma	PA164754992	9913	0.577
NULL	Clin_Ophthalmol_2012_Jul_26_6_1175-1186.nxml.txt.nlp	22973088	SENT59	15	15	0	0	heparin	VEGF-A	PA449855	7422	0.577
NULL	Mol_Cancer_2009_Nov_10_8_99.nxml.txt.nlp	19903356	SENT98	17	17	15	15	imatinib	IGFBP3	PA10804	3486	0.577
NULL	Int_J_Biomed_Sci_2013_Sep_9(3)_129-134.nxml.txt.nlp	24170988	SENT87	25	25	15	15	estradiol	aromatase	PA449503	1588	0.577
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jul_29_65(Pt_8)_o2022.nxml.txt.nlp	21583691	SENT72	35	35	18	18	ethanol	mol	PA448073	90527	0.577
NULL	Addict_Sci_Clin_Pract_2013_Mar_13_8(1)_6.nxml.txt.nlp	23497615	SENT208	21	21	23	23	buprenorphine	CD4	PA448685	920	0.577
NULL	Biomed_Res_Int_2013_May_28_2013_919374.nxml.txt.nlp	23781510	SENT32	0	0	10	10	resveratrol	RUNX2		860	0.577
NULL	Breast_Cancer_(Dove_Med_Press)_2013_Aug_22_5_73-78.nxml.txt.nlp	24648760	SENT153	4	4	6	6	tamoxifen	END	PA451581	2022	0.577
NULL	Brain_Sci_2013_Jun_19_3(2)_964-991.nxml.txt.nlp	24961433	SENT306	3	3	5	5	ethanol	spatial	PA448073	219793	0.577
NULL	Aging_(Albany_NY)_2011_Jan_18_3(1)_33-43.nxml.txt.nlp	21248371	SENT210	0	0	2	2	zinc	p53	PA451956	7157	0.577
NULL	Saudi_J_Anaesth_2014_Apr-Jun_8(2)_209-214.nxml.txt.nlp	24843334	SENT8	24	24	11	11	bupivacaine	C15	PA135057240	51316	0.577
NULL	J_Biol_Inorg_Chem_2014_Oct_17_19(1)_17-27.nxml.txt.nlp	24132751	SENT22	22	22	18	18	cisplatin	CTR1	PA449014	1317	0.577
NULL	Arthritis_Res_Ther_2009_Apr_30_11(2)_R58.nxml.txt.nlp	19405951	SENT86	19	19	26	26	clodronate	RANKL	PA10239	8600	0.577
NULL	Chem_Cent_J_2013_Jul_31_7_133.nxml.txt.nlp	23899303	SENT4	5	5	7	7	moxifloxacin	MOX	PA450555	26002	0.577
NULL	Alzheimers_Res_Ther_2012_Nov_26_4(6)_50.nxml.txt.nlp	23181523	SENT444	7	7	31	31	donepezil	spatial	PA449394	219793	0.577
NULL	Clin_Pharmacol_2013_Dec_10_5_193-199.nxml.txt.nlp	24353447	SENT82	9	9	32	32	midazolam	CYP3A4	PA450496	1576	0.577
NULL	Int_J_Nephrol_2011_Jun_16_2011_436856.nxml.txt.nlp	21716699	SENT85	12	12	10	10	vancomycin	VAN	PA451850	10318	0.577
NULL	Eur_J_Clin_Pharmacol_2012_Sep_15_68(9)_1267-1274.nxml.txt.nlp	22418828	SENT117	12	12	9	9	pantoprazole	CYP2C19	PA450774	1557	0.577
NULL	Environ_Health_Perspect_2010_May_8_118(5)_640-646.nxml.txt.nlp	20061214	SENT67	14	14	29	29	fluorescein	San	PA164746009	80218	0.577
NULL	J_Cell_Biol_2000_Feb_7_148(3)_557-566.nxml.txt.nlp	10662780	SENT36	14	14	21	21	kanamycin	CO2	PA450137	4513	0.577
NULL	Front_Neurosci_2012_Apr_9_6_44.nxml.txt.nlp	22509146	SENT466	28	28	11	11	ethanol	gamma	PA448073	9913	0.577
NULL	Mol_Clin_Oncol_2013_Jul_15_1(4)_661-667.nxml.txt.nlp	24649225	SENT197	22	22	0	0	leucovorin	OAT2	PA450198	10864	0.577
NULL	J_Immunother_Cancer_2014_Jan_27_2_2.nxml.txt.nlp	24829759	SENT118	48	48	46	46	sorafenib	IL-21	PA7000	59067;50616;27189	0.577
NULL	Am_J_Clin_Dermatol_2013_Feb_14_14(1)_27-47.nxml.txt.nlp	23329078	SENT686	12	12	3	3	pimecrolimus	Bcl-2	PA164783790	596	0.577
NULL	Cancer_Causes_Control_2013_Aug_18_24(8)_1605-1614.nxml.txt.nlp	23775025	SENT64	38	38	32	32	epirubicin	ABCB1	PA449476	5243	0.577
NULL	Crit_Care_2008_Apr_10_12(2)_132.nxml.txt.nlp	18423065	SENT35	3	3	0	0	vasopressin	AVP	PA451858	114548;551	0.577
NULL	Br_J_Cancer_2010_Nov_9_103(10)_1548-1553.nxml.txt.nlp	20924376	SENT185	14	14	34	34	dacarbazine	GM-CSF	PA449197	1437	0.577
NULL	Oncotarget_2014_Dec_4_5(22)_11365-11380.nxml.txt.nlp	25426548	SENT74	5	5	14	14	nutlin-3	TP53		7157	0.577
NULL	Breast_Cancer_Res_2005_Jan_17_7(2)_R248-R255.nxml.txt.nlp	15743505	SENT38	5	5	11	11	nitrogen	BRL	PA450643	23774	0.577
NULL	Cancer_Cell_Int_2006_Aug_9_6_20.nxml.txt.nlp	16899133	SENT65	0	0	10	10	curcumin	p27	PA151958596	5715;10534	0.577
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT110	1	1	26	26	curcumin	survivin	PA151958596	332	0.577
NULL	Clin_Mol_Hepatol_2013_Sep_30_19(3)_195-209.nxml.txt.nlp	24133659	SENT288	2	2	0	0	lamivudine	LAM	PA450163	7249;7248	0.577
NULL	Clin_Ophthalmol_2014_Dec_30_9_43-49.nxml.txt.nlp	25565767	SENT44	10	10	21	21	acetazolamide	OCT	PA448018	5362	0.577
NULL	J_Radiat_Res_2012_Sep_10_53(5)_704-709.nxml.txt.nlp	22843360	SENT94	8	8	10	10	irinotecan	CRT	PA450085	811	0.577
NULL	Oncotarget_2011_Aug_30_2(8)_610-626.nxml.txt.nlp	21881167	SENT95	22	22	18	18	doxorubicin	Raf-1	PA449412	5894	0.577
NULL	Front_Neurosci_2012_Jun_12_6_84.nxml.txt.nlp	22701400	SENT2503	4	4	11	11	citalopram	STAR	PA449015	6770;2984	0.577
NULL	Oncotarget_2014_Oct_21_5(22)_11252-11268.nxml.txt.nlp	25361004	SENT250	6	6	29	29	metformin	CLIC1	PA450395	1192	0.577
NULL	Zookeys_2014_Nov_25_(457)_1-14.nxml.txt.nlp	25561827	SENT142	43	43	28	28	ethanol	hole	PA448073	80757	0.577
NULL	Lab_Invest_2011_Jun_14_91(6)_852-858.nxml.txt.nlp	21403643	SENT16	5	5	2	2	tenofovir	OAT1	PA10204	9356	0.577
NULL	Biochem_Res_Int_2012_Feb_12_2012_346972.nxml.txt.nlp	22400115	SENT238	4	4	19	19	hyaluronan	TLR2	PA165958431	7097	0.577
NULL	Breast_Cancer_(Auckl)_2011_Apr_13_5_53-65.nxml.txt.nlp	21603258	SENT239	8	8	19	19	paclitaxel	HER2	PA450761	2064	0.577
NULL	Mediators_Inflamm_2010_Sep_14_2010_581837.nxml.txt.nlp	20871832	SENT75	6	6	0	0	dextran	TLR4	PA449261	7099	0.577
NULL	Neural_Plast_2007_Jan_1_2007_30585.nxml.txt.nlp	25148070	SENT3514	34	34	24	24	imipramine	VPAC2	PA449969	7434	0.577
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT144	2	2	6	6	pp2	LYN		4067	0.577
NULL	Front_Endocrinol_(Lausanne)_2013_May_27_4_59.nxml.txt.nlp	23750153	SENT92	14	14	7	7	nadh	MAL	PA164755085	57591;4118	0.577
NULL	Acta_Pharmacol_Sin_2012_Jan_28_33(1)_66-74.nxml.txt.nlp	22120966	SENT258	24	24	14	14	genistein	OPG	PA165109660	690	0.577
NULL	Osteoporos_Int_2012_Feb_4_23(Suppl_1)_S1-S23.nxml.txt.nlp	22311111	SENT481	2	2	4	4	teriparatide	PTH	PA451620	5741	0.577
NULL	Alcohol_Res_Health_2008_31(2)_155-167.nxml.txt.nlp	23584817	SENT236	4	4	35	35	baclofen	ASAM	PA448533	79827	0.577
NULL	J_Antimicrob_Chemother_2011_Oct_21_66(10)_2240-2247.nxml.txt.nlp	21778195	SENT38	35	35	25	25	isoniazid	DST	PA450112	667	0.577
NULL	Viruses_2014_Mar_10_6(3)_1091-1111.nxml.txt.nlp	24618810	SENT214	30	30	45	45	ciprofloxacin	CO2	PA449009	4513	0.577
NULL	Br_J_Cancer_2010_Aug_24_103(5)_649-655.nxml.txt.nlp	20664591	SENT244	26	26	20	20	oxaliplatin	GEM	PA131285527	2669	0.577
NULL	Evid_Based_Complement_Alternat_Med_2014_May_8_2014_364819.nxml.txt.nlp	24899907	SENT44	0	0	3	3	tacrolimus	FKBP52	PA451578	2288	0.577
NULL	Clin_Interv_Aging_2008_Sep_3(3)_421-430.nxml.txt.nlp	18982913	SENT231	0	0	3	3	buprenorphine	CYP3A4	PA448685	1576	0.577
NULL	Clin_Psychopharmacol_Neurosci_2011_Apr_30_9(1)_36-43.nxml.txt.nlp	23431025	SENT115	5	5	26	26	clozapine	FLI	PA449061	2314	0.577
NULL	Exp_Diabetes_Res_2012_Jan_29_2012_159874.nxml.txt.nlp	22319521	SENT233	0	0	5	5	telmisartan	VEGF-A	PA451605	7422	0.577
NULL	Cardiovasc_Ther_2009_27(4)_259-274.nxml.txt.nlp	19604248	SENT126	11	11	4	4	ticagrelor	ADP	PA165374673	23038	0.577
NULL	Curr_Nutr_Rep_2014_Dec_15_3(1)_22-34.nxml.txt.nlp	24563822	SENT90	30	30	27	27	estradiol	SHBG	PA449503	6462	0.577
NULL	Braz_J_Med_Biol_Res_2012_Jun_8_45(10)_988-994.nxml.txt.nlp	22666778	SENT79	28	28	8	8	lipase	ADD1	PA450239	118	0.577
NULL	Int_J_Gen_Med_2011_Jul_20_4_539-545.nxml.txt.nlp	21845063	SENT102	3	3	6	6	miglitol	adiponectin	PA164776726	9370	0.577
NULL	Arthritis_Res_Ther_2005_Mar_16_7(Suppl_2)_S21-S25.nxml.txt.nlp	15833145	SENT26	6	6	9	9	abatacept	CD80	PA164747080	941	0.577
NULL	Diabetes_2011_Nov_17_60(11)_2691-2700.nxml.txt.nlp	21896928	SENT264	10	10	6	6	resveratrol	AMPK		5563	0.577
NULL	Clin_Ophthalmol_2013_Dec_21_7_7-14.nxml.txt.nlp	23293509	SENT97	7	7	12	12	tafluprost	BAK	PA165958432	578	0.577
NULL	Biochem_Res_Int_2012_Nov_1_2012_738471.nxml.txt.nlp	22110962	SENT135	16	16	3	3	choline	DAG	PA448976	1605	0.577
NULL	Mol_Biol_Cell_2012_Mar_15_23(6)_966.nxml.txt.nlp	NULL	SENT34	17	17	14	14	paclitaxel	Mcl-1	PA450761	4170	0.577
NULL	J_Gen_Physiol_2009_Sep_134(3)_243-258.nxml.txt.nlp	19720962	SENT728	7	7	25	25	capsaicin	TRPV1	PA448776	7442	0.577
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Dec_17_3(12)_e152.nxml.txt.nlp	25518025	SENT67	27	27	21	21	oxycodone	CYP2C19	PA450741	1557	0.577
NULL	Afr_J_Infect_Dis_2011_5(2)_40-46.nxml.txt.nlp	23878706	SENT88	22	22	8	8	ciprofloxacin	Gen	PA449009	348654	0.577
NULL	Diabetes_2011_Nov_17_60(11)_2691-2700.nxml.txt.nlp	21896928	SENT229	30	30	24	24	resveratrol	SIRT1		23411	0.577
NULL	Neuroscience_2015_Jan_22_284_872-887.nxml.txt.nlp	25450967	SENT18	10	10	5	5	choline	PPG	PA448976	5552	0.577
NULL	Breast_Cancer_Res_2007_Jul_5_9(4)_R41.nxml.txt.nlp	17612393	SENT216	25	25	7	7	celecoxib	Bcl-2	PA448871	596	0.577
NULL	Br_J_Ophthalmol_2013_Aug_6_97(8)_989-993.nxml.txt.nlp	23743437	SENT114	2	2	11	11	bimatoprost	BIM	PA164748867	10018	0.577
NULL	Biologics_2012_Sep_25_6_337-345.nxml.txt.nlp	23055691	SENT153	34	34	25	25	erlotinib	EGFR	PA134687924	1956	0.577
NULL	Ann_Rehabil_Med_2012_Aug_27_36(4)_466-473.nxml.txt.nlp	22977771	SENT13	7	7	3	3	triamcinolone	ILEI	PA451749	10447	0.577
NULL	Extremophiles_2009_Nov_23_13(6)_885-894.nxml.txt.nlp	19701714	SENT136	23	23	37	37	ethanol	mol	PA448073	90527	0.577
NULL	J_Korean_Med_Sci_2013_Dec_26_28(12)_1774-1780.nxml.txt.nlp	24339708	SENT184	19	19	17	17	octreotide	OST	PA450678	1650;23263	0.577
NULL	Br_J_Cancer_2011_Jul_12_105(2)_255-262.nxml.txt.nlp	21694725	SENT190	4	4	6	6	capecitabine	EGFR	PA448771	1956	0.577
NULL	Tanaffos_2013_12(1)_6-15.nxml.txt.nlp	25191444	SENT60	7	7	5	5	ethambutol	EMB	PA164784021	133418	0.577
NULL	Drugs_Context_2012_Dec_11_2012_212244.nxml.txt.nlp	24432033	SENT72	9	9	20	20	urokinase	HER-2	PA451836	2064	0.577
NULL	Thorax_2012_Sep_11_67(9)_796-803.nxml.txt.nlp	22496351	SENT104	13	13	23	23	bleomycin	TRAIL	PA448645	8743	0.577
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT140	31	31	5	5	perifosine	DR5	PA165291471	8795	0.577
NULL	Pharmaceuticals_(Basel)_2012_Feb_2_5(2)_114-132.nxml.txt.nlp	24288084	SENT300	2	2	4	4	capsaicin	TRPV1	PA448776	7442	0.577
NULL	Cardiovasc_J_Afr_2010_Oct_21(5)_280-285.nxml.txt.nlp	20972517	SENT128	20	20	15	15	talinolol	ABC1	PA146123005	63897	0.577
NULL	Br_J_Haematol_2014_Jun_12_165(6)_768-776.nxml.txt.nlp	24617454	SENT180	13	13	24	24	vorinostat	EP300	PA164748224	2033	0.577
NULL	Hum_Genomics_Proteomics_2010_Aug_3_2010_159761.nxml.txt.nlp	20981231	SENT130	3	3	5	5	lithium	AP-1	PA450243	2353;3727;2354;3725	0.577
NULL	Arch_Virol_2014_Dec_24_159(6)_1365-1371.nxml.txt.nlp	24366548	SENT164	22	22	20	20	ribavirin	IFN	PA451241	3439	0.577
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT128	9	9	1	1	quinidine	CYP2C9	PA451209	1559	0.577
NULL	Pharmaceutics_2011_Nov_18_3(4)_865-913.nxml.txt.nlp	24309312	SENT112	9	9	22	22	repaglinide	CYP3A4	PA451234	1576	0.577
NULL	Br_J_Cancer_2010_Jan_5_102(1)_80-86.nxml.txt.nlp	19920817	SENT64	25	25	27	27	bevacizumab	IFN	PA130232992	3439	0.577
NULL	Saudi_J_Anaesth_2014_Apr-Jun_8(2)_209-214.nxml.txt.nlp	24843334	SENT38	41	41	14	14	clonidine	C15	PA449051	51316	0.577
NULL	BMB_Rep_2013_Nov_46(11)_544-549.nxml.txt.nlp	24152910	SENT98	23	23	9	9	thrombin	TLR2	PA451674	7097	0.577
NULL	Cardiovasc_Diabetol_2013_Jun_19_12_92.nxml.txt.nlp	23777506	SENT142	1	1	5	5	miglitol	GLP-1	PA164776726	100125288	0.577
NULL	F1000_Biol_Rep_2009_Mar_24_1_23.nxml.txt.nlp	20948663	SENT44	39	39	14	14	citalopram	STAR	PA449015	6770;2984	0.577
NULL	Infect_Dis_Ther_2014_Jun_18_3(1)_35-43.nxml.txt.nlp	25134810	SENT167	3	3	16	16	vancomycin	VISA	PA451850	57506	0.577
NULL	Case_Rep_Med_2014_Nov_12_2014_231651.nxml.txt.nlp	25477968	SENT100	15	15	6	6	methimazole	AIT	PA450422	160728	0.577
NULL	Front_Cell_Neurosci_2013_Aug_30_7_139.nxml.txt.nlp	24009559	SENT224	11	11	7	7	pilocarpine	P2X7	PA450962	5027	0.577
NULL	FEBS_Lett_2014_Sep_17_588(18)_3382-3389.nxml.txt.nlp	25093298	SENT112	21	21	28	28	l-glutamine	CO2	PA10090	4513	0.577
NULL	Anat_Cell_Biol_2011_Sep_29_44(3)_186-193.nxml.txt.nlp	22025970	SENT48	28	28	24	24	paraformaldehyde	PLP	PA450790	25824;5744	0.577
NULL	J_Thromb_Thrombolysis_2010_Nov_23_30(4)_446-451.nxml.txt.nlp	20571920	SENT148	7	7	28	28	heparin	ARNO	PA449855	9266	0.577
NULL	Clin_Ophthalmol_2014_Feb_10_8_389-399.nxml.txt.nlp	24550667	SENT203	33	33	31	31	timolol	TIM	PA451690	7984;8914	0.577
NULL	Aging_(Albany_NY)_2011_Dec_12_3(11)_1051-1062.nxml.txt.nlp	22166724	SENT195	0	0	20	20	resveratrol	AMPK		5563	0.577
NULL	Arthritis_Res_Ther_2014_Jan_15_16(1)_R10.nxml.txt.nlp	24423138	SENT369	3	3	6	6	collagenase	TRPV1	PA449107	7442	0.577
NULL	Case_Rep_Oncol_2012_Jul_24_5(2)_385-387.nxml.txt.nlp	23525261	SENT45	15	15	13	13	diethylstilbestrol	DES	PA449307	1674	0.577
NULL	EMBO_J_2009_Jul_22_28(14)_2028-2041.nxml.txt.nlp	19536134	SENT255	18	18	6	6	ethanol	CO2	PA448073	4513	0.577
NULL	Clin_Ophthalmol_2008_Mar_2(1)_1-14.nxml.txt.nlp	19668384	SENT84	11	11	16	16	heparin	VEGF-A	PA449855	7422	0.577
NULL	J_Korean_Med_Sci_2006_Dec_31_21(6)_1037-1040.nxml.txt.nlp	17179683	SENT86	2	2	8	8	omeprazole	BAM	PA450704	9126	0.577
NULL	Front_Genet_2014_Jan_24_5_3.nxml.txt.nlp	24478792	SENT250	13	13	16	16	cisapride	HERG	PA449011	3757	0.577
NULL	Antimicrob_Agents_Chemother_2013_Oct_57(10)_4882-4893.nxml.txt.nlp	23877697	SENT228	28	28	7	7	tetracycline	CARP	PA451640	27063;80013;767	0.577
NULL	Int_J_Womens_Health_2010_Aug_9_1_11-20.nxml.txt.nlp	21072271	SENT147	36	36	25	25	alendronate	STAR	PA448082	6770;2984	0.577
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT168	11	11	14	14	rosiglitazone	CD36	PA451283	948	0.577
NULL	Br_J_Cancer_2006_Feb_13_94(3)_407-426.nxml.txt.nlp	16434996	SENT116	0	0	4	4	genistein	BRCA2	PA165109660	675	0.577
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1495-1502.nxml.txt.nlp	21989186	SENT189	27	27	9	9	panitumumab	HSI	PA162373091	57016	0.577
NULL	Indian_J_Pharm_Sci_2013_May-Jun_75(3)_302-309.nxml.txt.nlp	24082346	SENT181	18	18	26	26	diclofenac	SRMS	PA449293	6725	0.577
NULL	Front_Mol_Neurosci_2012_Nov_12_5_99.nxml.txt.nlp	23162427	SENT821	16	16	7	7	cocaine	AP-1	PA449072	2353;3727;2354;3725	0.577
NULL	Chin_J_Cancer_2012_Feb_31(2)_73-99.nxml.txt.nlp	22098950	SENT234	0	0	12	12	erlotinib	EGFR	PA134687924	1956	0.577
NULL	Biomed_Res_Int_2014_Feb_6_2014_323594.nxml.txt.nlp	24689036	SENT218	6	6	2	2	raloxifene	PC3	PA451221	57332;7832;5122	0.577
NULL	Nat_Med_2010_Jun_23_16(6)_671-677.nxml.txt.nlp	20495567	SENT244	23	23	6	6	sorafenib	CREB3L2	PA7000	64764	0.577
NULL	Anticancer_Agents_Med_Chem_2014_Jan_14(1)_170-180.nxml.txt.nlp	24164046	SENT262	10	10	3	3	tamoxifen	BRCA1	PA451581	672	0.577
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT81	1	1	7	7	curcumin	TRAIL	PA151958596	8743	0.577
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT119	0	0	11	11	nutlin-3	DR5		8795	0.577
NULL	Int_J_Vasc_Med_2013_Mar_31_2013_543141.nxml.txt.nlp	23606968	SENT242	0	0	6	6	etanercept	IL-6	PA449515	3569	0.577
NULL	Mol_Cancer_2012_Dec_12_11_91.nxml.txt.nlp	23234355	SENT138	22	22	33	33	erlotinib	ANOVA	PA134687924	4858	0.577
NULL	Chem_Cent_J_2012_May_11_6_41.nxml.txt.nlp	22578215	SENT74	6	6	8	8	naringin	castor	PA151958360	54897	0.577
NULL	Exp_Diabetes_Res_2012_Oct_26_2012_820989.nxml.txt.nlp	22110480	SENT5	4	4	10	10	rosiglitazone	LYRM1	PA451283	57149	0.577
NULL	Br_J_Anaesth_2014_Jul_22_113(1)_157-167.nxml.txt.nlp	24154701	SENT261	0	0	4	4	sevoflurane	TREK-1	PA451341	3776	0.577
NULL	Endocrine_2012_Dec_14_42(3)_622-636.nxml.txt.nlp	22695986	SENT220	34	34	36	36	forskolin	PTH	PA146096022	5741	0.577
NULL	Arthritis_Res_Ther_2011_Feb_16_13(1)_R25.nxml.txt.nlp	21324169	SENT151	1	1	21	21	infliximab	ACR	PA452639	49	0.577
NULL	Nat_Genet_2011_Dec_11_44(1)_53-57.nxml.txt.nlp	22158538	SENT165	27	27	25	25	l-glutamine	FBS	PA10090	64319;26269	0.577
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R91.nxml.txt.nlp	22541814	SENT34	5	5	7	7	thrombin	HO-1	PA451674	3162	0.577
NULL	J_Med_Case_Reports_2011_Dec_21_5_593.nxml.txt.nlp	22188652	SENT52	11	11	14	14	erlotinib	CYP2D6	PA134687924	1565	0.577
NULL	Front_Neurosci_2013_Dec_24_7_254.nxml.txt.nlp	24399926	SENT167	16	16	0	0	eszopiclone	ANOVA	PA162630444	4858	0.577
NULL	Br_J_Cancer_2013_Feb_5_108(2)_469-476.nxml.txt.nlp	23169292	SENT174	4	4	34	34	capecitabine	TTF2	PA448771	8458	0.577
NULL	Ann_Hematol_2014_Mar_18_93(8)_1335-1344.nxml.txt.nlp	24638841	SENT50	6	6	4	4	rituximab	CLB	PA451261	171425	0.577
NULL	Mol_Vis_2012_Jan_1_18_1-9.nxml.txt.nlp	22232563	SENT0	6	6	25	25	bevacizumab	HIF-1	PA130232992	29072	0.577
NULL	Exp_Ther_Med_2013_Jul_25_6(1)_109-114.nxml.txt.nlp	23935730	SENT137	22	22	19	19	rituximab	CHOP	PA451261	1649	0.577
NULL	Cardiovasc_Diabetol_2010_Nov_5_9_72.nxml.txt.nlp	21054861	SENT110	22	22	6	6	isoproterenol	ANOVA	PA450121	4858	0.577
NULL	Exp_Ther_Med_2013_Feb_30_5(2)_616-620.nxml.txt.nlp	23407814	SENT127	9	9	0	0	nitroprusside	ANG	PA451406	283	0.577
NULL	Br_J_Cancer_1990_Sep_62(3)_388-394.nxml.txt.nlp	1698441	SENT6	25	25	23	23	neomycin	GM-CSF	PA450608	1437	0.577
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT159	29	29	4	4	tacrolimus	RANKL	PA451578	8600	0.577
NULL	J_Cell_Biol_2003_Aug_18_162(4)_587-597.nxml.txt.nlp	12913114	SENT17	42	42	24	24	staurosporine	CHOP	PA165109623	1649	0.577
NULL	Front_Genet_2012_Nov_22_3_249.nxml.txt.nlp	23189085	SENT146	2	2	32	32	s-adenosylmethionine	ITPA	PA164754994	3704	0.577
NULL	ScientificWorldJournal_2013_Sep_19_2013_809891.nxml.txt.nlp	24170983	SENT180	0	0	2	2	dexketoprofen	CD80	PA166049175	941	0.577
NULL	Gut_Liver_2013_Sep_14_7(5)_552-559.nxml.txt.nlp	24073313	SENT150	13	13	4	4	heparin	EGFR	PA449855	1956	0.577
NULL	Oxid_Med_Cell_Longev_2012_Oct_15_2012_781516.nxml.txt.nlp	23119122	SENT45	35	35	42	42	gentamicin	CO2	PA449753	4513	0.577
NULL	Virulence_2013_Nov_15_4(8)_734-739.nxml.txt.nlp	24165210	SENT93	2	2	0	0	vancomycin	VAN	PA451850	10318	0.577
NULL	Int_J_Mol_Sci_2014_Mar_20_15(3)_4977-4993.nxml.txt.nlp	24658441	SENT472	4	4	2	2	resveratrol	adiponectin		9370	0.577
NULL	Neural_Plast_2012_May_31_2012_456478.nxml.txt.nlp	22701806	SENT162	5	5	10	10	salbutamol	SMN2	PA448068	6607	0.576
NULL	Arthritis_Res_Ther_2003_May_14_5(4)_R210-R213.nxml.txt.nlp	12823856	SENT106	8	8	11	11	fluorescein	IFN	PA164746009	3439	0.576
NULL	Eur_J_Clin_Pharmacol_2013_Jan_11_69(6)_1275-1283.nxml.txt.nlp	23307232	SENT82	41	41	18	18	warfarin	CYP2C9	PA451906	1559	0.576
NULL	J_Breast_Cancer_2011_Mar_31_14(1)_46-51.nxml.txt.nlp	21847394	SENT137	21	21	0	0	cyclophosphamide	HER2	PA449165	2064	0.576
NULL	Nanotoxicology_2013_Mar_20_7(2)_202-211.nxml.txt.nlp	22264036	SENT60	35	35	46	46	gentamicin	CO2	PA449753	4513	0.576
NULL	Asian-Australas_J_Anim_Sci_2013_Feb_26(2)_266-274.nxml.txt.nlp	25049786	SENT226	3	3	13	13	ginseng	FA3	PA164781150	2176	0.576
NULL	Ann_Rheum_Dis_2015_Jan_14_74(1)_242-251.nxml.txt.nlp	24130267	SENT280	42	42	24	24	raloxifene	RANKL	PA451221	8600	0.576
NULL	Int_J_Tryptophan_Res_2013_Jul_21_6(Suppl_1)_47-54.nxml.txt.nlp	23922502	SENT10	15	15	13	13	l-tryptophan	KMO	PA10323	8564	0.576
NULL	Eur_J_Med_Res_2011_Mar_28_16(3)_115-126.nxml.txt.nlp	21486724	SENT285	32	32	42	42	ertapenem	Met	PA164777032	79811	0.576
NULL	Drugs_2009_Mar_17_69(5)_549-565.nxml.txt.nlp	19368417	SENT148	2	2	4	4	budesonide	DPI	PA448681	1832	0.576
NULL	Biochimie_2012_Aug_94(8)_1749-1753.nxml.txt.nlp	22522093	SENT253	10	10	1	1	camptothecin	SCAN1	PA153590860	55775	0.576
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT273	16	16	4	4	adalimumab	CD36	PA10004	948	0.576
NULL	J_Cancer_Prev_2013_Sep_18(3)_227-234.nxml.txt.nlp	25337550	SENT42	26	26	34	34	decitabine	p53	PA164749631	7157	0.576
NULL	Oncotarget_2014_Sep_3_5(19)_9362-9381.nxml.txt.nlp	25313139	SENT117	23	23	35	35	lipase	ACSL5	PA450239	51703	0.576
NULL	Biologics_2012_Jan_5_6_13-20.nxml.txt.nlp	22291463	SENT40	6	6	15	15	trastuzumab	HER2	PA451743	2064	0.576
NULL	Emerg_Infect_Dis_2011_Oct_17(10)_1879-1882.nxml.txt.nlp	22000360	SENT60	14	14	0	0	cefuroxime	PEN	PA448868	9933	0.576
NULL	Iran_Red_Crescent_Med_J_2014_Jun_5_16(6)_e18115.nxml.txt.nlp	25068056	SENT125	10	10	18	18	bosentan	PTH	PA10034	5741	0.576
NULL	Front_Genet_2013_Aug_29_4_163.nxml.txt.nlp	24009622	SENT68	19	19	11	11	ethanol	ABCG2	PA448073	9429	0.576
NULL	Int_J_Vasc_Med_2012_Oct_5_2012_784536.nxml.txt.nlp	22007304	SENT316	15	15	12	12	heparin	GPIHBP1	PA449855	338328	0.576
NULL	Mol_Syst_Biol_2009_Jul_28_5_288.nxml.txt.nlp	19638969	SENT223	8	8	5	5	resveratrol	HuR		1994	0.576
NULL	Int_J_Mol_Sci_2014_Oct_8_15(10)_17974-17999.nxml.txt.nlp	25299695	SENT136	6	6	21	21	curcumin	HO-2	PA151958596	3163	0.576
NULL	Mol_Cancer_2009_Nov_24_8_109.nxml.txt.nlp	19930708	SENT125	7	7	9	9	exemestane	EGFR	PA449563	1956	0.576
NULL	Br_J_Cancer_2010_Oct_26_103(9)_1325-1330.nxml.txt.nlp	20940720	SENT157	16	16	20	20	docetaxel	CRT	PA449383	811	0.576
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT77	0	0	4	4	chloroquine	BMPR-II	PA448948	659	0.576
NULL	Crit_Care_2009_Jul_10_13(4)_R113.nxml.txt.nlp	19591694	SENT5	2	2	4	4	vasopressin	AVP	PA451858	114548;551	0.576
NULL	Exp_Ther_Med_2014_Mar_19_7(3)_573-578.nxml.txt.nlp	24520247	SENT142	13	13	5	5	dextran	DAI	PA449261	81030	0.576
NULL	Clin_Ophthalmol_2010_Nov_3_4_1253-1261.nxml.txt.nlp	21151330	SENT6	11	11	8	8	latanoprost	BAK	PA164774763	578	0.576
NULL	Br_J_Cancer_2010_Jun_29_103(1)_61-72.nxml.txt.nlp	20588279	SENT248	39	39	14	14	trastuzumab	RhoB	PA451743	388	0.576
NULL	Int_Dairy_J_2010_Apr_20(4)_236-242.nxml.txt.nlp	20204054	SENT61	11	11	13	13	tolbutamide	GLP-1	PA451718	100125288	0.576
NULL	Onco_Targets_Ther_2014_Mar_24_7_491-500.nxml.txt.nlp	24711706	SENT96	15	15	17	17	trastuzumab	DM1	PA451743	338023;1760;28509	0.576
NULL	Diabetes_2013_Mar_14_62(3)_789-800.nxml.txt.nlp	22966074	SENT216	2	2	13	13	forskolin	AMPK	PA146096022	5563	0.576
NULL	Neural_Develop_2007_Jun_8_2_11.nxml.txt.nlp	17559664	SENT235	33	33	35	35	tamoxifen	E16	PA451581	8140	0.576
NULL	J_Vet_Med_Sci_2013_Dec_25_75(12)_1637-1642.nxml.txt.nlp	23884081	SENT8	10	10	25	25	dextran	c-Jun	PA449261	3725	0.576
NULL	Arthritis_Res_Ther_2006_Dec_6_8(6)_R180.nxml.txt.nlp	17150088	SENT77	22	22	42	42	l-glutamine	CO2	PA10090	4513	0.576
NULL	Breast_Cancer_Res_2011_May_26_13(3)_209.nxml.txt.nlp	21635709	SENT168	29	29	10	10	letrozole	HER2	PA450196	2064	0.576
NULL	Virol_J_2009_Dec_1_6_213.nxml.txt.nlp	19951438	SENT127	10	10	23	23	mitomycin	TRAIL	PA450524	8743	0.576
NULL	J_Biomed_Sci_2013_Sep_18_20(1)_69.nxml.txt.nlp	24047403	SENT125	22	22	18	18	thrombin	EGF	PA451674	1950	0.576
NULL	J_Gen_Physiol_2008_May_131(5)_503-513.nxml.txt.nlp	18443361	SENT12	9	9	11	11	fluorescein	COD	PA164746009	6628	0.576
NULL	Mol_Vis_2011_Oct_31_17_2824-2834.nxml.txt.nlp	22128230	SENT44	10	10	12	12	atropine	APO	PA448505	84909	0.576
NULL	Angew_Chem_Int_Ed_Engl_2013_Jan_21_52(4)_1253-1256.nxml.txt.nlp	23225333	SENT69	11	11	16	16	ethanol	CC3	PA448073	10553	0.576
NULL	J_Cell_Biol_2001_Aug_6_154(3)_485-490.nxml.txt.nlp	11489912	SENT296	12	12	20	20	glutaraldehyde	M-CSF	PA449777	1435	0.576
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT1686	1	1	6	6	diflomotecan	ABCG2	PA134653756	9429	0.576
NULL	Chonnam_Med_J_2013_Apr_25_49(1)_31-37.nxml.txt.nlp	23678475	SENT120	43	43	32	32	telmisartan	adiponectin	PA451605	9370	0.576
NULL	Int_J_Mol_Sci_2012_Aug_10_13(8)_9971-9979.nxml.txt.nlp	22949842	SENT69	2	2	4	4	lipase	PPL	PA450239	5493	0.576
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT154	45	45	27	27	vinorelbine	ASC	PA451881	29108	0.576
NULL	Prz_Gastroenterol_2014_Sep_16_9(4)_214-219.nxml.txt.nlp	25276252	SENT7	17	17	19	19	cisplatin	DDP	PA449014	1678	0.576
NULL	Diabetes_Care_2009_Sep_32(9)_e104-e111.nxml.txt.nlp	19717816	SENT134	23	23	30	30	glimepiride	GLP-1	PA449761	100125288	0.576
NULL	Gut_Pathog_2012_Jul_16_4_7.nxml.txt.nlp	22800501	SENT75	34	34	8	8	tigecycline	CTX	PA164746412	1593	0.576
NULL	Curr_Neuropharmacol_2010_Sep_8(3)_287-304.nxml.txt.nlp	21358978	SENT401	36	36	7	7	agomelatine	PRL	PA165958363	5617	0.576
NULL	Extremophiles_2009_Nov_23_13(6)_885-894.nxml.txt.nlp	19701714	SENT136	23	23	16	16	ethanol	mol	PA448073	90527	0.576
NULL	Biologics_2014_Apr_22_8_193-198.nxml.txt.nlp	24790412	SENT126	31	31	21	21	etanercept	Yes	PA449515	7525	0.576
NULL	Cancer_Cell_Int_2014_Jun_11_14_49.nxml.txt.nlp	24991192	SENT20	13	13	37	37	berberine	AMPK	PA165860812	5563	0.576
NULL	Chem_Rev_2011_Oct_12_111(10)_5899-5921.nxml.txt.nlp	21923193	SENT50	22	22	9	9	lipase	CES1	PA450239	1066	0.576
NULL	FEBS_Open_Bio_2013_Aug_17_3_352-356.nxml.txt.nlp	24251095	SENT190	10	10	13	13	hyaluronan	RHAMM	PA165958431	3161	0.576
NULL	Blood_Cancer_J_2013_Mar_1_3(3)_e103.nxml.txt.nlp	23454896	SENT92	2	2	11	11	nelfinavir	P27	PA450606	3429	0.576
NULL	Br_J_Cancer_1997_75(6)_884-891.nxml.txt.nlp	9062411	SENT19	19	19	7	7	docetaxel	P-gp	PA449383	5243	0.576
NULL	Orphanet_J_Rare_Dis_2013_Aug_23_8_127.nxml.txt.nlp	23972085	SENT4	16	16	7	7	ifosfamide	NF1	PA449964	4763	0.576
NULL	Virol_J_2011_Sep_20_8_442.nxml.txt.nlp	21933386	SENT40	27	27	48	48	l-glutamine	CO2	PA10090	4513	0.576
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_May_7_67(Pt_6)_m706-m707.nxml.txt.nlp	21754608	SENT77	20	20	6	6	ethanol	NO3	PA448073	4681	0.576
NULL	Breast_Cancer_Res_2008_Mar_27_10(2)_R27.nxml.txt.nlp	18371219	SENT10	31	31	14	14	paclitaxel	PIK3CA	PA450761	5290	0.576
NULL	J_Cancer_Prev_2014_Mar_19(1)_1-6.nxml.txt.nlp	25337566	SENT54	2	2	7	7	noscapine	survivin		332	0.576
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT103	19	19	25	25	resveratrol	TRAIL		8743	0.576
NULL	Allergy_Asthma_Immunol_Res_2015_Jan_5_7(1)_14-21.nxml.txt.nlp	25553258	SENT64	15	15	13	13	bleomycin	CHIT1	PA448645	1118	0.576
NULL	J_Cell_Biol_2002_Nov_25_159(4)_695-705.nxml.txt.nlp	12446745	SENT293	15	15	11	11	l-glutamine	BCS	PA10090	617	0.576
NULL	Oncotarget_2013_Nov_23_5(1)_196-210.nxml.txt.nlp	24344116	SENT204	26	26	5	5	doxorubicin	p53	PA449412	7157	0.576
NULL	Cancer_Cell_Int_2008_Apr_29_8_4.nxml.txt.nlp	18442416	SENT198	0	0	5	5	trypsin	Ku86	PA451806	7520	0.576
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S279-S284.nxml.txt.nlp	21525469	SENT182	14	14	11	11	liraglutide	GLP-1	PA165958364	100125288	0.576
NULL	Crit_Care_2011_Dec_7_15(6)_R291.nxml.txt.nlp	22152228	SENT91	25	25	7	7	propafenone	AT2	PA451131	186	0.576
NULL	Oncol_Lett_2014_Mar_16_7(3)_827-833.nxml.txt.nlp	24527090	SENT159	18	18	15	15	cisplatin	IFN	PA449014	3439	0.576
NULL	Exp_Diabetes_Res_2011_Jun_27_2011_947138.nxml.txt.nlp	21754922	SENT230	7	7	15	15	atropine	STZ	PA448505	6484	0.576
NULL	ScientificWorldJournal_2014_Jan_29_2014_265953.nxml.txt.nlp	24688374	SENT158	3	3	15	15	resveratrol	CMC2		56942	0.576
NULL	J_Autoimmune_Dis_2005_Mar_15_2_2.nxml.txt.nlp	15769293	SENT12	33	33	39	39	thyroglobulin	TPO	PA164754910	7066;7173	0.576
NULL	Aging_(Albany_NY)_2014_Aug_7_6(8)_645-660.nxml.txt.nlp	25133314	SENT291	28	28	7	7	ethanol	CO2	PA448073	4513	0.576
NULL	Clin_Epigenetics_2011_Dec_5_3(1)_9.nxml.txt.nlp	22414300	SENT174	4	4	20	20	irinotecan	HIF-1	PA450085	29072	0.576
NULL	Iran_J_Ped_Hematol_Oncol_2014_Jul_20_4(3)_118-126.nxml.txt.nlp	25254091	SENT112	16	16	30	30	doxorubicin	ABCA3	PA449412	21	0.576
NULL	J_Mol_Signal_2009_Apr_28_4_2.nxml.txt.nlp	19400946	SENT112	36	36	38	38	genistein	Gen	PA165109660	348654	0.576
NULL	Breast_Cancer_Res_2011_Jan_17_13(1)_R5.nxml.txt.nlp	21241485	SENT195	9	9	2	2	estradiol	Brn-3b	PA449503	5458	0.576
NULL	Nucleic_Acids_Res_2013_Apr_1_41(6)_3734-3747.nxml.txt.nlp	23376929	SENT341	7	7	9	9	amiloride	SMN2	PA448368	6607	0.576
NULL	Front_Physiol_2011_Nov_24_2_83.nxml.txt.nlp	22131977	SENT164	5	5	8	8	dobutamine	ANOVA	PA449381	4858	0.576
NULL	Ann_Surg_Treat_Res_2014_Feb_22_86(2)_68-75.nxml.txt.nlp	24761411	SENT130	0	0	7	7	resveratrol	survivin		332	0.576
NULL	Int_J_Nanomedicine_2012_Sep_21_7_5091-5106.nxml.txt.nlp	23049256	SENT239	4	4	14	14	fluorescein	SOD1	PA164746009	6647	0.576
NULL	Case_Rep_Med_2014_Dec_17_2014_804917.nxml.txt.nlp	25580133	SENT45	11	11	18	18	vincristine	CHOP	PA451879	1649	0.576
NULL	Genome_Biol_2008_Mar_18_9(3)_R56.nxml.txt.nlp	18348716	SENT231	12	12	5	5	streptomycin	DHPS	PA451512	1725	0.576
NULL	Br_J_Cancer_2003_Mar_10_88(5)_788-795.nxml.txt.nlp	12618891	SENT175	12	12	18	18	bosentan	FasL	PA10034	356	0.576
NULL	Cancer_Metab_2013_Aug_14_1_18.nxml.txt.nlp	24280377	SENT415	27	27	16	16	metformin	4E-BP1	PA450395	1978	0.576
NULL	Indian_J_Med_Res_2010_Dec_132(6)_676-682.nxml.txt.nlp	21245614	SENT94	32	32	24	24	zinc	p53	PA451956	7157	0.576
NULL	Cardiol_Res_Pract_2011_Aug_15_2011_156146.nxml.txt.nlp	21876822	SENT180	3	3	18	18	potassium	KIR	PA451047	2669	0.576
NULL	Br_J_Haematol_2008_Feb_140(4)_394-401.nxml.txt.nlp	18217891	SENT52	7	7	34	34	paraformaldehyde	beta-catenin	PA450790	1499	0.576
NULL	Drugs_Context_2014_Jun_11_3_212262.nxml.txt.nlp	24991224	SENT388	28	28	9	9	glucose	FDC	PA449773	1218	0.576
NULL	Arthritis_Res_Ther_2012_Sep_20_14(5)_R199.nxml.txt.nlp	22995428	SENT173	10	10	16	16	collagenase	GM-CSF	PA449107	1437	0.576
NULL	J_Biol_Chem_2013_Oct_11_288(41)_29642-29653.nxml.txt.nlp	24005673	SENT766	17	17	13	13	hyaluronan	TSG-6	PA165958431	7130	0.576
NULL	JMIR_Med_Inform_2014_Mar_18_2(1)_e5.nxml.txt.nlp	25601137	SENT228	19	19	17	17	warfarin	CYP2C9	PA451906	1559	0.576
NULL	Ann_Hematol_2014_Sep_10_93(1)_1-11.nxml.txt.nlp	24018623	SENT291	9	9	16	16	lenalidomide	EPO	PA162363968	7076;8288;2056	0.576
NULL	Mol_Pain_2013_Nov_28_9_60.nxml.txt.nlp	24283218	SENT243	27	27	17	17	capsaicin	TRPV1	PA448776	7442	0.576
NULL	Exp_Ther_Med_2013_Jul_25_6(1)_109-114.nxml.txt.nlp	23935730	SENT122	7	7	2	2	rituximab	CHOP	PA451261	1649	0.576
NULL	J_Cancer_2013_Nov_23_4(9)_736-754.nxml.txt.nlp	24312144	SENT310	8	8	20	20	bevacizumab	OTT	PA130232992	64783	0.576
NULL	Front_Oncol_2013_Sep_9_3_235.nxml.txt.nlp	24058902	SENT68	7	7	12	12	vorinostat	BIM	PA164748224	10018	0.576
NULL	Hum_Genomics_2010_Aug_1_4(6)_402-405.nxml.txt.nlp	20846929	SENT67	3	3	30	30	nadh	CYP1A2	PA164755085	1544	0.576
NULL	Clin_Ophthalmol_2014_Jun_3_8_1057-1064.nxml.txt.nlp	24940042	SENT60	14	14	19	19	bevacizumab	CST	PA130232992	9514	0.576
NULL	J_Gen_Physiol_2010_Apr_135(4)_307-319.nxml.txt.nlp	20231372	SENT155	11	11	17	17	creatine	spatial	PA164778930	219793	0.576
NULL	Biologics_2009_Sep_15_3_429-441.nxml.txt.nlp	19774210	SENT309	33	33	31	31	irinotecan	IFL	PA450085	3439	0.576
NULL	Ann_Oncol_2009_Aug_20(Suppl_6)_vi41-vi50.nxml.txt.nlp	19617297	SENT51	2	2	27	27	dacarbazine	IL-2	PA449197	3558	0.576
NULL	Int_J_Hypertens_2012_Nov_21_2012_474870.nxml.txt.nlp	23227311	SENT92	7	7	10	10	candesartan	AT1	PA448765	9197;185	0.576
NULL	BMJ_2011_Aug_4_343_d4588.nxml.txt.nlp	21816733	SENT294	35	35	26	26	clopidogrel	CYP2C19	PA449053	1557	0.576
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT376	10	10	0	0	neratinib	HRG	PA165291472	3084;3273	0.576
NULL	Oncotarget_2014_May_27_5(19)_9049-9064.nxml.txt.nlp	24979294	SENT114	34	34	42	42	fulvestrant	ANOVA	PA164747170	4858	0.576
NULL	BMB_Rep_2014_May_47(5)_268-273.nxml.txt.nlp	24286315	SENT105	23	23	5	5	trastuzumab	PTEN	PA451743	5728	0.576
NULL	Am_J_Physiol_Cell_Physiol_2010_Jul_31_299(1)_C148-C154.nxml.txt.nlp	20357184	SENT285	1	1	8	8	l-arginine	CAT1	PA448478	1384	0.576
NULL	Cells_2012_Jun_20_1(2)_168-203.nxml.txt.nlp	24710422	SENT212	25	25	21	21	lipase	ATGL	PA450239	57104	0.576
NULL	Europace_2012_Dec_6_14(12)_1700-1707.nxml.txt.nlp	22772054	SENT128	25	25	17	17	heparin	Yes	PA449855	7525	0.576
NULL	Pharmacogn_Rev_2011_Jul-Dec_5(10)_120-137.nxml.txt.nlp	22279370	SENT36	31	31	15	15	etoricoxib	COX2	PA164776853	4513;5743	0.576
NULL	J_Cancer_Epidemiol_2012_Apr_9_2012_819210.nxml.txt.nlp	22570657	SENT19	17	17	11	11	trastuzumab	HER2	PA451743	2064	0.576
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT124	5	5	7	7	curcumin	TRAIL	PA151958596	8743	0.576
NULL	Exp_Anim_2014_Jul_22_63(4)_447-457.nxml.txt.nlp	25048263	SENT144	30	30	6	6	estradiol	LEP	PA449503	3952	0.576
NULL	Exp_Mol_Med_2012_Sep_30_44(9)_545-553.nxml.txt.nlp	22809901	SENT63	0	0	6	6	quetiapine	PRDM16	PA451201	63976	0.576
NULL	Mol_Vis_2011_Oct_31_17_2824-2834.nxml.txt.nlp	22128230	SENT6	11	11	13	13	apomorphine	APO	PA164781163	84909	0.576
NULL	Aging_(Albany_NY)_2009_Mar_31_1(4)_412-424.nxml.txt.nlp	20195491	SENT151	0	0	10	10	resveratrol	AMPK		5563	0.576
NULL	Eur_J_Med_Res_2011_Jul_25_16(7)_303-314.nxml.txt.nlp	21813371	SENT44	21	21	35	35	telaprevir	SOC	PA165958354	91544	0.576
NULL	Pancreas_2014_Oct_12_43(7)_1060-1065.nxml.txt.nlp	25121413	SENT7	23	23	28	28	glucose	EGFR	PA449773	1956	0.576
NULL	Mol_Biol_Cell_2014_Jul_15_25(14)_2161-2170.nxml.txt.nlp	24850887	SENT203	30	30	37	37	l-glutamine	CO2	PA10090	4513	0.576
NULL	Clin_Interv_Aging_2009_Jun_29_4_315-317.nxml.txt.nlp	19750233	SENT64	4	4	13	13	fluorescein	PED	PA164746009	8682	0.576
NULL	Breast_Cancer_Res_2005_Jul_18_7(5)_187-189.nxml.txt.nlp	16168136	SENT41	18	18	8	8	gefitinib	PI3K	PA131301952	5290	0.576
NULL	Br_J_Cancer_2013_Jul_9_109(1)_68-75.nxml.txt.nlp	23807173	SENT246	4	4	7	7	cisplatin	ERCC1	PA449014	2067	0.576
NULL	Case_Rep_Neurol_2013_Jun_29_5(2)_116-124.nxml.txt.nlp	23898283	SENT107	22	22	28	28	carbamazepine	LZP	PA448785	170392	0.576
NULL	Aging_Cell_2012_Aug_11(4)_579-587.nxml.txt.nlp	22435726	SENT94	23	23	19	19	etoposide	CD28	PA449552	1493;940	0.576
NULL	Iran_J_Reprod_Med_2014_Apr_12(4)_257-262.nxml.txt.nlp	24976820	SENT98	36	36	16	16	protamine	TP1	PA10366	7011	0.576
NULL	Clin_Mol_Hepatol_2014_Sep_25_20(3)_283-290.nxml.txt.nlp	25320732	SENT141	2	2	4	4	propranolol	EVL	PA451145	51466	0.576
NULL	Diabetes_Care_2012_Feb_16_35(2)_327-333.nxml.txt.nlp	22179958	SENT180	9	9	13	13	metformin	B12	PA450395	7126;4709	0.576
NULL	Exp_Mol_Med_2012_Sep_30_44(9)_545-553.nxml.txt.nlp	22809901	SENT8	40	40	7	7	clozapine	PRDM16	PA449061	63976	0.576
NULL	Nucleic_Acids_Res_2007_Jan_7_35(2)_e9.nxml.txt.nlp	17158148	SENT526	10	10	1	1	camptothecin	SCAN1	PA153590860	55775	0.576
NULL	J_Cell_Biol_2005_Nov_7_171(3)_559-568.nxml.txt.nlp	16275757	SENT106	22	22	30	30	heparin	CCN1	PA449855	3491	0.576
NULL	Aging_(Albany_NY)_2011_Apr_6_3(4)_444-449.nxml.txt.nlp	21483037	SENT17	5	5	24	24	resveratrol	AMPK		5563	0.576
NULL	J_Oncol_2012_Nov_1_2012_707156.nxml.txt.nlp	23193402	SENT66	14	14	20	20	iodine	RAI	PA450049	10848;6050	0.576
NULL	J_Gastroenterol_2014_Jun_19_49(6)_1001-1010.nxml.txt.nlp	23780559	SENT118	13	13	16	16	genistein	HCN	PA165109660	378938	0.576
NULL	Cancer_Med_2013_Jun_25_2(3)_277-285.nxml.txt.nlp	23930204	SENT110	2	2	16	16	capecitabine	PTEN	PA448771	5728	0.576
NULL	Indian_J_Psychol_Med_2014_Jan-Mar_36(1)_66-70.nxml.txt.nlp	24701014	SENT106	4	4	26	26	risperidone	CARS	PA451257	833	0.576
NULL	J_Cell_Biol_1998_Mar_9_140(5)_1199-1209.nxml.txt.nlp	9490732	SENT30	39	39	37	37	thrombin	LPA	PA451674	4018	0.576
NULL	Exp_Ther_Med_2012_Oct_16_4(4)_705-710.nxml.txt.nlp	23170130	SENT186	2	2	0	0	cyclophosphamide	CTX	PA449165	1593	0.576
NULL	Clin_Cosmet_Investig_Dermatol_2011_Apr_26_4_41-53.nxml.txt.nlp	21691566	SENT259	8	8	6	6	clindamycin	CDP	PA449035	1523	0.576
NULL	J_Carcinog_Mutagen_2013_Aug_5_Suppl_7_4.nxml.txt.nlp	25587491	SENT154	46	46	44	44	gefitinib	EGF	PA131301952	1950	0.576
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT31	4	4	14	14	metformin	AMPK	PA450395	5563	0.576
NULL	Ann_Clin_Microbiol_Antimicrob_2005_Sep_13_4_13.nxml.txt.nlp	16159399	SENT195	17	17	15	15	ribavirin	IFN	PA451241	3439	0.576
NULL	Diabetes_2009_Jul_28_58(7)_1526-1531.nxml.txt.nlp	19401428	SENT187	4	4	11	11	propranolol	FDG	PA451145	23583	0.576
NULL	Sci_Rep_2014_Dec_19_4_7571.nxml.txt.nlp	25524368	SENT309	21	21	8	8	estradiol	mer	PA449503	10461	0.576
NULL	Front_Neurosci_2014_May_27_8_129.nxml.txt.nlp	24904269	SENT153	18	18	12	12	ethanol	AC1	PA448073	107	0.576
NULL	Oncotarget_2014_Aug_19_5(18)_8703-8715.nxml.txt.nlp	25237928	SENT52	30	30	5	5	glucose	CD44	PA449773	960	0.576
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Feb_24_66(Pt_3)_m327.nxml.txt.nlp	21580263	SENT74	12	12	5	5	ethanol	NO3	PA448073	4681	0.576
NULL	Indian_J_Pharm_Sci_2008_Nov-Dec_70(6)_745-753.nxml.txt.nlp	21369435	SENT75	27	27	42	42	ketoprofen	San	PA450149	80218	0.576
NULL	Int_J_Mol_Sci_2014_Oct_6_15(10)_17886-17900.nxml.txt.nlp	25290095	SENT5	0	0	5	5	resveratrol	OPG		690	0.576
NULL	ASN_Neuro_2010_Mar_15_2(2)_e00030.nxml.txt.nlp	20396375	SENT43	6	6	12	12	creatine	STZ	PA164778930	6484	0.576
NULL	Mol_Cell_Proteomics_2012_Mar_29_11(3)_M111_014407.nxml.txt.nlp	22038470	SENT67	21	21	37	37	l-glutamine	CO2	PA10090	4513	0.576
NULL	Mol_Cells_2014_Sep_30_37(9)_664-671.nxml.txt.nlp	25234467	SENT205	22	22	10	10	cisplatin	miR-217	PA449014	406999	0.576
NULL	J_Cardiothorac_Surg_2013_May_13_8_127.nxml.txt.nlp	23668669	SENT92	14	14	6	6	oxycodone	EDA	PA450741	1896	0.576
NULL	Br_J_Cancer_2013_Mar_19_108(5)_1052-1060.nxml.txt.nlp	23422754	SENT141	12	12	2	2	bevacizumab	VEGF-A	PA130232992	7422	0.576
NULL	Cells_2014_Apr_8_3(2)_258-287.nxml.txt.nlp	24717323	SENT714	9	9	12	12	capsaicin	VR1	PA448776	56664	0.576
NULL	Acta_Crystallogr_Sect_F_Struct_Biol_Cryst_Commun_2011_Aug_16_67(Pt_9)_1070-1077.nxml.txt.nlp	21904052	SENT129	20	20	17	17	pemetrexed	DHFR	PA10810	1719	0.576
NULL	Mol_Cancer_2010_Aug_23_9_222.nxml.txt.nlp	20731837	SENT205	35	35	15	15	hydroxyurea	ATR	PA449942	390502;84168;545	0.576
NULL	Exp_Ther_Med_2013_Nov_6_6(5)_1089-1095.nxml.txt.nlp	24223627	SENT183	4	4	29	29	epirubicin	HER2	PA449476	2064	0.576
NULL	Neuro_Oncol_2014_Apr_4_16(4)_540-551.nxml.txt.nlp	24311639	SENT46	28	28	22	22	glutaraldehyde	PLP	PA449777	25824;5744	0.576
NULL	Diabetes_2013_Jun_17_62(6)_1876-1887.nxml.txt.nlp	23349477	SENT369	10	10	23	23	ketoconazole	NR1I2	PA450146	8856	0.576
NULL	Breast_Cancer_Res_2008_Apr_1_10(2)_R30.nxml.txt.nlp	18380893	SENT117	10	10	18	18	docetaxel	HER2	PA449383	2064	0.576
NULL	Cell_Commun_Signal_2013_Apr_16_11_25.nxml.txt.nlp	23590831	SENT130	5	5	2	2	etoposide	USP34	PA449552	9736	0.576
NULL	Crit_Care_2010_Oct_13_14(5)_R181.nxml.txt.nlp	20942931	SENT14	20	20	5	5	furosemide	IL-6	PA449719	3569	0.576
NULL	Curr_Hematol_Malig_Rep_2014_Jun_27_9(3)_243-253.nxml.txt.nlp	24969265	SENT255	21	21	4	4	methotrexate	MTHFR	PA450428	4524	0.576
NULL	Br_J_Cancer_2010_Feb_16_102(4)_658-664.nxml.txt.nlp	20104222	SENT99	6	6	9	9	sunitinib	IFN	PA162372840	3439	0.576
NULL	Basic_Clin_Pharmacol_Toxicol_2013_Feb_5_112(2)_132-137.nxml.txt.nlp	22900583	SENT54	26	26	36	36	midazolam	CYP3A	PA450496	1574	0.576
NULL	EJC_Suppl_2013_Sep_5_11(2)_307-309.nxml.txt.nlp	NULL	SENT112	13	13	18	18	erlotinib	EGFR	PA134687924	1956	0.576
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT216	6	6	8	8	nutlin-3	DR5		8795	0.576
NULL	Cell_Regen_(Lond)_2012_Jun_28_1(1)_3.nxml.txt.nlp	25408866	SENT136	12	12	5	5	glucose	MSC	PA449773	9242	0.576
NULL	Allergy_Asthma_Clin_Immunol_2012_Jan_20_8(1)_1.nxml.txt.nlp	22264407	SENT215	5	5	31	31	paraformaldehyde	CD203c	PA450790	5169	0.576
NULL	Thorax_2012_Sep_11_67(9)_796-803.nxml.txt.nlp	22496351	SENT100	21	21	11	11	bleomycin	TRAIL	PA448645	8743	0.576
NULL	Mol_Clin_Oncol_2013_Sep_12_1(5)_911-917.nxml.txt.nlp	24649270	SENT34	19	19	11	11	mitoxantrone	CHOP	PA450526	1649	0.576
NULL	Int_J_Med_Sci_2013_Mar_15_10(5)_567-574.nxml.txt.nlp	23533048	SENT169	6	6	4	4	lamivudine	LAM	PA450163	7249;7248	0.576
NULL	Crit_Care_2012_May_23_16(3)_R93.nxml.txt.nlp	22621676	SENT66	7	7	13	13	ethanol	CO2	PA448073	4513	0.576
NULL	J_Nucl_Cardiol_2010_Jun_18_17(3)_479-485.nxml.txt.nlp	20238193	SENT79	12	12	1	1	dipyridamole	FDG	PA449367	23583	0.575
NULL	J_Clin_Biochem_Nutr_2010_Jan_29_46(1)_36-42.nxml.txt.nlp	20104263	SENT27	30	30	26	26	ribavirin	IFN	PA451241	3439	0.575
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT227	25	25	27	27	doxorubicin	B7-H1	PA449412	29126	0.575
NULL	Cancers_(Basel)_2012_Apr_5_4(2)_354-378.nxml.txt.nlp	24213315	SENT1009	0	0	6	6	quinacrine	TRAIL	PA164745551	8743	0.575
NULL	JRSM_Cardiovasc_Dis_2012_Sep_24_1(6)_cvd_2012_012015.nxml.txt.nlp	24175073	SENT12	17	17	32	32	clopidogrel	ADP	PA449053	23038	0.575
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1150.nxml.txt.nlp	24675468	SENT93	40	40	18	18	ethanol	adiponectin	PA448073	9370	0.575
NULL	Diabetes_Metab_J_2012_Aug_20_36(4)_293-299.nxml.txt.nlp	22950061	SENT166	25	25	13	13	metformin	NPY	PA450395	4852	0.575
NULL	Oncol_Lett_2013_Sep_12_6(3)_667-672.nxml.txt.nlp	24137387	SENT166	25	25	16	16	sorafenib	ARG	PA7000	473;27	0.575
NULL	Front_Hum_Neurosci_2013_May_20_7_216.nxml.txt.nlp	23730284	SENT64	34	34	32	32	chlorpromazine	CPZ	PA448964	8532	0.575
NULL	Avicenna_J_Med_Biotechnol_2013_Oct-Dec_5(4)_241-250.nxml.txt.nlp	24285999	SENT112	47	47	14	14	nitrogen	SDS	PA450643	51119;10993	0.575
NULL	Cardiol_Res_Pract_2013_Feb_19_2013_195456.nxml.txt.nlp	23533940	SENT127	7	7	23	23	prasugrel	CYP2C9	PA154410481	1559	0.575
NULL	J_Hematol_Oncol_2012_Sep_18_5_57.nxml.txt.nlp	22989009	SENT271	17	17	33	33	berberine	DAXX	PA165860812	1616	0.575
NULL	Breast_Cancer_Res_2010_Jun_2_12(3)_R31.nxml.txt.nlp	20525204	SENT47	20	20	28	28	fluorescein	San	PA164746009	80218	0.575
NULL	Neural_Regen_Res_2014_Nov_1_9(21)_1897-1901.nxml.txt.nlp	25558239	SENT135	3	3	14	14	diazepam	CA1	PA449283	759	0.575
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1066.nxml.txt.nlp	24556681	SENT10	0	0	17	17	ethanol	ATG5	PA448073	9474	0.575
NULL	J_Ginseng_Res_2011_Nov_35(4)_436-441.nxml.txt.nlp	23717089	SENT84	10	10	14	14	ginseng	CAGC	PA164781150	6283	0.575
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT188	0	0	23	23	curcumin	DR4	PA151958596	8797	0.575
NULL	Nat_Med_2013_Feb_6_19(2)_217-226.nxml.txt.nlp	23291629	SENT355	11	11	13	13	lipase	ATGL	PA450239	57104	0.575
NULL	Biomed_Res_Int_2014_May_29_2014_349074.nxml.txt.nlp	24977149	SENT292	29	29	8	8	ethanol	ANOVA	PA448073	4858	0.575
NULL	J_Neurol_2011_Jul_2_258(7)_1207-1222.nxml.txt.nlp	21461686	SENT260	17	17	35	35	memantine	OPT	PA10364	51430	0.575
NULL	Oncol_Lett_2014_Jun_8_7(6)_2035-2040.nxml.txt.nlp	24932285	SENT157	2	2	38	38	irinotecan	ALP	PA450085	6590;10850;27295;80150;470;26033	0.575
NULL	Nat_Commun_2014_Dec_3_5_5565.nxml.txt.nlp	25470305	SENT648	20	20	14	14	cyclosporine	OATP1B3	PA449167	28234	0.575
NULL	Eur_J_Med_Res_2014_Jun_24_19(1)_34.nxml.txt.nlp	24961604	SENT98	18	18	13	13	vincristine	BCL11A	PA451879	53335	0.575
NULL	Mol_Brain_2014_Sep_4_7(1)_69.nxml.txt.nlp	NULL	SENT51	32	32	20	20	sevoflurane	CXCL10	PA451341	3627	0.575
NULL	Front_Neurosci_2014_May_27_8_129.nxml.txt.nlp	24904269	SENT474	11	11	7	7	ethanol	AC5	PA448073	111	0.575
NULL	Med_Sci_Monit_2013_May_1_19_317-326.nxml.txt.nlp	23632427	SENT261	15	15	13	13	cefotaxime	CTX	PA448852	1593	0.575
NULL	Oncol_Lett_2013_Jun_3_5(6)_1760-1764.nxml.txt.nlp	23833637	SENT5	47	47	44	44	gemcitabine	TRAIL	PA449748	8743	0.575
NULL	Ann_Hematol_2010_Nov_25_89(11)_1115-1124.nxml.txt.nlp	20499237	SENT118	32	32	5	5	simvastatin	CD5	PA451363	921	0.575
NULL	Arthritis_Res_Ther_2009_Aug_24_11(4)_R127.nxml.txt.nlp	19703304	SENT113	17	17	25	25	adalimumab	OASIS	PA10004	90993	0.575
NULL	J_Physiol_2014_Nov_1_592(21)_4715-4731.nxml.txt.nlp	25172947	SENT93	31	31	21	21	l-arginine	ADP	PA448478	23038	0.575
NULL	Lab_Invest_2009_Nov_7_89(11)_1275-1290.nxml.txt.nlp	19736547	SENT455	25	25	4	4	curcumin	LOX-1	PA151958596	4973	0.575
NULL	Crit_Care_2011_Dec_7_15(6)_R291.nxml.txt.nlp	22152228	SENT91	21	21	7	7	amiodarone	AT2	PA448383	186	0.575
NULL	Neural_Regen_Res_2014_Mar_15_9(6)_622-629.nxml.txt.nlp	25206865	SENT110	0	0	5	5	vasopressin	c-Jun	PA451858	3725	0.575
NULL	Exp_Ther_Med_2013_Mar_20_5(3)_689-694.nxml.txt.nlp	23403765	SENT229	6	6	0	0	l-cysteine	PAG	PA449173	55824	0.575
NULL	J_Cell_Biol_2008_Jul_14_182(1)_197-213.nxml.txt.nlp	18625847	SENT98	0	0	8	8	nutlin-3	p53		7157	0.575
NULL	Evid_Based_Complement_Alternat_Med_2014_Sep_3_2014_809083.nxml.txt.nlp	25276218	SENT225	11	11	18	18	berberine	TLR-4	PA165860812	7099	0.575
NULL	Core_Evid_2011_Sep_8_6_67-79.nxml.txt.nlp	22022289	SENT287	8	8	10	10	metformin	PCB	PA450395	5091	0.575
NULL	Gut_2012_May_3_61(5)_695-705.nxml.txt.nlp	21813473	SENT354	30	30	14	14	dextran	CCR2	PA449261	729230	0.575
NULL	Bioinformation_2012_Nov_13_8(22)_1114-1118.nxml.txt.nlp	23251047	SENT67	15	15	8	8	pyrimethamine	DHFR	PA451193	1719	0.575
NULL	ACS_Med_Chem_Lett_2012_Oct_22_3(12)_1034-1038.nxml.txt.nlp	23256033	SENT91	3	3	20	20	fasudil	AurB	PA165946121	9212	0.575
NULL	Clin_Cosmet_Investig_Dermatol_2013_Mar_14_6_75-80.nxml.txt.nlp	23515267	SENT52	16	16	24	24	etanercept	IL-17	PA449515	3605	0.575
NULL	J_Ginseng_Res_2011_Nov_35(4)_436-441.nxml.txt.nlp	23717089	SENT106	17	17	7	7	ginseng	CAGC	PA164781150	6283	0.575
NULL	Mol_Vis_2012_Apr_11_18_901-908.nxml.txt.nlp	22539869	SENT79	22	22	6	6	curcumin	HO-1	PA151958596	3162	0.575
NULL	Nat_Biotechnol_2011_May_29_29(6)_542-546.nxml.txt.nlp	21623355	SENT267	26	26	9	9	imatinib	CDC25A	PA10804	993	0.575
NULL	Biosci_Rep_2014_Dec_12_34(6)_e00160.nxml.txt.nlp	25495645	SENT166	9	9	21	21	rosiglitazone	ANGPTL3	PA451283	27329	0.575
NULL	Comp_Hepatol_2005_Feb_8_4_2.nxml.txt.nlp	15701172	SENT20	0	0	10	10	ketoconazole	CYP3A	PA450146	1574	0.575
NULL	J_Ophthalmol_2012_Aug_27_2012_285851.nxml.txt.nlp	23050121	SENT126	10	10	19	19	bimatoprost	BAK	PA164748867	578	0.575
NULL	Cell_Mol_Neurobiol_2011_Jul_20_31(5)_715-727.nxml.txt.nlp	21424551	SENT59	16	16	26	26	l-glutamine	EGF	PA10090	1950	0.575
NULL	Clin_Ophthalmol_2014_Feb_10_8_389-399.nxml.txt.nlp	24550667	SENT167	26	26	24	24	timolol	TIM	PA451690	7984;8914	0.575
NULL	Angiogenesis_2010_Dec_7_13(4)_305-315.nxml.txt.nlp	20927579	SENT157	0	0	6	6	resveratrol	HIF-1		29072	0.575
NULL	Interdiscip_Toxicol_2011_Jun_4(2)_69-77.nxml.txt.nlp	21753902	SENT143	17	17	23	23	galactose	Bravo	PA449725	4897	0.575
NULL	Int_J_Mol_Sci_2012_Aug_29_13(9)_10771-10806.nxml.txt.nlp	23109822	SENT250	19	19	32	32	nadh	SIRT1	PA164755085	23411	0.575
NULL	Br_J_Cancer_2013_Mar_5_108(4)_887-900.nxml.txt.nlp	23462807	SENT108	20	20	32	32	sunitinib	FGFR2	PA162372840	2263	0.575
NULL	Can_J_Infect_Dis_Med_Microbiol_2014_May-Jun_25(3)_163-169.nxml.txt.nlp	25285114	SENT225	1	1	30	30	amikacin	TOB	PA164744372	10140	0.575
NULL	Oncotarget_2012_Aug_9_3(8)_774-782.nxml.txt.nlp	22885298	SENT32	9	9	26	26	tetracycline	IDH1	PA451640	3417	0.575
NULL	Mol_Cancer_2010_Nov_13_9_293.nxml.txt.nlp	21073737	SENT56	14	14	0	0	lipase	HK2	PA450239	3796;3099;29911;3741	0.575
NULL	Br_J_Cancer_2000_Jul_3_83(3)_375-383.nxml.txt.nlp	10917554	SENT4	5	5	8	8	daunorubicin	MRP2	PA449212	100130958;57626;1244	0.575
NULL	Target_Oncol_2010_Jun_14_5(2)_95-112.nxml.txt.nlp	20625845	SENT238	0	0	11	11	sorafenib	FDG	PA7000	23583	0.575
NULL	Diabetes_Care_2009_Aug_32(8)_1556-1562.nxml.txt.nlp	19638526	SENT225	10	10	18	18	fenofibrate	AMPK	PA449594	5563	0.575
NULL	BioDrugs_2014_Aug_18_28(1)_27-39.nxml.txt.nlp	23955284	SENT443	3	3	15	15	belinostat	TGFbeta		7040	0.575
NULL	Br_J_Cancer_2013_Mar_5_108(4)_748-754.nxml.txt.nlp	23361058	SENT46	0	0	2	2	vorinostat	RAD51	PA164748224	5888	0.575
NULL	Cent_European_J_Urol_2013_Apr_26_66(1)_39-44.nxml.txt.nlp	24578986	SENT87	36	36	23	23	etoposide	ADM	PA449552	133	0.575
NULL	Front_Oncol_2014_Oct_21_4_285.nxml.txt.nlp	25374842	SENT680	17	17	29	29	dasatinib	p53	PA162372878	7157	0.575
NULL	Front_Immunol_2014_Apr_23_5_182.nxml.txt.nlp	24795724	SENT113	1	1	8	8	heparin	DC-SIGN	PA449855	30835	0.575
NULL	Neural_Regen_Res_2014_Mar_15_9(6)_622-629.nxml.txt.nlp	25206865	SENT66	0	0	5	5	vasopressin	c-Jun	PA451858	3725	0.575
NULL	Front_Public_Health_2014_Oct_31_2_217.nxml.txt.nlp	25401098	SENT216	2	2	14	14	vancomycin	spatial	PA451850	219793	0.575
NULL	Oncotarget_2014_Jun_30_5(12)_3970-3982.nxml.txt.nlp	24994116	SENT108	43	43	31	31	metformin	TOX1	PA450395	9760	0.575
NULL	Acta_Pharmacol_Sin_2013_Apr_18_34(4)_555-560.nxml.txt.nlp	23503472	SENT124	8	8	4	4	tacrolimus	CYP3A5	PA451578	1577	0.575
NULL	Indian_J_Pharm_Sci_2011_Nov-Dec_73(6)_601-607.nxml.txt.nlp	23112392	SENT117	0	0	37	37	pioglitazone	LPO	PA450970	4025	0.575
NULL	Exp_Cell_Res_2007_Dec_10_313(20)_4158-4169.nxml.txt.nlp	17869245	SENT42	28	28	39	39	l-glutamine	CO2	PA10090	4513	0.575
NULL	Clin_Exp_Reprod_Med_2011_Mar_31_38(1)_18-23.nxml.txt.nlp	22384413	SENT90	26	26	28	28	diethylstilbestrol	DES	PA449307	1674	0.575
NULL	Summit_on_Translat_Bioinforma_2009_Mar_1_2009_124-128.nxml.txt.nlp	21347183	SENT69	34	34	40	40	azathioprine	TPMT	PA448515	7172	0.575
NULL	Iran_J_Public_Health_2010_Jun_30_39(2)_63-68.nxml.txt.nlp	23113008	SENT144	28	28	14	14	imipenem	TOB	PA449968	10140	0.575
NULL	J_Am_Heart_Assoc_2013_Aug_23_2(4)_e000249.nxml.txt.nlp	23817469	SENT307	2	2	29	29	creatine	APLN	PA164778930	8862	0.575
NULL	Mol_Cancer_2007_Aug_21_6_53.nxml.txt.nlp	17711579	SENT262	7	7	22	22	cisplatin	SOX17	PA449014	64321	0.575
NULL	J_Oncol_2012_Jun_4_2012_928127.nxml.txt.nlp	22701483	SENT151	15	15	21	21	metformin	CD24	PA450395	100133941	0.575
NULL	J_Cell_Mol_Med_2014_Dec_7_18(12)_2361-2366.nxml.txt.nlp	25287476	SENT33	6	6	12	12	tacrolimus	STZ	PA451578	6484	0.575
NULL	Brain_Sci_2013_Jun_14_3(2)_941-963.nxml.txt.nlp	24961432	SENT237	23	23	6	6	ethanol	AP-1	PA448073	2353;3727;2354;3725	0.575
NULL	Int_J_Mol_Sci_2014_Nov_25_15(12)_21703-21722.nxml.txt.nlp	25429431	SENT146	5	5	7	7	curcumin	p53	PA151958596	7157	0.575
NULL	EMBO_Mol_Med_2009_Jul_1(4)_236-248.nxml.txt.nlp	20049725	SENT252	18	18	1	1	forskolin	NF1	PA146096022	4763	0.575
NULL	Nat_Commun_2014_Apr_3_5_3546.nxml.txt.nlp	24699423	SENT671	3	3	10	10	calcein	mol	PA132595336	90527	0.575
NULL	Cancer_Cell_Int_2012_Mar_22_12_9.nxml.txt.nlp	22439612	SENT63	10	10	24	24	l-glutamine	CO2	PA10090	4513	0.575
NULL	ScientificWorldJournal_2014_Mar_24_2014_694326.nxml.txt.nlp	24782665	SENT162	20	20	5	5	metformin	FDG	PA450395	23583	0.575
NULL	Oncotarget_2011_Mar_27_2(3)_209-221.nxml.txt.nlp	21444945	SENT130	20	20	5	5	bortezomib	p53	PA10252	7157	0.575
NULL	Oxid_Med_Cell_Longev_2013_Jun_2_2013_793525.nxml.txt.nlp	23819014	SENT188	31	31	12	12	resveratrol	AMPK		5563	0.575
NULL	Cancer_Cell_Int_2011_Nov_17_11_40.nxml.txt.nlp	22088142	SENT102	0	0	11	11	gemcitabine	EGFR	PA449748	1956	0.575
NULL	Breast_Cancer_Res_2010_Oct_22_12(Suppl_2)_S1.nxml.txt.nlp	21050422	SENT423	6	6	23	23	bsi-201	TRN		3842	0.575
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_12_2013_437948.nxml.txt.nlp	23840256	SENT151	4	4	33	33	curcumin	EZH2	PA151958596	2146	0.575
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Apr_15_9_13.nxml.txt.nlp	20398300	SENT134	18	18	0	0	moxifloxacin	LAM	PA450555	7249;7248	0.575
NULL	J_Korean_Med_Sci_2006_Apr_20_21(2)_188-192.nxml.txt.nlp	16614499	SENT11	5	5	24	24	vancomycin	VISA	PA451850	57506	0.575
NULL	Curr_Neuropharmacol_2008_Jun_6(2)_151-163.nxml.txt.nlp	19305794	SENT59	14	14	22	22	capsaicin	TRPV1	PA448776	7442	0.575
NULL	J_Breast_Cancer_2011_Mar_31_14(1)_46-51.nxml.txt.nlp	21847394	SENT137	15	15	0	0	fluorouracil	HER2	PA128406956	2064	0.575
NULL	Front_Physiol_2013_Dec_24_4_386.nxml.txt.nlp	24399968	SENT64	15	15	4	4	glibenclamide	SUR1	PA449782	6833	0.575
NULL	Indian_J_Endocrinol_Metab_2012_Mar-Apr_16(2)_183-191.nxml.txt.nlp	22470853	SENT93	2	2	11	11	vasopressin	AVP	PA451858	114548;551	0.575
NULL	J_Gen_Physiol_2000_Dec_1_116(6)_769-780.nxml.txt.nlp	11099346	SENT138	30	30	28	28	tetracaine	DAG	PA451638	1605	0.575
NULL	Croat_Med_J_2013_Apr_54(2)_171-179.nxml.txt.nlp	23630144	SENT45	17	17	19	19	taurine	STZ	PA451590	6484	0.575
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Feb_13_66(Pt_3)_m301.nxml.txt.nlp	21580244	SENT60	35	35	16	16	nitrogen	mol	PA450643	90527	0.575
NULL	Indian_J_Pharmacol_2014_Sep-Oct_46(5)_549-550.nxml.txt.nlp	25298588	SENT46	16	16	20	20	warfarin	CYP2C9	PA451906	1559	0.575
NULL	Mucosal_Immunol_2012_Jan_21_5(1)_19-29.nxml.txt.nlp	21937985	SENT186	23	23	10	10	ciprofloxacin	CO2	PA449009	4513	0.575
NULL	Biologics_2013_Apr_15_7_77-90.nxml.txt.nlp	23723688	SENT116	41	41	16	16	cetuximab	CRT	PA10040	811	0.575
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT128	9	9	3	3	quinidine	CYP2D6	PA451209	1565	0.575
NULL	Pharmaceuticals_(Basel)_2011_Nov_11_4(11)_1503-1517.nxml.txt.nlp	NULL	SENT145	6	6	20	20	capsaicin	TRPV1	PA448776	7442	0.575
NULL	Diabetes_Metab_J_2012_Jun_14_36(3)_199-206.nxml.txt.nlp	22737659	SENT26	17	17	11	11	glucose	ADA	PA449773	100	0.575
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT250	0	0	3	3	pp2	ECM		22915	0.575
NULL	Part_Fibre_Toxicol_2011_Aug_2_8_23.nxml.txt.nlp	21810225	SENT272	26	26	15	15	oxygen	Men	PA450744	8178	0.575
NULL	J_Cell_Biol_2000_Jul_24_150(2)_335-348.nxml.txt.nlp	10908576	SENT893	40	40	18	18	nitroprusside	JNK	PA451406	5599	0.575
NULL	Br_J_Cancer_2012_Feb_14_106(4)_685-692.nxml.txt.nlp	22294184	SENT194	3	3	8	8	lovastatin	survivin	PA450272	332	0.575
NULL	Can_J_Infect_Dis_Med_Microbiol_2014_Nov-Dec_25(6)_327-343.nxml.txt.nlp	25587296	SENT74	27	27	11	11	itraconazole	P-gp	PA450132	5243	0.575
NULL	Acta_Orthop_2010_Apr_6_81(2)_263-267.nxml.txt.nlp	20148646	SENT11	1	1	8	8	taurine	LIR	PA451590	10871	0.575
NULL	J_Korean_Med_Sci_2006_Dec_31_21(6)_1037-1040.nxml.txt.nlp	17179683	SENT96	6	6	8	8	clarithromycin	BAM	PA449028	9126	0.575
NULL	Indian_J_Pharmacol_2014_Mar-Apr_46(2)_147-151.nxml.txt.nlp	24741183	SENT140	19	19	21	21	ketamine	IL-4	PA450144	3565	0.575
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_127043.nxml.txt.nlp	23227093	SENT231	5	5	17	17	furafylline	CYP2C9	PA452614	1559	0.575
NULL	Endocrinol_Diabetes_Metab_Case_Rep_2014_Jan_1_2014_130071.nxml.txt.nlp	24683482	SENT53	6	6	14	14	vasopressin	ACTH	PA451858	5443	0.575
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT436	10	10	13	13	olanzapine	PRL	PA450688	5617	0.575
NULL	Case_Rep_Dent_2013_Dec_11_2013_634052.nxml.txt.nlp	24396611	SENT49	7	7	14	14	chlorhexidine	San	PA164776863	80218	0.575
NULL	J_Clin_Biochem_Nutr_2010_Jan_29_46(1)_87-92.nxml.txt.nlp	20104270	SENT315	15	15	7	7	hesperidin	STZ	PA449867	6484	0.575
NULL	Drug_Des_Devel_Ther_2014_Sep_23_8_1527-1538.nxml.txt.nlp	25284985	SENT214	35	35	10	10	celecoxib	VIII	PA448871	1351	0.575
NULL	Infect_Dis_Obstet_Gynecol_2013_Mar_7_2013_195637.nxml.txt.nlp	23533318	SENT61	12	12	8	8	isoniazid	IPT	PA450112	54802	0.575
NULL	Acta_Pharmacol_Sin_2009_Sep_24_30(9)_1262-1275.nxml.txt.nlp	19701231	SENT226	20	20	30	30	lovastatin	TMCO3	PA450272	55002	0.575
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT9	0	0	3	3	perifosine	c-Jun	PA165291471	3725	0.575
NULL	Br_J_Cancer_2014_Jan_21_110(2)_469-478.nxml.txt.nlp	24346288	SENT48	6	6	18	18	tocilizumab	IL-6	PA165292659	3569	0.575
NULL	Nat_Commun_2013_4_1449.nxml.txt.nlp	23385593	SENT104	4	4	18	18	nadh	BRCA1	PA164755085	672	0.575
NULL	Core_Evid_2008_Jun_3(1)_13-30.nxml.txt.nlp	20694081	SENT288	0	0	7	7	vildagliptin	GLP-1	PA165958346	100125288	0.575
NULL	Int_J_Biomed_Sci_2014_Dec_10(4)_236-242.nxml.txt.nlp	25598753	SENT138	22	22	15	15	chlorpropamide	NUT	PA448966	256646	0.575
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_8_2013_964070.nxml.txt.nlp	23690868	SENT33	20	20	28	28	resveratrol	AMPK		5563	0.575
NULL	Br_J_Pharmacol_2011_Jul_163(6)_1263-1275.nxml.txt.nlp	21391977	SENT51	17	17	15	15	ketoconazole	CYP3A4	PA450146	1576	0.575
NULL	Diabetes_Metab_J_2012_Aug_20_36(4)_293-299.nxml.txt.nlp	22950061	SENT22	0	0	13	13	metformin	AMPK	PA450395	5563	0.575
NULL	Int_J_Chron_Obstruct_Pulmon_Dis_2007_Jun_2(2)_121-129.nxml.txt.nlp	18044684	SENT58	2	2	7	7	roflumilast	MUC5AC	PA165948052	4586	0.575
NULL	Drugs_R_D_2011_Jun_27_11(2)_101-111.nxml.txt.nlp	21679003	SENT37	5	5	25	25	fluorouracil	IFL	PA128406956	3439	0.575
NULL	Mol_Cancer_2007_Apr_2_6_26.nxml.txt.nlp	17407576	SENT119	0	0	16	16	cisplatin	p53	PA449014	7157	0.575
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT128	9	9	4	4	quinidine	CYP3A4	PA451209	1576	0.575
NULL	Braz_J_Med_Biol_Res_2012_Jul_20_45(10)_935-941.nxml.txt.nlp	22801415	SENT147	7	7	15	15	pioglitazone	gamma	PA450970	9913	0.575
NULL	Br_J_Cancer_2010_Jan_5_102(1)_162-164.nxml.txt.nlp	19953097	SENT56	23	23	17	17	cetuximab	PTEN	PA10040	5728	0.575
NULL	Exp_Ther_Med_2013_May_15_5(5)_1293-1300.nxml.txt.nlp	23737867	SENT234	10	10	12	12	finasteride	EGFR	PA449627	1956	0.575
NULL	Br_J_Cancer_2000_Jul_3_83(3)_366-374.nxml.txt.nlp	10917553	SENT5	5	5	8	8	daunorubicin	MRP1	PA449212	4437	0.575
NULL	Aging_(Albany_NY)_2010_Dec_31_2(12)_924-935.nxml.txt.nlp	21212465	SENT9	13	13	10	10	etoposide	p53	PA449552	7157	0.575
NULL	Ann_Hematol_2012_May_11_91(5)_697-703.nxml.txt.nlp	22071570	SENT154	9	9	4	4	rituximab	CHOP	PA451261	1649	0.575
NULL	Nucleic_Acids_Res_2011_Mar_4_39(5)_1843-1854.nxml.txt.nlp	21051342	SENT198	35	35	20	20	carbenicillin	IFN	PA448788	3439	0.575
NULL	Oncogene_2010_Nov_18_29(46)_6115-6124.nxml.txt.nlp	20729912	SENT80	10	10	0	0	doxorubicin	ABCB5	PA449412	340273	0.575
NULL	J_Ophthalmic_Inflamm_Infect_2011_Nov_6_2(1)_21-28.nxml.txt.nlp	22057810	SENT76	1	1	13	13	methotrexate	CTX	PA450428	1593	0.575
NULL	Br_J_Haematol_2014_Mar_13_164(1)_811-821.nxml.txt.nlp	24328678	SENT10	20	20	2	2	lenalidomide	Aiolos	PA162363968	22806	0.575
NULL	Crit_Care_2006_Jan_31_10(1)_R20.nxml.txt.nlp	16469127	SENT149	19	19	0	0	terlipressin	AVP	PA164781020	114548;551	0.575
NULL	Neural_Plast_2014_Feb_25_2014_571285.nxml.txt.nlp	24719772	SENT141	13	13	26	26	fluoxetine	CA1	PA449673	759	0.575
NULL	Cell_Commun_Signal_2012_Jul_9_10_18.nxml.txt.nlp	22776333	SENT213	13	13	48	48	phenol	CO2	PA450913	4513	0.575
NULL	Clinics_(Sao_Paulo)_2010_Nov_65(11)_1175-1181.nxml.txt.nlp	21243293	SENT68	29	29	15	15	methimazole	NO3	PA450422	4681	0.575
NULL	Arthritis_Res_Ther_2010_Sep_20_12(5)_R176.nxml.txt.nlp	20854662	SENT93	11	11	21	21	tramadol	IL-6	PA451735	3569	0.575
NULL	Acta_Pharmacol_Sin_2009_Aug_20_30(8)_1169-1176.nxml.txt.nlp	19617894	SENT79	17	17	29	29	phenol	CO2	PA450913	4513	0.575
NULL	Breast_Cancer_Res_2012_Apr_4_14(2)_R57.nxml.txt.nlp	22475046	SENT41	18	18	45	45	tamoxifen	CCND1	PA451581	595	0.575
NULL	Curr_Clin_Pharmacol_2013_May_8(2)_135-155.nxml.txt.nlp	23062036	SENT348	36	36	28	28	raloxifene	PTH	PA451221	5741	0.575
NULL	J_Clin_Biochem_Nutr_2007_Nov_30_41(3)_224-230.nxml.txt.nlp	18299720	SENT215	36	36	39	39	creatine	AST	PA164778930	26503	0.575
NULL	Oncoimmunology_2014_Jan_17_3_e27572.nxml.txt.nlp	24734216	SENT79	18	18	7	7	zoledronate	IL-2	PA10235	3558	0.575
NULL	Nat_Commun_2013_Apr_23_4_1758.nxml.txt.nlp	23612299	SENT539	13	13	7	7	isoproterenol	SOD1	PA450121	6647	0.575
NULL	J_Korean_Assoc_Oral_Maxillofac_Surg_2014_Dec_26_40(6)_291-296.nxml.txt.nlp	25551094	SENT125	7	7	24	24	alendronate	OPG	PA448082	690	0.575
NULL	Ann_Hematol_2010_Nov_25_89(11)_1115-1124.nxml.txt.nlp	20499237	SENT108	38	38	26	26	simvastatin	CD5	PA451363	921	0.575
NULL	Front_Oncol_2013_Nov_14_3_279.nxml.txt.nlp	24294592	SENT133	36	36	26	26	cisplatin	ADP	PA449014	23038	0.575
NULL	Emerg_Infect_Dis_2012_Mar_18(3)_515-516.nxml.txt.nlp	22377354	SENT33	2	2	0	0	cefotaxime	CTX	PA448852	1593	0.575
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT271	30	30	11	11	phenprocoumon	VKORC1	PA450921	79001	0.575
NULL	Allergy_Asthma_Immunol_Res_2014_Mar_15_6(2)_126-130.nxml.txt.nlp	24587948	SENT30	10	10	16	16	salbutamol	TTN	PA448068	7273	0.575
NULL	J_Gastroenterol_Hepatol_2014_Mar_19_29(3)_545-553.nxml.txt.nlp	24090188	SENT197	19	19	3	3	ribavirin	IL28B	PA451241	282617	0.575
NULL	Oncotarget_2014_Aug_29_5(18)_8052-8082.nxml.txt.nlp	25211298	SENT150	0	0	8	8	artesunate	U87	PA165111697	677775;641648	0.575
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Mar_31_68(Pt_4)_o1259.nxml.txt.nlp	22606188	SENT3	12	12	2	2	piperazine	mol	PA450977	90527	0.575
NULL	Diabetes_Care_2013_Aug_17_36(Suppl_2)_S245-S252.nxml.txt.nlp	23882053	SENT28	37	37	22	22	metformin	HIP	PA450395	6767;6159;64399;5068	0.575
NULL	Orphanet_J_Rare_Dis_2014_Sep_26_9(1)_145.nxml.txt.nlp	NULL	SENT133	11	11	3	3	denosumab	DPD	PA166048634	1806	0.575
NULL	Biomed_Res_Int_2013_Jun_13_2013_493643.nxml.txt.nlp	23841073	SENT102	3	3	5	5	estradiol	ACTH	PA449503	5443	0.575
NULL	Protein_Cell_2014_May_26_5(5)_343-347.nxml.txt.nlp	24668462	SENT76	26	26	30	30	heparin	FGF2	PA449855	2247;2258	0.575
NULL	Oncotarget_2012_Sep_11_3(9)_1026-1035.nxml.txt.nlp	22976441	SENT31	11	11	17	17	oxygen	ATM	PA450744	472	0.575
NULL	Arthritis_Res_Ther_2007_Nov_12_9(6)_R118.nxml.txt.nlp	17997858	SENT216	4	4	0	0	hyaluronan	LYVE-1	PA165958431	10894	0.575
NULL	Exp_Cell_Res_2011_Apr_15_317(7)_1028-1039.nxml.txt.nlp	21237154	SENT781	10	10	8	8	staurosporine	TRAIL	PA165109623	8743	0.575
NULL	Int_J_Gen_Med_2011_Jul_20_4_539-545.nxml.txt.nlp	21845063	SENT101	11	11	14	14	miglitol	adiponectin	PA164776726	9370	0.575
NULL	Arthritis_Res_Ther_2011_Aug_11_13(4)_R129.nxml.txt.nlp	21835002	SENT275	5	5	3	3	collagenase	MCP-1	PA449107	6347	0.575
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1018.nxml.txt.nlp	24457962	SENT74	0	0	5	5	afatinib	HER2	PA165981154	2064	0.575
NULL	Exp_Mol_Med_2012_Sep_30_44(9)_545-553.nxml.txt.nlp	22809901	SENT8	28	28	7	7	quetiapine	PRDM16	PA451201	63976	0.575
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT187	6	6	3	3	tacrolimus	OPG	PA451578	690	0.575
NULL	Breast_Cancer_Res_2011_Apr_14_13(2)_R43.nxml.txt.nlp	21492444	SENT35	28	28	9	9	tamoxifen	HER3	PA451581	2065	0.575
NULL	Int_J_Anal_Chem_2013_May_12_2013_743792.nxml.txt.nlp	23737791	SENT120	31	31	40	40	ethanol	mol	PA448073	90527	0.575
NULL	Mol_Cancer_2006_Oct_17_5_45.nxml.txt.nlp	17044934	SENT139	26	26	19	19	resveratrol	AKT		207	0.575
NULL	Biologics_2009_Sep_15_3_429-441.nxml.txt.nlp	19774210	SENT24	47	47	45	45	bevacizumab	IFL	PA130232992	3439	0.575
NULL	J_Gen_Physiol_2000_Jun_1_115(6)_685-696.nxml.txt.nlp	10828243	SENT116	13	13	24	24	genistein	OLF	PA165109660	83857	0.575
NULL	Indian_J_Pharmacol_2013_May-Jun_45(3)_286-288.nxml.txt.nlp	23833375	SENT60	13	13	16	16	montelukast	NMU	PA450546	10874	0.575
NULL	Breast_Cancer_Res_2011_Nov_23_13(6)_R116.nxml.txt.nlp	22113133	SENT332	10	10	6	6	diethylstilbestrol	DES	PA449307	1674	0.574
NULL	Int_J_Alzheimers_Dis_2010_Dec_27_2011_231595.nxml.txt.nlp	21234401	SENT108	12	12	30	30	copper	APP	PA449114	351	0.574
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_25_2013_504642.nxml.txt.nlp	23878600	SENT213	33	33	15	15	captopril	TFG	PA448780	10342	0.574
NULL	Amino_Acids_2012_Apr_6_42(4)_1317-1327.nxml.txt.nlp	21210163	SENT33	15	15	20	20	taurine	SLC6A6	PA451590	6533	0.574
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT236	27	27	35	35	metformin	LKB1	PA450395	6794	0.574
NULL	Acta_Pharmacol_Sin_2009_Oct_5_30(10)_1428-1435.nxml.txt.nlp	19801997	SENT145	17	17	26	26	artemisinin	p38	PA165111696	10598;1432;7965	0.574
NULL	Arthritis_Res_Ther_2009_Aug_24_11(4)_R127.nxml.txt.nlp	19703304	SENT104	18	18	7	7	adalimumab	OASIS	PA10004	90993	0.574
NULL	Int_J_Mol_Cell_Med_2012_Summer_1(3)_145-152.nxml.txt.nlp	24551770	SENT115	2	2	14	14	memantine	Bcl-2	PA10364	596	0.574
NULL	Adipocyte_2012_Jul_1_1(3)_182-187.nxml.txt.nlp	23700531	SENT46	15	15	17	17	lipase	ATGL	PA450239	57104	0.574
NULL	J_Cardiovasc_Magn_Reson_2009_Jun_28_11(1)_20.nxml.txt.nlp	19558722	SENT95	17	17	11	11	iron	CIC	PA450087	23152	0.574
NULL	Carcinogenesis_2013_Nov_10_34(11)_2580-2586.nxml.txt.nlp	23843037	SENT294	3	3	6	6	mesalazine	CDC25A	PA450384	993	0.574
NULL	J_Korean_Med_Sci_2013_Apr_27_28(4)_527-533.nxml.txt.nlp	23580227	SENT94	6	6	8	8	genistein	TRAIL	PA165109660	8743	0.574
NULL	J_Oncol_2009_Mar_24_2009_491985.nxml.txt.nlp	19325924	SENT128	25	25	20	20	genistein	CXCL12	PA165109660	6387	0.574
NULL	Indian_J_Med_Res_2014_Aug_140(2)_262-270.nxml.txt.nlp	25297360	SENT96	8	8	10	10	meropenem	P24	PA164764445	928	0.574
NULL	Gut_Pathog_2012_Jul_16_4_7.nxml.txt.nlp	22800501	SENT75	18	18	8	8	cefepime	CTX	PA164754876	1593	0.574
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT316	23	23	9	9	heparin	FGF1	PA449855	2246	0.574
NULL	Cell_Cycle_2013_Dec_15_12(24)_3791-3803.nxml.txt.nlp	24107631	SENT276	26	26	12	12	mitomycin	YB-1	PA450524	4904	0.574
NULL	Am_J_Physiol_Cell_Physiol_2014_Jan_15_306(2)_C89-C97.nxml.txt.nlp	24133067	SENT53	29	29	6	6	hyaluronan	HAS2	PA165958431	3037	0.574
NULL	Emerg_Infect_Dis_2011_Mar_17(3)_495-497.nxml.txt.nlp	21392442	SENT32	33	33	9	9	amikacin	EMB	PA164744372	133418	0.574
NULL	Gastric_Cancer_2013_Apr_11_16(2)_175-182.nxml.txt.nlp	22782463	SENT6	4	4	21	21	bevacizumab	HER2	PA130232992	2064	0.574
NULL	Nucleic_Acids_Res_2011_Sep_11_39(17)_7750-7763.nxml.txt.nlp	21666256	SENT266	14	14	8	8	galactose	PDE12	PA449725	201626	0.574
NULL	Crit_Care_2010_Mar_1_14(Suppl_1)_P80.nxml.txt.nlp	NULL	SENT5	25	25	27	27	vancomycin	VAN	PA451850	10318	0.574
NULL	Trials_2014_Aug_15_15(1)_324.nxml.txt.nlp	NULL	SENT209	1	1	8	8	fluorescein	IFN	PA164746009	3439	0.574
NULL	Front_Genet_2014_Sep_11_5_312.nxml.txt.nlp	25309574	SENT202	23	23	7	7	mannitol	MAP3K15	PA450320	389840	0.574
NULL	Nat_Biotechnol_2010_Mar_14_28(3)_249-255.nxml.txt.nlp	20160716	SENT198	14	14	17	17	pyrilamine	ANOVA	PA165817939	4858	0.574
NULL	Angiogenesis_2013_Apr_10_16(2)_373-386.nxml.txt.nlp	23143659	SENT231	9	9	16	16	verapamil	ABCB1	PA451868	5243	0.574
NULL	Arthritis_Res_Ther_2011_Sep_21_13(5)_239.nxml.txt.nlp	21955617	SENT246	10	10	14	14	celecoxib	RANKL	PA448871	8600	0.574
NULL	Afr_J_Infect_Dis_2011_5(2)_40-46.nxml.txt.nlp	23878706	SENT88	2	2	8	8	ampicillin	Gen	PA448419	348654	0.574
NULL	Front_Physiol_2013_May_15_4_103.nxml.txt.nlp	23720630	SENT128	34	34	29	29	l-carnitine	Q10	PA450154	27161	0.574
NULL	Nucleic_Acids_Res_2013_Nov_16_41(20)_9349-9360.nxml.txt.nlp	23956219	SENT164	19	19	8	8	cisplatin	RMI1	PA449014	80010	0.574
NULL	Front_Neurosci_2011_May_13_5_69.nxml.txt.nlp	21625610	SENT392	30	30	23	23	zolpidem	GIRK3	PA451976	3765	0.574
NULL	Breast_Cancer_Res_2012_Jul_20_14(4)_R110.nxml.txt.nlp	22817698	SENT153	14	14	17	17	olaparib	BRCA1		672	0.574
NULL	Oncogene_2010_Jul_22_29(29)_4170-4182.nxml.txt.nlp	20498638	SENT119	7	7	27	27	paclitaxel	EMT	PA450761	3702;6581	0.574
NULL	Nat_Commun_2013_Sep_3_4_2394.nxml.txt.nlp	23999152	SENT71	17	17	12	12	dextran	BDNF	PA449261	627	0.574
NULL	Front_Aging_Neurosci_2015_Jan_6_6_342.nxml.txt.nlp	25610395	SENT555	10	10	7	7	imatinib	GSAP	PA10804	54103	0.574
NULL	Oncotarget_2013_Nov_24_4(12)_2186-2207.nxml.txt.nlp	24327604	SENT238	19	19	26	26	melphalan	Bcl-2	PA450354	596	0.574
NULL	Diagn_Pathol_2014_Jan_20_9_11.nxml.txt.nlp	24443801	SENT26	15	15	5	5	trypsin	CK7	PA451806	3855	0.574
NULL	Arthritis_Res_Ther_2013_Dec_4_15(6)_R206.nxml.txt.nlp	24299152	SENT105	11	11	8	8	thrombin	FXI	PA451674	2160	0.574
NULL	Daru_2011_19(6)_424-432.nxml.txt.nlp	23008688	SENT53	18	18	4	4	sertraline	DBT	PA451333	1629	0.574
NULL	J_Biol_Chem_2008_Jun_20_283(25)_17194-17204.nxml.txt.nlp	18442977	SENT289	6	6	12	12	ketanserin	NR1	PA131053734	27158	0.574
NULL	Ann_Rheum_Dis_2008_Oct_5_67(10)_1444-1447.nxml.txt.nlp	18535115	SENT52	9	9	0	0	etanercept	ACR	PA449515	49	0.574
NULL	J_Immunother_Cancer_2014_Feb_18_2_4.nxml.txt.nlp	24829761	SENT198	24	24	20	20	gentamicin	EGF	PA449753	1950	0.574
NULL	Evid_Based_Complement_Alternat_Med_2012_May_8_2012_132829.nxml.txt.nlp	22645624	SENT254	47	47	32	32	terbutaline	ANOVA	PA451616	4858	0.574
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2012_Nov_21_1(11)_e15.nxml.txt.nlp	23835797	SENT98	25	25	23	23	doxorubicin	MVD	PA449412	4597	0.574
NULL	Curr_Dermatol_Rep_2014_Jan_22_3(1)_46-53.nxml.txt.nlp	24587977	SENT158	22	22	20	20	aldesleukin	IL-2	PA448081	3558	0.574
NULL	Front_Immunol_2013_Mar_27_4_76.nxml.txt.nlp	23543707	SENT218	31	31	4	4	irinotecan	gamma	PA450085	9913	0.574
NULL	Clin_Interv_Aging_2013_Feb_11_8_139-148.nxml.txt.nlp	23430672	SENT17	30	30	34	34	fluorescein	IL6	PA164746009	3569	0.574
NULL	Cell_Commun_Signal_2014_Jan_10_12_3.nxml.txt.nlp	24410813	SENT107	13	13	15	15	tamoxifen	THOC5	PA451581	8563	0.574
NULL	J_Cell_Biol_2002_Sep_16_158(6)_1051-1066.nxml.txt.nlp	12235123	SENT212	14	14	22	22	etoposide	DEDD	PA449552	9191	0.574
NULL	Mar_Drugs_2011_Nov_2_9(11)_2188-2200.nxml.txt.nlp	22163181	SENT462	13	13	16	16	ethanol	ANOVA	PA448073	4858	0.574
NULL	Neural_Dev_2011_Mar_18_6_8.nxml.txt.nlp	21418557	SENT109	24	24	34	34	carbachol	ANOVA	PA448784	4858	0.574
NULL	Korean_Circ_J_2014_Mar_12_44(2)_82-88.nxml.txt.nlp	24653737	SENT11	20	20	4	4	clopidogrel	P2Y12	PA449053	64805	0.574
NULL	BMJ_2010_Jan_12_340_b5465.nxml.txt.nlp	20068258	SENT333	0	0	8	8	valsartan	spatial	PA451848	219793	0.574
NULL	Diabetes_2009_Dec_9_58(12)_2788-2796.nxml.txt.nlp	19741162	SENT199	27	27	47	47	lipase	DAG	PA450239	1605	0.574
NULL	Osong_Public_Health_Res_Perspect_2013_Dec_12_4(6)_316-322.nxml.txt.nlp	24524020	SENT206	44	44	33	33	tetracycline	PEN	PA451640	9933	0.574
NULL	J_Korean_Med_Sci_2010_Aug_21_25(8)_1222-1227.nxml.txt.nlp	20676337	SENT145	2	2	8	8	aminophylline	LPA	PA164781029	4018	0.574
NULL	Front_Pharmacol_2014_Oct_31_5_231.nxml.txt.nlp	25400580	SENT4923	0	0	11	11	paclitaxel	CNT1	PA450761	9154	0.574
NULL	Ann_Gastroenterol_2012_25(2)_106-118.nxml.txt.nlp	24713845	SENT113	0	0	6	6	methotrexate	DHFR	PA450428	1719	0.574
NULL	Atherosclerosis_2011_Nov_219(1)_109-115.nxml.txt.nlp	21820657	SENT183	5	5	16	16	probucol	CETP	PA451107	1071	0.574
NULL	Cancers_(Basel)_2011_Aug_9_3(3)_3189-3205.nxml.txt.nlp	24212952	SENT87	11	11	7	7	hyaluronan	HYAL-1	PA165958431	3373	0.574
NULL	Indian_J_Dermatol_2011_Jan-Feb_56(1)_87-91.nxml.txt.nlp	21572802	SENT81	22	22	12	12	chlorambucil	CHOP	PA448926	1649	0.574
NULL	Diabetes_Care_2010_Feb_23_33(2)_246-251.nxml.txt.nlp	19933994	SENT186	13	13	24	24	rosiglitazone	B12	PA451283	7126;4709	0.574
NULL	Infect_Dis_Ther_2013_Dec_8_2(2)_95-110.nxml.txt.nlp	25134474	SENT131	10	10	38	38	vancomycin	VISA	PA451850	57506	0.574
NULL	Biomed_Res_Int_2013_Nov_26_2013_843657.nxml.txt.nlp	24371833	SENT25	0	0	8	8	exenatide	GLP-1	PA164749238	100125288	0.574
NULL	Exp_Ther_Med_2013_Jul_17_6(1)_52-56.nxml.txt.nlp	23935717	SENT70	23	23	39	39	ethanol	San	PA448073	80218	0.574
NULL	Arthritis_Res_Ther_2014_Sep_24_16(5)_434.nxml.txt.nlp	25249397	SENT9	23	23	11	11	methotrexate	CXCL13	PA450428	10563	0.574
NULL	Mol_Cancer_2008_Mar_26_7_27.nxml.txt.nlp	18366759	SENT146	5	5	8	8	etoposide	p53	PA449552	7157	0.574
NULL	Biomed_Res_Int_2013_Jun_13_2013_493643.nxml.txt.nlp	23841073	SENT150	6	6	8	8	estradiol	ACTH	PA449503	5443	0.574
NULL	Open_Biochem_J_2011_Sep_23_5_45-51.nxml.txt.nlp	21966325	SENT7	2	2	7	7	diclofenac	ATF6	PA449293	22926	0.574
NULL	Indian_J_Palliat_Care_2011_May-Aug_17(2)_143-145.nxml.txt.nlp	21976855	SENT52	17	17	13	13	heparin	PTI	PA449855	5269	0.574
NULL	J_Adv_Pharm_Technol_Res_2010_Jan-Mar_1(1)_22-29.nxml.txt.nlp	22247828	SENT4	0	0	2	2	cyclophosphamide	CPZ	PA449165	8532	0.574
NULL	J_Antimicrob_Chemother_2008_Nov_13_62(5)_1086-1093.nxml.txt.nlp	18703526	SENT86	28	28	9	9	ceftazidime	CTX	PA448861	1593	0.574
NULL	Case_Rep_Oncol_2012_Jul_24_5(2)_385-387.nxml.txt.nlp	23525261	SENT45	11	11	13	13	mitoxantrone	DES	PA450526	1674	0.574
NULL	Behav_Brain_Funct_2005_Aug_9_1_14.nxml.txt.nlp	16091141	SENT298	20	20	8	8	olanzapine	CPZ	PA450688	8532	0.574
NULL	Patient_Prefer_Adherence_2010_Feb_4_4_17-23.nxml.txt.nlp	20165595	SENT74	12	12	10	10	formoterol	BDP	PA134687907	10620;152926	0.574
NULL	Acta_Pharmacol_Sin_2010_Apr_22_31(4)_450-454.nxml.txt.nlp	20305679	SENT25	9	9	3	3	glucose	nNOS	PA449773	4842	0.574
NULL	Drugs_2009_Mar_17_69(5)_549-565.nxml.txt.nlp	19368417	SENT19	3	3	14	14	budesonide	DPI	PA448681	1832	0.574
NULL	Asia_Pac_Allergy_2013_Oct_31_3(4)_231-240.nxml.txt.nlp	24260728	SENT91	5	5	13	13	theophylline	CYP1A2	PA451647	1544	0.574
NULL	Calcif_Tissue_Int_2013_Sep_11_93(6)_526-539.nxml.txt.nlp	24022329	SENT92	29	29	42	42	l-glutamine	RANKL	PA10090	8600	0.574
NULL	Clin_Ophthalmol_2011_May_24_5_705-713.nxml.txt.nlp	21629578	SENT45	3	3	12	12	ranibizumab	San	PA164746012	80218	0.574
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Jun_27_5_15.nxml.txt.nlp	16803618	SENT161	20	20	42	42	erythromycin	GEN1	PA449493	348654	0.574
NULL	Environ_Health_Perspect_2008_Jul_26_116(7)_854-862.nxml.txt.nlp	18629305	SENT203	4	4	2	2	ebselen	NAC	PA161660841	22861	0.574
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT3	5	5	7	7	erlotinib	CYP3A	PA134687924	1574	0.574
NULL	Diabetes_Care_2010_Dec_30_33(12)_2549-2551.nxml.txt.nlp	20805256	SENT63	9	9	12	12	bupropion	ADM	PA448687	133	0.574
NULL	Exp_Ther_Med_2014_Apr_21_7(4)_855-859.nxml.txt.nlp	24669240	SENT82	10	10	12	12	cisplatin	EGFR	PA449014	1956	0.574
NULL	Breast_Cancer_Res_2009_Oct_28_11(5)_211.nxml.txt.nlp	19889200	SENT150	20	20	18	18	exemestane	PTH	PA449563	5741	0.574
NULL	Clin_Psychopharmacol_Neurosci_2011_Apr_30_9(1)_36-43.nxml.txt.nlp	23431025	SENT49	16	16	29	29	aripiprazole	FLI	PA10026	2314	0.574
NULL	J_Obes_2011_Dec_15_2011_928165.nxml.txt.nlp	21197151	SENT169	9	9	38	38	lipase	GLP-1	PA450239	100125288	0.574
NULL	Mol_Cancer_2014_Jul_5_13_165.nxml.txt.nlp	24996221	SENT118	8	8	3	3	docetaxel	HMGB1	PA449383	3146	0.574
NULL	Mol_Brain_2013_Mar_12_6_12.nxml.txt.nlp	23497716	SENT9	30	30	0	0	fluoxetine	SNAP-25	PA449673	6616	0.574
NULL	J_Antimicrob_Chemother_2011_Jun_25_66(6)_1332-1339.nxml.txt.nlp	21441248	SENT7	12	12	24	24	nevirapine	CYP2B6	PA450616	1555	0.574
NULL	Pancreas_2014_Oct_12_43(7)_1060-1065.nxml.txt.nlp	25121413	SENT159	10	10	17	17	glucose	FDG	PA449773	23583	0.574
NULL	Biomed_Res_Int_2013_Jul_18_2013_603782.nxml.txt.nlp	23971041	SENT171	15	15	12	12	travoprost	BAK	PA164781371	578	0.574
NULL	J_Korean_Med_Sci_2010_Dec_24_25(12)_1766-1770.nxml.txt.nlp	21165292	SENT139	10	10	0	0	glucose	GFR	PA449773	9771	0.574
NULL	Iran_J_Pharm_Res_2013_Summer_12(3)_457-469.nxml.txt.nlp	24250652	SENT208	18	18	9	9	indomethacin	COX	PA449982	1351	0.574
NULL	Indian_J_Psychiatry_2010_Jan_52(Suppl1)_S317-S340.nxml.txt.nlp	21836703	SENT119	22	22	15	15	thiothixene	TFP	PA451669	7034	0.574
NULL	Neural_Regen_Res_2012_Oct_5_7(28)_2189-2198.nxml.txt.nlp	25538739	SENT196	17	17	37	37	phenol	CO2	PA450913	4513	0.574
NULL	Acta_Pharmacol_Sin_2010_Feb_5_31(2)_150-159.nxml.txt.nlp	20139897	SENT43	32	32	7	7	isoflurane	PAR4	PA450106	9002;5074	0.574
NULL	J_Biol_Chem_2013_Nov_15_288(46)_33049-33059.nxml.txt.nlp	24089524	SENT137	18	18	13	13	nicotine	FBS	PA450626	64319;26269	0.574
NULL	Oxid_Med_Cell_Longev_2013_Dec_5_2013_963520.nxml.txt.nlp	24381719	SENT111	8	8	3	3	nitrogen	ROS	PA450643	6098	0.574
NULL	Cancer_Res_Treat_2011_Dec_27_43(4)_255-259.nxml.txt.nlp	22247712	SENT6	0	0	8	8	cyclophosphamide	CHOP	PA449165	1649	0.574
NULL	Indian_J_Psychiatry_2013_Apr-Jun_55(2)_144-148.nxml.txt.nlp	23825848	SENT133	6	6	3	3	imipramine	Gen	PA449969	348654	0.574
NULL	Arch_Med_Sci_2011_Apr_17_7(2)_230-234.nxml.txt.nlp	22291761	SENT120	16	16	22	22	curcumin	SMN2	PA151958596	6607	0.574
NULL	J_Korean_Med_Sci_2011_Jan_22_26(1)_47-52.nxml.txt.nlp	21218029	SENT158	25	25	15	15	creatine	H-FABP	PA164778930	2170	0.574
NULL	Int_J_Biol_Sci_2012_Sep_6_8(8)_1109-1120.nxml.txt.nlp	22991499	SENT152	21	21	9	9	l-arginine	ARG	PA448478	473;27	0.574
NULL	Chin_J_Cancer_2011_Sep_30(9)_645-654.nxml.txt.nlp	21880186	SENT177	30	30	33	33	cisplatin	NACT	PA449014	284111	0.574
NULL	J_Gen_Physiol_2009_Oct_134(4)_323-337.nxml.txt.nlp	19786585	SENT329	1	1	7	7	dantrolene	ClC-1	PA449208	1180	0.574
NULL	Exp_Ther_Med_2013_Mar_20_5(3)_689-694.nxml.txt.nlp	23403765	SENT222	6	6	0	0	l-cysteine	PAG	PA449173	55824	0.574
NULL	N_Am_J_Med_Sci_2011_Jan_3(1)_1-12.nxml.txt.nlp	22540056	SENT132	11	11	23	23	gemcitabine	MRP5	PA449748	10057	0.574
NULL	Endocrinology_2013_Dec_30_154(12)_4536-4547.nxml.txt.nlp	24080367	SENT198	18	18	20	20	lipase	AKT1	PA450239	207	0.574
NULL	Diabetes_Care_2013_Aug_17_36(Suppl_2)_S180-S189.nxml.txt.nlp	23882044	SENT210	14	14	4	4	liraglutide	GLP-1	PA165958364	100125288	0.574
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT609	0	0	13	13	aripiprazole	PRL	PA10026	5617	0.574
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT121	8	8	5	5	glucose	EGFR	PA449773	1956	0.574
NULL	Nat_Struct_Mol_Biol_2014_Jul_22_21(7)_633-640.nxml.txt.nlp	24952594	SENT199	18	18	25	25	l-glutamine	CO2	PA10090	4513	0.574
NULL	Kidney_Int_Suppl_(2011)_2013_Jan_28_3(1)_19-62.nxml.txt.nlp	25018975	SENT635	30	30	43	43	iohexol	GFR	PA450061	9771	0.574
NULL	Oncotarget_2014_Feb_14_5(3)_841-852.nxml.txt.nlp	24553354	SENT310	9	9	2	2	arsenite	p53	PA452638	7157	0.574
NULL	Allergy_Asthma_Immunol_Res_2012_May_14_4(3)_137-142.nxml.txt.nlp	22548206	SENT134	23	23	17	17	naproxen	IPA	PA450595	3160	0.574
NULL	J_Cardiothorac_Surg_2013_Sep_11_8(Suppl_1)_P122.nxml.txt.nlp	NULL	SENT7	17	17	36	36	clopidogrel	APT	PA449053	653639	0.574
NULL	Int_J_Vasc_Med_2014_Jul_22_2014_659617.nxml.txt.nlp	25140254	SENT50	23	23	32	32	isoflurane	CO2	PA450106	4513	0.574
NULL	Mol_Cancer_2014_Jan_13_13_7.nxml.txt.nlp	24418169	SENT46	14	14	12	12	sorafenib	STAT3	PA7000	6774	0.574
NULL	Clinics_(Sao_Paulo)_2014_Jun_69(6)_438-446.nxml.txt.nlp	24964310	SENT86	14	14	29	29	teriparatide	PTH	PA451620	5741	0.574
NULL	J_Invest_Dermatol_2012_Apr_22_132(4)_1253-1262.nxml.txt.nlp	22189789	SENT279	9	9	18	18	capsaicin	TRPV4	PA448776	59341	0.574
NULL	J_Cardiovasc_Magn_Reson_2014_Sep_27_16(1)_80.nxml.txt.nlp	25270330	SENT19	18	18	14	14	iron	spatial	PA450087	219793	0.574
NULL	Aging_(Albany_NY)_2009_Jun_3_1(6)_515-528.nxml.txt.nlp	20157535	SENT6	18	18	12	12	resveratrol	S6K1		6198	0.574
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jul_31_65(Pt_8)_o2055.nxml.txt.nlp	21583717	SENT76	20	20	31	31	ethanol	mol	PA448073	90527	0.574
NULL	Int_J_Gen_Med_2009_Nov_30_1_21-25.nxml.txt.nlp	20428402	SENT37	2	2	4	4	vasopressin	AVP	PA451858	114548;551	0.574
NULL	Oncotarget_2012_May_4_3(4)_395-398.nxml.txt.nlp	22565037	SENT19	0	0	8	8	metformin	CD24	PA450395	100133941	0.574
NULL	Arch_Med_Sci_2011_Feb_8_7(1)_67-72.nxml.txt.nlp	22291735	SENT45	25	25	10	10	creatine	PMI	PA164778930	8834;5373	0.574
NULL	Eur_J_Clin_Pharmacol_2012_Sep_15_68(9)_1267-1274.nxml.txt.nlp	22418828	SENT151	0	0	4	4	pantoprazole	CYP2C19	PA450774	1557	0.574
NULL	Exp_Ther_Med_2013_Mar_21_5(3)_987-991.nxml.txt.nlp	23407636	SENT103	1	1	12	12	losartan	IL-8	PA450268	3576	0.574
NULL	Front_Immunol_2014_Apr_1_5_131.nxml.txt.nlp	24744755	SENT279	17	17	21	21	imiquimod	IFN	PA449972	3439	0.574
NULL	Crit_Care_2012_Jul_26_16(4)_317.nxml.txt.nlp	22839207	SENT15	27	27	12	12	fenoldopam	GFR	PA164784034	9771	0.574
NULL	Breast_Cancer_Res_2008_Dec_18_10(Suppl_4)_S25.nxml.txt.nlp	19128439	SENT12	8	8	17	17	anastrozole	ATAC	PA448432	6375	0.574
NULL	J_Clin_Biochem_Nutr_2010_Mar_27_46(2)_126-134.nxml.txt.nlp	20216945	SENT329	23	23	9	9	taurine	NAC	PA451590	22861	0.574
NULL	Pharmaceuticals_(Basel)_2014_Mar_5_7(3)_311-338.nxml.txt.nlp	24603603	SENT44	21	21	16	16	cetuximab	EGF	PA10040	1950	0.574
NULL	J_Cell_Biol_2004_Jan_19_164(2)_291-300.nxml.txt.nlp	14718519	SENT128	8	8	6	6	pp2	PP1		5540;5464	0.574
NULL	AIDS_Res_Treat_2011_Jun_7_2011_354908.nxml.txt.nlp	21716719	SENT161	7	7	1	1	tenofovir	ABCC2	PA10204	1244	0.574
NULL	Oncotarget_2013_Nov_24_4(12)_2430-2438.nxml.txt.nlp	24280348	SENT41	3	3	22	22	gefitinib	JNK	PA131301952	5599	0.574
NULL	Curr_Neuropharmacol_2008_Sep_6(3)_215-234.nxml.txt.nlp	19506722	SENT220	0	0	22	22	fluoxetine	c-FLIP	PA449673	8837	0.574
NULL	Diabetes_2013_Nov_18_62(11)_3677-3686.nxml.txt.nlp	24158999	SENT359	10	10	19	19	capsaicin	TRPV4	PA448776	59341	0.574
NULL	Clin_Pediatr_Endocrinol_2006_Feb_22_15(1)_41-43.nxml.txt.nlp	24790319	SENT2	21	21	23	23	vasopressin	AVP	PA451858	114548;551	0.574
NULL	Oncotarget_2014_Sep_3_5(19)_9362-9381.nxml.txt.nlp	25313139	SENT117	23	23	16	16	lipase	SLC27A1	PA450239	376497	0.574
NULL	BMB_Rep_2014_Apr_47(4)_221-226.nxml.txt.nlp	24286312	SENT96	23	23	7	7	nutlin-3	p53		7157	0.574
NULL	ScientificWorldJournal_2013_Dec_24_2013_958724.nxml.txt.nlp	24453930	SENT104	9	9	27	27	bevacizumab	ERM	PA130232992	2119	0.574
NULL	J_Immunol_Res_2014_Feb_3_2014_671431.nxml.txt.nlp	24741615	SENT234	13	13	33	33	paraformaldehyde	CD22	PA450790	933	0.574
NULL	Br_J_Cancer_2012_Oct_9_107(8)_1257-1267.nxml.txt.nlp	23047592	SENT205	24	24	2	2	fluorouracil	BCS	PA128406956	617	0.574
NULL	Diabetes_2013_Jun_20_62(6)_2122-2129.nxml.txt.nlp	23378607	SENT199	20	20	1	1	glucose	ANOVA	PA449773	4858	0.574
NULL	Aging_(Albany_NY)_2011_Aug_22_3(8)_782-793.nxml.txt.nlp	21869459	SENT90	0	0	10	10	doxorubicin	AC3	PA449412	109	0.574
NULL	Allergy_Asthma_Clin_Immunol_2010_May_12_6(1)_8.nxml.txt.nlp	20462426	SENT278	8	8	4	4	saxagliptin	DDP	PA165958362	1678	0.574
NULL	Oncol_Lett_2014_May_21_7(5)_1569-1575.nxml.txt.nlp	24765178	SENT173	26	26	17	17	fluorescein	CD44	PA164746009	960	0.574
NULL	Mol_Cells_2014_Jan_31_37(1)_66-73.nxml.txt.nlp	24552712	SENT132	47	47	40	40	ribavirin	RVR	PA451241	9975	0.574
NULL	Front_Endocrinol_(Lausanne)_2014_Dec_18_5_218.nxml.txt.nlp	25566190	SENT337	10	10	13	13	oxygen	NOX4	PA450744	50507	0.574
NULL	DNA_Repair_(Amst)_2009_Jun_4_8(6)_760-766.nxml.txt.nlp	19303373	SENT296	10	10	1	1	camptothecin	SCAN1	PA153590860	55775	0.574
NULL	BMJ_2011_Aug_4_343_d4588.nxml.txt.nlp	21816733	SENT294	35	35	20	20	clopidogrel	CYP3A	PA449053	1574	0.574
NULL	Nucl_Recept_Signal_2014_Nov_4_12_e005.nxml.txt.nlp	25422595	SENT214	13	13	31	31	geldanamycin	Hsp90	PA152031327	3320	0.574
NULL	Biomed_Res_Int_2014_Jun_4_2014_253243.nxml.txt.nlp	24995279	SENT45	3	3	7	7	chlorambucil	CHOP	PA448926	1649	0.574
NULL	Diabetes_2011_May_23_60(5)_1617-1623.nxml.txt.nlp	21441441	SENT186	24	24	3	3	metformin	S16	PA450395	6217	0.574
NULL	J_Biol_Chem_2013_Oct_11_288(41)_29642-29653.nxml.txt.nlp	24005673	SENT960	4	4	10	10	hyaluronan	TSG-6	PA165958431	7130	0.574
NULL	Acta_Neuropathol_2014_Dec_8_127(1)_109-135.nxml.txt.nlp	24318124	SENT550	6	6	16	16	citalopram	NDRG2	PA449015	57447	0.573
NULL	Int_J_Endocrinol_2014_Feb_23_2014_397307.nxml.txt.nlp	24707287	SENT8	0	0	5	5	taurine	ACR	PA451590	49	0.573
NULL	Oncotarget_2011_Dec_24_2(12)_896-917.nxml.txt.nlp	22203527	SENT114	27	27	29	29	metformin	AMPK	PA450395	5563	0.573
NULL	ASN_Neuro_2010_Oct_4_2(5)_e00046.nxml.txt.nlp	20957077	SENT152	2	2	11	11	ganciclovir	E12	PA449733	64100	0.573
NULL	J_Biol_Chem_2013_Nov_15_288(46)_33049-33059.nxml.txt.nlp	24089524	SENT270	8	8	19	19	nicotine	GATA6	PA450626	2627	0.573
NULL	Case_Rep_Pathol_2014_Dec_25_2014_753694.nxml.txt.nlp	25610687	SENT54	40	40	29	29	thyroglobulin	PTH	PA164754910	5741	0.573
NULL	Curr_Neuropharmacol_2013_Jan_11(1)_102-108.nxml.txt.nlp	23814542	SENT224	42	42	7	7	curcumin	Yes	PA151958596	7525	0.573
NULL	Acta_Pharmacol_Sin_2009_Jul_3_30(7)_889-898.nxml.txt.nlp	19574994	SENT59	29	29	11	11	dpcpx	PI3K		5290	0.573
NULL	Ann_Rehabil_Med_2012_Aug_27_36(4)_466-473.nxml.txt.nlp	22977771	SENT145	11	11	33	33	bupivacaine	TLF	PA135057240	9519	0.573
NULL	Biomed_Res_Int_2014_Jan_2_2014_526301.nxml.txt.nlp	24524079	SENT56	15	15	34	34	propofol	GOX	PA451141	54363	0.573
NULL	Clinics_(Sao_Paulo)_2012_Nov_67(11)_1321-1325.nxml.txt.nlp	23184211	SENT59	12	12	0	0	vasopressin	AVP	PA451858	114548;551	0.573
NULL	Environ_Health_Perspect_2005_Sep_7_113(9)_1125-1133.nxml.txt.nlp	16140616	SENT206	22	22	24	24	tamoxifen	DES	PA451581	1674	0.573
NULL	F1000Res_2014_Mar_4_2_252.nxml.txt.nlp	24715962	SENT53	34	34	5	5	heparin	F12	PA449855	2161	0.573
NULL	Cell_Cycle_2012_Dec_1_11(23)_4474-4483.nxml.txt.nlp	23159862	SENT87	6	6	12	12	etoposide	GAPDH	PA449552	2597	0.573
NULL	Cancer_Med_2013_Feb_3_2(1)_76-85.nxml.txt.nlp	24133630	SENT346	25	25	13	13	vemurafenib	ABCG2	PA165946873	9429	0.573
NULL	Mol_Vis_2011_May_4_17_1172-1181.nxml.txt.nlp	21617754	SENT244	21	21	10	10	staurosporine	FKBP51	PA165109623	2289	0.573
NULL	Breast_Cancer_Res_2011_May_19_13(3)_R52.nxml.txt.nlp	21595894	SENT345	12	12	7	7	tamoxifen	FOXC1	PA451581	2296	0.573
NULL	Diabetes_Obes_Metab_2010_May_12(5)_437-441.nxml.txt.nlp	20415692	SENT35	32	32	22	22	metformin	GLA	PA450395	9027;2717	0.573
NULL	Breast_Cancer_Res_2012_Jun_19_14(3)_311.nxml.txt.nlp	22713135	SENT7	26	26	17	17	fulvestrant	aromatase	PA164747170	1588	0.573
NULL	Appl_Plant_Sci_2014_Apr_3_2(4)_apps_1400011.nxml.txt.nlp	25202621	SENT154	10	10	12	12	ethanol	IPA	PA448073	3160	0.573
NULL	Oncotarget_2013_Apr_13_4(4)_502-530.nxml.txt.nlp	23594434	SENT271	39	39	27	27	nelfinavir	U87	PA450606	677775;641648	0.573
NULL	Indian_J_Med_Res_2014_Jan_139(1)_7-9.nxml.txt.nlp	24604036	SENT30	18	18	3	3	albendazole	STH	PA164746058	246744	0.573
NULL	Clin_Ophthalmol_2014_Aug_18_8_1527-1534.nxml.txt.nlp	25170245	SENT142	9	9	7	7	timolol	TIM	PA451690	7984;8914	0.573
NULL	Pancreas_2014_Oct_12_43(7)_1060-1065.nxml.txt.nlp	25121413	SENT169	11	11	7	7	glucose	FDG	PA449773	23583	0.573
NULL	Clin_Ophthalmol_2009_Jun_2_3_199-210.nxml.txt.nlp	19668566	SENT182	9	9	0	0	bromfenac	Rho	PA448670	29984	0.573
NULL	Bioinformation_2011_Sep_6_7(2)_59-63.nxml.txt.nlp	21938206	SENT6	19	19	17	17	cefazolin	PON1	PA448839	5444	0.573
NULL	Oncotarget_2014_Aug_19_5(17)_7316-7327.nxml.txt.nlp	25261373	SENT260	15	15	5	5	ethanol	AP4	PA448073	29803	0.573
NULL	Crit_Care_2010_Mar_15_14(2)_R30.nxml.txt.nlp	20226064	SENT196	0	0	20	20	propofol	GMP	PA451141	22978	0.573
NULL	Br_J_Dermatol_2009_Feb_160(2)_438-441.nxml.txt.nlp	19016697	SENT87	14	14	9	9	methotrexate	ATIC	PA450428	471	0.573
NULL	Mol_Cancer_2007_Mar_7_6_18.nxml.txt.nlp	17343740	SENT27	25	25	27	27	hyaluronan	CD44	PA165958431	960	0.573
NULL	Osteoporos_Int_2013_Aug_12_24(8)_2309-2317.nxml.txt.nlp	23404615	SENT41	29	29	25	25	denosumab	RANK	PA166048634	8792	0.573
NULL	Eur_J_Neurosci_2008_Oct_28(8)_1518-1535.nxml.txt.nlp	18793322	SENT85	16	16	18	18	halothane	CO2	PA449845	4513	0.573
NULL	Nat_Commun_2014_Nov_25_5_5548.nxml.txt.nlp	25420520	SENT118	16	16	23	23	docetaxel	DTE	PA449383	199699	0.573
NULL	Front_Pharmacol_2014_Sep_1_5_199.nxml.txt.nlp	25225485	SENT562	0	0	5	5	arsenite	AQP7	PA452638	364	0.573
NULL	Emerg_Infect_Dis_2014_May_20(5)_910-911.nxml.txt.nlp	24751334	SENT31	28	28	14	14	gentamicin	COT	PA449753	54677	0.573
NULL	Drugs_R_D_2014_Dec_18_14(4)_233-239.nxml.txt.nlp	25231707	SENT80	11	11	20	20	clopidogrel	PTX3	PA449053	5806	0.573
NULL	Int_J_Mol_Sci_2014_Oct_23_15(10)_19265-19280.nxml.txt.nlp	25342321	SENT64	2	2	12	12	sc-560	MVD		4597	0.573
NULL	Front_Behav_Neurosci_2009_Sep_30_3_31.nxml.txt.nlp	19862348	SENT196	21	21	5	5	carrageenan	PAG	PA448814	55824	0.573
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT149	3	3	5	5	curcumin	TRAIL	PA151958596	8743	0.573
NULL	Basic_Clin_Pharmacol_Toxicol_2013_Feb_5_112(2)_132-137.nxml.txt.nlp	22900583	SENT54	18	18	32	32	flurbiprofen	CYP2C9	PA449683	1559	0.573
NULL	Cancers_(Basel)_2010_Jun_14_2(2)_1288-1311.nxml.txt.nlp	24281116	SENT47	18	18	11	11	oxygen	NOX1	PA450744	27035	0.573
NULL	Int_J_Biomed_Sci_2014_Dec_10(4)_229-235.nxml.txt.nlp	25598752	SENT105	2	2	23	23	abatacept	IL-6	PA164747080	3569	0.573
NULL	Arthritis_Res_Ther_2014_Jan_24_16(1)_R23.nxml.txt.nlp	24460726	SENT192	10	10	38	38	hydroxychloroquine	STAT1	PA164777036	6772	0.573
NULL	Crit_Care_2006_May_12_10(3)_R75.nxml.txt.nlp	16696866	SENT161	3	3	0	0	vasopressin	AVP	PA451858	114548;551	0.573
NULL	Part_Fibre_Toxicol_2010_Sep_11_7_25.nxml.txt.nlp	20831820	SENT189	41	41	12	12	gentamicin	CO2	PA449753	4513	0.573
NULL	EJC_Suppl_2013_Sep_5_11(2)_3-22.nxml.txt.nlp	NULL	SENT1178	1	1	29	29	exemestane	p53	PA449563	7157	0.573
NULL	Oxid_Med_Cell_Longev_2012_May_13_2012_250825.nxml.txt.nlp	22666518	SENT65	33	33	40	40	glucose	ROS	PA449773	6098	0.573
NULL	Drugs_R_D_2011_Jun_27_11(2)_101-111.nxml.txt.nlp	21679003	SENT37	9	9	25	25	bevacizumab	IFL	PA130232992	3439	0.573
NULL	Appl_Microbiol_Biotechnol_2013_Aug_16_97(18)_7999-8009.nxml.txt.nlp	23948723	SENT79	22	22	10	10	glucose	mol	PA449773	90527	0.573
NULL	Nat_Photonics_2013_Oct_20_7_987-994.nxml.txt.nlp	25346777	SENT195	18	18	31	31	neomycin	GLP1	PA450608	100125288;2641	0.573
NULL	J_Neurochem_2010_Jun_113(5)_1177-1187.nxml.txt.nlp	20374431	SENT195	8	8	34	34	forskolin	P2X1	PA146096022	5023	0.573
NULL	Braz_J_Microbiol_2010_Jun_1_Apr-Jun_41(2)_452-460.nxml.txt.nlp	24031516	SENT121	30	30	27	27	chloramphenicol	STX	PA448927	8128	0.573
NULL	Sci_Rep_2015_Jan_6_5_7647.nxml.txt.nlp	25558795	SENT377	18	18	24	24	vincristine	CHOP	PA451879	1649	0.573
NULL	Clin_Ophthalmol_2007_Mar_1(1)_11-24.nxml.txt.nlp	19668462	SENT192	14	14	16	16	travoprost	BAK	PA164781371	578	0.573
NULL	Mol_Biol_Cell_2012_Jul_1_23(13)_2481-2489.nxml.txt.nlp	22573888	SENT123	23	23	15	15	dextran	ARAP1	PA449261	116985	0.573
NULL	Genetics_2015_Jan_13_199(1)_247-262.nxml.txt.nlp	25398792	SENT7	33	33	20	20	galactose	GALT	PA449725	2592	0.573
NULL	J_Immunol_Res_2014_Jul_16_2014_696812.nxml.txt.nlp	25133198	SENT247	17	17	7	7	rifaximin	TLR4	PA164752443	7099	0.573
NULL	EMBO_Mol_Med_2012_Jun_13_4(6)_515-527.nxml.txt.nlp	22416035	SENT179	10	10	4	4	olaparib	p53		7157	0.573
NULL	Front_Oncol_2013_Nov_15_3_281.nxml.txt.nlp	24298448	SENT195	26	26	21	21	panitumumab	BRAF	PA162373091	673	0.573
NULL	Cytotechnology_2015_Jan_29_67(1)_39-49.nxml.txt.nlp	24166597	SENT33	18	18	9	9	pentobarbital	CO2	PA450859	4513	0.573
NULL	Int_J_Genomics_2014_Oct_21_2014_312102.nxml.txt.nlp	25401099	SENT12	29	29	25	25	heparin	epigen	PA449855	255324	0.573
NULL	Environ_Health_Perspect_2009_Feb_28_117(2)_223-230.nxml.txt.nlp	19270792	SENT198	11	11	8	8	estradiol	CYP3A	PA449503	1574	0.573
NULL	Acta_Pharmacol_Sin_2009_Sep_17_30(9)_1316-1322.nxml.txt.nlp	19684609	SENT195	3	3	5	5	rosiglitazone	PTEN	PA451283	5728	0.573
NULL	Int_J_Environ_Res_Public_Health_2010_Dec_21_7(12)_4281-4304.nxml.txt.nlp	21318009	SENT454	15	15	0	0	ethanol	CYP2E1	PA448073	1571	0.573
NULL	Biosci_Rep_2013_Nov_25_33(6)_e00081.nxml.txt.nlp	24070327	SENT862	1	1	8	8	imatinib	survivin	PA10804	332	0.573
NULL	Lab_Anim_Res_2012_Jun_26_28(2)_123-129.nxml.txt.nlp	22787486	SENT19	11	11	40	40	orlistat	CB1	PA164776864	1268	0.573
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT287	2	2	19	19	resveratrol	Bcl-2		596	0.573
NULL	J_Adv_Pract_Oncol_2012_May_1_May-Jun_3(3)_161-169.nxml.txt.nlp	25031942	SENT272	5	5	16	16	cetuximab	EGFR	PA10040	1956	0.573
NULL	Clin_Ophthalmol_2008_Mar_2(1)_159-166.nxml.txt.nlp	19668400	SENT153	22	22	14	14	fluorescein	CRT	PA164746009	811	0.573
NULL	Anticancer_Drugs_2015_Jan_28_26(1)_117-122.nxml.txt.nlp	25115342	SENT124	18	18	29	29	paclitaxel	HER2	PA450761	2064	0.573
NULL	Cancer_Cell_Int_2013_Apr_16_13_36.nxml.txt.nlp	23590596	SENT105	7	7	10	10	doxorubicin	TRAIL	PA449412	8743	0.573
NULL	Mol_Cell_Proteomics_2013_Aug_14_12(8)_2313-2323.nxml.txt.nlp	23674616	SENT230	12	12	6	6	levamisole	ALPL	PA450205	249	0.573
NULL	Child_Adolesc_Psychiatry_Ment_Health_2008_Sep_15_2_25.nxml.txt.nlp	18793405	SENT111	9	9	7	7	atomoxetine	ATX	PA134688071	5168;23049	0.573
NULL	Asian-Australas_J_Anim_Sci_2013_Apr_26(4)_573-578.nxml.txt.nlp	25049825	SENT141	12	12	17	17	bacitracin	BP1	PA448531	1748	0.573
NULL	Biochemistry_2008_Jun_10_47(23)_6242-6250.nxml.txt.nlp	18470998	SENT208	8	8	11	11	resveratrol	SIRT1		23411	0.573
NULL	Anal_Bioanal_Chem_2008_Apr_31_390(8)_1987-1998.nxml.txt.nlp	18236033	SENT269	2	2	0	0	diethylstilbestrol	DES	PA449307	1674	0.573
NULL	Breast_Cancer_Res_2011_Nov_1_13(6)_224.nxml.txt.nlp	22114931	SENT83	25	25	21	21	estradiol	PI3K	PA449503	5290	0.573
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT320	25	25	13	13	haloperidol	PRL	PA449841	5617	0.573
NULL	Oncotarget_2013_Aug_21_4(9)_1484-1495.nxml.txt.nlp	23986086	SENT12	22	22	3	3	metformin	PIK3CA	PA450395	5290	0.573
NULL	Cough_2005_Aug_4_1_2.nxml.txt.nlp	16270920	SENT83	25	25	28	28	capsaicin	TRPV1	PA448776	7442	0.573
NULL	Oncol_Rep_2012_Apr_30_27(4)_923-928.nxml.txt.nlp	22209766	SENT46	37	37	11	11	hydrocortisone	F12	PA449905	2161	0.573
NULL	Mol_Pain_2013_Jan_2_9_1.nxml.txt.nlp	23279936	SENT129	32	32	28	28	capsaicin	TRPV1	PA448776	7442	0.573
NULL	J_Invest_Dermatol_2012_Mar_8_132(3)_882-886.nxml.txt.nlp	22158552	SENT93	5	5	8	8	heparin	HMGB1	PA449855	3146	0.573
NULL	J_Clin_Biochem_Nutr_2009_Mar_28_44(2)_185-195.nxml.txt.nlp	19308273	SENT13	4	4	18	18	oxygen	ROS	PA450744	6098	0.573
NULL	Cell_Death_Dis_2014_Mar_13_5(3)_e1118.nxml.txt.nlp	24625977	SENT301	18	18	6	6	etoposide	UBXN2A	PA449552	165324	0.573
NULL	Front_Neurosci_2011_Jan_14_4_207.nxml.txt.nlp	21258618	SENT108	7	7	31	31	ethanol	HET	PA448073	6294	0.573
NULL	J_Mol_Med_(Berl)_2013_Aug_17_91(11)_1257-1271.nxml.txt.nlp	23955016	SENT172	23	23	27	27	thrombin	p38	PA451674	10598;1432;7965	0.573
NULL	Braz_J_Med_Biol_Res_2012_Jun_29_45(8)_777-783.nxml.txt.nlp	22735180	SENT139	28	28	40	40	lipase	PGC1	PA450239	10891	0.573
NULL	J_Biomed_Sci_2014_Feb_3_21(1)_10.nxml.txt.nlp	24490900	SENT246	19	19	28	28	alendronate	M-CSF	PA448082	1435	0.573
NULL	Front_Chem_2014_Dec_23_2_113.nxml.txt.nlp	25566531	SENT161	0	0	6	6	curcumin	GSTT1	PA151958596	2952	0.573
NULL	Core_Evid_2009_Jun_15_4_131-147.nxml.txt.nlp	20694070	SENT434	5	5	23	23	efavirenz	San	PA449441	80218	0.573
NULL	J_Korean_Med_Sci_2013_Aug_31_28(8)_1213-1219.nxml.txt.nlp	23960450	SENT178	25	25	27	27	ribavirin	ITPA	PA451241	3704	0.573
NULL	Diabetes_Metab_J_2014_Jun_17_38(3)_211-219.nxml.txt.nlp	25003075	SENT139	2	2	24	24	sitagliptin	PPG	PA164748978	5552	0.573
NULL	Ther_Clin_Risk_Manag_2007_Dec_3(6)_1077-1086.nxml.txt.nlp	18516259	SENT86	0	0	12	12	entecavir	LAM	PA164784025	7249;7248	0.573
NULL	Viruses_2014_Apr_14_6(4)_1715-1758.nxml.txt.nlp	24736215	SENT132	0	0	17	17	disulfiram	HEXIM1	PA449376	10614	0.573
NULL	Front_Oncol_2012_Oct_31_2_157.nxml.txt.nlp	23120745	SENT1143	14	14	2	2	cisplatin	p53	PA449014	7157	0.573
NULL	Allergy_Asthma_Clin_Immunol_2011_Dec_7_7(1)_21.nxml.txt.nlp	22152089	SENT119	30	30	5	5	mometasone	DPI	PA450541	1832	0.573
NULL	Cancer_Med_2014_Apr_17_3(2)_434-444.nxml.txt.nlp	24706592	SENT208	9	9	4	4	etoposide	CHOP	PA449552	1649	0.573
NULL	Clin_Med_Insights_Oncol_2013_May_20_7_87-102.nxml.txt.nlp	23761989	SENT393	34	34	23	23	sorafenib	CD221	PA7000	3480	0.573
NULL	Exp_Ther_Med_2013_May_8_5(5)_1491-1495.nxml.txt.nlp	23737905	SENT188	3	3	9	9	hemin	HO-1	PA449849	3162	0.573
NULL	J_Invest_Dermatol_2012_Sep_10_132(9)_2255-2262.nxml.txt.nlp	22572817	SENT194	18	18	10	10	forskolin	HBD3	PA146096022	414325	0.573
NULL	Oxid_Med_Cell_Longev_2012_May_28_2012_632959.nxml.txt.nlp	22690272	SENT52	9	9	38	38	curcumin	CDK4	PA151958596	1019	0.573
NULL	Curr_Hepat_Rep_2010_May_21_9(2)_75-90.nxml.txt.nlp	20461127	SENT286	5	5	13	13	telbivudine	LAM	PA164760861	7249;7248	0.573
NULL	Arthritis_Res_Ther_2014_Jan_20_16(1)_R17.nxml.txt.nlp	24444433	SENT127	12	12	0	0	methotrexate	ANOVA	PA450428	4858	0.573
NULL	Arthritis_Res_Ther_2011_Feb_16_13(1)_R25.nxml.txt.nlp	21324169	SENT120	2	2	8	8	abatacept	ANA	PA164747080	10950	0.573
NULL	Crit_Care_2006_Mar_21_10(Suppl_1)_P249.nxml.txt.nlp	NULL	SENT15	13	13	0	0	glucose	NGF	PA449773	4803	0.573
NULL	Exp_Diabetes_Res_2012_Oct_15_2012_465282.nxml.txt.nlp	23118742	SENT160	35	35	9	9	metformin	FGF21	PA450395	26291	0.573
NULL	Int_J_Breast_Cancer_2013_Jan_16_2013_872743.nxml.txt.nlp	23401782	SENT288	28	28	20	20	maytansine	DM1	PA165291473	338023;1760;28509	0.573
NULL	Chin_J_Cancer_2012_Jun_31(6)_266-280.nxml.txt.nlp	22313597	SENT222	30	30	38	38	lipase	IGFBP5	PA450239	3488	0.573
NULL	J_Hum_Kinet_2013_Dec_31_39_137-145.nxml.txt.nlp	24511349	SENT12	6	6	47	47	creatine	ADP	PA164778930	23038	0.573
NULL	Front_Neurol_2014_Sep_11_5_173.nxml.txt.nlp	25309501	SENT295	16	16	21	21	hyaluronan	MUC5B	PA165958431	727897	0.573
NULL	Int_J_Med_Sci_2015_Jan_1_12(1)_63-71.nxml.txt.nlp	25552920	SENT115	2	2	22	22	berberine	PDGFRB	PA165860812	5159	0.573
NULL	Curr_Cardiol_Rev_2008_Nov_4(4)_287-292.nxml.txt.nlp	20066136	SENT105	19	19	13	13	potassium	GFR	PA451047	9771	0.573
NULL	J_Hematol_Oncol_2013_Aug_2_6_56.nxml.txt.nlp	23915951	SENT44	29	29	20	20	pp2	VAMP-1		6843	0.573
NULL	Br_J_Cancer_2012_Jun_5_106(12)_1960-1966.nxml.txt.nlp	22596237	SENT159	36	36	19	19	saracatinib	PC3		57332;7832;5122	0.573
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Apr_15_9_13.nxml.txt.nlp	20398300	SENT72	11	11	0	0	moxifloxacin	LAM	PA450555	7249;7248	0.573
NULL	J_Public_Health_Res_2014_Mar_26_3(1)_204.nxml.txt.nlp	25170509	SENT288	8	8	0	0	buprenorphine	OST	PA448685	1650;23263	0.573
NULL	Stroke_Res_Treat_2009_Dec_20_2010_386389.nxml.txt.nlp	20700422	SENT140	5	5	11	11	resveratrol	MCP-1		6347	0.573
NULL	Evid_Based_Complement_Alternat_Med_2011_Feb_14_2011_429843.nxml.txt.nlp	21869897	SENT134	21	21	31	31	ethanol	PC6	PA448073	5125	0.573
NULL	Indian_J_Dermatol_2013_Mar-Apr_58(2)_101-106.nxml.txt.nlp	23716797	SENT132	11	11	7	7	heparin	EGFR	PA449855	1956	0.573
NULL	Braz_J_Microbiol_2014_Apr_11_45(1)_153-161.nxml.txt.nlp	24948926	SENT138	5	5	3	3	ketoconazole	KET	PA450146	8626	0.573
NULL	Diabetes_Care_2009_Sep_28_32(9)_1649-1655.nxml.txt.nlp	19478198	SENT139	2	2	0	0	metformin	MET	PA450395	4233	0.573
NULL	Breast_Cancer_Res_2009_Mar_19_11(2)_R16.nxml.txt.nlp	19298655	SENT118	15	15	0	0	lipase	aP2	PA450239	2167	0.573
NULL	Endocrinology_2014_Nov_14_155(11)_4591-4601.nxml.txt.nlp	25121996	SENT54	0	0	2	2	tamoxifen	TMX	PA451581	81542	0.573
NULL	Cancer_Cell_Int_2005_Jul_29_5_24.nxml.txt.nlp	16053526	SENT162	10	10	14	14	estradiol	beta-catenin	PA449503	1499	0.573
NULL	Front_Genet_2014_Oct_13_5_356.nxml.txt.nlp	25352863	SENT118	1	1	4	4	ethanol	CHRNA5	PA448073	1138	0.573
NULL	J_Oncol_2010_Nov_19_2010_568938.nxml.txt.nlp	20037743	SENT315	21	21	35	35	carboplatin	EGFR	PA448803	1956	0.573
NULL	Calcif_Tissue_Int_2013_Sep_11_93(6)_526-539.nxml.txt.nlp	24022329	SENT72	30	30	43	43	l-glutamine	RANKL	PA10090	8600	0.573
NULL	Int_J_Nanomedicine_2007_Mar_2(1)_25-32.nxml.txt.nlp	17722509	SENT65	3	3	11	11	tacrolimus	FKBP-12	PA451578	2280	0.573
NULL	Oxid_Med_Cell_Longev_2013_Apr_18_2013_239854.nxml.txt.nlp	23710284	SENT83	0	0	8	8	zonisamide	HRD1	PA451978	84447	0.573
NULL	Breast_Cancer_Res_2011_Mar_10_13(2)_R28.nxml.txt.nlp	21392397	SENT200	11	11	13	13	erlotinib	YB-1	PA134687924	4904	0.573
NULL	Arthritis_Res_Ther_2006_Mar_6_8(2)_R53.nxml.txt.nlp	16519795	SENT65	1	1	3	3	methotrexate	IL-10	PA450428	3586	0.573
NULL	Exp_Ther_Med_2013_Mar_20_5(3)_689-694.nxml.txt.nlp	23403765	SENT248	8	8	0	0	l-cysteine	PAG	PA449173	55824	0.573
NULL	Arthritis_Res_Ther_2003_Sep_12_5(Suppl_3)_145.nxml.txt.nlp	NULL	SENT5	21	21	9	9	forskolin	IL-16	PA146096022	3603	0.573
NULL	Diabetes_2011_May_23_60(5)_1458-1466.nxml.txt.nlp	21464445	SENT39	3	3	5	5	lipase	HSL	PA450239	3991	0.573
NULL	Front_Genet_2013_Aug_30_4_166.nxml.txt.nlp	24009623	SENT506	7	7	0	0	estradiol	TIS21	PA449503	7832	0.573
NULL	Adipocyte_2014_Jul_1_3(3)_224-229.nxml.txt.nlp	25068091	SENT77	41	41	5	5	oxygen	GSTA4	PA450744	2941	0.573
NULL	Arch_Toxicol_2014_Nov_5_88(12)_2135-2190.nxml.txt.nlp	25370008	SENT1284	5	5	0	0	4-methylumbelliferone	UGT	PA154081778	7361;7355	0.573
NULL	Br_J_Cancer_2010_Nov_9_103(10)_1548-1553.nxml.txt.nlp	20924376	SENT185	14	14	42	42	dacarbazine	IL-2	PA449197	3558	0.573
NULL	Int_J_Mol_Sci_2014_Jun_5_15(6)_10083-10100.nxml.txt.nlp	24905407	SENT58	21	21	13	13	tetracycline	TRB	PA451640	6957	0.573
NULL	Mol_Cancer_2010_Nov_25_9_305.nxml.txt.nlp	21108789	SENT332	2	2	8	8	decitabine	p53	PA164749631	7157	0.573
NULL	Oncotarget_2013_Nov_24_4(12)_2430-2438.nxml.txt.nlp	24280348	SENT62	16	16	32	32	gefitinib	EGFR	PA131301952	1956	0.573
NULL	Crit_Care_2009_Jul_10_13(4)_R113.nxml.txt.nlp	19591694	SENT81	3	3	0	0	vasopressin	AVP	PA451858	114548;551	0.573
NULL	Eur_J_Haematol_2014_Feb_25_92(2)_127-136.nxml.txt.nlp	24118452	SENT123	19	19	15	15	anagrelide	CRT	PA164742986	811	0.572
NULL	ScientificWorldJournal_2014_Jan_30_2014_583090.nxml.txt.nlp	24672337	SENT273	1	1	18	18	emtricitabine	zeta	PA10069	9907	0.572
NULL	Biologics_2009_Jul_13_3_39-49.nxml.txt.nlp	19707394	SENT190	20	20	22	22	infliximab	CDAI	PA452639	146059	0.572
NULL	Cell_Death_Differ_2010_Mar_16_17(3)_499-512.nxml.txt.nlp	19834490	SENT110	0	0	2	2	bevacizumab	VEGFR1	PA130232992	2321	0.572
NULL	J_Cell_Biol_2008_Jul_28_182(2)_327-340.nxml.txt.nlp	18644889	SENT351	0	0	9	9	estradiol	PI3K	PA449503	5290	0.572
NULL	Cancers_(Basel)_2010_Jun_14_2(2)_1288-1311.nxml.txt.nlp	24281116	SENT357	9	9	1	1	oxygen	c-Myc	PA450744	4609	0.572
NULL	Mycobiology_2008_Mar_31_36(1)_70-73.nxml.txt.nlp	23997612	SENT79	6	6	8	8	nystatin	PDH	PA450666	54704	0.572
NULL	Clin_Ophthalmol_2014_Jun_3_8_1057-1064.nxml.txt.nlp	24940042	SENT135	4	4	6	6	bevacizumab	CST	PA130232992	9514	0.572
NULL	Open_Access_J_Urol_2010_Aug_12_2_143-154.nxml.txt.nlp	24198622	SENT65	44	44	30	30	carboplatin	CS1	PA448803	57823	0.572
NULL	Ann_Hematol_2013_Apr_15_92(4)_433-442.nxml.txt.nlp	23412562	SENT239	9	9	4	4	rituximab	CHOP	PA451261	1649	0.572
NULL	Oncol_Lett_2014_Nov_10_8(5)_2333-2339.nxml.txt.nlp	25295120	SENT143	21	21	9	9	sorafenib	ADM	PA7000	133	0.572
NULL	Curr_Oncol_2006_Feb_13(1)_14-26.nxml.txt.nlp	17576437	SENT232	0	0	9	9	curcumin	MMP9	PA151958596	4318	0.572
NULL	Clin_Ophthalmol_2014_Nov_19_8_2301-2305.nxml.txt.nlp	25429200	SENT94	24	24	8	8	bevacizumab	CRT	PA130232992	811	0.572
NULL	J_Cell_Biol_2008_Jul_14_182(1)_171-184.nxml.txt.nlp	18606850	SENT204	20	20	18	18	geldanamycin	TWEAK	PA152031327	8742	0.572
NULL	Support_Care_Cancer_2012_Nov_2_20(11)_2661-2668.nxml.txt.nlp	22382588	SENT217	14	14	10	10	paclitaxel	castor	PA450761	54897	0.572
NULL	Clin_Ophthalmol_2014_Feb_10_8_389-399.nxml.txt.nlp	24550667	SENT147	16	16	14	14	timolol	TIM	PA451690	7984;8914	0.572
NULL	Brain_Behav_2014_Jul_14_4(4)_468-483.nxml.txt.nlp	25161814	SENT98	4	4	22	22	ethanol	ANOVA	PA448073	4858	0.572
NULL	Mult_Scler_Int_2013_Jan_10_2013_231345.nxml.txt.nlp	23365753	SENT33	36	36	18	18	azathioprine	IFN	PA448515	3439	0.572
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Mar_9_67(Pt_4)_o829.nxml.txt.nlp	21754113	SENT69	17	17	12	12	ethanol	mol	PA448073	90527	0.572
NULL	Arch_Med_Sci_2013_Oct_31_9(5)_916-921.nxml.txt.nlp	24273579	SENT99	7	7	2	2	bleomycin	AQP5	PA448645	362	0.572
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT262	3	3	9	9	tacrolimus	RANKL	PA451578	8600	0.572
NULL	Int_J_Mol_Sci_2014_Oct_8_15(10)_17974-17999.nxml.txt.nlp	25299695	SENT125	2	2	10	10	curcumin	HO-2	PA151958596	3163	0.572
NULL	J_Cell_Biol_2004_Jan_5_164(1)_123-131.nxml.txt.nlp	14709545	SENT162	7	7	31	31	trypsin	F12	PA451806	2161	0.572
NULL	Cell_Cycle_2014_Feb_1_13(3)_440-452.nxml.txt.nlp	24275038	SENT195	25	25	29	29	hydrocortisone	EGF	PA449905	1950	0.572
NULL	Clin_Epigenetics_2010_Nov_9_1(3-4)_117-136.nxml.txt.nlp	21258646	SENT206	18	18	26	26	vorinostat	HR23B	PA164748224	5887	0.572
NULL	Mol_Vis_2012_Oct_5_18_2454-2467.nxml.txt.nlp	23077404	SENT206	22	22	27	27	bevacizumab	VEGF-A	PA130232992	7422	0.572
NULL	Oncol_Rep_2014_Jan_31_31(1)_41-49.nxml.txt.nlp	24172981	SENT58	29	29	14	14	l-glutamine	CO2	PA10090	4513	0.572
NULL	J_Vis_Exp_2011_Jun_24_(52)_3094.nxml.txt.nlp	21730945	SENT111	33	33	41	41	cycloserine	EMB	PA164764600	133418	0.572
NULL	Clin_Cosmet_Investig_Dermatol_2014_Sep_2_7_243-249.nxml.txt.nlp	25214798	SENT52	4	4	17	17	ustekinumab	ACR	PA166048654	49	0.572
NULL	Arthritis_Res_Ther_2005_May_18_7(Suppl_3)_S13-S18.nxml.txt.nlp	15960817	SENT92	2	2	0	0	cyclophosphamide	CTX	PA449165	1593	0.572
NULL	Iran_J_Public_Health_2012_Mar_31_41(3)_127-132.nxml.txt.nlp	23113157	SENT86	26	26	20	20	ceftizoxime	CTX	PA164748758	1593	0.572
NULL	Front_Physiol_2013_May_15_4_103.nxml.txt.nlp	23720630	SENT151	38	38	33	33	l-carnitine	Q10	PA450154	27161	0.572
NULL	Cancer_Cell_Int_2012_Jun_6_12_22.nxml.txt.nlp	22672528	SENT119	3	3	18	18	epirubicin	DR4	PA449476	8797	0.572
NULL	Int_J_Biol_Sci_2011_May_24_7(5)_673-684.nxml.txt.nlp	21647250	SENT136	0	0	3	3	berberine	AMPK	PA165860812	5563	0.572
NULL	Mol_Cancer_2008_Jan_22_7_8.nxml.txt.nlp	18211683	SENT124	8	8	4	4	cisplatin	CLDN4	PA449014	1364	0.572
NULL	Cardiovasc_Ther_2009_27(4)_259-274.nxml.txt.nlp	19604248	SENT48	48	48	46	46	ticagrelor	ADP	PA165374673	23038	0.572
NULL	Arthritis_Res_Ther_2005_Apr_28_7(4)_R844-R851.nxml.txt.nlp	15987486	SENT192	8	8	0	0	nadh	ND1	PA164755085	4535;10625	0.572
NULL	Case_Rep_Dermatol_2013_Dec_21_5(3)_379-381.nxml.txt.nlp	24516409	SENT17	9	9	5	5	ribavirin	IFN	PA451241	3439	0.572
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Sep_25_66(Pt_10)_o2642.nxml.txt.nlp	21587613	SENT71	25	25	4	4	ethanol	mol	PA448073	90527	0.572
NULL	FEBS_Open_Bio_2014_Jan_6_4_77-89.nxml.txt.nlp	24490132	SENT761	3	3	5	5	ebselen	GDH	PA161660841	51084;2746	0.572
NULL	J_Gen_Physiol_2009_Apr_133(4)_421-438.nxml.txt.nlp	19289574	SENT486	35	35	29	29	forskolin	SLC26A9	PA146096022	115019	0.572
NULL	Front_Behav_Neurosci_2014_Nov_28_8_416.nxml.txt.nlp	25506320	SENT75	2	2	0	0	chlorpromazine	CPZ	PA448964	8532	0.572
NULL	Evid_Based_Complement_Alternat_Med_2011_Jun_8_2011_950461.nxml.txt.nlp	21799696	SENT191	3	3	5	5	vasopressin	AVP	PA451858	114548;551	0.572
NULL	Nat_Commun_2013_Apr_23_4_1758.nxml.txt.nlp	23612299	SENT538	14	14	7	7	isoproterenol	SOD1	PA450121	6647	0.572
NULL	BMJ_2014_Apr_24_348_g2780.nxml.txt.nlp	24764569	SENT33	24	24	19	19	liraglutide	GLP-1	PA165958364	100125288	0.572
NULL	Cardiovasc_Diabetol_2010_Nov_16_9_76.nxml.txt.nlp	21080957	SENT3	9	9	6	6	exenatide	GLP-1	PA164749238	100125288	0.572
NULL	Mol_Cell_Endocrinol_2013_Jan_30_365(2)_303-308.nxml.txt.nlp	23178796	SENT382	4	4	9	9	lipase	AT1	PA450239	9197;185	0.572
NULL	Open_Dent_J_2011_Jan_6_5_1-6.nxml.txt.nlp	21339860	SENT133	8	8	10	10	capsaicin	TRPV1	PA448776	7442	0.572
NULL	Br_J_Pharmacol_2014_Sep_28_171(18)_4255-4272.nxml.txt.nlp	24846338	SENT50	0	0	14	14	paroxetine	gamma	PA450801	9913	0.572
NULL	Biosci_Rep_2013_Jun_27_33(3)_e00047.nxml.txt.nlp	23721518	SENT743	6	6	9	9	capsaicin	TRPV1	PA448776	7442	0.572
NULL	Ann_Oncol_2009_Aug_20(Suppl_6)_vi22-vi29.nxml.txt.nlp	19617294	SENT333	12	12	10	10	melphalan	gamma	PA450354	9913	0.572
NULL	J_Orthop_Surg_2008_Apr_17_3_14.nxml.txt.nlp	18419823	SENT65	3	3	14	14	creatine	CRP	PA164778930	1401;140913	0.572
NULL	Oxid_Med_Cell_Longev_2010_Nov-Dec_3(6)_434-441.nxml.txt.nlp	21307644	SENT169	0	0	10	10	resveratrol	CTR		799	0.572
NULL	Arthritis_Res_Ther_2012_Sep_20_14(5)_R199.nxml.txt.nlp	22995428	SENT181	15	15	31	31	collagenase	GM-CSF	PA449107	1437	0.572
NULL	Nat_Neurosci_2012_Sep_5_15(9)_1245-1254.nxml.txt.nlp	22864611	SENT485	4	4	13	13	clozapine	HDAC1	PA449061	3065	0.572
NULL	Case_Rep_Infect_Dis_2013_May_12_2013_761793.nxml.txt.nlp	23762676	SENT79	6	6	22	22	vancomycin	TMX	PA451850	81542	0.572
NULL	Asian-Australas_J_Anim_Sci_2013_Apr_26(4)_573-578.nxml.txt.nlp	25049825	SENT147	12	12	17	17	bacitracin	BP1	PA448531	1748	0.572
NULL	Exp_Anim_2014_Jul_22_63(4)_447-457.nxml.txt.nlp	25048263	SENT144	30	30	24	24	estradiol	PRL	PA449503	5617	0.572
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT61	9	9	6	6	trastuzumab	STAT3	PA451743	6774	0.572
NULL	J_Am_Heart_Assoc_2013_Dec_19_2(6)_e000441.nxml.txt.nlp	24252844	SENT300	15	15	12	12	pioglitazone	gamma	PA450970	9913	0.572
NULL	Autophagy_2012_Jul_1_8(7)_1113-1123.nxml.txt.nlp	22522825	SENT225	13	13	37	37	fluorescein	CD69	PA164746009	969	0.572
NULL	Arthritis_Res_Ther_2012_May_17_14(3)_R118.nxml.txt.nlp	22594821	SENT54	2	2	4	4	abatacept	ACPA	PA164747080	5657	0.572
NULL	Infect_Drug_Resist_2011_Mar_2_4_77-86.nxml.txt.nlp	21694911	SENT94	5	5	13	13	tigecycline	CABP	PA164746412	6277	0.572
NULL	Breast_Cancer_Res_2008_Dec_4_10(6)_R103.nxml.txt.nlp	19055788	SENT72	20	20	18	18	tamoxifen	CDH1	PA451581	51343;999	0.572
NULL	Eur_J_Immunol_2013_Apr_11_43(5)_1153-1161.nxml.txt.nlp	23400868	SENT170	16	16	11	11	chloroquine	MARCH8	PA448948	220972	0.572
NULL	Front_Neurosci_2011_Oct_10_5_109.nxml.txt.nlp	22013406	SENT1183	0	0	7	7	olanzapine	DRD4	PA450688	1815	0.572
NULL	Cancer_Causes_Control_2013_Aug_18_24(8)_1605-1614.nxml.txt.nlp	23775025	SENT64	38	38	18	18	epirubicin	CYP3A5	PA449476	1577	0.572
NULL	Virol_J_2010_Nov_25_7_343.nxml.txt.nlp	21108831	SENT124	16	16	4	4	paraformaldehyde	CD4	PA450790	920	0.572
NULL	ISRN_Oxidative_Med_2013_2013_831596.nxml.txt.nlp	25506596	SENT42	6	6	10	10	hemin	TLR4	PA449849	7099	0.572
NULL	Reprod_Biol_Endocrinol_2003_Oct_3_1_62.nxml.txt.nlp	14567758	SENT172	28	28	41	41	lindane	ANOVA	PA164754914	4858	0.572
NULL	Curr_Med_Chem_2013_Jun_20(19)_2415-2437.nxml.txt.nlp	23394552	SENT735	14	14	5	5	naproxen	OTC	PA450595	5009	0.572
NULL	Diabetes_2014_Jan_13_63(1)_89-100.nxml.txt.nlp	24062247	SENT285	19	19	11	11	doxorubicin	RLIP76	PA449412	10928	0.572
NULL	Mol_Biol_Cell_2013_Sep_1_24(17)_2678-2688.nxml.txt.nlp	23864716	SENT259	15	15	26	26	thrombin	GEF	PA451674	56731	0.572
NULL	EJNMMI_Res_2011_Aug_17_1_15.nxml.txt.nlp	22214307	SENT240	37	37	26	26	trastuzumab	HER2	PA451743	2064	0.572
NULL	Ther_Clin_Risk_Manag_2006_Mar_2(1)_87-98.nxml.txt.nlp	18360584	SENT107	2	2	13	13	sorafenib	VEGFR2	PA7000	3791	0.572
NULL	Evid_Based_Complement_Alternat_Med_2015_Jan_6_2015_736431.nxml.txt.nlp	25632290	SENT120	4	4	12	12	curcumin	P-gp	PA151958596	5243	0.572
NULL	Acta_Pharmacol_Sin_2009_Sep_24_30(9)_1262-1275.nxml.txt.nlp	19701231	SENT226	20	20	25	25	lovastatin	PIGB	PA450272	9488	0.572
NULL	Br_J_Cancer_2012_Oct_9_107(8)_1399-1408.nxml.txt.nlp	22976800	SENT11	0	0	39	39	temozolomide	MLH1	PA451609	4292	0.572
NULL	Br_J_Cancer_2010_Feb_16_102(4)_658-664.nxml.txt.nlp	20104222	SENT200	4	4	6	6	sunitinib	IFN	PA162372840	3439	0.572
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1449-1456.nxml.txt.nlp	24077631	SENT83	23	23	10	10	tolbutamide	CYP2C9	PA451718	1559	0.572
NULL	Oncol_Rep_2014_Jun_9_31(6)_2482-2492.nxml.txt.nlp	24718854	SENT29	0	0	2	2	gemcitabine	GEM	PA449748	2669	0.572
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT282	5	5	7	7	chloroquine	BMP9	PA448948	2658	0.572
NULL	J_Hematol_Oncol_2012_Jun_28_5_34.nxml.txt.nlp	22742411	SENT348	20	20	14	14	ganciclovir	IFN	PA449733	3439	0.572
NULL	Oncotarget_2011_Mar_27_2(3)_209-221.nxml.txt.nlp	21444945	SENT158	12	12	22	22	bortezomib	p53	PA10252	7157	0.572
NULL	Mol_Biol_Cell_2012_Mar_15_23(6)_996-1009.nxml.txt.nlp	22278744	SENT13	4	4	22	22	forskolin	COP1	PA146096022	64326;114769	0.572
NULL	Sensors_(Basel)_2010_May_4_10(5)_4558-4576.nxml.txt.nlp	22399892	SENT68	7	7	0	0	nadh	GDH	PA164755085	51084;2746	0.572
NULL	Ann_Hematol_2014_Mar_18_93(8)_1335-1344.nxml.txt.nlp	24638841	SENT84	30	30	39	39	fludarabine	CLB	PA449655	171425	0.572
NULL	Case_Rep_Oncol_2014_Jul_5_7(2)_435-443.nxml.txt.nlp	25126073	SENT153	13	13	11	11	gemcitabine	Gem	PA449748	51053	0.572
NULL	Braz_J_Med_Biol_Res_2011_Nov_25_45(1)_58-67.nxml.txt.nlp	22124704	SENT130	19	19	39	39	staurosporine	ANOVA	PA165109623	4858	0.572
NULL	Curr_Microbiol_2012_Dec_28_65(6)_673-678.nxml.txt.nlp	22926720	SENT75	10	10	21	21	imipenem	TMP	PA449968	2012	0.572
NULL	J_Inflamm_(Lond)_2007_May_4_4_10.nxml.txt.nlp	17480224	SENT323	6	6	34	34	ketamine	IL-4	PA450144	3565	0.572
NULL	AIDS_Res_Ther_2008_Oct_28_5_24.nxml.txt.nlp	18957095	SENT135	5	5	13	13	nevirapine	CD4	PA450616	920	0.572
NULL	Breast_Cancer_Res_2012_Jun_7_14(3)_R89.nxml.txt.nlp	22676470	SENT86	23	23	31	31	trastuzumab	EGF	PA451743	1950	0.572
NULL	Br_J_Cancer_2009_Jun_2_100(11)_1697-1703.nxml.txt.nlp	19384299	SENT58	0	0	4	4	cyclophosphamide	CD25	PA449165	3669;3559	0.572
NULL	Environ_Health_Perspect_2010_Jan_10_118(1)_108-115.nxml.txt.nlp	20056578	SENT130	0	0	2	2	arsenite	PTEN	PA452638	5728	0.572
NULL	Clin_Mol_Hepatol_2014_Sep_25_20(3)_283-290.nxml.txt.nlp	25320732	SENT141	2	2	0	0	propranolol	PPN	PA451145	64840	0.572
NULL	Iran_J_Basic_Med_Sci_2012_Jan-Feb_15(1)_678-682.nxml.txt.nlp	23493931	SENT58	14	14	16	16	cefotaxime	CTX	PA448852	1593	0.572
NULL	Cancer_Res_Treat_2014_Jan_15_46(1)_55-64.nxml.txt.nlp	24520224	SENT6	23	23	6	6	oxaliplatin	ERCC1	PA131285527	2067	0.572
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_16_2014_926087.nxml.txt.nlp	25478000	SENT153	1	1	10	10	atorvastatin	PCSK9	PA448500	255738	0.572
NULL	Environ_Health_Perspect_2010_Sep_21_118(9)_1286-1291.nxml.txt.nlp	20494855	SENT22	23	23	32	32	estradiol	SHBG	PA449503	6462	0.572
NULL	Biomed_Res_Int_2014_Jan_19_2014_215872.nxml.txt.nlp	24575401	SENT85	43	43	35	35	artemisinin	TC2	PA165111696	6948	0.572
NULL	Ther_Clin_Risk_Manag_2006_Dec_2(4)_435-445.nxml.txt.nlp	18360654	SENT99	0	0	10	10	erlotinib	CYP3A4	PA134687924	1576	0.572
NULL	Int_J_Environ_Res_Public_Health_2011_Jul_14_8(7)_2876-2894.nxml.txt.nlp	21845163	SENT206	2	2	5	5	ethanol	TTF-1	PA448073	7080	0.572
NULL	J_Biomed_Biotechnol_2010_Sep_14_2010_326020.nxml.txt.nlp	20936132	SENT46	15	15	6	6	tetracycline	DHFR	PA451640	1719	0.572
NULL	Oncol_Lett_2014_Jan_6_7(1)_87-94.nxml.txt.nlp	24348827	SENT124	8	8	11	11	thrombin	ADP	PA451674	23038	0.572
NULL	J_Venom_Res_2011_Dec_28_2_59-67.nxml.txt.nlp	22331993	SENT29	14	14	12	12	thrombin	ADP	PA451674	23038	0.572
NULL	J_Cell_Biol_2008_Jul_14_182(1)_197-213.nxml.txt.nlp	18625847	SENT9	16	16	2	2	nutlin-3	p53		7157	0.572
NULL	Inflamm_Res_2014_Nov_5_63(2)_99-103.nxml.txt.nlp	24189710	SENT113	6	6	17	17	cyclosporine	CD25	PA449167	3669;3559	0.572
NULL	Clin_Mol_Hepatol_2014_Sep_25_20(3)_283-290.nxml.txt.nlp	25320732	SENT138	2	2	0	0	propranolol	PPN	PA451145	64840	0.572
NULL	J_Biol_Chem_2009_Nov_27_284(48)_33130-33138.nxml.txt.nlp	19801632	SENT41	27	27	38	38	coumarin	ADP	PA134521193	23038	0.572
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT275	11	11	5	5	resveratrol	TRAIL		8743	0.572
NULL	Nat_Commun_2013_Nov_28_4_2852.nxml.txt.nlp	24284943	SENT281	33	33	11	11	paraformaldehyde	mol	PA450790	90527	0.572
NULL	Ann_Indian_Acad_Neurol_2008_Jan-Mar_11(1)_13-19.nxml.txt.nlp	19966973	SENT55	13	13	7	7	curcumin	C21	PA151958596	79718	0.572
NULL	Allergy_Asthma_Immunol_Res_2014_Nov_28_6(6)_567-572.nxml.txt.nlp	25374757	SENT80	7	7	3	3	ranitidine	IL-6	PA451224	3569	0.572
NULL	Br_J_Cancer_2012_Oct_23_107(9)_1474-1480.nxml.txt.nlp	23033004	SENT36	0	0	8	8	docetaxel	DPD	PA449383	1806	0.572
NULL	Breast_Cancer_Res_2012_Jun_12_14(3)_R92.nxml.txt.nlp	22691413	SENT219	18	18	9	9	estradiol	HSD1	PA449503	26871	0.572
NULL	Arthritis_Res_Ther_2012_Jun_25_14(3)_215.nxml.txt.nlp	22731694	SENT99	16	16	6	6	rituximab	IFN	PA451261	3439	0.572
NULL	Indian_J_Endocrinol_Metab_2012_Jan-Feb_16(1)_33-43.nxml.txt.nlp	22276251	SENT143	7	7	10	10	rosiglitazone	DREAM	PA451283	30818	0.572
NULL	Basic_Clin_Neurosci_2013_Autumn_4(4)_323-328.nxml.txt.nlp	25337364	SENT96	4	4	9	9	colchicine	CA1	PA449092	759	0.572
NULL	J_Int_Soc_Sports_Nutr_2012_Dec_21_9_56.nxml.txt.nlp	23259853	SENT125	9	9	22	22	creatine	COT	PA164778930	54677	0.572
NULL	Oncotarget_2014_Aug_14_5(16)_6552-6553.nxml.txt.nlp	25138048	SENT24	23	23	2	2	doxorubicin	STAT6	PA449412	6778	0.572
NULL	Cell_Commun_Signal_2013_Oct_1_11_73.nxml.txt.nlp	24083678	SENT215	0	0	32	32	sulindac	c-Jun	PA451565	3725	0.572
NULL	Br_J_Cancer_2011_Jan_4_104(1)_91-100.nxml.txt.nlp	21139584	SENT201	12	12	24	24	bortezomib	c-Raf	PA10252	5894	0.572
NULL	J_Psychopharmacol_2010_Nov_24(4_supplement)_91-118.nxml.txt.nlp	18801830	SENT621	16	16	19	19	haloperidol	ACTH	PA449841	5443	0.572
NULL	Br_J_Cancer_2004_Mar_5_90(Suppl_1)_S7-S10.nxml.txt.nlp	15094758	SENT88	9	9	17	17	ketoconazole	CYP3A4	PA450146	1576	0.572
NULL	Biol_Cell_2011_Nov_1_103(Pt_11)_499-517.nxml.txt.nlp	21787361	SENT227	7	7	4	4	lipase	MGLL	PA450239	11343	0.572
NULL	Cancer_Med_2014_Dec_11_3(6)_1502-1511.nxml.txt.nlp	25111859	SENT25	16	16	6	6	oxaliplatin	BTC	PA131285527	685	0.572
NULL	Angiogenesis_2011_Mar_4_14(1)_17-27.nxml.txt.nlp	21049284	SENT141	23	23	16	16	thrombin	CD34	PA451674	947	0.572
NULL	Br_J_Cancer_2009_Jul_21_101(2)_238-243.nxml.txt.nlp	19568242	SENT74	9	9	11	11	sunitinib	IFN	PA162372840	3439	0.572
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT48	38	38	10	10	metformin	PI3K	PA450395	5290	0.572
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT2379	2	2	0	0	phenacetin	CYP1A2	PA450897	1544	0.572
NULL	Curr_Neuropharmacol_2013_Dec_11(6)_652-663.nxml.txt.nlp	24396340	SENT565	6	6	13	13	propofol	TRPA1	PA451141	8989	0.572
NULL	Acta_Neuropathol_2015_Oct_17_129_81-96.nxml.txt.nlp	25322817	SENT114	1	1	4	4	capsaicin	TRPV1	PA448776	7442	0.572
NULL	Part_Fibre_Toxicol_2011_Jan_25_8_5.nxml.txt.nlp	21266073	SENT215	0	0	11	11	copper	BAL	PA449114	83666	0.572
NULL	Onco_Targets_Ther_2014_Jul_31_7_1367-1373.nxml.txt.nlp	25114575	SENT39	7	7	9	9	lapatinib	HER2	PA152241907	2064	0.572
NULL	JSLS_2005_Jul-Sep_9(3)_316-321.nxml.txt.nlp	16121879	SENT34	14	14	12	12	sevoflurane	CO2	PA451341	4513	0.572
NULL	Cardiovasc_Diabetol_2005_Oct_5_4_16.nxml.txt.nlp	16207378	SENT103	27	27	33	33	glucosamine	perlecan	PA164747613	3339	0.572
NULL	Contemp_Clin_Dent_2011_Oct-Dec_2(4)_278-282.nxml.txt.nlp	22346152	SENT74	8	8	5	5	potassium	GCF	PA451047	6936	0.572
NULL	Extremophiles_2009_Sep_5_13(5)_769-783.nxml.txt.nlp	19579003	SENT391	35	35	17	17	lipase	Gen	PA450239	348654	0.572
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT10	1	1	12	12	glucose	EGFR	PA449773	1956	0.572
NULL	Cancers_(Basel)_2014_May_9_6(2)_1128-1137.nxml.txt.nlp	24821131	SENT105	26	26	39	39	pazopanib	CD56	PA165291492	4684	0.572
NULL	Breast_Cancer_Res_2010_Nov_16_12(6)_R96.nxml.txt.nlp	21080941	SENT149	45	45	41	41	lapatinib	HRG	PA152241907	3084;3273	0.572
NULL	Acta_Pharmacol_Sin_2014_Jun_4_35(6)_792-805.nxml.txt.nlp	24902787	SENT337	2	2	24	24	paroxetine	INS-1	PA450801	2305	0.572
NULL	Acta_Orthop_2014_Apr_20_85(2)_141-146.nxml.txt.nlp	24650022	SENT4	13	13	19	19	ropivacaine	PAO	PA451271	196743;54498	0.572
NULL	J_Clin_Biochem_Nutr_2010_Sep_3_47(2)_138-147.nxml.txt.nlp	20838569	SENT363	29	29	12	12	loxoprofen	COX	PA166049180	1351	0.571
NULL	Front_Oncol_2014_May_30_4_128.nxml.txt.nlp	24910845	SENT134	8	8	20	20	glibenclamide	TRAIL	PA449782	8743	0.571
NULL	J_Exp_Med_1996_Dec_1_184(6)_2433-2438.nxml.txt.nlp	8976200	SENT88	3	3	10	10	trypsin	CD4	PA451806	920	0.571
NULL	Asia_Pac_Allergy_2014_Jul_29_4(3)_156-163.nxml.txt.nlp	25097851	SENT16	7	7	19	19	isoniazid	EMB	PA450112	133418	0.571
NULL	Mar_Drugs_2014_Jun_27_12(7)_3818-3837.nxml.txt.nlp	24979269	SENT149	12	12	35	35	calcein	MRP1	PA132595336	4437	0.571
NULL	Nat_Chem_Biol_2010_Apr_28_6(4)_291-299.nxml.txt.nlp	20190765	SENT119	17	17	27	27	dasatinib	S5B	PA162372878	5711	0.571
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT28	9	9	20	20	gefitinib	KRAS	PA131301952	3845	0.571
NULL	Lipids_Health_Dis_2011_Feb_28_10_38.nxml.txt.nlp	21352602	SENT109	15	15	18	18	ezetimibe	PCSK9	PA10816	255738	0.571
NULL	Adv_Ther_2014_Dec_2_31_1228-1246.nxml.txt.nlp	25447269	SENT64	20	20	24	24	timolol	TIM	PA451690	7984;8914	0.571
NULL	J_Antimicrob_Chemother_2013_Jul_14_68(7)_1551-1557.nxml.txt.nlp	23493314	SENT85	2	2	0	0	chlorpromazine	CPZ	PA448964	8532	0.571
NULL	Emerg_Microbes_Infect_2013_Nov_20_2(11)_e79.nxml.txt.nlp	NULL	SENT14	18	18	15	15	ribavirin	IFN	PA451241	3439	0.571
NULL	Ann_Surg_Treat_Res_2014_Feb_22_86(2)_55-60.nxml.txt.nlp	24761409	SENT103	24	24	27	27	thyroglobulin	CTX	PA164754910	1593	0.571
NULL	Int_J_Endocrinol_2013_Sep_5_2013_895102.nxml.txt.nlp	24089613	SENT21	11	11	24	24	sitagliptin	GLP-1	PA164748978	100125288	0.571
NULL	Ann_Biomed_Eng_2011_Jan_30_39(1)_1-13.nxml.txt.nlp	20676773	SENT181	6	6	11	11	heparin	PLG	PA449855	5340	0.571
NULL	J_Antimicrob_Chemother_2011_Feb_9_66(2)_363-370.nxml.txt.nlp	21148235	SENT126	2	2	0	0	atazanavir	ATV	PA10251	4683	0.571
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT5	7	7	13	13	tamoxifen	p27	PA451581	5715;10534	0.571
NULL	J_Cell_Biol_1998_Apr_20_141(2)_539-551.nxml.txt.nlp	9548730	SENT67	41	41	32	32	hydrocortisone	EGF	PA449905	1950	0.571
NULL	Infect_Dis_Obstet_Gynecol_2012_Mar_15_2012_950650.nxml.txt.nlp	22496602	SENT98	6	6	17	17	isoniazid	IPT	PA450112	54802	0.571
NULL	Oxid_Med_Cell_Longev_2012_Jun_3_2012_914273.nxml.txt.nlp	22701758	SENT151	3	3	14	14	resveratrol	IL-10		3586	0.571
NULL	Diabetes_Care_2012_Feb_16_35(2)_327-333.nxml.txt.nlp	22179958	SENT93	2	2	16	16	metformin	B12	PA450395	7126;4709	0.571
NULL	Oncogene_2014_Apr_24_33(17)_2215-2224.nxml.txt.nlp	23708665	SENT220	25	25	21	21	estradiol	PRL	PA449503	5617	0.571
NULL	Eur_J_Med_Res_2014_Jun_24_19(1)_34.nxml.txt.nlp	24961604	SENT103	26	26	30	30	vincristine	BCL11A	PA451879	53335	0.571
NULL	Cancer_Med_2013_Feb_3_2(1)_11-20.nxml.txt.nlp	24133623	SENT291	0	0	24	24	cetuximab	KRAS	PA10040	3845	0.571
NULL	Oncotarget_2014_Nov_6_5(22)_11038-11053.nxml.txt.nlp	25402820	SENT9	13	13	31	31	gemcitabine	FACT	PA449748	11198	0.571
NULL	Mol_Cancer_2014_Jan_13_13_7.nxml.txt.nlp	24418169	SENT164	21	21	6	6	sorafenib	STAT3	PA7000	6774	0.571
NULL	EPMA_J_2011_Mar_10_2(1)_27-38.nxml.txt.nlp	21654904	SENT169	38	38	43	43	darapladib	IL-6	PA165884699	3569	0.571
NULL	Cardiovasc_Res_2011_Feb_15_89(3)_560-565.nxml.txt.nlp	20889759	SENT114	28	28	23	23	raloxifene	ANOVA	PA451221	4858	0.571
NULL	Clin_Ophthalmol_2014_Feb_10_8_389-399.nxml.txt.nlp	24550667	SENT4	23	23	27	27	timolol	TIM	PA451690	7984;8914	0.571
NULL	Case_Rep_Neurol_2013_Mar_25_5(1)_56-61.nxml.txt.nlp	23626566	SENT24	21	21	26	26	thrombin	BCS	PA451674	617	0.571
NULL	Ecancermedicalscience_2009_Apr_9_3_104.nxml.txt.nlp	22275993	SENT35	20	20	7	7	cyclophosphamide	B18	PA449165	59271;4713	0.571
NULL	Arthritis_Res_Ther_2009_Dec_11_11(6)_R187.nxml.txt.nlp	20003323	SENT232	16	16	4	4	denosumab	RANKL	PA166048634	8600	0.571
NULL	Genome_Biol_2005_Jul_29_6(8)_228.nxml.txt.nlp	16086858	SENT40	2	2	0	0	daunorubicin	CBR1	PA449212	873	0.571
NULL	Eur_J_Haematol_2014_Feb_25_92(2)_127-136.nxml.txt.nlp	24118452	SENT121	2	2	4	4	anagrelide	CRT	PA164742986	811	0.571
NULL	EMBO_Mol_Med_2012_Oct_30_4(10)_1087-1096.nxml.txt.nlp	22933245	SENT5	27	27	20	20	olaparib	NAMPT		10135	0.571
NULL	Pharmaceuticals_(Basel)_2014_Jan_9_7(1)_46-57.nxml.txt.nlp	24451403	SENT156	2	2	10	10	ritonavir	AKT	PA451260	207	0.571
NULL	Endocrinology_2012_Dec_15_153(12)_5961-5971.nxml.txt.nlp	23070543	SENT368	24	24	5	5	phenylephrine	p38	PA450935	10598;1432;7965	0.571
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_13_2014_478653.nxml.txt.nlp	25477992	SENT192	0	0	17	17	gemcitabine	IFN	PA449748	3439	0.571
NULL	J_Korean_Neurosurg_Soc_2013_Oct_31_54(4)_302-308.nxml.txt.nlp	24294453	SENT56	29	29	31	31	acetazolamide	ACZ	PA448018	27445	0.571
NULL	Allergy_Asthma_Immunol_Res_2014_Nov_19_6(6)_548-557.nxml.txt.nlp	25374755	SENT117	9	9	12	12	lovastatin	IL-4	PA450272	3565	0.571
NULL	Nat_Commun_2014_Nov_25_5_5548.nxml.txt.nlp	25420520	SENT39	8	8	1	1	cabazitaxel	ERG	PA165958401	2078	0.571
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT8	19	19	17	17	nutlin-3	p53		7157	0.571
NULL	Glycobiology_2014_Dec_15_24(12)_1291-1300.nxml.txt.nlp	25028392	SENT51	14	14	5	5	guanidine	mincle	PA164781028	26253	0.571
NULL	Breast_Cancer_Res_2003_Mar_14_5(3)_R77-R81.nxml.txt.nlp	12793904	SENT109	30	30	0	0	urokinase	JNK	PA451836	5599	0.571
NULL	Cancer_Med_2014_Oct_2_3(5)_1246-1255.nxml.txt.nlp	24890221	SENT123	12	12	10	10	fluorescein	LAT1	PA164746009	8140;27040	0.571
NULL	Mol_Brain_2013_May_4_6_22.nxml.txt.nlp	23641686	SENT265	26	26	30	30	forskolin	CNTF	PA146096022	1270	0.571
NULL	Leukemia_2014_Jun_25_28(6)_1280-1288.nxml.txt.nlp	24270737	SENT121	7	7	12	12	decitabine	PD-L1	PA164749631	29126	0.571
NULL	J_Mol_Signal_2013_Apr_23_8_5.nxml.txt.nlp	23618372	SENT72	27	27	20	20	taurine	TAUT	PA451590	6533	0.571
NULL	Cell_J_2014_May_25_Summer_16(2)_163-170.nxml.txt.nlp	24567946	SENT106	24	24	16	16	naloxone	OAT	PA450586	4942	0.571
NULL	Br_J_Cancer_2011_May_10_104(10)_1564-1574.nxml.txt.nlp	21487404	SENT59	0	0	13	13	disulfiram	NAC	PA449376	22861	0.571
NULL	BMB_Rep_2013_Aug_46(8)_410-415.nxml.txt.nlp	23977989	SENT201	1	1	22	22	curcumin	NFkappaB	PA151958596	4790	0.571
NULL	Asia_Pac_Allergy_2013_Oct_31_3(4)_231-240.nxml.txt.nlp	24260728	SENT30	22	22	7	7	theophylline	CYP1A2	PA451647	1544	0.571
NULL	Clin_Med_Insights_Oncol_2011_Sep_21_5_315-323.nxml.txt.nlp	22084620	SENT31	15	15	17	17	gemcitabine	IFN	PA449748	3439	0.571
NULL	J_Res_Med_Sci_2010_Nov-Dec_15(6)_331-343.nxml.txt.nlp	21526106	SENT26	3	3	1	1	l-arginine	HDEL	PA448478	10945	0.571
NULL	Osong_Public_Health_Res_Perspect_2014_Dec_13_5(6)_333-338.nxml.txt.nlp	25562041	SENT207	6	6	8	8	cefotetan	CTX	PA164784033	1593	0.571
NULL	ACS_Nano_2011_Mar_22_5(3)_1877-1887.nxml.txt.nlp	21322531	SENT314	2	2	4	4	doxorubicin	Bcl-2	PA449412	596	0.571
NULL	J_Gen_Physiol_2013_Jan_141(1)_29-60.nxml.txt.nlp	23250867	SENT1067	10	10	13	13	capsaicin	TRPV1	PA448776	7442	0.571
NULL	Adv_Biomed_Res_2014_Nov_29_3_232.nxml.txt.nlp	25538918	SENT32	5	5	21	21	ketamine	ACL	PA450144	47	0.571
NULL	Behav_Brain_Funct_2014_Feb_13_10_5.nxml.txt.nlp	24524628	SENT16	10	10	14	14	capsaicin	TRPV1	PA448776	7442	0.571
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_May_21_3(5)_e115.nxml.txt.nlp	24850445	SENT221	10	10	20	20	paclitaxel	HER-2	PA450761	2064	0.571
NULL	Cell_Microbiol_2014_Feb_21_16(2)_269-279.nxml.txt.nlp	24112286	SENT203	32	32	44	44	l-glutamine	TBL3	PA10090	10607	0.571
NULL	Apoptosis_2014_Aug_26_19(11)_1603-1615.nxml.txt.nlp	25156145	SENT3	7	7	0	0	mitomycin	TRAIL	PA450524	8743	0.571
NULL	Int_J_Inflam_2011_Sep_20_2011_367284.nxml.txt.nlp	21941675	SENT357	6	6	41	41	pravastatin	IL-6	PA451089	3569	0.571
NULL	Oncoimmunology_2013_Jan_1_2(1)_e23033.nxml.txt.nlp	23483678	SENT66	30	30	40	40	vinblastine	IFN	PA451877	3439	0.571
NULL	Diabetes_Care_2013_Jan_11_36(1)_e13.nxml.txt.nlp	23264296	SENT7	5	5	2	2	vildagliptin	GLP-1	PA165958346	100125288	0.571
NULL	Braz_J_Med_Biol_Res_2014_Oct_10_48(1)_6-12.nxml.txt.nlp	25493377	SENT84	18	18	13	13	vincristine	CHOP	PA451879	1649	0.571
NULL	Front_Neurosci_2014_Feb_14_8_23.nxml.txt.nlp	24592205	SENT271	7	7	10	10	capsaicin	VR1	PA448776	56664	0.571
NULL	Breast_Cancer_(Auckl)_2009_Apr_7_3_23-34.nxml.txt.nlp	21556247	SENT217	17	17	11	11	doxorubicin	NF-kappaB	PA449412	4790	0.571
NULL	Biomed_Res_Int_2013_Jun_5_2013_348167.nxml.txt.nlp	23862143	SENT157	8	8	4	4	bevacizumab	NAC	PA130232992	22861	0.571
NULL	Eur_J_Haematol_2014_Feb_25_92(2)_127-136.nxml.txt.nlp	24118452	SENT192	11	11	29	29	anagrelide	CRT	PA164742986	811	0.571
NULL	Mol_Cancer_2010_Nov_23_9_300.nxml.txt.nlp	21092249	SENT30	23	23	0	0	tamoxifen	IL-6	PA451581	3569	0.571
NULL	Hum_Genomics_2009_Jan_1_3(2)_157-168.nxml.txt.nlp	19164092	SENT23	18	18	1	1	lipase	LIPE	PA450239	3991	0.571
NULL	Case_Rep_Surg_2011_Oct_29_2011_371082.nxml.txt.nlp	22606576	SENT98	14	14	33	33	creatine	p53	PA164778930	7157	0.571
NULL	CNS_Drugs_2014_Jul_20_28(11)_1059-1069.nxml.txt.nlp	25038977	SENT131	9	9	0	0	lisdexamfetamine	ATX	PA164748975	5168;23049	0.571
NULL	Int_J_Emerg_Med_2010_May_12_3(2)_133-134.nxml.txt.nlp	20606823	SENT18	15	15	9	9	atropine	PAM	PA448505	5066;23077	0.571
NULL	Cancer_Inform_2014_Oct_14_13(Suppl_1)_103-111.nxml.txt.nlp	25392688	SENT213	7	7	15	15	curcumin	FADD	PA151958596	8772	0.571
NULL	Inflammation_2014_Apr_6_37(5)_1476-1485.nxml.txt.nlp	24706026	SENT168	36	36	26	26	curcumin	GATA3	PA151958596	2625	0.571
NULL	Drugs_Context_2013_Sep_13_2013_212260.nxml.txt.nlp	24432046	SENT303	9	9	7	7	atomoxetine	ATX	PA134688071	5168;23049	0.571
NULL	Eur_J_Clin_Microbiol_Infect_Dis_2012_Apr_30_31(4)_379-388.nxml.txt.nlp	21805196	SENT315	10	10	8	8	rosiglitazone	gamma	PA451283	9913	0.571
NULL	ScientificWorldJournal_2013_Oct_1_2013_265234.nxml.txt.nlp	24235880	SENT43	20	20	37	37	doxazosin	c-FLIP	PA449407	8837	0.571
NULL	Nat_Med_2014_Jul_22_20(7)_748-753.nxml.txt.nlp	24952648	SENT174	28	28	38	38	l-glutamine	CO2	PA10090	4513	0.571
NULL	Arthritis_Res_Ther_2009_Jan_26_11(1)_R12.nxml.txt.nlp	19171052	SENT323	10	10	12	12	dipyridamole	POMC	PA449367	5443	0.571
NULL	F1000_Med_Rep_2010_Apr_27_2_29.nxml.txt.nlp	20948857	SENT44	10	10	20	20	paclitaxel	HER-2	PA450761	2064	0.571
NULL	Anticancer_Agents_Med_Chem_2013_Jun_13(5)_681-688.nxml.txt.nlp	23092289	SENT223	13	13	17	17	rituximab	CD55	PA451261	1604	0.571
NULL	Br_J_Cancer_2012_Jan_17_106(2)_274-278.nxml.txt.nlp	22215062	SENT23	0	0	7	7	cetuximab	EGFR	PA10040	1956	0.571
NULL	Indian_J_Med_Res_2011_Sep_134(3)_295-301.nxml.txt.nlp	21985811	SENT109	14	14	17	17	phenytoin	CYP2C19	PA450947	1557	0.571
NULL	An_Bras_Dermatol_2013_Sep-Oct_88(5)_844-846.nxml.txt.nlp	24173202	SENT8	44	44	31	31	imiquimod	por	PA449972	64840	0.571
NULL	Exp_Diabetes_Res_2012_Sep_20_2012_936518.nxml.txt.nlp	23049542	SENT199	3	3	11	11	glucose	HCD	PA449773	1732	0.571
NULL	J_Antimicrob_Chemother_2013_Jul_14_68(7)_1551-1557.nxml.txt.nlp	23493314	SENT91	2	2	0	0	chlorpromazine	CPZ	PA448964	8532	0.571
NULL	Cancer_Med_2013_Apr_24_2(2)_185-195.nxml.txt.nlp	23634286	SENT317	12	12	0	0	bevacizumab	MRI	PA130232992	78996	0.571
NULL	Nucleic_Acids_Res_2012_Jul_6_40(13)_6070-6081.nxml.txt.nlp	22492624	SENT64	8	8	17	17	guanidine	UNG	PA164781028	7374	0.571
NULL	Ann_Surg_Treat_Res_2014_Feb_22_86(2)_55-60.nxml.txt.nlp	24761409	SENT99	24	24	27	27	thyroglobulin	CTX	PA164754910	1593	0.571
NULL	Breast_Cancer_(Auckl)_2011_Jul_27_5_175-199.nxml.txt.nlp	21863131	SENT218	12	12	38	38	everolimus	HER-2	PA164746311	2064	0.571
NULL	Front_Oncol_2013_Nov_15_3_281.nxml.txt.nlp	24298448	SENT85	33	33	22	22	leucovorin	KRAS	PA450198	3845	0.571
NULL	Clin_Mol_Hepatol_2014_Jun_30_20(2)_168-176.nxml.txt.nlp	25032183	SENT162	2	2	0	0	lamivudine	LAM	PA450163	7249;7248	0.571
NULL	Evid_Based_Complement_Alternat_Med_2011_Jan_20_2011_713523.nxml.txt.nlp	21318104	SENT61	31	31	8	8	naproxen	SRM	PA450595	6723;6725	0.571
NULL	Arthritis_Res_Ther_2010_Apr_1_12(2)_R60.nxml.txt.nlp	20359365	SENT178	6	6	9	9	bleomycin	BLM	PA448645	641	0.571
NULL	ScientificWorldJournal_2012_Apr_24_2012_194848.nxml.txt.nlp	22619624	SENT99	9	9	20	20	tretinoin	DES	PA451746	1674	0.571
NULL	Diabetes_Care_2013_Aug_17_36(Suppl_2)_S245-S252.nxml.txt.nlp	23882053	SENT204	42	42	7	7	liraglutide	GLP-1	PA165958364	100125288	0.571
NULL	Oncotarget_2013_Jun_26_4(7)_1008-1018.nxml.txt.nlp	23900284	SENT156	4	4	27	27	bortezomib	SLAMF7	PA10252	57823	0.571
NULL	Ann_Surg_Treat_Res_2014_Feb_22_86(2)_68-75.nxml.txt.nlp	24761411	SENT173	9	9	16	16	oxaliplatin	survivin	PA131285527	332	0.571
NULL	Arthritis_Res_Ther_2010_Jul_7_12(4)_R131.nxml.txt.nlp	20609215	SENT213	28	28	17	17	iloprost	TLR3	PA164746843	7098	0.571
NULL	Eur_J_Clin_Microbiol_Infect_Dis_2010_May_13_29(5)_543-550.nxml.txt.nlp	20229224	SENT73	41	41	7	7	teicoplanin	PEN	PA164746244	9933	0.571
NULL	J_Neuroinflammation_2010_Sep_7_7_51.nxml.txt.nlp	20822529	SENT187	6	6	3	3	hemin	p38	PA449849	10598;1432;7965	0.571
NULL	J_Immunol_Res_2014_Nov_30_2014_342693.nxml.txt.nlp	25762441	SENT142	2	2	7	7	valsartan	IL-6	PA451848	3569	0.571
NULL	Diabetes_Metab_J_2013_Oct_17_37(5)_301-314.nxml.txt.nlp	24199158	SENT90	6	6	10	10	simvastatin	PDK2	PA451363	5164	0.571
NULL	Front_Neuroenergetics_2010_May_21_2_5.nxml.txt.nlp	20725515	SENT350	2	2	15	15	potassium	PKG	PA451047	5592	0.571
NULL	Cardiovasc_Diabetol_2010_Mar_23_9_11.nxml.txt.nlp	20331890	SENT119	12	12	17	17	pravastatin	IL-18	PA451089	3606	0.571
NULL	J_Biol_Chem_2008_Oct_24_283(43)_29292-29300.nxml.txt.nlp	18687689	SENT105	30	30	34	34	cyclosporine	ADP	PA449167	23038	0.571
NULL	Case_Rep_Oncol_2011_Dec_7_4(3)_583-586.nxml.txt.nlp	22220154	SENT60	6	6	8	8	sunitinib	IFN	PA162372840	3439	0.571
NULL	Cardiovasc_Res_2011_Feb_15_89(3)_560-565.nxml.txt.nlp	20889759	SENT114	28	28	47	47	raloxifene	ANOVA	PA451221	4858	0.571
NULL	Adv_Pharmacol_Sci_2013_Apr_11_2013_692613.nxml.txt.nlp	23662099	SENT75	20	20	7	7	chloramphenicol	KAL	PA448927	5267	0.571
NULL	Cardiovasc_Diabetol_2006_Aug_30_5_17.nxml.txt.nlp	16939660	SENT102	10	10	15	15	metformin	IL-6	PA450395	3569	0.571
NULL	J_Mol_Signal_2009_Apr_28_4_2.nxml.txt.nlp	19400946	SENT112	21	21	38	38	estradiol	Gen	PA449503	348654	0.571
NULL	Appl_Microbiol_Biotechnol_2013_Aug_16_97(18)_7999-8009.nxml.txt.nlp	23948723	SENT79	12	12	20	20	glucose	mol	PA449773	90527	0.571
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1067.nxml.txt.nlp	24556682	SENT36	0	0	2	2	bortezomib	BTZ	PA10252	22794	0.571
NULL	Pharmaceuticals_(Basel)_2012_Aug_10_5(8)_802-836.nxml.txt.nlp	24280676	SENT1251	32	32	11	11	resveratrol	ABCG2		9429	0.571
NULL	Curr_Chem_Genomics_2010_Mar_1_4_1-8.nxml.txt.nlp	20448812	SENT120	9	9	23	23	bosentan	OATP1B3	PA10034	28234	0.571
NULL	Onco_Targets_Ther_2014_May_28_7_841-852.nxml.txt.nlp	24920926	SENT55	7	7	18	18	gefitinib	EGFR	PA131301952	1956	0.571
NULL	Apoptosis_2008_May_9_13(5)_681-692.nxml.txt.nlp	18392938	SENT158	22	22	6	6	forskolin	EGFR	PA146096022	1956	0.571
NULL	Front_Oncol_2013_Sep_9_3_235.nxml.txt.nlp	24058902	SENT67	6	6	20	20	gefitinib	BIM	PA131301952	10018	0.571
NULL	Br_J_Pharmacol_2014_Dec_24_171(23)_5431-5445.nxml.txt.nlp	25052258	SENT135	20	20	9	9	propranolol	SPAP	PA451145	10158	0.571
NULL	Front_Neuroanat_2011_Aug_26_5_50.nxml.txt.nlp	21904525	SENT188	18	18	2	2	haloperidol	DARPP-32	PA449841	84152	0.571
NULL	Alcohol_Res_Health_2007_30(1)_38-47.nxml.txt.nlp	17718399	SENT30	15	15	4	4	ethanol	CYP2E1	PA448073	1571	0.571
NULL	Support_Care_Cancer_2012_Sep_17_20(9)_1991-1997.nxml.txt.nlp	22089428	SENT154	12	12	10	10	paclitaxel	castor	PA450761	54897	0.571
NULL	Cell_Death_Dis_2013_Jun_13_4(6)_e665.nxml.txt.nlp	23764846	SENT62	2	2	13	13	sorafenib	ZO-1	PA7000	7082	0.571
NULL	J_Young_Pharm_2012_Jan-Mar_4(1)_42-48.nxml.txt.nlp	22523460	SENT38	0	0	2	2	tropicamide	TPC	PA164749389	8030;60386	0.571
NULL	Diabetes_2011_Jul_20_60(7)_1990-1999.nxml.txt.nlp	21617181	SENT188	20	20	11	11	geldanamycin	STAT3	PA152031327	6774	0.571
NULL	Int_J_Med_Sci_2012_Jul_25_9(6)_435-440.nxml.txt.nlp	22859903	SENT68	15	15	18	18	sevoflurane	CO2	PA451341	4513	0.571
NULL	Oncol_Lett_2013_Jul_17_6(1)_156-160.nxml.txt.nlp	23946796	SENT32	27	27	46	46	l-glutamine	CO2	PA10090	4513	0.571
NULL	Breast_Cancer_Res_2002_Apr_4_4(3)_85-89.nxml.txt.nlp	12052249	SENT38	27	27	23	23	tamoxifen	SULT1A1	PA451581	6817	0.571
NULL	Br_J_Cancer_2011_Jun_28_105(1)_118-123.nxml.txt.nlp	21654685	SENT34	17	17	10	10	dasatinib	S100beta	PA162372878	6285	0.571
NULL	Cancer_Cell_Int_2006_Aug_9_6_20.nxml.txt.nlp	16899133	SENT65	19	19	24	24	curcumin	p27	PA151958596	5715;10534	0.571
NULL	Oncotarget_2014_Jun_19_5(15)_6540-6551.nxml.txt.nlp	25153728	SENT96	13	13	28	28	paclitaxel	CDK4	PA450761	1019	0.571
NULL	Breast_Cancer_Res_2012_Jul_19_14(4)_R108.nxml.txt.nlp	22812534	SENT184	2	2	4	4	pargyline	PELP1	PA450797	27043	0.571
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT8	9	9	11	11	tacrolimus	RANKL	PA451578	8600	0.571
NULL	Arthritis_Res_Ther_2005_Mar_30_7(3)_111-113.nxml.txt.nlp	15899059	SENT13	38	38	41	41	anakinra	IL-6	PA10799	3569	0.571
NULL	Indian_J_Anaesth_2013_May-Jun_57(3)_276-281.nxml.txt.nlp	23983287	SENT51	13	13	30	30	alprazolam	CO2	PA448333	4513	0.571
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Jun_27_5_15.nxml.txt.nlp	16803618	SENT178	38	38	30	30	gentamicin	CIP1	PA449753	1026;56996	0.571
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT160	3	3	5	5	doxorubicin	B7-H1	PA449412	29126	0.571
NULL	Case_Rep_Oncol_Med_2013_Nov_18_2013_901246.nxml.txt.nlp	24349811	SENT53	5	5	7	7	thyroglobulin	TTF-1	PA164754910	7080	0.571
NULL	Acta_Pharmacol_Sin_2011_Nov_10_32(11)_1402-1410.nxml.txt.nlp	21986579	SENT159	7	7	29	29	curcumin	CDK4	PA151958596	1019	0.571
NULL	Protein_Cell_2014_Jun_19_5(6)_469-479.nxml.txt.nlp	24748116	SENT141	2	2	0	0	paclitaxel	EB1	PA450761	9167;22919;10982	0.571
NULL	Neural_Dev_2011_Nov_15_6_36.nxml.txt.nlp	22085733	SENT223	23	23	37	37	forskolin	p38	PA146096022	10598;1432;7965	0.571
NULL	AIDS_Res_Ther_2009_Apr_9_6_3.nxml.txt.nlp	19358725	SENT43	14	14	28	28	atazanavir	BID	PA10251	637	0.571
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT152	14	14	8	8	capsaicin	p53	PA448776	7157	0.571
NULL	Front_Neural_Circuits_2014_Apr_8_8_33.nxml.txt.nlp	24782714	SENT753	2	2	4	4	methylphenidate	spatial	PA450464	219793	0.571
NULL	Front_Behav_Neurosci_2014_Dec_16_8_437.nxml.txt.nlp	25566005	SENT436	6	6	13	13	menthol	VR1	PA164776605	56664	0.571
NULL	N_Am_J_Med_Sci_2011_May_3(5)_212-216.nxml.txt.nlp	22558596	SENT117	5	5	20	20	gemcitabine	BTC	PA449748	685	0.571
NULL	Clin_Mol_Allergy_2004_Jul_14_2_9.nxml.txt.nlp	15253771	SENT220	35	35	44	44	medroxyprogesterone	CEE	PA450344	51608	0.571
NULL	Case_Rep_Pathol_2013_Jul_14_2013_198643.nxml.txt.nlp	23936709	SENT73	35	35	30	30	thyroglobulin	TTF-1	PA164754910	7080	0.571
NULL	Pharmacogn_Rev_2011_Jul-Dec_5(10)_120-137.nxml.txt.nlp	22279370	SENT36	21	21	15	15	nimesulide	COX2	PA137179528	4513;5743	0.571
NULL	Nat_Chem_Biol_2010_Jun_9_6(6)_424-432.nxml.txt.nlp	20453863	SENT104	22	22	9	9	diltiazem	Hsp40	PA449334	3337	0.571
NULL	J_Carcinog_2013_Dec_31_12_22.nxml.txt.nlp	24574860	SENT81	15	15	10	10	afatinib	EGFR	PA165981154	1956	0.571
NULL	Cancers_(Basel)_2010_Mar_12_2(1)_165-189.nxml.txt.nlp	24281039	SENT790	6	6	9	9	sargramostim	IL-2	PA164748631	3558	0.571
NULL	Cancer_Immunol_Immunother_2013_May_16_62(5)_897-908.nxml.txt.nlp	23589107	SENT1	11	11	13	13	cyclophosphamide	IL-2	PA449165	3558	0.571
NULL	Acta_Vet_Scand_2009_Nov_22_51(1)_45.nxml.txt.nlp	19930608	SENT77	11	11	20	20	ivermectin	EPG	PA450133	255324	0.571
NULL	J_Gen_Physiol_2003_Mar_121(3)_181-197.nxml.txt.nlp	12601083	SENT397	27	27	25	25	forskolin	GLP-1	PA146096022	100125288	0.571
NULL	Case_Rep_Rheumatol_2013_Jul_24_2013_249471.nxml.txt.nlp	23984159	SENT46	17	17	5	5	methotrexate	PAPA	PA450428	2737;5069	0.571
NULL	J_Lipid_Res_2014_Dec_55(12)_2562-2575.nxml.txt.nlp	25316883	SENT251	36	36	11	11	l-glutamine	CGI-58	PA10090	51099	0.571
NULL	Int_J_Mol_Imaging_2013_Jan_17_2013_426961.nxml.txt.nlp	23401767	SENT103	12	12	34	34	paraformaldehyde	Oct4	PA450790	5460	0.571
NULL	Blood_Cancer_J_2012_Oct_19_2(10)_e95.nxml.txt.nlp	23085780	SENT188	4	4	15	15	nilotinib	CML	PA165958345	613	0.571
NULL	Chem_Cent_J_2014_Sep_17_8(1)_59.nxml.txt.nlp	NULL	SENT179	21	21	12	12	moxifloxacin	MOX	PA450555	26002	0.571
NULL	Indian_J_Endocrinol_Metab_2012_Jul-Aug_16(4)_631-636.nxml.txt.nlp	22837931	SENT68	8	8	18	18	thyroglobulin	TTF1	PA164754910	7080;7270	0.571
NULL	Pharmaceutics_2011_Feb_7_3(1)_53-72.nxml.txt.nlp	24310425	SENT856	29	29	17	17	carbamazepine	CYP2C19	PA448785	1557	0.571
NULL	Hum_Mol_Genet_2012_May_1_21(9)_1979-1988.nxml.txt.nlp	22258555	SENT202	45	45	29	29	l-glutamine	B27	PA10090	56246	0.571
NULL	Exp_Lung_Res_2013_Oct_1_39(8)_336-348.nxml.txt.nlp	23919450	SENT243	5	5	3	3	thrombin	PAR-1	PA451674	2011;2149	0.571
NULL	Int_J_Lab_Hematol_2009_Aug_31(4)_468-470.nxml.txt.nlp	18294236	SENT37	7	7	9	9	rituximab	CHOP	PA451261	1649	0.571
NULL	FEBS_J_2009_Jan_276(1)_199-209.nxml.txt.nlp	19032597	SENT184	28	28	26	26	geldanamycin	ADP	PA152031327	23038	0.571
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT205	13	13	15	15	adalimumab	CD36	PA10004	948	0.571
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1724-1730.nxml.txt.nlp	19861964	SENT208	23	23	2	2	temozolomide	BRAF	PA451609	673	0.571
NULL	Front_Pharmacol_2014_Sep_2_5_203.nxml.txt.nlp	25228880	SENT586	10	10	2	2	brompheniramine	HERG	PA448675	3757	0.571
NULL	Clinics_(Sao_Paulo)_2011_Jan_66(1)_65-71.nxml.txt.nlp	21437438	SENT139	6	6	0	0	nortriptyline	BUP	PA450657	23412	0.571
NULL	Crit_Care_2007_May_24_11(3)_R61.nxml.txt.nlp	17524133	SENT121	25	25	28	28	oxygen	SAPS	PA450744	8935	0.571
NULL	Angew_Chem_Int_Ed_Engl_2013_Jan_21_52(4)_1253-1256.nxml.txt.nlp	23225333	SENT69	11	11	6	6	ethanol	CO2	PA448073	4513	0.571
NULL	Patient_Prefer_Adherence_2013_Sep_6_7_885-890.nxml.txt.nlp	24043932	SENT13	5	5	17	17	bupivacaine	San	PA135057240	80218	0.571
NULL	Br_J_Cancer_2012_May_8_106(10)_1587-1590.nxml.txt.nlp	22568998	SENT83	22	22	26	26	sunitinib	IFN	PA162372840	3439	0.571
NULL	Clin_Ophthalmol_2014_Feb_10_8_389-399.nxml.txt.nlp	24550667	SENT195	31	31	29	29	timolol	TIM	PA451690	7984;8914	0.57
NULL	Br_J_Cancer_2009_Mar_24_100(6)_950-958.nxml.txt.nlp	19293809	SENT37	42	42	13	13	glutaraldehyde	NKH	PA449777	275;2731	0.57
NULL	Cells_2014_Feb_19_3(1)_129-149.nxml.txt.nlp	24709906	SENT1001	3	3	6	6	thrombin	PAR1	PA451674	79581;2149	0.57
NULL	Ann_Oncol_2013_Sep_4_24(9)_2206-2223.nxml.txt.nlp	23917950	SENT331	4	4	0	0	trastuzumab	SP7	PA451743	121340	0.57
NULL	Nucleic_Acids_Res_2013_May_5_41(10)_5210-5222.nxml.txt.nlp	23563151	SENT214	0	0	9	9	arsenite	GADD45	PA452638	1647	0.57
NULL	Clin_Ophthalmol_2009_Jun_2_3_291-295.nxml.txt.nlp	19668581	SENT7	7	7	9	9	latanoprost	BAK	PA164774763	578	0.57
NULL	Acta_Pharmacol_Sin_2010_May_26_31(5)_554-559.nxml.txt.nlp	20418892	SENT185	2	2	0	0	bleomycin	BLM	PA448645	641	0.57
NULL	Clin_Ophthalmol_2011_Jun_9_5_771-781.nxml.txt.nlp	21750610	SENT59	28	28	3	3	ranibizumab	CRT	PA164746012	811	0.57
NULL	Avicenna_J_Phytomed_2014_May-Jun_4(3)_215-224.nxml.txt.nlp	25050319	SENT7	13	13	7	7	carrageenan	MEPI	PA448814	5276	0.57
NULL	Cancer_Cell_Int_2011_May_15_11_13.nxml.txt.nlp	21569620	SENT142	15	15	9	9	bortezomib	PC-3	PA10252	692094	0.57
NULL	Nucleic_Acids_Res_2012_Jun_10_40(11)_4804-4815.nxml.txt.nlp	22328728	SENT235	31	31	23	23	hemin	SIRT1	PA449849	23411	0.57
NULL	Cell_Death_Dis_2014_Jan_16_5(1)_e1000.nxml.txt.nlp	24434508	SENT88	0	0	7	7	etoposide	p53	PA449552	7157	0.57
NULL	Arthritis_Res_Ther_2014_Apr_3_16(2)_R86.nxml.txt.nlp	24708674	SENT30	5	5	7	7	bleomycin	BLM	PA448645	641	0.57
NULL	Ann_Surg_Oncol_2007_Apr_26_14(4)_1499-1506.nxml.txt.nlp	17253101	SENT218	14	14	12	12	melphalan	gamma	PA450354	9913	0.57
NULL	J_Antimicrob_Chemother_2014_Mar_11_69(3)_594-597.nxml.txt.nlp	24216768	SENT36	21	21	13	13	ceftriaxone	PEN	PA448866	9933	0.57
NULL	NMR_Biomed_2014_Jul_5_27(7)_760-773.nxml.txt.nlp	24798066	SENT108	4	4	1	1	trastuzumab	NACT	PA451743	284111	0.57
NULL	Diabetes_Care_2013_Dec_13_36(12)_3930-3937.nxml.txt.nlp	23990523	SENT120	27	27	24	24	glucose	adiponectin	PA449773	9370	0.57
NULL	Br_J_Cancer_1982_Jan_45(1)_35-43.nxml.txt.nlp	7059463	SENT4	37	37	39	39	cyclophosphamide	CTX	PA449165	1593	0.57
NULL	J_Cell_Biol_1998_May_4_141(3)_637-646.nxml.txt.nlp	9566965	SENT38	24	24	40	40	methotrexate	CO2	PA450428	4513	0.57
NULL	Pain_2013_Sep_154(9)_1680-1690.nxml.txt.nlp	23707289	SENT547	12	12	19	19	yohimbine	c-fos	PA451946	2353	0.57
NULL	J_Gen_Physiol_1985_Aug_1_86(2)_189-213.nxml.txt.nlp	3876405	SENT3	23	23	25	25	ethanol	gamma	PA448073	9913	0.57
NULL	J_Hematol_Oncol_2012_May_15_5_23.nxml.txt.nlp	22587422	SENT29	21	21	14	14	dasatinib	ALL	PA162372878	613	0.57
NULL	Breast_Cancer_Res_2008_Apr_24_10(2)_R36.nxml.txt.nlp	18435854	SENT103	0	0	2	2	fluorescein	EGFR	PA164746009	1956	0.57
NULL	Curr_Genomics_2014_Jun_15(3)_217-230.nxml.txt.nlp	24955029	SENT238	22	22	26	26	oxygen	ADP	PA450744	23038	0.57
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Sep_12_69(Pt_10)_o1535.nxml.txt.nlp	24098222	SENT60	10	10	27	27	piperazine	C11	PA450977	1109	0.57
NULL	Biologics_2009_Oct_12_3_469-474.nxml.txt.nlp	19851472	SENT5	44	44	18	18	montelukast	IFN	PA450546	3439	0.57
NULL	Clin_Ophthalmol_2010_Oct_21_4_1229-1236.nxml.txt.nlp	21060677	SENT88	25	25	40	40	tafluprost	BAK	PA165958432	578	0.57
NULL	Cardiovasc_Diabetol_2006_Sep_26_5_20.nxml.txt.nlp	17002798	SENT33	14	14	23	23	gemfibrozil	CAD	PA449750	1677;790	0.57
NULL	Virulence_2013_Nov_15_4(8)_734-739.nxml.txt.nlp	24165210	SENT67	2	2	0	0	vancomycin	VAN	PA451850	10318	0.57
NULL	Arch_Med_Sci_2014_Oct_27_10(5)_1007-1018.nxml.txt.nlp	25395954	SENT178	13	13	23	23	melphalan	CTX	PA450354	1593	0.57
NULL	Cell_Death_Dis_2010_Oct_21_1(10)_e86.nxml.txt.nlp	21368859	SENT46	6	6	4	4	doxorubicin	TRAIL	PA449412	8743	0.57
NULL	Front_Genet_2013_Aug_29_4_163.nxml.txt.nlp	24009622	SENT45	12	12	6	6	ethanol	ABCG2	PA448073	9429	0.57
NULL	J_Med_Chem_2014_Jan_23_57(2)_449-461.nxml.txt.nlp	24387105	SENT260	27	27	17	17	benzaldehyde	ALDH1A2	PA448571	8854	0.57
NULL	AAPS_J_2012_Dec_7_15(2)_308-315.nxml.txt.nlp	23224752	SENT253	3	3	13	13	atazanavir	UGT1A1	PA10251	54658	0.57
NULL	Biomed_Res_Int_2013_Aug_6_2013_909613.nxml.txt.nlp	24027765	SENT13	6	6	0	0	hydrocortisone	EEN	PA449905	6455	0.57
NULL	Oncotarget_2013_Dec_18_5(2)_375-385.nxml.txt.nlp	24495868	SENT157	3	3	12	12	fludarabine	XIAP	PA449655	331	0.57
NULL	Exp_Ther_Med_2013_May_15_5(5)_1327-1331.nxml.txt.nlp	23737873	SENT193	3	3	0	0	vasopressin	AVP	PA451858	114548;551	0.57
NULL	Eur_Radiol_2014_Aug_6_24(12)_3277-3288.nxml.txt.nlp	25097126	SENT332	7	7	26	26	abciximab	AIDA	PA448006	64853	0.57
NULL	J_Cell_Mol_Med_2014_Aug_1_18(8)_1599-1611.nxml.txt.nlp	24889822	SENT259	0	0	8	8	resveratrol	SIRT1		23411	0.57
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT167	0	0	3	3	cisplatin	p53	PA449014	7157	0.57
NULL	Drugs_R_D_2012_Mar_27_12(1)_9-14.nxml.txt.nlp	22329608	SENT49	7	7	9	9	budesonide	DPI	PA448681	1832	0.57
NULL	Avicenna_J_Phytomed_2014_May-Jun_4(3)_215-224.nxml.txt.nlp	25050319	SENT150	8	8	6	6	carrageenan	MEPI	PA448814	5276	0.57
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_91-103.nxml.txt.nlp	17912639	SENT70	27	27	11	11	anastrozole	HER2	PA448432	2064	0.57
NULL	J_Headache_Pain_2009_Apr_27_10(2)_105-110.nxml.txt.nlp	19172228	SENT97	5	5	7	7	capsaicin	c-fos	PA448776	2353	0.57
NULL	Arthritis_Res_Ther_2008_Aug_18_10(4)_R93.nxml.txt.nlp	18710567	SENT142	32	32	23	23	etanercept	IL-17	PA449515	3605	0.57
NULL	J_Int_Soc_Sports_Nutr_2012_Dec_21_9_56.nxml.txt.nlp	23259853	SENT142	9	9	22	22	creatine	COT	PA164778930	54677	0.57
NULL	Clin_Mol_Hepatol_2014_Sep_25_20(3)_283-290.nxml.txt.nlp	25320732	SENT138	12	12	4	4	propranolol	EVL	PA451145	51466	0.57
NULL	Oncotarget_2013_Dec_28_5(6)_1475-1490.nxml.txt.nlp	24721996	SENT75	9	9	11	11	celecoxib	CD133	PA448871	8842	0.57
NULL	Br_J_Cancer_2014_Jan_21_110(2)_469-478.nxml.txt.nlp	24346288	SENT48	6	6	9	9	tocilizumab	IL-6	PA165292659	3569	0.57
NULL	Int_J_Biol_Sci_2014_Sep_6_10(9)_990-996.nxml.txt.nlp	25210497	SENT73	6	6	16	16	heparin	CPZ	PA449855	8532	0.57
NULL	Emerg_Infect_Dis_2005_Jul_11(7)_1142-1145.nxml.txt.nlp	16022801	SENT157	24	24	32	32	ribavirin	IL-8	PA451241	3576	0.57
NULL	J_Am_Heart_Assoc_2013_Aug_23_2(4)_e000361.nxml.txt.nlp	23954796	SENT275	34	34	22	22	nitroprusside	ERK2	PA451406	5594	0.57
NULL	J_Am_Heart_Assoc_2013_Apr_24_2(2)_e000191.nxml.txt.nlp	23608608	SENT182	12	12	0	0	phenylephrine	LC3	PA450935	84557	0.57
NULL	Mol_Brain_2014_May_15_7_37.nxml.txt.nlp	24886748	SENT125	18	18	12	12	vorinostat	TIMP1	PA164748224	7076	0.57
NULL	Antimicrob_Agents_Chemother_2014_Nov_10_59(1)_490-497.nxml.txt.nlp	25385107	SENT182	2	2	0	0	atovaquone	ATV	PA448502	4683	0.57
NULL	Indian_J_Pharmacol_2014_Nov-Dec_46(6)_608-612.nxml.txt.nlp	25538331	SENT10	0	0	19	19	gentamicin	gamma	PA449753	9913	0.57
NULL	Int_J_Genomics_2014_Oct_21_2014_312102.nxml.txt.nlp	25401099	SENT12	29	29	23	23	heparin	EGF	PA449855	1950	0.57
NULL	Oncol_Lett_2014_Nov_14_8(5)_2086-2092.nxml.txt.nlp	25295095	SENT84	4	4	8	8	gemcitabine	LKB1	PA449748	6794	0.57
NULL	Sensors_(Basel)_2012_Dec_28_13(1)_500-515.nxml.txt.nlp	23275085	SENT138	7	7	10	10	isoflurane	ARC	PA450106	8996;23237	0.57
NULL	Core_Evid_2009_Jun_15_4_131-147.nxml.txt.nlp	20694070	SENT20	15	15	8	8	raltegravir	CD4		920	0.57
NULL	Virol_J_2010_Oct_20_7_279.nxml.txt.nlp	20961433	SENT161	0	0	6	6	trypsin	VLP	PA451806	391104	0.57
NULL	Am_J_Transplant_2014_Aug_17_14(8)_1817-1827.nxml.txt.nlp	25041339	SENT140	45	45	4	4	tacrolimus	HAI	PA451578	6692;6768	0.57
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT1443	44	44	30	30	heparin	ECM	PA449855	22915	0.57
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT93	17	17	23	23	erlotinib	TDI	PA134687924	100038246	0.57
NULL	Anc_Sci_Life_2012_Oct-Dec_32(2)_93-98.nxml.txt.nlp	24167334	SENT81	10	10	19	19	cyclophosphamide	ANOVA	PA449165	4858	0.57
NULL	FEBS_Open_Bio_2012_Jul_20_2_179-186.nxml.txt.nlp	23650597	SENT270	6	6	11	11	imiquimod	MxA	PA449972	4599	0.57
NULL	Arthritis_Res_2001_Nov_21_3(1)_72-76.nxml.txt.nlp	11178129	SENT118	14	14	33	33	collagenase	CO2	PA449107	4513	0.57
NULL	Oncol_Lett_2014_Jun_3_7(6)_1796-1802.nxml.txt.nlp	24932236	SENT164	11	11	13	13	thyroglobulin	TTF-1	PA164754910	7080	0.57
NULL	Oncoscience_2014_Oct_22_1(10)_614-623.nxml.txt.nlp	25593991	SENT119	23	23	13	13	bevacizumab	TP53	PA130232992	7157	0.57
NULL	Neuropsychopharmacology_2009_Sep_13_34(10)_2197-2207.nxml.txt.nlp	19440190	SENT191	6	6	10	10	fluoxetine	5-HTT	PA449673	6532	0.57
NULL	Biomed_Res_Int_2014_Jun_26_2014_161346.nxml.txt.nlp	25054130	SENT236	45	45	21	21	curcumin	STZ	PA151958596	6484	0.57
NULL	Int_J_Mol_Sci_2014_Sep_30_15(10)_17686-17704.nxml.txt.nlp	25272226	SENT128	21	21	39	39	cetuximab	VEGF-A	PA10040	7422	0.57
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2011_Mar_14_4_13-24.nxml.txt.nlp	22879790	SENT244	16	16	13	13	liraglutide	GLP-1	PA165958364	100125288	0.57
NULL	Mol_Cancer_2010_Oct_12_9_269.nxml.txt.nlp	20939893	SENT133	4	4	12	12	isoproterenol	AP-1	PA450121	2353;3727;2354;3725	0.57
NULL	Crit_Care_2007_Dec_21_11(6)_181.nxml.txt.nlp	18190727	SENT21	7	7	9	9	vasopressin	AVP	PA451858	114548;551	0.57
NULL	Antimicrob_Agents_Chemother_2014_Nov_10_59(1)_490-497.nxml.txt.nlp	25385107	SENT80	2	2	0	0	atovaquone	ATV	PA448502	4683	0.57
NULL	Breast_Cancer_Res_2004_Mar_18_6(3)_119-127.nxml.txt.nlp	15084232	SENT109	3	3	14	14	tamoxifen	pS2	PA451581	7031	0.57
NULL	Mol_Cancer_2010_Mar_2_9_46.nxml.txt.nlp	20196838	SENT202	15	15	18	18	ketoconazole	MDR1	PA450146	5243	0.57
NULL	J_Immunother_2014_Feb_21_37(2)_105-114.nxml.txt.nlp	24509173	SENT6	12	12	14	14	gemcitabine	WT1	PA449748	7490	0.57
NULL	Iran_Red_Crescent_Med_J_2014_Aug_5_16(8)_e6915.nxml.txt.nlp	25389496	SENT149	8	8	10	10	fluvastatin	IL-8	PA449688	3576	0.57
NULL	Cell_Death_Differ_2010_Mar_16_17(3)_499-512.nxml.txt.nlp	19834490	SENT119	5	5	7	7	bevacizumab	VEGFR1	PA130232992	2321	0.57
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Nov_8_64(Pt_12)_o2286-o2287.nxml.txt.nlp	21581265	SENT83	19	19	22	22	benzaldehyde	mol	PA448571	90527	0.57
NULL	J_Ophthalmic_Inflamm_Infect_2010_Dec_7_1(1)_29-34.nxml.txt.nlp	21475659	SENT24	0	0	8	8	sirolimus	FKBP12	PA451365	2280	0.57
NULL	Int_J_Mol_Sci_2007_Apr_16_8(4)_295-303.nxml.txt.nlp	NULL	SENT204	20	20	8	8	diethylstilbestrol	mol	PA449307	90527	0.57
NULL	J_Bras_Pneumol_2013_Jun-Aug_39(4)_434-439.nxml.txt.nlp	24068264	SENT232	17	17	8	8	tramadol	por	PA451735	64840	0.57
NULL	Cancer_Manag_Res_2012_Mar_12_4_75-89.nxml.txt.nlp	22457602	SENT85	0	0	6	6	bexarotene	IFN	PA164752250	3439	0.57
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT94	31	31	15	15	pertuzumab	HER2		2064	0.57
NULL	Oncol_Lett_2014_Jun_9_7(6)_2053-2058.nxml.txt.nlp	24932288	SENT159	8	8	0	0	celecoxib	ANOVA	PA448871	4858	0.57
NULL	Core_Evid_2010_Oct_22_5_91-105.nxml.txt.nlp	21468365	SENT110	12	12	10	10	fluvastatin	CYP3A4	PA449688	1576	0.57
NULL	Oxid_Med_Cell_Longev_2012_Jan_19_2012_390678.nxml.txt.nlp	22315655	SENT7	4	4	0	0	gliclazide	NAC	PA10892	22861	0.57
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT128	6	6	0	0	phenytoin	CYP1A2	PA450947	1544	0.57
NULL	Front_Neurol_2014_Sep_11_5_173.nxml.txt.nlp	25309501	SENT297	12	12	15	15	hyaluronan	CD44	PA165958431	960	0.57
NULL	Exp_Ther_Med_2013_Mar_8_5(3)_707-710.nxml.txt.nlp	23404433	SENT148	14	14	9	9	cisplatin	OST	PA449014	1650;23263	0.57
NULL	J_Antimicrob_Chemother_2011_Feb_31_66(2)_265-272.nxml.txt.nlp	21196489	SENT158	8	8	0	0	maraviroc	RTR	PA164768835	2649	0.57
NULL	Acta_Pharmacol_Sin_2009_Nov_12_30(11)_1566-1572.nxml.txt.nlp	19820718	SENT155	4	4	33	33	omeprazole	P-gp	PA450704	5243	0.57
NULL	EMBO_J_2009_Mar_18_28(6)_686-696.nxml.txt.nlp	19197242	SENT198	23	23	38	38	l-glutamine	CO2	PA10090	4513	0.57
NULL	Clin_Ophthalmol_2012_Feb_20_6_277-282.nxml.txt.nlp	22375096	SENT113	33	33	2	2	ranibizumab	CRT	PA164746012	811	0.57
NULL	Case_Rep_Nephrol_2012_Jul_9_2012_640365.nxml.txt.nlp	24555139	SENT42	11	11	13	13	vasopressin	AVP	PA451858	114548;551	0.57
NULL	Curr_Nutr_Rep_2014_Dec_15_3(1)_22-34.nxml.txt.nlp	24563822	SENT71	21	21	42	42	estradiol	SHBG	PA449503	6462	0.57
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT194	3	3	5	5	tacrolimus	JAK2	PA451578	3717	0.57
NULL	Br_J_Cancer_2004_Mar_22_90(6)_1285-1292.nxml.txt.nlp	15026814	SENT92	24	24	7	7	doxorubicin	p53	PA449412	7157	0.57
NULL	Clinics_(Sao_Paulo)_2009_May_64(5)_409-414.nxml.txt.nlp	19488606	SENT106	5	5	7	7	vasopressin	AVP	PA451858	114548;551	0.57
NULL	Ann_Oncol_2009_Nov_23_20(11)_1803-1812.nxml.txt.nlp	19549706	SENT114	34	34	36	36	sunitinib	IFN	PA162372840	3439	0.57
NULL	J_Cancer_2014_Jul_4_5(7)_559-571.nxml.txt.nlp	25057307	SENT234	12	12	26	26	tamoxifen	RANTES	PA451581	6352	0.57
NULL	BMB_Rep_2013_Nov_46(11)_533-538.nxml.txt.nlp	24152909	SENT236	1	1	5	5	curcumin	NF-kappaB	PA151958596	4790	0.57
NULL	Arthritis_Res_2002_Mar_27_4(Suppl_2)_S16-S21.nxml.txt.nlp	12110153	SENT138	27	27	0	0	methotrexate	ACR	PA450428	49	0.57
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2014_Jun_29_70(Pt_7)_1922-1933.nxml.txt.nlp	25004969	SENT453	6	6	8	8	cycloserine	PLP	PA164764600	25824;5744	0.57
NULL	Clin_Ophthalmol_2008_Jun_2(2)_355-368.nxml.txt.nlp	19668727	SENT81	30	30	18	18	amfenac	COX	PA166049186	1351	0.57
NULL	Crit_Care_2009_Jul_10_13(4)_R113.nxml.txt.nlp	19591694	SENT75	3	3	0	0	vasopressin	AVP	PA451858	114548;551	0.57
NULL	Oncol_Lett_2013_Sep_1_6(3)_840-844.nxml.txt.nlp	24137422	SENT122	8	8	17	17	berberine	p53	PA165860812	7157	0.57
NULL	Oncotarget_2014_Aug_29_5(18)_8052-8082.nxml.txt.nlp	25211298	SENT151	14	14	18	18	temozolomide	U87	PA451609	677775;641648	0.57
NULL	Clin_Interv_Aging_2012_Jul_12_7_235-247.nxml.txt.nlp	22866001	SENT131	34	34	32	32	alendronate	PTH	PA448082	5741	0.57
NULL	Allergy_2014_Jun_16_69(6)_741-751.nxml.txt.nlp	24735481	SENT124	3	3	17	17	papain	TLR4	PA450778	7099	0.57
NULL	Breast_Cancer_Res_2000_Mar_12_2(Suppl_1)_P2_03.nxml.txt.nlp	NULL	SENT7	23	23	7	7	estradiol	HES-1	PA449503	3280	0.57
NULL	Oncotarget_2013_Nov_22_5(4)_933-943.nxml.txt.nlp	24659749	SENT42	10	10	1	1	nutlin-3	p53		7157	0.57
NULL	Pain_Ther_2014_Dec_29_3(2)_73-84.nxml.txt.nlp	25069571	SENT87	6	6	24	24	capsaicin	TRPV1	PA448776	7442	0.57
NULL	J_Cell_Mol_Med_2014_Dec_9_18(12)_2499-2511.nxml.txt.nlp	24912879	SENT288	9	9	19	19	docetaxel	DACH1	PA449383	1602	0.57
NULL	Nucleic_Acids_Res_2005_Jun_9_33(10)_3323-3330.nxml.txt.nlp	15947132	SENT77	0	0	5	5	cisplatin	MSH2	PA449014	4436	0.57
NULL	Int_J_Breast_Cancer_2012_Feb_26_2012_761917.nxml.txt.nlp	22482061	SENT56	13	13	9	9	tamoxifen	HER2	PA451581	2064	0.57
NULL	Evid_Based_Complement_Alternat_Med_2013_Dec_17_2013_589169.nxml.txt.nlp	24454499	SENT145	42	42	35	35	resveratrol	AT1		9197;185	0.57
NULL	Daru_2013_Jan_5_21(1)_5.nxml.txt.nlp	23351529	SENT79	18	18	24	24	dextran	T200	PA449261	5788	0.57
NULL	J_Adv_Pract_Oncol_2013_Jul_1_Jul-Aug_4(4)_238-250.nxml.txt.nlp	25032004	SENT124	7	7	23	23	imatinib	CML	PA10804	613	0.57
NULL	J_Biomed_Sci_2014_Feb_3_21(1)_10.nxml.txt.nlp	24490900	SENT91	19	19	21	21	alendronate	RANKL	PA448082	8600	0.57
NULL	Exp_Ther_Med_2013_Feb_20_5(2)_443-447.nxml.txt.nlp	23407364	SENT180	11	11	13	13	cyclophosphamide	ANOVA	PA449165	4858	0.57
NULL	Diabetes_Metab_J_2012_Oct_18_36(5)_328-335.nxml.txt.nlp	23130316	SENT66	18	18	21	21	lipase	PDK4	PA450239	5166	0.57
NULL	Breast_Cancer_Res_2010_Jul_1_12(4)_R45.nxml.txt.nlp	20594311	SENT179	37	37	39	39	bortezomib	BTZ	PA10252	22794	0.57
NULL	Cancer_Med_2013_Feb_3_2(1)_40-49.nxml.txt.nlp	24133626	SENT366	0	0	4	4	cilostazol	c-Myc	PA164746334	4609	0.57
NULL	Mol_Cancer_2009_Jul_31_8_54.nxml.txt.nlp	19646236	SENT159	5	5	10	10	nadh	NAMPT	PA164755085	10135	0.57
NULL	Br_J_Cancer_2012_May_22_106(11)_1742-1752.nxml.txt.nlp	22538973	SENT185	10	10	12	12	imatinib	IFN	PA10804	3439	0.57
NULL	Mol_Cells_2014_Mar_31_37(3)_234-240.nxml.txt.nlp	24642709	SENT374	10	10	6	6	cisplatin	ANOVA	PA449014	4858	0.57
NULL	J_Biomed_Sci_2014_Nov_18_21(1)_101.nxml.txt.nlp	25407516	SENT113	0	0	5	5	doxorubicin	UCP2	PA449412	7351	0.57
NULL	J_Immunother_Cancer_2014_Feb_24_2(Suppl_1)_O1.nxml.txt.nlp	NULL	SENT8	2	2	18	18	bortezomib	IFN	PA10252	3439	0.57
NULL	J_Oncol_2012_Aug_24_2012_281261.nxml.txt.nlp	21876693	SENT270	15	15	18	18	bevacizumab	EGFR	PA130232992	1956	0.57
NULL	Front_Neurosci_2014_Feb_5_8_11.nxml.txt.nlp	24550772	SENT146	8	8	10	10	vasopressin	AVP	PA451858	114548;551	0.57
NULL	EPMA_J_2012_Sep_27_3(1)_10.nxml.txt.nlp	23016735	SENT216	36	36	13	13	warfarin	PROC	PA451906	5624	0.57
NULL	Oncotarget_2013_Jul_15_4(8)_1241-1252.nxml.txt.nlp	23872733	SENT243	16	16	33	33	sorafenib	JNK	PA7000	5599	0.57
NULL	Indian_J_Endocrinol_Metab_2013_Dec_17(Suppl_3)_S674-S679.nxml.txt.nlp	24910836	SENT153	9	9	7	7	acarbose	PPG	PA448010	5552	0.57
NULL	J_Exp_Clin_Cancer_Res_2010_Apr_27_29(1)_38.nxml.txt.nlp	20423465	SENT5	20	20	44	44	cisplatin	B12	PA449014	7126;4709	0.57
NULL	Ann_Surg_Treat_Res_2014_Feb_22_86(2)_68-75.nxml.txt.nlp	24761411	SENT17	5	5	10	10	resveratrol	survivin		332	0.57
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Apr_7_9_12.nxml.txt.nlp	20374640	SENT83	8	8	10	10	ampicillin	APR	PA448419	5366	0.57
NULL	Crit_Care_2009_Jul_10_13(4)_R113.nxml.txt.nlp	19591694	SENT20	2	2	4	4	vasopressin	AVP	PA451858	114548;551	0.57
NULL	Breast_Cancer_Res_2009_May_20_11(3)_R29.nxml.txt.nlp	19457236	SENT142	4	4	7	7	heparin	EGF	PA449855	1950	0.57
NULL	Case_Rep_Nephrol_Urol_2012_Oct_24_2(2)_145-151.nxml.txt.nlp	23197970	SENT131	39	39	12	12	levofloxacin	CTX	PA450214	1593	0.57
NULL	Eur_J_Med_Res_2014_Apr_9_19(1)_19.nxml.txt.nlp	24717101	SENT80	39	39	11	11	vincristine	FDG	PA451879	23583	0.57
NULL	FEBS_Open_Bio_2014_Jun_2_4_510-521.nxml.txt.nlp	24967154	SENT256	20	20	29	29	streptomycin	CO2	PA451512	4513	0.57
NULL	Braz_J_Med_Biol_Res_2014_Mar_3_47(3)_245-251.nxml.txt.nlp	24554037	SENT3	19	19	24	24	atorvastatin	gamma	PA448500	9913	0.57
NULL	Biomed_Res_Int_2014_Jan_20_2014_948427.nxml.txt.nlp	24563867	SENT8	0	0	3	3	buspirone	STZ	PA448689	6484	0.57
NULL	Iran_J_Pharm_Res_2013_Winter_12(1)_47-56.nxml.txt.nlp	24250571	SENT216	3	3	29	29	curcumin	AP-1	PA151958596	2353;3727;2354;3725	0.57
NULL	Hum_Mol_Genet_2013_Nov_15_22(22)_4616-4626.nxml.txt.nlp	23814041	SENT142	4	4	14	14	doxycycline	SREBP2	PA449415	6721	0.57
NULL	J_Korean_Med_Sci_2011_Aug_27_26(8)_1007-1013.nxml.txt.nlp	21860550	SENT148	2	2	0	0	tamoxifen	CYP2D6	PA451581	1565	0.57
NULL	Pharmaceutics_2011_Feb_7_3(1)_53-72.nxml.txt.nlp	24310425	SENT856	12	12	1	1	phenytoin	CYP1A2	PA450947	1544	0.57
NULL	Core_Evid_2007_Nov_30_2(2)_121-129.nxml.txt.nlp	21221180	SENT151	16	16	19	19	rituximab	CHOP	PA451261	1649	0.57
NULL	Oncol_Rep_2012_Nov_22_28(5)_1851-1858.nxml.txt.nlp	22922937	SENT248	23	23	25	25	bortezomib	BTZ	PA10252	22794	0.57
NULL	Amyloid_2014_Sep_11_21(3)_175-184.nxml.txt.nlp	24918964	SENT197	1	1	6	6	anakinra	TTR	PA10799	7276	0.569
NULL	Diabetes_Metab_J_2013_Oct_17_37(5)_301-314.nxml.txt.nlp	24199158	SENT171	6	6	18	18	nadh	ADP	PA164755085	23038	0.569
NULL	Exp_Ther_Med_2013_Nov_6_6(5)_1089-1095.nxml.txt.nlp	24223627	SENT183	8	8	29	29	fluorouracil	HER2	PA128406956	2064	0.569
NULL	AIDS_Res_Ther_2013_May_16_10_13.nxml.txt.nlp	23680529	SENT30	17	17	13	13	ritonavir	ATV	PA451260	4683	0.569
NULL	Arthritis_Res_Ther_2008_Jan_16_10(1)_R6.nxml.txt.nlp	18199331	SENT237	14	14	39	39	rosiglitazone	MCP-1	PA451283	6347	0.569
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_21-38.nxml.txt.nlp	19305786	SENT488	6	6	13	13	capsaicin	TRPV3	PA448776	162514	0.569
NULL	Leukemia_2014_Jun_17_28(6)_1216-1226.nxml.txt.nlp	24301524	SENT105	2	2	8	8	bortezomib	p65	PA10252	5970	0.569
NULL	Biotechnol_Res_Int_2012_Jul_20_2012_817549.nxml.txt.nlp	22919503	SENT73	19	19	17	17	nadh	mol	PA164755085	90527	0.569
NULL	Cancer_Med_2013_Apr_6_2(2)_234-242.nxml.txt.nlp	23634291	SENT162	24	24	15	15	bevacizumab	VEGF-D	PA130232992	2277	0.569
NULL	Case_Rep_Hematol_2014_Jun_29_2014_161952.nxml.txt.nlp	25093130	SENT52	24	24	26	26	rituximab	CHOP	PA451261	1649	0.569
NULL	Cancers_(Basel)_2011_Sep_13_3(3)_3506-3524.nxml.txt.nlp	24212966	SENT162	7	7	18	18	docetaxel	VEGFR	PA449383	3791	0.569
NULL	Gastric_Cancer_2012_Jul_17_15(3)_313-322.nxml.txt.nlp	22179434	SENT115	28	28	16	16	capecitabine	HER2	PA448771	2064	0.569
NULL	EMBO_Mol_Med_2012_Dec_15_4(12)_1276-1293.nxml.txt.nlp	23065753	SENT179	7	7	20	20	cisplatin	DPI	PA449014	1832	0.569
NULL	Ann_Clin_Microbiol_Antimicrob_2005_Sep_13_4_13.nxml.txt.nlp	16159399	SENT201	9	9	7	7	ribavirin	IFN	PA451241	3439	0.569
NULL	Br_J_Cancer_2013_Feb_19_108(3)_557-563.nxml.txt.nlp	23361053	SENT14	20	20	18	18	tamoxifen	PAK1	PA451581	5585;5058	0.569
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT259	22	22	32	32	ranibizumab	VEGF-A	PA164746012	7422	0.569
NULL	Br_J_Cancer_2004_Mar_22_90(6)_1252-1258.nxml.txt.nlp	15026809	SENT28	26	26	43	43	l-glutamine	CO2	PA10090	4513	0.569
NULL	Front_Immunol_2013_Oct_22_4_334.nxml.txt.nlp	24155745	SENT218	38	38	21	21	tamoxifen	CD34	PA451581	947	0.569
NULL	Cancer_Microenviron_2009_Sep_26_2(Suppl_1)_19-204.nxml.txt.nlp	NULL	SENT2423	11	11	22	22	urokinase	MRP2	PA451836	100130958;57626;1244	0.569
NULL	Br_J_Cancer_2013_Jan_15_108(1)_163-169.nxml.txt.nlp	23257899	SENT25	6	6	4	4	urokinase	MRC2	PA451836	9902	0.569
NULL	Case_Rep_Surg_2011_Oct_29_2011_371082.nxml.txt.nlp	22606576	SENT98	14	14	24	24	creatine	DOG1	PA164778930	55107	0.569
NULL	Crit_Care_2011_Jun_24_15(3)_R153.nxml.txt.nlp	21702944	SENT169	4	4	9	9	dexmedetomidine	HMGB1	PA449256	3146	0.569
NULL	Croat_Med_J_2012_Dec_53(6)_605-611.nxml.txt.nlp	23275326	SENT164	25	25	8	8	propafenone	CYP2D6	PA451131	1565	0.569
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1563-1573.nxml.txt.nlp	22015557	SENT171	17	17	11	11	sunitinib	c-Myc	PA162372840	4609	0.569
NULL	Front_Endocrinol_(Lausanne)_2011_Aug_26_2_17.nxml.txt.nlp	22649365	SENT1284	0	0	8	8	valsartan	spatial	PA451848	219793	0.569
NULL	Crit_Care_2011_Nov_20_15(6)_R275.nxml.txt.nlp	22099212	SENT24	15	15	25	25	heparin	ACT	PA449855	12;11332;9457;641455	0.569
NULL	Oncogene_2009_Apr_2_28(13)_1616-1625.nxml.txt.nlp	19219073	SENT125	6	6	14	14	nutlin-3	p53		7157	0.569
NULL	Int_J_Gen_Med_2013_Jun_7_6_453-464.nxml.txt.nlp	23785241	SENT205	5	5	17	17	nedocromil	IL-8	PA450601	3576	0.569
NULL	J_Cell_Biol_2005_Jun_20_169(6)_921-928.nxml.txt.nlp	15967813	SENT137	25	25	5	5	reserpine	BCRP1	PA451236	317687	0.569
NULL	Acta_Histochem_Cytochem_2012_Apr_26_45(2)_139-146.nxml.txt.nlp	22685356	SENT35	42	42	31	31	forskolin	CO2	PA146096022	4513	0.569
NULL	Molecules_2013_Dec_16_18(12)_15662-15688.nxml.txt.nlp	24352021	SENT319	13	13	41	41	urea	TH1	PA451831	51497	0.569
NULL	Oncol_Lett_2014_Jun_9_7(6)_2053-2058.nxml.txt.nlp	24932288	SENT175	6	6	8	8	doxorubicin	MDR1	PA449412	5243	0.569
NULL	Pharmaceuticals_(Basel)_2011_Jun_14_4(6)_804-821.nxml.txt.nlp	23997653	SENT165	13	13	6	6	ethanol	OX2R	PA448073	3062;131450	0.569
NULL	Pharmaceuticals_(Basel)_2014_Apr_10_7(4)_433-452.nxml.txt.nlp	24727459	SENT378	27	27	20	20	saquinavir	CYP3A4	PA451305	1576	0.569
NULL	Springerplus_2014_Sep_9_3_510.nxml.txt.nlp	25279302	SENT215	6	6	8	8	creatine	CT1	PA164778930	1489;6535	0.569
NULL	Anticancer_Agents_Med_Chem_2014_Oct_14(8)_1121-1127.nxml.txt.nlp	24893730	SENT136	33	33	29	29	erlotinib	EGFR	PA134687924	1956	0.569
NULL	Diabetes_2013_Oct_17_62(10)_3500-3513.nxml.txt.nlp	23884882	SENT173	0	0	11	11	resveratrol	FOXO1		2308	0.569
NULL	Clin_Infect_Dis_2012_Sep_15_55(6)_816-824.nxml.txt.nlp	22700830	SENT67	14	14	38	38	gentamicin	CO2	PA449753	4513	0.569
NULL	Diabetes_Care_2010_Nov_33(11)_2399-2405.nxml.txt.nlp	20980427	SENT145	0	0	11	11	ranibizumab	CRT	PA164746012	811	0.569
NULL	J_Adv_Pract_Oncol_2012_May_1_May-Jun_3(3)_161-169.nxml.txt.nlp	25031942	SENT217	6	6	23	23	mitomycin	ACT	PA450524	12;11332;9457;641455	0.569
NULL	Int_J_Biol_Sci_2012_Sep_6_8(8)_1109-1120.nxml.txt.nlp	22991499	SENT23	12	12	10	10	l-arginine	IFN	PA448478	3439	0.569
NULL	Infect_Dis_Rep_2010_Feb_17_2(1)_e2.nxml.txt.nlp	24470885	SENT63	2	2	16	16	clindamycin	COT	PA449035	54677	0.569
NULL	J_Cell_Biol_1998_Aug_10_142(3)_827-835.nxml.txt.nlp	9700169	SENT198	23	23	9	9	forskolin	GAPDH	PA146096022	2597	0.569
NULL	Case_Rep_Dermatol_2012_Mar_23_4(1)_61-65.nxml.txt.nlp	22548038	SENT48	10	10	32	32	tetracycline	gamma	PA451640	9913	0.569
NULL	Endocrinol_Metab_(Seoul)_2014_Mar_14_29(1)_33-39.nxml.txt.nlp	24741452	SENT133	2	2	4	4	thyroglobulin	WBS	PA164754910	2006	0.569
NULL	Toxins_(Basel)_2010_Oct_26_2(11)_2490-2518.nxml.txt.nlp	22069563	SENT228	11	11	5	5	cisplatin	TLR4	PA449014	7099	0.569
NULL	Ann_Dermatol_2014_Apr_30_26(2)_221-230.nxml.txt.nlp	24882978	SENT171	8	8	5	5	imiquimod	IL-5	PA449972	3567	0.569
NULL	Eur_J_Lipid_Sci_Technol_2011_Aug_113(8)_973-979.nxml.txt.nlp	21966255	SENT244	16	16	10	10	lipase	DAG	PA450239	1605	0.569
NULL	Front_Endocrinol_(Lausanne)_2013_Jan_7_3_180.nxml.txt.nlp	23316185	SENT191	25	25	12	12	glucose	CRF2	PA449773	1395	0.569
NULL	Evid_Based_Complement_Alternat_Med_2011_Feb_14_2011_429843.nxml.txt.nlp	21869897	SENT154	17	17	26	26	ethanol	ACTH	PA448073	5443	0.569
NULL	J_Gen_Physiol_2000_Dec_1_116(6)_769-780.nxml.txt.nlp	11099346	SENT139	34	34	32	32	tetracaine	DAG	PA451638	1605	0.569
NULL	EJNMMI_Res_2011_Jul_29_1_12.nxml.txt.nlp	22214199	SENT6	10	10	13	13	cyclosporine	P-gp	PA449167	5243	0.569
NULL	Pharmaceutics_2011_Feb_7_3(1)_53-72.nxml.txt.nlp	24310425	SENT856	7	7	17	17	theophylline	CYP2C19	PA451647	1557	0.569
NULL	J_Ophthalmol_2012_Aug_27_2012_285851.nxml.txt.nlp	23050121	SENT126	0	0	12	12	travoprost	BAK	PA164781371	578	0.569
NULL	Mol_Cancer_2014_Aug_15_13(1)_192.nxml.txt.nlp	NULL	SENT201	21	21	25	25	l-glutamine	CO2	PA10090	4513	0.569
NULL	ISRN_Neurol_2014_Mar_19_2014_579242.nxml.txt.nlp	25006499	SENT35	24	24	3	3	glucose	SFN	PA449773	25996;2810	0.569
NULL	Subst_Abuse_Treat_Prev_Policy_2007_Oct_31_2_32.nxml.txt.nlp	17974020	SENT283	7	7	2	2	methamphetamine	NMU	PA450403	10874	0.569
NULL	Biol_Open_2014_Nov_13_3(12)_1164-1172.nxml.txt.nlp	25395667	SENT372	6	6	9	9	capsaicin	TRPV1	PA448776	7442	0.569
NULL	Cell_Logist_2012_Apr_1_2(2)_117-125.nxml.txt.nlp	23162743	SENT103	26	26	24	24	pp2	PP1		5540;5464	0.569
NULL	J_Cell_Mol_Med_2014_Aug_1_18(8)_1599-1611.nxml.txt.nlp	24889822	SENT236	0	0	5	5	resveratrol	p62		8878;10657;23636	0.569
NULL	Curr_Respir_Care_Rep_2014_Jul_6_3(3)_121-132.nxml.txt.nlp	25089228	SENT407	8	8	0	0	tiotropium	Mal	PA164769056	114609	0.569
NULL	Br_J_Cancer_2013_Feb_5_108(2)_409-419.nxml.txt.nlp	23287991	SENT182	17	17	27	27	deferasirox	REDD1	PA164760843	54541	0.569
NULL	Avicenna_J_Med_2014_Apr-Jun_4(2)_29-33.nxml.txt.nlp	24761380	SENT96	17	17	10	10	liraglutide	GLP-1	PA165958364	100125288	0.569
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT128	6	6	1	1	phenytoin	CYP2C9	PA450947	1559	0.569
NULL	Diabetes_2008_Sep_57(9)_2272-2279.nxml.txt.nlp	18519799	SENT277	20	20	6	6	rosiglitazone	PDK4	PA451283	5166	0.569
NULL	Clin_Interv_Aging_2014_Nov_18_9_1963-1980.nxml.txt.nlp	25429208	SENT43	9	9	14	14	metformin	DPP4	PA450395	1803	0.569
NULL	Infect_Drug_Resist_2010_Apr_26_3_15-23.nxml.txt.nlp	21694890	SENT130	35	35	24	24	darunavir	TRIO	PA163522472	7204	0.569
NULL	Clin_Ophthalmol_2013_Dec_31_7_39-45.nxml.txt.nlp	23308037	SENT36	19	19	31	31	triamcinolone	San	PA451749	80218	0.569
NULL	Br_J_Haematol_2014_Feb_16_164(4)_586-596.nxml.txt.nlp	24236640	SENT161	27	27	18	18	carboplatin	CARB	PA448803	9482	0.569
NULL	Breast_Cancer_Res_2011_Mar_10_13(2)_R27.nxml.txt.nlp	21392396	SENT13	8	8	13	13	tamoxifen	CYP2D6	PA451581	1565	0.569
NULL	Br_J_Cancer_2010_May_11_102(10)_1495-1502.nxml.txt.nlp	20461092	SENT66	41	41	36	36	l-glutamine	EGF	PA10090	1950	0.569
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT3264	16	16	10	10	abacavir	HLA-B	PA448004	3106	0.569
NULL	Indian_J_Psychiatry_2013_Jul-Sep_55(3)_283-286.nxml.txt.nlp	24082251	SENT56	9	9	2	2	diphenhydramine	OTC	PA449349	5009	0.569
NULL	Mol_Cancer_2010_Nov_8_9_291.nxml.txt.nlp	21059223	SENT134	13	13	6	6	paclitaxel	PARP	PA450761	142	0.569
NULL	Br_J_Cancer_2010_May_25_102(11)_1578-1591.nxml.txt.nlp	20502461	SENT28	21	21	19	19	geldanamycin	Hsp90	PA152031327	3320	0.569
NULL	Br_J_Cancer_2013_Feb_5_108(2)_469-476.nxml.txt.nlp	23169292	SENT174	12	12	10	10	gemcitabine	Gem	PA449748	51053	0.569
NULL	Curr_Opin_Infect_Dis_2013_Dec_6_26(6)_538-544.nxml.txt.nlp	24126716	SENT148	9	9	19	19	fosfomycin	PARI	PA164748039	55010	0.569
NULL	Cancer_Causes_Control_2013_Aug_18_24(8)_1605-1614.nxml.txt.nlp	23775025	SENT64	38	38	20	20	epirubicin	GSTM1	PA449476	2944	0.569
NULL	Breast_Cancer_Res_Treat_2015_Dec_30_149_171-179.nxml.txt.nlp	25547219	SENT10	12	12	8	8	docetaxel	survivin	PA449383	332	0.569
NULL	Ann_Rehabil_Med_2012_Dec_28_36(6)_857-860.nxml.txt.nlp	23342320	SENT13	37	37	17	17	warfarin	CYP2C9	PA451906	1559	0.569
NULL	Cancers_(Basel)_2013_Dec_4_5(4)_1655-1675.nxml.txt.nlp	24305655	SENT100	15	15	10	10	bleomycin	CASP3	PA448645	836	0.569
NULL	BMB_Rep_2013_Feb_46(2)_92-96.nxml.txt.nlp	23433111	SENT25	3	3	8	8	etoposide	BRCA1	PA449552	672	0.569
NULL	Ann_Oncol_2012_Nov_22_23(11)_2782-2790.nxml.txt.nlp	22730099	SENT143	8	8	6	6	estradiol	AMH	PA449503	268	0.569
NULL	Biologics_2012_Dec_17_6_429-464.nxml.txt.nlp	23269860	SENT183	13	13	31	31	etanercept	ACR	PA449515	49	0.569
NULL	Br_J_Haematol_2009_Nov_2_147(3)_396-410.nxml.txt.nlp	19758122	SENT36	0	0	8	8	dasatinib	p53	PA162372878	7157	0.569
NULL	J_Cell_Biol_2001_Apr_16_153(2)_367-380.nxml.txt.nlp	11309417	SENT226	0	0	3	3	etoposide	BLM	PA449552	641	0.569
NULL	J_Gen_Physiol_2003_Mar_121(3)_245-260.nxml.txt.nlp	12601087	SENT186	34	34	9	9	spermine	TRPV6	PA164781199	55503	0.569
NULL	Med_Sci_Monit_2013_May_1_19_317-326.nxml.txt.nlp	23632427	SENT261	23	23	13	13	cefuroxime	CTX	PA448868	1593	0.569
NULL	Mol_Pain_2013_Feb_15_9_3.nxml.txt.nlp	23413875	SENT74	12	12	16	16	resveratrol	TRPA1		8989	0.569
NULL	J_Korean_Med_Sci_2005_Oct_31_20(5)_883-885.nxml.txt.nlp	16224167	SENT15	17	17	33	33	azathioprine	gamma	PA448515	9913	0.569
NULL	Insights_Imaging_2014_Aug_26_5(5)_585-602.nxml.txt.nlp	25154759	SENT136	18	18	7	7	docetaxel	FDG	PA449383	23583	0.569
NULL	Diabetes_2013_May_16_62(5)_1490-1499.nxml.txt.nlp	23349504	SENT306	21	21	9	9	phenformin	LKB1	PA1000	6794	0.569
NULL	J_Biol_Chem_2008_Nov_7_283(45)_31005-31011.nxml.txt.nlp	18765663	SENT176	4	4	12	12	baclofen	CA1	PA448533	759	0.569
NULL	Mol_Biol_Cell_2012_Nov_1_23(21)_4212-4225.nxml.txt.nlp	22956765	SENT142	14	14	2	2	thrombin	SHP2	PA451674	5781	0.569
NULL	Clin_Pharmacol_2013_Dec_9_5_185-192.nxml.txt.nlp	24353446	SENT20	18	18	7	7	clopidogrel	ADP	PA449053	23038	0.569
NULL	Arthritis_Res_Ther_2011_Dec_22_13(6)_R213.nxml.txt.nlp	22192852	SENT63	12	12	4	4	methotrexate	LOR	PA450428	4014	0.569
NULL	Gut_Pathog_2014_Jul_29_6_33.nxml.txt.nlp	25110521	SENT268	0	0	9	9	fluorescein	CD25	PA164746009	3669;3559	0.569
NULL	Biochem_Res_Int_2012_Dec_18_2012_893947.nxml.txt.nlp	22216413	SENT175	18	18	14	14	hyaluronidase	PH-20	PA164745713	6677	0.569
NULL	Clin_Interv_Aging_2011_Jun_21_6_151-160.nxml.txt.nlp	21753870	SENT177	2	2	26	26	tamoxifen	STAR	PA451581	6770;2984	0.569
NULL	Curr_Opin_Infect_Dis_2013_Dec_6_26(6)_538-544.nxml.txt.nlp	24126716	SENT148	2	2	19	19	fosfomycin	PARI	PA164748039	55010	0.569
NULL	Contemp_Clin_Dent_2013_Apr-Jun_4(2)_156-161.nxml.txt.nlp	24015002	SENT119	20	20	15	15	chlorhexidine	SRP	PA164776863	90226	0.569
NULL	Front_Behav_Neurosci_2013_Dec_17_7_197.nxml.txt.nlp	24381546	SENT586	6	6	13	13	clonidine	spatial	PA449051	219793	0.569
NULL	Exp_Diabetes_Res_2012_Nov_12_2012_618923.nxml.txt.nlp	23197974	SENT174	27	27	17	17	telmisartan	STZ	PA451605	6484	0.569
NULL	Pharmaceutics_2011_Nov_18_3(4)_865-913.nxml.txt.nlp	24309312	SENT67	21	21	15	15	phenylpropanolamine	OTC	PA164748965	5009	0.569
NULL	Diabetes_2009_Jan_58(1)_243-249.nxml.txt.nlp	18840785	SENT169	31	31	27	27	glucose	GLP-1	PA449773	100125288	0.569
NULL	Cancer_Cell_Int_2009_Sep_10_9_25.nxml.txt.nlp	19744341	SENT19	22	22	40	40	glucosamine	HBP	PA164747613	3069;50865;7884;566	0.569
NULL	Case_Rep_Dermatol_2013_Jan_18_5(1)_11-14.nxml.txt.nlp	23466694	SENT15	11	11	5	5	calcipotriol	LAM	PA448714	7249;7248	0.569
NULL	Arthritis_Res_Ther_2005_Feb_21_7(3)_R427-R438.nxml.txt.nlp	15899029	SENT202	20	20	17	17	estradiol	p29	PA449503	25949;9588	0.569
NULL	Acta_Physiol_(Oxf)_2012_Feb_204(2)_227-237.nxml.txt.nlp	21624095	SENT191	17	17	20	20	propofol	TRPC5	PA451141	7224	0.569
NULL	Front_Behav_Neurosci_2014_Oct_30_8_366.nxml.txt.nlp	25400560	SENT318	4	4	11	11	ethanol	xCT	PA448073	23657	0.569
NULL	Clin_Ophthalmol_2011_Aug_19_5_1177-1183.nxml.txt.nlp	21887101	SENT189	3	3	17	17	triamcinolone	hole	PA451749	80757	0.569
NULL	Pharmaceuticals_(Basel)_2012_Sep_4_5(9)_899-924.nxml.txt.nlp	24280697	SENT76	24	24	16	16	medroxyprogesterone	CEE	PA450344	51608	0.569
NULL	Cancers_(Basel)_2013_Jul_4_5(3)_838-856.nxml.txt.nlp	24202322	SENT191	5	5	30	30	flavopiridol	p53	PA452627	7157	0.569
NULL	Oxid_Med_Cell_Longev_2012_Aug_22_2012_534705.nxml.txt.nlp	22966415	SENT224	15	15	6	6	riluzole	GLAST	PA451251	6507	0.569
NULL	Drugs_2014_Jun_25_74(10)_1063-1072.nxml.txt.nlp	24962424	SENT70	7	7	3	3	ethionamide	EMB	PA164768738	133418	0.569
NULL	Bull_Math_Biol_2014_Dec_14_76(2)_401-430.nxml.txt.nlp	24338592	SENT26	30	30	39	39	cyclophosphamide	CHOP	PA449165	1649	0.569
NULL	Exp_Ther_Med_2014_May_20_7(5)_1354-1358.nxml.txt.nlp	24940438	SENT29	6	6	25	25	dextran	CD32	PA449261	2213;2212	0.569
NULL	Ecancermedicalscience_2010_Aug_27_4_167.nxml.txt.nlp	22276028	SENT125	1	1	13	13	trastuzumab	HER2	PA451743	2064	0.569
NULL	Arthritis_Res_Ther_2012_Jun_25_14(3)_215.nxml.txt.nlp	22731694	SENT70	2	2	0	0	cyclophosphamide	CPX	PA449165	1371;10682;1377	0.569
NULL	Ann_Rheum_Dis_2012_Jan_12_71(6)_869-874.nxml.txt.nlp	22241900	SENT211	31	31	16	16	infliximab	TNF	PA452639	7124	0.569
NULL	Braz_J_Med_Biol_Res_2012_Feb_17_45(3)_244-249.nxml.txt.nlp	22331137	SENT15	23	23	7	7	gentamicin	PAG	PA449753	55824	0.569
NULL	Open_Biol_2014_May_4(5)_140065.nxml.txt.nlp	24850914	SENT255	17	17	10	10	bortezomib	ALK3	PA10252	657	0.569
NULL	Indian_J_Anaesth_2011_Mar-Apr_55(2)_190-192.nxml.txt.nlp	21712882	SENT65	0	0	6	6	metformin	B12	PA450395	7126;4709	0.569
NULL	Front_Oncol_2014_Jun_18_4_159.nxml.txt.nlp	24995161	SENT223	17	17	8	8	estradiol	AKR1C3	PA449503	8644	0.569
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT154	2	2	0	0	dasatinib	PP2	PA162372878	4888	0.569
NULL	Endocrinol_Metab_(Seoul)_2014_Mar_14_29(1)_33-39.nxml.txt.nlp	24741452	SENT125	9	9	15	15	thyroglobulin	WBS	PA164754910	2006	0.569
NULL	Cardiol_Res_Pract_2012_Apr_22_2012_181394.nxml.txt.nlp	22577589	SENT39	38	38	18	18	hyaluronan	HMGB1	PA165958431	3146	0.569
NULL	J_Brachial_Plex_Peripher_Nerve_Inj_2008_Mar_19_3_8.nxml.txt.nlp	18353188	SENT203	16	16	3	3	capsaicin	VR1	PA448776	56664	0.569
NULL	Acta_Pharmacol_Sin_2011_Aug_18_32(8)_1031-1037.nxml.txt.nlp	21765446	SENT189	24	24	7	7	raloxifene	MCP-1	PA451221	6347	0.569
NULL	Archaea_2013_Jun_2_2013_104147.nxml.txt.nlp	23818813	SENT178	28	28	47	47	l-glutamine	CO2	PA10090	4513	0.569
NULL	Int_J_Breast_Cancer_2014_Nov_12_2014_564308.nxml.txt.nlp	25478233	SENT135	17	17	13	13	urokinase	HER2	PA451836	2064	0.569
NULL	J_Biol_Chem_2012_Dec_14_287(51)_43094-43107.nxml.txt.nlp	23118219	SENT350	9	9	31	31	hyaluronan	CD44	PA165958431	960	0.569
NULL	Open_Biol_2014_May_4(5)_140045.nxml.txt.nlp	24850912	SENT186	22	22	41	41	azithromycin	L22	PA448519	6146	0.569
NULL	Child_Adolesc_Psychiatry_Ment_Health_2012_Jun_7_6_23.nxml.txt.nlp	22676070	SENT186	36	36	7	7	risperidone	BARS	PA451257	1487	0.569
NULL	Orphanet_J_Rare_Dis_2014_Dec_18_9(1)_199.nxml.txt.nlp	NULL	SENT9	23	23	1	1	naltrexone	CMT1A	PA450588	1248	0.569
NULL	Hum_Genomics_2008_Sep_1_3(1)_7-16.nxml.txt.nlp	19129086	SENT40	19	19	13	13	rosiglitazone	CYP2C8	PA451283	1558	0.569
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT169	1	1	3	3	trastuzumab	HER2	PA451743	2064	0.569
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT180	25	25	18	18	perifosine	DR5	PA165291471	8795	0.569
NULL	Nat_Commun_2014_5_3206.nxml.txt.nlp	24487777	SENT224	10	10	33	33	ethanol	CO2	PA448073	4513	0.569
NULL	Cardiovasc_Res_2011_Apr_1_90(1)_157-164.nxml.txt.nlp	21106562	SENT68	31	31	14	14	glutaraldehyde	LPA	PA449777	4018	0.569
NULL	J_Neuroinflammation_2011_Feb_4_8_10.nxml.txt.nlp	21294877	SENT8	15	15	22	22	capsaicin	NK1	PA448776	11126	0.569
NULL	Cell_Mol_Life_Sci_2011_Aug_13_68(15)_2499-2512.nxml.txt.nlp	21318261	SENT314	8	8	19	19	methylphenidate	c-fos	PA450464	2353	0.569
NULL	Iran_J_Public_Health_2010_Jun_30_39(2)_63-68.nxml.txt.nlp	23113008	SENT144	0	0	14	14	ciprofloxacin	TOB	PA449009	10140	0.569
NULL	Breast_Cancer_Res_2010_Nov_16_12(6)_R96.nxml.txt.nlp	21080941	SENT63	38	38	34	34	lapatinib	HRG	PA152241907	3084;3273	0.569
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT108	5	5	7	7	perifosine	TRAIL	PA165291471	8743	0.569
NULL	Cell_Rep_2012_Aug_30_2(2)_419-431.nxml.txt.nlp	22902405	SENT319	16	16	6	6	nadh	GPD1	PA164755085	2819	0.569
NULL	Acta_Vet_Scand_2008_Jul_4_50(1)_27.nxml.txt.nlp	18601734	SENT18	27	27	15	15	doxorubicin	MTSS1	PA449412	9788	0.569
NULL	J_Vet_Med_Sci_2014_Feb_8_76(2)_173-182.nxml.txt.nlp	24107430	SENT126	23	23	10	10	prazosin	AVP	PA451093	114548;551	0.569
NULL	Exp_Ther_Med_2013_May_15_5(5)_1293-1300.nxml.txt.nlp	23737867	SENT214	10	10	12	12	finasteride	EGF	PA449627	1950	0.569
NULL	Ann_Lab_Med_2014_Jan_6_34(1)_43-50.nxml.txt.nlp	24422195	SENT66	30	30	26	26	l-glutamine	FBS	PA10090	64319;26269	0.569
NULL	J_Oncol_2013_Feb_17_2013_872957.nxml.txt.nlp	23476648	SENT204	16	16	4	4	cisplatin	SFN	PA449014	25996;2810	0.569
NULL	Int_J_Biol_Macromol_2012_Mar_1_50(2)_362-368.nxml.txt.nlp	22210486	SENT182	4	4	6	6	lamivudine	LAM	PA450163	7249;7248	0.569
NULL	Genet_Vaccines_Ther_2011_Jun_23_9_11.nxml.txt.nlp	21699699	SENT59	17	17	14	14	boceprevir	IFN	PA165948902	3439	0.569
NULL	J_Immune_Based_Ther_Vaccines_2005_May_18_3_3.nxml.txt.nlp	15904525	SENT175	9	9	18	18	indinavir	CD4	PA449977	920	0.569
NULL	J_Int_Soc_Sports_Nutr_2014_Aug_13_11_38.nxml.txt.nlp	25132809	SENT120	11	11	23	23	creatine	MSTN	PA164778930	2660	0.569
NULL	Osteopath_Med_Prim_Care_2007_Apr_20_1_9.nxml.txt.nlp	17448241	SENT144	5	5	7	7	exenatide	PPG	PA164749238	5552	0.569
NULL	J_Gen_Physiol_1990_Sep_1_96(3)_535-557.nxml.txt.nlp	2230711	SENT10	13	13	20	20	nifedipine	gamma	PA450631	9913	0.569
NULL	Cell_Commun_Signal_2013_Aug_27_11_63.nxml.txt.nlp	24103640	SENT447	18	18	8	8	mitomycin	YB-1	PA450524	4904	0.569
NULL	Cancer_Med_2013_Feb_3_2(1)_86-98.nxml.txt.nlp	24133631	SENT73	15	15	11	11	cisplatin	HAI	PA449014	6692;6768	0.569
NULL	Eur_J_Haematol_2014_Feb_25_92(2)_127-136.nxml.txt.nlp	24118452	SENT172	40	40	37	37	anagrelide	CRT	PA164742986	811	0.569
NULL	AIDS_Res_Ther_2009_Apr_9_6_3.nxml.txt.nlp	19358725	SENT115	8	8	10	10	atazanavir	ATV	PA10251	4683	0.568
NULL	Clin_Infect_Dis_2012_Aug_1_55(Suppl_2)_S162-S169.nxml.txt.nlp	22752866	SENT128	25	25	39	39	vancomycin	CD196	PA451850	1235	0.568
NULL	Int_J_Biomed_Sci_2013_Sep_9(3)_153-161.nxml.txt.nlp	24170990	SENT213	11	11	13	13	atorvastatin	SR-BI	PA448500	949	0.568
NULL	Front_Oncol_2014_Mar_6_4_40.nxml.txt.nlp	24639951	SENT62	18	18	24	24	epirubicin	UNK	PA449476	85451	0.568
NULL	Int_J_Mol_Sci_2007_Jun_8_8(6)_492-504.nxml.txt.nlp	NULL	SENT279	4	4	12	12	estradiol	p65	PA449503	5970	0.568
NULL	Ann_Rheum_Dis_2008_Oct_25_68(10)_1644-1650.nxml.txt.nlp	18957484	SENT0	34	34	31	31	leflunomide	IL-17	PA450192	3605	0.568
NULL	Amino_Acids_2011_May_22_40(5)_1369-1383.nxml.txt.nlp	21424716	SENT217	8	8	14	14	creatine	CEE	PA164778930	51608	0.568
NULL	ScientificWorldJournal_2012_Sep_17_2012_637953.nxml.txt.nlp	23028251	SENT604	20	20	17	17	etoposide	CLB	PA449552	171425	0.568
NULL	Exp_Gerontol_2010_Aug_45(7-8)_573-579.nxml.txt.nlp	20096767	SENT111	16	16	23	23	nadh	MT-ND5	PA164755085	4540	0.568
NULL	Arthritis_Res_Ther_2010_Sep_8_12(5)_R167.nxml.txt.nlp	20825639	SENT174	0	0	3	3	resveratrol	AP-1		2353;3727;2354;3725	0.568
NULL	Diabetes_2009_Dec_58(12)_2718-2725.nxml.txt.nlp	19940235	SENT78	20	20	18	18	choline	B12	PA448976	7126;4709	0.568
NULL	Oncogene_2014_Oct_23_33(43)_5109-5120.nxml.txt.nlp	24858043	SENT279	23	23	28	28	pp2	PP2		4888	0.568
NULL	Arthritis_Res_Ther_2009_Sep_7_11(5)_R136.nxml.txt.nlp	19735566	SENT88	16	16	26	26	gentamicin	CO2	PA449753	4513	0.568
NULL	Crit_Care_2009_Jul_10_13(4)_R113.nxml.txt.nlp	19591694	SENT138	3	3	0	0	vasopressin	AVP	PA451858	114548;551	0.568
NULL	Br_J_Cancer_2012_Jan_17_106(2)_284-289.nxml.txt.nlp	22215065	SENT116	16	16	3	3	atrasentan	IFN	PA143414738	3439	0.568
NULL	Biochem_Res_Int_2012_Feb_12_2012_346972.nxml.txt.nlp	22400115	SENT237	20	20	8	8	hyaluronan	CXCL12	PA165958431	6387	0.568
NULL	Biomed_Res_Int_2013_Jun_13_2013_493643.nxml.txt.nlp	23841073	SENT118	12	12	14	14	estradiol	ACTH	PA449503	5443	0.568
NULL	Curr_Opin_Allergy_Clin_Immunol_2014_Oct_28_14(5)_397-403.nxml.txt.nlp	25115682	SENT121	33	33	17	17	montelukast	IL-4	PA450546	3565	0.568
NULL	Arthritis_Res_Ther_2008_Jan_18_10(1)_R8.nxml.txt.nlp	18205921	SENT138	22	22	10	10	tadalafil	IL-17	PA10333	3605	0.568
NULL	Chem_Cent_J_2012_Apr_27_6_35.nxml.txt.nlp	22540963	SENT85	19	19	5	5	ethanol	flower	PA448073	11094	0.568
NULL	Acta_Pharmacol_Sin_2012_Jan_3_33(1)_49-56.nxml.txt.nlp	22212430	SENT168	0	0	8	8	thrombin	p38	PA451674	10598;1432;7965	0.568
NULL	Mol_Clin_Oncol_2013_Sep_12_1(5)_911-917.nxml.txt.nlp	24649270	SENT34	17	17	11	11	idarubicin	CHOP	PA449961	1649	0.568
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2007_Dec_6_64(Pt_1)_m86.nxml.txt.nlp	21200654	SENT57	6	6	27	27	oxygen	DDP	PA450744	1678	0.568
NULL	Br_J_Cancer_2010_Nov_2_103(11)_1671-1679.nxml.txt.nlp	21045835	SENT155	11	11	17	17	gemcitabine	CXCL12	PA449748	6387	0.568
NULL	Calcif_Tissue_Int_2010_Dec_16_87(6)_485-492.nxml.txt.nlp	20953593	SENT25	33	33	30	30	teriparatide	mol	PA451620	90527	0.568
NULL	Nat_Commun_2012_Feb_21_3_682.nxml.txt.nlp	22353713	SENT348	6	6	16	16	galactose	GAL	PA449725	51083	0.568
NULL	Adv_Hematol_2012_Jun_16_2012_435342.nxml.txt.nlp	21822434	SENT77	2	2	11	11	sirolimus	S6K1	PA451365	6198	0.568
NULL	Braz_J_Med_Biol_Res_2013_Apr_5_46(4)_375-381.nxml.txt.nlp	23558858	SENT151	24	24	14	14	thrombin	VWF	PA451674	7450	0.568
NULL	Oncol_Lett_2013_Feb_7_5(2)_440-446.nxml.txt.nlp	23420122	SENT247	2	2	0	0	gemcitabine	Gem	PA449748	51053	0.568
NULL	Nat_Neurosci_2012_Sep_5_15(9)_1245-1254.nxml.txt.nlp	22864611	SENT74	7	7	12	12	clozapine	HDAC2	PA449061	3066	0.568
NULL	Case_Rep_Med_2012_Oct_24_2012_659654.nxml.txt.nlp	23150733	SENT70	19	19	16	16	thyroglobulin	TTF-1	PA164754910	7080	0.568
NULL	Eur_J_Med_Res_2014_Jun_19_19(Suppl_1)_S13.nxml.txt.nlp	NULL	SENT30	4	4	17	17	taurine	C23	PA451590	4691	0.568
NULL	Front_Chem_2014_Dec_23_2_113.nxml.txt.nlp	25566531	SENT418	0	0	10	10	curcumin	STAT3	PA151958596	6774	0.568
NULL	Behav_Brain_Funct_2012_Jun_20_8_32.nxml.txt.nlp	22716128	SENT259	4	4	32	32	ethanol	CPP	PA448073	340451	0.568
NULL	Spermatogenesis_2013_Jan_1_3(1)_e23870.nxml.txt.nlp	23687616	SENT144	19	19	27	27	hyaluronan	CCL3	PA165958431	6348	0.568
NULL	Crit_Care_2005_Nov_15_9(2)_134-135.nxml.txt.nlp	15774061	SENT40	3	3	0	0	vasopressin	AVP	PA451858	114548;551	0.568
NULL	Sci_Rep_2014_Dec_23_4_7564.nxml.txt.nlp	25532911	SENT421	18	18	22	22	estradiol	GPER	PA449503	2852	0.568
NULL	Front_Immunol_2013_Oct_28_4_346.nxml.txt.nlp	24194739	SENT72	31	31	29	29	vemurafenib	ACT	PA165946873	12;11332;9457;641455	0.568
NULL	Biomed_Res_Int_2013_Dec_30_2013_187204.nxml.txt.nlp	23533994	SENT289	12	12	15	15	bevacizumab	VEGFR2	PA130232992	3791	0.568
NULL	Ann_Oncol_2011_Mar_8_22(3)_503-514.nxml.txt.nlp	20616198	SENT302	19	19	28	28	anastrozole	IMPACT	PA448432	55364	0.568
NULL	Exp_Ther_Med_2014_Dec_13_8(6)_1939-1945.nxml.txt.nlp	25371760	SENT237	6	6	0	0	cisplatin	NAC	PA449014	22861	0.568
NULL	Oncol_Lett_2014_Jun_28_7(6)_2093-2098.nxml.txt.nlp	24932295	SENT122	31	31	18	18	resveratrol	PI3K		5290	0.568
NULL	J_Biol_Chem_2013_Jun_14_288(24)_17285-17295.nxml.txt.nlp	23615912	SENT664	9	9	15	15	heparin	spatial	PA449855	219793	0.568
NULL	Endocr_Relat_Cancer_2014_Apr_21(2)_311-326.nxml.txt.nlp	24478054	SENT165	28	28	30	30	denosumab	OPG	PA166048634	690	0.568
NULL	Clinics_(Sao_Paulo)_2013_May_68(5)_694-701.nxml.txt.nlp	23778405	SENT188	22	22	24	24	curcumin	P-gp	PA151958596	5243	0.568
NULL	Breast_Cancer_Res_2001_Oct_1_3(6)_395-398.nxml.txt.nlp	11737892	SENT79	11	11	18	18	zinc	AP-2	PA451956	7020	0.568
NULL	Chin_J_Cancer_2011_May_30(5)_327-335.nxml.txt.nlp	21527065	SENT35	46	46	15	15	capecitabine	PIK3CA	PA448771	5290	0.568
NULL	Reprod_Biol_Endocrinol_2003_Oct_7_1_66.nxml.txt.nlp	14609433	SENT83	5	5	11	11	cisplatin	FasL	PA449014	356	0.568
NULL	Leukemia_2013_Feb_3_27(2)_315-324.nxml.txt.nlp	22751450	SENT350	7	7	11	11	sorafenib	Mcl-1	PA7000	4170	0.568
NULL	Br_J_Pharmacol_2014_Jan_23_171(2)_523-535.nxml.txt.nlp	24372553	SENT144	2	2	13	13	metformin	p53	PA450395	7157	0.568
NULL	Exp_Ther_Med_2014_May_25_7(5)_1327-1331.nxml.txt.nlp	24940433	SENT155	10	10	15	15	aminophylline	HDAC2	PA164781029	3066	0.568
NULL	Mol_Neurodegener_2011_Dec_20_6_84.nxml.txt.nlp	22185458	SENT190	20	20	12	12	l-glutamine	B27	PA10090	56246	0.568
NULL	Med_Sci_Monit_2013_May_1_19_317-326.nxml.txt.nlp	23632427	SENT261	35	35	13	13	gentamicin	CTX	PA449753	1593	0.568
NULL	Afr_J_Infect_Dis_2011_5(2)_40-46.nxml.txt.nlp	23878706	SENT98	2	2	8	8	ampicillin	Gen	PA448419	348654	0.568
NULL	Contemp_Oncol_(Pozn)_2012_Nov_20_16(5)_401-406.nxml.txt.nlp	23788917	SENT165	9	9	3	3	cetuximab	EGFR	PA10040	1956	0.568
NULL	Neuropsychopharmacology_2009_Jul_11_34(8)_1946-1957.nxml.txt.nlp	19279569	SENT172	12	12	5	5	cocaine	DOR	PA449072	58476	0.568
NULL	Curr_Neuropharmacol_2014_Jan_12(1)_71-98.nxml.txt.nlp	24533017	SENT330	12	12	32	32	baclofen	GluN1	PA448533	2902	0.568
NULL	Evid_Based_Complement_Alternat_Med_2012_May_23_2012_514134.nxml.txt.nlp	22675382	SENT55	34	34	41	41	streptomycin	CO2	PA451512	4513	0.568
NULL	Front_Oncol_2014_May_16_4_108.nxml.txt.nlp	24904824	SENT93	9	9	22	22	everolimus	MPN	PA164746311	83886	0.568
NULL	Anat_Cell_Biol_2010_Sep_30_43(3)_194-200.nxml.txt.nlp	21212859	SENT94	5	5	7	7	ethanol	PLP	PA448073	25824;5744	0.568
NULL	Cancers_(Basel)_2013_May_27_5(2)_617-638.nxml.txt.nlp	24216994	SENT218	0	0	2	2	curcumin	MMP9	PA151958596	4318	0.568
NULL	Open_Biomed_Eng_J_2010_Jul_9_4_129-134.nxml.txt.nlp	21611138	SENT33	14	14	30	30	trypsin	CD31	PA451806	5175	0.568
NULL	ScientificWorldJournal_2014_Feb_12_2014_378950.nxml.txt.nlp	24688382	SENT14	10	10	6	6	oxygen	ROS	PA450744	6098	0.568
NULL	J_Exp_Med_1996_Dec_1_184(6)_2109-2118.nxml.txt.nlp	8976167	SENT63	22	22	9	9	paraformaldehyde	CD4	PA450790	920	0.568
NULL	Cell_Death_Differ_2010_Apr_16_17(4)_666-676.nxml.txt.nlp	19834494	SENT92	12	12	18	18	oxaliplatin	p53	PA131285527	7157	0.568
NULL	Cell_Cycle_2013_Apr_15_12(8)_1303-1315.nxml.txt.nlp	23535298	SENT235	5	5	5	5	pp2	PP2		4888	0.568
NULL	Diabetes_2011_May_23_60(5)_1493-1503.nxml.txt.nlp	21478464	SENT111	5	5	7	7	metformin	AMPK	PA450395	5563	0.568
NULL	Breast_Cancer_(Auckl)_2011_Apr_13_5_53-65.nxml.txt.nlp	21603258	SENT254	14	14	10	10	paclitaxel	castor	PA450761	54897	0.568
NULL	J_Cardiothorac_Surg_2013_May_13_8_127.nxml.txt.nlp	23668669	SENT102	14	14	6	6	oxycodone	EDA	PA450741	1896	0.568
NULL	Case_Rep_Oncol_2010_Jun_30_4(2)_327-335.nxml.txt.nlp	21738504	SENT13	3	3	40	40	cisplatin	HCC	PA449014	84668	0.568
NULL	Br_J_Cancer_2009_Oct_6_101(7)_1114-1123.nxml.txt.nlp	19755995	SENT62	25	25	21	21	hydrocortisone	EGF	PA449905	1950	0.568
NULL	J_Cell_Mol_Med_2014_Aug_1_18(8)_1599-1611.nxml.txt.nlp	24889822	SENT298	2	2	8	8	resveratrol	SIRT1		23411	0.568
NULL	Lab_Anim_Res_2012_Mar_21_28(1)_1-9.nxml.txt.nlp	22474468	SENT21	34	34	37	37	choline	CAT	PA448976	847	0.568
NULL	Hum_Genomics_2013_Apr_5_7(1)_10.nxml.txt.nlp	23561625	SENT378	0	0	4	4	flavopiridol	CDK7	PA452627	1022	0.568
NULL	Curr_Health_Sci_J_2014_Dec_29_Jan-Mar_40(1)_12-17.nxml.txt.nlp	24791199	SENT53	19	19	26	26	olanzapine	NPY	PA450688	4852	0.568
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT141	5	5	10	10	perifosine	DR5	PA165291471	8795	0.568
NULL	Am_J_Pathol_2011_Dec_179(6)_2709-2719.nxml.txt.nlp	21983634	SENT344	21	21	18	18	capsaicin	PKR1	PA448776	10887	0.568
NULL	Pharmaceuticals_(Basel)_2013_Nov_7_6(11)_1381-1406.nxml.txt.nlp	24287463	SENT42	5	5	17	17	linezolid	VAN	PA450233	10318	0.568
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Jun_29_69(Pt_7)_o1190.nxml.txt.nlp	24046728	SENT3	20	20	2	2	phenol	mol	PA450913	90527	0.568
NULL	Front_Physiol_2015_Jan_14_5_522.nxml.txt.nlp	25642192	SENT280	17	17	5	5	nadh	HIF-1	PA164755085	29072	0.568
NULL	Biomed_Res_Int_2014_Jun_24_2014_546479.nxml.txt.nlp	25050361	SENT49	9	9	26	26	collagenase	CO2	PA449107	4513	0.568
NULL	Exp_Ther_Med_2015_Feb_1_9(2)_446-450.nxml.txt.nlp	25574213	SENT140	2	2	21	21	rosiglitazone	aP2	PA451283	2167	0.568
NULL	AIDS_Res_Ther_2008_Aug_14_5_18.nxml.txt.nlp	18700986	SENT35	9	9	11	11	atazanavir	ATV	PA10251	4683	0.568
NULL	Nat_Commun_2014_Dec_18_5_5815.nxml.txt.nlp	25519973	SENT157	17	17	15	15	tranylcypromine	ATN1	PA451741	1822	0.568
NULL	Adv_Urol_2012_Oct_26_2012_812398.nxml.txt.nlp	22110495	SENT67	3	3	1	1	cisplatin	CRT	PA449014	811	0.568
NULL	Cancers_(Basel)_2011_May_18_3(2)_2444-2461.nxml.txt.nlp	24212818	SENT150	25	25	29	29	thrombin	IL-8	PA451674	3576	0.568
NULL	Exp_Diabetes_Res_2012_Nov_1_2012_892706.nxml.txt.nlp	23197976	SENT183	30	30	9	9	vildagliptin	HIF-1	PA165958346	29072	0.568
NULL	Anesth_Pain_Med_2013_Dec_26_4(1)_e11187.nxml.txt.nlp	24660143	SENT95	15	15	5	5	dextromethorphan	ANOVA	PA449273	4858	0.568
NULL	Biosci_Rep_2012_Apr_1_32(Pt_2)_105-112.nxml.txt.nlp	22115362	SENT108	9	9	36	36	infliximab	IL-4	PA452639	3565	0.568
NULL	Am_J_Cardiovasc_Drugs_2014_Oct_18_14(6)_451-462.nxml.txt.nlp	25326294	SENT277	13	13	8	8	acenocoumarol	CYP2C9	PA452632	1559	0.568
NULL	J_Evol_Biol_2010_May_23(5)_1033-1049.nxml.txt.nlp	20345808	SENT39	40	40	23	23	nadh	ND1	PA164755085	4535;10625	0.568
NULL	Mol_Biol_Cell_2012_May_1_23(9)_1628-1635.nxml.txt.nlp	22398723	SENT190	0	0	8	8	fluorescein	CD14	PA164746009	929	0.568
NULL	Mol_Cancer_2009_Nov_24_8_109.nxml.txt.nlp	19930708	SENT131	3	3	5	5	exemestane	EGFR	PA449563	1956	0.568
NULL	Virol_J_2009_Dec_1_6_213.nxml.txt.nlp	19951438	SENT115	28	28	36	36	mitomycin	TRAIL	PA450524	8743	0.568
NULL	Eur_J_Nutr_2009_Jun_24_48(4)_229-234.nxml.txt.nlp	19238310	SENT137	13	13	6	6	capsaicin	GLP-1	PA448776	100125288	0.568
NULL	Environ_Health_Perspect_2013_May_22_121(5)_551-557.nxml.txt.nlp	23434795	SENT66	8	8	22	22	hyaluronan	San	PA165958431	80218	0.568
NULL	Oncol_Lett_2014_Nov_12_8(5)_2203-2208.nxml.txt.nlp	25295109	SENT101	0	0	4	4	celecoxib	SMO	PA448871	6608;54498	0.568
NULL	Curr_Neuropharmacol_2008_Jun_6(2)_151-163.nxml.txt.nlp	19305794	SENT35	4	4	9	9	capsaicin	TRPV1	PA448776	7442	0.568
NULL	J_Gynecol_Oncol_2014_Apr_9_25(2)_130-135.nxml.txt.nlp	24761217	SENT120	7	7	9	9	paclitaxel	P-gp	PA450761	5243	0.568
NULL	Nucleic_Acids_Res_2013_Apr_17_41(7)_4129-4143.nxml.txt.nlp	23420868	SENT97	29	29	48	48	l-glutamine	EPO	PA10090	7076;8288;2056	0.568
NULL	Eur_J_Nutr_2014_Jul_12_53(2)_521-532.nxml.txt.nlp	23846557	SENT100	7	7	0	0	mannitol	B12	PA450320	7126;4709	0.568
NULL	Indian_J_Urol_2008_Jul-Sep_24(3)_289-294.nxml.txt.nlp	19468456	SENT167	6	6	18	18	desmopressin	AVP	PA449237	114548;551	0.568
NULL	Arthritis_Res_Ther_2012_May_17_14(3)_R118.nxml.txt.nlp	22594821	SENT54	24	24	4	4	sulfasalazine	ACPA	PA451547	5657	0.568
NULL	AMB_Express_2012_Jul_29_2_38.nxml.txt.nlp	22838397	SENT157	13	13	15	15	ethanol	EPG	PA448073	255324	0.568
NULL	Asian_J_Androl_2014_Jan_17_Mar-Apr_16(2)_274-279.nxml.txt.nlp	24457841	SENT89	35	35	8	8	dutasteride	ARIA	PA164749300	641700	0.568
NULL	Eur_J_Clin_Pharmacol_2010_Nov_29_66(11)_1131-1136.nxml.txt.nlp	20669013	SENT21	0	0	15	15	voriconazole	CYP3A4	PA10233	1576	0.568
NULL	Acta_Pharmacol_Sin_2013_Sep_5_34(9)_1208-1216.nxml.txt.nlp	23852087	SENT164	11	11	13	13	disulfiram	HIF-1	PA449376	29072	0.568
NULL	Breast_Cancer_Res_Treat_2013_Aug_20_141(1)_43-53.nxml.txt.nlp	23959396	SENT187	20	20	16	16	trastuzumab	HER3	PA451743	2065	0.568
NULL	Arch_Med_Sci_2014_Aug_29_10(4)_684-691.nxml.txt.nlp	25276151	SENT110	12	12	26	26	dobutamine	CRT	PA449381	811	0.568
NULL	Cardiovasc_Diabetol_2011_Dec_22_10_115.nxml.txt.nlp	22189184	SENT126	14	14	19	19	sitagliptin	GLP-1	PA164748978	100125288	0.568
NULL	Cough_2009_Dec_16_5_11.nxml.txt.nlp	20015366	SENT118	20	20	1	1	guaifenesin	OTC	PA449818	5009	0.568
NULL	Exp_Ther_Med_2014_Feb_4_7(2)_478-482.nxml.txt.nlp	24396429	SENT133	40	40	31	31	glucose	HO-1	PA449773	3162	0.568
NULL	J_Int_Soc_Sports_Nutr_2012_Sep_3_9_41.nxml.txt.nlp	22943072	SENT13	17	17	15	15	creatine	ADP	PA164778930	23038	0.568
NULL	Biomed_Res_Int_2013_Jan_21_2013_581631.nxml.txt.nlp	23484133	SENT75	0	0	17	17	infliximab	IL-4	PA452639	3565	0.568
NULL	ScientificWorldJournal_2013_Oct_1_2013_265234.nxml.txt.nlp	24235880	SENT44	22	22	24	24	doxazosin	PC-3	PA449407	692094	0.568
NULL	Mol_Cancer_2009_Dec_23_8_129.nxml.txt.nlp	20030852	SENT198	5	5	7	7	curcumin	ABCA1	PA151958596	19	0.568
NULL	Biochimie_2014_Mar_98(100)_135-142.nxml.txt.nlp	24316281	SENT408	1	1	4	4	phospholipids	adrenoleukodystrophy	PA450952	215	0.568
NULL	Oncol_Rep_2014_Apr_28_31(4)_1605-1612.nxml.txt.nlp	24481648	SENT111	0	0	2	2	ponatinib	MRP7	PA165980594	89845;1080	0.568
NULL	J_Cardiothorac_Surg_2012_Jun_28_7_61.nxml.txt.nlp	22741616	SENT127	25	25	19	19	amiodarone	NAC	PA448383	22861	0.568
NULL	Int_J_Nanomedicine_2012_Sep_21_7_5091-5106.nxml.txt.nlp	23049256	SENT229	7	7	9	9	protamine	SOD1	PA10366	6647	0.568
NULL	Exp_Ther_Med_2013_Mar_20_5(3)_689-694.nxml.txt.nlp	23403765	SENT208	8	8	0	0	l-cysteine	PAG	PA449173	55824	0.568
NULL	Breast_Cancer_(Auckl)_2011_Jul_27_5_175-199.nxml.txt.nlp	21863131	SENT423	22	22	1	1	carboplatin	Met	PA448803	79811	0.568
NULL	Nat_Commun_2011_Oct_18_2_504.nxml.txt.nlp	22009036	SENT228	24	24	14	14	nimodipine	ANOVA	PA450633	4858	0.568
NULL	Nat_Genet_2011_Jan_12_43(1)_27-33.nxml.txt.nlp	21151129	SENT112	12	12	18	18	tamoxifen	FOXA1	PA451581	3169	0.568
NULL	Exp_Ther_Med_2013_Aug_20_6(2)_310-316.nxml.txt.nlp	24137180	SENT117	10	10	27	27	fasudil	MCP-1	PA165946121	6347	0.568
NULL	Brain_Struct_Funct_2013_Jan_14_218(1)_59-72.nxml.txt.nlp	22246100	SENT235	1	1	3	3	pilocarpine	CA1	PA450962	759	0.568
NULL	Exp_Ther_Med_2014_Nov_22_8(5)_1559-1564.nxml.txt.nlp	25289059	SENT149	9	9	0	0	geldanamycin	Hsp90	PA152031327	3320	0.568
NULL	Front_Oncol_2014_Mar_6_4_40.nxml.txt.nlp	24639951	SENT62	22	22	24	24	oxaliplatin	UNK	PA131285527	85451	0.568
NULL	Cancers_(Basel)_2013_Jun_24_5(3)_762-785.nxml.txt.nlp	24202320	SENT222	41	41	30	30	levamisole	LIM	PA450205	10611	0.568
NULL	Pharmacogn_Mag_2014_Oct-Dec_10(40)_536-540.nxml.txt.nlp	25422558	SENT120	24	24	28	28	ethanol	SLB	PA448073	26160	0.568
NULL	Ann_Oncol_2009_Nov_23_20(11)_1803-1812.nxml.txt.nlp	19549706	SENT215	11	11	22	22	sunitinib	IFN	PA162372840	3439	0.568
NULL	Reprod_Biol_Endocrinol_2013_Feb_26_11_15.nxml.txt.nlp	23442442	SENT165	8	8	12	12	l-arginine	SLC7A2	PA448478	6542	0.568
NULL	J_Am_Heart_Assoc_2013_Dec_19_2(6)_e000433.nxml.txt.nlp	24275630	SENT391	30	30	35	35	troglitazone	gamma	PA451799	9913	0.568
NULL	Oncotarget_2014_Oct_21_5(22)_11252-11268.nxml.txt.nlp	25361004	SENT128	2	2	5	5	metformin	CLIC1	PA450395	1192	0.568
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT253	2	2	34	34	nutlin-3	p53		7157	0.568
NULL	Patient_Prefer_Adherence_2013_Apr_26_7_369-377.nxml.txt.nlp	23641151	SENT73	17	17	33	33	ustekinumab	IL-23	PA166048654	51561	0.568
NULL	Int_J_Surg_Oncol_2012_Jun_24_2012_868645.nxml.txt.nlp	22778942	SENT77	7	7	4	4	pertuzumab	HER2		2064	0.568
NULL	Osteoporos_Int_2011_Jun_12_22(6)_1935-1946.nxml.txt.nlp	20938767	SENT276	6	6	11	11	raloxifene	PTH	PA451221	5741	0.568
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1495-1502.nxml.txt.nlp	21989186	SENT199	27	27	9	9	panitumumab	HSI	PA162373091	57016	0.568
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Apr_7_9_12.nxml.txt.nlp	20374640	SENT119	32	32	24	24	ampicillin	TEM	PA448419	64102	0.568
NULL	J_Biol_2003_Oct_29_2(4)_24.nxml.txt.nlp	NULL	SENT69	18	18	5	5	phenformin	LKB1	PA1000	6794	0.568
NULL	Breast_Cancer_Res_2005_Jul_20_7(5)_198-204.nxml.txt.nlp	16168138	SENT134	18	18	10	10	estradiol	aromatase	PA449503	1588	0.568
NULL	Eur_J_Haematol_2014_Feb_25_92(2)_127-136.nxml.txt.nlp	24118452	SENT67	2	2	4	4	anagrelide	CRT	PA164742986	811	0.567
NULL	Arch_Med_Sci_2013_Oct_31_9(5)_916-921.nxml.txt.nlp	24273579	SENT106	8	8	4	4	bleomycin	AQP1	PA448645	358	0.567
NULL	Cardiovasc_Ther_2012_Jun_19_30(3)_e146-e155.nxml.txt.nlp	21167014	SENT40	18	18	16	16	exenatide	GLP-1	PA164749238	100125288	0.567
NULL	Oncotarget_2014_Sep_26_5(21)_10237-10250.nxml.txt.nlp	25296978	SENT170	2	2	8	8	bortezomib	Mcl-1	PA10252	4170	0.567
NULL	Curr_Neuropharmacol_2010_Mar_8(1)_62-68.nxml.txt.nlp	20808546	SENT138	16	16	18	18	celecoxib	P-gp	PA448871	5243	0.567
NULL	Arthritis_Res_Ther_2011_Sep_20_13(5)_R154.nxml.txt.nlp	21933395	SENT107	10	10	18	18	paraformaldehyde	San	PA450790	80218	0.567
NULL	Front_Neurosci_2010_Dec_8_4_205.nxml.txt.nlp	21165178	SENT66	10	10	5	5	ethanol	CO2	PA448073	4513	0.567
NULL	FEBS_Open_Bio_2014_Jan_6_4_77-89.nxml.txt.nlp	24490132	SENT207	7	7	9	9	ebselen	GDH	PA161660841	51084;2746	0.567
NULL	Nucleic_Acids_Res_2011_Oct_9_39(19)_8430-8444.nxml.txt.nlp	21745813	SENT51	17	17	32	32	l-glutamine	CO2	PA10090	4513	0.567
NULL	Int_J_Nanomedicine_2012_Sep_21_7_5091-5106.nxml.txt.nlp	23049256	SENT269	7	7	9	9	protamine	SOD1	PA10366	6647	0.567
NULL	Acta_Pharmacol_Sin_2012_Oct_3_33(10)_1311-1318.nxml.txt.nlp	22941289	SENT206	3	3	10	10	sorafenib	VEGFR2	PA7000	3791	0.567
NULL	Carcinogenesis_2013_Mar_7_34(3)_703-712.nxml.txt.nlp	23222814	SENT89	0	0	21	21	curcumin	CDK2	PA151958596	1017	0.567
NULL	Asian-Australas_J_Anim_Sci_2013_Apr_26(4)_573-578.nxml.txt.nlp	25049825	SENT163	12	12	17	17	bacitracin	BP1	PA448531	1748	0.567
NULL	J_Res_Pharm_Pract_2012_Oct-Dec_1(2)_55-59.nxml.txt.nlp	24991590	SENT4	6	6	15	15	phentolamine	STA	PA450926	2010;2656	0.567
NULL	J_Oncol_2010_Jun_29_2010_179491.nxml.txt.nlp	20671939	SENT22	10	10	18	18	bortezomib	TRAIL	PA10252	8743	0.567
NULL	J_Biol_Chem_2012_Apr_20_287(17)_14122-14135.nxml.txt.nlp	22351750	SENT623	11	11	14	14	hyaluronan	TSG-6	PA165958431	7130	0.567
NULL	Osong_Public_Health_Res_Perspect_2013_Feb_4(1)_27-33.nxml.txt.nlp	24159526	SENT174	6	6	12	12	chloramphenicol	CTX	PA448927	1593	0.567
NULL	Diabetes_Care_2010_Apr_12_33(4)_861-868.nxml.txt.nlp	20067962	SENT31	26	26	4	4	hyaluronan	TLR4	PA165958431	7099	0.567
NULL	Int_J_Endocrinol_2014_Aug_21_2014_790834.nxml.txt.nlp	25214840	SENT95	8	8	12	12	thyroglobulin	TTF-1	PA164754910	7080	0.567
NULL	Clin_Mol_Hepatol_2014_Sep_25_20(3)_283-290.nxml.txt.nlp	25320732	SENT144	2	2	0	0	propranolol	PPN	PA451145	64840	0.567
NULL	Biologics_2014_Apr_22_8_193-198.nxml.txt.nlp	24790412	SENT126	29	29	43	43	adalimumab	Yes	PA10004	7525	0.567
NULL	Br_J_Cancer_2009_Mar_24_100(6)_881-887.nxml.txt.nlp	19259089	SENT141	20	20	0	0	irinotecan	CEA	PA450085	5670;1087	0.567
NULL	Epilepsia_2014_Jun_6_55(6)_806-818.nxml.txt.nlp	24802699	SENT154	14	14	0	0	bumetanide	NKCC1	PA448682	6558	0.567
NULL	Arthritis_Res_Ther_2011_Mar_2_13(2)_R38.nxml.txt.nlp	21366908	SENT52	13	13	20	20	thyroglobulin	San	PA164754910	80218	0.567
NULL	Semin_Immunopathol_2012_Jan_4_34(1)_93-106.nxml.txt.nlp	21845431	SENT175	14	14	8	8	thrombin	PAR-1	PA451674	2011;2149	0.567
NULL	Cardiovasc_Ultrasound_2010_Nov_28_8_52.nxml.txt.nlp	21110895	SENT51	11	11	28	28	protamine	LAX	PA10366	54900	0.567
NULL	Ann_Indian_Acad_Neurol_2013_Apr-Jun_16(2)_208-210.nxml.txt.nlp	23956565	SENT68	23	23	21	21	choline	Dok-7	PA448976	285489	0.567
NULL	Brain_Sci_2013_Sep_24_3(3)_1415-1416.nxml.txt.nlp	NULL	SENT10	37	37	17	17	taurine	ghrelin	PA451590	51738	0.567
NULL	Leukemia_2013_Feb_3_27(2)_315-324.nxml.txt.nlp	22751450	SENT351	9	9	25	25	sorafenib	Mcl-1	PA7000	4170	0.567
NULL	Mol_Cancer_2009_Jul_30_8_52.nxml.txt.nlp	19642973	SENT42	13	13	9	9	diazepam	TSN	PA449283	7247	0.567
NULL	J_Med_Chem_2014_Jan_23_57(2)_449-461.nxml.txt.nlp	24387105	SENT260	27	27	19	19	benzaldehyde	ALDH1A3	PA448571	220	0.567
NULL	Vet_Res_2013_Aug_21_44(1)_70.nxml.txt.nlp	23964850	SENT82	29	29	47	47	l-glutamine	CO2	PA10090	4513	0.567
NULL	Physiology_(Bethesda)_2014_Mar_29(2)_99-107.nxml.txt.nlp	24583766	SENT323	17	17	3	3	phenformin	LKB1	PA1000	6794	0.567
NULL	Clin_Transl_Allergy_2014_Feb_28_4(Suppl_1)_P35.nxml.txt.nlp	25045492	SENT16	0	0	5	5	atorvastatin	IFN	PA448500	3439	0.567
NULL	J_Physiol_2013_Aug_15_591(16)_3901-3917.nxml.txt.nlp	23732644	SENT131	7	7	0	0	picrotoxin	BIC	PA164777007	114614	0.567
NULL	eLife_2014_May_27_3_e02439.nxml.txt.nlp	24867641	SENT347	25	25	41	41	l-glutamine	EGF	PA10090	1950	0.567
NULL	Eur_J_Clin_Pharmacol_2014_Oct_8_70(1)_37-45.nxml.txt.nlp	24100471	SENT54	16	16	14	14	pioglitazone	CYP3A4	PA450970	1576	0.567
NULL	Nucleic_Acids_Res_2007_Jan_7_35(1)_214-222.nxml.txt.nlp	17158161	SENT185	8	8	39	39	kanamycin	CGA	PA450137	1081	0.567
NULL	Eur_J_Pharmacol_2014_Apr_15_729(100)_75-85.nxml.txt.nlp	24534492	SENT36	19	19	32	32	fluorescein	CD194	PA164746009	1233	0.567
NULL	Comp_Funct_Genomics_2012_Feb_6_2012_876893.nxml.txt.nlp	22400011	SENT209	22	22	5	5	zinc	CTD	PA451956	1283	0.567
NULL	Curr_Cardiol_Rev_2009_Aug_5(3)_216-222.nxml.txt.nlp	20676280	SENT51	3	3	5	5	lipase	ATGL	PA450239	57104	0.567
NULL	J_Gynecol_Oncol_2013_Jul_4_24(3)_265-272.nxml.txt.nlp	23875077	SENT104	0	0	11	11	thrombin	IL-8	PA451674	3576	0.567
NULL	J_Cell_Biol_1999_Jan_25_144(2)_305-313.nxml.txt.nlp	9922456	SENT38	26	26	8	8	l-glutamine	F12	PA10090	2161	0.567
NULL	Oncogene_2013_Oct_10_32(41)_4903-4912.nxml.txt.nlp	23208499	SENT346	2	2	4	4	ethanol	GAPDH	PA448073	2597	0.567
NULL	Diagn_Pathol_2014_Jan_20_9_11.nxml.txt.nlp	24443801	SENT9	23	23	8	8	chymotrypsin	MUC1	PA448994	4582	0.567
NULL	Eur_J_Clin_Microbiol_Infect_Dis_2012_May_7_31(5)_739-745.nxml.txt.nlp	21822974	SENT63	10	10	12	12	tigecycline	SYN	PA164746412	2534;23336	0.567
NULL	Front_Endocrinol_(Lausanne)_2013_Mar_12_4_26.nxml.txt.nlp	23486926	SENT1398	3	3	7	7	vasopressin	ACTH	PA451858	5443	0.567
NULL	Front_Neurosci_2013_Dec_24_7_254.nxml.txt.nlp	24399926	SENT167	12	12	0	0	ethanol	ANOVA	PA448073	4858	0.567
NULL	ISRN_Pediatr_2011_Apr_5_2011_365712.nxml.txt.nlp	22389775	SENT115	0	0	13	13	cholestyramine	B12	PA448974	7126;4709	0.567
NULL	Crit_Care_2006_Feb_3_10(1)_R24.nxml.txt.nlp	16469128	SENT151	18	18	10	10	heparin	TP1	PA449855	7011	0.567
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_P108.nxml.txt.nlp	NULL	SENT15	30	30	13	13	piperacillin	IFN	PA450975	3439	0.567
NULL	Diabetes_2009_Jan_58(1)_243-249.nxml.txt.nlp	18840785	SENT15	18	18	9	9	glucose	GLP-1	PA449773	100125288	0.567
NULL	Allergy_Asthma_Clin_Immunol_2010_Jul_28_6(1)_15.nxml.txt.nlp	20667118	SENT199	16	16	13	13	icatibant	C1-INH	PA164749185	710	0.567
NULL	Case_Rep_Oncol_2010_Jun_30_4(2)_327-335.nxml.txt.nlp	21738504	SENT3	3	3	37	37	cisplatin	HCC	PA449014	84668	0.567
NULL	Breast_Cancer_Res_2003_Feb_5_5(2)_113-116.nxml.txt.nlp	12631392	SENT94	39	39	0	0	carboplatin	ATAC	PA448803	6375	0.567
NULL	Diabetes_2013_Oct_17_62(10)_3547-3552.nxml.txt.nlp	23863812	SENT108	2	2	6	6	pravastatin	adiponectin	PA451089	9370	0.567
NULL	Case_Rep_Hematol_2015_Jan_5_2015_321602.nxml.txt.nlp	25628902	SENT23	14	14	21	21	fludarabine	CTX	PA449655	1593	0.567
NULL	Indian_J_Psychiatry_2007_Oct-Dec_49(4)_271-276.nxml.txt.nlp	20680140	SENT66	13	13	19	19	risperidone	spatial	PA451257	219793	0.567
NULL	J_Oncol_2012_Sep_5_2012_128608.nxml.txt.nlp	21904549	SENT159	4	4	10	10	sorafenib	FLT3	PA7000	2322	0.567
NULL	Arthritis_Res_Ther_2012_May_1_14(3)_R99.nxml.txt.nlp	22546542	SENT234	7	7	10	10	infliximab	IFN	PA452639	3439	0.567
NULL	Indian_Dermatol_Online_J_2012_May-Aug_3(2)_122-124.nxml.txt.nlp	23130286	SENT73	12	12	5	5	doxorubicin	CHOP	PA449412	1649	0.567
NULL	Nat_Med_2010_Jun_23_16(6)_671-677.nxml.txt.nlp	20495567	SENT243	25	25	6	6	sorafenib	CREB3L2	PA7000	64764	0.567
NULL	Exp_Ther_Med_2014_Feb_4_7(2)_478-482.nxml.txt.nlp	24396429	SENT8	14	14	20	20	oxygen	HO-1	PA450744	3162	0.567
NULL	Exp_Cell_Res_2013_Aug_1_319(13)_2037-2048.nxml.txt.nlp	23562655	SENT15	33	33	19	19	urokinase	ITGA2	PA451836	3673	0.567
NULL	Breast_Cancer_Res_2004_Jun_29_6(5)_R488-R498.nxml.txt.nlp	15318931	SENT129	26	26	14	14	estradiol	UGT	PA449503	7361;7355	0.567
NULL	Eur_J_Neurosci_2014_Aug_29_40(3)_2487-2501.nxml.txt.nlp	24773078	SENT442	3	3	10	10	zolpidem	CA1	PA451976	759	0.567
NULL	Exp_Ther_Med_2014_Nov_22_8(5)_1559-1564.nxml.txt.nlp	25289059	SENT195	12	12	14	14	geldanamycin	Bcl-2	PA152031327	596	0.567
NULL	Neuropsychologia_2012_Nov_50(13)_3156-3168.nxml.txt.nlp	22884957	SENT446	26	26	4	4	scopolamine	CA1	PA451308	759	0.567
NULL	Exp_Diabetes_Res_2012_Aug_5_2012_201295.nxml.txt.nlp	22919367	SENT107	13	13	23	23	l-glutamine	activin	PA10090	83729	0.567
NULL	Nucleic_Acids_Res_2005_Jun_9_33(10)_3323-3330.nxml.txt.nlp	15947132	SENT78	10	10	6	6	cisplatin	MSH2	PA449014	4436	0.567
NULL	Br_J_Ophthalmol_2014_Jul_98(Suppl_2)_ii24-ii29.nxml.txt.nlp	24934220	SENT105	11	11	3	3	fluorescein	ERM	PA164746009	2119	0.567
NULL	Cancer_Biol_Med_2012_Dec_9(4)_213-220.nxml.txt.nlp	23691481	SENT292	19	19	9	9	tamoxifen	adiponectin	PA451581	9370	0.567
NULL	BMJ_Open_2014_Feb_13_4(2)_e003960.nxml.txt.nlp	24525389	SENT124	13	13	5	5	warfarin	OAT	PA451906	4942	0.567
NULL	Oncol_Lett_2013_Sep_1_6(3)_840-844.nxml.txt.nlp	24137422	SENT116	8	8	13	13	berberine	p53	PA165860812	7157	0.567
NULL	Cancer_Immunol_Immunother_2013_Aug_27_62(10)_1637-1648.nxml.txt.nlp	23982484	SENT248	14	14	34	34	lenalidomide	CD122	PA162363968	3560	0.567
NULL	Allergy_Asthma_Clin_Immunol_2007_Jun_15_3(2)_70-72.nxml.txt.nlp	20525146	SENT58	3	3	1	1	amoxicillin	DLST	PA448406	1743	0.567
NULL	Arthritis_Res_2001_Jan_26_3(Suppl_A)_L013.nxml.txt.nlp	NULL	SENT17	0	0	8	8	fluvastatin	IL-6	PA449688	3569	0.567
NULL	Arthritis_Res_2001_Aug_2_3(5)_311-318.nxml.txt.nlp	11549373	SENT243	16	16	0	0	camptothecin	COL1A2	PA153590860	1278	0.567
NULL	Acta_Pharmacol_Sin_2012_Jan_3_33(1)_49-56.nxml.txt.nlp	22212430	SENT103	6	6	1	1	thrombin	A10	PA451674	28870	0.567
NULL	Br_J_Cancer_2013_Aug_6_109(3)_686-693.nxml.txt.nlp	23839492	SENT100	7	7	16	16	everolimus	HIF-1	PA164746311	29072	0.567
NULL	J_Obes_2011_Feb_8_2011_636181.nxml.txt.nlp	21331293	SENT194	19	19	13	13	glucose	GLP-1	PA449773	100125288	0.567
NULL	Drugs_2009_Mar_17_69(5)_549-565.nxml.txt.nlp	19368417	SENT104	12	12	14	14	budesonide	DPI	PA448681	1832	0.567
NULL	Mol_Vis_2007_Jul_9_13_1083-1093.nxml.txt.nlp	17653053	SENT163	0	0	15	15	minocycline	MCP-3	PA450519	6354	0.567
NULL	FEBS_Open_Bio_2012_Jul_20_2_179-186.nxml.txt.nlp	23650597	SENT274	6	6	13	13	imiquimod	MxA	PA449972	4599	0.567
NULL	Hum_Genomics_Proteomics_2010_Aug_3_2010_159761.nxml.txt.nlp	20981231	SENT60	5	5	7	7	gabapentin	GBP	PA449720	54972;3030;3956;8554	0.567
NULL	JAKSTAT_2012_Jan_1_1(1)_44-54.nxml.txt.nlp	24058750	SENT47	46	46	33	33	hydrocortisone	EGF	PA449905	1950	0.567
NULL	Comp_Hepatol_2004_Jan_14_3(Suppl_1)_S37.nxml.txt.nlp	14960189	SENT111	36	36	32	32	ethanol	TNF-alpha	PA448073	7124	0.567
NULL	Oncoimmunology_2012_May_1_1(3)_326-333.nxml.txt.nlp	22737608	SENT85	18	18	2	2	methylcholanthrene	GITR	PA165816878	8784	0.567
NULL	Arthritis_Res_Ther_2011_Mar_16_13(2)_R44.nxml.txt.nlp	21410959	SENT188	0	0	5	5	glucosamine	RANKL	PA164747613	8600	0.567
NULL	Mol_Vis_2011_Jun_9_17_1564-1576.nxml.txt.nlp	21738386	SENT81	9	9	11	11	ethambutol	EMB	PA164784021	133418	0.567
NULL	Mol_Cancer_2014_Feb_20_13_32.nxml.txt.nlp	24555657	SENT192	13	13	2	2	collagenase	SET	PA449107	6418	0.567
NULL	Eur_J_Clin_Pharmacol_2011_May_2_67(Suppl_1)_87-107.nxml.txt.nlp	21287160	SENT324	14	14	2	2	sn-38	UGT1A		7361;54658	0.567
NULL	Indian_J_Endocrinol_Metab_2012_Sep-Oct_16(5)_830-832.nxml.txt.nlp	23087876	SENT33	5	5	13	13	hydrocortisone	B12	PA449905	7126;4709	0.567
NULL	Eur_J_Pediatr_2012_Feb_17_171(2)_207-214.nxml.txt.nlp	21922352	SENT38	5	5	19	19	thrombin	VWF	PA451674	7450	0.567
NULL	J_Young_Pharm_2011_Apr-Jun_3(2)_132-137.nxml.txt.nlp	21731359	SENT80	21	21	8	8	pioglitazone	DM2	PA450970	28508	0.567
NULL	J_Hematol_Oncol_2011_Apr_20_4_16.nxml.txt.nlp	21504625	SENT49	7	7	5	5	nutlin-3	p53		7157	0.567
NULL	Ther_Clin_Risk_Manag_2007_Mar_3(1)_133-148.nxml.txt.nlp	18360621	SENT33	0	0	15	15	adalimumab	p75	PA10004	7133;11168	0.567
NULL	Cell_Death_Dis_2013_Jun_27_4(6)_e696.nxml.txt.nlp	23807225	SENT268	11	11	13	13	doxycycline	ACL	PA449415	47	0.567
NULL	Int_J_Circumpolar_Health_2013_Aug_5_72_10_3402_ijch_v72i0_20854.nxml.txt.nlp	23984273	SENT170	17	17	19	19	erythromycin	TMP	PA449493	2012	0.567
NULL	Arthritis_Res_Ther_2013_Dec_3_15(6)_R205.nxml.txt.nlp	24295447	SENT113	0	0	8	8	methotrexate	RANK	PA450428	8792	0.567
NULL	Neural_Regen_Res_2014_Feb_15_9(4)_430-435.nxml.txt.nlp	25206831	SENT85	3	3	19	19	creatine	ADP	PA164778930	23038	0.567
NULL	Cancer_Immunol_Immunother_2011_Jun_25_60(6)_793-808.nxml.txt.nlp	21350947	SENT149	12	12	9	9	sorafenib	IFN	PA7000	3439	0.567
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT7	2	2	9	9	perifosine	DR5	PA165291471	8795	0.567
NULL	Ann_Rehabil_Med_2012_Aug_27_36(4)_466-473.nxml.txt.nlp	22977771	SENT145	20	20	33	33	bupivacaine	TLF	PA135057240	9519	0.567
NULL	Breast_Cancer_Res_2007_Oct_1_9(5)_R64.nxml.txt.nlp	17908324	SENT138	22	22	4	4	fluorescein	HER2	PA164746009	2064	0.567
NULL	J_Cell_Mol_Med_2014_Aug_1_18(8)_1599-1611.nxml.txt.nlp	24889822	SENT201	29	29	37	37	resveratrol	SIRT1		23411	0.567
NULL	Int_J_Breast_Cancer_2011_Sep_6_2011_352182.nxml.txt.nlp	22295219	SENT122	3	3	1	1	hyaluronan	CD44	PA165958431	960	0.567
NULL	Case_Rep_Surg_2014_Mar_11_2014_795726.nxml.txt.nlp	24741444	SENT37	18	18	36	36	heparin	ACT	PA449855	12;11332;9457;641455	0.567
NULL	Exp_Ther_Med_2014_Feb_4_7(2)_478-482.nxml.txt.nlp	24396429	SENT8	14	14	23	23	oxygen	HO-1	PA450744	3162	0.567
NULL	Breast_Cancer_Res_2014_Sep_11_16(5)_430.nxml.txt.nlp	25212826	SENT201	40	40	31	31	tamoxifen	PTEN	PA451581	5728	0.567
NULL	Indian_Dermatol_Online_J_2013_Jul-Sep_4(3)_246-249.nxml.txt.nlp	23984250	SENT38	15	15	35	35	vismodegib	EGFR		1956	0.567
NULL	Diabetes_2011_Jul_20_60(7)_1917-1925.nxml.txt.nlp	21593202	SENT134	31	31	2	2	troglitazone	adiponectin	PA451799	9370	0.567
NULL	Biochem_Res_Int_2012_Feb_9_2012_592806.nxml.txt.nlp	22400117	SENT155	4	4	12	12	nadh	EGF	PA164755085	1950	0.567
NULL	Surg_Neurol_Int_2014_Jun_5_5_86.nxml.txt.nlp	25024886	SENT115	16	16	14	14	zidovudine	TRIP	PA451954	9208;10293	0.567
NULL	EMBO_J_2014_Jul_17_33(14)_1514-1526.nxml.txt.nlp	24872509	SENT106	5	5	30	30	zinc	C15	PA451956	51316	0.567
NULL	Curr_Gerontol_Geriatr_Res_2010_May_4_2010_420139.nxml.txt.nlp	20454643	SENT86	19	19	12	12	estradiol	AMPK	PA449503	5563	0.567
NULL	Indian_J_Ophthalmol_2014_Apr_62(4)_424-428.nxml.txt.nlp	24145571	SENT65	7	7	37	37	l-cysteine	PRK	PA449173	1263	0.567
NULL	Cell_Commun_Signal_2013_Nov_11_11_86.nxml.txt.nlp	24215724	SENT265	10	10	24	24	thrombin	PAR4	PA451674	9002;5074	0.567
NULL	EMBO_Mol_Med_2012_Apr_4(4)_298-312.nxml.txt.nlp	22331558	SENT25	3	3	36	36	nutlin-3	p53		7157	0.567
NULL	Osong_Public_Health_Res_Perspect_2013_Feb_4(1)_27-33.nxml.txt.nlp	24159526	SENT174	22	22	12	12	cefazolin	CTX	PA448839	1593	0.567
NULL	Oncol_Lett_2014_Sep_19_8(3)_1269-1274.nxml.txt.nlp	25120704	SENT165	11	11	9	9	cisplatin	Met	PA449014	79811	0.567
NULL	J_Cell_Biol_2001_Oct_1_155(1)_101-112.nxml.txt.nlp	11571311	SENT547	25	25	20	20	paraformaldehyde	LIM	PA450790	10611	0.567
NULL	Breast_Cancer_Res_2004_Jun_29_6(5)_R488-R498.nxml.txt.nlp	15318931	SENT193	18	18	30	30	tamoxifen	UGT	PA451581	7361;7355	0.567
NULL	J_Allergy_(Cairo)_2011_Apr_6_2011_479129.nxml.txt.nlp	21603171	SENT62	0	0	26	26	tacrolimus	IL-6	PA451578	3569	0.567
NULL	Br_J_Cancer_2013_Mar_19_108(5)_1052-1060.nxml.txt.nlp	23422754	SENT146	13	13	18	18	bevacizumab	VEGF-A	PA130232992	7422	0.567
NULL	Iran_Red_Crescent_Med_J_2012_Jul_30_14(7)_442-446.nxml.txt.nlp	22997561	SENT28	8	8	10	10	sugar	FBS	PA451529	64319;26269	0.567
NULL	Comp_Hepatol_2004_Jan_14_3(Suppl_1)_S31.nxml.txt.nlp	14960183	SENT87	1	1	5	5	ethanol	TNF-alpha	PA448073	7124	0.567
NULL	Mol_Cancer_2014_Jan_15_13_9.nxml.txt.nlp	24428911	SENT166	13	13	3	3	bevacizumab	VEGF-A	PA130232992	7422	0.567
NULL	Biomed_Res_Int_2013_Dec_30_2013_187204.nxml.txt.nlp	23533994	SENT289	23	23	21	21	cetuximab	EGFR	PA10040	1956	0.567
NULL	Diabetes_2013_Nov_18_62(11)_3677-3686.nxml.txt.nlp	24158999	SENT359	10	10	17	17	capsaicin	TRPV3	PA448776	162514	0.567
NULL	Diabetes_2011_Nov_17_60(11)_2691-2700.nxml.txt.nlp	21896928	SENT113	10	10	12	12	resveratrol	SIRT1		23411	0.567
NULL	Indian_J_Pharmacol_2008_Feb_40(Suppl1)_S31-S34.nxml.txt.nlp	21369412	SENT82	11	11	8	8	phenytoin	OTC	PA450947	5009	0.567
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_11_2014_274786.nxml.txt.nlp	25505920	SENT194	9	9	43	43	oxaliplatin	CPP32	PA131285527	836	0.567
NULL	Biosci_Rep_2012_Aug_1_32(Pt_4)_361-374.nxml.txt.nlp	22762204	SENT112	31	31	21	21	cyclophosphamide	p19Arf	PA449165	1029	0.567
NULL	Diabetes_Obes_Metab_2011_Nov_13(11)_982-989.nxml.txt.nlp	21615670	SENT164	3	3	7	7	exenatide	GLP-1	PA164749238	100125288	0.567
NULL	Aging_(Albany_NY)_2012_Jun_11_4(6)_402-416.nxml.txt.nlp	22691943	SENT197	24	24	7	7	tamoxifen	SIRT1	PA451581	23411	0.567
NULL	J_Gen_Physiol_1997_Aug_1_110(2)_141-153.nxml.txt.nlp	9236207	SENT158	19	19	1	1	spermine	ROMK1	PA164781199	3758	0.567
NULL	J_Mol_Med_(Berl)_2014_May_10_92(7)_709-722.nxml.txt.nlp	24811491	SENT235	14	14	7	7	cetuximab	KRAS	PA10040	3845	0.567
NULL	Arthritis_Res_Ther_2014_Jan_20_16(1)_R17.nxml.txt.nlp	24444433	SENT91	18	18	0	0	methotrexate	ANOVA	PA450428	4858	0.567
NULL	Med_Sci_Monit_2013_May_1_19_317-326.nxml.txt.nlp	23632427	SENT261	11	11	13	13	ceftazidime	CTX	PA448861	1593	0.567
NULL	Front_Neurosci_2012_Apr_3_6_43.nxml.txt.nlp	22493568	SENT763	5	5	9	9	clonidine	spatial	PA449051	219793	0.567
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_33-43.nxml.txt.nlp	17912634	SENT126	20	20	4	4	tamoxifen	TFF1	PA451581	7031	0.567
NULL	AIDS_Res_Ther_2013_May_1_10_10.nxml.txt.nlp	23634877	SENT12	14	14	21	21	atorvastatin	CCL3	PA448500	6348	0.567
NULL	Oncotarget_2014_Oct_21_5(22)_11252-11268.nxml.txt.nlp	25361004	SENT265	3	3	23	23	metformin	CLIC1	PA450395	1192	0.567
NULL	J_Gastroenterol_2013_Jan_27_48(1)_22-30.nxml.txt.nlp	23104468	SENT34	20	20	18	18	ribavirin	IFN	PA451241	3439	0.567
NULL	Croat_Med_J_2013_Dec_54(6)_579-584.nxml.txt.nlp	24382854	SENT97	5	5	18	18	creatine	COX	PA164778930	1351	0.567
NULL	Oncol_Rep_2013_Dec_1_30(6)_2632-2638.nxml.txt.nlp	24085151	SENT127	0	0	11	11	estradiol	CYP2A6	PA449503	1548	0.567
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Aug_12_65(Pt_9)_o2129.nxml.txt.nlp	21577541	SENT6	22	22	26	26	benzaldehyde	mol	PA448571	90527	0.567
NULL	Eur_J_Clin_Microbiol_Infect_Dis_2010_May_13_29(5)_543-550.nxml.txt.nlp	20229224	SENT73	13	13	7	7	ciprofloxacin	PEN	PA449009	9933	0.567
NULL	Alcohol_Res_2012_34(4)_441-447.nxml.txt.nlp	23584110	SENT146	32	32	34	34	vasopressin	AVP	PA451858	114548;551	0.567
NULL	Arthritis_Res_Ther_2007_Oct_9_9(5)_R104.nxml.txt.nlp	17925024	SENT167	6	6	8	8	glucosamine	AP-1	PA164747613	2353;3727;2354;3725	0.567
NULL	J_Clin_Exp_Pathol_2012_May_17_Suppl_4_7327.nxml.txt.nlp	25379357	SENT44	1	1	11	11	resveratrol	AMPK		5563	0.567
NULL	FEBS_Open_Bio_2014_Oct_22_4_905-914.nxml.txt.nlp	25383314	SENT570	12	12	18	18	physostigmine	ANOVA	PA450957	4858	0.567
NULL	Nat_Commun_2013_4_2540.nxml.txt.nlp	24096474	SENT216	23	23	35	35	l-glutamine	GDNF	PA10090	2668	0.567
NULL	J_Cell_Biol_2004_Jan_19_164(2)_169-174.nxml.txt.nlp	14718521	SENT79	10	10	6	6	dextran	MARCKS	PA449261	4082	0.567
NULL	Cancer_Imaging_2008_Mar_25_8(1)_57-69.nxml.txt.nlp	18390389	SENT199	29	29	22	22	thyroglobulin	WBS	PA164754910	2006	0.567
NULL	Arch_Dis_Child_2015_Jan_3_100(1)_95-100.nxml.txt.nlp	25281734	SENT131	11	11	20	20	midazolam	CYP3A	PA450496	1574	0.567
NULL	Clin_Dev_Immunol_2011_Sep_14_2011_267539.nxml.txt.nlp	21922022	SENT44	15	15	3	3	cetuximab	EGFR	PA10040	1956	0.567
NULL	Gut_Liver_2012_Oct_18_6(4)_464-470.nxml.txt.nlp	23170151	SENT6	19	19	26	26	propofol	ESD	PA451141	2098	0.567
NULL	Front_Neurosci_2011_Apr_1_5_42.nxml.txt.nlp	21503146	SENT521	14	14	5	5	choline	spatial	PA448976	219793	0.567
NULL	Curr_Opin_Infect_Dis_2013_Dec_6_26(6)_538-544.nxml.txt.nlp	24126716	SENT143	1	1	18	18	amikacin	PARI	PA164744372	55010	0.567
NULL	Asian-Australas_J_Anim_Sci_2014_May_27(5)_757-766.nxml.txt.nlp	25050012	SENT205	9	9	28	28	lipase	HSL	PA450239	3991	0.567
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_P64.nxml.txt.nlp	NULL	SENT16	22	22	16	16	cefuroxime	PPL	PA448868	5493	0.567
NULL	Biomed_Res_Int_2014_Jun_26_2014_161346.nxml.txt.nlp	25054130	SENT225	45	45	21	21	curcumin	STZ	PA151958596	6484	0.567
NULL	FEBS_J_2012_May_279(10)_1857-1870.nxml.txt.nlp	22420714	SENT306	6	6	9	9	capsaicin	TRPV1	PA448776	7442	0.567
NULL	Front_Aging_Neurosci_2010_Apr_8_2_15.nxml.txt.nlp	20552051	SENT1160	15	15	3	3	flutamide	spatial	PA449685	219793	0.567
NULL	Curr_Oncol_2009_Jul_16(Suppl_2)_S1-S13.nxml.txt.nlp	19672416	SENT97	31	31	22	22	anastrozole	TTR	PA448432	7276	0.567
NULL	Arthritis_Res_Ther_2010_Apr_29_12(2)_R73.nxml.txt.nlp	20429888	SENT183	2	2	10	10	bortezomib	COL1A2	PA10252	1278	0.567
NULL	Mol_Cell_Biochem_2015_Oct_8_398(1-2)_165-173.nxml.txt.nlp	25292312	SENT197	31	31	27	27	bortezomib	ORP150	PA10252	10525	0.567
NULL	Lancet_2011_Jun_18_377(9783)_2103-2114.nxml.txt.nlp	21641636	SENT21	28	28	31	31	cetuximab	KRAS	PA10040	3845	0.567
NULL	Lipids_Health_Dis_2011_Dec_6_10_229.nxml.txt.nlp	22146099	SENT65	28	28	26	26	rosiglitazone	IL-13	PA451283	3596	0.567
NULL	Clin_Interv_Aging_2008_Sep_3(3)_453-472.nxml.txt.nlp	18982916	SENT513	22	22	20	20	atazanavir	ATV	PA10251	4683	0.567
NULL	Eur_J_Med_Res_2014_Jun_24_19(1)_34.nxml.txt.nlp	24961604	SENT103	18	18	13	13	vincristine	BCL11A	PA451879	53335	0.567
NULL	Croat_Med_J_2012_Jun_53(3)_214-223.nxml.txt.nlp	22661134	SENT62	1	1	12	12	diazepam	ACTH	PA449283	5443	0.567
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT171	14	14	16	16	erlotinib	CYP3A	PA134687924	1574	0.567
NULL	Case_Rep_Hematol_2012_Sep_10_2012_517546.nxml.txt.nlp	22997594	SENT122	0	0	7	7	dasatinib	KIT	PA162372878	3815	0.567
NULL	Case_Rep_Endocrinol_2014_Dec_29_2014_213283.nxml.txt.nlp	25610671	SENT73	3	3	5	5	thyroglobulin	PTH	PA164754910	5741	0.566
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT30	5	5	11	11	erlotinib	CYP3A	PA134687924	1574	0.566
NULL	Exp_Ther_Med_2014_Sep_14_8(3)_836-840.nxml.txt.nlp	25120610	SENT5	42	42	19	19	fasudil	RhoA	PA165946121	387	0.566
NULL	EPMA_J_2010_Sep_17_1(3)_369-375.nxml.txt.nlp	21151487	SENT70	14	14	18	18	tamoxifen	CYP2D6	PA451581	1565	0.566
NULL	Indian_J_Crit_Care_Med_2012_Jul-Sep_16(3)_136-140.nxml.txt.nlp	23188953	SENT57	10	10	8	8	cefotaxime	CTX	PA448852	1593	0.566
NULL	EPMA_J_2012_Sep_27_3(1)_10.nxml.txt.nlp	23016735	SENT214	39	39	15	15	warfarin	PROC	PA451906	5624	0.566
NULL	Diabetes_Care_2013_May_13_36(5)_1368-1376.nxml.txt.nlp	23275363	SENT251	34	34	2	2	exenatide	Gen	PA164749238	348654	0.566
NULL	Cell_Death_Dis_2010_May_13_1(5)_e41.nxml.txt.nlp	21364648	SENT269	12	12	16	16	etoposide	p65	PA449552	5970	0.566
NULL	J_Infect_Dis_2011_May_1_203(9)_1204-1214.nxml.txt.nlp	21459813	SENT215	13	13	15	15	atazanavir	ATV	PA10251	4683	0.566
NULL	Tumour_Biol_2012_Jun_21_33(3)_607-615.nxml.txt.nlp	22270450	SENT123	24	24	5	5	trastuzumab	spatial	PA451743	219793	0.566
NULL	J_Inflamm_(Lond)_2008_Dec_5_5_23.nxml.txt.nlp	19061493	SENT175	19	19	5	5	hemin	HO-1	PA449849	3162	0.566
NULL	J_Clin_Biochem_Nutr_2010_Mar_27_46(2)_126-134.nxml.txt.nlp	20216945	SENT329	23	23	4	4	taurine	Met	PA451590	79811	0.566
NULL	Pharmacogn_Mag_2014_Oct-Dec_10(40)_536-540.nxml.txt.nlp	25422558	SENT118	9	9	25	25	ethanol	SLB	PA448073	26160	0.566
NULL	Front_Aging_Neurosci_2014_Sep_18_6_245.nxml.txt.nlp	25278877	SENT210	29	29	13	13	tetracycline	ADAM12	PA451640	8038	0.566
NULL	Apoptosis_2012_Jun_9_17(6)_566-578.nxml.txt.nlp	22402981	SENT166	35	35	18	18	pp2	PP2		4888	0.566
NULL	Acta_Histochem_Cytochem_2010_May_1_43(2)_61-68.nxml.txt.nlp	20514293	SENT68	11	11	14	14	hyaluronan	LYVE-1	PA165958431	10894	0.566
NULL	Antimicrob_Agents_Chemother_2014_Nov_10_59(1)_505-513.nxml.txt.nlp	25385096	SENT147	2	2	10	10	creatine	AST	PA164778930	26503	0.566
NULL	BMB_Rep_2014_Jan_47(1)_33-38.nxml.txt.nlp	24209634	SENT326	9	9	1	1	tamoxifen	CXCR4	PA451581	7852	0.566
NULL	Arthritis_Rheum_2011_Oct_63(10)_2854-2864.nxml.txt.nlp	21618201	SENT225	13	13	17	17	abatacept	ACR	PA164747080	49	0.566
NULL	Cancer_Med_2013_Jun_25_2(3)_277-285.nxml.txt.nlp	23930204	SENT110	6	6	16	16	capecitabine	PTEN	PA448771	5728	0.566
NULL	Crit_Care_2006_May_12_10(3)_R75.nxml.txt.nlp	16696866	SENT126	3	3	0	0	vasopressin	AVP	PA451858	114548;551	0.566
NULL	Cancer_Cell_Int_2005_Jul_24_5_22.nxml.txt.nlp	16042792	SENT66	4	4	11	11	vincristine	NAC	PA451879	22861	0.566
NULL	Clin_Exp_Gastroenterol_2014_Jan_24_7_13-23.nxml.txt.nlp	24493931	SENT170	4	4	8	8	dextran	IL-10	PA449261	3586	0.566
NULL	Int_J_Hypertens_2012_Nov_30_2012_192567.nxml.txt.nlp	22187625	SENT164	27	27	41	41	candesartan	ANOVA	PA448765	4858	0.566
NULL	Arthritis_Res_Ther_2009_Aug_24_11(4)_R127.nxml.txt.nlp	19703304	SENT56	18	18	7	7	adalimumab	OASIS	PA10004	90993	0.566
NULL	Oncotarget_2014_Oct_15_5(21)_10763-10777.nxml.txt.nlp	25333257	SENT57	21	21	29	29	irinotecan	FasL	PA450085	356	0.566
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT13	3	3	6	6	pemetrexed	UNG	PA10810	7374	0.566
NULL	J_Adv_Pract_Oncol_2012_May_1_May-Jun_3(3)_184-190.nxml.txt.nlp	25031945	SENT10	17	17	6	6	cyclophosphamide	ALK1	PA449165	6590;94	0.566
NULL	J_Immunol_Res_2014_Nov_30_2014_342693.nxml.txt.nlp	25762441	SENT139	22	22	6	6	valsartan	IL-6	PA451848	3569	0.566
NULL	J_Immunol_Res_2014_May_12_2014_897249.nxml.txt.nlp	24901013	SENT123	0	0	3	3	natalizumab	CD49d	PA164747191	3676	0.566
NULL	Front_Immunol_2013_Sep_9_4_269.nxml.txt.nlp	24058364	SENT21	9	9	0	0	oxygen	TRX	PA450744	7295	0.566
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT120	24	24	22	22	vinorelbine	ASC	PA451881	29108	0.566
NULL	Mar_Drugs_2014_Oct_17_12(10)_5209-5221.nxml.txt.nlp	25329704	SENT49	0	0	11	11	verapamil	P-gp	PA451868	5243	0.566
NULL	Europace_2011_Feb_7_13(2)_161-173.nxml.txt.nlp	21138930	SENT155	28	28	23	23	flecainide	CAST	PA449646	10849;26059;831	0.566
NULL	Mucosal_Immunol_2013_Jan_1_6(1)_177-188.nxml.txt.nlp	22854708	SENT183	17	17	19	19	collagenase	VIII	PA449107	1351	0.566
NULL	Oncol_Lett_2014_Jun_3_7(6)_2083-2088.nxml.txt.nlp	24932293	SENT111	2	2	0	0	cyclophosphamide	CTX	PA449165	1593	0.566
NULL	Indian_J_Pharmacol_2013_May-Jun_45(3)_274-277.nxml.txt.nlp	23833372	SENT87	4	4	9	9	colchicine	CA1	PA449092	759	0.566
NULL	Mol_Cancer_2009_Jul_1_8_42.nxml.txt.nlp	19570220	SENT190	31	31	39	39	glucose	CO2	PA449773	4513	0.566
NULL	Br_J_Clin_Pharmacol_2014_Sep_20_78(3)_509-523.nxml.txt.nlp	25279405	SENT113	21	21	5	5	tacrolimus	CYP3A	PA451578	1574	0.566
NULL	Breast_Cancer_Res_2010_Oct_28_12(5)_212.nxml.txt.nlp	21067532	SENT109	22	22	29	29	doxorubicin	ACT	PA449412	12;11332;9457;641455	0.566
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT110	10	10	24	24	trastuzumab	HER2	PA451743	2064	0.566
NULL	Carcinogenesis_2010_Dec_27_31(12)_2049-2057.nxml.txt.nlp	20876285	SENT10	18	18	15	15	tamoxifen	HER2	PA451581	2064	0.566
NULL	Indian_J_Ophthalmol_2007_Nov-Dec_55(6)_483b-486.nxml.txt.nlp	17951918	SENT64	11	11	8	8	bevacizumab	PED	PA130232992	8682	0.566
NULL	Arthritis_Res_Ther_2011_Feb_16_13(1)_R25.nxml.txt.nlp	21324169	SENT120	22	22	4	4	infliximab	ADA	PA452639	100	0.566
NULL	J_Breast_Cancer_2013_Jun_28_16(2)_133-137.nxml.txt.nlp	23843843	SENT43	0	0	2	2	curcumin	HER2	PA151958596	2064	0.566
NULL	Multidiscip_Respir_Med_2011_Oct_31_6(5)_291-298.nxml.txt.nlp	22958759	SENT46	27	27	11	11	methacholine	ACT	PA165958382	12;11332;9457;641455	0.566
NULL	Cell_Death_Dis_2010_Sep_23_1(9)_e78.nxml.txt.nlp	21364680	SENT163	41	41	14	14	cisplatin	P31	PA449014	529	0.566
NULL	Pharmaceuticals_(Basel)_2011_Jan_12_4(1)_187-201.nxml.txt.nlp	NULL	SENT155	2	2	29	29	l-arginine	OTC	PA448478	5009	0.566
NULL	J_Physiol_2011_Feb_1_589(Pt_3)_755-766.nxml.txt.nlp	21173081	SENT262	5	5	7	7	vasopressin	AVP	PA451858	114548;551	0.566
NULL	J_Gen_Physiol_2003_Jul_122(1)_45-61.nxml.txt.nlp	12835470	SENT0	18	18	1	1	capsaicin	Gen	PA448776	348654	0.566
NULL	Cell_Commun_Signal_2013_Oct_1_11_73.nxml.txt.nlp	24083678	SENT246	0	0	8	8	sulindac	NIK	PA451565	9020;9448	0.566
NULL	Br_J_Cancer_2010_Jan_5_102(1)_80-86.nxml.txt.nlp	19920817	SENT12	29	29	31	31	bevacizumab	IFN	PA130232992	3439	0.566
NULL	Clin_Ophthalmol_2014_Feb_10_8_389-399.nxml.txt.nlp	24550667	SENT151	16	16	14	14	timolol	TIM	PA451690	7984;8914	0.566
NULL	Cancers_(Basel)_2010_May_28_2(2)_1027-1039.nxml.txt.nlp	24281105	SENT52	8	8	14	14	bevacizumab	IL-8	PA130232992	3576	0.566
NULL	Infect_Ecol_Epidemiol_2014_Jan_15_4_10_3402_iee_v4_23011.nxml.txt.nlp	24455106	SENT55	34	34	24	24	streptomycin	FBS	PA451512	64319;26269	0.566
NULL	Breast_Cancer_Res_2011_Jan_7_13(1)_R1.nxml.txt.nlp	21214929	SENT180	2	2	8	8	cisplatin	GAPDH	PA449014	2597	0.566
NULL	Biomed_Res_Int_2013_Dec_20_2013_962376.nxml.txt.nlp	23509823	SENT143	9	9	32	32	ethanol	CO2	PA448073	4513	0.566
NULL	Mar_Drugs_2014_Dec_18_12(12)_6125-6141.nxml.txt.nlp	25528957	SENT313	4	4	22	22	cyclophosphamide	p53	PA449165	7157	0.566
NULL	Front_Genet_2013_Aug_29_4_163.nxml.txt.nlp	24009622	SENT143	9	9	11	11	ethanol	ABCG2	PA448073	9429	0.566
NULL	Cardiol_Res_Pract_2013_Jan_31_2013_128795.nxml.txt.nlp	23431496	SENT8	8	8	19	19	clopidogrel	CYP2C19	PA449053	1557	0.566
NULL	Front_Microbiol_2013_Aug_19_4_241.nxml.txt.nlp	23966991	SENT872	16	16	2	2	ceftriaxone	GLT-1	PA448866	6506	0.566
NULL	Clin_Ophthalmol_2009_Jun_2_3_291-295.nxml.txt.nlp	19668581	SENT63	17	17	19	19	latanoprost	BAK	PA164774763	578	0.566
NULL	Front_Neurol_2014_Feb_18_5_17.nxml.txt.nlp	24600432	SENT106	25	25	11	11	levetiracetam	CD80	PA450206	941	0.566
NULL	Arthritis_Res_Ther_2004_Mar_8_6(3)_R199-R207.nxml.txt.nlp	15142265	SENT26	2	2	0	0	collagenase	MMP1	PA449107	4312	0.566
NULL	Acta_Pharmacol_Sin_2012_Dec_29_33(12)_1518-1524.nxml.txt.nlp	23103625	SENT168	16	16	3	3	telmisartan	ACE	PA451605	1636	0.566
NULL	J_Breast_Cancer_2013_Mar_31_16(1)_12-15.nxml.txt.nlp	23593076	SENT61	33	33	21	21	capecitabine	TPC	PA448771	8030;60386	0.566
NULL	Indian_J_Pharmacol_2014_Sep-Oct_46(5)_549-550.nxml.txt.nlp	25298588	SENT46	16	16	22	22	warfarin	VKORC1	PA451906	79001	0.566
NULL	Case_Rep_Gastroenterol_2011_Oct_7_5(3)_610-616.nxml.txt.nlp	22110423	SENT66	21	21	25	25	mesalazine	DLST	PA450384	1743	0.566
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2011_Aug_23_4_39-45.nxml.txt.nlp	22879793	SENT89	42	42	8	8	ribavirin	IFN	PA451241	3439	0.566
NULL	Ann_Hematol_2010_Nov_25_89(11)_1115-1124.nxml.txt.nlp	20499237	SENT119	32	32	5	5	simvastatin	CD5	PA451363	921	0.566
NULL	Biol_Open_2014_Nov_21_3(12)_1207-1216.nxml.txt.nlp	25416063	SENT23	17	17	11	11	zinc	NANOS2	PA451956	339345	0.566
NULL	Pain_2012_Apr_153(4)_775-783.nxml.txt.nlp	22325744	SENT78	13	13	10	10	isoflurane	P28	PA450106	9446;7802;9527	0.566
NULL	J_Invest_Dermatol_2012_Jan_18_132(1)_163-169.nxml.txt.nlp	21850019	SENT78	29	29	33	33	imiquimod	IL-2	PA449972	3558	0.566
NULL	Oncotarget_2014_Oct_21_5(22)_11252-11268.nxml.txt.nlp	25361004	SENT19	12	12	1	1	metformin	AMPK	PA450395	5563	0.566
NULL	Breast_Cancer_Res_2003_Feb_5_5(2)_113-116.nxml.txt.nlp	12631392	SENT94	35	35	33	33	trastuzumab	TPC	PA451743	8030;60386	0.566
NULL	Cell_Death_Dis_2012_Mar_8_3(3)_e278.nxml.txt.nlp	22402602	SENT55	4	4	38	38	nifedipine	SOC	PA450631	91544	0.566
NULL	Int_J_Nanomedicine_2007_Mar_2(1)_13-18.nxml.txt.nlp	17722507	SENT3	0	0	7	7	aprepitant	CYP3A4	PA164747039	1576	0.566
NULL	Oncol_Lett_2013_Aug_20_6(2)_329-335.nxml.txt.nlp	24137325	SENT233	3	3	19	19	pp2	PP2		4888	0.566
NULL	Cancer_Med_2013_Dec_31_2(6)_950-963.nxml.txt.nlp	24403269	SENT100	20	20	10	10	hydrocortisone	F12	PA449905	2161	0.566
NULL	Br_J_Haematol_2014_Mar_13_164(1)_811-821.nxml.txt.nlp	24328678	SENT164	14	14	6	6	lenalidomide	IL2	PA162363968	3558	0.566
NULL	Mediators_Inflamm_2010_Jun_21_2010_194896.nxml.txt.nlp	20652055	SENT48	33	33	12	12	telmisartan	mol	PA451605	90527	0.566
NULL	Biosci_Rep_2012_Dec_1_32(Pt_6)_511-519.nxml.txt.nlp	NULL	SENT179	4	4	10	10	simvastatin	RANKL	PA451363	8600	0.566
NULL	Int_J_Womens_Health_2010_Aug_9_1_11-20.nxml.txt.nlp	21072271	SENT147	19	19	25	25	raloxifene	STAR	PA451221	6770;2984	0.566
NULL	Contemp_Oncol_(Pozn)_2012_Nov_20_16(5)_363-370.nxml.txt.nlp	23788912	SENT24	13	13	28	28	dacarbazine	IL-2	PA449197	3558	0.566
NULL	Eur_J_Haematol_2014_Feb_25_92(2)_127-136.nxml.txt.nlp	24118452	SENT109	2	2	4	4	anagrelide	CRT	PA164742986	811	0.566
NULL	Pharmaceutics_2011_Oct_12_3(4)_680-705.nxml.txt.nlp	24309303	SENT60	18	18	23	23	pravastatin	OATP1B3	PA451089	28234	0.566
NULL	Eur_J_Clin_Microbiol_Infect_Dis_2010_May_13_29(5)_543-550.nxml.txt.nlp	20229224	SENT73	5	5	7	7	oxacillin	PEN	PA450725	9933	0.566
NULL	Int_J_Mol_Sci_2014_Oct_7_15(10)_17901-17919.nxml.txt.nlp	25295482	SENT77	16	16	5	5	thrombin	ADP	PA451674	23038	0.566
NULL	Crit_Care_2012_Mar_9_16(2)_R43.nxml.txt.nlp	NULL	SENT104	33	33	24	24	heparin	TKR	PA449855	8277	0.566
NULL	Oncol_Rep_2013_Jun_22_29(6)_2479-2485.nxml.txt.nlp	23525656	SENT117	26	26	20	20	cisplatin	MRP7	PA449014	89845;1080	0.566
NULL	Clin_Sci_(Lond)_2013_Feb_1_124(Pt_3)_153-164.nxml.txt.nlp	23075334	SENT704	13	13	19	19	metformin	HIF-1	PA450395	29072	0.566
NULL	Asian-Australas_J_Anim_Sci_2012_Apr_25(4)_471-478.nxml.txt.nlp	25049587	SENT37	31	31	14	14	pp2	PP1		5540;5464	0.566
NULL	Evid_Based_Complement_Alternat_Med_2012_May_29_2012_548430.nxml.txt.nlp	22690247	SENT180	10	10	5	5	l-carnitine	OCTN2	PA450154	6584	0.566
NULL	Mol_Cell_Proteomics_2013_Aug_14_12(8)_2313-2323.nxml.txt.nlp	23674616	SENT213	8	8	4	4	levamisole	ALPL	PA450205	249	0.566
NULL	Bioinformation_2012_Jan_6_8(1)_13-19.nxml.txt.nlp	22359429	SENT88	2	2	4	4	curcumin	MRP1	PA151958596	4437	0.566
NULL	Pain_Res_Treat_2012_Sep_29_2012_427869.nxml.txt.nlp	22110941	SENT54	27	27	23	23	capsaicin	TRPV1	PA448776	7442	0.566
NULL	Breast_Cancer_(Auckl)_2011_Jul_27_5_175-199.nxml.txt.nlp	21863131	SENT435	0	0	9	9	olaparib	BRCA1		672	0.566
NULL	Oncol_Lett_2014_Jun_8_7(6)_2035-2040.nxml.txt.nlp	24932285	SENT168	18	18	7	7	irinotecan	ABCG2	PA450085	9429	0.566
NULL	Patient_Prefer_Adherence_2009_Nov_29_3_345-355.nxml.txt.nlp	20016798	SENT161	4	4	16	16	olanzapine	NNT	PA450688	23530	0.566
NULL	Exp_Ther_Med_2014_Dec_15_8(6)_1909-1913.nxml.txt.nlp	25371754	SENT51	11	11	9	9	l-glutamine	B27	PA10090	56246	0.566
NULL	Antimicrob_Resist_Infect_Control_2012_Mar_16_1_12.nxml.txt.nlp	22958880	SENT107	11	11	16	16	amoxicillin	Gen	PA448406	348654	0.566
NULL	Arthritis_Res_Ther_2006_Mar_22_8(3)_R62.nxml.txt.nlp	16563187	SENT324	6	6	9	9	fluorescein	ICOS	PA164746009	29851;1493	0.566
NULL	Exp_Lung_Res_2013_Oct_1_39(8)_336-348.nxml.txt.nlp	23919450	SENT100	21	21	8	8	thrombin	PAR-1	PA451674	2011;2149	0.566
NULL	Front_Cell_Neurosci_2015_Jan_15_8_459.nxml.txt.nlp	25642166	SENT40	22	22	17	17	hemin	HO-1	PA449849	3162	0.566
NULL	Breast_Cancer_Res_2009_Oct_29_11(5)_R77.nxml.txt.nlp	19874578	SENT52	25	25	9	9	hydrocortisone	F12	PA449905	2161	0.566
NULL	Br_J_Cancer_2010_Feb_16_102(4)_658-664.nxml.txt.nlp	20104222	SENT152	12	12	17	17	sunitinib	IFN	PA162372840	3439	0.566
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT325	6	6	2	2	nutlin-3	p53		7157	0.566
NULL	Reprod_Biol_Endocrinol_2003_Aug_12_1_55.nxml.txt.nlp	12941156	SENT73	26	26	16	16	l-glutamine	F12	PA10090	2161	0.566
NULL	Int_J_Endocrinol_2011_Dec_20_2011_746482.nxml.txt.nlp	22216029	SENT265	44	44	14	14	forskolin	K60	PA146096022	3576	0.566
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Aug_22_65(Pt_9)_m1106-m1107.nxml.txt.nlp	21577453	SENT67	2	2	29	29	ethanol	NO3	PA448073	4681	0.566
NULL	Mol_Biol_Rep_2012_May_20_39(5)_5253-5267.nxml.txt.nlp	22183301	SENT150	10	10	8	8	gliclazide	NAC	PA10892	22861	0.566
NULL	Int_J_Environ_Res_Public_Health_2013_Sep_12_10(9)_4274-4305.nxml.txt.nlp	24036486	SENT71	5	5	25	25	ertapenem	HCAP	PA164777032	117159;9126	0.566
NULL	Aging_(Albany_NY)_2009_Feb_18_1(3)_335-349.nxml.txt.nlp	20195489	SENT216	23	23	17	17	etoposide	p65	PA449552	5970	0.566
NULL	FEBS_Open_Bio_2014_Oct_22_4_905-914.nxml.txt.nlp	25383314	SENT561	12	12	18	18	physostigmine	ANOVA	PA450957	4858	0.566
NULL	Int_J_Biol_Sci_2014_Aug_23_10(8)_921-939.nxml.txt.nlp	25170305	SENT302	8	8	31	31	nadh	EPO	PA164755085	7076;8288;2056	0.566
NULL	Environ_Health_Perspect_2011_Jun_17_119(6)_778-783.nxml.txt.nlp	21169129	SENT189	14	14	34	34	fluorescein	CD40	PA164746009	958	0.566
NULL	Br_J_Ophthalmol_2014_Sep_98(9)_1144-1167.nxml.txt.nlp	25136079	SENT321	9	9	4	4	ranibizumab	CRT	PA164746012	811	0.566
NULL	Clin_Proteomics_2014_Nov_1_11(1)_38.nxml.txt.nlp	25392709	SENT95	22	22	27	27	trypsin	SRM	PA451806	6723;6725	0.566
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT144	42	42	34	34	vinorelbine	MVP	PA451881	9961	0.566
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT11	5	5	13	13	glucose	EGFR	PA449773	1956	0.566
NULL	Mol_Cancer_2008_May_16_7_38.nxml.txt.nlp	18485224	SENT194	30	30	8	8	streptomycin	BRL	PA451512	23774	0.566
NULL	Eur_J_Clin_Pharmacol_2008_Feb_26_64(2)_133-157.nxml.txt.nlp	18224312	SENT544	11	11	43	43	trimipramine	CYP2C19	PA451791	1557	0.566
NULL	Oncol_Lett_2013_Sep_12_6(3)_667-672.nxml.txt.nlp	24137387	SENT156	11	11	32	32	sorafenib	ARG	PA7000	473;27	0.566
NULL	Indian_J_Pharmacol_2014_Jan-Feb_46(1)_46-50.nxml.txt.nlp	24550584	SENT129	18	18	26	26	vildagliptin	GLP-1	PA165958346	100125288	0.566
NULL	Diabetol_Metab_Syndr_2014_Sep_23_6(1)_102.nxml.txt.nlp	NULL	SENT148	0	0	5	5	atorvastatin	RAGE	PA448500	177	0.566
NULL	Mediators_Inflamm_2010_Jun_28_2010_174341.nxml.txt.nlp	20652043	SENT171	17	17	15	15	thrombin	ADP	PA451674	23038	0.566
NULL	Vet_Res_2013_Oct_1_44(1)_86.nxml.txt.nlp	24083845	SENT134	10	10	8	8	vancomycin	VAN	PA451850	10318	0.566
NULL	Curr_Genomics_2013_May_14(3)_195-203.nxml.txt.nlp	24179442	SENT86	35	35	43	43	nadh	CO3	PA164755085	4514	0.566
NULL	Arthritis_Res_Ther_2011_Feb_16_13(1)_R25.nxml.txt.nlp	21324169	SENT120	37	37	4	4	tocilizumab	ADA	PA165292659	100	0.566
NULL	J_Adv_Pract_Oncol_2013_Jul_1_Jul-Aug_4(4)_238-250.nxml.txt.nlp	25032004	SENT163	8	8	10	10	imatinib	CYP3A4	PA10804	1576	0.566
NULL	Oncoscience_2014_Apr_30_1(4)_283-286.nxml.txt.nlp	25594020	SENT6	31	31	24	24	doxorubicin	STAT6	PA449412	6778	0.566
NULL	Mol_Biol_Rep_2013_May_11_40(8)_5013-5026.nxml.txt.nlp	23666059	SENT348	3	3	12	12	resveratrol	HER-2		2064	0.566
NULL	J_Immune_Based_Ther_Vaccines_2008_Jun_9_6_3.nxml.txt.nlp	18541039	SENT4	6	6	2	2	ribavirin	IFN	PA451241	3439	0.566
NULL	Cardiol_Res_Pract_2012_Aug_15_2012_713294.nxml.txt.nlp	22928146	SENT50	16	16	19	19	carvedilol	Q10	PA448817	27161	0.566
NULL	J_Biol_Chem_2008_Nov_14_283(46)_31679-31689.nxml.txt.nlp	18755684	SENT328	24	24	6	6	iron	FTL	PA450087	2512	0.566
NULL	Front_Oncol_2014_Jun_20_4_163.nxml.txt.nlp	24999452	SENT353	15	15	12	12	cisplatin	p53	PA449014	7157	0.566
NULL	Neuropsychopharmacology_2011_Jul_30_36(8)_1575-1586.nxml.txt.nlp	21451498	SENT233	12	12	8	8	methylphenidate	ANOVA	PA450464	4858	0.566
NULL	Allergy_Asthma_Clin_Immunol_2014_Mar_3_10(Suppl_1)_A69.nxml.txt.nlp	NULL	SENT23	4	4	10	10	formoterol	ASM	PA134687907	6609;283120	0.566
NULL	Hum_Genomics_2009_Jan_1_3(2)_128-142.nxml.txt.nlp	19164090	SENT235	20	20	13	13	carboplatin	CD44	PA448803	960	0.566
NULL	Curr_Neuropharmacol_2013_Dec_11(6)_652-663.nxml.txt.nlp	24396340	SENT253	24	24	21	21	capsaicin	PKR1	PA448776	10887	0.566
NULL	Crit_Care_2010_Apr_19_14(2)_R70.nxml.txt.nlp	20403177	SENT252	9	9	5	5	thrombin	cPLA2	PA451674	10524	0.566
NULL	Lab_Invest_2012_Aug_23_92(8)_1171-1180.nxml.txt.nlp	22525426	SENT54	24	24	12	12	paraformaldehyde	adiponectin	PA450790	9370	0.566
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Dec_10_68(Pt_1)_o60.nxml.txt.nlp	22259561	SENT61	19	19	27	27	ethanol	mol	PA448073	90527	0.566
NULL	Case_Rep_Rheumatol_2014_Jul_3_2014_358567.nxml.txt.nlp	25097790	SENT60	2	2	13	13	etanercept	IL-18	PA449515	3606	0.566
NULL	Br_J_Cancer_2013_Sep_3_109(5)_1157-1164.nxml.txt.nlp	23942075	SENT8	10	10	3	3	cyclophosphamide	NAT	PA449165	6046	0.566
NULL	Ann_Hematol_2014_Sep_12_93(1)_13-32.nxml.txt.nlp	24026426	SENT274	17	17	29	29	caspofungin	BII	PA164743013	777	0.566
NULL	J_Biol_Chem_2012_Apr_6_287(15)_12433-12444.nxml.txt.nlp	22351758	SENT980	21	21	23	23	hyaluronan	TSG-6	PA165958431	7130	0.566
NULL	Cancers_(Basel)_2014_Apr_30_6(2)_1031-1046.nxml.txt.nlp	24785146	SENT93	9	9	12	12	geldanamycin	HER2	PA152031327	2064	0.566
NULL	Arthritis_Res_Ther_2011_May_25_13(Suppl_1)_S2.nxml.txt.nlp	21624181	SENT265	0	0	22	22	infliximab	IMPACT	PA452639	55364	0.566
NULL	Cell_Mol_Life_Sci_2011_Mar_25_68(5)_847-862.nxml.txt.nlp	20734105	SENT222	31	31	11	11	forskolin	CRM1	PA146096022	7514	0.566
NULL	Br_J_Nutr_2013_May_14_109(9)_1678-1687.nxml.txt.nlp	22935250	SENT92	3	3	0	0	vasopressin	AVP	PA451858	114548;551	0.566
NULL	Br_J_Cancer_2012_May_8_106(10)_1638-1647.nxml.txt.nlp	22498643	SENT252	16	16	18	18	deferoxamine	HIF-1	PA164746490	29072	0.566
NULL	Oncol_Lett_2014_Sep_19_8(3)_1269-1274.nxml.txt.nlp	25120704	SENT104	20	20	18	18	cisplatin	Met	PA449014	79811	0.566
NULL	Int_J_Vasc_Med_2012_Aug_21_2012_648167.nxml.txt.nlp	22957259	SENT63	4	4	9	9	estradiol	MCP-1	PA449503	6347	0.566
NULL	Crit_Care_2012_Mar_2_16(2)_R37.nxml.txt.nlp	22386062	SENT170	28	28	31	31	oxygen	CENPV	PA450744	201161	0.566
NULL	Environ_Health_Perspect_2008_Mar_26_116(3)_322-328.nxml.txt.nlp	18335098	SENT168	22	22	45	45	estradiol	PMI	PA449503	8834;5373	0.566
NULL	Acta_Pharmacol_Sin_2012_Feb_3_33(2)_145-147.nxml.txt.nlp	22301854	SENT31	9	9	20	20	exenatide	GLP-1	PA164749238	100125288	0.566
NULL	J_Inherit_Metab_Dis_2011_Apr_29_34(2)_315-325.nxml.txt.nlp	20668944	SENT174	34	34	14	14	resveratrol	AMPK		5563	0.566
NULL	Neuroimage_Clin_2013_Sep_3_3_242-248.nxml.txt.nlp	24273709	SENT294	22	22	4	4	phenytoin	CLB	PA450947	171425	0.566
NULL	Br_J_Nutr_2013_May_14_109(9)_1678-1687.nxml.txt.nlp	22935250	SENT15	11	11	8	8	vasopressin	AVP	PA451858	114548;551	0.566
NULL	Ann_Neurosci_2011_Apr_18(2)_48-55.nxml.txt.nlp	25205921	SENT188	1	1	15	15	reserpine	SOD1	PA451236	6647	0.566
NULL	J_Breast_Cancer_2013_Jun_28_16(2)_164-170.nxml.txt.nlp	23843848	SENT187	18	18	8	8	doxorubicin	p53	PA449412	7157	0.566
NULL	Cancers_(Basel)_2010_Mar_12_2(1)_165-189.nxml.txt.nlp	24281039	SENT790	6	6	4	4	sargramostim	GM-CSF	PA164748631	1437	0.566
NULL	J_Ayurveda_Integr_Med_2014_Jan-Mar_5(1)_38-42.nxml.txt.nlp	24812474	SENT16	36	36	5	5	ethanol	CEE	PA448073	51608	0.566
NULL	Arch_Med_Sci_2013_Oct_31_9(5)_936-943.nxml.txt.nlp	24273582	SENT103	3	3	5	5	nateglinide	GLP-1	PA450600	100125288	0.566
NULL	Ann_Oncol_2012_Dec_2_23(12)_3007-3016.nxml.txt.nlp	22865781	SENT111	18	18	16	16	trastuzumab	PTEN	PA451743	5728	0.566
NULL	Evid_Based_Complement_Alternat_Med_2013_Aug_20_2013_789067.nxml.txt.nlp	24069055	SENT219	8	8	22	22	lipase	gamma	PA450239	9913	0.566
NULL	Acta_Pharmacol_Sin_2011_May_18_32(5)_647-654.nxml.txt.nlp	21499289	SENT47	28	28	48	48	l-glutamine	CO2	PA10090	4513	0.566
NULL	J_Clin_Biochem_Nutr_2010_Jan_29_46(1)_36-42.nxml.txt.nlp	20104263	SENT61	12	12	8	8	ribavirin	IFN	PA451241	3439	0.566
NULL	J_Adv_Pract_Oncol_2012_Nov_1_Nov-Dec_3(6)_355-356.nxml.txt.nlp	25031966	SENT30	23	23	20	20	warfarin	DES	PA451906	1674	0.565
NULL	Arthritis_Res_Ther_2008_Jan_18_10(1)_R8.nxml.txt.nlp	18205921	SENT185	41	41	44	44	hyaluronan	MRP5	PA165958431	10057	0.565
NULL	Cancer_Immunol_Immunother_2013_May_16_62(5)_897-908.nxml.txt.nlp	23589107	SENT4	5	5	7	7	cyclophosphamide	CTX	PA449165	1593	0.565
NULL	Nat_Commun_2014_Mar_17_5_3438.nxml.txt.nlp	24633423	SENT628	24	24	27	27	spermine	PAO	PA164781199	196743;54498	0.565
NULL	Front_Neurosci_2014_Jul_17_8_200.nxml.txt.nlp	25100932	SENT77	4	4	11	11	ethanol	xCT	PA448073	23657	0.565
NULL	Cell_Cycle_2013_Jul_1_12(13)_1987-1988.nxml.txt.nlp	23759579	SENT32	16	16	35	35	glucose	IDH1	PA449773	3417	0.565
NULL	Core_Evid_2009_Jun_15_4_25-36.nxml.txt.nlp	20694062	SENT161	29	29	18	18	febuxostat	FACT	PA165958521	11198	0.565
NULL	Mol_Cancer_2009_Dec_23_8_129.nxml.txt.nlp	20030852	SENT193	7	7	9	9	curcumin	p65	PA151958596	5970	0.565
NULL	Case_Rep_Ophthalmol_Med_2011_Jan_31_2011_679751.nxml.txt.nlp	22606470	SENT31	12	12	9	9	triamcinolone	hole	PA451749	80757	0.565
NULL	Angiogenesis_2011_Mar_4_14(1)_17-27.nxml.txt.nlp	21049284	SENT141	23	23	20	20	thrombin	CD144	PA451674	1003	0.565
NULL	Oncogene_2009_Jan_15_28(2)_157-169.nxml.txt.nlp	18931700	SENT152	2	2	23	23	geldanamycin	CDC37	PA152031327	11140	0.565
NULL	Ann_Oncol_2009_Nov_23_20(11)_1803-1812.nxml.txt.nlp	19549706	SENT202	14	14	29	29	sunitinib	IFN	PA162372840	3439	0.565
NULL	Front_Genet_2014_Jun_4_5_167.nxml.txt.nlp	24926315	SENT602	11	11	0	0	efavirenz	ABCB1	PA449441	5243	0.565
NULL	Oncotarget_2014_Aug_14_5(16)_6552-6553.nxml.txt.nlp	25138048	SENT24	36	36	2	2	vincristine	STAT6	PA451879	6778	0.565
NULL	Biochemistry_2009_Sep_15_48(36)_8664-8671.nxml.txt.nlp	19653655	SENT24	33	33	18	18	nadh	DTNB	PA164755085	1838	0.565
NULL	Arch_Med_Sci_2014_Oct_27_10(5)_1007-1018.nxml.txt.nlp	25395954	SENT178	2	2	23	23	cytarabine	CTX	PA449177	1593	0.565
NULL	Oncol_Lett_2014_Jun_3_7(6)_2083-2088.nxml.txt.nlp	24932293	SENT116	2	2	8	8	cyclophosphamide	CXCR4	PA449165	7852	0.565
NULL	Acta_Pharmacol_Sin_2012_Feb_2_33(2)_230-236.nxml.txt.nlp	22212389	SENT27	34	34	36	36	vasopressin	AVP	PA451858	114548;551	0.565
NULL	Int_J_Mol_Sci_2012_Dec_5_13(12)_16636-16657.nxml.txt.nlp	23443123	SENT660	1	1	14	14	nilotinib	CD34	PA165958345	947	0.565
NULL	Mol_Cancer_2014_Apr_17_13_84.nxml.txt.nlp	24742333	SENT262	45	45	24	24	l-glutamine	CO2	PA10090	4513	0.565
NULL	Curr_Hepat_Rep_2010_May_21_9(2)_75-90.nxml.txt.nlp	20461127	SENT244	27	27	37	37	lamivudine	LAM	PA450163	7249;7248	0.565
NULL	Front_Genet_2012_Nov_22_3_249.nxml.txt.nlp	23189085	SENT402	0	0	14	14	methotrexate	MTHFR	PA450428	4524	0.565
NULL	Br_J_Cancer_2012_Sep_4_107(6)_947-955.nxml.txt.nlp	22892392	SENT37	1	1	10	10	tamoxifen	HER2	PA451581	2064	0.565
NULL	Stroke_Res_Treat_2009_Dec_20_2010_386389.nxml.txt.nlp	20700422	SENT51	2	2	9	9	resveratrol	NAC		22861	0.565
NULL	Clin_Med_Insights_Womens_Health_2013_Jan_23_6_13-24.nxml.txt.nlp	24665210	SENT176	18	18	20	20	dydrogesterone	CEE	PA164745443	51608	0.565
NULL	Pharmaceuticals_(Basel)_2014_Jan_23_7(2)_113-135.nxml.txt.nlp	24463342	SENT99	16	16	4	4	memantine	PS1	PA10364	5663	0.565
NULL	J_Carcinog_2013_Dec_31_12_22.nxml.txt.nlp	24574860	SENT6	18	18	32	32	afatinib	EML4	PA165981154	27436	0.565
NULL	Acta_Pharmacol_Sin_2009_Feb_5_30(2)_228-234.nxml.txt.nlp	19122672	SENT30	6	6	19	19	isoflurane	HO-1	PA450106	3162	0.565
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1051.nxml.txt.nlp	24503543	SENT76	12	12	17	17	sunitinib	HER2	PA162372840	2064	0.565
NULL	Exp_Ther_Med_2014_Jul_8_8(1)_248-254.nxml.txt.nlp	24944630	SENT205	4	4	7	7	trypsin	CTX	PA451806	1593	0.565
NULL	Arthritis_Res_Ther_2008_Mar_19_10(2)_R36.nxml.txt.nlp	18353171	SENT79	9	9	27	27	paraformaldehyde	CD69	PA450790	969	0.565
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT156	8	8	12	12	doxorubicin	SLK	PA449412	9748;2534	0.565
NULL	Diabetes_Care_2010_Sep_21_33(9)_1954-1956.nxml.txt.nlp	20566677	SENT18	8	8	14	14	simvastatin	ESD	PA451363	2098	0.565
NULL	J_Oncol_2009_Nov_12_2009_457418.nxml.txt.nlp	19920864	SENT78	32	32	21	21	gemcitabine	p53	PA449748	7157	0.565
NULL	Front_Neurosci_2012_Apr_9_6_44.nxml.txt.nlp	22509146	SENT452	11	11	7	7	ethanol	AC5	PA448073	111	0.565
NULL	Iran_Red_Crescent_Med_J_2014_Mar_5_16(3)_e15344.nxml.txt.nlp	24829782	SENT10	10	10	22	22	sibutramine	slim	PA451344	23008	0.565
NULL	Front_Aging_Neurosci_2009_Dec_9_1_4.nxml.txt.nlp	20552055	SENT380	3	3	5	5	resveratrol	SIRT1		23411	0.565
NULL	Crit_Care_2011_Oct_25_15(5)_R255.nxml.txt.nlp	22026977	SENT22	31	31	33	33	vasopressin	AVP	PA451858	114548;551	0.565
NULL	J_Cell_Biol_2001_Oct_1_155(1)_101-112.nxml.txt.nlp	11571311	SENT547	25	25	18	18	paraformaldehyde	LIMK	PA450790	3984	0.565
NULL	Br_J_Haematol_2014_Feb_16_164(4)_469-480.nxml.txt.nlp	24372186	SENT162	12	12	8	8	rasburicase	G6PD	PA10176	2539	0.565
NULL	Behav_Neurol_2014_Nov_16_2014_360978.nxml.txt.nlp	25477708	SENT3	19	19	3	3	nicotine	spatial	PA450626	219793	0.565
NULL	Mol_Cancer_2006_Sep_5_5_34.nxml.txt.nlp	16953886	SENT151	24	24	40	40	gentamicin	CO2	PA449753	4513	0.565
NULL	Front_Neurol_2014_Feb_18_5_17.nxml.txt.nlp	24600432	SENT106	25	25	18	18	levetiracetam	CD86	PA450206	942	0.565
NULL	Acta_Pharmacol_Sin_2012_Jan_3_33(1)_49-56.nxml.txt.nlp	22212430	SENT97	4	4	10	10	thrombin	A10	PA451674	28870	0.565
NULL	J_Biomed_Biotechnol_2008_Jul_8_2008_597913.nxml.txt.nlp	18629230	SENT68	32	32	19	19	ethanol	PFK-1	PA448073	5213	0.565
NULL	J_Cell_Mol_Med_2014_Jul_13_18(7)_1278-1289.nxml.txt.nlp	24725826	SENT66	22	22	33	33	l-glutamine	CO2	PA10090	4513	0.565
NULL	Drug_Target_Insights_2007_Mar_22_2_83-96.nxml.txt.nlp	21901065	SENT14	12	12	16	16	thrombin	CRT	PA451674	811	0.565
NULL	Int_J_Mol_Sci_2014_Sep_22_15(9)_16800-16815.nxml.txt.nlp	25247578	SENT85	0	0	2	2	minoxidil	MNX	PA450521	3892	0.565
NULL	Front_Behav_Neurosci_2013_Dec_18_7_203.nxml.txt.nlp	24385956	SENT735	8	8	10	10	memantine	spatial	PA10364	219793	0.565
NULL	J_Allergy_(Cairo)_2011_Apr_6_2011_479129.nxml.txt.nlp	21603171	SENT62	0	0	22	22	tacrolimus	IL-4	PA451578	3565	0.565
NULL	Exp_Ther_Med_2013_Mar_20_5(3)_689-694.nxml.txt.nlp	23403765	SENT236	6	6	0	0	l-cysteine	PAG	PA449173	55824	0.565
NULL	Biomed_Eng_Online_2010_Mar_9_9_15.nxml.txt.nlp	20214774	SENT71	17	17	30	30	everolimus	DES	PA164746311	1674	0.565
NULL	J_Mol_Signal_2011_Aug_10_6_8.nxml.txt.nlp	21831305	SENT163	18	18	24	24	isoproterenol	AKAP5	PA450121	9495	0.565
NULL	J_Cancer_2013_Sep_27_4(8)_679-685.nxml.txt.nlp	24155780	SENT123	0	0	7	7	pertuzumab	HER2		2064	0.565
NULL	Curr_Pharm_Des_2011_Feb_17(6)_578-590.nxml.txt.nlp	21391908	SENT179	6	6	20	20	nutlin-3	p53		7157	0.565
NULL	J_Hepatobiliary_Pancreat_Surg_2008_Jan_16_15(1)_55-62.nxml.txt.nlp	18274844	SENT87	21	21	23	23	leucovorin	IFN	PA450198	3439	0.565
NULL	Mol_Cancer_2007_Nov_24_6_76.nxml.txt.nlp	18036246	SENT208	25	25	36	36	l-glutamine	CO2	PA10090	4513	0.565
NULL	Arthritis_Res_Ther_2012_Jun_12_14(3)_R142.nxml.txt.nlp	22691272	SENT14	5	5	7	7	mianserin	TLR7	PA134687937	51284	0.565
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT170	3	3	5	5	tacrolimus	RANKL	PA451578	8600	0.565
NULL	Arthritis_Res_Ther_2006_Nov_22_8(6)_R174.nxml.txt.nlp	17121678	SENT211	18	18	36	36	methotrexate	ART5	PA450428	116969	0.565
NULL	Breast_Cancer_Res_2012_Feb_14_14(1)_R30.nxml.txt.nlp	22333315	SENT159	4	4	9	9	celecoxib	CXCR3	PA448871	2833	0.565
NULL	Allergy_Asthma_Clin_Immunol_2010_Nov_4_6(Suppl_2)_P27.nxml.txt.nlp	NULL	SENT12	6	6	12	12	hydrocortisone	ACTH	PA449905	5443	0.565
NULL	EMBO_Mol_Med_2010_Jan_2(1)_26-37.nxml.txt.nlp	20043279	SENT273	13	13	0	0	fluorescein	FOR	PA164746009	51741	0.565
NULL	J_Appl_Oral_Sci_2010_Nov-Dec_18(6)_551-559.nxml.txt.nlp	21308284	SENT145	18	18	0	0	tetracycline	AMN	PA451640	215;81693	0.565
NULL	J_Int_AIDS_Soc_2012_Jul_10_15(2)_17393.nxml.txt.nlp	22789611	SENT122	2	2	4	4	abacavir	LTA	PA448004	4049	0.565
NULL	Front_Neurosci_2010_May_15_4_13.nxml.txt.nlp	20859447	SENT266	3	3	5	5	phencyclidine	PCP	PA128406980	5547	0.565
NULL	Cell_Death_Dis_2010_Oct_21_1(10)_e86.nxml.txt.nlp	21368859	SENT76	20	20	16	16	doxorubicin	Mcl-1	PA449412	4170	0.565
NULL	Front_Immunol_2014_Apr_23_5_182.nxml.txt.nlp	24795724	SENT113	1	1	17	17	heparin	CD4	PA449855	920	0.565
NULL	DNA_Res_2011_Aug_26_18(4)_291-303.nxml.txt.nlp	21791478	SENT44	21	21	6	6	paraformaldehyde	CD4	PA450790	920	0.565
NULL	Iran_J_Pharm_Res_2014_Summer_13(3)_975-985.nxml.txt.nlp	25276199	SENT187	13	13	22	22	naloxone	SON	PA450586	6651	0.565
NULL	Cancers_(Basel)_2014_Aug_5_6(3)_1597-1614.nxml.txt.nlp	25099886	SENT178	16	16	4	4	methotrexate	POLG	PA450428	5428	0.565
NULL	Biologics_2009_Sep_15_3_429-441.nxml.txt.nlp	19774210	SENT309	33	33	43	43	irinotecan	IFL	PA450085	3439	0.565
NULL	Saudi_J_Anaesth_2013_Jan-Mar_7(1)_14-17.nxml.txt.nlp	23717225	SENT7	19	19	33	33	hydrocortisone	CO2	PA449905	4513	0.565
NULL	ScientificWorldJournal_2012_Apr_30_2012_384936.nxml.txt.nlp	22623892	SENT70	19	19	39	39	l-glutamine	IL-3	PA10090	3562	0.565
NULL	Behav_Genet_2012_Jul_17_42(4)_509-527.nxml.txt.nlp	22426781	SENT384	12	12	36	36	phenol	CO2	PA450913	4513	0.565
NULL	Iran_J_Pharm_Res_2015_Winter_14(1)_313-320.nxml.txt.nlp	25561937	SENT186	6	6	8	8	resveratrol	SIRT1		23411	0.565
NULL	Oncotarget_2013_Feb_27_4(2)_316-328.nxml.txt.nlp	23530112	SENT281	13	13	16	16	medroxyprogesterone	PI3K	PA450344	5290	0.565
NULL	J_Exp_Clin_Cancer_Res_2009_Feb_13_28(1)_17.nxml.txt.nlp	19216775	SENT7	19	19	47	47	cisplatin	CCND1	PA449014	595	0.565
NULL	J_Cell_Biol_2000_Jul_24_150(2)_321-334.nxml.txt.nlp	10908575	SENT193	3	3	5	5	staurosporine	ICAD	PA165109623	1676	0.565
NULL	Exp_Mol_Med_2012_Sep_30_44(9)_545-553.nxml.txt.nlp	22809901	SENT8	0	0	30	30	clozapine	PRDM16	PA449061	63976	0.565
NULL	Evid_Based_Complement_Alternat_Med_2014_Dec_22_2014_180234.nxml.txt.nlp	25610475	SENT63	21	21	43	43	l-glutamine	CO2	PA10090	4513	0.565
NULL	Virulence_2013_Nov_15_4(8)_734-739.nxml.txt.nlp	24165210	SENT79	2	2	0	0	vancomycin	VAN	PA451850	10318	0.565
NULL	Front_Endocrinol_(Lausanne)_2011_Nov_10_2_72.nxml.txt.nlp	22649383	SENT108	16	16	11	11	estradiol	StAR	PA449503	6770	0.565
NULL	Mol_Vis_2012_May_1_18_1115-1122.nxml.txt.nlp	22605923	SENT41	9	9	21	21	estradiol	EGF	PA449503	1950	0.565
NULL	Diabetol_Metab_Syndr_2014_Mar_31_6_47.nxml.txt.nlp	24684779	SENT100	0	0	5	5	simvastatin	IL-6	PA451363	3569	0.565
NULL	Breast_Cancer_(Auckl)_2009_Sep_2_3_61-75.nxml.txt.nlp	19809577	SENT256	0	0	2	2	curcumin	BRCA1	PA151958596	672	0.565
NULL	Oncol_Lett_2014_Jul_28_8(1)_404-408.nxml.txt.nlp	24959285	SENT100	37	37	35	35	gemcitabine	GEM	PA449748	2669	0.565
NULL	Emerg_Infect_Dis_2014_Mar_20(3)_400-408.nxml.txt.nlp	24565738	SENT104	8	8	0	0	rifampin	DST	PA451250	667	0.565
NULL	Oncotarget_2013_Oct_19_4(11)_2045-2056.nxml.txt.nlp	24185104	SENT5	8	8	2	2	cisplatin	14-3-3	PA449014	10971	0.565
NULL	Cardiovasc_Diabetol_2013_Jun_8_12_86.nxml.txt.nlp	23758640	SENT61	8	8	17	17	urea	CRP	PA451831	1401;140913	0.565
NULL	Am_J_Trop_Med_Hyg_2010_Apr_82(4)_542-547.nxml.txt.nlp	20348496	SENT100	13	13	8	8	primaquine	G6PD	PA451103	2539	0.565
NULL	J_Orthop_Traumatol_2012_Sep_13_13(3)_125-130.nxml.txt.nlp	22688402	SENT69	6	6	16	16	coumarin	MIO	PA134521193	51085	0.565
NULL	Indian_J_Med_Paediatr_Oncol_2013_Apr-Jun_34(2)_96-98.nxml.txt.nlp	24049295	SENT54	4	4	15	15	cyclophosphamide	CHOP	PA449165	1649	0.565
NULL	Hum_Genomics_2013_Sep_23_7(1)_20.nxml.txt.nlp	24060470	SENT19	1	1	18	18	imatinib	KIT	PA10804	3815	0.565
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Aug_27_67(Pt_9)_o2403.nxml.txt.nlp	22058995	SENT66	17	17	9	9	ethanol	mol	PA448073	90527	0.565
NULL	Oncol_Lett_2014_Aug_19_8(2)_620-626.nxml.txt.nlp	25013476	SENT41	0	0	16	16	fluorescein	CD14	PA164746009	929	0.565
NULL	J_Ophthalmol_2011_Aug_8_2011_706849.nxml.txt.nlp	21845214	SENT36	15	15	10	10	fluorescein	FAF	PA164746009	8239;2188	0.565
NULL	J_Immunol_Res_2014_May_12_2014_897249.nxml.txt.nlp	24901013	SENT259	27	27	20	20	natalizumab	CD4	PA164747191	920	0.565
NULL	Int_J_Environ_Res_Public_Health_2010_Feb_11_7(2)_473-493.nxml.txt.nlp	20616986	SENT357	1	1	12	12	ethanol	ACTH	PA448073	5443	0.565
NULL	Protein_Cell_2014_Jun_19_5(6)_469-479.nxml.txt.nlp	24748116	SENT167	8	8	6	6	paclitaxel	EB1	PA450761	9167;22919;10982	0.565
NULL	Mol_Cancer_2009_Jun_9_8_37.nxml.txt.nlp	19508729	SENT51	1	1	6	6	gemcitabine	HO-1	PA449748	3162	0.565
NULL	Cancers_(Basel)_2010_Jun_14_2(2)_1288-1311.nxml.txt.nlp	24281116	SENT703	2	2	19	19	oxygen	AKT	PA450744	207	0.565
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT86	9	9	14	14	celecoxib	survivin	PA448871	332	0.565
NULL	Exp_Hematol_Oncol_2013_Aug_2_2_19.nxml.txt.nlp	23915571	SENT148	7	7	14	14	doxorubicin	CHOP	PA449412	1649	0.565
NULL	Biomed_Res_Int_2014_Jan_29_2014_876712.nxml.txt.nlp	24605339	SENT210	15	15	23	23	diazepam	GIV	PA449283	55704	0.565
NULL	Pharmaceutics_2011_Jul_11_3(3)_354-378.nxml.txt.nlp	24310585	SENT196	3	3	6	6	fluorescein	LCE	PA164746009	79071	0.565
NULL	Int_J_Mol_Sci_2012_Sep_25_13(10)_12153-12168.nxml.txt.nlp	23202889	SENT377	16	16	2	2	oxaliplatin	KRAS	PA131285527	3845	0.565
NULL	J_Gynecol_Oncol_2012_Jan_9_23(1)_35-42.nxml.txt.nlp	22355465	SENT163	10	10	6	6	cisplatin	CDK1	PA449014	983	0.565
NULL	Drug_Target_Insights_2006_Oct_23_1_5-10.nxml.txt.nlp	21901053	SENT68	11	11	15	15	thrombin	INCA	PA451674	440068	0.565
NULL	J_Gastroenterol_2013_Jan_28_48(1)_1-12.nxml.txt.nlp	23188091	SENT221	36	36	42	42	ribavirin	IFN	PA451241	3439	0.565
NULL	Clin_Drug_Investig_2014_Jun_7_34(7)_501-511.nxml.txt.nlp	24906437	SENT63	13	13	29	29	oxycodone	TDD	PA450741	6994	0.565
NULL	Curr_Pharm_Des_2011_Dec_17(35)_3846-3853.nxml.txt.nlp	21933140	SENT146	26	26	17	17	liraglutide	GLP-1	PA165958364	100125288	0.565
NULL	Iran_J_Basic_Med_Sci_2013_Jun_16(6)_743-750.nxml.txt.nlp	23997899	SENT93	2	2	0	0	apomorphine	APO	PA164781163	84909	0.565
NULL	Diabetes_Care_2010_Jul_31_33(7)_1544-1548.nxml.txt.nlp	20357370	SENT81	14	14	17	17	metformin	STK11	PA450395	6794	0.565
NULL	Clin_Interv_Aging_2013_May_30_8_597-603.nxml.txt.nlp	23761968	SENT138	13	13	26	26	risedronate	BSAP	PA451255	5079	0.565
NULL	Arthritis_Res_Ther_2005_Mar_16_7(Suppl_2)_S21-S25.nxml.txt.nlp	15833145	SENT90	22	22	29	29	abatacept	ACR	PA164747080	49	0.565
NULL	Clin_Mol_Hepatol_2014_Sep_25_20(3)_283-290.nxml.txt.nlp	25320732	SENT144	2	2	4	4	propranolol	EVL	PA451145	51466	0.565
NULL	J_Cardiothorac_Surg_2012_Sep_27_7_97.nxml.txt.nlp	23013706	SENT9	16	16	7	7	warfarin	CYP4F2	PA451906	8529	0.565
NULL	Genet_Vaccines_Ther_2012_Aug_28_10_6.nxml.txt.nlp	22929369	SENT82	24	24	26	26	heparin	DC-SIGN	PA449855	30835	0.565
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_55-78.nxml.txt.nlp	19305788	SENT622	2	2	6	6	memantine	ERG	PA10364	2078	0.565
NULL	Acta_Pharmacol_Sin_2011_Aug_18_32(8)_1031-1037.nxml.txt.nlp	21765446	SENT137	12	12	22	22	estradiol	MCP-1	PA449503	6347	0.565
NULL	J_Skin_Cancer_2012_Dec_13_2012_147863.nxml.txt.nlp	23316365	SENT181	17	17	1	1	curcumin	IL-6	PA151958596	3569	0.565
NULL	Acta_Pharmacol_Sin_2012_May_16_33(5)_682-690.nxml.txt.nlp	22504904	SENT158	2	2	11	11	celecoxib	PI3K	PA448871	5290	0.565
NULL	Oncologist_2010_May_28_15(5)_436-446.nxml.txt.nlp	20427383	SENT69	20	20	34	34	carboplatin	San	PA448803	80218	0.565
NULL	Breast_Cancer_Res_2000_Jul_11_2(6)_423-429.nxml.txt.nlp	11250736	SENT101	42	42	22	22	estradiol	EGFR	PA449503	1956	0.565
NULL	Mol_Neurodegener_2011_Aug_8_6_57.nxml.txt.nlp	21819629	SENT348	44	44	19	19	arsenite	TDP-43	PA452638	23435	0.565
NULL	Cell_Death_Dis_2010_Sep_23_1(9)_e78.nxml.txt.nlp	21364680	SENT96	10	10	15	15	cisplatin	P31	PA449014	529	0.565
NULL	Infect_Dis_Ther_2013_Dec_3_2(2)_111-122.nxml.txt.nlp	25134475	SENT96	7	7	0	0	emtricitabine	ATV	PA10069	4683	0.565
NULL	Support_Care_Cancer_2010_May_27_18(5)_529-541.nxml.txt.nlp	20191292	SENT259	10	10	5	5	etoposide	CHOP	PA449552	1649	0.565
NULL	Mol_Clin_Oncol_2013_Jul_30_1(4)_655-660.nxml.txt.nlp	24649224	SENT199	24	24	22	22	cyclophosphamide	CHOP	PA449165	1649	0.565
NULL	Int_J_Nephrol_2011_Apr_26_2011_245823.nxml.txt.nlp	21603155	SENT131	27	27	23	23	ribavirin	IFN	PA451241	3439	0.565
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2009_Jun_1_65(Pt_6)_513-522.nxml.txt.nlp	19465765	SENT421	11	11	18	18	chloramphenicol	CLS	PA448927	1210	0.565
NULL	Cell_Commun_Signal_2014_Sep_21_12(1)_57.nxml.txt.nlp	NULL	SENT318	13	13	29	29	l-glutamine	CO2	PA10090	4513	0.565
NULL	J_Invest_Dermatol_2013_Sep_31_133(9)_2247-2254.nxml.txt.nlp	23370537	SENT69	2	2	7	7	chloroquine	PUMA	PA448948	27113	0.565
NULL	Acta_Pharmacol_Sin_2012_Feb_3_33(2)_148-154.nxml.txt.nlp	22301855	SENT86	5	5	2	2	exenatide	GLP-1	PA164749238	100125288	0.565
NULL	Mol_Biol_Rep_2014_Jan_29_41(5)_2851-2857.nxml.txt.nlp	24469723	SENT87	8	8	16	16	epirubicin	BCS	PA449476	617	0.565
NULL	Oxid_Med_Cell_Longev_2013_Jun_6_2013_462361.nxml.txt.nlp	23840917	SENT272	18	18	20	20	minocycline	p67phox	PA450519	4688	0.565
NULL	J_Int_AIDS_Soc_2010_Nov_8_13(Suppl_4)_P75.nxml.txt.nlp	NULL	SENT20	0	0	3	3	stavudine	adiponectin	PA451494	9370	0.565
NULL	Comp_Funct_Genomics_2009_Jun_1_2009_837514.nxml.txt.nlp	19753298	SENT157	21	21	9	9	cisplatin	HMGA2	PA449014	8091	0.565
NULL	J_Adv_Pract_Oncol_2012_May_1_May-Jun_3(3)_161-169.nxml.txt.nlp	25031942	SENT217	8	8	23	23	cisplatin	ACT	PA449014	12;11332;9457;641455	0.564
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT81	16	16	9	9	trastuzumab	IL-6	PA451743	3569	0.564
NULL	Arthritis_Res_Ther_2006_Feb_3_8(2)_R43.nxml.txt.nlp	16507142	SENT52	14	14	37	37	fluorescein	San	PA164746009	80218	0.564
NULL	Adv_Hematol_2012_Aug_2_2012_842945.nxml.txt.nlp	22919394	SENT126	4	4	6	6	lenalidomide	PI3K	PA162363968	5290	0.564
NULL	J_Asthma_Allergy_2014_Dec_2_7_165-167.nxml.txt.nlp	25506230	SENT45	2	2	15	15	rituximab	C1-INH	PA451261	710	0.564
NULL	J_Cell_Biol_1990_Nov_1_111(5)_1839-1847.nxml.txt.nlp	2229175	SENT7	8	8	16	16	trypsin	PH-20	PA451806	6677	0.564
NULL	Ann_Hematol_2014_Mar_18_93(8)_1335-1344.nxml.txt.nlp	24638841	SENT123	12	12	4	4	rituximab	CLB	PA451261	171425	0.564
NULL	Oxid_Med_Cell_Longev_2012_Sep_6_2012_718491.nxml.txt.nlp	22991584	SENT180	0	0	16	16	curcumin	JNK	PA151958596	5599	0.564
NULL	Mar_Drugs_2012_Dec_14_10(12)_2826-2845.nxml.txt.nlp	23242204	SENT718	3	3	6	6	vinblastine	gamma	PA451877	9913	0.564
NULL	Cancer_Cell_Int_2011_Feb_15_11_4.nxml.txt.nlp	21320357	SENT171	33	33	44	44	streptomycin	CO2	PA451512	4513	0.564
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R28.nxml.txt.nlp	23406982	SENT207	4	4	15	15	collagenase	cadherin	PA449107	1015	0.564
NULL	J_Biol_Chem_2009_Oct_16_284(42)_28885-28895.nxml.txt.nlp	19687008	SENT29	6	6	8	8	pravastatin	PCSK9	PA451089	255738	0.564
NULL	EMBO_Mol_Med_2012_Oct_30_4(10)_1087-1096.nxml.txt.nlp	22933245	SENT133	10	10	18	18	olaparib	ANOVA		4858	0.564
NULL	Breast_Cancer_Res_2009_Nov_18_11(6)_R85.nxml.txt.nlp	19922614	SENT103	35	35	33	33	tamoxifen	BCS	PA451581	617	0.564
NULL	Breast_Cancer_Res_2014_Sep_11_16(5)_430.nxml.txt.nlp	25212826	SENT278	8	8	0	0	doxycycline	AKT	PA449415	207	0.564
NULL	Anat_Cell_Biol_2014_Jun_20_47(2)_111-116.nxml.txt.nlp	24987547	SENT22	17	17	26	26	rosiglitazone	CA1	PA451283	759	0.564
NULL	Cancer_Cell_Int_2012_Dec_15_12_52.nxml.txt.nlp	23241263	SENT128	17	17	14	14	imatinib	IFN	PA10804	3439	0.564
NULL	ScientificWorldJournal_2012_Mar_12_2012_746412.nxml.txt.nlp	22489201	SENT59	36	36	18	18	ethanol	mol	PA448073	90527	0.564
NULL	J_Cell_Biol_1998_Jan_26_140(2)_335-345.nxml.txt.nlp	9442109	SENT81	35	35	33	33	chloroquine	NHE	PA448948	285335	0.564
NULL	Case_Rep_Oncol_2011_Nov_22_4(3)_534-541.nxml.txt.nlp	22187539	SENT22	0	0	2	2	gemcitabine	GEM	PA449748	2669	0.564
NULL	Curr_Neuropharmacol_2014_Jul_12(4)_365-379.nxml.txt.nlp	25342944	SENT129	11	11	7	7	fluoxetine	cPLA2	PA449673	10524	0.564
NULL	Gastroenterol_Hepatol_Bed_Bench_2013_6(Suppl_1)_S65-S69.nxml.txt.nlp	24834290	SENT69	35	35	14	14	ribavirin	Yes	PA451241	7525	0.564
NULL	Crit_Care_2011_Apr_11_15(2)_R112.nxml.txt.nlp	21481266	SENT91	21	21	26	26	piperacillin	SAPS	PA450975	8935	0.564
NULL	EMBO_Mol_Med_2013_Apr_25_5(4)_531-547.nxml.txt.nlp	23526793	SENT253	25	25	31	31	rosiglitazone	MAP2	PA451283	4133;10988	0.564
NULL	Protein_Expr_Purif_2009_Aug_66(2)_181-184.nxml.txt.nlp	19269329	SENT67	30	30	39	39	thrombin	AMPK	PA451674	5563	0.564
NULL	Core_Evid_2010_Oct_22_5_91-105.nxml.txt.nlp	21468365	SENT314	6	6	10	10	atorvastatin	Q10	PA448500	27161	0.564
NULL	Acta_Pharmacol_Sin_2010_Mar_8_31(3)_382-386.nxml.txt.nlp	20140004	SENT71	21	21	11	11	pitavastatin	SLCO1B1	PA142650384	10599	0.564
NULL	Blood_Cancer_J_2013_Oct_11_3(10)_e151.nxml.txt.nlp	24121163	SENT183	4	4	7	7	fluorescein	GAPDH	PA164746009	2597	0.564
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1066.nxml.txt.nlp	24556681	SENT10	0	0	24	24	ethanol	LC3	PA448073	84557	0.564
NULL	Endocrinology_2011_Feb_5_152(2)_405-413.nxml.txt.nlp	21209017	SENT92	0	0	2	2	l-glutamine	GLP-1	PA10090	100125288	0.564
NULL	Cancer_Res_Treat_2013_Sep_30_45(3)_234-238.nxml.txt.nlp	24155683	SENT21	21	21	29	29	cyclophosphamide	CHOP	PA449165	1649	0.564
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT79	0	0	12	12	metformin	p27	PA450395	5715;10534	0.564
NULL	Mol_Cancer_2013_Nov_13_12_137.nxml.txt.nlp	24225025	SENT344	22	22	34	34	l-glutamine	CO2	PA10090	4513	0.564
NULL	Biomed_Res_Int_2013_Aug_6_2013_909613.nxml.txt.nlp	24027765	SENT8	24	24	22	22	metronidazole	EEN	PA450484	6455	0.564
NULL	Diabetes_2011_Mar_21_60(3)_1008-1018.nxml.txt.nlp	21282362	SENT320	21	21	9	9	lipase	ANGPTL3	PA450239	27329	0.564
NULL	Amino_Acids_2014_Feb_20_46(5)_1275-1283.nxml.txt.nlp	24553827	SENT186	17	17	2	2	taurine	Met	PA451590	79811	0.564
NULL	Breast_Cancer_Res_2006_Nov_1_8(Suppl_2)_P18.nxml.txt.nlp	NULL	SENT3	11	11	13	13	hyaluronan	CD44	PA165958431	960	0.564
NULL	Crit_Care_2009_Jun_3_13(3)_213.nxml.txt.nlp	19519960	SENT42	2	2	25	25	glibenclamide	PAG	PA449782	55824	0.564
NULL	Ann_Oncol_2013_Aug_12_24(8)_1994-1999.nxml.txt.nlp	23670096	SENT128	5	5	3	3	tamoxifen	AIB1	PA451581	8202	0.564
NULL	Genetics_2013_Jan_193(1)_1-50.nxml.txt.nlp	23275493	SENT190	7	7	13	13	lipase	DAG	PA450239	1605	0.564
NULL	Lab_Invest_2009_Nov_7_89(11)_1275-1290.nxml.txt.nlp	19736547	SENT353	12	12	0	0	curcumin	LOX-1	PA151958596	4973	0.564
NULL	Mol_Vis_2007_Feb_2_13_164-173.nxml.txt.nlp	17293780	SENT232	23	23	25	25	collagenase	IL1B	PA449107	3553	0.564
NULL	J_Korean_Med_Sci_2011_Jan_22_26(1)_33-41.nxml.txt.nlp	21218027	SENT169	14	14	35	35	pyrazinamide	PTH	PA451182	5741	0.564
NULL	Clin_Ophthalmol_2008_Jun_2(2)_355-368.nxml.txt.nlp	19668727	SENT81	16	16	18	18	bromfenac	COX	PA448670	1351	0.564
NULL	Br_J_Cancer_2011_Jul_26_105(3)_393-402.nxml.txt.nlp	21750550	SENT10	0	0	2	2	etodolac	SNAIL	PA449550	6615	0.564
NULL	Protein_Cell_2014_May_26_5(5)_343-347.nxml.txt.nlp	24668462	SENT17	2	2	0	0	heparin	FGF18	PA449855	8817	0.564
NULL	Eur_J_Neurosci_2014_Feb_4_39(3)_419-434.nxml.txt.nlp	24494682	SENT262	15	15	17	17	lipase	MGL	PA450239	11343	0.564
NULL	Mol_Vis_2012_Mar_2_18_547-564.nxml.txt.nlp	22419848	SENT461	17	17	15	15	indomethacin	EGF	PA449982	1950	0.564
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT181	12	12	14	14	adalimumab	CD36	PA10004	948	0.564
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Sep_6_64(Pt_10)_o1872.nxml.txt.nlp	21201087	SENT68	30	30	18	18	piperazine	mol	PA450977	90527	0.564
NULL	J_Biol_Chem_2013_Nov_15_288(46)_33016-33026.nxml.txt.nlp	24089531	SENT119	43	43	14	14	s-adenosylmethionine	SET	PA164754994	6418	0.564
NULL	J_Breast_Cancer_2013_Mar_31_16(1)_122-126.nxml.txt.nlp	23593093	SENT115	6	6	14	14	paclitaxel	gamma	PA450761	9913	0.564
NULL	Glycobiology_2013_Jul_18_23(7)_853-864.nxml.txt.nlp	23507965	SENT302	23	23	20	20	galactose	MGL	PA449725	11343	0.564
NULL	Nat_Commun_2011_Feb_15_2_199.nxml.txt.nlp	21326231	SENT148	38	38	21	21	potassium	KCC2	PA451047	57468	0.564
NULL	Comput_Math_Methods_Med_2012_Mar_15_2012_790281.nxml.txt.nlp	22474537	SENT5	16	16	18	18	vasopressin	AVP	PA451858	114548;551	0.564
NULL	Br_J_Pharmacol_2014_Oct_26_171(20)_4785-4796.nxml.txt.nlp	25074741	SENT148	0	0	7	7	guanfacine	NK1R	PA449825	6869	0.564
NULL	Cancer_Cell_Int_2005_Jul_24_5_22.nxml.txt.nlp	16042792	SENT17	13	13	24	24	vincristine	MRP1	PA451879	4437	0.564
NULL	Curr_Neuropharmacol_2008_Jun_6(2)_151-163.nxml.txt.nlp	19305794	SENT207	7	7	3	3	capsaicin	TRPV1	PA448776	7442	0.564
NULL	J_Immunother_Cancer_2014_Mar_11_2_5.nxml.txt.nlp	24829762	SENT31	20	20	26	26	l-arginine	ARG	PA448478	473;27	0.564
NULL	Br_J_Cancer_2013_Mar_5_108(4)_887-900.nxml.txt.nlp	23462807	SENT108	10	10	32	32	sunitinib	FGFR2	PA162372840	2263	0.564
NULL	Gut_Liver_2013_Sep_14_7(5)_585-593.nxml.txt.nlp	24073317	SENT190	28	28	22	22	ribavirin	IFN	PA451241	3439	0.564
NULL	J_Aging_Res_2011_Oct_18_2011_383091.nxml.txt.nlp	22028968	SENT63	4	4	8	8	haloperidol	CLOCK	PA449841	9575	0.564
NULL	Open_Biol_2014_May_4(5)_140065.nxml.txt.nlp	24850914	SENT205	10	10	12	12	bortezomib	SMAD6	PA10252	4091	0.564
NULL	Emerg_Infect_Dis_2014_May_20(5)_899-901.nxml.txt.nlp	24751149	SENT22	27	27	17	17	erythromycin	PEN	PA449493	9933	0.564
NULL	Lipids_Health_Dis_2011_Dec_6_10_229.nxml.txt.nlp	22146099	SENT66	5	5	3	3	rosiglitazone	IL-13	PA451283	3596	0.564
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT142	11	11	4	4	vinorelbine	ASC	PA451881	29108	0.564
NULL	Cancer_Med_2013_Dec_22_2(6)_862-871.nxml.txt.nlp	24403259	SENT78	27	27	16	16	everolimus	p53	PA164746311	7157	0.564
NULL	Arthritis_Res_Ther_2009_Dec_11_11(6)_R187.nxml.txt.nlp	20003323	SENT271	17	17	19	19	indomethacin	RANKL	PA449982	8600	0.564
NULL	Cancer_Cell_Int_2003_Jul_23_3_12.nxml.txt.nlp	12914669	SENT69	1	1	6	6	doxycycline	PP1	PA449415	5540;5464	0.564
NULL	Int_J_Mol_Sci_2014_Nov_17_15(11)_21229-21252.nxml.txt.nlp	25407528	SENT26	15	15	2	2	urokinase	PLG	PA451836	5340	0.564
NULL	Clinics_(Sao_Paulo)_2011_Aug_66(8)_1457-1462.nxml.txt.nlp	21915500	SENT121	3	3	11	11	rosuvastatin	TNF	PA134308647	7124	0.564
NULL	J_Clin_Biochem_Nutr_2011_May_13_48(3)_214-221.nxml.txt.nlp	21562641	SENT210	32	32	7	7	ethanol	flower	PA448073	11094	0.564
NULL	Emerg_Infect_Dis_2014_May_20(5)_910-911.nxml.txt.nlp	24751334	SENT31	7	7	14	14	ampicillin	COT	PA448419	54677	0.564
NULL	Curr_Cardiol_Rev_2011_Nov_7(4)_214-220.nxml.txt.nlp	22758622	SENT80	26	26	30	30	doxorubicin	MRP2	PA449412	100130958;57626;1244	0.564
NULL	Br_J_Cancer_2010_Jan_5_102(1)_80-86.nxml.txt.nlp	19920817	SENT14	9	9	11	11	bevacizumab	IFN	PA130232992	3439	0.564
NULL	Curr_Control_Trials_Cardiovasc_Med_2001_Sep_11_2(5)_233-239.nxml.txt.nlp	11806802	SENT172	19	19	4	4	heparin	RISC	PA449855	59342	0.564
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Dec_10_3(12)_e151.nxml.txt.nlp	25494035	SENT252	6	6	21	21	gemfibrozil	OATP1B1	PA449750	10599	0.564
NULL	Mol_Vis_2011_Dec_24_17_3384-3391.nxml.txt.nlp	22219634	SENT135	18	18	8	8	mannitol	IL-6	PA450320	3569	0.564
NULL	Drug_Target_Insights_2007_Feb_7_2_19-27.nxml.txt.nlp	21901059	SENT139	0	0	11	11	ribavirin	IL-10	PA451241	3586	0.564
NULL	Ann_Oncol_2009_Aug_20(Suppl_6)_vi41-vi50.nxml.txt.nlp	19617297	SENT51	6	6	27	27	cisplatin	IL-2	PA449014	3558	0.564
NULL	Cancer_Cell_2014_Mar_17_25(3)_304-317.nxml.txt.nlp	24651012	SENT369	8	8	5	5	etoposide	ETS2	PA449552	2114	0.564
NULL	Cancers_(Basel)_2012_Oct_12_4(4)_989-1035.nxml.txt.nlp	24213498	SENT450	1	1	11	11	gemcitabine	ABCB1	PA449748	5243	0.564
NULL	Diabetes_Care_2009_Sep_28_32(9)_1649-1655.nxml.txt.nlp	19478198	SENT10	24	24	32	32	glucose	PPG	PA449773	5552	0.564
NULL	Biosci_Rep_2012_Dec_20_33(1)_e00011.nxml.txt.nlp	23137297	SENT141	27	27	18	18	heparin	RPSA	PA449855	3921	0.564
NULL	Vet_Res_Forum_2013_Winter_4(1)_19-24.nxml.txt.nlp	25593681	SENT13	11	11	9	9	diclofenac	B12	PA449293	7126;4709	0.564
NULL	Aging_(Albany_NY)_2011_Apr_6_3(4)_444-449.nxml.txt.nlp	21483037	SENT72	2	2	0	0	resveratrol	SIRT1		23411	0.564
NULL	Int_J_Cell_Biol_2012_May_20_2012_273947.nxml.txt.nlp	22675360	SENT217	10	10	35	35	nadh	IDH2	PA164755085	3418	0.564
NULL	Pak_J_Med_Sci_2014_Jul-Aug_30(4)_814-818.nxml.txt.nlp	25097523	SENT65	10	10	16	16	imipenem	TOB	PA449968	10140	0.564
NULL	BMJ_Open_2013_Dec_18_3(12)_e003815.nxml.txt.nlp	24353255	SENT133	8	8	10	10	levonorgestrel	NNT	PA450218	23530	0.564
NULL	J_Korean_Med_Sci_2009_Jan_29_24(Suppl_1)_S170-S175.nxml.txt.nlp	19194548	SENT75	27	27	11	11	cisplatin	EPO	PA449014	7076;8288;2056	0.564
NULL	J_Midlife_Health_2013_Jul-Sep_4(3)_147-152.nxml.txt.nlp	24672186	SENT144	11	11	8	8	teriparatide	PTH	PA451620	5741	0.564
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT104	4	4	20	20	metformin	MEK1	PA450395	5604	0.564
NULL	Front_Pharmacol_2014_Sep_16_5_209.nxml.txt.nlp	25278895	SENT497	3	3	6	6	l-arginine	SLC7A1	PA448478	6541	0.564
NULL	J_Gen_Physiol_1936_Jul_20_19(6)_991-1007.nxml.txt.nlp	19872978	SENT0	27	27	1	1	trypsin	Gen	PA451806	348654	0.564
NULL	Am_J_Clin_Dermatol_2013_Feb_14_14(1)_27-47.nxml.txt.nlp	23329078	SENT686	12	12	1	1	pimecrolimus	p53	PA164783790	7157	0.564
NULL	J_Oncol_2013_Feb_17_2013_872957.nxml.txt.nlp	23476648	SENT212	16	16	4	4	cisplatin	SFN	PA449014	25996;2810	0.564
NULL	Front_Neurosci_2010_Mar_19_4_22.nxml.txt.nlp	20582262	SENT83	0	0	9	9	bethanechol	P2X2	PA448613	22953	0.564
NULL	Evid_Based_Complement_Alternat_Med_2014_May_8_2014_364819.nxml.txt.nlp	24899907	SENT5	17	17	15	15	tacrolimus	FKBP52	PA451578	2288	0.564
NULL	Biomed_Res_Int_2013_Jul_30_2013_754946.nxml.txt.nlp	23984405	SENT166	22	22	30	30	mannitol	ND2	PA450320	4536	0.564
NULL	Br_J_Clin_Pharmacol_2013_Aug_23_76(2)_299-315.nxml.txt.nlp	23701319	SENT93	0	0	7	7	alemtuzumab	IFN	PA164783958	3439	0.564
NULL	Anticancer_Drugs_2015_Jan_28_26(1)_117-122.nxml.txt.nlp	25115342	SENT125	19	19	17	17	paclitaxel	castor	PA450761	54897	0.564
NULL	Exp_Transl_Stroke_Med_2013_Apr_25_5_6.nxml.txt.nlp	23618347	SENT260	21	21	0	0	nimodipine	NEU	PA450633	2064	0.564
NULL	Cancer_Cell_Int_2008_Apr_29_8_4.nxml.txt.nlp	18442416	SENT182	0	0	13	13	trypsin	Ku86	PA451806	7520	0.564
NULL	Acta_Pharmacol_Sin_2012_Apr_12_33(4)_542-550.nxml.txt.nlp	22407228	SENT179	0	0	11	11	perifosine	JNK	PA165291471	5599	0.564
NULL	Oncol_Discov_2013_1(4)_10_7243_2052-6199-1-4.nxml.txt.nlp	25383193	SENT194	21	21	12	12	celecoxib	COX	PA448871	1351	0.564
NULL	Oncol_Lett_2013_Oct_29_6(4)_1031-1038.nxml.txt.nlp	24137459	SENT211	2	2	0	0	cisplatin	DDP	PA449014	1678	0.564
NULL	ChemistryOpen_2013_Jun_12_2(3)_99-105.nxml.txt.nlp	24551546	SENT120	4	4	18	18	marimastat	THP1	PA164748329	2736	0.564
NULL	Clin_Ophthalmol_2010_Oct_21_4_1151-1158.nxml.txt.nlp	21060664	SENT118	30	30	18	18	hydroxychloroquine	FAF	PA164777036	8239;2188	0.564
NULL	Clin_Mol_Hepatol_2014_Sep_25_20(3)_283-290.nxml.txt.nlp	25320732	SENT138	2	2	4	4	propranolol	EVL	PA451145	51466	0.564
NULL	Open_Allergy_J_2010_3_91-101.nxml.txt.nlp	25018787	SENT14	6	6	26	26	omalizumab	IL-4	PA164752253	3565	0.564
NULL	Mol_Cells_2014_Jan_31_37(1)_66-73.nxml.txt.nlp	24552712	SENT132	47	47	26	26	ribavirin	HAI	PA451241	6692;6768	0.564
NULL	Br_J_Cancer_2012_Aug_7_107(4)_588-591.nxml.txt.nlp	22836511	SENT122	12	12	38	38	doxorubicin	TFI	PA449412	7035	0.564
NULL	Bone_Marrow_Res_2011_Mar_2_2011_924058.nxml.txt.nlp	22046572	SENT55	0	0	10	10	tocilizumab	IL-6	PA165292659	3569	0.564
NULL	Front_Behav_Neurosci_2011_Oct_24_5_71.nxml.txt.nlp	22028687	SENT969	0	0	2	2	lovastatin	N-ras	PA450272	4893	0.564
NULL	Clin_Ophthalmol_2012_Dec_13_6_1-4.nxml.txt.nlp	22259229	SENT70	25	25	33	33	travoprost	BAK	PA164781371	578	0.564
NULL	Sci_Rep_2014_Dec_17_4_7461.nxml.txt.nlp	25514838	SENT8	22	22	5	5	cisplatin	STAT3	PA449014	6774	0.564
NULL	Arthritis_Res_Ther_2005_Feb_18_7(3)_R476-R484.nxml.txt.nlp	15899034	SENT239	15	15	6	6	thrombin	IL-6	PA451674	3569	0.564
NULL	Acta_Pharmacol_Sin_2011_Oct_12_32(10)_1259-1265.nxml.txt.nlp	21909126	SENT126	10	10	18	18	irbesartan	MCP-1	PA450084	6347	0.564
NULL	Onco_Targets_Ther_2014_Sep_9_7_1571-1582.nxml.txt.nlp	25228815	SENT26	22	22	17	17	sunitinib	VEGFA	PA162372840	7422	0.564
NULL	Drug_Des_Devel_Ther_2014_Oct_31_8_2121-2128.nxml.txt.nlp	25382970	SENT125	3	3	5	5	curcumin	TTR	PA151958596	7276	0.564
NULL	Oncotarget_2014_Aug_29_5(17)_7217-7259.nxml.txt.nlp	25277175	SENT301	21	21	25	25	axitinib	VEGFR	PA164924493	3791	0.564
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT159	15	15	25	25	phenprocoumon	VKORC1	PA450921	79001	0.564
NULL	Clinics_(Sao_Paulo)_2013_Oct_68(10)_1350-1357.nxml.txt.nlp	24212843	SENT118	15	15	10	10	bleomycin	COL1A1	PA448645	1277	0.564
NULL	Lab_Invest_2013_Feb_19_93(2)_181-193.nxml.txt.nlp	23212100	SENT5	23	23	25	25	cyclophosphamide	CTX	PA449165	1593	0.564
NULL	Allergy_Asthma_Clin_Immunol_2011_Dec_7_7(1)_21.nxml.txt.nlp	22152089	SENT42	23	23	5	5	mometasone	DPI	PA450541	1832	0.564
NULL	Clin_Med_Insights_Womens_Health_2013_Jan_23_6_13-24.nxml.txt.nlp	24665210	SENT176	14	14	20	20	drospirenone	CEE	PA164749409	51608	0.564
NULL	Cancer_Cell_Int_2013_Feb_8_13_11.nxml.txt.nlp	23394616	SENT115	15	15	27	27	geldanamycin	Hsp90	PA152031327	3320	0.564
NULL	Clin_Ophthalmol_2012_Jan_12_6_111-116.nxml.txt.nlp	22275815	SENT18	5	5	13	13	tafluprost	PGF	PA165958432	5228	0.564
NULL	Breast_Cancer_(Auckl)_2011_Jul_12_5_143-154.nxml.txt.nlp	21792311	SENT35	22	22	13	13	hydrocortisone	EGF	PA449905	1950	0.564
NULL	Cancers_(Basel)_2013_May_27_5(2)_617-638.nxml.txt.nlp	24216994	SENT158	0	0	8	8	curcumin	PC3	PA151958596	57332;7832;5122	0.564
NULL	Exp_Cell_Res_2011_Apr_15_317(7)_1028-1039.nxml.txt.nlp	21237154	SENT11	6	6	23	23	staurosporine	JNK	PA165109623	5599	0.564
NULL	Bioinformation_2008_Jan_27_2(6)_240-244.nxml.txt.nlp	18317572	SENT79	19	19	24	24	galactose	NAG	PA449725	51594;4669	0.564
NULL	J_Neurochem_2008_Jan_104(1)_74-88.nxml.txt.nlp	17995938	SENT12	2	2	31	31	forskolin	JNK	PA146096022	5599	0.564
NULL	J_Biol_Chem_2013_Nov_15_288(46)_33049-33059.nxml.txt.nlp	24089524	SENT265	22	22	29	29	nicotine	GATA4	PA450626	2626	0.564
NULL	Orthop_Rev_(Pavia)_2012_Sep_4_4(3)_e29.nxml.txt.nlp	23066497	SENT107	6	6	9	9	ibandronate	DPD	PA10270	1806	0.564
NULL	J_Infect_Dev_Ctries_2011_Jul_4_5(6)_484-488.nxml.txt.nlp	21727649	SENT51	18	18	4	4	methotrexate	PDH	PA450428	54704	0.564
NULL	J_Med_Case_Rep_2013_May_31_7_144.nxml.txt.nlp	23724918	SENT89	5	5	3	3	l-carnitine	NAC	PA450154	22861	0.564
NULL	Biomed_Res_Int_2013_Jun_5_2013_348167.nxml.txt.nlp	23862143	SENT202	12	12	32	32	choline	NAC	PA448976	22861	0.564
NULL	J_Cardiovasc_Dis_Res_2010_Jan-Mar_1(1)_37-39.nxml.txt.nlp	21188089	SENT89	39	39	8	8	amiodarone	CAST	PA448383	10849;26059;831	0.564
NULL	Ann_Dermatol_2013_Nov_30_25(4)_500-502.nxml.txt.nlp	24371403	SENT6	11	11	8	8	imatinib	LDE	PA10804	7957	0.564
NULL	Evid_Based_Complement_Alternat_Med_2012_May_7_2012_242810.nxml.txt.nlp	22645625	SENT160	5	5	14	14	rifampin	CYP3A4	PA451250	1576	0.564
NULL	Cell_Death_Dis_2013_Sep_19_4(9)_e807.nxml.txt.nlp	24052075	SENT81	4	4	16	16	doxorubicin	ADP	PA449412	23038	0.564
NULL	Br_J_Cancer_2014_Nov_25_111(11)_2091-2102.nxml.txt.nlp	25349971	SENT163	8	8	24	24	imatinib	KIT	PA10804	3815	0.564
NULL	Front_Mol_Neurosci_2009_May_14_2_1.nxml.txt.nlp	19506703	SENT17	14	14	29	29	candesartan	ACTH	PA448765	5443	0.564
NULL	Int_J_Environ_Res_Public_Health_2006_Mar_31_3(1)_23-30.nxml.txt.nlp	16823073	SENT253	2	2	5	5	salbutamol	CXCL8	PA448068	3576	0.564
NULL	Sci_Rep_2015_Jan_14_5_7789.nxml.txt.nlp	25586329	SENT553	10	10	19	19	fluorescein	VCL	PA164746009	7414	0.563
NULL	Diabetes_Care_2011_Apr_21_34(4)_845-851.nxml.txt.nlp	21330640	SENT135	8	8	2	2	ramipril	DREAM	PA451223	30818	0.563
NULL	Pharmaceuticals_(Basel)_2013_Aug_2_6(8)_915-928.nxml.txt.nlp	24276376	SENT13	3	3	5	5	aspirin	P2Y12	PA448497	64805	0.563
NULL	Nucleic_Acids_Res_2007_Jan_7_35(1)_113-124.nxml.txt.nlp	17158150	SENT63	24	24	32	32	thrombin	LEDGF	PA451674	11168	0.563
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_127043.nxml.txt.nlp	23227093	SENT231	19	19	26	26	quinidine	CYP3A4	PA451209	1576	0.563
NULL	Br_J_Cancer_2013_Feb_19_108(3)_557-563.nxml.txt.nlp	23361053	SENT185	2	2	0	0	tamoxifen	IPA	PA451581	3160	0.563
NULL	Biosci_Rep_2012_Aug_1_32(Pt_4)_393-400.nxml.txt.nlp	22639801	SENT30	31	31	38	38	heparin	CO2	PA449855	4513	0.563
NULL	Mol_Cancer_2010_Nov_2_9_289.nxml.txt.nlp	21044322	SENT39	11	11	15	15	paclitaxel	FBS	PA450761	64319;26269	0.563
NULL	J_Cell_Biol_1992_Feb_1_116(3)_817-825.nxml.txt.nlp	1730778	SENT15	16	16	8	8	heparin	CD44	PA449855	960	0.563
NULL	Ann_Gastroenterol_2014_27(4)_380-386.nxml.txt.nlp	25331321	SENT27	22	22	10	10	lamivudine	IFN	PA450163	3439	0.563
NULL	Arthritis_Res_Ther_2013_Dec_3_15(6)_R205.nxml.txt.nlp	24295447	SENT121	0	0	4	4	methotrexate	RANKL	PA450428	8600	0.563
NULL	Cell_Death_Dis_2013_Oct_3_4(10)_e827.nxml.txt.nlp	24091670	SENT35	11	11	29	29	everolimus	CD34	PA164746311	947	0.563
NULL	J_Hematol_Oncol_2010_Apr_7_3_13.nxml.txt.nlp	20374647	SENT174	16	16	14	14	bortezomib	PSMB5	PA10252	5693	0.563
NULL	Br_J_Cancer_2013_Dec_10_109(12)_3084-3091.nxml.txt.nlp	24149177	SENT146	38	38	16	16	crizotinib	PTN	PA165946122	5764	0.563
NULL	Breast_Cancer_Res_2004_Apr_7_6(4)_R275-R283.nxml.txt.nlp	15217493	SENT199	12	12	19	19	fluorescein	IFN	PA164746009	3439	0.563
NULL	ASN_Neuro_2012_Mar_27_4(2)_e00081.nxml.txt.nlp	22369757	SENT30	8	8	15	15	isoflurane	CO2	PA450106	4513	0.563
NULL	Kidney_Int_Suppl_(2011)_2012_Mar_29_2(1)_69-88.nxml.txt.nlp	25018920	SENT129	26	26	14	14	furosemide	NAC	PA449719	22861	0.563
NULL	Neural_Dev_2014_Apr_23_9_9.nxml.txt.nlp	24755297	SENT66	32	32	13	13	hydroxyurea	ZO-1	PA449942	7082	0.563
NULL	Theranostics_2014_Jan_14_4(2)_215-228.nxml.txt.nlp	24465277	SENT269	15	15	2	2	napqi	NAC		22861	0.563
NULL	J_Hematol_Oncol_2010_Apr_7_3_13.nxml.txt.nlp	20374647	SENT174	21	21	25	25	flavopiridol	RRM2	PA452627	6241	0.563
NULL	Int_J_Biol_Sci_2012_Jan_1_8(2)_228-235.nxml.txt.nlp	22253566	SENT203	4	4	21	21	etanercept	IL-23	PA449515	51561	0.563
NULL	Nucleic_Acids_Res_2013_Feb_14_41(3)_1873-1884.nxml.txt.nlp	23241386	SENT77	15	15	43	43	paraformaldehyde	San	PA450790	80218	0.563
NULL	Anat_Cell_Biol_2010_Sep_30_43(3)_194-200.nxml.txt.nlp	21212859	SENT27	24	24	12	12	ethanol	PLP	PA448073	25824;5744	0.563
NULL	AIDS_Res_Ther_2006_Apr_24_3_12.nxml.txt.nlp	16635263	SENT167	12	12	20	20	fluorescein	PEG3	PA164746009	5178	0.563
NULL	Breast_Cancer_Res_2009_Nov_18_11(6)_R85.nxml.txt.nlp	19922614	SENT177	15	15	6	6	tamoxifen	BCS	PA451581	617	0.563
NULL	Iran_J_Pharm_Res_2013_Winter_12(1)_141-146.nxml.txt.nlp	24250582	SENT98	11	11	14	14	rifampin	NAC	PA451250	22861	0.563
NULL	Chem_Cent_J_2012_Feb_21_6_15.nxml.txt.nlp	22353684	SENT82	0	0	9	9	acebutolol	mol	PA448011	90527	0.563
NULL	Arthritis_Res_Ther_2005_Feb_17_7(Suppl_1)_P3.nxml.txt.nlp	NULL	SENT3	10	10	19	19	oxygen	HIF-1	PA450744	29072	0.563
NULL	Oncotarget_2014_Jun_19_5(15)_6540-6551.nxml.txt.nlp	25153728	SENT131	5	5	14	14	paclitaxel	PI3K	PA450761	5290	0.563
NULL	Cell_Res_2012_Aug_3_22(8)_1246-1257.nxml.txt.nlp	22473005	SENT152	26	26	45	45	l-glutamine	CO2	PA10090	4513	0.563
NULL	Mol_Biol_Cell_2014_Feb_1_25(3)_368-379.nxml.txt.nlp	24307679	SENT219	37	37	6	6	carbachol	INS-1	PA448784	2305	0.563
NULL	N_Z_Vet_J_2010_Jun_7_58(3)_121-129.nxml.txt.nlp	20514085	SENT168	13	13	15	15	ivermectin	MOX	PA450133	26002	0.563
NULL	Diabetes_2013_Nov_18_62(11)_3697-3708.nxml.txt.nlp	23919961	SENT314	12	12	28	28	rosiglitazone	gamma	PA451283	9913	0.563
NULL	Iran_J_Basic_Med_Sci_2013_Jan_16(1)_12-26.nxml.txt.nlp	23638289	SENT240	25	25	36	36	creatine	MCH	PA164778930	5367	0.563
NULL	ScientificWorldJournal_2013_Oct_29_2013_274570.nxml.txt.nlp	24288475	SENT223	17	17	31	31	l-glutamine	CO2	PA10090	4513	0.563
NULL	Cancer_Causes_Control_2013_Aug_18_24(8)_1605-1614.nxml.txt.nlp	23775025	SENT64	38	38	14	14	epirubicin	CYP2D6	PA449476	1565	0.563
NULL	Cancers_(Basel)_2011_Oct_19_3(4)_3909-3920.nxml.txt.nlp	24213117	SENT147	0	0	10	10	cisplatin	ZNF143	PA449014	7702	0.563
NULL	Environ_Health_2011_Nov_3_10_94.nxml.txt.nlp	22050967	SENT35	11	11	19	19	lipase	aP2	PA450239	2167	0.563
NULL	Crit_Care_2011_Aug_11_15(4)_226.nxml.txt.nlp	21892977	SENT344	30	30	17	17	vasopressin	AVPR2	PA451858	554	0.563
NULL	Clin_Med_Insights_Blood_Disord_2014_Aug_14_7_7-16.nxml.txt.nlp	25512719	SENT126	4	4	11	11	lenalidomide	SBDS	PA162363968	51119	0.563
NULL	Br_J_Cancer_2009_Jul_21_101(2)_238-243.nxml.txt.nlp	19568242	SENT118	36	36	27	27	sunitinib	IFN	PA162372840	3439	0.563
NULL	Nat_Commun_2011_Jul_5_2_376.nxml.txt.nlp	21730957	SENT1480	13	13	8	8	picrotoxin	GAD65	PA164777007	2572	0.563
NULL	Nucleic_Acids_Res_2012_Jun_10_40(11)_4804-4815.nxml.txt.nlp	22328728	SENT234	5	5	7	7	hemin	SIRT1	PA449849	23411	0.563
NULL	Bioimpacts_2014_Feb_27_4(1)_21-27.nxml.txt.nlp	24790895	SENT130	2	2	33	33	isoproterenol	ANOVA	PA450121	4858	0.563
NULL	Int_J_Mol_Sci_2012_Sep_25_13(10)_12153-12168.nxml.txt.nlp	23202889	SENT497	0	0	24	24	cetuximab	KRAS	PA10040	3845	0.563
NULL	Oncotarget_2012_Dec_17_4(1)_48-63.nxml.txt.nlp	23295955	SENT181	15	15	6	6	methotrexate	MTHFD2	PA450428	10797	0.563
NULL	Cell_Mol_Neurobiol_2014_Jan_14_34(3)_323-331.nxml.txt.nlp	24420496	SENT94	24	24	44	44	l-glutamine	CO2	PA10090	4513	0.563
NULL	Diabetes_Care_2013_Jul_12_36(7)_1974-1980.nxml.txt.nlp	23340889	SENT156	21	21	18	18	lipase	PRL	PA450239	5617	0.563
NULL	N_Am_J_Med_Sci_2011_Jan_3(1)_1-12.nxml.txt.nlp	22540056	SENT82	29	29	37	37	gemcitabine	CRT	PA449748	811	0.563
NULL	J_Anim_Sci_Biotechnol_2013_Feb_27_4(1)_7.nxml.txt.nlp	23445937	SENT39	18	18	0	0	glucose	BCAA	PA449773	51742	0.563
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1437-1448.nxml.txt.nlp	24056706	SENT111	14	14	12	12	sulfaphenazole	CYP1A2	PA130231310	1544	0.563
NULL	Int_J_Mol_Sci_2012_Sep_25_13(10)_12213-12223.nxml.txt.nlp	23202893	SENT438	28	28	30	30	azathioprine	AQP4	PA448515	361	0.563
NULL	Cell_Logist_2012_Apr_1_2(2)_117-125.nxml.txt.nlp	23162743	SENT99	8	8	23	23	curcumin	CA1	PA151958596	759	0.563
NULL	Crit_Care_2008_Jun_25_12(3)_R84.nxml.txt.nlp	18578859	SENT90	27	27	9	9	heparin	PF4	PA449855	5196	0.563
NULL	Case_Rep_Med_2014_Aug_12_2014_138963.nxml.txt.nlp	25180038	SENT13	10	10	38	38	omalizumab	VIT	PA164752253	5212	0.563
NULL	Cancer_Med_2013_Dec_31_2(6)_826-835.nxml.txt.nlp	24403256	SENT218	16	16	45	45	nutlin-3	p53		7157	0.563
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT129	8	8	2	2	methotrexate	MSH2	PA450428	4436	0.563
NULL	Oncol_Lett_2013_May_22_5(5)_1541-1545.nxml.txt.nlp	23760395	SENT41	15	15	29	29	l-glutamine	CO2	PA10090	4513	0.563
NULL	Viruses_2014_Jul_22_6(7)_2858-2879.nxml.txt.nlp	25054884	SENT149	11	11	17	17	elvitegravir	ESD	PA165291498	2098	0.563
NULL	J_Exp_Med_1995_Aug_1_182(2)_431-437.nxml.txt.nlp	7543138	SENT0	20	20	22	22	hyaluronan	CD44	PA165958431	960	0.563
NULL	Br_J_Cancer_1996_Aug_74(3)_387-393.nxml.txt.nlp	8695353	SENT0	10	10	12	12	cisplatin	c-myb	PA449014	4602	0.563
NULL	Front_Behav_Neurosci_2014_Dec_23_8_432.nxml.txt.nlp	25566001	SENT117	6	6	0	0	methylphenidate	AMPH	PA450464	273	0.563
NULL	Acta_Pharmacol_Sin_2012_Oct_3_33(10)_1311-1318.nxml.txt.nlp	22941289	SENT116	13	13	19	19	sorafenib	VEGFR2	PA7000	3791	0.563
NULL	Ann_Biomed_Eng_2011_Apr_1_39(4)_1174-1185.nxml.txt.nlp	21120695	SENT174	7	7	16	16	calcein	DM1	PA132595336	338023;1760;28509	0.563
NULL	Br_J_Cancer_2013_Feb_5_108(2)_469-476.nxml.txt.nlp	23169292	SENT174	12	12	34	34	gemcitabine	TTF2	PA449748	8458	0.563
NULL	Exp_Ther_Med_2013_Mar_21_5(3)_987-991.nxml.txt.nlp	23407636	SENT99	17	17	19	19	losartan	IL-8	PA450268	3576	0.563
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT155	4	4	6	6	erlotinib	CYP3A	PA134687924	1574	0.563
NULL	Front_Oncol_2014_Apr_9_4_75.nxml.txt.nlp	24782986	SENT16	9	9	21	21	paclitaxel	CD117	PA450761	3815	0.563
NULL	J_Cell_Biol_2005_Jul_18_170(2)_305-316.nxml.txt.nlp	16009726	SENT399	21	21	26	26	heparin	EGF	PA449855	1950	0.563
NULL	Pharmaceuticals_(Basel)_2013_Oct_11_6(10)_1287-1303.nxml.txt.nlp	24275850	SENT73	0	0	3	3	glibenclamide	ZO-1	PA449782	7082	0.563
NULL	Acta_Orthop_2010_Apr_6_81(2)_263-267.nxml.txt.nlp	20148646	SENT165	2	2	30	30	taurine	CHOP	PA451590	1649	0.563
NULL	J_Biol_Chem_2010_Aug_20_285(34)_25928-25940.nxml.txt.nlp	20547488	SENT302	27	27	10	10	arsenite	p38	PA452638	10598;1432;7965	0.563
NULL	Br_J_Cancer_2010_Oct_26_103(9)_1325-1330.nxml.txt.nlp	20940720	SENT157	22	22	20	20	cisplatin	CRT	PA449014	811	0.563
NULL	J_Cell_Biol_2008_Jan_28_180(2)_417-426.nxml.txt.nlp	18227283	SENT15	15	15	9	9	letrozole	aromatase	PA450196	1588	0.563
NULL	Breast_Cancer_(Auckl)_2011_Jul_27_5_175-199.nxml.txt.nlp	21863131	SENT497	11	11	1	1	carboplatin	Met	PA448803	79811	0.563
NULL	J_Clin_Biochem_Nutr_2010_Jan_29_46(1)_36-42.nxml.txt.nlp	20104263	SENT491	13	13	9	9	ribavirin	IFN	PA451241	3439	0.563
NULL	Front_Endocrinol_(Lausanne)_2013_May_10_4_52.nxml.txt.nlp	23675368	SENT674	11	11	13	13	lipase	HSL	PA450239	3991	0.563
NULL	Ann_Gen_Psychiatry_2011_Nov_3_10_30.nxml.txt.nlp	22053728	SENT2	7	7	13	13	succinylcholine	BCHE	PA451522	590	0.563
NULL	Diabetes_Care_2013_Aug_17_36(Suppl_2)_S245-S252.nxml.txt.nlp	23882053	SENT73	24	24	22	22	exenatide	GLP-1	PA164749238	100125288	0.563
NULL	Exp_Ther_Med_2013_Feb_20_5(2)_443-447.nxml.txt.nlp	23407364	SENT168	11	11	13	13	cyclophosphamide	ANOVA	PA449165	4858	0.563
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT111	24	24	8	8	trastuzumab	MUC4	PA451743	4585	0.563
NULL	J_Am_Heart_Assoc_2013_Apr_24_2(2)_e000131.nxml.txt.nlp	23537811	SENT88	7	7	20	20	clopidogrel	CYP2C19	PA449053	1557	0.563
NULL	ScientificWorldJournal_2014_Jul_23_2014_854093.nxml.txt.nlp	25147870	SENT237	5	5	2	2	chlorophyll	gamma	PA448942	9913	0.563
NULL	Arthritis_Care_Res_(Hoboken)_2014_Mar_24_66(3)_344-354.nxml.txt.nlp	23983039	SENT172	14	14	0	0	tocilizumab	SOC	PA165292659	91544	0.563
NULL	Br_J_Cancer_1997_75(2)_268-274.nxml.txt.nlp	9010037	SENT10	30	30	37	37	cyclosporine	P-gp	PA449167	5243	0.563
NULL	Br_J_Cancer_2009_Jul_21_101(2)_327-334.nxml.txt.nlp	19568240	SENT49	0	0	10	10	pp2	San		80218	0.563
NULL	Alcohol_Res_Health_2011_34(1)_76-85.nxml.txt.nlp	23580044	SENT124	2	2	13	13	choline	spatial	PA448976	219793	0.563
NULL	Arthritis_Res_Ther_2006_Feb_3_8(2)_R43.nxml.txt.nlp	16507142	SENT85	2	2	7	7	heparin	CXCL12	PA449855	6387	0.563
NULL	Front_Genet_2012_Oct_26_3_213.nxml.txt.nlp	23112805	SENT608	20	20	34	34	phenacetin	CYP2D6	PA450897	1565	0.563
NULL	EMBO_Mol_Med_2012_Dec_29_4(12)_1261-1275.nxml.txt.nlp	23109291	SENT175	20	20	34	34	thyroglobulin	Carabin	PA164754910	374403	0.563
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT159	29	29	34	34	doxorubicin	SLK	PA449412	9748;2534	0.563
NULL	Breast_Cancer_Res_2010_Jun_28_12(3)_R43.nxml.txt.nlp	20579400	SENT0	28	28	19	19	fulvestrant	MAPT	PA164747170	4137	0.563
NULL	Acta_Myol_2011_Oct_30(2)_121-126.nxml.txt.nlp	22106715	SENT92	24	24	20	20	nadh	COX	PA164755085	1351	0.563
NULL	Carcinogenesis_2008_Aug_24_29(8)_1587-1593.nxml.txt.nlp	18299278	SENT32	9	9	4	4	etoposide	CIAPIN1	PA449552	57019	0.563
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT44	0	0	10	10	chloroquine	BMPR-II	PA448948	659	0.563
NULL	Biosci_Rep_2012_Dec_1_32(Pt_6)_511-519.nxml.txt.nlp	NULL	SENT661	3	3	15	15	estradiol	ST-2	PA449503	27111	0.563
NULL	Adv_Ther_2013_Nov_30_30(12)_1086-1099.nxml.txt.nlp	24293132	SENT105	19	19	3	3	perindopril	CSBP	PA450877	3190	0.563
NULL	Arthritis_Res_2002_Jul_26_4(5)_R9.nxml.txt.nlp	12223112	SENT61	0	0	4	4	fluorescein	CD14	PA164746009	929	0.563
NULL	Curr_Oncol_2009_Jul_16(Suppl_2)_S1-S13.nxml.txt.nlp	19672416	SENT301	42	42	34	34	exemestane	ARNO	PA449563	9266	0.563
NULL	Clin_Pharmacokinet_2014_Sep_3_53(1)_1-16.nxml.txt.nlp	23999929	SENT287	40	40	30	30	rivaroxaban	P-gp	PA165958360	5243	0.563
NULL	Clin_Psychopharmacol_Neurosci_2013_Dec_24_11(3)_144-151.nxml.txt.nlp	24465251	SENT101	14	14	23	23	haloperidol	IL-10	PA449841	3586	0.563
NULL	Brain_Sci_2013_Mar_7_3(1)_215-238.nxml.txt.nlp	23667741	SENT994	1	1	8	8	glibenclamide	spatial	PA449782	219793	0.563
NULL	Crit_Care_2012_Oct_12_16(5)_R189.nxml.txt.nlp	23062226	SENT78	13	13	22	22	creatine	SAPS	PA164778930	8935	0.563
NULL	J_Thromb_Haemost_2011_May_9(5)_979-986.nxml.txt.nlp	21251205	SENT95	26	26	16	16	thrombin	mol	PA451674	90527	0.563
NULL	Br_J_Cancer_2010_Sep_7_103(6)_889-898.nxml.txt.nlp	20664599	SENT139	9	9	22	22	paclitaxel	AKT	PA450761	207	0.563
NULL	Ann_Gen_Psychiatry_2014_Oct_14_13(1)_32.nxml.txt.nlp	NULL	SENT101	6	6	19	19	levetiracetam	mol	PA450206	90527	0.563
NULL	Hum_Genomics_2004_Jan_1_1(2)_111-125.nxml.txt.nlp	15601539	SENT128	2	2	4	4	lipase	LIPC	PA450239	3990	0.563
NULL	Eur_J_Nutr_2009_Jun_24_48(4)_229-234.nxml.txt.nlp	19238310	SENT4	3	3	5	5	capsaicin	ghrelin	PA448776	51738	0.563
NULL	J_Epilepsy_Res_2014_Jun_30_4(1)_7-13.nxml.txt.nlp	24977124	SENT72	22	22	16	16	pilocarpine	CA3	PA450962	761	0.563
NULL	Diabetes_Care_2009_Feb_32(2)_209-214.nxml.txt.nlp	18957532	SENT183	31	31	40	40	simvastatin	adiponectin	PA451363	9370	0.563
NULL	Biosci_Rep_2012_Aug_1_32(Pt_4)_361-374.nxml.txt.nlp	22762204	SENT1139	5	5	0	0	cetuximab	PTEN	PA10040	5728	0.563
NULL	Acta_Neuropathol_Commun_2014_Sep_16_2(1)_138.nxml.txt.nlp	NULL	SENT64	28	28	21	21	mitoxantrone	IFN	PA450526	3439	0.563
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_127043.nxml.txt.nlp	23227093	SENT231	5	5	11	11	furafylline	CYP2B6	PA452614	1555	0.563
NULL	Biomed_Res_Int_2014_Jan_27_2014_696107.nxml.txt.nlp	24587987	SENT9	20	20	11	11	ebselen	NAC	PA161660841	22861	0.563
NULL	Nucleic_Acids_Res_2012_Jul_19_40(13)_5910-5925.nxml.txt.nlp	22434882	SENT327	10	10	12	12	etoposide	ETO	PA449552	862	0.563
NULL	Crit_Care_2009_Jul_10_13(4)_R113.nxml.txt.nlp	19591694	SENT155	17	17	25	25	vasopressin	AVP	PA451858	114548;551	0.563
NULL	J_Res_Med_Sci_2012_Feb_17(2)_159-163.nxml.txt.nlp	23264790	SENT5	8	8	13	13	imatinib	CD117	PA10804	3815	0.563
NULL	J_Gynecol_Oncol_2013_Jul_4_24(3)_222-228.nxml.txt.nlp	23875071	SENT41	26	26	8	8	platinum	DSI	PA150595617	5034	0.563
NULL	Br_J_Haematol_2009_Nov_2_147(3)_396-410.nxml.txt.nlp	19758122	SENT14	4	4	14	14	dasatinib	TP53	PA162372878	7157	0.563
NULL	Can_J_Infect_Dis_Med_Microbiol_2014_May-Jun_25(3)_163-169.nxml.txt.nlp	25285114	SENT221	4	4	26	26	ciprofloxacin	TOB	PA449009	10140	0.563
NULL	Indian_J_Endocrinol_Metab_2013_Jul-Aug_17(4)_636-646.nxml.txt.nlp	23961479	SENT138	19	19	16	16	pravastatin	CYP2C9	PA451089	1559	0.563
NULL	Front_Genet_2014_Aug_26_5_289.nxml.txt.nlp	25206362	SENT49	9	9	24	24	choline	B12	PA448976	7126;4709	0.563
NULL	Clinics_(Sao_Paulo)_2012_Jul_67(7)_711-717.nxml.txt.nlp	22892913	SENT209	3	3	6	6	glimepiride	TFI	PA449761	7035	0.563
NULL	Carcinogenesis_2013_Mar_7_34(3)_703-712.nxml.txt.nlp	23222814	SENT89	0	0	27	27	curcumin	MCM2	PA151958596	4171	0.563
NULL	Nat_Commun_2013_Aug_15_4_2130.nxml.txt.nlp	23945651	SENT7	15	15	27	27	cisplatin	ATG5	PA449014	9474	0.563
NULL	Neural_Dev_2012_Jun_13_7_21.nxml.txt.nlp	22694806	SENT385	31	31	15	15	l-glutamine	CO2	PA10090	4513	0.563
NULL	Int_J_Inflam_2012_Apr_26_2012_480373.nxml.txt.nlp	22611516	SENT107	29	29	20	20	vasopressin	ACTH	PA451858	5443	0.563
NULL	Front_Neurol_2014_Sep_11_5_173.nxml.txt.nlp	25309501	SENT265	14	14	24	24	hyaluronan	TLR2	PA165958431	7097	0.563
NULL	Int_J_Womens_Health_2010_Aug_24_2_279-290.nxml.txt.nlp	21151673	SENT228	17	17	37	37	levonorgestrel	PRL	PA450218	5617	0.563
NULL	Mol_Cancer_2012_Mar_23_11_15.nxml.txt.nlp	22439866	SENT98	8	8	5	5	collagenase	MMP1	PA449107	4312	0.563
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_11_2014_780385.nxml.txt.nlp	25435891	SENT53	13	13	30	30	l-glutamine	CO2	PA10090	4513	0.563
NULL	EMBO_Mol_Med_2012_Jul_19_4(7)_647-659.nxml.txt.nlp	22514144	SENT131	3	3	5	5	trypsin	ADAM10	PA451806	102	0.563
NULL	Nucleic_Acids_Res_2011_Mar_20_39(6)_2234-2248.nxml.txt.nlp	21097889	SENT426	13	13	4	4	cisplatin	p53	PA449014	7157	0.563
NULL	Br_J_Cancer_2010_May_11_102(10)_1495-1502.nxml.txt.nlp	20461092	SENT238	33	33	44	44	gefitinib	CEK	PA131301952	2260	0.563
NULL	Int_J_Nanomedicine_2009_Apr_1_4_27-35.nxml.txt.nlp	19421368	SENT101	21	21	29	29	genistein	IL-10	PA165109660	3586	0.563
NULL	Breast_Cancer_Res_2005_Mar_4_7(3)_R345-R352.nxml.txt.nlp	15987429	SENT245	28	28	18	18	ns-398	CARB		9482	0.563
NULL	J_Mol_Signal_2008_Dec_1_3_18.nxml.txt.nlp	19046439	SENT88	24	24	17	17	metformin	CDK2	PA450395	1017	0.563
NULL	Oncol_Lett_2014_May_11_7(5)_1401-1408.nxml.txt.nlp	24765145	SENT175	0	0	9	9	paclitaxel	HIF-1	PA450761	29072	0.563
NULL	Front_Synaptic_Neurosci_2010_Dec_22_2_152.nxml.txt.nlp	21423538	SENT181	11	11	9	9	forskolin	CA1	PA146096022	759	0.563
NULL	Oncol_Lett_2013_Oct_29_6(4)_1031-1038.nxml.txt.nlp	24137459	SENT204	2	2	40	40	cisplatin	LC3	PA449014	84557	0.563
NULL	Case_Rep_Oncol_2013_Feb_28_6(1)_114-118.nxml.txt.nlp	23569445	SENT71	15	15	11	11	rituximab	CHOP	PA451261	1649	0.563
NULL	Indian_J_Pharm_Sci_2008_Nov-Dec_70(6)_825-827.nxml.txt.nlp	21369455	SENT14	0	0	20	20	duloxetine	gamma	PA10066	9913	0.563
NULL	Clin_Dev_Immunol_2008_Apr_29_2008_718386.nxml.txt.nlp	18483571	SENT330	6	6	8	8	tacrolimus	HAI	PA451578	6692;6768	0.563
NULL	Cancer_Microenviron_2010_Jun_22_4(1)_39-50.nxml.txt.nlp	21505561	SENT44	27	27	42	42	gentamicin	CO2	PA449753	4513	0.563
NULL	Breast_Cancer_2013_Mar_1_20(4)_302-309.nxml.txt.nlp	23456736	SENT29	8	8	3	3	tegafur	DPD	PA452620	1806	0.563
NULL	Vet_Res_Forum_2013_Winter_4(1)_19-24.nxml.txt.nlp	25593681	SENT80	25	25	44	44	diclofenac	ANOVA	PA449293	4858	0.563
NULL	J_Antimicrob_Chemother_2009_Sep_4_64(3)_515-523.nxml.txt.nlp	19578178	SENT120	2	2	8	8	isoniazid	THP1	PA450112	2736	0.563
NULL	AIDS_2014_Jul_17_28(11)_1579-1591.nxml.txt.nlp	24752083	SENT93	23	23	12	12	choline	ART	PA448976	181	0.563
NULL	Facts_Views_Vis_Obgyn_2010_2(4)_278-286.nxml.txt.nlp	25009715	SENT134	14	14	10	10	paclitaxel	CYP2C8	PA450761	1558	0.563
NULL	Korean_J_Anesthesiol_2013_Jan_21_64(1)_47-53.nxml.txt.nlp	23372886	SENT156	30	30	6	6	bupivacaine	PTG	PA135057240	5507	0.563
NULL	Patient_Prefer_Adherence_2010_Feb_4_4_17-23.nxml.txt.nlp	20165595	SENT74	12	12	17	17	formoterol	BDP	PA134687907	10620;152926	0.563
NULL	J_Clin_Biochem_Nutr_2007_Nov_30_41(3)_224-230.nxml.txt.nlp	18299720	SENT84	10	10	29	29	glucose	ACTH	PA449773	5443	0.563
NULL	J_Carcinog_2014_Feb_20_13_4.nxml.txt.nlp	24737952	SENT56	30	30	8	8	cisplatin	HER2	PA449014	2064	0.563
NULL	Afr_J_Infect_Dis_2010_4(2)_29-42.nxml.txt.nlp	23878698	SENT28	32	32	24	24	artemisinin	ACT	PA165111696	12;11332;9457;641455	0.563
NULL	Curr_Infect_Dis_Rep_2010_Mar_26_12(2)_147-154.nxml.txt.nlp	20461118	SENT131	16	16	19	19	rituximab	IL-6	PA451261	3569	0.563
NULL	Med_Sci_Monit_2013_Nov_29_19_1080-1088.nxml.txt.nlp	24287619	SENT138	16	16	18	18	estradiol	ACL	PA449503	47	0.563
NULL	J_Clin_Biochem_Nutr_2010_Jan_29_46(1)_36-42.nxml.txt.nlp	20104263	SENT9	15	15	21	21	ribavirin	IFN	PA451241	3439	0.563
NULL	Behav_Brain_Funct_2012_Jun_11_8_30.nxml.txt.nlp	22686184	SENT200	4	4	7	7	diazepam	CORT	PA449283	1325	0.563
NULL	Breast_Cancer_Res_2011_Sep_14_13(5)_R88.nxml.txt.nlp	21914219	SENT146	4	4	21	21	trypsin	TRAIL	PA451806	8743	0.563
NULL	Acta_Pharmacol_Sin_2013_Apr_18_34(4)_555-560.nxml.txt.nlp	23503472	SENT38	25	25	23	23	cyclosporine	NFKB1	PA449167	4790	0.563
NULL	J_Biol_Chem_2013_Mar_8_288(10)_6946-6956.nxml.txt.nlp	23293023	SENT373	7	7	16	16	thrombin	TLR2	PA451674	7097	0.563
NULL	Int_J_Cell_Biol_2009_Dec_30_2009_750482.nxml.txt.nlp	20130821	SENT52	32	32	26	26	hydrocortisone	San	PA449905	80218	0.563
NULL	J_Gen_Physiol_2012_Jun_139(6)_407-414.nxml.txt.nlp	22641635	SENT110	7	7	28	28	nadh	ADP	PA164755085	23038	0.563
NULL	Cardiovasc_Diabetol_2013_May_30_12(Suppl_1)_S2.nxml.txt.nlp	23819752	SENT129	20	20	31	31	pitavastatin	CYP3A4	PA142650384	1576	0.563
NULL	Biomed_Res_Int_2014_May_18_2014_424982.nxml.txt.nlp	24949446	SENT158	31	31	13	13	bumetanide	NKCC1	PA448682	6558	0.563
NULL	Indian_J_Endocrinol_Metab_2012_May-Jun_16(3)_406-408.nxml.txt.nlp	22629508	SENT40	20	20	23	23	octreotide	gamma	PA450678	9913	0.563
NULL	Diabetes_Care_2011_Feb_20_34(2)_412-417.nxml.txt.nlp	21216851	SENT6	15	15	12	12	exenatide	GLP-1	PA164749238	100125288	0.563
NULL	Iran_J_Basic_Med_Sci_2012_Mar-Apr_15(2)_709-718.nxml.txt.nlp	23493500	SENT151	13	13	19	19	celecoxib	spatial	PA448871	219793	0.563
NULL	Arthritis_Res_Ther_2009_Aug_17_11(4)_R123.nxml.txt.nlp	19686595	SENT147	9	9	17	17	rituximab	CD27	PA451261	939	0.563
NULL	Biomed_Res_Int_2014_Aug_6_2014_967826.nxml.txt.nlp	25165721	SENT236	12	12	15	15	cisplatin	IL-10	PA449014	3586	0.563
NULL	Int_J_Alzheimers_Dis_2012_Apr_4_2012_258454.nxml.txt.nlp	22548198	SENT54	25	25	22	22	medroxyprogesterone	CEE	PA450344	51608	0.563
NULL	Cardiovasc_Diabetol_2013_Oct_17_12_150.nxml.txt.nlp	24134550	SENT136	17	17	12	12	pioglitazone	activin	PA450970	83729	0.563
NULL	BMB_Rep_2013_Mar_46(3)_157-162.nxml.txt.nlp	23527859	SENT110	17	17	15	15	galactose	mol	PA449725	90527	0.562
NULL	Am_J_Physiol_Endocrinol_Metab_2013_Jul_15_305(2)_E263-E270.nxml.txt.nlp	23715727	SENT14	13	13	18	18	creatine	SLC6A8	PA164778930	6535	0.562
NULL	J_Gen_Physiol_2009_Apr_133(4)_421-438.nxml.txt.nlp	19289574	SENT312	1	1	7	7	forskolin	SLC26A9	PA146096022	115019	0.562
NULL	Oncotarget_2014_Jun_8_5(13)_5040-5053.nxml.txt.nlp	24970815	SENT166	18	18	8	8	cisplatin	EGF	PA449014	1950	0.562
NULL	Epigenetics_Chromatin_2014_Aug_3_7_17.nxml.txt.nlp	25170345	SENT317	14	14	42	42	formaldehyde	P28	PA449703	9446;7802;9527	0.562
NULL	Exp_Ther_Med_2014_Aug_6_8(2)_585-590.nxml.txt.nlp	25009624	SENT130	3	3	6	6	oxygen	STZ	PA450744	6484	0.562
NULL	Mol_Med_Rep_2015_Feb_5_11(2)_805-814.nxml.txt.nlp	25373883	SENT236	34	34	13	13	colchicine	APE	PA449092	55704;328	0.562
NULL	Daru_2013_Dec_20_21(1)_78.nxml.txt.nlp	24359941	SENT10	4	4	6	6	gentamicin	EPO	PA449753	7076;8288;2056	0.562
NULL	Aging_(Albany_NY)_2009_Apr_21_1(4)_402-411.nxml.txt.nlp	20148189	SENT115	30	30	11	11	bleomycin	IL-8	PA448645	3576	0.562
NULL	Indian_J_Pharmacol_2008_Jan-Feb_40(1)_10-14.nxml.txt.nlp	21264154	SENT100	11	11	19	19	vildagliptin	GLP-1	PA165958346	100125288	0.562
NULL	Diabetes_2013_Oct_17_62(10)_3500-3513.nxml.txt.nlp	23884882	SENT363	10	10	8	8	resveratrol	adiponectin		9370	0.562
NULL	Breast_Cancer_Res_2002_May_15_4(4)_133-136.nxml.txt.nlp	12100736	SENT83	7	7	5	5	diethylstilbestrol	DES	PA449307	1674	0.562
NULL	J_Biol_Chem_2013_Mar_22_288(12)_8279-8288.nxml.txt.nlp	23400816	SENT731	5	5	14	14	atorvastatin	PCSK9	PA448500	255738	0.562
NULL	Indian_Dermatol_Online_J_2012_May-Aug_3(2)_122-124.nxml.txt.nlp	23130286	SENT73	17	17	5	5	vincristine	CHOP	PA451879	1649	0.562
NULL	J_Antimicrob_Chemother_2014_Nov_17_69(11)_2920-2927.nxml.txt.nlp	25038069	SENT139	10	10	12	12	oxacillin	FUS	PA450725	2521	0.562
NULL	Cancer_Cell_Int_2007_Jun_8_7_11.nxml.txt.nlp	17559657	SENT47	30	30	12	12	estradiol	IL3	PA449503	3562	0.562
NULL	BMJ_2014_Apr_15_348_g2366.nxml.txt.nlp	24736555	SENT465	29	29	23	23	glibenclamide	GLP-1	PA449782	100125288	0.562
NULL	Libyan_J_Med_2007_Dec_1_2(4)_176-179.nxml.txt.nlp	21503241	SENT8	33	33	24	24	vancomycin	VISA	PA451850	57506	0.562
NULL	Oncogene_2014_May_15_33(20)_2620-2628.nxml.txt.nlp	23770854	SENT157	44	44	40	40	hydrocortisone	EGF	PA449905	1950	0.562
NULL	Arthritis_Res_Ther_2003_Jun_11_5(4)_202-204.nxml.txt.nlp	12823851	SENT35	0	0	4	4	simvastatin	IFN	PA451363	3439	0.562
NULL	J_Korean_Med_Sci_2010_Aug_21_25(8)_1222-1227.nxml.txt.nlp	20676337	SENT163	30	30	18	18	aminophylline	LPA	PA164781029	4018	0.562
NULL	Nucleic_Acids_Res_2013_May_5_41(10)_5210-5222.nxml.txt.nlp	23563151	SENT83	1	1	8	8	arsenite	GADD45	PA452638	1647	0.562
NULL	Clin_Interv_Aging_2013_May_30_8_597-603.nxml.txt.nlp	23761968	SENT138	13	13	21	21	risedronate	PTH	PA451255	5741	0.562
NULL	J_Antimicrob_Chemother_2014_Mar_11_69(3)_594-597.nxml.txt.nlp	24216768	SENT43	36	36	19	19	oxacillin	BSAC	PA450725	57591	0.562
NULL	Biol_Direct_2010_Nov_2_5_61.nxml.txt.nlp	21040590	SENT271	17	17	3	3	lipase	COM1	PA450239	26471;5932	0.562
NULL	Diabetes_Care_2013_Jul_12_36(7)_1974-1980.nxml.txt.nlp	23340889	SENT156	21	21	12	12	lipase	PRL	PA450239	5617	0.562
NULL	BMJ_Open_2014_Oct_8_4(10)_e005767.nxml.txt.nlp	25296654	SENT93	17	17	29	29	hyaluronan	gremlin	PA165958431	26585	0.562
NULL	Ital_J_Pediatr_2010_Jan_22_36_8.nxml.txt.nlp	20205780	SENT28	10	10	13	13	estradiol	aromatase	PA449503	1588	0.562
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT262	23	23	17	17	methotrexate	MLH1	PA450428	4292	0.562
NULL	Endocrinol_Metab_(Seoul)_2014_Sep_25_29(3)_379-387.nxml.txt.nlp	25309798	SENT143	29	29	31	31	resveratrol	SIRT1		23411	0.562
NULL	Cancers_(Basel)_2011_Aug_19_3(3)_3370-3393.nxml.txt.nlp	24212958	SENT280	7	7	4	4	docetaxel	IFN	PA449383	3439	0.562
NULL	Iran_J_Pharm_Res_2014_Winter_13(1)_243-251.nxml.txt.nlp	24734077	SENT20	0	0	2	2	minoxidil	MOX	PA450521	26002	0.562
NULL	Anticancer_Drugs_2015_Jan_28_26(1)_46-55.nxml.txt.nlp	25099621	SENT156	9	9	18	18	doxorubicin	KE-3	PA449412	6222	0.562
NULL	Leukemia_2013_Dec_27_27(12)_2322-2331.nxml.txt.nlp	24072044	SENT111	16	16	13	13	plerixafor	CXCL12	PA165958410	6387	0.562
NULL	J_Hum_Genet_2013_Jun_16_58(6)_353-361.nxml.txt.nlp	23677058	SENT153	17	17	9	9	cytarabine	SLC28A3	PA449177	64078	0.562
NULL	Arthritis_Res_Ther_2009_Aug_3_11(4)_238.nxml.txt.nlp	19678909	SENT41	0	0	9	9	hydroquinone	IFN	PA449924	3439	0.562
NULL	Exp_Diabetes_Res_2012_Oct_15_2012_465282.nxml.txt.nlp	23118742	SENT85	0	0	17	17	metformin	FGF21	PA450395	26291	0.562
NULL	Br_J_Cancer_2009_Jul_21_101(2)_269-277.nxml.txt.nlp	19603033	SENT93	8	8	2	2	cisplatin	XIAP	PA449014	331	0.562
NULL	Front_Immunol_2013_Mar_27_4_76.nxml.txt.nlp	23543707	SENT74	12	12	22	22	rituximab	EGFR	PA451261	1956	0.562
NULL	Front_Behav_Neurosci_2011_Sep_8_5_56.nxml.txt.nlp	21927600	SENT210	3	3	20	20	cocaine	DARPP-32	PA449072	84152	0.562
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1066.nxml.txt.nlp	24556681	SENT10	0	0	22	22	ethanol	p62	PA448073	8878;10657;23636	0.562
NULL	Evid_Based_Complement_Alternat_Med_2006_Sep_20_3(3)_365-372.nxml.txt.nlp	16951721	SENT101	6	6	0	0	ginseng	Bcl-2	PA164781150	596	0.562
NULL	Front_Hum_Neurosci_2010_Nov_2_4_204.nxml.txt.nlp	21120136	SENT1002	4	4	9	9	choline	spatial	PA448976	219793	0.562
NULL	Basic_Res_Cardiol_2014_Oct_31_109(6)_451.nxml.txt.nlp	25358972	SENT10	24	24	37	37	phenylephrine	FHL2	PA450935	2274	0.562
NULL	EMBO_Mol_Med_2013_Jul_6_5(7)_905-915.nxml.txt.nlp	23740690	SENT48	12	12	14	14	lipase	ATGL	PA450239	57104	0.562
NULL	Iran_J_Public_Health_2010_Jun_30_39(2)_63-68.nxml.txt.nlp	23113008	SENT144	44	44	14	14	doxycycline	TOB	PA449415	10140	0.562
NULL	Clin_Med_Insights_Arthritis_Musculoskelet_Disord_2012_Jan_5_5_1-14.nxml.txt.nlp	22267947	SENT82	20	20	30	30	risedronate	NNT	PA451255	23530	0.562
NULL	Breast_Cancer_Res_2012_Feb_14_14(1)_R30.nxml.txt.nlp	22333315	SENT229	8	8	18	18	sulindac	CXCL9	PA451565	4283	0.562
NULL	J_Pain_Res_2014_Jun_23_7_353-357.nxml.txt.nlp	25018649	SENT22	22	22	15	15	lidocaine	LNP	PA450226	80856;51203	0.562
NULL	Oxid_Med_Cell_Longev_2013_Jun_2_2013_793525.nxml.txt.nlp	23819014	SENT167	3	3	23	23	resveratrol	AMPK		5563	0.562
NULL	Int_J_Mol_Sci_2014_Sep_2_15(9)_15512-15529.nxml.txt.nlp	25184950	SENT72	13	13	6	6	resveratrol	IL-10		3586	0.562
NULL	Evid_Based_Complement_Alternat_Med_2011_Jan_4_2011_392627.nxml.txt.nlp	19542183	SENT65	27	27	13	13	phenylephrine	mol	PA450935	90527	0.562
NULL	Vet_Res_2013_Jan_11_44(1)_2.nxml.txt.nlp	23311865	SENT71	14	14	34	34	gentamicin	CO2	PA449753	4513	0.562
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT1706	22	22	4	4	ritonavir	ATV	PA451260	4683	0.562
NULL	Springerplus_2013_Feb_23_2_64.nxml.txt.nlp	23667797	SENT102	22	22	5	5	ethanol	mol	PA448073	90527	0.562
NULL	Comput_Struct_Biotechnol_J_2013_Feb_22_3_e201210020.nxml.txt.nlp	24688680	SENT165	3	3	16	16	naringenin	CHS	PA151958361	1130	0.562
NULL	Antiviral_Res_2009_May_82(2)_A99-A109.nxml.txt.nlp	19176219	SENT1122	33	33	35	35	nelfinavir	P-gp	PA450606	5243	0.562
NULL	Arthritis_Res_Ther_2011_Apr_4_13(2)_R56.nxml.txt.nlp	21463515	SENT19	22	22	26	26	anakinra	IL-6	PA10799	3569	0.562
NULL	J_Gen_Physiol_1922_May_20_4(5)_559-568.nxml.txt.nlp	19871954	SENT0	17	17	1	1	atropine	Gen	PA448505	348654	0.562
NULL	Case_Rep_Ophthalmol_2011_Mar_12_2(1)_105-110.nxml.txt.nlp	22110438	SENT19	18	18	15	15	ribavirin	IFN	PA451241	3439	0.562
NULL	J_Cell_Biol_2008_Jul_14_182(1)_61-76.nxml.txt.nlp	18625843	SENT41	16	16	8	8	neomycin	7SK	PA450608	125050	0.562
NULL	Breast_Cancer_Res_2007_Oct_19_9(5)_111.nxml.txt.nlp	17983482	SENT75	30	30	33	33	gefitinib	HER3	PA131301952	2065	0.562
NULL	J_Korean_Med_Sci_1996_Jun_11(3)_250-257.nxml.txt.nlp	8843008	SENT12	8	8	18	18	nitroprusside	GMP	PA451406	22978	0.562
NULL	Ann_Hematol_2014_Mar_18_93(8)_1335-1344.nxml.txt.nlp	24638841	SENT92	1	1	19	19	rituximab	CHOP	PA451261	1649	0.562
NULL	AIDS_Res_Ther_2009_Apr_9_6_3.nxml.txt.nlp	19358725	SENT56	9	9	28	28	abacavir	TDF	PA448004	6736	0.562
NULL	Curr_Neuropharmacol_2009_Sep_7(3)_217-227.nxml.txt.nlp	20190963	SENT421	35	35	25	25	heparin	VCAM1	PA449855	7412	0.562
NULL	Orphanet_J_Rare_Dis_2014_Sep_26_9(1)_145.nxml.txt.nlp	NULL	SENT97	6	6	3	3	denosumab	DPD	PA166048634	1806	0.562
NULL	Br_J_Dermatol_2009_Feb_160(2)_438-441.nxml.txt.nlp	19016697	SENT96	26	26	23	23	methotrexate	MTHFR	PA450428	4524	0.562
NULL	Onco_Targets_Ther_2014_May_10_7_633-636.nxml.txt.nlp	24872711	SENT5	15	15	4	4	vincristine	CHOP	PA451879	1649	0.562
NULL	Ther_Clin_Risk_Manag_2006_Sep_2(3)_235-249.nxml.txt.nlp	18360599	SENT299	25	25	21	21	alendronate	PTH	PA448082	5741	0.562
NULL	Cancers_(Basel)_2013_Jul_4_5(3)_838-856.nxml.txt.nlp	24202322	SENT192	2	2	31	31	flavopiridol	p53	PA452627	7157	0.562
NULL	Leukemia_2014_Jun_17_28(6)_1216-1226.nxml.txt.nlp	24301524	SENT101	2	2	25	25	bortezomib	CYLD	PA10252	1540	0.562
NULL	Nat_Commun_2012_Dec_18_3_1303.nxml.txt.nlp	23250433	SENT152	20	20	42	42	l-glutamine	CO2	PA10090	4513	0.562
NULL	J_Cell_Biol_2000_Jul_10_150(1)_155-164.nxml.txt.nlp	10893264	SENT180	12	12	10	10	choline	CDP	PA448976	1523	0.562
NULL	Oncol_Lett_2014_Jul_25_8(1)_313-316.nxml.txt.nlp	24959268	SENT89	0	0	25	25	sulindac	PC-3	PA451565	692094	0.562
NULL	Virol_J_2009_Dec_1_6_213.nxml.txt.nlp	19951438	SENT210	29	29	36	36	etoposide	TRAIL	PA449552	8743	0.562
NULL	EMBO_Mol_Med_2012_Nov_15_4(11)_1200-1213.nxml.txt.nlp	23065768	SENT47	22	22	13	13	tamoxifen	PI3K	PA451581	5290	0.562
NULL	J_Cardiothorac_Surg_2011_Apr_8_6_44.nxml.txt.nlp	21477293	SENT104	6	6	9	9	lepirudin	ACT	PA450195	12;11332;9457;641455	0.562
NULL	ScientificWorldJournal_2012_Mar_12_2012_793823.nxml.txt.nlp	22500143	SENT332	29	29	23	23	lipase	KLF5	PA450239	688	0.562
NULL	Nucleic_Acids_Res_2005_Feb_18_33(3)_1132-1139.nxml.txt.nlp	15722487	SENT401	19	19	21	21	nadh	ND6	PA164755085	4541	0.562
NULL	Clin_Ophthalmol_2009_Jun_2_3_189-194.nxml.txt.nlp	19668564	SENT95	35	35	33	33	latanoprost	BAK	PA164774763	578	0.562
NULL	Cardiol_Res_Pract_2012_Feb_7_2012_121237.nxml.txt.nlp	22454775	SENT83	8	8	13	13	heparin	HSP60	PA449855	3329	0.562
NULL	Cardiol_Res_Pract_2013_Feb_21_2013_127270.nxml.txt.nlp	23509665	SENT134	10	10	29	29	ticagrelor	NNT	PA165374673	23530	0.562
NULL	J_Cell_Biol_1998_Jul_13_142(1)_85-100.nxml.txt.nlp	9660865	SENT2	11	11	3	3	tetracycline	RhoA	PA451640	387	0.562
NULL	AMB_Express_2012_Dec_7_2_65.nxml.txt.nlp	23217124	SENT308	6	6	24	24	ethanol	SHF	PA448073	90525	0.562
NULL	Ethiop_J_Health_Sci_2010_Mar_20(1)_41-48.nxml.txt.nlp	22434959	SENT115	24	24	26	26	ceftriaxone	Gen	PA448866	348654	0.562
NULL	J_Cell_Biol_1998_Jul_13_142(1)_101-115.nxml.txt.nlp	9660866	SENT161	45	45	22	22	dextran	RhoA	PA449261	387	0.562
NULL	Diabetes_Care_2013_Aug_17_36(Suppl_2)_S127-S138.nxml.txt.nlp	23882037	SENT98	0	0	2	2	metformin	GLP-1	PA450395	100125288	0.562
NULL	Diabetes_Care_2010_Apr_12_33(4)_861-868.nxml.txt.nlp	20067962	SENT136	16	16	11	11	hyaluronan	HMGB1	PA165958431	3146	0.562
NULL	Mol_Cancer_2014_Jul_5_13_165.nxml.txt.nlp	24996221	SENT249	0	0	6	6	docetaxel	HMGB1	PA449383	3146	0.562
NULL	Autoimmune_Dis_2013_Nov_5_2013_716813.nxml.txt.nlp	24294521	SENT77	17	17	27	27	bevacizumab	CRT	PA130232992	811	0.562
NULL	Int_J_Environ_Res_Public_Health_2010_Apr_30_7(4)_1448-1466.nxml.txt.nlp	20617039	SENT40	6	6	8	8	ethanol	DRD2	PA448073	1813	0.562
NULL	J_Exp_Med_1977_Dec_1_146(6)_1484-1499.nxml.txt.nlp	925610	SENT6	31	31	18	18	trypsin	C42	PA451806	51654	0.562
NULL	Breast_Cancer_Res_2004_May_7_6(4)_R352-R365.nxml.txt.nlp	15217502	SENT229	18	18	14	14	estradiol	CYP1A2	PA449503	1544	0.562
NULL	Oncol_Lett_2014_Jan_29_7(1)_121-124.nxml.txt.nlp	24348832	SENT13	0	0	5	5	cisplatin	Bcl-2	PA449014	596	0.562
NULL	Breast_Cancer_Res_Treat_2014_Dec_19_143(2)_351-358.nxml.txt.nlp	24352574	SENT6	25	25	28	28	filgrastim	2-21	PA449626	54097	0.562
NULL	Diabetes_Care_2013_Jun_15_36(6)_1654-1659.nxml.txt.nlp	23250803	SENT7	20	20	7	7	vildagliptin	ET1	PA165958346	1906	0.562
NULL	Am_J_Cardiovasc_Drugs_2014_Oct_31_14(2)_79-87.nxml.txt.nlp	24174174	SENT28	18	18	22	22	rosuvastatin	adiponectin	PA134308647	9370	0.562
NULL	Iran_J_Neurol_2012_11(2)_70-73.nxml.txt.nlp	24250865	SENT49	14	14	4	4	doxycycline	IFN	PA449415	3439	0.562
NULL	Eur_J_Clin_Pharmacol_2010_Feb_17_66(2)_165-170.nxml.txt.nlp	19838691	SENT143	41	41	29	29	midazolam	UGT2B7	PA450496	7364	0.562
NULL	Oncogene_2014_Aug_28_33(35)_4396-4406.nxml.txt.nlp	24531714	SENT58	0	0	2	2	nutlin-3	MDM2		4193	0.562
NULL	Int_J_Mol_Sci_2007_Jan_29_8(1)_13-28.nxml.txt.nlp	NULL	SENT128	23	23	25	25	galactose	NAG	PA449725	51594;4669	0.562
NULL	Int_J_Mol_Sci_2012_Feb_22_13(2)_2387-2404.nxml.txt.nlp	22408460	SENT344	16	16	24	24	urea	KDR	PA451831	3791	0.562
NULL	Nat_Chem_2014_Jul_25_6(7)_614-622.nxml.txt.nlp	24950332	SENT279	12	12	16	16	imatinib	ABL1	PA10804	25	0.562
NULL	J_Biol_Chem_2013_Apr_26_288(17)_11865-11876.nxml.txt.nlp	23449983	SENT270	19	19	11	11	vanillin	CXCR4	PA451852	7852	0.562
NULL	Biomed_Res_Int_2014_Jun_25_2014_764981.nxml.txt.nlp	25057499	SENT213	23	23	10	10	sorafenib	Bcl-2	PA7000	596	0.562
NULL	Front_Cell_Neurosci_2014_Dec_11_8_427.nxml.txt.nlp	25565961	SENT815	10	10	7	7	imatinib	GSAP	PA10804	54103	0.562
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Mar_17_68(Pt_4)_o1104-o1105.nxml.txt.nlp	22589963	SENT74	13	13	19	19	coumarin	mol	PA134521193	90527	0.562
NULL	J_Virol_2014_Jan_88(1)_10-20.nxml.txt.nlp	24155369	SENT394	20	20	22	22	lipase	ATGL	PA450239	57104	0.562
NULL	Oncotarget_2014_Mar_16_5(12)_4087-4102.nxml.txt.nlp	24961479	SENT48	17	17	29	29	hemin	PC3	PA449849	57332;7832;5122	0.562
NULL	Curr_Neuropharmacol_2012_Mar_10(1)_12-48.nxml.txt.nlp	22942876	SENT823	21	21	15	15	fluvoxamine	GRM3	PA449690	2913	0.562
NULL	J_Hematol_Oncol_2013_Nov_5_6_83.nxml.txt.nlp	24283248	SENT34	24	24	16	16	nutlin-3	TP53		7157	0.562
NULL	Brain_Sci_2013_Jul_31_3(3)_1153-1181.nxml.txt.nlp	24587895	SENT750	3	3	21	21	isoflurane	San	PA450106	80218	0.562
NULL	Front_Physiol_2013_Dec_24_4_386.nxml.txt.nlp	24399968	SENT293	8	8	11	11	tolbutamide	SUR1	PA451718	6833	0.562
NULL	Acta_Pharmacol_Sin_2014_Jul_9_35(7)_889-898.nxml.txt.nlp	24909515	SENT214	36	36	21	21	methamphetamine	SULT	PA450403	6816	0.562
NULL	Commun_Integr_Biol_2014_Jan_8_6(6)_e27595.nxml.txt.nlp	24753792	SENT87	13	13	11	11	vasopressin	ADP	PA451858	23038	0.562
NULL	Curr_Cardiol_Rev_2009_May_5(2)_125-132.nxml.txt.nlp	20436853	SENT20	13	13	3	3	ticlopidine	ADP	PA451686	23038	0.562
NULL	Ecol_Evol_2013_Dec_7_3(15)_4910-4924.nxml.txt.nlp	24455125	SENT54	31	31	8	8	ethanol	mol	PA448073	90527	0.562
NULL	Breast_Cancer_Res_2010_May_18_12(Suppl_1)_P58.nxml.txt.nlp	NULL	SENT16	45	45	32	32	doxorubicin	TRAIL	PA449412	8743	0.562
NULL	Acta_Orthop_2009_Jun_5_80(3)_357-362.nxml.txt.nlp	19421912	SENT32	29	29	45	45	collagenase	CO2	PA449107	4513	0.562
NULL	Springerplus_2014_Oct_24_3_627.nxml.txt.nlp	25392797	SENT49	2	2	5	5	mannitol	K10	PA450320	3858	0.562
NULL	F1000_Biol_Rep_2012_Mar_1_4_5.nxml.txt.nlp	22403588	SENT22	40	40	20	20	ribavirin	IFN	PA451241	3439	0.562
NULL	Biomed_Res_Int_2014_Feb_17_2014_429198.nxml.txt.nlp	24696850	SENT316	15	15	13	13	cyclophosphamide	Bcl-2	PA449165	596	0.562
NULL	Curr_Cardiol_Rev_2009_Aug_5(3)_166-176.nxml.txt.nlp	20676275	SENT206	11	11	17	17	chlorpromazine	HERG	PA448964	3757	0.562
NULL	Epigenetics_Chromatin_2014_Sep_11_7_24.nxml.txt.nlp	25276231	SENT36	13	13	15	15	tamoxifen	TMX	PA451581	81542	0.562
NULL	J_Cell_Sci_2014_Nov_1_127(21)_4728-4739.nxml.txt.nlp	25179605	SENT101	3	3	8	8	bortezomib	SGTA	PA10252	6449	0.562
NULL	Eur_J_Med_Res_2011_Feb_24_16(2)_63-66.nxml.txt.nlp	21463983	SENT122	7	7	22	22	tobramycin	PARI	PA451704	55010	0.562
NULL	Int_J_Mol_Sci_2012_Sep_26_13(10)_12287-12314.nxml.txt.nlp	23202899	SENT231	17	17	23	23	trypsin	ICAT	PA451806	56998	0.562
NULL	F1000_Med_Rep_2010_Jul_14_2_52.nxml.txt.nlp	21170362	SENT96	2	2	31	31	lidocaine	TRPV1	PA450226	7442	0.562
NULL	ISRN_Neurosci_2013_Jul_17_2013_253210.nxml.txt.nlp	24967306	SENT123	0	0	9	9	naltrexone	ANOVA	PA450588	4858	0.562
NULL	Oncotarget_2013_Dec_28_5(6)_1475-1490.nxml.txt.nlp	24721996	SENT191	4	4	20	20	rosiglitazone	PTEN	PA451283	5728	0.562
NULL	Br_J_Cancer_2012_Sep_4_107(6)_947-955.nxml.txt.nlp	22892392	SENT125	13	13	5	5	lapatinib	ERBB2	PA152241907	2064	0.562
NULL	Mol_Cancer_2012_Dec_12_11_91.nxml.txt.nlp	23234355	SENT171	16	16	1	1	erlotinib	EGFR	PA134687924	1956	0.562
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT148	6	6	15	15	perifosine	p38	PA165291471	10598;1432;7965	0.562
NULL	J_Cell_Biol_2001_Nov_12_155(4)_593-604.nxml.txt.nlp	11696560	SENT138	30	30	8	8	iodixanol	TGN	PA164783998	7038	0.562
NULL	Adipocyte_2012_Jul_1_1(3)_132-181.nxml.txt.nlp	23700522	SENT90	16	16	18	18	lipase	ATGL	PA450239	57104	0.562
NULL	Oncol_Lett_2013_Jun_3_5(6)_1836-1838.nxml.txt.nlp	23833651	SENT68	2	2	4	4	thyroglobulin	TTF-1	PA164754910	7080	0.562
NULL	Ann_Maxillofac_Surg_2013_Jul-Dec_3(2)_114-125.nxml.txt.nlp	24205470	SENT110	12	12	25	25	collagenase	GMP	PA449107	22978	0.562
NULL	Front_Behav_Neurosci_2014_Oct_30_8_366.nxml.txt.nlp	25400560	SENT318	4	4	13	13	ethanol	GLT-1	PA448073	6506	0.562
NULL	Tumour_Biol_2013_Apr_29_34(2)_661-668.nxml.txt.nlp	23192642	SENT17	10	10	13	13	sunitinib	EGF	PA162372840	1950	0.562
NULL	Cardiovasc_J_Afr_2013_Apr_24(3)_78-81.nxml.txt.nlp	23736131	SENT48	37	37	24	24	nitrogen	OCT	PA450643	5362	0.562
NULL	Int_J_Biol_Sci_2014_Jun_10_10(7)_654-663.nxml.txt.nlp	25013375	SENT165	8	8	13	13	nitroxoline	p53	PA164754993	7157	0.562
NULL	Adv_Urol_2012_Oct_16_2012_893193.nxml.txt.nlp	22013439	SENT60	27	27	17	17	atrasentan	CRCP	PA143414738	27297	0.562
NULL	Hum_Mol_Genet_2012_May_1_21(9)_2111-2123.nxml.txt.nlp	22286170	SENT249	23	23	10	10	gentamicin	CO2	PA449753	4513	0.562
NULL	Diabetes_Obes_Metab_2012_Apr_14(4)_304-314.nxml.txt.nlp	22051096	SENT70	16	16	13	13	exenatide	GLP-1	PA164749238	100125288	0.562
NULL	Comp_Hepatol_2004_Jan_14_3(Suppl_1)_S37.nxml.txt.nlp	14960189	SENT14	11	11	18	18	ethanol	TNF-alpha	PA448073	7124	0.562
NULL	Exp_Ther_Med_2014_Apr_13_7(4)_923-928.nxml.txt.nlp	24669252	SENT192	12	12	0	0	resveratrol	PRL		5617	0.562
NULL	Exp_Diabetes_Res_2012_Aug_5_2012_201295.nxml.txt.nlp	22919367	SENT106	20	20	30	30	l-glutamine	activin	PA10090	83729	0.562
NULL	Mol_Med_Rep_2015_Jan_17_11(1)_43-52.nxml.txt.nlp	25333456	SENT266	25	25	45	45	mitomycin	ADM	PA450524	133	0.562
NULL	Indian_J_Pharmacol_2014_Jul-Aug_46(4)_430-432.nxml.txt.nlp	25097284	SENT73	15	15	13	13	thrombin	ADP	PA451674	23038	0.562
NULL	J_Cell_Biol_2002_Jun_24_157(7)_1151-1160.nxml.txt.nlp	12082077	SENT168	8	8	11	11	trypsin	COX	PA451806	1351	0.561
NULL	JAKSTAT_2014_Jun_12_3_e29554.nxml.txt.nlp	25105067	SENT104	19	19	39	39	propofol	p65	PA451141	5970	0.561
NULL	Lab_Invest_2009_Nov_7_89(11)_1275-1290.nxml.txt.nlp	19736547	SENT141	12	12	0	0	curcumin	LOX-1	PA151958596	4973	0.561
NULL	J_Cell_Mol_Med_2013_Jun_15_17(6)_792-799.nxml.txt.nlp	23672538	SENT61	7	7	38	38	fluorescein	CD235a	PA164746009	2993	0.561
NULL	BMB_Rep_2014_Jul_47(7)_388-392.nxml.txt.nlp	24286329	SENT179	1	1	3	3	berberine	AP-1	PA165860812	2353;3727;2354;3725	0.561
NULL	J_Vet_Med_Sci_2014_Mar_1_76(3)_323-330.nxml.txt.nlp	24189582	SENT140	21	21	19	19	leflunomide	A-2	PA450192	27239	0.561
NULL	Exp_Ther_Med_2013_Feb_29_5(2)_527-532.nxml.txt.nlp	23404385	SENT102	2	2	5	5	cyclosporine	CYP3A4	PA449167	1576	0.561
NULL	FEBS_Open_Bio_2014_Jan_6_4_77-89.nxml.txt.nlp	24490132	SENT763	7	7	13	13	ebselen	GDH	PA161660841	51084;2746	0.561
NULL	Mediators_Inflamm_1998_7(3)_169-173.nxml.txt.nlp	9705604	SENT8	3	3	24	24	octreotide	IL-6	PA450678	3569	0.561
NULL	Adv_Pharmacol_Sci_2013_Dec_5_2013_387071.nxml.txt.nlp	24381587	SENT87	2	2	4	4	curcumin	TNF	PA151958596	7124	0.561
NULL	Arthritis_Res_Ther_2014_Apr_3_16(2)_R86.nxml.txt.nlp	24708674	SENT195	19	19	35	35	bosentan	Fli1	PA10034	2314	0.561
NULL	Front_Behav_Neurosci_2014_Oct_6_8_343.nxml.txt.nlp	25339876	SENT105	41	41	30	30	chlorpromazine	B12	PA448964	7126;4709	0.561
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2675-2684.nxml.txt.nlp	24129246	SENT197	24	24	18	18	etoposide	p53	PA449552	7157	0.561
NULL	Nat_Commun_2014_Jun_9_5_4039.nxml.txt.nlp	24909261	SENT192	18	18	48	48	l-glutamine	CO2	PA10090	4513	0.561
NULL	Acta_Pharmacol_Sin_2010_Feb_5_31(2)_150-159.nxml.txt.nlp	20139897	SENT103	24	24	21	21	thrombin	ADP	PA451674	23038	0.561
NULL	Mucosal_Immunol_2014_Jan_22_7(1)_10_1038_mi_2013_32.nxml.txt.nlp	23695512	SENT12	2	2	19	19	dextran	CD100	PA449261	10507	0.561
NULL	Diabetes_2009_Jan_58(1)_243-249.nxml.txt.nlp	18840785	SENT126	21	21	15	15	glucose	GLP-1	PA449773	100125288	0.561
NULL	J_Korean_Med_Sci_2009_Jan_29_24(Suppl_1)_S183-S188.nxml.txt.nlp	19194550	SENT85	2	2	10	10	celecoxib	CD2AP	PA448871	23607	0.561
NULL	Tuberc_Respir_Dis_(Seoul)_2012_Apr_30_72(4)_343-351.nxml.txt.nlp	23227075	SENT44	17	17	21	21	gentamicin	CO2	PA449753	4513	0.561
NULL	Oncoscience_2014_Jun_4_1(6)_446-456.nxml.txt.nlp	25594043	SENT163	21	21	32	32	l-glutamine	CO2	PA10090	4513	0.561
NULL	Indian_J_Nucl_Med_2014_Jan-Mar_29(1)_32-33.nxml.txt.nlp	24591780	SENT36	22	22	7	7	octreotide	FDG	PA450678	23583	0.561
NULL	Cancer_Cell_Int_2011_Nov_17_11_40.nxml.txt.nlp	22088142	SENT155	0	0	8	8	doxorubicin	MRP1	PA449412	4437	0.561
NULL	Clin_Ophthalmol_2014_Feb_10_8_389-399.nxml.txt.nlp	24550667	SENT172	7	7	32	32	brinzolamide	TIM	PA164744929	7984;8914	0.561
NULL	Allergy_Asthma_Immunol_Res_2014_Sep_18_6(5)_376-388.nxml.txt.nlp	25228994	SENT133	15	15	0	0	ciclesonide	BDP	PA164781399	10620;152926	0.561
NULL	Physiol_Rep_2014_Nov_20_2(11)_e12202.nxml.txt.nlp	25413322	SENT123	25	25	35	35	propranolol	ANOVA	PA451145	4858	0.561
NULL	Acta_Naturae_2011_Jan-Mar_3(1)_29-47.nxml.txt.nlp	22649672	SENT328	33	33	8	8	doxorubicin	A10	PA449412	28870	0.561
NULL	Int_J_Mol_Sci_2014_May_13_15(5)_8407-8427.nxml.txt.nlp	24828202	SENT444	14	14	12	12	urokinase	CEACAM1	PA451836	634	0.561
NULL	J_Biomed_Sci_2014_Aug_19_21(1)_77.nxml.txt.nlp	25135350	SENT66	14	14	21	21	choline	B12	PA448976	7126;4709	0.561
NULL	Biomed_Res_Int_2014_Jan_27_2014_683123.nxml.txt.nlp	24592395	SENT58	19	19	42	42	gentamicin	CO2	PA449753	4513	0.561
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Dec_4_66(Pt_1)_m14.nxml.txt.nlp	21579915	SENT53	3	3	20	20	copper	Ray	PA449114	26751	0.561
NULL	Neuropsychopharmacology_2009_May_3_34(6)_1504-1513.nxml.txt.nlp	19052543	SENT2	36	36	22	22	cocaine	CNR1	PA449072	1268;56117;56144	0.561
NULL	J_Biomed_Biotechnol_2003_Mar_19_2003(1)_35-47.nxml.txt.nlp	12686721	SENT188	14	14	10	10	thyroglobulin	CEA	PA164754910	5670;1087	0.561
NULL	Mol_Cancer_2008_Jun_30_7_60.nxml.txt.nlp	18590557	SENT4	34	34	39	39	tamoxifen	TRAIL	PA451581	8743	0.561
NULL	J_Mol_Signal_2009_Apr_28_4_2.nxml.txt.nlp	19400946	SENT144	21	21	38	38	estradiol	Gen	PA449503	348654	0.561
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jul_28_68(Pt_8)_o2592-o2593.nxml.txt.nlp	22905016	SENT71	46	46	39	39	ethanol	mol	PA448073	90527	0.561
NULL	J_Cardiothorac_Surg_2012_Nov_15_7_123.nxml.txt.nlp	23151309	SENT134	19	19	0	0	heparin	IL-6	PA449855	3569	0.561
NULL	Fibrogenesis_Tissue_Repair_2011_Jun_28_4_14.nxml.txt.nlp	21711521	SENT69	32	32	17	17	imatinib	EGF	PA10804	1950	0.561
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT128	7	7	2	2	phenytoin	CYP2C19	PA450947	1557	0.561
NULL	Biosci_Rep_2012_Aug_1_32(Pt_4)_361-374.nxml.txt.nlp	22762204	SENT152	14	14	11	11	trastuzumab	PTEN	PA451743	5728	0.561
NULL	Turk_J_Haematol_2012_Dec_5_29(4)_392-396.nxml.txt.nlp	24385727	SENT56	0	0	8	8	fludarabine	CD4	PA449655	920	0.561
NULL	J_Invest_Dermatol_2012_Sep_10_132(9)_2255-2262.nxml.txt.nlp	22572817	SENT49	28	28	32	32	forskolin	HBD3	PA146096022	414325	0.561
NULL	Exp_Ther_Med_2014_Dec_13_8(6)_1939-1945.nxml.txt.nlp	25371760	SENT224	2	2	4	4	cisplatin	NAC	PA449014	22861	0.561
NULL	J_Mol_Signal_2008_May_22_3_11.nxml.txt.nlp	18498628	SENT296	16	16	18	18	isoproterenol	LPA	PA450121	4018	0.561
NULL	Front_Genet_2012_Oct_26_3_213.nxml.txt.nlp	23112805	SENT608	25	25	34	34	diclofenac	CYP2D6	PA449293	1565	0.561
NULL	Diabetes_Care_2011_Jun_20_34(6)_1406-1411.nxml.txt.nlp	21515837	SENT145	25	25	32	32	glucose	LVM	PA449773	23209	0.561
NULL	Ann_Neurosci_2011_Apr_18(2)_76-83.nxml.txt.nlp	25205926	SENT13	22	22	6	6	selegiline	COMT	PA451316	1312	0.561
NULL	Mol_Cancer_2004_Jul_12_3_19.nxml.txt.nlp	15248896	SENT385	9	9	26	26	oxygen	ND6	PA450744	4541	0.561
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT38	28	28	21	21	glucose	FBS	PA449773	64319;26269	0.561
NULL	Mol_Biol_Rep_2014_Jan_29_41(5)_2851-2857.nxml.txt.nlp	24469723	SENT87	11	11	16	16	cyclophosphamide	BCS	PA449165	617	0.561
NULL	Daru_2011_19(6)_433-439.nxml.txt.nlp	23008689	SENT101	26	26	28	28	ethanol	IPA	PA448073	3160	0.561
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT469	5	5	7	7	iloperidone	PRL	PA161199368	5617	0.561
NULL	Arthritis_Res_Ther_2007_Mar_12_9(2)_R28.nxml.txt.nlp	17352828	SENT61	16	16	2	2	anakinra	MSU	PA10799	593	0.561
NULL	Ann_Oncol_2009_Aug_20(Suppl_6)_vi41-vi50.nxml.txt.nlp	19617297	SENT51	21	21	23	23	tamoxifen	IFN	PA451581	3439	0.561
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_127043.nxml.txt.nlp	23227093	SENT10	33	33	30	30	gemfibrozil	P-gp	PA449750	5243	0.561
NULL	Brain_Sci_2012_Oct_30_2(4)_553-572.nxml.txt.nlp	24961260	SENT689	10	10	2	2	methamphetamine	MRI	PA450403	78996	0.561
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT33	7	7	20	20	metformin	HIF-1	PA450395	29072	0.561
NULL	Eur_J_Haematol_2014_Feb_25_92(2)_127-136.nxml.txt.nlp	24118452	SENT138	8	8	10	10	anagrelide	CRT	PA164742986	811	0.561
NULL	Nucleic_Acids_Res_2012_Jun_10_40(11)_4804-4815.nxml.txt.nlp	22328728	SENT283	27	27	24	24	resveratrol	SIRT1		23411	0.561
NULL	Hum_Mol_Genet_2014_Aug_1_23(15)_4077-4085.nxml.txt.nlp	24670599	SENT180	10	10	5	5	lipase	PNPLA3	PA450239	80339	0.561
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT118	19	19	21	21	perifosine	TRAIL	PA165291471	8743	0.561
NULL	Bioinformation_2012_Jan_6_8(1)_13-19.nxml.txt.nlp	22359429	SENT6	5	5	7	7	curcumin	MRP1	PA151958596	4437	0.561
NULL	Evid_Based_Complement_Alternat_Med_2011_Jan_11_2011_109809.nxml.txt.nlp	19687191	SENT47	43	43	14	14	l-glutamine	CO2	PA10090	4513	0.561
NULL	Drugs_2009_Mar_17_69(5)_549-565.nxml.txt.nlp	19368417	SENT120	2	2	4	4	budesonide	DPI	PA448681	1832	0.561
NULL	J_Immunol_Methods_2013_Dec_31_400-401(100)_45-57.nxml.txt.nlp	24140419	SENT116	11	11	24	24	collagenase	CO2	PA449107	4513	0.561
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_21-38.nxml.txt.nlp	19305786	SENT453	22	22	13	13	capsaicin	TRP	PA448776	7306	0.561
NULL	J_Korean_Med_Sci_2011_Jan_22_26(1)_33-41.nxml.txt.nlp	21218027	SENT169	10	10	35	35	ethambutol	PTH	PA164784021	5741	0.561
NULL	EMBO_J_2013_Feb_20_32(4)_511-523.nxml.txt.nlp	23241948	SENT127	10	10	27	27	kanamycin	CCA1	PA450137	51095;878	0.561
NULL	Braz_J_Microbiol_2014_Jan_15_44(3)_807-812.nxml.txt.nlp	24516449	SENT133	26	26	18	18	chloramphenicol	CTX	PA448927	1593	0.561
NULL	ScientificWorldJournal_2012_Jun_18_2012_564939.nxml.txt.nlp	22778699	SENT129	11	11	6	6	tramadol	IL-6	PA451735	3569	0.561
NULL	Arthritis_Res_Ther_2010_Jul_6_12(4)_R129.nxml.txt.nlp	20604932	SENT87	13	13	24	24	paraformaldehyde	IL-27	PA450790	246778;56005;53342	0.561
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1437-1448.nxml.txt.nlp	24056706	SENT111	22	22	29	29	quinidine	CYP3A4	PA451209	1576	0.561
NULL	Arthritis_Res_Ther_2011_Feb_16_13(1)_R25.nxml.txt.nlp	21324169	SENT120	10	10	8	8	anakinra	ANA	PA10799	10950	0.561
NULL	Reprod_Biol_Endocrinol_2003_Oct_7_1_71.nxml.txt.nlp	14577832	SENT110	12	12	20	20	cisplatin	JNK	PA449014	5599	0.561
NULL	J_Mol_Signal_2009_May_14_4_3.nxml.txt.nlp	19442290	SENT76	30	30	3	3	genistein	BRCA2	PA165109660	675	0.561
NULL	Adv_Ther_2013_Nov_22_30(12)_1031-1032.nxml.txt.nlp	24263555	SENT12	9	9	3	3	liraglutide	GLP-1	PA165958364	100125288	0.561
NULL	Cell_Death_Dis_2014_Apr_17_5(4)_e1188.nxml.txt.nlp	24743743	SENT78	29	29	21	21	dantrolene	IRE1	PA449208	2081	0.561
NULL	Adv_Ther_2014_Jul_2_31(7)_762-775.nxml.txt.nlp	24985411	SENT235	13	13	30	30	amlodipine	Xin	PA448388	165904	0.561
NULL	Br_J_Cancer_2010_Jan_5_102(1)_80-86.nxml.txt.nlp	19920817	SENT57	43	43	45	45	bevacizumab	IFN	PA130232992	3439	0.561
NULL	Br_J_Cancer_2004_Mar_5_90(Suppl_1)_S15-S18.nxml.txt.nlp	15094760	SENT106	21	21	6	6	anastrozole	FACT	PA448432	11198	0.561
NULL	J_Thromb_Haemost_2010_Mar_8(3)_577-587.nxml.txt.nlp	20040043	SENT207	44	44	22	22	rosiglitazone	PGA1	PA451283	326	0.561
NULL	Oncotarget_2014_Sep_16_5(20)_9930-9938.nxml.txt.nlp	25294819	SENT98	10	10	2	2	plerixafor	CXCR4	PA165958410	7852	0.561
NULL	Onco_Targets_Ther_2014_Sep_9_7_1571-1582.nxml.txt.nlp	25228815	SENT253	7	7	16	16	sunitinib	VEGFR2	PA162372840	3791	0.561
NULL	Exp_Ther_Med_2014_Mar_31_7(3)_553-559.nxml.txt.nlp	24520244	SENT41	1	1	3	3	cyclophosphamide	CTX	PA449165	1593	0.561
NULL	Oncotarget_2014_Feb_7_5(3)_775-787.nxml.txt.nlp	24519956	SENT102	8	8	11	11	dasatinib	PC3	PA162372878	57332;7832;5122	0.561
NULL	Case_Rep_Ophthalmol_2012_Sep_28_3(3)_311-316.nxml.txt.nlp	23139674	SENT33	27	27	13	13	thyroglobulin	TTF-1	PA164754910	7080	0.561
NULL	Oxid_Med_Cell_Longev_2013_Nov_14_2013_680545.nxml.txt.nlp	24349614	SENT53	25	25	16	16	streptomycin	FBS	PA451512	64319;26269	0.561
NULL	Arthritis_Res_Ther_2013_Sep_23_15(5)_R131.nxml.txt.nlp	24286299	SENT94	2	2	12	12	creatine	CMAS	PA164778930	55907	0.561
NULL	J_Korean_Med_Sci_2013_Dec_26_28(12)_1774-1780.nxml.txt.nlp	24339708	SENT174	19	19	17	17	octreotide	OST	PA450678	1650;23263	0.561
NULL	Cancer_Cell_Int_2013_Feb_12_13_14.nxml.txt.nlp	23402310	SENT127	3	3	0	0	celecoxib	p65	PA448871	5970	0.561
NULL	J_Carcinog_Mutagen_2013_Aug_5_Suppl_7_4.nxml.txt.nlp	25587491	SENT155	25	25	22	22	gefitinib	EGF	PA131301952	1950	0.561
NULL	Biosci_Rep_2012_Dec_20_33(1)_e00011.nxml.txt.nlp	23137297	SENT136	10	10	8	8	heparin	RPSA	PA449855	3921	0.561
NULL	Biomed_Res_Int_2014_May_4_2014_472459.nxml.txt.nlp	24883315	SENT236	36	36	38	38	nadh	CO2	PA164755085	4513	0.561
NULL	Ann_N_Y_Acad_Sci_2014_Nov_5_1329(1)_93-106.nxml.txt.nlp	25377080	SENT191	15	15	20	20	warfarin	TTR	PA451906	7276	0.561
NULL	J_Neural_Transm_2014_Mar_27_121(10)_1221-1232.nxml.txt.nlp	24671607	SENT204	18	18	32	32	sertraline	PSD-95	PA451333	1742	0.561
NULL	Front_Immunol_2013_Oct_28_4_346.nxml.txt.nlp	24194739	SENT70	26	26	24	24	vemurafenib	ACT	PA165946873	12;11332;9457;641455	0.561
NULL	Aging_(Albany_NY)_2011_Jan_11_3(1)_1-2.nxml.txt.nlp	21248372	SENT12	28	28	4	4	cyclosporine	SIRT3	PA449167	23410	0.561
NULL	Animal_2010_Jul_21_4(7)_1227-1239.nxml.txt.nlp	20582145	SENT140	12	12	10	10	diethylstilbestrol	DES	PA449307	1674	0.561
NULL	Ann_Nucl_Med_2014_Jul_8_28(9)_836-850.nxml.txt.nlp	25001261	SENT11	21	21	32	32	acetazolamide	spatial	PA448018	219793	0.561
NULL	Eur_J_Haematol_2014_Feb_25_92(2)_127-136.nxml.txt.nlp	24118452	SENT95	8	8	10	10	anagrelide	CRT	PA164742986	811	0.561
NULL	J_Viral_Hepat_2009_May_16(5)_315-324.nxml.txt.nlp	19243499	SENT17	33	33	25	25	ribavirin	IFN	PA451241	3439	0.561
NULL	J_Neurol_2011_Jul_2_258(7)_1207-1222.nxml.txt.nlp	21461686	SENT260	25	25	35	35	clonazepam	OPT	PA449050	51430	0.561
NULL	Environ_Health_Perspect_2011_Apr_16_119(4)_534-541.nxml.txt.nlp	21081300	SENT107	24	24	28	28	genistein	DES	PA165109660	1674	0.561
NULL	Clin_Exp_Otorhinolaryngol_2009_Mar_26_2(1)_6-12.nxml.txt.nlp	19434285	SENT118	0	0	20	20	gentamicin	Bcl-2	PA449753	596	0.561
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_16_2012_395912.nxml.txt.nlp	23118789	SENT75	29	29	33	33	phenylbutazone	UGT1A10	PA450932	54575	0.561
NULL	Oncotarget_2014_Aug_25_5(17)_7945-7959.nxml.txt.nlp	25277206	SENT332	6	6	1	1	hyaluronan	HAS3	PA165958431	3038	0.561
NULL	J_Cancer_2013_May_26_4(5)_358-370.nxml.txt.nlp	23781282	SENT59	35	35	30	30	hydrocortisone	EGF	PA449905	1950	0.561
NULL	Pharmaceuticals_(Basel)_2013_Aug_6_6(8)_929-959.nxml.txt.nlp	24276377	SENT98	23	23	7	7	etoposide	CXCL8	PA449552	3576	0.561
NULL	Afr_J_Infect_Dis_2011_5(2)_40-46.nxml.txt.nlp	23878706	SENT98	18	18	8	8	erythromycin	Gen	PA449493	348654	0.561
NULL	Int_J_Nanomedicine_2012_Sep_21_7_5091-5106.nxml.txt.nlp	23049256	SENT239	12	12	14	14	protamine	SOD1	PA10366	6647	0.561
NULL	Oxid_Med_Cell_Longev_2009_Apr-Jun_2(2)_73-81.nxml.txt.nlp	20357928	SENT227	0	0	16	16	l-carnitine	IL-2	PA450154	3558	0.561
NULL	Evid_Based_Complement_Alternat_Med_2013_Nov_28_2013_938764.nxml.txt.nlp	24369484	SENT233	13	13	10	10	galactose	adrenoleukodystrophy	PA449725	215	0.561
NULL	J_Cell_Sci_2013_Jun_15_126(12)_2595-2606.nxml.txt.nlp	23606741	SENT332	19	19	26	26	l-glutamine	CO2	PA10090	4513	0.561
NULL	Braz_J_Microbiol_2014_Mar_10_44(4)_1279-1283.nxml.txt.nlp	24688523	SENT123	2	2	4	4	tetracycline	TMP	PA451640	2012	0.561
NULL	J_Geriatr_Cardiol_2012_Jun_9(2)_180-184.nxml.txt.nlp	22916066	SENT86	15	15	10	10	rosuvastatin	Rho	PA134308647	29984	0.561
NULL	J_Biomed_Biotechnol_2010_Jun_7_2010_150960.nxml.txt.nlp	20617134	SENT203	24	24	12	12	gefitinib	KRAS	PA131301952	3845	0.561
NULL	Exp_Ther_Med_2013_Feb_29_5(2)_527-532.nxml.txt.nlp	23404385	SENT109	10	10	7	7	tacrolimus	CYP3A	PA451578	1574	0.561
NULL	Mol_Biol_Cell_2014_Sep_15_25(18)_2828-2839.nxml.txt.nlp	25031430	SENT187	28	28	21	21	dantrolene	ANOVA	PA449208	4858	0.561
NULL	J_Gen_Physiol_2010_Jul_136(1)_29-34.nxml.txt.nlp	20584890	SENT169	13	13	8	8	creatine	TRPC6	PA164778930	7225	0.561
NULL	J_Biol_Eng_2009_Oct_16_3_18.nxml.txt.nlp	19835592	SENT48	11	11	25	25	kanamycin	CPZ	PA450137	8532	0.561
NULL	Indian_J_Ophthalmol_2013_May_61(5)_202-207.nxml.txt.nlp	23552358	SENT90	15	15	4	4	fluorescein	ABCG2	PA164746009	9429	0.561
NULL	Nucleic_Acids_Res_2013_May_5_41(10)_5210-5222.nxml.txt.nlp	23563151	SENT206	0	0	9	9	arsenite	GADD45	PA452638	1647	0.561
NULL	Front_Endocrinol_(Lausanne)_2013_Oct_25_4_158.nxml.txt.nlp	24298267	SENT308	1	1	9	9	valsartan	spatial	PA451848	219793	0.561
NULL	Ann_Intensive_Care_2011_Jul_19_1_26.nxml.txt.nlp	21906376	SENT85	32	32	19	19	vancomycin	SAPS	PA451850	8935	0.561
NULL	Hum_Reprod_2010_Jan_19_25(1)_85-93.nxml.txt.nlp	19840988	SENT180	18	18	40	40	levonorgestrel	CTR	PA450218	799	0.561
NULL	Ann_Thorac_Med_2010_Jul-Sep_5(3)_133-139.nxml.txt.nlp	20835306	SENT73	8	8	6	6	collagenase	AP-1	PA449107	2353;3727;2354;3725	0.561
NULL	CNS_Drugs_2014_Feb_7_28(3)_185-193.nxml.txt.nlp	24504829	SENT20	39	39	33	33	choline	CDP	PA448976	1523	0.561
NULL	Avicenna_J_Phytomed_2012_Spring_2(2)_72-78.nxml.txt.nlp	25050233	SENT157	8	8	19	19	imipramine	HIC	PA449969	29969	0.561
NULL	Oncol_Lett_2014_Jun_28_7(6)_2093-2098.nxml.txt.nlp	24932295	SENT6	3	3	8	8	resveratrol	PI3K		5290	0.561
NULL	Curr_Neuropharmacol_2013_Dec_11(6)_652-663.nxml.txt.nlp	24396340	SENT191	23	23	25	25	lidocaine	TRPV1	PA450226	7442	0.561
NULL	Lab_Invest_2012_Jun_26_92(6)_827-841.nxml.txt.nlp	22449800	SENT234	13	13	19	19	curcumin	RAGE	PA151958596	177	0.561
NULL	Int_J_Mol_Imaging_2011_Oct_26_2011_874585.nxml.txt.nlp	21490735	SENT162	18	18	4	4	glucose	FDG	PA449773	23583	0.561
NULL	Libyan_J_Med_2006_Jul_28_1(1)_42-59.nxml.txt.nlp	21526020	SENT203	25	25	23	23	bevacizumab	IFL	PA130232992	3439	0.561
NULL	Front_Endocrinol_(Lausanne)_2011_Aug_11_2_21.nxml.txt.nlp	22654797	SENT17	4	4	1	1	estradiol	aromatase	PA449503	1588	0.561
NULL	Front_Neurol_2013_Jun_26_4_79.nxml.txt.nlp	23805125	SENT1604	0	0	2	2	lithium	BACE1	PA450243	23621	0.561
NULL	J_Appl_Oral_Sci_2013_Mar-Apr_21(2)_196-202.nxml.txt.nlp	23739856	SENT67	37	37	24	24	ethanol	HEMA	PA448073	2157	0.561
NULL	Br_J_Pharmacol_2014_Dec_24_171(23)_5431-5445.nxml.txt.nlp	25052258	SENT135	20	20	3	3	propranolol	SPAP	PA451145	10158	0.561
NULL	Drug_Des_Devel_Ther_2014_Sep_23_8_1527-1538.nxml.txt.nlp	25284985	SENT130	7	7	5	5	celecoxib	IFN	PA448871	3439	0.561
NULL	Croat_Med_J_2012_Jun_53(3)_214-223.nxml.txt.nlp	22661134	SENT169	15	15	22	22	clonidine	spatial	PA449051	219793	0.561
NULL	J_Invest_Dermatol_2014_May_6_134(5)_1246-1254.nxml.txt.nlp	24317394	SENT127	39	39	27	27	protamine	KLF4	PA10366	9314	0.561
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT209	6	6	8	8	adalimumab	DPI	PA10004	1832	0.561
NULL	Crit_Care_2006_May_12_10(3)_R76.nxml.txt.nlp	16696867	SENT160	16	16	27	27	oxygen	TNF	PA450744	7124	0.561
NULL	Oncogene_2010_Jul_22_29(29)_4170-4182.nxml.txt.nlp	20498638	SENT147	18	18	13	13	hydrocortisone	F12	PA449905	2161	0.561
NULL	Autoimmune_Dis_2013_Nov_5_2013_716813.nxml.txt.nlp	24294521	SENT77	30	30	27	27	temozolomide	CRT	PA451609	811	0.561
NULL	Case_Rep_Oncol_2012_May_24_5(2)_260-266.nxml.txt.nlp	22712014	SENT15	2	2	9	9	doxorubicin	CHOP	PA449412	1649	0.561
NULL	Front_Pharmacol_2014_May_30_5_132.nxml.txt.nlp	24910615	SENT51	22	22	35	35	l-glutamine	CO2	PA10090	4513	0.561
NULL	Int_J_Mol_Sci_2014_Nov_7_15(11)_20500-20517.nxml.txt.nlp	25387078	SENT128	2	2	4	4	vorinostat	c-FLIP	PA164748224	8837	0.561
NULL	Br_J_Cancer_2012_Apr_10_106(8)_1406-1414.nxml.txt.nlp	22491422	SENT168	12	12	32	32	trastuzumab	HRG	PA451743	3084;3273	0.561
NULL	Clin_Med_Insights_Oncol_2012_Feb_28_6_125-135.nxml.txt.nlp	22408376	SENT276	10	10	26	26	cetuximab	KRAS	PA10040	3845	0.561
NULL	EMBO_Mol_Med_2012_Oct_30_4(10)_1087-1096.nxml.txt.nlp	22933245	SENT66	14	14	35	35	olaparib	NAMPT		10135	0.561
NULL	BMJ_2013_Nov_6_347_f6530.nxml.txt.nlp	24196498	SENT78	14	14	6	6	everolimus	PES	PA164746311	23481	0.561
NULL	Cell_Death_Dis_2010_Feb_4_1(2)_e23.nxml.txt.nlp	21364631	SENT242	26	26	35	35	curcumin	JNK	PA151958596	5599	0.561
NULL	Eur_J_Clin_Pharmacol_2007_Apr_21_63(4)_335-343.nxml.txt.nlp	17318526	SENT224	42	42	34	34	warfarin	CYP2C9	PA451906	1559	0.561
NULL	J_Parasitol_Res_2012_Mar_22_2012_589295.nxml.txt.nlp	22545203	SENT64	22	22	18	18	nitroprusside	CO2	PA451406	4513	0.561
NULL	Evid_Based_Complement_Alternat_Med_2013_Aug_12_2013_982689.nxml.txt.nlp	23997806	SENT247	3	3	22	22	tolbutamide	APE	PA451718	55704;328	0.561
NULL	EPMA_J_2012_Sep_27_3(1)_10.nxml.txt.nlp	23016735	SENT214	39	39	21	21	warfarin	CALU	PA451906	813	0.561
NULL	Infect_Dis_Ther_2014_Dec_5_3(2)_69-81.nxml.txt.nlp	25475412	SENT204	8	8	1	1	colistin	CAL	PA164760862	54751;57120	0.561
NULL	Br_J_Cancer_2006_Dec_4_95(11)_1483-1489.nxml.txt.nlp	17106442	SENT9	12	12	9	9	gefitinib	MST	PA131301952	55154;4357;4294	0.561
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Nov_12_3(11)_e147.nxml.txt.nlp	25390686	SENT195	4	4	6	6	nevirapine	CD4	PA450616	920	0.561
NULL	Neural_Regen_Res_2013_May_5_8(13)_1180-1189.nxml.txt.nlp	25206412	SENT92	2	2	5	5	fasudil	RhoA	PA165946121	387	0.561
NULL	Cancer_Causes_Control_2013_Aug_18_24(8)_1605-1614.nxml.txt.nlp	23775025	SENT55	23	23	7	7	cyclophosphamide	UBC	PA449165	7316	0.561
NULL	Oncotarget_2013_Nov_16_4(12)_2366-2382.nxml.txt.nlp	24280306	SENT296	3	3	11	11	levamisole	FDG	PA450205	23583	0.561
NULL	Anat_Cell_Biol_2010_Sep_30_43(3)_194-200.nxml.txt.nlp	21212859	SENT13	2	2	6	6	ethanol	PLP	PA448073	25824;5744	0.561
NULL	Br_J_Cancer_2012_Aug_7_107(4)_658-666.nxml.txt.nlp	22805330	SENT69	7	7	5	5	pentobarbital	HRI	PA450859	27102	0.561
NULL	Surg_Today_2012_Jan_6_42(1)_8-28.nxml.txt.nlp	22139128	SENT167	14	14	11	11	docetaxel	PSK	PA449383	9344	0.561
NULL	Biologics_2011_Aug_9_5_87-94.nxml.txt.nlp	21847344	SENT24	10	10	2	2	cyclophosphamide	B27	PA449165	56246	0.561
NULL	Breast_Cancer_Res_2012_Mar_20_14(2)_R53.nxml.txt.nlp	22433433	SENT318	20	20	7	7	paclitaxel	CCNE1	PA450761	898	0.561
NULL	Case_Rep_Gastroenterol_2011_May_3_5(2)_262-266.nxml.txt.nlp	21887126	SENT8	19	19	17	17	rituximab	CHOP	PA451261	1649	0.561
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Dec_10_3(12)_e151.nxml.txt.nlp	25494035	SENT62	11	11	7	7	rosuvastatin	OATP1B1	PA134308647	10599	0.561
NULL	J_Cell_Biol_2001_Oct_29_155(3)_427-438.nxml.txt.nlp	11673478	SENT178	23	23	14	14	genistein	PP1	PA165109660	5540;5464	0.561
NULL	Arthritis_Res_Ther_2013_Sep_13_15(5)_R119.nxml.txt.nlp	24034344	SENT291	16	16	10	10	lipase	GAPDH	PA450239	2597	0.561
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Dec_17_3(12)_e152.nxml.txt.nlp	25518025	SENT4	32	32	36	36	oxymorphone	CYP2D6	PA450748	1565	0.561
NULL	Environ_Health_Perspect_2011_Mar_29_119(3)_326-331.nxml.txt.nlp	21036692	SENT189	18	18	13	13	medroxyprogesterone	CEE	PA450344	51608	0.561
NULL	Chemother_Res_Pract_2012_Apr_11_2012_283181.nxml.txt.nlp	22567280	SENT287	20	20	22	22	hyaluronan	PI3	PA165958431	5266	0.561
NULL	Diabetes_2013_May_16_62(5)_1697-1708.nxml.txt.nlp	23364453	SENT259	6	6	4	4	fasudil	GLP-1	PA165946121	100125288	0.561
NULL	Exp_Ther_Med_2013_Apr_8_5(4)_1153-1156.nxml.txt.nlp	23596482	SENT99	17	17	0	0	heparin	OMI	PA449855	27429	0.561
NULL	ASN_Neuro_2011_Feb_8_3(1)_e00050.nxml.txt.nlp	21434871	SENT39	24	24	13	13	l-glutamine	BCS	PA10090	617	0.561
NULL	Exp_Mol_Med_2012_Apr_30_44(4)_251-259.nxml.txt.nlp	22198296	SENT12	14	14	26	26	doxorubicin	ABCG2	PA449412	9429	0.561
NULL	Exp_Ther_Med_2013_Mar_17_5(3)_797-802.nxml.txt.nlp	23403698	SENT114	23	23	6	6	triciribine	PI3K	PA165958661	5290	0.561
NULL	J_Hematol_Oncol_2011_Mar_26_4_11.nxml.txt.nlp	21439076	SENT128	12	12	4	4	axitinib	Gem	PA164924493	51053	0.56
NULL	Breast_Cancer_Res_2012_May_22_14(3)_R81.nxml.txt.nlp	22616919	SENT141	18	18	13	13	hyaluronan	LYVE-1	PA165958431	10894	0.56
NULL	Breast_Cancer_Res_2012_Dec_21_14(6)_404.nxml.txt.nlp	NULL	SENT15	2	2	4	4	pargyline	PELP1	PA450797	27043	0.56
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Oct_15_70(Pt_11)_m369-m370.nxml.txt.nlp	25484779	SENT3	23	23	2	2	coumarin	mol	PA134521193	90527	0.56
NULL	Exp_Ther_Med_2013_Mar_20_5(3)_689-694.nxml.txt.nlp	23403765	SENT215	6	6	0	0	l-cysteine	PAG	PA449173	55824	0.56
NULL	Front_Zool_2013_Aug_3_10_44.nxml.txt.nlp	23915384	SENT86	14	14	34	34	glutaraldehyde	mol	PA449777	90527	0.56
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1522-1532.nxml.txt.nlp	21997136	SENT153	3	3	9	9	lapatinib	ABCG2	PA152241907	9429	0.56
NULL	Nat_Neurosci_2013_Apr_17_16(4)_464-472.nxml.txt.nlp	23502536	SENT78	31	31	26	26	fluoxetine	GluA1	PA449673	2890	0.56
NULL	Evid_Based_Complement_Alternat_Med_2013_May_13_2013_506324.nxml.txt.nlp	23818927	SENT185	19	19	34	34	doxorubicin	STAT3	PA449412	6774	0.56
NULL	Asian-Australas_J_Anim_Sci_2015_Jan_28(1)_127-134.nxml.txt.nlp	25557684	SENT172	15	15	0	0	lipase	CD36	PA450239	948	0.56
NULL	Reprod_Biol_Endocrinol_2003_Oct_7_1_71.nxml.txt.nlp	14577832	SENT108	0	0	11	11	cisplatin	JNK1	PA449014	5599	0.56
NULL	Cells_2014_Apr_9_3(2)_288-303.nxml.txt.nlp	24722470	SENT151	13	13	23	23	pilocarpine	ANOVA	PA450962	4858	0.56
NULL	Oncotarget_2013_Dec_18_5(2)_375-385.nxml.txt.nlp	24495868	SENT116	3	3	9	9	fludarabine	XIAP	PA449655	331	0.56
NULL	Int_J_Mol_Sci_2014_Sep_30_15(10)_17686-17704.nxml.txt.nlp	25272226	SENT87	13	13	9	9	cetuximab	EGF	PA10040	1950	0.56
NULL	Cell_Commun_Signal_2013_Jul_31_11_52.nxml.txt.nlp	23902637	SENT123	10	10	20	20	geldanamycin	Raf-1	PA152031327	5894	0.56
NULL	Pharmaceutics_2011_Feb_7_3(1)_53-72.nxml.txt.nlp	24310425	SENT856	7	7	28	28	theophylline	CYP3A	PA451647	1574	0.56
NULL	Int_J_Mol_Sci_2013_Aug_14_14(8)_16732-16801.nxml.txt.nlp	23949635	SENT225	30	30	22	22	estradiol	AKT	PA449503	207	0.56
NULL	Br_J_Cancer_2011_Aug_23_105(5)_618-627.nxml.txt.nlp	21829197	SENT7	19	19	29	29	lapatinib	CRT	PA152241907	811	0.56
NULL	Allergy_Asthma_Immunol_Res_2011_Apr_14_3(2)_89-95.nxml.txt.nlp	21461247	SENT98	28	28	25	25	cyclosporine	IFN	PA449167	3439	0.56
NULL	Clin_Pharmacol_2012_Feb_20_4_13-20.nxml.txt.nlp	22427735	SENT75	33	33	15	15	clopidogrel	PON1	PA449053	5444	0.56
NULL	Mol_Cancer_2010_Aug_23_9_222.nxml.txt.nlp	20731837	SENT262	13	13	3	3	cetuximab	ATM	PA10040	472	0.56
NULL	J_Korean_Med_Sci_2013_Apr_27_28(4)_527-533.nxml.txt.nlp	23580227	SENT139	4	4	6	6	genistein	TRAIL	PA165109660	8743	0.56
NULL	Breast_Cancer_Res_2006_Oct_24_8(5)_R59.nxml.txt.nlp	17062128	SENT103	16	16	9	9	dextran	CXCR4	PA449261	7852	0.56
NULL	Braz_J_Microbiol_2008_Dec_1_Oct-Dec_39(4)_718-723.nxml.txt.nlp	24031296	SENT112	13	13	5	5	galactose	por	PA449725	64840	0.56
NULL	Acta_Naturae_2011_Jul-Sep_3(3)_12-28.nxml.txt.nlp	22649690	SENT315	32	32	20	20	elvitegravir	CD4	PA165291498	920	0.56
NULL	Mol_Pain_2013_Feb_15_9_3.nxml.txt.nlp	23413875	SENT50	0	0	7	7	resveratrol	TRPV1		7442	0.56
NULL	Gut_Liver_2013_Sep_14_7(5)_585-593.nxml.txt.nlp	24073317	SENT186	6	6	0	0	ribavirin	IFN	PA451241	3439	0.56
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Apr_15_9_13.nxml.txt.nlp	20398300	SENT97	9	9	18	18	lansoprazole	LAM	PA450180	7249;7248	0.56
NULL	Cell_Death_Dis_2010_Oct_21_1(10)_e86.nxml.txt.nlp	21368859	SENT87	48	48	46	46	doxorubicin	TRAIL	PA449412	8743	0.56
NULL	Pain_Res_Treat_2012_Apr_24_2012_265605.nxml.txt.nlp	22619712	SENT238	0	0	6	6	baclofen	c-fos	PA448533	2353	0.56
NULL	Int_J_Cell_Biol_2010_Jan_17_2010_930509.nxml.txt.nlp	20145727	SENT368	16	16	12	12	bortezomib	CHOP	PA10252	1649	0.56
NULL	J_Nat_Prod_2014_Apr_25_77(4)_842-847.nxml.txt.nlp	24597776	SENT104	47	47	23	23	l-glutamine	CO2	PA10090	4513	0.56
NULL	Eur_J_Clin_Pharmacol_2012_Jan_8_68(1)_29-37.nxml.txt.nlp	21739267	SENT12	34	34	31	31	fluvoxamine	CYP2D6	PA449690	1565	0.56
NULL	J_Biomed_Sci_2014_Feb_3_21(1)_10.nxml.txt.nlp	24490900	SENT246	19	19	25	25	alendronate	RANKL	PA448082	8600	0.56
NULL	Oncol_Lett_2014_Mar_16_7(3)_827-833.nxml.txt.nlp	24527090	SENT166	13	13	10	10	cisplatin	IFN	PA449014	3439	0.56
NULL	Diabetes_Obes_Metab_2011_Nov_13(11)_982-989.nxml.txt.nlp	21615670	SENT26	23	23	36	36	sitagliptin	PPG	PA164748978	5552	0.56
NULL	Indian_J_Med_Res_2014_Jul_140(1)_116-122.nxml.txt.nlp	25222786	SENT49	18	18	16	16	pyrazinamide	EMB	PA451182	133418	0.56
NULL	Exp_Ther_Med_2012_Sep_12_4(3)_475-480.nxml.txt.nlp	23181121	SENT163	18	18	22	22	rituximab	CHOP	PA451261	1649	0.56
NULL	Ann_Rheum_Dis_2011_Apr_22_70(8)_1395-1400.nxml.txt.nlp	21515602	SENT106	8	8	0	0	methotrexate	MAF	PA450428	4094	0.56
NULL	Eur_J_Med_Res_2014_Jun_24_19(1)_34.nxml.txt.nlp	24961604	SENT98	26	26	30	30	vincristine	BCL11A	PA451879	53335	0.56
NULL	Mol_Cancer_2008_Aug_7_7_65.nxml.txt.nlp	18687124	SENT255	8	8	5	5	thrombin	RPA2	PA451674	6118;84172	0.56
NULL	Mol_Biol_Rep_2012_May_20_39(5)_5253-5267.nxml.txt.nlp	22183301	SENT29	16	16	24	24	glibenclamide	SUR1	PA449782	6833	0.56
NULL	Cancer_Immunol_Immunother_2011_Jun_25_60(6)_793-808.nxml.txt.nlp	21350947	SENT208	12	12	9	9	sorafenib	IFN	PA7000	3439	0.56
NULL	Case_Rep_Infect_Dis_2011_Oct_29_2011_167963.nxml.txt.nlp	22567460	SENT13	8	8	22	22	oseltamivir	San	PA450721	80218	0.56
NULL	Scientifica_(Cairo)_2012_Aug_30_2012_525374.nxml.txt.nlp	24278711	SENT190	17	17	15	15	thrombin	ADP	PA451674	23038	0.56
NULL	Clin_Pediatr_Endocrinol_2006_Feb_22_15(1)_41-43.nxml.txt.nlp	24790319	SENT2	21	21	32	32	vasopressin	AQP2	PA451858	359	0.56
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1437-1448.nxml.txt.nlp	24056706	SENT111	18	18	12	12	tranylcypromine	CYP1A2	PA451741	1544	0.56
NULL	Front_Bioeng_Biotechnol_2015_Jan_5_2_76.nxml.txt.nlp	25601910	SENT220	46	46	19	19	nadh	PDH	PA164755085	54704	0.56
NULL	Br_J_Cancer_2004_Mar_22_90(6)_1285-1292.nxml.txt.nlp	15026814	SENT144	14	14	7	7	doxorubicin	p53	PA449412	7157	0.56
NULL	Cancer_Metastasis_Rev_2010_Dec_10_29(4)_581-594.nxml.txt.nlp	20830503	SENT313	2	2	30	30	tamoxifen	ATAC	PA451581	6375	0.56
NULL	Core_Evid_2007_Nov_30_2(2)_121-129.nxml.txt.nlp	21221180	SENT234	19	19	36	36	rituximab	CHOP	PA451261	1649	0.56
NULL	Adv_Ther_2014_Jan_30_31(2)_202-216.nxml.txt.nlp	24477354	SENT208	6	6	9	9	liraglutide	BID	PA165958364	637	0.56
NULL	Clin_Ophthalmol_2012_Sep_7_6_1471-1476.nxml.txt.nlp	23055666	SENT22	5	5	13	13	propofol	NAC	PA451141	22861	0.56
NULL	Hum_Genomics_2009_Jan_1_3(2)_121-127.nxml.txt.nlp	19164089	SENT98	15	15	5	5	ethanol	ALDH1A1	PA448073	216	0.56
NULL	Oncol_Lett_2014_Jun_8_7(6)_2035-2040.nxml.txt.nlp	24932285	SENT168	26	26	7	7	mitomycin	ABCG2	PA450524	9429	0.56
NULL	J_Hematol_Oncol_2012_May_15_5_23.nxml.txt.nlp	22587422	SENT13	4	4	22	22	dasatinib	ALL	PA162372878	613	0.56
NULL	J_Med_Chem_2014_Feb_13_57(3)_714-722.nxml.txt.nlp	24444054	SENT110	9	9	42	42	piperazine	ALDH1A1	PA450977	216	0.56
NULL	J_Oncol_2013_Feb_17_2013_872957.nxml.txt.nlp	23476648	SENT212	8	8	14	14	cisplatin	SFN	PA449014	25996;2810	0.56
NULL	Oncol_Rep_2014_Apr_28_31(4)_1605-1612.nxml.txt.nlp	24481648	SENT39	3	3	12	12	ponatinib	P-gp	PA165980594	5243	0.56
NULL	Cancer_Cell_Int_2002_Oct_8_2_15.nxml.txt.nlp	12392597	SENT205	25	25	36	36	gentamicin	CO2	PA449753	4513	0.56
NULL	Clin_Interv_Aging_2014_Apr_8_9_593-601.nxml.txt.nlp	24748777	SENT81	23	23	18	18	denosumab	CTX	PA166048634	1593	0.56
NULL	Mol_Cell_2014_Sep_4_55(5)_723-732.nxml.txt.nlp	25066234	SENT304	6	6	19	19	camptothecin	KAP-1	PA153590860	22920	0.56
NULL	J_Ophthalmic_Inflamm_Infect_2013_Jan_15_3_12.nxml.txt.nlp	23514269	SENT144	8	8	37	37	paraformaldehyde	San	PA450790	80218	0.56
NULL	Br_J_Pharmacol_2011_Mar_162(5)_1029-1044.nxml.txt.nlp	20958290	SENT199	30	30	36	36	carbachol	NMS	PA448784	129521	0.56
NULL	Int_J_Environ_Res_Public_Health_2006_Jun_30_3(2)_141-173.nxml.txt.nlp	16823088	SENT724	5	5	9	9	hyaluronan	HABP4	PA165958431	22927	0.56
NULL	Lipids_Health_Dis_2011_Jan_24_10_20.nxml.txt.nlp	21261970	SENT7	20	20	29	29	lipase	ATGL	PA450239	57104	0.56
NULL	AMB_Express_2014_Apr_1_4_20.nxml.txt.nlp	24949255	SENT123	28	28	15	15	kanamycin	GP2	PA450137	2813	0.56
NULL	Mol_Neurodegener_2011_Nov_17_6_78.nxml.txt.nlp	22093090	SENT268	17	17	13	13	l-glutamine	B27	PA10090	56246	0.56
NULL	Pharmaceutics_2011_Nov_18_3(4)_865-913.nxml.txt.nlp	24309312	SENT206	9	9	22	22	risperidone	CYP3A4	PA451257	1576	0.56
NULL	Curr_Neuropharmacol_2013_Mar_11(2)_141-159.nxml.txt.nlp	23997750	SENT294	21	21	23	23	vasopressin	AVP	PA451858	114548;551	0.56
NULL	Cardiol_Res_Pract_2012_Jul_12_2012_986813.nxml.txt.nlp	22844633	SENT31	19	19	15	15	bosentan	ETB	PA10034	1910	0.56
NULL	Arthritis_Res_Ther_2004_Jul_29_6(5)_183-196.nxml.txt.nlp	15380032	SENT323	18	18	4	4	tetracycline	Enh	PA451640	10611	0.56
NULL	Braz_J_Med_Biol_Res_2013_Sep_6_46(9)_746-751.nxml.txt.nlp	24036910	SENT119	0	0	2	2	genistein	PP1	PA165109660	5540;5464	0.56
NULL	ScientificWorldJournal_2012_Apr_30_2012_384936.nxml.txt.nlp	22623892	SENT70	19	19	33	33	l-glutamine	M-CSF	PA10090	1435	0.56
NULL	Nucleic_Acids_Res_2010_Oct_4_38(19)_6433-6446.nxml.txt.nlp	20525790	SENT83	23	23	17	17	spectinomycin	G16	PA164781342	6048	0.56
NULL	J_Oncol_2010_Jan_3_2010_149362.nxml.txt.nlp	20069122	SENT133	2	2	32	32	imatinib	CDP	PA10804	1523	0.56
NULL	Emerg_Infect_Dis_2014_Mar_20(3)_400-408.nxml.txt.nlp	24565738	SENT128	24	24	30	30	ethambutol	DST	PA164784021	667	0.56
NULL	Front_Behav_Neurosci_2011_Nov_8_5_76.nxml.txt.nlp	22073033	SENT697	4	4	15	15	carbachol	CA1	PA448784	759	0.56
NULL	Adv_Urol_2012_Feb_13_2012_364919.nxml.txt.nlp	22400017	SENT275	21	21	19	19	gemcitabine	RRM1	PA449748	6240	0.56
NULL	Chin_J_Cancer_2011_Oct_30(10)_690-700.nxml.txt.nlp	21959046	SENT20	10	10	7	7	doxorubicin	TPT	PA449412	23590;6469	0.56
NULL	Ann_Hematol_2010_Apr_13_89(4)_341-348.nxml.txt.nlp	19823823	SENT93	6	6	15	15	daunorubicin	LAK	PA449212	10123	0.56
NULL	Cardiovasc_Res_2012_Dec_1_96(3)_552-560.nxml.txt.nlp	22918977	SENT198	4	4	6	6	hydralazine	JAM-A	PA449894	50848	0.56
NULL	Arthritis_Res_Ther_2005_Nov_2_7(1)_1-11.nxml.txt.nlp	15642148	SENT189	10	10	25	25	heparin	IL-18	PA449855	3606	0.56
NULL	Acta_Pharmacol_Sin_2013_Apr_18_34(4)_555-560.nxml.txt.nlp	23503472	SENT135	8	8	5	5	cyclosporine	NR1I2	PA449167	8856	0.56
NULL	Front_Endocrinol_(Lausanne)_2013_Nov_11_4_171.nxml.txt.nlp	24273532	SENT134	19	19	15	15	forskolin	RXFP1	PA146096022	59350	0.56
NULL	Cancer_Cell_Int_2012_Jun_11_12_26.nxml.txt.nlp	22686580	SENT63	30	30	40	40	gentamicin	CO2	PA449753	4513	0.56
NULL	JAKSTAT_2013_Jul_1_2(3)_e24812.nxml.txt.nlp	24069562	SENT54	3	3	24	24	pp2	HL-1		55600	0.56
NULL	Mol_Brain_2014_Nov_7_7(1)_77.nxml.txt.nlp	NULL	SENT359	12	12	8	8	ethanol	AC5	PA448073	111	0.56
NULL	Clin_Exp_Gastroenterol_2011_Jul_15_4_163-172.nxml.txt.nlp	21904462	SENT84	3	3	10	10	adalimumab	CDAI	PA10004	146059	0.56
NULL	J_Exp_Clin_Cancer_Res_2009_Aug_26_28(1)_119.nxml.txt.nlp	19709417	SENT52	26	26	28	28	cyclophosphamide	CTX	PA449165	1593	0.56
NULL	Cancer_Immunol_Immunother_2011_Jul_24_60(7)_943-951.nxml.txt.nlp	21431918	SENT184	11	11	33	33	doxorubicin	HMGB1	PA449412	3146	0.56
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Jun_8_69(Pt_7)_m362-m363.nxml.txt.nlp	24046549	SENT7	13	13	4	4	ethanol	mol	PA448073	90527	0.56
NULL	Br_J_Cancer_2009_Oct_20_101(8)_1290-1297.nxml.txt.nlp	19755992	SENT200	32	32	30	30	glucose	HIF-1	PA449773	29072	0.56
NULL	Exp_Ther_Med_2015_Feb_26_9(2)_389-394.nxml.txt.nlp	25574203	SENT111	24	24	9	9	hyaluronan	VEGF-D	PA165958431	2277	0.56
NULL	Acta_Myol_2010_Oct_29(2)_351-356.nxml.txt.nlp	21314018	SENT128	23	23	25	25	lipase	ATGL	PA450239	57104	0.56
NULL	Oncol_Lett_2013_Oct_29_6(4)_1031-1038.nxml.txt.nlp	24137459	SENT204	2	2	0	0	cisplatin	DDP	PA449014	1678	0.56
NULL	Cell_Death_Dis_2010_Oct_21_1(10)_e86.nxml.txt.nlp	21368859	SENT202	10	10	14	14	doxorubicin	TRAIL	PA449412	8743	0.56
NULL	J_Mammary_Gland_Biol_Neoplasia_2010_Mar_27_15(1)_5-17.nxml.txt.nlp	20101446	SENT200	15	15	17	17	cisplatin	HuR	PA449014	1994	0.56
NULL	Br_J_Cancer_2009_Jul_21_101(2)_269-277.nxml.txt.nlp	19603033	SENT157	16	16	18	18	cisplatin	XIAP	PA449014	331	0.56
NULL	J_Clin_Biochem_Nutr_2010_Jan_29_46(1)_87-92.nxml.txt.nlp	20104270	SENT321	15	15	7	7	hesperidin	STZ	PA449867	6484	0.56
NULL	Breast_Cancer_Res_2005_May_24_7(5)_R589-R597.nxml.txt.nlp	16168102	SENT25	11	11	32	32	doxorubicin	HER2	PA449412	2064	0.56
NULL	Arthritis_Res_Ther_2006_May_11_8(3)_209.nxml.txt.nlp	16712713	SENT123	25	25	6	6	tolmetin	AAP	PA451721	5345	0.56
NULL	Am_J_Clin_Dermatol_2013_Feb_14_14(1)_27-47.nxml.txt.nlp	23329078	SENT400	3	3	5	5	pimecrolimus	p53	PA164783790	7157	0.56
NULL	Indian_J_Ophthalmol_2007_Nov-Dec_55(6)_483b-486.nxml.txt.nlp	17951918	SENT60	12	12	8	8	bevacizumab	PED	PA130232992	8682	0.56
NULL	Oncol_Lett_2013_Oct_24_6(4)_970-976.nxml.txt.nlp	24137447	SENT159	8	8	20	20	doxorubicin	ADM	PA449412	133	0.56
NULL	Comp_Hepatol_2004_Jan_14_3(Suppl_1)_S31.nxml.txt.nlp	14960183	SENT69	5	5	1	1	ethanol	TNF-alpha	PA448073	7124	0.56
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT123	33	33	31	31	vinorelbine	ASC	PA451881	29108	0.56
NULL	Brain_Behav_2014_Jul_14_4(4)_468-483.nxml.txt.nlp	25161814	SENT127	10	10	16	16	ethanol	ANOVA	PA448073	4858	0.56
NULL	Oncoimmunology_2012_Sep_1_1(6)_894-907.nxml.txt.nlp	23162757	SENT6	29	29	26	26	imiquimod	MPL	PA449972	4352	0.56
NULL	J_Korean_Med_Sci_2014_Jan_26_29(1)_53-60.nxml.txt.nlp	24431906	SENT9	13	13	18	18	vincristine	CHOP	PA451879	1649	0.56
NULL	Int_Semin_Surg_Oncol_2008_Apr_28_5_9.nxml.txt.nlp	18442393	SENT78	10	10	4	4	tamoxifen	HER-2	PA451581	2064	0.56
NULL	ScientificWorldJournal_2013_Dec_30_2013_565813.nxml.txt.nlp	24489506	SENT42	23	23	26	26	resveratrol	Q10		27161	0.56
NULL	Trials_2012_Jan_13_13_9.nxml.txt.nlp	22243649	SENT161	5	5	23	23	donepezil	sit	PA449394	55733	0.56
NULL	Nat_Commun_2013_Sep_20_4_2444.nxml.txt.nlp	24051492	SENT110	5	5	8	8	nutlin-3	p53		7157	0.56
NULL	Arthritis_Res_Ther_2006_May_11_8(3)_209.nxml.txt.nlp	16712713	SENT123	12	12	6	6	ibuprofen	AAP	PA449957	5345	0.56
NULL	Acta_Pharmacol_Sin_2010_Jan_21_31(1)_35-42.nxml.txt.nlp	20023693	SENT142	2	2	11	11	atorvastatin	IL-6	PA448500	3569	0.56
NULL	Cardiovasc_Psychiatry_Neurol_2011_Feb_16_2011_646958.nxml.txt.nlp	21350722	SENT114	8	8	28	28	calcein	ROS	PA132595336	6098	0.56
NULL	Stroke_Res_Treat_2012_Nov_30_2012_382361.nxml.txt.nlp	22195291	SENT86	12	12	18	18	aspirin	CEA	PA448497	5670;1087	0.56
NULL	Diabetes_Care_2008_Oct_31(10)_2062-2069.nxml.txt.nlp	18820229	SENT127	20	20	11	11	rosiglitazone	DREAM	PA451283	30818	0.56
NULL	Aging_(Albany_NY)_2009_Feb_12_1(2)_245-253.nxml.txt.nlp	19946467	SENT190	14	14	16	16	vasopressin	AVP	PA451858	114548;551	0.56
NULL	Emerg_Med_J_2011_Apr_26_28(4)_313-315.nxml.txt.nlp	20581384	SENT101	8	8	6	6	atropine	PON1	PA448505	5444	0.56
NULL	Iran_J_Pharm_Res_2014_Winter_13(1)_243-251.nxml.txt.nlp	24734077	SENT41	44	44	31	31	sulfadiazine	MOX	PA451539	26002	0.56
NULL	J_Viral_Hepat_2013_Nov_7_20(11)_745-760.nxml.txt.nlp	24168254	SENT54	13	13	7	7	ribavirin	IFN	PA451241	3439	0.56
NULL	J_Histochem_Cytochem_2012_Dec_60(12)_908-915.nxml.txt.nlp	22899865	SENT214	7	7	5	5	hyaluronan	CD44	PA165958431	960	0.56
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Sep_18_69(Pt_10)_o1545.nxml.txt.nlp	24098230	SENT72	21	21	9	9	ethanol	mol	PA448073	90527	0.56
NULL	Oncol_Rep_2013_Apr_23_29(4)_1268-1274.nxml.txt.nlp	23354756	SENT125	25	25	6	6	epirubicin	SLC25A43	PA449476	203427	0.56
NULL	Exp_Neurobiol_2013_Mar_31_22(1)_11-17.nxml.txt.nlp	23585717	SENT105	38	38	28	28	hydroquinone	NQO1	PA449924	1728	0.56
NULL	Neural_Regen_Res_2014_Apr_1_9(7)_677-683.nxml.txt.nlp	25206871	SENT181	0	0	8	8	hydralazine	TRPA1	PA449894	8989	0.56
NULL	Cell_Death_Differ_2012_Feb_5_19(2)_295-309.nxml.txt.nlp	21818117	SENT222	8	8	19	19	dextran	Bcl-2	PA449261	596	0.56
NULL	Int_J_Med_Sci_2015_Jan_1_12(1)_63-71.nxml.txt.nlp	25552920	SENT61	18	18	5	5	berberine	PC-3	PA165860812	692094	0.56
NULL	Breast_Cancer_Res_Treat_2013_Oct_22_142(1)_31-44.nxml.txt.nlp	24146212	SENT256	19	19	14	14	doxycycline	PRL	PA449415	5617	0.56
NULL	Cardiovasc_Diabetol_2013_Jan_9_12_8.nxml.txt.nlp	23298374	SENT140	28	28	40	40	voglibose	GLP-1	PA164752433	100125288	0.56
NULL	J_Mol_Signal_2011_Oct_5_6_13.nxml.txt.nlp	21975218	SENT139	24	24	14	14	ethanol	ID4	PA448073	3400	0.56
NULL	Br_J_Pharmacol_2011_Mar_162(5)_1029-1044.nxml.txt.nlp	20958290	SENT212	33	33	39	39	carbachol	NMS	PA448784	129521	0.56
NULL	Mol_Pain_2014_Aug_15_10_53.nxml.txt.nlp	25127716	SENT94	20	20	32	32	paclitaxel	CCL3	PA450761	6348	0.56
NULL	J_Immunol_Res_2014_May_12_2014_897249.nxml.txt.nlp	24901013	SENT171	19	19	14	14	natalizumab	CD4	PA164747191	920	0.56
NULL	Evid_Based_Complement_Alternat_Med_2014_Mar_26_2014_158987.nxml.txt.nlp	24795763	SENT156	8	8	17	17	fluoxetine	EPM	PA449673	2054	0.56
NULL	Anesth_Pain_Med_2014_Sep_9_4(4)_e14221.nxml.txt.nlp	25599022	SENT129	9	9	6	6	propofol	LPO	PA451141	4025	0.56
NULL	Front_Neuroanat_2014_Dec_1_8_143.nxml.txt.nlp	25520627	SENT46	2	2	4	4	vasopressin	AVP	PA451858	114548;551	0.56
NULL	Diabetes_Care_2010_Jan_21_33(1)_156-161.nxml.txt.nlp	19846797	SENT172	10	10	13	13	metformin	B12	PA450395	7126;4709	0.56
NULL	Cancers_(Basel)_2010_Mar_30_2(2)_338-363.nxml.txt.nlp	24281073	SENT994	0	0	6	6	doxorubicin	RLIP76	PA449412	10928	0.56
NULL	Cancer_Med_2014_Dec_13_3(6)_1579-1594.nxml.txt.nlp	25124282	SENT233	22	22	28	28	cisplatin	DNA-PKcs	PA449014	5591	0.56
NULL	J_Mol_Med_2010_Mar_27_88(3)_227-233.nxml.txt.nlp	19943027	SENT196	5	5	19	19	everolimus	NF-kappaB	PA164746311	4790	0.56
NULL	Aging_(Albany_NY)_2009_Apr_21_1(4)_402-411.nxml.txt.nlp	20148189	SENT115	30	30	23	23	bleomycin	HCA2	PA448645	139081;55811;338442	0.56
NULL	Arthritis_Res_Ther_2014_Jul_18_16(4)_R153.nxml.txt.nlp	25037855	SENT122	10	10	6	6	methotrexate	CD14	PA450428	929	0.56
NULL	EMBO_Mol_Med_2013_Aug_5_5(8)_1213-1226.nxml.txt.nlp	23918228	SENT147	19	19	30	30	cetuximab	EGFR	PA10040	1956	0.56
NULL	Br_J_Cancer_2012_Feb_14_106(4)_685-692.nxml.txt.nlp	22294184	SENT31	0	0	7	7	docetaxel	Bcl-2	PA449383	596	0.56
NULL	Emerg_Infect_Dis_2011_Oct_17(10)_1879-1882.nxml.txt.nlp	22000360	SENT60	10	10	0	0	ampicillin	PEN	PA448419	9933	0.56
NULL	J_Immune_Based_Ther_Vaccines_2010_Nov_24_8_8.nxml.txt.nlp	21106069	SENT37	20	20	46	46	l-glutamine	CO2	PA10090	4513	0.56
NULL	J_Cell_Biol_1998_May_18_141(4)_1061-1071.nxml.txt.nlp	9585423	SENT47	19	19	9	9	l-glutamine	BRL	PA10090	23774	0.56
NULL	Nucleic_Acids_Res_2010_Oct_27_38(18)_6247-6264.nxml.txt.nlp	20507916	SENT164	4	4	2	2	pp2	PP1		5540;5464	0.56
NULL	Thorax_2012_Sep_11_67(9)_796-803.nxml.txt.nlp	22496351	SENT82	14	14	24	24	bleomycin	TRAIL	PA448645	8743	0.56
NULL	J_Radiat_Res_2014_Nov_16_55(6)_1171-1177.nxml.txt.nlp	25129557	SENT156	32	32	34	34	bevacizumab	CRT	PA130232992	811	0.56
NULL	Int_J_Mol_Sci_2012_Feb_13_13(2)_2012-2024.nxml.txt.nlp	22408434	SENT117	33	33	41	41	ethanol	mol	PA448073	90527	0.56
NULL	ScientificWorldJournal_2014_Dec_29_2014_457380.nxml.txt.nlp	25614888	SENT69	26	26	32	32	gentamicin	D-10	PA449753	89832	0.559
NULL	J_Mol_Signal_2008_Mar_31_3_8.nxml.txt.nlp	18377662	SENT64	6	6	14	14	pp2	KDR		3791	0.559
NULL	BMJ_Open_Respir_Res_2014_Dec_11_1(1)_e000061.nxml.txt.nlp	25553247	SENT7	12	12	6	6	pemetrexed	B12	PA10810	7126;4709	0.559
NULL	Rare_Tumors_2010_Dec_31_2(4)_e62.nxml.txt.nlp	21234254	SENT23	1	1	10	10	lipase	CEA	PA450239	5670;1087	0.559
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT7	0	0	19	19	resveratrol	TRAIL-R2		8795	0.559
NULL	Adv_Hematol_2011_Apr_10_2011_960137.nxml.txt.nlp	21547266	SENT88	4	4	2	2	cyclophosphamide	CHOP	PA449165	1649	0.559
NULL	J_Vet_Med_Sci_2014_Oct_7_76(10)_1367-1374.nxml.txt.nlp	24998396	SENT368	0	0	18	18	resveratrol	Bcl-2		596	0.559
NULL	J_Inflamm_(Lond)_2007_May_4_4_10.nxml.txt.nlp	17480224	SENT319	1	1	22	22	ketamine	IL-4	PA450144	3565	0.559
NULL	J_Biol_Chem_2013_Nov_15_288(46)_33049-33059.nxml.txt.nlp	24089524	SENT257	8	8	17	17	nicotine	GATA4	PA450626	2626	0.559
NULL	Cell_Death_Differ_2010_Mar_16_17(3)_499-512.nxml.txt.nlp	19834490	SENT32	10	10	20	20	bevacizumab	VEGFR2	PA130232992	3791	0.559
NULL	Acta_Pharmacol_Sin_2014_Jan_9_35(1)_1-10.nxml.txt.nlp	24317012	SENT160	13	13	3	3	tamoxifen	SULT1A1	PA451581	6817	0.559
NULL	J_Biol_Chem_2012_Dec_14_287(51)_43094-43107.nxml.txt.nlp	23118219	SENT764	18	18	12	12	hyaluronan	RHAMM	PA165958431	3161	0.559
NULL	Oncotarget_2014_Aug_4_5(17)_7776-7787.nxml.txt.nlp	25277200	SENT123	11	11	18	18	cisplatin	ANXA4	PA449014	307	0.559
NULL	Cardiovasc_Res_2014_Oct_1_104(1)_206-215.nxml.txt.nlp	25205295	SENT161	18	18	10	10	atenolol	ANOVA	PA448499	4858	0.559
NULL	Mol_Brain_2014_Aug_12_7_58.nxml.txt.nlp	25112718	SENT227	19	19	5	5	chlorpheniramine	E14	PA448960	4863	0.559
NULL	Blood_Cancer_J_2014_Aug_1_4(8)_e232.nxml.txt.nlp	25083816	SENT218	37	37	13	13	vincristine	HMGCR	PA451879	3156	0.559
NULL	Mol_Cell_Proteomics_2012_Feb_6_11(2)_M111_015222.nxml.txt.nlp	22147731	SENT313	4	4	8	8	cetuximab	TOMM20	PA10040	9804	0.559
NULL	Mol_Cancer_2012_Jul_12_11_45.nxml.txt.nlp	22788833	SENT138	31	31	20	20	cisplatin	EGFR	PA449014	1956	0.559
NULL	F1000_Med_Rep_2009_May_28_1_43.nxml.txt.nlp	20948738	SENT35	10	10	25	25	abacavir	IL-6	PA448004	3569	0.559
NULL	Acta_Pharmacol_Sin_2009_Jul_22_30(7)_956-964.nxml.txt.nlp	19543298	SENT238	11	11	16	16	simvastatin	ANOVA	PA451363	4858	0.559
NULL	Behav_Genet_2008_Jul_7_38(4)_396-406.nxml.txt.nlp	18461434	SENT222	35	35	32	32	glucose	GLUT8	PA449773	29988;154091	0.559
NULL	Arthritis_Res_Ther_2008_Mar_19_10(2)_R36.nxml.txt.nlp	18353171	SENT79	9	9	29	29	paraformaldehyde	CD49d	PA450790	3676	0.559
NULL	J_Int_Soc_Sports_Nutr_2008_Jul_28_5_11.nxml.txt.nlp	18662395	SENT107	11	11	13	13	vasopressin	AVP	PA451858	114548;551	0.559
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_127043.nxml.txt.nlp	23227093	SENT231	9	9	26	26	ticlopidine	CYP3A4	PA451686	1576	0.559
NULL	Ann_Gen_Psychiatry_2008_Aug_18_7_11.nxml.txt.nlp	18706108	SENT84	2	2	0	0	bupropion	BUP	PA448687	23412	0.559
NULL	Acta_Pharmacol_Sin_2011_Jan_6_32(1)_133-138.nxml.txt.nlp	21131997	SENT138	3	3	32	32	heparin	ACT	PA449855	12;11332;9457;641455	0.559
NULL	Arthritis_Res_2000_Jul_20_2(5)_379-385.nxml.txt.nlp	11094452	SENT205	23	23	13	13	piroxicam	COX	PA450985	1351	0.559
NULL	Front_Neurosci_2014_Jun_3_8_128.nxml.txt.nlp	24917782	SENT139	17	17	8	8	ethanol	MC4R	PA448073	4160	0.559
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT227	8	8	0	0	sulindac	GAPDH	PA451565	2597	0.559
NULL	J_Cell_Biol_1998_Jun_29_141(7)_1515-1527.nxml.txt.nlp	9647645	SENT246	20	20	8	8	galactose	UDP-GalNAc	PA449725	26301	0.559
NULL	Breast_Cancer_(Auckl)_2009_Aug_17_3_47-60.nxml.txt.nlp	21556249	SENT3	18	18	31	31	urokinase	BRCA1	PA451836	672	0.559
NULL	Cell_Death_Dis_2014_Jul_17_5(7)_e1333.nxml.txt.nlp	25032856	SENT209	2	2	7	7	candesartan	EAAC1	PA448765	6505	0.559
NULL	Mol_Cancer_2007_Aug_21_6_53.nxml.txt.nlp	17711579	SENT272	16	16	9	9	cisplatin	IGFBP6	PA449014	3489	0.559
NULL	J_Cell_Biol_1999_Feb_22_144(4)_631-643.nxml.txt.nlp	10037786	SENT42	28	28	14	14	streptomycin	BRL	PA451512	23774	0.559
NULL	Nat_Struct_Mol_Biol_2014_Jul_22_21(7)_633-640.nxml.txt.nlp	24952594	SENT199	11	11	25	25	tetracycline	CO2	PA451640	4513	0.559
NULL	J_Med_Life_2011_Feb_15_4(1)_11-20.nxml.txt.nlp	21505570	SENT195	5	5	2	2	ns-398	COX2		4513;5743	0.559
NULL	Arthritis_Res_Ther_2013_Feb_27_15(1)_R35.nxml.txt.nlp	23446139	SENT6	34	34	36	36	cyclophosphamide	CTX	PA449165	1593	0.559
NULL	Mol_Cancer_2014_Mar_2_13_43.nxml.txt.nlp	24580730	SENT294	17	17	24	24	fluorescein	CD206	PA164746009	4360	0.559
NULL	Pharmaceuticals_(Basel)_2014_Mar_5_7(3)_311-338.nxml.txt.nlp	24603603	SENT296	6	6	4	4	cetuximab	KRAS	PA10040	3845	0.559
NULL	Front_Oncol_2014_Sep_23_4_263.nxml.txt.nlp	25295230	SENT645	18	18	12	12	sorafenib	FLT3	PA7000	2322	0.559
NULL	AIDS_Behav_2008_Jul_9_12(4)_662-669.nxml.txt.nlp	17487577	SENT105	20	20	5	5	naltrexone	RAB	PA450588	3267	0.559
NULL	Clinics_(Sao_Paulo)_2009_Apr_64(4)_313-318.nxml.txt.nlp	19488588	SENT40	20	20	11	11	budesonide	BDP	PA448681	10620;152926	0.559
NULL	Crit_Care_2010_Mar_15_14(2)_R30.nxml.txt.nlp	20226064	SENT278	1	1	21	21	midazolam	IL-8	PA450496	3576	0.559
NULL	J_Hematol_Oncol_2014_Aug_1_7_54.nxml.txt.nlp	25084809	SENT81	0	0	5	5	thrombin	C5a	PA451674	727	0.559
NULL	Health_Policy_Plan_2012_Dec_29_27(8)_677-686.nxml.txt.nlp	22460007	SENT306	2	2	22	22	chloroquine	ACT	PA448948	12;11332;9457;641455	0.559
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_16_2012_395912.nxml.txt.nlp	23118789	SENT75	29	29	18	18	phenylbutazone	UGT1A9	PA450932	54600	0.559
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1437-1448.nxml.txt.nlp	24056706	SENT111	18	18	29	29	tranylcypromine	CYP3A4	PA451741	1576	0.559
NULL	Cell_Death_Differ_2010_Apr_16_17(4)_666-676.nxml.txt.nlp	19834494	SENT90	21	21	16	16	oxaliplatin	RAGE	PA131285527	177	0.559
NULL	Behav_Brain_Funct_2005_Apr_22_1_2.nxml.txt.nlp	15916700	SENT234	13	13	36	36	guanfacine	spatial	PA449825	219793	0.559
NULL	Lung_2011_Jun_21_189(3)_257-258.nxml.txt.nlp	21509562	SENT24	40	40	48	48	estradiol	TRPV1	PA449503	7442	0.559
NULL	Br_J_Anaesth_2014_Jul_22_113(1)_157-167.nxml.txt.nlp	24154701	SENT216	14	14	6	6	sevoflurane	TREK-1	PA451341	3776	0.559
NULL	Mol_Vis_2007_Jul_9_13_1083-1093.nxml.txt.nlp	17653053	SENT152	0	0	14	14	minocycline	MCP-1	PA450519	6347	0.559
NULL	Case_Rep_Oncol_2010_Nov_29_3(3)_439-444.nxml.txt.nlp	21151639	SENT35	4	4	8	8	thyroglobulin	TTF1	PA164754910	7080;7270	0.559
NULL	Cancer_Causes_Control_2013_Aug_18_24(8)_1605-1614.nxml.txt.nlp	23775025	SENT64	38	38	10	10	epirubicin	CYP2B6	PA449476	1555	0.559
NULL	Oncoimmunology_2012_Mar_1_1(2)_189-194.nxml.txt.nlp	22720240	SENT23	7	7	29	29	imiquimod	IFN	PA449972	3439	0.559
NULL	Oncogene_2009_Feb_5_28(5)_674-685.nxml.txt.nlp	19015634	SENT223	15	15	9	9	fluorescein	53BP1	PA164746009	7158	0.559
NULL	Arthritis_Res_Ther_2007_Oct_9_9(5)_R104.nxml.txt.nlp	17925024	SENT193	28	28	7	7	glucosamine	p38	PA164747613	10598;1432;7965	0.559
NULL	Breast_Cancer_Res_2007_Mar_2_9(2)_205.nxml.txt.nlp	NULL	SENT142	0	0	13	13	trastuzumab	HER-2	PA451743	2064	0.559
NULL	Mar_Drugs_2011_Dec_13_9(12)_2605-2621.nxml.txt.nlp	22363242	SENT215	38	38	45	45	l-glutamine	CO2	PA10090	4513	0.559
NULL	Cell_Death_Dis_2013_Oct_3_4(10)_e827.nxml.txt.nlp	24091670	SENT35	19	19	32	32	nilotinib	CD38	PA165958345	952	0.559
NULL	Acta_Pharmacol_Sin_2011_Oct_12_32(10)_1259-1265.nxml.txt.nlp	21909126	SENT94	5	5	7	7	losartan	MCP-1	PA450268	6347	0.559
NULL	Oncotarget_2014_Aug_29_5(18)_8052-8082.nxml.txt.nlp	25211298	SENT367	0	0	8	8	itraconazole	COX	PA450132	1351	0.559
NULL	J_Asthma_Allergy_2013_Feb_22_6_31-39.nxml.txt.nlp	23459334	SENT98	22	22	35	35	desloratadine	ANOVA	PA164776964	4858	0.559
NULL	Curr_Neuropharmacol_2013_May_11(3)_276-297.nxml.txt.nlp	24179464	SENT162	21	21	13	13	tetracycline	APP	PA451640	351	0.559
NULL	Drugs_R_D_2014_Jun_6_14(2)_113-123.nxml.txt.nlp	24797400	SENT148	44	44	36	36	dabigatran	P-gp		5243	0.559
NULL	Exp_Ther_Med_2014_Nov_22_8(5)_1559-1564.nxml.txt.nlp	25289059	SENT153	14	14	0	0	geldanamycin	Bcl-2	PA152031327	596	0.559
NULL	ScientificWorldJournal_2013_Apr_18_2013_978394.nxml.txt.nlp	23710154	SENT108	26	26	30	30	fluorouracil	IFL	PA128406956	3439	0.559
NULL	Trials_2013_Sep_23_14_307.nxml.txt.nlp	24059911	SENT249	31	31	16	16	clindamycin	ACT	PA449035	12;11332;9457;641455	0.559
NULL	Mol_Cancer_2014_Jun_9_13_146.nxml.txt.nlp	24913494	SENT141	24	24	12	12	bicalutamide	GAPDH	PA164746255	2597	0.559
NULL	J_Antimicrob_Chemother_2014_Nov_17_69(11)_2920-2927.nxml.txt.nlp	25038069	SENT139	19	19	12	12	tetracycline	FUS	PA451640	2521	0.559
NULL	Appl_Biochem_Biotechnol_2012_Nov_16_168(6)_1584-1593.nxml.txt.nlp	22983742	SENT151	15	15	37	37	nitrogen	CYP3A4	PA450643	1576	0.559
NULL	Protein_Cell_2014_Jun_19_5(6)_469-479.nxml.txt.nlp	24748116	SENT49	2	2	0	0	paclitaxel	EB1	PA450761	9167;22919;10982	0.559
NULL	Comp_Funct_Genomics_2012_Feb_6_2012_876893.nxml.txt.nlp	22400011	SENT273	10	10	0	0	zinc	CPSF4	PA451956	10898	0.559
NULL	Cancer_Causes_Control_2013_Aug_18_24(8)_1605-1614.nxml.txt.nlp	23775025	SENT64	3	3	24	24	cyclophosphamide	GSTP1	PA449165	2950	0.559
NULL	EMBO_Mol_Med_2010_Jan_2(1)_26-37.nxml.txt.nlp	20043279	SENT273	13	13	18	18	fluorescein	hole	PA164746009	80757	0.559
NULL	Int_J_Mol_Sci_2014_Mar_5_15(3)_3970-3988.nxml.txt.nlp	24603537	SENT45	9	9	5	5	curcumin	MCH	PA151958596	5367	0.559
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT272	20	20	14	14	acenocoumarol	VKORC1	PA452632	79001	0.559
NULL	Arthritis_Res_2002_Jul_26_4(5)_R9.nxml.txt.nlp	12223112	SENT62	0	0	8	8	fluorescein	CD86	PA164746009	942	0.559
NULL	Mol_Cancer_2010_Nov_2_9_289.nxml.txt.nlp	21044322	SENT171	20	20	30	30	docetaxel	RGS10	PA449383	6001	0.559
NULL	Contemp_Oncol_(Pozn)_2012_Nov_20_16(5)_363-370.nxml.txt.nlp	23788912	SENT4	13	13	28	28	dacarbazine	IL-2	PA449197	3558	0.559
NULL	Cancers_(Basel)_2010_Mar_30_2(2)_338-363.nxml.txt.nlp	24281073	SENT992	7	7	3	3	doxorubicin	RLIP76	PA449412	10928	0.559
NULL	Int_J_Womens_Health_2010_Aug_9_1_11-20.nxml.txt.nlp	21072271	SENT147	6	6	25	25	raloxifene	STAR	PA451221	6770;2984	0.559
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Jul_23_3(7)_e126.nxml.txt.nlp	25054314	SENT206	9	9	3	3	paclitaxel	ABCC2	PA450761	1244	0.559
NULL	Nucleic_Acids_Res_2013_Nov_16_41(20)_9349-9360.nxml.txt.nlp	23956219	SENT158	15	15	7	7	cisplatin	OB1	PA449014	84525	0.559
NULL	Front_Genet_2014_Nov_14_5_391.nxml.txt.nlp	25452763	SENT434	0	0	23	23	cisplatin	UGT1A1	PA449014	54658	0.559
NULL	Indian_J_Ophthalmol_2014_Apr_62(4)_424-428.nxml.txt.nlp	24145571	SENT65	10	10	37	37	l-cysteine	PRK	PA449173	1263	0.559
NULL	Breast_Cancer_Res_2007_Dec_18_9(6)_R88.nxml.txt.nlp	18088411	SENT292	19	19	8	8	oxygen	NIR	PA450744	26155	0.559
NULL	J_Hum_Genet_2013_Jun_16_58(6)_353-361.nxml.txt.nlp	23677058	SENT163	10	10	42	42	cytarabine	NT5C2	PA449177	22978	0.559
NULL	Drug_Saf_2014_Oct_29_37(Suppl_1)_57-62.nxml.txt.nlp	25352328	SENT25	4	4	27	27	ribavirin	UGT1A1	PA451241	54658	0.559
NULL	Cell_Death_Differ_2009_Dec_9_16(12)_1590-1598.nxml.txt.nlp	19816508	SENT147	20	20	36	36	l-glutamine	CO2	PA10090	4513	0.559
NULL	FEBS_Open_Bio_2014_Oct_22_4_905-914.nxml.txt.nlp	25383314	SENT138	16	16	22	22	physostigmine	L-FABP	PA450957	2168	0.559
NULL	Anal_Bioanal_Chem_2010_May_17_397(2)_631-641.nxml.txt.nlp	20237917	SENT77	21	21	8	8	ethanol	mol	PA448073	90527	0.559
NULL	Gastric_Cancer_2014_Apr_7_17(1)_1-12.nxml.txt.nlp	23563986	SENT299	17	17	24	24	paclitaxel	HER2	PA450761	2064	0.559
NULL	Oncol_Lett_2014_May_7_7(5)_1439-1442.nxml.txt.nlp	24765152	SENT166	14	14	6	6	chloramphenicol	MMP1	PA448927	4312	0.559
NULL	Oncol_Lett_2014_Jan_6_7(1)_255-259.nxml.txt.nlp	24348859	SENT93	14	14	27	27	cisplatin	DCX	PA449014	1641	0.559
NULL	Eur_J_Med_Res_2009_Dec_7_14(Suppl_4)_71-77.nxml.txt.nlp	20156730	SENT91	0	0	30	30	tobramycin	PARI	PA451704	55010	0.559
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT1733	15	15	6	6	maraviroc	ATV	PA164768835	4683	0.559
NULL	Mol_Biol_Cell_2013_Sep_1_24(17)_2678-2688.nxml.txt.nlp	23864716	SENT74	7	7	4	4	thrombin	PP2	PA451674	4888	0.559
NULL	Asian-Australas_J_Anim_Sci_2015_Jan_28(1)_127-134.nxml.txt.nlp	25557684	SENT172	15	15	2	2	lipase	CD36	PA450239	948	0.559
NULL	J_Obes_2011_May_18_2011_141024.nxml.txt.nlp	21772998	SENT31	0	0	15	15	calcidiol	PTH	PA164745614	5741	0.559
NULL	J_Biomed_Biotechnol_2010_Jun_7_2010_150960.nxml.txt.nlp	20617134	SENT241	46	46	35	35	bevacizumab	KRAS	PA130232992	3845	0.559
NULL	Indian_J_Endocrinol_Metab_2012_Jul-Aug_16(4)_631-636.nxml.txt.nlp	22837931	SENT68	8	8	13	13	thyroglobulin	CK19	PA164754910	3880	0.559
NULL	Nutr_J_2014_Jan_24_13_11.nxml.txt.nlp	24461029	SENT118	4	4	15	15	curcumin	CTR	PA151958596	799	0.559
NULL	Braz_J_Microbiol_2014_Jan_15_44(3)_807-812.nxml.txt.nlp	24516449	SENT133	32	32	18	18	colistin	CTX	PA164760862	1593	0.559
NULL	Biosci_Rep_2012_Apr_1_32(Pt_2)_105-112.nxml.txt.nlp	22115362	SENT134	4	4	13	13	collagenase	AP-1	PA449107	2353;3727;2354;3725	0.559
NULL	Mol_Biol_Cell_2013_Sep_1_24(17)_2678-2688.nxml.txt.nlp	23864716	SENT75	14	14	11	11	thrombin	PP2	PA451674	4888	0.559
NULL	Mol_Med_Rep_2015_Feb_30_11(2)_775-782.nxml.txt.nlp	25371181	SENT160	23	23	9	9	donepezil	CA1	PA449394	759	0.559
NULL	Clin_Ophthalmol_2010_Aug_19_4_673-679.nxml.txt.nlp	20823929	SENT130	11	11	9	9	ketamine	Gen	PA450144	348654	0.559
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1063.nxml.txt.nlp	24556678	SENT225	24	24	15	15	thioridazine	TRAIL	PA451666	8743	0.559
NULL	Int_J_Breast_Cancer_2012_Nov_2_2012_217185.nxml.txt.nlp	22295242	SENT203	6	6	25	25	dasatinib	PI3K	PA162372878	5290	0.559
NULL	Int_J_Mol_Sci_2014_Oct_31_15(11)_19791-19815.nxml.txt.nlp	25365172	SENT287	3	3	8	8	deferoxamine	HIF-1	PA164746490	29072	0.559
NULL	Nature_2012_Apr_8_485(7396)_128-132.nxml.txt.nlp	22495310	SENT13	5	5	35	35	cyclosporine	PP4	PA449167	5531	0.559
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT197	14	14	8	8	perifosine	DR5	PA165291471	8795	0.559
NULL	Diabetes_2009_Dec_31_58(12)_2851-2862.nxml.txt.nlp	19720788	SENT190	11	11	8	8	forskolin	BiP	PA146096022	3309	0.559
NULL	Braz_J_Med_Biol_Res_2014_Feb_17_47(2)_101-109.nxml.txt.nlp	24519125	SENT38	21	21	41	41	l-glutamine	CO2	PA10090	4513	0.559
NULL	Front_Neuroinform_2011_Oct_14_5_23.nxml.txt.nlp	22016733	SENT72	9	9	11	11	chlorpromazine	CPZ	PA448964	8532	0.559
NULL	J_Antimicrob_Chemother_2014_Nov_17_69(11)_2920-2927.nxml.txt.nlp	25038069	SENT139	41	41	12	12	fosfomycin	FUS	PA164748039	2521	0.559
NULL	AIDS_Res_Ther_2006_Apr_24_3_12.nxml.txt.nlp	16635263	SENT293	34	34	43	43	l-glutamine	CO2	PA10090	4513	0.559
NULL	Cancer_Med_2014_Apr_27_3(2)_310-321.nxml.txt.nlp	24464839	SENT222	0	0	8	8	everolimus	MVD	PA164746311	4597	0.559
NULL	Onco_Targets_Ther_2014_May_10_7_633-636.nxml.txt.nlp	24872711	SENT5	11	11	4	4	doxorubicin	CHOP	PA449412	1649	0.559
NULL	Clin_Ophthalmol_2008_Jun_2(2)_355-368.nxml.txt.nlp	19668727	SENT248	1	1	4	4	amfenac	COX	PA166049186	1351	0.559
NULL	Clin_Ophthalmol_2011_Nov_1_5_1575-1583.nxml.txt.nlp	22125404	SENT61	1	1	5	5	travoprost	BAK	PA164781371	578	0.559
NULL	Front_Immunol_2012_Jun_11_3_144.nxml.txt.nlp	22701453	SENT192	0	0	15	15	imiquimod	IFN	PA449972	3439	0.559
NULL	Arthritis_Res_Ther_2008_Mar_31_10(2)_205.nxml.txt.nlp	18394179	SENT154	13	13	11	11	collagenase	MMP1	PA449107	4312	0.559
NULL	J_Immunol_Res_2014_May_8_2014_565320.nxml.txt.nlp	24901010	SENT143	26	26	28	28	carbamazepine	HLA-B	PA448785	3106	0.559
NULL	Oncogene_2011_Apr_14_30(15)_1798-1811.nxml.txt.nlp	21170087	SENT140	12	12	36	36	etoposide	RPS27L	PA449552	51065	0.559
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Mar_27_66(Pt_4)_m463-m464.nxml.txt.nlp	21580548	SENT69	15	15	27	27	phenol	C42	PA450913	51654	0.559
NULL	Psychiatry_Investig_2012_Jun_30_9(2)_187-190.nxml.txt.nlp	22707971	SENT78	2	2	8	8	capsaicin	POMC	PA448776	5443	0.559
NULL	F1000Res_2014_Mar_18_3_74.nxml.txt.nlp	25580222	SENT144	28	28	18	18	ciprofloxacin	TOX	PA449009	9760	0.559
NULL	Environ_Health_Perspect_2007_Apr_4_115(4)_548-555.nxml.txt.nlp	17450223	SENT102	20	20	40	40	paraformaldehyde	PLP	PA450790	25824;5744	0.559
NULL	Pain_Res_Treat_2014_Nov_18_2014_179029.nxml.txt.nlp	25485150	SENT392	3	3	20	20	mepivacaine	AAP	PA164748741	5345	0.559
NULL	Cardiovasc_Diabetol_2013_Oct_17_12_150.nxml.txt.nlp	24134550	SENT137	11	11	13	13	pioglitazone	activin	PA450970	83729	0.559
NULL	Cardiovasc_Diabetol_2013_Nov_21_12_172.nxml.txt.nlp	24261558	SENT218	0	0	3	3	eplerenone	DGAT1	PA164749044	8694	0.559
NULL	Front_Oncol_2014_Oct_30_4_289.nxml.txt.nlp	25401086	SENT316	5	5	3	3	etoposide	RAD51	PA449552	5888	0.559
NULL	Breast_Cancer_(Auckl)_2009_Aug_17_3_47-60.nxml.txt.nlp	21556249	SENT3	18	18	22	22	urokinase	p53	PA451836	7157	0.559
NULL	Br_J_Cancer_2013_Jun_25_108(12)_2464-2469.nxml.txt.nlp	23695016	SENT164	23	23	20	20	cisplatin	CRT	PA449014	811	0.559
NULL	Crit_Care_2006_May_12_10(3)_R75.nxml.txt.nlp	16696866	SENT18	15	15	17	17	vasopressin	AVP	PA451858	114548;551	0.559
NULL	J_Clin_Biochem_Nutr_2010_Jul_17_47(1)_53-58.nxml.txt.nlp	20664731	SENT395	2	2	0	0	rabeprazole	RAC	PA451216	207	0.559
NULL	J_Cell_Mol_Med_2013_Jun_15_17(6)_792-799.nxml.txt.nlp	23672538	SENT61	7	7	28	28	fluorescein	CD66b	PA164746009	1088	0.559
NULL	Mol_Cancer_2010_Nov_2_9_289.nxml.txt.nlp	21044322	SENT171	11	11	33	33	cisplatin	RGS17	PA449014	26575	0.559
NULL	Int_J_Mol_Sci_2012_Sep_26_13(10)_12349-12366.nxml.txt.nlp	23202902	SENT401	2	2	8	8	arsenite	AKT	PA452638	207	0.559
NULL	Exp_Ther_Med_2013_Sep_2_6(3)_765-768.nxml.txt.nlp	24137262	SENT46	13	13	6	6	moxifloxacin	CPAP	PA450555	55835	0.559
NULL	J_Gen_Physiol_1938_Nov_20_22(2)_207-237.nxml.txt.nlp	19873101	SENT3	15	15	8	8	chymotrypsin	gamma	PA448994	9913	0.559
NULL	Cardiovasc_Diabetol_2010_Nov_5_9_72.nxml.txt.nlp	21054861	SENT110	22	22	17	17	isoproterenol	LSD	PA450121	1776	0.559
NULL	Nucleic_Acids_Res_2012_Jun_22_40(11)_4861-4878.nxml.txt.nlp	22362753	SENT501	1	1	11	11	trypsin	NPM	PA451806	4869	0.559
NULL	Core_Evid_2007_Nov_30_2(2)_121-129.nxml.txt.nlp	21221180	SENT267	11	11	23	23	rituximab	MCP	PA451261	822	0.559
NULL	Exp_Ther_Med_2014_Feb_25_7(2)_417-422.nxml.txt.nlp	24396417	SENT96	12	12	17	17	estradiol	IL-4	PA449503	3565	0.559
NULL	Oncotarget_2013_Dec_18_5(2)_375-385.nxml.txt.nlp	24495868	SENT263	8	8	25	25	fludarabine	TP53	PA449655	7157	0.559
NULL	J_Cell_Biol_2002_Jun_24_157(7)_1151-1160.nxml.txt.nlp	12082077	SENT160	3	3	6	6	trypsin	COX	PA451806	1351	0.559
NULL	Clin_Dev_Immunol_2013_Nov_26_2013_325481.nxml.txt.nlp	24371447	SENT139	0	0	3	3	propofol	p47phox	PA451141	653361	0.559
NULL	Breast_Cancer_Res_2005_Jul_27_7(5)_R753-R764.nxml.txt.nlp	16168121	SENT202	17	17	19	19	estradiol	EGF	PA449503	1950	0.559
NULL	Diabetes_2009_Jan_58(1)_61-70.nxml.txt.nlp	18931039	SENT294	20	20	16	16	forskolin	adiponectin	PA146096022	9370	0.559
NULL	Cell_Commun_Signal_2013_Nov_11_11_86.nxml.txt.nlp	24215724	SENT265	10	10	16	16	thrombin	PAR1	PA451674	79581;2149	0.559
NULL	EPMA_J_2013_Jan_28_4(1)_3.nxml.txt.nlp	23356214	SENT350	17	17	26	26	cetuximab	KRAS	PA10040	3845	0.559
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT158	5	5	19	19	phenprocoumon	VKORC1	PA450921	79001	0.559
NULL	Front_Genet_2014_Jul_16_5_201.nxml.txt.nlp	25076963	SENT1456	2	2	9	9	arsenite	c-fos	PA452638	2353	0.559
NULL	J_Exp_Bot_2008_May_59(8)_2109-2123.nxml.txt.nlp	18535297	SENT309	10	10	2	2	galactose	PC3	PA449725	57332;7832;5122	0.559
NULL	Curr_Hepat_Rep_2010_May_21_9(2)_75-90.nxml.txt.nlp	20461127	SENT244	23	23	45	45	telbivudine	LAM	PA164760861	7249;7248	0.559
NULL	J_Cardiothorac_Surg_2009_Jun_18_4_25.nxml.txt.nlp	19538741	SENT53	3	3	15	15	heparin	ACT	PA449855	12;11332;9457;641455	0.559
NULL	AIDS_Res_Treat_2013_Sep_17_2013_231956.nxml.txt.nlp	24159383	SENT129	14	14	4	4	buprenorphine	OAT	PA448685	4942	0.559
NULL	Ann_Dermatol_2012_Nov_8_24(4)_474-475.nxml.txt.nlp	23197918	SENT26	11	11	9	9	lipase	LPAR6	PA450239	10161	0.559
NULL	J_Cell_Biol_2001_Mar_19_152(6)_1135-1144.nxml.txt.nlp	11257115	SENT166	9	9	3	3	lipase	DAG	PA450239	1605	0.559
NULL	Oncoimmunology_2013_Nov_1_2(11)_e26586.nxml.txt.nlp	24404429	SENT28	2	2	23	23	pioglitazone	CD36	PA450970	948	0.559
NULL	J_Hematol_Oncol_2010_Mar_13_3_10.nxml.txt.nlp	20226083	SENT3	20	20	5	5	gemcitabine	RRM1	PA449748	6240	0.558
NULL	Exp_Ther_Med_2013_Sep_12_6(3)_831-839.nxml.txt.nlp	24137275	SENT206	6	6	0	0	fluorescein	RGDS	PA164746009	5900	0.558
NULL	ACS_Appl_Mater_Interfaces_2014_Feb_12_6(3)_1424-1438.nxml.txt.nlp	24397537	SENT82	47	47	36	36	l-glutamine	B27	PA10090	56246	0.558
NULL	Biomed_Res_Int_2013_May_22_2013_267375.nxml.txt.nlp	23762832	SENT132	17	17	25	25	etoposide	PI3K	PA449552	5290	0.558
NULL	BMJ_Open_2013_Nov_4_3(11)_e003995.nxml.txt.nlp	24189085	SENT336	32	32	29	29	liraglutide	GLP-1	PA165958364	100125288	0.558
NULL	Br_J_Cancer_2009_Jan_13_100(1)_37-43.nxml.txt.nlp	19088724	SENT170	11	11	9	9	cisplatin	Gem	PA449014	51053	0.558
NULL	Biochem_Res_Int_2012_Mar_4_2012_685267.nxml.txt.nlp	22496978	SENT198	26	26	4	4	thrombin	HSPC	PA451674	5688	0.558
NULL	Pharmaceuticals_(Basel)_2014_Mar_5_7(3)_311-338.nxml.txt.nlp	24603603	SENT1032	1	1	10	10	cetuximab	EGFR	PA10040	1956	0.558
NULL	Mol_Cancer_2007_Sep_26_6_61.nxml.txt.nlp	17894897	SENT206	32	32	25	25	etoposide	p53	PA449552	7157	0.558
NULL	Oncol_Lett_2013_Sep_1_6(3)_840-844.nxml.txt.nlp	24137422	SENT116	8	8	0	0	berberine	TRAIL	PA165860812	8743	0.558
NULL	Cell_Death_Dis_2014_Jan_30_5(1)_e1043.nxml.txt.nlp	24481457	SENT10	12	12	8	8	urokinase	PLAU	PA451836	5328	0.558
NULL	J_Cancer_Prev_2013_Jun_18(2)_186-191.nxml.txt.nlp	25337545	SENT93	18	18	32	32	curcumin	IFN	PA151958596	3439	0.558
NULL	Front_Cell_Neurosci_2014_Jul_18_8_185.nxml.txt.nlp	25100946	SENT404	37	37	11	11	pp2	Isl-1		3670	0.558
NULL	J_Biomed_Biotechnol_2011_Jan_24_2011_250860.nxml.txt.nlp	21318107	SENT218	23	23	30	30	galactose	CD163	PA449725	9332	0.558
NULL	Int_J_Biol_Sci_2015_Jan_1_11(1)_48-58.nxml.txt.nlp	25552929	SENT24	0	0	13	13	paclitaxel	TSP-1	PA450761	7057	0.558
NULL	Asian-Australas_J_Anim_Sci_2014_Dec_27(12)_1783-1793.nxml.txt.nlp	25358373	SENT39	0	0	22	22	capsaicin	CASP3	PA448776	836	0.558
NULL	Front_Microbiol_2012_Jun_8_3_196.nxml.txt.nlp	22701113	SENT88	15	15	13	13	nadh	CO2	PA164755085	4513	0.558
NULL	Breast_Cancer_Res_2011_May_26_13(3)_209.nxml.txt.nlp	21635709	SENT149	7	7	9	9	letrozole	STEPP	PA450196	222659	0.558
NULL	Int_J_Cell_Biol_2013_Apr_18_2013_273086.nxml.txt.nlp	23690780	SENT174	38	38	17	17	urokinase	EGF	PA451836	1950	0.558
NULL	Indian_J_Anaesth_2011_Nov-Dec_55(6)_567-572.nxml.txt.nlp	22223899	SENT157	1	1	5	5	isoflurane	NAC	PA450106	22861	0.558
NULL	Indian_J_Endocrinol_Metab_2012_Dec_16(Suppl_2)_S245-S247.nxml.txt.nlp	23565390	SENT62	33	33	19	19	exenatide	GLP	PA164749238	342096	0.558
NULL	Comp_Hepatol_2004_Jan_14_3(Suppl_1)_S37.nxml.txt.nlp	14960189	SENT91	16	16	23	23	ethanol	TNF-alpha	PA448073	7124	0.558
NULL	Oncotarget_2013_Nov_22_5(4)_933-943.nxml.txt.nlp	24659749	SENT51	29	29	16	16	nutlin-3	p53		7157	0.558
NULL	Case_Rep_Oncol_2012_May_15_5(2)_238-245.nxml.txt.nlp	22679430	SENT67	9	9	7	7	rituximab	CHOP	PA451261	1649	0.558
NULL	J_Biomed_Biotechnol_2010_Oct_4_2010_641025.nxml.txt.nlp	20976270	SENT26	0	0	12	12	thrombin	VIII	PA451674	1351	0.558
NULL	J_Inherit_Metab_Dis_2010_Oct_3_33(5)_625-632.nxml.txt.nlp	20814828	SENT75	25	25	19	19	simvastatin	RhoA	PA451363	387	0.558
NULL	Clinics_(Sao_Paulo)_2013_May_68(5)_694-701.nxml.txt.nlp	23778405	SENT135	5	5	7	7	curcumin	MDR1	PA151958596	5243	0.558
NULL	Med_Sci_Monit_2013_May_1_19_317-326.nxml.txt.nlp	23632427	SENT261	47	47	13	13	nitrofurantoin	CTX	PA450640	1593	0.558
NULL	J_Headache_Pain_2014_Sep_18_15(Suppl_1)_G16.nxml.txt.nlp	NULL	SENT17	0	0	26	26	sumatriptan	TRPV1	PA451566	7442	0.558
NULL	Diabetes_2009_Apr_9_58(4)_965-974.nxml.txt.nlp	19136651	SENT119	6	6	12	12	nadh	NQO1	PA164755085	1728	0.558
NULL	eLife_2013_Nov_5_2_e00969.nxml.txt.nlp	24192036	SENT151	5	5	17	17	vemurafenib	MKK4	PA165946873	6416	0.558
NULL	Cells_2014_May_23_3(2)_517-545.nxml.txt.nlp	24861977	SENT1062	4	4	1	1	gentamicin	TRPV1	PA449753	7442	0.558
NULL	Croat_Med_J_2012_Jun_53(3)_214-223.nxml.txt.nlp	22661134	SENT95	2	2	14	14	yohimbine	ACTH	PA451946	5443	0.558
NULL	Braz_J_Med_Biol_Res_2012_Jul_27_45(10)_948-954.nxml.txt.nlp	22832600	SENT145	8	8	20	20	fluoxetine	ANOVA	PA449673	4858	0.558
NULL	Nat_Chem_Biol_2010_Apr_28_6(4)_291-299.nxml.txt.nlp	20190765	SENT128	32	32	9	9	dasatinib	EGFR	PA162372878	1956	0.558
NULL	Eur_J_Clin_Pharmacol_2011_May_9_67(5)_477-482.nxml.txt.nlp	21305273	SENT103	32	32	5	5	atropine	DBP	PA448505	3295;1628;2638	0.558
NULL	Crit_Care_2011_Apr_11_15(2)_R112.nxml.txt.nlp	21481266	SENT91	14	14	26	26	piperacillin	SAPS	PA450975	8935	0.558
NULL	Front_Neurosci_2010_Jun_28_4_41.nxml.txt.nlp	20661453	SENT78	9	9	36	36	ethanol	AKT	PA448073	207	0.558
NULL	Ann_Hematol_2013_Feb_19_92(2)_239-244.nxml.txt.nlp	23079891	SENT119	8	8	3	3	etoposide	CHOP	PA449552	1649	0.558
NULL	Reprod_Biol_Endocrinol_2003_Aug_12_1_55.nxml.txt.nlp	12941156	SENT80	21	21	11	11	l-glutamine	F12	PA10090	2161	0.558
NULL	Int_J_Mol_Sci_2014_Nov_25_15(12)_21703-21722.nxml.txt.nlp	25429431	SENT144	2	2	29	29	paclitaxel	P-gp	PA450761	5243	0.558
NULL	Int_J_Fertil_Steril_2014_Mar_9_Apr-Jun_8(1)_99-104.nxml.txt.nlp	24696774	SENT106	15	15	20	20	estradiol	aromatase	PA449503	1588	0.558
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT192	41	41	30	30	erlotinib	Yes	PA134687924	7525	0.558
NULL	Allergy_Asthma_Immunol_Res_2011_Jan_29_3(1)_21-26.nxml.txt.nlp	21217921	SENT49	24	24	31	31	methacholine	CTNNA3	PA165958382	29119	0.558
NULL	Exp_Neurobiol_2014_Sep_18_23(3)_224-230.nxml.txt.nlp	25258569	SENT102	3	3	1	1	duloxetine	EPM	PA10066	2054	0.558
NULL	Clin_Ophthalmol_2010_Apr_26_4_331-341.nxml.txt.nlp	20463802	SENT85	10	10	27	27	moxifloxacin	API	PA450555	5345	0.558
NULL	J_Clin_Biochem_Nutr_2009_Jul_30_45(1)_9-13.nxml.txt.nlp	19590701	SENT4	6	6	14	14	lansoprazole	HO-1	PA450180	3162	0.558
NULL	J_Clin_Biochem_Nutr_2009_Jul_30_45(1)_37-43.nxml.txt.nlp	19590705	SENT159	1	1	9	9	taurine	TNF-alpha	PA451590	7124	0.558
NULL	J_Cell_Biol_2002_May_28_157(5)_761-770.nxml.txt.nlp	12034770	SENT309	13	13	3	3	doxycycline	TFF1	PA449415	7031	0.558
NULL	Psychiatry_Investig_2009_Sep_3_6(3)_222-225.nxml.txt.nlp	20046399	SENT76	5	5	16	16	perospirone	DRD4	PA165291546	1815	0.558
NULL	Crit_Care_2011_Oct_25_15(5)_R255.nxml.txt.nlp	22026977	SENT107	4	4	0	0	vasopressin	AVP	PA451858	114548;551	0.558
NULL	Cancer_Cell_Int_2013_Jun_26_13_64.nxml.txt.nlp	23802572	SENT101	0	0	12	12	curcumin	Bcl-2	PA151958596	596	0.558
NULL	Breast_Cancer_Res_2002_Sep_10_4(6)_218-221.nxml.txt.nlp	12473166	SENT78	4	4	0	0	tamoxifen	ATAC	PA451581	6375	0.558
NULL	J_Mol_Signal_2009_Apr_28_4_2.nxml.txt.nlp	19400946	SENT124	22	22	39	39	estradiol	Gen	PA449503	348654	0.558
NULL	Indian_J_Nephrol_2013_Sep-Oct_23(5)_332-337.nxml.txt.nlp	24049267	SENT12	7	7	19	19	iron	CAD	PA450087	1677;790	0.558
NULL	Front_Plant_Sci_2012_Jun_22_3_138.nxml.txt.nlp	22737159	SENT425	0	0	6	6	hyaluronan	MRP5	PA165958431	10057	0.558
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Jun_27_5_15.nxml.txt.nlp	16803618	SENT145	32	32	42	42	ciprofloxacin	GEN1	PA449009	348654	0.558
NULL	Curr_Neuropharmacol_2009_Sep_7(3)_195-206.nxml.txt.nlp	20190961	SENT324	6	6	8	8	theophylline	p50	PA451647	958;4790	0.558
NULL	J_Vet_Med_Sci_2014_Sep_3_76(9)_1235-1240.nxml.txt.nlp	24897959	SENT302	27	27	3	3	cisplatin	SET	PA449014	6418	0.558
NULL	J_Cell_Mol_Med_2013_Jun_15_17(6)_792-799.nxml.txt.nlp	23672538	SENT61	7	7	36	36	fluorescein	CD19	PA164746009	930	0.558
NULL	Arthritis_Res_Ther_2006_Apr_12_8(Suppl_1)_S3.nxml.txt.nlp	16820042	SENT52	14	14	24	24	colchicine	ACTH	PA449092	5443	0.558
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT301	2	2	43	43	resveratrol	AMPK		5563	0.558
NULL	J_Nat_Prod_2014_Nov_26_77(11)_2513-2521.nxml.txt.nlp	25333853	SENT256	45	45	36	36	streptomycin	FBS	PA451512	64319;26269	0.558
NULL	EMBO_J_2010_Nov_17_29(22)_3869-3878.nxml.txt.nlp	21037554	SENT160	30	30	14	14	l-glutamine	B27	PA10090	56246	0.558
NULL	Avicenna_J_Phytomed_2013_Autumn_3(4)_302-312.nxml.txt.nlp	25050287	SENT152	2	2	14	14	ethanol	hole	PA448073	80757	0.558
NULL	Arthritis_Res_Ther_2011_Feb_16_13(1)_R25.nxml.txt.nlp	21324169	SENT120	22	22	8	8	infliximab	ANA	PA452639	10950	0.558
NULL	Mol_Cancer_2008_Jun_3_7_47.nxml.txt.nlp	18519000	SENT194	7	7	19	19	gefitinib	EGFR	PA131301952	1956	0.558
NULL	Oncol_Lett_2014_Jul_12_8(1)_223-229.nxml.txt.nlp	24959250	SENT120	5	5	15	15	captopril	IL-18	PA448780	3606	0.558
NULL	Oncotarget_2014_Oct_23_5(21)_10816-10829.nxml.txt.nlp	25333261	SENT181	7	7	17	17	doxorubicin	MTDH	PA449412	92140	0.558
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Apr_30_65(Pt_5)_m594.nxml.txt.nlp	21583816	SENT52	40	40	18	18	ethanol	mol	PA448073	90527	0.558
NULL	Orphanet_J_Rare_Dis_2014_Nov_30_9(1)_197.nxml.txt.nlp	NULL	SENT136	38	38	42	42	creatine	AGAT	PA164778930	2628	0.558
NULL	Ann_Gastroenterol_2013_26(1)_29-36.nxml.txt.nlp	24714698	SENT135	6	6	8	8	cisplatin	STZ	PA449014	6484	0.558
NULL	Front_Microbiol_2015_Jan_12_5_776.nxml.txt.nlp	25628615	SENT283	16	16	13	13	nitrogen	CO2	PA450643	4513	0.558
NULL	Calcif_Tissue_Int_2013_Sep_11_93(6)_526-539.nxml.txt.nlp	24022329	SENT100	31	31	44	44	l-glutamine	RANKL	PA10090	8600	0.558
NULL	Exp_Ther_Med_2014_May_26_7(5)_1170-1176.nxml.txt.nlp	24940406	SENT213	2	2	4	4	doxorubicin	PinX1	PA449412	54984	0.558
NULL	Core_Evid_2010_Jul_27_5_1-10.nxml.txt.nlp	20694135	SENT123	29	29	31	31	levodopa	CLE	PA450213	51637	0.558
NULL	Acta_Neuropathol_Commun_2013_Aug_9_1_49.nxml.txt.nlp	24252504	SENT106	14	14	22	22	arsenite	TDP-43	PA452638	23435	0.558
NULL	J_Inflamm_(Lond)_2008_Jul_29_5_11.nxml.txt.nlp	18664275	SENT125	29	29	19	19	clarithromycin	IL-8	PA449028	3576	0.558
NULL	Infect_Dis_Ther_2014_Jun_20_3(1)_1-17.nxml.txt.nlp	25134808	SENT130	19	19	3	3	elvitegravir	ATV	PA165291498	4683	0.558
NULL	Int_J_Nanomedicine_2009_Nov_23_4_251-259.nxml.txt.nlp	20011242	SENT163	7	7	2	2	paclitaxel	survivin	PA450761	332	0.558
NULL	J_Oncol_2009_Sep_2_2009_519563.nxml.txt.nlp	19746172	SENT55	41	41	23	23	gentamicin	CO2	PA449753	4513	0.558
NULL	Exp_Ther_Med_2014_May_26_7(5)_1305-1310.nxml.txt.nlp	24940429	SENT147	6	6	9	9	fluorescein	TLR2	PA164746009	7097	0.558
NULL	Ann_Oncol_2012_Nov_22_23(11)_2782-2790.nxml.txt.nlp	22730099	SENT143	8	8	22	22	estradiol	AMH	PA449503	268	0.558
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1437-1448.nxml.txt.nlp	24056706	SENT111	14	14	29	29	sulfaphenazole	CYP3A4	PA130231310	1576	0.558
NULL	Biochem_Biophys_Res_Commun_2010_Jan_1_391(1)_437-442.nxml.txt.nlp	19914210	SENT66	19	19	15	15	bacitracin	NFM	PA448531	4741	0.558
NULL	Clin_Interv_Aging_2008_Sep_3(3)_453-472.nxml.txt.nlp	18982916	SENT357	5	5	8	8	pyrimethamine	CD4	PA451193	920	0.558
NULL	Indian_J_Endocrinol_Metab_2012_Dec_16(Suppl_2)_S474-S476.nxml.txt.nlp	23565471	SENT16	38	38	29	29	metformin	PPG	PA450395	5552	0.558
NULL	Mol_Brain_2014_Sep_4_7(1)_69.nxml.txt.nlp	NULL	SENT157	0	0	18	18	sevoflurane	CCL2	PA451341	6347	0.558
NULL	J_Biomed_Biotechnol_2010_Oct_4_2010_641025.nxml.txt.nlp	20976270	SENT29	1	1	25	25	thrombin	VIII	PA451674	1351	0.558
NULL	Front_Oncol_2014_Mar_3_4_41.nxml.txt.nlp	24624364	SENT601	47	47	30	30	curcumin	ABCG2	PA151958596	9429	0.558
NULL	Biotechnol_Res_Int_2014_Jun_9_2014_674286.nxml.txt.nlp	25009746	SENT157	23	23	27	27	l-histidine	X11	PA449882	320	0.558
NULL	Ann_Hematol_2014_Mar_18_93(8)_1335-1344.nxml.txt.nlp	24638841	SENT107	24	24	6	6	rituximab	CLB	PA451261	171425	0.558
NULL	J_Immunol_Res_2014_Mar_24_2014_320674.nxml.txt.nlp	24741588	SENT165	42	42	18	18	heparin	FVIII	PA449855	2157	0.558
NULL	Stroke_Res_Treat_2009_Dec_20_2010_386389.nxml.txt.nlp	20700422	SENT162	25	25	19	19	resveratrol	NAC		22861	0.558
NULL	Angiogenesis_2013_Apr_10_16(2)_373-386.nxml.txt.nlp	23143659	SENT223	38	38	24	24	cyclophosphamide	LDM	PA449165	1595	0.558
NULL	Breast_Cancer_Res_Treat_2014_Apr_1_145(1)_23-32.nxml.txt.nlp	24687377	SENT269	9	9	5	5	zinc	KAP1	PA451956	10155	0.558
NULL	Cerebrovasc_Dis_Extra_2013_Jun_11_3(1)_85-94.nxml.txt.nlp	23885261	SENT145	15	15	12	12	alteplase	OCSP	PA164776730	83882	0.558
NULL	Extremophiles_2009_Nov_23_13(6)_885-894.nxml.txt.nlp	19701714	SENT136	23	23	11	11	ethanol	mol	PA448073	90527	0.558
NULL	Ann_Gastroenterol_2012_25(3)_249-253.nxml.txt.nlp	24714152	SENT23	22	22	8	8	thioguanine	TPMT	PA451663	7172	0.558
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT10	0	0	6	6	nutlin-3	MDM2		4193	0.558
NULL	Mol_Pain_2012_Sep_27_8_75.nxml.txt.nlp	23013719	SENT375	30	30	36	36	capsaicin	TRPA1	PA448776	8989	0.558
NULL	Int_J_Biol_Sci_2013_Nov_21_9(10)_1089-1098.nxml.txt.nlp	24339730	SENT25	0	0	13	13	genistein	RUNX2	PA165109660	860	0.558
NULL	Cancer_Med_2012_Aug_15_1(1)_28-38.nxml.txt.nlp	23342251	SENT37	20	20	15	15	pertuzumab	HER2		2064	0.558
NULL	Int_J_Biol_Sci_2013_Mar_7_9(3)_279-288.nxml.txt.nlp	23493630	SENT129	21	21	9	9	tocilizumab	CD4	PA165292659	920	0.558
NULL	Org_Med_Chem_Lett_2012_Oct_15_2_32.nxml.txt.nlp	23067874	SENT136	12	12	15	15	sr144528	CB1		1268	0.558
NULL	Arthritis_Res_Ther_2003_Jan_20_5(2)_68-75.nxml.txt.nlp	12718746	SENT268	3	3	21	21	imiquimod	IFN	PA449972	3439	0.558
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT9	0	0	10	10	perifosine	c-Jun	PA165291471	3725	0.558
NULL	J_Hum_Genet_2013_Jun_16_58(6)_353-361.nxml.txt.nlp	23677058	SENT96	7	7	12	12	cytarabine	RRM2B	PA449177	50484	0.558
NULL	Arch_Med_Sci_2011_Jun_11_7(3)_517-522.nxml.txt.nlp	22295038	SENT25	21	21	19	19	cyanocobalamin	B12	PA451892	7126;4709	0.558
NULL	Int_J_Biol_Sci_2012_Sep_14_8(8)_1142-1155.nxml.txt.nlp	23091412	SENT91	29	29	23	23	chymotrypsin	cadherin	PA448994	1015	0.558
NULL	Biologics_2013_Apr_15_7_77-90.nxml.txt.nlp	23723688	SENT116	41	41	32	32	cetuximab	CRT	PA10040	811	0.558
NULL	Core_Evid_2008_Jun_3(1)_31-43.nxml.txt.nlp	20694082	SENT22	6	6	15	15	vasopressin	AVP	PA451858	114548;551	0.558
NULL	Eur_J_Immunol_2014_Jun_10_44(6)_1759-1769.nxml.txt.nlp	24595810	SENT67	3	3	5	5	fludrocortisone	CD62L	PA164743961	6402	0.558
NULL	J_Med_Case_Reports_2011_Oct_23_5_522.nxml.txt.nlp	22018056	SENT34	22	22	0	0	thyroglobulin	FDG	PA164754910	23583	0.558
NULL	Arthritis_Res_Ther_2005_Feb_18_7(3)_R476-R484.nxml.txt.nlp	15899034	SENT114	4	4	7	7	thrombin	IL-6	PA451674	3569	0.558
NULL	Oncotarget_2014_Feb_25_5(5)_1304-1314.nxml.txt.nlp	24675421	SENT153	9	9	16	16	cisplatin	RIP1	PA449014	10928;7386	0.558
NULL	Open_Orthop_J_2008_Oct_24_2_137-144.nxml.txt.nlp	19478889	SENT167	18	18	14	14	heparin	PTN	PA449855	5764	0.558
NULL	J_Cell_Biol_1998_Jan_26_140(2)_335-345.nxml.txt.nlp	9442109	SENT21	21	21	13	13	chloroquine	NHE	PA448948	285335	0.558
NULL	Ann_Rehabil_Med_2012_Aug_27_36(4)_466-473.nxml.txt.nlp	22977771	SENT145	18	18	33	33	hyaluronidase	TLF	PA164745713	9519	0.558
NULL	Int_J_Nanomedicine_2012_Nov_9_7_5693-5704.nxml.txt.nlp	23180964	SENT299	22	22	14	14	cyclosporine	zeta	PA449167	9907	0.558
NULL	Cancer_Cell_Int_2011_Feb_15_11_4.nxml.txt.nlp	21320357	SENT171	24	24	44	44	l-glutamine	CO2	PA10090	4513	0.558
NULL	Case_Rep_Oncol_2013_Aug_24_6(2)_441-449.nxml.txt.nlp	24019785	SENT118	27	27	21	21	temozolomide	STZ	PA451609	6484	0.558
NULL	Biologics_2009_Sep_15_3_429-441.nxml.txt.nlp	19774210	SENT304	32	32	42	42	irinotecan	IFL	PA450085	3439	0.558
NULL	Breast_Cancer_Res_2009_Mar_19_11(2)_R16.nxml.txt.nlp	19298655	SENT118	15	15	11	11	lipase	ATGL	PA450239	57104	0.558
NULL	Eur_J_Med_Res_2014_Apr_9_19(1)_19.nxml.txt.nlp	24717101	SENT80	23	23	11	11	rituximab	FDG	PA451261	23583	0.558
NULL	Pharmaceuticals_(Basel)_2014_Sep_17_7(9)_943-953.nxml.txt.nlp	25232798	SENT90	32	32	34	34	trastuzumab	HER2	PA451743	2064	0.558
NULL	Mol_Brain_2014_Aug_21_7_59.nxml.txt.nlp	25139109	SENT202	13	13	30	30	ampicillin	CO2	PA448419	4513	0.558
NULL	Ann_Rheum_Dis_2008_Sep_11_68(7)_1146-1152.nxml.txt.nlp	18794178	SENT159	6	6	23	23	adalimumab	ACR	PA10004	49	0.558
NULL	Cell_Commun_Signal_2013_Oct_1_11_73.nxml.txt.nlp	24083678	SENT204	5	5	7	7	sulindac	A20	PA451565	7128;28935	0.558
NULL	Breast_Cancer_Res_Treat_2013_Jan_8_137(2)_457-464.nxml.txt.nlp	23224144	SENT215	14	14	10	10	paclitaxel	castor	PA450761	54897	0.558
NULL	Neuroscience_2008_Aug_13_155(2)_556-564.nxml.txt.nlp	18619738	SENT181	9	9	7	7	choline	CDP	PA448976	1523	0.558
NULL	Oxid_Med_Cell_Longev_2009_Apr-Jun_2(2)_73-81.nxml.txt.nlp	20357928	SENT100	0	0	8	8	l-carnitine	IL-2	PA450154	3558	0.558
NULL	Allergy_Asthma_Clin_Immunol_2013_Feb_7_9(1)_6.nxml.txt.nlp	23390895	SENT182	7	7	30	30	calcein	MCP-1	PA132595336	6347	0.558
NULL	Front_Immunol_2012_Mar_15_3_46.nxml.txt.nlp	22566928	SENT64	7	7	7	7	pp2	PP2		4888	0.558
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT64	0	0	7	7	resveratrol	TRAIL		8743	0.558
NULL	Asian-Australas_J_Anim_Sci_2013_Apr_26(4)_573-578.nxml.txt.nlp	25049825	SENT133	12	12	17	17	bacitracin	BP1	PA448531	1748	0.558
NULL	Ann_Gen_Psychiatry_2012_Jan_23_11_2.nxml.txt.nlp	22269819	SENT0	22	22	1	1	risperidone	Gen	PA451257	348654	0.558
NULL	Aging_Cell_2008_Apr_1_7(2)_199-206.nxml.txt.nlp	18221413	SENT169	9	9	20	20	ethanol	mol	PA448073	90527	0.558
NULL	Diabetes_2009_Apr_58(4)_773-795.nxml.txt.nlp	19336687	SENT693	12	12	24	24	pioglitazone	adiponectin	PA450970	9370	0.558
NULL	Arthritis_Res_Ther_2005_Apr_4_7(4)_R756-R768.nxml.txt.nlp	15987477	SENT27	26	26	30	30	hyaluronidase	PH-20	PA164745713	6677	0.558
NULL	Int_J_Mol_Sci_2014_Oct_8_15(10)_17974-17999.nxml.txt.nlp	25299695	SENT100	7	7	13	13	curcumin	HO-1	PA151958596	3162	0.558
NULL	Mol_Cancer_2010_May_17_9_108.nxml.txt.nlp	20478051	SENT19	6	6	3	3	deferoxamine	HIF-1	PA164746490	29072	0.558
NULL	Patient_Prefer_Adherence_2009_Nov_29_3_345-355.nxml.txt.nlp	20016798	SENT172	14	14	18	18	olanzapine	NNT	PA450688	23530	0.558
NULL	Clin_Oral_Investig_2012_Aug_20_16(4)_1237-1242.nxml.txt.nlp	22012468	SENT124	10	10	16	16	tolbutamide	DM2	PA451718	28508	0.558
NULL	Mol_Vis_2007_Dec_17_13_2282-2288.nxml.txt.nlp	18199969	SENT5	13	13	36	36	oxygen	IL-6	PA450744	3569	0.558
NULL	Oxid_Med_Cell_Longev_2013_Nov_4_2013_564902.nxml.txt.nlp	24303086	SENT40	11	11	3	3	glucose	STZ	PA449773	6484	0.558
NULL	Surg_Neurol_Int_2014_Oct_7_5_145.nxml.txt.nlp	25324974	SENT151	20	20	26	26	sunitinib	EGFR	PA162372840	1956	0.558
NULL	Mol_Cancer_2010_Nov_2_9_289.nxml.txt.nlp	21044322	SENT171	15	15	30	30	vincristine	RGS10	PA451879	6001	0.558
NULL	Crit_Care_2000_Mar_21_4(Suppl_1)_P28.nxml.txt.nlp	NULL	SENT10	7	7	20	20	thrombin	IL-6	PA451674	3569	0.558
NULL	Ann_Rehabil_Med_2012_Aug_27_36(4)_466-473.nxml.txt.nlp	22977771	SENT14	11	11	3	3	bupivacaine	ILEI	PA135057240	10447	0.558
NULL	Cardiovasc_Ther_2009_27(4)_259-274.nxml.txt.nlp	19604248	SENT160	11	11	23	23	ticagrelor	IPA	PA165374673	3160	0.558
NULL	EMBO_Mol_Med_2011_May_3(5)_266-278.nxml.txt.nlp	21438154	SENT144	5	5	20	20	oxaliplatin	TRAAK	PA131285527	50801	0.558
NULL	Drugs_2009_Mar_17_69(5)_549-565.nxml.txt.nlp	19368417	SENT139	2	2	4	4	budesonide	DPI	PA448681	1832	0.558
NULL	Oncogene_2009_Dec_3_28(48)_4237-4248.nxml.txt.nlp	19734937	SENT81	14	14	4	4	collagenase	PAR-1	PA449107	2011;2149	0.558
NULL	Acta_Vet_Scand_2013_Aug_28_55(1)_61.nxml.txt.nlp	23985065	SENT71	9	9	1	1	erythromycin	PEN	PA449493	9933	0.558
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT83	0	0	3	3	perifosine	TRAIL	PA165291471	8743	0.558
NULL	ScientificWorldJournal_2012_Jun_4_2012_705872.nxml.txt.nlp	22701368	SENT19	31	31	17	17	xanthophyll	CO2	PA164748318	4513	0.558
NULL	Cell_Death_Dis_2014_Jan_30_5(1)_e1036.nxml.txt.nlp	24481450	SENT119	24	24	11	11	heparin	F12	PA449855	2161	0.558
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Dec_2_5_30.nxml.txt.nlp	17140452	SENT194	19	19	5	5	mupirocin	GAT	PA164764568	10249	0.558
NULL	Diabetes_Metab_Syndr_Obes_2014_Jan_18_7_15-24.nxml.txt.nlp	24465132	SENT20	16	16	41	41	pioglitazone	GLP-1	PA450970	100125288	0.558
NULL	Nucleic_Acids_Res_2013_Dec_17_41(22)_10371-10378.nxml.txt.nlp	24049076	SENT31	9	9	5	5	cisplatin	HMGB1	PA449014	3146	0.558
NULL	Cancers_(Basel)_2011_Apr_26_3(2)_2195-2213.nxml.txt.nlp	24212804	SENT190	21	21	19	19	cyclophosphamide	GITR	PA449165	8784	0.558
NULL	Int_J_Mol_Sci_2014_Mar_20_15(3)_4977-4993.nxml.txt.nlp	24658441	SENT434	0	0	10	10	resveratrol	Mcl-1		4170	0.558
NULL	J_Exp_Med_1994_May_1_179(5)_1737-1741.nxml.txt.nlp	8163952	SENT7	1	1	3	3	thrombin	MCP-1	PA451674	6347	0.558
NULL	Indian_J_Anaesth_2011_May-Jun_55(3)_318-320.nxml.txt.nlp	21808420	SENT45	26	26	12	12	tramadol	CO2	PA451735	4513	0.558
NULL	Breast_Cancer_Res_2007_Jul_5_9(4)_R41.nxml.txt.nlp	17612393	SENT157	6	6	13	13	celecoxib	Bcl-2	PA448871	596	0.558
NULL	Acta_Pharmacol_Sin_2014_Sep_25_35(9)_1103-1110.nxml.txt.nlp	25152025	SENT75	38	38	23	23	thrombin	VIII	PA451674	1351	0.558
NULL	Breast_Cancer_(Auckl)_2011_Jul_27_5_175-199.nxml.txt.nlp	21863131	SENT491	8	8	1	1	irinotecan	Met	PA450085	79811	0.558
NULL	Drug_Des_Devel_Ther_2014_Sep_23_8_1527-1538.nxml.txt.nlp	25284985	SENT149	13	13	24	24	celecoxib	IFN	PA448871	3439	0.558
NULL	Mol_Vis_2012_Nov_12_18_2673-2686.nxml.txt.nlp	23170060	SENT322	5	5	15	15	taurine	ERG	PA451590	2078	0.557
NULL	Breast_Cancer_Res_2005_Nov_11_7(6)_255-257.nxml.txt.nlp	16457700	SENT10	8	8	14	14	tamoxifen	ATAC	PA451581	6375	0.557
NULL	J_Oncol_2012_Jul_14_2012_193436.nxml.txt.nlp	21804824	SENT160	25	25	37	37	irinotecan	SNO	PA450085	6498	0.557
NULL	BMB_Rep_2013_Nov_46(11)_555-560.nxml.txt.nlp	24152914	SENT38	22	22	28	28	mannitol	NAC	PA450320	22861	0.557
NULL	Oncotarget_2014_Oct_21_5(22)_11252-11268.nxml.txt.nlp	25361004	SENT250	6	6	10	10	metformin	CLIC1	PA450395	1192	0.557
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2011_Sep_13_4_47-62.nxml.txt.nlp	22879794	SENT346	4	4	2	2	liraglutide	GLP-1	PA165958364	100125288	0.557
NULL	Eur_J_Lipid_Sci_Technol_2011_Aug_113(8)_973-979.nxml.txt.nlp	21966255	SENT166	28	28	8	8	lipase	DAG	PA450239	1605	0.557
NULL	Breast_Cancer_Res_2006_Oct_24_8(5)_R59.nxml.txt.nlp	17062128	SENT277	19	19	0	0	urokinase	COX	PA451836	1351	0.557
NULL	Clin_Ophthalmol_2008_Dec_2(4)_897-905.nxml.txt.nlp	19668444	SENT130	7	7	9	9	travoprost	BAK	PA164781371	578	0.557
NULL	J_Biomed_Sci_2014_Jul_22_21(1)_65.nxml.txt.nlp	25047949	SENT51	34	34	22	22	docetaxel	PC-3	PA449383	692094	0.557
NULL	Biomed_Res_Int_2014_May_18_2014_453707.nxml.txt.nlp	24955358	SENT298	7	7	9	9	colchicine	BAP	PA449092	64374	0.557
NULL	Breast_Cancer_Res_2005_Jul_20_7(5)_205-211.nxml.txt.nlp	16168139	SENT172	31	31	14	14	tamoxifen	AKT	PA451581	207	0.557
NULL	J_Korean_Med_Sci_2011_Jan_22_26(1)_33-41.nxml.txt.nlp	21218027	SENT169	41	41	35	35	cycloserine	PTH	PA164764600	5741	0.557
NULL	Glycobiology_2009_Aug_11_19(8)_899-909.nxml.txt.nlp	19433864	SENT31	34	34	27	27	galactose	MUC1	PA449725	4582	0.557
NULL	Mol_Cancer_2012_Jun_18_11_41.nxml.txt.nlp	22709873	SENT328	3	3	24	24	lapatinib	NR3C1	PA152241907	2908	0.557
NULL	Breast_Cancer_Res_2011_Nov_23_13(6)_R116.nxml.txt.nlp	22113133	SENT327	28	28	0	0	tamoxifen	CTRL	PA451581	1506	0.557
NULL	J_Korean_Med_Sci_2010_Nov_26_25(11)_1683-1687.nxml.txt.nlp	21060764	SENT40	13	13	24	24	thyroglobulin	CEA	PA164754910	5670;1087	0.557
NULL	Nat_Commun_2013_Aug_13_4_2316.nxml.txt.nlp	23939267	SENT38	8	8	10	10	lipase	ATGL	PA450239	57104	0.557
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT286	10	10	6	6	warfarin	CYP2C9	PA451906	1559	0.557
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT24	13	13	10	10	imatinib	SLC22A1	PA10804	6580	0.557
NULL	Indian_J_Sex_Transm_Dis_2013_Jul-Dec_34(2)_148-149.nxml.txt.nlp	24339470	SENT18	20	20	28	28	lamivudine	AKT	PA450163	207	0.557
NULL	Front_Oncol_2014_Apr_8_4_71.nxml.txt.nlp	24782983	SENT466	23	23	27	27	levetiracetam	HDAC7	PA450206	51564	0.557
NULL	Acta_Histochem_Cytochem_2011_Oct_26_44(5)_213-221.nxml.txt.nlp	22096261	SENT576	12	12	10	10	staurosporine	CNTF	PA165109623	1270	0.557
NULL	Asian-Australas_J_Anim_Sci_2014_May_27(5)_757-766.nxml.txt.nlp	25050012	SENT205	9	9	5	5	lipase	ATGL	PA450239	57104	0.557
NULL	Int_Semin_Surg_Oncol_2006_Aug_25_3_22.nxml.txt.nlp	16930493	SENT77	12	12	23	23	mitomycin	ADM	PA450524	133	0.557
NULL	Oncoimmunology_2014_Jun_3_3_e29030.nxml.txt.nlp	25083328	SENT57	13	13	22	22	temozolomide	IFN	PA451609	3439	0.557
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT134	3	3	5	5	doxorubicin	B7-H1	PA449412	29126	0.557
NULL	J_Vet_Med_Sci_2014_Aug_15_76(8)_1119-1127.nxml.txt.nlp	24829081	SENT183	8	8	24	24	trypsin	fractalkine	PA451806	6376	0.557
NULL	Nat_Commun_2013_Oct_1_4_2516.nxml.txt.nlp	24084631	SENT652	0	0	20	20	losartan	AK4	PA450268	205	0.557
NULL	Exp_Diabetes_Res_2012_Nov_12_2012_618923.nxml.txt.nlp	23197974	SENT198	27	27	17	17	telmisartan	STZ	PA451605	6484	0.557
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT140	31	31	17	17	perifosine	TRAIL	PA165291471	8743	0.557
NULL	J_Nutr_Metab_2010_Nov_23_2010_415075.nxml.txt.nlp	20721351	SENT145	18	18	32	32	lipase	PLB	PA450239	151056	0.557
NULL	Mediators_Inflamm_2010_May_17_2010_841343.nxml.txt.nlp	20490358	SENT6	6	6	21	21	candesartan	MCP-1	PA448765	6347	0.557
NULL	Sci_Rep_2014_Dec_17_4_7519.nxml.txt.nlp	25515777	SENT218	19	19	4	4	l-glutamine	KSR	PA10090	10256	0.557
NULL	Diabetes_Care_2013_Aug_17_36(Suppl_2)_S139-S144.nxml.txt.nlp	23882038	SENT121	12	12	14	14	pioglitazone	GLP-1	PA450970	100125288	0.557
NULL	J_Cancer_2013_Sep_27_4(8)_679-685.nxml.txt.nlp	24155780	SENT123	0	0	4	4	pertuzumab	HER2		2064	0.557
NULL	Mol_Cancer_2010_May_18_9_110.nxml.txt.nlp	20482802	SENT130	16	16	5	5	bortezomib	CHOP	PA10252	1649	0.557
NULL	Front_Behav_Neurosci_2014_Oct_30_8_366.nxml.txt.nlp	25400560	SENT154	17	17	1	1	ethanol	ANOVA	PA448073	4858	0.557
NULL	Ann_Rheum_Dis_2014_Jun_30_73(6)_990-999.nxml.txt.nlp	24482301	SENT83	22	22	0	0	methotrexate	ACR	PA450428	49	0.557
NULL	Biomed_Res_Int_2013_Jul_18_2013_603782.nxml.txt.nlp	23971041	SENT136	29	29	24	24	latanoprost	BAK	PA164774763	578	0.557
NULL	Ann_Oncol_2012_Dec_2_23(12)_3007-3016.nxml.txt.nlp	22865781	SENT170	41	41	18	18	trastuzumab	HER2	PA451743	2064	0.557
NULL	Med_Sci_Monit_2013_Nov_29_19_1080-1088.nxml.txt.nlp	24287619	SENT182	23	23	12	12	estradiol	ACL	PA449503	47	0.557
NULL	Cancer_Cell_Int_2003_Jul_23_3_12.nxml.txt.nlp	12914669	SENT45	4	4	23	23	tetracycline	PP1	PA451640	5540;5464	0.557
NULL	Nat_Neurosci_2012_Sep_5_15(9)_1245-1254.nxml.txt.nlp	22864611	SENT485	4	4	9	9	clozapine	HDAC2	PA449061	3066	0.557
NULL	Mol_Cancer_2010_Apr_23_9_87.nxml.txt.nlp	20416058	SENT198	22	22	25	25	doxorubicin	TRAIL	PA449412	8743	0.557
NULL	Virol_J_2010_Jun_30_7_145.nxml.txt.nlp	20591155	SENT67	19	19	7	7	oseltamivir	H10	PA450721	3005	0.557
NULL	Nat_Chem_Biol_2008_Nov_12_4(11)_691-699.nxml.txt.nlp	18849971	SENT127	22	22	20	20	sorafenib	PP1	PA7000	5540;5464	0.557
NULL	J_Radiat_Res_2013_Sep_13_54(5)_789-797.nxml.txt.nlp	23764456	SENT56	12	12	7	7	l-glutamine	F10	PA10090	2159	0.557
NULL	Child_Adolesc_Psychiatry_Ment_Health_2012_May_29_6_21.nxml.txt.nlp	22643087	SENT40	0	0	8	8	risperidone	AAP	PA451257	5345	0.557
NULL	Oncol_Rep_2013_Dec_1_30(6)_2632-2638.nxml.txt.nlp	24085151	SENT127	0	0	13	13	estradiol	CYP1A2	PA449503	1544	0.557
NULL	Bone_Joint_Res_2014_Mar_1_3(3)_51-59.nxml.txt.nlp	24615710	SENT257	15	15	25	25	resveratrol	RUNX2		860	0.557
NULL	Breast_Cancer_Res_Treat_2012_Jul_24_134(1)_13-20.nxml.txt.nlp	22198412	SENT236	13	13	25	25	bevacizumab	NEU	PA130232992	2064	0.557
NULL	Diabetes_Care_2013_May_13_36(5)_1353-1360.nxml.txt.nlp	23275357	SENT202	6	6	16	16	pioglitazone	adiponectin	PA450970	9370	0.557
NULL	Biomed_Res_Int_2014_Feb_19_2014_240642.nxml.txt.nlp	24701565	SENT159	18	18	22	22	doxorubicin	AMPK	PA449412	5563	0.557
NULL	Calcif_Tissue_Int_2013_Jan_13_92(1)_59-67.nxml.txt.nlp	23150144	SENT10	0	0	7	7	risedronate	BMD	PA451255	1756;7439	0.557
NULL	J_Thromb_Haemost_2014_May_22_12(5)_748-760.nxml.txt.nlp	24612393	SENT200	8	8	13	13	thrombin	ADP	PA451674	23038	0.557
NULL	Breast_Cancer_Res_2010_Oct_22_12(Suppl_2)_S1.nxml.txt.nlp	21050422	SENT464	34	34	4	4	cetuximab	San	PA10040	80218	0.557
NULL	Asia_Pac_Allergy_2013_Oct_31_3(4)_231-240.nxml.txt.nlp	24260728	SENT34	13	13	26	26	theophylline	CYP2E1	PA451647	1571	0.557
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT68	3	3	5	5	resveratrol	SRC3		8202	0.557
NULL	Eur_J_Med_Res_2009_Dec_7_14(Suppl_4)_255-258.nxml.txt.nlp	20156767	SENT34	14	14	10	10	estradiol	adiponectin	PA449503	9370	0.557
NULL	Biologics_2009_Sep_15_3_429-441.nxml.txt.nlp	19774210	SENT24	14	14	21	21	irinotecan	IFL	PA450085	3439	0.557
NULL	Neuroimage_Clin_2013_Sep_3_3_242-248.nxml.txt.nlp	24273709	SENT294	14	14	4	4	lamotrigine	CLB	PA450164	171425	0.557
NULL	Environ_Health_Perspect_2009_Feb_8_117(2)_175-180.nxml.txt.nlp	19270784	SENT140	22	22	17	17	doxorubicin	BPA	PA449412	667	0.557
NULL	Balkan_J_Med_Genet_2011_Jun_25_14(1)_25-30.nxml.txt.nlp	24052699	SENT71	32	32	27	27	phenytoin	RLIP76	PA450947	10928	0.557
NULL	Front_Neurosci_2011_Jan_14_4_207.nxml.txt.nlp	21258618	SENT108	7	7	30	30	ethanol	AC7	PA448073	113	0.557
NULL	Br_J_Cancer_2013_Feb_5_108(2)_469-476.nxml.txt.nlp	23169292	SENT174	8	8	34	34	erlotinib	TTF2	PA134687924	8458	0.557
NULL	Br_J_Cancer_2012_Sep_25_107(7)_1059-1068.nxml.txt.nlp	22935581	SENT27	31	31	12	12	temsirolimus	IFN	PA164746890	3439	0.557
NULL	J_Int_Soc_Sports_Nutr_2012_Nov_15_9_49.nxml.txt.nlp	23153110	SENT44	32	32	9	9	l-arginine	SHOT	PA448478	6474	0.557
NULL	Case_Rep_Pathol_2013_Jul_14_2013_198643.nxml.txt.nlp	23936709	SENT73	35	35	16	16	thyroglobulin	TTF-1	PA164754910	7080	0.557
NULL	Breast_Cancer_(Dove_Med_Press)_2014_May_2_6_59-71.nxml.txt.nlp	24833917	SENT112	14	14	5	5	raloxifene	STAR	PA451221	6770;2984	0.557
NULL	Cardiovasc_Diabetol_2005_Oct_5_4_16.nxml.txt.nlp	16207378	SENT214	1	1	3	3	glucosamine	perlecan	PA164747613	3339	0.557
NULL	Behav_Brain_Funct_2014_Jun_16_10_21.nxml.txt.nlp	24934302	SENT149	0	0	22	22	rosiglitazone	IL-10	PA451283	3586	0.557
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1051.nxml.txt.nlp	24503543	SENT144	36	36	19	19	hexachlorophene	Yes	PA449871	7525	0.557
NULL	Mol_Cancer_2009_May_15_8_28.nxml.txt.nlp	19445670	SENT183	13	13	28	28	doxorubicin	XIAP	PA449412	331	0.557
NULL	Oncol_Lett_2013_Aug_14_6(2)_600-604.nxml.txt.nlp	24137378	SENT154	9	9	0	0	doxorubicin	SIRT1	PA449412	23411	0.557
NULL	Clin_Dev_Immunol_2013_Sep_30_2013_238035.nxml.txt.nlp	24194771	SENT153	19	19	21	21	cyclophosphamide	CTX	PA449165	1593	0.557
NULL	Int_J_Med_Sci_2013_Mar_19_10(5)_599-606.nxml.txt.nlp	23569422	SENT53	0	0	7	7	propofol	JNK	PA451141	5599	0.557
NULL	Arthritis_Res_Ther_2011_Feb_16_13(1)_R25.nxml.txt.nlp	21324169	SENT120	14	14	4	4	etanercept	ADA	PA449515	100	0.557
NULL	Mol_Vis_2011_Feb_1_17_323-331.nxml.txt.nlp	21293736	SENT79	15	15	25	25	urea	SDS	PA451831	51119;10993	0.557
NULL	Infect_Dis_Ther_2014_Jun_20_3(1)_1-17.nxml.txt.nlp	25134808	SENT130	44	44	3	3	tenofovir	ATV	PA10204	4683	0.557
NULL	Eur_J_Neurosci_2007_Sep_26(6)_1657-1669.nxml.txt.nlp	17880399	SENT271	9	9	0	0	haloperidol	DAO	PA449841	26;1610	0.557
NULL	Biomed_Res_Int_2013_Oct_1_2013_403151.nxml.txt.nlp	24195069	SENT144	31	31	12	12	ribavirin	Yes	PA451241	7525	0.557
NULL	F1000Prime_Rep_2014_Dec_1_6_117.nxml.txt.nlp	25580271	SENT143	14	14	5	5	bevacizumab	EGFR	PA130232992	1956	0.557
NULL	Arthritis_Res_Ther_2004_Nov_4_6(1)_R39-R45.nxml.txt.nlp	14979936	SENT131	11	11	16	16	methotrexate	IFN	PA450428	3439	0.557
NULL	Biomed_Res_Int_2013_Jul_31_2013_692071.nxml.txt.nlp	23984399	SENT4	37	37	15	15	sorafenib	OCT1	PA7000	5451;6580	0.557
NULL	Behav_Brain_Funct_2011_Sep_7_7_39.nxml.txt.nlp	21899751	SENT79	1	1	8	8	lidocaine	KCNC1	PA450226	3746	0.557
NULL	Biologics_2011_Feb_14_5_21-31.nxml.txt.nlp	21383913	SENT168	17	17	30	30	tacrolimus	CLE	PA451578	51637	0.557
NULL	Acta_Pharmacol_Sin_2014_Jun_4_35(6)_792-805.nxml.txt.nlp	24902787	SENT200	3	3	12	12	paroxetine	INS-1	PA450801	2305	0.557
NULL	J_Mol_Signal_2011_May_16_6_4.nxml.txt.nlp	21575178	SENT220	22	22	37	37	forskolin	HSP27	PA146096022	3315	0.557
NULL	Breast_Cancer_Res_2008_Feb_12_10(1)_R11.nxml.txt.nlp	18267033	SENT222	7	7	18	18	paraformaldehyde	p40	PA450790	3921;339541;10314	0.557
NULL	J_Antimicrob_Chemother_2014_Apr_2_69(4)_911-918.nxml.txt.nlp	24302651	SENT39	18	18	20	20	tetracycline	FUS	PA451640	2521	0.557
NULL	Drugs_2009_Mar_17_69(5)_549-565.nxml.txt.nlp	19368417	SENT19	5	5	14	14	formoterol	DPI	PA134687907	1832	0.557
NULL	Ann_Oncol_2010_Mar_28_21(3)_498-505.nxml.txt.nlp	19717534	SENT219	18	18	10	10	tamoxifen	ATAC	PA451581	6375	0.557
NULL	Oncotarget_2012_Nov_8_3(11)_1472-1482.nxml.txt.nlp	23178531	SENT145	5	5	11	11	glucose	FBS	PA449773	64319;26269	0.557
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT164	6	6	8	8	methotrexate	MSH2	PA450428	4436	0.557
NULL	Biomed_Res_Int_2013_Jan_8_2013_250462.nxml.txt.nlp	23484098	SENT51	21	21	35	35	hydroxyprogesterone	ACTH	PA449932	5443	0.557
NULL	J_Biol_Chem_2013_Mar_22_288(12)_8279-8288.nxml.txt.nlp	23400816	SENT236	26	26	15	15	chloroquine	PCSK9	PA448948	255738	0.557
NULL	Int_Cardiovasc_Res_J_2014_Sep_1_8(3)_89-93.nxml.txt.nlp	25177670	SENT86	4	4	9	9	amlodipine	TNF-alpha	PA448388	7124	0.557
NULL	Biol_Proced_Online_2004_Jul_1_6_144-148.nxml.txt.nlp	15243647	SENT0	21	21	29	29	imatinib	CML	PA10804	613	0.557
NULL	Clin_Med_Insights_Circ_Respir_Pulm_Med_2013_Nov_13_7_61-77.nxml.txt.nlp	24324354	SENT293	14	14	4	4	colistin	TOB	PA164760862	10140	0.557
NULL	Cancer_Cell_Int_2010_May_11_10_16.nxml.txt.nlp	20459793	SENT97	2	2	17	17	cisplatin	CDKN1A	PA449014	1026	0.557
NULL	J_Korean_Med_Sci_2014_Jul_11_29(7)_965-972.nxml.txt.nlp	25045229	SENT109	25	25	20	20	metformin	B12	PA450395	7126;4709	0.557
NULL	Indian_J_Anaesth_2014_Jul-Aug_58(4)_423-429.nxml.txt.nlp	25197110	SENT162	5	5	3	3	ondansetron	ODF	PA450705	8600	0.557
NULL	Indian_J_Med_Res_2012_Aug_136(2)_249-259.nxml.txt.nlp	22960892	SENT30	23	23	2	2	sn-38	UGT1A1		54658	0.557
NULL	Endocrinology_2011_Feb_5_152(2)_405-413.nxml.txt.nlp	21209017	SENT98	0	0	2	2	l-glutamine	GLP1	PA10090	100125288;2641	0.557
NULL	Oncotarget_2012_Oct_20_3(10)_1236-1245.nxml.txt.nlp	23100449	SENT78	10	10	4	4	doxorubicin	NGAL	PA449412	3934	0.557
NULL	Curr_Cardiol_Rev_2012_Aug_8(3)_239-249.nxml.txt.nlp	22935021	SENT9	47	47	34	34	rivaroxaban	PAR-1	PA165958360	2011;2149	0.557
NULL	Ann_Dermatol_2012_Nov_8_24(4)_482-484.nxml.txt.nlp	23197922	SENT23	3	3	12	12	imiquimod	IL-10	PA449972	3586	0.557
NULL	Hum_Mol_Genet_2014_Aug_1_23(15)_4077-4085.nxml.txt.nlp	24670599	SENT159	25	25	17	17	lipase	PNPLA3	PA450239	80339	0.557
NULL	Arch_Toxicol_2011_Nov_29_85(11)_1453-1461.nxml.txt.nlp	20878393	SENT47	24	24	41	41	l-glutamine	CO2	PA10090	4513	0.557
NULL	Alcohol_Res_Health_2007_30(1)_5-13.nxml.txt.nlp	17718394	SENT17	20	20	10	10	ethanol	CYP2E1	PA448073	1571	0.557
NULL	Biomed_Res_Int_2013_Jan_8_2013_252158.nxml.txt.nlp	23509696	SENT72	15	15	17	17	valsartan	CD34	PA451848	947	0.557
NULL	J_Viral_Hepat_2007_Nov_14(11)_751-766.nxml.txt.nlp	17927611	SENT75	21	21	7	7	lamivudine	IFN	PA450163	3439	0.557
NULL	Anesth_Essays_Res_2013_Sep-Dec_7(3)_319-325.nxml.txt.nlp	NULL	SENT31	5	5	0	0	desmopressin	AVP	PA449237	114548;551	0.557
NULL	Br_J_Cancer_1996_Oct_74(7)_1109-1113.nxml.txt.nlp	8855983	SENT15	29	29	10	10	levamisole	IL-2	PA450205	3558	0.557
NULL	Biomed_Res_Int_2013_Jun_19_2013_230805.nxml.txt.nlp	23862137	SENT164	31	31	16	16	heparin	RANKL	PA449855	8600	0.557
NULL	Cancer_Causes_Control_2013_Aug_18_24(8)_1605-1614.nxml.txt.nlp	23775025	SENT64	38	38	8	8	epirubicin	CYP2A6	PA449476	1548	0.557
NULL	Mar_Drugs_2011_Nov_2_9(11)_2188-2200.nxml.txt.nlp	22163181	SENT443	13	13	16	16	ethanol	ANOVA	PA448073	4858	0.557
NULL	Biomed_Res_Int_2014_Jun_26_2014_161346.nxml.txt.nlp	25054130	SENT232	11	11	21	21	curcumin	STZ	PA151958596	6484	0.557
NULL	Aging_(Albany_NY)_2010_Dec_29_2(12)_914-923.nxml.txt.nlp	21212461	SENT4	25	25	27	27	cyclosporine	SIRT3	PA449167	23410	0.557
NULL	JRSM_Short_Rep_2011_Feb_10_2(2)_9.nxml.txt.nlp	21369527	SENT16	26	26	36	36	cyclophosphamide	GM-CSF	PA449165	1437	0.557
NULL	BMB_Rep_2013_Jun_46(6)_295-304.nxml.txt.nlp	23790972	SENT345	20	20	16	16	amiloride	ASIC3	PA448368	9311	0.557
NULL	Breast_Cancer_Res_2005_Jul_18_7(5)_187-189.nxml.txt.nlp	16168136	SENT4	14	14	28	28	tamoxifen	HER2	PA451581	2064	0.557
NULL	Pharmaceutics_2011_Aug_24_3(3)_510-524.nxml.txt.nlp	24310594	SENT36	0	0	34	34	trastuzumab	PI3K	PA451743	5290	0.557
NULL	Oxid_Med_Cell_Longev_2012_Nov_28_2012_162934.nxml.txt.nlp	23251719	SENT179	4	4	17	17	oxygen	ROS	PA450744	6098	0.557
NULL	Amino_Acids_2012_Apr_20_42(4)_1193-1204.nxml.txt.nlp	20960212	SENT211	9	9	15	15	heparin	RAGE	PA449855	177	0.557
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Nov_18_65(Pt_12)_o3103.nxml.txt.nlp	21578830	SENT66	43	43	33	33	ethanol	mol	PA448073	90527	0.557
NULL	Front_Cell_Neurosci_2014_Jun_17_8_161.nxml.txt.nlp	24987330	SENT186	27	27	12	12	tiagabine	CA1	PA451682	759	0.557
NULL	Acta_Pharmacol_Sin_2009_Jul_22_30(7)_956-964.nxml.txt.nlp	19543298	SENT135	3	3	5	5	simvastatin	SLC22A1	PA451363	6580	0.557
NULL	Breast_Cancer_Res_2014_May_28_16(3)_R53.nxml.txt.nlp	24886537	SENT280	16	16	28	28	tamoxifen	VAV3	PA451581	10451	0.557
NULL	BMB_Rep_2013_Mar_46(3)_157-162.nxml.txt.nlp	23527859	SENT110	42	42	40	40	galactose	mol	PA449725	90527	0.557
NULL	Eur_J_Endocrinol_2012_Feb_166(2)_159-170.nxml.txt.nlp	21930715	SENT212	30	30	23	23	metformin	BID	PA450395	637	0.557
NULL	Exp_Ther_Med_2014_Sep_18_8(3)_813-817.nxml.txt.nlp	25120605	SENT67	29	29	32	32	irinotecan	AMPK	PA450085	5563	0.557
NULL	Arch_Med_Sci_2012_Nov_9_8(5)_899-906.nxml.txt.nlp	23185202	SENT147	31	31	20	20	pioglitazone	ADN	PA450970	1675	0.557
NULL	Mol_Cancer_2004_Jul_12_3_19.nxml.txt.nlp	15248896	SENT189	22	22	19	19	nadh	ND6	PA164755085	4541	0.557
NULL	ScientificWorldJournal_2013_Apr_18_2013_808460.nxml.txt.nlp	23710149	SENT130	7	7	4	4	diazepam	BOR	PA449283	55143	0.557
NULL	Ann_Dermatol_2014_Dec_26_26(6)_706-712.nxml.txt.nlp	25473222	SENT8	22	22	26	26	isotretinoin	EPO	PA450128	7076;8288;2056	0.557
NULL	Indian_J_Anaesth_2011_Nov-Dec_55(6)_567-572.nxml.txt.nlp	22223899	SENT68	17	17	26	26	atropine	NAC	PA448505	22861	0.557
NULL	Scientifica_(Cairo)_2012_Dec_16_2012_402783.nxml.txt.nlp	24278688	SENT171	27	27	18	18	thrombin	C5a	PA451674	727	0.557
NULL	Am_J_Trop_Med_Hyg_2012_Nov_7_87(5_Suppl)_21-29.nxml.txt.nlp	23136274	SENT317	2	2	15	15	artemisinin	RDT	PA165111696	6598	0.557
NULL	Int_J_Alzheimers_Dis_2011_Nov_15_2011_345614.nxml.txt.nlp	22145082	SENT4	0	0	8	8	copper	APP	PA449114	351	0.557
NULL	Indian_J_Pharmacol_2014_Jul-Aug_46(4)_372-377.nxml.txt.nlp	25097273	SENT9	23	23	18	18	chlordiazepoxide	CEA	PA448932	5670;1087	0.557
NULL	Adipocyte_2012_Jul_1_1(3)_123-131.nxml.txt.nlp	23145367	SENT58	5	5	1	1	lipase	CGI-58	PA450239	51099	0.557
NULL	Cancer_Causes_Control_2013_Aug_18_24(8)_1605-1614.nxml.txt.nlp	23775025	SENT64	38	38	4	4	epirubicin	CYP1A1	PA449476	1543	0.557
NULL	Pain_Ther_2014_Dec_29_3(2)_73-84.nxml.txt.nlp	25069571	SENT63	9	9	19	19	capsaicin	TRPV1	PA448776	7442	0.557
NULL	Ital_J_Pediatr_2009_Dec_11_35_40.nxml.txt.nlp	20003334	SENT30	5	5	11	11	methotrexate	VIII	PA450428	1351	0.557
NULL	J_Am_Heart_Assoc_2013_Apr_24_2(2)_e000131.nxml.txt.nlp	23537811	SENT88	7	7	24	24	clopidogrel	PON1	PA449053	5444	0.557
NULL	Nanoscale_Res_Lett_2014_Jul_4_9(1)_333.nxml.txt.nlp	25114633	SENT133	14	14	32	32	l-glutamine	CO2	PA10090	4513	0.557
NULL	Int_J_Endocrinol_2014_Aug_11_2014_312452.nxml.txt.nlp	25183970	SENT126	7	7	9	9	liraglutide	PI3K	PA165958364	5290	0.557
NULL	Exp_Diabetes_Res_2012_Nov_12_2012_618923.nxml.txt.nlp	23197974	SENT183	27	27	17	17	telmisartan	STZ	PA451605	6484	0.557
NULL	Breast_Cancer_Res_2012_Mar_7_14(2)_R39.nxml.txt.nlp	22397502	SENT183	3	3	16	16	fluorescein	IFN	PA164746009	3439	0.557
NULL	Cell_Commun_Signal_2012_Jan_24_10_1.nxml.txt.nlp	22273506	SENT104	15	15	39	39	curcumin	PARP-1	PA151958596	25976	0.557
NULL	Evid_Based_Complement_Alternat_Med_2012_May_7_2012_242810.nxml.txt.nlp	22645625	SENT208	22	22	19	19	rifampin	HNF4	PA451250	3172	0.557
NULL	Endocrinology_2012_Jan_15_153(1)_200-211.nxml.txt.nlp	22087024	SENT141	15	15	23	23	methylprednisolone	ANOVA	PA450466	4858	0.557
NULL	J_Int_AIDS_Soc_2012_Jan_30_15_5.nxml.txt.nlp	22289654	SENT12	27	27	15	15	zidovudine	CD4	PA451954	920	0.557
NULL	Front_Synaptic_Neurosci_2014_Sep_5_6_18.nxml.txt.nlp	25249974	SENT214	3	3	6	6	morphine	CA3	PA450550	761	0.557
NULL	Ther_Clin_Risk_Manag_2006_Sep_2(3)_271-279.nxml.txt.nlp	18360602	SENT63	0	0	33	33	bortezomib	San	PA10252	80218	0.557
NULL	Clin_Mol_Allergy_2010_Feb_16_8_2.nxml.txt.nlp	20158902	SENT219	16	16	11	11	amoxicillin	CD203c	PA448406	5169	0.557
NULL	J_Radiat_Res_2014_Nov_16_55(6)_1171-1177.nxml.txt.nlp	25129557	SENT46	8	8	6	6	capecitabine	CRT	PA448771	811	0.556
NULL	Case_Rep_Dermatol_2013_Mar_20_5(1)_79-83.nxml.txt.nlp	23626544	SENT50	16	16	19	19	tacrolimus	CD163	PA451578	9332	0.556
NULL	Oncogene_2010_Sep_2_29(35)_4925-4937.nxml.txt.nlp	20562914	SENT293	16	16	5	5	collagenase	AP-1	PA449107	2353;3727;2354;3725	0.556
NULL	Reprod_Biol_Endocrinol_2003_Aug_27_1_59.nxml.txt.nlp	12967350	SENT138	7	7	12	12	estradiol	XIAP	PA449503	331	0.556
NULL	J_Ophthalmic_Inflamm_Infect_2013_Feb_11_3_34.nxml.txt.nlp	23514634	SENT71	0	0	5	5	fluorescein	hole	PA164746009	80757	0.556
NULL	Diabetes_Care_2009_Nov_32(Suppl_2)_S223-S231.nxml.txt.nlp	19875556	SENT240	31	31	28	28	liraglutide	GLP-1	PA165958364	100125288	0.556
NULL	Br_J_Cancer_2010_Jan_5_102(1)_80-86.nxml.txt.nlp	19920817	SENT40	28	28	30	30	bevacizumab	IFN	PA130232992	3439	0.556
NULL	Cancers_(Basel)_2011_Mar_4_3(1)_1111-1128.nxml.txt.nlp	24212655	SENT1012	1	1	7	7	berberine	ABCG2	PA165860812	9429	0.556
NULL	Biomed_Res_Int_2013_Dec_5_2013_984523.nxml.txt.nlp	23509827	SENT215	36	36	14	14	oxygen	HIF-1	PA450744	29072	0.556
NULL	Genome_Biol_2003_Jan_6_4(1)_R5.nxml.txt.nlp	12540297	SENT138	42	42	29	29	creatine	14-3-3	PA164778930	10971	0.556
NULL	Biomed_Res_Int_2013_Aug_6_2013_602987.nxml.txt.nlp	24027759	SENT274	38	38	36	36	paclitaxel	SMF	PA450761	22993	0.556
NULL	J_Korean_Med_Sci_2013_Jul_3_28(7)_1111-1113.nxml.txt.nlp	23853500	SENT78	2	2	4	4	vasopressin	AVP	PA451858	114548;551	0.556
NULL	J_Cell_Biol_2003_Dec_22_163(6)_1385-1395.nxml.txt.nlp	14676308	SENT226	0	0	3	3	thrombin	Rho	PA451674	29984	0.556
NULL	Oncogenesis_2012_Apr_2_1(4)_e5.nxml.txt.nlp	23552603	SENT514	8	8	3	3	ns-398	p65		5970	0.556
NULL	Br_J_Cancer_2009_Jul_21_101(2)_269-277.nxml.txt.nlp	19603033	SENT106	3	3	0	0	cisplatin	MLH1	PA449014	4292	0.556
NULL	Clinics_(Sao_Paulo)_2010_Nov_65(11)_1175-1181.nxml.txt.nlp	21243293	SENT130	26	26	12	12	methimazole	NO3	PA450422	4681	0.556
NULL	Front_Cell_Neurosci_2014_Jan_29_8_11.nxml.txt.nlp	24523671	SENT177	9	9	26	26	ethanol	GluA3	PA448073	2892	0.556
NULL	Diabetologia_2010_Oct_26_53(10)_2209-2219.nxml.txt.nlp	20582536	SENT53	20	20	48	48	l-glutamine	CO2	PA10090	4513	0.556
NULL	Br_J_Haematol_2008_Jun_141(5)_659-671.nxml.txt.nlp	18410446	SENT161	8	8	18	18	cerulenin	JNK	PA164764551	5599	0.556
NULL	J_Lipids_2011_Aug_1_2011_702853.nxml.txt.nlp	21837278	SENT146	20	20	16	16	choline	PEMT	PA448976	10400	0.556
NULL	Oxid_Med_Cell_Longev_2012_May_28_2012_386527.nxml.txt.nlp	22690271	SENT79	2	2	23	23	curcumin	STAT3	PA151958596	6774	0.556
NULL	Cancer_Med_2013_Apr_24_2(2)_185-195.nxml.txt.nlp	23634286	SENT317	8	8	0	0	temozolomide	MRI	PA451609	78996	0.556
NULL	Mol_Cancer_2008_Oct_23_7_82.nxml.txt.nlp	18947424	SENT337	4	4	7	7	procainamide	DNMT1	PA451108	1786	0.556
NULL	Cancer_Manag_Res_2014_May_23_6_225-252.nxml.txt.nlp	24904222	SENT487	3	3	5	5	diethylstilbestrol	DES	PA449307	1674	0.556
NULL	Neuropsychopharmacology_2009_Jul_11_34(8)_1946-1957.nxml.txt.nlp	19279569	SENT30	12	12	8	8	cocaine	DOR	PA449072	58476	0.556
NULL	Eur_J_Neurosci_2007_Sep_26(6)_1657-1669.nxml.txt.nlp	17880399	SENT444	6	6	12	12	imipramine	5-HT1A	PA449969	3350	0.556
NULL	J_Obes_2010_Oct_31_2010_892081.nxml.txt.nlp	21052532	SENT6	12	12	7	7	glucose	adiponectin	PA449773	9370	0.556
NULL	Int_J_Mol_Sci_2014_Nov_25_15(12)_21703-21722.nxml.txt.nlp	25429431	SENT144	0	0	29	29	curcumin	P-gp	PA151958596	5243	0.556
NULL	Breast_Cancer_Res_2011_Nov_23_13(6)_R116.nxml.txt.nlp	22113133	SENT327	16	16	12	12	diethylstilbestrol	DES	PA449307	1674	0.556
NULL	Cell_Death_Dis_2014_Jan_16_5(1)_e1000.nxml.txt.nlp	24434508	SENT86	2	2	6	6	bortezomib	p53	PA10252	7157	0.556
NULL	J_Cell_Biol_2000_Jul_24_150(2)_335-348.nxml.txt.nlp	10908576	SENT893	40	40	20	20	nitroprusside	c-Jun	PA451406	3725	0.556
NULL	Oncol_Lett_2014_Nov_14_8(5)_2086-2092.nxml.txt.nlp	25295095	SENT146	9	9	7	7	gemcitabine	LKB1	PA449748	6794	0.556
NULL	Ann_Indian_Acad_Neurol_2010_Jul-Sep_13(3)_211-212.nxml.txt.nlp	21085535	SENT57	18	18	20	20	rituximab	ACTH	PA451261	5443	0.556
NULL	Evid_Based_Complement_Alternat_Med_2011_Aug_11_2011_237941.nxml.txt.nlp	19887507	SENT173	21	21	11	11	ethanol	STZ	PA448073	6484	0.556
NULL	Allergy_Asthma_Clin_Immunol_2008_Sep_15_4(3)_95-105.nxml.txt.nlp	20525130	SENT200	12	12	28	28	fluorescein	CD40	PA164746009	958	0.556
NULL	Indian_J_Ophthalmol_2011_Jul-Aug_59(4)_335-336.nxml.txt.nlp	21666334	SENT28	7	7	11	11	triamcinolone	hole	PA451749	80757	0.556
NULL	EJC_Suppl_2013_Sep_5_11(2)_45-59.nxml.txt.nlp	NULL	SENT198	18	18	21	21	irinotecan	CRT	PA450085	811	0.556
NULL	Front_Cell_Neurosci_2013_Aug_12_7_125.nxml.txt.nlp	23964200	SENT59	9	9	18	18	halothane	E14	PA449845	4863	0.556
NULL	Front_Endocrinol_(Lausanne)_2015_Jan_9_5_235.nxml.txt.nlp	25620956	SENT140	17	17	29	29	glucosamine	c-Rel	PA164747613	5966	0.556
NULL	Clin_Dev_Immunol_2013_Sep_22_2013_317682.nxml.txt.nlp	24171032	SENT160	8	8	19	19	hyaluronan	IL-6	PA165958431	3569	0.556
NULL	Clin_Ophthalmol_2010_Nov_3_4_1253-1261.nxml.txt.nlp	21151330	SENT58	9	9	13	13	latanoprost	BAK	PA164774763	578	0.556
NULL	J_Gen_Physiol_1970_Nov_1_56(5)_583-620.nxml.txt.nlp	5475997	SENT4	11	11	18	18	creatine	ADP	PA164778930	23038	0.556
NULL	Ther_Clin_Risk_Manag_2006_Sep_2(3)_235-249.nxml.txt.nlp	18360599	SENT303	3	3	8	8	alendronate	PTH	PA448082	5741	0.556
NULL	Curr_Mol_Med_2013_Mar_13(3)_446-458.nxml.txt.nlp	23331017	SENT67	16	16	23	23	ethanol	IL-11	PA448073	3589	0.556
NULL	J_Ginseng_Res_2011_Nov_35(4)_436-441.nxml.txt.nlp	23717089	SENT141	3	3	7	7	ginseng	CAGC	PA164781150	6283	0.556
NULL	Calcif_Tissue_Int_2013_Sep_11_93(6)_526-539.nxml.txt.nlp	24022329	SENT100	31	31	39	39	l-glutamine	M-CSF	PA10090	1435	0.556
NULL	Nat_Commun_2014_Nov_19_5_5479.nxml.txt.nlp	25407222	SENT503	15	15	25	25	dextran	YTS	PA449261	8565	0.556
NULL	Oncotarget_2012_May_4_3(4)_395-398.nxml.txt.nlp	22565037	SENT6	0	0	12	12	metformin	CD44	PA450395	960	0.556
NULL	F1000_Med_Rep_2009_May_28_1_41.nxml.txt.nlp	20052398	SENT25	8	8	6	6	ribavirin	IFN	PA451241	3439	0.556
NULL	Comput_Struct_Biotechnol_J_2013_Jan_18_3_e201210019.nxml.txt.nlp	24688679	SENT50	33	33	36	36	nadh	CO2	PA164755085	4513	0.556
NULL	Nat_Commun_2012_Jun_12_3_902.nxml.txt.nlp	22692545	SENT59	45	45	47	47	lipase	ATGL	PA450239	57104	0.556
NULL	Breast_Cancer_Res_2014_Nov_11_16(6)_463.nxml.txt.nlp	25385439	SENT383	17	17	8	8	tamoxifen	p53	PA451581	7157	0.556
NULL	Cell_Res_2012_Aug_22_22(8)_1227-1245.nxml.txt.nlp	22613949	SENT397	9	9	25	25	bortezomib	KRAS	PA10252	3845	0.556
NULL	BMB_Rep_2014_Apr_47(4)_233-238.nxml.txt.nlp	24286314	SENT168	10	10	20	20	paraformaldehyde	nPTB	PA450790	58155	0.556
NULL	Acta_Vet_Scand_2014_Aug_14_56(1)_49.nxml.txt.nlp	25124268	SENT109	26	26	12	12	salbutamol	IBP	PA448068	706;50619	0.556
NULL	Cell_Cycle_2012_Nov_1_11(21)_3983-3996.nxml.txt.nlp	22987153	SENT204	18	18	29	29	mitomycin	DNA-PKcs	PA450524	5591	0.556
NULL	J_Cell_Biol_2003_Dec_8_163(5)_1099-1109.nxml.txt.nlp	14662748	SENT17	8	8	10	10	vasopressin	AVP	PA451858	114548;551	0.556
NULL	Contemp_Oncol_(Pozn)_2012_Feb_29_16(1)_86-89.nxml.txt.nlp	23788860	SENT27	6	6	8	8	cisplatin	DDP	PA449014	1678	0.556
NULL	Clin_Transl_Allergy_2013_Sep_2_3_29.nxml.txt.nlp	24004581	SENT192	2	2	12	12	omalizumab	IL-8	PA164752253	3576	0.556
NULL	Acta_Pharmacol_Sin_2010_Jun_4_31(6)_649-664.nxml.txt.nlp	20523337	SENT204	3	3	9	9	curcumin	HO-1	PA151958596	3162	0.556
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT93	27	27	5	5	metformin	HIP	PA450395	6767;6159;64399;5068	0.556
NULL	Ann_Hematol_2013_Apr_15_92(4)_433-442.nxml.txt.nlp	23412562	SENT238	10	10	12	12	rituximab	CHOP	PA451261	1649	0.556
NULL	Oncol_Lett_2013_Mar_14_5(3)_756-760.nxml.txt.nlp	23426872	SENT141	2	2	4	4	cisplatin	NAC	PA449014	22861	0.556
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT29	20	20	24	24	imatinib	CML	PA10804	613	0.556
NULL	Case_Rep_Surg_2012_Sep_17_2012_230538.nxml.txt.nlp	23024879	SENT30	17	17	25	25	cyclophosphamide	CHOP	PA449165	1649	0.556
NULL	Int_J_Med_Sci_2012_Jun_8_9(4)_311-315.nxml.txt.nlp	22701339	SENT76	23	23	4	4	remifentanil	DAP	PA451232	23549;3375;1611	0.556
NULL	Crit_Care_2007_Aug_14_11(4)_R87.nxml.txt.nlp	17697359	SENT175	20	20	9	9	dextran	IL-10	PA449261	3586	0.556
NULL	Anat_Cell_Biol_2012_Jun_30_45(2)_114-120.nxml.txt.nlp	22822466	SENT131	3	3	18	18	vasopressin	SON	PA451858	6651	0.556
NULL	J_Hematol_Oncol_2013_Jun_24_6_42.nxml.txt.nlp	23800319	SENT92	8	8	4	4	heparin	NAP-2	PA449855	5473	0.556
NULL	Diabetes_2011_Nov_17_60(11)_2928-2938.nxml.txt.nlp	21885868	SENT312	7	7	14	14	curcumin	IL-8	PA151958596	3576	0.556
NULL	Oncotarget_2013_Dec_2_4(12)_2523-2531.nxml.txt.nlp	24344114	SENT44	22	22	9	9	trypsin	RP53	PA451806	145226	0.556
NULL	Cell_Cycle_2013_Sep_1_12(17)_2899-2913.nxml.txt.nlp	23966157	SENT17	14	14	5	5	collagenase	CD147	PA449107	682	0.556
NULL	Mol_Cancer_2007_Oct_25_6_67.nxml.txt.nlp	17958915	SENT307	13	13	10	10	imatinib	GM-CSF	PA10804	1437	0.556
NULL	Comp_Hepatol_2004_Jan_14_3(Suppl_1)_S31.nxml.txt.nlp	14960183	SENT71	4	4	11	11	ethanol	TNF-alpha	PA448073	7124	0.556
NULL	Open_Cardiovasc_Med_J_2010_Nov_26_4_240-256.nxml.txt.nlp	21270942	SENT116	24	24	36	36	l-arginine	EDRF	PA448478	51327	0.556
NULL	Br_J_Cancer_2013_Oct_15_109(8)_2096-2105.nxml.txt.nlp	24064970	SENT143	19	19	21	21	erlotinib	ERCC1	PA134687924	2067	0.556
NULL	Acta_Pharmacol_Sin_2009_Jul_22_30(7)_956-964.nxml.txt.nlp	19543298	SENT232	11	11	16	16	atorvastatin	ANOVA	PA448500	4858	0.556
NULL	Acta_Pharmacol_Sin_2012_Dec_17_33(12)_1441-1458.nxml.txt.nlp	22983389	SENT368	0	0	26	26	perifosine	JNK	PA165291471	5599	0.556
NULL	Oncotarget_2012_May_18_3(5)_525-534.nxml.txt.nlp	22619113	SENT122	10	10	8	8	fludarabine	CD40L	PA449655	959	0.556
NULL	Pharmaceuticals_(Basel)_2014_Mar_5_7(3)_311-338.nxml.txt.nlp	24603603	SENT295	16	16	29	29	cisplatin	p53	PA449014	7157	0.556
NULL	Exp_Transl_Stroke_Med_2012_Oct_2_4_20.nxml.txt.nlp	23031714	SENT83	8	8	24	24	ketamine	CO2	PA450144	4513	0.556
NULL	Behav_Brain_Funct_2012_Jun_20_8_32.nxml.txt.nlp	22716128	SENT262	5	5	7	7	ethanol	spatial	PA448073	219793	0.556
NULL	Orphanet_J_Rare_Dis_2014_May_21_9_78.nxml.txt.nlp	24885036	SENT57	16	16	0	0	resveratrol	SOD1		6647	0.556
NULL	Cardiovasc_Diabetol_2013_Oct_17_12_150.nxml.txt.nlp	24134550	SENT148	15	15	11	11	metformin	activin	PA450395	83729	0.556
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT213	9	9	12	12	sitagliptin	HIP	PA164748978	6767;6159;64399;5068	0.556
NULL	Br_J_Ophthalmol_2008_Sep_22_92(9)_1275-1282.nxml.txt.nlp	18723745	SENT152	15	15	22	22	tafluprost	BAK	PA165958432	578	0.556
NULL	J_Radiat_Res_2012_Jul_12_53(4)_551-557.nxml.txt.nlp	22843620	SENT95	18	18	14	14	lindane	CBX	PA164754914	10951	0.556
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT75	7	7	26	26	curcumin	PC-3	PA151958596	692094	0.556
NULL	Int_J_Mol_Sci_2014_Jun_18_15(6)_11013-11029.nxml.txt.nlp	24945311	SENT41	7	7	9	9	celecoxib	STAT3	PA448871	6774	0.556
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1063.nxml.txt.nlp	24556678	SENT207	19	19	10	10	thioridazine	TRAIL	PA451666	8743	0.556
NULL	Comp_Hepatol_2005_Feb_8_4_2.nxml.txt.nlp	15701172	SENT104	37	37	16	16	coumarin	CYP3A4	PA134521193	1576	0.556
NULL	Oxid_Med_Cell_Longev_2013_Apr_24_2013_168039.nxml.txt.nlp	23738033	SENT195	8	8	4	4	oxycodone	NNT	PA450741	23530	0.556
NULL	Mol_Biol_Cell_2013_Sep_15_24(18)_2849-2860.nxml.txt.nlp	23885123	SENT178	3	3	9	9	dextran	JAM-A	PA449261	50848	0.556
NULL	Acta_Pharmacol_Sin_2011_Jan_6_32(1)_133-138.nxml.txt.nlp	21131997	SENT50	8	8	14	14	heparin	HSI	PA449855	57016	0.556
NULL	Acta_Pharmacol_Sin_2011_Jan_6_32(1)_133-138.nxml.txt.nlp	21131997	SENT50	8	8	18	18	heparin	ACT	PA449855	12;11332;9457;641455	0.556
NULL	Endocrinol_Metab_(Seoul)_2014_Sep_25_29(3)_379-387.nxml.txt.nlp	25309798	SENT113	25	25	15	15	resveratrol	SIRT1		23411	0.556
NULL	Adv_Ther_2013_Nov_28_30(12)_1067-1085.nxml.txt.nlp	24287690	SENT107	12	12	7	7	rifampin	CYP3A4	PA451250	1576	0.556
NULL	Adipocyte_2012_Jul_1_1(3)_142-183.nxml.txt.nlp	23700523	SENT90	14	14	27	27	lipase	aP2	PA450239	2167	0.556
NULL	Indian_J_Endocrinol_Metab_2012_Dec_16(Suppl_2)_S498-S500.nxml.txt.nlp	23565478	SENT29	15	15	21	21	rosuvastatin	Q10	PA134308647	27161	0.556
NULL	Oncol_Rep_2014_Sep_20_32(3)_875-886.nxml.txt.nlp	24969320	SENT90	10	10	16	16	bevacizumab	IFN	PA130232992	3439	0.556
NULL	Can_J_Infect_Dis_Med_Microbiol_2014_May-Jun_25(3)_163-169.nxml.txt.nlp	25285114	SENT221	1	1	26	26	amikacin	TOB	PA164744372	10140	0.556
NULL	Breast_Cancer_Res_Treat_2013_Aug_20_141(1)_43-53.nxml.txt.nlp	23959396	SENT187	20	20	14	14	trastuzumab	HER2	PA451743	2064	0.556
NULL	Front_Neurosci_2013_Dec_24_7_254.nxml.txt.nlp	24399926	SENT167	8	8	0	0	diazepam	ANOVA	PA449283	4858	0.556
NULL	Cell_J_2012_Dec_22_Winter_13(4)_281-289.nxml.txt.nlp	23507624	SENT58	11	11	34	34	isoproterenol	IL-4	PA450121	3565	0.556
NULL	Clin_Exp_Reprod_Med_2011_Jun_30_38(2)_98-102.nxml.txt.nlp	22384426	SENT112	0	0	15	15	pioglitazone	IL-6	PA450970	3569	0.556
NULL	Mol_Biol_Cell_2014_Jun_1_25(11)_1782-1792.nxml.txt.nlp	24719457	SENT242	16	16	11	11	nicotine	BDNF	PA450626	627	0.556
NULL	EMBO_Mol_Med_2011_May_3(5)_266-278.nxml.txt.nlp	21438154	SENT25	3	3	10	10	oxaliplatin	TRPM8	PA131285527	79054	0.556
NULL	Cancer_Cell_Int_2005_Aug_23_5_27.nxml.txt.nlp	16117829	SENT157	8	8	15	15	doxycycline	p53	PA449415	7157	0.556
NULL	Lancet_2011_Aug_13_378(9791)_595-605.nxml.txt.nlp	21784508	SENT286	19	19	6	6	lisinopril	Yes	PA450242	7525	0.556
NULL	Front_Hum_Neurosci_2011_Nov_4_5_127.nxml.txt.nlp	22069385	SENT197	15	15	17	17	chlorpromazine	CPZ	PA448964	8532	0.556
NULL	Mol_Cancer_2010_Aug_10_9_213.nxml.txt.nlp	20698951	SENT158	11	11	7	7	zinc	L3MBTL4	PA451956	91133	0.556
NULL	Oxid_Med_Cell_Longev_2012_Apr_22_2012_479348.nxml.txt.nlp	22577490	SENT142	17	17	10	10	ethanol	IL-6	PA448073	3569	0.556
NULL	Biosci_Rep_2013_Aug_2_33(4)_e00055.nxml.txt.nlp	23802190	SENT29	24	24	29	29	nebivolol	p67phox	PA151958426	4688	0.556
NULL	Front_Aging_Neurosci_2010_Mar_30_2_12.nxml.txt.nlp	20552050	SENT1109	0	0	8	8	nimodipine	CA1	PA450633	759	0.556
NULL	Int_J_Med_Sci_2012_Dec_22_10(1)_79-89.nxml.txt.nlp	23289009	SENT88	20	20	36	36	fluorescein	CD4	PA164746009	920	0.556
NULL	Cancer_Cell_Int_2010_Nov_2_10_44.nxml.txt.nlp	21044305	SENT69	12	12	20	20	methotrexate	CO2	PA450428	4513	0.556
NULL	Osong_Public_Health_Res_Perspect_2013_Dec_12_4(6)_316-322.nxml.txt.nlp	24524020	SENT206	22	22	20	20	cefotaxime	CTX	PA448852	1593	0.556
NULL	Environ_Health_Perspect_2004_Nov_28_112(15)_1512-1518.nxml.txt.nlp	15531436	SENT143	10	10	22	22	coumarin	NAG	PA134521193	51594;4669	0.556
NULL	Eur_J_Clin_Microbiol_Infect_Dis_2010_May_13_29(5)_543-550.nxml.txt.nlp	20229224	SENT73	33	33	7	7	linezolid	PEN	PA450233	9933	0.556
NULL	Orphanet_J_Rare_Dis_2012_Apr_23_7_22.nxml.txt.nlp	22524701	SENT37	6	6	4	4	laronidase	IDUA	PA164776670	3425	0.556
NULL	J_Ophthalmic_Inflamm_Infect_2011_Sep_20_1(4)_147-155.nxml.txt.nlp	21932014	SENT20	0	0	8	8	amfenac	COX	PA166049186	1351	0.556
NULL	Acta_Pharmacol_Sin_2009_Nov_12_30(11)_1566-1572.nxml.txt.nlp	19820718	SENT3	9	9	26	26	omeprazole	P-gp	PA450704	5243	0.556
NULL	Clin_Ophthalmol_2010_Oct_28_4_1249-1252.nxml.txt.nlp	21151329	SENT63	5	5	27	27	ranibizumab	PED	PA164746012	8682	0.556
NULL	Chemother_Res_Pract_2011_Sep_25_2011_730360.nxml.txt.nlp	22295205	SENT236	32	32	30	30	trastuzumab	DM1	PA451743	338023;1760;28509	0.556
NULL	Pharmaceutics_2013_Dec_19_6(1)_1-25.nxml.txt.nlp	24662363	SENT253	22	22	5	5	calcein	DC8	PA132595336	25936	0.556
NULL	Front_Behav_Neurosci_2012_Nov_22_6_78.nxml.txt.nlp	23189046	SENT143	3	3	0	0	ethanol	OX1R	PA448073	3061	0.556
NULL	Acta_Pharmacol_Sin_2009_Feb_26_30(2)_219-227.nxml.txt.nlp	19169271	SENT171	9	9	15	15	atropine	CTX	PA448505	1593	0.556
NULL	Exp_Ther_Med_2014_Jun_31_7(6)_1647-1652.nxml.txt.nlp	24926360	SENT167	31	31	5	5	fluvastatin	MCP-1	PA449688	6347	0.556
NULL	Int_J_Med_Sci_2012_Oct_23_9(9)_748-756.nxml.txt.nlp	23136537	SENT15	18	18	13	13	cisplatin	CRT	PA449014	811	0.556
NULL	Evid_Based_Complement_Alternat_Med_2014_May_8_2014_404505.nxml.txt.nlp	24899908	SENT53	4	4	10	10	warfarin	CYP2C9	PA451906	1559	0.556
NULL	Reprod_Biol_Endocrinol_2013_May_10_11_36.nxml.txt.nlp	23663257	SENT62	10	10	6	6	estradiol	ghrelin	PA449503	51738	0.556
NULL	Pain_Res_Treat_2012_Apr_23_2012_295926.nxml.txt.nlp	22577544	SENT26	22	22	25	25	dicyclomine	DLD	PA164744928	1738	0.556
NULL	Protein_Cell_2014_Jun_19_5(6)_469-479.nxml.txt.nlp	24748116	SENT165	9	9	7	7	paclitaxel	EB1	PA450761	9167;22919;10982	0.556
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT140	28	28	17	17	vinorelbine	ASC	PA451881	29108	0.556
NULL	Br_J_Ophthalmol_2008_Sep_22_92(9)_1275-1282.nxml.txt.nlp	18723745	SENT138	2	2	9	9	latanoprost	BAK	PA164774763	578	0.556
NULL	Hum_Genomics_2013_Apr_5_7(1)_10.nxml.txt.nlp	23561625	SENT175	6	6	17	17	flavopiridol	CDK7	PA452627	1022	0.556
NULL	Oncotarget_2012_Sep_3_3(9)_921-939.nxml.txt.nlp	22948112	SENT26	0	0	25	25	heparin	VEGFR2	PA449855	3791	0.556
NULL	Br_J_Cancer_2010_Jan_5_102(1)_80-86.nxml.txt.nlp	19920817	SENT111	10	10	12	12	bevacizumab	IFN	PA130232992	3439	0.556
NULL	Br_J_Haematol_2014_Mar_13_164(1)_811-821.nxml.txt.nlp	24328678	SENT10	20	20	22	22	lenalidomide	Aiolos	PA162363968	22806	0.556
NULL	Osteopath_Med_Prim_Care_2009_Jul_2_3_5.nxml.txt.nlp	19573240	SENT136	17	17	12	12	protamine	PPG	PA10366	5552	0.556
NULL	Orphanet_J_Rare_Dis_2013_Sep_22_8_147.nxml.txt.nlp	24053568	SENT22	38	38	21	21	heparin	IDUA	PA449855	3425	0.556
NULL	Ann_Gastroenterol_2014_27(4)_320-330.nxml.txt.nlp	25331917	SENT45	7	7	17	17	infliximab	TNF	PA452639	7124	0.556
NULL	Br_J_Pharmacol_2012_Aug_166(8)_2263-2276.nxml.txt.nlp	22471905	SENT53	10	10	26	26	choline	CDP	PA448976	1523	0.556
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT214	0	0	5	5	nutlin-3	DR4		8797	0.556
NULL	Oncogene_2013_Oct_24_32(43)_5176-5185.nxml.txt.nlp	23208500	SENT189	14	14	2	2	camptothecin	p53	PA153590860	7157	0.556
NULL	Iran_J_Reprod_Med_2013_Jul_11(7)_565-576.nxml.txt.nlp	24639792	SENT16	13	13	21	21	berberine	SP-D	PA165860812	6441	0.556
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT228	7	7	5	5	cisplatin	IBP	PA449014	706;50619	0.556
NULL	Mar_Drugs_2014_Oct_23_12(10)_5295-5315.nxml.txt.nlp	25342459	SENT727	0	0	8	8	doxorubicin	p38	PA449412	10598;1432;7965	0.556
NULL	Br_J_Cancer_2010_Jan_5_102(1)_80-86.nxml.txt.nlp	19920817	SENT97	31	31	33	33	bevacizumab	IFN	PA130232992	3439	0.556
NULL	Emerg_Infect_Dis_2014_May_20(5)_910-911.nxml.txt.nlp	24751334	SENT31	45	45	14	14	tetracycline	COT	PA451640	54677	0.556
NULL	Breast_Cancer_Res_Treat_2012_Jun_18_133(3)_937-947.nxml.txt.nlp	22094936	SENT208	22	22	16	16	tamoxifen	EZH2	PA451581	2146	0.556
NULL	Exp_Mol_Med_2012_Sep_30_44(9)_562-570.nxml.txt.nlp	22809900	SENT73	9	9	11	11	rosiglitazone	adiponectin	PA451283	9370	0.556
NULL	Mol_Cancer_2012_Jul_25_11_47.nxml.txt.nlp	22830443	SENT145	29	29	40	40	panitumumab	EGFR	PA162373091	1956	0.556
NULL	Cell_Cycle_2013_May_15_12(10)_1492-1500.nxml.txt.nlp	23598717	SENT98	12	12	6	6	doxorubicin	ROCK1	PA449412	6093	0.556
NULL	Ann_Hematol_2014_Mar_18_93(8)_1335-1344.nxml.txt.nlp	24638841	SENT22	4	4	6	6	chlorambucil	CLB	PA448926	171425	0.556
NULL	Cancer_Cell_Int_2013_Apr_30_13_38.nxml.txt.nlp	23631593	SENT30	16	16	7	7	heparin	EGF	PA449855	1950	0.556
NULL	Open_Cardiovasc_Med_J_2007_Nov_14_1_22-26.nxml.txt.nlp	18949087	SENT70	0	0	12	12	eprosartan	PON1	PA449481	5444	0.555
NULL	Eur_J_Med_Res_2010_Oct_25_15(10)_422-427.nxml.txt.nlp	21156401	SENT41	26	26	34	34	vincristine	IFN	PA451879	3439	0.555
NULL	Infect_Drug_Resist_2014_Dec_12_7_343-363.nxml.txt.nlp	25548523	SENT115	12	12	9	9	heparin	NAC	PA449855	22861	0.555
NULL	Diabetes_Care_2010_Jul_31_33(7)_1544-1548.nxml.txt.nlp	20357370	SENT95	11	11	20	20	metformin	AMPK	PA450395	5563	0.555
NULL	Front_Hum_Neurosci_2013_Mar_26_7_97.nxml.txt.nlp	23532379	SENT148	20	20	15	15	choline	B12	PA448976	7126;4709	0.555
NULL	Part_Fibre_Toxicol_2011_Aug_2_8_23.nxml.txt.nlp	21810225	SENT329	23	23	27	27	streptomycin	CO2	PA451512	4513	0.555
NULL	Oncol_Lett_2013_Jul_24_6(1)_169-174.nxml.txt.nlp	23946798	SENT232	2	2	4	4	deferoxamine	HIF-1	PA164746490	29072	0.555
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_127043.nxml.txt.nlp	23227093	SENT231	15	15	21	21	sulfaphenazole	CYP2D6	PA130231310	1565	0.555
NULL	Brain_Sci_2013_Jun_14_3(2)_941-963.nxml.txt.nlp	24961432	SENT237	23	23	29	29	ethanol	AP-1	PA448073	2353;3727;2354;3725	0.555
NULL	Oncol_Lett_2014_Mar_19_7(3)_674-678.nxml.txt.nlp	24527071	SENT152	11	11	0	0	cisplatin	AKR1C2	PA449014	1646	0.555
NULL	Int_J_Inflam_2011_Sep_20_2011_367284.nxml.txt.nlp	21941675	SENT383	23	23	33	33	enoxaparin	IL-6	PA449463	3569	0.555
NULL	Arthritis_Res_Ther_2010_Apr_29_12(2)_R73.nxml.txt.nlp	20429888	SENT161	4	4	12	12	bortezomib	SP1	PA10252	6667	0.555
NULL	J_Brachial_Plex_Peripher_Nerve_Inj_2008_Oct_25_3_22.nxml.txt.nlp	18950516	SENT76	6	6	0	0	bupivacaine	SGB	PA135057240	2719	0.555
NULL	Neuropsychopharmacology_2009_Apr_2_34(5)_1135-1148.nxml.txt.nlp	18596687	SENT15	34	34	21	21	cocaine	CRF	PA449072	1392;10882	0.555
NULL	Case_Rep_Ophthalmol_2010_Aug_18_1(1)_36-41.nxml.txt.nlp	21369348	SENT35	21	21	16	16	bevacizumab	hole	PA130232992	80757	0.555
NULL	Mol_Neurodegener_2011_Jun_8_6_41.nxml.txt.nlp	21651786	SENT267	31	31	26	26	l-glutamine	B27	PA10090	56246	0.555
NULL	Vet_Res_2013_Oct_2_44(1)_89.nxml.txt.nlp	24088531	SENT114	25	25	31	31	hemin	HO-1	PA449849	3162	0.555
NULL	Iran_J_Reprod_Med_2014_Apr_12(4)_257-262.nxml.txt.nlp	24976820	SENT31	29	29	34	34	protamine	TNP1	PA10366	7141	0.555
NULL	J_Invest_Dermatol_2013_Jul_13_133(7)_1742-1751.nxml.txt.nlp	23407402	SENT146	26	26	3	3	ustekinumab	TREM-1	PA166048654	54210	0.555
NULL	J_Immunother_Cancer_2014_Jan_27_2_2.nxml.txt.nlp	24829759	SENT12	15	15	13	13	sorafenib	IL-21	PA7000	59067;50616;27189	0.555
NULL	J_Clin_Biochem_Nutr_2010_Jan_29_46(1)_36-42.nxml.txt.nlp	20104263	SENT60	12	12	8	8	ribavirin	IFN	PA451241	3439	0.555
NULL	Acta_Diabetol_2012_Aug_11_49(4)_277-289.nxml.txt.nlp	21833779	SENT116	33	33	29	29	carbachol	ANOVA	PA448784	4858	0.555
NULL	J_Ginseng_Res_2011_Nov_35(4)_436-441.nxml.txt.nlp	23717089	SENT106	10	10	7	7	ginseng	CAGC	PA164781150	6283	0.555
NULL	Afr_J_Infect_Dis_2011_5(2)_40-46.nxml.txt.nlp	23878706	SENT102	10	10	4	4	tetracycline	Gen	PA451640	348654	0.555
NULL	EMBO_Rep_2013_Jan_30_14(1)_49-56.nxml.txt.nlp	23196367	SENT100	25	25	17	17	granisetron	5-HT3R	PA449809	3359	0.555
NULL	Crit_Care_2001_Mar_2_5(Suppl_1)_P197.nxml.txt.nlp	NULL	SENT15	0	0	9	9	propofol	PTH	PA451141	5741	0.555
NULL	Oncol_Lett_2013_Feb_9_5(2)_495-498.nxml.txt.nlp	23420572	SENT29	12	12	14	14	tamsulosin	PRN	PA451583	64428	0.555
NULL	Br_J_Cancer_2010_Jan_5_102(1)_80-86.nxml.txt.nlp	19920817	SENT67	28	28	30	30	bevacizumab	IFN	PA130232992	3439	0.555
NULL	Cancer_Cell_Int_2009_Feb_17_9_4.nxml.txt.nlp	19222856	SENT194	25	25	17	17	cisplatin	p53	PA449014	7157	0.555
NULL	Clin_Mol_Hepatol_2014_Sep_25_20(3)_283-290.nxml.txt.nlp	25320732	SENT138	2	2	17	17	propranolol	EVL	PA451145	51466	0.555
NULL	Cancer_Med_2013_Oct_19_2(5)_646-653.nxml.txt.nlp	24403230	SENT142	8	8	10	10	trastuzumab	MKK6	PA451743	5608	0.555
NULL	J_Gen_Physiol_1923_May_20_5(5)_647-659.nxml.txt.nlp	19872026	SENT7	21	21	10	10	trypsin	gamma	PA451806	9913	0.555
NULL	Clin_Interv_Aging_2013_May_10_8_531-542.nxml.txt.nlp	23696698	SENT140	35	35	20	20	s-adenosylmethionine	B12	PA164754994	7126;4709	0.555
NULL	Neuroimage_Clin_2013_Sep_3_3_242-248.nxml.txt.nlp	24273709	SENT294	30	30	4	4	topiramate	CLB	PA451728	171425	0.555
NULL	Mol_Cancer_2006_Oct_3_5_40.nxml.txt.nlp	17018141	SENT102	29	29	45	45	l-glutamine	CO2	PA10090	4513	0.555
NULL	Clinics_(Sao_Paulo)_2014_Jan_69(1)_68-74.nxml.txt.nlp	24473562	SENT91	5	5	39	39	nutlin-3	SOCS-1		8651	0.555
NULL	Gut_Liver_2015_Jan_15_9(1)_38-42.nxml.txt.nlp	NULL	SENT78	20	20	37	37	propofol	ESD	PA451141	2098	0.555
NULL	Oncoimmunology_2014_Jan_17_3_e27572.nxml.txt.nlp	24734216	SENT92	9	9	6	6	zoledronate	IL-2	PA10235	3558	0.555
NULL	Indian_J_Pharmacol_2013_Sep-Oct_45(5)_479-482.nxml.txt.nlp	24130383	SENT93	41	41	38	38	ethanol	NF-kappaB	PA448073	4790	0.555
NULL	Cell_Death_Dis_2013_Jun_27_4(6)_e695.nxml.txt.nlp	23807224	SENT208	21	21	34	34	ethanol	San	PA448073	80218	0.555
NULL	J_Gen_Physiol_2012_Oct_140(4)_403-419.nxml.txt.nlp	23008434	SENT159	16	16	22	22	phenol	TMX	PA450913	81542	0.555
NULL	Infect_Dis_Ther_2014_Jun_20_3(1)_1-17.nxml.txt.nlp	25134808	SENT130	22	22	3	3	emtricitabine	ATV	PA10069	4683	0.555
NULL	J_Oncol_2009_May_6_2009_567486.nxml.txt.nlp	19424511	SENT248	6	6	8	8	sunitinib	IFN	PA162372840	3439	0.555
NULL	Arthritis_Res_Ther_2012_Jun_12_14(3)_R141.nxml.txt.nlp	22691241	SENT175	2	2	14	14	abatacept	AKT	PA164747080	207	0.555
NULL	ASN_Neuro_2013_Mar_28_5(2)_e00110.nxml.txt.nlp	23452162	SENT39	27	27	16	16	l-glutamine	PLP	PA10090	25824;5744	0.555
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jul_24_66(Pt_8)_o2092.nxml.txt.nlp	21588387	SENT7	17	17	29	29	rocuronium	Tuba	PA164754992	23268	0.555
NULL	Bioinformation_2012_Jan_6_8(1)_13-19.nxml.txt.nlp	22359429	SENT171	14	14	16	16	curcumin	MRP1	PA151958596	4437	0.555
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_21-38.nxml.txt.nlp	19305786	SENT584	24	24	21	21	capsaicin	PKR1	PA448776	10887	0.555
NULL	Comp_Funct_Genomics_2012_Jan_19_2012_851379.nxml.txt.nlp	22312319	SENT48	10	10	5	5	nadh	ND2	PA164755085	4536	0.555
NULL	Biochem_Res_Int_2011_Sep_22_2011_285618.nxml.txt.nlp	21949907	SENT50	21	21	12	12	l-glutamine	F12	PA10090	2161	0.555
NULL	Iran_J_Neurol_2013_12(3)_114-116.nxml.txt.nlp	24250917	SENT56	11	11	5	5	alteplase	C5a	PA164776730	727	0.555
NULL	J_Autom_Methods_Manag_Chem_2008_Apr_5_2008_502953.nxml.txt.nlp	19365566	SENT2703	14	14	3	3	nevirapine	FOR	PA450616	51741	0.555
NULL	J_Cell_Biol_1995_Jun_2_129(6)_1543-1558.nxml.txt.nlp	7790353	SENT5	0	0	12	12	fluorescein	EGF	PA164746009	1950	0.555
NULL	J_Breast_Cancer_2013_Mar_31_16(1)_12-15.nxml.txt.nlp	23593076	SENT61	25	25	21	21	gemcitabine	TPC	PA449748	8030;60386	0.555
NULL	Open_Biochem_J_2013_Feb_22_7_19-23.nxml.txt.nlp	23526382	SENT94	14	14	19	19	repaglinide	DM2	PA451234	28508	0.555
NULL	Virol_J_2010_Nov_25_7_343.nxml.txt.nlp	21108831	SENT124	16	16	9	9	paraformaldehyde	DPP4	PA450790	1803	0.555
NULL	Mol_Cell_Proteomics_2012_Feb_6_11(2)_M111_015222.nxml.txt.nlp	22147731	SENT192	28	28	24	24	cetuximab	EGF	PA10040	1950	0.555
NULL	Mol_Clin_Oncol_2013_Jul_15_1(4)_661-667.nxml.txt.nlp	24649225	SENT187	22	22	0	0	leucovorin	OAT2	PA450198	10864	0.555
NULL	Int_J_Hypertens_2014_Jan_12_2014_381082.nxml.txt.nlp	24678415	SENT168	2	2	7	7	sevelamer	FGF23	PA164781197	8074	0.555
NULL	Curr_Chem_Genomics_2010_Mar_1_4_1-8.nxml.txt.nlp	20448812	SENT142	2	2	37	37	fluorescein	OATP1B3	PA164746009	28234	0.555
NULL	Nucleic_Acids_Res_2013_May_5_41(10)_5210-5222.nxml.txt.nlp	23563151	SENT104	12	12	8	8	arsenite	GADD45	PA452638	1647	0.555
NULL	Indian_J_Anaesth_2014_Jul-Aug_58(4)_423-429.nxml.txt.nlp	25197110	SENT161	12	12	10	10	ondansetron	ODF	PA450705	8600	0.555
NULL	Breast_Cancer_Res_2014_Sep_11_16(5)_430.nxml.txt.nlp	25212826	SENT278	13	13	0	0	estradiol	AKT	PA449503	207	0.555
NULL	J_Geriatr_Cardiol_2014_Mar_11(1)_39-43.nxml.txt.nlp	24748880	SENT91	1	1	4	4	esmolol	DBP1	PA449500	1665	0.555
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_127043.nxml.txt.nlp	23227093	SENT231	15	15	13	13	sulfaphenazole	CYP2C19	PA130231310	1557	0.555
NULL	Acta_Histochem_Cytochem_2012_Apr_26_45(2)_139-146.nxml.txt.nlp	22685356	SENT5	2	2	5	5	forskolin	AQP2	PA146096022	359	0.555
NULL	Gut_Liver_2015_Jan_9(1)_18-27.nxml.txt.nlp	NULL	SENT60	10	10	1	1	infliximab	ACT	PA452639	12;11332;9457;641455	0.555
NULL	Crit_Care_2011_Sep_19_15(5)_R217.nxml.txt.nlp	21929764	SENT2	29	29	31	31	vasopressin	AVP	PA451858	114548;551	0.555
NULL	Exp_Diabetes_Res_2012_Jun_26_2012_107130.nxml.txt.nlp	22792090	SENT151	9	9	20	20	pioglitazone	STZ	PA450970	6484	0.555
NULL	J_Oncol_2010_May_4_2010_373491.nxml.txt.nlp	20454582	SENT153	25	25	27	27	troglitazone	TRG	PA451799	6965	0.555
NULL	Basic_Res_Cardiol_2012_Mar_19_107(2)_242.nxml.txt.nlp	22258067	SENT266	8	8	0	0	nimesulide	CTRL	PA137179528	1506	0.555
NULL	Virol_J_2010_May_26_7_108.nxml.txt.nlp	20504340	SENT223	37	37	44	44	l-glutamine	CO2	PA10090	4513	0.555
NULL	Arthritis_Res_Ther_2006_May_15_8(3)_108.nxml.txt.nlp	16732895	SENT11	2	2	8	8	rituximab	CD22	PA451261	933	0.555
NULL	J_Immunol_Res_2014_Feb_9_2014_897487.nxml.txt.nlp	24741630	SENT15	24	24	5	5	hyaluronan	IL-6	PA165958431	3569	0.555
NULL	Osteoporos_Int_2012_Jan_3_23(1)_327-337.nxml.txt.nlp	21892677	SENT41	34	34	7	7	denosumab	RANKL	PA166048634	8600	0.555
NULL	Subst_Abuse_Treat_Prev_Policy_2007_Oct_31_2_32.nxml.txt.nlp	17974020	SENT281	22	22	14	14	methamphetamine	NMU	PA450403	10874	0.555
NULL	Nat_Commun_2013_Sep_20_4_2444.nxml.txt.nlp	24051492	SENT169	6	6	12	12	nutlin-3	p53		7157	0.555
NULL	Oncotarget_2014_Aug_27_5(21)_10486-10502.nxml.txt.nlp	25401222	SENT132	19	19	22	22	pp2	EGFR		1956	0.555
NULL	Cardiovasc_Toxicol_2011_Jun_12_11(2)_118-127.nxml.txt.nlp	21312070	SENT178	3	3	5	5	lipase	HSL	PA450239	3991	0.555
NULL	Front_Oncol_2014_Apr_9_4_75.nxml.txt.nlp	24782986	SENT218	31	31	10	10	paclitaxel	CXCR4	PA450761	7852	0.555
NULL	Cytotechnology_2015_Jan_29_67(1)_39-49.nxml.txt.nlp	24166597	SENT33	20	20	9	9	phenytoin	CO2	PA450947	4513	0.555
NULL	Breast_Cancer_Res_2001_Jan_17_3(2)_99-103.nxml.txt.nlp	11250754	SENT31	18	18	28	28	tamoxifen	AP-1	PA451581	2353;3727;2354;3725	0.555
NULL	Diabetes_Metab_Syndr_Obes_2010_Aug_24_3_297-299.nxml.txt.nlp	21437098	SENT6	12	12	6	6	exenatide	GLP-1	PA164749238	100125288	0.555
NULL	Mol_Vis_2011_Oct_31_17_2824-2834.nxml.txt.nlp	22128230	SENT33	6	6	27	27	sulpiride	APO	PA164745485	84909	0.555
NULL	Crit_Care_2009_Jun_22_13(3)_157.nxml.txt.nlp	19591641	SENT61	21	21	6	6	mannitol	HSL	PA450320	3991	0.555
NULL	Curr_Chem_Genomics_2009_Mar_17_3_7-12.nxml.txt.nlp	19936037	SENT49	3	3	5	5	forskolin	NKH	PA146096022	275;2731	0.555
NULL	Oncoimmunology_2013_Jan_1_2(1)_e22664.nxml.txt.nlp	23482679	SENT191	19	19	43	43	cyclophosphamide	EOS	PA449165	260429	0.555
NULL	Exp_Ther_Med_2014_Jun_27_7(6)_1752-1756.nxml.txt.nlp	24926379	SENT23	7	7	25	25	vildagliptin	PPG	PA165958346	5552	0.555
NULL	Neuropsychopharmacology_2009_May_8_34(6)_1454-1466.nxml.txt.nlp	18843265	SENT303	5	5	1	1	topiramate	Gen	PA451728	348654	0.555
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_288-294.nxml.txt.nlp	21372823	SENT52	18	18	9	9	streptomycin	FBS	PA451512	64319;26269	0.555
NULL	Exp_Mol_Med_2012_May_31_44(5)_319-329.nxml.txt.nlp	22314196	SENT49	33	33	10	10	methacholine	VDBP	PA165958382	2638	0.555
NULL	Vet_Res_Forum_2013_Winter_4(1)_19-24.nxml.txt.nlp	25593681	SENT4	20	20	18	18	diclofenac	B12	PA449293	7126;4709	0.555
NULL	Evid_Based_Complement_Alternat_Med_2011_Jan_12_2011_578092.nxml.txt.nlp	19706693	SENT49	16	16	30	30	l-glutamine	CO2	PA10090	4513	0.555
NULL	Protein_Cell_2014_Jun_19_5(6)_469-479.nxml.txt.nlp	24748116	SENT142	9	9	7	7	paclitaxel	EB1	PA450761	9167;22919;10982	0.555
NULL	Front_Immunol_2013_Nov_7_4_360.nxml.txt.nlp	24223576	SENT390	2	2	5	5	fluorescein	IRF5	PA164746009	3663	0.555
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT16	4	4	2	2	tacrolimus	SOCS3	PA451578	9021	0.555
NULL	Brain_Behav_2014_Jul_14_4(4)_468-483.nxml.txt.nlp	25161814	SENT131	9	9	6	6	ethanol	ANOVA	PA448073	4858	0.555
NULL	Pharmaceutics_2011_Oct_12_3(4)_680-705.nxml.txt.nlp	24309303	SENT774	6	6	23	23	repaglinide	CYP2C8	PA451234	1558	0.555
NULL	J_Thromb_Haemost_2010_Nov_8(11)_2530-2541.nxml.txt.nlp	20723025	SENT217	29	29	27	27	thrombin	ADP	PA451674	23038	0.555
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT93	29	29	21	21	resveratrol	TNF		7124	0.555
NULL	Case_Rep_Oncol_Med_2013_Dec_19_2013_208213.nxml.txt.nlp	24455357	SENT41	12	12	8	8	thyroglobulin	TTF-1	PA164754910	7080	0.555
NULL	J_Infect_Chemother_2012_Oct_28_18(5)_753-755.nxml.txt.nlp	22203121	SENT26	12	12	25	25	doxorubicin	ADM	PA449412	133	0.555
NULL	J_Biol_Chem_2012_Apr_13_287(16)_12952-12965.nxml.txt.nlp	22371491	SENT244	3	3	0	0	vasopressin	AVP	PA451858	114548;551	0.555
NULL	Mol_Neurodegener_2010_Nov_18_5_52.nxml.txt.nlp	21087519	SENT222	42	42	20	20	gentamicin	B27	PA449753	56246	0.555
NULL	J_Immune_Based_Ther_Vaccines_2008_Jun_9_6_3.nxml.txt.nlp	18541039	SENT7	47	47	39	39	ribavirin	IFN	PA451241	3439	0.555
NULL	Cardiovasc_Diabetol_2011_Dec_22_10_115.nxml.txt.nlp	22189184	SENT116	20	20	22	22	miglitol	GLP-1	PA164776726	100125288	0.555
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT54	46	46	39	39	vinorelbine	ASC	PA451881	29108	0.555
NULL	Int_J_Biol_Sci_2011_May_5_7(5)_567-574.nxml.txt.nlp	21552422	SENT106	27	27	47	47	l-glutamine	CO2	PA10090	4513	0.555
NULL	Br_J_Cancer_2013_Dec_10_109(12)_2965-2972.nxml.txt.nlp	24149178	SENT7	25	25	15	15	doxorubicin	HER2	PA449412	2064	0.555
NULL	Front_Neurosci_2014_Jun_3_8_128.nxml.txt.nlp	24917782	SENT139	17	17	12	12	ethanol	MC3R	PA448073	4159	0.555
NULL	Neuroscience_2008_Aug_13_155(2)_556-564.nxml.txt.nlp	18619738	SENT200	11	11	9	9	choline	CDP	PA448976	1523	0.555
NULL	Hum_Genomics_2006_Mar_1_2(5)_329-335.nxml.txt.nlp	16595077	SENT91	34	34	20	20	nadh	NQO1	PA164755085	1728	0.555
NULL	Environ_Health_Perspect_2005_Oct_14_113(10)_1330-1335.nxml.txt.nlp	16203242	SENT18	20	20	15	15	phenylephrine	MLC	PA450935	23209	0.555
NULL	Onco_Targets_Ther_2014_Nov_28_7_2183-2195.nxml.txt.nlp	25506223	SENT225	3	3	8	8	doxorubicin	MICA	PA449412	100507436	0.555
NULL	Exp_Cell_Res_2011_May_1_317(8)_1093-1107.nxml.txt.nlp	21320486	SENT334	2	2	4	4	bortezomib	APPL1	PA10252	26060	0.555
NULL	Oncol_Lett_2014_Nov_12_8(5)_2203-2208.nxml.txt.nlp	25295109	SENT101	0	0	2	2	celecoxib	PTCH1	PA448871	5727	0.555
NULL	Clin_Mol_Hepatol_2014_Sep_25_20(3)_283-290.nxml.txt.nlp	25320732	SENT111	19	19	17	17	propranolol	EVL	PA451145	51466	0.555
NULL	Int_J_Vasc_Med_2014_Jul_22_2014_659617.nxml.txt.nlp	25140254	SENT40	9	9	18	18	isoflurane	CO2	PA450106	4513	0.555
NULL	Allergy_Asthma_Immunol_Res_2014_Sep_18_6(5)_376-388.nxml.txt.nlp	25228994	SENT133	15	15	17	17	ciclesonide	DPI	PA164781399	1832	0.555
NULL	Cardiovasc_Diabetol_2005_Oct_5_4_16.nxml.txt.nlp	16207378	SENT190	3	3	8	8	glucosamine	perlecan	PA164747613	3339	0.555
NULL	Amino_Acids_2012_Oct_10_43(4)_1751-1759.nxml.txt.nlp	22407485	SENT3	22	22	11	11	carrageenan	ghrelin	PA448814	51738	0.555
NULL	Mol_Biol_Cell_2014_Aug_1_25(15)_2220-2234.nxml.txt.nlp	24899641	SENT232	12	12	18	18	trypsin	GRP94	PA451806	7184	0.555
NULL	Oncol_Lett_2013_Jun_20_5(6)_1897-1902.nxml.txt.nlp	23833663	SENT236	17	17	5	5	fluorescein	IFN	PA164746009	3439	0.555
NULL	Clin_Med_Insights_Oncol_2011_Sep_21_5_315-323.nxml.txt.nlp	22084620	SENT8	32	32	25	25	gemcitabine	IL-2	PA449748	3558	0.555
NULL	J_Ginseng_Res_2011_Nov_35(4)_436-441.nxml.txt.nlp	23717089	SENT131	17	17	7	7	ginseng	CAGC	PA164781150	6283	0.555
NULL	Crit_Care_2004_Sep_29_8(2)_122-129.nxml.txt.nlp	15025773	SENT190	8	8	0	0	vasopressin	ACTH	PA451858	5443	0.555
NULL	Front_Neurosci_2015_Jan_6_8_435.nxml.txt.nlp	25610365	SENT147	13	13	9	9	losartan	AT1	PA450268	9197;185	0.555
NULL	Arthritis_Res_Ther_2009_Feb_9_11(1)_R19.nxml.txt.nlp	19203382	SENT243	22	22	36	36	infliximab	CRP	PA452639	1401;140913	0.555
NULL	Case_Rep_Gastrointest_Med_2014_Jun_17_2014_906759.nxml.txt.nlp	25031875	SENT70	8	8	6	6	trometamol	DLST	PA451802	1743	0.555
NULL	Breast_Cancer_Res_2010_Mar_5_12(2)_R16.nxml.txt.nlp	20205716	SENT340	18	18	13	13	lovastatin	PTEN	PA450272	5728	0.555
NULL	J_Carcinog_Mutagen_2013_Suppl_6_003.nxml.txt.nlp	25379355	SENT171	16	16	37	37	camptothecin	PI3K	PA153590860	5290	0.555
NULL	Cancer_Metab_2014_Nov_3_2(1)_20.nxml.txt.nlp	NULL	SENT206	28	28	6	6	erlotinib	PDK4	PA134687924	5166	0.555
NULL	Int_J_Mol_Sci_2014_Oct_20_15(10)_18840-18855.nxml.txt.nlp	25334060	SENT182	9	9	16	16	formaldehyde	TRAP	PA449703	959;54;57410	0.555
NULL	Arthritis_Res_Ther_2013_Mar_4_15(2)_R39.nxml.txt.nlp	23497717	SENT15	3	3	20	20	imiquimod	IL-6	PA449972	3569	0.555
NULL	Clin_Mol_Hepatol_2013_Dec_28_19(4)_417-420.nxml.txt.nlp	24459647	SENT78	20	20	22	22	terlipressin	HRS	PA164781020	6430	0.555
NULL	Arthritis_Res_Ther_2014_Jul_24_16(4)_R157.nxml.txt.nlp	25059342	SENT274	26	26	9	9	bleomycin	IL-6	PA448645	3569	0.555
NULL	Crit_Care_2009_Mar_16_13(2)_R37.nxml.txt.nlp	19291300	SENT159	5	5	13	13	alemtuzumab	CRP	PA164783958	1401;140913	0.555
NULL	Nucleic_Acids_Res_2012_Apr_16_40(8)_3641-3652.nxml.txt.nlp	22180534	SENT180	15	15	4	4	galactose	GAL	PA449725	51083	0.555
NULL	Curr_Neuropharmacol_2008_Sep_6(3)_215-234.nxml.txt.nlp	19506722	SENT562	1	1	7	7	fluoxetine	5-HT1B	PA449673	3351	0.555
NULL	Acta_Pharmacol_Sin_2009_Dec_4_30(12)_1688-1693.nxml.txt.nlp	19960013	SENT78	23	23	42	42	l-glutamine	CO2	PA10090	4513	0.555
NULL	Front_Neuroanat_2010_Jun_14_4_21.nxml.txt.nlp	20589096	SENT65	4	4	7	7	choline	EAAC1	PA448976	6505	0.555
NULL	Cancer_Causes_Control_2012_Oct_21_23(10)_1739-1744.nxml.txt.nlp	22907422	SENT87	27	27	8	8	sulindac	CRA	PA451565	51747;10903	0.555
NULL	Ann_Pediatr_Endocrinol_Metab_2014_Mar_31_19(1)_8-12.nxml.txt.nlp	24926457	SENT53	4	4	24	24	iodine	IDD	PA450049	9993;1299	0.555
NULL	Biomed_Res_Int_2013_Aug_6_2013_909613.nxml.txt.nlp	24027765	SENT16	6	6	0	0	hydrocortisone	EEN	PA449905	6455	0.555
NULL	Clin_Endosc_2014_Mar_31_47(2)_129-134.nxml.txt.nlp	24765594	SENT45	12	12	3	3	propofol	FOR	PA451141	51741	0.555
NULL	Exp_Hematol_Oncol_2012_Sep_24_1_30.nxml.txt.nlp	23210663	SENT40	16	16	21	21	rituximab	CHOP	PA451261	1649	0.555
NULL	Oncol_Rep_2013_Oct_22_30(4)_1535-1541.nxml.txt.nlp	23877481	SENT165	20	20	29	29	indinavir	CD4	PA449977	920	0.554
NULL	Cell_J_2014_May_25_Summer_16(2)_117-130.nxml.txt.nlp	24567941	SENT72	17	17	37	37	l-glutamine	EGF	PA10090	1950	0.554
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT17	33	33	24	24	vinorelbine	MVP	PA451881	9961	0.554
NULL	Diabetes_2013_Mar_14_62(3)_931-943.nxml.txt.nlp	23172920	SENT325	8	8	17	17	pioglitazone	CD36	PA450970	948	0.554
NULL	Br_J_Cancer_2009_Mar_10_100(5)_758-763.nxml.txt.nlp	19259094	SENT100	0	0	6	6	belinostat	MLH1		4292	0.554
NULL	BMB_Rep_2014_Jul_47(7)_376-381.nxml.txt.nlp	24286332	SENT32	19	19	13	13	thrombin	PPG	PA451674	5552	0.554
NULL	Open_AIDS_J_2010_Jan_19_4_70-75.nxml.txt.nlp	20200604	SENT220	14	14	36	36	nevirapine	ATV	PA450616	4683	0.554
NULL	Mol_Cancer_2007_Sep_26_6_61.nxml.txt.nlp	17894897	SENT152	19	19	13	13	etoposide	p53	PA449552	7157	0.554
NULL	Evid_Based_Complement_Alternat_Med_2014_Dec_25_2014_605914.nxml.txt.nlp	25610478	SENT89	31	31	39	39	paraformaldehyde	mol	PA450790	90527	0.554
NULL	Arthritis_Res_Ther_2011_Dec_22_13(6)_R213.nxml.txt.nlp	22192852	SENT177	18	18	36	36	methotrexate	ART5	PA450428	116969	0.554
NULL	Front_Mol_Neurosci_2012_Feb_24_5_22.nxml.txt.nlp	22375105	SENT134	30	30	17	17	spermine	CA1	PA164781199	759	0.554
NULL	Braz_J_Med_Biol_Res_2013_May_10_46(5)_433-439.nxml.txt.nlp	23681290	SENT151	18	18	23	23	bezafibrate	IL-10	PA162364313	3586	0.554
NULL	Clin_Med_Insights_Circ_Respir_Pulm_Med_2013_Nov_13_7_61-77.nxml.txt.nlp	24324354	SENT130	12	12	4	4	tobramycin	TIP	PA451704	81533;79828	0.554
NULL	Clin_Interv_Aging_2013_Feb_11_8_139-148.nxml.txt.nlp	23430672	SENT17	30	30	18	18	fluorescein	IL8	PA164746009	3576	0.554
NULL	Curr_Opin_Endocrinol_Diabetes_Obes_2014_Oct_28_21(5)_394-404.nxml.txt.nlp	25122493	SENT125	15	15	5	5	thyroglobulin	RAI	PA164754910	10848;6050	0.554
NULL	Nucleic_Acids_Res_2013_May_5_41(10)_5210-5222.nxml.txt.nlp	23563151	SENT13	25	25	12	12	arsenite	GADD45	PA452638	1647	0.554
NULL	Biosci_Rep_2012_Dec_20_33(1)_e00011.nxml.txt.nlp	23137297	SENT313	10	10	6	6	heparin	RPSA	PA449855	3921	0.554
NULL	Open_AIDS_J_2010_Jan_19_4_70-75.nxml.txt.nlp	20200604	SENT220	18	18	36	36	stavudine	ATV	PA451494	4683	0.554
NULL	J_Oncol_2012_Jun_19_2012_521215.nxml.txt.nlp	22778735	SENT258	18	18	16	16	gefitinib	EGFR	PA131301952	1956	0.554
NULL	J_Asthma_Allergy_2013_Feb_22_6_31-39.nxml.txt.nlp	23459334	SENT5	16	16	18	18	desloratadine	DES	PA164776964	1674	0.554
NULL	Int_J_Mol_Sci_2014_Nov_4_15(11)_20022-20044.nxml.txt.nlp	25375187	SENT191	0	0	17	17	rosiglitazone	adiponectin	PA451283	9370	0.554
NULL	Cells_2014_Apr_29_3(2)_331-362.nxml.txt.nlp	24785347	SENT1447	5	5	7	7	capsaicin	TRPV1	PA448776	7442	0.554
NULL	Acta_Pharmacol_Sin_2009_Nov_5_30(11)_1522-1528.nxml.txt.nlp	19890360	SENT125	6	6	8	8	fenoterol	IL-8	PA10079	3576	0.554
NULL	Int_J_Mol_Sci_2014_Sep_25_15(9)_17065-17076.nxml.txt.nlp	25257528	SENT56	5	5	13	13	decitabine	SMG1	PA164749631	23049	0.554
NULL	Exp_Neurol_2011_May_229(1)_2-9.nxml.txt.nlp	20816825	SENT60	22	22	18	18	heparin	FGF2	PA449855	2247;2258	0.554
NULL	Br_J_Cancer_2009_Sep_15_101(6)_908-915.nxml.txt.nlp	19690548	SENT201	9	9	7	7	gemcitabine	GEM	PA449748	2669	0.554
NULL	J_Korean_Med_Sci_2007_Dec_20_22(6)_963-967.nxml.txt.nlp	18162707	SENT52	26	26	7	7	ethambutol	DST	PA164784021	667	0.554
NULL	Biochem_Biophys_Res_Commun_2011_Jul_15_410(4)_895-900.nxml.txt.nlp	21708126	SENT59	19	19	36	36	l-glutamine	CO2	PA10090	4513	0.554
NULL	Diabetes_2009_Mar_58(3)_579-589.nxml.txt.nlp	19074989	SENT136	13	13	19	19	lipase	LIPE	PA450239	3991	0.554
NULL	Arch_Drug_Inf_2009_Sep_2(3)_41-50.nxml.txt.nlp	19915711	SENT124	19	19	5	5	creatine	SLC6A8	PA164778930	6535	0.554
NULL	Archaea_2012_Aug_15_2012_315153.nxml.txt.nlp	22927778	SENT314	32	32	19	19	nadh	ADP	PA164755085	23038	0.554
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT148	6	6	8	8	curcumin	TRAIL	PA151958596	8743	0.554
NULL	J_Cell_Mol_Med_2013_Jun_15_17(6)_792-799.nxml.txt.nlp	23672538	SENT61	7	7	34	34	fluorescein	CD16	PA164746009	2215;2214	0.554
NULL	Ann_N_Y_Acad_Sci_2012_Aug_30_1264(1)_49-63.nxml.txt.nlp	22548651	SENT53	18	18	6	6	glucose	BDNF	PA449773	627	0.554
NULL	J_Adv_Pract_Oncol_2012_Jul_1_Jul-Aug_3(4)_237-241.nxml.txt.nlp	25031951	SENT3	2	2	24	24	topotecan	MSN	PA451729	4478	0.554
NULL	Epilepsia_2011_Mar_26_52(3)_531-540.nxml.txt.nlp	21269296	SENT198	21	21	6	6	nifedipine	spatial	PA450631	219793	0.554
NULL	Pharmaceutics_2011_Apr_14_3(2)_171-185.nxml.txt.nlp	24310494	SENT410	14	14	10	10	paclitaxel	castor	PA450761	54897	0.554
NULL	Environ_Health_2013_Mar_7_12_22.nxml.txt.nlp	23497059	SENT80	20	20	11	11	calcidiol	PTH	PA164745614	5741	0.554
NULL	Biogerontology_2014_Nov_16_15(1)_47-64.nxml.txt.nlp	24243065	SENT204	5	5	13	13	doxorubicin	p53	PA449412	7157	0.554
NULL	F1000_Biol_Rep_2011_Nov_1_3_23.nxml.txt.nlp	22065982	SENT130	0	0	18	18	mitoxantrone	ABCG2	PA450526	9429	0.554
NULL	Toxins_(Basel)_2011_Apr_6_3(4)_409-419.nxml.txt.nlp	22069716	SENT84	35	35	31	31	l-glutamine	FBS	PA10090	64319;26269	0.554
NULL	Br_J_Dermatol_2009_Feb_160(2)_438-441.nxml.txt.nlp	19016697	SENT73	26	26	16	16	methotrexate	FPGS	PA450428	2356	0.554
NULL	Int_J_Endocrinol_Metab_2013_Jul_1_Summer_11(3)_184-190.nxml.txt.nlp	24348591	SENT112	0	0	5	5	liraglutide	INS-1	PA165958364	2305	0.554
NULL	Hum_Mol_Genet_2014_Aug_1_23(15)_4077-4085.nxml.txt.nlp	24670599	SENT95	4	4	16	16	lipase	PNPLA3	PA450239	80339	0.554
NULL	Evid_Based_Complement_Alternat_Med_2011_Apr_26_2011_965095.nxml.txt.nlp	21584198	SENT25	2	2	21	21	iron	mol	PA450087	90527	0.554
NULL	Viruses_2013_May_22_5(5)_1292-1324.nxml.txt.nlp	23698400	SENT104	15	15	13	13	ribavirin	IFN	PA451241	3439	0.554
NULL	Clinics_(Sao_Paulo)_2012_Aug_67(8)_911-916.nxml.txt.nlp	22948459	SENT177	20	20	22	22	estradiol	PTH	PA449503	5741	0.554
NULL	Gastric_Cancer_2012_Jul_17_15(3)_313-322.nxml.txt.nlp	22179434	SENT91	24	24	12	12	capecitabine	HER2	PA448771	2064	0.554
NULL	Pharmaceuticals_(Basel)_2013_Aug_21_6(8)_988-1038.nxml.txt.nlp	24276379	SENT2104	14	14	2	2	sn-38	UGT1A		7361;54658	0.554
NULL	Oncol_Lett_2013_Oct_29_6(4)_1031-1038.nxml.txt.nlp	24137459	SENT204	32	32	0	0	fluorescein	DDP	PA164746009	1678	0.554
NULL	Mol_Pain_2013_Jun_10_9_27.nxml.txt.nlp	23758830	SENT164	10	10	19	19	tetracaine	ASIC2a	PA451638	40	0.554
NULL	Pharmaceuticals_(Basel)_2011_May_17_4(5)_741-757.nxml.txt.nlp	NULL	SENT199	5	5	16	16	ethanol	RhoA	PA448073	387	0.554
NULL	Arthritis_Res_Ther_2007_Jul_5_9(4)_R65.nxml.txt.nlp	17612407	SENT88	41	41	23	23	streptomycin	CO2	PA451512	4513	0.554
NULL	J_Appl_Microbiol_2013_Apr_31_114(4)_992-1000.nxml.txt.nlp	23279070	SENT97	32	32	24	24	ethanol	San	PA448073	80218	0.554
NULL	Oncol_Lett_2013_Dec_4_6(6)_1665-1672.nxml.txt.nlp	24273604	SENT8	6	6	8	8	chloroquine	TLR9	PA448948	54106	0.554
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT207	16	16	12	12	tacrolimus	RANKL	PA451578	8600	0.554
NULL	Cytotherapy_2013_Jan_15(1)_89-101.nxml.txt.nlp	23260089	SENT177	28	28	11	11	lipase	FABP4	PA450239	2167	0.554
NULL	Clin_Ophthalmol_2009_Jun_2_3_291-295.nxml.txt.nlp	19668581	SENT5	13	13	15	15	latanoprost	BAK	PA164774763	578	0.554
NULL	Pharmacogn_Rev_2011_Jul-Dec_5(10)_159-163.nxml.txt.nlp	22279373	SENT138	18	18	5	5	ethanol	CEE	PA448073	51608	0.554
NULL	Ann_Oncol_2011_Jan_13_22(1)_215-223.nxml.txt.nlp	20627875	SENT134	18	18	12	12	methotrexate	ETO	PA450428	862	0.554
NULL	Chem_Rev_2011_Oct_12_111(10)_5899-5921.nxml.txt.nlp	21923193	SENT370	6	6	3	3	lipase	FAAH	PA450239	79152;2166	0.554
NULL	Evid_Based_Complement_Alternat_Med_2012_Aug_27_2012_361516.nxml.txt.nlp	22969825	SENT65	35	35	32	32	verapamil	P-gp	PA451868	5243	0.554
NULL	Clin_Epidemiol_2014_Apr_1_6_111-118.nxml.txt.nlp	24729727	SENT69	37	37	35	35	ethionamide	DST	PA164768738	667	0.554
NULL	Br_J_Pharmacol_2011_Apr_162(7)_1509-1520.nxml.txt.nlp	21108630	SENT247	23	23	25	25	allopregnanolone	TRPC5	PA142320763	7224	0.554
NULL	Apoptosis_2014_Aug_26_19(11)_1603-1615.nxml.txt.nlp	25156145	SENT245	2	2	0	0	mitomycin	TRAIL	PA450524	8743	0.554
NULL	Breast_Cancer_Res_2008_Dec_5_10(6)_R104.nxml.txt.nlp	19061505	SENT296	9	9	13	13	estradiol	c-Jun	PA449503	3725	0.554
NULL	Breast_Cancer_Res_2006_Nov_6_8(6)_215.nxml.txt.nlp	17096862	SENT74	4	4	6	6	trastuzumab	HER2	PA451743	2064	0.554
NULL	Oncol_Lett_2014_Jul_25_8(1)_367-373.nxml.txt.nlp	24959278	SENT204	16	16	18	18	phenol	DDP	PA450913	1678	0.554
NULL	J_Cell_Biol_2000_Jul_10_150(1)_155-164.nxml.txt.nlp	10893264	SENT161	17	17	14	14	etoposide	CD95	PA449552	355	0.554
NULL	J_Cancer_2012_Jun_21_3_269-284.nxml.txt.nlp	22773931	SENT24	32	32	28	28	urokinase	BRCA1	PA451836	672	0.554
NULL	Biosci_Rep_2012_Dec_13_33(1)_e00007.nxml.txt.nlp	23095119	SENT617	0	0	2	2	metformin	adiponectin	PA450395	9370	0.554
NULL	Tumour_Biol_2013_Apr_29_34(2)_661-668.nxml.txt.nlp	23192642	SENT17	15	15	13	13	erlotinib	EGF	PA134687924	1950	0.554
NULL	J_Infect_Dis_2011_May_1_203(9)_1204-1214.nxml.txt.nlp	21459813	SENT173	15	15	2	2	etravirine	TRIO	PA166014703	7204	0.554
NULL	Exp_Diabetes_Res_2012_Nov_12_2012_618923.nxml.txt.nlp	23197974	SENT191	27	27	17	17	telmisartan	STZ	PA451605	6484	0.554
NULL	Breast_Cancer_Res_2002_Aug_27_4(6)_213-217.nxml.txt.nlp	12473165	SENT137	4	4	0	0	tamoxifen	ATAC	PA451581	6375	0.554
NULL	J_Korean_Med_Sci_1999_Oct_14(5)_565-570.nxml.txt.nlp	10576154	SENT9	10	10	18	18	cyclophosphamide	CHOP	PA449165	1649	0.554
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT333	2	2	27	27	lapatinib	HER3	PA152241907	2065	0.554
NULL	Ann_Gen_Psychiatry_2008_Aug_18_7_11.nxml.txt.nlp	18706108	SENT70	21	21	18	18	bupropion	CD50	PA448687	3385	0.554
NULL	Diabetes_Care_2009_Nov_32(Suppl_2)_S362-S367.nxml.txt.nlp	19875582	SENT103	6	6	16	16	orlistat	adiponectin	PA164776864	9370	0.554
NULL	Oncol_Lett_2014_Jan_6_7(1)_87-94.nxml.txt.nlp	24348827	SENT234	17	17	28	28	thrombin	ADP	PA451674	23038	0.554
NULL	Front_Neurosci_2013_Dec_17_7_244.nxml.txt.nlp	24381537	SENT155	41	41	11	11	naloxone	ANOVA	PA450586	4858	0.554
NULL	Emerg_Infect_Dis_2014_Mar_20(3)_400-408.nxml.txt.nlp	24565738	SENT128	20	20	30	30	rifampin	DST	PA451250	667	0.554
NULL	Cell_Commun_Signal_2014_Oct_5_12(1)_54.nxml.txt.nlp	NULL	SENT119	8	8	12	12	doxycycline	ROCK2	PA449415	9475	0.554
NULL	Cancer_Immunol_Immunother_2012_Jul_23_61(7)_1101-1111.nxml.txt.nlp	22193989	SENT205	10	10	8	8	oxaliplatin	STAT3	PA131285527	6774	0.554
NULL	Diabetes_2009_Dec_31_58(12)_2851-2862.nxml.txt.nlp	19720788	SENT206	14	14	16	16	forskolin	Bcl-2	PA146096022	596	0.554
NULL	Arthritis_Res_Ther_2011_Feb_16_13(1)_R25.nxml.txt.nlp	21324169	SENT120	37	37	31	31	tocilizumab	TNF	PA165292659	7124	0.554
NULL	Oncogene_2014_Jul_24_33(30)_3980-3991.nxml.txt.nlp	24121271	SENT164	17	17	24	24	l-glutamine	CO2	PA10090	4513	0.554
NULL	J_Cell_Sci_2014_Nov_1_127(21)_4728-4739.nxml.txt.nlp	25179605	SENT326	17	17	24	24	l-glutamine	CO2	PA10090	4513	0.554
NULL	Exp_Hematol_Oncol_2013_Aug_8_2_21.nxml.txt.nlp	23927414	SENT94	30	30	25	25	enoxaparin	HARE	PA449463	55576	0.554
NULL	Behav_Genet_2008_Jul_7_38(4)_396-406.nxml.txt.nlp	18461434	SENT26	2	2	0	0	glucose	GLUT8	PA449773	29988;154091	0.554
NULL	Cancer_Metab_2013_Jul_24_1_16.nxml.txt.nlp	24280319	SENT235	20	20	32	32	nadh	ADP	PA164755085	23038	0.554
NULL	Br_J_Cancer_2009_May_19_100(10)_1540-1548.nxml.txt.nlp	19384300	SENT161	18	18	15	15	trypsin	TATI	PA451806	6690	0.554
NULL	Drugs_R_D_2011_Jun_27_11(2)_159-170.nxml.txt.nlp	21679006	SENT296	8	8	20	20	estradiol	S26	PA449503	6231	0.554
NULL	Cardiovasc_Diabetol_2013_Jun_7_12_84.nxml.txt.nlp	23759020	SENT62	38	38	24	24	dipyridamole	LSR	PA449367	51599	0.554
NULL	BMB_Rep_2014_May_47(5)_274-279.nxml.txt.nlp	24286313	SENT152	43	43	22	22	paraformaldehyde	San	PA450790	80218	0.554
NULL	Mol_Cell_Biochem_2013_Jul_3_379(1-2)_29-36.nxml.txt.nlp	23549681	SENT4	19	19	25	25	phenol	HIF-1	PA450913	29072	0.554
NULL	Clin_Pharmacokinet_2014_Sep_3_53(1)_1-16.nxml.txt.nlp	23999929	SENT284	35	35	10	10	rivaroxaban	P-gp	PA165958360	5243	0.554
NULL	J_Mol_Signal_2009_Apr_28_4_2.nxml.txt.nlp	19400946	SENT144	36	36	38	38	genistein	Gen	PA165109660	348654	0.554
NULL	Asian-Australas_J_Anim_Sci_2013_Apr_26(4)_573-578.nxml.txt.nlp	25049825	SENT155	12	12	17	17	bacitracin	BP1	PA448531	1748	0.554
NULL	Front_Chem_2014_Dec_23_2_113.nxml.txt.nlp	25566531	SENT793	16	16	3	3	curcumin	maspin	PA151958596	5268	0.554
NULL	Neuropsychopharmacology_2012_Feb_2_37(3)_641-650.nxml.txt.nlp	22048466	SENT142	19	19	9	9	bupropion	CYP2B6	PA448687	1555	0.554
NULL	Neural_Regen_Res_2013_Jun_15_8(17)_1623-1630.nxml.txt.nlp	25206459	SENT128	0	0	10	10	topiramate	gamma	PA451728	9913	0.554
NULL	Acta_Pharmacol_Sin_2009_Feb_5_30(2)_228-234.nxml.txt.nlp	19122672	SENT108	1	1	4	4	isoflurane	HO-1	PA450106	3162	0.554
NULL	Oncotarget_2010_Aug_10_1(4)_239-245.nxml.txt.nlp	21304176	SENT41	8	8	13	13	dacarbazine	Bcl-2	PA449197	596	0.554
NULL	Cardiovasc_Ther_2012_Jun_19_30(3)_e146-e155.nxml.txt.nlp	21167014	SENT6	8	8	6	6	exenatide	GLP-1	PA164749238	100125288	0.554
NULL	J_Exp_Med_1995_Jul_1_182(1)_147-154.nxml.txt.nlp	7790814	SENT6	12	12	7	7	estradiol	Raf-1	PA449503	5894	0.554
NULL	Infect_Drug_Resist_2009_Apr_24_2_13-26.nxml.txt.nlp	21694884	SENT36	38	38	9	9	entecavir	IFN	PA164784025	3439	0.554
NULL	Cancer_Causes_Control_2013_Aug_18_24(8)_1605-1614.nxml.txt.nlp	23775025	SENT64	25	25	16	16	methotrexate	CYP3A4	PA450428	1576	0.554
NULL	Tech_Coloproctol_2014_Sep_13_18(4)_373-380.nxml.txt.nlp	24030782	SENT0	10	10	0	0	lidocaine	Tech	PA450226	57449	0.554
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT286	0	0	5	5	cisplatin	p53	PA449014	7157	0.554
NULL	Indian_J_Pharmacol_2009_Aug_41(4)_167-172.nxml.txt.nlp	20523867	SENT144	17	17	14	14	imatinib	CYP3A4	PA10804	1576	0.554
NULL	J_Biomed_Biotechnol_2010_May_5_2010_203503.nxml.txt.nlp	20454535	SENT135	6	6	18	18	cisplatin	p65	PA449014	5970	0.554
NULL	Front_Neurol_2013_May_15_4_53.nxml.txt.nlp	23720649	SENT339	34	34	25	25	nadh	SOD2	PA164755085	6648	0.554
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Jun_27_5_15.nxml.txt.nlp	16803618	SENT178	14	14	42	42	erythromycin	GEN1	PA449493	348654	0.554
NULL	Protein_J_2012_Aug_5_31(6)_511-518.nxml.txt.nlp	22763563	SENT130	0	0	5	5	atorvastatin	CD36	PA448500	948	0.554
NULL	Pharmaceutics_2011_Feb_7_3(1)_53-72.nxml.txt.nlp	24310425	SENT856	34	34	17	17	lidocaine	CYP2C19	PA450226	1557	0.554
NULL	Leukemia_2014_Mar_13_28(3)_600-608.nxml.txt.nlp	24240203	SENT112	18	18	4	4	nutlin-3	p53		7157	0.554
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT188	25	25	8	8	hydrocortisone	F12	PA449905	2161	0.554
NULL	J_Cell_Biol_2005_May_23_169(4)_681-691.nxml.txt.nlp	15911882	SENT79	22	22	14	14	aprotinin	TIMP1	PA448472	7076	0.554
NULL	J_Exp_Bot_2011_Oct_16_62(14)_5105-5116.nxml.txt.nlp	21765172	SENT276	39	39	36	36	naringenin	CHS	PA151958361	1130	0.554
NULL	Mol_Cancer_2010_Apr_23_9_87.nxml.txt.nlp	20416058	SENT192	13	13	28	28	doxorubicin	TRAIL	PA449412	8743	0.554
NULL	Ann_Clin_Microbiol_Antimicrob_2008_Jan_22_7_2.nxml.txt.nlp	18211682	SENT47	10	10	4	4	vancomycin	VISA	PA451850	57506	0.554
NULL	Behav_Brain_Funct_2009_Jun_4_5_23.nxml.txt.nlp	19497110	SENT40	8	8	19	19	ethanol	P90	PA448073	821	0.554
NULL	Cell_Commun_Signal_2013_Aug_15_11_59.nxml.txt.nlp	23947369	SENT54	28	28	24	24	pp2	PP1		5540;5464	0.554
NULL	Case_Rep_Oncol_2012_Jul_24_5(2)_385-387.nxml.txt.nlp	23525261	SENT45	7	7	13	13	bicalutamide	DES	PA164746255	1674	0.554
NULL	Drug_Target_Insights_2006_Oct_23_1_5-10.nxml.txt.nlp	21901053	SENT8	18	18	21	21	thrombin	INCA	PA451674	440068	0.554
NULL	Oncol_Lett_2013_Feb_7_5(2)_440-446.nxml.txt.nlp	23420122	SENT247	21	21	24	24	gemcitabine	Gem	PA449748	51053	0.554
NULL	Breast_Cancer_Res_2003_Oct_9_5(6)_309-312.nxml.txt.nlp	14580248	SENT66	24	24	14	14	tamoxifen	BCS	PA451581	617	0.554
NULL	Daru_2011_19(6)_433-439.nxml.txt.nlp	23008689	SENT92	14	14	16	16	ethanol	IPA	PA448073	3160	0.554
NULL	J_Lipid_Res_2015_Jan_56(1)_109-121.nxml.txt.nlp	25421061	SENT10	6	6	8	8	lipase	ATGL	PA450239	57104	0.554
NULL	J_Appl_Genet_2014_Jan_11_55(2)_173-181.nxml.txt.nlp	24414975	SENT199	9	9	11	11	nadh	ND5	PA164755085	4540	0.554
NULL	FEBS_Open_Bio_2012_Aug_22_2_279-283.nxml.txt.nlp	23650611	SENT106	8	8	10	10	raloxifene	IFN	PA451221	3439	0.554
NULL	Breast_Cancer_Res_2014_Sep_11_16(5)_430.nxml.txt.nlp	25212826	SENT278	13	13	39	39	estradiol	PTEN	PA449503	5728	0.554
NULL	Mol_Cancer_2008_May_16_7_38.nxml.txt.nlp	18485224	SENT60	15	15	35	35	celecoxib	CHOP	PA448871	1649	0.554
NULL	Indian_J_Pharmacol_2012_Sep-Oct_44(5)_619-623.nxml.txt.nlp	23112425	SENT41	30	30	8	8	streptomycin	F12	PA451512	2161	0.554
NULL	Nat_Commun_2013_Oct_1_4_2516.nxml.txt.nlp	24084631	SENT51	7	7	9	9	losartan	CCN2	PA450268	1490	0.554
NULL	eLife_2014_Apr_22_3_e02053.nxml.txt.nlp	24755289	SENT102	20	20	15	15	baclofen	RGS7	PA448533	6000	0.554
NULL	Behav_Brain_Funct_2014_Jun_16_10_21.nxml.txt.nlp	24934302	SENT134	2	2	4	4	rosiglitazone	spatial	PA451283	219793	0.554
NULL	Exp_Ther_Med_2012_Oct_16_4(4)_705-710.nxml.txt.nlp	23170130	SENT186	2	2	4	4	cyclophosphamide	P-gp	PA449165	5243	0.554
NULL	Diabetes_2008_Sep_57(9)_2272-2279.nxml.txt.nlp	18519799	SENT197	22	22	25	25	rosiglitazone	PDK4	PA451283	5166	0.554
NULL	Drug_Des_Devel_Ther_2014_Sep_26_8_1613-1619.nxml.txt.nlp	25302016	SENT129	9	9	18	18	efavirenz	CYP3A	PA449441	1574	0.554
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT58	12	12	10	10	curcumin	FADD	PA151958596	8772	0.554
NULL	Clin_Ophthalmol_2009_Jun_2_3_291-295.nxml.txt.nlp	19668581	SENT69	17	17	19	19	latanoprost	BAK	PA164774763	578	0.554
NULL	Mol_Med_Rep_2015_Feb_5_11(2)_805-814.nxml.txt.nlp	25373883	SENT236	34	34	3	3	colchicine	APE	PA449092	55704;328	0.554
NULL	Cancers_(Basel)_2014_Sep_5_6(3)_1769-1792.nxml.txt.nlp	25198391	SENT283	26	26	14	14	methotrexate	DAC	PA450428	13	0.554
NULL	Front_Psychol_2011_Apr_5_2_58.nxml.txt.nlp	21716581	SENT36	35	35	7	7	propofol	ACTH	PA451141	5443	0.554
NULL	Exp_Diabetes_Res_2012_Sep_20_2012_936518.nxml.txt.nlp	23049542	SENT199	3	3	5	5	glucose	TRPV4	PA449773	59341	0.554
NULL	Open_AIDS_J_2011_Apr_22_5_44-50.nxml.txt.nlp	21643422	SENT39	32	32	22	22	lamivudine	ATV	PA450163	4683	0.554
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT816	0	0	7	7	nilotinib	ABCB1	PA165958345	5243	0.554
NULL	Afr_J_Infect_Dis_2010_4(2)_20-28.nxml.txt.nlp	23878697	SENT39	4	4	16	16	artesunate	ACT	PA165111697	12;11332;9457;641455	0.554
NULL	Genome_Biol_2011_Jan_13_12(1)_R3.nxml.txt.nlp	21232131	SENT25	14	14	29	29	galactose	CDC25	PA449725	5923	0.554
NULL	Crit_Care_2006_Mar_29_10(2)_135.nxml.txt.nlp	16594988	SENT43	3	3	0	0	vasopressin	AVP	PA451858	114548;551	0.554
NULL	Infect_Drug_Resist_2011_Aug_4_4_149-154.nxml.txt.nlp	21904460	SENT105	44	44	23	23	cefepime	HAI	PA164754876	6692;6768	0.554
NULL	J_Korean_Med_Sci_2004_Apr_30_19(2)_167-171.nxml.txt.nlp	15082886	SENT118	44	44	0	0	pyrazinamide	PTH	PA451182	5741	0.554
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1437-1448.nxml.txt.nlp	24056706	SENT111	10	10	12	12	furafylline	CYP1A2	PA452614	1544	0.554
NULL	J_Cell_Mol_Med_2013_May_4_17(5)_672-680.nxml.txt.nlp	23551430	SENT62	30	30	17	17	gentamicin	CO2	PA449753	4513	0.554
NULL	Diabetes_Care_2013_Aug_17_36(Suppl_2)_S127-S138.nxml.txt.nlp	23882037	SENT476	18	18	16	16	liraglutide	GLP-1	PA165958364	100125288	0.554
NULL	Biomed_Res_Int_2014_Jan_29_2014_876712.nxml.txt.nlp	24605339	SENT212	22	22	30	30	diazepam	GIV	PA449283	55704	0.554
NULL	Oncotarget_2013_Oct_19_4(11)_2045-2056.nxml.txt.nlp	24185104	SENT72	9	9	12	12	cisplatin	14-3-3	PA449014	10971	0.554
NULL	Mol_Cancer_2010_Aug_20_9_220.nxml.txt.nlp	20727180	SENT101	0	0	10	10	curcumin	AP-1	PA151958596	2353;3727;2354;3725	0.554
NULL	Ther_Clin_Risk_Manag_2006_Sep_2(3)_297-301.nxml.txt.nlp	18360604	SENT75	21	21	8	8	paricalcitol	PTH	PA450798	5741	0.554
NULL	Allergy_Asthma_Immunol_Res_2014_Nov_19_6(6)_548-557.nxml.txt.nlp	25374755	SENT96	0	0	5	5	lovastatin	IL-6	PA450272	3569	0.553
NULL	Exp_Ther_Med_2013_Oct_19_6(4)_1070-1076.nxml.txt.nlp	24137319	SENT205	2	2	0	0	cyclophosphamide	CTX	PA449165	1593	0.553
NULL	Mol_Cell_Biochem_2014_Oct_9_385(1-2)_265-275.nxml.txt.nlp	24104452	SENT101	23	23	17	17	bortezomib	U87	PA10252	677775;641648	0.553
NULL	Int_J_Mol_Sci_2012_Aug_24_13(9)_10722-10735.nxml.txt.nlp	23109818	SENT458	12	12	26	26	fluorescein	CD11c	PA164746009	3687	0.553
NULL	Front_Behav_Neurosci_2010_Aug_3_4_50.nxml.txt.nlp	20802857	SENT330	27	27	10	10	indomethacin	COX	PA449982	1351	0.553
NULL	Exp_Ther_Med_2013_Feb_20_5(2)_443-447.nxml.txt.nlp	23407364	SENT162	11	11	13	13	cyclophosphamide	ANOVA	PA449165	4858	0.553
NULL	Breast_Cancer_Res_2013_Oct_3_15(5)_R93.nxml.txt.nlp	24088226	SENT99	6	6	27	27	tamoxifen	CYP2D6	PA451581	1565	0.553
NULL	Br_J_Cancer_1995_Mar_71(3)_619-624.nxml.txt.nlp	7880748	SENT9	21	21	25	25	vincristine	HOP	PA451879	84525;10963	0.553
NULL	Arthritis_Res_Ther_2006_Feb_8_8(2)_R44.nxml.txt.nlp	16507143	SENT47	35	35	46	46	l-glutamine	CO2	PA10090	4513	0.553
NULL	Cardiovasc_Diabetol_2013_Mar_18_12_46.nxml.txt.nlp	23497197	SENT212	4	4	6	6	metformin	adiponectin	PA450395	9370	0.553
NULL	J_Immunol_2015_Feb_1_194(3)_1252-1260.nxml.txt.nlp	25548224	SENT503	11	11	6	6	dextran	IL-18	PA449261	3606	0.553
NULL	J_Korean_Neurosurg_Soc_2013_Oct_31_54(4)_280-288.nxml.txt.nlp	24294450	SENT163	14	14	16	16	acetazolamide	ACZ	PA448018	27445	0.553
NULL	Core_Evid_2007_Nov_30_2(2)_121-129.nxml.txt.nlp	21221180	SENT267	13	13	23	23	mitoxantrone	MCP	PA450526	822	0.553
NULL	Alcohol_Res_2012_34(3)_282-292.nxml.txt.nlp	23134044	SENT60	6	6	29	29	ethanol	PSD-95	PA448073	1742	0.553
NULL	Cells_2012_Nov_5_1(4)_1029-1044.nxml.txt.nlp	24710541	SENT169	31	31	13	13	paraformaldehyde	CO2	PA450790	4513	0.553
NULL	Cancer_Metab_2014_Jan_3_2_1.nxml.txt.nlp	24383451	SENT114	20	20	22	22	l-cysteine	NAC	PA449173	22861	0.553
NULL	Eur_J_Endocrinol_2011_Jan_164(1)_69-74.nxml.txt.nlp	20961967	SENT76	9	9	3	3	pioglitazone	OPG	PA450970	690	0.553
NULL	Arthritis_Res_Ther_2013_Jul_9_15(4)_R73.nxml.txt.nlp	23837669	SENT251	3	3	5	5	colchicine	MICL	PA449092	160364	0.553
NULL	Cases_J_2009_Jul_30_2_7134.nxml.txt.nlp	19829918	SENT62	12	12	22	22	rasagiline	LCE	PA164764584	79071	0.553
NULL	J_Gen_Physiol_2013_Apr_141(4)_445-465.nxml.txt.nlp	23530137	SENT78	36	36	7	7	l-glutamine	CO2	PA10090	4513	0.553
NULL	Mol_Cells_2014_Dec_31_37(12)_899a-906.nxml.txt.nlp	25431425	SENT40	0	0	15	15	curcumin	ADP	PA151958596	23038	0.553
NULL	Cancer_Med_2014_Jun_28_3(3)_719-730.nxml.txt.nlp	24683044	SENT21	0	0	18	18	metformin	AMPK	PA450395	5563	0.553
NULL	Chin_J_Cancer_2011_Oct_30(10)_690-700.nxml.txt.nlp	21959046	SENT20	5	5	7	7	topotecan	TPT	PA451729	23590;6469	0.553
NULL	Int_J_Mol_Sci_2014_Sep_29_15(10)_17411-17441.nxml.txt.nlp	25268615	SENT214	2	2	0	0	hyaluronan	CD147	PA165958431	682	0.553
NULL	Biomed_Res_Int_2014_Jun_26_2014_161346.nxml.txt.nlp	25054130	SENT240	45	45	21	21	curcumin	STZ	PA151958596	6484	0.553
NULL	Front_Neural_Circuits_2015_Jan_12_8_150.nxml.txt.nlp	25628540	SENT155	9	9	46	46	atropine	ANOVA	PA448505	4858	0.553
NULL	Breast_Cancer_Res_Treat_2013_May_12_139(1)_107-113.nxml.txt.nlp	23580070	SENT25	18	18	28	28	geldanamycin	HER2	PA152031327	2064	0.553
NULL	J_Mol_Signal_2006_Nov_10_1_3.nxml.txt.nlp	17224078	SENT255	2	2	4	4	paclitaxel	P-gp	PA450761	5243	0.553
NULL	J_Korean_Med_Sci_2008_Aug_25_23(4)_657-661.nxml.txt.nlp	18756053	SENT104	1	1	9	9	estradiol	AMH	PA449503	268	0.553
NULL	Cancer_Causes_Control_2013_Aug_18_24(8)_1605-1614.nxml.txt.nlp	23775025	SENT64	25	25	8	8	methotrexate	CYP2A6	PA450428	1548	0.553
NULL	Exp_Ther_Med_2012_Sep_12_4(3)_475-480.nxml.txt.nlp	23181121	SENT159	12	12	16	16	rituximab	CHOP	PA451261	1649	0.553
NULL	Cardiovasc_Diabetol_2013_Jun_7_12_84.nxml.txt.nlp	23759020	SENT198	11	11	2	2	dipyridamole	LSR	PA449367	51599	0.553
NULL	Pan_Afr_Med_J_2014_Jun_19_18_169.nxml.txt.nlp	25422687	SENT73	33	33	24	24	vincristine	CO2	PA451879	4513	0.553
NULL	Mol_Cancer_2006_Sep_5_5_34.nxml.txt.nlp	16953886	SENT17	0	0	3	3	doxorubicin	XIAP	PA449412	331	0.553
NULL	Diabetes_2013_Jul_14_62(7)_2545-2558.nxml.txt.nlp	23423573	SENT294	10	10	8	8	camptothecin	CXCR7	PA153590860	57007	0.553
NULL	Ann_Rheum_Dis_2014_Jan_20_73(1)_86-94.nxml.txt.nlp	23962455	SENT99	32	32	7	7	methotrexate	CDAI	PA450428	146059	0.553
NULL	Genet_Mol_Biol_2009_Dec_1_Oct-Dec_32(4)_802-810.nxml.txt.nlp	21637458	SENT129	12	12	36	36	theobromine	AC1	PA451646	107	0.553
NULL	Front_Neurol_2010_Jul_12_1_11.nxml.txt.nlp	21206763	SENT85	0	0	8	8	riluzole	GDNF	PA451251	2668	0.553
NULL	Oncoimmunology_2013_Dec_1_2(12)_e27058.nxml.txt.nlp	24498564	SENT61	33	33	26	26	cyclophosphamide	THBS1	PA449165	7057	0.553
NULL	Mar_Drugs_2010_Mar_15_8(3)_629-657.nxml.txt.nlp	20411119	SENT3	17	17	14	14	pp2	PP1		5540;5464	0.553
NULL	J_Biol_Chem_2013_Nov_15_288(46)_33049-33059.nxml.txt.nlp	24089524	SENT129	16	16	12	12	nicotine	FBS	PA450626	64319;26269	0.553
NULL	Mol_Cancer_2009_Nov_10_8_99.nxml.txt.nlp	19903356	SENT37	5	5	3	3	imatinib	IGFBP3	PA10804	3486	0.553
NULL	Int_J_Endocrinol_2010_Mar_2_2010_621687.nxml.txt.nlp	20204178	SENT123	19	19	14	14	paricalcitol	PTH	PA450798	5741	0.553
NULL	Braz_J_Microbiol_2011_Jun_1_Apr-Jun_42(2)_693-702.nxml.txt.nlp	24031681	SENT157	17	17	19	19	ethanol	CO2	PA448073	4513	0.553
NULL	Eur_J_Pharm_Sci_2012_Jul_16_46(4)_244-258.nxml.txt.nlp	22085636	SENT767	24	24	33	33	pertuzumab	UCN		7349	0.553
NULL	Acta_Pharmacol_Sin_2012_Jul_18_33(7)_861-872.nxml.txt.nlp	22705730	SENT290	6	6	8	8	atorvastatin	PI3K	PA448500	5290	0.553
NULL	Anal_Bioanal_Chem_2012_Dec_4_404(10)_3071-3080.nxml.txt.nlp	23052869	SENT139	8	8	17	17	pilocarpine	MAX	PA450962	4149	0.553
NULL	Ther_Clin_Risk_Manag_2007_Jun_3(3)_411-420.nxml.txt.nlp	18488075	SENT132	7	7	13	13	alefacept	CD4	PA164748040	920	0.553
NULL	Front_Endocrinol_(Lausanne)_2011_Dec_6_2_93.nxml.txt.nlp	22654833	SENT610	11	11	9	9	troglitazone	gamma	PA451799	9913	0.553
NULL	Curr_Cardiol_Rev_2012_May_8(2)_158-165.nxml.txt.nlp	22708914	SENT123	17	17	12	12	rivaroxaban	CYP3A4	PA165958360	1576	0.553
NULL	Arthritis_Res_Ther_2006_Apr_12_8(Suppl_1)_S3.nxml.txt.nlp	16820042	SENT52	33	33	24	24	colchicine	ACTH	PA449092	5443	0.553
NULL	Pharmaceuticals_(Basel)_2011_Jan_11_4(1)_154-168.nxml.txt.nlp	NULL	SENT42	20	20	22	22	vasopressin	AVP	PA451858	114548;551	0.553
NULL	J_Hematol_Oncol_2012_May_15_5_23.nxml.txt.nlp	22587422	SENT32	4	4	27	27	dasatinib	ALL	PA162372878	613	0.553
NULL	J_Neurol_2011_Jul_2_258(7)_1207-1222.nxml.txt.nlp	21461686	SENT251	4	4	10	10	gabapentin	OPT	PA449720	51430	0.553
NULL	F1000Prime_Rep_2014_Aug_1_6_66.nxml.txt.nlp	25165565	SENT112	15	15	9	9	trastuzumab	HER2	PA451743	2064	0.553
NULL	Exp_Ther_Med_2014_Mar_17_7(3)_703-708.nxml.txt.nlp	24520271	SENT173	15	15	0	0	cisplatin	IFN	PA449014	3439	0.553
NULL	Indian_J_Pharm_Sci_2013_Nov-Dec_75(6)_680-687.nxml.txt.nlp	24591743	SENT30	7	7	16	16	gemfibrozil	UGT	PA449750	7361;7355	0.553
NULL	Cardiovasc_J_Afr_2013_Apr_24(3)_78-81.nxml.txt.nlp	23736131	SENT9	6	6	16	16	hemin	HO-1	PA449849	3162	0.553
NULL	EMBO_Mol_Med_2013_Jul_6_5(7)_905-915.nxml.txt.nlp	23740690	SENT181	6	6	8	8	lipase	ATGL	PA450239	57104	0.553
NULL	Clinics_(Sao_Paulo)_2009_Jun_64(6)_599-606.nxml.txt.nlp	19578667	SENT120	19	19	15	15	imiquimod	CO2	PA449972	4513	0.553
NULL	Oncol_Lett_2013_Apr_5_5(4)_1123-1128.nxml.txt.nlp	23599750	SENT29	26	26	23	23	docetaxel	LDM	PA449383	1595	0.553
NULL	Br_J_Cancer_2004_Mar_22_90(6)_1274-1278.nxml.txt.nlp	15026812	SENT85	21	21	23	23	bleomycin	ZAG	PA448645	563	0.553
NULL	Neural_Regen_Res_2014_Oct_15_9(20)_1830-1838.nxml.txt.nlp	25422646	SENT92	25	25	13	13	dextran	SP5	PA449261	389058	0.553
NULL	Curr_Respir_Med_Rev_2013_Aug_9(4)_238-247.nxml.txt.nlp	24634642	SENT24	9	9	11	11	fludarabine	CHOP	PA449655	1649	0.553
NULL	J_Immunother_Cancer_2014_Jan_27_2_2.nxml.txt.nlp	24829759	SENT178	5	5	21	21	sorafenib	IL-2	PA7000	3558	0.553
NULL	Breast_Cancer_(Auckl)_2014_Oct_8_8_125-133.nxml.txt.nlp	25336961	SENT125	5	5	23	23	trastuzumab	DM1	PA451743	338023;1760;28509	0.553
NULL	Stroke_Res_Treat_2012_Nov_9_2012_156975.nxml.txt.nlp	22135770	SENT35	30	30	27	27	remifentanil	CEA	PA451232	5670;1087	0.553
NULL	Eur_J_Haematol_2009_May_82(5)_339-349.nxml.txt.nlp	19187276	SENT219	12	12	23	23	enoxaparin	TKR	PA449463	8277	0.553
NULL	Oncotarget_2014_Feb_16_5(4)_1062-1070.nxml.txt.nlp	24658085	SENT224	7	7	12	12	pemetrexed	AMPK	PA10810	5563	0.553
NULL	Breast_Cancer_(Dove_Med_Press)_2013_Aug_22_5_73-78.nxml.txt.nlp	24648760	SENT114	18	18	12	12	tamoxifen	CYP2D6	PA451581	1565	0.553
NULL	Oncol_Lett_2014_Apr_24_7(4)_1265-1269.nxml.txt.nlp	24944704	SENT27	30	30	37	37	gentamicin	CO2	PA449753	4513	0.553
NULL	Korean_J_Anesthesiol_2013_Dec_26_65(6_Suppl)_S62-S64.nxml.txt.nlp	24478876	SENT54	20	20	13	13	heparin	CEA	PA449855	5670;1087	0.553
NULL	Cell_J_2012_Aug_31_Summer_14(2)_130-141.nxml.txt.nlp	23507689	SENT210	33	33	8	8	collagenase	spatial	PA449107	219793	0.553
NULL	J_Mol_Signal_2009_Apr_28_4_2.nxml.txt.nlp	19400946	SENT149	16	16	33	33	estradiol	Gen	PA449503	348654	0.553
NULL	Oncol_Rep_2013_Dec_1_30(6)_2632-2638.nxml.txt.nlp	24085151	SENT127	0	0	15	15	estradiol	CYP3A4	PA449503	1576	0.553
NULL	Endocrinology_2015_Jan_6_156(1)_24-31.nxml.txt.nlp	25375036	SENT30	22	22	29	29	flutamide	DES	PA449685	1674	0.553
NULL	Afr_J_Infect_Dis_2011_5(2)_40-46.nxml.txt.nlp	23878706	SENT88	14	14	8	8	ceftazidime	Gen	PA448861	348654	0.553
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Apr_15_9_13.nxml.txt.nlp	20398300	SENT134	2	2	11	11	lansoprazole	LAM	PA450180	7249;7248	0.553
NULL	Ann_Gen_Psychiatry_2008_Aug_18_7_11.nxml.txt.nlp	18706108	SENT120	7	7	0	0	ethanol	BUP	PA448073	23412	0.553
NULL	J_Mater_Sci_Mater_Med_2012_Jul_20_23(7)_1637-1644.nxml.txt.nlp	22528070	SENT61	4	4	7	7	ethanol	PES	PA448073	23481	0.553
NULL	J_Ophthalmic_Inflamm_Infect_2011_Nov_6_2(1)_21-28.nxml.txt.nlp	22057810	SENT76	8	8	13	13	azathioprine	CTX	PA448515	1593	0.553
NULL	J_Biomed_Sci_2013_May_20_20(1)_30.nxml.txt.nlp	23687991	SENT73	21	21	45	45	l-glutamine	CO2	PA10090	4513	0.553
NULL	Oncol_Lett_2014_Nov_10_8(5)_2333-2339.nxml.txt.nlp	25295120	SENT143	2	2	9	9	sorafenib	ADM	PA7000	133	0.553
NULL	Mucosal_Immunol_2012_Nov_23_5(6)_610-622.nxml.txt.nlp	22617838	SENT404	8	8	15	15	fluorescein	IFN	PA164746009	3439	0.553
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT74	18	18	8	8	nutlin-3	IBP		706;50619	0.553
NULL	J_Hematol_Oncol_2013_Feb_25_6_19.nxml.txt.nlp	23442817	SENT264	14	14	33	33	nadh	HIF-1	PA164755085	29072	0.553
NULL	Braz_J_Med_Biol_Res_2013_Dec_10_46(12)_1033-1039.nxml.txt.nlp	24345912	SENT18	10	10	6	6	ethanol	IL-6	PA448073	3569	0.553
NULL	BMJ_2011_Aug_4_343_d4588.nxml.txt.nlp	21816733	SENT28	46	46	41	41	clopidogrel	CYP2C19	PA449053	1557	0.553
NULL	Lab_Anim_Res_2012_Dec_26_28(4)_245-253.nxml.txt.nlp	23326285	SENT37	9	9	20	20	heparin	San	PA449855	80218	0.553
NULL	Leukemia_2014_Mar_13_28(3)_600-608.nxml.txt.nlp	24240203	SENT12	2	2	8	8	nutlin-3	p53		7157	0.553
NULL	J_Oncol_2012_Jun_19_2012_521215.nxml.txt.nlp	22778735	SENT232	20	20	30	30	lapatinib	CRT	PA152241907	811	0.553
NULL	Sci_Rep_2015_Jan_15_5_7817.nxml.txt.nlp	25588710	SENT213	14	14	9	9	trastuzumab	MPL	PA451743	4352	0.553
NULL	Indian_J_Ophthalmol_2014_Oct_62(10)_985-991.nxml.txt.nlp	25449931	SENT103	7	7	14	14	edrophonium	OMG	PA449437	4974	0.553
NULL	Br_J_Cancer_2011_May_24_104(11)_1786-1790.nxml.txt.nlp	21559018	SENT101	12	12	19	19	decitabine	EGFR	PA164749631	1956	0.553
NULL	J_Gynecol_Oncol_2012_Jan_9_23(1)_53-64.nxml.txt.nlp	22355468	SENT74	24	24	15	15	olaparib	BRCA1		672	0.553
NULL	Exp_Anim_2014_Jul_22_63(4)_447-457.nxml.txt.nlp	25048263	SENT144	30	30	36	36	estradiol	IGF1	PA449503	3479	0.553
NULL	CNS_Drugs_2014_May_1_28(6)_497-511.nxml.txt.nlp	24788672	SENT107	14	14	5	5	lisdexamfetamine	ATX	PA164748975	5168;23049	0.553
NULL	Int_J_Hypertens_2012_Nov_30_2012_192567.nxml.txt.nlp	22187625	SENT164	20	20	41	41	candesartan	ANOVA	PA448765	4858	0.553
NULL	J_Oncol_2012_Aug_25_2012_782020.nxml.txt.nlp	21876694	SENT302	15	15	5	5	cyclophosphamide	IFN	PA449165	3439	0.553
NULL	Front_Genet_2012_Nov_5_3_236.nxml.txt.nlp	23133441	SENT132	14	14	21	21	efavirenz	CYP2B6	PA449441	1555	0.553
NULL	Int_J_Nanomedicine_2012_Sep_21_7_5091-5106.nxml.txt.nlp	23049256	SENT336	7	7	9	9	protamine	SOD1	PA10366	6647	0.553
NULL	Antimicrob_Resist_Infect_Control_2012_Mar_16_1_12.nxml.txt.nlp	22958880	SENT107	14	14	28	28	chloramphenicol	CTX	PA448927	1593	0.553
NULL	Front_Neurol_2014_Feb_18_5_17.nxml.txt.nlp	24600432	SENT180	19	19	12	12	levetiracetam	mol	PA450206	90527	0.553
NULL	Indian_J_Hum_Genet_2014_Jan-Mar_20(1)_10-19.nxml.txt.nlp	24959009	SENT118	5	5	10	10	heparin	EC-SOD	PA449855	6649	0.553
NULL	Cell_Commun_Signal_2013_Dec_23_11_100.nxml.txt.nlp	24364863	SENT404	25	25	17	17	paraformaldehyde	CO2	PA450790	4513	0.553
NULL	Case_Rep_Oncol_Med_2013_Nov_26_2013_862585.nxml.txt.nlp	24371535	SENT57	22	22	31	31	cyclophosphamide	CHOP	PA449165	1649	0.553
NULL	Proteome_Sci_2009_May_28_7_20.nxml.txt.nlp	19476632	SENT163	20	20	10	10	galactose	NDUFA9	PA449725	4704	0.553
NULL	Nucleic_Acids_Res_2011_Oct_9_39(19)_8314-8328.nxml.txt.nlp	21745818	SENT251	24	24	4	4	galactose	GAL	PA449725	51083	0.553
NULL	Biomed_Res_Int_2014_Feb_6_2014_323594.nxml.txt.nlp	24689036	SENT54	21	21	10	10	l-glutamine	F12	PA10090	2161	0.553
NULL	J_Invest_Dermatol_2012_Sep_19_132(9)_2198-2205.nxml.txt.nlp	22513780	SENT43	0	0	10	10	isotretinoin	TLR-4	PA450128	7099	0.553
NULL	Nat_Commun_2013_Oct_1_4_2516.nxml.txt.nlp	24084631	SENT655	0	0	20	20	losartan	AK4	PA450268	205	0.553
NULL	Pharmaceuticals_(Basel)_2012_Oct_25_5(11)_1147-1159.nxml.txt.nlp	23580869	SENT355	6	6	13	13	ethionamide	FMO2	PA164768738	2327	0.553
NULL	J_Clin_Biochem_Nutr_2011_May_13_48(3)_237-244.nxml.txt.nlp	21562645	SENT181	5	5	14	14	resveratrol	RAGE		177	0.553
NULL	Pharmaceuticals_(Basel)_2012_Oct_25_5(11)_1147-1159.nxml.txt.nlp	23580869	SENT355	6	6	15	15	ethionamide	FMO3	PA164768738	2328	0.553
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Nov_13_64(Pt_12)_o2332.nxml.txt.nlp	21581307	SENT64	27	27	19	19	ethanol	mol	PA448073	90527	0.553
NULL	Clin_Endosc_2013_Jul_31_46(4)_311-312.nxml.txt.nlp	23964324	SENT0	23	23	17	17	propofol	Solo	PA451141	91404	0.553
NULL	Int_J_Mol_Sci_2014_Mar_26_15(4)_5323-5336.nxml.txt.nlp	24675699	SENT415	0	0	11	11	sunitinib	S6K1	PA162372840	6198	0.553
NULL	Oncotarget_2014_Mar_13_5(4)_1101-1110.nxml.txt.nlp	24658355	SENT2	18	18	26	26	tamoxifen	MKP-2	PA451581	1846	0.553
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Nov_14_65(Pt_12)_m1584.nxml.txt.nlp	21578614	SENT59	11	11	4	4	sulfadiazine	NO3	PA451539	4681	0.553
NULL	J_Clin_Biochem_Nutr_2010_Jan_29_46(1)_36-42.nxml.txt.nlp	20104263	SENT121	17	17	23	23	ribavirin	IFN	PA451241	3439	0.553
NULL	Chem_Cent_J_2014_Jan_17_8_4.nxml.txt.nlp	24438453	SENT131	6	6	28	28	genistein	IFN	PA165109660	3439	0.553
NULL	J_Mol_Med_(Berl)_2013_Aug_17_91(11)_1257-1271.nxml.txt.nlp	23955016	SENT176	7	7	2	2	thrombin	p38	PA451674	10598;1432;7965	0.553
NULL	Mol_Cancer_2008_Mar_26_7_27.nxml.txt.nlp	18366759	SENT262	18	18	6	6	etoposide	p53	PA449552	7157	0.553
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1224-1233.nxml.txt.nlp	22353810	SENT164	13	13	21	21	doxorubicin	MRP-1	PA449412	928	0.553
NULL	Emerg_Med_Int_2014_Feb_20_2014_935474.nxml.txt.nlp	24696784	SENT48	7	7	12	12	rivaroxaban	STA	PA165958360	2010;2656	0.553
NULL	Croat_Med_J_2014_Aug_55(4)_377-387.nxml.txt.nlp	25165051	SENT136	10	10	19	19	bumetanide	AQP1	PA448682	358	0.553
NULL	AIDS_Res_Ther_2011_Oct_6_8_36.nxml.txt.nlp	21978457	SENT142	16	16	18	18	zinc	ZIP4	PA451956	55630	0.553
NULL	Int_J_Biol_Sci_2011_Nov_5_8(1)_1-14.nxml.txt.nlp	22211100	SENT169	2	2	17	17	evodiamine	survivin	PA165860788	332	0.553
NULL	Biomed_Res_Int_2014_Mar_6_2014_712893.nxml.txt.nlp	24734240	SENT206	5	5	7	7	ethanol	HIF-1alpha	PA448073	3091	0.553
NULL	Korean_J_Anesthesiol_2013_Feb_15_64(2)_105-111.nxml.txt.nlp	23459312	SENT81	32	32	23	23	heparin	ACT	PA449855	12;11332;9457;641455	0.553
NULL	Oncotarget_2014_Aug_19_5(18)_8737-8749.nxml.txt.nlp	25228590	SENT81	9	9	20	20	crizotinib	PI3K	PA165946122	5290	0.553
NULL	J_Hematol_Oncol_2011_Mar_26_4_11.nxml.txt.nlp	21439076	SENT117	22	22	28	28	camptothecin	Gem	PA153590860	51053	0.553
NULL	Vet_Res_2012_Jun_27_43(1)_54.nxml.txt.nlp	22738036	SENT99	3	3	6	6	mitomycin	MDDC	PA450524	1541	0.553
NULL	J_Mol_Med_(Berl)_2012_Apr_30_90(4)_401-411.nxml.txt.nlp	22038171	SENT197	35	35	27	27	tetracycline	HIF-1	PA451640	29072	0.553
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT606	11	11	31	31	metformin	p53	PA450395	7157	0.553
NULL	Eur_J_Med_Res_2009_Jul_22_14(7)_309-314.nxml.txt.nlp	19661014	SENT178	6	6	12	12	clarithromycin	IL-8	PA449028	3576	0.553
NULL	Am_J_Trop_Med_Hyg_2014_Jul_2_91(1)_3-4.nxml.txt.nlp	24752685	SENT28	17	17	26	26	primaquine	G6PD	PA451103	2539	0.553
NULL	J_Clin_Biochem_Nutr_2009_Jan_27_44(1)_79-84.nxml.txt.nlp	19177192	SENT7	26	26	12	12	curcumin	HO-1	PA151958596	3162	0.553
NULL	Eur_J_Pharmacol_2008_Feb_12_580(3-3)_291-297.nxml.txt.nlp	18082160	SENT8	25	25	33	33	granisetron	5-HT3A	PA449809	3359	0.553
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT70	14	14	4	4	metformin	ADP	PA450395	23038	0.553
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT1699	0	0	19	19	atazanavir	ATV	PA10251	4683	0.553
NULL	Diabetes_2013_Oct_17_62(10)_3500-3513.nxml.txt.nlp	23884882	SENT207	0	0	21	21	resveratrol	SIRT1		23411	0.553
NULL	Drugs_2014_Jun_25_74(10)_1063-1072.nxml.txt.nlp	24962424	SENT153	10	10	3	3	isoniazid	EMB	PA450112	133418	0.553
NULL	Front_Neurosci_2014_Jul_17_8_200.nxml.txt.nlp	25100932	SENT77	4	4	13	13	ethanol	GLT-1	PA448073	6506	0.553
NULL	Arthritis_Res_Ther_2004_Mar_8_6(3)_R199-R207.nxml.txt.nlp	15142265	SENT26	2	2	5	5	collagenase	MMP3	PA449107	4314	0.553
NULL	Mol_Syst_Biol_2010_Jul_27_6_391.nxml.txt.nlp	20664637	SENT322	23	23	14	14	chloramphenicol	CAT	PA448927	847	0.553
NULL	Indian_J_Med_Res_2013_Jan_137(1)_102-110.nxml.txt.nlp	23481058	SENT129	8	8	21	21	oxygen	ARD1	PA450744	5511;373	0.553
NULL	J_Exp_Med_1996_Dec_1_184(6)_2445-2450.nxml.txt.nlp	8976202	SENT8	15	15	12	12	etoposide	IL-2	PA449552	3558	0.553
NULL	Int_J_Mol_Sci_2012_Sep_26_13(10)_12268-12286.nxml.txt.nlp	23202898	SENT856	27	27	29	29	heparin	EGF	PA449855	1950	0.553
NULL	Chin_J_Cancer_2011_Aug_30(8)_508-525.nxml.txt.nlp	21801600	SENT168	9	9	18	18	nadh	ND5	PA164755085	4540	0.553
NULL	AIDS_Res_Ther_2008_Jun_5_5_11.nxml.txt.nlp	18534033	SENT316	24	24	9	9	paraformaldehyde	CD24	PA450790	100133941	0.553
NULL	Cell_Death_Dis_2010_Sep_23_1(9)_e78.nxml.txt.nlp	21364680	SENT177	41	41	13	13	cisplatin	P31	PA449014	529	0.553
NULL	J_Obes_2011_Apr_28_2011_587495.nxml.txt.nlp	21603273	SENT178	13	13	15	15	lipase	ATGL	PA450239	57104	0.553
NULL	Crit_Care_2007_Mar_22_11(Suppl_2)_P19.nxml.txt.nlp	NULL	SENT14	9	9	6	6	hyaluronan	APC	PA165958431	324	0.553
NULL	Cancer_Med_2013_Feb_3_2(1)_40-49.nxml.txt.nlp	24133626	SENT169	2	2	4	4	cilostazol	PDE3B	PA164746334	5140	0.553
NULL	Curr_Neuropharmacol_2013_May_11(3)_263-275.nxml.txt.nlp	24179463	SENT296	17	17	6	6	olanzapine	beta-catenin	PA450688	1499	0.553
NULL	Reprod_Biol_Endocrinol_2003_Oct_10_1_75.nxml.txt.nlp	14613549	SENT198	7	7	9	9	diethylstilbestrol	DES	PA449307	1674	0.553
NULL	Cancer_Manag_Res_2012_Nov_9_4_383-395.nxml.txt.nlp	23204869	SENT122	9	9	0	0	ethanol	PC-3	PA448073	692094	0.553
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT190	13	13	7	7	cisplatin	p53	PA449014	7157	0.553
NULL	Curr_Control_Trials_Cardiovasc_Med_2001_Feb_8_2(1)_45-53.nxml.txt.nlp	11806772	SENT37	12	12	0	0	basiliximab	CD4	PA164747126	920	0.552
NULL	J_Gen_Physiol_1996_Apr_1_107(4)_535-544.nxml.txt.nlp	8722565	SENT10	7	7	22	22	picrotoxin	ERG	PA164777007	2078	0.552
NULL	Oncogene_2013_Sep_12_32(37)_4355-4365.nxml.txt.nlp	23108409	SENT179	5	5	3	3	hyaluronan	HAS2	PA165958431	3037	0.552
NULL	J_Cell_Mol_Med_2013_Jun_15_17(6)_792-799.nxml.txt.nlp	23672538	SENT61	7	7	26	26	fluorescein	CD14	PA164746009	929	0.552
NULL	Int_J_Environ_Res_Public_Health_2010_Apr_30_7(4)_1448-1466.nxml.txt.nlp	20617039	SENT38	0	0	6	6	ethanol	DRD2	PA448073	1813	0.552
NULL	Gene_Regul_Syst_Bio_2014_Mar_4_8_63-73.nxml.txt.nlp	24634581	SENT201	0	0	6	6	minocycline	BNIP3	PA450519	664	0.552
NULL	Adv_Pharmacol_Sci_2013_Dec_5_2013_387071.nxml.txt.nlp	24381587	SENT114	18	18	10	10	methotrexate	TNF	PA450428	7124	0.552
NULL	Crit_Care_2007_Dec_18_11(6)_178.nxml.txt.nlp	18177510	SENT10	18	18	20	20	vasopressin	AVP	PA451858	114548;551	0.552
NULL	Sex_Transm_Infect_2011_Dec_87(Suppl_2)_ii39-ii43.nxml.txt.nlp	22110154	SENT110	4	4	8	8	azithromycin	San	PA448519	80218	0.552
NULL	Mol_Cancer_2010_Aug_20_9_220.nxml.txt.nlp	20727180	SENT206	0	0	5	5	nicotine	AP-1	PA450626	2353;3727;2354;3725	0.552
NULL	J_Cell_Mol_Med_2014_Apr_20_18(4)_709-720.nxml.txt.nlp	24444314	SENT165	6	6	19	19	metformin	p53	PA450395	7157	0.552
NULL	Environ_Health_Perspect_2008_Mar_26_116(3)_322-328.nxml.txt.nlp	18335098	SENT186	18	18	25	25	estradiol	PMI	PA449503	8834;5373	0.552
NULL	Br_J_Cancer_2009_Oct_6_101(7)_1044-1050.nxml.txt.nlp	19738609	SENT1	9	9	35	35	doxorubicin	San	PA449412	80218	0.552
NULL	Mar_Drugs_2014_Nov_24_12(11)_5677-5697.nxml.txt.nlp	25421323	SENT617	4	4	7	7	taurine	TNF-alpha	PA451590	7124	0.552
NULL	J_Emerg_Trauma_Shock_2012_Oct-Dec_5(4)_279-284.nxml.txt.nlp	23248494	SENT65	18	18	23	23	ketamine	OST	PA450144	1650;23263	0.552
NULL	J_Vis_Exp_2009_Jan_16_(23)_990.nxml.txt.nlp	19229177	SENT92	4	4	23	23	papain	CO2	PA450778	4513	0.552
NULL	EMBO_J_2013_Aug_14_32(16)_2275-2286.nxml.txt.nlp	23881097	SENT114	20	20	7	7	diazepam	P14	PA449283	11102;;6280;56259	0.552
NULL	Int_J_Biomed_Sci_2013_Sep_9(3)_112-122.nxml.txt.nlp	24170986	SENT113	3	3	16	16	captopril	STAT3	PA448780	6774	0.552
NULL	Crit_Care_2010_Nov_5_14(6)_R200.nxml.txt.nlp	21054850	SENT119	3	3	0	0	vasopressin	AVP	PA451858	114548;551	0.552
NULL	J_Headache_Pain_2012_Nov_16_13(8)_677-684.nxml.txt.nlp	23070400	SENT170	0	0	5	5	nabilone	DAI	PA164746998	81030	0.552
NULL	Environ_Health_Perspect_2004_Jul_21_112(10)_1074-1079.nxml.txt.nlp	15238280	SENT254	9	9	22	22	creatine	HGB	PA164778930	114757	0.552
NULL	Glycoconj_J_2013_Apr_29_30(3)_205-225.nxml.txt.nlp	22544341	SENT167	44	44	33	33	galactose	SPG	PA449725	55764	0.552
NULL	Lab_Invest_2014_May_10_94(5)_503-516.nxml.txt.nlp	24614199	SENT325	7	7	21	21	curcumin	RAGE	PA151958596	177	0.552
NULL	Evid_Based_Complement_Alternat_Med_2015_Jan_6_2015_736431.nxml.txt.nlp	25632290	SENT466	3	3	10	10	curcumin	P-gp	PA151958596	5243	0.552
NULL	Br_J_Haematol_2014_Mar_13_164(1)_811-821.nxml.txt.nlp	24328678	SENT151	10	10	21	21	lenalidomide	Aiolos	PA162363968	22806	0.552
NULL	J_Korean_Med_Sci_2010_Apr_19_25(4)_557-563.nxml.txt.nlp	20357998	SENT111	0	0	25	25	rosiglitazone	MCP-1	PA451283	6347	0.552
NULL	Clin_Ophthalmol_2010_Nov_23_4_1355-1359.nxml.txt.nlp	21179218	SENT65	19	19	23	23	latanoprost	BAK	PA164774763	578	0.552
NULL	J_Clin_Biochem_Nutr_2011_Jul_17_49(1)_50-56.nxml.txt.nlp	21765607	SENT170	27	27	13	13	arsenite	JNK	PA452638	5599	0.552
NULL	Breast_Cancer_Res_2008_Mar_17_10(2)_204.nxml.txt.nlp	18373885	SENT128	17	17	20	20	thrombin	PAR-1	PA451674	2011;2149	0.552
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT19	13	13	21	21	pemetrexed	UNG	PA10810	7374	0.552
NULL	Environ_Health_Perspect_2010_Sep_28_118(9)_1267-1272.nxml.txt.nlp	20427257	SENT231	16	16	25	25	estradiol	BPA	PA449503	667	0.552
NULL	Br_J_Cancer_2003_Mar_10_88(5)_754-759.nxml.txt.nlp	12618886	SENT150	4	4	13	13	amifostine	p53	PA448365	7157	0.552
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT192	23	23	30	30	panitumumab	Yes	PA162373091	7525	0.552
NULL	Environ_Health_Perspect_2006_Sep_23_114(9)_1401-1406.nxml.txt.nlp	16966095	SENT18	13	13	7	7	arsenite	p53	PA452638	7157	0.552
NULL	Cancer_Cell_Int_2014_Jun_11_14_49.nxml.txt.nlp	24991192	SENT49	2	2	8	8	berberine	Bcl-2	PA165860812	596	0.552
NULL	Exp_Mol_Med_2012_Sep_30_44(9)_554-561.nxml.txt.nlp	22809871	SENT94	30	30	36	36	streptomycin	CO2	PA451512	4513	0.552
NULL	Ann_Dermatol_2011_Dec_27_23(Suppl_3)_S322-S325.nxml.txt.nlp	22346268	SENT30	10	10	20	20	tretinoin	CO2	PA451746	4513	0.552
NULL	Front_Pharmacol_2014_Dec_10_5_271.nxml.txt.nlp	25540621	SENT95	9	9	14	14	fenfluramine	ghrelin	PA449592	51738	0.552
NULL	Mol_Syst_Biol_2010_Jul_27_6_391.nxml.txt.nlp	20664637	SENT57	8	8	11	11	choline	CHKA	PA448976	1119	0.552
NULL	Oncotarget_2014_Sep_2_5(19)_9308-9321.nxml.txt.nlp	25301721	SENT115	12	12	3	3	rolipram	MRP4	PA153906323	10257	0.552
NULL	Oncogene_2014_Oct_9_33(41)_4941-4951.nxml.txt.nlp	24681952	SENT115	13	13	34	34	metformin	WNT5A	PA450395	7474	0.552
NULL	J_Lipid_Res_2015_Jan_56(1)_109-121.nxml.txt.nlp	25421061	SENT775	21	21	23	23	lipase	ATGL	PA450239	57104	0.552
NULL	Cancer_Res_Treat_2012_Mar_31_44(1)_1-10.nxml.txt.nlp	22500155	SENT124	7	7	12	12	vemurafenib	BRAF	PA165946873	673	0.552
NULL	Cell_Biosci_2011_Mar_8_1_10.nxml.txt.nlp	21711726	SENT117	15	15	6	6	chloroquine	LAMP	PA448948	4045;27074	0.552
NULL	Adv_Hematol_2013_Jan_10_2013_953982.nxml.txt.nlp	23365579	SENT146	9	9	12	12	imatinib	CXCR4	PA10804	7852	0.552
NULL	Arch_Sex_Behav_2011_Apr_28_40(2)_273-279.nxml.txt.nlp	19330436	SENT59	8	8	10	10	ketamine	gamma	PA450144	9913	0.552
NULL	Exp_Ther_Med_2013_Mar_21_5(3)_987-991.nxml.txt.nlp	23407636	SENT140	13	13	19	19	losartan	CXCR2	PA450268	3579	0.552
NULL	Nucl_Recept_Signal_2008_Nov_26_6_e010.nxml.txt.nlp	19079612	SENT195	5	5	10	10	leuprolide	SARM	PA450203	23098	0.552
NULL	Br_J_Cancer_2013_Jan_15_108(1)_115-120.nxml.txt.nlp	23175150	SENT105	17	17	4	4	bevacizumab	KRAS	PA130232992	3845	0.552
NULL	EMBO_Mol_Med_2011_May_3(5)_266-278.nxml.txt.nlp	21438154	SENT5	2	2	17	17	oxaliplatin	TRAAK	PA131285527	50801	0.552
NULL	Clin_Med_Insights_Womens_Health_2013_Jan_23_6_13-24.nxml.txt.nlp	24665210	SENT172	17	17	28	28	medroxyprogesterone	CEE	PA450344	51608	0.552
NULL	Allergy_Asthma_Immunol_Res_2014_Nov_19_6(6)_548-557.nxml.txt.nlp	25374755	SENT127	21	21	23	23	lovastatin	IL-6	PA450272	3569	0.552
NULL	Front_Genet_2012_Nov_5_3_236.nxml.txt.nlp	23133441	SENT118	17	17	12	12	efavirenz	ABCB1	PA449441	5243	0.552
NULL	Oxid_Med_Cell_Longev_2012_Apr_5_2012_983427.nxml.txt.nlp	22550557	SENT165	28	28	24	24	ethanol	Bcl-2	PA448073	596	0.552
NULL	Genome_Med_2010_Nov_12_2(11)_81.nxml.txt.nlp	21092148	SENT112	22	22	12	12	tamoxifen	HER2	PA451581	2064	0.552
NULL	Indian_J_Pharm_Sci_2013_Nov-Dec_75(6)_680-687.nxml.txt.nlp	24591743	SENT43	4	4	7	7	gemfibrozil	CYP2C8	PA449750	1558	0.552
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT53	3	3	0	0	estradiol	ABCC10	PA449503	89845	0.552
NULL	Acta_Pharmacol_Sin_2011_May_18_32(5)_591-600.nxml.txt.nlp	21499286	SENT246	2	2	4	4	bezafibrate	AMPK	PA162364313	5563	0.552
NULL	Nucleic_Acids_Res_2012_Apr_16_40(8)_3511-3523.nxml.txt.nlp	22180533	SENT153	9	9	2	2	doxycycline	E2F7	PA449415	144455	0.552
NULL	Clin_Med_Oncol_2008_Jun_11_2_469-470.nxml.txt.nlp	21892319	SENT32	32	32	34	34	trastuzumab	HER-2	PA451743	2064	0.552
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT128	7	7	3	3	phenytoin	CYP2D6	PA450947	1565	0.552
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT195	35	35	30	30	metformin	HIP	PA450395	6767;6159;64399;5068	0.552
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT72	1	1	6	6	pp2	PP2		4888	0.552
NULL	Curr_Neuropharmacol_2009_Jun_7(2)_125-131.nxml.txt.nlp	19949571	SENT188	3	3	10	10	zolpidem	CA1	PA451976	759	0.552
NULL	Reprod_Biol_Endocrinol_2003_Oct_3_1_62.nxml.txt.nlp	14567758	SENT187	6	6	30	30	lindane	ANOVA	PA164754914	4858	0.552
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT63	16	16	14	14	vinorelbine	ASC	PA451881	29108	0.552
NULL	Aging_(Albany_NY)_2009_Jun_3_1(6)_515-528.nxml.txt.nlp	20157535	SENT155	7	7	10	10	resveratrol	S6K1		6198	0.552
NULL	Cancer_Cell_Int_2014_Jun_16_14_53.nxml.txt.nlp	24966801	SENT186	3	3	22	22	metformin	p62	PA450395	8878;10657;23636	0.552
NULL	Arthritis_Rheumatol_2014_Jun_27_66(6)_1574-1582.nxml.txt.nlp	24577881	SENT105	11	11	13	13	hydralazine	CD4	PA449894	920	0.552
NULL	CNS_Drugs_2014_May_1_28(6)_497-511.nxml.txt.nlp	24788672	SENT103	14	14	0	0	lisdexamfetamine	ATX	PA164748975	5168;23049	0.552
NULL	Indian_J_Med_Res_2011_Nov_134(5)_704-708.nxml.txt.nlp	22199111	SENT54	6	6	13	13	vancomycin	VISA	PA451850	57506	0.552
NULL	Infect_Dis_Ther_2014_Jun_18_3(1)_35-43.nxml.txt.nlp	25134810	SENT93	4	4	9	9	daptomycin	VAN	PA164768820	10318	0.552
NULL	Case_Rep_Med_2012_Dec_3_2012_163173.nxml.txt.nlp	23326270	SENT16	11	11	21	21	l-carnitine	CPT2	PA450154	1376	0.552
NULL	Clin_Exp_Otorhinolaryngol_2011_Mar_17_4(1)_18-23.nxml.txt.nlp	21461058	SENT94	20	20	27	27	furosemide	KCC2	PA449719	57468	0.552
NULL	Arch_Med_Sci_2013_Oct_31_9(5)_916-921.nxml.txt.nlp	24273579	SENT90	8	8	4	4	bleomycin	AQP1	PA448645	358	0.552
NULL	Surg_Neurol_Int_2010_Dec_25_1_93.nxml.txt.nlp	21246060	SENT212	48	48	32	32	l-glutamine	EGF	PA10090	1950	0.552
NULL	Croat_Med_J_2014_Jun_55(3)_206-217.nxml.txt.nlp	24891279	SENT82	22	22	42	42	doxorubicin	p53	PA449412	7157	0.552
NULL	J_Exp_Med_1980_Dec_1_152(6)_1699-1708.nxml.txt.nlp	7452150	SENT10	25	25	9	9	galactose	mol	PA449725	90527	0.552
NULL	J_Gen_Physiol_2009_Apr_133(4)_421-438.nxml.txt.nlp	19289574	SENT236	32	32	12	12	glibenclamide	SLC26A9	PA449782	115019	0.552
NULL	EMBO_J_2009_May_6_28(9)_1197-1207.nxml.txt.nlp	19322195	SENT264	33	33	27	27	dextran	EGF	PA449261	1950	0.552
NULL	Clin_Exp_Reprod_Med_2013_Sep_30_40(3)_115-121.nxml.txt.nlp	24179868	SENT28	0	0	6	6	letrozole	aromatase	PA450196	1588	0.552
NULL	Breast_Cancer_Res_2012_Nov_5_14(6)_324.nxml.txt.nlp	23127286	SENT38	21	21	11	11	docetaxel	DUSP4	PA449383	1846	0.552
NULL	Leukemia_2014_Jun_25_28(6)_1280-1288.nxml.txt.nlp	24270737	SENT121	7	7	9	9	decitabine	DAC	PA164749631	13	0.552
NULL	Neuropsychopharmacology_2009_Jul_11_34(8)_1946-1957.nxml.txt.nlp	19279569	SENT170	44	44	38	38	cocaine	DOR	PA449072	58476	0.552
NULL	Oncotarget_2014_Jun_4_5(18)_8284-8305.nxml.txt.nlp	25268740	SENT254	42	42	33	33	streptomycin	FBS	PA451512	64319;26269	0.552
NULL	Ann_Surg_Oncol_2014_Feb_13_21(5)_1575-1582.nxml.txt.nlp	24522992	SENT174	20	20	29	29	anastrozole	IMPACT	PA448432	55364	0.552
NULL	Arch_Microbiol_2013_Jun_10_195(6)_439-445.nxml.txt.nlp	23661196	SENT116	17	17	23	23	ethanol	CO2	PA448073	4513	0.552
NULL	Cancer_Biol_Med_2013_Dec_10(4)_192-205.nxml.txt.nlp	24349829	SENT101	1	1	13	13	gefitinib	PI3K	PA131301952	5290	0.552
NULL	BioDrugs_2013_May_9_27(5)_469-478.nxml.txt.nlp	23658121	SENT273	15	15	28	28	paclitaxel	HER-2	PA450761	2064	0.552
NULL	Cardiovasc_Diabetol_2013_May_4_12_73.nxml.txt.nlp	23642288	SENT121	14	14	4	4	acarbose	GLP-1	PA448010	100125288	0.552
NULL	Mol_Cancer_2013_Mar_2_12_16.nxml.txt.nlp	23452820	SENT107	40	40	18	18	chloroquine	Mcl-1	PA448948	4170	0.552
NULL	Am_J_Rhinol_Allergy_2013_Nov-Dec_27(6)_482-489.nxml.txt.nlp	24274224	SENT145	8	8	6	6	zafirlukast	LTA	PA451949	4049	0.552
NULL	Biochemistry_2011_May_3_50(17)_3408-3410.nxml.txt.nlp	21425834	SENT47	40	40	36	36	nadh	VDAC2	PA164755085	7417	0.552
NULL	Clin_Exp_Metastasis_2013_Jun_6_30(5)_681-693.nxml.txt.nlp	23385555	SENT69	25	25	36	36	l-glutamine	CO2	PA10090	4513	0.552
NULL	J_Allergy_(Cairo)_2011_Apr_26_2011_736319.nxml.txt.nlp	21747870	SENT63	37	37	10	10	l-proline	ODC	PA451125	4953;89874	0.552
NULL	J_Biol_Chem_2013_May_3_288(18)_12733-12741.nxml.txt.nlp	23443656	SENT68	26	26	44	44	l-glutamine	CO2	PA10090	4513	0.552
NULL	Mol_Cancer_2014_Jan_28_13_17.nxml.txt.nlp	24472312	SENT237	5	5	2	2	ponatinib	p28	PA165980594	246778;5716	0.552
NULL	Adv_Virol_2012_Apr_4_2012_574967.nxml.txt.nlp	22548060	SENT207	10	10	6	6	raltegravir	CCR5		1234	0.552
NULL	Angiogenesis_2013_Apr_10_16(2)_373-386.nxml.txt.nlp	23143659	SENT7	9	9	4	4	etoposide	LDM	PA449552	1595	0.552
NULL	JSLS_2012_Apr-Jun_16(2)_292-295.nxml.txt.nlp	23477182	SENT30	5	5	12	12	lipase	CEA	PA450239	5670;1087	0.552
NULL	Int_J_Chron_Obstruct_Pulmon_Dis_2007_Dec_2(4)_517-533.nxml.txt.nlp	18268925	SENT202	26	26	18	18	roflumilast	2-21	PA165948052	54097	0.552
NULL	Exp_Diabetes_Res_2008_Jan_4_2008_704045.nxml.txt.nlp	19132099	SENT250	28	28	14	14	berberine	STZ	PA165860812	6484	0.552
NULL	Cardiovasc_Diabetol_2005_Aug_9_4_12.nxml.txt.nlp	16086844	SENT110	15	15	25	25	heparin	ANOVA	PA449855	4858	0.552
NULL	Cancer_Cell_Int_2003_Jul_23_3_12.nxml.txt.nlp	12914669	SENT54	40	40	20	20	tetracycline	PP1	PA451640	5540;5464	0.552
NULL	Front_Oncol_2013_Apr_29_3_99.nxml.txt.nlp	23641363	SENT87	38	38	9	9	vorinostat	CD112	PA164748224	5819	0.552
NULL	Cell_Regen_(Lond)_2012_Jun_28_1(1)_3.nxml.txt.nlp	25408866	SENT61	22	22	7	7	glucose	CO2	PA449773	4513	0.552
NULL	Acta_Pharmacol_Sin_2011_Jan_6_32(1)_133-138.nxml.txt.nlp	21131997	SENT50	8	8	21	21	heparin	ACT	PA449855	12;11332;9457;641455	0.552
NULL	Front_Physiol_2011_Dec_19_2_104.nxml.txt.nlp	22194727	SENT95	0	0	28	28	triciribine	ANOVA	PA165958661	4858	0.552
NULL	Breast_Cancer_Res_2011_Mar_14_13(2)_205.nxml.txt.nlp	21457526	SENT47	18	18	10	10	tamoxifen	ARNO	PA451581	9266	0.552
NULL	Comput_Math_Methods_Med_2012_Jan_16_2012_792375.nxml.txt.nlp	22291855	SENT67	7	7	1	1	estradiol	E2F1	PA449503	1869	0.552
NULL	Front_Neural_Circuits_2013_Sep_3_7_135.nxml.txt.nlp	24027497	SENT1131	1	1	8	8	ethanol	spatial	PA448073	219793	0.552
NULL	Biomed_Res_Int_2014_Jun_3_2014_656370.nxml.txt.nlp	24995318	SENT94	9	9	7	7	perphenazine	FGA	PA450882	2243	0.552
NULL	J_Biol_2009_Apr_15_8(3)_30.nxml.txt.nlp	19435483	SENT33	0	0	3	3	imatinib	NQO2	PA10804	4835	0.552
NULL	Cancer_Immunol_Immunother_2015_Oct_7_64_61-73.nxml.txt.nlp	25287778	SENT190	9	9	15	15	lenalidomide	IFN	PA162363968	3439	0.552
NULL	Clin_Med_Insights_Oncol_2011_Nov_7_5_349-364.nxml.txt.nlp	22174596	SENT189	1	1	16	16	pazopanib	VEGFR	PA165291492	3791	0.552
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Dec_2_5_30.nxml.txt.nlp	17140452	SENT229	22	22	8	8	mupirocin	GAT	PA164764568	10249	0.552
NULL	Blood_Res_2013_Mar_25_48(1)_35-39.nxml.txt.nlp	23589793	SENT8	0	0	8	8	bortezomib	CD4	PA10252	920	0.552
NULL	FASEB_J_2011_Dec_25(12)_4486-4497.nxml.txt.nlp	21865315	SENT45	25	25	33	33	l-glutamine	CO2	PA10090	4513	0.552
NULL	Int_J_Biol_Sci_2012_Feb_9_8(3)_310-327.nxml.txt.nlp	22355267	SENT395	27	27	3	3	atorvastatin	PCSK9	PA448500	255738	0.552
NULL	Adv_Urol_2014_May_28_2014_746298.nxml.txt.nlp	24982672	SENT140	11	11	6	6	cisplatin	NAC	PA449014	22861	0.552
NULL	Mol_Cancer_2013_Nov_26_12_149.nxml.txt.nlp	24274578	SENT11	26	26	23	23	urokinase	MMP9	PA451836	4318	0.552
NULL	Breast_Cancer_Res_2011_Jan_17_13(1)_R5.nxml.txt.nlp	21241485	SENT323	9	9	6	6	estradiol	EGF	PA449503	1950	0.552
NULL	Patient_Prefer_Adherence_2010_Mar_24_4_51-60.nxml.txt.nlp	20361065	SENT83	23	23	26	26	warfarin	Men	PA451906	8178	0.552
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1059-1066.nxml.txt.nlp	21364577	SENT3	27	27	25	25	exemestane	aromatase	PA449563	1588	0.552
NULL	Oxid_Med_Cell_Longev_2013_Dec_5_2013_963520.nxml.txt.nlp	24381719	SENT241	3	3	5	5	lithium	BDNF	PA450243	627	0.552
NULL	Neural_Plast_2012_May_31_2012_456478.nxml.txt.nlp	22701806	SENT161	2	2	19	19	salbutamol	SMN2	PA448068	6607	0.552
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT74	18	18	34	34	metformin	p53	PA450395	7157	0.552
NULL	Exp_Ther_Med_2014_Aug_26_8(2)_371-376.nxml.txt.nlp	25009585	SENT136	3	3	18	18	fluorescein	PED	PA164746009	8682	0.552
NULL	Clin_Med_Insights_Oncol_2013_Aug_12_7_181-197.nxml.txt.nlp	23997579	SENT200	32	32	10	10	cytarabine	AIDA	PA449177	64853	0.552
NULL	Case_Rep_Hematol_2013_Sep_5_2013_708489.nxml.txt.nlp	24083040	SENT13	14	14	10	10	iron	B12	PA450087	7126;4709	0.552
NULL	Front_Immunol_2014_Aug_22_5_406.nxml.txt.nlp	25202312	SENT214	7	7	5	5	eculizumab	C1-INH	PA164776637	710	0.552
NULL	Pharmaceutics_2010_Oct_14_2(4)_321-338.nxml.txt.nlp	NULL	SENT188	3	3	19	19	creatine	ADP	PA164778930	23038	0.552
NULL	Oncol_Lett_2014_Jul_12_8(1)_117-122.nxml.txt.nlp	24959230	SENT141	14	14	0	0	fluorescein	DAC	PA164746009	13	0.552
NULL	Front_Genet_2012_Oct_26_3_213.nxml.txt.nlp	23112805	SENT608	40	40	29	29	midazolam	CYP2C19	PA450496	1557	0.552
NULL	J_Orthop_Traumatol_2011_Mar_19_12(1)_69-76.nxml.txt.nlp	21246392	SENT53	14	14	4	4	heparin	FON	PA449855	741	0.552
NULL	Br_J_Haematol_2014_Feb_16_164(4)_586-596.nxml.txt.nlp	24236640	SENT167	27	27	22	22	carboplatin	EPO	PA448803	7076;8288;2056	0.552
NULL	J_Invest_Dermatol_2012_Sep_10_132(9)_2255-2262.nxml.txt.nlp	22572817	SENT194	18	18	23	23	forskolin	ASIP	PA146096022	434;56288	0.552
NULL	Biochem_Res_Int_2011_Sep_22_2011_285618.nxml.txt.nlp	21949907	SENT50	21	21	44	44	l-glutamine	CO2	PA10090	4513	0.552
NULL	Clin_Genet_2014_Jan_1_86(1)_21-28.nxml.txt.nlp	24684508	SENT58	17	17	32	32	warfarin	GGCX	PA451906	2677	0.552
NULL	Int_J_Nanomedicine_2012_Sep_21_7_5091-5106.nxml.txt.nlp	23049256	SENT323	7	7	9	9	protamine	SOD1	PA10366	6647	0.552
NULL	Cancer_Cell_Int_2012_May_28_12_20.nxml.txt.nlp	22640800	SENT128	18	18	16	16	s-adenosylmethionine	ODC	PA164754994	4953;89874	0.552
NULL	Exp_Transl_Stroke_Med_2011_Dec_16_3_16.nxml.txt.nlp	22177314	SENT121	27	27	29	29	minocycline	ANOVA	PA450519	4858	0.552
NULL	Iran_J_Pediatr_2011_Jun_21(2)_139-150.nxml.txt.nlp	23056780	SENT112	8	8	6	6	cosyntropin	ACTH	PA164749052	5443	0.552
NULL	Drug_Des_Devel_Ther_2014_Sep_9_8_1307-1314.nxml.txt.nlp	25246772	SENT158	40	40	18	18	tacrolimus	HTX	PA451578	7547	0.552
NULL	Case_Rep_Ophthalmol_2010_Aug_18_1(1)_36-41.nxml.txt.nlp	21369348	SENT58	7	7	31	31	bevacizumab	hole	PA130232992	80757	0.552
NULL	Nat_Genet_2013_Dec_3_45(12)_1439-1445.nxml.txt.nlp	24185512	SENT195	10	10	17	17	phenol	FBS	PA450913	64319;26269	0.552
NULL	Curr_Neuropharmacol_2014_Mar_12(2)_120-139.nxml.txt.nlp	24669207	SENT936	3	3	0	0	vasopressin	AVP	PA451858	114548;551	0.552
NULL	Diabetes_2013_May_16_62(5)_1537-1546.nxml.txt.nlp	23321073	SENT91	22	22	25	25	fluorescein	CD4	PA164746009	920	0.552
NULL	Cancer_Inform_2009_Nov_13_7_253-269.nxml.txt.nlp	20011461	SENT156	21	21	27	27	diethylstilbestrol	C40	PA449307	55571	0.552
NULL	Cancer_Med_2013_Aug_10_2(4)_488-495.nxml.txt.nlp	24156021	SENT121	22	22	20	20	gemcitabine	GEM	PA449748	2669	0.552
NULL	Acta_Pharmacol_Sin_2012_Jun_6_33(6)_798-808.nxml.txt.nlp	22669117	SENT21	0	0	12	12	heparin	14-3-3	PA449855	10971	0.552
NULL	J_Immunol_Res_2014_Jul_16_2014_696812.nxml.txt.nlp	25133198	SENT140	26	26	9	9	rifaximin	CD103	PA164752443	3682	0.552
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT158	9	9	24	24	phenprocoumon	VKORC1	PA450921	79001	0.552
NULL	Neuropsychopharmacology_2009_Apr_2_34(5)_1135-1148.nxml.txt.nlp	18596687	SENT170	0	0	7	7	betaxolol	CRF	PA448611	1392;10882	0.552
NULL	Cell_Commun_Signal_2013_Nov_11_11_86.nxml.txt.nlp	24215724	SENT591	12	12	8	8	thrombin	ADP	PA451674	23038	0.552
NULL	Breast_Cancer_Res_Treat_2014_Apr_9_145(1)_73-82.nxml.txt.nlp	24715380	SENT120	30	30	28	28	tamoxifen	CXCL10	PA451581	3627	0.552
NULL	Front_Oncol_2014_Jun_18_4_153.nxml.txt.nlp	24995158	SENT539	6	6	15	15	paclitaxel	JNK	PA450761	5599	0.552
NULL	FEBS_Open_Bio_2014_May_9_4_458-467.nxml.txt.nlp	24918061	SENT167	12	12	4	4	doxorubicin	p53	PA449412	7157	0.552
NULL	Environ_Health_Perspect_2009_Jul_23_117(7)_1155-1161.nxml.txt.nlp	19654927	SENT94	19	19	21	21	dextran	FBS	PA449261	64319;26269	0.552
NULL	Indian_J_Nephrol_2010_Apr_20(2)_106-113.nxml.txt.nlp	20835329	SENT144	7	7	1	1	nitroprusside	Ray	PA451406	26751	0.551
NULL	Iran_J_Microbiol_2013_Mar_5(1)_42-47.nxml.txt.nlp	23466523	SENT91	39	39	8	8	norfloxacin	CTX	PA450654	1593	0.551
NULL	Anesth_Essays_Res_2011_Jul-Dec_5(2)_204-206.nxml.txt.nlp	NULL	SENT64	30	30	26	26	ropivacaine	CEA	PA451271	5670;1087	0.551
NULL	Mol_Biol_Rep_2013_Sep_28_40(10)_5573-5585.nxml.txt.nlp	24078156	SENT43	32	32	21	21	iron	IRP2	PA450087	3658	0.551
NULL	Br_J_Haematol_2014_Mar_13_164(1)_811-821.nxml.txt.nlp	24328678	SENT122	3	3	9	9	lenalidomide	Aiolos	PA162363968	22806	0.551
NULL	Breast_Cancer_Res_2014_Sep_12_16(5)_436.nxml.txt.nlp	25213081	SENT164	11	11	4	4	tamoxifen	FOXM1	PA451581	2305	0.551
NULL	Nat_Commun_2014_Aug_5_5_4408.nxml.txt.nlp	25093291	SENT373	8	8	11	11	cetirizine	HRH2	PA448905	1665;3274	0.551
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT177	16	16	20	20	sn-38	ABCG2		9429	0.551
NULL	Nucleic_Acids_Res_2013_Nov_16_41(20)_9349-9360.nxml.txt.nlp	23956219	SENT165	20	20	11	11	cisplatin	OB1	PA449014	84525	0.551
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_29_2013_327629.nxml.txt.nlp	23737827	SENT153	7	7	5	5	berberine	TPMT	PA165860812	7172	0.551
NULL	Neuroimage_Clin_2013_Sep_3_3_242-248.nxml.txt.nlp	24273709	SENT294	10	10	4	4	levetiracetam	CLB	PA450206	171425	0.551
NULL	Br_J_Cancer_2013_Sep_3_109(5)_1157-1164.nxml.txt.nlp	23942075	SENT21	21	21	17	17	trastuzumab	NAT	PA451743	6046	0.551
NULL	J_Korean_Med_Sci_2010_Jun_24_25(6)_829-834.nxml.txt.nlp	20514301	SENT9	2	2	7	7	papain	p38	PA450778	10598;1432;7965	0.551
NULL	Eur_Heart_J_2013_Dec_1_34(45)_3515-3524.nxml.txt.nlp	23594590	SENT17	0	0	9	9	eplerenone	COX	PA164749044	1351	0.551
NULL	Cancer_Metab_2013_Aug_14_1_18.nxml.txt.nlp	24280377	SENT290	0	0	9	9	metformin	LKB1	PA450395	6794	0.551
NULL	Physiol_Rep_2014_Nov_4_2(11)_e12197.nxml.txt.nlp	25367695	SENT76	24	24	13	13	nitrogen	PCP	PA450643	5547	0.551
NULL	Diabetes_2011_Nov_17_60(11)_2691-2700.nxml.txt.nlp	21896928	SENT229	16	16	24	24	resveratrol	SIRT1		23411	0.551
NULL	J_Oncol_2012_Sep_18_2012_125278.nxml.txt.nlp	21941547	SENT234	7	7	23	23	heparin	VEGFR2	PA449855	3791	0.551
NULL	Br_J_Cancer_2013_Sep_3_109(5)_1214-1222.nxml.txt.nlp	23922104	SENT234	31	31	5	5	dasatinib	AKT	PA162372878	207	0.551
NULL	Evid_Based_Complement_Alternat_Med_2011_Feb_14_2011_429843.nxml.txt.nlp	21869897	SENT153	31	31	29	29	ethanol	CEA	PA448073	5670;1087	0.551
NULL	Cancer_Causes_Control_2013_Aug_18_24(8)_1605-1614.nxml.txt.nlp	23775025	SENT64	3	3	16	16	cyclophosphamide	CYP3A4	PA449165	1576	0.551
NULL	Cancer_Metab_2013_Feb_4_1_7.nxml.txt.nlp	24280108	SENT189	12	12	0	0	doxycycline	GPT2	PA449415	84706	0.551
NULL	Crit_Care_2010_Sep_21_14(5)_R169.nxml.txt.nlp	20858239	SENT146	3	3	0	0	vasopressin	AVP	PA451858	114548;551	0.551
NULL	Gene_Regul_Syst_Bio_2014_Mar_4_8_63-73.nxml.txt.nlp	24634581	SENT201	0	0	8	8	minocycline	MT1-MMP	PA450519	4323	0.551
NULL	Evid_Based_Complement_Alternat_Med_2012_Feb_12_2012_472897.nxml.txt.nlp	22454667	SENT23	3	3	0	0	hesperetin	Men	PA164742902	8178	0.551
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT151	15	15	33	33	glucose	p38	PA449773	10598;1432;7965	0.551
NULL	Environ_Health_Perspect_2004_Jul_21_112(10)_1074-1079.nxml.txt.nlp	15238280	SENT254	9	9	18	18	creatine	gamma	PA164778930	9913	0.551
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S258-S263.nxml.txt.nlp	21525465	SENT185	13	13	11	11	liraglutide	GLP-1	PA165958364	100125288	0.551
NULL	Clin_Interv_Aging_2009_May_14_4_179-186.nxml.txt.nlp	19503779	SENT54	5	5	2	2	levodopa	COMT	PA450213	1312	0.551
NULL	Cell_Death_Dis_2012_Jun_7_3(6)_e319.nxml.txt.nlp	22673193	SENT24	27	27	23	23	cisplatin	Mcl-1	PA449014	4170	0.551
NULL	Diabetes_2014_Jan_13_63(1)_132-141.nxml.txt.nlp	23974920	SENT108	11	11	17	17	creatine	ADP	PA164778930	23038	0.551
NULL	Mar_Drugs_2014_Jun_27_12(7)_3818-3837.nxml.txt.nlp	24979269	SENT558	0	0	7	7	nilotinib	ABCB1	PA165958345	5243	0.551
NULL	Braz_J_Med_Biol_Res_2011_Nov_18_45(1)_86-92.nxml.txt.nlp	22086466	SENT146	35	35	11	11	thrombin	PAR-1	PA451674	2011;2149	0.551
NULL	Clin_Ophthalmol_2007_Jun_1(2)_93-97.nxml.txt.nlp	19668496	SENT87	24	24	6	6	timolol	CNTF	PA451690	1270	0.551
NULL	Cancer_Res_Treat_2011_Sep_30_43(3)_189-194.nxml.txt.nlp	22022297	SENT113	9	9	0	0	oxaliplatin	CEA	PA131285527	5670;1087	0.551
NULL	Blood_Cancer_J_2012_Mar_2_2(3)_e58.nxml.txt.nlp	22829253	SENT53	17	17	0	0	s-adenosylmethionine	MTHFR	PA164754994	4524	0.551
NULL	Daru_2011_19(6)_433-439.nxml.txt.nlp	23008689	SENT36	15	15	20	20	ethanol	IPA	PA448073	3160	0.551
NULL	Clin_Ophthalmol_2009_Jun_2_3_291-295.nxml.txt.nlp	19668581	SENT27	27	27	31	31	latanoprost	BAK	PA164774763	578	0.551
NULL	Viruses_2009_Dec_3_1(3)_1110-1136.nxml.txt.nlp	21994585	SENT305	9	9	18	18	indinavir	CD4	PA449977	920	0.551
NULL	Exp_Ther_Med_2014_May_26_7(5)_1170-1176.nxml.txt.nlp	24940406	SENT218	2	2	4	4	doxorubicin	PinX1	PA449412	54984	0.551
NULL	J_Infect_Dis_2013_Sep_1_208(5)_801-812.nxml.txt.nlp	23766527	SENT121	6	6	4	4	artemether	LUM	PA165111698	4060	0.551
NULL	Arthritis_Res_Ther_2012_Aug_3_14(4)_R179.nxml.txt.nlp	22863285	SENT120	18	18	36	36	collagenase	TLR-4	PA449107	7099	0.551
NULL	J_Mol_Med_2011_Mar_23_89(3)_237-245.nxml.txt.nlp	21340684	SENT49	16	16	5	5	nadh	MDH1	PA164755085	4190	0.551
NULL	Cell_Biosci_2011_May_24_1_20.nxml.txt.nlp	21711933	SENT158	7	7	28	28	calcipotriol	RANKL	PA448714	8600	0.551
NULL	Arthritis_Res_Ther_2010_Apr_29_12(2)_R73.nxml.txt.nlp	20429888	SENT296	31	31	33	33	bortezomib	COL1A2	PA10252	1278	0.551
NULL	J_Korean_Med_Sci_2005_Dec_31_20(6)_1076-1078.nxml.txt.nlp	16361827	SENT45	11	11	15	15	vasopressin	AVPR2	PA451858	554	0.551
NULL	Oncotarget_2013_Nov_22_5(4)_933-943.nxml.txt.nlp	24659749	SENT52	16	16	11	11	nutlin-3	p53		7157	0.551
NULL	Eur_J_Pediatr_2011_Jun_8_170(6)_709-718.nxml.txt.nlp	20931226	SENT29	35	35	33	33	ciclesonide	BDP	PA164781399	10620;152926	0.551
NULL	J_Cell_Mol_Med_2014_Jul_10_18(7)_1257-1266.nxml.txt.nlp	24720804	SENT67	13	13	21	21	hydrocortisone	EGF	PA449905	1950	0.551
NULL	Front_Microbiol_2012_May_28_3_180.nxml.txt.nlp	22783233	SENT59	22	22	0	0	spermine	Cad	PA164781199	124872	0.551
NULL	Breast_Cancer_(Auckl)_2011_Jul_27_5_175-199.nxml.txt.nlp	21863131	SENT491	10	10	1	1	carboplatin	Met	PA448803	79811	0.551
NULL	Neuropsychopharmacology_2009_Apr_2_34(5)_1135-1148.nxml.txt.nlp	18596687	SENT170	2	2	7	7	cocaine	CRF	PA449072	1392;10882	0.551
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Aug_27_67(Pt_9)_o2494.nxml.txt.nlp	22059044	SENT65	9	9	13	13	coumarin	C11	PA134521193	1109	0.551
NULL	Exp_Ther_Med_2014_Sep_26_8(3)_899-906.nxml.txt.nlp	25120621	SENT224	17	17	0	0	2-methoxyestradiol	AMY	PA134967247	10439	0.551
NULL	J_Gen_Physiol_2003_Nov_122(5)_621-639.nxml.txt.nlp	14581586	SENT306	3	3	14	14	glucose	ADP	PA449773	23038	0.551
NULL	Comput_Intell_Neurosci_2012_Nov_20_2012_817485.nxml.txt.nlp	23251144	SENT460	3	3	11	11	choline	gamma	PA448976	9913	0.551
NULL	Cardiovasc_J_Afr_2008_Apr_19(2)_77-83.nxml.txt.nlp	18516352	SENT15	7	7	0	0	glucose	GLP-1	PA449773	100125288	0.551
NULL	Diabetol_Metab_Syndr_2014_Mar_31_6_47.nxml.txt.nlp	24684779	SENT100	21	21	5	5	pioglitazone	IL-6	PA450970	3569	0.551
NULL	J_Cell_Biol_2003_Dec_8_163(5)_1157-1165.nxml.txt.nlp	14662753	SENT34	33	33	8	8	neomycin	PLIC-2	PA450608	29978	0.551
NULL	J_Inflamm_(Lond)_2005_Oct_31_2_13.nxml.txt.nlp	16259632	SENT5	21	21	7	7	dextran	IL-10	PA449261	3586	0.551
NULL	Int_J_Endocrinol_2013_Sep_5_2013_895102.nxml.txt.nlp	24089613	SENT86	5	5	7	7	vildagliptin	GLP-1	PA165958346	100125288	0.551
NULL	Ann_Gastroenterol_2012_25(3)_249-253.nxml.txt.nlp	24714152	SENT101	18	18	4	4	thioguanine	TPMT	PA451663	7172	0.551
NULL	Mol_Biol_Cell_2012_Jul_1_23(13)_2490-2504.nxml.txt.nlp	22573887	SENT76	2	2	7	7	staurosporine	KCTD6	PA165109623	200845	0.551
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1051.nxml.txt.nlp	24503543	SENT144	24	24	15	15	tamoxifen	Yes	PA451581	7525	0.551
NULL	Crit_Care_1998_May_22_2(2)_49-55.nxml.txt.nlp	11056709	SENT54	0	0	4	4	telmisartan	ANG	PA451605	283	0.551
NULL	AIDS_Res_Ther_2013_May_1_10_10.nxml.txt.nlp	23634877	SENT187	30	30	7	7	lovastatin	CCR5	PA450272	1234	0.551
NULL	Biomed_Res_Int_2014_Jun_26_2014_483501.nxml.txt.nlp	25057490	SENT125	0	0	7	7	resveratrol	PGC1		10891	0.551
NULL	Amino_Acids_2011_May_22_40(5)_1369-1383.nxml.txt.nlp	21424716	SENT178	13	13	4	4	creatine	CEE	PA164778930	51608	0.551
NULL	Case_Rep_Oncol_2009_Nov_14_2(3)_210-216.nxml.txt.nlp	20737039	SENT117	27	27	25	25	tamoxifen	TMX	PA451581	81542	0.551
NULL	Saudi_J_Anaesth_2013_Apr-Jun_7(2)_151-154.nxml.txt.nlp	23956714	SENT63	34	34	36	36	theophylline	NAC	PA451647	22861	0.551
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Nov_13_64(Pt_12)_m1532.nxml.txt.nlp	21581147	SENT3	27	27	7	7	ethanol	NO3	PA448073	4681	0.551
NULL	Arthritis_Res_Ther_2011_Dec_9_13(6)_R202.nxml.txt.nlp	22152723	SENT112	19	19	1	1	canakinumab	IL-6	PA165958358	3569	0.551
NULL	J_Gastroenterol_2013_Jan_23_48(1)_31-72.nxml.txt.nlp	23090001	SENT735	17	17	22	22	mesalazine	CDAI	PA450384	146059	0.551
NULL	Pharmaceuticals_(Basel)_2013_Oct_11_6(10)_1304-1321.nxml.txt.nlp	24275851	SENT615	1	1	9	9	valsartan	spatial	PA451848	219793	0.551
NULL	J_Exp_Med_1994_May_1_179(5)_1737-1741.nxml.txt.nlp	8163952	SENT6	5	5	7	7	thrombin	MCP-1	PA451674	6347	0.551
NULL	J_Thromb_Haemost_2011_Oct_9(10)_2103-2105.nxml.txt.nlp	21812912	SENT18	5	5	31	31	ticagrelor	ADP	PA165374673	23038	0.551
NULL	Oncogene_2014_Oct_9_33(41)_4941-4951.nxml.txt.nlp	24681952	SENT115	13	13	32	32	metformin	HNF4	PA450395	3172	0.551
NULL	Clin_Dev_Immunol_2011_Jan_5_2011_587315.nxml.txt.nlp	21253470	SENT238	37	37	45	45	zoledronate	IL-2	PA10235	3558	0.551
NULL	Cell_Res_2013_Mar_4_23(3)_340-350.nxml.txt.nlp	23208419	SENT42	16	16	6	6	doxorubicin	p53	PA449412	7157	0.551
NULL	Basic_Clin_Neurosci_2014_Winter_5(1)_31-41.nxml.txt.nlp	25436082	SENT109	17	17	6	6	bupropion	ANOVA	PA448687	4858	0.551
NULL	Nucleic_Acids_Res_2005_Feb_18_33(3)_1132-1139.nxml.txt.nlp	15722487	SENT401	19	19	10	10	nadh	UCN	PA164755085	7349	0.551
NULL	BMB_Rep_2013_Aug_46(8)_410-415.nxml.txt.nlp	23977989	SENT37	8	8	16	16	curcumin	HO-1	PA151958596	3162	0.551
NULL	Proteome_Sci_2003_Jun_12_1_4.nxml.txt.nlp	12818002	SENT86	21	21	16	16	trypsin	neuropsin	PA451806	11202	0.551
NULL	Oncogene_2010_Jul_8_29(27)_3896-3907.nxml.txt.nlp	20453888	SENT111	7	7	17	17	trastuzumab	CDK1	PA451743	983	0.551
NULL	Dev_Cell_2014_Nov_10_31(3)_358-373.nxml.txt.nlp	25453831	SENT223	21	21	11	11	glucose	TBC1D1	PA449773	23216	0.551
NULL	J_Obes_2011_Dec_22_2011_252817.nxml.txt.nlp	21318055	SENT242	2	2	6	6	orlistat	AMPK	PA164776864	5563	0.551
NULL	ScientificWorldJournal_2012_Jun_18_2012_564939.nxml.txt.nlp	22778699	SENT164	15	15	2	2	tramadol	IL-6	PA451735	3569	0.551
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT128	7	7	0	0	phenytoin	CYP1A2	PA450947	1544	0.551
NULL	J_Mol_Signal_2012_Aug_16_7_12.nxml.txt.nlp	22898329	SENT138	13	13	2	2	etoposide	NOXA	PA449552	5366	0.551
NULL	J_Clin_Biochem_Nutr_2010_Jan_29_46(1)_36-42.nxml.txt.nlp	20104263	SENT55	25	25	21	21	ribavirin	IFN	PA451241	3439	0.551
NULL	Eur_J_Dent_2007_Jul_1(3)_158b-166.nxml.txt.nlp	19212560	SENT162	6	6	4	4	ethanol	HEMA	PA448073	2157	0.551
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Dec_2_5_30.nxml.txt.nlp	17140452	SENT239	19	19	5	5	mupirocin	GAT	PA164764568	10249	0.551
NULL	Indian_Dermatol_Online_J_2012_May-Aug_3(2)_122-124.nxml.txt.nlp	23130286	SENT73	8	8	5	5	cyclophosphamide	CHOP	PA449165	1649	0.551
NULL	Drug_Des_Devel_Ther_2014_Dec_5_8_2431-2438.nxml.txt.nlp	25525333	SENT158	13	13	15	15	doxorubicin	P-gp	PA449412	5243	0.551
NULL	J_Brachial_Plex_Peripher_Nerve_Inj_2008_Mar_19_3_8.nxml.txt.nlp	18353188	SENT9	22	22	11	11	capsaicin	SSeCKS	PA448776	9590	0.551
NULL	Cancers_(Basel)_2013_Nov_7_5(4)_1456-1468.nxml.txt.nlp	24213559	SENT91	15	15	20	20	bevacizumab	BBP	PA130232992	83941	0.551
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT66	31	31	35	35	metformin	OCT3	PA450395	5460;6581	0.551
NULL	J_Clin_Biochem_Nutr_2008_May_29_42(3)_197-203.nxml.txt.nlp	18545641	SENT88	15	15	12	12	curcumin	HO-1	PA151958596	3162	0.551
NULL	Viruses_2013_Oct_7_5(10)_2483-2511.nxml.txt.nlp	24103892	SENT235	1	1	10	10	cyclosporine	TNPO3	PA449167	23534	0.551
NULL	Arthritis_Res_Ther_2009_Mar_30_11(2)_R49.nxml.txt.nlp	19327174	SENT25	37	37	28	28	celecoxib	COX	PA448871	1351	0.551
NULL	Front_Physiol_2013_Jan_3_3_485.nxml.txt.nlp	23316165	SENT119	21	21	14	14	creatine	GCGR	PA164778930	2642	0.551
NULL	ScientificWorldJournal_2014_Jul_22_2014_643715.nxml.txt.nlp	25147856	SENT160	21	21	19	19	pp2	PP1		5540;5464	0.551
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT11	0	0	5	5	chloroquine	BMPR-II	PA448948	659	0.551
NULL	Alcohol_Res_2013_35(1)_6-16.nxml.txt.nlp	24313160	SENT242	20	20	18	18	betaine	BHMT	PA448603	635	0.551
NULL	Cancer_Med_2014_Aug_7_3(4)_796-811.nxml.txt.nlp	24802970	SENT364	28	28	25	25	etoposide	ETS2	PA449552	2114	0.551
NULL	Mol_Med_Rep_2014_Nov_5_10(5)_2334-2340.nxml.txt.nlp	25189202	SENT25	16	16	11	11	cefotaxime	CFP	PA448852	5199	0.551
NULL	Indian_J_Pharm_Sci_2014_Mar-Apr_76(2)_116-124.nxml.txt.nlp	24843184	SENT21	2	2	12	12	pyrimethamine	TMP	PA451193	2012	0.551
NULL	Mol_Vis_2012_Apr_11_18_901-908.nxml.txt.nlp	22539869	SENT31	0	0	18	18	curcumin	HO-1	PA151958596	3162	0.551
NULL	J_Immune_Based_Ther_Vaccines_2010_Nov_24_8_8.nxml.txt.nlp	21106069	SENT40	22	22	46	46	l-glutamine	CO2	PA10090	4513	0.551
NULL	Br_J_Haematol_2014_Mar_13_164(1)_811-821.nxml.txt.nlp	24328678	SENT25	12	12	6	6	lenalidomide	Aiolos	PA162363968	22806	0.551
NULL	Reprod_Biol_Endocrinol_2003_Aug_27_1_59.nxml.txt.nlp	12967350	SENT0	30	30	18	18	estradiol	XIAP	PA449503	331	0.551
NULL	Pain_Res_Treat_2011_Dec_12_2011_507029.nxml.txt.nlp	22220274	SENT279	19	19	21	21	ceftriaxone	CTX	PA448866	1593	0.551
NULL	Exp_Hematol_Oncol_2013_Jan_10_2_2.nxml.txt.nlp	23305345	SENT2	18	18	20	20	bortezomib	BTZ	PA10252	22794	0.551
NULL	J_Geriatr_Cardiol_2013_Jun_10(2)_151-158.nxml.txt.nlp	23888175	SENT4	38	38	36	36	rosuvastatin	ACE2	PA134308647	59272	0.551
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Oct_20_68(Pt_11)_o3168.nxml.txt.nlp	23284482	SENT67	34	34	26	26	ethanol	mol	PA448073	90527	0.551
NULL	J_Cardiovasc_Thorac_Res_2014_Jun_30_6(2)_97-100.nxml.txt.nlp	25031824	SENT22	25	25	31	31	heparin	ACT	PA449855	12;11332;9457;641455	0.551
NULL	EPMA_J_2012_Sep_27_3(1)_10.nxml.txt.nlp	23016735	SENT214	39	39	17	17	warfarin	APOE	PA451906	348	0.551
NULL	J_Gen_Physiol_1924_Mar_20_6(4)_417-428.nxml.txt.nlp	19872083	SENT11	31	31	21	21	trypsin	PDF	PA451806	64146;9518	0.551
NULL	Mol_Cytogenet_2013_Jul_16_6_27.nxml.txt.nlp	23866735	SENT34	15	15	11	11	imatinib	IFN	PA10804	3439	0.551
NULL	Brain_Sci_2013_Jul_30_3(3)_1128-1152.nxml.txt.nlp	24734165	SENT566	3	3	21	21	isoflurane	San	PA450106	80218	0.551
NULL	Nat_Commun_2014_Dec_9_5_5691.nxml.txt.nlp	25487737	SENT638	11	11	29	29	doxorubicin	SUV39H2	PA449412	79723	0.551
NULL	Arch_Med_Sci_2011_Aug_2_7(4)_597-603.nxml.txt.nlp	22291794	SENT115	0	0	16	16	clenbuterol	RANTES	PA164745640	6352	0.551
NULL	Int_J_Surg_Case_Rep_2014_Oct_23_5(12)_979-983.nxml.txt.nlp	25460452	SENT172	23	23	15	15	paclitaxel	CK7	PA450761	3855	0.551
NULL	Front_Microbiol_2014_Oct_9_5_503.nxml.txt.nlp	25346725	SENT114	16	16	14	14	diethylstilbestrol	DES	PA449307	1674	0.551
NULL	Chemother_Res_Pract_2011_Feb_27_2011_175054.nxml.txt.nlp	22295203	SENT224	2	2	4	4	cisplatin	MBT	PA449014	5657	0.551
NULL	Cardiovasc_Res_2011_Apr_1_90(1)_140-147.nxml.txt.nlp	21071431	SENT144	0	0	13	13	resveratrol	EGF		1950	0.551
NULL	Neuroscience_2009_Jun_30_161(2-3)_572-577.nxml.txt.nlp	19327387	SENT9	17	17	12	12	capsaicin	NAPE-PLD	PA448776	222236	0.551
NULL	Cancer_Causes_Control_2013_Aug_18_24(8)_1605-1614.nxml.txt.nlp	23775025	SENT64	38	38	6	6	epirubicin	CYP1B1	PA449476	1545	0.551
NULL	J_Immunol_Res_2014_May_21_2014_371087.nxml.txt.nlp	24963497	SENT25	0	0	2	2	decitabine	DAC	PA164749631	13	0.551
NULL	AIDS_Res_Ther_2007_May_1_4_8.nxml.txt.nlp	17472747	SENT98	5	5	7	7	ritonavir	adiponectin	PA451260	9370	0.551
NULL	Mol_Cancer_2009_Jun_9_8_37.nxml.txt.nlp	19508729	SENT53	1	1	6	6	gemcitabine	HO-1	PA449748	3162	0.551
NULL	J_Korean_Med_Sci_2011_Apr_28_26(4)_528-533.nxml.txt.nlp	21468260	SENT43	0	0	15	15	fluorescein	CD19	PA164746009	930	0.551
NULL	Endocrinol_Metab_(Seoul)_2014_Sep_25_29(3)_379-387.nxml.txt.nlp	25309798	SENT42	20	20	5	5	resveratrol	SIRT1		23411	0.551
NULL	J_Gen_Physiol_2009_Apr_133(4)_421-438.nxml.txt.nlp	19289574	SENT472	11	11	24	24	forskolin	SLC26A9	PA146096022	115019	0.551
NULL	Cardiovasc_Diabetol_2013_Jan_3_12_3.nxml.txt.nlp	23286208	SENT150	30	30	33	33	glimepiride	GLP-1	PA449761	100125288	0.551
NULL	Arthritis_Res_Ther_2010_Jul_16_12(4)_R145.nxml.txt.nlp	20637100	SENT227	18	18	36	36	methotrexate	ART5	PA450428	116969	0.551
NULL	Anal_Bioanal_Chem_2011_Jun_22_400(8)_2475-2485.nxml.txt.nlp	21258785	SENT243	16	16	11	11	fluorescein	PBI	PA164746009	27350;26952	0.551
NULL	CNS_Drugs_2013_Aug_23_27(11)_943-953.nxml.txt.nlp	23975660	SENT141	14	14	10	10	guanfacine	ATX	PA449825	5168;23049	0.551
NULL	Surg_Today_2015_Oct_14_45_221-226.nxml.txt.nlp	25734195	SENT108	11	11	3	3	cisplatin	CRT	PA449014	811	0.551
NULL	Acta_Pharmacol_Sin_2011_Jul_13_32(7)_967-972.nxml.txt.nlp	21666702	SENT30	3	3	5	5	ticlopidine	P-gp	PA451686	5243	0.551
NULL	Am_J_Physiol_Endocrinol_Metab_2013_Jul_15_305(2)_E263-E270.nxml.txt.nlp	23715727	SENT266	6	6	1	1	creatine	AMPK	PA164778930	5563	0.551
NULL	Front_Neurosci_2011_Dec_5_5_131.nxml.txt.nlp	22164129	SENT2155	2	2	14	14	allopregnanolone	AKR1C2	PA142320763	1646	0.551
NULL	EMBO_Mol_Med_2012_Apr_4(4)_298-312.nxml.txt.nlp	22331558	SENT164	24	24	8	8	etoposide	SIRT1	PA449552	23411	0.551
NULL	Mol_Cancer_2010_Dec_7_9_311.nxml.txt.nlp	21138557	SENT81	1	1	3	3	etoposide	ETO	PA449552	862	0.551
NULL	Nat_Commun_2013_4_10_1038_ncomms3834.nxml.txt.nlp	24280772	SENT190	25	25	29	29	l-glutamine	MCSF	PA10090	1435	0.551
NULL	Ann_Thorac_Med_2007_Apr-Jun_2(2)_52-57.nxml.txt.nlp	19727346	SENT129	14	14	20	20	ciprofloxacin	CTX	PA449009	1593	0.551
NULL	Breast_Cancer_Res_2005_Jun_21_7(5)_181-183.nxml.txt.nlp	16168134	SENT72	4	4	0	0	tamoxifen	ATAC	PA451581	6375	0.551
NULL	J_Exp_Med_2003_Aug_4_198(3)_411-421.nxml.txt.nlp	12900517	SENT380	9	9	7	7	rosiglitazone	gamma	PA451283	9913	0.551
NULL	Cancers_(Basel)_2011_Oct_26_3(4)_4024-4045.nxml.txt.nlp	24213123	SENT179	24	24	15	15	curcumin	PTEN	PA151958596	5728	0.551
NULL	J_Korean_Med_Sci_2007_Dec_20_22(6)_963-967.nxml.txt.nlp	18162707	SENT52	19	19	7	7	isoniazid	DST	PA450112	667	0.551
NULL	Exp_Ther_Med_2014_Apr_13_7(4)_923-928.nxml.txt.nlp	24669252	SENT108	7	7	15	15	phenol	PRL	PA450913	5617	0.551
NULL	Ann_Hematol_2014_Sep_12_93(1)_13-32.nxml.txt.nlp	24026426	SENT274	17	17	12	12	caspofungin	BII	PA164743013	777	0.551
NULL	Arthritis_Rheum_2010_Dec_62(12)_3666-3676.nxml.txt.nlp	20722027	SENT11	29	29	25	25	lipase	NAPE-PLD	PA450239	222236	0.551
NULL	F1000Res_2014_Aug_19_3_198.nxml.txt.nlp	25400908	SENT265	1	1	32	32	everolimus	PI3K	PA164746311	5290	0.551
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1699-1708.nxml.txt.nlp	19861960	SENT154	3	3	9	9	dasatinib	Yes	PA162372878	7525	0.551
NULL	Int_J_Mol_Sci_2014_Sep_29_15(10)_17411-17441.nxml.txt.nlp	25268615	SENT240	30	30	18	18	docetaxel	MCT4	PA449383	9122;9123	0.551
NULL	Acta_Oncol_2014_Oct_9_53(10)_1347-1355.nxml.txt.nlp	24909504	SENT187	19	19	12	12	mitomycin	TP53	PA450524	7157	0.551
NULL	Cell_Commun_Signal_2013_Sep_18_11_67.nxml.txt.nlp	24047406	SENT90	22	22	43	43	paraformaldehyde	CK8	PA450790	3856	0.551
NULL	EMBO_Mol_Med_2011_May_3(5)_266-278.nxml.txt.nlp	21438154	SENT138	12	12	4	4	oxaliplatin	TRPA1	PA131285527	8989	0.551
NULL	Diabetes_Care_2010_Jun_23_33(6)_1300-1303.nxml.txt.nlp	20332351	SENT111	20	20	18	18	liraglutide	GLP-1	PA165958364	100125288	0.551
NULL	Cardiovasc_Diabetol_2008_Aug_11_7_24.nxml.txt.nlp	18694484	SENT57	12	12	5	5	exenatide	Ray	PA164749238	26751	0.551
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT123	6	6	17	17	paclitaxel	ABCG2	PA450761	9429	0.551
NULL	Front_Chem_2014_Nov_26_2_105.nxml.txt.nlp	25505783	SENT1052	5	5	8	8	paclitaxel	PPX	PA450761	5531	0.551
NULL	Indian_J_Pharmacol_2009_Aug_41(4)_167-172.nxml.txt.nlp	20523867	SENT40	38	38	13	13	napqi	CYP2E1		1571	0.551
NULL	Int_J_Mol_Sci_2014_Sep_30_15(10)_17686-17704.nxml.txt.nlp	25272226	SENT128	21	21	8	8	cetuximab	VEGF-A	PA10040	7422	0.551
NULL	Head_Face_Med_2012_Mar_1_8_5.nxml.txt.nlp	22376948	SENT41	25	25	0	0	methotrexate	OST	PA450428	1650;23263	0.551
NULL	Biotechnol_Res_Int_2013_Dec_1_2013_253286.nxml.txt.nlp	24363937	SENT136	24	24	36	36	ethanol	DAP	PA448073	23549;3375;1611	0.551
NULL	Diabetes_2009_Jan_58(1)_104-115.nxml.txt.nlp	18835938	SENT207	0	0	5	5	rosiglitazone	MCP-1	PA451283	6347	0.551
NULL	Crit_Care_2011_Aug_11_15(4)_226.nxml.txt.nlp	21892977	SENT435	11	11	23	23	vasopressin	SHK	PA451858	23729	0.55
NULL	Br_J_Cancer_2014_Dec_9_111(12)_2379-2380.nxml.txt.nlp	24619075	SENT10	23	23	17	17	irinotecan	KRAS	PA450085	3845	0.55
NULL	Clin_Dev_Immunol_2013_Oct_1_2013_764395.nxml.txt.nlp	24194774	SENT247	0	0	4	4	terbutaline	IFN	PA451616	3439	0.55
NULL	Cell_Death_Dis_2012_Mar_15_3(3)_e283.nxml.txt.nlp	22419112	SENT23	8	8	27	27	etoposide	CSIG	PA449552	26156	0.55
NULL	Summit_on_Translat_Bioinforma_2009_Mar_1_2009_124-128.nxml.txt.nlp	21347183	SENT70	9	9	22	22	thioguanine	TPMT	PA451663	7172	0.55
NULL	Br_J_Pharmacol_2011_Jul_163(6)_1263-1275.nxml.txt.nlp	21391977	SENT227	11	11	14	14	fluconazole	CYP3A4	PA449653	1576	0.55
NULL	Crit_Care_2012_Mar_2_16(2)_R37.nxml.txt.nlp	22386062	SENT50	28	28	38	38	oxygen	SAPS	PA450744	8935	0.55
NULL	J_Cancer_Epidemiol_2012_Aug_27_2012_978391.nxml.txt.nlp	22969803	SENT194	16	16	9	9	rituximab	CHOP	PA451261	1649	0.55
NULL	Oncoscience_2014_Mar_25_1(3)_205-215.nxml.txt.nlp	25594013	SENT201	35	35	22	22	paraformaldehyde	EGF	PA450790	1950	0.55
NULL	J_Cancer_Prev_2014_Mar_19(1)_14-22.nxml.txt.nlp	25337568	SENT162	8	8	6	6	trastuzumab	Bcl-2	PA451743	596	0.55
NULL	Crit_Care_2013_Mar_19_17(Suppl_2)_P289.nxml.txt.nlp	NULL	SENT5	29	29	18	18	estradiol	IL-6	PA449503	3569	0.55
NULL	J_Med_Chem_2014_Jan_23_57(2)_449-461.nxml.txt.nlp	24387105	SENT260	27	27	15	15	benzaldehyde	ALDH1A1	PA448571	216	0.55
NULL	Avicenna_J_Med_Biotechnol_2010_Apr-Jun_2(2)_107-111.nxml.txt.nlp	23407866	SENT35	26	26	42	42	heparin	CO2	PA449855	4513	0.55
NULL	Br_J_Cancer_2000_Jul_24_83(4)_447-453.nxml.txt.nlp	10945489	SENT9	10	10	3	3	gemcitabine	L13	PA449748	28998;6137	0.55
NULL	Eur_J_Clin_Pharmacol_2011_May_9_67(5)_477-482.nxml.txt.nlp	21305273	SENT33	7	7	10	10	atropine	DSE	PA448505	29940	0.55
NULL	Clin_Epigenetics_2011_Dec_5_3(1)_8.nxml.txt.nlp	22414275	SENT108	8	8	21	21	ribavirin	ESR1	PA451241	2099	0.55
NULL	Cell_Death_Dis_2014_Jan_30_5(1)_e1036.nxml.txt.nlp	24481450	SENT119	15	15	28	28	l-glutamine	EGF	PA10090	1950	0.55
NULL	Curr_Chem_Genomics_2009_May_28_3_22-32.nxml.txt.nlp	20161833	SENT189	17	17	15	15	estradiol	IL-17	PA449503	3605	0.55
NULL	Mol_Vis_2012_Jan_1_18_1-9.nxml.txt.nlp	22232563	SENT6	9	9	27	27	bevacizumab	HIF-1	PA130232992	29072	0.55
NULL	J_Oral_Pathol_Med_2013_Jul_18_42(6)_499-506.nxml.txt.nlp	23331485	SENT184	0	0	7	7	indomethacin	IL-6	PA449982	3569	0.55
NULL	Nat_Commun_2013_Apr_23_4_1758.nxml.txt.nlp	23612299	SENT78	4	4	8	8	isoproterenol	SOD1	PA450121	6647	0.55
NULL	Curr_Genomics_2014_Jun_15(3)_217-230.nxml.txt.nlp	24955029	SENT643	2	2	5	5	oxygen	ROS	PA450744	6098	0.55
NULL	J_Gen_Physiol_2004_Aug_124(2)_115-124.nxml.txt.nlp	15277573	SENT309	14	14	20	20	creatine	ADP	PA164778930	23038	0.55
NULL	Eur_J_Appl_Physiol_2011_Feb_24_111(2)_275-283.nxml.txt.nlp	20865425	SENT152	4	4	1	1	glucose	MRS	PA449773	8011	0.55
NULL	FEBS_Open_Bio_2014_Jan_6_4_77-89.nxml.txt.nlp	24490132	SENT762	6	6	8	8	ebselen	GDH	PA161660841	51084;2746	0.55
NULL	Adv_Hematol_2012_Jun_16_2012_435342.nxml.txt.nlp	21822434	SENT77	2	2	13	13	sirolimus	4E-BP1	PA451365	1978	0.55
NULL	Trials_2013_Sep_23_14_307.nxml.txt.nlp	24059911	SENT58	8	8	11	11	clindamycin	ACT	PA449035	12;11332;9457;641455	0.55
NULL	J_Hematol_Oncol_2012_Sep_18_5_57.nxml.txt.nlp	22989009	SENT201	17	17	15	15	nutlin-3	HDM2		4193	0.55
NULL	Case_Rep_Pathol_2013_Feb_21_2013_687427.nxml.txt.nlp	23533895	SENT104	11	11	15	15	thyroglobulin	CK20	PA164754910	54474	0.55
NULL	Age_(Dordr)_2011_Dec_11_33(4)_565-578.nxml.txt.nlp	21222044	SENT56	27	27	29	29	estradiol	aromatase	PA449503	1588	0.55
NULL	Comp_Hepatol_2004_Jan_14_3(Suppl_1)_S37.nxml.txt.nlp	14960189	SENT84	32	32	36	36	thalidomide	TNF-alpha	PA451644	7124	0.55
NULL	J_Cell_Biol_1975_Nov_1_67(2)_476-480.nxml.txt.nlp	1104641	SENT5	5	5	11	11	ethanol	CO2	PA448073	4513	0.55
NULL	Br_J_Cancer_2010_Nov_9_103(10)_1588-1596.nxml.txt.nlp	20978505	SENT128	26	26	15	15	temozolomide	MSH6	PA451609	2956	0.55
NULL	Biomed_Res_Int_2014_Jan_20_2014_948427.nxml.txt.nlp	24563867	SENT128	4	4	13	13	buspirone	STZ	PA448689	6484	0.55
NULL	Autoimmune_Dis_2013_Aug_28_2013_613086.nxml.txt.nlp	24069534	SENT173	13	13	10	10	adalimumab	TNFAIP3	PA10004	7128	0.55
NULL	J_Int_AIDS_Soc_2012_Jul_10_15(2)_17393.nxml.txt.nlp	22789611	SENT103	2	2	4	4	abacavir	LTA	PA448004	4049	0.55
NULL	J_Gen_Physiol_2013_Apr_141(4)_409-411.nxml.txt.nlp	23478994	SENT104	15	15	9	9	potassium	HERG	PA451047	3757	0.55
NULL	Cells_2014_May_23_3(2)_517-545.nxml.txt.nlp	24861977	SENT420	18	18	20	20	capsaicin	TRPV1	PA448776	7442	0.55
NULL	Clin_Exp_Otorhinolaryngol_2012_Sep_27_5(3)_117-121.nxml.txt.nlp	22977707	SENT77	12	12	20	20	kanamycin	KCC2	PA450137	57468	0.55
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT192	43	43	33	33	gefitinib	Yes	PA131301952	7525	0.55
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT198	9	9	17	17	curcumin	PC-3	PA151958596	692094	0.55
NULL	Aging_(Albany_NY)_2009_May_22_1(6)_557-572.nxml.txt.nlp	20195383	SENT254	14	14	21	21	creatine	ADP	PA164778930	23038	0.55
NULL	Nat_Commun_2013_Oct_15_4_2602.nxml.txt.nlp	24129506	SENT161	19	19	11	11	coumarin	CYP2A6	PA134521193	1548	0.55
NULL	Int_J_Biol_Sci_2011_May_24_7(5)_673-684.nxml.txt.nlp	21647250	SENT175	1	1	20	20	metformin	PDK1	PA450395	5170;5163	0.55
NULL	Trials_2014_Oct_21_15(1)_400.nxml.txt.nlp	NULL	SENT461	11	11	14	14	ropivacaine	TAP	PA451271	8615;2317;10482;23541	0.55
NULL	Cancers_(Basel)_2013_Jul_24_5(3)_901-918.nxml.txt.nlp	24202326	SENT7	26	26	36	36	doxorubicin	CDK9	PA449412	1025	0.55
NULL	Exp_Ther_Med_2014_Aug_4_8(2)_657-661.nxml.txt.nlp	25009636	SENT92	0	0	18	18	propofol	CCR2	PA451141	729230	0.55
NULL	Indian_J_Nephrol_2013_Nov-Dec_23(6)_419-423.nxml.txt.nlp	24339519	SENT29	4	4	8	8	ketoconazole	CYP3A4	PA450146	1576	0.55
NULL	Anal_Bioanal_Chem_2013_Jul_6_405(21)_6667-6674.nxml.txt.nlp	23831755	SENT48	18	18	2	2	filgrastim	Met	PA449626	79811	0.55
NULL	Protein_Expr_Purif_2009_Aug_66(2)_181-184.nxml.txt.nlp	19269329	SENT169	18	18	4	4	thrombin	AMPK	PA451674	5563	0.55
NULL	Braz_J_Med_Biol_Res_2012_Mar_16_45(5)_444-449.nxml.txt.nlp	22415118	SENT32	3	3	23	23	thiopental	ADN	PA451664	1675	0.55
NULL	Support_Care_Cancer_2012_Sep_17_20(9)_1991-1997.nxml.txt.nlp	22089428	SENT19	27	27	18	18	ethanol	castor	PA448073	54897	0.55
NULL	Toxins_(Basel)_2010_Mar_31_2(4)_517-551.nxml.txt.nlp	22069598	SENT110	19	19	28	28	curcumin	CD31	PA151958596	5175	0.55
NULL	Biol_Open_2014_Nov_21_3(12)_1207-1216.nxml.txt.nlp	25416063	SENT72	6	6	10	10	zinc	NANOS2	PA451956	339345	0.55
NULL	Anal_Bioanal_Chem_2012_May_13_403(3)_785-796.nxml.txt.nlp	22411537	SENT238	17	17	3	3	linezolid	SBF	PA450233	7702	0.55
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT141	5	5	12	12	perifosine	DR4	PA165291471	8797	0.55
NULL	Clin_Drug_Investig_2013_Jul_24_33(9)_621-631.nxml.txt.nlp	23881565	SENT143	11	11	19	19	pioglitazone	IPT	PA450970	54802	0.55
NULL	Korean_J_Thorac_Cardiovasc_Surg_2014_Jun_5_47(3)_249-254.nxml.txt.nlp	25207222	SENT129	7	7	14	14	remifentanil	AVP	PA451232	114548;551	0.55
NULL	J_Biomed_Sci_2014_Feb_3_21(1)_10.nxml.txt.nlp	24490900	SENT115	20	20	23	23	alendronate	RANKL	PA448082	8600	0.55
NULL	Exp_Ther_Med_2012_Sep_12_4(3)_475-480.nxml.txt.nlp	23181121	SENT170	28	28	32	32	rituximab	CHOP	PA451261	1649	0.55
NULL	Mol_Cancer_2010_Dec_20_9_316.nxml.txt.nlp	21172016	SENT163	22	22	20	20	heparin	CCL21	PA449855	6366	0.55
NULL	Diabetes_Care_2009_Dec_6_32(12)_2251-2257.nxml.txt.nlp	19808924	SENT132	3	3	6	6	exenatide	GLP-1	PA164749238	100125288	0.55
NULL	Cost_Eff_Resour_Alloc_2013_Sep_30_11_24.nxml.txt.nlp	24079522	SENT226	27	27	22	22	vasopressin	ACTH	PA451858	5443	0.55
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Oct_20_68(Pt_11)_o3168.nxml.txt.nlp	23284482	SENT67	34	34	22	22	ethanol	mol	PA448073	90527	0.55
NULL	Environ_Health_Perspect_2006_Sep_23_114(9)_1401-1406.nxml.txt.nlp	16966095	SENT139	41	41	43	43	tetracycline	p53	PA451640	7157	0.55
NULL	Scientifica_(Cairo)_2014_Apr_6_2014_394270.nxml.txt.nlp	24808974	SENT228	10	10	23	23	halothane	CO2	PA449845	4513	0.55
NULL	Brain_Sci_2013_Jun_14_3(2)_941-963.nxml.txt.nlp	24961432	SENT812	3	3	19	19	ethanol	p38	PA448073	10598;1432;7965	0.55
NULL	Front_Behav_Neurosci_2013_Dec_23_7_211.nxml.txt.nlp	24391566	SENT105	31	31	27	27	propranolol	ANOVA	PA451145	4858	0.55
NULL	Front_Neural_Circuits_2014_Nov_6_8_132.nxml.txt.nlp	25414645	SENT239	5	5	10	10	atropine	ENG	PA448505	2022	0.55
NULL	Ther_Clin_Risk_Manag_2006_Sep_2(3)_235-249.nxml.txt.nlp	18360599	SENT178	8	8	3	3	alendronate	BSAP	PA448082	5079	0.55
NULL	J_Oncol_2012_Nov_1_2012_707156.nxml.txt.nlp	23193402	SENT62	21	21	14	14	iodine	RAI	PA450049	10848;6050	0.55
NULL	Oncoimmunology_2012_Oct_1_1(7)_1038-1047.nxml.txt.nlp	23170252	SENT168	8	8	20	20	paraformaldehyde	San	PA450790	80218	0.55
NULL	Diabetologia_2009_Oct_14_52(10)_2046-2055.nxml.txt.nlp	19688338	SENT313	34	34	3	3	liraglutide	GLP-1	PA165958364	100125288	0.55
NULL	Infect_Dis_Obstet_Gynecol_2014_Sep_25_2014_961375.nxml.txt.nlp	25328370	SENT196	6	6	0	0	atazanavir	ATV	PA10251	4683	0.55
NULL	Gut_Pathog_2012_Jul_16_4_7.nxml.txt.nlp	22800501	SENT75	6	6	8	8	meropenem	CTX	PA164764445	1593	0.55
NULL	Int_J_Cardiovasc_Imaging_2013_Jun_3_29(5)_959-966.nxml.txt.nlp	23378157	SENT84	23	23	11	11	iodine	GFR	PA450049	9771	0.55
NULL	J_Cardiovasc_Thorac_Res_2014_Jun_30_6(2)_97-100.nxml.txt.nlp	25031824	SENT74	10	10	13	13	heparin	ACT	PA449855	12;11332;9457;641455	0.55
NULL	J_Adv_Pharm_Technol_Res_2014_Oct-Dec_5(4)_185-190.nxml.txt.nlp	25364697	SENT152	14	14	19	19	talinolol	P-gp	PA146123005	5243	0.55
NULL	J_Cell_Biol_1997_May_5_137(3)_609-618.nxml.txt.nlp	9151668	SENT97	30	30	8	8	thyroglobulin	API	PA164754910	5345	0.55
NULL	Exp_Ther_Med_2015_Jan_12_9(1)_77-83.nxml.txt.nlp	25452779	SENT212	14	14	9	9	trypsin	ITIH4	PA451806	3700	0.55
NULL	Breast_Cancer_Res_2007_Dec_20_9(Suppl_2)_S13.nxml.txt.nlp	NULL	SENT49	6	6	2	2	anastrozole	IMPACT	PA448432	55364	0.55
NULL	Clinics_(Sao_Paulo)_2013_Oct_68(10)_1350-1357.nxml.txt.nlp	24212843	SENT119	16	16	6	6	bleomycin	COL1A1	PA448645	1277	0.55
NULL	Ann_Gen_Psychiatry_2008_Aug_18_7_11.nxml.txt.nlp	18706108	SENT71	28	28	13	13	bupropion	ANOVA	PA448687	4858	0.55
NULL	J_Gen_Physiol_2013_Aug_142(2)_137-155.nxml.txt.nlp	23858003	SENT438	19	19	21	21	forskolin	ACTH	PA146096022	5443	0.55
NULL	Oncotarget_2011_May_13_2(5)_401-406.nxml.txt.nlp	21576761	SENT78	17	17	14	14	lapatinib	YB-1	PA152241907	4904	0.55
NULL	Oncotarget_2011_Sep_8_2(9)_728-736.nxml.txt.nlp	21908901	SENT99	16	16	8	8	pertuzumab	EGF		1950	0.55
NULL	Breast_Cancer_Res_2005_Jul_20_7(5)_205-211.nxml.txt.nlp	16168139	SENT123	31	31	26	26	tamoxifen	AIB1	PA451581	8202	0.55
NULL	Diabetes_2008_Sep_57(9)_2470-2479.nxml.txt.nlp	18511847	SENT143	3	3	11	11	pioglitazone	adiponectin	PA450970	9370	0.55
NULL	Oncotarget_2012_Jan_28_3(1)_84-97.nxml.txt.nlp	22289741	SENT223	12	12	27	27	coumarin	CAIX	PA134521193	768	0.55
NULL	Cancer_Microenviron_2008_Dec_20_1(1)_103-111.nxml.txt.nlp	19308689	SENT274	3	3	11	11	thrombin	MIA	PA451674	8190	0.55
NULL	Case_Rep_Oncol_Med_2012_Dec_2_2012_689291.nxml.txt.nlp	23243533	SENT79	20	20	18	18	thyroglobulin	TTF-1	PA164754910	7080	0.55
NULL	Front_Genet_2014_Aug_26_5_289.nxml.txt.nlp	25206362	SENT47	28	28	24	24	l-methionine	B12	PA450423	7126;4709	0.55
NULL	Ann_Clin_Microbiol_Antimicrob_2005_Sep_13_4_13.nxml.txt.nlp	16159399	SENT213	24	24	22	22	ribavirin	IFN	PA451241	3439	0.55
NULL	Int_J_Mol_Sci_2007_Feb_23_8(2)_145-155.nxml.txt.nlp	NULL	SENT12	0	0	14	14	acetazolamide	CA-II	PA448018	760	0.55
NULL	Mol_Pain_2013_Feb_15_9_3.nxml.txt.nlp	23413875	SENT70	8	8	10	10	resveratrol	TRPA1		8989	0.55
NULL	Front_Cell_Neurosci_2014_Feb_24_8_58.nxml.txt.nlp	24605088	SENT253	8	8	26	26	risperidone	CNTNAP2	PA451257	26047	0.55
NULL	Cancer_Causes_Control_2013_Aug_18_24(8)_1605-1614.nxml.txt.nlp	23775025	SENT64	25	25	12	12	methotrexate	CYP2C9	PA450428	1559	0.55
NULL	Cancer_Med_2014_Aug_16_3(4)_775-786.nxml.txt.nlp	24737784	SENT175	23	23	5	5	warfarin	ANOVA	PA451906	4858	0.55
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT203	8	8	28	28	perifosine	TRAIL	PA165291471	8743	0.55
NULL	Diabetes_Care_2010_Jul_31_33(7)_1544-1548.nxml.txt.nlp	20357370	SENT27	25	25	15	15	metformin	STK11	PA450395	6794	0.55
NULL	Oncotarget_2014_Jun_26_5(14)_5559-5569.nxml.txt.nlp	24980819	SENT199	23	23	16	16	vemurafenib	NOXA	PA165946873	5366	0.55
NULL	Biomed_Res_Int_2014_Feb_24_2014_480921.nxml.txt.nlp	24707486	SENT90	4	4	9	9	l-cysteine	PAG	PA449173	55824	0.55
NULL	Pharmaceutics_2011_Jul_13_3(3)_425-439.nxml.txt.nlp	24310588	SENT368	21	21	0	0	diazepam	SERS	PA449283	6301;54938	0.55
NULL	J_Immunol_Res_2014_Jul_16_2014_696812.nxml.txt.nlp	25133198	SENT269	11	11	5	5	rifaximin	CD103	PA164752443	3682	0.55
NULL	Adv_Appl_Bioinform_Chem_2012_Sep_6_5_61-79.nxml.txt.nlp	23055752	SENT139	24	24	20	20	thrombin	DHFR	PA451674	1719	0.55
NULL	J_Mol_Signal_2013_Mar_25_8_3.nxml.txt.nlp	23531275	SENT29	22	22	33	33	thrombin	LPA	PA451674	4018	0.55
NULL	Neural_Regen_Res_2013_May_5_8(13)_1180-1189.nxml.txt.nlp	25206412	SENT78	0	0	3	3	fasudil	RhoA	PA165946121	387	0.55
NULL	Cancer_Med_2014_Feb_10_3(1)_134-142.nxml.txt.nlp	24407937	SENT228	20	20	29	29	anastrozole	IMPACT	PA448432	55364	0.55
NULL	Biol_Proced_Online_2002_Oct_28_4_32-37.nxml.txt.nlp	12734571	SENT165	23	23	43	43	collagenase	CO2	PA449107	4513	0.55
NULL	J_Neurophysiol_2013_May_1_109(9)_2393-2403.nxml.txt.nlp	23427303	SENT234	2	2	4	4	capsaicin	LEP	PA448776	3952	0.55
NULL	Angew_Chem_Int_Ed_Engl_2012_Dec_21_51(52)_13140-13143.nxml.txt.nlp	23161730	SENT76	10	10	15	15	heparin	mol	PA449855	90527	0.55
NULL	Cancer_Cell_Int_2004_Aug_17_4_5.nxml.txt.nlp	15315711	SENT10	1	1	12	12	genistein	PC3	PA165109660	57332;7832;5122	0.55
NULL	Tech_Coloproctol_2010_Dec_29_14(4)_301-310.nxml.txt.nlp	20585822	SENT36	0	0	7	7	gentamicin	gamma	PA449753	9913	0.55
NULL	Arch_Immunol_Ther_Exp_(Warsz)_2007_Aug_23_55(4)_267-279.nxml.txt.nlp	17659374	SENT828	6	6	4	4	melphalan	TNF-alpha	PA450354	7124	0.55
NULL	Mol_Cancer_2010_May_26_9_121.nxml.txt.nlp	20500904	SENT52	33	33	22	22	gefitinib	EGF	PA131301952	1950	0.55
NULL	Cell_Microbiol_2013_Aug_13_15(8)_1304-1312.nxml.txt.nlp	23617720	SENT49	14	14	46	46	chymotrypsin	CR1	PA448994	1378	0.55
NULL	Ann_Rheum_Dis_2013_Jan_7_72(1)_43-50.nxml.txt.nlp	22562983	SENT104	25	25	0	0	methotrexate	ACR	PA450428	49	0.55
NULL	Hum_Genomics_2011_Jan_1_5(2)_76-78.nxml.txt.nlp	NULL	SENT23	18	18	22	22	acenocoumarol	CYP2C9	PA452632	1559	0.55
NULL	Arthritis_Res_Ther_2013_Aug_21_15(4)_R93.nxml.txt.nlp	23965253	SENT19	4	4	2	2	collagenase	MMP1	PA449107	4312	0.55
NULL	Arthritis_Res_Ther_2007_May_24_9(3)_211.nxml.txt.nlp	17540047	SENT159	18	18	36	36	methotrexate	ART5	PA450428	116969	0.55
NULL	Mol_Cancer_2010_Nov_2_9_289.nxml.txt.nlp	21044322	SENT149	11	11	19	19	cisplatin	RGS17	PA449014	26575	0.55
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Jan_12_69(Pt_2)_o225.nxml.txt.nlp	23424506	SENT70	25	25	21	21	oxygen	spatial	PA450744	219793	0.55
NULL	Semin_Immunopathol_2012_Jan_30_34(1)_167-179.nxml.txt.nlp	21805225	SENT121	8	8	12	12	thrombin	PAR-1	PA451674	2011;2149	0.55
NULL	Biomed_Imaging_Interv_J_2011_Oct_1_7(4)_e25.nxml.txt.nlp	22279502	SENT7	8	8	32	32	oxaliplatin	LARC	PA131285527	6364	0.55
NULL	Subst_Abuse_Rehabil_2014_Jan_23_5_1-12.nxml.txt.nlp	24648792	SENT116	0	0	47	47	olanzapine	DRD4	PA450688	1815	0.55
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1420-1426.nxml.txt.nlp	24056704	SENT126	17	17	19	19	ketoconazole	CYP3A	PA450146	1574	0.55
NULL	Diabetes_2008_Sep_57(9)_2272-2279.nxml.txt.nlp	18519799	SENT278	12	12	24	24	rosiglitazone	PDK4	PA451283	5166	0.55
NULL	Anesth_Essays_Res_2012_Jul-Dec_6(2)_115-123.nxml.txt.nlp	NULL	SENT69	27	27	17	17	chlorhexidine	gamma	PA164776863	9913	0.55
NULL	Calcif_Tissue_Int_2013_Sep_11_93(6)_526-539.nxml.txt.nlp	24022329	SENT92	29	29	37	37	l-glutamine	M-CSF	PA10090	1435	0.55
NULL	Springerplus_2014_Sep_15_3_526.nxml.txt.nlp	25279317	SENT51	22	22	36	36	glucose	IFN	PA449773	3439	0.55
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT148	20	20	28	28	l-cysteine	SIRT3	PA449173	23410	0.55
NULL	Cancer_Cell_Int_2011_Nov_17_11_40.nxml.txt.nlp	22088142	SENT147	10	10	7	7	gemcitabine	EGFR	PA449748	1956	0.55
NULL	Aging_(Albany_NY)_2014_May_17_6(5)_369-379.nxml.txt.nlp	24860943	SENT83	13	13	0	0	l-arginine	S6K1	PA448478	6198	0.55
NULL	J_Hematol_Oncol_2008_Aug_11_1_11.nxml.txt.nlp	18694493	SENT132	31	31	21	21	bevacizumab	IFN	PA130232992	3439	0.55
NULL	Front_Endocrinol_(Lausanne)_2011_Dec_21_2_84.nxml.txt.nlp	22654830	SENT62	7	7	15	15	rosiglitazone	DGAT1	PA451283	8694	0.55
NULL	J_Anaesthesiol_Clin_Pharmacol_2012_Oct-Dec_28(4)_486-490.nxml.txt.nlp	23225930	SENT4	23	23	34	34	fentanyl	TKR	PA449599	8277	0.55
NULL	Diabetes_Care_2009_Oct_32(10)_1753-1768.nxml.txt.nlp	19794001	SENT207	19	19	7	7	exenatide	GLP-1	PA164749238	100125288	0.55
NULL	Cases_J_2009_May_29_2_7527.nxml.txt.nlp	19829997	SENT91	13	13	6	6	chymotrypsin	CD68	PA448994	968	0.55
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT4	10	10	12	12	perifosine	TRAIL	PA165291471	8743	0.55
NULL	Cardiovasc_Res_2012_Dec_1_96(3)_552-560.nxml.txt.nlp	22918977	SENT19	19	19	8	8	hydralazine	AT1	PA449894	9197;185	0.55
NULL	Biomed_Res_Int_2014_Feb_26_2014_236930.nxml.txt.nlp	24719848	SENT256	21	21	39	39	nebivolol	NAC	PA151958426	22861	0.55
NULL	Atherosclerosis_2011_Nov_219(1)_109-115.nxml.txt.nlp	21820657	SENT43	0	0	9	9	probucol	CETP	PA451107	1071	0.55
NULL	Arthritis_Res_Ther_2014_Oct_29_16(5)_469.nxml.txt.nlp	25606596	SENT224	18	18	16	16	abatacept	CD275	PA164747080	23308	0.55
NULL	NDT_Plus_2010_Feb_4_3(1)_37-41.nxml.txt.nlp	20090879	SENT23	0	0	21	21	cinacalcet	PTH	PA164776671	5741	0.55
NULL	Exp_Diabetes_Res_2011_Jun_27_2011_947138.nxml.txt.nlp	21754922	SENT221	6	6	8	8	atropine	STZ	PA448505	6484	0.55
NULL	J_Headache_Pain_2008_Oct_31_9(5)_277-288.nxml.txt.nlp	18668199	SENT67	2	2	7	7	levothyroxine	Yes	PA450221	7525	0.55
NULL	Oncotarget_2013_Dec_4_5(2)_351-362.nxml.txt.nlp	24504051	SENT8	17	17	12	12	cytarabine	AKT	PA449177	207	0.55
NULL	Orphanet_J_Rare_Dis_2014_Nov_30_9(1)_197.nxml.txt.nlp	NULL	SENT136	38	38	33	33	creatine	GAMT	PA164778930	2593	0.55
NULL	Saudi_J_Anaesth_2013_Apr-Jun_7(2)_151-154.nxml.txt.nlp	23956714	SENT98	0	0	2	2	theophylline	NAC	PA451647	22861	0.55
NULL	Oncotarget_2013_Nov_19_5(1)_95-102.nxml.txt.nlp	24395633	SENT34	3	3	9	9	ifosfamide	ICE	PA449964	834	0.55
NULL	Breast_Cancer_Res_Treat_2009_Jul_22_116(2)_371-378.nxml.txt.nlp	18941892	SENT84	16	16	11	11	tamoxifen	aromatase	PA451581	1588	0.55
NULL	Crit_Care_2005_Sep_9_9(2)_212-222.nxml.txt.nlp	15774080	SENT306	3	3	0	0	vasopressin	AVP	PA451858	114548;551	0.55
NULL	Gut_2011_Feb_4_60(2)_166-176.nxml.txt.nlp	21205878	SENT112	20	20	8	8	tamoxifen	Hes1	PA451581	3280	0.55
NULL	Infect_Dis_Ther_2014_Jun_20_3(1)_1-17.nxml.txt.nlp	25134808	SENT130	37	37	3	3	ritonavir	ATV	PA451260	4683	0.55
NULL	J_Mol_Signal_2009_Apr_28_4_2.nxml.txt.nlp	19400946	SENT101	22	22	39	39	estradiol	Gen	PA449503	348654	0.55
NULL	Oncotarget_2011_Dec_24_2(12)_896-917.nxml.txt.nlp	22203527	SENT164	2	2	9	9	metformin	ADP	PA450395	23038	0.55
NULL	Indian_J_Dermatol_2011_Nov-Dec_56(6)_615-621.nxml.txt.nlp	22345758	SENT179	1	1	3	3	glucosamine	NAG	PA164747613	51594;4669	0.55
NULL	J_Gen_Physiol_1956_Sep_20_40(1)_27-35.nxml.txt.nlp	13357735	SENT0	15	15	1	1	glucose	Gen	PA449773	348654	0.55
NULL	Iran_J_Public_Health_2010_Jun_30_39(2)_63-68.nxml.txt.nlp	23113008	SENT144	20	20	14	14	gentamicin	TOB	PA449753	10140	0.55
NULL	Indian_J_Med_Res_2013_May_137(5)_942-949.nxml.txt.nlp	23760381	SENT143	8	8	17	17	indinavir	CD4	PA449977	920	0.55
NULL	Biologics_2010_Aug_9_4_173-185.nxml.txt.nlp	20714355	SENT266	24	24	20	20	cetuximab	EGFR	PA10040	1956	0.55
NULL	Diabetes_Metab_J_2013_Oct_17_37(5)_301-314.nxml.txt.nlp	24199158	SENT168	11	11	23	23	nadh	ADP	PA164755085	23038	0.55
NULL	Nat_Biotechnol_2013_Jul_30_31(7)_630-637.nxml.txt.nlp	23811600	SENT144	3	3	5	5	staurosporine	JAK1	PA165109623	3716	0.55
NULL	Oncotarget_2014_Oct_21_5(22)_11180-11192.nxml.txt.nlp	25361003	SENT113	12	12	7	7	tetracycline	NTRK1	PA451640	4914	0.55
NULL	Arthritis_Res_Ther_2012_May_1_14(3)_R99.nxml.txt.nlp	22546542	SENT11	34	34	20	20	infliximab	IL-2	PA452639	3558	0.55
NULL	Biologics_2013_Dec_16_8_13-25.nxml.txt.nlp	24368879	SENT179	24	24	15	15	capecitabine	IFL	PA448771	3439	0.55
NULL	Front_Chem_2014_Dec_23_2_113.nxml.txt.nlp	25566531	SENT806	11	11	21	21	curcumin	PTPN1	PA151958596	5770	0.55
NULL	Stroke_Res_Treat_2009_Dec_20_2010_386389.nxml.txt.nlp	20700422	SENT35	24	24	10	10	resveratrol	NAC		22861	0.55
NULL	Acta_Histochem_Cytochem_2007_Jul_3_40(3)_93-99.nxml.txt.nlp	17653301	SENT44	23	23	41	41	kanamycin	CO2	PA450137	4513	0.55
NULL	Mol_Pain_2013_Feb_15_9_3.nxml.txt.nlp	23413875	SENT64	25	25	5	5	resveratrol	TRPA1		8989	0.55
NULL	Cancer_Metastasis_Rev_2010_Dec_9_29(4)_777-784.nxml.txt.nlp	20936327	SENT73	0	0	15	15	thrombin	PAR1	PA451674	79581;2149	0.549
NULL	Evid_Based_Complement_Alternat_Med_2011_Feb_14_2011_429843.nxml.txt.nlp	21869897	SENT154	17	17	15	15	ethanol	CEA	PA448073	5670;1087	0.549
NULL	Exp_Cell_Res_2011_Apr_15_317(7)_1028-1039.nxml.txt.nlp	21237154	SENT210	4	4	2	2	staurosporine	TRAIL	PA165109623	8743	0.549
NULL	Biologics_2014_Apr_23_8_183-192.nxml.txt.nlp	24790411	SENT56	25	25	10	10	afatinib	EGFR	PA165981154	1956	0.549
NULL	J_Ophthalmol_2013_Dec_18_2013_135798.nxml.txt.nlp	24455194	SENT77	12	12	16	16	phenylephrine	ERG	PA450935	2078	0.549
NULL	Oncotarget_2014_Jun_4_5(18)_8284-8305.nxml.txt.nlp	25268740	SENT254	46	46	9	9	l-glutamine	STR	PA10090	6779	0.549
NULL	Exp_Ther_Med_2013_May_15_5(5)_1293-1300.nxml.txt.nlp	23737867	SENT220	10	10	12	12	finasteride	EGF	PA449627	1950	0.549
NULL	Cardiovasc_Ther_2009_27(4)_259-274.nxml.txt.nlp	19604248	SENT132	26	26	5	5	clopidogrel	ADP	PA449053	23038	0.549
NULL	Br_J_Cancer_2013_Jan_15_108(1)_82-90.nxml.txt.nlp	23321512	SENT156	11	11	32	32	paclitaxel	TUBB	PA450761	203068	0.549
NULL	Crit_Care_2011_Jun_28_15(3)_R159.nxml.txt.nlp	21711554	SENT106	18	18	14	14	quetiapine	CYP3A4	PA451201	1576	0.549
NULL	J_Geriatr_Cardiol_2012_Sep_9(3)_305-317.nxml.txt.nlp	23097661	SENT154	36	36	12	12	colestipol	FATS	PA449096	118611	0.549
NULL	Evid_Based_Complement_Alternat_Med_2011_Feb_14_2011_429843.nxml.txt.nlp	21869897	SENT98	23	23	30	30	ethanol	CORT	PA448073	1325	0.549
NULL	Nat_Commun_2014_Apr_28_5_3695.nxml.txt.nlp	24770583	SENT133	11	11	17	17	doxycycline	p97	PA449415	50628;10428;1982;7415	0.549
NULL	Osteopath_Med_Prim_Care_2008_Feb_15_2_4.nxml.txt.nlp	18279520	SENT115	3	3	6	6	protamine	NPL	PA10366	80896	0.549
NULL	Acta_Pharmacol_Sin_2013_Mar_21_34(3)_373-379.nxml.txt.nlp	23334240	SENT184	9	9	23	23	raloxifene	BC-2	PA451221	27243	0.549
NULL	Mol_Cancer_2008_Mar_6_7_24.nxml.txt.nlp	18325101	SENT91	20	20	9	9	cisplatin	FANCD2	PA449014	2177	0.549
NULL	J_Hematol_Oncol_2012_Sep_18_5_57.nxml.txt.nlp	22989009	SENT202	7	7	10	10	nutlin-3	HDM2		4193	0.549
NULL	Exp_Ther_Med_2012_Oct_16_4(4)_705-710.nxml.txt.nlp	23170130	SENT173	2	2	0	0	cyclophosphamide	CTX	PA449165	1593	0.549
NULL	Biomed_Res_Int_2014_Jan_2_2014_126586.nxml.txt.nlp	24527434	SENT123	9	9	28	28	trastuzumab	CD24	PA451743	100133941	0.549
NULL	Oncotarget_2011_Dec_24_2(12)_896-917.nxml.txt.nlp	22203527	SENT2	0	0	12	12	metformin	HER2	PA450395	2064	0.549
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT40	7	7	12	12	pemetrexed	UNG	PA10810	7374	0.549
NULL	Neuropsychopharmacology_2011_May_23_36(6)_1237-1247.nxml.txt.nlp	21346736	SENT4	11	11	13	13	atomoxetine	ATX	PA134688071	5168;23049	0.549
NULL	Cardiovasc_Psychiatry_Neurol_2010_May_24_2010_106123.nxml.txt.nlp	20508809	SENT176	3	3	18	18	choline	c-fos	PA448976	2353	0.549
NULL	Cancer_Cell_Int_2013_Jun_26_13_63.nxml.txt.nlp	23800022	SENT210	0	0	13	13	genistein	MDM2	PA165109660	4193	0.549
NULL	Oncogene_2013_Sep_26_32(39)_10_1038_onc_2012_491.nxml.txt.nlp	23108394	SENT0	19	19	12	12	epirubicin	BRIP1	PA449476	64979;83990	0.549
NULL	Oxid_Med_Cell_Longev_2012_Jul_25_2012_472932.nxml.txt.nlp	22888398	SENT179	8	8	5	5	choline	B12	PA448976	7126;4709	0.549
NULL	Clin_Proteomics_2014_Nov_1_11(1)_38.nxml.txt.nlp	25392709	SENT33	31	31	10	10	thyroglobulin	alpha-1-antitrypsin	PA164754910	5265	0.549
NULL	Biomed_Res_Int_2014_Feb_6_2014_323594.nxml.txt.nlp	24689036	SENT287	6	6	1	1	raloxifene	PC3	PA451221	57332;7832;5122	0.549
NULL	Iran_J_Pharm_Res_2014_Spring_13(2)_683-693.nxml.txt.nlp	25237365	SENT157	3	3	5	5	tranilast	CXCL12	PA131890628	6387	0.549
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1437-1448.nxml.txt.nlp	24056706	SENT111	22	22	20	20	quinidine	CYP2C19	PA451209	1557	0.549
NULL	Int_J_Mol_Sci_2013_Apr_16_14(4)_8306-8327.nxml.txt.nlp	23591844	SENT145	21	21	26	26	l-glutamine	CO2	PA10090	4513	0.549
NULL	Biomed_Res_Int_2013_Jun_13_2013_493643.nxml.txt.nlp	23841073	SENT127	1	1	3	3	estradiol	ACTH	PA449503	5443	0.549
NULL	Front_Neurol_2014_Sep_11_5_173.nxml.txt.nlp	25309501	SENT27	39	39	47	47	hyaluronan	HAS3	PA165958431	3038	0.549
NULL	Evid_Based_Complement_Alternat_Med_2014_May_8_2014_364819.nxml.txt.nlp	24899907	SENT8	22	22	19	19	tacrolimus	FKBP52	PA451578	2288	0.549
NULL	Oncologist_2010_Nov_4_15(11)_1135-1146.nxml.txt.nlp	21051659	SENT130	8	8	10	10	bevacizumab	IFN	PA130232992	3439	0.549
NULL	Ann_N_Y_Acad_Sci_2013_Apr_1_1281(1)_64-91.nxml.txt.nlp	23551121	SENT452	13	13	7	7	glibenclamide	GLP-1	PA449782	100125288	0.549
NULL	Indian_J_Med_Res_2011_Mar_133(3)_257-266.nxml.txt.nlp	21441678	SENT56	26	26	28	28	pyrazinamide	RIF	PA451182	54509;80196	0.549
NULL	Mol_Cells_2014_Jan_31_37(1)_66-73.nxml.txt.nlp	24552712	SENT153	40	40	33	33	ribavirin	RVR	PA451241	9975	0.549
NULL	Comp_Funct_Genomics_2009_Jan_31_2009_761512.nxml.txt.nlp	20148076	SENT183	17	17	27	27	debrisoquine	CYP11B2	PA452616	1585	0.549
NULL	Cancer_Imaging_2013_Oct_4_13(3)_423-428.nxml.txt.nlp	24240137	SENT5	11	11	5	5	gemcitabine	CRT	PA449748	811	0.549
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jun_17_65(Pt_7)_o1596.nxml.txt.nlp	21582870	SENT68	41	41	31	31	ethanol	mol	PA448073	90527	0.549
NULL	Mol_Cancer_2010_Nov_2_9_289.nxml.txt.nlp	21044322	SENT171	15	15	33	33	vincristine	RGS17	PA451879	26575	0.549
NULL	J_Korean_Med_Sci_2008_Aug_25_23(4)_657-661.nxml.txt.nlp	18756053	SENT105	39	39	9	9	estradiol	AMH	PA449503	268	0.549
NULL	Int_J_Womens_Health_2014_Aug_13_6_759-769.nxml.txt.nlp	25152632	SENT148	13	13	9	9	denosumab	RANK	PA166048634	8792	0.549
NULL	BMJ_2014_Apr_24_348_g2780.nxml.txt.nlp	24764569	SENT33	29	29	19	19	sitagliptin	GLP-1	PA164748978	100125288	0.549
NULL	Eur_J_Clin_Pharmacol_2011_May_9_67(5)_477-482.nxml.txt.nlp	21305273	SENT99	20	20	24	24	dobutamine	DBP	PA449381	3295;1628;2638	0.549
NULL	J_Mol_Signal_2011_May_16_6_4.nxml.txt.nlp	21575178	SENT169	4	4	6	6	forskolin	HSP27	PA146096022	3315	0.549
NULL	Breast_Cancer_Res_2014_Sep_9_16(5)_433.nxml.txt.nlp	25212966	SENT330	22	22	10	10	urokinase	ILEI	PA451836	10447	0.549
NULL	Oncologist_2010_Nov_4_15(11)_1135-1146.nxml.txt.nlp	21051659	SENT127	14	14	16	16	bevacizumab	IFN	PA130232992	3439	0.549
NULL	J_Asthma_Allergy_2008_Sep_19_1_19-29.nxml.txt.nlp	21436982	SENT118	0	0	5	5	fexofenadine	RANTES	PA449621	6352	0.549
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_1-20.nxml.txt.nlp	19305785	SENT129	0	0	2	2	estradiol	KCC2	PA449503	57468	0.549
NULL	J_Int_Soc_Sports_Nutr_2012_Dec_21_9_56.nxml.txt.nlp	23259853	SENT133	9	9	22	22	creatine	COT	PA164778930	54677	0.549
NULL	Nucleic_Acids_Res_2012_Jul_29_40(12)_5615-5624.nxml.txt.nlp	22379136	SENT69	23	23	36	36	fluorescein	PR1	PA164746009	140738	0.549
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT91	3	3	5	5	doxorubicin	B7-H1	PA449412	29126	0.549
NULL	Br_J_Cancer_2013_Aug_6_109(3)_686-693.nxml.txt.nlp	23839492	SENT91	5	5	35	35	sunitinib	IL-8	PA162372840	3576	0.549
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Feb_28_69(Pt_3)_o456.nxml.txt.nlp	23476623	SENT3	15	15	4	4	ethanol	mol	PA448073	90527	0.549
NULL	Breast_Cancer_Res_2007_Oct_19_9(5)_111.nxml.txt.nlp	17983482	SENT75	30	30	2	2	gefitinib	HER3	PA131301952	2065	0.549
NULL	Acta_Pharmacol_Sin_2011_Jul_20_32(7)_956-966.nxml.txt.nlp	21685928	SENT40	11	11	2	2	pentobarbital	STZ	PA450859	6484	0.549
NULL	Chemother_Res_Pract_2011_Dec_1_2011_715469.nxml.txt.nlp	22312557	SENT106	13	13	8	8	cisplatin	p53	PA449014	7157	0.549
NULL	Cytotherapy_2014_Jun_16(6)_800-809.nxml.txt.nlp	24642019	SENT174	29	29	40	40	collagenase	NAC	PA449107	22861	0.549
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Feb_17_66(Pt_3)_o641-o642.nxml.txt.nlp	21580396	SENT79	42	42	35	35	ethanol	mol	PA448073	90527	0.549
NULL	J_Immunother_Cancer_2014_Jan_27_2_2.nxml.txt.nlp	24829759	SENT178	19	19	21	21	sorafenib	IL-2	PA7000	3558	0.549
NULL	ARYA_Atheroscler_2014_Sep_10(5)_259-265.nxml.txt.nlp	25477983	SENT51	37	37	39	39	sugar	FBS	PA451529	64319;26269	0.549
NULL	Mol_Pain_2012_Sep_22_8_71.nxml.txt.nlp	22998838	SENT150	0	0	8	8	cisplatin	TRPV1	PA449014	7442	0.549
NULL	Front_Neurosci_2014_Dec_5_8_398.nxml.txt.nlp	25538552	SENT195	12	12	18	18	glucose	gamma	PA449773	9913	0.549
NULL	Biomed_Res_Int_2013_Dec_17_2013_696317.nxml.txt.nlp	24455716	SENT166	5	5	2	2	l-arginine	NAC	PA448478	22861	0.549
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_127043.nxml.txt.nlp	23227093	SENT231	5	5	21	21	furafylline	CYP2D6	PA452614	1565	0.549
NULL	Asian_J_Androl_2014_Apr_15_Sep-Oct_16(5)_792-793.nxml.txt.nlp	24759591	SENT6	35	35	29	29	tamsulosin	UPP	PA451583	7378	0.549
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT98	15	15	19	19	perifosine	TRAIL	PA165291471	8743	0.549
NULL	EMBO_J_2009_Apr_8_28(7)_854-865.nxml.txt.nlp	19214185	SENT293	39	39	17	17	cisplatin	FACT	PA449014	11198	0.549
NULL	Core_Evid_2009_Jun_15_4_131-147.nxml.txt.nlp	20694070	SENT449	2	2	17	17	tipranavir	San	PA163522473	80218	0.549
NULL	Mol_Cancer_2009_May_15_8_28.nxml.txt.nlp	19445670	SENT8	38	38	31	31	doxorubicin	mol	PA449412	90527	0.549
NULL	Exp_Diabetes_Res_2012_Aug_5_2012_201295.nxml.txt.nlp	22919367	SENT38	13	13	23	23	l-glutamine	activin	PA10090	83729	0.549
NULL	Endocrinology_2011_Jul_3_152(7)_2678-2689.nxml.txt.nlp	21540289	SENT76	17	17	44	44	l-glutamine	CO2	PA10090	4513	0.549
NULL	Cell_Mol_Life_Sci_2012_Apr_1_69(8)_1377-1389.nxml.txt.nlp	22130515	SENT98	6	6	1	1	tamoxifen	TBX3	PA451581	6926	0.549
NULL	Mol_Cancer_2007_Apr_23_6_31.nxml.txt.nlp	17451600	SENT190	13	13	2	2	daunorubicin	p52	PA449212	11168;4791	0.549
NULL	Emerg_Infect_Dis_2007_Feb_13(2)_255-258.nxml.txt.nlp	17479888	SENT77	19	19	1	1	oxytetracycline	PEN	PA450757	9933	0.549
NULL	Br_J_Clin_Pharmacol_2014_Sep_20_78(3)_509-523.nxml.txt.nlp	25279405	SENT12	0	0	30	30	tacrolimus	CYP3A5	PA451578	1577	0.549
NULL	Oncotarget_2013_Nov_24_4(12)_2430-2438.nxml.txt.nlp	24280348	SENT145	31	31	42	42	gefitinib	STAT3	PA131301952	6774	0.549
NULL	Case_Rep_Nephrol_Urol_2012_May_31_2(1)_38-45.nxml.txt.nlp	23197954	SENT90	3	3	15	15	eculizumab	C3a	PA164776637	718	0.549
NULL	Ann_Gastroenterol_2014_27(1)_73.nxml.txt.nlp	24714769	SENT9	6	6	9	9	clopidogrel	ESD	PA449053	2098	0.549
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT78	10	10	12	12	resveratrol	TRAIL		8743	0.549
NULL	Scientifica_(Cairo)_2012_Dec_23_2012_606104.nxml.txt.nlp	24278719	SENT149	18	18	37	37	spermine	KEAP1	PA164781199	9817	0.549
NULL	Cardiol_Res_Pract_2013_Feb_19_2013_195456.nxml.txt.nlp	23533940	SENT127	7	7	13	13	prasugrel	CYP3A4	PA154410481	1576	0.549
NULL	J_Hematop_2009_Feb_28_2(2)_113-119.nxml.txt.nlp	19669197	SENT147	11	11	9	9	troglitazone	Bcl-2	PA451799	596	0.549
NULL	An_Bras_Dermatol_2014_Mar-Apr_89(2)_266-273.nxml.txt.nlp	24770503	SENT90	15	15	10	10	thalidomide	ENL	PA451644	4298	0.549
NULL	Sci_Rep_2014_Dec_19_4_7571.nxml.txt.nlp	25524368	SENT8	19	19	14	14	estradiol	mer	PA449503	10461	0.549
NULL	Int_J_Anal_Chem_2013_Jul_16_2013_419716.nxml.txt.nlp	23956748	SENT184	32	32	14	14	heparin	PF6	PA449855	200162	0.549
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT144	42	42	40	40	vinorelbine	ASC	PA451881	29108	0.549
NULL	Mol_Cancer_2013_Mar_5_12_17.nxml.txt.nlp	23497256	SENT154	33	33	15	15	sunitinib	p53	PA162372840	7157	0.549
NULL	Br_J_Cancer_2010_Mar_2_102(5)_815-826.nxml.txt.nlp	20145614	SENT289	9	9	28	28	tamoxifen	HER2	PA451581	2064	0.549
NULL	Br_J_Cancer_2009_Jan_27_100(2)_322-333.nxml.txt.nlp	19127257	SENT253	11	11	23	23	fluorescein	CDK4	PA164746009	1019	0.549
NULL	J_Gen_Physiol_2003_Mar_121(3)_181-197.nxml.txt.nlp	12601083	SENT405	30	30	23	23	forskolin	GLP-1	PA146096022	100125288	0.549
NULL	Breast_Cancer_Res_2010_Oct_14_12(5)_R84.nxml.txt.nlp	20946630	SENT269	22	22	28	28	choline	SLC22A1	PA448976	6580	0.549
NULL	Front_Genet_2012_Oct_26_3_213.nxml.txt.nlp	23112805	SENT608	20	20	24	24	phenacetin	CYP2C9	PA450897	1559	0.549
NULL	Amino_Acids_2014_Jul_19_46(1)_7-20.nxml.txt.nlp	22810731	SENT274	25	25	18	18	taurine	NF-kappaB	PA451590	4790	0.549
NULL	Cell_Res_2010_Apr_9_20(4)_458-469.nxml.txt.nlp	20142842	SENT29	18	18	31	31	doxycycline	BCL2	PA449415	596	0.549
NULL	Arthritis_Res_Ther_2008_Mar_17_10(2)_R33.nxml.txt.nlp	18346273	SENT204	18	18	36	36	methotrexate	ART5	PA450428	116969	0.549
NULL	Cell_Death_Dis_2013_Oct_3_4(10)_e830.nxml.txt.nlp	24091673	SENT23	33	33	17	17	doxorubicin	SAPK	PA449412	5601	0.549
NULL	Biomed_Res_Int_2014_Apr_27_2014_459676.nxml.txt.nlp	24864244	SENT81	27	27	47	47	l-glutamine	CO2	PA10090	4513	0.549
NULL	Eur_J_Neurosci_2011_Mar_33(5)_914-922.nxml.txt.nlp	21255131	SENT113	30	30	13	13	pentobarbital	gamma	PA450859	9913	0.549
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT98	18	18	9	9	vinorelbine	ASC	PA451881	29108	0.549
NULL	Infect_Dis_Ther_2014_Dec_12_3(2)_103-122.nxml.txt.nlp	25388760	SENT92	10	10	21	21	raltegravir	CCR5		1234	0.549
NULL	Diabetes_Care_2012_Feb_16_35(2)_327-333.nxml.txt.nlp	22179958	SENT101	13	13	20	20	metformin	B12	PA450395	7126;4709	0.549
NULL	Cell_Mol_Neurobiol_2012_Jul_24_32(5)_725-735.nxml.txt.nlp	22113371	SENT60	1	1	3	3	vasopressin	ACTH	PA451858	5443	0.549
NULL	J_Immunother_Cancer_2013_Nov_7_1(Suppl_1)_P88.nxml.txt.nlp	NULL	SENT8	20	20	10	10	bortezomib	DLL1	PA10252	28514	0.549
NULL	Clin_Interv_Aging_2013_May_30_8_597-603.nxml.txt.nlp	23761968	SENT138	13	13	32	32	risedronate	CTX	PA451255	1593	0.549
NULL	Case_Rep_Endocrinol_2012_Oct_14_2012_503290.nxml.txt.nlp	23097726	SENT75	34	34	22	22	vasopressin	ACTH	PA451858	5443	0.549
NULL	Diabetes_Metab_J_2014_Dec_15_38(6)_456-463.nxml.txt.nlp	25541609	SENT49	12	12	17	17	urea	AST	PA451831	26503	0.549
NULL	CNS_Drugs_2013_Aug_23_27(11)_943-953.nxml.txt.nlp	23975660	SENT158	14	14	10	10	guanfacine	ATX	PA449825	5168;23049	0.549
NULL	EPMA_J_2012_Sep_27_3(1)_10.nxml.txt.nlp	23016735	SENT216	36	36	15	15	warfarin	EPHX1	PA451906	2052	0.549
NULL	Cancers_(Basel)_2012_Sep_6_4(3)_873-903.nxml.txt.nlp	24213471	SENT138	7	7	11	11	hyaluronidase	HYAL-1	PA164745713	3373	0.549
NULL	Adv_Ther_2014_Feb_15_31(3)_289-317.nxml.txt.nlp	24535623	SENT341	13	13	7	7	glibenclamide	GLP-1	PA449782	100125288	0.549
NULL	Open_Med_Chem_J_2011_Sep_9_5_82-92.nxml.txt.nlp	21966329	SENT81	3	3	1	1	liraglutide	GLP-1	PA165958364	100125288	0.549
NULL	Front_Genet_2014_Jun_2_5_161.nxml.txt.nlp	24917881	SENT1072	0	0	12	12	ethanol	PTEN	PA448073	5728	0.549
NULL	ScientificWorldJournal_2012_Mar_12_2012_359721.nxml.txt.nlp	22536136	SENT152	31	31	13	13	cyanocobalamin	PLP	PA451892	25824;5744	0.549
NULL	Acta_Pharmacol_Sin_2014_Jun_4_35(6)_792-805.nxml.txt.nlp	24902787	SENT338	2	2	27	27	pravastatin	INS-1	PA451089	2305	0.549
NULL	Oxid_Med_Cell_Longev_2013_Nov_14_2013_680545.nxml.txt.nlp	24349614	SENT52	33	33	44	44	streptomycin	CO2	PA451512	4513	0.549
NULL	J_Cardiothorac_Surg_2013_Jun_12_8_154.nxml.txt.nlp	23758688	SENT127	6	6	9	9	protamine	ACT	PA10366	12;11332;9457;641455	0.549
NULL	Biomed_Res_Int_2014_Jun_26_2014_161346.nxml.txt.nlp	25054130	SENT232	45	45	21	21	curcumin	STZ	PA151958596	6484	0.549
NULL	Aging_(Albany_NY)_2010_Dec_29_2(12)_914-923.nxml.txt.nlp	21212461	SENT3	34	34	10	10	cyclosporine	SIRT3	PA449167	23410	0.549
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2013_Sep_1_6_25-37.nxml.txt.nlp	24031162	SENT226	4	4	6	6	sitagliptin	Met	PA164748978	79811	0.549
NULL	Sci_Rep_2015_Jan_21_5_7924.nxml.txt.nlp	25603780	SENT237	17	17	48	48	phenol	CO2	PA450913	4513	0.549
NULL	Arthritis_Res_Ther_2011_Sep_21_13(5)_239.nxml.txt.nlp	21955617	SENT229	2	2	4	4	celecoxib	IL-6	PA448871	3569	0.549
NULL	Ann_Surg_Treat_Res_2014_Feb_22_86(2)_68-75.nxml.txt.nlp	24761411	SENT144	2	2	9	9	resveratrol	Bcl-2		596	0.549
NULL	Breast_Cancer_Res_2010_May_10_12(3)_R26.nxml.txt.nlp	20459744	SENT99	2	2	19	19	cyclophosphamide	HDC	PA449165	3067;51696	0.549
NULL	Cell_Cycle_2013_Sep_15_12(18)_3013-3024.nxml.txt.nlp	23974104	SENT11	0	0	20	20	disulfiram	CD24	PA449376	100133941	0.549
NULL	Oncotarget_2010_May_1_1(1)_48-58.nxml.txt.nlp	21293053	SENT130	33	33	20	20	cisplatin	p53	PA449014	7157	0.549
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT251	17	17	21	21	lapatinib	HER3	PA152241907	2065	0.549
NULL	Cancer_Med_2013_Feb_3_2(1)_108-115.nxml.txt.nlp	24279005	SENT145	3	3	27	27	tamoxifen	STAR	PA451581	6770;2984	0.549
NULL	Cardiovasc_Diabetol_2004_Apr_29_3_6.nxml.txt.nlp	15117408	SENT197	15	15	23	23	glucose	perlecan	PA449773	3339	0.549
NULL	Drug_Target_Insights_2007_Feb_7_2_19-27.nxml.txt.nlp	21901059	SENT139	28	28	9	9	ribavirin	TNF-alpha	PA451241	7124	0.549
NULL	Breast_Cancer_Res_2007_Nov_1_9(6)_R75.nxml.txt.nlp	17976236	SENT173	24	24	31	31	letrozole	EGFR	PA450196	1956	0.549
NULL	Oncol_Lett_2013_Aug_25_6(2)_480-486.nxml.txt.nlp	24137351	SENT21	30	30	27	27	levothyroxine	RAI	PA450221	10848;6050	0.549
NULL	Sensors_(Basel)_2010_May_19_10(5)_5031-5053.nxml.txt.nlp	22399922	SENT68	0	0	16	16	rosiglitazone	INS-1	PA451283	2305	0.549
NULL	J_Allergy_(Cairo)_2012_Dec_17_2012_604854.nxml.txt.nlp	23316250	SENT136	0	0	3	3	metformin	aromatase	PA450395	1588	0.549
NULL	J_Korean_Neurosurg_Soc_2013_Oct_31_54(4)_280-288.nxml.txt.nlp	24294450	SENT205	4	4	6	6	acetazolamide	ACZ	PA448018	27445	0.549
NULL	Diabetes_Care_2013_Feb_17_36(2)_422-428.nxml.txt.nlp	23033246	SENT140	25	25	27	27	fenofibrate	PPL	PA449594	5493	0.549
NULL	Antimicrob_Resist_Infect_Control_2012_Mar_16_1_12.nxml.txt.nlp	22958880	SENT107	42	42	28	28	norfloxacin	CTX	PA450654	1593	0.549
NULL	Breast_Cancer_Res_2012_Jul_12_14(4)_R104.nxml.txt.nlp	22788954	SENT197	17	17	14	14	erlotinib	EGFR	PA134687924	1956	0.549
NULL	Mol_Neurodegener_2011_Aug_8_6_57.nxml.txt.nlp	21819629	SENT348	44	44	40	40	arsenite	TDP-43	PA452638	23435	0.549
NULL	Oxid_Med_Cell_Longev_2012_May_28_2012_632959.nxml.txt.nlp	22690272	SENT52	9	9	11	11	curcumin	MDM2	PA151958596	4193	0.549
NULL	Genet_Med_2013_May_25_15(5)_354-360.nxml.txt.nlp	23100014	SENT94	26	26	23	23	creatine	MECP2	PA164778930	4204	0.549
NULL	Int_J_Chron_Obstruct_Pulmon_Dis_2008_Dec_3(4)_563-573.nxml.txt.nlp	19281074	SENT205	8	8	27	27	budesonide	p53	PA448681	7157	0.549
NULL	J_Immunol_Res_2014_Feb_13_2014_814598.nxml.txt.nlp	24741625	SENT212	4	4	13	13	estradiol	LTF	PA449503	4057	0.549
NULL	Diabetologia_2010_Jun_27_53(6)_1142-1150.nxml.txt.nlp	20349036	SENT0	21	21	16	16	glucose	AMPK	PA449773	5563	0.549
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT134	28	28	22	22	metformin	HIP	PA450395	6767;6159;64399;5068	0.549
NULL	Mol_Cancer_2009_Dec_21_8_125.nxml.txt.nlp	20021699	SENT18	0	0	2	2	gemcitabine	Gem	PA449748	51053	0.549
NULL	Arthritis_Res_Ther_2004_Mar_8_6(3)_R199-R207.nxml.txt.nlp	15142265	SENT4	6	6	9	9	collagenase	MMP3	PA449107	4314	0.549
NULL	Ann_Surg_Oncol_2007_Jul_25_14(7)_2105-2112.nxml.txt.nlp	17457649	SENT258	16	16	14	14	melphalan	gamma	PA450354	9913	0.549
NULL	Br_J_Cancer_2011_Aug_9_105(4)_469-474.nxml.txt.nlp	21712825	SENT110	13	13	26	26	nadh	p53	PA164755085	7157	0.549
NULL	Arthritis_Res_Ther_2013_Nov_6_15(6)_124.nxml.txt.nlp	24229459	SENT29	4	4	31	31	atorvastatin	IL-6	PA448500	3569	0.549
NULL	Diabetes_2013_May_16_62(5)_1464-1477.nxml.txt.nlp	23349479	SENT5	7	7	9	9	lipase	ATGL	PA450239	57104	0.549
NULL	Int_J_Alzheimer_Dis_2009_Jul_14_2009_257403.nxml.txt.nlp	20721293	SENT90	41	41	17	17	forskolin	F12	PA146096022	2161	0.549
NULL	Nutr_J_2014_Jan_24_13_11.nxml.txt.nlp	24461029	SENT152	21	21	14	14	curcumin	CTR	PA151958596	799	0.549
NULL	J_Korean_Med_Sci_2011_Jan_22_26(1)_33-41.nxml.txt.nlp	21218027	SENT169	2	2	35	35	isoniazid	PTH	PA450112	5741	0.549
NULL	Structure_2013_Jan_8_21(1)_143-153.nxml.txt.nlp	23245851	SENT221	47	47	17	17	l-glutamine	CO2	PA10090	4513	0.549
NULL	ScientificWorldJournal_2013_Oct_24_2013_726912.nxml.txt.nlp	24282387	SENT9	1	1	5	5	fluorescein	AVP	PA164746009	114548;551	0.549
NULL	Am_J_Trop_Med_Hyg_2014_Aug_6_91(2)_424-434.nxml.txt.nlp	24799369	SENT298	7	7	5	5	chloroquine	ACT	PA448948	12;11332;9457;641455	0.549
NULL	J_Gen_Physiol_2010_Feb_135(2)_149-167.nxml.txt.nlp	20100894	SENT710	16	16	7	7	spermine	IRK1	PA164781199	3759	0.549
NULL	Mol_Biol_Cell_2014_Feb_15_25(4)_457-469.nxml.txt.nlp	24336521	SENT245	24	24	42	42	l-glutamine	CO2	PA10090	4513	0.549
NULL	Mol_Cancer_2009_Nov_24_8_109.nxml.txt.nlp	19930708	SENT52	7	7	9	9	exemestane	EGFR	PA449563	1956	0.549
NULL	Front_Endocrinol_(Lausanne)_2013_Jun_26_4_75.nxml.txt.nlp	23805127	SENT66	18	18	15	15	gemfibrozil	UGT1A4	PA449750	54657	0.549
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT1733	0	0	6	6	atazanavir	ATV	PA10251	4683	0.549
NULL	Core_Evid_2009_Jun_15_4_25-36.nxml.txt.nlp	20694062	SENT325	24	24	13	13	allopurinol	ACTH	PA448320	5443	0.549
NULL	Nucleic_Acids_Res_2011_Sep_28_39(17)_7858-7867.nxml.txt.nlp	21715374	SENT165	9	9	4	4	thrombin	TGT	PA451674	9097;81890	0.549
NULL	Chem_Senses_2008_Sep_5_33(7)_665-680.nxml.txt.nlp	18603652	SENT76	16	16	9	9	ethanol	TRPV1	PA448073	7442	0.549
NULL	EMBO_J_2008_Mar_19_27(6)_852-864.nxml.txt.nlp	18309296	SENT333	6	6	8	8	nutlin-3	p53		7157	0.549
NULL	Braz_J_Microbiol_2014_Jan_15_44(3)_807-812.nxml.txt.nlp	24516449	SENT133	29	29	18	18	rifampin	CTX	PA451250	1593	0.549
NULL	Arthritis_Res_Ther_2012_Dec_7_14(6)_R265.nxml.txt.nlp	23217273	SENT168	17	17	25	25	thalidomide	CLE	PA451644	51637	0.549
NULL	Diabetes_2013_Sep_15_62(9)_3019-3021.nxml.txt.nlp	23970522	SENT24	27	27	17	17	chymotrypsin	CTRB1	PA448994	1504	0.548
NULL	Head_Face_Med_2010_Jul_19_6_17.nxml.txt.nlp	20642842	SENT90	6	6	9	9	glutaraldehyde	mol	PA449777	90527	0.548
NULL	Acta_Pharmacol_Sin_2011_Jun_3_32(6)_805-816.nxml.txt.nlp	21642949	SENT308	0	0	13	13	curcumin	c-fos	PA151958596	2353	0.548
NULL	Ann_Hematol_2011_May_21_90(5)_601-602.nxml.txt.nlp	20730538	SENT46	7	7	16	16	methotrexate	SMILE	PA450428	160418	0.548
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Jun_27_5_15.nxml.txt.nlp	16803618	SENT161	14	14	42	42	erythromycin	GEN1	PA449493	348654	0.548
NULL	Eur_J_Appl_Physiol_2011_Feb_24_111(2)_275-283.nxml.txt.nlp	20865425	SENT156	15	15	26	26	glucose	MRS	PA449773	8011	0.548
NULL	Front_Oncol_2012_Oct_31_2_157.nxml.txt.nlp	23120745	SENT420	4	4	0	0	temozolomide	p53	PA451609	7157	0.548
NULL	Indian_J_Endocrinol_Metab_2012_Dec_16(Suppl_2)_S498-S500.nxml.txt.nlp	23565478	SENT38	28	28	11	11	rosuvastatin	Q10	PA134308647	27161	0.548
NULL	Br_J_Cancer_2013_Jun_25_108(12)_2464-2469.nxml.txt.nlp	23695016	SENT162	25	25	22	22	cisplatin	CRT	PA449014	811	0.548
NULL	J_Clin_Biochem_Nutr_2009_Jan_27_44(1)_28-40.nxml.txt.nlp	19177185	SENT102	0	0	9	9	dobutamine	HO-1	PA449381	3162	0.548
NULL	Int_J_Nanomedicine_2007_Sep_2(3)_277-288.nxml.txt.nlp	18019828	SENT46	15	15	13	13	cyclophosphamide	CHOP	PA449165	1649	0.548
NULL	ScientificWorldJournal_2012_Mar_12_2012_746412.nxml.txt.nlp	22489201	SENT59	36	36	29	29	ethanol	mol	PA448073	90527	0.548
NULL	Cell_Commun_Signal_2014_Sep_25_12(1)_61.nxml.txt.nlp	NULL	SENT52	19	19	22	22	doxycycline	INPP4B	PA449415	8821	0.548
NULL	Int_J_Mol_Sci_2014_Nov_5_15(11)_20169-20208.nxml.txt.nlp	25380523	SENT1808	5	5	2	2	creatine	Q10	PA164778930	27161	0.548
NULL	Diabetes_2013_Jun_20_62(6)_1970-1980.nxml.txt.nlp	23378608	SENT8	13	13	4	4	celecoxib	apelin	PA448871	8862	0.548
NULL	Acta_Neuropathol_Commun_2014_May_30_2_57.nxml.txt.nlp	24887326	SENT186	4	4	23	23	etoposide	MED1	PA449552	5469;8930	0.548
NULL	Br_J_Cancer_1997_76(10)_1328-1332.nxml.txt.nlp	9374379	SENT10	29	29	43	43	cisplatin	IFN	PA449014	3439	0.548
NULL	Curr_Neuropharmacol_2012_Mar_10(1)_53-63.nxml.txt.nlp	22942878	SENT236	21	21	30	30	naloxone	AVP	PA450586	114548;551	0.548
NULL	Ann_Hematol_2013_Feb_19_92(2)_239-244.nxml.txt.nlp	23079891	SENT136	18	18	20	20	rituximab	CHOP	PA451261	1649	0.548
NULL	Int_J_Biol_Sci_2013_Nov_21_9(10)_1089-1098.nxml.txt.nlp	24339730	SENT24	10	10	12	12	genistein	BMP2	PA165109660	650	0.548
NULL	Int_J_Biomed_Sci_2008_Mar_4(1)_8-13.nxml.txt.nlp	23675060	SENT56	17	17	14	14	estradiol	CD4	PA449503	920	0.548
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Jun_27_5_15.nxml.txt.nlp	16803618	SENT145	8	8	42	42	flucloxacillin	GEN1	PA164781042	348654	0.548
NULL	Biomed_Res_Int_2013_Nov_6_2013_798164.nxml.txt.nlp	24308005	SENT78	20	20	44	44	paraformaldehyde	IFN	PA450790	3439	0.548
NULL	J_Immunother_Cancer_2014_Jan_27_2_2.nxml.txt.nlp	24829759	SENT179	16	16	18	18	sorafenib	IL-21	PA7000	59067;50616;27189	0.548
NULL	Community_Ment_Health_J_2014_May_18_50(8)_896-902.nxml.txt.nlp	24838373	SENT53	19	19	31	31	cocaine	PCP	PA449072	5547	0.548
NULL	Oncogene_2010_Jul_8_29(27)_3896-3907.nxml.txt.nlp	20453888	SENT28	20	20	11	11	trastuzumab	HER2	PA451743	2064	0.548
NULL	Front_Neurol_2013_Nov_1_4_170.nxml.txt.nlp	24198810	SENT171	11	11	28	28	phenytoin	CYP3A	PA450947	1574	0.548
NULL	Lipids_Health_Dis_2011_Jan_28_10_25.nxml.txt.nlp	21272376	SENT55	0	0	15	15	scopolamine	spatial	PA451308	219793	0.548
NULL	J_Med_Case_Rep_2014_Apr_3_8_113.nxml.txt.nlp	24708915	SENT85	4	4	0	0	doxorubicin	CHOP	PA449412	1649	0.548
NULL	Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.nxml.txt.nlp	24736980	SENT250	18	18	21	21	rosuvastatin	OATP1B1	PA134308647	10599	0.548
NULL	Exp_Diabetes_Res_2012_Nov_1_2012_892706.nxml.txt.nlp	23197976	SENT269	2	2	4	4	vildagliptin	HIF-1	PA165958346	29072	0.548
NULL	Cardiovasc_Psychiatry_Neurol_2011_Feb_16_2011_646958.nxml.txt.nlp	21350722	SENT114	34	34	28	28	calcein	ROS	PA132595336	6098	0.548
NULL	Diabetes_Metab_J_2014_Dec_15_38(6)_456-463.nxml.txt.nlp	25541609	SENT101	41	41	37	37	glucose	ACR	PA449773	49	0.548
NULL	Nat_Commun_2013_Aug_14_4_2312.nxml.txt.nlp	23942241	SENT233	4	4	7	7	heparin	FGF2	PA449855	2247;2258	0.548
NULL	Mult_Scler_Int_2013_Mar_10_2013_189624.nxml.txt.nlp	23555057	SENT191	28	28	7	7	daclizumab	IFN	PA164764446	3439	0.548
NULL	Clin_Med_Insights_Oncol_2011_May_18_5_145-156.nxml.txt.nlp	21695099	SENT287	9	9	6	6	cyclophosphamide	BOP	PA449165	611;150572	0.548
NULL	Fibrogenesis_Tissue_Repair_2010_Sep_3_3_18.nxml.txt.nlp	20815874	SENT28	12	12	9	9	bleomycin	CCR7	PA448645	1236	0.548
NULL	J_Clin_Biochem_Nutr_2010_Jan_29_46(1)_36-42.nxml.txt.nlp	20104263	SENT64	23	23	19	19	ribavirin	IFN	PA451241	3439	0.548
NULL	Cell_Mol_Life_Sci_2011_Mar_6_68(5)_903-917.nxml.txt.nlp	20820851	SENT49	12	12	47	47	l-glutamine	CO2	PA10090	4513	0.548
NULL	Braz_J_Med_Biol_Res_2012_Mar_2_45(3)_250-255.nxml.txt.nlp	22370705	SENT105	6	6	25	25	vasopressin	ADM	PA451858	133	0.548
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Jun_27_5_15.nxml.txt.nlp	16803618	SENT145	20	20	42	42	erythromycin	GEN1	PA449493	348654	0.548
NULL	Ann_Oncol_2009_Aug_20(Suppl_6)_vi41-vi50.nxml.txt.nlp	19617297	SENT51	16	16	23	23	carmustine	IFN	PA448810	3439	0.548
NULL	Diabetes_Care_2011_Jun_20_34(6)_1406-1411.nxml.txt.nlp	21515837	SENT72	30	30	21	21	glucose	DBP	PA449773	3295;1628;2638	0.548
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT287	2	2	4	4	resveratrol	ROS		6098	0.548
NULL	Environ_Health_Perspect_2012_Mar_2_120(3)_406-412.nxml.txt.nlp	22049383	SENT242	4	4	6	6	diethylstilbestrol	DES	PA449307	1674	0.548
NULL	Int_J_Mol_Sci_2012_Aug_16_13(8)_10257-10267.nxml.txt.nlp	22949859	SENT116	22	22	5	5	phenol	TPC	PA450913	8030;60386	0.548
NULL	Diabetes_Care_2009_Oct_8_32(10)_1873-1879.nxml.txt.nlp	19587362	SENT106	0	0	5	5	aliskiren	ANG	PA143487910	283	0.548
NULL	Cancer_Immunol_Immunother_2012_Jul_23_61(7)_1101-1111.nxml.txt.nlp	22193989	SENT165	18	18	14	14	oxaliplatin	IL-4	PA131285527	3565	0.548
NULL	AIDS_Res_Ther_2006_Apr_24_3_12.nxml.txt.nlp	16635263	SENT201	5	5	13	13	fluorescein	PEG10	PA164746009	23089	0.548
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT250	14	14	10	10	vinorelbine	MVP	PA451881	9961	0.548
NULL	Cardiovasc_Ultrasound_2005_Aug_18_3_22.nxml.txt.nlp	16107221	SENT165	23	23	5	5	creatine	PIR	PA164778930	8544	0.548
NULL	Acta_Pharmacol_Sin_2012_Dec_29_33(12)_1518-1524.nxml.txt.nlp	23103625	SENT165	16	16	3	3	telmisartan	ACE2	PA451605	59272	0.548
NULL	Acta_Neuropathol_Commun_2014_Oct_21_2(1)_149.nxml.txt.nlp	NULL	SENT11	24	24	28	28	riluzole	p38	PA451251	10598;1432;7965	0.548
NULL	Breast_Cancer_Res_2010_Oct_22_12(Suppl_2)_S1.nxml.txt.nlp	21050422	SENT128	9	9	19	19	cetuximab	TRN	PA10040	3842	0.548
NULL	Daru_2012_Sep_3_20(1)_24.nxml.txt.nlp	23351176	SENT82	10	10	14	14	itopride	EPO	PA152432599	7076;8288;2056	0.548
NULL	J_Cell_Mol_Med_2014_Apr_20_18(4)_709-720.nxml.txt.nlp	24444314	SENT260	3	3	8	8	metformin	PI3K	PA450395	5290	0.548
NULL	Oncotarget_2014_Nov_6_5(22)_11038-11053.nxml.txt.nlp	25402820	SENT150	36	36	27	27	gemcitabine	GEM	PA449748	2669	0.548
NULL	Biomed_Res_Int_2014_Jun_26_2014_161346.nxml.txt.nlp	25054130	SENT228	45	45	21	21	curcumin	STZ	PA151958596	6484	0.548
NULL	Evid_Based_Complement_Alternat_Med_2013_Nov_5_2013_937370.nxml.txt.nlp	24302971	SENT170	9	9	17	17	donepezil	CAT	PA449394	847	0.548
NULL	Iran_J_Basic_Med_Sci_2013_Dec_16(12)_1254-1258.nxml.txt.nlp	24570831	SENT40	17	17	13	13	ciprofloxacin	LBA	PA449009	987	0.548
NULL	Arthritis_Res_Ther_2008_Jan_16_10(1)_R6.nxml.txt.nlp	18199331	SENT237	21	21	39	39	pioglitazone	MCP-1	PA450970	6347	0.548
NULL	Biotechnol_Res_Int_2013_Dec_1_2013_253286.nxml.txt.nlp	24363937	SENT63	27	27	10	10	ethanol	DAP	PA448073	23549;3375;1611	0.548
NULL	Int_J_Biol_Sci_2013_Nov_21_9(10)_1089-1098.nxml.txt.nlp	24339730	SENT183	25	25	20	20	genistein	COL2A1	PA165109660	1280	0.548
NULL	Brain_Sci_2013_Jun_14_3(2)_941-963.nxml.txt.nlp	24961432	SENT57	0	0	28	28	ethanol	CYP2E1	PA448073	1571	0.548
NULL	J_Asthma_Allergy_2013_Feb_22_6_31-39.nxml.txt.nlp	23459334	SENT103	16	16	20	20	desloratadine	ANOVA	PA164776964	4858	0.548
NULL	Indian_J_Endocrinol_Metab_2012_Dec_16(Suppl_2)_S498-S500.nxml.txt.nlp	23565478	SENT8	6	6	17	17	rosuvastatin	Q10	PA134308647	27161	0.548
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT133	8	8	10	10	resveratrol	Bcl-2		596	0.548
NULL	Allergy_Asthma_Clin_Immunol_2010_May_12_6(1)_8.nxml.txt.nlp	20462426	SENT65	2	2	4	4	metformin	Met	PA450395	79811	0.548
NULL	Ann_Hematol_2010_Sep_13_89(9)_861-871.nxml.txt.nlp	20387067	SENT225	0	0	15	15	dasatinib	GM-CSF	PA162372878	1437	0.548
NULL	Pain_Res_Treat_2012_Apr_23_2012_295926.nxml.txt.nlp	22577544	SENT60	26	26	32	32	diclofenac	DLD	PA449293	1738	0.548
NULL	Cancers_(Basel)_2014_Aug_29_6(3)_1753-1768.nxml.txt.nlp	25256831	SENT547	1	1	21	21	bevacizumab	S15	PA130232992	6209	0.548
NULL	Croat_Med_J_2012_Aug_53(4)_314-320.nxml.txt.nlp	22911523	SENT62	29	29	17	17	warfarin	VKORC1	PA451906	79001	0.548
NULL	Biosci_Rep_2012_Dec_20_33(1)_e00011.nxml.txt.nlp	23137297	SENT147	27	27	6	6	heparin	RPSA	PA449855	3921	0.548
NULL	Oncol_Rep_2012_Apr_30_27(4)_1266-1276.nxml.txt.nlp	22209942	SENT311	16	16	0	0	cisplatin	BTC	PA449014	685	0.548
NULL	Br_J_Cancer_2013_Jul_23_109(2)_502-511.nxml.txt.nlp	23799850	SENT258	10	10	34	34	gemcitabine	PSN1	PA449748	51251	0.548
NULL	Case_Rep_Med_2010_Dec_16_2010_351084.nxml.txt.nlp	21209800	SENT83	8	8	18	18	voriconazole	MC1R	PA10233	4157	0.548
NULL	J_Gastroenterol_2013_Jan_28_48(1)_1-12.nxml.txt.nlp	23188091	SENT221	36	36	38	38	ribavirin	IFN	PA451241	3439	0.548
NULL	Oncol_Lett_2013_Dec_4_6(6)_1665-1672.nxml.txt.nlp	24273604	SENT181	42	42	4	4	chloroquine	TLR9	PA448948	54106	0.548
NULL	Clin_Ophthalmol_2012_Sep_5_6_1433-1440.nxml.txt.nlp	23055659	SENT153	21	21	12	12	timolol	BAK	PA451690	578	0.548
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT163	21	21	26	26	didanosine	Ray	PA449301	26751	0.548
NULL	J_Cell_Mol_Med_2013_Jan_11_17(1)_134-146.nxml.txt.nlp	23305490	SENT302	12	12	31	31	lidocaine	TASK	PA450226	3777	0.548
NULL	Oncogene_2014_Jan_23_33(4)_421-428.nxml.txt.nlp	23318437	SENT323	19	19	9	9	etoposide	RNF2	PA449552	6045	0.548
NULL	Case_Rep_Neurol_2013_Jun_29_5(2)_116-124.nxml.txt.nlp	23898283	SENT107	30	30	28	28	lorazepam	LZP	PA450267	170392	0.548
NULL	Chem_Cent_J_2014_Jan_17_8_4.nxml.txt.nlp	24438453	SENT131	6	6	23	23	genistein	IL-10	PA165109660	3586	0.548
NULL	Front_Neurosci_2013_Jun_13_7_97.nxml.txt.nlp	23781167	SENT492	2	2	4	4	methylphenidate	spatial	PA450464	219793	0.548
NULL	Pharmaceuticals_(Basel)_2011_Mar_17_4(3)_551-566.nxml.txt.nlp	NULL	SENT562	7	7	9	9	simvastatin	RhoA	PA451363	387	0.548
NULL	Acta_Pharmacol_Sin_2013_Sep_5_34(9)_1192-1200.nxml.txt.nlp	23685957	SENT240	3	3	14	14	curcumin	FasL	PA151958596	356	0.548
NULL	Eur_Radiol_2011_Feb_22_21(2)_265-273.nxml.txt.nlp	20730540	SENT42	11	11	23	23	capecitabine	CRT	PA448771	811	0.548
NULL	J_Ginseng_Res_2011_Nov_35(4)_436-441.nxml.txt.nlp	23717089	SENT117	10	10	7	7	ginseng	CAGC	PA164781150	6283	0.548
NULL	Int_J_Fertil_Steril_2014_Nov_1_Oct-Dec_8(3)_243-248.nxml.txt.nlp	25379151	SENT90	14	14	31	31	piroxicam	ART	PA450985	181	0.548
NULL	Basic_Clin_Neurosci_2013_Autumn_4(4)_323-328.nxml.txt.nlp	25337364	SENT48	7	7	14	14	colchicine	CA1	PA449092	759	0.548
NULL	EMBO_Mol_Med_2012_Sep_7_4(9)_896-909.nxml.txt.nlp	22887866	SENT145	0	0	5	5	lovastatin	c-Myc	PA450272	4609	0.548
NULL	J_Immunol_Res_2014_Feb_3_2014_671431.nxml.txt.nlp	24741615	SENT241	16	16	36	36	paraformaldehyde	CD22	PA450790	933	0.548
NULL	Indian_J_Pharm_Sci_2013_Jan-Feb_75(1)_94-98.nxml.txt.nlp	23901167	SENT87	30	30	15	15	tolbutamide	CYP2C9	PA451718	1559	0.548
NULL	Br_J_Clin_Pharmacol_2010_Dec_70(6)_807-814.nxml.txt.nlp	21175436	SENT98	17	17	41	41	liraglutide	Mal	PA165958364	114609	0.548
NULL	J_Headache_Pain_2011_Apr_5_12(2)_127-133.nxml.txt.nlp	21298314	SENT135	7	7	9	9	amitriptyline	CSMT	PA448385	1442	0.548
NULL	Mar_Drugs_2011_May_11_9(5)_819-831.nxml.txt.nlp	21673891	SENT165	13	13	21	21	troglitazone	Gen	PA451799	348654	0.548
NULL	Breast_Cancer_Res_2007_Oct_19_9(5)_111.nxml.txt.nlp	17983482	SENT49	20	20	1	1	lapatinib	HER3	PA152241907	2065	0.548
NULL	Arthritis_Res_Ther_2004_Jun_21_6(4)_R384-R392.nxml.txt.nlp	15225374	SENT27	22	22	24	24	collagenase	MMP1	PA449107	4312	0.548
NULL	Summit_on_Translat_Bioinforma_2010_Mar_1_2010_6a-10.nxml.txt.nlp	21347134	SENT46	14	14	12	12	aldesleukin	IL-2	PA448081	3558	0.548
NULL	Cancer_Med_2014_Apr_12_3(2)_390-396.nxml.txt.nlp	24519810	SENT96	6	6	0	0	tenofovir	LAM	PA10204	7249;7248	0.548
NULL	J_Exp_Med_1968_Oct_1_128(4)_699-713.nxml.txt.nlp	19867304	SENT8	11	11	13	13	galactose	NAG	PA449725	51594;4669	0.548
NULL	Diabetes_Care_2008_Aug_31(8)_1502-1509.nxml.txt.nlp	18487480	SENT182	24	24	22	22	fenofibrate	Q10	PA449594	27161	0.548
NULL	Mol_Vis_2011_Dec_24_17_3384-3391.nxml.txt.nlp	22219634	SENT135	18	18	23	23	mannitol	TLR2	PA450320	7097	0.548
NULL	Diabetol_Metab_Syndr_2014_Sep_23_6(1)_102.nxml.txt.nlp	NULL	SENT158	0	0	6	6	atorvastatin	RAGE	PA448500	177	0.548
NULL	Lab_Invest_2009_Nov_7_89(11)_1275-1290.nxml.txt.nlp	19736547	SENT218	25	25	45	45	curcumin	LOX-1	PA151958596	4973	0.548
NULL	Evid_Based_Complement_Alternat_Med_2004_Dec_1(3)_259-267.nxml.txt.nlp	15841259	SENT154	1	1	14	14	ethanol	IL-8	PA448073	3576	0.548
NULL	J_Korean_Med_Sci_2011_Dec_29_26(12)_1556-1562.nxml.txt.nlp	22147991	SENT37	8	8	5	5	rituximab	CHOP	PA451261	1649	0.548
NULL	Front_Neurosci_2010_Jun_17_4_35.nxml.txt.nlp	20661455	SENT11	5	5	14	14	buspirone	5-HT1A	PA448689	3350	0.548
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT85	37	37	34	34	trastuzumab	IL-6	PA451743	3569	0.548
NULL	Bull_Math_Biol_2014_Dec_14_76(2)_401-430.nxml.txt.nlp	24338592	SENT876	8	8	3	3	etoposide	CHOP	PA449552	1649	0.548
NULL	Arthritis_Res_Ther_2008_Jan_7_10(1)_R1.nxml.txt.nlp	18179697	SENT174	0	0	2	2	oxaliplatin	HMGB1	PA131285527	3146	0.548
NULL	Curr_Opin_Clin_Nutr_Metab_Care_2015_Jan_4_18(1)_71-77.nxml.txt.nlp	25474014	SENT131	15	15	9	9	lipase	AMPK	PA450239	5563	0.548
NULL	J_Antibiot_(Tokyo)_2014_May_19_67(5)_379-386.nxml.txt.nlp	24549153	SENT101	33	33	16	16	gentamicin	CO2	PA449753	4513	0.548
NULL	Exp_Ther_Med_2013_Mar_22_5(3)_819-824.nxml.txt.nlp	23403613	SENT94	13	13	23	23	thrombin	IFN	PA451674	3439	0.548
NULL	Cancers_(Basel)_2013_Jul_4_5(3)_838-856.nxml.txt.nlp	24202322	SENT200	2	2	24	24	flavopiridol	HEXIM1	PA452627	10614	0.548
NULL	J_Gen_Physiol_2004_Apr_123(4)_427-439.nxml.txt.nlp	15024039	SENT296	15	15	23	23	pp2	PP2		4888	0.548
NULL	Exp_Hematol_Oncol_2013_Nov_8_2_30.nxml.txt.nlp	24499550	SENT129	3	3	24	24	vemurafenib	BRAF	PA165946873	673	0.548
NULL	Arch_Med_Sci_2011_Feb_8_7(1)_154-160.nxml.txt.nlp	22291749	SENT165	2	2	16	16	chlorhexidine	S15	PA164776863	6209	0.548
NULL	Mol_Cell_Biochem_2013_Jun_20_378(1-2)_257-266.nxml.txt.nlp	23512522	SENT112	28	28	19	19	paraformaldehyde	MDC	PA450790	6367	0.548
NULL	Br_J_Cancer_2012_Feb_14_106(4)_646-650.nxml.txt.nlp	22240794	SENT88	13	13	16	16	sunitinib	IFN	PA162372840	3439	0.548
NULL	Diabetes_2013_Nov_18_62(11)_3677-3686.nxml.txt.nlp	24158999	SENT182	10	10	13	13	capsaicin	TRPV1	PA448776	7442	0.548
NULL	Mol_Cancer_2010_Apr_23_9_87.nxml.txt.nlp	20416058	SENT164	23	23	17	17	doxorubicin	TRAIL	PA449412	8743	0.548
NULL	Avicenna_J_Med_Biotechnol_2009_Apr-Jun_1(1)_47-51.nxml.txt.nlp	23407807	SENT28	26	26	17	17	streptokinase	DIP	PA164754919	23151;1831	0.548
NULL	J_Inherit_Metab_Dis_2012_Jan_10_35(1)_141-149.nxml.txt.nlp	21556832	SENT21	6	6	22	22	creatine	CRTR	PA164778930	6535	0.548
NULL	Cardiol_Res_Pract_2012_Sep_5_2012_607486.nxml.txt.nlp	22988540	SENT150	9	9	4	4	dobutamine	TDI	PA449381	100038246	0.548
NULL	Diabetes_2013_Jun_17_62(6)_1843-1854.nxml.txt.nlp	23349486	SENT158	4	4	2	2	hyaluronan	MCP-1	PA165958431	6347	0.548
NULL	Antimicrob_Resist_Infect_Control_2012_Mar_16_1_12.nxml.txt.nlp	22958880	SENT107	34	34	16	16	ceftriaxone	Gen	PA448866	348654	0.548
NULL	Breast_Cancer_Res_Treat_2013_Aug_20_141(1)_43-53.nxml.txt.nlp	23959396	SENT5	20	20	7	7	trastuzumab	HER3	PA451743	2065	0.548
NULL	J_Immunother_Cancer_2013_Nov_7_1(Suppl_1)_P248.nxml.txt.nlp	NULL	SENT5	5	5	2	2	ribavirin	IFN	PA451241	3439	0.548
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_3_2014_473213.nxml.txt.nlp	25538791	SENT119	9	9	17	17	fexofenadine	MDR1	PA449621	5243	0.548
NULL	J_Korean_Med_Sci_1996_Jun_11(3)_250-257.nxml.txt.nlp	8843008	SENT12	8	8	12	12	nitroprusside	GMP	PA451406	22978	0.548
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT446	9	9	19	19	phenol	FBS	PA450913	64319;26269	0.548
NULL	Acta_Pharmacol_Sin_2013_Jan_17_34(1)_157-166.nxml.txt.nlp	23247593	SENT140	0	0	4	4	berberine	Set9	PA165860812	80854	0.548
NULL	J_Clin_Biochem_Nutr_2010_Jan_29_46(1)_36-42.nxml.txt.nlp	20104263	SENT63	14	14	10	10	ribavirin	IFN	PA451241	3439	0.548
NULL	Mol_Cancer_2012_Jul_25_11_47.nxml.txt.nlp	22830443	SENT145	29	29	13	13	panitumumab	EGFR	PA162373091	1956	0.548
NULL	Eur_J_Clin_Pharmacol_2011_Dec_23_67(12)_1231-1241.nxml.txt.nlp	21698374	SENT266	11	11	3	3	tacrolimus	CYP3A4	PA451578	1576	0.548
NULL	Oncol_Lett_2014_Apr_4_7(4)_1007-1010.nxml.txt.nlp	24944659	SENT45	24	24	36	36	neomycin	CO2	PA450608	4513	0.548
NULL	Pan_Afr_Med_J_2012_Jul_9_12_67.nxml.txt.nlp	23024826	SENT35	7	7	5	5	cyclophosphamide	CHOP	PA449165	1649	0.548
NULL	Oncotarget_2014_Mar_26_5(21)_10342-10355.nxml.txt.nlp	25431950	SENT22	8	8	5	5	imatinib	EGFR	PA10804	1956	0.548
NULL	J_Invest_Dermatol_2011_Dec_22_131(12)_2467-2476.nxml.txt.nlp	21938011	SENT129	22	22	19	19	urokinase	MCP-1	PA451836	6347	0.548
NULL	Biomed_Res_Int_2013_Jun_18_2013_104315.nxml.txt.nlp	23853765	SENT110	37	37	14	14	pitrakinra	IL-13	PA165983754	3596	0.548
NULL	Mol_Biol_Evol_2013_Mar_11_30(3)_669-688.nxml.txt.nlp	23233462	SENT138	17	17	11	11	heparin	FGF1	PA449855	2246	0.548
NULL	Bioinformation_2008_Jan_27_2(6)_240-244.nxml.txt.nlp	18317572	SENT38	36	36	38	38	galactose	GAL	PA449725	51083	0.548
NULL	Ecancermedicalscience_2011_Apr_28_5_211.nxml.txt.nlp	22276054	SENT114	22	22	38	38	aprepitant	NK-1	PA164747039	27087	0.548
NULL	Oncol_Lett_2014_Jan_6_7(1)_255-259.nxml.txt.nlp	24348859	SENT93	37	37	27	27	tegafur	DCX	PA452620	1641	0.548
NULL	Cancer_Cell_Int_2013_Jun_26_13_63.nxml.txt.nlp	23800022	SENT227	12	12	19	19	genistein	MDM2	PA165109660	4193	0.548
NULL	Br_J_Cancer_1992_Jun_65(6)_865-869.nxml.txt.nlp	1616857	SENT6	23	23	12	12	tamoxifen	EGFR	PA451581	1956	0.548
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT148	11	11	15	15	heparin	FGF1	PA449855	2246	0.548
NULL	J_Biol_Chem_2013_Feb_1_288(5)_3512-3522.nxml.txt.nlp	23239883	SENT211	13	13	6	6	calcein	mol	PA132595336	90527	0.548
NULL	Front_Genet_2013_Aug_29_4_163.nxml.txt.nlp	24009622	SENT102	28	28	23	23	ethanol	DDP	PA448073	1678	0.548
NULL	Endocrinology_2011_Dec_11_152(12)_4641-4651.nxml.txt.nlp	21990309	SENT115	27	27	25	25	neomycin	SCHAD	PA450608	3033	0.548
NULL	Breast_Cancer_(Auckl)_2011_Jul_27_5_175-199.nxml.txt.nlp	21863131	SENT451	17	17	1	1	paclitaxel	Met	PA450761	79811	0.548
NULL	Epigenetics_2012_Oct_1_7(10)_1109-1114.nxml.txt.nlp	22968430	SENT80	9	9	35	35	l-glutamine	CO2	PA10090	4513	0.548
NULL	Biol_Open_2014_Nov_13_3(12)_1164-1172.nxml.txt.nlp	25395667	SENT24	15	15	17	17	capsaicin	TRPV1	PA448776	7442	0.548
NULL	Ann_Rheum_Dis_2008_Nov_17_68(6)_797-804.nxml.txt.nlp	19015207	SENT107	43	43	0	0	methotrexate	ACR	PA450428	49	0.548
NULL	Oncotarget_2012_Nov_17_3(12)_1600-1614.nxml.txt.nlp	23307622	SENT41	0	0	22	22	trastuzumab	PRKAA2	PA451743	5563	0.548
NULL	Arthritis_Res_Ther_2009_May_26_11(3)_R78.nxml.txt.nlp	19470154	SENT117	19	19	11	11	urea	AST	PA451831	26503	0.548
NULL	Diabetes_2011_Jun_21_60(6)_1770-1778.nxml.txt.nlp	21562078	SENT216	0	0	2	2	metformin	Met	PA450395	79811	0.548
NULL	Oncol_Lett_2013_Oct_1_6(4)_921-926.nxml.txt.nlp	24137437	SENT131	9	9	7	7	docetaxel	ID1	PA449383	3397	0.548
NULL	An_Bras_Dermatol_2013_Sep-Oct_88(5)_844-846.nxml.txt.nlp	24173202	SENT8	44	44	17	17	imiquimod	CO2	PA449972	4513	0.548
NULL	Adv_Urol_2009_Nov_5_2009_472831.nxml.txt.nlp	19020655	SENT184	8	8	17	17	mitomycin	IFN	PA450524	3439	0.548
NULL	J_Obes_2011_Jul_6_2011_432607.nxml.txt.nlp	21773005	SENT42	0	0	14	14	rimonabant	adiponectin	PA152407999	9370	0.548
NULL	Stroke_Res_Treat_2011_Jun_9_2011_534257.nxml.txt.nlp	21776361	SENT41	26	26	41	41	l-glutamine	CO2	PA10090	4513	0.548
NULL	Front_Oncol_2014_Oct_21_4_285.nxml.txt.nlp	25374842	SENT674	5	5	19	19	nutlin-3	p53		7157	0.548
NULL	Oncotarget_2014_Feb_14_5(3)_841-852.nxml.txt.nlp	24553354	SENT221	42	42	17	17	gentamicin	CO2	PA449753	4513	0.548
NULL	J_Korean_Med_Sci_2006_Apr_20_21(2)_199-207.nxml.txt.nlp	16614501	SENT33	15	15	13	13	tacrolimus	IL-2	PA451578	3558	0.548
NULL	Breast_Cancer_(Auckl)_2009_Apr_7_3_23-34.nxml.txt.nlp	21556247	SENT10	4	4	10	10	celecoxib	AKT	PA448871	207	0.548
NULL	Exp_Ther_Med_2014_Aug_4_8(2)_657-661.nxml.txt.nlp	25009636	SENT24	10	10	18	18	propofol	CCR2	PA451141	729230	0.548
NULL	Front_Genet_2014_Nov_28_5_386.nxml.txt.nlp	25506353	SENT346	23	23	21	21	mecamylamine	NAC	PA450334	22861	0.547
NULL	Mol_Vis_2012_Nov_29_18_2839-2846.nxml.txt.nlp	23233786	SENT166	3	3	5	5	geldanamycin	CB2	PA152031327	1269	0.547
NULL	Diabetes_Care_2009_Dec_6_32(12)_2251-2257.nxml.txt.nlp	19808924	SENT24	33	33	10	10	daclizumab	GLP	PA164764446	342096	0.547
NULL	Braz_J_Med_Biol_Res_2013_Jan_11_46(1)_91-97.nxml.txt.nlp	23314338	SENT105	20	20	4	4	estradiol	ANOVA	PA449503	4858	0.547
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Dec_10_3(12)_e151.nxml.txt.nlp	25494035	SENT33	20	20	22	22	rosuvastatin	OATP1B1	PA134308647	10599	0.547
NULL	Ann_Hematol_2014_Sep_10_93(1)_1-11.nxml.txt.nlp	24018623	SENT170	0	0	9	9	lenalidomide	CD34	PA162363968	947	0.547
NULL	Proteome_Sci_2010_Apr_8_8_21.nxml.txt.nlp	20377898	SENT64	12	12	1	1	trypsin	K10	PA451806	3858	0.547
NULL	Nucleic_Acids_Res_2005_Feb_24_33(4)_1169-1181.nxml.txt.nlp	15731337	SENT128	32	32	19	19	l-glutamine	CO2	PA10090	4513	0.547
NULL	Clin_Exp_Gastroenterol_2013_Aug_5_6_139-148.nxml.txt.nlp	23950655	SENT164	13	13	7	7	thrombin	ADP	PA451674	23038	0.547
NULL	Clin_Interv_Aging_2014_Oct_23_9_1815-1822.nxml.txt.nlp	25364239	SENT148	32	32	24	24	protamine	GLP-1	PA10366	100125288	0.547
NULL	Ann_Oncol_2012_Dec_2_23(12)_3007-3016.nxml.txt.nlp	22865781	SENT45	1	1	22	22	trastuzumab	HER2	PA451743	2064	0.547
NULL	J_Clin_Biochem_Nutr_2007_Nov_30_41(3)_160-168.nxml.txt.nlp	18299710	SENT345	16	16	5	5	ecabet	IL-8	PA165958350	3576	0.547
NULL	Front_Genet_2012_Oct_26_3_213.nxml.txt.nlp	23112805	SENT608	20	20	29	29	phenacetin	CYP2C19	PA450897	1557	0.547
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT128	8	8	2	2	flecainide	CYP2C19	PA449646	1557	0.547
NULL	J_Korean_Neurosurg_Soc_2013_Mar_31_53(3)_139-144.nxml.txt.nlp	23634262	SENT112	25	25	11	11	isoflurane	CA3	PA450106	761	0.547
NULL	Core_Evid_2009_Jun_15_4_83-92.nxml.txt.nlp	20694067	SENT11	7	7	9	9	vasopressin	AVP	PA451858	114548;551	0.547
NULL	Nat_Genet_2014_Feb_15_46(2)_152-160.nxml.txt.nlp	24336168	SENT244	6	6	22	22	galactose	TDP-43	PA449725	23435	0.547
NULL	Clin_Pharmacol_2013_Dec_9_5_185-192.nxml.txt.nlp	24353446	SENT75	4	4	9	9	clopidogrel	CYP3A4	PA449053	1576	0.547
NULL	J_Gen_Physiol_2003_Mar_121(3)_181-197.nxml.txt.nlp	12601083	SENT260	12	12	10	10	forskolin	GLP-1	PA146096022	100125288	0.547
NULL	Brain_Sci_2012_Nov_27_2(4)_667-683.nxml.txt.nlp	24371520	SENT131	14	14	16	16	vasopressin	AVP	PA451858	114548;551	0.547
NULL	Pharmacogn_Rev_2012_Jan-Jun_6(11)_68-73.nxml.txt.nlp	22654407	SENT165	9	9	11	11	cyclophosphamide	CTX	PA449165	1593	0.547
NULL	Arthritis_Res_Ther_2007_Nov_29_9(6)_222.nxml.txt.nlp	18086320	SENT48	24	24	8	8	hydralazine	TLR9	PA449894	54106	0.547
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S272-S275.nxml.txt.nlp	21525467	SENT145	15	15	13	13	liraglutide	GLP-1	PA165958364	100125288	0.547
NULL	Diagn_Pathol_2013_Feb_22_8_33.nxml.txt.nlp	23432846	SENT94	25	25	19	19	mitomycin	ADM	PA450524	133	0.547
NULL	Br_J_Cancer_2010_Jun_29_103(1)_61-72.nxml.txt.nlp	20588279	SENT17	14	14	18	18	trastuzumab	RhoB	PA451743	388	0.547
NULL	Ann_Surg_Oncol_2010_Apr_20_17(4)_1168-1176.nxml.txt.nlp	19936839	SENT73	33	33	24	24	cetuximab	KRAS	PA10040	3845	0.547
NULL	Iran_J_Public_Health_2010_Jun_30_39(2)_63-68.nxml.txt.nlp	23113008	SENT144	12	12	14	14	tobramycin	TOB	PA451704	10140	0.547
NULL	Mol_Microbiol_2012_Sep_26_85(6)_1148-1165.nxml.txt.nlp	22780904	SENT40	19	19	13	13	ethanol	CHP	PA448073	11261	0.547
NULL	J_Ophthalmol_2012_Aug_27_2012_285851.nxml.txt.nlp	23050121	SENT126	0	0	19	19	travoprost	BAK	PA164781371	578	0.547
NULL	Oncol_Lett_2014_May_11_7(5)_1401-1408.nxml.txt.nlp	24765145	SENT153	4	4	10	10	paclitaxel	PI3K	PA450761	5290	0.547
NULL	Biomed_Res_Int_2014_Jan_16_2014_821513.nxml.txt.nlp	24527458	SENT115	9	9	15	15	ketamine	NAC	PA450144	22861	0.547
NULL	Cancer_Gene_Ther_2013_Jan_9_20(1)_10_1038_cgt_2012_75.nxml.txt.nlp	23138870	SENT102	16	16	28	28	vincristine	PC3	PA451879	57332;7832;5122	0.547
NULL	Indian_J_Endocrinol_Metab_2012_May-Jun_16(3)_343-348.nxml.txt.nlp	22629497	SENT29	16	16	14	14	teriparatide	PTH	PA451620	5741	0.547
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Jun_27_5_15.nxml.txt.nlp	16803618	SENT161	8	8	42	42	flucloxacillin	GEN1	PA164781042	348654	0.547
NULL	Leukemia_2013_Apr_14_27(4)_803-812.nxml.txt.nlp	23238589	SENT126	9	9	17	17	imatinib	IFN	PA10804	3439	0.547
NULL	Part_Fibre_Toxicol_2011_Feb_9_8_8.nxml.txt.nlp	21306632	SENT137	11	11	47	47	l-glutamine	CO2	PA10090	4513	0.547
NULL	Oncotarget_2011_Aug_30_2(8)_610-626.nxml.txt.nlp	21881167	SENT148	9	9	3	3	doxorubicin	p53	PA449412	7157	0.547
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_17_2012_250584.nxml.txt.nlp	23118786	SENT299	16	16	12	12	nicotine	TEF	PA450626	7008	0.547
NULL	Calcif_Tissue_Int_2013_Sep_11_93(6)_526-539.nxml.txt.nlp	24022329	SENT72	30	30	38	38	l-glutamine	M-CSF	PA10090	1435	0.547
NULL	Clin_J_Gastroenterol_2013_Nov_8_6(6)_485-489.nxml.txt.nlp	24319501	SENT76	19	19	13	13	methotrexate	HAI	PA450428	6692;6768	0.547
NULL	Cardiovasc_Diabetol_2003_Sep_12_2_11.nxml.txt.nlp	14525620	SENT184	9	9	24	24	carvedilol	gamma	PA448817	9913	0.547
NULL	Acta_Pharmacol_Sin_2013_Feb_12_34(2)_255-261.nxml.txt.nlp	23147557	SENT3	38	38	25	25	pioglitazone	PTPRD	PA450970	5789	0.547
NULL	J_Cell_Mol_Med_2013_Oct_16_17(10)_1261-1270.nxml.txt.nlp	23855452	SENT25	5	5	7	7	gemcitabine	GEM	PA449748	2669	0.547
NULL	Indian_J_Anaesth_2014_Jul-Aug_58(4)_423-429.nxml.txt.nlp	25197110	SENT34	12	12	10	10	ondansetron	ODF	PA450705	8600	0.547
NULL	Int_J_Endocrinol_Metab_2013_Oct_1_11(4)_e10927.nxml.txt.nlp	24719626	SENT194	4	4	7	7	gliclazide	CYP2E1	PA10892	1571	0.547
NULL	Indian_J_Nephrol_2013_Mar-Apr_23(2)_143-145.nxml.txt.nlp	23716924	SENT40	6	6	13	13	ribavirin	IFN	PA451241	3439	0.547
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_127043.nxml.txt.nlp	23227093	SENT231	19	19	17	17	quinidine	CYP2C9	PA451209	1559	0.547
NULL	J_Oncol_2010_Jan_3_2010_149362.nxml.txt.nlp	20069122	SENT115	4	4	20	20	pertuzumab	HER3		2065	0.547
NULL	Leukemia_2014_Aug_14_28(8)_1657-1665.nxml.txt.nlp	24451410	SENT31	13	13	35	35	l-glutamine	CO2	PA10090	4513	0.547
NULL	Gene_Ther_2010_Sep_22_17(9)_1063-1076.nxml.txt.nlp	20410930	SENT112	27	27	39	39	paraformaldehyde	San	PA450790	80218	0.547
NULL	Oncol_Lett_2014_Jun_28_7(6)_1843-1846.nxml.txt.nlp	24932245	SENT49	9	9	13	13	vincristine	CHOP	PA451879	1649	0.547
NULL	J_Clin_Biochem_Nutr_2010_Jan_29_46(1)_36-42.nxml.txt.nlp	20104263	SENT93	14	14	10	10	ribavirin	IFN	PA451241	3439	0.547
NULL	Apoptosis_2012_Jun_9_17(6)_566-578.nxml.txt.nlp	22402981	SENT166	18	18	35	35	pp2	PP2		4888	0.547
NULL	Calcif_Tissue_Int_2010_Nov_20_87(5)_375-384.nxml.txt.nlp	20725827	SENT324	46	46	36	36	teriparatide	DANCE	PA451620	10516	0.547
NULL	Front_Oncol_2014_Sep_23_4_264.nxml.txt.nlp	25295231	SENT119	0	0	10	10	lenalidomide	MDM2	PA162363968	4193	0.547
NULL	J_Cell_Biol_1997_Jun_30_137(7)_1603-1613.nxml.txt.nlp	9199174	SENT2	31	31	25	25	thrombin	LPA	PA451674	4018	0.547
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Dec_17_3(12)_e152.nxml.txt.nlp	25518025	SENT107	0	0	3	3	oxymorphone	UGT2B7	PA450748	7364	0.547
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Dec_2_5_30.nxml.txt.nlp	17140452	SENT187	19	19	5	5	mupirocin	GAT	PA164764568	10249	0.547
NULL	Drugs_Context_2012_Nov_19_2012_212242.nxml.txt.nlp	24432031	SENT231	6	6	12	12	bevacizumab	IFN	PA130232992	3439	0.547
NULL	Ann_Indian_Acad_Neurol_2011_Jul_14(Suppl1)_S65-S69.nxml.txt.nlp	21847332	SENT68	24	24	17	17	mitoxantrone	IFN	PA450526	3439	0.547
NULL	J_Gen_Physiol_2000_Jun_1_115(6)_697-706.nxml.txt.nlp	10828244	SENT75	29	29	9	9	gentamicin	F10	PA449753	2159	0.547
NULL	Mol_Cell_2013_Mar_7_49(5)_922-933.nxml.txt.nlp	23375502	SENT644	22	22	11	11	etoposide	FMN2	PA449552	56776	0.547
NULL	J_Asthma_Allergy_2014_Dec_2_7_165-167.nxml.txt.nlp	25506230	SENT44	17	17	6	6	rituximab	C1-INH	PA451261	710	0.547
NULL	J_Gen_Physiol_1981_Jul_1_78(1)_63-86.nxml.txt.nlp	6114129	SENT0	13	13	1	1	potassium	Gen	PA451047	348654	0.547
NULL	Diabetes_Obes_Metab_2011_Nov_13(11)_982-989.nxml.txt.nlp	21615670	SENT157	18	18	12	12	exenatide	PPG	PA164749238	5552	0.547
NULL	Front_Zool_2013_Aug_3_10_44.nxml.txt.nlp	23915384	SENT86	14	14	17	17	glutaraldehyde	mol	PA449777	90527	0.547
NULL	Infect_Dis_Obstet_Gynecol_2014_Sep_25_2014_961375.nxml.txt.nlp	25328370	SENT198	10	10	0	0	atazanavir	ATV	PA10251	4683	0.547
NULL	Leukemia_2014_Apr_8_28(4)_894-903.nxml.txt.nlp	23925045	SENT162	3	3	5	5	tamoxifen	TMX	PA451581	81542	0.547
NULL	Cough_2009_Dec_16_5_11.nxml.txt.nlp	20015366	SENT155	0	0	5	5	guaifenesin	OTC	PA449818	5009	0.547
NULL	Diabetes_2013_Jun_17_62(6)_2141-2150.nxml.txt.nlp	23378610	SENT213	39	39	28	28	betaine	BHMT	PA448603	635	0.547
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT7	17	17	10	10	cisplatin	p53	PA449014	7157	0.547
NULL	Exp_Ther_Med_2013_Jul_25_6(1)_172-176.nxml.txt.nlp	23935741	SENT205	12	12	14	14	resveratrol	TPT		23590;6469	0.547
NULL	Cancer_Cell_Int_2012_Mar_22_12_9.nxml.txt.nlp	22439612	SENT61	18	18	38	38	l-glutamine	CO2	PA10090	4513	0.547
NULL	Oncoimmunology_2013_Jan_1_2(1)_e22664.nxml.txt.nlp	23482679	SENT191	16	16	43	43	bevacizumab	EOS	PA130232992	260429	0.547
NULL	Curr_Chem_Genomics_2008_Feb_25_1_43-53.nxml.txt.nlp	20161827	SENT101	19	19	21	21	fluorescein	MEK1	PA164746009	5604	0.547
NULL	Autoimmune_Dis_2013_Nov_5_2013_716813.nxml.txt.nlp	24294521	SENT190	14	14	11	11	sorafenib	STAT3	PA7000	6774	0.547
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2013_Sep_1_6_25-37.nxml.txt.nlp	24031162	SENT226	8	8	6	6	metformin	Met	PA450395	79811	0.547
NULL	Diabetes_2011_Jun_21_60(6)_1770-1778.nxml.txt.nlp	21562078	SENT251	0	0	2	2	metformin	Met	PA450395	79811	0.547
NULL	Mol_Vis_2012_Feb_9_18_390-402.nxml.txt.nlp	22355250	SENT476	16	16	5	5	warfarin	Q10	PA451906	27161	0.547
NULL	J_Biol_2003_Oct_29_2(4)_24.nxml.txt.nlp	NULL	SENT69	18	18	32	32	phenformin	LKB1	PA1000	6794	0.547
NULL	Cardiovasc_Res_2012_Dec_1_96(3)_466-475.nxml.txt.nlp	22915766	SENT100	27	27	36	36	creatine	HL-1	PA164778930	55600	0.547
NULL	Cancer_Inform_2009_Nov_13_7_253-269.nxml.txt.nlp	20011461	SENT180	12	12	26	26	clofibrate	C42	PA449045	51654	0.547
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT144	9	9	12	12	gefitinib	KRAS	PA131301952	3845	0.547
NULL	Arthritis_Res_Ther_2003_Feb_24_5(Suppl_1)_56.nxml.txt.nlp	NULL	SENT4	19	19	12	12	hyaluronan	IL-10	PA165958431	3586	0.547
NULL	Br_J_Cancer_2010_Oct_12_103(8)_1309-1310.nxml.txt.nlp	NULL	SENT18	12	12	14	14	bevacizumab	IFN	PA130232992	3439	0.547
NULL	Cancer_Cell_2007_Dec_11_12(6)_514-527.nxml.txt.nlp	18068629	SENT193	7	7	18	18	paclitaxel	TGFBI	PA450761	7045	0.547
NULL	Oncogene_2013_Nov_28_32(48)_5439-5448.nxml.txt.nlp	23563182	SENT147	0	0	5	5	vincristine	Mcl-1	PA451879	4170	0.547
NULL	Case_Rep_Oncol_2013_Feb_19_6(1)_98-103.nxml.txt.nlp	23626552	SENT12	24	24	10	10	urea	alpha-1-antitrypsin	PA451831	5265	0.547
NULL	Front_Pharmacol_2014_May_27_5_119.nxml.txt.nlp	24904422	SENT895	0	0	6	6	pravastatin	PGF	PA451089	5228	0.547
NULL	Braz_J_Med_Biol_Res_2014_Jan_10_47(1)_60-69.nxml.txt.nlp	24519092	SENT201	13	13	11	11	doxorubicin	YWHAZ	PA449412	7534	0.547
NULL	J_Korean_Med_Sci_2008_Aug_25_23(4)_657-661.nxml.txt.nlp	18756053	SENT105	39	39	26	26	estradiol	AMH	PA449503	268	0.547
NULL	Diabetes_2013_Jun_17_62(6)_1843-1854.nxml.txt.nlp	23349486	SENT235	26	26	39	39	hyaluronan	CCR2	PA165958431	729230	0.547
NULL	ScientificWorldJournal_2014_Dec_9_2014_808320.nxml.txt.nlp	25548793	SENT42	6	6	11	11	heparin	ACT	PA449855	12;11332;9457;641455	0.547
NULL	Exp_Diabetes_Res_2011_Apr_26_2011_215764.nxml.txt.nlp	21584276	SENT144	12	12	17	17	metformin	Yes	PA450395	7525	0.547
NULL	J_Hematol_Oncol_2013_Oct_1_6_75.nxml.txt.nlp	24279871	SENT161	15	15	17	17	cyclophosphamide	CTX	PA449165	1593	0.547
NULL	Arthritis_Res_Ther_2014_Apr_15_16(2)_208.nxml.txt.nlp	25099015	SENT145	24	24	10	10	infliximab	CD4	PA452639	920	0.547
NULL	Curr_Neuropharmacol_2014_Jul_12(4)_365-379.nxml.txt.nlp	25342944	SENT534	17	17	4	4	citalopram	5-HT2A	PA449015	3356	0.547
NULL	Acta_Pharmacol_Sin_2013_Oct_7_34(10)_1317-1324.nxml.txt.nlp	23933652	SENT124	0	0	6	6	rosiglitazone	TNF	PA451283	7124	0.547
NULL	J_Cell_Biol_2005_Jul_18_170(2)_225-235.nxml.txt.nlp	16027220	SENT342	17	17	8	8	heparin	EB1	PA449855	9167;22919;10982	0.547
NULL	Eur_J_Haematol_2014_Feb_25_92(2)_127-136.nxml.txt.nlp	24118452	SENT172	13	13	37	37	anagrelide	CRT	PA164742986	811	0.547
NULL	Br_J_Cancer_2009_Sep_15_101(6)_957-966.nxml.txt.nlp	19738618	SENT14	11	11	15	15	dexrazoxane	THBS-1	PA449259	7057	0.547
NULL	Ann_Indian_Acad_Neurol_2010_Apr-Jun_13(2)_136-138.nxml.txt.nlp	20814499	SENT46	7	7	23	23	voriconazole	CD4	PA10233	920	0.547
NULL	Oncol_Lett_2013_Apr_4_5(4)_1165-1170.nxml.txt.nlp	23599757	SENT5	36	36	27	27	pemetrexed	SLC19A1	PA10810	6573	0.547
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT41	10	10	12	12	chloroquine	BMPR-II	PA448948	659	0.547
NULL	Cancer_Metastasis_Rev_2010_Dec_10_29(4)_581-594.nxml.txt.nlp	20830503	SENT103	3	3	0	0	tamoxifen	ATAC	PA451581	6375	0.547
NULL	J_Anaesthesiol_Clin_Pharmacol_2011_Jan-Mar_27(1)_91-96.nxml.txt.nlp	21804715	SENT50	38	38	22	22	oxygen	DBP	PA450744	3295;1628;2638	0.547
NULL	Int_J_Mol_Sci_2014_Nov_4_15(11)_20022-20044.nxml.txt.nlp	25375187	SENT587	0	0	15	15	rosiglitazone	adiponectin	PA451283	9370	0.547
NULL	Cancer_Cell_Int_2013_Sep_23_13_94.nxml.txt.nlp	24059699	SENT209	27	27	16	16	bevacizumab	VEGFR1	PA130232992	2321	0.547
NULL	Eur_J_Clin_Pharmacol_2008_Feb_26_64(2)_133-157.nxml.txt.nlp	18224312	SENT544	11	11	9	9	trimipramine	CYP2C19	PA451791	1557	0.547
NULL	Niger_Med_J_2013_Mar-Apr_54(2)_100-106.nxml.txt.nlp	23798795	SENT5	20	20	31	31	indomethacin	HEC	PA449982	10403	0.547
NULL	Diabetes_2011_Nov_17_60(11)_2701-2709.nxml.txt.nlp	21885869	SENT117	2	2	40	40	picrotoxin	PPG	PA164777007	5552	0.547
NULL	Exp_Diabetes_Res_2011_Nov_30_2011_162092.nxml.txt.nlp	22203828	SENT213	19	19	21	21	lipase	HSL	PA450239	3991	0.547
NULL	Adipocyte_2012_Jan_1_1(1)_25-37.nxml.txt.nlp	23700508	SENT114	25	25	19	19	estradiol	aromatase	PA449503	1588	0.547
NULL	J_Cell_Biol_2006_Sep_25_174(7)_1047-1058.nxml.txt.nlp	17000881	SENT37	15	15	11	11	hydrocortisone	FGF2	PA449905	2247;2258	0.547
NULL	Infect_Dis_Ther_2013_Dec_3_2(2)_111-122.nxml.txt.nlp	25134475	SENT32	19	19	21	21	lopinavir	ATV	PA450264	4683	0.547
NULL	J_Gen_Physiol_2010_Apr_135(4)_333-353.nxml.txt.nlp	20231374	SENT383	10	10	21	21	fluoxetine	P2X4	PA449673	5025	0.547
NULL	Oncoscience_2014_Oct_24_1(10)_665-673.nxml.txt.nlp	25593995	SENT73	8	8	24	24	doxorubicin	NANOG	PA449412	79923	0.547
NULL	Int_J_Endocrinol_2014_Apr_30_2014_674987.nxml.txt.nlp	24883061	SENT63	15	15	13	13	nadh	PARP	PA164755085	142	0.547
NULL	Protein_Cell_2014_Jun_19_5(6)_469-479.nxml.txt.nlp	24748116	SENT84	12	12	10	10	paclitaxel	EB1	PA450761	9167;22919;10982	0.547
NULL	Cancers_(Basel)_2011_Aug_5_3(3)_3114-3142.nxml.txt.nlp	24212948	SENT135	0	0	2	2	gemcitabine	GEM	PA449748	2669	0.547
NULL	Front_Hum_Neurosci_2013_Feb_20_7_36.nxml.txt.nlp	23430280	SENT617	8	8	5	5	lipase	CD36	PA450239	948	0.547
NULL	Clin_Ophthalmol_2014_Jan_9_8_191-197.nxml.txt.nlp	24531560	SENT23	12	12	15	15	fluorescein	ERG	PA164746009	2078	0.547
NULL	Crit_Care_2004_May_25_8(4)_243-252.nxml.txt.nlp	15312206	SENT29	16	16	7	7	vasopressin	ACTH	PA451858	5443	0.547
NULL	Clin_Ophthalmol_2010_Oct_5_4_1073-1079.nxml.txt.nlp	20957143	SENT116	23	23	15	15	verteporfin	CRT	PA451871	811	0.547
NULL	Asian-Australas_J_Anim_Sci_2013_Jan_26(1)_108-115.nxml.txt.nlp	25049712	SENT142	2	2	9	9	berberine	AMPK	PA165860812	5563	0.547
NULL	Protein_Cell_2014_Jun_19_5(6)_469-479.nxml.txt.nlp	24748116	SENT156	11	11	9	9	paclitaxel	EB1	PA450761	9167;22919;10982	0.547
NULL	J_Geriatr_Cardiol_2014_Mar_11(1)_39-43.nxml.txt.nlp	24748880	SENT86	1	1	4	4	esmolol	SBP1	PA449500	1954	0.547
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT180	13	13	27	27	glucose	EGFR	PA449773	1956	0.547
NULL	Ann_N_Y_Acad_Sci_2012_Aug_30_1264(1)_49-63.nxml.txt.nlp	22548651	SENT184	3	3	6	6	glucose	BDNF	PA449773	627	0.547
NULL	Diabetes_Care_2013_Jun_15_36(6)_1765-1771.nxml.txt.nlp	23704676	SENT180	0	0	4	4	metformin	B12	PA450395	7126;4709	0.547
NULL	Mucosal_Immunol_2013_Nov_10_6(6)_1179-1190.nxml.txt.nlp	23571504	SENT111	13	13	11	11	dextran	TRX	PA449261	7295	0.547
NULL	Exp_Ther_Med_2013_Mar_10_5(3)_783-788.nxml.txt.nlp	23408783	SENT194	7	7	13	13	rosiglitazone	MCP-1	PA451283	6347	0.547
NULL	J_Cell_Mol_Med_2014_Feb_8_18(2)_197-207.nxml.txt.nlp	24400890	SENT122	5	5	38	38	ethanol	DNMT1	PA448073	1786	0.547
NULL	Exp_Diabetes_Res_2012_May_17_2012_137607.nxml.txt.nlp	22675339	SENT184	19	19	22	22	estradiol	NAC	PA449503	22861	0.547
NULL	Front_Neurosci_2011_Jan_14_4_207.nxml.txt.nlp	21258618	SENT158	28	28	8	8	ethanol	HET	PA448073	6294	0.546
NULL	Oncotarget_2014_Sep_8_5(19)_9498-9513.nxml.txt.nlp	25237769	SENT104	27	27	25	25	cisplatin	DDP	PA449014	1678	0.546
NULL	Antimicrob_Resist_Infect_Control_2012_Mar_16_1_12.nxml.txt.nlp	22958880	SENT107	2	2	16	16	ampicillin	Gen	PA448419	348654	0.546
NULL	EMBO_Mol_Med_2013_Apr_5_5(4)_572-590.nxml.txt.nlp	23460527	SENT333	29	29	18	18	paraformaldehyde	CD4	PA450790	920	0.546
NULL	Breast_Cancer_Res_2012_Jan_20_14(1)_R16.nxml.txt.nlp	22264274	SENT117	18	18	9	9	collagenase	STAT1	PA449107	6772	0.546
NULL	J_Clin_Biochem_Nutr_2010_Jan_29_46(1)_36-42.nxml.txt.nlp	20104263	SENT56	25	25	21	21	ribavirin	IFN	PA451241	3439	0.546
NULL	Cytotherapy_2013_Jan_15(1)_89-101.nxml.txt.nlp	23260089	SENT177	28	28	20	20	lipase	IGFBP2	PA450239	3485	0.546
NULL	J_Hematol_Oncol_2013_Sep_5_6_66.nxml.txt.nlp	24010946	SENT311	5	5	8	8	trastuzumab	CRT	PA451743	811	0.546
NULL	Cells_2014_Apr_29_3(2)_363-385.nxml.txt.nlp	24785348	SENT187	0	0	6	6	chloroquine	VEGFR2	PA448948	3791	0.546
NULL	Diagn_Pathol_2013_Jul_2_8_108.nxml.txt.nlp	23819507	SENT131	10	10	19	19	thyroglobulin	TTF-1	PA164754910	7080	0.546
NULL	Cancer_Causes_Control_2013_Aug_18_24(8)_1605-1614.nxml.txt.nlp	23775025	SENT64	25	25	32	32	methotrexate	ABCB1	PA450428	5243	0.546
NULL	Arthritis_Res_Ther_2011_Jun_20_13(3)_R94.nxml.txt.nlp	21689401	SENT86	2	2	17	17	adalimumab	GDA	PA10004	8034;9615	0.546
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_33-43.nxml.txt.nlp	17912634	SENT122	4	4	15	15	tamoxifen	TFF1	PA451581	7031	0.546
NULL	Croat_Med_J_2014_Aug_55(4)_366-376.nxml.txt.nlp	25165050	SENT257	22	22	8	8	buprenorphine	ABCB1	PA448685	5243	0.546
NULL	Biologics_2012_Aug_17_6_267-276.nxml.txt.nlp	22956858	SENT82	41	41	29	29	sorafenib	STAT3	PA7000	6774	0.546
NULL	F1000_Biol_Rep_2009_Sep_8_1_70.nxml.txt.nlp	20948617	SENT91	9	9	5	5	ustekinumab	p40	PA166048654	3921;339541;10314	0.546
NULL	J_Biol_Chem_2013_Mar_29_288(13)_9035-9048.nxml.txt.nlp	23362266	SENT1523	5	5	17	17	estradiol	ST-2	PA449503	27111	0.546
NULL	Acta_Pharmacol_Sin_2013_May_18_34(5)_605-611.nxml.txt.nlp	23416930	SENT44	39	39	24	24	resveratrol	p53		7157	0.546
NULL	J_Geriatr_Cardiol_2014_Jun_11(2)_151-157.nxml.txt.nlp	25009566	SENT126	15	15	13	13	cilostazol	CDP	PA164746334	1523	0.546
NULL	Front_Hum_Neurosci_2013_Mar_26_7_97.nxml.txt.nlp	23532379	SENT1668	16	16	6	6	ethanol	spatial	PA448073	219793	0.546
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT76	3	3	11	11	curcumin	PC-3	PA151958596	692094	0.546
NULL	J_Bras_Pneumol_2014_Jan-Feb_40(1)_30-37.nxml.txt.nlp	24626267	SENT180	8	8	13	13	salbutamol	por	PA448068	64840	0.546
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT140	15	15	17	17	perifosine	TRAIL	PA165291471	8743	0.546
NULL	J_Clin_Biochem_Nutr_2010_Jan_29_46(1)_36-42.nxml.txt.nlp	20104263	SENT37	22	22	18	18	ribavirin	IFN	PA451241	3439	0.546
NULL	Virol_J_2011_May_25_8_258.nxml.txt.nlp	21609495	SENT6	12	12	9	9	ribavirin	IFN	PA451241	3439	0.546
NULL	CNS_Drugs_2013_Aug_20_27(12)_1081-1092.nxml.txt.nlp	23959815	SENT131	9	9	0	0	lisdexamfetamine	ATX	PA164748975	5168;23049	0.546
NULL	Cancers_(Basel)_2011_Oct_26_3(4)_4024-4045.nxml.txt.nlp	24213123	SENT687	1	1	11	11	resveratrol	SIRT1		23411	0.546
NULL	Breast_Cancer_(Auckl)_2012_Oct_25_6_159-171.nxml.txt.nlp	23133315	SENT86	15	15	24	24	paclitaxel	BRCA1	PA450761	672	0.546
NULL	Cancer_Med_2013_Jun_2_2(3)_325-333.nxml.txt.nlp	23930209	SENT204	8	8	4	4	everolimus	HIF-1	PA164746311	29072	0.546
NULL	Diabetes_Care_2012_Dec_14_35(12)_2631-2639.nxml.txt.nlp	22912426	SENT294	9	9	11	11	rosiglitazone	adiponectin	PA451283	9370	0.546
NULL	J_Cancer_2011_May_19_2_292-301.nxml.txt.nlp	21611110	SENT177	3	3	8	8	cytarabine	spatial	PA449177	219793	0.546
NULL	Clin_Microbiol_Infect_2014_Jun_21_20(6)_536-541.nxml.txt.nlp	24107197	SENT27	5	5	7	7	isoniazid	DST	PA450112	667	0.546
NULL	Breast_Cancer_Res_2010_Aug_9_12(4)_R62.nxml.txt.nlp	20696059	SENT239	26	26	35	35	trastuzumab	HER2	PA451743	2064	0.546
NULL	Arthritis_Rheum_2013_Jan_1_65(12)_3130-3140.nxml.txt.nlp	23983046	SENT151	30	30	26	26	staurosporine	SFN	PA165109623	25996;2810	0.546
NULL	J_Korean_Assoc_Oral_Maxillofac_Surg_2014_Aug_26_40(4)_173-180.nxml.txt.nlp	25247147	SENT57	24	24	11	11	choline	NF-M	PA448976	4741	0.546
NULL	Reprod_Biol_Endocrinol_2003_Aug_6_1_54.nxml.txt.nlp	12932297	SENT23	17	17	15	15	hyaluronidase	SPAM1	PA164745713	6677	0.546
NULL	J_Antimicrob_Chemother_2014_Apr_8_69(4)_924-931.nxml.txt.nlp	24324223	SENT110	6	6	0	0	tetracycline	PEN	PA451640	9933	0.546
NULL	Iran_J_Basic_Med_Sci_2012_Jul-Aug_15(4)_937-944.nxml.txt.nlp	23493039	SENT21	18	18	25	25	nitrogen	TNF	PA450643	7124	0.546
NULL	J_Antimicrob_Chemother_2014_Apr_13_69(4)_955-958.nxml.txt.nlp	24235096	SENT6	10	10	30	30	amikacin	GC1	PA164744372	79751;10562	0.546
NULL	Breast_Cancer_Res_2008_Mar_17_10(2)_204.nxml.txt.nlp	18373885	SENT93	1	1	3	3	thrombin	PAR-1	PA451674	2011;2149	0.546
NULL	EMBO_Mol_Med_2011_Jul_3(7)_367-369.nxml.txt.nlp	21591260	SENT28	18	18	12	12	collagenase	MMP8	PA449107	4317	0.546
NULL	Cardiovasc_Diabetol_2005_May_15_4_6.nxml.txt.nlp	15892894	SENT86	16	16	12	12	losartan	DBP	PA450268	3295;1628;2638	0.546
NULL	Mol_Vis_2012_Jun_20_18_1640-1648.nxml.txt.nlp	22773902	SENT172	18	18	14	14	nitrogen	ROS	PA450643	6098	0.546
NULL	Ann_Hematol_2010_Jul_1_89(Suppl_1)_5-10.nxml.txt.nlp	NULL	SENT6	20	20	17	17	cyclosporine	TPO	PA449167	7066;7173	0.546
NULL	Arthritis_Res_Ther_2014_Jan_20_16(1)_R17.nxml.txt.nlp	24444433	SENT127	8	8	0	0	hydroxychloroquine	ANOVA	PA164777036	4858	0.546
NULL	Front_Endocrinol_(Lausanne)_2014_Oct_27_5_163.nxml.txt.nlp	25386163	SENT382	0	0	5	5	ethanol	ghrelin	PA448073	51738	0.546
NULL	Eur_J_Med_Res_2011_Mar_28_16(3)_115-126.nxml.txt.nlp	21486724	SENT285	28	28	42	42	meropenem	Met	PA164764445	79811	0.546
NULL	Thorax_2010_Jul_13_65(7)_654-658.nxml.txt.nlp	20627927	SENT45	24	24	10	10	gentamicin	NAG	PA449753	51594;4669	0.546
NULL	Addict_Health_2014_Winter-Spring_6(1-2)_54-64.nxml.txt.nlp	25140218	SENT142	10	10	16	16	ethanol	spatial	PA448073	219793	0.546
NULL	Int_J_Vasc_Med_2012_Mar_19_2012_536392.nxml.txt.nlp	22506117	SENT134	26	26	10	10	heparin	CEA	PA449855	5670;1087	0.546
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jul_31_66(Pt_8)_o2190.nxml.txt.nlp	21588467	SENT3	11	11	18	18	coumarin	mol	PA134521193	90527	0.546
NULL	Drugs_R_D_2010_Nov_25_10(4)_219-224.nxml.txt.nlp	21171668	SENT18	29	29	27	27	ticlopidine	P2Y12	PA451686	64805	0.546
NULL	Br_J_Clin_Pharmacol_2013_Aug_23_76(2)_299-315.nxml.txt.nlp	23701319	SENT137	25	25	22	22	muromonab	IL-2	PA164743097	3558	0.546
NULL	Anat_Cell_Biol_2011_Sep_29_44(3)_194-203.nxml.txt.nlp	22025971	SENT68	23	23	10	10	paraformaldehyde	CTRL	PA450790	1506	0.546
NULL	Ther_Clin_Risk_Manag_2007_Dec_3(6)_1009-1020.nxml.txt.nlp	18516316	SENT76	42	42	37	37	cisplatin	HEC	PA449014	10403	0.546
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1076.nxml.txt.nlp	24556691	SENT111	25	25	32	32	l-glutamine	CO2	PA10090	4513	0.546
NULL	Cancer_Cell_Int_2011_Dec_29_11_44.nxml.txt.nlp	22206574	SENT66	20	20	26	26	sunitinib	VEGFR2	PA162372840	3791	0.546
NULL	Front_Cell_Neurosci_2014_Dec_5_8_415.nxml.txt.nlp	25538565	SENT992	0	0	13	13	ethanol	gamma	PA448073	9913	0.546
NULL	Patient_Prefer_Adherence_2009_Nov_3_3_173-177.nxml.txt.nlp	19936159	SENT73	12	12	34	34	dabigatran	CLCR		11330	0.546
NULL	Am_J_Physiol_Cell_Physiol_2010_Nov_18_299(5)_C1180-C1194.nxml.txt.nlp	20720182	SENT133	23	23	25	25	hyaluronan	HAS2	PA165958431	3037	0.546
NULL	J_Asthma_Allergy_2013_Jul_1_6_93-101.nxml.txt.nlp	23843695	SENT199	10	10	12	12	budesonide	BDP	PA448681	10620;152926	0.546
NULL	Mol_Cancer_2008_Jun_3_7_47.nxml.txt.nlp	18519000	SENT203	27	27	32	32	l-glutamine	CO2	PA10090	4513	0.546
NULL	Front_Genet_2012_Oct_26_3_213.nxml.txt.nlp	23112805	SENT608	35	35	39	39	dextromethorphan	CYP3A4	PA449273	1576	0.546
NULL	Diabetes_2009_Feb_58(2)_344-351.nxml.txt.nlp	19008341	SENT217	0	0	5	5	resveratrol	SIRT1		23411	0.546
NULL	Indian_J_Pharm_Sci_2012_Jul-Aug_74(4)_292-301.nxml.txt.nlp	23626384	SENT106	17	17	20	20	propranolol	PPN	PA451145	64840	0.546
NULL	J_Biol_Chem_2013_Nov_15_288(46)_33049-33059.nxml.txt.nlp	24089524	SENT111	8	8	23	23	nicotine	CAM	PA450626	889	0.546
NULL	Eur_J_Med_Res_2009_Dec_7_14(Suppl_4)_71-77.nxml.txt.nlp	20156730	SENT94	7	7	3	3	tobramycin	gamma	PA451704	9913	0.546
NULL	J_Immunol_Res_2014_Jun_2_2014_210241.nxml.txt.nlp	24987708	SENT360	13	13	18	18	estradiol	CD25	PA449503	3669;3559	0.546
NULL	AIDS_Res_Ther_2006_Apr_24_3_12.nxml.txt.nlp	16635263	SENT167	25	25	20	20	fluorescein	PEG3	PA164746009	5178	0.546
NULL	Indian_J_Med_Res_2014_Jan_139(1)_117-124.nxml.txt.nlp	24604047	SENT38	11	11	4	4	fluvastatin	PI3K	PA449688	5290	0.546
NULL	Arch_Med_Sci_2011_Feb_8_7(1)_154-160.nxml.txt.nlp	22291749	SENT161	9	9	23	23	chlorhexidine	S15	PA164776863	6209	0.546
NULL	Cell_Death_Dis_2010_Oct_21_1(10)_e86.nxml.txt.nlp	21368859	SENT179	10	10	14	14	doxorubicin	TRAIL	PA449412	8743	0.546
NULL	Arthritis_Res_Ther_2011_Sep_14_13(5)_R149.nxml.txt.nlp	21914218	SENT64	34	34	6	6	methotrexate	BiP	PA450428	3309	0.546
NULL	Mol_Syst_Biol_2010_Jun_8_6_378.nxml.txt.nlp	20531407	SENT277	40	40	1	1	ethanol	Gen	PA448073	348654	0.546
NULL	Breast_Cancer_(Auckl)_2011_Apr_13_5_53-65.nxml.txt.nlp	21603258	SENT239	11	11	21	21	docetaxel	SPARC	PA449383	6678	0.546
NULL	Brain_Sci_2013_Apr_26_3(2)_670-703.nxml.txt.nlp	24961420	SENT136	14	14	16	16	ethanol	AMPK	PA448073	5563	0.546
NULL	Endocrinol_Diabetes_Metab_Case_Rep_2014_Dec_1_2014_140083.nxml.txt.nlp	25535576	SENT67	8	8	5	5	ketoconazole	ACTH	PA450146	5443	0.546
NULL	Cell_Biol_Int_Rep_(2010)_2012_Jun_21_19(1)_e00017.nxml.txt.nlp	23124518	SENT90	43	43	48	48	etoposide	TRAIL	PA449552	8743	0.546
NULL	Breast_Cancer_Res_Treat_2014_Nov_8_148(3)_553-561.nxml.txt.nlp	NULL	SENT160	20	20	15	15	capecitabine	TPC	PA448771	8030;60386	0.546
NULL	Diabetes_2008_Sep_57(9)_2272-2279.nxml.txt.nlp	18519799	SENT131	3	3	13	13	rosiglitazone	PDK4	PA451283	5166	0.546
NULL	FEBS_Open_Bio_2014_Jun_2_4_510-521.nxml.txt.nlp	24967154	SENT256	20	20	11	11	streptomycin	FBS	PA451512	64319;26269	0.546
NULL	J_Cachexia_Sarcopenia_Muscle_2010_Dec_17_1(2)_159-167.nxml.txt.nlp	21475701	SENT63	17	17	4	4	lipase	ghrelin	PA450239	51738	0.546
NULL	J_Ginseng_Res_2011_Nov_35(4)_436-441.nxml.txt.nlp	23717089	SENT106	3	3	7	7	ginseng	CAGC	PA164781150	6283	0.546
NULL	Exp_Ther_Med_2013_Nov_6_6(5)_1089-1095.nxml.txt.nlp	24223627	SENT183	4	4	24	24	epirubicin	NAC	PA449476	22861	0.546
NULL	Oxid_Med_Cell_Longev_2012_Jan_19_2012_390678.nxml.txt.nlp	22315655	SENT95	6	6	18	18	gliclazide	NAC	PA10892	22861	0.546
NULL	Int_J_Inflam_2011_Sep_15_2011_376909.nxml.txt.nlp	21941676	SENT47	6	6	17	17	pioglitazone	adiponectin	PA450970	9370	0.546
NULL	Clin_Sci_(Lond)_2009_Nov_16_118(Pt_4)_269-279.nxml.txt.nlp	19698082	SENT29	15	15	20	20	ramipril	ACE2	PA451223	59272	0.546
NULL	Front_Behav_Neurosci_2012_Jul_24_6_32.nxml.txt.nlp	22837741	SENT310	9	9	25	25	carbachol	CA3	PA448784	761	0.546
NULL	Oncotarget_2013_Nov_19_5(2)_309-325.nxml.txt.nlp	24525395	SENT80	0	0	7	7	flavopiridol	Mcl-1	PA452627	4170	0.546
NULL	Onco_Targets_Ther_2014_May_10_7_633-636.nxml.txt.nlp	24872711	SENT5	7	7	4	4	cyclophosphamide	CHOP	PA449165	1649	0.546
NULL	Biologics_2009_Sep_15_3_377-383.nxml.txt.nlp	19774205	SENT216	23	23	13	13	zanamivir	Yes	PA164740891	7525	0.546
NULL	Evid_Based_Complement_Alternat_Med_2015_Jan_6_2015_736431.nxml.txt.nlp	25632290	SENT275	9	9	16	16	ritonavir	P-gp	PA451260	5243	0.546
NULL	Int_J_Hypertens_2013_Jun_17_2013_627938.nxml.txt.nlp	23844279	SENT37	17	17	15	15	telmisartan	A10	PA451605	28870	0.546
NULL	Oxid_Med_Cell_Longev_2014_Apr_3_2014_897296.nxml.txt.nlp	24803987	SENT37	2	2	0	0	resveratrol	STZ		6484	0.546
NULL	Gut_2013_Apr_14_62(4)_540-549.nxml.txt.nlp	22798500	SENT258	12	12	7	7	cetuximab	PTEN	PA10040	5728	0.546
NULL	Mol_Cancer_2007_Apr_3_6_27.nxml.txt.nlp	17407586	SENT37	17	17	7	7	gemcitabine	E2F1	PA449748	1869	0.546
NULL	J_Mol_Signal_2013_Aug_7_8_8.nxml.txt.nlp	23924390	SENT58	20	20	32	32	pp2	EGF		1950	0.546
NULL	Gut_2015_Jan_19_64(1)_111-120.nxml.txt.nlp	24647007	SENT21	5	5	0	0	capecitabine	DPYD	PA448771	1806	0.546
NULL	Breast_Cancer_(Auckl)_2009_Aug_17_3_47-60.nxml.txt.nlp	21556249	SENT3	18	18	33	33	urokinase	BRCA2	PA451836	675	0.546
NULL	J_Cell_Biol_1998_Jul_27_142(2)_523-535.nxml.txt.nlp	9679149	SENT0	33	33	12	12	phenylephrine	p38	PA450935	10598;1432;7965	0.546
NULL	J_Antibiot_(Tokyo)_2012_Jun_11_65(6)_289-294.nxml.txt.nlp	22491136	SENT312	14	14	5	5	trypsin	L10	PA451806	6134	0.546
NULL	Acta_Orthop_2010_Apr_6_81(2)_263-267.nxml.txt.nlp	20148646	SENT121	0	0	11	11	taurine	CHOP	PA451590	1649	0.546
NULL	Cancers_(Basel)_2013_Apr_15_5(2)_430-461.nxml.txt.nlp	24216985	SENT1469	1	1	13	13	decitabine	WAF1	PA164749631	1026	0.546
NULL	Oncol_Lett_2014_Sep_19_8(3)_1269-1274.nxml.txt.nlp	25120704	SENT23	0	0	2	2	metformin	Met	PA450395	79811	0.546
NULL	Diabetes_Obes_Metab_2010_Aug_12(8)_700-708.nxml.txt.nlp	20590747	SENT190	21	21	11	11	vildagliptin	PPG	PA165958346	5552	0.546
NULL	Curr_Chem_Genomics_2008_Jul_11_1_70-78.nxml.txt.nlp	20161830	SENT241	25	25	34	34	carbachol	FFAR1	PA448784	2864	0.546
NULL	Cancers_(Basel)_2012_Feb_7_4(1)_88-99.nxml.txt.nlp	24213228	SENT601	18	18	9	9	piroxicam	COX	PA450985	1351	0.546
NULL	Front_Mol_Neurosci_2012_Jan_23_5_2.nxml.txt.nlp	22291616	SENT384	6	6	9	9	capsaicin	VR1	PA448776	56664	0.546
NULL	Eur_Arch_Psychiatry_Clin_Neurosci_2012_Dec_28_262(8)_667-676.nxml.txt.nlp	22454241	SENT289	3	3	5	5	risperidone	spatial	PA451257	219793	0.546
NULL	Ann_Surg_Treat_Res_2014_Feb_22_86(2)_68-75.nxml.txt.nlp	24761411	SENT15	14	14	4	4	resveratrol	survivin		332	0.546
NULL	Front_Behav_Neurosci_2009_Sep_30_3_31.nxml.txt.nlp	19862348	SENT195	20	20	4	4	carrageenan	PAG	PA448814	55824	0.546
NULL	Thorax_2013_Sep_8_68(9)_818-825.nxml.txt.nlp	23749840	SENT255	12	12	20	20	colistimethate	DPI	PA164749509	1832	0.546
NULL	Mol_Cancer_2008_Oct_23_7_82.nxml.txt.nlp	18947424	SENT504	7	7	12	12	orlistat	DM2	PA164776864	28508	0.546
NULL	Indian_J_Med_Res_2012_Dec_136(6)_963-970.nxml.txt.nlp	23391791	SENT56	5	5	3	3	glutaraldehyde	PTH	PA449777	5741	0.546
NULL	Int_J_Biol_Sci_2006_Mar_1_2(1)_1-9.nxml.txt.nlp	16585947	SENT53	19	19	14	14	pp2	PP1		5540;5464	0.546
NULL	Clin_Ophthalmol_2014_Sep_1_8_1689-1695.nxml.txt.nlp	25214762	SENT96	3	3	8	8	fluorescein	PED	PA164746009	8682	0.546
NULL	Cancer_Metab_2013_Feb_4_1_7.nxml.txt.nlp	24280108	SENT75	25	25	10	10	l-glutamine	FBS	PA10090	64319;26269	0.546
NULL	Diabetes_Obes_Metab_2009_Dec_11(12)_1153-1162.nxml.txt.nlp	19930005	SENT122	24	24	13	13	exenatide	SOC	PA164749238	91544	0.546
NULL	Case_Rep_Oncol_2011_Apr_6_4(1)_204-210.nxml.txt.nlp	21516270	SENT17	20	20	8	8	imatinib	CD117	PA10804	3815	0.546
NULL	Diabetes_Care_2013_Aug_17_36(Suppl_2)_S226-S232.nxml.txt.nlp	23882050	SENT22	14	14	12	12	exenatide	PPG	PA164749238	5552	0.546
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1150.nxml.txt.nlp	24675468	SENT103	34	34	31	31	ethanol	adiponectin	PA448073	9370	0.546
NULL	Br_J_Cancer_2004_Mar_22_90(6)_1285-1292.nxml.txt.nlp	15026814	SENT100	26	26	7	7	doxorubicin	p53	PA449412	7157	0.546
NULL	J_Gastroenterol_2013_Jan_28_48(1)_1-12.nxml.txt.nlp	23188091	SENT221	21	21	14	14	ribavirin	IFN	PA451241	3439	0.546
NULL	J_Brachial_Plex_Peripher_Nerve_Inj_2008_Oct_25_3_22.nxml.txt.nlp	18950516	SENT79	4	4	7	7	ketamine	SGB	PA450144	2719	0.546
NULL	Cancer_Res_Treat_2014_Jul_15_46(3)_297-306.nxml.txt.nlp	25038765	SENT24	22	22	26	26	galactose	CD163	PA449725	9332	0.546
NULL	Anesth_Essays_Res_2011_Jan-Jun_5(1)_33-38.nxml.txt.nlp	NULL	SENT129	9	9	2	2	propofol	NNT	PA451141	23530	0.546
NULL	J_Biomed_Biotechnol_2010_Sep_19_2010_518743.nxml.txt.nlp	20886007	SENT173	31	31	36	36	nadh	CO2	PA164755085	4513	0.546
NULL	Cell_Death_Dis_2012_Jun_21_3(6)_e325.nxml.txt.nlp	22717580	SENT133	11	11	9	9	heparin	EGF	PA449855	1950	0.546
NULL	Mol_Cell_Proteomics_2012_Feb_6_11(2)_M111_015222.nxml.txt.nlp	22147731	SENT295	18	18	23	23	cetuximab	EGF	PA10040	1950	0.546
NULL	Cancer_Cell_Int_2011_Nov_17_11_40.nxml.txt.nlp	22088142	SENT147	10	10	22	22	gemcitabine	EGFR	PA449748	1956	0.546
NULL	Ann_Med_2013_Feb_25_45(1)_4-16.nxml.txt.nlp	21867371	SENT230	8	8	5	5	l-arginine	MELAS	PA448478	4219	0.546
NULL	J_Cell_Mol_Med_2014_Dec_22_18(12)_2519-2529.nxml.txt.nlp	25338520	SENT96	24	24	15	15	oxygen	TNF	PA450744	7124	0.546
NULL	Front_Behav_Neurosci_2012_Jun_13_6_24.nxml.txt.nlp	22707936	SENT291	3	3	10	10	scopolamine	CA1	PA451308	759	0.546
NULL	Cancers_(Basel)_2012_Feb_21_4(1)_165-183.nxml.txt.nlp	24213234	SENT285	4	4	0	0	sorafenib	SHARP	PA7000	23013	0.546
NULL	Oncotarget_2011_May_16_2(5)_418-421.nxml.txt.nlp	21789791	SENT37	12	12	14	14	bortezomib	TRAIL	PA10252	8743	0.546
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT289	9	9	12	12	ranibizumab	VEGF-A	PA164746012	7422	0.546
NULL	Clin_Mol_Hepatol_2013_Sep_30_19(3)_273-279.nxml.txt.nlp	24133665	SENT6	0	0	2	2	lamivudine	LAM	PA450163	7249;7248	0.546
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT174	24	24	12	12	cetuximab	EGFR	PA10040	1956	0.546
NULL	Breast_Cancer_Res_2011_Jun_14_13(3)_R63.nxml.txt.nlp	21679465	SENT82	14	14	7	7	l-glutamine	mol	PA10090	90527	0.546
NULL	J_Cell_Sci_2012_May_15_125(10)_2446-2456.nxml.txt.nlp	22357953	SENT115	22	22	16	16	l-methionine	G3BP2	PA450423	9908	0.546
NULL	Neuropsychopharmacology_2009_Apr_2_34(5)_1135-1148.nxml.txt.nlp	18596687	SENT199	21	21	37	37	cocaine	CRF	PA449072	1392;10882	0.546
NULL	J_Immunother_Cancer_2014_Jan_27_2_2.nxml.txt.nlp	24829759	SENT208	15	15	13	13	sorafenib	IL-21	PA7000	59067;50616;27189	0.546
NULL	Cancer_Cell_Int_2012_Jul_4_12_19.nxml.txt.nlp	22631225	SENT180	2	2	0	0	heparin	PPIA	PA449855	5478	0.546
NULL	Bioinformatics_2012_Oct_15_28(20)_2640-2647.nxml.txt.nlp	22923290	SENT258	1	1	5	5	phospholipids	ATF4	PA450952	468	0.546
NULL	Virol_J_2010_Oct_20_7_279.nxml.txt.nlp	20961433	SENT169	10	10	2	2	trypsin	VLP	PA451806	391104	0.546
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT3	34	34	32	32	curcumin	TRAIL	PA151958596	8743	0.546
NULL	Hum_Genomics_2008_Sep_1_3(1)_7-16.nxml.txt.nlp	19129086	SENT112	0	0	5	5	rosiglitazone	SLCO1B1	PA451283	10599	0.546
NULL	Br_J_Cancer_2013_Feb_19_108(3)_512-518.nxml.txt.nlp	23340449	SENT146	10	10	30	30	sulindac	ODC	PA451565	4953;89874	0.546
NULL	Bioinformation_2011_May_7_6(4)_153-157.nxml.txt.nlp	21572882	SENT14	16	16	21	21	collagenase	IL-6	PA449107	3569	0.546
NULL	Diabetes_Care_2010_Apr_7_33(4)_695-700.nxml.txt.nlp	20056950	SENT190	6	6	4	4	exenatide	Ray	PA164749238	26751	0.546
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_79-96.nxml.txt.nlp	19305789	SENT275	3	3	15	15	ethanol	TRPV1	PA448073	7442	0.546
NULL	Clin_Med_Insights_Oncol_2014_Aug_24_8_95-100.nxml.txt.nlp	25210485	SENT71	13	13	18	18	asparaginase	ATF5	PA448492	22809	0.546
NULL	Org_Med_Chem_Lett_2012_Oct_15_2_32.nxml.txt.nlp	23067874	SENT136	12	12	10	10	sr144528	CB2		1269	0.546
NULL	J_Ginseng_Res_2011_Nov_35(4)_436-441.nxml.txt.nlp	23717089	SENT84	3	3	14	14	ginseng	CAGC	PA164781150	6283	0.546
NULL	Biofactors_2014_May_6_40(3)_277-283.nxml.txt.nlp	24353111	SENT50	6	6	9	9	choline	PEMT	PA448976	10400	0.546
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT562	11	11	31	31	metformin	p53	PA450395	7157	0.546
NULL	Neural_Plast_2007_Oct_10_2007_23250.nxml.txt.nlp	NULL	SENT3216	24	24	26	26	vasopressin	AVP	PA451858	114548;551	0.546
NULL	Neural_Develop_2007_Jun_8_2_11.nxml.txt.nlp	17559664	SENT235	33	33	10	10	tamoxifen	GLAST	PA451581	6507	0.546
NULL	J_Cell_Biol_1997_Jun_16_137(6)_1433-1443.nxml.txt.nlp	9182673	SENT70	32	32	13	13	streptomycin	FBS	PA451512	64319;26269	0.546
NULL	Lab_Invest_2013_Mar_7_93(3)_354-364.nxml.txt.nlp	23295648	SENT193	32	32	11	11	doxorubicin	p53	PA449412	7157	0.546
NULL	Br_J_Cancer_1985_Apr_51(4)_525-532.nxml.txt.nlp	3978031	SENT11	21	21	23	23	procarbazine	PCB	PA451112	5091	0.545
NULL	J_Immunol_Res_2014_Feb_3_2014_671431.nxml.txt.nlp	24741615	SENT234	13	13	29	29	paraformaldehyde	CD7	PA450790	924	0.545
NULL	Arthritis_Res_Ther_2005_Feb_18_7(3)_R476-R484.nxml.txt.nlp	15899034	SENT240	16	16	10	10	thrombin	IL-6	PA451674	3569	0.545
NULL	J_Korean_Neurosurg_Soc_2013_Oct_31_54(4)_280-288.nxml.txt.nlp	24294450	SENT211	4	4	6	6	acetazolamide	ACZ	PA448018	27445	0.545
NULL	Child_Adolesc_Psychiatry_Ment_Health_2009_Dec_15_3_40.nxml.txt.nlp	20003507	SENT117	15	15	13	13	atomoxetine	ATX	PA134688071	5168;23049	0.545
NULL	J_Geriatr_Cardiol_2012_Jun_9(2)_108-114.nxml.txt.nlp	22916055	SENT135	35	35	13	13	clopidogrel	ADP	PA449053	23038	0.545
NULL	Virol_J_2009_Feb_6_6_17.nxml.txt.nlp	19196485	SENT28	21	21	16	16	zidovudine	p24	PA451954	11261;140767	0.545
NULL	Mol_Cancer_2004_Jul_12_3_19.nxml.txt.nlp	15248896	SENT137	9	9	4	4	oxygen	HIF-1	PA450744	29072	0.545
NULL	Arthritis_Res_Ther_2012_Jun_25_14(3)_215.nxml.txt.nlp	22731694	SENT99	12	12	6	6	ribavirin	IFN	PA451241	3439	0.545
NULL	Exp_Ther_Med_2014_Mar_10_7(3)_640-648.nxml.txt.nlp	24520260	SENT10	22	22	11	11	triciribine	PI3K	PA165958661	5290	0.545
NULL	J_Anim_Sci_Biotechnol_2014_Aug_20_5(1)_40.nxml.txt.nlp	25279142	SENT52	24	24	45	45	choline	B12	PA448976	7126;4709	0.545
NULL	Indian_J_Pharm_Sci_2008_Mar-Apr_70(2)_145-153.nxml.txt.nlp	20046703	SENT191	38	38	44	44	cisplatin	IL-2	PA449014	3558	0.545
NULL	Front_Oncol_2014_Jun_18_4_153.nxml.txt.nlp	24995158	SENT232	23	23	12	12	paclitaxel	ERCC1	PA450761	2067	0.545
NULL	J_Clin_Biochem_Nutr_2009_Sep_28_45(2)_214-218.nxml.txt.nlp	19794931	SENT38	10	10	22	22	ethanol	CO2	PA448073	4513	0.545
NULL	Cardiol_Res_Pract_2013_Jan_31_2013_128795.nxml.txt.nlp	23431496	SENT96	8	8	2	2	clopidogrel	CYP2C19	PA449053	1557	0.545
NULL	Exp_Ther_Med_2014_Dec_13_8(6)_1939-1945.nxml.txt.nlp	25371760	SENT215	2	2	4	4	cisplatin	NAC	PA449014	22861	0.545
NULL	Mol_Cancer_2010_Dec_20_9_316.nxml.txt.nlp	21172016	SENT163	31	31	24	24	heparin	CCL21	PA449855	6366	0.545
NULL	Diabetes_2011_Jun_21_60(6)_1770-1778.nxml.txt.nlp	21562078	SENT27	2	2	29	29	metformin	AMPK	PA450395	5563	0.545
NULL	Oncol_Lett_2013_Jul_24_6(1)_169-174.nxml.txt.nlp	23946798	SENT226	2	2	4	4	deferoxamine	HIF-1	PA164746490	29072	0.545
NULL	Iran_J_Public_Health_2012_Mar_31_41(3)_127-132.nxml.txt.nlp	23113157	SENT86	10	10	20	20	amikacin	CTX	PA164744372	1593	0.545
NULL	Inflamm_Res_2014_Nov_5_63(2)_99-103.nxml.txt.nlp	24189710	SENT113	6	6	15	15	cyclosporine	CD4	PA449167	920	0.545
NULL	Int_J_Endocrinol_2011_Nov_17_2011_401258.nxml.txt.nlp	22164158	SENT20	17	17	5	5	tetracycline	GPR39	PA451640	2863	0.545
NULL	Cancer_Cell_Int_2005_Jul_24_5_22.nxml.txt.nlp	16042792	SENT54	4	4	2	2	vincristine	NAC	PA451879	22861	0.545
NULL	Case_Rep_Dermatol_2012_Mar_17_4(1)_56-60.nxml.txt.nlp	22548037	SENT67	3	3	27	27	bexarotene	CHOP	PA164752250	1649	0.545
NULL	J_Oncol_2012_Aug_7_2012_803294.nxml.txt.nlp	22919383	SENT124	6	6	32	32	urokinase	PC3	PA451836	57332;7832;5122	0.545
NULL	J_Allergy_(Cairo)_2011_Oct_24_2011_457169.nxml.txt.nlp	22121382	SENT99	1	1	7	7	salmeterol	IL-8	PA451300	3576	0.545
NULL	Diabetes_Care_2009_Sep_28_32(9)_1649-1655.nxml.txt.nlp	19478198	SENT180	0	0	16	16	saxagliptin	PPG	PA165958362	5552	0.545
NULL	Cell_Cycle_2012_Jun_15_11(12)_2272-2284.nxml.txt.nlp	22684333	SENT300	9	9	4	4	fluorescein	FDG	PA164746009	23583	0.545
NULL	Nat_Med_2014_Jun_11_20(6)_616-623.nxml.txt.nlp	24813252	SENT63	14	14	3	3	galactose	BTHS	PA449725	6901	0.545
NULL	Breast_Cancer_Res_Treat_2014_Dec_21_143(3)_459-467.nxml.txt.nlp	24362951	SENT112	13	13	23	23	tamoxifen	HER2	PA451581	2064	0.545
NULL	Oncoimmunology_2014_Jan_3_3_e27357.nxml.txt.nlp	24790790	SENT206	21	21	11	11	temozolomide	IL-15	PA451609	3600	0.545
NULL	Nat_Methods_2010_Feb_24_7(2)_148-155.nxml.txt.nlp	20101245	SENT104	14	14	12	12	heparin	FGF2	PA449855	2247;2258	0.545
NULL	Br_J_Cancer_1996_Dec_74(12)_1908-1915.nxml.txt.nlp	8980389	SENT0	13	13	11	11	melphalan	TNF-alpha	PA450354	7124	0.545
NULL	Protein_Cell_2014_Jun_19_5(6)_469-479.nxml.txt.nlp	24748116	SENT171	28	28	26	26	paclitaxel	EB1	PA450761	9167;22919;10982	0.545
NULL	Cancer_Microenviron_2008_Dec_19_1(1)_85-91.nxml.txt.nlp	19308687	SENT123	9	9	11	11	collagenase	MMP9	PA449107	4318	0.545
NULL	Ann_Surg_Treat_Res_2014_Feb_22_86(2)_68-75.nxml.txt.nlp	24761411	SENT142	0	0	5	5	oxaliplatin	survivin	PA131285527	332	0.545
NULL	Indian_J_Crit_Care_Med_2014_May_18(5)_323-325.nxml.txt.nlp	24914263	SENT28	21	21	31	31	voriconazole	IPA	PA10233	3160	0.545
NULL	Eur_J_Clin_Pharmacol_2011_May_9_67(5)_477-482.nxml.txt.nlp	21305273	SENT81	2	2	0	0	dobutamine	DSE	PA449381	29940	0.545
NULL	Acta_Vet_Scand_2011_Mar_7_53(1)_16.nxml.txt.nlp	21375785	SENT204	27	27	23	23	oxygen	CA-II	PA450744	760	0.545
NULL	J_Gen_Physiol_1997_Dec_1_110(6)_643-654.nxml.txt.nlp	9382893	SENT207	20	20	5	5	diazoxide	ACT	PA449285	12;11332;9457;641455	0.545
NULL	Crit_Care_2008_Mar_13_12(Suppl_2)_P407.nxml.txt.nlp	NULL	SENT4	7	7	9	9	vasopressin	AVP	PA451858	114548;551	0.545
NULL	Cancer_Cell_Int_2006_Nov_8_6_25.nxml.txt.nlp	17092342	SENT239	5	5	3	3	cisplatin	Yes	PA449014	7525	0.545
NULL	Int_J_Mol_Sci_2014_Sep_23_15(9)_16911-16935.nxml.txt.nlp	25250910	SENT143	3	3	10	10	potassium	mol	PA451047	90527	0.545
NULL	Ann_Maxillofac_Surg_2012_Jan-Jun_2(1)_90-93.nxml.txt.nlp	23483721	SENT62	10	10	0	0	cyclophosphamide	CHOP	PA449165	1649	0.545
NULL	Virol_J_2011_Oct_31_8_487.nxml.txt.nlp	22040359	SENT93	20	20	37	37	l-glutamine	CO2	PA10090	4513	0.545
NULL	Cancer_Med_2014_Feb_10_3(1)_134-142.nxml.txt.nlp	24407937	SENT228	10	10	29	29	tamoxifen	IMPACT	PA451581	55364	0.545
NULL	J_Korean_Med_Sci_2011_Jan_22_26(1)_33-41.nxml.txt.nlp	21218027	SENT36	26	26	19	19	roxithromycin	DST	PA164750505	667	0.545
NULL	Mol_Cell_Proteomics_2012_Feb_6_11(2)_M111_015222.nxml.txt.nlp	22147731	SENT369	13	13	7	7	gefitinib	EGF	PA131301952	1950	0.545
NULL	Contemp_Oncol_(Pozn)_2012_Feb_29_16(1)_86-89.nxml.txt.nlp	23788860	SENT59	32	32	7	7	irinotecan	DDP	PA450085	1678	0.545
NULL	J_Cell_Mol_Med_2014_Aug_1_18(8)_1599-1611.nxml.txt.nlp	24889822	SENT259	0	0	6	6	resveratrol	FOXO1		2308	0.545
NULL	J_Exp_Med_1998_Jun_1_187(11)_1885-1892.nxml.txt.nlp	9607928	SENT160	15	15	21	21	thalidomide	IL-2	PA451644	3558	0.545
NULL	Arch_Med_Sci_2013_Aug_30_9(4)_724-730.nxml.txt.nlp	24049536	SENT88	8	8	6	6	genistein	PTH	PA165109660	5741	0.545
NULL	J_Biomed_Biotechnol_2010_Oct_4_2010_641025.nxml.txt.nlp	20976270	SENT86	3	3	17	17	thrombin	VIII	PA451674	1351	0.545
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1033-1038.nxml.txt.nlp	22374460	SENT168	16	16	35	35	capecitabine	HER2	PA448771	2064	0.545
NULL	Chemother_Res_Pract_2012_Jul_15_2012_905796.nxml.txt.nlp	22844591	SENT68	29	29	20	20	streptomycin	FBS	PA451512	64319;26269	0.545
NULL	Ann_Lab_Med_2012_Jul_20_32(4)_298-303.nxml.txt.nlp	22779073	SENT86	41	41	37	37	clarithromycin	EMB	PA449028	133418	0.545
NULL	Environ_Health_Perspect_2010_Jul_3_118(7)_936-942.nxml.txt.nlp	20199942	SENT201	31	31	9	9	arsenite	mot-2	PA452638	3313	0.545
NULL	Scientifica_(Cairo)_2012_Dec_23_2012_857516.nxml.txt.nlp	24278747	SENT284	7	7	19	19	celecoxib	CEA	PA448871	5670;1087	0.545
NULL	Core_Evid_2009_Jun_15_4_149-158.nxml.txt.nlp	20694071	SENT98	5	5	2	2	etravirine	DUET	PA166014703	8997	0.545
NULL	Mol_Cancer_2012_Jun_26_11_43.nxml.txt.nlp	22731636	SENT242	29	29	17	17	pp2	PP2		4888	0.545
NULL	J_Oncol_2011_Dec_5_2011_465343.nxml.txt.nlp	21188169	SENT174	18	18	23	23	gemcitabine	CD133	PA449748	8842	0.545
NULL	BioDrugs_2013_Jun_7_27(6)_591-603.nxml.txt.nlp	23743670	SENT270	12	12	10	10	melphalan	gamma	PA450354	9913	0.545
NULL	J_Antibiot_(Tokyo)_2014_Feb_30_67(2)_147-151.nxml.txt.nlp	24169795	SENT71	28	28	15	15	nadh	DPI	PA164755085	1832	0.545
NULL	Avicenna_J_Med_Biotechnol_2014_Jan-Mar_6(1)_10-20.nxml.txt.nlp	24523953	SENT9	5	5	13	13	trypsin	CD105	PA451806	2022	0.545
NULL	Nat_Biotechnol_2011_Oct_9_29(11)_1005-1010.nxml.txt.nlp	21983520	SENT126	13	13	17	17	methotrexate	CCR2	PA450428	729230	0.545
NULL	J_Gen_Physiol_2008_Nov_132(5)_521-535.nxml.txt.nlp	18852303	SENT118	11	11	13	13	aprotinin	CAP2	PA448472	5271;10486	0.545
NULL	Blood_Cancer_J_2013_Aug_2_3(8)_e129.nxml.txt.nlp	23912609	SENT271	14	14	6	6	fluorescein	ECD	PA164746009	7979;11319	0.545
NULL	Diabetes_Metab_J_2014_Apr_18_38(2)_100-106.nxml.txt.nlp	24851203	SENT110	7	7	0	0	glucose	PEPCK	PA449773	5106	0.545
NULL	Behav_Brain_Funct_2009_Jan_15_5_3.nxml.txt.nlp	19146665	SENT79	5	5	22	22	ethanol	P29	PA448073	5657	0.545
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_P64.nxml.txt.nlp	NULL	SENT16	22	22	30	30	cefuroxime	PPL	PA448868	5493	0.545
NULL	Oxid_Med_Cell_Longev_2012_Aug_29_2012_819623.nxml.txt.nlp	22973468	SENT57	32	32	11	11	isoproterenol	F12	PA450121	2161	0.545
NULL	Arthritis_Res_Ther_2006_May_11_8(3)_209.nxml.txt.nlp	16712713	SENT123	21	21	6	6	naproxen	AAP	PA450595	5345	0.545
NULL	Adv_Ther_2014_Feb_15_31(3)_289-317.nxml.txt.nlp	24535623	SENT99	8	8	11	11	metformin	GLP	PA450395	342096	0.545
NULL	J_Breast_Cancer_2013_Sep_30_16(3)_291-299.nxml.txt.nlp	24155758	SENT187	10	10	0	0	mitomycin	FANCF	PA450524	2188	0.545
NULL	Emerg_Infect_Dis_2011_Oct_17(10)_1879-1882.nxml.txt.nlp	22000360	SENT60	18	18	0	0	gentamicin	PEN	PA449753	9933	0.545
NULL	Cancer_Cell_2014_Mar_17_25(3)_304-317.nxml.txt.nlp	24651012	SENT369	8	8	2	2	etoposide	p53	PA449552	7157	0.545
NULL	Ann_Rheum_Dis_2015_Jan_3_74(1)_19-26.nxml.txt.nlp	25367713	SENT85	21	21	0	0	methotrexate	ACR	PA450428	49	0.545
NULL	Blood_Cancer_J_2012_Jul_20_2(7)_e79.nxml.txt.nlp	22852048	SENT18	2	2	4	4	bortezomib	BTZ	PA10252	22794	0.545
NULL	Eur_J_Haematol_2008_Feb_80(2)_93-106.nxml.txt.nlp	18081719	SENT326	27	27	18	18	iron	MRI	PA450087	78996	0.545
NULL	Br_J_Cancer_2014_Jan_21_110(2)_421-429.nxml.txt.nlp	24300973	SENT206	14	14	6	6	oxaliplatin	DAP3	PA131285527	58512;7818	0.545
NULL	Osong_Public_Health_Res_Perspect_2013_Dec_12_4(6)_316-322.nxml.txt.nlp	24524020	SENT206	6	6	33	33	azithromycin	PEN	PA448519	9933	0.545
NULL	Indian_J_Dermatol_2009_Apr-Jun_54(2)_100-109.nxml.txt.nlp	20101303	SENT209	17	17	19	19	alefacept	CD4	PA164748040	920	0.545
NULL	Aging_(Albany_NY)_2011_Apr_6_3(4)_444-449.nxml.txt.nlp	21483037	SENT100	4	4	15	15	resveratrol	AMPK		5563	0.545
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Jun_27_5_15.nxml.txt.nlp	16803618	SENT145	2	2	42	42	flucloxacillin	GEN1	PA164781042	348654	0.545
NULL	Contemp_Clin_Dent_2013_Apr-Jun_4(2)_156-161.nxml.txt.nlp	24015002	SENT99	19	19	14	14	chlorhexidine	SRP	PA164776863	90226	0.545
NULL	Acta_Orthop_2010_Oct_8_81(5)_647.nxml.txt.nlp	NULL	SENT77	23	23	0	0	taurine	Men	PA451590	8178	0.545
NULL	Front_Pharmacol_2014_Nov_27_5_254.nxml.txt.nlp	25505885	SENT58	12	12	42	42	ganciclovir	EGFR	PA449733	1956	0.545
NULL	Nat_Med_2013_Apr_10_19(4)_421-428.nxml.txt.nlp	23475202	SENT111	15	15	13	13	palifermin	p50	PA164744014	958;4790	0.545
NULL	Cancers_(Basel)_2014_Jun_27_6(3)_1220-1255.nxml.txt.nlp	24978432	SENT1150	0	0	10	10	pioglitazone	adiponectin	PA450970	9370	0.545
NULL	Int_J_Endocrinol_2010_Feb_10_2010_625852.nxml.txt.nlp	20169119	SENT10	13	13	15	15	cinacalcet	PTH	PA164776671	5741	0.545
NULL	Oxid_Med_Cell_Longev_2012_May_28_2012_386527.nxml.txt.nlp	22690271	SENT79	2	2	8	8	curcumin	IL-6	PA151958596	3569	0.545
NULL	J_Biomed_Biotechnol_2003_Mar_19_2003(1)_35-47.nxml.txt.nlp	12686721	SENT188	14	14	8	8	thyroglobulin	MUC1	PA164754910	4582	0.545
NULL	Arthritis_Res_Ther_2011_Feb_16_13(1)_R25.nxml.txt.nlp	21324169	SENT120	26	26	8	8	rituximab	ANA	PA451261	10950	0.545
NULL	J_Lipid_Res_2015_Jan_56(1)_109-121.nxml.txt.nlp	25421061	SENT860	6	6	8	8	lipase	ATGL	PA450239	57104	0.545
NULL	Mol_Vis_2012_Nov_12_18_2687-2699.nxml.txt.nlp	23170061	SENT19	2	2	7	7	nadh	ND4	PA164755085	4538	0.545
NULL	Biomed_Opt_Express_2014_Jul_14_5(8)_2614-2619.nxml.txt.nlp	25136489	SENT146	18	18	12	12	fluorescein	LTA	PA164746009	4049	0.545
NULL	J_Clin_Biochem_Nutr_2011_Mar_26_48(2)_126-133.nxml.txt.nlp	21373265	SENT121	11	11	8	8	lansoprazole	HO-1	PA450180	3162	0.545
NULL	Arthritis_Res_Ther_2004_Nov_4_6(1)_R39-R45.nxml.txt.nlp	14979936	SENT7	12	12	3	3	collagenase	IFN	PA449107	3439	0.545
NULL	Cell_Commun_Signal_2013_Nov_11_11_86.nxml.txt.nlp	24215724	SENT59	16	16	21	21	thrombin	MMP1	PA451674	4312	0.545
NULL	Ann_Gastroenterol_2013_26(3)_233-238.nxml.txt.nlp	NULL	SENT33	8	8	40	40	natalizumab	NAT	PA164747191	6046	0.545
NULL	F1000_Med_Rep_2010_May_24_2_40.nxml.txt.nlp	20948844	SENT44	10	10	7	7	heparin	APC	PA449855	324	0.545
NULL	Exp_Neurobiol_2013_Jun_27_22(2)_116-123.nxml.txt.nlp	23833560	SENT32	2	2	22	22	tamoxifen	Bcl-2	PA451581	596	0.545
NULL	Biomed_Res_Int_2013_Jul_14_2013_437613.nxml.txt.nlp	23936799	SENT261	10	10	16	16	l-carnitine	Q10	PA450154	27161	0.545
NULL	J_Biomed_Sci_2013_Oct_23_20(1)_78.nxml.txt.nlp	24152138	SENT87	7	7	22	22	papain	B27	PA450778	56246	0.545
NULL	Arthritis_Res_Ther_2011_Dec_22_13(6)_R213.nxml.txt.nlp	22192852	SENT63	2	2	4	4	infliximab	LOR	PA452639	4014	0.545
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Sep_11_66(Pt_10)_o2555.nxml.txt.nlp	21587542	SENT56	23	23	18	18	benzaldehyde	C11	PA448571	1109	0.545
NULL	Cancer_2014_Sep_1_120(17)_2657-2664.nxml.txt.nlp	24930388	SENT150	5	5	14	14	trastuzumab	HER2	PA451743	2064	0.545
NULL	Diabetes_Care_2009_Aug_26_32(8)_1411-1417.nxml.txt.nlp	19470837	SENT144	6	6	23	23	glucose	PPG	PA449773	5552	0.545
NULL	Emerg_Infect_Dis_2011_Mar_17(3)_495-497.nxml.txt.nlp	21392442	SENT32	6	6	9	9	rifampin	EMB	PA451250	133418	0.545
NULL	Cell_Commun_Signal_2010_Sep_22_8_27.nxml.txt.nlp	20860841	SENT177	23	23	20	20	hydroxyurea	CHK1	PA449942	1111	0.545
NULL	Eur_J_Clin_Pharmacol_2008_Feb_26_64(2)_133-157.nxml.txt.nlp	18224312	SENT125	4	4	12	12	metformin	OCT1	PA450395	5451;6580	0.545
NULL	Asian-Australas_J_Anim_Sci_2013_Feb_26(2)_266-274.nxml.txt.nlp	25049786	SENT132	8	8	15	15	nitrogen	NO3	PA450643	4681	0.545
NULL	J_Vis_Exp_2010_Aug_1_(42)_2036.nxml.txt.nlp	20729802	SENT19	22	22	6	6	collagenase	KSR	PA449107	10256	0.545
NULL	Cancer_Manag_Res_2011_May_9_3_117-141.nxml.txt.nlp	21625397	SENT524	0	0	16	16	belinostat	TACC1		6867	0.545
NULL	Fibrogenesis_Tissue_Repair_2012_Jul_23_5_11.nxml.txt.nlp	22824096	SENT192	2	2	9	9	bleomycin	FasL	PA448645	356	0.545
NULL	Front_Physiol_2011_Jun_30_2_33.nxml.txt.nlp	21747769	SENT17	0	0	2	2	berberine	p38	PA165860812	10598;1432;7965	0.545
NULL	J_Oncol_2010_May_4_2010_373491.nxml.txt.nlp	20454582	SENT161	13	13	15	15	troglitazone	TRG	PA451799	6965	0.545
NULL	Allergy_Asthma_Immunol_Res_2014_Sep_18_6(5)_376-388.nxml.txt.nlp	25228994	SENT133	7	7	0	0	budesonide	BDP	PA448681	10620;152926	0.545
NULL	Br_J_Cancer_2002_Feb_1_86(3)_449-455.nxml.txt.nlp	11875714	SENT26	15	15	37	37	l-glutamine	CO2	PA10090	4513	0.545
NULL	Endocrinol_Metab_(Seoul)_2014_Mar_14_29(1)_20-29.nxml.txt.nlp	24741450	SENT73	18	18	14	14	thyroglobulin	TPO	PA164754910	7066;7173	0.545
NULL	Iran_Red_Crescent_Med_J_2014_Aug_5_16(8)_e13079.nxml.txt.nlp	25389473	SENT141	11	11	6	6	ondansetron	AAP	PA450705	5345	0.545
NULL	Diabetes_2009_Jan_58(1)_243-249.nxml.txt.nlp	18840785	SENT28	9	9	11	11	vildagliptin	GLP-1	PA165958346	100125288	0.545
NULL	Oxid_Med_Cell_Longev_2013_Nov_12_2013_589606.nxml.txt.nlp	24327826	SENT102	28	28	25	25	sevoflurane	CO2	PA451341	4513	0.545
NULL	Core_Evid_2009_Jun_15_4_113-129.nxml.txt.nlp	20694069	SENT363	14	14	8	8	raloxifene	LAS	PA451221	11019	0.545
NULL	Arthritis_Res_Ther_2003_Mar_14_5(3)_R140-R157.nxml.txt.nlp	12723986	SENT417	4	4	8	8	etoposide	p53	PA449552	7157	0.545
NULL	Cerebrospinal_Fluid_Res_2010_Aug_12_7_11.nxml.txt.nlp	20704740	SENT66	27	27	19	19	l-glutamine	F12	PA10090	2161	0.545
NULL	J_Gen_Physiol_2009_Apr_133(4)_421-438.nxml.txt.nlp	19289574	SENT304	30	30	6	6	forskolin	SLC26A9	PA146096022	115019	0.545
NULL	J_Cardiothorac_Surg_2014_May_9_9_81.nxml.txt.nlp	24885948	SENT153	6	6	15	15	sorafenib	c-fos	PA7000	2353	0.545
NULL	An_Bras_Dermatol_2013_Sep-Oct_88(5)_844-846.nxml.txt.nlp	24173202	SENT3	40	40	12	12	imiquimod	CO2	PA449972	4513	0.545
NULL	Sci_Rep_2014_Dec_12_4_7467.nxml.txt.nlp	25502280	SENT294	0	0	10	10	taurine	SIRT1	PA451590	23411	0.545
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jul_29_65(Pt_8)_o2022.nxml.txt.nlp	21583691	SENT72	21	21	32	32	ethanol	mol	PA448073	90527	0.545
NULL	Int_J_Med_Sci_2014_Jan_10_11(2)_192-198.nxml.txt.nlp	24465165	SENT178	20	20	14	14	vasopressin	AVP	PA451858	114548;551	0.545
NULL	Chem_Cent_J_2013_Sep_4_7_147.nxml.txt.nlp	24006941	SENT92	0	0	2	2	lipase	LOX	PA450239	4015	0.545
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT667	15	15	17	17	resveratrol	SIRT1		23411	0.545
NULL	Int_J_Endocrinol_2013_Oct_31_2013_865965.nxml.txt.nlp	24288531	SENT225	21	21	42	42	telmisartan	adiponectin	PA451605	9370	0.545
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT1706	21	21	4	4	atazanavir	ATV	PA10251	4683	0.545
NULL	Oncotarget_2014_Aug_19_5(18)_8703-8715.nxml.txt.nlp	25237928	SENT98	22	22	27	27	glucose	CD44	PA449773	960	0.545
NULL	Oncol_Lett_2013_Jun_16_5(6)_1854-1858.nxml.txt.nlp	23833655	SENT41	38	38	42	42	l-glutamine	CO2	PA10090	4513	0.545
NULL	Front_Neural_Circuits_2013_Oct_2_7_155.nxml.txt.nlp	24106462	SENT194	3	3	22	22	haloperidol	gamma	PA449841	9913	0.545
NULL	Int_J_Med_Sci_2014_Sep_3_11(11)_1172-1184.nxml.txt.nlp	25249786	SENT226	9	9	14	14	glibenclamide	STZ	PA449782	6484	0.545
NULL	J_Neurovirol_2013_Oct_1_19(5)_432-441.nxml.txt.nlp	24081883	SENT230	5	5	24	24	nitrogen	AID	PA450643	57379	0.545
NULL	Braz_J_Med_Biol_Res_2012_Jul_20_45(10)_935-941.nxml.txt.nlp	22801415	SENT45	9	9	39	39	pioglitazone	ghrelin	PA450970	51738	0.545
NULL	J_Hematol_Oncol_2009_Feb_23_2_10.nxml.txt.nlp	19236716	SENT110	4	4	0	0	dasatinib	CYP3A4	PA162372878	1576	0.545
NULL	Cancer_Cell_Int_2008_Mar_18_8_3.nxml.txt.nlp	18348720	SENT82	31	31	12	12	lapatinib	EGFR	PA152241907	1956	0.545
NULL	Arch_Virol_2011_Sep_26_156(9)_1551-1557.nxml.txt.nlp	21614435	SENT124	24	24	22	22	ethanol	SET	PA448073	6418	0.545
NULL	J_Cell_Biol_2008_Jan_28_180(2)_417-426.nxml.txt.nlp	18227283	SENT246	13	13	22	22	phenol	B27	PA450913	56246	0.545
NULL	Apoptosis_2012_Sep_30_17(9)_989-997.nxml.txt.nlp	22460505	SENT56	32	32	46	46	coumarin	San	PA134521193	80218	0.545
NULL	Int_J_Environ_Res_Public_Health_2010_May_28_7(5)_1996-2007.nxml.txt.nlp	20632473	SENT35	16	16	4	4	trypsin	FBS	PA451806	64319;26269	0.545
NULL	Arch_Osteoporos_2013_Oct_11_8(1-2)_136.nxml.txt.nlp	24113837	SENT2910	9	9	18	18	denosumab	PTH	PA166048634	5741	0.545
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_17_2013_308134.nxml.txt.nlp	23843872	SENT124	10	10	2	2	verapamil	P-gp	PA451868	5243	0.545
NULL	Exp_Diabetes_Res_2012_Aug_5_2012_201295.nxml.txt.nlp	22919367	SENT37	21	21	31	31	l-glutamine	activin	PA10090	83729	0.545
NULL	Oncotarget_2010_May_1_1(1)_6-8.nxml.txt.nlp	21293050	SENT26	29	29	19	19	bortezomib	KIT	PA10252	3815	0.545
NULL	Core_Evid_2007_Nov_30_2(2)_121-129.nxml.txt.nlp	21221180	SENT230	20	20	32	32	rituximab	CHOP	PA451261	1649	0.545
NULL	Arthritis_Res_Ther_2009_Jun_29_11(3)_R100.nxml.txt.nlp	19563672	SENT219	22	22	11	11	infliximab	IFN	PA452639	3439	0.545
NULL	Br_J_Pharmacol_2014_Oct_26_171(20)_4785-4796.nxml.txt.nlp	25074741	SENT198	6	6	33	33	guanfacine	NK1R	PA449825	6869	0.545
NULL	Arthritis_Res_Ther_2005_Feb_22_7(3)_R503-R512.nxml.txt.nlp	15899037	SENT109	6	6	4	4	collagenase	OSM	PA449107	5008	0.545
NULL	Breast_Cancer_Res_2010_May_10_12(3)_R26.nxml.txt.nlp	20459744	SENT164	20	20	24	24	cyclophosphamide	CYP3A4	PA449165	1576	0.545
NULL	Pharmaceuticals_(Basel)_2013_May_23_6(6)_689-699.nxml.txt.nlp	24276256	SENT89	17	17	19	19	nicardipine	PTB	PA450620	58155	0.545
NULL	J_Breast_Cancer_2014_Mar_28_17(1)_61-68.nxml.txt.nlp	24744799	SENT6	14	14	27	27	sorafenib	HER2	PA7000	2064	0.545
NULL	Diabetes_2011_Jun_21_60(6)_1770-1778.nxml.txt.nlp	21562078	SENT204	0	0	2	2	metformin	Met	PA450395	79811	0.545
NULL	Arthritis_Res_Ther_2011_May_13_13(3)_R75.nxml.txt.nlp	21569519	SENT51	23	23	30	30	rituximab	SOC	PA451261	91544	0.545
NULL	J_Appl_Oral_Sci_2010_Nov-Dec_18(6)_551-559.nxml.txt.nlp	21308284	SENT145	14	14	0	0	rifampin	AMN	PA451250	215;81693	0.545
NULL	Curr_Cardiol_Rev_2009_Aug_5(3)_243-250.nxml.txt.nlp	20676284	SENT108	14	14	26	26	nadh	ADP	PA164755085	23038	0.545
NULL	Epilepsy_Res_Treat_2010_Jun_22_2010_654265.nxml.txt.nlp	22937226	SENT182	35	35	10	10	etomidate	EAAT1	PA164743987	6507	0.545
NULL	Patient_Prefer_Adherence_2013_Jun_19_7_531-542.nxml.txt.nlp	23814462	SENT33	18	18	12	12	rifabutin	CYP3A	PA451249	1574	0.544
NULL	Biol_Open_2014_Nov_13_3(12)_1164-1172.nxml.txt.nlp	25395667	SENT7	16	16	32	32	sr144528	TRPV1		7442	0.544
NULL	Apoptosis_2012_Jun_9_17(6)_566-578.nxml.txt.nlp	22402981	SENT166	22	22	35	35	pp2	PP2		4888	0.544
NULL	Front_Behav_Neurosci_2009_Sep_30_3_31.nxml.txt.nlp	19862348	SENT14	3	3	21	21	naloxone	PAG	PA450586	55824	0.544
NULL	Apoptosis_2014_Nov_9_19(4)_629-642.nxml.txt.nlp	24213561	SENT212	1	1	10	10	cisplatin	Bcl-2	PA449014	596	0.544
NULL	Br_J_Cancer_2012_Jul_10_107(2)_360-369.nxml.txt.nlp	22713663	SENT61	6	6	26	26	bevacizumab	DDP	PA130232992	1678	0.544
NULL	Int_J_Endocrinol_2014_Apr_30_2014_674987.nxml.txt.nlp	24883061	SENT122	34	34	28	28	collagenase	AP-1	PA449107	2353;3727;2354;3725	0.544
NULL	Apoptosis_2012_Jun_9_17(6)_566-578.nxml.txt.nlp	22402981	SENT166	39	39	18	18	pp2	PP2		4888	0.544
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT160	11	11	7	7	perifosine	JNK	PA165291471	5599	0.544
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT143	7	7	9	9	methotrexate	MSH2	PA450428	4436	0.544
NULL	J_Ginseng_Res_2012_Apr_36(2)_161-168.nxml.txt.nlp	23717116	SENT43	19	19	24	24	neomycin	CO2	PA450608	4513	0.544
NULL	Biol_Open_2014_Nov_21_3(12)_1207-1216.nxml.txt.nlp	25416063	SENT3	24	24	0	0	zinc	NANOS2	PA451956	339345	0.544
NULL	Int_J_Environ_Res_Public_Health_2010_Apr_25_7(4)_1285-1301.nxml.txt.nlp	20617031	SENT141	34	34	10	10	ethanol	AMPK	PA448073	5563	0.544
NULL	AIDS_Res_Ther_2011_Oct_6_8_36.nxml.txt.nlp	21978457	SENT7	5	5	12	12	zinc	ZIP1	PA451956	27173	0.544
NULL	Environ_Health_Perspect_2006_Sep_23_114(9)_1401-1406.nxml.txt.nlp	16966095	SENT187	7	7	10	10	arsenite	p53	PA452638	7157	0.544
NULL	Eur_J_Endocrinol_2012_Apr_166(4)_657-667.nxml.txt.nlp	22275472	SENT127	23	23	17	17	creatine	ACTB	PA164778930	60	0.544
NULL	Case_Rep_Oncol_2013_Mar_29_6(1)_189-196.nxml.txt.nlp	23626560	SENT16	15	15	10	10	erlotinib	EGFR	PA134687924	1956	0.544
NULL	Arch_Med_Sci_2011_Dec_31_7(6)_977-983.nxml.txt.nlp	22328880	SENT7	0	0	4	4	heparin	PAPP-A	PA449855	5069	0.544
NULL	J_Antimicrob_Chemother_2014_Mar_13_69(3)_651-663.nxml.txt.nlp	24235095	SENT229	34	34	32	32	pentamidine	AQP2	PA450850	359	0.544
NULL	Arthritis_Res_Ther_2014_Jan_20_16(1)_R17.nxml.txt.nlp	24444433	SENT117	29	29	0	0	theophylline	ANOVA	PA451647	4858	0.544
NULL	Indian_J_Endocrinol_Metab_2012_Mar-Apr_16(2)_164-176.nxml.txt.nlp	22470851	SENT152	16	16	21	21	raloxifene	PTH	PA451221	5741	0.544
NULL	Exp_Ther_Med_2013_May_15_5(5)_1327-1331.nxml.txt.nlp	23737873	SENT10	5	5	7	7	vasopressin	AVP	PA451858	114548;551	0.544
NULL	Clin_Res_Cardiol_2009_Jun_20_98(6)_391-399.nxml.txt.nlp	19301059	SENT184	5	5	44	44	pantoprazole	mol	PA450774	90527	0.544
NULL	Clin_Pharmacokinet_2013_Jun_26_52(6)_453-462.nxml.txt.nlp	23529813	SENT246	9	9	7	7	dabigatran	CLCR		11330	0.544
NULL	Curr_Hepat_Rep_2010_May_21_9(2)_75-90.nxml.txt.nlp	20461127	SENT251	12	12	8	8	telbivudine	LAM	PA164760861	7249;7248	0.544
NULL	Osong_Public_Health_Res_Perspect_2013_Feb_4(1)_27-33.nxml.txt.nlp	24159526	SENT174	2	2	12	12	ampicillin	CTX	PA448419	1593	0.544
NULL	Nat_Commun_2010_Aug_1(5)_1-8.nxml.txt.nlp	20975714	SENT1120	20	20	26	26	ethambutol	EMB	PA164784021	133418	0.544
NULL	J_Korean_Med_Sci_2013_Mar_4_28(3)_480-484.nxml.txt.nlp	23486547	SENT54	18	18	16	16	thyroglobulin	CD56	PA164754910	4684	0.544
NULL	Front_Endocrinol_(Lausanne)_2015_Jan_12_5_236.nxml.txt.nlp	25628603	SENT46	9	9	14	14	salbutamol	HSD1	PA448068	26871	0.544
NULL	Cancer_Cell_Int_2011_Nov_17_11_40.nxml.txt.nlp	22088142	SENT102	0	0	5	5	gemcitabine	RAF1	PA449748	5894	0.544
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT44	27	27	20	20	bevacizumab	VEGF-A	PA130232992	7422	0.544
NULL	Physiol_Rep_2014_Sep_28_2(9)_e12159.nxml.txt.nlp	25263208	SENT398	12	12	14	14	nadh	CO2	PA164755085	4513	0.544
NULL	Carcinogenesis_2013_Nov_10_34(11)_2580-2586.nxml.txt.nlp	23843037	SENT290	3	3	14	14	mesalazine	activin	PA450384	83729	0.544
NULL	Clin_Pharmacokinet_2014_Sep_3_53(1)_1-16.nxml.txt.nlp	23999929	SENT284	11	11	8	8	fluconazole	CYP3A4	PA449653	1576	0.544
NULL	Autoimmune_Dis_2012_Oct_31_2012_874680.nxml.txt.nlp	23193443	SENT316	0	0	5	5	cyclosporine	IL-2	PA449167	3558	0.544
NULL	Case_Rep_Med_2014_Jul_22_2014_562929.nxml.txt.nlp	25140181	SENT86	3	3	13	13	creatine	ASAT	PA164778930	22	0.544
NULL	J_Antimicrob_Chemother_2014_Apr_8_69(4)_924-931.nxml.txt.nlp	24324223	SENT110	22	22	0	0	clindamycin	PEN	PA449035	9933	0.544
NULL	Mol_Cancer_2008_Mar_26_7_27.nxml.txt.nlp	18366759	SENT234	10	10	17	17	etoposide	HIF-1	PA449552	29072	0.544
NULL	J_Cancer_Prev_2013_Jun_18(2)_177-185.nxml.txt.nlp	25337544	SENT142	12	12	22	22	capsaicin	p53	PA448776	7157	0.544
NULL	Case_Rep_Hematol_2012_Oct_2_2012_620967.nxml.txt.nlp	23082258	SENT56	10	10	17	17	ponatinib	FLT3	PA165980594	2322	0.544
NULL	Breast_Cancer_Res_2000_Feb_21_2(2)_139-148.nxml.txt.nlp	11056686	SENT120	15	15	5	5	phenol	BRCA1	PA450913	672	0.544
NULL	Patient_Prefer_Adherence_2009_Nov_3_3_131-143.nxml.txt.nlp	19936155	SENT334	9	9	28	28	cyproterone	MGA	PA10049	8972;23269	0.544
NULL	Clin_Ophthalmol_2012_Sep_5_6_1433-1440.nxml.txt.nlp	23055659	SENT153	33	33	15	15	timolol	BAK	PA451690	578	0.544
NULL	Br_J_Cancer_2011_Apr_12_104(8)_1256-1261.nxml.txt.nlp	21448165	SENT161	24	24	35	35	sorafenib	IL2	PA7000	3558	0.544
NULL	Evid_Based_Complement_Alternat_Med_2011_Feb_13_2011_236186.nxml.txt.nlp	21607013	SENT5	8	8	13	13	scopolamine	spatial	PA451308	219793	0.544
NULL	Diabetes_Care_2013_Jul_12_36(7)_1933-1940.nxml.txt.nlp	23462665	SENT28	18	18	10	10	exenatide	GLP-1	PA164749238	100125288	0.544
NULL	J_Cancer_Prev_2014_Mar_19(1)_7-13.nxml.txt.nlp	25337567	SENT101	6	6	11	11	evodiamine	Bcl-2	PA165860788	596	0.544
NULL	FEBS_Open_Bio_2014_Jan_6_4_77-89.nxml.txt.nlp	24490132	SENT692	0	0	19	19	ebselen	NF-kappaB	PA161660841	4790	0.544
NULL	J_Cell_Biol_2005_Nov_21_171(4)_651-661.nxml.txt.nlp	16301331	SENT86	13	13	4	4	flutamide	Cbl-b	PA449685	868	0.544
NULL	Breast_Cancer_Res_2011_Nov_24_13(6)_R120.nxml.txt.nlp	22115051	SENT171	45	45	21	21	tamoxifen	HER-2	PA451581	2064	0.544
NULL	Ther_Clin_Risk_Manag_2006_Mar_2(1)_115-125.nxml.txt.nlp	18360586	SENT35	0	0	13	13	buprenorphine	ORL1	PA448685	4987	0.544
NULL	Evid_Based_Complement_Alternat_Med_2013_May_13_2013_506324.nxml.txt.nlp	23818927	SENT146	24	24	18	18	doxorubicin	SHP-2	PA449412	5781	0.544
NULL	Neuroimage_Clin_2013_Sep_3_3_242-248.nxml.txt.nlp	24273709	SENT294	6	6	24	24	clobazam	PRG	PA10888	5544	0.544
NULL	Environ_Health_Perspect_2011_Mar_10_119(3)_357-363.nxml.txt.nlp	21362589	SENT19	21	21	5	5	picrotoxin	RDX	PA164777007	5962	0.544
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Jul_19_70(Pt_8)_80-83.nxml.txt.nlp	25249860	SENT36	17	17	19	19	ethanol	mol	PA448073	90527	0.544
NULL	Oxid_Med_Cell_Longev_2010_Jan-Feb_3(1)_23-34.nxml.txt.nlp	20716925	SENT102	0	0	6	6	curcumin	UGT1A7	PA151958596	54577	0.544
NULL	Exp_Ther_Med_2013_Aug_20_6(2)_310-316.nxml.txt.nlp	24137180	SENT187	10	10	24	24	fasudil	MCP-1	PA165946121	6347	0.544
NULL	Mol_Vis_2012_Nov_29_18_2839-2846.nxml.txt.nlp	23233786	SENT142	3	3	5	5	geldanamycin	CB2	PA152031327	1269	0.544
NULL	Cancer_Causes_Control_2013_Aug_18_24(8)_1605-1614.nxml.txt.nlp	23775025	SENT64	25	25	18	18	methotrexate	CYP3A5	PA450428	1577	0.544
NULL	Cancer_Cell_Int_2010_Sep_6_10_31.nxml.txt.nlp	20819205	SENT85	21	21	9	9	oxaliplatin	CIS	PA131285527	1154	0.544
NULL	Front_Neurosci_2014_Jun_3_8_128.nxml.txt.nlp	24917782	SENT133	26	26	31	31	ethanol	MC3R	PA448073	4159	0.544
NULL	Anal_Bioanal_Chem_2010_Aug_14_397(7)_2977-2986.nxml.txt.nlp	20549493	SENT184	21	21	3	3	estradiol	mol	PA449503	90527	0.544
NULL	Acta_Pharmacol_Sin_2014_Jul_9_35(7)_889-898.nxml.txt.nlp	24909515	SENT214	36	36	14	14	methamphetamine	DRD1	PA450403	1812	0.544
NULL	J_Clin_Biochem_Nutr_2011_Jul_17_49(1)_1-7.nxml.txt.nlp	21765599	SENT213	10	10	12	12	lipase	ATGL	PA450239	57104	0.544
NULL	Free_Radic_Biol_Med_2013_Aug_61(100)_438-452.nxml.txt.nlp	23608463	SENT873	33	33	5	5	apomorphine	HO-1	PA164781163	3162	0.544
NULL	Front_Endocrinol_(Lausanne)_2014_Feb_25_5_22.nxml.txt.nlp	24611062	SENT245	5	5	24	24	estradiol	PTEN	PA449503	5728	0.544
NULL	Semin_Immunopathol_2007_Jun_15_29(2)_193-210.nxml.txt.nlp	17621704	SENT209	4	4	15	15	estradiol	HSD-1	PA449503	26206	0.544
NULL	Mol_Cancer_2010_Dec_20_9_316.nxml.txt.nlp	21172016	SENT428	7	7	14	14	heparin	CCL21	PA449855	6366	0.544
NULL	BMJ_2013_Nov_6_347_f6530.nxml.txt.nlp	24196498	SENT92	14	14	6	6	everolimus	PES	PA164746311	23481	0.544
NULL	Br_J_Cancer_2003_Mar_10_88(5)_788-795.nxml.txt.nlp	12618891	SENT175	16	16	6	6	bosentan	FasL	PA10034	356	0.544
NULL	Mol_Cancer_2010_Apr_23_9_87.nxml.txt.nlp	20416058	SENT151	13	13	11	11	doxorubicin	TRAIL	PA449412	8743	0.544
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT13	3	3	6	6	adalimumab	CD36	PA10004	948	0.544
NULL	Ann_Surg_Treat_Res_2014_Feb_22_86(2)_68-75.nxml.txt.nlp	24761411	SENT144	2	2	7	7	resveratrol	survivin		332	0.544
NULL	Clinics_(Sao_Paulo)_2012_Aug_67(8)_885-890.nxml.txt.nlp	22948454	SENT94	31	31	41	41	creatine	ADM	PA164778930	133	0.544
NULL	Cancers_(Basel)_2014_May_6_6(2)_1065-1097.nxml.txt.nlp	24805867	SENT155	21	21	23	23	hyaluronan	CD44	PA165958431	960	0.544
NULL	Front_Oncol_2014_Jun_18_4_159.nxml.txt.nlp	24995161	SENT157	5	5	20	20	estradiol	ANOVA	PA449503	4858	0.544
NULL	F1000_Biol_Rep_2012_Mar_1_4_5.nxml.txt.nlp	22403588	SENT117	15	15	12	12	ribavirin	IFN	PA451241	3439	0.544
NULL	Crit_Care_2011_Oct_25_15(5)_R255.nxml.txt.nlp	22026977	SENT118	3	3	0	0	vasopressin	AVP	PA451858	114548;551	0.544
NULL	J_Biol_Chem_2013_Nov_1_288(44)_31715-31727.nxml.txt.nlp	24025329	SENT171	21	21	16	16	lamivudine	IFN	PA450163	3439	0.544
NULL	Int_Clin_Psychopharmacol_2014_Jul_26_29(4)_185-196.nxml.txt.nlp	24424469	SENT113	11	11	33	33	escitalopram	5-HT1A	PA10074	3350	0.544
NULL	EMBO_Mol_Med_2013_May_22_5(5)_723-736.nxml.txt.nlp	23606532	SENT259	0	0	8	8	tamoxifen	NAC	PA451581	22861	0.544
NULL	Ann_Gen_Psychiatry_2014_Sep_24_13_27.nxml.txt.nlp	25478001	SENT182	25	25	20	20	creatine	GAMT	PA164778930	2593	0.544
NULL	Int_Cardiovasc_Res_J_2014_Sep_1_8(3)_89-93.nxml.txt.nlp	25177670	SENT86	13	13	9	9	enalapril	TNF-alpha	PA449456	7124	0.544
NULL	Breast_Cancer_Res_2003_Feb_5_5(2)_113-116.nxml.txt.nlp	12631392	SENT94	4	4	27	27	tamoxifen	HER-2	PA451581	2064	0.544
NULL	Curr_Neuropharmacol_2013_May_11(3)_263-275.nxml.txt.nlp	24179463	SENT139	6	6	17	17	fluoxetine	CB1	PA449673	1268	0.544
NULL	Springerplus_2014_Sep_9_3_510.nxml.txt.nlp	25279302	SENT159	0	0	3	3	creatine	SLC6A8	PA164778930	6535	0.544
NULL	J_Biomed_Biotechnol_2010_Sep_19_2010_518743.nxml.txt.nlp	20886007	SENT335	8	8	10	10	nadh	CO2	PA164755085	4513	0.544
NULL	Int_J_Surg_Oncol_2012_Jun_12_2012_862879.nxml.txt.nlp	22778941	SENT64	2	2	5	5	cisplatin	MRP2	PA449014	100130958;57626;1244	0.544
NULL	Clin_Exp_Pharmacol_Physiol_2009_Oct_36(10)_969-980.nxml.txt.nlp	19298534	SENT250	32	32	46	46	nifedipine	spatial	PA450631	219793	0.544
NULL	Cancers_(Basel)_2011_Oct_11_3(4)_3838-3855.nxml.txt.nlp	24213114	SENT24	28	28	14	14	thyroglobulin	RAI	PA164754910	10848;6050	0.544
NULL	Mol_Cytogenet_2013_Jul_16_6_27.nxml.txt.nlp	23866735	SENT34	21	21	11	11	nilotinib	IFN	PA165958345	3439	0.544
NULL	Biochemistry_2013_Apr_9_52(14)_2453-2460.nxml.txt.nlp	23506391	SENT179	25	25	19	19	d-sorbitol	LAD1	PA451455	3898	0.544
NULL	Epilepsia_2012_Jun_21_53(Suppl_1)_18-25.nxml.txt.nlp	22612805	SENT92	11	11	9	9	furosemide	NKCC1	PA449719	6558	0.544
NULL	Front_Aging_Neurosci_2014_Dec_8_6_325.nxml.txt.nlp	25538616	SENT132	4	4	6	6	vasopressin	AVP	PA451858	114548;551	0.544
NULL	Apoptosis_2014_Aug_26_19(11)_1603-1615.nxml.txt.nlp	25156145	SENT248	2	2	0	0	mitomycin	TRAIL	PA450524	8743	0.544
NULL	Cancer_Immunol_Immunother_2011_Jun_25_60(6)_793-808.nxml.txt.nlp	21350947	SENT164	9	9	6	6	sorafenib	IFN	PA7000	3439	0.544
NULL	Breast_Cancer_Res_2003_Feb_5_5(2)_113-116.nxml.txt.nlp	12631392	SENT94	4	4	0	0	tamoxifen	ATAC	PA451581	6375	0.544
NULL	Leukemia_2013_Apr_14_27(4)_803-812.nxml.txt.nlp	23238589	SENT3	13	13	21	21	busulfan	IFN	PA448691	3439	0.544
NULL	Front_Genet_2012_Oct_26_3_213.nxml.txt.nlp	23112805	SENT608	40	40	34	34	midazolam	CYP2D6	PA450496	1565	0.544
NULL	Front_Behav_Neurosci_2014_Oct_30_8_366.nxml.txt.nlp	25400560	SENT121	22	22	7	7	ethanol	ANOVA	PA448073	4858	0.544
NULL	Diabetologia_2009_Oct_14_52(10)_2046-2055.nxml.txt.nlp	19688338	SENT321	37	37	34	34	liraglutide	GLP-1	PA165958364	100125288	0.544
NULL	Nat_Chem_Biol_2014_Jul_1_10(7)_582-589.nxml.txt.nlp	24880859	SENT227	32	32	7	7	l-glutamine	CO2	PA10090	4513	0.544
NULL	Eur_J_Clin_Pharmacol_2011_May_2_67(Suppl_1)_87-107.nxml.txt.nlp	21287160	SENT328	4	4	18	18	sn-38	UGT1A1		54658	0.544
NULL	Genet_Mol_Biol_2009_Mar_1_Jan-Mar_32(1)_144-150.nxml.txt.nlp	21637660	SENT110	15	15	22	22	etoposide	mol	PA449552	90527	0.544
NULL	Cancers_(Basel)_2013_Jun_24_5(3)_762-785.nxml.txt.nlp	24202320	SENT330	2	2	0	0	suramin	PF4	PA10292	5196	0.544
NULL	Cancer_Metab_2013_Feb_4_1_7.nxml.txt.nlp	24280108	SENT7	20	20	12	12	glucose	MYC	PA449773	4609	0.544
NULL	Ann_Dermatol_2013_Aug_13_25(3)_398-399.nxml.txt.nlp	24003298	SENT14	21	21	14	14	cimetidine	gamma	PA449001	9913	0.544
NULL	Clin_Ophthalmol_2011_Feb_11_5_167-170.nxml.txt.nlp	21383944	SENT76	11	11	4	4	bevacizumab	hole	PA130232992	80757	0.544
NULL	J_Mov_Disord_2011_May_30_4(1)_46-48.nxml.txt.nlp	24868392	SENT51	0	0	3	3	pramipexole	AVP	PA164742949	114548;551	0.544
NULL	Core_Evid_2011_Jan_6_6_13-21.nxml.txt.nlp	21468239	SENT31	48	48	37	37	natalizumab	IFN	PA164747191	3439	0.544
NULL	Ageing_Res_Rev_2014_Mar_14(100)_19-30.nxml.txt.nlp	24503004	SENT397	4	4	0	0	iron	MRI	PA450087	78996	0.544
NULL	F1000_Med_Rep_2010_Jun_23_2_47.nxml.txt.nlp	20948837	SENT84	11	11	18	18	haloperidol	Gen	PA449841	348654	0.544
NULL	Crit_Care_2010_Mar_15_14(2)_R30.nxml.txt.nlp	20226064	SENT279	11	11	6	6	midazolam	IFN	PA450496	3439	0.544
NULL	Mol_Pain_2012_Sep_21_8_70.nxml.txt.nlp	22998799	SENT248	14	14	9	9	capsaicin	ATF3	PA448776	467	0.544
NULL	Biomed_Res_Int_2014_Jan_20_2014_948427.nxml.txt.nlp	24563867	SENT153	5	5	15	15	buspirone	STZ	PA448689	6484	0.544
NULL	Cancer_Med_2013_Apr_6_2(2)_234-242.nxml.txt.nlp	23634291	SENT162	8	8	15	15	bevacizumab	VEGF-D	PA130232992	2277	0.544
NULL	Front_Genet_2013_Aug_29_4_163.nxml.txt.nlp	24009622	SENT84	18	18	20	20	ethanol	DDP	PA448073	1678	0.544
NULL	Cancer_Cell_Int_2011_Aug_19_11_29.nxml.txt.nlp	21854619	SENT151	27	27	4	4	cisplatin	BRCA1	PA449014	672	0.544
NULL	Virol_J_2011_May_17_8_234.nxml.txt.nlp	21575275	SENT3	12	12	10	10	ribavirin	IFN	PA451241	3439	0.544
NULL	Mol_Cancer_2009_Nov_24_8_109.nxml.txt.nlp	19930708	SENT108	5	5	11	11	exemestane	aromatase	PA449563	1588	0.544
NULL	Oncogene_2010_Jun_24_29(25)_3619-3629.nxml.txt.nlp	20418905	SENT192	12	12	39	39	phenol	CO2	PA450913	4513	0.544
NULL	Emerg_Med_Int_2013_Oct_31_2013_258517.nxml.txt.nlp	24307946	SENT21	4	4	8	8	nitrofurantoin	TMP	PA450640	2012	0.544
NULL	Br_J_Cancer_2010_Nov_2_103(11)_1671-1679.nxml.txt.nlp	21045835	SENT238	22	22	2	2	gemcitabine	CXCR4	PA449748	7852	0.544
NULL	J_Geriatr_Cardiol_2014_Jun_11(2)_151-157.nxml.txt.nlp	25009566	SENT126	15	15	17	17	cilostazol	CDP	PA164746334	1523	0.544
NULL	Ann_Surg_Treat_Res_2014_Feb_22_86(2)_68-75.nxml.txt.nlp	24761411	SENT15	1	1	4	4	oxaliplatin	survivin	PA131285527	332	0.544
NULL	J_Neurophysiol_2014_Dec_1_112(11)_2799-2809.nxml.txt.nlp	25185816	SENT67	17	17	28	28	dextran	mol	PA449261	90527	0.544
NULL	Br_J_Haematol_2014_Jan_28_164(2)_233-244.nxml.txt.nlp	24206017	SENT190	6	6	0	0	lenalidomide	CRBN	PA162363968	51185	0.544
NULL	J_Vet_Med_Sci_2014_Oct_16_76(10)_1383-1387.nxml.txt.nlp	24931645	SENT77	4	4	1	1	sitagliptin	GLP-1	PA164748978	100125288	0.544
NULL	Mol_Pain_2014_Aug_15_10_53.nxml.txt.nlp	25127716	SENT85	5	5	11	11	paclitaxel	CCL3	PA450761	6348	0.544
NULL	J_Clin_Biochem_Nutr_2007_Sep_29_41(2)_106-114.nxml.txt.nlp	18193104	SENT61	42	42	21	21	indomethacin	VIII	PA449982	1351	0.544
NULL	Nat_Chem_Biol_2009_Jan_23_5(1)_37-44.nxml.txt.nlp	19029917	SENT57	3	3	28	28	piperazine	FAAH	PA450977	79152;2166	0.544
NULL	N_Am_J_Med_Sci_2011_Jan_3(1)_1-12.nxml.txt.nlp	22540056	SENT266	7	7	9	9	gemcitabine	GEM	PA449748	2669	0.544
NULL	Enzyme_Res_2009_Nov_1_2010_165878.nxml.txt.nlp	21048860	SENT192	1	1	7	7	asparaginase	NAC	PA448492	22861	0.544
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Mar_24_66(Pt_4)_m445-m446.nxml.txt.nlp	21580535	SENT54	3	3	21	21	copper	Ray	PA449114	26751	0.544
NULL	Curr_Chem_Genomics_2008_Jul_11_1_70-78.nxml.txt.nlp	20161830	SENT11	14	14	12	12	vasopressin	FFAR1	PA451858	2864	0.544
NULL	J_Mol_Signal_2011_May_16_6_4.nxml.txt.nlp	21575178	SENT136	7	7	9	9	arsenite	HSP27	PA452638	3315	0.544
NULL	Clin_Ophthalmol_2007_Mar_1(1)_37-42.nxml.txt.nlp	19668464	SENT168	4	4	38	38	creatine	TED	PA164778930	27112	0.544
NULL	Acta_Orthop_2010_Apr_6_81(2)_263-267.nxml.txt.nlp	20148646	SENT112	0	0	5	5	taurine	CHOP	PA451590	1649	0.544
NULL	Curr_Biol_2012_Mar_6_22(5)_397-402.nxml.txt.nlp	22305751	SENT7	18	18	22	22	physostigmine	spatial	PA450957	219793	0.544
NULL	Diabetes_2009_Dec_31_58(12)_2851-2862.nxml.txt.nlp	19720788	SENT158	5	5	0	0	forskolin	XBP1	PA146096022	7494	0.544
NULL	Cancer_Cell_Int_2013_May_16_13_44.nxml.txt.nlp	23680357	SENT29	28	28	25	25	zinc	ZEB1	PA451956	6935	0.544
NULL	Cancers_(Basel)_2011_Aug_31_3(3)_3405-3418.nxml.txt.nlp	24212960	SENT66	34	34	21	21	oxygen	MVD	PA450744	4597	0.544
NULL	Indian_J_Med_Res_2012_Jul_136(1)_54-59.nxml.txt.nlp	22885264	SENT123	1	1	7	7	cisplatin	IFN	PA449014	3439	0.544
NULL	Channels_(Austin)_2010_Jan_1_4(1)_22-41.nxml.txt.nlp	19934650	SENT13	3	3	1	1	quinidine	Slo3	PA451209	157855	0.544
NULL	J_Clin_Biochem_Nutr_2010_Jan_29_46(1)_87-92.nxml.txt.nlp	20104270	SENT309	15	15	7	7	hesperidin	STZ	PA449867	6484	0.544
NULL	Virol_J_2012_Aug_3_9_143.nxml.txt.nlp	22863531	SENT20	20	20	16	16	ribavirin	IFN	PA451241	3439	0.544
NULL	Clin_Transl_Allergy_2013_Sep_2_3_29.nxml.txt.nlp	24004581	SENT179	11	11	19	19	omalizumab	CD23	PA164752253	2208	0.544
NULL	J_Immunol_Res_2014_Jun_9_2014_326545.nxml.txt.nlp	25009822	SENT229	26	26	32	32	vemurafenib	ACT	PA165946873	12;11332;9457;641455	0.544
NULL	Biochimie_2015_Jan_108_40-47.nxml.txt.nlp	25447146	SENT201	3	3	1	1	thiamylal	TFP	PA164746997	7034	0.544
NULL	Arthritis_Res_Ther_2013_Aug_21_15(4)_R93.nxml.txt.nlp	23965253	SENT19	4	4	7	7	collagenase	MMP3	PA449107	4314	0.544
NULL	Hematol_Rep_2011_Oct_28_3(3_Suppl)_e1.nxml.txt.nlp	22586509	SENT11	1	1	10	10	cyclophosphamide	CHOP	PA449165	1649	0.544
NULL	Front_Oncol_2014_Sep_23_4_264.nxml.txt.nlp	25295231	SENT119	0	0	18	18	lenalidomide	MDM2	PA162363968	4193	0.544
NULL	Asian_J_Androl_2015_Oct_14_Jan-Feb_17(1)_21-25.nxml.txt.nlp	25337840	SENT110	12	12	9	9	nebivolol	CAD	PA151958426	1677;790	0.544
NULL	Breast_Cancer_Res_2013_Sep_18_15(5)_R85.nxml.txt.nlp	24044505	SENT109	8	8	3	3	lapatinib	PI3K	PA152241907	5290	0.544
NULL	J_Biol_Chem_2008_Nov_14_283(46)_31679-31689.nxml.txt.nlp	18755684	SENT30	6	6	22	22	iron	FTH1	PA450087	2495	0.544
NULL	J_Gastroenterol_2013_Jan_28_48(1)_1-12.nxml.txt.nlp	23188091	SENT221	36	36	14	14	ribavirin	IFN	PA451241	3439	0.544
NULL	ScientificWorldJournal_2014_Jan_8_2014_989501.nxml.txt.nlp	24526927	SENT236	4	4	12	12	ranibizumab	CRT	PA164746012	811	0.543
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_P64.nxml.txt.nlp	NULL	SENT16	40	40	36	36	cefuroxime	PPL	PA448868	5493	0.543
NULL	Acta_Pharmacol_Sin_2012_Mar_23_33(3)_372-384.nxml.txt.nlp	22266728	SENT115	27	27	25	25	vasopressin	FFAR1	PA451858	2864	0.543
NULL	Gastroenterol_Hepatol_Bed_Bench_2013_6(Suppl_1)_S65-S69.nxml.txt.nlp	24834290	SENT69	40	40	14	14	ribavirin	Yes	PA451241	7525	0.543
NULL	J_Mov_Disord_2010_Oct_30_3(2)_54-56.nxml.txt.nlp	24868384	SENT51	0	0	3	3	pramipexole	AVP	PA164742949	114548;551	0.543
NULL	J_Biomed_Biotechnol_2003_Mar_19_2003(1)_35-47.nxml.txt.nlp	12686721	SENT101	13	13	21	21	cisplatin	GM-CSF	PA449014	1437	0.543
NULL	J_Cancer_2014_Jul_4_5(7)_559-571.nxml.txt.nlp	25057307	SENT128	17	17	22	22	tamoxifen	PTEN	PA451581	5728	0.543
NULL	Int_J_Endocrinol_Metab_2014_Apr_1_12(2)_e14098.nxml.txt.nlp	24803942	SENT113	20	20	12	12	vasopressin	AQP2	PA451858	359	0.543
NULL	Cell_Div_2013_May_16_8_7.nxml.txt.nlp	23680298	SENT199	13	13	34	34	phenol	CO2	PA450913	4513	0.543
NULL	Aging_(Albany_NY)_2009_Mar_31_1(4)_412-424.nxml.txt.nlp	20195491	SENT103	7	7	9	9	resveratrol	G6PD		2539	0.543
NULL	J_Ophthalmol_2012_Aug_27_2012_285851.nxml.txt.nlp	23050121	SENT126	10	10	25	25	bimatoprost	BAK	PA164748867	578	0.543
NULL	Exp_Ther_Med_2013_Mar_10_5(3)_783-788.nxml.txt.nlp	23408783	SENT200	24	24	0	0	bezafibrate	MCP-1	PA162364313	6347	0.543
NULL	Eur_J_Med_Res_2011_Apr_28_16(4)_180-186.nxml.txt.nlp	21486732	SENT88	15	15	9	9	caspofungin	DAC	PA164743013	13	0.543
NULL	J_Epilepsy_Res_2011_Dec_30_1(2)_52-56.nxml.txt.nlp	24649446	SENT20	38	38	16	16	fosphenytoin	LZP	PA164746820	170392	0.543
NULL	An_Bras_Dermatol_2014_Nov-Dec_89(6)_925-938.nxml.txt.nlp	25387498	SENT324	1	1	14	14	ethambutol	DDC	PA164784021	1644	0.543
NULL	Int_J_Breast_Cancer_2012_Nov_2_2012_217185.nxml.txt.nlp	22295242	SENT203	6	6	21	21	dasatinib	EGFR	PA162372878	1956	0.543
NULL	Oncol_Rep_2014_Apr_28_31(4)_1605-1612.nxml.txt.nlp	24481648	SENT39	3	3	26	26	ponatinib	P-gp	PA165980594	5243	0.543
NULL	J_Gastrointest_Cancer_2014_Dec_17_45(2)_190-201.nxml.txt.nlp	24343588	SENT349	4	4	21	21	mitomycin	BRCA2	PA450524	675	0.543
NULL	Arthritis_Res_2002_Mar_27_4(Suppl_2)_S22-S28.nxml.txt.nlp	12110154	SENT60	2	2	4	4	infliximab	IL-6	PA452639	3569	0.543
NULL	Cancers_(Basel)_2014_Aug_5_6(3)_1597-1614.nxml.txt.nlp	25099886	SENT178	16	16	6	6	methotrexate	PINK1	PA450428	65018	0.543
NULL	J_Ophthalmic_Inflamm_Infect_2011_Nov_6_2(1)_21-28.nxml.txt.nlp	22057810	SENT76	11	11	13	13	cyclosporine	CTX	PA449167	1593	0.543
NULL	Mol_Neurodegener_2010_Nov_18_5_52.nxml.txt.nlp	21087519	SENT222	33	33	20	20	l-glutamine	B27	PA10090	56246	0.543
NULL	Neural_Regen_Res_2014_Mar_15_9(6)_622-629.nxml.txt.nlp	25206865	SENT110	0	0	9	9	vasopressin	p38	PA451858	10598;1432;7965	0.543
NULL	Br_J_Cancer_2012_Jan_17_106(2)_284-289.nxml.txt.nlp	22215065	SENT159	21	21	11	11	atrasentan	IFN	PA143414738	3439	0.543
NULL	Support_Care_Cancer_2011_Oct_12_19(10)_1609-1617.nxml.txt.nlp	20835873	SENT93	14	14	2	2	granisetron	FAS	PA449809	355;2194	0.543
NULL	Lab_Invest_2011_Apr_14_91(4)_598-608.nxml.txt.nlp	21321535	SENT130	20	20	29	29	sorafenib	CD4	PA7000	920	0.543
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Oct_11_70(Pt_11)_319-321.nxml.txt.nlp	25484733	SENT23	2	2	12	12	coumarin	C11	PA134521193	1109	0.543
NULL	J_Mol_Med_(Berl)_2012_Dec_23_90(12)_1361-1389.nxml.txt.nlp	23090008	SENT676	12	12	8	8	oxygen	JNK	PA450744	5599	0.543
NULL	Acta_Pharmacol_Sin_2010_Jul_28_31(7)_775-783.nxml.txt.nlp	20581849	SENT238	12	12	0	0	imipramine	NHC	PA449969	10473	0.543
NULL	Exp_Ther_Med_2013_Mar_17_5(3)_807-812.nxml.txt.nlp	23407772	SENT23	7	7	27	27	sufentanil	ACTH	PA451527	5443	0.543
NULL	Clin_Med_Insights_Oncol_2012_Dec_20_7_1-12.nxml.txt.nlp	23362372	SENT35	20	20	37	37	ketoconazole	CYP3A	PA450146	1574	0.543
NULL	Curr_Oncol_2009_Jul_16(Suppl_2)_S14-S23.nxml.txt.nlp	19672417	SENT183	13	13	23	23	tamoxifen	aromatase	PA451581	1588	0.543
NULL	Structure_2013_Jun_4_21(6)_1051-1058.nxml.txt.nlp	23665170	SENT351	2	2	8	8	oxygen	hole	PA450744	80757	0.543
NULL	EJC_Suppl_2013_Sep_5_11(2)_275-277.nxml.txt.nlp	NULL	SENT11	25	25	22	22	cetuximab	EGFR	PA10040	1956	0.543
NULL	Vet_Res_Forum_2013_Winter_4(1)_19-24.nxml.txt.nlp	25593681	SENT76	15	15	13	13	diclofenac	B12	PA449293	7126;4709	0.543
NULL	Front_Neurosci_2012_Feb_21_6_26.nxml.txt.nlp	22363256	SENT713	5	5	13	13	estradiol	aromatase	PA449503	1588	0.543
NULL	Clinics_(Sao_Paulo)_2012_Aug_67(8)_885-890.nxml.txt.nlp	22948454	SENT75	19	19	30	30	creatine	ADM	PA164778930	133	0.543
NULL	Front_Genet_2014_Aug_26_5_289.nxml.txt.nlp	25206362	SENT47	10	10	24	24	choline	B12	PA448976	7126;4709	0.543
NULL	Front_Aging_Neurosci_2014_Sep_11_6_218.nxml.txt.nlp	25309423	SENT165	6	6	8	8	resveratrol	PARP-1		25976	0.543
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT192	35	35	47	47	cetuximab	Yes	PA10040	7525	0.543
NULL	Diagn_Pathol_2014_Jan_20_9_11.nxml.txt.nlp	24443801	SENT26	15	15	9	9	trypsin	MUC1	PA451806	4582	0.543
NULL	Exp_Diabetes_Res_2012_Nov_12_2012_618923.nxml.txt.nlp	23197974	SENT180	27	27	17	17	telmisartan	STZ	PA451605	6484	0.543
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT320	25	25	5	5	haloperidol	PRL	PA449841	5617	0.543
NULL	Behav_Brain_Funct_2010_Aug_30_6_50.nxml.txt.nlp	20799992	SENT164	34	34	8	8	methamphetamine	alpha-synuclein	PA450403	6622	0.543
NULL	J_Adv_Pharm_Technol_Res_2014_Apr-Jun_5(2)_70-77.nxml.txt.nlp	24959415	SENT170	4	4	1	1	theophylline	ANOVA	PA451647	4858	0.543
NULL	Asian_J_Transfus_Sci_2014_8(Suppl1)_S26-S87.nxml.txt.nlp	NULL	SENT1576	3	3	10	10	fludarabine	ABO	PA449655	28	0.543
NULL	Iran_J_Ped_Hematol_Oncol_2014_Jul_20_4(3)_127-130.nxml.txt.nlp	25254092	SENT12	6	6	11	11	propranolol	IFN	PA451145	3439	0.543
NULL	EMBO_Mol_Med_2011_Sep_3(9)_545-558.nxml.txt.nlp	21774078	SENT233	22	22	29	29	gentamicin	CO2	PA449753	4513	0.543
NULL	Exp_Ther_Med_2012_Sep_12_4(3)_475-480.nxml.txt.nlp	23181121	SENT148	18	18	20	20	rituximab	CHOP	PA451261	1649	0.543
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT110	3	3	21	21	perifosine	DR4	PA165291471	8797	0.543
NULL	Acta_Pharmacol_Sin_2013_Sep_5_34(9)_1229-1236.nxml.txt.nlp	23892269	SENT136	10	10	8	8	ketoconazole	CYP3A4	PA450146	1576	0.543
NULL	Arthritis_Res_Ther_2009_Nov_13_11(6)_R172.nxml.txt.nlp	19912653	SENT2	30	30	20	20	simvastatin	IVD	PA451363	3712	0.543
NULL	Cent_European_J_Urol_2013_Apr_26_66(1)_39-44.nxml.txt.nlp	24578986	SENT87	36	36	13	13	etoposide	ACT	PA449552	12;11332;9457;641455	0.543
NULL	Front_Physiol_2013_Dec_24_4_386.nxml.txt.nlp	24399968	SENT757	17	17	9	9	diazoxide	SUR1	PA449285	6833	0.543
NULL	Proteome_Sci_2005_May_31_3_4.nxml.txt.nlp	15927046	SENT142	10	10	7	7	glucose	PHB	PA449773	5245	0.543
NULL	J_Cell_Biol_2001_Oct_29_155(3)_427-438.nxml.txt.nlp	11673478	SENT178	23	23	16	16	genistein	PP2	PA165109660	4888	0.543
NULL	Neuroscience_2008_Aug_13_155(2)_556-564.nxml.txt.nlp	18619738	SENT210	3	3	1	1	choline	CDP	PA448976	1523	0.543
NULL	Mol_Cancer_2009_Nov_10_8_99.nxml.txt.nlp	19903356	SENT76	30	30	16	16	imatinib	IGFBP3	PA10804	3486	0.543
NULL	J_Anaesthesiol_Clin_Pharmacol_2011_Jul-Sep_27(3)_349-353.nxml.txt.nlp	21897506	SENT63	11	11	9	9	oxygen	NIBP	PA450744	83696	0.543
NULL	Evid_Based_Complement_Alternat_Med_2011_Feb_14_2011_429843.nxml.txt.nlp	21869897	SENT105	31	31	29	29	ethanol	CEA	PA448073	5670;1087	0.543
NULL	Biosci_Rep_2013_Sep_17_33(5)_e00068.nxml.txt.nlp	23919527	SENT255	6	6	0	0	guanidine	CXCL8	PA164781028	3576	0.543
NULL	J_Minim_Access_Surg_2006_Jun_2(2)_47-48.nxml.txt.nlp	21170234	SENT16	12	12	0	0	sevoflurane	CO2	PA451341	4513	0.543
NULL	Exp_Ther_Med_2013_Feb_20_5(2)_443-447.nxml.txt.nlp	23407364	SENT186	11	11	13	13	cyclophosphamide	IL-2	PA449165	3558	0.543
NULL	Mol_Cancer_2010_Apr_23_9_87.nxml.txt.nlp	20416058	SENT228	23	23	17	17	doxorubicin	TRAIL	PA449412	8743	0.543
NULL	Folia_Microbiol_(Praha)_2014_Aug_16_59(6)_543-552.nxml.txt.nlp	25128200	SENT188	15	15	5	5	lincomycin	POR	PA164749212	5447	0.543
NULL	J_Biomed_Biotechnol_2010_Oct_27_2010_948543.nxml.txt.nlp	21048930	SENT86	10	10	15	15	chlorpromazine	MDC	PA448964	6367	0.543
NULL	Int_J_Mol_Sci_2014_May_12_15(5)_8335-8351.nxml.txt.nlp	24823879	SENT529	0	0	12	12	cisplatin	DR5	PA449014	8795	0.543
NULL	J_Gen_Physiol_2010_Jan_135(1)_3-13.nxml.txt.nlp	20038523	SENT35	12	12	25	25	bumetanide	NKCC1	PA448682	6558	0.543
NULL	Environ_Health_Perspect_2008_Oct_27_116(10)_1315-1321.nxml.txt.nlp	18941571	SENT65	9	9	23	23	phenol	F12	PA450913	2161	0.543
NULL	Environ_Health_Perspect_2011_Aug_7_119(8)_1117-1122.nxml.txt.nlp	21382770	SENT53	28	28	30	30	mk-571	SFN		25996;2810	0.543
NULL	J_Korean_Med_Sci_2010_Nov_26_25(11)_1683-1687.nxml.txt.nlp	21060764	SENT40	13	13	22	22	thyroglobulin	p63	PA164754910	8626	0.543
NULL	Asia_Pac_Allergy_2012_Oct_31_2(4)_280-282.nxml.txt.nlp	23130335	SENT32	32	32	7	7	tamsulosin	ACE	PA451583	1636	0.543
NULL	Oncol_Lett_2013_Oct_29_6(4)_1031-1038.nxml.txt.nlp	24137459	SENT204	32	32	40	40	fluorescein	LC3	PA164746009	84557	0.543
NULL	J_Immigr_Minor_Health_2012_Apr_26_14(2)_281-286.nxml.txt.nlp	21442300	SENT107	21	21	36	36	methamphetamine	San	PA450403	80218	0.543
NULL	Cardiovasc_J_Afr_2009_Apr_20(2)_122-125.nxml.txt.nlp	19421648	SENT31	20	20	23	23	vancomycin	DBL	PA451850	4168	0.543
NULL	Chin_J_Cancer_2011_Sep_30(9)_645-654.nxml.txt.nlp	21880186	SENT53	13	13	11	11	bleomycin	DDP	PA448645	1678	0.543
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT109	0	0	5	5	perifosine	DR4	PA165291471	8797	0.543
NULL	J_Cell_Biol_2001_Jun_11_153(6)_1239-1250.nxml.txt.nlp	11402067	SENT97	19	19	11	11	zinc	LPP	PA451956	4026	0.543
NULL	J_Headache_Pain_2010_Feb_10_11(1)_5-12.nxml.txt.nlp	20012125	SENT49	3	3	7	7	sumatriptan	c-fos	PA451566	2353	0.543
NULL	Cancer_Microenviron_2009_Sep_26_2(Suppl_1)_19-204.nxml.txt.nlp	NULL	SENT3691	11	11	13	13	lipase	ATGL	PA450239	57104	0.543
NULL	Mol_Cancer_2004_Dec_21_3_38.nxml.txt.nlp	15613236	SENT199	27	27	34	34	hydrocortisone	CO2	PA449905	4513	0.543
NULL	Int_J_Biol_Sci_2015_Jan_1_11(1)_48-58.nxml.txt.nlp	25552929	SENT34	24	24	8	8	paclitaxel	LDM	PA450761	1595	0.543
NULL	Nat_Commun_2013_Sep_3_4_2394.nxml.txt.nlp	23999152	SENT75	6	6	2	2	dextran	BDNF	PA449261	627	0.543
NULL	Pediatr_Cardiol_2010_Jan_14_31(1)_90-95.nxml.txt.nlp	19915892	SENT57	19	19	24	24	palivizumab	AAP	PA164748781	5345	0.543
NULL	Eur_J_Clin_Pharmacol_2007_Apr_21_63(4)_335-343.nxml.txt.nlp	17318526	SENT174	22	22	19	19	acenocoumarol	CYP2C9	PA452632	1559	0.543
NULL	J_Med_Chem_2014_Jan_23_57(2)_462-476.nxml.txt.nlp	24313754	SENT116	2	2	13	13	piperazine	CECR2	PA450977	27443	0.543
NULL	Case_Rep_Oncol_Med_2012_Sep_11_2012_726424.nxml.txt.nlp	22997596	SENT11	23	23	29	29	vincristine	CHOP	PA451879	1649	0.543
NULL	Eur_J_Clin_Pharmacol_2012_Jan_8_68(1)_29-37.nxml.txt.nlp	21739267	SENT101	16	16	18	18	paroxetine	PRX	PA450801	9588;57716	0.543
NULL	Oncotarget_2012_Dec_18_3(12)_1615-1628.nxml.txt.nlp	23271044	SENT67	26	26	28	28	temsirolimus	TOR	PA164746890	6097	0.543
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_6_2014_270930.nxml.txt.nlp	25431606	SENT258	0	0	6	6	curcumin	IL-6	PA151958596	3569	0.543
NULL	Nat_Commun_2014_Dec_8_5_5736.nxml.txt.nlp	25484020	SENT19	20	20	30	30	exemestane	aromatase	PA449563	1588	0.543
NULL	Cancer_Cell_Int_2011_Nov_17_11_40.nxml.txt.nlp	22088142	SENT42	26	26	12	12	gemcitabine	EGF	PA449748	1950	0.543
NULL	Br_J_Cancer_2013_Aug_6_109(3)_686-693.nxml.txt.nlp	23839492	SENT100	5	5	16	16	sunitinib	HIF-1	PA162372840	29072	0.543
NULL	Cancer_Cell_Int_2013_Jun_26_13_63.nxml.txt.nlp	23800022	SENT210	0	0	15	15	genistein	TP53	PA165109660	7157	0.543
NULL	Arch_Drug_Inf_2008_Jul_1(1)_14-22.nxml.txt.nlp	20157364	SENT98	2	2	4	4	pravastatin	IL-6	PA451089	3569	0.543
NULL	Aging_(Albany_NY)_2012_Dec_6_4(11)_823-842.nxml.txt.nlp	23235539	SENT180	34	34	17	17	bleomycin	HCA2	PA448645	139081;55811;338442	0.543
NULL	Mol_Biol_Cell_2013_Aug_1_24(15)_2328-2339.nxml.txt.nlp	23783029	SENT330	13	13	6	6	nitrogen	SLA1	PA450643	6503	0.543
NULL	J_Oncol_2010_Nov_19_2010_568938.nxml.txt.nlp	20037743	SENT315	19	19	35	35	lapatinib	EGFR	PA152241907	1956	0.543
NULL	Clin_Ophthalmol_2014_Jun_10_8_1097-1104.nxml.txt.nlp	24959067	SENT38	19	19	25	25	latanoprost	BAK	PA164774763	578	0.543
NULL	Cell_Commun_Signal_2009_Oct_27_7_25.nxml.txt.nlp	19860902	SENT238	0	0	5	5	tropisetron	p38	PA161925594	10598;1432;7965	0.543
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1075.nxml.txt.nlp	24556690	SENT263	2	2	0	0	spermine	SMO	PA164781199	6608;54498	0.543
NULL	Biol_Cell_2011_Nov_1_103(Pt_11)_499-517.nxml.txt.nlp	21787361	SENT240	16	16	0	0	choline	PCYT1A	PA448976	5130	0.543
NULL	Int_J_Gen_Med_2013_Jun_7_6_453-464.nxml.txt.nlp	23785241	SENT205	10	10	15	15	budesonide	IL-6	PA448681	3569	0.543
NULL	Inflamm_Bowel_Dis_2014_Nov_2_20(11)_2029-2037.nxml.txt.nlp	25185684	SENT43	33	33	14	14	adalimumab	CDAI	PA10004	146059	0.543
NULL	Cancer_Cell_Int_2012_Mar_22_12_9.nxml.txt.nlp	22439612	SENT65	11	11	25	25	l-glutamine	CO2	PA10090	4513	0.543
NULL	Behav_Brain_Funct_2009_Jan_15_5_3.nxml.txt.nlp	19146665	SENT205	13	13	2	2	ethanol	ANOVA	PA448073	4858	0.543
NULL	Biomed_Res_Int_2013_Dec_31_2013_273498.nxml.txt.nlp	23484100	SENT105	20	20	23	23	genistein	OTC	PA165109660	5009	0.543
NULL	Br_J_Cancer_2010_Jan_5_102(1)_73-79.nxml.txt.nlp	19953092	SENT152	16	16	25	25	warfarin	FVIII	PA451906	2157	0.543
NULL	Biomed_Res_Int_2014_Jan_29_2014_361020.nxml.txt.nlp	24605326	SENT223	7	7	16	16	flavopiridol	CDK1	PA452627	983	0.543
NULL	Arthritis_Res_Ther_2013_Apr_4_15(Suppl_1)_S4.nxml.txt.nlp	23566679	SENT522	2	2	20	20	rituximab	CD40L	PA451261	959	0.543
NULL	J_Clin_Biochem_Nutr_2009_Jul_30_45(1)_14-19.nxml.txt.nlp	19590702	SENT35	34	34	21	21	l-glutamine	B27	PA10090	56246	0.543
NULL	Curr_Neuropharmacol_2013_Dec_11(6)_652-663.nxml.txt.nlp	24396340	SENT343	4	4	6	6	capsaicin	TRPV1	PA448776	7442	0.543
NULL	Iran_J_Public_Health_2012_Jan_31_41(1)_59-65.nxml.txt.nlp	23113123	SENT133	17	17	25	25	lipase	HDL2	PA450239	57338	0.543
NULL	Ann_Thorac_Med_2011_Oct-Dec_6(4)_221-226.nxml.txt.nlp	21977068	SENT125	10	10	4	4	doxycycline	MIDAS	PA449415	64083	0.543
NULL	Biomed_Res_Int_2014_May_29_2014_349074.nxml.txt.nlp	24977149	SENT324	27	27	6	6	ethanol	ANOVA	PA448073	4858	0.543
NULL	Eur_J_Med_Res_2009_Nov_24_14(Suppl_3)_17-21.nxml.txt.nlp	19959412	SENT80	13	13	6	6	raltegravir	UGT1A1		54658	0.543
NULL	EMBO_Mol_Med_2013_Jun_30_5(6)_935-948.nxml.txt.nlp	23629957	SENT254	15	15	18	18	cisplatin	ANOVA	PA449014	4858	0.543
NULL	Int_J_Endocrinol_Metab_2013_Apr_1_Spring_11(2)_65-70.nxml.txt.nlp	23825975	SENT150	14	14	9	9	estradiol	CEE	PA449503	51608	0.543
NULL	Drugs_2014_Apr_17_74(6)_659-674.nxml.txt.nlp	24740824	SENT430	21	21	5	5	daclizumab	CD25	PA164764446	3669;3559	0.543
NULL	Mol_Cancer_2010_Apr_23_9_87.nxml.txt.nlp	20416058	SENT190	23	23	17	17	doxorubicin	TRAIL	PA449412	8743	0.543
NULL	Arch_Toxicol_2009_Jun_27_83(6)_609-617.nxml.txt.nlp	18754102	SENT235	20	20	29	29	curcumin	PC-3	PA151958596	692094	0.543
NULL	Exp_Biol_Med_(Maywood)_2012_May_237(5)_540-547.nxml.txt.nlp	22569032	SENT32	19	19	11	11	bacitracin	CO2	PA448531	4513	0.543
NULL	Mol_Cancer_2014_Jan_28_13_17.nxml.txt.nlp	24472312	SENT239	23	23	21	21	ponatinib	Mcl-1	PA165980594	4170	0.543
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT312	19	19	11	11	resveratrol	TNF		7124	0.543
NULL	Drug_Des_Devel_Ther_2014_Oct_31_8_2121-2128.nxml.txt.nlp	25382970	SENT99	6	6	8	8	curcumin	TTR	PA151958596	7276	0.543
NULL	Open_Ophthalmol_J_2014_Nov_28_8_87-90.nxml.txt.nlp	25493104	SENT67	1	1	7	7	bevacizumab	PED	PA130232992	8682	0.543
NULL	Nat_Med_2012_Feb_19_18(3)_446-451.nxml.txt.nlp	22344296	SENT152	9	9	18	18	indinavir	CD4	PA449977	920	0.543
NULL	Br_J_Cancer_2010_Dec_7_103(12)_1822-1830.nxml.txt.nlp	21063405	SENT32	30	30	12	12	cisplatin	NBS1	PA449014	55655	0.543
NULL	Mol_Neurodegener_2010_Nov_11_5_51.nxml.txt.nlp	21070634	SENT194	20	20	4	4	paraformaldehyde	CO2	PA450790	4513	0.543
NULL	Cell_Commun_Signal_2014_Sep_25_12(1)_61.nxml.txt.nlp	NULL	SENT52	19	19	1	1	doxycycline	INPP4B	PA449415	8821	0.543
NULL	Mol_Vis_2011_Aug_18_17_2221-2227.nxml.txt.nlp	21897744	SENT13	8	8	11	11	l-arginine	NAC	PA448478	22861	0.543
NULL	J_Cell_Biol_1998_Jun_29_141(7)_1625-1636.nxml.txt.nlp	9647654	SENT181	35	35	33	33	thrombin	LPA	PA451674	4018	0.543
NULL	Br_J_Cancer_2013_Jul_9_109(1)_68-75.nxml.txt.nlp	23807173	SENT246	36	36	7	7	cisplatin	ERCC1	PA449014	2067	0.543
NULL	Curr_Neuropharmacol_2014_Mar_12(2)_100-107.nxml.txt.nlp	24669205	SENT45	10	10	12	12	l-glutamine	B27	PA10090	56246	0.543
NULL	Oxid_Med_Cell_Longev_2013_Apr_21_2013_412576.nxml.txt.nlp	23710286	SENT5	6	6	19	19	curcumin	NRF2	PA151958596	2551;4780	0.543
NULL	Oncol_Rep_2013_Apr_23_29(4)_1268-1274.nxml.txt.nlp	23354756	SENT85	1	1	4	4	paclitaxel	SLC25A43	PA450761	203427	0.543
NULL	JMIR_Mhealth_Uhealth_2014_Jul_23_2(3)_e32.nxml.txt.nlp	25098413	SENT310	4	4	17	17	warfarin	MASS	PA451906	2200	0.543
NULL	J_Biol_Chem_2014_Dec_26_289(52)_36018-36030.nxml.txt.nlp	25336647	SENT11	11	11	4	4	sulfur	CBS	PA451558	875	0.543
NULL	Br_J_Pharmacol_2014_Sep_28_171(18)_4255-4272.nxml.txt.nlp	24846338	SENT257	2	2	16	16	ondansetron	CA1	PA450705	759	0.543
NULL	Am_J_Physiol_Cell_Physiol_2010_Mar_16_298(3)_C430-C441.nxml.txt.nlp	20018950	SENT403	14	14	12	12	vasopressin	ADP	PA451858	23038	0.543
NULL	Cardiovasc_Diabetol_2013_Jun_7_12_84.nxml.txt.nlp	23759020	SENT16	7	7	0	0	dipyridamole	LSR	PA449367	51599	0.543
NULL	Br_J_Cancer_2009_Mar_24_100(6)_881-887.nxml.txt.nlp	19259089	SENT141	24	24	0	0	oxaliplatin	CEA	PA131285527	5670;1087	0.543
NULL	Clin_Neuropathol_2011_Oct_18_Nov-Dec_30(6)_291-296.nxml.txt.nlp	22011733	SENT48	17	17	7	7	thyroglobulin	CK20	PA164754910	54474	0.543
NULL	J_Burns_Wounds_2007_Apr_11_6_e6.nxml.txt.nlp	17492051	SENT162	19	19	13	13	sulfadiazine	VIII	PA451539	1351	0.543
NULL	J_Am_Heart_Assoc_2013_Aug_23_2(4)_e000264.nxml.txt.nlp	23896681	SENT156	31	31	12	12	thrombin	FVIII	PA451674	2157	0.543
NULL	J_Exp_Bot_2008_May_59(8)_2109-2123.nxml.txt.nlp	18535297	SENT309	10	10	0	0	galactose	PC1	PA449725	5122	0.543
NULL	Diabetes_2013_Mar_14_62(3)_825-836.nxml.txt.nlp	23193184	SENT78	12	12	4	4	lipase	aP2	PA450239	2167	0.543
NULL	Acta_Histochem_Cytochem_2014_Aug_29_47(4)_165-174.nxml.txt.nlp	25392570	SENT31	9	9	4	4	isoflurane	ADX	PA450106	2230	0.543
NULL	Clin_Med_Case_Rep_2008_Aug_29_1_119-122.nxml.txt.nlp	24179360	SENT57	5	5	13	13	teriparatide	IL-6	PA451620	3569	0.543
NULL	Lab_Invest_2013_Dec_14_93(12)_1265-1275.nxml.txt.nlp	24126890	SENT184	0	0	6	6	celecoxib	IL-6	PA448871	3569	0.543
NULL	Angiogenesis_2009_Dec_21_12(4)_303-311.nxml.txt.nlp	19544080	SENT149	27	27	14	14	oxygen	HIF-1	PA450744	29072	0.543
NULL	Mol_Cancer_2014_Jun_10_13_147.nxml.txt.nlp	24913641	SENT46	9	9	1	1	etoposide	p53	PA449552	7157	0.542
NULL	Diabetes_2008_Sep_57(9)_2272-2279.nxml.txt.nlp	18519799	SENT155	7	7	9	9	rosiglitazone	PDK4	PA451283	5166	0.542
NULL	Acta_Orthop_2010_Apr_6_81(2)_263-267.nxml.txt.nlp	20148646	SENT165	2	2	15	15	taurine	ATF4	PA451590	468	0.542
NULL	Diabetol_Metab_Syndr_2014_Mar_31_6_47.nxml.txt.nlp	24684779	SENT100	21	21	24	24	pioglitazone	IL-6	PA450970	3569	0.542
NULL	Oncotarget_2013_Aug_21_4(9)_1484-1495.nxml.txt.nlp	23986086	SENT157	9	9	14	14	metformin	PIK3CA	PA450395	5290	0.542
NULL	Indian_J_Anaesth_2011_May-Jun_55(3)_318-320.nxml.txt.nlp	21808420	SENT51	4	4	11	11	tramadol	CYP2D6	PA451735	1565	0.542
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT9	13	13	6	6	celecoxib	IL-6	PA448871	3569	0.542
NULL	Diabetes_2011_May_23_60(5)_1458-1466.nxml.txt.nlp	21464445	SENT28	12	12	14	14	lipase	ATGL	PA450239	57104	0.542
NULL	Biosci_Rep_2012_Aug_1_32(Pt_4)_361-374.nxml.txt.nlp	22762204	SENT184	19	19	5	5	etoposide	LATS2	PA449552	26524	0.542
NULL	J_Biol_Chem_2013_Nov_22_288(47)_34217-34229.nxml.txt.nlp	24106270	SENT179	16	16	28	28	thrombin	RhoG	PA451674	391	0.542
NULL	Antimicrob_Resist_Infect_Control_2012_Mar_16_1_12.nxml.txt.nlp	22958880	SENT107	11	11	28	28	amoxicillin	CTX	PA448406	1593	0.542
NULL	Cardiovasc_Diabetol_2010_Nov_16_9_76.nxml.txt.nlp	21080957	SENT24	27	27	25	25	exenatide	GLP-1	PA164749238	100125288	0.542
NULL	Ayu_2010_Apr-Jun_31(2)_167-169.nxml.txt.nlp	22131705	SENT65	8	8	15	15	theophylline	Cocoa	PA451647	57658	0.542
NULL	Front_Endocrinol_(Lausanne)_2011_Aug_11_2_19.nxml.txt.nlp	22649366	SENT81	33	33	35	35	vasopressin	AVP	PA451858	114548;551	0.542
NULL	Adv_Ther_2014_Dec_2_31_1228-1246.nxml.txt.nlp	25447269	SENT204	22	22	19	19	timolol	TIM	PA451690	7984;8914	0.542
NULL	Acta_Neurochir_(Wien)_2010_Jan_4_152(1)_163-168.nxml.txt.nlp	19578806	SENT22	27	27	42	42	methotrexate	TMX	PA450428	81542	0.542
NULL	Oncotarget_2013_Dec_28_5(6)_1475-1490.nxml.txt.nlp	24721996	SENT188	0	0	8	8	celecoxib	PTEN	PA448871	5728	0.542
NULL	J_Young_Pharm_2011_Oct-Dec_3(4)_304-309.nxml.txt.nlp	22224037	SENT26	0	0	2	2	gatifloxacin	GTX	PA449738	84504	0.542
NULL	Gut_Liver_2013_May_9_7(3)_329-334.nxml.txt.nlp	23710315	SENT137	38	38	0	0	entecavir	LAM	PA164784025	7249;7248	0.542
NULL	Lancet_2011_Aug_13_378(9791)_595-605.nxml.txt.nlp	21784508	SENT286	19	19	0	0	lisinopril	P18	PA450242	7975;10168	0.542
NULL	Biomed_Res_Int_2014_Jan_23_2014_129048.nxml.txt.nlp	24575400	SENT38	25	25	16	16	streptomycin	FBS	PA451512	64319;26269	0.542
NULL	Breast_Cancer_Res_2003_Oct_9_5(6)_R250-R256.nxml.txt.nlp	14580261	SENT51	18	18	8	8	fluorescein	AAT	PA164746009	5265	0.542
NULL	Cancer_Gene_Ther_2012_Aug_25_19(8)_523-529.nxml.txt.nlp	22627392	SENT116	20	20	17	17	cyclosporine	DPT	PA449167	1805	0.542
NULL	Cases_J_2009_Jun_26_2_6384.nxml.txt.nlp	19829800	SENT68	0	0	6	6	rituximab	CHOP	PA451261	1649	0.542
NULL	J_Cell_Biol_2008_Jan_28_180(2)_417-426.nxml.txt.nlp	18227283	SENT501	0	0	12	12	estradiol	CA1	PA449503	759	0.542
NULL	ISRN_AIDS_2012_Jul_12_2012_485307.nxml.txt.nlp	24052874	SENT90	22	22	7	7	efavirenz	CD4	PA449441	920	0.542
NULL	J_Cell_Biol_1998_Apr_6_141(1)_115-133.nxml.txt.nlp	9531552	SENT59	21	21	9	9	aminopterin	F12	PA165109541	2161	0.542
NULL	Exp_Ther_Med_2013_Mar_10_5(3)_783-788.nxml.txt.nlp	23408783	SENT194	11	11	13	13	bezafibrate	MCP-1	PA162364313	6347	0.542
NULL	Acta_Histochem_Cytochem_2011_Apr_28_44(2)_51-60.nxml.txt.nlp	21614166	SENT171	41	41	15	15	thalidomide	PCNA	PA451644	5111	0.542
NULL	Clin_Ophthalmol_2014_Aug_13_8_1495-1505.nxml.txt.nlp	25152611	SENT246	9	9	22	22	bepotastine	SPK	PA164781356	55872;8189	0.542
NULL	Pak_J_Med_Sci_2013_May-Jun_29(3)_788-792.nxml.txt.nlp	24353629	SENT78	22	22	20	20	cefotaxime	CTX	PA448852	1593	0.542
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_39-54.nxml.txt.nlp	19305787	SENT125	16	16	28	28	ethanol	NR1	PA448073	27158	0.542
NULL	Oncol_Lett_2014_Jul_12_8(1)_223-229.nxml.txt.nlp	24959250	SENT120	5	5	17	17	captopril	MCP-1	PA448780	6347	0.542
NULL	Diabetes_Care_2013_Jul_12_36(7)_1913-1918.nxml.txt.nlp	23359361	SENT5	13	13	21	21	sitagliptin	GLP-1	PA164748978	100125288	0.542
NULL	Environ_Health_Perspect_2006_Apr_21_114(Suppl_1)_20-26.nxml.txt.nlp	16818242	SENT26	28	28	30	30	diethylstilbestrol	DES	PA449307	1674	0.542
NULL	Breast_Cancer_Res_2014_Dec_6_16(6)_491.nxml.txt.nlp	25479686	SENT198	21	21	11	11	medroxyprogesterone	EZH2	PA450344	2146	0.542
NULL	Int_J_Mol_Sci_2014_Mar_20_15(3)_4977-4993.nxml.txt.nlp	24658441	SENT446	0	0	4	4	resveratrol	survivin		332	0.542
NULL	J_Biol_Chem_2012_Apr_6_287(15)_12433-12444.nxml.txt.nlp	22351758	SENT980	3	3	5	5	hyaluronan	TSG-6	PA165958431	7130	0.542
NULL	Scientifica_(Cairo)_2012_Dec_13_2012_980812.nxml.txt.nlp	24278765	SENT48	12	12	1	1	misoprostol	TOP	PA450523	649159	0.542
NULL	Open_AIDS_J_2010_May_14_4_105-115.nxml.txt.nlp	20657829	SENT76	25	25	13	13	methamphetamine	San	PA450403	80218	0.542
NULL	Nat_Med_2012_Feb_19_18(3)_446-451.nxml.txt.nlp	22344296	SENT23	8	8	10	10	atazanavir	ATV	PA10251	4683	0.542
NULL	Cardiovasc_Diabetol_2013_Oct_17_12_150.nxml.txt.nlp	24134550	SENT102	12	12	18	18	pioglitazone	activin	PA450970	83729	0.542
NULL	Front_Endocrinol_(Lausanne)_2011_Nov_10_2_65.nxml.txt.nlp	22649380	SENT102	18	18	14	14	estradiol	aromatase	PA449503	1588	0.542
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_May_25_67(Pt_6)_o1492.nxml.txt.nlp	21754860	SENT65	17	17	12	12	ethanol	mol	PA448073	90527	0.542
NULL	Acta_Pharmacol_Sin_2011_Jun_3_32(6)_805-816.nxml.txt.nlp	21642949	SENT308	0	0	18	18	curcumin	NAB2	PA151958596	4665	0.542
NULL	J_Immunother_Cancer_2014_Nov_6_2(Suppl_3)_P199.nxml.txt.nlp	NULL	SENT8	36	36	6	6	cetuximab	IFN	PA10040	3439	0.542
NULL	Contemp_Clin_Dent_2011_Oct-Dec_2(4)_278-282.nxml.txt.nlp	22346152	SENT5	13	13	18	18	potassium	GCF	PA451047	6936	0.542
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jan_31_68(Pt_2)_o531.nxml.txt.nlp	22347127	SENT3	10	10	2	2	piperazine	mol	PA450977	90527	0.542
NULL	Exp_Ther_Med_2013_Mar_10_5(3)_783-788.nxml.txt.nlp	23408783	SENT200	20	20	0	0	rosiglitazone	MCP-1	PA451283	6347	0.542
NULL	Clin_Pediatr_Endocrinol_2005_Feb_14_14(1)_27-33.nxml.txt.nlp	24790307	SENT13	10	10	14	14	vasopressin	AVPR2	PA451858	554	0.542
NULL	J_Carcinog_2011_Nov_30_10_28.nxml.txt.nlp	22190870	SENT56	17	17	7	7	trastuzumab	PTEN	PA451743	5728	0.542
NULL	Int_J_Mol_Sci_2014_May_9_15(5)_8153-8168.nxml.txt.nlp	24821539	SENT296	2	2	12	12	estradiol	p27	PA449503	5715;10534	0.542
NULL	Front_Syst_Neurosci_2014_Feb_4_8_12.nxml.txt.nlp	24550792	SENT358	2	2	4	4	methylphenidate	spatial	PA450464	219793	0.542
NULL	Breast_Cancer_Res_2012_Mar_15_14(2)_R47.nxml.txt.nlp	22420423	SENT0	30	30	23	23	mitomycin	TP53	PA450524	7157	0.542
NULL	Int_J_Biometeorol_2014_May_16_58(3)_311-323.nxml.txt.nlp	23677421	SENT226	13	13	35	35	paroxetine	CO2	PA450801	4513	0.542
NULL	Front_Endocrinol_(Lausanne)_2013_May_10_4_52.nxml.txt.nlp	23675368	SENT2835	3	3	5	5	rosiglitazone	adiponectin	PA451283	9370	0.542
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Dec_2_5_30.nxml.txt.nlp	17140452	SENT229	14	14	0	0	gentamicin	VAN	PA449753	10318	0.542
NULL	Cell_J_2014_May_25_Summer_16(2)_163-170.nxml.txt.nlp	24567946	SENT21	6	6	4	4	naloxone	CA1	PA450586	759	0.542
NULL	J_Biol_Chem_2008_Sep_19_283(38)_25952-25962.nxml.txt.nlp	18586671	SENT202	20	20	14	14	heparin	TSG-6	PA449855	7130	0.542
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_33-43.nxml.txt.nlp	17912634	SENT122	0	0	15	15	letrozole	TFF1	PA450196	7031	0.542
NULL	Diabetes_2013_Sep_15_62(9)_3275-3281.nxml.txt.nlp	23674605	SENT28	15	15	7	7	chymotrypsin	CTRB2	PA448994	440387	0.542
NULL	Trials_2014_Oct_21_15(1)_400.nxml.txt.nlp	NULL	SENT98	36	36	28	28	morphine	PCA	PA450550	28982	0.542
NULL	Ann_Oncol_2013_Aug_12_24(8)_1994-1999.nxml.txt.nlp	23670096	SENT34	11	11	22	22	tamoxifen	AIB1	PA451581	8202	0.542
NULL	J_Parasitol_Res_2013_Dec_10_2013_430413.nxml.txt.nlp	24386558	SENT101	9	9	20	20	praziquantel	por	PA164764583	64840	0.542
NULL	Mol_Cancer_2010_Apr_23_9_87.nxml.txt.nlp	20416058	SENT166	14	14	12	12	doxorubicin	TRAIL	PA449412	8743	0.542
NULL	Aging_(Albany_NY)_2009_Apr_21_1(4)_402-411.nxml.txt.nlp	20148189	SENT58	23	23	37	37	bleomycin	HCA2	PA448645	139081;55811;338442	0.542
NULL	Cancers_(Basel)_2014_Apr_9_6(2)_829-859.nxml.txt.nlp	24722453	SENT1206	5	5	1	1	docetaxel	RANK	PA449383	8792	0.542
NULL	Aging_(Albany_NY)_2009_Mar_31_1(4)_412-424.nxml.txt.nlp	20195491	SENT46	7	7	15	15	resveratrol	TXNIP		10628	0.542
NULL	Daru_2012_Jul_19_20(1)_4.nxml.txt.nlp	23226721	SENT17	24	24	30	30	indomethacin	BCS	PA449982	617	0.542
NULL	Nat_Commun_2013_Oct_1_4_2516.nxml.txt.nlp	24084631	SENT642	0	0	21	21	losartan	AK4	PA450268	205	0.542
NULL	Mol_Cancer_2010_Dec_20_9_316.nxml.txt.nlp	21172016	SENT147	4	4	13	13	heparin	CCL21	PA449855	6366	0.542
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_May_29_65(Pt_6)_o1409.nxml.txt.nlp	21583252	SENT5	16	16	22	22	curcumin	mol	PA151958596	90527	0.542
NULL	Core_Evid_2009_Jun_15_4_149-158.nxml.txt.nlp	20694071	SENT93	13	13	2	2	etravirine	CD4	PA166014703	920	0.542
NULL	Biomed_Res_Int_2014_Jan_23_2014_129048.nxml.txt.nlp	24575400	SENT49	46	46	37	37	streptomycin	FBS	PA451512	64319;26269	0.542
NULL	J_Ophthalmol_2011_Oct_20_2011_252549.nxml.txt.nlp	22046503	SENT33	12	12	14	14	lipase	LIPC	PA450239	3990	0.542
NULL	Cancers_(Basel)_2011_Apr_1_3(2)_1844-1860.nxml.txt.nlp	24212785	SENT52	8	8	11	11	panitumumab	STEPP	PA162373091	222659	0.542
NULL	Indian_J_Pharm_Sci_2008_Jan-Feb_70(1)_102-105.nxml.txt.nlp	20390092	SENT16	0	0	2	2	domperidone	DOM	PA134711056	6663	0.542
NULL	Amyloid_2014_Sep_11_21(3)_175-184.nxml.txt.nlp	24918964	SENT206	0	0	8	8	anakinra	TTR	PA10799	7276	0.542
NULL	Ann_Neurol_2014_Mar_19_75(2)_186-195.nxml.txt.nlp	24523223	SENT117	32	32	5	5	nadh	MELAS	PA164755085	4219	0.542
NULL	Antimicrob_Agents_Chemother_2014_Feb_58(2)_706-712.nxml.txt.nlp	24217698	SENT169	0	0	20	20	nevirapine	CYP2B6	PA450616	1555	0.542
NULL	Br_J_Cancer_1997_75(10)_1497-1500.nxml.txt.nlp	9166943	SENT0	22	22	20	20	melphalan	TNF-alpha	PA450354	7124	0.542
NULL	Br_J_Cancer_2011_Jun_7_104(12)_1848-1853.nxml.txt.nlp	21610704	SENT164	0	0	23	23	panitumumab	TOX	PA162373091	9760	0.542
NULL	Front_Genet_2014_Nov_14_5_391.nxml.txt.nlp	25452763	SENT434	0	0	21	21	cisplatin	XRCC3	PA449014	7517	0.542
NULL	Arch_Med_Sci_2014_Oct_27_10(5)_1007-1018.nxml.txt.nlp	25395954	SENT225	11	11	0	0	trastuzumab	Yes	PA451743	7525	0.542
NULL	Curr_Microbiol_2012_Dec_28_65(6)_673-678.nxml.txt.nlp	22926720	SENT75	16	16	21	21	amikacin	TMP	PA164744372	2012	0.542
NULL	Exp_Cell_Res_2011_Apr_15_317(7)_1028-1039.nxml.txt.nlp	21237154	SENT109	6	6	4	4	staurosporine	TRAIL	PA165109623	8743	0.542
NULL	Cancer_Med_2013_Dec_22_2(6)_862-871.nxml.txt.nlp	24403259	SENT29	0	0	9	9	everolimus	FKBP-12	PA164746311	2280	0.542
NULL	Scientifica_(Cairo)_2012_Sep_3_2012_757890.nxml.txt.nlp	24278738	SENT121	13	13	17	17	curcumin	p53	PA151958596	7157	0.542
NULL	Diabetes_2009_Apr_9_58(4)_965-974.nxml.txt.nlp	19136651	SENT118	2	2	5	5	nadh	NQO1	PA164755085	1728	0.542
NULL	Breast_Cancer_(Dove_Med_Press)_2013_Aug_22_5_73-78.nxml.txt.nlp	24648760	SENT162	4	4	6	6	tamoxifen	END	PA451581	2022	0.542
NULL	Pharmaceuticals_(Basel)_2011_Nov_11_4(11)_1503-1517.nxml.txt.nlp	NULL	SENT139	0	0	6	6	capsaicin	TRPV1	PA448776	7442	0.542
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT280	9	9	14	14	acetaminophen	iNOS	PA448015	4843	0.542
NULL	N_Z_Vet_J_2010_Jun_7_58(3)_121-129.nxml.txt.nlp	20514085	SENT111	18	18	20	20	ivermectin	MOX	PA450133	26002	0.542
NULL	Cancer_Med_2014_Aug_3_3(4)_787-795.nxml.txt.nlp	24799376	SENT46	26	26	10	10	l-glutamine	CO2	PA10090	4513	0.542
NULL	Ann_Oncol_2009_Aug_20(Suppl_6)_vi41-vi50.nxml.txt.nlp	19617297	SENT268	7	7	32	32	carmustine	IL-2	PA448810	3558	0.542
NULL	Neuroscience_2008_Aug_13_155(2)_556-564.nxml.txt.nlp	18619738	SENT186	22	22	20	20	choline	CDP	PA448976	1523	0.542
NULL	Ann_Neurosci_2012_Oct_19(4)_165-168.nxml.txt.nlp	25205992	SENT121	3	3	9	9	estradiol	spatial	PA449503	219793	0.542
NULL	Cancer_Inform_2014_Apr_2_13_67-76.nxml.txt.nlp	24737930	SENT214	35	35	20	20	nadh	CARS	PA164755085	833	0.542
NULL	Cancer_Cell_Int_2010_May_11_10_16.nxml.txt.nlp	20459793	SENT97	2	2	10	10	cisplatin	ABCC6	PA449014	368	0.542
NULL	F1000Res_2014_Sep_29_3_228.nxml.txt.nlp	25485098	SENT323	13	13	11	11	creatine	GAMT	PA164778930	2593	0.542
NULL	J_Antimicrob_Chemother_2011_Oct_21_66(10)_2240-2247.nxml.txt.nlp	21778195	SENT38	43	43	25	25	ethambutol	DST	PA164784021	667	0.542
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT49	6	6	8	8	resveratrol	IL-6		3569	0.542
NULL	Eur_J_Med_Chem_2014_Dec_17_88_89-100.nxml.txt.nlp	25159123	SENT320	31	31	47	47	l-glutamine	CO2	PA10090	4513	0.542
NULL	Crit_Care_2003_Dec_12_7(1)_63-71.nxml.txt.nlp	12617742	SENT249	34	34	41	41	oxygen	SAPS	PA450744	8935	0.542
NULL	Front_Immunol_2012_Jan_24_3_2.nxml.txt.nlp	22566888	SENT717	15	15	12	12	rituximab	BAFF	PA451261	10673	0.542
NULL	Breast_Cancer_Res_2011_Oct_14_13(5)_R98.nxml.txt.nlp	21999244	SENT227	11	11	27	27	tamoxifen	HOXB13	PA451581	10481	0.542
NULL	Parasit_Vectors_2013_Oct_8_6_290.nxml.txt.nlp	24192424	SENT167	15	15	21	21	nadh	ND5	PA164755085	4540	0.542
NULL	Pharmaceutics_2011_Aug_31_3(3)_601-614.nxml.txt.nlp	24310599	SENT11	0	0	34	34	diclofenac	API	PA449293	5345	0.542
NULL	Environ_Health_Perspect_2005_Mar_113(3)_A178-A181.nxml.txt.nlp	15743707	SENT51	31	31	27	27	ethanol	CO2	PA448073	4513	0.542
NULL	Mol_Biol_Cell_2012_Jun_1_23(11)_2028-2040.nxml.txt.nlp	22496422	SENT228	22	22	38	38	hydrocortisone	CO2	PA449905	4513	0.542
NULL	Pak_J_Med_Sci_2013_Nov-Dec_29(6)_1465-1467.nxml.txt.nlp	24550978	SENT43	22	22	24	24	cyclophosphamide	CTX	PA449165	1593	0.542
NULL	Front_Genet_2013_Aug_30_4_166.nxml.txt.nlp	24009623	SENT124	31	31	21	21	everolimus	FBXW7	PA164746311	55294	0.542
NULL	Mar_Drugs_2009_Aug_26_7(3)_401-434.nxml.txt.nlp	19841722	SENT312	2	2	0	0	s-adenosylmethionine	SAMDC	PA164754994	262	0.542
NULL	Mol_Cancer_2012_Dec_12_11_91.nxml.txt.nlp	23234355	SENT138	28	28	33	33	cetuximab	ANOVA	PA10040	4858	0.542
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Sep_6_64(Pt_10)_o1872.nxml.txt.nlp	21201087	SENT68	30	30	23	23	piperazine	mol	PA450977	90527	0.542
NULL	Tumour_Biol_2011_Oct_16_32(5)_965-976.nxml.txt.nlp	21678067	SENT109	4	4	6	6	urokinase	PLAU	PA451836	5328	0.542
NULL	Cell_Commun_Signal_2009_Aug_10_7_18.nxml.txt.nlp	19664273	SENT525	16	16	22	22	enoxacin	TRBP	PA449462	23054;6896	0.542
NULL	Drugs_Context_2012_Nov_19_2012_212242.nxml.txt.nlp	24432031	SENT391	12	12	32	32	cisplatin	IL-2	PA449014	3558	0.542
NULL	Cancer_Cell_Int_2010_May_11_10_16.nxml.txt.nlp	20459793	SENT97	2	2	8	8	cisplatin	ABCC5	PA449014	10057	0.542
NULL	Oncol_Lett_2013_Oct_24_6(4)_970-976.nxml.txt.nlp	24137447	SENT15	20	20	15	15	methotrexate	ADM	PA450428	133	0.542
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT69	2	2	8	8	curcumin	TRAIL	PA151958596	8743	0.542
NULL	Core_Evid_2008_Jun_3(1)_31-43.nxml.txt.nlp	20694082	SENT4	13	13	15	15	vasopressin	AVP	PA451858	114548;551	0.542
NULL	Acta_Pharmacol_Sin_2010_Jun_4_31(6)_709-717.nxml.txt.nlp	20523342	SENT53	33	33	15	15	repaglinide	IGF2BP2	PA451234	10644	0.542
NULL	Comp_Hepatol_2004_Jan_14_3(Suppl_1)_S37.nxml.txt.nlp	14960189	SENT114	2	2	11	11	thalidomide	CD14	PA451644	929	0.542
NULL	Oncogene_2014_Sep_11_33(37)_4579-4588.nxml.txt.nlp	24662835	SENT104	40	40	13	13	tamoxifen	MAGEA2	PA451581	4101;266740	0.542
NULL	Lab_Invest_2014_May_10_94(5)_503-516.nxml.txt.nlp	24614199	SENT15	3	3	17	17	curcumin	RAGE	PA151958596	177	0.542
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Dec_2_5_30.nxml.txt.nlp	17140452	SENT187	19	19	29	29	mupirocin	CHL	PA164764568	91851	0.542
NULL	Front_Oncol_2013_Aug_5_3_195.nxml.txt.nlp	23936763	SENT55	12	12	14	14	imatinib	DDR2	PA10804	4921	0.542
NULL	Front_Neurosci_2013_Jun_12_7_100.nxml.txt.nlp	23781169	SENT835	0	0	13	13	hyaluronan	TLR4	PA165958431	7099	0.542
NULL	Br_J_Cancer_2009_Jul_7_101(1)_7-11.nxml.txt.nlp	19536093	SENT28	18	18	8	8	imatinib	KIT	PA10804	3815	0.542
NULL	Arthritis_Res_Ther_2006_May_11_8(3)_209.nxml.txt.nlp	16712713	SENT551	3	3	6	6	methotrexate	Yes	PA450428	7525	0.542
NULL	Oncotarget_2013_Dec_19_5(1)_5-6.nxml.txt.nlp	24371157	SENT29	15	15	36	36	tetracycline	p25	PA451640	11076;84516	0.542
NULL	Breast_Cancer_(Auckl)_2011_Oct_9_5_209-226.nxml.txt.nlp	22084574	SENT277	24	24	34	34	tamoxifen	San	PA451581	80218	0.542
NULL	J_Biomed_Biotechnol_2010_Mar_30_2010_307231.nxml.txt.nlp	20369072	SENT36	23	23	15	15	l-glutamine	F12	PA10090	2161	0.542
NULL	J_Breast_Cancer_2013_Sep_30_16(3)_291-299.nxml.txt.nlp	24155758	SENT209	10	10	0	0	mitomycin	FANCF	PA450524	2188	0.542
NULL	Front_Synaptic_Neurosci_2014_Mar_18_6_4.nxml.txt.nlp	24672476	SENT1018	0	0	18	18	fluoxetine	AKT	PA449673	207	0.542
NULL	Aging_(Albany_NY)_2011_Apr_6_3(4)_444-449.nxml.txt.nlp	21483037	SENT22	2	2	0	0	resveratrol	SIRT1		23411	0.542
NULL	Brain_Sci_2014_May_6_4(2)_356-375.nxml.txt.nlp	24961766	SENT227	0	0	15	15	propofol	CA1	PA451141	759	0.542
NULL	ScientificWorldJournal_2013_Sep_19_2013_809891.nxml.txt.nlp	24170983	SENT180	8	8	15	15	ketorolac	CD86	PA450150	942	0.541
NULL	Front_Neurosci_2014_Dec_5_8_398.nxml.txt.nlp	25538552	SENT246	17	17	11	11	glucose	gamma	PA449773	9913	0.541
NULL	Br_J_Cancer_2010_Oct_12_103(8)_1309-1310.nxml.txt.nlp	NULL	SENT15	17	17	15	15	sunitinib	IFN	PA162372840	3439	0.541
NULL	Front_Hum_Neurosci_2013_May_20_7_216.nxml.txt.nlp	23730284	SENT235	13	13	17	17	chlorpromazine	CPZ	PA448964	8532	0.541
NULL	Adv_Hematol_2010_Dec_5_2010_595934.nxml.txt.nlp	21151515	SENT154	7	7	20	20	prasugrel	Yes	PA154410481	7525	0.541
NULL	BMB_Rep_2013_Nov_46(11)_544-549.nxml.txt.nlp	24152910	SENT98	23	23	1	1	thrombin	HMGB1	PA451674	3146	0.541
NULL	Arthritis_Res_Ther_2011_Dec_12_13(6)_R204.nxml.txt.nlp	22151924	SENT72	14	14	0	0	methotrexate	CFB	PA450428	629	0.541
NULL	Biomed_Opt_Express_2012_Aug_1_3(9)_1978-1992.nxml.txt.nlp	23024894	SENT209	32	32	23	23	isoflurane	OCT	PA450106	5362	0.541
NULL	J_Cell_Mol_Med_2014_Nov_12_18(11)_2135-2146.nxml.txt.nlp	25216213	SENT183	19	19	8	8	phenylephrine	AKAP-Lbc	PA450935	11214	0.541
NULL	Cancer_Cell_Int_2010_Sep_1_10_30.nxml.txt.nlp	20809984	SENT143	31	31	25	25	phenol	EGF	PA450913	1950	0.541
NULL	Diabetes_Care_2013_Jun_15_36(6)_1654-1659.nxml.txt.nlp	23250803	SENT8	14	14	24	24	vildagliptin	ET3	PA165958346	1908	0.541
NULL	Oncol_Lett_2014_Nov_14_8(5)_2086-2092.nxml.txt.nlp	25295095	SENT177	8	8	5	5	gemcitabine	Gem	PA449748	51053	0.541
NULL	Ann_Oncol_2014_Sep_13_25(9)_1813-1820.nxml.txt.nlp	24928832	SENT132	27	27	24	24	afatinib	p16	PA165981154	1029	0.541
NULL	Biomed_Res_Int_2014_Jan_29_2014_361020.nxml.txt.nlp	24605326	SENT223	1	1	12	12	staurosporine	CDK4	PA165109623	1019	0.541
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Mar_22_70(Pt_4)_m139.nxml.txt.nlp	24826100	SENT3	20	20	3	3	piperazine	mol	PA450977	90527	0.541
NULL	Crit_Care_2010_Nov_5_14(6)_R200.nxml.txt.nlp	21054850	SENT67	3	3	0	0	vasopressin	AVP	PA451858	114548;551	0.541
NULL	Reprod_Biol_Endocrinol_2003_Apr_11_1_35.nxml.txt.nlp	12747806	SENT82	25	25	9	9	estradiol	aromatase	PA449503	1588	0.541
NULL	Acta_Pharmacol_Sin_2013_Jan_17_34(1)_157-166.nxml.txt.nlp	23247593	SENT205	4	4	31	31	berberine	Bcl-2	PA165860812	596	0.541
NULL	Indian_J_Med_Res_2014_Jul_140(1)_130-137.nxml.txt.nlp	25222788	SENT8	23	23	13	13	ciprofloxacin	CTX	PA449009	1593	0.541
NULL	Oncol_Lett_2013_Feb_3_5(2)_505-510.nxml.txt.nlp	23420812	SENT114	13	13	28	28	cisplatin	PI3K	PA449014	5290	0.541
NULL	Front_Genet_2012_Nov_12_3_235.nxml.txt.nlp	23162568	SENT163	5	5	10	10	methamphetamine	CYP2D6	PA450403	1565	0.541
NULL	Arthritis_Res_Ther_2013_Nov_1_15(6)_R176.nxml.txt.nlp	24456929	SENT101	11	11	3	3	colchicine	MSU	PA449092	593	0.541
NULL	J_Invest_Dermatol_2012_Sep_10_132(9)_2255-2262.nxml.txt.nlp	22572817	SENT139	26	26	29	29	forskolin	ASIP	PA146096022	434;56288	0.541
NULL	J_Korean_Neurosurg_Soc_2013_Oct_31_54(4)_280-288.nxml.txt.nlp	24294450	SENT199	4	4	6	6	acetazolamide	ACZ	PA448018	27445	0.541
NULL	Cardiovasc_Diabetol_2013_Jul_6_12_99.nxml.txt.nlp	23829275	SENT71	2	2	0	0	pentobarbital	STZ	PA450859	6484	0.541
NULL	J_Obes_2010_Jan_14_2010_970865.nxml.txt.nlp	20798864	SENT82	0	0	2	2	metformin	AMPK	PA450395	5563	0.541
NULL	Oncol_Lett_2014_May_11_7(5)_1401-1408.nxml.txt.nlp	24765145	SENT107	14	14	23	23	paclitaxel	HIF-1	PA450761	29072	0.541
NULL	Int_J_Mol_Sci_2014_Jun_2_15(6)_9809-9825.nxml.txt.nlp	24893223	SENT1017	2	2	13	13	physostigmine	SHK	PA450957	23729	0.541
NULL	Clinics_(Sao_Paulo)_2013_Jul_68(7)_1018-1027.nxml.txt.nlp	23917669	SENT139	26	26	22	22	l-cysteine	NAC	PA449173	22861	0.541
NULL	Biomed_Eng_Online_2010_Mar_9_9_15.nxml.txt.nlp	20214774	SENT71	29	29	18	18	paclitaxel	DES	PA450761	1674	0.541
NULL	Curr_Med_Chem_2013_Jan_20(3)_438-447.nxml.txt.nlp	23157636	SENT453	22	22	12	12	olanzapine	FGA	PA450688	2243	0.541
NULL	Ital_J_Pediatr_2013_Sep_17_39_57.nxml.txt.nlp	24044547	SENT82	30	30	43	43	everolimus	LAM	PA164746311	7249;7248	0.541
NULL	Int_J_Fertil_Steril_2012_Dec_17_Oct-Dec_6(3)_185-188.nxml.txt.nlp	24520437	SENT29	7	7	33	33	creatine	ADP	PA164778930	23038	0.541
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT254	23	23	25	25	doxorubicin	SLK	PA449412	9748;2534	0.541
NULL	Oncotarget_2014_Jun_4_5(18)_8284-8305.nxml.txt.nlp	25268740	SENT256	21	21	25	25	hydrocortisone	EGF	PA449905	1950	0.541
NULL	Open_Biochem_J_2014_May_16_8_44-51.nxml.txt.nlp	24894970	SENT56	12	12	14	14	calcidiol	PON1	PA164745614	5444	0.541
NULL	Int_J_Mol_Sci_2010_Sep_13_11(9)_3195-3208.nxml.txt.nlp	20957088	SENT162	4	4	8	8	lipase	AT2	PA450239	186	0.541
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT224	3	3	5	5	doxorubicin	B7-H1	PA449412	29126	0.541
NULL	Ann_Surg_Oncol_2010_Jan_20_17(1)_14-17.nxml.txt.nlp	19841980	SENT104	12	12	29	29	trastuzumab	HER2	PA451743	2064	0.541
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Aug_27_67(Pt_9)_o2494.nxml.txt.nlp	22059044	SENT65	9	9	15	15	coumarin	H11	PA134521193	26353	0.541
NULL	Mol_Biol_Cell_2014_Apr_1_25(7)_965-976.nxml.txt.nlp	24478450	SENT38	11	11	18	18	chloramphenicol	COX	PA448927	1351	0.541
NULL	Int_J_Mol_Sci_2012_Sep_26_13(10)_12268-12286.nxml.txt.nlp	23202898	SENT856	27	27	0	0	heparin	EGF	PA449855	1950	0.541
NULL	Clin_Ophthalmol_2009_Jun_2_3_291-295.nxml.txt.nlp	19668581	SENT112	7	7	9	9	latanoprost	BAK	PA164774763	578	0.541
NULL	Nat_Commun_2014_Nov_19_5_5479.nxml.txt.nlp	25407222	SENT50	23	23	35	35	dextran	YTS	PA449261	8565	0.541
NULL	Cardiovasc_Ultrasound_2010_Nov_28_8_52.nxml.txt.nlp	21110895	SENT115	11	11	18	18	protamine	LAX	PA10366	54900	0.541
NULL	Front_Oncol_2013_Sep_23_3_250.nxml.txt.nlp	24069582	SENT338	14	14	38	38	tamoxifen	STAR	PA451581	6770;2984	0.541
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT128	18	18	1	1	mexiletine	CYP2C9	PA450488	1559	0.541
NULL	Mol_Cancer_2014_Jan_13_13_7.nxml.txt.nlp	24418169	SENT235	6	6	12	12	sorafenib	STAT3	PA7000	6774	0.541
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Jan_22_70(Pt_2)_m63-m64.nxml.txt.nlp	24764827	SENT59	25	25	16	16	ethanol	CA2	PA448073	760	0.541
NULL	Bioengineered_2013_May_1_4(3)_147-152.nxml.txt.nlp	23196745	SENT151	24	24	22	22	nadh	mol	PA164755085	90527	0.541
NULL	Oxid_Med_Cell_Longev_2013_Jun_11_2013_870472.nxml.txt.nlp	23840921	SENT61	7	7	9	9	chloroquine	CD163	PA448948	9332	0.541
NULL	J_Cell_Mol_Med_2014_Nov_12_18(11)_2252-2265.nxml.txt.nlp	25216078	SENT42	17	17	34	34	l-glutamine	CO2	PA10090	4513	0.541
NULL	Eur_J_Clin_Microbiol_Infect_Dis_2012_May_7_31(5)_739-745.nxml.txt.nlp	21822974	SENT20	29	29	19	19	vancomycin	VISA	PA451850	57506	0.541
NULL	Cancers_(Basel)_2013_Jul_4_5(3)_838-856.nxml.txt.nlp	24202322	SENT1097	0	0	6	6	camptothecin	7SK	PA153590860	125050	0.541
NULL	Neural_Plast_2007_Sep_19_2007_26496.nxml.txt.nlp	18301726	SENT35	31	31	16	16	fluoxetine	TIEG1	PA449673	7071	0.541
NULL	Oncotarget_2012_Oct_20_3(10)_1236-1245.nxml.txt.nlp	23100449	SENT87	1	1	5	5	doxorubicin	NGAL	PA449412	3934	0.541
NULL	J_Korean_Med_Sci_2006_Dec_31_21(6)_1037-1040.nxml.txt.nlp	17179683	SENT5	6	6	10	10	amoxicillin	BAM	PA448406	9126	0.541
NULL	Diabetes_2011_Mar_21_60(3)_757-765.nxml.txt.nlp	21282370	SENT302	15	15	17	17	lipase	PTRF	PA450239	284119	0.541
NULL	Oncotarget_2013_Nov_7_4(12)_2550-2566.nxml.txt.nlp	24334291	SENT220	20	20	23	23	rituximab	CHOP	PA451261	1649	0.541
NULL	J_Hematol_Oncol_2008_Oct_1_1_16.nxml.txt.nlp	18828924	SENT116	10	10	12	12	trastuzumab	HER2	PA451743	2064	0.541
NULL	Biomed_Res_Int_2013_Jul_30_2013_754946.nxml.txt.nlp	23984405	SENT166	22	22	32	32	mannitol	CYTB	PA450320	4519	0.541
NULL	Arthritis_Res_Ther_2005_Jan_11_7(2)_R268-R273.nxml.txt.nlp	15743473	SENT108	13	13	35	35	hyaluronidase	PADI4	PA164745713	23569	0.541
NULL	Breast_Cancer_Res_2014_Nov_3_16(Suppl_1)_P44.nxml.txt.nlp	NULL	SENT6	14	14	11	11	trastuzumab	NACT	PA451743	284111	0.541
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Apr_30_65(Pt_5)_m595.nxml.txt.nlp	21583817	SENT56	40	40	18	18	ethanol	mol	PA448073	90527	0.541
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT211	10	10	24	24	tacrolimus	SOCS3	PA451578	9021	0.541
NULL	Clin_Pharmacokinet_2014_Oct_15_53(2)_155-164.nxml.txt.nlp	24127209	SENT191	34	34	17	17	clopidogrel	CYP2C19	PA449053	1557	0.541
NULL	Oncotarget_2014_Aug_31_5(19)_9239-9255.nxml.txt.nlp	25238453	SENT177	16	16	11	11	glutaraldehyde	EGF	PA449777	1950	0.541
NULL	Evid_Based_Complement_Alternat_Med_2014_Sep_3_2014_809083.nxml.txt.nlp	25276218	SENT215	12	12	35	35	berberine	IL-6	PA165860812	3569	0.541
NULL	Chin_J_Cancer_2012_Apr_31(4)_178-184.nxml.txt.nlp	22237038	SENT78	8	8	10	10	niclosamide	S100A4	PA165958408	6275	0.541
NULL	Int_J_Breast_Cancer_2012_Nov_2_2012_217185.nxml.txt.nlp	22295242	SENT203	11	11	21	21	olaparib	EGFR		1956	0.541
NULL	Int_J_Mol_Sci_2014_Sep_2_15(9)_15512-15529.nxml.txt.nlp	25184950	SENT36	3	3	9	9	resveratrol	IL-10		3586	0.541
NULL	eLife_2013_Nov_5_2_e00924.nxml.txt.nlp	24192035	SENT359	17	17	6	6	doxycycline	IMP1	PA449415	81502	0.541
NULL	Cancer_Cell_Int_2013_Jun_26_13_63.nxml.txt.nlp	23800022	SENT115	0	0	14	14	genistein	XIAP	PA165109660	331	0.541
NULL	Front_Genet_2013_Aug_29_4_163.nxml.txt.nlp	24009622	SENT51	11	11	5	5	ethanol	ABCG2	PA448073	9429	0.541
NULL	Front_Neurol_2014_Sep_11_5_173.nxml.txt.nlp	25309501	SENT41	2	2	33	33	hyaluronan	CD44	PA165958431	960	0.541
NULL	Breast_Cancer_Res_2012_Mar_19_14(2)_R50.nxml.txt.nlp	22429397	SENT225	20	20	23	23	choline	DAG	PA448976	1605	0.541
NULL	Depress_Res_Treat_2012_Dec_18_2012_752563.nxml.txt.nlp	23320155	SENT49	1	1	7	7	fluoxetine	AKT	PA449673	207	0.541
NULL	Clin_Dev_Immunol_2013_Sep_30_2013_238035.nxml.txt.nlp	24194771	SENT35	19	19	21	21	cyclophosphamide	CTX	PA449165	1593	0.541
NULL	Exp_Ther_Med_2014_Dec_30_8(6)_1813-1818.nxml.txt.nlp	25371737	SENT134	16	16	2	2	rosiglitazone	glypican	PA451283	2817	0.541
NULL	Cytotherapy_2014_Jul_16(7)_893-905.nxml.txt.nlp	24794181	SENT63	23	23	40	40	l-glutamine	CO2	PA10090	4513	0.541
NULL	Br_J_Haematol_2014_Mar_13_164(1)_811-821.nxml.txt.nlp	24328678	SENT149	3	3	0	0	lenalidomide	Aiolos	PA162363968	22806	0.541
NULL	Indian_J_Anaesth_2014_Sep-Oct_58(5)_658-664.nxml.txt.nlp	25535432	SENT178	12	12	6	6	aprotinin	BART	PA448472	7809;23568	0.541
NULL	Br_J_Cancer_2010_Jan_5_102(1)_80-86.nxml.txt.nlp	19920817	SENT123	27	27	29	29	bevacizumab	IFN	PA130232992	3439	0.541
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_105-115.nxml.txt.nlp	17912640	SENT72	9	9	13	13	letrozole	HER2	PA450196	2064	0.541
NULL	Evid_Based_Complement_Alternat_Med_2011_Feb_14_2011_429843.nxml.txt.nlp	21869897	SENT8	12	12	5	5	ethanol	PC6	PA448073	5125	0.541
NULL	Front_Behav_Neurosci_2010_Apr_5_4_14.nxml.txt.nlp	20407577	SENT147	25	25	36	36	doxycycline	San	PA449415	80218	0.541
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Dec_2_5_30.nxml.txt.nlp	17140452	SENT194	19	19	29	29	mupirocin	CHL	PA164764568	91851	0.541
NULL	Breast_Cancer_Res_2010_Nov_16_12(6)_R96.nxml.txt.nlp	21080941	SENT184	0	0	13	13	lapatinib	HRG	PA152241907	3084;3273	0.541
NULL	Mol_Cancer_2008_Mar_26_7_27.nxml.txt.nlp	18366759	SENT315	6	6	1	1	etoposide	p53	PA449552	7157	0.541
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT106	35	35	39	39	streptomycin	M-CSF	PA451512	1435	0.541
NULL	N_Z_Vet_J_2010_Jun_7_58(3)_121-129.nxml.txt.nlp	20514085	SENT168	4	4	15	15	albendazole	MOX	PA164746058	26002	0.541
NULL	Environ_Sci_Technol_2013_Aug_20_47(16)_9014-9027.nxml.txt.nlp	23931701	SENT920	1	1	8	8	ethanol	P11	PA448073	8909;6281	0.541
NULL	Aesthet_Surg_J_2013_Mar_33(3)_400-408.nxml.txt.nlp	23439063	SENT19	24	24	27	27	lipase	CD36	PA450239	948	0.541
NULL	Iran_J_Pharm_Res_2013_Winter_12(1)_141-146.nxml.txt.nlp	24250582	SENT110	10	10	16	16	rifampin	NAC	PA451250	22861	0.541
NULL	J_Geriatr_Cardiol_2012_Jun_9(2)_172-179.nxml.txt.nlp	22916065	SENT95	18	18	21	21	paraformaldehyde	mol	PA450790	90527	0.541
NULL	Cancer_Med_2014_Oct_25_3(5)_1099-1111.nxml.txt.nlp	24961511	SENT257	32	32	20	20	cisplatin	VEGFC	PA449014	7424	0.541
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT143	31	31	22	22	vinorelbine	MVP	PA451881	9961	0.541
NULL	Case_Rep_Pathol_2014_Sep_9_2014_301780.nxml.txt.nlp	25295208	SENT33	25	25	11	11	thyroglobulin	p63	PA164754910	8626	0.541
NULL	J_Biomed_Sci_2014_Feb_3_21(1)_10.nxml.txt.nlp	24490900	SENT150	20	20	24	24	alendronate	M-CSF	PA448082	1435	0.541
NULL	Nat_Med_2011_Dec_11_18(1)_74-82.nxml.txt.nlp	22157681	SENT269	16	16	22	22	gefitinib	APAF-1	PA131301952	317	0.541
NULL	Crit_Care_2006_Feb_3_10(1)_R24.nxml.txt.nlp	16469128	SENT131	11	11	35	35	heparin	MARS	PA449855	4141	0.541
NULL	J_Headache_Pain_2011_Apr_5_12(2)_127-133.nxml.txt.nlp	21298314	SENT97	27	27	35	35	amitriptyline	CSMT	PA448385	1442	0.541
NULL	Arthritis_Res_Ther_2006_Mar_22_8(3)_R62.nxml.txt.nlp	16563187	SENT292	2	2	5	5	fluorescein	ICOS	PA164746009	29851;1493	0.541
NULL	Breast_Cancer_Res_2014_May_22_16(3)_R49.nxml.txt.nlp	24887419	SENT185	8	8	0	0	estradiol	ANOVA	PA449503	4858	0.541
NULL	J_Hum_Kinet_2011_Dec_25_30_65-73.nxml.txt.nlp	23487396	SENT163	40	40	31	31	creatine	IL-6	PA164778930	3569	0.541
NULL	Br_J_Cancer_2012_Jan_31_106(3)_482-489.nxml.txt.nlp	22233925	SENT255	12	12	5	5	carboplatin	PEO1	PA448803	56652	0.541
NULL	Iran_J_Basic_Med_Sci_2013_Apr_16(4)_610-614.nxml.txt.nlp	24250937	SENT109	2	2	0	0	coumarin	CYP2A6	PA134521193	1548	0.541
NULL	J_Young_Pharm_2010_Oct-Dec_2(4)_379-383.nxml.txt.nlp	21264098	SENT2	9	9	7	7	carbamazepine	P-gp	PA448785	5243	0.541
NULL	Mucosal_Immunol_2013_May_19_6(3)_474-484.nxml.txt.nlp	22990623	SENT62	26	26	30	30	budesonide	CXCR2	PA448681	3579	0.541
NULL	J_Hematol_Oncol_2011_Mar_26_4_11.nxml.txt.nlp	21439076	SENT117	22	22	0	0	camptothecin	Gem	PA153590860	51053	0.541
NULL	Aging_(Albany_NY)_2012_Jul_31_4(7)_499-508.nxml.txt.nlp	22868943	SENT47	6	6	13	13	resveratrol	ANOVA		4858	0.541
NULL	Arch_Med_Sci_2011_Dec_31_7(6)_977-983.nxml.txt.nlp	22328880	SENT126	3	3	5	5	heparin	PAPP-A	PA449855	5069	0.541
NULL	J_Cell_Sci_2012_Jun_15_125(12)_2940-2953.nxml.txt.nlp	22366451	SENT292	24	24	16	16	imatinib	PP2	PA10804	4888	0.541
NULL	CNS_Drugs_2013_Aug_23_27(11)_943-953.nxml.txt.nlp	23975660	SENT148	16	16	12	12	guanfacine	ATX	PA449825	5168;23049	0.541
NULL	Int_J_Environ_Res_Public_Health_2010_Apr_30_7(4)_1448-1466.nxml.txt.nlp	20617039	SENT175	14	14	11	11	ethanol	DRD2	PA448073	1813	0.541
NULL	Drugs_Aging_2013_Oct_26_30(12)_999-1008.nxml.txt.nlp	24163280	SENT113	12	12	0	0	gabapentin	ADP	PA449720	23038	0.541
NULL	F1000Res_2013_Feb_28_2_65.nxml.txt.nlp	24358861	SENT364	11	11	20	20	naloxone	TLR4	PA450586	7099	0.541
NULL	Breast_Cancer_Res_2007_Dec_20_9(Suppl_2)_S22.nxml.txt.nlp	NULL	SENT86	24	24	28	28	tamoxifen	STAR	PA451581	6770;2984	0.541
NULL	Gene_Ther_2010_Apr_26_17(4)_531-540.nxml.txt.nlp	19940864	SENT62	23	23	45	45	l-glutamine	CO2	PA10090	4513	0.541
NULL	Summit_on_Translat_Bioinforma_2009_Mar_1_2009_124-128.nxml.txt.nlp	21347183	SENT70	18	18	22	22	thioguanine	TPMT	PA451663	7172	0.541
NULL	Nat_Chem_Biol_2013_Feb_2_9(2)_97-104.nxml.txt.nlp	23201900	SENT309	17	17	11	11	clonazepam	PKD1	PA449050	5310	0.541
NULL	Exp_Hematol_Oncol_2013_Jul_1_2_17.nxml.txt.nlp	23815814	SENT72	12	12	20	20	doxorubicin	ABCB5	PA449412	340273	0.541
NULL	AIDS_Res_Treat_2011_Jun_7_2011_354908.nxml.txt.nlp	21716719	SENT216	6	6	14	14	tenofovir	OAT3	PA10204	9376	0.541
NULL	Clinics_(Sao_Paulo)_2011_Dec_66(12)_2141-2149.nxml.txt.nlp	22189742	SENT54	8	8	34	34	indomethacin	NNT	PA449982	23530	0.541
NULL	Inorg_Chem_2014_Feb_17_53(4)_2058-2067.nxml.txt.nlp	24476103	SENT330	17	17	40	40	l-glutamine	CO2	PA10090	4513	0.541
NULL	J_Cell_Sci_2014_May_1_127(9)_1869-1874.nxml.txt.nlp	24790221	SENT145	16	16	35	35	l-glutamine	CO2	PA10090	4513	0.541
NULL	Nat_Commun_2011_Oct_18_2_504.nxml.txt.nlp	22009036	SENT103	3	3	18	18	nimodipine	ANOVA	PA450633	4858	0.541
NULL	J_Invest_Dermatol_2014_Jun_17_134(6)_1589-1598.nxml.txt.nlp	24499735	SENT75	8	8	10	10	lipase	ATGL	PA450239	57104	0.541
NULL	Acta_Pharmacol_Sin_2009_Jul_22_30(7)_956-964.nxml.txt.nlp	19543298	SENT135	1	1	5	5	atorvastatin	SLC22A1	PA448500	6580	0.541
NULL	Contemp_Clin_Dent_2013_Apr-Jun_4(2)_156-161.nxml.txt.nlp	24015002	SENT133	22	22	17	17	chlorhexidine	SRP	PA164776863	90226	0.541
NULL	Front_Public_Health_2013_Nov_14_1_50.nxml.txt.nlp	24350219	SENT191	4	4	15	15	hydrocortisone	TREM-1	PA449905	54210	0.541
NULL	Ann_N_Y_Acad_Sci_2012_Aug_30_1264(1)_49-63.nxml.txt.nlp	22548651	SENT145	14	14	22	22	glucose	BDNF	PA449773	627	0.541
NULL	Front_Neurosci_2012_May_30_6_77.nxml.txt.nlp	22661925	SENT252	28	28	16	16	ethanol	DCX	PA448073	1641	0.541
NULL	Arthritis_Res_Ther_2005_Dec_1_7(1)_R149-R155.nxml.txt.nlp	15642135	SENT92	23	23	11	11	infliximab	OPG	PA452639	690	0.541
NULL	Int_J_Nanomedicine_2012_Sep_14_7_4943-4951.nxml.txt.nlp	23028222	SENT119	9	9	12	12	fluorescein	IFN	PA164746009	3439	0.541
NULL	Pharmaceuticals_(Basel)_2013_Apr_3_6(4)_480-499.nxml.txt.nlp	24276119	SENT145	5	5	7	7	fluoxetine	GluN2B	PA449673	2904	0.541
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT216	26	26	20	20	cisplatin	p53	PA449014	7157	0.541
NULL	Diabetes_2011_Jul_20_60(7)_1990-1999.nxml.txt.nlp	21617181	SENT188	20	20	9	9	geldanamycin	Hsp90	PA152031327	3320	0.541
NULL	Int_J_Alzheimers_Dis_2012_Feb_15_2012_381974.nxml.txt.nlp	22506133	SENT110	7	7	45	45	phenol	CO2	PA450913	4513	0.541
NULL	Open_Biochem_J_2011_Sep_23_5_45-51.nxml.txt.nlp	21966325	SENT122	17	17	37	37	diclofenac	JNK	PA449293	5599	0.541
NULL	Br_J_Cancer_2012_Jun_5_106(12)_1960-1966.nxml.txt.nlp	22596237	SENT161	37	37	25	25	saracatinib	PC3		57332;7832;5122	0.541
NULL	Cancer_Inform_2008_Apr_23_6_381-387.nxml.txt.nlp	19259418	SENT52	6	6	4	4	ribavirin	IFN	PA451241	3439	0.541
NULL	J_Cell_Biol_2001_Aug_6_154(3)_599-610.nxml.txt.nlp	11481345	SENT161	20	20	17	17	doxycycline	ARNO	PA449415	9266	0.541
NULL	Indian_J_Pharmacol_2012_Sep-Oct_44(5)_651-653.nxml.txt.nlp	23112433	SENT18	14	14	26	26	tenofovir	CD4	PA10204	920	0.541
NULL	Clin_Ophthalmol_2012_Sep_5_6_1433-1440.nxml.txt.nlp	23055659	SENT153	27	27	15	15	timolol	BAK	PA451690	578	0.541
NULL	Environ_Health_Perspect_2005_Aug_12_113(8)_1100-1107.nxml.txt.nlp	16079085	SENT117	11	11	8	8	thalidomide	DES	PA451644	1674	0.541
NULL	Cell_Death_Dis_2013_Jun_27_4(6)_e694.nxml.txt.nlp	23807223	SENT51	21	21	48	48	chloroquine	p38	PA448948	10598;1432;7965	0.541
NULL	Cardiovasc_Diabetol_2013_May_30_12_81.nxml.txt.nlp	23721170	SENT52	32	32	26	26	acarbose	GLP-1	PA448010	100125288	0.54
NULL	J_Gen_Physiol_2003_Nov_122(5)_621-639.nxml.txt.nlp	14581586	SENT46	35	35	7	7	gentamicin	CO2	PA449753	4513	0.54
NULL	Am_J_Trop_Med_Hyg_2009_Jan_80(1)_126-132.nxml.txt.nlp	19141850	SENT53	18	18	8	8	artesunate	SRM	PA165111697	6723;6725	0.54
NULL	Br_J_Cancer_2011_Jun_7_104(12)_1941-1944.nxml.txt.nlp	NULL	SENT25	6	6	18	18	vatalanib	VEGF-A	PA7001	7422	0.54
NULL	J_Carcinog_2014_Feb_20_13_4.nxml.txt.nlp	24737952	SENT43	3	3	8	8	panitumumab	KRAS	PA162373091	3845	0.54
NULL	Patient_Prefer_Adherence_2013_Apr_26_7_369-377.nxml.txt.nlp	23641151	SENT2	0	0	7	7	ustekinumab	IL-23	PA166048654	51561	0.54
NULL	Curr_Neuropharmacol_2014_Jul_12(4)_365-379.nxml.txt.nlp	25342944	SENT534	17	17	5	5	citalopram	5-HT2B	PA449015	3357	0.54
NULL	J_Hematol_Oncol_2008_Aug_11_1_11.nxml.txt.nlp	18694493	SENT94	8	8	21	21	temsirolimus	IFN	PA164746890	3439	0.54
NULL	J_Carcinog_2014_Nov_27_13_13.nxml.txt.nlp	25525412	SENT90	16	16	18	18	cetuximab	KRAS	PA10040	3845	0.54
NULL	Braz_J_Med_Biol_Res_2012_Jul_20_45(10)_935-941.nxml.txt.nlp	22801415	SENT146	14	14	31	31	pioglitazone	adiponectin	PA450970	9370	0.54
NULL	Indian_J_Ophthalmol_2007_Nov-Dec_55(6)_483b-486.nxml.txt.nlp	17951918	SENT62	21	21	9	9	bevacizumab	PED	PA130232992	8682	0.54
NULL	Exp_Mol_Med_2012_Jun_30_44(6)_403-411.nxml.txt.nlp	22510730	SENT78	0	0	6	6	anastrozole	PSD-95	PA448432	1742	0.54
NULL	Braz_J_Med_Biol_Res_2014_Oct_14_47(12)_1068-1074.nxml.txt.nlp	25387674	SENT105	23	23	21	21	taurine	HCS	PA451590	3141;54205	0.54
NULL	Br_J_Cancer_2009_Jun_2_100(11)_1739-1745.nxml.txt.nlp	19436299	SENT168	18	18	23	23	everolimus	FDG	PA164746311	23583	0.54
NULL	J_Biol_Chem_2011_Sep_30_286(39)_34271-34285.nxml.txt.nlp	21784845	SENT139	10	10	21	21	collagenase	PHEX	PA449107	5251	0.54
NULL	Int_J_Biol_Sci_2014_Jul_2_10(7)_757-770.nxml.txt.nlp	25013383	SENT254	3	3	5	5	doxorubicin	DAC	PA449412	13	0.54
NULL	EMBO_Mol_Med_2013_Aug_8_5(8)_1227-1246.nxml.txt.nlp	23836498	SENT259	22	22	20	20	nadh	mol	PA164755085	90527	0.54
NULL	J_Headache_Pain_2013_Apr_10_14(1)_33.nxml.txt.nlp	23574808	SENT41	12	12	4	4	capsaicin	CO2	PA448776	4513	0.54
NULL	Acta_Histochem_Cytochem_2013_Dec_28_46(6)_187-197.nxml.txt.nlp	24610966	SENT117	9	9	5	5	pilocarpine	AQP5	PA450962	362	0.54
NULL	Hum_Mol_Genet_2013_Nov_15_22(22)_4602-4615.nxml.txt.nlp	23814040	SENT158	15	15	5	5	l-cysteine	TRMU	PA449173	55687	0.54
NULL	Mol_Vis_2010_Oct_7_16_1982-1995.nxml.txt.nlp	21031024	SENT381	4	4	7	7	bevacizumab	VEGF-A	PA130232992	7422	0.54
NULL	J_Cell_Biol_2002_Sep_16_158(6)_1051-1066.nxml.txt.nlp	12235123	SENT86	7	7	21	21	etoposide	DEDD	PA449552	9191	0.54
NULL	Clin_Med_Insights_Cardiol_2011_Jun_28_5_55-66.nxml.txt.nlp	21792345	SENT90	5	5	22	22	bucindolol	BEST	PA165945764	7439	0.54
NULL	J_Headache_Pain_2009_Jun_27_10(3)_177-185.nxml.txt.nlp	19326184	SENT15	35	35	21	21	ethanol	ALDH2	PA448073	217	0.54
NULL	Mol_Vis_2012_Apr_11_18_901-908.nxml.txt.nlp	22539869	SENT3	3	3	13	13	curcumin	HO-1	PA151958596	3162	0.54
NULL	J_Biol_Chem_2008_Nov_14_283(46)_31679-31689.nxml.txt.nlp	18755684	SENT234	16	16	5	5	iron	FTL	PA450087	2512	0.54
NULL	ISRN_Neurosci_2013_Dec_8_2013_152567.nxml.txt.nlp	24967301	SENT61	28	28	16	16	isoflurane	CO2	PA450106	4513	0.54
NULL	Breast_Cancer_Res_2001_Apr_2_3(4)_253-263.nxml.txt.nlp	11434876	SENT171	39	39	0	0	verapamil	ADM	PA451868	133	0.54
NULL	Br_J_Cancer_2010_Jan_5_102(1)_97-103.nxml.txt.nlp	19904270	SENT184	12	12	10	10	staurosporine	STA	PA165109623	2010;2656	0.54
NULL	Clin_Ophthalmol_2008_Dec_2(4)_821-828.nxml.txt.nlp	19668436	SENT142	12	12	25	25	nifedipine	ERG	PA450631	2078	0.54
NULL	Cardiovasc_Diabetol_2013_Jun_18_12_90.nxml.txt.nlp	23777457	SENT114	15	15	10	10	metformin	GLP-1	PA450395	100125288	0.54
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT138	18	18	15	15	methotrexate	MSH2	PA450428	4436	0.54
NULL	Appl_Plant_Sci_2015_Jan_5_3(1)_apps_1400086.nxml.txt.nlp	25606353	SENT98	24	24	2	2	vancomycin	ANOVA	PA451850	4858	0.54
NULL	Br_J_Cancer_2009_May_19_100(10)_1540-1548.nxml.txt.nlp	19384300	SENT103	8	8	6	6	trypsin	TATI	PA451806	6690	0.54
NULL	CNS_Drugs_2013_Aug_20_27(12)_1081-1092.nxml.txt.nlp	23959815	SENT156	9	9	0	0	lisdexamfetamine	ATX	PA164748975	5168;23049	0.54
NULL	Oncotarget_2014_Nov_2_5(21)_10222-10236.nxml.txt.nlp	25400118	SENT98	15	15	18	18	trastuzumab	HER2	PA451743	2064	0.54
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT2215	1	1	14	14	decitabine	TSA	PA164749631	7001	0.54
NULL	Nat_Chem_Biol_2009_Apr_22_5(4)_244-250.nxml.txt.nlp	19234452	SENT153	18	18	47	47	l-glutamine	CO2	PA10090	4513	0.54
NULL	Front_Genet_2012_Nov_12_3_235.nxml.txt.nlp	23162568	SENT2	12	12	15	15	methamphetamine	CYP2D6	PA450403	1565	0.54
NULL	Aging_(Albany_NY)_2013_Feb_21_5(2)_94-95.nxml.txt.nlp	23518473	SENT6	14	14	26	26	resveratrol	SIRT1		23411	0.54
NULL	Pharmaceuticals_(Basel)_2014_Sep_4_7(9)_913-942.nxml.txt.nlp	25192192	SENT113	21	21	3	3	nadh	AMPK	PA164755085	5563	0.54
NULL	Ecancermedicalscience_2009_Apr_2_3_141.nxml.txt.nlp	22276006	SENT27	29	29	25	25	bortezomib	DR4	PA10252	8797	0.54
NULL	J_Biol_Chem_2013_Nov_15_288(46)_33049-33059.nxml.txt.nlp	24089524	SENT146	20	20	11	11	nicotine	FBS	PA450626	64319;26269	0.54
NULL	Diabetes_Care_2012_Aug_14_35(8)_1701-1707.nxml.txt.nlp	22584136	SENT167	10	10	3	3	lipase	FABP4	PA450239	2167	0.54
NULL	Mol_Biol_Cell_2012_May_15_23(10)_1928-1942.nxml.txt.nlp	22438580	SENT252	18	18	15	15	galactose	GAL	PA449725	51083	0.54
NULL	Adv_Ther_2014_Oct_1_31(10)_1045-1058.nxml.txt.nlp	25269854	SENT262	5	5	12	12	olopatadine	OPT	PA450698	51430	0.54
NULL	J_Int_Soc_Sports_Nutr_2014_Aug_13_11_38.nxml.txt.nlp	25132809	SENT42	19	19	6	6	creatine	MSTN	PA164778930	2660	0.54
NULL	Endocrinology_2015_Jan_6_156(1)_24-31.nxml.txt.nlp	25375036	SENT7	17	17	19	19	diethylstilbestrol	DES	PA449307	1674	0.54
NULL	J_Breast_Cancer_2013_Jun_28_16(2)_133-137.nxml.txt.nlp	23843843	SENT95	0	0	45	45	mitomycin	p27	PA450524	5715;10534	0.54
NULL	Iran_J_Pharm_Res_2013_Summer_12(3)_457-469.nxml.txt.nlp	24250652	SENT141	6	6	17	17	indomethacin	spatial	PA449982	219793	0.54
NULL	J_Allergy_(Cairo)_2011_Oct_24_2011_457169.nxml.txt.nlp	22121382	SENT212	0	0	16	16	salmeterol	IL-6	PA451300	3569	0.54
NULL	Mol_Cancer_2013_Sep_11_12_104.nxml.txt.nlp	24025152	SENT315	3	3	0	0	gemcitabine	STAT3	PA449748	6774	0.54
NULL	Br_J_Cancer_2013_Jul_23_109(2)_351-359.nxml.txt.nlp	23799854	SENT11	7	7	4	4	paclitaxel	BLT2	PA450761	56413	0.54
NULL	Front_Physiol_2013_Dec_24_4_386.nxml.txt.nlp	24399968	SENT318	2	2	0	0	glibenclamide	SUR1	PA449782	6833	0.54
NULL	Evid_Based_Complement_Alternat_Med_2014_Sep_3_2014_809083.nxml.txt.nlp	25276218	SENT128	12	12	14	14	berberine	IRAK1	PA165860812	3654	0.54
NULL	J_Carcinog_2011_Mar_24_10_8.nxml.txt.nlp	21483656	SENT42	28	28	16	16	spermine	ODC	PA164781199	4953;89874	0.54
NULL	Front_Physiol_2012_Oct_11_3_402.nxml.txt.nlp	23087650	SENT330	16	16	14	14	l-glutamine	EGF	PA10090	1950	0.54
NULL	Ann_Oncol_2011_Jan_13_22(1)_215-223.nxml.txt.nlp	20627875	SENT134	2	2	12	12	ifosfamide	ETO	PA449964	862	0.54
NULL	Arthritis_Res_Ther_2005_Feb_18_7(3)_R476-R484.nxml.txt.nlp	15899034	SENT238	13	13	4	4	thrombin	IL-6	PA451674	3569	0.54
NULL	J_Cancer_Prev_2014_Jun_19(2)_111-117.nxml.txt.nlp	25337579	SENT154	10	10	7	7	doxorubicin	ADM	PA449412	133	0.54
NULL	J_Antimicrob_Chemother_2014_Feb_3_69(2)_343-348.nxml.txt.nlp	24092655	SENT48	24	24	4	4	tetracycline	FUS	PA451640	2521	0.54
NULL	EMBO_Mol_Med_2013_Mar_21_5(3)_332-343.nxml.txt.nlp	23427196	SENT178	0	0	6	6	mupirocin	IARS	PA164764568	3376	0.54
NULL	Oncotarget_2011_Sep_9_2(9)_658-668.nxml.txt.nlp	21911919	SENT57	27	27	16	16	daunorubicin	HO-1	PA449212	3162	0.54
NULL	Crit_Care_2010_Sep_21_14(5)_R169.nxml.txt.nlp	20858239	SENT146	17	17	0	0	phenylephrine	AVP	PA450935	114548;551	0.54
NULL	J_Cell_Biol_2008_Jul_14_182(1)_157-169.nxml.txt.nlp	18606851	SENT323	3	3	3	3	pp2	PP2		4888	0.54
NULL	J_Immune_Based_Ther_Vaccines_2010_Nov_24_8_8.nxml.txt.nlp	21106069	SENT38	24	24	48	48	l-glutamine	CO2	PA10090	4513	0.54
NULL	Cardiovasc_Ultrasound_2007_Nov_22_5_42.nxml.txt.nlp	18031588	SENT293	17	17	12	12	dipyridamole	FFR	PA449367	738	0.54
NULL	Arthritis_Res_Ther_2014_Jul_24_16(4)_R157.nxml.txt.nlp	25059342	SENT20	1	1	7	7	bleomycin	IL-6	PA448645	3569	0.54
NULL	Ann_Dermatol_2014_Apr_30_26(2)_221-230.nxml.txt.nlp	24882978	SENT48	0	0	12	12	imiquimod	IL-17	PA449972	3605	0.54
NULL	Mar_Drugs_2010_Mar_15_8(3)_629-657.nxml.txt.nlp	20411119	SENT209	24	24	14	14	l-arginine	PP1	PA448478	5540;5464	0.54
NULL	Clin_Med_Insights_Oncol_2011_Mar_16_5_35-43.nxml.txt.nlp	21499557	SENT46	19	19	15	15	trabectedin	p53	PA165958349	7157	0.54
NULL	Int_J_Biol_Sci_2012_Sep_6_8(8)_1109-1120.nxml.txt.nlp	22991499	SENT209	10	10	4	4	sunitinib	IFN	PA162372840	3439	0.54
NULL	Br_J_Haematol_2014_Mar_13_164(1)_811-821.nxml.txt.nlp	24328678	SENT148	2	2	8	8	lenalidomide	CRBN	PA162363968	51185	0.54
NULL	Drug_Des_Devel_Ther_2014_Sep_18_8_1467-1479.nxml.txt.nlp	25258515	SENT256	29	29	16	16	norfloxacin	BCS	PA450654	617	0.54
NULL	Diabetes_2011_May_23_60(5)_1519-1527.nxml.txt.nlp	21430087	SENT26	18	18	20	20	lipase	HSL	PA450239	3991	0.54
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT287	2	2	7	7	resveratrol	p53		7157	0.54
NULL	Mol_Cancer_2006_Sep_5_5_34.nxml.txt.nlp	16953886	SENT154	19	19	35	35	gentamicin	CO2	PA449753	4513	0.54
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT151	16	16	9	9	simvastatin	survivin	PA451363	332	0.54
NULL	Pharmaceuticals_(Basel)_2012_Feb_2_5(2)_114-132.nxml.txt.nlp	24288084	SENT565	5	5	7	7	capsaicin	TRPV1	PA448776	7442	0.54
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_127043.nxml.txt.nlp	23227093	SENT231	5	5	13	13	furafylline	CYP2C19	PA452614	1557	0.54
NULL	Ann_Dermatol_2014_Dec_26_26(6)_706-712.nxml.txt.nlp	25473222	SENT87	26	26	10	10	isotretinoin	EPO	PA450128	7076;8288;2056	0.54
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jul_25_65(Pt_8)_m985.nxml.txt.nlp	21583427	SENT61	26	26	14	14	ethanol	NO3	PA448073	4681	0.54
NULL	Cancer_Cell_Int_2013_Jun_26_13_63.nxml.txt.nlp	23800022	SENT210	0	0	17	17	genistein	NOXA	PA165109660	5366	0.54
NULL	Cancer_Causes_Control_2013_Aug_18_24(8)_1605-1614.nxml.txt.nlp	23775025	SENT64	3	3	32	32	cyclophosphamide	ABCB1	PA449165	5243	0.54
NULL	Front_Neurosci_2014_Dec_5_8_398.nxml.txt.nlp	25538552	SENT167	22	22	11	11	oxygen	gamma	PA450744	9913	0.54
NULL	Mol_Cancer_2008_Oct_23_7_82.nxml.txt.nlp	18947424	SENT592	2	2	14	14	simvastatin	CHOP	PA451363	1649	0.54
NULL	J_Clin_Biochem_Nutr_2007_Nov_30_41(3)_224-230.nxml.txt.nlp	18299720	SENT215	31	31	12	12	urea	DBP	PA451831	3295;1628;2638	0.54
NULL	Cell_Div_2013_May_16_8_7.nxml.txt.nlp	23680298	SENT79	11	11	8	8	doxycycline	PACT	PA449415	8575;5930	0.54
NULL	Neuroimage_Clin_2013_Sep_3_3_242-248.nxml.txt.nlp	24273709	SENT294	30	30	24	24	topiramate	PRG	PA451728	5544	0.54
NULL	Anesth_Essays_Res_2012_Jan-Jun_6(1)_84-86.nxml.txt.nlp	NULL	SENT45	25	25	14	14	mannitol	CO2	PA450320	4513	0.54
NULL	J_Cell_Biol_1999_Dec_27_147(7)_1493-1502.nxml.txt.nlp	10613907	SENT153	11	11	6	6	galactose	ANT-1	PA449725	24148	0.54
NULL	Curr_Nutr_Rep_2014_Apr_27_3(3)_204-212.nxml.txt.nlp	25101217	SENT254	10	10	16	16	metformin	CKIepsilon	PA450395	1454	0.54
NULL	Crit_Care_2011_Nov_16_15(6)_R271.nxml.txt.nlp	22087790	SENT164	2	2	8	8	nitroprusside	Yes	PA451406	7525	0.54
NULL	Front_Hum_Neurosci_2010_Nov_22_4_219.nxml.txt.nlp	21152340	SENT67	30	30	21	21	cladribine	DMT	PA449027	2039	0.54
NULL	J_Cell_Biol_2000_Dec_11_151(6)_1295-1304.nxml.txt.nlp	11121443	SENT503	32	32	22	22	creatine	p53	PA164778930	7157	0.54
NULL	J_Oncol_2009_Mar_24_2009_491985.nxml.txt.nlp	19325924	SENT172	0	0	2	2	genistein	CXCR4	PA165109660	7852	0.54
NULL	Curr_Neuropharmacol_2014_Mar_12(2)_186-192.nxml.txt.nlp	24669211	SENT33	40	40	46	46	l-methionine	Met	PA450423	79811	0.54
NULL	Clin_Psychopharmacol_Neurosci_2011_Apr_30_9(1)_29-35.nxml.txt.nlp	23430964	SENT173	15	15	7	7	methylphenidate	Gen	PA450464	348654	0.54
NULL	Clin_Ophthalmol_2010_Oct_5_4_1137-1143.nxml.txt.nlp	20957061	SENT13	14	14	27	27	bimatoprost	BAK	PA164748867	578	0.54
NULL	Curr_Oncol_2009_Jul_16(Suppl_2)_S14-S23.nxml.txt.nlp	19672417	SENT202	4	4	0	0	tamoxifen	ATAC	PA451581	6375	0.54
NULL	Biomed_Res_Int_2013_Dec_16_2013_741403.nxml.txt.nlp	24455721	SENT61	21	21	9	9	carbamazepine	CYP3A4	PA448785	1576	0.54
NULL	Allergy_Asthma_Clin_Immunol_2011_Dec_7_7(1)_21.nxml.txt.nlp	22152089	SENT109	32	32	7	7	mometasone	DPI	PA450541	1832	0.54
NULL	Front_Neurosci_2013_Jul_31_7_132.nxml.txt.nlp	23914152	SENT191	7	7	27	27	paroxetine	NAT	PA450801	6046	0.54
NULL	Basic_Clin_Neurosci_2014_Winter_5(1)_31-41.nxml.txt.nlp	25436082	SENT159	22	22	20	20	bupropion	mol	PA448687	90527	0.54
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT123	15	15	8	8	mitoxantrone	ABCB1	PA450526	5243	0.54
NULL	Oncotarget_2012_Dec_18_3(12)_1615-1628.nxml.txt.nlp	23271044	SENT80	11	11	0	0	temsirolimus	CTRL	PA164746890	1506	0.54
NULL	Br_J_Cancer_2010_Sep_7_103(6)_889-898.nxml.txt.nlp	20664599	SENT153	7	7	11	11	paclitaxel	HER-2	PA450761	2064	0.54
NULL	ScientificWorldJournal_2013_Sep_21_2013_208309.nxml.txt.nlp	24170980	SENT91	27	27	22	22	lenalidomide	MRP8	PA162363968	6833;6279;85320	0.54
NULL	Mol_Vis_2011_Aug_18_17_2221-2227.nxml.txt.nlp	21897744	SENT119	4	4	28	28	l-arginine	NAC	PA448478	22861	0.54
NULL	Mol_Vis_2011_Feb_1_17_332-340.nxml.txt.nlp	21297899	SENT193	34	34	41	41	benazepril	DPI	PA448561	1832	0.54
NULL	Arch_Dis_Child_2014_Dec_8_99(12)_1143-1146.nxml.txt.nlp	25202131	SENT58	15	15	5	5	diazepam	CYP1A2	PA449283	1544	0.54
NULL	Mol_Vis_2014_Oct_17_20_1443-1455.nxml.txt.nlp	25352750	SENT73	23	23	12	12	paraformaldehyde	P21	PA450790	1026;9338	0.54
NULL	Crit_Care_2003_Jun_26_7(6)_427-434.nxml.txt.nlp	14624682	SENT177	5	5	28	28	vasopressin	SON	PA451858	6651	0.54
NULL	Front_Immunol_2013_Nov_7_4_360.nxml.txt.nlp	24223576	SENT222	9	9	6	6	imiquimod	IRF5	PA449972	3663	0.54
NULL	EMBO_Mol_Med_2013_Jul_14_5(7)_999-1018.nxml.txt.nlp	23776131	SENT199	10	10	3	3	doxycycline	MYC	PA449415	4609	0.54
NULL	Curr_Genomics_2014_Jun_15(3)_217-230.nxml.txt.nlp	24955029	SENT188	15	15	6	6	oxygen	ROS	PA450744	6098	0.54
NULL	F1000_Biol_Rep_2012_Mar_1_4_5.nxml.txt.nlp	22403588	SENT127	24	24	21	21	ribavirin	IFN	PA451241	3439	0.54
NULL	Open_Allergy_J_2010_3_91-101.nxml.txt.nlp	25018787	SENT14	6	6	30	30	omalizumab	IL-13	PA164752253	3596	0.54
NULL	Acta_Pharmacol_Sin_2011_Jun_23_32(6)_711-715.nxml.txt.nlp	21602841	SENT97	19	19	21	21	vasopressin	AVP	PA451858	114548;551	0.54
NULL	Curr_Cardiol_Rev_2012_Aug_8(3)_239-249.nxml.txt.nlp	22935021	SENT295	16	16	5	5	heparin	ADP	PA449855	23038	0.54
NULL	Evid_Based_Complement_Alternat_Med_2013_Nov_5_2013_937370.nxml.txt.nlp	24302971	SENT171	0	0	28	28	donepezil	p53	PA449394	7157	0.54
NULL	Biomed_Res_Int_2014_May_4_2014_351252.nxml.txt.nlp	24877084	SENT177	10	10	8	8	bevacizumab	FTM	PA130232992	23322	0.54
NULL	Mar_Drugs_2009_Mar_31_7(2)_71-84.nxml.txt.nlp	19597572	SENT24	22	22	32	32	heparin	RECK	PA449855	8434	0.54
NULL	Mol_Cancer_2010_Nov_2_9_289.nxml.txt.nlp	21044322	SENT171	11	11	30	30	cisplatin	RGS10	PA449014	6001	0.54
NULL	Breast_Cancer_Res_2008_Mar_31_10(2)_205.nxml.txt.nlp	18394187	SENT158	11	11	25	25	collagenase	MMP12	PA449107	4321	0.54
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_127043.nxml.txt.nlp	23227093	SENT231	15	15	11	11	sulfaphenazole	CYP2B6	PA130231310	1555	0.54
NULL	Acta_Pharmacol_Sin_2012_May_26_33(5)_675-681.nxml.txt.nlp	22447226	SENT103	7	7	23	23	gefitinib	PLK1	PA131301952	5347	0.54
NULL	BMJ_2013_Nov_6_347_f6530.nxml.txt.nlp	24196498	SENT92	8	8	6	6	paclitaxel	PES	PA450761	23481	0.539
NULL	Core_Evid_2008_Jun_3(1)_13-30.nxml.txt.nlp	20694081	SENT288	18	18	7	7	vildagliptin	GLP-1	PA165958346	100125288	0.539
NULL	Orphanet_J_Rare_Dis_2012_Apr_19_7_21.nxml.txt.nlp	22515166	SENT213	7	7	27	27	bezafibrate	PPARgamma	PA162364313	5468	0.539
NULL	J_Biomed_Biotechnol_2010_Sep_19_2010_518743.nxml.txt.nlp	20886007	SENT90	5	5	17	17	nadh	ADP	PA164755085	23038	0.539
NULL	Cancer_Cell_Int_2010_Sep_9_10_32.nxml.txt.nlp	20828393	SENT157	24	24	12	12	cisplatin	ATF3	PA449014	467	0.539
NULL	Br_J_Dermatol_2009_Feb_160(2)_438-441.nxml.txt.nlp	19016697	SENT96	26	26	21	21	methotrexate	GGH	PA450428	8836	0.539
NULL	Iran_J_Public_Health_2012_Mar_31_41(3)_127-132.nxml.txt.nlp	23113157	SENT86	30	30	20	20	ciprofloxacin	CTX	PA449009	1593	0.539
NULL	Clin_Cosmet_Investig_Dermatol_2011_Jul_1_4_93-99.nxml.txt.nlp	21760744	SENT159	7	7	5	5	ustekinumab	IL-23	PA166048654	51561	0.539
NULL	Arthritis_Res_Ther_2007_Nov_9_9(6)_R117.nxml.txt.nlp	17996099	SENT249	7	7	32	32	urokinase	AID	PA451836	57379	0.539
NULL	J_Biomed_Sci_2013_Jan_25_20(1)_4.nxml.txt.nlp	23350663	SENT181	12	12	16	16	thrombin	ADP	PA451674	23038	0.539
NULL	Case_Rep_Med_2013_Jul_2_2013_618358.nxml.txt.nlp	23935636	SENT53	11	11	19	19	ethanol	CO2	PA448073	4513	0.539
NULL	Nucleic_Acids_Res_2012_Jun_10_40(11)_4804-4815.nxml.txt.nlp	22328728	SENT221	22	22	6	6	hemin	SIRT1	PA449849	23411	0.539
NULL	Exp_Diabetes_Res_2011_Dec_27_2011_604989.nxml.txt.nlp	21253359	SENT5	8	8	15	15	clonidine	INS-1	PA449051	2305	0.539
NULL	Front_Oncol_2014_May_14_4_106.nxml.txt.nlp	24860786	SENT209	5	5	7	7	estradiol	p53	PA449503	7157	0.539
NULL	Exp_Cell_Res_2013_Aug_1_319(13)_2037-2048.nxml.txt.nlp	23562655	SENT239	24	24	3	3	urokinase	c-Jun	PA451836	3725	0.539
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_11_2014_274786.nxml.txt.nlp	25505920	SENT194	9	9	26	26	oxaliplatin	FLICE	PA131285527	841	0.539
NULL	Br_J_Cancer_2013_Sep_3_109(5)_1279-1286.nxml.txt.nlp	23949154	SENT133	4	4	34	34	flutamide	PC-3	PA449685	692094	0.539
NULL	Curr_Chem_Genomics_2010_Mar_1_4_1-8.nxml.txt.nlp	20448812	SENT120	28	28	18	18	bosentan	OATP1B1	PA10034	10599	0.539
NULL	Cell_Death_Dis_2014_Jul_10_5(7)_e1322.nxml.txt.nlp	25010988	SENT125	19	19	37	37	temozolomide	BNIP3	PA451609	664	0.539
NULL	Breast_Cancer_Res_2012_Jun_19_14(3)_209.nxml.txt.nlp	22713170	SENT29	24	24	26	26	trastuzumab	DM1	PA451743	338023;1760;28509	0.539
NULL	Biologics_2009_Sep_15_3_377-383.nxml.txt.nlp	19774205	SENT216	23	23	18	18	zanamivir	Yes	PA164740891	7525	0.539
NULL	Ecancermedicalscience_2011_Apr_28_5_211.nxml.txt.nlp	22276054	SENT114	14	14	24	24	aprepitant	NK-1	PA164747039	27087	0.539
NULL	Int_J_Surg_Oncol_2012_May_17_2012_406830.nxml.txt.nlp	22675625	SENT91	0	0	25	25	cetuximab	PLAGL1	PA10040	5325	0.539
NULL	Arthritis_Res_Ther_2014_Jan_20_16(1)_R17.nxml.txt.nlp	24444433	SENT103	18	18	0	0	methotrexate	ANOVA	PA450428	4858	0.539
NULL	Br_J_Cancer_2013_Feb_19_108(3)_503-511.nxml.txt.nlp	23361051	SENT152	24	24	15	15	irinotecan	DPD	PA450085	1806	0.539
NULL	Br_J_Cancer_2010_Jun_29_103(1)_61-72.nxml.txt.nlp	20588279	SENT13	12	12	0	0	trastuzumab	RhoB	PA451743	388	0.539
NULL	Ann_Clin_Microbiol_Antimicrob_2015_Jan_16_14(1)_4.nxml.txt.nlp	NULL	SENT39	1	1	3	3	cefotaxime	CTX	PA448852	1593	0.539
NULL	J_Exp_Med_1994_May_1_179(5)_1737-1741.nxml.txt.nlp	8163952	SENT8	10	10	5	5	thrombin	gamma	PA451674	9913	0.539
NULL	Acta_Pharmacol_Sin_2010_Dec_3_31(12)_1635-1642.nxml.txt.nlp	21127497	SENT82	0	0	11	11	fluconazole	UGT	PA449653	7361;7355	0.539
NULL	Comp_Hepatol_2004_Jan_14_3(Suppl_1)_S37.nxml.txt.nlp	14960189	SENT66	4	4	6	6	thalidomide	CD14	PA451644	929	0.539
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_315-322.nxml.txt.nlp	20049735	SENT97	24	24	10	10	olaparib	PTEN		5728	0.539
NULL	Brain_Sci_2014_Mar_14_4(1)_136-149.nxml.txt.nlp	24961704	SENT26	0	0	14	14	desflurane	spatial	PA164749136	219793	0.539
NULL	Curr_Neuropharmacol_2008_Sep_6(3)_193-202.nxml.txt.nlp	19506720	SENT352	9	9	5	5	mirtazapine	p75	PA450522	7133;11168	0.539
NULL	J_Cell_Biol_2005_Jul_18_170(2)_225-235.nxml.txt.nlp	16027220	SENT342	28	28	8	8	heparin	EB1	PA449855	9167;22919;10982	0.539
NULL	CNS_Drugs_2014_May_1_28(6)_497-511.nxml.txt.nlp	24788672	SENT68	12	12	0	0	lisdexamfetamine	ATX	PA164748975	5168;23049	0.539
NULL	Exp_Cell_Res_2011_Apr_15_317(7)_1028-1039.nxml.txt.nlp	21237154	SENT199	1	1	6	6	staurosporine	JNK	PA165109623	5599	0.539
NULL	Lipids_Health_Dis_2011_Jan_18_10_8.nxml.txt.nlp	21241519	SENT160	10	10	18	18	simvastatin	ABCG5	PA451363	64240	0.539
NULL	J_Gastrointest_Cancer_2013_Aug_7_44(4)_385-392.nxml.txt.nlp	23921604	SENT74	9	9	4	4	imatinib	TTP	PA10804	7538;11093	0.539
NULL	Acta_Naturae_2012_Jan-Mar_4(1)_93-100.nxml.txt.nlp	22708069	SENT186	12	12	6	6	methotrexate	FVIII	PA450428	2157	0.539
NULL	Mar_Drugs_2014_Oct_17_12(10)_5209-5221.nxml.txt.nlp	25329704	SENT49	0	0	5	5	verapamil	P-gp	PA451868	5243	0.539
NULL	Braz_J_Microbiol_2014_Jan_15_44(3)_807-812.nxml.txt.nlp	24516449	SENT133	38	38	18	18	vancomycin	CTX	PA451850	1593	0.539
NULL	Neurorehabil_Neural_Repair_2013_Feb_27(2)_118-124.nxml.txt.nlp	22961264	SENT61	18	18	37	37	creatine	GPC	PA164778930	2995	0.539
NULL	Indian_J_Pharmacol_2008_Oct_40(Suppl_2)_S178-S211.nxml.txt.nlp	21593974	SENT280	5	5	10	10	metformin	NAC	PA450395	22861	0.539
NULL	Br_J_Cancer_2012_Feb_14_106(4)_685-692.nxml.txt.nlp	22294184	SENT125	35	35	9	9	docetaxel	survivin	PA449383	332	0.539
NULL	Afr_J_Infect_Dis_2010_4(2)_20-28.nxml.txt.nlp	23878697	SENT39	12	12	16	16	artemisinin	ACT	PA165111696	12;11332;9457;641455	0.539
NULL	J_Cell_Biol_2002_May_28_157(5)_761-770.nxml.txt.nlp	12034770	SENT281	2	2	5	5	doxycycline	TFF1	PA449415	7031	0.539
NULL	Biochem_Res_Int_2012_May_7_2012_395974.nxml.txt.nlp	22611495	SENT232	0	0	9	9	tacrolimus	IL-2	PA451578	3558	0.539
NULL	Biochemistry_2011_May_31_50(21)_4393-4395.nxml.txt.nlp	21520952	SENT84	0	0	8	8	benzbromarone	P-gp	PA134852920	5243	0.539
NULL	Environ_Health_Perspect_1983_Mar_49_51-58.nxml.txt.nlp	6832097	SENT6	16	16	14	14	diethylstilbestrol	DDT	PA449307	1652	0.539
NULL	J_Korean_Med_Sci_2013_Apr_27_28(4)_527-533.nxml.txt.nlp	23580227	SENT104	15	15	26	26	genistein	TRAIL	PA165109660	8743	0.539
NULL	Osteoporos_Int_2012_Jan_28_23(1)_213-221.nxml.txt.nlp	21953472	SENT31	35	35	39	39	teriparatide	PTH	PA451620	5741	0.539
NULL	J_Neurophysiol_2013_May_1_109(9)_2393-2403.nxml.txt.nlp	23427303	SENT325	9	9	16	16	capsaicin	CO2	PA448776	4513	0.539
NULL	Brain_Sci_2013_Jun_14_3(2)_941-963.nxml.txt.nlp	24961432	SENT1236	0	0	12	12	ethanol	PTEN	PA448073	5728	0.539
NULL	Diabetes_2011_Jun_21_60(6)_1770-1778.nxml.txt.nlp	21562078	SENT237	0	0	2	2	metformin	Met	PA450395	79811	0.539
NULL	Allergy_Asthma_Immunol_Res_2010_Oct_17_2(4)_228-234.nxml.txt.nlp	20885907	SENT59	9	9	15	15	l-tyrosine	MPL	PA451822	4352	0.539
NULL	Braz_J_Microbiol_2014_Jan_15_44(3)_807-812.nxml.txt.nlp	24516449	SENT133	11	11	18	18	imipenem	CTX	PA449968	1593	0.539
NULL	Int_J_Environ_Res_Public_Health_2010_Dec_21_7(12)_4281-4304.nxml.txt.nlp	21318009	SENT433	3	3	23	23	ethanol	Bcl-2	PA448073	596	0.539
NULL	J_Med_Phys_2006_Jan-Mar_31(1)_13-21.nxml.txt.nlp	21206635	SENT262	10	10	12	12	glucose	FDG	PA449773	23583	0.539
NULL	Front_Hum_Neurosci_2009_Dec_23_3_49.nxml.txt.nlp	20087437	SENT449	10	10	8	8	venlafaxine	CBT	PA451866	611	0.539
NULL	Mol_Vis_2011_Feb_17_17_508-518.nxml.txt.nlp	21365018	SENT173	35	35	11	11	bleomycin	RAGE	PA448645	177	0.539
NULL	Glycoconj_J_2012_Apr_14_29(2-3)_93-105.nxml.txt.nlp	22246380	SENT35	27	27	15	15	sugar	DARC	PA451529	2532	0.539
NULL	Drug_Des_Devel_Ther_2014_Sep_23_8_1527-1538.nxml.txt.nlp	25284985	SENT131	39	39	37	37	celecoxib	IFN	PA448871	3439	0.539
NULL	Orphanet_J_Rare_Dis_2014_Oct_29_9(1)_162.nxml.txt.nlp	NULL	SENT158	0	0	7	7	iron	MRI	PA450087	78996	0.539
NULL	Mol_Biol_Rep_2012_May_20_39(5)_5253-5267.nxml.txt.nlp	22183301	SENT66	5	5	3	3	gliclazide	NAC	PA10892	22861	0.539
NULL	J_Carcinog_2011_Dec_31_10_37.nxml.txt.nlp	22279422	SENT123	21	21	13	13	urokinase	MMP3	PA451836	4314	0.539
NULL	Breast_Cancer_Res_2000_Dec_17_2(1)_32-44.nxml.txt.nlp	11250691	SENT145	14	14	5	5	paclitaxel	p53	PA450761	7157	0.539
NULL	Aging_(Albany_NY)_2014_Jan_21_6(1)_9-25.nxml.txt.nlp	24457528	SENT121	18	18	20	20	lipase	ATGL	PA450239	57104	0.539
NULL	Cancer_Med_2014_Feb_10_3(1)_134-142.nxml.txt.nlp	24407937	SENT228	22	22	29	29	tamoxifen	IMPACT	PA451581	55364	0.539
NULL	Mol_Vis_2011_Dec_24_17_3384-3391.nxml.txt.nlp	22219634	SENT124	25	25	11	11	mannitol	TLR4	PA450320	7099	0.539
NULL	Oxid_Med_Cell_Longev_2013_Jun_6_2013_462361.nxml.txt.nlp	23840917	SENT272	18	18	7	7	minocycline	p47phox	PA450519	653361	0.539
NULL	Libyan_J_Med_2006_Nov_18_1(2)_156-161.nxml.txt.nlp	21526013	SENT30	16	16	9	9	midazolam	VCP	PA450496	7415	0.539
NULL	eLife_2014_May_27_3_e02510.nxml.txt.nlp	24867642	SENT493	35	35	45	45	lipase	Dicer	PA450239	23405	0.539
NULL	J_Immunol_Res_2014_May_12_2014_897249.nxml.txt.nlp	24901013	SENT182	28	28	12	12	natalizumab	CD4	PA164747191	920	0.539
NULL	Mol_Cancer_2008_Mar_26_7_27.nxml.txt.nlp	18366759	SENT210	9	9	0	0	etoposide	HIF-1	PA449552	29072	0.539
NULL	Oncologist_2010_Mar_9_15(3)_236-245.nxml.txt.nlp	20215359	SENT80	8	8	5	5	bevacizumab	IFN	PA130232992	3439	0.539
NULL	Aging_(Albany_NY)_2010_Dec_31_2(12)_924-935.nxml.txt.nlp	21212465	SENT230	2	2	8	8	etoposide	p53	PA449552	7157	0.539
NULL	Patient_Prefer_Adherence_2010_Nov_3_4_397-406.nxml.txt.nlp	21206515	SENT4	29	29	26	26	liraglutide	GLP-1	PA165958364	100125288	0.539
NULL	Infect_Dis_Ther_2014_Jun_18_3(1)_35-43.nxml.txt.nlp	25134810	SENT97	12	12	14	14	teicoplanin	VAN	PA164746244	10318	0.539
NULL	Br_J_Cancer_2009_Jun_2_100(11)_1739-1745.nxml.txt.nlp	19436299	SENT187	19	19	28	28	everolimus	FDG	PA164746311	23583	0.539
NULL	ScientificWorldJournal_2012_Apr_22_2012_643904.nxml.txt.nlp	22619632	SENT212	15	15	13	13	pp2	PP1		5540;5464	0.539
NULL	Avicenna_J_Phytomed_2013_Autumn_3(4)_302-312.nxml.txt.nlp	25050287	SENT184	2	2	14	14	ethanol	castor	PA448073	54897	0.539
NULL	Viruses_2014_Apr_22_6(4)_1837-1860.nxml.txt.nlp	24759213	SENT368	9	9	18	18	indinavir	CD4	PA449977	920	0.539
NULL	Mol_Biol_Cell_2012_Nov_1_23(21)_4212-4225.nxml.txt.nlp	22956765	SENT159	21	21	8	8	thrombin	SHP2	PA451674	5781	0.539
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT53	33	33	27	27	trastuzumab	HRG	PA451743	3084;3273	0.539
NULL	Clin_Med_Insights_Oncol_2011_Oct_31_5_333-342.nxml.txt.nlp	22084622	SENT129	19	19	12	12	pazopanib	IL-6	PA165291492	3569	0.539
NULL	FEBS_Open_Bio_2014_Oct_22_4_905-914.nxml.txt.nlp	25383314	SENT134	5	5	15	15	physostigmine	L-FABP	PA450957	2168	0.539
NULL	Breast_Cancer_Res_2012_May_14_14(3)_R77.nxml.txt.nlp	22583478	SENT391	12	12	0	0	medroxyprogesterone	HRG	PA450344	3084;3273	0.539
NULL	Cardiovasc_J_Afr_2008_Apr_19(2)_77-83.nxml.txt.nlp	18516352	SENT191	20	20	14	14	glucose	GLP-1	PA449773	100125288	0.539
NULL	J_Cell_Biol_2003_Sep_1_162(5)_877-888.nxml.txt.nlp	12952938	SENT240	46	46	8	8	staurosporine	IL-3	PA165109623	3562	0.539
NULL	Tanaffos_2012_11(1)_67-70.nxml.txt.nlp	25191405	SENT38	4	4	8	8	thyroglobulin	TTF1	PA164754910	7080;7270	0.539
NULL	Int_J_Mol_Sci_2007_Jan_29_8(1)_13-28.nxml.txt.nlp	NULL	SENT361	18	18	24	24	galactose	NAG	PA449725	51594;4669	0.539
NULL	Cancer_Causes_Control_2013_Aug_18_24(8)_1605-1614.nxml.txt.nlp	23775025	SENT64	3	3	22	22	cyclophosphamide	GSTM2	PA449165	2946	0.539
NULL	Front_Behav_Neurosci_2009_Aug_20_3_18.nxml.txt.nlp	19738931	SENT562	3	3	6	6	citalopram	5-HT1A	PA449015	3350	0.539
NULL	Iran_J_Basic_Med_Sci_2012_Jul-Aug_15(4)_937-944.nxml.txt.nlp	23493039	SENT30	13	13	7	7	oxygen	CCR2	PA450744	729230	0.539
NULL	Indian_J_Endocrinol_Metab_2013_Jan-Feb_17(1)_50-59.nxml.txt.nlp	23776853	SENT196	29	29	17	17	collagenase	IL-6	PA449107	3569	0.539
NULL	Br_J_Cancer_2010_Sep_28_103(7)_975-986.nxml.txt.nlp	20717114	SENT51	38	38	10	10	kanamycin	CO2	PA450137	4513	0.539
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT100	1	1	7	7	resveratrol	TRAIL		8743	0.539
NULL	Exp_Ther_Med_2014_Nov_11_8(5)_1660-1664.nxml.txt.nlp	25289077	SENT24	8	8	3	3	resveratrol	OTC		5009	0.539
NULL	Bioinformation_2012_Jan_6_8(1)_13-19.nxml.txt.nlp	22359429	SENT93	2	2	7	7	curcumin	MRP1	PA151958596	4437	0.539
NULL	Arthritis_Res_Ther_2009_Apr_30_11(2)_R58.nxml.txt.nlp	19405951	SENT107	13	13	26	26	alendronate	RANKL	PA448082	8600	0.539
NULL	Environ_Health_Perspect_2008_Mar_13_116(3)_340-348.nxml.txt.nlp	18335101	SENT46	14	14	26	26	choline	HC3	PA448976	5683;360177	0.539
NULL	Int_J_Mol_Sci_2014_Sep_29_15(10)_17411-17441.nxml.txt.nlp	25268615	SENT248	0	0	4	4	cyclosporine	CD147	PA449167	682	0.539
NULL	Oncoimmunology_2013_Jan_1_2(1)_e22664.nxml.txt.nlp	23482679	SENT191	19	19	26	26	cyclophosphamide	EOS	PA449165	260429	0.539
NULL	Iran_J_Pharm_Res_2014_Winter_13(1)_19-27.nxml.txt.nlp	24734053	SENT143	19	19	17	17	mannitol	HEC	PA450320	10403	0.539
NULL	Cancer_Cell_Int_2006_Mar_23_6_6.nxml.txt.nlp	16556298	SENT10	0	0	6	6	tamoxifen	FDG	PA451581	23583	0.539
NULL	Pak_J_Med_Sci_2014_Jul-Aug_30(4)_814-818.nxml.txt.nlp	25097523	SENT65	14	14	16	16	gentamicin	TOB	PA449753	10140	0.539
NULL	J_Mol_Signal_2011_May_16_6_4.nxml.txt.nlp	21575178	SENT172	14	14	17	17	arsenite	HSP27	PA452638	3315	0.539
NULL	Int_J_Vasc_Med_2011_Jun_30_2011_250518.nxml.txt.nlp	21761004	SENT56	13	13	22	22	clopidogrel	ADP	PA449053	23038	0.539
NULL	Exp_Diabetes_Res_2011_Dec_27_2011_604989.nxml.txt.nlp	21253359	SENT151	3	3	10	10	clonidine	INS-1	PA449051	2305	0.539
NULL	Br_J_Cancer_2001_Sep_85(5)_772-779.nxml.txt.nlp	11531266	SENT5	0	0	7	7	trypsin	AP2	PA451806	2971	0.539
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Jun_27_5_15.nxml.txt.nlp	16803618	SENT145	2	2	30	30	flucloxacillin	CIP1	PA164781042	1026;56996	0.539
NULL	Proteome_Sci_2010_Mar_26_8_18.nxml.txt.nlp	20346146	SENT113	21	21	30	30	hyaluronan	CD34	PA165958431	947	0.539
NULL	Cell_Commun_Signal_2014_May_15_12_34.nxml.txt.nlp	24885272	SENT469	20	20	14	14	heparin	FGF2	PA449855	2247;2258	0.539
NULL	Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_1038-1044.nxml.txt.nlp	25049661	SENT55	28	28	36	36	l-glutamine	CO2	PA10090	4513	0.539
NULL	Biol_Proced_Online_2002_Oct_28_4_55-61.nxml.txt.nlp	12734568	SENT72	14	14	37	37	phenol	EGF	PA450913	1950	0.539
NULL	J_Biol_Chem_2013_Jun_28_288(26)_18789-18802.nxml.txt.nlp	23625922	SENT329	23	23	27	27	thrombin	C5a	PA451674	727	0.539
NULL	Br_J_Cancer_2010_Dec_7_103(12)_1822-1830.nxml.txt.nlp	21063405	SENT18	5	5	9	9	cisplatin	NBS1	PA449014	55655	0.539
NULL	Front_Aging_Neurosci_2014_Sep_1_6_234.nxml.txt.nlp	25225484	SENT377	5	5	11	11	fluoxetine	ghrelin	PA449673	51738	0.539
NULL	Mol_Cancer_2010_Nov_13_9_293.nxml.txt.nlp	21073737	SENT56	14	14	23	23	lipase	VEGFA	PA450239	7422	0.539
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT142	16	16	39	39	phenol	CO2	PA450913	4513	0.539
NULL	Infect_Dis_Ther_2014_Jun_20_3(1)_1-17.nxml.txt.nlp	25134808	SENT130	1	1	3	3	abacavir	ATV	PA448004	4683	0.539
NULL	Bioinformation_2012_Jan_6_8(1)_13-19.nxml.txt.nlp	22359429	SENT143	4	4	13	13	curcumin	MRP1	PA151958596	4437	0.539
NULL	Arch_Med_Sci_2012_Dec_20_8(6)_1117-1119.nxml.txt.nlp	23319991	SENT58	7	7	16	16	heparin	gamma	PA449855	9913	0.539
NULL	Ann_Gen_Psychiatry_2014_Jun_13_13_17.nxml.txt.nlp	25053968	SENT94	14	14	10	10	citalopram	IDO2	PA449015	169355	0.539
NULL	Mol_Pain_2014_Apr_9_10_24.nxml.txt.nlp	24716552	SENT55	1	1	21	21	capsaicin	ANOVA	PA448776	4858	0.539
NULL	J_Cell_Mol_Med_2014_Aug_1_18(8)_1599-1611.nxml.txt.nlp	24889822	SENT314	15	15	31	31	resveratrol	FOXO1		2308	0.539
NULL	J_Clin_Biochem_Nutr_2011_Jul_17_49(1)_1-7.nxml.txt.nlp	21765599	SENT213	16	16	12	12	lipase	ATGL	PA450239	57104	0.539
NULL	Diabetes_2008_Sep_57(9)_2321-2331.nxml.txt.nlp	18599527	SENT313	29	29	31	31	rosiglitazone	PI3K	PA451283	5290	0.539
NULL	Pharmaceutics_2012_Feb_16_4(1)_179-196.nxml.txt.nlp	24300187	SENT1	0	0	2	2	trimethoprim	TMP	PA451788	2012	0.539
NULL	Clin_Ophthalmol_2007_Mar_1(1)_37-42.nxml.txt.nlp	19668464	SENT168	4	4	7	7	creatine	DM1	PA164778930	338023;1760;28509	0.539
NULL	Int_J_Mol_Sci_2013_Aug_14_14(8)_16719-16731.nxml.txt.nlp	23949634	SENT115	24	24	16	16	thrombin	TPC	PA451674	8030;60386	0.539
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_7-17.nxml.txt.nlp	17912633	SENT6	2	2	8	8	letrozole	aromatase	PA450196	1588	0.539
NULL	J_Oncol_2009_Mar_24_2009_491985.nxml.txt.nlp	19325924	SENT164	18	18	3	3	genistein	CXCR4	PA165109660	7852	0.539
NULL	Acta_Pharmacol_Sin_2010_Jan_7_31(1)_73-80.nxml.txt.nlp	19966835	SENT28	18	18	41	41	gemcitabine	Bcl-2	PA449748	596	0.539
NULL	Clinics_(Sao_Paulo)_2013_May_68(5)_694-701.nxml.txt.nlp	23778405	SENT241	13	13	22	22	curcumin	DDP	PA151958596	1678	0.539
NULL	Acta_Pharmacol_Sin_2012_Jan_3_33(1)_49-56.nxml.txt.nlp	22212430	SENT175	11	11	14	14	thrombin	PAR-1	PA451674	2011;2149	0.539
NULL	Mol_Cancer_2012_Aug_24_11_61.nxml.txt.nlp	22917467	SENT221	28	28	23	23	hydrocortisone	EGF	PA449905	1950	0.538
NULL	Breast_Cancer_Res_2009_Jul_15_11(4)_207.nxml.txt.nlp	19664181	SENT226	16	16	20	20	docetaxel	HER2	PA449383	2064	0.538
NULL	Ann_Hematol_2014_Mar_18_93(8)_1335-1344.nxml.txt.nlp	24638841	SENT84	7	7	39	39	fludarabine	CLB	PA449655	171425	0.538
NULL	Cancer_Med_2014_Oct_3_3(5)_1322-1335.nxml.txt.nlp	24989836	SENT152	19	19	11	11	vorinostat	PC3	PA164748224	57332;7832;5122	0.538
NULL	Indian_J_Nephrol_2012_May-Jun_22(3)_196-199.nxml.txt.nlp	23087555	SENT71	25	25	6	6	cisplatin	IL-18	PA449014	3606	0.538
NULL	Arthritis_Res_Ther_2014_Oct_30_16(5)_467.nxml.txt.nlp	25359150	SENT162	11	11	3	3	adalimumab	CXCL13	PA10004	10563	0.538
NULL	Ann_Rheum_Dis_2011_Mar_6_70(6)_909-920.nxml.txt.nlp	21378402	SENT429	14	14	12	12	rituximab	CHOP	PA451261	1649	0.538
NULL	Cancer_Cell_Int_2012_Feb_21_12_5.nxml.txt.nlp	22353776	SENT131	10	10	8	8	sorafenib	MAT1A	PA7000	4143	0.538
NULL	Ann_Clin_Transl_Neurol_2014_Dec_21_1(12)_996-1005.nxml.txt.nlp	25574474	SENT125	36	36	2	2	riluzole	P-gp	PA451251	5243	0.538
NULL	Environ_Health_Perspect_2008_Oct_19_116(10)_1308-1314.nxml.txt.nlp	18941570	SENT37	11	11	23	23	choline	HC3	PA448976	5683;360177	0.538
NULL	J_Cell_Biol_1998_Aug_24_142(4)_1145-1156.nxml.txt.nlp	9722624	SENT39	16	16	20	20	thyroglobulin	TTF-1	PA164754910	7080	0.538
NULL	Curr_Opin_Endocrinol_Diabetes_Obes_2014_Oct_28_21(5)_394-404.nxml.txt.nlp	25122493	SENT139	29	29	20	20	thyroglobulin	RAI	PA164754910	10848;6050	0.538
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1068.nxml.txt.nlp	24556683	SENT126	11	11	3	3	pp2	CXCL12		6387	0.538
NULL	Anemia_2012_May_24_2012_238731.nxml.txt.nlp	22693659	SENT84	0	0	5	5	mitomycin	mol	PA450524	90527	0.538
NULL	Exp_Ther_Med_2014_Aug_6_8(2)_585-590.nxml.txt.nlp	25009624	SENT72	12	12	4	4	glucose	STZ	PA449773	6484	0.538
NULL	Biol_Open_2013_Apr_9_2(6)_535-545.nxml.txt.nlp	23789104	SENT532	13	13	2	2	arsenite	p38	PA452638	10598;1432;7965	0.538
NULL	Hum_Mol_Genet_2014_Apr_15_23(8)_2055-2077.nxml.txt.nlp	24282027	SENT240	9	9	4	4	galactose	LRRK2	PA449725	120892	0.538
NULL	Nucleic_Acids_Res_2013_Nov_16_41(20)_9349-9360.nxml.txt.nlp	23956219	SENT166	27	27	9	9	cisplatin	RMI1	PA449014	80010	0.538
NULL	Arch_Orthop_Trauma_Surg_2009_Nov_7_129(11)_1495-1504.nxml.txt.nlp	18989686	SENT183	32	32	25	25	linezolid	VAN	PA450233	10318	0.538
NULL	Cancer_Cell_Int_2011_Dec_2_11_42.nxml.txt.nlp	22136382	SENT87	22	22	9	9	ethanol	PC3	PA448073	57332;7832;5122	0.538
NULL	Bull_Math_Biol_2014_Dec_14_76(2)_401-430.nxml.txt.nlp	24338592	SENT867	8	8	3	3	etoposide	CHOP	PA449552	1649	0.538
NULL	Drugs_2014_Jun_25_74(10)_1063-1072.nxml.txt.nlp	24962424	SENT70	13	13	3	3	isoniazid	EMB	PA450112	133418	0.538
NULL	Clin_Psychopharmacol_Neurosci_2011_Apr_30_9(1)_36-43.nxml.txt.nlp	23431025	SENT87	4	4	7	7	haloperidol	FLI	PA449841	2314	0.538
NULL	Antimicrob_Agents_Chemother_2013_Oct_57(10)_4882-4893.nxml.txt.nlp	23877697	SENT225	31	31	6	6	tetracycline	CARP	PA451640	27063;80013;767	0.538
NULL	Cell_Death_Dis_2011_Apr_28_2(4)_e152.nxml.txt.nlp	21525939	SENT136	29	29	24	24	gentamicin	FBS	PA449753	64319;26269	0.538
NULL	Indian_J_Pharm_Sci_2008_Jan-Feb_70(1)_102-105.nxml.txt.nlp	20390092	SENT40	7	7	19	19	domperidone	LAN	PA134711056	9993	0.538
NULL	J_Exp_Bot_2012_Mar_15_63(5)_1969-1983.nxml.txt.nlp	22174442	SENT173	7	7	13	13	l-alanine	mol	PA448055	90527	0.538
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT562	11	11	19	19	metformin	p53	PA450395	7157	0.538
NULL	Arthritis_Res_Ther_2011_Mar_16_13(2)_R44.nxml.txt.nlp	21410959	SENT14	0	0	10	10	glucosamine	RANKL	PA164747613	8600	0.538
NULL	J_Gen_Intern_Med_2008_Sep_10_23(9)_1495-1498.nxml.txt.nlp	18618194	SENT59	0	0	10	10	echinacea	flower	PA131550706	11094	0.538
NULL	Cancer_Cell_Int_2005_Aug_24_5_28.nxml.txt.nlp	16120219	SENT155	34	34	25	25	etoposide	MDM2	PA449552	4193	0.538
NULL	J_Neuroinflammation_2010_Sep_7_7_51.nxml.txt.nlp	20822529	SENT178	34	34	9	9	hemin	p38	PA449849	10598;1432;7965	0.538
NULL	Oncogene_2014_Oct_23_33(43)_5109-5120.nxml.txt.nlp	24858043	SENT78	19	19	12	12	pp2	MCT-1		28985	0.538
NULL	Pain_Ther_2014_Dec_29_3(2)_73-84.nxml.txt.nlp	25069571	SENT63	5	5	19	19	capsaicin	TRPV1	PA448776	7442	0.538
NULL	Int_J_Biol_Sci_2012_Feb_9_8(3)_310-327.nxml.txt.nlp	22355267	SENT395	27	27	36	36	atorvastatin	PCSK9	PA448500	255738	0.538
NULL	Acta_Neuropathol_2011_Jun_22_121(6)_775-783.nxml.txt.nlp	21424749	SENT177	7	7	22	22	creatine	COX	PA164778930	1351	0.538
NULL	Indian_J_Endocrinol_Metab_2011_Sep_15(Suppl3)_S180-S187.nxml.txt.nlp	22029022	SENT93	13	13	21	21	vasopressin	AVP	PA451858	114548;551	0.538
NULL	Breast_Cancer_Res_2003_Feb_5_5(2)_113-116.nxml.txt.nlp	12631392	SENT94	37	37	0	0	paclitaxel	ATAC	PA450761	6375	0.538
NULL	AIDS_Care_2011_Sep_14_23(9)_1154-1162.nxml.txt.nlp	21500025	SENT76	12	12	2	2	emtricitabine	ATV	PA10069	4683	0.538
NULL	J_Immunother_Cancer_2013_Nov_7_1(Suppl_1)_P88.nxml.txt.nlp	NULL	SENT12	2	2	10	10	bortezomib	Hes1	PA10252	3280	0.538
NULL	Biologics_2012_Dec_17_6_429-464.nxml.txt.nlp	23269860	SENT246	6	6	11	11	tocilizumab	ACR	PA165292659	49	0.538
NULL	Cancer_Inform_2009_Nov_13_7_253-269.nxml.txt.nlp	20011461	SENT192	17	17	27	27	diethylstilbestrol	C40	PA449307	55571	0.538
NULL	Biol_Cell_2010_Aug_6_102(Pt_9)_525-537.nxml.txt.nlp	20590528	SENT274	19	19	43	43	l-glutamine	CO2	PA10090	4513	0.538
NULL	Sci_Rep_2014_Dec_19_4_7571.nxml.txt.nlp	25524368	SENT67	39	39	11	11	estradiol	mer	PA449503	10461	0.538
NULL	J_Oncol_2012_Jul_14_2012_193436.nxml.txt.nlp	21804824	SENT160	11	11	37	37	bevacizumab	SNO	PA130232992	6498	0.538
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Jun_27_5_15.nxml.txt.nlp	16803618	SENT145	32	32	30	30	ciprofloxacin	CIP1	PA449009	1026;56996	0.538
NULL	Environ_Health_Perspect_2007_Dec_115(12)_A595a.nxml.txt.nlp	NULL	SENT12	26	26	28	28	diethylstilbestrol	DES	PA449307	1674	0.538
NULL	Evid_Based_Complement_Alternat_Med_2011_Feb_14_2011_429843.nxml.txt.nlp	21869897	SENT106	22	22	20	20	ethanol	CEA	PA448073	5670;1087	0.538
NULL	Cancer_Causes_Control_2013_Aug_18_24(8)_1605-1614.nxml.txt.nlp	23775025	SENT64	38	38	45	45	epirubicin	ABCB1	PA449476	5243	0.538
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_13_2012_636848.nxml.txt.nlp	23258994	SENT296	8	8	2	2	carrageenan	TRPV4	PA448814	59341	0.538
NULL	Front_Psychiatry_2014_Mar_6_5_20.nxml.txt.nlp	24639656	SENT487	6	6	8	8	methylphenidate	spatial	PA450464	219793	0.538
NULL	Oxid_Med_Cell_Longev_2013_Mar_5_2013_264935.nxml.txt.nlp	23533686	SENT123	22	22	13	13	hemin	HO-1	PA449849	3162	0.538
NULL	Ann_Thorac_Med_2007_Jul-Sep_2(3)_128-142.nxml.txt.nlp	19727362	SENT297	4	4	1	1	streptokinase	MIST	PA164754919	116449	0.538
NULL	Oncoimmunology_2012_Oct_1_1(7)_1038-1047.nxml.txt.nlp	23170252	SENT147	25	25	44	44	l-glutamine	CO2	PA10090	4513	0.538
NULL	J_Nucl_Cardiol_2009_Oct_7_16(5)_753-762.nxml.txt.nlp	19662466	SENT101	29	29	36	36	l-glutamine	CO2	PA10090	4513	0.538
NULL	J_Antimicrob_Chemother_2014_Feb_3_69(2)_343-348.nxml.txt.nlp	24092655	SENT48	11	11	4	4	tetracycline	FUS	PA451640	2521	0.538
NULL	J_Biomed_Sci_2013_Jan_25_20(1)_4.nxml.txt.nlp	23350663	SENT188	16	16	12	12	thrombin	PAR4	PA451674	9002;5074	0.538
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1051.nxml.txt.nlp	24503543	SENT144	20	20	23	23	mitoxantrone	Yes	PA450526	7525	0.538
NULL	Oncotarget_2014_Sep_5_5(22)_11333-11344.nxml.txt.nlp	25226614	SENT120	31	31	19	19	celecoxib	HBD-2	PA448871	1673	0.538
NULL	Brain_Behav_2014_Jul_14_4(4)_468-483.nxml.txt.nlp	25161814	SENT141	7	7	4	4	ethanol	ANOVA	PA448073	4858	0.538
NULL	Surg_Today_2012_Jan_6_42(1)_8-28.nxml.txt.nlp	22139128	SENT235	20	20	18	18	tegafur	PSK	PA452620	9344	0.538
NULL	Semin_Immunopathol_2013_Jan_26_35(1)_39-52.nxml.txt.nlp	22829332	SENT197	42	42	18	18	vincristine	CHOP	PA451879	1649	0.538
NULL	Mol_Cell_Proteomics_2014_Dec_15_13(12)_3497-3506.nxml.txt.nlp	25225357	SENT48	21	21	17	17	streptomycin	FBS	PA451512	64319;26269	0.538
NULL	Oncoimmunology_2012_Mar_1_1(2)_189-194.nxml.txt.nlp	22720240	SENT23	7	7	16	16	imiquimod	TLR7	PA449972	51284	0.538
NULL	Hum_Genomics_2008_Sep_1_3(1)_7-16.nxml.txt.nlp	19129086	SENT133	28	28	18	18	rosiglitazone	SLCO1B1	PA451283	10599	0.538
NULL	Adipocyte_2014_Jul_1_3(3)_224-229.nxml.txt.nlp	25068091	SENT77	41	41	38	38	oxygen	ROS	PA450744	6098	0.538
NULL	J_Radiat_Res_2014_Mar_1_55(2)_359-363.nxml.txt.nlp	24187329	SENT43	44	44	0	0	bleomycin	CHOP	PA448645	1649	0.538
NULL	Breast_Cancer_Res_2011_Mar_1_13(2)_R21.nxml.txt.nlp	21362200	SENT156	12	12	17	17	estradiol	PI3K	PA449503	5290	0.538
NULL	J_Vis_Exp_2014_Jun_4_(88)_51236.nxml.txt.nlp	24961177	SENT176	1	1	27	27	ethanol	hole	PA448073	80757	0.538
NULL	Front_Neurosci_2013_Jul_25_7_131.nxml.txt.nlp	23898238	SENT492	2	2	4	4	minocycline	spatial	PA450519	219793	0.538
NULL	Eur_J_Pharmacol_2012_May_5_682(1-3)_21-28.nxml.txt.nlp	22381066	SENT147	18	18	30	30	doxycycline	PARP-1	PA449415	25976	0.538
NULL	Chin_J_Cancer_2011_May_30(5)_293-302.nxml.txt.nlp	21527062	SENT149	16	16	8	8	trastuzumab	DM1	PA451743	338023;1760;28509	0.538
NULL	Islets_2012_Jan_1_4(1)_64-70.nxml.txt.nlp	22504862	SENT202	16	16	14	14	forskolin	ADP	PA146096022	23038	0.538
NULL	Hematol_Rep_2011_Nov_16_3(3)_e26.nxml.txt.nlp	22593817	SENT58	13	13	5	5	vincristine	CHOP	PA451879	1649	0.538
NULL	Br_J_Pharmacol_2011_Jul_163(6)_1263-1275.nxml.txt.nlp	21391977	SENT100	26	26	24	24	ketoconazole	CYP3A4	PA450146	1576	0.538
NULL	Orphanet_J_Rare_Dis_2010_Dec_1_5_33.nxml.txt.nlp	21122093	SENT175	9	9	5	5	lipase	ATGL	PA450239	57104	0.538
NULL	Neuropsychologia_2013_Sep_51(11)_2194-2201.nxml.txt.nlp	23911779	SENT372	3	3	5	5	methylphenidate	spatial	PA450464	219793	0.538
NULL	Cancer_Cell_Int_2013_Nov_5_13_110.nxml.txt.nlp	24191888	SENT56	16	16	36	36	fluorescein	San	PA164746009	80218	0.538
NULL	Arthritis_Res_Ther_2008_Jan_7_10(1)_R1.nxml.txt.nlp	18179697	SENT175	11	11	17	17	oxaliplatin	HMGB1	PA131285527	3146	0.538
NULL	Curr_Hepat_Rep_2010_May_21_9(2)_75-90.nxml.txt.nlp	20461127	SENT287	10	10	25	25	telbivudine	LAM	PA164760861	7249;7248	0.538
NULL	J_Breast_Cancer_2011_Mar_31_14(1)_20-27.nxml.txt.nlp	21847390	SENT5	24	24	33	33	estradiol	CLDN6	PA449503	9074	0.538
NULL	Br_J_Cancer_2010_Jan_5_102(1)_80-86.nxml.txt.nlp	19920817	SENT147	10	10	12	12	bevacizumab	IFN	PA130232992	3439	0.538
NULL	Mol_Biol_Cell_2014_May_15_25(10)_1608-1619.nxml.txt.nlp	24623720	SENT118	24	24	19	19	propranolol	Vps34	PA451145	5289	0.538
NULL	Br_J_Cancer_2000_Jul_3_83(3)_366-374.nxml.txt.nlp	10917553	SENT5	11	11	8	8	vinblastine	MRP1	PA451877	4437	0.538
NULL	Adv_Hematol_2012_May_28_2012_945138.nxml.txt.nlp	22693514	SENT30	18	18	13	13	doxorubicin	CHOP	PA449412	1649	0.538
NULL	Afr_J_Infect_Dis_2011_5(2)_40-46.nxml.txt.nlp	23878706	SENT98	26	26	8	8	ceftazidime	Gen	PA448861	348654	0.538
NULL	Diabetes_2013_Oct_17_62(10)_3316-3323.nxml.txt.nlp	23818527	SENT231	13	13	29	29	exenatide	GLP-1	PA164749238	100125288	0.538
NULL	Int_J_Hypertens_2012_Mar_7_2012_842632.nxml.txt.nlp	22506100	SENT77	34	34	17	17	doxorubicin	HO-1	PA449412	3162	0.538
NULL	BMJ_Open_2014_Oct_16_4(10)_e005859.nxml.txt.nlp	25324322	SENT116	19	19	21	21	metformin	A10	PA450395	28870	0.538
NULL	BMJ_2013_Jan_16_346_f55.nxml.txt.nlp	23325883	SENT182	14	14	12	12	carvedilol	CARMEN	PA448817	8915	0.538
NULL	Environ_Health_Perspect_2013_Feb_5_121(2)_237-243.nxml.txt.nlp	23221991	SENT274	14	14	18	18	arsenite	AKT	PA452638	207	0.538
NULL	J_Cardiothorac_Surg_2014_Dec_18_9(1)_196.nxml.txt.nlp	NULL	SENT47	5	5	29	29	heparin	ACT	PA449855	12;11332;9457;641455	0.538
NULL	Breast_Cancer_Res_2010_Mar_5_12(2)_R16.nxml.txt.nlp	20205716	SENT357	12	12	22	22	lovastatin	AKT	PA450272	207	0.538
NULL	Acta_Pharmacol_Sin_2013_Jan_3_34(1)_119-128.nxml.txt.nlp	23202804	SENT149	22	22	14	14	rimonabant	NG2	PA152407999	1464;6048	0.538
NULL	Neural_Plast_2012_Nov_2_2012_309494.nxml.txt.nlp	22164341	SENT108	24	24	13	13	raloxifene	CA1	PA451221	759	0.538
NULL	AIDS_Res_Ther_2006_Apr_24_3_12.nxml.txt.nlp	16635263	SENT147	28	28	23	23	fluorescein	PEG3	PA164746009	5178	0.538
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Apr_8_65(Pt_5)_m489.nxml.txt.nlp	21583740	SENT54	27	27	30	30	ethanol	mol	PA448073	90527	0.538
NULL	Adv_Hematol_2012_Mar_8_2012_856341.nxml.txt.nlp	22496694	SENT108	5	5	13	13	rivaroxaban	TKR	PA165958360	8277	0.538
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT150	23	23	44	44	tamoxifen	SIRT3	PA451581	23410	0.538
NULL	Clinicoecon_Outcomes_Res_2014_Oct_17_6_451-461.nxml.txt.nlp	25378939	SENT126	12	12	34	34	linezolid	HAP	PA450233	5915;10313	0.538
NULL	Arch_Trauma_Res_2013_Aug_1_2(2)_76-80.nxml.txt.nlp	24396798	SENT33	22	22	39	39	creatine	S100B	PA164778930	6285	0.538
NULL	Oncotarget_2014_Jun_4_5(18)_8284-8305.nxml.txt.nlp	25268740	SENT256	21	21	12	12	hydrocortisone	FBS	PA449905	64319;26269	0.538
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Dec_17_3(12)_e152.nxml.txt.nlp	25518025	SENT249	1	1	7	7	oxycodone	ABCB1	PA450741	5243	0.538
NULL	BioDrugs_2013_May_9_27(5)_469-478.nxml.txt.nlp	23658121	SENT121	1	1	7	7	capecitabine	HER2	PA448771	2064	0.538
NULL	Oncotarget_2011_Dec_31_2(12)_1314-1321.nxml.txt.nlp	22248929	SENT36	9	9	29	29	everolimus	AKT	PA164746311	207	0.538
NULL	Eur_J_Clin_Pharmacol_2008_Jul_16_64(7)_683-690.nxml.txt.nlp	18415093	SENT100	37	37	12	12	amodiaquine	ANOVA	PA448404	4858	0.538
NULL	Cancer_Med_2014_Aug_7_3(4)_796-811.nxml.txt.nlp	24802970	SENT364	28	28	22	22	etoposide	p53	PA449552	7157	0.538
NULL	Cell_Death_Dis_2013_Sep_5_4(9)_e791.nxml.txt.nlp	24008735	SENT63	10	10	13	13	gemcitabine	p53	PA449748	7157	0.538
NULL	J_Cell_Biol_2005_Nov_7_171(3)_505-516.nxml.txt.nlp	16275754	SENT333	18	18	25	25	pp2	HRG		3084;3273	0.538
NULL	Br_J_Cancer_2013_May_28_108(10)_2039-2044.nxml.txt.nlp	23652306	SENT86	14	14	20	20	tamoxifen	SRC3	PA451581	8202	0.538
NULL	Neuroimage_Clin_2013_Sep_3_3_242-248.nxml.txt.nlp	24273709	SENT294	14	14	24	24	lamotrigine	PRG	PA450164	5544	0.538
NULL	Mol_Vis_2012_Nov_12_18_2673-2686.nxml.txt.nlp	23170060	SENT257	14	14	7	7	taurine	S12	PA451590	3351;6206;5713;6268	0.538
NULL	Surg_Today_2012_Jan_6_42(1)_8-28.nxml.txt.nlp	22139128	SENT236	28	28	11	11	tegafur	PSK	PA452620	9344	0.538
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT616	11	11	21	21	amisulpride	PRL	PA162565877	5617	0.538
NULL	Case_Rep_Gastroenterol_2009_Aug_28_3(2)_240-247.nxml.txt.nlp	21103282	SENT86	3	3	5	5	cyclophosphamide	CTX	PA449165	1593	0.538
NULL	Arthritis_Res_Ther_2011_Mar_20_13(2)_R46.nxml.txt.nlp	21418601	SENT255	10	10	21	21	hyaluronan	RHAMM	PA165958431	3161	0.538
NULL	Nanoscale_Res_Lett_2009_Aug_2_4(11)_1319-1323.nxml.txt.nlp	20628461	SENT37	11	11	9	9	ethanol	OTS	PA448073	5012	0.538
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT34	5	5	7	7	resveratrol	p53		7157	0.538
NULL	Alcohol_Res_2013_35(1)_25-35.nxml.txt.nlp	24313162	SENT51	20	20	24	24	betaine	BHMT	PA448603	635	0.538
NULL	Environ_Health_Perspect_2010_Jul_22_118(7)_902-908.nxml.txt.nlp	20413366	SENT51	41	41	48	48	gentamicin	CO2	PA449753	4513	0.538
NULL	Angew_Chem_Int_Ed_Engl_2011_Nov_18_50(47)_11206-11209.nxml.txt.nlp	21953685	SENT101	19	19	16	16	fluorescein	PALM	PA164746009	5064	0.538
NULL	Cell_Death_Dis_2014_Feb_27_5(2)_e1088.nxml.txt.nlp	24577086	SENT109	8	8	14	14	metformin	Bcl-2	PA450395	596	0.538
NULL	Clin_Ophthalmol_2013_Sep_25_7_1929-1935.nxml.txt.nlp	24109173	SENT103	36	36	29	29	mitomycin	PEX	PA450524	5251	0.538
NULL	J_Viral_Hepat_2010_Feb_17(2)_139-147.nxml.txt.nlp	19674282	SENT132	7	7	10	10	ribavirin	RVR	PA451241	9975	0.538
NULL	Glycobiology_2013_Jul_18_23(7)_853-864.nxml.txt.nlp	23507965	SENT302	23	23	5	5	galactose	DC-SIGN	PA449725	30835	0.538
NULL	Oncol_Lett_2013_May_27_5(5)_1554-1558.nxml.txt.nlp	23761818	SENT44	7	7	9	9	cyclophosphamide	CTX	PA449165	1593	0.538
NULL	Environ_Health_Perspect_2012_Sep_16_120(9)_1320-1326.nxml.txt.nlp	22591701	SENT31	4	4	21	21	l-arginine	NOS1	PA448478	340719;4842	0.538
NULL	Diabetes_Metab_J_2012_Aug_20_36(4)_293-299.nxml.txt.nlp	22950061	SENT161	32	32	26	26	metformin	PI3K	PA450395	5290	0.538
NULL	J_Breast_Cancer_2013_Mar_31_16(1)_122-126.nxml.txt.nlp	23593093	SENT115	35	35	14	14	capecitabine	gamma	PA448771	9913	0.538
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Apr_15_9_13.nxml.txt.nlp	20398300	SENT74	11	11	0	0	moxifloxacin	LAM	PA450555	7249;7248	0.538
NULL	Br_J_Cancer_2012_Jan_3_106(1)_53-60.nxml.txt.nlp	22068817	SENT212	1	1	3	3	cetuximab	KRAS	PA10040	3845	0.538
NULL	J_Hematol_Oncol_2013_Jan_15_6_5.nxml.txt.nlp	23320987	SENT142	7	7	9	9	heparin	PI-PLC	PA449855	2923	0.538
NULL	Glycobiology_2012_Mar_28_22(3)_369-378.nxml.txt.nlp	21964725	SENT221	3	3	29	29	fluorescein	SNA	PA164746009	6615	0.538
NULL	Iran_J_Basic_Med_Sci_2012_Jul-Aug_15(4)_937-944.nxml.txt.nlp	23493039	SENT21	16	16	25	25	oxygen	TNF	PA450744	7124	0.538
NULL	Cell_Death_Dis_2010_Nov_4_1(11)_e95.nxml.txt.nlp	21368871	SENT80	5	5	29	29	nadh	ATP5B	PA164755085	506	0.538
NULL	Braz_J_Med_Biol_Res_2014_Oct_10_48(1)_6-12.nxml.txt.nlp	25493377	SENT84	16	16	13	13	cyclophosphamide	CHOP	PA449165	1649	0.538
NULL	J_Thromb_Thrombolysis_2009_Nov_6_28(4)_410-417.nxml.txt.nlp	19504052	SENT113	7	7	0	0	sirolimus	PES	PA451365	23481	0.538
NULL	J_Gen_Physiol_1970_Nov_1_56(5)_583-620.nxml.txt.nlp	5475997	SENT4	11	11	2	2	creatine	ADP	PA164778930	23038	0.538
NULL	Breast_Cancer_Res_2011_Mar_1_13(2)_R21.nxml.txt.nlp	21362200	SENT281	5	5	12	12	estradiol	PIK3CA	PA449503	5290	0.538
NULL	Crit_Care_2012_Oct_14_16(5)_R191.nxml.txt.nlp	23062276	SENT117	19	19	1	1	propofol	POD1	PA451141	6943	0.538
NULL	Arthritis_Res_Ther_2012_Jan_31_14(1)_R24.nxml.txt.nlp	22293286	SENT83	30	30	19	19	methotrexate	ACPA	PA450428	5657	0.538
NULL	Lipids_Health_Dis_2011_Feb_28_10_38.nxml.txt.nlp	21352602	SENT144	19	19	21	21	fenofibrate	PCSK9	PA449594	255738	0.538
NULL	Indian_J_Med_Res_2014_Aug_140(2)_163-164.nxml.txt.nlp	25297347	SENT49	10	10	12	12	carbamazepine	CLB	PA448785	171425	0.538
NULL	Alzheimers_Res_Ther_2013_Oct_24_5(5)_50.nxml.txt.nlp	24401551	SENT10	4	4	17	17	donepezil	spatial	PA449394	219793	0.537
NULL	Eur_J_Dent_2013_Apr-Jun_7(2)_246-250.nxml.txt.nlp	24883036	SENT47	18	18	11	11	tretinoin	MAF	PA451746	4094	0.537
NULL	Biomed_Res_Int_2014_Mar_6_2014_215097.nxml.txt.nlp	24734228	SENT41	10	10	36	36	l-glutamine	CO2	PA10090	4513	0.537
NULL	Aging_(Albany_NY)_2009_May_22_1(6)_557-572.nxml.txt.nlp	20195383	SENT253	3	3	9	9	creatine	ADP	PA164778930	23038	0.537
NULL	Crit_Care_2010_Jul_9_14(4)_R131.nxml.txt.nlp	20615266	SENT26	4	4	6	6	vasopressin	AVP	PA451858	114548;551	0.537
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1051.nxml.txt.nlp	24503543	SENT144	36	36	27	27	hexachlorophene	Yes	PA449871	7525	0.537
NULL	Leukemia_2013_Apr_14_27(4)_803-812.nxml.txt.nlp	23238589	SENT122	16	16	9	9	imatinib	IFN	PA10804	3439	0.537
NULL	Int_J_Mol_Sci_2014_Sep_29_15(10)_17411-17441.nxml.txt.nlp	25268615	SENT214	2	2	17	17	hyaluronan	CD44	PA165958431	960	0.537
NULL	Indian_J_Psychiatry_2010_Jan_52(Suppl1)_S317-S340.nxml.txt.nlp	21836703	SENT115	17	17	24	24	thiothixene	CPZ	PA451669	8532	0.537
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT1736	3	3	7	7	sulfasalazine	NAT2	PA451547	10;81539	0.537
NULL	Acta_Pharmacol_Sin_2010_Dec_22_31(12)_1576-1582.nxml.txt.nlp	21102485	SENT114	2	2	4	4	ethanol	PI3K	PA448073	5290	0.537
NULL	Clin_Drug_Investig_2015_Dec_16_35_141-147.nxml.txt.nlp	25511640	SENT69	0	0	4	4	miglitol	GLP-1	PA164776726	100125288	0.537
NULL	Front_Oncol_2014_Sep_11_4_245.nxml.txt.nlp	25309871	SENT43	20	20	5	5	thrombin	LPA	PA451674	4018	0.537
NULL	J_Gastroenterol_2013_Feb_23_48(12)_1373-1383.nxml.txt.nlp	23435670	SENT156	16	16	8	8	entecavir	LAM	PA164784025	7249;7248	0.537
NULL	Curr_Hepat_Rep_2010_May_21_9(2)_75-90.nxml.txt.nlp	20461127	SENT244	19	19	45	45	telbivudine	LAM	PA164760861	7249;7248	0.537
NULL	J_Clin_Biochem_Nutr_2007_Nov_30_41(3)_224-230.nxml.txt.nlp	18299720	SENT215	36	36	12	12	creatine	DBP	PA164778930	3295;1628;2638	0.537
NULL	Cardiovasc_Diabetol_2013_Mar_18_12_46.nxml.txt.nlp	23497197	SENT215	11	11	13	13	metformin	adiponectin	PA450395	9370	0.537
NULL	Front_Oncol_2013_Aug_13_3_208.nxml.txt.nlp	23986880	SENT108	20	20	13	13	docetaxel	mol	PA449383	90527	0.537
NULL	Protein_Cell_2014_Jun_19_5(6)_469-479.nxml.txt.nlp	24748116	SENT171	10	10	4	4	paclitaxel	EB1	PA450761	9167;22919;10982	0.537
NULL	F1000Prime_Rep_2014_Dec_1_6_117.nxml.txt.nlp	25580271	SENT16	5	5	22	22	docetaxel	VEGFR2	PA449383	3791	0.537
NULL	Biomed_Res_Int_2014_Apr_10_2014_615363.nxml.txt.nlp	24818147	SENT5	18	18	12	12	thrombin	ADP	PA451674	23038	0.537
NULL	Mol_Cell_Proteomics_2012_Feb_6_11(2)_M111_015222.nxml.txt.nlp	22147731	SENT369	13	13	16	16	gefitinib	EGF	PA131301952	1950	0.537
NULL	Neuropsychopharmacology_2009_Jun_14_34(7)_1743-1752.nxml.txt.nlp	19145226	SENT181	3	3	9	9	naloxone	c-fos	PA450586	2353	0.537
NULL	Indian_J_Dermatol_2010_Apr-Jun_55(2)_198-199.nxml.txt.nlp	20606897	SENT0	18	18	22	22	terbinafine	FOR	PA451614	51741	0.537
NULL	J_Antimicrob_Chemother_2008_Nov_13_62(5)_1086-1093.nxml.txt.nlp	18703526	SENT86	12	12	9	9	cefotaxime	CTX	PA448852	1593	0.537
NULL	Arthritis_Res_Ther_2004_Jun_21_6(Suppl_2)_S3-S11.nxml.txt.nlp	15228615	SENT89	21	21	10	10	methotrexate	ACR	PA450428	49	0.537
NULL	Int_J_Mol_Sci_2014_Sep_29_15(10)_17411-17441.nxml.txt.nlp	25268615	SENT1685	1	1	3	3	hyaluronan	CD44	PA165958431	960	0.537
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_P64.nxml.txt.nlp	NULL	SENT16	26	26	36	36	ceftriaxone	PPL	PA448866	5493	0.537
NULL	Br_J_Cancer_1998_Apr_77(8)_1280-1286.nxml.txt.nlp	9579834	SENT0	15	15	40	40	carmustine	IL-2	PA448810	3558	0.537
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Jun_27_5_15.nxml.txt.nlp	16803618	SENT178	32	32	30	30	ciprofloxacin	CIP1	PA449009	1026;56996	0.537
NULL	Mol_Vis_2011_Mar_16_17_745-755.nxml.txt.nlp	21437201	SENT196	27	27	38	38	fluorescein	ZO-1	PA164746009	7082	0.537
NULL	J_Oncol_2010_Apr_6_2010_689018.nxml.txt.nlp	20379377	SENT50	40	40	33	33	urokinase	IL-8	PA451836	3576	0.537
NULL	Neural_Plast_2012_Nov_2_2012_309494.nxml.txt.nlp	22164341	SENT102	21	21	7	7	raloxifene	CA1	PA451221	759	0.537
NULL	Breast_Cancer_Res_2007_Aug_8_9(4)_R50.nxml.txt.nlp	17686159	SENT194	6	6	8	8	trastuzumab	HRG	PA451743	3084;3273	0.537
NULL	Drugs_R_D_2010_Nov_25_10(4)_213-217.nxml.txt.nlp	21171667	SENT100	6	6	21	21	infliximab	MPG	PA452639	4350	0.537
NULL	Insights_Imaging_2011_Jun_28_2(5)_609-619.nxml.txt.nlp	22347980	SENT89	12	12	3	3	mexiletine	MRI	PA450488	78996	0.537
NULL	Clin_Mol_Allergy_2008_Oct_16_6_12.nxml.txt.nlp	18925959	SENT215	13	13	8	8	amoxicillin	CD203c	PA448406	5169	0.537
NULL	Diabetes_2013_Jun_20_62(6)_2122-2129.nxml.txt.nlp	23378607	SENT210	20	20	1	1	glucose	ANOVA	PA449773	4858	0.537
NULL	Int_J_Mol_Sci_2007_Jan_29_8(1)_13-28.nxml.txt.nlp	NULL	SENT104	11	11	13	13	galactose	NAG	PA449725	51594;4669	0.537
NULL	Br_J_Cancer_2013_May_28_108(10)_2039-2044.nxml.txt.nlp	23652306	SENT77	15	15	31	31	carboplatin	SRC3	PA448803	8202	0.537
NULL	Hematol_Rep_2011_Nov_16_3(3)_e26.nxml.txt.nlp	22593817	SENT58	8	8	5	5	cyclophosphamide	CHOP	PA449165	1649	0.537
NULL	J_Hematol_Oncol_2013_Sep_5_6_66.nxml.txt.nlp	24010946	SENT301	38	38	26	26	bevacizumab	HER2	PA130232992	2064	0.537
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_3_2012_908562.nxml.txt.nlp	23082087	SENT150	2	2	14	14	hesperidin	IFN	PA449867	3439	0.537
NULL	Exp_Mol_Med_2012_Oct_31_44(10)_622-632.nxml.txt.nlp	23095254	SENT119	7	7	2	2	glucose	STAMP2	PA449773	79689	0.537
NULL	Br_J_Haematol_2014_Mar_13_164(1)_811-821.nxml.txt.nlp	24328678	SENT168	19	19	27	27	lenalidomide	IL2	PA162363968	3558	0.537
NULL	J_Emerg_Trauma_Shock_2013_Jul-Sep_6(3)_171-175.nxml.txt.nlp	23960372	SENT76	29	29	34	34	thrombin	PF1	PA451674	57649	0.537
NULL	Alcohol_Res_Health_2007_30(1)_38-47.nxml.txt.nlp	17718399	SENT182	14	14	4	4	oxygen	CYP2E1	PA450744	1571	0.537
NULL	Br_J_Cancer_2011_Aug_9_105(4)_469-474.nxml.txt.nlp	21712825	SENT110	13	13	18	18	nadh	UCP2	PA164755085	7351	0.537
NULL	Cancers_(Basel)_2012_Jul_25_4(3)_743-762.nxml.txt.nlp	24213464	SENT284	4	4	0	0	collagenase	MT1-MMP	PA449107	4323	0.537
NULL	ScientificWorldJournal_2012_Apr_19_2012_804730.nxml.txt.nlp	22606063	SENT161	30	30	18	18	bimatoprost	BAK	PA164748867	578	0.537
NULL	Breast_Cancer_Res_2010_May_10_12(3)_R26.nxml.txt.nlp	20459744	SENT76	2	2	23	23	cyclophosphamide	HDC	PA449165	3067;51696	0.537
NULL	J_Adv_Pract_Oncol_2013_Sep_1_Sep-Oct_4(5)_307-321.nxml.txt.nlp	25032010	SENT49	27	27	40	40	melphalan	San	PA450354	80218	0.537
NULL	Adv_Biomed_Res_2014_Mar_25_3_97.nxml.txt.nlp	24800186	SENT110	32	32	15	15	sertraline	MAP2	PA451333	4133;10988	0.537
NULL	Acta_Orthop_2010_Apr_6_81(2)_263-267.nxml.txt.nlp	20148646	SENT12	22	22	33	33	taurine	LIR	PA451590	10871	0.537
NULL	Breast_Cancer_Res_2004_Apr_7_6(4)_R275-R283.nxml.txt.nlp	15217493	SENT225	17	17	2	2	paclitaxel	IFN	PA450761	3439	0.537
NULL	Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_1009-1014.nxml.txt.nlp	25049657	SENT139	16	16	0	0	choline	B12	PA448976	7126;4709	0.537
NULL	Biomed_Res_Int_2014_May_4_2014_351252.nxml.txt.nlp	24877084	SENT54	28	28	30	30	bevacizumab	FTM	PA130232992	23322	0.537
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_16_2012_395912.nxml.txt.nlp	23118789	SENT75	9	9	24	24	diclofenac	UGT2B7	PA449293	7364	0.537
NULL	Br_J_Cancer_2009_Jul_21_101(2)_312-319.nxml.txt.nlp	19568237	SENT106	25	25	19	19	pp2	PP1		5540;5464	0.537
NULL	Nat_Commun_2013_Oct_1_4_2516.nxml.txt.nlp	24084631	SENT684	5	5	22	22	losartan	AK4	PA450268	205	0.537
NULL	J_Biomed_Biotechnol_2011_Jun_16_2011_807929.nxml.txt.nlp	21738405	SENT203	25	25	13	13	choline	FDG	PA448976	23583	0.537
NULL	Br_J_Cancer_2011_Jul_26_105(3)_372-381.nxml.txt.nlp	21730979	SENT35	7	7	10	10	cisplatin	ATR	PA449014	390502;84168;545	0.537
NULL	Front_Microbiol_2012_Mar_15_3_94.nxml.txt.nlp	22457660	SENT49	23	23	26	26	ethanol	CO2	PA448073	4513	0.537
NULL	Breast_Cancer_Res_2011_Jun_29_13(3)_R70.nxml.txt.nlp	21707964	SENT116	0	0	7	7	tamoxifen	14-3-3	PA451581	10971	0.537
NULL	J_Infect_Dis_2013_Dec_15_208(12)_2046-2057.nxml.txt.nlp	23911710	SENT122	9	9	2	2	galactose	LTA	PA449725	4049	0.537
NULL	BMJ_Open_2014_Feb_27_4(2)_e004071.nxml.txt.nlp	24578536	SENT150	6	6	23	23	warfarin	TTR	PA451906	7276	0.537
NULL	Exp_Ther_Med_2013_Jul_25_6(1)_109-114.nxml.txt.nlp	23935730	SENT27	1	1	10	10	cyclophosphamide	CHOP	PA449165	1649	0.537
NULL	Biomed_Eng_Online_2006_Jun_21_5_42.nxml.txt.nlp	16790065	SENT463	10	10	14	14	dobutamine	FFR	PA449381	738	0.537
NULL	Cancer_Med_2013_Aug_2_2(4)_571-582.nxml.txt.nlp	24156030	SENT162	10	10	13	13	curcumin	IL-6	PA151958596	3569	0.537
NULL	Indian_J_Urol_2010_Jan-Mar_26(1)_26-35.nxml.txt.nlp	20535281	SENT70	17	17	24	24	capsaicin	TRPV1	PA448776	7442	0.537
NULL	Case_Rep_Hematol_2014_Dec_7_2014_208597.nxml.txt.nlp	25544909	SENT288	1	1	8	8	rituximab	VIII	PA451261	1351	0.537
NULL	Oncol_Lett_2014_May_11_7(5)_1401-1408.nxml.txt.nlp	24765145	SENT160	4	4	14	14	paclitaxel	HIF-1	PA450761	29072	0.537
NULL	Paediatr_Drugs_2013_Apr_20_15(2)_119-131.nxml.txt.nlp	23512128	SENT138	8	8	33	33	pantoprazole	CYP2C19	PA450774	1557	0.537
NULL	Cardiovasc_Res_2011_Apr_1_90(1)_140-147.nxml.txt.nlp	21071431	SENT144	0	0	2	2	resveratrol	NAC		22861	0.537
NULL	Psychiatry_Investig_2009_Sep_3_6(3)_222-225.nxml.txt.nlp	20046399	SENT78	10	10	0	0	perospirone	DRD4	PA165291546	1815	0.537
NULL	Ann_Thorac_Med_2011_Oct-Dec_6(4)_221-226.nxml.txt.nlp	21977068	SENT78	13	13	5	5	doxycycline	FEV	PA449415	54738	0.537
NULL	J_Biomed_Biotechnol_2001_1(3)_114-121.nxml.txt.nlp	12488604	SENT38	20	20	31	31	gentamicin	CO2	PA449753	4513	0.537
NULL	Aging_(Albany_NY)_2009_May_12_1(5)_481-489.nxml.txt.nlp	20195487	SENT24	25	25	30	30	oxygen	ROS	PA450744	6098	0.537
NULL	Diabetes_Care_2009_Sep_28_32(9)_1649-1655.nxml.txt.nlp	19478198	SENT20	5	5	0	0	glucose	GLP-1	PA449773	100125288	0.537
NULL	Cell_Death_Dis_2010_Oct_21_1(10)_e86.nxml.txt.nlp	21368859	SENT229	8	8	6	6	doxorubicin	TRAIL	PA449412	8743	0.537
NULL	Crit_Care_2011_Mar_22_15(2)_211.nxml.txt.nlp	21457505	SENT28	5	5	8	8	heparin	PF4	PA449855	5196	0.537
NULL	Bioanal_Rev_2012_Mar_17_4(1)_1-30.nxml.txt.nlp	22389661	SENT884	5	5	0	0	vasopressin	SERS	PA451858	6301;54938	0.537
NULL	Mol_Biol_Cell_2012_Sep_1_23(17)_3407-3419.nxml.txt.nlp	22809629	SENT447	12	12	36	36	fluorescein	SP5	PA164746009	389058	0.537
NULL	Mol_Vis_2012_May_1_18_1115-1122.nxml.txt.nlp	22605923	SENT134	3	3	13	13	estradiol	IL-6	PA449503	3569	0.537
NULL	Cancer_Cell_Int_2012_Jun_6_12_22.nxml.txt.nlp	22672528	SENT119	3	3	11	11	epirubicin	DR5	PA449476	8795	0.537
NULL	J_Vis_Exp_2010_Dec_19_(46)_2483.nxml.txt.nlp	21258319	SENT24	16	16	26	26	l-glutamine	B27	PA10090	56246	0.537
NULL	Brain_Sci_2013_Apr_26_3(2)_670-703.nxml.txt.nlp	24961420	SENT719	2	2	5	5	ethanol	spatial	PA448073	219793	0.537
NULL	J_Cell_Biol_1999_Dec_27_147(7)_1493-1502.nxml.txt.nlp	10613907	SENT619	12	12	2	2	galactose	ANT-1	PA449725	24148	0.537
NULL	Breast_Cancer_Res_2007_Sep_13_9(5)_R60.nxml.txt.nlp	17854498	SENT238	13	13	5	5	fluorescein	BP1	PA164746009	1748	0.537
NULL	Curr_Genomics_2014_Jun_15(3)_217-230.nxml.txt.nlp	24955029	SENT173	2	2	5	5	oxygen	ROS	PA450744	6098	0.537
NULL	Oncotarget_2012_Dec_18_3(12)_1615-1628.nxml.txt.nlp	23271044	SENT55	15	15	8	8	clofarabine	CTRL	PA164754863	1506	0.537
NULL	Nucleic_Acids_Res_2012_Apr_16_40(8)_3641-3652.nxml.txt.nlp	22180534	SENT97	6	6	8	8	tobramycin	TOB	PA451704	10140	0.537
NULL	Endocrinol_Metab_(Seoul)_2014_Dec_29_29(4)_505-513.nxml.txt.nlp	25325273	SENT54	14	14	24	24	thyroglobulin	WBS	PA164754910	2006	0.537
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2012_Oct_10_1(10)_e10.nxml.txt.nlp	23887362	SENT57	27	27	21	21	zidovudine	UGT2B7	PA451954	7364	0.537
NULL	Mol_Cancer_2012_May_28_11_36.nxml.txt.nlp	22640878	SENT11	8	8	4	4	paclitaxel	TGFBI	PA450761	7045	0.537
NULL	J_Cell_Mol_Med_2014_Aug_1_18(8)_1599-1611.nxml.txt.nlp	24889822	SENT260	3	3	20	20	resveratrol	FOXO1		2308	0.537
NULL	Crit_Care_2011_Apr_11_15(2)_R112.nxml.txt.nlp	21481266	SENT79	14	14	26	26	piperacillin	SAPS	PA450975	8935	0.537
NULL	Emerg_Infect_Dis_2007_Jul_13(7)_1024-1030.nxml.txt.nlp	18214174	SENT150	28	28	14	14	linezolid	LSE	PA450233	54414	0.537
NULL	Diabetes_Metab_J_2013_Aug_14_37(4)_240-248.nxml.txt.nlp	23991401	SENT91	0	0	6	6	ezetimibe	NPC1L1	PA10816	29881	0.537
NULL	Biologics_2011_Aug_9_5_87-94.nxml.txt.nlp	21847344	SENT24	27	27	2	2	docetaxel	B27	PA449383	56246	0.537
NULL	Angew_Chem_Int_Ed_Engl_2012_Feb_13_51(7)_1572-1575.nxml.txt.nlp	22213572	SENT33	23	23	8	8	ethanol	CO2	PA448073	4513	0.537
NULL	Exp_Ther_Med_2013_Jul_25_6(1)_172-176.nxml.txt.nlp	23935741	SENT201	7	7	9	9	resveratrol	TPT		23590;6469	0.537
NULL	Biomed_Res_Int_2014_Feb_27_2014_802539.nxml.txt.nlp	24719888	SENT180	18	18	46	46	isoflurane	ANOVA	PA450106	4858	0.537
NULL	Curr_Neuropharmacol_2008_Jun_6(2)_151-163.nxml.txt.nlp	19305794	SENT425	21	21	28	28	kanamycin	TRPV1	PA450137	7442	0.537
NULL	Libyan_J_Med_2008_Mar_1_3(1)_42-48.nxml.txt.nlp	21499481	SENT253	19	19	17	17	artesunate	ACT	PA165111697	12;11332;9457;641455	0.537
NULL	Oncotarget_2014_Oct_16_5(22)_11442-11451.nxml.txt.nlp	25347345	SENT75	12	12	26	26	oxaliplatin	IFN	PA131285527	3439	0.537
NULL	Case_Rep_Oncol_2013_Jan_8_6(1)_1-5.nxml.txt.nlp	23466482	SENT36	5	5	9	9	capecitabine	CEA	PA448771	5670;1087	0.537
NULL	Neural_Plast_2012_May_20_2012_569149.nxml.txt.nlp	22685677	SENT37	35	35	9	9	lipase	iPLA2	PA450239	8398	0.537
NULL	Am_J_Trop_Med_Hyg_2014_Oct_1_91(4)_833-843.nxml.txt.nlp	25048375	SENT28	16	16	26	26	amodiaquine	ACT	PA448404	12;11332;9457;641455	0.537
NULL	Int_J_Mol_Sci_2010_Sep_13_11(9)_3195-3208.nxml.txt.nlp	20957088	SENT1	4	4	9	9	lipase	AT2	PA450239	186	0.537
NULL	Evid_Based_Complement_Alternat_Med_2011_Feb_14_2011_429843.nxml.txt.nlp	21869897	SENT167	30	30	27	27	ethanol	CEA	PA448073	5670;1087	0.537
NULL	Vet_Res_2013_Oct_1_44(1)_86.nxml.txt.nlp	24083845	SENT134	10	10	4	4	vancomycin	TYL	PA451850	5662	0.537
NULL	Cancer_Metastasis_Rev_2010_Dec_9_29(4)_777-784.nxml.txt.nlp	20936327	SENT76	2	2	0	0	thrombin	PAR1	PA451674	79581;2149	0.537
NULL	Mol_Vis_2012_Nov_29_18_2839-2846.nxml.txt.nlp	23233786	SENT130	3	3	5	5	geldanamycin	CB2	PA152031327	1269	0.537
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Apr_13_69(Pt_5)_m257-m258.nxml.txt.nlp	23723769	SENT3	36	36	9	9	ethanol	NO3	PA448073	4681	0.537
NULL	Asian-Australas_J_Anim_Sci_2013_Feb_26(2)_233-240.nxml.txt.nlp	25049781	SENT85	0	0	8	8	l-carnitine	SDH	PA450154	1757;10993	0.537
NULL	Arthritis_Res_Ther_2006_Jul_21_8(4)_R130.nxml.txt.nlp	16859540	SENT97	3	3	10	10	atorvastatin	CD59	PA448500	966	0.537
NULL	Arthritis_Res_Ther_2013_Feb_11_15(Suppl_1)_S1.nxml.txt.nlp	23566714	SENT221	0	0	9	9	dextran	CD19	PA449261	930	0.537
NULL	Oncologist_2010_Mar_3_15(3)_216-235.nxml.txt.nlp	20200040	SENT104	11	11	17	17	trastuzumab	DM1	PA451743	338023;1760;28509	0.537
NULL	Cell_Mol_Life_Sci_2012_Oct_24_69(20)_3419-3428.nxml.txt.nlp	22527724	SENT67	25	25	12	12	heparin	TPO	PA449855	7066;7173	0.537
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1013.nxml.txt.nlp	24457957	SENT72	3	3	10	10	bortezomib	NOXA	PA10252	5366	0.537
NULL	Mol_Cell_Proteomics_2013_Dec_16_12(12)_3851-3873.nxml.txt.nlp	24043423	SENT360	13	13	16	16	doxycycline	MORF4L1	PA449415	10933	0.537
NULL	Front_Bioeng_Biotechnol_2015_Jan_5_2_76.nxml.txt.nlp	25601910	SENT220	46	46	12	12	nadh	fumarase	PA164755085	2271	0.537
NULL	Acta_Pharmacol_Sin_2010_Jun_4_31(6)_709-717.nxml.txt.nlp	20523342	SENT148	12	12	31	31	repaglinide	OATP1B1	PA451234	10599	0.537
NULL	Exp_Ther_Med_2014_Sep_26_8(3)_899-906.nxml.txt.nlp	25120621	SENT196	27	27	0	0	2-methoxyestradiol	HIF-1	PA134967247	29072	0.537
NULL	Nucleic_Acids_Res_2010_Oct_27_38(18)_6247-6264.nxml.txt.nlp	20507916	SENT256	5	5	3	3	pp2	PP1		5540;5464	0.537
NULL	Indian_J_Pharmacol_2008_Oct_40(Suppl_2)_S160-S171.nxml.txt.nlp	21593969	SENT269	13	13	19	19	ethanol	CYP2E1	PA448073	1571	0.537
NULL	Br_J_Cancer_2010_Jun_29_103(1)_52-60.nxml.txt.nlp	20531411	SENT137	34	34	32	32	gemcitabine	MTD	PA449748	4493	0.537
NULL	Biosci_Rep_2014_Oct_2_34(5)_e00141.nxml.txt.nlp	25195639	SENT150	13	13	1	1	lipase	BSCL2	PA450239	26580	0.537
NULL	AMB_Express_2012_Aug_17_2_44.nxml.txt.nlp	22901717	SENT3	15	15	20	20	ethanol	CO2	PA448073	4513	0.537
NULL	J_Vet_Med_Sci_2014_Mar_1_76(3)_323-330.nxml.txt.nlp	24189582	SENT25	3	3	5	5	atovaquone	ATV	PA448502	4683	0.537
NULL	Mol_Cancer_2007_Jul_15_6_48.nxml.txt.nlp	17631687	SENT37	16	16	27	27	rituximab	TRAIL	PA451261	8743	0.537
NULL	Oncotarget_2010_Oct_25_1(7)_497-514.nxml.txt.nlp	21165163	SENT96	43	43	21	21	gefitinib	EGFR	PA131301952	1956	0.537
NULL	Cancer_Manag_Res_2012_Nov_9_4_383-395.nxml.txt.nlp	23204869	SENT137	0	0	10	10	carmustine	Mcl-1	PA448810	4170	0.537
NULL	J_Sens_Technol_2013_Sep_3(3)_10_4236_jst_2013_33015.nxml.txt.nlp	24409399	SENT140	20	20	18	18	ketamine	DC2	PA450144	58505	0.536
NULL	J_Prev_Med_Public_Health_2014_Jan_29_47(1)_36-46.nxml.txt.nlp	24570805	SENT174	16	16	0	0	levothyroxine	HIRA	PA450221	7290	0.536
NULL	Nat_Commun_2014_Nov_19_5_5479.nxml.txt.nlp	25407222	SENT510	11	11	23	23	dextran	YTS	PA449261	8565	0.536
NULL	Clin_Med_Insights_Case_Rep_2010_Sep_27_3_55-58.nxml.txt.nlp	21769255	SENT7	3	3	5	5	vasopressin	AVP	PA451858	114548;551	0.536
NULL	Genome_Med_2010_Sep_13_2(9)_64.nxml.txt.nlp	20831840	SENT56	19	19	0	0	lipase	ALOX5AP	PA450239	241	0.536
NULL	J_Invest_Dermatol_2014_May_22_134(5)_1418-1427.nxml.txt.nlp	24270662	SENT149	4	4	0	0	heparin	MMP7	PA449855	4316	0.536
NULL	Acta_Pharmacol_Sin_2011_Jun_23_32(6)_834-839.nxml.txt.nlp	21602836	SENT36	5	5	7	7	genistein	F12	PA165109660	2161	0.536
NULL	Diabetes_Care_2010_Aug_33(8)_e103-e108.nxml.txt.nlp	20668144	SENT157	12	12	10	10	fenofibrate	Q10	PA449594	27161	0.536
NULL	Eur_J_Endocrinol_2012_Feb_166(2)_159-170.nxml.txt.nlp	21930715	SENT253	47	47	38	38	protamine	CDA	PA10366	978	0.536
NULL	Allergy_Asthma_Immunol_Res_2012_Sep_21_4(5)_290-294.nxml.txt.nlp	22950035	SENT70	20	20	35	35	simvastatin	IL-5	PA451363	3567	0.536
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1066.nxml.txt.nlp	24556681	SENT216	24	24	9	9	ethanol	p62	PA448073	8878;10657;23636	0.536
NULL	J_Gen_Physiol_1932_Nov_20_16(2)_267-294.nxml.txt.nlp	19872705	SENT0	10	10	1	1	trypsin	Gen	PA451806	348654	0.536
NULL	Am_J_Physiol_Cell_Physiol_2014_Jan_15_306(2)_C89-C97.nxml.txt.nlp	24133067	SENT53	0	0	4	4	hyaluronan	HAS1	PA165958431	3036	0.536
NULL	Eur_J_Clin_Pharmacol_2012_Jan_8_68(1)_29-37.nxml.txt.nlp	21739267	SENT26	4	4	6	6	paroxetine	PRX	PA450801	9588;57716	0.536
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Nov_21_70(Pt_12)_562-565.nxml.txt.nlp	25552993	SENT11	4	4	32	32	phenol	mol	PA450913	90527	0.536
NULL	Nucleic_Acids_Res_2011_Sep_28_39(17)_7764-7774.nxml.txt.nlp	21712243	SENT194	16	16	9	9	doxycycline	TEF2	PA449415	8405	0.536
NULL	AJP_Rep_2011_Sep_11_1(1)_43-46.nxml.txt.nlp	23705084	SENT57	4	4	10	10	galactose	GALT	PA449725	2592	0.536
NULL	Anal_Bioanal_Chem_2012_Dec_4_404(10)_3071-3080.nxml.txt.nlp	23052869	SENT88	29	29	16	16	pilocarpine	CA3	PA450962	761	0.536
NULL	Cancer_Res_Treat_2011_Dec_27_43(4)_255-259.nxml.txt.nlp	22247712	SENT20	3	3	11	11	cyclophosphamide	CHOP	PA449165	1649	0.536
NULL	Arch_Med_Sci_2013_Apr_20_9(2)_332-339.nxml.txt.nlp	23671446	SENT164	40	40	27	27	midazolam	p38	PA450496	10598;1432;7965	0.536
NULL	Mol_Biol_Rep_2013_Sep_28_40(10)_5573-5585.nxml.txt.nlp	24078156	SENT322	22	22	2	2	iron	HFE	PA450087	3077	0.536
NULL	J_Biomed_Sci_2014_Apr_29_21(1)_35.nxml.txt.nlp	24780003	SENT112	6	6	4	4	bevacizumab	VEGF-A	PA130232992	7422	0.536
NULL	Nucleic_Acids_Res_2011_Dec_31_39(22)_9536-9548.nxml.txt.nlp	21880590	SENT168	10	10	23	23	etoposide	BRCA1	PA449552	672	0.536
NULL	Nanoscale_Res_Lett_2011_Apr_11_6(1)_321.nxml.txt.nlp	21711834	SENT3	6	6	21	21	fluorescein	NIR	PA164746009	26155	0.536
NULL	Neural_Regen_Res_2013_Jul_15_8(20)_1853-1862.nxml.txt.nlp	25206494	SENT137	18	18	12	12	ethanol	p53	PA448073	7157	0.536
NULL	Acta_Neuropathol_Commun_2014_Oct_21_2(1)_149.nxml.txt.nlp	NULL	SENT200	35	35	12	12	riluzole	ANOVA	PA451251	4858	0.536
NULL	J_Mol_Med_(Berl)_2012_Dec_23_90(12)_1361-1389.nxml.txt.nlp	23090008	SENT676	12	12	6	6	oxygen	ERK	PA450744	5594	0.536
NULL	J_Oncol_2012_Jul_30_2012_370272.nxml.txt.nlp	22899920	SENT86	15	15	7	7	ibritumomab	FDG	PA164781375	23583	0.536
NULL	Infect_Dis_Ther_2014_Jun_20_3(1)_1-17.nxml.txt.nlp	25134808	SENT130	31	31	3	3	raltegravir	ATV		4683	0.536
NULL	Fibrogenesis_Tissue_Repair_2011_Feb_2_4_5.nxml.txt.nlp	21288331	SENT15	29	29	42	42	l-tryptophan	DDR2	PA10323	4921	0.536
NULL	J_Cell_Biol_2002_Jun_24_157(7)_1151-1160.nxml.txt.nlp	12082077	SENT179	3	3	6	6	trypsin	COX	PA451806	1351	0.536
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Jun_27_5_15.nxml.txt.nlp	16803618	SENT178	2	2	42	42	flucloxacillin	GEN1	PA164781042	348654	0.536
NULL	BioData_Min_2012_Dec_12_5_21.nxml.txt.nlp	23234571	SENT46	19	19	33	33	fluorouracil	CHN2	PA128406956	1124	0.536
NULL	Int_J_Womens_Health_2012_Oct_10_4_543-549.nxml.txt.nlp	23091400	SENT117	12	12	3	3	resveratrol	aromatase		1588	0.536
NULL	Orphanet_J_Rare_Dis_2011_Sep_8_6_60.nxml.txt.nlp	21902819	SENT158	16	16	12	12	heparin	C3b	PA449855	718	0.536
NULL	Mol_Brain_2014_May_15_7_37.nxml.txt.nlp	24886748	SENT126	5	5	12	12	vorinostat	EGR4	PA164748224	1961	0.536
NULL	Diabetes_2011_Jun_21_60(6)_1770-1778.nxml.txt.nlp	21562078	SENT135	0	0	2	2	metformin	Met	PA450395	79811	0.536
NULL	Oncotarget_2014_Jun_6_5(13)_4929-4934.nxml.txt.nlp	24952635	SENT59	4	4	34	34	thioridazine	ADP	PA451666	23038	0.536
NULL	Trials_2014_Oct_7_15(1)_391.nxml.txt.nlp	NULL	SENT185	3	3	21	21	varenicline	ANOVA	PA164781343	4858	0.536
NULL	Ann_Rheum_Dis_2009_Jul_4_68(7)_1220-1227.nxml.txt.nlp	18772191	SENT132	8	8	10	10	abatacept	IFN	PA164747080	3439	0.536
NULL	Ann_Neurol_2013_Oct_24_74(4)_527-536.nxml.txt.nlp	23794460	SENT100	19	19	31	31	metyrapone	ACTH	PA450486	5443	0.536
NULL	Mol_Cancer_2008_Mar_26_7_27.nxml.txt.nlp	18366759	SENT242	12	12	19	19	etoposide	HIF-1	PA449552	29072	0.536
NULL	Biomed_Res_Int_2014_May_20_2014_625176.nxml.txt.nlp	24967388	SENT112	25	25	27	27	urokinase	CDK2	PA451836	1017	0.536
NULL	Front_Oncol_2013_Apr_2_3_64.nxml.txt.nlp	23565502	SENT1016	0	0	8	8	nutlin-3	p53		7157	0.536
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT161	17	17	12	12	carbamazepine	CYP3A4	PA448785	1576	0.536
NULL	Mol_Cancer_2012_Dec_12_11_91.nxml.txt.nlp	23234355	SENT199	9	9	23	23	erlotinib	EGFR	PA134687924	1956	0.536
NULL	Oxid_Med_Cell_Longev_2012_Aug_23_2012_139327.nxml.txt.nlp	22966413	SENT138	12	12	3	3	doxorubicin	METL	PA449412	55798	0.536
NULL	Oncol_Lett_2014_May_21_7(5)_1569-1575.nxml.txt.nlp	24765178	SENT173	26	26	10	10	fluorescein	Oct4	PA164746009	5460	0.536
NULL	Ann_Oncol_2013_Aug_12_24(8)_1994-1999.nxml.txt.nlp	23670096	SENT93	7	7	5	5	tamoxifen	AIB1	PA451581	8202	0.536
NULL	Int_J_Anal_Chem_2013_Jul_16_2013_419716.nxml.txt.nlp	23956748	SENT92	31	31	22	22	heparin	PF6	PA449855	200162	0.536
NULL	EMBO_Mol_Med_2012_Jul_11_4(7)_577-593.nxml.txt.nlp	22496117	SENT112	13	13	7	7	clofazimine	PAP-1	PA164748759	6100	0.536
NULL	J_Korean_Neurosurg_Soc_2013_Oct_31_54(4)_280-288.nxml.txt.nlp	24294450	SENT178	18	18	20	20	acetazolamide	ACZ	PA448018	27445	0.536
NULL	J_Biol_2003_Oct_29_2(4)_24.nxml.txt.nlp	NULL	SENT69	18	18	13	13	phenformin	LKB1	PA1000	6794	0.536
NULL	Ann_Neurosci_2014_Jul_21(3)_90-96.nxml.txt.nlp	25206072	SENT149	8	8	17	17	bromocriptine	spatial	PA448671	219793	0.536
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT192	31	31	20	20	trastuzumab	Yes	PA451743	7525	0.536
NULL	J_Immunol_Res_2014_Feb_3_2014_671431.nxml.txt.nlp	24741615	SENT234	13	13	31	31	paraformaldehyde	CD11c	PA450790	3687	0.536
NULL	Free_Radic_Biol_Med_2013_Aug_61(100)_438-452.nxml.txt.nlp	23608463	SENT117	7	7	11	11	apomorphine	NQO1	PA164781163	1728	0.536
NULL	Br_J_Pharmacol_2013_Jun_27_169(4)_736-747.nxml.txt.nlp	23489111	SENT162	41	41	36	36	morphine	5-HT3B	PA450550	9177	0.536
NULL	Oxid_Med_Cell_Longev_2012_Jul_9_2012_326731.nxml.txt.nlp	22848780	SENT39	20	20	12	12	nadh	DTNB	PA164755085	1838	0.536
NULL	Front_Genet_2014_Oct_14_5_314.nxml.txt.nlp	25352860	SENT105	17	17	29	29	napqi	CYP2E1		1571	0.536
NULL	Oncol_Rep_2013_Apr_23_29(4)_1268-1274.nxml.txt.nlp	23354756	SENT161	14	14	4	4	trastuzumab	SLC25A43	PA451743	203427	0.536
NULL	Environ_Health_Perspect_2005_Aug_10_113(8)_1046-1051.nxml.txt.nlp	16079077	SENT139	22	22	16	16	malathion	EBBP	PA164748092	10626	0.536
NULL	ARYA_Atheroscler_2011_Summer_7(2)_78-86.nxml.txt.nlp	22577451	SENT51	7	7	23	23	betaine	mol	PA448603	90527	0.536
NULL	Biomed_Res_Int_2013_Sep_8_2013_172479.nxml.txt.nlp	24089666	SENT49	30	30	37	37	l-glutamine	CO2	PA10090	4513	0.536
NULL	Neuro_Oncol_2014_Apr_4_16(4)_540-551.nxml.txt.nlp	24311639	SENT46	20	20	22	22	paraformaldehyde	PLP	PA450790	25824;5744	0.536
NULL	J_Korean_Med_Sci_2004_Apr_30_19(2)_167-171.nxml.txt.nlp	15082886	SENT118	28	28	0	0	kanamycin	PTH	PA450137	5741	0.536
NULL	Gut_Liver_2013_Sep_14_7(5)_585-593.nxml.txt.nlp	24073317	SENT134	31	31	29	29	ribavirin	IFN	PA451241	3439	0.536
NULL	Int_J_Environ_Res_Public_Health_2010_Apr_30_7(4)_1448-1466.nxml.txt.nlp	20617039	SENT78	6	6	10	10	ethanol	NR1	PA448073	27158	0.536
NULL	Ann_Clin_Transl_Neurol_2014_Feb_13_1(2)_88-98.nxml.txt.nlp	25356388	SENT97	21	21	36	36	l-glutamine	CO2	PA10090	4513	0.536
NULL	Cardiovasc_Res_2012_Dec_1_96(3)_466-475.nxml.txt.nlp	22915766	SENT216	14	14	23	23	creatine	HL-1	PA164778930	55600	0.536
NULL	Breast_Cancer_(Auckl)_2010_Feb_16_4_1-3.nxml.txt.nlp	20697527	SENT19	30	30	12	12	curcumin	CTX	PA151958596	1593	0.536
NULL	Infect_Drug_Resist_2009_Jun_8_2_27-40.nxml.txt.nlp	21694885	SENT164	17	17	38	38	clindamycin	San	PA449035	80218	0.536
NULL	Acta_Pharmacol_Sin_2012_May_16_33(5)_682-690.nxml.txt.nlp	22504904	SENT42	33	33	4	4	celecoxib	STAT3	PA448871	6774	0.536
NULL	Ann_Dermatol_2013_May_10_25(2)_213-217.nxml.txt.nlp	23717014	SENT66	7	7	17	17	bleomycin	CO2	PA448645	4513	0.536
NULL	Br_J_Cancer_2009_Jul_21_101(2)_312-319.nxml.txt.nlp	19568237	SENT143	4	4	2	2	pp2	PP1		5540;5464	0.536
NULL	Oncotarget_2013_Nov_22_5(4)_933-943.nxml.txt.nlp	24659749	SENT49	15	15	9	9	nutlin-3	AML3		860	0.536
NULL	Br_J_Clin_Pharmacol_2013_Aug_23_76(2)_299-315.nxml.txt.nlp	23701319	SENT186	18	18	15	15	alemtuzumab	CD4	PA164783958	920	0.536
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT51	0	0	3	3	doxorubicin	SLK	PA449412	9748;2534	0.536
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT149	19	19	21	21	atazanavir	UGT1A1	PA10251	54658	0.536
NULL	Emerg_Infect_Dis_2007_Feb_13(2)_255-258.nxml.txt.nlp	17479888	SENT77	7	7	1	1	gentamicin	PEN	PA449753	9933	0.536
NULL	J_Immunother_Cancer_2014_Apr_15_2_7.nxml.txt.nlp	24855562	SENT90	13	13	11	11	cyclophosphamide	OX40	PA449165	7293	0.536
NULL	Nat_Commun_2011_Apr_5_2_270.nxml.txt.nlp	21468022	SENT147	16	16	38	38	l-glutamine	CO2	PA10090	4513	0.536
NULL	Biomed_Res_Int_2013_Dec_5_2013_642848.nxml.txt.nlp	24381940	SENT167	10	10	5	5	telmisartan	IL-6	PA451605	3569	0.536
NULL	Br_J_Cancer_2013_Jun_25_108(12)_2464-2469.nxml.txt.nlp	23695016	SENT4	14	14	19	19	carboplatin	CRT	PA448803	811	0.536
NULL	Clin_Ophthalmol_2013_Aug_22_7_1669-1682.nxml.txt.nlp	24003303	SENT242	22	22	20	20	thalidomide	IL-2	PA451644	3558	0.536
NULL	Cancer_Immunol_Immunother_2012_Jul_23_61(7)_1101-1111.nxml.txt.nlp	22193989	SENT124	1	1	24	24	oxaliplatin	CD86	PA131285527	942	0.536
NULL	Oncogene_2010_Nov_18_29(46)_6160-6171.nxml.txt.nlp	20729916	SENT127	47	47	31	31	cisplatin	YAP	PA449014	55249	0.536
NULL	J_Geriatr_Cardiol_2012_Jun_9(2)_108-114.nxml.txt.nlp	22916055	SENT135	39	39	13	13	ticagrelor	ADP	PA165374673	23038	0.536
NULL	J_Clin_Biochem_Nutr_2010_Mar_27_46(2)_177-185.nxml.txt.nlp	20216951	SENT435	4	4	12	12	l-arginine	DDAH	PA448478	23576	0.536
NULL	Arthritis_Res_Ther_2005_Jan_26_7(2)_R380-R391.nxml.txt.nlp	15743486	SENT54	20	20	40	40	l-glutamine	CO2	PA10090	4513	0.536
NULL	Diabetes_2013_Oct_17_62(10)_3547-3552.nxml.txt.nlp	23863812	SENT107	0	0	16	16	pravastatin	adiponectin	PA451089	9370	0.536
NULL	J_Exp_Med_1994_May_1_179(5)_1417-1427.nxml.txt.nlp	7513009	SENT3	0	0	21	21	paraformaldehyde	CD54	PA450790	3383	0.536
NULL	Environ_Health_Perspect_2010_Sep_28_118(9)_1267-1272.nxml.txt.nlp	20427257	SENT201	34	34	6	6	estradiol	BPA	PA449503	667	0.536
NULL	Biosci_Rep_2013_Nov_25_33(6)_e00081.nxml.txt.nlp	24070327	SENT510	1	1	21	21	imatinib	MDR1	PA10804	5243	0.536
NULL	J_Cell_Mol_Med_2013_Nov_17_17(11)_1385-1396.nxml.txt.nlp	24237791	SENT23	9	9	3	3	hydroxyurea	MPN	PA449942	83886	0.536
NULL	Oncol_Lett_2014_Sep_19_8(3)_1269-1274.nxml.txt.nlp	25120704	SENT3	0	0	2	2	metformin	Met	PA450395	79811	0.536
NULL	Antimicrob_Resist_Infect_Control_2012_Jan_26_1_1.nxml.txt.nlp	22958725	SENT172	6	6	0	0	ceftazidime	CTX	PA448861	1593	0.536
NULL	Clinics_(Sao_Paulo)_2010_Jan_65(1)_29-34.nxml.txt.nlp	20126343	SENT124	9	9	5	5	ropivacaine	LPSB	PA451271	8991	0.536
NULL	J_Cancer_2011_Mar_8_2_142-152.nxml.txt.nlp	21475719	SENT117	1	1	3	3	lipase	CEA	PA450239	5670;1087	0.536
NULL	J_Gen_Physiol_2010_Apr_135(4)_333-353.nxml.txt.nlp	20231374	SENT383	19	19	21	21	desipramine	P2X4	PA449233	5025	0.536
NULL	Biochemistry_2011_Dec_13_50(49)_10576-10589.nxml.txt.nlp	22026921	SENT112	25	25	2	2	mesna	IPL	PA450385	7262	0.536
NULL	J_Biomed_Biotechnol_2006_May_28_2006_82323.nxml.txt.nlp	17047315	SENT52	3	3	9	9	oxygen	FOR	PA450744	51741	0.536
NULL	Indian_J_Endocrinol_Metab_2013_May-Jun_17(3)_514-518.nxml.txt.nlp	23869313	SENT40	1	1	3	3	glucose	FDG	PA449773	23583	0.536
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Dec_17_65(Pt_1)_m82-m83.nxml.txt.nlp	21581547	SENT73	1	1	34	34	ethanol	mol	PA448073	90527	0.536
NULL	Front_Cell_Neurosci_2014_Feb_6_8_27.nxml.txt.nlp	24567703	SENT1073	14	14	10	10	creatine	KCC2	PA164778930	57468	0.536
NULL	Iran_J_Public_Health_2010_Jun_30_39(2)_63-68.nxml.txt.nlp	23113008	SENT144	40	40	14	14	minocycline	TOB	PA450519	10140	0.536
NULL	Clin_Interv_Aging_2012_May_10_7_113-118.nxml.txt.nlp	22654511	SENT19	27	27	25	25	choline	CDP	PA448976	1523	0.536
NULL	Cell_Death_Dis_2014_Feb_27_5(2)_e1082.nxml.txt.nlp	24577080	SENT43	20	20	11	11	isoproterenol	DJ-1	PA450121	11315	0.536
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT158	9	9	19	19	phenprocoumon	VKORC1	PA450921	79001	0.536
NULL	Diabetes_2013_Mar_14_62(3)_953-964.nxml.txt.nlp	23223176	SENT126	0	0	7	7	paroxetine	ROS	PA450801	6098	0.536
NULL	Indian_J_Pharm_Sci_2013_Sep-Oct_75(5)_523-532.nxml.txt.nlp	24403652	SENT195	7	7	20	20	atorvastatin	AD3	PA448500	11138	0.536
NULL	J_Oncol_2013_Feb_17_2013_872957.nxml.txt.nlp	23476648	SENT109	18	18	16	16	cisplatin	SFN	PA449014	25996;2810	0.536
NULL	Acta_Pharmacol_Sin_2009_Sep_4_30(9)_1337-1343.nxml.txt.nlp	19730429	SENT5	6	6	8	8	gemcitabine	GEM	PA449748	2669	0.536
NULL	Toxins_(Basel)_2010_Oct_26_2(11)_2490-2518.nxml.txt.nlp	22069563	SENT55	13	13	19	19	cisplatin	OCT2	PA449014	6582;5452	0.536
NULL	Front_Neurosci_2010_Mar_19_4_22.nxml.txt.nlp	20582262	SENT129	20	20	26	26	mecamylamine	P2X3	PA450334	5024	0.536
NULL	Free_Radic_Biol_Med_2013_Aug_61(100)_438-452.nxml.txt.nlp	23608463	SENT887	5	5	15	15	apomorphine	SOD1	PA164781163	6647	0.536
NULL	Ecotoxicology_2012_Mar_30_21(2)_439-455.nxml.txt.nlp	22037694	SENT340	26	26	8	8	arsenite	spatial	PA452638	219793	0.536
NULL	J_Cell_Biol_2008_Jul_28_182(2)_367-379.nxml.txt.nlp	18644892	SENT74	28	28	28	28	pp2	PP2		4888	0.536
NULL	Br_J_Clin_Pharmacol_2014_Aug_17_78(2)_353-363.nxml.txt.nlp	24528331	SENT51	19	19	26	26	warfarin	VKORC1	PA451906	79001	0.536
NULL	Mol_Biol_Cell_2012_Jul_15_23(14)_2658-2670.nxml.txt.nlp	22621899	SENT227	0	0	4	4	tetracycline	AURKA	PA451640	6790	0.536
NULL	CNS_Drugs_2014_Feb_7_28(3)_185-193.nxml.txt.nlp	24504829	SENT236	4	4	2	2	choline	CDP	PA448976	1523	0.536
NULL	Arthritis_Res_Ther_2013_Nov_25_15(6)_R199.nxml.txt.nlp	24267267	SENT118	23	23	16	16	methotrexate	ACPA	PA450428	5657	0.536
NULL	AIDS_Behav_2011_Apr_15_15(Suppl_1)_51-56.nxml.txt.nlp	21404011	SENT159	3	3	23	23	methamphetamine	San	PA450403	80218	0.536
NULL	BMJ_2013_Nov_6_347_f6530.nxml.txt.nlp	24196498	SENT78	8	8	6	6	paclitaxel	PES	PA450761	23481	0.536
NULL	Pharm_Pract_(Granada)_2011_Mar_15_Jan-Mar_9(1)_1-10.nxml.txt.nlp	25132883	SENT162	13	13	19	19	dabigatran	SPAF		166378	0.536
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Jun_27_5_15.nxml.txt.nlp	16803618	SENT145	8	8	30	30	flucloxacillin	CIP1	PA164781042	1026;56996	0.536
NULL	Mol_Biol_Cell_2013_Sep_15_24(18)_2990-2999.nxml.txt.nlp	23885116	SENT61	8	8	10	10	heparin	PAK1	PA449855	5585;5058	0.536
NULL	Cell_Death_Dis_2014_Jul_3_5(7)_e1316.nxml.txt.nlp	24991768	SENT67	0	0	11	11	pemetrexed	Mcl-1	PA10810	4170	0.536
NULL	Int_J_Mol_Sci_2014_Jun_25_15(7)_11234-11244.nxml.txt.nlp	24968266	SENT88	17	17	11	11	docetaxel	PC-3	PA449383	692094	0.536
NULL	Diabetes_Care_2011_Nov_15_34(11)_e164-e169.nxml.txt.nlp	22025788	SENT179	8	8	1	1	metformin	Gen	PA450395	348654	0.536
NULL	Oncotarget_2014_Nov_8_5(21)_10280-10292.nxml.txt.nlp	25373733	SENT197	10	10	15	15	bortezomib	HIF-1	PA10252	29072	0.536
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Aug_11_68(Pt_9)_o2694.nxml.txt.nlp	22969586	SENT61	45	45	20	20	ethanol	mol	PA448073	90527	0.536
NULL	Indian_J_Pharmacol_2013_Jan-Feb_45(1)_9-12.nxml.txt.nlp	23543259	SENT21	7	7	20	20	l-arginine	eNOS	PA448478	4846	0.536
NULL	Br_J_Cancer_2009_Jul_21_101(2)_263-268.nxml.txt.nlp	19603032	SENT188	21	21	26	26	dasatinib	ANOVA	PA162372878	4858	0.536
NULL	Emerg_Med_J_2011_Apr_26_28(4)_313-315.nxml.txt.nlp	20581384	SENT18	8	8	6	6	atropine	PON1	PA448505	5444	0.536
NULL	Nat_Commun_2014_5_3071.nxml.txt.nlp	24468981	SENT186	23	23	10	10	hydrocortisone	F12	PA449905	2161	0.536
NULL	Breast_Cancer_Res_2006_Jun_15_8(3)_R27.nxml.txt.nlp	16776849	SENT259	20	20	10	10	tamoxifen	MUC1	PA451581	4582	0.536
NULL	Arch_Drug_Inf_2009_Mar_2(1)_8-16.nxml.txt.nlp	19381336	SENT27	19	19	26	26	rifampin	CYP3A4	PA451250	1576	0.536
NULL	Clin_Exp_Otorhinolaryngol_2013_Mar_1_6(1)_48-51.nxml.txt.nlp	23526700	SENT81	11	11	13	13	thyroglobulin	CK20	PA164754910	54474	0.536
NULL	J_Korean_Med_Sci_2010_Aug_21_25(8)_1222-1227.nxml.txt.nlp	20676337	SENT46	29	29	27	27	propofol	LPA	PA451141	4018	0.536
NULL	Indian_J_Med_Paediatr_Oncol_2014_Jan-Mar_35(1)_17-20.nxml.txt.nlp	25006278	SENT19	13	13	8	8	carboplatin	NACT	PA448803	284111	0.536
NULL	Biochim_Biophys_Acta_2014_Apr_1841(4)_588-594.nxml.txt.nlp	24440819	SENT159	8	8	14	14	lipase	HSL	PA450239	3991	0.536
NULL	Indian_J_Med_Res_2012_Dec_136(6)_907-925.nxml.txt.nlp	23391787	SENT152	5	5	11	11	artemisinin	ACT	PA165111696	12;11332;9457;641455	0.536
NULL	Breast_Cancer_Res_2010_Mar_5_12(2)_R16.nxml.txt.nlp	20205716	SENT340	18	18	9	9	lovastatin	PTEN	PA450272	5728	0.536
NULL	Alcohol_Res_2013_35(1)_6-16.nxml.txt.nlp	24313160	SENT128	15	15	9	9	nadh	ALDH2	PA164755085	217	0.536
NULL	Oxid_Med_Cell_Longev_2012_Aug_22_2012_534705.nxml.txt.nlp	22966415	SENT228	15	15	6	6	riluzole	GLAST	PA451251	6507	0.536
NULL	J_Gynecol_Oncol_2012_Jul_2_23(3)_190-196.nxml.txt.nlp	22808362	SENT42	23	23	38	38	gentamicin	CO2	PA449753	4513	0.536
NULL	J_Oncol_2010_Nov_19_2010_568938.nxml.txt.nlp	20037743	SENT313	19	19	36	36	erlotinib	VEGFR	PA134687924	3791	0.536
NULL	Cell_Death_Dis_2010_May_27_1(5)_e46.nxml.txt.nlp	21364652	SENT66	26	26	15	15	betaine	CDP	PA448603	1523	0.536
NULL	Proteome_Sci_2009_Mar_26_7_12.nxml.txt.nlp	19323824	SENT310	8	8	37	37	creatine	alpha-1-antitrypsin	PA164778930	5265	0.536
NULL	Cell_Regen_(Lond)_2012_Jun_28_1(1)_3.nxml.txt.nlp	25408866	SENT163	6	6	4	4	oxygen	ADP	PA450744	23038	0.536
NULL	Cancers_(Basel)_2014_Jul_8_6(3)_1487-1499.nxml.txt.nlp	25006835	SENT105	13	13	16	16	platinum	FAK	PA150595617	5747	0.536
NULL	Exp_Ther_Med_2013_Apr_24_5(4)_1105-1112.nxml.txt.nlp	23596478	SENT19	29	29	23	23	hydroxyurea	IFN	PA449942	3439	0.536
NULL	J_Cancer_2012_Jun_21_3_269-284.nxml.txt.nlp	22773931	SENT24	32	32	30	30	urokinase	BRCA2	PA451836	675	0.536
NULL	Bone_Joint_Res_2013_Dec_1_2(12)_270-275.nxml.txt.nlp	24333946	SENT182	16	16	2	2	hyaluronan	Gen	PA165958431	348654	0.536
NULL	Aging_(Albany_NY)_2009_Jun_3_1(6)_515-528.nxml.txt.nlp	20157535	SENT58	0	0	5	5	resveratrol	SIRT1		23411	0.536
NULL	Neuroscience_2013_Oct_10_250(100)_493-506.nxml.txt.nlp	23892006	SENT188	21	21	14	14	ethanol	ZO-1	PA448073	7082	0.536
NULL	Iran_J_Microbiol_2013_Mar_5(1)_42-47.nxml.txt.nlp	23466523	SENT91	10	10	8	8	cefotaxime	CTX	PA448852	1593	0.536
NULL	Clin_Psychopharmacol_Neurosci_2011_Apr_30_9(1)_29-35.nxml.txt.nlp	23430964	SENT173	15	15	42	42	methylphenidate	Gen	PA450464	348654	0.536
NULL	Fibrogenesis_Tissue_Repair_2011_Aug_2_4_18.nxml.txt.nlp	21810214	SENT159	0	0	7	7	bleomycin	IFN	PA448645	3439	0.536
NULL	Curr_HIV_Res_2011_Sep_9(6)_429-445.nxml.txt.nlp	21999778	SENT188	0	0	33	33	nevirapine	CD4	PA450616	920	0.536
NULL	Curr_Nutr_Rep_2012_Jul_10_1(3)_132-141.nxml.txt.nlp	24392268	SENT167	3	3	19	19	resveratrol	DNMT1		1786	0.536
NULL	Br_J_Cancer_2010_Jun_29_103(1)_61-72.nxml.txt.nlp	20588279	SENT188	2	2	4	4	trastuzumab	PTEN	PA451743	5728	0.535
NULL	J_Cell_Mol_Med_2014_Dec_22_18(12)_2519-2529.nxml.txt.nlp	25338520	SENT138	24	24	21	21	oxygen	ROS	PA450744	6098	0.535
NULL	J_Am_Heart_Assoc_2013_Dec_19_2(6)_e000246.nxml.txt.nlp	24356527	SENT317	18	18	26	26	fluorescein	RAN	PA164746009	5901	0.535
NULL	J_Korean_Med_Sci_2014_Jul_11_29(7)_965-972.nxml.txt.nlp	25045229	SENT6	17	17	6	6	metformin	B12	PA450395	7126;4709	0.535
NULL	Gut_2008_Nov_2_57(11)_1509-1517.nxml.txt.nlp	18596194	SENT265	7	7	21	21	cyclosporine	p38	PA449167	10598;1432;7965	0.535
NULL	Br_J_Cancer_2013_Feb_19_108(3)_668-675.nxml.txt.nlp	23348520	SENT123	18	18	5	5	panitumumab	KRAS	PA162373091	3845	0.535
NULL	Diabetes_Care_2013_Aug_17_36(Suppl_2)_S245-S252.nxml.txt.nlp	23882053	SENT204	42	42	39	39	liraglutide	GLP-1	PA165958364	100125288	0.535
NULL	Carbohydr_Res_2014_Mar_31_387(100)_54-58.nxml.txt.nlp	24589444	SENT259	8	8	15	15	zinc	D52	PA451956	7163	0.535
NULL	Allergy_Asthma_Immunol_Res_2014_Sep_18_6(5)_376-388.nxml.txt.nlp	25228994	SENT133	24	24	0	0	formoterol	BDP	PA134687907	10620;152926	0.535
NULL	Ther_Clin_Risk_Manag_2006_Sep_2(3)_235-249.nxml.txt.nlp	18360599	SENT302	3	3	12	12	alendronate	PTH	PA448082	5741	0.535
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT73	39	39	30	30	vinorelbine	ASC	PA451881	29108	0.535
NULL	Biomed_Res_Int_2014_Jun_26_2014_321486.nxml.txt.nlp	25054138	SENT148	16	16	7	7	raloxifene	ESR1	PA451221	2099	0.535
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S320-S324.nxml.txt.nlp	21525476	SENT68	14	14	3	3	ramipril	DREAM	PA451223	30818	0.535
NULL	Open_Virol_J_2007_Aug_13_1_1-7.nxml.txt.nlp	19440453	SENT54	6	6	24	24	l-glutamine	CD4	PA10090	920	0.535
NULL	Biomed_Res_Int_2013_Jul_15_2013_542168.nxml.txt.nlp	23936816	SENT81	10	10	16	16	hydroquinone	MCP-1	PA449924	6347	0.535
NULL	Front_Neuroeng_2014_Jun_11_7_17.nxml.txt.nlp	24966832	SENT88	8	8	28	28	ethanol	CO2	PA448073	4513	0.535
NULL	Front_Oncol_2013_Sep_11_3_229.nxml.txt.nlp	24062982	SENT226	18	18	14	14	cisplatin	PAX3	PA449014	5077	0.535
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Dec_2_5_30.nxml.txt.nlp	17140452	SENT229	22	22	0	0	mupirocin	VAN	PA164764568	10318	0.535
NULL	Mol_Cancer_2006_Oct_5_5_42.nxml.txt.nlp	17022811	SENT107	3	3	12	12	imipramine	GAPDH	PA449969	2597	0.535
NULL	Front_Oncol_2014_May_19_4_96.nxml.txt.nlp	24904820	SENT859	25	25	31	31	metformin	CKIepsilon	PA450395	1454	0.535
NULL	J_Cereb_Blood_Flow_Metab_2014_Oct_23_34(10)_1688-1694.nxml.txt.nlp	25052553	SENT122	7	7	15	15	losartan	ALK1	PA450268	6590;94	0.535
NULL	Exp_Ther_Med_2013_Nov_6_6(5)_1089-1095.nxml.txt.nlp	24223627	SENT4	19	19	14	14	docetaxel	NAC	PA449383	22861	0.535
NULL	Lab_Invest_2011_Dec_19_91(12)_1787-1795.nxml.txt.nlp	21931299	SENT61	22	22	32	32	dextran	CO2	PA449261	4513	0.535
NULL	Endocr_Relat_Cancer_2014_Feb_21(1)_85-99.nxml.txt.nlp	24189182	SENT158	35	35	28	28	amiloride	FGFR1	PA448368	2260	0.535
NULL	Mol_Cytogenet_2013_Jul_16_6_27.nxml.txt.nlp	23866735	SENT34	18	18	11	11	dasatinib	IFN	PA162372878	3439	0.535
NULL	Bone_Joint_Res_2013_Jan_1_2(1)_9-17.nxml.txt.nlp	23610697	SENT282	28	28	16	16	trypsin	MRI	PA451806	78996	0.535
NULL	Anal_Bioanal_Chem_2014_Sep_12_406(28)_7049-7057.nxml.txt.nlp	25213215	SENT77	44	44	10	10	hemin	mol	PA449849	90527	0.535
NULL	Biologics_2012_Jul_13_6_221-231.nxml.txt.nlp	22904614	SENT198	8	8	12	12	gefitinib	EGFR	PA131301952	1956	0.535
NULL	J_Neuroinflammation_2010_Sep_7_7_51.nxml.txt.nlp	20822529	SENT178	34	34	22	22	hemin	p38	PA449849	10598;1432;7965	0.535
NULL	Acta_Pharmacol_Sin_2014_Jun_4_35(6)_792-805.nxml.txt.nlp	24902787	SENT244	3	3	8	8	pravastatin	INS-1	PA451089	2305	0.535
NULL	Environ_Health_Perspect_2010_Sep_28_118(9)_1267-1272.nxml.txt.nlp	20427257	SENT220	12	12	25	25	estradiol	BPA	PA449503	667	0.535
NULL	Oncol_Lett_2014_May_25_7(5)_1537-1543.nxml.txt.nlp	24765172	SENT75	16	16	5	5	hyaluronan	COL6A3	PA165958431	1293	0.535
NULL	Case_Rep_Gastrointest_Med_2011_Jul_9_2011_628902.nxml.txt.nlp	22606424	SENT28	23	23	4	4	cyclophosphamide	SHARP	PA449165	23013	0.535
NULL	Ann_Rheum_Dis_2014_Sep_2_73(9)_1626-1634.nxml.txt.nlp	24297381	SENT115	18	18	0	0	methotrexate	ACR	PA450428	49	0.535
NULL	Child_Adolesc_Psychiatry_Ment_Health_2012_May_29_6_21.nxml.txt.nlp	22643087	SENT267	31	31	19	19	risperidone	AAP	PA451257	5345	0.535
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT229	4	4	12	12	curcumin	PC-3	PA151958596	692094	0.535
NULL	Indian_J_Dermatol_2014_Nov-Dec_59(6)_562-566.nxml.txt.nlp	25484384	SENT96	19	19	16	16	bromocriptine	PRL	PA448671	5617	0.535
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT55	2	2	7	7	chloroquine	BMPR-II	PA448948	659	0.535
NULL	Ther_Clin_Risk_Manag_2007_Mar_3(1)_59-69.nxml.txt.nlp	18360616	SENT123	20	20	23	23	venlafaxine	PRX	PA451866	9588;57716	0.535
NULL	Mol_Med_Rep_2015_Jan_20_11(1)_37-42.nxml.txt.nlp	25333459	SENT3	11	11	24	24	cyclosporine	IL-15	PA449167	3600	0.535
NULL	Indian_J_Endocrinol_Metab_2014_Jan-Feb_18(1)_23-31.nxml.txt.nlp	24701426	SENT135	24	24	18	18	estradiol	TFI	PA449503	7035	0.535
NULL	Case_Rep_Pediatr_2013_Sep_11_2013_153239.nxml.txt.nlp	24106631	SENT61	12	12	20	20	vancomycin	VISA	PA451850	57506	0.535
NULL	Crit_Care_2011_Mar_11_15(Suppl_1)_P278.nxml.txt.nlp	NULL	SENT2	10	10	24	24	collagenase	MMP8	PA449107	4317	0.535
NULL	Front_Immunol_2013_Mar_27_4_76.nxml.txt.nlp	23543707	SENT266	20	20	18	18	rituximab	CHOP	PA451261	1649	0.535
NULL	Anal_Bioanal_Chem_2012_Apr_3_402(10)_3177-3204.nxml.txt.nlp	22302165	SENT486	1	1	3	3	oxytetracycline	OTC	PA450757	5009	0.535
NULL	Cancers_(Basel)_2011_Aug_9_3(3)_3189-3205.nxml.txt.nlp	24212952	SENT108	27	27	9	9	hyaluronan	HAS2	PA165958431	3037	0.535
NULL	Curr_Microbiol_2012_Dec_28_65(6)_673-678.nxml.txt.nlp	22926720	SENT75	7	7	21	21	piperacillin	TMP	PA450975	2012	0.535
NULL	Endocr_Relat_Cancer_2014_Apr_21(2)_311-326.nxml.txt.nlp	24478054	SENT291	5	5	3	3	denosumab	OPG	PA166048634	690	0.535
NULL	Oncotarget_2013_Nov_23_5(1)_196-210.nxml.txt.nlp	24344116	SENT359	10	10	2	2	tamoxifen	TNFAIP3	PA451581	7128	0.535
NULL	Acta_Pharmacol_Sin_2012_Oct_3_33(10)_1311-1318.nxml.txt.nlp	22941289	SENT208	0	0	10	10	sorafenib	VEGFR2	PA7000	3791	0.535
NULL	Br_J_Cancer_2011_Aug_9_105(4)_469-474.nxml.txt.nlp	21712825	SENT167	10	10	26	26	nadh	p53	PA164755085	7157	0.535
NULL	Front_Genet_2012_Oct_26_3_213.nxml.txt.nlp	23112805	SENT608	20	20	39	39	phenacetin	CYP3A4	PA450897	1576	0.535
NULL	Open_AIDS_J_2010_Jan_19_4_70-75.nxml.txt.nlp	20200604	SENT220	26	26	36	36	efavirenz	ATV	PA449441	4683	0.535
NULL	J_Radiat_Res_2013_Sep_13_54(5)_789-797.nxml.txt.nlp	23764456	SENT40	20	20	12	12	l-glutamine	F10	PA10090	2159	0.535
NULL	Oncol_Lett_2014_Sep_19_8(3)_1320-1322.nxml.txt.nlp	25120716	SENT35	22	22	24	24	cisplatin	DDP	PA449014	1678	0.535
NULL	Aging_Cell_2008_Apr_1_7(2)_199-206.nxml.txt.nlp	18221413	SENT169	22	22	20	20	ethanol	mol	PA448073	90527	0.535
NULL	Am_J_Trop_Med_Hyg_2014_Oct_1_91(4)_833-843.nxml.txt.nlp	25048375	SENT28	14	14	26	26	artesunate	ACT	PA165111697	12;11332;9457;641455	0.535
NULL	J_Gen_Physiol_2008_Nov_132(5)_521-535.nxml.txt.nlp	18852303	SENT354	26	26	3	3	trypsin	CAP2	PA451806	5271;10486	0.535
NULL	Br_J_Cancer_2001_Aug_85(4)_509-517.nxml.txt.nlp	11506488	SENT2	23	23	2	2	oxaliplatin	ACRC	PA131285527	93953	0.535
NULL	Cell_Biochem_Biophys_2013_Jan_13_66(3)_499-512.nxml.txt.nlp	23314884	SENT286	29	29	26	26	doxorubicin	ABCG2	PA449412	9429	0.535
NULL	Pharmaceutics_2011_Nov_18_3(4)_865-913.nxml.txt.nlp	24309312	SENT219	7	7	20	20	gefitinib	CYP3A4	PA131301952	1576	0.535
NULL	Br_J_Cancer_2003_Mar_10_88(5)_788-795.nxml.txt.nlp	12618891	SENT175	16	16	18	18	bosentan	FasL	PA10034	356	0.535
NULL	Arthritis_Res_Ther_2007_Oct_9_9(5)_R104.nxml.txt.nlp	17925024	SENT166	2	2	4	4	glucosamine	AP-1	PA164747613	2353;3727;2354;3725	0.535
NULL	Brain_Behav_2011_Sep_1(1)_44-54.nxml.txt.nlp	22398980	SENT24	16	16	18	18	phencyclidine	PCP	PA128406980	5547	0.535
NULL	Oncol_Lett_2013_Sep_3_6(3)_807-810.nxml.txt.nlp	24137415	SENT29	35	35	47	47	l-glutamine	CO2	PA10090	4513	0.535
NULL	Ann_Rheum_Dis_2008_Apr_20_67(4)_511-517.nxml.txt.nlp	17644552	SENT142	2	2	6	6	infliximab	IL-6	PA452639	3569	0.535
NULL	Oncotarget_2012_May_23_3(5)_518-524.nxml.txt.nlp	22643838	SENT72	31	31	11	11	imatinib	MYL	PA10804	5371	0.535
NULL	Oxid_Med_Cell_Longev_2012_May_28_2012_632959.nxml.txt.nlp	22690272	SENT51	17	17	1	1	curcumin	PC-3	PA151958596	692094	0.535
NULL	Arthritis_Res_Ther_2009_Feb_3_11(1)_R15.nxml.txt.nlp	19192274	SENT212	34	34	13	13	diclofenac	IL-8	PA449293	3576	0.535
NULL	Br_J_Cancer_1997_75(9)_1330-1335.nxml.txt.nlp	9155054	SENT9	10	10	0	0	doxorubicin	P-gp	PA449412	5243	0.535
NULL	Curr_Cardiol_Rev_2010_May_6(2)_82-90.nxml.txt.nlp	21532773	SENT37	6	6	21	21	s-adenosylmethionine	PRMT1	PA164754994	3276	0.535
NULL	J_Vet_Pharmacol_Ther_2014_Oct_10_37(5)_421-434.nxml.txt.nlp	24611573	SENT441	7	7	19	19	cimetidine	CYP2D	PA449001	1565	0.535
NULL	J_Hematol_Oncol_2013_Jun_3_6_38.nxml.txt.nlp	23731980	SENT184	11	11	5	5	trastuzumab	HER2	PA451743	2064	0.535
NULL	Acta_Pharmacol_Sin_2013_Oct_7_34(10)_1292-1300.nxml.txt.nlp	23933651	SENT245	5	5	5	5	pp2	PP2		4888	0.535
NULL	Indian_J_Endocrinol_Metab_2013_May-Jun_17(3)_524-528.nxml.txt.nlp	23869316	SENT38	15	15	41	41	thyroglobulin	TTF-1	PA164754910	7080	0.535
NULL	J_Ophthalmic_Inflamm_Infect_2011_Nov_6_2(1)_21-28.nxml.txt.nlp	22057810	SENT101	17	17	13	13	infliximab	CTX	PA452639	1593	0.535
NULL	J_Hematol_Oncol_2009_Apr_22_2_18.nxml.txt.nlp	19386128	SENT142	0	0	6	6	cetuximab	KRAS	PA10040	3845	0.535
NULL	Biomed_Eng_Online_2004_Oct_22_3_37.nxml.txt.nlp	15500687	SENT192	21	21	18	18	isoproterenol	spatial	PA450121	219793	0.535
NULL	Front_Neurosci_2014_Feb_11_8_19.nxml.txt.nlp	24574956	SENT1380	0	0	8	8	phenytoin	CA3	PA450947	761	0.535
NULL	Oncogene_2010_Sep_16_29(37)_5193-5203.nxml.txt.nlp	20581867	SENT363	7	7	2	2	lapatinib	HRG	PA152241907	3084;3273	0.535
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT17	2	2	5	5	gefitinib	KRAS	PA131301952	3845	0.535
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Jun_27_5_15.nxml.txt.nlp	16803618	SENT178	8	8	30	30	flucloxacillin	CIP1	PA164781042	1026;56996	0.535
NULL	Aging_(Albany_NY)_2012_Feb_4_4(1)_60-73.nxml.txt.nlp	22308265	SENT226	18	18	10	10	nadh	CYTB	PA164755085	4519	0.535
NULL	Int_J_Mol_Sci_2014_Oct_6_15(10)_17886-17900.nxml.txt.nlp	25290095	SENT5	0	0	12	12	resveratrol	OPG		690	0.535
NULL	Biomed_Res_Int_2014_Jan_27_2014_696107.nxml.txt.nlp	24587987	SENT197	23	23	35	35	ebselen	NAC	PA161660841	22861	0.535
NULL	Am_J_Rhinol_Allergy_2013_Nov-Dec_27(6)_482-489.nxml.txt.nlp	24274224	SENT111	11	11	35	35	montelukast	LTA	PA450546	4049	0.535
NULL	Apoptosis_2012_Jun_9_17(6)_566-578.nxml.txt.nlp	22402981	SENT166	22	22	39	39	pp2	PP2		4888	0.535
NULL	Breast_Cancer_Res_2012_Jun_7_14(3)_R89.nxml.txt.nlp	22676470	SENT328	7	7	24	24	geldanamycin	HER2	PA152031327	2064	0.535
NULL	BMB_Rep_2014_Aug_47(8)_457-462.nxml.txt.nlp	24325816	SENT181	26	26	9	9	l-glutamine	CO2	PA10090	4513	0.535
NULL	Diabetes_Care_2011_Jul_17_34(7)_e115-e120.nxml.txt.nlp	21709286	SENT64	7	7	12	12	lipase	AMPK	PA450239	5563	0.535
NULL	Ann_Hematol_2014_Apr_30_93(9)_1515-1522.nxml.txt.nlp	24782121	SENT62	13	13	7	7	fluorescein	CD29	PA164746009	3688	0.535
NULL	Curr_Hepat_Rep_2010_May_21_9(2)_75-90.nxml.txt.nlp	20461127	SENT244	34	34	37	37	telbivudine	LAM	PA164760861	7249;7248	0.535
NULL	Croat_Med_J_2012_Jun_53(3)_214-223.nxml.txt.nlp	22661134	SENT9	0	0	20	20	diazepam	ACTH	PA449283	5443	0.535
NULL	Comput_Struct_Biotechnol_J_2012_Oct_29_3_e201210002.nxml.txt.nlp	24688662	SENT144	13	13	22	22	ethanol	CO2	PA448073	4513	0.535
NULL	Cardiovasc_Ther_2009_27(4)_259-274.nxml.txt.nlp	19604248	SENT160	25	25	23	23	clopidogrel	IPA	PA449053	3160	0.535
NULL	Leukemia_2013_Apr_14_27(4)_803-812.nxml.txt.nlp	23238589	SENT185	20	20	5	5	imatinib	IFN	PA10804	3439	0.535
NULL	Front_Pharmacol_2014_Dec_23_5_286.nxml.txt.nlp	25566078	SENT65	24	24	17	17	gemcitabine	APE-1	PA449748	328	0.535
NULL	Jpn_Clin_Med_2010_Oct_19_1_5-11.nxml.txt.nlp	23946675	SENT4	16	16	6	6	exenatide	GLP-1	PA164749238	100125288	0.535
NULL	Breast_Cancer_Res_2010_Oct_14_12(5)_R84.nxml.txt.nlp	20946630	SENT281	32	32	21	21	geldanamycin	Hsp90	PA152031327	3320	0.535
NULL	Int_J_Biomed_Sci_2014_Mar_10(1)_1-7.nxml.txt.nlp	24711742	SENT186	3	3	6	6	thrombin	PAR-1	PA451674	2011;2149	0.535
NULL	Curr_Neuropharmacol_2010_Dec_8(4)_409-421.nxml.txt.nlp	21629447	SENT121	12	12	14	14	phenytoin	PTH	PA450947	5741	0.535
NULL	Acta_Vet_Scand_2013_Aug_28_55(1)_61.nxml.txt.nlp	23985065	SENT71	3	3	1	1	oxacillin	PEN	PA450725	9933	0.535
NULL	Pharmaceuticals_(Basel)_2012_Jan_5_5(1)_79-93.nxml.txt.nlp	24288044	SENT60	17	17	19	19	trastuzumab	HER2	PA451743	2064	0.535
NULL	Cancer_Res_Treat_2012_Sep_30_44(3)_195-201.nxml.txt.nlp	23091446	SENT161	10	10	3	3	irinotecan	c-Jun	PA450085	3725	0.535
NULL	Drug_Des_Devel_Ther_2014_Sep_27_8_1629-1647.nxml.txt.nlp	25302018	SENT310	21	21	8	8	fluorescein	Bcl-2	PA164746009	596	0.535
NULL	J_Nat_Med_2014_Feb_19_68(2)_253-266.nxml.txt.nlp	24550097	SENT156	31	31	15	15	ethanol	adiponectin	PA448073	9370	0.535
NULL	Diabetes_2011_May_23_60(5)_1361-1369.nxml.txt.nlp	21525507	SENT256	30	30	9	9	oxygen	MRS	PA450744	8011	0.535
NULL	Ann_Rheum_Dis_2014_Jun_30_73(6)_990-999.nxml.txt.nlp	24482301	SENT83	41	41	0	0	ustekinumab	ACR	PA166048654	49	0.535
NULL	Mol_Cancer_2014_Jun_5_13_143.nxml.txt.nlp	24898067	SENT42	35	35	27	27	gefitinib	HER-2	PA131301952	2064	0.535
NULL	Cancer_Causes_Control_2013_Aug_18_24(8)_1605-1614.nxml.txt.nlp	23775025	SENT64	3	3	14	14	cyclophosphamide	CYP2D6	PA449165	1565	0.535
NULL	Gene_Regul_Syst_Bio_2013_Feb_6_7_11-22.nxml.txt.nlp	23440603	SENT288	13	13	20	20	lapatinib	TRAIL	PA152241907	8743	0.535
NULL	Br_J_Pharmacol_2011_Apr_162(8)_1832-1842.nxml.txt.nlp	21232033	SENT253	9	9	15	15	resveratrol	SAP97		1739	0.535
NULL	Biomed_Res_Int_2014_Jan_20_2014_948427.nxml.txt.nlp	24563867	SENT6	7	7	0	0	urea	STZ	PA451831	6484	0.535
NULL	Antimicrob_Resist_Infect_Control_2012_Mar_16_1_12.nxml.txt.nlp	22958880	SENT107	22	22	16	16	cefotaxime	Gen	PA448852	348654	0.535
NULL	Int_J_Mol_Sci_2014_Mar_5_15(3)_3970-3988.nxml.txt.nlp	24603537	SENT183	7	7	5	5	curcumin	MCH	PA151958596	5367	0.535
NULL	Mol_Biol_Cell_2014_Mar_1_25(5)_583-593.nxml.txt.nlp	24403604	SENT124	6	6	13	13	collagenase	MMP2	PA449107	4313	0.535
NULL	Case_Rep_Oncol_Med_2014_Sep_14_2014_532924.nxml.txt.nlp	25298899	SENT96	17	17	13	13	paclitaxel	NAC	PA450761	22861	0.535
NULL	Oxid_Med_Cell_Longev_2013_Nov_28_2013_568093.nxml.txt.nlp	24379901	SENT56	14	14	22	22	resveratrol	SIRT1		23411	0.535
NULL	J_Cell_Biol_1998_Jul_13_142(1)_101-115.nxml.txt.nlp	9660866	SENT161	45	45	17	17	dextran	RhoA	PA449261	387	0.535
NULL	Cancer_Res_Treat_2012_Sep_30_44(3)_195-201.nxml.txt.nlp	23091446	SENT155	11	11	7	7	irinotecan	MKP-1	PA450085	1843	0.535
NULL	Korean_Circ_J_2013_Jun_30_43(6)_400-407.nxml.txt.nlp	23882289	SENT84	0	0	2	2	doxorubicin	survivin	PA449412	332	0.535
NULL	J_Ginseng_Res_2011_Nov_35(4)_436-441.nxml.txt.nlp	23717089	SENT84	17	17	14	14	ginseng	CAGC	PA164781150	6283	0.535
NULL	J_Hematol_Oncol_2009_Oct_27_2_45.nxml.txt.nlp	19860903	SENT124	7	7	11	11	temsirolimus	IFN	PA164746890	3439	0.535
NULL	J_Viral_Hepat_2010_Feb_17(2)_139-147.nxml.txt.nlp	19674282	SENT94	12	12	20	20	ribavirin	RVR	PA451241	9975	0.535
NULL	Adv_Ther_2014_Dec_2_31_1228-1246.nxml.txt.nlp	25447269	SENT7	26	26	30	30	timolol	TIM	PA451690	7984;8914	0.535
NULL	Biologics_2014_Apr_22_8_193-198.nxml.txt.nlp	24790412	SENT126	29	29	21	21	adalimumab	Yes	PA10004	7525	0.535
NULL	Mol_Biol_Cell_2013_Aug_1_24(15)_2477-2490.nxml.txt.nlp	23761072	SENT143	31	31	22	22	arsenite	ATF5	PA452638	22809	0.535
NULL	Diabetes_2013_Sep_15_62(9)_3261-3267.nxml.txt.nlp	23775764	SENT243	26	26	23	23	liraglutide	GLP-1	PA165958364	100125288	0.535
NULL	Cancer_Manag_Res_2013_Nov_21_5_387-400.nxml.txt.nlp	24294007	SENT124	18	18	11	11	cetuximab	HER2	PA10040	2064	0.535
NULL	Br_J_Cancer_2010_Oct_12_103(8)_1309-1310.nxml.txt.nlp	NULL	SENT10	17	17	15	15	sunitinib	IFN	PA162372840	3439	0.535
NULL	Br_J_Cancer_2006_Feb_13_94(3)_407-426.nxml.txt.nlp	16434996	SENT378	9	9	12	12	genistein	BRCA1	PA165109660	672	0.535
NULL	Mol_Imaging_Radionucl_Ther_2013_Aug_1_22(2)_49-55.nxml.txt.nlp	24003397	SENT145	25	25	31	31	octreotide	FDG	PA450678	23583	0.535
NULL	Korean_J_Anesthesiol_2013_Jan_21_64(1)_47-53.nxml.txt.nlp	23372886	SENT97	9	9	0	0	bupivacaine	IGK	PA135057240	50802	0.535
NULL	Mar_Drugs_2014_Jun_27_12(7)_3818-3837.nxml.txt.nlp	24979269	SENT157	14	14	11	11	calcein	MRP1	PA132595336	4437	0.535
NULL	Cells_2014_Nov_27_3(4)_1089-1101.nxml.txt.nlp	25437439	SENT78	17	17	34	34	quinine	TRPM7	PA451213	54822	0.535
NULL	Diabetes_Metab_J_2012_Aug_20_36(4)_293-299.nxml.txt.nlp	22950061	SENT143	6	6	14	14	metformin	POMC	PA450395	5443	0.535
NULL	AIDS_Res_Ther_2014_Aug_4_11_25.nxml.txt.nlp	25120580	SENT64	25	25	7	7	voriconazole	CYP2C19	PA10233	1557	0.535
NULL	Iran_Red_Crescent_Med_J_2012_Dec_6_14(12)_782-786.nxml.txt.nlp	23483042	SENT36	5	5	17	17	vancomycin	VISA	PA451850	57506	0.535
NULL	Curr_Chem_Genomics_2008_Jul_11_1_70-78.nxml.txt.nlp	20161830	SENT241	30	30	34	34	vasopressin	FFAR1	PA451858	2864	0.535
NULL	Mol_Cancer_2009_Nov_10_8_99.nxml.txt.nlp	19903356	SENT113	27	27	22	22	imatinib	IGFBP3	PA10804	3486	0.535
NULL	Breast_Cancer_Res_2010_Jul_1_12(4)_R45.nxml.txt.nlp	20594311	SENT135	32	32	11	11	tamoxifen	AKT	PA451581	207	0.535
NULL	Int_J_Mol_Sci_2014_Mar_5_15(3)_3970-3988.nxml.txt.nlp	24603537	SENT33	7	7	5	5	curcumin	MCH	PA151958596	5367	0.535
NULL	Arch_Med_Sci_2012_Nov_9_8(5)_899-906.nxml.txt.nlp	23185202	SENT143	15	15	23	23	voglibose	ADN	PA164752433	1675	0.535
NULL	J_Lipid_Res_2013_Sep_54(9)_2485-2494.nxml.txt.nlp	23840049	SENT426	10	10	7	7	lipase	CD36	PA450239	948	0.535
NULL	J_Lipids_2011_Aug_1_2011_702853.nxml.txt.nlp	21837278	SENT93	36	36	10	10	choline	PEMT	PA448976	10400	0.535
NULL	J_Exp_Med_2003_Jan_20_197(2)_143-151.nxml.txt.nlp	12538654	SENT69	24	24	44	44	l-glutamine	GM-CSF	PA10090	1437	0.535
NULL	J_Clin_Biochem_Nutr_2010_Jan_29_46(1)_87-92.nxml.txt.nlp	20104270	SENT105	22	22	18	18	hesperidin	STZ	PA449867	6484	0.535
NULL	Mult_Scler_Int_2013_Mar_10_2013_189624.nxml.txt.nlp	23555057	SENT191	22	22	7	7	natalizumab	IFN	PA164747191	3439	0.535
NULL	Arch_Med_Sci_2011_Feb_8_7(1)_154-160.nxml.txt.nlp	22291749	SENT168	9	9	23	23	chlorhexidine	S15	PA164776863	6209	0.535
NULL	Cell_J_2012_Dec_22_Winter_13(4)_281-289.nxml.txt.nlp	23507624	SENT58	11	11	24	24	isoproterenol	IFN	PA450121	3439	0.535
NULL	Front_Psychol_2013_Oct_16_4_731.nxml.txt.nlp	24137145	SENT90	16	16	23	23	prazosin	gamma	PA451093	9913	0.535
NULL	Oncotarget_2011_Nov_30_2(11)_874-885.nxml.txt.nlp	22141136	SENT228	0	0	17	17	staurosporine	San	PA165109623	80218	0.535
NULL	J_Cell_Biol_1997_Nov_17_139(4)_851-864.nxml.txt.nlp	9362504	SENT22	42	42	26	26	thrombin	glypican	PA451674	2817	0.535
NULL	Mol_Brain_2014_Nov_19_7(1)_80.nxml.txt.nlp	NULL	SENT26	33	33	26	26	halothane	TWIK-1	PA449845	3775	0.535
NULL	Genome_Med_2010_Feb_22_2(2)_13.nxml.txt.nlp	20236491	SENT45	15	15	11	11	amlodipine	CYP2D6	PA448388	1565	0.535
NULL	Anesth_Essays_Res_2012_Jul-Dec_6(2)_115-123.nxml.txt.nlp	NULL	SENT69	15	15	17	17	protamine	gamma	PA10366	9913	0.535
NULL	ISRN_Nutr_2014_Jan_16_2014_149549.nxml.txt.nlp	24967264	SENT23	3	3	17	17	echinacea	EPO	PA131550706	7076;8288;2056	0.535
NULL	J_Antimicrob_Chemother_2014_Apr_8_69(4)_924-931.nxml.txt.nlp	24324223	SENT110	10	10	0	0	chloramphenicol	PEN	PA448927	9933	0.535
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Jun_27_5_15.nxml.txt.nlp	16803618	SENT178	2	2	30	30	flucloxacillin	CIP1	PA164781042	1026;56996	0.535
NULL	Cancer_Cell_Int_2005_Jul_24_5_22.nxml.txt.nlp	16042792	SENT75	23	23	21	21	vincristine	NAC	PA451879	22861	0.535
NULL	Evid_Based_Complement_Alternat_Med_2013_Nov_26_2013_731370.nxml.txt.nlp	24376467	SENT210	3	3	12	12	resveratrol	EGFR		1956	0.535
NULL	J_Cell_Biol_1998_Jul_13_142(1)_85-100.nxml.txt.nlp	9660865	SENT237	18	18	7	7	tetracycline	RhoA	PA451640	387	0.535
NULL	Environ_Health_Perspect_2010_Mar_23_118(3)_427-431.nxml.txt.nlp	20194071	SENT24	7	7	14	14	ethanol	IL-10	PA448073	3586	0.535
NULL	Biomed_Eng_Online_2007_Apr_20_6_14.nxml.txt.nlp	17448235	SENT393	24	24	20	20	nadh	ADP	PA164755085	23038	0.535
NULL	Front_Physiol_2011_Jun_30_2_33.nxml.txt.nlp	21747769	SENT292	0	0	13	13	berberine	KCNE3	PA165860812	10008	0.534
NULL	Environ_Health_Perspect_1998_Oct_106(Suppl_5)_1191-1195.nxml.txt.nlp	9788897	SENT7	12	12	17	17	nadh	ND6	PA164755085	4541	0.534
NULL	Pain_2012_Apr_153(4)_775-783.nxml.txt.nlp	22325744	SENT170	12	12	14	14	naloxone	P21	PA450586	1026;9338	0.534
NULL	Curr_Oncol_2009_Jul_16(Suppl_2)_S1-S13.nxml.txt.nlp	19672416	SENT301	20	20	34	34	tamoxifen	ARNO	PA451581	9266	0.534
NULL	Breast_Cancer_Res_2011_Mar_11_13(2)_R30.nxml.txt.nlp	21396117	SENT273	3	3	33	33	erlotinib	BRCA1	PA134687924	672	0.534
NULL	J_Med_Chem_2014_Feb_13_57(3)_1079-1089.nxml.txt.nlp	24456116	SENT500	2	2	13	13	piperazine	FAAH	PA450977	79152;2166	0.534
NULL	Biomed_Eng_Online_2007_Apr_20_6_14.nxml.txt.nlp	17448235	SENT82	13	13	9	9	nadh	ADP	PA164755085	23038	0.534
NULL	Ann_N_Y_Acad_Sci_2012_Aug_30_1264(1)_49-63.nxml.txt.nlp	22548651	SENT145	7	7	22	22	glucose	BDNF	PA449773	627	0.534
NULL	Breast_Cancer_Res_Treat_2013_Oct_6_141(3)_409-420.nxml.txt.nlp	24096568	SENT254	13	13	4	4	tamoxifen	SMRT	PA451581	9612	0.534
NULL	Cardiol_Res_Pract_2011_Aug_15_2011_156146.nxml.txt.nlp	21876822	SENT195	8	8	26	26	potassium	KIR	PA451047	2669	0.534
NULL	Breast_Cancer_Res_2005_Jan_17_7(2)_R248-R255.nxml.txt.nlp	15743505	SENT40	31	31	15	15	nitrogen	OCT	PA450643	5362	0.534
NULL	Front_Neurol_2014_Feb_18_5_17.nxml.txt.nlp	24600432	SENT145	3	3	15	15	levetiracetam	C17	PA450206	54360	0.534
NULL	Cardiovasc_Diabetol_2010_Nov_25_9_78.nxml.txt.nlp	21106105	SENT219	9	9	17	17	dextran	STZ	PA449261	6484	0.534
NULL	Front_Immunol_2013_Nov_18_4_387.nxml.txt.nlp	24302927	SENT284	25	25	23	23	ribavirin	IFN	PA451241	3439	0.534
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Apr_15_9_13.nxml.txt.nlp	20398300	SENT134	16	16	0	0	amoxicillin	LAM	PA448406	7249;7248	0.534
NULL	Cancers_(Basel)_2014_Sep_30_6(4)_2035-2048.nxml.txt.nlp	25271833	SENT25	13	13	11	11	gefitinib	IL-2	PA131301952	3558	0.534
NULL	J_Geriatr_Cardiol_2014_Jun_11(2)_151-157.nxml.txt.nlp	25009566	SENT140	6	6	10	10	cilostazol	CDP	PA164746334	1523	0.534
NULL	Exp_Mol_Med_2012_Oct_31_44(10)_622-632.nxml.txt.nlp	23095254	SENT108	7	7	2	2	glucose	STAMP2	PA449773	79689	0.534
NULL	J_Cell_Biol_1998_Aug_10_142(3)_625-633.nxml.txt.nlp	9700154	SENT107	42	42	9	9	estradiol	Raf-1	PA449503	5894	0.534
NULL	Biomed_Res_Int_2013_Jun_13_2013_493643.nxml.txt.nlp	23841073	SENT116	15	15	17	17	estradiol	ACTH	PA449503	5443	0.534
NULL	Br_J_Ophthalmol_2008_Sep_22_92(9)_1275-1282.nxml.txt.nlp	18723745	SENT124	9	9	11	11	latanoprost	BAK	PA164774763	578	0.534
NULL	Eur_Heart_J_2012_Mar_33(6)_705-713.nxml.txt.nlp	22422912	SENT161	13	13	8	8	warfarin	ARCH	PA451906	339487	0.534
NULL	Int_J_Mol_Sci_2014_Nov_25_15(12)_21703-21722.nxml.txt.nlp	25429431	SENT139	19	19	16	16	mitoxantrone	P-gp	PA450526	5243	0.534
NULL	J_Gastroenterol_2013_Jan_27_48(1)_22-30.nxml.txt.nlp	23104468	SENT84	7	7	5	5	ribavirin	IFN	PA451241	3439	0.534
NULL	Int_J_Mol_Sci_2013_Apr_2_14(4)_7273-7285.nxml.txt.nlp	23549264	SENT64	22	22	6	6	lipase	HIF-1	PA450239	29072	0.534
NULL	J_Vet_Med_Sci_2014_Nov_24_76(11)_1471-1478.nxml.txt.nlp	25056673	SENT34	4	4	6	6	chlorpromazine	CPZ	PA448964	8532	0.534
NULL	Infect_Dis_Ther_2014_Jun_18_3(1)_35-43.nxml.txt.nlp	25134810	SENT102	7	7	9	9	teicoplanin	VAN	PA164746244	10318	0.534
NULL	Oncotarget_2013_Aug_30_4(10)_1698-1711.nxml.txt.nlp	24091605	SENT175	18	18	26	26	cisplatin	TIC	PA449014	23550	0.534
NULL	AMB_Express_2014_Oct_28_4_76.nxml.txt.nlp	25401076	SENT229	25	25	10	10	l-serine	ACT	PA451330	12;11332;9457;641455	0.534
NULL	Curr_Oncol_2009_Jul_16(Suppl_2)_S14-S23.nxml.txt.nlp	19672417	SENT212	4	4	0	0	tamoxifen	ATAC	PA451581	6375	0.534
NULL	Cell_Regen_(Lond)_2012_Jun_28_1(1)_3.nxml.txt.nlp	25408866	SENT61	13	13	7	7	glucose	CO2	PA449773	4513	0.534
NULL	Clin_Ophthalmol_2009_Jun_2_3_291-295.nxml.txt.nlp	19668581	SENT12	25	25	27	27	latanoprost	BAK	PA164774763	578	0.534
NULL	Diabetes_Obes_Metab_2011_Nov_13(11)_982-989.nxml.txt.nlp	21615670	SENT22	33	33	10	10	saxagliptin	GLP-1	PA165958362	100125288	0.534
NULL	J_Korean_Med_Sci_2004_Apr_30_19(2)_167-171.nxml.txt.nlp	15082886	SENT118	48	48	0	0	ofloxacin	PTH	PA450684	5741	0.534
NULL	AIDS_Res_Ther_2012_Nov_24_9_34.nxml.txt.nlp	23181827	SENT28	9	9	3	3	guanidine	APOBEC3G	PA164781028	60489	0.534
NULL	BMJ_Open_2014_Oct_29_4(10)_e006344.nxml.txt.nlp	25354826	SENT51	16	16	22	22	heparin	ACT	PA449855	12;11332;9457;641455	0.534
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT185	14	14	23	23	atorvastatin	TRAP	PA448500	959;54;57410	0.534
NULL	Genome_Med_2010_Sep_15_2(9)_66.nxml.txt.nlp	20854646	SENT36	0	0	4	4	tramadol	CYP2D6	PA451735	1565	0.534
NULL	Evid_Based_Complement_Alternat_Med_2012_May_27_2012_272710.nxml.txt.nlp	22685484	SENT120	4	4	6	6	lipase	HSL	PA450239	3991	0.534
NULL	Case_Rep_Med_2014_Nov_12_2014_231651.nxml.txt.nlp	25477968	SENT181	4	4	9	9	amiodarone	AIT	PA448383	160728	0.534
NULL	Case_Rep_Ophthalmol_2012_Jan_31_3(1)_24-29.nxml.txt.nlp	22615697	SENT37	14	14	10	10	ofloxacin	SDU	PA450684	6393	0.534
NULL	Anesthesiol_Res_Pract_2011_Oct_25_2011_271539.nxml.txt.nlp	22110496	SENT44	27	27	14	14	desflurane	CO2	PA164749136	4513	0.534
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT163	23	23	7	7	heparin	FGF1	PA449855	2246	0.534
NULL	Indian_J_Pharmacol_2008_Oct_40(Suppl_2)_S221-S236.nxml.txt.nlp	21593976	SENT774	18	18	20	20	heparin	CD44	PA449855	960	0.534
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT14	0	0	6	6	capsaicin	p53	PA448776	7157	0.534
NULL	Stroke_Res_Treat_2009_Dec_20_2010_386389.nxml.txt.nlp	20700422	SENT156	5	5	9	9	resveratrol	NAC		22861	0.534
NULL	Mol_Biol_Cell_2013_Sep_1_24(17)_2645-2654.nxml.txt.nlp	23864714	SENT68	15	15	9	9	neomycin	Bsr	PA450608	79104	0.534
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT1674	32	32	24	24	diphenhydramine	UGT	PA449349	7361;7355	0.534
NULL	J_Cell_Biol_2001_Jun_11_153(6)_1265-1276.nxml.txt.nlp	11402069	SENT501	36	36	14	14	staurosporine	Bcl-2	PA165109623	596	0.534
NULL	Osteoporos_Int_2012_May_19_23(5)_1613-1622.nxml.txt.nlp	21769661	SENT59	6	6	11	11	teriparatide	VCF	PA451620	7413	0.534
NULL	CNS_Drugs_2014_Jul_20_28(11)_1059-1069.nxml.txt.nlp	25038977	SENT118	20	20	9	9	lisdexamfetamine	ATX	PA164748975	5168;23049	0.534
NULL	Cell_Death_Dis_2010_Oct_21_1(10)_e86.nxml.txt.nlp	21368859	SENT78	8	8	6	6	doxorubicin	TRAIL	PA449412	8743	0.534
NULL	Ann_Gen_Psychiatry_2014_Apr_1_13_10.nxml.txt.nlp	24690136	SENT133	0	0	11	11	paliperidone	5-HT2A	PA163518919	3356	0.534
NULL	Evid_Based_Complement_Alternat_Med_2013_Mar_13_2013_685642.nxml.txt.nlp	23573144	SENT49	8	8	6	6	nimodipine	STZ	PA450633	6484	0.534
NULL	Exp_Ther_Med_2013_Aug_20_6(2)_310-316.nxml.txt.nlp	24137180	SENT179	14	14	24	24	fasudil	MCP-1	PA165946121	6347	0.534
NULL	J_Exp_Bot_2008_May_59(8)_2109-2123.nxml.txt.nlp	18535297	SENT309	14	14	2	2	galactose	PC3	PA449725	57332;7832;5122	0.534
NULL	J_Immune_Based_Ther_Vaccines_2005_Sep_2_3_6.nxml.txt.nlp	16138929	SENT129	13	13	8	8	infliximab	ACR	PA452639	49	0.534
NULL	J_Hematol_Oncol_2009_Aug_12_2_36.nxml.txt.nlp	19674465	SENT22	0	0	8	8	thalidomide	IFN	PA451644	3439	0.534
NULL	Arch_Med_Sci_2013_Aug_30_9(4)_724-730.nxml.txt.nlp	24049536	SENT104	6	6	23	23	genistein	PTH	PA165109660	5741	0.534
NULL	Indian_J_Ophthalmol_2008_Sep-Oct_56(5)_439-440.nxml.txt.nlp	18711283	SENT23	5	5	3	3	azelastine	BAK	PA448517	578	0.534
NULL	Int_J_Surg_Oncol_2012_May_17_2012_347385.nxml.txt.nlp	22675624	SENT193	17	17	9	9	tamoxifen	BCS	PA451581	617	0.534
NULL	J_Exp_Med_1976_Sep_1_144(3)_840-846.nxml.txt.nlp	182900	SENT12	26	26	32	32	phenol	mol	PA450913	90527	0.534
NULL	Orphanet_J_Rare_Dis_2006_Mar_1_1_3.nxml.txt.nlp	16722573	SENT87	2	2	5	5	iron	B12	PA450087	7126;4709	0.534
NULL	Eur_J_Clin_Pharmacol_2013_Jan_11_69(6)_1275-1283.nxml.txt.nlp	23307232	SENT249	9	9	19	19	warfarin	CYP2C9	PA451906	1559	0.534
NULL	Cell_Cycle_2013_Sep_15_12(18)_3013-3024.nxml.txt.nlp	23974104	SENT157	44	44	22	22	doxorubicin	CD24	PA449412	100133941	0.534
NULL	Biomed_Res_Int_2014_Apr_27_2014_180428.nxml.txt.nlp	24877063	SENT29	4	4	0	0	chymotrypsin	BTZ	PA448994	22794	0.534
NULL	Cancers_(Basel)_2011_Mar_2_3(1)_945-970.nxml.txt.nlp	24212648	SENT587	10	10	1	1	cyclophosphamide	VEGFR2	PA449165	3791	0.534
NULL	Mol_Cancer_2012_Apr_26_11_24.nxml.txt.nlp	22537161	SENT139	36	36	34	34	pp2	MUC4		4585	0.534
NULL	Mucosal_Immunol_2013_Nov_10_6(6)_1179-1190.nxml.txt.nlp	23571504	SENT111	13	13	27	27	dextran	TRX	PA449261	7295	0.534
NULL	Drugs_2014_Jun_25_74(10)_1063-1072.nxml.txt.nlp	24962424	SENT118	7	7	0	0	isoniazid	EMB	PA450112	133418	0.534
NULL	Ann_Gastroenterol_2011_24(3)_181-187.nxml.txt.nlp	24713706	SENT119	8	8	13	13	atorvastatin	CXCL10	PA448500	3627	0.534
NULL	Biologics_2013_Apr_15_7_77-90.nxml.txt.nlp	23723688	SENT116	41	41	27	27	cetuximab	CRT	PA10040	811	0.534
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_39-54.nxml.txt.nlp	19305787	SENT148	4	4	6	6	ethanol	NR1	PA448073	27158	0.534
NULL	J_Clin_Biochem_Nutr_2009_Nov_28_45(3)_285-291.nxml.txt.nlp	19902018	SENT107	0	0	15	15	allopurinol	XDH	PA448320	7498	0.534
NULL	Arthritis_Res_Ther_2012_May_1_14(3)_R99.nxml.txt.nlp	22546542	SENT11	34	34	28	28	infliximab	IL-17	PA452639	3605	0.534
NULL	Core_Evid_2007_Nov_30_2(2)_131-150.nxml.txt.nlp	21221181	SENT161	34	34	40	40	misoprostol	ACR	PA450523	49	0.534
NULL	Diabetes_Metab_Syndr_Obes_2014_Jul_17_7_313-319.nxml.txt.nlp	25092992	SENT29	13	13	21	21	lipase	LPL	PA450239	4023	0.534
NULL	Eur_J_Clin_Pharmacol_2012_Jan_8_68(1)_29-37.nxml.txt.nlp	21739267	SENT93	23	23	25	25	paroxetine	PRX	PA450801	9588;57716	0.534
NULL	Adipocyte_2014_Jul_1_3(3)_224-229.nxml.txt.nlp	25068091	SENT77	41	41	19	19	oxygen	HNE	PA450744	1991	0.534
NULL	Cell_Cycle_2013_Sep_15_12(18)_3013-3024.nxml.txt.nlp	23974104	SENT11	2	2	20	20	doxorubicin	CD24	PA449412	100133941	0.534
NULL	J_Hematol_Oncol_2011_Feb_7_4_6.nxml.txt.nlp	21299849	SENT134	8	8	4	4	imatinib	RPS6	PA10804	6194	0.534
NULL	J_Cell_Biol_2004_Jul_5_166(1)_37-47.nxml.txt.nlp	15240568	SENT188	0	0	9	9	doxycycline	CDX2	PA449415	1045	0.534
NULL	Br_J_Cancer_2013_Jul_23_109(2)_502-511.nxml.txt.nlp	23799850	SENT43	8	8	18	18	gemcitabine	PSN1	PA449748	51251	0.534
NULL	J_Lipid_Res_2014_Mar_55(3)_385-397.nxml.txt.nlp	24347527	SENT588	6	6	8	8	lipase	HSL	PA450239	3991	0.534
NULL	J_Adv_Pract_Oncol_2012_May_1_May-Jun_3(3)_184-190.nxml.txt.nlp	25031945	SENT10	21	21	6	6	vincristine	ALK1	PA451879	6590;94	0.534
NULL	Nucleic_Acids_Res_2011_Mar_21_39(4)_1197-1207.nxml.txt.nlp	20965966	SENT201	1	1	12	12	lipase	ghrelin	PA450239	51738	0.534
NULL	Crit_Care_2011_Feb_10_15(1)_R58.nxml.txt.nlp	21310070	SENT85	11	11	22	22	filgrastim	GM-CSF	PA449626	1437	0.534
NULL	Clin_Ophthalmol_2014_Jan_7_8_177-185.nxml.txt.nlp	24531415	SENT104	25	25	21	21	dorzolamide	ANOVA	PA164748765	4858	0.534
NULL	Indian_J_Med_Res_2014_Jul_140(1)_130-137.nxml.txt.nlp	25222788	SENT8	6	6	13	13	cefotaxime	CTX	PA448852	1593	0.534
NULL	Diabetes_Care_2012_Dec_14_35(12)_2618-2625.nxml.txt.nlp	22912424	SENT215	8	8	32	32	pioglitazone	FDG	PA450970	23583	0.534
NULL	Ann_Clin_Microbiol_Antimicrob_2014_Jan_6_13_2.nxml.txt.nlp	24393536	SENT45	16	16	27	27	gentamicin	ANOVA	PA449753	4858	0.534
NULL	Eur_J_Haematol_2008_May_1_80(5)_397-406.nxml.txt.nlp	18221391	SENT137	3	3	1	1	cyclophosphamide	CTX	PA449165	1593	0.534
NULL	Front_Cell_Neurosci_2014_Jul_8_8_190.nxml.txt.nlp	25071449	SENT62	35	35	43	43	l-glutamine	CO2	PA10090	4513	0.534
NULL	Eur_J_Clin_Pharmacol_2013_Mar_11_69(3)_327-339.nxml.txt.nlp	22782539	SENT270	25	25	3	3	dabigatran	P-gp		5243	0.534
NULL	Avicenna_J_Med_2013_Apr-Jun_3(2)_37-47.nxml.txt.nlp	23930241	SENT202	13	13	5	5	cyclophosphamide	CD4	PA449165	920	0.534
NULL	Oncogene_2010_Jun_24_29(25)_3619-3629.nxml.txt.nlp	20418905	SENT192	12	12	17	17	phenol	F12	PA450913	2161	0.534
NULL	Korean_J_Anesthesiol_2013_Jan_21_64(1)_47-53.nxml.txt.nlp	23372886	SENT82	4	4	10	10	bupivacaine	PTG	PA135057240	5507	0.534
NULL	Clin_Ophthalmol_2011_Apr_18_5_495-502.nxml.txt.nlp	21573098	SENT117	20	20	18	18	gatifloxacin	BAK	PA449738	578	0.534
NULL	Oncol_Lett_2014_Mar_16_7(3)_827-833.nxml.txt.nlp	24527090	SENT147	12	12	9	9	cisplatin	IFN	PA449014	3439	0.534
NULL	Front_Genet_2013_Aug_29_4_163.nxml.txt.nlp	24009622	SENT137	20	20	8	8	ethanol	DDP	PA448073	1678	0.534
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_91-103.nxml.txt.nlp	17912639	SENT70	8	8	11	11	trastuzumab	HER2	PA451743	2064	0.534
NULL	Front_Neural_Circuits_2013_Oct_2_7_155.nxml.txt.nlp	24106462	SENT140	41	41	24	24	haloperidol	CPU	PA449841	1361	0.534
NULL	Core_Evid_2011_Apr_4_6_43-57.nxml.txt.nlp	21654882	SENT310	15	15	13	13	vorinostat	DDP	PA164748224	1678	0.534
NULL	J_Physiol_2009_Feb_15_587(Pt_4)_731-744.nxml.txt.nlp	19074966	SENT177	27	27	4	4	taurine	PAT1	PA451590	10513;206358	0.534
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT128	5	5	0	0	mexiletine	CYP1A2	PA450488	1544	0.534
NULL	Clin_Interv_Aging_2015_Jan_6_10_157-174.nxml.txt.nlp	25609933	SENT251	30	30	8	8	tamoxifen	BCS	PA451581	617	0.534
NULL	Breast_Cancer_Res_2006_Nov_14_8(6)_112.nxml.txt.nlp	17118219	SENT32	2	2	0	0	diethylstilbestrol	DES	PA449307	1674	0.534
NULL	ACS_Chem_Biol_2011_Apr_15_6(4)_325-335.nxml.txt.nlp	21175222	SENT132	8	8	20	20	chymotrypsin	L41	PA448994	6171	0.534
NULL	Arq_Bras_Cardiol_2013_Aug_101(2)_117-126.nxml.txt.nlp	23821408	SENT43	12	12	6	6	sirolimus	DES	PA451365	1674	0.534
NULL	Infect_Drug_Resist_2012_Jan_19_5_23-35.nxml.txt.nlp	22294860	SENT51	11	11	0	0	vancomycin	VISA	PA451850	57506	0.534
NULL	J_Gen_Physiol_1993_Nov_1_102(5)_897-906.nxml.txt.nlp	8301262	SENT0	12	12	1	1	glucose	Gen	PA449773	348654	0.534
NULL	Biomed_Res_Int_2014_Jan_29_2014_361020.nxml.txt.nlp	24605326	SENT223	1	1	8	8	staurosporine	CDK1	PA165109623	983	0.534
NULL	Adv_Ther_2014_Dec_2_31_1228-1246.nxml.txt.nlp	25447269	SENT199	26	26	23	23	timolol	TIM	PA451690	7984;8914	0.534
NULL	Front_Plant_Sci_2011_Dec_26_2_101.nxml.txt.nlp	22639623	SENT124	17	17	7	7	erlotinib	EGFR	PA134687924	1956	0.534
NULL	Arch_Med_Sci_2013_Apr_20_9(2)_361-367.nxml.txt.nlp	23671450	SENT128	1	1	4	4	budesonide	HIF-1	PA448681	29072	0.534
NULL	Biomed_Res_Int_2014_Jun_3_2014_691724.nxml.txt.nlp	24995321	SENT231	39	39	31	31	heparin	ADP	PA449855	23038	0.534
NULL	Biomed_Res_Int_2014_Feb_27_2014_827415.nxml.txt.nlp	24719890	SENT47	13	13	9	9	bortezomib	HuR	PA10252	1994	0.534
NULL	J_Ophthalmol_2011_Aug_8_2011_706849.nxml.txt.nlp	21845214	SENT85	30	30	15	15	fluorescein	PED	PA164746009	8682	0.534
NULL	Br_J_Cancer_2006_Feb_13_94(3)_407-426.nxml.txt.nlp	16434996	SENT296	0	0	2	2	genistein	BRCA1	PA165109660	672	0.534
NULL	Mediators_Inflamm_2010_Jun_29_2010_627803.nxml.txt.nlp	20671920	SENT33	32	32	21	21	estradiol	IL-6	PA449503	3569	0.534
NULL	J_Oncol_2013_Feb_17_2013_872957.nxml.txt.nlp	23476648	SENT204	8	8	14	14	cisplatin	SFN	PA449014	25996;2810	0.534
NULL	Oncol_Lett_2014_Jun_8_7(6)_2035-2040.nxml.txt.nlp	24932285	SENT168	22	22	0	0	cisplatin	UGT1A1	PA449014	54658	0.534
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT192	43	43	30	30	gefitinib	Yes	PA131301952	7525	0.534
NULL	Acta_Histochem_Cytochem_2011_Apr_28_44(2)_81-90.nxml.txt.nlp	21614169	SENT236	8	8	10	10	hyaluronan	LYVE-1	PA165958431	10894	0.534
NULL	Front_Comput_Neurosci_2013_Apr_5_7_22.nxml.txt.nlp	23576979	SENT56	2	2	9	9	etomidate	HCN1	PA164743987	348980	0.534
NULL	Exp_Ther_Med_2014_Aug_6_8(2)_585-590.nxml.txt.nlp	25009624	SENT128	14	14	27	27	glucose	ROS	PA449773	6098	0.534
NULL	J_Immunol_Res_2014_May_12_2014_897249.nxml.txt.nlp	24901013	SENT180	6	6	14	14	natalizumab	PTEN	PA164747191	5728	0.534
NULL	Br_J_Cancer_2013_Jul_23_109(2)_351-359.nxml.txt.nlp	23799854	SENT144	13	13	7	7	paclitaxel	MDR1	PA450761	5243	0.534
NULL	Oncotarget_2013_Nov_7_4(12)_2550-2566.nxml.txt.nlp	24334291	SENT42	6	6	13	13	dasatinib	RAI	PA162372878	10848;6050	0.534
NULL	Front_Endocrinol_(Lausanne)_2013_Mar_18_4_23.nxml.txt.nlp	23515889	SENT232	20	20	18	18	estradiol	ACTH	PA449503	5443	0.534
NULL	Curr_Oncol_2009_Jul_16(Suppl_2)_S1-S13.nxml.txt.nlp	19672416	SENT301	20	20	0	0	tamoxifen	ATAC	PA451581	6375	0.534
NULL	Oncotarget_2011_Nov_30_2(11)_874-885.nxml.txt.nlp	22141136	SENT228	0	0	10	10	staurosporine	PP2	PA165109623	4888	0.534
NULL	Ann_Med_Health_Sci_Res_2014_Jul-Aug_4(Suppl_2)_S115-S118.nxml.txt.nlp	25184076	SENT98	15	15	0	0	bupivacaine	Ray	PA135057240	26751	0.534
NULL	Eur_J_Nutr_2009_Jun_24_48(4)_229-234.nxml.txt.nlp	19238310	SENT41	17	17	24	24	capsaicin	GLP-1	PA448776	100125288	0.534
NULL	Nat_Commun_2014_Nov_25_5_5548.nxml.txt.nlp	25420520	SENT67	14	14	30	30	cabazitaxel	P-gp	PA165958401	5243	0.534
NULL	Libyan_J_Med_2007_Dec_1_2(4)_176-179.nxml.txt.nlp	21503241	SENT23	26	26	33	33	vancomycin	VISA	PA451850	57506	0.534
NULL	J_Headache_Pain_2013_Feb_21_14(Suppl_1)_P124.nxml.txt.nlp	NULL	SENT6	7	7	18	18	capsaicin	TRPV1	PA448776	7442	0.534
NULL	Cardiovasc_Diabetol_2013_Nov_12_12_169.nxml.txt.nlp	24215514	SENT305	6	6	8	8	valsartan	ANG	PA451848	283	0.534
NULL	Cell_Death_Dis_2012_Nov_15_3(11)_e422.nxml.txt.nlp	23152058	SENT89	10	10	20	20	cisplatin	ZNF143	PA449014	7702	0.534
NULL	Neuroscience_2008_Aug_13_155(2)_556-564.nxml.txt.nlp	18619738	SENT163	11	11	9	9	choline	CDP	PA448976	1523	0.534
NULL	Am_J_Pathol_2011_Jul_179(1)_23-29.nxml.txt.nlp	21703391	SENT37	35	35	23	23	fluorescein	San	PA164746009	80218	0.534
NULL	Asian_J_Transfus_Sci_2011_Jan_5(1)_11-14.nxml.txt.nlp	21572707	SENT132	22	22	18	18	thrombin	ADP	PA451674	23038	0.534
NULL	F1000_Med_Rep_2009_Dec_9_1_93.nxml.txt.nlp	20948684	SENT80	0	0	6	6	estradiol	TSC2	PA449503	7249	0.534
NULL	Case_Rep_Hematol_2014_Aug_6_2014_635237.nxml.txt.nlp	25165587	SENT20	16	16	6	6	melphalan	BTD	PA450354	686	0.533
NULL	Oncol_Lett_2014_Mar_16_7(3)_871-877.nxml.txt.nlp	24527095	SENT234	14	14	0	0	paclitaxel	TLR4	PA450761	7099	0.533
NULL	Cell_Commun_Signal_2013_Feb_20_11_13.nxml.txt.nlp	23425659	SENT35	27	27	8	8	midazolam	MCAD	PA450496	34	0.533
NULL	Infection_2012_Dec_12_40(6)_601-611.nxml.txt.nlp	22968971	SENT38	4	4	11	11	ethanol	gamma	PA448073	9913	0.533
NULL	J_Exp_Med_1968_Oct_1_128(4)_699-713.nxml.txt.nlp	19867304	SENT6	9	9	12	12	galactose	NAG	PA449725	51594;4669	0.533
NULL	Neural_Plast_2012_Jun_13_2012_171636.nxml.txt.nlp	22745917	SENT153	1	1	13	13	curcumin	CMT1A	PA151958596	1248	0.533
NULL	Pain_Res_Treat_2012_Apr_23_2012_295926.nxml.txt.nlp	22577544	SENT60	15	15	32	32	dexketoprofen	DLD	PA166049175	1738	0.533
NULL	Open_AIDS_J_2010_Jan_19_4_70-75.nxml.txt.nlp	20200604	SENT220	34	34	36	36	emtricitabine	ATV	PA10069	4683	0.533
NULL	Crit_Care_2011_Jun_29_15(3)_R160.nxml.txt.nlp	21714857	SENT43	10	10	31	31	fenoldopam	NGAL	PA164784034	3934	0.533
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Apr_15_6_37-41.nxml.txt.nlp	24833915	SENT38	36	36	27	27	trastuzumab	DM1	PA451743	338023;1760;28509	0.533
NULL	Depress_Res_Treat_2011_Jul_18_2011_529638.nxml.txt.nlp	21789279	SENT78	24	24	15	15	lithium	GSK3B	PA450243	2932	0.533
NULL	Exp_Mol_Med_2012_Sep_30_44(9)_545-553.nxml.txt.nlp	22809901	SENT10	3	3	16	16	quetiapine	adiponectin	PA451201	9370	0.533
NULL	Cardiovasc_J_Afr_2009_May_20(3)_162-167.nxml.txt.nlp	19575078	SENT9	14	14	6	6	indomethacin	EDRF	PA449982	51327	0.533
NULL	Onco_Targets_Ther_2014_Jul_12_7_1273-1284.nxml.txt.nlp	25050069	SENT36	34	34	31	31	trabectedin	CYP3A4	PA165958349	1576	0.533
NULL	Evid_Based_Complement_Alternat_Med_2014_Oct_29_2014_594354.nxml.txt.nlp	25530784	SENT57	3	3	5	5	trifluoperazine	TFP	PA451771	7034	0.533
NULL	Ann_Oncol_2009_Nov_23_20(11)_1803-1812.nxml.txt.nlp	19549706	SENT28	19	19	23	23	sunitinib	IFN	PA162372840	3439	0.533
NULL	Evid_Based_Complement_Alternat_Med_2014_Sep_2_2014_627181.nxml.txt.nlp	25258643	SENT114	2	2	0	0	losartan	TMP	PA450268	2012	0.533
NULL	Int_J_Vasc_Med_2013_Mar_31_2013_543141.nxml.txt.nlp	23606968	SENT132	0	0	17	17	etanercept	IL-6	PA449515	3569	0.533
NULL	Oncotarget_2013_Apr_15_4(4)_636-646.nxml.txt.nlp	23592437	SENT221	34	34	36	36	decitabine	DAC	PA164749631	13	0.533
NULL	Front_Oncol_2014_Jun_18_4_153.nxml.txt.nlp	24995158	SENT682	12	12	9	9	temozolomide	P4HB	PA451609	5034	0.533
NULL	EvoDevo_2013_Nov_4_4_31.nxml.txt.nlp	24180614	SENT100	10	10	12	12	dextran	RDX	PA449261	5962	0.533
NULL	Oncotarget_2012_Jan_28_3(1)_22-30.nxml.txt.nlp	22289880	SENT116	18	18	32	32	rituximab	IFN	PA451261	3439	0.533
NULL	Acta_Pharmacol_Sin_2010_Jul_21_31(7)_855-860.nxml.txt.nlp	20562904	SENT14	10	10	21	21	fluconazole	CDR1	PA449653	1038	0.533
NULL	J_Cell_Biol_1983_May_1_96(5)_1234-1240.nxml.txt.nlp	6404909	SENT12	10	10	8	8	thrombin	ADP	PA451674	23038	0.533
NULL	Leukemia_2014_Jun_25_28(6)_1280-1288.nxml.txt.nlp	24270737	SENT105	13	13	25	25	decitabine	PD-L2	PA164749631	80380	0.533
NULL	Neuroimage_Clin_2013_Sep_3_3_242-248.nxml.txt.nlp	24273709	SENT294	2	2	24	24	carbamazepine	PRG	PA448785	5544	0.533
NULL	Asia_Pac_Allergy_2013_Jul_30_3(3)_194-199.nxml.txt.nlp	23956966	SENT70	2	2	8	8	methacholine	IL-13	PA165958382	3596	0.533
NULL	Acta_Pharmacol_Sin_2010_Jul_28_31(7)_805-812.nxml.txt.nlp	20581856	SENT77	28	28	35	35	heparin	CO2	PA449855	4513	0.533
NULL	Clin_Interv_Aging_2013_Jan_31_8_103-110.nxml.txt.nlp	23386786	SENT111	18	18	11	11	atorvastatin	IL-6	PA448500	3569	0.533
NULL	Clinicoecon_Outcomes_Res_2014_Sep_23_6_409-414.nxml.txt.nlp	25285019	SENT143	12	12	2	2	emtricitabine	ATV	PA10069	4683	0.533
NULL	Iran_J_Pharm_Res_2014_Spring_13(2)_551-559.nxml.txt.nlp	25237350	SENT4	19	19	4	4	ethanol	TPC	PA448073	8030;60386	0.533
NULL	Oncol_Lett_2013_Sep_1_6(3)_840-844.nxml.txt.nlp	24137422	SENT122	8	8	0	0	berberine	TRAIL	PA165860812	8743	0.533
NULL	Curr_Neuropharmacol_2014_May_12(3)_219-238.nxml.txt.nlp	24851087	SENT128	26	26	8	8	sertindole	PSD-95	PA164784002	1742	0.533
NULL	Curr_Neuropharmacol_2008_Sep_6(3)_215-234.nxml.txt.nlp	19506722	SENT277	0	0	2	2	fluoxetine	AVP	PA449673	114548;551	0.533
NULL	Diabetes_2013_Jun_17_62(6)_1816-1817.nxml.txt.nlp	23704523	SENT24	18	18	27	27	oxygen	ECM	PA450744	22915	0.533
NULL	Nucleic_Acids_Res_2011_Mar_4_39(5)_1843-1854.nxml.txt.nlp	21051342	SENT198	35	35	16	16	carbenicillin	IFN	PA448788	3439	0.533
NULL	Int_J_Environ_Res_Public_Health_2013_Sep_12_10(9)_4274-4305.nxml.txt.nlp	24036486	SENT71	23	23	25	25	meropenem	HCAP	PA164764445	117159;9126	0.533
NULL	Oncoimmunology_2014_Jun_3_3_e29030.nxml.txt.nlp	25083328	SENT57	13	13	38	38	temozolomide	IFN	PA451609	3439	0.533
NULL	Emerg_Infect_Dis_2011_Oct_17(10)_1879-1882.nxml.txt.nlp	22000360	SENT60	6	6	0	0	oxacillin	PEN	PA450725	9933	0.533
NULL	Front_Immunol_2013_Oct_29_4_338.nxml.txt.nlp	24194738	SENT209	11	11	16	16	estradiol	TLR3	PA449503	7098	0.533
NULL	Br_J_Cancer_1996_Apr_73(7)_849-855.nxml.txt.nlp	8611394	SENT12	11	11	5	5	calcein	MAF	PA132595336	4094	0.533
NULL	J_Ginseng_Res_2011_Jun_35(2)_219-225.nxml.txt.nlp	23717064	SENT149	20	20	26	26	scopolamine	spatial	PA451308	219793	0.533
NULL	Mol_Biol_Cell_2014_May_1_25(9)_1411-1420.nxml.txt.nlp	24623724	SENT116	21	21	13	13	doxycycline	ATF6	PA449415	22926	0.533
NULL	Biosci_Rep_2012_Aug_1_32(Pt_4)_361-374.nxml.txt.nlp	22762204	SENT61	23	23	3	3	doxorubicin	p53	PA449412	7157	0.533
NULL	Cancer_Med_2014_Oct_25_3(5)_1099-1111.nxml.txt.nlp	24961511	SENT257	32	32	18	18	cisplatin	DUSP6	PA449014	1848	0.533
NULL	Oncogene_2014_Aug_28_33(35)_4396-4406.nxml.txt.nlp	24531714	SENT58	0	0	19	19	nutlin-3	p53		7157	0.533
NULL	Lab_Invest_2009_Nov_7_89(11)_1275-1290.nxml.txt.nlp	19736547	SENT166	10	10	27	27	curcumin	LOX-1	PA151958596	4973	0.533
NULL	Cases_J_2009_Jul_30_2_7134.nxml.txt.nlp	19829918	SENT45	25	25	17	17	levodopa	LCE	PA450213	79071	0.533
NULL	J_Breast_Cancer_2011_Jun_18_14(2)_135-139.nxml.txt.nlp	21847409	SENT21	38	38	36	36	exemestane	aromatase	PA449563	1588	0.533
NULL	Arthritis_Res_Ther_2004_Feb_24_6(Suppl_1)_86.nxml.txt.nlp	NULL	SENT20	3	3	6	6	abatacept	IL-6	PA164747080	3569	0.533
NULL	Front_Microbiol_2015_Jan_15_5_798.nxml.txt.nlp	25642226	SENT65	8	8	3	3	oxygen	p53	PA450744	7157	0.533
NULL	Clin_Med_Insights_Oncol_2013_Jul_4_7_159-163.nxml.txt.nlp	23885182	SENT86	22	22	27	27	vincristine	CHOP	PA451879	1649	0.533
NULL	Eur_J_Med_Chem_2014_Nov_24_87_722-734.nxml.txt.nlp	25305716	SENT28	22	22	14	14	ezetimibe	NPC1L1	PA10816	29881	0.533
NULL	J_Hum_Hypertens_2011_Feb_13_25(2)_114-121.nxml.txt.nlp	20463748	SENT81	4	4	24	24	cosyntropin	ADX	PA164749052	2230	0.533
NULL	Br_J_Cancer_2013_Jul_23_109(2)_502-511.nxml.txt.nlp	23799850	SENT258	10	10	26	26	gemcitabine	PSN1	PA449748	51251	0.533
NULL	Apoptosis_2014_Aug_26_19(11)_1603-1615.nxml.txt.nlp	25156145	SENT258	2	2	0	0	mitomycin	TRAIL	PA450524	8743	0.533
NULL	J_Cell_Biol_1998_Jan_12_140(1)_233-245.nxml.txt.nlp	9425170	SENT363	20	20	6	6	urokinase	CD87	PA451836	5329	0.533
NULL	Front_Behav_Neurosci_2012_Sep_18_6_61.nxml.txt.nlp	23049505	SENT113	15	15	7	7	donepezil	ANOVA	PA449394	4858	0.533
NULL	Iran_Red_Crescent_Med_J_2014_Mar_5_16(3)_e15344.nxml.txt.nlp	24829782	SENT10	10	10	28	28	sibutramine	slim	PA451344	23008	0.533
NULL	Environ_Health_Perspect_1990_Apr_85_89-94.nxml.txt.nlp	2384071	SENT6	4	4	2	2	methylprednisolone	NAC	PA450466	22861	0.533
NULL	Cell_Mol_Life_Sci_2011_Aug_6_68(15)_2525-2538.nxml.txt.nlp	21547502	SENT133	24	24	18	18	arsenite	CD36	PA452638	948	0.533
NULL	Eur_J_Clin_Microbiol_Infect_Dis_2010_Nov_1_29(11)_1361-1367.nxml.txt.nlp	20680368	SENT32	11	11	19	19	cefotaxime	VAN	PA448852	10318	0.533
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT40	7	7	25	25	pemetrexed	UNG	PA10810	7374	0.533
NULL	J_Asthma_Allergy_2011_Apr_14_4_27-35.nxml.txt.nlp	21698213	SENT32	14	14	33	33	rupatadine	C10		113246	0.533
NULL	Int_J_Biomater_2012_May_22_2012_743465.nxml.txt.nlp	22675359	SENT65	25	25	48	48	kanamycin	CO2	PA450137	4513	0.533
NULL	Mar_Drugs_2014_Sep_25_12(9)_4984-5020.nxml.txt.nlp	25257786	SENT124	2	2	12	12	heparin	SP2	PA449855	6668	0.533
NULL	Br_J_Cancer_1995_Aug_72(2)_399-404.nxml.txt.nlp	7640225	SENT6	9	9	2	2	camptothecin	TPT	PA153590860	23590;6469	0.533
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT195	35	35	25	25	metformin	HIP	PA450395	6767;6159;64399;5068	0.533
NULL	Pharmaceuticals_(Basel)_2012_Oct_25_5(11)_1147-1159.nxml.txt.nlp	23580869	SENT355	6	6	11	11	ethionamide	FMO1	PA164768738	2326	0.533
NULL	Ann_Surg_Treat_Res_2014_Feb_22_86(2)_68-75.nxml.txt.nlp	24761411	SENT143	14	14	4	4	oxaliplatin	survivin	PA131285527	332	0.533
NULL	Nat_Genet_2011_Jan_12_43(1)_27-33.nxml.txt.nlp	21151129	SENT111	10	10	6	6	tamoxifen	FOXA1	PA451581	3169	0.533
NULL	Clin_Ophthalmol_2013_Dec_31_7_39-45.nxml.txt.nlp	23308037	SENT36	44	44	31	31	triamcinolone	San	PA451749	80218	0.533
NULL	Ann_Rheum_Dis_2013_Aug_21_72(8)_1287-1294.nxml.txt.nlp	22915624	SENT132	10	10	16	16	methotrexate	MRI	PA450428	78996	0.533
NULL	J_Korean_Med_Sci_2010_Dec_24_25(12)_1766-1770.nxml.txt.nlp	21165292	SENT131	28	28	0	0	glucose	GFR	PA449773	9771	0.533
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Apr_23_64(Pt_5)_m709.nxml.txt.nlp	21202239	SENT56	13	13	22	22	ethanol	mol	PA448073	90527	0.533
NULL	Adv_Biomed_Res_2014_Mar_25_3_97.nxml.txt.nlp	24800186	SENT103	20	20	14	14	sertraline	MAP2	PA451333	4133;10988	0.533
NULL	Breast_Cancer_Res_2011_Nov_1_13(6)_R109.nxml.txt.nlp	22044691	SENT374	13	13	42	42	docetaxel	S12	PA449383	3351;6206;5713;6268	0.533
NULL	Clin_Med_Insights_Oncol_2011_Mar_16_5_35-43.nxml.txt.nlp	21499557	SENT269	14	14	23	23	trabectedin	IFF	PA165958349	3456	0.533
NULL	Oncogene_2013_Sep_12_32(37)_4355-4365.nxml.txt.nlp	23108409	SENT154	2	2	10	10	hyaluronan	HAS2	PA165958431	3037	0.533
NULL	Cancer_Manag_Res_2013_Aug_27_5_225-233.nxml.txt.nlp	24023523	SENT159	3	3	15	15	rituximab	CD52	PA451261	1043	0.533
NULL	Cardiovasc_Diabetol_2013_Jun_7_12_84.nxml.txt.nlp	23759020	SENT111	3	3	5	5	dipyridamole	LSR	PA449367	51599	0.533
NULL	Int_J_Mol_Sci_2014_Sep_11_15(9)_16043-16056.nxml.txt.nlp	25216337	SENT719	3	3	5	5	estradiol	IL-2	PA449503	3558	0.533
NULL	Scientifica_(Cairo)_2013_Feb_7_2013_249101.nxml.txt.nlp	24278770	SENT126	0	0	17	17	mitoxantrone	IFN	PA450526	3439	0.533
NULL	Indian_J_Nephrol_2013_Jul-Aug_23(4)_287-291.nxml.txt.nlp	23960346	SENT129	14	14	16	16	rituximab	CHOP	PA451261	1649	0.533
NULL	Case_Rep_Ophthalmol_Med_2013_Sep_12_2013_213124.nxml.txt.nlp	24109538	SENT47	10	10	4	4	gefitinib	EGFR	PA131301952	1956	0.533
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1522-1532.nxml.txt.nlp	21997136	SENT154	0	0	6	6	gefitinib	UGT1A1	PA131301952	54658	0.533
NULL	J_Autoimmune_Dis_2005_Nov_9_2_9.nxml.txt.nlp	16280086	SENT51	6	6	1	1	methimazole	Yes	PA450422	7525	0.533
NULL	Aging_(Albany_NY)_2010_Dec_20_2(12)_959-968.nxml.txt.nlp	21191146	SENT24	6	6	15	15	cisplatin	Rpn13	PA449014	11047	0.533
NULL	Oncol_Lett_2013_Feb_3_5(2)_505-510.nxml.txt.nlp	23420812	SENT6	29	29	2	2	cisplatin	AEG-1	PA449014	92140	0.533
NULL	Indian_J_Med_Res_2011_Sep_134(3)_295-301.nxml.txt.nlp	21985811	SENT106	21	21	24	24	phenytoin	CYP2C19	PA450947	1557	0.533
NULL	Int_J_Impot_Res_2009_Sep_18_21(5)_306-310.nxml.txt.nlp	19536124	SENT126	13	13	0	0	silodosin	Yes	PA165291889	7525	0.533
NULL	J_Hematol_Oncol_2010_Mar_23_3_11.nxml.txt.nlp	20331897	SENT163	8	8	10	10	oxaliplatin	CRT	PA131285527	811	0.533
NULL	J_Mol_Signal_2006_Dec_6_1_8.nxml.txt.nlp	17224083	SENT44	3	3	6	6	thrombin	Rho	PA451674	29984	0.533
NULL	Curr_Neuropharmacol_2008_Jun_6(2)_151-163.nxml.txt.nlp	19305794	SENT119	9	9	21	21	capsaicin	COX	PA448776	1351	0.533
NULL	Nucleic_Acids_Res_2005_Jun_8_33(10)_3283-3291.nxml.txt.nlp	15944449	SENT166	19	19	11	11	melphalan	ERCC1	PA450354	2067	0.533
NULL	Br_J_Pharmacol_2012_Jan_165(2)_390-400.nxml.txt.nlp	21671897	SENT191	0	0	14	14	suramin	P2X1	PA10292	5023	0.533
NULL	Biomed_Res_Int_2013_Sep_5_2013_929531.nxml.txt.nlp	24083250	SENT56	25	25	15	15	hyaluronan	HAS1	PA165958431	3036	0.533
NULL	Hum_Genomics_2008_Sep_1_3(1)_71-78.nxml.txt.nlp	19129091	SENT32	17	17	24	24	nadh	ND2	PA164755085	4536	0.533
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Oct_4_70(Pt_11)_269-271.nxml.txt.nlp	25484720	SENT6	41	41	36	36	nitrile	mol	PA450636	90527	0.533
NULL	J_Hematol_Oncol_2012_Sep_18_5_57.nxml.txt.nlp	22989009	SENT202	7	7	29	29	nutlin-3	HDM2		4193	0.533
NULL	Cancers_(Basel)_2011_Aug_5_3(3)_3114-3142.nxml.txt.nlp	24212948	SENT1127	13	13	8	8	gemcitabine	WT1	PA449748	7490	0.533
NULL	Int_J_Med_Sci_2013_Jun_20_10(8)_1035-1046.nxml.txt.nlp	23801891	SENT71	25	25	12	12	trypsin	CO2	PA451806	4513	0.533
NULL	Comp_Hepatol_2004_Jan_14_3(Suppl_1)_S31.nxml.txt.nlp	14960183	SENT80	6	6	9	9	ethanol	TNF-alpha	PA448073	7124	0.533
NULL	Front_Genet_2013_Aug_29_4_163.nxml.txt.nlp	24009622	SENT50	6	6	0	0	ethanol	ABCG2	PA448073	9429	0.533
NULL	Mol_Vis_2011_Aug_18_17_2241-2247.nxml.txt.nlp	21897746	SENT46	16	16	14	14	fluorescein	ERG	PA164746009	2078	0.533
NULL	Oncol_Lett_2014_Apr_7_7(4)_1313-1319.nxml.txt.nlp	24660038	SENT202	24	24	0	0	imatinib	P-gp	PA10804	5243	0.533
NULL	Ann_Clin_Microbiol_Antimicrob_2005_Sep_13_4_13.nxml.txt.nlp	16159399	SENT137	35	35	27	27	lamivudine	IFN	PA450163	3439	0.533
NULL	Cardiovasc_Res_2013_May_1_98(2)_286-296.nxml.txt.nlp	23334259	SENT177	9	9	4	4	flecainide	NCX	PA449646	3196	0.533
NULL	Nucleic_Acids_Res_2006_Jun_6_34(10)_3067-3081.nxml.txt.nlp	16757574	SENT663	16	16	2	2	lipase	PPARgamma	PA450239	5468	0.533
NULL	Crit_Care_2007_Dec_18_11(6)_178.nxml.txt.nlp	18177510	SENT2	2	2	4	4	vasopressin	AVP	PA451858	114548;551	0.533
NULL	J_Immunother_Cancer_2014_Jan_27_2_2.nxml.txt.nlp	24829759	SENT169	3	3	6	6	sorafenib	IFN	PA7000	3439	0.533
NULL	Nat_Biotechnol_2010_Aug_2_28(8)_839-847.nxml.txt.nlp	20601939	SENT187	10	10	30	30	l-glutamine	IL-3	PA10090	3562	0.533
NULL	Oncotarget_2013_Nov_7_4(12)_2550-2566.nxml.txt.nlp	24334291	SENT201	13	13	18	18	dasatinib	AMPK	PA162372878	5563	0.533
NULL	Oxid_Med_Cell_Longev_2012_Mar_13_2012_768101.nxml.txt.nlp	22530077	SENT310	17	17	20	20	fluorescein	p67phox	PA164746009	4688	0.533
NULL	Mol_Biol_Cell_2013_Jun_15_24(12)_1974-1995.nxml.txt.nlp	23615442	SENT493	32	32	11	11	l-glutamine	F12	PA10090	2161	0.533
NULL	J_Gen_Physiol_2003_Feb_121(2)_97-110.nxml.txt.nlp	12566538	SENT248	13	13	23	23	trypsin	ANOVA	PA451806	4858	0.533
NULL	ARYA_Atheroscler_2012_Summer_8(2)_70-75.nxml.txt.nlp	23056106	SENT134	36	36	25	25	dextran	IIS	PA449261	404552	0.533
NULL	J_Gen_Physiol_1997_Jul_1_110(1)_1-10.nxml.txt.nlp	9234166	SENT49	31	31	10	10	l-glutamine	CO2	PA10090	4513	0.533
NULL	Int_J_Breast_Cancer_2012_Nov_2_2012_217185.nxml.txt.nlp	22295242	SENT203	17	17	25	25	bicalutamide	PI3K	PA164746255	5290	0.533
NULL	Mol_Biol_Cell_2014_Jan_1_25(1)_76-86.nxml.txt.nlp	24173717	SENT287	9	9	11	11	colchicine	NLRP3	PA449092	114548	0.533
NULL	ISRN_Neurol_2014_Jan_22_2014_861091.nxml.txt.nlp	24587917	SENT17	19	19	27	27	natalizumab	DMT	PA164747191	2039	0.533
NULL	Biomed_Res_Int_2014_Feb_19_2014_627510.nxml.txt.nlp	24701578	SENT259	12	12	10	10	docetaxel	CYP1B1	PA449383	1545	0.533
NULL	Anat_Cell_Biol_2014_Jun_20_47(2)_83-90.nxml.txt.nlp	24987544	SENT10	17	17	21	21	lipase	adiponectin	PA450239	9370	0.533
NULL	Arthritis_Res_Ther_2006_Mar_15_8(3)_R58.nxml.txt.nlp	16542506	SENT267	18	18	6	6	collagenase	GAPDH	PA449107	2597	0.533
NULL	Cardiovasc_Diabetol_2013_Jun_8_12_86.nxml.txt.nlp	23758640	SENT135	21	21	28	28	glucose	CAD	PA449773	1677;790	0.533
NULL	Biomed_Res_Int_2014_Jun_26_2014_321486.nxml.txt.nlp	25054138	SENT104	35	35	33	33	raloxifene	ESR1	PA451221	2099	0.533
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Aug_9_70(Pt_9)_o987-o988.nxml.txt.nlp	25309295	SENT6	31	31	27	27	nitrile	mol	PA450636	90527	0.533
NULL	J_Cancer_Prev_2014_Mar_19(1)_39-46.nxml.txt.nlp	25337571	SENT98	24	24	18	18	ethanol	p53	PA448073	7157	0.533
NULL	Cell_Host_Microbe_2013_Mar_13_13(3)_324-335.nxml.txt.nlp	23498957	SENT384	3	3	11	11	bortezomib	TRAIL	PA10252	8743	0.533
NULL	Oncoimmunology_2013_Jan_1_2(1)_e22890.nxml.txt.nlp	23483066	SENT76	0	0	12	12	sorafenib	IFN	PA7000	3439	0.533
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_May_29_65(Pt_6)_m697.nxml.txt.nlp	21583052	SENT68	15	15	3	3	ethanol	NO3	PA448073	4681	0.533
NULL	Nutr_J_2014_Jan_24_13_11.nxml.txt.nlp	24461029	SENT35	22	22	11	11	curcumin	CTR	PA151958596	799	0.533
NULL	Cancer_Cell_Int_2011_Nov_17_11_40.nxml.txt.nlp	22088142	SENT147	25	25	33	33	gemcitabine	EGFR	PA449748	1956	0.533
NULL	Diabetes_Metab_Syndr_Obes_2009_Jun_12_2_83-90.nxml.txt.nlp	21437121	SENT55	3	3	1	1	exenatide	GLP-1	PA164749238	100125288	0.533
NULL	Int_J_Cell_Biol_2009_Dec_30_2009_750482.nxml.txt.nlp	20130821	SENT52	32	32	36	36	hydrocortisone	San	PA449905	80218	0.533
NULL	Br_J_Cancer_2012_Jan_17_106(2)_284-289.nxml.txt.nlp	22215065	SENT51	5	5	13	13	atrasentan	IFN	PA143414738	3439	0.533
NULL	Bone_Marrow_Transplant_2012_Feb_28_47(2)_203-211.nxml.txt.nlp	21441963	SENT106	16	16	1	1	cyclophosphamide	NMA	PA449165	25805	0.533
NULL	Int_J_Biol_Sci_2006_Mar_1_2(1)_1-9.nxml.txt.nlp	16585947	SENT53	19	19	4	4	pp2	PP1		5540;5464	0.533
NULL	Acta_Pharmacol_Sin_2014_Jun_4_35(6)_752-757.nxml.txt.nlp	24902786	SENT96	14	14	25	25	tamoxifen	STL2	PA451581	1301	0.533
NULL	Diagn_Pathol_2013_Feb_22_8_33.nxml.txt.nlp	23432846	SENT94	13	13	19	19	cisplatin	ADM	PA449014	133	0.533
NULL	Br_J_Cancer_2013_Apr_16_108(7)_1408-1414.nxml.txt.nlp	23511562	SENT17	12	12	6	6	tamoxifen	aromatase	PA451581	1588	0.533
NULL	Mol_Cancer_2012_Jun_18_11_41.nxml.txt.nlp	22709873	SENT328	3	3	12	12	lapatinib	CCND1	PA152241907	595	0.533
NULL	Gut_Pathog_2010_Dec_7_2_17.nxml.txt.nlp	21138594	SENT39	44	44	32	32	trimethoprim	OTC	PA451788	5009	0.533
NULL	Cancer_Cell_Int_2013_Jun_26_13_63.nxml.txt.nlp	23800022	SENT227	12	12	17	17	genistein	XIAP	PA165109660	331	0.533
NULL	Curr_Neuropharmacol_2011_Dec_9(4)_530-552.nxml.txt.nlp	22654714	SENT906	8	8	24	24	venlafaxine	BDNF	PA451866	627	0.533
NULL	Cerebrospinal_Fluid_Res_2006_Dec_21_3(Suppl_1)_S41.nxml.txt.nlp	NULL	SENT13	23	23	21	21	hyaluronan	OTS	PA165958431	5012	0.532
NULL	Case_Rep_Radiol_2012_Dec_17_2012_146540.nxml.txt.nlp	23316405	SENT71	3	3	9	9	irinotecan	CEA	PA450085	5670;1087	0.532
NULL	J_Korean_Med_Sci_2010_Apr_19_25(4)_557-563.nxml.txt.nlp	20357998	SENT9	2	2	8	8	rosiglitazone	IL-10	PA451283	3586	0.532
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT271	30	30	6	6	phenprocoumon	CYP2C9	PA450921	1559	0.532
NULL	Mol_Biol_Cell_2012_Sep_15_23(18)_3612-3623.nxml.txt.nlp	22833563	SENT14	17	17	9	9	thrombin	PAR1	PA451674	79581;2149	0.532
NULL	CNS_Drugs_2013_Aug_20_27(12)_1081-1092.nxml.txt.nlp	23959815	SENT135	26	26	10	10	lisdexamfetamine	ATX	PA164748975	5168;23049	0.532
NULL	Curr_Neuropharmacol_2012_Sep_10(3)_212-218.nxml.txt.nlp	23449551	SENT229	8	8	20	20	ethanol	CB1	PA448073	1268	0.532
NULL	Br_J_Cancer_2013_Jan_15_108(1)_183-187.nxml.txt.nlp	23299529	SENT71	28	28	37	37	choline	B12	PA448976	7126;4709	0.532
NULL	Br_J_Cancer_2010_Sep_7_103(6)_796-801.nxml.txt.nlp	20823888	SENT172	19	19	38	38	erlotinib	D29	PA134687924	55520	0.532
NULL	Anesth_Essays_Res_2013_Sep-Dec_7(3)_302-306.nxml.txt.nlp	NULL	SENT4	45	45	33	33	vecuronium	NMB	PA164748865	10457;4828	0.532
NULL	Ann_Hematol_2014_Apr_30_93(9)_1515-1522.nxml.txt.nlp	24782121	SENT62	13	13	11	11	fluorescein	CD34	PA164746009	947	0.532
NULL	Aging_(Albany_NY)_2014_Jan_14_6(1)_70-81.nxml.txt.nlp	24429382	SENT160	10	10	0	0	etoposide	WRN	PA449552	7486	0.532
NULL	Br_J_Clin_Pharmacol_2013_Aug_23_76(2)_299-315.nxml.txt.nlp	23701319	SENT92	0	0	6	6	muromonab	IFN	PA164743097	3439	0.532
NULL	Mol_Cancer_2012_Jun_18_11_41.nxml.txt.nlp	22709873	SENT15	4	4	9	9	lapatinib	NR3C1	PA152241907	2908	0.532
NULL	Acta_Histochem_Cytochem_2011_Apr_28_44(2)_51-60.nxml.txt.nlp	21614166	SENT171	41	41	7	7	thalidomide	EMT	PA451644	3702;6581	0.532
NULL	Mucosal_Immunol_2014_Mar_24_7(2)_335-347.nxml.txt.nlp	23881354	SENT33	0	0	2	2	galantamine	GAL	PA449726	51083	0.532
NULL	Afr_J_Infect_Dis_2011_5(2)_40-46.nxml.txt.nlp	23878706	SENT88	26	26	8	8	erythromycin	Gen	PA449493	348654	0.532
NULL	Arthritis_Res_Ther_2013_Jan_16_15(1)_R13.nxml.txt.nlp	23324173	SENT169	23	23	19	19	neomycin	ST2	PA450608	9173;6761	0.532
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Nov_30_67(Pt_12)_o3476-o3477.nxml.txt.nlp	22199950	SENT76	26	26	20	20	ethanol	mol	PA448073	90527	0.532
NULL	Med_Sci_Monit_2013_Nov_29_19_1080-1088.nxml.txt.nlp	24287619	SENT69	14	14	18	18	estradiol	ACL	PA449503	47	0.532
NULL	Nat_Genet_2011_Jun_5_43(7)_621-629.nxml.txt.nlp	21642992	SENT337	3	3	8	8	doxorubicin	p53	PA449412	7157	0.532
NULL	Oncol_Lett_2013_Oct_29_6(4)_1031-1038.nxml.txt.nlp	24137459	SENT211	2	2	30	30	cisplatin	LC3	PA449014	84557	0.532
NULL	Acta_Neuropathol_Commun_2014_Oct_21_2(1)_149.nxml.txt.nlp	NULL	SENT186	9	9	6	6	riluzole	gamma	PA451251	9913	0.532
NULL	Summit_on_Translat_Bioinforma_2009_Mar_1_2009_124-128.nxml.txt.nlp	21347183	SENT69	7	7	13	13	mercaptopurine	TPMT	PA450379	7172	0.532
NULL	Acta_Pharmacol_Sin_2010_Jul_21_31(7)_855-860.nxml.txt.nlp	20562904	SENT14	10	10	23	23	fluconazole	CDR2	PA449653	1039	0.532
NULL	Br_J_Cancer_2012_Jan_17_106(2)_284-289.nxml.txt.nlp	22215065	SENT163	27	27	29	29	bevacizumab	IFN	PA130232992	3439	0.532
NULL	Oncotarget_2014_Feb_7_5(3)_775-787.nxml.txt.nlp	24519956	SENT103	8	8	4	4	dasatinib	PC3	PA162372878	57332;7832;5122	0.532
NULL	Ann_Rheum_Dis_2008_Dec_3_68(7)_1105-1112.nxml.txt.nlp	19054823	SENT59	31	31	0	0	methotrexate	ACR	PA450428	49	0.532
NULL	Case_Rep_Ophthalmol_2011_Dec_13_2(3)_387-391.nxml.txt.nlp	22220164	SENT60	14	14	25	25	bevacizumab	CRT	PA130232992	811	0.532
NULL	EMBO_Mol_Med_2012_Jun_13_4(6)_515-527.nxml.txt.nlp	22416035	SENT278	15	15	10	10	olaparib	DNA-PKcs		5591	0.532
NULL	Hum_Mol_Genet_2012_Jan_15_21(2)_300-310.nxml.txt.nlp	21979946	SENT141	15	15	20	20	nadh	NQO1	PA164755085	1728	0.532
NULL	Indian_J_Endocrinol_Metab_2012_Dec_16(Suppl_2)_S248-S251.nxml.txt.nlp	23565391	SENT43	4	4	8	8	icodextrin	GDH	PA164743096	51084;2746	0.532
NULL	Cancer_Cell_Int_2006_Nov_8_6_25.nxml.txt.nlp	17092342	SENT226	6	6	4	4	etoposide	Yes	PA449552	7525	0.532
NULL	Oncol_Lett_2013_Mar_11_5(3)_1010-1016.nxml.txt.nlp	23426784	SENT180	3	3	9	9	midazolam	TRPM7	PA450496	54822	0.532
NULL	Breast_Cancer_Res_2007_Aug_8_9(4)_R50.nxml.txt.nlp	17686159	SENT192	36	36	25	25	gefitinib	HRG	PA131301952	3084;3273	0.532
NULL	J_Geriatr_Cardiol_2013_Jun_10(2)_151-158.nxml.txt.nlp	23888175	SENT4	7	7	15	15	rosuvastatin	ACE2	PA134308647	59272	0.532
NULL	Mol_Vis_2012_Nov_12_18_2687-2699.nxml.txt.nlp	23170061	SENT17	2	2	7	7	nadh	ND6	PA164755085	4541	0.532
NULL	Int_J_Environ_Res_Public_Health_2010_Apr_30_7(4)_1448-1466.nxml.txt.nlp	20617039	SENT41	23	23	8	8	bromocriptine	DRD2	PA448671	1813	0.532
NULL	Diabetes_Care_2010_May_15_33(5)_1134-1139.nxml.txt.nlp	20185740	SENT138	9	9	18	18	ezetimibe	IL-6	PA10816	3569	0.532
NULL	Clin_Med_Oncol_2008_Jun_11_2_469-470.nxml.txt.nlp	21892319	SENT32	30	30	34	34	doxorubicin	HER-2	PA449412	2064	0.532
NULL	Fibrogenesis_Tissue_Repair_2012_Apr_13_5_5.nxml.txt.nlp	22502865	SENT122	17	17	19	19	troglitazone	CCN2	PA451799	1490	0.532
NULL	Arthritis_Res_Ther_2013_May_29_15(3)_R64.nxml.txt.nlp	23718630	SENT207	0	0	15	15	canakinumab	S100A12	PA165958358	6283	0.532
NULL	Core_Evid_2009_Jun_15_4_83-92.nxml.txt.nlp	20694067	SENT11	2	2	4	4	vasopressin	AVP	PA451858	114548;551	0.532
NULL	J_Immunother_2014_Apr_12_37(3)_180-186.nxml.txt.nlp	24598448	SENT162	10	10	8	8	sorafenib	IL-2	PA7000	3558	0.532
NULL	Cardiovasc_Drugs_Ther_2014_May_20_28(3)_281-289.nxml.txt.nlp	24842558	SENT225	1	1	10	10	atorvastatin	PCSK9	PA448500	255738	0.532
NULL	Brain_2014_Dec_4_137(12)_3200-3212.nxml.txt.nlp	25281868	SENT59	8	8	33	33	creatine	B12	PA164778930	7126;4709	0.532
NULL	Cancer_Med_2014_Aug_16_3(4)_775-786.nxml.txt.nlp	24737784	SENT197	16	16	5	5	warfarin	ANOVA	PA451906	4858	0.532
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT126	22	22	20	20	erlotinib	CYP3A	PA134687924	1574	0.532
NULL	Biol_Proced_Online_2004_Jul_1_6_144-148.nxml.txt.nlp	15243647	SENT152	13	13	8	8	cytarabine	IFN	PA449177	3439	0.532
NULL	Cell_Death_Dis_2013_Sep_19_4(9)_e807.nxml.txt.nlp	24052075	SENT72	39	39	8	8	doxorubicin	p53	PA449412	7157	0.532
NULL	J_Immunol_Res_2014_May_8_2014_565320.nxml.txt.nlp	24901010	SENT83	10	10	15	15	allopurinol	HLA-B	PA448320	3106	0.532
NULL	Oncol_Lett_2014_Jan_19_7(1)_148-152.nxml.txt.nlp	24348838	SENT53	12	12	5	5	creatine	CD34	PA164778930	947	0.532
NULL	EPMA_J_2011_Mar_12_2(1)_9-14.nxml.txt.nlp	23199123	SENT129	4	4	19	19	pravastatin	FAST	PA451089	10922	0.532
NULL	Gut_Pathog_2009_Nov_26_1_20.nxml.txt.nlp	19941660	SENT436	5	5	12	12	levodopa	COMT	PA450213	1312	0.532
NULL	Hum_Genomics_2009_Jan_1_3(2)_121-127.nxml.txt.nlp	19164089	SENT88	13	13	15	15	ethanol	ALDH2	PA448073	217	0.532
NULL	Antimicrob_Resist_Infect_Control_2012_Mar_16_1_12.nxml.txt.nlp	22958880	SENT107	38	38	28	28	doxycycline	CTX	PA449415	1593	0.532
NULL	Arthritis_Res_Ther_2013_Apr_4_15(Suppl_1)_S4.nxml.txt.nlp	23566679	SENT248	5	5	2	2	rituximab	HERMES	PA451261	11030	0.532
NULL	Open_Microbiol_J_2008_Jun_19_2_89-93.nxml.txt.nlp	19088917	SENT30	31	31	22	22	spectinomycin	CO2	PA164781342	4513	0.532
NULL	Breast_Cancer_Res_2014_Dec_6_16(6)_491.nxml.txt.nlp	25479686	SENT303	13	13	5	5	medroxyprogesterone	ANOVA	PA450344	4858	0.532
NULL	Curr_Genomics_2014_Jun_15(3)_217-230.nxml.txt.nlp	24955029	SENT129	5	5	8	8	oxygen	ROS	PA450744	6098	0.532
NULL	Arch_Dis_Child_2014_Dec_8_99(12)_1143-1146.nxml.txt.nlp	25202131	SENT58	16	16	8	8	omeprazole	CYP2B6	PA450704	1555	0.532
NULL	Biologics_2013_Apr_15_7_77-90.nxml.txt.nlp	23723688	SENT282	13	13	5	5	cetuximab	ERG	PA10040	2078	0.532
NULL	Mol_Pain_2012_Sep_22_8_71.nxml.txt.nlp	22998838	SENT155	14	14	25	25	paclitaxel	CB2	PA450761	1269	0.532
NULL	Indian_J_Dermatol_2010_Jul-Sep_55(3)_300-301.nxml.txt.nlp	21063535	SENT28	27	27	19	19	isotretinoin	CO2	PA450128	4513	0.532
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Mar_27_66(Pt_4)_m463-m464.nxml.txt.nlp	21580548	SENT69	15	15	36	36	phenol	C48	PA450913	55755	0.532
NULL	Alzheimers_Res_Ther_2013_Nov_7_5(6)_54.nxml.txt.nlp	24229456	SENT47	5	5	2	2	bexarotene	spatial	PA164752250	219793	0.532
NULL	Front_Neurosci_2012_May_30_6_78.nxml.txt.nlp	22661926	SENT12	18	18	3	3	vasopressin	VR2	PA451858	56663	0.532
NULL	J_Mol_Med_(Berl)_2014_Jan_10_92(5)_497-507.nxml.txt.nlp	24408111	SENT187	0	0	2	2	pioglitazone	HIF-1	PA450970	29072	0.532
NULL	Cells_2014_Jan_27_3(1)_53-78.nxml.txt.nlp	24709902	SENT261	22	22	16	16	trastuzumab	PTEN	PA451743	5728	0.532
NULL	Crit_Care_2011_Mar_11_15(Suppl_1)_P232.nxml.txt.nlp	NULL	SENT4	31	31	39	39	vancomycin	VISA	PA451850	57506	0.532
NULL	Arthritis_Res_Ther_2014_Jul_24_16(4)_R157.nxml.txt.nlp	25059342	SENT18	19	19	12	12	bleomycin	IL-6	PA448645	3569	0.532
NULL	Asian_J_Transfus_Sci_2011_Jul-Dec_5(2)_160-163.nxml.txt.nlp	21897597	SENT127	22	22	18	18	thrombin	ADP	PA451674	23038	0.532
NULL	Brain_Behav_2013_Mar_6_3(2)_114-133.nxml.txt.nlp	23533150	SENT181	0	0	7	7	ethanol	HSF1	PA448073	3297	0.532
NULL	Case_Rep_Dermatol_2012_Sep_16_4(3)_256-260.nxml.txt.nlp	23275770	SENT73	8	8	16	16	isotretinoin	OMG	PA450128	4974	0.532
NULL	Crit_Care_2007_Jan_12_11(1)_R4.nxml.txt.nlp	17222339	SENT131	13	13	0	0	creatine	ANOVA	PA164778930	4858	0.532
NULL	Cancer_Cell_Int_2004_Mar_19_4_3.nxml.txt.nlp	15035672	SENT92	27	27	12	12	cisplatin	APO	PA449014	84909	0.532
NULL	J_Hematol_Oncol_2009_Aug_6_2_34.nxml.txt.nlp	19660111	SENT35	16	16	42	42	l-glutamine	CO2	PA10090	4513	0.532
NULL	Indian_J_Anaesth_2011_May-Jun_55(3)_318-320.nxml.txt.nlp	21808420	SENT45	17	17	5	5	tramadol	CO2	PA451735	4513	0.532
NULL	Crit_Care_2003_Dec_20_7(1)_23-38.nxml.txt.nlp	12617738	SENT157	0	0	17	17	thrombin	VIII	PA451674	1351	0.532
NULL	Anal_Bioanal_Chem_2014_Sep_12_406(28)_7049-7057.nxml.txt.nlp	25213215	SENT77	44	44	4	4	hemin	mol	PA449849	90527	0.532
NULL	Int_J_Endocrinol_2014_Feb_25_2014_581069.nxml.txt.nlp	24707288	SENT3	15	15	38	38	thyroglobulin	IP-10	PA164754910	3627	0.532
NULL	Oncotarget_2013_Oct_19_4(11)_2045-2056.nxml.txt.nlp	24185104	SENT59	9	9	12	12	cisplatin	14-3-3	PA449014	10971	0.532
NULL	Cell_Cycle_2012_Nov_1_11(21)_3983-3996.nxml.txt.nlp	22987153	SENT213	4	4	11	11	cisplatin	FANCD2	PA449014	2177	0.532
NULL	Mol_Biol_Cell_2014_Jan_1_25(1)_118-132.nxml.txt.nlp	24173715	SENT260	5	5	28	28	lipase	LAMP1	PA450239	3916	0.532
NULL	J_Korean_Med_Sci_2013_Dec_26_28(12)_1729-1733.nxml.txt.nlp	24339701	SENT53	29	29	21	21	adalimumab	TNF	PA10004	7124	0.532
NULL	Mol_Vis_2012_May_1_18_1115-1122.nxml.txt.nlp	22605923	SENT113	6	6	8	8	estradiol	IL-6	PA449503	3569	0.532
NULL	Indian_J_Endocrinol_Metab_2013_Oct_17(Suppl1)_S243-S245.nxml.txt.nlp	24251173	SENT25	25	25	32	32	hydroxyprogesterone	ACTH	PA449932	5443	0.532
NULL	Exp_Diabetes_Res_2012_Nov_12_2012_618923.nxml.txt.nlp	23197974	SENT191	27	27	30	30	telmisartan	STZ	PA451605	6484	0.532
NULL	Br_J_Cancer_2013_Feb_5_108(2)_319-326.nxml.txt.nlp	23322198	SENT145	8	8	11	11	meloxicam	IFN	PA450353	3439	0.532
NULL	Eur_J_Clin_Pharmacol_2011_Dec_23_67(12)_1231-1241.nxml.txt.nlp	21698374	SENT16	10	10	17	17	tacrolimus	ABCB1	PA451578	5243	0.532
NULL	Crit_Care_1998_Mar_1_2(Suppl_1)_P154.nxml.txt.nlp	NULL	SENT5	26	26	28	28	acetaminophen	ALF	PA448015	11036	0.532
NULL	J_Neurol_Sci_2012_Nov_15_322(1-2)_92-95.nxml.txt.nlp	22819352	SENT118	4	4	11	11	ethanol	MCP-1	PA448073	6347	0.532
NULL	J_Inherit_Metab_Dis_2011_Apr_27_34(2)_357-366.nxml.txt.nlp	20978943	SENT239	6	6	16	16	galactose	GDF9	PA449725	2661	0.532
NULL	Indian_J_Crit_Care_Med_2008_Oct-Dec_12(4)_181-189.nxml.txt.nlp	19742267	SENT202	5	5	14	14	anakinra	ACR	PA10799	49	0.532
NULL	Int_J_Biol_Sci_2015_Jan_1_11(1)_48-58.nxml.txt.nlp	25552929	SENT211	5	5	10	10	paclitaxel	TSP-1	PA450761	7057	0.532
NULL	Cancer_Cell_Int_2009_Sep_10_9_25.nxml.txt.nlp	19744341	SENT100	7	7	9	9	glucosamine	STAT3	PA164747613	6774	0.532
NULL	Oxid_Med_Cell_Longev_2009_Sep-Oct_2(4)_214-221.nxml.txt.nlp	20716907	SENT255	19	19	33	33	pilocarpine	P400	PA450962	57634	0.532
NULL	Libyan_J_Med_2007_Dec_1_2(4)_169-175.nxml.txt.nlp	21503240	SENT239	29	29	33	33	clonidine	CA1	PA449051	759	0.532
NULL	Gut_Liver_2012_Jul_2_6(3)_316-320.nxml.txt.nlp	22844558	SENT56	4	4	2	2	pantoprazole	ESD	PA450774	2098	0.532
NULL	Oncotarget_2014_Oct_21_5(22)_11709-11722.nxml.txt.nlp	25365944	SENT141	0	0	5	5	metformin	Rho	PA450395	29984	0.532
NULL	Curr_Hepat_Rep_2010_May_21_9(2)_75-90.nxml.txt.nlp	20461127	SENT271	8	8	15	15	telbivudine	LAM	PA164760861	7249;7248	0.532
NULL	Clin_Med_Insights_Oncol_2011_Mar_16_5_35-43.nxml.txt.nlp	21499557	SENT269	12	12	23	23	doxorubicin	IFF	PA449412	3456	0.532
NULL	Cancer_Cell_Int_2011_Dec_29_11_44.nxml.txt.nlp	22206574	SENT67	10	10	14	14	sorafenib	p38	PA7000	10598;1432;7965	0.532
NULL	Cancer_Metab_2013_Jan_23_1_3.nxml.txt.nlp	24280005	SENT481	20	20	9	9	ethanol	SREBP1	PA448073	6720	0.532
NULL	Front_Mol_Neurosci_2012_Nov_12_5_99.nxml.txt.nlp	23162427	SENT268	4	4	6	6	cocaine	CBP	PA449072	55824;1387	0.532
NULL	J_Geriatr_Cardiol_2014_Jun_11(2)_151-157.nxml.txt.nlp	25009566	SENT124	14	14	16	16	cilostazol	CDP	PA164746334	1523	0.532
NULL	J_Korean_Med_Sci_2009_Jan_29_24(Suppl_1)_S183-S188.nxml.txt.nlp	19194550	SENT15	0	0	8	8	celecoxib	CD2AP	PA448871	23607	0.532
NULL	J_Korean_Med_Sci_2010_Nov_26_25(11)_1683-1687.nxml.txt.nlp	21060764	SENT11	10	10	18	18	thyroglobulin	p63	PA164754910	8626	0.532
NULL	Int_J_Nanomedicine_2012_Sep_21_7_5091-5106.nxml.txt.nlp	23049256	SENT288	16	16	9	9	fluorescein	SOD1	PA164746009	6647	0.532
NULL	Curr_Cardiol_Rev_2008_Nov_4(4)_309-322.nxml.txt.nlp	20066139	SENT328	16	16	18	18	estradiol	aromatase	PA449503	1588	0.532
NULL	Curr_Neuropharmacol_2009_Dec_7(4)_296-301.nxml.txt.nlp	20514209	SENT230	8	8	6	6	vasopressin	AVP	PA451858	114548;551	0.532
NULL	Acta_Pharmacol_Sin_2014_Oct_25_35(10)_1293-1301.nxml.txt.nlp	25152022	SENT15	0	0	11	11	enalapril	NLRP3	PA449456	114548	0.532
NULL	Clin_Interv_Aging_2012_Jul_12_7_235-247.nxml.txt.nlp	22866001	SENT131	42	42	45	45	alendronate	PTH	PA448082	5741	0.532
NULL	J_Hematol_Oncol_2013_Sep_6_6_67.nxml.txt.nlp	24010981	SENT54	16	16	12	12	oxaliplatin	Gem	PA131285527	51053	0.532
NULL	Breast_Cancer_Res_2009_Sep_29_11(5)_209.nxml.txt.nlp	19818165	SENT225	10	10	37	37	tamoxifen	JNK	PA451581	5599	0.532
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT366	21	21	15	15	streptomycin	FBS	PA451512	64319;26269	0.532
NULL	Cancers_(Basel)_2010_Dec_23_3(1)_17-42.nxml.txt.nlp	24212604	SENT904	31	31	29	29	paclitaxel	PPX	PA450761	5531	0.532
NULL	Adv_Hematol_2010_Dec_5_2010_595934.nxml.txt.nlp	21151515	SENT154	24	24	20	20	cangrelor	Yes	PA165945763	7525	0.532
NULL	J_Invest_Dermatol_2012_Sep_10_132(9)_2255-2262.nxml.txt.nlp	22572817	SENT202	25	25	29	29	forskolin	HBD3	PA146096022	414325	0.532
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Oct_20_68(Pt_11)_o3168.nxml.txt.nlp	23284482	SENT67	34	34	13	13	ethanol	mol	PA448073	90527	0.532
NULL	Fibrogenesis_Tissue_Repair_2010_Oct_21_3_21.nxml.txt.nlp	20964825	SENT179	17	17	19	19	hyaluronan	TLR4	PA165958431	7099	0.532
NULL	Cells_2014_Jun_26_3(3)_662-673.nxml.txt.nlp	24971848	SENT77	2	2	12	12	capsaicin	TRPV4	PA448776	59341	0.532
NULL	Chemother_Res_Pract_2012_Aug_29_2012_817297.nxml.txt.nlp	22970367	SENT126	25	25	20	20	erlotinib	EGFR	PA134687924	1956	0.532
NULL	J_Breast_Cancer_2012_Sep_28_15(3)_273-282.nxml.txt.nlp	23091539	SENT162	24	24	20	20	doxycycline	TRAIL	PA449415	8743	0.532
NULL	Oncotarget_2011_May_16_2(5)_418-421.nxml.txt.nlp	21789791	SENT4	15	15	13	13	bortezomib	TRAIL	PA10252	8743	0.532
NULL	J_Hematol_Oncol_2010_Apr_7_3_13.nxml.txt.nlp	20374647	SENT174	27	27	25	25	fludarabine	RRM2	PA449655	6241	0.532
NULL	J_Nat_Med_2014_Feb_19_68(2)_253-266.nxml.txt.nlp	24550097	SENT226	6	6	14	14	ethanol	SREBP-1c	PA448073	6720	0.532
NULL	J_Gen_Intern_Med_2009_May_21_24(5)_656-664.nxml.txt.nlp	19306050	SENT514	3	3	8	8	warfarin	CYP2C9	PA451906	1559	0.532
NULL	Iran_J_Neurol_2013_12(4)_149-156.nxml.txt.nlp	24250925	SENT3	22	22	13	13	mitoxantrone	IFN	PA450526	3439	0.531
NULL	Ann_Oncol_2009_Aug_20(Suppl_6)_vi41-vi50.nxml.txt.nlp	19617297	SENT51	16	16	27	27	carmustine	IL-2	PA448810	3558	0.531
NULL	J_Biomed_Biotechnol_2011_Dec_5_2011_172965.nxml.txt.nlp	22187520	SENT8	23	23	28	28	dextran	IFN	PA449261	3439	0.531
NULL	Osteoporos_Int_2008_Apr_12_19(4)_399-428.nxml.txt.nlp	18266020	SENT307	10	10	8	8	alendronate	PTH	PA448082	5741	0.531
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT98	11	11	18	18	curcumin	p27	PA151958596	5715;10534	0.531
NULL	Cardiovasc_Diabetol_2013_May_4_12_73.nxml.txt.nlp	23642288	SENT47	20	20	27	27	sitagliptin	Tech	PA164748978	57449	0.531
NULL	Crit_Care_2010_Feb_15_14(1)_118.nxml.txt.nlp	20236489	SENT17	35	35	32	32	thrombin	ADP	PA451674	23038	0.531
NULL	Bioinorg_Chem_Appl_2013_Sep_19_2013_541030.nxml.txt.nlp	24170995	SENT59	16	16	18	18	amoxicillin	SBF	PA448406	7702	0.531
NULL	Clin_Med_Insights_Oncol_2011_Nov_7_5_349-364.nxml.txt.nlp	22174596	SENT22	2	2	4	4	bevacizumab	IFN	PA130232992	3439	0.531
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Aug_9_70(Pt_9)_o987-o988.nxml.txt.nlp	25309295	SENT6	31	31	16	16	nitrile	mol	PA450636	90527	0.531
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_May_20_65(Pt_6)_o1356.nxml.txt.nlp	21583207	SENT69	13	13	6	6	ethanol	mol	PA448073	90527	0.531
NULL	Case_Rep_Hematol_2013_Sep_5_2013_708489.nxml.txt.nlp	24083040	SENT19	15	15	7	7	iron	B12	PA450087	7126;4709	0.531
NULL	Acta_Pharmacol_Sin_2009_Oct_21_30(10)_1392-1398.nxml.txt.nlp	19767766	SENT161	18	18	22	22	atorvastatin	DPI	PA448500	1832	0.531
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Jun_27_5_15.nxml.txt.nlp	16803618	SENT161	2	2	42	42	flucloxacillin	GEN1	PA164781042	348654	0.531
NULL	Int_J_Hypertens_2013_Feb_12_2013_156179.nxml.txt.nlp	23476743	SENT121	15	15	12	12	captopril	CTR	PA448780	799	0.531
NULL	Psychiatry_Investig_2012_Mar_18_9(1)_73-79.nxml.txt.nlp	22396688	SENT128	12	12	7	7	atenolol	Gen	PA448499	348654	0.531
NULL	Br_J_Cancer_2009_Jul_7_101(1)_38-47.nxml.txt.nlp	19513066	SENT301	25	25	13	13	dasatinib	N-WASP	PA162372878	8976	0.531
NULL	Pharmaceuticals_(Basel)_2013_May_23_6(6)_689-699.nxml.txt.nlp	24276256	SENT101	12	12	21	21	terbutaline	PTB	PA451616	58155	0.531
NULL	Curr_Neuropharmacol_2013_Jul_11(4)_338-378.nxml.txt.nlp	24381528	SENT329	3	3	24	24	curcumin	JNK	PA151958596	5599	0.531
NULL	Mol_Biol_Cell_2013_Aug_1_24(15)_2328-2339.nxml.txt.nlp	23783029	SENT353	1	1	6	6	glucose	GEF	PA449773	56731	0.531
NULL	Allergy_Asthma_Immunol_Res_2011_Jul_17_3(3)_205-211.nxml.txt.nlp	21738887	SENT152	10	10	19	19	methacholine	TDI	PA165958382	100038246	0.531
NULL	Diabetes_Care_2010_Jul_31_33(7)_1607-1609.nxml.txt.nlp	20357375	SENT70	6	6	13	13	sitagliptin	CXCR4	PA164748978	7852	0.531
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Nov_21_65(Pt_12)_o3170-o3171.nxml.txt.nlp	21578886	SENT7	15	15	2	2	efavirenz	mol	PA449441	90527	0.531
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Jun_8_69(Pt_7)_m360-m361.nxml.txt.nlp	24046548	SENT4	29	29	21	21	nitrile	mol	PA450636	90527	0.531
NULL	Mol_Microbiol_2013_Aug_27_89(3)_420-432.nxml.txt.nlp	23750752	SENT44	6	6	0	0	lipase	MCOLN2	PA450239	255231	0.531
NULL	Cancer_Immunol_Immunother_2012_Jul_23_61(7)_1101-1111.nxml.txt.nlp	22193989	SENT164	2	2	0	0	oxaliplatin	IL-4	PA131285527	3565	0.531
NULL	Ann_Oncol_2009_Aug_17_20(8)_1319-1329.nxml.txt.nlp	19535820	SENT336	11	11	21	21	trastuzumab	S25	PA451743	6230	0.531
NULL	Core_Evid_2009_Jun_15_4_25-36.nxml.txt.nlp	20694062	SENT325	34	34	13	13	benzbromarone	ACTH	PA134852920	5443	0.531
NULL	Front_Endocrinol_(Lausanne)_2013_May_10_4_52.nxml.txt.nlp	23675368	SENT1552	11	11	8	8	lipase	PPARgamma	PA450239	5468	0.531
NULL	J_Oncol_2009_May_6_2009_567486.nxml.txt.nlp	19424511	SENT76	15	15	17	17	cetuximab	KRAS	PA10040	3845	0.531
NULL	Diabetes_2011_May_23_60(5)_1458-1466.nxml.txt.nlp	21464445	SENT327	12	12	14	14	lipase	HSL	PA450239	3991	0.531
NULL	Br_J_Cancer_2012_Feb_28_106(5)_858-866.nxml.txt.nlp	22343622	SENT122	11	11	4	4	docetaxel	PD2	PA449383	54623	0.531
NULL	Iran_J_Public_Health_2012_Mar_31_41(3)_127-132.nxml.txt.nlp	23113157	SENT86	14	14	20	20	ceftazidime	CTX	PA448861	1593	0.531
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT210	3	3	5	5	perifosine	DR4	PA165291471	8797	0.531
NULL	Mol_Cancer_2010_Apr_23_9_87.nxml.txt.nlp	20416058	SENT91	20	20	18	18	doxorubicin	TRAIL	PA449412	8743	0.531
NULL	Arch_Med_Sci_2011_Feb_8_7(1)_154-160.nxml.txt.nlp	22291749	SENT177	2	2	16	16	chlorhexidine	S15	PA164776863	6209	0.531
NULL	Autoimmune_Dis_2011_Dec_9_2011_932351.nxml.txt.nlp	21197462	SENT188	19	19	12	12	natalizumab	IFN	PA164747191	3439	0.531
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_3_2012_856029.nxml.txt.nlp	23091559	SENT237	15	15	7	7	flutamide	PC-3	PA449685	692094	0.531
NULL	Br_J_Cancer_2012_Sep_25_107(7)_1009-1016.nxml.txt.nlp	22948724	SENT67	38	38	22	22	sorafenib	TRAIL	PA7000	8743	0.531
NULL	Nat_Commun_2013_Oct_1_4_2516.nxml.txt.nlp	24084631	SENT645	0	0	19	19	losartan	AK4	PA450268	205	0.531
NULL	Thorax_2010_Sep_65(9)_775-781.nxml.txt.nlp	20805170	SENT92	9	9	0	0	mometasone	BDP	PA450541	10620;152926	0.531
NULL	Oncotarget_2014_Jun_6_5(13)_4929-4934.nxml.txt.nlp	24952635	SENT92	3	3	10	10	thioridazine	HIF-1	PA451666	29072	0.531
NULL	Diabetes_2009_Dec_31_58(12)_2813-2819.nxml.txt.nlp	19720793	SENT292	17	17	15	15	diazoxide	ADP	PA449285	23038	0.531
NULL	Int_J_Environ_Res_Public_Health_2010_Apr_30_7(4)_1448-1466.nxml.txt.nlp	20617039	SENT41	4	4	8	8	ethanol	DRD2	PA448073	1813	0.531
NULL	Ann_Oncol_2009_Nov_23_20(11)_1803-1812.nxml.txt.nlp	19549706	SENT94	32	32	22	22	sunitinib	IFN	PA162372840	3439	0.531
NULL	Int_J_Appl_Basic_Med_Res_2012_Jul-Dec_2(2)_77-83.nxml.txt.nlp	23776817	SENT119	5	5	11	11	conivaptan	CYP3A4	PA164742939	1576	0.531
NULL	Cereb_Cortex_2014_Jan_9_24(1)_174-185.nxml.txt.nlp	23048018	SENT19	9	9	11	11	atomoxetine	ATX	PA134688071	5168;23049	0.531
NULL	Biomed_Res_Int_2014_Apr_10_2014_615363.nxml.txt.nlp	24818147	SENT150	16	16	19	19	thrombin	ADP	PA451674	23038	0.531
NULL	J_Korean_Med_Sci_2006_Oct_31_21(5)_827-832.nxml.txt.nlp	17043414	SENT62	4	4	15	15	mupirocin	Kua	PA164764568	387521	0.531
NULL	Acta_Neuropathol_2011_Mar_7_121(3)_291-312.nxml.txt.nlp	21136068	SENT181	5	5	8	8	creatine	MCT-1	PA164778930	28985	0.531
NULL	Mol_Cancer_2013_May_24_12_47.nxml.txt.nlp	23705854	SENT215	29	29	27	27	celecoxib	P-gp	PA448871	5243	0.531
NULL	Indian_J_Ophthalmol_2007_Nov-Dec_55(6)_483b-486.nxml.txt.nlp	17951918	SENT74	24	24	9	9	bevacizumab	PED	PA130232992	8682	0.531
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT39	37	37	34	34	nutlin-3	RITA		55422;84934	0.531
NULL	J_Hematol_Oncol_2011_Mar_26_4_11.nxml.txt.nlp	21439076	SENT130	22	22	4	4	marimastat	Gem	PA164748329	51053	0.531
NULL	Chin_J_Cancer_2011_May_30(5)_293-302.nxml.txt.nlp	21527062	SENT77	27	27	25	25	irinotecan	IFL	PA450085	3439	0.531
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT230	10	10	8	8	resveratrol	FADD		8772	0.531
NULL	Br_J_Cancer_2010_Nov_9_103(10)_1588-1596.nxml.txt.nlp	20978505	SENT128	26	26	9	9	temozolomide	MLH1	PA451609	4292	0.531
NULL	Psychiatr_Bull_(2014)_2014_Oct_38(5)_226-229.nxml.txt.nlp	25285221	SENT77	24	24	0	0	clozapine	Gen	PA449061	348654	0.531
NULL	Braz_J_Med_Biol_Res_2014_Nov_4_48(1)_13-24.nxml.txt.nlp	25493378	SENT291	12	12	14	14	topotecan	TPC	PA451729	8030;60386	0.531
NULL	Biomed_Res_Int_2014_Jun_25_2014_539151.nxml.txt.nlp	25057494	SENT94	14	14	10	10	warfarin	GGCX	PA451906	2677	0.531
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_12_2014_342506.nxml.txt.nlp	25477990	SENT39	0	0	2	2	apomorphine	APO	PA164781163	84909	0.531
NULL	Oxid_Med_Cell_Longev_2009_Sep-Oct_2(4)_214-221.nxml.txt.nlp	20716907	SENT220	19	19	33	33	pilocarpine	P400	PA450962	57634	0.531
NULL	Br_J_Cancer_2003_Jun_16_88(12)_1963-1970.nxml.txt.nlp	12799644	SENT129	21	21	2	2	doxorubicin	TK2	PA449412	7084	0.531
NULL	Gut_Pathog_2009_Jun_25_1_13.nxml.txt.nlp	19555480	SENT178	18	18	11	11	kanamycin	LBA	PA450137	987	0.531
NULL	Indian_J_Nephrol_2014_Jul-Aug_24(4)_203-205.nxml.txt.nlp	25097331	SENT39	41	41	43	43	vasopressin	AVP	PA451858	114548;551	0.531
NULL	Amino_Acids_2014_Feb_20_46(5)_1275-1283.nxml.txt.nlp	24553827	SENT98	0	0	3	3	taurine	CDO	PA451590	50937	0.531
NULL	Exp_Diabetes_Res_2012_Nov_12_2012_618923.nxml.txt.nlp	23197974	SENT174	27	27	30	30	telmisartan	STZ	PA451605	6484	0.531
NULL	Ann_Gastroenterol_2013_26(3)_233-238.nxml.txt.nlp	NULL	SENT2	0	0	2	2	natalizumab	NAT	PA164747191	6046	0.531
NULL	J_Emerg_Trauma_Shock_2013_Apr-Jun_6(2)_150-151.nxml.txt.nlp	23723633	SENT10	19	19	33	33	labetalol	RDS	PA164743150	7263	0.531
NULL	Case_Rep_Med_2014_Dec_8_2014_516549.nxml.txt.nlp	25544844	SENT31	33	33	35	35	thyroglobulin	CK7	PA164754910	3855	0.531
NULL	Curr_Microbiol_2012_Dec_28_65(6)_673-678.nxml.txt.nlp	22926720	SENT75	1	1	21	21	ceftazidime	TMP	PA448861	2012	0.531
NULL	EMBO_Mol_Med_2010_Apr_2(4)_120-129.nxml.txt.nlp	20373285	SENT251	14	14	21	21	l-glutamine	CO2	PA10090	4513	0.531
NULL	Mol_Cancer_2007_Oct_11_6_63.nxml.txt.nlp	17931419	SENT19	14	14	22	22	gefitinib	HIF-1	PA131301952	29072	0.531
NULL	Allergy_Asthma_Clin_Immunol_2007_Jun_15_3(2)_50-52.nxml.txt.nlp	20525143	SENT59	24	24	16	16	zafirlukast	LTC4S	PA451949	4056	0.531
NULL	Front_Oncol_2014_Jun_16_4_146.nxml.txt.nlp	24982847	SENT279	23	23	19	19	docetaxel	RANK	PA449383	8792	0.531
NULL	J_Pain_Res_2014_Jun_23_7_353-357.nxml.txt.nlp	25018649	SENT65	4	4	16	16	lidocaine	TRPV1	PA450226	7442	0.531
NULL	Curr_Neuropharmacol_2012_Sep_10(3)_212-218.nxml.txt.nlp	23449551	SENT142	0	0	14	14	rimonabant	adiponectin	PA152407999	9370	0.531
NULL	EMBO_Mol_Med_2009_Apr_1(1)_30-36.nxml.txt.nlp	20049701	SENT49	29	29	23	23	doxycycline	COX10	PA449415	1352	0.531
NULL	Clin_Ophthalmol_2014_Jan_13_8_219-228.nxml.txt.nlp	24531757	SENT153	18	18	4	4	brinzolamide	TIM	PA164744929	7984;8914	0.531
NULL	BMB_Rep_2014_Jun_47(6)_342-347.nxml.txt.nlp	24286324	SENT267	22	22	6	6	doxorubicin	MDR1	PA449412	5243	0.531
NULL	J_Cardiothorac_Surg_2012_Jun_28_7_61.nxml.txt.nlp	22741616	SENT98	7	7	5	5	amiodarone	NAC	PA448383	22861	0.531
NULL	Arthritis_Res_2000_Jun_8_2(5)_348-355.nxml.txt.nlp	11094447	SENT107	19	19	33	33	fluorescein	RGDS	PA164746009	5900	0.531
NULL	Arthritis_Res_Ther_2008_Apr_16_10(2)_R43.nxml.txt.nlp	18416822	SENT53	6	6	22	22	ketorolac	COX	PA450150	1351	0.531
NULL	Acta_Physiol_(Oxf)_2008_Oct_194(2)_123-140.nxml.txt.nlp	18419777	SENT270	16	16	22	22	isoproterenol	PES	PA450121	23481	0.531
NULL	Comp_Hepatol_2004_Jan_14_3(Suppl_1)_S31.nxml.txt.nlp	14960183	SENT67	8	8	4	4	ethanol	TNF-alpha	PA448073	7124	0.531
NULL	J_Cancer_2013_Aug_28_4(7)_585-596.nxml.txt.nlp	24069069	SENT227	12	12	14	14	gemcitabine	Gem	PA449748	51053	0.531
NULL	Clin_Exp_Metastasis_2014_Sep_17_31(1)_135-147.nxml.txt.nlp	24043563	SENT29	34	34	32	32	urokinase	MMP9	PA451836	4318	0.531
NULL	Int_J_Vasc_Med_2012_Jul_24_2012_508416.nxml.txt.nlp	22888436	SENT163	38	38	31	31	farglitazar	SRC-3		8202	0.531
NULL	Breast_Cancer_Res_2010_Nov_16_12(6)_R96.nxml.txt.nlp	21080941	SENT159	31	31	27	27	lapatinib	HRG	PA152241907	3084;3273	0.531
NULL	Br_J_Cancer_2012_Nov_20_107(11)_1844-1852.nxml.txt.nlp	23169337	SENT160	0	0	12	12	bortezomib	c-Myc	PA10252	4609	0.531
NULL	J_Anaesthesiol_Clin_Pharmacol_2012_Oct-Dec_28(4)_486-490.nxml.txt.nlp	23225930	SENT99	11	11	21	21	fentanyl	TKR	PA449599	8277	0.531
NULL	Diabetes_2011_Mar_21_60(3)_909-917.nxml.txt.nlp	21300843	SENT162	20	20	13	13	galactose	GdA	PA449725	5047	0.531
NULL	Oncologist_2010_Apr_15(4)_360-371.nxml.txt.nlp	20413641	SENT184	11	11	25	25	cblb502	TLR5		7100	0.531
NULL	ScientificWorldJournal_2014_Dec_9_2014_808320.nxml.txt.nlp	25548793	SENT6	6	6	12	12	heparin	RAC	PA449855	207	0.531
NULL	Cancer_Metastasis_Rev_2011_Jun_23_30(2)_185-197.nxml.txt.nlp	21340664	SENT317	3	3	0	0	docetaxel	BMI1	PA449383	648	0.531
NULL	Biomed_Res_Int_2013_Dec_17_2013_696317.nxml.txt.nlp	24455716	SENT169	9	9	6	6	l-arginine	NAC	PA448478	22861	0.531
NULL	Basic_Clin_Pharmacol_Toxicol_2013_Feb_5_112(2)_132-137.nxml.txt.nlp	22900583	SENT54	18	18	30	30	flurbiprofen	CYP2B6	PA449683	1555	0.531
NULL	Evid_Based_Complement_Alternat_Med_2004_Dec_6_1(3)_251-257.nxml.txt.nlp	15841258	SENT178	6	6	0	0	diclofenac	PHL	PA449293	613	0.531
NULL	Libyan_J_Med_2008_Jun_1_3(2)_101-103.nxml.txt.nlp	21499466	SENT90	18	18	13	13	rituximab	CHOP	PA451261	1649	0.531
NULL	J_Anim_Sci_Biotechnol_2014_Aug_28_5(1)_42.nxml.txt.nlp	25343027	SENT135	8	8	11	11	creatine	NEFA	PA164778930	4925	0.531
NULL	Gut_Liver_2014_Jan_5_8(1)_49-57.nxml.txt.nlp	24516701	SENT129	11	11	3	3	diclofenac	cPLA2	PA449293	10524	0.531
NULL	Acta_Pharmacol_Sin_2009_May_6_30(5)_589-596.nxml.txt.nlp	19349964	SENT106	20	20	30	30	thrombin	VWF	PA451674	7450	0.531
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1063.nxml.txt.nlp	24556678	SENT102	22	22	16	16	thioridazine	PSMA5	PA451666	5686	0.531
NULL	Acta_Pharmacol_Sin_2014_Sep_4_35(9)_1137-1149.nxml.txt.nlp	25088000	SENT154	19	19	17	17	pilocarpine	FKBP1A	PA450962	2280	0.531
NULL	Crit_Care_2011_Feb_7_15(1)_R53.nxml.txt.nlp	21299901	SENT58	10	10	0	0	vasopressin	ACTH	PA451858	5443	0.531
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_21-38.nxml.txt.nlp	19305786	SENT498	28	28	15	15	menthol	TRPV4	PA164776605	59341	0.531
NULL	Nat_Genet_2011_Jan_12_43(1)_27-33.nxml.txt.nlp	21151129	SENT12	18	18	32	32	tamoxifen	FOXA1	PA451581	3169	0.531
NULL	Int_J_Nanomedicine_2010_Aug_9_5_517-523.nxml.txt.nlp	20957114	SENT119	8	8	16	16	creatine	ADP	PA164778930	23038	0.531
NULL	Exp_Ther_Med_2013_May_15_5(5)_1327-1331.nxml.txt.nlp	23737873	SENT129	0	0	6	6	imidapril	AQP2	PA452640	359	0.531
NULL	Open_Cardiovasc_Med_J_2010_Jun_17_4_135-145.nxml.txt.nlp	20700394	SENT94	0	0	27	27	abciximab	MAC-1	PA448006	3689;3684	0.531
NULL	J_Cell_Biol_2004_Jul_5_166(1)_97-109.nxml.txt.nlp	15240572	SENT220	12	12	17	17	heparin	EGF	PA449855	1950	0.531
NULL	J_Int_Soc_Sports_Nutr_2011_Nov_7_8(Suppl_1)_P25.nxml.txt.nlp	NULL	SENT9	32	32	18	18	creatine	OTC	PA164778930	5009	0.531
NULL	Insights_Imaging_2011_Mar_25_2(3)_235-246.nxml.txt.nlp	22347950	SENT113	11	11	5	5	choline	MRS	PA448976	8011	0.531
NULL	Oncotarget_2014_Aug_29_5(17)_7217-7259.nxml.txt.nlp	25277175	SENT213	14	14	3	3	itraconazole	gamma	PA450132	9913	0.531
NULL	Cancer_Cell_Int_2013_May_15_13_42.nxml.txt.nlp	23672670	SENT58	31	31	17	17	paclitaxel	p53	PA450761	7157	0.531
NULL	Indian_J_Pharm_Sci_2008_Jan-Feb_70(1)_102-105.nxml.txt.nlp	20390092	SENT40	7	7	32	32	domperidone	DOM	PA134711056	6663	0.531
NULL	Ann_R_Coll_Surg_Engl_2012_May_94(4)_221-223.nxml.txt.nlp	22613296	SENT35	9	9	17	17	sitagliptin	GLP-1	PA164748978	100125288	0.531
NULL	Hum_Genomics_2009_Dec_1_4(2)_91-106.nxml.txt.nlp	20038497	SENT197	25	25	16	16	tacrine	GSTM1	PA451576	2944	0.531
NULL	Am_J_Trop_Med_Hyg_2012_Jul_1_87(1)_190-191.nxml.txt.nlp	22764313	SENT18	30	30	6	6	primaquine	G6PD	PA451103	2539	0.531
NULL	J_Cell_Biol_1998_Jun_15_141(6)_1449-1465.nxml.txt.nlp	9628900	SENT397	11	11	13	13	genistein	Gen	PA165109660	348654	0.531
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT3	5	5	17	17	trastuzumab	IL-6	PA451743	3569	0.531
NULL	Front_Genet_2014_Aug_26_5_289.nxml.txt.nlp	25206362	SENT48	5	5	20	20	choline	B12	PA448976	7126;4709	0.531
NULL	Front_Genet_2014_Jul_1_5_193.nxml.txt.nlp	25071823	SENT120	29	29	22	22	tolbutamide	INS-1	PA451718	2305	0.531
NULL	J_Cell_Biol_2002_Nov_11_159(3)_465-476.nxml.txt.nlp	12427869	SENT675	24	24	6	6	neomycin	ARM	PA450608	80210	0.531
NULL	Ann_Med_2014_Nov_21_46(7)_475-489.nxml.txt.nlp	25045928	SENT141	21	21	6	6	thrombin	ADP	PA451674	23038	0.531
NULL	Clin_Ophthalmol_2014_Jan_13_8_219-228.nxml.txt.nlp	24531757	SENT145	23	23	9	9	brinzolamide	TIM	PA164744929	7984;8914	0.531
NULL	Avicenna_J_Phytomed_2013_Autumn_3(4)_302-312.nxml.txt.nlp	25050287	SENT141	2	2	18	18	ethanol	hole	PA448073	80757	0.531
NULL	Braz_J_Med_Biol_Res_2011_Nov_18_45(1)_86-92.nxml.txt.nlp	22086466	SENT140	0	0	6	6	thrombin	PAR-1	PA451674	2011;2149	0.531
NULL	J_Korean_Neurosurg_Soc_2014_Jul_31_56(1)_1-4.nxml.txt.nlp	25289117	SENT126	0	0	15	15	curcumin	p38	PA151958596	10598;1432;7965	0.531
NULL	Anesth_Pain_Med_2014_Sep_9_4(4)_e14221.nxml.txt.nlp	25599022	SENT80	0	0	6	6	propofol	LPO	PA451141	4025	0.531
NULL	Clinics_(Sao_Paulo)_2012_Jan_67(1)_61-67.nxml.txt.nlp	22249482	SENT50	34	34	42	42	bevacizumab	San	PA130232992	80218	0.531
NULL	Diabetes_2013_Mar_14_62(3)_789-800.nxml.txt.nlp	22966074	SENT217	27	27	7	7	forskolin	AMPK	PA146096022	5563	0.531
NULL	Arthritis_Res_Ther_2012_Mar_12_14(2)_R57.nxml.txt.nlp	22409963	SENT67	31	31	47	47	l-glutamine	CO2	PA10090	4513	0.531
NULL	Oncol_Rep_2013_Apr_5_29(4)_1671-1677.nxml.txt.nlp	23404329	SENT18	0	0	2	2	aspirin	ASP	PA448497	259266;443;9474;29974;434;83853	0.531
NULL	Arthritis_Res_Ther_2006_Jul_28_8(Suppl_2)_S2.nxml.txt.nlp	16899106	SENT109	11	11	2	2	tocilizumab	IL-6	PA165292659	3569	0.531
NULL	Diabetes_2013_Mar_14_62(3)_825-836.nxml.txt.nlp	23193184	SENT78	12	12	8	8	lipase	adiponectin	PA450239	9370	0.531
NULL	Biomed_Res_Int_2014_Jan_20_2014_948427.nxml.txt.nlp	24563867	SENT131	4	4	11	11	buspirone	STZ	PA448689	6484	0.531
NULL	Neuroscience_2011_Dec_1_197(1)_280-292.nxml.txt.nlp	21945033	SENT244	14	14	19	19	galantamine	CA1	PA449726	759	0.531
NULL	Hematol_Rep_2011_Oct_27_3(3)_e20.nxml.txt.nlp	22593812	SENT11	10	10	2	2	eltrombopag	TPO	PA165981594	7066;7173	0.531
NULL	J_Gen_Physiol_1933_Nov_20_17(2)_159-164.nxml.txt.nlp	19872772	SENT0	14	14	1	1	trypsin	Gen	PA451806	348654	0.531
NULL	Int_J_Hypertens_2012_Dec_18_2012_290635.nxml.txt.nlp	23316344	SENT21	18	18	20	20	vasopressin	AVP	PA451858	114548;551	0.531
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_79-96.nxml.txt.nlp	19305789	SENT67	35	35	43	43	capsaicin	TRPV1	PA448776	7442	0.531
NULL	ScientificWorldJournal_2014_Mar_13_2014_604685.nxml.txt.nlp	24757426	SENT143	8	8	14	14	resveratrol	SIRT1		23411	0.531
NULL	Chem_Cent_J_2012_Dec_20_6_160.nxml.txt.nlp	23256754	SENT201	16	16	43	43	l-glutamine	CO2	PA10090	4513	0.531
NULL	J_Carcinog_2012_Mar_12_11_5.nxml.txt.nlp	22529741	SENT166	43	43	17	17	isoniazid	CYP2E1	PA450112	1571	0.531
NULL	J_Exp_Med_2000_Mar_20_191(6)_1005-1016.nxml.txt.nlp	10727462	SENT335	1	1	15	15	flavopiridol	CDK4	PA452627	1019	0.531
NULL	Crit_Care_2011_Nov_16_15(6)_R271.nxml.txt.nlp	22087790	SENT164	2	2	9	9	nitroprusside	Yes	PA451406	7525	0.531
NULL	Int_J_Breast_Cancer_2012_Nov_2_2012_217185.nxml.txt.nlp	22295242	SENT203	11	11	25	25	olaparib	PI3K		5290	0.531
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Dec_2_5_30.nxml.txt.nlp	17140452	SENT229	10	10	8	8	gatifloxacin	GAT	PA449738	10249	0.531
NULL	Biomed_Opt_Express_2012_Jan_10_3(2)_273-281.nxml.txt.nlp	22312580	SENT120	3	3	24	24	nadh	TSP1	PA164755085	7057	0.531
NULL	EMBO_J_2010_Apr_21_29(8)_1401-1411.nxml.txt.nlp	20300060	SENT180	13	13	18	18	fluorescein	hole	PA164746009	80757	0.531
NULL	J_Headache_Pain_2011_Feb_18_12(1)_25-34.nxml.txt.nlp	21170567	SENT87	13	13	4	4	sumatriptan	6-16	PA451566	2537	0.531
NULL	Int_J_Anal_Chem_2013_May_12_2013_743792.nxml.txt.nlp	23737791	SENT124	30	30	41	41	ethanol	mol	PA448073	90527	0.531
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Apr_15_9_13.nxml.txt.nlp	20398300	SENT72	7	7	0	0	amoxicillin	LAM	PA448406	7249;7248	0.531
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT211	10	10	15	15	perifosine	DR4	PA165291471	8797	0.531
NULL	Cancer_Med_2013_Oct_19_2(5)_646-653.nxml.txt.nlp	24403230	SENT142	8	8	15	15	trastuzumab	p38	PA451743	10598;1432;7965	0.531
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT195	33	33	25	25	sitagliptin	HIP	PA164748978	6767;6159;64399;5068	0.531
NULL	Cell_Mol_Neurobiol_2014_Jan_14_34(3)_323-331.nxml.txt.nlp	24420496	SENT94	24	24	13	13	l-glutamine	F12	PA10090	2161	0.53
NULL	J_Adv_Pract_Oncol_2012_Jul_1_Jul-Aug_3(4)_237-241.nxml.txt.nlp	25031951	SENT3	2	2	20	20	topotecan	MSN	PA451729	4478	0.53
NULL	Blood_Cancer_J_2014_Aug_1_4(8)_e232.nxml.txt.nlp	25083816	SENT218	37	37	25	25	vincristine	PI3K	PA451879	5290	0.53
NULL	Clin_Ophthalmol_2012_Jan_12_6_111-116.nxml.txt.nlp	22275815	SENT18	2	2	13	13	travoprost	PGF	PA164781371	5228	0.53
NULL	Gene_Regul_Syst_Bio_2014_Mar_4_8_63-73.nxml.txt.nlp	24634581	SENT72	41	41	35	35	minocycline	MT1-MMP	PA450519	4323	0.53
NULL	Antimicrob_Resist_Infect_Control_2012_Mar_16_1_12.nxml.txt.nlp	22958880	SENT107	34	34	28	28	ceftriaxone	CTX	PA448866	1593	0.53
NULL	Front_Immunol_2012_Jan_24_3_3.nxml.txt.nlp	22566889	SENT191	24	24	26	26	rituximab	CHOP	PA451261	1649	0.53
NULL	Oxid_Med_Cell_Longev_2013_Jun_2_2013_793525.nxml.txt.nlp	23819014	SENT167	3	3	25	25	resveratrol	PI3K		5290	0.53
NULL	J_Int_Soc_Sports_Nutr_2011_Nov_7_8(Suppl_1)_P25.nxml.txt.nlp	NULL	SENT9	14	14	18	18	creatine	OTC	PA164778930	5009	0.53
NULL	Exp_Cell_Res_2011_Apr_15_317(7)_1028-1039.nxml.txt.nlp	21237154	SENT187	7	7	5	5	staurosporine	TRAIL	PA165109623	8743	0.53
NULL	J_Orthop_Traumatol_2011_Jun_4_12(2)_77-80.nxml.txt.nlp	21541772	SENT63	19	19	11	11	nitrogen	GPT	PA450643	1798;2875	0.53
NULL	Exp_Cell_Res_2013_Aug_1_319(13)_2037-2048.nxml.txt.nlp	23562655	SENT15	33	33	44	44	urokinase	MMP1	PA451836	4312	0.53
NULL	Arch_Med_Sci_2011_Feb_8_7(1)_154-160.nxml.txt.nlp	22291749	SENT182	29	29	20	20	chlorhexidine	S15	PA164776863	6209	0.53
NULL	Sensors_(Basel)_2013_Dec_27_14(1)_458-467.nxml.txt.nlp	24379050	SENT46	20	20	17	17	glucose	MTB	PA449773	54892;4498	0.53
NULL	Cell_Death_Dis_2014_Jan_16_5(1)_e1000.nxml.txt.nlp	24434508	SENT85	0	0	7	7	bortezomib	p53	PA10252	7157	0.53
NULL	Front_Genet_2011_May_4_2_20.nxml.txt.nlp	22303316	SENT33	2	2	4	4	hyaluronan	CD44	PA165958431	960	0.53
NULL	Front_Oncol_2013_Nov_14_3_279.nxml.txt.nlp	24294592	SENT133	33	33	26	26	gemcitabine	ADP	PA449748	23038	0.53
NULL	J_Mol_Med_(Berl)_2014_May_10_92(7)_709-722.nxml.txt.nlp	24811491	SENT96	35	35	20	20	panitumumab	BRAF	PA162373091	673	0.53
NULL	Open_Biochem_J_2014_Feb_21_8_21-34.nxml.txt.nlp	24688608	SENT125	29	29	22	22	etanercept	CLDN8	PA449515	9073	0.53
NULL	Iran_J_Psychiatry_2010_Fall_5(4)_119-127.nxml.txt.nlp	22952505	SENT41	0	0	18	18	atorvastatin	TNF-alpha	PA448500	7124	0.53
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT435	2	2	4	4	resveratrol	SIRT1		23411	0.53
NULL	Oncotarget_2013_Nov_24_4(12)_2430-2438.nxml.txt.nlp	24280348	SENT99	0	0	5	5	gefitinib	STAT3	PA131301952	6774	0.53
NULL	Cell_Death_Dis_2012_Nov_15_3(11)_e422.nxml.txt.nlp	23152058	SENT130	26	26	21	21	doxycycline	ZNF143	PA449415	7702	0.53
NULL	Bone_Marrow_Transplant_2011_Jul_11_46(7)_943-949.nxml.txt.nlp	20935680	SENT22	10	10	20	20	cyclophosphamide	GM-CSF	PA449165	1437	0.53
NULL	Environ_Health_Perspect_2010_Mar_23_118(3)_427-431.nxml.txt.nlp	20194071	SENT95	13	13	29	29	ethanol	IL-10	PA448073	3586	0.53
NULL	Case_Rep_Med_2012_Jul_2_2012_794354.nxml.txt.nlp	22811727	SENT45	9	9	20	20	thyroglobulin	CDX2	PA164754910	1045	0.53
NULL	Ann_Maxillofac_Surg_2011_Jul-Dec_1(2)_145-149.nxml.txt.nlp	23482687	SENT35	13	13	0	0	collagenase	CD147	PA449107	682	0.53
NULL	Pharmaceuticals_(Basel)_2012_Feb_14_5(2)_189-208.nxml.txt.nlp	24288088	SENT51	28	28	44	44	l-glutamine	CO2	PA10090	4513	0.53
NULL	Cancer_Med_2013_Dec_22_2(6)_862-871.nxml.txt.nlp	24403259	SENT78	27	27	7	7	everolimus	JNK	PA164746311	5599	0.53
NULL	Arthritis_Res_Ther_2005_Apr_4_7(4)_R756-R768.nxml.txt.nlp	15987477	SENT137	1	1	8	8	hyaluronidase	PH-20	PA164745713	6677	0.53
NULL	Cancers_(Basel)_2013_Apr_15_5(2)_430-461.nxml.txt.nlp	24216985	SENT333	17	17	19	19	decitabine	DAC	PA164749631	13	0.53
NULL	Lipids_Health_Dis_2011_Feb_28_10_38.nxml.txt.nlp	21352602	SENT110	33	33	41	41	ezetimibe	PCSK9	PA10816	255738	0.53
NULL	ScientificWorldJournal_2014_Dec_9_2014_808320.nxml.txt.nlp	25548793	SENT22	9	9	16	16	heparin	RAC	PA449855	207	0.53
NULL	N_Z_Vet_J_2010_Jun_7_58(3)_121-129.nxml.txt.nlp	20514085	SENT42	25	25	36	36	albendazole	MOX	PA164746058	26002	0.53
NULL	Reprod_Biol_Endocrinol_2003_Aug_6_1_54.nxml.txt.nlp	12932297	SENT198	3	3	1	1	hyaluronidase	SPAM1	PA164745713	6677	0.53
NULL	Reprod_Biol_Endocrinol_2003_Feb_11_1_18.nxml.txt.nlp	12694627	SENT89	19	19	35	35	galactose	LTA	PA449725	4049	0.53
NULL	J_Gen_Physiol_2012_Jun_139(6)_407-414.nxml.txt.nlp	22641635	SENT138	22	22	30	30	nadh	ADP	PA164755085	23038	0.53
NULL	Gut_Liver_2013_Nov_11_7(6)_629-641.nxml.txt.nlp	24312702	SENT136	16	16	0	0	glucosamine	EGFR	PA164747613	1956	0.53
NULL	J_Korean_Med_Sci_2009_Jan_29_24(Suppl_1)_S170-S175.nxml.txt.nlp	19194548	SENT82	28	28	5	5	cisplatin	EPO	PA449014	7076;8288;2056	0.53
NULL	Multidiscip_Respir_Med_2013_Feb_13_8(1)_13.nxml.txt.nlp	23406847	SENT47	32	32	21	21	moxifloxacin	EMB	PA450555	133418	0.53
NULL	Exp_Ther_Med_2013_Mar_17_5(3)_797-802.nxml.txt.nlp	23403698	SENT187	12	12	0	0	glucose	TEM	PA449773	64102	0.53
NULL	Breast_Cancer_Res_2012_Jun_7_14(3)_R89.nxml.txt.nlp	22676470	SENT319	13	13	16	16	trastuzumab	HER2	PA451743	2064	0.53
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1013.nxml.txt.nlp	24457957	SENT80	12	12	21	21	bortezomib	NOXA	PA10252	5366	0.53
NULL	Curr_Oncol_2010_Feb_17(1)_81-86.nxml.txt.nlp	20179808	SENT115	27	27	36	36	tamoxifen	CYP2D6	PA451581	1565	0.53
NULL	J_Mol_Signal_2010_May_10_5_4.nxml.txt.nlp	20459745	SENT12	0	0	18	18	cisplatin	p53	PA449014	7157	0.53
NULL	Curr_Control_Trials_Cardiovasc_Med_2001_May_31_2(3)_129-140.nxml.txt.nlp	11806786	SENT182	0	0	6	6	ticlopidine	ADP	PA451686	23038	0.53
NULL	Clin_Ophthalmol_2014_Jan_13_8_219-228.nxml.txt.nlp	24531757	SENT174	18	18	4	4	brinzolamide	TIM	PA164744929	7984;8914	0.53
NULL	Adv_Biomed_Res_2012_Oct_31_1_70.nxml.txt.nlp	23326800	SENT121	8	8	5	5	erythromycin	IPL	PA449493	7262	0.53
NULL	J_Hematol_Oncol_2012_Sep_18_5_57.nxml.txt.nlp	22989009	SENT403	8	8	10	10	berberine	DAXX	PA165860812	1616	0.53
NULL	Arch_Med_Sci_2011_Aug_2_7(4)_597-603.nxml.txt.nlp	22291794	SENT115	0	0	18	18	clenbuterol	IP-10	PA164745640	3627	0.53
NULL	Pharmaceuticals_(Basel)_2012_Feb_3_5(2)_155-168.nxml.txt.nlp	24288086	SENT114	20	20	25	25	thrombin	Yes	PA451674	7525	0.53
NULL	Exp_Ther_Med_2014_Mar_31_7(3)_553-559.nxml.txt.nlp	24520244	SENT156	28	28	26	26	cyclophosphamide	CTX	PA449165	1593	0.53
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT216	2	2	14	14	cisplatin	p53	PA449014	7157	0.53
NULL	Pak_J_Med_Sci_2014_Jul-Aug_30(4)_814-818.nxml.txt.nlp	25097523	SENT65	2	2	16	16	vancomycin	TOB	PA451850	10140	0.53
NULL	Oncol_Lett_2013_Feb_22_5(2)_641-644.nxml.txt.nlp	23419988	SENT120	23	23	11	11	paclitaxel	CT7	PA450761	9947	0.53
NULL	Indian_J_Pharm_Sci_2008_Jul-Aug_70(4)_415-422.nxml.txt.nlp	20046764	SENT71	29	29	15	15	econazole	PLG	PA164746010	5340	0.53
NULL	Cell_Death_Dis_2010_Oct_21_1(10)_e86.nxml.txt.nlp	21368859	SENT63	30	30	28	28	doxorubicin	TRAIL	PA449412	8743	0.53
NULL	Crit_Care_2009_Mar_13_13(Suppl_1)_P182.nxml.txt.nlp	NULL	SENT2	5	5	7	7	vasopressin	AVP	PA451858	114548;551	0.53
NULL	Open_Biochem_J_2011_Sep_23_5_45-51.nxml.txt.nlp	21966325	SENT82	0	0	9	9	diclofenac	JNK	PA449293	5599	0.53
NULL	Braz_J_Med_Biol_Res_2013_Mar_15_46(3)_299-305.nxml.txt.nlp	23532269	SENT135	19	19	0	0	propofol	CD14	PA451141	929	0.53
NULL	Eur_J_Clin_Pharmacol_2012_Jan_8_68(1)_29-37.nxml.txt.nlp	21739267	SENT188	8	8	5	5	paroxetine	CYP2D6	PA450801	1565	0.53
NULL	J_Hematol_Oncol_2013_Jun_3_6_38.nxml.txt.nlp	23731980	SENT184	13	13	5	5	lapatinib	HER2	PA152241907	2064	0.53
NULL	Eur_J_Immunol_2014_Jun_10_44(6)_1759-1769.nxml.txt.nlp	24595810	SENT126	5	5	11	11	fludrocortisone	CXCR4	PA164743961	7852	0.53
NULL	J_Innate_Immun_2011_Dec_12_4(1)_69-79.nxml.txt.nlp	21997473	SENT208	20	20	13	13	hyaluronan	CD44	PA165958431	960	0.53
NULL	Korean_J_Anesthesiol_2013_Mar_19_64(3)_218-222.nxml.txt.nlp	23560186	SENT62	13	13	21	21	propofol	CO2	PA451141	4513	0.53
NULL	Glycobiology_2011_Apr_2_21(4)_410-425.nxml.txt.nlp	21045009	SENT364	18	18	25	25	nadh	mol	PA164755085	90527	0.53
NULL	Oncologist_2010_Mar_9_15(3)_236-245.nxml.txt.nlp	20215359	SENT80	8	8	10	10	bevacizumab	IFN	PA130232992	3439	0.53
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1013.nxml.txt.nlp	24457957	SENT80	12	12	5	5	bortezomib	NOXA	PA10252	5366	0.53
NULL	Front_Oncol_2014_Sep_23_4_264.nxml.txt.nlp	25295231	SENT264	29	29	18	18	cytarabine	p53	PA449177	7157	0.53
NULL	Arch_Med_Sci_2010_Dec_29_6(6)_919-925.nxml.txt.nlp	22427767	SENT137	9	9	0	0	theophylline	LTA	PA451647	4049	0.53
NULL	Cancer_Causes_Control_2013_Aug_18_24(8)_1605-1614.nxml.txt.nlp	23775025	SENT64	3	3	20	20	cyclophosphamide	GSTM1	PA449165	2944	0.53
NULL	Exp_Ther_Med_2013_Mar_21_5(3)_987-991.nxml.txt.nlp	23407636	SENT11	0	0	27	27	losartan	IL-8	PA450268	3576	0.53
NULL	Int_J_Mol_Sci_2012_Sep_26_13(10)_12336-12348.nxml.txt.nlp	23202901	SENT64	27	27	14	14	phenol	P90	PA450913	821	0.53
NULL	Ann_N_Y_Acad_Sci_2012_Oct_10_1271(1)_82-87.nxml.txt.nlp	23050968	SENT82	24	24	37	37	urokinase	PI3K	PA451836	5290	0.53
NULL	ScientificWorldJournal_2014_Mar_30_2014_818502.nxml.txt.nlp	24983002	SENT222	8	8	31	31	hyaluronan	IVD	PA165958431	3712	0.53
NULL	Nucleic_Acids_Res_2010_Oct_4_38(19)_6375-6388.nxml.txt.nlp	20525792	SENT294	22	22	25	25	doxycycline	YY1	PA449415	7528	0.53
NULL	Nat_Commun_2013_Sep_16_4_2420.nxml.txt.nlp	24036533	SENT260	32	32	43	43	ceftazidime	BSAC	PA448861	57591	0.53
NULL	Chemother_Res_Pract_2011_Sep_21_2011_839742.nxml.txt.nlp	22295206	SENT95	5	5	17	17	cetuximab	CRT	PA10040	811	0.53
NULL	Oxid_Med_Cell_Longev_2013_Nov_24_2013_971024.nxml.txt.nlp	24371505	SENT151	23	23	15	15	boceprevir	IFN	PA165948902	3439	0.53
NULL	Dement_Geriatr_Cogn_Dis_Extra_2012_Sep_21_2(1)_387-399.nxml.txt.nlp	23277779	SENT187	20	20	27	27	cyanocobalamin	B12	PA451892	7126;4709	0.53
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT106	35	35	26	26	streptomycin	FBS	PA451512	64319;26269	0.53
NULL	Br_J_Pharmacol_2008_Sep_9_155(1)_127-137.nxml.txt.nlp	18536750	SENT187	11	11	13	13	piroxicam	IL-10	PA450985	3586	0.53
NULL	J_Mol_Signal_2012_Aug_16_7_12.nxml.txt.nlp	22898329	SENT138	18	18	2	2	vinblastine	NOXA	PA451877	5366	0.53
NULL	J_Int_Soc_Sports_Nutr_2013_Aug_22_10_39.nxml.txt.nlp	23967897	SENT212	5	5	7	7	betaine	Met	PA448603	79811	0.53
NULL	Indian_J_Endocrinol_Metab_2011_Jan-Mar_15(1)_9-17.nxml.txt.nlp	21584160	SENT189	0	0	8	8	liraglutide	GLP-1	PA165958364	100125288	0.53
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Dec_2_5_30.nxml.txt.nlp	17140452	SENT187	31	31	5	5	chloramphenicol	GAT	PA448927	10249	0.53
NULL	BMB_Rep_2014_Jan_47(1)_1-7.nxml.txt.nlp	24388105	SENT484	0	0	10	10	pravastatin	LOX-1	PA451089	4973	0.53
NULL	Comput_Struct_Biotechnol_J_2013_Mar_12_4_e201301008.nxml.txt.nlp	24688689	SENT167	17	17	19	19	taurine	NAT	PA451590	6046	0.53
NULL	Toxins_(Basel)_2010_Oct_28_2(11)_2584-2592.nxml.txt.nlp	22069565	SENT316	0	0	4	4	warfarin	CYP2C9	PA451906	1559	0.53
NULL	Clin_Med_Oncol_2008_Apr_28_2_375-383.nxml.txt.nlp	21892302	SENT122	6	6	10	10	tegafur	CDHP	PA452620	1001	0.53
NULL	Breast_Cancer_Res_Treat_2013_Apr_12_138(2)_427-435.nxml.txt.nlp	23479422	SENT271	24	24	5	5	trastuzumab	NCCT	PA451743	6559	0.53
NULL	Bone_2012_Jan_50(1)_218-225.nxml.txt.nlp	22023931	SENT330	7	7	1	1	iron	FGF23	PA450087	8074	0.53
NULL	Br_J_Cancer_2013_Sep_3_109(5)_1079-1084.nxml.txt.nlp	23928659	SENT65	12	12	10	10	docetaxel	DES	PA449383	1674	0.53
NULL	Indian_J_Nephrol_2014_Nov-Dec_24(6)_349-355.nxml.txt.nlp	25484527	SENT57	3	3	20	20	fluorescein	CD69	PA164746009	969	0.53
NULL	Ann_Surg_Oncol_2007_Apr_26_14(4)_1499-1506.nxml.txt.nlp	17253101	SENT217	12	12	10	10	melphalan	gamma	PA450354	9913	0.53
NULL	J_Skin_Cancer_2012_Dec_13_2012_147863.nxml.txt.nlp	23316365	SENT132	2	2	19	19	curcumin	STAT3	PA151958596	6774	0.53
NULL	Cell_Biol_Toxicol_2012_Apr_19_28(2)_69-87.nxml.txt.nlp	22258563	SENT104	20	20	33	33	bupropion	CYP1A2	PA448687	1544	0.53
NULL	Environ_Toxicol_Chem_2014_Oct_25_33(10)_2363-2367.nxml.txt.nlp	25043914	SENT59	9	9	5	5	galactose	GAL	PA449725	51083	0.53
NULL	Int_J_Mol_Sci_2012_Sep_26_13(10)_12349-12366.nxml.txt.nlp	23202902	SENT391	1	1	13	13	arsenite	p38	PA452638	10598;1432;7965	0.53
NULL	Oncotarget_2012_Nov_17_4(1)_18-28.nxml.txt.nlp	23248157	SENT92	12	12	16	16	pargyline	U87	PA450797	677775;641648	0.53
NULL	Indian_J_Anaesth_2013_Sep-Oct_57(5)_446-454.nxml.txt.nlp	24249877	SENT196	13	13	18	18	isoflurane	CO2	PA450106	4513	0.53
NULL	J_Exp_Clin_Cancer_Res_2008_Sep_12_27(1)_37.nxml.txt.nlp	18789152	SENT141	0	0	12	12	docetaxel	BIRC5	PA449383	332	0.53
NULL	Indian_J_Pharmacol_2009_Dec_41(6)_252-254.nxml.txt.nlp	20407554	SENT8	12	12	16	16	irbesartan	STZ	PA450084	6484	0.53
NULL	Front_Genet_2013_Aug_29_4_163.nxml.txt.nlp	24009622	SENT62	2	2	4	4	ethanol	NOT	PA448073	4929	0.53
NULL	Int_J_Biol_Sci_2014_Aug_23_10(8)_921-939.nxml.txt.nlp	25170305	SENT307	12	12	4	4	nadh	EPO	PA164755085	7076;8288;2056	0.53
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Nov_21_70(Pt_12)_559-561.nxml.txt.nlp	25552992	SENT19	22	22	12	12	phenol	mol	PA450913	90527	0.53
NULL	Ann_Rheum_Dis_2009_Jan_5_68(6)_1051-1058.nxml.txt.nlp	18662930	SENT190	14	14	16	16	hyaluronan	CD44	PA165958431	960	0.53
NULL	Antimicrob_Resist_Infect_Control_2012_Mar_16_1_12.nxml.txt.nlp	22958880	SENT107	2	2	28	28	ampicillin	CTX	PA448419	1593	0.53
NULL	Br_J_Ophthalmol_2013_Aug_6_97(8)_989-993.nxml.txt.nlp	23743437	SENT114	2	2	0	0	bimatoprost	BIM	PA164748867	10018	0.53
NULL	Crit_Care_2006_Mar_7_10(2)_R40.nxml.txt.nlp	16542484	SENT4	6	6	8	8	vasopressin	AVP	PA451858	114548;551	0.53
NULL	Front_Neural_Circuits_2013_Oct_18_7_149.nxml.txt.nlp	24151456	SENT529	5	5	13	13	estradiol	aromatase	PA449503	1588	0.53
NULL	J_Hematol_Oncol_2009_Aug_12_2_36.nxml.txt.nlp	19674465	SENT62	0	0	5	5	lenalidomide	IL-6	PA162363968	3569	0.53
NULL	Curr_Neuropharmacol_2008_Sep_6(3)_193-202.nxml.txt.nlp	19506720	SENT352	13	13	5	5	paroxetine	p75	PA450801	7133;11168	0.53
NULL	Cancer_Cell_Int_2014_Apr_3_14_32.nxml.txt.nlp	24693884	SENT3	1	1	6	6	rituximab	CHOP	PA451261	1649	0.53
NULL	Brain_2013_Jul_24_136(7)_2279-2297.nxml.txt.nlp	23801741	SENT275	15	15	29	29	tamoxifen	ANOVA	PA451581	4858	0.53
NULL	Diabetes_2013_Oct_17_62(10)_3500-3513.nxml.txt.nlp	23884882	SENT173	0	0	13	13	resveratrol	NKX6-1		4825	0.53
NULL	Cell_Commun_Signal_2013_Nov_4_11_82.nxml.txt.nlp	24188565	SENT15	30	30	20	20	gentamicin	N-WASP	PA449753	8976	0.53
NULL	J_Oncol_2012_Jan_26_2012_750270.nxml.txt.nlp	22363346	SENT211	9	9	6	6	fulvestrant	EGFR	PA164747170	1956	0.53
NULL	Cancer_Manag_Res_2011_May_9_3_117-141.nxml.txt.nlp	21625397	SENT524	0	0	12	12	belinostat	ODC		4953;89874	0.53
NULL	BMB_Rep_2013_Mar_46(3)_157-162.nxml.txt.nlp	23527859	SENT111	16	16	14	14	galactose	mol	PA449725	90527	0.53
NULL	Arthritis_Res_Ther_2009_Oct_14_11(5)_251.nxml.txt.nlp	19849819	SENT194	3	3	1	1	teriparatide	PTH	PA451620	5741	0.53
NULL	Mol_Pain_2013_Jun_17_9_29.nxml.txt.nlp	23773289	SENT75	2	2	24	24	minocycline	LPA	PA450519	4018	0.53
NULL	Open_Biochem_J_2008_Feb_6_2_6-15.nxml.txt.nlp	18949070	SENT202	13	13	9	9	heparin	MCP-1	PA449855	6347	0.53
NULL	Iran_J_Pharm_Res_2015_Winter_14(1)_167-175.nxml.txt.nlp	25561923	SENT112	23	23	13	13	propofol	Yes	PA451141	7525	0.53
NULL	Biogerontology_2009_Oct_23_10(5)_549-564.nxml.txt.nlp	19031007	SENT220	7	7	15	15	nadh	Np15	PA164755085	54539	0.53
NULL	Mol_Biol_Cell_2012_May_15_23(10)_1812-1825.nxml.txt.nlp	22438585	SENT400	18	18	35	35	amiloride	VIII	PA448368	1351	0.53
NULL	Int_J_Alzheimers_Dis_2011_Oct_19_2011_864753.nxml.txt.nlp	22028985	SENT109	8	8	5	5	picrotoxin	CA3	PA164777007	761	0.53
NULL	J_Clin_Biochem_Nutr_2010_Jan_29_46(1)_36-42.nxml.txt.nlp	20104263	SENT64	10	10	19	19	ribavirin	IFN	PA451241	3439	0.53
NULL	Case_Rep_Med_2010_Mar_30_2010_836214.nxml.txt.nlp	20369069	SENT72	3	3	10	10	aripiprazole	IFN	PA10026	3439	0.53
NULL	ISRN_Nutr_2014_Jan_16_2014_149549.nxml.txt.nlp	24967264	SENT41	4	4	19	19	echinacea	EPO	PA131550706	7076;8288;2056	0.53
NULL	Cardiol_Res_Pract_2011_Aug_15_2011_156146.nxml.txt.nlp	21876822	SENT180	15	15	18	18	potassium	KIR	PA451047	2669	0.53
NULL	J_Infect_Dis_2013_Sep_1_208(5)_801-812.nxml.txt.nlp	23766527	SENT113	6	6	4	4	artemether	LUM	PA165111698	4060	0.53
NULL	Br_J_Cancer_2004_May_17_90(10)_1933-1941.nxml.txt.nlp	15138474	SENT70	31	31	16	16	urokinase	P27	PA451836	3429	0.53
NULL	Diabetes_2011_Jan_7_60(1)_157-167.nxml.txt.nlp	20929977	SENT124	18	18	35	35	l-glutamine	CO2	PA10090	4513	0.53
NULL	Clinics_(Sao_Paulo)_2011_Jan_66(1)_65-71.nxml.txt.nlp	21437438	SENT139	2	2	0	0	bupropion	BUP	PA448687	23412	0.53
NULL	J_Inflamm_(Lond)_2007_Sep_20_4_18.nxml.txt.nlp	17883846	SENT187	2	2	0	0	bleomycin	BLM	PA448645	641	0.53
NULL	Biochim_Biophys_Acta_2014_Apr_1841(4)_588-594.nxml.txt.nlp	24440819	SENT351	5	5	7	7	lipase	ATGL	PA450239	57104	0.53
NULL	Arthritis_Res_Ther_2005_Dec_1_7(1)_R149-R155.nxml.txt.nlp	15642135	SENT176	13	13	24	24	infliximab	ACR	PA452639	49	0.53
NULL	Arch_Plast_Surg_2014_Jan_13_41(1)_85-88.nxml.txt.nlp	24511501	SENT24	7	7	14	14	lidocaine	hole	PA450226	80757	0.53
NULL	FEBS_J_2009_Oct_276(19)_5571-5578.nxml.txt.nlp	19702827	SENT51	39	39	34	34	gefitinib	EGF	PA131301952	1950	0.53
NULL	Arch_Med_Sci_2012_May_9_8(2)_310-315.nxml.txt.nlp	22662005	SENT80	27	27	17	17	anastrozole	P11	PA448432	8909;6281	0.53
NULL	J_Biomed_Biotechnol_2010_Oct_27_2010_948543.nxml.txt.nlp	21048930	SENT216	11	11	9	9	chlorpromazine	MDC	PA448964	6367	0.53
NULL	Mol_Brain_2014_Sep_4_7(1)_69.nxml.txt.nlp	NULL	SENT51	32	32	22	22	sevoflurane	CCL2	PA451341	6347	0.53
NULL	J_Mol_Med_(Berl)_2012_Oct_20_90(10)_1223-1231.nxml.txt.nlp	22527886	SENT76	9	9	15	15	hyaluronan	MMP3	PA165958431	4314	0.53
NULL	J_Breast_Cancer_2013_Jun_28_16(2)_133-137.nxml.txt.nlp	23843843	SENT95	0	0	32	32	mitomycin	CDK2	PA450524	1017	0.53
NULL	Eur_J_Appl_Physiol_2011_Feb_24_111(2)_275-283.nxml.txt.nlp	20865425	SENT187	7	7	5	5	glucose	AMPK	PA449773	5563	0.53
NULL	Indian_J_Pharmacol_2014_Jul-Aug_46(4)_372-377.nxml.txt.nlp	25097273	SENT9	21	21	18	18	baclofen	CEA	PA448533	5670;1087	0.53
NULL	Int_J_Mol_Sci_2014_Jun_25_15(7)_11234-11244.nxml.txt.nlp	24968266	SENT37	19	19	22	22	docetaxel	PC-3	PA449383	692094	0.53
NULL	Nat_Biotechnol_2010_Aug_2_28(8)_839-847.nxml.txt.nlp	20601939	SENT187	10	10	34	34	l-glutamine	IL-6	PA10090	3569	0.53
NULL	Front_Genet_2012_Nov_21_3_248.nxml.txt.nlp	23181071	SENT488	10	10	7	7	methotrexate	SLCO1B1	PA450428	10599	0.53
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT159	29	29	0	0	tacrolimus	OPG	PA451578	690	0.53
NULL	Hum_Genomics_2009_Jan_1_3(2)_128-142.nxml.txt.nlp	19164090	SENT199	3	3	6	6	carboplatin	CD44	PA448803	960	0.53
NULL	Eur_Heart_J_2012_Mar_33(6)_705-713.nxml.txt.nlp	22422912	SENT148	6	6	22	22	simvastatin	FDG	PA451363	23583	0.53
NULL	Cancer_Manag_Res_2012_Jul_31_4_207-214.nxml.txt.nlp	22904642	SENT32	18	18	9	9	everolimus	INS-1	PA164746311	2305	0.53
NULL	Int_J_Mol_Sci_2014_Mar_5_15(3)_3970-3988.nxml.txt.nlp	24603537	SENT520	4	4	2	2	curcumin	MCH	PA151958596	5367	0.53
NULL	Ann_Gastroenterol_2013_26(3)_233-238.nxml.txt.nlp	NULL	SENT146	0	0	2	2	natalizumab	NAT	PA164747191	6046	0.53
NULL	J_Cell_Biol_1999_Jul_12_146(1)_149-164.nxml.txt.nlp	10402467	SENT823	7	7	10	10	urokinase	CD87	PA451836	5329	0.53
NULL	Ann_Rheum_Dis_2013_Oct_17_72(10)_1613-1620.nxml.txt.nlp	23687260	SENT141	22	22	0	0	infliximab	CDAI	PA452639	146059	0.53
NULL	J_Cell_Mol_Med_2013_Sep_11_17(9)_1160-1172.nxml.txt.nlp	23844832	SENT83	19	19	17	17	gefitinib	EGF	PA131301952	1950	0.529
NULL	Clin_Sci_(Lond)_2013_Aug_1_125(Pt_3)_121-130.nxml.txt.nlp	23577635	SENT158	28	28	24	24	lipase	ATGL	PA450239	57104	0.529
NULL	Neural_Plast_2012_Nov_2_2012_309494.nxml.txt.nlp	22164341	SENT5	10	10	21	21	tamoxifen	CA1	PA451581	759	0.529
NULL	Part_Fibre_Toxicol_2012_Aug_17_9_33.nxml.txt.nlp	22901679	SENT348	21	21	43	43	l-glutamine	IL-4	PA10090	3565	0.529
NULL	Avicenna_J_Med_2013_Apr-Jun_3(2)_37-47.nxml.txt.nlp	23930241	SENT202	13	13	22	22	cyclophosphamide	CD4	PA449165	920	0.529
NULL	Eur_J_Cancer_2014_Sep_50(14)_2367-2374.nxml.txt.nlp	25027307	SENT137	5	5	7	7	tamoxifen	AMH	PA451581	268	0.529
NULL	Iran_J_Pharm_Res_2014_Autumn_13(4)_1393-1401.nxml.txt.nlp	25587329	SENT131	25	25	34	34	celecoxib	MRP1	PA448871	4437	0.529
NULL	Environ_Health_Perspect_2011_Mar_10_119(3)_357-363.nxml.txt.nlp	21362589	SENT164	17	17	0	0	picrotoxin	RDX	PA164777007	5962	0.529
NULL	Iran_Red_Crescent_Med_J_2014_Aug_5_16(8)_e12106.nxml.txt.nlp	25389471	SENT257	8	8	18	18	glucose	adiponectin	PA449773	9370	0.529
NULL	Oncogene_2010_Jul_8_29(27)_3896-3907.nxml.txt.nlp	20453888	SENT111	7	7	19	19	trastuzumab	CDK2	PA451743	1017	0.529
NULL	Biologics_2009_Jul_13_3_77-97.nxml.txt.nlp	19707398	SENT440	4	4	2	2	sargramostim	GM-CSF	PA164748631	1437	0.529
NULL	Spermatogenesis_2013_Jan_1_3(1)_e23870.nxml.txt.nlp	23687616	SENT144	19	19	25	25	hyaluronan	CCL2	PA165958431	6347	0.529
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT209	13	13	15	15	adalimumab	CD36	PA10004	948	0.529
NULL	Environ_Health_Perspect_2012_Apr_6_120(4)_547-553.nxml.txt.nlp	22472290	SENT270	20	20	15	15	arsenite	p50	PA452638	958;4790	0.529
NULL	Biologics_2009_Oct_12_3_469-474.nxml.txt.nlp	19851472	SENT84	21	21	10	10	azelastine	IL-4	PA448517	3565	0.529
NULL	Mol_Cancer_2009_Aug_28_8_68.nxml.txt.nlp	19715609	SENT50	0	0	2	2	staurosporine	STS	PA165109623	412	0.529
NULL	J_Biol_Chem_2013_Apr_12_288(15)_10923-10935.nxml.txt.nlp	23426361	SENT154	23	23	27	27	creatine	ADP	PA164778930	23038	0.529
NULL	J_Inherit_Metab_Dis_2011_Apr_29_34(2)_315-325.nxml.txt.nlp	20668944	SENT174	32	32	14	14	bezafibrate	AMPK	PA162364313	5563	0.529
NULL	J_Biol_Chem_2013_Nov_15_288(46)_33049-33059.nxml.txt.nlp	24089524	SENT264	0	0	9	9	nicotine	GATA6	PA450626	2627	0.529
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2014_May_23_70(Pt_6)_1517-1527.nxml.txt.nlp	24914963	SENT145	19	19	17	17	l-serine	PLP	PA451330	25824;5744	0.529
NULL	Front_Endocrinol_(Lausanne)_2013_Oct_8_4_137.nxml.txt.nlp	24115944	SENT200	43	43	45	45	nadh	GDH	PA164755085	51084;2746	0.529
NULL	Clin_Med_Insights_Arthritis_Musculoskelet_Disord_2012_Mar_5_5_27-42.nxml.txt.nlp	22438671	SENT286	8	8	33	33	tocilizumab	ACR	PA165292659	49	0.529
NULL	Child_Adolesc_Psychiatry_Ment_Health_2008_Sep_15_2_25.nxml.txt.nlp	18793405	SENT130	2	2	0	0	atomoxetine	ATX	PA134688071	5168;23049	0.529
NULL	Can_J_Infect_Dis_Med_Microbiol_2014_Nov-Dec_25(6)_311-320.nxml.txt.nlp	25587293	SENT67	28	28	7	7	efavirenz	CD4	PA449441	920	0.529
NULL	Oncol_Lett_2013_Oct_24_6(4)_970-976.nxml.txt.nlp	24137447	SENT15	18	18	15	15	cisplatin	ADM	PA449014	133	0.529
NULL	Blood_Res_2014_Jun_25_49(2)_107-114.nxml.txt.nlp	25025012	SENT22	27	27	24	24	cyclophosphamide	CHOP	PA449165	1649	0.529
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT281	5	5	23	23	bortezomib	c-FLIP	PA10252	8837	0.529
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Apr_15_9_13.nxml.txt.nlp	20398300	SENT108	9	9	7	7	lansoprazole	LAM	PA450180	7249;7248	0.529
NULL	J_Cell_Biol_1992_Feb_2_116(4)_1055-1062.nxml.txt.nlp	1370836	SENT3	1	1	9	9	hyaluronan	CD44	PA165958431	960	0.529
NULL	Pharmaceuticals_(Basel)_2011_Jan_12_4(1)_187-201.nxml.txt.nlp	NULL	SENT163	9	9	27	27	l-arginine	NOS2	PA448478	339345;4843	0.529
NULL	J_Vis_Exp_2011_Jun_24_(52)_3094.nxml.txt.nlp	21730945	SENT111	30	30	41	41	ethionamide	EMB	PA164768738	133418	0.529
NULL	Drugs_R_D_2014_Jun_6_14(2)_113-123.nxml.txt.nlp	24797400	SENT28	8	8	3	3	amiodarone	P-gp	PA448383	5243	0.529
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_P23.nxml.txt.nlp	NULL	SENT18	1	1	8	8	cyclophosphamide	DAO	PA449165	26;1610	0.529
NULL	Br_J_Cancer_2010_Oct_12_103(8)_1309-1310.nxml.txt.nlp	NULL	SENT15	13	13	15	15	bevacizumab	IFN	PA130232992	3439	0.529
NULL	Neural_Plast_2012_May_20_2012_569149.nxml.txt.nlp	22685677	SENT37	35	35	16	16	lipase	iPLA2	PA450239	8398	0.529
NULL	Br_J_Cancer_2013_Feb_19_108(3)_557-563.nxml.txt.nlp	23361053	SENT113	5	5	7	7	tamoxifen	PAK1	PA451581	5585;5058	0.529
NULL	Front_Endocrinol_(Lausanne)_2013_Nov_11_4_165.nxml.txt.nlp	24273530	SENT548	39	39	25	25	taurine	GAT2	PA451590	6540	0.529
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT1656	4	4	12	12	oxygen	ROS	PA450744	6098	0.529
NULL	Case_Rep_Ophthalmol_2011_Mar_12_2(1)_105-110.nxml.txt.nlp	22110438	SENT54	14	14	12	12	ribavirin	IFN	PA451241	3439	0.529
NULL	Clin_Kidney_J_2012_Oct_5(5)_434-437.nxml.txt.nlp	23986860	SENT19	38	38	25	25	valganciclovir	SPK	PA10227	55872;8189	0.529
NULL	Cell_Div_2012_Dec_26_7_26.nxml.txt.nlp	23268747	SENT149	20	20	10	10	sn-38	p53		7157	0.529
NULL	Adipocyte_2013_Jan_1_2(1)_28-32.nxml.txt.nlp	23700549	SENT60	6	6	14	14	valsartan	IL-6	PA451848	3569	0.529
NULL	Breast_Cancer_Res_2011_Jan_24_13(1)_401.nxml.txt.nlp	21349137	SENT38	0	0	17	17	lapatinib	HER2	PA152241907	2064	0.529
NULL	Front_Pharmacol_2014_Sep_1_5_199.nxml.txt.nlp	25225485	SENT562	0	0	7	7	arsenite	AQP9	PA452638	366;364	0.529
NULL	Front_Genet_2012_Oct_26_3_213.nxml.txt.nlp	23112805	SENT608	40	40	19	19	midazolam	CYP1A2	PA450496	1544	0.529
NULL	Ann_Dermatol_2011_Aug_6_23(3)_365-368.nxml.txt.nlp	21909210	SENT38	13	13	22	22	mequitazine	gamma	PA164748010	9913	0.529
NULL	Br_J_Cancer_1998_Apr_77(8)_1280-1286.nxml.txt.nlp	9579834	SENT0	20	20	40	40	cisplatin	IL-2	PA449014	3558	0.529
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1067-1070.nxml.txt.nlp	21386841	SENT81	18	18	20	20	capecitabine	STZ	PA448771	6484	0.529
NULL	Ann_Rehabil_Med_2012_Aug_27_36(4)_466-473.nxml.txt.nlp	22977771	SENT13	13	13	3	3	bupivacaine	ILEI	PA135057240	10447	0.529
NULL	Mol_Cancer_2006_Oct_17_5_45.nxml.txt.nlp	17044934	SENT143	25	25	12	12	resveratrol	COX		1351	0.529
NULL	CNS_Neurosci_Ther_2010_Oct_16(5)_e138-e156.nxml.txt.nlp	20626426	SENT101	28	28	21	21	vasopressin	ACTH	PA451858	5443	0.529
NULL	Acta_Histochem_Cytochem_2010_May_1_43(2)_61-68.nxml.txt.nlp	20514293	SENT34	13	13	0	0	hyaluronan	LYVE-1	PA165958431	10894	0.529
NULL	J_Cell_Mol_Med_2014_Dec_22_18(12)_2519-2529.nxml.txt.nlp	25338520	SENT161	18	18	15	15	oxygen	ROS	PA450744	6098	0.529
NULL	Arch_Microbiol_2013_Jun_10_195(6)_439-445.nxml.txt.nlp	23661196	SENT11	6	6	12	12	ethanol	CO2	PA448073	4513	0.529
NULL	Mol_Syst_Biol_2010_Jul_27_6_391.nxml.txt.nlp	20664637	SENT57	8	8	5	5	choline	PKN2	PA448976	5586	0.529
NULL	Arch_Med_Sci_2012_Nov_9_8(5)_899-906.nxml.txt.nlp	23185202	SENT147	13	13	25	25	pioglitazone	ADN	PA450970	1675	0.529
NULL	Br_J_Cancer_2010_Jan_5_102(1)_80-86.nxml.txt.nlp	19920817	SENT112	24	24	22	22	sunitinib	IFN	PA162372840	3439	0.529
NULL	Oncol_Lett_2013_Oct_29_6(4)_1031-1038.nxml.txt.nlp	24137459	SENT32	23	23	48	48	l-glutamine	CO2	PA10090	4513	0.529
NULL	Diabetes_Care_2012_Jan_9_35(1)_131-136.nxml.txt.nlp	22040838	SENT21	3	3	22	22	metformin	AMPK	PA450395	5563	0.529
NULL	J_Neurosci_Rural_Pract_2012_Sep-Dec_3(3)_429-430.nxml.txt.nlp	23189026	SENT54	23	23	7	7	thalidomide	IFN	PA451644	3439	0.529
NULL	Can_J_Infect_Dis_Med_Microbiol_2014_Nov-Dec_25(6)_311-320.nxml.txt.nlp	25587293	SENT67	28	28	16	16	efavirenz	CD4	PA449441	920	0.529
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2587-2596.nxml.txt.nlp	24129237	SENT60	21	21	25	25	hydrocortisone	B27	PA449905	56246	0.529
NULL	Br_J_Cancer_2013_Feb_19_108(3)_557-563.nxml.txt.nlp	23361053	SENT56	11	11	5	5	tamoxifen	aromatase	PA451581	1588	0.529
NULL	Case_Rep_Endocrinol_2013_Dec_22_2013_675298.nxml.txt.nlp	24455332	SENT38	5	5	26	26	etoposide	ACTH	PA449552	5443	0.529
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Aug_20_70(Pt_9)_m333-m334.nxml.txt.nlp	25309187	SENT6	2	2	13	13	nitrile	RhII	PA450636	6007	0.529
NULL	Aging_(Albany_NY)_2012_Feb_21_4(2)_133-143.nxml.txt.nlp	22361433	SENT191	30	30	15	15	nitrogen	Tech	PA450643	57449	0.529
NULL	Case_Rep_Med_2014_Nov_9_2014_413136.nxml.txt.nlp	25431598	SENT210	8	8	15	15	octreotide	ACTH	PA450678	5443	0.529
NULL	Br_J_Cancer_2010_Jun_29_103(1)_52-60.nxml.txt.nlp	20531411	SENT62	19	19	6	6	nitrogen	OCT	PA450643	5362	0.529
NULL	J_Korean_Med_Sci_2004_Apr_30_19(2)_167-171.nxml.txt.nlp	15082886	SENT118	24	24	0	0	clarithromycin	PTH	PA449028	5741	0.529
NULL	Biologics_2012_Aug_3_6_249-256.nxml.txt.nlp	22904616	SENT4	12	12	14	14	boceprevir	BOC	PA165948902	91653	0.529
NULL	Sensors_(Basel)_2010_May_19_10(5)_5031-5053.nxml.txt.nlp	22399922	SENT125	3	3	12	12	troglitazone	GCK	PA451799	5871;2645	0.529
NULL	Adv_Ther_2014_Dec_2_31_1228-1246.nxml.txt.nlp	25447269	SENT119	24	24	28	28	tafluprost	TIM	PA165958432	7984;8914	0.529
NULL	Clin_Pharmacol_2010_Sep_6_2_155-162.nxml.txt.nlp	22291500	SENT122	5	5	18	18	clopidogrel	SCAI	PA449053	286205	0.529
NULL	J_Int_Soc_Sports_Nutr_2009_Jun_5_6_14.nxml.txt.nlp	19500355	SENT62	4	4	36	36	creatine	IL-6	PA164778930	3569	0.529
NULL	Multivariate_Behav_Res_2011_May_8_46(3)_399-424.nxml.txt.nlp	21818162	SENT446	6	6	8	8	zidovudine	CD4	PA451954	920	0.529
NULL	Br_J_Cancer_2012_Feb_14_106(4)_685-692.nxml.txt.nlp	22294184	SENT125	3	3	41	41	lovastatin	survivin	PA450272	332	0.529
NULL	Diabetes_2009_Feb_58(2)_460-468.nxml.txt.nlp	19017762	SENT236	18	18	0	0	genistein	Genesis	PA165109660	27022	0.529
NULL	Environ_Monit_Assess_2014_Mar_28_186(7)_4569-4580.nxml.txt.nlp	24671617	SENT173	39	39	37	37	benzaldehyde	C10	PA448571	113246	0.529
NULL	Antimicrob_Resist_Infect_Control_2012_Mar_16_1_12.nxml.txt.nlp	22958880	SENT107	26	26	16	16	tetracycline	Gen	PA451640	348654	0.529
NULL	Breast_Cancer_Res_2000_Jul_11_2(6)_423-429.nxml.txt.nlp	11250736	SENT101	42	42	14	14	estradiol	c-fos	PA449503	2353	0.529
NULL	N_Am_J_Med_Sci_2012_Sep_4(9)_424-426.nxml.txt.nlp	23050257	SENT11	32	32	15	15	fosamprenavir	CD4	PA10084	920	0.529
NULL	Br_J_Cancer_2012_Sep_4_107(6)_947-955.nxml.txt.nlp	22892392	SENT119	6	6	13	13	lapatinib	ERBB2	PA152241907	2064	0.529
NULL	Br_J_Haematol_2008_Jun_141(5)_659-671.nxml.txt.nlp	18410446	SENT129	0	0	6	6	cerulenin	IL-6	PA164764551	3569	0.529
NULL	Oncotarget_2014_Oct_21_5(22)_11709-11722.nxml.txt.nlp	25365944	SENT171	4	4	0	0	metformin	Rho	PA450395	29984	0.529
NULL	Mol_Med_Rep_2015_Jan_16_11(1)_91-98.nxml.txt.nlp	25322694	SENT88	10	10	26	26	cisplatin	LC3	PA449014	84557	0.529
NULL	Front_Oncol_2014_May_19_4_113.nxml.txt.nlp	24904827	SENT87	9	9	17	17	cocaine	AGO2	PA449072	27161	0.529
NULL	J_Int_AIDS_Soc_2011_Jan_24_14_4.nxml.txt.nlp	21255462	SENT166	12	12	14	14	vorinostat	IL-7	PA164748224	3574	0.529
NULL	Neuropsychopharmacology_2009_Jul_11_34(8)_1946-1957.nxml.txt.nlp	19279569	SENT204	23	23	8	8	cocaine	DOR	PA449072	58476	0.529
NULL	Indian_J_Pharm_Sci_2013_Sep-Oct_75(5)_523-532.nxml.txt.nlp	24403652	SENT201	7	7	20	20	atorvastatin	AD3	PA448500	11138	0.529
NULL	J_Cell_Mol_Med_2014_Aug_1_18(8)_1599-1611.nxml.txt.nlp	24889822	SENT193	0	0	5	5	resveratrol	SIRT1		23411	0.529
NULL	J_Invest_Dermatol_2012_May_16_132(5)_1435-1442.nxml.txt.nlp	22336948	SENT232	8	8	10	10	doxycycline	TLSP	PA449415	11012	0.529
NULL	J_Vet_Med_Sci_2014_Feb_21_76(2)_219-227.nxml.txt.nlp	24141321	SENT142	12	12	17	17	ns-398	OXT		5020	0.529
NULL	Arch_Med_Sci_2011_Aug_2_7(4)_597-603.nxml.txt.nlp	22291794	SENT115	0	0	11	11	clenbuterol	IL-6	PA164745640	3569	0.529
NULL	Breast_Cancer_Res_2010_Jun_4_12(3)_R32.nxml.txt.nlp	20525379	SENT222	12	12	30	30	fulvestrant	c-Myc	PA164747170	4609	0.529
NULL	Biochemistry_2013_Oct_8_52(40)_7145-7149.nxml.txt.nlp	24033232	SENT32	13	13	15	15	nadh	PEP	PA164755085	5047	0.529
NULL	Curr_Neuropharmacol_2009_Mar_7(1)_37-49.nxml.txt.nlp	19721816	SENT375	6	6	12	12	fluoxetine	ghrelin	PA449673	51738	0.529
NULL	Drug_Des_Devel_Ther_2014_Sep_23_8_1527-1538.nxml.txt.nlp	25284985	SENT128	22	22	20	20	celecoxib	IFN	PA448871	3439	0.529
NULL	AAPS_J_2014_Jun_19_16(5)_1056-1063.nxml.txt.nlp	24942210	SENT130	7	7	34	34	bevacizumab	VEGF-A	PA130232992	7422	0.529
NULL	Breast_Cancer_Res_2006_Jun_15_8(3)_R27.nxml.txt.nlp	16776849	SENT255	20	20	10	10	tamoxifen	MUC1	PA451581	4582	0.529
NULL	Front_Cell_Neurosci_2014_Jul_18_8_185.nxml.txt.nlp	25100946	SENT404	37	37	19	19	pp2	PP2		4888	0.529
NULL	Br_J_Cancer_2013_Mar_5_108(4)_748-754.nxml.txt.nlp	23361058	SENT58	5	5	7	7	vorinostat	RAD51	PA164748224	5888	0.529
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Jun_27_5_15.nxml.txt.nlp	16803618	SENT145	38	38	42	42	gentamicin	GEN1	PA449753	348654	0.529
NULL	Front_Cell_Neurosci_2013_Aug_30_7_137.nxml.txt.nlp	24009557	SENT60	24	24	33	33	gentamicin	CO2	PA449753	4513	0.529
NULL	Arch_Med_Sci_2013_Apr_20_9(2)_332-339.nxml.txt.nlp	23671446	SENT164	4	4	27	27	midazolam	p38	PA450496	10598;1432;7965	0.529
NULL	Mol_Vis_2011_Apr_24_17_1011-1015.nxml.txt.nlp	21541272	SENT50	9	9	5	5	iron	GCNT2	PA450087	2651	0.529
NULL	Protein_Eng_Des_Sel_2009_Jul_10_22(7)_421-430.nxml.txt.nlp	19515728	SENT138	6	6	9	9	urea	p53	PA451831	7157	0.529
NULL	Pharmaceuticals_(Basel)_2011_Nov_11_4(11)_1503-1517.nxml.txt.nlp	NULL	SENT37	0	0	8	8	capsaicin	TRPV1	PA448776	7442	0.529
NULL	J_Med_Chem_2014_Jan_23_57(2)_449-461.nxml.txt.nlp	24387105	SENT260	27	27	24	24	benzaldehyde	ALDH2	PA448571	217	0.529
NULL	Korean_J_Radiol_2010_Feb_22_Mar-Apr_11(2)_234-238.nxml.txt.nlp	20191072	SENT62	18	18	33	33	cyclophosphamide	CHOP	PA449165	1649	0.529
NULL	Nucleic_Acids_Res_2011_Oct_4_39(18)_7946-7960.nxml.txt.nlp	21729870	SENT393	6	6	9	9	bortezomib	CD4	PA10252	920	0.529
NULL	Arthritis_Res_Ther_2006_May_11_8(3)_209.nxml.txt.nlp	16712713	SENT123	16	16	6	6	diclofenac	AAP	PA449293	5345	0.529
NULL	Cancers_(Basel)_2012_Sep_25_4(4)_969-988.nxml.txt.nlp	24213497	SENT197	16	16	18	18	gefitinib	EGFR	PA131301952	1956	0.529
NULL	Crit_Care_2012_Oct_15_16(5)_R193.nxml.txt.nlp	23068293	SENT70	6	6	9	9	mannitol	NMB	PA450320	10457;4828	0.529
NULL	J_Biol_Eng_2014_Feb_2_8_6.nxml.txt.nlp	24485181	SENT96	3	3	5	5	estradiol	NOT	PA449503	4929	0.529
NULL	Curr_Neuropharmacol_2008_Sep_6(3)_193-202.nxml.txt.nlp	19506720	SENT352	8	8	5	5	amitriptyline	p75	PA448385	7133;11168	0.529
NULL	Chem_Cent_J_2014_Sep_16_8(1)_51.nxml.txt.nlp	NULL	SENT209	2	2	18	18	phenol	CO2	PA450913	4513	0.529
NULL	Cancer_Cell_Int_2005_May_24_5_15.nxml.txt.nlp	15910691	SENT41	21	21	41	41	l-glutamine	CO2	PA10090	4513	0.529
NULL	Harm_Reduct_J_2012_Jan_19_9_5.nxml.txt.nlp	22260315	SENT219	3	3	6	6	medroxyprogesterone	LARC	PA450344	6364	0.529
NULL	Allergy_Asthma_Clin_Immunol_2011_Dec_7_7(1)_21.nxml.txt.nlp	22152089	SENT96	32	32	5	5	mometasone	DPI	PA450541	1832	0.529
NULL	J_Cell_Sci_2012_Jun_15_125(12)_2940-2953.nxml.txt.nlp	22366451	SENT289	18	18	10	10	imatinib	PP2	PA10804	4888	0.529
NULL	Mol_Cell_Biochem_2014_Oct_9_385(1-2)_265-275.nxml.txt.nlp	24104452	SENT151	8	8	10	10	bortezomib	U87	PA10252	677775;641648	0.529
NULL	Trials_2012_Dec_13_13_239.nxml.txt.nlp	23237631	SENT269	32	32	36	36	acenocoumarol	CYP2C9	PA452632	1559	0.529
NULL	Oncoscience_2014_Oct_24_1(10)_665-673.nxml.txt.nlp	25593995	SENT76	2	2	20	20	doxorubicin	MDR1	PA449412	5243	0.529
NULL	Acta_Paediatr_2009_Nov_98(11)_1768-1775.nxml.txt.nlp	19706020	SENT70	15	15	24	24	thyroglobulin	ANOVA	PA164754910	4858	0.529
NULL	Cancers_(Basel)_2010_Mar_12_2(1)_165-189.nxml.txt.nlp	24281039	SENT1474	12	12	24	24	curcumin	San	PA151958596	80218	0.529
NULL	Diabetes_Care_2010_Jul_31_33(7)_1544-1548.nxml.txt.nlp	20357370	SENT6	17	17	9	9	metformin	STK11	PA450395	6794	0.529
NULL	Oncol_Lett_2013_Aug_25_6(2)_480-486.nxml.txt.nlp	24137351	SENT213	3	3	0	0	iodine	RAI	PA450049	10848;6050	0.529
NULL	Oxid_Med_Cell_Longev_2012_Jul_9_2012_326731.nxml.txt.nlp	22848780	SENT39	18	18	12	12	l-glutamine	DTNB	PA10090	1838	0.529
NULL	Hum_Genomics_2004_Jan_1_1(2)_111-125.nxml.txt.nlp	15601539	SENT226	19	19	27	27	lipase	HDL2	PA450239	57338	0.529
NULL	Acta_Pharmacol_Sin_2011_Aug_27_32(8)_1045-1054.nxml.txt.nlp	21706041	SENT82	7	7	37	37	paraformaldehyde	IL-13	PA450790	3596	0.529
NULL	Cancer_Immunol_Immunother_2011_Jun_25_60(6)_793-808.nxml.txt.nlp	21350947	SENT203	40	40	38	38	sorafenib	IFN	PA7000	3439	0.529
NULL	Amino_Acids_2011_May_30_40(5)_1271-1296.nxml.txt.nlp	21448658	SENT472	43	43	37	37	creatine	Gen	PA164778930	348654	0.529
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT159	15	15	30	30	phenprocoumon	VKORC1	PA450921	79001	0.529
NULL	J_Gen_Physiol_1945_May_20_28(5)_463-537.nxml.txt.nlp	19873433	SENT0	43	43	1	1	sulfanilamide	Gen	PA451545	348654	0.529
NULL	Int_J_Biomed_Sci_2008_Dec_4(4)_255-259.nxml.txt.nlp	23675099	SENT87	7	7	15	15	l-cysteine	PLP	PA449173	25824;5744	0.529
NULL	J_Cell_Biol_2008_Jul_14_182(1)_171-184.nxml.txt.nlp	18606850	SENT319	19	19	47	47	l-glutamine	CO2	PA10090	4513	0.529
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Dec_2_5_30.nxml.txt.nlp	17140452	SENT229	18	18	0	0	linezolid	VAN	PA450233	10318	0.529
NULL	J_Cell_Biol_2002_Nov_25_159(4)_637-648.nxml.txt.nlp	12438416	SENT81	20	20	7	7	staurosporine	p115	PA165109623	8615;393	0.529
NULL	J_Biol_Chem_2013_Jun_28_288(26)_18789-18802.nxml.txt.nlp	23625922	SENT44	31	31	14	14	oxygen	IL-6	PA450744	3569	0.529
NULL	Lung_2011_Jun_21_189(3)_257-258.nxml.txt.nlp	21509562	SENT24	33	33	48	48	estradiol	TRPV1	PA449503	7442	0.529
NULL	Adv_Biomed_Res_2014_Jan_9_3_1.nxml.txt.nlp	24592358	SENT203	8	8	29	29	estradiol	CCL20	PA449503	6364	0.529
NULL	Br_J_Haematol_2014_Mar_13_164(1)_811-821.nxml.txt.nlp	24328678	SENT148	2	2	15	15	lenalidomide	CRBN	PA162363968	51185	0.529
NULL	Mol_Cells_2014_Aug_31_37(8)_585-591.nxml.txt.nlp	25134539	SENT98	0	0	5	5	indacaterol	ADRB2	PA165958348	154	0.529
NULL	Exp_Ther_Med_2013_Mar_16_5(3)_777-782.nxml.txt.nlp	23403801	SENT159	22	22	26	26	octreotide	GAPDH	PA450678	2597	0.529
NULL	Br_J_Cancer_2013_Jul_23_109(2)_351-359.nxml.txt.nlp	23799854	SENT160	6	6	3	3	paclitaxel	BLT2	PA450761	56413	0.529
NULL	South_Asian_J_Cancer_2014_Jul-Sep_3(3)_186.nxml.txt.nlp	25136531	SENT14	6	6	13	13	doxorubicin	CHOP	PA449412	1649	0.529
NULL	Onco_Targets_Ther_2014_Sep_24_7_1663-1687.nxml.txt.nlp	25285016	SENT242	19	19	33	33	bevacizumab	NRP1	PA130232992	8829	0.529
NULL	J_Oncol_2013_Apr_29_2013_854121.nxml.txt.nlp	23737784	SENT76	18	18	9	9	trastuzumab	BCS	PA451743	617	0.529
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2013_Dec_8_6_75-79.nxml.txt.nlp	24348081	SENT20	0	0	8	8	colesevelam	GLP-1	PA449095	100125288	0.529
NULL	Indian_J_Dermatol_2011_Jan-Feb_56(1)_48-51.nxml.txt.nlp	21572792	SENT24	41	41	24	24	tretinoin	IPL	PA451746	7262	0.528
NULL	Avicenna_J_Phytomed_2013_Spring_3(2)_135-142.nxml.txt.nlp	25050267	SENT50	25	25	40	40	l-glutamine	CO2	PA10090	4513	0.528
NULL	J_Res_Med_Sci_2012_Oct_17(10)_928-933.nxml.txt.nlp	23825991	SENT57	19	19	6	6	tretinoin	CO2	PA451746	4513	0.528
NULL	Ann_Nucl_Med_2014_Jul_8_28(9)_836-850.nxml.txt.nlp	25001261	SENT176	15	15	7	7	acetazolamide	spatial	PA448018	219793	0.528
NULL	Cancers_(Basel)_2013_Nov_1_5(4)_1379-1412.nxml.txt.nlp	24202450	SENT84	7	7	4	4	etoposide	FasL	PA449552	356	0.528
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT57	18	18	45	45	vinblastine	ASC	PA451877	29108	0.528
NULL	Braz_J_Med_Biol_Res_2011_Nov_25_45(1)_58-67.nxml.txt.nlp	22124704	SENT130	26	26	39	39	staurosporine	ANOVA	PA165109623	4858	0.528
NULL	Evid_Based_Complement_Alternat_Med_2011_Mar_13_2011_913898.nxml.txt.nlp	21785639	SENT218	6	6	12	12	curcumin	CYP3A4	PA151958596	1576	0.528
NULL	Brain_Behav_2011_Sep_1(1)_44-54.nxml.txt.nlp	22398980	SENT24	8	8	18	18	cocaine	PCP	PA449072	5547	0.528
NULL	Biomed_Res_Int_2014_Jun_26_2014_161346.nxml.txt.nlp	25054130	SENT225	11	11	21	21	curcumin	STZ	PA151958596	6484	0.528
NULL	Chromatographia_2009_Jun_26_69(Suppl_2)_167-173.nxml.txt.nlp	19554204	SENT134	6	6	11	11	hesperetin	SRM	PA164742902	6723;6725	0.528
NULL	Biochim_Biophys_Acta_2013_Oct_1830(10)_4813-4819.nxml.txt.nlp	23811337	SENT81	19	19	25	25	phenol	FBS	PA450913	64319;26269	0.528
NULL	Indian_J_Pharm_Sci_2013_Nov-Dec_75(6)_680-687.nxml.txt.nlp	24591743	SENT35	38	38	15	15	gemfibrozil	CYP2C8	PA449750	1558	0.528
NULL	Scientifica_(Cairo)_2012_Nov_25_2012_473829.nxml.txt.nlp	24278698	SENT335	10	10	26	26	cisplatin	OCT3	PA449014	5460;6581	0.528
NULL	Hum_Reprod_2008_Oct_16_23(10)_2273-2281.nxml.txt.nlp	18635530	SENT148	13	13	11	11	etoposide	p53	PA449552	7157	0.528
NULL	Cancer_Cell_Int_2010_Sep_6_10_31.nxml.txt.nlp	20819205	SENT85	11	11	9	9	cisplatin	CIS	PA449014	1154	0.528
NULL	Behav_Brain_Funct_2011_Dec_31_7_50.nxml.txt.nlp	22208616	SENT152	14	14	16	16	pp2	PP4		5531	0.528
NULL	Int_J_Hypertens_2012_Nov_30_2012_192567.nxml.txt.nlp	22187625	SENT159	24	24	34	34	candesartan	ANOVA	PA448765	4858	0.528
NULL	Cancer_Microenviron_2008_Dec_14_1(1)_69-83.nxml.txt.nlp	19308686	SENT328	8	8	4	4	heparin	ECM	PA449855	22915	0.528
NULL	J_Int_AIDS_Soc_2011_Aug_15_14_41.nxml.txt.nlp	21843351	SENT5	35	35	11	11	ganciclovir	CD4	PA449733	920	0.528
NULL	Biochim_Biophys_Acta_2014_Jun_1841(6)_906-917.nxml.txt.nlp	24657704	SENT8	5	5	7	7	lipase	ATGL	PA450239	57104	0.528
NULL	Clin_Mol_Hepatol_2013_Dec_28_19(4)_417-420.nxml.txt.nlp	24459647	SENT15	14	14	16	16	terlipressin	HRS	PA164781020	6430	0.528
NULL	Adv_Hematol_2010_Dec_5_2010_595934.nxml.txt.nlp	21151515	SENT154	7	7	10	10	prasugrel	Yes	PA154410481	7525	0.528
NULL	J_Psychopharmacol_2010_Nov_24(4_supplement)_91-118.nxml.txt.nlp	18801830	SENT308	3	3	0	0	vasopressin	AVP	PA451858	114548;551	0.528
NULL	Front_Neural_Circuits_2010_Mar_22_4_8.nxml.txt.nlp	20407636	SENT67	8	8	12	12	carbachol	gamma	PA448784	9913	0.528
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT236	4	4	2	2	pemetrexed	UNG	PA10810	7374	0.528
NULL	Drugs_R_D_2013_Sep_28_13(3)_191-197.nxml.txt.nlp	23982688	SENT107	30	30	23	23	furosemide	Yes	PA449719	7525	0.528
NULL	Drug_Target_Insights_2012_Aug_6_6_19-39.nxml.txt.nlp	22915839	SENT138	7	7	25	25	doxorubicin	p53	PA449412	7157	0.528
NULL	Mar_Drugs_2011_Nov_2_9(11)_2188-2200.nxml.txt.nlp	22163181	SENT454	13	13	16	16	ethanol	ANOVA	PA448073	4858	0.528
NULL	Oncotarget_2011_Jan_25_2(1-2)_8-17.nxml.txt.nlp	21378407	SENT41	0	0	7	7	thrombin	PAR-1	PA451674	2011;2149	0.528
NULL	Cytotherapy_2014_Jun_16(6)_800-809.nxml.txt.nlp	24642019	SENT8	30	30	27	27	collagenase	NAC	PA449107	22861	0.528
NULL	Br_J_Cancer_2011_Oct_11_105(8)_1123-1130.nxml.txt.nlp	21934690	SENT120	7	7	14	14	docetaxel	TTP1	PA449383	55352	0.528
NULL	J_Autom_Methods_Manag_Chem_2007_Jun_19_2007_86857.nxml.txt.nlp	17671612	SENT196	43	43	31	31	tinidazole	mol	PA10813	90527	0.528
NULL	Endocrinology_2011_Jul_3_152(7)_2678-2689.nxml.txt.nlp	21540289	SENT219	8	8	4	4	lipase	ATGL	PA450239	57104	0.528
NULL	Nucleic_Acids_Res_2011_Jun_1_39(11)_e74.nxml.txt.nlp	21459849	SENT249	5	5	0	0	glucosamine	HS3ST1	PA164747613	9957	0.528
NULL	Clin_Sarcoma_Res_2014_Aug_10_4_10.nxml.txt.nlp	25132955	SENT152	7	7	0	0	imatinib	MVD	PA10804	4597	0.528
NULL	Summit_on_Translat_Bioinforma_2009_Mar_1_2009_124-128.nxml.txt.nlp	21347183	SENT69	20	20	26	26	thioguanine	TPMT	PA451663	7172	0.528
NULL	Curr_Cardiol_Rev_2010_May_6(2)_82-90.nxml.txt.nlp	21532773	SENT37	6	6	23	23	s-adenosylmethionine	PRMT2	PA164754994	3275	0.528
NULL	Nat_Methods_2012_Apr_1_9(5)_477-479.nxml.txt.nlp	22466794	SENT87	14	14	36	36	levamisole	SP2	PA450205	6668	0.528
NULL	Ann_Hematol_2014_Mar_18_93(8)_1335-1344.nxml.txt.nlp	24638841	SENT84	15	15	39	39	rituximab	CLB	PA451261	171425	0.528
NULL	Physiol_Rep_2014_Nov_26_2(11)_e12231.nxml.txt.nlp	25428953	SENT655	2	2	20	20	phenylephrine	p38	PA450935	10598;1432;7965	0.528
NULL	Br_J_Cancer_1999_Feb_79(5-6)_821-824.nxml.txt.nlp	10070875	SENT5	6	6	15	15	verteporfin	mol	PA451871	90527	0.528
NULL	Acta_Pharmacol_Sin_2012_Jan_3_33(1)_49-56.nxml.txt.nlp	22212430	SENT57	15	15	44	44	l-glutamine	CO2	PA10090	4513	0.528
NULL	Osteoarthritis_Cartilage_2014_Sep_22(9)_1241-1250.nxml.txt.nlp	25042552	SENT473	16	16	19	19	thrombin	OKS	PA451674	9968	0.528
NULL	Arthritis_Res_2002_Mar_27_4(Suppl_2)_S22-S28.nxml.txt.nlp	12110154	SENT61	21	21	4	4	infliximab	IL-6	PA452639	3569	0.528
NULL	Arthritis_Res_Ther_2008_Jan_7_10(1)_R1.nxml.txt.nlp	18179697	SENT213	14	14	18	18	oxaliplatin	HMGB1	PA131285527	3146	0.528
NULL	Mol_Cancer_2008_Mar_26_7_27.nxml.txt.nlp	18366759	SENT274	19	19	29	29	etoposide	HIF-1	PA449552	29072	0.528
NULL	Cilia_2012_Sep_3_1_17.nxml.txt.nlp	23308345	SENT250	28	28	4	4	vasopressin	TRPP2	PA451858	5311	0.528
NULL	Lipids_Health_Dis_2011_Jan_24_10_20.nxml.txt.nlp	21261970	SENT79	17	17	19	19	lipase	ATGL	PA450239	57104	0.528
NULL	Int_J_Gen_Med_2012_Jun_18_5_535-540.nxml.txt.nlp	22807641	SENT63	6	6	19	19	pitavastatin	adiponectin	PA142650384	9370	0.528
NULL	Drug_Des_Devel_Ther_2014_Sep_23_8_1527-1538.nxml.txt.nlp	25284985	SENT149	26	26	24	24	celecoxib	IFN	PA448871	3439	0.528
NULL	Braz_J_Med_Biol_Res_2013_Feb_1_46(2)_171-177.nxml.txt.nlp	23369979	SENT26	0	0	2	2	enalapril	IL-10	PA449456	3586	0.528
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_315-322.nxml.txt.nlp	20049735	SENT102	4	4	6	6	olaparib	PTEN		5728	0.528
NULL	J_Gynecol_Oncol_2014_Apr_9_25(2)_130-135.nxml.txt.nlp	24761217	SENT123	8	8	12	12	paclitaxel	P-gp	PA450761	5243	0.528
NULL	Cell_Tissue_Res_2014_Sep_11_358(3)_793-805.nxml.txt.nlp	25209703	SENT41	26	26	42	42	l-glutamine	CO2	PA10090	4513	0.528
NULL	BMJ_Open_2014_Feb_27_4(2)_e004071.nxml.txt.nlp	24578536	SENT62	11	11	1	1	warfarin	TTR	PA451906	7276	0.528
NULL	Mol_Med_Rep_2014_Oct_23_10(4)_1717-1724.nxml.txt.nlp	25069516	SENT93	5	5	11	11	resveratrol	PC-3		692094	0.528
NULL	J_Carcinog_2013_Dec_31_12_22.nxml.txt.nlp	24574860	SENT6	38	38	32	32	bevacizumab	EML4	PA130232992	27436	0.528
NULL	Biosensors_(Basel)_2013_Nov_13_3(4)_374-384.nxml.txt.nlp	25586413	SENT5	17	17	11	11	capsaicin	SPR	PA448776	6697;6869	0.528
NULL	Pak_J_Med_Sci_2013_Jan-Mar_29(1)_97-102.nxml.txt.nlp	24353516	SENT85	6	6	14	14	clopidogrel	LTA	PA449053	4049	0.528
NULL	Clin_Exp_Otorhinolaryngol_2011_Jun_31_4(2)_77-82.nxml.txt.nlp	21716954	SENT157	5	5	16	16	minocycline	Bcl-2	PA450519	596	0.528
NULL	AIDS_Care_2011_Sep_14_23(9)_1154-1162.nxml.txt.nlp	21500025	SENT140	16	16	2	2	emtricitabine	ATV	PA10069	4683	0.528
NULL	Breast_Cancer_Res_2014_Dec_6_16(6)_491.nxml.txt.nlp	25479686	SENT212	22	22	14	14	medroxyprogesterone	ANOVA	PA450344	4858	0.528
NULL	Infect_Dis_Ther_2014_Jun_18_3(1)_35-43.nxml.txt.nlp	25134810	SENT93	7	7	9	9	teicoplanin	VAN	PA164746244	10318	0.528
NULL	J_Biomed_Biotechnol_2010_Sep_19_2010_518743.nxml.txt.nlp	20886007	SENT293	28	28	35	35	ethanol	CO2	PA448073	4513	0.528
NULL	Cancer_Cell_Int_2013_Mar_4_13_21.nxml.txt.nlp	23497288	SENT191	8	8	3	3	camptothecin	p53	PA153590860	7157	0.528
NULL	J_Cell_Sci_2014_May_15_127(10)_2313-2325.nxml.txt.nlp	24634514	SENT203	30	30	19	19	forskolin	DRP1	PA146096022	8562;10059;7402	0.528
NULL	Mol_Pain_2013_Aug_8_9_39.nxml.txt.nlp	23924059	SENT39	15	15	4	4	vasopressin	MSN	PA451858	4478	0.528
NULL	Nature_2011_Sep_4_477(7366)_616-620.nxml.txt.nlp	21892188	SENT121	9	9	21	21	galactose	PARG	PA449725	8505	0.528
NULL	Biosci_Rep_2012_Dec_20_33(1)_e00011.nxml.txt.nlp	23137297	SENT311	6	6	4	4	heparin	RPSA	PA449855	3921	0.528
NULL	Br_J_Haematol_2009_Nov_2_147(3)_396-410.nxml.txt.nlp	19758122	SENT50	15	15	5	5	dasatinib	p53	PA162372878	7157	0.528
NULL	Cancers_(Basel)_2012_Sep_6_4(3)_873-903.nxml.txt.nlp	24213471	SENT1635	22	22	20	20	hyaluronan	HYAL1	PA165958431	3373	0.528
NULL	Afr_J_Infect_Dis_2011_5(2)_40-46.nxml.txt.nlp	23878706	SENT102	18	18	4	4	ceftazidime	Gen	PA448861	348654	0.528
NULL	Cell_Mol_Life_Sci_2011_May_26_68(10)_1785-1798.nxml.txt.nlp	20976523	SENT414	6	6	4	4	cisplatin	c-fos	PA449014	2353	0.528
NULL	Cancer_Metab_2014_Nov_3_2(1)_20.nxml.txt.nlp	NULL	SENT9	24	24	27	27	erlotinib	EGFR	PA134687924	1956	0.528
NULL	Iran_J_Public_Health_2012_Mar_31_41(3)_127-132.nxml.txt.nlp	23113157	SENT86	2	2	20	20	amoxicillin	CTX	PA448406	1593	0.528
NULL	Br_J_Cancer_2009_Nov_3_101(9)_1596-1605.nxml.txt.nlp	19826421	SENT133	10	10	8	8	nadh	ND2	PA164755085	4536	0.528
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Dec_2_5_30.nxml.txt.nlp	17140452	SENT229	18	18	8	8	linezolid	GAT	PA450233	10249	0.528
NULL	Acta_Neuropathol_Commun_2013_Nov_18_1(1)_76.nxml.txt.nlp	24252208	SENT78	7	7	22	22	ethanol	San	PA448073	80218	0.528
NULL	Curr_Chem_Genomics_2012_Dec_28_6_79-86.nxml.txt.nlp	23346268	SENT34	5	5	20	20	phenol	CO2	PA450913	4513	0.528
NULL	BMJ_2013_Nov_8_347_f6625.nxml.txt.nlp	24212107	SENT128	19	19	4	4	everolimus	ARC	PA164746311	8996;23237	0.528
NULL	Curr_Oncol_2009_Jul_16(Suppl_2)_S1-S13.nxml.txt.nlp	19672416	SENT301	4	4	0	0	tamoxifen	ATAC	PA451581	6375	0.528
NULL	J_Biol_Chem_2013_Nov_15_288(46)_33049-33059.nxml.txt.nlp	24089524	SENT284	5	5	16	16	nicotine	GATA6	PA450626	2627	0.528
NULL	Exp_Ther_Med_2013_Nov_6_6(5)_1089-1095.nxml.txt.nlp	24223627	SENT183	8	8	24	24	fluorouracil	NAC	PA128406956	22861	0.528
NULL	Acta_Histochem_Cytochem_2006_Mar_2_39(1)_1-7.nxml.txt.nlp	17460766	SENT53	11	11	9	9	choline	FGF1	PA448976	2246	0.528
NULL	Exp_Ther_Med_2013_Oct_19_6(4)_1070-1076.nxml.txt.nlp	24137319	SENT6	36	36	38	38	cyclophosphamide	CTX	PA449165	1593	0.528
NULL	Oncol_Rep_2013_Apr_23_29(4)_1268-1274.nxml.txt.nlp	23354756	SENT171	18	18	9	9	paclitaxel	SLC25A43	PA450761	203427	0.528
NULL	Ann_Indian_Acad_Neurol_2014_Mar_17(Suppl_1)_S27-S31.nxml.txt.nlp	24791084	SENT113	17	17	21	21	diazepam	LOR	PA449283	4014	0.528
NULL	AIDS_Care_2011_Sep_14_23(9)_1154-1162.nxml.txt.nlp	21500025	SENT76	16	16	2	2	lopinavir	ATV	PA450264	4683	0.528
NULL	BMJ_2013_Nov_6_347_f6530.nxml.txt.nlp	24196498	SENT92	2	2	6	6	sirolimus	PES	PA451365	23481	0.528
NULL	Cell_Death_Dis_2012_Nov_15_3(11)_e418.nxml.txt.nlp	23152054	SENT47	0	0	11	11	chloroquine	p62	PA448948	8878;10657;23636	0.528
NULL	Med_Sci_Monit_2012_Jan_1_18(1)_RA1-RA11.nxml.txt.nlp	22207127	SENT217	8	8	15	15	raloxifene	RANKL	PA451221	8600	0.528
NULL	Adipocyte_2012_Jan_1_1(1)_68-72.nxml.txt.nlp	23700513	SENT97	17	17	14	14	liraglutide	GLP-1	PA165958364	100125288	0.528
NULL	Pharm_Pract_(Granada)_2009_Mar_15_Apr-Jun_7(2)_113-123.nxml.txt.nlp	25152787	SENT188	9	9	0	0	warfarin	Yes	PA451906	7525	0.528
NULL	Nat_Genet_2013_Nov_6_45(11)_1345-1352.nxml.txt.nlp	24097064	SENT109	10	10	16	16	triglycerides	CAD	PA451776	1677;790	0.528
NULL	Arthritis_Res_Ther_2012_Jul_12_14(4)_R163.nxml.txt.nlp	22784880	SENT15	12	12	8	8	leflunomide	CYP2C19	PA450192	1557	0.528
NULL	Breast_Cancer_Res_Treat_2008_Jun_28_109(3)_567-572.nxml.txt.nlp	17661169	SENT127	8	8	17	17	anastrozole	ATAC	PA448432	6375	0.528
NULL	Arthritis_Res_Ther_2014_Jan_24_16(1)_R23.nxml.txt.nlp	24460726	SENT1	28	28	13	13	hydroxychloroquine	CXCL10	PA164777036	3627	0.528
NULL	J_Korean_Med_Sci_2007_Sep_30_22(Suppl)_S66-S72.nxml.txt.nlp	17923758	SENT118	13	13	7	7	isotretinoin	IL-2	PA450128	3558	0.528
NULL	Crit_Care_2005_Sep_8_9(1)_37-44.nxml.txt.nlp	15693982	SENT76	34	34	32	32	vasopressin	ACTH	PA451858	5443	0.528
NULL	Int_J_Mol_Sci_2013_Aug_14_14(8)_16719-16731.nxml.txt.nlp	23949634	SENT27	8	8	23	23	thrombin	CA1	PA451674	759	0.528
NULL	J_Thromb_Haemost_2013_Mar_13_11(3)_529-538.nxml.txt.nlp	23279194	SENT25	18	18	11	11	thrombin	MMP9	PA451674	4318	0.528
NULL	Cancers_(Basel)_2014_Aug_13_6(3)_1670-1690.nxml.txt.nlp	25125485	SENT631	1	1	11	11	hyaluronan	TLR2	PA165958431	7097	0.528
NULL	EMBO_Rep_2013_Jan_30_14(1)_49-56.nxml.txt.nlp	23196367	SENT192	12	12	8	8	granisetron	5-HT3R	PA449809	3359	0.528
NULL	Neural_Plast_2009_Dec_2_2009_625469.nxml.txt.nlp	19096514	SENT35	19	19	21	21	lipase	MGL	PA450239	11343	0.528
NULL	Front_Oncol_2014_Oct_21_4_285.nxml.txt.nlp	25374842	SENT674	3	3	19	19	sorafenib	p53	PA7000	7157	0.528
NULL	Front_Genet_2014_Nov_7_5_382.nxml.txt.nlp	25426138	SENT882	0	0	4	4	metformin	alpha-synuclein	PA450395	6622	0.528
NULL	J_Anaesthesiol_Clin_Pharmacol_2011_Oct-Dec_27(4)_537-540.nxml.txt.nlp	22096292	SENT77	22	22	10	10	tirofiban	DES	PA451698	1674	0.528
NULL	Acta_Pharmacol_Sin_2009_Sep_17_30(9)_1351-1358.nxml.txt.nlp	19684608	SENT191	20	20	2	2	rosiglitazone	mol	PA451283	90527	0.528
NULL	Am_J_Trop_Med_Hyg_2014_Oct_1_91(4)_833-843.nxml.txt.nlp	25048375	SENT28	20	20	26	26	artemether	ACT	PA165111698	12;11332;9457;641455	0.528
NULL	Curr_Clin_Pharmacol_2013_May_8(2)_135-155.nxml.txt.nlp	23062036	SENT348	36	36	34	34	raloxifene	PTH	PA451221	5741	0.528
NULL	Biomed_Res_Int_2014_Apr_15_2014_182862.nxml.txt.nlp	24839598	SENT98	3	3	8	8	cyclophosphamide	COX2	PA449165	4513;5743	0.528
NULL	Br_J_Cancer_2012_May_8_106(10)_1587-1590.nxml.txt.nlp	22568998	SENT4	15	15	31	31	sunitinib	IFN	PA162372840	3439	0.528
NULL	Ann_Clin_Microbiol_Antimicrob_2011_Jun_24_10_27.nxml.txt.nlp	21702921	SENT111	10	10	4	4	colistin	MDR1	PA164760862	5243	0.528
NULL	Eur_J_Cell_Biol_2012_Aug_91(8)_614-628.nxml.txt.nlp	22555292	SENT52	10	10	28	28	paraformaldehyde	Nesprin-2	PA450790	23224	0.528
NULL	Oncol_Lett_2014_May_11_7(5)_1474-1478.nxml.txt.nlp	24765159	SENT59	17	17	21	21	paraformaldehyde	B7-H4	PA450790	79679	0.528
NULL	Int_J_Mol_Sci_2014_May_8_15(5)_8106-8121.nxml.txt.nlp	24815071	SENT55	3	3	21	21	atorvastatin	SQSTM1	PA448500	8878	0.528
NULL	Cell_Commun_Signal_2014_Dec_24_12(1)_78.nxml.txt.nlp	NULL	SENT355	0	0	7	7	losartan	MYH7	PA450268	4625	0.528
NULL	Br_J_Cancer_2010_Jan_5_102(1)_80-86.nxml.txt.nlp	19920817	SENT63	23	23	28	28	sunitinib	IFN	PA162372840	3439	0.528
NULL	Mol_Biol_Cell_2013_Sep_1_24(17)_2597-2608.nxml.txt.nlp	23864712	SENT314	20	20	7	7	paraformaldehyde	UGGT1	PA450790	56886	0.528
NULL	Genome_Biol_2011_Mar_21_12(3)_R25.nxml.txt.nlp	21418647	SENT227	23	23	48	48	l-glutamine	CO2	PA10090	4513	0.528
NULL	Clin_Ophthalmol_2010_Apr_26_4_285-299.nxml.txt.nlp	20463796	SENT116	22	22	33	33	ganciclovir	San	PA449733	80218	0.528
NULL	Front_Oncol_2014_Jun_23_4_162.nxml.txt.nlp	25003082	SENT9	18	18	47	47	estradiol	SMF	PA449503	22993	0.528
NULL	Anesth_Essays_Res_2011_Jul-Dec_5(2)_204-206.nxml.txt.nlp	NULL	SENT66	22	22	10	10	bupivacaine	CEA	PA135057240	5670;1087	0.528
NULL	J_Clin_Biochem_Nutr_2008_Sep_30_43(2)_75-81.nxml.txt.nlp	18818756	SENT54	7	7	15	15	estradiol	ACTH	PA449503	5443	0.528
NULL	Clin_Drug_Investig_2013_Jun_20_33(6)_419-427.nxml.txt.nlp	23605507	SENT153	23	23	6	6	ciprofloxacin	DPI	PA449009	1832	0.528
NULL	Iran_J_Pharm_Res_2015_Winter_14(1)_167-175.nxml.txt.nlp	25561923	SENT118	23	23	13	13	propofol	Yes	PA451141	7525	0.528
NULL	Carbon_Balance_Manag_2006_Jul_25_1_6.nxml.txt.nlp	16930462	SENT171	6	6	17	17	nitrogen	CO2	PA450643	4513	0.528
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S202-S209.nxml.txt.nlp	21525456	SENT134	4	4	1	1	pioglitazone	ACT	PA450970	12;11332;9457;641455	0.528
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT97	0	0	6	6	resveratrol	TRAIL-R2		8795	0.528
NULL	Ann_Gen_Psychiatry_2010_Sep_17_9_35.nxml.txt.nlp	20849577	SENT163	25	25	15	15	aripiprazole	STAR	PA10026	6770;2984	0.528
NULL	J_Korean_Med_Sci_2007_Jun_30_22(3)_412-419.nxml.txt.nlp	17596646	SENT73	11	11	36	36	fluorescein	CD19	PA164746009	930	0.528
NULL	Int_J_Fertil_Steril_2013_Jul_31_Jul-Sep_7(2)_138-141.nxml.txt.nlp	24520477	SENT80	9	9	11	11	estradiol	ART	PA449503	181	0.528
NULL	Cell_Death_Differ_2010_Apr_23_17(4)_699-709.nxml.txt.nlp	19851330	SENT295	16	16	25	25	tetracycline	PUMA	PA451640	27113	0.528
NULL	J_Cardiothorac_Surg_2013_Jul_18_8_176.nxml.txt.nlp	23866777	SENT75	25	25	6	6	creatine	IL-6	PA164778930	3569	0.528
NULL	Acta_Orthop_2010_Apr_6_81(2)_263-267.nxml.txt.nlp	20148646	SENT116	0	0	5	5	taurine	CHOP	PA451590	1649	0.528
NULL	Oncologist_2010_Oct_7_15(10)_1034-1042.nxml.txt.nlp	20930098	SENT65	14	14	11	11	gefitinib	EGFR	PA131301952	1956	0.528
NULL	Cardiovasc_Diabetol_2013_Jun_8_12_86.nxml.txt.nlp	23758640	SENT135	25	25	28	28	glucose	CAD	PA449773	1677;790	0.528
NULL	Drugs_R_D_2014_Jun_6_14(2)_113-123.nxml.txt.nlp	24797400	SENT27	0	0	12	12	dabigatran	P-gp		5243	0.528
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT128	8	8	3	3	flecainide	CYP2D6	PA449646	1565	0.528
NULL	Avicenna_J_Phytomed_2013_Autumn_3(4)_302-312.nxml.txt.nlp	25050287	SENT141	12	12	18	18	diazepam	hole	PA449283	80757	0.528
NULL	Oncotarget_2012_Mar_31_3(3)_236-260.nxml.txt.nlp	22470194	SENT247	2	2	7	7	celecoxib	IL-6	PA448871	3569	0.528
NULL	Aging_(Albany_NY)_2009_Jun_3_1(6)_515-528.nxml.txt.nlp	20157535	SENT22	22	22	16	16	resveratrol	S6K1		6198	0.528
NULL	Infect_Dis_Obstet_Gynecol_2014_Sep_25_2014_961375.nxml.txt.nlp	25328370	SENT195	6	6	0	0	atazanavir	ATV	PA10251	4683	0.528
NULL	J_Ginseng_Res_2011_Nov_35(4)_436-441.nxml.txt.nlp	23717089	SENT141	10	10	7	7	ginseng	CAGC	PA164781150	6283	0.528
NULL	Case_Rep_Surg_2011_Oct_29_2011_371082.nxml.txt.nlp	22606576	SENT98	14	14	22	22	creatine	CD34	PA164778930	947	0.528
NULL	Cancer_Metab_2013_Dec_23_1_23.nxml.txt.nlp	24359630	SENT86	4	4	2	2	glucose	CO2	PA449773	4513	0.528
NULL	Front_Immunol_2014_Apr_23_5_187.nxml.txt.nlp	24795729	SENT69	24	24	37	37	l-glutamine	CO2	PA10090	4513	0.528
NULL	J_Biol_Chem_2012_Apr_6_287(15)_12433-12444.nxml.txt.nlp	22351758	SENT46	16	16	4	4	gentamicin	F12	PA449753	2161	0.528
NULL	Cell_Commun_Signal_2014_Oct_14_12(1)_64.nxml.txt.nlp	NULL	SENT50	7	7	13	13	paraformaldehyde	CD63	PA450790	967	0.528
NULL	J_Cell_Biol_1997_Mar_24_136(6)_1249-1261.nxml.txt.nlp	9087441	SENT60	26	26	28	28	paraformaldehyde	PLP	PA450790	25824;5744	0.528
NULL	Mol_Vis_2007_Jan_31_13_133-141.nxml.txt.nlp	17293777	SENT121	7	7	9	9	streptozocin	STZ	PA451514	6484	0.528
NULL	J_Gen_Physiol_2004_Jul_124(1)_1b.nxml.txt.nlp	NULL	SENT1327	12	12	10	10	thrombin	EGF	PA451674	1950	0.528
NULL	Appl_Plant_Sci_2015_Jan_5_3(1)_apps_1400086.nxml.txt.nlp	25606353	SENT62	1	1	12	12	chloramphenicol	UNK	PA448927	85451	0.528
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT1126	13	13	17	17	atorvastatin	CYP3A4	PA448500	1576	0.528
NULL	Front_Genet_2014_May_9_5_112.nxml.txt.nlp	24847353	SENT129	6	6	9	9	ethanol	CHOP	PA448073	1649	0.528
NULL	Ann_Gen_Psychiatry_2008_Aug_18_7_11.nxml.txt.nlp	18706108	SENT120	2	2	0	0	bupropion	BUP	PA448687	23412	0.528
NULL	Endocrinol_Metab_(Seoul)_2013_Dec_12_28(4)_297-308.nxml.txt.nlp	24396695	SENT14	10	10	24	24	cerulenin	ACL	PA164764551	47	0.527
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT7	12	12	7	7	gefitinib	KRAS	PA131301952	3845	0.527
NULL	Front_Neurol_2011_Apr_28_2_27.nxml.txt.nlp	21562603	SENT36	13	13	23	23	nifedipine	Q10	PA450631	27161	0.527
NULL	Curr_Neuropharmacol_2013_Jul_11(4)_338-378.nxml.txt.nlp	24381528	SENT1124	16	16	11	11	curcumin	BACE1	PA151958596	23621	0.527
NULL	Cardiovasc_Res_2011_Apr_1_90(1)_140-147.nxml.txt.nlp	21071431	SENT144	0	0	4	4	resveratrol	DPI		1832	0.527
NULL	Bioinform_Biol_Insights_2008_Nov_19_2_383-400.nxml.txt.nlp	19812790	SENT460	15	15	2	2	hyaluronan	HABP4	PA165958431	22927	0.527
NULL	Oncotarget_2014_Dec_4_5(22)_11365-11380.nxml.txt.nlp	25426548	SENT34	0	0	13	13	nutlin-3	TP53		7157	0.527
NULL	Nat_Commun_2013_4_10_1038_ncomms3834.nxml.txt.nlp	24280772	SENT270	6	6	4	4	troglitazone	IL-4	PA451799	3565	0.527
NULL	Clin_Ophthalmol_2007_Mar_1(1)_61-64.nxml.txt.nlp	19668467	SENT39	22	22	24	24	tacrolimus	castor	PA451578	54897	0.527
NULL	Biomed_Res_Int_2013_May_12_2013_408491.nxml.txt.nlp	23762844	SENT41	15	15	6	6	ethanol	CO2	PA448073	4513	0.527
NULL	Oncotarget_2013_Nov_15_4(11)_1866-1867.nxml.txt.nlp	24272818	SENT36	20	20	30	30	pertuzumab	San		80218	0.527
NULL	Cell_Death_Differ_2010_May_6_17(5)_872-882.nxml.txt.nlp	19893570	SENT243	18	18	28	28	etoposide	Bcl-2	PA449552	596	0.527
NULL	Ann_Dermatol_2013_May_10_25(2)_261-263.nxml.txt.nlp	23717030	SENT36	30	30	28	28	imiquimod	p40	PA449972	3921;339541;10314	0.527
NULL	Arthritis_Res_Ther_2004_Mar_8_6(3)_R199-R207.nxml.txt.nlp	15142265	SENT26	2	2	21	21	collagenase	MMP3	PA449107	4314	0.527
NULL	J_Hepatol_2010_Dec_53(6)_1101-1107.nxml.txt.nlp	20801540	SENT150	6	6	9	9	deferasirox	ACP	PA164760843	4706	0.527
NULL	Clin_Exp_Gastroenterol_2014_Jan_24_7_13-23.nxml.txt.nlp	24493931	SENT166	4	4	8	8	dextran	DAI	PA449261	81030	0.527
NULL	Pak_J_Med_Sci_2013_Jan-Mar_29(1)_97-102.nxml.txt.nlp	24353516	SENT9	11	11	15	15	clopidogrel	ADP	PA449053	23038	0.527
NULL	Indian_J_Anaesth_2013_May-Jun_57(3)_223-229.nxml.txt.nlp	23983278	SENT117	3	3	41	41	isoflurane	HO-1	PA450106	3162	0.527
NULL	Daru_2012_Dec_5_20(1)_86.nxml.txt.nlp	23351440	SENT220	22	22	32	32	curcumin	JNK	PA151958596	5599	0.527
NULL	Oncotarget_2011_Oct_17_2(10)_797-809.nxml.txt.nlp	22006582	SENT108	7	7	3	3	paclitaxel	ANOVA	PA450761	4858	0.527
NULL	Cancer_Immunol_Immunother_2012_Jun_10_61(6)_941-947.nxml.txt.nlp	22402907	SENT51	24	24	8	8	paraformaldehyde	IFN	PA450790	3439	0.527
NULL	Oncol_Rep_2012_Apr_14_27(4)_1227-1232.nxml.txt.nlp	22179681	SENT23	1	1	13	13	spermine	SMO	PA164781199	6608;54498	0.527
NULL	ARYA_Atheroscler_2012_Fall_8(3)_125-129.nxml.txt.nlp	23358827	SENT113	10	10	0	0	oxygen	JAMA	PA450744	50848	0.527
NULL	J_Exp_Med_1998_Jun_1_187(11)_1885-1892.nxml.txt.nlp	9607928	SENT209	5	5	7	7	thalidomide	IL-2	PA451644	3558	0.527
NULL	Cell_Death_Dis_2010_Mar_18_1(3)_e31.nxml.txt.nlp	21364639	SENT249	40	40	35	35	staurosporine	F12	PA165109623	2161	0.527
NULL	J_Cell_Mol_Med_2014_Aug_1_18(8)_1599-1611.nxml.txt.nlp	24889822	SENT266	0	0	5	5	resveratrol	SIRT1		23411	0.527
NULL	Diabetes_Care_2010_Nov_33(11)_2399-2405.nxml.txt.nlp	20980427	SENT186	22	22	9	9	ranibizumab	CRT	PA164746012	811	0.527
NULL	Diabetes_2011_Jun_21_60(6)_1770-1778.nxml.txt.nlp	21562078	SENT154	0	0	2	2	metformin	Met	PA450395	79811	0.527
NULL	Mol_Vis_2012_Jul_18_18_1966-1972.nxml.txt.nlp	22876123	SENT117	0	0	12	12	curcumin	IL-5	PA151958596	3567	0.527
NULL	Br_J_Cancer_2004_Mar_5_90(Suppl_1)_S7-S10.nxml.txt.nlp	15094758	SENT95	26	26	28	28	ketoconazole	CYP3A4	PA450146	1576	0.527
NULL	Oncotarget_2014_Mar_16_5(12)_4087-4102.nxml.txt.nlp	24961479	SENT277	2	2	0	0	hemin	PC3	PA449849	57332;7832;5122	0.527
NULL	Am_J_Pathol_2013_Apr_182(4)_1448-1458.nxml.txt.nlp	23410520	SENT86	40	40	30	30	dextran	CO2	PA449261	4513	0.527
NULL	ISRN_Allergy_2013_Feb_7_2013_971036.nxml.txt.nlp	23738146	SENT246	33	33	2	2	papain	IL-13	PA450778	3596	0.527
NULL	J_Anim_Sci_Biotechnol_2013_Jul_30_4(1)_27.nxml.txt.nlp	23899038	SENT193	17	17	22	22	taurine	GALT	PA451590	2592	0.527
NULL	Acta_Pharmacol_Sin_2010_Feb_5_31(2)_137-144.nxml.txt.nlp	20139896	SENT5	21	21	24	24	oxygen	ROS	PA450744	6098	0.527
NULL	Acta_Histochem_Cytochem_2011_Apr_28_44(2)_51-60.nxml.txt.nlp	21614166	SENT462	27	27	8	8	thalidomide	PCNA	PA451644	5111	0.527
NULL	Front_Genet_2014_Oct_14_5_314.nxml.txt.nlp	25352860	SENT118	8	8	4	4	napqi	CYP3A4		1576	0.527
NULL	Cancer_Metab_2013_Feb_4_1_7.nxml.txt.nlp	24280108	SENT188	13	13	22	22	doxycycline	GOT2	PA449415	2806	0.527
NULL	Cancers_(Basel)_2010_Mar_30_2(2)_338-363.nxml.txt.nlp	24281073	SENT1003	7	7	3	3	doxorubicin	RLIP76	PA449412	10928	0.527
NULL	Sci_Rep_2015_Jan_14_5_7789.nxml.txt.nlp	25586329	SENT553	10	10	0	0	fluorescein	MTR	PA164746009	4548	0.527
NULL	Hum_Mol_Genet_2010_Dec_15_19(24)_4939-4947.nxml.txt.nlp	20876613	SENT173	19	19	28	28	l-glutamine	CO2	PA10090	4513	0.527
NULL	Behav_Brain_Funct_2006_Apr_7_2_13.nxml.txt.nlp	16603077	SENT82	27	27	12	12	betaine	PC2	PA448603	5126;5311;8535	0.527
NULL	Braz_J_Med_Biol_Res_2014_Oct_14_47(12)_1068-1074.nxml.txt.nlp	25387674	SENT87	23	23	21	21	taurine	HCS	PA451590	3141;54205	0.527
NULL	Indian_J_Med_Res_2011_Mar_133(3)_257-266.nxml.txt.nlp	21441678	SENT56	8	8	28	28	isoniazid	RIF	PA450112	54509;80196	0.527
NULL	Mol_Biol_Cell_2013_Dec_15_24(24)_3805-3818.nxml.txt.nlp	24152730	SENT215	0	0	6	6	creatine	HDAC2	PA164778930	3066	0.527
NULL	Eur_J_Immunol_2012_Nov_18_42(11)_3049-3061.nxml.txt.nlp	22806397	SENT99	19	19	10	10	imiquimod	CD28	PA449972	1493;940	0.527
NULL	Int_J_Mol_Cell_Med_2012_Summer_1(3)_145-152.nxml.txt.nlp	24551770	SENT11	0	0	10	10	memantine	Bcl-2	PA10364	596	0.527
NULL	Int_J_Mol_Sci_2014_Mar_5_15(3)_3970-3988.nxml.txt.nlp	24603537	SENT183	32	32	30	30	curcumin	MCH	PA151958596	5367	0.527
NULL	Braz_J_Microbiol_2014_Jan_15_44(3)_807-812.nxml.txt.nlp	24516449	SENT133	23	23	18	18	ofloxacin	CTX	PA450684	1593	0.527
NULL	Br_J_Cancer_2010_Jan_5_102(1)_80-86.nxml.txt.nlp	19920817	SENT112	20	20	22	22	bevacizumab	IFN	PA130232992	3439	0.527
NULL	Core_Evid_2007_Nov_30_2(2)_121-129.nxml.txt.nlp	21221180	SENT234	19	19	31	31	rituximab	CHOP	PA451261	1649	0.527
NULL	N_Am_J_Med_Sci_2011_Jan_3(1)_1-12.nxml.txt.nlp	22540056	SENT398	0	0	11	11	curcumin	Bcl-2	PA151958596	596	0.527
NULL	Acta_Pharmacol_Sin_2011_Oct_12_32(10)_1259-1265.nxml.txt.nlp	21909126	SENT119	7	7	13	13	losartan	LOX-1	PA450268	4973	0.527
NULL	Int_J_Mol_Sci_2012_Aug_10_13(8)_9971-9979.nxml.txt.nlp	22949842	SENT1	8	8	10	10	lipase	PPL	PA450239	5493	0.527
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2011_Sep_13_4_47-62.nxml.txt.nlp	22879794	SENT120	3	3	29	29	liraglutide	PPG	PA165958364	5552	0.527
NULL	Environ_Health_Perspect_2006_Sep_23_114(9)_1401-1406.nxml.txt.nlp	16966095	SENT49	7	7	14	14	arsenite	p53	PA452638	7157	0.527
NULL	Biomed_Res_Int_2014_Jan_27_2014_696107.nxml.txt.nlp	24587987	SENT123	28	28	21	21	ebselen	NAC	PA161660841	22861	0.527
NULL	Clin_Med_Insights_Oncol_2011_May_18_5_145-156.nxml.txt.nlp	21695099	SENT241	10	10	4	4	tositumomab	CHOP	PA164748364	1649	0.527
NULL	Arthritis_Res_Ther_2013_Aug_21_15(4)_R93.nxml.txt.nlp	23965253	SENT19	19	19	17	17	collagenase	MMP13	PA449107	4322	0.527
NULL	J_Hum_Hypertens_2011_Feb_13_25(2)_114-121.nxml.txt.nlp	20463748	SENT41	10	10	5	5	cosyntropin	ACTH	PA164749052	5443	0.527
NULL	Nat_Neurosci_2011_May_17_14(5)_612-619.nxml.txt.nlp	21499254	SENT326	3	3	21	21	ethanol	ANOVA	PA448073	4858	0.527
NULL	Oncol_Lett_2014_Jun_4_7(6)_2175-2179.nxml.txt.nlp	24932311	SENT133	16	16	0	0	lipase	PEMT	PA450239	10400	0.527
NULL	Adv_Hematol_2012_Jul_24_2012_513702.nxml.txt.nlp	22888354	SENT108	0	0	13	13	lenalidomide	FasL	PA162363968	356	0.527
NULL	Curr_Microbiol_2012_Dec_28_65(6)_673-678.nxml.txt.nlp	22926720	SENT75	13	13	21	21	meropenem	TMP	PA164764445	2012	0.527
NULL	EMBO_J_2009_May_6_28(9)_1197-1207.nxml.txt.nlp	19322195	SENT239	21	21	15	15	dextran	EGF	PA449261	1950	0.527
NULL	Biomed_Res_Int_2014_Feb_24_2014_480921.nxml.txt.nlp	24707486	SENT90	4	4	6	6	l-cysteine	PAG	PA449173	55824	0.527
NULL	Ann_Gen_Psychiatry_2012_Jan_23_11_2.nxml.txt.nlp	22269819	SENT0	22	22	3	3	risperidone	Gen	PA451257	348654	0.527
NULL	Br_J_Pharmacol_2012_Aug_166(8)_2263-2276.nxml.txt.nlp	22471905	SENT53	4	4	26	26	choline	CDP	PA448976	1523	0.527
NULL	Cancer_Cell_Int_2013_Jun_26_13_63.nxml.txt.nlp	23800022	SENT210	0	0	11	11	genistein	XIAP	PA165109660	331	0.527
NULL	Exp_Ther_Med_2013_Apr_15_5(4)_1025-1029.nxml.txt.nlp	23596468	SENT7	17	17	2	2	temozolomide	PODXL	PA451609	5420	0.527
NULL	Arthritis_Res_2002_Sep_16_4(6)_R12.nxml.txt.nlp	12453315	SENT98	34	34	29	29	methotrexate	CRP	PA450428	1401;140913	0.527
NULL	Clin_Ophthalmol_2009_Jun_2_3_219-226.nxml.txt.nlp	19668569	SENT199	12	12	0	0	nepafenac	ANOVA	PA165958407	4858	0.527
NULL	Ann_Lab_Med_2012_Jul_20_32(4)_264-269.nxml.txt.nlp	22779067	SENT117	8	8	16	16	isoniazid	DST	PA450112	667	0.527
NULL	Front_Immunol_2013_Sep_17_4_280.nxml.txt.nlp	24062746	SENT325	12	12	8	8	sargramostim	GM-CSF	PA164748631	1437	0.527
NULL	Ann_Gen_Psychiatry_2011_Mar_24_10_8.nxml.txt.nlp	21435226	SENT201	7	7	3	3	carbamazepine	Gen	PA448785	348654	0.527
NULL	Curr_Opin_Pharmacol_2012_Jun_12(3)_335-339.nxml.txt.nlp	22560920	SENT68	12	12	5	5	erlotinib	EGF	PA134687924	1950	0.527
NULL	J_Young_Pharm_2010_Oct-Dec_2(4)_428-429.nxml.txt.nlp	21264109	SENT31	22	22	25	25	metformin	B12	PA450395	7126;4709	0.527
NULL	Virol_J_2012_Aug_3_9_143.nxml.txt.nlp	22863531	SENT235	14	14	11	11	ribavirin	IFN	PA451241	3439	0.527
NULL	J_Cancer_2013_Jan_11_4(2)_117-132.nxml.txt.nlp	23386910	SENT157	20	20	9	9	olaparib	BRCA2		675	0.527
NULL	Cells_2014_May_23_3(2)_517-545.nxml.txt.nlp	24861977	SENT1194	0	0	2	2	capsaicin	TRPV1	PA448776	7442	0.527
NULL	J_Korean_Med_Sci_2010_Nov_26_25(11)_1683-1687.nxml.txt.nlp	21060764	SENT11	10	10	8	8	thyroglobulin	TTF-1	PA164754910	7080	0.527
NULL	Open_AIDS_J_2010_Jan_19_4_70-75.nxml.txt.nlp	20200604	SENT220	10	10	36	36	abacavir	ATV	PA448004	4683	0.527
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Jun_21_70(Pt_7)_o801.nxml.txt.nlp	25161582	SENT4	22	22	4	4	phenol	mol	PA450913	90527	0.527
NULL	Breast_Cancer_Res_2012_Mar_20_14(2)_R53.nxml.txt.nlp	22433433	SENT318	12	12	7	7	doxorubicin	CCNE1	PA449412	898	0.527
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT128	16	16	0	0	propafenone	CYP1A2	PA451131	1544	0.527
NULL	Breast_Cancer_Res_2011_Sep_14_13(5)_R88.nxml.txt.nlp	21914219	SENT195	48	48	32	32	estradiol	TRAIL	PA449503	8743	0.527
NULL	Proteins_2013_Aug_1_81(8)_1457-1465.nxml.txt.nlp	23589421	SENT132	34	34	47	47	l-alanine	AGT	PA448055	183;189	0.527
NULL	Biochem_Biophys_Res_Commun_2009_May_22_383(1)_63-67.nxml.txt.nlp	19332024	SENT279	3	3	5	5	lipase	PNPLA2	PA450239	57104	0.527
NULL	Nat_Commun_2013_Nov_27_4_2824.nxml.txt.nlp	24280686	SENT615	5	5	20	20	dextran	RhoB	PA449261	388	0.527
NULL	Arthritis_Res_Ther_2013_Sep_18_15(5)_R125.nxml.txt.nlp	24432364	SENT28	8	8	15	15	denosumab	TNF-alpha	PA166048634	7124	0.527
NULL	Front_Genet_2012_Nov_5_3_236.nxml.txt.nlp	23133441	SENT162	25	25	20	20	efavirenz	ABCB1	PA449441	5243	0.527
NULL	J_Phys_Ther_Sci_2014_Nov_13_26(11)_1723-1727.nxml.txt.nlp	25435686	SENT100	9	9	0	0	oxygen	DBP	PA450744	3295;1628;2638	0.527
NULL	Breast_Cancer_Res_2007_Mar_6_9(2)_R22.nxml.txt.nlp	17341305	SENT351	19	19	31	31	medroxyprogesterone	PRL	PA450344	5617	0.527
NULL	Br_J_Anaesth_2014_Jul_22_113(1)_157-167.nxml.txt.nlp	24154701	SENT28	0	0	10	10	sevoflurane	TREK-1	PA451341	3776	0.527
NULL	J_Gastroenterol_2014_Apr_17_49(1)_126-137.nxml.txt.nlp	23591768	SENT316	17	17	3	3	ribavirin	IL28B	PA451241	282617	0.527
NULL	Arthritis_Res_Ther_2006_Nov_27_8(6)_R178.nxml.txt.nlp	17129378	SENT81	27	27	35	35	fluorescein	IFN	PA164746009	3439	0.527
NULL	ScientificWorldJournal_2012_Apr_1_2012_671728.nxml.txt.nlp	22547992	SENT183	17	17	19	19	fluvastatin	ANOVA	PA449688	4858	0.527
NULL	Viruses_2014_Mar_10_6(3)_1091-1111.nxml.txt.nlp	24618810	SENT214	34	34	45	45	l-glutamine	CO2	PA10090	4513	0.527
NULL	Arthritis_Res_Ther_2011_Feb_23_13(1)_R33.nxml.txt.nlp	21345222	SENT185	16	16	19	19	hyaluronan	HMGB1	PA165958431	3146	0.527
NULL	BMB_Rep_2014_Oct_47(10)_575-580.nxml.txt.nlp	24499675	SENT106	10	10	16	16	arsenite	p53	PA452638	7157	0.527
NULL	Crit_Care_2006_Jan_31_10(1)_R20.nxml.txt.nlp	16469127	SENT149	2	2	0	0	vasopressin	AVP	PA451858	114548;551	0.527
NULL	J_Biol_Chem_2013_Mar_29_288(13)_9035-9048.nxml.txt.nlp	23362266	SENT972	24	24	20	20	tamoxifen	PTEN	PA451581	5728	0.527
NULL	Arch_Med_Sci_2011_Dec_31_7(6)_977-983.nxml.txt.nlp	22328880	SENT36	8	8	2	2	heparin	PAPP-A	PA449855	5069	0.527
NULL	Mol_Neurodegener_2011_Nov_17_6_77.nxml.txt.nlp	22094223	SENT376	25	25	15	15	l-glutamine	F12	PA10090	2161	0.527
NULL	Oncotarget_2014_Aug_29_5(17)_7217-7259.nxml.txt.nlp	25277175	SENT301	21	21	17	17	axitinib	FLT3	PA164924493	2322	0.527
NULL	Kidney_Int_Suppl_(2011)_2012_Jun_15_2(2)_186-197.nxml.txt.nlp	25018932	SENT276	9	9	14	14	rituximab	ACTH	PA451261	5443	0.527
NULL	J_Oncol_2013_Feb_17_2013_872957.nxml.txt.nlp	23476648	SENT35	15	15	4	4	cisplatin	SFN	PA449014	25996;2810	0.527
NULL	Oncoimmunology_2012_Mar_1_1(2)_205-207.nxml.txt.nlp	22720243	SENT45	6	6	29	29	hydrocortisone	IL-15	PA449905	3600	0.527
NULL	Braz_J_Med_Biol_Res_2014_Sep_5_47(11)_929-939.nxml.txt.nlp	25296354	SENT114	33	33	35	35	afatinib	EGFR	PA165981154	1956	0.527
NULL	Cancer_Med_2014_Apr_12_3(2)_390-396.nxml.txt.nlp	24519810	SENT53	4	4	6	6	lamivudine	LAM	PA450163	7249;7248	0.527
NULL	Chem_Cent_J_2012_Dec_10_6_151.nxml.txt.nlp	23216944	SENT107	17	17	4	4	hydroquinone	mol	PA449924	90527	0.527
NULL	Front_Neurosci_2014_Jun_3_8_128.nxml.txt.nlp	24917782	SENT145	32	32	43	43	ethanol	MC3R	PA448073	4159	0.527
NULL	Int_J_Alzheimers_Dis_2010_Dec_27_2011_231595.nxml.txt.nlp	21234401	SENT109	11	11	7	7	iron	APP	PA450087	351	0.527
NULL	Mol_Med_Rep_2015_Jan_17_11(1)_43-52.nxml.txt.nlp	25333456	SENT266	25	25	11	11	mitomycin	ADM	PA450524	133	0.527
NULL	Diagn_Pathol_2006_Aug_15_1_19.nxml.txt.nlp	16911776	SENT147	16	16	20	20	gefitinib	EGFR	PA131301952	1956	0.527
NULL	J_Biol_Chem_2013_Mar_8_288(10)_7363-7372.nxml.txt.nlp	23335559	SENT194	14	14	9	9	doxycycline	VCP	PA449415	7415	0.527
NULL	Front_Genet_2014_Oct_14_5_314.nxml.txt.nlp	25352860	SENT105	17	17	31	31	napqi	CYP1A2		1544	0.527
NULL	J_Lipid_Res_2014_Dec_55(12)_2562-2575.nxml.txt.nlp	25316883	SENT196	31	31	28	28	lipase	ATGL	PA450239	57104	0.527
NULL	Bioinformation_2006_Dec_23_1(8)_314-320.nxml.txt.nlp	17597912	SENT156	19	19	9	9	flavopiridol	ACE	PA452627	1636	0.527
NULL	Cerebrospinal_Fluid_Res_2010_Aug_12_7_11.nxml.txt.nlp	20704740	SENT149	0	0	24	24	calcein	P-gp	PA132595336	5243	0.527
NULL	Mol_Syst_Biol_2009_Jul_28_5_288.nxml.txt.nlp	19638969	SENT437	0	0	5	5	resveratrol	HuR		1994	0.527
NULL	Oncotarget_2014_Feb_8_5(6)_1609-1620.nxml.txt.nlp	24742492	SENT222	32	32	20	20	l-glutamine	EGF	PA10090	1950	0.527
NULL	Int_J_Cell_Biol_2013_Nov_13_2013_674751.nxml.txt.nlp	24324498	SENT154	10	10	16	16	bacitracin	SOD1	PA448531	6647	0.527
NULL	Community_Ment_Health_J_2010_Dec_18_46(6)_563-569.nxml.txt.nlp	19688594	SENT90	13	13	1	1	glucosamine	Q10	PA164747613	27161	0.527
NULL	J_Gen_Physiol_2003_Jul_122(1)_45-61.nxml.txt.nlp	12835470	SENT366	21	21	10	10	capsaicin	VR1	PA448776	56664	0.527
NULL	Diabetes_Care_2013_Aug_17_36(Suppl_2)_S139-S144.nxml.txt.nlp	23882038	SENT79	10	10	0	0	liraglutide	GLP-1	PA165958364	100125288	0.527
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Jun_27_5_15.nxml.txt.nlp	16803618	SENT161	44	44	42	42	gentamicin	GEN1	PA449753	348654	0.527
NULL	Environ_Health_Perspect_2013_May_22_121(5)_551-557.nxml.txt.nlp	23434795	SENT175	30	30	36	36	hyaluronan	AHR	PA165958431	196	0.527
NULL	Brain_Sci_2012_Nov_7_2(4)_589-604.nxml.txt.nlp	24349762	SENT19	24	24	26	26	vasopressin	AVP	PA451858	114548;551	0.527
NULL	Clin_Interv_Aging_2013_Apr_29_8_467-483.nxml.txt.nlp	23766636	SENT175	18	18	4	4	ranibizumab	CRT	PA164746012	811	0.527
NULL	Sensors_(Basel)_2011_Feb_28_11(3)_2525-2565.nxml.txt.nlp	22163754	SENT347	15	15	6	6	copper	spatial	PA449114	219793	0.527
NULL	Arch_Med_Sci_2011_Feb_8_7(1)_154-160.nxml.txt.nlp	22291749	SENT172	2	2	16	16	chlorhexidine	S15	PA164776863	6209	0.527
NULL	Comp_Hepatol_2004_Aug_12_3_4.nxml.txt.nlp	15306034	SENT8	12	12	25	25	hyaluronan	gamma	PA165958431	9913	0.527
NULL	Mol_Cell_Proteomics_2014_May_20_13(5)_1184-1197.nxml.txt.nlp	24556848	SENT301	27	27	25	25	staurosporine	TRAIL	PA165109623	8743	0.527
NULL	Br_J_Cancer_2009_Jan_27_100(2)_315-321.nxml.txt.nlp	19127256	SENT121	5	5	15	15	paclitaxel	CYP3A4	PA450761	1576	0.527
NULL	Oncotarget_2013_Nov_23_5(1)_196-210.nxml.txt.nlp	24344116	SENT111	0	0	15	15	doxorubicin	TNFAIP3	PA449412	7128	0.527
NULL	J_Med_Case_Rep_2014_Aug_21_8_281.nxml.txt.nlp	25146249	SENT119	13	13	11	11	entecavir	IFN	PA164784025	3439	0.527
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1063.nxml.txt.nlp	24556678	SENT210	10	10	14	14	thioridazine	TRAIL	PA451666	8743	0.527
NULL	J_Hematol_Oncol_2009_Oct_27_2_45.nxml.txt.nlp	19860903	SENT114	12	12	24	24	temsirolimus	IFN	PA164746890	3439	0.527
NULL	Ann_Rheum_Dis_2012_Aug_71(8)_1289-1296.nxml.txt.nlp	22307942	SENT145	27	27	0	0	methotrexate	ACR	PA450428	49	0.527
NULL	Mol_Cancer_2013_Mar_5_12_17.nxml.txt.nlp	23497256	SENT185	13	13	5	5	sunitinib	p53	PA162372840	7157	0.527
NULL	J_Korean_Med_Sci_2013_Feb_29_28(2)_308-314.nxml.txt.nlp	23399960	SENT6	7	7	26	26	gabapentin	IL-10	PA449720	3586	0.527
NULL	Oncotarget_2013_May_11_4(6)_830-843.nxml.txt.nlp	23919981	SENT150	7	7	10	10	temsirolimus	PI3K	PA164746890	5290	0.527
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_9_2013_358673.nxml.txt.nlp	23840254	SENT167	16	16	7	7	lipase	adiponectin	PA450239	9370	0.527
NULL	Mar_Drugs_2012_Apr_10_10(4)_890-899.nxml.txt.nlp	22690149	SENT98	36	36	8	8	l-glutamine	CO2	PA10090	4513	0.527
NULL	Exp_Ther_Med_2014_Feb_4_7(2)_478-482.nxml.txt.nlp	24396429	SENT159	9	9	6	6	oxygen	ROS	PA450744	6098	0.527
NULL	J_Cell_Mol_Med_2014_Dec_7_18(12)_2536-2552.nxml.txt.nlp	25287328	SENT267	26	26	0	0	estradiol	PKD1	PA449503	5310	0.527
NULL	Br_J_Cancer_2010_Jul_13_103(2)_256-264.nxml.txt.nlp	20588276	SENT193	2	2	11	11	genistein	PC3	PA165109660	57332;7832;5122	0.527
NULL	Daru_2011_19(6)_433-439.nxml.txt.nlp	23008689	SENT42	33	33	35	35	ethanol	IPA	PA448073	3160	0.527
NULL	Front_Neurosci_2011_Dec_5_5_131.nxml.txt.nlp	22164129	SENT333	4	4	7	7	ethanol	CA1	PA448073	759	0.527
NULL	Genome_Biol_2003_May_29_4(6)_216.nxml.txt.nlp	12801404	SENT153	15	15	2	2	collagenase	CD147	PA449107	682	0.527
NULL	Breast_Cancer_Res_Treat_2014_Dec_21_143(3)_459-467.nxml.txt.nlp	24362951	SENT112	15	15	23	23	tamoxifen	HER2	PA451581	2064	0.527
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT218	22	22	17	17	posaconazole	UGT	PA151958574	7361;7355	0.527
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1495-1502.nxml.txt.nlp	21989186	SENT10	13	13	9	9	panitumumab	KRAS	PA162373091	3845	0.527
NULL	Front_Oncol_2013_Nov_18_3_282.nxml.txt.nlp	24303367	SENT640	5	5	7	7	gemcitabine	Gem	PA449748	51053	0.527
NULL	Breast_Cancer_Res_2011_Dec_9_13(6)_R127.nxml.txt.nlp	22151997	SENT160	2	2	33	33	doxycycline	SNAI2	PA449415	6591	0.527
NULL	Breast_Cancer_Res_2009_Jun_23_11(Suppl_1)_S22.nxml.txt.nlp	NULL	SENT12	3	3	5	5	trastuzumab	HER2	PA451743	2064	0.527
NULL	J_Int_Soc_Sports_Nutr_2015_Jan_21_12(1)_5.nxml.txt.nlp	NULL	SENT179	10	10	12	12	curcumin	IL-6	PA151958596	3569	0.527
NULL	Cardiovasc_Diabetol_2006_Sep_26_5_20.nxml.txt.nlp	17002798	SENT45	14	14	23	23	fenofibrate	CAD	PA449594	1677;790	0.527
NULL	J_Hematol_Oncol_2008_Aug_11_1_11.nxml.txt.nlp	18694493	SENT94	8	8	12	12	temsirolimus	IFN	PA164746890	3439	0.526
NULL	Br_J_Cancer_2009_Jul_21_101(2)_238-243.nxml.txt.nlp	19568242	SENT123	9	9	11	11	bevacizumab	IFN	PA130232992	3439	0.526
NULL	J_Biol_Chem_2013_Mar_8_288(10)_6946-6956.nxml.txt.nlp	23293023	SENT373	7	7	18	18	thrombin	TLR4	PA451674	7099	0.526
NULL	J_Geriatr_Cardiol_2013_Jun_10(2)_151-158.nxml.txt.nlp	23888175	SENT41	8	8	6	6	rosuvastatin	ACE2	PA134308647	59272	0.526
NULL	Brain_Sci_2014_Apr_22_4(2)_311-320.nxml.txt.nlp	24961763	SENT45	10	10	18	18	isoflurane	CO2	PA450106	4513	0.526
NULL	Int_J_Cardiovasc_Imaging_2012_Mar_27_28(3)_455-465.nxml.txt.nlp	21359834	SENT25	17	17	4	4	rosiglitazone	GLP	PA451283	342096	0.526
NULL	Br_J_Cancer_2013_Dec_10_109(12)_2954-2958.nxml.txt.nlp	24231949	SENT66	4	4	9	9	nutlin-3	p53		7157	0.526
NULL	Arch_Orthop_Trauma_Surg_2009_Nov_7_129(11)_1495-1504.nxml.txt.nlp	18989686	SENT103	13	13	11	11	daptomycin	VISA	PA164768820	57506	0.526
NULL	Arthritis_Res_Ther_2009_Aug_24_11(4)_R127.nxml.txt.nlp	19703304	SENT61	18	18	15	15	adalimumab	OASIS	PA10004	90993	0.526
NULL	Mol_Cancer_2008_May_16_7_38.nxml.txt.nlp	18485224	SENT169	43	43	45	45	celecoxib	DMC	PA448871	284340;54808	0.526
NULL	Arthritis_Res_Ther_2014_Oct_30_16(5)_470.nxml.txt.nlp	25606597	SENT189	7	7	13	13	etanercept	IL-17A	PA449515	3605	0.526
NULL	Mol_Cells_2014_Mar_31_37(3)_234-240.nxml.txt.nlp	24642709	SENT96	26	26	15	15	capsaicin	TLR4	PA448776	7099	0.526
NULL	Arthritis_Res_Ther_2009_Jul_17_11(4)_R111.nxml.txt.nlp	19615053	SENT191	2	2	0	0	cyclophosphamide	CTX	PA449165	1593	0.526
NULL	Oncotarget_2013_Dec_12_5(1)_249-257.nxml.txt.nlp	24371149	SENT156	14	14	35	35	tamoxifen	14-3-3	PA451581	10971	0.526
NULL	Cancer_Cell_Int_2011_Aug_12_11_27.nxml.txt.nlp	21838899	SENT296	34	34	21	21	chlorpromazine	CO2	PA448964	4513	0.526
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1066.nxml.txt.nlp	24556681	SENT236	23	23	30	30	ethanol	ANOVA	PA448073	4858	0.526
NULL	Int_J_Fertil_Steril_2014_Nov_1_Oct-Dec_8(3)_243-248.nxml.txt.nlp	25379151	SENT21	17	17	19	19	piroxicam	ART	PA450985	181	0.526
NULL	J_Pregnancy_2014_Jun_2_2014_910751.nxml.txt.nlp	24991435	SENT104	33	33	19	19	urokinase	COL1A1	PA451836	1277	0.526
NULL	Sensors_(Basel)_2013_Feb_28_13(3)_2895-2910.nxml.txt.nlp	23449119	SENT122	9	9	7	7	pp2	PP1		5540;5464	0.526
NULL	Clin_Exp_Gastroenterol_2014_Jul_5_7_221-239.nxml.txt.nlp	25045276	SENT248	16	16	41	41	lipase	CB2	PA450239	1269	0.526
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Nov_24_68(Pt_12)_o3411.nxml.txt.nlp	23476234	SENT5	28	28	24	24	phenol	mol	PA450913	90527	0.526
NULL	Int_J_Chron_Obstruct_Pulmon_Dis_2007_Dec_2(4)_517-533.nxml.txt.nlp	18268925	SENT160	0	0	14	14	cilomilast	GM-CSF	PA165948031	1437	0.526
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Mar_25_65(Pt_4)_o836.nxml.txt.nlp	21582555	SENT63	33	33	27	27	ethanol	mol	PA448073	90527	0.526
NULL	Ann_Lab_Med_2013_Nov_17_33(6)_410-414.nxml.txt.nlp	24205489	SENT53	19	19	30	30	fluorescein	hole	PA164746009	80757	0.526
NULL	J_Gen_Physiol_2008_Nov_132(5)_521-535.nxml.txt.nlp	18852303	SENT404	13	13	22	22	trypsin	CAP2	PA451806	5271;10486	0.526
NULL	Autophagy_2012_May_1_8(5)_853-855.nxml.txt.nlp	22617440	SENT58	16	16	13	13	imatinib	ATG5	PA10804	9474	0.526
NULL	Proteome_Sci_2010_Jun_17_8_34.nxml.txt.nlp	20565803	SENT292	16	16	21	21	creatine	Rho	PA164778930	29984	0.526
NULL	Mol_Biol_Cell_2012_Sep_1_23(17)_3461-3472.nxml.txt.nlp	22767580	SENT270	32	32	2	2	paraformaldehyde	ADAM12	PA450790	8038	0.526
NULL	Diabetes_Care_2009_Nov_32(Suppl_2)_S362-S367.nxml.txt.nlp	19875582	SENT32	26	26	16	16	lipase	adiponectin	PA450239	9370	0.526
NULL	Structure_2013_Jun_4_21(6)_1051-1058.nxml.txt.nlp	23665170	SENT129	10	10	20	20	oxygen	hole	PA450744	80757	0.526
NULL	Arch_Med_Sci_2010_Dec_29_6(6)_964-970.nxml.txt.nlp	22427774	SENT122	32	32	7	7	cyclosporine	IL-19	PA449167	29949	0.526
NULL	J_Cell_Biol_1983_Jan_1_96(1)_282-285.nxml.txt.nlp	6826648	SENT6	25	25	23	23	thrombin	gamma	PA451674	9913	0.526
NULL	Mol_Cancer_2013_Mar_5_12_17.nxml.txt.nlp	23497256	SENT154	38	38	15	15	doxycycline	p53	PA449415	7157	0.526
NULL	Curr_Pharm_Des_2011_Apr_17(10)_985-989.nxml.txt.nlp	21524255	SENT84	37	37	29	29	imipramine	VPAC2	PA449969	7434	0.526
NULL	Int_J_Cell_Biol_2014_Jan_22_2014_709828.nxml.txt.nlp	24578708	SENT76	32	32	45	45	choline	CDw92	PA448976	23446	0.526
NULL	Clin_Med_Insights_Blood_Disord_2013_Nov_14_6_23-27.nxml.txt.nlp	25512717	SENT60	11	11	9	9	rituximab	CHOP	PA451261	1649	0.526
NULL	Mol_Cancer_2007_Aug_21_6_53.nxml.txt.nlp	17711579	SENT131	11	11	29	29	cisplatin	p53	PA449014	7157	0.526
NULL	J_Cell_Biol_2003_Aug_18_162(4)_587-597.nxml.txt.nlp	12913114	SENT17	42	42	8	8	staurosporine	Bcl-2	PA165109623	596	0.526
NULL	Biomed_Res_Int_2014_Jun_26_2014_161346.nxml.txt.nlp	25054130	SENT216	45	45	21	21	curcumin	STZ	PA151958596	6484	0.526
NULL	J_Cell_Mol_Med_2014_Dec_22_18(12)_2519-2529.nxml.txt.nlp	25338520	SENT155	8	8	5	5	oxygen	ROS	PA450744	6098	0.526
NULL	J_Med_Case_Rep_2014_Aug_25_8_286.nxml.txt.nlp	25155131	SENT42	17	17	24	24	heparin	B12	PA449855	7126;4709	0.526
NULL	Front_Aging_Neurosci_2010_Feb_3_2_2.nxml.txt.nlp	20552042	SENT631	0	0	8	8	nimodipine	CA1	PA450633	759	0.526
NULL	Nucleic_Acids_Res_2005_Apr_20_33(7)_2239-2247.nxml.txt.nlp	15843686	SENT62	10	10	4	4	ampicillin	LEU2	PA448419	8847	0.526
NULL	Arthritis_Res_Ther_2014_Jul_24_16(4)_R157.nxml.txt.nlp	25059342	SENT229	1	1	4	4	bleomycin	IL-6	PA448645	3569	0.526
NULL	Ann_Gen_Psychiatry_2008_Aug_18_7_11.nxml.txt.nlp	18706108	SENT130	2	2	0	0	bupropion	BUP	PA448687	23412	0.526
NULL	Cancer_Metab_2013_Feb_4_1_7.nxml.txt.nlp	24280108	SENT7	5	5	12	12	oxygen	MYC	PA450744	4609	0.526
NULL	Alzheimers_Res_Ther_2013_Jan_25_5(1)_3.nxml.txt.nlp	23347747	SENT146	11	11	34	34	ethanol	spatial	PA448073	219793	0.526
NULL	Croat_Med_J_2013_Apr_54(2)_171-179.nxml.txt.nlp	23630144	SENT70	10	10	1	1	taurine	STZ	PA451590	6484	0.526
NULL	Pharmaceuticals_(Basel)_2013_Oct_11_6(10)_1304-1321.nxml.txt.nlp	24275851	SENT768	0	0	5	5	nilvadipine	spatial	PA165958385	219793	0.526
NULL	Clin_Kidney_J_2013_Jun_11_6(3)_287-294.nxml.txt.nlp	23717787	SENT164	11	11	9	9	cinacalcet	PTH	PA164776671	5741	0.526
NULL	Ann_Indian_Acad_Neurol_2009_Oct-Dec_12(4)_264-272.nxml.txt.nlp	20182574	SENT127	12	12	6	6	methylprednisolone	ACTH	PA450466	5443	0.526
NULL	Cancers_(Basel)_2012_Nov_29_4(4)_1252-1299.nxml.txt.nlp	24213506	SENT732	12	12	2	2	thrombin	ADAMTS18	PA451674	170692	0.526
NULL	Clin_Med_Insights_Oncol_2013_Jul_28_7_165-172.nxml.txt.nlp	23926442	SENT43	29	29	19	19	fluorescein	CD14	PA164746009	929	0.526
NULL	Biologics_2009_Sep_15_3_377-383.nxml.txt.nlp	19774205	SENT216	14	14	18	18	rimantadine	Yes	PA164748038	7525	0.526
NULL	Arthritis_Res_Ther_2005_Feb_17_7(Suppl_1)_S10.nxml.txt.nlp	NULL	SENT6	9	9	21	21	collagenase	AP-1	PA449107	2353;3727;2354;3725	0.526
NULL	Int_J_Mol_Sci_2012_Aug_21_13(8)_10461-10477.nxml.txt.nlp	22949874	SENT790	14	14	10	10	paclitaxel	TGFBI	PA450761	7045	0.526
NULL	J_Oncol_2012_Sep_5_2012_128608.nxml.txt.nlp	21904549	SENT171	7	7	20	20	sunitinib	FLT3	PA162372840	2322	0.526
NULL	J_Biol_Chem_2008_Apr_4_283(14)_8837-8845.nxml.txt.nlp	18250166	SENT185	14	14	7	7	methotrexate	DHFR	PA450428	1719	0.526
NULL	Hum_Genomics_2006_Jan_1_2(4)_252-257.nxml.txt.nlp	16460650	SENT94	17	17	26	26	nadh	ND5	PA164755085	4540	0.526
NULL	Crit_Care_2010_Mar_15_14(2)_R30.nxml.txt.nlp	20226064	SENT286	18	18	12	12	dexmedetomidine	IL-6	PA449256	3569	0.526
NULL	Front_Genet_2012_Oct_26_3_213.nxml.txt.nlp	23112805	SENT608	25	25	39	39	diclofenac	CYP3A4	PA449293	1576	0.526
NULL	Core_Evid_2007_Nov_30_2(2)_121-129.nxml.txt.nlp	21221180	SENT233	22	22	14	14	rituximab	EFS	PA451261	10278	0.526
NULL	Arthritis_Res_Ther_2010_Apr_1_12(2)_R60.nxml.txt.nlp	20359365	SENT168	8	8	25	25	bleomycin	SPARC	PA448645	6678	0.526
NULL	J_Ophthalmic_Inflamm_Infect_2011_Nov_6_2(1)_21-28.nxml.txt.nlp	22057810	SENT101	8	8	13	13	azathioprine	CTX	PA448515	1593	0.526
NULL	Cholesterol_2013_Oct_7_2013_792090.nxml.txt.nlp	24222847	SENT266	13	13	23	23	bleomycin	PON3	PA448645	5446	0.526
NULL	Exp_Ther_Med_2013_Jul_25_6(1)_109-114.nxml.txt.nlp	23935730	SENT137	11	11	19	19	cyclophosphamide	CHOP	PA449165	1649	0.526
NULL	Exp_Hematol_2014_Dec_42(12)_1053-1058_e1.nxml.txt.nlp	25127743	SENT16	20	20	9	9	potassium	KCNE2	PA451047	9992	0.526
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Jun_27_5_15.nxml.txt.nlp	16803618	SENT145	14	14	42	42	erythromycin	GEN1	PA449493	348654	0.526
NULL	Open_Biochem_J_2008_Feb_6_2_6-15.nxml.txt.nlp	18949070	SENT350	6	6	25	25	heparin	Yes	PA449855	7525	0.526
NULL	Biomed_Res_Int_2014_Jan_29_2014_361020.nxml.txt.nlp	24605326	SENT223	1	1	10	10	staurosporine	CDK2	PA165109623	1017	0.526
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_3_2014_473213.nxml.txt.nlp	25538791	SENT19	4	4	8	8	ethanol	CYP3A4	PA448073	1576	0.526
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT812	16	16	20	20	glucose	GLUT9	PA449773	11182	0.526
NULL	Infect_Dis_Ther_2014_Jun_18_3(1)_35-43.nxml.txt.nlp	25134810	SENT102	4	4	9	9	daptomycin	VAN	PA164768820	10318	0.526
NULL	Behav_Genet_2008_Jul_7_38(4)_396-406.nxml.txt.nlp	18461434	SENT15	0	0	2	2	glucose	hole	PA449773	80757	0.526
NULL	J_Exp_Bot_2012_Mar_15_63(5)_1969-1983.nxml.txt.nlp	22174442	SENT173	7	7	29	29	l-alanine	mol	PA448055	90527	0.526
NULL	Ecancermedicalscience_2009_Sep_24_3_153.nxml.txt.nlp	22276017	SENT41	18	18	3	3	platinum	XPA	PA150595617	7507	0.526
NULL	Int_J_Gen_Med_2012_Oct_25_5_849-859.nxml.txt.nlp	23204853	SENT178	40	40	28	28	hyaluronan	TLR4	PA165958431	7099	0.526
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT10	1	1	28	28	glucose	p38	PA449773	10598;1432;7965	0.526
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_16_2012_395912.nxml.txt.nlp	23118789	SENT75	9	9	15	15	diclofenac	UGT1A7	PA449293	54577	0.526
NULL	Front_Behav_Neurosci_2013_Dec_23_7_211.nxml.txt.nlp	24391566	SENT123	31	31	27	27	propranolol	ANOVA	PA451145	4858	0.526
NULL	Open_Biochem_J_2014_Dec_31_8_107-111.nxml.txt.nlp	25598850	SENT189	22	22	19	19	liraglutide	GLP-1	PA165958364	100125288	0.526
NULL	Avicenna_J_Med_2014_Apr-Jun_4(2)_29-33.nxml.txt.nlp	24761380	SENT96	15	15	10	10	exenatide	GLP-1	PA164749238	100125288	0.526
NULL	Hum_Reprod_Update_2009_Jan_27_May-Jun_15(3)_323-339.nxml.txt.nlp	19174449	SENT203	10	10	34	34	estradiol	AMH	PA449503	268	0.526
NULL	Case_Rep_Med_2010_Jun_7_2010_495281.nxml.txt.nlp	20593036	SENT61	18	18	16	16	thyroglobulin	TTF-1	PA164754910	7080	0.526
NULL	Brain_2013_May_4_136(5)_1462-1475.nxml.txt.nlp	23460667	SENT119	20	20	28	28	verapamil	ABCG2	PA451868	9429	0.526
NULL	Mar_Drugs_2010_Mar_15_8(3)_629-657.nxml.txt.nlp	20411119	SENT218	3	3	19	19	l-leucine	PP1	PA450197	5540;5464	0.526
NULL	Breast_Cancer_Res_2014_May_5_16(3)_R45.nxml.txt.nlp	24887236	SENT130	0	0	2	2	lapatinib	HER2	PA152241907	2064	0.526
NULL	J_Biomed_Biotechnol_2010_Nov_2_2010_232016.nxml.txt.nlp	21052559	SENT147	39	39	16	16	theophylline	IL-2	PA451647	3558	0.526
NULL	Infect_Drug_Resist_2011_Mar_2_4_77-86.nxml.txt.nlp	21694911	SENT87	14	14	12	12	tigecycline	CABP	PA164746412	6277	0.526
NULL	Mol_Cancer_2012_Jul_12_11_45.nxml.txt.nlp	22788833	SENT134	34	34	14	14	cisplatin	EGFR	PA449014	1956	0.526
NULL	Antimicrob_Resist_Infect_Control_2012_Mar_16_1_12.nxml.txt.nlp	22958880	SENT107	38	38	16	16	doxycycline	Gen	PA449415	348654	0.526
NULL	Aging_(Albany_NY)_2010_Dec_20_2(12)_959-968.nxml.txt.nlp	21191146	SENT90	0	0	21	21	cisplatin	LKB1	PA449014	6794	0.526
NULL	Neuropsychopharmacology_2009_Oct_1_34(11)_2430-2441.nxml.txt.nlp	19571794	SENT252	43	43	21	21	methamphetamine	c-fos	PA450403	2353	0.526
NULL	Diabetes_Care_2013_Jul_12_36(7)_e92-e93.nxml.txt.nlp	23801816	SENT16	7	7	19	19	cilostazol	SMAP	PA164746334	22920;10944;10902	0.526
NULL	Pharmaceuticals_(Basel)_2011_Nov_11_4(11)_1503-1517.nxml.txt.nlp	NULL	SENT8	0	0	3	3	capsaicin	TRPV1	PA448776	7442	0.526
NULL	Adv_Hematol_2010_Dec_5_2010_595934.nxml.txt.nlp	21151515	SENT154	15	15	20	20	ticagrelor	Yes	PA165374673	7525	0.526
NULL	Nucleic_Acids_Res_2011_Nov_16_39(21)_9390-9404.nxml.txt.nlp	21846770	SENT65	32	32	41	41	l-glutamine	CO2	PA10090	4513	0.526
NULL	J_Med_Case_Reports_2008_May_23_2_174.nxml.txt.nlp	18500979	SENT30	23	23	10	10	gentamicin	TMP	PA449753	2012	0.526
NULL	Nat_Commun_2013_Nov_26_4_10_1038_ncomms3816.nxml.txt.nlp	24281383	SENT170	23	23	47	47	diazepam	S15	PA449283	6209	0.526
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_16_2014_926087.nxml.txt.nlp	25478000	SENT12	6	6	11	11	atorvastatin	PCSK9	PA448500	255738	0.526
NULL	Nanoscale_Res_Lett_2014_Apr_4_9(1)_164.nxml.txt.nlp	24708898	SENT27	0	0	8	8	dextran	mol	PA449261	90527	0.526
NULL	Mol_Brain_2014_Aug_12_7_58.nxml.txt.nlp	25112718	SENT229	37	37	16	16	cimetidine	E14	PA449001	4863	0.526
NULL	J_Ginseng_Res_2011_Nov_35(4)_436-441.nxml.txt.nlp	23717089	SENT131	10	10	7	7	ginseng	CAGC	PA164781150	6283	0.526
NULL	Br_J_Cancer_2009_Jul_21_101(2)_350-356.nxml.txt.nlp	19513075	SENT35	19	19	27	27	cyclophosphamide	p53	PA449165	7157	0.526
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_127043.nxml.txt.nlp	23227093	SENT231	15	15	17	17	sulfaphenazole	CYP2C9	PA130231310	1559	0.526
NULL	Curr_Opin_Infect_Dis_2013_Dec_6_26(6)_538-544.nxml.txt.nlp	24126716	SENT143	8	8	18	18	amikacin	PARI	PA164744372	55010	0.526
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2012_Sep_13_68(Pt_10)_1311-1319.nxml.txt.nlp	22993085	SENT52	24	24	19	19	guanidine	Eg5	PA164781028	3832	0.526
NULL	BMJ_Open_2014_Feb_13_4(2)_e003960.nxml.txt.nlp	24525389	SENT124	13	13	26	26	warfarin	OAT	PA451906	4942	0.526
NULL	J_Lipid_Res_2015_Jan_56(1)_109-121.nxml.txt.nlp	25421061	SENT24	11	11	13	13	lipase	ATGL	PA450239	57104	0.526
NULL	Arthritis_Res_Ther_2014_Jan_20_16(1)_R17.nxml.txt.nlp	24444433	SENT117	21	21	0	0	methotrexate	ANOVA	PA450428	4858	0.526
NULL	Clinics_(Sao_Paulo)_2012_Jun_67(6)_661-667.nxml.txt.nlp	22760907	SENT150	11	11	14	14	nifedipine	CYP3A4	PA450631	1576	0.526
NULL	Clin_Ophthalmol_2012_Sep_5_6_1433-1440.nxml.txt.nlp	23055659	SENT153	27	27	12	12	timolol	BAK	PA451690	578	0.526
NULL	J_Young_Pharm_2010_Apr-Jun_2(2)_183-189.nxml.txt.nlp	21264123	SENT55	18	18	23	23	valsartan	API	PA451848	5345	0.526
NULL	J_Vis_Exp_2011_Jun_24_(52)_3094.nxml.txt.nlp	21730945	SENT111	36	36	41	41	isoniazid	EMB	PA450112	133418	0.526
NULL	Cancer_Causes_Control_2013_Aug_18_24(8)_1605-1614.nxml.txt.nlp	23775025	SENT64	25	25	10	10	methotrexate	CYP2B6	PA450428	1555	0.526
NULL	Korean_J_Anesthesiol_2013_Dec_26_65(6)_501-507.nxml.txt.nlp	24427455	SENT31	20	20	18	18	neostigmine	NMB	PA450611	10457;4828	0.526
NULL	Br_J_Cancer_2004_Mar_22_90(6)_1285-1292.nxml.txt.nlp	15026814	SENT118	24	24	7	7	cisplatin	p53	PA449014	7157	0.526
NULL	J_Ophthalmic_Inflamm_Infect_2011_Nov_6_2(1)_21-28.nxml.txt.nlp	22057810	SENT112	11	11	13	13	cyclosporine	CTX	PA449167	1593	0.526
NULL	Int_J_Mol_Sci_2013_Apr_26_14(5)_9111-9125.nxml.txt.nlp	23624604	SENT92	33	33	9	9	iron	TAT	PA450087	6898	0.526
NULL	Mol_Cancer_2009_Dec_23_8_129.nxml.txt.nlp	20030852	SENT199	1	1	7	7	curcumin	ABCA1	PA151958596	19	0.526
NULL	Emerg_Infect_Dis_2011_Oct_17(10)_1879-1882.nxml.txt.nlp	22000360	SENT60	30	30	0	0	ciprofloxacin	PEN	PA449009	9933	0.526
NULL	Int_J_Mol_Sci_2010_Sep_13_11(9)_3195-3208.nxml.txt.nlp	20957088	SENT35	10	10	17	17	lipase	Met	PA450239	79811	0.526
NULL	ScientificWorldJournal_2014_Mar_12_2014_731462.nxml.txt.nlp	24715817	SENT163	15	15	6	6	carrageenan	IL-6	PA448814	3569	0.526
NULL	J_Cell_Biol_2008_Jul_28_182(2)_327-340.nxml.txt.nlp	18644889	SENT244	15	15	13	13	estradiol	AKT	PA449503	207	0.526
NULL	Acta_Histochem_Cytochem_2014_Jun_28_47(3)_103-112.nxml.txt.nlp	25320407	SENT209	22	22	4	4	estradiol	SF-1	PA449503	2516	0.526
NULL	Int_J_Tryptophan_Res_2013_Aug_19_6_35-45.nxml.txt.nlp	24023520	SENT93	39	39	21	21	hydroquinone	IDO1	PA449924	3620	0.526
NULL	Indian_J_Ophthalmol_2007_Nov-Dec_55(6)_483b-486.nxml.txt.nlp	17951918	SENT10	1	1	9	9	fluorescein	PED	PA164746009	8682	0.526
NULL	Pak_J_Med_Sci_2014_Jul-Aug_30(4)_814-818.nxml.txt.nlp	25097523	SENT65	18	18	16	16	tobramycin	TOB	PA451704	10140	0.526
NULL	Diabetes_Obes_Metab_2012_Apr_14(4)_304-314.nxml.txt.nlp	22051096	SENT148	22	22	0	0	liraglutide	GLP-1	PA165958364	100125288	0.526
NULL	Clin_Ophthalmol_2011_Feb_28_5_269-274.nxml.txt.nlp	21468332	SENT59	16	16	34	34	ketorolac	BAK	PA450150	578	0.526
NULL	Breast_Cancer_Res_2010_Mar_5_12(2)_R16.nxml.txt.nlp	20205716	SENT363	20	20	13	13	lovastatin	DJ-1	PA450272	11315	0.526
NULL	Int_J_Fertil_Steril_2014_Nov_1_Oct-Dec_8(3)_243-248.nxml.txt.nlp	25379151	SENT88	15	15	29	29	piroxicam	IVF	PA450985	6331	0.526
NULL	Nat_Neurosci_2014_Jan_8_17(1)_131-143.nxml.txt.nlp	24316888	SENT311	5	5	15	15	trypsin	CO2	PA451806	4513	0.526
NULL	Cancers_(Basel)_2011_Aug_9_3(3)_3189-3205.nxml.txt.nlp	24212952	SENT88	4	4	13	13	hyaluronan	HYAL-1	PA165958431	3373	0.526
NULL	Br_J_Cancer_2012_Apr_24_106(9)_1543-1550.nxml.txt.nlp	22531721	SENT81	34	34	22	22	trastuzumab	CD46	PA451743	4179	0.526
NULL	J_Biomed_Biotechnol_2010_Oct_27_2010_948543.nxml.txt.nlp	21048930	SENT85	8	8	11	11	chlorpromazine	MDC	PA448964	6367	0.526
NULL	Cancers_(Basel)_2011_Aug_5_3(3)_3114-3142.nxml.txt.nlp	24212948	SENT949	3	3	21	21	doxorubicin	HER-2	PA449412	2064	0.526
NULL	Ann_Neurosci_2011_Jul_18(3)_118-122.nxml.txt.nlp	25205937	SENT50	1	1	20	20	gabapentin	NKCC1	PA449720	6558	0.526
NULL	J_Korean_Med_Sci_2011_Jul_20_26(7)_893-899.nxml.txt.nlp	21738342	SENT78	0	0	2	2	resveratrol	CD97		976	0.526
NULL	Mol_Biol_Int_2012_Jun_14_2012_536802.nxml.txt.nlp	22745908	SENT133	24	24	26	26	etoposide	TRAIL	PA449552	8743	0.526
NULL	Cholesterol_2013_Oct_7_2013_792090.nxml.txt.nlp	24222847	SENT266	13	13	21	21	bleomycin	PON1	PA448645	5444	0.526
NULL	Clin_Endosc_2014_Nov_30_47(6)_538-543.nxml.txt.nlp	25505720	SENT114	8	8	11	11	fentanyl	ESD	PA449599	2098	0.526
NULL	Cardiovasc_Ultrasound_2005_Jan_28_3_2.nxml.txt.nlp	15679889	SENT94	8	8	0	0	dobutamine	TDI	PA449381	100038246	0.526
NULL	Diabetes_2008_Sep_57(9)_2503-2510.nxml.txt.nlp	18544707	SENT134	4	4	16	16	troglitazone	HHEX	PA451799	3087	0.526
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Aug_11_68(Pt_9)_o2694.nxml.txt.nlp	22969586	SENT61	29	29	35	35	benzaldehyde	mol	PA448571	90527	0.526
NULL	Front_Syst_Neurosci_2014_Jun_11_8_107.nxml.txt.nlp	24999320	SENT459	2	2	4	4	methylphenidate	spatial	PA450464	219793	0.526
NULL	Front_Neurol_2013_May_1_4_10.nxml.txt.nlp	23641231	SENT176	14	14	17	17	methylprednisolone	IFN	PA450466	3439	0.526
NULL	Mediators_Inflamm_2010_Jun_21_2010_194896.nxml.txt.nlp	20652055	SENT48	33	33	27	27	telmisartan	mol	PA451605	90527	0.526
NULL	Cardiovasc_Diabetol_2013_Jan_3_12_3.nxml.txt.nlp	23286208	SENT150	30	30	3	3	glimepiride	GLP-1	PA449761	100125288	0.526
NULL	J_Cell_Biol_1984_Jan_1_98(1)_90-96.nxml.txt.nlp	6323486	SENT6	25	25	17	17	collagenase	mol	PA449107	90527	0.526
NULL	Diabetes_Care_2013_Jul_12_36(7)_2126-2132.nxml.txt.nlp	23645884	SENT184	42	42	39	39	liraglutide	GLP-1	PA165958364	100125288	0.526
NULL	Adipocyte_2013_Oct_1_2(4)_237-245.nxml.txt.nlp	24052899	SENT54	2	2	4	4	lipase	HSL	PA450239	3991	0.525
NULL	Autoimmunity_2011_Feb_23_45(1)_7-35.nxml.txt.nlp	21939410	SENT443	0	0	15	15	sirolimus	IL-2	PA451365	3558	0.525
NULL	Semin_Immunopathol_2012_Jan_4_34(1)_93-106.nxml.txt.nlp	21845431	SENT250	0	0	26	26	thrombin	ADAMTS18	PA451674	170692	0.525
NULL	DNA_Res_2013_Aug_18_20(4)_339-354.nxml.txt.nlp	23599422	SENT571	5	5	10	10	choline	bet	PA448976	92737	0.525
NULL	Oncol_Lett_2014_Mar_16_7(3)_827-833.nxml.txt.nlp	24527090	SENT142	16	16	13	13	cisplatin	IFN	PA449014	3439	0.525
NULL	Trials_2014_Feb_19_15_63.nxml.txt.nlp	24552184	SENT1	2	2	0	0	paclitaxel	PACT	PA450761	8575;5930	0.525
NULL	Physiol_Rep_2014_Nov_4_2(11)_e12193.nxml.txt.nlp	25367694	SENT71	30	30	21	21	gentamicin	FBS	PA449753	64319;26269	0.525
NULL	Med_Sci_Monit_2013_Dec_23_19_1195-1210.nxml.txt.nlp	24362017	SENT422	14	14	11	11	vasopressin	AVP	PA451858	114548;551	0.525
NULL	Indian_J_Crit_Care_Med_2012_Jul-Sep_16(3)_136-140.nxml.txt.nlp	23188953	SENT74	11	11	9	9	cefotaxime	CTX	PA448852	1593	0.525
NULL	J_Breast_Cancer_2011_Dec_27_14(4)_283-288.nxml.txt.nlp	22323914	SENT130	14	14	0	0	doxorubicin	BCS	PA449412	617	0.525
NULL	Oncotarget_2010_Nov_28_1(7)_651-661.nxml.txt.nlp	21317460	SENT39	17	17	38	38	urokinase	CD44	PA451836	960	0.525
NULL	Toxins_(Basel)_2010_Oct_26_2(11)_2490-2518.nxml.txt.nlp	22069563	SENT1619	4	4	2	2	cisplatin	IL-10	PA449014	3586	0.525
NULL	J_Cell_Mol_Med_2014_Dec_7_18(12)_2536-2552.nxml.txt.nlp	25287328	SENT307	30	30	0	0	estradiol	PKD1	PA449503	5310	0.525
NULL	Open_Biochem_J_2013_Apr_19_7_44-53.nxml.txt.nlp	23730364	SENT246	32	32	16	16	resveratrol	CTRL		1506	0.525
NULL	Clin_Pediatr_Endocrinol_2009_May_1_18(2)_65-72.nxml.txt.nlp	24790382	SENT25	0	0	5	5	cabergoline	PRL	PA448708	5617	0.525
NULL	CNS_Drugs_2014_Jul_20_28(11)_1059-1069.nxml.txt.nlp	25038977	SENT107	13	13	9	9	lisdexamfetamine	ATX	PA164748975	5168;23049	0.525
NULL	Mol_Cancer_2009_Dec_23_8_129.nxml.txt.nlp	20030852	SENT183	5	5	7	7	curcumin	ABCA1	PA151958596	19	0.525
NULL	Drugs_2014_Jun_25_74(10)_1063-1072.nxml.txt.nlp	24962424	SENT70	20	20	3	3	pyrazinamide	EMB	PA451182	133418	0.525
NULL	Arch_Osteoporos_2013_Oct_11_8(1-2)_136.nxml.txt.nlp	24113837	SENT2910	7	7	18	18	alendronate	PTH	PA448082	5741	0.525
NULL	J_Cell_Mol_Med_2014_Dec_22_18(12)_2519-2529.nxml.txt.nlp	25338520	SENT138	24	24	15	15	oxygen	TNF	PA450744	7124	0.525
NULL	Front_Endocrinol_(Lausanne)_2014_Feb_25_5_22.nxml.txt.nlp	24611062	SENT355	18	18	13	13	fasudil	Rho	PA165946121	29984	0.525
NULL	Curr_Neuropharmacol_2013_Mar_11(2)_129-140.nxml.txt.nlp	23997749	SENT452	13	13	26	26	mannitol	San	PA450320	80218	0.525
NULL	Cancers_(Basel)_2011_Oct_21_3(4)_3921-3956.nxml.txt.nlp	24213118	SENT964	6	6	0	0	bortezomib	p38	PA10252	10598;1432;7965	0.525
NULL	Cancer_Med_2014_Oct_5_3(5)_1458-1466.nxml.txt.nlp	25091592	SENT99	47	47	13	13	metformin	Men	PA450395	8178	0.525
NULL	Toxins_(Basel)_2010_Oct_26_2(11)_2490-2518.nxml.txt.nlp	22069563	SENT249	22	22	12	12	clodronate	CX3CL1	PA10239	6376	0.525
NULL	J_Hematol_Oncol_2014_Aug_1_7_52.nxml.txt.nlp	25085632	SENT171	3	3	7	7	sunitinib	AKT	PA162372840	207	0.525
NULL	Front_Neurosci_2014_Jun_3_8_128.nxml.txt.nlp	24917782	SENT134	11	11	20	20	ethanol	MC3R	PA448073	4159	0.525
NULL	Front_Mol_Neurosci_2012_Nov_12_5_99.nxml.txt.nlp	23162427	SENT908	3	3	12	12	morphine	A10	PA450550	28870	0.525
NULL	Bone_Marrow_Transplant_2011_Jul_11_46(7)_943-949.nxml.txt.nlp	20935680	SENT105	5	5	14	14	plerixafor	CXCR4	PA165958410	7852	0.525
NULL	J_Biol_Eng_2014_May_1_8_10.nxml.txt.nlp	25061479	SENT195	19	19	9	9	doxycycline	CO2	PA449415	4513	0.525
NULL	J_Vet_Med_Sci_2014_Feb_21_76(2)_219-227.nxml.txt.nlp	24141321	SENT113	5	5	17	17	ns-398	SON		6651	0.525
NULL	Case_Rep_Endocrinol_2012_Aug_15_2012_826901.nxml.txt.nlp	22934202	SENT102	6	6	2	2	chlorpromazine	PRL	PA448964	5617	0.525
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT96	12	12	16	16	perifosine	TRAIL	PA165291471	8743	0.525
NULL	Nat_Commun_2011_Jun_7_2_336.nxml.txt.nlp	21654636	SENT173	6	6	10	10	phenol	F12	PA450913	2161	0.525
NULL	Arthritis_Res_Ther_2012_May_1_14(3)_R99.nxml.txt.nlp	22546542	SENT234	7	7	15	15	infliximab	IL-17	PA452639	3605	0.525
NULL	Oncotarget_2013_Dec_4_5(4)_944-958.nxml.txt.nlp	24659709	SENT10	27	27	7	7	cisplatin	JAG1	PA449014	182	0.525
NULL	Cardiovasc_Ultrasound_2010_Nov_28_8_52.nxml.txt.nlp	21110895	SENT107	3	3	11	11	protamine	CFD	PA10366	1675	0.525
NULL	Acta_Neuropathol_2012_Jul_7_124(1)_99-110.nxml.txt.nlp	22311740	SENT56	11	11	32	32	ethanol	CD31	PA448073	5175	0.525
NULL	J_Hematol_Oncol_2012_Apr_30_5_17.nxml.txt.nlp	22546217	SENT97	5	5	23	23	l-arginine	PC-3	PA448478	692094	0.525
NULL	J_Oncol_2009_Mar_24_2009_491985.nxml.txt.nlp	19325924	SENT180	24	24	5	5	genistein	CXCR4	PA165109660	7852	0.525
NULL	Oncotarget_2012_Dec_18_3(12)_1615-1628.nxml.txt.nlp	23271044	SENT55	19	19	8	8	temsirolimus	CTRL	PA164746890	1506	0.525
NULL	CNS_Drugs_2013_Aug_20_27(12)_1081-1092.nxml.txt.nlp	23959815	SENT191	12	12	0	0	lisdexamfetamine	ATX	PA164748975	5168;23049	0.525
NULL	Mar_Drugs_2011_Nov_28_9(12)_2488-2498.nxml.txt.nlp	22363235	SENT26	11	11	8	8	glucosamine	NAG	PA164747613	51594;4669	0.525
NULL	Appl_Clin_Genet_2013_Oct_18_6_91-101.nxml.txt.nlp	24159262	SENT18	15	15	10	10	thrombin	VIII	PA451674	1351	0.525
NULL	Cancer_Med_2013_Dec_31_2(6)_826-835.nxml.txt.nlp	24403256	SENT203	0	0	2	2	daunorubicin	p53	PA449212	7157	0.525
NULL	Mediators_Inflamm_2010_Jun_28_2010_174341.nxml.txt.nlp	20652043	SENT131	8	8	2	2	thrombin	IL-6	PA451674	3569	0.525
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Apr_30_65(Pt_5)_o1161.nxml.txt.nlp	21583964	SENT59	37	37	18	18	ethanol	mol	PA448073	90527	0.525
NULL	Biologics_2009_Sep_15_3_377-383.nxml.txt.nlp	19774205	SENT216	9	9	13	13	amantadine	Yes	PA448360	7525	0.525
NULL	Drug_Des_Devel_Ther_2014_Sep_23_8_1527-1538.nxml.txt.nlp	25284985	SENT203	2	2	0	0	celecoxib	IFN	PA448871	3439	0.525
NULL	Exp_Hematol_Oncol_2012_Apr_26_1_11.nxml.txt.nlp	23210562	SENT78	19	19	25	25	ethanol	IFN	PA448073	3439	0.525
NULL	J_Invest_Dermatol_2012_May_16_132(5)_1435-1442.nxml.txt.nlp	22336948	SENT223	0	0	15	15	doxycycline	TLSP	PA449415	11012	0.525
NULL	Nucleic_Acids_Res_2007_Jan_7_35(2)_e9.nxml.txt.nlp	17158148	SENT106	8	8	4	4	neomycin	RAD18	PA450608	56852	0.525
NULL	J_Cardiothorac_Surg_2011_Apr_8_6_44.nxml.txt.nlp	21477293	SENT14	19	19	12	12	thrombin	PF4	PA451674	5196	0.525
NULL	Br_J_Cancer_2011_Aug_9_105(4)_469-474.nxml.txt.nlp	21712825	SENT87	30	30	1	1	doxorubicin	MX2	PA449412	4600	0.525
NULL	Br_J_Cancer_2009_Mar_10_100(5)_758-763.nxml.txt.nlp	19259094	SENT79	0	0	7	7	belinostat	MLH1		4292	0.525
NULL	Cell_Commun_Signal_2011_May_15_9_13.nxml.txt.nlp	21569639	SENT3	3	3	15	15	quinacrine	AKT	PA164745551	207	0.525
NULL	J_Clin_Biochem_Nutr_2007_Jul_27_41(1)_32-42.nxml.txt.nlp	18392098	SENT10	0	0	6	6	curcumin	ROS	PA151958596	6098	0.525
NULL	Mol_Pain_2012_Sep_22_8_71.nxml.txt.nlp	22998838	SENT120	9	9	5	5	paclitaxel	CXCR4	PA450761	7852	0.525
NULL	Exp_Ther_Med_2013_Nov_10_6(5)_1163-1168.nxml.txt.nlp	24223639	SENT181	33	33	28	28	thrombin	HO-1	PA451674	3162	0.525
NULL	J_Biomed_Biotechnol_2006_May_28_2006_82323.nxml.txt.nlp	17047315	SENT57	20	20	14	14	iron	ROS	PA450087	6098	0.525
NULL	Indian_J_Pharm_Sci_2014_Mar-Apr_76(2)_125-131.nxml.txt.nlp	24843185	SENT172	4	4	6	6	resveratrol	spatial		219793	0.525
NULL	Ann_Rheum_Dis_2014_Jun_30_73(6)_990-999.nxml.txt.nlp	24482301	SENT117	37	37	0	0	ustekinumab	ACR	PA166048654	49	0.525
NULL	Int_J_Mol_Sci_2014_Nov_25_15(12)_21703-21722.nxml.txt.nlp	25429431	SENT139	19	19	23	23	mitoxantrone	MXR	PA450526	9429	0.525
NULL	Environ_Health_Perspect_2009_Feb_8_117(2)_175-180.nxml.txt.nlp	19270784	SENT136	2	2	0	0	doxorubicin	BPA	PA449412	667	0.525
NULL	Diabetes_2011_Nov_17_60(11)_2691-2700.nxml.txt.nlp	21896928	SENT262	3	3	9	9	resveratrol	AMPK		5563	0.525
NULL	Acta_Histochem_Cytochem_2012_Oct_31_45(5)_251-259.nxml.txt.nlp	23209334	SENT9	4	4	18	18	pilocarpine	AQP5	PA450962	362	0.525
NULL	Br_J_Cancer_2009_Jun_2_100(11)_1739-1745.nxml.txt.nlp	19436299	SENT187	39	39	28	28	everolimus	FDG	PA164746311	23583	0.525
NULL	Front_Psychiatry_2014_Jun_13_5_67.nxml.txt.nlp	24982640	SENT318	34	34	19	19	ethanol	gamma	PA448073	9913	0.525
NULL	Int_J_Biol_Sci_2014_Sep_13_10(9)_1064-1071.nxml.txt.nlp	25285038	SENT60	20	20	27	27	trypsin	CO2	PA451806	4513	0.525
NULL	Front_Neurol_2013_Jun_25_4_78.nxml.txt.nlp	23805124	SENT78	4	4	18	18	phenytoin	spatial	PA450947	219793	0.525
NULL	Patient_Prefer_Adherence_2008_Feb_2_2_387-392.nxml.txt.nlp	19920986	SENT110	23	23	13	13	azathioprine	TPMT	PA448515	7172	0.525
NULL	Ann_Oncol_2012_Dec_2_23(12)_3007-3016.nxml.txt.nlp	22865781	SENT45	1	1	36	36	trastuzumab	HER2	PA451743	2064	0.525
NULL	Cancers_(Basel)_2011_Oct_26_3(4)_4024-4045.nxml.txt.nlp	24213123	SENT115	27	27	25	25	curcumin	mol	PA151958596	90527	0.525
NULL	Biomed_Res_Int_2014_Jun_26_2014_161346.nxml.txt.nlp	25054130	SENT216	11	11	21	21	curcumin	STZ	PA151958596	6484	0.525
NULL	Infect_Dis_Ther_2013_Dec_3_2(2)_111-122.nxml.txt.nlp	25134475	SENT96	30	30	0	0	ritonavir	ATV	PA451260	4683	0.525
NULL	Afr_J_Infect_Dis_2011_5(2)_40-46.nxml.txt.nlp	23878706	SENT98	10	10	8	8	gentamicin	Gen	PA449753	348654	0.525
NULL	Ann_Indian_Acad_Neurol_2008_Jul-Sep_11(3)_170-178.nxml.txt.nlp	19893664	SENT99	3	3	1	1	dextran	mol	PA449261	90527	0.525
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT28	17	17	20	20	gefitinib	KRAS	PA131301952	3845	0.525
NULL	Mol_Biol_Cell_2012_Jun_1_23(11)_2017-2027.nxml.txt.nlp	22496424	SENT108	20	20	11	11	warfarin	PRDX4	PA451906	10549	0.525
NULL	Cases_J_2009_Mar_10_2_6464.nxml.txt.nlp	20181162	SENT51	14	14	12	12	ribavirin	IFN	PA451241	3439	0.525
NULL	J_Adv_Pract_Oncol_2013_Sep_1_Sep-Oct_4(5)_307-321.nxml.txt.nlp	25032010	SENT49	19	19	40	40	melphalan	San	PA450354	80218	0.525
NULL	Biol_Open_2014_Nov_21_3(12)_1207-1216.nxml.txt.nlp	25416063	SENT258	8	8	12	12	zinc	NANOS2	PA451956	339345	0.525
NULL	Vet_Res_Forum_2014_Autumn_5(4)_287-293.nxml.txt.nlp	25610580	SENT51	28	28	24	24	choline	B12	PA448976	7126;4709	0.525
NULL	Biomed_Res_Int_2013_Jan_21_2013_581631.nxml.txt.nlp	23484133	SENT81	10	10	22	22	infliximab	GM-CSF	PA452639	1437	0.525
NULL	J_Biomed_Sci_2014_Feb_3_21(1)_10.nxml.txt.nlp	24490900	SENT150	20	20	22	22	alendronate	RANKL	PA448082	8600	0.525
NULL	J_Cell_Biol_2001_Oct_29_155(3)_447-458.nxml.txt.nlp	11684709	SENT9	7	7	5	5	pp2	PP1		5540;5464	0.525
NULL	J_Hematol_Oncol_2009_Oct_27_2_45.nxml.txt.nlp	19860903	SENT114	22	22	17	17	temsirolimus	IFN	PA164746890	3439	0.525
NULL	Neuro_Oncol_2011_Jan_25_13(1)_70-83.nxml.txt.nlp	20978004	SENT259	26	26	32	32	etoposide	ABCC1	PA449552	4363	0.525
NULL	Biosci_Rep_2012_Dec_20_33(1)_e00011.nxml.txt.nlp	23137297	SENT323	13	13	4	4	heparin	RPSA	PA449855	3921	0.525
NULL	Emerg_Infect_Dis_2007_Feb_13(2)_255-258.nxml.txt.nlp	17479888	SENT77	11	11	1	1	erythromycin	PEN	PA449493	9933	0.525
NULL	Ann_Rheum_Dis_2008_Sep_11_68(7)_1146-1152.nxml.txt.nlp	18794178	SENT160	20	20	13	13	sulfasalazine	ACR	PA451547	49	0.525
NULL	Cancer_Inform_2013_Feb_13_12_31-51.nxml.txt.nlp	23470717	SENT335	11	11	2	2	epirubicin	p38	PA449476	10598;1432;7965	0.525
NULL	Int_J_Biol_Sci_2012_Feb_9_8(3)_310-327.nxml.txt.nlp	22355267	SENT173	33	33	12	12	simvastatin	PCSK9	PA451363	255738	0.525
NULL	Oncotarget_2014_Feb_8_5(6)_1609-1620.nxml.txt.nlp	24742492	SENT56	15	15	6	6	tetracycline	CST6	PA451640	1476;1474	0.525
NULL	Acta_Pharmacol_Sin_2010_Jul_28_31(7)_775-783.nxml.txt.nlp	20581849	SENT244	12	12	0	0	imipramine	NHC	PA449969	10473	0.525
NULL	Bioinformation_2013_Jul_12_9(12)_633-638.nxml.txt.nlp	23904741	SENT92	25	25	16	16	genistein	TWEAK	PA165109660	8742	0.525
NULL	Brain_Sci_2013_Apr_29_3(2)_704-727.nxml.txt.nlp	24027632	SENT246	21	21	6	6	ethanol	spatial	PA448073	219793	0.525
NULL	J_Addict_2013_Dec_17_2013_461029.nxml.txt.nlp	23951549	SENT65	20	20	40	40	phencyclidine	San	PA128406980	80218	0.525
NULL	Crit_Care_2011_Nov_16_15(6)_R271.nxml.txt.nlp	22087790	SENT164	2	2	11	11	nitroprusside	Yes	PA451406	7525	0.525
NULL	EMBO_Mol_Med_2013_Aug_5_5(8)_1213-1226.nxml.txt.nlp	23918228	SENT209	12	12	19	19	cetuximab	EGFR	PA10040	1956	0.525
NULL	Anal_Chem_2014_Feb_18_86(4)_1988-1996.nxml.txt.nlp	24446580	SENT180	22	22	31	31	ethanol	PPG	PA448073	5552	0.525
NULL	EJC_Suppl_2013_Sep_5_11(2)_45-59.nxml.txt.nlp	NULL	SENT9	11	11	20	20	oxaliplatin	CRT	PA131285527	811	0.525
NULL	Nucleic_Acids_Res_2010_Oct_28_38(19)_6418-6432.nxml.txt.nlp	20511593	SENT177	17	17	31	31	collagenase	AP-1	PA449107	2353;3727;2354;3725	0.525
NULL	Cancer_Causes_Control_2013_Aug_18_24(8)_1605-1614.nxml.txt.nlp	23775025	SENT64	25	25	14	14	methotrexate	CYP2D6	PA450428	1565	0.525
NULL	Cardiovasc_Diabetol_2013_Jun_8_12_86.nxml.txt.nlp	23758640	SENT61	9	9	17	17	nitrogen	CRP	PA450643	1401;140913	0.525
NULL	Int_J_Biol_Sci_2014_Jun_10_10(7)_654-663.nxml.txt.nlp	25013375	SENT115	6	6	10	10	nelfinavir	HER2	PA450606	2064	0.525
NULL	J_Cell_Mol_Med_2014_Mar_22_18(3)_480-491.nxml.txt.nlp	24450440	SENT62	17	17	9	9	axitinib	EDD	PA164924493	51366	0.525
NULL	Indian_J_Pharmacol_2014_Jul-Aug_46(4)_453-454.nxml.txt.nlp	25097292	SENT1	26	26	8	8	olanzapine	BPAD	PA450688	4095	0.525
NULL	Sci_Rep_2015_Jan_22_5_7947.nxml.txt.nlp	25609312	SENT162	18	18	27	27	l-glutamine	CO2	PA10090	4513	0.525
NULL	Front_Hum_Neurosci_2013_Apr_8_7_117.nxml.txt.nlp	23580360	SENT166	34	34	10	10	sulpiride	ANOVA	PA164745485	4858	0.525
NULL	J_Korean_Med_Sci_2004_Apr_30_19(2)_167-171.nxml.txt.nlp	15082886	SENT118	15	15	0	0	levofloxacin	PTH	PA450214	5741	0.525
NULL	Eur_J_Clin_Pharmacol_2010_Nov_29_66(11)_1131-1136.nxml.txt.nlp	20669013	SENT21	0	0	24	24	voriconazole	CYP2C9	PA10233	1559	0.525
NULL	Nat_Neurosci_2012_Sep_5_15(9)_1245-1254.nxml.txt.nlp	22864611	SENT168	14	14	27	27	clozapine	mGlu3	PA449061	2913	0.525
NULL	Cancer_Manag_Res_2012_Nov_9_4_383-395.nxml.txt.nlp	23204869	SENT123	42	42	33	33	carmustine	PC-3	PA448810	692094	0.525
NULL	J_Gen_Physiol_2003_Nov_122(5)_621-639.nxml.txt.nlp	14581586	SENT46	22	22	7	7	l-glutamine	CO2	PA10090	4513	0.525
NULL	Arthritis_Res_Ther_2003_Jan_14_5(2)_54-67.nxml.txt.nlp	12718745	SENT383	23	23	0	0	methylprednisolone	ACL	PA450466	47	0.525
NULL	Arch_Microbiol_2013_Jun_10_195(6)_439-445.nxml.txt.nlp	23661196	SENT116	17	17	32	32	ethanol	CO2	PA448073	4513	0.525
NULL	Cell_Biochem_Biophys_2013_May_28_67(1)_25-43.nxml.txt.nlp	23712866	SENT146	19	19	8	8	doxorubicin	USP4	PA449412	7375	0.525
NULL	Pharmaceutics_2011_Feb_7_3(1)_53-72.nxml.txt.nlp	24310425	SENT856	23	23	1	1	diazepam	CYP1A2	PA449283	1544	0.525
NULL	Biomed_Res_Int_2014_Apr_29_2014_186864.nxml.txt.nlp	24877064	SENT175	6	6	8	8	curcumin	IFN	PA151958596	3439	0.525
NULL	J_Cell_Biol_2000_Feb_21_148(4)_811-824.nxml.txt.nlp	10684261	SENT931	27	27	23	23	thrombin	EGF	PA451674	1950	0.525
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jun_20_65(Pt_7)_o1647.nxml.txt.nlp	21582911	SENT51	11	11	15	15	risperidone	NO3	PA451257	4681	0.525
NULL	Nat_Commun_2014_Jun_20_5_4122.nxml.txt.nlp	24947823	SENT389	2	2	6	6	capsaicin	TRPV1	PA448776	7442	0.525
NULL	Turk_J_Haematol_2012_Dec_5_29(4)_413-419.nxml.txt.nlp	24385732	SENT55	11	11	8	8	cyclophosphamide	CHOP	PA449165	1649	0.525
NULL	Int_J_Biol_Sci_2011_Sep_8_7(8)_1077-1092.nxml.txt.nlp	21927577	SENT19	0	0	11	11	telmisartan	p47phox	PA451605	653361	0.525
NULL	Mol_Cancer_2007_Aug_21_6_53.nxml.txt.nlp	17711579	SENT262	7	7	20	20	cisplatin	SPAG17	PA449014	200162	0.525
NULL	Biomed_Res_Int_2014_Apr_10_2014_580852.nxml.txt.nlp	24812624	SENT44	0	0	2	2	resveratrol	PTEN		5728	0.525
NULL	Cancer_Biol_Med_2012_Dec_9(4)_261-265.nxml.txt.nlp	23691487	SENT38	21	21	12	12	streptomycin	FBS	PA451512	64319;26269	0.525
NULL	Br_J_Cancer_2011_Apr_12_104(8)_1256-1261.nxml.txt.nlp	21448165	SENT25	7	7	9	9	sorafenib	IFN	PA7000	3439	0.525
NULL	Oncoimmunology_2013_Feb_1_2(2)_e23079.nxml.txt.nlp	23525192	SENT35	6	6	0	0	imatinib	IL-2	PA10804	3558	0.525
NULL	Patient_Prefer_Adherence_2008_Feb_2_2_149-155.nxml.txt.nlp	19920956	SENT75	3	3	0	0	tadalafil	Men	PA10333	8178	0.525
NULL	Exp_Ther_Med_2012_Sep_12_4(3)_475-480.nxml.txt.nlp	23181121	SENT156	12	12	16	16	rituximab	CHOP	PA451261	1649	0.525
NULL	Int_J_Biol_Sci_2012_Sep_14_8(8)_1142-1155.nxml.txt.nlp	23091412	SENT91	33	33	23	23	trypsin	cadherin	PA451806	1015	0.525
NULL	Int_J_Anal_Chem_2014_Nov_18_2014_536823.nxml.txt.nlp	25484901	SENT140	21	21	23	23	glutaraldehyde	DTNB	PA449777	1838	0.525
NULL	Biotechnol_Res_Int_2014_Jun_9_2014_674286.nxml.txt.nlp	25009746	SENT250	4	4	17	17	neomycin	X11	PA450608	320	0.525
NULL	Indian_J_Pharm_Sci_2013_Sep-Oct_75(5)_523-532.nxml.txt.nlp	24403652	SENT198	7	7	20	20	atorvastatin	AD3	PA448500	11138	0.525
NULL	Cancer_Cell_Int_2008_Apr_29_8_4.nxml.txt.nlp	18442416	SENT182	0	0	4	4	trypsin	Ku86	PA451806	7520	0.525
NULL	Clin_Med_Insights_Oncol_2013_Jul_28_7_165-172.nxml.txt.nlp	23926442	SENT43	29	29	23	23	fluorescein	CD56	PA164746009	4684	0.525
NULL	Indian_J_Med_Res_2014_May_139(5)_762-768.nxml.txt.nlp	25027087	SENT151	5	5	8	8	heparin	DC-SIGN	PA449855	30835	0.525
NULL	J_Exp_Med_1995_Dec_1_182(6)_1683-1693.nxml.txt.nlp	7500013	SENT1	6	6	22	22	l-tryptophan	IFN	PA10323	3439	0.525
NULL	Epilepsia_2011_Mar_26_52(3)_531-540.nxml.txt.nlp	21269296	SENT143	14	14	4	4	nifedipine	spatial	PA450631	219793	0.525
NULL	Nat_Commun_2013_Sep_11_4_2416.nxml.txt.nlp	24022506	SENT150	7	7	11	11	phenol	F12	PA450913	2161	0.525
NULL	JAKSTAT_2012_Jan_1_1(1)_44-54.nxml.txt.nlp	24058750	SENT47	28	28	33	33	l-glutamine	EGF	PA10090	1950	0.525
NULL	Amyloid_2014_Sep_11_21(3)_175-184.nxml.txt.nlp	24918964	SENT136	5	5	17	17	anakinra	p65	PA10799	5970	0.525
NULL	Clin_Med_Oncol_2008_Jul_8_2_471-475.nxml.txt.nlp	21892320	SENT47	24	24	22	22	thalidomide	GM-CSF	PA451644	1437	0.525
NULL	Pharmaceutics_2011_Feb_7_3(1)_53-72.nxml.txt.nlp	24310425	SENT856	23	23	28	28	diazepam	CYP3A	PA449283	1574	0.525
NULL	Toxins_(Basel)_2010_Oct_26_2(11)_2490-2518.nxml.txt.nlp	22069563	SENT249	22	22	9	9	clodronate	CX3CL1	PA10239	6376	0.525
NULL	Br_J_Cancer_2012_Oct_23_107(9)_1488-1497.nxml.txt.nlp	23033007	SENT175	0	0	3	3	disulfiram	c-Jun	PA449376	3725	0.525
NULL	Ann_Gen_Psychiatry_2007_Jan_29_6_3.nxml.txt.nlp	17261186	SENT212	3	3	5	5	fluphenazine	Gen	PA449676	348654	0.525
NULL	Emerg_Infect_Dis_2014_Jan_20(1)_142-145.nxml.txt.nlp	24378072	SENT21	24	24	37	37	imiquimod	CO2	PA449972	4513	0.525
NULL	Cardiovasc_Diabetol_2007_Aug_15_6_20.nxml.txt.nlp	17697384	SENT29	8	8	0	0	rosiglitazone	DREAM	PA451283	30818	0.525
NULL	Cell_Tissue_Res_2014_Apr_26_357(1)_253-266.nxml.txt.nlp	24770893	SENT178	21	21	17	17	staurosporine	CXCL12	PA165109623	6387	0.525
NULL	Breast_Cancer_Res_2013_Sep_25_15(5)_R88.nxml.txt.nlp	24063698	SENT177	16	16	32	32	olaparib	SOC		91544	0.524
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Jun_27_5_15.nxml.txt.nlp	16803618	SENT161	38	38	42	42	gentamicin	GEN1	PA449753	348654	0.524
NULL	J_Cell_Sci_2011_Mar_15_124(6)_921-932.nxml.txt.nlp	21378310	SENT151	6	6	31	31	chloroquine	RNF41	PA448948	10193	0.524
NULL	Exp_Ther_Med_2014_Feb_4_7(2)_478-482.nxml.txt.nlp	24396429	SENT117	12	12	19	19	glucose	HO-1	PA449773	3162	0.524
NULL	Cancer_Metastasis_Rev_2010_Dec_10_29(4)_581-594.nxml.txt.nlp	20830503	SENT103	3	3	42	42	tamoxifen	TTR	PA451581	7276	0.524
NULL	Front_Synaptic_Neurosci_2010_Jul_12_2_24.nxml.txt.nlp	21423510	SENT1221	0	0	8	8	phenytoin	CA3	PA450947	761	0.524
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2012_Aug_1_68(Pt_8)_975-984.nxml.txt.nlp	22868763	SENT419	18	18	6	6	trypsin	BEST	PA451806	7439	0.524
NULL	Crit_Care_2011_Nov_30_15(6)_R289.nxml.txt.nlp	22129171	SENT161	0	0	4	4	dipyridamole	IL-10	PA449367	3586	0.524
NULL	Adv_Ther_2014_Dec_2_31_1228-1246.nxml.txt.nlp	25447269	SENT140	4	4	40	40	tafluprost	TIM	PA165958432	7984;8914	0.524
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT23	2	2	11	11	imatinib	CML	PA10804	613	0.524
NULL	Mol_Cancer_2013_Sep_11_12_104.nxml.txt.nlp	24025152	SENT49	4	4	2	2	gemcitabine	STAT3	PA449748	6774	0.524
NULL	Acta_Pharmacol_Sin_2014_Sep_25_35(9)_1199-1206.nxml.txt.nlp	25152024	SENT136	20	20	23	23	cisplatin	mig-2	PA449014	10979	0.524
NULL	Acta_Pharmacol_Sin_2011_Oct_5_32(10)_1276-1284.nxml.txt.nlp	21970838	SENT35	0	0	2	2	ketoconazole	KET	PA450146	8626	0.524
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT364	20	20	18	18	pp2	PP1		5540;5464	0.524
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT557	8	8	16	16	reserpine	PRL	PA451236	5617	0.524
NULL	Child_Adolesc_Psychiatry_Ment_Health_2013_Aug_15_7_31.nxml.txt.nlp	23947389	SENT86	9	9	20	20	aripiprazole	IMPACT	PA10026	55364	0.524
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT7	0	0	10	10	metformin	HIF-1	PA450395	29072	0.524
NULL	Breast_Cancer_Res_2012_Apr_24_14(2)_R67.nxml.txt.nlp	22531600	SENT370	2	2	5	5	fluorescein	NG2	PA164746009	1464;6048	0.524
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT52	7	7	10	10	bromocriptine	PRL	PA448671	5617	0.524
NULL	Front_Oncol_2014_Apr_9_4_75.nxml.txt.nlp	24782986	SENT185	22	22	3	3	paclitaxel	CD117	PA450761	3815	0.524
NULL	Curr_Oncol_2009_Jul_16(Suppl_2)_S14-S23.nxml.txt.nlp	19672417	SENT219	4	4	0	0	tamoxifen	ATAC	PA451581	6375	0.524
NULL	Pharmaceuticals_(Basel)_2011_Oct_25_4(11)_1400-1422.nxml.txt.nlp	NULL	SENT1168	11	11	8	8	hydroquinone	NQO1	PA449924	1728	0.524
NULL	Exp_Ther_Med_2014_Sep_1_8(3)_881-886.nxml.txt.nlp	25120618	SENT45	10	10	21	21	paraformaldehyde	ZO-1	PA450790	7082	0.524
NULL	AIDS_Res_Treat_2012_Mar_5_2012_703604.nxml.txt.nlp	22500218	SENT112	32	32	14	14	artesunate	CYP3A4	PA165111697	1576	0.524
NULL	Front_Oncol_2014_Mar_3_4_41.nxml.txt.nlp	24624364	SENT601	47	47	23	23	curcumin	ABCB1	PA151958596	5243	0.524
NULL	Arthritis_Res_Ther_2009_Jan_30_11(1)_206.nxml.txt.nlp	19232066	SENT308	3	3	0	0	ustekinumab	IL-23	PA166048654	51561	0.524
NULL	Environ_Health_Perspect_2010_Sep_28_118(9)_1267-1272.nxml.txt.nlp	20427257	SENT230	5	5	7	7	estradiol	BPA	PA449503	667	0.524
NULL	Cardiovasc_Diabetol_2013_Jun_8_12_86.nxml.txt.nlp	23758640	SENT135	25	25	17	17	glucose	CRP	PA449773	1401;140913	0.524
NULL	Apoptosis_2014_Aug_26_19(11)_1603-1615.nxml.txt.nlp	25156145	SENT278	2	2	0	0	mitomycin	TRAIL	PA450524	8743	0.524
NULL	J_Korean_Med_Sci_2013_Sep_28_28(9)_1307-1315.nxml.txt.nlp	24015035	SENT161	24	24	5	5	creatine	TFI	PA164778930	7035	0.524
NULL	Arch_Med_Sci_2011_Feb_8_7(1)_154-160.nxml.txt.nlp	22291749	SENT189	29	29	20	20	chlorhexidine	S15	PA164776863	6209	0.524
NULL	Int_Cardiovasc_Res_J_2014_Sep_1_8(3)_89-93.nxml.txt.nlp	25177670	SENT86	13	13	6	6	enalapril	IL-6	PA449456	3569	0.524
NULL	Exp_Ther_Med_2014_Apr_13_7(4)_923-928.nxml.txt.nlp	24669252	SENT173	9	9	3	3	resveratrol	ADP		23038	0.524
NULL	Nat_Neurosci_2012_Sep_5_15(9)_1245-1254.nxml.txt.nlp	22864611	SENT98	0	0	2	2	clozapine	HDAC2	PA449061	3066	0.524
NULL	CNS_Drugs_2014_Feb_7_28(3)_185-193.nxml.txt.nlp	24504829	SENT25	9	9	0	0	choline	ADP	PA448976	23038	0.524
NULL	Br_J_Cancer_2013_Jan_15_108(1)_82-90.nxml.txt.nlp	23321512	SENT157	16	16	10	10	paclitaxel	TUBB3	PA450761	10381	0.524
NULL	Br_J_Cancer_2011_Jun_7_104(12)_1941-1944.nxml.txt.nlp	NULL	SENT25	27	27	18	18	vinorelbine	VEGF-A	PA451881	7422	0.524
NULL	Aging_(Albany_NY)_2012_Dec_6_4(11)_823-842.nxml.txt.nlp	23235539	SENT180	44	44	17	17	bleomycin	HCA2	PA448645	139081;55811;338442	0.524
NULL	Ann_Hematol_2014_Mar_18_93(8)_1335-1344.nxml.txt.nlp	24638841	SENT107	30	30	6	6	rituximab	CLB	PA451261	171425	0.524
NULL	Eur_J_Endocrinol_2011_Jan_164(1)_69-74.nxml.txt.nlp	20961967	SENT106	3	3	5	5	pioglitazone	OPG	PA450970	690	0.524
NULL	J_Invest_Dermatol_2012_Apr_22_132(4)_1253-1262.nxml.txt.nlp	22189789	SENT282	3	3	5	5	capsaicin	TRPV1	PA448776	7442	0.524
NULL	Clin_Ophthalmol_2014_Jan_13_8_219-228.nxml.txt.nlp	24531757	SENT141	18	18	4	4	brinzolamide	TIM	PA164744929	7984;8914	0.524
NULL	Clin_Drug_Investig_2013_Jun_20_33(6)_419-427.nxml.txt.nlp	23605507	SENT161	1	1	15	15	ciprofloxacin	DPI	PA449009	1832	0.524
NULL	Breast_Cancer_(Auckl)_2011_Jul_27_5_175-199.nxml.txt.nlp	21863131	SENT365	25	25	13	13	fluorouracil	HER2	PA128406956	2064	0.524
NULL	Exp_Diabetes_Res_2012_Nov_12_2012_618923.nxml.txt.nlp	23197974	SENT31	17	17	29	29	telmisartan	STZ	PA451605	6484	0.524
NULL	Biosci_Rep_2013_Oct_16_33(5)_e00073.nxml.txt.nlp	24050266	SENT220	27	27	9	9	doxorubicin	Bcl-2	PA449412	596	0.524
NULL	Mol_Cancer_2013_May_24_12_47.nxml.txt.nlp	23705854	SENT94	26	26	17	17	vinblastine	P-gp	PA451877	5243	0.524
NULL	Diabetes_Care_2009_Oct_8_32(10)_1873-1879.nxml.txt.nlp	19587362	SENT106	0	0	9	9	aliskiren	ANG	PA143487910	283	0.524
NULL	F1000Res_2014_Aug_19_3_198.nxml.txt.nlp	25400908	SENT533	28	28	11	11	doxorubicin	S17	PA449412	6218	0.524
NULL	J_Ginseng_Res_2011_Nov_35(4)_436-441.nxml.txt.nlp	23717089	SENT117	3	3	7	7	ginseng	CAGC	PA164781150	6283	0.524
NULL	Anal_Bioanal_Chem_2011_Mar_29_399(9)_3157-3176.nxml.txt.nlp	21046088	SENT49	13	13	23	23	fluorescein	HEX	PA164746009	3087	0.524
NULL	Breast_Cancer_Res_2011_Mar_10_13(2)_R28.nxml.txt.nlp	21392397	SENT69	3	3	15	15	erlotinib	API	PA134687924	5345	0.524
NULL	Breast_Cancer_Res_2012_Jul_23_14(4)_R112.nxml.txt.nlp	22824341	SENT232	27	27	19	19	doxorubicin	RANKL	PA449412	8600	0.524
NULL	Cancer_Med_2013_Dec_31_2(6)_826-835.nxml.txt.nlp	24403256	SENT203	0	0	17	17	daunorubicin	p53	PA449212	7157	0.524
NULL	Aging_(Albany_NY)_2009_May_22_1(6)_557-572.nxml.txt.nlp	20195383	SENT253	13	13	9	9	creatine	ADP	PA164778930	23038	0.524
NULL	Comp_Funct_Genomics_2012_Feb_6_2012_876893.nxml.txt.nlp	22400011	SENT209	22	22	12	12	zinc	CLP1	PA451956	10978	0.524
NULL	Amyloid_2014_Sep_11_21(3)_175-184.nxml.txt.nlp	24918964	SENT86	0	0	3	3	anakinra	TTR	PA10799	7276	0.524
NULL	Reprod_Biol_Endocrinol_2004_Jan_7_2_2.nxml.txt.nlp	14711377	SENT160	9	9	7	7	thrombin	PAR1	PA451674	79581;2149	0.524
NULL	J_Oncol_2010_Jun_6_2010_921682.nxml.txt.nlp	20628483	SENT77	5	5	3	3	pp2	PP1		5540;5464	0.524
NULL	Ann_N_Y_Acad_Sci_2013_Apr_1_1281(1)_64-91.nxml.txt.nlp	23551121	SENT452	10	10	7	7	liraglutide	GLP-1	PA165958364	100125288	0.524
NULL	Emerg_Infect_Dis_2012_Jul_18(7)_1072-1080.nxml.txt.nlp	22709685	SENT119	20	20	6	6	vancomycin	VISA	PA451850	57506	0.524
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Jul_19_64(Pt_8)_o1520.nxml.txt.nlp	21203228	SENT3	39	39	16	16	ethanol	mol	PA448073	90527	0.524
NULL	Indian_J_Endocrinol_Metab_2013_May-Jun_17(3)_413-421.nxml.txt.nlp	23869296	SENT80	0	0	37	37	liraglutide	GLP-1	PA165958364	100125288	0.524
NULL	Physiol_Rep_2014_Sep_11_2(9)_e12147.nxml.txt.nlp	25214524	SENT52	25	25	32	32	phenol	San	PA450913	80218	0.524
NULL	J_Lipid_Res_2014_Feb_55(2)_190-200.nxml.txt.nlp	24273196	SENT143	13	13	15	15	lipase	ATGL	PA450239	57104	0.524
NULL	Case_Rep_Oncol_Med_2012_Dec_2_2012_689291.nxml.txt.nlp	23243533	SENT79	20	20	16	16	thyroglobulin	CK19	PA164754910	3880	0.524
NULL	Drug_Des_Devel_Ther_2014_Oct_31_8_2121-2128.nxml.txt.nlp	25382970	SENT84	3	3	5	5	curcumin	TTR	PA151958596	7276	0.524
NULL	Exp_Ther_Med_2014_Mar_24_7(3)_663-668.nxml.txt.nlp	24520264	SENT96	4	4	12	12	curcumin	IL-6	PA151958596	3569	0.524
NULL	Biochem_Biophys_Res_Commun_2007_Mar_23_354(4)_1084-1088.nxml.txt.nlp	17276402	SENT21	19	19	21	21	metformin	adiponectin	PA450395	9370	0.524
NULL	Int_J_Mol_Sci_2014_Mar_5_15(3)_3970-3988.nxml.txt.nlp	24603537	SENT559	23	23	13	13	curcumin	MCH	PA151958596	5367	0.524
NULL	AMB_Express_2011_Sep_30_1_26.nxml.txt.nlp	21961566	SENT281	5	5	13	13	trypsin	Gen	PA451806	348654	0.524
NULL	Int_J_Mol_Sci_2014_Sep_23_15(9)_16911-16935.nxml.txt.nlp	25250910	SENT107	3	3	10	10	potassium	mol	PA451047	90527	0.524
NULL	Indian_J_Psychiatry_2010_Jan_52(Suppl1)_S317-S340.nxml.txt.nlp	21836703	SENT117	29	29	16	16	triflupromazine	TFP	PA451773	7034	0.524
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT331	38	38	35	35	risperidone	PRL	PA451257	5617	0.524
NULL	J_Exp_Bot_2011_Oct_4_62(14)_4787-4803.nxml.txt.nlp	21821598	SENT297	23	23	9	9	mannitol	M6PR	PA450320	4074	0.524
NULL	Oncol_Lett_2014_Aug_22_8(2)_852-858.nxml.txt.nlp	25009661	SENT34	19	19	21	21	trypsin	p53	PA451806	7157	0.524
NULL	Front_Oncol_2013_Aug_13_3_208.nxml.txt.nlp	23986880	SENT108	31	31	13	13	docetaxel	mol	PA449383	90527	0.524
NULL	Iran_J_Microbiol_2013_Mar_5(1)_42-47.nxml.txt.nlp	23466523	SENT91	6	6	8	8	ceftriaxone	CTX	PA448866	1593	0.524
NULL	Ann_Oncol_2009_Aug_17_20(8)_1319-1329.nxml.txt.nlp	19535820	SENT49	4	4	7	7	tamoxifen	HER2	PA451581	2064	0.524
NULL	Mol_Syst_Biol_2009_Feb_17_5_246.nxml.txt.nlp	19225459	SENT141	39	39	21	21	l-glutamine	CO2	PA10090	4513	0.524
NULL	Clin_Ophthalmol_2011_Apr_26_5_517-525.nxml.txt.nlp	21573041	SENT96	1	1	16	16	latanoprost	BAK	PA164774763	578	0.524
NULL	Breast_Cancer_Res_2010_Jun_28_12(3)_R43.nxml.txt.nlp	20579400	SENT19	5	5	12	12	fulvestrant	MAPT	PA164747170	4137	0.524
NULL	Nucleic_Acids_Res_2013_May_29_41(9)_4926-4937.nxml.txt.nlp	23543461	SENT295	5	5	17	17	fluorescein	KIFC1	PA164746009	3833	0.524
NULL	Acta_Histochem_Cytochem_2010_May_1_43(2)_61-68.nxml.txt.nlp	20514293	SENT67	32	32	30	30	hyaluronan	LYVE-1	PA165958431	10894	0.524
NULL	J_Gen_Intern_Med_2009_May_21_24(5)_656-664.nxml.txt.nlp	19306050	SENT543	6	6	9	9	warfarin	CYP2C9	PA451906	1559	0.524
NULL	Case_Rep_Endocrinol_2015_Jan_5_2015_268714.nxml.txt.nlp	25628901	SENT68	14	14	16	16	thyroglobulin	TTF-1	PA164754910	7080	0.524
NULL	Oncotarget_2014_Oct_18_5(22)_11653-11668.nxml.txt.nlp	25362242	SENT237	24	24	32	32	l-glutamine	CO2	PA10090	4513	0.524
NULL	Nanoscale_Res_Lett_2014_Jun_20_9(1)_311.nxml.txt.nlp	25024678	SENT44	17	17	24	24	fluorescein	CD83	PA164746009	9308	0.524
NULL	J_Lipid_Res_2014_Jul_55(7)_1465-1477.nxml.txt.nlp	24868093	SENT170	27	27	0	0	choline	DAG	PA448976	1605	0.524
NULL	Int_J_Mol_Sci_2012_Feb_24_13(3)_2590-2617.nxml.txt.nlp	22489113	SENT202	15	15	33	33	benzaldehyde	mol	PA448571	90527	0.524
NULL	Curr_Neuropharmacol_2013_May_11(3)_263-275.nxml.txt.nlp	24179463	SENT129	13	13	15	15	citalopram	CB1	PA449015	1268	0.524
NULL	Diabetes_Care_2008_Nov_31(11)_2222-2229.nxml.txt.nlp	18955719	SENT224	30	30	41	41	orlistat	GLP-1	PA164776864	100125288	0.524
NULL	Cancers_(Basel)_2014_Apr_30_6(2)_1031-1046.nxml.txt.nlp	24785146	SENT173	32	32	9	9	geldanamycin	Hsp90	PA152031327	3320	0.524
NULL	Cancers_(Basel)_2013_Nov_1_5(4)_1379-1412.nxml.txt.nlp	24202450	SENT400	12	12	17	17	imiquimod	GM-CSF	PA449972	1437	0.524
NULL	Antimicrob_Resist_Infect_Control_2012_Mar_16_1_12.nxml.txt.nlp	22958880	SENT107	26	26	28	28	tetracycline	CTX	PA451640	1593	0.524
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Sep_11_66(Pt_10)_o2555.nxml.txt.nlp	21587542	SENT56	23	23	20	20	benzaldehyde	C17	PA448571	54360	0.524
NULL	J_Headache_Pain_2010_Dec_8_11(6)_457-468.nxml.txt.nlp	20931348	SENT338	4	4	20	20	naproxen	Gen	PA450595	348654	0.524
NULL	J_Cell_Mol_Med_2014_Aug_1_18(8)_1599-1611.nxml.txt.nlp	24889822	SENT201	15	15	37	37	resveratrol	SIRT1		23411	0.524
NULL	J_Lipid_Res_2014_Mar_55(3)_385-397.nxml.txt.nlp	24347527	SENT14	14	14	16	16	lipase	HSL	PA450239	3991	0.524
NULL	Indian_J_Endocrinol_Metab_2012_Mar-Apr_16(2)_252-257.nxml.txt.nlp	22470863	SENT30	11	11	9	9	vasopressin	ACTH	PA451858	5443	0.524
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Jun_27_5_15.nxml.txt.nlp	16803618	SENT178	8	8	42	42	flucloxacillin	GEN1	PA164781042	348654	0.524
NULL	J_Cell_Mol_Med_2013_Jun_15_17(6)_792-799.nxml.txt.nlp	23672538	SENT61	7	7	32	32	fluorescein	CD56	PA164746009	4684	0.524
NULL	Diabetes_Care_2013_Jun_15_36(6)_1765-1771.nxml.txt.nlp	23704676	SENT142	8	8	31	31	metformin	B12	PA450395	7126;4709	0.524
NULL	Arch_Med_Sci_2011_Dec_31_7(6)_977-983.nxml.txt.nlp	22328880	SENT87	7	7	11	11	heparin	PAPP-A	PA449855	5069	0.524
NULL	Nat_Commun_2013_Oct_1_4_2516.nxml.txt.nlp	24084631	SENT190	10	10	28	28	losartan	AK4	PA450268	205	0.524
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT235	16	16	27	27	delavirdine	CYP3A4	PA449223	1576	0.524
NULL	Braz_J_Med_Biol_Res_2012_Feb_17_45(3)_244-249.nxml.txt.nlp	22331137	SENT146	6	6	4	4	gentamicin	PAG	PA449753	55824	0.524
NULL	Biologics_2009_Oct_12_3_469-474.nxml.txt.nlp	19851472	SENT71	13	13	27	27	montelukast	IL-5	PA450546	3567	0.524
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_16_2012_395912.nxml.txt.nlp	23118789	SENT75	29	29	38	38	phenylbutazone	UGT1A4	PA450932	54657	0.524
NULL	Nat_Commun_2013_Apr_3_4_1652.nxml.txt.nlp	23552067	SENT426	9	9	31	31	ketamine	gamma	PA450144	9913	0.524
NULL	Br_J_Cancer_1997_75(2)_161-168.nxml.txt.nlp	9010020	SENT0	12	12	29	29	glucose	MRP	PA449773	79971	0.524
NULL	Front_Endocrinol_(Lausanne)_2014_Jan_16_5_1.nxml.txt.nlp	24474947	SENT143	14	14	7	7	estradiol	GPER	PA449503	2852	0.524
NULL	Acta_Pharmacol_Sin_2011_Dec_10_32(12)_1460-1465.nxml.txt.nlp	21986578	SENT68	5	5	27	27	propofol	hole	PA451141	80757	0.524
NULL	Mucosal_Immunol_2013_Sep_30_6(5)_1027-1037.nxml.txt.nlp	23360902	SENT136	13	13	21	21	paraformaldehyde	CCL20	PA450790	6364	0.524
NULL	J_Cancer_Prev_2014_Jun_19(2)_111-117.nxml.txt.nlp	25337579	SENT153	9	9	6	6	doxorubicin	ADM	PA449412	133	0.524
NULL	Front_Oncol_2013_Apr_29_3_92.nxml.txt.nlp	23641361	SENT162	0	0	14	14	bevacizumab	CLS	PA130232992	1210	0.524
NULL	Ann_Indian_Acad_Neurol_2014_Mar_17(Suppl_1)_S32-S36.nxml.txt.nlp	24791086	SENT119	7	7	9	9	midazolam	PTB	PA450496	58155	0.524
NULL	Carcinogenesis_2013_Mar_7_34(3)_703-712.nxml.txt.nlp	23222814	SENT68	23	23	34	34	curcumin	ANOVA	PA151958596	4858	0.524
NULL	Front_Immunol_2013_Sep_17_4_281.nxml.txt.nlp	24062747	SENT388	5	5	7	7	atorvastatin	IFN	PA448500	3439	0.524
NULL	Int_J_Environ_Res_Public_Health_2013_Sep_17_10(9)_4352-4389.nxml.txt.nlp	24048206	SENT4	13	13	15	15	choline	B12	PA448976	7126;4709	0.524
NULL	Breast_Cancer_Res_2002_Jun_25_4(4)_155-164.nxml.txt.nlp	12100741	SENT112	23	23	4	4	urokinase	EGF	PA451836	1950	0.524
NULL	Mol_Vis_2011_Aug_18_17_2221-2227.nxml.txt.nlp	21897744	SENT119	12	12	28	28	l-arginine	NAC	PA448478	22861	0.524
NULL	Alcohol_Res_2012_34(4)_484-494.nxml.txt.nlp	23584114	SENT146	18	18	20	20	vasopressin	AVP	PA451858	114548;551	0.524
NULL	Nucleic_Acids_Res_2010_Oct_4_38(19)_6375-6388.nxml.txt.nlp	20525792	SENT283	0	0	9	9	doxycycline	YY1	PA449415	7528	0.524
NULL	Int_J_Nanomedicine_2009_Apr_1_4_27-35.nxml.txt.nlp	19421368	SENT101	21	21	27	27	genistein	IL-4	PA165109660	3565	0.524
NULL	Sensors_(Basel)_2011_Oct_12_11(10)_9685-9699.nxml.txt.nlp	22163720	SENT33	14	14	3	3	ethanol	NO3	PA448073	4681	0.524
NULL	Environ_Health_Perspect_2010_Jul_3_118(7)_936-942.nxml.txt.nlp	20199942	SENT201	31	31	7	7	arsenite	NKRF	PA452638	55922	0.524
NULL	Exp_Hematol_Oncol_2014_Jan_11_3_2.nxml.txt.nlp	24410791	SENT29	9	9	2	2	afatinib	EGFR	PA165981154	1956	0.524
NULL	Chem_Res_Toxicol_2008_Jul_21_21(7)_1359-1367.nxml.txt.nlp	18549251	SENT106	16	16	13	13	hydroquinone	PCB	PA449924	5091	0.524
NULL	J_Exp_Bot_2008_May_59(8)_2109-2123.nxml.txt.nlp	18535297	SENT309	14	14	1	1	galactose	PC2	PA449725	5126;5311;8535	0.524
NULL	Crit_Care_2011_Nov_17_15(6)_R272.nxml.txt.nlp	22087841	SENT117	10	10	13	13	thrombin	PF1	PA451674	57649	0.524
NULL	Cancer_Med_2014_Oct_23_3(5)_1146-1158.nxml.txt.nlp	25052069	SENT284	8	8	11	11	gefitinib	HER2	PA131301952	2064	0.524
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Jul_23_3(7)_e126.nxml.txt.nlp	25054314	SENT329	24	24	35	35	docetaxel	ABCC2	PA449383	1244	0.524
NULL	Indian_J_Plast_Surg_2014_Jan-Apr_47(1)_102-108.nxml.txt.nlp	24987213	SENT70	21	21	28	28	fluorescein	FOR	PA164746009	51741	0.524
NULL	Ann_Intensive_Care_2011_May_25_1_14.nxml.txt.nlp	21906345	SENT157	3	3	1	1	colistin	San	PA164760862	80218	0.524
NULL	Lipids_Health_Dis_2011_Jan_27_10_24.nxml.txt.nlp	21272342	SENT36	31	31	19	19	lipase	PPL	PA450239	5493	0.524
NULL	Front_Oncol_2014_Sep_23_4_264.nxml.txt.nlp	25295231	SENT20	7	7	12	12	lenalidomide	p53	PA162363968	7157	0.523
NULL	Mol_Cancer_2014_Jan_28_13_17.nxml.txt.nlp	24472312	SENT113	0	0	5	5	ponatinib	Mcl-1	PA165980594	4170	0.523
NULL	Indian_J_Endocrinol_Metab_2013_Dec_17(Suppl_3)_S696-S699.nxml.txt.nlp	24910842	SENT30	27	27	31	31	metoclopramide	PRL	PA450475	5617	0.523
NULL	Croat_Med_J_2012_Jun_53(3)_214-223.nxml.txt.nlp	22661134	SENT169	19	19	22	22	diazepam	spatial	PA449283	219793	0.523
NULL	Exp_Neurol_2011_May_229(1)_2-9.nxml.txt.nlp	20816825	SENT108	17	17	15	15	forskolin	FGF2	PA146096022	2247;2258	0.523
NULL	Eur_J_Immunol_2014_Jun_10_44(6)_1759-1769.nxml.txt.nlp	24595810	SENT9	6	6	8	8	fludrocortisone	CXCR4	PA164743961	7852	0.523
NULL	J_Cell_Biol_2004_Feb_16_164(4)_613-623.nxml.txt.nlp	14769860	SENT514	10	10	2	2	collagenase	SAPK	PA449107	5601	0.523
NULL	J_Antimicrob_Chemother_2014_Apr_8_69(4)_924-931.nxml.txt.nlp	24324223	SENT110	26	26	0	0	levofloxacin	PEN	PA450214	9933	0.523
NULL	Reprod_Biol_Endocrinol_2013_Jul_16_11_66.nxml.txt.nlp	23870423	SENT95	19	19	11	11	estradiol	aromatase	PA449503	1588	0.523
NULL	Br_J_Nutr_2013_May_14_109(9)_1678-1687.nxml.txt.nlp	22935250	SENT276	14	14	23	23	creatine	SGK3	PA164778930	23678	0.523
NULL	AIDS_2014_Jun_1_28(9)_1333-1339.nxml.txt.nlp	24583670	SENT43	26	26	28	28	nevirapine	CD4	PA450616	920	0.523
NULL	Int_J_Biol_Sci_2007_Dec_3_4(1)_1-7.nxml.txt.nlp	18167530	SENT42	34	34	25	25	heparin	EGF	PA449855	1950	0.523
NULL	Clin_Med_Insights_Cardiol_2013_Jul_23_7_115-126.nxml.txt.nlp	23926441	SENT183	20	20	8	8	paclitaxel	ARC	PA450761	8996;23237	0.523
NULL	Surg_Neurol_Int_2013_Sep_6_4_114.nxml.txt.nlp	24083050	SENT189	29	29	19	19	clopidogrel	PED	PA449053	8682	0.523
NULL	Cell_Biochem_Biophys_2013_May_14_66(1)_65-71.nxml.txt.nlp	23065501	SENT41	31	31	22	22	neomycin	telethonin	PA450608	8557	0.523
NULL	Carcinogenesis_2010_Dec_27_31(12)_2049-2057.nxml.txt.nlp	20876285	SENT8	21	21	3	3	tamoxifen	HER2	PA451581	2064	0.523
NULL	Adv_Ther_2014_Dec_2_31_1228-1246.nxml.txt.nlp	25447269	SENT82	18	18	15	15	timolol	TIM	PA451690	7984;8914	0.523
NULL	Mol_Vis_2011_Aug_18_17_2221-2227.nxml.txt.nlp	21897744	SENT119	4	4	20	20	l-arginine	NAC	PA448478	22861	0.523
NULL	Cancer_Causes_Control_2013_Aug_18_24(8)_1605-1614.nxml.txt.nlp	23775025	SENT64	3	3	6	6	cyclophosphamide	CYP1B1	PA449165	1545	0.523
NULL	Br_J_Clin_Pharmacol_2013_Aug_23_76(2)_299-315.nxml.txt.nlp	23701319	SENT208	28	28	20	20	alemtuzumab	CRA	PA164783958	51747;10903	0.523
NULL	Mol_Cell_Biochem_2014_Jul_26_396(1-2)_221-228.nxml.txt.nlp	25063218	SENT217	14	14	19	19	resveratrol	CYP1A1		1543	0.523
NULL	Mol_Cancer_2009_Dec_23_8_129.nxml.txt.nlp	20030852	SENT184	1	1	7	7	curcumin	ABCA1	PA151958596	19	0.523
NULL	Int_J_Emerg_Med_2013_Jul_16_6_25.nxml.txt.nlp	23866080	SENT115	26	26	15	15	ritonavir	P-gp	PA451260	5243	0.523
NULL	Cell_Res_2012_Dec_4_22(12)_1696-1706.nxml.txt.nlp	22945357	SENT211	19	19	9	9	glutaraldehyde	IL-2	PA449777	3558	0.523
NULL	ACS_Synth_Biol_2014_May_16_3(5)_264-272.nxml.txt.nlp	24313393	SENT224	22	22	29	29	l-glutamine	CO2	PA10090	4513	0.523
NULL	Arch_Med_Sci_2013_Aug_30_9(4)_724-730.nxml.txt.nlp	24049536	SENT89	15	15	11	11	genistein	PTH	PA165109660	5741	0.523
NULL	Viruses_2014_Apr_14_6(4)_1715-1758.nxml.txt.nlp	24736215	SENT249	5	5	9	9	disulfiram	PTEN	PA449376	5728	0.523
NULL	J_Antimicrob_Chemother_2014_Apr_13_69(4)_955-958.nxml.txt.nlp	24235096	SENT17	8	8	11	11	amikacin	GC1	PA164744372	79751;10562	0.523
NULL	Carcinogenesis_2010_Dec_27_31(12)_2049-2057.nxml.txt.nlp	20876285	SENT136	29	29	16	16	tamoxifen	HER2	PA451581	2064	0.523
NULL	Clin_Ophthalmol_2007_Dec_1(4)_383-391.nxml.txt.nlp	19668515	SENT143	23	23	29	29	ranibizumab	San	PA164746012	80218	0.523
NULL	Clin_Ophthalmol_2011_Feb_28_5_269-274.nxml.txt.nlp	21468332	SENT2	9	9	17	17	ketorolac	BAK	PA450150	578	0.523
NULL	Acta_Pharmacol_Sin_2014_Jun_4_35(6)_792-805.nxml.txt.nlp	24902787	SENT338	14	14	27	27	paroxetine	INS-1	PA450801	2305	0.523
NULL	Arthritis_Res_Ther_2010_Apr_1_12(2)_R60.nxml.txt.nlp	20359365	SENT155	8	8	25	25	bleomycin	SPARC	PA448645	6678	0.523
NULL	Asian_Spine_J_2011_Sep_12_5(3)_192-195.nxml.txt.nlp	21892393	SENT49	16	16	20	20	vincristine	CHOP	PA451879	1649	0.523
NULL	Summit_on_Translat_Bioinforma_2009_Mar_1_2009_124-128.nxml.txt.nlp	21347183	SENT70	7	7	22	22	azathioprine	TPMT	PA448515	7172	0.523
NULL	Oncol_Lett_2013_Aug_17_6(2)_295-305.nxml.txt.nlp	24137320	SENT177	5	5	8	8	tamoxifen	14-3-3	PA451581	10971	0.523
NULL	AIDS_Care_2011_Sep_14_23(9)_1154-1162.nxml.txt.nlp	21500025	SENT140	12	12	2	2	efavirenz	ATV	PA449441	4683	0.523
NULL	Aging_(Albany_NY)_2009_Dec_29_2(1)_63-68.nxml.txt.nlp	20228936	SENT79	3	3	10	10	nadh	SIRT1	PA164755085	23411	0.523
NULL	Arthritis_Res_Ther_2010_Apr_1_12(2)_R60.nxml.txt.nlp	20359365	SENT178	6	6	14	14	bleomycin	BLM	PA448645	641	0.523
NULL	Iran_J_Public_Health_2010_Jun_30_39(2)_63-68.nxml.txt.nlp	23113008	SENT144	16	16	14	14	amikacin	TOB	PA164744372	10140	0.523
NULL	Chem_Cent_J_2012_Jun_20_6_58.nxml.txt.nlp	22716299	SENT162	22	22	40	40	genistein	Gen	PA165109660	348654	0.523
NULL	Diabetes_Obes_Metab_2010_May_12(5)_437-441.nxml.txt.nlp	20415692	SENT125	2	2	11	11	glucose	GLA	PA449773	9027;2717	0.523
NULL	Pharmaceuticals_(Basel)_2013_Jul_4_6(7)_851-866.nxml.txt.nlp	24276318	SENT34	9	9	11	11	vasopressin	AVP	PA451858	114548;551	0.523
NULL	Crit_Care_2008_Jul_25_12(4)_R93.nxml.txt.nlp	18657277	SENT49	6	6	18	18	heparin	ACT	PA449855	12;11332;9457;641455	0.523
NULL	Biochim_Biophys_Acta_2014_Jul_1842(7)_959-970.nxml.txt.nlp	24594481	SENT54	2	2	4	4	lipase	MGL	PA450239	11343	0.523
NULL	G3_(Bethesda)_2014_Feb_5_4(4)_613-622.nxml.txt.nlp	24504254	SENT108	25	25	41	41	nadh	ADP	PA164755085	23038	0.523
NULL	J_Mol_Signal_2006_Dec_6_1_8.nxml.txt.nlp	17224083	SENT42	10	10	13	13	thrombin	Rho	PA451674	29984	0.523
NULL	Oncol_Lett_2014_Nov_12_8(5)_2203-2208.nxml.txt.nlp	25295109	SENT101	0	0	6	6	celecoxib	GLI1	PA448871	2735	0.523
NULL	J_Cell_Biol_2003_Sep_1_162(5)_773-780.nxml.txt.nlp	12952931	SENT51	3	3	14	14	tetracycline	AAK1	PA451640	22848	0.523
NULL	Exp_Ther_Med_2014_Nov_29_8(5)_1473-1478.nxml.txt.nlp	25289044	SENT8	14	14	12	12	heparin	AZU	PA449855	566	0.523
NULL	Curr_Neuropharmacol_2014_Jul_12(4)_365-379.nxml.txt.nlp	25342944	SENT534	8	8	1	1	fluoxetine	5-HT1A	PA449673	3350	0.523
NULL	Oncoimmunology_2013_Jan_1_2(1)_e22890.nxml.txt.nlp	23483066	SENT101	0	0	8	8	vemurafenib	IFN	PA165946873	3439	0.523
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Apr_29_67(Pt_5)_o1256.nxml.txt.nlp	21754546	SENT68	23	23	33	33	acetone	mol	PA448025	90527	0.523
NULL	Oncotarget_2014_Jun_6_5(13)_4935-4944.nxml.txt.nlp	24952732	SENT189	3	3	15	15	doxazosin	4E-BP1	PA449407	1978	0.523
NULL	Environ_Health_Perspect_1997_Jun_105(Suppl_4)_767-774.nxml.txt.nlp	9255560	SENT15	29	29	27	27	debrisoquine	CYP2D6	PA452616	1565	0.523
NULL	Cardiovasc_Diabetol_2010_Nov_16_9_76.nxml.txt.nlp	21080957	SENT262	20	20	25	25	exenatide	AKT2	PA164749238	208	0.523
NULL	J_Korean_Med_Sci_2007_Aug_31_22(4)_677-681.nxml.txt.nlp	17728509	SENT45	12	12	39	39	isoniazid	EMB	PA450112	133418	0.523
NULL	J_Occup_Med_Toxicol_2014_Dec_20_9(1)_42.nxml.txt.nlp	NULL	SENT92	12	12	23	23	arsenite	p53	PA452638	7157	0.523
NULL	Mar_Drugs_2014_Nov_24_12(11)_5677-5697.nxml.txt.nlp	25421323	SENT565	6	6	14	14	berberine	TNF-alpha	PA165860812	7124	0.523
NULL	J_Cell_Biol_1998_Jul_13_142(1)_101-115.nxml.txt.nlp	9660866	SENT39	31	31	4	4	tetracycline	RhoA	PA451640	387	0.523
NULL	Parasit_Vectors_2011_Jan_25_4_7.nxml.txt.nlp	21266069	SENT99	37	37	47	47	gentamicin	CO2	PA449753	4513	0.523
NULL	Cancer_Metab_2013_Feb_4_1_7.nxml.txt.nlp	24280108	SENT8	5	5	11	11	oxygen	MYC	PA450744	4609	0.523
NULL	Crit_Care_2011_Jun_29_15(3)_R160.nxml.txt.nlp	21714857	SENT50	12	12	24	24	fenoldopam	NGAL	PA164784034	3934	0.523
NULL	Front_Microbiol_2012_Jun_8_3_196.nxml.txt.nlp	22701113	SENT88	23	23	13	13	nadh	CO2	PA164755085	4513	0.523
NULL	Cell_Regen_(Lond)_2012_Jun_28_1(1)_3.nxml.txt.nlp	25408866	SENT28	28	28	18	18	oxygen	MSC	PA450744	9242	0.523
NULL	J_Neuroinflammation_2011_Apr_8_8_28.nxml.txt.nlp	21473788	SENT278	4	4	9	9	thrombin	PAR-1	PA451674	2011;2149	0.523
NULL	J_Lipid_Res_2014_Jul_55(7)_1298-1309.nxml.txt.nlp	24823941	SENT267	22	22	10	10	choline	CERK	PA448976	64781	0.523
NULL	Surg_Today_2014_Mar_22_44(1)_142-151.nxml.txt.nlp	23519648	SENT62	35	35	33	33	heparin	GIV	PA449855	55704	0.523
NULL	Crit_Care_2012_Oct_14_16(5)_R191.nxml.txt.nlp	23062276	SENT140	6	6	13	13	sevoflurane	POD1	PA451341	6943	0.523
NULL	Br_J_Cancer_2010_Jun_29_103(1)_61-72.nxml.txt.nlp	20588279	SENT197	6	6	3	3	trastuzumab	RhoB	PA451743	388	0.523
NULL	Biochem_Res_Int_2012_Feb_12_2012_346972.nxml.txt.nlp	22400115	SENT178	13	13	15	15	hyaluronan	CD44	PA165958431	960	0.523
NULL	J_Gynecol_Oncol_2013_Jul_4_24(3)_265-272.nxml.txt.nlp	23875077	SENT104	0	0	9	9	thrombin	IL-6	PA451674	3569	0.523
NULL	Mol_Vis_2007_Jan_24_13_57-65.nxml.txt.nlp	17277739	SENT224	6	6	11	11	heparin	FGF2	PA449855	2247;2258	0.523
NULL	Oxid_Med_Cell_Longev_2012_Aug_9_2012_794237.nxml.txt.nlp	22928087	SENT234	8	8	18	18	hemin	adiponectin	PA449849	9370	0.523
NULL	Cent_European_J_Urol_2013_Dec_19_66(4)_405-410.nxml.txt.nlp	24757528	SENT32	8	8	0	0	collagenase	MMP8	PA449107	4317	0.523
NULL	Am_J_Med_Genet_A_2012_Sep_7_158A(9)_2221-2224.nxml.txt.nlp	22887731	SENT90	40	40	36	36	losartan	AT1	PA450268	9197;185	0.523
NULL	Nucleic_Acids_Res_2011_Sep_11_39(17)_7444-7454.nxml.txt.nlp	21666257	SENT303	14	14	19	19	cisplatin	DNAJ	PA449014	85406;10294	0.523
NULL	Mol_Cancer_2010_Apr_12_9_75.nxml.txt.nlp	20385023	SENT315	41	41	2	2	trastuzumab	EGFR	PA451743	1956	0.523
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT107	5	5	1	1	erlotinib	CYP3A	PA134687924	1574	0.523
NULL	Diabetes_2009_Dec_31_58(12)_2731-2740.nxml.txt.nlp	19720798	SENT138	22	22	17	17	troglitazone	adiponectin	PA451799	9370	0.523
NULL	Clin_Interv_Aging_2013_Feb_5_8_131-137.nxml.txt.nlp	23403474	SENT105	18	18	40	40	choline	CDP	PA448976	1523	0.523
NULL	Health_Policy_Plan_2012_Dec_29_27(8)_677-686.nxml.txt.nlp	22460007	SENT306	6	6	22	22	lumefantrine	ACT	PA165111722	12;11332;9457;641455	0.523
NULL	Drug_Des_Devel_Ther_2014_Sep_26_8_1613-1619.nxml.txt.nlp	25302016	SENT129	9	9	22	22	efavirenz	CYP3A4	PA449441	1576	0.523
NULL	Indian_J_Med_Res_2014_Mar_139(3)_463-467.nxml.txt.nlp	24820843	SENT15	15	15	7	7	linezolid	L22	PA450233	6146	0.523
NULL	Nat_Neurosci_2014_Jun_4_17(6)_813-821.nxml.txt.nlp	24793032	SENT314	5	5	26	26	topotecan	E14	PA451729	4863	0.523
NULL	Exp_Diabetes_Res_2012_Nov_12_2012_618923.nxml.txt.nlp	23197974	SENT180	27	27	30	30	telmisartan	STZ	PA451605	6484	0.523
NULL	Brain_Sci_2013_Jul_31_3(3)_1153-1181.nxml.txt.nlp	24587895	SENT750	1	1	21	21	ketamine	San	PA450144	80218	0.523
NULL	Case_Rep_Ophthalmol_2012_May_30_3(2)_185-189.nxml.txt.nlp	22740828	SENT72	1	1	12	12	fluorescein	hole	PA164746009	80757	0.523
NULL	J_Cell_Mol_Med_2014_Oct_11_18(10)_2031-2043.nxml.txt.nlp	25109475	SENT354	3	3	15	15	valsartan	STZ	PA451848	6484	0.523
NULL	Cancers_(Basel)_2012_Sep_6_4(3)_873-903.nxml.txt.nlp	24213471	SENT526	6	6	19	19	hyaluronan	YY1	PA165958431	7528	0.523
NULL	Oncotarget_2013_Nov_23_5(1)_196-210.nxml.txt.nlp	24344116	SENT204	26	26	24	24	doxorubicin	p53	PA449412	7157	0.523
NULL	Cardiovasc_Diabetol_2013_Jul_17_12_105.nxml.txt.nlp	23866022	SENT3	22	22	11	11	dipyridamole	A-FABP	PA449367	2167	0.523
NULL	Arch_Med_Sci_2011_Dec_31_7(6)_977-983.nxml.txt.nlp	22328880	SENT122	8	8	2	2	heparin	PAPP-A	PA449855	5069	0.523
NULL	Clin_Psychopharmacol_Neurosci_2011_Apr_30_9(1)_29-35.nxml.txt.nlp	23430964	SENT173	12	12	7	7	methylphenidate	Gen	PA450464	348654	0.523
NULL	Case_Rep_Ophthalmol_2014_Aug_4_5(2)_243-248.nxml.txt.nlp	25232337	SENT53	0	0	7	7	ranibizumab	VEGF-A	PA164746012	7422	0.523
NULL	Breast_Cancer_Res_2005_Jul_20_7(5)_205-211.nxml.txt.nlp	16168139	SENT85	20	20	22	22	heparin	EGF	PA449855	1950	0.523
NULL	Nat_Genet_2013_May_31_45(5)_531-536.nxml.txt.nlp	23542698	SENT253	12	12	15	15	eculizumab	HUS	PA164776637	3075	0.523
NULL	Arthritis_Res_Ther_2006_May_11_8(3)_209.nxml.txt.nlp	16712713	SENT551	14	14	20	20	cyclophosphamide	Yes	PA449165	7525	0.523
NULL	Br_J_Cancer_2013_May_14_108(9)_1862-1869.nxml.txt.nlp	23579219	SENT84	2	2	15	15	bevacizumab	ANXA11	PA130232992	311	0.523
NULL	Mol_Cancer_2010_Jun_25_9_166.nxml.txt.nlp	20579378	SENT171	4	4	2	2	gefitinib	EGF	PA131301952	1950	0.523
NULL	Biosci_Rep_2013_Jun_11_33(3)_e00044.nxml.txt.nlp	23662735	SENT121	19	19	13	13	hydroxyurea	PARP1	PA449942	142	0.523
NULL	Am_J_Trop_Med_Hyg_2014_Aug_6_91(2)_424-434.nxml.txt.nlp	24799369	SENT297	11	11	9	9	chloroquine	ACT	PA448948	12;11332;9457;641455	0.523
NULL	Front_Syst_Neurosci_2010_Oct_15_4_149.nxml.txt.nlp	21048904	SENT338	11	11	6	6	ethanol	CA1	PA448073	759	0.523
NULL	Toxins_(Basel)_2010_Oct_26_2(11)_2490-2518.nxml.txt.nlp	22069563	SENT1719	3	3	16	16	cisplatin	HMGB1	PA449014	3146	0.523
NULL	Oncogene_2014_Aug_28_33(35)_4407-4417.nxml.txt.nlp	24469038	SENT141	18	18	9	9	arsenite	CNOT6	PA452638	57472	0.523
NULL	Front_Neurol_2011_Nov_21_2_68.nxml.txt.nlp	22125548	SENT2824	6	6	4	4	creatine	Q10	PA164778930	27161	0.523
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT131	0	0	10	10	perifosine	DR4	PA165291471	8797	0.523
NULL	Front_Genet_2013_Aug_29_4_163.nxml.txt.nlp	24009622	SENT80	32	32	23	23	ethanol	DDP	PA448073	1678	0.523
NULL	Ann_Oncol_2011_Jan_13_22(1)_215-223.nxml.txt.nlp	20627875	SENT133	2	2	12	12	ifosfamide	ETO	PA449964	862	0.523
NULL	Biologics_2012_Dec_17_6_429-464.nxml.txt.nlp	23269860	SENT246	17	17	8	8	infliximab	ACR	PA452639	49	0.523
NULL	Mol_Vis_2012_May_1_18_1115-1122.nxml.txt.nlp	22605923	SENT135	13	13	18	18	estradiol	IL-6	PA449503	3569	0.523
NULL	Biochemistry_2011_May_31_50(21)_4393-4395.nxml.txt.nlp	21520952	SENT85	26	26	7	7	benzbromarone	P-gp	PA134852920	5243	0.523
NULL	Clin_Endosc_2014_Mar_31_47(2)_129-134.nxml.txt.nlp	24765594	SENT45	9	9	3	3	propofol	FOR	PA451141	51741	0.523
NULL	Drugs_Aging_2013_Oct_26_30(12)_999-1008.nxml.txt.nlp	24163280	SENT121	7	7	0	0	gabapentin	ADP	PA449720	23038	0.523
NULL	Clin_Dev_Immunol_2013_Oct_1_2013_764395.nxml.txt.nlp	24194774	SENT82	14	14	23	23	terbutaline	IFN	PA451616	3439	0.523
NULL	Chem_Cent_J_2014_Sep_16_8(1)_51.nxml.txt.nlp	NULL	SENT178	2	2	18	18	phenol	CO2	PA450913	4513	0.523
NULL	Curr_Hepat_Rep_2010_May_21_9(2)_75-90.nxml.txt.nlp	20461127	SENT244	19	19	37	37	telbivudine	LAM	PA164760861	7249;7248	0.523
NULL	Contemp_Clin_Dent_2013_Jan-Mar_4(1)_48-53.nxml.txt.nlp	23853452	SENT15	9	9	14	14	metronidazole	CAL	PA450484	54751;57120	0.523
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1013.nxml.txt.nlp	24457957	SENT115	5	5	7	7	bortezomib	NOXA	PA10252	5366	0.523
NULL	Cardiovasc_Diabetol_2008_Aug_11_7_24.nxml.txt.nlp	18694484	SENT40	5	5	3	3	exenatide	GLP-1	PA164749238	100125288	0.523
NULL	Biotechnol_Res_Int_2013_Dec_1_2013_253286.nxml.txt.nlp	24363937	SENT159	7	7	5	5	ethanol	DAP	PA448073	23549;3375;1611	0.523
NULL	Ann_Hematol_2014_Apr_30_93(9)_1515-1522.nxml.txt.nlp	24782121	SENT62	13	13	21	21	fluorescein	CD44	PA164746009	960	0.523
NULL	Br_J_Cancer_2012_Feb_14_106(4)_646-650.nxml.txt.nlp	22240794	SENT3	7	7	11	11	sunitinib	IFN	PA162372840	3439	0.523
NULL	Exp_Ther_Med_2013_Mar_21_5(3)_987-991.nxml.txt.nlp	23407636	SENT40	15	15	19	19	fluorescein	CXCR2	PA164746009	3579	0.523
NULL	Bioinformation_2012_Jan_6_8(1)_13-19.nxml.txt.nlp	22359429	SENT3	8	8	25	25	curcumin	MRP1	PA151958596	4437	0.523
NULL	Mol_Vis_2012_Nov_30_18_2847-2859.nxml.txt.nlp	23233787	SENT255	17	17	5	5	fluorescein	15-LOX-1	PA164746009	246	0.523
NULL	Mol_Imaging_Radionucl_Ther_2012_Apr_1_21(1)_38-41.nxml.txt.nlp	23487501	SENT40	12	12	6	6	thyroglobulin	CD10	PA164754910	4311	0.523
NULL	Int_J_Biol_Sci_2006_Mar_1_2(1)_10-16.nxml.txt.nlp	16585948	SENT63	8	8	6	6	galactose	mol	PA449725	90527	0.523
NULL	Oncotarget_2012_Dec_30_3(12)_1505-1521.nxml.txt.nlp	23455493	SENT254	2	2	24	24	metformin	CD4	PA450395	920	0.523
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT1406	9	9	3	3	paclitaxel	ABCC2	PA450761	1244	0.523
NULL	Indian_J_Pharmacol_2013_Mar-Apr_45(2)_121-125.nxml.txt.nlp	23716885	SENT11	25	25	16	16	aripiprazole	CYP3A4	PA10026	1576	0.523
NULL	Asian-Australas_J_Anim_Sci_2012_Apr_25(4)_471-478.nxml.txt.nlp	25049587	SENT157	9	9	0	0	pp2	PP1		5540;5464	0.523
NULL	Ann_Rheum_Dis_2014_Jan_25_73(1)_56-61.nxml.txt.nlp	24067785	SENT42	24	24	19	19	vasopressin	IL-10	PA451858	3586	0.523
NULL	Eur_J_Med_Res_2009_Dec_7_14(Suppl_4)_71-77.nxml.txt.nlp	20156730	SENT97	0	0	3	3	tobramycin	gamma	PA451704	9913	0.523
NULL	Adv_Hematol_2012_May_28_2012_945138.nxml.txt.nlp	22693514	SENT30	16	16	13	13	cyclophosphamide	CHOP	PA449165	1649	0.523
NULL	Mol_Cancer_2014_Jan_28_13_17.nxml.txt.nlp	24472312	SENT128	7	7	20	20	ponatinib	Mcl-1	PA165980594	4170	0.523
NULL	Breast_Cancer_Res_2004_Jul_6_6(5)_R514-R530.nxml.txt.nlp	15318933	SENT79	20	20	26	26	phenol	San	PA450913	80218	0.523
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT192	23	23	19	19	panitumumab	Yes	PA162373091	7525	0.523
NULL	Crit_Care_2004_Sep_29_8(2)_122-129.nxml.txt.nlp	15025773	SENT195	18	18	37	37	fludrocortisone	ACTH	PA164743961	5443	0.523
NULL	Physiol_Rep_2014_Nov_4_2(11)_e12197.nxml.txt.nlp	25367695	SENT363	22	22	16	16	bleomycin	BAL	PA448645	83666	0.523
NULL	Hum_Genomics_2003_Nov_1_1(1)_41-51.nxml.txt.nlp	15601532	SENT25	7	7	12	12	saquinavir	Yes	PA451305	7525	0.523
NULL	J_Oncol_2010_May_24_2010_729725.nxml.txt.nlp	20508816	SENT71	8	8	5	5	bevacizumab	MVD	PA130232992	4597	0.523
NULL	J_Med_Chem_2014_Apr_10_57(7)_2942-2952.nxml.txt.nlp	24601592	SENT399	1	1	4	4	lamotrigine	CA1	PA450164	759	0.523
NULL	Curr_Dermatol_Rep_2014_Nov_28_3(1)_13-22.nxml.txt.nlp	24587975	SENT156	32	32	11	11	calcipotriol	IL-13	PA448714	3596	0.523
NULL	Oncogene_2013_Sep_26_32(39)_10_1038_onc_2012_491.nxml.txt.nlp	23108394	SENT47	19	19	2	2	epirubicin	FOXM1	PA449476	2305	0.523
NULL	Acta_Pharmacol_Sin_2009_May_13_30(5)_628-636.nxml.txt.nlp	19363519	SENT34	0	0	2	2	topotecan	TPT	PA451729	23590;6469	0.523
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Sep_20_64(Pt_10)_o1983.nxml.txt.nlp	21201183	SENT52	20	20	15	15	ethanol	mol	PA448073	90527	0.523
NULL	Int_J_Nanomedicine_2012_May_7_7_2307-2314.nxml.txt.nlp	22661887	SENT48	17	17	7	7	gemcitabine	F10	PA449748	2159	0.523
NULL	Oncotarget_2014_Oct_21_5(22)_11180-11192.nxml.txt.nlp	25361003	SENT113	12	12	27	27	tetracycline	NTRK1	PA451640	4914	0.522
NULL	Int_J_Mol_Sci_2012_Feb_1_13(2)_1512-1523.nxml.txt.nlp	22408405	SENT4	7	7	22	22	olmesartan	LOX-1	PA164742950	4973	0.522
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT110	1	1	24	24	curcumin	XIAP	PA151958596	331	0.522
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT305	16	16	12	12	methotrexate	ABCC2	PA450428	1244	0.522
NULL	Iran_J_Basic_Med_Sci_2012_Jan-Feb_15(1)_678-682.nxml.txt.nlp	23493931	SENT60	11	11	9	9	cefepime	CTX	PA164754876	1593	0.522
NULL	Br_J_Cancer_2013_Mar_19_108(5)_1052-1060.nxml.txt.nlp	23422754	SENT141	27	27	2	2	bevacizumab	VEGF-A	PA130232992	7422	0.522
NULL	Cancers_(Basel)_2010_Sep_9_2(3)_1661-1682.nxml.txt.nlp	24281180	SENT1059	9	9	13	13	collagenase	p38	PA449107	10598;1432;7965	0.522
NULL	Basic_Clin_Pharmacol_Toxicol_2013_Feb_5_112(2)_132-137.nxml.txt.nlp	22900583	SENT54	14	14	32	32	bupropion	CYP2C9	PA448687	1559	0.522
NULL	Oncotarget_2013_Nov_23_5(1)_196-210.nxml.txt.nlp	24344116	SENT111	0	0	24	24	doxorubicin	CXCL1	PA449412	2919	0.522
NULL	J_Biomed_Sci_2012_Oct_17_19(1)_90.nxml.txt.nlp	23075324	SENT69	9	9	23	23	resveratrol	FOXC2		2303	0.522
NULL	J_Anim_Sci_Biotechnol_2014_May_7_5(1)_26.nxml.txt.nlp	25045520	SENT60	19	19	36	36	choline	B12	PA448976	7126;4709	0.522
NULL	Clinics_(Sao_Paulo)_2011_Jan_66(1)_65-71.nxml.txt.nlp	21437438	SENT153	2	2	0	0	bupropion	BUP	PA448687	23412	0.522
NULL	J_Hematol_Oncol_2009_Apr_22_2_18.nxml.txt.nlp	19386128	SENT68	22	22	39	39	cetuximab	KRAS	PA10040	3845	0.522
NULL	Cell_Host_Microbe_2009_Mar_19_5(3-3)_225-233.nxml.txt.nlp	19286132	SENT156	29	29	47	47	l-glutamine	CO2	PA10090	4513	0.522
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT58	12	12	14	14	curcumin	TRAIL	PA151958596	8743	0.522
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT192	35	35	20	20	cetuximab	Yes	PA10040	7525	0.522
NULL	Afr_J_Infect_Dis_2011_5(2)_40-46.nxml.txt.nlp	23878706	SENT102	6	6	4	4	gentamicin	Gen	PA449753	348654	0.522
NULL	Cell_Biol_Int_Rep_(2010)_2012_Jun_21_19(1)_e00017.nxml.txt.nlp	23124518	SENT10	10	10	12	12	etoposide	TRAIL	PA449552	8743	0.522
NULL	Diabetes_2013_Oct_17_62(10)_3488-3499.nxml.txt.nlp	23863811	SENT388	18	18	10	10	oxygen	NOX2	PA450744	1536	0.522
NULL	Daru_2011_19(6)_446-454.nxml.txt.nlp	23008691	SENT59	15	15	6	6	ethanol	PF6	PA448073	200162	0.522
NULL	Evid_Based_Complement_Alternat_Med_2011_Feb_14_2011_429843.nxml.txt.nlp	21869897	SENT145	25	25	23	23	ethanol	CEA	PA448073	5670;1087	0.522
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT1699	1	1	19	19	ritonavir	ATV	PA451260	4683	0.522
NULL	Glycoconj_J_2011_Oct_6_28(7)_481-492.nxml.txt.nlp	21894462	SENT32	18	18	10	10	galactose	UGT	PA449725	7361;7355	0.522
NULL	Oncotarget_2013_Nov_22_5(4)_933-943.nxml.txt.nlp	24659749	SENT53	10	10	5	5	nutlin-3	AML2		864	0.522
NULL	Indian_J_Endocrinol_Metab_2012_Dec_16(Suppl_2)_S501-S503.nxml.txt.nlp	23565479	SENT9	12	12	0	0	estradiol	ACTH	PA449503	5443	0.522
NULL	Ann_Lab_Med_2012_Jul_20_32(4)_264-269.nxml.txt.nlp	22779067	SENT18	34	34	8	8	isoniazid	DST	PA450112	667	0.522
NULL	Clinics_(Sao_Paulo)_2013_Jun_68(6)_766-771.nxml.txt.nlp	23778483	SENT22	37	37	32	32	hydroxychloroquine	IL-22	PA164777036	50616;53342	0.522
NULL	J_Immunol_Res_2014_Feb_3_2014_671431.nxml.txt.nlp	24741615	SENT234	13	13	36	36	paraformaldehyde	CD27	PA450790	939	0.522
NULL	Diabetes_2011_Nov_17_60(11)_2928-2938.nxml.txt.nlp	21885868	SENT312	7	7	10	10	curcumin	TNF-alpha	PA151958596	7124	0.522
NULL	Mol_Cell_Proteomics_2012_Feb_6_11(2)_M111_015222.nxml.txt.nlp	22147731	SENT386	30	30	21	21	gefitinib	PRIM1	PA131301952	5557	0.522
NULL	J_Cell_Biol_2001_Nov_26_155(5)_845-858.nxml.txt.nlp	11724824	SENT260	6	6	29	29	heparin	Era	PA449855	2099	0.522
NULL	Anc_Sci_Life_2013_Jan_32(Suppl_2)_S7.nxml.txt.nlp	NULL	SENT9	0	0	35	35	curcumin	CO2	PA151958596	4513	0.522
NULL	Infect_Dis_Ther_2013_Dec_3_2(2)_111-122.nxml.txt.nlp	25134475	SENT96	33	33	0	0	tenofovir	ATV	PA10204	4683	0.522
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT128	26	26	35	35	erlotinib	CYP3A	PA134687924	1574	0.522
NULL	J_Lipid_Res_2012_Nov_53(11)_2256-2265.nxml.txt.nlp	22904345	SENT396	12	12	8	8	lipase	CD36	PA450239	948	0.522
NULL	Oncogene_2013_Sep_12_32(37)_4355-4365.nxml.txt.nlp	23108409	SENT52	6	6	4	4	hyaluronan	HAS2	PA165958431	3037	0.522
NULL	Adv_Ther_2014_Dec_2_31_1228-1246.nxml.txt.nlp	25447269	SENT140	48	48	40	40	timolol	TIM	PA451690	7984;8914	0.522
NULL	Aging_Cell_2007_Jun_6(3)_361-370.nxml.txt.nlp	17517043	SENT97	19	19	7	7	l-cysteine	EAAC1	PA449173	6505	0.522
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jan_21_68(Pt_2)_m178-m179.nxml.txt.nlp	22346852	SENT10	10	10	27	27	ethanol	mol	PA448073	90527	0.522
NULL	Chem_Rev_2012_May_9_112(5)_2593-2603.nxml.txt.nlp	22335786	SENT41	12	12	10	10	choline	LPA	PA448976	4018	0.522
NULL	Mol_Cells_2014_Sep_30_37(9)_664-671.nxml.txt.nlp	25234467	SENT202	3	3	5	5	cisplatin	miR-217	PA449014	406999	0.522
NULL	Mol_Vis_2012_Jun_22_18_1696-1700.nxml.txt.nlp	22773907	SENT132	17	17	8	8	colchicine	MDR1	PA449092	5243	0.522
NULL	Breast_Cancer_(Auckl)_2014_Jul_29_8_109-118.nxml.txt.nlp	25125981	SENT70	12	12	14	14	lapatinib	HER2	PA152241907	2064	0.522
NULL	Front_Endocrinol_(Lausanne)_2013_Jul_8_4_83.nxml.txt.nlp	23847594	SENT70	28	28	10	10	heparin	KAL1	PA449855	3730	0.522
NULL	Diabetes_Care_2012_Apr_13_35(4)_706-710.nxml.txt.nlp	22357189	SENT194	10	10	3	3	glucose	Tech	PA449773	57449	0.522
NULL	J_Exp_Med_1998_Jun_1_187(11)_1885-1892.nxml.txt.nlp	9607928	SENT13	7	7	9	9	thalidomide	ENL	PA451644	4298	0.522
NULL	Semin_Immunopathol_2013_Jan_26_35(1)_39-52.nxml.txt.nlp	22829332	SENT197	23	23	30	30	vincristine	CHOP	PA451879	1649	0.522
NULL	Curr_Cardiol_Rev_2012_May_8(2)_137-151.nxml.txt.nlp	22708912	SENT236	9	9	1	1	atropine	ACLS	PA448505	46;2737	0.522
NULL	F1000Res_2013_Feb_28_2_65.nxml.txt.nlp	24358861	SENT69	26	26	24	24	naloxone	TLR4	PA450586	7099	0.522
NULL	Nat_Commun_2013_Apr_23_4_1758.nxml.txt.nlp	23612299	SENT562	9	9	7	7	isoproterenol	SOD1	PA450121	6647	0.522
NULL	J_Cell_Biol_2004_Dec_6_167(5)_863-874.nxml.txt.nlp	15569715	SENT19	8	8	4	4	galactose	DAG	PA449725	1605	0.522
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT1424	12	12	9	9	heparin	HGF	PA449855	3569;6654;3082	0.522
NULL	J_Cell_Biol_2002_Jun_24_157(7)_1151-1160.nxml.txt.nlp	12082077	SENT115	13	13	16	16	trypsin	COX	PA451806	1351	0.522
NULL	Indian_J_Pharmacol_2008_Oct_40(Suppl_2)_S37-S56.nxml.txt.nlp	21593978	SENT1150	15	15	9	9	pregabalin	gamma	PA164754814	9913	0.522
NULL	J_Biol_Chem_2013_Oct_11_288(41)_29642-29653.nxml.txt.nlp	24005673	SENT553	9	9	3	3	trypsin	PTX3	PA451806	5806	0.522
NULL	J_Anaesthesiol_Clin_Pharmacol_2011_Jan-Mar_27(1)_91-96.nxml.txt.nlp	21804715	SENT50	38	38	29	29	oxygen	MBP	PA450744	5553;4155	0.522
NULL	J_Vet_Med_Sci_2014_May_10_76(5)_719-722.nxml.txt.nlp	24419873	SENT39	11	11	14	14	propranolol	PRL	PA451145	5617	0.522
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_P108.nxml.txt.nlp	NULL	SENT15	30	30	19	19	piperacillin	CD4	PA450975	920	0.522
NULL	Mol_Syst_Biol_2010_Jun_8_6_375.nxml.txt.nlp	20531405	SENT37	3	3	10	10	simvastatin	HMGCR	PA451363	3156	0.522
NULL	Cells_2012_Sep_28_1(4)_699-710.nxml.txt.nlp	24710526	SENT80	12	12	23	23	hyaluronan	HMGB1	PA165958431	3146	0.522
NULL	Int_J_Inflam_2011_Oct_30_2011_642612.nxml.txt.nlp	22121495	SENT49	15	15	12	12	lipase	FABP4	PA450239	2167	0.522
NULL	Arthritis_Res_Ther_2007_Nov_29_9(6)_222.nxml.txt.nlp	18086320	SENT48	26	26	8	8	procainamide	TLR9	PA451108	54106	0.522
NULL	Nucleic_Acids_Res_2013_Nov_16_41(20)_9349-9360.nxml.txt.nlp	23956219	SENT165	20	20	10	10	cisplatin	RMI1	PA449014	80010	0.522
NULL	CNS_Drugs_2013_Aug_20_27(12)_1081-1092.nxml.txt.nlp	23959815	SENT177	4	4	0	0	lisdexamfetamine	ATX	PA164748975	5168;23049	0.522
NULL	Front_Genet_2012_Oct_10_3_206.nxml.txt.nlp	23087703	SENT621	15	15	13	13	proguanil	CYP2C19	PA451124	1557	0.522
NULL	Evid_Based_Complement_Alternat_Med_2014_May_8_2014_364819.nxml.txt.nlp	24899907	SENT169	32	32	30	30	tacrolimus	FKBP52	PA451578	2288	0.522
NULL	Evid_Based_Complement_Alternat_Med_2014_May_8_2014_364819.nxml.txt.nlp	24899907	SENT183	19	19	17	17	tacrolimus	FKBP52	PA451578	2288	0.522
NULL	J_Hematol_Oncol_2010_Apr_7_3_13.nxml.txt.nlp	20374647	SENT174	21	21	19	19	flavopiridol	CDK2	PA452627	1017	0.522
NULL	Iran_Red_Crescent_Med_J_2014_Aug_5_16(8)_e6915.nxml.txt.nlp	25389496	SENT164	9	9	21	21	atorvastatin	adiponectin	PA448500	9370	0.522
NULL	J_Neuroinflammation_2011_Feb_4_8_10.nxml.txt.nlp	21294877	SENT6	15	15	26	26	capsaicin	TAC1	PA448776	6863	0.522
NULL	Cancer_Cell_Int_2009_Aug_18_9_23.nxml.txt.nlp	19689790	SENT12	12	12	18	18	hyperforin	TRPC6	PA165985514	7225	0.522
NULL	Mol_Vis_2012_Jan_12_18_74-80.nxml.txt.nlp	22262940	SENT46	22	22	39	39	l-glutamine	CO2	PA10090	4513	0.522
NULL	Oncotarget_2014_Aug_19_5(18)_8737-8749.nxml.txt.nlp	25228590	SENT81	9	9	6	6	crizotinib	MYCN	PA165946122	4613	0.522
NULL	Curr_Genomics_2014_Jun_15(3)_217-230.nxml.txt.nlp	24955029	SENT16	9	9	7	7	glucose	mol	PA449773	90527	0.522
NULL	Case_Rep_Med_2010_Mar_30_2010_836214.nxml.txt.nlp	20369069	SENT78	2	2	9	9	aripiprazole	CD4	PA10026	920	0.522
NULL	J_Cell_Biol_2004_Dec_6_167(5)_973-983.nxml.txt.nlp	15583034	SENT320	14	14	20	20	ethanol	CO2	PA448073	4513	0.522
NULL	Exp_Transl_Stroke_Med_2014_Nov_4_6(1)_11.nxml.txt.nlp	NULL	SENT40	12	12	8	8	isoflurane	CO2	PA450106	4513	0.522
NULL	Leukemia_2013_Apr_14_27(4)_803-812.nxml.txt.nlp	23238589	SENT53	29	29	26	26	imatinib	IFN	PA10804	3439	0.522
NULL	Curr_Neuropharmacol_2008_Sep_6(3)_193-202.nxml.txt.nlp	19506720	SENT220	6	6	12	12	fluoxetine	ghrelin	PA449673	51738	0.522
NULL	Trials_2012_Jul_26_13_118.nxml.txt.nlp	22834768	SENT162	15	15	13	13	estradiol	PAPP-A	PA449503	5069	0.522
NULL	Cancer_Res_Treat_2010_Dec_31_42(4)_185-190.nxml.txt.nlp	21253319	SENT150	30	30	28	28	oxaliplatin	GSTP1	PA131285527	2950	0.522
NULL	Clin_Dev_Immunol_2013_May_29_2013_289458.nxml.txt.nlp	23818912	SENT221	6	6	21	21	denosumab	DKK1	PA166048634	22943	0.522
NULL	Leukemia_2013_Apr_14_27(4)_803-812.nxml.txt.nlp	23238589	SENT3	15	15	21	21	hydroxyurea	IFN	PA449942	3439	0.522
NULL	Antimicrob_Resist_Infect_Control_2012_Mar_16_1_12.nxml.txt.nlp	22958880	SENT107	42	42	16	16	norfloxacin	Gen	PA450654	348654	0.522
NULL	Case_Rep_Rheumatol_2012_Dec_24_2012_270315.nxml.txt.nlp	23424706	SENT50	14	14	7	7	tocilizumab	IL-6	PA165292659	3569	0.522
NULL	J_Biol_Chem_2013_Nov_15_288(46)_33016-33026.nxml.txt.nlp	24089531	SENT119	43	43	16	16	s-adenosylmethionine	SET	PA164754994	6418	0.522
NULL	Nat_Neurosci_2014_Jun_4_17(6)_813-821.nxml.txt.nlp	24793032	SENT431	21	21	24	24	topotecan	E12	PA451729	64100	0.522
NULL	J_Korean_Med_Sci_2007_Jun_30_22(3)_412-419.nxml.txt.nlp	17596646	SENT73	11	11	31	31	fluorescein	CD33	PA164746009	945	0.522
NULL	Exp_Ther_Med_2013_Jul_25_6(1)_109-114.nxml.txt.nlp	23935730	SENT150	25	25	27	27	rituximab	CHOP	PA451261	1649	0.522
NULL	Mol_Biol_Rep_2013_Jul_11_40(7)_4211-4217.nxml.txt.nlp	23666051	SENT120	20	20	9	9	celiprolol	SLCO2B1		11309	0.522
NULL	Amino_Acids_2012_May_25_42(5)_1529-1539.nxml.txt.nlp	21437784	SENT32	2	2	9	9	taurine	STZ	PA451590	6484	0.522
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT257	1	1	14	14	doxorubicin	SLK	PA449412	9748;2534	0.522
NULL	Crit_Care_2011_Mar_22_15(2)_211.nxml.txt.nlp	21457505	SENT42	16	16	14	14	heparin	PF4	PA449855	5196	0.522
NULL	Cancers_(Basel)_2010_Dec_23_3(1)_17-42.nxml.txt.nlp	24212604	SENT734	20	20	10	10	carboplatin	PPX	PA448803	5531	0.522
NULL	Br_J_Cancer_1988_Apr_57(4)_348-352.nxml.txt.nlp	3390371	SENT10	8	8	15	15	vincristine	PMI	PA451879	8834;5373	0.522
NULL	Biomed_Res_Int_2014_Jun_26_2014_161346.nxml.txt.nlp	25054130	SENT236	11	11	21	21	curcumin	STZ	PA151958596	6484	0.522
NULL	Eur_J_Immunol_2014_Aug_24_44(8)_2380-2393.nxml.txt.nlp	24782112	SENT368	11	11	17	17	oxygen	CARD9	PA450744	64170	0.522
NULL	Iran_J_Public_Health_2012_Mar_31_41(3)_127-132.nxml.txt.nlp	23113157	SENT86	22	22	20	20	cefotaxime	CTX	PA448852	1593	0.522
NULL	Acta_Pharmacol_Sin_2012_Jan_21_33(1)_19-26.nxml.txt.nlp	22101171	SENT57	20	20	25	25	papain	DTE	PA450778	199699	0.522
NULL	Diabetes_Care_2010_Jul_31_33(7)_1607-1609.nxml.txt.nlp	20357375	SENT12	12	12	25	25	sitagliptin	MCP-1	PA164748978	6347	0.522
NULL	Mol_Cancer_2010_Apr_21_9_83.nxml.txt.nlp	20409325	SENT192	12	12	16	16	cisplatin	XIAP	PA449014	331	0.522
NULL	Cancer_Cell_Int_2005_Jul_24_5_22.nxml.txt.nlp	16042792	SENT112	23	23	21	21	vincristine	NAC	PA451879	22861	0.522
NULL	Patient_Prefer_Adherence_2008_Feb_2_2_167-175.nxml.txt.nlp	19920959	SENT19	23	23	38	38	clopidogrel	DES	PA449053	1674	0.522
NULL	AIDS_Res_Ther_2006_Apr_24_3_12.nxml.txt.nlp	16635263	SENT147	18	18	23	23	fluorescein	PEG3	PA164746009	5178	0.522
NULL	Br_J_Cancer_2012_Sep_25_107(7)_1059-1068.nxml.txt.nlp	22935581	SENT27	28	28	12	12	everolimus	IFN	PA164746311	3439	0.522
NULL	Ann_Thorac_Med_2007_Apr-Jun_2(2)_52-57.nxml.txt.nlp	19727346	SENT129	44	44	20	20	meropenem	CTX	PA164764445	1593	0.522
NULL	Br_J_Cancer_2013_Sep_3_109(5)_1079-1084.nxml.txt.nlp	23928659	SENT69	8	8	12	12	docetaxel	DES	PA449383	1674	0.522
NULL	Breast_Cancer_(Auckl)_2009_Sep_2_3_61-75.nxml.txt.nlp	19809577	SENT127	4	4	19	19	curcumin	PARP	PA151958596	142	0.522
NULL	Cancer_Med_2013_Apr_6_2(2)_234-242.nxml.txt.nlp	23634291	SENT162	41	41	15	15	bevacizumab	VEGF-D	PA130232992	2277	0.522
NULL	Mol_Vis_2010_Sep_2_16_1781-1790.nxml.txt.nlp	20824160	SENT293	4	4	15	15	acetylcysteine	IL-8	PA448033	3576	0.522
NULL	Hematol_Rep_2012_Dec_6_4(4)_e26.nxml.txt.nlp	23355944	SENT46	7	7	24	24	filgrastim	CD34	PA449626	947	0.522
NULL	Diabetes_Care_2011_Jul_17_34(7)_1678-1680.nxml.txt.nlp	21709302	SENT83	27	27	7	7	ramipril	DREAM	PA451223	30818	0.522
NULL	Braz_J_Med_Biol_Res_2014_Sep_5_47(11)_1008-1015.nxml.txt.nlp	25296365	SENT23	0	0	2	2	tamoxifen	TMX	PA451581	81542	0.522
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT162	9	9	18	18	trastuzumab	MUC4	PA451743	4585	0.522
NULL	Oncogene_2010_Jul_8_29(27)_3953-3963.nxml.txt.nlp	20440263	SENT21	11	11	27	27	oxygen	ROS	PA450744	6098	0.522
NULL	Kidney_Int_Suppl_(2011)_2013_Dec_27_3(5)_436-441.nxml.txt.nlp	25019026	SENT130	4	4	22	22	cinacalcet	PTH	PA164776671	5741	0.522
NULL	Mol_Biol_Int_2011_Feb_24_2011_137459.nxml.txt.nlp	22091395	SENT201	8	8	35	35	arsenite	PRMT3	PA452638	10196	0.522
NULL	Int_J_Biol_Sci_2014_Jun_10_10(7)_654-663.nxml.txt.nlp	25013375	SENT211	0	0	11	11	itraconazole	SMO	PA450132	6608;54498	0.522
NULL	F1000_Med_Rep_2012_Feb_1_4_4.nxml.txt.nlp	22312414	SENT115	22	22	15	15	vancomycin	Yes	PA451850	7525	0.522
NULL	Biomed_Res_Int_2014_May_20_2014_418975.nxml.txt.nlp	24967364	SENT198	0	0	8	8	resveratrol	SIRT1		23411	0.522
NULL	Mar_Drugs_2014_Jun_27_12(7)_3818-3837.nxml.txt.nlp	24979269	SENT558	0	0	10	10	nilotinib	ABCG2	PA165958345	9429	0.522
NULL	J_Autom_Methods_Manag_Chem_2008_Mar_31_2008_498921.nxml.txt.nlp	18401449	SENT117	24	24	33	33	lipase	CA125	PA450239	4077;94025	0.522
NULL	Eur_Arch_Otorhinolaryngol_2013_Mar_13_270(4)_1397-1404.nxml.txt.nlp	23404469	SENT192	6	6	4	4	dasatinib	DDP	PA162372878	1678	0.522
NULL	J_Biol_Chem_2009_Apr_24_284(17)_11572-11578.nxml.txt.nlp	19244244	SENT314	28	28	24	24	lipase	ATGL	PA450239	57104	0.522
NULL	Int_J_Biomater_2014_Jul_2_2014_924278.nxml.txt.nlp	25101127	SENT125	23	23	20	20	curcumin	GIT	PA151958596	5034	0.522
NULL	Nat_Commun_2014_Dec_8_5_5736.nxml.txt.nlp	25484020	SENT612	30	30	37	37	tamoxifen	ATAC	PA451581	6375	0.522
NULL	Case_Rep_Oncol_2014_Mar_26_7(1)_204-209.nxml.txt.nlp	24803896	SENT66	11	11	13	13	trabectedin	MRCL	PA165958349	348174	0.521
NULL	Trials_2013_Sep_24_14_311.nxml.txt.nlp	24063608	SENT372	27	27	29	29	amodiaquine	IPT	PA448404	54802	0.521
NULL	Curr_Neuropharmacol_2010_Sep_8(3)_287-304.nxml.txt.nlp	21358978	SENT249	13	13	15	15	fluoxetine	5-HT1A	PA449673	3350	0.521
NULL	Arthritis_Res_Ther_2006_May_11_8(3)_209.nxml.txt.nlp	16712713	SENT551	1	1	6	6	methotrexate	Yes	PA450428	7525	0.521
NULL	Front_Genet_2013_Aug_29_4_163.nxml.txt.nlp	24009622	SENT206	32	32	36	36	ethanol	DDP	PA448073	1678	0.521
NULL	Cases_J_2008_Nov_19_1_331.nxml.txt.nlp	19019232	SENT19	8	8	13	13	metoprolol	ACE	PA450480	1636	0.521
NULL	Front_Immunol_2013_Mar_27_4_76.nxml.txt.nlp	23543707	SENT74	16	16	22	22	alemtuzumab	EGFR	PA164783958	1956	0.521
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Apr_15_9_13.nxml.txt.nlp	20398300	SENT134	4	4	0	0	amoxicillin	LAM	PA448406	7249;7248	0.521
NULL	Arthritis_Res_Ther_2009_Aug_24_11(4)_R127.nxml.txt.nlp	19703304	SENT119	21	21	27	27	adalimumab	OASIS	PA10004	90993	0.521
NULL	Arthritis_Res_Ther_2009_Apr_6_11(Suppl_1)_S1.nxml.txt.nlp	19368701	SENT122	9	9	0	0	abatacept	ACR	PA164747080	49	0.521
NULL	Diabetes_2013_Jun_17_62(6)_1888-1896.nxml.txt.nlp	23349492	SENT367	14	14	16	16	hyaluronan	CD44	PA165958431	960	0.521
NULL	Arthritis_Res_Ther_2011_Feb_3_13(1)_102.nxml.txt.nlp	21345249	SENT46	0	0	19	19	curcumin	IL-6	PA151958596	3569	0.521
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT17	0	0	13	13	atorvastatin	PTEN	PA448500	5728	0.521
NULL	Mol_Biol_Cell_2013_Sep_1_24(17)_2678-2688.nxml.txt.nlp	23864716	SENT124	18	18	15	15	thrombin	Rho	PA451674	29984	0.521
NULL	Front_Oncol_2013_Apr_23_3_86.nxml.txt.nlp	23630663	SENT104	15	15	20	20	maytansine	DM1	PA165291473	338023;1760;28509	0.521
NULL	Epigenetics_Chromatin_2014_Jun_26_7_12.nxml.txt.nlp	25028596	SENT216	23	23	6	6	l-glutamine	DR4	PA10090	8797	0.521
NULL	Case_Rep_Dermatol_2012_Mar_23_4(1)_61-65.nxml.txt.nlp	22548038	SENT48	20	20	32	32	methotrexate	gamma	PA450428	9913	0.521
NULL	Front_Endocrinol_(Lausanne)_2014_Feb_28_5_23.nxml.txt.nlp	24592256	SENT74	4	4	0	0	candesartan	GLP-1	PA448765	100125288	0.521
NULL	Mol_Pain_2013_Mar_4_9_9.nxml.txt.nlp	23497345	SENT319	14	14	10	10	collagenase	CO2	PA449107	4513	0.521
NULL	Br_J_Dermatol_2013_Aug_13_169(2)_374-383.nxml.txt.nlp	23517330	SENT78	16	16	21	21	glutaraldehyde	mol	PA449777	90527	0.521
NULL	Iran_J_Neurol_2012_11(2)_70-73.nxml.txt.nlp	24250865	SENT90	12	12	7	7	doxycycline	IFN	PA449415	3439	0.521
NULL	J_Biol_Chem_2008_Dec_19_283(51)_35419-35427.nxml.txt.nlp	18955485	SENT65	19	19	7	7	pp2	PP1		5540;5464	0.521
NULL	Channels_(Austin)_2010_Jan_1_4(1)_22-41.nxml.txt.nlp	19934650	SENT15	15	15	21	21	quinidine	Slo3	PA451209	157855	0.521
NULL	Diabetes_2009_Dec_15_58(12)_2766-2775.nxml.txt.nlp	19755527	SENT63	3	3	12	12	glucose	NEFA	PA449773	4925	0.521
NULL	Eur_J_Pharmacol_2008_Feb_12_580(3-3)_291-297.nxml.txt.nlp	18082160	SENT100	17	17	19	19	granisetron	5-HT3A	PA449809	3359	0.521
NULL	Nucleic_Acids_Res_2005_Aug_12_33(14)_4584-4592.nxml.txt.nlp	16100380	SENT112	8	8	12	12	paromomycin	GCN2	PA164784023	440275	0.521
NULL	Adv_Ther_2014_Dec_2_31_1228-1246.nxml.txt.nlp	25447269	SENT119	4	4	28	28	tafluprost	TIM	PA165958432	7984;8914	0.521
NULL	J_Korean_Med_Sci_2009_Oct_24_24(5)_910-917.nxml.txt.nlp	19794992	SENT23	6	6	13	13	trastuzumab	HER2	PA451743	2064	0.521
NULL	Case_Rep_Transplant_2014_Jan_2_2014_548243.nxml.txt.nlp	24575309	SENT80	9	9	27	27	sirolimus	CYP3A	PA451365	1574	0.521
NULL	Comput_Math_Methods_Med_2013_Mar_20_2013_802512.nxml.txt.nlp	23573174	SENT81	20	20	16	16	doxycycline	MYC	PA449415	4609	0.521
NULL	Mol_Cancer_2008_Mar_26_7_27.nxml.txt.nlp	18366759	SENT267	14	14	32	32	etoposide	MCL1	PA449552	4170	0.521
NULL	Eur_J_Nucl_Med_Mol_Imaging_2010_Aug_9_37(Suppl_1)_104-113.nxml.txt.nlp	20617435	SENT75	10	10	16	16	bevacizumab	VEGF-A	PA130232992	7422	0.521
NULL	Biomed_Res_Int_2014_Jan_29_2014_361020.nxml.txt.nlp	24605326	SENT223	7	7	22	22	flavopiridol	CDK2	PA452627	1017	0.521
NULL	Breast_Cancer_Res_2013_Nov_29_15(6)_R114.nxml.txt.nlp	24289103	SENT215	20	20	0	0	tamoxifen	EGFR	PA451581	1956	0.521
NULL	Cardiovasc_Diabetol_2013_Nov_21_12_172.nxml.txt.nlp	24261558	SENT74	36	36	9	9	l-glutamine	CO2	PA10090	4513	0.521
NULL	Int_J_Mol_Sci_2010_Sep_13_11(9)_3195-3208.nxml.txt.nlp	20957088	SENT206	11	11	16	16	lipase	AT2	PA450239	186	0.521
NULL	Arthritis_Res_Ther_2005_Aug_25_7(6)_R1208-R1220.nxml.txt.nlp	16277673	SENT356	15	15	26	26	fluorescein	CXCR4	PA164746009	7852	0.521
NULL	Clinics_(Sao_Paulo)_2013_Sep_68(9)_1247-1254.nxml.txt.nlp	24141842	SENT184	0	0	22	22	estradiol	NF-kappaB	PA449503	4790	0.521
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT70	10	10	18	18	pemetrexed	UNG	PA10810	7374	0.521
NULL	Environ_Health_Perspect_2008_Mar_13_116(3)_340-348.nxml.txt.nlp	18335101	SENT48	7	7	3	3	choline	HC3	PA448976	5683;360177	0.521
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT1443	44	44	14	14	heparin	ECM	PA449855	22915	0.521
NULL	Toxins_(Basel)_2011_Jun_10_3(6)_551-565.nxml.txt.nlp	22069725	SENT203	11	11	7	7	choline	PTMA	PA448976	5757	0.521
NULL	Arch_Med_Sci_2014_Feb_24_10(1)_154-160.nxml.txt.nlp	24701228	SENT137	0	0	11	11	thrombin	MCP-1	PA451674	6347	0.521
NULL	Int_J_Bipolar_Disord_2013_Jul_4_1_10.nxml.txt.nlp	25505677	SENT89	11	11	1	1	quetiapine	NNT	PA451201	23530	0.521
NULL	Front_Genet_2012_Sep_6_3_173.nxml.txt.nlp	22973297	SENT214	7	7	5	5	gemcitabine	FKBP5	PA449748	2289	0.521
NULL	Korean_Circ_J_2013_Jun_30_43(6)_400-407.nxml.txt.nlp	23882289	SENT142	37	37	5	5	doxorubicin	p38	PA449412	10598;1432;7965	0.521
NULL	Arthritis_Res_Ther_2006_Jul_28_8(Suppl_2)_S5.nxml.txt.nlp	16899109	SENT92	24	24	0	0	methotrexate	ACR	PA450428	49	0.521
NULL	Free_Radic_Biol_Med_2013_Dec_65(100)_1521-1532.nxml.txt.nlp	23806384	SENT707	0	0	9	9	spermine	ADP	PA164781199	23038	0.521
NULL	Arthritis_Res_Ther_2013_Oct_24_15(5)_R161.nxml.txt.nlp	24286516	SENT56	0	0	6	6	fluorescein	CD16	PA164746009	2215;2214	0.521
NULL	Eur_J_Clin_Pharmacol_2013_Jan_11_69(6)_1275-1283.nxml.txt.nlp	23307232	SENT82	41	41	10	10	warfarin	VKORC1	PA451906	79001	0.521
NULL	J_Korean_Med_Sci_1996_Jun_11(3)_250-257.nxml.txt.nlp	8843008	SENT7	0	0	2	2	nifedipine	NIF	PA450631	6280	0.521
NULL	Oncol_Lett_2013_Mar_19_5(3)_923-928.nxml.txt.nlp	23426648	SENT180	4	4	8	8	celecoxib	MVD	PA448871	4597	0.521
NULL	J_Hematol_Oncol_2013_Jul_9_6_49.nxml.txt.nlp	23837843	SENT216	37	37	43	43	verapamil	MRK	PA451868	22858	0.521
NULL	Part_Fibre_Toxicol_2012_Aug_17_9_33.nxml.txt.nlp	22901679	SENT348	21	21	39	39	l-glutamine	GM-CSF	PA10090	1437	0.521
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT167	28	28	4	4	trastuzumab	STAT3	PA451743	6774	0.521
NULL	AMB_Express_2012_Dec_7_2_65.nxml.txt.nlp	23217124	SENT308	19	19	24	24	ethanol	SHF	PA448073	90525	0.521
NULL	Clin_Ophthalmol_2011_Feb_28_5_269-274.nxml.txt.nlp	21468332	SENT59	27	27	34	34	ketorolac	BAK	PA450150	578	0.521
NULL	Patient_Prefer_Adherence_2010_Sep_7_4_313-324.nxml.txt.nlp	20859458	SENT70	0	0	11	11	exenatide	PPG	PA164749238	5552	0.521
NULL	Crit_Care_2001_Jul_3_5(Suppl_C)_8.nxml.txt.nlp	NULL	SENT18	2	2	8	8	fentanyl	CPBP	PA449599	1316	0.521
NULL	Int_J_Biochem_Cell_Biol_2011_May_43(5)_805-811.nxml.txt.nlp	21334453	SENT159	25	25	14	14	lipase	IFN	PA450239	3439	0.521
NULL	J_Ophthalmic_Inflamm_Infect_2011_Nov_6_2(1)_21-28.nxml.txt.nlp	22057810	SENT81	11	11	13	13	cyclosporine	CTX	PA449167	1593	0.521
NULL	Oncol_Lett_2013_Feb_27_5(2)_435-439.nxml.txt.nlp	23420613	SENT22	11	11	7	7	carboplatin	EGFR	PA448803	1956	0.521
NULL	Aging_(Albany_NY)_2009_Jul_31_1(9)_784-802.nxml.txt.nlp	20157567	SENT294	10	10	30	30	collagenase	CO2	PA449107	4513	0.521
NULL	J_Korean_Med_Sci_2007_Dec_20_22(6)_1055-1059.nxml.txt.nlp	18162722	SENT36	7	7	5	5	famotidine	ESD	PA449586	2098	0.521
NULL	Ther_Clin_Risk_Manag_2005_Jun_1(2)_125-140.nxml.txt.nlp	18360552	SENT174	16	16	10	10	cyclosporine	gamma	PA449167	9913	0.521
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Dec_2_5_30.nxml.txt.nlp	17140452	SENT187	31	31	29	29	chloramphenicol	CHL	PA448927	91851	0.521
NULL	Arthritis_Res_Ther_2006_Mar_22_8(3)_R62.nxml.txt.nlp	16563187	SENT279	2	2	5	5	fluorescein	ICOS	PA164746009	29851;1493	0.521
NULL	Clin_Drug_Investig_2013_Jun_20_33(6)_419-427.nxml.txt.nlp	23605507	SENT161	8	8	15	15	ciprofloxacin	DPI	PA449009	1832	0.521
NULL	J_Immunol_Res_2014_Feb_3_2014_671431.nxml.txt.nlp	24741615	SENT241	16	16	34	34	paraformaldehyde	CD11c	PA450790	3687	0.521
NULL	Int_J_Alzheimers_Dis_2011_May_2_2011_985085.nxml.txt.nlp	21629716	SENT53	9	9	27	27	hemin	NF-E2	PA449849	4778	0.521
NULL	Fibrogenesis_Tissue_Repair_2011_Aug_2_4_18.nxml.txt.nlp	21810214	SENT156	21	21	18	18	bleomycin	IFN	PA448645	3439	0.521
NULL	Anticancer_Agents_Med_Chem_2010_Oct_10(8)_617-624.nxml.txt.nlp	21182469	SENT267	20	20	5	5	tamoxifen	ABCC11	PA451581	85320	0.521
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1051.nxml.txt.nlp	24503543	SENT144	28	28	19	19	erlotinib	Yes	PA134687924	7525	0.521
NULL	J_Immunother_Cancer_2014_Nov_6_2(Suppl_3)_P250.nxml.txt.nlp	NULL	SENT4	11	11	5	5	l-tryptophan	IDO1	PA10323	3620	0.521
NULL	EMBO_J_2014_Jul_17_33(14)_1514-1526.nxml.txt.nlp	24872509	SENT100	22	22	30	30	zinc	mer	PA451956	10461	0.521
NULL	J_Biomed_Sci_2014_Apr_29_21(1)_35.nxml.txt.nlp	24780003	SENT35	11	11	8	8	bevacizumab	NIRF	PA130232992	27190;115426	0.521
NULL	J_Vis_Exp_2011_Jun_24_(52)_3094.nxml.txt.nlp	21730945	SENT111	23	23	41	41	rifabutin	EMB	PA451249	133418	0.521
NULL	J_Immunol_Res_2014_Feb_10_2014_264723.nxml.txt.nlp	24741582	SENT17	26	26	29	29	rituximab	CHOP	PA451261	1649	0.521
NULL	Cancer_Cell_Int_2003_Jul_23_3_12.nxml.txt.nlp	12914669	SENT80	19	19	12	12	doxycycline	PP1	PA449415	5540;5464	0.521
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT227	12	12	16	16	simvastatin	survivin	PA451363	332	0.521
NULL	Cancer_Microenviron_2008_Dec_20_1(1)_103-111.nxml.txt.nlp	19308689	SENT226	25	25	8	8	thrombin	PAR-1	PA451674	2011;2149	0.521
NULL	Crit_Care_2006_Feb_3_10(1)_R24.nxml.txt.nlp	16469128	SENT149	13	13	28	28	heparin	TP1	PA449855	7011	0.521
NULL	Mol_Cancer_2007_Aug_21_6_53.nxml.txt.nlp	17711579	SENT262	7	7	16	16	cisplatin	SPATA22	PA449014	84690	0.521
NULL	Ann_Intensive_Care_2011_Jul_19_1_26.nxml.txt.nlp	21906376	SENT85	43	43	19	19	vancomycin	SAPS	PA451850	8935	0.521
NULL	Ann_Thorac_Med_2007_Apr-Jun_2(2)_52-57.nxml.txt.nlp	19727346	SENT129	10	10	20	20	amikacin	CTX	PA164744372	1593	0.521
NULL	Int_J_Cardiovasc_Imaging_2013_Jun_3_29(5)_959-966.nxml.txt.nlp	23378157	SENT84	23	23	19	19	iodine	HGB	PA450049	114757	0.521
NULL	Iran_J_Pharm_Res_2014_Summer_13(3)_881-892.nxml.txt.nlp	25276188	SENT235	14	14	22	22	piperazine	FAAH	PA450977	79152;2166	0.521
NULL	Int_J_Biol_Sci_2015_Jan_1_11(1)_48-58.nxml.txt.nlp	25552929	SENT35	5	5	24	24	paclitaxel	VEGFR2	PA450761	3791	0.521
NULL	Clin_Med_Insights_Oncol_2011_May_18_5_145-156.nxml.txt.nlp	21695099	SENT287	2	2	6	6	vincristine	BOP	PA451879	611;150572	0.521
NULL	Cancer_Med_2013_Dec_27_2(6)_751-762.nxml.txt.nlp	24403249	SENT299	17	17	40	40	paclitaxel	KLF4	PA450761	9314	0.521
NULL	Biomed_Res_Int_2013_Mar_28_2013_154073.nxml.txt.nlp	23607088	SENT21	9	9	18	18	clopidogrel	CYP2C19	PA449053	1557	0.521
NULL	Arthritis_Res_Ther_2005_Apr_4_7(4)_R756-R768.nxml.txt.nlp	15987477	SENT4	13	13	8	8	hyaluronidase	PH-20	PA164745713	6677	0.521
NULL	Front_Neurosci_2014_Jun_24_8_176.nxml.txt.nlp	25009459	SENT754	8	8	2	2	ivermectin	P2X4	PA450133	5025	0.521
NULL	Curr_Control_Trials_Cardiovasc_Med_2005_May_23_6(1)_9.nxml.txt.nlp	15910680	SENT106	26	26	13	13	ezetimibe	SHARP	PA10816	23013	0.521
NULL	Br_J_Cancer_2010_Jul_13_103(2)_186-195.nxml.txt.nlp	20588277	SENT200	0	0	2	2	nutlin-3	p53		7157	0.521
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Oct_31_66(Pt_11)_o3017-o3018.nxml.txt.nlp	21589176	SENT8	3	3	13	13	isoniazid	mol	PA450112	90527	0.521
NULL	Eur_J_Clin_Pharmacol_2014_May_21_70(8)_915-920.nxml.txt.nlp	24839948	SENT128	27	27	9	9	nifedipine	CYP3A4	PA450631	1576	0.521
NULL	Nano_Rev_2014_Feb_26_5_10_3402_nano_v5_22762.nxml.txt.nlp	24600516	SENT182	22	22	1	1	fluorescein	FISH	PA164746009	9644	0.521
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Dec_2_5_30.nxml.txt.nlp	17140452	SENT187	15	15	5	5	linezolid	GAT	PA450233	10249	0.521
NULL	Breast_Cancer_Res_2012_May_22_14(3)_R81.nxml.txt.nlp	22616919	SENT141	18	18	0	0	hyaluronan	HIF-1	PA165958431	29072	0.521
NULL	J_Oncol_2010_Jan_5_2010_257058.nxml.txt.nlp	20069126	SENT276	10	10	8	8	estradiol	p53	PA449503	7157	0.521
NULL	J_Parasitol_Res_2012_Aug_13_2012_296856.nxml.txt.nlp	22934153	SENT176	21	21	12	12	praziquantel	SWAP	PA164764583	6433;50618	0.521
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Apr_29_67(Pt_5)_o1266-o1267.nxml.txt.nlp	21754553	SENT71	38	38	35	35	ethanol	mol	PA448073	90527	0.521
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT181	2	2	22	22	curcumin	PUMA	PA151958596	27113	0.521
NULL	EPMA_J_2011_Sep_14_2(3)_271-276.nxml.txt.nlp	23199162	SENT88	6	6	16	16	iron	B12	PA450087	7126;4709	0.521
NULL	J_Cell_Biol_2008_Jul_14_182(1)_171-184.nxml.txt.nlp	18606850	SENT319	19	19	26	26	l-glutamine	EGF	PA10090	1950	0.521
NULL	Mol_Syst_Biol_2010_Feb_16_6_347.nxml.txt.nlp	20160708	SENT83	30	30	25	25	doxycycline	TRF2	PA449415	7014;9519	0.521
NULL	Ann_Clin_Transl_Neurol_2014_Jan_20_1(1)_15-26.nxml.txt.nlp	25356379	SENT159	5	5	18	18	isoflurane	EGO	PA450106	100126791	0.521
NULL	Int_J_Mol_Sci_2014_Nov_25_15(12)_21703-21722.nxml.txt.nlp	25429431	SENT985	36	36	19	19	curcumin	ABCG2	PA151958596	9429	0.521
NULL	Evid_Based_Complement_Alternat_Med_2012_May_7_2012_242810.nxml.txt.nlp	22645625	SENT254	4	4	12	12	rifampin	CYP3A4	PA451250	1576	0.521
NULL	Aging_(Albany_NY)_2014_Oct_30_6(10)_788-819.nxml.txt.nlp	25411230	SENT245	4	4	9	9	entacapone	COMT	PA164748726	1312	0.521
NULL	Exp_Neurobiol_2014_Jun_13_23(2)_124-129.nxml.txt.nlp	24963276	SENT38	0	0	5	5	naringin	FOR	PA151958360	51741	0.521
NULL	J_Clin_Biochem_Nutr_2007_May_25_40(3)_216-220.nxml.txt.nlp	18398499	SENT53	0	0	8	8	fluorescein	CD4	PA164746009	920	0.521
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT17	0	0	11	11	atorvastatin	PIK3CA	PA448500	5290	0.521
NULL	Nat_Biotechnol_2010_May_28(5)_478-485.nxml.txt.nlp	20458318	SENT343	19	19	11	11	cisplatin	NAG	PA449014	51594;4669	0.521
NULL	J_Clin_Biochem_Nutr_2011_Jul_14_49(1)_57-61.nxml.txt.nlp	21765608	SENT187	26	26	33	33	choline	GBF	PA448976	1316	0.521
NULL	Oncol_Lett_2014_Mar_16_7(3)_827-833.nxml.txt.nlp	24527090	SENT146	21	21	18	18	cisplatin	IFN	PA449014	3439	0.521
NULL	Front_Pharmacol_2014_Oct_31_5_231.nxml.txt.nlp	25400580	SENT4923	0	0	13	13	paclitaxel	CNT3	PA450761	64078	0.521
NULL	Apoptosis_2014_Aug_26_19(11)_1603-1615.nxml.txt.nlp	25156145	SENT193	5	5	10	10	mitomycin	JNK	PA450524	5599	0.521
NULL	Eur_J_Clin_Pharmacol_2012_Sep_15_68(9)_1267-1274.nxml.txt.nlp	22418828	SENT219	14	14	23	23	rabeprazole	CYP2C19	PA451216	1557	0.521
NULL	Cancer_Med_2012_Oct_6_1(2)_198-206.nxml.txt.nlp	23342269	SENT226	6	6	30	30	leucovorin	ROX	PA450198	4335	0.521
NULL	Drug_Target_Insights_2007_Oct_30_2_239-247.nxml.txt.nlp	21901078	SENT23	17	17	28	28	tocilizumab	CD152	PA165292659	1493	0.521
NULL	Iran_J_Pharm_Res_2013_Summer_12(3)_457-469.nxml.txt.nlp	24250652	SENT269	1	1	8	8	ethanol	spatial	PA448073	219793	0.521
NULL	J_Hematol_Oncol_2011_Mar_26_4_11.nxml.txt.nlp	21439076	SENT123	2	2	7	7	pemetrexed	Gem	PA10810	51053	0.521
NULL	Front_Chem_2013_Dec_16_1_36.nxml.txt.nlp	24790964	SENT164	33	33	25	25	phenol	COD	PA450913	6628	0.521
NULL	Oncotarget_2014_Feb_1_5(6)_1576-1594.nxml.txt.nlp	24742531	SENT370	8	8	6	6	doxorubicin	NGAL	PA449412	3934	0.521
NULL	AIDS_Res_Ther_2011_Oct_6_8_36.nxml.txt.nlp	21978457	SENT7	9	9	12	12	zinc	ZIP1	PA451956	27173	0.521
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Oct_31_65(Pt_11)_o2953.nxml.txt.nlp	21578526	SENT68	26	26	11	11	ethanol	mol	PA448073	90527	0.521
NULL	Front_Neurosci_2014_Aug_14_8_242.nxml.txt.nlp	25177264	SENT486	5	5	14	14	estradiol	aromatase	PA449503	1588	0.521
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT300	18	18	16	16	nelfinavir	ABCC1	PA450606	4363	0.521
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT192	39	39	20	20	afatinib	Yes	PA165981154	7525	0.521
NULL	Cancer_Cell_Int_2010_Aug_19_10_27.nxml.txt.nlp	20723247	SENT112	10	10	35	35	l-glutamine	CO2	PA10090	4513	0.521
NULL	Curr_Neuropharmacol_2010_Sep_8(3)_287-304.nxml.txt.nlp	21358978	SENT56	0	0	36	36	agomelatine	5-HT2B	PA165958363	3357	0.521
NULL	Breast_Cancer_(Auckl)_2011_Apr_13_5_53-65.nxml.txt.nlp	21603258	SENT239	8	8	21	21	paclitaxel	SPARC	PA450761	6678	0.521
NULL	Ann_Thorac_Med_2013_Apr-Jun_8(2)_109-115.nxml.txt.nlp	23741274	SENT3	21	21	13	13	cisplatin	CRT	PA449014	811	0.521
NULL	Cardiovasc_Diabetol_2013_Nov_2_12_158.nxml.txt.nlp	24180212	SENT42	2	2	4	4	acetylcysteine	NAC	PA448033	22861	0.521
NULL	Eur_Arch_Otorhinolaryngol_2013_Mar_13_270(4)_1397-1404.nxml.txt.nlp	23404469	SENT8	20	20	18	18	dasatinib	DDP	PA162372878	1678	0.521
NULL	Neuroimage_Clin_2014_Jul_22_5_359-364.nxml.txt.nlp	25161901	SENT269	2	2	0	0	chlorpromazine	CPZ	PA448964	8532	0.521
NULL	Mol_Cancer_2010_Apr_23_9_87.nxml.txt.nlp	20416058	SENT224	15	15	13	13	doxorubicin	TRAIL	PA449412	8743	0.521
NULL	EMBO_J_2013_Feb_20_32(4)_511-523.nxml.txt.nlp	23241948	SENT127	10	10	38	38	kanamycin	16A	PA450137	537	0.52
NULL	Case_Rep_Pediatr_2012_Aug_9_2012_323681.nxml.txt.nlp	22924145	SENT92	14	14	10	10	tocilizumab	IL-6	PA165292659	3569	0.52
NULL	Diabetes_Care_2013_Aug_17_36(Suppl_2)_S139-S144.nxml.txt.nlp	23882038	SENT206	20	20	26	26	metformin	GLP-1	PA450395	100125288	0.52
NULL	Respir_Med_Case_Rep_2012_Dec_31_8_10-13.nxml.txt.nlp	NULL	SENT100	3	3	8	8	tocilizumab	IL-6	PA165292659	3569	0.52
NULL	Indian_J_Dermatol_2010_Apr-Jun_55(2)_195-197.nxml.txt.nlp	20606896	SENT37	0	0	7	7	ivermectin	gamma	PA450133	9913	0.52
NULL	Int_J_Biomed_Sci_2013_Mar_9(1)_48-53.nxml.txt.nlp	23675289	SENT44	13	13	15	15	busulfan	IFN	PA448691	3439	0.52
NULL	Cases_J_2009_Mar_10_2_6464.nxml.txt.nlp	20181162	SENT6	37	37	35	35	ribavirin	IFN	PA451241	3439	0.52
NULL	Mol_Med_Rep_2015_Feb_5_11(2)_805-814.nxml.txt.nlp	25373883	SENT236	34	34	23	23	colchicine	APE	PA449092	55704;328	0.52
NULL	Onco_Targets_Ther_2014_Sep_9_7_1571-1582.nxml.txt.nlp	25228815	SENT138	1	1	6	6	sunitinib	VEGFR	PA162372840	3791	0.52
NULL	Curr_Opin_Endocrinol_Diabetes_Obes_2014_Oct_28_21(5)_313-322.nxml.txt.nlp	25105998	SENT173	26	26	23	23	liraglutide	GLP-1	PA165958364	100125288	0.52
NULL	Hum_Mol_Genet_2014_Aug_1_23(15)_4077-4085.nxml.txt.nlp	24670599	SENT90	3	3	16	16	lipase	PNPLA3	PA450239	80339	0.52
NULL	Nucl_Recept_Signal_2010_Apr_16_8_e004.nxml.txt.nlp	20419060	SENT1616	16	16	2	2	lipase	PPARgamma	PA450239	5468	0.52
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1051.nxml.txt.nlp	24503543	SENT144	24	24	19	19	tamoxifen	Yes	PA451581	7525	0.52
NULL	Arch_Med_Sci_2014_Feb_24_10(1)_154-160.nxml.txt.nlp	24701228	SENT137	0	0	16	16	thrombin	RANTES	PA451674	6352	0.52
NULL	Front_Neurosci_2013_Dec_24_7_254.nxml.txt.nlp	24399926	SENT167	24	24	0	0	zolpidem	ANOVA	PA451976	4858	0.52
NULL	Angiogenesis_2010_Dec_7_13(4)_305-315.nxml.txt.nlp	20927579	SENT169	5	5	16	16	resveratrol	p53		7157	0.52
NULL	Environ_Health_Perspect_2013_Mar_3_121(3)_332-338.nxml.txt.nlp	23458687	SENT90	30	30	18	18	l-glutamine	F12	PA10090	2161	0.52
NULL	Br_J_Cancer_2012_Dec_4_107(12)_1978-1986.nxml.txt.nlp	23169291	SENT43	12	12	0	0	cisplatin	P31	PA449014	529	0.52
NULL	Leukemia_2013_Apr_14_27(4)_803-812.nxml.txt.nlp	23238589	SENT150	32	32	34	34	imatinib	IFN	PA10804	3439	0.52
NULL	Front_Neurol_2013_Jun_25_4_78.nxml.txt.nlp	23805124	SENT78	7	7	18	18	lamotrigine	spatial	PA450164	219793	0.52
NULL	Int_J_Mol_Sci_2014_Mar_20_15(3)_4977-4993.nxml.txt.nlp	24658441	SENT490	0	0	17	17	resveratrol	AMPK		5563	0.52
NULL	Cell_Death_Dis_2014_Mar_13_5(3)_e1118.nxml.txt.nlp	24625977	SENT81	36	36	22	22	etoposide	UBXN2A	PA449552	165324	0.52
NULL	Diabetes_Care_2011_Aug_16_34(8)_1778-1784.nxml.txt.nlp	21700918	SENT53	23	23	9	9	ether	PCB	PA449525	5091	0.52
NULL	Tob_Control_2009_Feb_13_18(1)_34-42.nxml.txt.nlp	18845621	SENT274	28	28	44	44	ticlopidine	CYP2B6	PA451686	1555	0.52
NULL	BMB_Rep_2013_Nov_46(11)_533-538.nxml.txt.nlp	24152909	SENT236	1	1	7	7	curcumin	AP-1	PA151958596	2353;3727;2354;3725	0.52
NULL	Cholesterol_2012_Jul_25_2012_861924.nxml.txt.nlp	22888414	SENT92	23	23	12	12	ezetimibe	SHARP	PA10816	23013	0.52
NULL	Front_Pharmacol_2014_Dec_10_5_273.nxml.txt.nlp	25540622	SENT111	14	14	23	23	epinastine	STZ	PA164764489	6484	0.52
NULL	Breast_Cancer_Res_2011_Aug_16_13(4)_218.nxml.txt.nlp	21884642	SENT62	13	13	15	15	olaparib	BRCA1		672	0.52
NULL	Mol_Biol_Cell_2014_Feb_15_25(4)_470-480.nxml.txt.nlp	24356448	SENT326	12	12	25	25	paraformaldehyde	SP3	PA450790	6670	0.52
NULL	Virulence_2013_Oct_1_4(7)_646-653.nxml.txt.nlp	24045422	SENT101	2	2	10	10	l-lysine	CD4	PA450280	920	0.52
NULL	Br_J_Cancer_2011_Jun_7_104(12)_1941-1944.nxml.txt.nlp	NULL	SENT25	6	6	20	20	vatalanib	VEGFR2	PA7001	3791	0.52
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT128	5	5	1	1	mexiletine	CYP2C9	PA450488	1559	0.52
NULL	Br_J_Pharmacol_2014_May_11_171(9)_2385-2398.nxml.txt.nlp	24467222	SENT113	16	16	32	32	roflumilast	Rho	PA165948052	29984	0.52
NULL	Arthritis_Res_2001_Aug_2_3(5)_311-318.nxml.txt.nlp	11549373	SENT243	11	11	0	0	chloramphenicol	COL1A2	PA448927	1278	0.52
NULL	Diabetes_Care_2013_Jul_12_36(7)_1933-1940.nxml.txt.nlp	23462665	SENT23	17	17	15	15	exenatide	GLP-1	PA164749238	100125288	0.52
NULL	Front_Microbiol_2013_Feb_20_4_33.nxml.txt.nlp	23430312	SENT46	15	15	12	12	oxygen	ROS	PA450744	6098	0.52
NULL	Mol_Brain_2014_Nov_18_7(1)_82.nxml.txt.nlp	NULL	SENT36	12	12	21	21	tamoxifen	p35	PA451581	3592;80761	0.52
NULL	Indian_J_Pharmacol_2009_Dec_41(6)_252-254.nxml.txt.nlp	20407554	SENT28	12	12	16	16	irbesartan	STZ	PA450084	6484	0.52
NULL	Genet_Mol_Biol_2009_Sep_1_Jul-Sep_32(3)_516-520.nxml.txt.nlp	21637514	SENT76	9	9	7	7	estradiol	IGF1	PA449503	3479	0.52
NULL	Case_Rep_Oncol_2013_Dec_12_6(3)_602-608.nxml.txt.nlp	24474924	SENT81	16	16	19	19	erlotinib	CYP3A4	PA134687924	1576	0.52
NULL	Acta_Pharmacol_Sin_2013_Jan_3_34(1)_119-128.nxml.txt.nlp	23202804	SENT129	9	9	17	17	rimonabant	CB1	PA152407999	1268	0.52
NULL	Exp_Cell_Res_2011_Apr_15_317(7)_1028-1039.nxml.txt.nlp	21237154	SENT201	4	4	2	2	staurosporine	TRAIL	PA165109623	8743	0.52
NULL	Front_Oncol_2014_Apr_9_4_75.nxml.txt.nlp	24782986	SENT218	31	31	4	4	paclitaxel	IL-6	PA450761	3569	0.52
NULL	J_Exp_Bot_2011_Oct_4_62(14)_4787-4803.nxml.txt.nlp	21821598	SENT297	6	6	9	9	mannitol	M6PR	PA450320	4074	0.52
NULL	J_Headache_Pain_2010_Dec_28_11(6)_519-523.nxml.txt.nlp	20665065	SENT87	16	16	29	29	lidocaine	SMO	PA450226	6608;54498	0.52
NULL	Parasit_Vectors_2011_Dec_13_4_232.nxml.txt.nlp	22166365	SENT31	0	0	6	6	albendazole	STH	PA164746058	246744	0.52
NULL	Exp_Ther_Med_2015_Jan_18_9(1)_105-111.nxml.txt.nlp	25452783	SENT178	7	7	13	13	celecoxib	ABCG2	PA448871	9429	0.52
NULL	An_Bras_Dermatol_2013_Nov-Dec_88(6_Suppl_1)_113-115.nxml.txt.nlp	24346895	SENT55	6	6	13	13	vincristine	IFN	PA451879	3439	0.52
NULL	Behav_Brain_Funct_2006_Apr_7_2_13.nxml.txt.nlp	16603077	SENT86	16	16	12	12	betaine	PC2	PA448603	5126;5311;8535	0.52
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT46	0	0	6	6	trastuzumab	HER-2	PA451743	2064	0.52
NULL	Biomed_Res_Int_2013_Jun_13_2013_493643.nxml.txt.nlp	23841073	SENT8	1	1	3	3	estradiol	ACTH	PA449503	5443	0.52
NULL	Cancer_Causes_Control_2013_Aug_18_24(8)_1605-1614.nxml.txt.nlp	23775025	SENT64	25	25	43	43	methotrexate	GSTP1	PA450428	2950	0.52
NULL	Clin_Ophthalmol_2014_Nov_21_8_2337-2345.nxml.txt.nlp	25473259	SENT135	4	4	11	11	fluorescein	PED	PA164746009	8682	0.52
NULL	Int_J_Med_Sci_2012_Jun_8_9(4)_311-315.nxml.txt.nlp	22701339	SENT76	23	23	2	2	remifentanil	SAP	PA451232	4068;325	0.52
NULL	Br_J_Cancer_2010_Jan_5_102(1)_134-143.nxml.txt.nlp	19920829	SENT183	26	26	14	14	rituximab	IL-2	PA451261	3558	0.52
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_21-38.nxml.txt.nlp	19305786	SENT555	13	13	10	10	capsaicin	TRPV2	PA448776	51393	0.52
NULL	Curr_Med_Chem_2014_May_21(14)_1595-1606.nxml.txt.nlp	23992330	SENT146	33	33	19	19	bevacizumab	DLL4	PA130232992	54567	0.52
NULL	Iran_J_Pharm_Res_2013_Summer_12(3)_457-469.nxml.txt.nlp	24250652	SENT269	5	5	8	8	allopregnanolone	spatial	PA142320763	219793	0.52
NULL	J_Cell_Sci_2011_Jul_1_124(13)_2231-2240.nxml.txt.nlp	21652626	SENT303	13	13	2	2	dextran	Necl-5	PA449261	5817	0.52
NULL	Front_Surg_2014_Jun_16_1_21.nxml.txt.nlp	25593945	SENT150	9	9	14	14	sorafenib	IFN	PA7000	3439	0.52
NULL	Int_J_Mol_Sci_2010_May_5_11(5)_2056-2066.nxml.txt.nlp	20559501	SENT2	12	12	29	29	metformin	STZ	PA450395	6484	0.52
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_28_2012_937605.nxml.txt.nlp	23304227	SENT163	0	0	4	4	resveratrol	GDNF		2668	0.52
NULL	J_Hematol_Oncol_2013_Nov_5_6_83.nxml.txt.nlp	24283248	SENT55	25	25	21	21	nutlin-3	TP53		7157	0.52
NULL	Hum_Genomics_2004_Aug_1_1(5)_375-380.nxml.txt.nlp	15588498	SENT221	21	21	4	4	debrisoquine	CYP2D6	PA452616	1565	0.52
NULL	Gene_Regul_Syst_Bio_2014_Mar_4_8_63-73.nxml.txt.nlp	24634581	SENT79	0	0	5	5	minocycline	MT1-MMP	PA450519	4323	0.52
NULL	Diabetes_Care_2013_Jul_12_36(7)_2098-2106.nxml.txt.nlp	23695817	SENT295	42	42	39	39	liraglutide	GLP-1	PA165958364	100125288	0.52
NULL	Comput_Struct_Biotechnol_J_2012_Oct_29_3_e201210003.nxml.txt.nlp	24688663	SENT169	20	20	12	12	nadh	mol	PA164755085	90527	0.52
NULL	Oncotarget_2012_Jul_22_3(7)_678-685.nxml.txt.nlp	22824673	SENT171	17	17	8	8	thrombin	rTS	PA451674	55556	0.52
NULL	AAPS_J_2011_Dec_22_14(1)_68-78.nxml.txt.nlp	22189899	SENT90	28	28	30	30	atorvastatin	OATP1B1	PA448500	10599	0.52
NULL	J_Neurol_2011_Jul_2_258(7)_1207-1222.nxml.txt.nlp	21461686	SENT261	11	11	31	31	gabapentin	OPT	PA449720	51430	0.52
NULL	Oncotarget_2012_May_19_3(5)_535-545.nxml.txt.nlp	22619121	SENT59	2	2	14	14	camptothecin	MYCN	PA153590860	4613	0.52
NULL	Ayu_2010_Apr-Jun_31(2)_167-169.nxml.txt.nlp	22131705	SENT65	6	6	15	15	theobromine	Cocoa	PA451646	57658	0.52
NULL	Adv_Appl_Bioinform_Chem_2012_Sep_6_5_61-79.nxml.txt.nlp	23055752	SENT204	14	14	22	22	thrombin	COX1	PA451674	4512;5742	0.52
NULL	Br_J_Cancer_2009_Oct_6_101(7)_1162-1167.nxml.txt.nlp	19724276	SENT8	28	28	16	16	gemcitabine	APC	PA449748	324	0.52
NULL	Diabetes_2011_Nov_17_60(11)_2691-2700.nxml.txt.nlp	21896928	SENT116	0	0	7	7	resveratrol	p53		7157	0.52
NULL	Ann_Hematol_2014_Apr_1_93(8)_1371-1380.nxml.txt.nlp	24687382	SENT29	1	1	24	24	lenalidomide	Aiolos	PA162363968	22806	0.52
NULL	Oxid_Med_Cell_Longev_2013_Jul_9_2013_574029.nxml.txt.nlp	23936610	SENT149	0	0	6	6	resveratrol	RAGE		177	0.52
NULL	Exp_Ther_Med_2013_Dec_26_6(6)_1359-1364.nxml.txt.nlp	24255662	SENT164	5	5	7	7	dexmedetomidine	IL-6	PA449256	3569	0.52
NULL	Oncogene_2010_Sep_2_29(35)_4905-4913.nxml.txt.nlp	20581869	SENT253	6	6	17	17	carboplatin	CA125	PA448803	4077;94025	0.52
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT7	0	0	9	9	resveratrol	PUMA		27113	0.52
NULL	Oncotarget_2014_Jun_19_5(15)_6540-6551.nxml.txt.nlp	25153728	SENT96	9	9	33	33	paclitaxel	CDK1	PA450761	983	0.52
NULL	Eur_J_Immunol_2014_Jun_10_44(6)_1759-1769.nxml.txt.nlp	24595810	SENT67	21	21	24	24	fludrocortisone	CD62L	PA164743961	6402	0.52
NULL	EMBO_Mol_Med_2012_Oct_30_4(10)_1087-1096.nxml.txt.nlp	22933245	SENT66	14	14	4	4	olaparib	NAMPT		10135	0.52
NULL	Cancer_Cell_Int_2014_Jul_12_14_61.nxml.txt.nlp	25120383	SENT37	35	35	33	33	heparin	LRP1	PA449855	10438;4035	0.52
NULL	Genome_Announc_2013_Aug_15_1(4)_e00628-13.nxml.txt.nlp	23950130	SENT1	17	17	15	15	ethanol	CO2	PA448073	4513	0.52
NULL	Front_Behav_Neurosci_2013_Dec_17_7_197.nxml.txt.nlp	24381546	SENT586	10	10	13	13	diazepam	spatial	PA449283	219793	0.52
NULL	Mediators_Inflamm_2010_Jun_21_2010_194896.nxml.txt.nlp	20652055	SENT48	13	13	17	17	rosuvastatin	mol	PA134308647	90527	0.52
NULL	Curr_Colorectal_Cancer_Rep_2013_Jul_23_9(3)_261-269.nxml.txt.nlp	24032000	SENT286	5	5	7	7	cetuximab	CTX	PA10040	1593	0.52
NULL	Ayu_2011_Oct-Dec_32(4)_451-457.nxml.txt.nlp	22661835	SENT130	10	10	5	5	exenatide	GLP-1	PA164749238	100125288	0.52
NULL	Anal_Bioanal_Chem_2014_Sep_12_406(28)_7049-7057.nxml.txt.nlp	25213215	SENT177	6	6	18	18	hemin	mol	PA449849	90527	0.52
NULL	Iran_J_Pediatr_2012_Mar_22(1)_43-51.nxml.txt.nlp	23056858	SENT55	6	6	13	13	fluorescein	CD56	PA164746009	4684	0.52
NULL	Br_J_Anaesth_2014_Jul_22_113(1)_157-167.nxml.txt.nlp	24154701	SENT213	18	18	10	10	sevoflurane	TREK-1	PA451341	3776	0.52
NULL	Front_Genet_2013_Aug_29_4_163.nxml.txt.nlp	24009622	SENT62	2	2	6	6	ethanol	ABCG2	PA448073	9429	0.52
NULL	Cardiol_Res_Pract_2013_Feb_21_2013_127270.nxml.txt.nlp	23509665	SENT41	1	1	10	10	ticagrelor	IPA	PA165374673	3160	0.52
NULL	Oxid_Med_Cell_Longev_2012_Nov_28_2012_162934.nxml.txt.nlp	23251719	SENT6	36	36	2	2	oxygen	TSPO	PA450744	706	0.52
NULL	Ann_Indian_Acad_Neurol_2011_Jul_14(Suppl1)_S16-S17.nxml.txt.nlp	21847320	SENT40	12	12	18	18	amantadine	COMT	PA448360	1312	0.52
NULL	Front_Aging_Neurosci_2010_May_18_2_16.nxml.txt.nlp	20559464	SENT227	6	6	9	9	triflusal	spatial	PA165958430	219793	0.52
NULL	Amyotroph_Lateral_Scler_Frontotemporal_Degener_2013_Dec_15_14(7-8)_562-573.nxml.txt.nlp	23678852	SENT245	20	20	12	12	flumazenil	SOD1	PA449659	6647	0.52
NULL	Int_J_Biol_Sci_2014_Aug_30_10(9)_957-965.nxml.txt.nlp	25210493	SENT128	0	0	19	19	sunitinib	KIT	PA162372840	3815	0.52
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT378	22	22	20	20	pp2	PP1		5540;5464	0.52
NULL	Allergy_Asthma_Immunol_Res_2010_Jul_17_2(3)_188-194.nxml.txt.nlp	20592918	SENT67	12	12	6	6	methacholine	IL-13	PA165958382	3596	0.52
NULL	J_Cell_Biol_2001_Jul_9_154(1)_177-186.nxml.txt.nlp	11448999	SENT112	19	19	19	19	pp2	PP2		4888	0.52
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT131	0	0	6	6	perifosine	DR5	PA165291471	8795	0.52
NULL	Cancer_Microenviron_2008_Dec_20_1(1)_103-111.nxml.txt.nlp	19308689	SENT274	3	3	32	32	thrombin	MIA	PA451674	8190	0.52
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT368	24	24	22	22	pp2	PP1		5540;5464	0.52
NULL	Calcif_Tissue_Int_2013_Sep_11_93(6)_526-539.nxml.txt.nlp	24022329	SENT71	20	20	24	24	l-glutamine	M-CSF	PA10090	1435	0.52
NULL	Endocrinology_2015_Jan_6_156(1)_24-31.nxml.txt.nlp	25375036	SENT7	13	13	19	19	flutamide	DES	PA449685	1674	0.52
NULL	Exp_Ther_Med_2013_Nov_6_6(5)_1089-1095.nxml.txt.nlp	24223627	SENT98	4	4	9	9	epirubicin	NAC	PA449476	22861	0.52
NULL	Scientifica_(Cairo)_2012_Sep_16_2012_683683.nxml.txt.nlp	24278728	SENT129	34	34	13	13	eptifibatide	TIM	PA449483	7984;8914	0.52
NULL	Virol_J_2010_Oct_20_7_279.nxml.txt.nlp	20961433	SENT435	22	22	29	29	trypsin	GP2	PA451806	2813	0.52
NULL	Indian_J_Anaesth_2014_Jan-Feb_58(1)_101-102.nxml.txt.nlp	24700924	SENT18	15	15	10	10	fentanyl	NIBP	PA449599	83696	0.52
NULL	Front_Oncol_2014_Sep_29_4_251.nxml.txt.nlp	25325012	SENT301	9	9	15	15	etoposide	POLB	PA449552	5423	0.52
NULL	Genet_Mol_Biol_2009_Dec_1_Oct-Dec_32(4)_802-810.nxml.txt.nlp	21637458	SENT28	9	9	7	7	theobromine	AC1	PA451646	107	0.52
NULL	Mol_Cancer_2012_Mar_21_11_13.nxml.txt.nlp	22436134	SENT185	3	3	0	0	doxorubicin	HuR	PA449412	1994	0.52
NULL	Crit_Care_2011_Oct_25_15(5)_R255.nxml.txt.nlp	22026977	SENT146	33	33	24	24	vasopressin	AVP	PA451858	114548;551	0.52
NULL	Breast_Cancer_Res_2009_Jan_16_11(1)_201.nxml.txt.nlp	19216727	SENT42	22	22	17	17	lapatinib	AGO	PA152241907	55294	0.52
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT145	5	5	3	3	pp2	PP1		5540;5464	0.52
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Dec_2_5_30.nxml.txt.nlp	17140452	SENT229	6	6	8	8	minocycline	GAT	PA450519	10249	0.52
NULL	Hum_Genomics_2008_Sep_1_3(1)_71-78.nxml.txt.nlp	19129091	SENT32	13	13	26	26	nadh	ND3	PA164755085	4537	0.52
NULL	Front_Behav_Neurosci_2013_Dec_19_7_196.nxml.txt.nlp	24391561	SENT251	22	22	14	14	estradiol	aromatase	PA449503	1588	0.52
NULL	Oxid_Med_Cell_Longev_2013_Dec_5_2013_963520.nxml.txt.nlp	24381719	SENT18	12	12	19	19	oxygen	ROS	PA450744	6098	0.52
NULL	Int_J_Biol_Sci_2011_May_24_7(5)_673-684.nxml.txt.nlp	21647250	SENT197	26	26	3	3	berberine	AMPK	PA165860812	5563	0.52
NULL	Environ_Health_Perspect_2006_Apr_10_114(4)_507-513.nxml.txt.nlp	16581537	SENT72	28	28	14	14	fluorescein	San	PA164746009	80218	0.52
NULL	Core_Evid_2009_Jun_15_4_131-147.nxml.txt.nlp	20694070	SENT20	15	15	2	2	raltegravir	CD4		920	0.52
NULL	Clin_Ophthalmol_2014_Jan_13_8_219-228.nxml.txt.nlp	24531757	SENT181	23	23	9	9	brinzolamide	TIM	PA164744929	7984;8914	0.52
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT2406	1	1	6	6	amiodarone	ROS	PA448383	6098	0.52
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_P64.nxml.txt.nlp	NULL	SENT16	22	22	36	36	cefuroxime	PPL	PA448868	5493	0.52
NULL	Biomed_Res_Int_2013_Aug_6_2013_909613.nxml.txt.nlp	24027765	SENT16	2	2	0	0	metronidazole	EEN	PA450484	6455	0.52
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT168	2	2	0	0	dasatinib	PP2	PA162372878	4888	0.52
NULL	Indian_J_Pharmacol_2009_Aug_41(4)_167-172.nxml.txt.nlp	20523867	SENT40	38	38	17	17	napqi	CYP1A2		1544	0.52
NULL	Eur_J_Endocrinol_2014_Mar_170(3)_451-459.nxml.txt.nlp	24362411	SENT202	0	0	10	10	liraglutide	GLP1	PA165958364	100125288;2641	0.52
NULL	Mol_Cancer_2007_Sep_26_6_61.nxml.txt.nlp	17894897	SENT234	0	0	15	15	etoposide	p53	PA449552	7157	0.52
NULL	Child_Adolesc_Psychiatry_Ment_Health_2008_Nov_17_2_33.nxml.txt.nlp	19014633	SENT38	2	2	4	4	lipase	MGLL	PA450239	11343	0.52
NULL	Cancers_(Basel)_2011_Sep_30_3(4)_3799-3823.nxml.txt.nlp	24213112	SENT165	12	12	30	30	urokinase	MMP2	PA451836	4313	0.52
NULL	Acta_Pharmacol_Sin_2009_Jul_3_30(7)_889-898.nxml.txt.nlp	19574994	SENT31	8	8	15	15	thrombin	EGF	PA451674	1950	0.52
NULL	Diabetes_2013_May_16_62(5)_1519-1526.nxml.txt.nlp	23274898	SENT31	13	13	2	2	suramin	ADP	PA10292	23038	0.52
NULL	Curr_Hypertens_Rep_2013_Oct_25_15(6)_559-574.nxml.txt.nlp	24158454	SENT293	18	18	28	28	atenolol	MRC	PA448499	4345	0.52
NULL	Adv_Hematol_2010_Dec_5_2010_595934.nxml.txt.nlp	21151515	SENT154	24	24	10	10	cangrelor	Yes	PA165945763	7525	0.52
NULL	Br_J_Cancer_2011_Jun_7_104(12)_1848-1853.nxml.txt.nlp	21610704	SENT164	0	0	33	33	panitumumab	REL	PA162373091	5966	0.52
NULL	Arthritis_Res_Ther_2008_Mar_17_10(2)_R33.nxml.txt.nlp	18346273	SENT44	19	19	28	28	infliximab	HMGB1	PA452639	3146	0.52
NULL	Brain_Sci_2013_Jun_14_3(2)_941-963.nxml.txt.nlp	24961432	SENT812	3	3	9	9	ethanol	TLR4	PA448073	7099	0.52
NULL	Eur_J_Clin_Pharmacol_2014_Mar_22_70(6)_685-693.nxml.txt.nlp	24658827	SENT220	11	11	3	3	tacrolimus	CYP3A4	PA451578	1576	0.52
NULL	J_Cell_Biol_2005_Oct_10_171(1)_121-131.nxml.txt.nlp	16203859	SENT98	11	11	11	11	pp2	PP2		4888	0.52
NULL	Extremophiles_2009_Nov_23_13(6)_885-894.nxml.txt.nlp	19701714	SENT136	23	23	26	26	ethanol	mol	PA448073	90527	0.52
NULL	Exp_Ther_Med_2013_Jun_9_5(6)_1765-1769.nxml.txt.nlp	23837070	SENT137	20	20	0	0	fluvastatin	UII	PA449688	10911	0.52
NULL	J_Headache_Pain_2011_Aug_25_12(4)_399-403.nxml.txt.nlp	21437713	SENT13	0	0	4	4	naratriptan	OTC	PA450597	5009	0.52
NULL	Indian_J_Anaesth_2012_Nov-Dec_56(6)_513-517.nxml.txt.nlp	23325933	SENT70	3	3	18	18	midazolam	ACTH	PA450496	5443	0.52
NULL	Oncol_Lett_2013_Feb_22_5(2)_641-644.nxml.txt.nlp	23419988	SENT120	23	23	3	3	paclitaxel	CT2	PA450761	85413	0.52
NULL	Int_J_Nanomedicine_2010_Apr_7_5_249-259.nxml.txt.nlp	20463941	SENT76	2	2	6	6	cisplatin	mol	PA449014	90527	0.52
NULL	Cardiovasc_Diabetol_2010_Sep_23_9_57.nxml.txt.nlp	20863381	SENT35	18	18	10	10	metformin	DM2	PA450395	28508	0.52
NULL	Nat_Commun_2013_Sep_16_4_2420.nxml.txt.nlp	24036533	SENT260	28	28	43	43	amoxicillin	BSAC	PA448406	57591	0.52
NULL	Oncotarget_2014_Oct_21_5(22)_11252-11268.nxml.txt.nlp	25361004	SENT225	4	4	0	0	metformin	CLIC1	PA450395	1192	0.52
NULL	J_Anaesthesiol_Clin_Pharmacol_2012_Jan-Mar_28(1)_106-110.nxml.txt.nlp	22345956	SENT38	8	8	2	2	argatroban	ACT	PA164745516	12;11332;9457;641455	0.52
NULL	J_Inherit_Metab_Dis_2012_Jan_10_35(1)_141-149.nxml.txt.nlp	21556832	SENT21	13	13	22	22	creatine	CRTR	PA164778930	6535	0.519
NULL	Environ_Health_Perspect_2013_Apr_5_121(4)_459-466.nxml.txt.nlp	23384675	SENT51	0	0	2	2	genistein	Gen	PA165109660	348654	0.519
NULL	EMBO_J_2009_May_6_28(9)_1197-1207.nxml.txt.nlp	19322195	SENT248	26	26	20	20	dextran	EGF	PA449261	1950	0.519
NULL	Front_Chem_2014_Aug_11_2_61.nxml.txt.nlp	25157349	SENT1081	3	3	12	12	l-glutamine	ASCT2	PA10090	6510	0.519
NULL	Croat_Med_J_2012_Aug_53(4)_314-320.nxml.txt.nlp	22911523	SENT52	10	10	22	22	venlafaxine	CYP2D6	PA451866	1565	0.519
NULL	J_Cell_Mol_Med_2014_Aug_1_18(8)_1599-1611.nxml.txt.nlp	24889822	SENT15	8	8	2	2	resveratrol	SIRT1		23411	0.519
NULL	Oncoimmunology_2012_Dec_1_1(9)_1661-1663.nxml.txt.nlp	23264929	SENT9	2	2	8	8	imiquimod	TLR7	PA449972	51284	0.519
NULL	J_Insect_Sci_2002_May_10_2_8.nxml.txt.nlp	15455042	SENT143	7	7	40	40	fluorescein	ANOVA	PA164746009	4858	0.519
NULL	J_Int_Soc_Sports_Nutr_2010_Feb_3_7_8.nxml.txt.nlp	20181080	SENT12	44	44	27	27	creatine	IL-6	PA164778930	3569	0.519
NULL	Curr_Neuropharmacol_2010_Mar_8(1)_41-61.nxml.txt.nlp	20808545	SENT287	0	0	7	7	phenytoin	EA2	PA450947	773	0.519
NULL	Pharmaceuticals_(Basel)_2012_Aug_10_5(8)_802-836.nxml.txt.nlp	24280676	SENT1251	17	17	11	11	methotrexate	ABCG2	PA450428	9429	0.519
NULL	Mol_Cancer_2007_Sep_26_6_61.nxml.txt.nlp	17894897	SENT114	10	10	15	15	etoposide	p53	PA449552	7157	0.519
NULL	Cardiovasc_Ultrasound_2005_Aug_18_3_22.nxml.txt.nlp	16107221	SENT165	23	23	13	13	creatine	PIR	PA164778930	8544	0.519
NULL	Glycoconj_J_2008_Jul_13_25(5)_401-414.nxml.txt.nlp	18080183	SENT27	24	24	32	32	glucosamine	spatial	PA164747613	219793	0.519
NULL	J_Cell_Biol_1997_Jun_16_137(6)_1433-1443.nxml.txt.nlp	9182673	SENT70	23	23	13	13	l-glutamine	FBS	PA10090	64319;26269	0.519
NULL	Calcif_Tissue_Int_2012_Nov_26_91(5)_325-334.nxml.txt.nlp	22923328	SENT182	13	13	26	26	alendronate	NLT	PA448082	10864	0.519
NULL	Protein_Cell_2014_Jun_19_5(6)_469-479.nxml.txt.nlp	24748116	SENT25	13	13	10	10	paclitaxel	EB1	PA450761	9167;22919;10982	0.519
NULL	Environ_Health_Perspect_2001_Mar_109(3)_257-264.nxml.txt.nlp	11333187	SENT7	0	0	6	6	estradiol	aromatase	PA449503	1588	0.519
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_May_8_66(Pt_6)_m617.nxml.txt.nlp	21579276	SENT65	13	13	5	5	ethanol	NO3	PA448073	4681	0.519
NULL	Open_Cardiovasc_Med_J_2012_Dec_28_6_147-155.nxml.txt.nlp	23346258	SENT184	12	12	14	14	lipase	HSL	PA450239	3991	0.519
NULL	Cent_European_J_Urol_2013_Dec_19_66(4)_405-410.nxml.txt.nlp	24757528	SENT32	8	8	26	26	collagenase	entactin	PA449107	4811	0.519
NULL	Cancer_Med_2014_Jun_8_3(3)_681-692.nxml.txt.nlp	24711160	SENT151	23	23	1	1	bevacizumab	San	PA130232992	80218	0.519
NULL	J_Orthop_Traumatol_2011_Jun_4_12(2)_77-80.nxml.txt.nlp	21541772	SENT63	19	19	24	24	nitrogen	CRP	PA450643	1401;140913	0.519
NULL	Cell_Microbiol_2014_Sep_2_16(9)_1425-1440.nxml.txt.nlp	24779357	SENT291	15	15	24	24	phenol	SP5	PA450913	389058	0.519
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Dec_2_5_30.nxml.txt.nlp	17140452	SENT229	2	2	8	8	vancomycin	GAT	PA451850	10249	0.519
NULL	Ann_Neurosci_2012_Oct_19(4)_165-168.nxml.txt.nlp	25205992	SENT121	3	3	5	5	estradiol	ACTH	PA449503	5443	0.519
NULL	Gut_Liver_2011_Jun_24_5(2)_160-164.nxml.txt.nlp	21814595	SENT83	12	12	7	7	meperidine	ESD	PA450369	2098	0.519
NULL	J_Nutr_Sci_2014_Aug_13_3_e17.nxml.txt.nlp	25191609	SENT73	3	3	22	22	choline	B12	PA448976	7126;4709	0.519
NULL	Cancer_Causes_Control_2013_Aug_18_24(8)_1605-1614.nxml.txt.nlp	23775025	SENT64	25	25	39	39	methotrexate	GSTM1	PA450428	2944	0.519
NULL	Anesth_Pain_Med_2014_Jul_8_4(3)_e16710.nxml.txt.nlp	25237635	SENT100	9	9	18	18	bupivacaine	CO2	PA135057240	4513	0.519
NULL	Mol_Cancer_2012_Jul_25_11_47.nxml.txt.nlp	22830443	SENT143	0	0	2	2	panitumumab	EGFR	PA162373091	1956	0.519
NULL	Curr_Cardiol_Rev_2009_Aug_5(3)_243-250.nxml.txt.nlp	20676284	SENT66	1	1	17	17	creatine	ADP	PA164778930	23038	0.519
NULL	Appl_Plant_Sci_2013_Oct_31_1(11)_apps_1300043.nxml.txt.nlp	25202498	SENT29	31	31	12	12	ampicillin	SOC	PA448419	91544	0.519
NULL	Pharmaceutics_2010_Apr_27_2(2)_136-158.nxml.txt.nlp	NULL	SENT201	14	14	0	0	diclofenac	HSM	PA449293	94030	0.519
NULL	Curr_Neuropharmacol_2008_Sep_6(3)_193-202.nxml.txt.nlp	19506720	SENT352	12	12	5	5	haloperidol	p75	PA449841	7133;11168	0.519
NULL	J_Biol_Chem_2013_Nov_22_288(47)_34217-34229.nxml.txt.nlp	24106270	SENT272	14	14	29	29	thrombin	RhoG	PA451674	391	0.519
NULL	Korean_J_Anesthesiol_2013_Jan_21_64(1)_47-53.nxml.txt.nlp	23372886	SENT156	16	16	6	6	bupivacaine	PTG	PA135057240	5507	0.519
NULL	Exp_Ther_Med_2013_Sep_2_6(3)_765-768.nxml.txt.nlp	24137262	SENT46	26	26	6	6	budesonide	CPAP	PA448681	55835	0.519
NULL	Cardiovasc_Diabetol_2010_Sep_23_9_57.nxml.txt.nlp	20863381	SENT25	13	13	21	21	pioglitazone	DM2	PA450970	28508	0.519
NULL	Oncol_Lett_2014_Sep_19_8(3)_1269-1274.nxml.txt.nlp	25120704	SENT54	12	12	10	10	cisplatin	Met	PA449014	79811	0.519
NULL	Exp_Neurobiol_2014_Dec_12_23(4)_365-371.nxml.txt.nlp	25548536	SENT8	36	36	5	5	dextran	ATP13A2	PA449261	23400	0.519
NULL	Eur_J_Clin_Microbiol_Infect_Dis_2010_Nov_17_29(11)_1315-1319.nxml.txt.nlp	20556465	SENT25	37	37	39	39	metronidazole	PEN	PA450484	9933	0.519
NULL	Carcinogenesis_2014_May_13_35(5)_1055-1066.nxml.txt.nlp	24419232	SENT249	10	10	6	6	heparin	VEGF-A	PA449855	7422	0.519
NULL	Case_Rep_Pediatr_2013_Feb_20_2013_727824.nxml.txt.nlp	23509655	SENT52	35	35	28	28	vancomycin	ETB	PA451850	1910	0.519
NULL	Drugs_R_D_2010_Jul_27_10(2)_111-122.nxml.txt.nlp	20698720	SENT191	2	2	18	18	sunitinib	IL-3	PA162372840	3562	0.519
NULL	Acta_Pharmacol_Sin_2012_Jan_3_33(1)_49-56.nxml.txt.nlp	22212430	SENT167	0	0	13	13	thrombin	AP-1	PA451674	2353;3727;2354;3725	0.519
NULL	J_Mol_Psychiatry_2013_Nov_4_1(1)_19.nxml.txt.nlp	25408910	SENT73	31	31	20	20	olanzapine	ATP2A2	PA450688	488	0.519
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Dec_2_5_30.nxml.txt.nlp	17140452	SENT239	31	31	29	29	chloramphenicol	CHL	PA448927	91851	0.519
NULL	Oncotarget_2014_Oct_24_5(22)_11452-11463.nxml.txt.nlp	25360516	SENT138	0	0	26	26	doxorubicin	CHOP	PA449412	1649	0.519
NULL	Front_Pharmacol_2014_May_9_5_103.nxml.txt.nlp	24847272	SENT232	5	5	9	9	tacrolimus	POR	PA451578	5447	0.519
NULL	J_Exerc_Nutrition_Biochem_2014_Mar_8_18(1)_69-78.nxml.txt.nlp	25566441	SENT144	11	11	8	8	creatine	ADP	PA164778930	23038	0.519
NULL	Nucleic_Acids_Res_2011_Sep_6_39(16)_7276-7288.nxml.txt.nlp	21646337	SENT66	38	38	13	13	l-glutamine	CO2	PA10090	4513	0.519
NULL	Semin_Immunopathol_2012_Jan_4_34(1)_93-106.nxml.txt.nlp	21845431	SENT250	0	0	7	7	thrombin	ADAMTS18	PA451674	170692	0.519
NULL	Lab_Invest_2013_Feb_19_93(2)_181-193.nxml.txt.nlp	23212100	SENT256	9	9	11	11	cyclophosphamide	CTX	PA449165	1593	0.519
NULL	Pharmaceutics_2011_Nov_18_3(4)_865-913.nxml.txt.nlp	24309312	SENT128	3	3	21	21	pioglitazone	CYP2C8	PA450970	1558	0.519
NULL	Ther_Clin_Risk_Manag_2006_Dec_2(4)_365-375.nxml.txt.nlp	18360649	SENT108	11	11	2	2	abatacept	ACR	PA164747080	49	0.519
NULL	Mol_Cancer_2004_Jul_12_3_19.nxml.txt.nlp	15248896	SENT243	19	19	15	15	oxygen	HIF-1	PA450744	29072	0.519
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Nov_26_3(11)_e149.nxml.txt.nlp	25426564	SENT31	3	3	5	5	atorvastatin	PCSK9	PA448500	255738	0.519
NULL	Br_J_Cancer_1998_Oct_78(8)_1058-1060.nxml.txt.nlp	9792150	SENT6	2	2	4	4	floxuridine	HAI	PA449652	6692;6768	0.519
NULL	J_Clin_Biochem_Nutr_2010_Jan_29_46(1)_87-92.nxml.txt.nlp	20104270	SENT78	23	23	19	19	hesperidin	STZ	PA449867	6484	0.519
NULL	Oxid_Med_Cell_Longev_2009_Sep-Oct_2(4)_214-221.nxml.txt.nlp	20716907	SENT243	19	19	33	33	pilocarpine	P400	PA450962	57634	0.519
NULL	Mol_Cell_Biochem_2014_Oct_9_385(1-2)_265-275.nxml.txt.nlp	24104452	SENT99	13	13	7	7	bortezomib	U87	PA10252	677775;641648	0.519
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1437-1448.nxml.txt.nlp	24056706	SENT111	18	18	20	20	tranylcypromine	CYP2C19	PA451741	1557	0.519
NULL	Oncotarget_2012_May_29_3(5)_581-585.nxml.txt.nlp	22653910	SENT50	36	36	38	38	resveratrol	P-gp		5243	0.519
NULL	J_Invest_Dermatol_2014_May_6_134(5)_1246-1254.nxml.txt.nlp	24317394	SENT127	39	39	25	25	protamine	SOX2	PA10366	6657	0.519
NULL	Acta_Pharmacol_Sin_2014_Jun_4_35(6)_752-757.nxml.txt.nlp	24902786	SENT88	7	7	16	16	tamoxifen	STL2	PA451581	1301	0.519
NULL	Physiol_Rep_2014_Oct_24_2(10)_e12175.nxml.txt.nlp	25344477	SENT118	0	0	22	22	thrombin	cadherin	PA451674	1015	0.519
NULL	Biochem_Biophys_Res_Commun_2009_Aug_14_386(1)_111-117.nxml.txt.nlp	19501051	SENT279	7	7	3	3	fluvoxamine	HERG	PA449690	3757	0.519
NULL	Clin_Interv_Aging_2012_Dec_30_7_1-13.nxml.txt.nlp	22291468	SENT56	30	30	26	26	dronedarone	CYP3A4	PA153619853	1576	0.519
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_O2.nxml.txt.nlp	NULL	SENT6	18	18	27	27	sulfamethoxazole	PD-L1	PA451544	29126	0.519
NULL	Ann_Rheum_Dis_2012_Jan_31_71(6)_935-942.nxml.txt.nlp	22294641	SENT254	26	26	4	4	milnacipran	ADM	PA164752812	133	0.519
NULL	Arthritis_Res_Ther_2006_Feb_8_8(2)_R44.nxml.txt.nlp	16507143	SENT57	23	23	36	36	fluorescein	San	PA164746009	80218	0.519
NULL	Exp_Ther_Med_2014_Nov_29_8(5)_1473-1478.nxml.txt.nlp	25289044	SENT130	9	9	7	7	heparin	AZU	PA449855	566	0.519
NULL	Evid_Based_Complement_Alternat_Med_2015_Jan_6_2015_802903.nxml.txt.nlp	25632291	SENT145	7	7	1	1	berberine	CYP2D	PA165860812	1565	0.519
NULL	Cholesterol_2011_Feb_22_2011_503028.nxml.txt.nlp	21490773	SENT110	0	0	10	10	methotrexate	ABCA1	PA450428	19	0.519
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT158	3	3	13	13	cisplatin	IBP	PA449014	706;50619	0.519
NULL	J_Int_Soc_Sports_Nutr_2014_Jun_14_11_29.nxml.txt.nlp	25006332	SENT159	41	41	19	19	estradiol	HSD2	PA449503	6060	0.519
NULL	Oxid_Med_Cell_Longev_2011_Aug_15_2011_824597.nxml.txt.nlp	21904648	SENT19	7	7	5	5	irinotecan	TPT	PA450085	23590;6469	0.519
NULL	Apoptosis_2012_Jun_9_17(6)_566-578.nxml.txt.nlp	22402981	SENT167	20	20	24	24	pp2	PP2		4888	0.519
NULL	J_Mol_Signal_2012_Aug_16_7_12.nxml.txt.nlp	22898329	SENT138	23	23	2	2	cisplatin	NOXA	PA449014	5366	0.519
NULL	J_Hum_Genet_2013_Jun_23_58(6)_339-345.nxml.txt.nlp	23697979	SENT86	16	16	12	12	clopidogrel	P2Y12	PA449053	64805	0.519
NULL	Breast_Cancer_Res_2007_Jul_22_9(4)_R45.nxml.txt.nlp	17659092	SENT180	11	11	0	0	doxorubicin	FDG	PA449412	23583	0.519
NULL	Biochimie_2010_Nov_92(11)_1546-1567.nxml.txt.nlp	20615447	SENT218	21	21	25	25	heparin	kallistatin	PA449855	5267	0.519
NULL	Oncogene_2010_Nov_18_29(46)_6115-6124.nxml.txt.nlp	20729912	SENT80	10	10	7	7	doxorubicin	ABCB1	PA449412	5243	0.519
NULL	Diabetes_Care_2013_Aug_17_36(Suppl_2)_S127-S138.nxml.txt.nlp	23882037	SENT376	26	26	23	23	liraglutide	GLP-1	PA165958364	100125288	0.519
NULL	Arthritis_Res_Ther_2011_Mar_16_13(2)_R44.nxml.txt.nlp	21410959	SENT178	0	0	7	7	glucosamine	IFN	PA164747613	3439	0.519
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Aug_12_65(Pt_9)_o2129.nxml.txt.nlp	21577541	SENT3	18	18	32	32	benzaldehyde	mol	PA448571	90527	0.519
NULL	Br_J_Cancer_2011_Apr_12_104(8)_1256-1261.nxml.txt.nlp	21448165	SENT8	17	17	26	26	sorafenib	IL-2	PA7000	3558	0.519
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT192	31	31	19	19	trastuzumab	Yes	PA451743	7525	0.519
NULL	J_Gastroenterol_2014_Sep_25_49(8)_1253-1263.nxml.txt.nlp	24065124	SENT212	9	9	15	15	eltrombopag	IFN	PA165981594	3439	0.519
NULL	Islets_2012_Jan_1_4(1)_64-70.nxml.txt.nlp	22504862	SENT202	16	16	8	8	forskolin	GMP	PA146096022	22978	0.519
NULL	J_Korean_Med_Sci_2013_Aug_31_28(8)_1248-1252.nxml.txt.nlp	23960456	SENT35	7	7	12	12	imatinib	FDG	PA10804	23583	0.519
NULL	Case_Rep_Rheumatol_2012_Dec_24_2012_270315.nxml.txt.nlp	23424706	SENT58	11	11	18	18	tocilizumab	IL-6	PA165292659	3569	0.519
NULL	Apoptosis_2014_Aug_26_19(11)_1603-1615.nxml.txt.nlp	25156145	SENT275	2	2	0	0	mitomycin	TRAIL	PA450524	8743	0.519
NULL	Evid_Based_Complement_Alternat_Med_2013_Aug_7_2013_641480.nxml.txt.nlp	23997797	SENT155	11	11	20	20	estradiol	castor	PA449503	54897	0.519
NULL	Mol_Cancer_2008_Jun_30_7_60.nxml.txt.nlp	18590557	SENT93	14	14	29	29	tamoxifen	TRAIL	PA451581	8743	0.519
NULL	Diabetes_Obes_Metab_2012_Apr_14(4)_304-314.nxml.txt.nlp	22051096	SENT142	10	10	5	5	liraglutide	PPG	PA165958364	5552	0.519
NULL	Autophagy_2013_Apr_1_9(4)_609-611.nxml.txt.nlp	23328265	SENT4	8	8	10	10	l-cysteine	DES1	PA449173	8560	0.519
NULL	J_Biomed_Biotechnol_2010_Oct_27_2010_948543.nxml.txt.nlp	21048930	SENT174	21	21	14	14	chlorpromazine	MDC	PA448964	6367	0.519
NULL	Cardiovasc_Diabetol_2013_Nov_11_12_168.nxml.txt.nlp	24215469	SENT17	3	3	5	5	vasopressin	AVP	PA451858	114548;551	0.519
NULL	Clin_Med_Insights_Oncol_2012_Aug_16_6_287-303.nxml.txt.nlp	22933844	SENT87	10	10	12	12	denosumab	RANKL	PA166048634	8600	0.519
NULL	Int_J_Environ_Res_Public_Health_2010_May_4_7(5)_2045-2056.nxml.txt.nlp	20623010	SENT204	3	3	5	5	estradiol	IL-2	PA449503	3558	0.519
NULL	Nat_Commun_2013_Nov_27_4_2824.nxml.txt.nlp	24280686	SENT614	10	10	34	34	dextran	RhoB	PA449261	388	0.519
NULL	Drug_Des_Devel_Ther_2014_Sep_23_8_1527-1538.nxml.txt.nlp	25284985	SENT110	14	14	11	11	celecoxib	IFN	PA448871	3439	0.519
NULL	Cell_Death_Dis_2012_Jun_28_3(6)_e336.nxml.txt.nlp	22739988	SENT94	8	8	11	11	perifosine	PI3K	PA165291471	5290	0.519
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT200	3	3	8	8	tacrolimus	SOCS3	PA451578	9021	0.519
NULL	J_Korean_Assoc_Oral_Maxillofac_Surg_2014_Dec_26_40(6)_291-296.nxml.txt.nlp	25551094	SENT121	18	18	12	12	alendronate	RANKL	PA448082	8600	0.519
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT73	13	13	19	19	vasopressin	PRL	PA451858	5617	0.519
NULL	Anal_Chem_2011_Feb_15_83(4)_1363-1369.nxml.txt.nlp	21268609	SENT36	16	16	32	32	l-glutamine	CO2	PA10090	4513	0.519
NULL	J_Biomed_Sci_2014_Feb_12_21(1)_14.nxml.txt.nlp	24521134	SENT92	0	0	15	15	quinacrine	PTB	PA164745551	58155	0.519
NULL	Acta_Crystallogr_F_Struct_Biol_Commun_2014_Apr_30_70(Pt_5)_543-554.nxml.txt.nlp	24817708	SENT233	5	5	26	26	l-arginine	mol	PA448478	90527	0.519
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT180	9	9	2	2	capsaicin	p53	PA448776	7157	0.519
NULL	Drugs_Aging_2014_Oct_10_31(11)_837-848.nxml.txt.nlp	25300507	SENT153	15	15	5	5	verteporfin	NMB	PA451871	10457;4828	0.519
NULL	Indian_J_Anaesth_2014_Jul-Aug_58(4)_423-429.nxml.txt.nlp	25197110	SENT34	25	25	10	10	ondansetron	ODF	PA450705	8600	0.519
NULL	Cancers_(Basel)_2010_Apr_20_2(2)_624-641.nxml.txt.nlp	24281085	SENT13	24	24	15	15	heparin	PTN	PA449855	5764	0.519
NULL	Oxid_Med_Cell_Longev_2012_Jan_19_2012_390678.nxml.txt.nlp	22315655	SENT141	12	12	10	10	gliclazide	NAC	PA10892	22861	0.519
NULL	Evid_Based_Complement_Alternat_Med_2012_May_7_2012_242810.nxml.txt.nlp	22645625	SENT322	13	13	16	16	rifampin	CYP3A4	PA451250	1576	0.519
NULL	Child_Adolesc_Psychiatry_Ment_Health_2013_Aug_15_7_31.nxml.txt.nlp	23947389	SENT86	11	11	20	20	perphenazine	IMPACT	PA450882	55364	0.519
NULL	Front_Genet_2012_Nov_22_3_249.nxml.txt.nlp	23189085	SENT681	0	0	10	10	bupropion	CYP2B6	PA448687	1555	0.519
NULL	Behav_Brain_Funct_2012_Dec_19_8_61.nxml.txt.nlp	23253178	SENT205	8	8	2	2	lamotrigine	Gen	PA450164	348654	0.519
NULL	Behav_Brain_Funct_2008_Aug_12_4_36.nxml.txt.nlp	18700002	SENT39	18	18	36	36	neomycin	PTPH1	PA450608	5774	0.519
NULL	Diabetes_2011_May_23_60(5)_1519-1527.nxml.txt.nlp	21430087	SENT122	4	4	6	6	lipase	ATGL	PA450239	57104	0.519
NULL	J_Gen_Physiol_2009_Apr_133(4)_421-438.nxml.txt.nlp	19289574	SENT258	29	29	23	23	forskolin	SLC26A9	PA146096022	115019	0.519
NULL	Drug_Des_Devel_Ther_2014_Sep_23_8_1527-1538.nxml.txt.nlp	25284985	SENT142	17	17	24	24	celecoxib	IFN	PA448871	3439	0.519
NULL	J_Hematol_Oncol_2011_Mar_26_4_11.nxml.txt.nlp	21439076	SENT123	2	2	0	0	pemetrexed	Gem	PA10810	51053	0.519
NULL	Cell_Res_2010_Apr_9_20(4)_458-469.nxml.txt.nlp	20142842	SENT214	0	0	9	9	doxycycline	BCL2	PA449415	596	0.519
NULL	Curr_Infect_Dis_Rep_2010_Mar_24_12(2)_126-133.nxml.txt.nlp	20461117	SENT176	19	19	4	4	fluorouracil	P19	PA128406956	51561	0.519
NULL	Indian_J_Psychiatry_2012_Oct-Dec_54(4)_394.nxml.txt.nlp	23372255	SENT11	22	22	37	37	chlorpromazine	B12	PA448964	7126;4709	0.519
NULL	Cell_Death_Dis_2014_Apr_24_5(4)_e1197.nxml.txt.nlp	24763054	SENT107	2	2	0	0	cisplatin	RUNX3	PA449014	864	0.519
NULL	Cardiovasc_Diabetol_2010_Nov_5_9_72.nxml.txt.nlp	21054861	SENT99	41	41	37	37	ethanol	SDS	PA448073	51119;10993	0.519
NULL	Indian_J_Crit_Care_Med_2011_Apr-Jun_15(2)_71-77.nxml.txt.nlp	21814369	SENT62	9	9	12	12	desmopressin	VIII	PA449237	1351	0.519
NULL	Adv_Hematol_2010_Dec_5_2010_595934.nxml.txt.nlp	21151515	SENT154	15	15	21	21	ticagrelor	Yes	PA165374673	7525	0.519
NULL	J_Clin_Biochem_Nutr_2010_Jan_29_46(1)_43-51.nxml.txt.nlp	20104264	SENT118	8	8	21	21	napqi	CYP2D6		1565	0.518
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_112-117.nxml.txt.nlp	23864844	SENT25	7	7	14	14	vincristine	CHOP	PA451879	1649	0.518
NULL	Breast_Cancer_Res_2003_Feb_5_5(2)_113-116.nxml.txt.nlp	12631392	SENT94	4	4	33	33	tamoxifen	TPC	PA451581	8030;60386	0.518
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT48	21	21	7	7	resveratrol	TRAIL		8743	0.518
NULL	Breast_Cancer_Res_Treat_2013_Jun_30_139(2)_441-451.nxml.txt.nlp	23715630	SENT88	31	31	14	14	anastrozole	EGFR	PA448432	1956	0.518
NULL	Front_Microbiol_2013_Feb_15_4_24.nxml.txt.nlp	23422735	SENT236	4	4	8	8	ethanol	FALDH	PA448073	224	0.518
NULL	Gut_Liver_2013_Sep_14_7(5)_552-559.nxml.txt.nlp	24073313	SENT116	1	1	6	6	celecoxib	EGFR	PA448871	1956	0.518
NULL	Amino_Acids_2011_May_30_40(5)_1271-1296.nxml.txt.nlp	21448658	SENT472	18	18	37	37	creatine	Gen	PA164778930	348654	0.518
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT128	20	20	4	4	metoprolol	CYP3A4	PA450480	1576	0.518
NULL	Indian_J_Dermatol_2010_Apr-Jun_55(2)_161-170.nxml.txt.nlp	20606887	SENT51	1	1	24	24	ustekinumab	IL-23	PA166048654	51561	0.518
NULL	Arthritis_Res_Ther_2014_Apr_11_16(2)_R93.nxml.txt.nlp	24725461	SENT32	7	7	16	16	estradiol	HSD17B1	PA449503	3292	0.518
NULL	Br_J_Cancer_2013_Mar_19_108(5)_1061-1070.nxml.txt.nlp	23449360	SENT260	16	16	10	10	tamoxifen	IFN	PA451581	3439	0.518
NULL	Diabetes_2009_Dec_31_58(12)_2851-2862.nxml.txt.nlp	19720788	SENT136	6	6	0	0	forskolin	CHOP	PA146096022	1649	0.518
NULL	Eur_J_Clin_Pharmacol_2013_May_14_69(5)_1091-1101.nxml.txt.nlp	23150149	SENT4	21	21	16	16	isoniazid	NAT2	PA450112	10;81539	0.518
NULL	J_Hematol_Oncol_2012_Mar_27_5_13.nxml.txt.nlp	22453030	SENT48	16	16	4	4	hyaluronan	ROCK1	PA165958431	6093	0.518
NULL	Gut_Liver_2015_Jan_9(1)_18-27.nxml.txt.nlp	NULL	SENT60	10	10	4	4	infliximab	ACT	PA452639	12;11332;9457;641455	0.518
NULL	Korean_J_Anesthesiol_2013_Dec_26_65(6_Suppl)_S1-S3.nxml.txt.nlp	24478828	SENT60	3	3	6	6	atracurium	BCHE	PA164776840	590	0.518
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT857	10	10	28	28	aripiprazole	STAR	PA10026	6770;2984	0.518
NULL	Brain_Sci_2013_Jun_19_3(2)_964-991.nxml.txt.nlp	24961433	SENT400	14	14	17	17	choline	B12	PA448976	7126;4709	0.518
NULL	Br_J_Pharmacol_2013_Mar_25_168(6)_1445-1455.nxml.txt.nlp	23121507	SENT97	34	34	14	14	tetracycline	TRPM3	PA451640	80036	0.518
NULL	Case_Rep_Genet_2011_Sep_28_2011_306072.nxml.txt.nlp	23074674	SENT67	8	8	0	0	creatine	CKBE	PA164778930	1156	0.518
NULL	Oncogene_2014_Sep_25_33(39)_4767-4777.nxml.txt.nlp	24141779	SENT270	18	18	13	13	fluorescein	HEX	PA164746009	3087	0.518
NULL	Br_J_Cancer_1980_Jun_41(6)_946-955.nxml.txt.nlp	7426319	SENT12	15	15	9	9	spermine	PAO	PA164781199	196743;54498	0.518
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Dec_2_5_30.nxml.txt.nlp	17140452	SENT239	19	19	29	29	mupirocin	CHL	PA164764568	91851	0.518
NULL	Cancers_(Basel)_2013_May_27_5(2)_617-638.nxml.txt.nlp	24216994	SENT219	0	0	2	2	curcumin	MMP2	PA151958596	4313	0.518
NULL	J_Biomed_Biotechnol_2010_Sep_19_2010_518743.nxml.txt.nlp	20886007	SENT293	28	28	32	32	ethanol	ADP	PA448073	23038	0.518
NULL	Biosci_Rep_2014_Dec_12_34(6)_e00160.nxml.txt.nlp	25495645	SENT18	9	9	23	23	lipase	ANGPTL3	PA450239	27329	0.518
NULL	Vet_Res_2014_Dec_16_45(1)_123.nxml.txt.nlp	25512064	SENT227	2	2	19	19	zinc	DC-SIGN	PA451956	30835	0.518
NULL	Cancer_Med_2012_Oct_6_1(2)_198-206.nxml.txt.nlp	23342269	SENT226	25	25	30	30	fluorouracil	ROX	PA128406956	4335	0.518
NULL	J_Cancer_2013_Jan_11_4(2)_117-132.nxml.txt.nlp	23386910	SENT130	14	14	25	25	exemestane	HER2	PA449563	2064	0.518
NULL	Alcohol_Res_2013_35(1)_47-55.nxml.txt.nlp	24313164	SENT108	4	4	19	19	ethanol	p300	PA448073	2033	0.518
NULL	J_Hematol_Oncol_2014_Aug_1_7_52.nxml.txt.nlp	25085632	SENT173	0	0	15	15	sunitinib	EGFR	PA162372840	1956	0.518
NULL	Psychiatry_Investig_2009_Sep_23_6(3)_185-193.nxml.txt.nlp	20046394	SENT174	7	7	9	9	tiagabine	TGB	PA451682	5473	0.518
NULL	Open_AIDS_J_2010_Jan_19_4_70-75.nxml.txt.nlp	20200604	SENT220	38	38	36	36	atazanavir	ATV	PA10251	4683	0.518
NULL	Diabetes_Metab_J_2012_Aug_20_36(4)_293-299.nxml.txt.nlp	22950061	SENT166	25	25	4	4	metformin	POMC	PA450395	5443	0.518
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Jul_23_70(Pt_8)_m304.nxml.txt.nlp	25249885	SENT6	2	2	13	13	nitrile	RhII	PA450636	6007	0.518
NULL	Int_J_Tryptophan_Res_2010_Oct_15_3_169-173.nxml.txt.nlp	22084597	SENT37	3	3	9	9	losartan	EXP	PA450268	4154	0.518
NULL	Int_J_Alzheimers_Dis_2010_Dec_27_2011_231595.nxml.txt.nlp	21234401	SENT106	4	4	11	11	iron	APP	PA450087	351	0.518
NULL	Br_J_Ophthalmol_2012_May_7_96(5)_688-693.nxml.txt.nlp	22399690	SENT22	28	28	41	41	ranibizumab	VEGF-A	PA164746012	7422	0.518
NULL	Adv_Ther_2014_Dec_2_31_1228-1246.nxml.txt.nlp	25447269	SENT204	15	15	19	19	tafluprost	TIM	PA165958432	7984;8914	0.518
NULL	Front_Neurosci_2014_Jun_3_8_128.nxml.txt.nlp	24917782	SENT89	22	22	16	16	ethanol	POMC	PA448073	5443	0.518
NULL	Int_J_Mol_Sci_2014_Nov_25_15(12)_21703-21722.nxml.txt.nlp	25429431	SENT633	2	2	0	0	curcumin	AMPK	PA151958596	5563	0.518
NULL	Org_Med_Chem_Lett_2012_Oct_24_2_33.nxml.txt.nlp	23095284	SENT13	19	19	8	8	galactose	flower	PA449725	11094	0.518
NULL	Iran_J_Basic_Med_Sci_2013_Apr_16(4)_610-614.nxml.txt.nlp	24250937	SENT126	9	9	28	28	coumarin	CYP2A6	PA134521193	1548	0.518
NULL	Indian_J_Plast_Surg_2014_Jan-Apr_47(1)_102-108.nxml.txt.nlp	24987213	SENT137	10	10	12	12	thrombin	ATIII	PA451674	462	0.518
NULL	Front_Genet_2013_Dec_12_4_277.nxml.txt.nlp	24376456	SENT402	0	0	14	14	ethanol	MITF	PA448073	4286	0.518
NULL	Curr_Oncol_2009_Jul_16(Suppl_2)_S14-S23.nxml.txt.nlp	19672417	SENT208	4	4	0	0	tamoxifen	ATAC	PA451581	6375	0.518
NULL	Mol_Cell_Proteomics_2012_Feb_6_11(2)_M111_015222.nxml.txt.nlp	22147731	SENT369	18	18	11	11	cetuximab	EGF	PA10040	1950	0.518
NULL	Ann_Surg_Oncol_2014_Feb_13_21(5)_1575-1582.nxml.txt.nlp	24522992	SENT174	10	10	29	29	tamoxifen	IMPACT	PA451581	55364	0.518
NULL	Cell_Microbiol_2013_Aug_13_15(8)_1304-1312.nxml.txt.nlp	23617720	SENT49	12	12	46	46	trypsin	CR1	PA451806	1378	0.518
NULL	Pain_2012_Apr_153(4)_775-783.nxml.txt.nlp	22325744	SENT78	13	13	7	7	isoflurane	P21	PA450106	1026;9338	0.518
NULL	Amino_Acids_2013_Aug_19_45(2)_351-358.nxml.txt.nlp	23685963	SENT68	28	28	36	36	l-tyrosine	PLP	PA451822	25824;5744	0.518
NULL	Front_Oncol_2013_Sep_9_3_235.nxml.txt.nlp	24058902	SENT58	0	0	2	2	vorinostat	EGFR	PA164748224	1956	0.518
NULL	Toxins_(Basel)_2010_Mar_31_2(4)_517-551.nxml.txt.nlp	22069598	SENT382	0	0	11	11	resveratrol	SIRT1		23411	0.518
NULL	J_Mol_Model_2011_Sep_21_17(9)_2133-2141.nxml.txt.nlp	20857153	SENT54	23	23	13	13	thrombin	COX2	PA451674	4513;5743	0.518
NULL	Case_Rep_Endocrinol_2013_Dec_22_2013_675298.nxml.txt.nlp	24455332	SENT12	5	5	26	26	etoposide	ACTH	PA449552	5443	0.518
NULL	Nat_Commun_2013_Apr_9_4_1684.nxml.txt.nlp	23575688	SENT96	2	2	15	15	rolipram	IL-8	PA153906323	3576	0.518
NULL	Case_Rep_Ophthalmol_2014_Aug_4_5(2)_243-248.nxml.txt.nlp	25232337	SENT51	12	12	27	27	ranibizumab	San	PA164746012	80218	0.518
NULL	Br_J_Cancer_2010_Jan_5_102(1)_80-86.nxml.txt.nlp	19920817	SENT111	14	14	12	12	sunitinib	IFN	PA162372840	3439	0.518
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT309	7	7	14	14	clozapine	PRL	PA449061	5617	0.518
NULL	Front_Genet_2013_Aug_29_4_163.nxml.txt.nlp	24009622	SENT16	25	25	27	27	ethanol	DDP	PA448073	1678	0.518
NULL	J_Int_Soc_Sports_Nutr_2010_Aug_22_7_28.nxml.txt.nlp	20727213	SENT152	12	12	20	20	l-glutamine	IL-6	PA10090	3569	0.518
NULL	Br_J_Cancer_2011_Aug_23_105(5)_649-657.nxml.txt.nlp	21811251	SENT213	10	10	13	13	gefitinib	IGF1R	PA131301952	3480	0.518
NULL	Protein_Cell_2014_May_26_5(5)_343-347.nxml.txt.nlp	24668462	SENT15	5	5	3	3	heparin	FGF18	PA449855	8817	0.518
NULL	Cancer_Immunol_Immunother_2011_Jun_25_60(6)_793-808.nxml.txt.nlp	21350947	SENT155	32	32	29	29	sorafenib	IFN	PA7000	3439	0.518
NULL	Saudi_J_Anaesth_2013_Apr-Jun_7(2)_151-154.nxml.txt.nlp	23956714	SENT17	0	0	2	2	theophylline	NAC	PA451647	22861	0.518
NULL	Breast_Cancer_Res_2007_Mar_6_9(2)_R22.nxml.txt.nlp	17341305	SENT351	19	19	0	0	medroxyprogesterone	ANOVA	PA450344	4858	0.518
NULL	Acta_Paediatr_2009_Nov_98(11)_1768-1775.nxml.txt.nlp	19706020	SENT70	37	37	24	24	thyroglobulin	ANOVA	PA164754910	4858	0.518
NULL	Front_Microbiol_2014_Mar_18_5_102.nxml.txt.nlp	24672518	SENT73	3	3	5	5	tamoxifen	miR-17-92	PA451581	407975	0.518
NULL	Aging_(Albany_NY)_2014_Sep_2_6(9)_742-754.nxml.txt.nlp	25324470	SENT109	21	21	23	23	lipase	HSL	PA450239	3991	0.518
NULL	Br_J_Cancer_2002_Feb_1_86(3)_470-476.nxml.txt.nlp	11875717	SENT42	19	19	42	42	cisplatin	MTD	PA449014	4493	0.518
NULL	Lipids_Health_Dis_2011_Feb_28_10_38.nxml.txt.nlp	21352602	SENT108	6	6	8	8	ezetimibe	PCSK9	PA10816	255738	0.518
NULL	Oncol_Lett_2014_Mar_19_7(3)_674-678.nxml.txt.nlp	24527071	SENT4	5	5	26	26	cisplatin	AKR1C2	PA449014	1646	0.518
NULL	Cancer_Cell_Int_2011_Nov_17_11_40.nxml.txt.nlp	22088142	SENT147	16	16	33	33	gemcitabine	EGFR	PA449748	1956	0.518
NULL	Indian_Dermatol_Online_J_2013_Jul-Sep_4(3)_262-263.nxml.txt.nlp	23984259	SENT23	10	10	15	15	imiquimod	CO2	PA449972	4513	0.518
NULL	Arthritis_Res_Ther_2003_Sep_12_5(Suppl_3)_145.nxml.txt.nlp	NULL	SENT5	6	6	9	9	staurosporine	IL-16	PA165109623	3603	0.518
NULL	Br_J_Clin_Pharmacol_2010_Dec_70(6)_807-814.nxml.txt.nlp	21175436	SENT201	7	7	12	12	liraglutide	ASAT	PA165958364	22	0.518
NULL	J_Am_Heart_Assoc_2013_Apr_24_2(2)_e000131.nxml.txt.nlp	23537811	SENT74	17	17	14	14	clopidogrel	CYP2C19	PA449053	1557	0.518
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT192	35	35	46	46	cetuximab	Yes	PA10040	7525	0.518
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Jun_27_5_15.nxml.txt.nlp	16803618	SENT178	20	20	42	42	erythromycin	GEN1	PA449493	348654	0.518
NULL	Breast_Cancer_2012_Oct_19_19(4)_302-308.nxml.txt.nlp	22711317	SENT59	6	6	31	31	estradiol	RANKL	PA449503	8600	0.518
NULL	Cardiovasc_Diabetol_2005_Oct_5_4_16.nxml.txt.nlp	16207378	SENT116	2	2	5	5	glucosamine	perlecan	PA164747613	3339	0.518
NULL	Int_J_Breast_Cancer_2012_May_9_2012_415170.nxml.txt.nlp	22649737	SENT136	31	31	28	28	trastuzumab	HER2	PA451743	2064	0.518
NULL	Cancers_(Basel)_2012_Apr_5_4(2)_354-378.nxml.txt.nlp	24213315	SENT931	1	1	7	7	capsaicin	DR5	PA448776	8795	0.518
NULL	Curr_Neuropharmacol_2008_Jun_6(2)_151-163.nxml.txt.nlp	19305794	SENT434	13	13	10	10	capsaicin	TRPV2	PA448776	51393	0.518
NULL	J_Adv_Pract_Oncol_2012_Jul_1_Jul-Aug_3(4)_267-272.nxml.txt.nlp	25031955	SENT98	0	0	11	11	crizotinib	CYP3A5	PA165946122	1577	0.518
NULL	ISRN_Otolaryngol_2012_Nov_14_2012_797619.nxml.txt.nlp	23762619	SENT143	3	3	9	9	gefitinib	BRAK	PA131301952	9547	0.518
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1224-1233.nxml.txt.nlp	22353810	SENT202	10	10	8	8	doxorubicin	MRP-1	PA449412	928	0.518
NULL	Adipocyte_2013_Jan_1_2(1)_28-32.nxml.txt.nlp	23700549	SENT24	2	2	18	18	valsartan	IL-6	PA451848	3569	0.518
NULL	Front_Endocrinol_(Lausanne)_2014_Feb_25_5_22.nxml.txt.nlp	24611062	SENT237	4	4	20	20	estradiol	PTEN	PA449503	5728	0.518
NULL	Mol_Cell_Proteomics_2012_Feb_6_11(2)_M111_015222.nxml.txt.nlp	22147731	SENT192	32	32	24	24	gefitinib	EGF	PA131301952	1950	0.518
NULL	Expert_Rev_Mol_Med_2011_Dec_13_e39.nxml.txt.nlp	22172201	SENT205	11	11	35	35	nadh	NO3	PA164755085	4681	0.518
NULL	Clin_Ophthalmol_2010_Nov_3_4_1253-1261.nxml.txt.nlp	21151330	SENT58	16	16	13	13	travoprost	BAK	PA164781371	578	0.518
NULL	Cancer_Med_2013_Aug_10_2(4)_545-552.nxml.txt.nlp	24156027	SENT157	10	10	12	12	everolimus	FDG	PA164746311	23583	0.518
NULL	Inflamm_Res_2010_Jan_28_59(1)_63-70.nxml.txt.nlp	19714295	SENT55	24	24	16	16	heparin	San	PA449855	80218	0.518
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_21-38.nxml.txt.nlp	19305786	SENT123	25	25	21	21	capsaicin	TRPV1	PA448776	7442	0.518
NULL	J_Thromb_Haemost_2011_Oct_9(10)_2103-2105.nxml.txt.nlp	21812912	SENT21	26	26	21	21	ticagrelor	mol	PA165374673	90527	0.518
NULL	Front_Genet_2012_Nov_2_3_229.nxml.txt.nlp	23130019	SENT122	20	20	7	7	azathioprine	TPMT	PA448515	7172	0.518
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Dec_2_5_30.nxml.txt.nlp	17140452	SENT194	15	15	5	5	linezolid	GAT	PA450233	10249	0.518
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Apr_15_9_13.nxml.txt.nlp	20398300	SENT74	7	7	0	0	amoxicillin	LAM	PA448406	7249;7248	0.518
NULL	Front_Neurol_2013_Jun_26_4_79.nxml.txt.nlp	23805125	SENT1604	0	0	10	10	lithium	spatial	PA450243	219793	0.518
NULL	Mediators_Inflamm_2010_Jun_21_2010_194896.nxml.txt.nlp	20652055	SENT48	18	18	12	12	fluvastatin	mol	PA449688	90527	0.518
NULL	Pharmaceuticals_(Basel)_2012_Nov_20_5(11)_1236-1264.nxml.txt.nlp	24281308	SENT1784	4	4	22	22	ridaforolimus	KRAS	PA165291475	3845	0.518
NULL	Arch_Orthop_Trauma_Surg_2009_Nov_7_129(11)_1495-1504.nxml.txt.nlp	18989686	SENT183	29	29	25	25	gentamicin	VAN	PA449753	10318	0.518
NULL	F1000Res_2013_Mar_5_2_74.nxml.txt.nlp	24358880	SENT16	0	0	12	12	capsaicin	TRPV1	PA448776	7442	0.518
NULL	Oncol_Lett_2014_Oct_22_8(4)_1603-1607.nxml.txt.nlp	25202376	SENT130	25	25	35	35	cisplatin	BRCA1	PA449014	672	0.518
NULL	Clin_Med_Insights_Oncol_2011_Mar_16_5_35-43.nxml.txt.nlp	21499557	SENT269	36	36	23	23	trabectedin	IFF	PA165958349	3456	0.518
NULL	J_Exp_Bot_2012_May_29_63(8)_3229-3241.nxml.txt.nlp	22378948	SENT210	18	18	3	3	ethanol	DR5	PA448073	8795	0.518
NULL	J_Mol_Med_2008_Sep_4_86(9)_1045-1056.nxml.txt.nlp	18600309	SENT246	15	15	22	22	salmeterol	IL-8	PA451300	3576	0.518
NULL	Exp_Hematol_2012_Feb_40(2)_97-106.nxml.txt.nlp	22085453	SENT295	1	1	31	31	sitagliptin	CD4	PA164748978	920	0.518
NULL	Evid_Based_Complement_Alternat_Med_2012_Dec_17_2012_857123.nxml.txt.nlp	23365602	SENT79	12	12	5	5	capsaicin	TRPV1	PA448776	7442	0.518
NULL	Breast_Cancer_Res_2003_Feb_5_5(2)_113-116.nxml.txt.nlp	12631392	SENT94	35	35	0	0	trastuzumab	ATAC	PA451743	6375	0.518
NULL	Surg_Today_2012_Jan_6_42(1)_8-28.nxml.txt.nlp	22139128	SENT235	16	16	18	18	tegafur	PSK	PA452620	9344	0.518
NULL	Protein_Eng_Des_Sel_2009_Jul_10_22(7)_421-430.nxml.txt.nlp	19515728	SENT127	6	6	9	9	urea	p53	PA451831	7157	0.518
NULL	Clin_Kidney_J_2012_Oct_5(5)_434-437.nxml.txt.nlp	23986860	SENT19	20	20	25	25	ganciclovir	SPK	PA449733	55872;8189	0.518
NULL	J_Hematol_Oncol_2011_Apr_25_4_20.nxml.txt.nlp	21518431	SENT48	12	12	35	35	l-glutamine	CO2	PA10090	4513	0.518
NULL	Int_J_Gen_Med_2012_May_4_5_391-398.nxml.txt.nlp	22615534	SENT101	10	10	27	27	risperidone	Gen	PA451257	348654	0.518
NULL	Cancer_Med_2012_Oct_6_1(2)_198-206.nxml.txt.nlp	23342269	SENT62	2	2	22	22	oxaliplatin	CD10	PA131285527	4311	0.518
NULL	J_Gen_Physiol_1938_Nov_20_22(2)_207-237.nxml.txt.nlp	19873101	SENT0	15	15	1	1	chymotrypsin	Gen	PA448994	348654	0.518
NULL	Cancers_(Basel)_2014_Nov_14_6(4)_2275-2295.nxml.txt.nlp	25405526	SENT201	21	21	25	25	vincristine	CHOP	PA451879	1649	0.518
NULL	Acta_Histochem_Cytochem_2011_Apr_28_44(2)_51-60.nxml.txt.nlp	21614166	SENT483	3	3	10	10	thalidomide	PCNA	PA451644	5111	0.518
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT225	0	0	14	14	sitagliptin	GLP-1	PA164748978	100125288	0.518
NULL	eLife_2013_Oct_29_2_e01236.nxml.txt.nlp	24171104	SENT457	11	11	13	13	bortezomib	MM1	PA10252	23654	0.518
NULL	Gut_Liver_2013_Sep_14_7(5)_552-559.nxml.txt.nlp	24073313	SENT11	7	7	5	5	heparin	EGFR	PA449855	1956	0.518
NULL	Eur_J_Clin_Pharmacol_2014_Oct_8_70(1)_37-45.nxml.txt.nlp	24100471	SENT54	20	20	22	22	omeprazole	CYP2C19	PA450704	1557	0.518
NULL	Carcinogenesis_2010_Dec_27_31(12)_2049-2057.nxml.txt.nlp	20876285	SENT13	28	28	3	3	tamoxifen	HER2	PA451581	2064	0.517
NULL	Int_J_Vasc_Med_2011_Aug_11_2011_867964.nxml.txt.nlp	21860799	SENT13	0	0	13	13	clopidogrel	ADP	PA449053	23038	0.517
NULL	Indian_J_Crit_Care_Med_2011_Apr-Jun_15(2)_137-139.nxml.txt.nlp	21814383	SENT23	21	21	14	14	isoflurane	NMB	PA450106	10457;4828	0.517
NULL	Breast_Cancer_Res_2011_Jan_28_13(1)_301.nxml.txt.nlp	21345282	SENT14	9	9	42	42	medroxyprogesterone	RANK	PA450344	8792	0.517
NULL	J_Clin_Gastroenterol_2014_Jul_24_48(6)_513-523.nxml.txt.nlp	24275714	SENT98	32	32	23	23	fluorescein	CD4	PA164746009	920	0.517
NULL	J_Int_AIDS_Soc_2012_May_31_15(2)_17381.nxml.txt.nlp	22713255	SENT160	30	30	0	0	stavudine	ART	PA451494	181	0.517
NULL	Br_J_Cancer_2010_Nov_9_103(10)_1588-1596.nxml.txt.nlp	20978505	SENT128	26	26	17	17	temozolomide	PMS2	PA451609	5395	0.517
NULL	Cell_Death_Dis_2010_Oct_21_1(10)_e86.nxml.txt.nlp	21368859	SENT88	2	2	0	0	doxorubicin	TRAIL	PA449412	8743	0.517
NULL	Ecancermedicalscience_2011_Apr_28_5_211.nxml.txt.nlp	22276054	SENT114	31	31	24	24	lorazepam	NK-1	PA450267	27087	0.517
NULL	Allergy_Asthma_Immunol_Res_2012_Mar_25_4(2)_68-79.nxml.txt.nlp	22379601	SENT32	27	27	24	24	zinc	GATA-1	PA451956	2623	0.517
NULL	J_Immune_Based_Ther_Vaccines_2006_Mar_17_4_1.nxml.txt.nlp	16545119	SENT103	9	9	16	16	glucose	DDP	PA449773	1678	0.517
NULL	F1000_Biol_Rep_2009_Sep_8_1_70.nxml.txt.nlp	20948617	SENT27	1	1	5	5	denosumab	IFN	PA166048634	3439	0.517
NULL	J_Oncol_2009_Mar_24_2009_491985.nxml.txt.nlp	19325924	SENT152	25	25	30	30	genistein	CXCR4	PA165109660	7852	0.517
NULL	Antimicrob_Agents_Chemother_2013_Dec_57(12)_5792-5807.nxml.txt.nlp	24002099	SENT210	4	4	8	8	artemisinin	ACT	PA165111696	12;11332;9457;641455	0.517
NULL	Nat_Genet_2014_Jun_20_46(6)_613-617.nxml.txt.nlp	24747643	SENT16	14	14	11	11	vasopressin	CRH	PA451858	1392	0.517
NULL	Biomed_Res_Int_2014_Jan_16_2014_821513.nxml.txt.nlp	24527458	SENT118	9	9	22	22	propofol	NAC	PA451141	22861	0.517
NULL	Philos_Trans_A_Math_Phys_Eng_Sci_2014_Mar_6_372(2010)_20130144.nxml.txt.nlp	24470422	SENT79	32	32	40	40	l-glutamine	CO2	PA10090	4513	0.517
NULL	Mol_Vis_2011_Apr_24_17_1011-1015.nxml.txt.nlp	21541272	SENT67	6	6	19	19	iron	FTL	PA450087	2512	0.517
NULL	Front_Genet_2012_Nov_9_3_223.nxml.txt.nlp	23162566	SENT14	0	0	2	2	fentanyl	NeuroD	PA449599	4760	0.517
NULL	Chem_Cent_J_2012_Feb_21_6_15.nxml.txt.nlp	22353684	SENT123	14	14	12	12	acebutolol	mol	PA448011	90527	0.517
NULL	Mol_Cell_Biochem_2013_Jul_3_379(1-2)_29-36.nxml.txt.nlp	23549681	SENT36	9	9	31	31	phenol	CO2	PA450913	4513	0.517
NULL	Cancer_Med_2014_Apr_7_3(2)_362-375.nxml.txt.nlp	24515916	SENT243	10	10	12	12	zoledronate	IL-2	PA10235	3558	0.517
NULL	Clin_J_Gastroenterol_2013_Nov_8_6(6)_485-489.nxml.txt.nlp	24319501	SENT76	22	22	13	13	cisplatin	HAI	PA449014	6692;6768	0.517
NULL	Afr_J_Infect_Dis_2011_5(2)_40-46.nxml.txt.nlp	23878706	SENT98	14	14	8	8	vancomycin	Gen	PA451850	348654	0.517
NULL	Front_Aging_Neurosci_2009_Dec_9_1_4.nxml.txt.nlp	20552055	SENT134	8	8	15	15	resveratrol	ANOVA		4858	0.517
NULL	Mol_Brain_2013_Dec_9_6_54.nxml.txt.nlp	24321245	SENT180	31	31	38	38	glucose	CO2	PA449773	4513	0.517
NULL	Gut_Liver_2014_Sep_18_8(5)_462-470.nxml.txt.nlp	25228969	SENT140	21	21	14	14	trypsin	CA-II	PA451806	760	0.517
NULL	Biomed_Res_Int_2014_Apr_10_2014_580852.nxml.txt.nlp	24812624	SENT147	6	6	8	8	resveratrol	PTEN		5728	0.517
NULL	Cancer_Res_Treat_2011_Dec_27_43(4)_212-216.nxml.txt.nlp	22247705	SENT27	9	9	22	22	docetaxel	EGFR	PA449383	1956	0.517
NULL	Cell_Commun_Signal_2014_Nov_7_12(1)_73.nxml.txt.nlp	NULL	SENT194	2	2	4	4	tamoxifen	THOC5	PA451581	8563	0.517
NULL	Ann_Hematol_2014_Apr_1_93(8)_1371-1380.nxml.txt.nlp	24687382	SENT29	6	6	24	24	thalidomide	Aiolos	PA451644	22806	0.517
NULL	J_Cell_Biol_1980_Mar_1_84(3)_692-704.nxml.txt.nlp	7358794	SENT6	3	3	12	12	choline	DDC	PA448976	1644	0.517
NULL	J_Biol_Chem_2011_Sep_2_286(35)_30324-30336.nxml.txt.nlp	21757751	SENT54	30	30	11	11	l-glutamine	CO2	PA10090	4513	0.517
NULL	Int_J_Mol_Sci_2010_Oct_19_11(10)_3999-4013.nxml.txt.nlp	21152316	SENT72	11	11	16	16	ns-398	LPA		4018	0.517
NULL	Clinics_(Sao_Paulo)_2012_Mar_67(3)_283-287.nxml.txt.nlp	22473412	SENT59	9	9	7	7	glucose	SHBG	PA449773	6462	0.517
NULL	NDT_Plus_2008_Aug_25_1(4)_218-220.nxml.txt.nlp	19461861	SENT69	0	0	2	2	cinacalcet	PTH	PA164776671	5741	0.517
NULL	Toxins_(Basel)_2010_Mar_31_2(4)_517-551.nxml.txt.nlp	22069598	SENT944	1	1	3	3	genistein	HER2	PA165109660	2064	0.517
NULL	Lancet_2011_Aug_13_378(9791)_595-605.nxml.txt.nlp	21784508	SENT264	23	23	4	4	risedronate	P11	PA451255	8909;6281	0.517
NULL	Ann_Hematol_2010_Nov_25_89(11)_1115-1124.nxml.txt.nlp	20499237	SENT108	40	40	23	23	cladribine	CD19	PA449027	930	0.517
NULL	J_Clin_Biochem_Nutr_2009_Jul_30_45(1)_9-13.nxml.txt.nlp	19590701	SENT60	3	3	18	18	lansoprazole	HO-1	PA450180	3162	0.517
NULL	Am_J_Trop_Med_Hyg_2014_Jul_2_91(1)_3-4.nxml.txt.nlp	24752685	SENT26	15	15	11	11	primaquine	G6PD	PA451103	2539	0.517
NULL	Cancer_Med_2013_Oct_5_2(5)_654-661.nxml.txt.nlp	24403231	SENT38	12	12	39	39	l-glutamine	CO2	PA10090	4513	0.517
NULL	Can_J_Infect_Dis_Med_Microbiol_2014_Nov-Dec_25(6)_327-343.nxml.txt.nlp	25587296	SENT190	0	0	8	8	posaconazole	P-gp	PA151958574	5243	0.517
NULL	Evid_Based_Complement_Alternat_Med_2011_Feb_14_2011_429843.nxml.txt.nlp	21869897	SENT102	15	15	13	13	ethanol	CEA	PA448073	5670;1087	0.517
NULL	Acta_Pharmacol_Sin_2009_Apr_9_30(4)_451-457.nxml.txt.nlp	19270722	SENT154	27	27	21	21	imatinib	P-gp	PA10804	5243	0.517
NULL	Comput_Math_Methods_Med_2012_Jan_16_2012_792375.nxml.txt.nlp	22291855	SENT82	26	26	29	29	estradiol	E2F1	PA449503	1869	0.517
NULL	Clin_Mol_Hepatol_2014_Sep_25_20(3)_283-290.nxml.txt.nlp	25320732	SENT95	33	33	31	31	propranolol	EVL	PA451145	51466	0.517
NULL	Crit_Care_2008_Nov_26_12(Suppl_6)_S3.nxml.txt.nlp	19105796	SENT155	32	32	34	34	thrombin	PAR1	PA451674	79581;2149	0.517
NULL	J_Res_Med_Sci_2010_Nov-Dec_15(6)_331-343.nxml.txt.nlp	21526106	SENT163	21	21	9	9	l-arginine	HDEL	PA448478	10945	0.517
NULL	Contemp_Clin_Dent_2011_Oct-Dec_2(4)_278-282.nxml.txt.nlp	22346152	SENT135	41	41	43	43	potassium	GCF	PA451047	6936	0.517
NULL	Anal_Biochem_2014_Jun_1_454(100)_17-22.nxml.txt.nlp	24637157	SENT65	36	36	7	7	l-glutamine	CO2	PA10090	4513	0.517
NULL	J_Biomed_Sci_2014_Apr_29_21(1)_35.nxml.txt.nlp	24780003	SENT109	10	10	17	17	bevacizumab	NIRF	PA130232992	27190;115426	0.517
NULL	CNS_Drugs_2014_May_1_28(6)_497-511.nxml.txt.nlp	24788672	SENT29	30	30	24	24	clonidine	ATX	PA449051	5168;23049	0.517
NULL	Nucleic_Acids_Res_2013_May_5_41(10)_5210-5222.nxml.txt.nlp	23563151	SENT227	18	18	11	11	arsenite	GADD45	PA452638	1647	0.517
NULL	Arch_Orthop_Trauma_Surg_2009_Nov_7_129(11)_1495-1504.nxml.txt.nlp	18989686	SENT183	41	41	25	25	cefepime	VAN	PA164754876	10318	0.517
NULL	Indian_J_Med_Res_2013_Jan_137(1)_102-110.nxml.txt.nlp	23481058	SENT131	14	14	0	0	oxygen	HIF-1	PA450744	29072	0.517
NULL	Indian_J_Pharm_Sci_2012_May-Jun_74(3)_275-278.nxml.txt.nlp	23440065	SENT10	31	31	25	25	zidovudine	ROD	PA451954	9735	0.517
NULL	J_Cell_Sci_2014_May_15_127(10)_2313-2325.nxml.txt.nlp	24634514	SENT278	31	31	25	25	forskolin	OMA1	PA146096022	115209	0.517
NULL	Biochimie_2010_Nov_92(11)_1546-1567.nxml.txt.nlp	20615447	SENT218	21	21	3	3	heparin	kallistatin	PA449855	5267	0.517
NULL	Nucl_Recept_Signal_2008_Nov_26_6_e010.nxml.txt.nlp	19079612	SENT503	4	4	9	9	bicalutamide	SMRT	PA164746255	9612	0.517
NULL	Breast_Cancer_Res_2012_Mar_7_14(2)_R39.nxml.txt.nlp	22397502	SENT259	3	3	16	16	fluorescein	IFN	PA164746009	3439	0.517
NULL	Crit_Care_2005_Sep_3_9(1)_23-24.nxml.txt.nlp	15693976	SENT10	10	10	12	12	dantrolene	CHS	PA449208	1130	0.517
NULL	Front_Genet_2013_Aug_29_4_163.nxml.txt.nlp	24009622	SENT205	19	19	21	21	ethanol	DDP	PA448073	1678	0.517
NULL	J_Bras_Pneumol_2013_Jun-Aug_39(4)_434-439.nxml.txt.nlp	24068264	SENT132	3	3	13	13	tramadol	por	PA451735	64840	0.517
NULL	Exp_Lung_Res_2013_Oct_1_39(8)_336-348.nxml.txt.nlp	23919450	SENT239	6	6	2	2	thrombin	PAR-1	PA451674	2011;2149	0.517
NULL	Cardiovasc_Diabetol_2013_Jan_31_12_28.nxml.txt.nlp	23368770	SENT205	17	17	33	33	copper	ROS	PA449114	6098	0.517
NULL	Endocrine_2012_Dec_14_42(3)_622-636.nxml.txt.nlp	22695986	SENT110	4	4	2	2	forskolin	PTH	PA146096022	5741	0.517
NULL	J_Cell_Biol_1997_Jun_30_137(7)_1639-1649.nxml.txt.nlp	9199177	SENT301	8	8	12	12	paraformaldehyde	ZAP-70	PA450790	7535	0.517
NULL	Chem_Cent_J_2012_Sep_20_6_105.nxml.txt.nlp	22995678	SENT25	10	10	13	13	moxifloxacin	MOX	PA450555	26002	0.517
NULL	Physiol_Rep_2014_Nov_4_2(11)_e12197.nxml.txt.nlp	25367695	SENT76	23	23	13	13	urea	PCP	PA451831	5547	0.517
NULL	Emerg_Infect_Dis_2011_Jan_17(1)_123-125.nxml.txt.nlp	21192872	SENT86	20	20	11	11	ceftriaxone	CD4	PA448866	920	0.517
NULL	Ann_Dermatol_2013_Aug_13_25(3)_398-399.nxml.txt.nlp	24003298	SENT14	10	10	14	14	imiquimod	gamma	PA449972	9913	0.517
NULL	Cancers_(Basel)_2011_Aug_12_3(3)_3279-3330.nxml.txt.nlp	24212956	SENT1211	15	15	9	9	denosumab	CD38	PA166048634	952	0.517
NULL	J_Hepatol_2013_Aug_59(2)_318-326.nxml.txt.nlp	23624001	SENT368	0	0	11	11	sorafenib	JNK	PA7000	5599	0.517
NULL	Br_J_Pharmacol_2014_Jun_15_171(11)_2705-2725.nxml.txt.nlp	24467436	SENT66	14	14	18	18	isoniazid	NAT	PA450112	6046	0.517
NULL	Genome_Biol_2003_Oct_27_4(11)_232.nxml.txt.nlp	14611649	SENT24	29	29	9	9	l-arginine	SLC7A2	PA448478	6542	0.517
NULL	Mol_Cell_Proteomics_2012_Jun_25_11(6)_M111_015073.nxml.txt.nlp	22278372	SENT677	9	9	3	3	trypsin	PTX3	PA451806	5806	0.517
NULL	J_Vis_Exp_2011_Jul_17_(53)_2858.nxml.txt.nlp	21788935	SENT42	12	12	28	28	choline	TES	PA448976	26136	0.517
NULL	Stroke_Res_Treat_2012_Oct_16_2012_385753.nxml.txt.nlp	23125943	SENT25	25	25	36	36	alteplase	PICH	PA164776730	54821	0.517
NULL	Curr_Oncol_2009_Jul_16(Suppl_2)_S1-S13.nxml.txt.nlp	19672416	SENT301	4	4	34	34	tamoxifen	ARNO	PA451581	9266	0.517
NULL	J_Mol_Signal_2006_Dec_6_1_8.nxml.txt.nlp	17224083	SENT5	15	15	18	18	thrombin	Rho	PA451674	29984	0.517
NULL	Oncotarget_2014_Mar_13_5(4)_1101-1110.nxml.txt.nlp	24658355	SENT161	9	9	3	3	tamoxifen	MKP-2	PA451581	1846	0.517
NULL	Mol_Vis_2012_Apr_24_18_1031-1039.nxml.txt.nlp	22605915	SENT98	4	4	9	9	fluorescein	ERG	PA164746009	2078	0.517
NULL	Acta_Crystallogr_F_Struct_Biol_Commun_2014_Aug_29_70(Pt_9)_1199-1205.nxml.txt.nlp	25195891	SENT21	22	22	13	13	l-alanine	PLP	PA448055	25824;5744	0.517
NULL	Oncotarget_2014_Aug_29_5(18)_8052-8082.nxml.txt.nlp	25211298	SENT453	15	15	7	7	temozolomide	U87	PA451609	677775;641648	0.517
NULL	J_Biomed_Biotechnol_2010_Sep_19_2010_518743.nxml.txt.nlp	20886007	SENT480	8	8	4	4	ethanol	CO2	PA448073	4513	0.517
NULL	Mol_Cancer_2008_Mar_26_7_27.nxml.txt.nlp	18366759	SENT92	32	32	15	15	etoposide	HIF-1	PA449552	29072	0.517
NULL	Am_J_Physiol_Cell_Physiol_2014_Jan_15_306(2)_C89-C97.nxml.txt.nlp	24133067	SENT174	9	9	11	11	doxorubicin	PC-3	PA449412	692094	0.517
NULL	Exp_Ther_Med_2013_Mar_17_5(3)_797-802.nxml.txt.nlp	23403698	SENT202	2	2	5	5	glucose	PI3K	PA449773	5290	0.517
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1051.nxml.txt.nlp	24503543	SENT144	36	36	31	31	hexachlorophene	Yes	PA449871	7525	0.517
NULL	J_Ophthalmic_Inflamm_Infect_2013_Jan_15_3_12.nxml.txt.nlp	23514269	SENT144	8	8	21	21	paraformaldehyde	San	PA450790	80218	0.517
NULL	Exp_Diabetes_Res_2011_Oct_29_2011_596060.nxml.txt.nlp	22110473	SENT163	43	43	33	33	lipase	adiponectin	PA450239	9370	0.517
NULL	Biol_Open_2014_Nov_21_3(12)_1207-1216.nxml.txt.nlp	25416063	SENT23	17	17	37	37	zinc	NANOS2	PA451956	339345	0.517
NULL	Nucl_Recept_Signal_2014_Nov_4_12_e005.nxml.txt.nlp	25422595	SENT214	13	13	26	26	geldanamycin	p23	PA152031327	10728	0.517
NULL	Cell_J_2013_Aug_24_Autumn_15(3)_206-211.nxml.txt.nlp	24027660	SENT130	3	3	0	0	estradiol	CYP1A2	PA449503	1544	0.517
NULL	J_Cell_Biol_2002_Sep_16_158(6)_1133-1144.nxml.txt.nlp	12235127	SENT498	5	5	3	3	hyaluronan	CD44	PA165958431	960	0.517
NULL	Lab_Invest_2010_Oct_28_90(10)_1415-1424.nxml.txt.nlp	20585313	SENT224	19	19	17	17	celecoxib	HRG	PA448871	3084;3273	0.517
NULL	J_Cancer_2013_Aug_28_4(7)_585-596.nxml.txt.nlp	24069069	SENT191	14	14	8	8	verteporfin	LC3	PA451871	84557	0.517
NULL	FEBS_Open_Bio_2013_Dec_25_4_60-64.nxml.txt.nlp	24392305	SENT19	2	2	25	25	dextran	TRIM	PA449261	50852	0.517
NULL	Front_Oncol_2013_Oct_1_3_237.nxml.txt.nlp	24098868	SENT114	12	12	7	7	olaparib	CA125		4077;94025	0.517
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2011_Sep_13_4_47-62.nxml.txt.nlp	22879794	SENT234	45	45	9	9	glimepiride	PPG	PA449761	5552	0.517
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Aug_11_68(Pt_9)_o2694.nxml.txt.nlp	22969586	SENT61	29	29	20	20	benzaldehyde	mol	PA448571	90527	0.517
NULL	Cancer_Metab_2013_Nov_7_1_20.nxml.txt.nlp	24279929	SENT44	14	14	21	21	l-glutamine	CO2	PA10090	4513	0.517
NULL	Nucl_Recept_Signal_2009_Jan_16_7_e001.nxml.txt.nlp	19240808	SENT180	6	6	12	12	hyperforin	SXR	PA165985514	8856	0.517
NULL	Springerplus_2014_Sep_9_3_510.nxml.txt.nlp	25279302	SENT209	5	5	7	7	creatine	CT1	PA164778930	1489;6535	0.517
NULL	Pharmaceuticals_(Basel)_2011_Nov_11_4(11)_1503-1517.nxml.txt.nlp	NULL	SENT150	27	27	30	30	capsaicin	TRPV1	PA448776	7442	0.517
NULL	Mol_Pain_2014_Apr_18_10_27.nxml.txt.nlp	24742127	SENT272	2	2	15	15	paclitaxel	CB2	PA450761	1269	0.517
NULL	Front_Neuroenergetics_2013_Dec_26_5_11.nxml.txt.nlp	24421768	SENT116	13	13	10	10	glucose	MRS	PA449773	8011	0.517
NULL	J_Vet_Emerg_Crit_Care_(San_Antonio)_2013_Mar_8_23(2)_134-162.nxml.txt.nlp	23566108	SENT260	10	10	8	8	calcidiol	PTH	PA164745614	5741	0.517
NULL	Oncotarget_2011_Jan_25_2(1-2)_8-17.nxml.txt.nlp	21378407	SENT37	4	4	19	19	thrombin	PAR-1	PA451674	2011;2149	0.517
NULL	Oncotarget_2014_Jun_3_5(12)_4504-4515.nxml.txt.nlp	24980825	SENT199	15	15	46	46	l-glutamine	CO2	PA10090	4513	0.517
NULL	Evid_Based_Complement_Alternat_Med_2013_Aug_13_2013_569160.nxml.txt.nlp	23997795	SENT159	26	26	29	29	thrombin	ADP	PA451674	23038	0.517
NULL	Drugs_R_D_2014_Jun_6_14(2)_113-123.nxml.txt.nlp	24797400	SENT148	39	39	36	36	dabigatran	P-gp		5243	0.517
NULL	Eur_J_Clin_Pharmacol_2014_Oct_8_70(1)_37-45.nxml.txt.nlp	24100471	SENT54	16	16	18	18	pioglitazone	CYP2C8	PA450970	1558	0.517
NULL	Diabetes_2009_Mar_58(3)_527-535.nxml.txt.nlp	19066312	SENT74	13	13	40	40	l-carnitine	CO2	PA450154	4513	0.517
NULL	J_Ophthalmic_Inflamm_Infect_2011_Nov_6_2(1)_21-28.nxml.txt.nlp	22057810	SENT101	11	11	13	13	cyclosporine	CTX	PA449167	1593	0.517
NULL	Exp_Diabetes_Res_2011_Oct_29_2011_596060.nxml.txt.nlp	22110473	SENT185	19	19	12	12	lipase	IL-6	PA450239	3569	0.517
NULL	Int_J_Mol_Sci_2013_Apr_26_14(5)_9111-9125.nxml.txt.nlp	23624604	SENT287	2	2	5	5	iron	MRI	PA450087	78996	0.517
NULL	Breast_Cancer_Res_2009_Mar_19_11(2)_R16.nxml.txt.nlp	19298655	SENT118	26	26	0	0	lipase	aP2	PA450239	2167	0.517
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT368	24	24	18	18	pp2	TFF3		7033	0.517
NULL	Arthritis_Res_Ther_2012_Jan_8_14(1)_R6.nxml.txt.nlp	22225620	SENT196	31	31	38	38	rituximab	CXCL13	PA451261	10563	0.517
NULL	Neural_Plast_2014_Oct_30_2014_320937.nxml.txt.nlp	25485157	SENT255	1	1	12	12	vasopressin	CA1	PA451858	759	0.517
NULL	Diabetes_Care_2013_May_13_36(5)_1074-1082.nxml.txt.nlp	23275352	SENT182	6	6	9	9	liraglutide	ZAG	PA165958364	563	0.517
NULL	Int_J_Mol_Sci_2014_Mar_6_15(3)_4088-4103.nxml.txt.nlp	24663083	SENT89	12	12	0	0	l-arginine	PRMT1	PA448478	3276	0.517
NULL	Osteoarthritis_Cartilage_2010_Apr_18(4)_555-562.nxml.txt.nlp	20060953	SENT62	8	8	5	5	clenbuterol	MNX	PA164745640	3892	0.517
NULL	Front_Physiol_2013_May_15_4_103.nxml.txt.nlp	23720630	SENT39	26	26	30	30	simvastatin	PC3	PA451363	57332;7832;5122	0.517
NULL	Mol_Cancer_2008_Mar_26_7_27.nxml.txt.nlp	18366759	SENT10	7	7	12	12	etoposide	p53	PA449552	7157	0.517
NULL	Mol_Cancer_2014_Jan_24_13_14.nxml.txt.nlp	24460609	SENT48	13	13	17	17	hydrocortisone	EGF	PA449905	1950	0.517
NULL	Cell_Res_2013_Jul_21_23(7)_915-930.nxml.txt.nlp	23689279	SENT106	24	24	2	2	ethanol	ALDH2	PA448073	217	0.517
NULL	Br_J_Haematol_2009_Nov_2_147(3)_396-410.nxml.txt.nlp	19758122	SENT28	0	0	2	2	dasatinib	p53	PA162372878	7157	0.517
NULL	Acta_Naturae_2012_Jan-Mar_4(1)_93-100.nxml.txt.nlp	22708069	SENT186	12	12	2	2	methotrexate	FVIII	PA450428	2157	0.517
NULL	Clinicoecon_Outcomes_Res_2014_Sep_23_6_409-414.nxml.txt.nlp	25285019	SENT143	24	24	2	2	tenofovir	ATV	PA10204	4683	0.516
NULL	Evid_Based_Complement_Alternat_Med_2011_Feb_14_2011_429843.nxml.txt.nlp	21869897	SENT164	21	21	11	11	ethanol	PC6	PA448073	5125	0.516
NULL	Br_J_Cancer_2010_Jan_5_102(1)_80-86.nxml.txt.nlp	19920817	SENT82	14	14	16	16	bevacizumab	IFN	PA130232992	3439	0.516
NULL	Allergy_Asthma_Clin_Immunol_2011_Dec_7_7(1)_21.nxml.txt.nlp	22152089	SENT42	28	28	5	5	mometasone	DPI	PA450541	1832	0.516
NULL	Environ_Health_Perspect_2009_Jul_23_117(7)_1155-1161.nxml.txt.nlp	19654927	SENT90	41	41	32	32	streptomycin	FBS	PA451512	64319;26269	0.516
NULL	Oxid_Med_Cell_Longev_2012_Apr_5_2012_983427.nxml.txt.nlp	22550557	SENT226	3	3	10	10	ethanol	BAX	PA448073	581	0.516
NULL	Curr_Oncol_2009_Jul_16(Suppl_2)_S14-S23.nxml.txt.nlp	19672417	SENT219	25	25	0	0	exemestane	ATAC	PA449563	6375	0.516
NULL	Acta_Neuropathol_Commun_2013_Aug_9_1_49.nxml.txt.nlp	24252504	SENT111	20	20	39	39	arsenite	ANOVA	PA452638	4858	0.516
NULL	Nucleic_Acids_Res_2011_Sep_28_39(17)_7858-7867.nxml.txt.nlp	21715374	SENT163	11	11	15	15	thrombin	TGT	PA451674	9097;81890	0.516
NULL	Allergy_Rhinol_(Providence)_2013_Fall_4(3)_e132-e139.nxml.txt.nlp	24498518	SENT185	6	6	0	0	collagenase	MMP8	PA449107	4317	0.516
NULL	Clin_Pract_Epidemiol_Ment_Health_2005_Jul_29_1_11.nxml.txt.nlp	16053528	SENT104	7	7	0	0	diazepam	CPZ	PA449283	8532	0.516
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_127043.nxml.txt.nlp	23227093	SENT216	17	17	12	12	lovastatin	RYR	PA450272	6261	0.516
NULL	Diabetes_Care_2010_Nov_33(11)_2399-2405.nxml.txt.nlp	20980427	SENT113	15	15	4	4	ranibizumab	CRT	PA164746012	811	0.516
NULL	Curr_Oncol_2007_Aug_14(4)_154-161.nxml.txt.nlp	17710208	SENT144	22	22	2	2	ketoconazole	CYP3A4	PA450146	1576	0.516
NULL	J_Anaesthesiol_Clin_Pharmacol_2011_Oct-Dec_27(4)_537-540.nxml.txt.nlp	22096292	SENT77	28	28	10	10	clopidogrel	DES	PA449053	1674	0.516
NULL	Biomed_Res_Int_2013_Jul_30_2013_754946.nxml.txt.nlp	23984405	SENT48	2	2	7	7	nadh	ND2	PA164755085	4536	0.516
NULL	Emerg_Infect_Dis_2011_Oct_17(10)_1879-1882.nxml.txt.nlp	22000360	SENT60	26	26	0	0	chloramphenicol	PEN	PA448927	9933	0.516
NULL	Braz_J_Med_Biol_Res_2012_Jul_20_45(10)_935-941.nxml.txt.nlp	22801415	SENT45	9	9	25	25	pioglitazone	adiponectin	PA450970	9370	0.516
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT93	16	16	18	18	atorvastatin	KRAS	PA448500	3845	0.516
NULL	Arthritis_Res_Ther_2006_Nov_8_8(6)_R167.nxml.txt.nlp	17092341	SENT35	12	12	6	6	rituximab	BAFF	PA451261	10673	0.516
NULL	Br_J_Pharmacol_2014_Jun_15_171(11)_2705-2725.nxml.txt.nlp	24467436	SENT8	14	14	12	12	hydralazine	NAT2	PA449894	10;81539	0.516
NULL	Pediatr_Cardiol_2010_Jan_14_31(1)_90-95.nxml.txt.nlp	19915892	SENT23	29	29	15	15	palivizumab	AAP	PA164748781	5345	0.516
NULL	Int_J_Hypertens_2014_Jan_12_2014_381082.nxml.txt.nlp	24678415	SENT172	16	16	5	5	cinacalcet	FGF23	PA164776671	8074	0.516
NULL	Cell_Death_Dis_2013_Jun_27_4(6)_e694.nxml.txt.nlp	23807223	SENT51	21	21	41	41	chloroquine	c-Jun	PA448948	3725	0.516
NULL	J_Cell_Mol_Med_2014_Apr_20_18(4)_709-720.nxml.txt.nlp	24444314	SENT9	0	0	11	11	metformin	Bcl-2	PA450395	596	0.516
NULL	F1000Prime_Rep_2014_Dec_1_6_117.nxml.txt.nlp	25580271	SENT143	10	10	5	5	erlotinib	EGFR	PA134687924	1956	0.516
NULL	J_Breast_Cancer_2011_Mar_31_14(1)_20-27.nxml.txt.nlp	21847390	SENT138	7	7	9	9	estradiol	CLDN6	PA449503	9074	0.516
NULL	Aging_(Albany_NY)_2009_Mar_31_1(4)_412-424.nxml.txt.nlp	20195491	SENT67	27	27	13	13	resveratrol	TXNIP		10628	0.516
NULL	Mol_Clin_Oncol_2013_Sep_23_1(5)_869-874.nxml.txt.nlp	24649263	SENT127	6	6	8	8	gemcitabine	GEM	PA449748	2669	0.516
NULL	Cancer_Biol_Med_2012_Mar_9(1)_1-8.nxml.txt.nlp	23691447	SENT170	10	10	32	32	lipase	LPA	PA450239	4018	0.516
NULL	Mol_Biol_Cell_2013_Aug_1_24(15)_2389-2397.nxml.txt.nlp	23741049	SENT284	0	0	7	7	iodixanol	LDM	PA164783998	1595	0.516
NULL	Mol_Cancer_2012_May_28_11_36.nxml.txt.nlp	22640878	SENT43	19	19	5	5	paclitaxel	TGFBI	PA450761	7045	0.516
NULL	Diabetes_Care_2013_May_13_36(5)_1290-1296.nxml.txt.nlp	23250800	SENT185	10	10	25	25	l-arginine	GMP	PA448478	22978	0.516
NULL	BioDrugs_2013_Aug_27_27(5)_541-543.nxml.txt.nlp	NULL	SENT65	1	1	7	7	capecitabine	HER2	PA448771	2064	0.516
NULL	Oxid_Med_Cell_Longev_2012_Jul_3_2012_498914.nxml.txt.nlp	22829956	SENT54	25	25	47	47	l-glutamine	CO2	PA10090	4513	0.516
NULL	Pharm_Pract_(Granada)_2011_Mar_15_Jan-Mar_9(1)_1-10.nxml.txt.nlp	25132883	SENT162	11	11	19	19	dabigatran	SPAF		166378	0.516
NULL	BMB_Rep_2013_Nov_46(11)_544-549.nxml.txt.nlp	24152910	SENT41	6	6	10	10	thrombin	HMGB1	PA451674	3146	0.516
NULL	Oncol_Lett_2014_Jun_8_7(6)_2035-2040.nxml.txt.nlp	24932285	SENT168	18	18	0	0	irinotecan	UGT1A1	PA450085	54658	0.516
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT31	33	33	13	13	atorvastatin	IL-6	PA448500	3569	0.516
NULL	Ann_Gen_Psychiatry_2008_Dec_23_7_27.nxml.txt.nlp	19105845	SENT6	11	11	21	21	bupropion	CD50	PA448687	3385	0.516
NULL	J_Clin_Biochem_Nutr_2010_Sep_20_47(2)_174-180.nxml.txt.nlp	20838574	SENT40	39	39	21	21	l-glutamine	B27	PA10090	56246	0.516
NULL	Biomed_Res_Int_2013_Aug_6_2013_909613.nxml.txt.nlp	24027765	SENT13	2	2	0	0	metronidazole	EEN	PA450484	6455	0.516
NULL	Eur_J_Neurosci_2007_Sep_26(6)_1657-1669.nxml.txt.nlp	17880399	SENT541	6	6	34	34	chlorpromazine	DAO	PA448964	26;1610	0.516
NULL	Drugs_Context_2012_Nov_19_2012_212242.nxml.txt.nlp	24432031	SENT472	12	12	5	5	dacarbazine	Bcl-2	PA449197	596	0.516
NULL	Diabetes_2009_Dec_31_58(12)_2731-2740.nxml.txt.nlp	19720798	SENT129	25	25	20	20	troglitazone	adiponectin	PA451799	9370	0.516
NULL	Diabetes_2014_Jan_13_63(1)_75-88.nxml.txt.nlp	24009260	SENT31	9	9	7	7	genistein	VIII	PA165109660	1351	0.516
NULL	Curr_Neuropharmacol_2014_Jul_12(4)_365-379.nxml.txt.nlp	25342944	SENT534	28	28	1	1	paroxetine	5-HT1A	PA450801	3350	0.516
NULL	Pain_Res_Treat_2013_Jan_30_2013_217864.nxml.txt.nlp	23431433	SENT145	12	12	2	2	dextran	NHE	PA449261	285335	0.516
NULL	Oncogene_2013_Nov_28_32(48)_5458-5470.nxml.txt.nlp	23435420	SENT72	22	22	18	18	bleomycin	53BP1	PA448645	7158	0.516
NULL	J_Oncol_2011_Jun_12_2011_542358.nxml.txt.nlp	21772843	SENT367	8	8	10	10	gefitinib	EGFR	PA131301952	1956	0.516
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT96	12	12	23	23	perifosine	TRAIL	PA165291471	8743	0.516
NULL	J_Cell_Biol_2001_Aug_6_154(3)_599-610.nxml.txt.nlp	11481345	SENT316	15	15	8	8	tetracycline	ARNO	PA451640	9266	0.516
NULL	Br_J_Haematol_2008_Jun_141(5)_659-671.nxml.txt.nlp	18410446	SENT35	12	12	5	5	cerulenin	JNK	PA164764551	5599	0.516
NULL	Case_Rep_Rheumatol_2012_Dec_24_2012_270315.nxml.txt.nlp	23424706	SENT48	13	13	9	9	tocilizumab	IL-8	PA165292659	3576	0.516
NULL	Aging_(Albany_NY)_2012_Mar_7_4(3)_166-175.nxml.txt.nlp	22411934	SENT160	19	19	6	6	metformin	AMPK	PA450395	5563	0.516
NULL	Neuropsychopharmacology_2009_Apr_2_34(5)_1135-1148.nxml.txt.nlp	18596687	SENT28	25	25	12	12	cocaine	CRF	PA449072	1392;10882	0.516
NULL	J_Biol_Eng_2010_Nov_29_4_15.nxml.txt.nlp	21114841	SENT211	14	14	16	16	chlorambucil	CLB	PA448926	171425	0.516
NULL	Oncotarget_2013_Dec_21_5(9)_2404-2417.nxml.txt.nlp	24811221	SENT353	5	5	8	8	bleomycin	gamma	PA448645	9913	0.516
NULL	ACS_Chem_Biol_2011_Apr_15_6(4)_325-335.nxml.txt.nlp	21175222	SENT133	25	25	15	15	chymotrypsin	L26	PA448994	6154	0.516
NULL	Pharmaceutics_2010_Apr_27_2(2)_136-158.nxml.txt.nlp	NULL	SENT201	23	23	0	0	diclofenac	HSM	PA449293	94030	0.516
NULL	Adv_Ther_2014_Dec_2_31_1228-1246.nxml.txt.nlp	25447269	SENT140	43	43	40	40	timolol	TIM	PA451690	7984;8914	0.516
NULL	Front_Behav_Neurosci_2014_May_27_8_191.nxml.txt.nlp	24904342	SENT63	18	18	20	20	vasopressin	AVP	PA451858	114548;551	0.516
NULL	Br_J_Cancer_2010_Oct_26_103(9)_1331-1334.nxml.txt.nlp	20877352	SENT93	16	16	14	14	trastuzumab	GM-CSF	PA451743	1437	0.516
NULL	Front_Psychol_2014_Jun_6_5_553.nxml.txt.nlp	24936193	SENT312	6	6	11	11	methysergide	NPY	PA164743265	4852	0.516
NULL	Lab_Invest_2011_Oct_1_91(10)_1540-1550.nxml.txt.nlp	21808234	SENT71	7	7	15	15	paraformaldehyde	ADP	PA450790	23038	0.516
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT192	23	23	46	46	panitumumab	Yes	PA162373091	7525	0.516
NULL	Arthritis_Res_Ther_2005_Apr_4_7(4)_R756-R768.nxml.txt.nlp	15987477	SENT163	34	34	37	37	hyaluronidase	PH-20	PA164745713	6677	0.516
NULL	Case_Rep_Oncol_2010_Jun_30_4(2)_327-335.nxml.txt.nlp	21738504	SENT50	30	30	43	43	mitoxantrone	HCC	PA450526	84668	0.516
NULL	Oncol_Lett_2014_Apr_6_7(4)_1260-1264.nxml.txt.nlp	24660037	SENT38	8	8	14	14	fluorescein	CD4	PA164746009	920	0.516
NULL	Biomed_Res_Int_2014_Jan_29_2014_361020.nxml.txt.nlp	24605326	SENT223	7	7	18	18	flavopiridol	CDK2	PA452627	1017	0.516
NULL	Crit_Care_2006_Mar_21_10(Suppl_1)_P293.nxml.txt.nlp	NULL	SENT9	28	28	24	24	heparin	SAPS	PA449855	8935	0.516
NULL	Nucleic_Acids_Res_2010_Oct_4_38(19)_6375-6388.nxml.txt.nlp	20525792	SENT273	13	13	7	7	doxycycline	YY1	PA449415	7528	0.516
NULL	Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_1038-1044.nxml.txt.nlp	25049661	SENT55	16	16	36	36	phenol	CO2	PA450913	4513	0.516
NULL	Curr_Neuropharmacol_2014_Jul_12(4)_365-379.nxml.txt.nlp	25342944	SENT534	17	17	6	6	citalopram	5-HT2C	PA449015	3358	0.516
NULL	Mol_Biol_Cell_2012_Jun_15_23(12)_2373-2387.nxml.txt.nlp	22535521	SENT339	39	39	26	26	gentamicin	EGF	PA449753	1950	0.516
NULL	Front_Neurol_2011_Nov_21_2_68.nxml.txt.nlp	22125548	SENT2882	21	21	3	3	rasagiline	Bcl-2	PA164764584	596	0.516
NULL	J_Cancer_Prev_2014_Jun_19(2)_111-117.nxml.txt.nlp	25337579	SENT76	1	1	40	40	doxorubicin	HO-1	PA449412	3162	0.516
NULL	Cancer_Causes_Control_2013_Aug_18_24(8)_1605-1614.nxml.txt.nlp	23775025	SENT64	25	25	4	4	methotrexate	CYP1A1	PA450428	1543	0.516
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R91.nxml.txt.nlp	22541814	SENT17	6	6	22	22	thrombin	PP2	PA451674	4888	0.516
NULL	Int_J_Gen_Med_2012_Nov_9_5_935-942.nxml.txt.nlp	23204857	SENT81	22	22	35	35	pentobarbital	CA3	PA450859	761	0.516
NULL	Front_Neuroanat_2009_Jul_2_3_9.nxml.txt.nlp	19636386	SENT225	9	9	25	25	quetiapine	spatial	PA451201	219793	0.516
NULL	Cell_Commun_Signal_2014_Oct_14_12(1)_64.nxml.txt.nlp	NULL	SENT50	7	7	19	19	paraformaldehyde	San	PA450790	80218	0.516
NULL	Indian_J_Crit_Care_Med_2008_Oct-Dec_12(4)_181-189.nxml.txt.nlp	19742267	SENT200	4	4	14	14	anakinra	ACR	PA10799	49	0.516
NULL	Nat_Commun_2013_Sep_11_4_2416.nxml.txt.nlp	24022506	SENT157	20	20	16	16	l-glutamine	F12	PA10090	2161	0.516
NULL	Brain_Sci_2014_Apr_16_4(2)_295-310.nxml.txt.nlp	24961762	SENT506	14	14	4	4	midazolam	CO2	PA450496	4513	0.516
NULL	Arthritis_Res_Ther_2005_Jan_14_7(2)_R310-R317.nxml.txt.nlp	15743478	SENT144	7	7	31	31	fluorescein	NIRF	PA164746009	27190;115426	0.516
NULL	Diabetologia_2009_Oct_4_52(10)_2182-2189.nxml.txt.nlp	19652946	SENT43	22	22	46	46	lidocaine	SNARK	PA450226	81788	0.516
NULL	Clinics_(Sao_Paulo)_2010_Jul_65(7)_663-674.nxml.txt.nlp	20668623	SENT352	12	12	35	35	indomethacin	Yes	PA449982	7525	0.516
NULL	Front_Behav_Neurosci_2012_Nov_22_6_78.nxml.txt.nlp	23189046	SENT79	13	13	10	10	ethanol	OX1R	PA448073	3061	0.516
NULL	Ann_Oncol_2013_Aug_12_24(8)_1994-1999.nxml.txt.nlp	23670096	SENT125	6	6	14	14	tamoxifen	AIB1	PA451581	8202	0.516
NULL	Chemother_Res_Pract_2011_Feb_27_2011_175054.nxml.txt.nlp	22295203	SENT221	5	5	7	7	cisplatin	MBT	PA449014	5657	0.516
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT128	18	18	2	2	mexiletine	CYP2C19	PA450488	1557	0.516
NULL	Lipids_Health_Dis_2011_Jan_11_10_3.nxml.txt.nlp	21223589	SENT219	9	9	26	26	lipase	NEFA	PA450239	4925	0.516
NULL	Oxid_Med_Cell_Longev_2009_Sep-Oct_2(4)_214-221.nxml.txt.nlp	20716907	SENT232	19	19	33	33	pilocarpine	P400	PA450962	57634	0.516
NULL	Clin_Ophthalmol_2012_Aug_27_6_1373-1376.nxml.txt.nlp	22969281	SENT95	4	4	7	7	fluorescein	PED	PA164746009	8682	0.516
NULL	Acta_Pharmacol_Sin_2011_Jun_23_32(6)_675-684.nxml.txt.nlp	21602838	SENT122	2	2	12	12	simvastatin	ClC-3	PA451363	1182	0.516
NULL	Diagn_Pathol_2014_Jan_20_9_11.nxml.txt.nlp	24443801	SENT9	23	23	14	14	chymotrypsin	MUC2	PA448994	4583	0.516
NULL	Eur_J_Neurosci_2012_Sep_36(5)_2597-2608.nxml.txt.nlp	22697179	SENT44	15	15	1	1	neomycin	SREB2	PA450608	54329	0.516
NULL	Ital_J_Pediatr_2012_Mar_26_38_10.nxml.txt.nlp	22449104	SENT15	18	18	15	15	thyroglobulin	TPO	PA164754910	7066;7173	0.516
NULL	Cancer_Cell_Int_2013_Jun_26_13_63.nxml.txt.nlp	23800022	SENT115	0	0	5	5	genistein	ATF3	PA165109660	467	0.516
NULL	Blood_Res_2014_Mar_24_49(1)_36-41.nxml.txt.nlp	24724065	SENT107	48	48	46	46	rituximab	CHOP	PA451261	1649	0.516
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Dec_2_5_30.nxml.txt.nlp	17140452	SENT239	15	15	5	5	linezolid	GAT	PA450233	10249	0.516
NULL	Biomed_Res_Int_2013_Mar_28_2013_154073.nxml.txt.nlp	23607088	SENT34	12	12	25	25	clopidogrel	P2Y12	PA449053	64805	0.516
NULL	Int_J_Cardiovasc_Imaging_2013_Jun_3_29(5)_959-966.nxml.txt.nlp	23378157	SENT108	3	3	16	16	nitrogen	HGB	PA450643	114757	0.516
NULL	Clin_Med_Oncol_2008_Mar_1_2_135-144.nxml.txt.nlp	21892276	SENT103	26	26	23	23	capecitabine	CRT	PA448771	811	0.516
NULL	Cancer_Cell_Int_2010_Sep_6_10_31.nxml.txt.nlp	20819205	SENT85	7	7	9	9	doxycycline	CIS	PA449415	1154	0.516
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1437-1448.nxml.txt.nlp	24056706	SENT111	18	18	16	16	tranylcypromine	CYP2C9	PA451741	1559	0.516
NULL	Biomed_Res_Int_2014_Jan_20_2014_948427.nxml.txt.nlp	24563867	SENT143	2	2	5	5	buspirone	STZ	PA448689	6484	0.516
NULL	Clin_Pharmacol_2010_Sep_17_2_185-198.nxml.txt.nlp	22291504	SENT112	8	8	4	4	creatine	spatial	PA164778930	219793	0.516
NULL	Acta_Pharmacol_Sin_2012_Jan_28_33(1)_66-74.nxml.txt.nlp	22120966	SENT154	3	3	18	18	genistein	OPG	PA165109660	690	0.516
NULL	Mol_Cancer_2013_May_24_12_46.nxml.txt.nlp	23705826	SENT114	26	26	23	23	sunitinib	ABL1	PA162372840	25	0.516
NULL	Biochem_Biophys_Res_Commun_2011_Nov_18_415(2)_300-304.nxml.txt.nlp	22027147	SENT212	6	6	2	2	nadh	ND6	PA164755085	4541	0.516
NULL	Subst_Abuse_Treat_Prev_Policy_2008_Jul_25_3_19.nxml.txt.nlp	18655714	SENT114	4	4	7	7	methamphetamine	Men	PA450403	8178	0.516
NULL	Biologics_2013_Apr_26_7_91-101.nxml.txt.nlp	23671386	SENT132	0	0	5	5	crizotinib	ROS1	PA165946122	6098	0.516
NULL	Drugs_2014_Jul_18_74(11)_1209-1231.nxml.txt.nlp	25034361	SENT211	2	2	7	7	warfarin	TTR	PA451906	7276	0.516
NULL	Insights_Imaging_2011_Jun_28_2(5)_609-619.nxml.txt.nlp	22347980	SENT134	1	1	3	3	oxygen	MRI	PA450744	78996	0.516
NULL	Anat_Cell_Biol_2010_Mar_31_43(1)_25-35.nxml.txt.nlp	21190002	SENT188	11	11	24	24	allopurinol	CD80	PA448320	941	0.516
NULL	Environ_Health_Perspect_2010_Mar_23_118(3)_427-431.nxml.txt.nlp	20194071	SENT24	7	7	12	12	ethanol	GM-CSF	PA448073	1437	0.516
NULL	Open_Virol_J_2014_Mar_7_8_1-8.nxml.txt.nlp	24799968	SENT87	8	8	33	33	cyclosporine	IFN	PA449167	3439	0.516
NULL	Am_J_Case_Rep_2014_Mar_14_15_111-114.nxml.txt.nlp	24665353	SENT71	22	22	28	28	thyroglobulin	TPO	PA164754910	7066;7173	0.516
NULL	J_Brachial_Plex_Peripher_Nerve_Inj_2008_Oct_25_3_22.nxml.txt.nlp	18950516	SENT45	9	9	12	12	lidocaine	SGB	PA450226	2719	0.516
NULL	Braz_J_Med_Biol_Res_2013_Feb_1_46(2)_171-177.nxml.txt.nlp	23369979	SENT124	41	41	12	12	enalapril	IL-6	PA449456	3569	0.516
NULL	Iran_J_Pharm_Res_2013_Winter_12(1)_47-56.nxml.txt.nlp	24250571	SENT216	35	35	15	15	curcumin	AP-1	PA151958596	2353;3727;2354;3725	0.516
NULL	Int_J_Biol_Sci_2013_Dec_22_10(1)_90-102.nxml.txt.nlp	24391455	SENT2	20	20	14	14	epirubicin	TRPM8	PA449476	79054	0.516
NULL	Cancer_Cell_Int_2006_Aug_9_6_20.nxml.txt.nlp	16899133	SENT53	8	8	12	12	tamoxifen	p27	PA451581	5715;10534	0.516
NULL	Cytotechnology_2012_May_6_64(3)_281-297.nxml.txt.nlp	22143345	SENT71	18	18	37	37	l-glutamine	CO2	PA10090	4513	0.516
NULL	Clin_Ophthalmol_2014_Jan_13_8_219-228.nxml.txt.nlp	24531757	SENT150	18	18	4	4	brinzolamide	TIM	PA164744929	7984;8914	0.516
NULL	Diabetes_2013_Nov_18_62(11)_3909-3919.nxml.txt.nlp	23835339	SENT307	14	14	1	1	tolbutamide	Gen	PA451718	348654	0.516
NULL	Exp_Ther_Med_2014_Apr_13_7(4)_799-803.nxml.txt.nlp	24669235	SENT7	11	11	2	2	vildagliptin	PPG	PA165958346	5552	0.516
NULL	Exp_Ther_Med_2013_Apr_5_5(4)_1259-1263.nxml.txt.nlp	23596498	SENT107	19	19	13	13	capsaicin	TRPV1	PA448776	7442	0.516
NULL	JRSM_Cardiovasc_Dis_2012_Apr_5_1(1)_cvd_2012_012001.nxml.txt.nlp	24175062	SENT245	18	18	39	39	ribavirin	IL28B	PA451241	282617	0.516
NULL	Osteoporos_Int_2011_Jan_1_22(1)_27-35.nxml.txt.nlp	20358360	SENT66	38	38	26	26	teriparatide	PTH	PA451620	5741	0.516
NULL	Indian_J_Pharmacol_2012_Sep-Oct_44(5)_619-623.nxml.txt.nlp	23112425	SENT41	21	21	8	8	l-glutamine	F12	PA10090	2161	0.516
NULL	Avicenna_J_Med_Biotechnol_2014_Jan-Mar_6(1)_10-20.nxml.txt.nlp	24523953	SENT219	8	8	22	22	trypsin	CD105	PA451806	2022	0.516
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT3067	11	11	20	20	oxygen	APC	PA450744	324	0.516
NULL	Cent_European_J_Urol_2011_Jun_2_64(2)_87-89.nxml.txt.nlp	24578871	SENT132	15	15	11	11	forskolin	GGF	PA146096022	3084	0.516
NULL	Adv_Urol_2010_Jul_20_2010_687043.nxml.txt.nlp	20721275	SENT108	7	7	14	14	bevacizumab	IFN	PA130232992	3439	0.516
NULL	J_Hematol_Oncol_2011_Jun_10_4_27.nxml.txt.nlp	21663651	SENT17	1	1	3	3	cyclophosphamide	CTX	PA449165	1593	0.516
NULL	Clin_Ophthalmol_2010_Oct_21_4_1217-1222.nxml.txt.nlp	21060675	SENT116	5	5	24	24	timolol	BAK	PA451690	578	0.516
NULL	J_Exp_Bot_2009_Apr_2_60(6)_1691-1702.nxml.txt.nlp	19342428	SENT46	37	37	14	14	kanamycin	TAP	PA450137	8615;2317;10482;23541	0.516
NULL	Indian_J_Dermatol_2011_Jan-Feb_56(1)_87-91.nxml.txt.nlp	21572802	SENT11	17	17	14	14	cyclophosphamide	CHOP	PA449165	1649	0.516
NULL	Cell_Death_Differ_2010_Mar_16_17(3)_439-451.nxml.txt.nlp	19834489	SENT70	11	11	9	9	fluorescein	GFAP	PA164746009	2670	0.516
NULL	AIDS_Res_Treat_2013_Sep_17_2013_231956.nxml.txt.nlp	24159383	SENT43	12	12	6	6	buprenorphine	OAT	PA448685	4942	0.516
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Dec_2_5_30.nxml.txt.nlp	17140452	SENT239	11	11	29	29	gentamicin	CHL	PA449753	91851	0.516
NULL	Mol_Cancer_2012_Dec_12_11_91.nxml.txt.nlp	23234355	SENT61	0	0	9	9	erlotinib	HER2	PA134687924	2064	0.515
NULL	Int_J_Biochem_Cell_Biol_2014_Mar_48(100)_77-84.nxml.txt.nlp	24412566	SENT133	9	9	17	17	l-cysteine	TRMU	PA449173	55687	0.515
NULL	Oncol_Lett_2013_Aug_7_6(2)_445-447.nxml.txt.nlp	24137344	SENT117	14	14	0	0	fluorescein	CRT	PA164746009	811	0.515
NULL	Diabetes_Metab_J_2012_Jun_14_36(3)_199-206.nxml.txt.nlp	22737659	SENT94	12	12	16	16	zinc	SLC30A8	PA451956	169026	0.515
NULL	Biomed_Res_Int_2013_Aug_6_2013_602987.nxml.txt.nlp	24027759	SENT275	19	19	17	17	paclitaxel	SMF	PA450761	22993	0.515
NULL	Afr_J_Infect_Dis_2011_5(2)_40-46.nxml.txt.nlp	23878706	SENT88	6	6	8	8	oxacillin	Gen	PA450725	348654	0.515
NULL	J_Biol_Chem_2012_Apr_27_287(18)_14644-14658.nxml.txt.nlp	22375002	SENT62	34	34	16	16	pp2	AKAP10		11216	0.515
NULL	Core_Evid_2010_Jul_27_5_1-10.nxml.txt.nlp	20694135	SENT126	16	16	7	7	entacapone	CLE	PA164748726	51637	0.515
NULL	Exp_Hematol_2009_Oct_37(10)_1238-1249_e5.nxml.txt.nlp	19619605	SENT383	14	14	34	34	l-glutamine	CO2	PA10090	4513	0.515
NULL	Acta_Pharmacol_Sin_2010_Apr_8_31(4)_461-469.nxml.txt.nlp	20208553	SENT205	4	4	6	6	ethanol	adiponectin	PA448073	9370	0.515
NULL	J_Gen_Physiol_2004_Aug_124(2)_125-137.nxml.txt.nlp	15277574	SENT149	11	11	1	1	forskolin	CFTR	PA146096022	1080	0.515
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT3	20	20	31	31	trastuzumab	STAT3	PA451743	6774	0.515
NULL	Biomed_Res_Int_2014_May_4_2014_351252.nxml.txt.nlp	24877084	SENT20	11	11	18	18	bevacizumab	FTM	PA130232992	23322	0.515
NULL	Oncotarget_2014_Jun_7_5(14)_5257-5271.nxml.txt.nlp	24913448	SENT106	30	30	7	7	forskolin	LASP1	PA146096022	3927	0.515
NULL	Virol_J_2009_Jul_1_6_91.nxml.txt.nlp	19566966	SENT239	32	32	21	21	fluorescein	ASK	PA164746009	10926	0.515
NULL	Brain_Behav_2011_Sep_1(1)_44-54.nxml.txt.nlp	22398980	SENT24	8	8	25	25	cocaine	LSD	PA449072	1776	0.515
NULL	Int_J_Nanomedicine_2009_Apr_1_4_27-35.nxml.txt.nlp	19421368	SENT130	20	20	15	15	genistein	IFN	PA165109660	3439	0.515
NULL	Clin_Cosmet_Investig_Dermatol_2013_Mar_14_6_75-80.nxml.txt.nlp	23515267	SENT52	16	16	26	26	etanercept	TNF-alpha	PA449515	7124	0.515
NULL	Ann_Surg_Oncol_2010_Apr_20_17(4)_1168-1176.nxml.txt.nlp	19936839	SENT212	39	39	3	3	cetuximab	EREG	PA10040	2069	0.515
NULL	Cell_Death_Dis_2014_Mar_13_5(3)_e1118.nxml.txt.nlp	24625977	SENT308	28	28	17	17	etoposide	UBXN2A	PA449552	165324	0.515
NULL	Pharmaceutics_2013_Dec_19_6(1)_1-25.nxml.txt.nlp	24662363	SENT252	9	9	22	22	calcein	DC8	PA132595336	25936	0.515
NULL	Biomed_Res_Int_2014_Aug_6_2014_967826.nxml.txt.nlp	25165721	SENT205	24	24	5	5	cisplatin	TNF-alpha	PA449014	7124	0.515
NULL	Mol_Cancer_2014_Jan_28_13_17.nxml.txt.nlp	24472312	SENT133	6	6	4	4	ponatinib	Mcl-1	PA165980594	4170	0.515
NULL	Br_J_Cancer_2002_Jan_21_86(2)_222-225.nxml.txt.nlp	11870510	SENT58	28	28	6	6	tamoxifen	DPD	PA451581	1806	0.515
NULL	Mol_Cells_2014_Mar_31_37(3)_234-240.nxml.txt.nlp	24642709	SENT111	12	12	10	10	capsaicin	NOX4	PA448776	50507	0.515
NULL	AMB_Express_2014_Apr_1_4_20.nxml.txt.nlp	24949255	SENT102	26	26	19	19	kanamycin	GP2	PA450137	2813	0.515
NULL	Indian_J_Pharmacol_2008_Oct_40(Suppl_2)_S37-S56.nxml.txt.nlp	21593978	SENT838	15	15	11	11	ethanol	AT1	PA448073	9197;185	0.515
NULL	Food_Dig_2012_Dec_7_3(1-3)_63-77.nxml.txt.nlp	23293684	SENT250	23	23	25	25	lipase	PLRP2	PA450239	5408	0.515
NULL	Nat_Commun_2013_Oct_1_4_2516.nxml.txt.nlp	24084631	SENT658	0	0	18	18	losartan	AK4	PA450268	205	0.515
NULL	Br_J_Cancer_2010_Jul_13_103(2)_178-185.nxml.txt.nlp	20551959	SENT165	3	3	29	29	doxorubicin	MDR1	PA449412	5243	0.515
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Jun_27_5_15.nxml.txt.nlp	16803618	SENT181	12	12	9	9	flucloxacillin	LTA	PA164781042	4049	0.515
NULL	J_Hematol_Oncol_2014_Aug_1_7_52.nxml.txt.nlp	25085632	SENT173	0	0	12	12	sunitinib	PTEN	PA162372840	5728	0.515
NULL	Drug_Target_Insights_2007_Oct_30_2_239-247.nxml.txt.nlp	21901078	SENT22	28	28	23	23	etanercept	p75	PA449515	7133;11168	0.515
NULL	Br_J_Cancer_2010_May_11_102(10)_1456-1460.nxml.txt.nlp	20461090	SENT101	7	7	9	9	temsirolimus	IFN	PA164746890	3439	0.515
NULL	Ecancermedicalscience_2011_Apr_28_5_211.nxml.txt.nlp	22276054	SENT114	42	42	24	24	lorazepam	NK-1	PA450267	27087	0.515
NULL	Allergy_Asthma_Immunol_Res_2010_Jan_30_2(1)_1-13.nxml.txt.nlp	20224672	SENT78	39	39	35	35	triamcinolone	DPI	PA451749	1832	0.515
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT128	21	21	4	4	verapamil	CYP3A4	PA451868	1576	0.515
NULL	Diabetes_2011_Jun_21_60(6)_1770-1778.nxml.txt.nlp	21562078	SENT161	0	0	2	2	metformin	Met	PA450395	79811	0.515
NULL	Clin_Dev_Immunol_2011_May_23_2011_349368.nxml.txt.nlp	21647405	SENT121	14	14	8	8	zinc	AIRE	PA451956	326	0.515
NULL	Ann_Indian_Acad_Neurol_2011_Jul_14(Suppl1)_S16-S17.nxml.txt.nlp	21847320	SENT40	7	7	18	18	selegiline	COMT	PA451316	1312	0.515
NULL	Drug_Target_Insights_2012_Aug_6_6_19-39.nxml.txt.nlp	22915839	SENT92	32	32	25	25	doxorubicin	Hsp90	PA449412	3320	0.515
NULL	Exp_Ther_Med_2013_Jun_3_5(6)_1631-1636.nxml.txt.nlp	23837045	SENT87	9	9	26	26	propranolol	PI3K	PA451145	5290	0.515
NULL	Drug_Target_Insights_2007_Jan_24_2_1-7.nxml.txt.nlp	21901057	SENT65	23	23	9	9	l-carnitine	EPO	PA450154	7076;8288;2056	0.515
NULL	EMBO_Mol_Med_2012_Dec_29_4(12)_1261-1275.nxml.txt.nlp	23109291	SENT175	20	20	4	4	thyroglobulin	TLR4	PA164754910	7099	0.515
NULL	ScientificWorldJournal_2012_Apr_19_2012_804730.nxml.txt.nlp	22606063	SENT161	26	26	18	18	travoprost	BAK	PA164781371	578	0.515
NULL	Exp_Ther_Med_2012_Oct_6_4(4)_655-660.nxml.txt.nlp	23170121	SENT67	14	14	29	29	fluorescein	San	PA164746009	80218	0.515
NULL	Saudi_J_Anaesth_2013_Apr-Jun_7(2)_151-154.nxml.txt.nlp	23956714	SENT59	0	0	2	2	theophylline	NAC	PA451647	22861	0.515
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT185	7	7	10	10	doxorubicin	B7-H1	PA449412	29126	0.515
NULL	Am_J_Trop_Med_Hyg_2012_Mar_1_86(3)_489-495.nxml.txt.nlp	22403324	SENT178	14	14	8	8	ritonavir	CYP2D6	PA451260	1565	0.515
NULL	Clin_Endocrinol_(Oxf)_2006_Aug_65(2)_169-177.nxml.txt.nlp	16886956	SENT114	25	25	15	15	glucose	MRI	PA449773	78996	0.515
NULL	Crit_Care_2006_Aug_9_10(4)_R119.nxml.txt.nlp	16899122	SENT49	10	10	18	18	fluorescein	San	PA164746009	80218	0.515
NULL	EMBO_Mol_Med_2011_Nov_3(11)_623-636.nxml.txt.nlp	21953712	SENT260	1	1	17	17	gefitinib	PI3K	PA131301952	5290	0.515
NULL	ASN_Neuro_2009_Aug_25_1(3)_e00014.nxml.txt.nlp	19663806	SENT295	8	8	3	3	creatine	PLP	PA164778930	25824;5744	0.515
NULL	Arthritis_Res_Ther_2005_Nov_16_7(1)_R93-R100.nxml.txt.nlp	15642147	SENT196	0	0	2	2	nifedipine	NIF	PA450631	6280	0.515
NULL	Acta_Pharmacol_Sin_2013_Jan_5_34(1)_24-32.nxml.txt.nlp	23123646	SENT87	0	0	15	15	diazoxide	SUR1	PA449285	6833	0.515
NULL	Front_Endocrinol_(Lausanne)_2014_Dec_18_5_218.nxml.txt.nlp	25566190	SENT337	10	10	18	18	oxygen	PUMA	PA450744	27113	0.515
NULL	Clin_Med_Insights_Oncol_2012_May_16_6_205-217.nxml.txt.nlp	22654526	SENT250	0	0	4	4	decitabine	IL-2	PA164749631	3558	0.515
NULL	Cereb_Cortex_2014_Jan_9_24(1)_174-185.nxml.txt.nlp	23048018	SENT8	9	9	11	11	atomoxetine	ATX	PA134688071	5168;23049	0.515
NULL	Mol_Biol_Cell_2013_Jul_15_24(14)_2186-2200.nxml.txt.nlp	23699397	SENT91	8	8	10	10	staurosporine	TRAIL	PA165109623	8743	0.515
NULL	Pharmaceutics_2011_Oct_12_3(4)_680-705.nxml.txt.nlp	24309303	SENT60	12	12	23	23	rosiglitazone	OATP1B3	PA451283	28234	0.515
NULL	Arthritis_Res_2002_Mar_27_4(Suppl_2)_S16-S21.nxml.txt.nlp	12110153	SENT138	27	27	9	9	methotrexate	ACR	PA450428	49	0.515
NULL	Appl_Clin_Genet_2012_Jun_18_5_37-41.nxml.txt.nlp	23776379	SENT75	35	35	40	40	diflunisal	TTR	PA449313	7276	0.515
NULL	Evid_Based_Complement_Alternat_Med_2013_May_28_2013_629750.nxml.txt.nlp	23781265	SENT192	2	2	11	11	capsaicin	GADD153	PA448776	1649	0.515
NULL	Arthritis_Res_Ther_2012_Jun_12_14(3)_R142.nxml.txt.nlp	22691272	SENT105	4	4	1	1	mianserin	TLR3	PA134687937	7098	0.515
NULL	J_Korean_Med_Sci_2010_Aug_21_25(8)_1222-1227.nxml.txt.nlp	20676337	SENT54	29	29	13	13	aminophylline	ANOVA	PA164781029	4858	0.515
NULL	Front_Behav_Neurosci_2012_Mar_14_6_9.nxml.txt.nlp	22457644	SENT272	0	0	3	3	echinacea	TNF-alpha	PA131550706	7124	0.515
NULL	J_Cell_Mol_Med_2014_May_14_18(5)_811-823.nxml.txt.nlp	24628949	SENT235	12	12	10	10	docetaxel	FOXM1	PA449383	2305	0.515
NULL	Front_Plant_Sci_2012_Mar_16_3_50.nxml.txt.nlp	22645589	SENT17	12	12	22	22	glucose	IPS	PA449773	51477	0.515
NULL	Ann_Surg_Oncol_2010_Apr_6_17(4)_1010-1023.nxml.txt.nlp	20052553	SENT82	4	4	10	10	leucovorin	CEA	PA450198	5670;1087	0.515
NULL	Cancers_(Basel)_2013_Jul_4_5(3)_838-856.nxml.txt.nlp	24202322	SENT192	2	2	33	33	flavopiridol	HEXIM1	PA452627	10614	0.515
NULL	Mol_Brain_2014_Aug_12_7_58.nxml.txt.nlp	25112718	SENT227	19	19	10	10	chlorpheniramine	E12	PA448960	64100	0.515
NULL	Nat_Commun_2013_Oct_1_4_2516.nxml.txt.nlp	24084631	SENT82	0	0	8	8	losartan	AK4	PA450268	205	0.515
NULL	Front_Hum_Neurosci_2013_May_20_7_216.nxml.txt.nlp	23730284	SENT247	13	13	17	17	chlorpromazine	CPZ	PA448964	8532	0.515
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_39-54.nxml.txt.nlp	19305787	SENT414	19	19	34	34	ethanol	CA1	PA448073	759	0.515
NULL	Diabetes_2013_Mar_14_62(3)_825-836.nxml.txt.nlp	23193184	SENT78	12	12	6	6	lipase	CD36	PA450239	948	0.515
NULL	Crit_Care_2011_Aug_11_15(4)_226.nxml.txt.nlp	21892977	SENT62	16	16	3	3	vasopressin	P2Y1	PA451858	5028	0.515
NULL	Br_J_Cancer_2006_Dec_4_95(11)_1483-1489.nxml.txt.nlp	17106442	SENT105	9	9	5	5	gefitinib	MST	PA131301952	55154;4357;4294	0.515
NULL	Diabetes_Care_2009_Sep_32(9)_1748-1750.nxml.txt.nlp	19717820	SENT23	3	3	15	15	metformin	AMPK	PA450395	5563	0.515
NULL	Oncol_Lett_2013_Apr_28_5(4)_1149-1154.nxml.txt.nlp	23599754	SENT104	13	13	34	34	cisplatin	Dicer	PA449014	23405	0.515
NULL	Biomed_Res_Int_2013_Jul_7_2013_692751.nxml.txt.nlp	23936834	SENT169	23	23	11	11	pilocarpine	TNF	PA450962	7124	0.515
NULL	Oncoimmunology_2013_Feb_1_2(2)_e23080.nxml.txt.nlp	23525357	SENT23	26	26	28	28	cyclophosphamide	CTX	PA449165	1593	0.515
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT93	26	26	15	15	cisplatin	MDM2	PA449014	4193	0.515
NULL	Int_J_Lab_Hematol_2009_Aug_31(4)_468-470.nxml.txt.nlp	18294236	SENT13	15	15	17	17	rituximab	CHOP	PA451261	1649	0.515
NULL	N_Am_J_Med_Sci_2011_Jan_3(1)_1-12.nxml.txt.nlp	22540056	SENT132	21	21	23	23	gemcitabine	MRP5	PA449748	10057	0.515
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Mar_6_65(Pt_4)_o673.nxml.txt.nlp	21582417	SENT62	15	15	6	6	ethanol	mol	PA448073	90527	0.515
NULL	J_Vis_Exp_2010_Aug_1_(42)_2036.nxml.txt.nlp	20729802	SENT21	1	1	11	11	collagenase	KSR	PA449107	10256	0.515
NULL	Acta_Pharmacol_Sin_2010_Oct_13_31(10)_1324-1328.nxml.txt.nlp	20835265	SENT99	5	5	8	8	l-arginine	NOS	PA448478	4843	0.515
NULL	Int_J_Mol_Sci_2012_Aug_23_13(8)_10608-10629.nxml.txt.nlp	22949883	SENT612	9	9	7	7	creatine	Q10	PA164778930	27161	0.515
NULL	J_Breast_Cancer_2013_Mar_31_16(1)_122-126.nxml.txt.nlp	23593093	SENT115	39	39	14	14	bevacizumab	gamma	PA130232992	9913	0.515
NULL	Biochimie_2013_Dec_95(12)_2445-2453.nxml.txt.nlp	24047540	SENT314	18	18	4	4	lipase	APOA5	PA450239	116519	0.515
NULL	Acta_Pharmacol_Sin_2014_Aug_4_35(8)_981-993.nxml.txt.nlp	25066321	SENT324	14	14	22	22	ethanol	CA1	PA448073	759	0.515
NULL	Nucleic_Acids_Res_2014_Jan_1_42(1)_e2.nxml.txt.nlp	24106087	SENT188	33	33	8	8	ethanol	CEB	PA448073	9341	0.515
NULL	Arthritis_Res_Ther_2008_Mar_14_10(2)_204.nxml.txt.nlp	18373887	SENT93	7	7	13	13	infliximab	CD4	PA452639	920	0.515
NULL	Viruses_2014_Sep_24_6(9)_3612-3642.nxml.txt.nlp	25254386	SENT145	16	16	11	11	aminopterin	TMP	PA165109541	2012	0.515
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Dec_2_5_30.nxml.txt.nlp	17140452	SENT229	6	6	0	0	minocycline	VAN	PA450519	10318	0.515
NULL	Biomed_Res_Int_2014_Jan_27_2014_696107.nxml.txt.nlp	24587987	SENT208	25	25	37	37	ebselen	NAC	PA161660841	22861	0.515
NULL	J_Korean_Assoc_Oral_Maxillofac_Surg_2014_Dec_26_40(6)_291-296.nxml.txt.nlp	25551094	SENT121	1	1	14	14	alendronate	M-CSF	PA448082	1435	0.515
NULL	J_Cancer_Prev_2014_Jun_19(2)_111-117.nxml.txt.nlp	25337579	SENT76	1	1	42	42	doxorubicin	AKR1B10	PA449412	57016	0.515
NULL	Front_Endocrinol_(Lausanne)_2014_Feb_25_5_22.nxml.txt.nlp	24611062	SENT355	18	18	28	28	fasudil	PTEN	PA165946121	5728	0.515
NULL	J_Clin_Biochem_Nutr_2010_Jan_29_46(1)_36-42.nxml.txt.nlp	20104263	SENT62	1	1	6	6	ribavirin	IFN	PA451241	3439	0.515
NULL	Int_J_Biol_Sci_2012_Sep_6_8(8)_1109-1120.nxml.txt.nlp	22991499	SENT151	8	8	2	2	l-arginine	IFN	PA448478	3439	0.515
NULL	Indian_J_Nucl_Med_2013_Dec_28(Suppl_1)_S25-S28.nxml.txt.nlp	NULL	SENT73	15	15	20	20	thyroglobulin	FDG	PA164754910	23583	0.515
NULL	Int_J_Emerg_Med_2011_Jun_15_4_31.nxml.txt.nlp	21676236	SENT32	6	6	13	13	creatine	gamma	PA164778930	9913	0.515
NULL	Indian_J_Crit_Care_Med_2010_Oct-Dec_14(4)_188-195.nxml.txt.nlp	21572750	SENT176	36	36	23	23	heparin	ACT	PA449855	12;11332;9457;641455	0.515
NULL	Croat_Med_J_2013_Apr_54(2)_171-179.nxml.txt.nlp	23630144	SENT103	3	3	15	15	creatine	STZ	PA164778930	6484	0.515
NULL	Indian_J_Anaesth_2014_Jul-Aug_58(4)_423-429.nxml.txt.nlp	25197110	SENT169	2	2	0	0	ondansetron	ODF	PA450705	8600	0.515
NULL	Comput_Struct_Biotechnol_J_2013_Nov_27_6_e201303017.nxml.txt.nlp	24688725	SENT116	19	19	17	17	denosumab	RANKL	PA166048634	8600	0.515
NULL	Mol_Cell_Biochem_2014_Jul_26_396(1-2)_221-228.nxml.txt.nlp	25063218	SENT207	8	8	3	3	resveratrol	STAT3		6774	0.515
NULL	J_Biomed_Biotechnol_2002_2(1)_7-13.nxml.txt.nlp	12488594	SENT16	15	15	23	23	thalidomide	ENL	PA451644	4298	0.515
NULL	Ann_Hematol_2011_Dec_9_90(12)_1391-1398.nxml.txt.nlp	21479535	SENT161	19	19	24	24	methotrexate	CHOP	PA450428	1649	0.515
NULL	Front_Physiol_2015_Jan_12_5_517.nxml.txt.nlp	25628569	SENT21	0	0	10	10	isoproterenol	spatial	PA450121	219793	0.515
NULL	J_Cell_Biol_2008_Jan_28_180(2)_417-426.nxml.txt.nlp	18227283	SENT408	5	5	14	14	estradiol	aromatase	PA449503	1588	0.515
NULL	Iran_J_Public_Health_2013_Jan_1_42(Supple1)_50-54.nxml.txt.nlp	23865016	SENT136	32	32	15	15	pregabalin	MAX	PA164754814	4149	0.515
NULL	Mol_Neurodegener_2010_Nov_10_5_49.nxml.txt.nlp	21067594	SENT88	12	12	14	14	staurosporine	STS	PA165109623	412	0.515
NULL	Cases_J_2009_Nov_18_2_205.nxml.txt.nlp	19946449	SENT11	0	0	31	31	amoxicillin	ASAT	PA448406	22	0.515
NULL	J_Biol_Chem_2009_Feb_13_284(7)_4705-4712.nxml.txt.nlp	19074433	SENT190	11	11	1	1	s-adenosylmethionine	viperin	PA164754994	91543	0.515
NULL	Arthritis_Res_Ther_2010_Dec_17_12(6)_301.nxml.txt.nlp	21235827	SENT97	17	17	2	2	etanercept	IFN	PA449515	3439	0.515
NULL	J_Oncol_2012_Oct_9_2012_105949.nxml.txt.nlp	23093960	SENT209	9	9	23	23	choline	B12	PA448976	7126;4709	0.515
NULL	Structure_2013_Jun_4_21(6)_1051-1058.nxml.txt.nlp	23665170	SENT398	3	3	9	9	oxygen	hole	PA450744	80757	0.515
NULL	J_Cell_Mol_Med_2014_Dec_22_18(12)_2519-2529.nxml.txt.nlp	25338520	SENT96	24	24	21	21	oxygen	ROS	PA450744	6098	0.515
NULL	Mol_Cancer_2013_Mar_5_12_17.nxml.txt.nlp	23497256	SENT92	14	14	20	20	sunitinib	p53	PA162372840	7157	0.515
NULL	Ann_Oncol_2013_Apr_31_24(4)_1067-1073.nxml.txt.nlp	23117073	SENT42	18	18	36	36	cisplatin	CYP3A4	PA449014	1576	0.515
NULL	Hum_Genomics_2008_Sep_1_3(1)_71-78.nxml.txt.nlp	19129091	SENT32	17	17	34	34	nadh	ND6	PA164755085	4541	0.515
NULL	Int_J_Nanomedicine_2007_Sep_2(3)_277-288.nxml.txt.nlp	18019828	SENT89	9	9	2	2	paclitaxel	LEP	PA450761	3952	0.515
NULL	Cancer_Metab_2013_Mar_21_1_12.nxml.txt.nlp	24280230	SENT197	9	9	12	12	urea	ASL	PA451831	435	0.515
NULL	Front_Genet_2014_Aug_26_5_289.nxml.txt.nlp	25206362	SENT102	43	43	32	32	choline	B12	PA448976	7126;4709	0.515
NULL	Saudi_J_Anaesth_2014_Apr-Jun_8(2)_209-214.nxml.txt.nlp	24843334	SENT38	9	9	14	14	bupivacaine	C15	PA135057240	51316	0.515
NULL	CNS_Drugs_2013_Aug_23_27(11)_943-953.nxml.txt.nlp	23975660	SENT129	14	14	10	10	guanfacine	ATX	PA449825	5168;23049	0.515
NULL	Cancer_Cell_Int_2005_Aug_23_5_27.nxml.txt.nlp	16117829	SENT162	2	2	4	4	doxycycline	p53	PA449415	7157	0.515
NULL	Int_J_Mol_Sci_2014_Nov_25_15(12)_21703-21722.nxml.txt.nlp	25429431	SENT652	0	0	3	3	curcumin	AQP3	PA151958596	360	0.515
NULL	Biomed_Res_Int_2014_Jan_2_2014_126586.nxml.txt.nlp	24527434	SENT123	5	5	28	28	metformin	CD24	PA450395	100133941	0.515
NULL	Summit_on_Translat_Bioinforma_2009_Mar_1_2009_124-128.nxml.txt.nlp	21347183	SENT69	34	34	13	13	azathioprine	TPMT	PA448515	7172	0.515
NULL	Gene_Ther_2011_Jul_3_18(7)_692-701.nxml.txt.nlp	21368903	SENT182	18	18	40	40	ethanol	CD133	PA448073	8842	0.515
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_21-38.nxml.txt.nlp	19305786	SENT498	2	2	4	4	capsaicin	TRPV1	PA448776	7442	0.515
NULL	Acta_Neuropathol_Commun_2013_Nov_18_1(1)_76.nxml.txt.nlp	24252208	SENT81	5	5	22	22	ethanol	San	PA448073	80218	0.515
NULL	Arthritis_Res_Ther_2008_Jan_7_10(1)_R1.nxml.txt.nlp	18179697	SENT15	14	14	23	23	oxaliplatin	HMGB1	PA131285527	3146	0.515
NULL	Tuberc_Respir_Dis_(Seoul)_2013_Aug_30_75(2)_47-51.nxml.txt.nlp	24023556	SENT54	8	8	11	11	azathioprine	NAC	PA448515	22861	0.515
NULL	Pain_2013_Sep_154(9)_1680-1690.nxml.txt.nlp	23707289	SENT548	17	17	23	23	yohimbine	c-fos	PA451946	2353	0.515
NULL	J_Inflamm_(Lond)_2008_Apr_27_5_5.nxml.txt.nlp	18439312	SENT174	14	14	12	12	genistein	AREG	PA165109660	374	0.515
NULL	Allergy_Asthma_Immunol_Res_2014_Mar_15_6(2)_169-174.nxml.txt.nlp	24587955	SENT173	17	17	15	15	methacholine	MCH	PA165958382	5367	0.515
NULL	Leukemia_2014_Apr_14_28(4)_961-964.nxml.txt.nlp	24418991	SENT46	9	9	15	15	nilotinib	P-gp	PA165958345	5243	0.515
NULL	Pak_J_Med_Sci_2014_Jul-Aug_30(4)_814-818.nxml.txt.nlp	25097523	SENT64	16	16	0	0	cefoperazone	CTX	PA448849	1593	0.515
NULL	Biologics_2014_Apr_22_8_193-198.nxml.txt.nlp	24790412	SENT126	31	31	43	43	etanercept	Yes	PA449515	7525	0.515
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Sep_1_5_19.nxml.txt.nlp	16945159	SENT34	32	32	24	24	mannitol	NO3	PA450320	4681	0.515
NULL	Amyloid_2014_Sep_11_21(3)_175-184.nxml.txt.nlp	24918964	SENT198	16	16	9	9	anakinra	TTR	PA10799	7276	0.515
NULL	Cancer_Manag_Res_2012_Mar_12_4_75-89.nxml.txt.nlp	22457602	SENT85	0	0	9	9	bexarotene	IFN	PA164752250	3439	0.515
NULL	Clin_Exp_Reprod_Med_2011_Jun_30_38(2)_98-102.nxml.txt.nlp	22384426	SENT15	0	0	6	6	pioglitazone	IL-6	PA450970	3569	0.515
NULL	Biomed_Res_Int_2013_Nov_26_2013_843657.nxml.txt.nlp	24371833	SENT27	14	14	20	20	exenatide	GLP-1	PA164749238	100125288	0.515
NULL	J_Geriatr_Cardiol_2014_Mar_11(1)_63-73.nxml.txt.nlp	24748884	SENT228	19	19	14	14	fenoldopam	DR5	PA164784034	8795	0.514
NULL	Osteoporos_Int_2012_Jan_3_23(1)_327-337.nxml.txt.nlp	21892677	SENT275	29	29	15	15	denosumab	RANKL	PA166048634	8600	0.514
NULL	J_Cancer_2013_Mar_15_4(3)_262-269.nxml.txt.nlp	23459716	SENT37	15	15	12	12	irinotecan	IFL	PA450085	3439	0.514
NULL	Nat_Neurosci_2012_Sep_5_15(9)_1245-1254.nxml.txt.nlp	22864611	SENT582	23	23	12	12	clozapine	mGlu3	PA449061	2913	0.514
NULL	Nat_Med_2011_Nov_6_17(12)_1685-1691.nxml.txt.nlp	22057348	SENT91	16	16	12	12	oxygen	ROS	PA450744	6098	0.514
NULL	Eur_J_Appl_Physiol_2011_Feb_24_111(2)_275-283.nxml.txt.nlp	20865425	SENT155	14	14	4	4	glucose	MRS	PA449773	8011	0.514
NULL	Cell_Commun_Signal_2013_Oct_1_11_73.nxml.txt.nlp	24083678	SENT215	0	0	28	28	sulindac	p65	PA451565	5970	0.514
NULL	Int_J_Cardiovasc_Imaging_2013_Jun_3_29(5)_959-966.nxml.txt.nlp	23378157	SENT84	2	2	11	11	urea	GFR	PA451831	9771	0.514
NULL	Arthritis_Res_Ther_2006_May_11_8(3)_209.nxml.txt.nlp	16712713	SENT551	14	14	6	6	cyclophosphamide	Yes	PA449165	7525	0.514
NULL	J_Gen_Physiol_2012_Jun_139(6)_479-491.nxml.txt.nlp	22585969	SENT187	34	34	43	43	nadh	ADP	PA164755085	23038	0.514
NULL	Cancer_Res_Treat_2014_Jan_15_46(1)_2-18.nxml.txt.nlp	24520218	SENT167	32	32	11	11	curcumin	TMC	PA151958596	3703	0.514
NULL	Breast_Cancer_Res_2011_Mar_14_13(2)_205.nxml.txt.nlp	21457526	SENT47	18	18	14	14	tamoxifen	ATAC	PA451581	6375	0.514
NULL	Croat_Med_J_2012_Jun_53(3)_214-223.nxml.txt.nlp	22661134	SENT158	13	13	3	3	alprazolam	Gen	PA448333	348654	0.514
NULL	J_Am_Heart_Assoc_2013_Aug_23_2(4)_e000106.nxml.txt.nlp	23959443	SENT172	24	24	13	13	nadh	ADP	PA164755085	23038	0.514
NULL	Environ_Health_Perspect_2010_Mar_23_118(3)_427-431.nxml.txt.nlp	20194071	SENT95	13	13	16	16	ethanol	GM-CSF	PA448073	1437	0.514
NULL	Exp_Ther_Med_2013_Apr_5_5(4)_1259-1263.nxml.txt.nlp	23596498	SENT105	29	29	26	26	capsaicin	TRPV1	PA448776	7442	0.514
NULL	Gut_2010_Oct_2_59(10)_1331-1339.nxml.txt.nlp	20813719	SENT79	20	20	16	16	l-glutamine	FBS	PA10090	64319;26269	0.514
NULL	Oncotarget_2014_Oct_21_5(21)_10916-10933.nxml.txt.nlp	25373734	SENT242	20	20	16	16	heparin	CXCL4	PA449855	5196	0.514
NULL	Indian_J_Pharmacol_2013_May-Jun_45(3)_274-277.nxml.txt.nlp	23833372	SENT114	14	14	23	23	colchicine	CA1	PA449092	759	0.514
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Apr_26_64(Pt_5)_o917.nxml.txt.nlp	21202399	SENT3	8	8	16	16	benzaldehyde	mol	PA448571	90527	0.514
NULL	Mol_Cancer_2010_May_17_9_107.nxml.txt.nlp	20470445	SENT23	31	31	8	8	dexrazoxane	p53	PA449259	7157	0.514
NULL	Case_Rep_Oncol_2012_Sep_28_5(3)_506-510.nxml.txt.nlp	23139662	SENT75	4	4	0	0	cisplatin	DDP	PA449014	1678	0.514
NULL	J_Korean_Med_Sci_2010_Feb_19_25(2)_304-308.nxml.txt.nlp	20119588	SENT34	15	15	27	27	isoniazid	EMB	PA450112	133418	0.514
NULL	J_Headache_Pain_2010_Feb_10_11(1)_5-12.nxml.txt.nlp	20012125	SENT213	8	8	16	16	sumatriptan	5-HT1F	PA451566	3355	0.514
NULL	Breast_Cancer_Res_2009_May_29_11(3)_206.nxml.txt.nlp	19519952	SENT50	7	7	9	9	tamoxifen	DES	PA451581	1674	0.514
NULL	Front_Oncol_2014_Sep_11_4_245.nxml.txt.nlp	25309871	SENT35	21	21	18	18	thrombin	ADP	PA451674	23038	0.514
NULL	J_Physiol_2013_Sep_1_591(17)_4167-4188.nxml.txt.nlp	23836691	SENT411	29	29	33	33	flecainide	10C	PA449646	64333	0.514
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Feb_23_69(Pt_3)_m165-m166.nxml.txt.nlp	23476507	SENT6	8	8	28	28	phenol	mer	PA450913	10461	0.514
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Sep_27_64(Pt_10)_m1325.nxml.txt.nlp	21201060	SENT60	34	34	5	5	oxygen	C11	PA450744	1109	0.514
NULL	J_Young_Pharm_2010_Oct-Dec_2(4)_417-419.nxml.txt.nlp	21264106	SENT2	23	23	29	29	lamivudine	API	PA450163	5345	0.514
NULL	Iran_J_Pharm_Res_2015_Winter_14(1)_167-175.nxml.txt.nlp	25561923	SENT112	12	12	42	42	clonidine	Yes	PA449051	7525	0.514
NULL	Br_J_Pharmacol_2014_May_11_171(9)_2385-2398.nxml.txt.nlp	24467222	SENT113	2	2	32	32	rolipram	Rho	PA153906323	29984	0.514
NULL	Environ_Health_Perspect_2005_Sep_13_113(9)_1184-1189.nxml.txt.nlp	16140625	SENT58	8	8	0	0	malathion	CARB	PA164748092	9482	0.514
NULL	Int_J_Med_Sci_2013_Mar_15_10(5)_567-574.nxml.txt.nlp	23533048	SENT177	5	5	7	7	lamivudine	LAM	PA450163	7249;7248	0.514
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT192	23	23	37	37	panitumumab	Yes	PA162373091	7525	0.514
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT142	0	0	2	2	chloroquine	BMPR-II	PA448948	659	0.514
NULL	Open_AIDS_J_2010_Jan_19_4_70-75.nxml.txt.nlp	20200604	SENT220	6	6	36	36	lamivudine	ATV	PA450163	4683	0.514
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_16_2012_395912.nxml.txt.nlp	23118789	SENT75	29	29	11	11	phenylbutazone	UGT1A1	PA450932	54658	0.514
NULL	Pharmaceutics_2011_Nov_18_3(4)_865-913.nxml.txt.nlp	24309312	SENT127	22	22	37	37	rosiglitazone	CYP2C8	PA451283	1558	0.514
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Apr_22_67(Pt_5)_o1196.nxml.txt.nlp	21754498	SENT69	31	31	28	28	ethanol	mol	PA448073	90527	0.514
NULL	Oncol_Lett_2014_Jun_4_7(6)_2175-2179.nxml.txt.nlp	24932311	SENT142	16	16	0	0	lipase	PEMT	PA450239	10400	0.514
NULL	Amino_Acids_2012_Aug_29_43(2)_617-627.nxml.txt.nlp	22038179	SENT12	4	4	6	6	vasopressin	AVP	PA451858	114548;551	0.514
NULL	Crit_Care_2000_Oct_13_4(Suppl_2)_S21-S25.nxml.txt.nlp	11255595	SENT73	14	14	7	7	furosemide	STP	PA449719	9322	0.514
NULL	J_Cell_Sci_2014_May_15_127(10)_2313-2325.nxml.txt.nlp	24634514	SENT69	10	10	38	38	galactose	ANOVA	PA449725	4858	0.514
NULL	Br_J_Cancer_1995_Feb_71(2)_282-289.nxml.txt.nlp	7841041	SENT8	18	18	25	25	cisplatin	U87	PA449014	677775;641648	0.514
NULL	NDT_Plus_2010_Feb_4_3(1)_37-41.nxml.txt.nlp	20090879	SENT96	10	10	24	24	cinacalcet	PTH	PA164776671	5741	0.514
NULL	Surg_Neurol_Int_2014_Oct_7_5_145.nxml.txt.nlp	25324974	SENT151	15	15	26	26	thalidomide	EGFR	PA451644	1956	0.514
NULL	Ann_Oncol_2011_Jan_13_22(1)_215-223.nxml.txt.nlp	20627875	SENT132	2	2	18	18	doxorubicin	DAC	PA449412	13	0.514
NULL	Appl_Microbiol_Biotechnol_2013_Aug_16_97(18)_7999-8009.nxml.txt.nlp	23948723	SENT73	16	16	24	24	glucose	mol	PA449773	90527	0.514
NULL	Emerg_Med_Int_2014_Apr_27_2014_638102.nxml.txt.nlp	24876968	SENT132	0	0	11	11	salbutamol	Men	PA448068	8178	0.514
NULL	Br_J_Cancer_2013_Jun_11_108(11)_2264-2271.nxml.txt.nlp	23652312	SENT211	42	42	27	27	bevacizumab	FACT	PA130232992	11198	0.514
NULL	Orphanet_J_Rare_Dis_2007_Apr_15_2_19.nxml.txt.nlp	17433111	SENT213	27	27	13	13	propylthiouracil	PAPA	PA451156	2737;5069	0.514
NULL	Cells_2012_Jun_20_1(2)_168-203.nxml.txt.nlp	24710422	SENT212	10	10	19	19	lipase	CGI-58	PA450239	51099	0.514
NULL	J_Korean_Med_Sci_2004_Apr_30_19(2)_167-171.nxml.txt.nlp	15082886	SENT118	32	32	0	0	ethambutol	PTH	PA164784021	5741	0.514
NULL	Am_J_Trop_Med_Hyg_2014_Aug_6_91(2)_424-434.nxml.txt.nlp	24799369	SENT297	7	7	16	16	zinc	RDT	PA451956	6598	0.514
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT133	38	38	34	34	glucose	EGFR	PA449773	1956	0.514
NULL	BMB_Rep_2014_Jul_47(7)_388-392.nxml.txt.nlp	24286329	SENT55	0	0	2	2	berberine	AP-1	PA165860812	2353;3727;2354;3725	0.514
NULL	Clin_Med_Insights_Oncol_2012_Dec_6_6_407-421.nxml.txt.nlp	23239933	SENT213	12	12	2	2	paclitaxel	GEM	PA450761	2669	0.514
NULL	Breast_Cancer_Res_2011_Jan_17_13(1)_R5.nxml.txt.nlp	21241485	SENT323	9	9	4	4	estradiol	NGF	PA449503	4803	0.514
NULL	Rare_Tumors_2010_Dec_31_2(4)_e63.nxml.txt.nlp	21234255	SENT33	9	9	6	6	cyclophosphamide	CHOP	PA449165	1649	0.514
NULL	Exp_Ther_Med_2014_May_20_7(5)_1354-1358.nxml.txt.nlp	24940438	SENT29	0	0	19	19	fluorescein	CD86	PA164746009	942	0.514
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Dec_2_5_30.nxml.txt.nlp	17140452	SENT239	31	31	5	5	chloramphenicol	GAT	PA448927	10249	0.514
NULL	Cytotherapy_2014_Jun_16(6)_800-809.nxml.txt.nlp	24642019	SENT44	43	43	45	45	collagenase	NAC	PA449107	22861	0.514
NULL	J_Invest_Dermatol_2013_Jul_13_133(7)_1742-1751.nxml.txt.nlp	23407402	SENT257	16	16	9	9	etanercept	TREM-1	PA449515	54210	0.514
NULL	Front_Physiol_2013_May_15_4_103.nxml.txt.nlp	23720630	SENT644	0	0	4	4	atorvastatin	Q10	PA448500	27161	0.514
NULL	Arthritis_Res_Ther_2008_Aug_18_10(4)_R93.nxml.txt.nlp	18710567	SENT62	5	5	27	27	fluorescein	San	PA164746009	80218	0.514
NULL	Acta_Neuropathol_Commun_2014_Oct_21_2(1)_149.nxml.txt.nlp	NULL	SENT375	14	14	29	29	riluzole	p38	PA451251	10598;1432;7965	0.514
NULL	Brain_2014_Jan_16_137(1)_172-182.nxml.txt.nlp	24253201	SENT58	2	2	0	0	chlorpromazine	CPZ	PA448964	8532	0.514
NULL	Mol_Cancer_2012_May_28_11_36.nxml.txt.nlp	22640878	SENT286	13	13	8	8	paclitaxel	TGFBI	PA450761	7045	0.514
NULL	Br_J_Cancer_2012_Apr_24_106(9)_1543-1550.nxml.txt.nlp	22531721	SENT160	11	11	20	20	trastuzumab	CD46	PA451743	4179	0.514
NULL	Saudi_J_Anaesth_2013_Apr-Jun_7(2)_151-154.nxml.txt.nlp	23956714	SENT56	21	21	19	19	theophylline	NAC	PA451647	22861	0.514
NULL	Front_Behav_Neurosci_2014_Oct_30_8_366.nxml.txt.nlp	25400560	SENT121	25	25	7	7	ethanol	ANOVA	PA448073	4858	0.514
NULL	Int_J_Vasc_Med_2012_Jul_24_2012_508416.nxml.txt.nlp	22888436	SENT163	24	24	42	42	pioglitazone	PRIP	PA450970	23054;5334	0.514
NULL	Adv_Hematol_2010_Dec_30_2010_624040.nxml.txt.nlp	21234357	SENT162	13	13	11	11	etoposide	CHOP	PA449552	1649	0.514
NULL	Lipids_Health_Dis_2011_Feb_28_10_38.nxml.txt.nlp	21352602	SENT121	15	15	19	19	fenofibrate	PCSK9	PA449594	255738	0.514
NULL	Drug_Des_Devel_Ther_2014_Sep_23_8_1527-1538.nxml.txt.nlp	25284985	SENT213	2	2	0	0	celecoxib	IFN	PA448871	3439	0.514
NULL	Psychiatr_Genet_2013_Aug_28_23(4)_153-162.nxml.txt.nlp	23811784	SENT5	11	11	9	9	clozapine	AP2	PA449061	2971	0.514
NULL	Biologics_2009_Sep_15_3_377-383.nxml.txt.nlp	19774205	SENT216	19	19	13	13	oseltamivir	Yes	PA450721	7525	0.514
NULL	Pharmaceuticals_(Basel)_2012_Aug_10_5(8)_802-836.nxml.txt.nlp	24280676	SENT1893	10	10	7	7	methotrexate	SLCO1B1	PA450428	10599	0.514
NULL	Environ_Health_Perspect_2004_Nov_21_112(15)_1472-1480.nxml.txt.nlp	15531430	SENT37	11	11	13	13	diethylstilbestrol	DES	PA449307	1674	0.514
NULL	Oxid_Med_Cell_Longev_2012_Jul_25_2012_472932.nxml.txt.nlp	22888398	SENT198	20	20	14	14	nadh	Q10	PA164755085	27161	0.514
NULL	Iran_J_Pharm_Res_2015_Winter_14(1)_167-175.nxml.txt.nlp	25561923	SENT118	12	12	24	24	clonidine	Yes	PA449051	7525	0.514
NULL	Front_Cell_Neurosci_2015_Jan_15_8_459.nxml.txt.nlp	25642166	SENT72	16	16	10	10	hemin	HO-1	PA449849	3162	0.514
NULL	Eur_J_Clin_Microbiol_Infect_Dis_2012_Jul_29_31(7)_1663-1666.nxml.txt.nlp	22124537	SENT64	9	9	25	25	vancomycin	VISA	PA451850	57506	0.514
NULL	Clin_Ophthalmol_2014_Jun_26_8_1213-1219.nxml.txt.nlp	25061267	SENT151	23	23	16	16	tetracaine	PRK	PA451638	1263	0.514
NULL	FEBS_Open_Bio_2013_Dec_30_4_96-104.nxml.txt.nlp	24490130	SENT136	25	25	20	20	cisplatin	BRCA1	PA449014	672	0.514
NULL	Clin_Mol_Allergy_2004_Mar_16_2_4.nxml.txt.nlp	15023231	SENT35	0	0	8	8	roxithromycin	TNF-alpha	PA164750505	7124	0.514
NULL	Br_J_Cancer_2009_Jan_13_100(1)_37-43.nxml.txt.nlp	19088724	SENT171	13	13	7	7	cisplatin	Gem	PA449014	51053	0.514
NULL	ScientificWorldJournal_2014_Jul_22_2014_643715.nxml.txt.nlp	25147856	SENT160	21	21	26	26	pp2	PPN		64840	0.514
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Jun_27_5_15.nxml.txt.nlp	16803618	SENT178	44	44	42	42	gentamicin	GEN1	PA449753	348654	0.514
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT140	1	1	6	6	phenprocoumon	VKORC1	PA450921	79001	0.514
NULL	Int_J_Med_Sci_2013_Mar_15_10(5)_567-574.nxml.txt.nlp	23533048	SENT174	5	5	7	7	lamivudine	LAM	PA450163	7249;7248	0.514
NULL	Curr_Microbiol_2012_Dec_28_65(6)_673-678.nxml.txt.nlp	22926720	SENT75	4	4	21	21	cefepime	TMP	PA164754876	2012	0.514
NULL	Hum_Genomics_2008_Sep_1_3(1)_7-16.nxml.txt.nlp	19129086	SENT9	6	6	10	10	rosiglitazone	SLCO1B1	PA451283	10599	0.514
NULL	Int_J_Environ_Res_Public_Health_2010_May_28_7(5)_1996-2007.nxml.txt.nlp	20632473	SENT6	6	6	13	13	fluorescein	p38	PA164746009	10598;1432;7965	0.514
NULL	Indian_J_Dermatol_2009_Jul-Sep_54(3)_280-282.nxml.txt.nlp	20161864	SENT49	27	27	12	12	icatibant	C1-INH	PA164749185	710	0.514
NULL	Brain_Sci_2013_Jul_30_3(3)_1128-1152.nxml.txt.nlp	24734165	SENT566	1	1	21	21	ketamine	San	PA450144	80218	0.514
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_16_2012_395912.nxml.txt.nlp	23118789	SENT75	9	9	27	27	diclofenac	UGT2B15	PA449293	7366	0.514
NULL	Aging_(Albany_NY)_2009_May_22_1(6)_557-572.nxml.txt.nlp	20195383	SENT286	9	9	2	2	creatine	ADP	PA164778930	23038	0.514
NULL	J_Cell_Biol_1997_Nov_17_139(4)_851-864.nxml.txt.nlp	9362504	SENT22	42	42	8	8	thrombin	glypican	PA451674	2817	0.514
NULL	Oncotarget_2013_May_11_4(6)_830-843.nxml.txt.nlp	23919981	SENT86	7	7	10	10	temsirolimus	PI3K	PA164746890	5290	0.514
NULL	Nano_Rev_2014_Feb_26_5_10_3402_nano_v5_22762.nxml.txt.nlp	24600516	SENT182	22	22	4	4	fluorescein	HER2	PA164746009	2064	0.514
NULL	Acta_Pharmacol_Sin_2011_Jun_3_32(6)_845-852.nxml.txt.nlp	21642952	SENT99	2	2	12	12	prazosin	TRPV1	PA451093	7442	0.514
NULL	Br_J_Cancer_2011_Aug_23_105(5)_649-657.nxml.txt.nlp	21811251	SENT213	10	10	7	7	gefitinib	EGFR	PA131301952	1956	0.514
NULL	J_Med_Case_Rep_2013_Oct_8_7_238.nxml.txt.nlp	24103078	SENT51	18	18	22	22	thrombin	FIB	PA451674	2091	0.514
NULL	Biochim_Biophys_Acta_2013_Nov_1831(11)_1600-1608.nxml.txt.nlp	23867907	SENT9	8	8	10	10	lipase	ATGL	PA450239	57104	0.514
NULL	Free_Radic_Biol_Med_2013_Dec_65(100)_1521-1532.nxml.txt.nlp	23806384	SENT707	0	0	16	16	spermine	ADP	PA164781199	23038	0.514
NULL	Infect_Dis_Obstet_Gynecol_2014_Sep_25_2014_961375.nxml.txt.nlp	25328370	SENT24	11	11	6	6	atazanavir	UGT	PA10251	7361;7355	0.514
NULL	Ophthalmol_Eye_Dis_2011_Jul_25_3_21-24.nxml.txt.nlp	23861620	SENT66	17	17	24	24	brimonidine	BAK	PA448665	578	0.514
NULL	Indian_J_Anaesth_2014_Nov-Dec_58(6)_778-779.nxml.txt.nlp	25624557	SENT5	22	22	14	14	glutaraldehyde	ETO	PA449777	862	0.514
NULL	Front_Oncol_2014_Apr_9_4_75.nxml.txt.nlp	24782986	SENT272	40	40	30	30	paclitaxel	CXCL12	PA450761	6387	0.514
NULL	Drug_Des_Devel_Ther_2014_Sep_23_8_1527-1538.nxml.txt.nlp	25284985	SENT112	2	2	0	0	celecoxib	IFN	PA448871	3439	0.514
NULL	Cancers_(Basel)_2011_Aug_12_3(3)_3279-3330.nxml.txt.nlp	24212956	SENT1211	15	15	23	23	denosumab	RANKL	PA166048634	8600	0.514
NULL	Int_J_Womens_Health_2014_Aug_13_6_759-769.nxml.txt.nlp	25152632	SENT148	15	15	9	9	raloxifene	RANK	PA451221	8792	0.514
NULL	Diabetes_2009_Mar_58(3)_579-589.nxml.txt.nlp	19074989	SENT136	24	24	19	19	lipase	LIPE	PA450239	3991	0.514
NULL	Biol_Open_2014_Nov_13_3(12)_1164-1172.nxml.txt.nlp	25395667	SENT96	27	27	37	37	capsaicin	TRPV1	PA448776	7442	0.514
NULL	J_Biol_Chem_2011_Sep_16_286(37)_31984-31992.nxml.txt.nlp	21768113	SENT260	4	4	8	8	heparin	CD81	PA449855	975	0.514
NULL	Mol_Cancer_2010_Jun_25_9_166.nxml.txt.nlp	20579378	SENT127	7	7	5	5	gefitinib	EGF	PA131301952	1950	0.514
NULL	Proteome_Sci_2009_May_28_7_20.nxml.txt.nlp	19476632	SENT146	6	6	35	35	galactose	ECH1	PA449725	1891	0.514
NULL	J_Cell_Sci_2012_Sep_1_125(17)_4067-4076.nxml.txt.nlp	22685330	SENT752	5	5	7	7	lipase	ATGL	PA450239	57104	0.514
NULL	Cancer_Res_Treat_2011_Dec_27_43(4)_255-259.nxml.txt.nlp	22247712	SENT6	4	4	8	8	vincristine	CHOP	PA451879	1649	0.514
NULL	Adv_Ther_2014_Dec_2_31_1228-1246.nxml.txt.nlp	25447269	SENT82	11	11	15	15	tafluprost	TIM	PA165958432	7984;8914	0.514
NULL	Anal_Bioanal_Chem_2008_Mar_25_391(7)_2385-2393.nxml.txt.nlp	18363049	SENT113	9	9	15	15	fluorescein	FDG	PA164746009	23583	0.514
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT3212	8	8	10	10	fluorescein	CLF	PA164746009	51340;9244	0.514
NULL	Curr_Neuropharmacol_2009_Mar_7(1)_37-49.nxml.txt.nlp	19721816	SENT149	32	32	12	12	fluoxetine	ghrelin	PA449673	51738	0.514
NULL	Ann_Thorac_Med_2007_Apr-Jun_2(2)_52-57.nxml.txt.nlp	19727346	SENT129	2	2	20	20	gentamicin	CTX	PA449753	1593	0.514
NULL	Cell_Commun_Signal_2013_Oct_1_11_73.nxml.txt.nlp	24083678	SENT115	18	18	35	35	sulindac	ICAM1	PA451565	3383	0.514
NULL	J_Cell_Biol_2005_Jul_4_170(1)_73-79.nxml.txt.nlp	15998800	SENT246	26	26	11	11	thrombin	NAC	PA451674	22861	0.514
NULL	Front_Neurosci_2015_Jan_13_8_448.nxml.txt.nlp	25628528	SENT1031	12	12	5	5	ethanol	5-HT1B	PA448073	3351	0.514
NULL	Breast_Cancer_Res_2011_Jan_17_13(1)_R5.nxml.txt.nlp	21241485	SENT197	10	10	14	14	estradiol	Brn-3b	PA449503	5458	0.514
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT136	15	15	4	4	cisplatin	IBP	PA449014	706;50619	0.514
NULL	Adv_Biol_Regul_2014_Jan_19_0_197-206.nxml.txt.nlp	24103483	SENT190	23	23	25	25	lipase	GEF	PA450239	56731	0.514
NULL	Open_Microbiol_J_2008_May_23_2_66-73.nxml.txt.nlp	19088913	SENT247	1	1	3	3	ketoconazole	Yes	PA450146	7525	0.514
NULL	EMBO_Mol_Med_2011_Apr_3(4)_235-245.nxml.txt.nlp	21374818	SENT127	22	22	8	8	sunitinib	CLDN5	PA162372840	7122	0.514
NULL	J_Korean_Med_Sci_2007_Jun_30_22(3)_412-419.nxml.txt.nlp	17596646	SENT73	11	11	27	27	fluorescein	CD34	PA164746009	947	0.514
NULL	Front_Endocrinol_(Lausanne)_2013_Nov_11_4_166.nxml.txt.nlp	24273531	SENT263	9	9	4	4	vasopressin	ANG	PA451858	283	0.514
NULL	Oncotarget_2011_Sep_9_2(9)_658-668.nxml.txt.nlp	21911919	SENT106	11	11	15	15	cytarabine	NAC	PA449177	22861	0.514
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R95.nxml.txt.nlp	22540992	SENT54	30	30	0	0	methotrexate	ACPA	PA450428	5657	0.514
NULL	Diabetes_Care_2009_Apr_8_32(4)_552-558.nxml.txt.nlp	19131459	SENT205	19	19	14	14	rosiglitazone	adiponectin	PA451283	9370	0.514
NULL	Evid_Based_Complement_Alternat_Med_2013_May_28_2013_629750.nxml.txt.nlp	23781265	SENT184	8	8	18	18	capsaicin	ATF4	PA448776	468	0.514
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Jul_20_69(Pt_8)_o1276.nxml.txt.nlp	24109358	SENT72	32	32	20	20	ethanol	mol	PA448073	90527	0.514
NULL	Allergy_Asthma_Immunol_Res_2014_Mar_5_6(2)_175-178.nxml.txt.nlp	24587956	SENT98	5	5	38	38	budesonide	ACT	PA448681	12;11332;9457;641455	0.514
NULL	CNS_Drugs_2013_Aug_20_27(12)_1081-1092.nxml.txt.nlp	23959815	SENT168	21	21	17	17	lisdexamfetamine	ATX	PA164748975	5168;23049	0.514
NULL	Cells_2012_Jun_20_1(2)_168-203.nxml.txt.nlp	24710422	SENT212	25	25	19	19	lipase	CGI-58	PA450239	51099	0.514
NULL	Oncotarget_2014_Jun_8_5(13)_5040-5053.nxml.txt.nlp	24970815	SENT255	18	18	10	10	cisplatin	EGF	PA449014	1950	0.514
NULL	Oncoimmunology_2012_Aug_1_1(5)_717-725.nxml.txt.nlp	22934263	SENT91	29	29	19	19	cyclophosphamide	IFN	PA449165	3439	0.514
NULL	Cancers_(Basel)_2010_Dec_23_3(1)_17-42.nxml.txt.nlp	24212604	SENT734	18	18	10	10	paclitaxel	PPX	PA450761	5531	0.514
NULL	Aging_(Albany_NY)_2014_Jan_14_6(1)_70-81.nxml.txt.nlp	24429382	SENT191	19	19	7	7	bleomycin	WRN	PA448645	7486	0.514
NULL	J_Cell_Mol_Med_2014_Aug_1_18(8)_1599-1611.nxml.txt.nlp	24889822	SENT260	3	3	9	9	resveratrol	FOXO1		2308	0.513
NULL	J_Headache_Pain_2007_Jun_11_8(3)_167-174.nxml.txt.nlp	17563842	SENT58	0	0	7	7	capsaicin	CO2	PA448776	4513	0.513
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_May_7_65(Pt_6)_o1211.nxml.txt.nlp	21583080	SENT56	5	5	9	9	piperazine	C10	PA450977	113246	0.513
NULL	Appl_Biochem_Biotechnol_2012_Nov_16_168(6)_1584-1593.nxml.txt.nlp	22983742	SENT151	15	15	35	35	nitrogen	CYP1A2	PA450643	1544	0.513
NULL	Oncotarget_2013_Jul_18_4(10)_1582-1591.nxml.txt.nlp	24123600	SENT8	27	27	8	8	imatinib	ABCG2	PA10804	9429	0.513
NULL	Adv_Ther_2014_Dec_2_31_1228-1246.nxml.txt.nlp	25447269	SENT148	4	4	16	16	tafluprost	TIM	PA165958432	7984;8914	0.513
NULL	Cancers_(Basel)_2010_Feb_23_2(1)_88-113.nxml.txt.nlp	24281034	SENT56	1	1	11	11	docetaxel	EGFR	PA449383	1956	0.513
NULL	J_Invest_Dermatol_2013_Jul_13_133(7)_1742-1751.nxml.txt.nlp	23407402	SENT146	26	26	16	16	ustekinumab	IL-17	PA166048654	3605	0.513
NULL	Oncoscience_2014_Apr_30_1(4)_283-286.nxml.txt.nlp	25594020	SENT6	33	33	24	24	rituximab	STAT6	PA451261	6778	0.513
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT39	23	23	37	37	capsaicin	p53	PA448776	7157	0.513
NULL	Cardiovasc_Diabetol_2013_Oct_17_12_150.nxml.txt.nlp	24134550	SENT7	42	42	16	16	metformin	activin	PA450395	83729	0.513
NULL	Indian_J_Pharm_Sci_2014_May-Jun_76(3)_203-210.nxml.txt.nlp	25035531	SENT28	5	5	11	11	pindolol	CYP2D6	PA450966	1565	0.513
NULL	J_Orthop_Traumatol_2011_Jun_4_12(2)_77-80.nxml.txt.nlp	21541772	SENT63	18	18	11	11	urea	GPT	PA451831	1798;2875	0.513
NULL	Exp_Ther_Med_2012_Oct_19_4(4)_589-593.nxml.txt.nlp	23170110	SENT28	8	8	15	15	tegafur	CDHP	PA452620	1001	0.513
NULL	J_Thorac_Oncol_2015_Jan_29_10(1)_134-142.nxml.txt.nlp	25371077	SENT264	18	18	20	20	bevacizumab	PCB	PA130232992	5091	0.513
NULL	Int_J_Surg_Case_Rep_2014_Nov_20_5(12)_1282-1284.nxml.txt.nlp	25460494	SENT74	17	17	13	13	hydroxychloroquine	duo	PA164777036	8997	0.513
NULL	Cancer_Immunol_Immunother_2014_Mar_30_63(6)_615-626.nxml.txt.nlp	24682539	SENT201	0	0	5	5	resveratrol	CD4		920	0.513
NULL	J_Cancer_Prev_2013_Sep_18(3)_264-270.nxml.txt.nlp	25337554	SENT24	12	12	16	16	doxorubicin	p53	PA449412	7157	0.513
NULL	Eur_J_Endocrinol_2014_Mar_170(3)_451-459.nxml.txt.nlp	24362411	SENT172	23	23	20	20	exenatide	GLP-1	PA164749238	100125288	0.513
NULL	Nucleic_Acids_Res_2013_Nov_16_41(20)_9349-9360.nxml.txt.nlp	23956219	SENT158	15	15	3	3	cisplatin	RMI1	PA449014	80010	0.513
NULL	Clin_Transl_Allergy_2013_Sep_2_3_29.nxml.txt.nlp	24004581	SENT88	0	0	2	2	omalizumab	IL-6	PA164752253	3569	0.513
NULL	Front_Immunol_2012_Jul_12_3_196.nxml.txt.nlp	22807927	SENT69	7	7	5	5	sirolimus	IL-2	PA451365	3558	0.513
NULL	Croat_Med_J_2012_Jun_53(3)_214-223.nxml.txt.nlp	22661134	SENT65	0	0	6	6	diazepam	ACTH	PA449283	5443	0.513
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT142	3	3	1	1	dasatinib	PP2	PA162372878	4888	0.513
NULL	Breast_Cancer_Res_2011_Sep_13_13(5)_R87.nxml.txt.nlp	21914172	SENT168	22	22	10	10	afatinib	HER2	PA165981154	2064	0.513
NULL	Ann_Surg_Treat_Res_2014_Feb_22_86(2)_68-75.nxml.txt.nlp	24761411	SENT142	0	0	7	7	oxaliplatin	Bcl-2	PA131285527	596	0.513
NULL	J_Hematol_Oncol_2014_Aug_1_7_52.nxml.txt.nlp	25085632	SENT173	0	0	17	17	sunitinib	KRAS	PA162372840	3845	0.513
NULL	Breast_Cancer_Res_2014_May_23_16(3)_R50.nxml.txt.nlp	24887458	SENT112	28	28	0	0	trastuzumab	HER2	PA451743	2064	0.513
NULL	Adv_Ther_2014_Dec_2_31_1228-1246.nxml.txt.nlp	25447269	SENT136	4	4	25	25	tafluprost	TIM	PA165958432	7984;8914	0.513
NULL	Br_J_Cancer_2011_Jul_12_105(2)_212-220.nxml.txt.nlp	21694723	SENT185	21	21	5	5	curcumin	STAT3	PA151958596	6774	0.513
NULL	J_Cell_Mol_Med_2014_Mar_22_18(3)_480-491.nxml.txt.nlp	24450440	SENT61	27	27	6	6	axitinib	San	PA164924493	80218	0.513
NULL	Biologics_2012_Dec_17_6_429-464.nxml.txt.nlp	23269860	SENT183	13	13	15	15	etanercept	ACR	PA449515	49	0.513
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT276	1	1	5	5	aripiprazole	PRL	PA10026	5617	0.513
NULL	Curr_Control_Trials_Cardiovasc_Med_2001_Jul_6_2(4)_155-159.nxml.txt.nlp	11806789	SENT131	16	16	11	11	ramipril	AIRE	PA451223	326	0.513
NULL	Drug_Saf_2014_Apr_29_37(5)_343-350.nxml.txt.nlp	24777653	SENT124	28	28	16	16	tramadol	OTC	PA451735	5009	0.513
NULL	Br_J_Cancer_2009_May_19_100(10)_1540-1548.nxml.txt.nlp	19384300	SENT154	3	3	0	0	trypsin	TATI	PA451806	6690	0.513
NULL	Mucosal_Immunol_2012_May_22_5(3)_342-351.nxml.txt.nlp	22354320	SENT131	12	12	6	6	doxycycline	CD4	PA449415	920	0.513
NULL	Br_J_Haematol_2014_Mar_13_164(1)_811-821.nxml.txt.nlp	24328678	SENT149	3	3	7	7	lenalidomide	IL2	PA162363968	3558	0.513
NULL	Int_J_Mol_Sci_2014_Oct_8_15(10)_17974-17999.nxml.txt.nlp	25299695	SENT153	3	3	15	15	curcumin	HO-2	PA151958596	3163	0.513
NULL	Arthritis_Res_Ther_2013_Mar_4_15(2)_R39.nxml.txt.nlp	23497717	SENT15	3	3	24	24	imiquimod	IFN	PA449972	3439	0.513
NULL	Biomed_Res_Int_2013_Jun_6_2013_928271.nxml.txt.nlp	23841099	SENT15	12	12	14	14	ticagrelor	ADP	PA165374673	23038	0.513
NULL	Open_AIDS_J_2010_May_14_4_105-115.nxml.txt.nlp	20657829	SENT76	6	6	13	13	methamphetamine	San	PA450403	80218	0.513
NULL	Clin_Epigenetics_2011_Jun_27_2(2)_171-185.nxml.txt.nlp	21949547	SENT66	24	24	12	12	doxorubicin	CYP3A4	PA449412	1576	0.513
NULL	Front_Neurosci_2014_Jun_3_8_128.nxml.txt.nlp	24917782	SENT64	6	6	14	14	ethanol	POMC	PA448073	5443	0.513
NULL	Mol_Biol_Cell_2014_Mar_1_25(5)_712-727.nxml.txt.nlp	24403601	SENT542	36	36	16	16	lipase	GBF1	PA450239	8729	0.513
NULL	Eur_J_Med_Res_2009_Dec_7_14(Suppl_4)_170-176.nxml.txt.nlp	20156751	SENT25	7	7	9	9	methacholine	MCH	PA165958382	5367	0.513
NULL	Virulence_2013_Oct_1_4(7)_646-653.nxml.txt.nlp	24045422	SENT59	2	2	5	5	l-lysine	CD4	PA450280	920	0.513
NULL	Braz_J_Med_Biol_Res_2012_Jun_8_45(10)_988-994.nxml.txt.nlp	22666778	SENT130	27	27	0	0	lipase	ADD1	PA450239	118	0.513
NULL	Nanoscale_Res_Lett_2012_Jan_16_7(1)_77.nxml.txt.nlp	22247975	SENT40	24	24	34	34	oxygen	LPO	PA450744	4025	0.513
NULL	Ann_Nucl_Med_2013_Apr_16_27(3)_209-216.nxml.txt.nlp	23242952	SENT64	19	19	17	17	creatine	CRP	PA164778930	1401;140913	0.513
NULL	Eur_J_Appl_Physiol_2014_Jun_5_114(3)_545-559.nxml.txt.nlp	23737006	SENT230	2	2	8	8	phentolamine	CO2	PA450926	4513	0.513
NULL	Genetics_2015_Jan_13_199(1)_247-262.nxml.txt.nlp	25398792	SENT7	33	33	12	12	galactose	GAL7	PA449725	3963;653499	0.513
NULL	Cardiovasc_Diabetol_2011_Dec_22_10_115.nxml.txt.nlp	22189184	SENT134	26	26	21	21	sitagliptin	GLP-1	PA164748978	100125288	0.513
NULL	Front_Physiol_2011_Nov_29_2_89.nxml.txt.nlp	22164144	SENT168	0	0	6	6	thrombin	PAR1	PA451674	79581;2149	0.513
NULL	Cerebrovasc_Dis_Extra_2013_Jun_11_3(1)_85-94.nxml.txt.nlp	23885261	SENT130	15	15	9	9	alteplase	OCSP	PA164776730	83882	0.513
NULL	Exp_Ther_Med_2014_May_20_7(5)_1354-1358.nxml.txt.nlp	24940438	SENT29	0	0	21	21	fluorescein	CD14	PA164746009	929	0.513
NULL	Oncol_Lett_2013_Oct_24_6(4)_970-976.nxml.txt.nlp	24137447	SENT168	6	6	10	10	doxorubicin	ADM	PA449412	133	0.513
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Dec_2_5_30.nxml.txt.nlp	17140452	SENT229	10	10	0	0	gatifloxacin	VAN	PA449738	10318	0.513
NULL	Biologics_2014_Feb_15_8_67-81.nxml.txt.nlp	24600203	SENT235	16	16	14	14	ustekinumab	IL-23	PA166048654	51561	0.513
NULL	Int_J_Alzheimers_Dis_2010_Dec_27_2011_231595.nxml.txt.nlp	21234401	SENT121	13	13	6	6	iron	HFE	PA450087	3077	0.513
NULL	Front_Psychiatry_2014_Mar_25_5_30.nxml.txt.nlp	24723894	SENT196	20	20	7	7	ketamine	spatial	PA450144	219793	0.513
NULL	Ann_Oncol_2013_Aug_12_24(8)_1994-1999.nxml.txt.nlp	23670096	SENT34	11	11	8	8	tamoxifen	AIB1	PA451581	8202	0.513
NULL	Cell_Regen_(Lond)_2012_Jun_28_1(1)_3.nxml.txt.nlp	25408866	SENT185	4	4	9	9	glucose	MSC	PA449773	9242	0.513
NULL	Breast_Cancer_Res_2012_Jul_20_14(4)_R110.nxml.txt.nlp	22817698	SENT33	9	9	12	12	cisplatin	BRCA1	PA449014	672	0.513
NULL	Apoptosis_2014_Apr_23_19(7)_1055-1068.nxml.txt.nlp	24756955	SENT152	17	17	22	22	cisplatin	p53	PA449014	7157	0.513
NULL	Eukaryot_Cell_2014_Mar_13(3)_412-426.nxml.txt.nlp	24442893	SENT36	21	21	13	13	chloramphenicol	PAD1	PA448927	29943	0.513
NULL	BMJ_Open_2014_Feb_27_4(2)_e004071.nxml.txt.nlp	24578536	SENT112	15	15	1	1	warfarin	TTR	PA451906	7276	0.513
NULL	Ann_Oncol_2009_Aug_20(Suppl_6)_vi30-vi34.nxml.txt.nlp	19617295	SENT115	18	18	13	13	thyroglobulin	IFN	PA164754910	3439	0.513
NULL	Br_J_Cancer_2009_Jul_21_101(2)_263-268.nxml.txt.nlp	19603032	SENT36	2	2	7	7	dasatinib	PC-3	PA162372878	692094	0.513
NULL	Br_J_Cancer_2010_Oct_26_103(9)_1331-1334.nxml.txt.nlp	20877352	SENT90	29	29	27	27	trastuzumab	GM-CSF	PA451743	1437	0.513
NULL	Cancer_Res_Treat_2013_Sep_30_45(3)_234-238.nxml.txt.nlp	24155683	SENT21	25	25	29	29	vincristine	CHOP	PA451879	1649	0.513
NULL	Acta_Pharmacol_Sin_2013_Aug_5_34(8)_998-1006.nxml.txt.nlp	23852086	SENT132	13	13	4	4	ketoprofen	DOM	PA450149	6663	0.513
NULL	Evid_Based_Complement_Alternat_Med_2012_May_27_2012_272710.nxml.txt.nlp	22685484	SENT135	10	10	6	6	lipase	HSL	PA450239	3991	0.513
NULL	Biomed_Res_Int_2014_Jun_26_2014_161346.nxml.txt.nlp	25054130	SENT240	11	11	21	21	curcumin	STZ	PA151958596	6484	0.513
NULL	Front_Aging_Neurosci_2014_Nov_27_6_322.nxml.txt.nlp	25505884	SENT154	0	0	10	10	dipyridamole	ANOVA	PA449367	4858	0.513
NULL	Nat_Biotechnol_2013_Jul_30_31(7)_630-637.nxml.txt.nlp	23811600	SENT143	13	13	22	22	staurosporine	JAK1	PA165109623	3716	0.513
NULL	Acta_Pharmacol_Sin_2009_Aug_13_30(8)_1132-1137.nxml.txt.nlp	19597528	SENT117	0	0	6	6	losartan	ADM	PA450268	133	0.513
NULL	Int_J_Biol_Sci_2014_Sep_21_10(10)_1108-1115.nxml.txt.nlp	25332685	SENT208	13	13	15	15	dexmedetomidine	DMT	PA449256	2039	0.513
NULL	Curr_Oncol_2007_Aug_14(4)_154-161.nxml.txt.nlp	17710208	SENT144	8	8	2	2	rifampin	CYP3A4	PA451250	1576	0.513
NULL	Adv_Ther_2013_Jun_29_30(6)_607-622.nxml.txt.nlp	23812875	SENT118	11	11	3	3	glucose	FAS	PA449773	355;2194	0.513
NULL	Exp_Hematol_Oncol_2014_Dec_17_3(1)_30.nxml.txt.nlp	NULL	SENT109	16	16	7	7	rivaroxaban	MCP-1	PA165958360	6347	0.513
NULL	Breast_Cancer_Res_2014_Dec_6_16(6)_491.nxml.txt.nlp	25479686	SENT68	0	0	18	18	medroxyprogesterone	F12	PA450344	2161	0.513
NULL	Cancer_Causes_Control_2013_Aug_18_24(8)_1605-1614.nxml.txt.nlp	23775025	SENT64	3	3	30	30	cyclophosphamide	MTHFR	PA449165	4524	0.513
NULL	Adv_Hematol_2012_Apr_24_2012_149780.nxml.txt.nlp	22593768	SENT61	22	22	29	29	l-glutamine	CO2	PA10090	4513	0.513
NULL	J_Hematol_Oncol_2011_Mar_26_4_11.nxml.txt.nlp	21439076	SENT142	22	22	1	1	erlotinib	Gem	PA134687924	51053	0.513
NULL	Evid_Based_Complement_Alternat_Med_2014_Dec_25_2014_605914.nxml.txt.nlp	25610478	SENT89	10	10	39	39	pentobarbital	mol	PA450859	90527	0.513
NULL	Cell_Death_Dis_2014_Jul_17_5(7)_e1336.nxml.txt.nlp	25032859	SENT208	19	19	17	17	nadh	mol	PA164755085	90527	0.513
NULL	Iran_J_Public_Health_2013_Jan_1_42(Supple1)_50-54.nxml.txt.nlp	23865016	SENT136	27	27	15	15	infliximab	MAX	PA452639	4149	0.513
NULL	Clinics_2008_Dec_63(6)_845b-848.nxml.txt.nlp	19061012	SENT77	20	20	12	12	thyroglobulin	CD56	PA164754910	4684	0.513
NULL	Br_J_Pharmacol_2014_May_11_171(9)_2385-2398.nxml.txt.nlp	24467222	SENT228	14	14	21	21	rolipram	CXCL10	PA153906323	3627	0.513
NULL	Br_J_Anaesth_2014_Jul_22_113(1)_157-167.nxml.txt.nlp	24154701	SENT61	9	9	21	21	sevoflurane	TREK-1	PA451341	3776	0.513
NULL	Ann_Rheum_Dis_2014_Jan_20_73(1)_86-94.nxml.txt.nlp	23962455	SENT99	32	32	0	0	methotrexate	ACR	PA450428	49	0.513
NULL	ScientificWorldJournal_2012_Jul_31_2012_475675.nxml.txt.nlp	22919323	SENT39	29	29	27	27	metformin	adiponectin	PA450395	9370	0.513
NULL	Carcinogenesis_2010_Dec_27_31(12)_2049-2057.nxml.txt.nlp	20876285	SENT25	25	25	15	15	tamoxifen	HER2	PA451581	2064	0.513
NULL	Cancers_(Basel)_2010_May_28_2(2)_1027-1039.nxml.txt.nlp	24281105	SENT95	15	15	13	13	methotrexate	CTX	PA450428	1593	0.513
NULL	Nucleic_Acids_Res_2012_Jul_30_40(13)_6319-6337.nxml.txt.nlp	22467215	SENT11	10	10	2	2	cisplatin	Bcl-2	PA449014	596	0.513
NULL	Clin_Proteomics_2014_Nov_1_11(1)_39.nxml.txt.nlp	25404878	SENT84	11	11	2	2	nadh	GPD1	PA164755085	2819	0.513
NULL	Cardiovasc_Diabetol_2007_Feb_20_6_7.nxml.txt.nlp	17311679	SENT0	29	29	24	24	glucose	adiponectin	PA449773	9370	0.513
NULL	Front_Behav_Neurosci_2012_Jun_13_6_24.nxml.txt.nlp	22707936	SENT479	0	0	6	6	scopolamine	spatial	PA451308	219793	0.513
NULL	Acta_Pharmacol_Sin_2011_Oct_12_32(10)_1259-1265.nxml.txt.nlp	21909126	SENT114	9	9	26	26	candesartan	LOX-1	PA448765	4973	0.513
NULL	Eur_J_Med_Res_2010_May_18_15(5)_214-219.nxml.txt.nlp	20562061	SENT14	7	7	18	18	thrombin	ADP	PA451674	23038	0.513
NULL	Exp_Diabetes_Res_2011_Jun_27_2011_947138.nxml.txt.nlp	21754922	SENT120	3	3	5	5	atropine	STZ	PA448505	6484	0.513
NULL	Eur_J_Immunol_2014_Jun_10_44(6)_1759-1769.nxml.txt.nlp	24595810	SENT71	23	23	2	2	fludrocortisone	CD62L	PA164743961	6402	0.513
NULL	J_Med_Chem_2014_Feb_13_57(3)_578-599.nxml.txt.nlp	24417566	SENT815	1	1	15	15	flavopiridol	CDK4	PA452627	1019	0.513
NULL	Indian_J_Pharmacol_2009_Aug_41(4)_167-172.nxml.txt.nlp	20523867	SENT40	38	38	19	19	napqi	CYP2A6		1548	0.513
NULL	Int_J_Alzheimers_Dis_2010_Sep_2_2010_621870.nxml.txt.nlp	20862336	SENT163	39	39	8	8	genistein	GMP	PA165109660	22978	0.513
NULL	Breast_Cancer_Res_2012_Feb_14_14(1)_R30.nxml.txt.nlp	22333315	SENT62	16	16	28	28	indomethacin	IFN	PA449982	3439	0.513
NULL	Oxid_Med_Cell_Longev_2013_Apr_17_2013_737591.nxml.txt.nlp	23710289	SENT169	19	19	8	8	ethanol	NRF2	PA448073	2551;4780	0.513
NULL	AIDS_Res_Ther_2011_Oct_6_8_36.nxml.txt.nlp	21978457	SENT135	10	10	7	7	zinc	ZIP4	PA451956	55630	0.513
NULL	J_Neurol_2011_Jul_2_258(7)_1207-1222.nxml.txt.nlp	21461686	SENT261	13	13	31	31	memantine	OPT	PA10364	51430	0.513
NULL	Mol_Biol_Cell_2013_Sep_1_24(17)_2678-2688.nxml.txt.nlp	23864716	SENT72	23	23	19	19	thrombin	PP2	PA451674	4888	0.513
NULL	Case_Rep_Ophthalmol_2011_Mar_12_2(1)_105-110.nxml.txt.nlp	22110438	SENT12	8	8	6	6	ribavirin	IFN	PA451241	3439	0.513
NULL	Int_J_Med_Sci_2013_Jun_21_10(8)_1061-1067.nxml.txt.nlp	23801894	SENT209	26	26	28	28	etoposide	ERT	PA449552	1999	0.513
NULL	Cancers_(Basel)_2011_Oct_26_3(4)_4024-4045.nxml.txt.nlp	24213123	SENT179	7	7	15	15	resveratrol	PTEN		5728	0.513
NULL	Biomed_Res_Int_2013_Jan_22_2013_758341.nxml.txt.nlp	23484154	SENT69	11	11	8	8	fluorescein	CLS	PA164746009	1210	0.513
NULL	Front_Aging_Neurosci_2014_Sep_11_6_238.nxml.txt.nlp	25309424	SENT1976	0	0	9	9	valsartan	spatial	PA451848	219793	0.513
NULL	Oncotarget_2014_Nov_6_5(22)_11038-11053.nxml.txt.nlp	25402820	SENT71	29	29	20	20	gemcitabine	GEM	PA449748	2669	0.513
NULL	Pharmaceutics_2011_Nov_18_3(4)_865-913.nxml.txt.nlp	24309312	SENT2232	11	11	22	22	erythromycin	CYP3A4	PA449493	1576	0.513
NULL	CNS_Drugs_2013_Aug_23_27(11)_943-953.nxml.txt.nlp	23975660	SENT208	15	15	7	7	clonidine	ATX	PA449051	5168;23049	0.513
NULL	Allergy_Asthma_Immunol_Res_2014_Nov_19_6(6)_548-557.nxml.txt.nlp	25374755	SENT117	9	9	17	17	lovastatin	IL-13	PA450272	3596	0.513
NULL	Int_J_Cell_Biol_2013_Apr_18_2013_273086.nxml.txt.nlp	23690780	SENT77	11	11	13	13	hydroquinone	GGCX	PA449924	2677	0.513
NULL	Crit_Care_2007_Sep_26_11(Suppl_4)_P51.nxml.txt.nlp	NULL	SENT19	25	25	15	15	desmopressin	AVP	PA449237	114548;551	0.513
NULL	Arthritis_Res_2002_Jul_26_4(5)_R9.nxml.txt.nlp	12223112	SENT61	0	0	13	13	fluorescein	CD14	PA164746009	929	0.513
NULL	J_Korean_Med_Sci_2005_Jun_30_20(3)_456-460.nxml.txt.nlp	15953869	SENT81	20	20	22	22	lipase	HSL	PA450239	3991	0.513
NULL	Open_Cardiovasc_Med_J_2014_Feb_7_8_12-17.nxml.txt.nlp	24653785	SENT196	0	0	22	22	simvastatin	CYP3A5	PA451363	1577	0.513
NULL	Osteoporos_Int_2008_Apr_12_19(4)_399-428.nxml.txt.nlp	18266020	SENT301	11	11	9	9	alendronate	PTH	PA448082	5741	0.513
NULL	Int_J_Womens_Health_2010_Aug_24_2_279-290.nxml.txt.nlp	21151673	SENT228	12	12	37	37	estradiol	PRL	PA449503	5617	0.513
NULL	Nat_Genet_2011_Feb_16_43(2)_142-146.nxml.txt.nlp	21240275	SENT64	31	31	19	19	streptomycin	FBS	PA451512	64319;26269	0.513
NULL	CNS_Drugs_2014_Feb_7_28(3)_185-193.nxml.txt.nlp	24504829	SENT20	35	35	33	33	choline	CDP	PA448976	1523	0.513
NULL	Cancer_Metastasis_Rev_2014_Apr_18_33(2-3)_695-720.nxml.txt.nlp	24744103	SENT336	25	25	11	11	cisplatin	HRAS	PA449014	3265	0.512
NULL	Curr_Cardiol_Rev_2008_Nov_4(4)_309-322.nxml.txt.nlp	20066139	SENT82	21	21	16	16	estradiol	CEE	PA449503	51608	0.512
NULL	Environ_Health_Perspect_1996_Dec_104(Suppl_6)_1247-1250.nxml.txt.nlp	9118900	SENT6	16	16	28	28	phenol	GM-CSF	PA450913	1437	0.512
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Feb_9_69(Pt_3)_o362.nxml.txt.nlp	23476552	SENT3	27	27	34	34	phenol	mol	PA450913	90527	0.512
NULL	Neuroimage_Clin_2013_Sep_3_3_242-248.nxml.txt.nlp	24273709	SENT294	6	6	4	4	clobazam	CLB	PA10888	171425	0.512
NULL	Indian_J_Endocrinol_Metab_2013_Mar-Apr_17(2)_318-319.nxml.txt.nlp	23776910	SENT25	28	28	16	16	levothyroxine	TPO	PA450221	7066;7173	0.512
NULL	Breast_Cancer_Res_2011_May_11_13(3)_R50.nxml.txt.nlp	21569367	SENT26	21	21	1	1	estradiol	aromatase	PA449503	1588	0.512
NULL	J_Cell_Biol_1998_Jul_13_142(1)_101-115.nxml.txt.nlp	9660866	SENT39	31	31	22	22	tetracycline	RhoA	PA451640	387	0.512
NULL	J_Exp_Bot_2012_Apr_16_63(7)_2465-2478.nxml.txt.nlp	22249996	SENT272	17	17	7	7	naringenin	PAL2	PA151958361	3261	0.512
NULL	Clin_Res_Cardiol_2009_Jun_20_98(6)_391-399.nxml.txt.nlp	19301059	SENT184	5	5	21	21	pantoprazole	mol	PA450774	90527	0.512
NULL	Br_J_Cancer_2010_Nov_2_103(11)_1671-1679.nxml.txt.nlp	21045835	SENT213	10	10	39	39	gemcitabine	CXCL12	PA449748	6387	0.512
NULL	Glycoconj_J_2013_Apr_29_30(3)_205-225.nxml.txt.nlp	22544341	SENT153	21	21	10	10	galactose	SPG	PA449725	55764	0.512
NULL	Cell_Commun_Signal_2011_May_15_9_13.nxml.txt.nlp	21569639	SENT239	0	0	9	9	quinacrine	PC-3	PA164745551	692094	0.512
NULL	J_Cell_Biol_2001_Oct_29_155(3)_427-438.nxml.txt.nlp	11673478	SENT230	5	5	3	3	pp2	PP1		5540;5464	0.512
NULL	Case_Rep_Gastroenterol_2008_Jan_24_2(1)_11-17.nxml.txt.nlp	21490831	SENT20	3	3	5	5	lipase	CEA	PA450239	5670;1087	0.512
NULL	J_Lipid_Res_2014_Dec_55(12)_2562-2575.nxml.txt.nlp	25316883	SENT23	12	12	14	14	lipase	ATGL	PA450239	57104	0.512
NULL	Arthritis_Res_Ther_2009_Apr_30_11(2)_R58.nxml.txt.nlp	19405951	SENT86	9	9	26	26	alendronate	RANKL	PA448082	8600	0.512
NULL	Mol_Cell_Biochem_2014_Oct_9_385(1-2)_265-275.nxml.txt.nlp	24104452	SENT176	29	29	25	25	bortezomib	U87	PA10252	677775;641648	0.512
NULL	Diabetes_2009_Jun_31_58(6)_1434-1439.nxml.txt.nlp	19336679	SENT153	13	13	15	15	metformin	SLC22A2	PA450395	6582	0.512
NULL	J_Biomed_Biotechnol_2011_Feb_14_2011_792362.nxml.txt.nlp	21490705	SENT348	1	1	22	22	choline	CDKN3	PA448976	1033	0.512
NULL	J_Gen_Physiol_1989_Jun_1_93(6)_1075-1090.nxml.txt.nlp	2549174	SENT0	29	29	1	1	lidocaine	Gen	PA450226	348654	0.512
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT142	11	11	6	6	vinorelbine	MVP	PA451881	9961	0.512
NULL	ASN_Neuro_2009_Aug_25_1(3)_e00014.nxml.txt.nlp	19663806	SENT295	8	8	36	36	creatine	PLP	PA164778930	25824;5744	0.512
NULL	Orphanet_J_Rare_Dis_2009_Jul_10_4_17.nxml.txt.nlp	19591690	SENT172	0	0	11	11	indomethacin	COX	PA449982	1351	0.512
NULL	Exp_Hematol_Oncol_2014_Mar_11_3_7.nxml.txt.nlp	24618035	SENT188	4	4	2	2	imatinib	ABL1	PA10804	25	0.512
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT606	11	11	19	19	metformin	p53	PA450395	7157	0.512
NULL	Curr_Gerontol_Geriatr_Res_2011_May_11_2011_624156.nxml.txt.nlp	21765826	SENT285	19	19	29	29	erythromycin	CYP3A4	PA449493	1576	0.512
NULL	Mol_Cancer_2010_Aug_11_9_214.nxml.txt.nlp	20701798	SENT242	40	40	12	12	streptomycin	F10	PA451512	2159	0.512
NULL	Cancers_(Basel)_2011_Apr_1_3(2)_1844-1860.nxml.txt.nlp	24212785	SENT631	13	13	2	2	cetuximab	PI3K	PA10040	5290	0.512
NULL	Oncogene_2014_Aug_28_33(35)_4407-4417.nxml.txt.nlp	24469038	SENT123	33	33	14	14	cisplatin	p53	PA449014	7157	0.512
NULL	Am_J_Physiol_Cell_Physiol_2014_Jan_15_306(2)_C89-C97.nxml.txt.nlp	24133067	SENT56	11	11	4	4	hyaluronan	HAS1	PA165958431	3036	0.512
NULL	Mol_Vis_2012_May_1_18_1115-1122.nxml.txt.nlp	22605923	SENT216	5	5	7	7	estradiol	p38	PA449503	10598;1432;7965	0.512
NULL	Environ_Health_Perspect_1985_Sep_61_111-121.nxml.txt.nlp	3905370	SENT5	9	9	4	4	estradiol	DES	PA449503	1674	0.512
NULL	Clin_Ophthalmol_2011_Aug_15_5_1127-1133.nxml.txt.nlp	21887094	SENT162	33	33	3	3	lipase	TIMP3	PA450239	7078	0.512
NULL	J_Biomed_Biotechnol_2011_Dec_5_2011_172965.nxml.txt.nlp	22187520	SENT31	15	15	25	25	dextran	IFN	PA449261	3439	0.512
NULL	Exp_Lung_Res_2013_Oct_1_39(8)_336-348.nxml.txt.nlp	23919450	SENT177	13	13	6	6	thrombin	PAR-1	PA451674	2011;2149	0.512
NULL	Cell_Death_Dis_2013_Sep_5_4(9)_e791.nxml.txt.nlp	24008735	SENT247	0	0	2	2	gemcitabine	PUMA	PA449748	27113	0.512
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1075.nxml.txt.nlp	24556690	SENT61	11	11	19	19	spermine	SMO	PA164781199	6608;54498	0.512
NULL	Virol_J_2010_Oct_20_7_279.nxml.txt.nlp	20961433	SENT155	2	2	10	10	trypsin	GP2	PA451806	2813	0.512
NULL	Cent_European_J_Urol_2013_Dec_19_66(4)_394-404.nxml.txt.nlp	24757527	SENT265	2	2	4	4	bevacizumab	IFN	PA130232992	3439	0.512
NULL	Alcohol_Res_2013_35(1)_6-16.nxml.txt.nlp	24313160	SENT213	3	3	5	5	nadh	SIRT1	PA164755085	23411	0.512
NULL	Clin_Ophthalmol_2012_Feb_20_6_277-282.nxml.txt.nlp	22375096	SENT95	31	31	2	2	triamcinolone	CRT	PA451749	811	0.512
NULL	Oncotarget_2014_Feb_8_5(6)_1609-1620.nxml.txt.nlp	24742492	SENT56	15	15	27	27	tetracycline	GAPDH	PA451640	2597	0.512
NULL	Arthritis_Res_Ther_2010_Apr_29_12(2)_R73.nxml.txt.nlp	20429888	SENT13	0	0	19	19	bortezomib	COL1A2	PA10252	1278	0.512
NULL	Acta_Histochem_Cytochem_2012_Apr_26_45(2)_83-106.nxml.txt.nlp	22685351	SENT304	11	11	4	4	arsenite	survivin	PA452638	332	0.512
NULL	EMBO_Mol_Med_2013_Apr_25_5(4)_531-547.nxml.txt.nlp	23526793	SENT10	18	18	26	26	rosiglitazone	EZH2	PA451283	2146	0.512
NULL	Diabetes_Care_2010_Apr_12_33(4)_861-868.nxml.txt.nlp	20067962	SENT134	10	10	8	8	hyaluronan	HMGB1	PA165958431	3146	0.512
NULL	Mol_Neurodegener_2011_Jun_22_6_43.nxml.txt.nlp	21696630	SENT146	10	10	17	17	desmopressin	PKD1	PA449237	5310	0.512
NULL	Exp_Ther_Med_2014_May_20_7(5)_1354-1358.nxml.txt.nlp	24940438	SENT29	0	0	17	17	fluorescein	CD80	PA164746009	941	0.512
NULL	J_Korean_Med_Sci_2008_Aug_25_23(4)_598-603.nxml.txt.nlp	18756044	SENT19	19	19	17	17	cisplatin	CRT	PA449014	811	0.512
NULL	EMBO_Mol_Med_2012_Jun_13_4(6)_515-527.nxml.txt.nlp	22416035	SENT90	12	12	40	40	olaparib	p53		7157	0.512
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT133	7	7	9	9	adalimumab	CD36	PA10004	948	0.512
NULL	J_Oncol_2012_Sep_29_2012_879623.nxml.txt.nlp	21977033	SENT175	11	11	29	29	curcumin	NAC	PA151958596	22861	0.512
NULL	Chem_Res_Toxicol_2011_Aug_15_24(8)_1275-1282.nxml.txt.nlp	21749116	SENT8	0	0	7	7	geldanamycin	Hsp90	PA152031327	3320	0.512
NULL	Cancer_Immunol_Immunother_2015_Oct_7_64_61-73.nxml.txt.nlp	25287778	SENT193	19	19	6	6	lenalidomide	CD56	PA162363968	4684	0.512
NULL	J_Biol_Chem_2012_Apr_27_287(18)_14644-14658.nxml.txt.nlp	22375002	SENT62	34	34	14	14	pp2	AKAP8		10270	0.512
NULL	Ann_Rheum_Dis_2012_Jan_12_71(6)_869-874.nxml.txt.nlp	22241900	SENT211	28	28	16	16	etanercept	TNF	PA449515	7124	0.512
NULL	Arch_Med_Sci_2014_Oct_27_10(5)_1007-1018.nxml.txt.nlp	25395954	SENT225	11	11	2	2	trastuzumab	Yes	PA451743	7525	0.512
NULL	Oncotarget_2014_Jun_4_5(18)_8284-8305.nxml.txt.nlp	25268740	SENT257	18	18	23	23	glucose	FBS	PA449773	64319;26269	0.512
NULL	Osteoporos_Int_2012_Feb_4_23(Suppl_1)_S1-S23.nxml.txt.nlp	22311111	SENT763	21	21	4	4	denosumab	RANK	PA166048634	8792	0.512
NULL	Oncotarget_2014_Feb_27_5(5)_1315-1325.nxml.txt.nlp	24675476	SENT159	11	11	15	15	choline	BRCA1	PA448976	672	0.512
NULL	Mol_Cancer_2009_Dec_14_8_121.nxml.txt.nlp	20003443	SENT51	16	16	6	6	hydroxyprogesterone	AKR1C3	PA449932	8644	0.512
NULL	Front_Genet_2013_Aug_29_4_163.nxml.txt.nlp	24009622	SENT206	19	19	36	36	ethanol	DDP	PA448073	1678	0.512
NULL	Ital_J_Pediatr_2014_Aug_11_40(Suppl_1)_A69.nxml.txt.nlp	NULL	SENT8	1	1	9	9	vigabatrin	ACTH	PA10231	5443	0.512
NULL	Hum_Mol_Genet_2010_Aug_15_19(16)_3254-3265.nxml.txt.nlp	20538880	SENT237	9	9	34	34	choline	p75NTR	PA448976	4804	0.512
NULL	Anal_Chem_2014_Feb_18_86(4)_1988-1996.nxml.txt.nlp	24446580	SENT98	12	12	10	10	trypsin	PPG	PA451806	5552	0.512
NULL	Diabetes_2009_Apr_15_58(4)_984-991.nxml.txt.nlp	19074982	SENT296	20	20	26	26	rosiglitazone	adiponectin	PA451283	9370	0.512
NULL	JAKSTAT_2013_Oct_1_2(4)_e24911.nxml.txt.nlp	24416641	SENT63	9	9	6	6	estradiol	aromatase	PA449503	1588	0.512
NULL	Antimicrob_Resist_Infect_Control_2012_Mar_16_1_12.nxml.txt.nlp	22958880	SENT107	14	14	16	16	chloramphenicol	Gen	PA448927	348654	0.512
NULL	Nucl_Recept_Signal_2009_Jan_16_7_e001.nxml.txt.nlp	19240808	SENT378	23	23	4	4	dextran	SXR	PA449261	8856	0.512
NULL	Arthritis_Res_Ther_2014_Aug_19_16(4)_413.nxml.txt.nlp	25135077	SENT91	4	4	1	1	infliximab	SRM	PA452639	6723;6725	0.512
NULL	Mol_Biol_Int_2012_Jun_14_2012_536802.nxml.txt.nlp	22745908	SENT71	23	23	34	34	staurosporine	TRAIL	PA165109623	8743	0.512
NULL	J_Infect_Dis_2011_May_1_203(9)_1204-1214.nxml.txt.nlp	21459813	SENT298	28	28	24	24	raltegravir	TRIO		7204	0.512
NULL	Neuroimage_Clin_2014_Jul_22_5_277-290.nxml.txt.nlp	25161894	SENT643	18	18	10	10	flumazenil	SOD1	PA449659	6647	0.512
NULL	Br_J_Cancer_2010_Jan_5_102(1)_97-103.nxml.txt.nlp	19904270	SENT184	6	6	10	10	etoposide	STA	PA449552	2010;2656	0.512
NULL	AIDS_Res_Treat_2011_Jun_7_2011_354908.nxml.txt.nlp	21716719	SENT161	7	7	9	9	tenofovir	MRP2	PA10204	100130958;57626;1244	0.512
NULL	Cell_Commun_Signal_2013_Feb_20_11_13.nxml.txt.nlp	23425659	SENT279	2	2	8	8	clonazepam	mol	PA449050	90527	0.512
NULL	Mar_Drugs_2014_Mar_24_12(3)_1690-1698.nxml.txt.nlp	24663119	SENT153	12	12	9	9	troglitazone	PPARgamma	PA451799	5468	0.512
NULL	Cancer_Biol_Med_2012_Mar_9(1)_1-8.nxml.txt.nlp	23691447	SENT170	14	14	32	32	lipase	LPA	PA450239	4018	0.512
NULL	Breast_Cancer_Res_2002_Aug_27_4(6)_213-217.nxml.txt.nlp	12473165	SENT12	13	13	21	21	anastrozole	ATAC	PA448432	6375	0.512
NULL	Diabetes_Care_2010_Jul_33(7)_1691-1692.nxml.txt.nlp	20587731	SENT30	24	24	22	22	liraglutide	GLP-1	PA165958364	100125288	0.512
NULL	Biomed_Res_Int_2014_Aug_6_2014_967826.nxml.txt.nlp	25165721	SENT333	15	15	4	4	cisplatin	NAC	PA449014	22861	0.512
NULL	Diabetes_Care_2013_Aug_17_36(Suppl_2)_S127-S138.nxml.txt.nlp	23882037	SENT202	1	1	3	3	pioglitazone	GLP-1	PA450970	100125288	0.512
NULL	Cancer_Imaging_2011_Oct_3_11(1A)_S129-S145.nxml.txt.nlp	22185786	SENT26	16	16	12	12	denosumab	RANK	PA166048634	8792	0.512
NULL	Breast_Cancer_Res_Treat_2012_Jul_5_134(2)_693-700.nxml.txt.nlp	22562123	SENT26	8	8	0	0	tamoxifen	CYP2B6	PA451581	1555	0.512
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_127043.nxml.txt.nlp	23227093	SENT231	5	5	26	26	furafylline	CYP3A4	PA452614	1576	0.512
NULL	Indian_J_Ophthalmol_2013_May_61(5)_213-217.nxml.txt.nlp	23314254	SENT77	36	36	16	16	bevacizumab	San	PA130232992	80218	0.512
NULL	AIDS_Care_2011_Sep_14_23(9)_1154-1162.nxml.txt.nlp	21500025	SENT123	37	37	2	2	ritonavir	ATV	PA451260	4683	0.512
NULL	Cancer_Cell_Int_2013_May_1_13_39.nxml.txt.nlp	23631621	SENT209	24	24	22	22	fluorescein	CD24	PA164746009	100133941	0.512
NULL	J_Ophthalmic_Inflamm_Infect_2011_Nov_6_2(1)_21-28.nxml.txt.nlp	22057810	SENT76	17	17	13	13	infliximab	CTX	PA452639	1593	0.512
NULL	Oncoimmunology_2012_Oct_1_1(7)_1004-1016.nxml.txt.nlp	23170249	SENT10	14	14	6	6	paclitaxel	HER-2	PA450761	2064	0.512
NULL	Drug_Des_Devel_Ther_2014_Sep_23_8_1527-1538.nxml.txt.nlp	25284985	SENT110	14	14	20	20	celecoxib	IFN	PA448871	3439	0.512
NULL	Crit_Care_2008_Jan_8_12(1)_202.nxml.txt.nlp	18279535	SENT182	15	15	24	24	creatine	gamma	PA164778930	9913	0.512
NULL	Bioinformatics_2013_Jul_1_29(13)_i126-i134.nxml.txt.nlp	23812976	SENT294	8	8	10	10	mesalazine	LTA4H	PA450384	4048	0.512
NULL	Crit_Care_2011_Nov_16_15(6)_R271.nxml.txt.nlp	22087790	SENT164	2	2	48	48	nitroprusside	Yes	PA451406	7525	0.512
NULL	Biologics_2013_Apr_15_7_77-90.nxml.txt.nlp	23723688	SENT246	0	0	10	10	bortezomib	EGFR	PA10252	1956	0.512
NULL	Environ_Health_Perspect_2008_Jul_26_116(7)_854-862.nxml.txt.nlp	18629305	SENT206	2	2	0	0	ebselen	NAC	PA161660841	22861	0.512
NULL	Aging_(Albany_NY)_2009_Feb_18_1(3)_335-349.nxml.txt.nlp	20195489	SENT89	17	17	11	11	etoposide	p65	PA449552	5970	0.512
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT311	16	16	24	24	clozapine	PRL	PA449061	5617	0.512
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1046.nxml.txt.nlp	24503538	SENT95	16	16	10	10	oxaliplatin	FGFR4	PA131285527	2264	0.512
NULL	Aging_(Albany_NY)_2013_May_23_5(5)_357-372.nxml.txt.nlp	23793469	SENT250	40	40	32	32	ethanol	CO2	PA448073	4513	0.512
NULL	Oxid_Med_Cell_Longev_2010_Nov-Dec_3(6)_361-373.nxml.txt.nlp	21311214	SENT269	16	16	14	14	taurine	NAC	PA451590	22861	0.512
NULL	Lipids_Health_Dis_2011_Dec_30_10_246.nxml.txt.nlp	22208561	SENT123	4	4	9	9	ethanol	HO-1	PA448073	3162	0.512
NULL	J_Immunother_2014_Apr_12_37(3)_180-186.nxml.txt.nlp	24598448	SENT105	20	20	18	18	sorafenib	IL-2	PA7000	3558	0.512
NULL	Exp_Ther_Med_2014_May_20_7(5)_1354-1358.nxml.txt.nlp	24940438	SENT29	0	0	27	27	fluorescein	CD40	PA164746009	958	0.512
NULL	Diabetologia_2009_Oct_14_52(10)_2046-2055.nxml.txt.nlp	19688338	SENT313	5	5	32	32	liraglutide	GLP-1	PA165958364	100125288	0.512
NULL	Tob_Induc_Dis_2004_Mar_15_2(1)_1.nxml.txt.nlp	NULL	SENT319	6	6	33	33	nicotine	CC10	PA450626	7356	0.512
NULL	Mol_Clin_Oncol_2013_Jul_27_1(4)_768-772.nxml.txt.nlp	24649244	SENT149	17	17	15	15	oxaliplatin	GEM	PA131285527	2669	0.512
NULL	Breast_Cancer_Res_2010_Oct_26_12(5)_210.nxml.txt.nlp	21067538	SENT35	20	20	25	25	urokinase	RhoC	PA451836	389	0.512
NULL	J_Exp_Bot_2009_Apr_2_60(6)_1691-1702.nxml.txt.nlp	19342428	SENT46	30	30	14	14	doxycycline	TAP	PA449415	8615;2317;10482;23541	0.512
NULL	Clin_Epidemiol_2013_Dec_18_6_1-13.nxml.txt.nlp	24379699	SENT197	47	47	32	32	glucose	Men	PA449773	8178	0.512
NULL	Int_J_Med_Sci_2013_Jan_3_10(2)_141-147.nxml.txt.nlp	23329885	SENT33	30	30	10	10	creatine	GAMT	PA164778930	2593	0.512
NULL	Acta_Pharmacol_Sin_2011_Jan_29_32(1)_38-44.nxml.txt.nlp	21113177	SENT116	0	0	6	6	chloroquine	LC3	PA448948	84557	0.512
NULL	J_Breast_Cancer_2011_Dec_27_14(4)_283-288.nxml.txt.nlp	22323914	SENT130	24	24	0	0	doxorubicin	BCS	PA449412	617	0.512
NULL	Autophagy_2012_Jul_1_8(7)_1045-1057.nxml.txt.nlp	22647547	SENT172	3	3	19	19	gentamicin	ATG12	PA449753	9140	0.512
NULL	Arthritis_Res_Ther_2008_Jan_7_10(1)_R1.nxml.txt.nlp	18179697	SENT15	14	14	10	10	oxaliplatin	HMGB1	PA131285527	3146	0.512
NULL	Oncotarget_2014_Mar_11_5(4)_901-907.nxml.txt.nlp	24658650	SENT130	14	14	25	25	ethanol	San	PA448073	80218	0.512
NULL	J_Immunother_2014_Apr_12_37(3)_180-186.nxml.txt.nlp	24598448	SENT133	11	11	9	9	sorafenib	IL-2	PA7000	3558	0.512
NULL	Ann_Hematol_2010_Nov_25_89(11)_1115-1124.nxml.txt.nlp	20499237	SENT150	15	15	20	20	simvastatin	CD38	PA451363	952	0.512
NULL	Infect_Dis_Obstet_Gynecol_2014_Sep_25_2014_961375.nxml.txt.nlp	25328370	SENT196	10	10	0	0	ritonavir	ATV	PA451260	4683	0.512
NULL	Core_Evid_2007_Nov_30_2(2)_121-129.nxml.txt.nlp	21221180	SENT230	30	30	32	32	rituximab	CHOP	PA451261	1649	0.512
NULL	Cancer_Cell_Int_2013_May_1_13_39.nxml.txt.nlp	23631621	SENT206	17	17	4	4	heparin	EGF	PA449855	1950	0.512
NULL	Contemp_Oncol_(Pozn)_2012_Feb_29_16(1)_86-89.nxml.txt.nlp	23788860	SENT45	26	26	18	18	mitomycin	ADM	PA450524	133	0.512
NULL	Front_Genet_2012_Oct_26_3_213.nxml.txt.nlp	23112805	SENT608	40	40	24	24	midazolam	CYP2C9	PA450496	1559	0.512
NULL	Exp_Ther_Med_2015_Jan_5_9(1)_84-88.nxml.txt.nlp	25452780	SENT71	13	13	3	3	vildagliptin	GLP-1	PA165958346	100125288	0.512
NULL	Breast_Cancer_Res_2011_May_26_13(3)_209.nxml.txt.nlp	21635709	SENT152	7	7	2	2	letrozole	HER2	PA450196	2064	0.512
NULL	Front_Oncol_2014_Sep_15_4_244.nxml.txt.nlp	25309870	SENT51	2	2	9	9	gefitinib	EGFR	PA131301952	1956	0.512
NULL	Gut_Pathog_2010_Dec_7_2_17.nxml.txt.nlp	21138594	SENT39	7	7	32	32	ampicillin	OTC	PA448419	5009	0.512
NULL	Bone_Marrow_Transplant_2011_Jul_11_46(7)_943-949.nxml.txt.nlp	20935680	SENT22	14	14	20	20	plerixafor	GM-CSF	PA165958410	1437	0.512
NULL	J_Cell_Mol_Med_2014_Feb_5_18(2)_263-273.nxml.txt.nlp	24304472	SENT138	3	3	17	17	prazosin	p65	PA451093	5970	0.512
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT759	1	1	3	3	vemurafenib	BRAF	PA165946873	673	0.512
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Jun_13_64(Pt_7)_m909-m910.nxml.txt.nlp	21202771	SENT5	38	38	20	20	ethanol	mol	PA448073	90527	0.512
NULL	Cell_Death_Differ_2010_Mar_16_17(3)_439-451.nxml.txt.nlp	19834489	SENT265	21	21	19	19	fluorescein	GFAP	PA164746009	2670	0.512
NULL	Drug_Des_Devel_Ther_2014_Sep_23_8_1527-1538.nxml.txt.nlp	25284985	SENT142	26	26	24	24	celecoxib	IFN	PA448871	3439	0.512
NULL	ScientificWorldJournal_2012_Apr_22_2012_643904.nxml.txt.nlp	22619632	SENT142	7	7	5	5	pp2	PP1		5540;5464	0.512
NULL	J_Neurosci_Rural_Pract_2013_Aug_4(Suppl_1)_S145-S146.nxml.txt.nlp	24174790	SENT29	19	19	28	28	primaquine	G6PD	PA451103	2539	0.512
NULL	Diabetes_Care_2013_Aug_17_36(Suppl_2)_S180-S189.nxml.txt.nlp	23882044	SENT36	0	0	5	5	liraglutide	GLP-1	PA165958364	100125288	0.512
NULL	Curr_Neuropharmacol_2014_Jul_12(4)_365-379.nxml.txt.nlp	25342944	SENT115	42	42	26	26	fluoxetine	cPLA2	PA449673	10524	0.512
NULL	Clin_Med_Insights_Womens_Health_2013_Jan_23_6_13-24.nxml.txt.nlp	24665210	SENT176	4	4	20	20	medroxyprogesterone	CEE	PA450344	51608	0.512
NULL	Mol_Cell_Endocrinol_2008_Mar_26_285(1-2)_51-61.nxml.txt.nlp	18316157	SENT40	9	9	0	0	ethanol	EP4	PA448073	5734	0.512
NULL	Mol_Brain_2014_Sep_4_7(1)_69.nxml.txt.nlp	NULL	SENT148	3	3	40	40	sevoflurane	CXCL10	PA451341	3627	0.512
NULL	Rare_Tumors_2010_Dec_31_2(4)_e63.nxml.txt.nlp	21234255	SENT33	13	13	6	6	doxorubicin	CHOP	PA449412	1649	0.512
NULL	Oncotarget_2014_Oct_23_5(22)_11154-11167.nxml.txt.nlp	25525888	SENT180	27	27	19	19	sorafenib	VEGFR	PA7000	3791	0.512
NULL	J_Immunol_Res_2014_May_12_2014_897249.nxml.txt.nlp	24901013	SENT182	28	28	4	4	natalizumab	PTEN	PA164747191	5728	0.511
NULL	Nat_Commun_2013_Nov_29_4_10_1038_ncomms3812.nxml.txt.nlp	24287487	SENT47	25	25	8	8	tetracycline	Dicer	PA451640	23405	0.511
NULL	Mol_Vis_2012_May_6_18_1189-1196.nxml.txt.nlp	22605930	SENT212	11	11	16	16	travoprost	BAK	PA164781371	578	0.511
NULL	Leukemia_2014_Jun_25_28(6)_1280-1288.nxml.txt.nlp	24270737	SENT210	19	19	11	11	cytarabine	THP1	PA449177	2736	0.511
NULL	Braz_J_Microbiol_2014_Jan_15_44(3)_807-812.nxml.txt.nlp	24516449	SENT133	44	44	18	18	moxifloxacin	CTX	PA450555	1593	0.511
NULL	Ann_Oncol_2009_Aug_20(Suppl_6)_vi41-vi50.nxml.txt.nlp	19617297	SENT268	12	12	32	32	cisplatin	IL-2	PA449014	3558	0.511
NULL	Blood_Cancer_J_2012_Mar_23_2(3)_e63.nxml.txt.nlp	22829258	SENT24	20	20	23	23	eculizumab	BCS	PA164776637	617	0.511
NULL	Comput_Struct_Biotechnol_J_2013_Feb_22_3_e201210020.nxml.txt.nlp	24688680	SENT144	28	28	17	17	naringenin	CHS	PA151958361	1130	0.511
NULL	Front_Neurosci_2014_Mar_26_8_47.nxml.txt.nlp	24723845	SENT206	25	25	27	27	theophylline	PARP-1	PA451647	25976	0.511
NULL	Mol_Cancer_2010_Jun_25_9_166.nxml.txt.nlp	20579378	SENT161	4	4	2	2	gefitinib	EGF	PA131301952	1950	0.511
NULL	Diabetes_Care_2010_Apr_12_33(4)_861-868.nxml.txt.nlp	20067962	SENT134	10	10	12	12	hyaluronan	HSP60	PA165958431	3329	0.511
NULL	Exp_Ther_Med_2013_Jun_9_5(6)_1770-1774.nxml.txt.nlp	23837071	SENT26	7	7	44	44	coumarin	JNK	PA134521193	5599	0.511
NULL	Med_Sci_Monit_2012_Jul_1_18(7)_HY27-HY31.nxml.txt.nlp	22739741	SENT82	0	0	5	5	arsenite	ARS2	PA452638	51593	0.511
NULL	Lipids_Health_Dis_2011_Jan_27_10_24.nxml.txt.nlp	21272342	SENT36	45	45	19	19	lipase	PPL	PA450239	5493	0.511
NULL	Thorax_2010_Sep_65(9)_775-781.nxml.txt.nlp	20805170	SENT92	15	15	0	0	ciclesonide	BDP	PA164781399	10620;152926	0.511
NULL	Br_J_Haematol_2014_Jan_28_164(2)_233-244.nxml.txt.nlp	24206017	SENT176	20	20	0	0	thalidomide	CRBN	PA451644	51185	0.511
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT407	3	3	6	6	bevacizumab	VEGF-A	PA130232992	7422	0.511
NULL	Infect_Dis_Ther_2013_Dec_3_2(2)_111-122.nxml.txt.nlp	25134475	SENT65	26	26	0	0	darunavir	ATV	PA163522472	4683	0.511
NULL	Br_J_Cancer_2009_Jul_21_101(2)_269-277.nxml.txt.nlp	19603033	SENT115	6	6	3	3	cisplatin	XIAP	PA449014	331	0.511
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT192	41	41	47	47	erlotinib	Yes	PA134687924	7525	0.511
NULL	Pak_J_Med_Sci_2013_May-Jun_29(3)_891-896.nxml.txt.nlp	24353652	SENT165	18	18	16	16	thrombin	ADP	PA451674	23038	0.511
NULL	Front_Neurosci_2012_May_30_6_77.nxml.txt.nlp	22661925	SENT335	9	9	23	23	ethanol	TLR4	PA448073	7099	0.511
NULL	J_Inherit_Metab_Dis_2011_Apr_27_34(2)_357-366.nxml.txt.nlp	20978943	SENT239	6	6	18	18	galactose	BMP15	PA449725	9210	0.511
NULL	Chem_Res_Toxicol_2013_Oct_21_26(10)_1570-1578.nxml.txt.nlp	24047243	SENT522	19	19	11	11	sparteine	CYP2D6	PA452610	1565	0.511
NULL	Cell_J_2012_Dec_22_Winter_13(4)_265-274.nxml.txt.nlp	23507995	SENT26	13	13	3	3	ethanol	CA1	PA448073	759	0.511
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Mar_26_3(3)_e107.nxml.txt.nlp	24670388	SENT31	14	14	8	8	midazolam	CYP3A	PA450496	1574	0.511
NULL	Breast_Cancer_Res_2010_Feb_10_12(1)_R11.nxml.txt.nlp	20146798	SENT80	45	45	21	21	ethanol	San	PA448073	80218	0.511
NULL	Indian_J_Nephrol_2008_Jan_18(1)_26-27.nxml.txt.nlp	20368918	SENT55	20	20	30	30	urea	CO2	PA451831	4513	0.511
NULL	Front_Mol_Neurosci_2014_Dec_1_7_94.nxml.txt.nlp	25520615	SENT86	0	0	2	2	ketamine	NOT	PA450144	4929	0.511
NULL	Springerplus_2014_Oct_24_3_628.nxml.txt.nlp	25392798	SENT92	6	6	12	12	ketoconazole	LDM	PA450146	1595	0.511
NULL	J_Gen_Physiol_1997_Aug_1_110(2)_141-153.nxml.txt.nlp	9236207	SENT211	38	38	8	8	spermine	ACT	PA164781199	12;11332;9457;641455	0.511
NULL	Infect_Dis_Obstet_Gynecol_2012_Feb_25_2012_157159.nxml.txt.nlp	22505797	SENT119	18	18	11	11	clindamycin	PTB	PA449035	58155	0.511
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT4019	1	1	45	45	ketamine	REF	PA450144	10189	0.511
NULL	Case_Rep_Oncol_Med_2014_Jun_23_2014_194636.nxml.txt.nlp	25045559	SENT75	4	4	14	14	trastuzumab	HER-2	PA451743	2064	0.511
NULL	Oncol_Lett_2014_May_7_7(5)_1439-1442.nxml.txt.nlp	24765152	SENT166	14	14	0	0	chloramphenicol	EGF	PA448927	1950	0.511
NULL	Front_Oncol_2014_Mar_3_4_41.nxml.txt.nlp	24624364	SENT601	26	26	23	23	mitoxantrone	ABCB1	PA450526	5243	0.511
NULL	Biomed_Res_Int_2013_May_8_2013_703130.nxml.txt.nlp	23738330	SENT132	26	26	32	32	lipase	SP75	PA450239	6674	0.511
NULL	Br_J_Cancer_1998_Apr_77(8)_1280-1286.nxml.txt.nlp	9579834	SENT0	27	27	40	40	tamoxifen	IL-2	PA451581	3558	0.511
NULL	Cells_2012_Jun_29_1(3)_248-262.nxml.txt.nlp	24710475	SENT171	32	32	26	26	zinc	PB1	PA451956	55193	0.511
NULL	Acta_Physiol_(Oxf)_2007_Sep_191(1)_43-57.nxml.txt.nlp	17524066	SENT237	26	26	20	20	nifedipine	KCNE1	PA450631	3753	0.511
NULL	Acta_Pharmacol_Sin_2010_Sep_9_31(9)_1154-1164.nxml.txt.nlp	20694022	SENT185	22	22	20	20	imatinib	IFN	PA10804	3439	0.511
NULL	Oncotarget_2014_Mar_13_5(4)_1101-1110.nxml.txt.nlp	24658355	SENT11	26	26	18	18	tamoxifen	MKP-2	PA451581	1846	0.511
NULL	Front_Genet_2013_Aug_29_4_163.nxml.txt.nlp	24009622	SENT17	5	5	7	7	ethanol	DDP	PA448073	1678	0.511
NULL	Int_J_Endocrinol_2013_Nov_13_2013_686315.nxml.txt.nlp	24324494	SENT8	4	4	8	8	metformin	MATE1	PA450395	55244	0.511
NULL	Arch_Osteoporos_2009_Dec_18_4(1-2)_1-8.nxml.txt.nlp	20234790	SENT76	23	23	28	28	zoledronate	PTH	PA10235	5741	0.511
NULL	BMB_Rep_2014_Aug_47(8)_424-432.nxml.txt.nlp	24874851	SENT92	8	8	22	22	temozolomide	gamma	PA451609	9913	0.511
NULL	Cancers_(Basel)_2010_Apr_9_2(2)_397-419.nxml.txt.nlp	24281076	SENT156	14	14	16	16	cisplatin	IL-2	PA449014	3558	0.511
NULL	Int_J_Cardiovasc_Imaging_2013_Jun_3_29(5)_959-966.nxml.txt.nlp	23378157	SENT84	3	3	11	11	nitrogen	GFR	PA450643	9771	0.511
NULL	Acta_Pharmacol_Sin_2011_Jan_6_32(1)_133-138.nxml.txt.nlp	21131997	SENT50	8	8	12	12	heparin	HSI	PA449855	57016	0.511
NULL	Bioinformation_2011_Feb_15_5(10)_422-429.nxml.txt.nlp	21423888	SENT18	15	15	19	19	galactose	GAL7	PA449725	3963;653499	0.511
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Jun_27_5_15.nxml.txt.nlp	16803618	SENT145	26	26	30	30	ciprofloxacin	CIP1	PA449009	1026;56996	0.511
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT113	3	3	7	7	pemetrexed	UNG	PA10810	7374	0.511
NULL	J_Korean_Med_Sci_2007_Dec_20_22(6)_1055-1059.nxml.txt.nlp	18162722	SENT34	7	7	5	5	pantoprazole	ESD	PA450774	2098	0.511
NULL	Indian_J_Psychol_Med_2012_Jul-Sep_34(3)_247-254.nxml.txt.nlp	23439746	SENT78	13	13	8	8	olanzapine	FGA	PA450688	2243	0.511
NULL	Int_J_Mol_Sci_2014_Nov_25_15(12)_21703-21722.nxml.txt.nlp	25429431	SENT65	33	33	24	24	curcumin	5-LOX	PA151958596	240	0.511
NULL	Clin_Ophthalmol_2014_Feb_10_8_389-399.nxml.txt.nlp	24550667	SENT4	7	7	27	27	brinzolamide	TIM	PA164744929	7984;8914	0.511
NULL	J_Acquir_Immune_Defic_Syndr_2014_Jan_1_65(1)_78-81.nxml.txt.nlp	24419064	SENT107	30	30	36	36	maraviroc	P65	PA164768835	64689;6857	0.511
NULL	Korean_J_Anesthesiol_2013_Dec_26_65(6)_501-507.nxml.txt.nlp	24427455	SENT19	24	24	11	11	neostigmine	NMB	PA450611	10457;4828	0.511
NULL	J_Korean_Med_Sci_2007_Apr_30_22(2)_283-289.nxml.txt.nlp	17449938	SENT98	20	20	8	8	minoxidil	Bcl-2	PA450521	596	0.511
NULL	Cardiovasc_Diabetol_2013_Oct_17_12_150.nxml.txt.nlp	24134550	SENT7	42	42	6	6	metformin	activin	PA450395	83729	0.511
NULL	Allergy_Asthma_Clin_Immunol_2008_Sep_15_4(3)_95-105.nxml.txt.nlp	20525130	SENT200	12	12	10	10	fluorescein	CD11c	PA164746009	3687	0.511
NULL	Oncogene_2010_Sep_2_29(35)_4905-4913.nxml.txt.nlp	20581869	SENT253	2	2	17	17	paclitaxel	CA125	PA450761	4077;94025	0.511
NULL	Acta_Histochem_Cytochem_2012_Apr_26_45(2)_139-146.nxml.txt.nlp	22685356	SENT6	34	34	10	10	forskolin	AQP2	PA146096022	359	0.511
NULL	Alzheimers_Res_Ther_2013_May_14_5(3)_25.nxml.txt.nlp	23673233	SENT386	17	17	13	13	scopolamine	spatial	PA451308	219793	0.511
NULL	Autophagy_2012_May_1_8(5)_853-855.nxml.txt.nlp	22617440	SENT34	2	2	21	21	imatinib	ATG7	PA10804	10533	0.511
NULL	J_Appl_Oral_Sci_2010_Nov-Dec_18(6)_551-559.nxml.txt.nlp	21308284	SENT145	6	6	0	0	chloramphenicol	AMN	PA448927	215;81693	0.511
NULL	Trials_2014_Feb_19_15_63.nxml.txt.nlp	24552184	SENT266	2	2	0	0	paclitaxel	PACT	PA450761	8575;5930	0.511
NULL	Ital_J_Pediatr_2014_Feb_11_40_16.nxml.txt.nlp	24517264	SENT87	15	15	20	20	tramadol	CYP2D6	PA451735	1565	0.511
NULL	J_Lipid_Res_2013_Feb_54(2)_425-435.nxml.txt.nlp	23220585	SENT28	29	29	31	31	lipase	ATGL	PA450239	57104	0.511
NULL	Exp_Ther_Med_2013_Mar_17_5(3)_797-802.nxml.txt.nlp	23403698	SENT207	2	2	5	5	glucose	PI3K	PA449773	5290	0.511
NULL	Aging_(Albany_NY)_2009_Oct_13_1(10)_842-844.nxml.txt.nlp	20157556	SENT19	21	21	10	10	nutlin-3	p53		7157	0.511
NULL	Mol_Cancer_2010_Nov_2_9_289.nxml.txt.nlp	21044322	SENT166	22	22	8	8	platinum	RGS17	PA150595617	26575	0.511
NULL	Diabetes_Metab_J_2013_Apr_16_37(2)_113-116.nxml.txt.nlp	23641351	SENT65	0	0	7	7	metformin	AMPK	PA450395	5563	0.511
NULL	Oncotarget_2013_Apr_13_4(4)_502-530.nxml.txt.nlp	23594434	SENT243	8	8	11	11	nelfinavir	AKT	PA450606	207	0.511
NULL	BMJ_2010_Feb_8_340_c693.nxml.txt.nlp	20142325	SENT222	8	8	5	5	paroxetine	CYP2D6	PA450801	1565	0.511
NULL	Oncotarget_2014_Oct_18_5(22)_11604-11619.nxml.txt.nlp	25344099	SENT142	9	9	6	6	cisplatin	RYBP	PA449014	23429	0.511
NULL	ScientificWorldJournal_2013_Oct_1_2013_654829.nxml.txt.nlp	24198725	SENT312	8	8	11	11	naproxen	NF1	PA450595	4763	0.511
NULL	J_Adv_Pract_Oncol_2013_Mar_1_Mar-Apr_4(2)_89-100.nxml.txt.nlp	25031987	SENT29	0	0	26	26	palifermin	IL-13	PA164744014	3596	0.511
NULL	Int_J_Emerg_Med_2013_Jul_16_6_25.nxml.txt.nlp	23866080	SENT115	3	3	15	15	rivaroxaban	P-gp	PA165958360	5243	0.511
NULL	Curr_Neuropharmacol_2014_Jul_12(4)_365-379.nxml.txt.nlp	25342944	SENT534	8	8	2	2	fluoxetine	5-HT1B	PA449673	3351	0.511
NULL	Chin_J_Cancer_2012_Nov_31(11)_507-518.nxml.txt.nlp	22640626	SENT173	43	43	19	19	nilotinib	ABL2	PA165958345	27	0.511
NULL	Chemother_Res_Pract_2012_Jul_15_2012_905796.nxml.txt.nlp	22844591	SENT68	29	29	36	36	streptomycin	CO2	PA451512	4513	0.511
NULL	J_Cell_Biol_1999_Feb_22_144(4)_603-615.nxml.txt.nlp	10037784	SENT394	32	32	22	22	fluorescein	ADAR1	PA164746009	103	0.511
NULL	Br_J_Clin_Pharmacol_2011_Oct_72(4)_647-657.nxml.txt.nlp	21518389	SENT95	12	12	5	5	prasugrel	CYP2C9	PA154410481	1559	0.511
NULL	Int_J_Med_Sci_2014_Jun_21_11(9)_897-904.nxml.txt.nlp	25013370	SENT108	28	28	0	0	hydrochlorothiazide	L-FABP	PA449899	2168	0.511
NULL	J_Korean_Med_Sci_2009_Jan_29_24(Suppl_1)_S183-S188.nxml.txt.nlp	19194550	SENT106	5	5	12	12	celecoxib	CD2AP	PA448871	23607	0.511
NULL	Rare_Tumors_2010_Dec_31_2(4)_e63.nxml.txt.nlp	21234255	SENT33	18	18	6	6	vincristine	CHOP	PA451879	1649	0.511
NULL	Oncoimmunology_2013_Dec_1_2(12)_e26689.nxml.txt.nlp	24527364	SENT23	35	35	21	21	doxorubicin	IFN	PA449412	3439	0.511
NULL	Biologics_2013_May_29_7_131-138.nxml.txt.nlp	23807836	SENT102	26	26	24	24	ribavirin	IFN	PA451241	3439	0.511
NULL	Indian_J_Ophthalmol_2007_Nov-Dec_55(6)_457-458.nxml.txt.nlp	17951904	SENT24	0	0	13	13	fluorescein	CRT	PA164746009	811	0.511
NULL	Exp_Hematol_Oncol_2013_Jan_10_2_2.nxml.txt.nlp	23305345	SENT143	23	23	10	10	rituximab	BTZ	PA451261	22794	0.511
NULL	Indian_J_Pharm_Sci_2009_Nov-Dec_71(6)_599-607.nxml.txt.nlp	20376211	SENT177	6	6	17	17	diltiazem	SLK	PA449334	9748;2534	0.511
NULL	Mol_Vis_2012_Jul_18_18_1966-1972.nxml.txt.nlp	22876123	SENT122	0	0	12	12	curcumin	IL-5	PA151958596	3567	0.511
NULL	Orphanet_J_Rare_Dis_2014_Nov_30_9(1)_197.nxml.txt.nlp	NULL	SENT136	30	30	42	42	creatine	AGAT	PA164778930	2628	0.511
NULL	Clin_Med_Insights_Circ_Respir_Pulm_Med_2012_Jun_12_6_27-40.nxml.txt.nlp	22745565	SENT188	23	23	30	30	omalizumab	ACT	PA164752253	12;11332;9457;641455	0.511
NULL	Curr_Neuropharmacol_2013_Jan_11(1)_102-108.nxml.txt.nlp	23814542	SENT225	14	14	20	20	simvastatin	Yes	PA451363	7525	0.511
NULL	J_Gen_Physiol_1959_Jan_20_42(3)_617-634.nxml.txt.nlp	13620891	SENT0	17	17	1	1	trypsin	Gen	PA451806	348654	0.511
NULL	Case_Rep_Oncol_2011_Oct_26_4(3)_526-530.nxml.txt.nlp	22125524	SENT20	11	11	6	6	ethanol	castor	PA448073	54897	0.511
NULL	J_Korean_Med_Sci_2010_Apr_19_25(4)_557-563.nxml.txt.nlp	20357998	SENT111	0	0	23	23	rosiglitazone	IL-6	PA451283	3569	0.511
NULL	Surg_Today_2012_Jan_6_42(1)_8-28.nxml.txt.nlp	22139128	SENT230	27	27	23	23	tegafur	PSK	PA452620	9344	0.511
NULL	Toxins_(Basel)_2010_Oct_26_2(11)_2490-2518.nxml.txt.nlp	22069563	SENT232	5	5	3	3	cisplatin	TLR2	PA449014	7097	0.511
NULL	Ann_Hematol_2014_Sep_12_93(1)_13-32.nxml.txt.nlp	24026426	SENT283	13	13	21	21	voriconazole	BII	PA10233	777	0.511
NULL	Curr_Neuropharmacol_2014_Mar_12(2)_186-192.nxml.txt.nlp	24669211	SENT220	28	28	31	31	metformin	Met	PA450395	79811	0.511
NULL	J_Korean_Med_Sci_2004_Apr_30_19(2)_167-171.nxml.txt.nlp	15082886	SENT118	36	36	0	0	isoniazid	PTH	PA450112	5741	0.511
NULL	Eur_J_Clin_Microbiol_Infect_Dis_2014_Nov_10_33(2)_201-209.nxml.txt.nlp	24213847	SENT145	33	33	24	24	meropenem	TMP	PA164764445	2012	0.511
NULL	Indian_J_Med_Res_2012_Oct_136(4)_641-648.nxml.txt.nlp	23168705	SENT48	24	24	45	45	dextran	CO2	PA449261	4513	0.511
NULL	Exp_Ther_Med_2013_Mar_15_5(3)_957-963.nxml.txt.nlp	23408713	SENT221	13	13	30	30	ethanol	GAPDH	PA448073	2597	0.511
NULL	Alcohol_Res_Health_2007_30(1)_38-47.nxml.txt.nlp	17718399	SENT229	11	11	14	14	oxygen	ROS	PA450744	6098	0.511
NULL	Front_Neuroanat_2011_Aug_8_5_49.nxml.txt.nlp	21852966	SENT214	7	7	10	10	haloperidol	RGS2	PA449841	5997	0.511
NULL	Bioinformation_2011_Jan_22_5(8)_336-340.nxml.txt.nlp	21383921	SENT79	31	31	20	20	choline	PI3K	PA448976	5290	0.511
NULL	J_Viral_Hepat_2014_Jul_12_21(7)_e39-e47.nxml.txt.nlp	24620791	SENT84	26	26	33	33	fluorescein	CD4	PA164746009	920	0.511
NULL	J_Hematol_Oncol_2008_Oct_1_1_16.nxml.txt.nlp	18828924	SENT122	19	19	13	13	trastuzumab	HER2	PA451743	2064	0.511
NULL	Cancer_Microenviron_2008_Dec_20_1(1)_103-111.nxml.txt.nlp	19308689	SENT72	0	0	8	8	thrombin	PAR-1	PA451674	2011;2149	0.511
NULL	Drug_Target_Insights_2012_Aug_6_6_19-39.nxml.txt.nlp	22915839	SENT245	38	38	33	33	doxorubicin	Hsp90	PA449412	3320	0.511
NULL	Appl_Plant_Sci_2015_Jan_5_3(1)_apps_1400086.nxml.txt.nlp	25606353	SENT62	2	2	12	12	cefotaxime	UNK	PA448852	85451	0.511
NULL	Cancer_Cell_Int_2006_Mar_23_6_6.nxml.txt.nlp	16556298	SENT9	0	0	6	6	doxorubicin	FDG	PA449412	23583	0.511
NULL	Front_Endocrinol_(Lausanne)_2013_Sep_2_4_111.nxml.txt.nlp	24065951	SENT413	14	14	30	30	estradiol	aromatase	PA449503	1588	0.511
NULL	AIDS_Res_Treat_2012_Feb_20_2012_105980.nxml.txt.nlp	22454762	SENT135	21	21	24	24	efavirenz	CYP2B6	PA449441	1555	0.511
NULL	Curr_Oncol_2009_Jan_16(1)_16-26.nxml.txt.nlp	19229368	SENT37	29	29	21	21	oxaliplatin	KRAS	PA131285527	3845	0.511
NULL	ASN_Neuro_2010_Oct_4_2(5)_e00046.nxml.txt.nlp	20957077	SENT304	43	43	40	40	ganciclovir	E14	PA449733	4863	0.511
NULL	Acta_Pharmacol_Sin_2014_Oct_15_35(10)_1227-1246.nxml.txt.nlp	25220640	SENT237	10	10	3	3	cisplatin	MKP-1	PA449014	1843	0.511
NULL	Front_Neuroenergetics_2010_May_21_2_5.nxml.txt.nlp	20725515	SENT213	8	8	32	32	glucose	p38	PA449773	10598;1432;7965	0.511
NULL	Arthritis_Res_Ther_2013_Sep_17_15(5)_R123.nxml.txt.nlp	24432362	SENT41	34	34	14	14	anakinra	MSU	PA10799	593	0.511
NULL	Ann_N_Y_Acad_Sci_2012_Aug_30_1264(1)_49-63.nxml.txt.nlp	22548651	SENT53	18	18	27	27	glucose	BDNF	PA449773	627	0.511
NULL	Iran_J_Pharm_Res_2013_Winter_12(1)_141-146.nxml.txt.nlp	24250582	SENT108	20	20	16	16	rifampin	NAC	PA451250	22861	0.511
NULL	Front_Physiol_2010_Nov_2_1_145.nxml.txt.nlp	21423385	SENT20	4	4	1	1	celecoxib	COX2	PA448871	4513;5743	0.511
NULL	AMB_Express_2011_Jul_13_1_16.nxml.txt.nlp	21906371	SENT114	5	5	12	12	nitrogen	PHB	PA450643	5245	0.511
NULL	Iran_J_Neurol_2013_12(4)_129-135.nxml.txt.nlp	24250922	SENT121	4	4	11	11	trypsin	neurosin	PA451806	5653	0.511
NULL	Cardiovasc_Diabetol_2013_Oct_17_12_150.nxml.txt.nlp	24134550	SENT102	12	12	6	6	pioglitazone	activin	PA450970	83729	0.51
NULL	Sci_Rep_2014_Dec_19_4_7571.nxml.txt.nlp	25524368	SENT322	7	7	14	14	estradiol	mer	PA449503	10461	0.51
NULL	Front_Neurosci_2014_Jun_3_8_128.nxml.txt.nlp	24917782	SENT59	18	18	28	28	ethanol	ACTH	PA448073	5443	0.51
NULL	Environ_Health_Perspect_2010_Sep_118(9)_A383.nxml.txt.nlp	20810348	SENT20	28	28	11	11	ciprofloxacin	API	PA449009	5345	0.51
NULL	Nucleic_Acids_Res_2011_Mar_21_39(4)_1197-1207.nxml.txt.nlp	20965966	SENT201	4	4	12	12	lipase	ghrelin	PA450239	51738	0.51
NULL	Front_Microbiol_2013_Feb_20_4_33.nxml.txt.nlp	23430312	SENT46	15	15	0	0	oxygen	COX	PA450744	1351	0.51
NULL	Mol_Cells_2014_Sep_30_37(9)_664-671.nxml.txt.nlp	25234467	SENT165	2	2	4	4	cisplatin	miR-217	PA449014	406999	0.51
NULL	Cardiovasc_Diabetol_2013_Mar_4_12_42.nxml.txt.nlp	23452502	SENT228	29	29	26	26	isoflurane	GLP1	PA450106	100125288;2641	0.51
NULL	Aging_(Albany_NY)_2010_Sep_18_2(9)_535-537.nxml.txt.nlp	20876940	SENT33	4	4	23	23	doxorubicin	CDKN1A	PA449412	1026	0.51
NULL	Curr_Control_Trials_Cardiovasc_Med_2001_May_31_2(3)_129-140.nxml.txt.nlp	11806786	SENT146	14	14	25	25	heparin	ACT	PA449855	12;11332;9457;641455	0.51
NULL	J_Vet_Pharmacol_Ther_2014_Oct_10_37(5)_421-434.nxml.txt.nlp	24611573	SENT441	9	9	19	19	ranitidine	CYP2D	PA451224	1565	0.51
NULL	Cell_Biol_Int_Rep_(2010)_2012_Jun_21_19(1)_e00017.nxml.txt.nlp	23124518	SENT150	17	17	13	13	etoposide	DR5	PA449552	8795	0.51
NULL	Iran_Red_Crescent_Med_J_2013_Jul_5_15(7)_541-546.nxml.txt.nlp	24396571	SENT115	30	30	6	6	propofol	Yes	PA451141	7525	0.51
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT275	10	10	6	6	glucose	EGFR	PA449773	1956	0.51
NULL	AIDS_Behav_2012_Feb_30_16(2)_396-403.nxml.txt.nlp	21190073	SENT164	16	16	25	25	methamphetamine	San	PA450403	80218	0.51
NULL	Cell_Biol_Int_Rep_(2010)_2012_Jun_21_19(1)_e00017.nxml.txt.nlp	23124518	SENT28	10	10	12	12	etoposide	TRAIL	PA449552	8743	0.51
NULL	Arch_Med_Sci_2011_Aug_2_7(4)_713-719.nxml.txt.nlp	22291810	SENT123	32	32	7	7	cyclosporine	IL-19	PA449167	29949	0.51
NULL	Chem_Cent_J_2014_May_7_8_32.nxml.txt.nlp	24883080	SENT107	20	20	9	9	benzaldehyde	mol	PA448571	90527	0.51
NULL	Cancers_(Basel)_2011_Sep_28_3(4)_3740-3761.nxml.txt.nlp	24213109	SENT97	0	0	16	16	hyaluronan	TLR2	PA165958431	7097	0.51
NULL	J_Appl_Genet_2014_Jan_11_55(2)_173-181.nxml.txt.nlp	24414975	SENT63	5	5	2	2	nadh	MT-ND3	PA164755085	4537	0.51
NULL	Gut_Liver_2011_Sep_18_5(3)_278-287.nxml.txt.nlp	21927654	SENT61	0	0	2	2	lamivudine	LAM	PA450163	7249;7248	0.51
NULL	J_Nat_Sci_Biol_Med_2011_Jul-Dec_2(2)_180-184.nxml.txt.nlp	22346232	SENT148	31	31	15	15	linezolid	SGB	PA450233	2719	0.51
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_39-54.nxml.txt.nlp	19305787	SENT239	7	7	0	0	ethanol	DARPP-32	PA448073	84152	0.51
NULL	Anesthesiol_Res_Pract_2011_Jul_12_2011_124898.nxml.txt.nlp	21776253	SENT172	14	14	23	23	bupivacaine	TRPV1	PA135057240	7442	0.51
NULL	Tuberc_Respir_Dis_(Seoul)_2013_Dec_24_75(6)_244-249.nxml.txt.nlp	24416055	SENT63	16	16	22	22	glucose	ADA	PA449773	100	0.51
NULL	ScientificWorldJournal_2012_Mar_12_2012_619080.nxml.txt.nlp	22536149	SENT35	38	38	6	6	copper	TEM	PA449114	64102	0.51
NULL	Biomed_Res_Int_2014_Jan_29_2014_361020.nxml.txt.nlp	24605326	SENT223	7	7	32	32	flavopiridol	CDK5	PA452627	1020	0.51
NULL	Cancer_Cell_Int_2004_Nov_21_4_7.nxml.txt.nlp	15555067	SENT147	11	11	24	24	collagenase	AAT	PA449107	5265	0.51
NULL	Contemp_Clin_Dent_2011_Oct-Dec_2(4)_278-282.nxml.txt.nlp	22346152	SENT81	4	4	21	21	potassium	GCF	PA451047	6936	0.51
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Dec_2_5_30.nxml.txt.nlp	17140452	SENT194	15	15	29	29	linezolid	CHL	PA450233	91851	0.51
NULL	Curr_Neuropharmacol_2010_Sep_8(3)_287-304.nxml.txt.nlp	21358978	SENT68	6	6	21	21	agomelatine	5-HT2C	PA165958363	3358	0.51
NULL	Emerg_Infect_Dis_2013_Jul_19(7)_1151-1152.nxml.txt.nlp	23763791	SENT19	42	42	19	19	ofloxacin	DST	PA450684	667	0.51
NULL	Cancer_Cell_Int_2011_Aug_19_11_29.nxml.txt.nlp	21854619	SENT42	24	24	17	17	cisplatin	BRCA1	PA449014	672	0.51
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1437-1448.nxml.txt.nlp	24056706	SENT111	14	14	16	16	sulfaphenazole	CYP2C9	PA130231310	1559	0.51
NULL	Antimicrob_Resist_Infect_Control_2012_Jan_26_1_1.nxml.txt.nlp	22958725	SENT172	2	2	0	0	cefotaxime	CTX	PA448852	1593	0.51
NULL	Diabetes_2009_Mar_58(3)_579-589.nxml.txt.nlp	19074989	SENT12	12	12	26	26	lipase	ANGPTL4	PA450239	51129	0.51
NULL	Breast_Cancer_Res_Treat_2013_Jun_30_139(2)_441-451.nxml.txt.nlp	23715630	SENT88	24	24	9	9	exemestane	HER2	PA449563	2064	0.51
NULL	Breast_Cancer_Res_2014_Jun_18_16(3)_212.nxml.txt.nlp	NULL	SENT141	20	20	14	14	raloxifene	LAS	PA451221	11019	0.51
NULL	Toxins_(Basel)_2010_Mar_31_2(4)_517-551.nxml.txt.nlp	22069598	SENT1522	0	0	6	6	resveratrol	SIRT1		23411	0.51
NULL	Hum_Mol_Genet_2011_Jan_1_20(1)_80-89.nxml.txt.nlp	20926450	SENT8	25	25	14	14	oxygen	p53	PA450744	7157	0.51
NULL	Cancers_(Basel)_2014_Apr_9_6(2)_829-859.nxml.txt.nlp	24722453	SENT1686	13	13	10	10	evodiamine	PC-3	PA165860788	692094	0.51
NULL	Biochimie_2014_Jan_96(100)_106-112.nxml.txt.nlp	23827855	SENT38	6	6	8	8	lipase	ATGL	PA450239	57104	0.51
NULL	Acta_Pharmacol_Sin_2010_Jan_21_31(1)_35-42.nxml.txt.nlp	20023693	SENT192	0	0	9	9	atorvastatin	p65	PA448500	5970	0.51
NULL	J_Exp_Med_1961_Oct_31_114(5)_761-778.nxml.txt.nlp	19867206	SENT1	9	9	12	12	nitrogen	FOR	PA450643	51741	0.51
NULL	Curr_Oncol_2009_Jul_16(Suppl_2)_S1-S13.nxml.txt.nlp	19672416	SENT301	21	21	0	0	anastrozole	ATAC	PA448432	6375	0.51
NULL	J_Biomed_Biotechnol_2010_Oct_4_2010_641025.nxml.txt.nlp	20976270	SENT92	6	6	16	16	thrombin	P18	PA451674	7975;10168	0.51
NULL	J_Korean_Med_Sci_2010_Jan_26_25(1)_110-116.nxml.txt.nlp	20054409	SENT165	37	37	12	12	cyclophosphamide	BCS	PA449165	617	0.51
NULL	Biomed_Eng_Online_2011_Dec_2_10_104.nxml.txt.nlp	22136408	SENT44	5	5	1	1	cisplatin	CFD	PA449014	1675	0.51
NULL	Case_Rep_Endocrinol_2013_Feb_20_2013_719304.nxml.txt.nlp	23509641	SENT31	13	13	11	11	thyroglobulin	TTF1	PA164754910	7080;7270	0.51
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT172	10	10	22	22	cisplatin	MDM2	PA449014	4193	0.51
NULL	Biologics_2009_Jul_13_3_225-232.nxml.txt.nlp	19707411	SENT157	8	8	2	2	methotrexate	CTX	PA450428	1593	0.51
NULL	Front_Mol_Neurosci_2013_Apr_11_6_8.nxml.txt.nlp	23596390	SENT311	12	12	14	14	vasopressin	AVP	PA451858	114548;551	0.51
NULL	Aging_(Albany_NY)_2013_May_23_5(5)_357-372.nxml.txt.nlp	23793469	SENT248	44	44	36	36	ethanol	CO2	PA448073	4513	0.51
NULL	Ann_Gen_Psychiatry_2010_Apr_22_9(Suppl_1)_S227.nxml.txt.nlp	NULL	SENT6	15	15	28	28	hydroxyzine	B12	PA449943	7126;4709	0.51
NULL	JRSM_Short_Rep_2011_Apr_6_2(4)_27.nxml.txt.nlp	21541075	SENT30	18	18	16	16	sevoflurane	CO2	PA451341	4513	0.51
NULL	Int_J_Mol_Sci_2013_Aug_14_14(8)_16719-16731.nxml.txt.nlp	23949634	SENT70	23	23	29	29	thrombin	TPC	PA451674	8030;60386	0.51
NULL	Cancer_Imaging_2005_Apr_13_5(1)_20-24.nxml.txt.nlp	16154814	SENT119	21	21	6	6	ethanol	FLASH	PA448073	9994	0.51
NULL	J_Asthma_Allergy_2008_Sep_19_1_19-29.nxml.txt.nlp	21436982	SENT118	0	0	14	14	fexofenadine	eotaxin	PA449621	6356	0.51
NULL	J_Vet_Med_Sci_2014_Feb_21_76(2)_219-227.nxml.txt.nlp	24141321	SENT101	5	5	17	17	ns-398	SON		6651	0.51
NULL	J_Exp_Bot_2012_May_29_63(8)_3229-3241.nxml.txt.nlp	22378948	SENT215	22	22	3	3	ethanol	DR5	PA448073	8795	0.51
NULL	Int_J_Mol_Sci_2014_Sep_1_15(9)_15475-15502.nxml.txt.nlp	25257526	SENT46	7	7	2	2	piperazine	MCHR1	PA450977	2847	0.51
NULL	Br_J_Cancer_2012_Nov_20_107(11)_1815-1819.nxml.txt.nlp	23099804	SENT33	5	5	1	1	tamoxifen	ATAC	PA451581	6375	0.51
NULL	Cell_J_2012_Dec_22_Winter_13(4)_265-274.nxml.txt.nlp	23507995	SENT246	3	3	6	6	ethanol	spatial	PA448073	219793	0.51
NULL	Breast_Cancer_Res_Treat_2014_Apr_9_145(1)_73-82.nxml.txt.nlp	24715380	SENT83	8	8	14	14	tamoxifen	CXCR3	PA451581	2833	0.51
NULL	Br_J_Cancer_2006_Feb_13_94(3)_407-426.nxml.txt.nlp	16434996	SENT218	7	7	10	10	genistein	BRCA1	PA165109660	672	0.51
NULL	Vet_Res_Forum_2013_Winter_4(1)_19-24.nxml.txt.nlp	25593681	SENT73	0	0	44	44	diclofenac	ANOVA	PA449293	4858	0.51
NULL	Mol_Cell_Endocrinol_2011_Jan_15_331(2)_194-204.nxml.txt.nlp	20688134	SENT889	23	23	29	29	cetrorelix	Yes	PA164764506	7525	0.51
NULL	Drugs_R_D_2013_Sep_28_13(3)_191-197.nxml.txt.nlp	23982688	SENT107	28	28	23	23	fluoxetine	Yes	PA449673	7525	0.51
NULL	Int_J_Biol_Sci_2013_Dec_22_10(1)_90-102.nxml.txt.nlp	24391455	SENT12	15	15	2	2	epirubicin	TRPM8	PA449476	79054	0.51
NULL	Nat_Med_2011_Nov_13_17(12)_1641-1645.nxml.txt.nlp	22081024	SENT40	10	10	12	12	paclitaxel	CRAF	PA450761	5894	0.51
NULL	Case_Rep_Oncol_2010_Jul_31_3(2)_282-286.nxml.txt.nlp	21347194	SENT41	21	21	25	25	bevacizumab	KRAS	PA130232992	3845	0.51
NULL	Breast_Cancer_(Auckl)_2011_Jul_27_5_175-199.nxml.txt.nlp	21863131	SENT372	24	24	13	13	fluorouracil	HER2	PA128406956	2064	0.51
NULL	FEBS_Open_Bio_2014_Jul_3_4_602-610.nxml.txt.nlp	25161868	SENT43	31	31	23	23	thrombin	VEGF-A	PA451674	7422	0.51
NULL	Curr_Med_Chem_2014_Jul_21_663-688.nxml.txt.nlp	24251566	SENT833	14	14	9	9	pilocarpine	ghrelin	PA450962	51738	0.51
NULL	Indian_J_Pharm_Sci_2012_Nov-Dec_74(6)_556-563.nxml.txt.nlp	23798782	SENT164	5	5	3	3	stavudine	FOR	PA451494	51741	0.51
NULL	Cancers_(Basel)_2010_Sep_9_2(3)_1661-1682.nxml.txt.nlp	24281180	SENT911	1	1	3	3	hyaluronan	CD44	PA165958431	960	0.51
NULL	Open_AIDS_J_2010_Jan_19_4_70-75.nxml.txt.nlp	20200604	SENT220	30	30	36	36	tenofovir	ATV	PA10204	4683	0.51
NULL	Ann_Oncol_2009_Aug_20(Suppl_6)_vi35-vi40.nxml.txt.nlp	19617296	SENT10	35	35	33	33	axitinib	VEGFR	PA164924493	3791	0.51
NULL	Mol_Neurodegener_2011_Jun_10_6_42.nxml.txt.nlp	21663635	SENT47	24	24	20	20	l-glutamine	B27	PA10090	56246	0.51
NULL	Cardiovasc_Diabetol_2010_Sep_23_9_57.nxml.txt.nlp	20863381	SENT3	7	7	21	21	pioglitazone	DM2	PA450970	28508	0.51
NULL	Cancer_Manag_Res_2012_Nov_9_4_383-395.nxml.txt.nlp	23204869	SENT100	21	21	4	4	carmustine	PC-3	PA448810	692094	0.51
NULL	Curr_Control_Trials_Cardiovasc_Med_2001_May_31_2(3)_129-140.nxml.txt.nlp	11806786	SENT160	33	33	28	28	abciximab	ACT	PA448006	12;11332;9457;641455	0.51
NULL	Diagn_Pathol_2013_Feb_16_8_26.nxml.txt.nlp	23414265	SENT23	16	16	5	5	thyroglobulin	CK19	PA164754910	3880	0.51
NULL	Evid_Based_Complement_Alternat_Med_2013_May_16_2013_857929.nxml.txt.nlp	23762164	SENT153	19	19	6	6	doxorubicin	p53	PA449412	7157	0.51
NULL	Neural_Plast_2012_May_20_2012_124548.nxml.txt.nlp	22685676	SENT50	5	5	1	1	minocycline	FMR1	PA450519	2332	0.51
NULL	Front_Genet_2012_May_30_3_94.nxml.txt.nlp	22666228	SENT1121	0	0	13	13	vorinostat	survivin	PA164748224	332	0.51
NULL	Pain_2013_Sep_154(9)_1680-1690.nxml.txt.nlp	23707289	SENT556	0	0	11	11	yohimbine	ANOVA	PA451946	4858	0.51
NULL	Int_J_Womens_Health_2012_Apr_12_4_167-174.nxml.txt.nlp	22532780	SENT164	10	10	0	0	ibandronate	HIP	PA10270	6767;6159;64399;5068	0.51
NULL	Cancer_Manag_Res_2012_Nov_9_4_383-395.nxml.txt.nlp	23204869	SENT149	22	22	4	4	carmustine	PC-3	PA448810	692094	0.51
NULL	J_Cardiothorac_Surg_2012_Sep_26_7_92.nxml.txt.nlp	23013526	SENT215	17	17	15	15	aprotinin	NAC	PA448472	22861	0.51
NULL	Nucleic_Acids_Res_2012_Jul_1_40(12)_5775-5786.nxml.txt.nlp	22383579	SENT259	7	7	10	10	theophylline	MS2	PA451647	101	0.51
NULL	Mol_Biol_Cell_2012_Jul_1_23(13)_2571-2582.nxml.txt.nlp	22573884	SENT113	11	11	14	14	dextran	EEA1	PA449261	8411	0.51
NULL	Gut_Liver_2013_Sep_14_7(5)_585-593.nxml.txt.nlp	24073317	SENT108	17	17	34	34	ribavirin	IFN	PA451241	3439	0.51
NULL	Brain_2008_Nov_22_131(11)_3072-3080.nxml.txt.nlp	18945724	SENT65	22	22	6	6	azathioprine	CD19	PA448515	930	0.51
NULL	Front_Endocrinol_(Lausanne)_2011_Dec_2_2_90.nxml.txt.nlp	22654832	SENT58	14	14	6	6	estradiol	ADX	PA449503	2230	0.51
NULL	Exp_Diabetes_Res_2007_Apr_12_2007_15803.nxml.txt.nlp	17641739	SENT59	5	5	3	3	gliclazide	STZ	PA10892	6484	0.51
NULL	Eur_J_Haematol_2008_Feb_80(2)_93-106.nxml.txt.nlp	18081719	SENT165	10	10	16	16	urea	AST	PA451831	26503	0.51
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT158	5	5	24	24	phenprocoumon	VKORC1	PA450921	79001	0.51
NULL	Viruses_2013_May_22_5(5)_1292-1324.nxml.txt.nlp	23698400	SENT225	36	36	16	16	ezetimibe	NPC1L1	PA10816	29881	0.51
NULL	Genome_Announc_2013_Mar_7_1(2)_e00073-13.nxml.txt.nlp	23516204	SENT8	10	10	12	12	ethanol	CO2	PA448073	4513	0.51
NULL	Breast_Cancer_Res_2008_Dec_5_10(6)_R104.nxml.txt.nlp	19061505	SENT301	29	29	31	31	diethylstilbestrol	DES	PA449307	1674	0.51
NULL	Cancers_(Basel)_2011_Sep_13_3(3)_3557-3584.nxml.txt.nlp	22163073	SENT281	2	2	22	22	ebselen	TRAIL	PA161660841	8743	0.51
NULL	Mol_Cell_Biochem_2014_Oct_9_385(1-2)_265-275.nxml.txt.nlp	24104452	SENT165	8	8	10	10	bortezomib	U87	PA10252	677775;641648	0.51
NULL	J_Cell_Mol_Med_2014_May_14_18(5)_811-823.nxml.txt.nlp	24628949	SENT162	8	8	5	5	docetaxel	FOXM1	PA449383	2305	0.51
NULL	Front_Neural_Circuits_2014_Jun_2_8_56.nxml.txt.nlp	24917791	SENT442	6	6	2	2	estradiol	activin	PA449503	83729	0.51
NULL	Cell_Mol_Life_Sci_2012_Dec_5_69(23)_3895-3909.nxml.txt.nlp	22562579	SENT105	17	17	7	7	tamoxifen	DES	PA451581	1674	0.51
NULL	Viruses_2014_Apr_14_6(4)_1715-1758.nxml.txt.nlp	24736215	SENT1962	8	8	20	20	staurosporine	CD4	PA165109623	920	0.51
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT192	39	39	30	30	afatinib	Yes	PA165981154	7525	0.51
NULL	Mol_Biol_Rep_2014_Mar_2_41(6)_4043-4051.nxml.txt.nlp	24584660	SENT72	9	9	16	16	paraformaldehyde	p65	PA450790	5970	0.51
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT128	21	21	3	3	verapamil	CYP2D6	PA451868	1565	0.51
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT173	8	8	1	1	pertuzumab	HER2		2064	0.51
NULL	ScientificWorldJournal_2012_Aug_13_2012_496453.nxml.txt.nlp	22927782	SENT170	20	20	17	17	exenatide	GLP-1	PA164749238	100125288	0.51
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jul_14_68(Pt_8)_o2450.nxml.txt.nlp	22904895	SENT4	12	12	20	20	phenol	mol	PA450913	90527	0.51
NULL	J_Cell_Biol_1997_Jun_30_137(7)_1639-1649.nxml.txt.nlp	9199177	SENT113	12	12	5	5	paraformaldehyde	ZAP-70	PA450790	7535	0.51
NULL	Arthritis_Res_Ther_2011_Feb_16_13(1)_R25.nxml.txt.nlp	21324169	SENT120	14	14	31	31	etanercept	TNF	PA449515	7124	0.51
NULL	Curr_Chem_Genomics_2009_May_28_3_22-32.nxml.txt.nlp	20161833	SENT189	17	17	13	13	estradiol	IL-2	PA449503	3558	0.51
NULL	Am_J_Trop_Med_Hyg_2012_Nov_7_87(5_Suppl)_21-29.nxml.txt.nlp	23136274	SENT323	2	2	0	0	artemisinin	ACT	PA165111696	12;11332;9457;641455	0.51
NULL	Alzheimers_Res_Ther_2013_Oct_24_5(5)_50.nxml.txt.nlp	24401551	SENT327	7	7	10	10	donepezil	spatial	PA449394	219793	0.51
NULL	Breast_Cancer_Res_2011_Apr_20_13(2)_307.nxml.txt.nlp	21575280	SENT31	29	29	39	39	tamoxifen	FOXA1	PA451581	3169	0.51
NULL	Br_J_Anaesth_2014_Jul_22_113(1)_157-167.nxml.txt.nlp	24154701	SENT53	21	21	18	18	sevoflurane	TREK-1	PA451341	3776	0.51
NULL	Mol_Cancer_2008_Mar_26_7_27.nxml.txt.nlp	18366759	SENT92	32	32	25	25	etoposide	p53	PA449552	7157	0.51
NULL	Curr_Neuropharmacol_2013_Jan_11(1)_102-108.nxml.txt.nlp	23814542	SENT225	14	14	24	24	simvastatin	Yes	PA451363	7525	0.51
NULL	Diabetes_2011_Jun_21_60(6)_1734-1742.nxml.txt.nlp	21498783	SENT298	11	11	13	13	lipase	PNPLA2	PA450239	57104	0.51
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Dec_6_65(Pt_1)_o39.nxml.txt.nlp	21581681	SENT61	22	22	7	7	nitrile	mol	PA450636	90527	0.51
NULL	J_Hematol_Oncol_2013_Mar_29_6_24.nxml.txt.nlp	23547827	SENT222	3	3	19	19	nadh	MT-ATP6	PA164755085	4508	0.51
NULL	Clin_Med_Insights_Case_Rep_2010_Sep_27_3_55-58.nxml.txt.nlp	21769255	SENT34	2	2	4	4	vasopressin	AVP	PA451858	114548;551	0.51
NULL	Afr_J_Infect_Dis_2011_5(2)_40-46.nxml.txt.nlp	23878706	SENT98	6	6	8	8	oxacillin	Gen	PA450725	348654	0.51
NULL	Calcif_Tissue_Int_2010_Dec_16_87(6)_485-492.nxml.txt.nlp	20953593	SENT11	5	5	23	23	teriparatide	PTH	PA451620	5741	0.51
NULL	J_Gen_Physiol_1994_Jan_1_103(1)_19-43.nxml.txt.nlp	8169596	SENT0	13	13	1	1	lidocaine	Gen	PA450226	348654	0.51
NULL	Biologics_2009_Oct_12_3_469-474.nxml.txt.nlp	19851472	SENT82	0	0	7	7	montelukast	IL-5	PA450546	3567	0.51
NULL	Front_Physiol_2011_Apr_12_2_13.nxml.txt.nlp	21559063	SENT2700	1	1	15	15	creatine	ADP	PA164778930	23038	0.51
NULL	Breast_Cancer_2013_Mar_1_20(4)_302-309.nxml.txt.nlp	23456736	SENT29	13	13	3	3	tegafur	DPD	PA452620	1806	0.51
NULL	J_Psychopharmacol_2014_Oct_28(10)_891-902.nxml.txt.nlp	25122043	SENT315	10	10	19	19	ondansetron	spatial	PA450705	219793	0.51
NULL	Head_Face_Med_2012_Feb_7_8_3.nxml.txt.nlp	22314195	SENT10	0	0	7	7	choline	FDG	PA448976	23583	0.51
NULL	J_Adv_Pract_Oncol_2013_Jul_1_Jul-Aug_4(4)_238-250.nxml.txt.nlp	25032004	SENT122	12	12	3	3	imatinib	CML	PA10804	613	0.51
NULL	Crit_Care_2011_Mar_11_15(Suppl_1)_P251.nxml.txt.nlp	NULL	SENT4	3	3	17	17	thrombin	PAR-1	PA451674	2011;2149	0.51
NULL	J_Clin_Biochem_Nutr_2010_Jan_29_46(1)_36-42.nxml.txt.nlp	20104263	SENT63	1	1	10	10	ribavirin	IFN	PA451241	3439	0.51
NULL	Curr_Med_Chem_2012_Sep_19(26)_4399-4413.nxml.txt.nlp	22830345	SENT237	28	28	9	9	rifampin	CYP3A4	PA451250	1576	0.51
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Jun_27_5_15.nxml.txt.nlp	16803618	SENT178	26	26	30	30	ciprofloxacin	CIP1	PA449009	1026;56996	0.51
NULL	Nat_Commun_2013_Nov_26_4_10_1038_ncomms3816.nxml.txt.nlp	24281383	SENT170	23	23	45	45	diazepam	S14	PA449283	5714;6208;7069	0.51
NULL	J_Ophthalmol_2012_Aug_27_2012_285851.nxml.txt.nlp	23050121	SENT126	16	16	12	12	latanoprost	BAK	PA164774763	578	0.51
NULL	ACS_Appl_Mater_Interfaces_2014_Feb_12_6(3)_1424-1438.nxml.txt.nlp	24397537	SENT42	17	17	12	12	l-glutamine	B27	PA10090	56246	0.51
NULL	Neuroimage_Clin_2013_Sep_3_3_242-248.nxml.txt.nlp	24273709	SENT294	2	2	4	4	carbamazepine	CLB	PA448785	171425	0.51
NULL	Diabetes_2014_Jan_13_63(1)_259-269.nxml.txt.nlp	24062244	SENT15	25	25	22	22	lipase	MODY8	PA450239	1056	0.51
NULL	Eur_J_Haematol_2014_Feb_25_92(2)_127-136.nxml.txt.nlp	24118452	SENT14	15	15	34	34	anagrelide	CRT	PA164742986	811	0.51
NULL	Ann_Oncol_2009_Aug_20(Suppl_6)_vi41-vi50.nxml.txt.nlp	19617297	SENT268	19	19	32	32	tamoxifen	IL-2	PA451581	3558	0.51
NULL	Adv_Ther_2014_Dec_2_31_1228-1246.nxml.txt.nlp	25447269	SENT136	28	28	25	25	timolol	TIM	PA451690	7984;8914	0.509
NULL	Aesthet_Surg_J_2013_Mar_33(3)_400-408.nxml.txt.nlp	23439063	SENT19	19	19	27	27	lipase	CD36	PA450239	948	0.509
NULL	Breast_Cancer_Res_2007_Nov_2_9(6)_R76.nxml.txt.nlp	17980029	SENT52	17	17	31	31	l-glutamine	CO2	PA10090	4513	0.509
NULL	Mol_Cancer_2009_Jul_31_8_57.nxml.txt.nlp	19646263	SENT18	7	7	21	21	staurosporine	IL-8	PA165109623	3576	0.509
NULL	Open_Cardiovasc_Med_J_2010_Dec_23_4_302-312.nxml.txt.nlp	21339899	SENT57	31	31	25	25	thrombin	ADP	PA451674	23038	0.509
NULL	J_Viral_Hepat_2007_Nov_14(11)_751-766.nxml.txt.nlp	17927611	SENT139	23	23	31	31	lamivudine	IFN	PA450163	3439	0.509
NULL	Breast_Cancer_(Auckl)_2011_Apr_27_5_67-72.nxml.txt.nlp	21603256	SENT105	7	7	9	9	cisplatin	TRAIL	PA449014	8743	0.509
NULL	Br_J_Cancer_2012_Oct_9_107(8)_1399-1408.nxml.txt.nlp	22976800	SENT11	0	0	27	27	temozolomide	MLH1	PA451609	4292	0.509
NULL	Front_Genet_2013_Aug_29_4_163.nxml.txt.nlp	24009622	SENT121	9	9	12	12	ethanol	DDP	PA448073	1678	0.509
NULL	Diabetes_2011_Jul_20_60(7)_1917-1925.nxml.txt.nlp	21593202	SENT130	9	9	22	22	troglitazone	adiponectin	PA451799	9370	0.509
NULL	J_Clin_Biochem_Nutr_2007_Nov_30_41(3)_224-230.nxml.txt.nlp	18299720	SENT215	31	31	39	39	urea	AST	PA451831	26503	0.509
NULL	Oncol_Lett_2013_Aug_29_6(2)_317-322.nxml.txt.nlp	24137323	SENT50	4	4	16	16	azacitidine	DAC	PA451996	13	0.509
NULL	Ann_Clin_Microbiol_Antimicrob_2009_Sep_24_8_26.nxml.txt.nlp	19778428	SENT102	30	30	4	4	erythromycin	PEN	PA449493	9933	0.509
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_6_2014_270930.nxml.txt.nlp	25431606	SENT258	0	0	25	25	curcumin	IL-6	PA151958596	3569	0.509
NULL	J_Immune_Based_Ther_Vaccines_2005_Sep_2_3_6.nxml.txt.nlp	16138929	SENT139	8	8	0	0	infliximab	ACR	PA452639	49	0.509
NULL	Curr_Neuropharmacol_2008_Sep_6(3)_193-202.nxml.txt.nlp	19506720	SENT352	14	14	5	5	venlafaxine	p75	PA451866	7133;11168	0.509
NULL	Ann_Maxillofac_Surg_2012_Jan-Jun_2(1)_90-93.nxml.txt.nlp	23483721	SENT62	14	14	0	0	daunorubicin	CHOP	PA449212	1649	0.509
NULL	J_Antimicrob_Chemother_2014_Apr_27_69(4)_907-910.nxml.txt.nlp	24284779	SENT73	9	9	11	11	oxacillin	BSAC	PA450725	57591	0.509
NULL	AMB_Express_2011_Oct_22_1_33.nxml.txt.nlp	22018139	SENT142	9	9	26	26	nadh	Hua	PA164755085	1994	0.509
NULL	Clinics_(Sao_Paulo)_2010_Dec_65(12)_1311-1314.nxml.txt.nlp	21340220	SENT96	10	10	7	7	tadalafil	BTC	PA10333	685	0.509
NULL	Interdiscip_Toxicol_2010_Dec_3(4)_122-126.nxml.txt.nlp	21331177	SENT19	0	0	16	16	carvedilol	CA1	PA448817	759	0.509
NULL	Cancers_(Basel)_2011_Nov_23_3(4)_4170-4190.nxml.txt.nlp	24213132	SENT655	1	1	15	15	flavopiridol	CDK4	PA452627	1019	0.509
NULL	J_Cell_Biol_1992_Apr_2_117(2)_383-393.nxml.txt.nlp	1313816	SENT9	22	22	29	29	forskolin	EGF	PA146096022	1950	0.509
NULL	Diabetes_2013_Oct_17_62(10)_3373-3383.nxml.txt.nlp	23835335	SENT299	21	21	12	12	glucose	POMC	PA449773	5443	0.509
NULL	Open_Allergy_J_2010_3_91-101.nxml.txt.nlp	25018787	SENT185	21	21	24	24	omalizumab	IL-13	PA164752253	3596	0.509
NULL	Acta_Neuropathol_2013_Sep_5_126(5)_741-756.nxml.txt.nlp	24005891	SENT138	8	8	0	0	pilocarpine	CTRL	PA450962	1506	0.509
NULL	Acta_Pharmacol_Sin_2012_Feb_3_33(2)_173-181.nxml.txt.nlp	22301857	SENT15	26	26	34	34	sibutramine	GLP	PA451344	342096	0.509
NULL	Cancer_Manag_Res_2012_Oct_11_4_357-365.nxml.txt.nlp	23091399	SENT117	4	4	22	22	hydroxychloroquine	San	PA164777036	80218	0.509
NULL	Mucosal_Immunol_2014_May_13_7(3)_730-740.nxml.txt.nlp	24220298	SENT109	18	18	28	28	papain	DR3	PA450778	8718	0.509
NULL	Diabetes_2009_Jan_58(1)_243-249.nxml.txt.nlp	18840785	SENT15	18	18	26	26	glucose	GLP-1	PA449773	100125288	0.509
NULL	Mol_Vis_2011_Oct_8_17_2634-2648.nxml.txt.nlp	22065916	SENT356	6	6	20	20	creatine	ADP	PA164778930	23038	0.509
NULL	J_Radiat_Res_2012_Jul_12_53(4)_551-557.nxml.txt.nlp	22843620	SENT142	2	2	2	2	pp2	PP2		4888	0.509
NULL	Exp_Diabetes_Res_2012_Jun_14_2012_859395.nxml.txt.nlp	22778716	SENT95	15	15	7	7	glucose	adiponectin	PA449773	9370	0.509
NULL	Cancers_(Basel)_2010_Apr_26_2(2)_693-712.nxml.txt.nlp	24281089	SENT860	21	21	12	12	temozolomide	San	PA451609	80218	0.509
NULL	Curr_HIV_Res_2014_May_12(3)_174-188.nxml.txt.nlp	24862327	SENT147	14	14	11	11	hemin	HO-1	PA449849	3162	0.509
NULL	Clin_Interv_Aging_2013_Aug_19_8_1089-1095.nxml.txt.nlp	23983461	SENT108	21	21	30	30	streptozocin	MT4	PA451514	84560	0.509
NULL	J_Vet_Med_Sci_2014_Aug_15_76(8)_1173-1176.nxml.txt.nlp	24829080	SENT48	27	27	41	41	sargramostim	GM-CSF	PA164748631	1437	0.509
NULL	Cerebrospinal_Fluid_Res_2009_Dec_11_6_16.nxml.txt.nlp	20003330	SENT131	10	10	1	1	dextran	MRI	PA449261	78996	0.509
NULL	ScientificWorldJournal_2012_Apr_19_2012_804730.nxml.txt.nlp	22606063	SENT161	40	40	18	18	tafluprost	BAK	PA165958432	578	0.509
NULL	Crit_Care_2008_Mar_13_12(Suppl_2)_P56.nxml.txt.nlp	NULL	SENT6	19	19	21	21	tobramycin	TOB	PA451704	10140	0.509
NULL	Evid_Based_Complement_Alternat_Med_2012_Aug_5_2012_396218.nxml.txt.nlp	22919412	SENT47	38	38	46	46	l-glutamine	CO2	PA10090	4513	0.509
NULL	Clin_Dev_Immunol_2011_Mar_22_2011_790460.nxml.txt.nlp	21603161	SENT421	0	0	7	7	thalidomide	OED	PA451644	4961	0.509
NULL	Clin_Ophthalmol_2011_Feb_11_5_167-170.nxml.txt.nlp	21383944	SENT0	23	23	19	19	ranibizumab	hole	PA164746012	80757	0.509
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Apr_22_67(Pt_5)_o1175-o1176.nxml.txt.nlp	21754480	SENT79	29	29	26	26	ethanol	mol	PA448073	90527	0.509
NULL	J_Antibiot_(Tokyo)_2012_Jun_11_65(6)_289-294.nxml.txt.nlp	22491136	SENT312	27	27	5	5	trypsin	L10	PA451806	6134	0.509
NULL	J_Cell_Biol_2008_Jul_14_182(1)_157-169.nxml.txt.nlp	18606851	SENT44	2	2	2	2	pp2	PP2		4888	0.509
NULL	Front_Neurosci_2014_Dec_5_8_398.nxml.txt.nlp	25538552	SENT581	0	0	12	12	oxygen	CA3	PA450744	761	0.509
NULL	J_Biol_2003_Apr_24_2(1)_7.nxml.txt.nlp	12733998	SENT100	19	19	16	16	forskolin	GGF	PA146096022	3084	0.509
NULL	Oncoscience_2014_Jun_19_1(7)_478-479.nxml.txt.nlp	25594047	SENT18	19	19	28	28	paclitaxel	P-gp	PA450761	5243	0.509
NULL	G3_(Bethesda)_2014_Sep_5_4(11)_2159-2165.nxml.txt.nlp	25193495	SENT268	13	13	5	5	urokinase	ACTB	PA451836	60	0.509
NULL	Curr_Gerontol_Geriatr_Res_2011_May_11_2011_624156.nxml.txt.nlp	21765826	SENT285	17	17	29	29	cyclosporine	CYP3A4	PA449167	1576	0.509
NULL	Subst_Abuse_Treat_Prev_Policy_2007_Oct_31_2_32.nxml.txt.nlp	17974020	SENT209	11	11	9	9	methamphetamine	NMU	PA450403	10874	0.509
NULL	Ann_Oncol_2013_Apr_31_24(4)_1067-1073.nxml.txt.nlp	23117073	SENT42	13	13	36	36	fosaprepitant	CYP3A4	PA165958390	1576	0.509
NULL	Surg_Neurol_Int_2013_Mar_25_4_35.nxml.txt.nlp	23607057	SENT124	6	6	20	20	temozolomide	END	PA451609	2022	0.509
NULL	Trials_2014_Feb_19_15_63.nxml.txt.nlp	24552184	SENT45	2	2	0	0	paclitaxel	PACT	PA450761	8575;5930	0.509
NULL	Nucleic_Acids_Res_2011_Mar_13_39(6)_2404-2415.nxml.txt.nlp	21076154	SENT80	18	18	39	39	thyroglobulin	B12	PA164754910	7126;4709	0.509
NULL	Brain_Sci_2014_May_6_4(2)_356-375.nxml.txt.nlp	24961766	SENT289	9	9	17	17	propofol	spatial	PA451141	219793	0.509
NULL	Cardiovasc_Ther_2009_27(4)_259-274.nxml.txt.nlp	19604248	SENT11	0	0	4	4	ticagrelor	IPA	PA165374673	3160	0.509
NULL	Front_Aging_Neurosci_2010_Feb_3_2_2.nxml.txt.nlp	20552042	SENT753	1	1	17	17	potassium	CA1	PA451047	759	0.509
NULL	Surg_Neurol_Int_2013_Mar_28_4_40.nxml.txt.nlp	23607062	SENT36	9	9	45	45	propofol	ERG	PA451141	2078	0.509
NULL	Endocrinol_Metab_(Seoul)_2014_Sep_25_29(3)_379-387.nxml.txt.nlp	25309798	SENT119	8	8	6	6	resveratrol	SIRT1		23411	0.509
NULL	Brain_Sci_2012_Dec_21_3(1)_1-38.nxml.txt.nlp	24961305	SENT990	1	1	7	7	ethanol	spatial	PA448073	219793	0.509
NULL	Front_Neurosci_2013_Dec_17_7_245.nxml.txt.nlp	24381538	SENT30	6	6	11	11	memantine	spatial	PA10364	219793	0.509
NULL	Mol_Brain_2014_Oct_4_7(1)_72.nxml.txt.nlp	NULL	SENT452	13	13	5	5	diazepam	ANOVA	PA449283	4858	0.509
NULL	Int_J_Mol_Sci_2014_Oct_14_15(10)_18557-18573.nxml.txt.nlp	25318057	SENT993	6	6	24	24	bortezomib	c-FLIP	PA10252	8837	0.509
NULL	Cells_2014_May_23_3(2)_517-545.nxml.txt.nlp	24861977	SENT878	10	10	12	12	capsaicin	TRPV1	PA448776	7442	0.509
NULL	Mol_Cancer_2006_Sep_5_5_34.nxml.txt.nlp	16953886	SENT151	24	24	7	7	gentamicin	F12	PA449753	2161	0.509
NULL	J_Breast_Cancer_2013_Sep_30_16(3)_291-299.nxml.txt.nlp	24155758	SENT201	10	10	0	0	mitomycin	FANCF	PA450524	2188	0.509
NULL	AIDS_Care_2011_Sep_14_23(9)_1154-1162.nxml.txt.nlp	21500025	SENT123	17	17	2	2	emtricitabine	ATV	PA10069	4683	0.509
NULL	ScientificWorldJournal_2013_Oct_1_2013_654829.nxml.txt.nlp	24198725	SENT300	9	9	15	15	naproxen	NF1	PA450595	4763	0.509
NULL	Acta_Pharmacol_Sin_2012_Jul_18_33(7)_861-872.nxml.txt.nlp	22705730	SENT141	0	0	7	7	atorvastatin	4E-BP1	PA448500	1978	0.509
NULL	J_Ophthalmic_Inflamm_Infect_2011_Nov_6_2(1)_21-28.nxml.txt.nlp	22057810	SENT81	17	17	13	13	infliximab	CTX	PA452639	1593	0.509
NULL	J_Oncol_2013_Feb_28_2013_897025.nxml.txt.nlp	23533410	SENT154	5	5	13	13	temsirolimus	MVD	PA164746890	4597	0.509
NULL	J_Biol_Chem_2012_Dec_14_287(51)_43094-43107.nxml.txt.nlp	23118219	SENT354	15	15	11	11	hyaluronan	CD44	PA165958431	960	0.509
NULL	Autophagy_2013_Sep_1_9(9)_1418-1430.nxml.txt.nlp	23748697	SENT292	16	16	13	13	glucose	STS	PA449773	412	0.509
NULL	Crit_Care_2011_Jun_24_15(3)_R153.nxml.txt.nlp	21702944	SENT37	10	10	42	42	l-glutamine	CO2	PA10090	4513	0.509
NULL	Int_J_Mol_Sci_2014_Mar_3_15(3)_3768-3783.nxml.txt.nlp	24595239	SENT449	14	14	10	10	hyaluronan	TSG-6	PA165958431	7130	0.509
NULL	J_Geriatr_Cardiol_2013_Jun_10(2)_151-158.nxml.txt.nlp	23888175	SENT4	38	38	15	15	rosuvastatin	ACE2	PA134308647	59272	0.509
NULL	Clin_Ophthalmol_2014_Jun_19_8_1179-1183.nxml.txt.nlp	24970996	SENT79	15	15	7	7	tafluprost	BAK	PA165958432	578	0.509
NULL	Evid_Based_Complement_Alternat_Med_2013_May_22_2013_921012.nxml.txt.nlp	23762167	SENT207	6	6	0	0	ethanol	STD	PA448073	7535	0.509
NULL	Cancer_Cell_Int_2008_Mar_18_8_3.nxml.txt.nlp	18348720	SENT81	38	38	15	15	gefitinib	EGF	PA131301952	1950	0.509
NULL	Breast_Cancer_2012_Oct_19_19(4)_302-308.nxml.txt.nlp	22711317	SENT59	6	6	32	32	estradiol	RANK	PA449503	8792	0.509
NULL	Mol_Cancer_2010_Jun_25_9_166.nxml.txt.nlp	20579378	SENT265	7	7	5	5	gefitinib	EGF	PA131301952	1950	0.509
NULL	Diabetes_2009_Aug_2_58(8)_1902-1913.nxml.txt.nlp	19491211	SENT186	8	8	12	12	fluorescein	P18	PA164746009	7975;10168	0.509
NULL	Int_Semin_Surg_Oncol_2007_Feb_14_4_5.nxml.txt.nlp	17394628	SENT15	35	35	21	21	cyclophosphamide	NACT	PA449165	284111	0.509
NULL	Front_Microbiol_2014_Oct_29_5_546.nxml.txt.nlp	25400622	SENT102	31	31	43	43	galactose	HBA	PA449725	85340	0.509
NULL	Exp_Ther_Med_2014_Mar_19_7(3)_669-674.nxml.txt.nlp	24520265	SENT29	6	6	8	8	bleomycin	BLM	PA448645	641	0.509
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT118	21	21	23	23	capsaicin	p53	PA448776	7157	0.509
NULL	Cancers_(Basel)_2010_Sep_9_2(3)_1661-1682.nxml.txt.nlp	24281180	SENT60	16	16	14	14	ethanol	IL-8	PA448073	3576	0.509
NULL	Mol_Cancer_2010_Apr_23_9_87.nxml.txt.nlp	20416058	SENT169	23	23	17	17	doxorubicin	TRAIL	PA449412	8743	0.509
NULL	Anal_Bioanal_Chem_2010_Aug_14_397(7)_2977-2986.nxml.txt.nlp	20549493	SENT52	14	14	31	31	estradiol	TRIM	PA449503	50852	0.509
NULL	Oncogene_2010_Sep_2_29(35)_4905-4913.nxml.txt.nlp	20581869	SENT253	2	2	8	8	paclitaxel	CA125	PA450761	4077;94025	0.509
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT569	1	1	14	14	chloroquine	BMPR-II	PA448948	659	0.509
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Feb_21_65(Pt_3)_o558.nxml.txt.nlp	21582216	SENT53	17	17	21	21	potassium	mol	PA451047	90527	0.509
NULL	Br_J_Cancer_2009_Mar_10_100(5)_680-683.nxml.txt.nlp	19223897	SENT7	24	24	7	7	trastuzumab	HER2	PA451743	2064	0.509
NULL	Interdiscip_Perspect_Infect_Dis_2013_Sep_12_2013_839456.nxml.txt.nlp	24163693	SENT25	11	11	22	22	vancomycin	VISA	PA451850	57506	0.509
NULL	Clin_Med_Insights_Circ_Respir_Pulm_Med_2013_Nov_13_7_61-77.nxml.txt.nlp	24324354	SENT226	24	24	10	10	tobramycin	TIP	PA451704	81533;79828	0.509
NULL	Oncol_Lett_2014_Jul_12_8(1)_117-122.nxml.txt.nlp	24959230	SENT146	14	14	0	0	fluorescein	DAC	PA164746009	13	0.509
NULL	Gut_Liver_2013_Sep_14_7(5)_552-559.nxml.txt.nlp	24073313	SENT122	19	19	16	16	heparin	EGFR	PA449855	1956	0.509
NULL	Oncol_Lett_2014_Aug_19_8(2)_620-626.nxml.txt.nlp	25013476	SENT41	0	0	10	10	fluorescein	CD80	PA164746009	941	0.509
NULL	Afr_J_Infect_Dis_2011_5(2)_40-46.nxml.txt.nlp	23878706	SENT88	10	10	8	8	gentamicin	Gen	PA449753	348654	0.509
NULL	Indian_J_Pharmacol_2014_Sep-Oct_46(5)_549-550.nxml.txt.nlp	25298588	SENT17	0	0	32	32	warfarin	VKORC1	PA451906	79001	0.509
NULL	J_Int_Soc_Sports_Nutr_2014_Jun_14_11_29.nxml.txt.nlp	25006332	SENT159	41	41	23	23	estradiol	HSD5	PA449503	6060	0.509
NULL	Mol_Brain_2014_Sep_4_7(1)_69.nxml.txt.nlp	NULL	SENT157	0	0	16	16	sevoflurane	CXCL10	PA451341	3627	0.509
NULL	Scientifica_(Cairo)_2012_Jul_8_2012_128382.nxml.txt.nlp	24278667	SENT168	22	22	20	20	ribavirin	IFN	PA451241	3439	0.509
NULL	J_Med_Case_Rep_2013_May_31_7_144.nxml.txt.nlp	23724918	SENT15	16	16	13	13	l-carnitine	NAC	PA450154	22861	0.509
NULL	Biochem_Res_Int_2012_Feb_22_2012_979351.nxml.txt.nlp	22461983	SENT97	10	10	47	47	collagenase	CO2	PA449107	4513	0.509
NULL	Arthritis_Res_2002_Jul_26_4(5)_R9.nxml.txt.nlp	12223112	SENT62	0	0	4	4	fluorescein	CD40	PA164746009	958	0.509
NULL	Brain_Sci_2013_Jun_14_3(2)_941-963.nxml.txt.nlp	24961432	SENT812	3	3	6	6	ethanol	TLR2	PA448073	7097	0.509
NULL	Nat_Commun_2013_Apr_23_4_1758.nxml.txt.nlp	23612299	SENT81	4	4	17	17	guanidine	SOD1	PA164781028	6647	0.509
NULL	Support_Care_Cancer_2014_Oct_19_22(2)_469-477.nxml.txt.nlp	24141698	SENT156	22	22	11	11	palonosetron	HEC	PA10352	10403	0.509
NULL	Summit_on_Translat_Bioinforma_2009_Mar_1_2009_124-128.nxml.txt.nlp	21347183	SENT69	34	34	26	26	azathioprine	TPMT	PA448515	7172	0.509
NULL	Arthritis_Res_Ther_2005_Oct_29_7(1)_R1-R11.nxml.txt.nlp	15642129	SENT150	44	44	12	12	estradiol	ANOVA	PA449503	4858	0.509
NULL	Front_Endocrinol_(Lausanne)_2011_Dec_6_2_93.nxml.txt.nlp	22654833	SENT1354	13	13	11	11	troglitazone	gamma	PA451799	9913	0.509
NULL	J_Adv_Pract_Oncol_2014_Mar_1_Mar-Apr_5(2)_134-139.nxml.txt.nlp	25032047	SENT45	8	8	10	10	trastuzumab	DM1	PA451743	338023;1760;28509	0.509
NULL	Breast_Cancer_Res_2001_Apr_2_3(4)_253-263.nxml.txt.nlp	11434876	SENT171	35	35	0	0	tamoxifen	ADM	PA451581	133	0.509
NULL	Appl_Microbiol_Biotechnol_2012_May_13_94(4)_875-886.nxml.txt.nlp	22526790	SENT58	7	7	5	5	ethanol	mol	PA448073	90527	0.509
NULL	Braz_J_Med_Biol_Res_2014_Apr_4_47(5)_411-418.nxml.txt.nlp	24820225	SENT174	4	4	28	28	prazosin	p38	PA451093	10598;1432;7965	0.509
NULL	J_Exp_Med_2000_Nov_20_192(10)_1479-1490.nxml.txt.nlp	11085749	SENT39	37	37	27	27	streptomycin	BRL	PA451512	23774	0.509
NULL	Arthritis_Res_Ther_2012_Jun_7_14(3)_R137.nxml.txt.nlp	22676399	SENT64	8	8	21	21	trypsin	San	PA451806	80218	0.509
NULL	Cancer_Cell_Int_2013_Apr_16_13_36.nxml.txt.nlp	23590596	SENT118	26	26	18	18	doxorubicin	TRAIL	PA449412	8743	0.509
NULL	Brain_Sci_2013_Jun_14_3(2)_941-963.nxml.txt.nlp	24961432	SENT729	1	1	4	4	ethanol	Rho	PA448073	29984	0.509
NULL	Allergy_Asthma_Immunol_Res_2010_Jan_30_2(1)_1-13.nxml.txt.nlp	20224672	SENT78	15	15	35	35	budesonide	DPI	PA448681	1832	0.509
NULL	AIDS_Care_2011_Sep_14_23(9)_1154-1162.nxml.txt.nlp	21500025	SENT76	8	8	2	2	efavirenz	ATV	PA449441	4683	0.509
NULL	J_Gen_Physiol_2012_Jun_139(6)_479-491.nxml.txt.nlp	22585969	SENT187	27	27	43	43	nadh	ADP	PA164755085	23038	0.509
NULL	Leukemia_2013_Feb_3_27(2)_315-324.nxml.txt.nlp	22751450	SENT143	2	2	20	20	sorafenib	Mcl-1	PA7000	4170	0.509
NULL	Endocrinol_Metab_(Seoul)_2014_Sep_25_29(3)_379-387.nxml.txt.nlp	25309798	SENT186	10	10	7	7	resveratrol	SIRT1		23411	0.509
NULL	J_Gen_Physiol_2008_Nov_132(5)_521-535.nxml.txt.nlp	18852303	SENT90	2	2	0	0	trypsin	CAP2	PA451806	5271;10486	0.509
NULL	Cardiovasc_Res_2011_Feb_15_89(3)_604-613.nxml.txt.nlp	21088116	SENT157	14	14	14	14	pp2	PP2		4888	0.509
NULL	J_Korean_Med_Sci_2010_Aug_21_25(8)_1222-1227.nxml.txt.nlp	20676337	SENT54	26	26	34	34	propofol	ANOVA	PA451141	4858	0.509
NULL	Patient_Prefer_Adherence_2014_Apr_8_8_463-471.nxml.txt.nlp	24748775	SENT124	13	13	22	22	denosumab	GFR	PA166048634	9771	0.509
NULL	J_Korean_Med_Sci_2005_Aug_31_20(4)_548-554.nxml.txt.nlp	16100442	SENT34	42	42	10	10	streptomycin	BRL	PA451512	23774	0.509
NULL	Biologics_2009_Oct_12_3_469-474.nxml.txt.nlp	19851472	SENT83	19	19	36	36	montelukast	IL-5	PA450546	3567	0.508
NULL	Front_Oncol_2014_May_15_4_112.nxml.txt.nlp	24860788	SENT312	3	3	6	6	imatinib	p190	PA10804	8506	0.508
NULL	J_Anim_Sci_Biotechnol_2013_Feb_27_4(1)_7.nxml.txt.nlp	23445937	SENT42	22	22	8	8	urea	CO2	PA451831	4513	0.508
NULL	Eur_J_Appl_Physiol_2011_Feb_24_111(2)_275-283.nxml.txt.nlp	20865425	SENT57	14	14	22	22	glucose	MRS	PA449773	8011	0.508
NULL	Environ_Health_Perspect_2007_Jul_5_115(7)_1094-1100.nxml.txt.nlp	17637928	SENT159	13	13	8	8	staurosporine	JNK	PA165109623	5599	0.508
NULL	J_Ophthalmol_2012_Aug_27_2012_285851.nxml.txt.nlp	23050121	SENT126	16	16	19	19	latanoprost	BAK	PA164774763	578	0.508
NULL	Breast_Cancer_Res_2012_Mar_14_14(2)_R46.nxml.txt.nlp	22417870	SENT197	13	13	15	15	trastuzumab	HER2	PA451743	2064	0.508
NULL	FEBS_Open_Bio_2013_Aug_19_3_379-386.nxml.txt.nlp	24251099	SENT179	13	13	3	3	nadh	ADP	PA164755085	23038	0.508
NULL	Exp_Ther_Med_2013_Jul_15_6(1)_275-279.nxml.txt.nlp	23935760	SENT157	12	12	8	8	parecoxib	COX	PA166049193	1351	0.508
NULL	Exp_Diabetes_Res_2012_Oct_26_2012_820989.nxml.txt.nlp	22110480	SENT27	19	19	21	21	rosiglitazone	LYRM1	PA451283	57149	0.508
NULL	ScientificWorldJournal_2013_Apr_18_2013_219840.nxml.txt.nlp	23690738	SENT262	32	32	30	30	taurine	NAC	PA451590	22861	0.508
NULL	J_Breast_Cancer_2012_Sep_28_15(3)_273-282.nxml.txt.nlp	23091539	SENT63	7	7	4	4	doxycycline	TRAIL	PA449415	8743	0.508
NULL	Depress_Res_Treat_2011_Jul_26_2011_531435.nxml.txt.nlp	21808731	SENT203	5	5	7	7	alprazolam	5-HT1A	PA448333	3350	0.508
NULL	Diabetes_Care_2011_Oct_15_34(10)_2323-2328.nxml.txt.nlp	21949223	SENT181	11	11	9	9	metformin	adiponectin	PA450395	9370	0.508
NULL	F1000_Med_Rep_2010_May_24_2_40.nxml.txt.nlp	20948844	SENT35	6	6	26	26	thrombin	APC	PA451674	324	0.508
NULL	Diabetes_Metab_Syndr_Obes_2009_May_5_2_11-21.nxml.txt.nlp	21437115	SENT34	20	20	42	42	pravastatin	B18	PA451089	59271;4713	0.508
NULL	Arthritis_Res_Ther_2005_Oct_29_7(1)_R1-R11.nxml.txt.nlp	15642129	SENT150	30	30	12	12	estradiol	ANOVA	PA449503	4858	0.508
NULL	Biomed_Res_Int_2013_Jun_13_2013_493643.nxml.txt.nlp	23841073	SENT149	3	3	5	5	estradiol	ACTH	PA449503	5443	0.508
NULL	Br_J_Cancer_2011_Sep_27_105(7)_1030-1038.nxml.txt.nlp	21863025	SENT119	8	8	4	4	saracatinib	COPA		1314	0.508
NULL	J_Vis_Exp_2011_Aug_4_(54)_2644.nxml.txt.nlp	21847079	SENT16	24	24	28	28	l-glutamine	EGF	PA10090	1950	0.508
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_May_20_65(Pt_6)_o1322-o1323.nxml.txt.nlp	21583178	SENT7	14	14	3	3	coumarin	mol	PA134521193	90527	0.508
NULL	Br_J_Cancer_2013_Jul_23_109(2)_502-511.nxml.txt.nlp	23799850	SENT43	16	16	18	18	gemcitabine	PSN1	PA449748	51251	0.508
NULL	J_Ophthalmic_Inflamm_Infect_2011_Nov_6_2(1)_21-28.nxml.txt.nlp	22057810	SENT92	8	8	13	13	azathioprine	CTX	PA448515	1593	0.508
NULL	Oncol_Lett_2013_May_22_5(5)_1653-1655.nxml.txt.nlp	23760305	SENT56	20	20	22	22	thyroglobulin	TTF-1	PA164754910	7080	0.508
NULL	Indian_J_Crit_Care_Med_2012_Jul-Sep_16(3)_136-140.nxml.txt.nlp	23188953	SENT74	7	7	9	9	ceftazidime	CTX	PA448861	1593	0.508
NULL	Int_J_Cell_Biol_2014_Jan_22_2014_709828.nxml.txt.nlp	24578708	SENT112	18	18	30	30	l-serine	PSS2	PA451330	81490	0.508
NULL	Orthop_Rev_(Pavia)_2014_Sep_18_6(3)_5405.nxml.txt.nlp	25317308	SENT40	8	8	14	14	acetaminophen	PRN	PA448015	64428	0.508
NULL	Cancer_Microenviron_2009_Sep_26_2(Suppl_1)_19-204.nxml.txt.nlp	NULL	SENT2221	13	13	11	11	thrombin	PAR1	PA451674	79581;2149	0.508
NULL	J_Eval_Clin_Pract_2014_Feb_7_20(1)_94-99.nxml.txt.nlp	24118607	SENT124	38	38	20	20	amoxicillin	PCAP	PA448406	7834;51380	0.508
NULL	Sci_Rep_2014_Dec_19_4_7571.nxml.txt.nlp	25524368	SENT313	9	9	13	13	estradiol	mer	PA449503	10461	0.508
NULL	Mol_Biol_Cell_2012_Nov_1_23(21)_4212-4225.nxml.txt.nlp	22956765	SENT169	11	11	0	0	thrombin	SHP2	PA451674	5781	0.508
NULL	Oncol_Lett_2013_Feb_22_5(2)_641-644.nxml.txt.nlp	23419988	SENT120	23	23	15	15	paclitaxel	CT10	PA450761	51438	0.508
NULL	Pediatr_Gastroenterol_Hepatol_Nutr_2013_Mar_31_16(1)_53-60.nxml.txt.nlp	24010107	SENT106	12	12	10	10	infliximab	EEN	PA452639	6455	0.508
NULL	J_Cell_Biol_2001_Oct_29_155(3)_427-438.nxml.txt.nlp	11673478	SENT271	17	17	15	15	pp2	PP1		5540;5464	0.508
NULL	Thorax_2010_Sep_65(9)_775-781.nxml.txt.nlp	20805170	SENT92	6	6	0	0	budesonide	BDP	PA448681	10620;152926	0.508
NULL	J_Carcinog_2011_Nov_30_10_28.nxml.txt.nlp	22190870	SENT150	11	11	17	17	trastuzumab	EGFR	PA451743	1956	0.508
NULL	Channels_(Austin)_2010_Jan_1_4(1)_22-41.nxml.txt.nlp	19934650	SENT391	8	8	6	6	quinidine	Slo3	PA451209	157855	0.508
NULL	Case_Rep_Med_2010_Aug_16_2010_436739.nxml.txt.nlp	20814558	SENT24	35	35	20	20	lipase	gamma	PA450239	9913	0.508
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT1706	21	21	23	23	atazanavir	ATV	PA10251	4683	0.508
NULL	Diabetes_Care_2011_Dec_14_34(12)_2591-2593.nxml.txt.nlp	21994425	SENT124	12	12	8	8	nadh	ND6	PA164755085	4541	0.508
NULL	Eur_J_Clin_Pharmacol_2009_Dec_16_65(12)_1211-1228.nxml.txt.nlp	19756557	SENT159	16	16	3	3	infliximab	ACT	PA452639	12;11332;9457;641455	0.508
NULL	Ann_Dermatol_2013_Aug_13_25(3)_368-370.nxml.txt.nlp	24003284	SENT35	3	3	15	15	ustekinumab	AD3	PA166048654	11138	0.508
NULL	Exp_Lung_Res_2009_Jun_9_35(5)_411-426.nxml.txt.nlp	19842842	SENT179	0	0	2	2	simvastatin	GATA6	PA451363	2627	0.508
NULL	Oxid_Med_Cell_Longev_2013_Nov_24_2013_971024.nxml.txt.nlp	24371505	SENT151	19	19	15	15	ribavirin	IFN	PA451241	3439	0.508
NULL	Br_J_Cancer_2004_Mar_22_90(6)_1285-1292.nxml.txt.nlp	15026814	SENT206	14	14	12	12	doxorubicin	p53	PA449412	7157	0.508
NULL	Am_J_Physiol_Cell_Physiol_2014_Jan_15_306(2)_C89-C97.nxml.txt.nlp	24133067	SENT190	9	9	11	11	docetaxel	PC-3	PA449383	692094	0.508
NULL	Eur_J_Nucl_Med_Mol_Imaging_2005_Feb_4_32(2)_153-162.nxml.txt.nlp	15690223	SENT38	16	16	10	10	imatinib	FDG	PA10804	23583	0.508
NULL	Mol_Cancer_2014_Jun_27_13_159.nxml.txt.nlp	24972933	SENT99	11	11	14	14	rituximab	CTRL	PA451261	1506	0.508
NULL	Comp_Hepatol_2004_Jan_14_3(Suppl_1)_S31.nxml.txt.nlp	14960183	SENT33	12	12	23	23	ethanol	TNF-alpha	PA448073	7124	0.508
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT38	35	35	21	21	glucose	FBS	PA449773	64319;26269	0.508
NULL	Oncotarget_2014_Nov_12_5(20)_9626-9640.nxml.txt.nlp	25275299	SENT82	24	24	22	22	thrombin	LPA	PA451674	4018	0.508
NULL	Curr_Oncol_2009_Jul_16(Suppl_2)_S1-S13.nxml.txt.nlp	19672416	SENT301	42	42	0	0	exemestane	ATAC	PA449563	6375	0.508
NULL	Oncologist_2010_Mar_3_15(3)_216-235.nxml.txt.nlp	20200040	SENT104	15	15	17	17	maytansine	DM1	PA165291473	338023;1760;28509	0.508
NULL	ISRN_Neurosci_2013_Jul_17_2013_253210.nxml.txt.nlp	24967306	SENT122	1	1	9	9	naltrexone	ANOVA	PA450588	4858	0.508
NULL	Case_Rep_Hematol_2013_Sep_5_2013_708489.nxml.txt.nlp	24083040	SENT68	13	13	10	10	iron	B12	PA450087	7126;4709	0.508
NULL	Br_J_Pharmacol_2011_Jul_163(6)_1263-1275.nxml.txt.nlp	21391977	SENT227	16	16	14	14	ketoconazole	CYP3A4	PA450146	1576	0.508
NULL	Diabetes_Care_2009_Nov_32(Suppl_2)_S342-S348.nxml.txt.nlp	19875578	SENT42	42	42	23	23	metformin	MEMO	PA450395	51072	0.508
NULL	Oncotarget_2014_Aug_19_5(18)_8737-8749.nxml.txt.nlp	25228590	SENT196	4	4	13	13	crizotinib	PI3K	PA165946122	5290	0.508
NULL	Front_Neurol_2013_Jun_20_4_77.nxml.txt.nlp	23801984	SENT598	5	5	18	18	ketamine	gamma	PA450144	9913	0.508
NULL	Arthritis_Res_Ther_2011_Aug_26_13(4)_R136.nxml.txt.nlp	21871094	SENT179	34	34	21	21	anakinra	HMGB1	PA10799	3146	0.508
NULL	Clin_Med_Insights_Oncol_2012_Dec_6_6_407-421.nxml.txt.nlp	23239933	SENT213	16	16	2	2	carboplatin	GEM	PA448803	2669	0.508
NULL	Ann_Rheum_Dis_2008_Nov_14_67(11)_1516-1523.nxml.txt.nlp	18625622	SENT213	22	22	0	0	tocilizumab	ACR	PA165292659	49	0.508
NULL	Cancer_Nanotechnol_2015_Jan_24_6_1.nxml.txt.nlp	25642297	SENT190	8	8	10	10	vinorelbine	GM-CSF	PA451881	1437	0.508
NULL	J_Cancer_2013_Aug_28_4(7)_585-596.nxml.txt.nlp	24069069	SENT217	12	12	14	14	gemcitabine	Gem	PA449748	51053	0.508
NULL	Iran_Red_Crescent_Med_J_2012_Dec_6_14(12)_782-786.nxml.txt.nlp	23483042	SENT37	13	13	20	20	vancomycin	VISA	PA451850	57506	0.508
NULL	Neuroimage_Clin_2013_Sep_3_3_242-248.nxml.txt.nlp	24273709	SENT294	10	10	24	24	levetiracetam	PRG	PA450206	5544	0.508
NULL	Int_J_Endocrinol_2010_Aug_29_2010_481326.nxml.txt.nlp	20871656	SENT25	16	16	38	38	glucose	MPG	PA449773	4350	0.508
NULL	Core_Evid_2009_Jun_15_4_25-36.nxml.txt.nlp	20694062	SENT325	30	30	13	13	probenecid	ACTH	PA451106	5443	0.508
NULL	Breast_Cancer_Res_2009_Jul_28_11(4)_R54.nxml.txt.nlp	19638208	SENT164	15	15	21	21	estradiol	aromatase	PA449503	1588	0.508
NULL	ScientificWorldJournal_2012_May_2_2012_982594.nxml.txt.nlp	22645500	SENT87	9	9	7	7	nadh	mol	PA164755085	90527	0.508
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT184	10	10	12	12	erlotinib	CYP3A	PA134687924	1574	0.508
NULL	Environ_Health_Perspect_2004_Nov_21_112(15)_1544-1549.nxml.txt.nlp	15531440	SENT50	26	26	22	22	estradiol	DES	PA449503	1674	0.508
NULL	Acta_Pharmacol_Sin_2012_May_26_33(5)_668-674.nxml.txt.nlp	22447223	SENT30	7	7	20	20	resveratrol	RANKL		8600	0.508
NULL	Curr_Oncol_2009_Jul_16(Suppl_2)_S14-S23.nxml.txt.nlp	19672417	SENT212	25	25	0	0	exemestane	ATAC	PA449563	6375	0.508
NULL	Fibrogenesis_Tissue_Repair_2012_Jul_23_5_11.nxml.txt.nlp	22824096	SENT148	3	3	8	8	bleomycin	CD19	PA448645	930	0.508
NULL	Cancer_Cell_Int_2008_Apr_29_8_4.nxml.txt.nlp	18442416	SENT198	0	0	13	13	trypsin	Ku86	PA451806	7520	0.508
NULL	Mol_Vis_2012_May_1_18_1115-1122.nxml.txt.nlp	22605923	SENT119	13	13	15	15	estradiol	p38	PA449503	10598;1432;7965	0.508
NULL	Breast_Cancer_Res_2007_Aug_8_9(4)_R50.nxml.txt.nlp	17686159	SENT177	0	0	8	8	gefitinib	HRG	PA131301952	3084;3273	0.508
NULL	CNS_Drugs_2014_Feb_7_28(3)_185-193.nxml.txt.nlp	24504829	SENT25	26	26	33	33	choline	DAG	PA448976	1605	0.508
NULL	Case_Rep_Gastroenterol_2011_Oct_7_5(3)_610-616.nxml.txt.nlp	22110423	SENT12	9	9	4	4	mesalazine	DLST	PA450384	1743	0.508
NULL	Tanaffos_2013_12(1)_6-15.nxml.txt.nlp	25191444	SENT59	7	7	10	10	clarithromycin	PTH	PA449028	5741	0.508
NULL	Biomed_Res_Int_2013_Oct_1_2013_403151.nxml.txt.nlp	24195069	SENT144	36	36	12	12	ribavirin	Yes	PA451241	7525	0.508
NULL	Nat_Commun_2011_May_24_2_326.nxml.txt.nlp	21610729	SENT59	11	11	19	19	l-tyrosine	TYR	PA451822	7299	0.508
NULL	Curr_Gerontol_Geriatr_Res_2011_May_11_2011_624156.nxml.txt.nlp	21765826	SENT285	26	26	29	29	antipyrine	CYP3A4	PA448453	1576	0.508
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT115	20	20	22	22	doxorubicin	B7-H1	PA449412	29126	0.508
NULL	AIDS_Care_2011_Sep_14_23(9)_1154-1162.nxml.txt.nlp	21500025	SENT123	21	21	2	2	lopinavir	ATV	PA450264	4683	0.508
NULL	J_Biol_Chem_2013_Apr_26_288(17)_11865-11876.nxml.txt.nlp	23449983	SENT270	19	19	8	8	vanillin	CXCL12	PA451852	6387	0.508
NULL	Iran_Red_Crescent_Med_J_2011_Feb_1_13(2)_80-98.nxml.txt.nlp	22737441	SENT317	27	27	14	14	tazarotene	CD44	PA164746821	960	0.508
NULL	Core_Evid_2011_Jan_6_6_13-21.nxml.txt.nlp	21468239	SENT31	45	45	37	37	mitoxantrone	IFN	PA450526	3439	0.508
NULL	Curr_Hepat_Rep_2010_May_21_9(2)_75-90.nxml.txt.nlp	20461127	SENT319	0	0	2	2	lamivudine	LAM	PA450163	7249;7248	0.508
NULL	Subst_Abuse_Treat_Prev_Policy_2009_Apr_17_4_6.nxml.txt.nlp	19374740	SENT48	26	26	37	37	buprenorphine	OST	PA448685	1650;23263	0.508
NULL	Adv_Appl_Bioinform_Chem_2012_Sep_6_5_61-79.nxml.txt.nlp	23055752	SENT205	8	8	6	6	trypsin	CDK2	PA451806	1017	0.508
NULL	Mol_Med_Rep_2015_Jan_21_11(1)_212-218.nxml.txt.nlp	25333745	SENT66	5	5	9	9	trypsin	ADAM10	PA451806	102	0.508
NULL	J_Asthma_Allergy_2013_Feb_22_6_31-39.nxml.txt.nlp	23459334	SENT98	14	14	35	35	rupatadine	ANOVA		4858	0.508
NULL	Curr_Opin_Allergy_Clin_Immunol_2014_Oct_28_14(5)_397-403.nxml.txt.nlp	25115682	SENT121	33	33	22	22	montelukast	IL-13	PA450546	3596	0.508
NULL	Case_Rep_Rheumatol_2012_Dec_24_2012_270315.nxml.txt.nlp	23424706	SENT85	9	9	5	5	tocilizumab	IL-8	PA165292659	3576	0.508
NULL	Oncotarget_2010_Oct_25_1(7)_497-514.nxml.txt.nlp	21165163	SENT85	10	10	22	22	gefitinib	EGFR	PA131301952	1956	0.508
NULL	Diabetes_Care_2013_Aug_17_36(Suppl_2)_S162-S174.nxml.txt.nlp	23882042	SENT343	6	6	20	20	pioglitazone	adiponectin	PA450970	9370	0.508
NULL	Viruses_2009_Aug_11_1(2)_126-143.nxml.txt.nlp	21994542	SENT240	13	13	11	11	pioglitazone	PPARgamma	PA450970	5468	0.508
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT351	21	21	26	26	sertindole	PRL	PA164784002	5617	0.508
NULL	Case_Rep_Pathol_2013_Feb_21_2013_687427.nxml.txt.nlp	23533895	SENT104	11	11	5	5	thyroglobulin	CD10	PA164754910	4311	0.508
NULL	J_Hematol_Oncol_2011_Mar_26_4_11.nxml.txt.nlp	21439076	SENT117	22	22	1	1	camptothecin	Gem	PA153590860	51053	0.508
NULL	Indian_J_Psychiatry_2012_Oct-Dec_54(4)_394.nxml.txt.nlp	23372255	SENT11	26	26	37	37	trihexyphenidyl	B12	PA164747026	7126;4709	0.508
NULL	Ann_Gen_Psychiatry_2011_Mar_24_10_8.nxml.txt.nlp	21435226	SENT201	9	9	3	3	carbamazepine	Gen	PA448785	348654	0.508
NULL	Clin_Med_Insights_Oncol_2012_Feb_28_6_125-135.nxml.txt.nlp	22408376	SENT18	17	17	15	15	cetuximab	EGFR	PA10040	1956	0.508
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT57	14	14	45	45	mitomycin	ASC	PA450524	29108	0.508
NULL	Autoimmune_Dis_2012_Dec_27_2012_236981.nxml.txt.nlp	22242199	SENT97	3	3	5	5	thyroglobulin	ZFAT	PA164754910	57623	0.508
NULL	Toxins_(Basel)_2010_Oct_28_2(11)_2584-2592.nxml.txt.nlp	22069565	SENT110	10	10	7	7	warfarin	CYP2D6	PA451906	1565	0.508
NULL	Anesth_Essays_Res_2014_Sep-Dec_8(3)_393-396.nxml.txt.nlp	NULL	SENT45	19	19	40	40	isoflurane	CO2	PA450106	4513	0.508
NULL	Environ_Health_Perspect_2010_Mar_23_118(3)_427-431.nxml.txt.nlp	20194071	SENT95	13	13	25	25	ethanol	IL-6	PA448073	3569	0.508
NULL	Arch_Med_Sci_2013_Aug_30_9(4)_724-730.nxml.txt.nlp	24049536	SENT89	13	13	11	11	genistein	PTH	PA165109660	5741	0.508
NULL	Adv_Ther_2014_Dec_2_31_1228-1246.nxml.txt.nlp	25447269	SENT199	19	19	23	23	tafluprost	TIM	PA165958432	7984;8914	0.508
NULL	Adv_Ther_2014_Dec_2_31_1228-1246.nxml.txt.nlp	25447269	SENT140	36	36	40	40	tafluprost	TIM	PA165958432	7984;8914	0.508
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT7	12	12	19	19	gefitinib	KRAS	PA131301952	3845	0.508
NULL	J_Immunother_Cancer_2014_Jan_27_2_2.nxml.txt.nlp	24829759	SENT102	5	5	3	3	sorafenib	IL-21	PA7000	59067;50616;27189	0.508
NULL	Mol_Biol_Rep_2013_Sep_28_40(10)_5573-5585.nxml.txt.nlp	24078156	SENT327	4	4	9	9	iron	IREG1	PA450087	30061	0.507
NULL	Braz_J_Microbiol_2011_Jun_1_Apr-Jun_42(2)_470-475.nxml.txt.nlp	24031657	SENT1	20	20	39	39	oxacillin	San	PA450725	80218	0.507
NULL	Int_J_Mol_Sci_2014_Mar_6_15(3)_4088-4103.nxml.txt.nlp	24663083	SENT46	12	12	0	0	l-arginine	PRMT1	PA448478	3276	0.507
NULL	Evid_Based_Complement_Alternat_Med_2013_Aug_13_2013_569160.nxml.txt.nlp	23997795	SENT132	33	33	6	6	paraformaldehyde	ADP	PA450790	23038	0.507
NULL	J_Exp_Clin_Cancer_Res_2009_Feb_13_28(1)_17.nxml.txt.nlp	19216775	SENT7	19	19	45	45	cisplatin	TP53	PA449014	7157	0.507
NULL	CNS_Drugs_2014_May_1_28(6)_497-511.nxml.txt.nlp	24788672	SENT103	21	21	0	0	methylphenidate	ATX	PA450464	5168;23049	0.507
NULL	J_Nutr_Metab_2012_Apr_10_2012_431574.nxml.txt.nlp	22570769	SENT156	6	6	4	4	sertraline	TPH2	PA451333	6999;121278	0.507
NULL	F1000Res_2014_Aug_19_3_198.nxml.txt.nlp	25400908	SENT524	22	22	41	41	tamoxifen	IMPACT	PA451581	55364	0.507
NULL	Biochimie_2010_Nov_92(11)_1546-1567.nxml.txt.nlp	20615447	SENT28	29	29	27	27	trypsin	KLK1	PA451806	3816	0.507
NULL	Crit_Care_2012_Mar_2_16(2)_R37.nxml.txt.nlp	22386062	SENT50	12	12	38	38	oxygen	SAPS	PA450744	8935	0.507
NULL	Mult_Scler_Int_2013_Nov_7_2013_151427.nxml.txt.nlp	24312732	SENT158	40	40	11	11	methylprednisolone	PLP	PA450466	25824;5744	0.507
NULL	Carcinogenesis_2010_Dec_27_31(12)_2049-2057.nxml.txt.nlp	20876285	SENT178	4	4	25	25	tamoxifen	HER2	PA451581	2064	0.507
NULL	J_Biol_Chem_2008_Nov_7_283(45)_31005-31011.nxml.txt.nlp	18765663	SENT166	5	5	16	16	baclofen	CA1	PA448533	759	0.507
NULL	Libyan_J_Med_2006_Sep_19_1(2)_176-184.nxml.txt.nlp	21526016	SENT94	31	31	5	5	vildagliptin	GLP-1	PA165958346	100125288	0.507
NULL	Int_J_Nanomedicine_2009_Apr_20_4_99-105.nxml.txt.nlp	19516888	SENT74	22	22	20	20	paclitaxel	castor	PA450761	54897	0.507
NULL	An_Bras_Dermatol_2013_Jul-Aug_88(4)_600-603.nxml.txt.nlp	24068132	SENT15	14	14	21	21	adalimumab	por	PA10004	64840	0.507
NULL	Oncologist_2010_Nov_4_15(11)_1135-1146.nxml.txt.nlp	21051659	SENT152	20	20	28	28	sunitinib	IFN	PA162372840	3439	0.507
NULL	Oxid_Med_Cell_Longev_2013_Feb_24_2013_375893.nxml.txt.nlp	23533689	SENT59	22	22	43	43	gentamicin	CO2	PA449753	4513	0.507
NULL	Int_J_Gen_Med_2009_Jul_30_2_129-140.nxml.txt.nlp	20360896	SENT163	24	24	19	19	anastrozole	ATAC	PA448432	6375	0.507
NULL	Case_Rep_Hematol_2012_Oct_2_2012_620967.nxml.txt.nlp	23082258	SENT56	10	10	36	36	ponatinib	FGFR1	PA165980594	2260	0.507
NULL	Cancers_(Basel)_2010_Sep_9_2(3)_1661-1682.nxml.txt.nlp	24281180	SENT1076	16	16	3	3	collagenase	CD147	PA449107	682	0.507
NULL	Oncotarget_2013_Nov_19_5(2)_309-325.nxml.txt.nlp	24525395	SENT80	0	0	9	9	flavopiridol	XIAP	PA452627	331	0.507
NULL	J_Cell_Biol_2002_Nov_25_159(4)_637-648.nxml.txt.nlp	12438416	SENT81	20	20	5	5	staurosporine	GM130	PA165109623	2801	0.507
NULL	Clin_Med_Insights_Circ_Respir_Pulm_Med_2013_Nov_13_7_61-77.nxml.txt.nlp	24324354	SENT293	14	14	6	6	colistin	DPI	PA164760862	1832	0.507
NULL	Pharm_Pract_(Granada)_2011_Mar_15_Jan-Mar_9(1)_1-10.nxml.txt.nlp	25132883	SENT162	15	15	19	19	rivaroxaban	SPAF	PA165958360	166378	0.507
NULL	ScientificWorldJournal_2013_Feb_13_2013_292687.nxml.txt.nlp	23476127	SENT244	0	0	12	12	dexmedetomidine	Bcl-2	PA449256	596	0.507
NULL	Core_Evid_2012_Sep_27_7_105-114.nxml.txt.nlp	23055948	SENT187	27	27	29	29	icatibant	C1-INH	PA164749185	710	0.507
NULL	J_Gen_Physiol_1991_May_1_97(5)_913-947.nxml.txt.nlp	1650812	SENT5	20	20	10	10	tetracaine	gamma	PA451638	9913	0.507
NULL	Orphanet_J_Rare_Dis_2007_Jan_4_2_1.nxml.txt.nlp	17204147	SENT89	6	6	8	8	trypsin	SPINK1	PA451806	6690	0.507
NULL	Breast_Cancer_Res_Treat_2013_Jan_6_137(1)_167-174.nxml.txt.nlp	23129173	SENT40	17	17	30	30	letrozole	aromatase	PA450196	1588	0.507
NULL	Ecol_Evol_2013_Aug_3_3(8)_2670-2683.nxml.txt.nlp	24567831	SENT88	16	16	21	21	nadh	ND1	PA164755085	4535;10625	0.507
NULL	Int_J_Vasc_Med_2012_Jul_24_2012_508416.nxml.txt.nlp	22888436	SENT163	16	16	42	42	rosiglitazone	PRIP	PA451283	23054;5334	0.507
NULL	Biol_Open_2014_Nov_21_3(12)_1207-1216.nxml.txt.nlp	25416063	SENT239	15	15	19	19	zinc	NANOS2	PA451956	339345	0.507
NULL	Biomed_Res_Int_2014_Jun_26_2014_161346.nxml.txt.nlp	25054130	SENT26	6	6	34	34	curcumin	JNK	PA151958596	5599	0.507
NULL	Ann_Rheum_Dis_2008_Oct_1_68(6)_930-937.nxml.txt.nlp	18829616	SENT126	7	7	21	21	adalimumab	ACR	PA10004	49	0.507
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT195	33	33	30	30	sitagliptin	HIP	PA164748978	6767;6159;64399;5068	0.507
NULL	Ann_Biomed_Eng_2009_Jul_8_37(7)_1294-1309.nxml.txt.nlp	19353268	SENT926	8	8	12	12	verapamil	HERG	PA451868	3757	0.507
NULL	Am_J_Rhinol_Allergy_2012_Jan-Feb_26(1)_1-6.nxml.txt.nlp	22391065	SENT267	11	11	15	15	oxygen	JNK	PA450744	5599	0.507
NULL	Ann_Indian_Acad_Neurol_2011_Jan-Mar_14(1)_50-52.nxml.txt.nlp	21655207	SENT98	10	10	6	6	modafinil	KLS	PA450530	6199	0.507
NULL	Cell_Cycle_2013_Sep_15_12(18)_3013-3024.nxml.txt.nlp	23974104	SENT157	12	12	22	22	doxorubicin	CD24	PA449412	100133941	0.507
NULL	J_Exerc_Nutrition_Biochem_2014_Sep_17_18(3)_267-275.nxml.txt.nlp	25566463	SENT29	16	16	13	13	creatine	ADP	PA164778930	23038	0.507
NULL	Braz_J_Med_Biol_Res_2013_Mar_15_46(3)_270-277.nxml.txt.nlp	23532271	SENT81	4	4	0	0	lipase	ATGL	PA450239	57104	0.507
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT105	15	15	28	28	imatinib	ABCG2	PA10804	9429	0.507
NULL	Ann_Oncol_2011_Jan_13_22(1)_215-223.nxml.txt.nlp	20627875	SENT132	8	8	18	18	ifosfamide	DAC	PA449964	13	0.507
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT192	41	41	46	46	erlotinib	Yes	PA134687924	7525	0.507
NULL	Evid_Based_Complement_Alternat_Med_2014_Oct_30_2014_143782.nxml.txt.nlp	25530774	SENT35	12	12	24	24	napqi	LPO		4025	0.507
NULL	Arthritis_Res_Ther_2004_Feb_5_6(1)_28-38.nxml.txt.nlp	14979930	SENT27	38	38	25	25	paraformaldehyde	San	PA450790	80218	0.507
NULL	Sci_Rep_2014_Dec_19_4_7571.nxml.txt.nlp	25524368	SENT322	7	7	18	18	estradiol	mer	PA449503	10461	0.507
NULL	Mol_Cell_Biochem_2014_Oct_9_385(1-2)_265-275.nxml.txt.nlp	24104452	SENT152	6	6	14	14	bortezomib	U87	PA10252	677775;641648	0.507
NULL	J_Korean_Neurosurg_Soc_2013_Oct_31_54(4)_309-316.nxml.txt.nlp	24294454	SENT178	21	21	26	26	vincristine	IFN	PA451879	3439	0.507
NULL	Emerg_Infect_Dis_2011_Mar_17(3)_395-402.nxml.txt.nlp	21392429	SENT256	4	4	12	12	cyclophosphamide	EMB	PA449165	133418	0.507
NULL	Breast_Cancer_Res_2004_Apr_7_6(4)_R275-R283.nxml.txt.nlp	15217493	SENT225	16	16	2	2	doxorubicin	IFN	PA449412	3439	0.507
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT168	32	32	12	12	methotrexate	MSH2	PA450428	4436	0.507
NULL	Iran_J_Pharm_Res_2014_Winter_13(1)_253-262.nxml.txt.nlp	24734078	SENT14	0	0	14	14	propofol	LPO	PA451141	4025	0.507
NULL	Cardiovasc_Diabetol_2011_Aug_10_10_75.nxml.txt.nlp	21831292	SENT40	0	0	7	7	desipramine	STZ	PA449233	6484	0.507
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT7	0	0	37	37	curcumin	DR5	PA151958596	8795	0.507
NULL	Eur_J_Dent_2012_Apr_6(2)_133-140.nxml.txt.nlp	22509115	SENT197	27	27	23	23	ethanol	HEMA	PA448073	2157	0.507
NULL	Basic_Res_Cardiol_2015_Jan_20_110_4.nxml.txt.nlp	25600226	SENT337	26	26	3	3	atorvastatin	PCSK9	PA448500	255738	0.507
NULL	Cell_Regen_(Lond)_2012_Jun_28_1(1)_3.nxml.txt.nlp	25408866	SENT166	13	13	27	27	oxygen	MSC	PA450744	9242	0.507
NULL	Cancer_Causes_Control_2013_Aug_18_24(8)_1605-1614.nxml.txt.nlp	23775025	SENT64	3	3	45	45	cyclophosphamide	ABCB1	PA449165	5243	0.507
NULL	Indian_J_Endocrinol_Metab_2013_May-Jun_17(3)_524-528.nxml.txt.nlp	23869316	SENT38	15	15	28	28	thyroglobulin	AC3	PA164754910	109	0.507
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT192	31	31	47	47	trastuzumab	Yes	PA451743	7525	0.507
NULL	Clin_Med_Insights_Oncol_2011_Mar_16_5_35-43.nxml.txt.nlp	21499557	SENT269	4	4	23	23	trabectedin	IFF	PA165958349	3456	0.507
NULL	Oncol_Lett_2013_Dec_9_6(6)_1656-1662.nxml.txt.nlp	24260060	SENT196	20	20	0	0	fluorescein	RIZ1	PA164746009	7799	0.507
NULL	J_Hematol_Oncol_2009_Apr_22_2_18.nxml.txt.nlp	19386128	SENT68	22	22	2	2	cetuximab	KRAS	PA10040	3845	0.507
NULL	Int_J_Endocrinol_2010_Aug_29_2010_481326.nxml.txt.nlp	20871656	SENT32	22	22	18	18	glucose	MPG	PA449773	4350	0.507
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT140	28	28	19	19	vinorelbine	MVP	PA451881	9961	0.507
NULL	Exp_Ther_Med_2013_Jan_22_5(1)_247-252.nxml.txt.nlp	23251277	SENT90	28	28	25	25	alendronate	GAPDH	PA448082	2597	0.507
NULL	Diabetes_2011_Jul_20_60(7)_1917-1925.nxml.txt.nlp	21593202	SENT130	9	9	32	32	troglitazone	DPP4	PA451799	1803	0.507
NULL	Evid_Based_Complement_Alternat_Med_2013_May_28_2013_629750.nxml.txt.nlp	23781265	SENT184	8	8	11	11	capsaicin	PERK	PA448776	9451	0.507
NULL	J_Skin_Cancer_2011_Nov_17_2011_423239.nxml.txt.nlp	22175026	SENT89	25	25	23	23	sorafenib	BRAF	PA7000	673	0.507
NULL	Chin_J_Cancer_2012_Aug_31(8)_373-380.nxml.txt.nlp	22739266	SENT123	16	16	10	10	cytarabine	XRCC3	PA449177	7517	0.507
NULL	Indian_J_Psychiatry_2010_Jan_52(Suppl1)_S317-S340.nxml.txt.nlp	21836703	SENT115	17	17	8	8	thiothixene	TFP	PA451669	7034	0.507
NULL	Front_Pharmacol_2014_Dec_10_5_271.nxml.txt.nlp	25540621	SENT185	17	17	19	19	bleomycin	BLM	PA448645	641	0.507
NULL	J_Infect_Dis_2012_Oct_1_206(7)_1138-1148.nxml.txt.nlp	22837490	SENT119	9	9	7	7	phenol	PSM	PA450913	2346	0.507
NULL	Apoptosis_2014_Aug_26_19(11)_1603-1615.nxml.txt.nlp	25156145	SENT273	2	2	0	0	mitomycin	TRAIL	PA450524	8743	0.507
NULL	Clin_Ophthalmol_2009_Oct_19_3_559-566.nxml.txt.nlp	19898628	SENT125	17	17	15	15	azathioprine	IFN	PA448515	3439	0.507
NULL	CNS_Drugs_2013_Aug_23_27(11)_943-953.nxml.txt.nlp	23975660	SENT164	14	14	10	10	guanfacine	ATX	PA449825	5168;23049	0.507
NULL	Mol_Biol_Cell_2013_Jun_1_24(11)_1700-1712.nxml.txt.nlp	23576545	SENT279	6	6	1	1	dextran	DGK	PA449261	8526;1607	0.507
NULL	J_Immunol_Res_2014_Feb_3_2014_671431.nxml.txt.nlp	24741615	SENT241	16	16	32	32	paraformaldehyde	CD7	PA450790	924	0.507
NULL	Cases_J_2009_Mar_10_2_6464.nxml.txt.nlp	20181162	SENT20	30	30	19	19	ribavirin	IFN	PA451241	3439	0.507
NULL	J_Infect_Chemother_2013_Jun_15_19(3)_381-392.nxml.txt.nlp	23673473	SENT263	8	8	16	16	voriconazole	CYP2C19	PA10233	1557	0.507
NULL	Mol_Biol_Cell_2013_Jul_15_24(14)_2186-2200.nxml.txt.nlp	23699397	SENT91	33	33	10	10	doxorubicin	TRAIL	PA449412	8743	0.507
NULL	Exp_Ther_Med_2013_Oct_30_6(4)_1015-1021.nxml.txt.nlp	24137308	SENT4	18	18	4	4	urokinase	BCS	PA451836	617	0.507
NULL	J_Exp_Bot_2012_Mar_15_63(5)_1969-1983.nxml.txt.nlp	22174442	SENT80	43	43	14	14	nitroprusside	San	PA451406	80218	0.507
NULL	Mol_Cancer_2014_Feb_24_13_35.nxml.txt.nlp	24565101	SENT127	10	10	5	5	doxorubicin	TAK1	PA449412	7182	0.507
NULL	Cancer_Cell_Int_2010_May_11_10_16.nxml.txt.nlp	20459793	SENT85	2	2	9	9	cisplatin	ABCC6	PA449014	368	0.507
NULL	Apoptosis_2012_Jun_9_17(6)_566-578.nxml.txt.nlp	22402981	SENT166	39	39	22	22	pp2	PP2		4888	0.507
NULL	Indian_J_Pharm_Sci_2013_May-Jun_75(3)_302-309.nxml.txt.nlp	24082346	SENT184	4	4	9	9	diclofenac	SRMS	PA449293	6725	0.507
NULL	Lab_Invest_2014_May_10_94(5)_503-516.nxml.txt.nlp	24614199	SENT186	0	0	12	12	curcumin	RAGE	PA151958596	177	0.507
NULL	Thorax_2012_Sep_11_67(9)_796-803.nxml.txt.nlp	22496351	SENT163	16	16	5	5	bleomycin	TRAIL	PA448645	8743	0.507
NULL	Cancer_Causes_Control_2013_Aug_18_24(8)_1605-1614.nxml.txt.nlp	23775025	SENT64	25	25	6	6	methotrexate	CYP1B1	PA450428	1545	0.507
NULL	Clin_Ophthalmol_2014_Apr_28_8_807-812.nxml.txt.nlp	24812486	SENT101	22	22	13	13	bevacizumab	CRT	PA130232992	811	0.507
NULL	J_Cell_Biol_2002_Oct_28_159(2)_291-302.nxml.txt.nlp	12391024	SENT198	7	7	12	12	vasopressin	AVP	PA451858	114548;551	0.507
NULL	J_Vis_Exp_2011_Jun_24_(52)_3094.nxml.txt.nlp	21730945	SENT111	17	17	41	41	amikacin	EMB	PA164744372	133418	0.507
NULL	Gut_2014_Apr_16_63(4)_552-558.nxml.txt.nlp	23856153	SENT217	20	20	1	1	esomeprazole	Gen	PA10075	348654	0.507
NULL	Front_Psychol_2014_Aug_26_5_950.nxml.txt.nlp	25206349	SENT834	3	3	10	10	yohimbine	NPY	PA451946	4852	0.507
NULL	Arthritis_Res_Ther_2014_May_28_16(3)_R117.nxml.txt.nlp	24887071	SENT84	25	25	29	29	fluorescein	IL-17A	PA164746009	3605	0.507
NULL	Inflamm_Res_2012_Dec_17_61(12)_1395-1404.nxml.txt.nlp	22899279	SENT285	4	4	14	14	gentamicin	TNF-alpha	PA449753	7124	0.507
NULL	J_Invest_Dermatol_2012_Sep_17_132(9)_2148-2157.nxml.txt.nlp	22592159	SENT4	24	24	18	18	heparin	AREG	PA449855	374	0.507
NULL	Int_J_Vasc_Med_2012_Jul_24_2012_508416.nxml.txt.nlp	22888436	SENT163	38	38	42	42	farglitazar	PRIP		23054;5334	0.507
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_P64.nxml.txt.nlp	NULL	SENT19	16	16	31	31	cefuroxime	PPL	PA448868	5493	0.507
NULL	Cancer_Cell_Int_2008_Jan_4_8_1.nxml.txt.nlp	18177496	SENT42	4	4	8	8	gefitinib	EWS	PA131301952	2130	0.507
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT275	11	11	9	9	resveratrol	ROS		6098	0.507
NULL	Clin_Med_Insights_Oncol_2013_Jul_28_7_165-172.nxml.txt.nlp	23926442	SENT43	29	29	15	15	fluorescein	CD19	PA164746009	930	0.507
NULL	Curr_Neuropharmacol_2008_Sep_6(3)_193-202.nxml.txt.nlp	19506720	SENT352	11	11	5	5	carbamazepine	p75	PA448785	7133;11168	0.507
NULL	Mol_Vis_2012_Nov_12_18_2687-2699.nxml.txt.nlp	23170061	SENT43	3	3	8	8	nadh	ND6	PA164755085	4541	0.507
NULL	Carcinogenesis_2010_Dec_27_31(12)_2049-2057.nxml.txt.nlp	20876285	SENT157	13	13	3	3	phenol	HER2	PA450913	2064	0.507
NULL	Br_J_Cancer_2010_Jun_29_103(1)_61-72.nxml.txt.nlp	20588279	SENT126	12	12	34	34	phenol	EGF	PA450913	1950	0.507
NULL	CNS_Drugs_2013_Jun_26_27(9)_743-751.nxml.txt.nlp	23801529	SENT119	21	21	28	28	lisdexamfetamine	NNT	PA164748975	23530	0.507
NULL	Nat_Neurosci_2012_Sep_5_15(9)_1245-1254.nxml.txt.nlp	22864611	SENT103	7	7	15	15	clozapine	mGlu3	PA449061	2913	0.507
NULL	Neurobiol_Aging_2013_Dec_34(12)_2889_e5-2889_e9.nxml.txt.nlp	23664753	SENT94	17	17	38	38	levodopa	TDP-43	PA450213	23435	0.507
NULL	Clinicoecon_Outcomes_Res_2014_Sep_23_6_409-414.nxml.txt.nlp	25285019	SENT143	16	16	2	2	lopinavir	ATV	PA450264	4683	0.507
NULL	Indian_J_Sex_Transm_Dis_2013_Jul-Dec_34(2)_77-82.nxml.txt.nlp	24339456	SENT124	21	21	10	10	cidofovir	CO2	PA448997	4513	0.507
NULL	Clinics_(Sao_Paulo)_2010_Mar_65(3)_285-290.nxml.txt.nlp	20360919	SENT39	11	11	9	9	phenol	mol	PA450913	90527	0.507
NULL	Arch_Med_Sci_2012_Nov_9_8(5)_899-906.nxml.txt.nlp	23185202	SENT147	13	13	20	20	pioglitazone	ADN	PA450970	1675	0.507
NULL	Mol_Cancer_2012_Sep_6_11_63.nxml.txt.nlp	22954255	SENT189	5	5	7	7	choline	B12	PA448976	7126;4709	0.507
NULL	Curr_Genomics_2013_Nov_14(7)_453-467.nxml.txt.nlp	24396277	SENT159	21	21	11	11	iron	PCSK7	PA450087	9159	0.507
NULL	Neuroscience_2008_Aug_13_155(2)_556-564.nxml.txt.nlp	18619738	SENT370	2	2	0	0	choline	CDP	PA448976	1523	0.507
NULL	Gut_Pathog_2014_Jul_29_6_33.nxml.txt.nlp	25110521	SENT268	0	0	11	11	fluorescein	CD11c	PA164746009	3687	0.507
NULL	Allergy_Asthma_Immunol_Res_2014_Mar_13_6(2)_156-162.nxml.txt.nlp	24587953	SENT157	21	21	9	9	celecoxib	AAP	PA448871	5345	0.507
NULL	Int_J_Nanomedicine_2007_Jun_2(2)_265-274.nxml.txt.nlp	17722554	SENT176	3	3	38	38	collagenase	spatial	PA449107	219793	0.507
NULL	Oncol_Lett_2014_Oct_22_8(4)_1603-1607.nxml.txt.nlp	25202376	SENT130	25	25	39	39	cisplatin	XRCC1	PA449014	7515	0.507
NULL	Eur_J_Endocrinol_2013_Apr_168(4)_557-564.nxml.txt.nlp	23345197	SENT80	13	13	28	28	diazoxide	HNF4A	PA449285	3172	0.507
NULL	Leukemia_2014_Jun_25_28(6)_1280-1288.nxml.txt.nlp	24270737	SENT105	13	13	30	30	decitabine	CTLA4	PA164749631	1493	0.506
NULL	Endocr_Connect_2012_Jun_8_1(1)_1-12.nxml.txt.nlp	23781298	SENT190	0	0	3	3	fenofibrate	adiponectin	PA449594	9370	0.506
NULL	J_Biol_Chem_2009_Jan_9_284(2)_784-791.nxml.txt.nlp	19008230	SENT204	16	16	19	19	isoproterenol	CO2	PA450121	4513	0.506
NULL	J_Cell_Biol_2000_Jan_10_148(1)_203-216.nxml.txt.nlp	10629229	SENT83	16	16	36	36	paraformaldehyde	cadherin	PA450790	1015	0.506
NULL	Evid_Based_Complement_Alternat_Med_2011_May_10_2011_523596.nxml.txt.nlp	21660305	SENT40	27	27	44	44	l-glutamine	CO2	PA10090	4513	0.506
NULL	Eur_J_Clin_Pharmacol_2012_May_21_68(5)_553-560.nxml.txt.nlp	22189672	SENT42	26	26	13	13	alprazolam	CYP2D6	PA448333	1565	0.506
NULL	Neural_Regen_Res_2014_Nov_1_9(21)_1897-1901.nxml.txt.nlp	25558239	SENT110	17	17	10	10	diazepam	CA1	PA449283	759	0.506
NULL	Can_J_Anaesth_2012_Jun_31_59(6)_516-521.nxml.txt.nlp	22467068	SENT132	13	13	8	8	atorvastatin	STAR	PA448500	6770;2984	0.506
NULL	Cancer_Cell_2007_Dec_11_12(6)_514-527.nxml.txt.nlp	18068629	SENT346	9	9	11	11	cisplatin	HMGB1	PA449014	3146	0.506
NULL	AIDS_Res_Ther_2011_Oct_6_8_36.nxml.txt.nlp	21978457	SENT122	3	3	18	18	zinc	TNF	PA451956	7124	0.506
NULL	J_Gen_Physiol_2009_Apr_133(4)_421-438.nxml.txt.nlp	19289574	SENT267	14	14	24	24	forskolin	SLC26A9	PA146096022	115019	0.506
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1051.nxml.txt.nlp	24503543	SENT144	12	12	15	15	sunitinib	Yes	PA162372840	7525	0.506
NULL	FEMS_Microbiol_Lett_2014_Apr_19_353(2)_106-115.nxml.txt.nlp	24605990	SENT28	23	23	10	10	minocycline	CO2	PA450519	4513	0.506
NULL	Cancer_Cell_2013_Aug_12_24(2)_167-181.nxml.txt.nlp	23948297	SENT66	9	9	19	19	doxycycline	p16INK4a	PA449415	1029	0.506
NULL	J_Hematol_Oncol_2011_Apr_20_4_16.nxml.txt.nlp	21504625	SENT49	7	7	14	14	nutlin-3	MDM2		4193	0.506
NULL	Stroke_Res_Treat_2012_Nov_30_2012_382361.nxml.txt.nlp	22195291	SENT86	8	8	18	18	clopidogrel	CEA	PA449053	5670;1087	0.506
NULL	J_Immunother_2014_Apr_12_37(3)_180-186.nxml.txt.nlp	24598448	SENT132	4	4	2	2	sorafenib	IL-2	PA7000	3558	0.506
NULL	Genome_Biol_2004_Apr_28_5(5)_224.nxml.txt.nlp	15128440	SENT236	17	17	29	29	nadh	p53	PA164755085	7157	0.506
NULL	Open_AIDS_J_2010_Jan_19_4_70-75.nxml.txt.nlp	20200604	SENT220	2	2	36	36	zidovudine	ATV	PA451954	4683	0.506
NULL	J_Gen_Physiol_2012_Nov_140(5)_541-555.nxml.txt.nlp	23109716	SENT441	13	13	21	21	capsaicin	TRPV1	PA448776	7442	0.506
NULL	Br_J_Cancer_2011_Jun_7_104(12)_1848-1853.nxml.txt.nlp	21610704	SENT11	8	8	5	5	panitumumab	KRAS	PA162373091	3845	0.506
NULL	Cancer_Inform_2010_Apr_27_9_93-103.nxml.txt.nlp	20467479	SENT73	7	7	3	3	tamoxifen	CYP2D6	PA451581	1565	0.506
NULL	Eur_J_Nutr_2009_Jun_24_48(4)_229-234.nxml.txt.nlp	19238310	SENT6	9	9	15	15	capsaicin	GLP-1	PA448776	100125288	0.506
NULL	Indian_J_Pharmacol_2009_Aug_41(4)_167-172.nxml.txt.nlp	20523867	SENT40	38	38	24	24	napqi	CYP3A4		1576	0.506
NULL	Acta_Pharmacol_Sin_2013_Jan_17_34(1)_157-166.nxml.txt.nlp	23247593	SENT199	9	9	5	5	berberine	Set9	PA165860812	80854	0.506
NULL	Oncogenesis_2014_May_12_3(5)_e102.nxml.txt.nlp	24819061	SENT72	9	9	18	18	nadh	p53	PA164755085	7157	0.506
NULL	Oncol_Lett_2013_Oct_24_6(4)_970-976.nxml.txt.nlp	24137447	SENT180	6	6	10	10	doxorubicin	ADM	PA449412	133	0.506
NULL	Mol_Biol_Cell_2013_Sep_15_24(18)_2849-2860.nxml.txt.nlp	23885123	SENT188	15	15	6	6	dextran	ZO-2	PA449261	9414	0.506
NULL	Indian_J_Anaesth_2011_Nov-Dec_55(6)_567-572.nxml.txt.nlp	22223899	SENT19	0	0	2	2	isoflurane	NAC	PA450106	22861	0.506
NULL	J_Asthma_Allergy_2013_Feb_22_6_31-39.nxml.txt.nlp	23459334	SENT103	5	5	20	20	rupatadine	ANOVA		4858	0.506
NULL	J_Headache_Pain_2011_Apr_5_12(2)_127-133.nxml.txt.nlp	21298314	SENT97	37	37	35	35	amitriptyline	CSMT	PA448385	1442	0.506
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT191	2	2	10	10	methotrexate	MSH2	PA450428	4436	0.506
NULL	Indian_J_Nucl_Med_2010_Jul-Sep_25(3)_103-108.nxml.txt.nlp	NULL	SENT191	17	17	9	9	doxorubicin	FDG	PA449412	23583	0.506
NULL	Tuberc_Respir_Dis_(Seoul)_2012_Apr_30_72(4)_343-351.nxml.txt.nlp	23227075	SENT44	17	17	28	28	gentamicin	CO2	PA449753	4513	0.506
NULL	Case_Reports_Hepatol_2013_Dec_14_2013_807537.nxml.txt.nlp	25379301	SENT80	41	41	32	32	infliximab	TH1	PA452639	51497	0.506
NULL	J_Appl_Genet_2014_Jan_11_55(2)_173-181.nxml.txt.nlp	24414975	SENT49	20	20	17	17	nadh	MT-ND1	PA164755085	4535	0.506
NULL	Case_Rep_Obstet_Gynecol_2014_Mar_24_2014_549619.nxml.txt.nlp	24782935	SENT86	7	7	16	16	cyclophosphamide	CHOP	PA449165	1649	0.506
NULL	Stroke_Res_Treat_2011_Jun_9_2011_534257.nxml.txt.nlp	21776361	SENT152	23	23	16	16	forskolin	PDE4D	PA146096022	5144	0.506
NULL	Breast_Cancer_Res_2010_May_10_12(3)_R26.nxml.txt.nlp	20459744	SENT110	2	2	19	19	cyclophosphamide	HDC	PA449165	3067;51696	0.506
NULL	Oncol_Lett_2014_Mar_16_7(3)_827-833.nxml.txt.nlp	24527090	SENT75	6	6	3	3	cisplatin	IFN	PA449014	3439	0.506
NULL	Daru_2011_19(2)_126-137.nxml.txt.nlp	22615649	SENT205	5	5	27	27	lamotrigine	C15	PA450164	51316	0.506
NULL	Cell_Commun_Signal_2013_Oct_1_11_73.nxml.txt.nlp	24083678	SENT145	10	10	7	7	sulindac	IL-8	PA451565	3576	0.506
NULL	Clin_Ophthalmol_2011_Feb_11_5_167-170.nxml.txt.nlp	21383944	SENT3	13	13	9	9	ranibizumab	hole	PA164746012	80757	0.506
NULL	Mol_Cancer_2009_Aug_25_8_66.nxml.txt.nlp	19706164	SENT35	10	10	7	7	oxygen	COX	PA450744	1351	0.506
NULL	Ann_Oncol_2011_May_6_22(5)_1189-1197.nxml.txt.nlp	21135053	SENT84	6	6	0	0	doxorubicin	CHOP	PA449412	1649	0.506
NULL	Mol_Vis_2010_Sep_2_16_1781-1790.nxml.txt.nlp	20824160	SENT293	4	4	7	7	acetylcysteine	p38	PA448033	10598;1432;7965	0.506
NULL	Surg_Neurol_Int_2013_Sep_6_4_114.nxml.txt.nlp	24083050	SENT189	29	29	43	43	clopidogrel	PED	PA449053	8682	0.506
NULL	Mol_Cancer_2010_May_27_9_124.nxml.txt.nlp	20504375	SENT141	27	27	24	24	doxycycline	HOXB13	PA449415	10481	0.506
NULL	Int_J_Breast_Cancer_2012_May_9_2012_415170.nxml.txt.nlp	22649737	SENT76	38	38	17	17	trastuzumab	MUC4	PA451743	4585	0.506
NULL	Endocr_Relat_Cancer_2014_Jun_21(3)_R209-R225.nxml.txt.nlp	24500760	SENT226	0	0	10	10	resveratrol	IL6		3569	0.506
NULL	Sensors_(Basel)_2013_Feb_28_13(3)_2895-2910.nxml.txt.nlp	23449119	SENT133	10	10	8	8	pp2	PP1		5540;5464	0.506
NULL	Ann_N_Y_Acad_Sci_2012_Oct_10_1271(1)_82-87.nxml.txt.nlp	23050968	SENT82	24	24	8	8	urokinase	adiponectin	PA451836	9370	0.506
NULL	Int_J_Med_Sci_2015_Jan_1_12(1)_23-31.nxml.txt.nlp	25552915	SENT148	10	10	2	2	oxygen	CAT	PA450744	847	0.506
NULL	Curr_Neuropharmacol_2008_Jun_6(2)_151-163.nxml.txt.nlp	19305794	SENT123	12	12	22	22	indomethacin	TRPV1	PA449982	7442	0.506
NULL	Cancers_(Basel)_2013_Jul_26_5(3)_959-984.nxml.txt.nlp	24202329	SENT123	20	20	25	25	collagenase	KSR	PA449107	10256	0.506
NULL	J_Cell_Biol_2001_Mar_19_152(6)_1145-1158.nxml.txt.nlp	11257116	SENT635	7	7	10	10	urokinase	CD87	PA451836	5329	0.506
NULL	Case_Rep_Dermatol_2013_Feb_24_5(1)_52-57.nxml.txt.nlp	23526061	SENT37	27	27	38	38	naproxen	B12	PA450595	7126;4709	0.506
NULL	Br_J_Cancer_2012_Feb_14_106(4)_685-692.nxml.txt.nlp	22294184	SENT154	0	0	7	7	lovastatin	Mcl-1	PA450272	4170	0.506
NULL	J_Neurosci_Rural_Pract_2014_Oct-Dec_5(4)_412-413.nxml.txt.nlp	25288852	SENT22	2	2	4	4	tocilizumab	IL-6	PA165292659	3569	0.506
NULL	Adv_Ther_2014_Dec_2_31_1228-1246.nxml.txt.nlp	25447269	SENT136	33	33	25	25	timolol	TIM	PA451690	7984;8914	0.506
NULL	Exp_Cell_Res_2009_Nov_15_315(19)_3433-3441.nxml.txt.nlp	19716819	SENT195	28	28	16	16	hyaluronidase	IL-8	PA164745713	3576	0.506
NULL	Appl_Microbiol_Biotechnol_2013_Aug_16_97(18)_7999-8009.nxml.txt.nlp	23948723	SENT73	26	26	14	14	glucose	mol	PA449773	90527	0.506
NULL	J_Vet_Med_Sci_2014_Aug_15_76(8)_1119-1127.nxml.txt.nlp	24829081	SENT120	23	23	7	7	trypsin	IL-8	PA451806	3576	0.506
NULL	Int_J_Cardiovasc_Imaging_2013_Jun_3_29(5)_959-966.nxml.txt.nlp	23378157	SENT108	20	20	16	16	iodine	HGB	PA450049	114757	0.506
NULL	J_Int_Soc_Sports_Nutr_2010_Aug_22_7_28.nxml.txt.nlp	20727213	SENT152	0	0	20	20	l-glutamine	IL-6	PA10090	3569	0.506
NULL	EJC_Suppl_2013_Sep_5_11(2)_307-309.nxml.txt.nlp	NULL	SENT51	2	2	6	6	afatinib	EGFR	PA165981154	1956	0.506
NULL	Br_J_Cancer_2010_Oct_26_103(9)_1380-1390.nxml.txt.nlp	20877355	SENT214	8	8	6	6	etoposide	TRAIL	PA449552	8743	0.506
NULL	Biochem_Res_Int_2012_May_22_2012_213403.nxml.txt.nlp	22675634	SENT256	6	6	39	39	creatine	PI3K	PA164778930	5290	0.506
NULL	BMJ_2013_Nov_6_347_f6530.nxml.txt.nlp	24196498	SENT78	2	2	6	6	sirolimus	PES	PA451365	23481	0.506
NULL	Cancer_Imaging_2012_Aug_10_12(1)_253-258.nxml.txt.nlp	22935131	SENT51	15	15	24	24	cyclophosphamide	CHOP	PA449165	1649	0.506
NULL	Comput_Struct_Biotechnol_J_2012_Mar_19_1_e201204005.nxml.txt.nlp	22737296	SENT119	0	0	10	10	cisplatin	BRCA1	PA449014	672	0.506
NULL	Biochem_Biophys_Res_Commun_2011_Sep_9_412(4)_747-751.nxml.txt.nlp	21871446	SENT97	16	16	8	8	l-arginine	PI3	PA448478	5266	0.506
NULL	J_Ophthalmol_2012_Aug_27_2012_285851.nxml.txt.nlp	23050121	SENT126	10	10	12	12	bimatoprost	BAK	PA164748867	578	0.506
NULL	Br_J_Pharmacol_2014_May_11_171(9)_2385-2398.nxml.txt.nlp	24467222	SENT228	14	14	25	25	rolipram	CXCL10	PA153906323	3627	0.506
NULL	Cell_Death_Dis_2014_Jan_30_5(1)_e1036.nxml.txt.nlp	24481450	SENT119	24	24	19	19	heparin	B27	PA449855	56246	0.506
NULL	Hum_Genomics_2008_Sep_1_3(1)_71-78.nxml.txt.nlp	19129091	SENT32	17	17	26	26	nadh	ND3	PA164755085	4537	0.506
NULL	Mol_Cancer_2010_Nov_23_9_300.nxml.txt.nlp	21092249	SENT30	23	23	17	17	tamoxifen	IL-6	PA451581	3569	0.506
NULL	Case_Rep_Med_2014_Nov_12_2014_231651.nxml.txt.nlp	25477968	SENT181	4	4	13	13	amiodarone	AIT	PA448383	160728	0.506
NULL	Evid_Based_Complement_Alternat_Med_2013_Aug_20_2013_789067.nxml.txt.nlp	24069055	SENT219	3	3	22	22	lipase	gamma	PA450239	9913	0.506
NULL	Hum_Reprod_2012_Jun_3_27(6)_1829-1839.nxml.txt.nlp	22473395	SENT113	28	28	19	19	estradiol	AMH	PA449503	268	0.506
NULL	Oncotarget_2014_Oct_21_5(22)_11252-11268.nxml.txt.nlp	25361004	SENT222	0	0	6	6	metformin	CLIC1	PA450395	1192	0.506
NULL	Biomed_Res_Int_2014_Feb_6_2014_323594.nxml.txt.nlp	24689036	SENT260	3	3	12	12	raloxifene	PC3	PA451221	57332;7832;5122	0.506
NULL	J_Gen_Physiol_1997_Dec_1_110(6)_643-654.nxml.txt.nlp	9382893	SENT112	8	8	10	10	diazoxide	ADP	PA449285	23038	0.506
NULL	J_Oncol_2009_May_6_2009_567486.nxml.txt.nlp	19424511	SENT56	4	4	8	8	gefitinib	EGFR	PA131301952	1956	0.506
NULL	Virol_J_2009_Jul_16_6_105.nxml.txt.nlp	19607718	SENT96	12	12	10	10	ribavirin	IFN	PA451241	3439	0.506
NULL	Biochemistry_2014_Jun_24_53(24)_3908-3921.nxml.txt.nlp	24840308	SENT164	7	7	5	5	trypsin	6-16	PA451806	2537	0.506
NULL	Biomed_Res_Int_2014_May_13_2014_348647.nxml.txt.nlp	24949436	SENT62	16	16	19	19	chlorhexidine	VCX	PA164776863	26609	0.506
NULL	Basic_Clin_Pharmacol_Toxicol_2013_Feb_5_112(2)_132-137.nxml.txt.nlp	22900583	SENT54	14	14	30	30	bupropion	CYP2B6	PA448687	1555	0.506
NULL	Clin_Interv_Aging_2012_Sep_13_7_351-361.nxml.txt.nlp	23049247	SENT277	14	14	3	3	letrozole	aromatase	PA450196	1588	0.506
NULL	Br_J_Cancer_2013_May_28_108(10)_2005-2012.nxml.txt.nlp	23632480	SENT60	24	24	12	12	mitoxantrone	San	PA450526	80218	0.506
NULL	Comput_Struct_Biotechnol_J_2012_Mar_19_1_e201204005.nxml.txt.nlp	22737296	SENT318	16	16	29	29	cisplatin	BRCA1	PA449014	672	0.506
NULL	Mol_Biol_Cell_2013_Dec_1_24(23)_3620-3633.nxml.txt.nlp	24109599	SENT285	4	4	12	12	galactose	RPL18	PA449725	6141	0.506
NULL	Sensors_(Basel)_2013_Feb_28_13(3)_2895-2910.nxml.txt.nlp	23449119	SENT133	10	10	14	14	pp2	PP4		5531	0.506
NULL	J_Am_Heart_Assoc_2013_Aug_23_2(4)_e000318.nxml.txt.nlp	23926118	SENT117	33	33	25	25	isoproterenol	AC3	PA450121	109	0.506
NULL	Biosci_Rep_2012_Dec_20_33(1)_e00011.nxml.txt.nlp	23137297	SENT151	22	22	31	31	heparin	RPSA	PA449855	3921	0.506
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_18_2012_129152.nxml.txt.nlp	23227095	SENT440	16	16	21	21	carrageenan	ANOVA	PA448814	4858	0.506
NULL	J_Psychopharmacol_2014_Sep_28(9)_837-846.nxml.txt.nlp	25035246	SENT27	27	27	19	19	dexmethylphenidate	ATX	PA10054	5168;23049	0.506
NULL	Cell_Death_Dis_2014_Feb_13_5(2)_e1060.nxml.txt.nlp	24525736	SENT122	2	2	4	4	bortezomib	TRAIL	PA10252	8743	0.506
NULL	Cancer_Manag_Res_2011_Sep_9_3_301-309.nxml.txt.nlp	21931504	SENT40	7	7	4	4	spermine	CXCR4	PA164781199	7852	0.506
NULL	Drug_Des_Devel_Ther_2014_Sep_23_8_1527-1538.nxml.txt.nlp	25284985	SENT131	5	5	2	2	celecoxib	IFN	PA448871	3439	0.506
NULL	Eur_J_Clin_Pharmacol_2014_Mar_22_70(6)_685-693.nxml.txt.nlp	24658827	SENT117	0	0	22	22	tacrolimus	PPARA	PA451578	5465	0.506
NULL	J_Bras_Pneumol_2013_Jun-Aug_39(4)_434-439.nxml.txt.nlp	24068264	SENT235	17	17	22	22	tramadol	por	PA451735	64840	0.506
NULL	Nat_Commun_2014_Dec_17_5_5777.nxml.txt.nlp	25517116	SENT125	0	0	7	7	metoprolol	Bcl-2	PA450480	596	0.506
NULL	Breast_Cancer_Res_2007_Dec_18_9(6)_216.nxml.txt.nlp	18190723	SENT140	0	0	5	5	bevacizumab	VEGF-A	PA130232992	7422	0.506
NULL	Oncotarget_2014_Mar_16_5(12)_4087-4102.nxml.txt.nlp	24961479	SENT277	2	2	4	4	hemin	PC3	PA449849	57332;7832;5122	0.506
NULL	Br_J_Pharmacol_2010_Sep_161(2)_241-270.nxml.txt.nlp	20735414	SENT406	17	17	26	26	bleomycin	LPA1	PA448645	1902	0.506
NULL	Emerg_Infect_Dis_2015_Jan_21(1)_164-166.nxml.txt.nlp	25531800	SENT6	13	13	21	21	artesunate	GMP	PA165111697	22978	0.506
NULL	J_Biol_2008_Jul_31_7(6)_20.nxml.txt.nlp	18710588	SENT25	38	38	36	36	atropine	B12	PA448505	7126;4709	0.506
NULL	Gut_Liver_2015_Jan_15_9(1)_38-42.nxml.txt.nlp	NULL	SENT78	20	20	34	34	propofol	ESD	PA451141	2098	0.506
NULL	Arthritis_Res_Ther_2012_Aug_6_14(4)_R180.nxml.txt.nlp	22866899	SENT137	15	15	11	11	urokinase	HIF-1	PA451836	29072	0.506
NULL	J_Vis_Exp_2011_Jul_15_(53)_3054.nxml.txt.nlp	21775968	SENT65	23	23	17	17	phenol	CO2	PA450913	4513	0.506
NULL	Int_J_Mol_Sci_2013_Aug_12_14(8)_16617-16637.nxml.txt.nlp	23941783	SENT167	25	25	20	20	paclitaxel	VIII	PA450761	1351	0.506
NULL	Arthritis_Res_Ther_2006_May_11_8(3)_209.nxml.txt.nlp	16712713	SENT551	3	3	20	20	methotrexate	Yes	PA450428	7525	0.506
NULL	Ther_Clin_Risk_Manag_2006_Mar_2(1)_87-98.nxml.txt.nlp	18360584	SENT154	6	6	8	8	sorafenib	IFN	PA7000	3439	0.506
NULL	Ann_Pediatr_Cardiol_2008_Jan-Jun_1(1)_18-26.nxml.txt.nlp	20300233	SENT195	8	8	19	19	verapamil	LQT8	PA451868	775	0.506
NULL	J_Exp_Bot_2008_May_59(8)_2109-2123.nxml.txt.nlp	18535297	SENT309	10	10	1	1	galactose	PC2	PA449725	5126;5311;8535	0.506
NULL	Br_J_Cancer_2012_May_22_106(11)_1718-1721.nxml.txt.nlp	22531628	SENT26	20	20	15	15	bevacizumab	IFL	PA130232992	3439	0.506
NULL	Cancer_Cell_Int_2009_Mar_16_9_7.nxml.txt.nlp	19291318	SENT153	14	14	16	16	hydrocortisone	EGF	PA449905	1950	0.506
NULL	Cell_Biochem_Biophys_2015_Oct_25_71_457-464.nxml.txt.nlp	25343940	SENT194	8	8	11	11	bortezomib	CD4	PA10252	920	0.506
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Dec_2_5_30.nxml.txt.nlp	17140452	SENT194	31	31	5	5	chloramphenicol	GAT	PA448927	10249	0.506
NULL	Breast_Cancer_Res_2007_Aug_8_9(4)_R50.nxml.txt.nlp	17686159	SENT11	0	0	15	15	gefitinib	HRG	PA131301952	3084;3273	0.506
NULL	Cell_Cycle_2014_Jan_15_13(2)_249-267.nxml.txt.nlp	24200965	SENT458	25	25	27	27	berberine	DAXX	PA165860812	1616	0.506
NULL	Mol_Cancer_2013_Sep_24_12_109.nxml.txt.nlp	24063540	SENT174	5	5	0	0	collagenase	MMP1	PA449107	4312	0.506
NULL	Clin_Ophthalmol_2012_Sep_5_6_1433-1440.nxml.txt.nlp	23055659	SENT153	21	21	29	29	timolol	BAK	PA451690	578	0.506
NULL	Front_Mol_Neurosci_2012_Feb_24_5_22.nxml.txt.nlp	22375105	SENT113	4	4	20	20	spermine	GluA1	PA164781199	2890	0.506
NULL	Fibrogenesis_Tissue_Repair_2010_Sep_3_3_18.nxml.txt.nlp	20815874	SENT80	23	23	15	15	bleomycin	CCR7	PA448645	1236	0.506
NULL	Diabetes_Care_2013_Aug_17_36(Suppl_2)_S155-S161.nxml.txt.nlp	23882041	SENT17	11	11	34	34	pioglitazone	ACT	PA450970	12;11332;9457;641455	0.506
NULL	Int_J_Endocrinol_2010_Aug_29_2010_481326.nxml.txt.nlp	20871656	SENT17	17	17	19	19	glucose	MPG	PA449773	4350	0.506
NULL	Int_J_Mol_Sci_2014_Sep_5_15(9)_15754-15765.nxml.txt.nlp	25198898	SENT213	12	12	6	6	curcumin	WT1	PA151958596	7490	0.506
NULL	Indian_J_Crit_Care_Med_2014_May_18(5)_323-325.nxml.txt.nlp	24914263	SENT28	5	5	31	31	voriconazole	IPA	PA10233	3160	0.506
NULL	Diabetes_Care_2013_Jun_15_36(6)_1654-1659.nxml.txt.nlp	23250803	SENT7	13	13	7	7	repaglinide	ET1	PA451234	1906	0.505
NULL	Mol_Vis_2012_Jul_20_18_2001-2011.nxml.txt.nlp	22876128	SENT160	22	22	0	0	collagenase	CD166	PA449107	214	0.505
NULL	AMB_Express_2012_Jul_29_2_38.nxml.txt.nlp	22838397	SENT151	30	30	28	28	ethanol	EPG	PA448073	255324	0.505
NULL	Cancer_Immunol_Immunother_2008_Jul_7_57(7)_931-950.nxml.txt.nlp	18256831	SENT62	10	10	12	12	cyclophosphamide	IL-2	PA449165	3558	0.505
NULL	J_Obes_2013_Jun_4_2013_874981.nxml.txt.nlp	23862058	SENT8	12	12	30	30	l-methionine	C15	PA450423	51316	0.505
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jul_25_65(Pt_8)_o1984.nxml.txt.nlp	21583660	SENT3	22	22	28	28	ethanol	mol	PA448073	90527	0.505
NULL	Crit_Care_2011_Nov_16_15(6)_R271.nxml.txt.nlp	22087790	SENT164	2	2	47	47	nitroprusside	Yes	PA451406	7525	0.505
NULL	Int_J_Gen_Med_2011_Jul_20_4_539-545.nxml.txt.nlp	21845063	SENT15	5	5	13	13	miglitol	adiponectin	PA164776726	9370	0.505
NULL	Front_Plant_Sci_2012_Mar_28_3_53.nxml.txt.nlp	22639651	SENT107	10	10	31	31	lipase	GRP17	PA450239	10912	0.505
NULL	Biologics_2014_Apr_22_8_193-198.nxml.txt.nlp	24790412	SENT126	41	41	21	21	infliximab	Yes	PA452639	7525	0.505
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jan_31_65(Pt_2)_o427-o428.nxml.txt.nlp	21582014	SENT76	22	22	26	26	potassium	mol	PA451047	90527	0.505
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT29	7	7	9	9	cisplatin	p53	PA449014	7157	0.505
NULL	Mol_Cancer_2010_May_18_9_110.nxml.txt.nlp	20482802	SENT195	10	10	26	26	bortezomib	p53	PA10252	7157	0.505
NULL	Cancer_Med_2013_Aug_2_2(4)_571-582.nxml.txt.nlp	24156030	SENT236	4	4	9	9	curcumin	IL-6	PA151958596	3569	0.505
NULL	Comput_Math_Methods_Med_2014_Feb_3_2014_813067.nxml.txt.nlp	24639887	SENT287	36	36	32	32	doxorubicin	TOP2A	PA449412	7153	0.505
NULL	Clin_Interv_Aging_2009_Nov_18_4_435-444.nxml.txt.nlp	19966912	SENT253	11	11	6	6	ramipril	AIRE	PA451223	326	0.505
NULL	Cancer_Med_2012_Oct_1_1(2)_114-127.nxml.txt.nlp	23342262	SENT26	0	0	13	13	sirolimus	FKBP12	PA451365	2280	0.505
NULL	Mol_Syst_Biol_2010_Jul_13_6_387.nxml.txt.nlp	20631681	SENT235	8	8	2	2	nadh	ADP	PA164755085	23038	0.505
NULL	J_Gastroenterol_2013_May_5_48(5)_559-573.nxml.txt.nlp	23460386	SENT42	10	10	28	28	omeprazole	COX	PA450704	1351	0.505
NULL	Iran_J_Reprod_Med_2013_Jul_11(7)_565-576.nxml.txt.nlp	24639792	SENT16	13	13	20	20	berberine	SLPI	PA165860812	6590	0.505
NULL	Mol_Cancer_2008_Dec_5_7_90.nxml.txt.nlp	19061500	SENT251	8	8	17	17	phenol	CO2	PA450913	4513	0.505
NULL	Oncotarget_2013_Feb_27_4(2)_329-345.nxml.txt.nlp	23593654	SENT284	14	14	11	11	trastuzumab	CD44	PA451743	960	0.505
NULL	Eur_J_Histochem_2011_Mar_24_55(1)_e6.nxml.txt.nlp	21556121	SENT77	28	28	24	24	heparin	HRG	PA449855	3084;3273	0.505
NULL	Mol_Biol_Cell_2013_Jul_15_24(14)_2269-2284.nxml.txt.nlp	23676666	SENT262	26	26	11	11	isoproterenol	PI4KII	PA450121	55361	0.505
NULL	Stroke_Res_Treat_2009_Dec_20_2010_386389.nxml.txt.nlp	20700422	SENT156	7	7	9	9	ebselen	NAC	PA161660841	22861	0.505
NULL	Front_Neurol_2014_Aug_12_5_153.nxml.txt.nlp	25161646	SENT114	26	26	6	6	urokinase	NCCT	PA451836	6559	0.505
NULL	Alcohol_Res_2013_35(1)_6-16.nxml.txt.nlp	24313160	SENT83	26	26	31	31	betaine	BHMT	PA448603	635	0.505
NULL	J_Appl_Oral_Sci_2010_Nov-Dec_18(6)_591-598.nxml.txt.nlp	21308290	SENT56	9	9	2	2	ethanol	HEMA	PA448073	2157	0.505
NULL	Front_Neurosci_2014_Dec_5_8_398.nxml.txt.nlp	25538552	SENT50	13	13	8	8	oxygen	gamma	PA450744	9913	0.505
NULL	Drug_Target_Insights_2006_Oct_23_1_5-10.nxml.txt.nlp	21901053	SENT71	14	14	7	7	aprotinin	INCA	PA448472	440068	0.505
NULL	Arthritis_2013_May_15_2013_818037.nxml.txt.nlp	23762554	SENT29	33	33	22	22	l-arginine	VAP-1	PA448478	8639	0.505
NULL	Mol_Cancer_2008_Jun_30_7_60.nxml.txt.nlp	18590557	SENT93	11	11	29	29	etoposide	TRAIL	PA449552	8743	0.505
NULL	J_Vis_Exp_2011_Aug_21_(54)_3324.nxml.txt.nlp	21876528	SENT54	14	14	1	1	papain	sit	PA450778	55733	0.505
NULL	J_Cell_Biol_2004_Jul_5_166(1)_133-143.nxml.txt.nlp	15226308	SENT243	27	27	15	15	hydrocortisone	F12	PA449905	2161	0.505
NULL	Lab_Invest_2011_Sep_23_91(9)_1396-1409.nxml.txt.nlp	21606925	SENT140	0	0	9	9	pp2	ZO-1		7082	0.505
NULL	Br_J_Cancer_1999_Aug_80(12)_1935-1944.nxml.txt.nlp	10471042	SENT1	7	7	33	33	vasopressin	NG5	PA451858	80863	0.505
NULL	Cancer_Metab_2013_Mar_7_1_10.nxml.txt.nlp	24280167	SENT174	0	0	23	23	metformin	AMPK	PA450395	5563	0.505
NULL	J_Hematol_Oncol_2009_Mar_24_2_14.nxml.txt.nlp	19309523	SENT20	1	1	9	9	cyclophosphamide	CHOP	PA449165	1649	0.505
NULL	Clin_Med_Insights_Oncol_2012_Dec_6_6_407-421.nxml.txt.nlp	23239933	SENT213	20	20	2	2	docetaxel	GEM	PA449383	2669	0.505
NULL	EMBO_Mol_Med_2013_Aug_5_5(8)_1213-1226.nxml.txt.nlp	23918228	SENT137	11	11	22	22	cetuximab	EGFR	PA10040	1956	0.505
NULL	Oncol_Lett_2014_Oct_22_8(4)_1603-1607.nxml.txt.nlp	25202376	SENT130	25	25	37	37	cisplatin	ERCC1	PA449014	2067	0.505
NULL	Iran_Red_Crescent_Med_J_2012_Nov_15_14(11)_719-721.nxml.txt.nlp	23396650	SENT38	6	6	3	3	cyclophosphamide	CHOP	PA449165	1649	0.505
NULL	Int_J_Mol_Sci_2014_Oct_8_15(10)_17974-17999.nxml.txt.nlp	25299695	SENT130	22	22	20	20	curcumin	HO-1	PA151958596	3162	0.505
NULL	Clin_Interv_Aging_2013_Feb_15_8_185-189.nxml.txt.nlp	23440003	SENT44	21	21	8	8	alendronate	DPD	PA448082	1806	0.505
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_3_2014_473213.nxml.txt.nlp	25538791	SENT127	5	5	9	9	ethanol	CYP3A	PA448073	1574	0.505
NULL	Hum_Genomics_2009_Jan_1_3(2)_128-142.nxml.txt.nlp	19164090	SENT174	24	24	7	7	carboplatin	CD44	PA448803	960	0.505
NULL	J_Cardiothorac_Surg_2011_Feb_8_6_14.nxml.txt.nlp	21303502	SENT130	23	23	25	25	helium	CO2	PA449848	4513	0.505
NULL	Breast_Cancer_(Auckl)_2011_Oct_9_5_209-226.nxml.txt.nlp	22084574	SENT208	12	12	9	9	exemestane	UGT2B17	PA449563	7367	0.505
NULL	Breast_Cancer_Res_2003_Mar_14_5(3)_R77-R81.nxml.txt.nlp	12793904	SENT109	30	30	2	2	urokinase	c-Jun	PA451836	3725	0.505
NULL	Breast_Cancer_Res_2011_Mar_1_13(2)_R21.nxml.txt.nlp	21362200	SENT6	3	3	11	11	estradiol	PI3K	PA449503	5290	0.505
NULL	J_Infect_Dis_2014_Nov_1_210(9)_1487-1498.nxml.txt.nlp	24823621	SENT97	27	27	10	10	gentamicin	IL-10	PA449753	3586	0.505
NULL	Arthritis_Res_Ther_2011_Oct_12_13(5)_R163.nxml.txt.nlp	21992149	SENT221	5	5	0	0	risedronate	ATV	PA451255	4683	0.505
NULL	Eur_J_Clin_Pharmacol_2012_Sep_15_68(9)_1267-1274.nxml.txt.nlp	22418828	SENT212	23	23	6	6	amoxicillin	CYP2C19	PA448406	1557	0.505
NULL	Sensors_(Basel)_2013_Dec_27_14(1)_458-467.nxml.txt.nlp	24379050	SENT91	10	10	12	12	glucose	MTB	PA449773	54892;4498	0.505
NULL	J_Int_AIDS_Soc_2012_Mar_12_15_13.nxml.txt.nlp	22410312	SENT25	16	16	39	39	tenofovir	CD4	PA10204	920	0.505
NULL	Oncogene_2013_Sep_12_32(37)_4355-4365.nxml.txt.nlp	23108409	SENT54	10	10	8	8	hyaluronan	HAS2	PA165958431	3037	0.505
NULL	Mol_Cancer_2012_Mar_21_11_13.nxml.txt.nlp	22436134	SENT17	42	42	20	20	doxorubicin	HuR	PA449412	1994	0.505
NULL	Cancer_Cell_Int_2011_Nov_17_11_40.nxml.txt.nlp	22088142	SENT147	10	10	33	33	gemcitabine	EGFR	PA449748	1956	0.505
NULL	J_Lipid_Res_2014_Oct_55(10)_2103-2112.nxml.txt.nlp	25139399	SENT735	2	2	7	7	niacin	APOE	PA450617	348	0.505
NULL	J_Oral_Pathol_Med_2013_Jul_18_42(6)_499-506.nxml.txt.nlp	23331485	SENT188	16	16	11	11	celecoxib	IL-6	PA448871	3569	0.505
NULL	Diabetes_2011_Jun_21_60(6)_1770-1778.nxml.txt.nlp	21562078	SENT201	3	3	8	8	metformin	STZ	PA450395	6484	0.505
NULL	Curr_Neuropharmacol_2012_Mar_10(1)_53-63.nxml.txt.nlp	22942878	SENT107	33	33	24	24	vasopressin	OXT	PA451858	5020	0.505
NULL	J_Cell_Biol_2001_Aug_6_154(3)_485-490.nxml.txt.nlp	11489912	SENT143	17	17	21	21	glutaraldehyde	GAPDH	PA449777	2597	0.505
NULL	Mol_Cancer_2013_Nov_20_12_144.nxml.txt.nlp	24257371	SENT211	8	8	4	4	cisplatin	PRL	PA449014	5617	0.505
NULL	Front_Cell_Neurosci_2015_Jan_15_8_467.nxml.txt.nlp	25642170	SENT132	6	6	36	36	capsaicin	p38	PA448776	10598;1432;7965	0.505
NULL	Oncol_Lett_2014_Oct_9_8(4)_1551-1556.nxml.txt.nlp	25202366	SENT97	19	19	21	21	rituximab	CHOP	PA451261	1649	0.505
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT128	19	19	3	3	amiodarone	CYP2D6	PA448383	1565	0.505
NULL	Case_Rep_Ophthalmol_2014_Jan_22_5(1)_34-37.nxml.txt.nlp	24575036	SENT25	9	9	6	6	fluorescein	FAF	PA164746009	8239;2188	0.505
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Aug_8_68(Pt_9)_m1155.nxml.txt.nlp	22969456	SENT61	1	1	32	32	ethanol	NO3	PA448073	4681	0.505
NULL	Iran_Red_Crescent_Med_J_2014_Aug_5_16(8)_e12106.nxml.txt.nlp	25389471	SENT166	18	18	20	20	nitrogen	DBP	PA450643	3295;1628;2638	0.505
NULL	J_Biomed_Biotechnol_2010_Sep_19_2010_518743.nxml.txt.nlp	20886007	SENT173	29	29	36	36	ethanol	CO2	PA448073	4513	0.505
NULL	J_Hematol_Oncol_2013_Nov_5_6_83.nxml.txt.nlp	24283248	SENT37	13	13	6	6	nutlin-3	TP53		7157	0.505
NULL	Arch_Microbiol_2013_Jun_10_195(6)_439-445.nxml.txt.nlp	23661196	SENT183	4	4	13	13	ethanol	CO2	PA448073	4513	0.505
NULL	Cardiovasc_Ultrasound_2005_Sep_2_3_26.nxml.txt.nlp	16138923	SENT54	35	35	26	26	sildenafil	IFN	PA451346	3439	0.505
NULL	Gut_Liver_2012_Oct_18_6(4)_464-470.nxml.txt.nlp	23170151	SENT6	24	24	26	26	midazolam	ESD	PA450496	2098	0.505
NULL	J_Viral_Hepat_2010_Feb_17(2)_139-147.nxml.txt.nlp	19674282	SENT70	8	8	20	20	ribavirin	RVR	PA451241	9975	0.505
NULL	Br_J_Cancer_2010_Oct_12_103(8)_1309-1310.nxml.txt.nlp	NULL	SENT10	13	13	15	15	bevacizumab	IFN	PA130232992	3439	0.505
NULL	Clinics_(Sao_Paulo)_2011_Jun_66(6)_1109-1111.nxml.txt.nlp	21808885	SENT35	19	19	10	10	imiquimod	CO2	PA449972	4513	0.505
NULL	Front_Genet_2011_May_20_2_21.nxml.txt.nlp	22303317	SENT551	6	6	17	17	sibutramine	GNB3	PA451344	2784	0.505
NULL	Br_J_Cancer_2013_Jun_25_108(12)_2464-2469.nxml.txt.nlp	23695016	SENT164	23	23	27	27	cisplatin	CRT	PA449014	811	0.505
NULL	Front_Mol_Neurosci_2009_May_14_2_1.nxml.txt.nlp	19506703	SENT193	17	17	5	5	candesartan	ACTH	PA448765	5443	0.505
NULL	Diabetes_2013_Jun_17_62(6)_1876-1887.nxml.txt.nlp	23349477	SENT369	10	10	27	27	ketoconazole	SXR	PA450146	8856	0.505
NULL	Drugs_Aging_2012_Dec_23_29(5)_e1-e12.nxml.txt.nlp	22530704	SENT84	13	13	7	7	liraglutide	GLP-1	PA165958364	100125288	0.505
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT128	21	21	0	0	verapamil	CYP1A2	PA451868	1544	0.505
NULL	J_Cell_Biol_2004_Jun_21_165(6)_893-902.nxml.txt.nlp	15197174	SENT474	16	16	0	0	hyaluronan	CD44	PA165958431	960	0.505
NULL	HSR_Proc_Intensive_Care_Cardiovasc_Anesth_2010_2(2)_119-127.nxml.txt.nlp	23440905	SENT173	15	15	9	9	desmopressin	ADAMTS13	PA449237	11093	0.505
NULL	Front_Pharmacol_2014_Oct_20_5_230.nxml.txt.nlp	25368579	SENT75	7	7	3	3	berberine	IL-6	PA165860812	3569	0.505
NULL	Environ_Health_Perspect_1990_Apr_85_89-94.nxml.txt.nlp	2384071	SENT6	20	20	2	2	oxygen	NAC	PA450744	22861	0.505
NULL	Int_J_Mol_Sci_2014_Mar_5_15(3)_3970-3988.nxml.txt.nlp	24603537	SENT36	25	25	27	27	curcumin	MCH	PA151958596	5367	0.505
NULL	Mol_Clin_Oncol_2013_Jul_27_1(4)_768-772.nxml.txt.nlp	24649244	SENT180	14	14	16	16	gemcitabine	GEM	PA449748	2669	0.505
NULL	Oxid_Med_Cell_Longev_2010_Jan-Feb_3(1)_23-34.nxml.txt.nlp	20716925	SENT102	0	0	8	8	curcumin	UGT1A10	PA151958596	54575	0.505
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_May_20_65(Pt_6)_o1346.nxml.txt.nlp	21583198	SENT57	20	20	15	15	ethanol	mol	PA448073	90527	0.505
NULL	Int_J_Mol_Sci_2014_Mar_5_15(3)_3970-3988.nxml.txt.nlp	24603537	SENT116	5	5	14	14	curcumin	HO-1	PA151958596	3162	0.505
NULL	Front_Neuroeng_2013_Feb_25_6_1.nxml.txt.nlp	23443302	SENT70	18	18	21	21	remifentanil	gamma	PA451232	9913	0.505
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Oct_31_70(Pt_11)_o1210-o1211.nxml.txt.nlp	25484834	SENT104	5	5	22	22	piperazine	mol	PA450977	90527	0.505
NULL	J_Headache_Pain_2011_Feb_23_12(1)_81-88.nxml.txt.nlp	20862509	SENT143	12	12	14	14	rizatriptan	5-HT1B	PA451264	3351	0.505
NULL	Biomed_Res_Int_2013_Aug_6_2013_602987.nxml.txt.nlp	24027759	SENT191	17	17	5	5	camptothecin	SMF	PA153590860	22993	0.505
NULL	Daru_2011_19(2)_126-137.nxml.txt.nlp	22615649	SENT215	5	5	20	20	lamotrigine	C17	PA450164	54360	0.505
NULL	Basic_Clin_Pharmacol_Toxicol_2013_Feb_5_112(2)_132-137.nxml.txt.nlp	22900583	SENT54	18	18	36	36	flurbiprofen	CYP3A	PA449683	1574	0.505
NULL	Chem_Cent_J_2014_Sep_16_8(1)_51.nxml.txt.nlp	NULL	SENT142	2	2	18	18	phenol	CO2	PA450913	4513	0.505
NULL	Oncogene_2010_Jul_8_29(27)_3953-3963.nxml.txt.nlp	20440263	SENT272	1	1	14	14	azathioprine	MYH	PA448515	4595	0.505
NULL	Br_J_Cancer_2013_Jun_25_108(12)_2464-2469.nxml.txt.nlp	23695016	SENT4	14	14	9	9	carboplatin	NACT	PA448803	284111	0.505
NULL	F1000_Med_Rep_2012_Jun_1_4_12.nxml.txt.nlp	22719795	SENT59	27	27	25	25	rifampin	CYP3A	PA451250	1574	0.505
NULL	Acta_Neuropathol_Commun_2014_Oct_21_2(1)_149.nxml.txt.nlp	NULL	SENT185	15	15	40	40	riluzole	ANOVA	PA451251	4858	0.505
NULL	Mucosal_Immunol_2014_Mar_24_7(2)_335-347.nxml.txt.nlp	23881354	SENT286	0	0	2	2	galantamine	GAL	PA449726	51083	0.505
NULL	Nat_Med_2011_Dec_11_18(1)_74-82.nxml.txt.nlp	22157681	SENT269	16	16	20	20	gefitinib	BIM	PA131301952	10018	0.505
NULL	Int_J_Hypertens_2012_Jan_26_2012_147825.nxml.txt.nlp	22319643	SENT119	28	28	23	23	bleomycin	JNK	PA448645	5599	0.505
NULL	Support_Care_Cancer_2013_Apr_12_21(9)_2409-2415.nxml.txt.nlp	23579947	SENT57	37	37	15	15	gentamicin	F12	PA449753	2161	0.505
NULL	Diabetes_2009_Jun_26_58(6)_1457-1462.nxml.txt.nlp	19324939	SENT175	31	31	10	10	vasopressin	SSTR2	PA451858	6752	0.505
NULL	Diagn_Pathol_2013_Jul_2_8_108.nxml.txt.nlp	23819507	SENT139	10	10	8	8	thyroglobulin	TTF-1	PA164754910	7080	0.505
NULL	J_Vis_Exp_2011_Feb_19_(48)_2541.nxml.txt.nlp	21372791	SENT64	10	10	28	28	ethanol	ANOVA	PA448073	4858	0.505
NULL	Anesthesiol_Res_Pract_2013_Sep_23_2013_297141.nxml.txt.nlp	24174934	SENT343	0	0	8	8	capsaicin	TRPV1	PA448776	7442	0.505
NULL	J_Immune_Based_Ther_Vaccines_2006_Nov_28_4_7.nxml.txt.nlp	17132168	SENT7	9	9	16	16	hydroxyurea	GM-CSF	PA449942	1437	0.505
NULL	Braz_J_Microbiol_2011_Mar_1_Jan-Mar_42(1)_22-29.nxml.txt.nlp	24031600	SENT306	7	7	13	13	lipase	Gen	PA450239	348654	0.505
NULL	Front_Aging_Neurosci_2010_Aug_26_2_138.nxml.txt.nlp	20838473	SENT59	24	24	0	0	nadh	ADP	PA164755085	23038	0.505
NULL	Neuroimage_Clin_2014_Feb_27_4_436-443.nxml.txt.nlp	24624329	SENT461	17	17	9	9	flumazenil	SOD1	PA449659	6647	0.505
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Dec_2_5_30.nxml.txt.nlp	17140452	SENT239	15	15	29	29	linezolid	CHL	PA450233	91851	0.505
NULL	J_Korean_Med_Sci_2004_Apr_30_19(2)_167-171.nxml.txt.nlp	15082886	SENT118	6	6	0	0	cycloserine	PTH	PA164764600	5741	0.505
NULL	Br_J_Cancer_2011_Apr_12_104(8)_1256-1261.nxml.txt.nlp	21448165	SENT113	16	16	18	18	sorafenib	IL-2	PA7000	3558	0.505
NULL	Breast_Cancer_Res_2006_Nov_6_8(6)_215.nxml.txt.nlp	17096862	SENT105	4	4	12	12	lapatinib	EGFR	PA152241907	1956	0.505
NULL	Cell_Death_Dis_2012_Jun_21_3(6)_e330.nxml.txt.nlp	22717585	SENT123	7	7	21	21	simvastatin	LC3	PA451363	84557	0.505
NULL	Iran_J_Microbiol_2013_Sep_5(3)_278-284.nxml.txt.nlp	24475337	SENT48	17	17	15	15	nadh	mol	PA164755085	90527	0.505
NULL	Ann_Rehabil_Med_2012_Aug_27_36(4)_466-473.nxml.txt.nlp	22977771	SENT145	4	4	33	33	bupivacaine	TLF	PA135057240	9519	0.505
NULL	Clin_Psychopharmacol_Neurosci_2011_Apr_30_9(1)_29-35.nxml.txt.nlp	23430964	SENT173	12	12	42	42	methylphenidate	Gen	PA450464	348654	0.505
NULL	Br_J_Cancer_2001_Sep_85(5)_764-771.nxml.txt.nlp	11531265	SENT7	10	10	8	8	chlorambucil	CPG2	PA448926	23345	0.505
NULL	Allergy_Asthma_Immunol_Res_2012_May_14_4(3)_137-142.nxml.txt.nlp	22548206	SENT138	23	23	0	0	diclofenac	FAST	PA449293	10922	0.505
NULL	Crit_Care_2008_Mar_13_12(Suppl_2)_P262.nxml.txt.nlp	NULL	SENT20	16	16	9	9	dobutamine	PAWP	PA449381	164684	0.505
NULL	J_Hum_Genet_2012_Jul_24_57(7)_459-464.nxml.txt.nlp	22622361	SENT95	9	9	5	5	heparin	SCR3	PA449855	5939	0.505
NULL	Part_Fibre_Toxicol_2013_Apr_15_10_15.nxml.txt.nlp	23587290	SENT448	15	15	34	34	taurine	PAG	PA451590	55824	0.505
NULL	Exp_Diabetes_Res_2011_Dec_27_2011_604989.nxml.txt.nlp	21253359	SENT51	0	0	2	2	clonidine	GLP-1	PA449051	100125288	0.505
NULL	Diabetes_2009_Feb_58(2)_352-359.nxml.txt.nlp	19011168	SENT175	20	20	18	18	exenatide	GLP-1	PA164749238	100125288	0.505
NULL	Lab_Invest_2014_May_10_94(5)_503-516.nxml.txt.nlp	24614199	SENT248	21	21	23	23	curcumin	NAC	PA151958596	22861	0.505
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Dec_14_68(Pt_1)_o116.nxml.txt.nlp	22259403	SENT73	2	2	16	16	nitrogen	mol	PA450643	90527	0.505
NULL	Ann_Clin_Transl_Neurol_2014_Jan_20_1(1)_15-26.nxml.txt.nlp	25356379	SENT160	5	5	21	21	isoflurane	EGO	PA450106	100126791	0.504
NULL	Front_Mol_Neurosci_2014_Dec_1_7_94.nxml.txt.nlp	25520615	SENT28	1	1	17	17	ketamine	CA1	PA450144	759	0.504
NULL	J_Clin_Biochem_Nutr_2009_Jul_30_45(1)_9-13.nxml.txt.nlp	19590701	SENT323	32	32	4	4	lansoprazole	HO-1	PA450180	3162	0.504
NULL	J_Young_Pharm_2010_Apr-Jun_2(2)_162-168.nxml.txt.nlp	21264120	SENT149	35	35	29	29	diclofenac	N10	PA449293	3164	0.504
NULL	Patient_Prefer_Adherence_2008_Feb_2_2_167-175.nxml.txt.nlp	19920959	SENT19	21	21	38	38	ticlopidine	DES	PA451686	1674	0.504
NULL	J_Autom_Methods_Manag_Chem_2007_Apr_23_2007_71943.nxml.txt.nlp	18528514	SENT1708	5	5	8	8	trypsin	FOR	PA451806	51741	0.504
NULL	Hum_Mol_Genet_2013_Nov_15_22(22)_4616-4626.nxml.txt.nlp	23814041	SENT38	5	5	10	10	doxycycline	neuroserpin	PA449415	5274	0.504
NULL	J_Med_Chem_2014_Feb_13_57(3)_1079-1089.nxml.txt.nlp	24456116	SENT651	12	12	20	20	piperazine	FAAH	PA450977	79152;2166	0.504
NULL	Hum_Genomics_2008_Sep_1_3(1)_71-78.nxml.txt.nlp	19129091	SENT32	17	17	28	28	nadh	ND4	PA164755085	4538	0.504
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT108	32	32	35	35	glucose	EGFR	PA449773	1956	0.504
NULL	Oncol_Lett_2014_Jul_16_8(1)_211-217.nxml.txt.nlp	24959248	SENT93	9	9	3	3	cisplatin	ALDOA	PA449014	226	0.504
NULL	Int_J_Cell_Biol_2013_Nov_18_2013_797914.nxml.txt.nlp	24348565	SENT190	5	5	3	3	bacitracin	PDIA3	PA448531	2923	0.504
NULL	Arthritis_Res_2002_Mar_19_4(4)_266-273.nxml.txt.nlp	12106498	SENT118	0	0	8	8	methotrexate	IFN	PA450428	3439	0.504
NULL	Cell_Host_Microbe_2014_Jul_9_16(1)_10-18.nxml.txt.nlp	25011104	SENT66	25	25	9	9	cyclosporine	CPSF6	PA449167	11052	0.504
NULL	Evid_Based_Complement_Alternat_Med_2013_Oct_21_2013_901943.nxml.txt.nlp	24288569	SENT94	6	6	29	29	thrombin	FIB	PA451674	2091	0.504
NULL	Anat_Cell_Biol_2011_Sep_29_44(3)_169-175.nxml.txt.nlp	22025968	SENT66	25	25	5	5	ethanol	CLU	PA448073	1191	0.504
NULL	J_Neuroinflammation_2010_Nov_18_7_81.nxml.txt.nlp	21087489	SENT74	1	1	10	10	pilocarpine	BDNF	PA450962	627	0.504
NULL	Cancer_Med_2013_Oct_19_2(5)_646-653.nxml.txt.nlp	24403230	SENT94	14	14	19	19	trastuzumab	SESN1	PA451743	27244	0.504
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT262	11	11	13	13	chloroquine	BMPR-II	PA448948	659	0.504
NULL	Ann_Hematol_2014_Sep_12_93(1)_13-32.nxml.txt.nlp	24026426	SENT274	11	11	29	29	posaconazole	BII	PA151958574	777	0.504
NULL	Clin_Mol_Hepatol_2014_Sep_25_20(3)_283-290.nxml.txt.nlp	25320732	SENT62	4	4	15	15	propranolol	EVL	PA451145	51466	0.504
NULL	Eur_J_Clin_Pharmacol_2008_Feb_26_64(2)_133-157.nxml.txt.nlp	18224312	SENT544	45	45	4	4	trimipramine	CYP2D6	PA451791	1565	0.504
NULL	Environ_Health_Perspect_2010_Jun_25_118(6)_864-870.nxml.txt.nlp	20100676	SENT139	9	9	12	12	arsenite	INS-1	PA452638	2305	0.504
NULL	Arthritis_Res_Ther_2005_Oct_18_7(6)_R1412-R1420.nxml.txt.nlp	16277694	SENT49	6	6	10	10	fluorescein	TLR4	PA164746009	7099	0.504
NULL	J_Infect_Dis_2013_Aug_15_208(4)_637-644.nxml.txt.nlp	23633403	SENT68	32	32	24	24	calcein	LAMP	PA132595336	4045;27074	0.504
NULL	J_Clin_Biochem_Nutr_2009_Jul_30_45(1)_74-81.nxml.txt.nlp	19590710	SENT68	0	0	8	8	fluorescein	CD4	PA164746009	920	0.504
NULL	Mol_Med_Rep_2015_Jan_23_11(1)_151-158.nxml.txt.nlp	25352008	SENT268	20	20	16	16	resveratrol	AKT		207	0.504
NULL	Acta_Pharmacol_Sin_2009_Jan_8_30(1)_25-30.nxml.txt.nlp	19060918	SENT36	10	10	6	6	ribavirin	IFN	PA451241	3439	0.504
NULL	Eur_J_Clin_Microbiol_Infect_Dis_2010_Nov_1_29(11)_1361-1367.nxml.txt.nlp	20680368	SENT32	15	15	19	19	teicoplanin	VAN	PA164746244	10318	0.504
NULL	Eukaryot_Cell_2014_Mar_13(3)_412-426.nxml.txt.nlp	24442893	SENT36	21	21	27	27	chloramphenicol	PAD1	PA448927	29943	0.504
NULL	EMBO_Mol_Med_2013_Aug_5_5(8)_1213-1226.nxml.txt.nlp	23918228	SENT149	7	7	5	5	cetuximab	EGFR	PA10040	1956	0.504
NULL	F1000Res_2013_Jul_9_2_150.nxml.txt.nlp	24627787	SENT60	15	15	19	19	olanzapine	DIP	PA450688	23151;1831	0.504
NULL	Chem_Cent_J_2012_Jun_20_6_58.nxml.txt.nlp	22716299	SENT162	22	22	36	36	genistein	Gen	PA165109660	348654	0.504
NULL	Braz_J_Med_Biol_Res_2012_Feb_17_45(3)_244-249.nxml.txt.nlp	22331137	SENT23	6	6	4	4	gentamicin	PAG	PA449753	55824	0.504
NULL	Diabetes_2013_Oct_17_62(10)_3316-3323.nxml.txt.nlp	23818527	SENT268	42	42	39	39	liraglutide	GLP-1	PA165958364	100125288	0.504
NULL	EMBO_Mol_Med_2010_Sep_2(9)_371-384.nxml.txt.nlp	20721990	SENT224	20	20	24	24	nadh	ND3	PA164755085	4537	0.504
NULL	Breast_Cancer_Res_2011_Mar_14_13(2)_205.nxml.txt.nlp	21457526	SENT27	7	7	15	15	anastrozole	ATAC	PA448432	6375	0.504
NULL	Cancers_(Basel)_2012_Apr_5_4(2)_354-378.nxml.txt.nlp	24213315	SENT771	1	1	17	17	cisplatin	TRAIL	PA449014	8743	0.504
NULL	J_Am_Heart_Assoc_2013_Aug_23_2(4)_e000318.nxml.txt.nlp	23926118	SENT117	33	33	29	29	isoproterenol	AC3	PA450121	109	0.504
NULL	Cardiol_Res_Pract_2011_Aug_15_2011_156146.nxml.txt.nlp	21876822	SENT33	36	36	39	39	potassium	KIR	PA451047	2669	0.504
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT308	12	12	14	14	paclitaxel	ABCC10	PA450761	89845	0.504
NULL	Clin_Ophthalmol_2011_Apr_18_5_495-502.nxml.txt.nlp	21573098	SENT117	20	20	26	26	gatifloxacin	BAK	PA449738	578	0.504
NULL	ISME_J_2014_Sep_27_8(9)_1843-1854.nxml.txt.nlp	24671086	SENT112	10	10	22	22	ethanol	CO2	PA448073	4513	0.504
NULL	Comp_Funct_Genomics_2009_Jun_1_2009_837514.nxml.txt.nlp	19753298	SENT157	18	18	9	9	doxorubicin	HMGA2	PA449412	8091	0.504
NULL	Genome_Biol_2003_Jan_6_4(1)_R5.nxml.txt.nlp	12540297	SENT138	42	42	31	31	creatine	gamma	PA164778930	9913	0.504
NULL	Gut_Pathog_2014_Jul_29_6_33.nxml.txt.nlp	25110521	SENT200	26	26	19	19	dextran	IL-10	PA449261	3586	0.504
NULL	ACS_Med_Chem_Lett_2012_Jan_30_3(3)_232-237.nxml.txt.nlp	22408714	SENT265	9	9	15	15	thrombin	PAR1	PA451674	79581;2149	0.504
NULL	J_Mol_Med_(Berl)_2013_Aug_17_91(11)_1257-1271.nxml.txt.nlp	23955016	SENT199	13	13	38	38	thrombin	p38	PA451674	10598;1432;7965	0.504
NULL	J_Cell_Biol_2005_Nov_21_171(4)_603-614.nxml.txt.nlp	16286508	SENT325	9	9	12	12	dextran	EGF	PA449261	1950	0.504
NULL	Exp_Ther_Med_2014_Feb_25_7(2)_417-422.nxml.txt.nlp	24396417	SENT165	16	16	23	23	fluorescein	CD25	PA164746009	3669;3559	0.504
NULL	Front_Genet_2012_Nov_12_3_235.nxml.txt.nlp	23162568	SENT35	5	5	0	0	methamphetamine	CYP2D6	PA450403	1565	0.504
NULL	Comp_Funct_Genomics_2012_Feb_13_2012_208390.nxml.txt.nlp	22400010	SENT149	18	18	6	6	glucose	ROS	PA449773	6098	0.504
NULL	Curr_Neuropharmacol_2008_Sep_6(3)_193-202.nxml.txt.nlp	19506720	SENT352	15	15	5	5	bupropion	p75	PA448687	7133;11168	0.504
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT110	3	3	23	23	perifosine	DR5	PA165291471	8795	0.504
NULL	Cancers_(Basel)_2013_Jul_4_5(3)_838-856.nxml.txt.nlp	24202322	SENT192	2	2	18	18	flavopiridol	HEXIM1	PA452627	10614	0.504
NULL	Structure_2013_Sep_3_21(9)_1581-1589.nxml.txt.nlp	23911089	SENT126	10	10	5	5	nadh	ADP	PA164755085	23038	0.504
NULL	Indian_J_Anaesth_2012_Mar-Apr_56(2)_139-144.nxml.txt.nlp	22701204	SENT61	13	13	28	28	succinylcholine	CO2	PA451522	4513	0.504
NULL	Diabetes_2009_Jul_28_58(7)_1659-1667.nxml.txt.nlp	19401417	SENT37	15	15	11	11	aspirin	ARI	PA448497	25820	0.504
NULL	Int_J_Mol_Sci_2014_Jun_5_15(6)_10034-10051.nxml.txt.nlp	24905404	SENT587	1	1	7	7	pemetrexed	AMPK	PA10810	5563	0.504
NULL	Oncotarget_2011_Apr_20_2(4)_274-276.nxml.txt.nlp	21512204	SENT31	1	1	10	10	nutlin-3	p53		7157	0.504
NULL	Cancer_Med_2013_Aug_29_2(4)_478-487.nxml.txt.nlp	24156020	SENT51	9	9	27	27	fluorescein	YTS	PA164746009	8565	0.504
NULL	Adv_Urol_2012_Dec_1_2012_823582.nxml.txt.nlp	22190920	SENT185	18	18	7	7	estradiol	PRL	PA449503	5617	0.504
NULL	An_Bras_Dermatol_2013_Sep-Oct_88(5)_844-846.nxml.txt.nlp	24173202	SENT8	44	44	42	42	imiquimod	CO2	PA449972	4513	0.504
NULL	Clinics_(Sao_Paulo)_2014_Jan_69(1)_68-74.nxml.txt.nlp	24473562	SENT19	20	20	22	22	nutlin-3	p53		7157	0.504
NULL	Diabetes_Care_2013_Aug_17_36(Suppl_2)_S245-S252.nxml.txt.nlp	23882053	SENT72	15	15	13	13	exenatide	GLP-1	PA164749238	100125288	0.504
NULL	J_Am_Heart_Assoc_2013_Dec_19_2(6)_e000433.nxml.txt.nlp	24275630	SENT391	30	30	18	18	troglitazone	gamma	PA451799	9913	0.504
NULL	Biomed_Res_Int_2013_Jun_13_2013_493643.nxml.txt.nlp	23841073	SENT218	3	3	5	5	estradiol	ACTH	PA449503	5443	0.504
NULL	Breast_Cancer_Res_2010_Jun_22_12(3)_R39.nxml.txt.nlp	20569502	SENT226	4	4	15	15	tamoxifen	IER3	PA451581	8870	0.504
NULL	Int_J_Mol_Sci_2007_Jan_29_8(1)_13-28.nxml.txt.nlp	NULL	SENT86	31	31	33	33	galactose	NAG	PA449725	51594;4669	0.504
NULL	Nat_Commun_2014_5_3078.nxml.txt.nlp	24452013	SENT342	0	0	2	2	tetracycline	DAZAP1	PA451640	26528	0.504
NULL	Bioinformation_2006_Dec_23_1(8)_314-320.nxml.txt.nlp	17597912	SENT156	3	3	9	9	methotrexate	ACE	PA450428	1636	0.504
NULL	Int_J_Mol_Sci_2014_Oct_28_15(11)_19650-19661.nxml.txt.nlp	25353180	SENT78	15	15	5	5	fluorescein	SEMA7A	PA164746009	8482	0.504
NULL	Amino_Acids_2011_May_22_40(5)_1369-1383.nxml.txt.nlp	21424716	SENT217	11	11	14	14	creatine	CEE	PA164778930	51608	0.504
NULL	J_Clin_Biochem_Nutr_2009_Jan_27_44(1)_28-40.nxml.txt.nlp	19177185	SENT22	0	0	9	9	dobutamine	HO-1	PA449381	3162	0.504
NULL	Drug_Des_Devel_Ther_2014_Sep_23_8_1527-1538.nxml.txt.nlp	25284985	SENT174	2	2	0	0	celecoxib	IFN	PA448871	3439	0.504
NULL	Patient_Prefer_Adherence_2009_Nov_3_3_9-20.nxml.txt.nlp	19936140	SENT354	17	17	20	20	temazepam	6-16	PA451608	2537	0.504
NULL	Cancer_Cell_Int_2013_Jun_26_13_63.nxml.txt.nlp	23800022	SENT210	0	0	9	9	genistein	ATF3	PA165109660	467	0.504
NULL	Mol_Cells_2014_Jun_30_37(6)_497-502.nxml.txt.nlp	24938227	SENT38	32	32	19	19	trypsin	CTK	PA451806	4145	0.504
NULL	Osong_Public_Health_Res_Perspect_2013_Feb_4(1)_27-33.nxml.txt.nlp	24159526	SENT174	10	10	12	12	gentamicin	CTX	PA449753	1593	0.504
NULL	Front_Mol_Neurosci_2012_Feb_24_5_22.nxml.txt.nlp	22375105	SENT68	38	38	10	10	spermine	CA1	PA164781199	759	0.504
NULL	Int_J_Hypertens_2012_Nov_30_2012_192567.nxml.txt.nlp	22187625	SENT164	35	35	41	41	candesartan	ANOVA	PA448765	4858	0.504
NULL	Brain_Sci_2014_Apr_22_4(2)_311-320.nxml.txt.nlp	24961763	SENT80	17	17	14	14	isoflurane	CO2	PA450106	4513	0.504
NULL	Clin_Exp_Gastroenterol_2012_Jul_19_5_139-150.nxml.txt.nlp	22888267	SENT130	12	12	9	9	indomethacin	I-FABP	PA449982	2169	0.504
NULL	Diabetologia_2010_Jan_22_53(1)_111-114.nxml.txt.nlp	19847395	SENT40	6	6	26	26	ketamine	STZ	PA450144	6484	0.504
NULL	Cancer_Metab_2013_Dec_23_1_23.nxml.txt.nlp	24359630	SENT37	28	28	18	18	sugar	TKTL1	PA451529	8277	0.504
NULL	Hum_Genomics_2009_Apr_1_3(3)_213-220.nxml.txt.nlp	19403456	SENT41	7	7	1	1	ethanol	ALDH2	PA448073	217	0.504
NULL	Mol_Vis_2011_Dec_24_17_3384-3391.nxml.txt.nlp	22219634	SENT135	18	18	25	25	mannitol	TLR4	PA450320	7099	0.504
NULL	Crit_Care_2006_Feb_3_10(1)_R24.nxml.txt.nlp	16469128	SENT149	13	13	40	40	heparin	TP2	PA449855	7015;7142	0.504
NULL	Int_J_Mol_Sci_2012_Aug_23_13(8)_10608-10629.nxml.txt.nlp	22949883	SENT977	19	19	38	38	creatine	alpha-synuclein	PA164778930	6622	0.504
NULL	Arthritis_Res_Ther_2011_Feb_16_13(1)_R25.nxml.txt.nlp	21324169	SENT120	10	10	4	4	anakinra	ADA	PA10799	100	0.504
NULL	J_Biomed_Sci_2013_Jan_25_20(1)_4.nxml.txt.nlp	23350663	SENT40	3	3	7	7	thrombin	ADP	PA451674	23038	0.504
NULL	J_Cell_Biol_2008_Jul_28_182(2)_327-340.nxml.txt.nlp	18644889	SENT35	23	23	37	37	estradiol	CRM1	PA449503	7514	0.504
NULL	Acta_Vet_Scand_2012_Sep_24_54(1)_56.nxml.txt.nlp	23006678	SENT102	9	9	19	19	ethanol	DRB1	PA448073	129831	0.504
NULL	Oncotarget_2012_Nov_8_3(11)_1472-1482.nxml.txt.nlp	23178531	SENT86	43	43	31	31	iron	IRP1	PA450087	48	0.504
NULL	Child_Adolesc_Psychiatry_Ment_Health_2012_May_29_6_21.nxml.txt.nlp	22643087	SENT306	11	11	22	22	clomipramine	Gen	PA449048	348654	0.504
NULL	Front_Neurosci_2014_Dec_5_8_398.nxml.txt.nlp	25538552	SENT167	14	14	11	11	glucose	gamma	PA449773	9913	0.504
NULL	Cardiovasc_Diabetol_2010_Nov_5_9_72.nxml.txt.nlp	21054861	SENT43	5	5	2	2	isoproterenol	STZ	PA450121	6484	0.504
NULL	Case_Rep_Med_2014_Mar_4_2014_923496.nxml.txt.nlp	24715926	SENT142	19	19	38	38	tocilizumab	IL-6	PA165292659	3569	0.504
NULL	Hum_Mol_Genet_2012_Sep_15_21(18)_4060-4072.nxml.txt.nlp	22706278	SENT299	32	32	9	9	fluorescein	ADP	PA164746009	23038	0.504
NULL	Int_J_Mol_Sci_2012_Feb_1_13(2)_1512-1523.nxml.txt.nlp	22408405	SENT60	4	4	18	18	olmesartan	LOX-1	PA164742950	4973	0.504
NULL	Int_J_Mol_Sci_2014_Oct_20_15(10)_18967-18984.nxml.txt.nlp	25334065	SENT610	7	7	15	15	ethanol	S20	PA448073	6224	0.504
NULL	Mol_Pain_2013_Dec_21_9_66.nxml.txt.nlp	24359609	SENT120	14	14	27	27	capsaicin	TRPV1	PA448776	7442	0.504
NULL	Cancers_(Basel)_2011_Apr_1_3(2)_1844-1860.nxml.txt.nlp	24212785	SENT552	0	0	26	26	cetuximab	KRAS	PA10040	3845	0.504
NULL	Drug_Des_Devel_Ther_2014_Sep_23_8_1527-1538.nxml.txt.nlp	25284985	SENT142	17	17	14	14	celecoxib	IFN	PA448871	3439	0.504
NULL	Pharmaceuticals_(Basel)_2012_Sep_12_5(9)_963-990.nxml.txt.nlp	24280700	SENT335	0	0	5	5	vorinostat	p27	PA164748224	5715;10534	0.504
NULL	J_Vis_Exp_2008_Nov_5_(21)_820.nxml.txt.nlp	19066533	SENT150	15	15	8	8	phenol	CO2	PA450913	4513	0.504
NULL	Indian_J_Med_Res_2013_May_137(5)_977-980.nxml.txt.nlp	23760386	SENT59	21	21	14	14	galantamine	ADP	PA449726	23038	0.504
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Aug_17_67(Pt_9)_o2362-o2363.nxml.txt.nlp	22064645	SENT69	4	4	18	18	phenol	C11	PA450913	1109	0.504
NULL	Indian_J_Pharm_Sci_2013_May-Jun_75(3)_251-261.nxml.txt.nlp	24082340	SENT59	28	28	16	16	trastuzumab	HER2	PA451743	2064	0.504
NULL	Arch_Dis_Child_2014_Dec_8_99(12)_1143-1146.nxml.txt.nlp	25202131	SENT58	13	13	5	5	phenytoin	CYP1A2	PA450947	1544	0.504
NULL	Diabetes_2013_Sep_15_62(9)_3151-3162.nxml.txt.nlp	23649518	SENT327	15	15	13	13	cisplatin	p53	PA449014	7157	0.504
NULL	Indian_J_Ophthalmol_2009_Mar-Apr_57(2)_91-97.nxml.txt.nlp	19237780	SENT171	14	14	18	18	vincristine	CHOP	PA451879	1649	0.504
NULL	J_Gastroenterol_2013_Jan_27_48(1)_22-30.nxml.txt.nlp	23104468	SENT71	22	22	20	20	ribavirin	IFN	PA451241	3439	0.504
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT294	2	2	17	17	resveratrol	Bcl-2		596	0.504
NULL	Cancer_Causes_Control_2013_Aug_18_24(8)_1605-1614.nxml.txt.nlp	23775025	SENT64	25	25	20	20	methotrexate	GSTM1	PA450428	2944	0.504
NULL	Am_J_Trop_Med_Hyg_2014_Aug_6_91(2)_424-434.nxml.txt.nlp	24799369	SENT297	7	7	9	9	zinc	ACT	PA451956	12;11332;9457;641455	0.504
NULL	EMBO_Mol_Med_2011_Apr_3(4)_235-245.nxml.txt.nlp	21374818	SENT30	32	32	11	11	ampicillin	beta-globin	PA448419	3043	0.504
NULL	Diabetes_2013_Sep_15_62(9)_3019-3021.nxml.txt.nlp	23970522	SENT39	9	9	17	17	chymotrypsin	GLP-1	PA448994	100125288	0.504
NULL	Appl_Microbiol_Biotechnol_2013_Oct_8_97(22)_9637-9646.nxml.txt.nlp	24100684	SENT143	19	19	23	23	lindane	PCB	PA164754914	5091	0.504
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Mar_22_70(Pt_4)_m139.nxml.txt.nlp	24826100	SENT3	15	15	3	3	piperazine	mol	PA450977	90527	0.504
NULL	J_Cell_Sci_2014_May_15_127(10)_2313-2325.nxml.txt.nlp	24634514	SENT93	14	14	9	9	galactose	HSP60	PA449725	3329	0.504
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT3	20	20	15	15	trastuzumab	EGF	PA451743	1950	0.504
NULL	J_Cell_Biol_2001_Oct_29_155(3)_427-438.nxml.txt.nlp	11673478	SENT11	19	19	17	17	pp2	PP1		5540;5464	0.504
NULL	Environ_Health_Perspect_2006_Apr_21_114(Suppl_1)_20-26.nxml.txt.nlp	16818242	SENT179	17	17	27	27	cyproterone	TPT	PA10049	23590;6469	0.504
NULL	Nat_Biotechnol_2010_May_28(5)_478-485.nxml.txt.nlp	20458318	SENT208	14	14	18	18	paraformaldehyde	PLP	PA450790	25824;5744	0.504
NULL	Breast_Cancer_Res_2011_Mar_11_13(2)_R29.nxml.txt.nlp	21396094	SENT208	9	9	6	6	fulvestrant	HRG	PA164747170	3084;3273	0.504
NULL	Mol_Cancer_2010_Jun_25_9_165.nxml.txt.nlp	20576164	SENT237	18	18	3	3	curcumin	STAT3	PA151958596	6774	0.504
NULL	Cell_Death_Dis_2010_Sep_23_1(9)_e78.nxml.txt.nlp	21364680	SENT65	5	5	15	15	cisplatin	XIAP	PA449014	331	0.504
NULL	Croat_Med_J_2012_Jun_53(3)_224-233.nxml.txt.nlp	22661135	SENT73	43	43	27	27	sulpiride	PRL	PA164745485	5617	0.504
NULL	Front_Synaptic_Neurosci_2010_Sep_28_2_138.nxml.txt.nlp	21423524	SENT27	25	25	12	12	diazepam	GAD65	PA449283	2572	0.504
NULL	Extremophiles_2009_Sep_5_13(5)_769-783.nxml.txt.nlp	19579003	SENT391	12	12	17	17	lipase	Gen	PA450239	348654	0.504
NULL	Cell_Res_2014_Jun_18_24(6)_665-679.nxml.txt.nlp	24638034	SENT162	27	27	31	31	heparin	EGF	PA449855	1950	0.504
NULL	Ann_Hematol_2011_May_21_90(5)_601-602.nxml.txt.nlp	20730538	SENT46	9	9	16	16	ifosfamide	SMILE	PA449964	160418	0.504
NULL	Oxid_Med_Cell_Longev_2011_Aug_15_2011_824597.nxml.txt.nlp	21904648	SENT19	2	2	5	5	camptothecin	TPT	PA153590860	23590;6469	0.504
NULL	Diabetes_Care_2009_Nov_32(Suppl_2)_S362-S367.nxml.txt.nlp	19875582	SENT198	10	10	16	16	simvastatin	adiponectin	PA451363	9370	0.504
NULL	Curr_Neuropharmacol_2014_Jul_12(4)_365-379.nxml.txt.nlp	25342944	SENT534	8	8	5	5	fluoxetine	5-HT2B	PA449673	3357	0.504
NULL	Open_Med_Chem_J_2011_Sep_9_5_82-92.nxml.txt.nlp	21966329	SENT69	16	16	3	3	exenatide	GLP-1	PA164749238	100125288	0.504
NULL	Front_Aging_Neurosci_2010_Mar_18_2_10.nxml.txt.nlp	20552048	SENT395	0	0	6	6	resveratrol	SIRT1		23411	0.504
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT7	0	0	34	34	resveratrol	survivin		332	0.504
NULL	Mol_Vis_2011_Aug_18_17_2221-2227.nxml.txt.nlp	21897744	SENT89	0	0	2	2	l-arginine	ARG	PA448478	473;27	0.504
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT29	20	20	16	16	imatinib	ABCB1	PA10804	5243	0.504
NULL	Virol_J_2009_Dec_1_6_213.nxml.txt.nlp	19951438	SENT142	32	32	34	34	etoposide	TRAIL	PA449552	8743	0.504
NULL	Evid_Based_Complement_Alternat_Med_2013_Mar_14_2013_429706.nxml.txt.nlp	23573127	SENT139	0	0	13	13	indomethacin	CD90	PA449982	7070	0.504
NULL	J_Korean_Med_Sci_2009_Jan_29_24(Suppl_1)_S170-S175.nxml.txt.nlp	19194548	SENT41	23	23	32	32	cisplatin	EPO	PA449014	7076;8288;2056	0.504
NULL	Cardiovasc_Diabetol_2013_May_4_12_73.nxml.txt.nlp	23642288	SENT47	15	15	27	27	heparin	Tech	PA449855	57449	0.504
NULL	Clin_Ophthalmol_2014_Jan_13_8_219-228.nxml.txt.nlp	24531757	SENT157	18	18	4	4	brinzolamide	TIM	PA164744929	7984;8914	0.504
NULL	Diagn_Pathol_2014_Jan_20_9_11.nxml.txt.nlp	24443801	SENT26	15	15	13	13	trypsin	SMAD4	PA451806	4089	0.504
NULL	Diabetes_2011_May_23_60(5)_1361-1369.nxml.txt.nlp	21525507	SENT108	16	16	4	4	glucose	MRS	PA449773	8011	0.504
NULL	Toxins_(Basel)_2010_Oct_26_2(11)_2490-2518.nxml.txt.nlp	22069563	SENT1470	6	6	1	1	cisplatin	p38	PA449014	10598;1432;7965	0.503
NULL	Cardiovasc_Diabetol_2013_Jun_7_12_84.nxml.txt.nlp	23759020	SENT212	7	7	5	5	dipyridamole	LSR	PA449367	51599	0.503
NULL	Proteome_Sci_2009_Sep_28_7_37.nxml.txt.nlp	19785748	SENT81	21	21	11	11	trypsin	Met	PA451806	79811	0.503
NULL	Lab_Invest_2011_Jun_14_91(6)_852-858.nxml.txt.nlp	21403643	SENT6	31	31	24	24	tenofovir	MRP4	PA10204	10257	0.503
NULL	ScientificWorldJournal_2012_Apr_22_2012_643904.nxml.txt.nlp	22619632	SENT100	3	3	1	1	pp2	PP1		5540;5464	0.503
NULL	Int_J_Gen_Med_2014_Apr_11_7_193-203.nxml.txt.nlp	24748813	SENT114	11	11	8	8	ribavirin	IFN	PA451241	3439	0.503
NULL	Nucleic_Acids_Res_2005_Oct_19_33(18)_5819-5828.nxml.txt.nlp	16237123	SENT364	9	9	11	11	cisplatin	HMGB1	PA449014	3146	0.503
NULL	Indian_J_Pharm_Sci_2013_Nov-Dec_75(6)_649-656.nxml.txt.nlp	24591739	SENT41	23	23	20	20	tacrine	DTNB	PA451576	1838	0.503
NULL	Int_J_Biol_Sci_2013_Apr_22_9(4)_350-360.nxml.txt.nlp	23630447	SENT188	20	20	11	11	doxorubicin	MDR1	PA449412	5243	0.503
NULL	Int_J_Cell_Biol_2013_Nov_17_2013_769536.nxml.txt.nlp	24348564	SENT3	20	20	9	9	estradiol	HSD1	PA449503	26871	0.503
NULL	Biofactors_2014_May_6_40(3)_277-283.nxml.txt.nlp	24353111	SENT50	13	13	9	9	choline	PEMT	PA448976	10400	0.503
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT122	0	0	7	7	nutlin-3	MDM2		4193	0.503
NULL	F1000_Med_Rep_2009_Nov_26_1_90.nxml.txt.nlp	20948687	SENT18	6	6	8	8	sunitinib	IFN	PA162372840	3439	0.503
NULL	J_Oncol_2012_Sep_29_2012_879623.nxml.txt.nlp	21977033	SENT175	7	7	29	29	tamoxifen	NAC	PA451581	22861	0.503
NULL	FEBS_Open_Bio_2013_Dec_30_4_96-104.nxml.txt.nlp	24490130	SENT133	15	15	13	13	cisplatin	BRCA1	PA449014	672	0.503
NULL	Eur_J_Med_Res_2014_Nov_29_19(1)_65.nxml.txt.nlp	25432384	SENT209	14	14	12	12	hyaluronan	ADAMTS5	PA165958431	11096	0.503
NULL	Int_Ophthalmol_2012_Dec_31_32(6)_577-582.nxml.txt.nlp	22847248	SENT17	25	25	32	32	mannitol	ALPI	PA450320	248	0.503
NULL	AMB_Express_2014_Apr_1_4_20.nxml.txt.nlp	24949255	SENT112	23	23	10	10	kanamycin	GP2	PA450137	2813	0.503
NULL	Curr_Neuropharmacol_2013_Dec_11(6)_652-663.nxml.txt.nlp	24396340	SENT240	5	5	7	7	capsaicin	TRPV1	PA448776	7442	0.503
NULL	Basic_Res_Cardiol_2013_Mar_1_108(2)_339.nxml.txt.nlp	23455426	SENT53	23	23	14	14	paraformaldehyde	E12	PA450790	64100	0.503
NULL	Int_J_Mol_Sci_2014_Jun_26_15(7)_11403-11415.nxml.txt.nlp	24972136	SENT21	16	16	32	32	abacavir	APOC3	PA448004	345	0.503
NULL	Ther_Clin_Risk_Manag_2007_Aug_3(4)_569-578.nxml.txt.nlp	18472978	SENT240	26	26	5	5	enalapril	MDC	PA449456	6367	0.503
NULL	Front_Neurol_2012_Apr_3_3_50.nxml.txt.nlp	22485107	SENT102	9	9	2	2	pilocarpine	HCN	PA450962	378938	0.503
NULL	Bioinformatics_2013_Jul_1_29(13)_i9-i17.nxml.txt.nlp	23813014	SENT60	16	16	36	36	glutaraldehyde	P14	PA449777	11102;;6280;56259	0.503
NULL	Front_Immunol_2012_Feb_27_3_23.nxml.txt.nlp	22566907	SENT405	2	2	14	14	hyaluronan	ERM	PA165958431	2119	0.503
NULL	Int_J_Cell_Biol_2014_May_8_2014_467452.nxml.txt.nlp	24899897	SENT272	12	12	15	15	trypsin	HOA	PA451806	4148	0.503
NULL	Exp_Ther_Med_2014_Apr_13_7(4)_799-803.nxml.txt.nlp	24669235	SENT64	18	18	12	12	vildagliptin	PPG	PA165958346	5552	0.503
NULL	Med_Sci_Monit_2013_Dec_23_19_1195-1210.nxml.txt.nlp	24362017	SENT422	2	2	11	11	vasopressin	AVP	PA451858	114548;551	0.503
NULL	Ann_Surg_Treat_Res_2014_Feb_22_86(2)_68-75.nxml.txt.nlp	24761411	SENT11	4	4	11	11	resveratrol	survivin		332	0.503
NULL	Core_Evid_2009_Jun_15_4_25-36.nxml.txt.nlp	20694062	SENT325	41	41	13	13	fenofibrate	ACTH	PA449594	5443	0.503
NULL	Nat_Commun_2013_Oct_15_4_2602.nxml.txt.nlp	24129506	SENT155	14	14	27	27	ethanol	S24	PA448073	6229	0.503
NULL	Adv_Urol_2014_May_28_2014_746298.nxml.txt.nlp	24982672	SENT140	13	13	6	6	carboplatin	NAC	PA448803	22861	0.503
NULL	Clin_Med_Insights_Oncol_2012_Aug_16_6_287-303.nxml.txt.nlp	22933844	SENT87	10	10	8	8	denosumab	RANKL	PA166048634	8600	0.503
NULL	J_Biol_Chem_2013_Nov_15_288(46)_33049-33059.nxml.txt.nlp	24089524	SENT203	0	0	10	10	nicotine	CAM	PA450626	889	0.503
NULL	Acta_Naturae_2012_Jan-Mar_4(1)_93-100.nxml.txt.nlp	22708069	SENT186	12	12	28	28	methotrexate	DHFR	PA450428	1719	0.503
NULL	Cancer_Causes_Control_2013_Aug_18_24(8)_1605-1614.nxml.txt.nlp	23775025	SENT64	25	25	41	41	methotrexate	GSTM2	PA450428	2946	0.503
NULL	Curr_Med_Chem_2013_Jan_20(3)_438-447.nxml.txt.nlp	23157636	SENT453	22	22	6	6	olanzapine	FGA	PA450688	2243	0.503
NULL	Exp_Ther_Med_2013_Jan_22_5(1)_247-252.nxml.txt.nlp	23251277	SENT90	28	28	39	39	alendronate	GAPDH	PA448082	2597	0.503
NULL	Int_J_Nanomedicine_2009_Apr_1_4_27-35.nxml.txt.nlp	19421368	SENT101	21	21	16	16	genistein	IFN	PA165109660	3439	0.503
NULL	Exp_Diabetes_Res_2012_Nov_12_2012_618923.nxml.txt.nlp	23197974	SENT198	27	27	30	30	telmisartan	STZ	PA451605	6484	0.503
NULL	Korean_Circ_J_2013_Nov_30_43(11)_744-751.nxml.txt.nlp	24363750	SENT87	27	27	31	31	paclitaxel	PES	PA450761	23481	0.503
NULL	Front_Neural_Circuits_2013_Oct_2_7_155.nxml.txt.nlp	24106462	SENT140	38	38	24	24	apomorphine	CPU	PA164781163	1361	0.503
NULL	Front_Neurosci_2011_Feb_2_5_12.nxml.txt.nlp	21344007	SENT224	6	6	8	8	capsaicin	NR1	PA448776	27158	0.503
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT812	22	22	20	20	glucose	GLUT9	PA449773	11182	0.503
NULL	Sci_Rep_2014_Dec_4_4_7310.nxml.txt.nlp	25472472	SENT127	2	2	9	9	decitabine	CD34	PA164749631	947	0.503
NULL	Cytojournal_2014_May_22_11_11.nxml.txt.nlp	24987442	SENT40	12	12	9	9	thyroglobulin	TTF-1	PA164754910	7080	0.503
NULL	Breast_Cancer_Res_2005_May_31_7(5)_R609-R616.nxml.txt.nlp	16168105	SENT71	9	9	19	19	fluorescein	San	PA164746009	80218	0.503
NULL	Cancer_Manag_Res_2014_Oct_17_6_423-430.nxml.txt.nlp	25378950	SENT142	6	6	15	15	tamoxifen	STAR	PA451581	6770;2984	0.503
NULL	Adv_Ther_2014_Dec_2_31_1228-1246.nxml.txt.nlp	25447269	SENT204	4	4	19	19	tafluprost	TIM	PA165958432	7984;8914	0.503
NULL	Breast_Cancer_Res_2007_Jul_5_9(4)_R41.nxml.txt.nlp	17612393	SENT37	27	27	13	13	celecoxib	Bcl-2	PA448871	596	0.503
NULL	Curr_Med_Chem_2013_Jan_20(3)_438-447.nxml.txt.nlp	23157636	SENT168	28	28	17	17	olanzapine	FGA	PA450688	2243	0.503
NULL	Br_J_Cancer_2010_Jul_27_103(3)_315-323.nxml.txt.nlp	20661248	SENT270	17	17	6	6	irinotecan	UGT1A1	PA450085	54658	0.503
NULL	Evid_Based_Complement_Alternat_Med_2014_Oct_19_2014_628712.nxml.txt.nlp	25389442	SENT114	0	0	10	10	erlotinib	PTEN	PA134687924	5728	0.503
NULL	Curr_Oncol_2009_Jul_16(Suppl_2)_S14-S23.nxml.txt.nlp	19672417	SENT202	20	20	0	0	exemestane	ATAC	PA449563	6375	0.503
NULL	Asian_J_Androl_2015_Jul_29_Jan-Feb_17(1)_149-153.nxml.txt.nlp	25130586	SENT42	23	23	25	25	estradiol	AMH	PA449503	268	0.503
NULL	Protein_Eng_Des_Sel_2014_Apr_28_27(4)_97-109.nxml.txt.nlp	24586053	SENT238	20	20	8	8	trastuzumab	CEA	PA451743	5670;1087	0.503
NULL	Viruses_2013_Mar_21_5(3)_902-927.nxml.txt.nlp	23518577	SENT1553	0	0	17	17	disulfiram	F11	PA449376	90338;2160	0.503
NULL	Orphanet_J_Rare_Dis_2014_Sep_2_9(1)_130.nxml.txt.nlp	NULL	SENT932	7	7	3	3	denosumab	RANKL	PA166048634	8600	0.503
NULL	Exp_Ther_Med_2014_Aug_28_8(2)_493-498.nxml.txt.nlp	25009607	SENT80	4	4	0	0	fluorescein	SP-C	PA164746009	6440	0.503
NULL	Int_J_Breast_Cancer_2012_Nov_2_2012_217185.nxml.txt.nlp	22295242	SENT203	17	17	21	21	bicalutamide	EGFR	PA164746255	1956	0.503
NULL	J_Cell_Biol_2003_Aug_4_162(3)_457-467.nxml.txt.nlp	12885762	SENT342	30	30	6	6	aprotinin	FasL	PA448472	356	0.503
NULL	Front_Zool_2008_Jul_14_5_11.nxml.txt.nlp	18625039	SENT124	15	15	31	31	lipase	LH2	PA450239	5352	0.503
NULL	Acta_Pharmacol_Sin_2011_Oct_19_32(10)_1294-1302.nxml.txt.nlp	21927013	SENT44	27	27	6	6	tacrolimus	P-gp	PA451578	5243	0.503
NULL	Mol_Cells_2014_Dec_31_37(12)_899a-906.nxml.txt.nlp	25431425	SENT479	0	0	9	9	curcumin	p50	PA151958596	958;4790	0.503
NULL	Ital_J_Pediatr_2010_Apr_21_36_33.nxml.txt.nlp	20406498	SENT349	0	0	5	5	ketotifen	Yes	PA450152	7525	0.503
NULL	Front_Oncol_2014_May_14_4_106.nxml.txt.nlp	24860786	SENT225	22	22	20	20	estradiol	p53	PA449503	7157	0.503
NULL	J_Biomed_Biotechnol_2010_Jun_7_2010_150960.nxml.txt.nlp	20617134	SENT203	26	26	12	12	erlotinib	KRAS	PA134687924	3845	0.503
NULL	J_Hematol_Oncol_2013_Feb_17_6_17.nxml.txt.nlp	23414938	SENT161	20	20	14	14	prasugrel	CD40L	PA154410481	959	0.503
NULL	Aging_(Albany_NY)_2011_Dec_10_3(11)_1078-1091.nxml.txt.nlp	22156391	SENT320	4	4	6	6	metformin	NAC	PA450395	22861	0.503
NULL	Oncogene_2013_Sep_12_32(37)_4355-4365.nxml.txt.nlp	23108409	SENT70	12	12	14	14	hyaluronan	CD44	PA165958431	960	0.503
NULL	Arthritis_Res_Ther_2011_Oct_7_13(5)_R161.nxml.txt.nlp	21982514	SENT162	15	15	23	23	etanercept	ANOVA	PA449515	4858	0.503
NULL	Br_J_Cancer_2012_Oct_9_107(8)_1233-1238.nxml.txt.nlp	22955852	SENT13	7	7	3	3	docetaxel	RPN2	PA449383	6185	0.503
NULL	J_Burns_Wounds_2005_Mar_24_4_e5.nxml.txt.nlp	16921410	SENT29	35	35	26	26	sulfadiazine	San	PA451539	80218	0.503
NULL	Nanoscale_Res_Lett_2012_Jan_16_7(1)_77.nxml.txt.nlp	22247975	SENT40	24	24	27	27	oxygen	ROS	PA450744	6098	0.503
NULL	Int_J_Breast_Cancer_2012_Nov_2_2012_217185.nxml.txt.nlp	22295242	SENT203	24	24	21	21	cetuximab	EGFR	PA10040	1956	0.503
NULL	Cell_Death_Dis_2014_Jul_3_5(7)_e1316.nxml.txt.nlp	24991768	SENT83	10	10	8	8	pemetrexed	Mcl-1	PA10810	4170	0.503
NULL	Indian_J_Pharm_Sci_2013_Sep-Oct_75(5)_523-532.nxml.txt.nlp	24403652	SENT120	20	20	6	6	atorvastatin	ATV	PA448500	4683	0.503
NULL	Int_J_Mol_Sci_2014_Oct_8_15(10)_17974-17999.nxml.txt.nlp	25299695	SENT355	12	12	7	7	curcumin	HO-1	PA151958596	3162	0.503
NULL	Nat_Commun_2011_Dec_20_2_593.nxml.txt.nlp	22186889	SENT26	28	28	11	11	doxorubicin	BRCA1	PA449412	672	0.503
NULL	Diabetes_Care_2009_Nov_32(Suppl_2)_S362-S367.nxml.txt.nlp	19875582	SENT32	26	26	2	2	lipase	LCN2	PA450239	3934	0.503
NULL	Oncogene_2009_Jan_15_28(2)_157-169.nxml.txt.nlp	18931700	SENT152	2	2	7	7	geldanamycin	CDC37	PA152031327	11140	0.503
NULL	Indian_J_Anaesth_2014_Jul-Aug_58(4)_423-429.nxml.txt.nlp	25197110	SENT5	7	7	5	5	ondansetron	ODF	PA450705	8600	0.503
NULL	Cell_Commun_Signal_2009_Feb_26_7(Suppl_1)_A63.nxml.txt.nlp	NULL	SENT20	11	11	9	9	pp2	PP2		4888	0.503
NULL	Cell_Death_Differ_2010_Sep_5_17(9)_1511-1523.nxml.txt.nlp	20203690	SENT301	8	8	15	15	ethanol	PC-3	PA448073	692094	0.503
NULL	Breast_Cancer_Res_2011_Jun_14_13(3)_R63.nxml.txt.nlp	21679465	SENT168	23	23	13	13	l-glutamine	FBS	PA10090	64319;26269	0.503
NULL	Diabetes_Care_2009_Nov_32(Suppl_2)_S232-S236.nxml.txt.nlp	19875557	SENT14	22	22	10	10	glucose	GAPDH	PA449773	2597	0.503
NULL	Cancer_Causes_Control_2013_Aug_18_24(8)_1605-1614.nxml.txt.nlp	23775025	SENT64	38	38	41	41	epirubicin	GSTM2	PA449476	2946	0.503
NULL	Indian_J_Endocrinol_Metab_2011_Oct-Dec_15(4)_251-260.nxml.txt.nlp	22028995	SENT130	3	3	7	7	stavudine	CD4	PA451494	920	0.503
NULL	J_Exp_Bot_2012_Mar_15_63(5)_1969-1983.nxml.txt.nlp	22174442	SENT257	21	21	10	10	ethanol	NO3	PA448073	4681	0.503
NULL	Open_Biomed_Eng_J_2013_Jun_14_7_50-61.nxml.txt.nlp	23847691	SENT244	14	14	23	23	collagenase	CD73	PA449107	4907	0.503
NULL	Br_J_Anaesth_2014_Jul_22_113(1)_157-167.nxml.txt.nlp	24154701	SENT166	2	2	0	0	sevoflurane	TREK-1	PA451341	3776	0.503
NULL	J_Cell_Mol_Med_2015_Jan_6_19(1)_143-154.nxml.txt.nlp	25376115	SENT45	28	28	35	35	l-glutamine	CO2	PA10090	4513	0.503
NULL	Ther_Clin_Risk_Manag_2007_Jun_3(2)_245-258.nxml.txt.nlp	18360633	SENT58	10	10	5	5	etanercept	TNF-alpha	PA449515	7124	0.503
NULL	Curr_Neuropharmacol_2014_Jan_12(1)_57-70.nxml.txt.nlp	24533016	SENT189	19	19	15	15	ketamine	Met	PA450144	79811	0.503
NULL	Int_Arch_Med_2010_Dec_13_3_36.nxml.txt.nlp	21144047	SENT452	4	4	14	14	zinc	SETBP1	PA451956	26040	0.503
NULL	Endocrinology_2011_Jul_3_152(7)_2678-2689.nxml.txt.nlp	21540289	SENT474	5	5	7	7	lipase	adiponectin	PA450239	9370	0.503
NULL	Oncotarget_2013_Apr_23_4(6)_816-829.nxml.txt.nlp	23615731	SENT87	15	15	13	13	doxycycline	HSF1	PA449415	3297	0.503
NULL	Clinics_(Sao_Paulo)_2013_Jul_68(7)_1018-1027.nxml.txt.nlp	23917669	SENT182	10	10	8	8	l-cysteine	NAC	PA449173	22861	0.503
NULL	Biologics_2009_Oct_12_3_469-474.nxml.txt.nlp	19851472	SENT71	15	15	5	5	desloratadine	IL-5	PA164776964	3567	0.503
NULL	Comp_Hepatol_2004_Jan_14_3(Suppl_1)_S31.nxml.txt.nlp	14960183	SENT106	14	14	11	11	ethanol	TNF-alpha	PA448073	7124	0.503
NULL	Curr_Hepat_Rep_2010_May_21_9(2)_75-90.nxml.txt.nlp	20461127	SENT273	13	13	19	19	telbivudine	LAM	PA164760861	7249;7248	0.503
NULL	Daru_2011_19(3)_173-186.nxml.txt.nlp	22615655	SENT52	17	17	9	9	betaine	VIII	PA448603	1351	0.503
NULL	Pediatr_Nephrol_2008_Sep_16_23(9)_1517-1521.nxml.txt.nlp	18483746	SENT73	25	25	23	23	heparin	C3b	PA449855	718	0.503
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1709-1716.nxml.txt.nlp	19844235	SENT190	15	15	17	17	gemcitabine	B7-H3	PA449748	80381	0.503
NULL	Sci_Rep_2014_Dec_19_4_7571.nxml.txt.nlp	25524368	SENT22	23	23	28	28	oxytetracycline	mer	PA450757	10461	0.503
NULL	Nat_Commun_2013_Sep_16_4_2420.nxml.txt.nlp	24036533	SENT260	24	24	43	43	ampicillin	BSAC	PA448419	57591	0.503
NULL	Clin_Exp_Otorhinolaryngol_2011_Jun_31_4(2)_77-82.nxml.txt.nlp	21716954	SENT157	5	5	24	24	minocycline	JNK	PA450519	5599	0.503
NULL	J_Cell_Biol_2004_Jun_7_165(5)_641-652.nxml.txt.nlp	15173188	SENT276	21	21	21	21	pp2	PP2		4888	0.503
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT1795	0	0	18	18	etravirine	ATV	PA166014703	4683	0.503
NULL	Pharmaceuticals_(Basel)_2011_Mar_17_4(3)_551-566.nxml.txt.nlp	NULL	SENT562	12	12	9	9	doxorubicin	RhoA	PA449412	387	0.503
NULL	Open_Ophthalmol_J_2009_Sep_17_3_46-49.nxml.txt.nlp	19816587	SENT16	25	25	16	16	chloroquine	G6PD	PA448948	2539	0.503
NULL	Indian_J_Radiol_Imaging_2011_Jul-Sep_21(3)_202-208.nxml.txt.nlp	22013296	SENT126	15	15	8	8	choline	FDG	PA448976	23583	0.503
NULL	J_Hematol_Oncol_2010_Nov_23_3_45.nxml.txt.nlp	21092307	SENT113	0	0	25	25	everolimus	4E-BP1	PA164746311	1978	0.503
NULL	Nat_Neurosci_2012_Sep_5_15(9)_1245-1254.nxml.txt.nlp	22864611	SENT496	3	3	9	9	clozapine	HDAC2	PA449061	3066	0.503
NULL	FEBS_Open_Bio_2014_Mar_19_4_301-309.nxml.txt.nlp	24918042	SENT229	10	10	37	37	gentamicin	NOK	PA449753	55359	0.503
NULL	Exp_Cell_Res_2011_Apr_15_317(7)_1028-1039.nxml.txt.nlp	21237154	SENT134	16	16	14	14	staurosporine	TRAIL	PA165109623	8743	0.503
NULL	Cancer_Causes_Control_2013_Aug_18_24(8)_1605-1614.nxml.txt.nlp	23775025	SENT64	3	3	28	28	cyclophosphamide	DHFR	PA449165	1719	0.503
NULL	Eur_J_Med_Genet_2012_Nov_55(11)_620-624.nxml.txt.nlp	22902344	SENT96	0	0	18	18	creatine	PTH	PA164778930	5741	0.503
NULL	ScientificWorldJournal_2013_Oct_1_2013_654829.nxml.txt.nlp	24198725	SENT303	6	6	11	11	naproxen	NF1	PA450595	4763	0.503
NULL	Breast_Cancer_Res_2012_Apr_17_14(2)_R61.nxml.txt.nlp	22510481	SENT54	31	31	44	44	l-glutamine	CO2	PA10090	4513	0.503
NULL	Cell_Biochem_Biophys_2013_Jan_13_66(3)_499-512.nxml.txt.nlp	23314884	SENT286	19	19	26	26	doxorubicin	ABCG2	PA449412	9429	0.503
NULL	J_Gen_Physiol_2010_Apr_135(4)_333-353.nxml.txt.nlp	20231374	SENT383	14	14	21	21	amitriptyline	P2X4	PA448385	5025	0.503
NULL	FEBS_Open_Bio_2014_Jun_7_4_554-559.nxml.txt.nlp	25009769	SENT30	10	10	3	3	hyaluronidase	HYAL1	PA164745713	3373	0.502
NULL	Oncoimmunology_2013_Apr_1_2(4)_e24185.nxml.txt.nlp	23734337	SENT18	30	30	33	33	methylcholanthrene	PRF1	PA165816878	5551	0.502
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT128	6	6	3	3	phenytoin	CYP2D6	PA450947	1565	0.502
NULL	F1000_Med_Rep_2009_Jan_21_1_8.nxml.txt.nlp	20948699	SENT16	4	4	42	42	clopidogrel	NNT	PA449053	23530	0.502
NULL	Br_J_Ophthalmol_2014_Jul_98(Suppl_2)_ii24-ii29.nxml.txt.nlp	24934220	SENT89	5	5	19	19	fluorescein	ERM	PA164746009	2119	0.502
NULL	Neuroscience_2014_Mar_7_261(100)_52-59.nxml.txt.nlp	24361736	SENT98	15	15	19	19	heparin	EGF	PA449855	1950	0.502
NULL	Ecotoxicology_2011_Jun_26_20(4)_625-634.nxml.txt.nlp	21267648	SENT125	3	3	6	6	malathion	HC5	PA164748092	5689;122950	0.502
NULL	J_Med_Case_Rep_2013_Mar_19_7_80.nxml.txt.nlp	23509950	SENT70	21	21	17	17	hydrocortisone	ACTH	PA449905	5443	0.502
NULL	Cancer_Cell_Int_2011_Aug_19_11_29.nxml.txt.nlp	21854619	SENT42	15	15	17	17	cisplatin	BRCA1	PA449014	672	0.502
NULL	Breast_Cancer_Res_2004_Mar_17_6(3)_R215-R231.nxml.txt.nlp	15084245	SENT68	33	33	10	10	hydrocortisone	F12	PA449905	2161	0.502
NULL	Gut_2009_Jul_4_58(7)_964-973.nxml.txt.nlp	19193669	SENT257	30	30	7	7	ribavirin	IFN	PA451241	3439	0.502
NULL	Arthritis_Res_Ther_2005_Oct_29_7(1)_R1-R11.nxml.txt.nlp	15642129	SENT138	45	45	13	13	estradiol	ANOVA	PA449503	4858	0.502
NULL	Iran_J_Ped_Hematol_Oncol_2014_Dec_10_4(4)_141-150.nxml.txt.nlp	25598954	SENT49	10	10	26	26	l-glutamine	CO2	PA10090	4513	0.502
NULL	Stroke_Res_Treat_2011_Nov_10_2011_212485.nxml.txt.nlp	22135769	SENT146	21	21	28	28	prasugrel	ABCB1	PA154410481	5243	0.502
NULL	Biomed_Res_Int_2014_Feb_17_2014_614506.nxml.txt.nlp	24696859	SENT116	14	14	5	5	indomethacin	COX	PA449982	1351	0.502
NULL	Front_Genet_2014_Jun_2_5_154.nxml.txt.nlp	24917878	SENT305	1	1	24	24	choline	POMC	PA448976	5443	0.502
NULL	J_Nat_Sci_Biol_Med_2011_Jul-Dec_2(2)_180-184.nxml.txt.nlp	22346232	SENT30	29	29	5	5	linezolid	SGB	PA450233	2719	0.502
NULL	Reprod_Biol_Endocrinol_2003_Oct_7_1_66.nxml.txt.nlp	14609433	SENT261	13	13	11	11	cisplatin	p53	PA449014	7157	0.502
NULL	AIDS_Care_2011_Sep_14_23(9)_1154-1162.nxml.txt.nlp	21500025	SENT140	20	20	2	2	lopinavir	ATV	PA450264	4683	0.502
NULL	Biomed_Res_Int_2014_Jun_26_2014_161346.nxml.txt.nlp	25054130	SENT228	11	11	21	21	curcumin	STZ	PA151958596	6484	0.502
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jan_7_68(Pt_2)_m121-m122.nxml.txt.nlp	22346809	SENT5	23	23	18	18	phenol	mol	PA450913	90527	0.502
NULL	Brain_2008_Nov_22_131(11)_3072-3080.nxml.txt.nlp	18945724	SENT65	31	31	6	6	cyclophosphamide	CD19	PA449165	930	0.502
NULL	J_Thromb_Haemost_2010_Nov_8(11)_2530-2541.nxml.txt.nlp	20723025	SENT215	16	16	14	14	thrombin	ADP	PA451674	23038	0.502
NULL	Br_J_Cancer_2010_Nov_9_103(10)_1588-1596.nxml.txt.nlp	20978505	SENT128	26	26	11	11	temozolomide	MSH2	PA451609	4436	0.502
NULL	Evid_Based_Complement_Alternat_Med_2011_Aug_11_2011_237941.nxml.txt.nlp	19887507	SENT95	4	4	11	11	metformin	STZ	PA450395	6484	0.502
NULL	Int_Cardiovasc_Res_J_2014_Sep_1_8(3)_89-93.nxml.txt.nlp	25177670	SENT86	4	4	15	15	amlodipine	IL-6	PA448388	3569	0.502
NULL	Endocr_Relat_Cancer_2014_Oct_21(5)_723-737.nxml.txt.nlp	24981110	SENT271	20	20	10	10	ethanol	RPL32	PA448073	6161	0.502
NULL	Anticancer_Agents_Med_Chem_2010_Dec_10(10)_753-768.nxml.txt.nlp	21269250	SENT185	4	4	29	29	cilengitide	MIDAS	PA164924491	64083	0.502
NULL	Arthritis_Res_Ther_2005_Mar_9_7(3)_93.nxml.txt.nlp	15899057	SENT72	25	25	33	33	methotrexate	TNF	PA450428	7124	0.502
NULL	Clin_Proteomics_2014_Nov_1_11(1)_38.nxml.txt.nlp	25392709	SENT41	11	11	17	17	trypsin	SRM	PA451806	6723;6725	0.502
NULL	Structure_2013_Jun_4_21(6)_1051-1058.nxml.txt.nlp	23665170	SENT63	3	3	9	9	oxygen	hole	PA450744	80757	0.502
NULL	Cases_J_2009_Dec_10_2_9303.nxml.txt.nlp	20062627	SENT96	17	17	11	11	clopidogrel	DES	PA449053	1674	0.502
NULL	F1000_Med_Rep_2012_Feb_1_4_4.nxml.txt.nlp	22312414	SENT174	8	8	16	16	vancomycin	VISA	PA451850	57506	0.502
NULL	Int_J_Mol_Sci_2014_Jun_25_15(7)_11234-11244.nxml.txt.nlp	24968266	SENT67	39	39	34	34	docetaxel	PC-3	PA449383	692094	0.502
NULL	Int_J_Mol_Sci_2014_Oct_23_15(10)_19239-19252.nxml.txt.nlp	25342319	SENT41	9	9	1	1	heparin	SERS	PA449855	6301;54938	0.502
NULL	Breast_Cancer_Res_2010_Mar_5_12(2)_R16.nxml.txt.nlp	20205716	SENT360	0	0	5	5	lovastatin	G3BP1	PA450272	10146	0.502
NULL	J_Cell_Biol_2001_Oct_29_155(3)_427-438.nxml.txt.nlp	11673478	SENT152	46	46	44	44	pp2	PP1		5540;5464	0.502
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT140	9	9	5	5	atazanavir	SLK	PA10251	9748;2534	0.502
NULL	Eur_J_Dent_2012_Jul_6(3)_280-286.nxml.txt.nlp	22904656	SENT166	28	28	24	24	ethanol	HEMA	PA448073	2157	0.502
NULL	Lancet_2011_Aug_13_378(9791)_595-605.nxml.txt.nlp	21784508	SENT248	22	22	6	6	perindopril	Yes	PA450877	7525	0.502
NULL	Front_Endocrinol_(Lausanne)_2013_Nov_11_4_171.nxml.txt.nlp	24273532	SENT135	23	23	10	10	forskolin	RXFP2	PA146096022	122042	0.502
NULL	CNS_Drugs_2013_Aug_20_27(12)_1081-1092.nxml.txt.nlp	23959815	SENT70	8	8	0	0	lisdexamfetamine	ATX	PA164748975	5168;23049	0.502
NULL	J_Ophthalmic_Inflamm_Infect_2011_Nov_6_2(1)_21-28.nxml.txt.nlp	22057810	SENT112	8	8	13	13	azathioprine	CTX	PA448515	1593	0.502
NULL	Curr_Neuropharmacol_2013_Jan_11(1)_102-108.nxml.txt.nlp	23814542	SENT225	14	14	9	9	simvastatin	Yes	PA451363	7525	0.502
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT157	19	19	14	14	perifosine	JNK	PA165291471	5599	0.502
NULL	Cardiovasc_Res_2011_Apr_1_90(1)_105-112.nxml.txt.nlp	21123217	SENT39	10	10	34	34	mibefradil	San	PA450492	80218	0.502
NULL	Arthritis_Res_Ther_2008_Jan_18_10(1)_R8.nxml.txt.nlp	18205921	SENT234	2	2	0	0	hyaluronan	HABP	PA165958431	3026	0.502
NULL	ScientificWorldJournal_2012_May_2_2012_982594.nxml.txt.nlp	22645500	SENT81	9	9	7	7	nadh	mol	PA164755085	90527	0.502
NULL	Adv_Ther_2014_Feb_15_31(3)_289-317.nxml.txt.nlp	24535623	SENT341	10	10	7	7	liraglutide	GLP-1	PA165958364	100125288	0.502
NULL	J_Vis_Exp_2010_Dec_9_(46)_2460.nxml.txt.nlp	21178968	SENT239	18	18	32	32	indinavir	ATV	PA449977	4683	0.502
NULL	J_Hematol_Oncol_2011_Mar_26_4_11.nxml.txt.nlp	21439076	SENT136	10	10	4	4	cilengitide	Gem	PA164924491	51053	0.502
NULL	Mol_Cell_2014_Jun_5_54(5)_858-869.nxml.txt.nlp	24905007	SENT724	23	23	10	10	mitomycin	FANCD2	PA450524	2177	0.502
NULL	Chin_J_Cancer_2012_Jul_31(7)_335-341.nxml.txt.nlp	22640629	SENT35	6	6	3	3	cyclophosphamide	CHOP	PA449165	1649	0.502
NULL	Avicenna_J_Phytomed_2013_Autumn_3(4)_302-312.nxml.txt.nlp	25050287	SENT152	12	12	14	14	diazepam	hole	PA449283	80757	0.502
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Dec_2_5_30.nxml.txt.nlp	17140452	SENT194	31	31	29	29	chloramphenicol	CHL	PA448927	91851	0.502
NULL	J_Int_Soc_Sports_Nutr_2014_Aug_13_11_38.nxml.txt.nlp	25132809	SENT3	24	24	36	36	creatine	MSTN	PA164778930	2660	0.502
NULL	Curr_Neuropharmacol_2013_Dec_11(6)_652-663.nxml.txt.nlp	24396340	SENT580	11	11	6	6	lidocaine	TRPV1	PA450226	7442	0.502
NULL	Environ_Health_Perspect_2010_Jul_18_118(7)_949-956.nxml.txt.nlp	20299303	SENT168	14	14	21	21	arsenite	p53	PA452638	7157	0.502
NULL	Clin_Dev_Immunol_2011_Dec_29_2011_160250.nxml.txt.nlp	22242035	SENT118	30	30	21	21	doxorubicin	IL-2	PA449412	3558	0.502
NULL	Br_J_Cancer_2010_Jun_29_103(1)_1-5.nxml.txt.nlp	20461086	SENT3	14	14	20	20	oxygen	PHD2	PA450744	54583	0.502
NULL	Exp_Hematol_2014_Dec_42(12)_1053-1058_e1.nxml.txt.nlp	25127743	SENT17	22	22	18	18	potassium	KCNE2	PA451047	9992	0.502
NULL	Pharm_Pract_(Granada)_2011_Mar_15_Jan-Mar_9(1)_1-10.nxml.txt.nlp	25132883	SENT162	9	9	19	19	enoxaparin	SPAF	PA449463	166378	0.502
NULL	Croat_Med_J_2012_Jun_53(3)_214-223.nxml.txt.nlp	22661134	SENT85	10	10	24	24	diazepam	ACTH	PA449283	5443	0.502
NULL	Front_Genet_2014_Aug_26_5_289.nxml.txt.nlp	25206362	SENT49	13	13	24	24	betaine	B12	PA448603	7126;4709	0.502
NULL	J_Oncol_2009_Jun_22_2009_849051.nxml.txt.nlp	19584908	SENT31	29	29	14	14	oxaliplatin	EGFR	PA131285527	1956	0.502
NULL	Brain_Behav_2011_Sep_1(1)_44-54.nxml.txt.nlp	22398980	SENT238	20	20	22	22	phencyclidine	LSD	PA128406980	1776	0.502
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Feb_29_68(Pt_3)_m341-m342.nxml.txt.nlp	22412472	SENT68	4	4	28	28	piperazine	C10	PA450977	113246	0.502
NULL	Anticancer_Agents_Med_Chem_2012_Feb_12(2)_163-171.nxml.txt.nlp	22043994	SENT295	5	5	31	31	cetuximab	KRAS	PA10040	3845	0.502
NULL	Case_Rep_Ophthalmol_2012_May_30_3(2)_185-189.nxml.txt.nlp	22740828	SENT34	1	1	12	12	fluorescein	hole	PA164746009	80757	0.502
NULL	Int_J_Biomed_Sci_2014_Sep_10(3)_146-157.nxml.txt.nlp	25324695	SENT268	14	14	10	10	bleomycin	RHAMM	PA448645	3161	0.502
NULL	Cardiol_Res_Pract_2014_Feb_6_2014_605810.nxml.txt.nlp	24653858	SENT96	31	31	41	41	pravastatin	CRP	PA451089	1401;140913	0.502
NULL	Biomed_Res_Int_2014_Apr_29_2014_186864.nxml.txt.nlp	24877064	SENT101	6	6	37	37	curcumin	HSL	PA151958596	3991	0.502
NULL	Nat_Commun_2013_Apr_23_4_1758.nxml.txt.nlp	23612299	SENT74	4	4	8	8	isoproterenol	SOD1	PA450121	6647	0.502
NULL	J_Biol_Chem_2013_Nov_15_288(46)_33049-33059.nxml.txt.nlp	24089524	SENT259	0	0	8	8	nicotine	GATA6	PA450626	2627	0.502
NULL	Acta_Pharmacol_Sin_2012_May_4_33(5)_710-716.nxml.txt.nlp	22555373	SENT16	14	14	5	5	ketoprofen	DOM	PA450149	6663	0.502
NULL	Environ_Health_Perspect_2008_Jun_116(6)_A240a.nxml.txt.nlp	NULL	SENT10	21	21	29	29	aspartame	ERF	PA448493	2077	0.502
NULL	Chin_J_Cancer_2012_Aug_31(8)_373-380.nxml.txt.nlp	22739266	SENT123	19	19	10	10	gemcitabine	XRCC3	PA449748	7517	0.502
NULL	Mol_Vis_2011_Apr_27_17_1044-1055.nxml.txt.nlp	21552499	SENT32	21	21	6	6	bevacizumab	apelin	PA130232992	8862	0.502
NULL	Exp_Anim_2014_Feb_7_63(1)_45-53.nxml.txt.nlp	24521862	SENT161	21	21	6	6	trypsin	SPINK1	PA451806	6690	0.502
NULL	Sci_Rep_2014_Dec_19_4_7571.nxml.txt.nlp	25524368	SENT311	5	5	10	10	estradiol	mer	PA449503	10461	0.502
NULL	Adipocyte_2013_Oct_1_2(4)_276-280.nxml.txt.nlp	24052906	SENT19	39	39	41	41	lipase	ATGL	PA450239	57104	0.502
NULL	Clinics_(Sao_Paulo)_2014_Jun_69(6)_438-446.nxml.txt.nlp	24964310	SENT86	14	14	23	23	teriparatide	PTH	PA451620	5741	0.502
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT11	3	3	0	0	phenprocoumon	CYP2C9	PA450921	1559	0.502
NULL	Int_J_Endocrinol_Metab_2013_Jul_1_Summer_11(3)_129-136.nxml.txt.nlp	24348584	SENT87	5	5	7	7	estradiol	Men	PA449503	8178	0.502
NULL	Eur_J_Endocrinol_2011_Jan_164(1)_69-74.nxml.txt.nlp	20961967	SENT17	6	6	8	8	pioglitazone	OPG	PA450970	690	0.502
NULL	Indian_J_Pharmacol_2013_Sep-Oct_45(5)_439-446.nxml.txt.nlp	24130376	SENT60	34	34	15	15	clozapine	FGA	PA449061	2243	0.502
NULL	Front_Zool_2008_Jul_14_5_11.nxml.txt.nlp	18625039	SENT124	15	15	30	30	lipase	LOX	PA450239	4015	0.502
NULL	J_Ophthalmic_Inflamm_Infect_2011_Nov_6_2(1)_21-28.nxml.txt.nlp	22057810	SENT92	17	17	13	13	infliximab	CTX	PA452639	1593	0.502
NULL	Cell_Death_Differ_2012_Jul_20_19(7)_1162-1174.nxml.txt.nlp	22261617	SENT159	14	14	24	24	paraformaldehyde	BMP2	PA450790	650	0.502
NULL	Onco_Targets_Ther_2014_Sep_30_7_1641-1645.nxml.txt.nlp	25336968	SENT88	11	11	15	15	chlorthalidone	Yes	PA448970	7525	0.502
NULL	J_Mol_Signal_2008_Dec_1_3_18.nxml.txt.nlp	19046439	SENT23	6	6	11	11	metformin	p53	PA450395	7157	0.502
NULL	Indian_J_Pharmacol_2008_Oct_40(Suppl_2)_S160-S171.nxml.txt.nlp	21593969	SENT599	29	29	31	31	l-cysteine	NAC	PA449173	22861	0.502
NULL	Breast_Cancer_Res_2012_Jun_19_14(3)_209.nxml.txt.nlp	22713170	SENT29	24	24	0	0	trastuzumab	EGFR	PA451743	1956	0.502
NULL	Acta_Pharmacol_Sin_2010_Apr_8_31(4)_461-469.nxml.txt.nlp	20208553	SENT228	3	3	6	6	ethanol	adiponectin	PA448073	9370	0.502
NULL	Front_Immunol_2013_Nov_8_4_363.nxml.txt.nlp	24265631	SENT255	16	16	26	26	cisplatin	CXCL10	PA449014	3627	0.502
NULL	Biologics_2013_Apr_15_7_77-90.nxml.txt.nlp	23723688	SENT116	41	41	11	11	cetuximab	CRT	PA10040	811	0.502
NULL	Mol_Vis_2007_Jan_24_13_57-65.nxml.txt.nlp	17277739	SENT222	26	26	34	34	heparin	FGF2	PA449855	2247;2258	0.502
NULL	Curr_Neuropharmacol_2014_Jul_12(4)_365-379.nxml.txt.nlp	25342944	SENT534	8	8	4	4	fluoxetine	5-HT2A	PA449673	3356	0.502
NULL	EMBO_Mol_Med_2013_Mar_4_5(3)_366-383.nxml.txt.nlp	23381944	SENT200	22	22	10	10	paromomycin	ALKBH8	PA164784023	91801	0.502
NULL	Arthritis_Res_Ther_2010_Apr_22_12(2)_112.nxml.txt.nlp	20441607	SENT12	13	13	11	11	rituximab	IL-6	PA451261	3569	0.502
NULL	Arthritis_Res_Ther_2014_Apr_30_16(2)_R90.nxml.txt.nlp	25167216	SENT219	16	16	10	10	adalimumab	ACR	PA10004	49	0.502
NULL	Mol_Cancer_2008_Jun_30_7_60.nxml.txt.nlp	18590557	SENT93	8	8	29	29	doxorubicin	TRAIL	PA449412	8743	0.502
NULL	Oncol_Lett_2014_Apr_29_7(4)_1033-1038.nxml.txt.nlp	24944664	SENT131	27	27	15	15	collagenase	MT1-MMP	PA449107	4323	0.502
NULL	Cell_Death_Dis_2014_Feb_27_5(2)_e1091.nxml.txt.nlp	24577089	SENT34	14	14	18	18	cetuximab	EGF	PA10040	1950	0.502
NULL	J_Thromb_Thrombolysis_2013_Feb_20_35(2)_264-270.nxml.txt.nlp	23086579	SENT85	18	18	35	35	thrombin	CD40	PA451674	958	0.502
NULL	Br_J_Cancer_2011_Jun_7_104(12)_1848-1853.nxml.txt.nlp	21610704	SENT125	6	6	28	28	panitumumab	TOX	PA162373091	9760	0.502
NULL	J_Biol_Chem_2013_Nov_15_288(46)_33049-33059.nxml.txt.nlp	24089524	SENT102	28	28	19	19	nicotine	FBS	PA450626	64319;26269	0.502
NULL	Br_J_Cancer_2010_May_11_102(10)_1495-1502.nxml.txt.nlp	20461092	SENT238	33	33	10	10	gefitinib	EGFR	PA131301952	1956	0.502
NULL	Crit_Care_2011_Nov_16_15(6)_R271.nxml.txt.nlp	22087790	SENT164	2	2	39	39	nitroprusside	Yes	PA451406	7525	0.502
NULL	Acta_Pharmacol_Sin_2011_Oct_15_32(10)_1233-1238.nxml.txt.nlp	21841815	SENT24	13	13	10	10	atropine	CTX	PA448505	1593	0.502
NULL	Viruses_2014_Feb_18_6(2)_875-892.nxml.txt.nlp	24553110	SENT156	3	3	13	13	tipifarnib	ITGB1	PA165110778	3688	0.502
NULL	Arthritis_Res_Ther_2010_Apr_29_12(2)_R73.nxml.txt.nlp	20429888	SENT237	0	0	8	8	bortezomib	c-Jun	PA10252	3725	0.502
NULL	Arch_Immunol_Ther_Exp_(Warsz)_2007_Jun_8_55(3)_199-203.nxml.txt.nlp	17557148	SENT29	22	22	12	12	imatinib	IFN	PA10804	3439	0.502
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1563-1573.nxml.txt.nlp	22015557	SENT171	9	9	11	11	sunitinib	c-Myc	PA162372840	4609	0.502
NULL	Diabetes_2008_Sep_57(9)_2332-2340.nxml.txt.nlp	18567824	SENT90	5	5	14	14	atropine	ghrelin	PA448505	51738	0.502
NULL	Front_Cell_Neurosci_2014_Jul_8_8_188.nxml.txt.nlp	25071448	SENT523	5	5	13	13	estradiol	aromatase	PA449503	1588	0.502
NULL	Mol_Cancer_2010_May_18_9_110.nxml.txt.nlp	20482802	SENT118	6	6	11	11	bortezomib	CHOP	PA10252	1649	0.502
NULL	Clin_Ophthalmol_2012_Sep_5_6_1433-1440.nxml.txt.nlp	23055659	SENT153	39	39	29	29	timolol	BAK	PA451690	578	0.502
NULL	Exp_Ther_Med_2013_Jun_2_5(6)_1701-1709.nxml.txt.nlp	23837058	SENT243	33	33	3	3	cisplatin	HK1	PA449014	3098;51361;3739	0.502
NULL	CNS_Drugs_2014_May_1_28(6)_497-511.nxml.txt.nlp	24788672	SENT103	14	14	8	8	lisdexamfetamine	DBP	PA164748975	3295;1628;2638	0.502
NULL	Curr_Med_Chem_2013_Jan_20(3)_438-447.nxml.txt.nlp	23157636	SENT453	16	16	6	6	risperidone	FGA	PA451257	2243	0.502
NULL	Oncotarget_2014_Nov_12_5(20)_9626-9640.nxml.txt.nlp	25275299	SENT78	19	19	17	17	thrombin	LPA	PA451674	4018	0.502
NULL	European_J_Med_Plants_2013_3(4)_603-615.nxml.txt.nlp	24478981	SENT73	11	11	17	17	nadh	LDHA	PA164755085	3939	0.502
NULL	Ann_Surg_Treat_Res_2014_Feb_22_86(2)_68-75.nxml.txt.nlp	24761411	SENT174	0	0	15	15	oxaliplatin	survivin	PA131285527	332	0.502
NULL	Front_Synaptic_Neurosci_2014_Oct_27_6_24.nxml.txt.nlp	25386136	SENT283	3	3	8	8	scopolamine	spatial	PA451308	219793	0.502
NULL	Nat_Med_2014_Jul_25_20(7)_769-777.nxml.txt.nlp	24859528	SENT176	11	11	5	5	gentamicin	F12	PA449753	2161	0.502
NULL	Crit_Care_2007_Mar_22_11(Suppl_2)_P94.nxml.txt.nlp	NULL	SENT7	12	12	26	26	meropenem	BII	PA164764445	777	0.502
NULL	Front_Endocrinol_(Lausanne)_2013_Sep_13_4_122.nxml.txt.nlp	24062725	SENT27	10	10	27	27	vasopressin	PRL	PA451858	5617	0.502
NULL	Iran_J_Pharm_Res_2014_Winter_13(1)_95-101.nxml.txt.nlp	24734060	SENT130	23	23	8	8	ethanol	mol	PA448073	90527	0.502
NULL	Cancer_Cell_Int_2008_Mar_18_8_3.nxml.txt.nlp	18348720	SENT81	38	38	12	12	gefitinib	EGFR	PA131301952	1956	0.502
NULL	Int_J_Mol_Sci_2014_Sep_30_15(10)_17733-17750.nxml.txt.nlp	25272228	SENT684	12	12	8	8	oxygen	ROS	PA450744	6098	0.502
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT1222	14	14	5	5	raltegravir	SLC22A6		9356	0.501
NULL	Autoimmune_Dis_2013_Aug_28_2013_613086.nxml.txt.nlp	24069534	SENT170	12	12	28	28	infliximab	TNFAIP3	PA452639	7128	0.501
NULL	Environ_Health_Perspect_2008_Dec_9_116(12)_1713-1719.nxml.txt.nlp	19079725	SENT140	26	26	8	8	choline	c-fos	PA448976	2353	0.501
NULL	J_Int_Soc_Sports_Nutr_2010_Feb_3_7_8.nxml.txt.nlp	20181080	SENT12	44	44	16	16	creatine	AVP	PA164778930	114548;551	0.501
NULL	Oncol_Lett_2014_Nov_12_8(5)_2203-2208.nxml.txt.nlp	25295109	SENT12	0	0	20	20	celecoxib	GLI1	PA448871	2735	0.501
NULL	Comp_Hepatol_2004_Jan_14_3(Suppl_1)_S46.nxml.txt.nlp	14960198	SENT66	7	7	11	11	allopurinol	AAP	PA448320	5345	0.501
NULL	J_Gastroenterol_2013_May_5_48(5)_559-573.nxml.txt.nlp	23460386	SENT42	7	7	28	28	esomeprazole	COX	PA10075	1351	0.501
NULL	Age_(Dordr)_2013_Apr_15_35(2)_431-438.nxml.txt.nlp	22170281	SENT177	0	0	43	43	pravastatin	Gen	PA451089	348654	0.501
NULL	J_Anaesthesiol_Clin_Pharmacol_2012_Oct-Dec_28(4)_423-425.nxml.txt.nlp	23225917	SENT55	18	18	12	12	desflurane	CO2	PA164749136	4513	0.501
NULL	Drugs_Context_2012_Nov_19_2012_212242.nxml.txt.nlp	24432031	SENT391	7	7	32	32	carmustine	IL-2	PA448810	3558	0.501
NULL	J_Pain_Res_2014_Nov_24_7_639-643.nxml.txt.nlp	25473307	SENT12	11	11	2	2	lidocaine	LNP	PA450226	80856;51203	0.501
NULL	Mol_Cells_2014_Mar_31_37(3)_234-240.nxml.txt.nlp	24642709	SENT395	10	10	8	8	cisplatin	HO-1	PA449014	3162	0.501
NULL	Cardiovasc_Diabetol_2013_Oct_17_12_150.nxml.txt.nlp	24134550	SENT102	10	10	6	6	metformin	activin	PA450395	83729	0.501
NULL	An_Bras_Dermatol_2014_Mar-Apr_89(2)_266-273.nxml.txt.nlp	24770503	SENT61	12	12	5	5	thalidomide	ENL	PA451644	4298	0.501
NULL	Front_Neurol_2011_Dec_12_2_81.nxml.txt.nlp	22180750	SENT594	4	4	7	7	guanfacine	spatial	PA449825	219793	0.501
NULL	J_Cell_Mol_Med_2014_Dec_7_18(12)_2536-2552.nxml.txt.nlp	25287328	SENT87	24	24	31	31	phenol	San	PA450913	80218	0.501
NULL	J_Ginseng_Res_2011_Nov_35(4)_436-441.nxml.txt.nlp	23717089	SENT118	4	4	29	29	sugar	CAGC	PA451529	6283	0.501
NULL	Environ_Health_Perspect_2008_Mar_116(3)_A104.nxml.txt.nlp	18335070	SENT25	10	10	16	16	choline	PEMT	PA448976	10400	0.501
NULL	Front_Neurol_2011_Apr_28_2_27.nxml.txt.nlp	21562603	SENT36	32	32	23	23	atorvastatin	Q10	PA448500	27161	0.501
NULL	CNS_Spectr_2014_Apr_1_19(2)_121-133.nxml.txt.nlp	23903233	SENT521	9	9	18	18	ondansetron	spatial	PA450705	219793	0.501
NULL	Cancer_Metab_2014_May_28_2(Suppl_1)_P61.nxml.txt.nlp	NULL	SENT17	2	2	12	12	troglitazone	c-Myc	PA451799	4609	0.501
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2014_Sep_27_70(Pt_10)_2740-2753.nxml.txt.nlp	25286857	SENT312	22	22	6	6	bsi-201	TNKS2		80351	0.501
NULL	Angiogenesis_2010_Dec_7_13(4)_305-315.nxml.txt.nlp	20927579	SENT169	5	5	10	10	resveratrol	p53		7157	0.501
NULL	J_Invest_Dermatol_2012_Nov_21_132(11)_2642-2651.nxml.txt.nlp	22718118	SENT54	15	15	0	0	collagenase	CD11b	PA449107	3684	0.501
NULL	Curr_Neuropharmacol_2012_Mar_10(1)_53-63.nxml.txt.nlp	22942878	SENT352	11	11	17	17	vasopressin	5-HT1A	PA451858	3350	0.501
NULL	Oncol_Rep_2015_Feb_21_33(2)_547-552.nxml.txt.nlp	25421355	SENT110	17	17	0	0	glucosamine	EXT1	PA164747613	2131	0.501
NULL	Eur_J_Haematol_2013_Feb_22_90(2)_89-98.nxml.txt.nlp	23181448	SENT110	6	6	2	2	cladribine	IFN	PA449027	3439	0.501
NULL	Pancreas_2014_Nov_24_43(8)_1223-1231.nxml.txt.nlp	25275271	SENT218	40	40	38	38	liraglutide	GLP-1	PA165958364	100125288	0.501
NULL	Saudi_J_Anaesth_2013_Apr-Jun_7(2)_151-154.nxml.txt.nlp	23956714	SENT6	11	11	16	16	theophylline	NAC	PA451647	22861	0.501
NULL	Clin_Drug_Investig_2013_Aug_23_33(10)_727-736.nxml.txt.nlp	23975654	SENT71	2	2	4	4	bupropion	CYP2D6	PA448687	1565	0.501
NULL	J_Nat_Med_2014_Feb_19_68(2)_253-266.nxml.txt.nlp	24550097	SENT226	40	40	14	14	lipase	SREBP-1c	PA450239	6720	0.501
NULL	Adv_Hematol_2010_Dec_5_2010_595934.nxml.txt.nlp	21151515	SENT154	24	24	29	29	cangrelor	Yes	PA165945763	7525	0.501
NULL	Br_J_Cancer_2011_Jul_26_105(3)_372-381.nxml.txt.nlp	21730979	SENT154	18	18	20	20	cisplatin	p53	PA449014	7157	0.501
NULL	Reprod_Biol_Endocrinol_2003_Aug_27_1_59.nxml.txt.nlp	12967350	SENT143	5	5	10	10	estradiol	XIAP	PA449503	331	0.501
NULL	J_Gen_Physiol_2013_Aug_142(2)_174.nxml.txt.nlp	NULL	SENT205	15	15	2	2	taurine	ANO6	PA451590	196527	0.501
NULL	Nanoscale_Res_Lett_2013_Sep_13_8(1)_386.nxml.txt.nlp	24034341	SENT185	29	29	32	32	ethanol	CO2	PA448073	4513	0.501
NULL	Front_Integr_Neurosci_2012_Dec_18_6_116.nxml.txt.nlp	23264764	SENT747	1	1	4	4	ethanol	spatial	PA448073	219793	0.501
NULL	Ann_Thorac_Med_2007_Apr-Jun_2(2)_52-57.nxml.txt.nlp	19727346	SENT129	30	30	20	20	cefoperazone	CTX	PA448849	1593	0.501
NULL	J_Cell_Biol_2005_Nov_21_171(4)_663-673.nxml.txt.nlp	16301332	SENT295	32	32	23	23	gentamicin	EGF	PA449753	1950	0.501
NULL	Exp_Transl_Stroke_Med_2011_Dec_16_3_16.nxml.txt.nlp	22177314	SENT120	20	20	22	22	minocycline	ANOVA	PA450519	4858	0.501
NULL	Cancers_(Basel)_2013_Jan_21_5(1)_64-91.nxml.txt.nlp	24216699	SENT1076	6	6	15	15	paclitaxel	HER2	PA450761	2064	0.501
NULL	Cell_Death_Dis_2013_Sep_5_4(9)_e791.nxml.txt.nlp	24008735	SENT284	1	1	4	4	gemcitabine	p53	PA449748	7157	0.501
NULL	Evid_Based_Complement_Alternat_Med_2013_Mar_28_2013_514908.nxml.txt.nlp	23606881	SENT12	4	4	2	2	scopolamine	BMX	PA451308	660	0.501
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT111	0	0	8	8	methotrexate	MSH2	PA450428	4436	0.501
NULL	FEBS_Open_Bio_2014_Jul_8_4_672-682.nxml.txt.nlp	25180151	SENT204	27	27	8	8	nadh	ADP	PA164755085	23038	0.501
NULL	Diabetes_Care_2013_Apr_14_36(4)_943-949.nxml.txt.nlp	23111057	SENT53	16	16	31	31	fluorescein	KDR	PA164746009	3791	0.501
NULL	Br_J_Clin_Pharmacol_2013_Aug_23_76(2)_299-315.nxml.txt.nlp	23701319	SENT186	18	18	20	20	alemtuzumab	CD4	PA164783958	920	0.501
NULL	Aging_(Albany_NY)_2009_Mar_31_1(4)_412-424.nxml.txt.nlp	20195491	SENT127	7	7	21	21	resveratrol	AMPK		5563	0.501
NULL	Subst_Abuse_Treat_Prev_Policy_2007_Jan_12_2_4.nxml.txt.nlp	17222348	SENT21	17	17	14	14	ribavirin	IFN	PA451241	3439	0.501
NULL	Breast_Cancer_(Auckl)_2011_Jul_27_5_175-199.nxml.txt.nlp	21863131	SENT451	11	11	1	1	olaparib	Met		79811	0.501
NULL	Oncol_Discov_2013_1(4)_10_7243_2052-6199-1-4.nxml.txt.nlp	25383193	SENT209	30	30	17	17	indomethacin	ODC	PA449982	4953;89874	0.501
NULL	Iran_J_Reprod_Med_2014_Apr_12(4)_257-262.nxml.txt.nlp	24976820	SENT98	36	36	20	20	protamine	TP2	PA10366	7015;7142	0.501
NULL	Cancers_(Basel)_2011_Aug_12_3(3)_3279-3330.nxml.txt.nlp	24212956	SENT1198	8	8	0	0	tocilizumab	CD62L	PA165292659	6402	0.501
NULL	Vet_Res_Forum_2013_Winter_4(1)_19-24.nxml.txt.nlp	25593681	SENT73	25	25	44	44	diclofenac	ANOVA	PA449293	4858	0.501
NULL	Int_J_Mol_Sci_2013_Apr_12_14(4)_8047-8061.nxml.txt.nlp	23584023	SENT262	16	16	12	12	choline	CXCR4	PA448976	7852	0.501
NULL	ISME_J_2014_Sep_13_8(9)_1892-1903.nxml.txt.nlp	24621524	SENT258	30	30	24	24	s-adenosylmethionine	FGGY	PA164754994	55277	0.501
NULL	J_Org_Chem_2011_Aug_19_76(16)_6703-6714.nxml.txt.nlp	21739961	SENT168	24	24	31	31	vanillin	mol	PA451852	90527	0.501
NULL	Biomed_Res_Int_2014_Jan_29_2014_361020.nxml.txt.nlp	24605326	SENT223	7	7	30	30	flavopiridol	CDK4	PA452627	1019	0.501
NULL	Crit_Care_2011_Aug_10_15(4)_R192.nxml.txt.nlp	21831302	SENT242	14	14	4	4	oxygen	CO2	PA450744	4513	0.501
NULL	J_Radiat_Res_2014_Nov_16_55(6)_1171-1177.nxml.txt.nlp	25129557	SENT188	18	18	16	16	bevacizumab	CRT	PA130232992	811	0.501
NULL	Cardiovasc_Diabetol_2011_Dec_22_10_115.nxml.txt.nlp	22189184	SENT95	5	5	11	11	miglitol	GLP-1	PA164776726	100125288	0.501
NULL	Front_Behav_Neurosci_2010_Dec_17_4_187.nxml.txt.nlp	21188275	SENT583	2	2	22	22	estradiol	CA3	PA449503	761	0.501
NULL	Virol_J_2009_Apr_28_6_44.nxml.txt.nlp	19400954	SENT308	3	3	6	6	lipase	p37	PA450239	902;137886	0.501
NULL	Onco_Targets_Ther_2014_Jul_1_7_1185-1193.nxml.txt.nlp	25061320	SENT127	9	9	14	14	docetaxel	EGFR	PA449383	1956	0.501
NULL	Vet_Res_Forum_2014_Winter_5(1)_65-68.nxml.txt.nlp	25568695	SENT80	7	7	9	9	trimethoprim	Yes	PA451788	7525	0.501
NULL	J_Clin_Biochem_Nutr_2009_Sep_28_45(2)_193-201.nxml.txt.nlp	19794928	SENT150	2	2	4	4	ethanol	NAC	PA448073	22861	0.501
NULL	J_Cell_Biol_1983_Aug_1_97(2)_323-328.nxml.txt.nlp	6224800	SENT3	16	16	13	13	thrombin	EGF	PA451674	1950	0.501
NULL	Sci_Rep_2014_Dec_11_4_7438.nxml.txt.nlp	25500904	SENT371	0	0	17	17	azithromycin	p38	PA448519	10598;1432;7965	0.501
NULL	Br_J_Cancer_2004_Mar_5_90(Suppl_1)_S2-S6.nxml.txt.nlp	15094757	SENT99	0	0	6	6	fulvestrant	pS2	PA164747170	7031	0.501
NULL	Mucosal_Immunol_2011_May_10_4(3)_304-313.nxml.txt.nlp	21068720	SENT116	6	6	15	15	dextran	mol	PA449261	90527	0.501
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Apr_15_9_13.nxml.txt.nlp	20398300	SENT97	9	9	7	7	lansoprazole	LAM	PA450180	7249;7248	0.501
NULL	J_Cancer_2013_Nov_23_4(9)_736-754.nxml.txt.nlp	24312144	SENT86	3	3	6	6	afatinib	HER2	PA165981154	2064	0.501
NULL	J_Hum_Reprod_Sci_2008_Jul-Dec_1(2)_86-89.nxml.txt.nlp	19562053	SENT12	28	28	39	39	estradiol	ART	PA449503	181	0.501
NULL	Psychiatry_Investig_2010_Sep_13_7(3)_215-219.nxml.txt.nlp	20927311	SENT9	4	4	16	16	glucose	FDG	PA449773	23583	0.501
NULL	Iran_J_Pharm_Res_2015_Winter_14(1)_167-175.nxml.txt.nlp	25561923	SENT112	23	23	42	42	propofol	Yes	PA451141	7525	0.501
NULL	Mol_Med_Rep_2014_Nov_5_10(5)_2334-2340.nxml.txt.nlp	25189202	SENT83	13	13	15	15	cefotaxime	CFP	PA448852	5199	0.501
NULL	Clin_Neuropathol_2011_Oct_18_Nov-Dec_30(6)_291-296.nxml.txt.nlp	22011733	SENT48	17	17	19	19	thyroglobulin	TTF1	PA164754910	7080;7270	0.501
NULL	Hum_Genomics_2008_Sep_1_3(1)_71-78.nxml.txt.nlp	19129091	SENT32	17	17	32	32	nadh	ND5	PA164755085	4540	0.501
NULL	Biomed_Res_Int_2014_Apr_13_2014_275178.nxml.txt.nlp	24822191	SENT147	6	6	9	9	rosiglitazone	AMPK	PA451283	5563	0.501
NULL	ScientificWorldJournal_2013_Oct_24_2013_726912.nxml.txt.nlp	24282387	SENT32	23	23	21	21	fluorescein	AVP	PA164746009	114548;551	0.501
NULL	Oncotarget_2014_Jun_6_5(13)_4935-4944.nxml.txt.nlp	24952732	SENT70	0	0	2	2	doxazosin	PI3K	PA449407	5290	0.501
NULL	J_Oncol_2012_Dec_7_2012_192464.nxml.txt.nlp	22187555	SENT397	0	0	4	4	genistein	SFN	PA165109660	25996;2810	0.501
NULL	Oncotarget_2012_Jan_28_3(1)_78-83.nxml.txt.nlp	22289679	SENT43	24	24	38	38	paclitaxel	PLK2	PA450761	10769	0.501
NULL	ScientificWorldJournal_2012_Apr_30_2012_327071.nxml.txt.nlp	22654592	SENT149	22	22	26	26	ethanol	LPO	PA448073	4025	0.501
NULL	Cancers_(Basel)_2010_May_26_2(2)_913-954.nxml.txt.nlp	24281100	SENT3263	11	11	6	6	cisplatin	CD24	PA449014	100133941	0.501
NULL	Protein_Cell_2014_Oct_31_5(10)_737-749.nxml.txt.nlp	25073422	SENT258	13	13	11	11	gemcitabine	XIAP	PA449748	331	0.501
NULL	EMBO_Mol_Med_2009_Jul_1(4)_211-222.nxml.txt.nlp	20049723	SENT296	22	22	20	20	fluorescein	CD11c	PA164746009	3687	0.501
NULL	J_Epilepsy_Res_2014_Jun_30_4(1)_7-13.nxml.txt.nlp	24977124	SENT70	22	22	16	16	pilocarpine	CA3	PA450962	761	0.501
NULL	Ital_J_Pediatr_2011_Aug_22_37_39.nxml.txt.nlp	21859484	SENT105	17	17	15	15	salbutamol	BDP	PA448068	10620;152926	0.501
NULL	Adv_Synth_Catal_2013_Nov_11_355(16)_3095-3118.nxml.txt.nlp	24971045	SENT207	16	16	25	25	benzaldehyde	mol	PA448571	90527	0.501
NULL	Acta_Pharmacol_Sin_2009_Dec_4_30(12)_1601-1606.nxml.txt.nlp	19960006	SENT36	23	23	28	28	suramin	DPI	PA10292	1832	0.501
NULL	Breast_Cancer_Res_2008_Dec_16_10(6)_R105.nxml.txt.nlp	19087274	SENT12	18	18	8	8	creatine	VIM	PA164778930	7431	0.501
NULL	Orphanet_J_Rare_Dis_2013_Oct_3_8_155.nxml.txt.nlp	24088413	SENT40	11	11	9	9	laronidase	IDUA	PA164776670	3425	0.501
NULL	Oncotarget_2011_May_16_2(5)_418-421.nxml.txt.nlp	21789791	SENT30	15	15	13	13	bortezomib	TRAIL	PA10252	8743	0.501
NULL	Neuroimage_Clin_2013_Sep_3_3_242-248.nxml.txt.nlp	24273709	SENT294	22	22	24	24	phenytoin	PRG	PA450947	5544	0.501
NULL	BMJ_Open_2014_Feb_27_4(2)_e004071.nxml.txt.nlp	24578536	SENT163	30	30	27	27	warfarin	TTR	PA451906	7276	0.501
NULL	Saudi_J_Anaesth_2013_Jan-Mar_7(1)_68-74.nxml.txt.nlp	23717236	SENT55	36	36	18	18	sevoflurane	CO2	PA451341	4513	0.501
NULL	Clin_Mol_Hepatol_2014_Sep_25_20(3)_283-290.nxml.txt.nlp	25320732	SENT147	9	9	7	7	propranolol	EVL	PA451145	51466	0.501
NULL	Cell_J_2014_Feb_3_Spring_16(1)_11-16.nxml.txt.nlp	24518970	SENT114	1	1	12	12	verapamil	IFN	PA451868	3439	0.501
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT128	19	19	2	2	amiodarone	CYP2C19	PA448383	1557	0.501
NULL	Emerg_Infect_Dis_2007_Feb_13(2)_255-258.nxml.txt.nlp	17479888	SENT77	15	15	1	1	clindamycin	PEN	PA449035	9933	0.501
NULL	Breast_Cancer_Res_2004_Mar_18_6(3)_119-127.nxml.txt.nlp	15084232	SENT161	9	9	25	25	genistein	EGF	PA165109660	1950	0.501
NULL	Oncotarget_2014_Oct_23_5(22)_11154-11167.nxml.txt.nlp	25525888	SENT193	27	27	12	12	docetaxel	PLGF	PA449383	5228	0.501
NULL	Open_Med_Chem_J_2012_Nov_30_6_29-34.nxml.txt.nlp	23525139	SENT96	9	9	5	5	atorvastatin	FOR	PA448500	51741	0.501
NULL	J_Korean_Neurosurg_Soc_2013_Oct_31_54(4)_309-316.nxml.txt.nlp	24294454	SENT178	17	17	26	26	cyclophosphamide	IFN	PA449165	3439	0.501
NULL	Contemp_Clin_Dent_2011_Oct-Dec_2(4)_278-282.nxml.txt.nlp	22346152	SENT37	11	11	13	13	potassium	GCF	PA451047	6936	0.501
NULL	Lab_Invest_2014_May_10_94(5)_503-516.nxml.txt.nlp	24614199	SENT429	0	0	12	12	curcumin	RAGE	PA151958596	177	0.501
NULL	eLife_2013_Nov_5_2_e00969.nxml.txt.nlp	24192036	SENT151	5	5	20	20	vemurafenib	MAP4K5	PA165946873	11183	0.501
NULL	Cancers_(Basel)_2014_Sep_30_6(4)_2035-2048.nxml.txt.nlp	25271833	SENT136	7	7	5	5	gefitinib	IL-2	PA131301952	3558	0.501
NULL	Clin_Ophthalmol_2012_Feb_20_6_277-282.nxml.txt.nlp	22375096	SENT113	25	25	2	2	triamcinolone	CRT	PA451749	811	0.501
NULL	Exp_Diabetes_Res_2012_Nov_12_2012_618923.nxml.txt.nlp	23197974	SENT183	27	27	30	30	telmisartan	STZ	PA451605	6484	0.501
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Oct_4_70(Pt_11)_269-271.nxml.txt.nlp	25484720	SENT22	26	26	21	21	nitrile	mol	PA450636	90527	0.501
NULL	Front_Neural_Circuits_2013_Aug_1_7_129.nxml.txt.nlp	23914157	SENT207	0	0	3	3	vasopressin	CEA	PA451858	5670;1087	0.5
NULL	Arthritis_Res_Ther_2013_Jul_9_15(4)_R73.nxml.txt.nlp	23837669	SENT263	20	20	14	14	colchicine	MSU	PA449092	593	0.5
NULL	Indian_J_Endocrinol_Metab_2012_May-Jun_16(3)_343-348.nxml.txt.nlp	22629497	SENT29	16	16	31	31	teriparatide	PTH	PA451620	5741	0.5
NULL	J_Carcinog_2011_Dec_31_10_37.nxml.txt.nlp	22279422	SENT123	21	21	0	0	urokinase	ERG	PA451836	2078	0.5
NULL	J_Clin_Biochem_Nutr_2007_Jan_27_40(1)_49-55.nxml.txt.nlp	18437213	SENT383	20	20	10	10	creatine	mol	PA164778930	90527	0.5
NULL	Cancer_Metab_2013_Dec_23_1_23.nxml.txt.nlp	24359630	SENT358	35	35	27	27	glucose	TIGAR	PA449773	57103	0.5
NULL	Neuropsychopharmacology_2009_Apr_2_34(5)_1135-1148.nxml.txt.nlp	18596687	SENT15	26	26	21	21	cocaine	CRF	PA449072	1392;10882	0.5
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2014_May_24_70(Pt_6)_1614-1621.nxml.txt.nlp	24914972	SENT108	13	13	15	15	guanidine	CD25	PA164781028	3669;3559	0.5
NULL	Comput_Struct_Biotechnol_J_2012_Oct_30_3_e201210004.nxml.txt.nlp	24688664	SENT158	17	17	9	9	l-methionine	mol	PA450423	90527	0.5
NULL	Clin_Mol_Hepatol_2014_Sep_25_20(3)_283-290.nxml.txt.nlp	25320732	SENT138	19	19	17	17	propranolol	EVL	PA451145	51466	0.5
NULL	J_Biol_Chem_2009_Nov_27_284(48)_33130-33138.nxml.txt.nlp	19801632	SENT41	27	27	15	15	coumarin	ADP	PA134521193	23038	0.5
NULL	Adv_Virol_2012_Jul_19_2012_267483.nxml.txt.nlp	22851970	SENT90	0	0	4	4	ribavirin	IFN	PA451241	3439	0.5
NULL	Int_J_Endocrinol_2013_Nov_13_2013_686315.nxml.txt.nlp	24324494	SENT8	4	4	2	2	metformin	SLC47A1	PA450395	55244	0.5
NULL	Diabetes_Care_2009_Nov_32(Suppl_2)_S223-S231.nxml.txt.nlp	19875556	SENT21	2	2	15	15	liraglutide	GLP-1	PA165958364	100125288	0.5
NULL	J_Cell_Mol_Med_2013_Sep_11_17(9)_1160-1172.nxml.txt.nlp	23844832	SENT263	18	18	16	16	pp2	PP1		5540;5464	0.5
NULL	Protein_Expr_Purif_2014_Sep_101(100)_68-75.nxml.txt.nlp	24907408	SENT41	21	21	11	11	valinomycin	CHS	PA151917011	1130	0.5
NULL	Biomed_Res_Int_2014_Feb_6_2014_323594.nxml.txt.nlp	24689036	SENT298	22	22	13	13	raloxifene	PC3	PA451221	57332;7832;5122	0.5
NULL	Theor_Appl_Genet_2008_May_12_116(8)_1051-1061.nxml.txt.nlp	18335203	SENT220	48	48	17	17	choline	ACL	PA448976	47	0.5
NULL	Front_Endocrinol_(Lausanne)_2014_Oct_27_5_163.nxml.txt.nlp	25386163	SENT216	12	12	21	21	ethanol	ghrelin	PA448073	51738	0.5
NULL	Cell_Div_2013_Jul_25_8_10.nxml.txt.nlp	23886499	SENT321	27	27	13	13	hydrocortisone	EGF	PA449905	1950	0.5
NULL	Int_J_Mol_Sci_2012_Dec_7_13(12)_16751-16768.nxml.txt.nlp	23222680	SENT247	23	23	3	3	tamoxifen	Q10	PA451581	27161	0.5
NULL	Eur_J_Endocrinol_2011_May_164(5)_765-771.nxml.txt.nlp	21325017	SENT110	2	2	0	0	nadh	NDUFC2	PA164755085	4718	0.5
NULL	Int_J_Biol_Macromol_2012_Mar_1_50(2)_362-368.nxml.txt.nlp	22210486	SENT27	0	0	2	2	lamivudine	LAM	PA450163	7249;7248	0.5
NULL	Acta_Neuropathol_2012_Jul_11_124(1)_51-65.nxml.txt.nlp	22491959	SENT192	20	20	11	11	chymotrypsin	SYN	PA448994	2534;23336	0.5
NULL	J_Cell_Biol_2001_May_28_153(5)_1049-1060.nxml.txt.nlp	11381089	SENT69	26	26	38	38	l-glutamine	BRL	PA10090	23774	0.5
NULL	Contemp_Oncol_(Pozn)_2013_Apr_29_17(2)_137-143.nxml.txt.nlp	23788980	SENT183	17	17	34	34	cabergoline	PRL	PA448708	5617	0.5
NULL	Curr_Hepat_Rep_2010_May_21_9(2)_75-90.nxml.txt.nlp	20461127	SENT244	23	23	37	37	telbivudine	LAM	PA164760861	7249;7248	0.5
NULL	Int_J_Mol_Sci_2014_Oct_27_15(11)_19458-19471.nxml.txt.nlp	25350111	SENT105	39	39	28	28	streptomycin	FBS	PA451512	64319;26269	0.5
NULL	Mol_Cancer_2012_Jul_25_11_47.nxml.txt.nlp	22830443	SENT200	7	7	10	10	panitumumab	EGFR	PA162373091	1956	0.5
NULL	J_Biomed_Biotechnol_2010_Sep_19_2010_518743.nxml.txt.nlp	20886007	SENT173	29	29	33	33	ethanol	ADP	PA448073	23038	0.5
NULL	Crit_Care_2011_Mar_22_15(2)_211.nxml.txt.nlp	21457505	SENT11	16	16	27	27	heparin	PF4	PA449855	5196	0.5
NULL	Chem_Cent_J_2012_Feb_21_6_15.nxml.txt.nlp	22353684	SENT120	15	15	13	13	acebutolol	mol	PA448011	90527	0.5
NULL	Neuropsychopharmacology_2009_Apr_2_34(5)_1135-1148.nxml.txt.nlp	18596687	SENT250	37	37	17	17	cocaine	CRF	PA449072	1392;10882	0.5
NULL	Cancers_(Basel)_2010_Jun_14_2(2)_1288-1311.nxml.txt.nlp	24281116	SENT485	7	7	1	1	oxygen	BRCA1	PA450744	672	0.5
NULL	Sci_Rep_2014_Dec_19_4_7571.nxml.txt.nlp	25524368	SENT33	15	15	19	19	estradiol	mer	PA449503	10461	0.5
NULL	Int_J_Mol_Sci_2014_Nov_5_15(11)_20169-20208.nxml.txt.nlp	25380523	SENT1845	6	6	4	4	fenofibrate	Q10	PA449594	27161	0.5
NULL	BMJ_Open_2013_Oct_14_3(10)_e003912.nxml.txt.nlp	24127058	SENT40	33	33	15	15	vancomycin	HAP	PA451850	5915;10313	0.5
NULL	Reprod_Biol_Endocrinol_2013_Feb_26_11_15.nxml.txt.nlp	23442442	SENT165	8	8	10	10	l-arginine	SLC7A1	PA448478	6541	0.5
NULL	Lancet_2010_Jan_9_375(9709)_123-131.nxml.txt.nlp	20004464	SENT50	26	26	7	7	nevirapine	CD4	PA450616	920	0.5
NULL	Open_Ophthalmol_J_2009_Sep_17_3_46-49.nxml.txt.nlp	19816587	SENT16	23	23	16	16	primaquine	G6PD	PA451103	2539	0.5
NULL	Clin_Med_Insights_Circ_Respir_Pulm_Med_2013_Nov_13_7_61-77.nxml.txt.nlp	24324354	SENT296	4	4	2	2	tobramycin	TOB	PA451704	10140	0.5
NULL	Biomed_Res_Int_2014_Jan_29_2014_361020.nxml.txt.nlp	24605326	SENT223	7	7	28	28	flavopiridol	CDK2	PA452627	1017	0.5
NULL	Br_J_Cancer_2013_Jan_15_108(1)_82-90.nxml.txt.nlp	23321512	SENT277	5	5	12	12	paclitaxel	TUBB3	PA450761	10381	0.5
NULL	Exp_Ther_Med_2013_Jul_25_6(1)_109-114.nxml.txt.nlp	23935730	SENT142	41	41	43	43	rituximab	CHOP	PA451261	1649	0.5
NULL	Physiol_Rep_2014_Nov_4_2(11)_e12193.nxml.txt.nlp	25367694	SENT68	32	32	23	23	gentamicin	FBS	PA449753	64319;26269	0.5
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R95.nxml.txt.nlp	22540992	SENT54	26	26	0	0	hydroxychloroquine	ACPA	PA164777036	5657	0.5
NULL	Cases_J_2009_Jul_9_2_7466.nxml.txt.nlp	19829971	SENT54	24	24	5	5	dobutamine	DST	PA449381	667	0.5
NULL	J_Exp_Med_1998_Jun_15_187(12)_1985-1993.nxml.txt.nlp	9625758	SENT69	24	24	35	35	neomycin	AAT	PA450608	5265	0.5
NULL	J_Gen_Physiol_2003_Mar_121(3)_181-197.nxml.txt.nlp	12601083	SENT262	2	2	0	0	forskolin	GLP-1	PA146096022	100125288	0.5
NULL	Proteome_Sci_2003_Jun_12_1_4.nxml.txt.nlp	12818002	SENT86	14	14	16	16	thrombin	neuropsin	PA451674	11202	0.5
NULL	Virol_J_2010_Nov_12_7_311.nxml.txt.nlp	21070682	SENT114	29	29	26	26	ribavirin	IFN	PA451241	3439	0.5
NULL	Adv_Hematol_2010_Dec_5_2010_595934.nxml.txt.nlp	21151515	SENT154	15	15	29	29	ticagrelor	Yes	PA165374673	7525	0.5
NULL	J_Immunol_Res_2014_Nov_11_2014_385352.nxml.txt.nlp	25436214	SENT64	23	23	10	10	paraformaldehyde	CD28	PA450790	1493;940	0.5
NULL	Acta_Neuropathol_2015_Oct_17_129_81-96.nxml.txt.nlp	25322817	SENT28	0	0	4	4	capsaicin	TRPV1	PA448776	7442	0.5
NULL	Environ_Health_Perspect_2008_Jul_26_116(7)_854-862.nxml.txt.nlp	18629305	SENT331	10	10	6	6	ebselen	NAC	PA161660841	22861	0.5
NULL	Inflamm_Res_2012_Sep_19_61(9)_955-966.nxml.txt.nlp	22610150	SENT10	35	35	9	9	ns-398	Bcl-2		596	0.5
NULL	Nucleic_Acids_Res_2005_Jun_9_33(10)_3323-3330.nxml.txt.nlp	15947132	SENT8	10	10	6	6	cisplatin	MSH2	PA449014	4436	0.5
NULL	J_Cardiothorac_Surg_2013_Jun_24_8_159.nxml.txt.nlp	23800231	SENT48	25	25	3	3	oxygen	SET	PA450744	6418	0.5
NULL	Chem_Cent_J_2012_Nov_23_6_140.nxml.txt.nlp	23173949	SENT112	21	21	0	0	ethanol	PERC	PA448073	133522	0.5
NULL	Environ_Health_Perspect_2010_Jul_3_118(7)_936-942.nxml.txt.nlp	20199942	SENT136	16	16	24	24	arsenite	p53	PA452638	7157	0.5
NULL	Drug_Des_Devel_Ther_2014_Sep_23_8_1527-1538.nxml.txt.nlp	25284985	SENT90	2	2	0	0	celecoxib	IFN	PA448871	3439	0.5
NULL	Antimicrob_Resist_Infect_Control_2012_Mar_16_1_12.nxml.txt.nlp	22958880	SENT107	18	18	16	16	gentamicin	Gen	PA449753	348654	0.5
NULL	Biomed_Eng_Online_2012_Nov_14_11_84.nxml.txt.nlp	23151049	SENT173	23	23	19	19	alendronate	PTH	PA448082	5741	0.5
NULL	Eur_J_Neurosci_2007_Apr_1_25(8)_2514-2522.nxml.txt.nlp	17445247	SENT82	3	3	15	15	oxygen	CO2	PA450744	4513	0.5
NULL	Hum_Genomics_2008_Sep_1_3(1)_71-78.nxml.txt.nlp	19129091	SENT32	17	17	30	30	nadh	ND4L	PA164755085	4539	0.5
NULL	Br_J_Pharmacol_2014_Sep_28_171(18)_4255-4272.nxml.txt.nlp	24846338	SENT274	3	3	10	10	escitalopram	gamma	PA10074	9913	0.5
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT192	39	39	47	47	afatinib	Yes	PA165981154	7525	0.5
NULL	Summit_on_Translat_Bioinforma_2009_Mar_1_2009_124-128.nxml.txt.nlp	21347183	SENT69	20	20	13	13	thioguanine	TPMT	PA451663	7172	0.5
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Oct_15_70(Pt_11)_o1158-o1159.nxml.txt.nlp	25484802	SENT92	31	31	18	18	ethanol	mol	PA448073	90527	0.5
NULL	Arch_Med_Sci_2011_Aug_2_7(4)_597-603.nxml.txt.nlp	22291794	SENT115	0	0	26	26	clenbuterol	CD40	PA164745640	958	0.5
NULL	ScientificWorldJournal_2014_Jul_23_2014_854093.nxml.txt.nlp	25147870	SENT168	11	11	14	14	chlorophyll	gamma	PA448942	9913	0.5
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Apr_13_69(Pt_5)_o727.nxml.txt.nlp	23723879	SENT78	21	21	18	18	ethanol	mol	PA448073	90527	0.5
NULL	Int_J_Cell_Biol_2012_May_13_2012_273549.nxml.txt.nlp	22654912	SENT61	21	21	29	29	l-glutamine	CO2	PA10090	4513	0.5
NULL	J_Physiol_2009_Feb_15_587(Pt_4)_731-744.nxml.txt.nlp	19074966	SENT268	7	7	11	11	taurine	PAT1	PA451590	10513;206358	0.5
NULL	J_Cell_Biol_2006_Sep_11_174(6)_759-765.nxml.txt.nlp	16954350	SENT159	33	33	11	11	l-glutamine	CO2	PA10090	4513	0.5
NULL	Diabetes_Metab_J_2013_Oct_17_37(5)_301-314.nxml.txt.nlp	24199158	SENT90	6	6	12	12	simvastatin	PDK4	PA451363	5166	0.5
NULL	Vet_Res_Forum_2013_Winter_4(1)_19-24.nxml.txt.nlp	25593681	SENT68	15	15	13	13	diclofenac	B12	PA449293	7126;4709	0.5
NULL	Pan_Afr_Med_J_2012_Sep_5_13_4.nxml.txt.nlp	23308311	SENT71	11	11	1	1	cytarabine	LAM	PA449177	7249;7248	0.5
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT192	23	23	9	9	panitumumab	Yes	PA162373091	7525	0.5
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT111	7	7	9	9	capsaicin	p53	PA448776	7157	0.5
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT89	0	0	11	11	etravirine	UGT	PA166014703	7361;7355	0.5
NULL	Aging_(Albany_NY)_2010_Dec_20_2(12)_959-968.nxml.txt.nlp	21191146	SENT90	0	0	11	11	cisplatin	Rpn13	PA449014	11047	0.5
NULL	Curr_Med_Chem_2013_Jan_20(3)_438-447.nxml.txt.nlp	23157636	SENT453	28	28	12	12	clozapine	FGA	PA449061	2243	0.5
NULL	Gut_Liver_2013_Sep_14_7(5)_585-593.nxml.txt.nlp	24073317	SENT20	17	17	15	15	ribavirin	IFN	PA451241	3439	0.5
NULL	J_Gen_Physiol_2008_Nov_132(5)_521-535.nxml.txt.nlp	18852303	SENT128	10	10	8	8	aprotinin	CAP2	PA448472	5271;10486	0.5
NULL	Arthritis_Res_Ther_2008_Dec_1_10(6)_R139.nxml.txt.nlp	19046432	SENT56	18	18	22	22	rosiglitazone	MMP13	PA451283	4322	0.5
NULL	Hum_Mol_Genet_2013_Dec_20_22(25)_5229-5236.nxml.txt.nlp	23933735	SENT111	19	19	23	23	nadh	COX	PA164755085	1351	0.5
NULL	J_Histochem_Cytochem_2012_Oct_60(10)_749-760.nxml.txt.nlp	22821669	SENT374	6	6	8	8	hyaluronan	TSG-6	PA165958431	7130	0.5
NULL	Core_Evid_2010_Oct_21_5_61-76.nxml.txt.nlp	21042543	SENT421	1	1	4	4	panitumumab	KRAS	PA162373091	3845	0.5
NULL	Cancers_(Basel)_2014_Aug_12_6(3)_1631-1669.nxml.txt.nlp	25119536	SENT440	1	1	8	8	imatinib	Met	PA10804	79811	0.5
NULL	J_Biol_Chem_2009_Jul_24_284(30)_20011-20021.nxml.txt.nlp	19473976	SENT190	3	3	46	46	trypsin	MCT1	PA451806	6566	0.5
NULL	CNS_Drugs_2014_May_1_28(6)_497-511.nxml.txt.nlp	24788672	SENT107	6	6	8	8	atomoxetine	DBP	PA134688071	3295;1628;2638	0.5
NULL	Cardiovasc_Diabetol_2008_Feb_26_7_3.nxml.txt.nlp	18302760	SENT196	10	10	13	13	rosiglitazone	CD36	PA451283	948	0.5
NULL	Cell_Cycle_2012_Nov_1_11(21)_3983-3996.nxml.txt.nlp	22987153	SENT233	11	11	4	4	cisplatin	EXO1	PA449014	9156	0.5
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT192	23	23	47	47	panitumumab	Yes	PA162373091	7525	0.5
NULL	Br_J_Cancer_2012_Apr_10_106(8)_1439-1445.nxml.txt.nlp	22433965	SENT124	17	17	24	24	sorafenib	CYP3A4	PA7000	1576	0.5
NULL	J_Immunotoxicol_2013_Jan_11_10(1)_75-82.nxml.txt.nlp	22967038	SENT97	9	9	16	16	muromonab	IFN	PA164743097	3439	0.5
NULL	Indian_J_Med_Res_2013_Nov_138(5)_577-590.nxml.txt.nlp	24434313	SENT81	9	9	7	7	staurosporine	CD2	PA165109623	914	0.5
NULL	F1000Res_2013_Mar_5_2_74.nxml.txt.nlp	24358880	SENT46	14	14	20	20	capsaicin	TRPV1	PA448776	7442	0.5
NULL	Arthritis_Res_Ther_2011_Dec_12_13(6)_R204.nxml.txt.nlp	22151924	SENT87	26	26	8	8	natalizumab	CFB	PA164747191	629	0.5
NULL	ScientificWorldJournal_2012_Dec_5_2012_925925.nxml.txt.nlp	23304092	SENT97	8	8	6	6	copper	mol	PA449114	90527	0.5
NULL	Allergy_Asthma_Immunol_Res_2014_Nov_19_6(6)_548-557.nxml.txt.nlp	25374755	SENT96	0	0	12	12	lovastatin	CCL11	PA450272	6356	0.5
NULL	Biologics_2013_Apr_15_7_77-90.nxml.txt.nlp	23723688	SENT188	0	0	3	3	cetuximab	CRT	PA10040	811	0.5
NULL	Nucleic_Acids_Res_2005_Mar_30_33(6)_e57.nxml.txt.nlp	15800208	SENT30	22	22	45	45	l-glutamine	CO2	PA10090	4513	0.5
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Oct_31_70(Pt_11)_o1210-o1211.nxml.txt.nlp	25484834	SENT104	5	5	12	12	piperazine	mol	PA450977	90527	0.5
NULL	Diabetes_2008_Sep_57(9)_2272-2279.nxml.txt.nlp	18519799	SENT205	0	0	6	6	rosiglitazone	PEPCK-C	PA451283	5105	0.5
NULL	Acta_Neuropathol_Commun_2014_Feb_28_2_25.nxml.txt.nlp	24581221	SENT54	14	14	10	10	gentamicin	B27	PA449753	56246	0.5
NULL	Hum_Genomics_2003_Nov_1_1(1)_41-51.nxml.txt.nlp	15601532	SENT25	7	7	20	20	saquinavir	Yes	PA451305	7525	0.5
NULL	Cancer_Med_2014_Aug_16_3(4)_775-786.nxml.txt.nlp	24737784	SENT175	41	41	5	5	quinidine	ANOVA	PA451209	4858	0.5
NULL	Mol_Cell_Proteomics_2012_Feb_13_11(2)_M111_013904.nxml.txt.nlp	21997733	SENT205	28	28	31	31	trypsin	ITIH2	PA451806	3698	0.5
NULL	J_Biomed_Biotechnol_2011_Jan_24_2011_250860.nxml.txt.nlp	21318107	SENT161	0	0	4	4	lenalidomide	IL-2	PA162363968	3558	0.5
NULL	Scientifica_(Cairo)_2013_Jan_17_2013_795964.nxml.txt.nlp	24278786	SENT159	24	24	35	35	xanthophyll	NPQ	PA164748318	80763	0.5
NULL	Nat_Commun_2014_Dec_12_5_5775.nxml.txt.nlp	25503391	SENT228	32	32	25	25	ethanol	mol	PA448073	90527	0.5
NULL	Indian_Dermatol_Online_J_2014_Dec_5(Suppl_2)_S116-S118.nxml.txt.nlp	25593799	SENT65	4	4	9	9	calcipotriol	CO2	PA448714	4513	0.5
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT250	14	14	12	12	vinorelbine	ASC	PA451881	29108	0.5
NULL	Curr_Neuropharmacol_2014_May_12(3)_219-238.nxml.txt.nlp	24851087	SENT440	11	11	0	0	phencyclidine	Gen	PA128406980	348654	0.5
NULL	Oncotarget_2011_Sep_9_2(9)_658-668.nxml.txt.nlp	21911919	SENT106	11	11	23	23	cytarabine	NAC	PA449177	22861	0.5
NULL	Clin_Ophthalmol_2007_Sep_1(3)_273-284.nxml.txt.nlp	19668481	SENT184	9	9	14	14	bevacizumab	CRT	PA130232992	811	0.5
NULL	Aging_(Albany_NY)_2013_May_23_5(5)_357-372.nxml.txt.nlp	23793469	SENT246	33	33	25	25	ethanol	CO2	PA448073	4513	0.499
NULL	Cancer_Med_2012_Oct_6_1(2)_198-206.nxml.txt.nlp	23342269	SENT226	21	21	30	30	oxaliplatin	ROX	PA131285527	4335	0.499
NULL	Sensors_(Basel)_2010_Mar_25_10(4)_2626-2637.nxml.txt.nlp	22319264	SENT130	39	39	17	17	ethanol	fumarase	PA448073	2271	0.499
NULL	Crit_Care_1998_Mar_1_2(Suppl_1)_P028.nxml.txt.nlp	NULL	SENT9	28	28	26	26	thrombin	ADP	PA451674	23038	0.499
NULL	Cell_Death_Dis_2014_Jan_30_5(1)_e1036.nxml.txt.nlp	24481450	SENT119	24	24	28	28	heparin	EGF	PA449855	1950	0.499
NULL	Int_J_Biol_Sci_2015_Jan_1_11(1)_48-58.nxml.txt.nlp	25552929	SENT24	0	0	30	30	paclitaxel	TSP-1	PA450761	7057	0.499
NULL	Breast_Cancer_(Auckl)_2011_Jul_27_5_175-199.nxml.txt.nlp	21863131	SENT458	12	12	10	10	ixabepilone	BCS		617	0.499
NULL	Cancers_(Basel)_2014_Aug_12_6(3)_1631-1669.nxml.txt.nlp	25119536	SENT372	3	3	0	0	crizotinib	Met	PA165946122	79811	0.499
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Jun_27_5_15.nxml.txt.nlp	16803618	SENT178	38	38	42	42	gentamicin	GEN1	PA449753	348654	0.499
NULL	Front_Immunol_2012_May_4_3_98.nxml.txt.nlp	22566974	SENT29	23	23	16	16	rituximab	CHOP	PA451261	1649	0.499
NULL	Virol_J_2010_Oct_27_7_285.nxml.txt.nlp	20979618	SENT153	16	16	8	8	naloxone	c-fos	PA450586	2353	0.499
NULL	Br_J_Ophthalmol_2008_Sep_22_92(9)_1275-1282.nxml.txt.nlp	18723745	SENT18	4	4	9	9	travoprost	BAK	PA164781371	578	0.499
NULL	Mol_Cancer_2008_Mar_26_7_27.nxml.txt.nlp	18366759	SENT288	13	13	26	26	etoposide	AP-1	PA449552	2353;3727;2354;3725	0.499
NULL	Breast_Cancer_Res_2009_Jun_29_11(3)_R41.nxml.txt.nlp	19563669	SENT12	9	9	5	5	lapatinib	TRAIL	PA152241907	8743	0.499
NULL	Eur_J_Appl_Physiol_2011_Feb_24_111(2)_275-283.nxml.txt.nlp	20865425	SENT110	36	36	9	9	glucose	MRS	PA449773	8011	0.499
NULL	Crit_Care_2009_Mar_16_13(2)_R37.nxml.txt.nlp	19291300	SENT10	12	12	2	2	urea	CRP	PA451831	1401;140913	0.499
NULL	Front_Genet_2012_Nov_26_3_244.nxml.txt.nlp	23248639	SENT73	6	6	4	4	l-proline	AMPK	PA451125	5563	0.499
NULL	Bioinformation_2006_Dec_23_1(8)_314-320.nxml.txt.nlp	17597912	SENT156	6	6	9	9	saquinavir	ACE	PA451305	1636	0.499
NULL	Oncotarget_2011_Mar_28_2(3)_222-233.nxml.txt.nlp	21447859	SENT191	0	0	4	4	metformin	p53	PA450395	7157	0.499
NULL	Arthritis_Res_Ther_2009_Feb_3_11(1)_R15.nxml.txt.nlp	19192274	SENT212	31	31	13	13	chloroquine	IL-8	PA448948	3576	0.499
NULL	Am_J_Pathol_2011_Dec_179(6)_2709-2719.nxml.txt.nlp	21983634	SENT344	21	21	12	12	capsaicin	PKR1	PA448776	10887	0.499
NULL	Acta_Pharmacol_Sin_2014_Jul_9_35(7)_889-898.nxml.txt.nlp	24909515	SENT159	18	18	29	29	phenol	SULT1E1	PA450913	6783	0.499
NULL	Curr_Mol_Med_2012_Jan_12(1)_3-13.nxml.txt.nlp	22082477	SENT54	10	10	6	6	creatine	TWEAK	PA164778930	8742	0.499
NULL	Drug_Des_Devel_Ther_2014_Sep_23_8_1527-1538.nxml.txt.nlp	25284985	SENT86	5	5	3	3	celecoxib	IFN	PA448871	3439	0.499
NULL	Mol_Cancer_2014_Jun_5_13_143.nxml.txt.nlp	24898067	SENT42	35	35	37	37	gefitinib	HER-2	PA131301952	2064	0.499
NULL	Cent_European_J_Urol_2013_Dec_19_66(4)_394-404.nxml.txt.nlp	24757527	SENT264	4	4	13	13	bevacizumab	IFN	PA130232992	3439	0.499
NULL	Crit_Care_2009_Jun_19_13(3)_R94.nxml.txt.nlp	19545361	SENT129	24	24	22	22	micafungin	MYC	PA164781026	4609	0.499
NULL	Mol_Pain_2013_Jun_22_9_30.nxml.txt.nlp	23800232	SENT45	29	29	33	33	capsaicin	TRPV1	PA448776	7442	0.499
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_39-54.nxml.txt.nlp	19305787	SENT409	6	6	14	14	ethanol	GMP	PA448073	22978	0.499
NULL	Europace_2012_Dec_6_14(12)_1700-1707.nxml.txt.nlp	22772054	SENT128	25	25	29	29	heparin	Yes	PA449855	7525	0.499
NULL	Behav_Brain_Funct_2009_Jan_15_5_3.nxml.txt.nlp	19146665	SENT79	5	5	11	11	ethanol	P29	PA448073	5657	0.499
NULL	Cardiol_Ther_2013_Jun_1_2(1)_111-124.nxml.txt.nlp	25135294	SENT86	10	10	28	28	thrombin	ACT	PA451674	12;11332;9457;641455	0.499
NULL	Int_J_Med_Sci_2015_Jan_1_12(1)_63-71.nxml.txt.nlp	25552920	SENT141	2	2	13	13	berberine	PC-3	PA165860812	692094	0.499
NULL	Infect_Dis_Ther_2013_Dec_2_2(2)_123-144.nxml.txt.nlp	25134476	SENT106	26	26	11	11	isoniazid	DST	PA450112	667	0.499
NULL	Endocrinology_2014_Mar_3_155(3)_908-922.nxml.txt.nlp	24302625	SENT444	10	10	3	3	timolol	ACTH	PA451690	5443	0.499
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT260	6	6	8	8	aripiprazole	PRL	PA10026	5617	0.499
NULL	J_Cell_Biol_1999_Jul_12_146(1)_243-254.nxml.txt.nlp	10402474	SENT72	18	18	4	4	ethanol	IP-10	PA448073	3627	0.499
NULL	Crit_Care_2005_Mar_11_9(3)_R191-R199.nxml.txt.nlp	15987390	SENT278	35	35	31	31	itraconazole	Yes	PA450132	7525	0.499
NULL	Mol_Cancer_2010_Nov_22_9_298.nxml.txt.nlp	21092190	SENT128	15	15	3	3	gemcitabine	SRM	PA449748	6723;6725	0.499
NULL	Cytotherapy_2014_Jun_16(6)_800-809.nxml.txt.nlp	24642019	SENT8	13	13	27	27	collagenase	NAC	PA449107	22861	0.499
NULL	J_Gen_Physiol_2000_Jun_1_115(6)_685-696.nxml.txt.nlp	10828243	SENT168	22	22	10	10	genistein	OLF	PA165109660	83857	0.499
NULL	Evid_Based_Complement_Alternat_Med_2013_May_2_2013_429738.nxml.txt.nlp	23762134	SENT166	9	9	0	0	lipase	SREBP-1c	PA450239	6720	0.499
NULL	J_Hematol_Oncol_2009_Nov_22_2_49.nxml.txt.nlp	19930611	SENT50	15	15	29	29	doxorubicin	CHOP	PA449412	1649	0.499
NULL	Clin_Interv_Aging_2014_Aug_16_9_1363-1373.nxml.txt.nlp	25170260	SENT241	12	12	26	26	amisulpride	Yes	PA162565877	7525	0.499
NULL	Cell_Death_Dis_2014_Feb_13_5(2)_e1055.nxml.txt.nlp	24525731	SENT6	18	18	43	43	cisplatin	DDP	PA449014	1678	0.499
NULL	Am_J_Trop_Med_Hyg_2012_Nov_7_87(5_Suppl)_92-96.nxml.txt.nlp	23136283	SENT84	24	24	14	14	artemisinin	ACT	PA165111696	12;11332;9457;641455	0.499
NULL	Evid_Based_Complement_Alternat_Med_2011_Feb_20_2011_675397.nxml.txt.nlp	19584081	SENT123	14	14	16	16	oxygen	CAT	PA450744	847	0.499
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Nov_19_67(Pt_12)_o3358.nxml.txt.nlp	22199852	SENT3	9	9	3	3	piperazine	mol	PA450977	90527	0.499
NULL	Environ_Health_Perspect_2001_Mar_109(3)_257-264.nxml.txt.nlp	11333187	SENT9	0	0	4	4	estradiol	aromatase	PA449503	1588	0.499
NULL	Oncotarget_2012_Dec_18_3(12)_1615-1628.nxml.txt.nlp	23271044	SENT80	7	7	0	0	clofarabine	CTRL	PA164754863	1506	0.499
NULL	Am_J_Physiol_Cell_Physiol_2014_Jan_15_306(2)_C89-C97.nxml.txt.nlp	24133067	SENT55	13	13	4	4	hyaluronan	HAS2	PA165958431	3037	0.499
NULL	An_Bras_Dermatol_2013_Jul-Aug_88(4)_676-678.nxml.txt.nlp	24068154	SENT14	19	19	28	28	rituximab	por	PA451261	64840	0.499
NULL	Mar_Drugs_2014_Jun_27_12(7)_3818-3837.nxml.txt.nlp	24979269	SENT68	10	10	8	8	doxorubicin	P-gp	PA449412	5243	0.499
NULL	Front_Neurosci_2012_May_30_6_77.nxml.txt.nlp	22661925	SENT252	28	28	24	24	ethanol	DCX	PA448073	1641	0.499
NULL	J_Gastroenterol_2013_Feb_22_48(2)_222-237.nxml.txt.nlp	22722906	SENT232	6	6	14	14	ethanol	p38	PA448073	10598;1432;7965	0.499
NULL	EMBO_Mol_Med_2011_May_3(5)_266-278.nxml.txt.nlp	21438154	SENT100	9	9	5	5	oxaliplatin	TRPM8	PA131285527	79054	0.499
NULL	Arthritis_Res_Ther_2011_Feb_16_13(1)_R25.nxml.txt.nlp	21324169	SENT120	22	22	31	31	infliximab	TNF	PA452639	7124	0.499
NULL	Int_J_Endocrinol_Metab_2013_Apr_1_Spring_11(2)_65-70.nxml.txt.nlp	23825975	SENT148	10	10	5	5	estradiol	CEE	PA449503	51608	0.499
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT166	2	2	0	0	dasatinib	PP2	PA162372878	4888	0.499
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Dec_10_68(Pt_1)_o70.nxml.txt.nlp	22259571	SENT3	9	9	3	3	piperazine	mol	PA450977	90527	0.499
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT166	45	45	34	34	glucose	p38	PA449773	10598;1432;7965	0.499
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_28_2012_937605.nxml.txt.nlp	23304227	SENT101	0	0	4	4	resveratrol	GDNF		2668	0.499
NULL	BMJ_2013_Nov_6_347_f6530.nxml.txt.nlp	24196498	SENT125	2	2	0	0	paclitaxel	PES	PA450761	23481	0.499
NULL	Br_J_Dermatol_2014_Feb_18_170(1)_342-351.nxml.txt.nlp	24547721	SENT82	6	6	11	11	lansoprazole	DIF	PA450180	7124	0.499
NULL	Case_Rep_Pathol_2013_Feb_21_2013_687427.nxml.txt.nlp	23533895	SENT104	11	11	13	13	thyroglobulin	CD117	PA164754910	3815	0.499
NULL	J_Exp_Med_2003_Aug_4_198(3)_505-512.nxml.txt.nlp	12900524	SENT130	6	6	9	9	dextran	CCL21	PA449261	6366	0.499
NULL	Front_Neurol_2012_Aug_1_3_120.nxml.txt.nlp	23015798	SENT529	3	3	11	11	ethanol	GMP	PA448073	22978	0.499
NULL	Mol_Biol_Rep_2014_Jan_29_41(5)_2851-2857.nxml.txt.nlp	24469723	SENT87	14	14	16	16	docetaxel	BCS	PA449383	617	0.499
NULL	Curr_Neuropharmacol_2014_Jul_12(4)_365-379.nxml.txt.nlp	25342944	SENT534	17	17	3	3	citalopram	5-HT1D	PA449015	3352	0.499
NULL	Braz_J_Med_Biol_Res_2013_Feb_1_46(2)_171-177.nxml.txt.nlp	23369979	SENT124	26	26	2	2	enalapril	IL-10	PA449456	3586	0.499
NULL	Br_J_Cancer_2010_Jun_8_102(12)_1707-1716.nxml.txt.nlp	20461078	SENT98	3	3	8	8	bortezomib	TRAIL	PA10252	8743	0.499
NULL	J_Med_Case_Reports_2011_Aug_3_5_345.nxml.txt.nlp	21812958	SENT70	14	14	16	16	temsirolimus	IL-2	PA164746890	3558	0.499
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT128	19	19	0	0	amiodarone	CYP1A2	PA448383	1544	0.499
NULL	Diabetes_Metab_J_2014_Dec_15_38(6)_456-463.nxml.txt.nlp	25541609	SENT49	13	13	17	17	nitrogen	AST	PA450643	26503	0.499
NULL	F1000_Med_Rep_2009_Nov_26_1_90.nxml.txt.nlp	20948687	SENT15	5	5	7	7	bevacizumab	IFN	PA130232992	3439	0.499
NULL	Nat_Med_2010_Jun_23_16(6)_671-677.nxml.txt.nlp	20495567	SENT244	23	23	10	10	sorafenib	MCL1	PA7000	4170	0.499
NULL	FASEB_J_2009_Feb_23(2)_575-585.nxml.txt.nlp	18957574	SENT168	18	18	24	24	oxygen	IFN	PA450744	3439	0.499
NULL	Arthritis_Res_Ther_2014_Jul_18_16(4)_R153.nxml.txt.nlp	25037855	SENT108	37	37	25	25	adalimumab	LTA	PA10004	4049	0.499
NULL	Br_J_Cancer_2012_Sep_25_107(7)_1009-1016.nxml.txt.nlp	22948724	SENT93	13	13	35	35	temsirolimus	PTEN	PA164746890	5728	0.499
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Dec_2_5_30.nxml.txt.nlp	17140452	SENT239	7	7	29	29	gatifloxacin	CHL	PA449738	91851	0.499
NULL	EMBO_Mol_Med_2012_Jul_11_4(7)_577-593.nxml.txt.nlp	22496117	SENT112	17	17	7	7	staurosporine	PAP-1	PA165109623	6100	0.499
NULL	Onco_Targets_Ther_2014_Nov_26_7_2155-2160.nxml.txt.nlp	25473297	SENT46	26	26	16	16	cisplatin	NACT	PA449014	284111	0.499
NULL	Exp_Diabetes_Res_2012_Nov_12_2012_618923.nxml.txt.nlp	23197974	SENT3	13	13	22	22	telmisartan	STZ	PA451605	6484	0.499
NULL	ScientificWorldJournal_2014_Mar_24_2014_694326.nxml.txt.nlp	24782665	SENT162	12	12	5	5	metformin	FDG	PA450395	23583	0.499
NULL	Acta_Pharmacol_Sin_2011_Jun_3_32(6)_805-816.nxml.txt.nlp	21642949	SENT70	7	7	5	5	vasopressin	AQP2	PA451858	359	0.499
NULL	Breast_Cancer_Res_2011_Jun_29_13(3)_R70.nxml.txt.nlp	21707964	SENT189	18	18	29	29	tamoxifen	FOXM1	PA451581	2305	0.499
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT192	35	35	19	19	cetuximab	Yes	PA10040	7525	0.499
NULL	Gut_2011_Sep_8_60(9)_1284-1293.nxml.txt.nlp	21303914	SENT86	16	16	14	14	ribavirin	IFN	PA451241	3439	0.499
NULL	Genome_Announc_2014_Jul_10_2(4)_e00688-14.nxml.txt.nlp	25013145	SENT5	5	5	40	40	vancomycin	VISA	PA451850	57506	0.499
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT192	41	41	33	33	erlotinib	Yes	PA134687924	7525	0.499
NULL	Int_J_Nanomedicine_2012_Oct_9_7_5395-5404.nxml.txt.nlp	23091382	SENT7	8	8	23	23	ethanol	zeta	PA448073	9907	0.499
NULL	Br_J_Cancer_2011_Nov_22_105(11)_1654-1662.nxml.txt.nlp	22045187	SENT153	13	13	21	21	irinotecan	MTHFR	PA450085	4524	0.499
NULL	Acta_Pharmacol_Sin_2013_Feb_10_34(2)_262-270.nxml.txt.nlp	23222270	SENT76	39	39	21	21	aprotinin	SDS	PA448472	51119;10993	0.499
NULL	Front_Aging_Neurosci_2010_Nov_5_2_146.nxml.txt.nlp	21119769	SENT312	11	11	14	14	tolcapone	COMT	PA451720	1312	0.499
NULL	Nat_Genet_2013_Sep_28_45(9)_1004-1012.nxml.txt.nlp	23892607	SENT90	41	41	23	23	doxycycline	LTA	PA449415	4049	0.499
NULL	Oncol_Rep_2012_Apr_22_27(4)_1123-1127.nxml.txt.nlp	22200897	SENT115	16	16	34	34	hyaluronan	p38	PA165958431	10598;1432;7965	0.499
NULL	Int_J_Endocrinol_2010_May_26_2010_906163.nxml.txt.nlp	20585352	SENT14	4	4	9	9	cinacalcet	MEN1	PA164776671	4221	0.499
NULL	Cell_Commun_Signal_2009_Oct_27_7_25.nxml.txt.nlp	19860902	SENT238	0	0	8	8	tropisetron	JNK	PA161925594	5599	0.499
NULL	Indian_J_Dermatol_2011_Jan-Feb_56(1)_87-91.nxml.txt.nlp	21572802	SENT11	21	21	14	14	doxorubicin	CHOP	PA449412	1649	0.499
NULL	Mar_Drugs_2014_Jun_27_12(7)_3818-3837.nxml.txt.nlp	24979269	SENT479	8	8	14	14	mitoxantrone	ABCG2	PA450526	9429	0.499
NULL	Evid_Based_Complement_Alternat_Med_2006_Sep_20_3(3)_365-372.nxml.txt.nlp	16951721	SENT104	10	10	5	5	ginseng	Bcl-2	PA164781150	596	0.499
NULL	Clin_Ophthalmol_2009_Dec_29_3_689-692.nxml.txt.nlp	20054418	SENT64	4	4	12	12	cyclophosphamide	CHOP	PA449165	1649	0.499
NULL	Virol_J_2011_Sep_21_8_444.nxml.txt.nlp	21936898	SENT19	7	7	4	4	telbivudine	LAM	PA164760861	7249;7248	0.499
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT163	16	16	9	9	erlotinib	CYP3A5	PA134687924	1577	0.499
NULL	Protein_Cell_2014_Jul_30_5(7)_552-562.nxml.txt.nlp	24870149	SENT103	11	11	38	38	kanamycin	PRK	PA450137	1263	0.499
NULL	Ann_Rheum_Dis_2008_Jul_22_68(8)_1303-1309.nxml.txt.nlp	18647851	SENT141	12	12	7	7	adalimumab	MMP3	PA10004	4314	0.499
NULL	Eur_J_Clin_Pharmacol_2014_Oct_8_70(1)_37-45.nxml.txt.nlp	24100471	SENT54	12	12	18	18	midazolam	CYP2C8	PA450496	1558	0.499
NULL	Chem_Res_Toxicol_2011_Aug_15_24(8)_1275-1282.nxml.txt.nlp	21749116	SENT254	16	16	34	34	geldanamycin	Hsp90	PA152031327	3320	0.499
NULL	Curr_Med_Chem_2013_Apr_20(10)_1241-1285.nxml.txt.nlp	23409712	SENT1006	14	14	25	25	amiloride	TRPC1	PA448368	7220	0.499
NULL	Br_J_Cancer_2013_Mar_19_108(5)_1052-1060.nxml.txt.nlp	23422754	SENT114	13	13	24	24	bevacizumab	VEGF-A	PA130232992	7422	0.499
NULL	Osteoarthritis_Cartilage_2013_Sep_21(9)_1336-1345.nxml.txt.nlp	23973148	SENT468	0	0	17	17	triamcinolone	MNX	PA451749	3892	0.499
NULL	Arthritis_Res_Ther_2011_Feb_16_13(1)_R25.nxml.txt.nlp	21324169	SENT120	10	10	31	31	anakinra	TNF	PA10799	7124	0.499
NULL	Breast_Cancer_Res_2005_Mar_4_7(3)_R345-R352.nxml.txt.nlp	15987429	SENT245	28	28	24	24	ns-398	CARB		9482	0.499
NULL	Case_Rep_Oncol_2013_Dec_12_6(3)_602-608.nxml.txt.nlp	24474924	SENT81	16	16	21	21	erlotinib	CYP1A2	PA134687924	1544	0.499
NULL	Head_Face_Med_2010_Jul_19_6_17.nxml.txt.nlp	20642842	SENT93	11	11	17	17	paraformaldehyde	mol	PA450790	90527	0.499
NULL	Exp_Ther_Med_2013_Nov_6_6(5)_1089-1095.nxml.txt.nlp	24223627	SENT98	6	6	9	9	docetaxel	NAC	PA449383	22861	0.499
NULL	Clin_Oncol_(R_Coll_Radiol)_2014_Sep_26(9)_581-596.nxml.txt.nlp	24998430	SENT226	27	27	4	4	gemcitabine	CRT	PA449748	811	0.499
NULL	Leukemia_2014_Jun_25_28(6)_1280-1288.nxml.txt.nlp	24270737	SENT105	13	13	23	23	decitabine	PD-L1	PA164749631	29126	0.499
NULL	Case_Rep_Genet_2012_Mar_26_2012_280813.nxml.txt.nlp	23074686	SENT77	5	5	8	8	minocycline	MMP9	PA450519	4318	0.499
NULL	Br_J_Cancer_2009_Jul_7_101(1)_38-47.nxml.txt.nlp	19513066	SENT274	11	11	19	19	dasatinib	p27	PA162372878	5715;10534	0.499
NULL	Diabetes_Care_2013_Feb_17_36(2)_422-428.nxml.txt.nlp	23033246	SENT218	27	27	13	13	lipase	PPARgamma	PA450239	5468	0.499
NULL	Front_Physiol_2013_Jul_29_4_194.nxml.txt.nlp	23908631	SENT622	3	3	9	9	isoflurane	CD73	PA450106	4907	0.499
NULL	Nat_Commun_2010_Nov_30_1_130.nxml.txt.nlp	21119643	SENT104	21	21	39	39	fenofibrate	PS1	PA449594	5663	0.499
NULL	Breast_Cancer_Res_2008_May_30_10(3)_207.nxml.txt.nlp	18557990	SENT119	9	9	4	4	zinc	ASV	PA451956	6714	0.499
NULL	AIDS_Care_2011_Sep_14_23(9)_1154-1162.nxml.txt.nlp	21500025	SENT140	24	24	2	2	ritonavir	ATV	PA451260	4683	0.499
NULL	J_Cell_Mol_Med_2014_Dec_22_18(12)_2519-2529.nxml.txt.nlp	25338520	SENT112	3	3	0	0	oxygen	ROS	PA450744	6098	0.499
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Sep_14_67(Pt_10)_o2574.nxml.txt.nlp	22058740	SENT3	9	9	3	3	piperazine	mol	PA450977	90527	0.499
NULL	Adv_Pharmacol_Sci_2013_Jun_18_2013_718313.nxml.txt.nlp	23853606	SENT197	12	12	14	14	phenylephrine	PE-1	PA450935	2117	0.498
NULL	Sensors_(Basel)_2012_Feb_1_12(2)_1383-1397.nxml.txt.nlp	22438715	SENT32	37	37	35	35	hydrocortisone	EGF	PA449905	1950	0.498
NULL	Mol_Cancer_2009_Aug_25_8_66.nxml.txt.nlp	19706164	SENT288	33	33	23	23	celecoxib	ANOVA	PA448871	4858	0.498
NULL	Indian_J_Med_Res_2012_Dec_136(6)_963-970.nxml.txt.nlp	23391791	SENT56	5	5	8	8	glutaraldehyde	gamma	PA449777	9913	0.498
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Dec_2_5_30.nxml.txt.nlp	17140452	SENT187	7	7	29	29	gatifloxacin	CHL	PA449738	91851	0.498
NULL	J_Viral_Hepat_2010_Feb_17(2)_139-147.nxml.txt.nlp	19674282	SENT63	5	5	15	15	ribavirin	RVR	PA451241	9975	0.498
NULL	Aging_(Albany_NY)_2010_Dec_20_2(12)_959-968.nxml.txt.nlp	21191146	SENT84	5	5	9	9	cisplatin	Rpn13	PA449014	11047	0.498
NULL	Biochem_Biophys_Res_Commun_2011_Nov_18_415(2)_300-304.nxml.txt.nlp	22027147	SENT210	9	9	24	24	nadh	ND4	PA164755085	4538	0.498
NULL	FEBS_Open_Bio_2013_Dec_30_4_96-104.nxml.txt.nlp	24490130	SENT75	16	16	18	18	cisplatin	BRCA1	PA449014	672	0.498
NULL	Br_J_Pharmacol_2011_May_163(2)_261-271.nxml.txt.nlp	21054345	SENT121	30	30	8	8	forskolin	GLP-1	PA146096022	100125288	0.498
NULL	Neural_Regen_Res_2014_Nov_1_9(21)_1897-1901.nxml.txt.nlp	25558239	SENT31	0	0	5	5	diazepam	gamma	PA449283	9913	0.498
NULL	ACS_Nano_2014_Mar_25_8(3)_2018-2032.nxml.txt.nlp	24555414	SENT264	11	11	16	16	gemcitabine	mol	PA449748	90527	0.498
NULL	Crit_Care_2011_Nov_16_15(6)_R271.nxml.txt.nlp	22087790	SENT164	2	2	43	43	nitroprusside	Yes	PA451406	7525	0.498
NULL	Sensors_(Basel)_2013_Feb_28_13(3)_2895-2910.nxml.txt.nlp	23449119	SENT133	10	10	17	17	pp2	PP5		7980;5536	0.498
NULL	J_Radiat_Res_2014_Nov_16_55(6)_1171-1177.nxml.txt.nlp	25129557	SENT9	30	30	20	20	capecitabine	CRT	PA448771	811	0.498
NULL	J_Cereb_Blood_Flow_Metab_2011_Oct_20_31(10)_2030-2040.nxml.txt.nlp	21505475	SENT10	0	0	9	9	cilostazol	Bcl-2	PA164746334	596	0.498
NULL	Mediators_Inflamm_2010_May_17_2010_841343.nxml.txt.nlp	20490358	SENT9	2	2	13	13	candesartan	IL-18	PA448765	3606	0.498
NULL	Bioinformation_2012_Oct_31_8(21)_1030-1034.nxml.txt.nlp	23275702	SENT32	32	32	40	40	estradiol	EGF	PA449503	1950	0.498
NULL	Iran_Red_Crescent_Med_J_2014_Jan_5_16(1)_e9641.nxml.txt.nlp	24719720	SENT84	34	34	26	26	tirofiban	LCX	PA451698	80312	0.498
NULL	Philos_Trans_R_Soc_Lond_B_Biol_Sci_2008_Nov_27_363(1510)_3697-3700.nxml.txt.nlp	18849284	SENT73	13	13	20	20	chymotrypsin	gamma	PA448994	9913	0.498
NULL	Crit_Care_2005_Mar_11_9(3)_R191-R199.nxml.txt.nlp	15987390	SENT278	35	35	30	30	itraconazole	Yes	PA450132	7525	0.498
NULL	Evid_Based_Complement_Alternat_Med_2013_Nov_26_2013_731370.nxml.txt.nlp	24376467	SENT348	8	8	18	18	oseltamivir	TLR7	PA450721	51284	0.498
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Apr_4_68(Pt_5)_o1293.nxml.txt.nlp	22590203	SENT3	9	9	3	3	piperazine	mol	PA450977	90527	0.498
NULL	Mol_Vis_2014_Oct_17_20_1443-1455.nxml.txt.nlp	25352750	SENT73	23	23	10	10	paraformaldehyde	P15	PA450790	1030;29107	0.498
NULL	Int_J_Mol_Sci_2012_Sep_26_13(10)_12336-12348.nxml.txt.nlp	23202901	SENT59	29	29	1	1	phenol	P90	PA450913	821	0.498
NULL	Indian_J_Pharm_Sci_2013_Sep-Oct_75(5)_523-532.nxml.txt.nlp	24403652	SENT138	3	3	6	6	atorvastatin	ATV	PA448500	4683	0.498
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Mar_25_65(Pt_4)_o839.nxml.txt.nlp	21582558	SENT5	35	35	24	24	ethanol	mol	PA448073	90527	0.498
NULL	Ann_Gen_Psychiatry_2011_Mar_24_10_8.nxml.txt.nlp	21435226	SENT158	31	31	4	4	carbamazepine	Gen	PA448785	348654	0.498
NULL	Ann_Hematol_2007_Dec_14_86(12)_871-877.nxml.txt.nlp	17874322	SENT65	22	22	16	16	vincristine	IFN	PA451879	3439	0.498
NULL	Nat_Commun_2014_Apr_29_5_3723.nxml.txt.nlp	24781344	SENT74	4	4	21	21	iron	CO2	PA450087	4513	0.498
NULL	Mol_Immunol_2009_Dec_47(2-3)_485-492.nxml.txt.nlp	19767105	SENT348	0	0	7	7	heparin	IP-10	PA449855	3627	0.498
NULL	Int_J_Fertil_Steril_2014_Dec_22_Jan-Mar_7(4)_281-290.nxml.txt.nlp	24520498	SENT107	19	19	21	21	estradiol	PRL	PA449503	5617	0.498
NULL	Acta_Histochem_Cytochem_2012_Apr_26_45(2)_139-146.nxml.txt.nlp	22685356	SENT19	3	3	7	7	vasopressin	AQP2	PA451858	359	0.498
NULL	J_Biol_Chem_2008_Nov_14_283(46)_31679-31689.nxml.txt.nlp	18755684	SENT7	26	26	8	8	iron	FTL	PA450087	2512	0.498
NULL	Clin_Med_Insights_Oncol_2012_Feb_28_6_125-135.nxml.txt.nlp	22408376	SENT90	10	10	8	8	panitumumab	KRAS	PA162373091	3845	0.498
NULL	J_Immunol_Res_2014_Feb_3_2014_671431.nxml.txt.nlp	24741615	SENT234	13	13	27	27	paraformaldehyde	CD56	PA450790	4684	0.498
NULL	J_Oncol_2009_Mar_24_2009_491985.nxml.txt.nlp	19325924	SENT157	9	9	13	13	genistein	CXCL12	PA165109660	6387	0.498
NULL	Exp_Ther_Med_2014_Jun_31_7(6)_1647-1652.nxml.txt.nlp	24926360	SENT167	31	31	0	0	fluvastatin	CRP	PA449688	1401;140913	0.498
NULL	J_Hematol_Oncol_2012_Jul_11_5_16.nxml.txt.nlp	22534171	SENT195	14	14	19	19	erlotinib	EGFR	PA134687924	1956	0.498
NULL	Am_J_Physiol_Cell_Physiol_2014_Jan_15_306(2)_C89-C97.nxml.txt.nlp	24133067	SENT53	15	15	6	6	hyaluronan	HAS2	PA165958431	3037	0.498
NULL	Indian_J_Pharm_Sci_2013_Jul-Aug_75(4)_427-434.nxml.txt.nlp	24302797	SENT176	4	4	9	9	ethanol	flower	PA448073	11094	0.498
NULL	Cancer_Immunol_Immunother_2015_Oct_7_64_61-73.nxml.txt.nlp	25287778	SENT261	11	11	40	40	lenalidomide	CD56	PA162363968	4684	0.498
NULL	Pharmaceuticals_(Basel)_2013_Aug_6_6(8)_929-959.nxml.txt.nlp	24276377	SENT1235	13	13	8	8	curcumin	JNK	PA151958596	5599	0.498
NULL	Crit_Care_2006_Feb_3_10(1)_R24.nxml.txt.nlp	16469128	SENT58	16	16	8	8	heparin	MARS	PA449855	4141	0.498
NULL	Mol_Cancer_2009_Oct_8_8_83.nxml.txt.nlp	19814803	SENT172	22	22	15	15	triciribine	CTRL	PA165958661	1506	0.498
NULL	Iran_J_Pharm_Res_2014_Winter_13(Suppl)_3-14.nxml.txt.nlp	24711824	SENT8	1	1	20	20	fluoxetine	zeta	PA449673	9907	0.498
NULL	Clin_Med_Cardiol_2009_Sep_3_3_77-91.nxml.txt.nlp	20508768	SENT119	22	22	6	6	thrombin	ADP	PA451674	23038	0.498
NULL	Acta_Neuropathol_2013_Sep_5_126(5)_741-756.nxml.txt.nlp	24005891	SENT227	16	16	8	8	pilocarpine	CTRL	PA450962	1506	0.498
NULL	Front_Neurosci_2014_Nov_10_8_364.nxml.txt.nlp	25426018	SENT271	12	12	5	5	fluorescein	ANOVA	PA164746009	4858	0.498
NULL	Breast_Cancer_Res_2007_Apr_10_9(2)_R25.nxml.txt.nlp	17428314	SENT212	35	35	0	0	tetracycline	CDC2	PA451640	5424	0.498
NULL	J_Korean_Med_Sci_2013_Feb_29_28(2)_308-314.nxml.txt.nlp	23399960	SENT87	2	2	28	28	gabapentin	IL-10	PA449720	3586	0.498
NULL	Biomed_Res_Int_2013_Sep_4_2013_419176.nxml.txt.nlp	24093097	SENT184	16	16	28	28	temsirolimus	IFN	PA164746890	3439	0.498
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT192	23	23	33	33	panitumumab	Yes	PA162373091	7525	0.498
NULL	Open_Ophthalmol_J_2012_Dec_14_6_125-128.nxml.txt.nlp	23264840	SENT1	16	16	11	11	fluorescein	FAF	PA164746009	8239;2188	0.498
NULL	Breast_Cancer_Res_2007_Jul_5_9(4)_R41.nxml.txt.nlp	17612393	SENT156	7	7	9	9	celecoxib	Bcl-2	PA448871	596	0.498
NULL	J_Carcinog_2011_Dec_8_10_33.nxml.txt.nlp	22279418	SENT120	7	7	11	11	estradiol	aromatase	PA449503	1588	0.498
NULL	Mol_Biol_Rep_2013_Sep_28_40(10)_5573-5585.nxml.txt.nlp	24078156	SENT58	13	13	18	18	iron	DMT1	PA450087	4891;1761	0.498
NULL	J_Neurophysiol_2014_Dec_1_112(11)_2799-2809.nxml.txt.nlp	25185816	SENT67	24	24	28	28	dextran	mol	PA449261	90527	0.498
NULL	Antiviral_Res_2009_May_82(2)_A99-A109.nxml.txt.nlp	19176219	SENT1133	40	40	3	3	indinavir	CNT3	PA449977	64078	0.498
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT132	21	21	8	8	bevacizumab	HER2	PA130232992	2064	0.498
NULL	Curr_Neuropharmacol_2009_Sep_7(3)_217-227.nxml.txt.nlp	20190963	SENT421	35	35	32	32	heparin	ICAM1	PA449855	3383	0.498
NULL	Summit_on_Translat_Bioinforma_2009_Mar_1_2009_124-128.nxml.txt.nlp	21347183	SENT69	20	20	40	40	thioguanine	TPMT	PA451663	7172	0.498
NULL	Br_J_Cancer_2013_Jun_25_108(12)_2505-2515.nxml.txt.nlp	23736036	SENT241	29	29	12	12	capecitabine	DPYD	PA448771	1806	0.498
NULL	Diabetes_2008_Sep_57(9)_2470-2479.nxml.txt.nlp	18511847	SENT109	18	18	6	6	pioglitazone	adiponectin	PA450970	9370	0.498
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT128	20	20	0	0	metoprolol	CYP1A2	PA450480	1544	0.498
NULL	J_Infect_Dis_2013_Mar_1_207(5)_842-847.nxml.txt.nlp	23225895	SENT60	14	14	16	16	artemether	LUM	PA165111698	4060	0.498
NULL	Case_Rep_Dermatol_2013_Dec_7_5(3)_363-367.nxml.txt.nlp	24474919	SENT15	2	2	8	8	lipase	LPAR6	PA450239	10161	0.498
NULL	Oncotarget_2014_Oct_21_5(22)_11252-11268.nxml.txt.nlp	25361004	SENT44	0	0	2	2	metformin	U87	PA450395	677775;641648	0.498
NULL	Front_Genet_2012_Nov_12_3_235.nxml.txt.nlp	23162568	SENT625	10	10	13	13	debrisoquine	CYP2D6	PA452616	1565	0.498
NULL	JRSM_Open_2014_Jul_8_5(8)_2054270414531121.nxml.txt.nlp	25289142	SENT121	20	20	11	11	ethanol	CYP2E1	PA448073	1571	0.498
NULL	J_Gen_Physiol_1932_Nov_20_16(2)_295-311.nxml.txt.nlp	19872706	SENT0	10	10	1	1	trypsin	Gen	PA451806	348654	0.498
NULL	J_Clin_Biochem_Nutr_2010_Jan_29_46(1)_36-42.nxml.txt.nlp	20104263	SENT49	18	18	16	16	ribavirin	IFN	PA451241	3439	0.498
NULL	Part_Fibre_Toxicol_2012_Jul_19_9_28.nxml.txt.nlp	22812506	SENT109	11	11	31	31	phenol	CO2	PA450913	4513	0.498
NULL	Arthritis_Res_Ther_2008_May_28_10(3)_R60.nxml.txt.nlp	18507845	SENT216	37	37	29	29	thyroglobulin	DREAM	PA164754910	30818	0.498
NULL	Cancers_(Basel)_2011_Aug_9_3(3)_3189-3205.nxml.txt.nlp	24212952	SENT88	16	16	13	13	hyaluronan	HYAL-1	PA165958431	3373	0.498
NULL	Exp_Ther_Med_2013_Jun_2_5(6)_1701-1709.nxml.txt.nlp	23837058	SENT248	38	38	3	3	cisplatin	HK1	PA449014	3098;51361;3739	0.498
NULL	Br_J_Cancer_2012_Jan_17_106(2)_284-289.nxml.txt.nlp	22215065	SENT186	8	8	10	10	atrasentan	IFN	PA143414738	3439	0.498
NULL	Curr_Cardiol_Rev_2012_Aug_8(3)_239-249.nxml.txt.nlp	22935021	SENT295	11	11	5	5	heparin	ADP	PA449855	23038	0.498
NULL	Tuberc_Respir_Dis_(Seoul)_2013_Dec_24_75(6)_244-249.nxml.txt.nlp	24416055	SENT86	11	11	17	17	glucose	ADA	PA449773	100	0.498
NULL	Curr_Med_Chem_2013_Apr_20(10)_1241-1285.nxml.txt.nlp	23409712	SENT1006	14	14	8	8	amiloride	TRPP2	PA448368	5311	0.498
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT243	16	16	23	23	ritonavir	CYP3A4	PA451260	1576	0.498
NULL	EMBO_Mol_Med_2012_Jul_21_4(7)_594-602.nxml.txt.nlp	22359342	SENT66	17	17	22	22	tetracycline	p53	PA451640	7157	0.498
NULL	Cardiovasc_Diabetol_2010_Nov_25_9_78.nxml.txt.nlp	21106105	SENT13	3	3	12	12	dextran	STZ	PA449261	6484	0.498
NULL	Int_J_Biol_Sci_2011_Sep_8_7(8)_1077-1092.nxml.txt.nlp	21927577	SENT19	0	0	13	13	telmisartan	p67	PA451605	945;10988	0.498
NULL	Br_J_Cancer_2003_Mar_10_88(5)_788-795.nxml.txt.nlp	12618891	SENT175	12	12	6	6	bosentan	FasL	PA10034	356	0.498
NULL	Nucleic_Acids_Res_2011_Aug_29_39(15)_6620-6632.nxml.txt.nlp	21531700	SENT224	27	27	12	12	doxycycline	TOP1MT	PA449415	116447	0.498
NULL	Arch_Med_Sci_2013_Aug_30_9(4)_739-744.nxml.txt.nlp	24049538	SENT39	18	18	25	25	candesartan	PC-3	PA448765	692094	0.498
NULL	Chem_Cent_J_2012_Nov_23_6_140.nxml.txt.nlp	23173949	SENT51	31	31	0	0	ethanol	PERC	PA448073	133522	0.498
NULL	Int_J_Womens_Health_2014_Aug_13_6_759-769.nxml.txt.nlp	25152632	SENT148	21	21	9	9	teriparatide	RANK	PA451620	8792	0.498
NULL	Arthritis_Res_Ther_2006_May_11_8(3)_209.nxml.txt.nlp	16712713	SENT551	3	3	16	16	methotrexate	Yes	PA450428	7525	0.498
NULL	Enzyme_Res_2010_Jun_28_2010_734182.nxml.txt.nlp	21048869	SENT134	17	17	5	5	ethanol	SSF	PA448073	56342	0.498
NULL	Infect_Drug_Resist_2008_Sep_9_1_27-44.nxml.txt.nlp	21694878	SENT243	9	9	11	11	trimethoprim	TMP	PA451788	2012	0.498
NULL	Aging_(Albany_NY)_2009_May_22_1(6)_557-572.nxml.txt.nlp	20195383	SENT169	8	8	11	11	creatine	ADP	PA164778930	23038	0.498
NULL	Indian_J_Crit_Care_Med_2008_Oct-Dec_12(4)_181-189.nxml.txt.nlp	19742267	SENT204	1	1	5	5	anakinra	ACR	PA10799	49	0.498
NULL	Anal_Bioanal_Chem_2010_Aug_14_397(7)_2977-2986.nxml.txt.nlp	20549493	SENT184	32	32	3	3	estradiol	mol	PA449503	90527	0.498
NULL	Case_Rep_Gastroenterol_2012_Jul_24_6(2)_496-501.nxml.txt.nlp	22855667	SENT39	14	14	20	20	metoprolol	B12	PA450480	7126;4709	0.498
NULL	Arthritis_Res_Ther_2011_Oct_7_13(5)_R161.nxml.txt.nlp	21982514	SENT162	15	15	35	35	etanercept	ANOVA	PA449515	4858	0.498
NULL	J_Clin_Neonatol_2012_Jul-Sep_1(3)_162-165.nxml.txt.nlp	24027718	SENT82	36	36	34	34	cloxacillin	Clox	PA449059	1523	0.498
NULL	Clin_Ophthalmol_2014_Jan_13_8_219-228.nxml.txt.nlp	24531757	SENT145	13	13	9	9	brinzolamide	TIM	PA164744929	7984;8914	0.498
NULL	Clin_Med_Insights_Oncol_2012_Feb_28_6_125-135.nxml.txt.nlp	22408376	SENT277	2	2	16	16	cetuximab	ACRC	PA10040	93953	0.498
NULL	Pain_Res_Treat_2010_Mar_4_2010_705874.nxml.txt.nlp	22110916	SENT121	7	7	22	22	gabapentin	EPM	PA449720	2054	0.498
NULL	EMBO_J_2014_Jul_17_33(14)_1514-1526.nxml.txt.nlp	24872509	SENT115	6	6	15	15	zinc	CYC1	PA451956	1537	0.498
NULL	Aging_(Albany_NY)_2012_Feb_4_4(1)_60-73.nxml.txt.nlp	22308265	SENT247	10	10	7	7	nadh	CYTB	PA164755085	4519	0.498
NULL	J_Biol_Chem_2008_Nov_14_283(46)_31679-31689.nxml.txt.nlp	18755684	SENT153	34	34	16	16	iron	FTL	PA450087	2512	0.498
NULL	J_Psychopharmacol_2013_Jun_27(6)_479-496.nxml.txt.nlp	23539642	SENT344	12	12	1	1	dextroamphetamine	Gen	PA449269	348654	0.498
NULL	J_Thromb_Haemost_2007_May_1_5(5)_910-917.nxml.txt.nlp	17362227	SENT26	25	25	14	14	thrombin	P2X1	PA451674	5023	0.498
NULL	Arthritis_Res_2001_Jan_26_3(Suppl_A)_P096.nxml.txt.nlp	NULL	SENT4	16	16	21	21	cyclophosphamide	CD34	PA449165	947	0.498
NULL	Cancer_Manag_Res_2011_May_9_3_117-141.nxml.txt.nlp	21625397	SENT524	0	0	7	7	belinostat	H1F0		3005	0.498
NULL	Mol_Cancer_2010_Jun_25_9_166.nxml.txt.nlp	20579378	SENT196	28	28	26	26	gefitinib	EGF	PA131301952	1950	0.498
NULL	Oncol_Lett_2013_Aug_29_6(2)_317-322.nxml.txt.nlp	24137323	SENT50	14	14	16	16	decitabine	DAC	PA164749631	13	0.498
NULL	Ann_Thorac_Med_2007_Apr-Jun_2(2)_52-57.nxml.txt.nlp	19727346	SENT129	40	40	20	20	imipenem	CTX	PA449968	1593	0.498
NULL	Exp_Mol_Med_2012_Feb_29_44(2)_167-175.nxml.txt.nlp	22139526	SENT125	22	22	10	10	tropicamide	Genesis	PA164749389	27022	0.498
NULL	Brain_Sci_2013_Jun_14_3(2)_941-963.nxml.txt.nlp	24961432	SENT972	3	3	11	11	ethanol	GMP	PA448073	22978	0.498
NULL	Adv_Biomed_Res_2014_Aug_19_3_173.nxml.txt.nlp	25250287	SENT46	13	13	9	9	glucose	STZ	PA449773	6484	0.498
NULL	J_Vet_Med_Sci_2014_Jun_15_76(6)_813-817.nxml.txt.nlp	24531829	SENT115	17	17	20	20	primaquine	DPT	PA451103	1805	0.498
NULL	Exp_Diabetes_Res_2012_Nov_1_2012_892706.nxml.txt.nlp	23197976	SENT160	32	32	27	27	vildagliptin	GLP-1	PA165958346	100125288	0.498
NULL	Breast_Cancer_Res_2009_Nov_18_11(6)_R85.nxml.txt.nlp	19922614	SENT27	25	25	12	12	tamoxifen	BCS	PA451581	617	0.498
NULL	Int_J_Mol_Sci_2014_Sep_22_15(9)_16848-16884.nxml.txt.nlp	25247581	SENT300	11	11	4	4	resveratrol	SIRT1		23411	0.498
NULL	Evid_Based_Complement_Alternat_Med_2012_May_7_2012_254960.nxml.txt.nlp	22611426	SENT66	29	29	16	16	l-glutamine	CO2	PA10090	4513	0.498
NULL	J_Ayurveda_Integr_Med_2012_Jul-Sep_3(3)_150-157.nxml.txt.nlp	23125512	SENT139	24	24	10	10	phosphorus	AST	PA450954	26503	0.497
NULL	Arthritis_Res_Ther_2013_Nov_1_15(6)_R176.nxml.txt.nlp	24456929	SENT101	31	31	3	3	pp2	MSU		593	0.497
NULL	Mol_Biol_Cell_2012_Nov_1_23(21)_4212-4225.nxml.txt.nlp	22956765	SENT212	3	3	11	11	thrombin	RhoA	PA451674	387	0.497
NULL	J_Immunother_Cancer_2014_Aug_19_2_27.nxml.txt.nlp	25324973	SENT58	9	9	20	20	gemcitabine	IFN	PA449748	3439	0.497
NULL	Clinics_(Sao_Paulo)_2014_Jun_69(6)_438-446.nxml.txt.nlp	24964310	SENT86	14	14	10	10	teriparatide	PTH	PA451620	5741	0.497
NULL	Front_Genet_2014_Aug_26_5_289.nxml.txt.nlp	25206362	SENT47	14	14	24	24	betaine	B12	PA448603	7126;4709	0.497
NULL	Asian-Australas_J_Anim_Sci_2013_Oct_26(10)_1416-1423.nxml.txt.nlp	25049725	SENT24	16	16	18	18	ethanol	CO2	PA448073	4513	0.497
NULL	Drug_Des_Devel_Ther_2014_Sep_9_8_1257-1267.nxml.txt.nlp	25246767	SENT182	19	19	22	22	haloperidol	NHE	PA449841	285335	0.497
NULL	J_Ginseng_Res_2012_Jan_36(1)_40-46.nxml.txt.nlp	23717102	SENT13	10	10	15	15	thrombin	ADP	PA451674	23038	0.497
NULL	J_Gen_Physiol_1991_Dec_1_98(6)_1161-1179.nxml.txt.nlp	1723748	SENT0	10	10	1	1	potassium	Gen	PA451047	348654	0.497
NULL	Int_J_Mol_Imaging_2011_Oct_26_2011_874585.nxml.txt.nlp	21490735	SENT35	22	22	7	7	doxorubicin	FDG	PA449412	23583	0.497
NULL	Int_J_Mol_Sci_2007_Feb_23_8(2)_145-155.nxml.txt.nlp	NULL	SENT12	8	8	14	14	dorzolamide	CA-II	PA164748765	760	0.497
NULL	Springerplus_2014_Sep_15_3_526.nxml.txt.nlp	25279317	SENT149	19	19	31	31	sugar	IFN	PA451529	3439	0.497
NULL	Braz_J_Microbiol_2014_Jan_15_44(3)_807-812.nxml.txt.nlp	24516449	SENT133	41	41	18	18	tigecycline	CTX	PA164746412	1593	0.497
NULL	Trials_2014_Feb_19_15_63.nxml.txt.nlp	24552184	SENT10	2	2	0	0	paclitaxel	PACT	PA450761	8575;5930	0.497
NULL	Support_Care_Cancer_2012_May_1_20(5)_941-949.nxml.txt.nlp	21533811	SENT129	11	11	32	32	ondansetron	HEC	PA450705	10403	0.497
NULL	J_Oncol_2012_Dec_7_2012_192464.nxml.txt.nlp	22187555	SENT67	14	14	5	5	genistein	EGF	PA165109660	1950	0.497
NULL	Ann_Rheum_Dis_2008_Oct_25_68(10)_1644-1650.nxml.txt.nlp	18957484	SENT9	21	21	14	14	leflunomide	IL-15	PA450192	3600	0.497
NULL	Clin_Ophthalmol_2014_Apr_28_8_807-812.nxml.txt.nlp	24812486	SENT20	12	12	9	9	bevacizumab	CRT	PA130232992	811	0.497
NULL	Oncol_Lett_2013_Aug_17_6(2)_295-305.nxml.txt.nlp	24137320	SENT165	20	20	27	27	tamoxifen	TIMP3	PA451581	7078	0.497
NULL	Dermatoendocrinol_2012_Jan_1_4(1)_58-64.nxml.txt.nlp	22870354	SENT16	13	13	6	6	estradiol	CYP19A1	PA449503	1588	0.497
NULL	Br_J_Cancer_2009_Jul_21_101(2)_263-268.nxml.txt.nlp	19603032	SENT94	7	7	19	19	dasatinib	ANOVA	PA162372878	4858	0.497
NULL	Clin_Interv_Aging_2008_Mar_3(1)_45-50.nxml.txt.nlp	18488877	SENT5	24	24	16	16	teriparatide	BMD	PA451620	1756;7439	0.497
NULL	J_Biol_Chem_2008_Nov_7_283(45)_31005-31011.nxml.txt.nlp	18765663	SENT180	13	13	15	15	baclofen	CA1	PA448533	759	0.497
NULL	Mol_Cell_Biochem_2014_Oct_9_385(1-2)_265-275.nxml.txt.nlp	24104452	SENT173	7	7	9	9	bortezomib	U87	PA10252	677775;641648	0.497
NULL	Oncoimmunology_2013_Jan_1_2(1)_e22890.nxml.txt.nlp	23483066	SENT62	32	32	42	42	vemurafenib	IFN	PA165946873	3439	0.497
NULL	Mol_Biol_Cell_2014_Jan_1_25(1)_145-159.nxml.txt.nlp	24196833	SENT331	23	23	2	2	valinomycin	Fis1	PA151917011	51024	0.497
NULL	J_Mol_Signal_2011_Oct_5_6_13.nxml.txt.nlp	21975218	SENT260	5	5	2	2	ethanol	E4BP4	PA448073	4783	0.497
NULL	Int_J_Breast_Cancer_2012_Feb_26_2012_740353.nxml.txt.nlp	22500240	SENT112	5	5	13	13	tamoxifen	DES	PA451581	1674	0.497
NULL	Support_Care_Cancer_2009_Sep_10_17(9)_1177-1185.nxml.txt.nlp	19205755	SENT93	35	35	41	41	ondansetron	HEC	PA450705	10403	0.497
NULL	Pain_2009_Jul_144(1-2)_110-118.nxml.txt.nlp	19410369	SENT490	31	31	11	11	capsaicin	ANOVA	PA448776	4858	0.497
NULL	Breast_Cancer_Res_2014_Dec_6_16(6)_491.nxml.txt.nlp	25479686	SENT283	16	16	8	8	medroxyprogesterone	ANOVA	PA450344	4858	0.497
NULL	J_Cardiovasc_Magn_Reson_2014_Sep_27_16(1)_80.nxml.txt.nlp	25270330	SENT4	4	4	12	12	iron	MRI	PA450087	78996	0.497
NULL	Oncol_Lett_2014_Mar_16_7(3)_827-833.nxml.txt.nlp	24527090	SENT143	12	12	9	9	cisplatin	IFN	PA449014	3439	0.497
NULL	Eur_J_Epidemiol_2011_Aug_30_26(8)_657-686.nxml.txt.nlp	21877163	SENT495	12	12	20	20	phenprocoumon	VKORC1	PA450921	79001	0.497
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Dec_2_5_30.nxml.txt.nlp	17140452	SENT194	11	11	29	29	gentamicin	CHL	PA449753	91851	0.497
NULL	Arthritis_Res_Ther_2013_Sep_10_15(5)_R110.nxml.txt.nlp	24020899	SENT151	8	8	3	3	pioglitazone	IL-6	PA450970	3569	0.497
NULL	J_Immunother_Cancer_2013_May_29_1_5.nxml.txt.nlp	24764535	SENT167	24	24	16	16	sargramostim	GM-CSF	PA164748631	1437	0.497
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT780	25	25	0	0	bosentan	OATP1B3	PA10034	28234	0.497
NULL	Ann_Surg_Treat_Res_2014_Feb_22_86(2)_68-75.nxml.txt.nlp	24761411	SENT179	24	24	12	12	resveratrol	survivin		332	0.497
NULL	Biomed_Res_Int_2014_Feb_24_2014_480921.nxml.txt.nlp	24707486	SENT41	25	25	15	15	nitroprusside	PAG	PA451406	55824	0.497
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT180	12	12	2	2	doxorubicin	SLK	PA449412	9748;2534	0.497
NULL	Breast_Cancer_Res_2014_May_23_16(3)_R50.nxml.txt.nlp	24887458	SENT24	26	26	30	30	trastuzumab	DM1	PA451743	338023;1760;28509	0.497
NULL	Diabetes_Care_2009_Jan_32(1)_193-203.nxml.txt.nlp	18945920	SENT96	0	0	4	4	metformin	B12	PA450395	7126;4709	0.497
NULL	Protein_Expr_Purif_2009_Aug_66(2)_181-184.nxml.txt.nlp	19269329	SENT67	30	30	5	5	thrombin	AMPK	PA451674	5563	0.497
NULL	Curr_Opin_Endocrinol_Diabetes_Obes_2014_Oct_28_21(5)_394-404.nxml.txt.nlp	25122493	SENT166	23	23	17	17	thyroglobulin	RAI	PA164754910	10848;6050	0.497
NULL	Hum_Genomics_Proteomics_2010_Aug_3_2010_159761.nxml.txt.nlp	20981231	SENT256	35	35	20	20	lithium	FYN	PA450243	2534	0.497
NULL	Br_J_Cancer_2012_Sep_4_107(6)_977-987.nxml.txt.nlp	22892389	SENT31	11	11	20	20	cerulenin	VEGFA	PA164764551	7422	0.497
NULL	Cell_Rep_2012_Aug_30_2(2)_419-431.nxml.txt.nlp	22902405	SENT317	19	19	9	9	nadh	ALDOB	PA164755085	229	0.497
NULL	Onco_Targets_Ther_2014_Dec_4_7_2249-2255.nxml.txt.nlp	25587220	SENT55	16	16	14	14	cyclosporine	ABCG2	PA449167	9429	0.497
NULL	Biochim_Biophys_Acta_2014_Jan_1842(1)_56-64.nxml.txt.nlp	24161539	SENT335	0	0	11	11	acetazolamide	DARS2	PA448018	55157	0.497
NULL	J_Oncol_2012_Aug_8_2012_635614.nxml.txt.nlp	22927847	SENT214	12	12	39	39	rosiglitazone	PI3K	PA451283	5290	0.497
NULL	Mol_Cancer_2009_Nov_19_8_107.nxml.txt.nlp	19925653	SENT278	9	9	20	20	gefitinib	TLR4	PA131301952	7099	0.497
NULL	Acta_Neuropathol_2013_Sep_5_126(5)_741-756.nxml.txt.nlp	24005891	SENT363	19	19	0	0	pilocarpine	CTRL	PA450962	1506	0.497
NULL	J_Mol_Med_2011_Jul_23_89(7)_667-676.nxml.txt.nlp	21431325	SENT284	12	12	2	2	glucosamine	p53	PA164747613	7157	0.497
NULL	Indian_J_Endocrinol_Metab_2012_Jul-Aug_16(4)_496-498.nxml.txt.nlp	22837902	SENT30	0	0	9	9	metformin	AMPK	PA450395	5563	0.497
NULL	J_Cell_Biol_1998_Jan_12_140(1)_81-90.nxml.txt.nlp	9425156	SENT205	3	3	8	8	thrombin	p110	PA451674	9733	0.497
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT1753	18	18	20	20	atazanavir	ATV	PA10251	4683	0.497
NULL	Crit_Care_2011_Jun_24_15(3)_R153.nxml.txt.nlp	21702944	SENT94	3	3	11	11	dexmedetomidine	HK2	PA449256	3796;3099;29911;3741	0.497
NULL	Anc_Sci_Life_2012_Oct-Dec_32(2)_93-98.nxml.txt.nlp	24167334	SENT158	7	7	5	5	cyclophosphamide	AR7	PA449165	7067	0.497
NULL	J_Vet_Med_Sci_2014_Feb_21_76(2)_219-227.nxml.txt.nlp	24141321	SENT107	5	5	17	17	ns-398	SON		6651	0.497
NULL	Mol_Med_Rep_2015_Jan_24_11(1)_75-82.nxml.txt.nlp	25351113	SENT94	9	9	0	0	trypsin	PRSS8	PA451806	5652	0.497
NULL	Oncol_Lett_2014_Mar_16_7(3)_827-833.nxml.txt.nlp	24527090	SENT61	12	12	9	9	cisplatin	IFN	PA449014	3439	0.497
NULL	Anesthesiol_Res_Pract_2013_Sep_23_2013_297141.nxml.txt.nlp	24174934	SENT189	7	7	12	12	bupivacaine	mol	PA135057240	90527	0.497
NULL	Clin_Med_Insights_Arthritis_Musculoskelet_Disord_2012_Jan_5_5_1-14.nxml.txt.nlp	22267947	SENT94	12	12	35	35	risedronate	NNT	PA451255	23530	0.497
NULL	Emerg_Infect_Dis_2013_Jun_19(6)_969-976.nxml.txt.nlp	23735084	SENT27	8	8	26	26	ethanol	PACT	PA448073	8575;5930	0.497
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1051.nxml.txt.nlp	24503543	SENT144	16	16	11	11	sorafenib	Yes	PA7000	7525	0.497
NULL	Front_Endocrinol_(Lausanne)_2014_Oct_27_5_163.nxml.txt.nlp	25386163	SENT118	14	14	31	31	ethanol	ghrelin	PA448073	51738	0.497
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1150.nxml.txt.nlp	24675468	SENT93	40	40	43	43	ethanol	adiponectin	PA448073	9370	0.497
NULL	Aging_Cell_2007_Aug_6(4)_577-591.nxml.txt.nlp	17578512	SENT73	15	15	3	3	tetracycline	HDAC1	PA451640	3065	0.497
NULL	Eur_J_Med_Res_2015_Jan_7_20(1)_1.nxml.txt.nlp	25563300	SENT91	20	20	33	33	l-glutamine	M-CSF	PA10090	1435	0.497
NULL	Biomed_Res_Int_2014_Jan_29_2014_361020.nxml.txt.nlp	24605326	SENT223	1	1	22	22	staurosporine	CDK2	PA165109623	1017	0.497
NULL	Cell_Death_Dis_2012_Nov_29_3(11)_e436.nxml.txt.nlp	23190608	SENT321	28	28	8	8	bortezomib	CD138	PA10252	6382	0.497
NULL	J_Headache_Pain_2009_Oct_5_10(5)_317-325.nxml.txt.nlp	19499287	SENT92	21	21	10	10	sildenafil	Yes	PA451346	7525	0.497
NULL	Oncotarget_2011_Jan_25_2(1-2)_8-17.nxml.txt.nlp	21378407	SENT25	19	19	26	26	thrombin	PAR-1	PA451674	2011;2149	0.497
NULL	Nat_Commun_2013_Sep_11_4_2416.nxml.txt.nlp	24022506	SENT150	15	15	11	11	l-glutamine	F12	PA10090	2161	0.497
NULL	J_Aging_Res_2012_Feb_21_2012_384017.nxml.txt.nlp	22500228	SENT171	28	28	9	9	taurine	STZ	PA451590	6484	0.497
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT122	0	0	3	3	nutlin-3	p53		7157	0.497
NULL	Clin_Ophthalmol_2012_Sep_5_6_1433-1440.nxml.txt.nlp	23055659	SENT153	33	33	41	41	timolol	BAK	PA451690	578	0.497
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT128	5	5	3	3	mexiletine	CYP2D6	PA450488	1565	0.497
NULL	Oncotarget_2014_Oct_21_5(22)_11252-11268.nxml.txt.nlp	25361004	SENT9	12	12	8	8	metformin	CLIC1	PA450395	1192	0.497
NULL	Arthritis_Res_Ther_2003_Feb_28_5(3)_105-115.nxml.txt.nlp	12723975	SENT138	30	30	26	26	hyaluronan	CD44	PA165958431	960	0.497
NULL	Ann_Dermatol_2012_Nov_8_24(4)_482-484.nxml.txt.nlp	23197922	SENT23	3	3	7	7	imiquimod	IL-6	PA449972	3569	0.497
NULL	Int_J_Environ_Res_Public_Health_2013_Sep_17_10(9)_4352-4389.nxml.txt.nlp	24048206	SENT282	7	7	9	9	choline	B12	PA448976	7126;4709	0.497
NULL	Hum_Genomics_2012_Dec_1_6(1)_25.nxml.txt.nlp	23199258	SENT49	30	30	25	25	cyclophosphamide	ALDH3A1	PA449165	218	0.497
NULL	Front_Aging_Neurosci_2009_Dec_9_1_4.nxml.txt.nlp	20552055	SENT34	10	10	34	34	resveratrol	spatial		219793	0.497
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2011_Sep_13_4_47-62.nxml.txt.nlp	22879794	SENT234	38	38	9	9	liraglutide	PPG	PA165958364	5552	0.497
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Apr_8_65(Pt_5)_o970-o971.nxml.txt.nlp	21584012	SENT4	5	5	13	13	torasemide	mol	PA451733	90527	0.497
NULL	Pharm_Pract_(Granada)_2011_Mar_15_Jan-Mar_9(1)_1-10.nxml.txt.nlp	25132883	SENT162	23	23	19	19	rivaroxaban	SPAF	PA165958360	166378	0.497
NULL	F1000Prime_Rep_2013_Jul_1_5_24.nxml.txt.nlp	23864931	SENT21	13	13	2	2	ribavirin	BOC	PA451241	91653	0.497
NULL	Diabetologia_2010_Jan_22_53(1)_111-114.nxml.txt.nlp	19847395	SENT40	6	6	15	15	ketamine	STZ	PA450144	6484	0.497
NULL	Biomed_Res_Int_2014_Jan_29_2014_361020.nxml.txt.nlp	24605326	SENT223	7	7	42	42	flavopiridol	CDK5	PA452627	1020	0.497
NULL	Virulence_2013_Oct_1_4(7)_646-653.nxml.txt.nlp	24045422	SENT56	8	8	11	11	l-lysine	CD4	PA450280	920	0.497
NULL	Br_J_Cancer_2006_Feb_13_94(3)_407-426.nxml.txt.nlp	16434996	SENT116	0	0	2	2	genistein	BRCA1	PA165109660	672	0.497
NULL	J_Hematol_Oncol_2012_May_8_5_21.nxml.txt.nlp	22569033	SENT42	9	9	14	14	imatinib	KIT	PA10804	3815	0.497
NULL	Curr_Neuropharmacol_2013_Jul_11(4)_338-378.nxml.txt.nlp	24381528	SENT362	0	0	10	10	curcumin	HO-1	PA151958596	3162	0.497
NULL	J_Cell_Biol_1984_Mar_1_98(3)_1144-1149.nxml.txt.nlp	6199363	SENT10	8	8	2	2	hydrocortisone	GMP	PA449905	22978	0.497
NULL	Ann_Med_Health_Sci_Res_2014_Jul-Aug_4(Suppl_2)_S115-S118.nxml.txt.nlp	25184076	SENT98	20	20	0	0	ropivacaine	Ray	PA451271	26751	0.497
NULL	J_Hematol_Oncol_2010_Mar_23_3_11.nxml.txt.nlp	20331897	SENT161	13	13	34	34	capecitabine	CRT	PA448771	811	0.497
NULL	Exp_Ther_Med_2013_May_8_5(5)_1491-1495.nxml.txt.nlp	23737905	SENT129	10	10	3	3	hemin	HO-1	PA449849	3162	0.497
NULL	EMBO_Mol_Med_2009_Nov_1(8-9)_392-406.nxml.txt.nlp	20049744	SENT166	14	14	31	31	galactose	COX	PA449725	1351	0.497
NULL	Oxid_Med_Cell_Longev_2012_Nov_11_2012_989372.nxml.txt.nlp	23213352	SENT175	0	0	6	6	staurosporine	INS-1	PA165109623	2305	0.497
NULL	Clin_Ophthalmol_2012_Dec_13_6_1-4.nxml.txt.nlp	22259229	SENT71	13	13	25	25	travoprost	BAK	PA164781371	578	0.497
NULL	Br_J_Cancer_2013_Aug_6_109(3)_686-693.nxml.txt.nlp	23839492	SENT142	11	11	19	19	everolimus	IL-8	PA164746311	3576	0.497
NULL	Diabetes_2013_Mar_14_62(3)_789-800.nxml.txt.nlp	22966074	SENT204	0	0	5	5	forskolin	AMPK	PA146096022	5563	0.497
NULL	Apoptosis_2012_Jun_9_17(6)_566-578.nxml.txt.nlp	22402981	SENT167	24	24	20	20	pp2	PP2		4888	0.497
NULL	Front_Genet_2015_Jan_14_5_469.nxml.txt.nlp	25642242	SENT253	0	0	6	6	paromomycin	MRPS12	PA164784023	6183	0.497
NULL	Ann_Rheum_Dis_2008_Oct_16_68(8)_1277-1284.nxml.txt.nlp	18930987	SENT113	15	15	18	18	infliximab	ANOVA	PA452639	4858	0.497
NULL	J_Korean_Med_Sci_2013_Jun_3_28(6)_821-826.nxml.txt.nlp	23772144	SENT37	36	36	21	21	neomycin	CLCNKB	PA450608	1188	0.497
NULL	Clin_Interv_Aging_2014_Aug_16_9_1363-1373.nxml.txt.nlp	25170260	SENT241	19	19	26	26	aripiprazole	Yes	PA10026	7525	0.497
NULL	Mol_Cancer_2013_May_24_12_47.nxml.txt.nlp	23705854	SENT95	13	13	8	8	vinblastine	P-gp	PA451877	5243	0.497
NULL	Cancers_(Basel)_2010_Jun_14_2(2)_1288-1311.nxml.txt.nlp	24281116	SENT148	7	7	4	4	verapamil	Bcl-2	PA451868	596	0.497
NULL	Indian_J_Dermatol_2010_Apr-Jun_55(2)_195-197.nxml.txt.nlp	20606896	SENT47	4	4	10	10	permethrin	gamma	PA164743137	9913	0.497
NULL	F1000_Med_Rep_2009_Nov_26_1_90.nxml.txt.nlp	20948687	SENT13	6	6	11	11	bevacizumab	IFN	PA130232992	3439	0.497
NULL	Summit_on_Translat_Bioinforma_2009_Mar_1_2009_124-128.nxml.txt.nlp	21347183	SENT72	5	5	9	9	salmeterol	ADRB2	PA451300	154	0.497
NULL	Biol_Open_2014_Nov_21_3(12)_1207-1216.nxml.txt.nlp	25416063	SENT3	14	14	2	2	zinc	NANOS3	PA451956	342977	0.497
NULL	Mol_Vis_2012_Nov_12_18_2673-2686.nxml.txt.nlp	23170060	SENT92	32	32	35	35	creatine	gamma	PA164778930	9913	0.497
NULL	Br_J_Anaesth_2014_Jul_22_113(1)_157-167.nxml.txt.nlp	24154701	SENT26	5	5	2	2	sevoflurane	TREK-1	PA451341	3776	0.497
NULL	Ann_Oncol_2011_Mar_8_22(3)_503-514.nxml.txt.nlp	20616198	SENT302	9	9	28	28	tamoxifen	IMPACT	PA451581	55364	0.497
NULL	Anesth_Essays_Res_2013_Jan-Apr_7(1)_44-48.nxml.txt.nlp	NULL	SENT132	21	21	29	29	clonidine	CO2	PA449051	4513	0.497
NULL	ScientificWorldJournal_2013_Nov_5_2013_383574.nxml.txt.nlp	24298214	SENT131	10	10	5	5	genistein	gamma	PA165109660	9913	0.497
NULL	Gut_Liver_2012_Oct_18_6(4)_464-470.nxml.txt.nlp	23170151	SENT112	20	20	23	23	propofol	ESD	PA451141	2098	0.497
NULL	Eur_J_Haematol_2014_Feb_25_92(2)_127-136.nxml.txt.nlp	24118452	SENT70	16	16	14	14	anagrelide	CRT	PA164742986	811	0.497
NULL	ScientificWorldJournal_2013_Oct_24_2013_726912.nxml.txt.nlp	24282387	SENT164	5	5	21	21	fluorescein	AVP	PA164746009	114548;551	0.497
NULL	Pharmaceutics_2011_Jul_13_3(3)_425-439.nxml.txt.nlp	24310588	SENT364	5	5	0	0	oxycodone	SERS	PA450741	6301;54938	0.497
NULL	Genome_Biol_2011_Oct_21_12(10)_R104.nxml.txt.nlp	22018332	SENT276	22	22	38	38	fluorescein	ROX	PA164746009	4335	0.497
NULL	Breast_Cancer_Res_2014_Dec_6_16(6)_491.nxml.txt.nlp	25479686	SENT198	21	21	0	0	medroxyprogesterone	ANOVA	PA450344	4858	0.497
NULL	Front_Public_Health_2013_Nov_14_1_50.nxml.txt.nlp	24350219	SENT273	11	11	22	22	azithromycin	TREM-1	PA448519	54210	0.497
NULL	Cancer_Causes_Control_2013_Aug_18_24(8)_1605-1614.nxml.txt.nlp	23775025	SENT64	3	3	39	39	cyclophosphamide	GSTM1	PA449165	2944	0.497
NULL	Braz_J_Microbiol_2014_Jan_15_44(3)_807-812.nxml.txt.nlp	24516449	SENT133	20	20	18	18	cefotaxime	CTX	PA448852	1593	0.497
NULL	JAKSTAT_2013_Jul_1_2(3)_e24574.nxml.txt.nlp	24069558	SENT56	16	16	8	8	doxycycline	JAK2	PA449415	3717	0.497
NULL	Cancer_Med_2014_Jun_19_3(3)_555-564.nxml.txt.nlp	24648042	SENT107	41	41	12	12	rituximab	PI3K	PA451261	5290	0.497
NULL	Front_Endocrinol_(Lausanne)_2013_Sep_2_4_111.nxml.txt.nlp	24065951	SENT196	28	28	9	9	estradiol	aromatase	PA449503	1588	0.497
NULL	Int_J_Vasc_Med_2012_Feb_14_2012_569654.nxml.txt.nlp	22489274	SENT319	17	17	13	13	nadh	DAG	PA164755085	1605	0.497
NULL	Curr_Hepat_Rep_2010_May_21_9(2)_75-90.nxml.txt.nlp	20461127	SENT276	20	20	14	14	telbivudine	LAM	PA164760861	7249;7248	0.497
NULL	Virol_J_2011_Nov_28_8_523.nxml.txt.nlp	22122911	SENT169	1	1	18	18	heparin	RANTES	PA449855	6352	0.496
NULL	Cardiovasc_Diabetol_2013_Nov_21_12_172.nxml.txt.nlp	24261558	SENT199	2	2	9	9	eplerenone	FABP3	PA164749044	2170	0.496
NULL	Diabetes_Care_2010_Jul_33(7)_1529-1535.nxml.txt.nlp	20587723	SENT218	23	23	18	18	thrombin	VIII	PA451674	1351	0.496
NULL	Int_J_Vasc_Med_2012_Feb_12_2012_918267.nxml.txt.nlp	22611498	SENT588	0	0	2	2	metformin	AMPK	PA450395	5563	0.496
NULL	Braz_J_Med_Biol_Res_2011_Nov_25_45(1)_58-67.nxml.txt.nlp	22124704	SENT144	11	11	22	22	ethanol	ANOVA	PA448073	4858	0.496
NULL	Cerebrospinal_Fluid_Res_2006_Dec_21_3(Suppl_1)_S41.nxml.txt.nlp	NULL	SENT6	6	6	10	10	hyaluronan	OTS	PA165958431	5012	0.496
NULL	Springerplus_2013_Dec_18_2_680.nxml.txt.nlp	24683528	SENT46	17	17	43	43	l-glutamine	CO2	PA10090	4513	0.496
NULL	Ann_Pediatr_Endocrinol_Metab_2014_Mar_31_19(1)_8-12.nxml.txt.nlp	24926457	SENT53	12	12	24	24	iodine	IDD	PA450049	9993;1299	0.496
NULL	Mol_Vis_2011_Oct_15_17_2665-2671.nxml.txt.nlp	22065919	SENT45	6	6	15	15	mitomycin	CO2	PA450524	4513	0.496
NULL	Subst_Abuse_Treat_Prev_Policy_2007_Nov_23_2_35.nxml.txt.nlp	18036213	SENT339	10	10	1	1	naltrexone	Gen	PA450588	348654	0.496
NULL	J_Adv_Pharm_Technol_Res_2014_Jan-Mar_5(1)_21-27.nxml.txt.nlp	24696814	SENT144	44	44	14	14	ethanol	mol	PA448073	90527	0.496
NULL	Br_J_Cancer_2011_Apr_12_104(8)_1256-1261.nxml.txt.nlp	21448165	SENT40	29	29	27	27	sorafenib	IL-2	PA7000	3558	0.496
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT6	26	26	20	20	atorvastatin	TNF	PA448500	7124	0.496
NULL	Int_J_Mol_Sci_2014_Jun_5_15(6)_10083-10100.nxml.txt.nlp	24905407	SENT60	7	7	37	37	tetracycline	TRB	PA451640	6957	0.496
NULL	J_Oncol_2012_Nov_1_2012_707156.nxml.txt.nlp	23193402	SENT12	9	9	11	11	iodine	RAI	PA450049	10848;6050	0.496
NULL	Indian_J_Med_Res_2012_Mar_135(3)_277-286.nxml.txt.nlp	22561612	SENT88	11	11	2	2	calcidiol	PTH	PA164745614	5741	0.496
NULL	Front_Hum_Neurosci_2013_Apr_8_7_117.nxml.txt.nlp	23580360	SENT446	12	12	17	17	methylphenidate	spatial	PA450464	219793	0.496
NULL	Biosci_Rep_2014_Dec_12_34(6)_e00160.nxml.txt.nlp	25495645	SENT170	21	21	33	33	rosiglitazone	ANGPTL3	PA451283	27329	0.496
NULL	Case_Rep_Infect_Dis_2012_Aug_16_2012_640104.nxml.txt.nlp	22953083	SENT77	21	21	26	26	vincristine	CHOP	PA451879	1649	0.496
NULL	Mol_Cancer_2013_Mar_5_12_17.nxml.txt.nlp	23497256	SENT154	36	36	15	15	sunitinib	p53	PA162372840	7157	0.496
NULL	Pain_2012_Apr_153(4)_775-783.nxml.txt.nlp	22325744	SENT170	12	12	16	16	naloxone	P28	PA450586	9446;7802;9527	0.496
NULL	CNS_Drugs_2014_May_1_28(6)_497-511.nxml.txt.nlp	24788672	SENT103	1	1	8	8	atomoxetine	DBP	PA134688071	3295;1628;2638	0.496
NULL	J_Korean_Med_Sci_2010_Jan_26_25(1)_110-116.nxml.txt.nlp	20054409	SENT165	38	38	12	12	doxorubicin	BCS	PA449412	617	0.496
NULL	Oncogene_2009_Dec_3_28(48)_4237-4248.nxml.txt.nlp	19734937	SENT84	24	24	4	4	collagenase	PAR-1	PA449107	2011;2149	0.496
NULL	Ecancermedicalscience_2011_Dec_1_5_237.nxml.txt.nlp	22276069	SENT29	23	23	11	11	exemestane	CEA	PA449563	5670;1087	0.496
NULL	J_Med_Life_2011_Feb_15_4(1)_11-20.nxml.txt.nlp	21505570	SENT141	0	0	9	9	indomethacin	CB2	PA449982	1269	0.496
NULL	Bioinformation_2011_Aug_2_6(10)_375-379.nxml.txt.nlp	21904424	SENT115	2	2	20	20	clindamycin	mol	PA449035	90527	0.496
NULL	Biochemistry_2008_Aug_19_47(33)_8689-8696.nxml.txt.nlp	18642884	SENT151	18	18	8	8	nadh	XMP	PA164755085	2013	0.496
NULL	J_Anaesthesiol_Clin_Pharmacol_2012_Oct-Dec_28(4)_486-490.nxml.txt.nlp	23225930	SENT99	16	16	21	21	neostigmine	TKR	PA450611	8277	0.496
NULL	J_Thorac_Oncol_2015_Jan_29_10(1)_156-163.nxml.txt.nlp	25247337	SENT105	2	2	0	0	afatinib	TTF	PA165981154	399	0.496
NULL	Ecancermedicalscience_2011_Apr_28_5_211.nxml.txt.nlp	22276054	SENT114	42	42	38	38	lorazepam	NK-1	PA450267	27087	0.496
NULL	Cancer_Cell_Int_2007_Jun_8_7_11.nxml.txt.nlp	17559657	SENT82	15	15	4	4	estradiol	CD133	PA449503	8842	0.496
NULL	Oncol_Lett_2014_Jun_2_7(6)_1889-1894.nxml.txt.nlp	24932254	SENT151	15	15	0	0	fluorescein	OCT1	PA164746009	5451;6580	0.496
NULL	ACS_Med_Chem_Lett_2011_May_16_2(7)_549-554.nxml.txt.nlp	21765967	SENT80	12	12	19	19	dextran	CCR5	PA449261	1234	0.496
NULL	Case_Rep_Pathol_2014_Sep_9_2014_301780.nxml.txt.nlp	25295208	SENT33	25	25	27	27	thyroglobulin	TTF-1	PA164754910	7080	0.496
NULL	Ann_Gen_Psychiatry_2013_Jan_24_12_1.nxml.txt.nlp	23347694	SENT172	33	33	35	35	olanzapine	5-HT1A	PA450688	3350	0.496
NULL	Crit_Care_2008_Apr_10_12(2)_132.nxml.txt.nlp	18423065	SENT22	17	17	30	30	vasopressin	AVP	PA451858	114548;551	0.496
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Jul_20_69(Pt_8)_o1276.nxml.txt.nlp	24109358	SENT74	22	22	19	19	ethanol	mol	PA448073	90527	0.496
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT192	43	43	19	19	gefitinib	Yes	PA131301952	7525	0.496
NULL	Croat_Med_J_2011_Apr_52(2)_159-163.nxml.txt.nlp	21495198	SENT28	20	20	23	23	drotaverine	HBB	PA165958398	85344;3043	0.496
NULL	Orphanet_J_Rare_Dis_2006_Nov_16_1_46.nxml.txt.nlp	17109744	SENT77	42	42	25	25	thrombin	FXI	PA451674	2160	0.496
NULL	Oxid_Med_Cell_Longev_2013_Nov_14_2013_680545.nxml.txt.nlp	24349614	SENT12	11	11	2	2	oxygen	TSG	PA450744	57045	0.496
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1563-1573.nxml.txt.nlp	22015557	SENT293	8	8	11	11	sunitinib	c-Myc	PA162372840	4609	0.496
NULL	Eur_J_Endocrinol_2012_Jan_166(1)_87-97.nxml.txt.nlp	22048967	SENT25	0	0	11	11	teriparatide	PTH	PA451620	5741	0.496
NULL	Oncol_Rep_2013_Apr_23_29(4)_1268-1274.nxml.txt.nlp	23354756	SENT182	9	9	4	4	epirubicin	SLC25A43	PA449476	203427	0.496
NULL	Int_J_Nephrol_2011_Apr_26_2011_245823.nxml.txt.nlp	21603155	SENT117	16	16	14	14	ribavirin	IFN	PA451241	3439	0.496
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT684	4	4	2	2	metoclopramide	ghrelin	PA450475	51738	0.496
NULL	J_Korean_Med_Sci_2009_Jan_29_24(Suppl_1)_S170-S175.nxml.txt.nlp	19194548	SENT41	25	25	32	32	cisplatin	EPO	PA449014	7076;8288;2056	0.496
NULL	Diabetes_Metab_Syndr_Obes_2009_May_18_2_37-49.nxml.txt.nlp	20148188	SENT37	28	28	17	17	metformin	GLP-1	PA450395	100125288	0.496
NULL	J_Cachexia_Sarcopenia_Muscle_2010_Sep_26_1(1)_43-128.nxml.txt.nlp	22477519	SENT1949	16	16	12	12	celecoxib	COX	PA448871	1351	0.496
NULL	Clin_Ophthalmol_2014_Jun_26_8_1213-1219.nxml.txt.nlp	25061267	SENT13	8	8	13	13	proparacaine	PRK	PA164776849	1263	0.496
NULL	J_Brachial_Plex_Peripher_Nerve_Inj_2008_Mar_19_3_8.nxml.txt.nlp	18353188	SENT40	26	26	32	32	capsaicin	SSeCKS	PA448776	9590	0.496
NULL	Viruses_2014_Apr_14_6(4)_1715-1758.nxml.txt.nlp	24736215	SENT2153	0	0	17	17	disulfiram	F11	PA449376	90338;2160	0.496
NULL	Cases_J_2008_Sep_19_1_167.nxml.txt.nlp	18803822	SENT68	18	18	29	29	propofol	ARX	PA451141	10054;170302	0.496
NULL	eLife_2014_Apr_30_3_e02445.nxml.txt.nlp	24843000	SENT449	10	10	27	27	ethanol	San	PA448073	80218	0.496
NULL	Med_Sci_Monit_2013_Nov_29_19_1080-1088.nxml.txt.nlp	24287619	SENT136	16	16	24	24	estradiol	ACL	PA449503	47	0.496
NULL	Clin_Ophthalmol_2014_Jan_13_8_219-228.nxml.txt.nlp	24531757	SENT181	13	13	9	9	brinzolamide	TIM	PA164744929	7984;8914	0.496
NULL	Antimicrob_Agents_Chemother_2014_Nov_10_59(1)_490-497.nxml.txt.nlp	25385107	SENT150	1	1	3	3	atovaquone	ATV	PA448502	4683	0.496
NULL	J_Cardiothorac_Surg_2013_Apr_29_8_115.nxml.txt.nlp	23628179	SENT78	9	9	18	18	heparin	ACT	PA449855	12;11332;9457;641455	0.496
NULL	Brain_Sci_2013_Jun_14_3(2)_941-963.nxml.txt.nlp	24961432	SENT173	0	0	2	2	ethanol	RhoA	PA448073	387	0.496
NULL	J_Cancer_Prev_2014_Mar_19(1)_39-46.nxml.txt.nlp	25337571	SENT97	7	7	17	17	ethanol	p53	PA448073	7157	0.496
NULL	Gut_2013_Jun_13_62(6)_812-823.nxml.txt.nlp	23408351	SENT326	9	9	16	16	aspirin	IRR	PA448497	3645	0.496
NULL	J_Cell_Mol_Med_2014_May_20_18(5)_844-851.nxml.txt.nlp	24444371	SENT133	13	13	15	15	mannitol	MAD2B	PA450320	10459	0.496
NULL	Front_Oncol_2014_Apr_9_4_75.nxml.txt.nlp	24782986	SENT193	20	20	3	3	paclitaxel	CD34	PA450761	947	0.496
NULL	J_Gen_Intern_Med_2010_Sep_11_25(9)_936-941.nxml.txt.nlp	20458550	SENT0	28	28	1	1	buprenorphine	Gen	PA448685	348654	0.496
NULL	Acta_Physiol_(Oxf)_2008_Apr_192(4)_505-517.nxml.txt.nlp	17973950	SENT245	5	5	34	34	propranolol	LQT3	PA451145	6331	0.496
NULL	Pharmaceuticals_(Basel)_2013_Aug_29_6(9)_1082-1093.nxml.txt.nlp	24276420	SENT29	2	2	5	5	camptothecin	CPT1	PA153590860	56994	0.496
NULL	Breast_Cancer_Res_2011_Mar_14_13(2)_205.nxml.txt.nlp	21457526	SENT47	34	34	10	10	exemestane	ARNO	PA449563	9266	0.496
NULL	J_Mol_Med_(Berl)_2013_Aug_17_91(11)_1257-1271.nxml.txt.nlp	23955016	SENT21	26	26	5	5	thrombin	THBD	PA451674	7056	0.496
NULL	Arch_Drug_Inf_2009_Sep_2(3)_41-50.nxml.txt.nlp	19915711	SENT147	8	8	23	23	atenolol	FKBP5	PA448499	2289	0.496
NULL	Ind_Psychiatry_J_2014_Jan-Jun_23(1)_10-14.nxml.txt.nlp	25535438	SENT167	3	3	10	10	olanzapine	FGA	PA450688	2243	0.496
NULL	Brain_2008_May_17_131(5)_1228-1240.nxml.txt.nlp	18420712	SENT35	12	12	21	21	paraformaldehyde	IFN	PA450790	3439	0.496
NULL	Curr_Neuropharmacol_2013_Jul_11(4)_338-378.nxml.txt.nlp	24381528	SENT654	3	3	1	1	curcumin	IMPACT	PA151958596	55364	0.496
NULL	Insights_Imaging_2011_Jun_28_2(5)_609-619.nxml.txt.nlp	22347980	SENT255	7	7	23	23	phosphorus	AID	PA450954	57379	0.496
NULL	Crit_Care_2007_Mar_22_11(Suppl_2)_P423.nxml.txt.nlp	NULL	SENT10	9	9	6	6	propofol	SOC	PA451141	91544	0.496
NULL	Basic_Clin_Neurosci_2013_Autumn_4(4)_329-333.nxml.txt.nlp	25337365	SENT159	0	0	8	8	methamphetamine	Bcl-2	PA450403	596	0.496
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1066.nxml.txt.nlp	24556681	SENT10	0	0	15	15	ethanol	ATG12	PA448073	9140	0.496
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT192	31	31	9	9	trastuzumab	Yes	PA451743	7525	0.496
NULL	Br_J_Pharmacol_2012_Jan_165(2)_390-400.nxml.txt.nlp	21671897	SENT191	0	0	17	17	suramin	P2X2	PA10292	22953	0.496
NULL	Mol_Vis_2011_Dec_24_17_3384-3391.nxml.txt.nlp	22219634	SENT135	18	18	10	10	mannitol	IL-8	PA450320	3576	0.496
NULL	Biotechnol_Res_Int_2014_Jun_9_2014_674286.nxml.txt.nlp	25009746	SENT252	4	4	18	18	neomycin	X11	PA450608	320	0.496
NULL	J_Exp_Bot_2008_May_59(8)_2109-2123.nxml.txt.nlp	18535297	SENT309	14	14	0	0	galactose	PC1	PA449725	5122	0.496
NULL	Ecancermedicalscience_2011_Apr_28_5_211.nxml.txt.nlp	22276054	SENT114	14	14	38	38	aprepitant	NK-1	PA164747039	27087	0.496
NULL	Clin_Ophthalmol_2014_Jan_13_8_219-228.nxml.txt.nlp	24531757	SENT157	8	8	4	4	brinzolamide	TIM	PA164744929	7984;8914	0.496
NULL	Basic_Res_Cardiol_2014_Jan_31_109(2)_403.nxml.txt.nlp	24481769	SENT101	5	5	17	17	creatine	MVD	PA164778930	4597	0.496
NULL	Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.nxml.txt.nlp	24736980	SENT45	11	11	14	14	rosuvastatin	OATP1B1	PA134308647	10599	0.496
NULL	Curr_HIV_Res_2011_Jan_9(1)_40-53.nxml.txt.nlp	21198432	SENT133	29	29	15	15	raltegravir	AST		26503	0.496
NULL	Biomed_Res_Int_2013_Nov_28_2013_789184.nxml.txt.nlp	24369535	SENT116	0	0	14	14	imatinib	CYP2C19	PA10804	1557	0.496
NULL	Cancers_(Basel)_2011_Oct_14_3(4)_3894-3908.nxml.txt.nlp	24213116	SENT83	16	16	10	10	heparin	EGF	PA449855	1950	0.496
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Dec_2_5_30.nxml.txt.nlp	17140452	SENT187	11	11	29	29	gentamicin	CHL	PA449753	91851	0.496
NULL	Ann_Rheum_Dis_2015_Jan_14_74(1)_242-251.nxml.txt.nlp	24130267	SENT280	42	42	11	11	raloxifene	IL-6	PA451221	3569	0.496
NULL	Front_Endocrinol_(Lausanne)_2011_Dec_8_2_91.nxml.txt.nlp	22649391	SENT80	8	8	0	0	heparin	EGF	PA449855	1950	0.496
NULL	J_Anim_Sci_Biotechnol_2014_May_7_5(1)_26.nxml.txt.nlp	25045520	SENT91	19	19	36	36	choline	B12	PA448976	7126;4709	0.496
NULL	J_Hematol_Oncol_2013_Nov_5_6_83.nxml.txt.nlp	24283248	SENT76	4	4	18	18	nutlin-3	TP53		7157	0.496
NULL	Int_J_Endocrinol_Metab_2013_Dec_21_Winter_11(1)_57-61.nxml.txt.nlp	23853622	SENT134	32	32	36	36	bromocriptine	PRL	PA448671	5617	0.496
NULL	Breast_Cancer_Res_2008_Dec_18_10(Suppl_4)_S25.nxml.txt.nlp	19128439	SENT10	5	5	11	11	tamoxifen	IMPACT	PA451581	55364	0.496
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT210	20	20	13	13	curcumin	DR5	PA151958596	8795	0.496
NULL	Allergy_Asthma_Clin_Immunol_2007_Mar_15_3(1)_1-9.nxml.txt.nlp	20525147	SENT131	7	7	0	0	chymotrypsin	IFN	PA448994	3439	0.496
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_127043.nxml.txt.nlp	23227093	SENT231	5	5	7	7	furafylline	CYP1A2	PA452614	1544	0.496
NULL	Chem_Cent_J_2012_Feb_21_6_15.nxml.txt.nlp	22353684	SENT94	12	12	10	10	acebutolol	mol	PA448011	90527	0.496
NULL	Pharmacogn_Mag_2014_Jan-Feb_10(Suppl_1)_S14-S21.nxml.txt.nlp	24914294	SENT118	10	10	12	12	phenol	PLK1	PA450913	5347	0.496
NULL	Clin_Sarcoma_Res_2014_Jun_28_4_6.nxml.txt.nlp	25009738	SENT12	13	13	8	8	rituximab	CHOP	PA451261	1649	0.496
NULL	Acta_Pharmacol_Sin_2010_Jan_28_31(1)_102-110.nxml.txt.nlp	20037603	SENT130	11	11	7	7	salbutamol	EGF	PA448068	1950	0.496
NULL	Int_J_Vasc_Med_2012_Oct_5_2012_784536.nxml.txt.nlp	22007304	SENT68	15	15	10	10	atorvastatin	NPC1L1	PA448500	29881	0.496
NULL	Anticancer_Agents_Med_Chem_2010_Oct_10(8)_617-624.nxml.txt.nlp	21182469	SENT267	0	0	5	5	estradiol	ABCC11	PA449503	85320	0.496
NULL	Front_Neurol_2014_Sep_11_5_173.nxml.txt.nlp	25309501	SENT27	39	39	42	42	hyaluronan	HAS1	PA165958431	3036	0.496
NULL	Endocr_Relat_Cancer_2014_Apr_21(2)_311-326.nxml.txt.nlp	24478054	SENT280	10	10	5	5	denosumab	OPG	PA166048634	690	0.496
NULL	Clin_Psychopharmacol_Neurosci_2012_Apr_30_10(1)_25-33.nxml.txt.nlp	23429852	SENT141	20	20	0	0	olanzapine	SNAP-25	PA450688	6616	0.496
NULL	Nat_Commun_2013_Apr_9_4_1684.nxml.txt.nlp	23575688	SENT112	6	6	12	12	rolipram	CYLD	PA153906323	1540	0.496
NULL	Cancer_Cell_Int_2007_Sep_10_7_14.nxml.txt.nlp	17845729	SENT204	17	17	10	10	decitabine	PAWR	PA164749631	5074	0.496
NULL	J_Korean_Med_Sci_2010_Nov_26_25(11)_1683-1687.nxml.txt.nlp	21060764	SENT41	19	19	11	11	thyroglobulin	CEA	PA164754910	5670;1087	0.496
NULL	Oxid_Med_Cell_Longev_2012_Jan_19_2012_390678.nxml.txt.nlp	22315655	SENT36	21	21	12	12	trypsin	CO2	PA451806	4513	0.496
NULL	JAKSTAT_2012_Jan_1_1(1)_44-54.nxml.txt.nlp	24058750	SENT39	9	9	1	1	mitomycin	IL-6	PA450524	3569	0.496
NULL	Hum_Genomics_2008_Sep_1_3(1)_71-78.nxml.txt.nlp	19129091	SENT32	13	13	32	32	nadh	ND5	PA164755085	4540	0.495
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_127043.nxml.txt.nlp	23227093	SENT231	19	19	21	21	quinidine	CYP2D6	PA451209	1565	0.495
NULL	Oxid_Med_Cell_Longev_2013_Nov_28_2013_367040.nxml.txt.nlp	24381715	SENT74	16	16	24	24	oxygen	SOD2	PA450744	6648	0.495
NULL	Health_Policy_Plan_2013_Sep_28_28(6)_636-646.nxml.txt.nlp	23197432	SENT54	24	24	28	28	artemisinin	ACT	PA165111696	12;11332;9457;641455	0.495
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Dec_2_5_30.nxml.txt.nlp	17140452	SENT187	15	15	29	29	linezolid	CHL	PA450233	91851	0.495
NULL	Hum_Mol_Genet_2013_Nov_15_22(22)_4602-4615.nxml.txt.nlp	23814040	SENT168	6	6	12	12	l-cysteine	ANOVA	PA449173	4858	0.495
NULL	EMBO_Mol_Med_2012_Jul_11_4(7)_577-593.nxml.txt.nlp	22496117	SENT101	30	30	28	28	clofazimine	PAP-1	PA164748759	6100	0.495
NULL	Proteome_Sci_2003_Jun_12_1_4.nxml.txt.nlp	12818002	SENT86	18	18	16	16	chymotrypsin	neuropsin	PA448994	11202	0.495
NULL	EMBO_Mol_Med_2013_Dec_8_5(12)_1821-1834.nxml.txt.nlp	24293316	SENT177	16	16	5	5	doxorubicin	p53	PA449412	7157	0.495
NULL	Arthritis_Res_Ther_2005_Dec_1_7(1)_R149-R155.nxml.txt.nlp	15642135	SENT92	23	23	3	3	infliximab	IL-6	PA452639	3569	0.495
NULL	J_Cell_Biol_2000_Feb_21_148(4)_791-800.nxml.txt.nlp	10684259	SENT190	17	17	20	20	estradiol	Raf-1	PA449503	5894	0.495
NULL	Drug_Target_Insights_2012_Aug_6_6_19-39.nxml.txt.nlp	22915839	SENT138	7	7	21	21	doxorubicin	p53	PA449412	7157	0.495
NULL	Cell_Death_Dis_2013_Jun_27_4(6)_e696.nxml.txt.nlp	23807225	SENT175	9	9	0	0	doxycycline	ACL	PA449415	47	0.495
NULL	Korean_J_Radiol_2010_Feb_22_Mar-Apr_11(2)_234-238.nxml.txt.nlp	20191072	SENT62	30	30	13	13	etoposide	CHOP	PA449552	1649	0.495
NULL	Front_Immunol_2013_Oct_7_4_325.nxml.txt.nlp	24109484	SENT79	13	13	11	11	nutlin-3	RITA		55422;84934	0.495
NULL	J_Evol_Biol_2010_May_23(5)_1033-1049.nxml.txt.nlp	20345808	SENT39	18	18	45	45	nadh	ND2	PA164755085	4536	0.495
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1051.nxml.txt.nlp	24503543	SENT144	28	28	31	31	erlotinib	Yes	PA134687924	7525	0.495
NULL	Cell_Death_Dis_2012_Mar_15_3(3)_e280.nxml.txt.nlp	22419109	SENT3	9	9	11	11	lipase	ATGL	PA450239	57104	0.495
NULL	Int_J_Fertil_Steril_2013_Mar_3_Jan-Mar_6(4)_258-265.nxml.txt.nlp	24520449	SENT72	24	24	22	22	creatine	mol	PA164778930	90527	0.495
NULL	ACS_Chem_Biol_2010_Jun_18_5(6)_589-601.nxml.txt.nlp	20392112	SENT37	31	31	28	28	fosfomycin	NAGK	PA164748039	55577	0.495
NULL	Adolesc_Health_Med_Ther_2013_Aug_27_4_79-87.nxml.txt.nlp	24600298	SENT61	24	24	18	18	raltegravir	UGT1A1		54658	0.495
NULL	Case_Rep_Dent_2013_Jul_10_2013_812323.nxml.txt.nlp	23936686	SENT96	18	18	24	24	hyaluronan	CD34	PA165958431	947	0.495
NULL	Crit_Care_2006_Feb_3_10(1)_R24.nxml.txt.nlp	16469128	SENT193	5	5	27	27	heparin	MARS	PA449855	4141	0.495
NULL	Int_J_Inflam_2011_Sep_20_2011_367284.nxml.txt.nlp	21941675	SENT307	20	20	13	13	heparin	PF4	PA449855	5196	0.495
NULL	Free_Radic_Biol_Med_2013_Aug_61(100)_438-452.nxml.txt.nlp	23608463	SENT873	33	33	7	7	apomorphine	NQO1	PA164781163	1728	0.495
NULL	J_Gastroenterol_2013_Jan_27_48(1)_22-30.nxml.txt.nlp	23104468	SENT37	17	17	15	15	ribavirin	IFN	PA451241	3439	0.495
NULL	Front_Oncol_2014_Apr_9_4_75.nxml.txt.nlp	24782986	SENT185	22	22	5	5	paclitaxel	Oct4	PA450761	5460	0.495
NULL	Br_J_Cancer_2011_Aug_23_105(5)_649-657.nxml.txt.nlp	21811251	SENT84	9	9	16	16	gefitinib	EGFR	PA131301952	1956	0.495
NULL	Reprod_Biol_Endocrinol_2003_Aug_6_1_54.nxml.txt.nlp	12932297	SENT320	25	25	6	6	hyaluronidase	PH-20	PA164745713	6677	0.495
NULL	Clin_Ophthalmol_2007_Sep_1(3)_273-284.nxml.txt.nlp	19668481	SENT111	19	19	3	3	triamcinolone	CRT	PA451749	811	0.495
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT172	7	7	9	9	erlotinib	CYP3A	PA134687924	1574	0.495
NULL	Oncol_Lett_2013_Sep_1_6(3)_821-828.nxml.txt.nlp	24137418	SENT138	7	7	14	14	octreotide	SSTR2	PA450678	6752	0.495
NULL	Br_J_Cancer_2012_Sep_25_107(7)_1009-1016.nxml.txt.nlp	22948724	SENT66	17	17	23	23	sorafenib	IFN	PA7000	3439	0.495
NULL	Front_Aging_Neurosci_2011_May_25_3_9.nxml.txt.nlp	21647305	SENT1343	2	2	5	5	atropine	spatial	PA448505	219793	0.495
NULL	Oxid_Med_Cell_Longev_2012_Aug_29_2012_819623.nxml.txt.nlp	22973468	SENT57	28	28	11	11	hydrocortisone	F12	PA449905	2161	0.495
NULL	Pharmacogn_Mag_2014_Jan-Feb_10(Suppl_1)_S14-S21.nxml.txt.nlp	24914294	SENT118	10	10	24	24	phenol	PLK1	PA450913	5347	0.495
NULL	Biologics_2012_Dec_17_6_429-464.nxml.txt.nlp	23269860	SENT10	24	24	14	14	rituximab	ACR	PA451261	49	0.495
NULL	Anal_Bioanal_Chem_2012_Apr_12_403(1)_151-155.nxml.txt.nlp	22327967	SENT50	5	5	9	9	fluorescein	mol	PA164746009	90527	0.495
NULL	Exp_Cell_Res_2013_Apr_1_319(6)_800-809.nxml.txt.nlp	23247073	SENT205	31	31	22	22	curcumin	AKT	PA151958596	207	0.495
NULL	Biochim_Biophys_Acta_2007_Aug_1767(8)_1007-1031.nxml.txt.nlp	17631856	SENT25	5	5	15	15	creatine	ADP	PA164778930	23038	0.495
NULL	J_Biol_Chem_2012_Apr_20_287(17)_13868-13876.nxml.txt.nlp	22389490	SENT269	14	14	22	22	capsaicin	TRPV1	PA448776	7442	0.495
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT63	4	4	6	6	resveratrol	TRAIL		8743	0.495
NULL	Biomed_Res_Int_2014_Jan_29_2014_361020.nxml.txt.nlp	24605326	SENT223	7	7	20	20	flavopiridol	CDK1	PA452627	983	0.495
NULL	Int_J_Endocrinol_2010_May_26_2010_906163.nxml.txt.nlp	20585352	SENT76	13	13	10	10	cinacalcet	MEN1	PA164776671	4221	0.495
NULL	J_Vis_Exp_2009_Sep_30_(31)_1304.nxml.txt.nlp	19794393	SENT84	15	15	11	11	forskolin	CNTF	PA146096022	1270	0.495
NULL	Br_J_Cancer_2002_Feb_1_86(3)_443-448.nxml.txt.nlp	11875713	SENT127	25	25	7	7	ciprofloxacin	Bcl-2	PA449009	596	0.495
NULL	J_Korean_Med_Sci_2010_Dec_24_25(12)_1766-1770.nxml.txt.nlp	21165292	SENT52	28	28	30	30	glucose	CRP	PA449773	1401;140913	0.495
NULL	Clin_Psychopharmacol_Neurosci_2012_Apr_30_10(1)_25-33.nxml.txt.nlp	23429852	SENT141	16	16	0	0	haloperidol	SNAP-25	PA449841	6616	0.495
NULL	Braz_J_Med_Biol_Res_2013_Feb_1_46(2)_171-177.nxml.txt.nlp	23369979	SENT124	26	26	12	12	enalapril	IL-6	PA449456	3569	0.495
NULL	Clin_Interv_Aging_2009_Jun_9_4_251-258.nxml.txt.nlp	19554096	SENT78	4	4	25	25	dutasteride	BII	PA164749300	777	0.495
NULL	Nutr_Diabetes_2014_Sep_1_4(9)_e131.nxml.txt.nlp	25177911	SENT58	9	9	12	12	paraformaldehyde	mol	PA450790	90527	0.495
NULL	Springerplus_2014_Sep_9_3_510.nxml.txt.nlp	25279302	SENT35	4	4	8	8	creatine	CT1	PA164778930	1489;6535	0.495
NULL	Oncol_Lett_2014_May_11_7(5)_1401-1408.nxml.txt.nlp	24765145	SENT160	4	4	10	10	paclitaxel	PI3K	PA450761	5290	0.495
NULL	J_Cell_Sci_2014_Jul_15_127(14)_3039-3051.nxml.txt.nlp	24928894	SENT964	2	2	0	0	thrombin	GIT1	PA451674	28964	0.495
NULL	Int_J_Biomed_Sci_2006_Dec_2(4)_414-421.nxml.txt.nlp	23675010	SENT233	18	18	6	6	mitomycin	Hua	PA450524	1994	0.495
NULL	Eur_J_Contracept_Reprod_Health_Care_2011_Aug_20_16(4)_258-269.nxml.txt.nlp	21774563	SENT53	23	23	11	11	iron	MBL	PA450087	50639	0.495
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2008_Jun_1_64(Pt_6)_611-619.nxml.txt.nlp	18560148	SENT193	4	4	6	6	heparin	CXCR3	PA449855	2833	0.495
NULL	Mol_Cancer_2006_Oct_17_5_45.nxml.txt.nlp	17044934	SENT143	7	7	12	12	resveratrol	COX		1351	0.495
NULL	Biomed_Res_Int_2013_Sep_30_2013_461204.nxml.txt.nlp	24195072	SENT15	19	19	22	22	d-xylitol	XDH	PA451938	7498	0.495
NULL	Lung_2011_Jun_21_189(3)_257-258.nxml.txt.nlp	21509562	SENT24	21	21	48	48	estradiol	TRPV1	PA449503	7442	0.495
NULL	CNS_Drugs_2014_May_1_28(6)_497-511.nxml.txt.nlp	24788672	SENT68	19	19	0	0	methylphenidate	ATX	PA450464	5168;23049	0.495
NULL	J_Nat_Med_2014_Feb_19_68(2)_253-266.nxml.txt.nlp	24550097	SENT226	35	35	14	14	ethanol	SREBP-1c	PA448073	6720	0.495
NULL	BMJ_2013_Jan_16_346_f55.nxml.txt.nlp	23325883	SENT185	29	29	12	12	carvedilol	Ray	PA448817	26751	0.495
NULL	Exp_Transl_Stroke_Med_2011_Dec_16_3_16.nxml.txt.nlp	22177314	SENT119	22	22	46	46	minocycline	ANOVA	PA450519	4858	0.495
NULL	Eur_Arch_Otorhinolaryngol_2013_Mar_13_270(4)_1397-1404.nxml.txt.nlp	23404469	SENT200	0	0	2	2	dasatinib	DDP	PA162372878	1678	0.495
NULL	Curr_Genomics_2013_Nov_14(7)_453-467.nxml.txt.nlp	24396277	SENT563	14	14	6	6	iron	hemojuvelin	PA450087	148738	0.495
NULL	J_Korean_Med_Sci_2013_Dec_26_28(12)_1729-1733.nxml.txt.nlp	24339701	SENT53	29	29	8	8	adalimumab	TNF	PA10004	7124	0.495
NULL	Br_J_Cancer_2009_May_19_100(10)_1540-1548.nxml.txt.nlp	19384300	SENT161	18	18	5	5	trypsin	CEA	PA451806	5670;1087	0.495
NULL	Ann_Rheum_Dis_2010_Oct_27_70(2)_299-304.nxml.txt.nlp	20980704	SENT16	12	12	0	0	infliximab	FCGR3B	PA452639	2215	0.495
NULL	J_Cardiovasc_Dis_Res_2012_Oct-Dec_3(4)_319-322.nxml.txt.nlp	23233778	SENT44	34	34	18	18	azithromycin	CYP3A4	PA448519	1576	0.495
NULL	Braz_J_Microbiol_2013_Apr_9_44(1)_245-252.nxml.txt.nlp	24159311	SENT94	11	11	8	8	lipase	castor	PA450239	54897	0.495
NULL	Endocrinology_2014_Aug_30_155(8)_2976-2985.nxml.txt.nlp	24877623	SENT12	14	14	42	42	estradiol	StAR	PA449503	6770	0.495
NULL	Oncoimmunology_2012_Aug_1_1(5)_581-592.nxml.txt.nlp	22934250	SENT253	13	13	23	23	mitomycin	IL-2	PA450524	3558	0.495
NULL	EMBO_Mol_Med_2012_May_4(5)_435-448.nxml.txt.nlp	22359280	SENT138	24	24	30	30	clodronate	HSPB4	PA10239	1409	0.495
NULL	Genome_Biol_2011_Mar_17_12(3)_218.nxml.txt.nlp	21401968	SENT270	28	28	36	36	capsaicin	TRPV1	PA448776	7442	0.495
NULL	Cancer_Causes_Control_2013_Aug_18_24(8)_1605-1614.nxml.txt.nlp	23775025	SENT64	25	25	45	45	methotrexate	ABCB1	PA450428	5243	0.495
NULL	Iran_J_Ped_Hematol_Oncol_2014_Jul_20_4(3)_127-130.nxml.txt.nlp	25254092	SENT55	30	30	32	32	propranolol	IFN	PA451145	3439	0.495
NULL	Am_J_Med_Sci_2014_Dec_20_348(6)_460-464.nxml.txt.nlp	25171546	SENT36	28	28	24	24	heparin	PGD2	PA449855	27306	0.495
NULL	Breast_Cancer_(Auckl)_2011_Jul_27_5_175-199.nxml.txt.nlp	21863131	SENT423	20	20	1	1	gemcitabine	Met	PA449748	79811	0.495
NULL	Mol_Syst_Biol_2011_Apr_26_7_486.nxml.txt.nlp	21525872	SENT501	7	7	33	33	simvastatin	PTGS1	PA451363	5742	0.495
NULL	Braz_J_Microbiol_2011_Dec_1_Oct-Dec_42(4)_1384-1389.nxml.txt.nlp	24031767	SENT19	36	36	24	24	nitrogen	BSG	PA450643	682	0.495
NULL	Open_Biochem_J_2008_Feb_6_2_6-15.nxml.txt.nlp	18949070	SENT350	6	6	41	41	heparin	Yes	PA449855	7525	0.495
NULL	Mol_Biol_Cell_2012_Mar_1_23(5)_781-791.nxml.txt.nlp	22238361	SENT243	10	10	22	22	paraformaldehyde	ZO-1	PA450790	7082	0.495
NULL	Clin_Dev_Immunol_2013_May_29_2013_289458.nxml.txt.nlp	23818912	SENT221	6	6	12	12	denosumab	BAFF	PA166048634	10673	0.495
NULL	Endocrinology_2011_Jul_3_152(7)_2678-2689.nxml.txt.nlp	21540289	SENT436	4	4	15	15	lipase	adiponutrin	PA450239	80339	0.495
NULL	Arq_Bras_Cardiol_2013_Aug_101(2)_117-126.nxml.txt.nlp	23821408	SENT43	9	9	6	6	paclitaxel	DES	PA450761	1674	0.495
NULL	Cancer_Metab_2014_Aug_28_2_12.nxml.txt.nlp	25184038	SENT45	30	30	7	7	hydrocortisone	F12	PA449905	2161	0.495
NULL	Croat_Med_J_2014_Jun_55(3)_206-217.nxml.txt.nlp	24891279	SENT82	22	22	34	34	doxorubicin	p53	PA449412	7157	0.495
NULL	J_Vis_Exp_2011_Jun_24_(52)_3094.nxml.txt.nlp	21730945	SENT111	7	7	41	41	ofloxacin	EMB	PA450684	133418	0.495
NULL	Int_J_Endocrinol_2010_May_26_2010_906163.nxml.txt.nlp	20585352	SENT0	14	14	16	16	cinacalcet	MEN1	PA164776671	4221	0.495
NULL	Mar_Drugs_2014_Oct_23_12(10)_5295-5315.nxml.txt.nlp	25342459	SENT727	0	0	12	12	doxorubicin	p53	PA449412	7157	0.495
NULL	Oncotarget_2014_Jun_30_5(14)_5624-5636.nxml.txt.nlp	25015549	SENT164	19	19	10	10	ethanol	TRAIL	PA448073	8743	0.495
NULL	Front_Neurosci_2014_Dec_5_8_398.nxml.txt.nlp	25538552	SENT145	14	14	6	6	glucose	gamma	PA449773	9913	0.495
NULL	Acta_Pharmacol_Sin_2014_Jan_16_35(1)_135-142.nxml.txt.nlp	24335841	SENT99	2	2	8	8	chloroquine	p62	PA448948	8878;10657;23636	0.495
NULL	J_Immunother_2014_Apr_12_37(3)_180-186.nxml.txt.nlp	24598448	SENT95	15	15	11	11	sorafenib	IL-2	PA7000	3558	0.495
NULL	Cardiovasc_Ther_2009_27(4)_259-274.nxml.txt.nlp	19604248	SENT136	8	8	41	41	ticagrelor	IPA	PA165374673	3160	0.495
NULL	Int_J_Mol_Sci_2014_Mar_20_15(3)_4965-4976.nxml.txt.nlp	24658440	SENT585	6	6	8	8	tacrolimus	IL-6	PA451578	3569	0.495
NULL	AAPS_J_2011_Jun_1_13(3)_405-416.nxml.txt.nlp	21630127	SENT217	3	3	17	17	clopidogrel	CYP2C19	PA449053	1557	0.495
NULL	ScientificWorldJournal_2012_Mar_12_2012_427081.nxml.txt.nlp	22536141	SENT72	40	40	36	36	desflurane	CO2	PA164749136	4513	0.495
NULL	J_Gen_Physiol_1958_Sep_20_42(1)_49-68.nxml.txt.nlp	13575774	SENT0	13	13	1	1	chymotrypsin	Gen	PA448994	348654	0.495
NULL	JRSM_Cardiovasc_Dis_2012_Sep_24_1(6)_cvd_2012_012015.nxml.txt.nlp	24175073	SENT57	27	27	13	13	clopidogrel	CYP3A4	PA449053	1576	0.495
NULL	Int_J_Endocrinol_2011_Nov_9_2011_724816.nxml.txt.nlp	22114592	SENT22	22	22	24	24	estradiol	adiponectin	PA449503	9370	0.495
NULL	J_Oncol_2011_Mar_30_2011_456743.nxml.txt.nlp	21541211	SENT78	12	12	6	6	urokinase	SLURP2	PA451836	66004	0.495
NULL	Cancers_(Basel)_2013_Apr_2_5(2)_320-333.nxml.txt.nlp	24216979	SENT642	9	9	15	15	cisplatin	p53	PA449014	7157	0.495
NULL	Acta_Pharmacol_Sin_2012_Nov_22_33(11)_1395-1400.nxml.txt.nlp	23085738	SENT150	19	19	10	10	prasugrel	P2Y12	PA154410481	64805	0.495
NULL	Biomed_Res_Int_2013_Jul_28_2013_724763.nxml.txt.nlp	23984402	SENT106	15	15	32	32	carrageenan	AD3	PA448814	11138	0.495
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT203	7	7	2	2	sulindac	AKT	PA451565	207	0.495
NULL	Diabetes_Care_2011_Nov_15_34(11)_2381-2386.nxml.txt.nlp	21926282	SENT179	10	10	24	24	pioglitazone	adiponectin	PA450970	9370	0.495
NULL	Front_Neuroeng_2013_Feb_25_6_1.nxml.txt.nlp	23443302	SENT70	18	18	27	27	remifentanil	gamma	PA451232	9913	0.495
NULL	J_Cell_Mol_Med_2013_Feb_10_17(2)_287-292.nxml.txt.nlp	23301946	SENT57	13	13	30	30	l-glutamine	CO2	PA10090	4513	0.495
NULL	J_Mol_Signal_2006_Dec_6_1_8.nxml.txt.nlp	17224083	SENT126	23	23	26	26	thrombin	Rho	PA451674	29984	0.495
NULL	Cell_Death_Dis_2014_Jan_30_5(1)_e1038.nxml.txt.nlp	24481452	SENT231	3	3	10	10	raloxifene	NQO1	PA451221	1728	0.495
NULL	J_Appl_Genet_2014_Jan_11_55(2)_173-181.nxml.txt.nlp	24414975	SENT56	5	5	2	2	nadh	MT-ND2	PA164755085	4536	0.495
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT747	18	18	23	23	resveratrol	AMPK		5563	0.495
NULL	Semin_Cell_Dev_Biol_2011_May_22(3)_271-277.nxml.txt.nlp	21310261	SENT368	3	3	1	1	nadh	mol	PA164755085	90527	0.495
NULL	Arthritis_Res_Ther_2005_Mar_16_7(Suppl_2)_S21-S25.nxml.txt.nlp	15833145	SENT72	21	21	0	0	abatacept	ACR	PA164747080	49	0.495
NULL	Acta_Pharmacol_Sin_2014_Sep_4_35(9)_1137-1149.nxml.txt.nlp	25088000	SENT117	18	18	15	15	pilocarpine	FKBP1A	PA450962	2280	0.495
NULL	Cell_Death_Dis_2013_Sep_12_4(9)_e798.nxml.txt.nlp	24030150	SENT6	11	11	38	38	vorinostat	MYC	PA164748224	4609	0.495
NULL	Curr_Biol_2012_Mar_6_22(5)_397-402.nxml.txt.nlp	22305751	SENT57	12	12	22	22	physostigmine	spatial	PA450957	219793	0.495
NULL	Mol_Cancer_2008_Jun_30_7_60.nxml.txt.nlp	18590557	SENT93	5	5	29	29	paclitaxel	TRAIL	PA450761	8743	0.495
NULL	Indian_J_Dermatol_2011_Jan-Feb_56(1)_87-91.nxml.txt.nlp	21572802	SENT63	9	9	2	2	cyclophosphamide	CHOP	PA449165	1649	0.495
NULL	Exp_Ther_Med_2014_Jun_7_7(6)_1677-1682.nxml.txt.nlp	24926365	SENT62	19	19	32	32	streptomycin	FBS	PA451512	64319;26269	0.495
NULL	Br_J_Cancer_2012_Apr_24_106(9)_1543-1550.nxml.txt.nlp	22531721	SENT172	36	36	28	28	trastuzumab	CD59	PA451743	966	0.495
NULL	J_Cell_Biol_2008_Jul_14_182(1)_103-116.nxml.txt.nlp	18606846	SENT12	13	13	20	20	lipase	aP2	PA450239	2167	0.495
NULL	Pharmaceuticals_(Basel)_2013_Sep_23_6(9)_1145-1169.nxml.txt.nlp	24276423	SENT26	29	29	17	17	hyaluronan	LFA-1	PA165958431	3683;3689	0.495
NULL	Cancer_Immunol_Immunother_2012_Oct_16_61(10)_1781-1790.nxml.txt.nlp	22422103	SENT197	33	33	27	27	cyclophosphamide	LAK	PA449165	10123	0.495
NULL	Trials_2014_Sep_10_15(1)_356.nxml.txt.nlp	NULL	SENT869	27	27	10	10	sertraline	Gen	PA451333	348654	0.495
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT86	3	3	9	9	perifosine	TRAIL	PA165291471	8743	0.495
NULL	Cell_Death_Differ_2010_Mar_16_17(3)_499-512.nxml.txt.nlp	19834490	SENT110	0	0	4	4	bevacizumab	VEGFR2	PA130232992	3791	0.495
NULL	Diabetes_2009_Dec_9_58(12)_2788-2796.nxml.txt.nlp	19741162	SENT199	27	27	32	32	lipase	PDK4	PA450239	5166	0.494
NULL	Biologics_2012_Jun_5_6_125-134.nxml.txt.nlp	22740771	SENT102	18	18	5	5	infliximab	ACT	PA452639	12;11332;9457;641455	0.494
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Jun_27_5_15.nxml.txt.nlp	16803618	SENT145	44	44	42	42	gentamicin	GEN1	PA449753	348654	0.494
NULL	Viruses_2009_Aug_11_1(2)_126-143.nxml.txt.nlp	21994542	SENT187	11	11	19	19	oxygen	STAT3	PA450744	6774	0.494
NULL	Oncogenesis_2014_May_12_3(5)_e102.nxml.txt.nlp	24819061	SENT59	15	15	22	22	nadh	p53	PA164755085	7157	0.494
NULL	Angew_Chem_Int_Ed_Engl_2013_Jan_21_52(4)_1253-1256.nxml.txt.nlp	23225333	SENT72	2	2	7	7	ethanol	CC3	PA448073	10553	0.494
NULL	Cell_Death_Dis_2014_Jan_30_5(1)_e1038.nxml.txt.nlp	24481452	SENT41	0	0	6	6	raloxifene	CYP1A1	PA451221	1543	0.494
NULL	Cardiovasc_Diabetol_2013_Oct_17_12_150.nxml.txt.nlp	24134550	SENT101	1	1	3	3	metformin	activin	PA450395	83729	0.494
NULL	Amino_Acids_2013_Aug_19_45(2)_351-358.nxml.txt.nlp	23685963	SENT68	20	20	36	36	l-phenylalanine	PLP	PA450931	25824;5744	0.494
NULL	Oncotarget_2014_Mar_26_5(21)_10342-10355.nxml.txt.nlp	25431950	SENT231	18	18	9	9	doxorubicin	San	PA449412	80218	0.494
NULL	Br_J_Cancer_2014_Nov_25_111(11)_2091-2102.nxml.txt.nlp	25349971	SENT221	21	21	7	7	imatinib	PTPN18	PA10804	26469	0.494
NULL	Am_J_Med_Sci_2014_Dec_20_348(6)_460-464.nxml.txt.nlp	25171546	SENT37	2	2	0	0	heparin	PGD2	PA449855	27306	0.494
NULL	Curr_Neuropharmacol_2014_Jul_12(4)_365-379.nxml.txt.nlp	25342944	SENT534	8	8	3	3	fluoxetine	5-HT1D	PA449673	3352	0.494
NULL	Breast_Cancer_Res_2011_May_26_13(3)_209.nxml.txt.nlp	21635709	SENT170	22	22	18	18	tamoxifen	aromatase	PA451581	1588	0.494
NULL	Clin_Epidemiol_2011_Sep_12_3_237-244.nxml.txt.nlp	22003307	SENT32	7	7	11	11	isoniazid	IPT	PA450112	54802	0.494
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT132	47	47	41	41	dofetilide	NAPA	PA449389	9476;8775	0.494
NULL	Hum_Genomics_2005_Jun_1_2(2)_138-143.nxml.txt.nlp	16004729	SENT37	43	43	21	21	nadh	Met	PA164755085	79811	0.494
NULL	Acta_Naturae_2011_Jul-Sep_3(3)_12-28.nxml.txt.nlp	22649690	SENT349	6	6	19	19	raltegravir	N155		9631	0.494
NULL	Case_Rep_Pathol_2012_Aug_8_2012_319434.nxml.txt.nlp	22934215	SENT43	11	11	13	13	thyroglobulin	TTF-1	PA164754910	7080	0.494
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT192	41	41	19	19	erlotinib	Yes	PA134687924	7525	0.494
NULL	Aging_(Albany_NY)_2014_Jan_14_6(1)_70-81.nxml.txt.nlp	24429382	SENT277	5	5	2	2	etoposide	WRN	PA449552	7486	0.494
NULL	J_Exp_Bot_2008_Jul_6_59(10)_2815-2829.nxml.txt.nlp	18540021	SENT243	24	24	34	34	thrombin	Met	PA451674	79811	0.494
NULL	J_Res_Med_Sci_2012_Jun_17(6)_587-595.nxml.txt.nlp	23626642	SENT195	3	3	13	13	capsaicin	TRPV1	PA448776	7442	0.494
NULL	Cancer_Cell_Int_2010_Sep_9_10_33.nxml.txt.nlp	20828399	SENT187	20	20	28	28	l-glutamine	CO2	PA10090	4513	0.494
NULL	Acta_Pharmacol_Sin_2010_Dec_22_31(12)_1643-1648.nxml.txt.nlp	21102481	SENT159	0	0	15	15	sorafenib	Mcl-1	PA7000	4170	0.494
NULL	Cancers_(Basel)_2013_Jun_24_5(3)_762-785.nxml.txt.nlp	24202320	SENT154	18	18	10	10	suramin	CXCL4	PA10292	5196	0.494
NULL	Mol_Cell_Biochem_2014_Oct_9_385(1-2)_265-275.nxml.txt.nlp	24104452	SENT102	6	6	17	17	bortezomib	U87	PA10252	677775;641648	0.494
NULL	Front_Immunol_2014_Aug_20_5_348.nxml.txt.nlp	25191322	SENT732	28	28	33	33	heparin	PP13	PA449855	29124	0.494
NULL	Cancer_Microenviron_2008_Dec_20_1(1)_103-111.nxml.txt.nlp	19308689	SENT226	5	5	28	28	thrombin	PAR-1	PA451674	2011;2149	0.494
NULL	Arthritis_Res_Ther_2010_May_28_12(3)_R105.nxml.txt.nlp	20509880	SENT213	22	22	24	24	celecoxib	p38	PA448871	10598;1432;7965	0.494
NULL	Crit_Care_2011_Nov_16_15(6)_R271.nxml.txt.nlp	22087790	SENT164	2	2	44	44	nitroprusside	Yes	PA451406	7525	0.494
NULL	Breast_Cancer_Res_2007_Aug_8_9(4)_R50.nxml.txt.nlp	17686159	SENT192	36	36	38	38	gefitinib	HRG	PA131301952	3084;3273	0.494
NULL	J_Headache_Pain_2012_Mar_14_13(2)_159-166.nxml.txt.nlp	22246026	SENT151	8	8	1	1	sumatriptan	ANOVA	PA451566	4858	0.494
NULL	Arch_Med_Sci_2010_Dec_29_6(6)_945-949.nxml.txt.nlp	22427771	SENT101	32	32	22	22	buserelin	ART	PA10253	181	0.494
NULL	Int_J_Mol_Sci_2014_Sep_5_15(9)_15754-15765.nxml.txt.nlp	25198898	SENT4	13	13	7	7	curcumin	NAC	PA151958596	22861	0.494
NULL	J_Cardiovasc_Magn_Reson_2009_Jun_28_11(1)_20.nxml.txt.nlp	19558722	SENT95	9	9	11	11	iron	CIC	PA450087	23152	0.494
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1051.nxml.txt.nlp	24503543	SENT144	28	28	23	23	erlotinib	Yes	PA134687924	7525	0.494
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT73	39	39	35	35	vinorelbine	ASC	PA451881	29108	0.494
NULL	Apoptosis_2012_Jun_9_17(6)_566-578.nxml.txt.nlp	22402981	SENT166	35	35	39	39	pp2	PP2		4888	0.494
NULL	Environ_Health_Perspect_2010_Sep_28_118(9)_1267-1272.nxml.txt.nlp	20427257	SENT115	8	8	13	13	estradiol	BPA	PA449503	667	0.494
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT128	20	20	2	2	metoprolol	CYP2C19	PA450480	1557	0.494
NULL	Arthritis_Res_Ther_2014_Jan_15_16(1)_R10.nxml.txt.nlp	24423138	SENT371	3	3	9	9	collagenase	TRPV1	PA449107	7442	0.494
NULL	Mol_Neurobiol_2010_Aug_16_42(1)_4-9.nxml.txt.nlp	20552413	SENT149	22	22	11	11	etoposide	spatial	PA449552	219793	0.494
NULL	Cardiovasc_Diabetol_2013_Nov_12_12_169.nxml.txt.nlp	24215514	SENT311	3	3	6	6	valsartan	AT2	PA451848	186	0.494
NULL	Eur_J_Endocrinol_2011_Jan_164(1)_69-74.nxml.txt.nlp	20961967	SENT4	23	23	26	26	metformin	OPG	PA450395	690	0.494
NULL	Braz_J_Microbiol_2014_Jan_15_44(3)_807-812.nxml.txt.nlp	24516449	SENT133	47	47	18	18	clindamycin	CTX	PA449035	1593	0.494
NULL	Oncotarget_2011_Dec_31_2(12)_1279-1290.nxml.txt.nlp	22249125	SENT34	20	20	32	32	2-methoxyestradiol	p38	PA134967247	10598;1432;7965	0.494
NULL	J_Cell_Mol_Med_2013_Jun_15_17(6)_792-799.nxml.txt.nlp	23672538	SENT61	7	7	30	30	fluorescein	CD24	PA164746009	100133941	0.494
NULL	Case_Rep_Oncol_Med_2013_Jan_16_2013_292301.nxml.txt.nlp	23401819	SENT131	18	18	2	2	cyclophosphamide	CHOP	PA449165	1649	0.494
NULL	Arch_Med_Sci_2013_Oct_31_9(5)_916-921.nxml.txt.nlp	24273579	SENT13	7	7	4	4	bleomycin	AQP1	PA448645	358	0.494
NULL	Cancers_(Basel)_2012_Sep_25_4(4)_969-988.nxml.txt.nlp	24213497	SENT132	16	16	12	12	estradiol	aromatase	PA449503	1588	0.494
NULL	Oncologist_2010_Mar_9_15(3)_236-245.nxml.txt.nlp	20215359	SENT138	11	11	8	8	everolimus	S6K1	PA164746311	6198	0.494
NULL	Front_Endocrinol_(Lausanne)_2013_Jan_7_3_180.nxml.txt.nlp	23316185	SENT385	0	0	22	22	cyclophosphamide	c-fos	PA449165	2353	0.494
NULL	Biomed_Res_Int_2014_Apr_13_2014_738625.nxml.txt.nlp	24822215	SENT164	4	4	6	6	montelukast	IL-13	PA450546	3596	0.494
NULL	Pharmaceutics_2011_Jan_13_3(1)_34-52.nxml.txt.nlp	21949900	SENT93	4	4	2	2	cisplatin	EGF	PA449014	1950	0.494
NULL	Indian_J_Nephrol_2014_Jan-Feb_24(1)_38-40.nxml.txt.nlp	24574630	SENT17	4	4	16	16	furosemide	B12	PA449719	7126;4709	0.494
NULL	Clin_Ophthalmol_2012_Aug_10_6_1307-1314.nxml.txt.nlp	22927745	SENT140	17	17	9	9	triamcinolone	hole	PA451749	80757	0.494
NULL	Case_Rep_Gastroenterol_2012_Jul_24_6(2)_496-501.nxml.txt.nlp	22855667	SENT39	10	10	20	20	simvastatin	B12	PA451363	7126;4709	0.494
NULL	Br_J_Cancer_2013_Mar_19_108(5)_1061-1070.nxml.txt.nlp	23449360	SENT260	16	16	18	18	tamoxifen	IL-2	PA451581	3558	0.494
NULL	Indian_J_Palliat_Care_2014_Jan-Apr_20(1)_66-87.nxml.txt.nlp	NULL	SENT355	4	4	7	7	tramadol	FOR	PA451735	51741	0.494
NULL	Comp_Hepatol_2004_Jan_14_3(Suppl_1)_S31.nxml.txt.nlp	14960183	SENT19	26	26	24	24	ethanol	TNF-alpha	PA448073	7124	0.494
NULL	Clin_Ophthalmol_2011_Feb_11_5_167-170.nxml.txt.nlp	21383944	SENT63	9	9	5	5	triamcinolone	hole	PA451749	80757	0.494
NULL	Breast_Cancer_Res_2011_Mar_1_13(2)_R21.nxml.txt.nlp	21362200	SENT18	6	6	9	9	fulvestrant	PI3K	PA164747170	5290	0.494
NULL	Cancers_(Basel)_2011_Mar_29_3(2)_1708-1731.nxml.txt.nlp	24212779	SENT1591	7	7	9	9	fluorouracil	GM-CSF	PA128406956	1437	0.494
NULL	Adv_Hematol_2012_Aug_2_2012_842945.nxml.txt.nlp	22919394	SENT146	15	15	8	8	thalidomide	CRBN	PA451644	51185	0.494
NULL	Eur_J_Endocrinol_2011_Jan_164(1)_69-74.nxml.txt.nlp	20961967	SENT33	23	23	26	26	metformin	OPG	PA450395	690	0.494
NULL	J_Appl_Genet_2014_Jan_11_55(2)_173-181.nxml.txt.nlp	24414975	SENT66	5	5	2	2	nadh	MT-ND6	PA164755085	4541	0.494
NULL	Acta_Neuropathol_Commun_2013_Sep_16_1_61.nxml.txt.nlp	24252310	SENT214	20	20	5	5	oxygen	HNE	PA450744	1991	0.494
NULL	Biologics_2012_Dec_17_6_429-464.nxml.txt.nlp	23269860	SENT183	2	2	15	15	etanercept	ACR	PA449515	49	0.494
NULL	Cell_Death_Dis_2014_Mar_13_5(3)_e1118.nxml.txt.nlp	24625977	SENT296	10	10	21	21	etoposide	p53	PA449552	7157	0.494
NULL	Drug_Target_Insights_2007_Feb_7_2_19-27.nxml.txt.nlp	21901059	SENT139	0	0	9	9	ribavirin	TNF-alpha	PA451241	7124	0.494
NULL	Protein_Expr_Purif_2009_Aug_66(2)_181-184.nxml.txt.nlp	19269329	SENT164	5	5	8	8	thrombin	AMPK	PA451674	5563	0.494
NULL	Clin_Med_Insights_Oncol_2012_Nov_19_6_375-380.nxml.txt.nlp	23226078	SENT28	23	23	32	32	cyclophosphamide	CHOP	PA449165	1649	0.494
NULL	Cancer_Immunol_Immunother_2011_Jun_25_60(6)_793-808.nxml.txt.nlp	21350947	SENT164	9	9	18	18	sorafenib	IFN	PA7000	3439	0.494
NULL	Chin_J_Cancer_2011_May_30(5)_293-302.nxml.txt.nlp	21527062	SENT81	10	10	17	17	bevacizumab	IFL	PA130232992	3439	0.494
NULL	Pharmaceutics_2011_Nov_18_3(4)_865-913.nxml.txt.nlp	24309312	SENT116	3	3	9	9	fexofenadine	P-gp	PA449621	5243	0.494
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1699-1708.nxml.txt.nlp	19861960	SENT250	24	24	21	21	dasatinib	mol	PA162372878	90527	0.494
NULL	Mol_Biol_Cell_2013_Sep_15_24(18)_2849-2860.nxml.txt.nlp	23885123	SENT180	11	11	15	15	dextran	JAM-A	PA449261	50848	0.494
NULL	J_Headache_Pain_2009_Oct_5_10(5)_317-325.nxml.txt.nlp	19499287	SENT92	21	21	11	11	sildenafil	Yes	PA451346	7525	0.494
NULL	J_Gen_Physiol_1990_Sep_1_96(3)_449-471.nxml.txt.nlp	2230708	SENT0	24	24	1	1	phenol	Gen	PA450913	348654	0.494
NULL	Cancer_Imaging_2006_Oct_31_6(Spec_No_A)_S71-S81.nxml.txt.nlp	17114081	SENT87	29	29	10	10	arcitumomab	CEA	PA164746540	5670;1087	0.494
NULL	Biomed_Res_Int_2013_Dec_11_2013_418132.nxml.txt.nlp	24392451	SENT139	21	21	14	14	dextran	CO2	PA449261	4513	0.494
NULL	Cancers_(Basel)_2013_Sep_10_5(3)_1163-1176.nxml.txt.nlp	24202339	SENT644	1	1	3	3	nitazoxanide	IL-6	PA164754874	3569	0.494
NULL	Breast_Cancer_(Auckl)_2012_Mar_7_6_67-77.nxml.txt.nlp	22438669	SENT124	25	25	36	36	trastuzumab	HER2	PA451743	2064	0.494
NULL	Cases_J_2008_Dec_30_1_426.nxml.txt.nlp	19116013	SENT11	8	8	29	29	cyclophosphamide	CHOP	PA449165	1649	0.494
NULL	J_Gen_Physiol_2000_Dec_1_116(6)_769-780.nxml.txt.nlp	11099346	SENT11	26	26	24	24	tetracaine	DAG	PA451638	1605	0.494
NULL	Crit_Care_2011_Nov_16_15(6)_R271.nxml.txt.nlp	22087790	SENT164	2	2	17	17	nitroprusside	Yes	PA451406	7525	0.494
NULL	J_Invest_Dermatol_2013_Feb_20_133(2)_344-353.nxml.txt.nlp	22992803	SENT112	23	23	26	26	tamoxifen	E16	PA451581	8140	0.494
NULL	Int_J_Nanomedicine_2012_Sep_13_7_4917-4926.nxml.txt.nlp	23028220	SENT139	12	12	19	19	calcein	mol	PA132595336	90527	0.494
NULL	Oncol_Rep_2014_Oct_7_32(4)_1369-1373.nxml.txt.nlp	25109605	SENT98	4	4	6	6	docetaxel	PC-3	PA449383	692094	0.494
NULL	Br_J_Cancer_2011_Jun_28_105(1)_53-57.nxml.txt.nlp	21654688	SENT29	6	6	27	27	sn-38	UGT1A1		54658	0.494
NULL	ScientificWorldJournal_2012_Apr_29_2012_842348.nxml.txt.nlp	22649325	SENT189	30	30	43	43	ciprofloxacin	GIT	PA449009	5034	0.494
NULL	Breast_Cancer_Res_Treat_2013_Jan_6_137(1)_167-174.nxml.txt.nlp	23129173	SENT40	17	17	14	14	letrozole	CYP19A1	PA450196	1588	0.494
NULL	Afr_J_Infect_Dis_2011_5(2)_40-46.nxml.txt.nlp	23878706	SENT102	2	2	4	4	ampicillin	Gen	PA448419	348654	0.494
NULL	J_Korean_Med_Sci_2009_Jan_29_24(Suppl_1)_S170-S175.nxml.txt.nlp	19194548	SENT11	13	13	20	20	cisplatin	EPO	PA449014	7076;8288;2056	0.494
NULL	Cancer_Cell_Int_2010_Sep_9_10_32.nxml.txt.nlp	20828393	SENT236	14	14	8	8	cisplatin	ATF3	PA449014	467	0.494
NULL	Diabetes_2013_Jun_17_62(6)_2048-2058.nxml.txt.nlp	23349496	SENT297	14	14	12	12	hyaluronan	TSG-6	PA165958431	7130	0.494
NULL	J_Headache_Pain_2011_Jun_18_12(3)_355-360.nxml.txt.nlp	21331754	SENT170	16	16	12	12	collagenase	CD40	PA449107	958	0.494
NULL	Acta_Pharmacol_Sin_2013_Jan_5_34(1)_24-32.nxml.txt.nlp	23123646	SENT82	34	34	39	39	glibenclamide	SUR1	PA449782	6833	0.494
NULL	J_Int_Soc_Sports_Nutr_2009_Feb_19_6_6.nxml.txt.nlp	19228401	SENT5	24	24	28	28	creatine	CEE	PA164778930	51608	0.494
NULL	Breast_Cancer_Res_2009_Jul_15_11(4)_207.nxml.txt.nlp	19664181	SENT226	13	13	37	37	trastuzumab	PTEN	PA451743	5728	0.494
NULL	J_Biol_Chem_2012_Apr_27_287(18)_14950-14959.nxml.txt.nlp	22393063	SENT120	21	21	14	14	heparin	K19	PA449855	3880	0.494
NULL	Nat_Neurosci_2011_May_17_14(5)_612-619.nxml.txt.nlp	21499254	SENT22	13	13	40	40	ethanol	EGF	PA448073	1950	0.494
NULL	J_Int_Soc_Sports_Nutr_2012_Apr_17_9_17.nxml.txt.nlp	22510253	SENT95	16	16	19	19	l-arginine	AAKG	PA448478	51422	0.494
NULL	Indian_J_Pharm_Sci_2013_Sep-Oct_75(5)_523-532.nxml.txt.nlp	24403652	SENT40	6	6	19	19	cholestyramine	API	PA448974	5345	0.494
NULL	Brain_2008_Nov_22_131(11)_3072-3080.nxml.txt.nlp	18945724	SENT65	28	28	6	6	rituximab	CD19	PA451261	930	0.494
NULL	Clin_Mol_Hepatol_2014_Sep_25_20(3)_283-290.nxml.txt.nlp	25320732	SENT147	2	2	7	7	propranolol	EVL	PA451145	51466	0.494
NULL	Angiogenesis_2012_Jun_2_15(2)_275-286.nxml.txt.nlp	22382585	SENT5	35	35	19	19	tegafur	CTX	PA452620	1593	0.494
NULL	Int_J_Anal_Chem_2012_Feb_8_2012_546282.nxml.txt.nlp	22505920	SENT216	3	3	17	17	terazosin	PF6	PA451612	200162	0.494
NULL	Adv_Ther_2014_Dec_2_31_1228-1246.nxml.txt.nlp	25447269	SENT148	19	19	16	16	timolol	TIM	PA451690	7984;8914	0.494
NULL	Cancer_Cell_Int_2011_Nov_17_11_40.nxml.txt.nlp	22088142	SENT147	16	16	22	22	gemcitabine	EGFR	PA449748	1956	0.494
NULL	ASN_Neuro_2011_Oct_6_3(4)_e00065.nxml.txt.nlp	21895607	SENT245	7	7	24	24	dextran	VPAC1	PA449261	7433	0.494
NULL	Mol_Cancer_2010_May_19_9_112.nxml.txt.nlp	20482842	SENT418	28	28	18	18	imatinib	NF-kappaB	PA10804	4790	0.494
NULL	Facts_Views_Vis_Obgyn_2010_2(4)_289-295.nxml.txt.nlp	25009716	SENT255	6	6	3	3	phenol	ISM1	PA450913	140862	0.494
NULL	Front_Behav_Neurosci_2010_Dec_17_4_187.nxml.txt.nlp	21188275	SENT550	5	5	13	13	estradiol	aromatase	PA449503	1588	0.494
NULL	Hum_Genomics_2010_Apr_1_4(4)_238-249.nxml.txt.nlp	20511137	SENT75	10	10	7	7	raloxifene	UGT	PA451221	7361;7355	0.494
NULL	J_Korean_Med_Sci_2011_Jan_22_26(1)_47-52.nxml.txt.nlp	21218029	SENT132	5	5	1	1	creatine	H-FABP	PA164778930	2170	0.494
NULL	Breast_Cancer_Res_2009_May_29_11(3)_206.nxml.txt.nlp	19519952	SENT49	12	12	10	10	tamoxifen	DES	PA451581	1674	0.494
NULL	Br_J_Cancer_2010_May_11_102(10)_1456-1460.nxml.txt.nlp	20461090	SENT97	18	18	20	20	temsirolimus	IFN	PA164746890	3439	0.494
NULL	Int_J_Tryptophan_Res_2013_Aug_19_6_35-45.nxml.txt.nlp	24023520	SENT93	39	39	42	42	hydroquinone	NQO1	PA449924	1728	0.494
NULL	Anat_Cell_Biol_2013_Mar_25_46(1)_19-31.nxml.txt.nlp	23560233	SENT144	25	25	4	4	vasopressin	ET1	PA451858	1906	0.494
NULL	J_Res_Med_Sci_2012_May_17(5)_456-460.nxml.txt.nlp	23626611	SENT83	20	20	9	9	protamine	OAT	PA10366	4942	0.494
NULL	Int_J_Mol_Sci_2012_Sep_26_13(10)_12336-12348.nxml.txt.nlp	23202901	SENT60	5	5	20	20	phenol	P90	PA450913	821	0.494
NULL	Infect_Drug_Resist_2009_Apr_24_2_13-26.nxml.txt.nlp	21694884	SENT36	43	43	9	9	tenofovir	IFN	PA10204	3439	0.494
NULL	Contemp_Oncol_(Pozn)_2012_Feb_29_16(1)_86-89.nxml.txt.nlp	23788860	SENT49	7	7	9	9	epirubicin	DDP	PA449476	1678	0.494
NULL	Front_Hum_Neurosci_2013_May_20_7_216.nxml.txt.nlp	23730284	SENT257	13	13	17	17	chlorpromazine	CPZ	PA448964	8532	0.494
NULL	Mol_Cancer_2014_Feb_24_13_36.nxml.txt.nlp	24568192	SENT241	15	15	8	8	isoproterenol	CO2	PA450121	4513	0.494
NULL	Br_J_Cancer_2002_Feb_1_86(3)_470-476.nxml.txt.nlp	11875717	SENT42	19	19	25	25	cisplatin	MTD	PA449014	4493	0.493
NULL	Exp_Ther_Med_2013_Mar_21_5(3)_987-991.nxml.txt.nlp	23407636	SENT71	22	22	24	24	telmisartan	CXCR1	PA451605	3577	0.493
NULL	Eur_J_Haematol_2014_Feb_25_92(2)_127-136.nxml.txt.nlp	24118452	SENT71	7	7	5	5	anagrelide	CRT	PA164742986	811	0.493
NULL	Onco_Targets_Ther_2014_Jun_13_7_1033-1042.nxml.txt.nlp	24966685	SENT143	38	38	24	24	gemcitabine	AKT1	PA449748	207	0.493
NULL	Oncotarget_2014_Jun_6_5(13)_4935-4944.nxml.txt.nlp	24952732	SENT288	5	5	15	15	thioridazine	PI3K	PA451666	5290	0.493
NULL	Curr_Neuropharmacol_2014_Jul_12(4)_365-379.nxml.txt.nlp	25342944	SENT534	17	17	1	1	citalopram	5-HT1A	PA449015	3350	0.493
NULL	Arch_Osteoporos_2013_Oct_11_8(1-2)_136.nxml.txt.nlp	24113837	SENT2910	22	22	18	18	raloxifene	PTH	PA451221	5741	0.493
NULL	Cells_2014_May_23_3(2)_517-545.nxml.txt.nlp	24861977	SENT556	7	7	9	9	capsaicin	TRPV1	PA448776	7442	0.493
NULL	Cardiovasc_Diabetol_2013_Jun_7_12_84.nxml.txt.nlp	23759020	SENT128	22	22	19	19	dipyridamole	LSR	PA449367	51599	0.493
NULL	EMBO_Mol_Med_2013_Dec_21_5(12)_1918-1934.nxml.txt.nlp	24293318	SENT149	16	16	0	0	rolipram	ANOVA	PA153906323	4858	0.493
NULL	Appl_Biochem_Biotechnol_2014_Jul_1_173(8)_2189-2197.nxml.txt.nlp	24980748	SENT28	27	27	22	22	lactulose	LBA	PA164748762	987	0.493
NULL	Oncotarget_2014_Feb_23_5(3)_802-814.nxml.txt.nlp	24583651	SENT222	24	24	45	45	l-glutamine	CO2	PA10090	4513	0.493
NULL	Antimicrob_Resist_Infect_Control_2012_Mar_16_1_12.nxml.txt.nlp	22958880	SENT107	22	22	28	28	cefotaxime	CTX	PA448852	1593	0.493
NULL	Ann_Oncol_2011_Aug_27_22(8)_1736-1747.nxml.txt.nlp	21709140	SENT87	23	23	2	2	trastuzumab	STEPP	PA451743	222659	0.493
NULL	Environ_Health_Perspect_2013_Apr_5_121(4)_459-466.nxml.txt.nlp	23384675	SENT187	24	24	15	15	collagenase	AP-1	PA449107	2353;3727;2354;3725	0.493
NULL	Int_J_Environ_Res_Public_Health_2013_Sep_17_10(9)_4352-4389.nxml.txt.nlp	24048206	SENT213	10	10	8	8	choline	B12	PA448976	7126;4709	0.493
NULL	Int_J_Nanomedicine_2012_Sep_17_7_5039-5049.nxml.txt.nlp	23055722	SENT230	4	4	20	20	fluorescein	PTEN	PA164746009	5728	0.493
NULL	J_Neuroinflammation_2011_Feb_4_8_10.nxml.txt.nlp	21294877	SENT48	21	21	33	33	paraformaldehyde	OCT	PA450790	5362	0.493
NULL	Core_Evid_2010_Jul_27_5_11-22.nxml.txt.nlp	20694136	SENT194	6	6	26	26	ustekinumab	ACR	PA166048654	49	0.493
NULL	Breast_Cancer_Res_2007_Mar_2_9(2)_205.nxml.txt.nlp	NULL	SENT142	0	0	2	2	trastuzumab	HER-2	PA451743	2064	0.493
NULL	Indian_J_Pharm_Sci_2013_Sep-Oct_75(5)_523-532.nxml.txt.nlp	24403652	SENT138	20	20	6	6	atorvastatin	ATV	PA448500	4683	0.493
NULL	Indian_J_Ophthalmol_2007_Nov-Dec_55(6)_483b-486.nxml.txt.nlp	17951918	SENT19	6	6	20	20	bevacizumab	PED	PA130232992	8682	0.493
NULL	Br_J_Cancer_2006_Feb_13_94(3)_407-426.nxml.txt.nlp	16434996	SENT216	2	2	5	5	genistein	BRCA1	PA165109660	672	0.493
NULL	Indian_J_Dermatol_2010_Apr-Jun_55(2)_161-170.nxml.txt.nlp	20606887	SENT51	1	1	12	12	ustekinumab	IL-23	PA166048654	51561	0.493
NULL	Oncotarget_2010_Jul_9_1(3)_185-197.nxml.txt.nlp	21037799	SENT100	5	5	27	27	choline	Hsp90	PA448976	3320	0.493
NULL	Indian_J_Ophthalmol_2014_Feb_62(2)_103-110.nxml.txt.nlp	24618482	SENT169	3	3	5	5	chlorpromazine	CPZ	PA448964	8532	0.493
NULL	Breast_Cancer_Res_2011_Jan_21_13(1)_R9.nxml.txt.nlp	21255398	SENT57	47	47	33	33	hydrocortisone	EGF	PA449905	1950	0.493
NULL	Clin_Endosc_2011_Sep_30_44(1)_22-26.nxml.txt.nlp	22741108	SENT5	11	11	8	8	propofol	ESD	PA451141	2098	0.493
NULL	Biosci_Rep_2012_Dec_20_33(1)_e00011.nxml.txt.nlp	23137297	SENT309	7	7	5	5	heparin	RPSA	PA449855	3921	0.493
NULL	Nat_Neurosci_2012_Sep_5_15(9)_1245-1254.nxml.txt.nlp	22864611	SENT168	14	14	21	21	clozapine	mGlu2	PA449061	2912	0.493
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_127043.nxml.txt.nlp	23227093	SENT228	9	9	5	5	lovastatin	RYR	PA450272	6261	0.493
NULL	Osteopath_Med_Prim_Care_2010_Aug_11_4_5.nxml.txt.nlp	20701768	SENT56	25	25	8	8	aspirin	ACE	PA448497	1636	0.493
NULL	Diabetes_Care_2011_Oct_15_34(10)_2323-2328.nxml.txt.nlp	21949223	SENT193	4	4	12	12	metformin	AMPK	PA450395	5563	0.493
NULL	Drug_Des_Devel_Ther_2014_Sep_23_8_1527-1538.nxml.txt.nlp	25284985	SENT95	21	21	19	19	celecoxib	IFN	PA448871	3439	0.493
NULL	J_Immunother_Cancer_2013_May_29_1_5.nxml.txt.nlp	24764535	SENT167	10	10	16	16	aldesleukin	GM-CSF	PA448081	1437	0.493
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT192	41	41	20	20	erlotinib	Yes	PA134687924	7525	0.493
NULL	Front_Mol_Neurosci_2011_May_17_4_6.nxml.txt.nlp	21629823	SENT521	0	0	17	17	hemin	NF-kappaB	PA449849	4790	0.493
NULL	Cardiovasc_Diabetol_2005_May_15_4_6.nxml.txt.nlp	15892894	SENT86	6	6	12	12	telmisartan	DBP	PA451605	3295;1628;2638	0.493
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT192	43	43	37	37	gefitinib	Yes	PA131301952	7525	0.493
NULL	Diabetes_Metab_J_2013_Aug_14_37(4)_240-248.nxml.txt.nlp	23991401	SENT121	5	5	22	22	ezetimibe	DPP4	PA10816	1803	0.493
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1150.nxml.txt.nlp	24675468	SENT93	20	20	43	43	ethanol	adiponectin	PA448073	9370	0.493
NULL	Onco_Targets_Ther_2014_Sep_24_7_1663-1687.nxml.txt.nlp	25285016	SENT242	19	19	35	35	bevacizumab	NRP2	PA130232992	8828;4753	0.493
NULL	J_Mol_Signal_2006_Nov_29_1_4.nxml.txt.nlp	17224080	SENT237	42	42	34	34	forskolin	EGF	PA146096022	1950	0.493
NULL	Arthritis_Res_Ther_2009_Feb_3_11(1)_R15.nxml.txt.nlp	19192274	SENT212	31	31	27	27	chloroquine	MIP-3	PA448948	6368	0.493
NULL	Nat_Med_2013_Aug_14_19(8)_1014-1022.nxml.txt.nlp	23852341	SENT239	22	22	34	34	tamoxifen	p53	PA451581	7157	0.493
NULL	Cancer_Cell_Int_2010_Sep_1_10_30.nxml.txt.nlp	20809984	SENT7	4	4	20	20	phenol	EGF	PA450913	1950	0.493
NULL	Oxid_Med_Cell_Longev_2013_Jun_11_2013_870472.nxml.txt.nlp	23840921	SENT58	35	35	4	4	chloroquine	SRM	PA448948	6723;6725	0.493
NULL	AIDS_Res_Ther_2008_Aug_15_5_19.nxml.txt.nlp	18702834	SENT40	10	10	12	12	maraviroc	RANTES	PA164768835	6352	0.493
NULL	Indian_J_Dermatol_2011_Jan-Feb_56(1)_87-91.nxml.txt.nlp	21572802	SENT63	13	13	2	2	doxorubicin	CHOP	PA449412	1649	0.493
NULL	Mol_Cancer_2010_Mar_25_9_68.nxml.txt.nlp	20338046	SENT178	24	24	6	6	doxorubicin	FOXC1	PA449412	2296	0.493
NULL	Cardiovasc_Res_2012_Mar_15_93(4)_674-681.nxml.txt.nlp	22166712	SENT42	3	3	28	28	buprenorphine	PPL	PA448685	5493	0.493
NULL	Front_Neurosci_2011_Jan_14_4_207.nxml.txt.nlp	21258618	SENT161	29	29	24	24	ethanol	AC7	PA448073	113	0.493
NULL	Asian_J_Androl_2015_Jul_29_Jan-Feb_17(1)_149-153.nxml.txt.nlp	25130586	SENT4	40	40	42	42	estradiol	AMH	PA449503	268	0.493
NULL	Mol_Syst_Biol_2010_Jul_27_6_391.nxml.txt.nlp	20664637	SENT4	16	16	20	20	sugar	NADK	PA451529	65220	0.493
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT46	10	10	14	14	pertuzumab	HER2		2064	0.493
NULL	Clinics_(Sao_Paulo)_2013_Oct_68(10)_1318-1324.nxml.txt.nlp	24212838	SENT184	8	8	20	20	bimatoprost	IL-6	PA164748867	3569	0.493
NULL	Cancer_Immunol_Immunother_2011_Jun_25_60(6)_793-808.nxml.txt.nlp	21350947	SENT220	43	43	25	25	sorafenib	IFN	PA7000	3439	0.493
NULL	Cancer_Cell_Int_2011_Mar_10_11_6.nxml.txt.nlp	21392380	SENT78	8	8	17	17	imipramine	HERG	PA449969	3757	0.493
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT182	5	5	9	9	ranibizumab	VEGF-A	PA164746012	7422	0.493
NULL	Int_J_Mol_Sci_2014_Jun_5_15(6)_10083-10100.nxml.txt.nlp	24905407	SENT60	7	7	9	9	tetracycline	TRB	PA451640	6957	0.493
NULL	Drug_Des_Devel_Ther_2014_Sep_9_8_1257-1267.nxml.txt.nlp	25246767	SENT173	5	5	29	29	haloperidol	NCX	PA449841	3196	0.493
NULL	Iran_Red_Crescent_Med_J_2014_Jan_5_16(1)_e8742.nxml.txt.nlp	24719717	SENT148	5	5	2	2	lipase	adiponectin	PA450239	9370	0.493
NULL	Environ_Health_Perspect_2010_Mar_23_118(3)_427-431.nxml.txt.nlp	20194071	SENT95	13	13	23	23	ethanol	IL-4	PA448073	3565	0.493
NULL	Oncotarget_2014_Oct_18_5(22)_11641-11652.nxml.txt.nlp	25361002	SENT243	14	14	41	41	l-glutamine	CO2	PA10090	4513	0.493
NULL	J_Hematol_Oncol_2012_May_15_5_23.nxml.txt.nlp	22587422	SENT32	22	22	27	27	dasatinib	ALL	PA162372878	613	0.493
NULL	Stroke_Res_Treat_2010_Dec_29_2010_427418.nxml.txt.nlp	21234304	SENT140	20	20	6	6	clopidogrel	ARCH	PA449053	339487	0.493
NULL	Exp_Ther_Med_2014_Mar_31_7(3)_553-559.nxml.txt.nlp	24520244	SENT156	23	23	26	26	azathioprine	CTX	PA448515	1593	0.493
NULL	J_Circadian_Rhythms_2013_Feb_1_11_2.nxml.txt.nlp	23369611	SENT46	32	32	25	25	paraformaldehyde	CT15	PA450790	2515	0.493
NULL	Mol_Vis_2007_Jan_24_13_57-65.nxml.txt.nlp	17277739	SENT222	26	26	28	28	heparin	FGF2	PA449855	2247;2258	0.493
NULL	Tanaffos_2012_11(1)_12-17.nxml.txt.nlp	25191395	SENT67	3	3	22	22	cisplatin	ALPI	PA449014	248	0.493
NULL	Oncoimmunology_2013_Jan_1_2(1)_e22890.nxml.txt.nlp	23483066	SENT127	2	2	7	7	vemurafenib	IFN	PA165946873	3439	0.493
NULL	Br_J_Cancer_2013_Aug_6_109(3)_686-693.nxml.txt.nlp	23839492	SENT142	5	5	19	19	sunitinib	IL-8	PA162372840	3576	0.493
NULL	Cell_Commun_Signal_2013_Oct_1_11_73.nxml.txt.nlp	24083678	SENT189	0	0	11	11	sulindac	A20	PA451565	7128;28935	0.493
NULL	Alzheimers_Res_Ther_2013_Oct_24_5(5)_50.nxml.txt.nlp	24401551	SENT27	2	2	10	10	donepezil	spatial	PA449394	219793	0.493
NULL	Open_Biochem_J_2009_Oct_13_3_55-65.nxml.txt.nlp	19911071	SENT241	13	13	11	11	l-arginine	CAT-2	PA448478	6542	0.493
NULL	Onco_Targets_Ther_2014_Jul_12_7_1273-1284.nxml.txt.nlp	25050069	SENT36	34	34	21	21	trabectedin	CYP2D6	PA165958349	1565	0.493
NULL	AIDS_Care_2011_Sep_14_23(9)_1154-1162.nxml.txt.nlp	21500025	SENT140	34	34	2	2	lamivudine	ATV	PA450163	4683	0.493
NULL	Int_J_Mol_Sci_2014_Nov_25_15(12)_21703-21722.nxml.txt.nlp	25429431	SENT985	36	36	27	27	curcumin	ABCC1	PA151958596	4363	0.493
NULL	Mol_Cell_Proteomics_2014_Dec_1_13(12)_3585-3601.nxml.txt.nlp	25277244	SENT603	18	18	20	20	estradiol	HSP27	PA449503	3315	0.493
NULL	Allergy_Asthma_Clin_Immunol_2011_Nov_10_7(Suppl_1)_S11.nxml.txt.nlp	22165913	SENT139	19	19	25	25	sulfisoxazole	TMP	PA164748964	2012	0.493
NULL	Br_J_Cancer_2010_Sep_7_103(6)_796-801.nxml.txt.nlp	20823888	SENT172	14	14	38	38	erlotinib	D29	PA134687924	55520	0.493
NULL	Gynecol_Oncol_Case_Rep_2013_Dec_28_8_4-6.nxml.txt.nlp	24567884	SENT17	19	19	17	17	irinotecan	NAC	PA450085	22861	0.493
NULL	J_Epilepsy_Res_2014_Jun_30_4(1)_7-13.nxml.txt.nlp	24977124	SENT55	2	2	21	21	pilocarpine	CA3	PA450962	761	0.493
NULL	Scientifica_(Cairo)_2013_Dec_26_2013_620504.nxml.txt.nlp	24459602	SENT24	0	0	25	25	calcidiol	CYP27B1	PA164745614	1594	0.493
NULL	Apoptosis_2012_Jun_9_17(6)_566-578.nxml.txt.nlp	22402981	SENT166	18	18	22	22	pp2	PP2		4888	0.493
NULL	Oncotarget_2013_Dec_18_5(3)_634-648.nxml.txt.nlp	24504138	SENT141	8	8	14	14	bortezomib	p65	PA10252	5970	0.493
NULL	Adv_Hematol_2012_Mar_25_2012_302570.nxml.txt.nlp	22536253	SENT89	18	18	26	26	fludarabine	Bcl-2	PA449655	596	0.493
NULL	Core_Evid_2009_Jun_15_4_113-129.nxml.txt.nlp	20694069	SENT385	18	18	12	12	medroxyprogesterone	LAS	PA450344	11019	0.493
NULL	Front_Neurol_2014_Apr_29_5_63.nxml.txt.nlp	24808888	SENT541	25	25	20	20	pilocarpine	ghrelin	PA450962	51738	0.493
NULL	Aging_(Albany_NY)_2009_Mar_31_1(4)_412-424.nxml.txt.nlp	20195491	SENT145	18	18	15	15	resveratrol	LGA		27165	0.493
NULL	Clinics_(Sao_Paulo)_2009_Apr_64(4)_295-302.nxml.txt.nlp	19488585	SENT207	47	47	41	41	trimethoprim	Gen	PA451788	348654	0.493
NULL	J_Hum_Genet_2013_Jun_2_58(6)_306-312.nxml.txt.nlp	23635953	SENT156	10	10	7	7	estradiol	CYP19A1	PA449503	1588	0.493
NULL	Iran_J_Pharm_Res_2015_Winter_14(1)_167-175.nxml.txt.nlp	25561923	SENT112	12	12	24	24	clonidine	Yes	PA449051	7525	0.493
NULL	Arch_Osteoporos_2013_Oct_11_8(1-2)_136.nxml.txt.nlp	24113837	SENT2910	24	24	18	18	risedronate	PTH	PA451255	5741	0.493
NULL	Adv_Ther_2014_Dec_2_31_1228-1246.nxml.txt.nlp	25447269	SENT82	23	23	15	15	timolol	TIM	PA451690	7984;8914	0.493
NULL	Eur_J_Cancer_2014_Sep_50(14)_2367-2374.nxml.txt.nlp	25027307	SENT126	9	9	5	5	estradiol	AMH	PA449503	268	0.493
NULL	Case_Rep_Oncol_2012_Apr_18_5(1)_181-186.nxml.txt.nlp	22666210	SENT77	25	25	27	27	lenalidomide	GM-CSF	PA162363968	1437	0.493
NULL	Mol_Vis_2010_Sep_2_16_1781-1790.nxml.txt.nlp	20824160	SENT293	4	4	12	12	acetylcysteine	p38	PA448033	10598;1432;7965	0.493
NULL	Oncol_Lett_2013_Dec_7_6(6)_1624-1630.nxml.txt.nlp	24260056	SENT212	25	25	0	0	fluorescein	DUSP6	PA164746009	1848	0.493
NULL	Br_J_Cancer_2012_Sep_25_107(7)_1059-1068.nxml.txt.nlp	22935581	SENT27	16	16	12	12	axitinib	IFN	PA164924493	3439	0.493
NULL	Diabetes_2013_Sep_15_62(9)_3019-3021.nxml.txt.nlp	23970522	SENT24	27	27	19	19	chymotrypsin	CTRB2	PA448994	440387	0.493
NULL	Indian_J_Anaesth_2013_Jul-Aug_57(4)_397-400.nxml.txt.nlp	24163457	SENT71	25	25	27	27	bupivacaine	SGB	PA135057240	2719	0.493
NULL	Pain_Res_Treat_2012_Apr_23_2012_295926.nxml.txt.nlp	22577544	SENT54	17	17	30	30	dexketoprofen	ARC	PA166049175	8996;23237	0.493
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_9_2013_358673.nxml.txt.nlp	23840254	SENT167	16	16	9	9	lipase	SREBP-1c	PA450239	6720	0.493
NULL	J_Biol_Chem_2013_Mar_22_288(12)_8279-8288.nxml.txt.nlp	23400816	SENT596	5	5	13	13	ezetimibe	PCSK9	PA10816	255738	0.493
NULL	Exp_Ther_Med_2013_Mar_21_5(3)_987-991.nxml.txt.nlp	23407636	SENT103	1	1	23	23	losartan	IL-8	PA450268	3576	0.493
NULL	J_Clin_Biochem_Nutr_2009_Jul_30_45(1)_14-19.nxml.txt.nlp	19590702	SENT35	34	34	26	26	l-glutamine	EGF	PA10090	1950	0.493
NULL	Biomed_Res_Int_2014_Jan_29_2014_361020.nxml.txt.nlp	24605326	SENT223	1	1	16	16	staurosporine	CDK1	PA165109623	983	0.493
NULL	Biomed_Res_Int_2013_Sep_5_2013_929531.nxml.txt.nlp	24083250	SENT114	2	2	6	6	hyaluronan	RHAMM	PA165958431	3161	0.493
NULL	Br_J_Cancer_2014_Jan_21_110(2)_304-312.nxml.txt.nlp	24300978	SENT194	3	3	0	0	gemcitabine	NT5C2	PA449748	22978	0.493
NULL	Mol_Vis_2011_Sep_27_17_2516-2526.nxml.txt.nlp	21976962	SENT301	21	21	14	14	diltiazem	GMP	PA449334	22978	0.493
NULL	Nat_Commun_2011_Dec_20_2_592.nxml.txt.nlp	22186888	SENT138	23	23	20	20	amisulpride	DRD2	PA162565877	1813	0.493
NULL	Biochim_Biophys_Acta_2014_Apr_1841(4)_588-594.nxml.txt.nlp	24440819	SENT325	5	5	14	14	lipase	TNF-alpha	PA450239	7124	0.493
NULL	Basic_Res_Cardiol_2015_Jan_20_110_4.nxml.txt.nlp	25600226	SENT293	10	10	14	14	ezetimibe	PCSK9	PA10816	255738	0.493
NULL	Front_Neurosci_2012_Feb_16_6_24.nxml.txt.nlp	22355282	SENT73	4	4	17	17	carbachol	ghrelin	PA448784	51738	0.493
NULL	AoB_Plants_2010_Jun_29_2010_plq010.nxml.txt.nlp	22476068	SENT107	23	23	21	21	nadh	mol	PA164755085	90527	0.493
NULL	Mol_Cancer_2009_Feb_25_8_10.nxml.txt.nlp	19243593	SENT93	24	24	8	8	paclitaxel	NEDD1	PA450761	121441	0.493
NULL	Oncoimmunology_2013_Jan_1_2(1)_e22890.nxml.txt.nlp	23483066	SENT119	5	5	10	10	vemurafenib	IFN	PA165946873	3439	0.493
NULL	Indian_J_Endocrinol_Metab_2013_Dec_17(Suppl_3)_S696-S699.nxml.txt.nlp	24910842	SENT30	27	27	24	24	metoclopramide	PRL	PA450475	5617	0.493
NULL	Arthritis_Res_Ther_2009_Aug_17_11(4)_R123.nxml.txt.nlp	19686595	SENT215	37	37	10	10	rituximab	CD38	PA451261	952	0.493
NULL	Acta_Pharmacol_Sin_2009_Oct_21_30(10)_1392-1398.nxml.txt.nlp	19767766	SENT120	6	6	12	12	atorvastatin	ROS	PA448500	6098	0.493
NULL	Ophthalmol_Eye_Dis_2011_Jul_25_3_21-24.nxml.txt.nlp	23861620	SENT66	15	15	24	24	timolol	BAK	PA451690	578	0.493
NULL	Int_J_Mol_Sci_2013_Aug_14_14(8)_16719-16731.nxml.txt.nlp	23949634	SENT111	4	4	6	6	thrombin	AQP4	PA451674	361	0.493
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT136	13	13	11	11	capsaicin	MDM2	PA448776	4193	0.493
NULL	Indian_Dermatol_Online_J_2014_Oct-Dec_5(4)_550-551.nxml.txt.nlp	25396166	SENT26	30	30	35	35	minocycline	CO2	PA450519	4513	0.493
NULL	Cancer_Cell_Int_2006_Aug_9_6_20.nxml.txt.nlp	16899133	SENT64	0	0	8	8	resveratrol	p27		5715;10534	0.493
NULL	Front_Genet_2013_Aug_29_4_163.nxml.txt.nlp	24009622	SENT84	12	12	14	14	ethanol	DDP	PA448073	1678	0.493
NULL	Gut_2012_Feb_4_61(2)_179-192.nxml.txt.nlp	22057051	SENT637	27	27	29	29	gemcitabine	GEM	PA449748	2669	0.493
NULL	Eur_J_Med_Res_2014_Apr_9_19(1)_19.nxml.txt.nlp	24717101	SENT80	33	33	11	11	rituximab	FDG	PA451261	23583	0.493
NULL	Nat_Commun_2011_Oct_18_2_504.nxml.txt.nlp	22009036	SENT99	14	14	20	20	nimodipine	ANOVA	PA450633	4858	0.493
NULL	J_Gen_Intern_Med_2009_May_21_24(5)_656-664.nxml.txt.nlp	19306050	SENT535	0	0	5	5	warfarin	CYP2C9	PA451906	1559	0.493
NULL	J_Asthma_Allergy_2010_Dec_30_4_1-12.nxml.txt.nlp	21701574	SENT283	7	7	14	14	omalizumab	San	PA164752253	80218	0.492
NULL	J_Med_Genet_2013_Sep_24_50(9)_567-578.nxml.txt.nlp	23709754	SENT156	9	9	11	11	staurosporine	STAT1	PA165109623	6772	0.492
NULL	Pharmaceuticals_(Basel)_2012_Aug_10_5(8)_802-836.nxml.txt.nlp	24280676	SENT775	1	1	13	13	methotrexate	gamma	PA450428	9913	0.492
NULL	Brain_Sci_2013_Jun_19_3(2)_964-991.nxml.txt.nlp	24961433	SENT1292	2	2	24	24	choline	POMC	PA448976	5443	0.492
NULL	J_Gynecol_Oncol_2014_Jan_8_25(1)_14-21.nxml.txt.nlp	24459576	SENT7	7	7	14	14	cisplatin	IB2	PA449014	23542	0.492
NULL	Mol_Biol_Cell_2014_Feb_1_25(3)_368-379.nxml.txt.nlp	24307679	SENT124	7	7	16	16	carbachol	INS-1	PA448784	2305	0.492
NULL	Indian_J_Psychiatry_2012_Oct-Dec_54(4)_304-319.nxml.txt.nlp	23372232	SENT410	3	3	22	22	olanzapine	DBT	PA450688	1629	0.492
NULL	Oncogene_2010_Sep_2_29(35)_4905-4913.nxml.txt.nlp	20581869	SENT253	6	6	8	8	carboplatin	CA125	PA448803	4077;94025	0.492
NULL	J_Hematol_Oncol_2013_Jul_9_6_49.nxml.txt.nlp	23837843	SENT212	5	5	7	7	verapamil	Rho	PA451868	29984	0.492
NULL	Exp_Neurobiol_2014_Jun_13_23(2)_148-154.nxml.txt.nlp	24963279	SENT28	6	6	8	8	thrombin	SOCS3	PA451674	9021	0.492
NULL	Cardiovasc_J_Afr_2009_May_20(3)_162-167.nxml.txt.nlp	19575078	SENT91	28	28	20	20	indomethacin	EDRF	PA449982	51327	0.492
NULL	Iran_J_Public_Health_2013_Feb_1_42(2)_129-133.nxml.txt.nlp	23515306	SENT23	2	2	10	10	artemisinin	ACT	PA165111696	12;11332;9457;641455	0.492
NULL	Br_J_Cancer_2011_Jun_7_104(12)_1848-1853.nxml.txt.nlp	21610704	SENT2	0	0	23	23	panitumumab	KRAS	PA162373091	3845	0.492
NULL	Biochimie_2010_Nov_92(11)_1546-1567.nxml.txt.nlp	20615447	SENT2419	14	14	10	10	trypsin	KLK7	PA451806	5650	0.492
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT378	22	22	16	16	pp2	TFF3		7033	0.492
NULL	Br_J_Cancer_2013_Apr_16_108(7)_1393-1401.nxml.txt.nlp	23511559	SENT177	8	8	33	33	bevacizumab	FLT3	PA130232992	2322	0.492
NULL	Atten_Defic_Hyperact_Disord_2013_Apr_6_5(3)_249-265.nxml.txt.nlp	23564273	SENT246	17	17	1	1	methylphenidate	Gen	PA450464	348654	0.492
NULL	Ann_Rehabil_Med_2012_Aug_27_36(4)_466-473.nxml.txt.nlp	22977771	SENT145	16	16	33	33	triamcinolone	TLF	PA451749	9519	0.492
NULL	Mol_Pain_2012_Sep_22_8_71.nxml.txt.nlp	22998838	SENT123	19	19	30	30	cisplatin	CXCR4	PA449014	7852	0.492
NULL	Am_J_Trop_Med_Hyg_2014_Aug_6_91(2)_424-434.nxml.txt.nlp	24799369	SENT308	5	5	10	10	zinc	ACT	PA451956	12;11332;9457;641455	0.492
NULL	Oxid_Med_Cell_Longev_2013_Jun_6_2013_891748.nxml.txt.nlp	23840922	SENT262	0	0	3	3	resveratrol	Bcl-2		596	0.492
NULL	F1000Res_2013_Mar_5_2_74.nxml.txt.nlp	24358880	SENT265	5	5	2	2	benzaldehyde	TRPA1	PA448571	8989	0.492
NULL	Crit_Care_2008_Apr_10_12(2)_132.nxml.txt.nlp	18423065	SENT1	8	8	10	10	vasopressin	AVP	PA451858	114548;551	0.492
NULL	J_Med_Case_Reports_2011_Jan_12_5_5.nxml.txt.nlp	21226894	SENT65	19	19	9	9	vincristine	CHOP	PA451879	1649	0.492
NULL	Curr_Neuropharmacol_2013_Dec_11(6)_652-663.nxml.txt.nlp	24396340	SENT253	24	24	26	26	capsaicin	TRPV1	PA448776	7442	0.492
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_16_2014_926087.nxml.txt.nlp	25478000	SENT227	2	2	10	10	ezetimibe	PCSK9	PA10816	255738	0.492
NULL	Breast_Cancer_Res_2010_Oct_28_12(5)_212.nxml.txt.nlp	21067532	SENT109	15	15	29	29	doxorubicin	ACT	PA449412	12;11332;9457;641455	0.492
NULL	Diabetes_2011_Mar_21_60(3)_936-946.nxml.txt.nlp	21289205	SENT324	6	6	20	20	pioglitazone	adiponectin	PA450970	9370	0.492
NULL	Diabetes_2011_Nov_17_60(11)_2928-2938.nxml.txt.nlp	21885868	SENT312	7	7	12	12	curcumin	IL-6	PA151958596	3569	0.492
NULL	Core_Evid_2010_Jul_27_5_11-22.nxml.txt.nlp	20694136	SENT194	6	6	9	9	ustekinumab	ACR	PA166048654	49	0.492
NULL	Drugs_Context_2012_Nov_19_2012_212242.nxml.txt.nlp	24432031	SENT87	20	20	10	10	temozolomide	IFN	PA451609	3439	0.492
NULL	Biomed_Res_Int_2014_Jan_29_2014_361020.nxml.txt.nlp	24605326	SENT223	1	1	24	24	staurosporine	CDK5	PA165109623	1020	0.492
NULL	Nature_2012_Jan_25_482(7384)_232-236.nxml.txt.nlp	22278056	SENT144	16	16	21	21	tetracycline	AP-1	PA451640	2353;3727;2354;3725	0.492
NULL	Ann_Oncol_2013_Apr_14_24(4)_878-888.nxml.txt.nlp	23152360	SENT119	17	17	36	36	paclitaxel	S12	PA450761	3351;6206;5713;6268	0.492
NULL	J_Ophthalmic_Inflamm_Infect_2013_Feb_11_3_34.nxml.txt.nlp	23514634	SENT83	5	5	13	13	fluorescein	RPE	PA164746009	6120	0.492
NULL	ScientificWorldJournal_2013_Oct_24_2013_726912.nxml.txt.nlp	24282387	SENT78	12	12	23	23	fluorescein	AVP	PA164746009	114548;551	0.492
NULL	Clin_Med_Insights_Arthritis_Musculoskelet_Disord_2012_Mar_5_5_27-42.nxml.txt.nlp	22438671	SENT286	4	4	33	33	methotrexate	ACR	PA450428	49	0.492
NULL	Iranian_J_Environ_Health_Sci_Eng_2012_Dec_10_9(1)_19.nxml.txt.nlp	23369431	SENT106	2	2	0	0	amoxicillin	ANOVA	PA448406	4858	0.492
NULL	J_Biol_Chem_2009_Sep_25_284(39)_26447-26455.nxml.txt.nlp	19633293	SENT17	0	0	6	6	hyaluronan	HAS1	PA165958431	3036	0.492
NULL	Eur_J_Clin_Pharmacol_2013_Mar_11_69(3)_327-339.nxml.txt.nlp	22782539	SENT270	20	20	3	3	dabigatran	P-gp		5243	0.492
NULL	Breast_Cancer_(Auckl)_2009_Sep_2_3_61-75.nxml.txt.nlp	19809577	SENT272	0	0	7	7	curcumin	survivin	PA151958596	332	0.492
NULL	Eur_J_Appl_Physiol_2011_Feb_24_111(2)_275-283.nxml.txt.nlp	20865425	SENT110	26	26	9	9	glucose	MRS	PA449773	8011	0.492
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Dec_2_5_30.nxml.txt.nlp	17140452	SENT194	7	7	29	29	gatifloxacin	CHL	PA449738	91851	0.492
NULL	Clinics_(Sao_Paulo)_2013_Oct_68(10)_1325-1332.nxml.txt.nlp	24212839	SENT45	40	40	26	26	ribavirin	SOCS3	PA451241	9021	0.492
NULL	Clin_Cosmet_Investig_Dermatol_2014_May_21_7_145-163.nxml.txt.nlp	24899818	SENT191	31	31	36	36	bleomycin	CO2	PA448645	4513	0.492
NULL	J_Cell_Biol_1997_Jun_16_137(6)_1229-1241.nxml.txt.nlp	9182658	SENT89	12	12	20	20	glucosamine	MUC1	PA164747613	4582	0.492
NULL	J_Biol_2008_Jul_31_7(6)_20.nxml.txt.nlp	18710588	SENT25	30	30	36	36	hydroxocobalamin	B12	PA164768689	7126;4709	0.492
NULL	Int_J_Environ_Res_Public_Health_2011_Feb_15_8(2)_480-497.nxml.txt.nlp	21556198	SENT410	16	16	34	34	tetracycline	DOM	PA451640	6663	0.492
NULL	Pharmaceutics_2011_Apr_14_3(2)_171-185.nxml.txt.nlp	24310494	SENT687	13	13	7	7	tositumomab	CHOP	PA164748364	1649	0.492
NULL	Mol_Pain_2013_Jan_2_9_1.nxml.txt.nlp	23279936	SENT66	19	19	7	7	capsaicin	TRPV1	PA448776	7442	0.492
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT143	6	6	13	13	perifosine	DR4	PA165291471	8797	0.492
NULL	J_Biomed_Sci_2014_Feb_3_21(1)_10.nxml.txt.nlp	24490900	SENT91	19	19	24	24	alendronate	M-CSF	PA448082	1435	0.492
NULL	Adv_Ther_2013_Nov_30_30(12)_1086-1099.nxml.txt.nlp	24293132	SENT105	1	1	3	3	amlodipine	CSBP	PA448388	3190	0.492
NULL	J_Cell_Biol_2001_Mar_19_152(6)_1169-1182.nxml.txt.nlp	11257118	SENT45	32	32	28	28	hydrocortisone	EGF	PA449905	1950	0.492
NULL	Hum_Genomics_2003_Nov_1_1(1)_41-51.nxml.txt.nlp	15601532	SENT25	24	24	20	20	neomycin	Yes	PA450608	7525	0.492
NULL	Int_J_Gen_Med_2012_Oct_25_5_849-859.nxml.txt.nlp	23204853	SENT178	40	40	5	5	hyaluronan	TLR6	PA165958431	10333	0.492
NULL	Chin_J_Cancer_2012_Feb_31(2)_51-57.nxml.txt.nlp	22257384	SENT67	0	0	19	19	verapamil	MRP1	PA451868	4437	0.492
NULL	J_Gen_Physiol_1947_Jul_20_30(6)_479-491.nxml.txt.nlp	19873514	SENT0	20	20	1	1	ethanol	Gen	PA448073	348654	0.492
NULL	Case_Rep_Ophthalmol_2010_Aug_18_1(1)_36-41.nxml.txt.nlp	21369348	SENT35	21	21	8	8	bevacizumab	PED	PA130232992	8682	0.492
NULL	Oncotarget_2011_Jan_25_2(1-2)_8-17.nxml.txt.nlp	21378407	SENT32	25	25	10	10	trypsin	PAR-1	PA451806	2011;2149	0.492
NULL	Clin_Ophthalmol_2012_Sep_5_6_1433-1440.nxml.txt.nlp	23055659	SENT153	39	39	12	12	timolol	BAK	PA451690	578	0.492
NULL	Acta_Neuropathol_2011_Jun_22_121(6)_775-783.nxml.txt.nlp	21424749	SENT177	7	7	10	10	creatine	RRF	PA164778930	92399	0.492
NULL	Int_J_Anal_Chem_2012_Feb_8_2012_546282.nxml.txt.nlp	22505920	SENT219	3	3	14	14	terazosin	PF6	PA451612	200162	0.492
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT262	23	23	19	19	methotrexate	PMS2	PA450428	5395	0.492
NULL	Br_J_Cancer_2010_Jun_8_102(12)_1707-1716.nxml.txt.nlp	20461078	SENT192	0	0	5	5	bortezomib	TRAIL	PA10252	8743	0.492
NULL	Hum_Genomics_2009_Jan_1_3(2)_157-168.nxml.txt.nlp	19164092	SENT16	2	2	4	4	lipase	HSL	PA450239	3991	0.492
NULL	Indian_J_Med_Res_2012_Apr_135(4)_500-505.nxml.txt.nlp	22664497	SENT7	17	17	1	1	estradiol	adiponectin	PA449503	9370	0.492
NULL	Biologics_2012_Dec_17_6_429-464.nxml.txt.nlp	23269860	SENT184	11	11	13	13	etanercept	ACR	PA449515	49	0.492
NULL	Ecancermedicalscience_2011_Apr_28_5_211.nxml.txt.nlp	22276054	SENT114	31	31	38	38	lorazepam	NK-1	PA450267	27087	0.492
NULL	Clin_Ophthalmol_2010_Nov_23_4_1355-1359.nxml.txt.nlp	21179218	SENT37	9	9	6	6	latanoprost	BAK	PA164774763	578	0.492
NULL	Breast_Cancer_Res_2002_May_15_4(4)_133-136.nxml.txt.nlp	12100736	SENT14	9	9	7	7	tamoxifen	DES	PA451581	1674	0.492
NULL	Int_Semin_Surg_Oncol_2007_Feb_14_4_5.nxml.txt.nlp	17394628	SENT15	35	35	30	30	cyclophosphamide	NACT	PA449165	284111	0.492
NULL	J_Antimicrob_Chemother_2014_Mar_29_69(3)_643-650.nxml.txt.nlp	24169580	SENT114	44	44	34	34	chlorpromazine	CPZ	PA448964	8532	0.492
NULL	Endocrinol_Diabetes_Metab_Case_Rep_2013_Sep_16_2013_130038.nxml.txt.nlp	24616770	SENT60	32	32	28	28	levothyroxine	ACTH	PA450221	5443	0.492
NULL	Arch_Drug_Inf_2008_Dec_1(3)_97-106.nxml.txt.nlp	19639031	SENT25	12	12	28	28	sn-38	UGT		7361;7355	0.492
NULL	Cardiovasc_Ther_2012_Jun_19_30(3)_e146-e155.nxml.txt.nlp	21167014	SENT68	26	26	11	11	exenatide	GLP-1	PA164749238	100125288	0.492
NULL	N_Am_J_Med_Sci_2010_May_2(5)_241-245.nxml.txt.nlp	22574297	SENT42	5	5	0	0	paraformaldehyde	PLP	PA450790	25824;5744	0.492
NULL	Acta_Pharmacol_Sin_2010_Nov_18_31(11)_1438-1446.nxml.txt.nlp	20953210	SENT41	0	0	7	7	forskolin	BIM	PA146096022	10018	0.492
NULL	J_Cell_Mol_Med_2014_Aug_9_18(8)_1549-1561.nxml.txt.nlp	24913911	SENT57	10	10	16	16	collagenase	C-1	PA449107	5203	0.492
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Aug_12_65(Pt_9)_o2129.nxml.txt.nlp	21577541	SENT3	18	18	37	37	benzaldehyde	mol	PA448571	90527	0.492
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Dec_2_5_30.nxml.txt.nlp	17140452	SENT187	7	7	5	5	gatifloxacin	GAT	PA449738	10249	0.492
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_May_31_68(Pt_6)_o1974.nxml.txt.nlp	22719719	SENT3	9	9	3	3	piperazine	mol	PA450977	90527	0.492
NULL	Front_Cell_Neurosci_2015_Jan_15_8_467.nxml.txt.nlp	25642170	SENT132	6	6	9	9	capsaicin	TRPV1	PA448776	7442	0.492
NULL	HSR_Proc_Intensive_Care_Cardiovasc_Anesth_2009_1(3)_54-59.nxml.txt.nlp	23439887	SENT21	1	1	17	17	fenoldopam	DA1	PA164784034	28495;7169	0.492
NULL	Drugs_R_D_2011_Jun_27_11(2)_113-126.nxml.txt.nlp	21679004	SENT94	0	0	25	25	axitinib	CYP1A2	PA164924493	1544	0.492
NULL	Open_AIDS_J_2014_Dec_29_8_66-78.nxml.txt.nlp	25624956	SENT412	10	10	20	20	hydroxychloroquine	IL-6	PA164777036	3569	0.492
NULL	Pharmaceuticals_(Basel)_2012_Mar_21_5(3)_325-338.nxml.txt.nlp	24281382	SENT10	16	16	12	12	timolol	CRA	PA451690	51747;10903	0.492
NULL	J_Hematol_Oncol_2009_Apr_22_2_18.nxml.txt.nlp	19386128	SENT68	22	22	27	27	cetuximab	CTX	PA10040	1593	0.492
NULL	Breast_Cancer_Res_2003_Feb_5_5(2)_113-116.nxml.txt.nlp	12631392	SENT100	4	4	33	33	anastrozole	ATAC	PA448432	6375	0.492
NULL	Arthritis_Res_Ther_2010_Apr_29_12(2)_R73.nxml.txt.nlp	20429888	SENT119	5	5	19	19	bortezomib	COL1A1	PA10252	1277	0.492
NULL	Cardiovasc_Ultrasound_2008_Jun_20_6_31.nxml.txt.nlp	18570640	SENT101	16	16	26	26	dobutamine	spatial	PA449381	219793	0.492
NULL	Cell_Death_Differ_2010_Apr_16_17(4)_666-676.nxml.txt.nlp	19834494	SENT251	27	27	4	4	melphalan	RAGE	PA450354	177	0.492
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Nov_7_68(Pt_12)_o3296.nxml.txt.nlp	23468805	SENT4	7	7	3	3	phenol	mol	PA450913	90527	0.492
NULL	Indian_J_Pharmacol_2014_Nov-Dec_46(6)_627-632.nxml.txt.nlp	25538335	SENT147	8	8	6	6	metformin	Q10	PA450395	27161	0.492
NULL	Br_J_Clin_Pharmacol_2014_Nov_20_78(5)_981-995.nxml.txt.nlp	24802902	SENT403	37	37	3	3	vigabatrin	gamma	PA10231	9913	0.492
NULL	Cancers_(Basel)_2013_Jun_24_5(3)_762-785.nxml.txt.nlp	24202320	SENT222	41	41	27	27	levamisole	MAPK2	PA450205	5594	0.492
NULL	Environ_Health_Perspect_2008_Mar_26_116(3)_322-328.nxml.txt.nlp	18335098	SENT108	6	6	17	17	estradiol	PMI	PA449503	8834;5373	0.492
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Feb_24_68(Pt_3)_o807-o808.nxml.txt.nlp	22412674	SENT80	17	17	13	13	guanidine	mol	PA164781028	90527	0.492
NULL	Pharmaceuticals_(Basel)_2012_Feb_2_5(2)_114-132.nxml.txt.nlp	24288084	SENT145	23	23	10	10	capsaicin	TRPV1	PA448776	7442	0.492
NULL	Hum_Genomics_2003_Nov_1_1(1)_41-51.nxml.txt.nlp	15601532	SENT25	24	24	12	12	neomycin	Yes	PA450608	7525	0.492
NULL	Mol_Cancer_2012_Jun_18_11_41.nxml.txt.nlp	22709873	SENT15	4	4	7	7	lapatinib	RB1CC1	PA152241907	9821	0.492
NULL	Int_J_Vasc_Med_2012_Jul_24_2012_508416.nxml.txt.nlp	22888436	SENT163	38	38	43	43	farglitazar	PRIC285		85441	0.492
NULL	Clin_Ophthalmol_2014_Jan_13_8_219-228.nxml.txt.nlp	24531757	SENT141	8	8	4	4	brinzolamide	TIM	PA164744929	7984;8914	0.492
NULL	Nat_Commun_2014_Nov_19_5_5479.nxml.txt.nlp	25407222	SENT125	11	11	16	16	dextran	YTS	PA449261	8565	0.492
NULL	Front_Endocrinol_(Lausanne)_2014_Sep_9_5_145.nxml.txt.nlp	25250015	SENT430	21	21	12	12	glucosamine	p53	PA164747613	7157	0.492
NULL	J_Oncol_2012_Dec_7_2012_192464.nxml.txt.nlp	22187555	SENT515	27	27	11	11	resveratrol	PC-3		692094	0.492
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Oct_31_66(Pt_11)_o3000.nxml.txt.nlp	21589161	SENT52	26	26	20	20	ethanol	mol	PA448073	90527	0.492
NULL	Front_Neurosci_2012_May_30_6_77.nxml.txt.nlp	22661925	SENT149	3	3	6	6	ethanol	HEC	PA448073	10403	0.492
NULL	BMB_Rep_2013_Aug_46(8)_410-415.nxml.txt.nlp	23977989	SENT201	1	1	11	11	curcumin	TNF-alpha	PA151958596	7124	0.492
NULL	Acta_Pharmacol_Sin_2009_Oct_5_30(10)_1428-1435.nxml.txt.nlp	19801997	SENT145	17	17	29	29	artemisinin	JNK	PA165111696	5599	0.492
NULL	Int_J_Mol_Sci_2014_Sep_29_15(10)_17411-17441.nxml.txt.nlp	25268615	SENT275	3	3	10	10	minocycline	CD147	PA450519	682	0.492
NULL	GMS_Curr_Top_Otorhinolaryngol_Head_Neck_Surg_2004_Dec_28_3_Doc04.nxml.txt.nlp	22073046	SENT324	16	16	20	20	methylprednisolone	C17	PA450466	54360	0.492
NULL	Oncoimmunology_2012_Mar_1_1(2)_179-188.nxml.txt.nlp	22720239	SENT39	3	3	11	11	cyclophosphamide	GM-CSF	PA449165	1437	0.492
NULL	Int_J_Mol_Sci_2010_May_5_11(5)_2056-2066.nxml.txt.nlp	20559501	SENT2	10	10	29	29	glibenclamide	STZ	PA449782	6484	0.491
NULL	Genome_Biol_2003_Jan_6_4(1)_R5.nxml.txt.nlp	12540297	SENT211	37	37	35	35	creatine	SCG10	PA164778930	11075	0.491
NULL	Anesth_Essays_Res_2013_Sep-Dec_7(3)_302-306.nxml.txt.nlp	NULL	SENT4	43	43	33	33	rocuronium	NMB	PA164754992	10457;4828	0.491
NULL	Mol_Cancer_2013_Oct_8_12_119.nxml.txt.nlp	24103454	SENT177	12	12	10	10	irinotecan	TOP1	PA450085	7150	0.491
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Oct_3_65(Pt_11)_o2641-o2642.nxml.txt.nlp	21578256	SENT76	24	24	18	18	ethanol	mol	PA448073	90527	0.491
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Apr_15_9_13.nxml.txt.nlp	20398300	SENT97	21	21	7	7	lansoprazole	LAM	PA450180	7249;7248	0.491
NULL	Adv_Ther_2014_Dec_2_31_1228-1246.nxml.txt.nlp	25447269	SENT119	31	31	28	28	timolol	TIM	PA451690	7984;8914	0.491
NULL	Ann_Clin_Microbiol_Antimicrob_2011_Jul_21_10_30.nxml.txt.nlp	21774834	SENT37	3	3	13	13	diclofenac	IFN	PA449293	3439	0.491
NULL	Biologics_2009_Sep_15_3_377-383.nxml.txt.nlp	19774205	SENT216	9	9	18	18	amantadine	Yes	PA448360	7525	0.491
NULL	Front_Oncol_2014_Jun_3_4_132.nxml.txt.nlp	24918087	SENT393	33	33	23	23	glucosamine	p53	PA164747613	7157	0.491
NULL	Diabetes_2013_May_16_62(5)_1537-1546.nxml.txt.nlp	23321073	SENT91	22	22	15	15	fluorescein	CD11c	PA164746009	3687	0.491
NULL	Nat_Commun_2013_Oct_1_4_2516.nxml.txt.nlp	24084631	SENT68	7	7	9	9	hyaluronan	AK4	PA165958431	205	0.491
NULL	Front_Neurosci_2011_May_13_5_69.nxml.txt.nlp	21625610	SENT392	28	28	23	23	pentobarbital	GIRK3	PA450859	3765	0.491
NULL	Drugs_(Abingdon_Engl)_2014_Dec_19_21(6)_470-475.nxml.txt.nlp	25552821	SENT129	15	15	6	6	diazepam	OST	PA449283	1650;23263	0.491
NULL	J_Gen_Physiol_2009_Apr_133(4)_421-438.nxml.txt.nlp	19289574	SENT312	1	1	19	19	forskolin	SLC26A9	PA146096022	115019	0.491
NULL	Acta_Pharmacol_Sin_2011_Oct_15_32(10)_1233-1238.nxml.txt.nlp	21841815	SENT85	25	25	11	11	mecamylamine	CTX	PA450334	1593	0.491
NULL	Br_J_Cancer_2010_Jun_29_103(1)_61-72.nxml.txt.nlp	20588279	SENT257	25	25	13	13	trastuzumab	PTEN	PA451743	5728	0.491
NULL	J_Invest_Dermatol_2014_Apr_19_134(4)_965-974.nxml.txt.nlp	24352044	SENT33	28	28	32	32	hyaluronan	LYVE-1	PA165958431	10894	0.491
NULL	Diabetes_2008_Sep_57(9)_2321-2331.nxml.txt.nlp	18599527	SENT58	25	25	17	17	lipase	aP2	PA450239	2167	0.491
NULL	J_Immunol_Res_2014_Feb_3_2014_671431.nxml.txt.nlp	24741615	SENT241	16	16	39	39	paraformaldehyde	CD27	PA450790	939	0.491
NULL	J_Korean_Med_Sci_2009_Jan_29_24(Suppl_1)_S170-S175.nxml.txt.nlp	19194548	SENT92	17	17	25	25	cisplatin	EPO	PA449014	7076;8288;2056	0.491
NULL	Neural_Plast_2007_Oct_10_2007_23250.nxml.txt.nlp	NULL	SENT3481	4	4	36	36	choline	VGLUT2	PA448976	57084	0.491
NULL	Mol_Cells_2014_Jun_30_37(6)_497-502.nxml.txt.nlp	24938227	SENT38	26	26	19	19	collagenase	CTK	PA449107	4145	0.491
NULL	Br_J_Cancer_2013_Apr_16_108(7)_1393-1401.nxml.txt.nlp	23511559	SENT177	14	14	33	33	erlotinib	FLT3	PA134687924	2322	0.491
NULL	Mol_Biol_Cell_2012_May_15_23(10)_1812-1825.nxml.txt.nlp	22438585	SENT400	18	18	37	37	amiloride	EGF	PA448368	1950	0.491
NULL	Curr_Neuropharmacol_2014_Jul_12(4)_365-379.nxml.txt.nlp	25342944	SENT534	28	28	5	5	paroxetine	5-HT2B	PA450801	3357	0.491
NULL	Eur_J_Clin_Pharmacol_2014_Oct_8_70(1)_37-45.nxml.txt.nlp	24100471	SENT54	12	12	22	22	midazolam	CYP2C19	PA450496	1557	0.491
NULL	Mediators_Inflamm_2010_Jun_21_2010_592760.nxml.txt.nlp	20652060	SENT165	24	24	7	7	sitagliptin	HIP	PA164748978	6767;6159;64399;5068	0.491
NULL	Breast_Cancer_Res_2011_Jun_29_13(3)_R70.nxml.txt.nlp	21707964	SENT174	4	4	2	2	tamoxifen	14-3-3	PA451581	10971	0.491
NULL	AAPS_J_2011_Oct_25_13(4)_665-673.nxml.txt.nlp	22028249	SENT247	4	4	14	14	midazolam	CYP3A	PA450496	1574	0.491
NULL	J_Gen_Physiol_2012_Nov_140(5)_541-555.nxml.txt.nlp	23109716	SENT314	23	23	20	20	capsaicin	TRPV1	PA448776	7442	0.491
NULL	Oncol_Lett_2014_Mar_16_7(3)_827-833.nxml.txt.nlp	24527090	SENT85	5	5	2	2	cisplatin	IFN	PA449014	3439	0.491
NULL	J_Orthop_Traumatol_2011_Jun_4_12(2)_77-80.nxml.txt.nlp	21541772	SENT63	18	18	24	24	urea	CRP	PA451831	1401;140913	0.491
NULL	Apoptosis_2012_Sep_30_17(9)_989-997.nxml.txt.nlp	22460505	SENT221	5	5	14	14	thioridazine	PI3K	PA451666	5290	0.491
NULL	Ann_Rheum_Dis_2011_Jun_27_70(9)_1631-1640.nxml.txt.nlp	21708910	SENT220	33	33	10	10	methotrexate	ACR	PA450428	49	0.491
NULL	Target_Oncol_2013_Jun_27_8(2)_127-136.nxml.txt.nlp	23625191	SENT100	41	41	16	16	panitumumab	KRAS	PA162373091	3845	0.491
NULL	Indian_J_Med_Paediatr_Oncol_2013_Oct-Dec_34(4)_317-319.nxml.txt.nlp	24604965	SENT65	0	0	7	7	cyclophosphamide	CHOP	PA449165	1649	0.491
NULL	J_Cell_Biol_1997_Jul_28_138(2)_423-434.nxml.txt.nlp	9230083	SENT276	25	25	22	22	hyaluronan	CD44	PA165958431	960	0.491
NULL	Aging_(Albany_NY)_2014_Aug_7_6(8)_645-660.nxml.txt.nlp	25133314	SENT291	23	23	7	7	ethanol	CO2	PA448073	4513	0.491
NULL	Cancer_Manag_Res_2011_May_9_3_117-141.nxml.txt.nlp	21625397	SENT522	0	0	3	3	vorinostat	CDK2	PA164748224	1017	0.491
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT250	14	14	6	6	vinorelbine	ASC	PA451881	29108	0.491
NULL	Breast_Cancer_Res_Treat_2012_Apr_3_132(3)_895-915.nxml.txt.nlp	22048814	SENT354	10	10	29	29	tamoxifen	IMPACT	PA451581	55364	0.491
NULL	Allergy_Asthma_Immunol_Res_2014_Nov_19_6(6)_548-557.nxml.txt.nlp	25374755	SENT88	6	6	30	30	lovastatin	IL-13	PA450272	3596	0.491
NULL	CNS_Neurosci_Ther_2014_Mar_5_20(3)_202-208.nxml.txt.nlp	24495505	SENT120	24	24	14	14	acetazolamide	CO2	PA448018	4513	0.491
NULL	Breast_Cancer_Res_2008_Dec_16_10(6)_R105.nxml.txt.nlp	19087274	SENT193	3	3	13	13	fulvestrant	SNAI2	PA164747170	6591	0.491
NULL	Ital_J_Pediatr_2010_Feb_6_36_14.nxml.txt.nlp	20181110	SENT78	2	2	0	0	lorazepam	LOR	PA450267	4014	0.491
NULL	Clin_Med_Insights_Oncol_2011_Mar_16_5_35-43.nxml.txt.nlp	21499557	SENT255	7	7	18	18	trabectedin	MRCL	PA165958349	348174	0.491
NULL	Gut_2011_Jun_7_60(6)_837-845.nxml.txt.nlp	21139063	SENT164	20	20	18	18	ribavirin	IFN	PA451241	3439	0.491
NULL	Cancers_(Basel)_2012_Apr_5_4(2)_354-378.nxml.txt.nlp	24213315	SENT156	7	7	5	5	etoposide	TRAIL	PA449552	8743	0.491
NULL	Acta_Neuropathol_Commun_2014_Oct_21_2(1)_149.nxml.txt.nlp	NULL	SENT331	2	2	4	4	riluzole	gamma	PA451251	9913	0.491
NULL	Indian_J_Dermatol_2012_Sep-Oct_57(5)_362-365.nxml.txt.nlp	23112355	SENT36	37	37	10	10	gabapentin	ANOVA	PA449720	4858	0.491
NULL	Neural_Develop_2007_Dec_3_2_26.nxml.txt.nlp	18053187	SENT82	3	3	5	5	tamoxifen	E12	PA451581	64100	0.491
NULL	Mol_Cancer_2007_Aug_21_6_53.nxml.txt.nlp	17711579	SENT262	7	7	14	14	cisplatin	SPAM1	PA449014	6677	0.491
NULL	Front_Genet_2014_Oct_31_5_379.nxml.txt.nlp	25400658	SENT321	8	8	3	3	estradiol	H19	PA449503	283120	0.491
NULL	Arthritis_Res_Ther_2008_Jun_25_10(3)_R71.nxml.txt.nlp	18578867	SENT38	13	13	16	16	urokinase	IL-6	PA451836	3569	0.491
NULL	Exp_Diabetes_Res_2012_Mar_4_2012_653678.nxml.txt.nlp	22474428	SENT115	12	12	17	17	repaglinide	LPO	PA451234	4025	0.491
NULL	J_Pain_Res_2014_Jul_11_7_415-423.nxml.txt.nlp	25050075	SENT30	10	10	39	39	l-glutamine	CO2	PA10090	4513	0.491
NULL	Front_Cell_Neurosci_2014_Feb_5_8_6.nxml.txt.nlp	24550775	SENT1008	7	7	3	3	capsaicin	TRPV1	PA448776	7442	0.491
NULL	Acta_Pharmacol_Sin_2010_Aug_19_31(8)_963-969.nxml.txt.nlp	20644547	SENT93	0	0	8	8	fenofibrate	PDX-1	PA449594	3651	0.491
NULL	G3_(Bethesda)_2014_Nov_6_5(1)_21-33.nxml.txt.nlp	25380729	SENT71	12	12	2	2	galactose	GAL7	PA449725	3963;653499	0.491
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT122	13	13	22	22	l-glutamine	CO2	PA10090	4513	0.491
NULL	Oncotarget_2013_Apr_23_4(6)_816-829.nxml.txt.nlp	23615731	SENT119	15	15	13	13	doxycycline	HSF1	PA449415	3297	0.491
NULL	Diabetes_2011_Nov_17_60(11)_2928-2938.nxml.txt.nlp	21885868	SENT312	7	7	28	28	curcumin	TNF-alpha	PA151958596	7124	0.491
NULL	Eur_J_Nutr_2013_Oct_23_52(5)_1483-1492.nxml.txt.nlp	23090135	SENT60	20	20	15	15	hydrocortisone	EGF	PA449905	1950	0.491
NULL	Mol_Syst_Biol_2011_Apr_26_7_486.nxml.txt.nlp	21525872	SENT501	7	7	29	29	simvastatin	COX1	PA451363	4512;5742	0.491
NULL	J_Clin_Biochem_Nutr_2009_Jan_27_44(1)_28-40.nxml.txt.nlp	19177185	SENT106	22	22	28	28	dobutamine	HO-1	PA449381	3162	0.491
NULL	Front_Cell_Neurosci_2013_Dec_5_7_243.nxml.txt.nlp	24367290	SENT122	10	10	6	6	resveratrol	SOD1		6647	0.491
NULL	Crit_Care_2005_Sep_9_9(2)_212-222.nxml.txt.nlp	15774080	SENT326	5	5	21	21	vasopressin	ACTH	PA451858	5443	0.491
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT236	30	30	27	27	olanzapine	PRL	PA450688	5617	0.491
NULL	Free_Radic_Biol_Med_2014_Mar_68(100)_87-100.nxml.txt.nlp	24333634	SENT90	4	4	0	0	calcein	LIP	PA132595336	23049	0.491
NULL	Exp_Diabetes_Res_2012_Nov_1_2012_972679.nxml.txt.nlp	22110483	SENT74	0	0	23	23	resveratrol	AP-1		2353;3727;2354;3725	0.491
NULL	Pak_J_Med_Sci_2014_Jul-Aug_30(4)_814-818.nxml.txt.nlp	25097523	SENT64	6	6	0	0	cefuroxime	CTX	PA448868	1593	0.491
NULL	Arthritis_Res_Ther_2009_Mar_30_11(2)_R49.nxml.txt.nlp	19327174	SENT25	42	42	28	28	valdecoxib	COX	PA10226	1351	0.491
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT219	0	0	3	3	capsaicin	p53	PA448776	7157	0.491
NULL	J_Biomed_Biotechnol_2002_2(1)_14-21.nxml.txt.nlp	12488595	SENT157	8	8	10	10	lipase	HSL	PA450239	3991	0.491
NULL	BMJ_2014_Apr_15_348_g2366.nxml.txt.nlp	24736555	SENT465	26	26	23	23	liraglutide	GLP-1	PA165958364	100125288	0.491
NULL	Nat_Med_2013_Mar_10_19(3)_313-321.nxml.txt.nlp	23396211	SENT50	0	0	31	31	amlexanox	IRF3	PA164745310	3661	0.491
NULL	Arch_Plast_Surg_2014_Nov_3_41(6)_620-629.nxml.txt.nlp	25396172	SENT117	9	9	15	15	triamcinolone	IFN	PA451749	3439	0.491
NULL	Virol_J_2009_Jan_27_6_13.nxml.txt.nlp	19173711	SENT20	25	25	23	23	ribavirin	IFN	PA451241	3439	0.491
NULL	Reprod_Biol_Endocrinol_2013_Jul_11_11_61.nxml.txt.nlp	23844631	SENT9	12	12	16	16	estradiol	PRL	PA449503	5617	0.491
NULL	BMB_Rep_2013_Nov_46(11)_555-560.nxml.txt.nlp	24152914	SENT38	24	24	28	28	ethanol	NAC	PA448073	22861	0.491
NULL	Br_J_Cancer_2010_Jan_5_102(1)_80-86.nxml.txt.nlp	19920817	SENT40	32	32	30	30	sunitinib	IFN	PA162372840	3439	0.491
NULL	J_Biomed_Sci_2014_Feb_3_21(1)_10.nxml.txt.nlp	24490900	SENT166	20	20	22	22	alendronate	RANKL	PA448082	8600	0.491
NULL	Infect_Drug_Resist_2011_Aug_4_4_149-154.nxml.txt.nlp	21904460	SENT105	44	44	33	33	cefepime	HAI	PA164754876	6692;6768	0.491
NULL	J_Cell_Biol_1998_Mar_9_140(5)_1199-1209.nxml.txt.nlp	9490732	SENT144	19	19	21	21	halothane	LPA	PA449845	4018	0.491
NULL	Basic_Clin_Neurosci_2014_Spring_5(2)_117-123.nxml.txt.nlp	25337369	SENT46	13	13	36	36	collagenase	FGF2	PA449107	2247;2258	0.491
NULL	Clin_Dev_Immunol_2011_Nov_17_2011_565187.nxml.txt.nlp	22162712	SENT181	8	8	3	3	sorafenib	CLIP	PA7000	5443;6249;7461	0.491
NULL	Mol_Cancer_2009_Nov_10_8_99.nxml.txt.nlp	19903356	SENT76	30	30	3	3	imatinib	IGFBP3	PA10804	3486	0.491
NULL	Cancers_(Basel)_2011_May_9_3(2)_2286-2301.nxml.txt.nlp	24212810	SENT939	11	11	13	13	docetaxel	Gem	PA449383	51053	0.491
NULL	Biol_Direct_2008_Aug_20_3_34.nxml.txt.nlp	18715501	SENT59	44	44	30	30	staurosporine	San	PA165109623	80218	0.491
NULL	J_Cardiothorac_Surg_2012_Jun_20_7_57.nxml.txt.nlp	22716287	SENT89	14	14	43	43	rosiglitazone	ANOVA	PA451283	4858	0.491
NULL	Sensors_(Basel)_2010_Mar_25_10(4)_2626-2637.nxml.txt.nlp	22319264	SENT130	39	39	28	28	ethanol	mol	PA448073	90527	0.491
NULL	Int_J_Mol_Sci_2010_Sep_13_11(9)_3195-3208.nxml.txt.nlp	20957088	SENT22	9	9	4	4	lipase	AT2	PA450239	186	0.491
NULL	Cells_2012_Jul_25_1(3)_325-345.nxml.txt.nlp	24710479	SENT817	1	1	5	5	metformin	AMPK	PA450395	5563	0.491
NULL	Brain_Sci_2014_Apr_22_4(2)_311-320.nxml.txt.nlp	24961763	SENT5	7	7	15	15	isoflurane	CO2	PA450106	4513	0.491
NULL	Diabetes_Care_2009_Sep_28_32(9)_1649-1655.nxml.txt.nlp	19478198	SENT151	0	0	16	16	saxagliptin	PPG	PA165958362	5552	0.491
NULL	Chem_Cent_J_2012_Feb_21_6_15.nxml.txt.nlp	22353684	SENT79	8	8	6	6	acebutolol	mol	PA448011	90527	0.491
NULL	Cancer_Causes_Control_2013_Aug_18_24(8)_1605-1614.nxml.txt.nlp	23775025	SENT64	3	3	43	43	cyclophosphamide	GSTP1	PA449165	2950	0.491
NULL	Appl_Plant_Sci_2015_Jan_5_3(1)_apps_1400086.nxml.txt.nlp	25606353	SENT62	3	3	16	16	vancomycin	BAM	PA451850	9126	0.491
NULL	J_Neurol_2013_Jan_30_260(1)_93-99.nxml.txt.nlp	22752065	SENT71	9	9	17	17	carbamazepine	DPK	PA448785	3775;51347	0.491
NULL	Mol_Biol_Rep_2012_May_20_39(5)_5253-5267.nxml.txt.nlp	22183301	SENT219	6	6	4	4	gliclazide	NAC	PA10892	22861	0.491
NULL	Mediators_Inflamm_2010_Jun_21_2010_194896.nxml.txt.nlp	20652055	SENT193	0	0	5	5	berberine	CCL2	PA165860812	6347	0.491
NULL	Int_J_Mol_Sci_2014_Nov_25_15(12)_21703-21722.nxml.txt.nlp	25429431	SENT985	15	15	12	12	mitoxantrone	ABCB1	PA450526	5243	0.491
NULL	Indian_J_Endocrinol_Metab_2013_Dec_17(Suppl_3)_S696-S699.nxml.txt.nlp	24910842	SENT42	0	0	5	5	metoclopramide	PRL	PA450475	5617	0.491
NULL	Breast_Cancer_Res_2007_Mar_6_9(2)_R22.nxml.txt.nlp	17341305	SENT299	7	7	0	0	medroxyprogesterone	ANOVA	PA450344	4858	0.491
NULL	Front_Endocrinol_(Lausanne)_2014_Aug_27_5_140.nxml.txt.nlp	25221543	SENT204	31	31	28	28	liraglutide	GLP-1	PA165958364	100125288	0.49
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT6	0	0	11	11	curcumin	PC-3	PA151958596	692094	0.49
NULL	Int_J_Environ_Res_Public_Health_2010_Jul_28_7(7)_2745-2788.nxml.txt.nlp	20717537	SENT388	5	5	3	3	succimer	NAC	PA451521	22861	0.49
NULL	J_Invest_Dermatol_2013_Sep_31_133(9)_2247-2254.nxml.txt.nlp	23370537	SENT157	13	13	16	16	temozolomide	BRAF	PA451609	673	0.49
NULL	Indian_J_Ophthalmol_2012_Mar-Apr_60(2)_162b-163.nxml.txt.nlp	22446925	SENT25	12	12	31	31	bevacizumab	PED	PA130232992	8682	0.49
NULL	J_Cell_Biol_2001_Oct_29_155(3)_427-438.nxml.txt.nlp	11673478	SENT271	7	7	17	17	genistein	PP2	PA165109660	4888	0.49
NULL	Cancers_(Basel)_2013_Jun_5_5(2)_676-713.nxml.txt.nlp	24216997	SENT278	29	29	37	37	decitabine	MLH1	PA164749631	4292	0.49
NULL	Clin_Ophthalmol_2007_Mar_1(1)_11-24.nxml.txt.nlp	19668462	SENT267	7	7	15	15	latanoprost	BAK	PA164774763	578	0.49
NULL	Nat_Commun_2013_Oct_1_4_2516.nxml.txt.nlp	24084631	SENT51	7	7	22	22	losartan	AK4	PA450268	205	0.49
NULL	ACS_Chem_Biol_2011_Feb_18_6(2)_169-175.nxml.txt.nlp	20886892	SENT83	6	6	15	15	choline	UDP-GalNAc	PA448976	26301	0.49
NULL	Chem_Rev_2011_Oct_12_111(10)_5899-5921.nxml.txt.nlp	21923193	SENT542	23	23	25	25	ibuprofen	COX	PA449957	1351	0.49
NULL	Comput_Struct_Biotechnol_J_2012_Dec_1_3_e201210017.nxml.txt.nlp	24688677	SENT162	29	29	8	8	ethanol	FBA	PA448073	26273	0.49
NULL	Front_Mol_Neurosci_2012_Nov_12_5_99.nxml.txt.nlp	23162427	SENT260	15	15	13	13	cocaine	CPP	PA449072	340451	0.49
NULL	Clin_Epigenetics_2010_Sep_18_1(3-4)_101-116.nxml.txt.nlp	21258631	SENT228	6	6	8	8	curcumin	DNMT1	PA151958596	1786	0.49
NULL	Acta_Pharmacol_Sin_2009_Jan_8_30(1)_125-133.nxml.txt.nlp	19060917	SENT63	12	12	7	7	fluorescein	CD4	PA164746009	920	0.49
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Feb_29_68(Pt_3)_o878-o879.nxml.txt.nlp	22412730	SENT84	20	20	17	17	potassium	mol	PA451047	90527	0.49
NULL	Brain_Sci_2014_Apr_22_4(2)_311-320.nxml.txt.nlp	24961763	SENT294	3	3	10	10	sevoflurane	BAX	PA451341	581	0.49
NULL	Braz_J_Microbiol_2014_Jan_15_44(3)_807-812.nxml.txt.nlp	24516449	SENT133	14	14	18	18	meropenem	CTX	PA164764445	1593	0.49
NULL	Breast_Cancer_2012_Oct_19_19(4)_302-308.nxml.txt.nlp	22711317	SENT3	0	0	11	11	estradiol	RANKL	PA449503	8600	0.49
NULL	Int_J_Gen_Med_2011_Dec_12_4_827-835.nxml.txt.nlp	22267935	SENT27	1	1	24	24	protamine	PPG	PA10366	5552	0.49
NULL	Lab_Invest_2011_Mar_15_91(3)_363-378.nxml.txt.nlp	21079581	SENT177	34	34	22	22	hyaluronan	DLX5	PA165958431	1749	0.49
NULL	Cancer_Med_2013_Dec_27_2(6)_751-762.nxml.txt.nlp	24403249	SENT139	0	0	5	5	paclitaxel	CD44	PA450761	960	0.49
NULL	Hum_Genomics_2003_Nov_1_1(1)_41-51.nxml.txt.nlp	15601532	SENT25	24	24	31	31	neomycin	Yes	PA450608	7525	0.49
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Apr_9_70(Pt_5)_o528.nxml.txt.nlp	24860341	SENT72	40	40	33	33	ethanol	mol	PA448073	90527	0.49
NULL	Acta_Neuropathol_2014_May_1_128(1)_99-109.nxml.txt.nlp	24788821	SENT149	22	22	17	17	levodopa	B12	PA450213	7126;4709	0.49
NULL	Br_J_Cancer_2013_Sep_3_109(5)_1079-1084.nxml.txt.nlp	23928659	SENT81	28	28	30	30	docetaxel	DES	PA449383	1674	0.49
NULL	Crit_Care_2011_Aug_2_15(4)_177.nxml.txt.nlp	21861863	SENT3	42	42	20	20	fenoldopam	NGAL	PA164784034	3934	0.49
NULL	Br_J_Cancer_1992_Mar_65(3)_413-416.nxml.txt.nlp	1558796	SENT10	20	20	30	30	mitomycin	PSK	PA450524	9344	0.49
NULL	Breast_Cancer_Res_2011_Mar_11_13(2)_R29.nxml.txt.nlp	21396094	SENT134	36	36	9	9	ethanol	HRG	PA448073	3084;3273	0.49
NULL	J_Vis_Exp_2014_Jul_4_(89)_51847.nxml.txt.nlp	25045833	SENT138	13	13	1	1	theophylline	CARS	PA451647	833	0.49
NULL	Clin_Med_Insights_Arthritis_Musculoskelet_Disord_2012_Jan_5_5_1-14.nxml.txt.nlp	22267947	SENT40	7	7	23	23	risedronate	NNT	PA451255	23530	0.49
NULL	Bioinformation_2006_Dec_23_1(8)_314-320.nxml.txt.nlp	17597912	SENT156	23	23	9	9	indomethacin	ACE	PA449982	1636	0.49
NULL	Case_Rep_Dent_2013_Jul_10_2013_812323.nxml.txt.nlp	23936686	SENT96	18	18	8	8	hyaluronan	CD31	PA165958431	5175	0.49
NULL	Mol_Vis_2011_Dec_21_17_3371-3378.nxml.txt.nlp	22219632	SENT61	7	7	16	16	mitomycin	CO2	PA450524	4513	0.49
NULL	Adv_Pharmacol_Sci_2013_Jun_24_2013_987692.nxml.txt.nlp	23864853	SENT155	18	18	16	16	acetaminophen	CCL4	PA448015	6351	0.49
NULL	Biomed_Res_Int_2014_Jan_29_2014_361020.nxml.txt.nlp	24605326	SENT223	7	7	40	40	flavopiridol	CDK2	PA452627	1017	0.49
NULL	Indian_J_Palliat_Care_2010_Sep-Dec_16(3)_129-137.nxml.txt.nlp	21218002	SENT7	14	14	20	20	thalidomide	ghrelin	PA451644	51738	0.49
NULL	Curr_Med_Chem_2013_Jan_20(3)_438-447.nxml.txt.nlp	23157636	SENT453	5	5	12	12	haloperidol	FGA	PA449841	2243	0.49
NULL	Apoptosis_2008_May_9_13(5)_681-692.nxml.txt.nlp	18392938	SENT159	3	3	5	5	forskolin	EGF	PA146096022	1950	0.49
NULL	Turk_J_Haematol_2012_Sep_5_29(3)_233-241.nxml.txt.nlp	24744666	SENT80	17	17	25	25	nadh	GDH	PA164755085	51084;2746	0.49
NULL	J_Gen_Physiol_1938_Sep_20_22(1)_79-89.nxml.txt.nlp	19873094	SENT0	14	14	1	1	trypsin	Gen	PA451806	348654	0.49
NULL	Ann_Hematol_2014_Apr_1_93(8)_1371-1380.nxml.txt.nlp	24687382	SENT34	41	41	9	9	thalidomide	CRBN	PA451644	51185	0.49
NULL	Cardiovasc_Diabetol_2010_Sep_23_9_57.nxml.txt.nlp	20863381	SENT189	17	17	14	14	pioglitazone	DM2	PA450970	28508	0.49
NULL	Core_Evid_2007_Nov_30_2(2)_121-129.nxml.txt.nlp	21221180	SENT41	20	20	25	25	rituximab	NHL	PA451261	51750	0.49
NULL	Oxid_Med_Cell_Longev_2013_May_14_2013_957947.nxml.txt.nlp	23766864	SENT221	13	13	25	25	napqi	GCLM		2730	0.49
NULL	Drug_Des_Devel_Ther_2014_Sep_9_8_1307-1314.nxml.txt.nlp	25246772	SENT158	10	10	18	18	cyclosporine	HTX	PA449167	7547	0.49
NULL	Biosci_Rep_2014_Oct_22_34(5)_e00146.nxml.txt.nlp	25188723	SENT351	21	21	19	19	heparin	C3b	PA449855	718	0.49
NULL	Cancer_Med_2013_Aug_30_2(4)_457-467.nxml.txt.nlp	24156018	SENT257	31	31	15	15	marimastat	PDGFRA	PA164748329	5156	0.49
NULL	Ann_Rheum_Dis_2013_Jan_7_72(1)_43-50.nxml.txt.nlp	22562983	SENT104	38	38	0	0	tocilizumab	ACR	PA165292659	49	0.49
NULL	Int_J_Biomed_Sci_2014_Sep_10(3)_146-157.nxml.txt.nlp	25324695	SENT268	8	8	10	10	hyaluronan	RHAMM	PA165958431	3161	0.49
NULL	F1000_Med_Rep_2010_May_24_2_40.nxml.txt.nlp	20948844	SENT43	0	0	4	4	heparin	APC	PA449855	324	0.49
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT6	25	25	13	13	methotrexate	MSH2	PA450428	4436	0.49
NULL	J_Invest_Dermatol_2013_Sep_31_133(9)_2247-2254.nxml.txt.nlp	23370537	SENT65	0	0	2	2	chloroquine	PUMA	PA448948	27113	0.49
NULL	Front_Oncol_2014_Sep_11_4_245.nxml.txt.nlp	25309871	SENT43	0	0	5	5	thrombin	LPA	PA451674	4018	0.49
NULL	J_Biol_Chem_2009_Aug_21_284(34)_22926-22937.nxml.txt.nlp	19520847	SENT407	6	6	29	29	amrinone	ADP	PA164746803	23038	0.49
NULL	Biomed_Res_Int_2014_Jan_29_2014_831845.nxml.txt.nlp	24605337	SENT207	10	10	8	8	bupivacaine	S6K1	PA135057240	6198	0.49
NULL	Genome_Med_2010_Sep_15_2(9)_66.nxml.txt.nlp	20854646	SENT94	6	6	3	3	tramadol	CYP2D6	PA451735	1565	0.49
NULL	Acta_Pharmacol_Sin_2013_Apr_18_34(4)_555-560.nxml.txt.nlp	23503472	SENT12	8	8	10	10	cyclosporine	ABCB1	PA449167	5243	0.49
NULL	Clinicoecon_Outcomes_Res_2014_Sep_23_6_409-414.nxml.txt.nlp	25285019	SENT143	8	8	2	2	darunavir	ATV	PA163522472	4683	0.49
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT258	7	7	27	27	cetuximab	EREG	PA10040	2069	0.49
NULL	Nucleic_Acids_Res_2013_Dec_21_41(22)_10283-10297.nxml.txt.nlp	24005041	SENT37	11	11	4	4	mitomycin	HELQ	PA450524	113510	0.49
NULL	Acta_Histochem_Cytochem_2011_Apr_28_44(2)_51-60.nxml.txt.nlp	21614166	SENT483	3	3	5	5	thalidomide	CD31	PA451644	5175	0.49
NULL	Biomed_Res_Int_2013_Sep_5_2013_908907.nxml.txt.nlp	24083248	SENT60	18	18	24	24	lipase	BSSL	PA450239	1056	0.49
NULL	Arthritis_Res_Ther_2009_Aug_24_11(4)_R127.nxml.txt.nlp	19703304	SENT119	32	32	16	16	adalimumab	OASIS	PA10004	90993	0.49
NULL	J_Korean_Med_Sci_2010_Oct_17_25(10)_1427-1430.nxml.txt.nlp	20890421	SENT20	0	0	12	12	atazanavir	UGT	PA10251	7361;7355	0.49
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Nov_26_3(11)_e149.nxml.txt.nlp	25426564	SENT81	39	39	14	14	atorvastatin	PCSK9	PA448500	255738	0.49
NULL	Acta_Neuropathol_2014_Dec_8_127(1)_109-135.nxml.txt.nlp	24318124	SENT60	10	10	29	29	vasopressin	OXT	PA451858	5020	0.49
NULL	Neural_Regen_Res_2013_Nov_5_8(31)_2932-2941.nxml.txt.nlp	25206614	SENT149	8	8	19	19	creatine	spatial	PA164778930	219793	0.49
NULL	Int_J_Biol_Sci_2015_Jan_1_11(1)_48-58.nxml.txt.nlp	25552929	SENT211	5	5	3	3	paclitaxel	LDM	PA450761	1595	0.49
NULL	Exp_Transl_Stroke_Med_2011_Dec_16_3_16.nxml.txt.nlp	22177314	SENT119	44	44	24	24	minocycline	ANOVA	PA450519	4858	0.49
NULL	J_Invest_Dermatol_2014_Jul_6_134(7)_1811-1816.nxml.txt.nlp	24599174	SENT4	0	0	5	5	tazarotene	TIG3	PA164746821	5920	0.49
NULL	Lipids_Health_Dis_2011_Feb_12_10_31.nxml.txt.nlp	21314960	SENT7	4	4	19	19	hemin	HO-1	PA449849	3162	0.49
NULL	Acta_Physiol_(Oxf)_2008_Apr_192(4)_505-517.nxml.txt.nlp	17973950	SENT241	16	16	12	12	isoproterenol	LQT3	PA450121	6331	0.49
NULL	Viruses_2014_Apr_14_6(4)_1715-1758.nxml.txt.nlp	24736215	SENT132	0	0	5	5	disulfiram	PTEN	PA449376	5728	0.49
NULL	Diabetes_2013_May_16_62(5)_1697-1708.nxml.txt.nlp	23364453	SENT256	6	6	4	4	fasudil	GLP-1	PA165946121	100125288	0.49
NULL	Int_J_Vasc_Med_2013_Mar_31_2013_543141.nxml.txt.nlp	23606968	SENT132	0	0	3	3	etanercept	IL-6	PA449515	3569	0.49
NULL	Cells_2014_Jan_8_3(1)_36-52.nxml.txt.nlp	24501683	SENT122	14	14	19	19	hydrocortisone	HSD2	PA449905	6060	0.49
NULL	J_Biol_Chem_2012_Apr_20_287(17)_14122-14135.nxml.txt.nlp	22351750	SENT1073	5	5	7	7	hyaluronan	TSG-6	PA165958431	7130	0.49
NULL	Breast_Cancer_Res_2011_Mar_14_13(2)_205.nxml.txt.nlp	21457526	SENT47	34	34	14	14	exemestane	ATAC	PA449563	6375	0.49
NULL	J_Breast_Cancer_2013_Mar_31_16(1)_23-31.nxml.txt.nlp	23593078	SENT150	9	9	11	11	curcumin	DNMT1	PA151958596	1786	0.49
NULL	Br_J_Cancer_2013_May_28_108(10)_2021-2032.nxml.txt.nlp	23632475	SENT198	0	0	2	2	metformin	CC3	PA450395	10553	0.49
NULL	Braz_J_Med_Biol_Res_2013_Aug_13_46(8)_650-658.nxml.txt.nlp	23969971	SENT188	19	19	16	16	oxaliplatin	STAT3	PA131285527	6774	0.49
NULL	Exp_Ther_Med_2013_Aug_20_6(2)_310-316.nxml.txt.nlp	24137180	SENT117	32	32	27	27	fasudil	MCP-1	PA165946121	6347	0.49
NULL	Adv_Urol_2010_Jul_20_2010_687043.nxml.txt.nlp	20721275	SENT113	12	12	9	9	bevacizumab	IFN	PA130232992	3439	0.49
NULL	Cancer_Cell_Int_2013_May_15_13_42.nxml.txt.nlp	23672670	SENT58	31	31	8	8	paclitaxel	p53	PA450761	7157	0.49
NULL	Int_J_Environ_Res_Public_Health_2006_Jun_30_3(2)_136-140.nxml.txt.nlp	16823087	SENT43	12	12	44	44	l-glutamine	CO2	PA10090	4513	0.49
NULL	Int_J_Pediatr_2010_Dec_23_2010_376287.nxml.txt.nlp	21234103	SENT92	12	12	28	28	ethambutol	gamma	PA164784021	9913	0.49
NULL	Cell_Commun_Signal_2009_Aug_13_7_19.nxml.txt.nlp	19678929	SENT56	16	16	19	19	cetuximab	KRAS	PA10040	3845	0.49
NULL	Proteome_Sci_2009_Oct_27_7_39.nxml.txt.nlp	19860894	SENT229	13	13	29	29	trypsin	CD5L	PA451806	922	0.49
NULL	Evid_Based_Complement_Alternat_Med_2013_Nov_5_2013_937370.nxml.txt.nlp	24302971	SENT170	4	4	17	17	tacrine	CAT	PA451576	847	0.49
NULL	Emerg_Infect_Dis_2007_Feb_13(2)_255-258.nxml.txt.nlp	17479888	SENT77	23	23	1	1	ciprofloxacin	PEN	PA449009	9933	0.49
NULL	Biomed_Res_Int_2014_Jan_29_2014_361020.nxml.txt.nlp	24605326	SENT223	1	1	20	20	staurosporine	CDK1	PA165109623	983	0.49
NULL	Biosci_Rep_2013_Nov_25_33(6)_e00081.nxml.txt.nlp	24070327	SENT435	12	12	5	5	imatinib	LRPPRC	PA10804	10128	0.49
NULL	Evid_Based_Complement_Alternat_Med_2013_Mar_28_2013_514908.nxml.txt.nlp	23606881	SENT12	4	4	23	23	scopolamine	BMX	PA451308	660	0.49
NULL	Cardiovasc_Diabetol_2010_Sep_23_9_57.nxml.txt.nlp	20863381	SENT30	4	4	1	1	metformin	DM2	PA450395	28508	0.49
NULL	Ann_Clin_Transl_Neurol_2014_Dec_21_1(12)_996-1005.nxml.txt.nlp	25574474	SENT122	9	9	7	7	riluzole	P-gp	PA451251	5243	0.49
NULL	Oncotarget_2014_Aug_19_5(18)_8737-8749.nxml.txt.nlp	25228590	SENT51	9	9	14	14	crizotinib	PI3K	PA165946122	5290	0.49
NULL	Eur_J_Dent_2011_Jan_5(1)_77-83.nxml.txt.nlp	21228958	SENT158	9	9	25	25	chlorhexidine	HEMA	PA164776863	2157	0.49
NULL	Asian-Australas_J_Anim_Sci_2013_Feb_26(2)_266-274.nxml.txt.nlp	25049786	SENT215	7	7	4	4	ginseng	FA1	PA164781150	8788	0.49
NULL	Cell_Microbiol_2013_Aug_14_15(8)_1385-1400.nxml.txt.nlp	23421931	SENT302	24	24	22	22	fluorescein	CD11c	PA164746009	3687	0.49
NULL	J_Cardiovasc_Dis_Res_2010_Oct-Dec_1(4)_171-176.nxml.txt.nlp	21264180	SENT122	10	10	23	23	resveratrol	Bcl-2		596	0.49
NULL	Curr_Neuropharmacol_2014_Jul_12(4)_365-379.nxml.txt.nlp	25342944	SENT534	17	17	2	2	citalopram	5-HT1B	PA449015	3351	0.49
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Apr_9_70(Pt_5)_o528.nxml.txt.nlp	24860341	SENT72	40	40	15	15	ethanol	mol	PA448073	90527	0.49
NULL	Acta_Pharmacol_Sin_2014_Aug_21_35(8)_994-1004.nxml.txt.nlp	25042549	SENT46	21	21	18	18	pravastatin	PCSK9	PA451089	255738	0.49
NULL	Osteoporos_Int_2008_Apr_12_19(4)_399-428.nxml.txt.nlp	18266020	SENT306	15	15	24	24	risedronate	PTH	PA451255	5741	0.49
NULL	Chemother_Res_Pract_2011_Sep_25_2011_730360.nxml.txt.nlp	22295205	SENT226	23	23	21	21	trastuzumab	HER2	PA451743	2064	0.49
NULL	J_Gastroenterol_2013_Jan_27_48(1)_22-30.nxml.txt.nlp	23104468	SENT99	16	16	14	14	ribavirin	IFN	PA451241	3439	0.49
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT151	2	2	4	4	atorvastatin	OPG	PA448500	690	0.49
NULL	Nat_Neurosci_2013_Dec_20_16(12)_10_1038_nn_3553.nxml.txt.nlp	24141309	SENT262	17	17	21	21	l-glutamine	B27	PA10090	56246	0.49
NULL	Ann_Surg_Treat_Res_2014_Feb_22_86(2)_68-75.nxml.txt.nlp	24761411	SENT17	5	5	2	2	resveratrol	survivin		332	0.49
NULL	Arthritis_Res_Ther_2005_Nov_10_7(1)_R57-R64.nxml.txt.nlp	15642143	SENT104	38	38	26	26	pamidronate	OPG	PA450767	690	0.49
NULL	Acta_Pharmacol_Sin_2011_Jan_20_32(1)_108-115.nxml.txt.nlp	21170082	SENT99	33	33	14	14	phenol	SLB	PA450913	26160	0.49
NULL	Mol_Brain_2013_May_25_6_27.nxml.txt.nlp	23705847	SENT239	7	7	9	9	capsaicin	TRPV1	PA448776	7442	0.49
NULL	Clin_Ophthalmol_2008_Sep_2(3)_613-621.nxml.txt.nlp	19668762	SENT15	14	14	6	6	travoprost	BAK	PA164781371	578	0.49
NULL	Clin_Ophthalmol_2012_Sep_5_6_1433-1440.nxml.txt.nlp	23055659	SENT153	39	39	15	15	timolol	BAK	PA451690	578	0.49
NULL	Proteome_Sci_2009_Jul_16_7_24.nxml.txt.nlp	19607692	SENT9	26	26	34	34	nadh	p45	PA164755085	5705;6502	0.49
NULL	Cell_J_2012_Dec_22_Winter_13(4)_265-274.nxml.txt.nlp	23507995	SENT53	5	5	18	18	ethanol	spatial	PA448073	219793	0.49
NULL	Braz_J_Microbiol_2011_Dec_1_Oct-Dec_42(4)_1516-1525.nxml.txt.nlp	24031786	SENT80	11	11	9	9	lipase	LAB	PA450239	7462	0.49
NULL	Onco_Targets_Ther_2014_Sep_30_7_1641-1645.nxml.txt.nlp	25336968	SENT88	11	11	13	13	chlorthalidone	Yes	PA448970	7525	0.49
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Jul_5_64(Pt_8)_o1398.nxml.txt.nlp	21203118	SENT4	13	13	17	17	phenol	mol	PA450913	90527	0.49
NULL	Cancer_Res_Treat_2012_Sep_30_44(3)_195-201.nxml.txt.nlp	23091446	SENT161	12	12	7	7	etoposide	JNK	PA449552	5599	0.49
NULL	J_Cell_Biol_2008_Jul_28_182(2)_327-340.nxml.txt.nlp	18644889	SENT351	0	0	25	25	estradiol	p27	PA449503	5715;10534	0.49
NULL	Breast_Cancer_Res_2011_Mar_1_13(2)_R21.nxml.txt.nlp	21362200	SENT11	0	0	2	2	estradiol	PI3K	PA449503	5290	0.49
NULL	J_Obes_2013_Jun_4_2013_874981.nxml.txt.nlp	23862058	SENT8	12	12	36	36	l-methionine	C17	PA450423	54360	0.489
NULL	Mol_Cancer_2010_Apr_23_9_87.nxml.txt.nlp	20416058	SENT278	17	17	15	15	doxorubicin	TRAIL	PA449412	8743	0.489
NULL	Addict_Health_2012_Summer-Autumn_4(3-4)_79-86.nxml.txt.nlp	24494140	SENT169	19	19	1	1	dextromethorphan	Gen	PA449273	348654	0.489
NULL	Cardiol_Ther_2013_Jun_27_2(1)_1-16.nxml.txt.nlp	25135285	SENT135	22	22	34	34	metformin	GLP-1	PA450395	100125288	0.489
NULL	Acta_Pharmacol_Sin_2013_May_25_34(5)_625-635.nxml.txt.nlp	23524572	SENT157	25	25	28	28	ethanol	LC3	PA448073	84557	0.489
NULL	Br_J_Cancer_2011_Jun_7_104(12)_1848-1853.nxml.txt.nlp	21610704	SENT144	10	10	7	7	panitumumab	KRAS	PA162373091	3845	0.489
NULL	Ann_Dermatol_2014_Apr_30_26(2)_236-240.nxml.txt.nlp	24882980	SENT83	6	6	1	1	clarithromycin	RGM	PA449028	56963	0.489
NULL	Acta_Pharmacol_Sin_2012_Jan_28_33(1)_66-74.nxml.txt.nlp	22120966	SENT258	24	24	16	16	genistein	RANKL	PA165109660	8600	0.489
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT7	0	0	36	36	resveratrol	XIAP		331	0.489
NULL	J_Gen_Physiol_1960_Mar_1_43(4)_753-758.nxml.txt.nlp	14433991	SENT5	8	8	10	10	dextran	gamma	PA449261	9913	0.489
NULL	Drug_Des_Devel_Ther_2014_Sep_23_8_1527-1538.nxml.txt.nlp	25284985	SENT134	2	2	0	0	celecoxib	IFN	PA448871	3439	0.489
NULL	Mol_Biol_Cell_2012_Nov_1_23(21)_4226-4241.nxml.txt.nlp	22956769	SENT263	0	0	6	6	paraformaldehyde	BICD2	PA450790	23299	0.489
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT128	6	6	2	2	phenytoin	CYP2C19	PA450947	1557	0.489
NULL	J_Neuroinflammation_2011_Feb_4_8_10.nxml.txt.nlp	21294877	SENT21	0	0	15	15	capsaicin	TRPV1	PA448776	7442	0.489
NULL	J_Cell_Biol_2004_Jul_5_166(1)_37-47.nxml.txt.nlp	15240568	SENT188	0	0	11	11	doxycycline	MUC2	PA449415	4583	0.489
NULL	Biol_Proced_Online_2001_Dec_11_3_43-53.nxml.txt.nlp	12734580	SENT166	26	26	13	13	hyaluronidase	CLS	PA164745713	1210	0.489
NULL	Front_Neurosci_2014_Jul_1_8_168.nxml.txt.nlp	25018691	SENT624	5	5	10	10	ketamine	gamma	PA450144	9913	0.489
NULL	Cancer_Res_Treat_2011_Dec_27_43(4)_255-259.nxml.txt.nlp	22247712	SENT6	2	2	8	8	doxorubicin	CHOP	PA449412	1649	0.489
NULL	Leukemia_2014_Aug_7_28(8)_1636-1646.nxml.txt.nlp	24418989	SENT37	0	0	12	12	chloroquine	TRAIL	PA448948	8743	0.489
NULL	Biochem_Res_Int_2012_May_7_2012_395974.nxml.txt.nlp	22611495	SENT132	10	10	28	28	anakinra	IFN	PA10799	3439	0.489
NULL	Pharmaceuticals_(Basel)_2013_Dec_23_7(1)_1-17.nxml.txt.nlp	24366113	SENT322	16	16	13	13	cyclosporine	IL-17	PA449167	3605	0.489
NULL	Cancer_Cell_Int_2008_Mar_18_8_3.nxml.txt.nlp	18348720	SENT82	31	31	15	15	lapatinib	EGF	PA152241907	1950	0.489
NULL	J_Mol_Signal_2006_Dec_6_1_8.nxml.txt.nlp	17224083	SENT7	28	28	31	31	thrombin	Rho	PA451674	29984	0.489
NULL	Acta_Pharmacol_Sin_2009_Dec_4_30(12)_1585-1593.nxml.txt.nlp	19960004	SENT54	25	25	22	22	prazosin	mol	PA451093	90527	0.489
NULL	Environ_Health_Perspect_2006_Apr_27_114(4)_500-506.nxml.txt.nlp	16581536	SENT195	19	19	10	10	estradiol	aromatase	PA449503	1588	0.489
NULL	EMBO_Mol_Med_2011_May_3(5)_266-278.nxml.txt.nlp	21438154	SENT99	1	1	7	7	oxaliplatin	TRPM8	PA131285527	79054	0.489
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Mar_19_67(Pt_4)_o902.nxml.txt.nlp	21754176	SENT68	27	27	24	24	ethanol	mol	PA448073	90527	0.489
NULL	Biologics_2012_Dec_17_6_429-464.nxml.txt.nlp	23269860	SENT246	17	17	15	15	infliximab	ACR	PA452639	49	0.489
NULL	J_Cell_Mol_Med_2014_Dec_9_18(12)_2499-2511.nxml.txt.nlp	24912879	SENT241	3	3	5	5	docetaxel	DACH1	PA449383	1602	0.489
NULL	Clin_Interv_Aging_2013_Feb_11_8_139-148.nxml.txt.nlp	23430672	SENT17	30	30	16	16	fluorescein	IL6	PA164746009	3569	0.489
NULL	Diabetes_Care_2008_Oct_31(10)_2062-2069.nxml.txt.nlp	18820229	SENT238	13	13	42	42	rosiglitazone	DREAM	PA451283	30818	0.489
NULL	Gut_2008_Nov_2_57(11)_1509-1517.nxml.txt.nlp	18596194	SENT191	6	6	24	24	curcumin	JNK	PA151958596	5599	0.489
NULL	J_Oncol_2013_Feb_17_2013_872957.nxml.txt.nlp	23476648	SENT9	24	24	4	4	cisplatin	SFN	PA449014	25996;2810	0.489
NULL	Front_Endocrinol_(Lausanne)_2013_Sep_13_4_122.nxml.txt.nlp	24062725	SENT95	14	14	21	21	choline	PRL	PA448976	5617	0.489
NULL	J_Vis_Exp_2011_Jun_24_(52)_3094.nxml.txt.nlp	21730945	SENT111	13	13	41	41	rifampin	EMB	PA451250	133418	0.489
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT43	5	5	7	7	gefitinib	KRAS	PA131301952	3845	0.489
NULL	Ann_Biomed_Eng_2011_Apr_1_39(4)_1174-1185.nxml.txt.nlp	21120695	SENT121	11	11	6	6	calcein	DM1	PA132595336	338023;1760;28509	0.489
NULL	Braz_J_Microbiol_2011_Dec_1_Oct-Dec_42(4)_1608-1615.nxml.txt.nlp	24031795	SENT55	13	13	11	11	glucose	mol	PA449773	90527	0.489
NULL	ScientificWorldJournal_2013_Apr_24_2013_928197.nxml.txt.nlp	23737732	SENT133	2	2	13	13	pitavastatin	p47	PA142650384	3621;55968	0.489
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1224-1233.nxml.txt.nlp	22353810	SENT198	19	19	31	31	vincristine	MRP-1	PA451879	928	0.489
NULL	Neuroscience_2008_Aug_13_155(2)_556-564.nxml.txt.nlp	18619738	SENT62	17	17	19	19	l-glutamine	B27	PA10090	56246	0.489
NULL	Eur_J_Med_Res_2011_Apr_28_16(4)_139-144.nxml.txt.nlp	21486727	SENT157	20	20	6	6	posaconazole	NNT	PA151958574	23530	0.489
NULL	Clin_Pharmacokinet_2014_Sep_3_53(1)_1-16.nxml.txt.nlp	23999929	SENT287	12	12	10	10	erythromycin	P-gp	PA449493	5243	0.489
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT184	14	14	17	17	cisplatin	p53	PA449014	7157	0.489
NULL	Clinics_(Sao_Paulo)_2011_Aug_66(8)_1457-1462.nxml.txt.nlp	21915500	SENT104	31	31	24	24	oxygen	TNF	PA450744	7124	0.489
NULL	ScientificWorldJournal_2013_Oct_24_2013_726912.nxml.txt.nlp	24282387	SENT5	11	11	9	9	fluorescein	AVP	PA164746009	114548;551	0.489
NULL	Cancer_Immunol_Immunother_2012_Jul_23_61(7)_1101-1111.nxml.txt.nlp	22193989	SENT156	12	12	15	15	oxaliplatin	CD80	PA131285527	941	0.489
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Aug_27_67(Pt_9)_o2450.nxml.txt.nlp	22059018	SENT10	26	26	33	33	ethanol	mol	PA448073	90527	0.489
NULL	J_Hematol_Oncol_2011_Dec_21_4_53.nxml.txt.nlp	22189016	SENT49	13	13	22	22	dabigatran	CLCR		11330	0.489
NULL	Br_J_Cancer_2014_Nov_25_111(11)_2091-2102.nxml.txt.nlp	25349971	SENT245	10	10	28	28	imatinib	PTPN18	PA10804	26469	0.489
NULL	Arthritis_Res_Ther_2007_Nov_9_9(6)_R117.nxml.txt.nlp	17996099	SENT196	12	12	17	17	heparin	OPG	PA449855	690	0.489
NULL	Arch_Dis_Child_2014_Dec_8_99(12)_1143-1146.nxml.txt.nlp	25202131	SENT58	15	15	11	11	diazepam	CYP2C9	PA449283	1559	0.489
NULL	Autism_Res_Treat_2012_Nov_28_2012_870391.nxml.txt.nlp	23243505	SENT238	34	34	30	30	haloperidol	CARS	PA449841	833	0.489
NULL	J_Breast_Cancer_2011_Dec_27_14(4)_333-336.nxml.txt.nlp	22323922	SENT26	16	16	20	20	vincristine	CHOP	PA451879	1649	0.489
NULL	Arthritis_Res_Ther_2008_Aug_18_10(4)_R93.nxml.txt.nlp	18710567	SENT62	5	5	15	15	fluorescein	San	PA164746009	80218	0.489
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Apr_9_70(Pt_5)_o528.nxml.txt.nlp	24860341	SENT72	40	40	24	24	ethanol	mol	PA448073	90527	0.489
NULL	Oncol_Lett_2014_May_11_7(5)_1401-1408.nxml.txt.nlp	24765145	SENT106	4	4	9	9	paclitaxel	PI3K	PA450761	5290	0.489
NULL	Ann_Surg_Oncol_2010_Apr_6_17(4)_1010-1023.nxml.txt.nlp	20052553	SENT141	31	31	37	37	leucovorin	CEA	PA450198	5670;1087	0.489
NULL	J_Hematol_Oncol_2013_Jun_3_6_38.nxml.txt.nlp	23731980	SENT172	24	24	19	19	vinorelbine	HER2	PA451881	2064	0.489
NULL	Exp_Neurobiol_2013_Jun_27_22(2)_59-67.nxml.txt.nlp	23833554	SENT68	21	21	16	16	thrombin	IFN	PA451674	3439	0.489
NULL	Front_Hum_Neurosci_2010_Nov_2_4_204.nxml.txt.nlp	21120136	SENT762	4	4	10	10	choline	spatial	PA448976	219793	0.489
NULL	Glycoconj_J_2012_Apr_14_29(2-3)_93-105.nxml.txt.nlp	22246380	SENT173	21	21	35	35	sugar	LCA	PA451529	5788	0.489
NULL	Cardiovasc_Diabetol_2010_Nov_25_9_78.nxml.txt.nlp	21106105	SENT287	7	7	1	1	dextran	STZ	PA449261	6484	0.489
NULL	Autoimmune_Dis_2012_Aug_1_2012_207190.nxml.txt.nlp	22900150	SENT7	8	8	10	10	hyaluronan	CD44	PA165958431	960	0.489
NULL	Hum_Mol_Genet_2013_Nov_15_22(22)_4616-4626.nxml.txt.nlp	23814041	SENT112	7	7	14	14	doxycycline	UBE2	PA449415	7318	0.489
NULL	Adv_Hematol_2010_May_16_2010_672137.nxml.txt.nlp	20490274	SENT22	23	23	17	17	idarubicin	AIDA	PA449961	64853	0.489
NULL	Ann_Thorac_Med_2007_Apr-Jun_2(2)_52-57.nxml.txt.nlp	19727346	SENT129	22	22	20	20	cefotaxime	CTX	PA448852	1593	0.489
NULL	Acta_Neuropathol_2010_Feb_21_119(2)_157-175.nxml.txt.nlp	19936768	SENT248	11	11	22	22	rosiglitazone	MKP-1	PA451283	1843	0.489
NULL	Gut_Pathog_2014_May_28_6_17.nxml.txt.nlp	24883113	SENT163	9	9	11	11	furazolidone	TMP	PA164746760	2012	0.489
NULL	Cardiovasc_Res_2011_Apr_1_90(1)_105-112.nxml.txt.nlp	21123217	SENT39	14	14	34	34	fluoxetine	San	PA449673	80218	0.489
NULL	Crit_Care_2000_Oct_13_4(Suppl_2)_S21-S25.nxml.txt.nlp	11255595	SENT8	12	12	6	6	furosemide	STP	PA449719	9322	0.489
NULL	Oncotarget_2014_Feb_8_5(6)_1609-1620.nxml.txt.nlp	24742492	SENT222	9	9	20	20	phenol	EGF	PA450913	1950	0.489
NULL	Nucleic_Acids_Res_2011_Oct_8_39(18)_e122.nxml.txt.nlp	21742759	SENT134	31	31	35	35	thrombin	CEA	PA451674	5670;1087	0.489
NULL	Clin_Pharmacokinet_2012_Jun_13_51(6)_e1-e18.nxml.txt.nlp	22550964	SENT299	46	46	19	19	canakinumab	IL-6	PA165958358	3569	0.489
NULL	J_Mol_Med_(Berl)_2012_Oct_20_90(10)_1223-1231.nxml.txt.nlp	22527886	SENT76	9	9	23	23	hyaluronan	PITPNC1	PA165958431	26207	0.489
NULL	Braz_J_Microbiol_2014_Jan_15_44(3)_807-812.nxml.txt.nlp	24516449	SENT133	35	35	18	18	kanamycin	CTX	PA450137	1593	0.489
NULL	Mar_Drugs_2014_Dec_17_12(12)_6038-6057.nxml.txt.nlp	25522316	SENT59	30	30	22	22	galactose	A10	PA449725	28870	0.489
NULL	Korean_J_Radiol_2011_Apr_25_May-Jun_12(3)_319-326.nxml.txt.nlp	21603291	SENT62	23	23	15	15	propranolol	DBP	PA451145	3295;1628;2638	0.489
NULL	Biomed_Res_Int_2014_Jan_29_2014_361020.nxml.txt.nlp	24605326	SENT223	1	1	32	32	staurosporine	CDK5	PA165109623	1020	0.489
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2011_Sep_13_4_47-62.nxml.txt.nlp	22879794	SENT120	13	13	29	29	exenatide	PPG	PA164749238	5552	0.489
NULL	Cancer_Gene_Ther_2013_Jul_14_20(7)_394-402.nxml.txt.nlp	23764901	SENT225	24	24	4	4	bicalutamide	PC3	PA164746255	57332;7832;5122	0.489
NULL	J_Bras_Pneumol_2013_Jan-Feb_39(1)_108-110.nxml.txt.nlp	23503494	SENT49	33	33	7	7	topotecan	TFI	PA451729	7035	0.489
NULL	Eur_J_Neurosci_2007_Feb_25(3)_837-846.nxml.txt.nlp	17313573	SENT217	10	10	17	17	colchicine	SRM	PA449092	6723;6725	0.489
NULL	Cardiovasc_Diabetol_2008_Feb_26_7_3.nxml.txt.nlp	18302760	SENT219	0	0	2	2	rosiglitazone	CD36	PA451283	948	0.489
NULL	Diabetes_2013_Jul_14_62(7)_2559-2568.nxml.txt.nlp	23423566	SENT296	13	13	16	16	collagenase	MTA1	PA449107	9112	0.489
NULL	J_Invest_Dermatol_2012_Apr_22_132(4)_1253-1262.nxml.txt.nlp	22189789	SENT282	3	3	16	16	capsaicin	TRPV4	PA448776	59341	0.489
NULL	Cardiovasc_Diabetol_2013_Jun_8_12_86.nxml.txt.nlp	23758640	SENT135	21	21	17	17	glucose	CRP	PA449773	1401;140913	0.489
NULL	Curr_Chem_Genomics_2010_Mar_1_4_1-8.nxml.txt.nlp	20448812	SENT142	10	10	25	25	methotrexate	OATP1B1	PA450428	10599	0.489
NULL	Ann_Rheum_Dis_2013_Aug_21_72(8)_1287-1294.nxml.txt.nlp	22915624	SENT8	22	22	15	15	methotrexate	MRI	PA450428	78996	0.489
NULL	Crit_Care_2011_Apr_20_15(2)_221.nxml.txt.nlp	21586104	SENT173	28	28	16	16	glucose	adiponectin	PA449773	9370	0.489
NULL	Clin_Ophthalmol_2012_May_29_6_817-830.nxml.txt.nlp	22701083	SENT70	34	34	30	30	glucosamine	DUOX1	PA164747613	53905	0.489
NULL	Indian_J_Med_Res_2014_Jan_139(1)_27-65.nxml.txt.nlp	24604039	SENT254	36	36	8	8	levodopa	COMT	PA450213	1312	0.489
NULL	Am_J_Physiol_Cell_Physiol_2014_Jan_15_306(2)_C89-C97.nxml.txt.nlp	24133067	SENT53	0	0	9	9	hyaluronan	HAS3	PA165958431	3038	0.489
NULL	Evid_Based_Complement_Alternat_Med_2011_Mar_17_2011_726723.nxml.txt.nlp	21584252	SENT58	0	0	14	14	berberine	AMPK	PA165860812	5563	0.489
NULL	Indian_J_Med_Res_2014_Jan_139(1)_76-82.nxml.txt.nlp	24604041	SENT30	26	26	28	28	albendazole	STH	PA164746058	246744	0.489
NULL	Curr_Neuropharmacol_2012_Jun_10(2)_97-123.nxml.txt.nlp	23204981	SENT754	15	15	17	17	fluoxetine	5-HT1A	PA449673	3350	0.489
NULL	Ecol_Evol_2014_Aug_25_4(16)_3218-3235.nxml.txt.nlp	25473475	SENT330	34	34	14	14	sulfanilamide	CO2	PA451545	4513	0.489
NULL	Ann_Med_2011_Nov_5_43(7)_531-544.nxml.txt.nlp	21815879	SENT15	27	27	12	12	thrombin	ADP	PA451674	23038	0.489
NULL	J_Inflamm_(Lond)_2007_May_4_4_10.nxml.txt.nlp	17480224	SENT204	14	14	6	6	ketamine	IL-4	PA450144	3565	0.489
NULL	Int_J_Mol_Sci_2012_Feb_1_13(2)_1512-1523.nxml.txt.nlp	22408405	SENT29	7	7	22	22	olmesartan	LOX-1	PA164742950	4973	0.489
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jun_20_68(Pt_7)_o2151.nxml.txt.nlp	22798824	SENT4	20	20	15	15	ethanol	mol	PA448073	90527	0.489
NULL	Summit_on_Translat_Bioinforma_2009_Mar_1_2009_124-128.nxml.txt.nlp	21347183	SENT72	16	16	9	9	salbutamol	ADRB2	PA448068	154	0.489
NULL	J_Hum_Kinet_2011_Dec_25_30_65-73.nxml.txt.nlp	23487396	SENT163	40	40	12	12	creatine	LPO	PA164778930	4025	0.489
NULL	Curr_Oncol_2009_Jul_16(Suppl_2)_S14-S23.nxml.txt.nlp	19672417	SENT208	20	20	0	0	exemestane	ATAC	PA449563	6375	0.489
NULL	J_Gen_Physiol_1959_Nov_1_43(2)_301-313.nxml.txt.nlp	13807760	SENT0	10	10	1	1	creatine	Gen	PA164778930	348654	0.489
NULL	Indian_J_Urol_2007_Jan-Mar_23(1)_67-69.nxml.txt.nlp	19675767	SENT22	17	17	5	5	aminoglutethimide	DES	PA448375	1674	0.489
NULL	J_Radiat_Res_2012_Sep_10_53(5)_704-709.nxml.txt.nlp	22843360	SENT94	20	20	2	2	docetaxel	ADM	PA449383	133	0.489
NULL	Crit_Care_2011_Nov_16_15(6)_R271.nxml.txt.nlp	22087790	SENT164	2	2	30	30	nitroprusside	Yes	PA451406	7525	0.489
NULL	J_Immunol_Res_2014_Feb_3_2014_671431.nxml.txt.nlp	24741615	SENT241	16	16	30	30	paraformaldehyde	CD56	PA450790	4684	0.489
NULL	Virol_J_2009_Dec_1_6_213.nxml.txt.nlp	19951438	SENT8	20	20	22	22	etoposide	TRAIL	PA449552	8743	0.489
NULL	Case_Rep_Hematol_2015_Jan_5_2015_321602.nxml.txt.nlp	25628902	SENT4	5	5	7	7	cyclophosphamide	CTX	PA449165	1593	0.489
NULL	Arch_Dis_Child_2014_Dec_8_99(12)_1143-1146.nxml.txt.nlp	25202131	SENT58	13	13	8	8	phenytoin	CYP2B6	PA450947	1555	0.489
NULL	Crit_Care_2011_Nov_16_15(6)_R271.nxml.txt.nlp	22087790	SENT164	2	2	46	46	nitroprusside	Yes	PA451406	7525	0.489
NULL	J_Geriatr_Cardiol_2014_Jun_11(2)_151-157.nxml.txt.nlp	25009566	SENT113	0	0	4	4	cilostazol	CDP	PA164746334	1523	0.489
NULL	Int_J_Anal_Chem_2011_Oct_10_2011_124917.nxml.txt.nlp	22007220	SENT177	13	13	15	15	risperidone	API	PA451257	5345	0.489
NULL	Clin_Med_Insights_Oncol_2012_May_16_6_205-217.nxml.txt.nlp	22654526	SENT250	1	1	4	4	dasatinib	IL-2	PA162372878	3558	0.489
NULL	Indian_J_Pharm_Sci_2014_Mar-Apr_76(2)_116-124.nxml.txt.nlp	24843184	SENT21	14	14	12	12	trimethoprim	TMP	PA451788	2012	0.489
NULL	Biomed_Eng_Online_2013_Apr_8_12_28.nxml.txt.nlp	23566031	SENT80	10	10	19	19	collagenase	CO2	PA449107	4513	0.489
NULL	Pharmaceutics_2013_Dec_19_6(1)_1-25.nxml.txt.nlp	24662363	SENT252	9	9	38	38	calcein	DC8	PA132595336	25936	0.489
NULL	Clin_Interv_Aging_2008_Mar_3(1)_45-50.nxml.txt.nlp	18488877	SENT148	19	19	8	8	raloxifene	STAR	PA451221	6770;2984	0.489
NULL	Ann_Indian_Acad_Neurol_2008_Jan-Mar_11(1)_13-19.nxml.txt.nlp	19966973	SENT55	19	19	7	7	curcumin	C21	PA151958596	79718	0.489
NULL	J_Evol_Biol_2010_May_23(5)_1033-1049.nxml.txt.nlp	20345808	SENT39	40	40	45	45	nadh	ND2	PA164755085	4536	0.489
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Dec_23_68(Pt_1)_o228.nxml.txt.nlp	22259509	SENT67	13	13	20	20	ethanol	mol	PA448073	90527	0.489
NULL	Arch_Osteoporos_2013_Oct_11_8(1-2)_136.nxml.txt.nlp	24113837	SENT2910	29	29	18	18	teriparatide	PTH	PA451620	5741	0.488
NULL	Arthritis_Res_Ther_2012_Mar_8_14(Suppl_2)_A2.nxml.txt.nlp	NULL	SENT2	11	11	13	13	teriparatide	PTH	PA451620	5741	0.488
NULL	Drug_Des_Devel_Ther_2014_Sep_23_8_1527-1538.nxml.txt.nlp	25284985	SENT184	30	30	26	26	celecoxib	IFN	PA448871	3439	0.488
NULL	Chem_Cent_J_2012_Feb_21_6_15.nxml.txt.nlp	22353684	SENT112	13	13	11	11	acebutolol	mol	PA448011	90527	0.488
NULL	Ann_Clin_Microbiol_Antimicrob_2009_Sep_24_8_26.nxml.txt.nlp	19778428	SENT244	30	30	4	4	erythromycin	PEN	PA449493	9933	0.488
NULL	Breast_Cancer_Res_2014_Dec_6_16(6)_491.nxml.txt.nlp	25479686	SENT252	12	12	0	0	medroxyprogesterone	ANOVA	PA450344	4858	0.488
NULL	Environ_Health_Perspect_2008_May_24_116(5)_599-604.nxml.txt.nlp	18470317	SENT207	1	1	3	3	diethylstilbestrol	DES	PA449307	1674	0.488
NULL	Mol_Cancer_2010_Jun_25_9_166.nxml.txt.nlp	20579378	SENT177	4	4	2	2	gefitinib	EGF	PA131301952	1950	0.488
NULL	Case_Rep_Gastroenterol_2013_Oct_5_7(3)_428-432.nxml.txt.nlp	24403880	SENT71	16	16	18	18	lipase	CEA	PA450239	5670;1087	0.488
NULL	Cardiol_Res_Pract_2011_Apr_7_2011_836806.nxml.txt.nlp	21559227	SENT189	8	8	5	5	resveratrol	AMPK		5563	0.488
NULL	Oncotarget_2011_Sep_22_2(9)_713-727.nxml.txt.nlp	21946665	SENT191	7	7	1	1	imatinib	IFN	PA10804	3439	0.488
NULL	Brain_2008_Nov_22_131(11)_3072-3080.nxml.txt.nlp	18945724	SENT65	16	16	6	6	methylprednisolone	CD19	PA450466	930	0.488
NULL	Mol_Biol_Int_2011_Feb_24_2011_137459.nxml.txt.nlp	22091395	SENT178	12	12	26	26	arsenite	FMRP	PA452638	2332	0.488
NULL	Cell_Commun_Signal_2014_Oct_5_12(1)_54.nxml.txt.nlp	NULL	SENT119	8	8	10	10	doxycycline	ROCK1	PA449415	6093	0.488
NULL	Oxid_Med_Cell_Longev_2013_Sep_8_2013_184598.nxml.txt.nlp	24194976	SENT171	0	0	7	7	oltipraz	AMPK		5563	0.488
NULL	Oncotarget_2011_Mar_10_2(3)_186-196.nxml.txt.nlp	21406729	SENT99	0	0	7	7	orlistat	TRAIL	PA164776864	8743	0.488
NULL	Front_Genet_2014_Oct_14_5_314.nxml.txt.nlp	25352860	SENT105	17	17	34	34	napqi	CYP3A4		1576	0.488
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Dec_15_67(Pt_1)_o136.nxml.txt.nlp	21522646	SENT6	7	7	2	2	coumarin	mol	PA134521193	90527	0.488
NULL	Neuroscience_2008_Aug_13_155(2)_556-564.nxml.txt.nlp	18619738	SENT147	5	5	3	3	choline	CDP	PA448976	1523	0.488
NULL	Environ_Health_Perspect_2010_Jan_10_118(1)_108-115.nxml.txt.nlp	20056578	SENT21	22	22	11	11	arsenite	ABCG2	PA452638	9429	0.488
NULL	Int_J_Med_Sci_2014_Jul_29_11(10)_1015-1021.nxml.txt.nlp	25136257	SENT30	6	6	8	8	rosiglitazone	APOM	PA451283	55937	0.488
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1063.nxml.txt.nlp	24556678	SENT32	3	3	5	5	thioridazine	TRAIL	PA451666	8743	0.488
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_21-38.nxml.txt.nlp	19305786	SENT555	13	13	15	15	capsaicin	TRPV1	PA448776	7442	0.488
NULL	Int_J_Hypertens_2012_Feb_8_2012_189512.nxml.txt.nlp	22518281	SENT153	4	4	19	19	hemin	HO-1	PA449849	3162	0.488
NULL	Int_J_Cell_Biol_2013_Apr_18_2013_273086.nxml.txt.nlp	23690780	SENT77	11	11	4	4	hydroquinone	CO2	PA449924	4513	0.488
NULL	J_Hematol_Oncol_2013_Jun_3_6_38.nxml.txt.nlp	23731980	SENT123	28	28	17	17	pertuzumab	HER2		2064	0.488
NULL	Br_J_Cancer_2012_May_8_106(10)_1587-1590.nxml.txt.nlp	22568998	SENT65	19	19	21	21	sunitinib	IFN	PA162372840	3439	0.488
NULL	Arthritis_Res_2001_Sep_12_3(6)_362-367.nxml.txt.nlp	11714390	SENT147	18	18	14	14	creatine	B27	PA164778930	56246	0.488
NULL	Chem_Cent_J_2012_Sep_20_6_105.nxml.txt.nlp	22995678	SENT25	16	16	13	13	cefixime	MOX	PA164768821	26002	0.488
NULL	Br_J_Cancer_2006_Dec_4_95(11)_1483-1489.nxml.txt.nlp	17106442	SENT104	14	14	10	10	gefitinib	TTP	PA131301952	7538;11093	0.488
NULL	Diabetes_2011_Mar_21_60(3)_1008-1018.nxml.txt.nlp	21282362	SENT200	21	21	6	6	glucose	FADS1	PA449773	3992	0.488
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT298	22	22	17	17	olanzapine	PRL	PA450688	5617	0.488
NULL	Nat_Commun_2013_Nov_26_4_10_1038_ncomms3816.nxml.txt.nlp	24281383	SENT98	4	4	34	34	ethanol	ANOVA	PA448073	4858	0.488
NULL	Cancers_(Basel)_2014_Jul_22_6(3)_1540-1552.nxml.txt.nlp	25055117	SENT571	18	18	10	10	carboplatin	LETS	PA448803	2335	0.488
NULL	Cell_Commun_Signal_2013_Nov_11_11_86.nxml.txt.nlp	24215724	SENT240	20	20	18	18	thrombin	PAR4	PA451674	9002;5074	0.488
NULL	Summit_on_Translat_Bioinforma_2009_Mar_1_2009_124-128.nxml.txt.nlp	21347183	SENT70	9	9	11	11	thioguanine	TPMT	PA451663	7172	0.488
NULL	Alzheimers_Res_Ther_2011_Jun_29_3(3)_21.nxml.txt.nlp	21722346	SENT120	3	3	1	1	creatine	Q10	PA164778930	27161	0.488
NULL	Curr_Pharm_Des_2008_Oct_14(28)_2983-2998.nxml.txt.nlp	18991714	SENT131	18	18	16	16	cetuximab	EGF	PA10040	1950	0.488
NULL	Basic_Res_Cardiol_2011_Sep_24_106(5)_829-847.nxml.txt.nlp	21516490	SENT73	42	42	10	10	fluorescein	CLB	PA164746009	171425	0.488
NULL	Neural_Plast_2013_Jun_12_2013_318596.nxml.txt.nlp	23840971	SENT206	39	39	27	27	pilocarpine	SNAP-25	PA450962	6616	0.488
NULL	Front_Behav_Neurosci_2013_Dec_19_7_196.nxml.txt.nlp	24391561	SENT284	24	24	26	26	estradiol	NCM	PA449503	57703	0.488
NULL	J_Indian_Soc_Periodontol_2014_Sep-Oct_18(5)_586-592.nxml.txt.nlp	25425820	SENT72	11	11	15	15	lidocaine	LOX	PA450226	4015	0.488
NULL	Int_J_Vasc_Med_2012_Jul_24_2012_508416.nxml.txt.nlp	22888436	SENT163	27	27	43	43	troglitazone	PRIC285	PA451799	85441	0.488
NULL	J_Cell_Mol_Med_2013_Nov_9_17(11)_1484-1493.nxml.txt.nlp	24015932	SENT132	10	10	4	4	berberine	PAO	PA165860812	196743;54498	0.488
NULL	Diabetes_2011_Mar_21_60(3)_909-917.nxml.txt.nlp	21300843	SENT162	43	43	13	13	galactose	GdA	PA449725	5047	0.488
NULL	J_Ophthalmic_Inflamm_Infect_2011_Nov_6_2(1)_21-28.nxml.txt.nlp	22057810	SENT112	17	17	13	13	infliximab	CTX	PA452639	1593	0.488
NULL	Biochemistry_2009_Dec_1_48(47)_11283-11295.nxml.txt.nlp	19863112	SENT106	21	21	17	17	streptomycin	FBS	PA451512	64319;26269	0.488
NULL	Acta_Pharmacol_Sin_2010_Jan_28_31(1)_102-110.nxml.txt.nlp	20037603	SENT130	9	9	7	7	isoproterenol	EGF	PA450121	1950	0.488
NULL	J_Korean_Med_Sci_2009_Jan_29_24(Suppl_1)_S170-S175.nxml.txt.nlp	19194548	SENT76	0	0	6	6	cisplatin	EPO	PA449014	7076;8288;2056	0.488
NULL	Case_Rep_Pediatr_2014_Feb_12_2014_692530.nxml.txt.nlp	24711953	SENT27	4	4	8	8	lipase	gamma	PA450239	9913	0.488
NULL	Int_J_Mol_Sci_2014_Mar_5_15(3)_3970-3988.nxml.txt.nlp	24603537	SENT97	4	4	2	2	curcumin	MCH	PA151958596	5367	0.488
NULL	Nat_Med_2013_Mar_24_19(3)_351-357.nxml.txt.nlp	23435171	SENT189	2	2	26	26	oxygen	CO2	PA450744	4513	0.488
NULL	Ther_Clin_Risk_Manag_2007_Aug_3(4)_591-604.nxml.txt.nlp	18472981	SENT201	15	15	19	19	ethanol	castor	PA448073	54897	0.488
NULL	BMB_Rep_2013_Nov_46(11)_544-549.nxml.txt.nlp	24152910	SENT98	23	23	14	14	thrombin	RAGE	PA451674	177	0.488
NULL	Nucleic_Acids_Res_2005_Aug_2_33(13)_4345-4356.nxml.txt.nlp	16077030	SENT102	27	27	34	34	l-glutamine	CO2	PA10090	4513	0.488
NULL	ScientificWorldJournal_2013_Oct_24_2013_726912.nxml.txt.nlp	24282387	SENT159	14	14	26	26	fluorescein	AVP	PA164746009	114548;551	0.488
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT368	24	24	5	5	pp2	CDH1		51343;999	0.488
NULL	Int_J_Endocrinol_2013_Sep_9_2013_483145.nxml.txt.nlp	24106499	SENT217	16	16	3	3	lipase	NPY	PA450239	4852	0.488
NULL	Br_J_Pharmacol_2014_Oct_26_171(20)_4785-4796.nxml.txt.nlp	25074741	SENT190	12	12	19	19	guanfacine	NK1R	PA449825	6869	0.488
NULL	Arthritis_Res_Ther_2003_Sep_12_5(Suppl_3)_71.nxml.txt.nlp	NULL	SENT2	12	12	29	29	collagenase	AP-1	PA449107	2353;3727;2354;3725	0.488
NULL	Adv_Hematol_2010_Dec_5_2010_595934.nxml.txt.nlp	21151515	SENT154	7	7	21	21	prasugrel	Yes	PA154410481	7525	0.488
NULL	Asian-Australas_J_Anim_Sci_2012_Oct_25(10)_1473-1480.nxml.txt.nlp	25049505	SENT62	35	35	12	12	streptomycin	FBS	PA451512	64319;26269	0.488
NULL	Int_J_Crit_Illn_Inj_Sci_2013_Apr-Jun_3(2)_143-151.nxml.txt.nlp	23961459	SENT116	43	43	40	40	heparin	PF4	PA449855	5196	0.488
NULL	Indian_J_Endocrinol_Metab_2012_Dec_16(Suppl_3)_S627-S636.nxml.txt.nlp	23565499	SENT44	4	4	8	8	vasopressin	OXT	PA451858	5020	0.488
NULL	Cell_Death_Dis_2013_Jun_27_4(6)_e696.nxml.txt.nlp	23807225	SENT176	13	13	7	7	doxycycline	ACL	PA449415	47	0.488
NULL	Hum_Genomics_2008_Sep_1_3(1)_71-78.nxml.txt.nlp	19129091	SENT32	13	13	24	24	nadh	ND2	PA164755085	4536	0.488
NULL	Toxins_(Basel)_2010_Oct_26_2(11)_2490-2518.nxml.txt.nlp	22069563	SENT250	11	11	5	5	cisplatin	CX3CL1	PA449014	6376	0.488
NULL	Biologics_2012_Dec_17_6_429-464.nxml.txt.nlp	23269860	SENT11	28	28	18	18	etanercept	ACR	PA449515	49	0.488
NULL	Cases_J_2009_Aug_5_2_6944.nxml.txt.nlp	19918498	SENT30	34	34	26	26	iron	ANA	PA450087	10950	0.488
NULL	Mol_Cancer_2007_Mar_7_6_18.nxml.txt.nlp	17343740	SENT472	11	11	21	21	genistein	RANK	PA165109660	8792	0.488
NULL	J_Infect_Dis_2014_Jul_15_210(2)_306-310.nxml.txt.nlp	24511100	SENT102	19	19	25	25	pentamidine	IFN	PA450850	3439	0.488
NULL	Breast_Cancer_Res_2009_Nov_18_11(6)_R85.nxml.txt.nlp	19922614	SENT35	16	16	18	18	tamoxifen	BCS	PA451581	617	0.488
NULL	Curr_Hypertens_Rep_2014_Feb_14_16(4)_423.nxml.txt.nlp	24522942	SENT56	24	24	28	28	cyclosporine	EPO	PA449167	7076;8288;2056	0.488
NULL	Toxins_(Basel)_2010_May_28_2(6)_1207-1224.nxml.txt.nlp	22069634	SENT521	0	0	10	10	capsaicin	AP-1	PA448776	2353;3727;2354;3725	0.488
NULL	Surg_Today_2012_Jan_6_42(1)_8-28.nxml.txt.nlp	22139128	SENT230	17	17	23	23	tegafur	PSK	PA452620	9344	0.488
NULL	Nucleic_Acids_Res_2011_May_16_39(10)_e71.nxml.txt.nlp	21415007	SENT207	13	13	5	5	tetracycline	SMN2	PA451640	6607	0.488
NULL	Oxid_Med_Cell_Longev_2009_Jan-Mar_2(1)_52-57.nxml.txt.nlp	20046645	SENT119	11	11	8	8	zolpidem	ROS	PA451976	6098	0.488
NULL	EMBO_Mol_Med_2012_Sep_7_4(9)_896-909.nxml.txt.nlp	22887866	SENT244	13	13	10	10	lovastatin	c-Myc	PA450272	4609	0.488
NULL	Acta_Histochem_Cytochem_2010_May_1_43(2)_61-68.nxml.txt.nlp	20514293	SENT67	19	19	15	15	hyaluronan	LYVE-1	PA165958431	10894	0.488
NULL	Environ_Health_Perspect_1995_Oct_103(Suppl_7)_79-82.nxml.txt.nlp	8593880	SENT6	8	8	3	3	tamoxifen	DES	PA451581	1674	0.488
NULL	Breast_Cancer_Res_2011_Apr_20_13(2)_307.nxml.txt.nlp	21575280	SENT21	13	13	10	10	tamoxifen	FOXA1	PA451581	3169	0.488
NULL	Biomed_Res_Int_2014_Jan_29_2014_831845.nxml.txt.nlp	24605337	SENT146	27	27	4	4	bupivacaine	S6K1	PA135057240	6198	0.488
NULL	Asian_J_Androl_2014_Jun_13_Nov-Dec_16(6)_864-868.nxml.txt.nlp	24923459	SENT39	23	23	17	17	ethanol	mol	PA448073	90527	0.488
NULL	Breast_Cancer_Res_2012_Jan_6_14(1)_R2.nxml.txt.nlp	22225778	SENT174	23	23	12	12	docetaxel	p50	PA449383	958;4790	0.488
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT13	2	2	4	4	atorvastatin	TNF	PA448500	7124	0.488
NULL	Hum_Genomics_2008_Sep_1_3(1)_71-78.nxml.txt.nlp	19129091	SENT32	13	13	30	30	nadh	ND4L	PA164755085	4539	0.488
NULL	Evid_Based_Complement_Alternat_Med_2013_May_28_2013_629750.nxml.txt.nlp	23781265	SENT241	0	0	11	11	capsaicin	GADD153	PA448776	1649	0.488
NULL	Autoimmune_Dis_2012_Dec_6_2012_784364.nxml.txt.nlp	23304459	SENT291	21	21	11	11	mitoxantrone	CSM1	PA450526	1674	0.488
NULL	J_Gen_Physiol_1981_Apr_1_77(4)_387-417.nxml.txt.nlp	7241088	SENT0	14	14	1	1	valinomycin	Gen	PA151917011	348654	0.488
NULL	Int_J_Cardiovasc_Imaging_2012_Apr_21_28(4)_843-853.nxml.txt.nlp	21509430	SENT165	30	30	12	12	iron	spatial	PA450087	219793	0.488
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT225	0	0	17	17	sitagliptin	GLP-1	PA164748978	100125288	0.488
NULL	Drugs_R_D_2013_Sep_19_13(3)_199-205.nxml.txt.nlp	24048773	SENT76	33	33	0	0	creatine	NAC	PA164778930	22861	0.488
NULL	J_Gynecol_Oncol_2011_Mar_31_22(1)_9-17.nxml.txt.nlp	21607090	SENT161	19	19	26	26	paclitaxel	PCFT	PA450761	113235	0.488
NULL	Acta_Physiol_(Oxf)_2007_Sep_191(1)_43-57.nxml.txt.nlp	17524066	SENT35	23	23	4	4	nifedipine	PES	PA450631	23481	0.488
NULL	Oxid_Med_Cell_Longev_2013_Nov_14_2013_210563.nxml.txt.nlp	24349609	SENT32	12	12	10	10	hemin	HO-1	PA449849	3162	0.488
NULL	Mediators_Inflamm_2010_Jun_21_2010_194896.nxml.txt.nlp	20652055	SENT195	11	11	13	13	berberine	MCP-1	PA165860812	6347	0.488
NULL	Adv_Hematol_2010_Dec_5_2010_595934.nxml.txt.nlp	21151515	SENT154	15	15	10	10	ticagrelor	Yes	PA165374673	7525	0.488
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_13_2012_978127.nxml.txt.nlp	23304234	SENT177	9	9	20	20	fosinopril	ACE2	PA449710	59272	0.488
NULL	Daru_2012_Dec_26_20(1)_100.nxml.txt.nlp	23351304	SENT20	27	27	25	25	pp2	PP1		5540;5464	0.488
NULL	Indian_J_Anaesth_2011_Mar-Apr_55(2)_101-103.nxml.txt.nlp	21712862	SENT6	7	7	9	9	diclofenac	COX	PA449293	1351	0.488
NULL	Indian_J_Anaesth_2014_Jul-Aug_58(4)_423-429.nxml.txt.nlp	25197110	SENT33	11	11	9	9	ondansetron	ODF	PA450705	8600	0.488
NULL	Breast_Cancer_Res_2005_Mar_4_7(3)_R345-R352.nxml.txt.nlp	15987429	SENT245	28	28	11	11	ns-398	CARB		9482	0.488
NULL	J_Young_Pharm_2010_Oct-Dec_2(4)_417-419.nxml.txt.nlp	21264106	SENT10	11	11	13	13	lamivudine	API	PA450163	5345	0.488
NULL	Front_Cell_Neurosci_2014_Jun_25_8_167.nxml.txt.nlp	24987334	SENT198	5	5	16	16	pentobarbital	APOE	PA450859	348	0.487
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Dec_17_3(12)_e152.nxml.txt.nlp	25518025	SENT34	6	6	8	8	oxymorphone	CYP2D6	PA450748	1565	0.487
NULL	Neural_Regen_Res_2013_Nov_5_8(31)_2932-2941.nxml.txt.nlp	25206614	SENT149	13	13	19	19	creatine	spatial	PA164778930	219793	0.487
NULL	Front_Endocrinol_(Lausanne)_2014_Jan_16_5_1.nxml.txt.nlp	24474947	SENT32	0	0	37	37	estradiol	PI3K	PA449503	5290	0.487
NULL	J_Gastroenterol_2013_Jan_27_48(1)_22-30.nxml.txt.nlp	23104468	SENT71	3	3	7	7	ribavirin	SOC	PA451241	91544	0.487
NULL	Biomed_Res_Int_2014_Jan_29_2014_361020.nxml.txt.nlp	24605326	SENT223	7	7	10	10	flavopiridol	CDK2	PA452627	1017	0.487
NULL	Breast_Cancer_Res_2000_Feb_18_2(2)_E005.nxml.txt.nlp	NULL	SENT41	37	37	24	24	vinorelbine	HER2	PA451881	2064	0.487
NULL	Case_Rep_Vasc_Med_2012_Dec_13_2012_750953.nxml.txt.nlp	23304629	SENT53	7	7	2	2	diltiazem	SPG	PA449334	55764	0.487
NULL	Cell_J_2012_Dec_22_Winter_13(4)_265-274.nxml.txt.nlp	23507995	SENT249	7	7	10	10	ethanol	spatial	PA448073	219793	0.487
NULL	Acta_Pharmacol_Sin_2010_Apr_8_31(4)_461-469.nxml.txt.nlp	20208553	SENT102	1	1	8	8	ethanol	adiponectin	PA448073	9370	0.487
NULL	Int_J_Cardiovasc_Imaging_2013_Jun_3_29(5)_959-966.nxml.txt.nlp	23378157	SENT84	3	3	19	19	nitrogen	HGB	PA450643	114757	0.487
NULL	Breast_Cancer_Res_2010_Jul_22_12(4)_R53.nxml.txt.nlp	20649975	SENT124	5	5	35	35	tamoxifen	HER2	PA451581	2064	0.487
NULL	Drug_Des_Devel_Ther_2014_Sep_9_8_1307-1314.nxml.txt.nlp	25246772	SENT166	15	15	23	23	cyclosporine	HTX	PA449167	7547	0.487
NULL	Arthritis_Res_Ther_2009_Feb_3_11(1)_R15.nxml.txt.nlp	19192274	SENT212	17	17	27	27	chloroquine	MIP-3	PA448948	6368	0.487
NULL	Oncotarget_2012_Mar_31_3(3)_236-260.nxml.txt.nlp	22470194	SENT9	22	22	19	19	sorafenib	SHARP	PA7000	23013	0.487
NULL	Front_Neurosci_2010_Mar_19_4_22.nxml.txt.nlp	20582262	SENT83	0	0	11	11	bethanechol	P2X3	PA448613	5024	0.487
NULL	Nucleic_Acids_Res_2012_Jun_10_40(11)_4804-4815.nxml.txt.nlp	22328728	SENT238	7	7	3	3	hemin	SIRT1	PA449849	23411	0.487
NULL	Mol_Cancer_2007_Jan_19_6_9.nxml.txt.nlp	17233922	SENT169	5	5	8	8	flavopiridol	ARC	PA452627	8996;23237	0.487
NULL	Ann_Surg_Oncol_2011_Jan_23_18(1)_125-133.nxml.txt.nlp	20652755	SENT105	14	14	3	3	tamoxifen	pT1	PA451581	58492	0.487
NULL	Oncoimmunology_2013_Aug_1_2(8)_e26218.nxml.txt.nlp	24179709	SENT149	20	20	29	29	hyaluronan	IL-6	PA165958431	3569	0.487
NULL	Int_J_Gen_Med_2009_Jul_30_2_91-108.nxml.txt.nlp	20360893	SENT115	12	12	10	10	mitomycin	PDF	PA450524	64146;9518	0.487
NULL	Br_J_Cancer_2003_Mar_10_88(5)_788-795.nxml.txt.nlp	12618891	SENT175	12	12	14	14	bosentan	FasL	PA10034	356	0.487
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT7	0	0	28	28	resveratrol	Bcl-2		596	0.487
NULL	Biomed_Res_Int_2014_Mar_6_2014_712893.nxml.txt.nlp	24734240	SENT123	9	9	6	6	ethanol	HIF-1alpha	PA448073	3091	0.487
NULL	Mol_Cytogenet_2014_Jan_21_7(Suppl_1)_I47.nxml.txt.nlp	24955123	SENT22	9	9	21	21	mitomycin	FANCD2	PA450524	2177	0.487
NULL	Eur_J_Clin_Pharmacol_2014_Mar_22_70(6)_685-693.nxml.txt.nlp	24658827	SENT142	0	0	22	22	cyclosporine	PPARA	PA449167	5465	0.487
NULL	Exp_Ther_Med_2015_Jan_10_9(1)_267-271.nxml.txt.nlp	25452814	SENT25	13	13	6	6	clopidogrel	P-gp	PA449053	5243	0.487
NULL	Open_Biol_2014_May_4(5)_140065.nxml.txt.nlp	24850914	SENT188	21	21	18	18	bortezomib	ALK3	PA10252	657	0.487
NULL	Int_J_Mol_Sci_2014_Sep_29_15(10)_17411-17441.nxml.txt.nlp	25268615	SENT1691	1	1	3	3	hyaluronan	CD44	PA165958431	960	0.487
NULL	Arch_Dis_Child_2014_Dec_8_99(12)_1143-1146.nxml.txt.nlp	25202131	SENT58	13	13	2	2	phenytoin	CYP3A4	PA450947	1576	0.487
NULL	Diabetes_2009_Jun_31_58(6)_1434-1439.nxml.txt.nlp	19336679	SENT147	45	45	32	32	metformin	SLC22A1	PA450395	6580	0.487
NULL	Br_J_Cancer_2010_Feb_2_102(3)_553-560.nxml.txt.nlp	20051956	SENT30	16	16	11	11	pemetrexed	FPGS	PA10810	2356	0.487
NULL	Cell_Death_Dis_2013_Jan_31_4(1)_e478.nxml.txt.nlp	23370278	SENT82	8	8	5	5	bleomycin	KAP1	PA448645	10155	0.487
NULL	Int_J_Mol_Sci_2014_Sep_19_15(9)_16698-16718.nxml.txt.nlp	25244018	SENT1363	15	15	1	1	phenformin	LKB1	PA1000	6794	0.487
NULL	Mol_Syst_Biol_2009_Jul_28_5_288.nxml.txt.nlp	19638969	SENT438	29	29	9	9	resveratrol	HuR		1994	0.487
NULL	J_Hematol_Oncol_2012_May_17_5_24.nxml.txt.nlp	22594538	SENT149	19	19	11	11	vorinostat	p65	PA164748224	5970	0.487
NULL	Eur_J_Nutr_2014_May_25_53(2)_387-393.nxml.txt.nlp	23708056	SENT104	9	9	36	36	l-arginine	ANOVA	PA448478	4858	0.487
NULL	Cancers_(Basel)_2014_Aug_13_6(3)_1670-1690.nxml.txt.nlp	25125485	SENT1162	0	0	2	2	hyaluronan	HAS2	PA165958431	3037	0.487
NULL	Br_J_Clin_Pharmacol_2013_Aug_23_76(2)_299-315.nxml.txt.nlp	23701319	SENT71	10	10	16	16	daclizumab	IL-2	PA164764446	3558	0.487
NULL	Expert_Rev_Mol_Med_2009_Dec_11_e36.nxml.txt.nlp	19951459	SENT390	12	12	21	21	doxycycline	DIRAS3	PA449415	9077	0.487
NULL	Blood_Res_2014_Sep_25_49(3)_148-153.nxml.txt.nlp	25325033	SENT60	8	8	39	39	tositumomab	B2M	PA164748364	567	0.487
NULL	Front_Immunol_2012_Jan_24_3_3.nxml.txt.nlp	22566889	SENT210	11	11	14	14	rituximab	CHOP	PA451261	1649	0.487
NULL	Acta_Pharmacol_Sin_2011_Jul_13_32(7)_967-972.nxml.txt.nlp	21666702	SENT68	9	9	11	11	ketoconazole	CYP2C9	PA450146	1559	0.487
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Sep_30_67(Pt_10)_o2772.nxml.txt.nlp	22064727	SENT4	17	17	2	2	bupropion	mol	PA448687	90527	0.487
NULL	Braz_J_Microbiol_2009_Jun_1_Apr-Jun_40(2)_358-366.nxml.txt.nlp	24031373	SENT242	7	7	10	10	lipase	por	PA450239	64840	0.487
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_13_2014_849783.nxml.txt.nlp	25477998	SENT8	3	3	28	28	creatine	IL-6	PA164778930	3569	0.487
NULL	Hum_Genomics_2009_Jan_1_3(2)_157-168.nxml.txt.nlp	19164092	SENT150	37	37	24	24	lipase	HSL	PA450239	3991	0.487
NULL	Diabetes_Care_2010_Oct_13_33(10)_2250-2253.nxml.txt.nlp	20628086	SENT23	11	11	14	14	rosiglitazone	DREAM	PA451283	30818	0.487
NULL	J_Biol_Chem_2013_Dec_6_288(49)_35387-35395.nxml.txt.nlp	24142790	SENT160	6	6	0	0	meclizine	PCYT2	PA450338	5833	0.487
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT1222	16	16	5	5	tenofovir	SLC22A6	PA10204	9356	0.487
NULL	J_Oncol_2012_Sep_29_2012_879623.nxml.txt.nlp	21977033	SENT175	35	35	29	29	celecoxib	NAC	PA448871	22861	0.487
NULL	Mol_Biol_Cell_2013_Dec_1_24(23)_3620-3633.nxml.txt.nlp	24109599	SENT285	4	4	10	10	galactose	RPL7	PA449725	6129	0.487
NULL	Oncotarget_2014_Jun_8_5(13)_5040-5053.nxml.txt.nlp	24970815	SENT109	4	4	8	8	cisplatin	BBC3	PA449014	27113	0.487
NULL	Open_Dent_J_2013_Apr_5_7_36-46.nxml.txt.nlp	23802022	SENT175	5	5	9	9	teriparatide	CAL	PA451620	54751;57120	0.487
NULL	J_Korean_Med_Sci_2011_Jan_22_26(1)_33-41.nxml.txt.nlp	21218027	SENT36	34	34	19	19	moxifloxacin	DST	PA450555	667	0.487
NULL	Drug_Target_Insights_2007_Oct_30_2_239-247.nxml.txt.nlp	21901078	SENT23	35	35	28	28	abatacept	CD152	PA164747080	1493	0.487
NULL	J_Radiat_Res_2014_Jul_11_55(4)_613-628.nxml.txt.nlp	24522270	SENT91	5	5	9	9	vorinostat	DNA-PKcs	PA164748224	5591	0.487
NULL	Curr_Chem_Genomics_2010_Mar_1_4_1-8.nxml.txt.nlp	20448812	SENT142	2	2	30	30	fluorescein	OATP1B1	PA164746009	10599	0.487
NULL	Extremophiles_2009_Nov_23_13(6)_885-894.nxml.txt.nlp	19701714	SENT136	23	23	21	21	ethanol	mol	PA448073	90527	0.487
NULL	Nat_Med_2013_Oct_8_19(10)_1345-1350.nxml.txt.nlp	24013701	SENT333	19	19	17	17	fluorescein	FDG	PA164746009	23583	0.487
NULL	F1000_Biol_Rep_2010_Sep_8_2_65.nxml.txt.nlp	21173868	SENT28	12	12	16	16	ethanol	SOC	PA448073	91544	0.487
NULL	Behav_Genet_2011_Jul_24_41(4)_625-628.nxml.txt.nlp	21184165	SENT53	19	19	30	30	ethanol	HAP	PA448073	5915;10313	0.487
NULL	Oxid_Med_Cell_Longev_2013_Nov_28_2013_367040.nxml.txt.nlp	24381715	SENT27	16	16	7	7	oxygen	flower	PA450744	11094	0.487
NULL	Br_J_Cancer_2010_Jul_13_103(2)_186-195.nxml.txt.nlp	20588277	SENT194	0	0	6	6	nutlin-3	p53		7157	0.487
NULL	J_Cell_Mol_Med_2014_Apr_20_18(4)_709-720.nxml.txt.nlp	24444314	SENT9	0	0	14	14	metformin	p53	PA450395	7157	0.487
NULL	J_Immunother_Cancer_2014_Aug_19_2_27.nxml.txt.nlp	25324973	SENT58	31	31	20	20	imatinib	IFN	PA10804	3439	0.487
NULL	J_Histochem_Cytochem_2013_Dec_61(12)_857-868.nxml.txt.nlp	24004859	SENT149	1	1	24	24	lipase	HCN2	PA450239	610	0.487
NULL	Clin_Ophthalmol_2012_Sep_7_6_1471-1476.nxml.txt.nlp	23055666	SENT3	14	14	22	22	propofol	NAC	PA451141	22861	0.487
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_6_2014_270930.nxml.txt.nlp	25431606	SENT258	0	0	11	11	curcumin	MCP-1	PA151958596	6347	0.487
NULL	Eur_J_Dent_2012_Apr_6(2)_133-140.nxml.txt.nlp	22509115	SENT197	27	27	1	1	ethanol	P90	PA448073	821	0.487
NULL	Oncotarget_2013_Nov_7_4(12)_2550-2566.nxml.txt.nlp	24334291	SENT207	31	31	36	36	chloroquine	p53	PA448948	7157	0.487
NULL	Int_J_Mol_Sci_2007_Jun_4_8(6)_478-491.nxml.txt.nlp	NULL	SENT158	36	36	34	34	cyclophosphamide	CTX	PA449165	1593	0.487
NULL	Br_J_Cancer_2004_Mar_8_90(5)_944-949.nxml.txt.nlp	14997187	SENT104	6	6	32	32	tamoxifen	FasL	PA451581	356	0.487
NULL	Part_Fibre_Toxicol_2011_Feb_23_8_9.nxml.txt.nlp	21345205	SENT265	0	0	7	7	phenol	F12	PA450913	2161	0.487
NULL	J_Oncol_2010_Feb_15_2010_135632.nxml.txt.nlp	21461395	SENT176	31	31	20	20	doxorubicin	HMGA2	PA449412	8091	0.487
NULL	J_Invest_Dermatol_2013_Aug_133(8)_1928-1929.nxml.txt.nlp	23856932	SENT34	7	7	3	3	vemurafenib	STAT3	PA165946873	6774	0.487
NULL	Int_J_Biol_Sci_2012_Jul_7_8(6)_913-934.nxml.txt.nlp	22811614	SENT85	26	26	40	40	metformin	STZ	PA450395	6484	0.487
NULL	Clin_Ophthalmol_2011_May_6_5_567-572.nxml.txt.nlp	21607026	SENT22	16	16	11	11	ranibizumab	ERG	PA164746012	2078	0.487
NULL	F1000Res_2014_Sep_29_3_228.nxml.txt.nlp	25485098	SENT270	5	5	12	12	creatine	AGAT	PA164778930	2628	0.487
NULL	Curr_Oncol_2008_Oct_15(5)_237-243.nxml.txt.nlp	19008999	SENT165	0	0	19	19	resveratrol	Yes		7525	0.487
NULL	Oxid_Med_Cell_Longev_2012_Jul_5_2012_718976.nxml.txt.nlp	22829960	SENT87	27	27	29	29	vasopressin	AVP	PA451858	114548;551	0.487
NULL	Br_J_Cancer_2009_Sep_15_101(6)_924-934.nxml.txt.nlp	19690550	SENT292	10	10	7	7	capecitabine	CRT	PA448771	811	0.487
NULL	Support_Care_Cancer_2012_Dec_26_20(12)_3241-3246.nxml.txt.nlp	22534864	SENT29	0	0	10	10	palonosetron	HEC	PA10352	10403	0.487
NULL	J_Hematol_Oncol_2011_Jan_21_4_5.nxml.txt.nlp	21255411	SENT229	9	9	12	12	paclitaxel	EGFR	PA450761	1956	0.487
NULL	J_Immunol_Res_2014_Jul_16_2014_696812.nxml.txt.nlp	25133198	SENT269	11	11	7	7	rifaximin	CD4	PA164752443	920	0.487
NULL	Exp_Ther_Med_2014_Jun_27_7(6)_1752-1756.nxml.txt.nlp	24926379	SENT7	9	9	3	3	vildagliptin	PPG	PA165958346	5552	0.487
NULL	Case_Rep_Ophthalmol_2011_Mar_12_2(1)_105-110.nxml.txt.nlp	22110438	SENT65	16	16	14	14	ribavirin	IFN	PA451241	3439	0.487
NULL	Amyloid_2014_Sep_11_21(3)_175-184.nxml.txt.nlp	24918964	SENT99	0	0	2	2	anakinra	TTR	PA10799	7276	0.487
NULL	Front_Neurol_2013_Jun_20_4_77.nxml.txt.nlp	23801984	SENT598	5	5	10	10	ketamine	gamma	PA450144	9913	0.487
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_7-17.nxml.txt.nlp	17912633	SENT130	0	0	14	14	letrozole	aromatase	PA450196	1588	0.487
NULL	FEBS_Open_Bio_2012_Aug_22_2_279-283.nxml.txt.nlp	23650611	SENT111	2	2	4	4	raloxifene	IFN	PA451221	3439	0.487
NULL	Oncotarget_2012_Oct_27_3(10)_1052-1053.nxml.txt.nlp	23165648	SENT26	12	12	10	10	nutlin-3	IFN		3439	0.487
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1051.nxml.txt.nlp	24503543	SENT144	16	16	19	19	sorafenib	Yes	PA7000	7525	0.487
NULL	Comp_Hepatol_2005_Feb_8_4_2.nxml.txt.nlp	15701172	SENT44	0	0	11	11	clotrimazole	CYP3A	PA449057	1574	0.487
NULL	Onco_Targets_Ther_2014_Oct_4_7_1817-1828.nxml.txt.nlp	25336973	SENT115	9	9	13	13	capecitabine	IFL	PA448771	3439	0.487
NULL	Oncoimmunology_2012_Oct_1_1(7)_1004-1016.nxml.txt.nlp	23170249	SENT113	21	21	23	23	paclitaxel	HER-2	PA450761	2064	0.487
NULL	Braz_J_Med_Biol_Res_2014_Feb_17_47(2)_101-109.nxml.txt.nlp	24519125	SENT194	4	4	18	18	propranolol	IL-6	PA451145	3569	0.487
NULL	Endocrine_2012_Dec_14_42(3)_622-636.nxml.txt.nlp	22695986	SENT193	4	4	2	2	forskolin	PTH	PA146096022	5741	0.487
NULL	Arthritis_Res_Ther_2014_Oct_30_16(5)_467.nxml.txt.nlp	25359150	SENT169	0	0	3	3	adalimumab	CXCL13	PA10004	10563	0.487
NULL	J_Cell_Biol_1998_Jul_13_142(1)_85-100.nxml.txt.nlp	9660865	SENT241	1	1	11	11	tetracycline	RhoA	PA451640	387	0.487
NULL	J_Allergy_(Cairo)_2011_Apr_26_2011_736319.nxml.txt.nlp	21747870	SENT63	37	37	30	30	l-proline	OAT	PA451125	4942	0.487
NULL	Kidney_Int_Suppl_(2011)_2013_Dec_27_3(5)_451-456.nxml.txt.nlp	25019029	SENT81	29	29	40	40	cinacalcet	PTH	PA164776671	5741	0.487
NULL	Theranostics_2013_Mar_21_3(4)_267-274.nxml.txt.nlp	23606913	SENT38	34	34	11	11	fluorescein	NIR	PA164746009	26155	0.487
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2011_Sep_13_4_47-62.nxml.txt.nlp	22879794	SENT234	26	26	9	9	liraglutide	PPG	PA165958364	5552	0.487
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Mar_9_67(Pt_4)_o820.nxml.txt.nlp	21754104	SENT68	31	31	28	28	ethanol	mol	PA448073	90527	0.487
NULL	Clinicoecon_Outcomes_Res_2014_Sep_23_6_409-414.nxml.txt.nlp	25285019	SENT143	20	20	2	2	ritonavir	ATV	PA451260	4683	0.487
NULL	Drugs_Context_2012_Nov_19_2012_212242.nxml.txt.nlp	24432031	SENT391	19	19	32	32	tamoxifen	IL-2	PA451581	3558	0.487
NULL	ScientificWorldJournal_2014_Dec_11_2014_194652.nxml.txt.nlp	25580452	SENT58	14	14	11	11	ethanol	mol	PA448073	90527	0.487
NULL	Brain_2008_Nov_22_131(11)_3072-3080.nxml.txt.nlp	18945724	SENT65	34	34	6	6	mitoxantrone	CD19	PA450526	930	0.487
NULL	Semin_Immunopathol_2012_Jan_30_34(1)_167-179.nxml.txt.nlp	21805225	SENT52	26	26	11	11	thrombin	IL-6	PA451674	3569	0.487
NULL	Mol_Cancer_2014_Jun_12_13_148.nxml.txt.nlp	24924916	SENT205	30	30	6	6	oxygen	Hsp90	PA450744	3320	0.487
NULL	Breast_Cancer_Res_2011_May_26_13(3)_209.nxml.txt.nlp	21635709	SENT152	9	9	2	2	tamoxifen	HER2	PA451581	2064	0.487
NULL	J_Ind_Microbiol_Biotechnol_2013_Jul_30_40(10)_1153-1160.nxml.txt.nlp	23896974	SENT31	15	15	23	23	nadh	CO2	PA164755085	4513	0.487
NULL	J_Cell_Biol_1982_Oct_1_95(1)_316-322.nxml.txt.nlp	6982901	SENT5	0	0	16	16	trifluoperazine	EGF	PA451771	1950	0.486
NULL	Curr_Med_Chem_2013_Jan_20(3)_438-447.nxml.txt.nlp	23157636	SENT453	16	16	12	12	risperidone	FGA	PA451257	2243	0.486
NULL	J_Antimicrob_Chemother_2014_Mar_29_69(3)_643-650.nxml.txt.nlp	24169580	SENT69	41	41	30	30	chlorpromazine	2-21	PA448964	54097	0.486
NULL	J_Insect_Sci_2002_Aug_21_2_17.nxml.txt.nlp	15455051	SENT1455	11	11	5	5	glucosamine	GFAT	PA164747613	2673	0.486
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT192	31	31	46	46	trastuzumab	Yes	PA451743	7525	0.486
NULL	Aging_(Albany_NY)_2009_Dec_31_1(12)_988-1007.nxml.txt.nlp	20157582	SENT101	12	12	10	10	ketoconazole	CTX	PA450146	1593	0.486
NULL	Biomed_Res_Int_2014_Apr_29_2014_186864.nxml.txt.nlp	24877064	SENT109	4	4	11	11	curcumin	IFN	PA151958596	3439	0.486
NULL	Epigenetics_2012_Oct_1_7(10)_1211-1216.nxml.txt.nlp	22965005	SENT151	5	5	11	11	guanidine	p53	PA164781028	7157	0.486
NULL	J_Obes_2011_Dec_22_2011_252817.nxml.txt.nlp	21318055	SENT225	0	0	3	3	berberine	AMPK	PA165860812	5563	0.486
NULL	Clinics_(Sao_Paulo)_2014_Jan_69(Suppl_1)_8-16.nxml.txt.nlp	24860853	SENT46	0	0	14	14	sirolimus	IL-2	PA451365	3558	0.486
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT128	20	20	1	1	metoprolol	CYP2C9	PA450480	1559	0.486
NULL	Orphanet_J_Rare_Dis_2007_Jan_8_2_3.nxml.txt.nlp	17210076	SENT321	35	35	43	43	anagrelide	IFN	PA164742986	3439	0.486
NULL	Drugs_R_D_2013_Sep_28_13(3)_191-197.nxml.txt.nlp	23982688	SENT69	11	11	23	23	warfarin	TTR	PA451906	7276	0.486
NULL	Int_J_Equity_Health_2013_Oct_4_12_82.nxml.txt.nlp	24090286	SENT159	15	15	18	18	oseltamivir	spatial	PA450721	219793	0.486
NULL	J_Ophthalmic_Inflamm_Infect_2011_Nov_6_2(1)_21-28.nxml.txt.nlp	22057810	SENT92	11	11	13	13	cyclosporine	CTX	PA449167	1593	0.486
NULL	Subst_Abuse_Treat_Prev_Policy_2007_Oct_31_2_32.nxml.txt.nlp	17974020	SENT26	2	2	11	11	methamphetamine	NMU	PA450403	10874	0.486
NULL	Anc_Sci_Life_2012_Oct-Dec_32(2)_93-98.nxml.txt.nlp	24167334	SENT170	7	7	5	5	cyclophosphamide	AR7	PA449165	7067	0.486
NULL	Lancet_2010_Jan_9_375(9709)_123-131.nxml.txt.nlp	20004464	SENT50	22	22	7	7	tenofovir	CD4	PA10204	920	0.486
NULL	Evid_Based_Complement_Alternat_Med_2012_Dec_17_2012_485262.nxml.txt.nlp	23304202	SENT21	22	22	18	18	thrombin	ADP	PA451674	23038	0.486
NULL	Ann_Maxillofac_Surg_2012_Jan-Jun_2(1)_90-93.nxml.txt.nlp	23483721	SENT62	28	28	0	0	vincristine	CHOP	PA451879	1649	0.486
NULL	Autoimmune_Dis_2014_Jan_16_2014_731806.nxml.txt.nlp	24527208	SENT17	27	27	21	21	rituximab	BAFF	PA451261	10673	0.486
NULL	Nat_Commun_2011_May_24_2_326.nxml.txt.nlp	21610729	SENT2004	1	1	7	7	l-tyrosine	TKT	PA451822	4921;7086	0.486
NULL	Diabetes_Care_2008_Oct_31(10)_2062-2069.nxml.txt.nlp	18820229	SENT238	39	39	42	42	rosiglitazone	DREAM	PA451283	30818	0.486
NULL	Arch_Trauma_Res_2013_Aug_1_2(2)_63-70.nxml.txt.nlp	24396796	SENT330	8	8	4	4	trypsin	Gen	PA451806	348654	0.486
NULL	Front_Neural_Circuits_2013_Sep_3_7_135.nxml.txt.nlp	24027497	SENT1131	5	5	8	8	allopregnanolone	spatial	PA142320763	219793	0.486
NULL	Front_Immunol_2013_Nov_4_4_356.nxml.txt.nlp	24204367	SENT101	9	9	0	0	thrombin	PAR-1	PA451674	2011;2149	0.486
NULL	Ann_Rheum_Dis_2011_Jul_8_70(11)_2022-2028.nxml.txt.nlp	21742639	SENT30	27	27	25	25	denosumab	RANKL	PA166048634	8600	0.486
NULL	Breast_Cancer_Res_2009_Jan_16_11(1)_201.nxml.txt.nlp	19216727	SENT42	23	23	17	17	trastuzumab	AGO	PA451743	55294	0.486
NULL	Core_Evid_2010_Jul_27_5_1-10.nxml.txt.nlp	20694135	SENT290	22	22	8	8	entacapone	CLE	PA164748726	51637	0.486
NULL	Cancer_Immunol_Immunother_2012_Jul_23_61(7)_1101-1111.nxml.txt.nlp	22193989	SENT118	0	0	6	6	oxaliplatin	CD40	PA131285527	958	0.486
NULL	Blood_Res_2013_Dec_24_48(4)_293-295.nxml.txt.nlp	24466556	SENT45	23	23	27	27	vincristine	IFN	PA451879	3439	0.486
NULL	Case_Rep_Oncol_2010_Nov_8_3(3)_397-405.nxml.txt.nlp	21113350	SENT69	9	9	13	13	vincristine	CHOP	PA451879	1649	0.486
NULL	Chin_J_Cancer_2011_Sep_30(9)_645-654.nxml.txt.nlp	21880186	SENT53	15	15	11	11	ifosfamide	DDP	PA449964	1678	0.486
NULL	Nat_Commun_2013_Oct_1_4_2516.nxml.txt.nlp	24084631	SENT52	0	0	13	13	losartan	AK4	PA450268	205	0.486
NULL	Front_Pharmacol_2014_May_30_5_132.nxml.txt.nlp	24910615	SENT54	5	5	27	27	ethanol	NMI	PA448073	9111	0.486
NULL	Arthritis_Res_Ther_2006_May_11_8(3)_209.nxml.txt.nlp	16712713	SENT551	1	1	20	20	methotrexate	Yes	PA450428	7525	0.486
NULL	Acta_Pharmacol_Sin_2012_Aug_23_33(8)_1023-1029.nxml.txt.nlp	22820911	SENT41	10	10	14	14	glibenclamide	PAG	PA449782	55824	0.486
NULL	Biomed_Res_Int_2013_Apr_18_2013_378207.nxml.txt.nlp	23691499	SENT32	26	26	47	47	l-glutamine	GM-CSF	PA10090	1437	0.486
NULL	Ann_Rheum_Dis_2014_Jun_19_73(6)_1000-1006.nxml.txt.nlp	24553909	SENT154	2	2	27	27	ustekinumab	IL-23	PA166048654	51561	0.486
NULL	J_Neurodev_Disord_2009_Dec_28_1(4)_252-263.nxml.txt.nlp	21547719	SENT28	3	3	9	9	choline	SLC5A7	PA448976	60482	0.486
NULL	Environ_Health_Perspect_2010_Dec_12_118(12)_1707-1713.nxml.txt.nlp	20705543	SENT15	21	21	2	2	bleomycin	XRCC1	PA448645	7515	0.486
NULL	Clin_Med_Insights_Oncol_2012_May_16_6_205-217.nxml.txt.nlp	22654526	SENT250	2	2	4	4	bortezomib	IL-2	PA10252	3558	0.486
NULL	Oncogenesis_2014_May_12_3(5)_e102.nxml.txt.nlp	24819061	SENT243	7	7	14	14	nadh	p53	PA164755085	7157	0.486
NULL	Ethiop_J_Health_Sci_2010_Nov_20(3)_179-183.nxml.txt.nlp	22434977	SENT45	22	22	26	26	amoxicillin	RDT	PA448406	6598	0.486
NULL	Int_J_Mol_Sci_2012_Aug_23_13(8)_10608-10629.nxml.txt.nlp	22949883	SENT977	27	27	38	38	creatine	alpha-synuclein	PA164778930	6622	0.486
NULL	Oncoimmunology_2013_May_1_2(5)_e24320.nxml.txt.nlp	23762807	SENT10	20	20	13	13	dacarbazine	BRAF	PA449197	673	0.486
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT192	39	39	33	33	afatinib	Yes	PA165981154	7525	0.486
NULL	Pharm_Pract_(Granada)_2007_Jun_18_Apr-Jun_5(2)_51-58.nxml.txt.nlp	25247008	SENT15	36	36	20	20	bupropion	OTC	PA448687	5009	0.486
NULL	J_Hematol_Oncol_2014_Aug_1_7_52.nxml.txt.nlp	25085632	SENT161	11	11	13	13	sunitinib	KRAS	PA162372840	3845	0.486
NULL	BMJ_Open_2012_Sep_13_2(5)_e001891.nxml.txt.nlp	22983782	SENT175	9	9	6	6	urea	CRP	PA451831	1401;140913	0.486
NULL	Allergy_Rhinol_(Providence)_2011_Apr-Jun_2(2)_e51-e53.nxml.txt.nlp	22852117	SENT54	1	1	10	10	curcumin	IL-5	PA151958596	3567	0.486
NULL	Anesth_Pain_Med_2014_Sep_9_4(4)_e14221.nxml.txt.nlp	25599022	SENT13	2	2	11	11	cisplatin	LPO	PA449014	4025	0.486
NULL	Infect_Dis_Obstet_Gynecol_2011_Aug_24_2011_806105.nxml.txt.nlp	21876641	SENT139	14	14	28	28	imiquimod	LSR	PA449972	51599	0.486
NULL	Am_J_Trop_Med_Hyg_2012_Nov_7_87(5_Suppl)_21-29.nxml.txt.nlp	23136274	SENT317	2	2	0	0	artemisinin	ACT	PA165111696	12;11332;9457;641455	0.486
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT135	0	0	5	5	curcumin	PC-3	PA151958596	692094	0.486
NULL	Oncol_Lett_2013_Oct_24_6(4)_985-989.nxml.txt.nlp	24137450	SENT128	16	16	20	20	cyclophosphamide	ADM	PA449165	133	0.486
NULL	J_Invest_Dermatol_2013_Sep_31_133(9)_2247-2254.nxml.txt.nlp	23370537	SENT81	0	0	19	19	chloroquine	PUMA	PA448948	27113	0.486
NULL	J_Immunother_Cancer_2014_Mar_12_2(Suppl_2)_I12.nxml.txt.nlp	NULL	SENT15	16	16	8	8	carboplatin	SOC	PA448803	91544	0.486
NULL	J_Cell_Biol_2005_Jun_20_169(6)_921-928.nxml.txt.nlp	15967813	SENT379	10	10	0	0	cisplatin	TNF-alpha	PA449014	7124	0.486
NULL	Mol_Imaging_Biol_2012_Feb_8_14(1)_32-39.nxml.txt.nlp	21384207	SENT48	11	11	16	16	l-lysine	NIR	PA450280	26155	0.486
NULL	Br_J_Cancer_2009_May_19_100(10)_1589-1602.nxml.txt.nlp	19436306	SENT3	19	19	9	9	urokinase	TLR-4	PA451836	7099	0.486
NULL	Clin_Pharmacokinet_2014_Jun_27_53(8)_741-751.nxml.txt.nlp	24968986	SENT250	23	23	21	21	docetaxel	OATP1B3	PA449383	28234	0.486
NULL	J_Exp_Bot_2012_Apr_20_63(7)_2595-2604.nxml.txt.nlp	22268144	SENT21	19	19	27	27	galactose	Ray	PA449725	26751	0.486
NULL	Crit_Care_2003_Jun_26_7(6)_427-434.nxml.txt.nlp	14624682	SENT99	3	3	7	7	vasopressin	ACTH	PA451858	5443	0.486
NULL	Curr_Biol_2012_Mar_6_22(5)_397-402.nxml.txt.nlp	22305751	SENT330	15	15	11	11	physostigmine	spatial	PA450957	219793	0.486
NULL	Mol_Cancer_2009_Nov_12_8_100.nxml.txt.nlp	19909554	SENT100	7	7	28	28	genistein	LC3	PA165109660	84557	0.486
NULL	Clin_Interv_Aging_2014_Aug_16_9_1363-1373.nxml.txt.nlp	25170260	SENT241	19	19	15	15	aripiprazole	Yes	PA10026	7525	0.486
NULL	Br_J_Pharmacol_2014_Dec_24_171(23)_5431-5445.nxml.txt.nlp	25052258	SENT127	29	29	1	1	propranolol	SPAP	PA451145	10158	0.486
NULL	Arthritis_Res_Ther_2013_Jul_9_15(4)_R73.nxml.txt.nlp	23837669	SENT265	0	0	3	3	colchicine	IL-8	PA449092	3576	0.486
NULL	ScientificWorldJournal_2012_Dec_5_2012_925925.nxml.txt.nlp	23304092	SENT25	12	12	5	5	vanillin	TLC	PA451852	3933	0.486
NULL	Mol_Cancer_2009_Nov_19_8_108.nxml.txt.nlp	19925669	SENT40	41	41	31	31	doxorubicin	CRT	PA449412	811	0.486
NULL	AMB_Express_2014_Aug_30_4_63.nxml.txt.nlp	25401066	SENT258	29	29	9	9	nadh	EMP	PA164755085	10296	0.486
NULL	J_Immunotoxicol_2013_Jan_11_10(1)_75-82.nxml.txt.nlp	22967038	SENT99	18	18	1	1	rituximab	IFN	PA451261	3439	0.486
NULL	Clin_Pract_2014_Aug_21_4(2)_656.nxml.txt.nlp	25332764	SENT29	24	24	20	20	isoniazid	AKT	PA450112	207	0.486
NULL	Arthritis_Res_Ther_2013_Dec_3_15(6)_R205.nxml.txt.nlp	24295447	SENT121	0	0	6	6	methotrexate	RANK	PA450428	8792	0.486
NULL	J_Hematol_Oncol_2008_Dec_18_1_26.nxml.txt.nlp	19094231	SENT30	23	23	19	19	levothyroxine	B12	PA450221	7126;4709	0.486
NULL	Curr_Neuropharmacol_2014_Jul_12(4)_365-379.nxml.txt.nlp	25342944	SENT534	28	28	2	2	paroxetine	5-HT1B	PA450801	3351	0.486
NULL	Indian_J_Endocrinol_Metab_2012_Jan-Feb_16(1)_33-43.nxml.txt.nlp	22276251	SENT156	0	0	10	10	orlistat	GLP-1	PA164776864	100125288	0.486
NULL	Int_J_Vasc_Med_2012_Jul_24_2012_508416.nxml.txt.nlp	22888436	SENT163	16	16	31	31	rosiglitazone	SRC-3	PA451283	8202	0.486
NULL	Open_Biochem_J_2012_Dec_11_6_139-159.nxml.txt.nlp	23264833	SENT1018	14	14	16	16	oxygen	ADP	PA450744	23038	0.486
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT143	34	34	13	13	perifosine	DR4	PA165291471	8797	0.486
NULL	Onco_Targets_Ther_2014_Nov_28_7_2183-2195.nxml.txt.nlp	25506223	SENT10	10	10	8	8	doxorubicin	MICA	PA449412	100507436	0.486
NULL	Eur_Biophys_J_2008_Mar_21_37(3)_269-279.nxml.txt.nlp	18030462	SENT68	13	13	2	2	heparin	APLP2	PA449855	334	0.486
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT356	36	36	6	6	acetaminophen	NK1	PA448015	11126	0.486
NULL	Br_J_Cancer_2011_Jun_7_104(12)_1941-1944.nxml.txt.nlp	NULL	SENT25	27	27	20	20	vinorelbine	VEGFR2	PA451881	3791	0.486
NULL	Int_J_Endocrinol_2013_Nov_14_2013_624962.nxml.txt.nlp	24348556	SENT101	6	6	8	8	mitotane	SR-BI	PA164746157	949	0.486
NULL	J_Cancer_Prev_2013_Sep_18(3)_227-234.nxml.txt.nlp	25337550	SENT42	26	26	4	4	decitabine	p53	PA164749631	7157	0.486
NULL	Front_Neurosci_2013_Jun_12_7_100.nxml.txt.nlp	23781169	SENT835	5	5	13	13	hyaluronidase	TLR4	PA164745713	7099	0.486
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jun_20_65(Pt_7)_o1647.nxml.txt.nlp	21582911	SENT56	13	13	1	1	risperidone	NO3	PA451257	4681	0.486
NULL	Pharmacogn_Rev_2011_Jul-Dec_5(10)_120-137.nxml.txt.nlp	22279370	SENT36	23	23	15	15	nabumetone	COX2	PA450572	4513;5743	0.486
NULL	J_Korean_Med_Sci_2005_Dec_31_20(6)_1046-1052.nxml.txt.nlp	16361820	SENT47	25	25	12	12	trypsin	CO2	PA451806	4513	0.486
NULL	J_Gen_Physiol_2000_Dec_1_116(6)_769-780.nxml.txt.nlp	11099346	SENT36	13	13	11	11	tetracaine	DAG	PA451638	1605	0.486
NULL	Mol_Cancer_2010_Dec_31_9_320.nxml.txt.nlp	21194429	SENT97	20	20	12	12	hydrocortisone	EGF	PA449905	1950	0.486
NULL	Diagn_Pathol_2014_Jan_20_9_11.nxml.txt.nlp	24443801	SENT26	15	15	17	17	trypsin	MUC2	PA451806	4583	0.486
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT182	2	2	7	7	doxorubicin	SLK	PA449412	9748;2534	0.486
NULL	J_Psychopharmacol_2013_Jun_27(6)_479-496.nxml.txt.nlp	23539642	SENT346	10	10	1	1	methylphenidate	Gen	PA450464	348654	0.485
NULL	Neural_Plast_2012_Jul_5_2012_405926.nxml.txt.nlp	22830051	SENT169	20	20	16	16	flurazepam	CA1	PA449681	759	0.485
NULL	Int_J_Gen_Med_2012_Nov_9_5_935-942.nxml.txt.nlp	23204857	SENT81	37	37	32	32	isoflurane	AIDA	PA450106	64853	0.485
NULL	Front_Behav_Neurosci_2014_Dec_18_8_438.nxml.txt.nlp	25566006	SENT1140	0	0	13	13	methamphetamine	spatial	PA450403	219793	0.485
NULL	Ther_Clin_Risk_Manag_2006_Sep_2(3)_235-249.nxml.txt.nlp	18360599	SENT343	14	14	16	16	alendronate	PTH	PA448082	5741	0.485
NULL	Asian_Spine_J_2013_Sep_4_7(3)_196-203.nxml.txt.nlp	24066215	SENT43	46	46	22	22	cefuroxime	I-1	PA448868	11188	0.485
NULL	Curr_Chem_Genomics_2008_Feb_25_1_43-53.nxml.txt.nlp	20161827	SENT157	18	18	21	21	fluorescein	MEK1	PA164746009	5604	0.485
NULL	J_Cell_Biol_2002_Oct_28_159(2)_373-382.nxml.txt.nlp	12391027	SENT104	27	27	19	19	sugar	TSR3	PA451529	115939	0.485
NULL	J_Inflamm_(Lond)_2007_May_4_4_10.nxml.txt.nlp	17480224	SENT303	6	6	26	26	ketamine	IL-4	PA450144	3565	0.485
NULL	J_Cancer_2012_Dec_25_4(1)_57-65.nxml.txt.nlp	23386905	SENT106	20	20	18	18	bleomycin	IL-22	PA448645	50616;53342	0.485
NULL	Open_Virol_J_2014_Mar_7_8_1-8.nxml.txt.nlp	24799968	SENT87	2	2	33	33	cyclosporine	IFN	PA449167	3439	0.485
NULL	Br_J_Cancer_2011_Jun_7_104(12)_1848-1853.nxml.txt.nlp	21610704	SENT99	8	8	5	5	panitumumab	KRAS	PA162373091	3845	0.485
NULL	Leukemia_2013_Jan_11_27(1)_32-40.nxml.txt.nlp	22781593	SENT105	30	30	23	23	ponatinib	BBC2	PA165980594	572	0.485
NULL	Biologics_2009_Oct_12_3_469-474.nxml.txt.nlp	19851472	SENT5	44	44	24	24	montelukast	IL-5	PA450546	3567	0.485
NULL	Basic_Clin_Neurosci_2013_Winter_4(1)_42-49.nxml.txt.nlp	25337327	SENT106	15	15	21	21	scopolamine	ANOVA	PA451308	4858	0.485
NULL	Cardiol_Ther_2012_Dec_16_1(1)_5.nxml.txt.nlp	25135159	SENT107	9	9	18	18	heparin	ACT	PA449855	12;11332;9457;641455	0.485
NULL	Crit_Care_2009_Mar_16_13(2)_R37.nxml.txt.nlp	19291300	SENT66	31	31	40	40	urea	GFR	PA451831	9771	0.485
NULL	Front_Endocrinol_(Lausanne)_2013_Jan_7_3_180.nxml.txt.nlp	23316185	SENT292	31	31	34	34	glucose	SNS	PA449773	6336	0.485
NULL	Core_Evid_2009_Jun_15_4_13-23.nxml.txt.nlp	20694061	SENT102	18	18	23	23	alendronate	BMD	PA448082	1756;7439	0.485
NULL	Nanoscale_Res_Lett_2014_Feb_10_9(1)_69.nxml.txt.nlp	24512605	SENT53	20	20	10	10	ethanol	NO3	PA448073	4681	0.485
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jun_20_68(Pt_7)_o2149.nxml.txt.nlp	22798822	SENT6	10	10	14	14	phenol	mol	PA450913	90527	0.485
NULL	Arthritis_Res_2000_Apr_12_2(3)_189-202.nxml.txt.nlp	11094428	SENT56	32	32	20	20	collagenase	GM-CSF	PA449107	1437	0.485
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1152.nxml.txt.nlp	24675470	SENT222	14	14	5	5	tetracycline	c-Myc	PA451640	4609	0.485
NULL	Acta_Pharmacol_Sin_2009_Jan_8_30(1)_125-133.nxml.txt.nlp	19060917	SENT63	12	12	20	20	fluorescein	CD25	PA164746009	3669;3559	0.485
NULL	Breast_Cancer_Res_2005_Mar_4_7(3)_R345-R352.nxml.txt.nlp	15987429	SENT124	19	19	33	33	ns-398	COX		1351	0.485
NULL	CNS_Drugs_2014_Feb_7_28(3)_185-193.nxml.txt.nlp	24504829	SENT25	26	26	0	0	choline	ADP	PA448976	23038	0.485
NULL	BMB_Rep_2014_Jan_47(1)_33-38.nxml.txt.nlp	24209634	SENT77	14	14	27	27	cisplatin	CXCR4	PA449014	7852	0.485
NULL	Vet_Res_Forum_2014_Winter_5(1)_65-68.nxml.txt.nlp	25568695	SENT80	7	7	31	31	trimethoprim	Yes	PA451788	7525	0.485
NULL	Case_Rep_Vasc_Med_2012_Dec_13_2012_750953.nxml.txt.nlp	23304629	SENT53	30	30	2	2	trimethaphan	SPG	PA451784	55764	0.485
NULL	Arthritis_Res_Ther_2012_Jun_25_14(3)_215.nxml.txt.nlp	22731694	SENT99	2	2	6	6	cyclophosphamide	IFN	PA449165	3439	0.485
NULL	Cardiovasc_Ther_2012_Jun_19_30(3)_e146-e155.nxml.txt.nlp	21167014	SENT24	18	18	9	9	liraglutide	GLP	PA165958364	342096	0.485
NULL	Braz_J_Microbiol_2011_Dec_1_Oct-Dec_42(4)_1384-1389.nxml.txt.nlp	24031767	SENT19	36	36	31	31	nitrogen	CSL	PA450643	1444	0.485
NULL	Comp_Funct_Genomics_2009_Jan_31_2009_761512.nxml.txt.nlp	20148076	SENT183	17	17	29	29	debrisoquine	CYP11B1	PA452616	1584	0.485
NULL	Neural_Dev_2013_Mar_7_8_4.nxml.txt.nlp	23497494	SENT230	3	3	9	9	chlorpheniramine	E12	PA448960	64100	0.485
NULL	Cardiovasc_Diabetol_2005_Jun_28_4_9.nxml.txt.nlp	15985157	SENT295	37	37	41	41	heparin	perlecan	PA449855	3339	0.485
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Apr_22_67(Pt_5)_o1177-o1178.nxml.txt.nlp	21754481	SENT76	30	30	27	27	ethanol	mol	PA448073	90527	0.485
NULL	Psychol_Res_Behav_Manag_2010_Oct_19_3_91-108.nxml.txt.nlp	22110333	SENT246	22	22	6	6	fluoxetine	Gen	PA449673	348654	0.485
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Aug_27_67(Pt_9)_o2505-o2506.nxml.txt.nlp	22059051	SENT75	16	16	12	12	phenol	C11	PA450913	1109	0.485
NULL	Front_Genet_2013_Aug_29_4_163.nxml.txt.nlp	24009622	SENT102	12	12	14	14	ethanol	DDP	PA448073	1678	0.485
NULL	J_Korean_Med_Sci_2013_Mar_4_28(3)_480-484.nxml.txt.nlp	23486547	SENT54	18	18	22	22	thyroglobulin	p53	PA164754910	7157	0.485
NULL	Apoptosis_2008_May_9_13(5)_681-692.nxml.txt.nlp	18392938	SENT32	0	0	6	6	forskolin	EGF	PA146096022	1950	0.485
NULL	Drug_Des_Devel_Ther_2014_Sep_23_8_1527-1538.nxml.txt.nlp	25284985	SENT132	14	14	11	11	celecoxib	IFN	PA448871	3439	0.485
NULL	J_Korean_Med_Sci_2007_Sep_30_22(Suppl)_S154-S158.nxml.txt.nlp	17923744	SENT77	14	14	16	16	thyroglobulin	TTF-1	PA164754910	7080	0.485
NULL	Exp_Ther_Med_2014_Apr_13_7(4)_799-803.nxml.txt.nlp	24669235	SENT8	9	9	3	3	vildagliptin	PPG	PA165958346	5552	0.485
NULL	ScientificWorldJournal_2014_Aug_5_2014_526105.nxml.txt.nlp	25162053	SENT130	24	24	5	5	lipase	ANOVA	PA450239	4858	0.485
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT207	16	16	14	14	tacrolimus	SOCS3	PA451578	9021	0.485
NULL	BMB_Rep_2014_Apr_47(4)_221-226.nxml.txt.nlp	24286312	SENT73	2	2	4	4	nutlin-3	p53		7157	0.485
NULL	Int_J_Mol_Sci_2014_Oct_20_15(10)_18967-18984.nxml.txt.nlp	25334065	SENT610	7	7	16	16	ethanol	S28	PA448073	6234	0.485
NULL	Cell_J_2014_May_25_Summer_16(2)_117-130.nxml.txt.nlp	24567941	SENT72	17	17	8	8	l-glutamine	B27	PA10090	56246	0.485
NULL	Case_Rep_Oncol_2010_Apr_8_3(1)_88-92.nxml.txt.nlp	20740165	SENT21	5	5	15	15	trypsin	TTF1	PA451806	7080;7270	0.485
NULL	Mol_Pain_2013_Aug_8_9_39.nxml.txt.nlp	23924059	SENT39	15	15	11	11	vasopressin	SON	PA451858	6651	0.485
NULL	Kidney_Int_Suppl_(2011)_2012_Jun_15_2(2)_186-197.nxml.txt.nlp	25018932	SENT316	2	2	5	5	rituximab	ACTH	PA451261	5443	0.485
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1068.nxml.txt.nlp	24556683	SENT166	7	7	20	20	paraformaldehyde	SHP-1	PA450790	5777	0.485
NULL	Cancer_Cell_Int_2008_Mar_18_8_3.nxml.txt.nlp	18348720	SENT81	31	31	15	15	gefitinib	EGF	PA131301952	1950	0.485
NULL	Carcinogenesis_2011_Nov_1_32(11)_1724-1733.nxml.txt.nlp	21890461	SENT242	37	37	18	18	glucose	ROS	PA449773	6098	0.485
NULL	Allergy_2015_Jan_28_70(1)_80-89.nxml.txt.nlp	25331546	SENT63	0	0	7	7	clodronate	IL-13	PA10239	3596	0.485
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Feb_9_69(Pt_3)_o362.nxml.txt.nlp	23476552	SENT3	32	32	28	28	ethanol	mol	PA448073	90527	0.485
NULL	Indian_Dermatol_Online_J_2013_Jan-Mar_4(1)_60-61.nxml.txt.nlp	23437427	SENT16	10	10	14	14	carbamazepine	CHS	PA448785	1130	0.485
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT158	3	3	1	1	cisplatin	IBP	PA449014	706;50619	0.485
NULL	Sensors_(Basel)_2008_Sep_3_8(9)_5386-5396.nxml.txt.nlp	NULL	SENT217	3	3	14	14	procaine	ITO	PA451110	3160	0.485
NULL	J_Gen_Physiol_2013_Apr_141(4)_409-411.nxml.txt.nlp	23478994	SENT119	9	9	7	7	potassium	HERG	PA451047	3757	0.485
NULL	FEBS_Open_Bio_2013_Aug_19_3_379-386.nxml.txt.nlp	24251099	SENT107	8	8	13	13	nadh	ADP	PA164755085	23038	0.485
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT82	5	5	22	22	cisplatin	p53	PA449014	7157	0.485
NULL	Arthritis_Res_2002_May_2_4(4)_R1.nxml.txt.nlp	12106500	SENT200	2	2	6	6	methotrexate	DRB1	PA450428	129831	0.485
NULL	Oncol_Lett_2013_Oct_5_6(4)_1123-1127.nxml.txt.nlp	24137475	SENT157	2	2	8	8	ethanol	GAPDH	PA448073	2597	0.485
NULL	Exp_Ther_Med_2013_May_15_5(5)_1327-1331.nxml.txt.nlp	23737873	SENT118	2	2	4	4	imidapril	AQP2	PA452640	359	0.485
NULL	Front_Oncol_2013_Nov_15_3_281.nxml.txt.nlp	24298448	SENT195	26	26	18	18	panitumumab	NRAS	PA162373091	4893	0.485
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT276	42	42	22	22	cisplatin	UNG	PA449014	7374	0.485
NULL	Evid_Based_Complement_Alternat_Med_2012_May_7_2012_242810.nxml.txt.nlp	22645625	SENT217	11	11	13	13	paclitaxel	CYP3A4	PA450761	1576	0.485
NULL	J_Breast_Cancer_2011_Mar_31_14(1)_20-27.nxml.txt.nlp	21847390	SENT6	7	7	10	10	estradiol	CLDN6	PA449503	9074	0.485
NULL	Cancer_Cell_Int_2010_Feb_19_10_3.nxml.txt.nlp	20170512	SENT165	9	9	19	19	tamoxifen	4E-BP1	PA451581	1978	0.485
NULL	F1000_Med_Rep_2009_May_8_1_40.nxml.txt.nlp	20948740	SENT12	15	15	20	20	octreotide	SSTR5	PA450678	6755	0.485
NULL	Emerg_Infect_Dis_2012_Jul_18(7)_1072-1080.nxml.txt.nlp	22709685	SENT36	6	6	9	9	vancomycin	VISA	PA451850	57506	0.485
NULL	Open_Biochem_J_2014_Feb_21_8_21-34.nxml.txt.nlp	24688608	SENT125	29	29	15	15	etanercept	MUC7	PA449515	4589	0.485
NULL	Nat_Commun_2014_Jul_17_5_4421.nxml.txt.nlp	25030704	SENT355	5	5	7	7	lipase	spatial	PA450239	219793	0.485
NULL	J_Korean_Med_Sci_2014_Jan_26_29(1)_53-60.nxml.txt.nlp	24431906	SENT9	32	32	18	18	rituximab	CHOP	PA451261	1649	0.485
NULL	Oncotarget_2014_Jun_19_5(15)_6540-6551.nxml.txt.nlp	25153728	SENT305	16	16	27	27	gemcitabine	BLU	PA449748	51364	0.485
NULL	J_Biomed_Biotechnol_2010_May_23_2010_798467.nxml.txt.nlp	20508851	SENT216	15	15	13	13	gemcitabine	CTX	PA449748	1593	0.485
NULL	J_Biomed_Biotechnol_2010_Jun_6_2010_571343.nxml.txt.nlp	20625496	SENT199	7	7	3	3	vincristine	ASS1	PA451879	445	0.485
NULL	Onco_Targets_Ther_2014_Nov_21_7_2143-2146.nxml.txt.nlp	25473295	SENT49	25	25	17	17	sn-38	UGT		7361;7355	0.485
NULL	Cancer_Cell_Int_2012_Feb_21_12_5.nxml.txt.nlp	22353776	SENT132	3	3	23	23	sorafenib	Mcl-1	PA7000	4170	0.485
NULL	Autoimmune_Dis_2012_Jul_25_2012_834291.nxml.txt.nlp	22888407	SENT122	21	21	23	23	chloroquine	CLE	PA448948	51637	0.485
NULL	Int_J_Mol_Sci_2007_Jan_29_8(1)_13-28.nxml.txt.nlp	NULL	SENT25	37	37	39	39	galactose	NAG	PA449725	51594;4669	0.485
NULL	Clin_Med_Insights_Oncol_2011_Sep_21_5_315-323.nxml.txt.nlp	22084620	SENT8	38	38	19	19	gemcitabine	IFN	PA449748	3439	0.485
NULL	Front_Cell_Neurosci_2014_Jan_24_8_7.nxml.txt.nlp	24478630	SENT531	8	8	11	11	potassium	KCC2	PA451047	57468	0.485
NULL	Nat_Med_2013_Dec_10_19(12)_10_1038_nm_3385.nxml.txt.nlp	24216752	SENT347	27	27	30	30	thrombin	PAR4	PA451674	9002;5074	0.485
NULL	Ann_N_Y_Acad_Sci_2014_Nov_5_1329(1)_93-106.nxml.txt.nlp	25377080	SENT192	20	20	26	26	warfarin	TTR	PA451906	7276	0.485
NULL	Iran_J_Pharm_Res_2015_Winter_14(1)_167-175.nxml.txt.nlp	25561923	SENT118	12	12	41	41	clonidine	Yes	PA449051	7525	0.485
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT128	5	5	2	2	mexiletine	CYP2C19	PA450488	1557	0.485
NULL	Oncol_Lett_2014_May_11_7(5)_1401-1408.nxml.txt.nlp	24765145	SENT106	4	4	13	13	paclitaxel	HIF-1	PA450761	29072	0.485
NULL	Diabetes_2011_Nov_17_60(11)_2928-2938.nxml.txt.nlp	21885868	SENT312	7	7	17	17	curcumin	MCP-1	PA151958596	6347	0.485
NULL	Mol_Cell_Biochem_2014_Oct_9_385(1-2)_265-275.nxml.txt.nlp	24104452	SENT97	6	6	14	14	bortezomib	U87	PA10252	677775;641648	0.485
NULL	Biol_Open_2014_Nov_21_3(12)_1207-1216.nxml.txt.nlp	25416063	SENT26	3	3	12	12	zinc	NANOS2	PA451956	339345	0.484
NULL	J_Appl_Oral_Sci_2013_Sep-Oct_21(5)_452-459.nxml.txt.nlp	24212992	SENT58	10	10	7	7	ethanol	HEMA	PA448073	2157	0.484
NULL	Afr_J_Infect_Dis_2010_4(2)_20-28.nxml.txt.nlp	23878697	SENT39	10	10	16	16	amodiaquine	ACT	PA448404	12;11332;9457;641455	0.484
NULL	Bioimpacts_2014_May_17_4(3)_123-132.nxml.txt.nlp	25337465	SENT195	14	14	20	20	zinc	TRAIL	PA451956	8743	0.484
NULL	Theranostics_2013_Mar_26_3(5)_331-345.nxml.txt.nlp	23650480	SENT87	23	23	38	38	ethanol	NO3	PA448073	4681	0.484
NULL	Eur_J_Clin_Microbiol_Infect_Dis_2014_Nov_10_33(2)_201-209.nxml.txt.nlp	24213847	SENT145	19	19	24	24	amikacin	TMP	PA164744372	2012	0.484
NULL	Adv_Biomed_Res_2012_Oct_31_1_70.nxml.txt.nlp	23326800	SENT40	9	9	38	38	erythromycin	IPL	PA449493	7262	0.484
NULL	Clin_Cosmet_Investig_Dermatol_2013_Sep_26_6_233-244.nxml.txt.nlp	24101875	SENT101	19	19	24	24	sunitinib	IFN	PA162372840	3439	0.484
NULL	Front_Oncol_2014_Sep_15_4_244.nxml.txt.nlp	25309870	SENT55	10	10	16	16	gefitinib	EGFR	PA131301952	1956	0.484
NULL	Cell_Cycle_2013_Aug_15_12(16)_2580-2597.nxml.txt.nlp	23860378	SENT294	17	17	31	31	ethanol	MCT4	PA448073	9122;9123	0.484
NULL	J_Cell_Biol_2001_Mar_5_152(5)_29-34.nxml.txt.nlp	11238468	SENT73	23	23	2	2	lipase	ADRP	PA450239	123	0.484
NULL	Atherosclerosis_2011_Jun_216(2)_342-347.nxml.txt.nlp	21420681	SENT160	6	6	22	22	thrombin	LRP1	PA451674	10438;4035	0.484
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT128	19	19	1	1	amiodarone	CYP2C9	PA448383	1559	0.484
NULL	Mol_Cell_Proteomics_2013_Jun_22_12(6)_1709-1722.nxml.txt.nlp	23436904	SENT261	20	20	9	9	nitrogen	HNF1	PA450643	6927	0.484
NULL	Behav_Neurol_2014_Nov_16_2014_360978.nxml.txt.nlp	25477708	SENT486	1	1	15	15	nicotine	P56	PA450626	8999	0.484
NULL	Ann_R_Coll_Surg_Engl_2012_Nov_94(8)_e251-e253.nxml.txt.nlp	23131217	SENT28	14	14	7	7	octreotide	ACTH	PA450678	5443	0.484
NULL	Oncotarget_2013_Nov_22_5(4)_933-943.nxml.txt.nlp	24659749	SENT42	10	10	13	13	nutlin-3	AML2		864	0.484
NULL	Br_J_Cancer_2012_Feb_14_106(4)_685-692.nxml.txt.nlp	22294184	SENT118	1	1	18	18	docetaxel	p27	PA449383	5715;10534	0.484
NULL	Front_Neurol_2013_Oct_28_4_167.nxml.txt.nlp	24191153	SENT37	38	38	36	36	pp2	PP1A		5499	0.484
NULL	J_Gynecol_Oncol_2013_Jan_8_24(1)_83-91.nxml.txt.nlp	23346317	SENT73	21	21	18	18	paclitaxel	AGO	PA450761	55294	0.484
NULL	Diabetes_Care_2011_Jul_17_34(7)_1678-1680.nxml.txt.nlp	21709302	SENT34	11	11	14	14	rosiglitazone	DREAM	PA451283	30818	0.484
NULL	Clin_Dev_Immunol_2013_May_2_2013_270301.nxml.txt.nlp	23737810	SENT188	26	26	16	16	trypsin	MMP7	PA451806	4316	0.484
NULL	Biochemistry_2008_Aug_19_47(33)_8689-8696.nxml.txt.nlp	18642884	SENT151	18	18	11	11	nadh	GMP	PA164755085	22978	0.484
NULL	Hum_Genomics_2008_Sep_1_3(1)_71-78.nxml.txt.nlp	19129091	SENT32	13	13	28	28	nadh	ND4	PA164755085	4538	0.484
NULL	J_Nat_Med_2014_Feb_19_68(2)_253-266.nxml.txt.nlp	24550097	SENT227	6	6	12	12	ethanol	ATGL	PA448073	57104	0.484
NULL	Breast_Cancer_(Auckl)_2011_Jul_27_5_175-199.nxml.txt.nlp	21863131	SENT508	30	30	1	1	cetuximab	Met	PA10040	79811	0.484
NULL	Biomed_Imaging_Interv_J_2011_Oct_1_7(4)_e25.nxml.txt.nlp	22279502	SENT195	12	12	20	20	oxaliplatin	LARC	PA131285527	6364	0.484
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jun_20_65(Pt_7)_o1647.nxml.txt.nlp	21582911	SENT3	2	2	12	12	risperidone	NO3	PA451257	4681	0.484
NULL	Indian_J_Anaesth_2014_Jul-Aug_58(4)_423-429.nxml.txt.nlp	25197110	SENT116	4	4	2	2	ondansetron	ODF	PA450705	8600	0.484
NULL	Int_J_Vasc_Med_2012_Sep_26_2012_794898.nxml.txt.nlp	23056947	SENT159	18	18	28	28	nadh	NDUFA4	PA164755085	4697	0.484
NULL	Mol_Brain_2014_Aug_21_7_59.nxml.txt.nlp	25139109	SENT43	14	14	5	5	imiquimod	TLR4	PA449972	7099	0.484
NULL	J_Oncol_2012_Dec_7_2012_192464.nxml.txt.nlp	22187555	SENT515	25	25	11	11	curcumin	PC-3	PA151958596	692094	0.484
NULL	Chem_Rev_2011_Oct_12_111(10)_5899-5921.nxml.txt.nlp	21923193	SENT50	22	22	11	11	lipase	CES2	PA450239	8824;1066	0.484
NULL	J_Int_AIDS_Soc_2012_Nov_11_15(6Suppl_4)_18154.nxml.txt.nlp	NULL	SENT16	0	0	10	10	ritonavir	Mip1	PA451260	57521	0.484
NULL	Oncoimmunology_2012_Jul_1_1(4)_493-506.nxml.txt.nlp	22754768	SENT38	36	36	4	4	aldesleukin	IFN	PA448081	3439	0.484
NULL	Mol_Cancer_2012_Jun_18_11_41.nxml.txt.nlp	22709873	SENT279	15	15	22	22	lapatinib	PAX3	PA152241907	5077	0.484
NULL	Evid_Based_Complement_Alternat_Med_2012_Sep_18_2012_674101.nxml.txt.nlp	23028394	SENT226	2	2	26	26	donepezil	CA3	PA449394	761	0.484
NULL	Mol_Vis_2011_Dec_24_17_3384-3391.nxml.txt.nlp	22219634	SENT106	17	17	10	10	mannitol	TLR4	PA450320	7099	0.484
NULL	Nat_Commun_2013_4_1966.nxml.txt.nlp	23739662	SENT27	31	31	24	24	tamoxifen	ORF	PA451581	537	0.484
NULL	Cell_Cycle_2012_Aug_15_11(16)_3097-3108.nxml.txt.nlp	22871741	SENT170	10	10	14	14	hyaluronan	HAS2	PA165958431	3037	0.484
NULL	Diabetes_Care_2010_May_25_33(5)_1050-1054.nxml.txt.nlp	20185741	SENT150	10	10	1	1	fluoxetine	Gen	PA449673	348654	0.484
NULL	Iran_J_Public_Health_2013_Jan_1_42(Supple1)_50-54.nxml.txt.nlp	23865016	SENT136	22	22	15	15	etanercept	MAX	PA449515	4149	0.484
NULL	Nucleic_Acids_Res_2012_Sep_31_40(16)_7967-7974.nxml.txt.nlp	22661575	SENT50	30	30	14	14	ampicillin	SOC	PA448419	91544	0.484
NULL	Br_J_Cancer_2013_Mar_5_108(4)_887-900.nxml.txt.nlp	23462807	SENT108	20	20	23	23	sunitinib	VEGFR3	PA162372840	2324	0.484
NULL	Crit_Care_2011_Nov_16_15(6)_R271.nxml.txt.nlp	22087790	SENT164	2	2	34	34	nitroprusside	Yes	PA451406	7525	0.484
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2008_Jun_1_64(Pt_6)_611-619.nxml.txt.nlp	18560148	SENT165	8	8	2	2	heparin	IP-10	PA449855	3627	0.484
NULL	J_Korean_Med_Sci_2010_May_16_25(5)_738-745.nxml.txt.nlp	20436711	SENT12	18	18	10	10	lamivudine	NUC	PA450163	4924	0.484
NULL	Adv_Biomed_Res_2014_Mar_25_3_100.nxml.txt.nlp	24800189	SENT237	16	16	12	12	carbamazepine	CYP3A	PA448785	1574	0.484
NULL	Antimicrob_Agents_Chemother_2014_Aug_58(8)_4971-4973.nxml.txt.nlp	24913169	SENT13	30	30	16	16	primaquine	G6PD	PA451103	2539	0.484
NULL	J_Biol_2003_Sep_24_2(4)_28.nxml.txt.nlp	14511394	SENT96	7	7	11	11	phenformin	LKB1	PA1000	6794	0.484
NULL	Ann_N_Y_Acad_Sci_2012_Oct_10_1271(1)_58-67.nxml.txt.nlp	23050965	SENT93	8	8	16	16	resveratrol	CYP1B1		1545	0.484
NULL	J_Biol_Chem_2008_Oct_31_283(44)_29841-29846.nxml.txt.nlp	18765669	SENT199	10	10	14	14	suramin	P2X1	PA10292	5023	0.484
NULL	J_Exp_Bot_2012_Jan_6_63(1)_121-130.nxml.txt.nlp	21984651	SENT287	29	29	24	24	starch	PCD	PA451492	27019;5092;352909;1767	0.484
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2007_Dec_6_64(Pt_1)_m92.nxml.txt.nlp	21200659	SENT56	0	0	4	4	potassium	mol	PA451047	90527	0.484
NULL	Oncotarget_2014_Mar_16_5(12)_4087-4102.nxml.txt.nlp	24961479	SENT64	2	2	4	4	hemin	PC3	PA449849	57332;7832;5122	0.484
NULL	Diabetes_2013_Nov_18_62(11)_3909-3919.nxml.txt.nlp	23835339	SENT207	12	12	23	23	gliclazide	SUR1	PA10892	6833	0.484
NULL	Indian_J_Endocrinol_Metab_2011_Jul-Sep_15(3)_220-223.nxml.txt.nlp	21897903	SENT57	12	12	16	16	vincristine	CHOP	PA451879	1649	0.484
NULL	Clin_Cosmet_Investig_Dermatol_2011_Jul_1_4_93-99.nxml.txt.nlp	21760744	SENT100	19	19	2	2	etanercept	IL-17	PA449515	3605	0.484
NULL	Arthritis_Res_Ther_2013_Sep_26_15(5)_R137.nxml.txt.nlp	24286509	SENT172	7	7	13	13	pegloticase	CAPER	PA165963961	9584	0.484
NULL	J_Infect_Dis_2014_Aug_1_210(3)_473-482.nxml.txt.nlp	24526740	SENT256	36	36	18	18	vancomycin	DNAJ	PA451850	85406;10294	0.484
NULL	Amyloid_2014_Sep_11_21(3)_175-184.nxml.txt.nlp	24918964	SENT198	16	16	18	18	anakinra	TTR	PA10799	7276	0.484
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Nov_16_67(Pt_12)_o3342.nxml.txt.nlp	22199837	SENT3	17	17	3	3	piperazine	mol	PA450977	90527	0.484
NULL	Mol_Vis_2007_Jun_11_13_833-839.nxml.txt.nlp	17615544	SENT47	9	9	27	27	l-glutamine	CNTF	PA10090	1270	0.484
NULL	Front_Endocrinol_(Lausanne)_2014_Jan_16_5_1.nxml.txt.nlp	24474947	SENT32	0	0	2	2	estradiol	GPER	PA449503	2852	0.484
NULL	Cancer_Cell_Int_2009_Feb_17_9_4.nxml.txt.nlp	19222856	SENT197	9	9	12	12	cisplatin	p53	PA449014	7157	0.484
NULL	Cancers_(Basel)_2011_Aug_9_3(3)_3189-3205.nxml.txt.nlp	24212952	SENT796	1	1	3	3	hyaluronidase	CD44	PA164745713	960	0.484
NULL	J_Am_Heart_Assoc_2013_Aug_23_2(4)_e000249.nxml.txt.nlp	23817469	SENT293	3	3	15	15	creatine	APLN	PA164778930	8862	0.484
NULL	Mol_Cancer_2008_Jun_5_7_50.nxml.txt.nlp	18534018	SENT130	21	21	19	19	bortezomib	NOXA	PA10252	5366	0.484
NULL	Nanotechnol_Sci_Appl_2014_Dec_1_7_105-112.nxml.txt.nlp	25489238	SENT175	14	14	18	18	methyltestosterone	zeta	PA165958383	9907	0.484
NULL	Case_Rep_Hematol_2012_Mar_29_2012_257023.nxml.txt.nlp	22937322	SENT21	30	30	27	27	heparin	PF4	PA449855	5196	0.484
NULL	Front_Cell_Neurosci_2013_Aug_30_7_139.nxml.txt.nlp	24009559	SENT163	2	2	20	20	pilocarpine	VGLUT1	PA450962	57030	0.484
NULL	Oncogene_2013_Sep_12_32(37)_4355-4365.nxml.txt.nlp	23108409	SENT7	11	11	15	15	hyaluronan	HAS2	PA165958431	3037	0.484
NULL	Blood_Cancer_J_2013_Oct_18_3(10)_e153.nxml.txt.nlp	24141622	SENT225	24	24	2	2	fludarabine	CLB	PA449655	171425	0.484
NULL	Mol_Cancer_2009_Jun_8_8_34.nxml.txt.nlp	19500427	SENT73	13	13	3	3	gemcitabine	p53	PA449748	7157	0.484
NULL	Braz_J_Med_Biol_Res_2014_Feb_17_47(2)_101-109.nxml.txt.nlp	24519125	SENT195	4	4	11	11	isoproterenol	IL-6	PA450121	3569	0.484
NULL	Cancers_(Basel)_2014_Aug_12_6(3)_1631-1669.nxml.txt.nlp	25119536	SENT1888	2	2	9	9	curcumin	SOCS3	PA151958596	9021	0.484
NULL	Mol_Vis_2007_Jan_24_13_57-65.nxml.txt.nlp	17277739	SENT222	26	26	39	39	heparin	FGF2	PA449855	2247;2258	0.484
NULL	Mol_Cancer_2012_Jul_12_11_45.nxml.txt.nlp	22788833	SENT138	31	31	14	14	cisplatin	EGFR	PA449014	1956	0.484
NULL	Crit_Care_2005_Oct_7_9(Suppl_5)_S15-S24.nxml.txt.nlp	16221315	SENT49	6	6	21	21	thrombin	FXI	PA451674	2160	0.484
NULL	Clin_Ophthalmol_2010_Oct_21_4_1165-1171.nxml.txt.nlp	21060666	SENT123	2	2	4	4	latanoprost	BAK	PA164774763	578	0.484
NULL	Nat_Commun_2012_Jan_17_3_626.nxml.txt.nlp	22252550	SENT505	15	15	5	5	imatinib	E16	PA10804	8140	0.484
NULL	Curr_Neuropharmacol_2013_Dec_11(6)_606-620.nxml.txt.nlp	24396337	SENT721	12	12	7	7	lidocaine	TRPV1	PA450226	7442	0.484
NULL	Exp_Ther_Med_2014_Aug_11_8(2)_671-675.nxml.txt.nlp	25009638	SENT111	12	12	10	10	scopolamine	FAE	PA451308	2178	0.484
NULL	Head_Face_Med_2012_Mar_1_8_5.nxml.txt.nlp	22376948	SENT41	34	34	0	0	ibandronate	OST	PA10270	1650;23263	0.484
NULL	Stud_Health_Technol_Inform_2013_192_62-66.nxml.txt.nlp	23920516	SENT131	19	19	8	8	cytarabine	IFNA	PA449177	3440	0.484
NULL	Arthritis_Res_Ther_2009_Jun_5_11(3)_R84.nxml.txt.nlp	19500335	SENT219	4	4	39	39	infliximab	CCL2	PA452639	6347	0.484
NULL	Cancer_Metab_2013_Mar_18_1_11.nxml.txt.nlp	24280190	SENT301	4	4	22	22	nadh	HIF-1	PA164755085	29072	0.484
NULL	Bioanal_Rev_2012_Mar_17_4(1)_1-30.nxml.txt.nlp	22389661	SENT882	14	14	6	6	vasopressin	SERS	PA451858	6301;54938	0.484
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1699-1708.nxml.txt.nlp	19861960	SENT246	16	16	13	13	dasatinib	mol	PA162372878	90527	0.484
NULL	Oncol_Lett_2013_Oct_24_6(4)_970-976.nxml.txt.nlp	24137447	SENT159	15	15	20	20	tamoxifen	ADM	PA451581	133	0.484
NULL	Int_J_Alzheimers_Dis_2010_Dec_27_2011_231595.nxml.txt.nlp	21234401	SENT78	4	4	7	7	glucose	B12	PA449773	7126;4709	0.484
NULL	Biosci_Rep_2014_Apr_14_34(2)_e00104.nxml.txt.nlp	24597785	SENT716	17	17	1	1	thrombin	p85	PA451674	5296;5295;54776;23368	0.484
NULL	FEBS_Open_Bio_2014_Jun_18_4_560-570.nxml.txt.nlp	25161866	SENT69	15	15	13	13	4-methylumbelliferone	mol	PA154081778	90527	0.484
NULL	Cancers_(Basel)_2014_Aug_5_6(3)_1597-1614.nxml.txt.nlp	25099886	SENT178	16	16	2	2	methotrexate	POLB	PA450428	5423	0.484
NULL	J_Vis_Exp_2010_Dec_9_(46)_2460.nxml.txt.nlp	21178968	SENT239	26	26	32	32	efavirenz	ATV	PA449441	4683	0.484
NULL	Brain_Behav_2013_Mar_6_3(2)_114-133.nxml.txt.nlp	23533150	SENT12	4	4	12	12	ethanol	HSF1	PA448073	3297	0.484
NULL	Oncotarget_2014_Jun_26_5(14)_5559-5569.nxml.txt.nlp	24980819	SENT122	0	0	2	2	vemurafenib	DR5	PA165946873	8795	0.484
NULL	Front_Physiol_2013_May_15_4_103.nxml.txt.nlp	23720630	SENT150	11	11	3	3	simvastatin	Q10	PA451363	27161	0.484
NULL	Mol_Biol_Cell_2014_Sep_15_25(18)_2774-2787.nxml.txt.nlp	25057014	SENT47	30	30	28	28	pp2	PP1		5540;5464	0.484
NULL	J_Korean_Med_Sci_2010_Nov_26_25(11)_1683-1687.nxml.txt.nlp	21060764	SENT41	19	19	17	17	thyroglobulin	TTF-1	PA164754910	7080	0.484
NULL	Biomed_Res_Int_2014_Jan_19_2014_215872.nxml.txt.nlp	24575401	SENT94	6	6	20	20	artemisinin	TC2	PA165111696	6948	0.483
NULL	J_Inflamm_(Lond)_2006_Oct_4_3_13.nxml.txt.nlp	17020618	SENT54	16	16	10	10	l-glutamine	F12	PA10090	2161	0.483
NULL	Cancer_Cell_Int_2005_Jul_29_5_24.nxml.txt.nlp	16053526	SENT48	20	20	9	9	chloramphenicol	p53	PA448927	7157	0.483
NULL	Aging_(Albany_NY)_2009_May_22_1(6)_557-572.nxml.txt.nlp	20195383	SENT16	14	14	20	20	creatine	ADP	PA164778930	23038	0.483
NULL	Case_Rep_Oncol_Med_2012_Feb_28_2012_276385.nxml.txt.nlp	22606452	SENT1	13	13	35	35	cisplatin	DD1	PA449014	1645	0.483
NULL	Biologics_2014_Apr_22_8_193-198.nxml.txt.nlp	24790412	SENT126	19	19	21	21	adalimumab	Yes	PA10004	7525	0.483
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT487	7	7	17	17	metformin	AMPK	PA450395	5563	0.483
NULL	J_Geriatr_Cardiol_2014_Jun_11(2)_151-157.nxml.txt.nlp	25009566	SENT139	3	3	7	7	cilostazol	CDP	PA164746334	1523	0.483
NULL	Diabetes_2013_Oct_17_62(10)_3324-3328.nxml.txt.nlp	24065789	SENT0	20	20	41	41	glucose	San	PA449773	80218	0.483
NULL	Diabetes_Care_2009_Dec_6_32(12)_2251-2257.nxml.txt.nlp	19808924	SENT165	0	0	2	2	exenatide	GLP-1	PA164749238	100125288	0.483
NULL	Mol_Vis_2011_Aug_18_17_2221-2227.nxml.txt.nlp	21897744	SENT119	12	12	20	20	l-arginine	NAC	PA448478	22861	0.483
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1051.nxml.txt.nlp	24503543	SENT144	24	24	27	27	tamoxifen	Yes	PA451581	7525	0.483
NULL	Curr_Gerontol_Geriatr_Res_2010_Jun_8_2010_915296.nxml.txt.nlp	20631897	SENT166	29	29	1	1	pravastatin	SAGE	PA451089	55511	0.483
NULL	Cancer_Cell_Int_2004_Mar_19_4_3.nxml.txt.nlp	15035672	SENT66	21	21	7	7	etoposide	PC3	PA449552	57332;7832;5122	0.483
NULL	Nat_Commun_2014_Nov_19_5_5479.nxml.txt.nlp	25407222	SENT127	15	15	33	33	dextran	YTS	PA449261	8565	0.483
NULL	Br_J_Cancer_2013_May_14_108(9)_1801-1806.nxml.txt.nlp	23632478	SENT14	0	0	7	7	lenalidomide	IL-8	PA162363968	3576	0.483
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_P64.nxml.txt.nlp	NULL	SENT16	26	26	30	30	ceftriaxone	PPL	PA448866	5493	0.483
NULL	Pharmaceutics_2012_Dec_20_5(1)_1-22.nxml.txt.nlp	24300394	SENT507	14	14	17	17	gliclazide	Tech	PA10892	57449	0.483
NULL	Indian_J_Endocrinol_Metab_2013_Jul-Aug_17(4)_636-646.nxml.txt.nlp	23961479	SENT157	19	19	24	24	rosuvastatin	CYP3A4	PA134308647	1576	0.483
NULL	Cell_Biol_Toxicol_2012_Apr_19_28(2)_69-87.nxml.txt.nlp	22258563	SENT104	20	20	38	38	bupropion	CYP3A4	PA448687	1576	0.483
NULL	Evid_Based_Complement_Alternat_Med_2013_Mar_26_2013_679635.nxml.txt.nlp	23589720	SENT81	0	0	12	12	phenylephrine	DPI	PA450935	1832	0.483
NULL	Pharmaceuticals_(Basel)_2014_Jan_9_7(1)_46-57.nxml.txt.nlp	24451403	SENT320	5	5	11	11	ritonavir	CYP3A4	PA451260	1576	0.483
NULL	Indian_J_Pharm_Sci_2013_Sep-Oct_75(5)_523-532.nxml.txt.nlp	24403652	SENT151	3	3	6	6	atorvastatin	ATV	PA448500	4683	0.483
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT184	0	0	6	6	doxorubicin	B7-H1	PA449412	29126	0.483
NULL	Cancers_(Basel)_2012_Feb_21_4(1)_165-183.nxml.txt.nlp	24213234	SENT686	1	1	18	18	cisplatin	Era	PA449014	2099	0.483
NULL	Curr_Neuropharmacol_2014_Jul_12(4)_365-379.nxml.txt.nlp	25342944	SENT534	28	28	6	6	paroxetine	5-HT2C	PA450801	3358	0.483
NULL	Exp_Ther_Med_2013_Jun_3_5(6)_1631-1636.nxml.txt.nlp	23837045	SENT9	13	13	10	10	phentolamine	ANGPTL2	PA450926	23452	0.483
NULL	Cell_Commun_Signal_2013_Jul_4_11_47.nxml.txt.nlp	23826796	SENT96	6	6	21	21	forskolin	CC2D1A	PA146096022	54862	0.483
NULL	Allergy_Asthma_Immunol_Res_2014_Mar_13_6(2)_156-162.nxml.txt.nlp	24587953	SENT157	21	21	16	16	celecoxib	AAP	PA448871	5345	0.483
NULL	Evid_Based_Complement_Alternat_Med_2014_Dec_29_2014_609594.nxml.txt.nlp	25614752	SENT457	4	4	6	6	capsaicin	TRPV1	PA448776	7442	0.483
NULL	Breast_Cancer_Res_2009_Jul_15_11(4)_207.nxml.txt.nlp	19664181	SENT226	6	6	37	37	bevacizumab	PTEN	PA130232992	5728	0.483
NULL	Clin_Pharmacol_2011_Jun_22_3_13-25.nxml.txt.nlp	22287853	SENT21	27	27	32	32	saxagliptin	GLP-1	PA165958362	100125288	0.483
NULL	Antibiotics_(Basel)_2014_Jul_1_3(3)_285-316.nxml.txt.nlp	25364574	SENT188	10	10	24	24	meropenem	IMP-1	PA164764445	10642	0.483
NULL	Indian_J_Psychol_Med_2012_Jul-Sep_34(3)_247-254.nxml.txt.nlp	23439746	SENT78	11	11	8	8	clozapine	FGA	PA449061	2243	0.483
NULL	Eur_J_Dent_2011_Jan_5(1)_77-83.nxml.txt.nlp	21228958	SENT36	13	13	11	11	chlorhexidine	HEMA	PA164776863	2157	0.483
NULL	Mol_Cell_Biochem_2014_Oct_9_385(1-2)_265-275.nxml.txt.nlp	24104452	SENT163	13	13	15	15	bortezomib	U87	PA10252	677775;641648	0.483
NULL	J_Biol_Chem_2013_Oct_11_288(41)_29642-29653.nxml.txt.nlp	24005673	SENT462	9	9	12	12	hyaluronan	TSG-6	PA165958431	7130	0.483
NULL	J_Oncol_2012_Apr_10_2012_931071.nxml.txt.nlp	22570654	SENT18	0	0	10	10	plerixafor	CD34	PA165958410	947	0.483
NULL	J_Exp_Med_1994_Aug_1_180(2)_663-671.nxml.txt.nlp	8046339	SENT7	33	33	35	35	hydrocortisone	IL-4	PA449905	3565	0.483
NULL	J_Headache_Pain_2009_Apr_27_10(2)_105-110.nxml.txt.nlp	19172228	SENT111	14	14	11	11	capsaicin	c-fos	PA448776	2353	0.483
NULL	Oncotarget_2014_Aug_19_5(18)_8703-8715.nxml.txt.nlp	25237928	SENT184	24	24	3	3	glucose	CD44	PA449773	960	0.483
NULL	Nat_Commun_2012_Dec_27_3_1316.nxml.txt.nlp	23271650	SENT531	34	34	43	43	tamoxifen	CA3	PA451581	761	0.483
NULL	Nat_Commun_2013_Sep_11_4_2416.nxml.txt.nlp	24022506	SENT157	10	10	16	16	phenol	F12	PA450913	2161	0.483
NULL	J_RNAi_Gene_Silencing_2009_Mar_9_5(1)_321-330.nxml.txt.nlp	19771229	SENT215	6	6	11	11	gemcitabine	RRM1	PA449748	6240	0.483
NULL	J_Viral_Hepat_2012_Feb_19(2)_e134-e142.nxml.txt.nlp	22239511	SENT30	26	26	29	29	telaprevir	SOC	PA165958354	91544	0.483
NULL	Angew_Chem_Int_Ed_Engl_2013_Jan_2_52(1)_325-330.nxml.txt.nlp	23080482	SENT33	11	11	26	26	thrombin	PAR-1	PA451674	2011;2149	0.483
NULL	Acta_Pharmacol_Sin_2012_Dec_22_33(12)_1563-1570.nxml.txt.nlp	23085740	SENT3	28	28	10	10	cyclosporine	CYP3A	PA449167	1574	0.483
NULL	Br_J_Cancer_2012_Feb_14_106(4)_685-692.nxml.txt.nlp	22294184	SENT125	3	3	9	9	lovastatin	survivin	PA450272	332	0.483
NULL	J_Bras_Pneumol_2013_Jun-Aug_39(4)_434-439.nxml.txt.nlp	24068264	SENT158	11	11	27	27	tramadol	por	PA451735	64840	0.483
NULL	J_Cell_Biol_2005_Nov_21_171(4)_663-673.nxml.txt.nlp	16301332	SENT295	19	19	23	23	l-glutamine	EGF	PA10090	1950	0.483
NULL	Pharmaceuticals_(Basel)_2014_Jul_16_7(7)_839-849.nxml.txt.nlp	NULL	SENT171	2	2	5	5	cetuximab	EGFR	PA10040	1956	0.483
NULL	J_Korean_Med_Sci_2010_Sep_12_25(9)_1364-1367.nxml.txt.nlp	20808682	SENT87	25	25	23	23	tacrolimus	P-gp	PA451578	5243	0.483
NULL	Case_Rep_Genet_2014_Jan_22_2014_413743.nxml.txt.nlp	24627811	SENT6	2	2	11	11	warfarin	CYP2C9	PA451906	1559	0.483
NULL	Oxid_Med_Cell_Longev_2013_Dec_5_2013_963520.nxml.txt.nlp	24381719	SENT245	29	29	8	8	oxygen	NOS	PA450744	4843	0.483
NULL	Int_J_Mol_Sci_2014_Nov_7_15(11)_20518-20537.nxml.txt.nlp	25387079	SENT223	22	22	30	30	trypsin	TLR4	PA451806	7099	0.483
NULL	J_Gastroenterol_2013_Jan_27_48(1)_22-30.nxml.txt.nlp	23104468	SENT71	22	22	7	7	ribavirin	SOC	PA451241	91544	0.483
NULL	Clin_Toxicol_(Phila)_2014_Nov_6_52(9)_926-944.nxml.txt.nlp	25283255	SENT306	4	4	8	8	verapamil	Mal	PA451868	114609	0.483
NULL	EMBO_Mol_Med_2013_Aug_4_5(8)_1180-1195.nxml.txt.nlp	23828858	SENT37	10	10	16	16	rituximab	MYC	PA451261	4609	0.483
NULL	Breast_Cancer_Res_2006_Oct_2_8(5)_R56.nxml.txt.nlp	17014703	SENT159	18	18	36	36	collagenase	COL1A1	PA449107	1277	0.483
NULL	J_Int_Soc_Sports_Nutr_2015_Jan_21_12(1)_5.nxml.txt.nlp	NULL	SENT146	0	0	8	8	curcumin	IL-6	PA151958596	3569	0.483
NULL	Pharmaceutics_2011_Oct_12_3(4)_680-705.nxml.txt.nlp	24309303	SENT969	15	15	12	12	metformin	OCT1	PA450395	5451;6580	0.483
NULL	Oncotarget_2012_Dec_30_3(12)_1505-1521.nxml.txt.nlp	23455493	SENT175	13	13	5	5	metformin	NAC	PA450395	22861	0.483
NULL	Drugs_R_D_2011_Sep_25_11(3)_227-249.nxml.txt.nlp	21902286	SENT303	9	9	17	17	genistein	CPX	PA165109660	1371;10682;1377	0.483
NULL	Front_Neural_Circuits_2014_Jun_2_8_56.nxml.txt.nlp	24917791	SENT608	5	5	13	13	estradiol	aromatase	PA449503	1588	0.483
NULL	Semin_Immunopathol_2013_Jan_26_35(1)_39-52.nxml.txt.nlp	22829332	SENT197	19	19	30	30	cyclophosphamide	CHOP	PA449165	1649	0.483
NULL	F1000Res_2013_Feb_28_2_65.nxml.txt.nlp	24358861	SENT132	0	0	7	7	naloxone	TLR4	PA450586	7099	0.483
NULL	Virulence_2013_Oct_1_4(7)_646-653.nxml.txt.nlp	24045422	SENT52	1	1	4	4	l-lysine	CD4	PA450280	920	0.483
NULL	Neural_Regen_Res_2014_Mar_15_9(6)_622-629.nxml.txt.nlp	25206865	SENT85	0	0	6	6	vasopressin	c-Jun	PA451858	3725	0.483
NULL	Hum_Mol_Genet_2013_Dec_1_22(23)_4857-4869.nxml.txt.nlp	23873044	SENT30	26	26	24	24	heparin	C3b	PA449855	718	0.483
NULL	Environ_Health_Perspect_1998_Oct_106(Suppl_5)_1191-1195.nxml.txt.nlp	9788897	SENT7	12	12	15	15	nadh	ND5	PA164755085	4540	0.483
NULL	J_Cell_Mol_Med_2013_Jun_15_17(6)_792-799.nxml.txt.nlp	23672538	SENT61	7	7	22	22	fluorescein	CD2	PA164746009	914	0.483
NULL	Oncol_Lett_2013_Feb_3_5(2)_505-510.nxml.txt.nlp	23420812	SENT8	29	29	2	2	cisplatin	AEG-1	PA449014	92140	0.483
NULL	Iran_J_Psychiatry_2010_Spring_5(2)_60-65.nxml.txt.nlp	22952493	SENT88	15	15	7	7	naltrexone	DBT	PA450588	1629	0.483
NULL	Indian_J_Pharm_Sci_2014_Jul-Aug_76(4)_299-307.nxml.txt.nlp	25284927	SENT119	25	25	22	22	phenylbutazone	2-19	PA450932	60343	0.483
NULL	Biomed_Res_Int_2014_Mar_4_2014_836769.nxml.txt.nlp	24724101	SENT85	5	5	29	29	fulvestrant	HER2	PA164747170	2064	0.483
NULL	Front_Mol_Neurosci_2012_Nov_12_5_99.nxml.txt.nlp	23162427	SENT259	0	0	17	17	cocaine	HDAC5	PA449072	10014	0.483
NULL	Amyloid_2014_Sep_11_21(3)_175-184.nxml.txt.nlp	24918964	SENT134	1	1	3	3	anakinra	TTR	PA10799	7276	0.483
NULL	Diabetes_Care_2009_Sep_5_32(9)_1591-1593.nxml.txt.nlp	19502538	SENT12	11	11	6	6	abacavir	NTRI	PA448004	50863	0.483
NULL	Thorax_2012_Nov_26_67(11)_985-992.nxml.txt.nlp	22735687	SENT209	12	12	9	9	dextran	LIGHT	PA449261	8740	0.483
NULL	J_Immunol_Res_2014_Feb_13_2014_814598.nxml.txt.nlp	24741625	SENT212	4	4	18	18	estradiol	DEFA4	PA449503	1669	0.483
NULL	Neuroscience_2011_Dec_1_197(1)_280-292.nxml.txt.nlp	21945033	SENT60	26	26	5	5	scopolamine	AP-5	PA451308	91056	0.483
NULL	Cases_J_2009_Jul_9_2_7466.nxml.txt.nlp	19829971	SENT64	3	3	7	7	dobutamine	DST	PA449381	667	0.483
NULL	Indian_J_Anaesth_2014_Jul-Aug_58(4)_423-429.nxml.txt.nlp	25197110	SENT43	12	12	19	19	ondansetron	ODF	PA450705	8600	0.483
NULL	J_Clin_Biochem_Nutr_2009_Nov_28_45(3)_285-291.nxml.txt.nlp	19902018	SENT150	14	14	16	16	naringenin	XDH	PA151958361	7498	0.483
NULL	Oncoimmunology_2014_Jun_25_3_e29080.nxml.txt.nlp	25101222	SENT24	22	22	26	26	hyaluronan	LYVE-1	PA165958431	10894	0.483
NULL	J_Korean_Med_Sci_2010_Feb_19_25(2)_304-308.nxml.txt.nlp	20119588	SENT34	20	20	27	27	rifampin	EMB	PA451250	133418	0.483
NULL	Ital_J_Pediatr_2013_Sep_26_39_60.nxml.txt.nlp	24069936	SENT22	29	29	25	25	l-arginine	Q10	PA448478	27161	0.483
NULL	ScientificWorldJournal_2013_Dec_5_2013_643954.nxml.txt.nlp	24382946	SENT142	10	10	12	12	thalidomide	ghrelin	PA451644	51738	0.483
NULL	Clin_Med_Insights_Oncol_2011_Sep_21_5_315-323.nxml.txt.nlp	22084620	SENT13	7	7	10	10	gemcitabine	IFN	PA449748	3439	0.483
NULL	Diabetes_Care_2011_Jun_20_34(6)_1265-1269.nxml.txt.nlp	21515846	SENT3	23	23	26	26	rosiglitazone	DREAM	PA451283	30818	0.483
NULL	Mol_Imaging_Radionucl_Ther_2013_Aug_1_22(2)_49-55.nxml.txt.nlp	24003397	SENT3	7	7	21	21	octreotide	ACTH	PA450678	5443	0.483
NULL	Mol_Cell_Biochem_2014_Oct_9_385(1-2)_265-275.nxml.txt.nlp	24104452	SENT103	20	20	16	16	bortezomib	U87	PA10252	677775;641648	0.483
NULL	Front_Plant_Sci_2012_Jul_2_3_147.nxml.txt.nlp	22783267	SENT95	0	0	23	23	lipase	DAG	PA450239	1605	0.483
NULL	J_Orthop_Traumatol_2011_Mar_19_12(1)_69-76.nxml.txt.nlp	21246392	SENT53	2	2	4	4	heparin	FON	PA449855	741	0.483
NULL	J_Biol_2003_Sep_24_2(4)_28.nxml.txt.nlp	14511394	SENT355	11	11	20	20	phenformin	LKB1	PA1000	6794	0.483
NULL	J_Autom_Methods_Manag_Chem_2007_Apr_23_2007_71943.nxml.txt.nlp	18528514	SENT3027	15	15	4	4	phenol	FOR	PA450913	51741	0.483
NULL	Cancers_(Basel)_2013_May_24_5(2)_569-590.nxml.txt.nlp	24216992	SENT1200	1	1	10	10	gemcitabine	CD11b	PA449748	3684	0.483
NULL	Br_J_Cancer_2009_Oct_6_101(7)_1155-1161.nxml.txt.nlp	19738614	SENT38	19	19	10	10	gemcitabine	MUC4	PA449748	4585	0.483
NULL	Front_Genet_2014_Aug_26_5_289.nxml.txt.nlp	25206362	SENT242	1	1	4	4	choline	spatial	PA448976	219793	0.483
NULL	Scientifica_(Cairo)_2012_Oct_14_2012_428139.nxml.txt.nlp	24278693	SENT108	23	23	9	9	metformin	OCT3	PA450395	5460;6581	0.483
NULL	Springerplus_2014_Sep_11_3_516.nxml.txt.nlp	25279308	SENT240	4	4	2	2	ethanol	SHF	PA448073	90525	0.483
NULL	AIDS_Behav_2012_Feb_30_16(2)_396-403.nxml.txt.nlp	21190073	SENT148	4	4	23	23	methamphetamine	San	PA450403	80218	0.482
NULL	J_Clin_Biochem_Nutr_2008_May_29_42(3)_204-214.nxml.txt.nlp	18545642	SENT123	12	12	14	14	heparin	EGF	PA449855	1950	0.482
NULL	Nucleic_Acids_Res_2005_Jun_8_33(10)_3283-3291.nxml.txt.nlp	15944449	SENT96	4	4	28	28	sjg-136	XRCC5		7520	0.482
NULL	Oxid_Med_Cell_Longev_2013_Sep_17_2013_521563.nxml.txt.nlp	24163720	SENT229	43	43	34	34	vasopressin	HO-2	PA451858	3163	0.482
NULL	Curr_Chem_Genomics_2010_Mar_1_4_1-8.nxml.txt.nlp	20448812	SENT120	28	28	23	23	bosentan	OATP1B3	PA10034	28234	0.482
NULL	Oncol_Lett_2014_Mar_16_7(3)_827-833.nxml.txt.nlp	24527090	SENT78	5	5	2	2	cisplatin	IFN	PA449014	3439	0.482
NULL	Case_Rep_Crit_Care_2014_Aug_19_2014_242703.nxml.txt.nlp	25215245	SENT243	11	11	28	28	salbutamol	Yes	PA448068	7525	0.482
NULL	Nano_Rev_2010_Feb_22_1_10_3402_nano_v1i0_4883.nxml.txt.nlp	22110854	SENT181	13	13	21	21	iron	MRI	PA450087	78996	0.482
NULL	Asian-Australas_J_Anim_Sci_2014_Jul_27(7)_1057-1068.nxml.txt.nlp	25050050	SENT61	9	9	33	33	l-methionine	HSL	PA450423	3991	0.482
NULL	AIDS_Care_2011_Sep_14_23(9)_1154-1162.nxml.txt.nlp	21500025	SENT123	8	8	2	2	efavirenz	ATV	PA449441	4683	0.482
NULL	J_Ayurveda_Integr_Med_2012_Jan-Mar_3(1)_29-32.nxml.txt.nlp	22529677	SENT109	1	1	6	6	phenol	MRK	PA450913	22858	0.482
NULL	Clin_Psychopharmacol_Neurosci_2013_Dec_24_11(3)_152-157.nxml.txt.nlp	24465252	SENT56	17	17	27	27	paliperidone	ANOVA	PA163518919	4858	0.482
NULL	Breast_Cancer_2013_Mar_1_20(4)_302-309.nxml.txt.nlp	23456736	SENT43	5	5	17	17	tegafur	GBL	PA452620	64223	0.482
NULL	Int_J_Mol_Sci_2007_Jan_29_8(1)_13-28.nxml.txt.nlp	NULL	SENT357	19	19	25	25	galactose	NAG	PA449725	51594;4669	0.482
NULL	Indian_J_Pharmacol_2008_Jun_40(3)_103-106.nxml.txt.nlp	20040935	SENT108	26	26	10	10	glibenclamide	ANOVA	PA449782	4858	0.482
NULL	Exp_Ther_Med_2015_Feb_15_9(2)_384-388.nxml.txt.nlp	25574202	SENT132	21	21	24	24	iohexol	HLP	PA450061	6499;9001;3002	0.482
NULL	Clin_Ophthalmol_2010_Nov_3_4_1253-1261.nxml.txt.nlp	21151330	SENT132	16	16	13	13	latanoprost	BAK	PA164774763	578	0.482
NULL	Cardiovasc_Diabetol_2013_Nov_21_12_172.nxml.txt.nlp	24261558	SENT217	10	10	18	18	eplerenone	FABP3	PA164749044	2170	0.482
NULL	Br_J_Cancer_2006_Feb_13_94(3)_407-426.nxml.txt.nlp	16434996	SENT119	0	0	12	12	genistein	BRCA2	PA165109660	675	0.482
NULL	Case_Rep_Dermatol_2013_Oct_9_5(3)_283-289.nxml.txt.nlp	24403891	SENT77	20	20	11	11	diclofenac	CO2	PA449293	4513	0.482
NULL	J_Biol_Chem_2009_Apr_24_284(17)_11613-11621.nxml.txt.nlp	19234302	SENT124	16	16	6	6	gentamicin	SEPT11	PA449753	55752	0.482
NULL	Arthritis_Res_Ther_2009_Jan_8_11(1)_R3.nxml.txt.nlp	20527084	SENT140	2	2	12	12	trypsin	GM-CSF	PA451806	1437	0.482
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Jun_8_69(Pt_7)_m360-m361.nxml.txt.nlp	24046548	SENT4	29	29	31	31	nitrile	mol	PA450636	90527	0.482
NULL	Biomed_Res_Int_2014_Jan_29_2014_361020.nxml.txt.nlp	24605326	SENT223	1	1	26	26	staurosporine	CDK1	PA165109623	983	0.482
NULL	Cells_2014_May_23_3(2)_517-545.nxml.txt.nlp	24861977	SENT717	11	11	19	19	capsaicin	TRPV1	PA448776	7442	0.482
NULL	Cell_Death_Dis_2010_Nov_11_1(11)_e98.nxml.txt.nlp	21368874	SENT168	11	11	25	25	thyroglobulin	B12	PA164754910	7126;4709	0.482
NULL	Mol_Cancer_2010_Jun_25_9_166.nxml.txt.nlp	20579378	SENT209	10	10	8	8	gefitinib	EGF	PA131301952	1950	0.482
NULL	Breast_Cancer_Res_2007_Jul_5_9(4)_R41.nxml.txt.nlp	17612393	SENT37	27	27	30	30	celecoxib	Bcl-2	PA448871	596	0.482
NULL	J_Young_Pharm_2010_Apr-Jun_2(2)_196-200.nxml.txt.nlp	21264125	SENT128	15	15	18	18	rosuvastatin	CYP2C9	PA134308647	1559	0.482
NULL	Oncotarget_2011_May_16_2(5)_418-421.nxml.txt.nlp	21789791	SENT14	17	17	15	15	bortezomib	TRAIL	PA10252	8743	0.482
NULL	Indian_J_Endocrinol_Metab_2012_Dec_16(Suppl_2)_S245-S247.nxml.txt.nlp	23565390	SENT47	14	14	37	37	glipizide	GLP	PA449762	342096	0.482
NULL	Oncol_Lett_2013_Jun_3_5(6)_1760-1764.nxml.txt.nlp	23833637	SENT113	7	7	5	5	gemcitabine	TRAIL	PA449748	8743	0.482
NULL	Arthritis_Res_Ther_2011_Dec_12_13(6)_R204.nxml.txt.nlp	22151924	SENT146	15	15	0	0	methotrexate	CFB	PA450428	629	0.482
NULL	Korean_J_Anesthesiol_2013_Jul_19_65(1)_91-92.nxml.txt.nlp	23904949	SENT8	24	24	8	8	fentanyl	CO2	PA449599	4513	0.482
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Aug_26_65(Pt_9)_m1136.nxml.txt.nlp	21577473	SENT63	31	31	8	8	phenol	NO3	PA450913	4681	0.482
NULL	Arch_Virol_2014_Dec_24_159(6)_1365-1371.nxml.txt.nlp	24366548	SENT54	14	14	12	12	ribavirin	IFN	PA451241	3439	0.482
NULL	Diabetes_2011_Jul_20_60(7)_1990-1999.nxml.txt.nlp	21617181	SENT188	20	20	0	0	geldanamycin	IL-6	PA152031327	3569	0.482
NULL	Iran_J_Basic_Med_Sci_2012_Mar-Apr_15(2)_709-718.nxml.txt.nlp	23493500	SENT151	32	32	19	19	indomethacin	spatial	PA449982	219793	0.482
NULL	Adv_Ther_2014_Dec_2_31_1228-1246.nxml.txt.nlp	25447269	SENT148	24	24	16	16	timolol	TIM	PA451690	7984;8914	0.482
NULL	Clin_Ophthalmol_2012_Sep_5_6_1433-1440.nxml.txt.nlp	23055659	SENT153	27	27	41	41	timolol	BAK	PA451690	578	0.482
NULL	J_Cell_Biol_1997_Jun_2_137(5)_1127-1136.nxml.txt.nlp	9166412	SENT120	32	32	12	12	mitomycin	PI3K	PA450524	5290	0.482
NULL	Cells_2014_Apr_29_3(2)_331-362.nxml.txt.nlp	24785347	SENT1475	3	3	5	5	capsaicin	TRPV1	PA448776	7442	0.482
NULL	Bioinformation_2012_Jan_6_8(1)_13-19.nxml.txt.nlp	22359429	SENT34	5	5	3	3	curcumin	MRP1	PA151958596	4437	0.482
NULL	Indian_J_Med_Paediatr_Oncol_2014_Jan-Mar_35(1)_103-105.nxml.txt.nlp	25006297	SENT33	25	25	6	6	cyclophosphamide	NACT	PA449165	284111	0.482
NULL	Arthritis_Res_Ther_2010_Apr_1_12(2)_R60.nxml.txt.nlp	20359365	SENT178	6	6	16	16	bleomycin	SPARC	PA448645	6678	0.482
NULL	Adv_Hematol_2010_Dec_5_2010_595934.nxml.txt.nlp	21151515	SENT154	7	7	11	11	prasugrel	Yes	PA154410481	7525	0.482
NULL	Breast_Cancer_Res_2012_Feb_14_14(1)_R30.nxml.txt.nlp	22333315	SENT62	20	20	28	28	celecoxib	IFN	PA448871	3439	0.482
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Mar_17_68(Pt_4)_o1077.nxml.txt.nlp	22589941	SENT3	9	9	3	3	piperazine	mol	PA450977	90527	0.482
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT199	15	15	17	17	sotalol	NAPA	PA451457	9476;8775	0.482
NULL	Indian_J_Endocrinol_Metab_2012_Dec_16(Suppl_2)_S338-S339.nxml.txt.nlp	23565420	SENT67	13	13	11	11	thyroglobulin	TPO	PA164754910	7066;7173	0.482
NULL	Oncotarget_2014_Jun_8_5(13)_5040-5053.nxml.txt.nlp	24970815	SENT109	4	4	11	11	cisplatin	PUMA	PA449014	27113	0.482
NULL	Case_Rep_Dermatol_2012_Mar_23_4(1)_61-65.nxml.txt.nlp	22548038	SENT48	15	15	32	32	erythromycin	gamma	PA449493	9913	0.482
NULL	Free_Radic_Biol_Med_2013_Aug_61(100)_438-452.nxml.txt.nlp	23608463	SENT120	26	26	11	11	apomorphine	NQO1	PA164781163	1728	0.482
NULL	Mol_Cancer_2008_Mar_26_7_27.nxml.txt.nlp	18366759	SENT267	14	14	26	26	etoposide	CDKN1A	PA449552	1026	0.482
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT177	18	18	20	20	doxorubicin	ABCG2	PA449412	9429	0.482
NULL	Biosci_Rep_2012_Aug_1_32(Pt_4)_361-374.nxml.txt.nlp	22762204	SENT179	31	31	36	36	hyaluronan	p53	PA165958431	7157	0.482
NULL	Front_Comput_Neurosci_2013_Apr_5_7_22.nxml.txt.nlp	23576979	SENT159	7	7	11	11	ketamine	HCN1	PA450144	348980	0.482
NULL	J_Gen_Physiol_2004_Aug_124(2)_115-124.nxml.txt.nlp	15277573	SENT309	17	17	20	20	creatine	ADP	PA164778930	23038	0.482
NULL	Nucleic_Acids_Res_2011_Mar_4_39(5)_1843-1854.nxml.txt.nlp	21051342	SENT198	35	35	23	23	carbenicillin	IFN	PA448788	3439	0.482
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_16_2012_395912.nxml.txt.nlp	23118789	SENT75	9	9	13	13	diclofenac	UGT1A6	PA449293	54578	0.482
NULL	Subst_Abuse_Rehabil_2011_Oct_28_2_181-188.nxml.txt.nlp	24474855	SENT156	8	8	3	3	naltrexone	Gen	PA450588	348654	0.482
NULL	Front_Endocrinol_(Lausanne)_2013_Jan_7_3_180.nxml.txt.nlp	23316185	SENT487	12	12	16	16	glucose	POMC	PA449773	5443	0.482
NULL	Cell_Death_Dis_2014_Jan_30_5(1)_e1038.nxml.txt.nlp	24481452	SENT229	3	3	10	10	raloxifene	NQO1	PA451221	1728	0.482
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Dec_2_5_30.nxml.txt.nlp	17140452	SENT229	14	14	8	8	gentamicin	GAT	PA449753	10249	0.482
NULL	Breast_Cancer_Res_2011_Mar_11_13(2)_R29.nxml.txt.nlp	21396094	SENT27	11	11	24	24	fulvestrant	EGFR	PA164747170	1956	0.482
NULL	J_Headache_Pain_2011_Oct_13_12(5)_527-534.nxml.txt.nlp	21567138	SENT84	15	15	17	17	carbamazepine	MVD	PA448785	4597	0.482
NULL	Br_J_Cancer_2014_Aug_12_111(4)_646-650.nxml.txt.nlp	24755886	SENT37	17	17	26	26	trabectedin	WRN	PA165958349	7486	0.482
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT192	23	23	8	8	panitumumab	Yes	PA162373091	7525	0.482
NULL	Front_Behav_Neurosci_2011_Sep_13_5_57.nxml.txt.nlp	21949506	SENT244	11	11	14	14	rimonabant	CB1	PA152407999	1268	0.482
NULL	Biomed_Res_Int_2013_May_28_2013_642964.nxml.txt.nlp	23781506	SENT333	34	34	9	9	trypsin	AMBP	PA451806	259	0.482
NULL	JSLS_2012_Apr-Jun_16(2)_202-207.nxml.txt.nlp	23477166	SENT74	27	27	25	25	morphine	MED	PA450550	1298;1299;1311	0.482
NULL	Contemp_Oncol_(Pozn)_2013_Apr_29_17(2)_137-143.nxml.txt.nlp	23788980	SENT179	13	13	24	24	cabergoline	PRL	PA448708	5617	0.482
NULL	J_Mol_Signal_2013_Dec_30_8_15.nxml.txt.nlp	24377906	SENT276	11	11	9	9	temozolomide	IL24	PA451609	11009	0.482
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_25_2013_734824.nxml.txt.nlp	23878606	SENT217	24	24	2	2	galantamine	5-LOX	PA449726	240	0.482
NULL	J_Physiol_2009_Feb_15_587(Pt_4)_731-744.nxml.txt.nlp	19074966	SENT141	25	25	23	23	taurine	PAT1	PA451590	10513;206358	0.482
NULL	Antiviral_Res_2009_May_82(2)_A99-A109.nxml.txt.nlp	19176219	SENT1100	3	3	5	5	abacavir	P-gp	PA448004	5243	0.482
NULL	Sensors_(Basel)_2013_Feb_28_13(3)_2895-2910.nxml.txt.nlp	23449119	SENT122	9	9	14	14	pp2	PP4		5531	0.482
NULL	Clin_Ophthalmol_2012_Sep_5_6_1433-1440.nxml.txt.nlp	23055659	SENT153	21	21	41	41	timolol	BAK	PA451690	578	0.482
NULL	Clin_Med_Insights_Oncol_2012_Dec_6_6_407-421.nxml.txt.nlp	23239933	SENT213	4	4	2	2	gemcitabine	GEM	PA449748	2669	0.482
NULL	Front_Neurosci_2010_Mar_19_4_22.nxml.txt.nlp	20582262	SENT195	16	16	18	18	mecamylamine	P2X3	PA450334	5024	0.482
NULL	Pain_Res_Treat_2013_Jan_30_2013_217864.nxml.txt.nlp	23431433	SENT77	26	26	3	3	capsaicin	NHE	PA448776	285335	0.482
NULL	Ann_Maxillofac_Surg_2012_Jan-Jun_2(1)_90-93.nxml.txt.nlp	23483721	SENT62	36	36	0	0	daunorubicin	CHOP	PA449212	1649	0.482
NULL	Oncogene_2010_Sep_2_29(35)_4925-4937.nxml.txt.nlp	20562914	SENT293	16	16	11	11	collagenase	AP-1	PA449107	2353;3727;2354;3725	0.482
NULL	Bioinform_Biol_Insights_2013_Sep_18_7_289-306.nxml.txt.nlp	24092970	SENT287	6	6	8	8	carboplatin	PRAME	PA448803	23532	0.482
NULL	Endocrine_2012_Dec_14_42(3)_622-636.nxml.txt.nlp	22695986	SENT138	4	4	2	2	forskolin	PTH	PA146096022	5741	0.482
NULL	Eur_J_Neurosci_2014_Feb_4_39(3)_419-434.nxml.txt.nlp	24494682	SENT458	8	8	10	10	lipase	spatial	PA450239	219793	0.482
NULL	Mol_Vis_2012_Jul_18_18_1973-1982.nxml.txt.nlp	22876124	SENT135	30	30	14	14	nitrogen	OCT	PA450643	5362	0.482
NULL	Int_J_Anal_Chem_2014_Nov_18_2014_536823.nxml.txt.nlp	25484901	SENT86	12	12	14	14	glutaraldehyde	DTNB	PA449777	1838	0.482
NULL	Acta_Pharmacol_Sin_2012_Jul_18_33(7)_861-872.nxml.txt.nlp	22705730	SENT129	11	11	13	13	atorvastatin	PDK1	PA448500	5170;5163	0.482
NULL	Trials_2012_Dec_13_13_239.nxml.txt.nlp	23237631	SENT8	14	14	30	30	acenocoumarol	VKORC1	PA452632	79001	0.482
NULL	J_Gastroenterol_2014_Dec_24_49(12)_1536-1547.nxml.txt.nlp	24366288	SENT211	6	6	11	11	omeprazole	CYP2C19	PA450704	1557	0.482
NULL	Front_Plant_Sci_2012_Mar_28_3_53.nxml.txt.nlp	22639651	SENT107	10	10	24	24	lipase	Yes	PA450239	7525	0.482
NULL	J_Hum_Genet_2013_Jun_23_58(6)_339-345.nxml.txt.nlp	23697979	SENT83	27	27	24	24	clopidogrel	PON1	PA449053	5444	0.482
NULL	Lab_Invest_2010_Jan_9_90(1)_128-139.nxml.txt.nlp	19901912	SENT53	25	25	33	33	heparin	ACT	PA449855	12;11332;9457;641455	0.482
NULL	Virol_J_2010_Oct_20_7_279.nxml.txt.nlp	20961433	SENT159	9	9	3	3	trypsin	VLP	PA451806	391104	0.482
NULL	Front_Neurosci_2011_Jan_20_5_3.nxml.txt.nlp	21270945	SENT557	12	12	5	5	ethanol	CB1	PA448073	1268	0.482
NULL	Clinics_(Sao_Paulo)_2013_Feb_68(Suppl_1)_5-14.nxml.txt.nlp	23503950	SENT191	4	4	26	26	protamine	TP2	PA10366	7015;7142	0.482
NULL	EMBO_Mol_Med_2013_Dec_21_5(12)_1918-1934.nxml.txt.nlp	24293318	SENT149	30	30	0	0	rolipram	ANOVA	PA153906323	4858	0.482
NULL	Biomed_Res_Int_2013_Jun_17_2013_312656.nxml.txt.nlp	23844360	SENT174	26	26	5	5	plerixafor	CD49d	PA165958410	3676	0.482
NULL	J_Korean_Med_Sci_2013_Apr_27_28(4)_527-533.nxml.txt.nlp	23580227	SENT104	15	15	7	7	genistein	TRAIL	PA165109660	8743	0.482
NULL	Drug_Des_Devel_Ther_2014_Sep_23_8_1527-1538.nxml.txt.nlp	25284985	SENT149	13	13	10	10	celecoxib	IFN	PA448871	3439	0.482
NULL	Front_Endocrinol_(Lausanne)_2013_Sep_4_4_116.nxml.txt.nlp	24027559	SENT203	27	27	25	25	tamoxifen	UGT2B15	PA451581	7366	0.482
NULL	Braz_J_Med_Biol_Res_2013_Feb_1_46(2)_171-177.nxml.txt.nlp	23369979	SENT124	41	41	2	2	enalapril	IL-10	PA449456	3586	0.482
NULL	Breast_Cancer_Res_Treat_2013_Oct_12_142(1)_69-80.nxml.txt.nlp	24122389	SENT109	28	28	7	7	docetaxel	HER2	PA449383	2064	0.482
NULL	Molecules_2013_Dec_16_18(12)_15662-15688.nxml.txt.nlp	24352021	SENT314	24	24	42	42	urea	IL-4	PA451831	3565	0.482
NULL	Environ_Health_Perspect_2010_Mar_23_118(3)_427-431.nxml.txt.nlp	20194071	SENT95	13	13	27	27	ethanol	IL-8	PA448073	3576	0.482
NULL	Child_Adolesc_Psychiatry_Ment_Health_2013_Jun_19_7_19.nxml.txt.nlp	23777626	SENT109	6	6	2	2	methylphenidate	ATX	PA450464	5168;23049	0.482
NULL	Diagn_Pathol_2013_Feb_16_8_26.nxml.txt.nlp	23414265	SENT23	16	16	26	26	thyroglobulin	CK7	PA164754910	3855	0.482
NULL	Mol_Biol_Cell_2012_Nov_1_23(21)_4212-4225.nxml.txt.nlp	22956765	SENT94	13	13	9	9	thrombin	SHP2	PA451674	5781	0.482
NULL	Diabetes_Care_2010_Apr_19_33(4)_914-919.nxml.txt.nlp	20086255	SENT118	10	10	13	13	rosiglitazone	DREAM	PA451283	30818	0.481
NULL	J_Autoimmune_Dis_2006_Oct_5_3_5.nxml.txt.nlp	17022813	SENT41	18	18	9	9	infliximab	IL-6	PA452639	3569	0.481
NULL	J_Cancer_2013_Jun_21_4(5)_383-390.nxml.txt.nlp	23833683	SENT36	31	31	13	13	gentamicin	IFN	PA449753	3439	0.481
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2007_Dec_18_64(Pt_1)_m219-m220.nxml.txt.nlp	21200566	SENT4	16	16	20	20	ethanol	mol	PA448073	90527	0.481
NULL	J_Vet_Med_Sci_2014_Aug_15_76(8)_1119-1127.nxml.txt.nlp	24829081	SENT121	23	23	38	38	trypsin	fractalkine	PA451806	6376	0.481
NULL	Oncotarget_2013_Aug_8_4(8)_1130-1142.nxml.txt.nlp	24029073	SENT75	7	7	14	14	glucose	TKT	PA449773	4921;7086	0.481
NULL	J_Exp_Bot_2012_Aug_5_63(13)_4723-4730.nxml.txt.nlp	22771853	SENT103	20	20	15	15	nadh	mol	PA164755085	90527	0.481
NULL	Crit_Care_2011_Oct_27_15(5)_R258.nxml.txt.nlp	22032777	SENT90	35	35	17	17	furosemide	GFR	PA449719	9771	0.481
NULL	J_Neurosci_Rural_Pract_2012_Sep-Dec_3(3)_429-430.nxml.txt.nlp	23189026	SENT54	19	19	12	12	semaxanib	IFN	PA131887911	3439	0.481
NULL	J_Gastroenterol_2013_May_5_48(5)_559-573.nxml.txt.nlp	23460386	SENT42	1	1	28	28	lansoprazole	COX	PA450180	1351	0.481
NULL	Eur_J_Endocrinol_2014_Mar_170(3)_451-459.nxml.txt.nlp	24362411	SENT172	10	10	7	7	liraglutide	GLP1	PA165958364	100125288;2641	0.481
NULL	Br_J_Cancer_2014_Jan_21_110(2)_421-429.nxml.txt.nlp	24300973	SENT246	11	11	14	14	oxaliplatin	DAP3	PA131285527	58512;7818	0.481
NULL	FASEB_J_2014_Jun_28(6)_2441-2454.nxml.txt.nlp	24577121	SENT306	5	5	8	8	potassium	ABCC9	PA451047	10060	0.481
NULL	Front_Bioeng_Biotechnol_2014_Nov_26_2_53.nxml.txt.nlp	25505786	SENT272	26	26	12	12	nadh	ADP	PA164755085	23038	0.481
NULL	Biologics_2014_Apr_22_8_193-198.nxml.txt.nlp	24790412	SENT126	41	41	43	43	infliximab	Yes	PA452639	7525	0.481
NULL	Nat_Commun_2014_Dec_8_5_5736.nxml.txt.nlp	25484020	SENT612	4	4	37	37	tamoxifen	ATAC	PA451581	6375	0.481
NULL	Clin_Sci_(Lond)_2013_Aug_1_125(Pt_3)_121-130.nxml.txt.nlp	23577635	SENT158	36	36	31	31	lipase	HSL	PA450239	3991	0.481
NULL	J_Biomed_Biotechnol_2002_2(2)_106-113.nxml.txt.nlp	12488590	SENT54	16	16	3	3	mitomycin	XRCC2	PA450524	7516	0.481
NULL	Diabetes_Care_2013_Aug_17_36(Suppl_2)_S127-S138.nxml.txt.nlp	23882037	SENT118	14	14	20	20	metformin	GLP-1	PA450395	100125288	0.481
NULL	Ann_Oncol_2014_Sep_13_25(9)_1813-1820.nxml.txt.nlp	24928832	SENT132	27	27	13	13	afatinib	p16	PA165981154	1029	0.481
NULL	J_Mol_Med_2008_Jul_15_86(7)_815-824.nxml.txt.nlp	18414821	SENT165	21	21	17	17	lipase	MTHFR	PA450239	4524	0.481
NULL	J_Biol_Chem_2008_Jun_20_283(25)_17194-17204.nxml.txt.nlp	18442977	SENT253	43	43	20	20	pp2	5-HT1A		3350	0.481
NULL	Acta_Neuropathol_Commun_2014_Jan_2_2_1.nxml.txt.nlp	24383468	SENT223	11	11	15	15	nadh	ND4L	PA164755085	4539	0.481
NULL	Osteopath_Med_Prim_Care_2010_Aug_11_4_5.nxml.txt.nlp	20701768	SENT217	8	8	0	0	glucose	STR	PA449773	6779	0.481
NULL	Cell_Commun_Signal_2013_Dec_23_11_100.nxml.txt.nlp	24364863	SENT377	20	20	16	16	erlotinib	PP2	PA134687924	4888	0.481
NULL	J_Korean_Med_Sci_2007_Sep_30_22(Suppl)_S154-S158.nxml.txt.nlp	17923744	SENT54	19	19	26	26	thyroglobulin	TTF-1	PA164754910	7080	0.481
NULL	Front_Behav_Neurosci_2014_Dec_23_8_432.nxml.txt.nlp	25566001	SENT187	2	2	4	4	methylphenidate	AMPH	PA450464	273	0.481
NULL	Clin_Ophthalmol_2014_Sep_1_8_1681-1687.nxml.txt.nlp	25214761	SENT21	26	26	28	28	brimonidine	BAK	PA448665	578	0.481
NULL	Curr_Oncol_2008_Oct_15(5)_229-233.nxml.txt.nlp	19008997	SENT136	12	12	22	22	fludarabine	Yes	PA449655	7525	0.481
NULL	Int_J_Endocrinol_2014_Apr_30_2014_674987.nxml.txt.nlp	24883061	SENT122	34	34	19	19	collagenase	JNK	PA449107	5599	0.481
NULL	Clin_Mol_Hepatol_2014_Sep_25_20(3)_283-290.nxml.txt.nlp	25320732	SENT138	12	12	17	17	propranolol	EVL	PA451145	51466	0.481
NULL	Int_J_Surg_Oncol_2012_Aug_27_2012_180574.nxml.txt.nlp	22970358	SENT26	29	29	18	18	tamoxifen	ATAC	PA451581	6375	0.481
NULL	Exp_Transl_Stroke_Med_2011_Dec_16_3_16.nxml.txt.nlp	22177314	SENT119	44	44	46	46	minocycline	ANOVA	PA450519	4858	0.481
NULL	J_Invest_Dermatol_2014_Jun_10_134(6)_1710-1717.nxml.txt.nlp	24326454	SENT123	6	6	27	27	imiquimod	TH1	PA449972	51497	0.481
NULL	Br_J_Cancer_2006_Feb_13_94(3)_407-426.nxml.txt.nlp	16434996	SENT148	5	5	32	32	genistein	BRCA2	PA165109660	675	0.481
NULL	Acta_Neuropathol_2013_Sep_5_126(5)_741-756.nxml.txt.nlp	24005891	SENT289	25	25	2	2	pilocarpine	CTRL	PA450962	1506	0.481
NULL	Exp_Ther_Med_2013_Sep_12_6(3)_831-839.nxml.txt.nlp	24137275	SENT223	19	19	0	0	fluorescein	RGDS	PA164746009	5900	0.481
NULL	Int_J_Nanomedicine_2012_Oct_25_7_5565-5575.nxml.txt.nlp	23118538	SENT137	5	5	9	9	fenofibrate	CO2	PA449594	4513	0.481
NULL	EMBO_Mol_Med_2011_May_3(5)_266-278.nxml.txt.nlp	21438154	SENT279	0	0	18	18	oxaliplatin	HCN1	PA131285527	348980	0.481
NULL	Biomed_Res_Int_2013_Sep_9_2013_239354.nxml.txt.nlp	24089667	SENT45	12	12	24	24	curcumin	mol	PA151958596	90527	0.481
NULL	Front_Immunol_2013_Nov_18_4_387.nxml.txt.nlp	24302927	SENT310	0	0	8	8	chloroquine	TLR4	PA448948	7099	0.481
NULL	Brain_Behav_2012_Sep_23_2(5)_661-677.nxml.txt.nlp	23139911	SENT390	15	15	20	20	methylphenidate	spatial	PA450464	219793	0.481
NULL	Clinics_2008_Apr_63(2)_267-270.nxml.txt.nlp	18438582	SENT33	14	14	19	19	lipase	gamma	PA450239	9913	0.481
NULL	Biomed_Res_Int_2013_Sep_9_2013_239354.nxml.txt.nlp	24089667	SENT45	12	12	16	16	curcumin	mol	PA151958596	90527	0.481
NULL	Alcohol_Res_2013_35(1)_97-113.nxml.txt.nlp	24313169	SENT55	18	18	9	9	ethanol	p300	PA448073	2033	0.481
NULL	J_Cell_Biol_2004_Apr_26_165(2)_263-273.nxml.txt.nlp	15117969	SENT259	34	34	26	26	hydrocortisone	EGF	PA449905	1950	0.481
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_16_2012_395912.nxml.txt.nlp	23118789	SENT75	9	9	33	33	diclofenac	UGT1A10	PA449293	54575	0.481
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT530	22	22	11	11	glucose	FXR	PA449773	9971	0.481
NULL	Br_J_Cancer_2013_Jan_15_108(1)_183-187.nxml.txt.nlp	23299529	SENT11	5	5	16	16	choline	B12	PA448976	7126;4709	0.481
NULL	Aquat_Biosyst_2012_Aug_31_8_19.nxml.txt.nlp	22938529	SENT120	21	21	41	41	chlorophyll	mol	PA448942	90527	0.481
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT192	39	39	19	19	afatinib	Yes	PA165981154	7525	0.481
NULL	Aging_(Albany_NY)_2011_Jan_18_3(1)_33-43.nxml.txt.nlp	21248371	SENT23	2	2	5	5	oxygen	HIF-1	PA450744	29072	0.481
NULL	J_Vet_Med_Sci_2013_Dec_25_75(12)_1637-1642.nxml.txt.nlp	23884081	SENT8	10	10	18	18	dextran	ERK	PA449261	5594	0.481
NULL	Breast_Cancer_Res_Treat_2013_Jun_30_139(2)_441-451.nxml.txt.nlp	23715630	SENT88	31	31	9	9	anastrozole	HER2	PA448432	2064	0.481
NULL	Clin_Med_Insights_Case_Rep_2013_Apr_29_6_67-74.nxml.txt.nlp	23700378	SENT96	45	45	37	37	pramipexole	MAOB	PA164742949	4129	0.481
NULL	Genome_Biol_2008_Dec_15_9(12)_R171.nxml.txt.nlp	19077304	SENT271	27	27	17	17	chloroquine	San	PA448948	80218	0.481
NULL	Clin_J_Gastroenterol_2014_Jun_6_7(4)_355-360.nxml.txt.nlp	25132867	SENT1	19	19	15	15	ribavirin	IFN	PA451241	3439	0.481
NULL	Case_Rep_Neurol_Med_2012_Jul_24_2012_183252.nxml.txt.nlp	22953086	SENT73	3	3	10	10	carbamazepine	CYP2C8	PA448785	1558	0.481
NULL	Eur_J_Neurosci_2010_Jun_31(12)_2234-2246.nxml.txt.nlp	20529124	SENT253	3	3	20	20	carbachol	CB1	PA448784	1268	0.481
NULL	Cardiovasc_Psychiatry_Neurol_2013_Jan_15_2013_530356.nxml.txt.nlp	23401746	SENT130	0	0	26	26	natalizumab	IFN	PA164747191	3439	0.481
NULL	South_Asian_J_Cancer_2014_Jan-Mar_3(1)_66-70.nxml.txt.nlp	24665451	SENT50	2	2	7	7	rituximab	ICE	PA451261	834	0.481
NULL	Front_Oncol_2013_Oct_1_3_259.nxml.txt.nlp	24102047	SENT264	10	10	19	19	paclitaxel	EDA	PA450761	1896	0.481
NULL	Br_J_Cancer_2009_Oct_6_101(7)_1100-1106.nxml.txt.nlp	19738610	SENT54	17	17	23	23	hyaluronan	CD31	PA165958431	5175	0.481
NULL	FEBS_Open_Bio_2012_Aug_22_2_279-283.nxml.txt.nlp	23650611	SENT366	0	0	6	6	raloxifene	IFN	PA451221	3439	0.481
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_21-38.nxml.txt.nlp	19305786	SENT669	1	1	20	20	menthol	TRPV4	PA164776605	59341	0.481
NULL	Int_J_Mol_Sci_2014_Jun_5_15(6)_10083-10100.nxml.txt.nlp	24905407	SENT65	4	4	8	8	tetracycline	TRB	PA451640	6957	0.481
NULL	Case_Rep_Obstet_Gynecol_2012_Dec_20_2012_385175.nxml.txt.nlp	23320214	SENT52	24	24	16	16	nicotine	STD	PA450626	7535	0.481
NULL	JRSM_Cardiovasc_Dis_2012_Sep_24_1(6)_cvd_2012_012015.nxml.txt.nlp	24175073	SENT17	11	11	17	17	clopidogrel	ACS	PA449053	55902;84680	0.481
NULL	Cancer_Med_2014_Oct_2_3(5)_1256-1265.nxml.txt.nlp	24890382	SENT19	20	20	27	27	trastuzumab	DM1	PA451743	338023;1760;28509	0.481
NULL	Leukemia_2013_Sep_10_27(9)_1882-1890.nxml.txt.nlp	23748344	SENT23	26	26	39	39	hydroxyurea	IFN	PA449942	3439	0.481
NULL	Eur_J_Clin_Pharmacol_2014_Mar_22_70(6)_685-693.nxml.txt.nlp	24658827	SENT142	0	0	27	27	cyclosporine	PPARA	PA449167	5465	0.481
NULL	Virol_J_2008_Oct_6_5_114.nxml.txt.nlp	18838000	SENT68	20	20	15	15	nadh	CD79A	PA164755085	973	0.481
NULL	Indian_J_Anaesth_2014_Jul-Aug_58(4)_423-429.nxml.txt.nlp	25197110	SENT8	20	20	18	18	ondansetron	ODF	PA450705	8600	0.481
NULL	Indian_J_Endocrinol_Metab_2012_Dec_16(Suppl_3)_S529-S531.nxml.txt.nlp	23565485	SENT19	0	0	5	5	metformin	GLP-1	PA450395	100125288	0.481
NULL	Int_J_Mol_Sci_2012_Feb_10_13(2)_1858-1885.nxml.txt.nlp	22408429	SENT1023	23	23	12	12	creatine	ADP	PA164778930	23038	0.481
NULL	Br_J_Cancer_2013_May_14_108(9)_1862-1869.nxml.txt.nlp	23579219	SENT109	0	0	5	5	cetuximab	KRAS	PA10040	3845	0.481
NULL	Clin_Dev_Immunol_2011_Dec_28_2011_438463.nxml.txt.nlp	21234358	SENT65	22	22	36	36	aldesleukin	CO2	PA448081	4513	0.481
NULL	Int_J_Alzheimers_Dis_2011_Dec_29_2011_501862.nxml.txt.nlp	22254144	SENT279	20	20	17	17	celecoxib	PTGS2	PA448871	5743	0.481
NULL	Saudi_J_Anaesth_2013_Apr-Jun_7(2)_181-186.nxml.txt.nlp	23956720	SENT132	17	17	0	0	clonidine	Ray	PA449051	26751	0.481
NULL	J_Thorac_Oncol_2014_Feb_23_9(2)_189-194.nxml.txt.nlp	24419415	SENT139	2	2	4	4	erlotinib	EGFR	PA134687924	1956	0.481
NULL	J_Clin_Biochem_Nutr_2009_Jul_30_45(1)_9-13.nxml.txt.nlp	19590701	SENT323	15	15	4	4	lansoprazole	HO-1	PA450180	3162	0.481
NULL	J_Cancer_2013_Jan_11_4(2)_117-132.nxml.txt.nlp	23386910	SENT130	16	16	25	25	exemestane	HER2	PA449563	2064	0.481
NULL	Mol_Vis_2012_Nov_12_18_2687-2699.nxml.txt.nlp	23170061	SENT16	9	9	14	14	nadh	ND1	PA164755085	4535;10625	0.481
NULL	Curr_Pharm_Biotechnol_2011_Jan_12(1)_35-41.nxml.txt.nlp	20932261	SENT96	2	2	14	14	hyperforin	TRPC6	PA165985514	7225	0.481
NULL	J_Ophthalmic_Inflamm_Infect_2011_Nov_6_2(1)_21-28.nxml.txt.nlp	22057810	SENT81	8	8	13	13	azathioprine	CTX	PA448515	1593	0.481
NULL	Clin_Interv_Aging_2010_Dec_3_5_395-402.nxml.txt.nlp	21152241	SENT28	13	13	21	21	cabazitaxel	LCK	PA165958401	3932	0.481
NULL	Cardiovasc_Diabetol_2010_Nov_16_9_76.nxml.txt.nlp	21080957	SENT320	4	4	1	1	exenatide	GLP-1	PA164749238	100125288	0.481
NULL	Cell_Commun_Signal_2013_May_29_11_38.nxml.txt.nlp	23718910	SENT107	10	10	10	10	pp2	PP2		4888	0.481
NULL	Cell_Death_Dis_2014_Jul_17_5(7)_e1333.nxml.txt.nlp	25032856	SENT212	2	2	7	7	candesartan	EAAC1	PA448765	6505	0.481
NULL	Mol_Cancer_2010_May_17_9_107.nxml.txt.nlp	20470445	SENT23	31	31	34	34	dexrazoxane	TSP1	PA449259	7057	0.481
NULL	J_Cell_Mol_Med_2014_Aug_1_18(8)_1599-1611.nxml.txt.nlp	24889822	SENT16	2	2	4	4	resveratrol	FOXO1		2308	0.481
NULL	Biomed_Res_Int_2014_Jan_29_2014_361020.nxml.txt.nlp	24605326	SENT223	7	7	38	38	flavopiridol	CDK1	PA452627	983	0.481
NULL	Iran_J_Pharm_Res_2014_Winter_13(1)_253-262.nxml.txt.nlp	24734078	SENT151	7	7	5	5	propofol	LPO	PA451141	4025	0.481
NULL	Cancer_Cell_Int_2013_Sep_23_13_94.nxml.txt.nlp	24059699	SENT142	26	26	19	19	bevacizumab	NRP1	PA130232992	8829	0.481
NULL	Cerebrospinal_Fluid_Res_2010_Aug_12_7_11.nxml.txt.nlp	20704740	SENT66	27	27	34	34	l-glutamine	EGF	PA10090	1950	0.481
NULL	Eur_J_Clin_Pharmacol_2010_Feb_17_66(2)_165-170.nxml.txt.nlp	19838691	SENT182	2	2	11	11	midazolam	CYP3A	PA450496	1574	0.481
NULL	Int_J_Gen_Med_2014_Nov_11_7_491-504.nxml.txt.nlp	25419156	SENT157	12	12	23	23	oxymetazoline	END	PA164748840	2022	0.481
NULL	Psychiatry_Investig_2009_Sep_23_6(3)_185-193.nxml.txt.nlp	20046394	SENT174	17	17	9	9	phenytoin	TGB	PA450947	5473	0.481
NULL	Br_J_Cancer_2006_Dec_4_95(11)_1504-1513.nxml.txt.nlp	17088902	SENT133	10	10	12	12	gefitinib	HER2	PA131301952	2064	0.481
NULL	Breast_Cancer_Res_2007_Jan_23_9(1)_R7.nxml.txt.nlp	17244352	SENT191	11	11	9	9	tamoxifen	SULT1A1	PA451581	6817	0.481
NULL	Adv_Ther_2014_Feb_18_31(3)_247-263.nxml.txt.nlp	24535624	SENT261	16	16	12	12	liraglutide	GLP-1	PA165958364	100125288	0.481
NULL	Case_Rep_Pediatr_2011_Nov_24_2011_562620.nxml.txt.nlp	22606516	SENT65	16	16	11	11	vancomycin	IFN	PA451850	3439	0.481
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT123	15	15	17	17	mitoxantrone	ABCG2	PA450526	9429	0.481
NULL	Stroke_Res_Treat_2009_Dec_20_2010_386389.nxml.txt.nlp	20700422	SENT162	23	23	19	19	pioglitazone	NAC	PA450970	22861	0.481
NULL	J_Hematol_Oncol_2011_Jan_21_4_5.nxml.txt.nlp	21255411	SENT160	15	15	23	23	paclitaxel	EGFR	PA450761	1956	0.481
NULL	J_Immune_Based_Ther_Vaccines_2005_May_18_3_3.nxml.txt.nlp	15904525	SENT35	11	11	13	13	zidovudine	GM-CSF	PA451954	1437	0.481
NULL	Ann_Oncol_2014_Sep_13_25(9)_1813-1820.nxml.txt.nlp	24928832	SENT132	5	5	13	13	afatinib	p16	PA165981154	1029	0.481
NULL	Pharm_Pract_(Granada)_2011_Mar_15_Jan-Mar_9(1)_1-10.nxml.txt.nlp	25132883	SENT102	7	7	9	9	warfarin	SPAF	PA451906	166378	0.481
NULL	Am_J_Physiol_Endocrinol_Metab_2010_Feb_17_298(2)_E278-E286.nxml.txt.nlp	19920213	SENT115	0	0	6	6	pioglitazone	NEFA	PA450970	4925	0.481
NULL	Leukemia_2014_Apr_14_28(4)_961-964.nxml.txt.nlp	24418991	SENT26	17	17	20	20	nilotinib	P-gp	PA165958345	5243	0.481
NULL	Leukemia_2013_Sep_10_27(9)_1882-1890.nxml.txt.nlp	23748344	SENT23	30	30	39	39	anagrelide	IFN	PA164742986	3439	0.481
NULL	Evid_Based_Complement_Alternat_Med_2011_Feb_14_2011_429843.nxml.txt.nlp	21869897	SENT98	23	23	20	20	ethanol	CORT	PA448073	1325	0.481
NULL	Viruses_2009_Nov_30_1(3)_1073-1088.nxml.txt.nlp	21994583	SENT67	21	21	11	11	ribavirin	IFN	PA451241	3439	0.481
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT192	41	41	9	9	erlotinib	Yes	PA134687924	7525	0.48
NULL	Drug_Des_Devel_Ther_2014_Sep_23_8_1527-1538.nxml.txt.nlp	25284985	SENT214	35	35	31	31	celecoxib	IFN	PA448871	3439	0.48
NULL	J_Immunother_Cancer_2014_Feb_24_2(Suppl_1)_O1.nxml.txt.nlp	NULL	SENT6	23	23	10	10	bortezomib	DLL1	PA10252	28514	0.48
NULL	J_Vis_Exp_2011_Jun_24_(52)_3094.nxml.txt.nlp	21730945	SENT111	10	10	41	41	moxifloxacin	EMB	PA450555	133418	0.48
NULL	Ann_R_Coll_Surg_Engl_2012_May_94(4)_221-223.nxml.txt.nlp	22613296	SENT35	11	11	17	17	vildagliptin	GLP-1	PA165958346	100125288	0.48
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT109	0	0	7	7	perifosine	DR5	PA165291471	8795	0.48
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jul_18_65(Pt_8)_o1910-o1911.nxml.txt.nlp	21583598	SENT70	26	26	23	23	ethanol	mol	PA448073	90527	0.48
NULL	Eur_J_Clin_Pharmacol_2011_Dec_23_67(12)_1231-1241.nxml.txt.nlp	21698374	SENT189	27	27	22	22	tacrolimus	CYP3A4	PA451578	1576	0.48
NULL	Int_J_Vasc_Med_2012_Jul_24_2012_508416.nxml.txt.nlp	22888436	SENT163	27	27	42	42	troglitazone	PRIP	PA451799	23054;5334	0.48
NULL	Dermatoendocrinol_2013_Apr_1_5(2)_252-263.nxml.txt.nlp	24194965	SENT316	7	7	12	12	pemetrexed	AMPK	PA10810	5563	0.48
NULL	J_Int_AIDS_Soc_2012_Nov_11_15(6Suppl_4)_18154.nxml.txt.nlp	NULL	SENT16	0	0	6	6	ritonavir	IL-6	PA451260	3569	0.48
NULL	Acta_Pharmacol_Sin_2012_May_4_33(5)_710-716.nxml.txt.nlp	22555373	SENT16	25	25	19	19	mexiletine	DOM	PA450488	6663	0.48
NULL	Front_Neuroanat_2011_Jul_12_5_38.nxml.txt.nlp	21808606	SENT165	21	21	18	18	haloperidol	MSK1	PA449841	9252	0.48
NULL	Trials_2013_Dec_10_14_424.nxml.txt.nlp	24325953	SENT130	44	44	29	29	morphine	TAP	PA450550	8615;2317;10482;23541	0.48
NULL	Breast_Cancer_Res_2012_Jul_20_14(4)_R110.nxml.txt.nlp	22817698	SENT34	11	11	13	13	cisplatin	BRCA1	PA449014	672	0.48
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT192	23	23	20	20	panitumumab	Yes	PA162373091	7525	0.48
NULL	Diabetes_Care_2009_Nov_32(Suppl_2)_S217-S222.nxml.txt.nlp	19875555	SENT57	28	28	38	38	voglibose	GLP-1	PA164752433	100125288	0.48
NULL	Exp_Ther_Med_2013_Aug_20_6(2)_310-316.nxml.txt.nlp	24137180	SENT194	9	9	11	11	fasudil	Rho	PA165946121	29984	0.48
NULL	Cancers_(Basel)_2011_Mar_4_3(1)_1081-1110.nxml.txt.nlp	24212654	SENT1410	16	16	28	28	calcein	GNS	PA132595336	2799	0.48
NULL	Cell_Commun_Signal_2011_Dec_28_9_32.nxml.txt.nlp	22204307	SENT311	0	0	27	27	gentamicin	EGFR	PA449753	1956	0.48
NULL	Arch_Plast_Surg_2013_May_16_40(3)_291-294.nxml.txt.nlp	23730618	SENT17	13	13	18	18	vincristine	CHOP	PA451879	1649	0.48
NULL	J_Hematol_Oncol_2013_Mar_27_6_23.nxml.txt.nlp	23531342	SENT104	4	4	2	2	mi-63	RITA		55422;84934	0.48
NULL	Adv_Ther_2014_Dec_2_31_1228-1246.nxml.txt.nlp	25447269	SENT199	4	4	23	23	tafluprost	TIM	PA165958432	7984;8914	0.48
NULL	Mar_Drugs_2009_Dec_15_7(4)_803-815.nxml.txt.nlp	20098611	SENT181	9	9	6	6	collagenase	CN2	PA449107	55748	0.48
NULL	J_Cell_Biol_1998_Nov_16_143(4)_1087-1099.nxml.txt.nlp	9817764	SENT69	5	5	17	17	chloramphenicol	AP-1	PA448927	2353;3727;2354;3725	0.48
NULL	Cancers_(Basel)_2011_Oct_21_3(4)_3921-3956.nxml.txt.nlp	24213118	SENT1000	2	2	0	0	arsenite	p27	PA452638	5715;10534	0.48
NULL	J_Biol_Chem_2010_Aug_20_285(34)_26406-26416.nxml.txt.nlp	20530490	SENT75	41	41	24	24	galactose	AM2	PA449725	79924	0.48
NULL	Br_J_Cancer_2013_Mar_5_108(4)_973-982.nxml.txt.nlp	23299537	SENT243	17	17	25	25	doxorubicin	BTG2	PA449412	7832	0.48
NULL	Hum_Genomics_2004_Jan_1_1(2)_111-125.nxml.txt.nlp	15601539	SENT227	6	6	0	0	lipase	ATV	PA450239	4683	0.48
NULL	J_Cell_Mol_Med_2013_Jul_7_17(7)_879-888.nxml.txt.nlp	23742697	SENT102	9	9	7	7	l-cysteine	PPG	PA449173	5552	0.48
NULL	Curr_Rheumatol_Rep_2012_Aug_17_14(4)_349-357.nxml.txt.nlp	22592745	SENT152	12	12	9	9	denosumab	RANKL	PA166048634	8600	0.48
NULL	Front_Immunol_2013_Nov_7_4_360.nxml.txt.nlp	24223576	SENT208	13	13	10	10	imiquimod	NOXA	PA449972	5366	0.48
NULL	Anal_Bioanal_Chem_2012_Dec_4_404(10)_3071-3080.nxml.txt.nlp	23052869	SENT88	29	29	14	14	pilocarpine	CA1	PA450962	759	0.48
NULL	Int_J_Gen_Med_2013_Jun_7_6_453-464.nxml.txt.nlp	23785241	SENT205	12	12	15	15	nedocromil	IL-6	PA450601	3569	0.48
NULL	EMBO_J_2014_Jul_17_33(14)_1514-1526.nxml.txt.nlp	24872509	SENT88	22	22	27	27	zinc	S3A	PA451956	6189	0.48
NULL	J_Cell_Biol_1998_Aug_10_142(3)_625-633.nxml.txt.nlp	9700154	SENT232	18	18	14	14	estradiol	Raf-1	PA449503	5894	0.48
NULL	Int_J_Endocrinol_2011_Dec_20_2011_746482.nxml.txt.nlp	22216029	SENT244	9	9	16	16	nifedipine	K60	PA450631	3576	0.48
NULL	Front_Neurosci_2012_May_30_6_77.nxml.txt.nlp	22661925	SENT718	12	12	17	17	ethanol	NF-kappaB	PA448073	4790	0.48
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT181	2	2	16	16	curcumin	p53	PA151958596	7157	0.48
NULL	Arthritis_Res_Ther_2008_Dec_1_10(6)_R139.nxml.txt.nlp	19046432	SENT222	0	0	9	9	rosiglitazone	AP-1	PA451283	2353;3727;2354;3725	0.48
NULL	Br_J_Cancer_1997_75(2)_268-274.nxml.txt.nlp	9010037	SENT10	30	30	7	7	cyclosporine	P-gp	PA449167	5243	0.48
NULL	Diabetes_2009_Dec_31_58(12)_2851-2862.nxml.txt.nlp	19720788	SENT190	5	5	8	8	forskolin	BiP	PA146096022	3309	0.48
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT127	3	3	8	8	chloroquine	BMPR-II	PA448948	659	0.48
NULL	J_Inflamm_(Lond)_2006_May_4_3_8.nxml.txt.nlp	16674821	SENT134	5	5	5	5	pp2	PP2		4888	0.48
NULL	J_Biol_Chem_2008_Nov_7_283(45)_31005-31011.nxml.txt.nlp	18765663	SENT195	9	9	21	21	baclofen	CA1	PA448533	759	0.48
NULL	Cancer_Cell_Int_2011_Nov_17_11_40.nxml.txt.nlp	22088142	SENT147	25	25	22	22	gemcitabine	EGFR	PA449748	1956	0.48
NULL	Infect_Dis_Ther_2014_Dec_12_3(2)_103-122.nxml.txt.nlp	25388760	SENT239	22	22	14	14	loperamide	P-gp	PA450262	5243	0.48
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Aug_18_66(Pt_9)_o2310.nxml.txt.nlp	21588659	SENT67	11	11	23	23	ethanol	mol	PA448073	90527	0.48
NULL	Oncol_Lett_2013_Feb_7_5(2)_440-446.nxml.txt.nlp	23420122	SENT247	18	18	24	24	sorafenib	Gem	PA7000	51053	0.48
NULL	Asian-Australas_J_Anim_Sci_2012_Jan_25(1)_1-16.nxml.txt.nlp	25049471	SENT112	0	0	2	2	estradiol	OXTR	PA449503	5021	0.48
NULL	Iran_J_Reprod_Med_2012_May_10(3)_223-228.nxml.txt.nlp	25242997	SENT25	19	19	14	14	estradiol	PRL	PA449503	5617	0.48
NULL	Case_Rep_Crit_Care_2014_Aug_19_2014_242703.nxml.txt.nlp	25215245	SENT243	11	11	20	20	salbutamol	Yes	PA448068	7525	0.48
NULL	N_Am_J_Med_Sci_2011_Jan_3(1)_1-12.nxml.txt.nlp	22540056	SENT130	7	7	4	4	gemcitabine	MRP5	PA449748	10057	0.48
NULL	J_Oncol_2012_Jun_19_2012_521215.nxml.txt.nlp	22778735	SENT23	5	5	3	3	cetuximab	EGFR	PA10040	1956	0.48
NULL	Mol_Imaging_Radionucl_Ther_2013_Aug_1_22(2)_49-55.nxml.txt.nlp	24003397	SENT114	8	8	15	15	octreotide	ACTH	PA450678	5443	0.48
NULL	Hum_Genomics_2006_Jan_1_2(4)_252-257.nxml.txt.nlp	16460650	SENT94	17	17	43	43	nadh	CYTB	PA164755085	4519	0.48
NULL	Eur_J_Haematol_2014_Feb_25_92(2)_127-136.nxml.txt.nlp	24118452	SENT172	13	13	10	10	anagrelide	CRT	PA164742986	811	0.48
NULL	Mol_Microbiol_2014_Jul_23_93(2)_369-389.nxml.txt.nlp	24912400	SENT152	16	16	14	14	urea	CO2	PA451831	4513	0.48
NULL	Clin_Ophthalmol_2014_Jan_13_8_219-228.nxml.txt.nlp	24531757	SENT166	8	8	4	4	brinzolamide	TIM	PA164744929	7984;8914	0.48
NULL	Br_J_Haematol_2008_Aug_28_142(4)_505-514.nxml.txt.nlp	18510682	SENT149	0	0	5	5	alemtuzumab	CD4	PA164783958	920	0.48
NULL	Angiogenesis_2013_Apr_10_16(2)_373-386.nxml.txt.nlp	23143659	SENT146	19	19	21	21	verapamil	P-gp	PA451868	5243	0.48
NULL	Bioinformation_2012_Apr_13_8(7)_309-315.nxml.txt.nlp	22553387	SENT138	26	26	29	29	betaine	CDP	PA448603	1523	0.48
NULL	Front_Neurol_2011_Dec_26_2_83.nxml.txt.nlp	22363312	SENT610	19	19	5	5	clopidogrel	P2Y12	PA449053	64805	0.48
NULL	Cases_J_2008_Nov_19_1_331.nxml.txt.nlp	19019232	SENT19	17	17	13	13	ramipril	ACE	PA451223	1636	0.48
NULL	Nucleic_Acids_Res_2011_Jun_1_39(11)_e74.nxml.txt.nlp	21459849	SENT289	5	5	0	0	glucosamine	HS3ST1	PA164747613	9957	0.48
NULL	Anal_Bioanal_Chem_2011_Mar_29_399(9)_3157-3176.nxml.txt.nlp	21046088	SENT49	34	34	23	23	coumarin	HEX	PA134521193	3087	0.48
NULL	Biomed_Eng_Online_2012_Nov_14_11_84.nxml.txt.nlp	23151049	SENT70	23	23	32	32	ibandronate	PTH	PA10270	5741	0.48
NULL	Vet_Res_Forum_2013_Winter_4(1)_19-24.nxml.txt.nlp	25593681	SENT102	11	11	9	9	diclofenac	B12	PA449293	7126;4709	0.48
NULL	F1000Prime_Rep_2013_Sep_2_5_37.nxml.txt.nlp	24049641	SENT97	0	0	6	6	tamoxifen	NG2	PA451581	1464;6048	0.48
NULL	Cell_Cycle_2013_Jun_1_12(11)_1679-1687.nxml.txt.nlp	23656790	SENT74	29	29	22	22	olaparib	CTRL		1506	0.48
NULL	Ann_Lab_Med_2014_May_8_34(3)_230-234.nxml.txt.nlp	24790911	SENT133	8	8	2	2	entecavir	LAM	PA164784025	7249;7248	0.48
NULL	Ann_Gen_Psychiatry_2012_Nov_16_11_29.nxml.txt.nlp	23157721	SENT72	2	2	0	0	risperidone	DPD	PA451257	1806	0.48
NULL	Int_J_Med_Sci_2012_Aug_10_9(6)_472-479.nxml.txt.nlp	22927772	SENT115	30	30	23	23	warfarin	CYP2C9	PA451906	1559	0.48
NULL	Brain_Behav_2011_Sep_1(1)_44-54.nxml.txt.nlp	22398980	SENT351	21	21	26	26	cocaine	LSD	PA449072	1776	0.48
NULL	Front_Neurosci_2014_Dec_5_8_398.nxml.txt.nlp	25538552	SENT464	14	14	21	21	oxygen	CA1	PA450744	759	0.48
NULL	Acta_Pharmacol_Sin_2010_Mar_22_31(3)_329-340.nxml.txt.nlp	20173759	SENT27	17	17	25	25	ethanol	AMPK	PA448073	5563	0.48
NULL	Arthritis_Res_Ther_2011_Feb_16_13(1)_R25.nxml.txt.nlp	21324169	SENT120	2	2	4	4	abatacept	ADA	PA164747080	100	0.48
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT191	3	3	8	8	glucose	STZ	PA449773	6484	0.48
NULL	Environ_Health_Perspect_2010_Jun_25_118(6)_864-870.nxml.txt.nlp	20100676	SENT227	3	3	15	15	arsenite	INS-1	PA452638	2305	0.48
NULL	Neural_Regen_Res_2013_Jul_5_8(19)_1803-1813.nxml.txt.nlp	25206477	SENT155	0	0	3	3	cilostazol	spatial	PA164746334	219793	0.48
NULL	Clinicoecon_Outcomes_Res_2014_Oct_17_6_451-461.nxml.txt.nlp	25378939	SENT116	7	7	11	11	vancomycin	HAP	PA451850	5915;10313	0.48
NULL	Comp_Hepatol_2004_Jan_14_3(Suppl_1)_S37.nxml.txt.nlp	14960189	SENT91	6	6	25	25	thalidomide	CD14	PA451644	929	0.48
NULL	Cancer_Immunol_Immunother_2015_Oct_7_64_61-73.nxml.txt.nlp	25287778	SENT221	16	16	9	9	lenalidomide	CD56	PA162363968	4684	0.48
NULL	Exp_Ther_Med_2013_Nov_6_6(5)_1089-1095.nxml.txt.nlp	24223627	SENT4	17	17	14	14	epirubicin	NAC	PA449476	22861	0.48
NULL	Mar_Drugs_2014_Nov_13_12(11)_5408-5424.nxml.txt.nlp	25402829	SENT112	32	32	10	10	methotrexate	HMGN5	PA450428	79366	0.48
NULL	Diabetes_Care_2010_Dec_30_33(12)_2549-2551.nxml.txt.nlp	20805256	SENT17	1	1	5	5	metformin	ADM	PA450395	133	0.48
NULL	Int_J_Endocrinol_2011_Dec_20_2011_746482.nxml.txt.nlp	22216029	SENT233	32	32	16	16	nifedipine	K60	PA450631	3576	0.48
NULL	Br_J_Cancer_2003_Mar_10_88(5)_788-795.nxml.txt.nlp	12618891	SENT175	16	16	14	14	bosentan	FasL	PA10034	356	0.48
NULL	Arthritis_Res_Ther_2006_May_11_8(3)_209.nxml.txt.nlp	16712713	SENT551	1	1	16	16	methotrexate	Yes	PA450428	7525	0.48
NULL	Biochem_Res_Int_2012_Mar_4_2012_685267.nxml.txt.nlp	22496978	SENT198	26	26	20	20	thrombin	C3a	PA451674	718	0.48
NULL	Aging_(Albany_NY)_2011_Apr_6_3(4)_444-449.nxml.txt.nlp	21483037	SENT65	0	0	2	2	resveratrol	AMPK		5563	0.48
NULL	Indian_J_Psychol_Med_2012_Jan-Mar_34(1)_97-98.nxml.txt.nlp	22661820	SENT22	9	9	11	11	haloperidol	Gen	PA449841	348654	0.48
NULL	Cardiol_Res_Pract_2012_Aug_15_2012_713294.nxml.txt.nlp	22928146	SENT120	26	26	10	10	carvedilol	CARMEN	PA448817	8915	0.48
NULL	Saudi_J_Anaesth_2013_Apr-Jun_7(2)_151-154.nxml.txt.nlp	23956714	SENT20	0	0	3	3	theophylline	NAC	PA451647	22861	0.48
NULL	Eur_J_Epidemiol_2011_Aug_30_26(8)_657-686.nxml.txt.nlp	21877163	SENT493	19	19	12	12	metformin	OCT1	PA450395	5451;6580	0.48
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT180	13	13	6	6	glucose	TMS	PA449773	7298	0.48
NULL	Cardiovasc_Res_2014_Mar_1_101(3)_513-521.nxml.txt.nlp	24323316	SENT113	6	6	8	8	maraviroc	CCL4	PA164768835	6351	0.48
NULL	Br_J_Haematol_2014_Mar_6_164(6)_759-766.nxml.txt.nlp	24387053	SENT208	14	14	16	16	eculizumab	PEX	PA164776637	5251	0.48
NULL	Breast_Cancer_Res_2004_Oct_6_6(6)_269-274.nxml.txt.nlp	15535858	SENT82	4	4	10	10	letrozole	pS2	PA450196	7031	0.48
NULL	Exp_Ther_Med_2014_Sep_14_8(3)_836-840.nxml.txt.nlp	25120610	SENT5	42	42	22	22	fasudil	Rho	PA165946121	29984	0.48
NULL	Mol_Cancer_2014_Feb_5_13_24.nxml.txt.nlp	24495306	SENT13	37	37	43	43	collagenase	ADAM17	PA449107	6868	0.48
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_127043.nxml.txt.nlp	23227093	SENT216	8	8	12	12	lovastatin	RYR	PA450272	6261	0.48
NULL	Chin_J_Cancer_2013_Dec_32(12)_640-647.nxml.txt.nlp	23816559	SENT88	6	6	3	3	mitoxantrone	p53	PA450526	7157	0.48
NULL	Diabetes_Care_2009_Nov_32(Suppl_2)_S217-S222.nxml.txt.nlp	19875555	SENT57	18	18	38	38	pioglitazone	GLP-1	PA450970	100125288	0.48
NULL	Cancer_Imaging_2006_Oct_31_6(Spec_No_A)_S71-S81.nxml.txt.nlp	17114081	SENT87	29	29	24	24	arcitumomab	CEA	PA164746540	5670;1087	0.48
NULL	Int_J_Cardiovasc_Imaging_2013_Jun_3_29(5)_959-966.nxml.txt.nlp	23378157	SENT108	2	2	16	16	urea	HGB	PA451831	114757	0.479
NULL	Emerg_Infect_Dis_2014_May_20(5)_903-905.nxml.txt.nlp	24751182	SENT71	3	3	9	9	linezolid	ST2	PA450233	9173;6761	0.479
NULL	Evid_Based_Complement_Alternat_Med_2013_Aug_12_2013_982689.nxml.txt.nlp	23997806	SENT230	45	45	11	11	tolbutamide	APE	PA451718	55704;328	0.479
NULL	Oncogene_2010_Sep_9_29(36)_5048-5060.nxml.txt.nlp	20639907	SENT234	5	5	3	3	cisplatin	TRAIL	PA449014	8743	0.479
NULL	Sci_Rep_2014_Dec_19_4_7571.nxml.txt.nlp	25524368	SENT322	7	7	10	10	estradiol	mer	PA449503	10461	0.479
NULL	Ann_Rehabil_Med_2012_Aug_27_36(4)_466-473.nxml.txt.nlp	22977771	SENT145	9	9	33	33	hyaluronidase	TLF	PA164745713	9519	0.479
NULL	Drugs_R_D_2014_Sep_28_14(3)_159-164.nxml.txt.nlp	24973042	SENT35	13	13	7	7	omeprazole	CYP2C19	PA450704	1557	0.479
NULL	Ann_Intensive_Care_2011_Jul_19_1_26.nxml.txt.nlp	21906376	SENT93	7	7	1	1	vancomycin	SAPS	PA451850	8935	0.479
NULL	Br_J_Ophthalmol_2008_Sep_22_92(9)_1275-1282.nxml.txt.nlp	18723745	SENT137	0	0	3	3	latanoprost	BAK	PA164774763	578	0.479
NULL	Drug_Des_Devel_Ther_2014_Sep_23_8_1527-1538.nxml.txt.nlp	25284985	SENT81	5	5	3	3	celecoxib	IFN	PA448871	3439	0.479
NULL	Biomed_Res_Int_2014_Jan_29_2014_361020.nxml.txt.nlp	24605326	SENT223	1	1	28	28	staurosporine	CDK2	PA165109623	1017	0.479
NULL	Diabetes_Metab_J_2012_Oct_18_36(5)_328-335.nxml.txt.nlp	23130316	SENT60	5	5	10	10	rosiglitazone	PDK4	PA451283	5166	0.479
NULL	Eur_J_Clin_Microbiol_Infect_Dis_2014_Nov_10_33(2)_201-209.nxml.txt.nlp	24213847	SENT145	30	30	24	24	clindamycin	TMP	PA449035	2012	0.479
NULL	Clin_Epigenetics_2011_Dec_5_3(1)_9.nxml.txt.nlp	22414300	SENT174	4	4	25	25	irinotecan	NAC	PA450085	22861	0.479
NULL	Oxid_Med_Cell_Longev_2011_Oct_15_2011_703676.nxml.txt.nlp	22013498	SENT27	0	0	17	17	resveratrol	IL-6		3569	0.479
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Aug_27_67(Pt_9)_o2494.nxml.txt.nlp	22059044	SENT65	9	9	22	22	coumarin	C15	PA134521193	51316	0.479
NULL	Mol_Cancer_2014_Jun_5_13_143.nxml.txt.nlp	24898067	SENT16	31	31	33	33	gefitinib	HER-2	PA131301952	2064	0.479
NULL	ScientificWorldJournal_2014_May_13_2014_701329.nxml.txt.nlp	24959618	SENT56	19	19	22	22	glycopyrrolate	NMT	PA164754882	4836	0.479
NULL	Cancer_Cell_Int_2013_Jun_26_13_63.nxml.txt.nlp	23800022	SENT210	0	0	19	19	genistein	PUMA	PA165109660	27113	0.479
NULL	Oncogene_2014_Oct_9_33(41)_4941-4951.nxml.txt.nlp	24681952	SENT70	4	4	10	10	metformin	AMPK	PA450395	5563	0.479
NULL	J_Oncol_2010_Jan_3_2010_149362.nxml.txt.nlp	20069122	SENT133	8	8	32	32	sorafenib	CDP	PA7000	1523	0.479
NULL	Diabetes_2013_Oct_17_62(10)_3500-3513.nxml.txt.nlp	23884882	SENT173	0	0	18	18	resveratrol	PDX1		8050;3651	0.479
NULL	F1000_Med_Rep_2012_Feb_1_4_4.nxml.txt.nlp	22312414	SENT111	13	13	10	10	vancomycin	Yes	PA451850	7525	0.479
NULL	Indian_J_Pharmacol_2014_Nov-Dec_46(6)_627-632.nxml.txt.nlp	25538335	SENT158	6	6	15	15	metformin	Q10	PA450395	27161	0.479
NULL	Int_J_Endocrinol_2014_Jul_2_2014_507395.nxml.txt.nlp	25165472	SENT158	14	14	8	8	estradiol	adiponectin	PA449503	9370	0.479
NULL	Biomed_Res_Int_2014_Feb_19_2014_162314.nxml.txt.nlp	24701564	SENT37	18	18	15	15	amiloride	NHE	PA448368	285335	0.479
NULL	Eur_J_Med_Res_2009_Dec_7_14(Suppl_4)_255-258.nxml.txt.nlp	20156767	SENT34	14	14	16	16	estradiol	IL-6	PA449503	3569	0.479
NULL	Contemp_Oncol_(Pozn)_2013_Apr_29_17(2)_128-133.nxml.txt.nlp	23788978	SENT44	19	19	21	21	oxymorphone	CYP2D6	PA450748	1565	0.479
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT75	7	7	19	19	atorvastatin	AKT	PA448500	207	0.479
NULL	Biochem_Res_Int_2012_Feb_12_2012_346972.nxml.txt.nlp	22400115	SENT271	0	0	11	11	hyaluronan	PI3K	PA165958431	5290	0.479
NULL	Ann_Thorac_Med_2007_Jul-Sep_2(3)_128-142.nxml.txt.nlp	19727362	SENT220	5	5	15	15	streptokinase	MIST	PA164754919	116449	0.479
NULL	Biochem_Res_Int_2012_Nov_1_2012_738471.nxml.txt.nlp	22110962	SENT47	25	25	10	10	choline	CPT1	PA448976	56994	0.479
NULL	J_Hum_Genet_2013_Jun_16_58(6)_353-361.nxml.txt.nlp	23677058	SENT161	17	17	3	3	cytarabine	DCK	PA449177	1633	0.479
NULL	Oncogene_2014_Jul_24_33(30)_3980-3991.nxml.txt.nlp	24121271	SENT162	24	24	14	14	hydrocortisone	EGF	PA449905	1950	0.479
NULL	Case_Rep_Oncol_2014_May_24_7(2)_343-348.nxml.txt.nlp	24987354	SENT102	22	22	14	14	vemurafenib	RAI	PA165946873	10848;6050	0.479
NULL	Front_Behav_Neurosci_2012_Nov_27_6_79.nxml.txt.nlp	23205006	SENT1228	0	0	10	10	sulpiride	spatial	PA164745485	219793	0.479
NULL	J_Int_Soc_Sports_Nutr_2012_Apr_17_9_17.nxml.txt.nlp	22510253	SENT100	2	2	0	0	l-arginine	AAKG	PA448478	51422	0.479
NULL	Clin_Med_Oncol_2008_Apr_1_2_223-225.nxml.txt.nlp	21892283	SENT38	22	22	8	8	pemetrexed	B12	PA10810	7126;4709	0.479
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT192	39	39	8	8	afatinib	Yes	PA165981154	7525	0.479
NULL	Front_Synaptic_Neurosci_2014_Sep_16_6_20.nxml.txt.nlp	25278874	SENT233	3	3	8	8	scopolamine	spatial	PA451308	219793	0.479
NULL	Crit_Care_2011_Nov_16_15(6)_R271.nxml.txt.nlp	22087790	SENT164	2	2	18	18	nitroprusside	Yes	PA451406	7525	0.479
NULL	Eur_J_Pharmacol_2013_Jan_5_698(1-3)_322-329.nxml.txt.nlp	23099254	SENT158	5	5	0	0	dpcpx	ANOVA		4858	0.479
NULL	Breast_Cancer_Res_2011_Mar_11_13(2)_R29.nxml.txt.nlp	21396094	SENT146	41	41	9	9	ethanol	HRG	PA448073	3084;3273	0.479
NULL	ScientificWorldJournal_2012_Apr_19_2012_790486.nxml.txt.nlp	22593706	SENT159	16	16	14	14	ethanol	CO2	PA448073	4513	0.479
NULL	Cell_Res_2009_Aug_19(8)_950-961.nxml.txt.nlp	19546888	SENT187	4	4	7	7	camptothecin	c-Myc	PA153590860	4609	0.479
NULL	J_Korean_Med_Sci_2013_Feb_29_28(2)_308-314.nxml.txt.nlp	23399960	SENT31	18	18	20	20	gabapentin	IL-10	PA449720	3586	0.479
NULL	Summit_on_Translat_Bioinforma_2009_Mar_1_2009_124-128.nxml.txt.nlp	21347183	SENT70	18	18	11	11	thioguanine	TPMT	PA451663	7172	0.479
NULL	Int_J_Lab_Hematol_2013_Dec_30_35(6)_652-657.nxml.txt.nlp	23718922	SENT69	0	0	4	4	thrombin	FVIII	PA451674	2157	0.479
NULL	Oncol_Lett_2013_Apr_28_5(4)_1149-1154.nxml.txt.nlp	23599754	SENT120	12	12	10	10	cisplatin	Dicer	PA449014	23405	0.479
NULL	Cancer_Manag_Res_2014_Oct_17_6_423-430.nxml.txt.nlp	25378950	SENT142	10	10	15	15	raloxifene	STAR	PA451221	6770;2984	0.479
NULL	Biomed_Res_Int_2014_Jan_29_2014_361020.nxml.txt.nlp	24605326	SENT223	7	7	24	24	flavopiridol	CDK5	PA452627	1020	0.479
NULL	An_Bras_Dermatol_2013_Nov-Dec_88(6_Suppl_1)_26-28.nxml.txt.nlp	24346872	SENT10	12	12	2	2	adalimumab	TNF-alpha	PA10004	7124	0.479
NULL	Case_Rep_Endocrinol_2011_Aug_11_2011_246872.nxml.txt.nlp	22937279	SENT50	13	13	11	11	thyroglobulin	TTF-1	PA164754910	7080	0.479
NULL	Crit_Care_2011_Nov_16_15(6)_R271.nxml.txt.nlp	22087790	SENT164	2	2	40	40	nitroprusside	Yes	PA451406	7525	0.479
NULL	Cell_Death_Dis_2014_Jan_30_5(1)_e1036.nxml.txt.nlp	24481450	SENT119	15	15	11	11	l-glutamine	F12	PA10090	2161	0.479
NULL	Mol_Cell_Biochem_2014_Oct_9_385(1-2)_265-275.nxml.txt.nlp	24104452	SENT105	20	20	16	16	bortezomib	U87	PA10252	677775;641648	0.479
NULL	Iran_J_Pharm_Res_2013_Winter_12(1)_141-146.nxml.txt.nlp	24250582	SENT5	19	19	13	13	rifampin	NAC	PA451250	22861	0.479
NULL	Int_J_Nanomedicine_2012_May_7_7_2307-2314.nxml.txt.nlp	22661887	SENT62	9	9	4	4	gemcitabine	zeta	PA449748	9907	0.479
NULL	Mol_Cancer_2009_Nov_24_8_109.nxml.txt.nlp	19930708	SENT194	16	16	10	10	exemestane	EGFR	PA449563	1956	0.479
NULL	J_Orthop_Surg_2008_Apr_17_3_14.nxml.txt.nlp	18419823	SENT196	10	10	44	44	phosphorus	AID	PA450954	57379	0.479
NULL	Cardiovasc_Diabetol_2013_Jun_7_12_84.nxml.txt.nlp	23759020	SENT62	38	38	7	7	dipyridamole	LSR	PA449367	51599	0.479
NULL	J_Adv_Pharm_Technol_Res_2012_Oct-Dec_3(4)_202-209.nxml.txt.nlp	23378940	SENT177	13	13	0	0	fosaprepitant	HEC	PA165958390	10403	0.479
NULL	Daru_2012_Sep_10_20(1)_30.nxml.txt.nlp	23351387	SENT45	5	5	3	3	diclofenac	NAC	PA449293	22861	0.479
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jul_10_68(Pt_8)_o2398.nxml.txt.nlp	22904855	SENT74	17	17	13	13	guanidine	mol	PA164781028	90527	0.479
NULL	Carcinogenesis_2014_May_13_35(5)_1055-1066.nxml.txt.nlp	24419232	SENT141	0	0	30	30	metformin	AMPK	PA450395	5563	0.479
NULL	Diabetes_2013_Mar_14_62(3)_953-964.nxml.txt.nlp	23223176	SENT158	2	2	39	39	paroxetine	ROS	PA450801	6098	0.479
NULL	Eur_J_Clin_Microbiol_Infect_Dis_2014_Nov_10_33(2)_201-209.nxml.txt.nlp	24213847	SENT145	6	6	24	24	amoxicillin	TMP	PA448406	2012	0.479
NULL	J_Immunother_2014_Apr_12_37(3)_180-186.nxml.txt.nlp	24598448	SENT60	10	10	8	8	sorafenib	IL-2	PA7000	3558	0.479
NULL	Crit_Care_2012_May_22_16(3)_312.nxml.txt.nlp	22621656	SENT41	20	20	13	13	streptokinase	MIST1	PA164754919	168620	0.479
NULL	Front_Immunol_2012_Jan_25_3_7.nxml.txt.nlp	22566893	SENT336	20	20	6	6	nedocromil	TNF-alpha	PA450601	7124	0.479
NULL	Cancer_Inform_2009_Aug_5_7_199-216.nxml.txt.nlp	19718451	SENT232	7	7	32	32	creatine	BST2	PA164778930	684	0.479
NULL	ScientificWorldJournal_2013_Apr_24_2013_928197.nxml.txt.nlp	23737732	SENT59	6	6	10	10	losartan	ACR	PA450268	49	0.479
NULL	Ann_Gen_Psychiatry_2005_Jan_25_4_1.nxml.txt.nlp	15845138	SENT148	9	9	5	5	fluvoxamine	HERG	PA449690	3757	0.479
NULL	Arthritis_Res_Ther_2009_Jan_30_11(1)_207.nxml.txt.nlp	19232067	SENT241	27	27	37	37	infliximab	IFN	PA452639	3439	0.479
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT277	6	6	2	2	risperidone	PRL	PA451257	5617	0.479
NULL	Cancer_Cell_Int_2013_Apr_16_13_36.nxml.txt.nlp	23590596	SENT93	24	24	16	16	doxorubicin	TRAIL	PA449412	8743	0.479
NULL	Front_Mol_Neurosci_2012_May_14_5_63.nxml.txt.nlp	22593734	SENT115	26	26	8	8	retigabine	AMH	PA144997862	268	0.479
NULL	J_Cell_Biol_2008_Jul_14_182(1)_103-116.nxml.txt.nlp	18606846	SENT61	13	13	15	15	lipase	aP2	PA450239	2167	0.479
NULL	Breast_Cancer_Res_2005_Nov_11_7(6)_255-257.nxml.txt.nlp	16457700	SENT10	6	6	14	14	anastrozole	ATAC	PA448432	6375	0.479
NULL	Environ_Health_Perspect_2006_Sep_23_114(9)_1401-1406.nxml.txt.nlp	16966095	SENT104	7	7	4	4	arsenite	p53	PA452638	7157	0.479
NULL	Avicenna_J_Phytomed_2012_Spring_2(2)_72-78.nxml.txt.nlp	25050233	SENT157	8	8	14	14	imipramine	FST	PA449969	10468	0.479
NULL	Bone_Marrow_Res_2014_Jul_23_2014_405920.nxml.txt.nlp	25147739	SENT259	12	12	5	5	hyaluronan	CD44	PA165958431	960	0.479
NULL	Eur_J_Clin_Pharmacol_2014_Oct_8_70(1)_37-45.nxml.txt.nlp	24100471	SENT54	12	12	29	29	midazolam	OATP1B1	PA450496	10599	0.479
NULL	Anal_Chem_2014_Jan_7_86(1)_443-452.nxml.txt.nlp	24313826	SENT85	35	35	46	46	diazepam	ACTB	PA449283	60	0.479
NULL	Cardiol_Res_Pract_2012_Aug_15_2012_713294.nxml.txt.nlp	22928146	SENT120	24	24	10	10	enalapril	CARMEN	PA449456	8915	0.479
NULL	Exp_Hematol_2014_Dec_42(12)_1053-1058_e1.nxml.txt.nlp	25127743	SENT10	8	8	5	5	iron	KCNQ1	PA450087	3784	0.479
NULL	Scientifica_(Cairo)_2013_Feb_7_2013_249101.nxml.txt.nlp	24278770	SENT182	0	0	5	5	alemtuzumab	CD52	PA164783958	1043	0.479
NULL	J_Vis_Exp_2011_Mar_6_(49)_2639.nxml.txt.nlp	21403640	SENT18	24	24	7	7	heparin	EGF	PA449855	1950	0.479
NULL	Vet_Res_Forum_2013_Winter_4(1)_19-24.nxml.txt.nlp	25593681	SENT32	10	10	8	8	diclofenac	B12	PA449293	7126;4709	0.479
NULL	J_Korean_Med_Sci_2007_Oct_31_22(5)_815-819.nxml.txt.nlp	17982228	SENT19	32	32	35	35	hyaluronan	CD43	PA165958431	6693	0.479
NULL	Crit_Care_2007_Feb_15_11(1)_R18.nxml.txt.nlp	17302971	SENT90	13	13	17	17	heparin	ACT	PA449855	12;11332;9457;641455	0.479
NULL	Mol_Cancer_2007_Sep_26_6_61.nxml.txt.nlp	17894897	SENT211	14	14	7	7	etoposide	CDKN1A	PA449552	1026	0.479
NULL	Cardiovasc_J_Afr_2008_Apr_19(2)_77-83.nxml.txt.nlp	18516352	SENT129	8	8	24	24	glucose	GLP-1	PA449773	100125288	0.479
NULL	Case_Rep_Oncol_2011_Nov_22_4(3)_534-541.nxml.txt.nlp	22187539	SENT107	6	6	8	8	paclitaxel	GEM	PA450761	2669	0.479
NULL	Allergy_Asthma_Immunol_Res_2014_Nov_28_6(6)_567-572.nxml.txt.nlp	25374757	SENT81	10	10	13	13	fexofenadine	IL-6	PA449621	3569	0.479
NULL	Br_J_Cancer_2010_Jun_29_103(1)_61-72.nxml.txt.nlp	20588279	SENT257	25	25	15	15	trastuzumab	p27	PA451743	5715;10534	0.479
NULL	DNA_Res_2011_Aug_26_18(4)_291-303.nxml.txt.nlp	21791478	SENT44	21	21	14	14	paraformaldehyde	IL-17A	PA450790	3605	0.479
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT192	39	39	46	46	afatinib	Yes	PA165981154	7525	0.479
NULL	J_Cell_Biol_2005_May_23_169(4)_681-691.nxml.txt.nlp	15911882	SENT79	22	22	18	18	aprotinin	TIMP2	PA448472	7077	0.479
NULL	Cardiovasc_Drugs_Ther_2010_Dec_13_24(5-6)_391-399.nxml.txt.nlp	20640495	SENT167	15	15	13	13	atorvastatin	DIP	PA448500	23151;1831	0.479
NULL	Viruses_2014_Sep_17_6(9)_3438-3449.nxml.txt.nlp	25256392	SENT141	11	11	19	19	oseltamivir	N10	PA450721	3164	0.479
NULL	Case_Rep_Ophthalmol_2011_Mar_12_2(1)_105-110.nxml.txt.nlp	22110438	SENT34	12	12	10	10	ribavirin	IFN	PA451241	3439	0.479
NULL	Oxid_Med_Cell_Longev_2013_Nov_24_2013_971024.nxml.txt.nlp	24371505	SENT151	21	21	15	15	telaprevir	IFN	PA165958354	3439	0.479
NULL	Clin_Ophthalmol_2010_Oct_21_4_1217-1222.nxml.txt.nlp	21060675	SENT116	31	31	24	24	timolol	BAK	PA451690	578	0.479
NULL	J_Biol_Chem_2013_Jul_19_288(29)_21412-21421.nxml.txt.nlp	23740251	SENT105	12	12	31	31	suramin	P2X1	PA10292	5023	0.479
NULL	FASEB_J_2014_Feb_28(2)_923-934.nxml.txt.nlp	24249636	SENT14	1	1	13	13	urokinase	CD87	PA451836	5329	0.479
NULL	Int_J_Mol_Sci_2014_Oct_23_15(10)_19265-19280.nxml.txt.nlp	25342321	SENT241	3	3	0	0	cisplatin	PTEN	PA449014	5728	0.479
NULL	Br_J_Cancer_2010_Jan_5_102(1)_104-114.nxml.txt.nlp	20051961	SENT210	23	23	20	20	tamoxifen	PDK1	PA451581	5170;5163	0.479
NULL	J_Gen_Physiol_1979_Feb_1_73(2)_159-174.nxml.txt.nlp	312312	SENT0	13	13	1	1	creatine	Gen	PA164778930	348654	0.479
NULL	J_Breast_Cancer_2012_Sep_28_15(3)_306-312.nxml.txt.nlp	23091543	SENT121	1	1	5	5	doxorubicin	Q10	PA449412	27161	0.478
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2014_May_23_70(Pt_6)_1517-1527.nxml.txt.nlp	24914963	SENT75	29	29	33	33	l-serine	PLP	PA451330	25824;5744	0.478
NULL	Exp_Hematol_2009_Oct_37(10)_1238-1249_e5.nxml.txt.nlp	19619605	SENT40	14	14	34	34	l-glutamine	CO2	PA10090	4513	0.478
NULL	Brain_2013_May_4_136(5)_1462-1475.nxml.txt.nlp	23460667	SENT119	20	20	22	22	verapamil	ABCB1	PA451868	5243	0.478
NULL	Case_Rep_Crit_Care_2014_Aug_19_2014_242703.nxml.txt.nlp	25215245	SENT243	11	11	29	29	salbutamol	Yes	PA448068	7525	0.478
NULL	J_Adv_Pharm_Technol_Res_2014_Apr-Jun_5(2)_70-77.nxml.txt.nlp	24959415	SENT125	26	26	21	21	theophylline	ANOVA	PA451647	4858	0.478
NULL	J_Lipid_Res_2015_Jan_56(1)_109-121.nxml.txt.nlp	25421061	SENT12	23	23	15	15	lipase	CGI-58	PA450239	51099	0.478
NULL	Curr_Genomics_2013_May_14(3)_195-203.nxml.txt.nlp	24179442	SENT56	11	11	16	16	nadh	ND4	PA164755085	4538	0.478
NULL	Breast_Cancer_Res_2011_Mar_11_13(2)_R29.nxml.txt.nlp	21396094	SENT242	39	39	2	2	ethanol	HRG	PA448073	3084;3273	0.478
NULL	Environ_Health_Perspect_2011_Jun_17_119(6)_778-783.nxml.txt.nlp	21169129	SENT189	14	14	32	32	fluorescein	CD80	PA164746009	941	0.478
NULL	Clinics_(Sao_Paulo)_2011_Jun_66(6)_1101-1104.nxml.txt.nlp	21808883	SENT35	11	11	0	0	metoclopramide	PRL	PA450475	5617	0.478
NULL	ScientificWorldJournal_2012_Jun_18_2012_565047.nxml.txt.nlp	22792045	SENT38	15	15	20	20	ethanol	CO2	PA448073	4513	0.478
NULL	J_Cell_Biol_1981_Feb_1_88(2)_422-429.nxml.txt.nlp	6259180	SENT3	2	2	5	5	trypsin	EGF	PA451806	1950	0.478
NULL	Chin_J_Cancer_2011_Oct_30(10)_690-700.nxml.txt.nlp	21959046	SENT20	22	22	7	7	paclitaxel	TPT	PA450761	23590;6469	0.478
NULL	Pharmaceutics_2011_Jul_13_3(3)_425-439.nxml.txt.nlp	24310588	SENT364	13	13	0	0	oxycodone	SERS	PA450741	6301;54938	0.478
NULL	Ann_Surg_Oncol_2010_Apr_6_17(4)_1010-1023.nxml.txt.nlp	20052553	SENT154	31	31	37	37	leucovorin	CEA	PA450198	5670;1087	0.478
NULL	Clin_Ophthalmol_2014_Jan_13_8_219-228.nxml.txt.nlp	24531757	SENT166	18	18	4	4	brinzolamide	TIM	PA164744929	7984;8914	0.478
NULL	Cancer_Causes_Control_2013_Aug_18_24(8)_1605-1614.nxml.txt.nlp	23775025	SENT64	25	25	30	30	methotrexate	MTHFR	PA450428	4524	0.478
NULL	Clin_Mol_Hepatol_2013_Sep_30_19(3)_320-323.nxml.txt.nlp	24133672	SENT55	11	11	15	15	vincristine	CHOP	PA451879	1649	0.478
NULL	Br_J_Dermatol_2009_Feb_160(2)_438-441.nxml.txt.nlp	19016697	SENT77	16	16	9	9	methotrexate	MTHFR	PA450428	4524	0.478
NULL	Clin_Med_Insights_Oncol_2012_Dec_20_7_1-12.nxml.txt.nlp	23362372	SENT148	14	14	10	10	denosumab	RANKL	PA166048634	8600	0.478
NULL	Front_Endocrinol_(Lausanne)_2014_Oct_9_5_161.nxml.txt.nlp	25346723	SENT407	11	11	33	33	metformin	GLP-1	PA450395	100125288	0.478
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT333	7	7	9	9	risperidone	PRL	PA451257	5617	0.478
NULL	Comput_Math_Methods_Med_2012_Jan_16_2012_792375.nxml.txt.nlp	22291855	SENT67	7	7	3	3	estradiol	E2F2	PA449503	1870	0.478
NULL	Pharmaceuticals_(Basel)_2012_Aug_10_5(8)_802-836.nxml.txt.nlp	24280676	SENT1815	25	25	16	16	methotrexate	ABCG2	PA450428	9429	0.478
NULL	CNS_Drugs_2014_May_1_28(6)_497-511.nxml.txt.nlp	24788672	SENT103	21	21	8	8	methylphenidate	DBP	PA450464	3295;1628;2638	0.478
NULL	Cell_Death_Differ_2010_Apr_23_17(4)_699-709.nxml.txt.nlp	19851330	SENT85	20	20	13	13	tetracycline	PUMA	PA451640	27113	0.478
NULL	ScientificWorldJournal_2013_Oct_24_2013_726912.nxml.txt.nlp	24282387	SENT79	16	16	21	21	fluorescein	PEX	PA164746009	5251	0.478
NULL	Br_J_Cancer_1998_Apr_77(7)_1149-1154.nxml.txt.nlp	9569054	SENT0	13	13	26	26	etoposide	GM-CSF	PA449552	1437	0.478
NULL	Clin_Psychopharmacol_Neurosci_2011_Aug_31_9(2)_86-90.nxml.txt.nlp	23429437	SENT99	29	29	11	11	nimodipine	CA1	PA450633	759	0.478
NULL	Hum_Genomics_Proteomics_2010_Sep_13_2010_754919.nxml.txt.nlp	20981234	SENT84	1	1	6	6	warfarin	VKORC1	PA451906	79001	0.478
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT182	7	7	9	9	bevacizumab	VEGF-A	PA130232992	7422	0.478
NULL	Mol_Cancer_2014_Jan_24_13_11.nxml.txt.nlp	24456667	SENT128	0	0	2	2	doxycycline	MLH1	PA449415	4292	0.478
NULL	Biomed_Res_Int_2014_Jan_29_2014_361020.nxml.txt.nlp	24605326	SENT223	1	1	38	38	staurosporine	CDK1	PA165109623	983	0.478
NULL	Bioinform_Biol_Insights_2013_Sep_18_7_289-306.nxml.txt.nlp	24092970	SENT286	6	6	8	8	etoposide	PRAME	PA449552	23532	0.478
NULL	Braz_J_Med_Biol_Res_2014_Oct_14_47(12)_1068-1074.nxml.txt.nlp	25387674	SENT87	23	23	27	27	taurine	ANOVA	PA451590	4858	0.478
NULL	Biologics_2009_Jul_13_3_225-232.nxml.txt.nlp	19707411	SENT157	4	4	2	2	cyclophosphamide	CTX	PA449165	1593	0.478
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Sep_28_69(Pt_10)_m568-m569.nxml.txt.nlp	24098191	SENT5	36	36	44	44	ethanol	mol	PA448073	90527	0.478
NULL	Biologics_2014_Apr_22_8_193-198.nxml.txt.nlp	24790412	SENT126	19	19	43	43	adalimumab	Yes	PA10004	7525	0.478
NULL	Oncotarget_2012_May_4_3(4)_371-394.nxml.txt.nlp	22564882	SENT305	10	10	14	14	nutlin-3	p53		7157	0.478
NULL	J_Hum_Genet_2013_Jun_23_58(6)_339-345.nxml.txt.nlp	23697979	SENT93	27	27	43	43	clopidogrel	CYP2C19	PA449053	1557	0.478
NULL	J_Immunother_Cancer_2014_Aug_19_2_27.nxml.txt.nlp	25324973	SENT58	1	1	20	20	carboplatin	IFN	PA448803	3439	0.478
NULL	Acta_Pharmacol_Sin_2013_Apr_11_34(4)_487-495.nxml.txt.nlp	23396376	SENT40	22	22	2	2	collagenase	NAC	PA449107	22861	0.478
NULL	Biomed_Res_Int_2014_Jan_29_2014_361020.nxml.txt.nlp	24605326	SENT223	7	7	26	26	flavopiridol	CDK1	PA452627	983	0.478
NULL	Nat_Commun_2014_Nov_19_5_5479.nxml.txt.nlp	25407222	SENT507	15	15	20	20	dextran	YTS	PA449261	8565	0.478
NULL	F1000Prime_Rep_2013_Jul_1_5_24.nxml.txt.nlp	23864931	SENT21	4	4	2	2	boceprevir	BOC	PA165948902	91653	0.478
NULL	Korean_J_Anesthesiol_2013_Dec_26_65(6)_501-507.nxml.txt.nlp	24427455	SENT17	20	20	29	29	neostigmine	NMB	PA450611	10457;4828	0.478
NULL	Cell_Res_2013_Sep_25_23(9)_1075-1090.nxml.txt.nlp	23797856	SENT96	12	12	28	28	tamoxifen	E12	PA451581	64100	0.478
NULL	Oncogenesis_2014_May_12_3(5)_e102.nxml.txt.nlp	24819061	SENT122	9	9	21	21	nadh	NQO1	PA164755085	1728	0.478
NULL	N_Am_J_Med_Sci_2013_Mar_5(3)_207-212.nxml.txt.nlp	23626957	SENT89	11	11	7	7	streptomycin	FBS	PA451512	64319;26269	0.478
NULL	J_Korean_Med_Sci_2007_Apr_30_22(2)_369-372.nxml.txt.nlp	17449953	SENT42	36	36	41	41	thyroglobulin	CD56	PA164754910	4684	0.478
NULL	Diabetes_2011_Nov_17_60(11)_2691-2700.nxml.txt.nlp	21896928	SENT155	0	0	13	13	resveratrol	CTRL		1506	0.478
NULL	Front_Neurol_2014_Sep_11_5_173.nxml.txt.nlp	25309501	SENT270	17	17	19	19	hyaluronan	RHAMM	PA165958431	3161	0.478
NULL	J_Mol_Med_2009_Oct_8_87(10)_971-980.nxml.txt.nlp	19669106	SENT23	19	19	6	6	thyroglobulin	TPO	PA164754910	7066;7173	0.478
NULL	J_Neuroinflammation_2011_Aug_5_8_91.nxml.txt.nlp	21819568	SENT210	40	40	2	2	pioglitazone	CD68	PA450970	968	0.478
NULL	Biomed_Res_Int_2014_Jan_29_2014_361020.nxml.txt.nlp	24605326	SENT223	7	7	44	44	flavopiridol	CDK1	PA452627	983	0.478
NULL	Endocrinol_Diabetes_Metab_Case_Rep_2014_Dec_1_2014_140083.nxml.txt.nlp	25535576	SENT8	0	0	7	7	ketoconazole	ACTH	PA450146	5443	0.478
NULL	Mol_Cancer_2014_Feb_5_13_24.nxml.txt.nlp	24495306	SENT26	19	19	6	6	collagenase	ADAM17	PA449107	6868	0.478
NULL	Ann_Microbiol_2013_Feb_14_63(4)_1477-1482.nxml.txt.nlp	24294189	SENT109	2	2	16	16	glucose	ANOVA	PA449773	4858	0.478
NULL	J_Anim_Sci_Biotechnol_2013_Feb_27_4(1)_7.nxml.txt.nlp	23445937	SENT131	22	22	8	8	urea	CO2	PA451831	4513	0.478
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_21-38.nxml.txt.nlp	19305786	SENT498	2	2	15	15	capsaicin	TRPV4	PA448776	59341	0.478
NULL	Diabetes_2013_Sep_15_62(9)_3019-3021.nxml.txt.nlp	23970522	SENT20	7	7	3	3	chymotrypsin	CTRB2	PA448994	440387	0.478
NULL	J_Thromb_Thrombolysis_2009_Nov_6_28(4)_410-417.nxml.txt.nlp	19504052	SENT116	17	17	14	14	clopidogrel	CD40L	PA449053	959	0.478
NULL	Mol_Cancer_2008_Aug_7_7_65.nxml.txt.nlp	18687124	SENT142	7	7	4	4	fluorescein	parafibromin	PA164746009	79577	0.478
NULL	J_Cell_Biol_2002_May_13_157(4)_703-714.nxml.txt.nlp	12011115	SENT325	27	27	6	6	ethanol	HC11	PA448073	6347	0.478
NULL	J_Exp_Bot_2012_Mar_15_63(5)_1969-1983.nxml.txt.nlp	22174442	SENT257	21	21	4	4	ethanol	NO3	PA448073	4681	0.478
NULL	Spermatogenesis_2013_Jan_1_3(1)_e23870.nxml.txt.nlp	23687616	SENT144	19	19	29	29	hyaluronan	CCL4	PA165958431	6351	0.478
NULL	Case_Rep_Vasc_Med_2012_Dec_13_2012_750953.nxml.txt.nlp	23304629	SENT53	13	13	2	2	haloperidol	SPG	PA449841	55764	0.478
NULL	Comput_Math_Methods_Med_2014_Feb_3_2014_813067.nxml.txt.nlp	24639887	SENT287	38	38	32	32	etoposide	TOP2A	PA449552	7153	0.478
NULL	Indian_J_Pharm_Sci_2013_Sep-Oct_75(5)_523-532.nxml.txt.nlp	24403652	SENT120	3	3	6	6	atorvastatin	ATV	PA448500	4683	0.478
NULL	Drug_Des_Devel_Ther_2014_Sep_23_8_1527-1538.nxml.txt.nlp	25284985	SENT176	19	19	15	15	celecoxib	IFN	PA448871	3439	0.478
NULL	Lab_Invest_2009_Nov_7_89(11)_1275-1290.nxml.txt.nlp	19736547	SENT160	20	20	10	10	curcumin	LOX-1	PA151958596	4973	0.478
NULL	AAPS_J_2011_Dec_22_14(1)_68-78.nxml.txt.nlp	22189899	SENT193	21	21	37	37	rifampin	CYP3A4	PA451250	1576	0.478
NULL	Arch_Dis_Child_2014_Dec_8_99(12)_1143-1146.nxml.txt.nlp	25202131	SENT58	15	15	17	17	diazepam	CYP2D6	PA449283	1565	0.478
NULL	J_Radiat_Res_2012_Sep_10_53(5)_704-709.nxml.txt.nlp	22843360	SENT94	16	16	2	2	cisplatin	ADM	PA449014	133	0.478
NULL	Mol_Biol_Rep_2012_May_20_39(5)_5253-5267.nxml.txt.nlp	22183301	SENT175	2	2	0	0	gliclazide	NAC	PA10892	22861	0.478
NULL	Clin_Transl_Allergy_2014_Jan_15_4_3.nxml.txt.nlp	24428928	SENT161	15	15	11	11	methacholine	CD4	PA165958382	920	0.478
NULL	Front_Neurosci_2014_Dec_5_8_398.nxml.txt.nlp	25538552	SENT20	15	15	12	12	glucose	gamma	PA449773	9913	0.478
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Dec_2_5_30.nxml.txt.nlp	17140452	SENT194	7	7	5	5	gatifloxacin	GAT	PA449738	10249	0.478
NULL	Mol_Cell_Proteomics_2012_Apr_9_11(4)_M111_014647.nxml.txt.nlp	22159717	SENT303	0	0	6	6	hyaluronan	HAPLN1	PA165958431	1404	0.478
NULL	Breast_Cancer_Res_2010_Jun_4_12(3)_R32.nxml.txt.nlp	20525379	SENT313	7	7	31	31	fulvestrant	AGR2	PA164747170	10551	0.478
NULL	Front_Oncol_2013_Oct_31_3_273.nxml.txt.nlp	24199173	SENT295	16	16	14	14	docetaxel	p53	PA449383	7157	0.478
NULL	Biologics_2010_May_25_4_83-90.nxml.txt.nlp	20531966	SENT101	0	0	18	18	gefitinib	EGFR	PA131301952	1956	0.478
NULL	Biomed_Res_Int_2013_Nov_6_2013_798164.nxml.txt.nlp	24308005	SENT78	20	20	41	41	paraformaldehyde	IL-4	PA450790	3565	0.478
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT127	19	19	21	21	capsaicin	p53	PA448776	7157	0.478
NULL	Brief_Bioinform_2014_Mar_21_15(2)_195-211.nxml.txt.nlp	23698722	SENT360	41	41	43	43	urokinase	PLAU	PA451836	5328	0.478
NULL	Sci_Rep_2014_Nov_28_4_7237.nxml.txt.nlp	25429875	SENT111	12	12	34	34	hesperidin	p38	PA449867	10598;1432;7965	0.478
NULL	Br_J_Pharmacol_2011_Mar_162(5)_1029-1044.nxml.txt.nlp	20958290	SENT145	26	26	31	31	pilocarpine	NMS	PA450962	129521	0.478
NULL	Biosci_Rep_2014_Apr_15_34(2)_e00105.nxml.txt.nlp	24617546	SENT89	0	0	2	2	metformin	AMPK	PA450395	5563	0.478
NULL	Biotechnol_Res_Int_2011_Dec_27_2011_162987.nxml.txt.nlp	22389769	SENT136	12	12	9	9	lipase	hole	PA450239	80757	0.478
NULL	Oncogene_2010_May_27_29(21)_3044-3053.nxml.txt.nlp	20348955	SENT70	26	26	21	21	neomycin	Met	PA450608	79811	0.478
NULL	AIDS_Care_2011_Sep_14_23(9)_1154-1162.nxml.txt.nlp	21500025	SENT123	4	4	2	2	atazanavir	ATV	PA10251	4683	0.478
NULL	Mol_Microbiol_2014_Apr_13_92(1)_153-163.nxml.txt.nlp	24673795	SENT224	22	22	2	2	platinum	SHARP	PA150595617	23013	0.478
NULL	Br_J_Anaesth_2014_Jul_22_113(1)_157-167.nxml.txt.nlp	24154701	SENT210	5	5	2	2	sevoflurane	TREK-1	PA451341	3776	0.478
NULL	Oxid_Med_Cell_Longev_2013_Dec_5_2013_963520.nxml.txt.nlp	24381719	SENT18	12	12	9	9	oxygen	ROS	PA450744	6098	0.478
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT117	3	3	13	13	l-leucine	S6K1	PA450197	6198	0.478
NULL	Database_(Oxford)_2014_Dec_23_2014_bau124.nxml.txt.nlp	25539768	SENT130	10	10	7	7	cetuximab	EGFR	PA10040	1956	0.478
NULL	J_Headache_Pain_2014_Feb_8_15(1)_7.nxml.txt.nlp	24506953	SENT221	30	30	28	28	capsaicin	TRPV1	PA448776	7442	0.478
NULL	Eur_J_Endocrinol_2012_Feb_166(2)_159-170.nxml.txt.nlp	21930715	SENT253	47	47	0	0	protamine	ADA	PA10366	100	0.478
NULL	Breast_Cancer_Res_2001_Mar_28_3(3)_150-153.nxml.txt.nlp	11305949	SENT57	16	16	22	22	paclitaxel	Bcl-2	PA450761	596	0.478
NULL	J_Headache_Pain_2011_Apr_25_12(2)_185-191.nxml.txt.nlp	21350791	SENT64	11	11	0	0	capsaicin	ANOVA	PA448776	4858	0.478
NULL	Indian_J_Ophthalmol_2011_Jan_59(Suppl1)_S102-S113.nxml.txt.nlp	21150020	SENT279	18	18	14	14	curcumin	Q10	PA151958596	27161	0.478
NULL	Diabetes_2009_Jan_58(1)_243-249.nxml.txt.nlp	18840785	SENT47	3	3	12	12	glucose	GLP-1	PA449773	100125288	0.478
NULL	Fibrogenesis_Tissue_Repair_2012_Jul_23_5_11.nxml.txt.nlp	22824096	SENT147	21	21	10	10	bleomycin	CD19	PA448645	930	0.478
NULL	Int_J_Mol_Sci_2014_May_12_15(5)_8335-8351.nxml.txt.nlp	24823879	SENT529	0	0	2	2	cisplatin	TRAIL	PA449014	8743	0.478
NULL	Crit_Care_2008_Jun_25_12(3)_R84.nxml.txt.nlp	18578859	SENT97	23	23	26	26	heparin	PF4	PA449855	5196	0.477
NULL	Adv_Hematol_2012_Nov_20_2012_861060.nxml.txt.nlp	23251161	SENT61	24	24	12	12	rituximab	IFN	PA451261	3439	0.477
NULL	eLife_2014_May_27_3_e02200.nxml.txt.nlp	24867637	SENT42	3	3	15	15	nutlin-3	MDM2		4193	0.477
NULL	EJC_Suppl_2013_Sep_5_11(2)_262-263.nxml.txt.nlp	NULL	SENT8	22	22	24	24	rituximab	CHOP	PA451261	1649	0.477
NULL	Endocrinology_2015_Jan_6_156(1)_24-31.nxml.txt.nlp	25375036	SENT163	4	4	6	6	flutamide	DES	PA449685	1674	0.477
NULL	Mol_Vis_2011_Feb_1_17_332-340.nxml.txt.nlp	21297899	SENT14	2	2	4	4	telmisartan	DPI	PA451605	1832	0.477
NULL	Hum_Genomics_Proteomics_2010_Sep_13_2010_754919.nxml.txt.nlp	20981234	SENT92	9	9	16	16	phenprocoumon	CYP2C9	PA450921	1559	0.477
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT192	43	43	20	20	gefitinib	Yes	PA131301952	7525	0.477
NULL	J_Antimicrob_Chemother_2009_May_5_63(5)_1034-1042.nxml.txt.nlp	19264792	SENT36	20	20	44	44	vancomycin	CLCR	PA451850	11330	0.477
NULL	Eur_J_Clin_Nutr_2011_Feb_3_65(2)_234-239.nxml.txt.nlp	21048773	SENT59	20	20	27	27	thrombin	mol	PA451674	90527	0.477
NULL	Anesth_Pain_Med_2014_Sep_8_4(4)_e17206.nxml.txt.nlp	25337471	SENT112	14	14	4	4	parecoxib	Tech	PA166049193	57449	0.477
NULL	BMB_Rep_2013_Mar_46(3)_169-174.nxml.txt.nlp	23527861	SENT19	24	24	27	27	cyanocobalamin	B12	PA451892	7126;4709	0.477
NULL	Indian_J_Endocrinol_Metab_2013_May-Jun_17(3)_413-421.nxml.txt.nlp	23869296	SENT79	4	4	21	21	liraglutide	gamma	PA165958364	9913	0.477
NULL	Adv_Hematol_2010_Dec_5_2010_595934.nxml.txt.nlp	21151515	SENT154	15	15	11	11	ticagrelor	Yes	PA165374673	7525	0.477
NULL	Exp_Ther_Med_2014_Aug_3_8(2)_557-562.nxml.txt.nlp	25009619	SENT160	37	37	0	0	fluorescein	IFN	PA164746009	3439	0.477
NULL	Diabetes_Care_2010_Sep_21_33(9)_1954-1956.nxml.txt.nlp	20566677	SENT18	6	6	14	14	ezetimibe	ESD	PA10816	2098	0.477
NULL	Toxins_(Basel)_2010_Oct_26_2(11)_2490-2518.nxml.txt.nlp	22069563	SENT193	21	21	18	18	cisplatin	IL-18	PA449014	3606	0.477
NULL	Int_J_Anal_Chem_2014_Dec_4_2014_239641.nxml.txt.nlp	25548566	SENT103	19	19	1	1	hydroquinone	SPG	PA449924	55764	0.477
NULL	Biomed_Res_Int_2014_Jan_29_2014_361020.nxml.txt.nlp	24605326	SENT223	1	1	44	44	staurosporine	CDK1	PA165109623	983	0.477
NULL	Evid_Based_Complement_Alternat_Med_2013_Nov_4_2013_434823.nxml.txt.nlp	24302965	SENT18	10	10	20	20	lamivudine	IFN	PA450163	3439	0.477
NULL	Crit_Care_2010_Jun_18_14(3)_R119.nxml.txt.nlp	20565863	SENT134	25	25	20	20	fentanyl	IL-6	PA449599	3569	0.477
NULL	Pharmaceuticals_(Basel)_2014_Jul_10_7(7)_797-838.nxml.txt.nlp	25014631	SENT246	8	8	3	3	nitrile	AIC	PA450636	192	0.477
NULL	Basic_Clin_Neurosci_2014_Winter_5(1)_74-79.nxml.txt.nlp	25436087	SENT169	7	7	2	2	fluoxetine	AQP4	PA449673	361	0.477
NULL	ISRN_Nutr_2014_Mar_16_2014_280837.nxml.txt.nlp	24967265	SENT167	2	2	6	6	trypsin	HCN	PA451806	378938	0.477
NULL	Korean_J_Anesthesiol_2013_Dec_26_65(6_Suppl)_S1-S3.nxml.txt.nlp	24478828	SENT62	5	5	7	7	atracurium	BCHE	PA164776840	590	0.477
NULL	J_Biomed_Biotechnol_2010_Sep_19_2010_518743.nxml.txt.nlp	20886007	SENT293	30	30	35	35	nadh	CO2	PA164755085	4513	0.477
NULL	Pharmaceuticals_(Basel)_2012_Aug_17_5(8)_837-852.nxml.txt.nlp	24280677	SENT45	17	17	6	6	capsaicin	TRPV1	PA448776	7442	0.477
NULL	Br_J_Cancer_2010_May_11_102(10)_1456-1460.nxml.txt.nlp	20461090	SENT144	3	3	5	5	temsirolimus	IFN	PA164746890	3439	0.477
NULL	Nat_Commun_2014_Sep_4_5_4497.nxml.txt.nlp	25187177	SENT103	12	12	6	6	s-adenosylmethionine	DIMT1	PA164754994	27292	0.477
NULL	Front_Genet_2012_Nov_22_3_249.nxml.txt.nlp	23189085	SENT1190	11	11	2	2	ifosfamide	GSTM1	PA449964	2944	0.477
NULL	Nat_Med_2010_Nov_24_16(11)_1299-1304.nxml.txt.nlp	20972434	SENT60	0	0	10	10	chloroquine	ASM	PA448948	6609;283120	0.477
NULL	Exp_Ther_Med_2014_Nov_29_8(5)_1473-1478.nxml.txt.nlp	25289044	SENT8	10	10	12	12	heparin	AZU	PA449855	566	0.477
NULL	Oncol_Lett_2013_Mar_19_5(3)_923-928.nxml.txt.nlp	23426648	SENT10	14	14	7	7	sc-560	MVD		4597	0.477
NULL	Front_Oncol_2014_Jun_18_4_159.nxml.txt.nlp	24995161	SENT157	5	5	12	12	estradiol	AKR1C3	PA449503	8644	0.477
NULL	Drug_Target_Insights_2006_Oct_23_1_5-10.nxml.txt.nlp	21901053	SENT68	2	2	17	17	heparin	CRT	PA449855	811	0.477
NULL	Gut_2009_Aug_24_58(8)_1091-1103.nxml.txt.nlp	19240062	SENT69	20	20	37	37	ethanol	ZO-1	PA448073	7082	0.477
NULL	J_Cell_Biol_2004_Apr_26_165(2)_243-254.nxml.txt.nlp	15096528	SENT332	33	33	17	17	l-glutamine	F12	PA10090	2161	0.477
NULL	Br_J_Pharmacol_2014_Jun_15_171(11)_2705-2725.nxml.txt.nlp	24467436	SENT15	19	19	8	8	isoniazid	NAT	PA450112	6046	0.477
NULL	Cancer_Med_2013_Aug_29_2(4)_478-487.nxml.txt.nlp	24156020	SENT51	9	9	13	13	fluorescein	YTS	PA164746009	8565	0.477
NULL	J_Korean_Med_Sci_2010_Apr_19_25(4)_557-563.nxml.txt.nlp	20357998	SENT111	0	0	14	14	rosiglitazone	IL-10	PA451283	3586	0.477
NULL	Oncotarget_2013_Dec_28_5(6)_1475-1490.nxml.txt.nlp	24721996	SENT78	4	4	12	12	celecoxib	CD133	PA448871	8842	0.477
NULL	Acta_Neuropathol_Commun_2014_Jul_12_2(1)_82.nxml.txt.nlp	NULL	SENT177	23	23	13	13	trastuzumab	NF2	PA451743	4771	0.477
NULL	Exp_Ther_Med_2013_Nov_13_6(5)_1277-1282.nxml.txt.nlp	24223658	SENT172	2	2	18	18	capsaicin	VR-OAC	PA448776	59341	0.477
NULL	J_Hematol_Oncol_2011_Mar_26_4_11.nxml.txt.nlp	21439076	SENT117	22	22	20	20	camptothecin	Gem	PA153590860	51053	0.477
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT116	0	0	3	3	capsaicin	p53	PA448776	7157	0.477
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT192	43	43	9	9	gefitinib	Yes	PA131301952	7525	0.477
NULL	Int_J_Mol_Sci_2014_Mar_20_15(3)_4946-4964.nxml.txt.nlp	24658439	SENT339	1	1	8	8	rosiglitazone	gamma	PA451283	9913	0.477
NULL	J_Cell_Biol_2008_Jul_28_182(2)_327-340.nxml.txt.nlp	18644889	SENT35	23	23	29	29	estradiol	PI3K	PA449503	5290	0.477
NULL	Arthritis_Res_Ther_2014_May_14_16(3)_R112.nxml.txt.nlp	24886807	SENT75	11	11	6	6	cyclosporine	CO2	PA449167	4513	0.477
NULL	Front_Neurol_2012_Aug_1_3_120.nxml.txt.nlp	23015798	SENT61	4	4	11	11	estradiol	AKT	PA449503	207	0.477
NULL	J_Org_Chem_2011_Aug_19_76(16)_6703-6714.nxml.txt.nlp	21739961	SENT168	34	34	31	31	ethanol	mol	PA448073	90527	0.477
NULL	Exp_Ther_Med_2014_Apr_13_7(4)_843-848.nxml.txt.nlp	24660032	SENT95	13	13	8	8	resveratrol	Bcl-2		596	0.477
NULL	Acta_Pharmacol_Sin_2013_Aug_5_34(8)_998-1006.nxml.txt.nlp	23852086	SENT132	22	22	4	4	mexiletine	DOM	PA450488	6663	0.477
NULL	Cells_2014_May_23_3(2)_517-545.nxml.txt.nlp	24861977	SENT176	6	6	3	3	cisplatin	TRPV1	PA449014	7442	0.477
NULL	Front_Cell_Neurosci_2013_Dec_26_7_277.nxml.txt.nlp	24421756	SENT165	39	39	43	43	forskolin	CNTF	PA146096022	1270	0.477
NULL	Diabetes_2009_Feb_58(2)_344-351.nxml.txt.nlp	19008341	SENT219	4	4	6	6	resveratrol	SIRT1		23411	0.477
NULL	Acta_Pharmacol_Sin_2010_Feb_5_31(2)_184-190.nxml.txt.nlp	20139901	SENT29	34	34	20	20	metformin	OCT2	PA450395	6582;5452	0.477
NULL	Adv_Ther_2013_Jun_29_30(6)_607-622.nxml.txt.nlp	23812875	SENT102	30	30	5	5	glucose	Met	PA449773	79811	0.477
NULL	Eur_J_Immunol_2014_Jun_10_44(6)_1759-1769.nxml.txt.nlp	24595810	SENT45	14	14	2	2	fludrocortisone	CXCR4	PA164743961	7852	0.477
NULL	Ann_Gen_Psychiatry_2010_Apr_22_9(Suppl_1)_S227.nxml.txt.nlp	NULL	SENT6	5	5	28	28	chlordiazepoxide	B12	PA448932	7126;4709	0.477
NULL	Clin_Med_Insights_Circ_Respir_Pulm_Med_2012_Jun_12_6_27-40.nxml.txt.nlp	22745565	SENT52	23	23	30	30	omalizumab	ACT	PA164752253	12;11332;9457;641455	0.477
NULL	Bioinformation_2006_Dec_23_1(8)_314-320.nxml.txt.nlp	17597912	SENT156	12	12	9	9	oseltamivir	ACE	PA450721	1636	0.477
NULL	Surg_Today_2012_Jan_6_42(1)_8-28.nxml.txt.nlp	22139128	SENT182	5	5	38	38	mitomycin	PSK	PA450524	9344	0.477
NULL	FEBS_Open_Bio_2012_Aug_22_2_279-283.nxml.txt.nlp	23650611	SENT343	0	0	6	6	tamoxifen	IFN	PA451581	3439	0.477
NULL	Environ_Health_Perspect_2013_May_22_121(5)_551-557.nxml.txt.nlp	23434795	SENT75	6	6	26	26	paraformaldehyde	San	PA450790	80218	0.477
NULL	Oxid_Med_Cell_Longev_2013_Mar_5_2013_264935.nxml.txt.nlp	23533686	SENT212	3	3	19	19	hemin	TLR4	PA449849	7099	0.477
NULL	Orphanet_J_Rare_Dis_2014_Oct_29_9(1)_162.nxml.txt.nlp	NULL	SENT253	22	22	19	19	fenofibrate	CYP3A4	PA449594	1576	0.477
NULL	ScientificWorldJournal_2013_Sep_21_2013_208309.nxml.txt.nlp	24170980	SENT91	20	20	22	22	lenalidomide	MRP8	PA162363968	6833;6279;85320	0.477
NULL	Behav_Brain_Funct_2014_Jun_16_10_21.nxml.txt.nlp	24934302	SENT149	0	0	16	16	rosiglitazone	IL-6	PA451283	3569	0.477
NULL	Iran_J_Basic_Med_Sci_2012_Jul-Aug_15(4)_937-944.nxml.txt.nlp	23493039	SENT30	13	13	2	2	oxygen	CCL2	PA450744	6347	0.477
NULL	Acta_Pharmacol_Sin_2012_Jan_28_33(1)_66-74.nxml.txt.nlp	22120966	SENT250	24	24	16	16	genistein	RANKL	PA165109660	8600	0.477
NULL	Crit_Care_2011_Nov_16_15(6)_R271.nxml.txt.nlp	22087790	SENT164	2	2	35	35	nitroprusside	Yes	PA451406	7525	0.477
NULL	Arthritis_Res_Ther_2014_Jul_18_16(4)_R153.nxml.txt.nlp	25037855	SENT166	0	0	7	7	adalimumab	CD14	PA10004	929	0.477
NULL	Int_J_Biol_Sci_2013_Aug_14_9(8)_766-777.nxml.txt.nlp	23983610	SENT162	11	11	13	13	curcumin	B19	PA151958596	59271	0.477
NULL	Mol_Neurodegener_2011_Jun_7_6_40.nxml.txt.nlp	21649894	SENT45	9	9	12	12	heparin	N-syndecan	PA449855	9672	0.477
NULL	Neural_Plast_2012_Nov_2_2012_309494.nxml.txt.nlp	22164341	SENT5	8	8	21	21	raloxifene	CA1	PA451221	759	0.477
NULL	Oncotarget_2013_Dec_28_5(6)_1475-1490.nxml.txt.nlp	24721996	SENT238	18	18	14	14	celecoxib	CO2	PA448871	4513	0.477
NULL	Sci_Rep_2015_Jan_6_5_7647.nxml.txt.nlp	25558795	SENT400	0	0	2	2	hyaluronan	CD44	PA165958431	960	0.477
NULL	J_Am_Heart_Assoc_2013_Aug_23_2(4)_e000264.nxml.txt.nlp	23896681	SENT170	12	12	6	6	thrombin	FVIII	PA451674	2157	0.477
NULL	Arthritis_Res_Ther_2006_Jan_16_8(2)_R36.nxml.txt.nlp	16469114	SENT245	5	5	8	8	paraformaldehyde	CCN2	PA450790	1490	0.477
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Dec_2_5_30.nxml.txt.nlp	17140452	SENT194	11	11	5	5	gentamicin	GAT	PA449753	10249	0.477
NULL	Cell_Mol_Life_Sci_2011_May_26_68(10)_1785-1798.nxml.txt.nlp	20976523	SENT220	2	2	13	13	collagenase	AP-1	PA449107	2353;3727;2354;3725	0.477
NULL	Acta_Vet_Scand_2002_Jun_30_43(2)_99-106.nxml.txt.nlp	12173507	SENT79	31	31	9	9	ivermectin	Yes	PA450133	7525	0.477
NULL	Cell_Res_2014_Feb_12_24(2)_143-160.nxml.txt.nlp	24217768	SENT68	16	16	14	14	heparin	FGF2	PA449855	2247;2258	0.477
NULL	Br_J_Clin_Pharmacol_2014_Nov_20_78(5)_981-995.nxml.txt.nlp	24802902	SENT403	26	26	3	3	vigabatrin	gamma	PA10231	9913	0.477
NULL	Diabetes_Care_2011_Oct_15_34(10)_2323-2328.nxml.txt.nlp	21949223	SENT119	3	3	5	5	metformin	LKB1	PA450395	6794	0.477
NULL	Hum_Genomics_2009_Jan_1_3(2)_121-127.nxml.txt.nlp	19164089	SENT78	2	2	12	12	ethanol	ADH1C	PA448073	126	0.477
NULL	Endocrinol_Metab_(Seoul)_2014_Sep_25_29(3)_379-387.nxml.txt.nlp	25309798	SENT113	25	25	27	27	resveratrol	SIRT1		23411	0.477
NULL	F1000_Med_Rep_2009_Nov_26_1_90.nxml.txt.nlp	20948687	SENT13	6	6	8	8	bevacizumab	IFN	PA130232992	3439	0.477
NULL	Curr_Neuropharmacol_2013_May_11(3)_276-297.nxml.txt.nlp	24179464	SENT164	0	0	27	27	isradipine	PS1	PA450131	5663	0.477
NULL	An_Bras_Dermatol_2014_Jan-Feb_89(1)_11-25.nxml.txt.nlp	24626644	SENT206	17	17	22	22	capsaicin	CO2	PA448776	4513	0.477
NULL	Hum_Genomics_2008_Sep_1_3(1)_7-16.nxml.txt.nlp	19129086	SENT176	26	26	29	29	rosiglitazone	SLCO1B1	PA451283	10599	0.477
NULL	Case_Rep_Nephrol_Urol_2014_Apr_12_4(1)_75-81.nxml.txt.nlp	24847349	SENT19	38	38	42	42	amiodarone	APT	PA448383	653639	0.477
NULL	Int_J_Chron_Obstruct_Pulmon_Dis_2007_Jun_2(2)_157-167.nxml.txt.nlp	18044688	SENT105	10	10	3	3	salmeterol	TDI	PA451300	100038246	0.477
NULL	Br_J_Pharmacol_2011_Feb_162(4)_989-999.nxml.txt.nlp	21054342	SENT86	22	22	14	14	phenol	COMT	PA450913	1312	0.477
NULL	J_Biomed_Sci_2014_Feb_3_21(1)_10.nxml.txt.nlp	24490900	SENT95	10	10	12	12	alendronate	RANKL	PA448082	8600	0.477
NULL	Chin_J_Cancer_2012_Feb_31(2)_58-72.nxml.txt.nlp	22098952	SENT112	12	12	30	30	vinblastine	MRP2	PA451877	100130958;57626;1244	0.477
NULL	Clin_Neuropathol_2011_Oct_18_Nov-Dec_30(6)_291-296.nxml.txt.nlp	22011733	SENT48	17	17	21	21	thyroglobulin	CEA	PA164754910	5670;1087	0.477
NULL	Breast_Cancer_Res_2011_Dec_16_13(6)_R131.nxml.txt.nlp	22177475	SENT24	43	43	4	4	trastuzumab	PTEN	PA451743	5728	0.477
NULL	J_Cardiovasc_Thorac_Res_2014_Jun_30_6(2)_79-84.nxml.txt.nlp	25031821	SENT64	6	6	13	13	hydrocortisone	IL-10	PA449905	3586	0.477
NULL	Int_J_Environ_Res_Public_Health_2010_May_27_7(5)_1872-1888.nxml.txt.nlp	20622998	SENT63	39	39	9	9	disulfiram	ALDH2	PA449376	217	0.477
NULL	Biomed_Res_Int_2014_Jan_29_2014_361020.nxml.txt.nlp	24605326	SENT223	1	1	30	30	staurosporine	CDK4	PA165109623	1019	0.477
NULL	Cancer_Cell_Int_2014_Jun_11_14_49.nxml.txt.nlp	24991192	SENT112	13	13	10	10	berberine	AMPK	PA165860812	5563	0.477
NULL	Int_J_Gen_Med_2009_Jul_30_2_91-108.nxml.txt.nlp	20360893	SENT323	2	2	5	5	mitomycin	PDF	PA450524	64146;9518	0.477
NULL	Nat_Commun_2012_Feb_14_3_672.nxml.txt.nlp	22334075	SENT108	2	2	10	10	pioglitazone	HK2	PA450970	3796;3099;29911;3741	0.477
NULL	Biomed_Res_Int_2014_May_4_2014_351252.nxml.txt.nlp	24877084	SENT34	0	0	2	2	bevacizumab	FTM	PA130232992	23322	0.477
NULL	CNS_Drugs_2014_Jul_20_28(11)_1059-1069.nxml.txt.nlp	25038977	SENT2	8	8	16	16	lisdexamfetamine	ATX	PA164748975	5168;23049	0.477
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT154	1	1	18	18	resveratrol	TRAIL		8743	0.477
NULL	Open_Dent_J_2010_Jul_20_4_147-152.nxml.txt.nlp	21339893	SENT99	6	6	9	9	chlorhexidine	Solo	PA164776863	91404	0.476
NULL	Mol_Cancer_2010_May_18_9_110.nxml.txt.nlp	20482802	SENT122	2	2	18	18	bortezomib	CHOP	PA10252	1649	0.476
NULL	J_Gen_Physiol_1956_Jul_20_39(6)_889-892.nxml.txt.nlp	13346042	SENT0	15	15	1	1	l-serine	Gen	PA451330	348654	0.476
NULL	Anc_Sci_Life_2012_Oct-Dec_32(2)_93-98.nxml.txt.nlp	24167334	SENT146	7	7	5	5	cyclophosphamide	AR7	PA449165	7067	0.476
NULL	Drugs_R_D_2010_Nov_25_10(4)_219-224.nxml.txt.nlp	21171668	SENT18	7	7	5	5	clopidogrel	P2Y12	PA449053	64805	0.476
NULL	Curr_Neuropharmacol_2012_Jun_10(2)_97-123.nxml.txt.nlp	23204981	SENT241	10	10	29	29	venlafaxine	IFN	PA451866	3439	0.476
NULL	Front_Neurosci_2014_Dec_5_8_398.nxml.txt.nlp	25538552	SENT179	13	13	10	10	glucose	gamma	PA449773	9913	0.476
NULL	Semin_Immunopathol_2008_Apr_26_30(2)_85-95.nxml.txt.nlp	18299835	SENT186	4	4	7	7	ethanol	CFB	PA448073	629	0.476
NULL	Exp_Ther_Med_2013_Jul_25_6(1)_109-114.nxml.txt.nlp	23935730	SENT115	6	6	8	8	rituximab	CHOP	PA451261	1649	0.476
NULL	Gut_2012_Aug_24_61(8)_1146-1153.nxml.txt.nlp	22115910	SENT108	8	8	6	6	fluorescein	CLE	PA164746009	51637	0.476
NULL	Summit_on_Translat_Bioinforma_2009_Mar_1_2009_124-128.nxml.txt.nlp	21347183	SENT69	7	7	26	26	mercaptopurine	TPMT	PA450379	7172	0.476
NULL	Mol_Cytogenet_2013_Jul_16_6_27.nxml.txt.nlp	23866735	SENT34	9	9	11	11	hydroxyurea	IFN	PA449942	3439	0.476
NULL	Acta_Pharmacol_Sin_2012_May_4_33(5)_710-716.nxml.txt.nlp	22555373	SENT16	25	25	5	5	mexiletine	DOM	PA450488	6663	0.476
NULL	Br_J_Cancer_2011_Apr_12_104(8)_1256-1261.nxml.txt.nlp	21448165	SENT29	25	25	23	23	sorafenib	IL-2	PA7000	3558	0.476
NULL	Drug_Des_Devel_Ther_2014_Sep_23_8_1527-1538.nxml.txt.nlp	25284985	SENT25	8	8	6	6	celecoxib	IFN	PA448871	3439	0.476
NULL	Cancer_Med_2014_Oct_23_3(5)_1146-1158.nxml.txt.nlp	25052069	SENT284	14	14	11	11	gefitinib	HER2	PA131301952	2064	0.476
NULL	Biomed_Res_Int_2014_Jan_29_2014_361020.nxml.txt.nlp	24605326	SENT223	1	1	18	18	staurosporine	CDK2	PA165109623	1017	0.476
NULL	J_Biomed_Biotechnol_2010_Jun_6_2010_571343.nxml.txt.nlp	20625496	SENT183	11	11	26	26	vincristine	ALG-2	PA451879	10016	0.476
NULL	Indian_J_Pharm_Sci_2014_Nov-Dec_76(6)_510-518.nxml.txt.nlp	25593384	SENT44	18	18	15	15	ethanol	mol	PA448073	90527	0.476
NULL	Case_Rep_Obstet_Gynecol_2014_Apr_10_2014_712657.nxml.txt.nlp	24818031	SENT68	7	7	5	5	thyroglobulin	TTF-1	PA164754910	7080	0.476
NULL	Clin_Endocrinol_(Oxf)_2009_Aug_71(2)_171-175.nxml.txt.nlp	19170705	SENT121	11	11	7	7	hydrocortisone	ACTH	PA449905	5443	0.476
NULL	Anal_Bioanal_Chem_2014_Jan_23_406(15)_3667-3680.nxml.txt.nlp	24452745	SENT250	1	1	5	5	ketoprofen	KET	PA450149	8626	0.476
NULL	Breast_Cancer_Res_2014_May_27_16(3)_R52.nxml.txt.nlp	24887554	SENT83	20	20	24	24	hydrocortisone	EGF	PA449905	1950	0.476
NULL	Cancers_(Basel)_2011_May_18_3(2)_2444-2461.nxml.txt.nlp	24212818	SENT150	25	25	31	31	thrombin	CXCL12	PA451674	6387	0.476
NULL	Core_Evid_2011_Mar_17_6_31-42.nxml.txt.nlp	21468241	SENT143	17	17	21	21	clopidogrel	CYP2C19	PA449053	1557	0.476
NULL	Br_J_Pharmacol_2011_Apr_162(8)_1832-1842.nxml.txt.nlp	21232033	SENT271	4	4	12	12	resveratrol	SAP97		1739	0.476
NULL	Cell_Commun_Signal_2014_Jan_30_12_8.nxml.txt.nlp	24479879	SENT60	7	7	14	14	dextran	LRRK2	PA449261	120892	0.476
NULL	Oncoimmunology_2012_Oct_1_1(7)_1004-1016.nxml.txt.nlp	23170249	SENT6	4	4	6	6	paclitaxel	HER-2	PA450761	2064	0.476
NULL	Surg_Today_2014_Jan_23_44(7)_1328-1335.nxml.txt.nlp	24452508	SENT47	21	21	33	33	l-glutamine	CO2	PA10090	4513	0.476
NULL	Oncogene_2014_Jul_24_33(30)_3980-3991.nxml.txt.nlp	24121271	SENT162	30	30	14	14	l-glutamine	EGF	PA10090	1950	0.476
NULL	J_Cancer_2011_Mar_8_2_142-152.nxml.txt.nlp	21475719	SENT41	8	8	17	17	lipase	CEA	PA450239	5670;1087	0.476
NULL	Front_Genet_2014_Aug_27_5_281.nxml.txt.nlp	25221567	SENT592	0	0	3	3	epirubicin	UGT2B7	PA449476	7364	0.476
NULL	Ann_Med_2011_Nov_5_43(7)_531-544.nxml.txt.nlp	21815879	SENT200	19	19	14	14	clopidogrel	ADP	PA449053	23038	0.476
NULL	Bioconjug_Chem_2013_Apr_17_24(4)_712-723.nxml.txt.nlp	23488616	SENT121	0	0	3	3	indomethacin	NIR	PA449982	26155	0.476
NULL	J_Korean_Assoc_Oral_Maxillofac_Surg_2014_Dec_26_40(6)_291-296.nxml.txt.nlp	25551094	SENT121	18	18	14	14	alendronate	M-CSF	PA448082	1435	0.476
NULL	Biochemistry_2008_Nov_4_47(44)_11446-11456.nxml.txt.nlp	18842000	SENT159	9	9	27	27	trypsin	BARD1	PA451806	580	0.476
NULL	Indian_J_Pharmacol_2013_Jan-Feb_45(1)_44-48.nxml.txt.nlp	23543849	SENT91	21	21	8	8	cyclophosphamide	LPO	PA449165	4025	0.476
NULL	Acta_Pharmacol_Sin_2014_Sep_4_35(9)_1188-1198.nxml.txt.nlp	25087997	SENT77	25	25	30	30	choline	TA3	PA448976	134860	0.476
NULL	Chem_Cent_J_2012_Nov_23_6_140.nxml.txt.nlp	23173949	SENT51	21	21	0	0	ethanol	PERC	PA448073	133522	0.476
NULL	Curr_Med_Chem_2013_Jan_20(3)_438-447.nxml.txt.nlp	23157636	SENT453	34	34	12	12	quetiapine	FGA	PA451201	2243	0.476
NULL	Bioinformation_2012_Apr_30_8(8)_369-380.nxml.txt.nlp	22570518	SENT98	25	25	23	23	artemisinin	mol	PA165111696	90527	0.476
NULL	J_Oncol_2011_Jun_12_2011_542358.nxml.txt.nlp	21772843	SENT367	8	8	0	0	gefitinib	EGFR	PA131301952	1956	0.476
NULL	Mol_Cancer_2007_Dec_21_6_81.nxml.txt.nlp	18096084	SENT38	14	14	14	14	pp2	PP2		4888	0.476
NULL	J_Gen_Physiol_1979_May_1_73(5)_605-628.nxml.txt.nlp	222876	SENT0	11	11	1	1	choline	Gen	PA448976	348654	0.476
NULL	Antimicrob_Agents_Chemother_2014_Nov_10_59(1)_490-497.nxml.txt.nlp	25385107	SENT72	8	8	10	10	sulfadiazine	ATV	PA451539	4683	0.476
NULL	J_Cell_Mol_Med_2014_Aug_1_18(8)_1599-1611.nxml.txt.nlp	24889822	SENT205	2	2	7	7	resveratrol	SIRT1		23411	0.476
NULL	Exp_Ther_Med_2014_May_20_7(5)_1354-1358.nxml.txt.nlp	24940438	SENT29	0	0	25	25	fluorescein	CD32	PA164746009	2213;2212	0.476
NULL	Mol_Brain_2013_Dec_16_6_56.nxml.txt.nlp	24330819	SENT210	0	0	18	18	dantrolene	GluN2D	PA449208	2906	0.476
NULL	Apoptosis_2008_May_9_13(5)_681-692.nxml.txt.nlp	18392938	SENT163	3	3	5	5	forskolin	EGF	PA146096022	1950	0.476
NULL	Crit_Care_2011_Nov_16_15(6)_R271.nxml.txt.nlp	22087790	SENT164	2	2	38	38	nitroprusside	Yes	PA451406	7525	0.476
NULL	Environ_Health_Perspect_2005_Sep_13_113(9)_1184-1189.nxml.txt.nlp	16140625	SENT45	13	13	29	29	malathion	CARB	PA164748092	9482	0.476
NULL	Appl_Plant_Sci_2015_Jan_5_3(1)_apps_1400086.nxml.txt.nlp	25606353	SENT62	3	3	12	12	vancomycin	UNK	PA451850	85451	0.476
NULL	EMBO_Mol_Med_2012_Jun_13_4(6)_515-527.nxml.txt.nlp	22416035	SENT236	0	0	2	2	olaparib	PARP-1		25976	0.476
NULL	Oxid_Med_Cell_Longev_2013_Sep_15_2013_419092.nxml.txt.nlp	24163719	SENT122	1	1	10	10	resveratrol	SOD2		6648	0.476
NULL	Drugs_Aging_2012_Dec_23_29(5)_e1-e12.nxml.txt.nlp	22530704	SENT84	11	11	7	7	exenatide	GLP-1	PA164749238	100125288	0.476
NULL	Arch_Med_Sci_2011_Dec_31_7(6)_1055-1066.nxml.txt.nlp	22328891	SENT16	15	15	9	9	ezetimibe	SHARP	PA10816	23013	0.476
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT192	41	41	37	37	erlotinib	Yes	PA134687924	7525	0.476
NULL	Springerplus_2015_Jan_23_4_29.nxml.txt.nlp	25628986	SENT25	10	10	23	23	dapsone	G6PD	PA449211	2539	0.476
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT6	14	14	16	16	erlotinib	CYP3A	PA134687924	1574	0.476
NULL	Indian_J_Endocrinol_Metab_2012_Dec_16(Suppl_2)_S498-S500.nxml.txt.nlp	23565478	SENT16	13	13	17	17	rosuvastatin	Q10	PA134308647	27161	0.476
NULL	Front_Neurol_2014_Sep_11_5_173.nxml.txt.nlp	25309501	SENT310	5	5	7	7	hyaluronan	CD44	PA165958431	960	0.476
NULL	Int_J_Nephrol_2011_Apr_26_2011_245823.nxml.txt.nlp	21603155	SENT132	4	4	6	6	telaprevir	IFN	PA165958354	3439	0.476
NULL	Infect_Dis_Obstet_Gynecol_2007_Jun_26_2007_46581.nxml.txt.nlp	17710240	SENT44	39	39	13	13	erythromycin	CO2	PA449493	4513	0.476
NULL	Aging_(Albany_NY)_2009_May_22_1(6)_557-572.nxml.txt.nlp	20195383	SENT216	0	0	3	3	creatine	ADP	PA164778930	23038	0.476
NULL	Cardiovasc_Diabetol_2013_Nov_21_12_172.nxml.txt.nlp	24261558	SENT278	4	4	6	6	eplerenone	adiponectin	PA164749044	9370	0.476
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Nov_27_66(Pt_12)_o3331-o3332.nxml.txt.nlp	21589606	SENT5	1	1	30	30	phenol	mol	PA450913	90527	0.476
NULL	Cardiovasc_Diabetol_2005_May_15_4_6.nxml.txt.nlp	15892894	SENT89	0	0	6	6	telmisartan	DBP	PA451605	3295;1628;2638	0.476
NULL	Clin_Ophthalmol_2013_Dec_21_7_7-14.nxml.txt.nlp	23293509	SENT86	15	15	0	0	tafluprost	Erb	PA165958432	2100	0.476
NULL	J_Headache_Pain_2014_Feb_8_15(1)_7.nxml.txt.nlp	24506953	SENT12	0	0	3	3	capsaicin	TRPV1	PA448776	7442	0.476
NULL	Environ_Health_Perspect_2005_Apr_14_113(4)_431-439.nxml.txt.nlp	15811834	SENT48	2	2	8	8	nifedipine	San	PA450631	80218	0.476
NULL	Eur_J_Clin_Pharmacol_2014_Mar_22_70(6)_685-693.nxml.txt.nlp	24658827	SENT117	0	0	27	27	tacrolimus	PPARA	PA451578	5465	0.476
NULL	Case_Rep_Med_2010_Jun_7_2010_495281.nxml.txt.nlp	20593036	SENT61	18	18	14	14	thyroglobulin	CK19	PA164754910	3880	0.476
NULL	Br_J_Clin_Pharmacol_2013_Aug_23_76(2)_299-315.nxml.txt.nlp	23701319	SENT208	30	30	20	20	rituximab	CRA	PA451261	51747;10903	0.476
NULL	Biol_Proced_Online_2004_Mar_19_6_16-22.nxml.txt.nlp	15103396	SENT76	13	13	17	17	trypsin	HAND1	PA451806	9421	0.476
NULL	Cancer_Microenviron_2010_Jun_22_4(1)_39-50.nxml.txt.nlp	21505561	SENT44	10	10	42	42	l-glutamine	CO2	PA10090	4513	0.476
NULL	Biomed_Res_Int_2013_Jul_15_2013_458571.nxml.txt.nlp	23956983	SENT287	9	9	5	5	l-serine	SHMT	PA451330	6470	0.476
NULL	FEBS_Open_Bio_2011_Dec_27_2_1-5.nxml.txt.nlp	23650573	SENT288	0	0	6	6	sunitinib	MDM2	PA162372840	4193	0.476
NULL	Front_Endocrinol_(Lausanne)_2013_Jun_26_4_75.nxml.txt.nlp	23805127	SENT66	18	18	30	30	gemfibrozil	UGT2B15	PA449750	7366	0.476
NULL	J_Med_Case_Rep_2013_Jul_26_7_200.nxml.txt.nlp	23889916	SENT76	11	11	13	13	thyroglobulin	TTF-1	PA164754910	7080	0.476
NULL	J_Ginseng_Res_2011_Nov_35(4)_436-441.nxml.txt.nlp	23717089	SENT139	0	0	19	19	caffeine	CAGC	PA448710	6283	0.476
NULL	Environ_Health_Perspect_2012_Apr_3_120(4)_583-589.nxml.txt.nlp	22476201	SENT185	16	16	12	12	oxygen	NRF2	PA450744	2551;4780	0.476
NULL	Mol_Biol_Cell_2012_Jun_15_23(12)_2302-2318.nxml.txt.nlp	22553350	SENT343	27	27	22	22	doxycycline	Rab11-FIP2	PA449415	22841	0.476
NULL	Clinicoecon_Outcomes_Res_2014_Oct_17_6_451-461.nxml.txt.nlp	25378939	SENT6	16	16	21	21	linezolid	HAP	PA450233	5915;10313	0.476
NULL	Oncol_Lett_2013_Sep_12_6(3)_860-864.nxml.txt.nlp	24137426	SENT98	28	28	26	26	ketoconazole	CYP1A2	PA450146	1544	0.476
NULL	Front_Neurosci_2011_Oct_10_5_109.nxml.txt.nlp	22013406	SENT1072	9	9	4	4	methylphenidate	DRD4	PA450464	1815	0.476
NULL	Front_Genet_2014_Aug_26_5_285.nxml.txt.nlp	25206361	SENT495	1	1	23	23	choline	POMC	PA448976	5443	0.476
NULL	Biochem_Res_Int_2012_May_22_2012_213403.nxml.txt.nlp	22675634	SENT256	6	6	9	9	creatine	PKG	PA164778930	5592	0.476
NULL	Korean_Circ_J_2013_Oct_30_43(10)_699-701.nxml.txt.nlp	24255655	SENT35	6	6	10	10	amiodarone	APT	PA448383	653639	0.476
NULL	Arthritis_Res_Ther_2009_Aug_24_11(4)_R127.nxml.txt.nlp	19703304	SENT119	21	21	16	16	adalimumab	OASIS	PA10004	90993	0.476
NULL	Clin_Pharmacokinet_2014_Sep_3_53(1)_1-16.nxml.txt.nlp	23999929	SENT279	21	21	8	8	rivaroxaban	P-gp	PA165958360	5243	0.476
NULL	J_Korean_Med_Sci_2010_Feb_19_25(2)_304-308.nxml.txt.nlp	20119588	SENT34	25	25	27	27	ethambutol	EMB	PA164784021	133418	0.476
NULL	Oxid_Med_Cell_Longev_2012_May_15_2012_890826.nxml.txt.nlp	22666522	SENT50	39	39	34	34	nadh	AST	PA164755085	26503	0.476
NULL	Int_J_Nanomedicine_2007_Jun_2(2)_241-252.nxml.txt.nlp	17722552	SENT146	31	31	27	27	dextran	HEMA	PA449261	2157	0.476
NULL	J_Cancer_Res_Clin_Oncol_2012_Sep_3_138(9)_1569-1577.nxml.txt.nlp	22552718	SENT156	24	24	11	11	letrozole	aromatase	PA450196	1588	0.476
NULL	Int_J_Biol_Sci_2014_Sep_6_10(9)_990-996.nxml.txt.nlp	25210497	SENT173	15	15	31	31	heparin	TRPV1	PA449855	7442	0.476
NULL	EMBO_Mol_Med_2012_Jun_13_4(6)_515-527.nxml.txt.nlp	22416035	SENT90	12	12	34	34	olaparib	p53		7157	0.476
NULL	Ann_Pediatr_Cardiol_2009_Jan-Jun_2(1)_65-73.nxml.txt.nlp	20300273	SENT130	3	3	0	0	vasopressin	AVP	PA451858	114548;551	0.476
NULL	Crit_Care_2009_Jun_22_13(3)_157.nxml.txt.nlp	19591641	SENT61	9	9	6	6	mannitol	HSL	PA450320	3991	0.476
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_5_2014_362573.nxml.txt.nlp	25431608	SENT158	7	7	31	31	creatine	AQP2	PA164778930	359	0.476
NULL	Mol_Cancer_2012_Apr_26_11_26.nxml.txt.nlp	22537224	SENT126	0	0	13	13	geldanamycin	FANCF	PA152031327	2188	0.476
NULL	Ann_Hematol_2014_Sep_12_93(1)_13-32.nxml.txt.nlp	24026426	SENT274	11	11	31	31	posaconazole	BII	PA151958574	777	0.476
NULL	Curr_Oncol_2008_Oct_15(5)_237-243.nxml.txt.nlp	19008999	SENT165	0	0	18	18	resveratrol	Yes		7525	0.476
NULL	Int_J_Fertil_Steril_2014_Mar_9_Apr-Jun_8(1)_13-20.nxml.txt.nlp	24696765	SENT48	15	15	17	17	diethylstilbestrol	DES	PA449307	1674	0.476
NULL	Arch_Microbiol_2013_Jun_10_195(6)_439-445.nxml.txt.nlp	23661196	SENT66	23	23	32	32	ethanol	CO2	PA448073	4513	0.476
NULL	Biol_Open_2013_Sep_17_2(11)_1192-1202.nxml.txt.nlp	24244856	SENT410	17	17	34	34	paraformaldehyde	hole	PA450790	80757	0.476
NULL	ScientificWorldJournal_2014_Jan_29_2014_265953.nxml.txt.nlp	24688374	SENT160	10	10	14	14	resveratrol	CMC1		152100	0.476
NULL	Exp_Ther_Med_2014_Oct_17_8(4)_1164-1166.nxml.txt.nlp	25187816	SENT63	0	0	3	3	filgrastim	IL-11	PA449626	3589	0.476
NULL	J_Korean_Med_Sci_2013_Feb_29_28(2)_308-314.nxml.txt.nlp	23399960	SENT92	2	2	32	32	gabapentin	IL-6	PA449720	3569	0.476
NULL	Behav_Neurol_2014_Nov_16_2014_360978.nxml.txt.nlp	25477708	SENT486	1	1	13	13	nicotine	P28	PA450626	9446;7802;9527	0.476
NULL	Oncotarget_2014_Nov_6_5(22)_11038-11053.nxml.txt.nlp	25402820	SENT286	25	25	3	3	gemcitabine	RRM2	PA449748	6241	0.476
NULL	Biosci_Rep_2012_Dec_13_33(1)_e00007.nxml.txt.nlp	23095119	SENT215	13	13	6	6	lipase	NEFA	PA450239	4925	0.476
NULL	Biomed_Res_Int_2014_Jan_29_2014_361020.nxml.txt.nlp	24605326	SENT223	1	1	42	42	staurosporine	CDK5	PA165109623	1020	0.475
NULL	Asian-Australas_J_Anim_Sci_2012_Apr_25(4)_471-478.nxml.txt.nlp	25049587	SENT37	31	31	35	35	pp2	PP4		5531	0.475
NULL	Mol_Syst_Biol_2009_Jul_28_5_288.nxml.txt.nlp	19638969	SENT172	2	2	9	9	resveratrol	HuR		1994	0.475
NULL	Clin_Pract_Epidemiol_Ment_Health_2005_Jul_29_1_11.nxml.txt.nlp	16053528	SENT104	2	2	0	0	chlorpromazine	CPZ	PA448964	8532	0.475
NULL	Drug_Healthc_Patient_Saf_2013_Mar_8_5_49-55.nxml.txt.nlp	23526112	SENT75	6	6	11	11	tiotropium	DPI	PA164769056	1832	0.475
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Feb_26_67(Pt_3)_m372-m373.nxml.txt.nlp	21522295	SENT69	33	33	30	30	ethanol	mol	PA448073	90527	0.475
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_May_29_65(Pt_6)_o1409.nxml.txt.nlp	21583252	SENT5	16	16	28	28	curcumin	mol	PA151958596	90527	0.475
NULL	Front_Psychiatry_2014_Mar_6_5_20.nxml.txt.nlp	24639656	SENT536	26	26	1	1	methamphetamine	Gen	PA450403	348654	0.475
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_9_2013_358673.nxml.txt.nlp	23840254	SENT32	11	11	15	15	metformin	GLP-1	PA450395	100125288	0.475
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT159	22	22	14	14	capsaicin	p53	PA448776	7157	0.475
NULL	Br_J_Haematol_2014_Feb_16_164(4)_586-596.nxml.txt.nlp	24236640	SENT171	15	15	17	17	carboplatin	EPO	PA448803	7076;8288;2056	0.475
NULL	Int_J_Gen_Med_2012_Jun_8_5_505-509.nxml.txt.nlp	22807637	SENT0	17	17	5	5	azithromycin	Gen	PA448519	348654	0.475
NULL	Neural_Regen_Res_2014_Mar_1_9(5)_540-548.nxml.txt.nlp	25206852	SENT37	24	24	22	22	choline	HSP27	PA448976	3315	0.475
NULL	Cancer_Causes_Control_2012_Oct_21_23(10)_1739-1744.nxml.txt.nlp	22907422	SENT117	11	11	6	6	sulindac	CRA	PA451565	51747;10903	0.475
NULL	AIDS_Res_Ther_2013_Dec_13_10_32.nxml.txt.nlp	24330597	SENT64	27	27	45	45	urokinase	IL-6	PA451836	3569	0.475
NULL	Surg_Today_2012_Jan_6_42(1)_8-28.nxml.txt.nlp	22139128	SENT182	5	5	29	29	mitomycin	PSK	PA450524	9344	0.475
NULL	Arthritis_Res_Ther_2003_Aug_1_5(5)_R301-R309.nxml.txt.nlp	12932294	SENT43	25	25	2	2	collagenase	F12	PA449107	2161	0.475
NULL	Int_J_Gen_Med_2009_Jul_30_2_129-140.nxml.txt.nlp	20360896	SENT270	0	0	11	11	tamoxifen	BRCA1	PA451581	672	0.475
NULL	Front_Neurol_2014_Dec_8_5_259.nxml.txt.nlp	25538678	SENT834	11	11	2	2	pilocarpine	c-fos	PA450962	2353	0.475
NULL	Mol_Cancer_2006_Sep_5_5_34.nxml.txt.nlp	16953886	SENT39	20	20	18	18	doxorubicin	TRAIL	PA449412	8743	0.475
NULL	Case_Rep_Hematol_2013_Sep_5_2013_708489.nxml.txt.nlp	24083040	SENT76	12	12	10	10	iron	B12	PA450087	7126;4709	0.475
NULL	Am_J_Pathol_2011_Dec_179(6)_2709-2719.nxml.txt.nlp	21983634	SENT344	21	21	23	23	capsaicin	TRPV1	PA448776	7442	0.475
NULL	J_Hematol_Oncol_2008_Aug_11_1_11.nxml.txt.nlp	18694493	SENT132	31	31	26	26	bevacizumab	IFN	PA130232992	3439	0.475
NULL	Diabetes_Care_2009_Nov_32(Suppl_2)_S217-S222.nxml.txt.nlp	19875555	SENT57	15	15	38	38	metformin	GLP-1	PA450395	100125288	0.475
NULL	Oxid_Med_Cell_Longev_2013_Sep_24_2013_102741.nxml.txt.nlp	24205431	SENT136	0	0	13	13	hesperidin	Bcl-2	PA449867	596	0.475
NULL	Diabetes_Metab_Syndr_Obes_2014_Jul_17_7_313-319.nxml.txt.nlp	25092992	SENT17	16	16	11	11	glimepiride	adiponectin	PA449761	9370	0.475
NULL	Evid_Based_Complement_Alternat_Med_2011_Feb_14_2011_248231.nxml.txt.nlp	19233878	SENT203	28	28	30	30	rosiglitazone	DBT	PA451283	1629	0.475
NULL	J_Biol_Inorg_Chem_2007_Jun_23_12(5)_645-654.nxml.txt.nlp	17318599	SENT117	38	38	19	19	dextromethorphan	CYP2D6	PA449273	1565	0.475
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_27_2013_584604.nxml.txt.nlp	23935669	SENT65	7	7	22	22	fluorescein	San	PA164746009	80218	0.475
NULL	Diabetes_Care_2008_Aug_31(8)_1635-1638.nxml.txt.nlp	18458144	SENT28	19	19	22	22	rosiglitazone	DREAM	PA451283	30818	0.475
NULL	Pharmaceuticals_(Basel)_2012_Jun_4_5(6)_553-590.nxml.txt.nlp	24281662	SENT2657	4	4	7	7	doxycycline	GDNF	PA449415	2668	0.475
NULL	Drug_Des_Devel_Ther_2014_Sep_23_8_1527-1538.nxml.txt.nlp	25284985	SENT98	5	5	3	3	celecoxib	IFN	PA448871	3439	0.475
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Dec_2_5_30.nxml.txt.nlp	17140452	SENT187	11	11	5	5	gentamicin	GAT	PA449753	10249	0.475
NULL	Curr_Neuropharmacol_2014_Mar_12(2)_186-192.nxml.txt.nlp	24669211	SENT33	40	40	35	35	l-methionine	Met	PA450423	79811	0.475
NULL	Diabetes_2008_Sep_57(9)_2332-2340.nxml.txt.nlp	18567824	SENT44	13	13	16	16	atropine	ghrelin	PA448505	51738	0.475
NULL	Cancers_(Basel)_2010_Dec_30_3(1)_106-125.nxml.txt.nlp	24212609	SENT26	35	35	29	29	gemcitabine	DCK	PA449748	1633	0.475
NULL	BMJ_Open_Respir_Res_2014_Dec_11_1(1)_e000061.nxml.txt.nlp	25553247	SENT42	18	18	13	13	pemetrexed	B12	PA10810	7126;4709	0.475
NULL	Evid_Based_Complement_Alternat_Med_2012_Sep_18_2012_674101.nxml.txt.nlp	23028394	SENT218	2	2	26	26	donepezil	CA1	PA449394	759	0.475
NULL	Ann_Maxillofac_Surg_2012_Jan-Jun_2(1)_90-93.nxml.txt.nlp	23483721	SENT62	32	32	0	0	cyclophosphamide	CHOP	PA449165	1649	0.475
NULL	Proteome_Sci_2008_May_22_6_14.nxml.txt.nlp	18498662	SENT116	14	14	17	17	creatine	spatial	PA164778930	219793	0.475
NULL	Arthritis_Res_Ther_2011_Jul_30_13(4)_R126.nxml.txt.nlp	21801431	SENT33	9	9	22	22	etanercept	IL-23	PA449515	51561	0.475
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Aug_1_70(Pt_9)_o959.nxml.txt.nlp	25309279	SENT9	19	19	21	21	nitrile	mol	PA450636	90527	0.475
NULL	Diabetes_Care_2009_Feb_32(2)_295-300.nxml.txt.nlp	19017774	SENT162	33	33	0	0	aspirin	JAMA	PA448497	50848	0.475
NULL	Exp_Ther_Med_2013_Mar_21_5(3)_987-991.nxml.txt.nlp	23407636	SENT71	22	22	26	26	telmisartan	CXCR2	PA451605	3579	0.475
NULL	Open_Virol_J_2013_Feb_25_7_28-36.nxml.txt.nlp	23493233	SENT89	29	29	33	33	l-glutamine	IL-2	PA10090	3558	0.475
NULL	Gut_Liver_2011_Jun_24_5(2)_117-132.nxml.txt.nlp	21814590	SENT174	12	12	10	10	ribavirin	IFN	PA451241	3439	0.475
NULL	Arthritis_Res_Ther_2004_Mar_8_6(3)_R199-R207.nxml.txt.nlp	15142265	SENT26	2	2	19	19	collagenase	MMP1	PA449107	4312	0.475
NULL	Exp_Mol_Med_2012_Aug_31_44(8)_473-482.nxml.txt.nlp	22627808	SENT117	2	2	7	7	lapatinib	HER3	PA152241907	2065	0.475
NULL	Int_J_Mol_Sci_2014_Mar_5_15(3)_3970-3988.nxml.txt.nlp	24603537	SENT516	5	5	3	3	curcumin	MCH	PA151958596	5367	0.475
NULL	Ann_Rheum_Dis_2009_Jul_4_68(7)_1220-1227.nxml.txt.nlp	18772191	SENT186	8	8	35	35	abatacept	IFN	PA164747080	3439	0.475
NULL	Nat_Commun_2013_Oct_25_4_2667.nxml.txt.nlp	24157709	SENT673	23	23	20	20	nutlin-3	mol		90527	0.475
NULL	Comput_Struct_Biotechnol_J_2013_Apr_5_5_e201302012.nxml.txt.nlp	24688705	SENT93	13	13	8	8	glucosamine	FA-1	PA164747613	4809	0.475
NULL	Chem_Cent_J_2012_Feb_21_6_15.nxml.txt.nlp	22353684	SENT104	15	15	13	13	acebutolol	mol	PA448011	90527	0.475
NULL	Front_Neurosci_2014_Jul_1_8_168.nxml.txt.nlp	25018691	SENT624	5	5	18	18	ketamine	gamma	PA450144	9913	0.475
NULL	Exp_Diabetes_Res_2012_Sep_20_2012_936518.nxml.txt.nlp	23049542	SENT131	6	6	13	13	glucose	HCD	PA449773	1732	0.475
NULL	Case_Rep_Endocrinol_2013_Sep_8_2013_415810.nxml.txt.nlp	24083038	SENT65	10	10	17	17	repaglinide	CYP2C8	PA451234	1558	0.475
NULL	Ann_Oncol_2010_Sep_11_21(9)_1804-1809.nxml.txt.nlp	20150572	SENT144	13	13	45	45	bevacizumab	LBA1	PA130232992	9881	0.475
NULL	Front_Oncol_2014_Apr_9_4_75.nxml.txt.nlp	24782986	SENT240	22	22	4	4	paclitaxel	Oct4	PA450761	5460	0.475
NULL	Cell_Commun_Signal_2013_Jan_11_11_2.nxml.txt.nlp	23305203	SENT137	1	1	4	4	forskolin	TIMAP	PA146096022	26051	0.475
NULL	Clinics_(Sao_Paulo)_2010_Dec_65(12)_1311-1314.nxml.txt.nlp	21340220	SENT49	22	22	16	16	tadalafil	mol	PA10333	90527	0.475
NULL	EJC_Suppl_2013_Sep_5_11(2)_3-22.nxml.txt.nlp	NULL	SENT894	25	25	13	13	fluorouracil	HER2	PA128406956	2064	0.475
NULL	Front_Oncol_2013_Sep_4_3_212.nxml.txt.nlp	24027671	SENT78	18	18	22	22	rituximab	PRIMA	PA451261	145270	0.475
NULL	Diabetes_Obes_Metab_2011_Nov_13(11)_982-989.nxml.txt.nlp	21615670	SENT157	20	20	12	12	sitagliptin	PPG	PA164748978	5552	0.475
NULL	J_Hum_Reprod_Sci_2008_Jul-Dec_1(2)_86-89.nxml.txt.nlp	19562053	SENT2	37	37	30	30	estradiol	IVF	PA449503	6331	0.475
NULL	Br_J_Cancer_2012_Feb_28_106(5)_858-866.nxml.txt.nlp	22343622	SENT122	22	22	4	4	docetaxel	PD2	PA449383	54623	0.475
NULL	Ann_Maxillofac_Surg_2012_Jan-Jun_2(1)_90-93.nxml.txt.nlp	23483721	SENT62	6	6	0	0	vincristine	CHOP	PA451879	1649	0.475
NULL	Int_J_Mol_Sci_2014_May_7_15(5)_8004-8023.nxml.txt.nlp	24810691	SENT496	19	19	13	13	betaine	BHMT	PA448603	635	0.475
NULL	Front_Aging_Neurosci_2009_Dec_9_1_4.nxml.txt.nlp	20552055	SENT214	3	3	5	5	resveratrol	SIRT1		23411	0.475
NULL	Environ_Health_Perspect_2010_Jun_25_118(6)_864-870.nxml.txt.nlp	20100676	SENT208	3	3	8	8	arsenite	INS-1	PA452638	2305	0.475
NULL	Clin_Ophthalmol_2012_Oct_30_6_1749-1753.nxml.txt.nlp	23152652	SENT58	10	10	27	27	latanoprost	ANOVA	PA164774763	4858	0.475
NULL	Indian_J_Anaesth_2014_Jul-Aug_58(4)_423-429.nxml.txt.nlp	25197110	SENT8	20	20	24	24	ondansetron	ODF4	PA450705	146852	0.475
NULL	Clin_Mol_Hepatol_2013_Sep_30_19(3)_195-209.nxml.txt.nlp	24133659	SENT296	14	14	29	29	entecavir	LAM	PA164784025	7249;7248	0.475
NULL	Clin_Ophthalmol_2012_Jul_13_6_1073-1082.nxml.txt.nlp	22888205	SENT6	31	31	15	15	ranibizumab	ERG	PA164746012	2078	0.475
NULL	J_Headache_Pain_2012_Mar_14_13(2)_159-166.nxml.txt.nlp	22246026	SENT146	9	9	7	7	sumatriptan	ANOVA	PA451566	4858	0.475
NULL	J_Vis_Exp_2011_Jun_24_(52)_3094.nxml.txt.nlp	21730945	SENT111	39	39	41	41	kanamycin	EMB	PA450137	133418	0.475
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT294	2	2	13	13	resveratrol	PC-3		692094	0.475
NULL	Breast_Cancer_Res_2012_Feb_14_14(1)_R30.nxml.txt.nlp	22333315	SENT162	4	4	10	10	celecoxib	CXCL9	PA448871	4283	0.475
NULL	Mol_Cancer_2010_Dec_20_9_316.nxml.txt.nlp	21172016	SENT163	7	7	42	42	heparin	CCL21	PA449855	6366	0.475
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT3159	9	9	12	12	diclofenac	CYP2C8	PA449293	1558	0.475
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT289	14	14	10	10	trypsin	FGF1	PA451806	2246	0.475
NULL	Front_Behav_Neurosci_2014_Oct_6_8_343.nxml.txt.nlp	25339876	SENT156	15	15	7	7	ketamine	B12	PA450144	7126;4709	0.475
NULL	Europace_2014_Aug_19_16(8)_1145-1153.nxml.txt.nlp	24843051	SENT182	39	39	20	20	heparin	ACT	PA449855	12;11332;9457;641455	0.475
NULL	J_Young_Pharm_2010_Apr-Jun_2(2)_183-189.nxml.txt.nlp	21264123	SENT187	23	23	25	25	valsartan	API	PA451848	5345	0.475
NULL	J_R_Soc_Interface_2008_Aug_6_5(25)_855-863.nxml.txt.nlp	18077244	SENT181	6	6	8	8	potassium	TREK-1	PA451047	3776	0.475
NULL	Nanoscale_Res_Lett_2008_Dec_16_4(3)_234-239.nxml.txt.nlp	20596368	SENT39	29	29	13	13	ethanol	TEM	PA448073	64102	0.475
NULL	Arthritis_Res_Ther_2009_Oct_14_11(5)_245.nxml.txt.nlp	19849817	SENT189	19	19	6	6	abatacept	CD28	PA164747080	1493;940	0.475
NULL	Arthritis_Res_Ther_2010_Mar_19_12(2)_R48.nxml.txt.nlp	20302641	SENT303	8	8	0	0	trypsin	KBL	PA451806	23464	0.475
NULL	J_Hematol_Oncol_2011_Mar_26_4_11.nxml.txt.nlp	21439076	SENT138	8	8	25	25	cetuximab	DDP	PA10040	1678	0.475
NULL	Cell_Res_2014_Jun_18_24(6)_665-679.nxml.txt.nlp	24638034	SENT162	27	27	5	5	heparin	E12	PA449855	64100	0.475
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Nov_17_68(Pt_12)_o3380.nxml.txt.nlp	23476212	SENT5	5	5	11	11	ethanol	mol	PA448073	90527	0.475
NULL	Oncol_Lett_2014_Jun_28_7(6)_2142-2148.nxml.txt.nlp	24932304	SENT153	7	7	17	17	pravastatin	PC-3	PA451089	692094	0.475
NULL	Br_J_Cancer_2010_Sep_7_103(6)_796-801.nxml.txt.nlp	20823888	SENT172	34	34	38	38	sirolimus	D29	PA451365	55520	0.475
NULL	Avicenna_J_Med_Biotechnol_2011_Apr-Jun_3(2)_87-93.nxml.txt.nlp	23408139	SENT163	12	12	8	8	ethanol	TMT	PA448073	25823	0.475
NULL	Front_Neural_Circuits_2013_Oct_11_7_152.nxml.txt.nlp	24130517	SENT140	23	23	35	35	tetracycline	MSN	PA451640	4478	0.475
NULL	Amino_Acids_2011_May_30_40(5)_1271-1296.nxml.txt.nlp	21448658	SENT199	18	18	21	21	oxygen	ROS	PA450744	6098	0.475
NULL	Ann_Rheum_Dis_2010_Dec_27_70(5)_755-759.nxml.txt.nlp	21187298	SENT38	30	30	23	23	tocilizumab	ACR	PA165292659	49	0.475
NULL	Breast_Cancer_Res_2010_Jun_22_12(3)_R39.nxml.txt.nlp	20569502	SENT236	14	14	11	11	tamoxifen	IGFBP5	PA451581	3488	0.475
NULL	Adv_Hematol_2012_Jul_1_2012_159807.nxml.txt.nlp	22811714	SENT242	24	24	13	13	l-arginine	ARG	PA448478	473;27	0.475
NULL	Oncoimmunology_2012_Oct_1_1(7)_1004-1016.nxml.txt.nlp	23170249	SENT70	4	4	6	6	paclitaxel	HER-2	PA450761	2064	0.475
NULL	Oncotarget_2014_Feb_25_5(5)_1304-1314.nxml.txt.nlp	24675421	SENT52	4	4	6	6	cisplatin	RIP1	PA449014	10928;7386	0.475
NULL	Cerebrovasc_Dis_Extra_2013_Jun_11_3(1)_85-94.nxml.txt.nlp	23885261	SENT143	27	27	12	12	alteplase	OCSP	PA164776730	83882	0.475
NULL	Ann_Surg_Oncol_2007_Dec_25_14(12)_3283-3284.nxml.txt.nlp	17899294	SENT45	0	0	6	6	tamoxifen	BRCA1	PA451581	672	0.475
NULL	Br_J_Cancer_2003_Mar_10_88(5)_754-759.nxml.txt.nlp	12618886	SENT17	8	8	14	14	amifostine	p53	PA448365	7157	0.475
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT80	22	22	6	6	celecoxib	IL-6	PA448871	3569	0.475
NULL	J_Neurodev_Disord_2014_Jul_30_6(1)_31.nxml.txt.nlp	25642984	SENT143	6	6	17	17	memantine	ERP	PA10364	2004	0.475
NULL	Indian_J_Psychiatry_2010_Jan_52(Suppl1)_S317-S340.nxml.txt.nlp	21836703	SENT118	17	17	13	13	thiothixene	TFP	PA451669	7034	0.475
NULL	Alcohol_Res_2013_35(1)_97-113.nxml.txt.nlp	24313169	SENT55	0	0	9	9	ethanol	p300	PA448073	2033	0.474
NULL	Sensors_(Basel)_2013_Mar_28_13(4)_4289-4302.nxml.txt.nlp	23539032	SENT96	7	7	4	4	tetracycline	TRPV1	PA451640	7442	0.474
NULL	Cell_Commun_Signal_2013_Oct_1_11_73.nxml.txt.nlp	24083678	SENT147	25	25	21	21	sulindac	c-Jun	PA451565	3725	0.474
NULL	ScientificWorldJournal_2013_Dec_24_2013_958724.nxml.txt.nlp	24453930	SENT104	9	9	16	16	bevacizumab	CRT	PA130232992	811	0.474
NULL	Pharmaceutics_2011_Jul_13_3(3)_425-439.nxml.txt.nlp	24310588	SENT364	23	23	0	0	hydrocodone	SERS	PA449900	6301;54938	0.474
NULL	Arthritis_Res_Ther_2012_Sep_20_14(5)_R199.nxml.txt.nlp	22995428	SENT95	13	13	6	6	collagenase	GM-CSF	PA449107	1437	0.474
NULL	Curr_Oncol_2008_Oct_15(5)_229-233.nxml.txt.nlp	19008997	SENT136	6	6	22	22	chlorambucil	Yes	PA448926	7525	0.474
NULL	Curr_Med_Chem_2013_Jan_20(3)_438-447.nxml.txt.nlp	23157636	SENT453	34	34	6	6	quetiapine	FGA	PA451201	2243	0.474
NULL	Cancer_Res_Treat_2014_Apr_22_46(2)_158-164.nxml.txt.nlp	24851107	SENT27	4	4	24	24	capecitabine	CRT	PA448771	811	0.474
NULL	Biomed_Res_Int_2014_Apr_10_2014_615363.nxml.txt.nlp	24818147	SENT155	23	23	16	16	ethanol	Xin	PA448073	165904	0.474
NULL	Biochem_Res_Int_2012_Feb_12_2012_346972.nxml.txt.nlp	22400115	SENT237	20	20	13	13	hyaluronan	CXCR5	PA165958431	643	0.474
NULL	J_Cancer_2013_Nov_21_4(9)_727-735.nxml.txt.nlp	24312143	SENT117	17	17	19	19	cisplatin	DDP	PA449014	1678	0.474
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S161-S165.nxml.txt.nlp	21525449	SENT139	27	27	0	0	glucose	JAMA	PA449773	50848	0.474
NULL	Int_J_Nanomedicine_2012_Sep_21_7_5079-5090.nxml.txt.nlp	23049255	SENT99	18	18	25	25	doxorubicin	mol	PA449412	90527	0.474
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Oct_11_70(Pt_11)_319-321.nxml.txt.nlp	25484733	SENT34	1	1	6	6	coumarin	mol	PA134521193	90527	0.474
NULL	Environ_Health_Perspect_2004_Nov_28_112(15)_1512-1518.nxml.txt.nlp	15531436	SENT217	31	31	16	16	coumarin	CYP2A6	PA134521193	1548	0.474
NULL	Adv_Biomed_Res_2013_Jul_30_2_66.nxml.txt.nlp	24223381	SENT49	28	28	22	22	doxepin	Ray	PA449409	26751	0.474
NULL	Front_Endocrinol_(Lausanne)_2013_Jul_16_4_87.nxml.txt.nlp	23882260	SENT32	30	30	27	27	l-cysteine	DAO	PA449173	26;1610	0.474
NULL	Multidiscip_Respir_Med_2013_Feb_13_8(1)_13.nxml.txt.nlp	23406847	SENT22	14	14	16	16	ethambutol	EMB	PA164784021	133418	0.474
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT232	12	12	5	5	metformin	HIF-1	PA450395	29072	0.474
NULL	Calcif_Tissue_Int_2011_Aug_3_89(2)_140-150.nxml.txt.nlp	21633782	SENT244	5	5	3	3	heparin	FGF23	PA449855	8074	0.474
NULL	Cardiovasc_Diabetol_2010_Nov_25_9_78.nxml.txt.nlp	21106105	SENT267	21	21	23	23	nitroprusside	STZ	PA451406	6484	0.474
NULL	Indian_J_Med_Res_2011_Sep_134(3)_295-301.nxml.txt.nlp	21985811	SENT111	9	9	24	24	carbamazepine	CYP2C9	PA448785	1559	0.474
NULL	Infect_Drug_Resist_2009_Apr_24_2_13-26.nxml.txt.nlp	21694884	SENT291	14	14	16	16	lamivudine	LAM	PA450163	7249;7248	0.474
NULL	Alcohol_Res_Health_2010_33(1-2)_76-86.nxml.txt.nlp	23579938	SENT170	24	24	26	26	ethanol	ALDH2	PA448073	217	0.474
NULL	Brain_Sci_2012_Nov_7_2(4)_589-604.nxml.txt.nlp	24349762	SENT19	17	17	31	31	estradiol	OXT	PA449503	5020	0.474
NULL	Int_J_Mol_Sci_2014_Sep_30_15(10)_17686-17704.nxml.txt.nlp	25272226	SENT198	14	14	21	21	paraformaldehyde	EGFR	PA450790	1956	0.474
NULL	Int_Semin_Surg_Oncol_2007_Jul_23_4_18.nxml.txt.nlp	17645796	SENT88	3	3	39	39	raloxifene	STAR	PA451221	6770;2984	0.474
NULL	Front_Oncol_2014_Sep_23_4_264.nxml.txt.nlp	25295231	SENT239	2	2	4	4	lenalidomide	p53	PA162363968	7157	0.474
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT375	23	23	21	21	pp2	PP1		5540;5464	0.474
NULL	Pharmaceuticals_(Basel)_2011_Jan_26_4(2)_285-342.nxml.txt.nlp	NULL	SENT323	5	5	10	10	milnacipran	c-fos	PA164752812	2353	0.474
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_May_24_70(Pt_6)_o700-o701.nxml.txt.nlp	24940274	SENT12	5	5	12	12	piperazine	mol	PA450977	90527	0.474
NULL	Org_Biomol_Chem_2008_Nov_7_6(21)_3977-3982.nxml.txt.nlp	18931805	SENT148	8	8	2	2	guanidine	EPO	PA164781028	7076;8288;2056	0.474
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2007_Dec_6_64(Pt_1)_m92.nxml.txt.nlp	21200659	SENT56	0	0	10	10	potassium	mol	PA451047	90527	0.474
NULL	Acta_Naturae_2011_Oct-Dec_3(4)_83-93.nxml.txt.nlp	22649707	SENT26	10	10	12	12	imiquimod	TLR7	PA449972	51284	0.474
NULL	Biomed_Res_Int_2013_Dec_5_2013_642848.nxml.txt.nlp	24381940	SENT167	23	23	5	5	telmisartan	IL-6	PA451605	3569	0.474
NULL	Bioinformation_2006_Dec_23_1(8)_314-320.nxml.txt.nlp	17597912	SENT156	32	32	9	9	allopurinol	ACE	PA448320	1636	0.474
NULL	Cancer_Cell_Int_2013_May_1_13_39.nxml.txt.nlp	23631621	SENT206	21	21	4	4	paclitaxel	EGF	PA450761	1950	0.474
NULL	Diabetologia_2014_Oct_23_57(1)_122-128.nxml.txt.nlp	24149837	SENT62	11	11	4	4	fluorescein	INS-1	PA164746009	2305	0.474
NULL	Biomed_Eng_Online_2004_Jul_19_3_23.nxml.txt.nlp	15260881	SENT69	38	38	24	24	dextran	CO2	PA449261	4513	0.474
NULL	Nucleic_Acids_Res_2007_Jan_7_35(1)_113-124.nxml.txt.nlp	17158150	SENT63	24	24	30	30	thrombin	LEDGF	PA451674	11168	0.474
NULL	Parasit_Vectors_2009_Sep_25_2(Suppl_2)_S5.nxml.txt.nlp	19778466	SENT137	29	29	27	27	praziquantel	MOX	PA164764583	26002	0.474
NULL	Nucleic_Acids_Res_2013_Dec_2_41(22)_10110-10123.nxml.txt.nlp	23999093	SENT56	16	16	13	13	etoposide	TPT	PA449552	23590;6469	0.474
NULL	Case_Rep_Crit_Care_2014_Aug_19_2014_242703.nxml.txt.nlp	25215245	SENT243	11	11	27	27	salbutamol	Yes	PA448068	7525	0.474
NULL	J_Oncol_2009_May_6_2009_567486.nxml.txt.nlp	19424511	SENT155	9	9	13	13	sunitinib	IFN	PA162372840	3439	0.474
NULL	Curr_Oncol_2006_Feb_13(1)_14-26.nxml.txt.nlp	17576437	SENT124	24	24	12	12	collagenase	IL-8	PA449107	3576	0.474
NULL	Croat_Med_J_2013_Dec_54(6)_579-584.nxml.txt.nlp	24382854	SENT97	5	5	22	22	creatine	SDH	PA164778930	1757;10993	0.474
NULL	J_Gen_Physiol_1921_Sep_20_4(1)_57-71.nxml.txt.nlp	19871916	SENT0	16	16	1	1	trypsin	Gen	PA451806	348654	0.474
NULL	Int_J_Endocrinol_2009_Nov_3_2009_687259.nxml.txt.nlp	20011060	SENT158	14	14	7	7	protamine	CREM	PA10366	1390	0.474
NULL	Diabetes_2013_Jun_17_62(6)_1791-1799.nxml.txt.nlp	23704520	SENT75	12	12	14	14	streptozocin	STZ	PA451514	6484	0.474
NULL	Diabetes_Care_2011_Jun_20_34(6)_1424-1430.nxml.txt.nlp	21602431	SENT141	6	6	4	4	pramlintide	GLP-1	PA164781394	100125288	0.474
NULL	Thorax_2012_Sep_11_67(9)_796-803.nxml.txt.nlp	22496351	SENT186	2	2	7	7	bleomycin	TRAIL	PA448645	8743	0.474
NULL	Diabetes_Metab_Syndr_Obes_2010_Aug_24_3_297-299.nxml.txt.nlp	21437098	SENT6	10	10	6	6	liraglutide	GLP-1	PA165958364	100125288	0.474
NULL	Arch_Med_Sci_2011_Aug_2_7(4)_713-719.nxml.txt.nlp	22291810	SENT123	25	25	7	7	calcipotriol	IL-19	PA448714	29949	0.474
NULL	Arthritis_Res_Ther_2011_Feb_23_13(1)_R33.nxml.txt.nlp	21345222	SENT185	16	16	21	21	hyaluronan	GP96	PA165958431	7184	0.474
NULL	J_Med_Case_Reports_2011_Oct_4_5_495.nxml.txt.nlp	21970715	SENT29	3	3	21	21	medroxyprogesterone	CEA	PA450344	5670;1087	0.474
NULL	Br_J_Cancer_1993_Aug_68(2)_352-356.nxml.txt.nlp	8347490	SENT4	8	8	10	10	tamoxifen	TMX	PA451581	81542	0.474
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_21-38.nxml.txt.nlp	19305786	SENT584	24	24	26	26	capsaicin	TRPV1	PA448776	7442	0.474
NULL	Comput_Struct_Biotechnol_J_2012_Oct_30_3_e201210004.nxml.txt.nlp	24688664	SENT158	17	17	13	13	l-methionine	mol	PA450423	90527	0.474
NULL	Diabetologia_2010_Jun_27_53(6)_1142-1150.nxml.txt.nlp	20349036	SENT19	4	4	11	11	spermine	AMPK	PA164781199	5563	0.474
NULL	Clin_Ophthalmol_2012_Sep_5_6_1433-1440.nxml.txt.nlp	23055659	SENT153	39	39	41	41	timolol	BAK	PA451690	578	0.474
NULL	J_Gen_Physiol_1933_Sep_20_17(1)_163.nxml.txt.nlp	NULL	SENT0	10	10	1	1	trypsin	Gen	PA451806	348654	0.474
NULL	Gene_Technol_2014_Aug_11_3(2)_114.nxml.txt.nlp	25606572	SENT231	13	13	7	7	azacitidine	EZH2	PA451996	2146	0.474
NULL	Bioinformation_2013_Nov_11_9(18)_929-936.nxml.txt.nlp	24307772	SENT25	7	7	4	4	s-adenosylmethionine	MTHFR	PA164754994	4524	0.474
NULL	Cancer_Manag_Res_2014_May_23_6_225-252.nxml.txt.nlp	24904222	SENT487	8	8	5	5	tamoxifen	DES	PA451581	1674	0.474
NULL	Front_Oncol_2013_Aug_26_3_214.nxml.txt.nlp	23986881	SENT173	17	17	15	15	rituximab	CHOP	PA451261	1649	0.474
NULL	Indian_J_Crit_Care_Med_2008_Oct-Dec_12(4)_181-189.nxml.txt.nlp	19742267	SENT204	1	1	8	8	anakinra	ACR	PA10799	49	0.474
NULL	J_Antibiot_(Tokyo)_2012_Jun_11_65(6)_289-294.nxml.txt.nlp	22491136	SENT87	20	20	26	26	mannitol	MYP	PA450320	8996	0.474
NULL	Int_J_Mol_Sci_2013_Apr_26_14(5)_9111-9125.nxml.txt.nlp	23624604	SENT92	3	3	9	9	iron	TAT	PA450087	6898	0.474
NULL	Indian_J_Med_Res_2012_Sep_136(3)_391-403.nxml.txt.nlp	23041732	SENT183	13	13	15	15	sorafenib	HCC	PA7000	84668	0.474
NULL	Ann_Rheum_Dis_2014_Jan_13_73(1)_95-100.nxml.txt.nlp	23765873	SENT34	26	26	28	28	infliximab	IL-6	PA452639	3569	0.474
NULL	Alzheimers_Res_Ther_2013_May_14_5(3)_25.nxml.txt.nlp	23673233	SENT468	14	14	9	9	scopolamine	spatial	PA451308	219793	0.474
NULL	Virol_J_2009_Dec_1_6_213.nxml.txt.nlp	19951438	SENT191	22	22	25	25	mitomycin	TRAIL	PA450524	8743	0.474
NULL	Biomed_Res_Int_2013_Feb_5_2013_478713.nxml.txt.nlp	23484122	SENT285	18	18	21	21	sugar	MUC5AC	PA451529	4586	0.474
NULL	Br_J_Pharmacol_2014_Sep_28_171(18)_4255-4272.nxml.txt.nlp	24846338	SENT274	5	5	10	10	duloxetine	gamma	PA10066	9913	0.474
NULL	Biosci_Rep_2014_Apr_14_34(2)_e00104.nxml.txt.nlp	24597785	SENT716	17	17	3	3	thrombin	p110	PA451674	9733	0.474
NULL	Oncol_Lett_2013_Feb_27_5(2)_435-439.nxml.txt.nlp	23420613	SENT21	11	11	6	6	gefitinib	EGFR	PA131301952	1956	0.474
NULL	Nucleic_Acids_Res_2010_Oct_27_38(18)_6247-6264.nxml.txt.nlp	20507916	SENT256	5	5	9	9	pp2	PP4		5531	0.474
NULL	Clinicoecon_Outcomes_Res_2014_Sep_23_6_409-414.nxml.txt.nlp	25285019	SENT143	4	4	2	2	atazanavir	ATV	PA10251	4683	0.474
NULL	Front_Synaptic_Neurosci_2014_May_30_6_12.nxml.txt.nlp	24910611	SENT30	0	0	12	12	l-serine	asc-1	PA451330	56301	0.474
NULL	Nucleic_Acids_Res_2013_Nov_16_41(20)_9349-9360.nxml.txt.nlp	23956219	SENT158	15	15	6	6	cisplatin	RMI1	PA449014	80010	0.474
NULL	Ann_Oncol_2011_Mar_8_22(3)_503-514.nxml.txt.nlp	20616198	SENT330	12	12	39	39	tamoxifen	San	PA451581	80218	0.474
NULL	Int_J_Endocrinol_2013_Jul_31_2013_632461.nxml.txt.nlp	23983688	SENT215	14	14	26	26	lipase	aromatase	PA450239	1588	0.474
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Aug_8_65(Pt_9)_o2087.nxml.txt.nlp	21577505	SENT54	17	17	26	26	benzaldehyde	C42	PA448571	51654	0.474
NULL	Cancer_Metastasis_Rev_2014_Jan_17_33(1)_217-229.nxml.txt.nlp	24436017	SENT58	13	13	5	5	nadh	AMPK	PA164755085	5563	0.474
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Jun_28_64(Pt_7)_o1360.nxml.txt.nlp	21202978	SENT3	14	14	20	20	phenol	mol	PA450913	90527	0.474
NULL	Cell_Res_2010_Apr_9_20(4)_458-469.nxml.txt.nlp	20142842	SENT29	18	18	6	6	doxycycline	BCL2	PA449415	596	0.474
NULL	Emerg_Med_J_2011_Apr_26_28(4)_313-315.nxml.txt.nlp	20581384	SENT39	9	9	16	16	atropine	PAM	PA448505	5066;23077	0.474
NULL	Stroke_Res_Treat_2009_Dec_20_2010_386389.nxml.txt.nlp	20700422	SENT133	17	17	14	14	resveratrol	MCP-1		6347	0.474
NULL	Pharmaceuticals_(Basel)_2012_Feb_16_5(2)_209-235.nxml.txt.nlp	24288089	SENT319	42	42	15	15	trastuzumab	EGFR	PA451743	1956	0.474
NULL	Oncol_Rep_2014_Jan_13_31(1)_376-383.nxml.txt.nlp	24220856	SENT101	20	20	5	5	paclitaxel	PA1	PA450761	79447	0.474
NULL	Cell_Death_Dis_2013_Jun_27_4(6)_e696.nxml.txt.nlp	23807225	SENT277	3	3	5	5	doxycycline	ACL	PA449415	47	0.474
NULL	Br_J_Cancer_2004_Mar_5_90(Suppl_1)_S7-S10.nxml.txt.nlp	15094758	SENT90	15	15	8	8	fulvestrant	CYP3A4	PA164747170	1576	0.474
NULL	Case_Rep_Med_2010_Dec_26_2010_403237.nxml.txt.nlp	21209804	SENT20	19	19	21	21	bortezomib	CHOP	PA10252	1649	0.474
NULL	Arthritis_Res_Ther_2014_Apr_11_16(2)_R93.nxml.txt.nlp	24725461	SENT147	11	11	16	16	letrozole	CYP1A1	PA450196	1543	0.474
NULL	Physiol_Rep_2014_Sep_11_2(9)_e12133.nxml.txt.nlp	25214520	SENT182	32	32	23	23	bleomycin	CXCL12	PA448645	6387	0.474
NULL	Br_J_Cancer_2006_Dec_4_95(11)_1504-1513.nxml.txt.nlp	17088902	SENT128	6	6	8	8	gefitinib	HER2	PA131301952	2064	0.474
NULL	Allergy_Asthma_Clin_Immunol_2005_Sep_15_1(3)_101-116.nxml.txt.nlp	20529221	SENT236	2	2	32	32	desloratadine	PACT	PA164776964	8575;5930	0.474
NULL	Front_Syst_Neurosci_2014_Mar_10_8_27.nxml.txt.nlp	24653682	SENT177	16	16	28	28	baclofen	ANOVA	PA448533	4858	0.474
NULL	Front_Aging_Neurosci_2010_May_18_2_18.nxml.txt.nlp	20559465	SENT280	20	20	9	9	diazepam	GAD65	PA449283	2572	0.474
NULL	Surg_Today_2012_Jan_6_42(1)_8-28.nxml.txt.nlp	22139128	SENT230	21	21	23	23	tegafur	PSK	PA452620	9344	0.474
NULL	Alcohol_Res_2012_34(3)_367-374.nxml.txt.nlp	23134054	SENT108	16	16	3	3	ethanol	MPDZ	PA448073	8777;84708	0.474
NULL	J_Oncol_2012_Sep_13_2012_749030.nxml.txt.nlp	23024654	SENT40	22	22	18	18	imiquimod	IFN	PA449972	3439	0.474
NULL	Crit_Care_2011_Nov_16_15(6)_R271.nxml.txt.nlp	22087790	SENT164	2	2	33	33	nitroprusside	Yes	PA451406	7525	0.474
NULL	Acta_Pharmacol_Sin_2013_May_8_34(5)_699-709.nxml.txt.nlp	23564084	SENT146	17	17	11	11	vorinostat	BSP	PA164748224	3381	0.474
NULL	Neural_Regen_Res_2014_Nov_1_9(21)_1897-1901.nxml.txt.nlp	25558239	SENT106	0	0	15	15	diazepam	CA1	PA449283	759	0.474
NULL	Cell_Death_Dis_2014_Jan_30_5(1)_e1043.nxml.txt.nlp	24481457	SENT234	9	9	5	5	urokinase	PLAU	PA451836	5328	0.474
NULL	J_Neuroinflammation_2011_Dec_21_8_178.nxml.txt.nlp	22189096	SENT364	23	23	21	21	neomycin	TLR3	PA450608	7098	0.473
NULL	J_Lipid_Res_2014_Feb_55(2)_190-200.nxml.txt.nlp	24273196	SENT143	13	13	25	25	lipase	G0S2	PA450239	50486	0.473
NULL	Iran_J_Public_Health_2010_Dec_31_39(4)_1-14.nxml.txt.nlp	23113033	SENT47	33	33	12	12	galactose	LPH	PA449725	5443	0.473
NULL	Clin_Endocrinol_(Oxf)_2010_May_72(5)_589-594.nxml.txt.nlp	19558534	SENT102	22	22	25	25	hydrocortisone	ACTH	PA449905	5443	0.473
NULL	Br_J_Cancer_2010_Nov_2_103(11)_1671-1679.nxml.txt.nlp	21045835	SENT238	22	22	16	16	gemcitabine	CXCL12	PA449748	6387	0.473
NULL	Iranian_J_Environ_Health_Sci_Eng_2012_Dec_10_9(1)_19.nxml.txt.nlp	23369431	SENT108	2	2	0	0	ampicillin	ANOVA	PA448419	4858	0.473
NULL	Infect_Dis_Ther_2014_Jun_18_3(1)_35-43.nxml.txt.nlp	25134810	SENT117	5	5	12	12	oxacillin	VAN	PA450725	10318	0.473
NULL	Genetics_2013_Nov_195(3)_757-767.nxml.txt.nlp	24002644	SENT196	20	20	28	28	fluorescein	RAD54B	PA164746009	25788	0.473
NULL	Cancers_(Basel)_2011_May_24_3(2)_2478-2500.nxml.txt.nlp	24212820	SENT753	0	0	4	4	metformin	AMPK	PA450395	5563	0.473
NULL	Arthritis_Res_Ther_2006_Nov_9_8(1)_R2.nxml.txt.nlp	16356188	SENT5	23	23	34	34	celecoxib	COX	PA448871	1351	0.473
NULL	EMBO_Mol_Med_2010_May_2(5)_172-187.nxml.txt.nlp	20432503	SENT273	15	15	33	33	l-glutamine	CO2	PA10090	4513	0.473
NULL	Curr_Neuropharmacol_2007_Dec_5(4)_289-294.nxml.txt.nlp	19305745	SENT51	19	19	21	21	apomorphine	APO	PA164781163	84909	0.473
NULL	J_Epidemiol_2012_May_5_22(3)_222-229.nxml.txt.nlp	22343328	SENT198	16	16	0	0	alteplase	STR	PA164776730	6779	0.473
NULL	Acta_Pharmacol_Sin_2014_Jul_26_35(7)_869-878.nxml.txt.nlp	24858312	SENT103	22	22	19	19	phenol	F12	PA450913	2161	0.473
NULL	Ther_Clin_Risk_Manag_2007_Aug_3(4)_675-684.nxml.txt.nlp	18472990	SENT73	15	15	20	20	vancomycin	VISA	PA451850	57506	0.473
NULL	Case_Rep_Transplant_2014_Oct_8_2014_742161.nxml.txt.nlp	25374744	SENT28	10	10	16	16	cefotaxime	San	PA448852	80218	0.473
NULL	Blood_Cancer_J_2013_Oct_18_3(10)_e153.nxml.txt.nlp	24141622	SENT225	4	4	2	2	chlorambucil	CLB	PA448926	171425	0.473
NULL	Case_Rep_Oncol_Med_2013_Apr_11_2013_485025.nxml.txt.nlp	23878753	SENT60	18	18	20	20	thyroglobulin	TTF-1	PA164754910	7080	0.473
NULL	Oncoimmunology_2013_Aug_1_2(8)_e26218.nxml.txt.nlp	24179709	SENT149	20	20	35	35	hyaluronan	CCL18	PA165958431	6362	0.473
NULL	Oncotarget_2014_Sep_3_5(19)_9362-9381.nxml.txt.nlp	25313139	SENT117	23	23	18	18	lipase	ACBP	PA450239	1622	0.473
NULL	Nat_Commun_2013_Sep_20_4_2444.nxml.txt.nlp	24051492	SENT50	13	13	7	7	nutlin-3	p53		7157	0.473
NULL	Indian_J_Urol_2010_Oct-Dec_26(4)_531-535.nxml.txt.nlp	21369386	SENT128	30	30	24	24	theophylline	ACTH	PA451647	5443	0.473
NULL	Front_Neural_Circuits_2014_Apr_8_8_33.nxml.txt.nlp	24782714	SENT572	0	0	2	2	reserpine	spatial	PA451236	219793	0.473
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1986-2011.nxml.txt.nlp	25268165	SENT166	30	30	33	33	paclitaxel	CD133	PA450761	8842	0.473
NULL	Cardiol_Res_Pract_2014_Feb_6_2014_605810.nxml.txt.nlp	24653858	SENT96	27	27	41	41	atorvastatin	CRP	PA448500	1401;140913	0.473
NULL	Exp_Ther_Med_2013_Nov_6_6(5)_1089-1095.nxml.txt.nlp	24223627	SENT46	9	9	5	5	docetaxel	NAC	PA449383	22861	0.473
NULL	Front_Endocrinol_(Lausanne)_2011_Dec_21_2_84.nxml.txt.nlp	22654830	SENT62	7	7	4	4	rosiglitazone	DGAT	PA451283	8694	0.473
NULL	Int_J_Vasc_Med_2012_Jul_24_2012_508416.nxml.txt.nlp	22888436	SENT163	24	24	43	43	pioglitazone	PRIC285	PA450970	85441	0.473
NULL	Int_J_Cell_Biol_2013_Apr_18_2013_273086.nxml.txt.nlp	23690780	SENT174	38	38	13	13	urokinase	VIII	PA451836	1351	0.473
NULL	CNS_Drugs_2014_Feb_7_28(3)_185-193.nxml.txt.nlp	24504829	SENT25	9	9	33	33	choline	DAG	PA448976	1605	0.473
NULL	J_Clin_Biochem_Nutr_2009_Nov_28_45(3)_285-291.nxml.txt.nlp	19902018	SENT2	11	11	40	40	hesperetin	XDH	PA164742902	7498	0.473
NULL	Br_J_Cancer_2009_Jul_21_101(2)_238-243.nxml.txt.nlp	19568242	SENT123	13	13	11	11	sunitinib	IFN	PA162372840	3439	0.473
NULL	JAKSTAT_2013_Jul_1_2(3)_e24812.nxml.txt.nlp	24069562	SENT63	23	23	23	23	pp2	PP2		4888	0.473
NULL	Indian_J_Ophthalmol_2010_May-Jun_58(3)_232-234.nxml.txt.nlp	20413928	SENT0	13	13	17	17	triamcinolone	hole	PA451749	80757	0.473
NULL	EMBO_Mol_Med_2013_Aug_5_5(8)_1213-1226.nxml.txt.nlp	23918228	SENT237	13	13	25	25	cetuximab	EGFR	PA10040	1956	0.473
NULL	Arthritis_Res_Ther_2005_May_18_7(Suppl_3)_S19-S25.nxml.txt.nlp	15960818	SENT168	39	39	37	37	rituximab	CHOP	PA451261	1649	0.473
NULL	J_Inflamm_(Lond)_2007_May_4_4_10.nxml.txt.nlp	17480224	SENT204	19	19	6	6	ketamine	IL-4	PA450144	3565	0.473
NULL	Indian_J_Psychiatry_2010_Jan_52(Suppl1)_S317-S340.nxml.txt.nlp	21836703	SENT120	21	21	19	19	triflupromazine	CPZ	PA451773	8532	0.473
NULL	Adv_Urol_2012_Nov_1_2012_641689.nxml.txt.nlp	22110494	SENT153	29	29	15	15	docetaxel	CRT	PA449383	811	0.473
NULL	Arch_Med_Sci_2010_Dec_29_6(6)_964-970.nxml.txt.nlp	22427774	SENT122	25	25	7	7	calcipotriol	IL-19	PA448714	29949	0.473
NULL	Acta_Pharmacol_Sin_2009_Oct_21_30(10)_1392-1398.nxml.txt.nlp	19767766	SENT161	18	18	26	26	atorvastatin	NAC	PA448500	22861	0.473
NULL	Cell_Commun_Signal_2013_Dec_23_11_100.nxml.txt.nlp	24364863	SENT183	21	21	28	28	erlotinib	PP2	PA134687924	4888	0.473
NULL	Cancer_Causes_Control_2013_Aug_18_24(8)_1605-1614.nxml.txt.nlp	23775025	SENT64	3	3	41	41	cyclophosphamide	GSTM2	PA449165	2946	0.473
NULL	Oxid_Med_Cell_Longev_2013_Apr_21_2013_412576.nxml.txt.nlp	23710286	SENT5	28	28	19	19	arsenite	NRF2	PA452638	2551;4780	0.473
NULL	Arch_Microbiol_2013_Jun_10_195(6)_439-445.nxml.txt.nlp	23661196	SENT66	10	10	32	32	mannitol	CO2	PA450320	4513	0.473
NULL	Alzheimers_Res_Ther_2013_Oct_24_5(5)_50.nxml.txt.nlp	24401551	SENT314	6	6	3	3	donepezil	STZ	PA449394	6484	0.473
NULL	Nat_Med_2014_Jun_11_20(6)_616-623.nxml.txt.nlp	24813252	SENT367	13	13	5	5	galactose	TAZ	PA449725	25937;6901	0.473
NULL	Adv_Hematol_2010_Dec_5_2010_595934.nxml.txt.nlp	21151515	SENT154	24	24	21	21	cangrelor	Yes	PA165945763	7525	0.473
NULL	Oncotarget_2013_Nov_24_4(12)_2186-2207.nxml.txt.nlp	24327604	SENT235	20	20	13	13	daunorubicin	survivin	PA449212	332	0.473
NULL	Clin_Ophthalmol_2012_Sep_5_6_1433-1440.nxml.txt.nlp	23055659	SENT153	33	33	12	12	timolol	BAK	PA451690	578	0.473
NULL	Mol_Pain_2012_Sep_22_8_71.nxml.txt.nlp	22998838	SENT150	0	0	17	17	cisplatin	TRPA1	PA449014	8989	0.473
NULL	Front_Physiol_2012_Sep_12_3_362.nxml.txt.nlp	22988443	SENT164	21	21	13	13	nadh	IDH2	PA164755085	3418	0.473
NULL	Pancreas_2015_Jan_11_44(1)_31-40.nxml.txt.nlp	25102438	SENT292	20	20	4	4	cyclophosphamide	S29	PA449165	6235	0.473
NULL	Cardiovasc_Diabetol_2013_Mar_23_12_48.nxml.txt.nlp	23522121	SENT44	8	8	26	26	exenatide	NNT	PA164749238	23530	0.473
NULL	Clin_Ophthalmol_2008_Dec_2(4)_897-905.nxml.txt.nlp	19668444	SENT133	21	21	23	23	latanoprost	BAK	PA164774763	578	0.473
NULL	ScientificWorldJournal_2014_Feb_9_2014_964380.nxml.txt.nlp	24764772	SENT110	2	2	9	9	paliperidone	VIII	PA163518919	1351	0.473
NULL	Mol_Vis_2011_May_4_17_1172-1181.nxml.txt.nlp	21617754	SENT135	16	16	8	8	staurosporine	FKBP51	PA165109623	2289	0.473
NULL	Cancers_(Basel)_2011_Apr_1_3(2)_1844-1860.nxml.txt.nlp	24212785	SENT46	2	2	13	13	panitumumab	ACRC	PA162373091	93953	0.473
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1699-1708.nxml.txt.nlp	19861960	SENT239	8	8	5	5	dasatinib	mol	PA162372878	90527	0.473
NULL	Cancer_Cell_2007_Dec_11_12(6)_514-527.nxml.txt.nlp	18068629	SENT165	9	9	7	7	paclitaxel	TGFBI	PA450761	7045	0.473
NULL	J_Oncol_2010_Jan_3_2010_149362.nxml.txt.nlp	20069122	SENT133	21	21	32	32	dasatinib	CDP	PA162372878	1523	0.473
NULL	J_Hum_Hypertens_2010_Nov_18_24(11)_730-738.nxml.txt.nlp	20164847	SENT168	2	2	15	15	amlodipine	A10	PA448388	28870	0.473
NULL	Diabetes_Care_2009_Nov_32(Suppl_2)_S266-S269.nxml.txt.nlp	19875562	SENT23	14	14	30	30	oxygen	PDX-1	PA450744	3651	0.473
NULL	J_Exerc_Rehabil_2014_Jun_30_10(3)_155-161.nxml.txt.nlp	25061594	SENT96	11	11	6	6	scopolamine	spatial	PA451308	219793	0.473
NULL	Indian_J_Nucl_Med_2011_Oct-Dec_26(4)_202-204.nxml.txt.nlp	23559719	SENT15	32	32	27	27	ethambutol	AKT	PA164784021	207	0.473
NULL	AIDS_Res_Ther_2014_Aug_4_11_25.nxml.txt.nlp	25120580	SENT64	25	25	9	9	voriconazole	CYP3A4	PA10233	1576	0.473
NULL	Diabetes_2011_Nov_17_60(11)_2928-2938.nxml.txt.nlp	21885868	SENT312	7	7	30	30	curcumin	IL-6	PA151958596	3569	0.473
NULL	Nat_Commun_2014_Apr_29_5_3723.nxml.txt.nlp	24781344	SENT71	17	17	6	6	iron	CO2	PA450087	4513	0.473
NULL	Ther_Clin_Risk_Manag_2006_Sep_2(3)_297-301.nxml.txt.nlp	18360604	SENT52	20	20	16	16	paricalcitol	PTH	PA450798	5741	0.473
NULL	J_Radiat_Res_2012_Sep_10_53(5)_704-709.nxml.txt.nlp	22843360	SENT94	8	8	2	2	irinotecan	ADM	PA450085	133	0.473
NULL	Pharmaceuticals_(Basel)_2012_Aug_10_5(8)_802-836.nxml.txt.nlp	24280676	SENT1761	22	22	13	13	methotrexate	ABCC4	PA450428	10257	0.473
NULL	Indian_J_Med_Paediatr_Oncol_2014_Jan-Mar_35(1)_118-119.nxml.txt.nlp	25006302	SENT29	4	4	8	8	vincristine	CHOP	PA451879	1649	0.473
NULL	Adv_Hematol_2010_Dec_5_2010_595934.nxml.txt.nlp	21151515	SENT154	24	24	11	11	cangrelor	Yes	PA165945763	7525	0.473
NULL	Front_Neurosci_2010_Jun_17_4_35.nxml.txt.nlp	20661455	SENT859	5	5	7	7	fluoxetine	5-HT1A	PA449673	3350	0.473
NULL	Nat_Chem_Biol_2010_Apr_28_6(4)_291-299.nxml.txt.nlp	20190765	SENT128	32	32	28	28	dasatinib	EGFR	PA162372878	1956	0.473
NULL	Cell_Commun_Signal_2014_Sep_21_12(1)_57.nxml.txt.nlp	NULL	SENT318	13	13	9	9	l-glutamine	FBS	PA10090	64319;26269	0.473
NULL	Oncoimmunology_2013_Aug_1_2(8)_e26218.nxml.txt.nlp	24179709	SENT84	19	19	28	28	hyaluronan	CCL18	PA165958431	6362	0.473
NULL	Biochem_Biophys_Res_Commun_2009_Apr_17_381(4)_523-527.nxml.txt.nlp	19239903	SENT78	27	27	19	19	betaine	GNMT	PA448603	27232	0.473
NULL	Oncotarget_2014_Jun_30_5(15)_6038-6048.nxml.txt.nlp	25153721	SENT209	18	18	14	14	hydrocortisone	EGF	PA449905	1950	0.473
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT5	10	10	28	28	sitagliptin	HIP	PA164748978	6767;6159;64399;5068	0.473
NULL	Oxid_Med_Cell_Longev_2012_Aug_22_2012_534705.nxml.txt.nlp	22966415	SENT224	15	15	8	8	riluzole	GLT-1	PA451251	6506	0.473
NULL	AAPS_J_2011_Dec_22_14(1)_68-78.nxml.txt.nlp	22189899	SENT261	25	25	8	8	rifampin	OATP1B3	PA451250	28234	0.473
NULL	Calcif_Tissue_Int_2010_Dec_16_87(6)_485-492.nxml.txt.nlp	20953593	SENT118	0	0	29	29	teriparatide	PTH	PA451620	5741	0.473
NULL	Ann_Indian_Acad_Neurol_2012_Oct-Dec_15(4)_332-335.nxml.txt.nlp	23349609	SENT15	9	9	18	18	l-carnitine	MADD	PA450154	8567;2108	0.473
NULL	Case_Rep_Gastroenterol_2012_Dec_22_6(3)_803-809.nxml.txt.nlp	23341805	SENT52	8	8	12	12	vincristine	CHOP	PA451879	1649	0.473
NULL	J_Gen_Physiol_2003_Mar_121(3)_181-197.nxml.txt.nlp	12601083	SENT266	2	2	0	0	forskolin	GLP-1	PA146096022	100125288	0.472
NULL	Tuberc_Respir_Dis_(Seoul)_2013_Jan_31_74(1)_1-6.nxml.txt.nlp	23390446	SENT71	21	21	26	26	azathioprine	NAC	PA448515	22861	0.472
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT192	39	39	9	9	afatinib	Yes	PA165981154	7525	0.472
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Feb_13_69(Pt_3)_o378-o379.nxml.txt.nlp	23476565	SENT7	18	18	26	26	fluconazole	mol	PA449653	90527	0.472
NULL	Clin_Med_Insights_Circ_Respir_Pulm_Med_2013_Nov_13_7_61-77.nxml.txt.nlp	24324354	SENT296	12	12	2	2	aztreonam	TOB	PA448523	10140	0.472
NULL	J_Biol_Chem_2012_Apr_20_287(17)_14122-14135.nxml.txt.nlp	22351750	SENT623	9	9	7	7	hyaluronan	TSG-6	PA165958431	7130	0.472
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT17	33	33	15	15	vinorelbine	ASC	PA451881	29108	0.472
NULL	Indian_J_Anaesth_2014_Jul-Aug_58(4)_423-429.nxml.txt.nlp	25197110	SENT164	5	5	3	3	ondansetron	ODF	PA450705	8600	0.472
NULL	Carcinogenesis_2013_Mar_7_34(3)_703-712.nxml.txt.nlp	23222814	SENT126	0	0	6	6	curcumin	RPS6	PA151958596	6194	0.472
NULL	Br_J_Clin_Pharmacol_2013_Aug_23_76(2)_299-315.nxml.txt.nlp	23701319	SENT208	26	26	20	20	infliximab	CRA	PA452639	51747;10903	0.472
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Mar_12_64(Pt_4)_o687.nxml.txt.nlp	21202079	SENT61	11	11	23	23	nitrogen	HN1	PA450643	51155	0.472
NULL	Indian_J_Nucl_Med_2010_Jul-Sep_25(3)_103-108.nxml.txt.nlp	NULL	SENT189	12	12	8	8	doxorubicin	FDG	PA449412	23583	0.472
NULL	Nucleic_Acids_Res_2011_Nov_20_39(20)_8857-8868.nxml.txt.nlp	21775341	SENT48	0	0	8	8	l-leucine	GMP	PA450197	22978	0.472
NULL	Int_Clin_Psychopharmacol_2014_Nov_3_29(6)_322-331.nxml.txt.nlp	24850228	SENT274	17	17	1	1	olanzapine	Gen	PA450688	348654	0.472
NULL	Crit_Care_2006_Feb_3_10(1)_R24.nxml.txt.nlp	16469128	SENT107	28	28	35	35	heparin	MARS	PA449855	4141	0.472
NULL	Biochem_Biophys_Res_Commun_2010_Nov_12_402(2-3)_180-185.nxml.txt.nlp	20707983	SENT432	14	14	18	18	collagenase	CDP	PA449107	1523	0.472
NULL	Iran_J_Pharm_Res_2015_Winter_14(1)_167-175.nxml.txt.nlp	25561923	SENT118	23	23	41	41	propofol	Yes	PA451141	7525	0.472
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT115	2	2	4	4	atorvastatin	RANKL	PA448500	8600	0.472
NULL	Breast_Cancer_Res_2010_Jun_4_12(3)_R32.nxml.txt.nlp	20525379	SENT316	13	13	4	4	estradiol	AGR2	PA449503	10551	0.472
NULL	Cell_Commun_Signal_2004_Jun_2_2_3.nxml.txt.nlp	15175101	SENT300	0	0	9	9	cyclosporine	San	PA449167	80218	0.472
NULL	Clin_Med_Insights_Oncol_2011_Nov_7_5_349-364.nxml.txt.nlp	22174596	SENT161	21	21	23	23	bevacizumab	IFN	PA130232992	3439	0.472
NULL	Front_Oncol_2014_Apr_9_4_75.nxml.txt.nlp	24782986	SENT173	22	22	5	5	paclitaxel	CA125	PA450761	4077;94025	0.472
NULL	Lipids_Health_Dis_2011_Jan_21_10_17.nxml.txt.nlp	21251287	SENT106	4	4	43	43	lipase	HDL2	PA450239	57338	0.472
NULL	Endocrine_2012_Dec_14_42(3)_622-636.nxml.txt.nlp	22695986	SENT62	14	14	12	12	forskolin	PTH	PA146096022	5741	0.472
NULL	Mol_Biol_Rep_2012_May_20_39(5)_5253-5267.nxml.txt.nlp	22183301	SENT220	6	6	4	4	gliclazide	NAC	PA10892	22861	0.472
NULL	Apoptosis_2014_Apr_23_19(7)_1055-1068.nxml.txt.nlp	24756955	SENT152	17	17	15	15	cisplatin	RITA	PA449014	55422;84934	0.472
NULL	Biol_Open_2013_Aug_14_2(10)_1013-1021.nxml.txt.nlp	24167711	SENT176	17	17	14	14	ethanol	EVL	PA448073	51466	0.472
NULL	Evid_Based_Complement_Alternat_Med_2012_Sep_18_2012_674101.nxml.txt.nlp	23028394	SENT222	2	2	26	26	donepezil	CA2	PA449394	760	0.472
NULL	Crit_Care_2011_Nov_16_15(6)_R271.nxml.txt.nlp	22087790	SENT164	2	2	20	20	nitroprusside	Yes	PA451406	7525	0.472
NULL	J_Korean_Med_Sci_2007_Dec_20_22(6)_1055-1059.nxml.txt.nlp	18162722	SENT119	14	14	21	21	pantoprazole	ESD	PA450774	2098	0.472
NULL	Front_Neuroenergetics_2013_Dec_26_5_11.nxml.txt.nlp	24421768	SENT1108	26	26	16	16	glucose	MRS	PA449773	8011	0.472
NULL	Br_J_Cancer_2013_Mar_5_108(4)_983-992.nxml.txt.nlp	23361057	SENT160	1	1	3	3	cytarabine	MLH1	PA449177	4292	0.472
NULL	Nat_Med_2011_Jul_7_17(7)_796-808.nxml.txt.nlp	21738161	SENT274	16	16	26	26	heparin	MMP2	PA449855	4313	0.472
NULL	Clinicoecon_Outcomes_Res_2014_Oct_17_6_451-461.nxml.txt.nlp	25378939	SENT116	9	9	11	11	linezolid	HAP	PA450233	5915;10313	0.472
NULL	Biomed_Res_Int_2014_Jan_29_2014_361020.nxml.txt.nlp	24605326	SENT223	1	1	46	46	staurosporine	CDK2	PA165109623	1017	0.472
NULL	Adv_Hematol_2010_Dec_5_2010_595934.nxml.txt.nlp	21151515	SENT154	7	7	29	29	prasugrel	Yes	PA154410481	7525	0.472
NULL	Virol_J_2011_May_17_8_234.nxml.txt.nlp	21575275	SENT4	30	30	28	28	ribavirin	IFN	PA451241	3439	0.472
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Aug_22_65(Pt_9)_o2213.nxml.txt.nlp	21577614	SENT72	33	33	30	30	ethanol	mol	PA448073	90527	0.472
NULL	J_Cell_Mol_Med_2014_Dec_22_18(12)_2519-2529.nxml.txt.nlp	25338520	SENT130	3	3	0	0	oxygen	ROS	PA450744	6098	0.472
NULL	J_Gen_Physiol_1987_Jun_1_89(6)_985-997.nxml.txt.nlp	2440980	SENT0	13	13	1	1	potassium	Gen	PA451047	348654	0.472
NULL	Clin_Ophthalmol_2014_Jan_13_8_219-228.nxml.txt.nlp	24531757	SENT153	8	8	4	4	brinzolamide	TIM	PA164744929	7984;8914	0.472
NULL	Indian_J_Dermatol_2013_Nov-Dec_58(6)_492d.nxml.txt.nlp	24249912	SENT47	17	17	7	7	dapsone	G6PD	PA449211	2539	0.472
NULL	Biomed_Res_Int_2013_Jun_17_2013_312656.nxml.txt.nlp	23844360	SENT172	23	23	6	6	plerixafor	HSPC	PA165958410	5688	0.472
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Feb_28_65(Pt_3)_o653.nxml.txt.nlp	21582301	SENT62	18	18	13	13	ethanol	mol	PA448073	90527	0.472
NULL	Indian_J_Anaesth_2012_Jan-Feb_56(1)_49-54.nxml.txt.nlp	22529420	SENT37	11	11	25	25	pregabalin	P150	PA164754814	10036	0.472
NULL	Chem_Cent_J_2012_Feb_21_6_15.nxml.txt.nlp	22353684	SENT101	15	15	13	13	acebutolol	mol	PA448011	90527	0.472
NULL	Br_J_Cancer_2010_May_11_102(10)_1474-1482.nxml.txt.nlp	20407438	SENT231	28	28	45	45	ethanol	P15	PA448073	1030;29107	0.472
NULL	J_Thorac_Oncol_2014_Feb_23_9(2)_205-213.nxml.txt.nlp	24419418	SENT38	24	24	14	14	pemetrexed	B12	PA10810	7126;4709	0.472
NULL	Cancer_Cell_Int_2004_Aug_17_4_5.nxml.txt.nlp	15315711	SENT102	16	16	29	29	genistein	CPP32	PA165109660	836	0.472
NULL	Oncol_Lett_2013_Oct_5_6(4)_1123-1127.nxml.txt.nlp	24137475	SENT157	2	2	14	14	ethanol	CDK4	PA448073	1019	0.472
NULL	Head_Face_Med_2012_Mar_1_8_5.nxml.txt.nlp	22376948	SENT41	28	28	0	0	alendronate	OST	PA448082	1650;23263	0.472
NULL	Mol_Pain_2013_Feb_15_9_3.nxml.txt.nlp	23413875	SENT50	0	0	2	2	resveratrol	TRPA1		8989	0.472
NULL	J_Cell_Biol_1978_Jun_1_77(3)_774-788.nxml.txt.nlp	308066	SENT6	9	9	7	7	thrombin	EGF	PA451674	1950	0.472
NULL	Infect_Drug_Resist_2009_Apr_24_2_13-26.nxml.txt.nlp	21694884	SENT300	8	8	10	10	emtricitabine	TDF	PA10069	6736	0.472
NULL	J_Cell_Biol_1998_Mar_23_140(6)_1519-1534.nxml.txt.nlp	9508783	SENT87	14	14	38	38	papain	KS1/4	PA450778	4072	0.472
NULL	Eur_J_Neurosci_2008_Oct_28(8)_1518-1535.nxml.txt.nlp	18793322	SENT78	6	6	25	25	trypsin	L15	PA451806	6138;91057	0.472
NULL	J_Korean_Med_Sci_2006_Oct_31_21(5)_904-910.nxml.txt.nlp	17043427	SENT54	13	13	11	11	4-methylumbelliferone	NAG	PA154081778	51594;4669	0.472
NULL	J_Exp_Med_2000_May_15_191(10)_1675-1686.nxml.txt.nlp	10811861	SENT156	28	28	24	24	neomycin	PFN1	PA450608	5216	0.472
NULL	Indian_J_Psychiatry_2013_Apr-Jun_55(2)_111-116.nxml.txt.nlp	23825842	SENT111	26	26	28	28	chlorpromazine	CPZ	PA448964	8532	0.472
NULL	Chem_Res_Toxicol_2011_Aug_15_24(8)_1275-1282.nxml.txt.nlp	21749116	SENT94	5	5	10	10	geldanamycin	Hsp90	PA152031327	3320	0.472
NULL	Eur_J_Psychotraumatol_2013_Jun_4_4_10_3402_ejpt_v4i0_21127.nxml.txt.nlp	NULL	SENT878	0	0	22	22	hydrocortisone	FDG	PA449905	23583	0.472
NULL	Diabetes_2009_Jul_58(7)_1471-1478.nxml.txt.nlp	19564458	SENT151	13	13	24	24	bevacizumab	VEGFR	PA130232992	3791	0.472
NULL	Br_J_Pharmacol_2011_Apr_162(7)_1509-1520.nxml.txt.nlp	21108630	SENT157	13	13	15	15	allopregnanolone	TRPC5	PA142320763	7224	0.472
NULL	Pharmaceutics_2012_May_14_4(2)_252-275.nxml.txt.nlp	24300231	SENT770	7	7	14	14	carmustine	LDE	PA448810	7957	0.472
NULL	Front_Physiol_2013_Dec_25_4_387.nxml.txt.nlp	24399969	SENT225	8	8	28	28	creatine	C3b	PA164778930	718	0.472
NULL	Cancers_(Basel)_2010_Mar_22_2(1)_190-208.nxml.txt.nlp	24281040	SENT753	6	6	20	20	choline	PSA	PA448976	29968;9520;354	0.472
NULL	J_Cardiothorac_Surg_2010_Nov_3_5_101.nxml.txt.nlp	21047408	SENT203	22	22	20	20	bivalirudin	IL-3	PA10032	3562	0.472
NULL	Cancer_Cell_Int_2010_Sep_9_10_32.nxml.txt.nlp	20828393	SENT164	24	24	21	21	cisplatin	ATF3	PA449014	467	0.472
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT10	0	0	2	2	nutlin-3	p53		7157	0.472
NULL	Int_J_Mol_Sci_2013_Apr_16_14(4)_8381-8392.nxml.txt.nlp	23591849	SENT235	11	11	9	9	efavirenz	CYP2B6	PA449441	1555	0.472
NULL	Insights_Imaging_2011_Jun_28_2(5)_609-619.nxml.txt.nlp	22347980	SENT135	1	1	6	6	oxygen	MRI	PA450744	78996	0.472
NULL	Indian_J_Pharm_Sci_2013_Sep-Oct_75(5)_523-532.nxml.txt.nlp	24403652	SENT151	20	20	6	6	atorvastatin	ATV	PA448500	4683	0.472
NULL	Front_Neurosci_2014_Mar_4_8_44.nxml.txt.nlp	24624056	SENT110	0	0	12	12	isoflurane	HO-1	PA450106	3162	0.472
NULL	Br_J_Cancer_2004_Mar_22_90(6)_1285-1292.nxml.txt.nlp	15026814	SENT96	10	10	15	15	doxorubicin	p53	PA449412	7157	0.472
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT146	8	8	6	6	pp2	PP1		5540;5464	0.472
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT273	20	20	9	9	pp2	EGFR		1956	0.472
NULL	Eur_J_Neurosci_2011_Jan_33(2)_322-337.nxml.txt.nlp	21105915	SENT596	29	29	9	9	chlordiazepoxide	GluA1	PA448932	2890	0.472
NULL	Mol_Cancer_2014_Jun_12_13_148.nxml.txt.nlp	24924916	SENT205	30	30	8	8	oxygen	TRAP1	PA450744	9392;10131	0.472
NULL	J_Cell_Biol_1998_Jun_29_141(7)_1675-1684.nxml.txt.nlp	9647658	SENT164	20	20	16	16	heparin	perlecan	PA449855	3339	0.472
NULL	Sensors_(Basel)_2013_Dec_27_14(1)_458-467.nxml.txt.nlp	24379050	SENT87	14	14	16	16	glucose	MTB	PA449773	54892;4498	0.472
NULL	Ann_Intensive_Care_2011_Jul_19_1_26.nxml.txt.nlp	21906376	SENT84	6	6	23	23	vancomycin	SAPS	PA451850	8935	0.472
NULL	Oncotarget_2013_Feb_25_4(2)_269-276.nxml.txt.nlp	23563166	SENT5	14	14	6	6	docetaxel	GEM	PA449383	2669	0.472
NULL	Case_Rep_Med_2010_Dec_26_2010_403237.nxml.txt.nlp	21209804	SENT7	7	7	5	5	bortezomib	CHOP	PA10252	1649	0.472
NULL	Breast_Cancer_(Auckl)_2011_Jul_27_5_175-199.nxml.txt.nlp	21863131	SENT497	7	7	1	1	cetuximab	Met	PA10040	79811	0.472
NULL	Oncotarget_2014_Dec_4_5(22)_11365-11380.nxml.txt.nlp	25426548	SENT32	19	19	13	13	nutlin-3	p53		7157	0.472
NULL	Anc_Sci_Life_2012_Oct-Dec_32(2)_93-98.nxml.txt.nlp	24167334	SENT134	8	8	6	6	cyclophosphamide	AR7	PA449165	7067	0.472
NULL	Korean_J_Anesthesiol_2013_Jan_21_64(1)_47-53.nxml.txt.nlp	23372886	SENT85	40	40	31	31	bupivacaine	PTG	PA135057240	5507	0.472
NULL	Exp_Neurobiol_2013_Jun_27_22(2)_96-106.nxml.txt.nlp	23833558	SENT149	15	15	26	26	sertraline	OAT	PA451333	4942	0.472
NULL	Diabetes_Care_2009_Feb_32(2)_e13-e19.nxml.txt.nlp	19171729	SENT67	7	7	10	10	rosiglitazone	DREAM	PA451283	30818	0.472
NULL	Nat_Neurosci_2011_May_17_14(5)_612-619.nxml.txt.nlp	21499254	SENT22	13	13	32	32	ethanol	NPY	PA448073	4852	0.472
NULL	Pharmaceuticals_(Basel)_2014_Mar_13_7(3)_353-365.nxml.txt.nlp	24633429	SENT78	25	25	23	23	phenol	B12	PA450913	7126;4709	0.472
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT192	31	31	8	8	trastuzumab	Yes	PA451743	7525	0.472
NULL	Nat_Commun_2013_Nov_26_4_10_1038_ncomms3816.nxml.txt.nlp	24281383	SENT98	12	12	34	34	ethanol	ANOVA	PA448073	4858	0.472
NULL	Anesth_Essays_Res_2011_Jul-Dec_5(2)_128-133.nxml.txt.nlp	NULL	SENT53	0	0	2	2	dexmedetomidine	spatial	PA449256	219793	0.472
NULL	Lab_Anim_Res_2011_Sep_30_27(3)_245-250.nxml.txt.nlp	21998614	SENT137	5	5	10	10	mannitol	EPO	PA450320	7076;8288;2056	0.472
NULL	Oncoimmunology_2012_Oct_1_1(7)_1004-1016.nxml.txt.nlp	23170249	SENT27	33	33	27	27	paclitaxel	HER-2	PA450761	2064	0.472
NULL	Diagn_Pathol_2014_Jan_20_9_11.nxml.txt.nlp	24443801	SENT9	23	23	17	17	chymotrypsin	MUC5AC	PA448994	4586	0.471
NULL	Emerg_Microbes_Infect_2014_Jan_8_3(1)_e3.nxml.txt.nlp	NULL	SENT206	4	4	2	2	ethambutol	EMB	PA164784021	133418	0.471
NULL	Mol_Biol_Rep_2013_May_16_40(9)_5315-5326.nxml.txt.nlp	23677714	SENT292	2	2	14	14	gefitinib	PC-3	PA131301952	692094	0.471
NULL	J_Cell_Biol_2005_Jul_4_170(1)_49-59.nxml.txt.nlp	15983061	SENT157	9	9	28	28	forskolin	HIF1	PA146096022	3091	0.471
NULL	Lab_Invest_2011_Jun_14_91(6)_852-858.nxml.txt.nlp	21403643	SENT16	5	5	10	10	tenofovir	MRP4	PA10204	10257	0.471
NULL	Front_Pharmacol_2014_Dec_10_5_273.nxml.txt.nlp	25540622	SENT111	16	16	23	23	cetirizine	STZ	PA448905	6484	0.471
NULL	Nat_Biotechnol_2010_May_28(5)_478-485.nxml.txt.nlp	20458318	SENT313	19	19	11	11	cyclosporine	NAG	PA449167	51594;4669	0.471
NULL	Int_J_Mol_Sci_2014_Sep_17_15(9)_16430-16457.nxml.txt.nlp	25233127	SENT1297	7	7	9	9	capsaicin	TRPV1	PA448776	7442	0.471
NULL	Front_Neurosci_2011_May_13_5_69.nxml.txt.nlp	21625610	SENT392	33	33	23	23	ethanol	GIRK3	PA448073	3765	0.471
NULL	J_Cell_Biol_2004_Jun_21_165(6)_813-822.nxml.txt.nlp	15197175	SENT219	36	36	43	43	l-glutamine	CO2	PA10090	4513	0.471
NULL	Mol_Vis_2007_Jan_24_13_57-65.nxml.txt.nlp	17277739	SENT158	15	15	11	11	heparin	FGF2	PA449855	2247;2258	0.471
NULL	J_Neuroinflammation_2011_Dec_21_8_178.nxml.txt.nlp	22189096	SENT64	23	23	21	21	neomycin	TLR3	PA450608	7098	0.471
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_13_2014_849783.nxml.txt.nlp	25477998	SENT124	0	0	5	5	berberine	IL-6	PA165860812	3569	0.471
NULL	AMB_Express_2011_Jul_13_1_16.nxml.txt.nlp	21906371	SENT9	10	10	34	34	nitrogen	PHB	PA450643	5245	0.471
NULL	Front_Cell_Neurosci_2013_Dec_3_7_239.nxml.txt.nlp	24348333	SENT323	0	0	5	5	copper	SOD1	PA449114	6647	0.471
NULL	Nat_Commun_2014_Dec_10_5_5619.nxml.txt.nlp	25493341	SENT114	27	27	8	8	l-glutamine	CO2	PA10090	4513	0.471
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT104	19	19	17	17	trypsin	FGF1	PA451806	2246	0.471
NULL	Int_J_Endocrinol_2011_Nov_17_2011_401258.nxml.txt.nlp	22164158	SENT20	12	12	5	5	tetracycline	GPR39	PA451640	2863	0.471
NULL	Arthritis_Res_Ther_2007_Oct_9_9(5)_R104.nxml.txt.nlp	17925024	SENT95	28	28	39	39	glucosamine	MMP1	PA164747613	4312	0.471
NULL	AIDS_Res_Ther_2013_May_1_10_10.nxml.txt.nlp	23634877	SENT187	30	30	27	27	lovastatin	CCL4	PA450272	6351	0.471
NULL	Front_Endocrinol_(Lausanne)_2013_Jul_8_4_80.nxml.txt.nlp	23847592	SENT36	6	6	14	14	diclofenac	UGT2B17	PA449293	7367	0.471
NULL	Exp_Hematol_Oncol_2013_Aug_2_2_19.nxml.txt.nlp	23915571	SENT148	10	10	14	14	vincristine	CHOP	PA451879	1649	0.471
NULL	Oncotarget_2014_Oct_21_5(22)_11252-11268.nxml.txt.nlp	25361004	SENT61	6	6	9	9	metformin	U87	PA450395	677775;641648	0.471
NULL	Int_J_Environ_Res_Public_Health_2010_Mar_15_7(3)_1093-1104.nxml.txt.nlp	20617020	SENT79	4	4	11	11	lipase	IL-10	PA450239	3586	0.471
NULL	Virol_J_2011_May_17_8_234.nxml.txt.nlp	21575275	SENT11	11	11	9	9	ribavirin	IFN	PA451241	3439	0.471
NULL	Angiogenesis_2010_Dec_7_13(4)_305-315.nxml.txt.nlp	20927579	SENT170	0	0	5	5	resveratrol	TSP1		7057	0.471
NULL	Clin_Ophthalmol_2010_Nov_23_4_1355-1359.nxml.txt.nlp	21179218	SENT2	10	10	16	16	travoprost	BAK	PA164781371	578	0.471
NULL	Infect_Dis_Ther_2013_Dec_3_2(2)_111-122.nxml.txt.nlp	25134475	SENT65	29	29	0	0	elvitegravir	ATV	PA165291498	4683	0.471
NULL	Exp_Hematol_Oncol_2014_Nov_7_3(1)_26.nxml.txt.nlp	NULL	SENT4	25	25	20	20	erlotinib	IGF1R	PA134687924	3480	0.471
NULL	Cell_Cycle_2013_Sep_15_12(18)_3063-3069.nxml.txt.nlp	23974099	SENT64	31	31	19	19	etoposide	MTOR	PA449552	2475	0.471
NULL	Subst_Abuse_Treat_Prev_Policy_2007_Nov_23_2_35.nxml.txt.nlp	18036213	SENT339	15	15	1	1	naltrexone	Gen	PA450588	348654	0.471
NULL	AIDS_Care_2011_Sep_14_23(9)_1154-1162.nxml.txt.nlp	21500025	SENT76	4	4	2	2	atazanavir	ATV	PA10251	4683	0.471
NULL	Mol_Cancer_2013_Nov_27_12_150.nxml.txt.nlp	24279793	SENT99	22	22	32	32	creatine	ACTA1	PA164778930	58	0.471
NULL	Br_J_Cancer_2009_Jul_21_101(2)_320-326.nxml.txt.nlp	19568234	SENT61	20	20	22	22	paraformaldehyde	CD133	PA450790	8842	0.471
NULL	Amino_Acids_2011_May_30_40(5)_1271-1296.nxml.txt.nlp	21448658	SENT26	17	17	26	26	creatine	spatial	PA164778930	219793	0.471
NULL	Pharmaceuticals_(Basel)_2013_Aug_2_6(8)_915-928.nxml.txt.nlp	24276376	SENT76	1	1	5	5	thrombin	TRA	PA451674	6955	0.471
NULL	Evid_Based_Complement_Alternat_Med_2013_Nov_4_2013_434823.nxml.txt.nlp	24302965	SENT18	14	14	20	20	entecavir	IFN	PA164784025	3439	0.471
NULL	Allergy_Asthma_Clin_Immunol_2008_Sep_15_4(3)_95-105.nxml.txt.nlp	20525130	SENT200	12	12	31	31	fluorescein	CD80	PA164746009	941	0.471
NULL	Hum_Genomics_2008_Sep_1_3(1)_71-78.nxml.txt.nlp	19129091	SENT32	13	13	34	34	nadh	ND6	PA164755085	4541	0.471
NULL	Case_Rep_Ophthalmol_2014_May_29_5(2)_162-167.nxml.txt.nlp	24987366	SENT74	13	13	24	24	ranibizumab	ERM	PA164746012	2119	0.471
NULL	Biochem_Res_Int_2012_Feb_12_2012_346972.nxml.txt.nlp	22400115	SENT238	4	4	22	22	hyaluronan	CD44	PA165958431	960	0.471
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT44	2	2	7	7	pertuzumab	HER-2		2064	0.471
NULL	Am_J_Trop_Med_Hyg_2014_Aug_6_91(2)_424-434.nxml.txt.nlp	24799369	SENT298	7	7	12	12	chloroquine	RDT	PA448948	6598	0.471
NULL	J_Inflamm_(Lond)_2006_May_4_3_8.nxml.txt.nlp	16674821	SENT56	4	4	10	10	pp2	SKI-1		8720	0.471
NULL	Int_J_Nanomedicine_2009_Apr_20_4_107-114.nxml.txt.nlp	19516889	SENT8	3	3	5	5	cisplatin	DDP	PA449014	1678	0.471
NULL	Case_Rep_Oncol_2013_May_30_6(2)_285-288.nxml.txt.nlp	23898270	SENT29	24	24	30	30	dacarbazine	BRAF	PA449197	673	0.471
NULL	Breast_Cancer_Res_Treat_2013_Aug_20_141(1)_43-53.nxml.txt.nlp	23959396	SENT28	15	15	12	12	trastuzumab	HER3	PA451743	2065	0.471
NULL	Int_J_Biol_Sci_2011_Sep_8_7(8)_1077-1092.nxml.txt.nlp	21927577	SENT52	6	6	18	18	telmisartan	ANG	PA451605	283	0.471
NULL	J_Hematol_Oncol_2009_Aug_12_2_36.nxml.txt.nlp	19674465	SENT15	6	6	17	17	thalidomide	ENL	PA451644	4298	0.471
NULL	Front_Endocrinol_(Lausanne)_2013_Jun_26_4_75.nxml.txt.nlp	23805127	SENT66	18	18	22	22	gemfibrozil	UGT2B7	PA449750	7364	0.471
NULL	Oncotarget_2014_Aug_27_5(21)_10486-10502.nxml.txt.nlp	25401222	SENT132	19	19	27	27	pp2	PI3		5266	0.471
NULL	Cell_J_2012_Dec_22_Winter_13(4)_265-274.nxml.txt.nlp	23507995	SENT218	13	13	3	3	ethanol	CA1	PA448073	759	0.471
NULL	Ann_Dermatol_2011_Aug_6_23(3)_365-368.nxml.txt.nlp	21909210	SENT38	17	17	22	22	bepotastine	gamma	PA164781356	9913	0.471
NULL	Drugs_R_D_2014_Dec_18_14(4)_233-239.nxml.txt.nlp	25231707	SENT11	20	20	6	6	creatine	PTX3	PA164778930	5806	0.471
NULL	J_Cell_Biol_2001_Jul_9_154(1)_95-108.nxml.txt.nlp	11448993	SENT162	0	0	9	9	trypsin	OTC	PA451806	5009	0.471
NULL	Br_J_Cancer_2010_Feb_16_102(4)_658-664.nxml.txt.nlp	20104222	SENT124	28	28	30	30	sunitinib	IFN	PA162372840	3439	0.471
NULL	Arthritis_Res_Ther_2004_Dec_5_6(1)_6-7.nxml.txt.nlp	14979925	SENT20	23	23	19	19	hyaluronidase	HAS3	PA164745713	3038	0.471
NULL	Bone_Marrow_Res_2014_Jul_23_2014_405920.nxml.txt.nlp	25147739	SENT259	12	12	19	19	hyaluronan	IL-8	PA165958431	3576	0.471
NULL	Arch_Toxicol_2014_Apr_2_88(5)_1109-1126.nxml.txt.nlp	24691702	SENT376	14	14	36	36	geldanamycin	IFN	PA152031327	3439	0.471
NULL	Int_J_Med_Sci_2012_Jul_25_9(6)_435-440.nxml.txt.nlp	22859903	SENT21	1	1	8	8	sevoflurane	CO2	PA451341	4513	0.471
NULL	ScientificWorldJournal_2012_Dec_5_2012_925925.nxml.txt.nlp	23304092	SENT56	8	8	6	6	copper	mol	PA449114	90527	0.471
NULL	Nucleic_Acids_Res_2010_Oct_27_38(18)_6247-6264.nxml.txt.nlp	20507916	SENT207	3	3	7	7	pp2	PP4		5531	0.471
NULL	Int_J_Breast_Cancer_2012_May_9_2012_415170.nxml.txt.nlp	22649737	SENT76	3	3	5	5	trastuzumab	HER2	PA451743	2064	0.471
NULL	Biologics_2011_Feb_14_5_21-31.nxml.txt.nlp	21383913	SENT148	27	27	8	8	tacrolimus	CLE	PA451578	51637	0.471
NULL	J_Cell_Biol_1997_Mar_10_136(5)_995-1005.nxml.txt.nlp	9060465	SENT46	17	17	7	7	dipyridamole	TFP	PA449367	7034	0.471
NULL	Am_J_Physiol_Cell_Physiol_2010_Nov_18_299(5)_C1180-C1194.nxml.txt.nlp	20720182	SENT167	11	11	15	15	hyaluronan	HAS2	PA165958431	3037	0.471
NULL	Acta_Pharmacol_Sin_2012_Oct_30_33(10)_1319-1324.nxml.txt.nlp	22842729	SENT31	9	9	6	6	cisplatin	ADM	PA449014	133	0.471
NULL	J_Korean_Med_Sci_2011_Jan_22_26(1)_33-41.nxml.txt.nlp	21218027	SENT36	36	36	19	19	gatifloxacin	DST	PA449738	667	0.471
NULL	Biomed_Res_Int_2013_Sep_4_2013_419176.nxml.txt.nlp	24093097	SENT184	39	39	28	28	axitinib	IFN	PA164924493	3439	0.471
NULL	Biomed_Res_Int_2014_Jan_27_2014_696107.nxml.txt.nlp	24587987	SENT197	31	31	35	35	ebselen	NAC	PA161660841	22861	0.471
NULL	Hum_Genomics_2009_Jan_1_3(2)_106-120.nxml.txt.nlp	19164088	SENT128	20	20	11	11	flumazenil	ALDH5A1	PA449659	7915	0.471
NULL	Environ_Health_Perspect_2010_Mar_23_118(3)_427-431.nxml.txt.nlp	20194071	SENT95	13	13	18	18	ethanol	IFN	PA448073	3439	0.471
NULL	Pharmaceuticals_(Basel)_2011_Oct_10_4(10)_1295-1314.nxml.txt.nlp	NULL	SENT655	17	17	13	13	nitrogen	gamma	PA450643	9913	0.471
NULL	Infect_Dis_Obstet_Gynecol_2011_Aug_24_2011_806105.nxml.txt.nlp	21876641	SENT109	26	26	16	16	imiquimod	EOS	PA449972	260429	0.471
NULL	Avicenna_J_Med_Biotechnol_2014_Apr-Jun_6(2)_94-103.nxml.txt.nlp	24834311	SENT49	9	9	18	18	collagenase	CO2	PA449107	4513	0.471
NULL	Brain_Sci_2014_Apr_16_4(2)_295-310.nxml.txt.nlp	24961762	SENT506	9	9	4	4	halothane	CO2	PA449845	4513	0.471
NULL	Diabetes_Care_2010_Oct_2_33(10)_2164-2168.nxml.txt.nlp	20519663	SENT25	11	11	14	14	rosiglitazone	DREAM	PA451283	30818	0.471
NULL	J_Anaesthesiol_Clin_Pharmacol_2012_Oct-Dec_28(4)_486-490.nxml.txt.nlp	23225930	SENT20	5	5	21	21	neostigmine	TKR	PA450611	8277	0.471
NULL	J_Cell_Biol_2004_Dec_6_167(5)_863-874.nxml.txt.nlp	15569715	SENT306	15	15	5	5	galactose	DAG	PA449725	1605	0.471
NULL	Mol_Cancer_2008_Mar_26_7_27.nxml.txt.nlp	18366759	SENT267	14	14	24	24	etoposide	MDM2	PA449552	4193	0.47
NULL	Cell_Death_Dis_2010_Oct_21_1(10)_e86.nxml.txt.nlp	21368859	SENT60	4	4	6	6	doxorubicin	TRAIL	PA449412	8743	0.47
NULL	Alzheimers_Res_Ther_2013_Oct_24_5(5)_50.nxml.txt.nlp	24401551	SENT328	19	19	15	15	donepezil	spatial	PA449394	219793	0.47
NULL	Bioengineered_2014_Jan_1_5(1)_38-44.nxml.txt.nlp	24445222	SENT195	17	17	1	1	mannitol	Gen	PA450320	348654	0.47
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Feb_10_68(Pt_3)_o645.nxml.txt.nlp	22412548	SENT65	15	15	12	12	ethanol	mol	PA448073	90527	0.47
NULL	J_Mol_Med_2011_Apr_16_89(4)_321-329.nxml.txt.nlp	21079906	SENT192	11	11	19	19	capsaicin	TRPV1	PA448776	7442	0.47
NULL	Breast_Cancer_Res_Treat_2012_Jun_15_133(3)_1057-1065.nxml.txt.nlp	22418700	SENT3	9	9	19	19	afatinib	HER2	PA165981154	2064	0.47
NULL	Mol_Biol_Int_2014_Sep_7_2014_852748.nxml.txt.nlp	25276427	SENT171	11	11	19	19	trastuzumab	DM1	PA451743	338023;1760;28509	0.47
NULL	Breast_Cancer_Res_2011_Sep_14_13(5)_R88.nxml.txt.nlp	21914219	SENT47	19	19	15	15	hydrocortisone	EGF	PA449905	1950	0.47
NULL	Crit_Care_2009_Jul_6_13(4)_R108.nxml.txt.nlp	19580651	SENT276	24	24	5	5	heparin	c-Jun	PA449855	3725	0.47
NULL	J_Cell_Mol_Med_2014_Sep_5_18(9)_1773-1784.nxml.txt.nlp	25091058	SENT10	14	14	8	8	anakinra	IL-17	PA10799	3605	0.47
NULL	Nucleic_Acids_Res_2012_Jul_8_40(12)_5497-5510.nxml.txt.nlp	22402492	SENT73	32	32	22	22	paraformaldehyde	CO2	PA450790	4513	0.47
NULL	Evid_Based_Complement_Alternat_Med_2014_May_8_2014_364819.nxml.txt.nlp	24899907	SENT148	18	18	20	20	tacrolimus	FKBP52	PA451578	2288	0.47
NULL	Iran_J_Pharm_Res_2014_Autumn_13(4)_1393-1401.nxml.txt.nlp	25587329	SENT107	2	2	4	4	celecoxib	ABCG2	PA448871	9429	0.47
NULL	Indian_J_Med_Res_2013_Nov_138(5)_766-778.nxml.txt.nlp	24434330	SENT177	8	8	6	6	ribavirin	IFN	PA451241	3439	0.47
NULL	Clin_Med_Insights_Oncol_2012_May_16_6_205-217.nxml.txt.nlp	22654526	SENT250	7	7	4	4	lenalidomide	IL-2	PA162363968	3558	0.47
NULL	J_Headache_Pain_2010_Feb_21_11(1)_23-31.nxml.txt.nlp	19936616	SENT53	23	23	11	11	estradiol	ACTH	PA449503	5443	0.47
NULL	Curr_Med_Chem_2014_Jul_21_663-688.nxml.txt.nlp	24251566	SENT561	8	8	24	24	pilocarpine	CA3	PA450962	761	0.47
NULL	Pain_Ther_2012_Dec_11_1(1)_3.nxml.txt.nlp	25134932	SENT359	8	8	30	30	rimonabant	CB1	PA152407999	1268	0.47
NULL	Cancers_(Basel)_2012_Sep_6_4(3)_873-903.nxml.txt.nlp	24213471	SENT989	1	1	3	3	hyaluronan	CD44	PA165958431	960	0.47
NULL	Bioinformation_2012_Jan_6_8(1)_13-19.nxml.txt.nlp	22359429	SENT26	15	15	17	17	curcumin	MRP1	PA151958596	4437	0.47
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Mar_31_66(Pt_4)_m479.nxml.txt.nlp	21580559	SENT77	40	40	37	37	ethanol	mol	PA448073	90527	0.47
NULL	BMJ_Open_2014_Feb_27_4(2)_e004071.nxml.txt.nlp	24578536	SENT90	20	20	8	8	warfarin	TTR	PA451906	7276	0.47
NULL	Int_J_Gen_Med_2012_Nov_9_5_935-942.nxml.txt.nlp	23204857	SENT81	22	22	32	32	pentobarbital	AIDA	PA450859	64853	0.47
NULL	Cancers_(Basel)_2014_Sep_5_6(3)_1769-1792.nxml.txt.nlp	25198391	SENT283	16	16	14	14	methotrexate	DAC	PA450428	13	0.47
NULL	Biomed_Res_Int_2014_Jan_16_2014_821513.nxml.txt.nlp	24527458	SENT150	4	4	6	6	propofol	NAC	PA451141	22861	0.47
NULL	Front_Synaptic_Neurosci_2014_Sep_5_6_18.nxml.txt.nlp	25249974	SENT1803	0	0	5	5	morphine	gamma	PA450550	9913	0.47
NULL	Breast_Cancer_Res_2011_Mar_10_13(2)_R27.nxml.txt.nlp	21392396	SENT254	20	20	22	22	tamoxifen	CYP2D6	PA451581	1565	0.47
NULL	F1000Res_2013_Nov_13_2_203.nxml.txt.nlp	24555099	SENT34	9	9	15	15	nadh	CBR1	PA164755085	873	0.47
NULL	J_Immunother_Cancer_2014_Aug_19_2_27.nxml.txt.nlp	25324973	SENT58	13	13	20	20	paclitaxel	IFN	PA450761	3439	0.47
NULL	Iran_J_Public_Health_2013_Feb_1_42(2)_145-148.nxml.txt.nlp	23515429	SENT67	15	15	19	19	naltrexone	NMT	PA450588	4836	0.47
NULL	Daru_2011_19(4)_249-256.nxml.txt.nlp	22615665	SENT200	9	9	0	0	aceclofenac	Tech	PA166049185	57449	0.47
NULL	Saudi_J_Anaesth_2013_Jul-Sep_7(3)_301-304.nxml.txt.nlp	24015134	SENT48	4	4	15	15	heparin	ACT	PA449855	12;11332;9457;641455	0.47
NULL	J_Midlife_Health_2013_Jan-Mar_4(1)_36-39.nxml.txt.nlp	23833532	SENT24	0	0	3	3	levonorgestrel	FOR	PA450218	51741	0.47
NULL	Cell_Res_2013_Sep_25_23(9)_1075-1090.nxml.txt.nlp	23797856	SENT99	5	5	3	3	tamoxifen	E12	PA451581	64100	0.47
NULL	Springerplus_2013_Jan_11_2_5.nxml.txt.nlp	23520572	SENT127	34	34	15	15	anastrozole	ATAC	PA448432	6375	0.47
NULL	Anal_Bioanal_Chem_2009_Oct_30_395(4)_893-905.nxml.txt.nlp	19484227	SENT143	15	15	17	17	sulfamethazine	OTC	PA451542	5009	0.47
NULL	Int_J_Genomics_2014_Jan_29_2014_894296.nxml.txt.nlp	24616891	SENT171	18	18	14	14	ethanol	PC2	PA448073	5126;5311;8535	0.47
NULL	Br_J_Cancer_2011_Apr_12_104(8)_1256-1261.nxml.txt.nlp	21448165	SENT161	24	24	21	21	sorafenib	IL2	PA7000	3558	0.47
NULL	J_Biol_Chem_2013_Oct_11_288(41)_29642-29653.nxml.txt.nlp	24005673	SENT462	9	9	7	7	hyaluronan	TSG-6	PA165958431	7130	0.47
NULL	Br_J_Cancer_2010_Feb_16_102(4)_658-664.nxml.txt.nlp	20104222	SENT201	1	1	3	3	sunitinib	IFN	PA162372840	3439	0.47
NULL	Oncol_Lett_2013_Jun_4_5(6)_1915-1920.nxml.txt.nlp	23833666	SENT100	10	10	17	17	cetuximab	EGF	PA10040	1950	0.47
NULL	Cases_J_2009_Jun_12_2_7429.nxml.txt.nlp	19829962	SENT38	5	5	3	3	ribavirin	IFN	PA451241	3439	0.47
NULL	Basic_Clin_Pharmacol_Toxicol_2013_Feb_5_112(2)_132-137.nxml.txt.nlp	22900583	SENT54	14	14	36	36	bupropion	CYP3A	PA448687	1574	0.47
NULL	Lab_Invest_2009_Nov_7_89(11)_1275-1290.nxml.txt.nlp	19736547	SENT502	6	6	11	11	curcumin	LOX-1	PA151958596	4973	0.47
NULL	Oxid_Med_Cell_Longev_2013_Mar_27_2013_607610.nxml.txt.nlp	23606926	SENT72	6	6	4	4	creatine	mol	PA164778930	90527	0.47
NULL	Int_J_Nanomedicine_2012_Oct_25_7_5565-5575.nxml.txt.nlp	23118538	SENT211	37	37	17	17	fenofibrate	SAS	PA449594	54187	0.47
NULL	Nat_Med_2011_Dec_11_18(1)_74-82.nxml.txt.nlp	22157681	SENT269	16	16	24	24	gefitinib	PTEN	PA131301952	5728	0.47
NULL	J_Neurol_Sci_2012_Nov_15_322(1-2)_92-95.nxml.txt.nlp	22819352	SENT19	12	12	15	15	ethanol	spatial	PA448073	219793	0.47
NULL	Acta_Pharmacol_Sin_2013_Oct_7_34(10)_1359-1366.nxml.txt.nlp	23933653	SENT271	2	2	7	7	retigabine	KCNQ2	PA144997862	3785	0.47
NULL	Ann_Gen_Psychiatry_2013_Jan_24_12_1.nxml.txt.nlp	23347694	SENT162	4	4	13	13	ziprasidone	MRS	PA451974	8011	0.47
NULL	Apoptosis_2012_Jun_9_17(6)_566-578.nxml.txt.nlp	22402981	SENT166	22	22	18	18	pp2	PP2		4888	0.47
NULL	Cases_J_2009_Jun_5_2_7762.nxml.txt.nlp	19830009	SENT2	17	17	26	26	ethanol	B12	PA448073	7126;4709	0.47
NULL	Mucosal_Immunol_2014_Mar_24_7(2)_335-347.nxml.txt.nlp	23881354	SENT286	8	8	2	2	dextran	GAL	PA449261	51083	0.47
NULL	Appl_Microbiol_Biotechnol_2012_Dec_18_96(5)_1157-1174.nxml.txt.nlp	23076591	SENT46	9	9	18	18	vancomycin	VISA	PA451850	57506	0.47
NULL	Exp_Ther_Med_2014_Feb_25_7(2)_417-422.nxml.txt.nlp	24396417	SENT165	16	16	14	14	fluorescein	CD4	PA164746009	920	0.47
NULL	Cancer_Cell_Int_2008_Mar_18_8_3.nxml.txt.nlp	18348720	SENT82	38	38	15	15	lapatinib	EGF	PA152241907	1950	0.47
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT101	0	0	8	8	resveratrol	DR4		8797	0.47
NULL	Antiviral_Res_2009_May_82(2)_A99-A109.nxml.txt.nlp	19176219	SENT1110	24	24	26	26	ritonavir	P-gp	PA451260	5243	0.47
NULL	Nucleic_Acids_Res_2012_Jul_1_40(12)_5775-5786.nxml.txt.nlp	22383579	SENT262	7	7	9	9	theophylline	MS2	PA451647	101	0.47
NULL	Biomed_Res_Int_2013_Jan_1_2013_458278.nxml.txt.nlp	23484118	SENT163	24	24	28	28	guanidine	GEF	PA164781028	56731	0.47
NULL	Int_J_Nanomedicine_2012_Nov_12_7_5733-5744.nxml.txt.nlp	23166438	SENT41	22	22	11	11	ethanol	Q10	PA448073	27161	0.47
NULL	Daru_2013_Dec_20_21(1)_78.nxml.txt.nlp	24359941	SENT13	5	5	3	3	cisplatin	EPO	PA449014	7076;8288;2056	0.47
NULL	J_Oncol_2012_Aug_9_2012_685213.nxml.txt.nlp	22934113	SENT228	0	0	3	3	gefitinib	ACTH	PA131301952	5443	0.47
NULL	Cancer_Manag_Res_2012_Nov_9_4_383-395.nxml.txt.nlp	23204869	SENT134	4	4	18	18	carmustine	PC-3	PA448810	692094	0.47
NULL	Diagn_Pathol_2014_Jul_10_9_143.nxml.txt.nlp	25012722	SENT102	6	6	15	15	cisplatin	PDCD4	PA449014	27250	0.47
NULL	Cell_Death_Dis_2010_Feb_4_1(2)_e23.nxml.txt.nlp	21364631	SENT242	26	26	23	23	curcumin	AP-1	PA151958596	2353;3727;2354;3725	0.47
NULL	ScientificWorldJournal_2012_Apr_19_2012_804730.nxml.txt.nlp	22606063	SENT162	25	25	27	27	tafluprost	BAK	PA165958432	578	0.47
NULL	Exp_Ther_Med_2013_Mar_17_5(3)_797-802.nxml.txt.nlp	23403698	SENT199	8	8	0	0	glucose	LC3	PA449773	84557	0.47
NULL	J_Cell_Biol_1998_May_4_141(3)_553-566.nxml.txt.nlp	9566959	SENT270	6	6	2	2	zinc	WT1	PA451956	7490	0.47
NULL	Exp_Ther_Med_2014_Nov_29_8(5)_1473-1478.nxml.txt.nlp	25289044	SENT167	27	27	29	29	heparin	AZU	PA449855	566	0.47
NULL	AIDS_Behav_2008_Jul_9_12(4)_662-669.nxml.txt.nlp	17487577	SENT113	20	20	6	6	naltrexone	RAB	PA450588	3267	0.47
NULL	Angew_Chem_Int_Ed_Engl_2013_Jan_2_52(1)_325-330.nxml.txt.nlp	23080482	SENT39	17	17	3	3	thrombin	ACPP	PA451674	55	0.47
NULL	Arthritis_Res_Ther_2008_Apr_2_10(2)_R39.nxml.txt.nlp	18384679	SENT41	16	16	6	6	etoricoxib	NNT	PA164776853	23530	0.47
NULL	CNS_Drugs_2014_Jun_24_28(10)_875-886.nxml.txt.nlp	24958205	SENT319	2	2	9	9	ethanol	NPY	PA448073	4852	0.47
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT154	45	45	43	43	vinorelbine	ASC	PA451881	29108	0.469
NULL	J_Gynecol_Oncol_2012_Jan_9_23(1)_35-42.nxml.txt.nlp	22355465	SENT106	25	25	12	12	cisplatin	CDK1	PA449014	983	0.469
NULL	Crit_Care_2007_Aug_14_11(4)_R87.nxml.txt.nlp	17697359	SENT33	2	2	10	10	dextran	IL-6	PA449261	3569	0.469
NULL	Braz_J_Med_Biol_Res_2013_Aug_10_46(7)_589-600.nxml.txt.nlp	23903679	SENT200	13	13	24	24	lidocaine	ANOVA	PA450226	4858	0.469
NULL	Virol_J_2009_Dec_1_6_213.nxml.txt.nlp	19951438	SENT160	9	9	12	12	mitomycin	TRAIL	PA450524	8743	0.469
NULL	Brain_Behav_2011_Sep_1(1)_44-54.nxml.txt.nlp	22398980	SENT178	32	32	29	29	oxygen	CO2	PA450744	4513	0.469
NULL	J_Hematol_Oncol_2008_Aug_11_1_11.nxml.txt.nlp	18694493	SENT39	8	8	10	10	sorafenib	IFN	PA7000	3439	0.469
NULL	Child_Adolesc_Psychiatry_Ment_Health_2008_Jan_15_2_1.nxml.txt.nlp	18197978	SENT131	10	10	17	17	methylphenidate	NNT	PA450464	23530	0.469
NULL	Nanoscale_Res_Lett_2010_Jul_28_5(11)_1749-1754.nxml.txt.nlp	21124643	SENT30	21	21	5	5	ethanol	NO3	PA448073	4681	0.469
NULL	Diabetes_Care_2010_Feb_16_33(2)_322-326.nxml.txt.nlp	19918015	SENT32	3	3	5	5	metformin	LKB1	PA450395	6794	0.469
NULL	Drug_Des_Devel_Ther_2014_Sep_16_8_1391-1403.nxml.txt.nlp	25258509	SENT190	13	13	5	5	ethanol	ANOVA	PA448073	4858	0.469
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT186	7	7	9	9	erlotinib	CYP3A	PA134687924	1574	0.469
NULL	J_Adv_Pharm_Technol_Res_2012_Jan-Mar_3(1)_57-61.nxml.txt.nlp	22470895	SENT77	10	10	7	7	ethanol	mol	PA448073	90527	0.469
NULL	Mol_Brain_2013_Dec_16_6_56.nxml.txt.nlp	24330819	SENT202	24	24	35	35	dantrolene	GluN2D	PA449208	2906	0.469
NULL	J_Anaesthesiol_Clin_Pharmacol_2011_Jul-Sep_27(3)_349-353.nxml.txt.nlp	21897506	SENT63	11	11	20	20	oxygen	CO2	PA450744	4513	0.469
NULL	Clin_Med_Insights_Oncol_2011_Sep_21_5_265-314.nxml.txt.nlp	22084619	SENT119	32	32	5	5	oxygen	HIF-1	PA450744	29072	0.469
NULL	Breast_Cancer_Res_2014_May_27_16(3)_R52.nxml.txt.nlp	24887554	SENT88	24	24	20	20	hydrocortisone	EGF	PA449905	1950	0.469
NULL	Br_J_Cancer_2010_Jan_19_102(2)_383-391.nxml.txt.nlp	20010943	SENT94	8	8	6	6	verapamil	mol	PA451868	90527	0.469
NULL	Mucosal_Immunol_2014_Mar_24_7(2)_335-347.nxml.txt.nlp	23881354	SENT335	23	23	7	7	dextran	GAL	PA449261	51083	0.469
NULL	Cancer_Cell_Int_2014_Jul_12_14_61.nxml.txt.nlp	25120383	SENT37	35	35	31	31	heparin	BMP4	PA449855	652	0.469
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT158	3	3	15	15	perifosine	JNK	PA165291471	5599	0.469
NULL	J_Breast_Cancer_2013_Mar_31_16(1)_122-126.nxml.txt.nlp	23593093	SENT115	10	10	14	14	trastuzumab	gamma	PA451743	9913	0.469
NULL	Curr_Cardiol_Rev_2012_May_8(2)_158-165.nxml.txt.nlp	22708914	SENT44	17	17	23	23	otamixaban	TAK	PA151958300	1025	0.469
NULL	Braz_J_Microbiol_2011_Dec_1_Oct-Dec_42(4)_1608-1615.nxml.txt.nlp	24031795	SENT149	13	13	11	11	glucose	mol	PA449773	90527	0.469
NULL	Int_J_Mol_Sci_2014_Sep_30_15(10)_17733-17750.nxml.txt.nlp	25272228	SENT30	16	16	8	8	oxygen	HIF-1	PA450744	29072	0.469
NULL	Clin_Ophthalmol_2009_Jun_2_3_117-122.nxml.txt.nlp	19668554	SENT85	13	13	27	27	brimonidine	BAK	PA448665	578	0.469
NULL	Curr_Cardiol_Rev_2012_Aug_8(3)_239-249.nxml.txt.nlp	22935021	SENT30	0	0	20	20	clopidogrel	ADP	PA449053	23038	0.469
NULL	Int_J_Cardiovasc_Imaging_2012_Apr_21_28(4)_843-853.nxml.txt.nlp	21509430	SENT167	38	38	10	10	iron	spatial	PA450087	219793	0.469
NULL	Nucleic_Acids_Res_2013_Apr_17_41(7)_4129-4143.nxml.txt.nlp	23420868	SENT281	17	17	10	10	hemin	GAPDH	PA449849	2597	0.469
NULL	Facts_Views_Vis_Obgyn_2010_2(2)_74-87.nxml.txt.nlp	25302102	SENT222	2	2	0	0	cyclophosphamide	CHOP	PA449165	1649	0.469
NULL	Crit_Care_2008_Jun_25_12(3)_R84.nxml.txt.nlp	18578859	SENT116	12	12	7	7	heparin	PF4	PA449855	5196	0.469
NULL	Indian_J_Ophthalmol_2011_May-Jun_59(3)_264b-266.nxml.txt.nlp	21586865	SENT2	9	9	13	13	triamcinolone	hole	PA451749	80757	0.469
NULL	Cell_Tissue_Res_2012_Sep_3_349(3)_849-862.nxml.txt.nlp	22298022	SENT58	12	12	14	14	estradiol	activin	PA449503	83729	0.469
NULL	Clin_Pharmacol_2010_Sep_17_2_185-198.nxml.txt.nlp	22291504	SENT8	3	3	1	1	creatine	Q10	PA164778930	27161	0.469
NULL	Mol_Vis_2011_May_4_17_1172-1181.nxml.txt.nlp	21617754	SENT150	12	12	2	2	staurosporine	FKBP51	PA165109623	2289	0.469
NULL	Amino_Acids_2014_Feb_20_46(5)_1275-1283.nxml.txt.nlp	24553827	SENT85	3	3	15	15	taurine	CSAD	PA451590	51380	0.469
NULL	Open_Biomed_Eng_J_2011_Jan_19_5_1-7.nxml.txt.nlp	21625374	SENT57	12	12	16	16	metformin	EGI	PA450395	1957	0.469
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT20	12	12	10	10	nutlin-3	RITA		55422;84934	0.469
NULL	Ann_Hematol_2007_Dec_14_86(12)_871-877.nxml.txt.nlp	17874322	SENT65	11	11	16	16	azathioprine	IFN	PA448515	3439	0.469
NULL	Clin_Ophthalmol_2013_Oct_31_7_2143-2146.nxml.txt.nlp	24204117	SENT27	16	16	24	24	ranibizumab	San	PA164746012	80218	0.469
NULL	Diabetes_Care_2013_Jan_11_36(1)_e13.nxml.txt.nlp	23264296	SENT26	19	19	0	0	glucose	JAMA	PA449773	50848	0.469
NULL	Front_Neurosci_2013_Jun_13_7_97.nxml.txt.nlp	23781167	SENT463	12	12	17	17	methylphenidate	spatial	PA450464	219793	0.469
NULL	Curr_Neuropharmacol_2008_Jun_6(2)_151-163.nxml.txt.nlp	19305794	SENT352	13	13	21	21	capsaicin	TRPV1	PA448776	7442	0.469
NULL	Acta_Pharmacol_Sin_2012_Jan_3_33(1)_49-56.nxml.txt.nlp	22212430	SENT90	12	12	16	16	thrombin	A10	PA451674	28870	0.469
NULL	Chem_Cent_J_2012_Dec_10_6_151.nxml.txt.nlp	23216944	SENT107	17	17	15	15	hydroquinone	mol	PA449924	90527	0.469
NULL	Mol_Cancer_2010_Mar_9_9_54.nxml.txt.nlp	20214788	SENT10	7	7	12	12	tetracycline	JDP2	PA451640	122953	0.469
NULL	Cancers_(Basel)_2013_May_3_5(2)_491-510.nxml.txt.nlp	24216987	SENT158	4	4	7	7	creatine	ADP	PA164778930	23038	0.469
NULL	Mol_Imaging_Biol_2012_Jun_13_14(3)_261-276.nxml.txt.nlp	22160875	SENT66	10	10	4	4	trastuzumab	NIRF	PA451743	27190;115426	0.469
NULL	Genome_Biol_Evol_2011_Mar_14_3_302-308.nxml.txt.nlp	21402865	SENT9	26	26	28	28	collagenase	HtrA	PA449107	5654	0.469
NULL	Biomed_Eng_Online_2012_Nov_14_11_84.nxml.txt.nlp	23151049	SENT180	30	30	26	26	alendronate	PTH	PA448082	5741	0.469
NULL	Korean_J_Anesthesiol_2013_Dec_26_65(6)_501-507.nxml.txt.nlp	24427455	SENT17	20	20	14	14	neostigmine	NMB	PA450611	10457;4828	0.469
NULL	Case_Rep_Pediatr_2012_Aug_9_2012_323681.nxml.txt.nlp	22924145	SENT74	3	3	6	6	tocilizumab	IL-6	PA165292659	3569	0.469
NULL	Nat_Commun_2011_Feb_15_2_199.nxml.txt.nlp	21326231	SENT428	9	9	2	2	pilocarpine	HCN	PA450962	378938	0.469
NULL	Arthritis_Res_Ther_2009_Feb_3_11(1)_R15.nxml.txt.nlp	19192274	SENT212	17	17	13	13	chloroquine	IL-8	PA448948	3576	0.469
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Sep_19_68(Pt_10)_o2944.nxml.txt.nlp	23125729	SENT3	31	31	3	3	phenol	mol	PA450913	90527	0.469
NULL	Int_J_Biomed_Sci_2006_Dec_2(4)_414-421.nxml.txt.nlp	23675010	SENT250	15	15	36	36	mitomycin	PRK	PA450524	1263	0.469
NULL	Oxid_Med_Cell_Longev_2011_May_23_2011_213286.nxml.txt.nlp	NULL	SENT52	24	24	34	34	choline	GAPDH	PA448976	2597	0.469
NULL	Biomed_Res_Int_2013_Jul_31_2013_389046.nxml.txt.nlp	23984356	SENT269	3	3	8	8	pemetrexed	B12	PA10810	7126;4709	0.469
NULL	J_Immunother_Cancer_2014_Jan_27_2_2.nxml.txt.nlp	24829759	SENT148	16	16	14	14	sorafenib	IL-21	PA7000	59067;50616;27189	0.469
NULL	Basic_Clin_Neurosci_2014_Winter_5(1)_66-73.nxml.txt.nlp	25436086	SENT16	14	14	7	7	lidocaine	LHA	PA450226	1081	0.469
NULL	Ann_Neurosci_2011_Apr_18(2)_48-55.nxml.txt.nlp	25205921	SENT247	34	34	18	18	riluzole	EAAT2	PA451251	6506	0.469
NULL	Carcinogenesis_2014_May_13_35(5)_1055-1066.nxml.txt.nlp	24419232	SENT337	0	0	7	7	metformin	MVD	PA450395	4597	0.469
NULL	Arthritis_Res_Ther_2012_Jan_30_14(1)_201.nxml.txt.nlp	22293240	SENT31	30	30	9	9	glucosamine	ACR	PA164747613	49	0.469
NULL	J_Korean_Med_Sci_2009_Jan_29_24(Suppl_1)_S170-S175.nxml.txt.nlp	19194548	SENT92	19	19	25	25	cisplatin	EPO	PA449014	7076;8288;2056	0.469
NULL	J_Exp_Med_2000_May_15_191(10)_1755-1764.nxml.txt.nlp	10811868	SENT90	21	21	28	28	neomycin	CCR4	PA450608	25819;57472;1233	0.469
NULL	Curr_Gerontol_Geriatr_Res_2011_May_11_2011_624156.nxml.txt.nlp	21765826	SENT73	7	7	27	27	erythromycin	P-gp	PA449493	5243	0.469
NULL	Lab_Invest_2014_May_17_94(5)_517-527.nxml.txt.nlp	24638272	SENT213	23	23	5	5	gemcitabine	ONECUT1	PA449748	3175	0.469
NULL	Int_Semin_Surg_Oncol_2008_Apr_28_5_9.nxml.txt.nlp	18442393	SENT74	11	11	14	14	tamoxifen	HER-2	PA451581	2064	0.469
NULL	Cells_2014_Jun_11_3(2)_616-626.nxml.txt.nlp	24921186	SENT62	40	40	38	38	capsaicin	TRPA1	PA448776	8989	0.469
NULL	J_Gen_Physiol_1955_May_20_38(5)_581-598.nxml.txt.nlp	14367774	SENT0	16	16	1	1	trypsin	Gen	PA451806	348654	0.469
NULL	Open_Biochem_J_2012_Dec_11_6_139-159.nxml.txt.nlp	23264833	SENT1018	14	14	20	20	oxygen	CO2	PA450744	4513	0.469
NULL	Oxid_Med_Cell_Longev_2012_Jan_19_2012_390678.nxml.txt.nlp	22315655	SENT26	0	0	2	2	gliclazide	NAC	PA10892	22861	0.469
NULL	Cancers_(Basel)_2014_Nov_14_6(4)_2275-2295.nxml.txt.nlp	25405526	SENT201	30	30	25	25	etoposide	CHOP	PA449552	1649	0.469
NULL	Diabetes_Metab_Syndr_Obes_2014_Mar_6_7_85-94.nxml.txt.nlp	24623984	SENT82	35	35	37	37	metformin	GLP	PA450395	342096	0.469
NULL	Crit_Care_2010_Mar_15_14(2)_R30.nxml.txt.nlp	20226064	SENT271	31	31	4	4	remifentanil	IL-10	PA451232	3586	0.469
NULL	J_Biomed_Sci_2014_Jul_22_21(1)_65.nxml.txt.nlp	25047949	SENT129	15	15	8	8	docetaxel	PC-3	PA449383	692094	0.469
NULL	J_Nat_Med_2014_Feb_19_68(2)_253-266.nxml.txt.nlp	24550097	SENT225	4	4	16	16	ethanol	aP2	PA448073	2167	0.469
NULL	Cell_Commun_Signal_2013_May_29_11_38.nxml.txt.nlp	23718910	SENT182	4	4	4	4	pp2	PP2		4888	0.469
NULL	Clinics_(Sao_Paulo)_2012_Jan_67(1)_79-82.nxml.txt.nlp	22249485	SENT12	12	12	16	16	vasopressin	AVPR2	PA451858	554	0.469
NULL	Clin_Psychopharmacol_Neurosci_2011_Apr_30_9(1)_36-43.nxml.txt.nlp	23431025	SENT102	13	13	7	7	haloperidol	FLI	PA449841	2314	0.469
NULL	Cases_J_2009_Jun_10_2_8183.nxml.txt.nlp	19830060	SENT62	14	14	7	7	doxorubicin	CHOP	PA449412	1649	0.469
NULL	Breast_Cancer_Res_2007_Jan_23_9(1)_R7.nxml.txt.nlp	17244352	SENT42	25	25	11	11	tamoxifen	SULT1A1	PA451581	6817	0.469
NULL	Clin_Mol_Hepatol_2013_Sep_30_19(3)_195-209.nxml.txt.nlp	24133659	SENT296	10	10	29	29	telbivudine	LAM	PA164760861	7249;7248	0.469
NULL	Crit_Care_2011_Apr_5_15(2)_R109.nxml.txt.nlp	21466684	SENT55	11	11	19	19	heparin	ACT	PA449855	12;11332;9457;641455	0.468
NULL	J_Oncol_2013_Feb_17_2013_872957.nxml.txt.nlp	23476648	SENT118	6	6	4	4	cisplatin	SFN	PA449014	25996;2810	0.468
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT210	20	20	15	15	curcumin	PC-3	PA151958596	692094	0.468
NULL	Biomed_Res_Int_2014_Jan_16_2014_821513.nxml.txt.nlp	24527458	SENT118	9	9	11	11	propofol	NAC	PA451141	22861	0.468
NULL	Environ_Health_Perspect_2010_Jul_3_118(7)_936-942.nxml.txt.nlp	20199942	SENT171	28	28	14	14	arsenite	mot-2	PA452638	3313	0.468
NULL	Curr_Neuropharmacol_2014_Jul_12(4)_365-379.nxml.txt.nlp	25342944	SENT534	28	28	3	3	paroxetine	5-HT1D	PA450801	3352	0.468
NULL	Nat_Commun_2011_Aug_9_2_420.nxml.txt.nlp	21829182	SENT67	16	16	28	28	helium	mol	PA449848	90527	0.468
NULL	Cancer_Manag_Res_2012_Nov_9_4_383-395.nxml.txt.nlp	23204869	SENT111	13	13	6	6	carmustine	PC-3	PA448810	692094	0.468
NULL	Acta_Pharmacol_Sin_2010_Feb_5_31(2)_184-190.nxml.txt.nlp	20139901	SENT120	28	28	22	22	metformin	OCT2	PA450395	6582;5452	0.468
NULL	Curr_Med_Chem_2013_Jan_20(3)_438-447.nxml.txt.nlp	23157636	SENT453	28	28	6	6	clozapine	FGA	PA449061	2243	0.468
NULL	Curr_Chem_Genomics_2010_Mar_1_4_1-8.nxml.txt.nlp	20448812	SENT142	10	10	32	32	methotrexate	OATP1B3	PA450428	28234	0.468
NULL	Cells_2014_Apr_29_3(2)_331-362.nxml.txt.nlp	24785347	SENT109	14	14	10	10	capsaicin	TRPV1	PA448776	7442	0.468
NULL	Contemp_Oncol_(Pozn)_2013_Apr_29_17(2)_137-143.nxml.txt.nlp	23788980	SENT179	45	45	24	24	bromocriptine	PRL	PA448671	5617	0.468
NULL	Oral_Dis_2008_Sep_14(6)_520-528.nxml.txt.nlp	18221457	SENT76	31	31	8	8	nitrogen	OCT	PA450643	5362	0.468
NULL	Int_Cardiovasc_Res_J_2012_Dec_15_6(4)_113-117.nxml.txt.nlp	24757604	SENT30	20	20	12	12	paclitaxel	DES	PA450761	1674	0.468
NULL	Front_Neurol_2014_Sep_3_5_169.nxml.txt.nlp	25232349	SENT431	9	9	17	17	estradiol	aromatase	PA449503	1588	0.468
NULL	Front_Genet_2014_Oct_21_5_372.nxml.txt.nlp	25374583	SENT158	12	12	33	33	cisplatin	FANCJ	PA449014	83990	0.468
NULL	Ital_J_Pediatr_2012_Dec_4_38_66.nxml.txt.nlp	23206577	SENT163	28	28	10	10	colchicine	MDR1	PA449092	5243	0.468
NULL	Indian_J_Nucl_Med_2010_Jul-Sep_25(3)_103-108.nxml.txt.nlp	NULL	SENT187	21	21	17	17	doxorubicin	FDG	PA449412	23583	0.468
NULL	J_Cancer_2011_Mar_8_2_142-152.nxml.txt.nlp	21475719	SENT229	1	1	3	3	lipase	CEA	PA450239	5670;1087	0.468
NULL	Cancer_Cell_Int_2011_May_15_11_13.nxml.txt.nlp	21569620	SENT138	11	11	5	5	bortezomib	PC-3	PA10252	692094	0.468
NULL	Anc_Sci_Life_2011_Jan-Mar_30(3)_78-83.nxml.txt.nlp	22557432	SENT8	20	20	6	6	diazepam	ASM	PA449283	6609;283120	0.468
NULL	Front_Psychol_2012_Aug_17_3_297.nxml.txt.nlp	22912626	SENT190	9	9	19	19	minocycline	IL-6	PA450519	3569	0.468
NULL	Curr_Hepat_Rep_2010_May_21_9(2)_75-90.nxml.txt.nlp	20461127	SENT149	0	0	35	35	entecavir	LAM	PA164784025	7249;7248	0.468
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT17	28	28	4	4	phenprocoumon	CYP4F2	PA450921	8529	0.468
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Feb_4_68(Pt_3)_o600.nxml.txt.nlp	22412513	SENT79	0	0	7	7	tramadol	mol	PA451735	90527	0.468
NULL	Oncotarget_2014_Oct_23_5(22)_11154-11167.nxml.txt.nlp	25525888	SENT180	34	34	19	19	sunitinib	VEGFR	PA162372840	3791	0.468
NULL	Front_Behav_Neurosci_2014_Sep_15_8_322.nxml.txt.nlp	25309372	SENT19	4	4	8	8	bupropion	DES	PA448687	1674	0.468
NULL	Oncol_Lett_2013_Jun_29_5(6)_1889-1896.nxml.txt.nlp	23833662	SENT124	25	25	20	20	choline	FDG	PA448976	23583	0.468
NULL	Neural_Plast_2012_Jul_8_2012_710943.nxml.txt.nlp	22830052	SENT234	12	12	17	17	creatine	B12	PA164778930	7126;4709	0.468
NULL	J_Biol_Chem_2013_Feb_1_288(5)_3512-3522.nxml.txt.nlp	23239883	SENT211	13	13	19	19	calcein	mol	PA132595336	90527	0.468
NULL	Nat_Commun_2011_Aug_9_2_420.nxml.txt.nlp	21829182	SENT67	16	16	4	4	helium	S10	PA449848	9861;6204	0.468
NULL	Glycobiology_2013_Apr_12_23(4)_398-411.nxml.txt.nlp	23315448	SENT267	25	25	37	37	hyaluronan	HARE	PA165958431	55576	0.468
NULL	Front_Neurosci_2014_Jun_3_8_128.nxml.txt.nlp	24917782	SENT140	13	13	33	33	ethanol	POMC	PA448073	5443	0.468
NULL	Cancers_(Basel)_2011_Aug_19_3(3)_3353-3369.nxml.txt.nlp	21961053	SENT480	0	0	16	16	genistein	TRAMP	PA165109660	8718;23471;9189	0.468
NULL	Anesth_Pain_Med_2014_Sep_9_4(4)_e14221.nxml.txt.nlp	25599022	SENT13	0	0	11	11	propofol	LPO	PA451141	4025	0.468
NULL	Case_Rep_Vasc_Med_2012_Dec_13_2012_750953.nxml.txt.nlp	23304629	SENT53	16	16	2	2	epoprostenol	SPG	PA449479	55764	0.468
NULL	Case_Rep_Nephrol_Urol_2014_Apr_12_4(1)_75-81.nxml.txt.nlp	24847349	SENT6	18	18	9	9	everolimus	APT	PA164746311	653639	0.468
NULL	Curr_Neuropharmacol_2013_Dec_11(6)_652-663.nxml.txt.nlp	24396340	SENT240	5	5	18	18	capsaicin	TRPV4	PA448776	59341	0.468
NULL	Diabetes_2013_Jun_17_62(6)_2048-2058.nxml.txt.nlp	23349496	SENT297	14	14	17	17	hyaluronan	TSG-6	PA165958431	7130	0.468
NULL	Exp_Diabetes_Res_2012_Oct_15_2012_465282.nxml.txt.nlp	23118742	SENT9	27	27	1	1	metformin	FGF21	PA450395	26291	0.468
NULL	Inflamm_Res_2014_Jan_24_63(5)_325-328.nxml.txt.nlp	24458309	SENT7	7	7	28	28	dextran	IL-8	PA449261	3576	0.468
NULL	Eur_J_Haematol_2009_May_82(5)_339-349.nxml.txt.nlp	19187276	SENT218	8	8	19	19	rivaroxaban	TKR	PA165958360	8277	0.468
NULL	Parasit_Vectors_2009_Sep_25_2(Suppl_2)_S5.nxml.txt.nlp	19778466	SENT135	32	32	30	30	praziquantel	MOX	PA164764583	26002	0.468
NULL	Mol_Cancer_2013_May_24_12_45.nxml.txt.nlp	23705792	SENT256	28	28	13	13	doxorubicin	ICBP90	PA449412	54887;29128	0.468
NULL	Bioinorg_Chem_Appl_2013_Sep_19_2013_541030.nxml.txt.nlp	24170995	SENT147	5	5	7	7	amoxicillin	SBF	PA448406	7702	0.468
NULL	Cancers_(Basel)_2010_Apr_16_2(2)_567-591.nxml.txt.nlp	24281083	SENT65	8	8	5	5	lipase	HSL	PA450239	3991	0.468
NULL	Arthritis_Res_Ther_2006_Dec_19_8(6)_R187.nxml.txt.nlp	17177994	SENT74	23	23	29	29	fluorescein	San	PA164746009	80218	0.468
NULL	J_Biol_Chem_2009_Sep_18_284(38)_26096-26105.nxml.txt.nlp	19628870	SENT117	10	10	10	10	pp2	PP2		4888	0.468
NULL	Biochim_Biophys_Acta_2014_Apr_1841(4)_588-594.nxml.txt.nlp	24440819	SENT127	16	16	11	11	lipase	ATGL	PA450239	57104	0.468
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT75	20	20	11	11	cyclosporine	ABCB1	PA449167	5243	0.468
NULL	Trials_2012_Feb_20_13_20.nxml.txt.nlp	22348447	SENT278	4	4	0	0	dobutamine	AGF	PA449381	83854	0.468
NULL	Pediatr_Cardiol_2010_Jan_14_31(1)_90-95.nxml.txt.nlp	19915892	SENT105	7	7	20	20	palivizumab	Era	PA164748781	2099	0.468
NULL	Springerplus_2014_Sep_9_3_510.nxml.txt.nlp	25279302	SENT246	12	12	16	16	creatine	GATM	PA164778930	2628	0.468
NULL	Int_J_Mol_Sci_2010_Oct_25_11(10)_4165-4174.nxml.txt.nlp	21152328	SENT111	27	27	24	24	ethanol	mol	PA448073	90527	0.468
NULL	Oxid_Med_Cell_Longev_2013_Jun_11_2013_870472.nxml.txt.nlp	23840921	SENT82	8	8	13	13	chloroquine	spatial	PA448948	219793	0.468
NULL	Open_Virol_J_2013_Feb_25_7_28-36.nxml.txt.nlp	23493233	SENT89	29	29	42	42	l-glutamine	CO2	PA10090	4513	0.468
NULL	Acta_Neuropathol_2013_Sep_5_126(5)_741-756.nxml.txt.nlp	24005891	SENT363	10	10	0	0	pilocarpine	CTRL	PA450962	1506	0.468
NULL	Leukemia_2014_Apr_8_28(4)_894-903.nxml.txt.nlp	23925045	SENT93	12	12	14	14	tamoxifen	TMX	PA451581	81542	0.468
NULL	Acta_Histochem_Cytochem_2013_Dec_28_46(6)_187-197.nxml.txt.nlp	24610966	SENT138	5	5	7	7	pilocarpine	AQP5	PA450962	362	0.468
NULL	Curr_Chem_Genomics_2009_Mar_17_3_7-12.nxml.txt.nlp	19936037	SENT48	19	19	13	13	forskolin	NKH	PA146096022	275;2731	0.468
NULL	Chem_Cent_J_2014_May_7_8_32.nxml.txt.nlp	24883080	SENT107	20	20	25	25	benzaldehyde	mol	PA448571	90527	0.468
NULL	Gut_Liver_2013_Sep_14_7(5)_585-593.nxml.txt.nlp	24073317	SENT108	17	17	15	15	ribavirin	IFN	PA451241	3439	0.468
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT140	28	28	10	10	vinorelbine	ASC	PA451881	29108	0.468
NULL	Front_Immunol_2012_Jan_24_3_3.nxml.txt.nlp	22566889	SENT191	24	24	22	22	rituximab	CHOP	PA451261	1649	0.468
NULL	Theranostics_2014_Jan_2_4(2)_119-133.nxml.txt.nlp	24465270	SENT133	28	28	22	22	estradiol	EGF	PA449503	1950	0.468
NULL	Cancer_Imaging_2010_Jul_19_10(1)_153-160.nxml.txt.nlp	20663736	SENT10	11	11	7	7	choline	FDG	PA448976	23583	0.468
NULL	Evid_Based_Complement_Alternat_Med_2011_Feb_14_2011_429843.nxml.txt.nlp	21869897	SENT136	34	34	31	31	ethanol	CORT	PA448073	1325	0.468
NULL	J_Hypertens_2014_Oct_4_32(10)_2054-2063.nxml.txt.nlp	24999799	SENT220	11	11	17	17	olmesartan	OSCAR	PA164742950	126014	0.468
NULL	Braz_J_Med_Biol_Res_2012_Mar_30_45(4)_299-307.nxml.txt.nlp	22450373	SENT37	21	21	32	32	ethanol	EPM	PA448073	2054	0.468
NULL	Int_J_Cell_Biol_2013_Feb_17_2013_162094.nxml.txt.nlp	23476651	SENT33	9	9	7	7	atorvastatin	HO-1	PA448500	3162	0.468
NULL	Breast_Cancer_Res_Treat_2013_Aug_20_141(1)_43-53.nxml.txt.nlp	23959396	SENT192	14	14	12	12	trastuzumab	HER2	PA451743	2064	0.468
NULL	Korean_Circ_J_2013_Jun_30_43(6)_400-407.nxml.txt.nlp	23882289	SENT106	13	13	4	4	doxorubicin	survivin	PA449412	332	0.468
NULL	Acta_Pharmacol_Sin_2010_Sep_23_31(9)_1208-1212.nxml.txt.nlp	20729871	SENT121	13	13	0	0	creatine	p53	PA164778930	7157	0.468
NULL	Int_J_Biomed_Sci_2014_Mar_10(1)_52-60.nxml.txt.nlp	24711750	SENT68	16	16	8	8	pargyline	San	PA450797	80218	0.468
NULL	Int_J_Environ_Res_Public_Health_2010_Apr_25_7(4)_1285-1301.nxml.txt.nlp	20617031	SENT411	21	21	8	8	ethanol	c-Jun	PA448073	3725	0.468
NULL	Br_J_Cancer_2010_Oct_26_103(9)_1380-1390.nxml.txt.nlp	20877355	SENT223	17	17	15	15	etoposide	TRAIL	PA449552	8743	0.468
NULL	Eye_(Lond)_2014_Aug_23_28(8)_962-967.nxml.txt.nlp	24858526	SENT101	12	12	8	8	mitomycin	IFN	PA450524	3439	0.468
NULL	Ann_Gastroenterol_2013_26(1)_29-36.nxml.txt.nlp	24714698	SENT75	10	10	7	7	mitomycin	STZ	PA450524	6484	0.468
NULL	Biomed_Res_Int_2014_Jan_29_2014_361020.nxml.txt.nlp	24605326	SENT223	7	7	4	4	flavopiridol	CDK2	PA452627	1017	0.468
NULL	Indian_J_Dermatol_2010_Jul-Sep_55(3)_281-283.nxml.txt.nlp	21063527	SENT20	22	22	26	26	heparin	IFN	PA449855	3439	0.468
NULL	J_Immunol_Res_2014_May_8_2014_565320.nxml.txt.nlp	24901010	SENT68	31	31	43	43	phenytoin	HLA-B	PA450947	3106	0.468
NULL	Clinics_(Sao_Paulo)_2014_Jun_69(6)_438-446.nxml.txt.nlp	24964310	SENT50	16	16	44	44	alendronate	OCN	PA448082	632	0.468
NULL	Biosci_Rep_2012_Dec_20_33(1)_e00011.nxml.txt.nlp	23137297	SENT256	29	29	31	31	heparin	RPSA	PA449855	3921	0.468
NULL	J_Int_AIDS_Soc_2011_Nov_11_14_53.nxml.txt.nlp	22078415	SENT111	12	12	22	22	fluorescein	San	PA164746009	80218	0.468
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT61	10	10	8	8	dasatinib	PP2	PA162372878	4888	0.468
NULL	J_Cardiothorac_Surg_2014_May_2_9_77.nxml.txt.nlp	24885502	SENT38	11	11	15	15	thyroglobulin	CD56	PA164754910	4684	0.468
NULL	Crit_Care_2010_Jul_19_14(4)_179.nxml.txt.nlp	20670385	SENT37	8	8	34	34	vasopressin	RAI	PA451858	10848;6050	0.468
NULL	Case_Rep_Pediatr_2011_Nov_24_2011_562620.nxml.txt.nlp	22606516	SENT19	9	9	5	5	vancomycin	CD69	PA451850	969	0.468
NULL	J_Gen_Physiol_1948_Nov_20_32(2)_241-263.nxml.txt.nlp	18891149	SENT0	19	19	1	1	trypsin	Gen	PA451806	348654	0.468
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT192	35	35	8	8	cetuximab	Yes	PA10040	7525	0.468
NULL	Nature_2012_Dec_20_492(7429)_387-392.nxml.txt.nlp	23222541	SENT309	2	2	4	4	thrombin	PAR1	PA451674	79581;2149	0.468
NULL	Oncol_Lett_2014_Jun_8_7(6)_2035-2040.nxml.txt.nlp	24932285	SENT168	26	26	0	0	mitomycin	UGT1A1	PA450524	54658	0.468
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1051.nxml.txt.nlp	24503543	SENT144	20	20	15	15	mitoxantrone	Yes	PA450526	7525	0.468
NULL	Crit_Care_2010_Jul_19_14(4)_179.nxml.txt.nlp	20670385	SENT37	8	8	5	5	vasopressin	AVP	PA451858	114548;551	0.468
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1437-1448.nxml.txt.nlp	24056706	SENT111	22	22	24	24	quinidine	CYP2D6	PA451209	1565	0.468
NULL	Nat_Methods_2011_Jun_24_8(6)_487-493.nxml.txt.nlp	21516115	SENT156	24	24	29	29	gefitinib	EGF	PA131301952	1950	0.468
NULL	Croat_Med_J_2012_Jun_53(3)_214-223.nxml.txt.nlp	22661134	SENT58	23	23	16	16	clonidine	ACTH	PA449051	5443	0.468
NULL	J_Cardiothorac_Surg_2010_Apr_19_5_26.nxml.txt.nlp	20403156	SENT143	22	22	9	9	etomidate	RAI	PA164743987	10848;6050	0.468
NULL	Cancer_Manag_Res_2014_May_23_6_225-252.nxml.txt.nlp	24904222	SENT487	14	14	5	5	raloxifene	DES	PA451221	1674	0.468
NULL	Oncotarget_2014_Nov_12_5(20)_9626-9640.nxml.txt.nlp	25275299	SENT77	14	14	12	12	thrombin	LPA	PA451674	4018	0.468
NULL	Korean_J_Anesthesiol_2013_Dec_26_65(6_Suppl)_S1-S3.nxml.txt.nlp	24478828	SENT54	9	9	11	11	atracurium	BCHE	PA164776840	590	0.467
NULL	N_Z_Vet_J_2010_Jun_7_58(3)_121-129.nxml.txt.nlp	20514085	SENT111	13	13	20	20	albendazole	MOX	PA164746058	26002	0.467
NULL	Evid_Based_Complement_Alternat_Med_2011_Mar_3_2011_304960.nxml.txt.nlp	21423691	SENT154	3	3	5	5	loperamide	castor	PA450262	54897	0.467
NULL	Cancer_Cell_Int_2014_Jan_23_14_6.nxml.txt.nlp	24456610	SENT213	22	22	25	25	resveratrol	p53		7157	0.467
NULL	Front_Oncol_2013_Apr_23_3_86.nxml.txt.nlp	23630663	SENT704	2	2	4	4	docetaxel	HER2	PA449383	2064	0.467
NULL	Case_Rep_Dermatol_2012_May_10_4(2)_114-118.nxml.txt.nlp	22679424	SENT23	3	3	24	24	budesonide	CD4	PA448681	920	0.467
NULL	Comput_Math_Methods_Med_2013_Mar_20_2013_802512.nxml.txt.nlp	23573174	SENT77	42	42	15	15	tetracycline	MYC	PA451640	4609	0.467
NULL	J_Biol_Chem_2012_Apr_27_287(18)_14644-14658.nxml.txt.nlp	22375002	SENT62	34	34	18	18	pp2	PDE4D		5144	0.467
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Dec_2_5_30.nxml.txt.nlp	17140452	SENT239	7	7	5	5	gatifloxacin	GAT	PA449738	10249	0.467
NULL	Appl_Microbiol_Biotechnol_2012_Sep_31_95(6)_1427-1436.nxml.txt.nlp	22846902	SENT165	2	2	7	7	zinc	ADH	PA451956	551	0.467
NULL	Exp_Ther_Med_2013_Mar_15_5(3)_957-963.nxml.txt.nlp	23408713	SENT234	2	2	29	29	ethanol	GAPDH	PA448073	2597	0.467
NULL	Oncol_Lett_2013_Feb_7_5(2)_440-446.nxml.txt.nlp	23420122	SENT247	29	29	24	24	gemcitabine	Gem	PA449748	51053	0.467
NULL	EMBO_Mol_Med_2012_Jun_15_4(6)_472-485.nxml.txt.nlp	22419550	SENT141	26	26	19	19	thyroglobulin	TROP1	PA164754910	4072	0.467
NULL	J_Cell_Mol_Med_2013_Oct_16_17(10)_1261-1270.nxml.txt.nlp	23855452	SENT231	28	28	23	23	cisplatin	GEM	PA449014	2669	0.467
NULL	Ann_Pediatr_Endocrinol_Metab_2014_Mar_31_19(1)_8-12.nxml.txt.nlp	24926457	SENT53	20	20	24	24	iodine	IDD	PA450049	9993;1299	0.467
NULL	Oncogenesis_2014_May_12_3(5)_e102.nxml.txt.nlp	24819061	SENT119	5	5	19	19	nadh	p53	PA164755085	7157	0.467
NULL	Oncologist_2013_Oct_18(Suppl_1)_S1-S7.nxml.txt.nlp	24157419	SENT5	21	21	18	18	afatinib	EGFR	PA165981154	1956	0.467
NULL	Comput_Math_Methods_Med_2013_Mar_20_2013_802512.nxml.txt.nlp	23573174	SENT77	42	42	10	10	tetracycline	MYC	PA451640	4609	0.467
NULL	Glia_2013_Aug_6_61(8)_1331-1346.nxml.txt.nlp	23832647	SENT270	7	7	9	9	clodronate	DKK2	PA10239	27123	0.467
NULL	Chem_Cent_J_2012_Dec_10_6_151.nxml.txt.nlp	23216944	SENT107	17	17	9	9	hydroquinone	mol	PA449924	90527	0.467
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2008_Jun_1_64(Pt_6)_611-619.nxml.txt.nlp	18560148	SENT191	10	10	12	12	heparin	CXCR3	PA449855	2833	0.467
NULL	Pharmaceuticals_(Basel)_2013_Aug_29_6(9)_1082-1093.nxml.txt.nlp	24276420	SENT29	2	2	7	7	camptothecin	CPT2	PA153590860	1376	0.467
NULL	Acta_Pharmacol_Sin_2014_Jul_9_35(7)_889-898.nxml.txt.nlp	24909515	SENT159	18	18	21	21	phenol	SULT1A1	PA450913	6817	0.467
NULL	J_Hematol_Oncol_2010_Mar_23_3_11.nxml.txt.nlp	20331897	SENT161	31	31	34	34	oxaliplatin	CRT	PA131285527	811	0.467
NULL	Ann_Clin_Microbiol_Antimicrob_2009_Sep_24_8_26.nxml.txt.nlp	19778428	SENT102	18	18	4	4	ceftriaxone	PEN	PA448866	9933	0.467
NULL	Int_J_Mol_Sci_2014_Jun_25_15(7)_11234-11244.nxml.txt.nlp	24968266	SENT65	13	13	8	8	docetaxel	PC-3	PA449383	692094	0.467
NULL	Mol_Cancer_2007_Sep_26_6_61.nxml.txt.nlp	17894897	SENT101	4	4	11	11	etoposide	HIF-1	PA449552	29072	0.467
NULL	Clin_Psychopharmacol_Neurosci_2011_Apr_30_9(1)_36-43.nxml.txt.nlp	23431025	SENT126	4	4	10	10	aripiprazole	FLI	PA10026	2314	0.467
NULL	J_Carcinog_2011_Jun_17_10_16.nxml.txt.nlp	NULL	SENT213	0	0	17	17	sulindac	SSAT	PA451565	6303	0.467
NULL	J_Histochem_Cytochem_2012_Oct_60(10)_749-760.nxml.txt.nlp	22821669	SENT262	9	9	7	7	hyaluronan	TSG-6	PA165958431	7130	0.467
NULL	Oncoimmunology_2012_Oct_1_1(7)_1027-1037.nxml.txt.nlp	23170251	SENT264	20	20	29	29	l-glutamine	IL-2	PA10090	3558	0.467
NULL	Nucleic_Acids_Res_2007_Jan_7_35(1)_143-151.nxml.txt.nlp	17158165	SENT52	27	27	35	35	cidofovir	San	PA448997	80218	0.467
NULL	Indian_J_Pharm_Sci_2008_Sep-Oct_70(5)_658-661.nxml.txt.nlp	21394269	SENT36	2	2	5	5	itopride	RAB	PA152432599	3267	0.467
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT184	10	10	27	27	l-leucine	ATP5A	PA450197	498	0.467
NULL	Indian_J_Med_Paediatr_Oncol_2013_Jul-Sep_34(3)_224-228.nxml.txt.nlp	24516317	SENT49	14	14	8	8	imatinib	CYP3A4	PA10804	1576	0.467
NULL	Curr_Gerontol_Geriatr_Res_2013_Dec_22_2013_495793.nxml.txt.nlp	24454359	SENT37	27	27	23	23	medroxyprogesterone	CEE	PA450344	51608	0.467
NULL	Arthritis_Res_Ther_2011_Jul_30_13(4)_R126.nxml.txt.nlp	21801431	SENT162	32	32	21	21	etanercept	IL-23	PA449515	51561	0.467
NULL	Curr_Neuropharmacol_2008_Jun_6(2)_151-163.nxml.txt.nlp	19305794	SENT434	13	13	15	15	capsaicin	TRPV1	PA448776	7442	0.467
NULL	Biomed_Res_Int_2014_Jan_29_2014_361020.nxml.txt.nlp	24605326	SENT223	7	7	46	46	flavopiridol	CDK2	PA452627	1017	0.467
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT143	31	31	29	29	vinorelbine	ASC	PA451881	29108	0.467
NULL	Neural_Plast_2007_Oct_10_2007_23250.nxml.txt.nlp	NULL	SENT4334	17	17	11	11	rimonabant	CB1	PA152407999	1268	0.467
NULL	Case_Rep_Oncol_2012_Dec_20_5(3)_676-681.nxml.txt.nlp	23341811	SENT39	29	29	14	14	bevacizumab	EGFR	PA130232992	1956	0.467
NULL	Br_J_Cancer_2009_Jul_21_101(2)_312-319.nxml.txt.nlp	19568237	SENT141	24	24	22	22	pp2	PP1		5540;5464	0.467
NULL	Ann_Indian_Acad_Neurol_2014_Mar_17(Suppl_1)_S32-S36.nxml.txt.nlp	24791086	SENT112	29	29	22	22	propofol	PTB	PA451141	58155	0.467
NULL	Front_Mol_Neurosci_2014_Dec_1_7_94.nxml.txt.nlp	25520615	SENT98	0	0	5	5	ketamine	NOT	PA450144	4929	0.467
NULL	BMJ_Open_Respir_Res_2014_Jan_3_1(1)_e000010.nxml.txt.nlp	25478169	SENT46	15	15	19	19	azathioprine	NAC	PA448515	22861	0.467
NULL	EMBO_Mol_Med_2013_Jan_26_5(1)_52-63.nxml.txt.nlp	23184605	SENT50	24	24	6	6	neomycin	HDAC6	PA450608	10013	0.467
NULL	Acta_Pharmacol_Sin_2010_Aug_5_31(8)_907-914.nxml.txt.nlp	20686515	SENT214	17	17	23	23	taurine	ANOVA	PA451590	4858	0.467
NULL	Clin_Pharmacokinet_2014_Sep_3_53(1)_1-16.nxml.txt.nlp	23999929	SENT203	19	19	25	25	rivaroxaban	CLCR	PA165958360	11330	0.467
NULL	Br_J_Cancer_2004_Mar_22_90(6)_1285-1292.nxml.txt.nlp	15026814	SENT123	10	10	15	15	cisplatin	p53	PA449014	7157	0.467
NULL	Amino_Acids_2011_May_22_40(5)_1369-1383.nxml.txt.nlp	21424716	SENT274	22	22	16	16	creatine	CEE	PA164778930	51608	0.467
NULL	Adv_Urol_2012_Jul_31_2012_429213.nxml.txt.nlp	22899908	SENT39	21	21	19	19	heparin	FGF1	PA449855	2246	0.467
NULL	Brain_Sci_2013_Jul_19_3(3)_1076-1094.nxml.txt.nlp	24961522	SENT339	1	1	4	4	ethanol	spatial	PA448073	219793	0.467
NULL	Cancer_Microenviron_2008_Dec_20_1(1)_103-111.nxml.txt.nlp	19308689	SENT274	24	24	32	32	thrombin	MIA	PA451674	8190	0.467
NULL	Breast_Cancer_Res_Treat_2012_Aug_29_135(1)_241-252.nxml.txt.nlp	22872523	SENT270	17	17	10	10	midazolam	CYP3A	PA450496	1574	0.467
NULL	Korean_J_Radiol_2011_Apr_25_May-Jun_12(3)_319-326.nxml.txt.nlp	21603291	SENT56	3	3	22	22	propranolol	DBP	PA451145	3295;1628;2638	0.467
NULL	J_Hematol_Oncol_2012_May_15_5_23.nxml.txt.nlp	22587422	SENT13	25	25	22	22	dasatinib	ALL	PA162372878	613	0.467
NULL	Int_J_Vasc_Med_2012_Sep_26_2012_794898.nxml.txt.nlp	23056947	SENT159	18	18	9	9	nadh	GPD1L	PA164755085	23171	0.467
NULL	Bioinformation_2011_Feb_15_5(10)_422-429.nxml.txt.nlp	21423888	SENT23	20	20	15	15	galactose	GAL	PA449725	51083	0.467
NULL	Int_J_Mol_Cell_Med_2014_Summer_3(3)_183-189.nxml.txt.nlp	25317405	SENT84	0	0	7	7	estradiol	MC4R	PA449503	4160	0.467
NULL	Nucleic_Acids_Res_2011_Sep_11_39(17)_7455-7464.nxml.txt.nlp	21666254	SENT321	6	6	24	24	cisplatin	zeta	PA449014	9907	0.467
NULL	Afr_J_Infect_Dis_2010_4(2)_20-28.nxml.txt.nlp	23878697	SENT39	8	8	16	16	lumefantrine	ACT	PA165111722	12;11332;9457;641455	0.467
NULL	Eur_J_Haematol_2014_Feb_25_92(2)_127-136.nxml.txt.nlp	24118452	SENT179	18	18	16	16	anagrelide	CRT	PA164742986	811	0.467
NULL	Cancer_Biol_Med_2013_Mar_10(1)_36-42.nxml.txt.nlp	23691443	SENT168	11	11	13	13	fludarabine	CTX	PA449655	1593	0.467
NULL	Mol_Vis_2011_Apr_27_17_1044-1055.nxml.txt.nlp	21552499	SENT2	6	6	25	25	bevacizumab	apelin	PA130232992	8862	0.467
NULL	Mol_Cancer_2009_Nov_19_8_108.nxml.txt.nlp	19925669	SENT258	8	8	21	21	doxorubicin	CRT	PA449412	811	0.467
NULL	Exp_Anim_2014_Aug_22_63(3)_277-287.nxml.txt.nlp	25077757	SENT571	4	4	0	0	resveratrol	NF-kappaB		4790	0.467
NULL	J_Histochem_Cytochem_2012_Oct_60(10)_749-760.nxml.txt.nlp	22821669	SENT262	11	11	7	7	hyaluronan	TSG-6	PA165958431	7130	0.467
NULL	Arthritis_Res_Ther_2008_Oct_15_10(Suppl_1)_S4.nxml.txt.nlp	19007424	SENT34	4	4	33	33	abatacept	ACR	PA164747080	49	0.467
NULL	Eur_J_Clin_Pharmacol_2011_May_9_67(5)_477-482.nxml.txt.nlp	21305273	SENT14	27	27	19	19	dobutamine	DBP	PA449381	3295;1628;2638	0.467
NULL	Br_J_Cancer_2013_Apr_16_108(7)_1393-1401.nxml.txt.nlp	23511559	SENT177	31	31	33	33	daunorubicin	FLT3	PA449212	2322	0.467
NULL	Front_Genet_2012_Sep_6_3_173.nxml.txt.nlp	22973297	SENT187	4	4	12	12	gemcitabine	FKBP5	PA449748	2289	0.467
NULL	Pharmaceuticals_(Basel)_2013_Aug_6_6(8)_929-959.nxml.txt.nlp	24276377	SENT105	25	25	7	7	oxaliplatin	c-FLIP	PA131285527	8837	0.467
NULL	Mol_Cancer_2009_May_15_8_28.nxml.txt.nlp	19445670	SENT183	13	13	11	11	doxorubicin	XIAP	PA449412	331	0.467
NULL	ASN_Neuro_2010_Aug_11_2(4)_e00040.nxml.txt.nlp	20711301	SENT67	29	29	20	20	trypsin	L15	PA451806	6138;91057	0.467
NULL	Mol_Cancer_2012_Apr_26_11_26.nxml.txt.nlp	22537224	SENT117	14	14	11	11	geldanamycin	FANCF	PA152031327	2188	0.467
NULL	Exp_Ther_Med_2013_Apr_5_5(4)_1259-1263.nxml.txt.nlp	23596498	SENT23	9	9	5	5	capsaicin	TRPV1	PA448776	7442	0.467
NULL	Oncotarget_2013_Aug_8_4(8)_1130-1142.nxml.txt.nlp	24029073	SENT75	7	7	20	20	glucose	G6PD	PA449773	2539	0.467
NULL	Clinics_(Sao_Paulo)_2013_Feb_68(Suppl_1)_5-14.nxml.txt.nlp	23503950	SENT191	4	4	24	24	protamine	TP1	PA10366	7011	0.467
NULL	Ther_Clin_Risk_Manag_2006_Sep_2(3)_281-295.nxml.txt.nlp	18360603	SENT170	0	0	13	13	alendronate	NNT	PA448082	23530	0.467
NULL	Am_J_Rhinol_Allergy_2012_Jan-Feb_26(1)_1-6.nxml.txt.nlp	22391065	SENT267	11	11	13	13	oxygen	AP-1	PA450744	2353;3727;2354;3725	0.467
NULL	Arthritis_Res_2002_Jul_26_4(5)_R9.nxml.txt.nlp	12223112	SENT61	0	0	15	15	fluorescein	CD80	PA164746009	941	0.467
NULL	Br_J_Cancer_2011_Jun_7_104(12)_1848-1853.nxml.txt.nlp	21610704	SENT75	10	10	7	7	panitumumab	KRAS	PA162373091	3845	0.467
NULL	J_Cancer_2013_Jan_11_4(2)_117-132.nxml.txt.nlp	23386910	SENT157	22	22	9	9	olaparib	BRCA2		675	0.467
NULL	Pharmaceuticals_(Basel)_2011_Jul_14_4(7)_1032-1051.nxml.txt.nlp	NULL	SENT188	27	27	24	24	ethanol	mol	PA448073	90527	0.467
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT330	2	2	0	0	chlorothiazide	ABCG2	PA448953	9429	0.467
NULL	ScientificWorldJournal_2013_Dec_14_2013_862763.nxml.txt.nlp	24396311	SENT55	2	2	5	5	phenol	TPC	PA450913	8030;60386	0.467
NULL	Biomed_Res_Int_2013_Aug_6_2013_602987.nxml.txt.nlp	24027759	SENT273	28	28	26	26	paclitaxel	SMF	PA450761	22993	0.467
NULL	Oncotarget_2011_Dec_31_2(12)_1279-1290.nxml.txt.nlp	22249125	SENT34	25	25	32	32	forskolin	p38	PA146096022	10598;1432;7965	0.466
NULL	Ann_Gastroenterol_2014_27(4)_313-319.nxml.txt.nlp	25331779	SENT145	20	20	18	18	mesalazine	POR	PA450384	5447	0.466
NULL	Br_J_Cancer_2009_Jul_21_101(2)_238-243.nxml.txt.nlp	19568242	SENT178	8	8	10	10	bevacizumab	IFN	PA130232992	3439	0.466
NULL	Indian_J_Anaesth_2014_Jul-Aug_58(4)_423-429.nxml.txt.nlp	25197110	SENT115	2	2	0	0	ondansetron	ODF	PA450705	8600	0.466
NULL	Int_J_Endocrinol_2014_Apr_30_2014_674987.nxml.txt.nlp	24883061	SENT122	34	34	32	32	collagenase	AP-1	PA449107	2353;3727;2354;3725	0.466
NULL	Drug_Saf_2014_Feb_19_37(4)_201-211.nxml.txt.nlp	24550106	SENT254	10	10	7	7	omeprazole	B12	PA450704	7126;4709	0.466
NULL	J_Parasitol_Res_2011_Oct_9_2011_174614.nxml.txt.nlp	22007287	SENT125	27	27	0	0	oxygen	ROS	PA450744	6098	0.466
NULL	Int_J_Inflam_2011_Sep_20_2011_367284.nxml.txt.nlp	21941675	SENT412	17	17	8	8	heparin	IL-8	PA449855	3576	0.466
NULL	J_Vis_Exp_2014_May_20_(87)_51655.nxml.txt.nlp	24893837	SENT53	27	27	9	9	hydrocortisone	F12	PA449905	2161	0.466
NULL	Oncol_Rep_2013_Apr_23_29(4)_1268-1274.nxml.txt.nlp	23354756	SENT92	3	3	8	8	paclitaxel	SLC25A43	PA450761	203427	0.466
NULL	Cholesterol_2011_Feb_22_2011_503028.nxml.txt.nlp	21490773	SENT8	0	0	7	7	methotrexate	ABCA1	PA450428	19	0.466
NULL	Br_J_Cancer_2010_May_11_102(10)_1456-1460.nxml.txt.nlp	20461090	SENT143	3	3	5	5	temsirolimus	IFN	PA164746890	3439	0.466
NULL	J_Cell_Biol_2002_Nov_11_159(3)_489-498.nxml.txt.nlp	12417579	SENT65	39	39	33	33	paraformaldehyde	E12	PA450790	64100	0.466
NULL	Gene_Technol_2014_Aug_11_3(2)_114.nxml.txt.nlp	25606572	SENT231	33	33	7	7	azacitidine	EZH2	PA451996	2146	0.466
NULL	FEBS_Open_Bio_2012_Aug_22_2_279-283.nxml.txt.nlp	23650611	SENT12	0	0	6	6	raloxifene	IFN	PA451221	3439	0.466
NULL	Clin_Mol_Hepatol_2014_Sep_25_20(3)_283-290.nxml.txt.nlp	25320732	SENT8	4	4	14	14	propranolol	EVL	PA451145	51466	0.466
NULL	Int_J_Mol_Sci_2013_Aug_14_14(8)_16719-16731.nxml.txt.nlp	23949634	SENT68	8	8	5	5	thrombin	TPC	PA451674	8030;60386	0.466
NULL	Front_Endocrinol_(Lausanne)_2015_Jan_9_5_235.nxml.txt.nlp	25620956	SENT259	11	11	2	2	glucosamine	p53	PA164747613	7157	0.466
NULL	Basic_Clin_Neurosci_2014_Summer_5(3)_182-190.nxml.txt.nlp	25337378	SENT180	8	8	14	14	bupropion	mol	PA448687	90527	0.466
NULL	Basic_Clin_Neurosci_2014_Summer_5(3)_182-190.nxml.txt.nlp	25337378	SENT163	7	7	5	5	bupropion	mol	PA448687	90527	0.466
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1063.nxml.txt.nlp	24556678	SENT79	23	23	14	14	thioridazine	Mcl-1	PA451666	4170	0.466
NULL	Clin_Interv_Aging_2009_Jun_9_4_241-250.nxml.txt.nlp	19554095	SENT55	0	0	5	5	denosumab	RANKL	PA166048634	8600	0.466
NULL	Int_J_Mol_Sci_2010_May_25_11(5)_2253-2266.nxml.txt.nlp	20559514	SENT32	26	26	22	22	ethanol	SN2	PA448073	92745	0.466
NULL	Arthritis_Res_Ther_2009_Aug_24_11(4)_R127.nxml.txt.nlp	19703304	SENT119	32	32	27	27	adalimumab	OASIS	PA10004	90993	0.466
NULL	Clin_Interv_Aging_2014_Aug_16_9_1363-1373.nxml.txt.nlp	25170260	SENT241	12	12	15	15	amisulpride	Yes	PA162565877	7525	0.466
NULL	J_Korean_Med_Sci_2011_Jul_20_26(7)_938-944.nxml.txt.nlp	21738349	SENT90	13	13	7	7	fluorescein	IL-17	PA164746009	3605	0.466
NULL	ISRN_Neurosci_2013_Sep_30_2013_784520.nxml.txt.nlp	24959566	SENT134	9	9	11	11	vasopressin	ACTH	PA451858	5443	0.466
NULL	Int_J_Mol_Sci_2013_Aug_14_14(8)_16719-16731.nxml.txt.nlp	23949634	SENT26	0	0	15	15	thrombin	PAR-1	PA451674	2011;2149	0.466
NULL	Nat_Chem_2011_Nov_20_4(2)_99-104.nxml.txt.nlp	22270625	SENT143	9	9	44	44	fluorescein	BRD4	PA164746009	23476	0.466
NULL	Basic_Clin_Neurosci_2014_Winter_5(1)_66-73.nxml.txt.nlp	25436086	SENT139	4	4	7	7	lidocaine	LHA	PA450226	1081	0.466
NULL	Mol_Cancer_2008_Jan_29_7_16.nxml.txt.nlp	18226269	SENT39	2	2	12	12	curcumin	TRAIL	PA151958596	8743	0.466
NULL	Genome_Biol_2003_May_15_4(6)_R37.nxml.txt.nlp	12801411	SENT139	17	17	15	15	l-glutamine	F12	PA10090	2161	0.466
NULL	Curr_Rev_Musculoskelet_Med_2009_Mar_10_2(1)_56-64.nxml.txt.nlp	19468919	SENT50	26	26	8	8	heparin	OPG	PA449855	690	0.466
NULL	Am_J_Cardiovasc_Drugs_2014_Oct_31_14(2)_79-87.nxml.txt.nlp	24174174	SENT212	0	0	8	8	pravastatin	adiponectin	PA451089	9370	0.466
NULL	Antiviral_Res_2009_May_82(2)_A99-A109.nxml.txt.nlp	19176219	SENT1133	40	40	42	42	indinavir	P-gp	PA449977	5243	0.466
NULL	Drug_Des_Devel_Ther_2014_Sep_23_8_1527-1538.nxml.txt.nlp	25284985	SENT204	30	30	26	26	celecoxib	IFN	PA448871	3439	0.466
NULL	Orphanet_J_Rare_Dis_2007_Jan_4_2_1.nxml.txt.nlp	17204147	SENT117	10	10	7	7	trypsin	PRSS2	PA451806	5645	0.466
NULL	J_Psychopharmacol_2013_Jun_27(6)_497-506.nxml.txt.nlp	23438502	SENT183	27	27	0	0	ketamine	CAGE	PA450144	168400	0.466
NULL	Endocrinol_Metab_(Seoul)_2014_Dec_29_29(4)_450-456.nxml.txt.nlp	25325263	SENT39	7	7	11	11	octreotide	OST	PA450678	1650;23263	0.466
NULL	Core_Evid_2011_Feb_8_6_23-29.nxml.txt.nlp	21468240	SENT32	2	2	11	11	plerixafor	CD34	PA165958410	947	0.466
NULL	Core_Evid_2010_Jul_27_5_1-10.nxml.txt.nlp	20694135	SENT130	16	16	12	12	levodopa	CLE	PA450213	51637	0.466
NULL	Bioinformation_2011_Sep_28_7(3)_130-133.nxml.txt.nlp	22125383	SENT53	12	12	14	14	ketoconazole	PLP1	PA450146	5354	0.466
NULL	Drug_Des_Devel_Ther_2014_Sep_23_8_1527-1538.nxml.txt.nlp	25284985	SENT194	30	30	26	26	celecoxib	IFN	PA448871	3439	0.466
NULL	Cells_2014_May_23_3(2)_517-545.nxml.txt.nlp	24861977	SENT1146	0	0	7	7	capsaicin	P2X3	PA448776	5024	0.466
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT11	8	8	3	3	sulindac	AKT	PA451565	207	0.466
NULL	eLife_2014_May_27_3_e02200.nxml.txt.nlp	24867637	SENT564	28	28	24	24	etoposide	RITA	PA449552	55422;84934	0.466
NULL	Cardiovasc_Res_2009_Jul_1_83(1)_24-33.nxml.txt.nlp	19297368	SENT168	3	3	0	0	heparin	Ang1	PA449855	284	0.466
NULL	Case_Rep_Vasc_Med_2012_Dec_13_2012_750953.nxml.txt.nlp	23304629	SENT53	25	25	2	2	phentolamine	SPG	PA450926	55764	0.466
NULL	Crit_Care_2011_Aug_11_15(4)_226.nxml.txt.nlp	21892977	SENT28	4	4	9	9	vasopressin	ACTH	PA451858	5443	0.466
NULL	Int_J_Fertil_Steril_2011_Mar_21_Apr-Jun_5(1)_1-8.nxml.txt.nlp	24917917	SENT76	13	13	32	32	mitomycin	CO2	PA450524	4513	0.466
NULL	Diabetes_Care_2012_Feb_16_35(2)_327-333.nxml.txt.nlp	22179958	SENT156	21	21	26	26	metformin	B12	PA450395	7126;4709	0.466
NULL	Cell_Commun_Signal_2013_Nov_11_11_86.nxml.txt.nlp	24215724	SENT548	3	3	25	25	thrombin	PAR3	PA451674	56288;2151	0.466
NULL	Br_J_Pharmacol_2014_Jul_25_171(14)_3463-3475.nxml.txt.nlp	24641440	SENT133	21	21	16	16	sildenafil	IL-13	PA451346	3596	0.466
NULL	Cardiovasc_Diabetol_2013_Oct_10_12_146.nxml.txt.nlp	24112518	SENT145	15	15	6	6	potassium	PAD	PA451047	79665;23569	0.466
NULL	Nucleic_Acids_Res_2006_Jul_4_34(11)_3299-3308.nxml.txt.nlp	16820530	SENT570	36	36	31	31	ethanol	PP1	PA448073	5540;5464	0.466
NULL	Neural_Regen_Res_2013_Jul_5_8(19)_1803-1813.nxml.txt.nlp	25206477	SENT158	0	0	3	3	cilostazol	spatial	PA164746334	219793	0.466
NULL	J_Int_Soc_Sports_Nutr_2012_Apr_17_9_17.nxml.txt.nlp	22510253	SENT3	11	11	16	16	l-arginine	AAKG	PA448478	51422	0.466
NULL	Europace_2012_Dec_6_14(12)_1700-1707.nxml.txt.nlp	22772054	SENT128	25	25	41	41	heparin	Yes	PA449855	7525	0.466
NULL	Mol_Cancer_2007_Sep_26_6_61.nxml.txt.nlp	17894897	SENT206	32	32	15	15	etoposide	HIF-1	PA449552	29072	0.466
NULL	Exp_Ther_Med_2014_Aug_6_8(2)_585-590.nxml.txt.nlp	25009624	SENT130	3	3	0	0	oxygen	ROS	PA450744	6098	0.466
NULL	Biol_Open_2014_Nov_21_3(12)_1207-1216.nxml.txt.nlp	25416063	SENT43	15	15	10	10	zinc	NANOS2	PA451956	339345	0.466
NULL	Kidney_Int_Suppl_(2011)_2012_Jun_15_2(2)_186-197.nxml.txt.nlp	25018932	SENT297	6	6	9	9	rituximab	ACTH	PA451261	5443	0.466
NULL	Protein_Pept_Lett_2014_Sep_21(7)_679-687.nxml.txt.nlp	24654848	SENT136	29	29	18	18	potassium	ADP	PA451047	23038	0.466
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Dec_6_65(Pt_1)_o39.nxml.txt.nlp	21581681	SENT61	22	22	16	16	nitrile	mol	PA450636	90527	0.466
NULL	Cell_Death_Dis_2014_Jul_17_5(7)_e1336.nxml.txt.nlp	25032859	SENT205	33	33	37	37	nadh	ADP	PA164755085	23038	0.466
NULL	Int_J_Inflam_2010_Aug_9_2010_151097.nxml.txt.nlp	21152121	SENT39	10	10	12	12	thrombin	HMGB1	PA451674	3146	0.466
NULL	Breast_Cancer_Res_2009_Oct_28_11(5)_211.nxml.txt.nlp	19889200	SENT74	31	31	5	5	anastrozole	ARNO	PA448432	9266	0.466
NULL	Br_J_Cancer_1988_Jun_57(6)_548-552.nxml.txt.nlp	3044430	SENT6	2	2	0	0	carboplatin	CHIP	PA448803	10273	0.466
NULL	Eur_J_Clin_Pharmacol_2012_Jan_7_68(1)_55-64.nxml.txt.nlp	21735164	SENT275	7	7	9	9	hydrocodone	CYP2D6	PA449900	1565	0.465
NULL	Indian_J_Med_Res_2014_Apr_139(4)_572-578.nxml.txt.nlp	24927344	SENT117	26	26	9	9	warfarin	CYP4F2	PA451906	8529	0.465
NULL	Clin_Infect_Dis_2012_Aug_1_55(Suppl_2)_S154-S161.nxml.txt.nlp	22752865	SENT128	22	22	33	33	vancomycin	Yes	PA451850	7525	0.465
NULL	Br_J_Cancer_2003_Mar_10_88(5)_788-795.nxml.txt.nlp	12618891	SENT142	24	24	22	22	bosentan	FasL	PA10034	356	0.465
NULL	Ann_Gen_Psychiatry_2008_Aug_18_7_11.nxml.txt.nlp	18706108	SENT0	23	23	1	1	bupropion	Gen	PA448687	348654	0.465
NULL	J_Cell_Biol_1998_Aug_10_142(3)_625-633.nxml.txt.nlp	9700154	SENT201	11	11	13	13	estradiol	Raf-1	PA449503	5894	0.465
NULL	Mol_Vis_2011_Aug_18_17_2221-2227.nxml.txt.nlp	21897744	SENT116	3	3	5	5	l-arginine	NAC	PA448478	22861	0.465
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT98	18	18	16	16	vinorelbine	ASC	PA451881	29108	0.465
NULL	Mol_Biol_Cell_2012_Mar_15_23(6)_1080-1095.nxml.txt.nlp	22262457	SENT412	6	6	13	13	ethanol	CO2	PA448073	4513	0.465
NULL	Avicenna_J_Phytomed_2013_Autumn_3(4)_302-312.nxml.txt.nlp	25050287	SENT184	12	12	14	14	loperamide	castor	PA450262	54897	0.465
NULL	Mol_Cancer_2014_Jan_28_13_17.nxml.txt.nlp	24472312	SENT179	8	8	19	19	ponatinib	c-Myc	PA165980594	4609	0.465
NULL	Open_Biochem_J_2012_Mar_19_6_11-15.nxml.txt.nlp	22481982	SENT26	17	17	29	29	nadh	Mal	PA164755085	114609	0.465
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jan_12_67(Pt_2)_o345.nxml.txt.nlp	21523026	SENT60	12	12	9	9	ethanol	mol	PA448073	90527	0.465
NULL	J_Vet_Med_Sci_2014_Aug_15_76(8)_1119-1127.nxml.txt.nlp	24829081	SENT121	23	23	34	34	trypsin	IL-8	PA451806	3576	0.465
NULL	Eur_J_Dent_2012_Oct_6(4)_349-360.nxml.txt.nlp	23077413	SENT320	14	14	8	8	ethanol	HEMA	PA448073	2157	0.465
NULL	Int_J_Cardiovasc_Imaging_2013_Jun_3_29(5)_959-966.nxml.txt.nlp	23378157	SENT84	2	2	19	19	urea	HGB	PA451831	114757	0.465
NULL	Anticancer_Agents_Med_Chem_2014_Jul_14(6)_840-851.nxml.txt.nlp	24066799	SENT65	33	33	40	40	gentamicin	CO2	PA449753	4513	0.465
NULL	ASN_Neuro_2011_Apr_7_3(2)_e00056.nxml.txt.nlp	21382016	SENT87	15	15	42	42	mannitol	San	PA450320	80218	0.465
NULL	Cancer_Metastasis_Rev_2010_Dec_9_29(4)_777-784.nxml.txt.nlp	20936327	SENT180	8	8	19	19	thrombin	PAFR	PA451674	64582	0.465
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT129	0	0	4	4	resveratrol	Bcl-2		596	0.465
NULL	Acta_Pharmacol_Sin_2010_Sep_23_31(9)_1208-1212.nxml.txt.nlp	20729871	SENT81	16	16	0	0	creatine	p53	PA164778930	7157	0.465
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT210	3	3	7	7	perifosine	DR5	PA165291471	8795	0.465
NULL	J_Biomed_Sci_2014_Jul_22_21(1)_65.nxml.txt.nlp	25047949	SENT134	9	9	12	12	docetaxel	PC-3	PA449383	692094	0.465
NULL	Vet_Res_2014_Dec_16_45(1)_123.nxml.txt.nlp	25512064	SENT227	2	2	6	6	zinc	MZF-1	PA451956	7593	0.465
NULL	Oncogene_2010_Sep_16_29(37)_5193-5203.nxml.txt.nlp	20581867	SENT118	8	8	10	10	lapatinib	HRG	PA152241907	3084;3273	0.465
NULL	Crit_Care_2010_Mar_15_14(2)_R30.nxml.txt.nlp	20226064	SENT271	36	36	4	4	fentanyl	IL-10	PA449599	3586	0.465
NULL	ACS_Synth_Biol_2013_Dec_20_2(12)_750-755.nxml.txt.nlp	24161008	SENT183	23	23	17	17	ampicillin	SOC	PA448419	91544	0.465
NULL	J_Gen_Physiol_2003_Mar_121(3)_181-197.nxml.txt.nlp	12601083	SENT394	27	27	25	25	forskolin	GLP-1	PA146096022	100125288	0.465
NULL	Int_J_Mol_Sci_2014_Mar_5_15(3)_3970-3988.nxml.txt.nlp	24603537	SENT560	29	29	27	27	curcumin	MCH	PA151958596	5367	0.465
NULL	Diabetologia_2009_Sep_17_52(9)_1866-1870.nxml.txt.nlp	19533084	SENT0	23	23	13	13	glucose	GCK	PA449773	5871;2645	0.465
NULL	Br_J_Pharmacol_2014_Jun_15_171(11)_2705-2725.nxml.txt.nlp	24467436	SENT15	19	19	0	0	isoniazid	NAT	PA450112	6046	0.465
NULL	J_Gen_Physiol_2004_Apr_123(4)_427-439.nxml.txt.nlp	15024039	SENT336	11	11	13	13	genistein	PP2	PA165109660	4888	0.465
NULL	Int_J_Mol_Sci_2014_Mar_5_15(3)_3970-3988.nxml.txt.nlp	24603537	SENT94	7	7	9	9	curcumin	MCH	PA151958596	5367	0.465
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Sep_18_66(Pt_10)_o2578.nxml.txt.nlp	21587560	SENT55	43	43	38	38	piperazine	NO3	PA450977	4681	0.465
NULL	Int_J_Inflam_2010_Aug_9_2010_151097.nxml.txt.nlp	21152121	SENT79	8	8	22	22	thrombin	PAR-1	PA451674	2011;2149	0.465
NULL	J_Immunother_Cancer_2014_Nov_6_2(Suppl_3)_P210.nxml.txt.nlp	NULL	SENT7	14	14	19	19	curcumin	PD-L1	PA151958596	29126	0.465
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Aug_27_67(Pt_9)_o2450.nxml.txt.nlp	22059018	SENT5	16	16	12	12	ethanol	mol	PA448073	90527	0.465
NULL	Cancer_Microenviron_2009_May_8_2(1)_49-57.nxml.txt.nlp	19424824	SENT48	26	26	12	12	ethanol	San	PA448073	80218	0.465
NULL	Indian_J_Med_Paediatr_Oncol_2013_Jul-Sep_34(3)_224-228.nxml.txt.nlp	24516317	SENT17	6	6	4	4	imatinib	IMPACT	PA10804	55364	0.465
NULL	Bone_2012_Jan_50(1)_218-225.nxml.txt.nlp	22023931	SENT219	17	17	19	19	iron	FGF23	PA450087	8074	0.465
NULL	Cell_Death_Dis_2012_Jun_21_3(6)_e330.nxml.txt.nlp	22717585	SENT123	7	7	26	26	simvastatin	BNIP3	PA451363	664	0.465
NULL	J_Neurosci_Rural_Pract_2012_Jan-Apr_3(1)_105-106.nxml.txt.nlp	22346220	SENT16	0	0	7	7	curcumin	spatial	PA151958596	219793	0.465
NULL	Cell_Death_Dis_2012_Nov_15_3(11)_e422.nxml.txt.nlp	23152058	SENT305	26	26	19	19	doxycycline	ZNF143	PA449415	7702	0.465
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Dec_2_5_30.nxml.txt.nlp	17140452	SENT229	2	2	0	0	vancomycin	VAN	PA451850	10318	0.465
NULL	Clin_Ophthalmol_2014_Jan_13_8_219-228.nxml.txt.nlp	24531757	SENT174	8	8	4	4	brinzolamide	TIM	PA164744929	7984;8914	0.465
NULL	Carcinogenesis_2010_Dec_27_31(12)_2049-2057.nxml.txt.nlp	20876285	SENT305	15	15	8	8	tamoxifen	SRC-3	PA451581	8202	0.465
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Mar_21_68(Pt_4)_o1129.nxml.txt.nlp	22589984	SENT65	3	3	27	27	acetone	mol	PA448025	90527	0.465
NULL	Br_J_Cancer_2006_Feb_13_94(3)_407-426.nxml.txt.nlp	16434996	SENT296	0	0	4	4	genistein	BRCA2	PA165109660	675	0.465
NULL	Natl_J_Maxillofac_Surg_2012_Jul-Dec_3(2)_187-189.nxml.txt.nlp	23833495	SENT73	13	13	18	18	rituximab	CHOP	PA451261	1649	0.465
NULL	Breast_Cancer_Res_2009_Jun_23_11(Suppl_1)_P10.nxml.txt.nlp	NULL	SENT16	18	18	23	23	tamoxifen	p27	PA451581	5715;10534	0.465
NULL	J_Oncol_2010_Jan_5_2010_257058.nxml.txt.nlp	20069126	SENT276	10	10	4	4	estradiol	PTH	PA449503	5741	0.465
NULL	Arthritis_Res_Ther_2005_Dec_1_7(1)_R149-R155.nxml.txt.nlp	15642135	SENT193	18	18	6	6	infliximab	OPG	PA452639	690	0.465
NULL	Nat_Commun_2012_Dec_27_3_1316.nxml.txt.nlp	23271650	SENT518	26	26	35	35	tamoxifen	CA3	PA451581	761	0.465
NULL	Patient_Prefer_Adherence_2014_Apr_8_8_463-471.nxml.txt.nlp	24748775	SENT67	34	34	43	43	denosumab	OPG	PA166048634	690	0.465
NULL	J_Cell_Biol_1998_Apr_6_141(1)_5-20.nxml.txt.nlp	9531544	SENT116	3	3	1	1	fluorescein	mol	PA164746009	90527	0.465
NULL	Comp_Hepatol_2004_Jan_14_3(Suppl_1)_S37.nxml.txt.nlp	14960189	SENT91	16	16	25	25	ethanol	CD14	PA448073	929	0.465
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT168	10	10	12	12	methotrexate	MSH2	PA450428	4436	0.465
NULL	J_Cell_Biol_2003_Dec_22_163(6)_1385-1395.nxml.txt.nlp	14676308	SENT264	30	30	5	5	thrombin	p38	PA451674	10598;1432;7965	0.465
NULL	Neural_Regen_Res_2014_Feb_15_9(4)_377-384.nxml.txt.nlp	24999352	SENT57	13	13	9	9	heparin	entactin	PA449855	4811	0.465
NULL	Front_Mol_Neurosci_2012_May_3_5_58.nxml.txt.nlp	22563308	SENT632	10	10	2	2	thyroglobulin	DREAM	PA164754910	30818	0.465
NULL	Front_Genet_2013_Aug_27_4_170.nxml.txt.nlp	23986775	SENT175	11	11	38	38	phenol	CO2	PA450913	4513	0.465
NULL	Surg_Neurol_Int_2010_Dec_25_1_93.nxml.txt.nlp	21246060	SENT212	48	48	45	45	l-glutamine	GM-CSF	PA10090	1437	0.465
NULL	Front_Endocrinol_(Lausanne)_2015_Jan_9_5_235.nxml.txt.nlp	25620956	SENT44	32	32	15	15	glucosamine	HBP	PA164747613	3069;50865;7884;566	0.465
NULL	Comp_Funct_Genomics_2012_Feb_6_2012_876893.nxml.txt.nlp	22400011	SENT138	13	13	8	8	zinc	CPSF4	PA451956	10898	0.465
NULL	Allergy_Asthma_Immunol_Res_2014_Mar_15_6(2)_126-130.nxml.txt.nlp	24587948	SENT6	5	5	12	12	salbutamol	TTN	PA448068	7273	0.465
NULL	Int_J_Biol_Sci_2013_Aug_14_9(8)_766-777.nxml.txt.nlp	23983610	SENT117	5	5	7	7	curcumin	B19	PA151958596	59271	0.465
NULL	Clin_Ophthalmol_2010_Oct_5_4_1137-1143.nxml.txt.nlp	20957061	SENT12	9	9	18	18	bimatoprost	BAK	PA164748867	578	0.465
NULL	Mol_Cancer_2014_Apr_17_13_85.nxml.txt.nlp	24741998	SENT173	20	20	34	34	rituximab	CD40L	PA451261	959	0.465
NULL	ScientificWorldJournal_2012_Apr_19_2012_804730.nxml.txt.nlp	22606063	SENT161	22	22	18	18	latanoprost	BAK	PA164774763	578	0.465
NULL	Curr_Gerontol_Geriatr_Res_2010_Jun_8_2010_915296.nxml.txt.nlp	20631897	SENT92	18	18	11	11	atorvastatin	SAGE	PA448500	55511	0.465
NULL	Adv_Appl_Bioinform_Chem_2014_Mar_24_7_1-9.nxml.txt.nlp	24711707	SENT89	28	28	19	19	verapamil	P-gp	PA451868	5243	0.465
NULL	J_Invest_Dermatol_2012_Nov_21_132(11)_2642-2651.nxml.txt.nlp	22718118	SENT72	3	3	10	10	collagenase	CD11b	PA449107	3684	0.465
NULL	Front_Oncol_2014_Mar_25_4_54.nxml.txt.nlp	24724051	SENT114	15	15	29	29	perifosine	MTOR	PA165291471	2475	0.465
NULL	F1000Res_2013_Mar_5_2_74.nxml.txt.nlp	24358880	SENT403	6	6	11	11	capsaicin	TRPV1	PA448776	7442	0.465
NULL	Eur_J_Med_Res_2013_Apr_2_18(1)_8.nxml.txt.nlp	23547898	SENT41	24	24	9	9	vincristine	CHOP	PA451879	1649	0.465
NULL	Surg_Today_2012_Jan_6_42(1)_8-28.nxml.txt.nlp	22139128	SENT237	8	8	10	10	tegafur	PSK	PA452620	9344	0.465
NULL	Eur_J_Med_Res_2010_Nov_30_15(12)_571-576.nxml.txt.nlp	21163732	SENT15	13	13	22	22	linezolid	HAP	PA450233	5915;10313	0.465
NULL	Cardiol_Res_Pract_2012_Feb_7_2012_121237.nxml.txt.nlp	22454775	SENT83	11	11	13	13	hyaluronan	HSP60	PA165958431	3329	0.465
NULL	Br_J_Cancer_1981_Aug_44(2)_201-207.nxml.txt.nlp	6168277	SENT4	11	11	8	8	melphalan	BLM	PA450354	641	0.465
NULL	Br_J_Cancer_2010_Jun_29_103(1)_52-60.nxml.txt.nlp	20531411	SENT31	29	29	25	25	gemcitabine	MTD	PA449748	4493	0.465
NULL	Br_J_Cancer_2010_Jul_27_103(3)_332-339.nxml.txt.nlp	20628389	SENT25	5	5	33	33	docetaxel	HER2	PA449383	2064	0.465
NULL	Br_J_Dermatol_2009_Feb_160(2)_438-441.nxml.txt.nlp	19016697	SENT98	27	27	21	21	methotrexate	ATIC	PA450428	471	0.465
NULL	Comp_Hepatol_2011_Nov_14_10_10.nxml.txt.nlp	22081873	SENT34	6	6	13	13	choline	p47	PA448976	3621;55968	0.465
NULL	J_Mol_Med_(Berl)_2013_Aug_17_91(11)_1257-1271.nxml.txt.nlp	23955016	SENT180	3	3	7	7	thrombin	p38	PA451674	10598;1432;7965	0.465
NULL	Mol_Biol_Cell_2014_Sep_15_25(18)_2695-2709.nxml.txt.nlp	25057021	SENT362	11	11	44	44	isoflurane	San	PA450106	80218	0.465
NULL	Gut_2013_Dec_21_62(12)_1714-1723.nxml.txt.nlp	23172891	SENT113	36	36	7	7	dextran	DAI	PA449261	81030	0.465
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1063.nxml.txt.nlp	24556678	SENT52	19	19	21	21	thioridazine	TRAIL	PA451666	8743	0.465
NULL	Clin_Pharmacokinet_2014_Sep_3_53(1)_1-16.nxml.txt.nlp	23999929	SENT279	21	21	6	6	rivaroxaban	CYP3A4	PA165958360	1576	0.465
NULL	Int_J_Anal_Chem_2013_May_16_2013_137279.nxml.txt.nlp	23762060	SENT39	0	0	11	11	gemifloxacin	KSA	PA10088	4072	0.465
NULL	J_Cell_Biol_1998_Jul_13_142(1)_85-100.nxml.txt.nlp	9660865	SENT37	31	31	25	25	tetracycline	RhoA	PA451640	387	0.465
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Apr_7_9_12.nxml.txt.nlp	20374640	SENT46	5	5	32	32	chloramphenicol	BSAC	PA448927	57591	0.465
NULL	Comp_Hepatol_2004_Jan_14_3(Suppl_1)_S31.nxml.txt.nlp	14960183	SENT82	4	4	19	19	ethanol	TNF-alpha	PA448073	7124	0.465
NULL	Exp_Ther_Med_2015_Jan_12_9(1)_77-83.nxml.txt.nlp	25452779	SENT207	5	5	0	0	trypsin	ITIH4	PA451806	3700	0.465
NULL	Acta_Pharmacol_Sin_2012_May_4_33(5)_710-716.nxml.txt.nlp	22555373	SENT16	14	14	19	19	ketoprofen	DOM	PA450149	6663	0.465
NULL	Int_J_Med_Sci_2012_Aug_10_9(6)_472-479.nxml.txt.nlp	22927772	SENT134	25	25	5	5	warfarin	CYP2C9	PA451906	1559	0.464
NULL	J_Cardiovasc_Thorac_Res_2014_Jun_30_6(2)_97-100.nxml.txt.nlp	25031824	SENT30	9	9	34	34	heparin	ACT	PA449855	12;11332;9457;641455	0.464
NULL	FASEB_J_2011_Dec_25(12)_4486-4497.nxml.txt.nlp	21865315	SENT460	17	17	7	7	bucindolol	BEST	PA165945764	7439	0.464
NULL	J_Mol_Med_(Berl)_2014_May_10_92(7)_709-722.nxml.txt.nlp	24811491	SENT96	18	18	20	20	cetuximab	BRAF	PA10040	673	0.464
NULL	Indian_J_Pharm_Sci_2009_Nov-Dec_71(6)_608-614.nxml.txt.nlp	20376212	SENT160	0	0	13	13	vildagliptin	GLP-1	PA165958346	100125288	0.464
NULL	J_Biol_Chem_2012_Apr_6_287(15)_12433-12444.nxml.txt.nlp	22351758	SENT968	5	5	7	7	hyaluronan	TSG-6	PA165958431	7130	0.464
NULL	Clin_Psychopharmacol_Neurosci_2011_Apr_30_9(1)_36-43.nxml.txt.nlp	23431025	SENT94	1	1	9	9	aripiprazole	FLI	PA10026	2314	0.464
NULL	Exp_Mol_Med_2012_Sep_30_44(9)_521-528.nxml.txt.nlp	22684244	SENT94	5	5	10	10	staurosporine	RhoA	PA165109623	387	0.464
NULL	Int_J_Mol_Sci_2014_Sep_30_15(10)_17686-17704.nxml.txt.nlp	25272226	SENT128	21	21	29	29	cetuximab	ANOVA	PA10040	4858	0.464
NULL	J_Immunother_Cancer_2014_Nov_6_2(Suppl_3)_P210.nxml.txt.nlp	NULL	SENT15	6	6	33	33	curcumin	PD-L1	PA151958596	29126	0.464
NULL	Oncogene_2010_Sep_16_29(37)_5159-5170.nxml.txt.nlp	20562917	SENT26	23	23	11	11	gefitinib	EGF	PA131301952	1950	0.464
NULL	Eur_J_Pharmacol_2012_May_5_682(1-3)_21-28.nxml.txt.nlp	22381066	SENT334	0	0	18	18	resveratrol	AP-1		2353;3727;2354;3725	0.464
NULL	J_Oncol_2009_Mar_24_2009_491985.nxml.txt.nlp	19325924	SENT90	31	31	13	13	genistein	CXCR4	PA165109660	7852	0.464
NULL	Cancer_Imaging_2011_Oct_3_11(1A)_S129-S145.nxml.txt.nlp	22185786	SENT26	9	9	12	12	trastuzumab	RANK	PA451743	8792	0.464
NULL	Mol_Cancer_2014_Jun_26_13_158.nxml.txt.nlp	24965046	SENT107	0	0	20	20	sorafenib	CD31	PA7000	5175	0.464
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1063.nxml.txt.nlp	24556678	SENT30	3	3	5	5	thioridazine	TRAIL	PA451666	8743	0.464
NULL	Clin_Ophthalmol_2011_Apr_18_5_495-502.nxml.txt.nlp	21573098	SENT118	9	9	11	11	gatifloxacin	BAK	PA449738	578	0.464
NULL	Oncol_Lett_2013_Feb_7_5(2)_440-446.nxml.txt.nlp	23420122	SENT247	7	7	24	24	sorafenib	Gem	PA7000	51053	0.464
NULL	J_Oral_Pathol_Med_2013_Jul_18_42(6)_499-506.nxml.txt.nlp	23331485	SENT185	3	3	14	14	celecoxib	IL-6	PA448871	3569	0.464
NULL	Nucleic_Acids_Res_2011_Jun_1_39(11)_e74.nxml.txt.nlp	21459849	SENT289	5	5	11	11	glucosamine	TAF10	PA164747613	6881	0.464
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1495-1502.nxml.txt.nlp	21989186	SENT88	35	35	31	31	panitumumab	HSI	PA162373091	57016	0.464
NULL	Carcinogenesis_2010_Dec_27_31(12)_2049-2057.nxml.txt.nlp	20876285	SENT110	9	9	4	4	tamoxifen	HER2	PA451581	2064	0.464
NULL	Front_Genet_2013_Aug_29_4_163.nxml.txt.nlp	24009622	SENT84	18	18	14	14	ethanol	DDP	PA448073	1678	0.464
NULL	Structure_2013_Apr_2_21(4)_595-603.nxml.txt.nlp	23499020	SENT184	14	14	42	42	thyroglobulin	B12	PA164754910	7126;4709	0.464
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jun_9_66(Pt_7)_o1606.nxml.txt.nlp	21587840	SENT62	11	11	5	5	coumarin	H10	PA134521193	3005	0.464
NULL	Aging_(Albany_NY)_2011_Jan_18_3(1)_33-43.nxml.txt.nlp	21248371	SENT219	0	0	2	2	zinc	HIPK2	PA451956	28996	0.464
NULL	J_Adv_Pharm_Technol_Res_2010_Jul-Sep_1(3)_297-301.nxml.txt.nlp	22247861	SENT11	12	12	22	22	estradiol	activin	PA449503	83729	0.464
NULL	JAKSTAT_2014_Jun_12_3_e29554.nxml.txt.nlp	25105067	SENT102	15	15	18	18	propofol	EGF	PA451141	1950	0.464
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1150.nxml.txt.nlp	24675468	SENT122	13	13	8	8	ethanol	AMPK	PA448073	5563	0.464
NULL	J_Oncol_2010_Jan_3_2010_149362.nxml.txt.nlp	20069122	SENT133	16	16	32	32	sunitinib	CDP	PA162372840	1523	0.464
NULL	Crit_Care_2011_Mar_22_15(2)_211.nxml.txt.nlp	21457505	SENT39	0	0	3	3	heparin	PF4	PA449855	5196	0.464
NULL	Curr_Chem_Genomics_2010_Mar_1_4_1-8.nxml.txt.nlp	20448812	SENT27	30	30	28	28	fluorescein	OATP1B3	PA164746009	28234	0.464
NULL	Diabetes_2009_Feb_58(2)_385-393.nxml.txt.nlp	19008342	SENT164	10	10	22	22	tolbutamide	CD68	PA451718	968	0.464
NULL	Indian_J_Nucl_Med_2010_Jul-Sep_25(3)_78-87.nxml.txt.nlp	NULL	SENT315	13	13	23	23	diclofenac	gamma	PA449293	9913	0.464
NULL	Cancer_Imaging_2012_Aug_10_12(1)_253-258.nxml.txt.nlp	22935131	SENT51	19	19	24	24	vincristine	CHOP	PA451879	1649	0.464
NULL	Cell_Res_2013_Sep_25_23(9)_1075-1090.nxml.txt.nlp	23797856	SENT101	5	5	12	12	tamoxifen	E12	PA451581	64100	0.464
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT73	39	39	37	37	vinorelbine	ASC	PA451881	29108	0.464
NULL	J_Biomed_Sci_2014_Apr_17_21(1)_30.nxml.txt.nlp	24742230	SENT163	5	5	12	12	lovastatin	RANKL	PA450272	8600	0.464
NULL	Front_Zool_2011_Jun_14_8_15.nxml.txt.nlp	21672209	SENT1007	44	44	15	15	ethanol	CO2	PA448073	4513	0.464
NULL	Nucleic_Acids_Res_2011_Mar_3_39(5)_1833-1842.nxml.txt.nlp	21051361	SENT179	38	38	23	23	galactose	LEU2	PA449725	8847	0.464
NULL	Biomed_Res_Int_2014_Apr_13_2014_738625.nxml.txt.nlp	24822215	SENT10	0	0	2	2	montelukast	IL-13	PA450546	3596	0.464
NULL	AIDS_Res_Ther_2011_Oct_6_8_36.nxml.txt.nlp	21978457	SENT140	8	8	17	17	zinc	ZIP4	PA451956	55630	0.464
NULL	Kidney_Int_Suppl_(2011)_2012_Dec_15_2(5)_398-403.nxml.txt.nlp	25018968	SENT63	10	10	18	18	fluvastatin	SHARP	PA449688	23013	0.464
NULL	Patient_Prefer_Adherence_2010_Sep_7_4_313-324.nxml.txt.nlp	20859458	SENT81	12	12	4	4	exenatide	PPG	PA164749238	5552	0.464
NULL	ScientificWorldJournal_2012_Apr_26_2012_358102.nxml.txt.nlp	22645419	SENT51	22	22	11	11	ethanol	DES	PA448073	1674	0.464
NULL	Clin_Med_Oncol_2008_Jul_8_2_471-475.nxml.txt.nlp	21892320	SENT47	39	39	37	37	thalidomide	GM-CSF	PA451644	1437	0.464
NULL	Case_Rep_Oncol_2011_Nov_22_4(3)_534-541.nxml.txt.nlp	22187539	SENT104	13	13	15	15	paclitaxel	GEM	PA450761	2669	0.464
NULL	J_Cell_Biol_2001_May_28_153(5)_1049-1060.nxml.txt.nlp	11381089	SENT69	26	26	22	22	l-glutamine	FBS	PA10090	64319;26269	0.464
NULL	Arthritis_Res_Ther_2007_Nov_12_9(6)_R118.nxml.txt.nlp	17997858	SENT24	11	11	15	15	hyaluronan	LYVE-1	PA165958431	10894	0.464
NULL	Br_J_Cancer_2012_Feb_14_106(4)_646-650.nxml.txt.nlp	22240794	SENT109	2	2	4	4	sunitinib	IFN	PA162372840	3439	0.464
NULL	Front_Behav_Neurosci_2014_Oct_30_8_366.nxml.txt.nlp	25400560	SENT137	7	7	1	1	ethanol	ANOVA	PA448073	4858	0.464
NULL	ScientificWorldJournal_2013_Sep_19_2013_809891.nxml.txt.nlp	24170983	SENT180	0	0	15	15	dexketoprofen	CD86	PA166049175	942	0.464
NULL	EMBO_J_2010_May_19_29(10)_1652-1658.nxml.txt.nlp	20389283	SENT78	2	2	5	5	choline	PC3	PA448976	57332;7832;5122	0.464
NULL	Clin_Ophthalmol_2014_Jun_3_8_1057-1064.nxml.txt.nlp	24940042	SENT40	23	23	7	7	bevacizumab	CST	PA130232992	9514	0.464
NULL	Am_J_Physiol_Endocrinol_Metab_2008_Nov_5_295(5)_E1047-E1055.nxml.txt.nlp	18682536	SENT277	7	7	7	7	pp2	PP2		4888	0.464
NULL	Exp_Ther_Med_2014_Nov_29_8(5)_1473-1478.nxml.txt.nlp	25289044	SENT131	13	13	8	8	heparin	AZU	PA449855	566	0.464
NULL	J_Hematol_Oncol_2011_Jan_21_4_5.nxml.txt.nlp	21255411	SENT272	4	4	46	46	docetaxel	CLC	PA449383	23529;1178	0.464
NULL	J_Obes_2011_Dec_22_2011_252817.nxml.txt.nlp	21318055	SENT242	4	4	6	6	sibutramine	AMPK	PA451344	5563	0.464
NULL	Indian_J_Med_Res_2013_Mar_137(3)_455-493.nxml.txt.nlp	23640554	SENT323	30	30	34	34	isoniazid	IPT	PA450112	54802	0.464
NULL	Appl_Plant_Sci_2015_Jan_5_3(1)_apps_1400086.nxml.txt.nlp	25606353	SENT62	2	2	16	16	cefotaxime	BAM	PA448852	9126	0.464
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Sep_30_70(Pt_10)_265-268.nxml.txt.nlp	25484670	SENT55	15	15	17	17	nitrile	mol	PA450636	90527	0.464
NULL	Case_Rep_Dermatol_2011_Feb_23_3(1)_42-48.nxml.txt.nlp	21487460	SENT42	6	6	10	10	tegafur	CDHP	PA452620	1001	0.464
NULL	Clin_Exp_Otorhinolaryngol_2009_Jun_27_2(2)_55-60.nxml.txt.nlp	19565028	SENT122	32	32	24	24	thyroglobulin	N-ras	PA164754910	4893	0.464
NULL	Biosci_Rep_2014_Sep_17_34(5)_e00138.nxml.txt.nlp	25137483	SENT54	20	20	18	18	fluorescein	SNA	PA164746009	6615	0.464
NULL	Case_Rep_Vasc_Med_2012_Dec_13_2012_750953.nxml.txt.nlp	23304629	SENT53	20	20	2	2	phenoxybenzamine	SPG	PA450919	55764	0.464
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT76	23	23	30	30	l-cysteine	p27	PA449173	5715;10534	0.464
NULL	Cancers_(Basel)_2010_Jun_4_2(2)_1125-1154.nxml.txt.nlp	24281110	SENT1724	4	4	7	7	trypsin	TATI	PA451806	6690	0.464
NULL	Biol_Open_2014_Nov_21_3(12)_1207-1216.nxml.txt.nlp	25416063	SENT3	24	24	2	2	zinc	NANOS3	PA451956	342977	0.464
NULL	Mol_Vis_2012_Dec_14_18_2993-3003.nxml.txt.nlp	23288991	SENT173	5	5	7	7	streptozocin	STZ	PA451514	6484	0.464
NULL	Mol_Cancer_2008_Aug_7_7_65.nxml.txt.nlp	18687124	SENT108	13	13	8	8	thrombin	parafibromin	PA451674	79577	0.464
NULL	Biomed_Res_Int_2014_Aug_6_2014_967826.nxml.txt.nlp	25165721	SENT72	26	26	16	16	taurine	PUMA	PA451590	27113	0.464
NULL	Breast_Cancer_Res_2007_Aug_8_9(4)_R50.nxml.txt.nlp	17686159	SENT11	0	0	2	2	gefitinib	HRG	PA131301952	3084;3273	0.464
NULL	Biotechnol_Res_Int_2013_Dec_1_2013_253286.nxml.txt.nlp	24363937	SENT128	14	14	18	18	urea	DAP	PA451831	23549;3375;1611	0.464
NULL	J_Biol_Chem_2008_Jun_20_283(25)_17194-17204.nxml.txt.nlp	18442977	SENT248	30	30	30	30	pp2	PP2		4888	0.464
NULL	Biol_Proced_Online_2003_Oct_24_5_197-203.nxml.txt.nlp	14615816	SENT133	20	20	12	12	dextran	IL-4	PA449261	3565	0.464
NULL	J_Cereb_Blood_Flow_Metab_2014_Oct_23_34(10)_1585-1598.nxml.txt.nlp	25052556	SENT194	2	2	20	20	mannitol	CTH	PA450320	1491;23584	0.464
NULL	Toxins_(Basel)_2010_Oct_28_2(11)_2584-2592.nxml.txt.nlp	22069565	SENT316	0	0	10	10	warfarin	MDR1	PA451906	5243	0.464
NULL	J_Asthma_Allergy_2011_Apr_14_4_27-35.nxml.txt.nlp	21698213	SENT32	29	29	33	33	cetirizine	C10	PA448905	113246	0.464
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT48	32	32	23	23	pemetrexed	UNG	PA10810	7374	0.464
NULL	J_Cell_Mol_Med_2013_Oct_16_17(10)_1261-1270.nxml.txt.nlp	23855452	SENT231	16	16	23	23	etoposide	GEM	PA449552	2669	0.464
NULL	Adv_Biomed_Res_2012_Oct_31_1_70.nxml.txt.nlp	23326800	SENT10	9	9	34	34	erythromycin	IPL	PA449493	7262	0.464
NULL	J_Korean_Med_Sci_2010_Jul_17_25(7)_1017-1023.nxml.txt.nlp	20592892	SENT32	23	23	29	29	ampicillin	CO2	PA448419	4513	0.464
NULL	Turk_J_Haematol_2012_Jun_15_29(2)_201-203.nxml.txt.nlp	24744660	SENT21	23	23	16	16	thrombin	VIII	PA451674	1351	0.464
NULL	Nucleic_Acids_Res_2013_May_5_41(10)_5210-5222.nxml.txt.nlp	23563151	SENT223	20	20	6	6	arsenite	GADD45	PA452638	1647	0.464
NULL	Cardiovasc_Diabetol_2013_Jun_27_12_97.nxml.txt.nlp	23806096	SENT121	9	9	12	12	metformin	GLP-1	PA450395	100125288	0.464
NULL	Oncotarget_2014_Aug_27_5(21)_10486-10502.nxml.txt.nlp	25401222	SENT132	24	24	27	27	gefitinib	PI3	PA131301952	5266	0.464
NULL	Blood_Res_2014_Dec_23_49(4)_253-258.nxml.txt.nlp	25548759	SENT73	23	23	33	33	cyclophosphamide	CHOP	PA449165	1649	0.464
NULL	Brain_Sci_2014_Mar_4_4(1)_125-135.nxml.txt.nlp	24961703	SENT427	3	3	8	8	allopregnanolone	gamma	PA142320763	9913	0.464
NULL	Curr_Neuropharmacol_2013_Dec_11(6)_652-663.nxml.txt.nlp	24396340	SENT342	5	5	7	7	capsaicin	TRPV1	PA448776	7442	0.464
NULL	Br_J_Cancer_2010_Feb_16_102(4)_658-664.nxml.txt.nlp	20104222	SENT192	1	1	3	3	sunitinib	IFN	PA162372840	3439	0.464
NULL	Open_Cardiovasc_Med_J_2011_Jun_20_5_136-147.nxml.txt.nlp	21760856	SENT41	20	20	31	31	rosiglitazone	ghrelin	PA451283	51738	0.464
NULL	Viruses_2014_Apr_14_6(4)_1715-1758.nxml.txt.nlp	24736215	SENT282	25	25	13	13	maraviroc	IL-7	PA164768835	3574	0.463
NULL	Case_Rep_Oncol_Med_2012_Oct_10_2012_235062.nxml.txt.nlp	23094166	SENT35	34	34	30	30	thyroglobulin	TTF-1	PA164754910	7080	0.463
NULL	Mol_Cancer_2007_Oct_25_6_67.nxml.txt.nlp	17958915	SENT154	17	17	35	35	nilotinib	E14	PA165958345	4863	0.463
NULL	J_Neural_Transm_2014_Mar_1_121(8)_799-817.nxml.txt.nlp	24578174	SENT325	21	21	27	27	taurine	GAT2	PA451590	6540	0.463
NULL	Neural_Regen_Res_2014_Mar_15_9(6)_622-629.nxml.txt.nlp	25206865	SENT79	0	0	3	3	vasopressin	p38	PA451858	10598;1432;7965	0.463
NULL	AIDS_Care_2011_Sep_14_23(9)_1154-1162.nxml.txt.nlp	21500025	SENT140	4	4	2	2	atazanavir	ATV	PA10251	4683	0.463
NULL	Aging_(Albany_NY)_2013_Feb_21_5(2)_94-95.nxml.txt.nlp	23518473	SENT23	2	2	7	7	resveratrol	SIRT1		23411	0.463
NULL	Physiol_Rep_2014_Aug_28_2(8)_e12143.nxml.txt.nlp	25168879	SENT66	31	31	18	18	gentamicin	CO2	PA449753	4513	0.463
NULL	Hum_Genomics_2009_Jan_1_3(2)_128-142.nxml.txt.nlp	19164090	SENT175	34	34	22	22	carboplatin	C8orf76	PA448803	84933	0.463
NULL	Int_J_Endocrinol_2014_Jul_14_2014_535401.nxml.txt.nlp	25132853	SENT139	21	21	19	19	chloramphenicol	MYC	PA448927	4609	0.463
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT97	0	0	8	8	resveratrol	DR5		8795	0.463
NULL	AIDS_Care_2011_Sep_14_23(9)_1154-1162.nxml.txt.nlp	21500025	SENT76	32	32	2	2	ritonavir	ATV	PA451260	4683	0.463
NULL	Bioinformation_2006_Dec_6_1(8)_281-284.nxml.txt.nlp	17597908	SENT88	8	8	10	10	thyroglobulin	neurotactin	PA164754910	6376	0.463
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT5	12	12	28	28	metformin	HIP	PA450395	6767;6159;64399;5068	0.463
NULL	Curr_Chem_Genomics_2008_Feb_25_1_43-53.nxml.txt.nlp	20161827	SENT265	10	10	26	26	fluorescein	MEK1	PA164746009	5604	0.463
NULL	Clin_Med_Insights_Cardiol_2013_Jul_23_7_115-126.nxml.txt.nlp	23926441	SENT41	9	9	12	12	everolimus	DES	PA164746311	1674	0.463
NULL	Front_Oncol_2014_Apr_28_4_90.nxml.txt.nlp	24809021	SENT149	10	10	17	17	resveratrol	U87		677775;641648	0.463
NULL	Cancer_Causes_Control_2013_Aug_18_24(8)_1605-1614.nxml.txt.nlp	23775025	SENT64	25	25	22	22	methotrexate	GSTM2	PA450428	2946	0.463
NULL	Appl_Microbiol_Biotechnol_2013_Aug_16_97(18)_7999-8009.nxml.txt.nlp	23948723	SENT73	16	16	14	14	glucose	mol	PA449773	90527	0.463
NULL	Clin_Exp_Reprod_Med_2014_Sep_30_41(3)_120-124.nxml.txt.nlp	25309856	SENT6	15	15	27	27	thyroglobulin	ADAMTS16	PA164754910	170690	0.463
NULL	Inflamm_Res_2014_Mar_13_63(7)_519-525.nxml.txt.nlp	24623532	SENT90	16	16	0	0	ethanol	IL-22	PA448073	50616;53342	0.463
NULL	Curr_Neuropharmacol_2014_Mar_12(2)_108-119.nxml.txt.nlp	24669206	SENT65	11	11	14	14	creatine	Q10	PA164778930	27161	0.463
NULL	Onco_Targets_Ther_2014_Jul_1_7_1177-1184.nxml.txt.nlp	25061319	SENT46	14	14	10	10	irinotecan	IFL	PA450085	3439	0.463
NULL	Korean_J_Anesthesiol_2013_Dec_26_65(6)_501-507.nxml.txt.nlp	24427455	SENT44	21	21	25	25	glycopyrrolate	NMB	PA164754882	10457;4828	0.463
NULL	AMB_Express_2011_Jul_13_1_16.nxml.txt.nlp	21906371	SENT114	5	5	24	24	nitrogen	PHB	PA450643	5245	0.463
NULL	J_Gen_Physiol_1947_Mar_20_30(4)_291-310.nxml.txt.nlp	19873496	SENT0	11	11	1	1	trypsin	Gen	PA451806	348654	0.463
NULL	Support_Care_Cancer_2012_May_1_20(5)_941-949.nxml.txt.nlp	21533811	SENT129	8	8	32	32	palonosetron	HEC	PA10352	10403	0.463
NULL	Br_J_Pharmacol_2012_Aug_166(8)_2263-2276.nxml.txt.nlp	22471905	SENT53	24	24	26	26	choline	CDP	PA448976	1523	0.463
NULL	Breast_Cancer_Res_2004_Mar_11_6(3)_109-118.nxml.txt.nlp	15084231	SENT91	25	25	34	34	trastuzumab	San	PA451743	80218	0.463
NULL	Curr_Chem_Genomics_2009_Mar_17_3_7-12.nxml.txt.nlp	19936037	SENT50	8	8	10	10	forskolin	NKH	PA146096022	275;2731	0.463
NULL	Front_Genet_2014_Aug_26_5_289.nxml.txt.nlp	25206362	SENT70	3	3	6	6	choline	spatial	PA448976	219793	0.463
NULL	Cases_J_2009_Mar_10_2_6464.nxml.txt.nlp	20181162	SENT6	37	37	16	16	ribavirin	IFN	PA451241	3439	0.463
NULL	Mol_Vis_2014_Sep_20_20_1328-1356.nxml.txt.nlp	25352741	SENT90	7	7	23	23	paraformaldehyde	PLP	PA450790	25824;5744	0.463
NULL	Case_Rep_Gastroenterol_2009_Aug_28_3(2)_240-247.nxml.txt.nlp	21103282	SENT86	13	13	5	5	cyclosporine	CTX	PA449167	1593	0.463
NULL	Acta_Histochem_Cytochem_2013_Dec_28_46(6)_187-197.nxml.txt.nlp	24610966	SENT28	14	14	16	16	pilocarpine	AQP5	PA450962	362	0.463
NULL	Cardiovasc_Ther_2012_Jun_19_30(3)_e146-e155.nxml.txt.nlp	21167014	SENT38	18	18	20	20	liraglutide	GLP-1	PA165958364	100125288	0.463
NULL	J_Gastroenterol_2014_Apr_17_49(1)_126-137.nxml.txt.nlp	23591768	SENT4	20	20	5	5	ribavirin	IL28B	PA451241	282617	0.463
NULL	Acta_Neuropathol_2012_Jun_27_123(6)_807-823.nxml.txt.nlp	22539017	SENT29	32	32	26	26	tetracycline	TDP-43	PA451640	23435	0.463
NULL	Cell_Death_Dis_2011_Apr_28_2(4)_e152.nxml.txt.nlp	21525939	SENT132	8	8	4	4	chloroquine	NAC	PA448948	22861	0.463
NULL	Diabetes_Care_2012_Dec_14_35(12)_2540-2547.nxml.txt.nlp	22933430	SENT155	19	19	14	14	metformin	adiponectin	PA450395	9370	0.463
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT360	14	14	12	12	pp2	PP1		5540;5464	0.463
NULL	ScientificWorldJournal_2014_Feb_5_2014_946503.nxml.txt.nlp	24672398	SENT235	24	24	10	10	ethanol	COD	PA448073	6628	0.463
NULL	Oncologist_2010_Mar_9_15(3)_236-245.nxml.txt.nlp	20215359	SENT86	18	18	20	20	bevacizumab	IFN	PA130232992	3439	0.463
NULL	Cancer_Manag_Res_2012_Oct_11_4_357-365.nxml.txt.nlp	23091399	SENT77	29	29	37	37	lucanthone	p53	PA164748783	7157	0.463
NULL	Int_J_Environ_Res_Public_Health_2011_Jul_21_8(7)_3019-3031.nxml.txt.nlp	21845171	SENT252	7	7	5	5	ethanol	adiponectin	PA448073	9370	0.463
NULL	Arthritis_Rheumatol_2014_Jun_27_66(6)_1574-1582.nxml.txt.nlp	24577881	SENT110	14	14	16	16	hydralazine	KIR	PA449894	2669	0.463
NULL	Cancer_Metab_2013_Jan_23_1_3.nxml.txt.nlp	24280005	SENT481	20	20	11	11	ethanol	SREBP2	PA448073	6721	0.463
NULL	Tumour_Biol_2014_Mar_19_35(3)_2211-2218.nxml.txt.nlp	24142530	SENT50	37	37	31	31	l-glutamine	IL-3	PA10090	3562	0.463
NULL	J_Mol_Signal_2010_Jul_12_5_8.nxml.txt.nlp	20624308	SENT50	20	20	22	22	gefitinib	Met	PA131301952	79811	0.463
NULL	Evid_Based_Complement_Alternat_Med_2011_Feb_10_2011_109164.nxml.txt.nlp	21331373	SENT27	15	15	19	19	ethanol	flower	PA448073	11094	0.463
NULL	Br_J_Cancer_2002_Jan_21_86(2)_179-184.nxml.txt.nlp	11870502	SENT59	10	10	21	21	cisplatin	IFN	PA449014	3439	0.463
NULL	Cancer_Med_2013_Aug_28_2(4)_468-477.nxml.txt.nlp	24156019	SENT64	8	8	17	17	mitoxantrone	CLU	PA450526	1191	0.463
NULL	Diabetes_Care_2010_Jul_33(7)_1674-1685.nxml.txt.nlp	20587728	SENT428	6	6	18	18	metformin	LLC1	PA450395	128602	0.463
NULL	ISRN_Otolaryngol_2012_Nov_14_2012_797619.nxml.txt.nlp	23762619	SENT193	0	0	4	4	gefitinib	EGF	PA131301952	1950	0.463
NULL	Front_Neurosci_2009_May_1_3(1)_25-33.nxml.txt.nlp	19753094	SENT335	9	9	2	2	pilocarpine	HCN	PA450962	378938	0.463
NULL	Oncoimmunology_2013_Jul_1_2(7)_e24850.nxml.txt.nlp	24073369	SENT34	6	6	4	4	imatinib	IL-2	PA10804	3558	0.463
NULL	Front_Neural_Circuits_2013_Sep_20_7_148.nxml.txt.nlp	24065892	SENT196	4	4	9	9	scopolamine	MOB	PA451308	259230	0.463
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT128	20	20	3	3	metoprolol	CYP2D6	PA450480	1565	0.463
NULL	Indian_J_Pharm_Sci_2008_Sep-Oct_70(5)_658-661.nxml.txt.nlp	21394269	SENT46	2	2	5	5	itopride	RAB	PA152432599	3267	0.463
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Nov_20_64(Pt_12)_o2387.nxml.txt.nlp	21581358	SENT60	30	30	24	24	ethanol	mol	PA448073	90527	0.463
NULL	Int_J_Gen_Med_2009_Nov_30_1_3-6.nxml.txt.nlp	20428398	SENT110	1	1	5	5	rofecoxib	COX	PA451268	1351	0.463
NULL	Semin_Immunopathol_2013_Jan_26_35(1)_39-52.nxml.txt.nlp	22829332	SENT197	42	42	30	30	vincristine	CHOP	PA451879	1649	0.463
NULL	Contemp_Clin_Dent_2011_Oct-Dec_2(4)_278-282.nxml.txt.nlp	22346152	SENT89	6	6	3	3	potassium	GCF	PA451047	6936	0.463
NULL	J_Cell_Biol_1982_Oct_1_95(1)_316-322.nxml.txt.nlp	6982901	SENT8	16	16	14	14	colchicine	EGF	PA449092	1950	0.463
NULL	Int_J_Cell_Biol_2012_May_16_2012_643929.nxml.txt.nlp	22666257	SENT39	1	1	28	28	staurosporine	COX	PA165109623	1351	0.463
NULL	Cases_J_2009_Jun_5_2_7762.nxml.txt.nlp	19830009	SENT11	17	17	26	26	ethanol	B12	PA448073	7126;4709	0.463
NULL	Genome_Announc_2014_Oct_9_2(5)_e01033-14.nxml.txt.nlp	25301662	SENT32	18	18	4	4	vancomycin	VISA	PA451850	57506	0.463
NULL	Br_J_Cancer_2012_May_8_106(10)_1689-1696.nxml.txt.nlp	22531631	SENT30	30	30	15	15	l-glutamine	F12	PA10090	2161	0.463
NULL	Br_J_Ophthalmol_2008_Sep_22_92(9)_1275-1282.nxml.txt.nlp	18723745	SENT101	24	24	41	41	tafluprost	BAK	PA165958432	578	0.463
NULL	J_Phys_Ther_Sci_2013_Oct_20_25(10)_1317-1319.nxml.txt.nlp	24259784	SENT15	22	22	15	15	oxygen	ADP	PA450744	23038	0.463
NULL	F1000_Med_Rep_2009_Jan_21_1_8.nxml.txt.nlp	20948699	SENT13	4	4	23	23	clopidogrel	NNT	PA449053	23530	0.463
NULL	J_Cell_Biol_2001_Oct_29_155(3)_427-438.nxml.txt.nlp	11673478	SENT178	16	16	14	14	pp2	PP1		5540;5464	0.463
NULL	Appl_Clin_Genet_2014_May_16_7_93-104.nxml.txt.nlp	24876791	SENT115	24	24	17	17	estradiol	E6-AP	PA449503	7337	0.463
NULL	Biochim_Biophys_Acta_2014_Apr_1841(4)_588-594.nxml.txt.nlp	24440819	SENT325	8	8	14	14	lipase	TNF-alpha	PA450239	7124	0.463
NULL	Breast_Cancer_Res_2008_Jan_8_10(1)_R2.nxml.txt.nlp	18182100	SENT216	14	14	21	21	tamoxifen	HER3	PA451581	2065	0.462
NULL	Nat_Biotechnol_2012_Jul_1_30(7)_715-720.nxml.txt.nlp	22750882	SENT137	27	27	10	10	l-glutamine	KSR	PA10090	10256	0.462
NULL	Oxid_Med_Cell_Longev_2013_Nov_24_2013_971024.nxml.txt.nlp	24371505	SENT149	25	25	21	21	ribavirin	IFN	PA451241	3439	0.462
NULL	Pain_2012_Apr_153(4)_775-783.nxml.txt.nlp	22325744	SENT158	12	12	17	17	naloxone	P21	PA450586	1026;9338	0.462
NULL	Clin_Ophthalmol_2012_Feb_20_6_277-282.nxml.txt.nlp	22375096	SENT17	5	5	8	8	triamcinolone	STA	PA451749	2010;2656	0.462
NULL	Braz_J_Med_Biol_Res_2014_Mar_3_47(3)_245-251.nxml.txt.nlp	24554037	SENT39	26	26	37	37	atorvastatin	IFN	PA448500	3439	0.462
NULL	Multidiscip_Respir_Med_2013_Feb_18_8(1)_14.nxml.txt.nlp	23414606	SENT20	26	26	23	23	cyclophosphamide	CHOP	PA449165	1649	0.462
NULL	Eur_J_Pharmacol_2011_Dec_15_672(1-3)_30-37.nxml.txt.nlp	21958870	SENT414	21	21	2	2	doxorubicin	gamma	PA449412	9913	0.462
NULL	Nat_Commun_2010_Jun_1_1(3)_1-9.nxml.txt.nlp	20975695	SENT380	21	21	27	27	tamoxifen	E12	PA451581	64100	0.462
NULL	Arthritis_Res_Ther_2004_Jun_18_6(4)_155-158.nxml.txt.nlp	15225359	SENT59	1	1	20	20	clodronate	CD40	PA10239	958	0.462
NULL	Oncol_Lett_2014_Sep_19_8(3)_1269-1274.nxml.txt.nlp	25120704	SENT156	2	2	14	14	metformin	ADP	PA450395	23038	0.462
NULL	Biologics_2009_Oct_12_3_469-474.nxml.txt.nlp	19851472	SENT5	42	42	24	24	mometasone	IL-5	PA450541	3567	0.462
NULL	Avicenna_J_Phytomed_2012_Spring_2(2)_72-78.nxml.txt.nlp	25050233	SENT5	6	6	16	16	imipramine	FST	PA449969	10468	0.462
NULL	Acta_Pharmacol_Sin_2013_Aug_5_34(8)_998-1006.nxml.txt.nlp	23852086	SENT132	13	13	18	18	ketoprofen	DOM	PA450149	6663	0.462
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT130	7	7	9	9	trastuzumab	HER2	PA451743	2064	0.462
NULL	Acta_Pharmacol_Sin_2013_Aug_5_34(8)_998-1006.nxml.txt.nlp	23852086	SENT132	22	22	18	18	mexiletine	DOM	PA450488	6663	0.462
NULL	Extremophiles_2009_Nov_23_13(6)_885-894.nxml.txt.nlp	19701714	SENT8	31	31	38	38	ethanol	CO2	PA448073	4513	0.462
NULL	Croat_Med_J_2012_Aug_53(4)_314-320.nxml.txt.nlp	22911523	SENT197	9	9	1	1	warfarin	Gen	PA451906	348654	0.462
NULL	Breast_Cancer_2014_Feb_13_21(6)_703-714.nxml.txt.nlp	23404211	SENT236	9	9	11	11	tamoxifen	aromatase	PA451581	1588	0.462
NULL	Clin_Ophthalmol_2009_Jun_29_3_381-390.nxml.txt.nlp	19668594	SENT31	1	1	34	34	difluprednate	castor	PA165958405	54897	0.462
NULL	Case_Rep_Endocrinol_2013_Dec_22_2013_675298.nxml.txt.nlp	24455332	SENT105	15	15	24	24	etoposide	ACTH	PA449552	5443	0.462
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Dec_10_65(Pt_1)_o66-o67.nxml.txt.nlp	21581706	SENT5	31	31	17	17	ethanol	mol	PA448073	90527	0.462
NULL	Braz_J_Med_Biol_Res_2012_Feb_17_45(3)_244-249.nxml.txt.nlp	22331137	SENT101	16	16	25	25	gentamicin	PAG	PA449753	55824	0.462
NULL	Curr_Neuropharmacol_2011_Dec_9(4)_530-552.nxml.txt.nlp	22654714	SENT906	12	12	24	24	nicotine	BDNF	PA450626	627	0.462
NULL	J_Clin_Exp_Dent_2014_Jul_1_6(3)_e265-e270.nxml.txt.nlp	25136428	SENT104	12	12	8	8	pentoxifylline	IFN	PA450864	3439	0.462
NULL	Diagn_Pathol_2013_Feb_16_8_26.nxml.txt.nlp	23414265	SENT23	16	16	11	11	thyroglobulin	CK7	PA164754910	3855	0.462
NULL	Crit_Care_2011_Oct_27_15(Suppl_3)_P22.nxml.txt.nlp	NULL	SENT21	6	6	8	8	hyaluronan	syndecan	PA165958431	6382	0.462
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_16_2012_395912.nxml.txt.nlp	23118789	SENT75	9	9	18	18	diclofenac	UGT1A9	PA449293	54600	0.462
NULL	Indian_J_Med_Res_2011_Sep_134(3)_295-301.nxml.txt.nlp	21985811	SENT111	11	11	24	24	phenobarbital	CYP2C9	PA450911	1559	0.462
NULL	Cell_Death_Dis_2012_Jul_19_3(7)_e352.nxml.txt.nlp	22825470	SENT78	9	9	33	33	cisplatin	S5B	PA449014	5711	0.462
NULL	Trials_2012_Aug_25_13_148.nxml.txt.nlp	22920307	SENT35	12	12	20	20	clopidogrel	ADP	PA449053	23038	0.462
NULL	Viruses_2013_Mar_22_5(3)_981-997.nxml.txt.nlp	23524389	SENT93	25	25	15	15	cyclosporine	CD4	PA449167	920	0.462
NULL	Indian_J_Nucl_Med_2012_Jan-Mar_27(1)_24-29.nxml.txt.nlp	23599594	SENT113	11	11	13	13	alprazolam	FDG	PA448333	23583	0.462
NULL	Diabetes_Care_2013_Apr_14_36(4)_943-949.nxml.txt.nlp	23111057	SENT53	16	16	19	19	fluorescein	CD34	PA164746009	947	0.462
NULL	Support_Care_Cancer_2009_Sep_10_17(9)_1187-1193.nxml.txt.nlp	19205754	SENT68	2	2	9	9	dolasetron	CYP2D6	PA449390	1565	0.462
NULL	Biomed_Res_Int_2014_Aug_6_2014_967826.nxml.txt.nlp	25165721	SENT215	23	23	16	16	cisplatin	TNF-alpha	PA449014	7124	0.462
NULL	Br_J_Cancer_2003_Mar_10_88(5)_788-795.nxml.txt.nlp	12618891	SENT175	4	4	18	18	bosentan	FasL	PA10034	356	0.462
NULL	Ann_Clin_Microbiol_Antimicrob_2011_Jun_24_10_27.nxml.txt.nlp	21702921	SENT111	10	10	6	6	colistin	MDR2	PA164760862	5244	0.462
NULL	Front_Genet_2014_Jun_2_5_154.nxml.txt.nlp	24917878	SENT40	18	18	29	29	vasopressin	POMC	PA451858	5443	0.462
NULL	Diabetes_Metab_J_2013_Aug_14_37(4)_240-248.nxml.txt.nlp	23991401	SENT53	3	3	16	16	fenofibrate	NPC1L1	PA449594	29881	0.462
NULL	Parasit_Vectors_2014_Apr_24_7_197.nxml.txt.nlp	24761813	SENT167	7	7	27	27	l-cysteine	mol	PA449173	90527	0.462
NULL	Curr_Neuropharmacol_2014_Jul_12(4)_365-379.nxml.txt.nlp	25342944	SENT534	8	8	6	6	fluoxetine	5-HT2C	PA449673	3358	0.462
NULL	Diabetes_Obes_Metab_2012_Apr_14(4)_304-314.nxml.txt.nlp	22051096	SENT182	7	7	0	0	liraglutide	San	PA165958364	80218	0.462
NULL	Front_Physiol_2013_Jun_20_4_147.nxml.txt.nlp	23801966	SENT495	0	0	13	13	doxorubicin	MDR1	PA449412	5243	0.462
NULL	Head_Face_Med_2006_May_25_2_15.nxml.txt.nlp	16725028	SENT4	47	47	12	12	amitriptyline	LEP	PA448385	3952	0.462
NULL	Cancer_Cell_Int_2007_Jun_8_7_11.nxml.txt.nlp	17559657	SENT82	15	15	7	7	estradiol	CD34	PA449503	947	0.462
NULL	Mol_Biol_Cell_2014_Sep_15_25(18)_2866-2881.nxml.txt.nlp	25057015	SENT440	31	31	17	17	paraformaldehyde	CSK	PA450790	1445	0.462
NULL	Mol_Biol_Cell_2012_May_15_23(10)_1955-1963.nxml.txt.nlp	22456512	SENT255	20	20	10	10	l-glutamine	CO2	PA10090	4513	0.462
NULL	Am_J_Physiol_Endocrinol_Metab_2013_Jul_15_305(2)_E263-E270.nxml.txt.nlp	23715727	SENT331	11	11	3	3	creatine	PIKfyve	PA164778930	200576	0.462
NULL	Arthritis_Res_Ther_2010_Aug_26_12(4)_138.nxml.txt.nlp	20815919	SENT25	39	39	19	19	methylprednisolone	IFN	PA450466	3439	0.462
NULL	Neural_Plast_2012_Nov_2_2012_309494.nxml.txt.nlp	22164341	SENT21	25	25	35	35	raloxifene	CA1	PA451221	759	0.462
NULL	Nucleic_Acids_Res_2011_Dec_10_39(22)_9498-9507.nxml.txt.nlp	21835778	SENT181	24	24	15	15	nutlin-3	PUMA		27113	0.462
NULL	J_Obes_2011_Apr_28_2011_587495.nxml.txt.nlp	21603273	SENT145	19	19	8	8	lipase	XOR	PA450239	7498	0.462
NULL	Environ_Health_Perspect_2009_Jul_23_117(7)_1155-1161.nxml.txt.nlp	19654927	SENT90	28	28	32	32	l-glutamine	FBS	PA10090	64319;26269	0.462
NULL	Cancers_(Basel)_2012_Apr_5_4(2)_354-378.nxml.txt.nlp	24213315	SENT771	1	1	28	28	cisplatin	DR5	PA449014	8795	0.462
NULL	eLife_2013_Oct_29_2_e01222.nxml.txt.nlp	24171103	SENT482	22	22	16	16	doxycycline	LBH	PA449415	81606;221491	0.462
NULL	Diabetes_2011_May_23_60(5)_1561-1565.nxml.txt.nlp	21430088	SENT81	8	8	28	28	ethanol	GLP-1	PA448073	100125288	0.462
NULL	J_Adv_Pract_Oncol_2013_Jul_1_Jul-Aug_4(4)_238-250.nxml.txt.nlp	25032004	SENT242	13	13	8	8	imatinib	CML	PA10804	613	0.462
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Sep_30_70(Pt_10)_265-268.nxml.txt.nlp	25484670	SENT164	19	19	21	21	nitrile	mol	PA450636	90527	0.462
NULL	Br_J_Cancer_1981_Apr_43(4)_451-457.nxml.txt.nlp	7236488	SENT11	6	6	9	9	cyclophosphamide	DEF	PA449165	27042	0.462
NULL	Indian_J_Anaesth_2014_Jul-Aug_58(4)_423-429.nxml.txt.nlp	25197110	SENT129	11	11	9	9	ondansetron	ODF	PA450705	8600	0.462
NULL	Cell_Biochem_Biophys_2013_May_14_66(1)_65-71.nxml.txt.nlp	23065501	SENT41	31	31	12	12	neomycin	telethonin	PA450608	8557	0.462
NULL	Exp_Ther_Med_2013_Apr_5_5(4)_1259-1263.nxml.txt.nlp	23596498	SENT4	0	0	37	37	propofol	TRPV1	PA451141	7442	0.462
NULL	Oncogene_2009_Jan_15_28(2)_157-169.nxml.txt.nlp	18931700	SENT152	2	2	4	4	geldanamycin	CRAF	PA152031327	5894	0.462
NULL	Breast_Cancer_Res_2007_Jan_26_9(1)_R13.nxml.txt.nlp	17257427	SENT68	9	9	30	30	ethanol	San	PA448073	80218	0.462
NULL	Front_Genet_2012_Nov_22_3_249.nxml.txt.nlp	23189085	SENT1190	11	11	7	7	ifosfamide	GSTT1	PA449964	2952	0.462
NULL	Breast_Cancer_Res_2010_Aug_9_12(4)_R62.nxml.txt.nlp	20696059	SENT238	1	1	26	26	trastuzumab	HER2	PA451743	2064	0.462
NULL	Arthritis_Res_Ther_2008_Jan_7_10(1)_R1.nxml.txt.nlp	18179697	SENT160	40	40	37	37	oxaliplatin	HMGB1	PA131285527	3146	0.462
NULL	Front_Neurosci_2013_Feb_13_7_13.nxml.txt.nlp	23407595	SENT136	4	4	15	15	estradiol	ACTH	PA449503	5443	0.462
NULL	Mol_Biol_Cell_2012_Oct_15_23(20)_3936-3947.nxml.txt.nlp	22933571	SENT113	15	15	18	18	galactose	GAL7	PA449725	3963;653499	0.462
NULL	Case_Rep_Pathol_2014_Sep_9_2014_301780.nxml.txt.nlp	25295208	SENT33	25	25	23	23	thyroglobulin	CEA	PA164754910	5670;1087	0.462
NULL	Clin_Epidemiol_2013_Dec_18_6_1-13.nxml.txt.nlp	24379699	SENT197	47	47	8	8	glucose	Men	PA449773	8178	0.462
NULL	Ecancermedicalscience_2009_Oct_29_3_157.nxml.txt.nlp	22276018	SENT71	6	6	12	12	tamoxifen	HER3	PA451581	2065	0.462
NULL	Ann_Surg_Treat_Res_2014_Feb_22_86(2)_68-75.nxml.txt.nlp	24761411	SENT11	8	8	11	11	oxaliplatin	survivin	PA131285527	332	0.462
NULL	Leukemia_2014_Apr_14_28(4)_961-964.nxml.txt.nlp	24418991	SENT26	44	44	20	20	nilotinib	P-gp	PA165958345	5243	0.461
NULL	J_Clin_Immunol_2007_May_14_27(3)_275-283.nxml.txt.nlp	17510806	SENT243	15	15	13	13	rosiglitazone	gamma	PA451283	9913	0.461
NULL	Breast_Cancer_(Auckl)_2009_Sep_2_3_61-75.nxml.txt.nlp	19809577	SENT86	28	28	30	30	curcumin	BRCA1	PA151958596	672	0.461
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1699-1708.nxml.txt.nlp	19861960	SENT168	24	24	21	21	dasatinib	mol	PA162372878	90527	0.461
NULL	Br_J_Cancer_2012_Jul_24_107(3)_516-526.nxml.txt.nlp	22782351	SENT334	0	0	2	2	tamoxifen	TIGAR	PA451581	57103	0.461
NULL	Front_Neurosci_2014_Jun_3_8_128.nxml.txt.nlp	24917782	SENT137	25	25	28	28	ethanol	MC4R	PA448073	4160	0.461
NULL	Orphanet_J_Rare_Dis_2007_Jan_4_2_1.nxml.txt.nlp	17204147	SENT96	24	24	18	18	trypsin	SPINK1	PA451806	6690	0.461
NULL	Subst_Abuse_Treat_Prev_Policy_2007_Oct_31_2_32.nxml.txt.nlp	17974020	SENT209	34	34	39	39	methamphetamine	NMU	PA450403	10874	0.461
NULL	Mol_Cell_Endocrinol_2011_Jan_15_331(2)_194-204.nxml.txt.nlp	20688134	SENT889	23	23	20	20	cetrorelix	Yes	PA164764506	7525	0.461
NULL	Cancer_Imaging_2005_Nov_23_5(Spec_No_A)_S27-S32.nxml.txt.nlp	16361133	SENT199	2	2	6	6	trastuzumab	HER2	PA451743	2064	0.461
NULL	Br_J_Cancer_1999_Feb_79(5-6)_821-824.nxml.txt.nlp	10070875	SENT5	6	6	44	44	verteporfin	mol	PA451871	90527	0.461
NULL	Diabetes_2013_Mar_14_62(3)_953-964.nxml.txt.nlp	23223176	SENT201	23	23	9	9	nitrogen	ROS	PA450643	6098	0.461
NULL	Cancer_Cell_Int_2006_Nov_8_6_25.nxml.txt.nlp	17092342	SENT223	6	6	4	4	etoposide	Yes	PA449552	7525	0.461
NULL	Diabetologia_2009_Oct_14_52(10)_2046-2055.nxml.txt.nlp	19688338	SENT313	5	5	3	3	liraglutide	GLP-1	PA165958364	100125288	0.461
NULL	Comput_Struct_Biotechnol_J_2012_Nov_15_3_e201210012.nxml.txt.nlp	24688672	SENT104	14	14	18	18	ethanol	CAT-1	PA448073	6541	0.461
NULL	J_Biol_Eng_2012_Jun_11_6_7.nxml.txt.nlp	22686441	SENT54	22	22	35	35	ganciclovir	EVA	PA449733	10205	0.461
NULL	J_Viral_Hepat_2013_Nov_7_20(11)_745-760.nxml.txt.nlp	24168254	SENT306	20	20	7	7	ribavirin	IFN	PA451241	3439	0.461
NULL	Cerebrospinal_Fluid_Res_2008_May_14_5_10.nxml.txt.nlp	18479516	SENT463	12	12	17	17	acetazolamide	FGF2	PA448018	2247;2258	0.461
NULL	J_Hematol_Oncol_2009_Nov_22_2_49.nxml.txt.nlp	19930611	SENT50	17	17	21	21	vincristine	CHOP	PA451879	1649	0.461
NULL	J_Exp_Clin_Cancer_Res_2009_Dec_13_28(1)_152.nxml.txt.nlp	20003385	SENT148	25	25	31	31	thrombin	LPA	PA451674	4018	0.461
NULL	J_Oncol_2012_Dec_7_2012_192464.nxml.txt.nlp	22187555	SENT525	22	22	11	11	resveratrol	Bcl-2		596	0.461
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT116	13	13	11	11	metformin	HIP	PA450395	6767;6159;64399;5068	0.461
NULL	J_Korean_Med_Sci_2013_Aug_31_28(8)_1213-1219.nxml.txt.nlp	23960450	SENT8	24	24	7	7	ribavirin	ITPA	PA451241	3704	0.461
NULL	Contemp_Clin_Dent_2011_Oct-Dec_2(4)_278-282.nxml.txt.nlp	22346152	SENT141	2	2	7	7	potassium	GCF	PA451047	6936	0.461
NULL	Arthritis_Res_Ther_2012_Aug_3_14(4)_R179.nxml.txt.nlp	22863285	SENT120	18	18	22	22	collagenase	INOS	PA449107	51477	0.461
NULL	Reprod_Biol_Endocrinol_2003_Oct_7_1_66.nxml.txt.nlp	14609433	SENT255	0	0	2	2	cisplatin	p53	PA449014	7157	0.461
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_16_2012_395912.nxml.txt.nlp	23118789	SENT75	29	29	22	22	phenylbutazone	UGT1A3	PA450932	54659	0.461
NULL	Breast_Cancer_Res_2000_Mar_25_2(3)_184-190.nxml.txt.nlp	11250708	SENT20	17	17	10	10	carbachol	LPA	PA448784	4018	0.461
NULL	J_Cell_Mol_Med_2014_Sep_19_18(9)_1705-1711.nxml.txt.nlp	25139375	SENT65	5	5	10	10	resveratrol	SIRT1		23411	0.461
NULL	Stroke_Res_Treat_2011_Jul_2_2011_282845.nxml.txt.nlp	21772967	SENT74	14	14	16	16	cilostazol	ICAD	PA164746334	1676	0.461
NULL	Oncol_Lett_2014_May_25_7(5)_1537-1543.nxml.txt.nlp	24765172	SENT75	16	16	21	21	hyaluronan	NG2	PA165958431	1464;6048	0.461
NULL	Clin_Ophthalmol_2012_Sep_5_6_1433-1440.nxml.txt.nlp	23055659	SENT153	33	33	29	29	timolol	BAK	PA451690	578	0.461
NULL	Br_J_Cancer_2006_Feb_13_94(3)_407-426.nxml.txt.nlp	16434996	SENT148	5	5	14	14	genistein	BRCA2	PA165109660	675	0.461
NULL	Part_Fibre_Toxicol_2013_Aug_13_10_39.nxml.txt.nlp	23937860	SENT199	29	29	25	25	hydrocortisone	EGF	PA449905	1950	0.461
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Oct_3_65(Pt_11)_o2603.nxml.txt.nlp	21578222	SENT3	17	17	29	29	febuxostat	mol	PA165958521	90527	0.461
NULL	Cancer_Med_2014_Apr_27_3(2)_310-321.nxml.txt.nlp	24464839	SENT364	20	20	9	9	everolimus	U87	PA164746311	677775;641648	0.461
NULL	Indian_J_Plast_Surg_2011_Sep-Dec_44(3)_467-473.nxml.txt.nlp	22279281	SENT111	7	7	11	11	artemisinin	ACT	PA165111696	12;11332;9457;641455	0.461
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Aug_21_69(Pt_9)_m510-m511.nxml.txt.nlp	24427002	SENT10	2	2	4	4	nitrile	mol	PA450636	90527	0.461
NULL	J_Pediatr_Neurosci_2014_Sep-Dec_9(3)_276-277.nxml.txt.nlp	25624937	SENT48	16	16	7	7	vancomycin	INA	PA451850	9118	0.461
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Sep_18_69(Pt_10)_o1545.nxml.txt.nlp	24098230	SENT72	21	21	18	18	ethanol	mol	PA448073	90527	0.461
NULL	J_Cardiothorac_Surg_2013_May_13_8_127.nxml.txt.nlp	23668669	SENT142	3	3	16	16	oxycodone	CPP	PA450741	340451	0.461
NULL	J_Headache_Pain_2009_Oct_5_10(5)_317-325.nxml.txt.nlp	19499287	SENT92	21	21	48	48	sildenafil	Yes	PA451346	7525	0.461
NULL	Eur_J_Histochem_2010_Jun_14_54(2)_e15.nxml.txt.nlp	20558338	SENT136	3	3	8	8	flutamide	PD2	PA449685	54623	0.461
NULL	Biomed_Res_Int_2013_Sep_5_2013_929531.nxml.txt.nlp	24083250	SENT56	25	25	31	31	hyaluronan	HAS2	PA165958431	3037	0.461
NULL	Vet_Res_Forum_2013_Winter_4(1)_19-24.nxml.txt.nlp	25593681	SENT12	7	7	5	5	diclofenac	B12	PA449293	7126;4709	0.461
NULL	Basic_Res_Cardiol_2013_Sep_26_108(6)_385.nxml.txt.nlp	24068185	SENT60	21	21	41	41	l-glutamine	BCS	PA10090	617	0.461
NULL	Br_J_Cancer_2002_Feb_1_86(3)_443-448.nxml.txt.nlp	11875713	SENT129	0	0	5	5	ciprofloxacin	Bcl-2	PA449009	596	0.461
NULL	Oncogene_2009_Dec_10_28(49)_4326-4343.nxml.txt.nlp	19826415	SENT328	13	13	13	13	pp2	PP2		4888	0.461
NULL	Oncotarget_2013_Dec_28_5(6)_1475-1490.nxml.txt.nlp	24721996	SENT134	0	0	4	4	celecoxib	PTEN	PA448871	5728	0.461
NULL	Acta_Pharmacol_Sin_2012_Jul_18_33(7)_918-923.nxml.txt.nlp	22705728	SENT12	15	15	19	19	estradiol	aromatase	PA449503	1588	0.461
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT273	13	13	20	20	glucose	PP2	PA449773	4888	0.461
NULL	Br_J_Pharmacol_2014_Jun_15_171(11)_2705-2725.nxml.txt.nlp	24467436	SENT15	12	12	8	8	isoniazid	NAT	PA450112	6046	0.461
NULL	Osteoporos_Int_2008_Apr_12_19(4)_399-428.nxml.txt.nlp	18266020	SENT879	3	3	27	27	tamoxifen	STAR	PA451581	6770;2984	0.461
NULL	Oncologist_2010_Mar_9_15(3)_236-245.nxml.txt.nlp	20215359	SENT91	6	6	15	15	bevacizumab	IFN	PA130232992	3439	0.461
NULL	Clin_Transl_Allergy_2014_Jan_15_4_3.nxml.txt.nlp	24428928	SENT161	15	15	4	4	methacholine	IL-17	PA165958382	3605	0.461
NULL	FEBS_J_2012_Sep_279(18)_3290-3313.nxml.txt.nlp	22443451	SENT575	4	4	8	8	ethanol	VIII	PA448073	1351	0.461
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Feb_26_70(Pt_3)_m108-m109.nxml.txt.nlp	24764940	SENT72	11	11	8	8	ethanol	mol	PA448073	90527	0.461
NULL	Carcinogenesis_2010_Dec_27_31(12)_2049-2057.nxml.txt.nlp	20876285	SENT111	6	6	11	11	tamoxifen	HER2	PA451581	2064	0.461
NULL	Physiol_Rep_2014_Aug_28_2(8)_e12143.nxml.txt.nlp	25168879	SENT598	2	2	7	7	staurosporine	UCN	PA165109623	7349	0.461
NULL	Clin_Ophthalmol_2012_Sep_5_6_1433-1440.nxml.txt.nlp	23055659	SENT153	21	21	15	15	timolol	BAK	PA451690	578	0.461
NULL	Curr_Neuropharmacol_2011_Dec_9(4)_530-552.nxml.txt.nlp	22654714	SENT725	25	25	6	6	escitalopram	BDNF	PA10074	627	0.461
NULL	Clin_Dev_Immunol_2013_Nov_26_2013_325481.nxml.txt.nlp	24371447	SENT153	22	22	41	41	propofol	IL-6	PA451141	3569	0.461
NULL	Cell_Death_Dis_2014_Feb_13_5(2)_e1055.nxml.txt.nlp	24525731	SENT20	22	22	13	13	cisplatin	TXNL1	PA449014	9352	0.461
NULL	J_Korean_Med_Sci_2011_Jan_22_26(1)_33-41.nxml.txt.nlp	21218027	SENT36	22	22	19	19	capreomycin	DST	PA164746226	667	0.461
NULL	Diabetes_Metab_Syndr_Obes_2014_Jul_17_7_313-319.nxml.txt.nlp	25092992	SENT117	8	8	3	3	glimepiride	adiponectin	PA449761	9370	0.461
NULL	Mol_Cancer_2009_Aug_25_8_66.nxml.txt.nlp	19706164	SENT18	5	5	2	2	celecoxib	p53	PA448871	7157	0.461
NULL	Cancer_Med_2013_Apr_6_2(2)_234-242.nxml.txt.nlp	23634291	SENT162	7	7	15	15	gemcitabine	VEGF-D	PA449748	2277	0.461
NULL	Diabetes_Metab_Syndr_Obes_2014_Jul_17_7_313-319.nxml.txt.nlp	25092992	SENT29	13	13	2	2	lipase	adiponectin	PA450239	9370	0.461
NULL	Case_Rep_Oncol_Med_2012_Dec_23_2012_784128.nxml.txt.nlp	23326742	SENT43	19	19	15	15	thrombin	FVIII	PA451674	2157	0.461
NULL	Cell_Death_Dis_2011_Apr_14_2(4)_e146.nxml.txt.nlp	21490678	SENT42	36	36	7	7	staurosporine	SMG1	PA165109623	23049	0.461
NULL	J_Hematol_Oncol_2012_May_15_5_23.nxml.txt.nlp	22587422	SENT32	30	30	27	27	dasatinib	ALL	PA162372878	613	0.461
NULL	J_Inflamm_(Lond)_2005_Oct_31_2_14.nxml.txt.nlp	16259633	SENT225	3	3	18	18	staurosporine	CCR2	PA165109623	729230	0.461
NULL	BMJ_Open_2014_May_5_4(5)_e005268.nxml.txt.nlp	24801283	SENT244	13	13	18	18	oxygen	TREM-1	PA450744	54210	0.461
NULL	Nat_Neurosci_2012_Sep_5_15(9)_1245-1254.nxml.txt.nlp	22864611	SENT98	0	0	5	5	clozapine	mGlu2	PA449061	2912	0.461
NULL	Acta_Neuropathol_2015_Oct_17_129_81-96.nxml.txt.nlp	25322817	SENT273	9	9	6	6	capsaicin	TRPV1	PA448776	7442	0.461
NULL	Int_J_Med_Sci_2012_Jul_25_9(6)_435-440.nxml.txt.nlp	22859903	SENT8	3	3	8	8	sevoflurane	CO2	PA451341	4513	0.461
NULL	Breast_Cancer_Res_2007_Jul_27_9(4)_R47.nxml.txt.nlp	17662123	SENT32	6	6	27	27	hyaluronan	EGF	PA165958431	1950	0.461
NULL	Breast_Cancer_Res_2007_Jan_23_9(1)_R7.nxml.txt.nlp	17244352	SENT203	11	11	9	9	tamoxifen	UGT2B15	PA451581	7366	0.461
NULL	Anal_Chem_Insights_2009_Apr_7_4_1-9.nxml.txt.nlp	19652757	SENT44	27	27	4	4	heparin	BHD	PA449855	201163	0.461
NULL	Int_J_Alzheimers_Dis_2011_Mar_31_2011_490140.nxml.txt.nlp	21547229	SENT154	22	22	2	2	memantine	GRIN2B	PA10364	2904	0.461
NULL	Cardiovasc_Diabetol_2010_Nov_16_9_76.nxml.txt.nlp	21080957	SENT339	3	3	0	0	exenatide	GLP-1	PA164749238	100125288	0.461
NULL	Cancer_2014_Jun_15_120(12)_1830-1837.nxml.txt.nlp	24668580	SENT25	3	3	7	7	rituximab	PRIMA	PA451261	145270	0.46
NULL	Nat_Commun_2013_Sep_11_4_2416.nxml.txt.nlp	24022506	SENT216	28	28	6	6	paraformaldehyde	PK1	PA450790	84432	0.46
NULL	Onco_Targets_Ther_2014_Mar_6_7_395-404.nxml.txt.nlp	24623982	SENT105	5	5	2	2	cytarabine	IFN	PA449177	3439	0.46
NULL	Oncotarget_2012_Dec_30_3(12)_1505-1521.nxml.txt.nlp	23455493	SENT175	19	19	5	5	chloroquine	NAC	PA448948	22861	0.46
NULL	Asia_Pac_Allergy_2013_Apr_26_3(2)_127-135.nxml.txt.nlp	23667837	SENT88	0	0	2	2	capsaicin	TRPV1	PA448776	7442	0.46
NULL	Indian_J_Pharm_Sci_2013_Jan-Feb_75(1)_94-98.nxml.txt.nlp	23901167	SENT87	36	36	15	15	bupropion	CYP2C9	PA448687	1559	0.46
NULL	Cancer_Metab_2014_Nov_3_2(1)_20.nxml.txt.nlp	NULL	SENT206	11	11	6	6	erlotinib	PDK4	PA134687924	5166	0.46
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1049.nxml.txt.nlp	24503541	SENT374	8	8	8	8	pp2	PP2		4888	0.46
NULL	Am_J_Med_Genet_A_2011_Oct_9_155(10)_2446-2452.nxml.txt.nlp	21910234	SENT45	22	22	25	25	creatine	SLC6A8	PA164778930	6535	0.46
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Oct_23_65(Pt_11)_o2830.nxml.txt.nlp	21578420	SENT63	16	16	13	13	ethanol	mol	PA448073	90527	0.46
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Apr_15_9_13.nxml.txt.nlp	20398300	SENT108	21	21	7	7	lansoprazole	LAM	PA450180	7249;7248	0.46
NULL	Biomed_Res_Int_2014_Jun_30_2014_921296.nxml.txt.nlp	25101299	SENT103	2	2	5	5	bleomycin	BLMH	PA448645	642	0.46
NULL	Crit_Care_2007_Apr_15_11(2)_R45.nxml.txt.nlp	17433112	SENT63	18	18	40	40	heparin	ACT	PA449855	12;11332;9457;641455	0.46
NULL	Int_J_Mol_Sci_2014_Nov_25_15(12)_21703-21722.nxml.txt.nlp	25429431	SENT985	36	36	12	12	curcumin	ABCB1	PA151958596	5243	0.46
NULL	J_Carcinog_2013_Dec_31_12_22.nxml.txt.nlp	24574860	SENT6	16	16	32	32	erlotinib	EML4	PA134687924	27436	0.46
NULL	J_Hematol_Oncol_2013_Jun_3_6_38.nxml.txt.nlp	23731980	SENT70	10	10	23	23	lapatinib	HER2	PA152241907	2064	0.46
NULL	CNS_Neurosci_Ther_2010_Jun_16(3)_e1-e17.nxml.txt.nlp	20406250	SENT229	28	28	8	8	mirtazapine	5-HT1A	PA450522	3350	0.46
NULL	Arthritis_Res_Ther_2007_Jun_29_9(Suppl_1)_S3.nxml.txt.nlp	17634142	SENT96	5	5	14	14	denosumab	OPG	PA166048634	690	0.46
NULL	Mol_Cancer_2010_Dec_20_9_316.nxml.txt.nlp	21172016	SENT163	22	22	45	45	heparin	CCL21	PA449855	6366	0.46
NULL	Oncoscience_2014_Mar_24_1(3)_196-204.nxml.txt.nlp	25594012	SENT72	5	5	12	12	erlotinib	HER3	PA134687924	2065	0.46
NULL	Int_J_Biomed_Sci_2007_Dec_3(4)_237-250.nxml.txt.nlp	23675049	SENT399	3	3	5	5	hyaluronan	CD44	PA165958431	960	0.46
NULL	Exp_Ther_Med_2012_Oct_16_4(4)_705-710.nxml.txt.nlp	23170130	SENT173	2	2	4	4	cyclophosphamide	P-gp	PA449165	5243	0.46
NULL	J_Parasitol_Res_2011_Nov_17_2011_104954.nxml.txt.nlp	22174990	SENT5	22	22	28	28	chloroquine	DD2	PA448948	1646	0.46
NULL	Case_Rep_Med_2011_Sep_7_2011_583978.nxml.txt.nlp	21912554	SENT58	2	2	7	7	thyroglobulin	CEA	PA164754910	5670;1087	0.46
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Dec_18_67(Pt_1)_o190-o191.nxml.txt.nlp	21522693	SENT75	0	0	7	7	orphenadrine	mol	PA450715	90527	0.46
NULL	Breast_Cancer_Res_2010_Oct_22_12(Suppl_2)_S2.nxml.txt.nlp	21050423	SENT266	5	5	10	10	olaparib	BRCA2		675	0.46
NULL	Breast_Cancer_Res_2011_Jun_29_13(3)_R70.nxml.txt.nlp	21707964	SENT189	18	18	25	25	tamoxifen	14-3-3	PA451581	10971	0.46
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jan_21_68(Pt_2)_m178-m179.nxml.txt.nlp	22346852	SENT10	10	10	12	12	ethanol	mol	PA448073	90527	0.46
NULL	Bioeng_Bugs_2012_May_1_3(3)_147-156.nxml.txt.nlp	22572786	SENT71	13	13	15	15	ethanol	CO2	PA448073	4513	0.46
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT294	2	2	8	8	resveratrol	TRAIL		8743	0.46
NULL	Vet_Res_2013_Dec_5_44(1)_119.nxml.txt.nlp	24308795	SENT23	0	0	13	13	glucose	ACE	PA449773	1636	0.46
NULL	Korean_Circ_J_2013_Jun_30_43(6)_400-407.nxml.txt.nlp	23882289	SENT31	16	16	14	14	doxorubicin	survivin	PA449412	332	0.46
NULL	Aging_(Albany_NY)_2011_Apr_6_3(4)_444-449.nxml.txt.nlp	21483037	SENT57	10	10	4	4	resveratrol	SIRT1		23411	0.46
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1067.nxml.txt.nlp	24556682	SENT86	34	34	32	32	doxorubicin	BTZ	PA449412	22794	0.46
NULL	Eur_J_Endocrinol_2013_Apr_168(4)_557-564.nxml.txt.nlp	23345197	SENT80	13	13	25	25	diazoxide	ABCC8	PA449285	6833	0.46
NULL	Mol_Syst_Biol_2010_Jun_8_6_375.nxml.txt.nlp	20531405	SENT136	9	9	30	30	terconazole	GAPDH	PA164768834	2597	0.46
NULL	Exp_Cell_Res_2011_Apr_15_317(7)_1028-1039.nxml.txt.nlp	21237154	SENT96	8	8	6	6	staurosporine	TRAIL	PA165109623	8743	0.46
NULL	Arthritis_Res_Ther_2014_Oct_4_16(5)_460.nxml.txt.nlp	25280749	SENT204	18	18	11	11	etanercept	OPG	PA449515	690	0.46
NULL	Int_J_Anal_Chem_2011_Oct_10_2011_124917.nxml.txt.nlp	22007220	SENT60	14	14	18	18	risperidone	API	PA451257	5345	0.46
NULL	Oncotarget_2013_Apr_13_4(4)_502-530.nxml.txt.nlp	23594434	SENT271	39	39	20	20	nelfinavir	U87	PA450606	677775;641648	0.46
NULL	Environ_Health_Perspect_2011_Mar_10_119(3)_357-363.nxml.txt.nlp	21362589	SENT203	5	5	3	3	picrotoxin	RDX	PA164777007	5962	0.46
NULL	J_Exp_Med_1998_Jun_1_187(11)_1885-1892.nxml.txt.nlp	9607928	SENT135	36	36	23	23	thalidomide	CD4	PA451644	920	0.46
NULL	Nat_Commun_2013_Oct_15_4_2602.nxml.txt.nlp	24129506	SENT155	14	14	28	28	ethanol	S26	PA448073	6231	0.46
NULL	J_Breast_Cancer_2013_Mar_31_16(1)_1-11.nxml.txt.nlp	23593075	SENT206	19	19	27	27	doxorubicin	HER2	PA449412	2064	0.46
NULL	J_Hematol_Oncol_2009_Oct_27_2_45.nxml.txt.nlp	19860903	SENT124	9	9	11	11	bevacizumab	IFN	PA130232992	3439	0.46
NULL	Breast_Cancer_Res_2008_Dec_18_10(Suppl_4)_S25.nxml.txt.nlp	19128439	SENT10	17	17	11	11	tamoxifen	IMPACT	PA451581	55364	0.46
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Feb_17_68(Pt_3)_o700-o701.nxml.txt.nlp	22412590	SENT4	8	8	10	10	erythromycin	mol	PA449493	90527	0.46
NULL	Mol_Clin_Oncol_2013_Jul_27_1(4)_768-772.nxml.txt.nlp	24649244	SENT180	5	5	16	16	gemcitabine	GEM	PA449748	2669	0.46
NULL	Biosci_Rep_2014_Mar_25_34(2)_e00100.nxml.txt.nlp	24527765	SENT419	0	0	13	13	doxorubicin	c-Jun	PA449412	3725	0.46
NULL	Environ_Health_Perspect_2005_Nov_14_113(11)_1600-1606.nxml.txt.nlp	16263518	SENT95	14	14	18	18	estradiol	HSD1	PA449503	26871	0.46
NULL	J_Breast_Cancer_2011_Mar_31_14(1)_20-27.nxml.txt.nlp	21847390	SENT5	24	24	10	10	estradiol	CLDN6	PA449503	9074	0.46
NULL	Cell_Res_2013_Jul_21_23(7)_915-930.nxml.txt.nlp	23689279	SENT349	0	0	5	5	ethanol	ALDH2	PA448073	217	0.46
NULL	Breast_Cancer_Res_2012_Apr_4_14(2)_R57.nxml.txt.nlp	22475046	SENT129	14	14	10	10	tamoxifen	TTR	PA451581	7276	0.46
NULL	Front_Behav_Neurosci_2014_Sep_29_8_298.nxml.txt.nlp	25324742	SENT1214	9	9	12	12	phencyclidine	spatial	PA128406980	219793	0.46
NULL	Nanoscale_Res_Lett_2010_Sep_30_6(1)_54.nxml.txt.nlp	NULL	SENT117	7	7	10	10	dextran	CYP11A1	PA449261	1583	0.46
NULL	Ann_Hematol_2014_Sep_12_93(1)_13-32.nxml.txt.nlp	24026426	SENT274	21	21	31	31	posaconazole	BII	PA151958574	777	0.46
NULL	Int_Cardiovasc_Res_J_2014_Sep_1_8(3)_89-93.nxml.txt.nlp	25177670	SENT86	4	4	6	6	amlodipine	IL-6	PA448388	3569	0.46
NULL	Neural_Plast_2007_Dec_11_2007_73079.nxml.txt.nlp	NULL	SENT3372	7	7	1	1	clomipramine	U87	PA449048	677775;641648	0.46
NULL	Br_J_Cancer_2001_Jul_85(2)_303-311.nxml.txt.nlp	11461094	SENT5	21	21	16	16	paclitaxel	EGF	PA450761	1950	0.46
NULL	Front_Genet_2013_Aug_29_4_163.nxml.txt.nlp	24009622	SENT142	2	2	4	4	ethanol	DDP	PA448073	1678	0.46
NULL	Surg_Today_2012_Jan_6_42(1)_8-28.nxml.txt.nlp	22139128	SENT236	18	18	11	11	tegafur	PSK	PA452620	9344	0.46
NULL	Clin_Ophthalmol_2014_Jan_13_8_219-228.nxml.txt.nlp	24531757	SENT150	8	8	4	4	brinzolamide	TIM	PA164744929	7984;8914	0.46
NULL	J_Korean_Med_Sci_2010_Aug_21_25(8)_1222-1227.nxml.txt.nlp	20676337	SENT80	2	2	13	13	propofol	LPA	PA451141	4018	0.46
NULL	Support_Care_Cancer_2012_May_1_20(5)_941-949.nxml.txt.nlp	21533811	SENT129	14	14	32	32	granisetron	HEC	PA449809	10403	0.46
NULL	Neuroscience_2011_Dec_1_197(1)_280-292.nxml.txt.nlp	21945033	SENT92	22	22	15	15	galantamine	AP-5	PA449726	91056	0.46
NULL	Front_Oncol_2014_Jun_11_4_145.nxml.txt.nlp	24967214	SENT412	5	5	23	23	doxorubicin	B7-H1	PA449412	29126	0.46
NULL	Bone_2012_Jan_50(1)_218-225.nxml.txt.nlp	22023931	SENT227	11	11	9	9	iron	GFR	PA450087	9771	0.46
NULL	Int_J_Endocrinol_2010_Feb_10_2010_625852.nxml.txt.nlp	20169119	SENT34	10	10	24	24	paricalcitol	PTH	PA450798	5741	0.46
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT143	31	31	13	13	vinorelbine	ASC	PA451881	29108	0.46
NULL	Eur_J_Cancer_2014_Sep_50(14)_2367-2374.nxml.txt.nlp	25027307	SENT79	11	11	6	6	estradiol	AMH	PA449503	268	0.46
NULL	Ann_Clin_Transl_Neurol_2014_Jan_20_1(1)_15-26.nxml.txt.nlp	25356379	SENT159	27	27	18	18	isoflurane	EGO	PA450106	100126791	0.46
NULL	Lab_Invest_2009_Nov_7_89(11)_1275-1290.nxml.txt.nlp	19736547	SENT343	19	19	24	24	curcumin	LOX-1	PA151958596	4973	0.46
NULL	Front_Cell_Neurosci_2014_Jan_24_8_7.nxml.txt.nlp	24478630	SENT542	14	14	17	17	potassium	KCC2	PA451047	57468	0.46
NULL	Behav_Brain_Funct_2009_Jun_4_5_23.nxml.txt.nlp	19497110	SENT10	8	8	2	2	ethanol	P29	PA448073	5657	0.46
NULL	Cancers_(Basel)_2013_May_3_5(2)_491-510.nxml.txt.nlp	24216987	SENT158	0	0	7	7	creatine	ADP	PA164778930	23038	0.46
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT1733	9	9	6	6	efavirenz	ATV	PA449441	4683	0.46
NULL	Oxid_Med_Cell_Longev_2012_Aug_22_2012_534705.nxml.txt.nlp	22966415	SENT228	15	15	8	8	riluzole	GLT-1	PA451251	6506	0.46
NULL	Arthritis_Res_Ther_2005_Mar_16_7(Suppl_2)_S21-S25.nxml.txt.nlp	15833145	SENT91	7	7	2	2	abatacept	ACR	PA164747080	49	0.46
NULL	Front_Neurol_2013_Oct_7_4_139.nxml.txt.nlp	24109471	SENT202	5	5	21	21	modafinil	TAAR1	PA450530	134864	0.46
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT236	32	32	27	27	risperidone	PRL	PA451257	5617	0.46
NULL	Front_Oncol_2013_Apr_2_3_67.nxml.txt.nlp	23565503	SENT395	2	2	0	0	resveratrol	Bcl-2		596	0.46
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Sep_3_67(Pt_10)_o2550.nxml.txt.nlp	22064894	SENT61	6	6	3	3	ethanol	mol	PA448073	90527	0.46
NULL	Br_J_Pharmacol_2010_Feb_159(4)_772-786.nxml.txt.nlp	20105183	SENT42	24	24	30	30	l-glutamine	CO2	PA10090	4513	0.459
NULL	Clin_Med_Insights_Oncol_2011_Mar_16_5_35-43.nxml.txt.nlp	21499557	SENT269	3	3	23	23	doxorubicin	IFF	PA449412	3456	0.459
NULL	Arthritis_Res_Ther_2006_Nov_30_8(1)_R10.nxml.txt.nlp	16356198	SENT31	1	1	41	41	bleomycin	IP-10	PA448645	3627	0.459
NULL	Hum_Mol_Genet_2013_Feb_15_22(4)_795-803.nxml.txt.nlp	23175443	SENT365	6	6	4	4	paclitaxel	TACC3	PA450761	10460	0.459
NULL	J_Neural_Transm_2014_Mar_27_121(10)_1221-1232.nxml.txt.nlp	24671607	SENT126	6	6	9	9	ethanol	CORT	PA448073	1325	0.459
NULL	Front_Neurosci_2010_Jun_28_4_41.nxml.txt.nlp	20661453	SENT52	0	0	6	6	ethanol	NRSF	PA448073	5978	0.459
NULL	Ann_Clin_Microbiol_Antimicrob_2009_Sep_24_8_26.nxml.txt.nlp	19778428	SENT176	18	18	4	4	ceftriaxone	PEN	PA448866	9933	0.459
NULL	Mol_Microbiol_2014_Jul_23_93(2)_369-389.nxml.txt.nlp	24912400	SENT329	31	31	6	6	nadh	P5C	PA164755085	5831	0.459
NULL	Ann_Lab_Med_2014_May_8_34(3)_230-234.nxml.txt.nlp	24790911	SENT133	4	4	2	2	lamivudine	LAM	PA450163	7249;7248	0.459
NULL	Glycobiology_2008_Jun_4_18(6)_426-440.nxml.txt.nlp	18390826	SENT79	5	5	7	7	heparin	IL8	PA449855	3576	0.459
NULL	Arch_Plast_Surg_2014_Nov_3_41(6)_620-629.nxml.txt.nlp	25396172	SENT117	9	9	12	12	triamcinolone	CO2	PA451749	4513	0.459
NULL	Evid_Based_Complement_Alternat_Med_2011_Feb_14_2011_650263.nxml.txt.nlp	21799686	SENT193	2	2	12	12	atropine	STZ	PA448505	6484	0.459
NULL	Indian_J_Med_Res_2013_Jan_137(1)_191-196.nxml.txt.nlp	23481072	SENT95	7	7	12	12	vancomycin	VISA	PA451850	57506	0.459
NULL	Clin_Ophthalmol_2007_Dec_1(4)_519-525.nxml.txt.nlp	19668531	SENT104	2	2	5	5	azithromycin	BAK	PA448519	578	0.459
NULL	J_Epilepsy_Res_2011_Dec_30_1(2)_52-56.nxml.txt.nlp	24649446	SENT20	19	19	16	16	diazepam	LZP	PA449283	170392	0.459
NULL	Psychiatry_Investig_2011_Sep_26_8(3)_262-268.nxml.txt.nlp	21994515	SENT16	32	32	10	10	clozapine	HTR2C	PA449061	3358	0.459
NULL	Hum_Genomics_2006_Jan_1_2(4)_252-257.nxml.txt.nlp	16460650	SENT94	17	17	22	22	nadh	ND1	PA164755085	4535;10625	0.459
NULL	Oncoimmunology_2012_Sep_1_1(6)_894-907.nxml.txt.nlp	23162757	SENT77	10	10	8	8	imiquimod	MPL	PA449972	4352	0.459
NULL	Sensors_(Basel)_2013_Mar_6_13(3)_3169-3203.nxml.txt.nlp	23467031	SENT321	37	37	28	28	cyclophosphamide	ACT	PA449165	12;11332;9457;641455	0.459
NULL	Front_Neurosci_2014_Feb_14_8_23.nxml.txt.nlp	24592205	SENT1288	0	0	7	7	capsaicin	P2X3	PA448776	5024	0.459
NULL	J_Cell_Biol_1998_Jan_26_140(2)_335-345.nxml.txt.nlp	9442109	SENT196	15	15	12	12	chloroquine	NHE	PA448948	285335	0.459
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jul_25_65(Pt_8)_o1984.nxml.txt.nlp	21583660	SENT3	22	22	18	18	ethanol	mol	PA448073	90527	0.459
NULL	Physiol_Rep_2014_Aug_28_2(8)_e12108.nxml.txt.nlp	25168868	SENT607	9	9	15	15	rimonabant	adiponectin	PA152407999	9370	0.459
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jul_18_65(Pt_8)_o1918-o1919.nxml.txt.nlp	21583604	SENT74	26	26	23	23	ethanol	mol	PA448073	90527	0.459
NULL	Bone_Marrow_Res_2014_Apr_3_2014_541345.nxml.txt.nlp	24860670	SENT252	6	6	12	12	clofarabine	GM-CSF	PA164754863	1437	0.459
NULL	Indian_J_Endocrinol_Metab_2012_Mar_16(Suppl1)_S47-S56.nxml.txt.nlp	22701844	SENT111	19	19	9	9	sitagliptin	GLP-1	PA164748978	100125288	0.459
NULL	Int_J_Med_Sci_2015_Jan_12_12(2)_187-200.nxml.txt.nlp	25589895	SENT160	26	26	6	6	erlotinib	EGFR	PA134687924	1956	0.459
NULL	Mol_Biol_Cell_2013_Dec_1_24(23)_3675-3688.nxml.txt.nlp	24088572	SENT317	35	35	41	41	galactose	LEU2	PA449725	8847	0.459
NULL	Parasit_Vectors_2013_Nov_23_6_335.nxml.txt.nlp	24267406	SENT50	27	27	34	34	kanamycin	CO2	PA450137	4513	0.459
NULL	Nucleic_Acids_Res_2012_Jul_20_40(13)_6270-6289.nxml.txt.nlp	22434888	SENT343	11	11	7	7	galactose	UTP6	PA449725	55813	0.459
NULL	Braz_J_Med_Biol_Res_2014_Oct_14_47(12)_1068-1074.nxml.txt.nlp	25387674	SENT105	23	23	27	27	taurine	ANOVA	PA451590	4858	0.459
NULL	Breast_Cancer_Res_2007_Dec_20_9(Suppl_2)_S25.nxml.txt.nlp	NULL	SENT11	16	16	14	14	tamoxifen	HER2	PA451581	2064	0.459
NULL	Curr_Neuropharmacol_2013_Jan_11(1)_102-108.nxml.txt.nlp	23814542	SENT225	14	14	35	35	simvastatin	Yes	PA451363	7525	0.459
NULL	Front_Oncol_2014_Sep_15_4_244.nxml.txt.nlp	25309870	SENT72	7	7	9	9	gefitinib	EGFR	PA131301952	1956	0.459
NULL	Indian_J_Endocrinol_Metab_2012_Dec_16(Suppl_3)_S627-S636.nxml.txt.nlp	23565499	SENT184	25	25	8	8	vasopressin	SON	PA451858	6651	0.459
NULL	Front_Oncol_2014_Oct_21_4_285.nxml.txt.nlp	25374842	SENT697	5	5	3	3	cisplatin	RITA	PA449014	55422;84934	0.459
NULL	Biomed_Res_Int_2013_Jul_30_2013_754946.nxml.txt.nlp	23984405	SENT48	2	2	13	13	nadh	CYTB	PA164755085	4519	0.459
NULL	J_Cancer_2011_May_16_2_280-291.nxml.txt.nlp	21611109	SENT237	33	33	12	12	kanamycin	IL2	PA450137	3558	0.459
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1699-1708.nxml.txt.nlp	19861960	SENT77	22	22	19	19	dasatinib	mol	PA162372878	90527	0.459
NULL	Int_J_Environ_Res_Public_Health_2010_May_4_7(5)_2045-2056.nxml.txt.nlp	20623010	SENT204	3	3	7	7	estradiol	IL-2	PA449503	3558	0.459
NULL	Evid_Based_Complement_Alternat_Med_2013_Aug_28_2013_516017.nxml.txt.nlp	24066014	SENT139	2	2	17	17	doxorubicin	AT1	PA449412	9197;185	0.459
NULL	Biomed_Eng_Online_2012_Nov_14_11_84.nxml.txt.nlp	23151049	SENT186	29	29	25	25	alendronate	PTH	PA448082	5741	0.459
NULL	Arch_Dis_Child_2014_Dec_8_99(12)_1143-1146.nxml.txt.nlp	25202131	SENT58	13	13	11	11	phenytoin	CYP2C9	PA450947	1559	0.459
NULL	Curr_Oncol_2009_Sep_16(5)_32-47.nxml.txt.nlp	19862360	SENT248	7	7	15	15	ibritumomab	San	PA164781375	80218	0.459
NULL	Biomed_Res_Int_2013_Jul_31_2013_965417.nxml.txt.nlp	23984423	SENT193	32	32	26	26	lipase	SREBP-1c	PA450239	6720	0.459
NULL	Ann_Clin_Microbiol_Antimicrob_2005_Sep_13_4_13.nxml.txt.nlp	16159399	SENT218	21	21	19	19	lamivudine	IFN	PA450163	3439	0.459
NULL	Front_Endocrinol_(Lausanne)_2013_Jan_7_3_180.nxml.txt.nlp	23316185	SENT268	22	22	5	5	glucose	CRF2	PA449773	1395	0.459
NULL	Breast_Cancer_Res_2005_Mar_4_7(3)_R345-R352.nxml.txt.nlp	15987429	SENT124	22	22	33	33	carbachol	COX	PA448784	1351	0.459
NULL	Bioanal_Rev_2012_Dec_24_4(2-4)_115-157.nxml.txt.nlp	23227132	SENT647	18	18	21	21	coumarin	NIR	PA134521193	26155	0.459
NULL	Oncotarget_2014_Oct_18_5(22)_11604-11619.nxml.txt.nlp	25344099	SENT150	4	4	0	0	cisplatin	RYBP	PA449014	23429	0.459
NULL	Cardiol_Res_Pract_2012_Aug_15_2012_713294.nxml.txt.nlp	22928146	SENT165	1	1	11	11	carvedilol	CARMEN	PA448817	8915	0.459
NULL	Viruses_2009_Aug_11_1(2)_126-143.nxml.txt.nlp	21994542	SENT47	14	14	17	17	oxygen	ROS	PA450744	6098	0.459
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Sep_6_64(Pt_10)_o1872.nxml.txt.nlp	21201087	SENT68	20	20	18	18	paraformaldehyde	mol	PA450790	90527	0.459
NULL	Curr_Hematol_Malig_Rep_2014_Feb_6_9(1)_9-16.nxml.txt.nlp	24500518	SENT270	3	3	5	5	sorafenib	FLT3	PA7000	2322	0.459
NULL	Cell_Death_Dis_2010_Oct_21_1(10)_e86.nxml.txt.nlp	21368859	SENT121	5	5	7	7	doxorubicin	TRAIL	PA449412	8743	0.459
NULL	J_Biol_Chem_2008_Apr_4_283(14)_8837-8845.nxml.txt.nlp	18250166	SENT186	32	32	8	8	methotrexate	StAR	PA450428	6770	0.459
NULL	Oncogene_2014_May_8_33(19)_2478-2486.nxml.txt.nlp	23752180	SENT95	3	3	15	15	guanidine	RAP1	PA164781028	54386	0.459
NULL	Oncotarget_2014_Oct_15_5(21)_10763-10777.nxml.txt.nlp	25333257	SENT257	15	15	5	5	sn-38	FasL		356	0.459
NULL	Case_Rep_Oncol_2010_Jun_30_4(2)_327-335.nxml.txt.nlp	21738504	SENT50	20	20	43	43	fluorouracil	HCC	PA128406956	84668	0.459
NULL	EMBO_Mol_Med_2013_Jun_4_5(6)_802-804.nxml.txt.nlp	23737442	SENT25	3	3	20	20	oxygen	HIF-1	PA450744	29072	0.459
NULL	Biosci_Rep_2014_Oct_2_34(5)_e00141.nxml.txt.nlp	25195639	SENT152	13	13	37	37	lipase	aP2	PA450239	2167	0.459
NULL	J_Korean_Med_Sci_2010_Nov_26_25(11)_1683-1687.nxml.txt.nlp	21060764	SENT11	10	10	14	14	thyroglobulin	CEA	PA164754910	5670;1087	0.459
NULL	Front_Aging_Neurosci_2011_May_20_3_7.nxml.txt.nlp	21647396	SENT1747	0	0	20	20	phenytoin	CA1	PA450947	759	0.459
NULL	Oncotarget_2011_May_16_2(5)_368-377.nxml.txt.nlp	21576762	SENT166	34	34	15	15	streptomycin	CO2	PA451512	4513	0.459
NULL	Int_J_Gen_Med_2013_Jun_7_6_453-464.nxml.txt.nlp	23785241	SENT205	5	5	15	15	nedocromil	IL-6	PA450601	3569	0.459
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT154	46	46	42	42	nutlin-3	p53		7157	0.459
NULL	Lipids_Health_Dis_2011_Dec_6_10_229.nxml.txt.nlp	22146099	SENT158	2	2	6	6	rosiglitazone	IL-13	PA451283	3596	0.458
NULL	ScientificWorldJournal_2013_Jun_24_2013_534807.nxml.txt.nlp	23864826	SENT84	28	28	36	36	fluoxetine	SNK	PA449673	10769	0.458
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Sep_30_70(Pt_10)_265-268.nxml.txt.nlp	25484670	SENT11	18	18	20	20	nitrile	mol	PA450636	90527	0.458
NULL	Arthritis_Res_2002_May_9_4(Suppl_3)_S169-S176.nxml.txt.nlp	12110136	SENT126	13	13	18	18	leflunomide	IFN	PA450192	3439	0.458
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jun_16_68(Pt_7)_o2121.nxml.txt.nlp	22798797	SENT68	22	22	19	19	ethanol	mol	PA448073	90527	0.458
NULL	Nanoscale_Res_Lett_2008_Nov_18_4(1)_54-62.nxml.txt.nlp	20596447	SENT117	11	11	3	3	oxygen	hole	PA450744	80757	0.458
NULL	Contemp_Oncol_(Pozn)_2012_Jul_6_16(3)_258-261.nxml.txt.nlp	23788891	SENT59	9	9	21	21	cisplatin	p53	PA449014	7157	0.458
NULL	Int_J_Womens_Health_2012_Oct_10_4_543-549.nxml.txt.nlp	23091400	SENT61	28	28	19	19	resveratrol	aromatase		1588	0.458
NULL	Breast_Cancer_Res_2005_Mar_4_7(3)_R345-R352.nxml.txt.nlp	15987429	SENT245	28	28	30	30	ns-398	CARB		9482	0.458
NULL	Virol_J_2009_Jul_1_6_91.nxml.txt.nlp	19566966	SENT94	12	12	3	3	staurosporine	ASK	PA165109623	10926	0.458
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jul_4_65(Pt_8)_o1750.nxml.txt.nlp	21583461	SENT60	26	26	20	20	ethanol	mol	PA448073	90527	0.458
NULL	Indian_J_Pharmacol_2014_Jan-Feb_46(1)_100-104.nxml.txt.nlp	24550593	SENT107	8	8	13	13	diazepam	hole	PA449283	80757	0.458
NULL	Exp_Ther_Med_2015_Feb_15_9(2)_384-388.nxml.txt.nlp	25574202	SENT23	8	8	11	11	oxygen	ROS	PA450744	6098	0.458
NULL	J_Oncol_2012_Mar_26_2012_198412.nxml.txt.nlp	22536237	SENT72	27	27	29	29	trastuzumab	GEM	PA451743	2669	0.458
NULL	Biomed_Eng_Online_2012_Nov_14_11_84.nxml.txt.nlp	23151049	SENT182	30	30	26	26	alendronate	PTH	PA448082	5741	0.458
NULL	Clin_Ophthalmol_2014_Jan_29_8_305-309.nxml.txt.nlp	24511224	SENT70	19	19	16	16	latanoprost	PEX	PA164774763	5251	0.458
NULL	Ann_Intensive_Care_2011_Jul_19_1_26.nxml.txt.nlp	21906376	SENT15	1	1	8	8	vancomycin	SAPS	PA451850	8935	0.458
NULL	Indian_J_Med_Res_2012_Oct_136(4)_571-584.nxml.txt.nlp	23168697	SENT123	16	16	42	42	heparin	IFN	PA449855	3439	0.458
NULL	Br_J_Cancer_2013_Sep_3_109(5)_1279-1286.nxml.txt.nlp	23949154	SENT143	16	16	9	9	flutamide	PC-3	PA449685	692094	0.458
NULL	J_Immunother_Cancer_2013_Aug_27_1_13.nxml.txt.nlp	NULL	SENT23	37	37	26	26	hyaluronan	WT1	PA165958431	7490	0.458
NULL	BMB_Rep_2014_Mar_47(3)_149-157.nxml.txt.nlp	24499666	SENT156	14	14	28	28	fluorescein	GSTO1	PA164746009	9446	0.458
NULL	Cancers_(Basel)_2010_Sep_9_2(3)_1661-1682.nxml.txt.nlp	24281180	SENT60	16	16	12	12	ethanol	IL-6	PA448073	3569	0.458
NULL	Crit_Care_2010_Jul_19_14(4)_179.nxml.txt.nlp	20670385	SENT37	8	8	0	0	vasopressin	ACTH	PA451858	5443	0.458
NULL	Nature_2009_Apr_23_458(7241)_1034-1038.nxml.txt.nlp	19262509	SENT196	12	12	14	14	paraformaldehyde	Diva	PA450790	10017	0.458
NULL	Front_Neurol_2014_Aug_12_5_153.nxml.txt.nlp	25161646	SENT114	29	29	6	6	urokinase	NCCT	PA451836	6559	0.458
NULL	J_Korean_Neurosurg_Soc_2014_Jan_31_55(1)_5-11.nxml.txt.nlp	24570811	SENT30	4	4	19	19	temozolomide	CRT	PA451609	811	0.458
NULL	Cancer_Cell_Int_2006_Mar_6_6_5.nxml.txt.nlp	16519802	SENT33	9	9	11	11	tamoxifen	SSTR1	PA451581	6751	0.458
NULL	Genome_Biol_2003_Oct_27_4(11)_232.nxml.txt.nlp	14611649	SENT24	38	38	9	9	l-arginine	SLC7A2	PA448478	6542	0.458
NULL	Eur_J_Nucl_Med_Mol_Imaging_2010_Dec_20_37(12)_2381-2397.nxml.txt.nlp	20306036	SENT463	16	16	12	12	collagenase	CD40	PA449107	958	0.458
NULL	Chemother_Res_Pract_2011_Dec_18_2011_965826.nxml.txt.nlp	22295208	SENT296	12	12	4	4	azacitidine	DAC	PA451996	13	0.458
NULL	Front_Physiol_2012_Sep_12_3_362.nxml.txt.nlp	22988443	SENT373	4	4	11	11	nadh	NNT	PA164755085	23530	0.458
NULL	Oncotarget_2013_Dec_28_5(6)_1475-1490.nxml.txt.nlp	24721996	SENT191	4	4	9	9	rosiglitazone	PTEN	PA451283	5728	0.458
NULL	Kidney_Int_Suppl_(2011)_2012_Dec_15_2(5)_370-371.nxml.txt.nlp	25018964	SENT26	5	5	11	11	candesartan	SECRET	PA448765	10590	0.458
NULL	Ann_Surg_Treat_Res_2014_Feb_22_86(2)_68-75.nxml.txt.nlp	24761411	SENT18	6	6	3	3	resveratrol	survivin		332	0.458
NULL	Oncoimmunology_2013_Jan_1_2(1)_e22890.nxml.txt.nlp	23483066	SENT50	8	8	23	23	vemurafenib	IFN	PA165946873	3439	0.458
NULL	Scientifica_(Cairo)_2012_Jul_8_2012_128382.nxml.txt.nlp	24278667	SENT178	21	21	19	19	ribavirin	IFN	PA451241	3439	0.458
NULL	EMBO_Mol_Med_2013_Jun_30_5(6)_935-948.nxml.txt.nlp	23629957	SENT297	15	15	8	8	cisplatin	COL6A3	PA449014	1293	0.458
NULL	J_Korean_Med_Sci_2007_Sep_30_22(Suppl)_S66-S72.nxml.txt.nlp	17923758	SENT47	7	7	5	5	aldesleukin	IL-2	PA448081	3558	0.458
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Oct_9_66(Pt_11)_o2790.nxml.txt.nlp	21588987	SENT6	15	15	8	8	ethanol	mol	PA448073	90527	0.458
NULL	Braz_J_Med_Biol_Res_2012_Mar_2_45(3)_250-255.nxml.txt.nlp	22370705	SENT150	6	6	19	19	vasopressin	ADM	PA451858	133	0.458
NULL	Toxins_(Basel)_2010_Oct_26_2(11)_2490-2518.nxml.txt.nlp	22069563	SENT238	5	5	30	30	cisplatin	IL-10	PA449014	3586	0.458
NULL	Carcinogenesis_2014_May_13_35(5)_1055-1066.nxml.txt.nlp	24419232	SENT188	5	5	14	14	metformin	CYP1B1	PA450395	1545	0.458
NULL	Oncoimmunology_2014_May_29_3_e28925.nxml.txt.nlp	25083322	SENT67	24	24	6	6	nilotinib	IFN	PA165958345	3439	0.458
NULL	J_Hematol_Oncol_2011_Mar_26_4_11.nxml.txt.nlp	21439076	SENT115	6	6	2	2	irinotecan	Gem	PA450085	51053	0.458
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT3067	11	11	9	9	oxygen	ROS	PA450744	6098	0.458
NULL	Biomed_Res_Int_2014_Jan_27_2014_696107.nxml.txt.nlp	24587987	SENT208	33	33	37	37	ebselen	NAC	PA161660841	22861	0.458
NULL	Osteoporos_Int_2013_Oct_19_24(1)_23-57.nxml.txt.nlp	23079689	SENT577	37	37	32	32	denosumab	PTH	PA166048634	5741	0.458
NULL	Curr_Neuropharmacol_2009_Mar_7(1)_9-36.nxml.txt.nlp	19721815	SENT1235	29	29	20	20	pramipexole	LRRK2	PA164742949	120892	0.458
NULL	Hum_Genomics_2009_Jan_1_3(2)_128-142.nxml.txt.nlp	19164090	SENT37	8	8	6	6	carboplatin	CD44	PA448803	960	0.458
NULL	Mol_Cancer_2009_Dec_31_8_131.nxml.txt.nlp	20042122	SENT252	17	17	24	24	choline	PDK1	PA448976	5170;5163	0.458
NULL	Breast_Cancer_Res_2007_Jan_23_9(1)_R7.nxml.txt.nlp	17244352	SENT199	11	11	9	9	tamoxifen	CYP2D6	PA451581	1565	0.458
NULL	Open_Cardiovasc_Med_J_2011_Jun_20_5_136-147.nxml.txt.nlp	21760856	SENT41	12	12	31	31	rosiglitazone	ghrelin	PA451283	51738	0.458
NULL	Front_Genet_2013_Aug_29_4_163.nxml.txt.nlp	24009622	SENT205	25	25	21	21	ethanol	DDP	PA448073	1678	0.458
NULL	Clin_Pharmacokinet_2014_Oct_15_53(2)_155-164.nxml.txt.nlp	24127209	SENT259	3	3	6	6	clopidogrel	CYP2C19	PA449053	1557	0.458
NULL	Cardiovasc_Res_2011_Apr_1_90(1)_105-112.nxml.txt.nlp	21123217	SENT39	17	17	34	34	nifedipine	San	PA450631	80218	0.458
NULL	Br_J_Cancer_2013_Sep_3_109(5)_1079-1084.nxml.txt.nlp	23928659	SENT81	28	28	17	17	docetaxel	DES	PA449383	1674	0.458
NULL	J_Infect_Dis_2013_Aug_15_208(4)_637-644.nxml.txt.nlp	23633403	SENT48	17	17	13	13	heparin	LAMP	PA449855	4045;27074	0.458
NULL	Cancers_(Basel)_2011_Sep_13_3(3)_3557-3584.nxml.txt.nlp	22163073	SENT281	2	2	4	4	ebselen	DPI	PA161660841	1832	0.458
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Oct_11_70(Pt_11)_319-321.nxml.txt.nlp	25484733	SENT34	1	1	14	14	coumarin	mol	PA134521193	90527	0.458
NULL	J_Exp_Med_1998_Jun_1_187(11)_1885-1892.nxml.txt.nlp	9607928	SENT111	0	0	7	7	thalidomide	IL-2	PA451644	3558	0.458
NULL	Mol_Biol_Cell_2012_Sep_1_23(17)_3461-3472.nxml.txt.nlp	22767580	SENT270	32	32	7	7	paraformaldehyde	ITGB1	PA450790	3688	0.458
NULL	Diabetes_2013_Oct_17_62(10)_3547-3552.nxml.txt.nlp	23863812	SENT107	0	0	2	2	pravastatin	adiponectin	PA451089	9370	0.458
NULL	J_Gen_Physiol_1932_Nov_20_16(2)_313-321.nxml.txt.nlp	19872707	SENT0	10	10	1	1	trypsin	Gen	PA451806	348654	0.458
NULL	Breast_Cancer_Res_2000_Jul_11_2(6)_423-429.nxml.txt.nlp	11250736	SENT101	42	42	8	8	estradiol	c-myb	PA449503	4602	0.458
NULL	J_Vis_Exp_2009_Jan_16_(23)_990.nxml.txt.nlp	19229177	SENT58	2	2	8	8	papain	CO2	PA450778	4513	0.458
NULL	Mol_Cancer_2012_Sep_14_11_69.nxml.txt.nlp	22978347	SENT31	17	17	21	21	estradiol	TRAP1	PA449503	9392;10131	0.458
NULL	Appl_Microbiol_Biotechnol_2013_Aug_16_97(18)_7999-8009.nxml.txt.nlp	23948723	SENT79	12	12	10	10	glucose	mol	PA449773	90527	0.458
NULL	Biomed_Res_Int_2013_Sep_5_2013_929531.nxml.txt.nlp	24083250	SENT56	25	25	20	20	hyaluronan	HAS3	PA165958431	3038	0.458
NULL	ScientificWorldJournal_2013_Oct_24_2013_726912.nxml.txt.nlp	24282387	SENT38	3	3	0	0	fluorescein	AVP	PA164746009	114548;551	0.458
NULL	Oncol_Lett_2014_May_26_7(5)_1345-1351.nxml.txt.nlp	24765136	SENT219	6	6	13	13	sorafenib	Mcl-1	PA7000	4170	0.458
NULL	Cancer_Med_2014_Apr_27_3(2)_293-299.nxml.txt.nlp	24464780	SENT31	15	15	11	11	capecitabine	TYMP	PA448771	1890	0.458
NULL	Int_J_Environ_Res_Public_Health_2010_May_27_7(5)_1872-1888.nxml.txt.nlp	20622998	SENT63	39	39	4	4	disulfiram	ADH1B	PA449376	125	0.458
NULL	Br_J_Cancer_2013_Aug_6_109(3)_686-693.nxml.txt.nlp	23839492	SENT101	3	3	15	15	sorafenib	IL-8	PA7000	3576	0.458
NULL	Cancer_Res_Treat_2013_Dec_31_45(4)_251-262.nxml.txt.nlp	24453997	SENT88	38	38	40	40	chloroquine	TRAIL	PA448948	8743	0.458
NULL	Indian_J_Dermatol_2012_Sep-Oct_57(5)_394-395.nxml.txt.nlp	23112363	SENT47	18	18	10	10	tretinoin	CO2	PA451746	4513	0.458
NULL	Mol_Biol_Evol_2013_Nov_16_30(11)_2531-2540.nxml.txt.nlp	23955518	SENT142	4	4	25	25	nadh	ND5	PA164755085	4540	0.458
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Nov_7_65(Pt_12)_m1540-m1541.nxml.txt.nlp	21578581	SENT75	5	5	9	9	guanidine	mol	PA164781028	90527	0.458
NULL	Acta_Pharmacol_Sin_2011_Jan_6_32(1)_133-138.nxml.txt.nlp	21131997	SENT138	9	9	32	32	heparin	ACT	PA449855	12;11332;9457;641455	0.458
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2009_Jun_1_65(Pt_6)_513-522.nxml.txt.nlp	19465765	SENT155	31	31	34	34	chloramphenicol	CLB	PA448927	171425	0.458
NULL	Cell_Death_Dis_2010_Jan_21_1(1)_e17.nxml.txt.nlp	21364618	SENT138	20	20	24	24	hydrocortisone	EGF	PA449905	1950	0.458
NULL	Oncotarget_2014_Oct_15_5(21)_10763-10777.nxml.txt.nlp	25333257	SENT257	20	20	5	5	oxaliplatin	FasL	PA131285527	356	0.458
NULL	Front_Neurol_2011_Jul_4_2_36.nxml.txt.nlp	21772826	SENT64	0	0	6	6	clopidogrel	ADP	PA449053	23038	0.458
NULL	Cancer_Cell_Int_2011_Aug_2_11_25.nxml.txt.nlp	21810252	SENT116	21	21	6	6	gentamicin	F12	PA449753	2161	0.458
NULL	Mol_Cancer_2008_Mar_26_7_27.nxml.txt.nlp	18366759	SENT267	14	14	22	22	etoposide	BAK1	PA449552	578	0.458
NULL	Exp_Cell_Res_2011_Apr_15_317(7)_1028-1039.nxml.txt.nlp	21237154	SENT216	31	31	29	29	staurosporine	TRAIL	PA165109623	8743	0.458
NULL	Emerg_Infect_Dis_2011_Mar_17(3)_395-402.nxml.txt.nlp	21392429	SENT256	4	4	0	0	cyclophosphamide	Yes	PA449165	7525	0.457
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Feb_18_65(Pt_3)_o546.nxml.txt.nlp	21582205	SENT70	27	27	24	24	ethanol	mol	PA448073	90527	0.457
NULL	Antimicrob_Agents_Chemother_2014_Jun_58(6)_3354-3359.nxml.txt.nlp	24687509	SENT176	7	7	9	9	primaquine	G6PD	PA451103	2539	0.457
NULL	Drugs_Aging_2014_May_6_31(6)_413-424.nxml.txt.nlp	24797286	SENT139	9	9	2	2	alendronate	CTX	PA448082	1593	0.457
NULL	Breast_Cancer_Res_2004_Aug_16_6(6)_R605-R615.nxml.txt.nlp	15535842	SENT223	21	21	26	26	fluorescein	gamma	PA164746009	9913	0.457
NULL	J_Infect_Dis_2013_Mar_1_207(5)_842-847.nxml.txt.nlp	23225895	SENT36	6	6	8	8	lumefantrine	LUM	PA165111722	4060	0.457
NULL	Clin_Dev_Immunol_2011_Sep_14_2011_267539.nxml.txt.nlp	21922022	SENT197	20	20	38	38	gemcitabine	VEGFR2	PA449748	3791	0.457
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Sep_11_66(Pt_10)_o2548-o2549.nxml.txt.nlp	21587537	SENT73	29	29	14	14	ethanol	mol	PA448073	90527	0.457
NULL	Curr_Health_Sci_J_2014_Dec_29_Jan-Mar_40(1)_5-11.nxml.txt.nlp	24791198	SENT82	7	7	21	21	heparin	VEGF-A	PA449855	7422	0.457
NULL	Cancer_Metastasis_Rev_2014_Dec_28_33(1)_161-171.nxml.txt.nlp	24375389	SENT283	5	5	8	8	paclitaxel	CHFR	PA450761	55743	0.457
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Dec_2_5_30.nxml.txt.nlp	17140452	SENT239	11	11	5	5	gentamicin	GAT	PA449753	10249	0.457
NULL	Front_Aging_Neurosci_2011_May_25_3_9.nxml.txt.nlp	21647305	SENT869	0	0	9	9	ondansetron	spatial	PA450705	219793	0.457
NULL	Crit_Care_2011_Nov_16_15(6)_R271.nxml.txt.nlp	22087790	SENT164	2	2	28	28	nitroprusside	Yes	PA451406	7525	0.457
NULL	J_Cell_Biol_2003_Dec_8_163(5)_1133-1143.nxml.txt.nlp	14662751	SENT9	28	28	22	22	urokinase	fractalkine	PA451836	6376	0.457
NULL	Br_J_Cancer_2012_May_8_106(10)_1587-1590.nxml.txt.nlp	22568998	SENT120	3	3	5	5	sunitinib	IFN	PA162372840	3439	0.457
NULL	Clin_Ophthalmol_2014_Feb_10_8_389-399.nxml.txt.nlp	24550667	SENT195	13	13	29	29	timolol	TIM	PA451690	7984;8914	0.457
NULL	Hum_Genomics_2004_Jan_1_1(2)_111-125.nxml.txt.nlp	15601539	SENT226	10	10	0	0	lipase	ATV	PA450239	4683	0.457
NULL	Cancers_(Basel)_2011_Apr_1_3(2)_1844-1860.nxml.txt.nlp	24212785	SENT52	32	32	11	11	doxycycline	STEPP	PA449415	222659	0.457
NULL	Clin_Ophthalmol_2009_Jun_2_3_57-67.nxml.txt.nlp	19668545	SENT16	18	18	6	6	cyclosporine	KCS	PA449167	3771	0.457
NULL	Infect_Drug_Resist_2010_Oct_13_3_103-114.nxml.txt.nlp	21694899	SENT93	24	24	4	4	raltegravir	CD4		920	0.457
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT140	28	28	26	26	vinorelbine	ASC	PA451881	29108	0.457
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT161	17	17	14	14	carbamazepine	CYP3A5	PA448785	1577	0.457
NULL	Cancer_Metab_2013_Feb_4_1_7.nxml.txt.nlp	24280108	SENT94	4	4	8	8	oxygen	MYC	PA450744	4609	0.457
NULL	Clin_Med_Insights_Case_Rep_2014_Oct_1_7_117-121.nxml.txt.nlp	25336995	SENT42	34	34	14	14	methotrexate	CHOP	PA450428	1649	0.457
NULL	J_Cell_Mol_Med_2014_Dec_9_18(12)_2499-2511.nxml.txt.nlp	24912879	SENT240	9	9	11	11	docetaxel	DACH1	PA449383	1602	0.457
NULL	Carcinogenesis_2010_Dec_27_31(12)_2049-2057.nxml.txt.nlp	20876285	SENT110	9	9	27	27	tamoxifen	HER2	PA451581	2064	0.457
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Oct_4_70(Pt_11)_269-271.nxml.txt.nlp	25484720	SENT6	41	41	43	43	nitrile	mol	PA450636	90527	0.457
NULL	Clin_Med_Insights_Oncol_2012_Dec_6_6_407-421.nxml.txt.nlp	23239933	SENT213	8	8	2	2	cisplatin	GEM	PA449014	2669	0.457
NULL	Front_Neurosci_2011_Mar_31_5_161.nxml.txt.nlp	21503142	SENT562	0	0	4	4	naloxone	spatial	PA450586	219793	0.457
NULL	Chin_J_Cancer_2012_Apr_31(4)_178-184.nxml.txt.nlp	22237038	SENT39	5	5	2	2	niclosamide	S100A4	PA165958408	6275	0.457
NULL	Curr_HIV_Res_2013_Oct_11(7)_570-575.nxml.txt.nlp	24467642	SENT144	15	15	21	21	darunavir	ARTEMIS	PA163522472	64421	0.457
NULL	Cell_Death_Dis_2014_Jan_30_5(1)_e1043.nxml.txt.nlp	24481457	SENT234	9	9	11	11	urokinase	G0S2	PA451836	50486	0.457
NULL	Front_Cell_Neurosci_2014_Jul_28_8_209.nxml.txt.nlp	25120433	SENT1328	3	3	8	8	potassium	eag	PA451047	3756	0.457
NULL	Front_Aging_Neurosci_2009_Nov_27_1_2.nxml.txt.nlp	20552053	SENT1615	0	0	11	11	memantine	spatial	PA10364	219793	0.457
NULL	Cardiovasc_Res_2011_Sep_1_91(4)_694-702.nxml.txt.nlp	21606183	SENT192	14	14	11	11	forskolin	AC3	PA146096022	109	0.457
NULL	Ther_Clin_Risk_Manag_2007_Dec_3(6)_1027-1033.nxml.txt.nlp	18516257	SENT60	34	34	37	37	vincristine	MRC	PA451879	4345	0.457
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Sep_6_64(Pt_10)_o1872.nxml.txt.nlp	21201087	SENT68	30	30	7	7	piperazine	mol	PA450977	90527	0.457
NULL	Cells_2014_Sep_12_3(3)_914-938.nxml.txt.nlp	25222270	SENT590	11	11	19	19	capsaicin	TRPV1	PA448776	7442	0.457
NULL	Evid_Based_Complement_Alternat_Med_2014_May_8_2014_682717.nxml.txt.nlp	24949079	SENT96	0	0	8	8	berberine	HO-1	PA165860812	3162	0.457
NULL	Cancer_Med_2013_Feb_3_2(1)_40-49.nxml.txt.nlp	24133626	SENT5	18	18	32	32	cisplatin	PDE3B	PA449014	5140	0.457
NULL	Case_Rep_Transplant_2014_Jan_2_2014_548243.nxml.txt.nlp	24575309	SENT12	35	35	28	28	sirolimus	CYP3A4	PA451365	1576	0.457
NULL	Int_J_Mol_Sci_2014_Sep_29_15(10)_17411-17441.nxml.txt.nlp	25268615	SENT37	13	13	22	22	collagenase	EMMPRIN	PA449107	682	0.457
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT37	13	13	18	18	curcumin	TRAIL	PA151958596	8743	0.457
NULL	Front_Oncol_2014_Sep_23_4_264.nxml.txt.nlp	25295231	SENT264	25	25	18	18	idarubicin	p53	PA449961	7157	0.457
NULL	Genome_Biol_2004_Jan_27_5(2)_R10.nxml.txt.nlp	14759260	SENT258	5	5	2	2	nadh	NR1	PA164755085	27158	0.457
NULL	Cardiol_Res_Pract_2013_Feb_21_2013_127270.nxml.txt.nlp	23509665	SENT41	3	3	10	10	prasugrel	IPA	PA154410481	3160	0.457
NULL	Genome_Announc_2013_Dec_5_1(6)_e01011-13.nxml.txt.nlp	24309740	SENT8	23	23	20	20	vancomycin	VISA	PA451850	57506	0.457
NULL	Acta_Pharmacol_Sin_2010_Feb_5_31(2)_137-144.nxml.txt.nlp	20139896	SENT116	8	8	10	10	zileuton	5-LOX	PA451955	240	0.457
NULL	Diabetes_2009_Jan_58(1)_215-226.nxml.txt.nlp	18840783	SENT314	21	21	7	7	fasudil	FasL	PA165946121	356	0.457
NULL	Biologics_2013_Apr_15_7_77-90.nxml.txt.nlp	23723688	SENT147	21	21	17	17	cisplatin	CRT	PA449014	811	0.457
NULL	Cancer_Cell_Int_2013_Feb_8_13_11.nxml.txt.nlp	23394616	SENT118	21	21	15	15	geldanamycin	Hsp90	PA152031327	3320	0.457
NULL	Case_Rep_Ophthalmol_2012_Dec_20_3(3)_410-417.nxml.txt.nlp	23341817	SENT54	25	25	28	28	fluorescein	ERG	PA164746009	2078	0.457
NULL	Br_J_Cancer_2013_Sep_3_109(5)_1117-1122.nxml.txt.nlp	23942070	SENT136	17	17	20	20	cetuximab	CRT	PA10040	811	0.457
NULL	Br_J_Cancer_2009_Oct_20_101(8)_1253-1260.nxml.txt.nlp	19755984	SENT192	4	4	10	10	letrozole	AIB1	PA450196	8202	0.457
NULL	Int_J_Biomed_Sci_2007_Jun_3(2)_104-111.nxml.txt.nlp	23675031	SENT46	34	34	25	25	l-glutamine	F12	PA10090	2161	0.457
NULL	Arthritis_Res_Ther_2009_Aug_24_11(4)_R127.nxml.txt.nlp	19703304	SENT56	21	21	10	10	adalimumab	OASIS	PA10004	90993	0.457
NULL	Core_Evid_2011_Mar_17_6_31-42.nxml.txt.nlp	21468241	SENT85	0	0	4	4	ticagrelor	IPA	PA165374673	3160	0.457
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_16_2012_395912.nxml.txt.nlp	23118789	SENT75	29	29	31	31	phenylbutazone	UGT1A8	PA450932	54576	0.457
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Sep_26_65(Pt_10)_m1244.nxml.txt.nlp	21577761	SENT62	35	35	7	7	ethanol	mol	PA448073	90527	0.457
NULL	Environ_Health_Perspect_2003_Feb_111(2)_139-145.nxml.txt.nlp	12573895	SENT9	14	14	21	21	estradiol	aromatase	PA449503	1588	0.457
NULL	Br_J_Cancer_2010_Oct_26_103(9)_1380-1390.nxml.txt.nlp	20877355	SENT182	25	25	27	27	vincristine	FasL	PA451879	356	0.457
NULL	Clin_Pract_2012_Mar_28_2(2)_e34.nxml.txt.nlp	24765433	SENT87	33	33	12	12	thrombin	STA	PA451674	2010;2656	0.457
NULL	Oxid_Med_Cell_Longev_2013_Sep_17_2013_521563.nxml.txt.nlp	24163720	SENT119	33	33	24	24	phentolamine	AVP	PA450926	114548;551	0.457
NULL	J_Immunother_2014_Apr_12_37(3)_180-186.nxml.txt.nlp	24598448	SENT165	16	16	14	14	sorafenib	IL-2	PA7000	3558	0.457
NULL	Arthritis_Res_Ther_2014_Apr_3_16(2)_R86.nxml.txt.nlp	24708674	SENT30	2	2	7	7	bosentan	BLM	PA10034	641	0.457
NULL	Diabetes_2008_Oct_57(10)_2774-2783.nxml.txt.nlp	18591389	SENT175	22	22	30	30	galactose	LGALS3	PA449725	3958	0.457
NULL	Cardiovasc_Diabetol_2013_Mar_18_12_46.nxml.txt.nlp	23497197	SENT213	2	2	9	9	metformin	adiponectin	PA450395	9370	0.457
NULL	Mol_Cell_Proteomics_2012_Dec_12_11(12)_1578-1585.nxml.txt.nlp	22790023	SENT69	22	22	18	18	trypsin	MS2	PA451806	101	0.457
NULL	Nat_Genet_2013_Dec_3_45(12)_1439-1445.nxml.txt.nlp	24185512	SENT190	40	40	31	31	streptomycin	FBS	PA451512	64319;26269	0.457
NULL	Diabetes_Care_2012_Feb_16_35(2)_327-333.nxml.txt.nlp	22179958	SENT184	8	8	12	12	metformin	B12	PA450395	7126;4709	0.457
NULL	Support_Care_Cancer_2013_Aug_19_21(8)_2341-2349.nxml.txt.nlp	23686401	SENT201	9	9	11	11	tamoxifen	aromatase	PA451581	1588	0.457
NULL	Angiogenesis_2012_Dec_28_15(4)_623-641.nxml.txt.nlp	22843200	SENT273	2	2	10	10	sunitinib	MVD	PA162372840	4597	0.457
NULL	Cancer_Manag_Res_2012_Nov_9_4_383-395.nxml.txt.nlp	23204869	SENT148	4	4	13	13	carmustine	PC-3	PA448810	692094	0.457
NULL	Nucleic_Acids_Res_2013_Feb_18_41(3)_1544-1554.nxml.txt.nlp	23254334	SENT102	24	24	26	26	glutaraldehyde	TGN	PA449777	7038	0.457
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Jul_9_3(7)_e124.nxml.txt.nlp	25006781	SENT335	11	11	25	25	rosuvastatin	OATP1B1	PA134308647	10599	0.457
NULL	J_Adv_Pract_Oncol_2012_Nov_1_Nov-Dec_3(6)_355-356.nxml.txt.nlp	25031966	SENT30	16	16	20	20	indomethacin	DES	PA449982	1674	0.457
NULL	Evid_Based_Complement_Alternat_Med_2014_May_8_2014_364819.nxml.txt.nlp	24899907	SENT80	15	15	17	17	tacrolimus	FKBP52	PA451578	2288	0.457
NULL	Child_Adolesc_Psychiatry_Ment_Health_2011_Nov_4_5_35.nxml.txt.nlp	22054243	SENT213	15	15	33	33	dextroamphetamine	Gen	PA449269	348654	0.457
NULL	Indian_J_Dermatol_2013_Sep-Oct_58(5)_410d.nxml.txt.nlp	24082224	SENT4	14	14	23	23	dapsone	G6PD	PA449211	2539	0.457
NULL	Pharmacogn_Rev_2011_Jan-Jun_5(9)_103-110.nxml.txt.nlp	22096324	SENT169	12	12	10	10	thrombin	ADP	PA451674	23038	0.457
NULL	Neural_Plast_2014_May_12_2014_563160.nxml.txt.nlp	24900924	SENT405	22	22	30	30	choline	B12	PA448976	7126;4709	0.457
NULL	Open_AIDS_J_2010_May_14_4_105-115.nxml.txt.nlp	20657829	SENT194	1	1	4	4	methamphetamine	sit	PA450403	55733	0.457
NULL	Carcinogenesis_2014_May_13_35(5)_1055-1066.nxml.txt.nlp	24419232	SENT200	0	0	2	2	metformin	CYP1B1	PA450395	1545	0.457
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT184	14	14	10	10	cisplatin	p53	PA449014	7157	0.457
NULL	Front_Neuroendocrinol_2012_Jan_33(1)_45-66.nxml.txt.nlp	21802439	SENT1381	6	6	4	4	vasopressin	c-fos	PA451858	2353	0.457
NULL	Mol_Neurodegener_2010_Nov_10_5_49.nxml.txt.nlp	21067594	SENT168	33	33	15	15	lipase	PTEN	PA450239	5728	0.457
NULL	Autoimmune_Dis_2011_Dec_9_2011_932351.nxml.txt.nlp	21197462	SENT188	17	17	12	12	mitoxantrone	IFN	PA450526	3439	0.457
NULL	Cancers_(Basel)_2013_Nov_7_5(4)_1456-1468.nxml.txt.nlp	24213559	SENT86	11	11	15	15	bevacizumab	BBP	PA130232992	83941	0.457
NULL	Case_Rep_Hematol_2013_Sep_5_2013_708489.nxml.txt.nlp	24083040	SENT82	12	12	17	17	iron	B12	PA450087	7126;4709	0.457
NULL	Biology_(Basel)_2012_Jul_26_1(2)_196-221.nxml.txt.nlp	24832223	SENT104	5	5	7	7	ethanol	CO2	PA448073	4513	0.457
NULL	Diabetes_Care_2008_Aug_31(8)_1635-1638.nxml.txt.nlp	18458144	SENT6	24	24	27	27	rosiglitazone	DREAM	PA451283	30818	0.456
NULL	Evid_Based_Complement_Alternat_Med_2015_Jan_6_2015_736431.nxml.txt.nlp	25632290	SENT83	8	8	10	10	daunorubicin	P-gp	PA449212	5243	0.456
NULL	ARYA_Atheroscler_2014_Sep_10(5)_259-265.nxml.txt.nlp	25477983	SENT163	25	25	21	21	sugar	FBS	PA451529	64319;26269	0.456
NULL	Mol_Cancer_2010_Mar_4_9_49.nxml.txt.nlp	20202195	SENT53	7	7	9	9	vorinostat	HOP	PA164748224	84525;10963	0.456
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jan_11_68(Pt_2)_o349-o350.nxml.txt.nlp	22346978	SENT7	1	1	19	19	ethanol	mol	PA448073	90527	0.456
NULL	Environ_Health_Perspect_2005_Jul_17_113(7)_849-852.nxml.txt.nlp	16002371	SENT33	1	1	8	8	capsaicin	VR1	PA448776	56664	0.456
NULL	AIDS_Care_2011_Sep_14_23(9)_1154-1162.nxml.txt.nlp	21500025	SENT140	8	8	2	2	zidovudine	ATV	PA451954	4683	0.456
NULL	Support_Care_Cancer_2011_Oct_12_19(10)_1609-1617.nxml.txt.nlp	20835873	SENT33	14	14	25	25	granisetron	MEC	PA449809	56477	0.456
NULL	Arch_Dis_Child_2014_Dec_8_99(12)_1143-1146.nxml.txt.nlp	25202131	SENT58	9	9	5	5	cyclophosphamide	CYP1A2	PA449165	1544	0.456
NULL	J_Obstet_Gynaecol_2014_Oct_16_34(7)_605-610.nxml.txt.nlp	25226401	SENT191	14	14	24	24	estradiol	PRL	PA449503	5617	0.456
NULL	Int_J_Environ_Res_Public_Health_2010_Apr_30_7(4)_1448-1466.nxml.txt.nlp	20617039	SENT346	9	9	4	4	ethanol	NR1	PA448073	27158	0.456
NULL	J_Korean_Med_Sci_2014_Jul_11_29(7)_965-972.nxml.txt.nlp	25045229	SENT60	15	15	13	13	metformin	B12	PA450395	7126;4709	0.456
NULL	Front_Behav_Neurosci_2010_Apr_5_4_14.nxml.txt.nlp	20407577	SENT313	10	10	3	3	cocaine	NAC1	PA449072	112939;6323	0.456
NULL	Cell_Death_Dis_2014_Mar_13_5(3)_e1118.nxml.txt.nlp	24625977	SENT291	23	23	14	14	etoposide	UBXN2A	PA449552	165324	0.456
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Apr_4_68(Pt_5)_o1282-o1283.nxml.txt.nlp	22590196	SENT4	1	1	3	3	ethanol	mol	PA448073	90527	0.456
NULL	Indian_J_Pharmacol_2013_Jan-Feb_45(1)_54-60.nxml.txt.nlp	23543867	SENT15	8	8	10	10	acetylcysteine	NAC	PA448033	22861	0.456
NULL	F1000_Med_Rep_2009_Feb_24_1_13.nxml.txt.nlp	20948769	SENT8	26	26	31	31	vincristine	CHOP	PA451879	1649	0.456
NULL	Hum_Mol_Genet_2013_Dec_1_22(23)_4784-4804.nxml.txt.nlp	23922229	SENT462	38	38	20	20	paraformaldehyde	PLP	PA450790	25824;5744	0.456
NULL	Neural_Plast_2012_Jul_8_2012_710943.nxml.txt.nlp	22830052	SENT234	12	12	39	39	creatine	UBE3A	PA164778930	7337	0.456
NULL	Iran_J_Pharm_Res_2013_Winter_12(Suppl)_169-174.nxml.txt.nlp	24250685	SENT52	18	18	24	24	clopidogrel	LTA	PA449053	4049	0.456
NULL	Biomed_Eng_Online_2012_Nov_14_11_84.nxml.txt.nlp	23151049	SENT50	22	22	20	20	alendronate	PTH	PA448082	5741	0.456
NULL	J_Gastrointest_Cancer_2010_Mar_28_41(1)_60-70.nxml.txt.nlp	19946763	SENT5	25	25	14	14	imatinib	LRG	PA10804	116844	0.456
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Dec_14_68(Pt_1)_o122.nxml.txt.nlp	22259410	SENT3	9	9	3	3	piperazine	mol	PA450977	90527	0.456
NULL	Front_Genet_2014_Jun_2_5_161.nxml.txt.nlp	24917881	SENT304	1	1	23	23	choline	POMC	PA448976	5443	0.456
NULL	Arthritis_Res_Ther_2009_Mar_16_11(2)_R41.nxml.txt.nlp	19291317	SENT218	27	27	16	16	alendronate	ACL	PA448082	47	0.456
NULL	Arthritis_Res_Ther_2008_Jan_18_10(1)_R8.nxml.txt.nlp	18205921	SENT13	12	12	19	19	hyaluronan	MRP5	PA165958431	10057	0.456
NULL	Epilepsia_2012_Jun_21_53(Suppl_1)_18-25.nxml.txt.nlp	22612805	SENT43	0	0	2	2	furosemide	KCC2	PA449719	57468	0.456
NULL	Int_J_Inflam_2010_Aug_4_2011_351010.nxml.txt.nlp	21151531	SENT43	0	0	5	5	collagenase	LPA	PA449107	4018	0.456
NULL	Patient_Prefer_Adherence_2010_Oct_5_4_369-377.nxml.txt.nlp	21049089	SENT174	18	18	2	2	risperidone	DAI	PA451257	81030	0.456
NULL	Breast_Cancer_Res_2012_Jul_23_14(4)_R112.nxml.txt.nlp	22824341	SENT96	14	14	12	12	doxorubicin	RANKL	PA449412	8600	0.456
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT257	1	1	5	5	doxorubicin	SLK	PA449412	9748;2534	0.456
NULL	Case_Rep_Pathol_2013_Feb_21_2013_687427.nxml.txt.nlp	23533895	SENT104	11	11	7	7	thyroglobulin	CK7	PA164754910	3855	0.456
NULL	Diabetes_2013_Jun_17_62(6)_1981-1989.nxml.txt.nlp	23382450	SENT303	7	7	12	12	metformin	SIRT1	PA450395	23411	0.456
NULL	J_Biol_Chem_2009_Jul_24_284(30)_20011-20021.nxml.txt.nlp	19473976	SENT187	3	3	10	10	trypsin	MCT1	PA451806	6566	0.456
NULL	Cancers_(Basel)_2011_Mar_29_3(2)_1708-1731.nxml.txt.nlp	24212779	SENT1591	7	7	11	11	fluorouracil	IL-2	PA128406956	3558	0.456
NULL	Crit_Care_2010_Apr_20_14(2)_R72.nxml.txt.nlp	20406444	SENT179	27	27	34	34	heparin	SYS	PA449855	54938	0.456
NULL	Breast_Cancer_Res_2007_Aug_10_9(4)_R52.nxml.txt.nlp	17692126	SENT28	9	9	7	7	exemestane	aromatase	PA449563	1588	0.456
NULL	Arthritis_Rheumatol_2014_Jun_27_66(6)_1574-1582.nxml.txt.nlp	24577881	SENT42	2	2	7	7	hydralazine	NAC	PA449894	22861	0.456
NULL	Behav_Brain_Funct_2013_Nov_26_9_43.nxml.txt.nlp	24279870	SENT231	4	4	17	17	ethanol	CA3	PA448073	761	0.456
NULL	Front_Pharmacol_2014_Sep_2_5_204.nxml.txt.nlp	25228881	SENT599	7	7	4	4	methamphetamine	GDNF	PA450403	2668	0.456
NULL	J_Headache_Pain_2011_Oct_9_12(5)_521-525.nxml.txt.nlp	21479703	SENT82	28	28	37	37	pregabalin	ANOVA	PA164754814	4858	0.456
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1699-1708.nxml.txt.nlp	19861960	SENT214	8	8	5	5	dasatinib	mol	PA162372878	90527	0.456
NULL	Neuroscience_2014_Dec_26_283_124-137.nxml.txt.nlp	24641886	SENT155	17	17	13	13	pilocarpine	CA1	PA450962	759	0.456
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2007_Dec_6_64(Pt_1)_o142.nxml.txt.nlp	21200707	SENT63	27	27	17	17	ethanol	mol	PA448073	90527	0.456
NULL	Breast_Cancer_Res_2010_Oct_22_12(Suppl_2)_S1.nxml.txt.nlp	21050422	SENT423	12	12	23	23	carboplatin	TRN	PA448803	3842	0.456
NULL	Breast_Cancer_Res_2012_Jul_20_14(4)_R110.nxml.txt.nlp	22817698	SENT35	14	14	16	16	cisplatin	BRCA1	PA449014	672	0.456
NULL	Cancers_(Basel)_2014_Nov_14_6(4)_2275-2295.nxml.txt.nlp	25405526	SENT83	15	15	13	13	etoposide	CHOP	PA449552	1649	0.456
NULL	Virol_J_2009_Jul_31_6_119.nxml.txt.nlp	19646266	SENT137	25	25	19	19	cefazolin	TEM1	PA448839	57124	0.456
NULL	AMB_Express_2014_May_22_4_37.nxml.txt.nlp	25401060	SENT300	4	4	2	2	nicotine	S16	PA450626	6217	0.456
NULL	Clin_Mol_Hepatol_2014_Sep_25_20(3)_283-290.nxml.txt.nlp	25320732	SENT29	7	7	5	5	propranolol	EVL	PA451145	51466	0.456
NULL	J_Cardiothorac_Surg_2014_Feb_17_9_35.nxml.txt.nlp	24533613	SENT178	12	12	22	22	heparin	ACT	PA449855	12;11332;9457;641455	0.456
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jul_31_65(Pt_8)_o2055.nxml.txt.nlp	21583717	SENT76	34	34	31	31	ethanol	mol	PA448073	90527	0.456
NULL	Arthritis_Res_2002_Jan_10_4(3)_190-195.nxml.txt.nlp	12010569	SENT169	22	22	18	18	collagenase	CD40	PA449107	958	0.456
NULL	Breast_Cancer_Res_2012_Jun_12_14(3)_R92.nxml.txt.nlp	22691413	SENT182	28	28	37	37	estradiol	HSD1	PA449503	26871	0.456
NULL	Arch_Med_Sci_2013_Feb_21_9(1)_68-73.nxml.txt.nlp	23515961	SENT37	1	1	18	18	cosyntropin	ACTH	PA164749052	5443	0.456
NULL	AAPS_PharmSciTech_2014_Jul_15_15(6)_1490-1497.nxml.txt.nlp	25023947	SENT253	8	8	11	11	naproxen	gamma	PA450595	9913	0.456
NULL	Cell_Commun_Signal_2013_Jan_11_11_2.nxml.txt.nlp	23305203	SENT160	10	10	8	8	forskolin	TIMAP	PA146096022	26051	0.456
NULL	J_Ginseng_Res_2011_Nov_35(4)_436-441.nxml.txt.nlp	23717089	SENT90	2	2	12	12	ginseng	CAGC	PA164781150	6283	0.456
NULL	EMBO_J_2008_Jan_23_27(2)_384-393.nxml.txt.nlp	18188154	SENT76	10	10	13	13	forskolin	PDE4D	PA146096022	5144	0.456
NULL	Environ_Health_Perspect_2010_Sep_28_118(9)_1267-1272.nxml.txt.nlp	20427257	SENT116	47	47	32	32	estradiol	BPA	PA449503	667	0.456
NULL	Virulence_2013_Oct_1_4(7)_646-653.nxml.txt.nlp	24045422	SENT89	4	4	11	11	l-lysine	CD4	PA450280	920	0.456
NULL	Int_J_Biol_Sci_2012_Mar_7_8(4)_470-485.nxml.txt.nlp	22419892	SENT301	16	16	11	11	letrozole	MMP9	PA450196	4318	0.456
NULL	Dement_Geriatr_Cogn_Dis_Extra_2012_Sep_21_2(1)_387-399.nxml.txt.nlp	23277779	SENT187	20	20	12	12	cyanocobalamin	B12	PA451892	7126;4709	0.456
NULL	J_Exp_Bot_2009_Apr_2_60(6)_1691-1702.nxml.txt.nlp	19342428	SENT46	34	34	14	14	streptomycin	TAP	PA451512	8615;2317;10482;23541	0.456
NULL	AIDS_Care_2011_Sep_14_23(9)_1154-1162.nxml.txt.nlp	21500025	SENT123	41	41	2	2	tenofovir	ATV	PA10204	4683	0.456
NULL	ScientificWorldJournal_2014_Jan_29_2014_265953.nxml.txt.nlp	24688374	SENT158	10	10	14	14	resveratrol	CMC1		152100	0.456
NULL	Diabetes_Care_2009_Dec_3_32(12)_2156-2160.nxml.txt.nlp	19729522	SENT161	10	10	1	1	sertraline	Gen	PA451333	348654	0.456
NULL	Curr_Microbiol_2012_Dec_28_65(6)_673-678.nxml.txt.nlp	22926720	SENT75	19	19	21	21	gentamicin	TMP	PA449753	2012	0.456
NULL	Breast_Cancer_Res_2002_Apr_18_4(3)_95-99.nxml.txt.nlp	12052251	SENT124	21	21	12	12	doxorubicin	PK1	PA449412	84432	0.455
NULL	Breast_Cancer_Res_2005_Nov_11_7(6)_255-257.nxml.txt.nlp	16457700	SENT10	36	36	14	14	tamoxifen	ATAC	PA451581	6375	0.455
NULL	J_Immunol_Res_2014_Sep_4_2014_232659.nxml.txt.nlp	25276840	SENT130	0	0	8	8	choline	CD4	PA448976	920	0.455
NULL	FEBS_Open_Bio_2013_Aug_19_3_379-386.nxml.txt.nlp	24251099	SENT202	19	19	23	23	nadh	ADP	PA164755085	23038	0.455
NULL	Cells_2014_May_23_3(2)_517-545.nxml.txt.nlp	24861977	SENT164	18	18	6	6	kanamycin	TRPV1	PA450137	7442	0.455
NULL	J_Am_Heart_Assoc_2013_Aug_23_2(4)_e000318.nxml.txt.nlp	23926118	SENT199	16	16	18	18	isoproterenol	AC3	PA450121	109	0.455
NULL	Gut_2008_Jul_4_57(7)_923-929.nxml.txt.nlp	18252749	SENT227	11	11	13	13	capsaicin	TRPV1	PA448776	7442	0.455
NULL	Basic_Clin_Neurosci_2014_Winter_5(1)_31-41.nxml.txt.nlp	25436082	SENT120	26	26	23	23	bupropion	mol	PA448687	90527	0.455
NULL	Cancer_Manag_Res_2012_Jan_18_4_1-8.nxml.txt.nlp	22346364	SENT18	11	11	16	16	dacarbazine	IL-2	PA449197	3558	0.455
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT162	2	2	4	4	atorvastatin	RANK	PA448500	8792	0.455
NULL	J_Am_Heart_Assoc_2013_Dec_19_2(6)_e000433.nxml.txt.nlp	24275630	SENT576	29	29	24	24	exenatide	GLP	PA164749238	342096	0.455
NULL	Diabetes_Care_2011_Oct_15_34(10)_2279-2284.nxml.txt.nlp	21949222	SENT110	8	8	13	13	metformin	FFM	PA450395	24	0.455
NULL	Int_J_Mol_Sci_2014_Nov_24_15(11)_21587-21602.nxml.txt.nlp	25421248	SENT158	15	15	12	12	ethanol	mol	PA448073	90527	0.455
NULL	Case_Rep_Oncol_2010_Jun_30_4(2)_327-335.nxml.txt.nlp	21738504	SENT50	10	10	43	43	mitomycin	HCC	PA450524	84668	0.455
NULL	Oncogene_2010_Sep_16_29(37)_5135-5145.nxml.txt.nlp	20622897	SENT227	36	36	8	8	aprotinin	STAT3	PA448472	6774	0.455
NULL	Croat_Med_J_2012_Aug_53(4)_314-320.nxml.txt.nlp	22911523	SENT186	5	5	18	18	debrisoquine	CYP2D6	PA452616	1565	0.455
NULL	Neural_Dev_2011_May_4_6_21.nxml.txt.nlp	21542907	SENT205	32	32	28	28	l-glutamine	B27	PA10090	56246	0.455
NULL	Virol_J_2011_May_17_8_234.nxml.txt.nlp	21575275	SENT13	9	9	7	7	ribavirin	IFN	PA451241	3439	0.455
NULL	ScientificWorldJournal_2013_Oct_24_2013_726912.nxml.txt.nlp	24282387	SENT159	34	34	26	26	fluorescein	AVP	PA164746009	114548;551	0.455
NULL	Mol_Vis_2007_Jun_24_13_988-992.nxml.txt.nlp	17653040	SENT107	13	13	3	3	thyroglobulin	TACSTD2	PA164754910	4070	0.455
NULL	Saudi_J_Anaesth_2014_Apr-Jun_8(2)_209-214.nxml.txt.nlp	24843334	SENT38	11	11	14	14	clonidine	C15	PA449051	51316	0.455
NULL	Biochem_Biophys_Res_Commun_2010_Nov_12_402(2-3)_180-185.nxml.txt.nlp	20707983	SENT112	23	23	27	27	collagenase	CDP	PA449107	1523	0.455
NULL	Patient_Prefer_Adherence_2010_Nov_3_4_397-406.nxml.txt.nlp	21206515	SENT27	21	21	18	18	liraglutide	GLP-1	PA165958364	100125288	0.455
NULL	Nat_Biotechnol_2009_Jun_17_27(6)_567-571.nxml.txt.nlp	19448630	SENT154	11	11	13	13	imiquimod	IFN	PA449972	3439	0.455
NULL	Diabetes_Care_2012_Jan_9_35(1)_131-136.nxml.txt.nlp	22040838	SENT159	0	0	2	2	metformin	FFM	PA450395	24	0.455
NULL	Brain_Sci_2013_Jun_14_3(2)_941-963.nxml.txt.nlp	24961432	SENT601	1	1	3	3	ethanol	Rho	PA448073	29984	0.455
NULL	Int_J_Mol_Sci_2014_Sep_30_15(10)_17686-17704.nxml.txt.nlp	25272226	SENT101	28	28	38	38	cetuximab	EGFR	PA10040	1956	0.455
NULL	Ann_Thorac_Med_2007_Jul-Sep_2(3)_128-142.nxml.txt.nlp	19727362	SENT57	5	5	15	15	streptokinase	MIST	PA164754919	116449	0.455
NULL	Cancer_Cell_Int_2013_Sep_23_13_94.nxml.txt.nlp	24059699	SENT142	26	26	14	14	bevacizumab	VEGFR1	PA130232992	2321	0.455
NULL	J_Viral_Hepat_2007_Nov_14(11)_751-766.nxml.txt.nlp	17927611	SENT331	30	30	28	28	lamivudine	IFN	PA450163	3439	0.455
NULL	Braz_J_Med_Biol_Res_2012_Jun_8_45(10)_988-994.nxml.txt.nlp	22666778	SENT18	23	23	33	33	lipase	adiponectin	PA450239	9370	0.455
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT192	39	39	37	37	afatinib	Yes	PA165981154	7525	0.455
NULL	Arch_Drug_Inf_2011_Mar_4(1)_1-9.nxml.txt.nlp	21572514	SENT207	5	5	13	13	ciprofloxacin	P-gp	PA449009	5243	0.455
NULL	Leukemia_2014_Apr_14_28(4)_961-964.nxml.txt.nlp	24418991	SENT23	2	2	6	6	nilotinib	P-gp	PA165958345	5243	0.455
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jan_31_65(Pt_2)_o427-o428.nxml.txt.nlp	21582014	SENT76	10	10	7	7	acetone	mol	PA448025	90527	0.455
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Sep_9_65(Pt_10)_o2395.nxml.txt.nlp	21577858	SENT3	14	14	11	11	nitrile	NO3	PA450636	4681	0.455
NULL	J_Clin_Biochem_Nutr_2010_Jul_17_47(1)_53-58.nxml.txt.nlp	20664731	SENT324	22	22	5	5	amoxicillin	CYP2C19	PA448406	1557	0.455
NULL	J_Vis_Exp_2011_Jun_18_(52)_3078.nxml.txt.nlp	21712799	SENT145	12	12	19	19	heparin	VEGF-A	PA449855	7422	0.455
NULL	J_Exp_Med_1976_Sep_1_144(3)_840-846.nxml.txt.nlp	182900	SENT12	26	26	24	24	phenol	mol	PA450913	90527	0.455
NULL	Indian_J_Psychol_Med_2012_Apr-Jun_34(2)_140-143.nxml.txt.nlp	23162189	SENT73	0	0	5	5	dextromethorphan	CRT	PA449273	811	0.455
NULL	Int_J_Environ_Res_Public_Health_2011_Jul_30_8(7)_2747-2757.nxml.txt.nlp	21845156	SENT139	9	9	25	25	trypsin	PRSS1	PA451806	5644	0.455
NULL	Int_J_Med_Sci_2015_Jan_1_12(1)_63-71.nxml.txt.nlp	25552920	SENT84	0	0	5	5	berberine	PC-3	PA165860812	692094	0.455
NULL	Oncol_Lett_2014_Jan_6_7(1)_255-259.nxml.txt.nlp	24348859	SENT93	30	30	27	27	docetaxel	DCX	PA449383	1641	0.455
NULL	Exp_Ther_Med_2013_Feb_30_5(2)_616-620.nxml.txt.nlp	23407814	SENT25	14	14	17	17	oxygen	ROS	PA450744	6098	0.455
NULL	Eur_J_Dent_2011_Jan_5(1)_77-83.nxml.txt.nlp	21228958	SENT29	20	20	14	14	chlorhexidine	HEMA	PA164776863	2157	0.455
NULL	Int_J_Genomics_2014_Jan_29_2014_894296.nxml.txt.nlp	24616891	SENT171	18	18	0	0	ethanol	PC1	PA448073	5122	0.455
NULL	Front_Aging_Neurosci_2010_Feb_3_2_2.nxml.txt.nlp	20552042	SENT766	7	7	11	11	potassium	CA1	PA451047	759	0.455
NULL	EMBO_Mol_Med_2013_Jun_30_5(6)_935-948.nxml.txt.nlp	23629957	SENT89	22	22	12	12	cisplatin	COL6A3	PA449014	1293	0.455
NULL	Br_J_Cancer_2004_Mar_22_90(6)_1285-1292.nxml.txt.nlp	15026814	SENT105	10	10	15	15	doxorubicin	p53	PA449412	7157	0.455
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1150.nxml.txt.nlp	24675468	SENT121	17	17	15	15	ethanol	adiponectin	PA448073	9370	0.455
NULL	Cancer_Cell_Int_2013_Oct_23_13_105.nxml.txt.nlp	24152585	SENT238	33	33	31	31	paclitaxel	TLR4	PA450761	7099	0.455
NULL	J_Gen_Physiol_2000_Jun_1_115(6)_685-696.nxml.txt.nlp	10828243	SENT114	7	7	2	2	genistein	OLF	PA165109660	83857	0.455
NULL	Exp_Diabetes_Res_2012_Nov_1_2012_892706.nxml.txt.nlp	23197976	SENT207	28	28	8	8	vildagliptin	HIF-1	PA165958346	29072	0.455
NULL	Eur_J_Med_Res_2009_Mar_17_14(3)_102-105.nxml.txt.nlp	19380279	SENT81	19	19	14	14	erlotinib	NF2	PA134687924	4771	0.455
NULL	Exp_Neurol_2012_Jun_235(2)_528-538.nxml.txt.nlp	22417924	SENT436	1	1	18	18	rosiglitazone	PPARgamma	PA451283	5468	0.455
NULL	J_Cell_Mol_Med_2014_Aug_1_18(8)_1599-1611.nxml.txt.nlp	24889822	SENT260	3	3	39	39	resveratrol	FOXO1		2308	0.455
NULL	Appl_Microbiol_Biotechnol_2012_Jun_25_94(5)_1347-1358.nxml.txt.nlp	22526805	SENT69	14	14	12	12	4-methylumbelliferone	mol	PA154081778	90527	0.455
NULL	EPMA_J_2012_Sep_27_3(1)_10.nxml.txt.nlp	23016735	SENT251	30	30	44	44	amiodarone	CYP2C9	PA448383	1559	0.455
NULL	Pharmacogn_Mag_2014_Oct-Dec_10(40)_522-528.nxml.txt.nlp	25422556	SENT138	25	25	22	22	allopurinol	NAC	PA448320	22861	0.455
NULL	Indian_J_Endocrinol_Metab_2012_Dec_16(Suppl_2)_S245-S247.nxml.txt.nlp	23565390	SENT62	25	25	19	19	exenatide	GLP	PA164749238	342096	0.455
NULL	Mediators_Inflamm_1998_7(3)_169-173.nxml.txt.nlp	9705604	SENT8	3	3	26	26	octreotide	IL-10	PA450678	3586	0.455
NULL	Cancer_Metab_2014_May_28_2(Suppl_1)_P24.nxml.txt.nlp	NULL	SENT18	0	0	10	10	etoposide	SIRT1	PA449552	23411	0.455
NULL	J_Mol_Signal_2012_Sep_8_7_15.nxml.txt.nlp	22958338	SENT112	29	29	29	29	pp2	PP2		4888	0.455
NULL	Arthritis_Res_Ther_2008_Dec_1_10(6)_R139.nxml.txt.nlp	19046432	SENT230	6	6	20	20	rosiglitazone	AP-1	PA451283	2353;3727;2354;3725	0.455
NULL	Hum_Genomics_2009_Jan_1_3(2)_128-142.nxml.txt.nlp	19164090	SENT36	24	24	12	12	carboplatin	CD44	PA448803	960	0.455
NULL	Front_Genet_2014_May_5_5_110.nxml.txt.nlp	24847352	SENT75	14	14	38	38	s-adenosylmethionine	N6AMT1	PA164754994	29104	0.455
NULL	Br_J_Cancer_2013_Feb_5_108(2)_334-341.nxml.txt.nlp	23257893	SENT155	0	0	6	6	sorafenib	NOXA	PA7000	5366	0.455
NULL	Core_Evid_2013_May_16_8_37-45.nxml.txt.nlp	23717217	SENT19	34	34	2	2	rituximab	BTK	PA451261	695	0.455
NULL	J_Radiat_Res_2014_Jul_11_55(4)_613-628.nxml.txt.nlp	24522270	SENT91	5	5	11	11	vorinostat	RAD51	PA164748224	5888	0.455
NULL	Biomed_Res_Int_2014_Jan_29_2014_361020.nxml.txt.nlp	24605326	SENT223	7	7	12	12	flavopiridol	CDK4	PA452627	1019	0.455
NULL	Acta_Pharmacol_Sin_2011_Apr_5_32(4)_478-486.nxml.txt.nlp	21468084	SENT149	2	2	15	15	ciprofloxacin	IL-8	PA449009	3576	0.455
NULL	Arch_Dis_Child_2014_Dec_8_99(12)_1143-1146.nxml.txt.nlp	25202131	SENT58	7	7	2	2	theophylline	CYP3A4	PA451647	1576	0.455
NULL	Ann_Rheum_Dis_2009_Jan_5_68(6)_1051-1058.nxml.txt.nlp	18662930	SENT217	13	13	17	17	hyaluronan	CD44	PA165958431	960	0.455
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT192	31	31	37	37	trastuzumab	Yes	PA451743	7525	0.455
NULL	J_Vis_Exp_2009_Jun_9_(28)_1305.nxml.txt.nlp	19513018	SENT26	13	13	21	21	l-cysteine	sit	PA449173	55733	0.455
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Apr_28_68(Pt_5)_m681.nxml.txt.nlp	22590163	SENT64	13	13	24	24	ethanol	mol	PA448073	90527	0.455
NULL	Br_J_Cancer_2014_Apr_15_110(8)_2144-2158.nxml.txt.nlp	24667650	SENT200	0	0	13	13	diethylstilbestrol	DES	PA449307	1674	0.455
NULL	Pharmaceuticals_(Basel)_2011_Jun_17_4(6)_880-914.nxml.txt.nlp	21904468	SENT177	17	17	5	5	haloperidol	DUP	PA449841	81620;4437	0.455
NULL	Br_J_Haematol_2011_Aug_14_154(3)_378-386.nxml.txt.nlp	21671895	SENT139	28	28	26	26	heparin	PF4	PA449855	5196	0.455
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT149	8	8	10	10	methotrexate	MSH2	PA450428	4436	0.455
NULL	Environ_Health_Perspect_2007_Mar_19_115(3)_346-353.nxml.txt.nlp	17431482	SENT31	20	20	23	23	oxygen	ROS	PA450744	6098	0.455
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jun_13_68(Pt_7)_m889.nxml.txt.nlp	22807732	SENT69	28	28	25	25	ethanol	mol	PA448073	90527	0.455
NULL	J_Vis_Exp_2014_May_20_(87)_51655.nxml.txt.nlp	24893837	SENT53	27	27	22	22	hydrocortisone	EGF	PA449905	1950	0.455
NULL	Cell_Mol_Life_Sci_2012_Apr_1_69(7)_1167-1178.nxml.txt.nlp	22130514	SENT64	10	10	24	24	paraformaldehyde	RGS5	PA450790	8490	0.455
NULL	Cell_Death_Dis_2010_Jan_21_1(1)_e17.nxml.txt.nlp	21364618	SENT138	28	28	24	24	gentamicin	EGF	PA449753	1950	0.455
NULL	Ann_Oncol_2014_Sep_13_25(9)_1813-1820.nxml.txt.nlp	24928832	SENT132	30	30	13	13	cetuximab	p16	PA10040	1029	0.454
NULL	Surg_Today_2012_Jan_6_42(1)_8-28.nxml.txt.nlp	22139128	SENT236	9	9	11	11	tegafur	PSK	PA452620	9344	0.454
NULL	J_Cell_Sci_2014_May_15_127(10)_2313-2325.nxml.txt.nlp	24634514	SENT278	31	31	15	15	forskolin	DRP1	PA146096022	8562;10059;7402	0.454
NULL	Cancer_Metab_2013_Dec_23_1_23.nxml.txt.nlp	24359630	SENT37	28	28	20	20	sugar	TKTL2	PA451529	84076	0.454
NULL	Cell_Res_2013_Feb_15_23(2)_201-212.nxml.txt.nlp	23318584	SENT33	39	39	25	25	l-cysteine	MSU	PA449173	593	0.454
NULL	Front_Oncol_2013_Apr_23_3_86.nxml.txt.nlp	23630663	SENT695	2	2	4	4	docetaxel	HER-2	PA449383	2064	0.454
NULL	Gut_Pathog_2014_Jul_29_6_33.nxml.txt.nlp	25110521	SENT268	0	0	23	23	fluorescein	CD11b	PA164746009	3684	0.454
NULL	Pharmaceutics_2010_Oct_14_2(4)_321-338.nxml.txt.nlp	NULL	SENT373	0	0	14	14	l-carnitine	CRAT	PA450154	1384	0.454
NULL	Biomed_Res_Int_2014_Feb_4_2014_975927.nxml.txt.nlp	24689066	SENT122	7	7	10	10	teriparatide	PTH	PA451620	5741	0.454
NULL	Ann_Gastroenterol_2012_25(2)_96-99.nxml.txt.nlp	24714074	SENT35	0	0	18	18	cisapride	5-HT4	PA449011	3360	0.454
NULL	Oxid_Med_Cell_Longev_2014_Apr_30_2014_463815.nxml.txt.nlp	24876912	SENT258	4	4	0	0	ethanol	TIC	PA448073	23550	0.454
NULL	Ann_Intensive_Care_2011_Mar_21_1_3.nxml.txt.nlp	21906325	SENT111	7	7	21	21	cisplatin	EPO	PA449014	7076;8288;2056	0.454
NULL	ScientificWorldJournal_2014_Jan_29_2014_265953.nxml.txt.nlp	24688374	SENT160	10	10	15	15	resveratrol	CMC2		56942	0.454
NULL	Eur_J_Clin_Pharmacol_2011_May_9_67(5)_477-482.nxml.txt.nlp	21305273	SENT130	30	30	22	22	dobutamine	DBP	PA449381	3295;1628;2638	0.454
NULL	Mol_Vis_2007_Jan_24_13_57-65.nxml.txt.nlp	17277739	SENT188	27	27	24	24	heparin	FGF2	PA449855	2247;2258	0.454
NULL	J_Korean_Med_Sci_2013_Apr_27_28(4)_527-533.nxml.txt.nlp	23580227	SENT104	24	24	7	7	genistein	TRAIL	PA165109660	8743	0.454
NULL	Theranostics_2014_Feb_15_4(5)_487-497.nxml.txt.nlp	24672582	SENT39	9	9	15	15	glucose	FBS	PA449773	64319;26269	0.454
NULL	J_Cell_Mol_Med_2014_Jul_24_18(7)_1358-1371.nxml.txt.nlp	24758741	SENT373	23	23	13	13	bevacizumab	CD31	PA130232992	5175	0.454
NULL	Angiogenesis_2010_Dec_7_13(4)_305-315.nxml.txt.nlp	20927579	SENT134	7	7	20	20	resveratrol	THBS1		7057	0.454
NULL	Cancer_Cell_Int_2013_May_15_13_42.nxml.txt.nlp	23672670	SENT5	12	12	35	35	paclitaxel	p53	PA450761	7157	0.454
NULL	J_Med_Case_Reports_2011_Oct_23_5_522.nxml.txt.nlp	22018056	SENT41	18	18	27	27	thyroglobulin	FDG	PA164754910	23583	0.454
NULL	Mar_Drugs_2009_Dec_15_7(4)_803-815.nxml.txt.nlp	20098611	SENT210	2	2	8	8	trypsin	Gen	PA451806	348654	0.454
NULL	Br_J_Cancer_2004_Mar_5_90(Suppl_1)_S7-S10.nxml.txt.nlp	15094758	SENT88	5	5	17	17	fulvestrant	CYP3A4	PA164747170	1576	0.454
NULL	Virulence_2013_Oct_1_4(7)_646-653.nxml.txt.nlp	24045422	SENT92	4	4	10	10	l-lysine	CD4	PA450280	920	0.454
NULL	Clin_Neuropathol_2011_Oct_18_Nov-Dec_30(6)_291-296.nxml.txt.nlp	22011733	SENT48	17	17	5	5	thyroglobulin	CK7	PA164754910	3855	0.454
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT6	0	0	6	6	curcumin	TRAIL	PA151958596	8743	0.454
NULL	J_Clin_Biochem_Nutr_2010_Mar_27_46(2)_177-185.nxml.txt.nlp	20216951	SENT37	22	22	16	16	l-lysine	CEA	PA450280	5670;1087	0.454
NULL	Mol_Cell_Biochem_2013_Jul_3_379(1-2)_29-36.nxml.txt.nlp	23549681	SENT4	22	22	25	25	estradiol	HIF-1	PA449503	29072	0.454
NULL	Toxins_(Basel)_2010_Oct_26_2(11)_2490-2518.nxml.txt.nlp	22069563	SENT1244	16	16	10	10	cisplatin	p53	PA449014	7157	0.454
NULL	Biomed_Res_Int_2013_Feb_12_2013_760236.nxml.txt.nlp	23509775	SENT49	17	17	30	30	ethanol	perlecan	PA448073	3339	0.454
NULL	Oncotarget_2012_Sep_20_3(9)_954-987.nxml.txt.nlp	23006971	SENT406	19	19	5	5	chloroquine	NAC	PA448948	22861	0.454
NULL	J_Int_Soc_Sports_Nutr_2012_Apr_17_9_17.nxml.txt.nlp	22510253	SENT107	2	2	0	0	l-arginine	AAKG	PA448478	51422	0.454
NULL	Case_Rep_Ophthalmol_Med_2012_Nov_6_2012_968180.nxml.txt.nlp	23198204	SENT13	6	6	3	3	tocilizumab	IL-6	PA165292659	3569	0.454
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Oct_31_65(Pt_11)_o2953.nxml.txt.nlp	21578526	SENT68	26	26	34	34	ethanol	mol	PA448073	90527	0.454
NULL	Indian_J_Endocrinol_Metab_2013_Mar-Apr_17(2)_245-248.nxml.txt.nlp	23776896	SENT79	4	4	9	9	bromocriptine	ACTH	PA448671	5443	0.454
NULL	J_Parasitol_Res_2012_Aug_13_2012_296856.nxml.txt.nlp	22934153	SENT176	21	21	8	8	praziquantel	IL-10	PA164764583	3586	0.454
NULL	Diabetes_Metab_J_2014_Jun_17_38(3)_211-219.nxml.txt.nlp	25003075	SENT13	19	19	24	24	sitagliptin	PPG	PA164748978	5552	0.454
NULL	Diabetes_2013_Nov_18_62(11)_3677-3686.nxml.txt.nlp	24158999	SENT359	10	10	21	21	capsaicin	TRPM8	PA448776	79054	0.454
NULL	Br_J_Cancer_2010_Oct_12_103(8)_1182-1191.nxml.txt.nlp	20842125	SENT79	7	7	11	11	ethanol	mol	PA448073	90527	0.454
NULL	Cardiovasc_Diabetol_2013_Jun_7_12_84.nxml.txt.nlp	23759020	SENT122	14	14	12	12	dipyridamole	LSR	PA449367	51599	0.454
NULL	J_Allergy_(Cairo)_2011_Apr_26_2011_736319.nxml.txt.nlp	21747870	SENT47	11	11	30	30	l-arginine	IFN	PA448478	3439	0.454
NULL	Aging_(Albany_NY)_2012_Mar_12_4(3)_146-158.nxml.txt.nlp	22436213	SENT11	5	5	7	7	resveratrol	SIRT1		23411	0.454
NULL	Indian_J_Med_Res_2014_Mar_139(3)_463-467.nxml.txt.nlp	24820843	SENT9	12	12	29	29	chloramphenicol	L22	PA448927	6146	0.454
NULL	J_Med_Case_Rep_2014_Apr_3_8_113.nxml.txt.nlp	24708915	SENT85	2	2	0	0	cyclophosphamide	CHOP	PA449165	1649	0.454
NULL	Asian-Australas_J_Anim_Sci_2012_Apr_25(4)_471-478.nxml.txt.nlp	25049587	SENT157	9	9	13	13	pp2	PP4		5531	0.454
NULL	Int_J_Mol_Sci_2012_Feb_24_13(3)_2590-2617.nxml.txt.nlp	22489113	SENT202	15	15	12	12	benzaldehyde	mol	PA448571	90527	0.454
NULL	J_Oncol_2010_Jun_20_2010_138758.nxml.txt.nlp	20634932	SENT45	5	5	15	15	vinblastine	FRG	PA451877	9855	0.454
NULL	Arthritis_Res_Ther_2005_May_18_7(Suppl_3)_S2-S8.nxml.txt.nlp	15960819	SENT61	0	0	10	10	etanercept	ACR	PA449515	49	0.454
NULL	Aging_(Albany_NY)_2012_Apr_30_4(5)_320-329.nxml.txt.nlp	22589237	SENT202	4	4	2	2	metformin	aromatase	PA450395	1588	0.454
NULL	Breast_Cancer_Res_2008_Dec_18_10(Suppl_4)_S26.nxml.txt.nlp	19128440	SENT61	22	22	11	11	tamoxifen	IMPACT	PA451581	55364	0.454
NULL	J_Headache_Pain_2010_Dec_28_11(6)_519-523.nxml.txt.nlp	20665065	SENT87	24	24	29	29	methylprednisolone	SMO	PA450466	6608;54498	0.454
NULL	BMJ_2014_Apr_24_348_g2780.nxml.txt.nlp	24764569	SENT33	22	22	19	19	exenatide	GLP-1	PA164749238	100125288	0.454
NULL	JAKSTAT_2013_Jul_1_2(3)_e24574.nxml.txt.nlp	24069558	SENT89	18	18	9	9	doxycycline	HEK	PA449415	2042	0.454
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_16_2012_395912.nxml.txt.nlp	23118789	SENT75	9	9	31	31	diclofenac	UGT1A8	PA449293	54576	0.454
NULL	Pharmaceuticals_(Basel)_2014_Jan_23_7(2)_113-135.nxml.txt.nlp	24463342	SENT591	1	1	12	12	memantine	spatial	PA10364	219793	0.454
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT468	8	8	10	10	iloperidone	PRL	PA161199368	5617	0.454
NULL	Clin_Med_Case_Rep_2008_Aug_29_1_119-122.nxml.txt.nlp	24179360	SENT67	1	1	17	17	teriparatide	RANKL	PA451620	8600	0.454
NULL	J_Korean_Med_Sci_2007_Apr_30_22(2)_209-212.nxml.txt.nlp	17449925	SENT88	13	13	10	10	pamidronate	PTH	PA450767	5741	0.454
NULL	JAKSTAT_2014_Jun_12_3_e29554.nxml.txt.nlp	25105067	SENT103	0	0	7	7	propofol	p65	PA451141	5970	0.454
NULL	Pharmaceutics_2011_Nov_18_3(4)_865-913.nxml.txt.nlp	24309312	SENT67	19	19	15	15	pseudoephedrine	OTC	PA451170	5009	0.454
NULL	J_Biol_Chem_2012_Apr_20_287(17)_14122-14135.nxml.txt.nlp	22351750	SENT623	11	11	7	7	hyaluronan	TSG-6	PA165958431	7130	0.454
NULL	Indian_J_Psychiatry_2010_Jan_52(Suppl1)_S317-S340.nxml.txt.nlp	21836703	SENT118	17	17	15	15	thiothixene	CPZ	PA451669	8532	0.454
NULL	Eur_J_Clin_Microbiol_Infect_Dis_2010_Nov_1_29(11)_1361-1367.nxml.txt.nlp	20680368	SENT32	7	7	19	19	cloxacillin	VAN	PA449059	10318	0.454
NULL	Cancer_Immunol_Immunother_2015_Oct_7_64_61-73.nxml.txt.nlp	25287778	SENT224	6	6	11	11	lenalidomide	CD56	PA162363968	4684	0.454
NULL	Diabetes_Care_2008_Oct_31(10)_2062-2069.nxml.txt.nlp	18820229	SENT127	8	8	11	11	rosiglitazone	DREAM	PA451283	30818	0.454
NULL	Exp_Mol_Med_2012_Nov_30_44(11)_665-673.nxml.txt.nlp	23114424	SENT246	15	15	4	4	taurine	adiponectin	PA451590	9370	0.454
NULL	J_Immunother_Cancer_2014_Mar_12_2(Suppl_2)_I12.nxml.txt.nlp	NULL	SENT15	14	14	8	8	gemcitabine	SOC	PA449748	91544	0.454
NULL	J_Nutr_Sci_2013_Oct_31_2_e34.nxml.txt.nlp	25191584	SENT231	26	26	30	30	acetone	CO2	PA448025	4513	0.454
NULL	Arthritis_Res_Ther_2013_Jul_9_15(4)_R73.nxml.txt.nlp	23837669	SENT263	20	20	18	18	colchicine	MICL	PA449092	160364	0.454
NULL	Environ_Health_Perspect_1985_Sep_61_111-121.nxml.txt.nlp	3905370	SENT5	1	1	4	4	phenol	DES	PA450913	1674	0.454
NULL	Cancer_2011_Mar_1_117(5)_884-896.nxml.txt.nlp	20939015	SENT209	15	15	20	20	bevacizumab	San	PA130232992	80218	0.454
NULL	Case_Rep_Ophthalmol_2010_Dec_8_1(2)_110-113.nxml.txt.nlp	21373383	SENT16	18	18	14	14	ranibizumab	PED	PA164746012	8682	0.454
NULL	Mol_Cancer_2010_Nov_22_9_298.nxml.txt.nlp	21092190	SENT38	19	19	24	24	pentazocine	SRM	PA164744326	6723;6725	0.454
NULL	Hum_Genomics_2003_Nov_1_1(1)_41-51.nxml.txt.nlp	15601532	SENT25	7	7	31	31	saquinavir	Yes	PA451305	7525	0.454
NULL	Pharmacogn_Rev_2011_Jan-Jun_5(9)_103-110.nxml.txt.nlp	22096324	SENT108	36	36	33	33	thrombin	ADP	PA451674	23038	0.454
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1063.nxml.txt.nlp	24556678	SENT40	3	3	5	5	thioridazine	TRAIL	PA451666	8743	0.454
NULL	Open_Virol_J_2014_Mar_7_8_1-8.nxml.txt.nlp	24799968	SENT5	5	5	28	28	cyclosporine	PKR	PA449167	5610	0.454
NULL	Biochemistry_2013_May_14_52(19)_3194-3196.nxml.txt.nlp	23634976	SENT58	9	9	22	22	cyclosporine	P-gp	PA449167	5243	0.454
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2011_Sep_13_4_47-62.nxml.txt.nlp	22879794	SENT234	32	32	9	9	liraglutide	PPG	PA165958364	5552	0.453
NULL	Cancer_Res_Treat_2013_Sep_30_45(3)_178-185.nxml.txt.nlp	24155676	SENT110	8	8	10	10	gefitinib	EGFR	PA131301952	1956	0.453
NULL	Open_Biochem_J_2011_Sep_23_5_45-51.nxml.txt.nlp	21966325	SENT38	35	35	17	17	l-glutamine	CO2	PA10090	4513	0.453
NULL	Avicenna_J_Phytomed_2012_Spring_2(2)_72-78.nxml.txt.nlp	25050233	SENT4	28	28	46	46	reserpine	PST	PA451236	7903	0.453
NULL	Nat_Biotechnol_2010_Jul_27_28(7)_743-747.nxml.txt.nlp	20581846	SENT84	12	12	12	12	pp2	PP2		4888	0.453
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Jun_25_70(Pt_7)_m278-m279.nxml.txt.nlp	25161535	SENT4	15	15	17	17	nitrile	mol	PA450636	90527	0.453
NULL	Cancer_Cell_Int_2005_Jul_24_5_22.nxml.txt.nlp	16042792	SENT30	19	19	4	4	vincristine	MRP1	PA451879	4437	0.453
NULL	Diabetes_2013_Oct_17_62(10)_3350-3361.nxml.txt.nlp	23835334	SENT337	10	10	21	21	lipase	adiponutrin	PA450239	80339	0.453
NULL	JAKSTAT_2014_Jun_12_3_e29554.nxml.txt.nlp	25105067	SENT58	26	26	18	18	propofol	AKT	PA451141	207	0.453
NULL	Cell_Death_Dis_2014_Jan_30_5(1)_e1038.nxml.txt.nlp	24481452	SENT141	28	28	24	24	hydrocortisone	EGF	PA449905	1950	0.453
NULL	Cancers_(Basel)_2011_Apr_1_3(2)_1844-1860.nxml.txt.nlp	24212785	SENT513	20	20	0	0	cetuximab	KRAS	PA10040	3845	0.453
NULL	Diabetes_2009_Dec_15_58(12)_2766-2775.nxml.txt.nlp	19755527	SENT270	22	22	16	16	glucose	STAT3	PA449773	6774	0.453
NULL	Arthritis_Res_Ther_2009_Jun_29_11(3)_R100.nxml.txt.nlp	19563672	SENT154	9	9	17	17	infliximab	IFN	PA452639	3439	0.453
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Feb_10_68(Pt_3)_o644.nxml.txt.nlp	22412547	SENT65	25	25	22	22	ethanol	mol	PA448073	90527	0.453
NULL	J_Gen_Physiol_1990_May_1_95(5)_941-960.nxml.txt.nlp	2163434	SENT0	23	23	1	1	vasopressin	Gen	PA451858	348654	0.453
NULL	Aging_Cell_2013_Feb_6_12(1)_148-155.nxml.txt.nlp	23157586	SENT227	23	23	7	7	s-adenosylmethionine	MTHFR	PA164754994	4524	0.453
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jun_23_68(Pt_7)_o2163.nxml.txt.nlp	22798835	SENT74	22	22	19	19	ethanol	mol	PA448073	90527	0.453
NULL	Int_J_Gen_Med_2012_Nov_9_5_935-942.nxml.txt.nlp	23204857	SENT81	37	37	35	35	isoflurane	CA3	PA450106	761	0.453
NULL	Cell_Commun_Signal_2014_Sep_25_12(1)_61.nxml.txt.nlp	NULL	SENT283	0	0	2	2	tetracycline	PC-3	PA451640	692094	0.453
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Feb_29_68(Pt_3)_o901.nxml.txt.nlp	22412749	SENT58	11	11	8	8	ethanol	mol	PA448073	90527	0.453
NULL	J_Ind_Microbiol_Biotechnol_2013_Jul_30_40(10)_1153-1160.nxml.txt.nlp	23896974	SENT90	25	25	18	18	nadh	mol	PA164755085	90527	0.453
NULL	Leukemia_2013_Apr_14_27(4)_803-812.nxml.txt.nlp	23238589	SENT6	3	3	0	0	imatinib	IFN	PA10804	3439	0.453
NULL	Environ_Health_Perspect_2009_Feb_8_117(2)_175-180.nxml.txt.nlp	19270784	SENT138	15	15	17	17	doxorubicin	BPA	PA449412	667	0.453
NULL	J_Cell_Biol_1998_Aug_24_142(4)_923-936.nxml.txt.nlp	9722606	SENT120	4	4	7	7	fluorescein	TGN	PA164746009	7038	0.453
NULL	Ann_Indian_Acad_Neurol_2008_Apr-Jun_11(2)_119-122.nxml.txt.nlp	19893652	SENT124	12	12	27	27	thalidomide	gremlin	PA451644	26585	0.453
NULL	Biochemistry_2008_Aug_26_47(34)_8961-8969.nxml.txt.nlp	18652489	SENT73	19	19	16	16	thrombin	NEDD8	PA451674	4738	0.453
NULL	Clin_Interv_Aging_2013_Feb_5_8_131-137.nxml.txt.nlp	23403474	SENT105	42	42	16	16	choline	CDP	PA448976	1523	0.453
NULL	Acta_Pharmacol_Sin_2011_Dec_10_32(12)_1529-1536.nxml.txt.nlp	21986580	SENT152	18	18	15	15	cisplatin	p53	PA449014	7157	0.453
NULL	Cell_Mol_Life_Sci_2012_Dec_5_69(23)_3895-3909.nxml.txt.nlp	22562579	SENT105	14	14	7	7	estradiol	DES	PA449503	1674	0.453
NULL	Allergy_Asthma_Clin_Immunol_2010_Sep_16_6(1)_27.nxml.txt.nlp	20846390	SENT144	13	13	18	18	methacholine	BRI	PA165958382	9445	0.453
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT216	4	4	6	6	methotrexate	MSH2	PA450428	4436	0.453
NULL	Orphanet_J_Rare_Dis_2008_Jul_7_3_18.nxml.txt.nlp	18606002	SENT350	34	34	43	43	mexiletine	LQT3	PA450488	6331	0.453
NULL	J_Young_Pharm_2011_Jul-Sep_3(3)_216-220.nxml.txt.nlp	21897661	SENT30	0	0	2	2	ramipril	SLN	PA451223	6588	0.453
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jul_10_66(Pt_8)_o1979-o1980.nxml.txt.nlp	21588296	SENT78	0	0	7	7	opipramol	mol	PA144614922	90527	0.453
NULL	Clin_Exp_Metastasis_2013_May_15_30(7)_867-876.nxml.txt.nlp	23673558	SENT191	21	21	37	37	vemurafenib	BRAF	PA165946873	673	0.453
NULL	Extremophiles_2009_Nov_23_13(6)_885-894.nxml.txt.nlp	19701714	SENT25	10	10	15	15	ethanol	CO2	PA448073	4513	0.453
NULL	Oncoimmunology_2012_Aug_1_1(5)_717-725.nxml.txt.nlp	22934263	SENT91	29	29	31	31	cyclophosphamide	CTX	PA449165	1593	0.453
NULL	Front_Endocrinol_(Lausanne)_2014_Aug_13_5_134.nxml.txt.nlp	25165463	SENT148	6	6	11	11	morphine	NPFF	PA450550	8620	0.453
NULL	Int_J_Environ_Res_Public_Health_2014_Apr_27_11(4)_3553-3569.nxml.txt.nlp	24681555	SENT173	6	6	21	21	phosphorus	COD	PA450954	6628	0.453
NULL	Curr_Control_Trials_Cardiovasc_Med_2001_May_31_2(3)_129-140.nxml.txt.nlp	11806786	SENT134	4	4	7	7	heparin	ACT	PA449855	12;11332;9457;641455	0.453
NULL	Acta_Neuropathol_Commun_2014_May_30_2_57.nxml.txt.nlp	24887326	SENT185	42	42	13	13	vardenafil	ABCB1	PA10229	5243	0.453
NULL	Neuropsychopharmacology_2009_Dec_12_34(13)_2675-2690.nxml.txt.nlp	19675535	SENT208	4	4	26	26	olanzapine	A10	PA450688	28870	0.453
NULL	Exp_Transl_Stroke_Med_2011_Dec_16_3_16.nxml.txt.nlp	22177314	SENT119	22	22	24	24	minocycline	ANOVA	PA450519	4858	0.453
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2007_Dec_6_64(Pt_1)_o1-o2.nxml.txt.nlp	21200665	SENT69	26	26	23	23	ethanol	mol	PA448073	90527	0.453
NULL	Anal_Bioanal_Chem_2010_Aug_14_397(7)_2977-2986.nxml.txt.nlp	20549493	SENT184	12	12	3	3	estradiol	mol	PA449503	90527	0.453
NULL	Bone_2012_Jan_50(1)_218-225.nxml.txt.nlp	22023931	SENT227	11	11	14	14	iron	FGF23	PA450087	8074	0.453
NULL	J_Inflamm_(Lond)_2006_Jul_12_3_10.nxml.txt.nlp	16834783	SENT149	5	5	15	15	mometasone	GM-CSF	PA450541	1437	0.453
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jun_20_68(Pt_7)_o2146-o2147.nxml.txt.nlp	22798820	SENT73	23	23	20	20	ethanol	mol	PA448073	90527	0.453
NULL	Ann_Hematol_2010_Nov_25_89(11)_1115-1124.nxml.txt.nlp	20499237	SENT108	40	40	26	26	cladribine	CD5	PA449027	921	0.453
NULL	J_Res_Med_Sci_2011_Apr_16(4)_568-573.nxml.txt.nlp	22091276	SENT9	21	21	32	32	octreotide	CEA	PA450678	5670;1087	0.453
NULL	Nat_Commun_2012_Dec_27_3_1316.nxml.txt.nlp	23271650	SENT531	20	20	43	43	tamoxifen	CA3	PA451581	761	0.453
NULL	Environ_Health_Perspect_2006_Sep_23_114(9)_1401-1406.nxml.txt.nlp	16966095	SENT140	0	0	6	6	arsenite	p53	PA452638	7157	0.453
NULL	Indian_J_Ophthalmol_2013_Sep_61(9)_514-515.nxml.txt.nlp	24104712	SENT25	6	6	23	23	fluorescein	PED	PA164746009	8682	0.453
NULL	Cell_Death_Dis_2014_Feb_13_5(2)_e1055.nxml.txt.nlp	24525731	SENT20	22	22	16	16	cisplatin	XRCC1	PA449014	7515	0.453
NULL	Clin_Med_Insights_Circ_Respir_Pulm_Med_2013_Nov_13_7_61-77.nxml.txt.nlp	24324354	SENT296	8	8	2	2	colistin	TOB	PA164760862	10140	0.453
NULL	Nucleic_Acids_Res_2013_Apr_17_41(7)_4129-4143.nxml.txt.nlp	23420868	SENT103	46	46	42	42	hemin	SHP2	PA449849	5781	0.453
NULL	Croat_Med_J_2012_Jun_53(3)_224-233.nxml.txt.nlp	22661135	SENT70	13	13	10	10	sulpiride	PRL	PA164745485	5617	0.453
NULL	Arthritis_Res_Ther_2009_Aug_24_11(4)_R127.nxml.txt.nlp	19703304	SENT104	21	21	10	10	adalimumab	OASIS	PA10004	90993	0.453
NULL	Cell_Death_Dis_2014_Jul_17_5(7)_e1333.nxml.txt.nlp	25032856	SENT55	23	23	18	18	candesartan	EAAC1	PA448765	6505	0.453
NULL	FEBS_Open_Bio_2014_Jun_6_4_571-583.nxml.txt.nlp	25009770	SENT47	1	1	6	6	doxycycline	PSMD9	PA449415	5715	0.453
NULL	Chemother_Res_Pract_2012_Jul_15_2012_905796.nxml.txt.nlp	22844591	SENT170	9	9	5	5	oxaliplatin	MTD	PA131285527	4493	0.453
NULL	Br_J_Cancer_2003_Mar_10_88(5)_788-795.nxml.txt.nlp	12618891	SENT175	4	4	14	14	bosentan	FasL	PA10034	356	0.453
NULL	Surg_Today_2012_Jan_6_42(1)_8-28.nxml.txt.nlp	22139128	SENT414	8	8	10	10	tegafur	PSK	PA452620	9344	0.453
NULL	Case_Rep_Gastroenterol_2011_Nov_9_5(3)_642-647.nxml.txt.nlp	22171216	SENT40	16	16	10	10	vincristine	CHOP	PA451879	1649	0.453
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_May_11_67(Pt_6)_o1379.nxml.txt.nlp	21754769	SENT68	26	26	20	20	ethanol	mol	PA448073	90527	0.453
NULL	Clin_Interv_Aging_2008_Sep_3(3)_453-472.nxml.txt.nlp	18982916	SENT360	9	9	15	15	clarithromycin	CD4	PA449028	920	0.453
NULL	Nat_Commun_2012_Dec_27_3_1316.nxml.txt.nlp	23271650	SENT518	12	12	35	35	tamoxifen	CA3	PA451581	761	0.453
NULL	Int_J_Mol_Sci_2012_Feb_28_13(3)_2650-2675.nxml.txt.nlp	22489116	SENT611	12	12	14	14	irinotecan	Apo2	PA450085	8797	0.453
NULL	J_Cell_Biol_2005_Nov_21_171(4)_663-673.nxml.txt.nlp	16301332	SENT292	20	20	4	4	ethanol	HC11	PA448073	6347	0.453
NULL	Evid_Based_Complement_Alternat_Med_2011_Jan_3_2011_274858.nxml.txt.nlp	19001481	SENT36	20	20	9	9	fluorescein	B7-1	PA164746009	941	0.453
NULL	Anesthesiol_Res_Pract_2012_Dec_5_2012_546409.nxml.txt.nlp	22190922	SENT53	9	9	13	13	ropivacaine	PPX	PA451271	5531	0.453
NULL	Br_J_Cancer_2012_Mar_13_106(6)_1100-1106.nxml.txt.nlp	22374459	SENT52	15	15	18	18	gefitinib	EGFR	PA131301952	1956	0.453
NULL	Diabetes_2011_Nov_17_60(11)_2691-2700.nxml.txt.nlp	21896928	SENT233	18	18	33	33	resveratrol	CTRL		1506	0.453
NULL	J_Young_Pharm_2011_Jul-Sep_3(3)_216-220.nxml.txt.nlp	21897661	SENT37	0	0	2	2	ramipril	SLN	PA451223	6588	0.453
NULL	Infect_Dis_Ther_2013_Jun_30_2(1)_47-58.nxml.txt.nlp	25135823	SENT60	20	20	5	5	lumefantrine	RDT	PA165111722	6598	0.453
NULL	Acta_Pharmacol_Sin_2010_Feb_5_31(2)_184-190.nxml.txt.nlp	20139901	SENT29	34	34	28	28	metformin	OCT2	PA450395	6582;5452	0.453
NULL	Am_J_Trop_Med_Hyg_2014_Aug_6_91(2)_424-434.nxml.txt.nlp	24799369	SENT297	11	11	16	16	chloroquine	RDT	PA448948	6598	0.453
NULL	J_Med_Chem_2014_Jan_23_57(2)_449-461.nxml.txt.nlp	24387105	SENT586	17	17	11	11	cyclophosphamide	ALDH3A1	PA449165	218	0.453
NULL	J_Exp_Med_1995_Apr_1_181(4)_1381-1390.nxml.txt.nlp	7535337	SENT1	9	9	15	15	urokinase	CD87	PA451836	5329	0.453
NULL	Nat_Med_2011_Dec_18_18(1)_120-127.nxml.txt.nlp	22179318	SENT148	2	2	8	8	hemin	mol	PA449849	90527	0.453
NULL	Int_J_Mol_Sci_2013_Apr_29_14(5)_9338-9364.nxml.txt.nlp	23629668	SENT93	9	9	6	6	bevacizumab	ACT	PA130232992	12;11332;9457;641455	0.452
NULL	Leukemia_2013_Apr_14_27(4)_803-812.nxml.txt.nlp	23238589	SENT139	9	9	11	11	imatinib	IFN	PA10804	3439	0.452
NULL	Cost_Eff_Resour_Alloc_2004_Apr_15_2_2.nxml.txt.nlp	15086954	SENT120	9	9	11	11	metformin	PPG	PA450395	5552	0.452
NULL	ASN_Neuro_2013_Dec_3_5(5)_e00128.nxml.txt.nlp	24175617	SENT143	28	28	9	9	chymotrypsin	PMP22	PA448994	5376;5827	0.452
NULL	Diabetes_Care_2010_Oct_13_33(10)_2250-2253.nxml.txt.nlp	20628086	SENT26	32	32	28	28	rosiglitazone	DREAM	PA451283	30818	0.452
NULL	J_Radiat_Res_2014_Mar_8_55(2)_265-276.nxml.txt.nlp	24105709	SENT21	9	9	27	27	oxygen	ROS	PA450744	6098	0.452
NULL	Mol_Cancer_2012_Aug_23_11_60.nxml.txt.nlp	22917272	SENT76	26	26	13	13	nadh	COX	PA164755085	1351	0.452
NULL	Neuroimage_Clin_2013_Sep_6_3_290-300.nxml.txt.nlp	24273714	SENT216	9	9	17	17	pioglitazone	spatial	PA450970	219793	0.452
NULL	Pak_J_Med_Sci_2014_Jul-Aug_30(4)_814-818.nxml.txt.nlp	25097523	SENT64	2	2	0	0	cefotaxime	CTX	PA448852	1593	0.452
NULL	Behav_Brain_Funct_2012_Mar_9_8_12.nxml.txt.nlp	22404856	SENT110	6	6	30	30	haloperidol	HPTP	PA449841	5789	0.452
NULL	Int_J_Mol_Sci_2014_Nov_4_15(11)_20022-20044.nxml.txt.nlp	25375187	SENT191	0	0	28	28	rosiglitazone	UCP2	PA451283	7351	0.452
NULL	Biomed_Res_Int_2014_Jan_29_2014_831845.nxml.txt.nlp	24605337	SENT5	16	16	8	8	bupivacaine	AMPK	PA135057240	5563	0.452
NULL	J_Gen_Physiol_1997_Aug_1_110(2)_141-153.nxml.txt.nlp	9236207	SENT211	10	10	8	8	spermine	ACT	PA164781199	12;11332;9457;641455	0.452
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Dec_8_69(Pt_1)_o28.nxml.txt.nlp	23476415	SENT71	31	31	28	28	ethanol	mol	PA448073	90527	0.452
NULL	Breast_Cancer_Res_2008_Dec_18_10(Suppl_4)_S25.nxml.txt.nlp	19128439	SENT10	15	15	11	11	anastrozole	IMPACT	PA448432	55364	0.452
NULL	Front_Endocrinol_(Lausanne)_2014_Oct_27_5_183.nxml.txt.nlp	25386167	SENT30	12	12	9	9	hyaluronidase	MGEA5	PA164745713	10724	0.452
NULL	Br_J_Cancer_2013_May_28_108(10)_2063-2069.nxml.txt.nlp	23591198	SENT73	25	25	23	23	axitinib	GEM	PA164924493	2669	0.452
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT4	13	13	19	19	curcumin	TRAIL	PA151958596	8743	0.452
NULL	Int_J_Gen_Med_2012_Jun_8_5_505-509.nxml.txt.nlp	22807637	SENT0	17	17	2	2	azithromycin	Gen	PA448519	348654	0.452
NULL	Oncotarget_2014_Jun_6_5(13)_4935-4944.nxml.txt.nlp	24952732	SENT100	5	5	20	20	doxazosin	4E-BP1	PA449407	1978	0.452
NULL	Biomed_Res_Int_2014_Jan_29_2014_361020.nxml.txt.nlp	24605326	SENT223	1	1	6	6	staurosporine	CDK4	PA165109623	1019	0.452
NULL	Breast_Cancer_Res_2007_Jan_23_9(1)_R7.nxml.txt.nlp	17244352	SENT195	11	11	9	9	tamoxifen	CYP3A5	PA451581	1577	0.452
NULL	Neural_Dev_2013_Mar_7_8_4.nxml.txt.nlp	23497494	SENT160	0	0	2	2	chlorpheniramine	FOXP2	PA448960	93986	0.452
NULL	Exp_Ther_Med_2014_Nov_29_8(5)_1473-1478.nxml.txt.nlp	25289044	SENT180	10	10	12	12	heparin	AZU	PA449855	566	0.452
NULL	Nat_Med_2011_Dec_18_18(1)_120-127.nxml.txt.nlp	22179318	SENT162	11	11	32	32	gentamicin	CD11b	PA449753	3684	0.452
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Sep_18_69(Pt_10)_m544.nxml.txt.nlp	24098175	SENT6	2	2	4	4	nitrile	mol	PA450636	90527	0.452
NULL	Ann_Rheum_Dis_2013_Aug_21_72(8)_1287-1294.nxml.txt.nlp	22915624	SENT246	7	7	29	29	tocilizumab	MRI	PA165292659	78996	0.452
NULL	J_Cancer_Prev_2013_Sep_18(3)_264-270.nxml.txt.nlp	25337554	SENT24	12	12	27	27	doxorubicin	p53	PA449412	7157	0.452
NULL	Case_Rep_Dermatol_2012_Mar_23_4(1)_61-65.nxml.txt.nlp	22548038	SENT48	29	29	32	32	cyclosporine	gamma	PA449167	9913	0.452
NULL	Nat_Commun_2014_Apr_28_5_3695.nxml.txt.nlp	24770583	SENT133	11	11	23	23	doxycycline	p97	PA449415	50628;10428;1982;7415	0.452
NULL	Exp_Ther_Med_2013_Feb_30_5(2)_616-620.nxml.txt.nlp	23407814	SENT25	23	23	17	17	nitrogen	ROS	PA450643	6098	0.452
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT130	37	37	27	27	atorvastatin	TNF	PA448500	7124	0.452
NULL	Mol_Vis_2014_Nov_5_20_1557-1568.nxml.txt.nlp	25489228	SENT99	11	11	23	23	trypsin	CO2	PA451806	4513	0.452
NULL	Indian_J_Pharm_Sci_2009_Nov-Dec_71(6)_608-614.nxml.txt.nlp	20376212	SENT14	2	2	20	20	metformin	GLP-1	PA450395	100125288	0.452
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_16_2014_926087.nxml.txt.nlp	25478000	SENT11	3	3	9	9	atorvastatin	PCSK9	PA448500	255738	0.452
NULL	Biochem_Res_Int_2012_Jul_1_2012_832059.nxml.txt.nlp	22811914	SENT38	8	8	18	18	epirubicin	PC3	PA449476	57332;7832;5122	0.452
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT3067	11	11	24	24	oxygen	MRP2	PA450744	100130958;57626;1244	0.452
NULL	Lab_Invest_2009_Nov_7_89(11)_1275-1290.nxml.txt.nlp	19736547	SENT299	12	12	14	14	curcumin	LOX-1	PA151958596	4973	0.452
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT192	35	35	9	9	cetuximab	Yes	PA10040	7525	0.452
NULL	Br_J_Cancer_2011_Apr_12_104(8)_1256-1261.nxml.txt.nlp	21448165	SENT126	16	16	14	14	sorafenib	IL-2	PA7000	3558	0.452
NULL	Open_Biochem_J_2013_Apr_19_7_44-53.nxml.txt.nlp	23730364	SENT265	45	45	13	13	resveratrol	CTRL		1506	0.452
NULL	J_Cereb_Blood_Flow_Metab_2013_Feb_5_33(2)_300-310.nxml.txt.nlp	23211962	SENT246	10	10	38	38	creatine	ANOVA	PA164778930	4858	0.452
NULL	Diabetologia_2009_Oct_14_52(10)_2046-2055.nxml.txt.nlp	19688338	SENT313	34	34	32	32	liraglutide	GLP-1	PA165958364	100125288	0.452
NULL	J_Korean_Med_Sci_2010_Dec_24_25(12)_1792-1797.nxml.txt.nlp	21165296	SENT26	13	13	9	9	desmopressin	AVP	PA449237	114548;551	0.452
NULL	Biologics_2009_Oct_12_3_469-474.nxml.txt.nlp	19851472	SENT5	47	47	24	24	desloratadine	IL-5	PA164776964	3567	0.452
NULL	Case_Rep_Pediatr_2012_Aug_9_2012_323681.nxml.txt.nlp	22924145	SENT91	9	9	4	4	tocilizumab	IL-6	PA165292659	3569	0.452
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_21-38.nxml.txt.nlp	19305786	SENT584	24	24	15	15	capsaicin	PKR1	PA448776	10887	0.452
NULL	Amino_Acids_2011_May_22_40(5)_1369-1383.nxml.txt.nlp	21424716	SENT107	13	13	17	17	creatine	CEE	PA164778930	51608	0.452
NULL	Biomed_Res_Int_2014_Jun_26_2014_321486.nxml.txt.nlp	25054138	SENT102	5	5	12	12	raloxifene	ESR1	PA451221	2099	0.452
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jun_5_66(Pt_7)_o1583.nxml.txt.nlp	21587823	SENT59	15	15	12	12	ethanol	mol	PA448073	90527	0.452
NULL	Oncol_Rep_2012_Oct_13_28(4)_1146-1152.nxml.txt.nlp	22797812	SENT52	28	28	2	2	camptothecin	WRN	PA153590860	7486	0.452
NULL	Crit_Care_2011_Jun_24_15(3)_R153.nxml.txt.nlp	21702944	SENT14	5	5	32	32	dexmedetomidine	TLR4	PA449256	7099	0.452
NULL	J_Carcinog_2011_Dec_31_10_37.nxml.txt.nlp	22279422	SENT123	21	21	18	18	urokinase	ADAM19	PA451836	8728	0.452
NULL	Front_Behav_Neurosci_2009_Feb_23_3_2.nxml.txt.nlp	19255630	SENT544	5	5	7	7	phencyclidine	spatial	PA128406980	219793	0.452
NULL	J_Biomed_Biotechnol_2003_Apr_21_2003(2)_92-101.nxml.txt.nlp	12721514	SENT90	11	11	0	0	thyroglobulin	TPO	PA164754910	7066;7173	0.452
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1699-1708.nxml.txt.nlp	19861960	SENT243	15	15	12	12	dasatinib	mol	PA162372878	90527	0.452
NULL	Front_Endocrinol_(Lausanne)_2011_Nov_10_2_72.nxml.txt.nlp	22649383	SENT83	22	22	19	19	allopregnanolone	StAR	PA142320763	6770	0.452
NULL	Oxid_Med_Cell_Longev_2012_Jul_8_2012_624925.nxml.txt.nlp	22829959	SENT69	28	28	5	5	levodopa	parkin	PA450213	5071	0.452
NULL	Indian_J_Psychiatry_2010_Jan-Mar_52(1)_90-93.nxml.txt.nlp	20174532	SENT50	10	10	13	13	lithium	CAT	PA450243	847	0.452
NULL	Biochemistry_2012_Apr_3_51(13)_2889-2898.nxml.txt.nlp	22409348	SENT49	36	36	24	24	ethanol	mol	PA448073	90527	0.452
NULL	J_Geriatr_Cardiol_2014_Jun_11(2)_151-157.nxml.txt.nlp	25009566	SENT134	10	10	15	15	cilostazol	CDP	PA164746334	1523	0.452
NULL	Curr_Genomics_2014_Jun_15(3)_190-202.nxml.txt.nlp	24955027	SENT76	9	9	4	4	pp2	PP1		5540;5464	0.452
NULL	J_Antimicrob_Chemother_2012_Feb_17_67(2)_404-414.nxml.txt.nlp	22101217	SENT135	2	2	12	12	isoniazid	EMB	PA450112	133418	0.452
NULL	Iran_Red_Crescent_Med_J_2014_Aug_5_16(8)_e6915.nxml.txt.nlp	25389496	SENT72	21	21	15	15	simvastatin	adiponectin	PA451363	9370	0.452
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jun_11_67(Pt_7)_o1611.nxml.txt.nlp	21837019	SENT63	9	9	6	6	ethanol	mol	PA448073	90527	0.452
NULL	J_Cancer_Res_Clin_Oncol_2010_Jul_21_136(7)_1007-1022.nxml.txt.nlp	20091186	SENT183	3	3	5	5	glucose	FDG	PA449773	23583	0.452
NULL	J_Clin_Biochem_Nutr_2010_Jan_29_46(1)_36-42.nxml.txt.nlp	20104263	SENT19	22	22	17	17	ribavirin	IFN	PA451241	3439	0.452
NULL	Mol_Cancer_2010_Jun_25_9_165.nxml.txt.nlp	20576164	SENT157	16	16	19	19	curcumin	IFN	PA151958596	3439	0.452
NULL	Genet_Mol_Biol_2009_Sep_1_Jul-Sep_32(3)_516-520.nxml.txt.nlp	21637514	SENT6	5	5	2	2	estradiol	IGF1	PA449503	3479	0.451
NULL	Iran_J_Radiol_2011_Mar_30_8(1)_39-41.nxml.txt.nlp	23329915	SENT50	15	15	4	4	vincristine	CHOP	PA451879	1649	0.451
NULL	Biomed_Res_Int_2014_Apr_10_2014_798093.nxml.txt.nlp	24818152	SENT125	8	8	23	23	lipase	IL-6	PA450239	3569	0.451
NULL	Indian_J_Endocrinol_Metab_2014_Jan-Feb_18(1)_77-82.nxml.txt.nlp	24701434	SENT6	11	11	8	8	liraglutide	GLP-1	PA165958364	100125288	0.451
NULL	Br_J_Cancer_2013_Mar_5_108(4)_887-900.nxml.txt.nlp	23462807	SENT108	10	10	13	13	sunitinib	ABCB1	PA162372840	5243	0.451
NULL	Oncogene_2014_Aug_21_33(34)_4316-4329.nxml.txt.nlp	24362530	SENT43	0	0	2	2	epirubicin	FOXM1	PA449476	2305	0.451
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Sep_8_68(Pt_10)_o2897-o2898.nxml.txt.nlp	23125693	SENT88	42	42	27	27	ethanol	mol	PA448073	90527	0.451
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT10	0	0	8	8	nutlin-3	DR5		8795	0.451
NULL	Mol_Biol_Rep_2014_Jan_29_41(5)_2851-2857.nxml.txt.nlp	24469723	SENT87	5	5	16	16	doxorubicin	BCS	PA449412	617	0.451
NULL	ScientificWorldJournal_2013_Oct_24_2013_726912.nxml.txt.nlp	24282387	SENT4	13	13	8	8	fluorescein	AVP	PA164746009	114548;551	0.451
NULL	J_Gen_Physiol_1946_Jan_20_29(3)_149-154.nxml.txt.nlp	19873452	SENT0	11	11	1	1	trypsin	Gen	PA451806	348654	0.451
NULL	Oncoimmunology_2014_May_15_3_e28927.nxml.txt.nlp	25057450	SENT37	9	9	26	26	temozolomide	PD-L1	PA451609	29126	0.451
NULL	Evid_Based_Complement_Alternat_Med_2013_Aug_20_2013_201643.nxml.txt.nlp	24027593	SENT30	25	25	11	11	ethanol	STZ	PA448073	6484	0.451
NULL	Indian_J_Dermatol_2010_Jul-Sep_55(3)_281-283.nxml.txt.nlp	21063527	SENT20	19	19	26	26	ticlopidine	IFN	PA451686	3439	0.451
NULL	Arthritis_Res_Ther_2011_Feb_16_13(1)_R25.nxml.txt.nlp	21324169	SENT120	26	26	31	31	rituximab	TNF	PA451261	7124	0.451
NULL	J_Ophthalmol_2011_Aug_8_2011_706849.nxml.txt.nlp	21845214	SENT6	25	25	21	21	fluorescein	FAF	PA164746009	8239;2188	0.451
NULL	Exp_Ther_Med_2014_Nov_29_8(5)_1473-1478.nxml.txt.nlp	25289044	SENT121	10	10	12	12	heparin	AZU	PA449855	566	0.451
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT1795	13	13	18	18	levothyroxine	ATV	PA450221	4683	0.451
NULL	Front_Behav_Neurosci_2012_Sep_24_6_64.nxml.txt.nlp	23015785	SENT516	9	9	12	12	ethanol	spatial	PA448073	219793	0.451
NULL	Oncotarget_2012_Sep_20_3(9)_954-987.nxml.txt.nlp	23006971	SENT406	13	13	5	5	metformin	NAC	PA450395	22861	0.451
NULL	J_Cell_Mol_Med_2013_May_12_17(5)_636-647.nxml.txt.nlp	23577651	SENT32	20	20	27	27	quinacrine	ADP	PA164745551	23038	0.451
NULL	Biomed_Res_Int_2014_Jan_29_2014_361020.nxml.txt.nlp	24605326	SENT223	1	1	4	4	staurosporine	CDK2	PA165109623	1017	0.451
NULL	Nat_Med_2013_Apr_17_19(4)_437-445.nxml.txt.nlp	23502961	SENT58	2	2	20	20	clodronate	EPO	PA10239	7076;8288;2056	0.451
NULL	Arthritis_Res_Ther_2011_Mar_16_13(2)_R44.nxml.txt.nlp	21410959	SENT169	0	0	9	9	glucosamine	IFN	PA164747613	3439	0.451
NULL	Clin_Med_Insights_Oncol_2011_Mar_16_5_35-43.nxml.txt.nlp	21499557	SENT269	25	25	23	23	trabectedin	IFF	PA165958349	3456	0.451
NULL	Oncotarget_2012_Jan_28_3(1)_78-83.nxml.txt.nlp	22289679	SENT87	6	6	3	3	gefitinib	EGFR	PA131301952	1956	0.451
NULL	Acta_Pharmacol_Sin_2009_Apr_9_30(4)_451-457.nxml.txt.nlp	19270722	SENT119	15	15	24	24	imatinib	P-gp	PA10804	5243	0.451
NULL	Thorax_2010_Jul_13_65(7)_654-658.nxml.txt.nlp	20627927	SENT71	4	4	32	32	gentamicin	VBP1	PA449753	7411	0.451
NULL	Acta_Pharmacol_Sin_2010_Nov_18_31(11)_1447-1453.nxml.txt.nlp	20953204	SENT118	4	4	19	19	rimonabant	CB2	PA152407999	1269	0.451
NULL	Acta_Pharmacol_Sin_2011_Oct_15_32(10)_1233-1238.nxml.txt.nlp	21841815	SENT86	25	25	21	21	mecamylamine	CTX	PA450334	1593	0.451
NULL	Oncotarget_2013_Nov_15_4(12)_2354-2365.nxml.txt.nlp	24259290	SENT231	20	20	6	6	forskolin	F12	PA146096022	2161	0.451
NULL	AMB_Express_2012_Jul_29_2_38.nxml.txt.nlp	22838397	SENT175	30	30	32	32	ethanol	EPG	PA448073	255324	0.451
NULL	Int_J_Nanomedicine_2007_Mar_2(1)_13-18.nxml.txt.nlp	17722507	SENT61	12	12	7	7	aprepitant	NK1	PA164747039	11126	0.451
NULL	Diabetes_2011_Jun_21_60(6)_1789-1796.nxml.txt.nlp	21562076	SENT49	5	5	34	34	ethanol	San	PA448073	80218	0.451
NULL	Tanaffos_2013_12(1)_6-15.nxml.txt.nlp	25191444	SENT186	1	1	4	4	streptomycin	DST	PA451512	667	0.451
NULL	Biosci_Rep_2012_Aug_1_32(Pt_4)_361-374.nxml.txt.nlp	22762204	SENT179	31	31	38	38	hyaluronan	ASPP1	PA165958431	23368	0.451
NULL	Cell_Death_Differ_2010_Apr_16_17(4)_666-676.nxml.txt.nlp	19834494	SENT251	18	18	4	4	oxaliplatin	RAGE	PA131285527	177	0.451
NULL	Cardiovasc_Ultrasound_2011_Nov_16_9_30.nxml.txt.nlp	22085903	SENT20	10	10	33	33	flecainide	TDI	PA449646	100038246	0.451
NULL	Environ_Health_Perspect_2008_Jan_5_116(1)_1-6.nxml.txt.nlp	18197291	SENT43	26	26	23	23	arsenite	eNOS	PA452638	4846	0.451
NULL	Indian_J_Pharm_Sci_2008_Nov-Dec_70(6)_721-726.nxml.txt.nlp	21369431	SENT86	10	10	12	12	streptozocin	STZ	PA451514	6484	0.451
NULL	F1000_Med_Rep_2009_May_28_1_43.nxml.txt.nlp	20948738	SENT35	29	29	25	25	abacavir	IL-6	PA448004	3569	0.451
NULL	Indian_J_Pharm_Sci_2011_Sep-Oct_73(5)_527-536.nxml.txt.nlp	22923865	SENT217	27	27	17	17	carvedilol	SPARC	PA448817	6678	0.451
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Nov_13_64(Pt_12)_o2319.nxml.txt.nlp	21581295	SENT58	20	20	17	17	ethanol	mol	PA448073	90527	0.451
NULL	Indian_J_Psychiatry_2010_Jan_52(Suppl1)_S317-S340.nxml.txt.nlp	21836703	SENT118	23	23	15	15	thioproperazine	CPZ	PA164754875	8532	0.451
NULL	Acta_Pharmacol_Sin_2009_Jan_8_30(1)_1-24.nxml.txt.nlp	19060915	SENT383	7	7	5	5	sildenafil	APE	PA451346	55704;328	0.451
NULL	Mol_Biol_Cell_2014_Mar_15_25(6)_791-799.nxml.txt.nlp	24451261	SENT131	13	13	17	17	nadh	ADP	PA164755085	23038	0.451
NULL	Breast_Cancer_Res_2001_Aug_10_3(5)_E004.nxml.txt.nlp	NULL	SENT31	13	13	18	18	trastuzumab	San	PA451743	80218	0.451
NULL	Int_J_Med_Sci_2012_Jan_26_9(2)_174-177.nxml.txt.nlp	22359484	SENT28	18	18	26	26	thrombin	FIG	PA451674	57120;11067	0.451
NULL	Breast_Cancer_Res_2011_Jun_14_13(3)_R63.nxml.txt.nlp	21679465	SENT141	7	7	11	11	formaldehyde	SDS	PA449703	51119;10993	0.451
NULL	Cell_Death_Dis_2014_Feb_13_5(2)_e1055.nxml.txt.nlp	24525731	SENT113	10	10	8	8	cisplatin	XRCC1	PA449014	7515	0.451
NULL	Curr_Cardiol_Rev_2011_Nov_7(4)_245-249.nxml.txt.nlp	22758625	SENT62	11	11	8	8	valsartan	CHOP	PA451848	1649	0.451
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT166	45	45	36	36	glucose	ERK	PA449773	5594	0.451
NULL	Br_J_Pharmacol_2014_May_11_171(9)_2385-2398.nxml.txt.nlp	24467222	SENT228	18	18	21	21	roflumilast	CXCL10	PA165948052	3627	0.451
NULL	Case_Rep_Endocrinol_2012_Sep_23_2012_231912.nxml.txt.nlp	23050172	SENT18	8	8	24	24	thyroglobulin	RAI	PA164754910	10848;6050	0.451
NULL	Int_J_Mol_Sci_2014_Nov_7_15(11)_20500-20517.nxml.txt.nlp	25387078	SENT13	0	0	26	26	sorafenib	Bcl-2	PA7000	596	0.451
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Oct_9_66(Pt_11)_o2729-o2730.nxml.txt.nlp	21588939	SENT65	21	21	18	18	ethanol	mol	PA448073	90527	0.451
NULL	J_Hematol_Oncol_2009_Aug_12_2_36.nxml.txt.nlp	19674465	SENT15	30	30	17	17	thalidomide	ENL	PA451644	4298	0.451
NULL	Basic_Res_Cardiol_2012_Mar_19_107(2)_242.nxml.txt.nlp	22258067	SENT266	5	5	0	0	indomethacin	CTRL	PA449982	1506	0.451
NULL	Clin_Ophthalmol_2014_Dec_31_9_57-62.nxml.txt.nlp	25584018	SENT61	25	25	29	29	cyclosporine	DES	PA449167	1674	0.451
NULL	Mol_Syst_Biol_2011_Apr_26_7_486.nxml.txt.nlp	21525872	SENT326	13	13	10	10	neomycin	NDN	PA450608	4692	0.451
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT197	9	9	11	11	methotrexate	MSH2	PA450428	4436	0.451
NULL	Breast_Cancer_Res_2008_Dec_16_10(6)_R105.nxml.txt.nlp	19087274	SENT12	18	18	14	14	creatine	GSTP1	PA164778930	2950	0.451
NULL	Appl_Plant_Sci_2015_Jan_5_3(1)_apps_1400086.nxml.txt.nlp	25606353	SENT62	1	1	16	16	chloramphenicol	BAM	PA448927	9126	0.451
NULL	Adv_Biomed_Res_2012_May_11_1_12.nxml.txt.nlp	23210071	SENT122	37	37	33	33	forskolin	GGF	PA146096022	3084	0.451
NULL	Mol_Cancer_2007_Oct_22_6_66.nxml.txt.nlp	17953743	SENT157	16	16	29	29	cisplatin	NAC	PA449014	22861	0.45
NULL	Clin_Infect_Dis_2013_Mar_1_56(5)_694-696.nxml.txt.nlp	23175557	SENT47	18	18	33	33	primaquine	G6PD	PA451103	2539	0.45
NULL	Curr_Neuropharmacol_2008_Jun_6(2)_151-163.nxml.txt.nlp	19305794	SENT531	11	11	8	8	capsaicin	TRPV1	PA448776	7442	0.45
NULL	Patient_Prefer_Adherence_2008_Feb_2_2_167-175.nxml.txt.nlp	19920959	SENT54	22	22	17	17	clopidogrel	DES	PA449053	1674	0.45
NULL	Exp_Mol_Med_2012_Nov_30_44(11)_665-673.nxml.txt.nlp	23114424	SENT72	7	7	12	12	taurine	adiponectin	PA451590	9370	0.45
NULL	J_Young_Pharm_2011_Oct-Dec_3(4)_310-314.nxml.txt.nlp	22224038	SENT26	25	25	22	22	ethanol	mol	PA448073	90527	0.45
NULL	J_Radiat_Res_2012_Sep_10_53(5)_704-709.nxml.txt.nlp	22843360	SENT94	4	4	2	2	doxorubicin	ADM	PA449412	133	0.45
NULL	Biochemistry_2013_Dec_17_52(50)_9059-9067.nxml.txt.nlp	24266852	SENT119	4	4	4	4	pp2	PP2		4888	0.45
NULL	Oxid_Med_Cell_Longev_2012_Jan_19_2012_390678.nxml.txt.nlp	22315655	SENT6	6	6	8	8	gliclazide	NAC	PA10892	22861	0.45
NULL	Am_J_Physiol_Cell_Physiol_2014_Jan_15_306(2)_C89-C97.nxml.txt.nlp	24133067	SENT178	7	7	5	5	trastuzumab	CD44	PA451743	960	0.45
NULL	Kidney_Int_Suppl_(2011)_2012_Jun_15_2(2)_186-197.nxml.txt.nlp	25018932	SENT183	7	7	12	12	rituximab	ACTH	PA451261	5443	0.45
NULL	Indian_J_Dermatol_2013_Mar-Apr_58(2)_164c.nxml.txt.nlp	23716858	SENT10	35	35	41	41	irinotecan	CEA	PA450085	5670;1087	0.45
NULL	Arthritis_Res_Ther_2014_Apr_3_16(2)_R86.nxml.txt.nlp	24708674	SENT227	0	0	26	26	bosentan	BLM	PA10034	641	0.45
NULL	Front_Behav_Neurosci_2014_Oct_30_8_366.nxml.txt.nlp	25400560	SENT208	37	37	23	23	ethanol	GAPDH	PA448073	2597	0.45
NULL	Acta_Pharmacol_Sin_2013_Sep_5_34(9)_1192-1200.nxml.txt.nlp	23685957	SENT139	17	17	12	12	curcumin	AP-2	PA151958596	7020	0.45
NULL	Arthritis_Res_Ther_2012_Aug_3_14(4)_R179.nxml.txt.nlp	22863285	SENT120	18	18	9	9	collagenase	ADAMTS-4	PA449107	9508	0.45
NULL	Pharm_Pract_(Granada)_2011_Mar_15_Jan-Mar_9(1)_1-10.nxml.txt.nlp	25132883	SENT162	17	17	19	19	rivaroxaban	SPAF	PA165958360	166378	0.45
NULL	EMBO_Mol_Med_2013_Jun_30_5(6)_935-948.nxml.txt.nlp	23629957	SENT39	0	0	2	2	cisplatin	COL6A3	PA449014	1293	0.45
NULL	Proteome_Sci_2009_Jul_16_7_24.nxml.txt.nlp	19607692	SENT106	26	26	34	34	nadh	p45	PA164755085	5705;6502	0.45
NULL	Int_J_Nanomedicine_2010_Feb_2_5_63-75.nxml.txt.nlp	20161988	SENT60	29	29	19	19	cisplatin	zeta	PA449014	9907	0.45
NULL	Arthritis_Res_Ther_2011_Dec_12_13(6)_R204.nxml.txt.nlp	22151924	SENT87	31	31	8	8	anakinra	CFB	PA10799	629	0.45
NULL	AIDS_Res_Ther_2014_Aug_4_11_25.nxml.txt.nlp	25120580	SENT60	18	18	9	9	voriconazole	CYP2C19	PA10233	1557	0.45
NULL	Diabetes_Care_2009_Nov_32(Suppl_2)_S217-S222.nxml.txt.nlp	19875555	SENT57	17	17	38	38	rosiglitazone	GLP-1	PA451283	100125288	0.45
NULL	Mol_Cancer_2013_Nov_27_12_150.nxml.txt.nlp	24279793	SENT99	22	22	27	27	creatine	CKM	PA164778930	1158	0.45
NULL	J_Hum_Genet_2013_Jun_16_58(6)_353-361.nxml.txt.nlp	23677058	SENT163	25	25	42	42	cytarabine	NT5C2	PA449177	22978	0.45
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Mar_21_68(Pt_4)_o1129.nxml.txt.nlp	22589984	SENT65	3	3	17	17	acetone	mol	PA448025	90527	0.45
NULL	Mol_Vis_2012_Apr_11_18_901-908.nxml.txt.nlp	22539869	SENT167	13	13	10	10	curcumin	HO-1	PA151958596	3162	0.45
NULL	Biomed_Res_Int_2014_Jan_29_2014_361020.nxml.txt.nlp	24605326	SENT223	1	1	40	40	staurosporine	CDK2	PA165109623	1017	0.45
NULL	Curr_Neuropharmacol_2012_Jun_10(2)_139-158.nxml.txt.nlp	23204984	SENT662	2	2	28	28	fluoxetine	IL-10	PA449673	3586	0.45
NULL	Oncol_Lett_2013_May_19_5(5)_1643-1648.nxml.txt.nlp	23760877	SENT73	5	5	13	13	cyclophosphamide	CHOP	PA449165	1649	0.45
NULL	Br_J_Cancer_2009_Sep_15_101(6)_957-966.nxml.txt.nlp	19738618	SENT236	16	16	30	30	dexrazoxane	THBS-1	PA449259	7057	0.45
NULL	Environ_Health_Perspect_2005_Jun_24_113(6)_675-679.nxml.txt.nlp	15929888	SENT132	5	5	7	7	estradiol	CA1	PA449503	759	0.45
NULL	Mol_Brain_2013_May_25_6_27.nxml.txt.nlp	23705847	SENT239	17	17	9	9	capsaicin	TRPV1	PA448776	7442	0.45
NULL	Case_Rep_Crit_Care_2014_Aug_19_2014_242703.nxml.txt.nlp	25215245	SENT243	11	11	46	46	salbutamol	Yes	PA448068	7525	0.45
NULL	Front_Cell_Neurosci_2013_Aug_30_7_139.nxml.txt.nlp	24009559	SENT404	11	11	6	6	pilocarpine	VGAT	PA450962	140679	0.45
NULL	J_Cardiothorac_Surg_2012_Sep_27_7_95.nxml.txt.nlp	23013647	SENT36	0	0	2	2	aprotinin	EPO	PA448472	7076;8288;2056	0.45
NULL	Crit_Care_2006_Jul_3_10(4)_218.nxml.txt.nlp	16834764	SENT18	4	4	2	2	octreotide	Yes	PA450678	7525	0.45
NULL	Enzyme_Res_2009_Nov_1_2010_165878.nxml.txt.nlp	21048860	SENT107	24	24	21	21	asparaginase	NAC	PA448492	22861	0.45
NULL	Bioinformation_2011_Oct_14_7(4)_199-206.nxml.txt.nlp	22102777	SENT103	26	26	30	30	indomethacin	OAP	PA449982	4937	0.45
NULL	Neural_Regen_Res_2014_Mar_1_9(5)_540-548.nxml.txt.nlp	25206852	SENT189	3	3	1	1	choline	HSP27	PA448976	3315	0.45
NULL	J_Carcinog_2011_Mar_24_10_8.nxml.txt.nlp	21483656	SENT48	3	3	19	19	sulindac	SSAT	PA451565	6303	0.45
NULL	Neural_Dev_2013_Mar_7_8_4.nxml.txt.nlp	23497494	SENT166	9	9	11	11	chlorpheniramine	E12	PA448960	64100	0.45
NULL	Clin_Ophthalmol_2014_Aug_30_8_1661-1670.nxml.txt.nlp	25210436	SENT131	15	15	3	3	ranibizumab	PED	PA164746012	8682	0.45
NULL	Oxid_Med_Cell_Longev_2012_Sep_16_2012_728547.nxml.txt.nlp	23029599	SENT78	18	18	4	4	nadh	SIRT1	PA164755085	23411	0.45
NULL	J_Cancer_Prev_2014_Jun_19(2)_111-117.nxml.txt.nlp	25337579	SENT76	1	1	45	45	doxorubicin	MRP5	PA449412	10057	0.45
NULL	J_Exp_Med_1994_May_1_179(5)_1737-1741.nxml.txt.nlp	8163952	SENT8	3	3	5	5	thrombin	gamma	PA451674	9913	0.45
NULL	Anal_Bioanal_Chem_2012_Dec_4_404(10)_3071-3080.nxml.txt.nlp	23052869	SENT109	16	16	26	26	pilocarpine	CA3	PA450962	761	0.45
NULL	Br_J_Cancer_2011_Apr_12_104(8)_1256-1261.nxml.txt.nlp	21448165	SENT135	24	24	26	26	sorafenib	IL-2	PA7000	3558	0.45
NULL	Diabetes_2011_Jul_20_60(7)_1990-1999.nxml.txt.nlp	21617181	SENT188	20	20	25	25	geldanamycin	Hsp90	PA152031327	3320	0.45
NULL	Oxid_Med_Cell_Longev_2013_Jun_2_2013_793525.nxml.txt.nlp	23819014	SENT103	13	13	15	15	resveratrol	SGBS		2719	0.45
NULL	Chemother_Res_Pract_2011_Apr_18_2011_619321.nxml.txt.nlp	22312555	SENT62	4	4	9	9	vancomycin	VISA	PA451850	57506	0.45
NULL	Diabetes_2009_Jan_58(1)_243-249.nxml.txt.nlp	18840785	SENT197	34	34	30	30	glucose	GLP-1	PA449773	100125288	0.45
NULL	Braz_J_Microbiol_2012_Jun_1_Apr-Jun_43(2)_506-516.nxml.txt.nlp	24031858	SENT7	6	6	13	13	ethanol	mol	PA448073	90527	0.45
NULL	Arthritis_Res_Ther_2006_May_11_8(3)_209.nxml.txt.nlp	16712713	SENT551	14	14	16	16	cyclophosphamide	Yes	PA449165	7525	0.45
NULL	Lab_Invest_2010_Nov_9_90(11)_1676-1686.nxml.txt.nlp	20697375	SENT49	16	16	38	38	trypsin	INS-1	PA451806	2305	0.45
NULL	J_Thromb_Haemost_2011_Oct_9(10)_2103-2105.nxml.txt.nlp	21812912	SENT18	33	33	28	28	ticagrelor	mol	PA165374673	90527	0.45
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT46	18	18	33	33	l-leucine	ATP5A	PA450197	498	0.45
NULL	Acta_Naturae_2010_Apr_2(1)_97-102.nxml.txt.nlp	22649634	SENT13	7	7	9	9	nadh	CO2	PA164755085	4513	0.45
NULL	Blood_Cancer_J_2012_Mar_23_2(3)_e63.nxml.txt.nlp	22829258	SENT24	20	20	6	6	eculizumab	BCS	PA164776637	617	0.45
NULL	Open_Cardiovasc_Med_J_2008_Jul_30_2_60-69.nxml.txt.nlp	18949101	SENT189	8	8	13	13	sirolimus	DES	PA451365	1674	0.45
NULL	Indian_J_Nucl_Med_2011_Oct-Dec_26(4)_202-204.nxml.txt.nlp	23559719	SENT15	38	38	27	27	pyrazinamide	AKT	PA451182	207	0.45
NULL	Eur_J_Med_Res_2011_Mar_28_16(3)_115-126.nxml.txt.nlp	21486724	SENT86	2	2	5	5	levofloxacin	Met	PA450214	79811	0.45
NULL	Exp_Ther_Med_2014_Nov_29_8(5)_1473-1478.nxml.txt.nlp	25289044	SENT111	19	19	21	21	heparin	AZU	PA449855	566	0.45
NULL	Mol_Cells_2014_Mar_31_37(3)_234-240.nxml.txt.nlp	24642709	SENT109	16	16	22	22	capsaicin	NOX4	PA448776	50507	0.45
NULL	Cancer_Cell_Int_2011_May_15_11_13.nxml.txt.nlp	21569620	SENT148	4	4	11	11	bortezomib	PC-3	PA10252	692094	0.45
NULL	J_Oncol_2009_Mar_24_2009_491985.nxml.txt.nlp	19325924	SENT117	14	14	16	16	genistein	CXCR4	PA165109660	7852	0.45
NULL	Am_J_Cardiovasc_Drugs_2014_Jan_3_14(3)_167-173.nxml.txt.nlp	24385234	SENT102	26	26	19	19	clopidogrel	SPICE	PA449053	152185	0.45
NULL	Cancer_Med_2014_Dec_1_3(6)_1493-1501.nxml.txt.nlp	25081631	SENT34	5	5	14	14	cetuximab	FDG	PA10040	23583	0.45
NULL	EMBO_Mol_Med_2012_Jul_11_4(7)_577-593.nxml.txt.nlp	22496117	SENT122	11	11	7	7	clofazimine	PAP-1	PA164748759	6100	0.45
NULL	Evid_Based_Complement_Alternat_Med_2013_Jun_25_2013_421051.nxml.txt.nlp	23878598	SENT44	25	25	5	5	l-glutamine	F12	PA10090	2161	0.45
NULL	Cell_Death_Dis_2014_Feb_13_5(2)_e1055.nxml.txt.nlp	24525731	SENT19	13	13	11	11	cisplatin	XRCC1	PA449014	7515	0.45
NULL	Carcinogenesis_2010_Mar_25_31(3)_446-454.nxml.txt.nlp	19942609	SENT95	32	32	17	17	doxycycline	DLD	PA449415	1738	0.45
NULL	ISRN_Cardiol_2013_Jan_2_2013_687069.nxml.txt.nlp	23346414	SENT57	14	14	16	16	lipase	HSL	PA450239	3991	0.45
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1063.nxml.txt.nlp	24556678	SENT10	10	10	8	8	thioridazine	Mcl-1	PA451666	4170	0.45
NULL	J_Biol_Chem_2010_Apr_2_285(14)_10546-10552.nxml.txt.nlp	20118239	SENT97	25	25	18	18	dextran	SP-A	PA449261	653509	0.45
NULL	Front_Hum_Neurosci_2014_Jun_4_8_405.nxml.txt.nlp	24926251	SENT543	1	1	6	6	oxygen	spatial	PA450744	219793	0.449
NULL	ScientificWorldJournal_2014_Jan_30_2014_867839.nxml.txt.nlp	24592194	SENT3	14	14	19	19	nadh	ND2	PA164755085	4536	0.449
NULL	NDT_Plus_2011_Jun_2_4(3)_158-163.nxml.txt.nlp	21629670	SENT4	41	41	8	8	vasopressin	AVPR2	PA451858	554	0.449
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Oct_31_65(Pt_11)_o2968-o2969.nxml.txt.nlp	21578539	SENT70	26	26	20	20	ethanol	mol	PA448073	90527	0.449
NULL	Cancer_Med_2014_Jun_14_3(3)_580-591.nxml.txt.nlp	24574330	SENT246	6	6	11	11	bevacizumab	VEGF-D	PA130232992	2277	0.449
NULL	Indian_J_Anaesth_2013_Jan-Feb_57(1)_41-45.nxml.txt.nlp	23716765	SENT119	19	19	13	13	granisetron	HERG	PA449809	3757	0.449
NULL	Nucleic_Acids_Res_2012_Jun_10_40(11)_4804-4815.nxml.txt.nlp	22328728	SENT285	20	20	29	29	hemin	SIRT1	PA449849	23411	0.449
NULL	J_Orthop_Traumatol_2013_Jun_1_14(2)_109-114.nxml.txt.nlp	23456483	SENT145	8	8	3	3	hyaluronan	ACP	PA165958431	4706	0.449
NULL	J_Neuroinflammation_2011_Feb_4_8_10.nxml.txt.nlp	21294877	SENT6	29	29	26	26	capsaicin	TAC1	PA448776	6863	0.449
NULL	Oxid_Med_Cell_Longev_2013_Mar_5_2013_264935.nxml.txt.nlp	23533686	SENT29	18	18	13	13	hemin	HO-1	PA449849	3162	0.449
NULL	Bioinorg_Chem_Appl_2013_Mar_27_2013_982423.nxml.txt.nlp	23606821	SENT3	17	17	10	10	curcumin	NO3	PA151958596	4681	0.449
NULL	Crit_Care_2000_Oct_13_4(Suppl_2)_S21-S25.nxml.txt.nlp	11255595	SENT70	6	6	1	1	furosemide	STP	PA449719	9322	0.449
NULL	Biomed_Res_Int_2014_Jan_29_2014_361020.nxml.txt.nlp	24605326	SENT223	7	7	2	2	flavopiridol	CDK1	PA452627	983	0.449
NULL	J_Viral_Hepat_2009_May_16(5)_315-324.nxml.txt.nlp	19243499	SENT17	33	33	11	11	ribavirin	IFN	PA451241	3439	0.449
NULL	Adv_Ther_2014_Feb_15_31(3)_289-317.nxml.txt.nlp	24535623	SENT274	15	15	13	13	liraglutide	GLP-1	PA165958364	100125288	0.449
NULL	Mediators_Inflamm_1999_8(6)_277-286.nxml.txt.nlp	10815616	SENT0	22	22	7	7	cladribine	IL-6	PA449027	3569	0.449
NULL	Inflamm_Res_2014_Mar_13_63(7)_519-525.nxml.txt.nlp	24623532	SENT90	20	20	0	0	ethanol	IL-22	PA448073	50616;53342	0.449
NULL	J_Clin_Biochem_Nutr_2010_Jan_29_46(1)_36-42.nxml.txt.nlp	20104263	SENT19	22	22	20	20	ribavirin	IFN	PA451241	3439	0.449
NULL	Adv_Nutr_2013_Mar_6_4(2)_226-235.nxml.txt.nlp	23493539	SENT351	22	22	9	9	ethanol	c-Jun	PA448073	3725	0.449
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1150.nxml.txt.nlp	24675468	SENT93	20	20	18	18	ethanol	adiponectin	PA448073	9370	0.449
NULL	Osteoporos_Int_2010_Oct_18_21(10)_1657-1680.nxml.txt.nlp	20480148	SENT590	4	4	28	28	tamoxifen	STAR	PA451581	6770;2984	0.449
NULL	Cancer_Imaging_2013_Dec_11_13(4)_466-481.nxml.txt.nlp	24334439	SENT29	17	17	14	14	choline	FDG	PA448976	23583	0.449
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Jul_20_69(Pt_8)_o1276.nxml.txt.nlp	24109358	SENT72	32	32	13	13	ethanol	mol	PA448073	90527	0.449
NULL	Arthritis_Res_Ther_2011_Mar_16_13(2)_R44.nxml.txt.nlp	21410959	SENT144	0	0	3	3	glucosamine	IL-10	PA164747613	3586	0.449
NULL	Endocrinol_Diabetes_Metab_Case_Rep_2014_Feb_1_2014_130079.nxml.txt.nlp	24683483	SENT3	13	13	4	4	glucose	IGF1	PA449773	3479	0.449
NULL	Cell_Death_Dis_2014_Jan_30_5(1)_e1036.nxml.txt.nlp	24481450	SENT119	15	15	19	19	l-glutamine	B27	PA10090	56246	0.449
NULL	Allergy_Asthma_Immunol_Res_2011_Jul_23_3(3)_199-204.nxml.txt.nlp	21738886	SENT133	12	12	4	4	methacholine	IFN	PA165958382	3439	0.449
NULL	J_Immunother_Cancer_2014_Jan_27_2_2.nxml.txt.nlp	24829759	SENT190	19	19	17	17	sorafenib	IL-21	PA7000	59067;50616;27189	0.449
NULL	Biologics_2009_Oct_12_3_469-474.nxml.txt.nlp	19851472	SENT103	28	28	3	3	mometasone	IL-5	PA450541	3567	0.449
NULL	FEBS_Open_Bio_2012_May_30_2_119-128.nxml.txt.nlp	23650590	SENT449	6	6	8	8	docetaxel	PC3	PA449383	57332;7832;5122	0.449
NULL	Int_J_Alzheimers_Dis_2011_Nov_15_2011_345614.nxml.txt.nlp	22145082	SENT4	0	0	30	30	copper	APP	PA449114	351	0.449
NULL	J_Mol_Model_2006_Jul_29_12(5)_597-609.nxml.txt.nlp	16261297	SENT172	11	11	28	28	sulfur	mol	PA451558	90527	0.449
NULL	J_Asthma_Allergy_2011_Apr_14_4_27-35.nxml.txt.nlp	21698213	SENT32	21	21	33	33	rupatadine	C10		113246	0.449
NULL	Cell_Commun_Signal_2008_Oct_24_6_8.nxml.txt.nlp	18950493	SENT282	8	8	19	19	carboplatin	p53	PA448803	7157	0.449
NULL	Arthritis_Res_2000_Aug_3_2(5)_424-427.nxml.txt.nlp	11056677	SENT168	11	11	14	14	glutaraldehyde	mol	PA449777	90527	0.449
NULL	FEBS_Open_Bio_2014_Mar_19_4_301-309.nxml.txt.nlp	24918042	SENT229	10	10	2	2	gentamicin	NOK	PA449753	55359	0.449
NULL	Patient_Prefer_Adherence_2010_Oct_5_4_369-377.nxml.txt.nlp	21049089	SENT174	14	14	2	2	olanzapine	DAI	PA450688	81030	0.449
NULL	Thorax_2010_Jul_13_65(7)_654-658.nxml.txt.nlp	20627927	SENT71	18	18	32	32	gentamicin	VBP1	PA449753	7411	0.449
NULL	Environ_Health_Perspect_2009_Feb_8_117(2)_175-180.nxml.txt.nlp	19270784	SENT134	8	8	6	6	doxorubicin	BPA	PA449412	667	0.449
NULL	Orphanet_J_Rare_Dis_2013_Sep_13_8_142.nxml.txt.nlp	24034279	SENT99	14	14	9	9	metoclopramide	AVP	PA450475	114548;551	0.449
NULL	Breast_Cancer_Res_2004_Nov_7_6(1)_39-52.nxml.txt.nlp	14680484	SENT158	14	14	8	8	tamoxifen	N-CoR	PA451581	9611	0.449
NULL	Head_Face_Med_2012_Mar_1_8_5.nxml.txt.nlp	22376948	SENT41	31	31	0	0	risedronate	OST	PA451255	1650;23263	0.449
NULL	Mol_Biol_Rep_2013_Sep_28_40(10)_5573-5585.nxml.txt.nlp	24078156	SENT58	13	13	33	33	iron	FPN1	PA450087	30061	0.449
NULL	Int_J_Vasc_Med_2012_Sep_27_2012_942512.nxml.txt.nlp	21961069	SENT145	12	12	36	36	probucol	MCP-1	PA451107	6347	0.449
NULL	Br_J_Cancer_2013_Mar_5_108(4)_887-900.nxml.txt.nlp	23462807	SENT108	20	20	13	13	sunitinib	ABCB1	PA162372840	5243	0.449
NULL	J_Cell_Biol_1998_Jun_29_141(7)_1685-1695.nxml.txt.nlp	9647659	SENT60	7	7	18	18	paraformaldehyde	San	PA450790	80218	0.449
NULL	Crit_Care_2011_Nov_16_15(6)_R271.nxml.txt.nlp	22087790	SENT164	2	2	29	29	nitroprusside	Yes	PA451406	7525	0.449
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jun_5_66(Pt_7)_o1586.nxml.txt.nlp	21587826	SENT69	22	22	19	19	ethanol	mol	PA448073	90527	0.449
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Sep_19_65(Pt_10)_o2501.nxml.txt.nlp	21577950	SENT61	16	16	13	13	ethanol	mol	PA448073	90527	0.449
NULL	Onco_Targets_Ther_2014_Sep_30_7_1641-1645.nxml.txt.nlp	25336968	SENT88	11	11	14	14	chlorthalidone	Yes	PA448970	7525	0.449
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT142	11	11	9	9	vinorelbine	ASC	PA451881	29108	0.449
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Feb_17_68(Pt_3)_o700-o701.nxml.txt.nlp	22412590	SENT4	8	8	20	20	erythromycin	mol	PA449493	90527	0.449
NULL	J_Geriatr_Cardiol_2014_Sep_11(3)_200-205.nxml.txt.nlp	25278967	SENT109	13	13	5	5	heparin	ADP	PA449855	23038	0.449
NULL	Biomed_Res_Int_2013_Dec_10_2013_783698.nxml.txt.nlp	24386640	SENT63	11	11	29	29	rifampin	DST	PA451250	667	0.449
NULL	J_Cell_Mol_Med_2014_Dec_9_18(12)_2499-2511.nxml.txt.nlp	24912879	SENT288	17	17	19	19	docetaxel	DACH1	PA449383	1602	0.449
NULL	Ann_Gen_Psychiatry_2008_Aug_28_7_16.nxml.txt.nlp	18755025	SENT242	12	12	3	3	quetiapine	Gen	PA451201	348654	0.449
NULL	ARYA_Atheroscler_2013_May_9(3)_172-178.nxml.txt.nlp	23766773	SENT80	8	8	20	20	lipase	gamma	PA450239	9913	0.449
NULL	Case_Rep_Oncol_Med_2012_Dec_2_2012_689291.nxml.txt.nlp	23243533	SENT79	20	20	32	32	thyroglobulin	UCHL1	PA164754910	7345	0.449
NULL	J_Ayurveda_Integr_Med_2014_Jan-Mar_5(1)_38-42.nxml.txt.nlp	24812474	SENT16	36	36	17	17	ethanol	CEE	PA448073	51608	0.449
NULL	Glycoconj_J_2013_Apr_29_30(3)_205-225.nxml.txt.nlp	22544341	SENT148	17	17	12	12	galactose	SPG	PA449725	55764	0.449
NULL	Lab_Invest_2009_Nov_7_89(11)_1275-1290.nxml.txt.nlp	19736547	SENT169	8	8	21	21	curcumin	LOX-1	PA151958596	4973	0.449
NULL	Mol_Pain_2013_Feb_15_9_3.nxml.txt.nlp	23413875	SENT64	3	3	5	5	resveratrol	TRPA1		8989	0.449
NULL	Curr_Neuropharmacol_2008_Sep_6(3)_193-202.nxml.txt.nlp	19506720	SENT352	7	7	5	5	olanzapine	p75	PA450688	7133;11168	0.449
NULL	Diabetes_Metab_J_2013_Feb_15_37(1)_72-80.nxml.txt.nlp	23439802	SENT97	34	34	28	28	vildagliptin	PPG	PA165958346	5552	0.449
NULL	Gut_Liver_2012_Apr_17_6(2)_139-148.nxml.txt.nlp	22570744	SENT149	1	1	14	14	sorafenib	SHARP	PA7000	23013	0.449
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jul_18_68(Pt_8)_o2473.nxml.txt.nlp	22904915	SENT5	10	10	16	16	phenol	mol	PA450913	90527	0.449
NULL	Int_J_Mol_Sci_2014_Oct_27_15(11)_19458-19471.nxml.txt.nlp	25350111	SENT163	7	7	21	21	formaldehyde	CAT	PA449703	847	0.449
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT1777	13	13	4	4	maraviroc	ATV	PA164768835	4683	0.449
NULL	Clin_Ophthalmol_2012_Dec_13_6_1-4.nxml.txt.nlp	22259229	SENT57	13	13	16	16	travoprost	BAK	PA164781371	578	0.449
NULL	Clin_Psychopharmacol_Neurosci_2011_Apr_30_9(1)_36-43.nxml.txt.nlp	23431025	SENT103	8	8	10	10	haloperidol	FLI	PA449841	2314	0.449
NULL	Cell_Death_Dis_2014_Apr_17_5(4)_e1182.nxml.txt.nlp	24743737	SENT42	3	3	13	13	capsaicin	TRPV1	PA448776	7442	0.449
NULL	J_Exp_Med_2000_Mar_6_191(5)_859-870.nxml.txt.nlp	10704466	SENT221	7	7	11	11	arsenite	p38	PA452638	10598;1432;7965	0.449
NULL	Br_J_Cancer_1998_Jul_78(2)_175-180.nxml.txt.nlp	9683290	SENT6	26	26	10	10	cisplatin	MRP1	PA449014	4437	0.449
NULL	Pharmacogn_Rev_2011_Jul-Dec_5(10)_159-163.nxml.txt.nlp	22279373	SENT126	9	9	7	7	tolbutamide	CEE	PA451718	51608	0.449
NULL	J_Gen_Physiol_1968_Jul_1_52(1)_1-21.nxml.txt.nlp	5742832	SENT4	15	15	11	11	potassium	RMP	PA451047	8725	0.448
NULL	Parasit_Vectors_2010_Apr_30_3_41.nxml.txt.nlp	20433694	SENT72	24	24	29	29	nadh	ND6	PA164755085	4541	0.448
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Feb_29_68(Pt_3)_m341-m342.nxml.txt.nlp	22412472	SENT4	18	18	20	20	ciprofloxacin	mol	PA449009	90527	0.448
NULL	Open_Biomed_Eng_J_2013_Jun_14_7_50-61.nxml.txt.nlp	23847691	SENT244	14	14	21	21	collagenase	CD44	PA449107	960	0.448
NULL	Adv_Hematol_2010_Dec_2_2010_424786.nxml.txt.nlp	21188274	SENT77	15	15	13	13	etoposide	CHOP	PA449552	1649	0.448
NULL	Br_J_Cancer_2013_Mar_5_108(4)_887-900.nxml.txt.nlp	23462807	SENT13	19	19	11	11	sunitinib	ABCB1	PA162372840	5243	0.448
NULL	Oncotarget_2013_Nov_24_4(12)_2186-2207.nxml.txt.nlp	24327604	SENT177	6	6	12	12	lenalidomide	CRBN	PA162363968	51185	0.448
NULL	Exp_Ther_Med_2013_Apr_24_5(4)_1105-1112.nxml.txt.nlp	23596478	SENT19	15	15	23	23	imatinib	IFN	PA10804	3439	0.448
NULL	Diabetes_Metab_J_2013_Aug_14_37(4)_240-248.nxml.txt.nlp	23991401	SENT121	5	5	14	14	ezetimibe	GLP-1	PA10816	100125288	0.448
NULL	Pharm_Methods_2012_Jul-Dec_3(2)_112-116.nxml.txt.nlp	23781490	SENT3	22	22	24	24	atorvastatin	ATV	PA448500	4683	0.448
NULL	Iran_J_Ped_Hematol_Oncol_2014_Jul_20_4(3)_127-130.nxml.txt.nlp	25254092	SENT17	2	2	4	4	propranolol	IFN	PA451145	3439	0.448
NULL	Adv_Hematol_2010_Dec_21_2010_320624.nxml.txt.nlp	21253465	SENT75	13	13	11	11	etoposide	CHOP	PA449552	1649	0.448
NULL	Oncotarget_2011_Aug_30_2(8)_610-626.nxml.txt.nlp	21881167	SENT216	0	0	13	13	doxorubicin	Raf-1	PA449412	5894	0.448
NULL	Acta_Neuropathol_Commun_2014_Sep_16_2(1)_137.nxml.txt.nlp	NULL	SENT29	30	30	36	36	nadh	COX	PA164755085	1351	0.448
NULL	Diagn_Pathol_2014_Jan_20_9_11.nxml.txt.nlp	24443801	SENT26	15	15	19	19	trypsin	MUC5AC	PA451806	4586	0.448
NULL	Oncotarget_2013_Jul_13_4(7)_958-971.nxml.txt.nlp	23948487	SENT114	1	1	12	12	cisplatin	p53	PA449014	7157	0.448
NULL	Indian_J_Dermatol_2010_Jul-Sep_55(3)_281-283.nxml.txt.nlp	21063527	SENT59	8	8	3	3	vincristine	IFN	PA451879	3439	0.448
NULL	Drugs_R_D_2013_Sep_28_13(3)_191-197.nxml.txt.nlp	23982688	SENT229	11	11	13	13	warfarin	Gen	PA451906	348654	0.448
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Jul_19_64(Pt_8)_o1520.nxml.txt.nlp	21203228	SENT3	39	39	41	41	ethanol	mol	PA448073	90527	0.448
NULL	Br_J_Sports_Med_2013_Dec_47(Suppl_1)_i17-i21.nxml.txt.nlp	24282200	SENT178	16	16	22	22	oxygen	MRS	PA450744	8011	0.448
NULL	Mol_Cancer_2010_Mar_9_9_54.nxml.txt.nlp	20214788	SENT70	4	4	18	18	tetracycline	LAP	PA451640	1051;51056;55835	0.448
NULL	Int_J_Mol_Sci_2012_Feb_24_13(3)_2590-2617.nxml.txt.nlp	22489113	SENT202	15	15	22	22	benzaldehyde	mol	PA448571	90527	0.448
NULL	Cell_Mol_Life_Sci_2011_May_26_68(10)_1785-1798.nxml.txt.nlp	20976523	SENT214	34	34	16	16	collagenase	AP-1	PA449107	2353;3727;2354;3725	0.448
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT302	0	0	23	23	paliperidone	PRL	PA163518919	5617	0.448
NULL	Br_J_Cancer_2010_Jun_8_102(12)_1699-1706.nxml.txt.nlp	20485286	SENT17	3	3	8	8	sunitinib	CYP3A	PA162372840	1574	0.448
NULL	Endocrinol_Metab_(Seoul)_2014_Sep_25_29(3)_356-362.nxml.txt.nlp	25309795	SENT104	22	22	20	20	hemin	HO-1	PA449849	3162	0.448
NULL	New_Phytol_2014_Apr_18_202(1)_322-335.nxml.txt.nlp	24350948	SENT74	13	13	24	24	ethanol	CO2	PA448073	4513	0.448
NULL	Arthritis_Res_Ther_2014_May_16_16(3)_R113.nxml.txt.nlp	24886859	SENT337	21	21	26	26	estradiol	LSD1	PA449503	23028	0.448
NULL	AMB_Express_2014_Aug_30_4_63.nxml.txt.nlp	25401066	SENT228	13	13	42	42	nadh	CH1	PA164755085	51430	0.448
NULL	Physiol_Rep_2014_Sep_11_2(9)_e12144.nxml.txt.nlp	25214522	SENT435	1	1	16	16	resveratrol	SOD1		6647	0.448
NULL	Curr_Neuropharmacol_2008_Sep_6(3)_215-234.nxml.txt.nlp	19506722	SENT450	17	17	19	19	fluoxetine	5-HT1A	PA449673	3350	0.448
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_May_14_65(Pt_6)_o1257.nxml.txt.nlp	21583122	SENT58	9	9	6	6	ethanol	mol	PA448073	90527	0.448
NULL	Breast_Cancer_Res_2003_Feb_5_5(2)_113-116.nxml.txt.nlp	12631392	SENT33	19	19	4	4	tamoxifen	San	PA451581	80218	0.448
NULL	ScientificWorldJournal_2013_Oct_24_2013_726912.nxml.txt.nlp	24282387	SENT26	11	11	7	7	fluorescein	AVP	PA164746009	114548;551	0.448
NULL	Exp_Mol_Med_2012_Sep_30_44(9)_554-561.nxml.txt.nlp	22809871	SENT94	30	30	18	18	streptomycin	FBS	PA451512	64319;26269	0.448
NULL	Mol_Cancer_2010_Apr_23_9_87.nxml.txt.nlp	20416058	SENT204	27	27	29	29	doxorubicin	TRAIL	PA449412	8743	0.448
NULL	Curr_Hepat_Rep_2010_May_21_9(2)_75-90.nxml.txt.nlp	20461127	SENT244	15	15	45	45	telbivudine	LAM	PA164760861	7249;7248	0.448
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jan_26_67(Pt_2)_o483-o484.nxml.txt.nlp	21523140	SENT76	0	0	7	7	lomefloxacin	mol	PA164749165	90527	0.448
NULL	Indian_Dermatol_Online_J_2011_Jan-Jun_2(1)_43-45.nxml.txt.nlp	23130220	SENT26	17	17	29	29	methotrexate	CO2	PA450428	4513	0.448
NULL	Exp_Ther_Med_2014_Aug_26_8(2)_505-508.nxml.txt.nlp	25009609	SENT35	31	31	11	11	streptomycin	FBS	PA451512	64319;26269	0.448
NULL	Crit_Care_2011_Nov_17_15(6)_R272.nxml.txt.nlp	22087841	SENT29	4	4	12	12	thrombin	FVIII	PA451674	2157	0.448
NULL	Clin_Interv_Aging_2008_Mar_3(1)_45-50.nxml.txt.nlp	18488877	SENT104	4	4	10	10	raloxifene	BMD	PA451221	1756;7439	0.448
NULL	Ann_Gen_Psychiatry_2012_Nov_16_11_29.nxml.txt.nlp	23157721	SENT70	2	2	0	0	risperidone	DAC	PA451257	13	0.448
NULL	Patient_Prefer_Adherence_2010_Oct_5_4_369-377.nxml.txt.nlp	21049089	SENT174	10	10	2	2	haloperidol	DAI	PA449841	81030	0.448
NULL	Zookeys_2014_Nov_25_(457)_1-14.nxml.txt.nlp	25561827	SENT121	36	36	15	15	ethanol	San	PA448073	80218	0.448
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT251	3	3	7	7	doxorubicin	B7-H1	PA449412	29126	0.448
NULL	Diabetes_2011_May_23_60(5)_1458-1466.nxml.txt.nlp	21464445	SENT336	10	10	21	21	lipase	adiponutrin	PA450239	80339	0.448
NULL	F1000Res_2014_Sep_29_3_228.nxml.txt.nlp	25485098	SENT272	8	8	20	20	fluoxetine	spatial	PA449673	219793	0.448
NULL	Evid_Based_Complement_Alternat_Med_2012_Feb_16_2012_430262.nxml.txt.nlp	22454664	SENT8	4	4	13	13	phenytoin	CYP2C19	PA450947	1557	0.448
NULL	Crit_Care_2011_Jun_24_15(3)_R153.nxml.txt.nlp	21702944	SENT109	3	3	16	16	dexmedetomidine	HK2	PA449256	3796;3099;29911;3741	0.448
NULL	Cell_Cycle_2012_Nov_1_11(21)_3983-3996.nxml.txt.nlp	22987153	SENT213	4	4	9	9	cisplatin	DNA2	PA449014	1763	0.448
NULL	Br_J_Cancer_2006_Feb_13_94(3)_407-426.nxml.txt.nlp	16434996	SENT121	35	35	31	31	genistein	BRCA2	PA165109660	675	0.448
NULL	Cancer_Manag_Res_2014_May_23_6_225-252.nxml.txt.nlp	24904222	SENT482	4	4	2	2	diethylstilbestrol	DES	PA449307	1674	0.448
NULL	J_Antimicrob_Chemother_2014_Feb_29_69(2)_368-374.nxml.txt.nlp	24080503	SENT106	11	11	9	9	trimethoprim	DHFR	PA451788	1719	0.448
NULL	Evid_Based_Complement_Alternat_Med_2013_Mar_26_2013_679635.nxml.txt.nlp	23589720	SENT81	7	7	12	12	nitroprusside	DPI	PA451406	1832	0.448
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_May_21_70(Pt_6)_m224.nxml.txt.nlp	24940208	SENT3	32	32	34	34	nitrile	mol	PA450636	90527	0.448
NULL	Mol_Cancer_2013_Sep_27_12_111.nxml.txt.nlp	24070020	SENT380	39	39	15	15	bezafibrate	FAF	PA162364313	8239;2188	0.448
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Nov_5_67(Pt_12)_o3168.nxml.txt.nlp	22199692	SENT70	21	21	18	18	ethanol	mol	PA448073	90527	0.448
NULL	Nat_Med_2010_Nov_24_16(11)_1299-1304.nxml.txt.nlp	20972434	SENT64	6	6	18	18	chloroquine	ASM	PA448948	6609;283120	0.448
NULL	Front_Neurol_2014_Feb_18_5_17.nxml.txt.nlp	24600432	SENT105	21	21	16	16	levetiracetam	CD178	PA450206	356	0.448
NULL	Curr_Neuropharmacol_2012_Mar_10(1)_80-87.nxml.txt.nlp	22942881	SENT151	7	7	12	12	methylprednisolone	IL-6	PA450466	3569	0.448
NULL	Br_J_Cancer_2012_Jan_17_106(2)_348-357.nxml.txt.nlp	22146521	SENT98	15	15	6	6	tetracycline	TP53	PA451640	7157	0.448
NULL	Breast_Cancer_Res_2005_May_27_7(Suppl_1)_S16.nxml.txt.nlp	NULL	SENT4	13	13	27	27	tamoxifen	BCS	PA451581	617	0.448
NULL	Case_Rep_Crit_Care_2014_Aug_19_2014_242703.nxml.txt.nlp	25215245	SENT243	11	11	39	39	salbutamol	Yes	PA448068	7525	0.448
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_29_2013_590393.nxml.txt.nlp	23737838	SENT198	3	3	5	5	resveratrol	p53		7157	0.448
NULL	Mol_Cancer_2009_Nov_10_8_99.nxml.txt.nlp	19903356	SENT32	10	10	6	6	imatinib	IGFBP3	PA10804	3486	0.448
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT250	18	18	13	13	heparin	FGF1	PA449855	2246	0.448
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2013_Oct_17_6_47-61.nxml.txt.nlp	24250240	SENT236	1	1	6	6	sitagliptin	DPP4	PA164748978	1803	0.448
NULL	Biomed_Res_Int_2013_Jan_21_2013_581631.nxml.txt.nlp	23484133	SENT188	23	23	29	29	infliximab	IL23R	PA452639	149233	0.448
NULL	Arch_Toxicol_2014_Apr_2_88(5)_1109-1126.nxml.txt.nlp	24691702	SENT376	16	16	36	36	imatinib	IFN	PA10804	3439	0.447
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Aug_27_67(Pt_9)_m1269.nxml.txt.nlp	22058871	SENT68	17	17	14	14	ethanol	mol	PA448073	90527	0.447
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jul_13_67(Pt_8)_o2017-o2018.nxml.txt.nlp	22091049	SENT75	0	0	7	7	flupenthixol	mol	PA10268	90527	0.447
NULL	Oncotarget_2014_May_27_5(19)_9049-9064.nxml.txt.nlp	24979294	SENT114	40	40	42	42	dasatinib	ANOVA	PA162372878	4858	0.447
NULL	Front_Aging_Neurosci_2009_Nov_27_1_2.nxml.txt.nlp	20552053	SENT1102	0	0	2	2	nimodipine	spatial	PA450633	219793	0.447
NULL	J_Korean_Med_Sci_2009_Jan_29_24(Suppl_1)_S170-S175.nxml.txt.nlp	19194548	SENT79	5	5	7	7	cisplatin	EPO	PA449014	7076;8288;2056	0.447
NULL	Clin_Ophthalmol_2008_Dec_2(4)_897-905.nxml.txt.nlp	19668444	SENT134	7	7	9	9	latanoprost	BAK	PA164774763	578	0.447
NULL	Ann_Surg_Oncol_2011_Jan_23_18(1)_125-133.nxml.txt.nlp	20652755	SENT105	29	29	3	3	tamoxifen	pT1	PA451581	58492	0.447
NULL	Exp_Ther_Med_2014_Nov_29_8(5)_1473-1478.nxml.txt.nlp	25289044	SENT118	16	16	18	18	heparin	AZU	PA449855	566	0.447
NULL	Int_J_Endocrinol_2010_Feb_10_2010_625852.nxml.txt.nlp	20169119	SENT10	13	13	3	3	cinacalcet	PTH	PA164776671	5741	0.447
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1467-1474.nxml.txt.nlp	23708553	SENT57	22	22	14	14	ethanol	Tech	PA448073	57449	0.447
NULL	Ann_Indian_Acad_Neurol_2010_Oct-Dec_13(4)_313.nxml.txt.nlp	21264146	SENT7	0	0	18	18	mitoxantrone	IFN	PA450526	3439	0.447
NULL	Cardiovasc_Drugs_Ther_2010_Dec_13_24(5-6)_391-399.nxml.txt.nlp	20640495	SENT166	7	7	9	9	atorvastatin	DIP	PA448500	23151;1831	0.447
NULL	Mol_Cancer_2008_Mar_26_7_27.nxml.txt.nlp	18366759	SENT267	14	14	18	18	etoposide	IGFBP4	PA449552	3487	0.447
NULL	Chin_J_Cancer_2012_Apr_31(4)_178-184.nxml.txt.nlp	22237038	SENT39	5	5	17	17	niclosamide	S100A4	PA165958408	6275	0.447
NULL	Oncoimmunology_2013_Aug_1_2(8)_e25238.nxml.txt.nlp	24083080	SENT25	14	14	12	12	imiquimod	MPL	PA449972	4352	0.447
NULL	Calcif_Tissue_Int_2010_Dec_16_87(6)_485-492.nxml.txt.nlp	20953593	SENT5	10	10	15	15	teriparatide	mol	PA451620	90527	0.447
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_May_24_70(Pt_6)_o713.nxml.txt.nlp	24940283	SENT77	27	27	24	24	ethanol	mol	PA448073	90527	0.447
NULL	Hum_Genomics_2006_Jan_1_2(4)_252-257.nxml.txt.nlp	16460650	SENT94	17	17	24	24	nadh	ND4	PA164755085	4538	0.447
NULL	Case_Rep_Oncol_Med_2012_Oct_17_2012_962305.nxml.txt.nlp	23119207	SENT130	8	8	0	0	trypsin	PRSS1	PA451806	5644	0.447
NULL	Exp_Ther_Med_2013_Jan_1_5(1)_338-342.nxml.txt.nlp	23251295	SENT90	0	0	5	5	everolimus	HK2	PA164746311	3796;3099;29911;3741	0.447
NULL	Eur_J_Immunol_2014_Jun_10_44(6)_1759-1769.nxml.txt.nlp	24595810	SENT196	14	14	4	4	fludrocortisone	ANOVA	PA164743961	4858	0.447
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Sep_19_65(Pt_10)_o2495.nxml.txt.nlp	21577945	SENT58	15	15	12	12	ethanol	mol	PA448073	90527	0.447
NULL	Breast_Cancer_Res_2005_May_27_7(Suppl_1)_S16.nxml.txt.nlp	NULL	SENT5	6	6	12	12	anastrozole	IMPACT	PA448432	55364	0.447
NULL	Cancer_Cell_Int_2013_May_15_13_42.nxml.txt.nlp	23672670	SENT5	12	12	26	26	paclitaxel	p53	PA450761	7157	0.447
NULL	Biomed_Res_Int_2013_Apr_18_2013_538790.nxml.txt.nlp	23691505	SENT45	19	19	21	21	nadh	CO2	PA164755085	4513	0.447
NULL	ScientificWorldJournal_2013_Dec_26_2013_451629.nxml.txt.nlp	24453851	SENT30	16	16	13	13	ethanol	mol	PA448073	90527	0.447
NULL	Clin_Interv_Aging_2008_Sep_3(3)_453-472.nxml.txt.nlp	18982916	SENT360	13	13	15	15	rifabutin	CD4	PA451249	920	0.447
NULL	Blood_Cancer_J_2013_Apr_12_3(4)_e108.nxml.txt.nlp	23584398	SENT51	9	9	17	17	fluorescein	San	PA164746009	80218	0.447
NULL	Iran_J_Pharm_Res_2013_Winter_12(Suppl)_91-103.nxml.txt.nlp	24250677	SENT40	2	2	23	23	coumarin	VIII	PA134521193	1351	0.447
NULL	Cardiovasc_Drugs_Ther_2012_Jun_17_26(3)_245-255.nxml.txt.nlp	22592524	SENT214	2	2	4	4	fenofibrate	adiponectin	PA449594	9370	0.447
NULL	Hum_Genomics_2010_Aug_1_4(6)_402-405.nxml.txt.nlp	20846929	SENT68	48	48	42	42	debrisoquine	CYP2D6	PA452616	1565	0.447
NULL	Clin_Interv_Aging_2009_May_14_4_121-136.nxml.txt.nlp	19503775	SENT375	2	2	26	26	tamoxifen	STAR	PA451581	6770;2984	0.447
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_May_14_65(Pt_6)_o1266.nxml.txt.nlp	21583130	SENT51	13	13	10	10	ethanol	mol	PA448073	90527	0.447
NULL	Front_Psychol_2013_Oct_17_4_712.nxml.txt.nlp	24151474	SENT338	3	3	5	5	vasopressin	AVPR1A	PA451858	552	0.447
NULL	Bioinformation_2012_Jan_6_8(1)_58-64.nxml.txt.nlp	22359436	SENT36	27	27	23	23	ribavirin	IFN	PA451241	3439	0.447
NULL	J_Mol_Signal_2006_Dec_6_1_8.nxml.txt.nlp	17224083	SENT50	12	12	15	15	thrombin	Rho	PA451674	29984	0.447
NULL	Genome_Med_2010_Sep_13_2(9)_64.nxml.txt.nlp	20831840	SENT124	29	29	7	7	lipase	APOA5	PA450239	116519	0.447
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Feb_28_65(Pt_3)_o653.nxml.txt.nlp	21582301	SENT62	18	18	4	4	ethanol	mol	PA448073	90527	0.447
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Feb_5_70(Pt_3)_m82.nxml.txt.nlp	24764947	SENT59	32	32	21	21	l-valine	PF6	PA451843	200162	0.447
NULL	Breast_Cancer_Res_2008_Apr_24_10(2)_R36.nxml.txt.nlp	18435854	SENT159	37	37	12	12	fluorescein	EGF	PA164746009	1950	0.447
NULL	Mol_Biol_Cell_2013_Sep_15_24(18)_2954-2965.nxml.txt.nlp	23904267	SENT317	22	22	10	10	l-glutamine	CO2	PA10090	4513	0.447
NULL	Adolesc_Health_Med_Ther_2012_Jun_20_3_85-93.nxml.txt.nlp	24600289	SENT77	6	6	15	15	adalimumab	ACR	PA10004	49	0.447
NULL	FEBS_Open_Bio_2014_Jul_5_4_659-671.nxml.txt.nlp	25161875	SENT329	14	14	4	4	etoposide	XIAP	PA449552	331	0.447
NULL	Int_J_Vasc_Med_2012_Aug_21_2012_648167.nxml.txt.nlp	22957259	SENT72	18	18	13	13	valsartan	AT1	PA451848	9197;185	0.447
NULL	Korean_J_Anesthesiol_2013_Jan_21_64(1)_47-53.nxml.txt.nlp	23372886	SENT33	25	25	28	28	bupivacaine	IGK	PA135057240	50802	0.447
NULL	Breast_Cancer_Res_2004_Aug_5_6(5)_R601-R607.nxml.txt.nlp	15318941	SENT112	7	7	18	18	docetaxel	p27	PA449383	5715;10534	0.447
NULL	Crit_Care_2004_May_14_8(4)_R172-R179.nxml.txt.nlp	15312215	SENT22	13	13	2	2	l-cysteine	NAC	PA449173	22861	0.447
NULL	Int_J_Mol_Sci_2014_Nov_5_15(11)_20169-20208.nxml.txt.nlp	25380523	SENT212	14	14	12	12	l-carnitine	Q10	PA450154	27161	0.447
NULL	Angiogenesis_2012_Jun_2_15(2)_275-286.nxml.txt.nlp	22382585	SENT5	35	35	5	5	tegafur	CTX	PA452620	1593	0.447
NULL	F1000_Biol_Rep_2011_Nov_1_3_24.nxml.txt.nlp	22076126	SENT76	16	16	30	30	primaquine	G6PD	PA451103	2539	0.447
NULL	Apoptosis_2012_Jun_9_17(6)_566-578.nxml.txt.nlp	22402981	SENT166	39	39	35	35	pp2	PP2		4888	0.447
NULL	Case_Rep_Oncol_2010_Jun_30_4(2)_327-335.nxml.txt.nlp	21738504	SENT50	5	5	43	43	epirubicin	HCC	PA449476	84668	0.447
NULL	Onco_Targets_Ther_2014_Nov_18_7_2133-2136.nxml.txt.nlp	25429230	SENT55	5	5	11	11	verapamil	CHOP	PA451868	1649	0.447
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Nov_24_66(Pt_12)_o3298.nxml.txt.nlp	21589577	SENT61	15	15	27	27	ethanol	mol	PA448073	90527	0.447
NULL	Oncotarget_2014_Sep_10_5(19)_8924-8936.nxml.txt.nlp	25238040	SENT87	23	23	15	15	decitabine	p53	PA164749631	7157	0.447
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT179	13	13	11	11	heparin	FGF1	PA449855	2246	0.447
NULL	Anesthesiol_Res_Pract_2014_Feb_11_2014_848051.nxml.txt.nlp	24672542	SENT84	31	31	29	29	sevoflurane	NMB	PA451341	10457;4828	0.447
NULL	J_Cell_Biol_1997_Mar_10_136(5)_995-1005.nxml.txt.nlp	9060465	SENT46	17	17	2	2	dipyridamole	CPZ	PA449367	8532	0.447
NULL	J_Korean_Med_Sci_2009_Jan_29_24(Suppl_1)_S170-S175.nxml.txt.nlp	19194548	SENT94	9	9	11	11	cisplatin	EPO	PA449014	7076;8288;2056	0.447
NULL	J_Antibiot_(Tokyo)_2011_Dec_21_64(12)_759-762.nxml.txt.nlp	21934692	SENT50	22	22	33	33	phenol	CO2	PA450913	4513	0.447
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1068.nxml.txt.nlp	24556683	SENT126	11	11	5	5	pp2	CXCL13		10563	0.447
NULL	Breast_Cancer_Res_2006_Nov_6_8(6)_215.nxml.txt.nlp	17096862	SENT12	0	0	11	11	trastuzumab	PI3K	PA451743	5290	0.447
NULL	Indian_J_Psychiatry_2010_Jan_52(Suppl1)_S317-S340.nxml.txt.nlp	21836703	SENT118	29	29	15	15	triflupromazine	CPZ	PA451773	8532	0.447
NULL	Breast_Cancer_Res_2011_Nov_28_13(6)_R121.nxml.txt.nlp	22123186	SENT57	16	16	7	7	hydrocortisone	F12	PA449905	2161	0.447
NULL	Clin_Ophthalmol_2010_Oct_5_4_1137-1143.nxml.txt.nlp	20957061	SENT12	13	13	18	18	latanoprost	BAK	PA164774763	578	0.447
NULL	Oncol_Rep_2012_Sep_15_28(3)_763-767.nxml.txt.nlp	22710607	SENT116	32	32	23	23	cetuximab	PS2	PA10040	5664	0.447
NULL	Cancer_Cell_Int_2003_Jul_23_3_12.nxml.txt.nlp	12914669	SENT132	20	20	24	24	doxycycline	PP1	PA449415	5540;5464	0.447
NULL	J_Biol_Chem_2009_Sep_25_284(39)_26447-26455.nxml.txt.nlp	19633293	SENT17	0	0	8	8	hyaluronan	HAS2	PA165958431	3037	0.447
NULL	J_Gen_Physiol_1990_Dec_1_96(6)_1247-1269.nxml.txt.nlp	1962815	SENT13	11	11	5	5	amiloride	CO2	PA448368	4513	0.446
NULL	Diabetes_Care_2009_Apr_29_32(4)_541-546.nxml.txt.nlp	19114614	SENT144	21	21	27	27	estradiol	aromatase	PA449503	1588	0.446
NULL	Curr_Cardiol_Rev_2011_Nov_7(4)_245-249.nxml.txt.nlp	22758625	SENT60	27	27	31	31	vincristine	CHOP	PA451879	1649	0.446
NULL	Eur_J_Haematol_2014_Feb_25_92(2)_127-136.nxml.txt.nlp	24118452	SENT191	16	16	14	14	anagrelide	CRT	PA164742986	811	0.446
NULL	Mol_Pain_2013_Jan_2_9_1.nxml.txt.nlp	23279936	SENT59	10	10	4	4	capsaicin	TRPV1	PA448776	7442	0.446
NULL	Ann_Occup_Hyg_2010_Aug_21_54(6)_697-709.nxml.txt.nlp	20660144	SENT195	24	24	4	4	fluorescein	GK2	PA164746009	2712;2585	0.446
NULL	J_Headache_Pain_2011_Aug_29_12(4)_411-417.nxml.txt.nlp	21626018	SENT108	0	0	2	2	capsaicin	mol	PA448776	90527	0.446
NULL	Acta_Pharmacol_Sin_2010_Mar_8_31(3)_313-328.nxml.txt.nlp	20140002	SENT255	33	33	29	29	nitrogen	spatial	PA450643	219793	0.446
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jun_11_67(Pt_7)_o1640.nxml.txt.nlp	21837045	SENT68	22	22	19	19	ethanol	mol	PA448073	90527	0.446
NULL	Open_Dent_J_2014_May_30_8_109-124.nxml.txt.nlp	24976875	SENT247	23	23	30	30	doxycycline	MIDAS	PA449415	64083	0.446
NULL	Curr_Cardiol_Rev_2009_Aug_5(3)_243-250.nxml.txt.nlp	20676284	SENT37	7	7	2	2	creatine	ADP	PA164778930	23038	0.446
NULL	Case_Rep_Crit_Care_2014_Aug_19_2014_242703.nxml.txt.nlp	25215245	SENT243	11	11	38	38	salbutamol	Yes	PA448068	7525	0.446
NULL	Arthritis_Res_Ther_2006_Jun_14_8(4)_R94.nxml.txt.nlp	16774691	SENT187	9	9	35	35	atorvastatin	IL-6	PA448500	3569	0.446
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Dec_17_65(Pt_1)_m82-m83.nxml.txt.nlp	21581547	SENT73	37	37	34	34	ethanol	mol	PA448073	90527	0.446
NULL	Int_J_Mol_Sci_2014_Nov_21_15(11)_21433-21454.nxml.txt.nlp	25421240	SENT98	5	5	5	5	pp2	PP2		4888	0.446
NULL	J_Antimicrob_Chemother_2012_May_8_67(5)_1217-1223.nxml.txt.nlp	22316571	SENT29	21	21	7	7	lumefantrine	ACT	PA165111722	12;11332;9457;641455	0.446
NULL	J_Cell_Biol_1998_May_4_141(3)_715-726.nxml.txt.nlp	9566971	SENT188	8	8	6	6	heparin	perlecan	PA449855	3339	0.446
NULL	Int_J_Mol_Sci_2014_May_8_15(5)_8063-8074.nxml.txt.nlp	24815068	SENT104	9	9	2	2	ethanol	CB2	PA448073	1269	0.446
NULL	Crit_Care_2006_Jan_13_10(1)_R16.nxml.txt.nlp	16420659	SENT32	16	16	14	14	thrombin	IL-6	PA451674	3569	0.446
NULL	Oncogenesis_2014_May_12_3(5)_e102.nxml.txt.nlp	24819061	SENT95	8	8	34	34	nadh	SIRT1	PA164755085	23411	0.446
NULL	Cell_Commun_Signal_2010_Sep_22_8_27.nxml.txt.nlp	20860841	SENT152	7	7	17	17	tetracycline	Wip1	PA451640	8493	0.446
NULL	Cancer_Metastasis_Rev_2010_Sep_24_29(3)_465-482.nxml.txt.nlp	20730632	SENT317	2	2	10	10	genistein	HSP27	PA165109660	3315	0.446
NULL	Ann_Surg_Oncol_2010_Apr_20_17(4)_1168-1176.nxml.txt.nlp	19936839	SENT212	14	14	24	24	cetuximab	ACRC	PA10040	93953	0.446
NULL	Open_AIDS_J_2011_Apr_22_5_44-50.nxml.txt.nlp	21643422	SENT39	34	34	22	22	zidovudine	ATV	PA451954	4683	0.446
NULL	Eur_J_Clin_Pharmacol_2009_Dec_16_65(12)_1211-1228.nxml.txt.nlp	19756557	SENT54	12	12	40	40	infliximab	ACT	PA452639	12;11332;9457;641455	0.446
NULL	J_Korean_Med_Sci_2008_Aug_25_23(4)_657-661.nxml.txt.nlp	18756053	SENT124	13	13	7	7	estradiol	AMH	PA449503	268	0.446
NULL	Arthritis_Res_Ther_2007_Jun_29_9(Suppl_1)_S7.nxml.txt.nlp	17634146	SENT36	0	0	8	8	denosumab	RANKL	PA166048634	8600	0.446
NULL	J_Inflamm_(Lond)_2013_Aug_14_10(Suppl_1)_I1.nxml.txt.nlp	24507418	SENT151	17	17	13	13	mk-7246	CRTH2		11251	0.446
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT188	0	0	27	27	curcumin	DR5	PA151958596	8795	0.446
NULL	Virol_J_2009_Dec_1_6_213.nxml.txt.nlp	19951438	SENT210	26	26	36	36	mitomycin	TRAIL	PA450524	8743	0.446
NULL	EMBO_Mol_Med_2012_Jul_11_4(7)_577-593.nxml.txt.nlp	22496117	SENT50	4	4	2	2	clofazimine	PAP-1	PA164748759	6100	0.446
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Feb_26_67(Pt_3)_m384-m385.nxml.txt.nlp	21522303	SENT66	28	28	25	25	ethanol	mol	PA448073	90527	0.446
NULL	Oncotarget_2013_Jun_21_4(6)_923-935.nxml.txt.nlp	23798621	SENT122	5	5	3	3	trypsin	DACH1	PA451806	1602	0.446
NULL	Indian_J_Pharmacol_2013_May-Jun_45(3)_274-277.nxml.txt.nlp	23833372	SENT121	8	8	18	18	colchicine	CA1	PA449092	759	0.446
NULL	J_Korean_Med_Sci_2007_Oct_31_22(5)_815-819.nxml.txt.nlp	17982228	SENT19	32	32	21	21	hyaluronan	LFA-1	PA165958431	3683;3689	0.446
NULL	Int_J_Gen_Med_2014_Apr_11_7_193-203.nxml.txt.nlp	24748813	SENT100	6	6	10	10	ribavirin	IFN	PA451241	3439	0.446
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Dec_13_65(Pt_1)_o116.nxml.txt.nlp	21581578	SENT59	21	21	12	12	ethanol	mol	PA448073	90527	0.446
NULL	Clin_J_Gastroenterol_2013_Apr_14_6(2)_188-192.nxml.txt.nlp	23606919	SENT99	5	5	7	7	entecavir	IFN	PA164784025	3439	0.446
NULL	Br_J_Ophthalmol_2013_Aug_6_97(8)_989-993.nxml.txt.nlp	23743437	SENT114	14	14	11	11	bimatoprost	BIM	PA164748867	10018	0.446
NULL	J_Hum_Kinet_2011_Dec_25_30_65-73.nxml.txt.nlp	23487396	SENT163	40	40	36	36	creatine	IL-10	PA164778930	3586	0.446
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT17	33	33	31	31	vinorelbine	ASC	PA451881	29108	0.446
NULL	J_Korean_Med_Sci_2007_Oct_31_22(5)_883-890.nxml.txt.nlp	17982240	SENT79	12	12	19	19	thyroglobulin	TTF-1	PA164754910	7080	0.446
NULL	Mol_Cancer_2009_Aug_25_8_66.nxml.txt.nlp	19706164	SENT76	15	15	9	9	celecoxib	p53	PA448871	7157	0.446
NULL	Cancers_(Basel)_2014_Apr_16_6(2)_926-957.nxml.txt.nlp	24743778	SENT1220	0	0	2	2	arsenite	IL-6	PA452638	3569	0.446
NULL	J_Inflamm_(Lond)_2006_May_4_3_8.nxml.txt.nlp	16674821	SENT99	7	7	7	7	pp2	PP2		4888	0.446
NULL	Br_J_Cancer_2010_Jan_19_102(2)_361-368.nxml.txt.nlp	20010949	SENT47	38	38	22	22	doxorubicin	PSMB7	PA449412	5695	0.446
NULL	Contemp_Clin_Dent_2011_Oct-Dec_2(4)_278-282.nxml.txt.nlp	22346152	SENT81	4	4	9	9	potassium	GCF	PA451047	6936	0.446
NULL	Case_Rep_Hematol_2014_May_7_2014_684689.nxml.txt.nlp	24891961	SENT94	4	4	10	10	rituximab	CHOP	PA451261	1649	0.446
NULL	Autoimmune_Dis_2013_Aug_28_2013_613086.nxml.txt.nlp	24069534	SENT173	15	15	10	10	infliximab	TNFAIP3	PA452639	7128	0.446
NULL	Mol_Cancer_2010_Dec_20_9_316.nxml.txt.nlp	21172016	SENT163	7	7	20	20	heparin	CCL21	PA449855	6366	0.446
NULL	Mol_Cancer_2012_Jun_18_11_41.nxml.txt.nlp	22709873	SENT279	15	15	26	26	lapatinib	ZNF143	PA152241907	7702	0.446
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT236	9	9	27	27	amisulpride	PRL	PA162565877	5617	0.446
NULL	J_Breast_Cancer_2011_Sep_29_14(3)_167-174.nxml.txt.nlp	22031796	SENT57	16	16	10	10	trastuzumab	HSP27	PA451743	3315	0.446
NULL	Ann_Lab_Med_2012_Jul_20_32(4)_264-269.nxml.txt.nlp	22779067	SENT117	10	10	16	16	rifampin	DST	PA451250	667	0.446
NULL	Int_J_Vasc_Med_2012_Jul_24_2012_508416.nxml.txt.nlp	22888436	SENT163	16	16	43	43	rosiglitazone	PRIC285	PA451283	85441	0.446
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Nov_8_64(Pt_12)_o2280.nxml.txt.nlp	21581260	SENT64	7	7	18	18	ethanol	mol	PA448073	90527	0.446
NULL	Surg_Neurol_Int_2014_Mar_10_5(Suppl_1)_S7-S12.nxml.txt.nlp	24791221	SENT155	15	15	8	8	ceftriaxone	por	PA448866	64840	0.446
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S335-S341.nxml.txt.nlp	21525479	SENT48	21	21	11	11	rosiglitazone	IL-6	PA451283	3569	0.446
NULL	J_Invest_Dermatol_2012_Feb_13_132(2)_485-487.nxml.txt.nlp	21993562	SENT11	6	6	22	22	cisplatin	CLPTM1L	PA449014	81037	0.446
NULL	J_Gen_Physiol_2009_Jun_133(6)_603-622.nxml.txt.nlp	19468075	SENT287	20	20	34	34	amiloride	CO2	PA448368	4513	0.446
NULL	Autoimmune_Dis_2013_Aug_28_2013_613086.nxml.txt.nlp	24069534	SENT170	18	18	28	28	etanercept	TNFAIP3	PA449515	7128	0.446
NULL	J_Res_Med_Sci_2011_Sep_16(9)_1176-1182.nxml.txt.nlp	22973386	SENT7	18	18	30	30	tramadol	ACL	PA451735	47	0.446
NULL	Indian_J_Ophthalmol_2013_Jul_61(7)_329-333.nxml.txt.nlp	23571257	SENT40	9	9	14	14	methotrexate	mol	PA450428	90527	0.446
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Dec_18_67(Pt_1)_o165.nxml.txt.nlp	21522672	SENT68	23	23	20	20	ethanol	mol	PA448073	90527	0.446
NULL	J_Oncol_2012_Jun_19_2012_521215.nxml.txt.nlp	22778735	SENT76	25	25	30	30	cetuximab	p16	PA10040	1029	0.445
NULL	Exp_Ther_Med_2013_Apr_29_5(4)_1093-1096.nxml.txt.nlp	23596475	SENT29	21	21	12	12	ketamine	IL-6	PA450144	3569	0.445
NULL	Int_J_Mol_Sci_2014_Jun_5_15(6)_10083-10100.nxml.txt.nlp	24905407	SENT2	28	28	32	32	tetracycline	TRB	PA451640	6957	0.445
NULL	Angiogenesis_2009_Dec_21_12(4)_303-311.nxml.txt.nlp	19544080	SENT190	21	21	12	12	oxygen	HIF-1	PA450744	29072	0.445
NULL	Crit_Care_2010_Nov_5_14(6)_R200.nxml.txt.nlp	21054850	SENT144	2	2	14	14	vasopressin	AVP	PA451858	114548;551	0.445
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jul_31_65(Pt_8)_o2055.nxml.txt.nlp	21583717	SENT76	20	20	17	17	ethanol	mol	PA448073	90527	0.445
NULL	Chemother_Res_Pract_2011_Dec_1_2011_715469.nxml.txt.nlp	22312557	SENT106	30	30	8	8	cisplatin	p53	PA449014	7157	0.445
NULL	Cell_Death_Dis_2013_Oct_3_4(10)_e827.nxml.txt.nlp	24091670	SENT87	3	3	18	18	nilotinib	CD38	PA165958345	952	0.445
NULL	Mol_Pain_2014_Apr_9_10_24.nxml.txt.nlp	24716552	SENT216	28	28	40	40	isoflurane	P21	PA450106	1026;9338	0.445
NULL	Breast_Cancer_(Auckl)_2008_Mar_26_1_25-34.nxml.txt.nlp	21655370	SENT210	31	31	7	7	estradiol	GIRK1	PA449503	3760	0.445
NULL	Br_J_Cancer_2009_May_19_100(10)_1540-1548.nxml.txt.nlp	19384300	SENT142	16	16	25	25	trypsin	TATI	PA451806	6690	0.445
NULL	Indian_J_Pharm_Sci_2014_Nov-Dec_76(6)_483-494.nxml.txt.nlp	25593381	SENT122	8	8	6	6	atorvastatin	ANOVA	PA448500	4858	0.445
NULL	Acta_Pharmacol_Sin_2011_May_25_32(5)_573-580.nxml.txt.nlp	21516134	SENT143	5	5	25	25	iptakalim	MCP-1	PA165949694	6347	0.445
NULL	Arthritis_Rheumatol_2014_Jun_27_66(6)_1574-1582.nxml.txt.nlp	24577881	SENT45	29	29	34	34	hydralazine	NAC	PA449894	22861	0.445
NULL	Br_J_Cancer_2010_Jan_19_102(2)_383-391.nxml.txt.nlp	20010943	SENT85	7	7	21	21	cisplatin	P31	PA449014	529	0.445
NULL	J_Asthma_Allergy_2013_Jul_1_6_93-101.nxml.txt.nlp	23843695	SENT199	19	19	2	2	formoterol	ACT	PA134687907	12;11332;9457;641455	0.445
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Mar_10_66(Pt_4)_o790.nxml.txt.nlp	21580629	SENT58	18	18	15	15	ethanol	mol	PA448073	90527	0.445
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_P64.nxml.txt.nlp	NULL	SENT16	32	32	30	30	ceftriaxone	PPL	PA448866	5493	0.445
NULL	Front_Physiol_2011_Dec_20_2_103.nxml.txt.nlp	22194726	SENT13	28	28	32	32	hyaluronan	LYVE1	PA165958431	10894	0.445
NULL	Cells_2012_Dec_13_1(4)_1261-1292.nxml.txt.nlp	24710554	SENT124	41	41	27	27	heparin	EGF	PA449855	1950	0.445
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT49	4	4	10	10	tamoxifen	p27	PA451581	5715;10534	0.445
NULL	Arch_Med_Sci_2010_Aug_30_6(4)_545-551.nxml.txt.nlp	22371798	SENT58	8	8	18	18	ethanol	TRAIL	PA448073	8743	0.445
NULL	Indian_J_Dermatol_2013_May-Jun_58(3)_197-199.nxml.txt.nlp	23723470	SENT6	13	13	17	17	minocycline	ROM	PA450519	6094	0.445
NULL	Nat_Commun_2013_Sep_17_4_2464.nxml.txt.nlp	24043118	SENT43	1	1	3	3	estradiol	FGFR2	PA449503	2263	0.445
NULL	Open_Biol_2013_Mar_3(3)_120186.nxml.txt.nlp	23536550	SENT244	14	14	18	18	lipase	NDR	PA450239	11329;55363	0.445
NULL	Mol_Vis_2010_Oct_13_16_2071-2083.nxml.txt.nlp	21042564	SENT121	23	23	9	9	fluorescein	CD16	PA164746009	2215;2214	0.445
NULL	Acta_Pharmacol_Sin_2010_Nov_18_31(11)_1447-1453.nxml.txt.nlp	20953204	SENT110	32	32	29	29	rimonabant	RANTES	PA152407999	6352	0.445
NULL	Neuroscience_2008_Sep_22_156(1)_175-183.nxml.txt.nlp	18694808	SENT408	9	9	9	9	pp2	PP2		4888	0.445
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_May_26_68(Pt_6)_o1909-o1910.nxml.txt.nlp	22719664	SENT80	0	0	16	16	ethanol	mol	PA448073	90527	0.445
NULL	Int_J_Chron_Obstruct_Pulmon_Dis_2008_Jun_3(2)_253-268.nxml.txt.nlp	18686734	SENT330	13	13	22	22	thrombin	PAR-1	PA451674	2011;2149	0.445
NULL	Diabetes_Metab_J_2012_Jun_14_36(3)_167-180.nxml.txt.nlp	22737656	SENT105	3	3	18	18	rosiglitazone	SH3KBP1	PA451283	30011	0.445
NULL	Blood_Cancer_J_2014_Feb_14_4(2)_e184.nxml.txt.nlp	24531447	SENT108	23	23	13	13	rituximab	IFN	PA451261	3439	0.445
NULL	Anal_Bioanal_Chem_2009_Oct_30_395(4)_893-905.nxml.txt.nlp	19484227	SENT186	6	6	8	8	sulfadimethoxine	OTC	PA165958357	5009	0.445
NULL	Cancer_Cell_Int_2011_Sep_9_11_31.nxml.txt.nlp	21906315	SENT55	4	4	10	10	tamoxifen	p27	PA451581	5715;10534	0.445
NULL	Crit_Care_2010_Dec_20_14(6)_R226.nxml.txt.nlp	21171991	SENT122	15	15	21	21	metformin	SAPS	PA450395	8935	0.445
NULL	Front_Genet_2012_Nov_5_3_236.nxml.txt.nlp	23133441	SENT38	15	15	10	10	efavirenz	ABCB1	PA449441	5243	0.445
NULL	Arthritis_Res_Ther_2014_Oct_29_16(5)_469.nxml.txt.nlp	25606596	SENT224	18	18	23	23	abatacept	CD154	PA164747080	959	0.445
NULL	Springerplus_2013_Jul_3_2_299.nxml.txt.nlp	23888270	SENT184	23	23	26	26	nadh	SDHB	PA164755085	6390	0.445
NULL	Leukemia_2014_Jun_17_28(6)_1216-1226.nxml.txt.nlp	24301524	SENT96	0	0	13	13	bortezomib	p50	PA10252	958;4790	0.445
NULL	Interdiscip_Toxicol_2011_Dec_4(4)_211-215.nxml.txt.nlp	22319256	SENT99	2	2	17	17	diazepam	ANOVA	PA449283	4858	0.445
NULL	J_Cell_Mol_Med_2015_Jan_8_19(1)_82-91.nxml.txt.nlp	25381905	SENT102	10	10	31	31	collagenase	CO2	PA449107	4513	0.445
NULL	Expert_Rev_Anti_Infect_Ther_2013_Dec_11_11(12)_1303-1332.nxml.txt.nlp	24191955	SENT421	7	7	16	16	azithromycin	STD	PA448519	7535	0.445
NULL	Breast_Cancer_Res_2010_Aug_23_12(4)_R64.nxml.txt.nlp	20731819	SENT341	15	15	9	9	debrisoquine	CYP2D6	PA452616	1565	0.445
NULL	Front_Neuroeng_2013_Nov_19_6_10.nxml.txt.nlp	24312049	SENT530	2	2	11	11	carbamazepine	CA1	PA448785	759	0.445
NULL	Eur_J_Clin_Pharmacol_2008_Feb_26_64(2)_133-157.nxml.txt.nlp	18224312	SENT544	45	45	38	38	trimipramine	CYP2D6	PA451791	1565	0.445
NULL	Oxid_Med_Cell_Longev_2014_Dec_9_2014_425496.nxml.txt.nlp	25574337	SENT626	0	0	17	17	resveratrol	GRP75		3313	0.445
NULL	Nat_Commun_2014_Nov_25_5_5437.nxml.txt.nlp	25421715	SENT467	5	5	3	3	cisplatin	zeta	PA449014	9907	0.445
NULL	Carcinogenesis_2014_May_13_35(5)_1055-1066.nxml.txt.nlp	24419232	SENT102	23	23	16	16	heparin	VEGF-A	PA449855	7422	0.445
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT1699	0	0	2	2	atazanavir	ATV	PA10251	4683	0.445
NULL	Cancer_Cell_Int_2013_Jun_26_13_63.nxml.txt.nlp	23800022	SENT227	12	12	6	6	genistein	AKT	PA165109660	207	0.445
NULL	Eur_Respir_J_2013_May_27_41(5)_1107-1115.nxml.txt.nlp	23018904	SENT5	19	19	25	25	ciprofloxacin	DPI	PA449009	1832	0.445
NULL	ScientificWorldJournal_2014_May_19_2014_567148.nxml.txt.nlp	24971383	SENT261	0	0	5	5	epirubicin	MRP-1	PA449476	928	0.445
NULL	Int_J_Med_Chem_2012_Sep_25_2012_196921.nxml.txt.nlp	25374683	SENT155	17	17	13	13	l-glutamine	FBS	PA10090	64319;26269	0.445
NULL	Am_J_Physiol_Endocrinol_Metab_2010_Feb_17_298(2)_E278-E286.nxml.txt.nlp	19920213	SENT196	4	4	25	25	pioglitazone	ERK1	PA450970	5595	0.445
NULL	Oncotarget_2012_Aug_9_3(8)_774-782.nxml.txt.nlp	22885298	SENT39	15	15	6	6	tetracycline	IDH1	PA451640	3417	0.445
NULL	Exp_Gerontol_2010_Aug_45(7-8)_573-579.nxml.txt.nlp	20096767	SENT66	32	32	11	11	ethanol	PEN	PA448073	9933	0.445
NULL	Oncol_Rep_2012_Sep_26_28(3)_777-784.nxml.txt.nlp	22751903	SENT141	18	18	10	10	celecoxib	MVD	PA448871	4597	0.445
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT27	10	10	12	12	perifosine	TRAIL	PA165291471	8743	0.445
NULL	Exp_Ther_Med_2014_Nov_29_8(5)_1473-1478.nxml.txt.nlp	25289044	SENT94	2	2	4	4	heparin	AZU	PA449855	566	0.445
NULL	Br_J_Cancer_2012_Jun_5_106(12)_1901-1906.nxml.txt.nlp	22596239	SENT139	22	22	12	12	imatinib	CXCR4	PA10804	7852	0.445
NULL	Int_Cardiovasc_Res_J_2014_Sep_1_8(3)_89-93.nxml.txt.nlp	25177670	SENT86	13	13	15	15	enalapril	IL-6	PA449456	3569	0.445
NULL	Cancer_Immunol_Immunother_2015_Oct_7_64_61-73.nxml.txt.nlp	25287778	SENT220	34	34	11	11	lenalidomide	CD56	PA162363968	4684	0.445
NULL	Cancers_(Basel)_2011_Apr_1_3(2)_1844-1860.nxml.txt.nlp	24212785	SENT76	19	19	25	25	oxaliplatin	ACRC	PA131285527	93953	0.445
NULL	J_Biomed_Sci_2014_Feb_3_21(1)_10.nxml.txt.nlp	24490900	SENT119	10	10	12	12	alendronate	RANKL	PA448082	8600	0.445
NULL	Chem_Res_Toxicol_2011_Aug_15_24(8)_1275-1282.nxml.txt.nlp	21749116	SENT254	16	16	13	13	geldanamycin	Hsp90	PA152031327	3320	0.445
NULL	Cardiovasc_Diabetol_2013_Jun_7_12_84.nxml.txt.nlp	23759020	SENT161	15	15	0	0	dipyridamole	LSR	PA449367	51599	0.445
NULL	Indian_J_Med_Paediatr_Oncol_2014_Apr-Jun_35(2)_176-180.nxml.txt.nlp	25197183	SENT14	11	11	18	18	bevacizumab	EGFR	PA130232992	1956	0.445
NULL	ScientificWorldJournal_2013_Oct_24_2013_726912.nxml.txt.nlp	24282387	SENT101	19	19	23	23	fluorescein	AVP	PA164746009	114548;551	0.445
NULL	J_Phys_Ther_Sci_2013_Oct_20_25(10)_1317-1319.nxml.txt.nlp	24259784	SENT15	11	11	15	15	oxygen	ADP	PA450744	23038	0.445
NULL	Mol_Vis_2011_Feb_25_17_598-606.nxml.txt.nlp	21386923	SENT163	9	9	2	2	collagenase	MMP9	PA449107	4318	0.444
NULL	Iran_Red_Crescent_Med_J_2014_Aug_5_16(8)_e13079.nxml.txt.nlp	25389473	SENT141	13	13	6	6	meperidine	AAP	PA450369	5345	0.444
NULL	Exp_Transl_Stroke_Med_2010_Jul_20_2_14.nxml.txt.nlp	20646278	SENT0	14	14	28	28	potassium	KCNK9	PA451047	51305	0.444
NULL	J_Adv_Pract_Oncol_2013_Sep_1_Sep-Oct_4(5)_307-321.nxml.txt.nlp	25032010	SENT49	14	14	40	40	bortezomib	San	PA10252	80218	0.444
NULL	Iran_J_Basic_Med_Sci_2013_Apr_16(4)_610-614.nxml.txt.nlp	24250937	SENT22	7	7	0	0	coumarin	CYP2A6	PA134521193	1548	0.444
NULL	Br_J_Cancer_2010_Feb_16_102(4)_658-664.nxml.txt.nlp	20104222	SENT155	34	34	36	36	sunitinib	IFN	PA162372840	3439	0.444
NULL	Nat_Med_2014_Jun_11_20(6)_616-623.nxml.txt.nlp	24813252	SENT63	14	14	8	8	galactose	TAZ	PA449725	25937;6901	0.444
NULL	Bioinformatics_2013_Feb_1_29(3)_338-346.nxml.txt.nlp	23271269	SENT189	13	13	8	8	galactose	GAL	PA449725	51083	0.444
NULL	Biosensors_(Basel)_2013_Jun_28_3(3)_238-258.nxml.txt.nlp	25506422	SENT326	1	1	6	6	etoposide	p53	PA449552	7157	0.444
NULL	J_Clin_Gastroenterol_2014_Jul_24_48(6)_513-523.nxml.txt.nlp	24275714	SENT98	32	32	41	41	fluorescein	San	PA164746009	80218	0.444
NULL	Diagn_Pathol_2014_Jan_20_9_11.nxml.txt.nlp	24443801	SENT9	23	23	26	26	chymotrypsin	CDX2	PA448994	1045	0.444
NULL	Indian_J_Psychiatry_2010_Jan_52(Suppl1)_S317-S340.nxml.txt.nlp	21836703	SENT115	26	26	8	8	triflupromazine	TFP	PA451773	7034	0.444
NULL	Clin_Proteomics_2014_Sep_24_11(1)_35.nxml.txt.nlp	25379033	SENT237	14	14	18	18	trypsin	AMBP	PA451806	259	0.444
NULL	Mucosal_Immunol_2012_Mar_14_5(2)_150-160.nxml.txt.nlp	22166938	SENT195	18	18	22	22	collagenase	VIII	PA449107	1351	0.444
NULL	Oncotarget_2014_Mar_13_5(4)_1101-1110.nxml.txt.nlp	24658355	SENT2	29	29	26	26	tamoxifen	MKP-2	PA451581	1846	0.444
NULL	J_Vet_Med_Sci_2014_Aug_15_76(8)_1119-1127.nxml.txt.nlp	24829081	SENT121	23	23	14	14	trypsin	fractalkine	PA451806	6376	0.444
NULL	Oncol_Lett_2013_Mar_8_5(3)_805-812.nxml.txt.nlp	23426281	SENT167	12	12	10	10	gemcitabine	B7-H3	PA449748	80381	0.444
NULL	Crit_Care_2008_Aug_29_12(4)_R111.nxml.txt.nlp	18759963	SENT151	16	16	13	13	tirofiban	PAC-1	PA451698	1844	0.444
NULL	Diabetes_2009_Jul_28_58(7)_1518-1525.nxml.txt.nlp	19401427	SENT193	18	18	5	5	lisinopril	HMGCR	PA450242	3156	0.444
NULL	Int_J_Biol_Sci_2013_Aug_14_9(8)_766-777.nxml.txt.nlp	23983610	SENT25	38	38	24	24	curcumin	B19	PA151958596	59271	0.444
NULL	Diabetes_Care_2009_Apr_32(4)_531-540.nxml.txt.nlp	19336638	SENT284	11	11	15	15	clopidogrel	P2Y12	PA449053	64805	0.444
NULL	Orphanet_J_Rare_Dis_2014_Dec_18_9(1)_199.nxml.txt.nlp	NULL	SENT9	21	21	1	1	baclofen	CMT1A	PA448533	1248	0.444
NULL	J_Cell_Biol_1997_Jun_16_137(6)_1229-1241.nxml.txt.nlp	9182658	SENT154	9	9	11	11	glucosamine	MUC1	PA164747613	4582	0.444
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1699-1708.nxml.txt.nlp	19861960	SENT80	8	8	5	5	dasatinib	mol	PA162372878	90527	0.444
NULL	Arthritis_Res_Ther_2009_Apr_30_11(2)_R58.nxml.txt.nlp	19405951	SENT133	7	7	10	10	alendronate	RANKL	PA448082	8600	0.444
NULL	Breast_Cancer_Res_2012_Apr_26_14(2)_R69.nxml.txt.nlp	22537934	SENT197	30	30	28	28	tamoxifen	RAD21	PA451581	5885	0.444
NULL	Nat_Methods_2011_Jun_24_8(6)_487-493.nxml.txt.nlp	21516115	SENT161	22	22	20	20	gefitinib	EGF	PA131301952	1950	0.444
NULL	J_Korean_Med_Sci_2009_Jan_29_24(Suppl_1)_S170-S175.nxml.txt.nlp	19194548	SENT81	3	3	9	9	cisplatin	EPO	PA449014	7076;8288;2056	0.444
NULL	ScientificWorldJournal_2013_Oct_24_2013_726912.nxml.txt.nlp	24282387	SENT11	13	13	24	24	fluorescein	AVP	PA164746009	114548;551	0.444
NULL	Acta_Pharmacol_Sin_2011_Jun_30_32(6)_853-860.nxml.txt.nlp	21623392	SENT28	30	30	22	22	capsaicin	TRPV1	PA448776	7442	0.444
NULL	Aging_(Albany_NY)_2010_Dec_14_2(12)_945-958.nxml.txt.nlp	21164223	SENT181	7	7	24	24	metformin	HER-2	PA450395	2064	0.444
NULL	Cancer_Cell_Int_2004_May_17_4_4.nxml.txt.nlp	15147581	SENT39	10	10	19	19	sulindac	NF1	PA451565	4763	0.444
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT157	9	9	9	9	pp2	PP2		4888	0.444
NULL	Case_Rep_Gastroenterol_2011_Nov_9_5(3)_642-647.nxml.txt.nlp	22171216	SENT40	12	12	10	10	cyclophosphamide	CHOP	PA449165	1649	0.444
NULL	Arthritis_Res_Ther_2005_Apr_28_7(4)_R844-R851.nxml.txt.nlp	15987486	SENT21	18	18	21	21	oxygen	ROS	PA450744	6098	0.444
NULL	Front_Neurosci_2013_Jan_10_6_194.nxml.txt.nlp	23335876	SENT477	9	9	4	4	methylphenidate	DRD4	PA450464	1815	0.444
NULL	Patient_Prefer_Adherence_2010_Oct_5_4_369-377.nxml.txt.nlp	21049089	SENT174	22	22	2	2	ziprasidone	DAI	PA451974	81030	0.444
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT192	41	41	8	8	erlotinib	Yes	PA134687924	7525	0.444
NULL	J_Hematol_Oncol_2008_Oct_23_1_19.nxml.txt.nlp	18947412	SENT114	0	0	4	4	alemtuzumab	CD34	PA164783958	947	0.444
NULL	Oncotarget_2012_May_19_3(5)_535-545.nxml.txt.nlp	22619121	SENT101	9	9	11	11	topotecan	MYCN	PA451729	4613	0.444
NULL	Int_J_Mol_Sci_2012_Apr_23_13(4)_5074-5097.nxml.txt.nlp	22606031	SENT56	6	6	30	30	ethanol	ANOVA	PA448073	4858	0.444
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2619-2628.nxml.txt.nlp	24129235	SENT286	22	22	2	2	oxaliplatin	GEM	PA131285527	2669	0.444
NULL	Clin_Exp_Gastroenterol_2012_May_14_5_49-59.nxml.txt.nlp	22649281	SENT102	3	3	9	9	esomeprazole	CYP2C19	PA10075	1557	0.444
NULL	J_Parasitol_Res_2011_Oct_9_2011_174614.nxml.txt.nlp	22007287	SENT19	3	3	6	6	oxygen	ROS	PA450744	6098	0.444
NULL	Clin_Mol_Hepatol_2013_Sep_30_19(3)_195-209.nxml.txt.nlp	24133659	SENT296	22	22	29	29	tenofovir	LAM	PA10204	7249;7248	0.444
NULL	Int_J_Hypertens_2014_Jan_12_2014_381082.nxml.txt.nlp	24678415	SENT172	2	2	5	5	cinacalcet	FGF23	PA164776671	8074	0.444
NULL	J_Gen_Physiol_1993_Aug_1_102(2)_257-275.nxml.txt.nlp	8228911	SENT0	14	14	1	1	isoproterenol	Gen	PA450121	348654	0.444
NULL	J_Antimicrob_Chemother_2012_Feb_17_67(2)_404-414.nxml.txt.nlp	22101217	SENT135	22	22	12	12	levofloxacin	EMB	PA450214	133418	0.444
NULL	Cell_Death_Dis_2014_Jul_3_5(7)_e1316.nxml.txt.nlp	24991768	SENT67	0	0	2	2	pemetrexed	Mcl-1	PA10810	4170	0.444
NULL	J_Korean_Med_Sci_2010_Dec_24_25(12)_1766-1770.nxml.txt.nlp	21165292	SENT52	28	28	9	9	glucose	GFR	PA449773	9771	0.444
NULL	Orphanet_J_Rare_Dis_2014_Dec_24_9(1)_213.nxml.txt.nlp	NULL	SENT132	16	16	2	2	thrombin	ADP	PA451674	23038	0.444
NULL	J_Oncol_2010_Dec_24_2010_497429.nxml.txt.nlp	20066162	SENT178	12	12	4	4	doxorubicin	GEM	PA449412	2669	0.444
NULL	ACS_Nano_2014_Aug_26_8(8)_8407-8418.nxml.txt.nlp	25050455	SENT0	9	9	0	0	copper	ACS	PA449114	55902;84680	0.444
NULL	Nutr_J_2014_Jan_24_13_11.nxml.txt.nlp	24461029	SENT12	28	28	31	31	curcumin	CTR	PA151958596	799	0.444
NULL	Appl_Microbiol_Biotechnol_2013_Aug_16_97(18)_7999-8009.nxml.txt.nlp	23948723	SENT73	26	26	24	24	glucose	mol	PA449773	90527	0.444
NULL	Biomed_Res_Int_2013_Sep_4_2013_419176.nxml.txt.nlp	24093097	SENT184	12	12	28	28	sunitinib	IFN	PA162372840	3439	0.444
NULL	Diabetes_Care_2011_Jun_20_34(6)_1265-1269.nxml.txt.nlp	21515846	SENT3	8	8	26	26	ramipril	DREAM	PA451223	30818	0.444
NULL	Nucleic_Acids_Res_2013_Mar_26_41(5)_e60.nxml.txt.nlp	23275569	SENT29	11	11	8	8	chloramphenicol	MRF	PA448927	745	0.444
NULL	EMBO_Mol_Med_2013_Aug_5_5(8)_1149-1150.nxml.txt.nlp	23918227	SENT17	1	1	3	3	rituximab	CHOP	PA451261	1649	0.444
NULL	Genome_Biol_2011_May_25_12(5)_R46.nxml.txt.nlp	21609475	SENT130	3	3	10	10	etoposide	CCND1	PA449552	595	0.444
NULL	Breast_Cancer_Res_2011_Nov_28_13(6)_R121.nxml.txt.nlp	22123186	SENT58	26	26	7	7	hydrocortisone	F12	PA449905	2161	0.444
NULL	Biochem_Res_Int_2012_Feb_12_2012_346972.nxml.txt.nlp	22400115	SENT118	22	22	5	5	hyaluronan	CD44	PA165958431	960	0.444
NULL	J_Cell_Biol_2000_Feb_7_148(3)_591-602.nxml.txt.nlp	10662783	SENT431	8	8	5	5	heparin	CD9	PA449855	928	0.444
NULL	Thorax_2009_Aug_12_64(8)_671-676.nxml.txt.nlp	19213775	SENT175	10	10	12	12	formoterol	NF-kappaB	PA134687907	4790	0.444
NULL	Contemp_Clin_Dent_2011_Oct-Dec_2(4)_278-282.nxml.txt.nlp	22346152	SENT83	7	7	12	12	potassium	GCF	PA451047	6936	0.444
NULL	Diabetes_2011_Jul_20_60(7)_1990-1999.nxml.txt.nlp	21617181	SENT188	20	20	27	27	geldanamycin	STAT3	PA152031327	6774	0.444
NULL	Diabetes_Metab_Syndr_Obes_2013_Sep_2_6_317-325.nxml.txt.nlp	24039439	SENT89	5	5	22	22	voglibose	GLP-1	PA164752433	100125288	0.444
NULL	Zookeys_2014_Nov_25_(457)_1-14.nxml.txt.nlp	25561827	SENT111	36	36	15	15	ethanol	San	PA448073	80218	0.444
NULL	Asian-Australas_J_Anim_Sci_2013_Oct_26(10)_1416-1423.nxml.txt.nlp	25049725	SENT17	17	17	21	21	ethanol	CO2	PA448073	4513	0.444
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Dec_13_65(Pt_1)_o116.nxml.txt.nlp	21581578	SENT59	21	21	27	27	ethanol	mol	PA448073	90527	0.444
NULL	Clin_Ophthalmol_2014_Jun_3_8_1057-1064.nxml.txt.nlp	24940042	SENT110	38	38	25	25	bevacizumab	CST	PA130232992	9514	0.444
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT163	7	7	26	26	didanosine	Ray	PA449301	26751	0.444
NULL	Int_J_Biol_Sci_2014_Aug_23_10(8)_921-939.nxml.txt.nlp	25170305	SENT305	11	11	0	0	nadh	EPO	PA164755085	7076;8288;2056	0.444
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Apr_15_9_13.nxml.txt.nlp	20398300	SENT134	2	2	0	0	lansoprazole	LAM	PA450180	7249;7248	0.443
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT319	34	34	18	18	sulpiride	PRL	PA164745485	5617	0.443
NULL	J_Mol_Signal_2011_Oct_5_6_13.nxml.txt.nlp	21975218	SENT210	30	30	14	14	ethanol	FBS	PA448073	64319;26269	0.443
NULL	J_Health_Popul_Nutr_2011_Jun_29(3)_183-190.nxml.txt.nlp	21766553	SENT139	19	19	9	9	l-isoleucine	HBD-2	PA164750430	1673	0.443
NULL	Crit_Care_2008_Oct_14_12(5)_227.nxml.txt.nlp	18983707	SENT98	3	3	0	0	vasopressin	AVP	PA451858	114548;551	0.443
NULL	Front_Genet_2013_Aug_29_4_163.nxml.txt.nlp	24009622	SENT140	1	1	3	3	ethanol	DDP	PA448073	1678	0.443
NULL	Clin_Mol_Allergy_2010_Nov_1_8_14.nxml.txt.nlp	21040557	SENT20	16	16	10	10	amiloride	HNMT	PA448368	3176	0.443
NULL	J_Gen_Physiol_1955_Jul_20_38(6)_757-769.nxml.txt.nlp	13242762	SENT0	19	19	1	1	trypsin	Gen	PA451806	348654	0.443
NULL	Int_J_Mol_Sci_2014_Sep_25_15(9)_17065-17076.nxml.txt.nlp	25257528	SENT19	5	5	7	7	decitabine	DAC	PA164749631	13	0.443
NULL	Int_J_Biomed_Imaging_2013_Feb_26_2013_230487.nxml.txt.nlp	23533377	SENT105	1	1	20	20	estradiol	FES	PA449503	2242	0.443
NULL	Nat_Commun_2013_Oct_1_4_2516.nxml.txt.nlp	24084631	SENT68	17	17	9	9	losartan	AK4	PA450268	205	0.443
NULL	J_Radiat_Res_2014_Mar_26_55(2)_205-209.nxml.txt.nlp	23979075	SENT74	8	8	10	10	tacrolimus	CD25	PA451578	3669;3559	0.443
NULL	Oncoimmunology_2014_Jun_3_3_e29030.nxml.txt.nlp	25083328	SENT190	22	22	36	36	gemcitabine	SLA	PA449748	6503;51091	0.443
NULL	Environ_Health_Perspect_2008_Jan_5_116(1)_1-6.nxml.txt.nlp	18197291	SENT146	45	45	19	19	arsenite	p85	PA452638	5296;5295;54776;23368	0.443
NULL	Arthritis_Res_Ther_2014_Sep_18_16(5)_427.nxml.txt.nlp	25230745	SENT145	2	2	21	21	bevacizumab	MMP3	PA130232992	4314	0.443
NULL	Oncol_Lett_2013_Apr_22_5(4)_1140-1148.nxml.txt.nlp	23599753	SENT131	30	30	10	10	docetaxel	ANOVA	PA449383	4858	0.443
NULL	Acta_Pharmacol_Sin_2010_Nov_18_31(11)_1447-1453.nxml.txt.nlp	20953204	SENT137	2	2	4	4	rimonabant	adiponectin	PA152407999	9370	0.443
NULL	Cell_Death_Dis_2014_Mar_13_5(3)_e1118.nxml.txt.nlp	24625977	SENT301	18	18	13	13	etoposide	UBXN2A	PA449552	165324	0.443
NULL	Nat_Commun_2011_Aug_9_2_420.nxml.txt.nlp	21829182	SENT67	16	16	35	35	helium	mol	PA449848	90527	0.443
NULL	Cell_Death_Dis_2014_Mar_13_5(3)_e1118.nxml.txt.nlp	24625977	SENT81	36	36	24	24	etoposide	mot-2	PA449552	3313	0.443
NULL	Front_Immunol_2013_May_15_4_116.nxml.txt.nlp	23720663	SENT307	14	14	11	11	daclizumab	CD25	PA164764446	3669;3559	0.443
NULL	Evid_Based_Complement_Alternat_Med_2012_Aug_2_2012_747020.nxml.txt.nlp	22919420	SENT54	36	36	11	11	estradiol	PTH	PA449503	5741	0.443
NULL	Br_J_Cancer_2012_Feb_28_106(5)_896-903.nxml.txt.nlp	22294186	SENT229	18	18	2	2	oxaliplatin	BCL7C	PA131285527	9274	0.443
NULL	Viruses_2013_Mar_22_5(3)_998-1022.nxml.txt.nlp	23524390	SENT163	16	16	19	19	oxygen	ROS	PA450744	6098	0.443
NULL	Br_J_Cancer_2009_Jun_2_100(11)_1739-1745.nxml.txt.nlp	19436299	SENT104	12	12	14	14	everolimus	FDG	PA164746311	23583	0.443
NULL	Drug_Target_Insights_2007_Oct_30_2_239-247.nxml.txt.nlp	21901078	SENT23	9	9	28	28	rituximab	CD152	PA451261	1493	0.443
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Nov_21_70(Pt_12)_562-565.nxml.txt.nlp	25552993	SENT33	10	10	6	6	phenol	mol	PA450913	90527	0.443
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Feb_9_69(Pt_3)_o362.nxml.txt.nlp	23476552	SENT3	32	32	34	34	ethanol	mol	PA448073	90527	0.443
NULL	Virol_J_2010_Nov_27_7_349.nxml.txt.nlp	21110887	SENT131	48	48	14	14	streptomycin	CO2	PA451512	4513	0.443
NULL	J_Asthma_Allergy_2009_Jul_30_2_63-72.nxml.txt.nlp	21437145	SENT177	21	21	27	27	fluticasone/salmeterol	DPI	PA165290926	1832	0.443
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_6_2012_570948.nxml.txt.nlp	23193424	SENT154	12	12	38	38	fenofibrate	CD36	PA449594	948	0.443
NULL	J_Korean_Med_Sci_2010_Nov_26_25(11)_1683-1687.nxml.txt.nlp	21060764	SENT56	13	13	11	11	thyroglobulin	TTF-1	PA164754910	7080	0.443
NULL	J_Asthma_Allergy_2013_Jul_1_6_93-101.nxml.txt.nlp	23843695	SENT199	10	10	2	2	budesonide	ACT	PA448681	12;11332;9457;641455	0.443
NULL	Oncotarget_2013_Nov_23_5(1)_196-210.nxml.txt.nlp	24344116	SENT108	11	11	5	5	doxorubicin	p65	PA449412	5970	0.443
NULL	Environ_Health_Perspect_2010_Jul_3_118(7)_936-942.nxml.txt.nlp	20199942	SENT199	27	27	12	12	arsenite	mot-2	PA452638	3313	0.443
NULL	Indian_J_Psychiatry_2010_Jan_52(Suppl1)_S317-S340.nxml.txt.nlp	21836703	SENT117	18	18	16	16	thiothixene	TFP	PA451669	7034	0.443
NULL	Acta_Myol_2011_Oct_30(2)_121-126.nxml.txt.nlp	22106715	SENT92	24	24	22	22	nadh	SDH	PA164755085	1757;10993	0.443
NULL	Iran_J_Basic_Med_Sci_2011_Jul-Aug_14(4)_308-317.nxml.txt.nlp	23492971	SENT86	11	11	23	23	vinblastine	P-gp	PA451877	5243	0.443
NULL	J_Carcinog_2013_Dec_31_12_22.nxml.txt.nlp	24574860	SENT6	14	14	32	32	gefitinib	EML4	PA131301952	27436	0.443
NULL	EPMA_J_2013_Jun_7_4(1)_14.nxml.txt.nlp	23742177	SENT1059	16	16	18	18	dorzolamide	OBF	PA164748765	284359	0.443
NULL	Oxid_Med_Cell_Longev_2013_Sep_17_2013_521563.nxml.txt.nlp	24163720	SENT229	43	43	40	40	vasopressin	AVP	PA451858	114548;551	0.443
NULL	Diabetes_2009_Apr_9_58(4)_855-866.nxml.txt.nlp	19136649	SENT10	11	11	13	13	lipase	ATGL	PA450239	57104	0.443
NULL	Amino_Acids_2011_May_30_40(5)_1271-1296.nxml.txt.nlp	21448658	SENT12	7	7	10	10	oxygen	ROS	PA450744	6098	0.443
NULL	Sci_Rep_2014_Nov_20_4_7049.nxml.txt.nlp	25412229	SENT163	4	4	9	9	vasopressin	AVPR1A	PA451858	552	0.443
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Feb_17_68(Pt_3)_o736.nxml.txt.nlp	22412616	SENT66	31	31	28	28	ethanol	mol	PA448073	90527	0.443
NULL	Int_J_Mol_Sci_2014_Jun_5_15(6)_10034-10051.nxml.txt.nlp	24905404	SENT35	6	6	12	12	doxorubicin	Bcl-2	PA449412	596	0.443
NULL	AIDS_Res_Ther_2015_Jan_17_12(1)_1.nxml.txt.nlp	NULL	SENT0	17	17	24	24	raltegravir	MAI		2954	0.443
NULL	Br_J_Haematol_2014_Feb_16_164(4)_586-596.nxml.txt.nlp	24236640	SENT161	27	27	25	25	carboplatin	EPO	PA448803	7076;8288;2056	0.443
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_May_31_70(Pt_6)_m238-m239.nxml.txt.nlp	24940217	SENT9	2	2	4	4	nitrile	mol	PA450636	90527	0.443
NULL	Case_Rep_Crit_Care_2014_Aug_19_2014_242703.nxml.txt.nlp	25215245	SENT243	11	11	45	45	salbutamol	Yes	PA448068	7525	0.443
NULL	Iran_Red_Crescent_Med_J_2011_Apr_1_13(4)_234-238.nxml.txt.nlp	22737471	SENT65	11	11	1	1	cloxacillin	MAX	PA449059	4149	0.443
NULL	Oncologist_2010_Mar_9_15(3)_236-245.nxml.txt.nlp	20215359	SENT90	14	14	16	16	bevacizumab	IFN	PA130232992	3439	0.443
NULL	F1000_Med_Rep_2011_Oct_3_3_19.nxml.txt.nlp	22003366	SENT65	18	18	11	11	capsaicin	TRPV1	PA448776	7442	0.443
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Apr_30_65(Pt_5)_m594.nxml.txt.nlp	21583816	SENT52	21	21	18	18	ethanol	mol	PA448073	90527	0.443
NULL	Exp_Ther_Med_2013_Aug_20_6(2)_310-316.nxml.txt.nlp	24137180	SENT178	10	10	27	27	fasudil	MCP-1	PA165946121	6347	0.443
NULL	J_Neurodev_Disord_2009_Dec_28_1(4)_252-263.nxml.txt.nlp	21547719	SENT28	3	3	7	7	choline	hCHT	PA448976	60482	0.443
NULL	Ann_Dermatol_2013_May_10_25(2)_135-144.nxml.txt.nlp	23717002	SENT16	3	3	7	7	dacarbazine	IL-2	PA449197	3558	0.443
NULL	Oncogene_2009_Feb_5_28(5)_674-685.nxml.txt.nlp	19015634	SENT223	15	15	11	11	fluorescein	FANCD2	PA164746009	2177	0.443
NULL	Crit_Care_2011_Nov_30_15(6)_235.nxml.txt.nlp	22216838	SENT65	13	13	16	16	hyaluronan	HAS3	PA165958431	3038	0.443
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_288-294.nxml.txt.nlp	21372823	SENT40	23	23	30	30	streptomycin	FBS	PA451512	64319;26269	0.443
NULL	Mol_Biol_Cell_2012_Sep_1_23(17)_3473-3484.nxml.txt.nlp	22787275	SENT112	27	27	8	8	doxorubicin	ABCC1	PA449412	4363	0.443
NULL	Curr_Med_Chem_2013_Jan_20(3)_438-447.nxml.txt.nlp	23157636	SENT453	11	11	6	6	zuclopenthixol	FGA	PA452629	2243	0.443
NULL	Infect_Dis_Ther_2014_Dec_12_3(2)_103-122.nxml.txt.nlp	25388760	SENT239	22	22	4	4	loperamide	P-gp	PA450262	5243	0.443
NULL	J_Geriatr_Cardiol_2014_Jun_11(2)_151-157.nxml.txt.nlp	25009566	SENT125	7	7	11	11	cilostazol	CDP	PA164746334	1523	0.443
NULL	Indian_J_Pharm_Sci_2008_Mar-Apr_70(2)_198-202.nxml.txt.nlp	20046712	SENT72	8	8	6	6	metformin	FOR	PA450395	51741	0.443
NULL	Oncogene_2010_May_27_29(21)_3054-3066.nxml.txt.nlp	20228839	SENT39	19	19	19	19	pp2	PP2		4888	0.443
NULL	Orphanet_J_Rare_Dis_2011_Nov_2_6_71.nxml.txt.nlp	22047105	SENT176	18	18	38	38	riluzole	SMN2	PA451251	6607	0.443
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Aug_28_66(Pt_9)_o2417.nxml.txt.nlp	21588743	SENT58	20	20	17	17	ethanol	mol	PA448073	90527	0.443
NULL	Mol_Biol_Cell_2013_Jul_1_24(13)_2134-2145.nxml.txt.nlp	23657817	SENT191	18	18	35	35	pp2	EGF		1950	0.443
NULL	Springerplus_2014_Sep_9_3_510.nxml.txt.nlp	25279302	SENT89	5	5	8	8	creatine	SLC6A8	PA164778930	6535	0.443
NULL	ARYA_Atheroscler_2013_Jan_9(1)_112-114.nxml.txt.nlp	23690810	SENT62	17	17	1	1	heparin	Mal	PA449855	114609	0.443
NULL	J_Korean_Med_Sci_2009_Jan_29_24(Suppl_1)_S170-S175.nxml.txt.nlp	19194548	SENT128	11	11	17	17	cisplatin	EPO	PA449014	7076;8288;2056	0.443
NULL	Crit_Care_2011_Oct_25_15(5)_R255.nxml.txt.nlp	22026977	SENT23	34	34	9	9	vasopressin	AVP	PA451858	114548;551	0.443
NULL	Nucleic_Acids_Res_2010_Oct_27_38(18)_6247-6264.nxml.txt.nlp	20507916	SENT164	4	4	8	8	pp2	PP4		5531	0.443
NULL	ASN_Neuro_2011_Oct_6_3(4)_e00065.nxml.txt.nlp	21895607	SENT245	7	7	36	36	dextran	VPAC2	PA449261	7434	0.443
NULL	Exp_Lung_Res_2013_Oct_1_39(8)_336-348.nxml.txt.nlp	23919450	SENT89	0	0	2	2	thrombin	PAR-1	PA451674	2011;2149	0.443
NULL	J_Hum_Kinet_2013_Dec_31_39_137-145.nxml.txt.nlp	24511349	SENT12	0	0	47	47	creatine	ADP	PA164778930	23038	0.443
NULL	Chin_J_Cancer_2011_Aug_30(8)_508-525.nxml.txt.nlp	21801600	SENT168	9	9	16	16	nadh	ND4L	PA164755085	4539	0.443
NULL	Eur_J_Haematol_2014_Feb_25_92(2)_127-136.nxml.txt.nlp	24118452	SENT14	36	36	34	34	anagrelide	CRT	PA164742986	811	0.443
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT202	8	8	14	14	resveratrol	TRAIL		8743	0.443
NULL	Crit_Care_2011_Oct_25_15(5)_R255.nxml.txt.nlp	22026977	SENT140	5	5	11	11	vasopressin	AVP	PA451858	114548;551	0.443
NULL	J_Oncol_2010_Jun_10_2010_943823.nxml.txt.nlp	20628485	SENT176	26	26	22	22	cytarabine	MICE	PA449177	4280;23581	0.443
NULL	Ann_Surg_Oncol_2014_Feb_13_21(5)_1575-1582.nxml.txt.nlp	24522992	SENT186	26	26	17	17	tamoxifen	HER-2	PA451581	2064	0.443
NULL	Indian_J_Ophthalmol_2014_May_62(5)_606-609.nxml.txt.nlp	24881610	SENT27	3	3	12	12	nepafenac	COX	PA165958407	1351	0.443
NULL	Cell_Death_Dis_2013_Jun_27_4(6)_e696.nxml.txt.nlp	23807225	SENT279	3	3	5	5	doxycycline	ACL	PA449415	47	0.443
NULL	ScientificWorldJournal_2014_Mar_11_2014_946265.nxml.txt.nlp	24741367	SENT26	34	34	31	31	exenatide	GLP-1	PA164749238	100125288	0.443
NULL	Cough_2010_Aug_10_6_8.nxml.txt.nlp	20698995	SENT205	7	7	24	24	dextromethorphan	CYP2D6	PA449273	1565	0.443
NULL	Oncol_Lett_2014_May_10_7(5)_1651-1656.nxml.txt.nlp	24765194	SENT17	10	10	20	20	capsaicin	TRPV1	PA448776	7442	0.443
NULL	Environ_Health_Perspect_2008_Apr_16_116(4)_426-433.nxml.txt.nlp	18414622	SENT82	0	0	9	9	resveratrol	aromatase		1588	0.442
NULL	Pediatr_Cardiol_2010_Jan_14_31(1)_90-95.nxml.txt.nlp	19915892	SENT108	28	28	25	25	palivizumab	Era	PA164748781	2099	0.442
NULL	Leukemia_2014_Aug_7_28(8)_1636-1646.nxml.txt.nlp	24418989	SENT37	10	10	12	12	flavopiridol	TRAIL	PA452627	8743	0.442
NULL	Br_J_Cancer_2009_Jun_2_100(11)_1739-1745.nxml.txt.nlp	19436299	SENT102	4	4	0	0	everolimus	FDG	PA164746311	23583	0.442
NULL	Scientifica_(Cairo)_2013_Jan_17_2013_795964.nxml.txt.nlp	24278786	SENT508	9	9	27	27	xanthophyll	CO2	PA164748318	4513	0.442
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Sep_6_64(Pt_10)_o1872.nxml.txt.nlp	21201087	SENT68	20	20	7	7	paraformaldehyde	mol	PA450790	90527	0.442
NULL	Mol_Cancer_2006_Sep_5_5_34.nxml.txt.nlp	16953886	SENT144	24	24	22	22	doxorubicin	TRAIL	PA449412	8743	0.442
NULL	Avicenna_J_Phytomed_2012_Spring_2(2)_72-78.nxml.txt.nlp	25050233	SENT29	23	23	41	41	reserpine	PST	PA451236	7903	0.442
NULL	ScientificWorldJournal_2013_Nov_5_2013_383574.nxml.txt.nlp	24298214	SENT92	13	13	8	8	phenol	gamma	PA450913	9913	0.442
NULL	Cancer_Microenviron_2008_Dec_20_1(1)_103-111.nxml.txt.nlp	19308689	SENT274	24	24	11	11	thrombin	MIA	PA451674	8190	0.442
NULL	Diabetes_Care_2011_Jun_20_34(6)_1406-1411.nxml.txt.nlp	21515837	SENT141	11	11	18	18	glucose	LVM	PA449773	23209	0.442
NULL	Oxid_Med_Cell_Longev_2011_Oct_9_2011_756938.nxml.txt.nlp	22007271	SENT10	18	18	16	16	forskolin	PNMT	PA146096022	5409	0.442
NULL	Subst_Abuse_Treat_Prev_Policy_2007_Oct_31_2_32.nxml.txt.nlp	17974020	SENT281	9	9	14	14	methamphetamine	NMU	PA450403	10874	0.442
NULL	Br_J_Cancer_2010_Dec_7_103(12)_1765-1772.nxml.txt.nlp	21139621	SENT132	23	23	17	17	cetuximab	KRAS	PA10040	3845	0.442
NULL	Cell_Commun_Signal_2013_Oct_1_11_73.nxml.txt.nlp	24083678	SENT167	4	4	10	10	sulindac	AP-1	PA451565	2353;3727;2354;3725	0.442
NULL	Nucleic_Acids_Res_2005_Jun_7_33(10)_e92.nxml.txt.nlp	15942024	SENT65	14	14	34	34	fluorescein	Raf-1	PA164746009	5894	0.442
NULL	Acta_Pharmacol_Sin_2014_Oct_1_35(10)_1333-1341.nxml.txt.nlp	25176400	SENT70	5	5	23	23	phenol	CO2	PA450913	4513	0.442
NULL	J_Skin_Cancer_2014_Jul_21_2014_284582.nxml.txt.nlp	25136458	SENT7	7	7	11	11	cetuximab	CRT	PA10040	811	0.442
NULL	J_Gen_Physiol_1986_Jan_1_87(1)_113-142.nxml.txt.nlp	3950574	SENT0	17	17	1	1	furosemide	Gen	PA449719	348654	0.442
NULL	Int_J_Mol_Sci_2014_Sep_26_15(10)_17204-17220.nxml.txt.nlp	25264738	SENT71	0	0	5	5	sildenafil	IL-6	PA451346	3569	0.442
NULL	Br_J_Cancer_2009_Mar_24_100(6)_1017.nxml.txt.nlp	19293816	SENT8	32	32	21	21	sn-38	UGT1A1		54658	0.442
NULL	Curr_Neuropharmacol_2008_Sep_6(3)_193-202.nxml.txt.nlp	19506720	SENT298	23	23	27	27	risperidone	ghrelin	PA451257	51738	0.442
NULL	Br_J_Cancer_2010_Jan_5_102(1)_8-18.nxml.txt.nlp	20010945	SENT122	3	3	21	21	bevacizumab	FDG	PA130232992	23583	0.442
NULL	Front_Neuroanat_2010_Feb_8_4_1.nxml.txt.nlp	20161990	SENT79	12	12	16	16	trypsin	SDS	PA451806	51119;10993	0.442
NULL	FEBS_Open_Bio_2011_Dec_27_2_1-5.nxml.txt.nlp	23650573	SENT102	0	0	6	6	sunitinib	MDM2	PA162372840	4193	0.442
NULL	Braz_J_Med_Biol_Res_2013_Mar_15_46(3)_270-277.nxml.txt.nlp	23532271	SENT150	5	5	7	7	lipase	ATGL	PA450239	57104	0.442
NULL	Oncotarget_2013_Nov_7_4(12)_2550-2566.nxml.txt.nlp	24334291	SENT20	20	20	23	23	dasatinib	BTK	PA162372878	695	0.442
NULL	Front_Neurosci_2014_Dec_9_8_407.nxml.txt.nlp	25538557	SENT63	21	21	5	5	nadh	RGM	PA164755085	56963	0.442
NULL	Br_J_Cancer_2012_Dec_4_107(12)_1950-1955.nxml.txt.nlp	23169295	SENT132	6	6	13	13	irinotecan	DPD	PA450085	1806	0.442
NULL	Cancer_Immunol_Immunother_2011_Jul_24_60(7)_943-951.nxml.txt.nlp	21431918	SENT143	0	0	6	6	doxorubicin	CD34	PA449412	947	0.442
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT192	43	43	8	8	gefitinib	Yes	PA131301952	7525	0.442
NULL	Breast_Cancer_Res_Treat_2014_Apr_9_145(1)_73-82.nxml.txt.nlp	24715380	SENT83	8	8	12	12	tamoxifen	CXCL10	PA451581	3627	0.442
NULL	Neurobiol_Aging_2013_Nov_34(11)_2585-2603.nxml.txt.nlp	23810450	SENT285	25	25	8	8	cyproterone	p62	PA10049	8878;10657;23636	0.442
NULL	J_Res_Med_Sci_2010_Nov-Dec_15(6)_331-343.nxml.txt.nlp	21526106	SENT208	7	7	5	5	l-arginine	HDEL	PA448478	10945	0.442
NULL	Acta_Pharmacol_Sin_2010_Oct_13_31(10)_1324-1328.nxml.txt.nlp	20835265	SENT99	5	5	13	13	l-arginine	nNOS	PA448478	4842	0.442
NULL	Comput_Math_Methods_Med_2012_Dec_19_2012_473572.nxml.txt.nlp	23365616	SENT348	33	33	14	14	estradiol	CYP1B1	PA449503	1545	0.442
NULL	Clin_Interv_Aging_2013_Aug_19_8_1089-1095.nxml.txt.nlp	23983461	SENT108	26	26	30	30	minocycline	MT4	PA450519	84560	0.442
NULL	Case_Rep_Pathol_2014_Dec_25_2014_753694.nxml.txt.nlp	25610687	SENT54	40	40	36	36	thyroglobulin	TTF-1	PA164754910	7080	0.442
NULL	Cancer_Microenviron_2009_Sep_26_2(Suppl_1)_19-204.nxml.txt.nlp	NULL	SENT6100	6	6	17	17	bortezomib	PC-3	PA10252	692094	0.442
NULL	J_Mol_Signal_2008_Mar_31_3_8.nxml.txt.nlp	18377662	SENT190	16	16	13	13	pp2	SHP-1		5777	0.442
NULL	Extremophiles_2009_Nov_23_13(6)_885-894.nxml.txt.nlp	19701714	SENT131	27	27	34	34	ethanol	CO2	PA448073	4513	0.442
NULL	Biologics_2009_Oct_12_3_469-474.nxml.txt.nlp	19851472	SENT103	31	31	3	3	desloratadine	IL-5	PA164776964	3567	0.442
NULL	CNS_Spectr_2014_Dec_18_19(6)_528-534.nxml.txt.nlp	24642260	SENT109	32	32	27	27	aripiprazole	NNT	PA10026	23530	0.442
NULL	Genome_Biol_2011_Jul_18_12(7)_R64.nxml.txt.nlp	21767385	SENT245	33	33	7	7	rosiglitazone	F12	PA451283	2161	0.442
NULL	Ann_Clin_Microbiol_Antimicrob_2009_Sep_24_8_26.nxml.txt.nlp	19778428	SENT176	14	14	4	4	chloramphenicol	PEN	PA448927	9933	0.442
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT199	1	1	8	8	doxorubicin	SLK	PA449412	9748;2534	0.442
NULL	ScientificWorldJournal_2014_Mar_30_2014_818502.nxml.txt.nlp	24983002	SENT11	11	11	23	23	hyaluronan	IVD	PA165958431	3712	0.442
NULL	Indian_J_Pharm_Sci_2008_Sep-Oct_70(5)_658-661.nxml.txt.nlp	21394269	SENT46	7	7	5	5	rabeprazole	RAB	PA451216	3267	0.442
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Aug_27_67(Pt_9)_o2443.nxml.txt.nlp	22059014	SENT60	9	9	6	6	ethanol	mol	PA448073	90527	0.442
NULL	Int_J_Mol_Sci_2014_Oct_21_15(10)_19037-19055.nxml.txt.nlp	25338045	SENT74	17	17	19	19	nifedipine	NIF	PA450631	6280	0.442
NULL	Scand_J_Prim_Health_Care_2013_Jun_31(2)_101-105.nxml.txt.nlp	23659709	SENT128	4	4	7	7	doxycycline	Gen	PA449415	348654	0.442
NULL	Biochim_Biophys_Acta_2014_Jul_1842(7)_959-970.nxml.txt.nlp	24594481	SENT360	4	4	6	6	lipase	PNPLA2	PA450239	57104	0.442
NULL	Front_Neurosci_2014_Feb_11_8_20.nxml.txt.nlp	24574957	SENT271	16	16	7	7	streptozocin	p75NTR	PA451514	4804	0.442
NULL	Iran_Red_Crescent_Med_J_2011_Apr_1_13(4)_234-238.nxml.txt.nlp	22737471	SENT65	9	9	1	1	ceftriaxone	MAX	PA448866	4149	0.442
NULL	Nat_Med_2014_Jul_8_20(7)_764-768.nxml.txt.nlp	24908571	SENT259	15	15	7	7	imipramine	GRM4	PA449969	2914	0.442
NULL	Mol_Cell_Proteomics_2014_Nov_18_13(11)_3152-3163.nxml.txt.nlp	25038066	SENT67	10	10	22	22	trypsin	SPEG	PA451806	10290	0.442
NULL	Adv_Pharmacol_Sci_2013_Nov_26_2013_423750.nxml.txt.nlp	24371437	SENT139	0	0	3	3	ethanol	flower	PA448073	11094	0.442
NULL	Eur_J_Clin_Microbiol_Infect_Dis_2014_Nov_10_33(2)_201-209.nxml.txt.nlp	24213847	SENT145	22	22	24	24	clarithromycin	TMP	PA449028	2012	0.442
NULL	J_Cell_Mol_Med_2015_Jan_9_19(1)_165-174.nxml.txt.nlp	25297851	SENT63	33	33	17	17	gentamicin	CO2	PA449753	4513	0.442
NULL	J_Korean_Med_Sci_2007_Apr_30_22(2)_283-289.nxml.txt.nlp	17449938	SENT106	17	17	9	9	minoxidil	P21	PA450521	1026;9338	0.442
NULL	Avicenna_J_Phytomed_2014_Jan-Feb_4(1)_53-58.nxml.txt.nlp	25050301	SENT18	16	16	12	12	pentobarbital	flower	PA450859	11094	0.442
NULL	Exp_Ther_Med_2013_Aug_20_6(2)_310-316.nxml.txt.nlp	24137180	SENT8	0	0	11	11	fasudil	MCP-1	PA165946121	6347	0.442
NULL	J_Lipid_Res_2015_Jan_56(1)_109-121.nxml.txt.nlp	25421061	SENT24	19	19	13	13	lipase	ATGL	PA450239	57104	0.441
NULL	Acta_Pharmacol_Sin_2013_Sep_5_34(9)_1192-1200.nxml.txt.nlp	23685957	SENT15	2	2	11	11	curcumin	AP-2	PA151958596	7020	0.441
NULL	Breast_Cancer_Res_2010_Jun_18_12(3)_110.nxml.txt.nlp	20584345	SENT59	20	20	7	7	letrozole	aromatase	PA450196	1588	0.441
NULL	J_Histotechnol_2014_Mar_37(1)_3-8.nxml.txt.nlp	25620823	SENT124	6	6	13	13	guaifenesin	MUC5AC	PA449818	4586	0.441
NULL	Cardiovasc_Diabetol_2004_Feb_4_3_1.nxml.txt.nlp	14761253	SENT477	4	4	0	0	nadh	MCP-1	PA164755085	6347	0.441
NULL	Surg_Endosc_2015_Aug_19_29_220-229.nxml.txt.nlp	25135443	SENT30	41	41	35	35	iron	B12	PA450087	7126;4709	0.441
NULL	Br_J_Pharmacol_2014_Feb_24_171(1)_1019-1032.nxml.txt.nlp	24251620	SENT10	29	29	6	6	nifedipine	TRPM3	PA450631	80036	0.441
NULL	ARYA_Atheroscler_2014_Jan_10(1)_1-5.nxml.txt.nlp	24963306	SENT3	21	21	16	16	atorvastatin	Q10	PA448500	27161	0.441
NULL	Biosci_Rep_2013_Sep_4_33(5)_e00064.nxml.txt.nlp	23889169	SENT555	5	5	8	8	thrombin	PAR-1	PA451674	2011;2149	0.441
NULL	Biomed_Res_Int_2013_Dec_31_2013_795103.nxml.txt.nlp	23710462	SENT207	6	6	8	8	fenofibrate	adiponectin	PA449594	9370	0.441
NULL	Br_J_Cancer_2009_Jul_21_101(2)_238-243.nxml.txt.nlp	19568242	SENT117	11	11	13	13	bevacizumab	IFN	PA130232992	3439	0.441
NULL	Front_Neurol_2013_May_1_4_10.nxml.txt.nlp	23641231	SENT178	17	17	23	23	methylprednisolone	IFN	PA450466	3439	0.441
NULL	Indian_J_Psychiatry_2010_Oct-Dec_52(4)_301-307.nxml.txt.nlp	21267362	SENT92	17	17	22	22	vasopressin	ACTH	PA451858	5443	0.441
NULL	Ann_Clin_Microbiol_Antimicrob_2015_Jan_16_14(1)_4.nxml.txt.nlp	NULL	SENT25	9	9	14	14	cefotaxime	CTX	PA448852	1593	0.441
NULL	Int_J_Inflam_2011_Sep_20_2011_367284.nxml.txt.nlp	21941675	SENT412	17	17	6	6	heparin	IL-6	PA449855	3569	0.441
NULL	J_Cardiothorac_Surg_2010_Apr_27_5_31.nxml.txt.nlp	20423499	SENT88	10	10	24	24	heparin	ACT	PA449855	12;11332;9457;641455	0.441
NULL	Mol_Cell_Biochem_2014_Oct_9_385(1-2)_265-275.nxml.txt.nlp	24104452	SENT107	19	19	15	15	bortezomib	U87	PA10252	677775;641648	0.441
NULL	Aging_(Albany_NY)_2009_Feb_5_1(2)_219-233.nxml.txt.nlp	20157511	SENT40	18	18	8	8	hydroxyurea	WRN	PA449942	7486	0.441
NULL	Int_J_Nanomedicine_2012_May_7_7_2307-2314.nxml.txt.nlp	22661887	SENT103	25	25	29	29	gemcitabine	F10	PA449748	2159	0.441
NULL	Eur_J_Clin_Pharmacol_2013_Mar_11_69(3)_327-339.nxml.txt.nlp	22782539	SENT192	14	14	11	11	clopidogrel	IPA	PA449053	3160	0.441
NULL	Indian_J_Crit_Care_Med_2011_Apr-Jun_15(2)_71-77.nxml.txt.nlp	21814369	SENT62	9	9	14	14	desmopressin	VWF	PA449237	7450	0.441
NULL	J_Korean_Med_Sci_2009_Jan_29_24(Suppl_1)_S170-S175.nxml.txt.nlp	19194548	SENT117	29	29	31	31	cisplatin	EPO	PA449014	7076;8288;2056	0.441
NULL	Int_J_Anal_Chem_2013_Jul_16_2013_419716.nxml.txt.nlp	23956748	SENT146	37	37	15	15	heparin	PF6	PA449855	200162	0.441
NULL	Exp_Ther_Med_2013_Apr_5_5(4)_1259-1263.nxml.txt.nlp	23596498	SENT25	0	0	19	19	propofol	TRPA1	PA451141	8989	0.441
NULL	Acta_Pharmacol_Sin_2013_Sep_5_34(9)_1156-1163.nxml.txt.nlp	23892270	SENT140	23	23	25	25	lipase	adiponectin	PA450239	9370	0.441
NULL	Arch_Dis_Child_2014_Dec_8_99(12)_1143-1146.nxml.txt.nlp	25202131	SENT58	10	10	5	5	propofol	CYP1A2	PA451141	1544	0.441
NULL	Cell_Biochem_Biophys_2013_May_24_66(1)_53-63.nxml.txt.nlp	22918821	SENT268	6	6	4	4	lubiprostone	ClC-2	PA164777012	1181	0.441
NULL	Cancers_(Basel)_2012_Sep_6_4(3)_873-903.nxml.txt.nlp	24213471	SENT526	6	6	21	21	hyaluronan	SP1	PA165958431	6667	0.441
NULL	J_Gen_Physiol_1932_Nov_20_16(2)_323-337.nxml.txt.nlp	19872708	SENT0	10	10	1	1	trypsin	Gen	PA451806	348654	0.441
NULL	ASN_Neuro_2011_Aug_3_3(3)_e00063.nxml.txt.nlp	21740400	SENT334	16	16	19	19	hyaluronan	BEHAB	PA165958431	63827	0.441
NULL	Diabetol_Metab_Syndr_2014_Oct_15_6(1)_110.nxml.txt.nlp	NULL	SENT223	22	22	18	18	exenatide	GLP-1	PA164749238	100125288	0.441
NULL	Braz_J_Med_Biol_Res_2014_Oct_14_47(12)_1068-1074.nxml.txt.nlp	25387674	SENT80	11	11	15	15	taurine	ANOVA	PA451590	4858	0.441
NULL	J_Gen_Physiol_2010_Mar_135(3)_197-215.nxml.txt.nlp	20142517	SENT759	2	2	13	13	verapamil	LQT8	PA451868	775	0.441
NULL	Asia_Pac_Allergy_2013_Oct_31_3(4)_266-280.nxml.txt.nlp	24260732	SENT134	0	0	8	8	naproxen	CD63	PA450595	967	0.441
NULL	Environ_Health_Perspect_2002_Dec_110(Suppl_6)_1031-1036.nxml.txt.nlp	12634135	SENT5	39	39	30	30	pyridostigmine	PTN	PA451185	5764	0.441
NULL	Cancers_(Basel)_2014_Mar_26_6(2)_708-722.nxml.txt.nlp	24675568	SENT880	0	0	9	9	niclosamide	STAT3	PA165958408	6774	0.441
NULL	Mol_Med_Rep_2014_Nov_5_10(5)_2334-2340.nxml.txt.nlp	25189202	SENT25	14	14	11	11	ceftriaxone	CFP	PA448866	5199	0.441
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT122	33	33	31	31	dasatinib	PP2	PA162372878	4888	0.441
NULL	Virol_J_2011_May_17_8_234.nxml.txt.nlp	21575275	SENT2	19	19	23	23	ribavirin	IFN	PA451241	3439	0.441
NULL	Part_Fibre_Toxicol_2011_Aug_2_8_23.nxml.txt.nlp	21810225	SENT192	11	11	22	22	zinc	ROS	PA451956	6098	0.441
NULL	Mol_Cancer_2012_Oct_22_11_80.nxml.txt.nlp	23088607	SENT95	19	19	12	12	fulvestrant	PI3K	PA164747170	5290	0.441
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jul_24_66(Pt_8)_o2092.nxml.txt.nlp	21588387	SENT7	24	24	29	29	rocuronium	Tuba	PA164754992	23268	0.441
NULL	Exp_Ther_Med_2013_Jan_1_5(1)_338-342.nxml.txt.nlp	23251295	SENT150	0	0	5	5	everolimus	HK2	PA164746311	3796;3099;29911;3741	0.441
NULL	Breast_Cancer_Res_Treat_2013_Feb_4_137(3)_721-731.nxml.txt.nlp	23288344	SENT208	16	16	9	9	tamoxifen	SRC-3	PA451581	8202	0.441
NULL	Curr_Neuropharmacol_2013_Mar_11(2)_218-230.nxml.txt.nlp	23997756	SENT293	4	4	9	9	vasopressin	AVPR1A	PA451858	552	0.441
NULL	Orphanet_J_Rare_Dis_2011_Nov_2_6_71.nxml.txt.nlp	22047105	SENT176	21	21	38	38	creatine	SMN2	PA164778930	6607	0.441
NULL	Br_J_Haematol_2014_Mar_13_164(1)_811-821.nxml.txt.nlp	24328678	SENT69	2	2	9	9	lenalidomide	Aiolos	PA162363968	22806	0.441
NULL	Anal_Bioanal_Chem_2014_Sep_12_406(28)_7049-7057.nxml.txt.nlp	25213215	SENT77	44	44	41	41	hemin	mol	PA449849	90527	0.441
NULL	Mol_Cancer_2013_Nov_27_12_150.nxml.txt.nlp	24279793	SENT99	22	22	7	7	creatine	LMOD2	PA164778930	442721	0.441
NULL	Iran_J_Reprod_Med_2012_Jul_10(4)_329-336.nxml.txt.nlp	25246894	SENT93	3	3	16	16	protamine	PRM1	PA10366	5619	0.441
NULL	Fibrogenesis_Tissue_Repair_2012_Jul_23_5_11.nxml.txt.nlp	22824096	SENT79	32	32	11	11	bleomycin	IL-10	PA448645	3586	0.441
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT425	3	3	9	9	amisulpride	PRL	PA162565877	5617	0.441
NULL	Adv_Appl_Bioinform_Chem_2012_Sep_6_5_61-79.nxml.txt.nlp	23055752	SENT204	14	14	12	12	thrombin	DHFR	PA451674	1719	0.441
NULL	Diabetes_Care_2010_Mar_15_33(3)_608-613.nxml.txt.nlp	20009095	SENT170	12	12	27	27	rosiglitazone	adiponectin	PA451283	9370	0.441
NULL	Stroke_Res_Treat_2011_Nov_10_2011_212485.nxml.txt.nlp	22135769	SENT64	12	12	23	23	lisinopril	FGB	PA450242	2244	0.441
NULL	Arch_Dis_Child_2014_Dec_8_99(12)_1143-1146.nxml.txt.nlp	25202131	SENT58	10	10	17	17	propofol	CYP2D6	PA451141	1565	0.441
NULL	Front_Genet_2013_Aug_29_4_163.nxml.txt.nlp	24009622	SENT206	19	19	24	24	ethanol	DDP	PA448073	1678	0.441
NULL	Nat_Chem_2010_Jan_31_2_179-186.nxml.txt.nlp	20625479	SENT126	17	17	11	11	oxygen	APC	PA450744	324	0.441
NULL	ISRN_Cardiol_2013_Mar_14_2013_617943.nxml.txt.nlp	23577267	SENT130	7	7	4	4	amiodarone	AIC	PA448383	192	0.44
NULL	Arthritis_Res_Ther_2012_Nov_22_14(6)_R253.nxml.txt.nlp	23171658	SENT203	9	9	0	0	collagenase	MMP3	PA449107	4314	0.44
NULL	Clin_Sci_(Lond)_2013_Aug_1_125(Pt_3)_121-130.nxml.txt.nlp	23577635	SENT158	28	28	31	31	lipase	HSL	PA450239	3991	0.44
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_321-328.nxml.txt.nlp	21372824	SENT182	26	26	9	9	fluvastatin	STZ	PA449688	6484	0.44
NULL	Cell_Death_Dis_2014_Jan_16_5(1)_e997.nxml.txt.nlp	24434520	SENT139	8	8	19	19	cyclosporine	LKB1	PA449167	6794	0.44
NULL	Anal_Chem_Insights_2009_Apr_7_4_1-9.nxml.txt.nlp	19652757	SENT44	27	27	12	12	heparin	BHD	PA449855	201163	0.44
NULL	Br_J_Cancer_2010_Jan_5_102(1)_80-86.nxml.txt.nlp	19920817	SENT73	27	27	29	29	bevacizumab	IFN	PA130232992	3439	0.44
NULL	ScientificWorldJournal_2013_Apr_9_2013_825375.nxml.txt.nlp	23710151	SENT111	3	3	5	5	ribavirin	IFN	PA451241	3439	0.44
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT24	8	8	27	27	glucose	STZ	PA449773	6484	0.44
NULL	Mol_Cancer_2007_Sep_26_6_61.nxml.txt.nlp	17894897	SENT88	1	1	9	9	etoposide	p53	PA449552	7157	0.44
NULL	Br_J_Cancer_2010_Jun_29_103(1)_61-72.nxml.txt.nlp	20588279	SENT78	13	13	30	30	phenol	CO2	PA450913	4513	0.44
NULL	Acta_Pharmacol_Sin_2011_Oct_15_32(10)_1233-1238.nxml.txt.nlp	21841815	SENT86	25	25	11	11	mecamylamine	CTX	PA450334	1593	0.44
NULL	AIDS_Res_Ther_2011_Oct_6_8_36.nxml.txt.nlp	21978457	SENT118	28	28	16	16	zinc	CDF	PA451956	3976	0.44
NULL	J_Am_Heart_Assoc_2013_Aug_23_2(4)_e000170.nxml.txt.nlp	23832325	SENT100	18	18	1	1	warfarin	LEP	PA451906	3952	0.44
NULL	Iran_Red_Crescent_Med_J_2012_Jul_30_14(7)_442-446.nxml.txt.nlp	22997561	SENT82	12	12	14	14	sugar	FBS	PA451529	64319;26269	0.44
NULL	Indian_J_Pharmacol_2013_Jan-Feb_45(1)_44-48.nxml.txt.nlp	23543849	SENT14	0	0	12	12	cyclophosphamide	LPO	PA449165	4025	0.44
NULL	Oncotarget_2011_Jan_25_2(1-2)_8-17.nxml.txt.nlp	21378407	SENT0	7	7	10	10	thrombin	PAR-1	PA451674	2011;2149	0.44
NULL	Kidney_Int_Suppl_(2011)_2013_Dec_27_3(4)_372-376.nxml.txt.nlp	25019022	SENT90	31	31	14	14	ezetimibe	SHARP	PA10816	23013	0.44
NULL	Cardiovasc_Diabetol_2006_Dec_4_5_26.nxml.txt.nlp	17144912	SENT17	11	11	13	13	dobutamine	STZ	PA449381	6484	0.44
NULL	Indian_J_Anaesth_2014_Jul-Aug_58(4)_423-429.nxml.txt.nlp	25197110	SENT128	17	17	15	15	ondansetron	ODF	PA450705	8600	0.44
NULL	Br_J_Cancer_2013_Jul_23_109(2)_351-359.nxml.txt.nlp	23799854	SENT196	12	12	10	10	paclitaxel	BLT2	PA450761	56413	0.44
NULL	Biochemistry_2013_Dec_17_52(50)_9059-9067.nxml.txt.nlp	24266852	SENT125	5	5	5	5	pp2	PP2		4888	0.44
NULL	Oncol_Lett_2014_Nov_12_8(5)_2203-2208.nxml.txt.nlp	25295109	SENT12	0	0	5	5	celecoxib	GLI1	PA448871	2735	0.44
NULL	JAKSTAT_2012_Jan_1_1(1)_44-54.nxml.txt.nlp	24058750	SENT39	4	4	1	1	chloroquine	IL-6	PA448948	3569	0.44
NULL	Br_J_Cancer_2012_Nov_20_107(11)_1844-1852.nxml.txt.nlp	23169337	SENT177	6	6	13	13	bortezomib	AKT	PA10252	207	0.44
NULL	Indian_J_Psychiatry_2007_Oct-Dec_49(4)_271-276.nxml.txt.nlp	20680140	SENT64	13	13	15	15	risperidone	spatial	PA451257	219793	0.44
NULL	Diabetes_Care_2011_Jun_20_34(6)_1265-1269.nxml.txt.nlp	21515846	SENT3	6	6	26	26	rosiglitazone	DREAM	PA451283	30818	0.44
NULL	J_Neurol_Sci_2012_Nov_15_322(1-2)_92-95.nxml.txt.nlp	22819352	SENT2	20	20	23	23	ethanol	spatial	PA448073	219793	0.44
NULL	Evid_Based_Complement_Alternat_Med_2011_Jan_3_2011_274858.nxml.txt.nlp	19001481	SENT36	20	20	30	30	fluorescein	B7-2	PA164746009	942	0.44
NULL	Br_J_Cancer_2010_Jan_5_102(1)_80-86.nxml.txt.nlp	19920817	SENT63	26	26	28	28	bevacizumab	IFN	PA130232992	3439	0.44
NULL	Diabetes_2011_Mar_21_60(3)_1008-1018.nxml.txt.nlp	21282362	SENT311	18	18	14	14	glucose	GCKR	PA449773	11183;2646	0.44
NULL	Br_J_Cancer_2011_Apr_12_104(8)_1256-1261.nxml.txt.nlp	21448165	SENT126	30	30	28	28	sorafenib	IL-2	PA7000	3558	0.44
NULL	Curr_Chem_Genomics_2008_Feb_25_1_43-53.nxml.txt.nlp	20161827	SENT265	10	10	15	15	fluorescein	MEK1	PA164746009	5604	0.44
NULL	Cells_2013_Sep_16_2(3)_621-634.nxml.txt.nlp	24709801	SENT68	8	8	15	15	heparin	EGF	PA449855	1950	0.44
NULL	Cells_2014_Apr_9_3(2)_288-303.nxml.txt.nlp	24722470	SENT143	25	25	12	12	pilocarpine	CA1	PA450962	759	0.44
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_127043.nxml.txt.nlp	23227093	SENT4	9	9	11	11	lovastatin	RYR	PA450272	6261	0.44
NULL	Exp_Ther_Med_2012_Oct_6_4(4)_655-660.nxml.txt.nlp	23170121	SENT67	14	14	12	12	fluorescein	CD86	PA164746009	942	0.44
NULL	Mol_Neurobiol_2007_Oct_10_36(2)_137-151.nxml.txt.nlp	17952658	SENT388	10	10	33	33	vasopressin	CXCL12	PA451858	6387	0.44
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Oct_28_65(Pt_11)_o2898.nxml.txt.nlp	21578480	SENT59	16	16	13	13	ethanol	mol	PA448073	90527	0.44
NULL	Br_J_Pharmacol_2014_Jun_15_171(11)_2705-2725.nxml.txt.nlp	24467436	SENT15	12	12	0	0	isoniazid	NAT	PA450112	6046	0.44
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Dec_18_67(Pt_1)_o193.nxml.txt.nlp	21522695	SENT62	10	10	7	7	ethanol	mol	PA448073	90527	0.44
NULL	EJC_Suppl_2013_Sep_5_11(2)_307-309.nxml.txt.nlp	NULL	SENT50	16	16	30	30	gefitinib	EGFR	PA131301952	1956	0.44
NULL	Pharmaceuticals_(Basel)_2012_May_18_5(5)_514-528.nxml.txt.nlp	24281561	SENT132	3	3	0	0	cyclophosphamide	IFN	PA449165	3439	0.44
NULL	Proteome_Sci_2010_Mar_18_8_14.nxml.txt.nlp	20298566	SENT323	11	11	23	23	creatine	H41	PA164778930	55573	0.44
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1522-1532.nxml.txt.nlp	21997136	SENT205	16	16	19	19	gefitinib	Rho	PA131301952	29984	0.44
NULL	Biochem_Biophys_Res_Commun_2010_Feb_26_393(1)_50-54.nxml.txt.nlp	20100462	SENT39	28	28	22	22	tetracycline	TRPM3	PA451640	80036	0.44
NULL	Neuroscience_2011_Jun_2_183(7)_71-80.nxml.txt.nlp	21458543	SENT268	17	17	21	21	flumazenil	Gen	PA449659	348654	0.44
NULL	Arch_Dis_Child_2014_Dec_8_99(12)_1143-1146.nxml.txt.nlp	25202131	SENT58	13	13	17	17	phenytoin	CYP2D6	PA450947	1565	0.44
NULL	Br_J_Cancer_2010_Oct_26_103(9)_1331-1334.nxml.txt.nlp	20877352	SENT96	1	1	3	3	trastuzumab	GM-CSF	PA451743	1437	0.44
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Nov_4_65(Pt_12)_o2996.nxml.txt.nlp	21578736	SENT3	9	9	3	3	piperazine	mol	PA450977	90527	0.44
NULL	Oncoimmunology_2014_May_29_3_e28925.nxml.txt.nlp	25083322	SENT67	20	20	6	6	imatinib	IFN	PA10804	3439	0.44
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Mar_19_67(Pt_4)_o936.nxml.txt.nlp	21754205	SENT63	11	11	7	7	ketamine	C-1	PA450144	5203	0.44
NULL	J_Cell_Biol_2005_Jan_3_168(1)_55-66.nxml.txt.nlp	15631990	SENT212	2	2	13	13	doxycycline	p27	PA449415	5715;10534	0.44
NULL	Arthritis_Res_Ther_2009_Apr_30_11(2)_R58.nxml.txt.nlp	19405951	SENT107	23	23	26	26	clodronate	RANKL	PA10239	8600	0.44
NULL	ScientificWorldJournal_2014_Mar_11_2014_946265.nxml.txt.nlp	24741367	SENT88	15	15	12	12	exenatide	GLP-1	PA164749238	100125288	0.44
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jan_26_67(Pt_2)_o483-o484.nxml.txt.nlp	21523140	SENT76	0	0	17	17	lomefloxacin	mol	PA164749165	90527	0.44
NULL	J_Clin_Immunol_2007_May_14_27(3)_275-283.nxml.txt.nlp	17510806	SENT245	24	24	22	22	rosiglitazone	gamma	PA451283	9913	0.44
NULL	J_Biomed_Biotechnol_2010_Sep_19_2010_518743.nxml.txt.nlp	20886007	SENT293	30	30	32	32	nadh	ADP	PA164755085	23038	0.44
NULL	Int_J_Nanomedicine_2012_Oct_25_7_5565-5575.nxml.txt.nlp	23118538	SENT226	7	7	12	12	atorvastatin	SAS	PA448500	54187	0.44
NULL	Mar_Drugs_2014_Sep_25_12(9)_4984-5020.nxml.txt.nlp	25257786	SENT124	14	14	12	12	thrombin	SP2	PA451674	6668	0.44
NULL	Int_J_Biol_Sci_2014_Aug_23_10(8)_921-939.nxml.txt.nlp	25170305	SENT463	13	13	2	2	nadh	AMPK	PA164755085	5563	0.44
NULL	Scientifica_(Cairo)_2012_Jul_28_2012_723678.nxml.txt.nlp	24278735	SENT140	26	26	14	14	warfarin	VKORC1	PA451906	79001	0.44
NULL	Int_J_Mol_Sci_2013_Apr_29_14(5)_9338-9364.nxml.txt.nlp	23629668	SENT770	1	1	25	25	capecitabine	MAX	PA448771	4149	0.44
NULL	Br_J_Cancer_1999_Dec_81(8)_1304-1310.nxml.txt.nlp	10604726	SENT2	21	21	10	10	topotecan	P-gp	PA451729	5243	0.44
NULL	Diabetes_2013_Oct_17_62(10)_3373-3383.nxml.txt.nlp	23835335	SENT316	13	13	22	22	glucose	POMC	PA449773	5443	0.44
NULL	Mol_Neurobiol_2007_Oct_10_36(2)_137-151.nxml.txt.nlp	17952658	SENT388	39	39	4	4	vasopressin	CXCL12	PA451858	6387	0.44
NULL	Carcinogenesis_2010_Dec_27_31(12)_2049-2057.nxml.txt.nlp	20876285	SENT125	3	3	9	9	tamoxifen	HER2	PA451581	2064	0.44
NULL	Eur_J_Haematol_2014_Feb_25_92(2)_127-136.nxml.txt.nlp	24118452	SENT191	5	5	14	14	anagrelide	CRT	PA164742986	811	0.439
NULL	Int_J_Biomed_Sci_2006_Sep_2(3)_260-272.nxml.txt.nlp	23674989	SENT294	38	38	40	40	estradiol	PRG	PA449503	5544	0.439
NULL	Cell_Death_Dis_2011_Apr_21_2(4)_e148.nxml.txt.nlp	21509038	SENT82	16	16	22	22	cisplatin	p53	PA449014	7157	0.439
NULL	J_Cardiothorac_Surg_2013_Apr_4_8_63.nxml.txt.nlp	23557204	SENT233	28	28	23	23	glucose	FDG	PA449773	23583	0.439
NULL	Case_Rep_Med_2011_Aug_22_2011_262674.nxml.txt.nlp	21869893	SENT70	0	0	2	2	thalidomide	IFN	PA451644	3439	0.439
NULL	Front_Hum_Neurosci_2012_Oct_19_6_288.nxml.txt.nlp	23091456	SENT93	20	20	22	22	ethanol	CO2	PA448073	4513	0.439
NULL	Core_Evid_2007_Nov_30_2(2)_81-88.nxml.txt.nlp	21221177	SENT227	6	6	11	11	leucovorin	IFL	PA450198	3439	0.439
NULL	Cancer_2014_Jun_15_120(12)_1871-1880.nxml.txt.nlp	24634003	SENT2	6	6	10	10	sunitinib	IFN	PA162372840	3439	0.439
NULL	Indian_J_Pharm_Sci_2014_Nov-Dec_76(6)_510-518.nxml.txt.nlp	25593384	SENT177	22	22	19	19	ethanol	mol	PA448073	90527	0.439
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Oct_9_66(Pt_11)_o2790.nxml.txt.nlp	21588987	SENT6	15	15	17	17	ethanol	mol	PA448073	90527	0.439
NULL	Oncol_Lett_2014_Sep_11_8(3)_1222-1228.nxml.txt.nlp	25120693	SENT8	6	6	8	8	cisplatin	DDP	PA449014	1678	0.439
NULL	Breast_Cancer_(Dove_Med_Press)_2014_May_2_6_59-71.nxml.txt.nlp	24833917	SENT112	8	8	5	5	raloxifene	STAR	PA451221	6770;2984	0.439
NULL	Arthritis_Res_Ther_2008_Sep_9_10(5)_R107.nxml.txt.nlp	18782442	SENT279	0	0	19	19	glucose	ECM	PA449773	22915	0.439
NULL	J_Cell_Biol_2003_Dec_22_163(6)_1213-1218.nxml.txt.nlp	14676309	SENT166	27	27	39	39	neomycin	Caspr	PA450608	8506	0.439
NULL	Theranostics_2013_Jun_25_3(7)_496-506.nxml.txt.nlp	23843897	SENT283	5	5	10	10	calcein	PC3	PA132595336	57332;7832;5122	0.439
NULL	Biomed_Res_Int_2013_Jul_8_2013_507103.nxml.txt.nlp	23936812	SENT150	7	7	28	28	curcumin	CO2	PA151958596	4513	0.439
NULL	Nat_Med_2011_Jul_7_17(7)_796-808.nxml.txt.nlp	21738161	SENT274	16	16	28	28	heparin	MMP9	PA449855	4318	0.439
NULL	ScientificWorldJournal_2013_Jun_19_2013_174392.nxml.txt.nlp	23853530	SENT9	21	21	23	23	doxazosin	PC-3	PA449407	692094	0.439
NULL	Oncologist_2010_Nov_4_15(11)_1135-1146.nxml.txt.nlp	21051659	SENT154	5	5	7	7	sorafenib	IFN	PA7000	3439	0.439
NULL	Cytotherapy_2014_Jun_16(6)_800-809.nxml.txt.nlp	24642019	SENT44	43	43	9	9	collagenase	NAC	PA449107	22861	0.439
NULL	Eur_Arch_Psychiatry_Clin_Neurosci_2012_Dec_28_262(8)_667-676.nxml.txt.nlp	22454241	SENT282	6	6	8	8	risperidone	spatial	PA451257	219793	0.439
NULL	Front_Plant_Sci_2012_Mar_28_3_53.nxml.txt.nlp	22639651	SENT107	10	10	34	34	lipase	Yes	PA450239	7525	0.439
NULL	Cancer_Med_2013_Oct_19_2(5)_646-653.nxml.txt.nlp	24403230	SENT109	15	15	13	13	trastuzumab	XPC	PA451743	7508	0.439
NULL	Acta_Pharmacol_Sin_2011_Oct_15_32(10)_1233-1238.nxml.txt.nlp	21841815	SENT85	25	25	21	21	mecamylamine	CTX	PA450334	1593	0.439
NULL	Anesthesiol_Res_Pract_2014_Apr_15_2014_324083.nxml.txt.nlp	24839439	SENT60	12	12	19	19	chlorhexidine	San	PA164776863	80218	0.439
NULL	Environ_Health_Perspect_2008_Jan_11_116(1)_57-63.nxml.txt.nlp	18197300	SENT140	4	4	7	7	chlorzoxazone	CYP2E1	PA448971	1571	0.439
NULL	J_Hematol_Oncol_2012_Aug_16_5_52.nxml.txt.nlp	22897982	SENT198	6	6	3	3	cetuximab	PTEN	PA10040	5728	0.439
NULL	Oncotarget_2011_Nov_9_2(11)_850-861.nxml.txt.nlp	22081665	SENT181	6	6	11	11	idarubicin	DNMT3A	PA449961	1788	0.439
NULL	Int_J_Fertil_Steril_2014_Dec_22_Jan-Mar_7(4)_281-290.nxml.txt.nlp	24520498	SENT107	19	19	25	25	estradiol	AMH	PA449503	268	0.439
NULL	J_Thorac_Cardiovasc_Surg_2014_Nov_148(5)_2335-2344.nxml.txt.nlp	24841445	SENT207	6	6	8	8	theophylline	p110	PA451647	9733	0.439
NULL	J_Korean_Med_Sci_2009_Jan_29_24(Suppl_1)_S170-S175.nxml.txt.nlp	19194548	SENT84	41	41	43	43	cisplatin	EPO	PA449014	7076;8288;2056	0.439
NULL	J_Cardiothorac_Surg_2012_Jun_20_7_57.nxml.txt.nlp	22716287	SENT119	6	6	0	0	rosiglitazone	ROS1	PA451283	6098	0.439
NULL	J_Exp_Clin_Cancer_Res_2009_Dec_13_28(1)_152.nxml.txt.nlp	20003385	SENT148	25	25	22	22	thrombin	EGF	PA451674	1950	0.439
NULL	Mol_Cancer_2010_Dec_20_9_317.nxml.txt.nlp	21172025	SENT8	6	6	15	15	tamoxifen	HER2	PA451581	2064	0.439
NULL	JRSM_Short_Rep_2013_Sep_13_4(10)_2042533313490516.nxml.txt.nlp	24319578	SENT128	8	8	16	16	trastuzumab	HER2	PA451743	2064	0.439
NULL	Nat_Commun_2014_Nov_19_5_5479.nxml.txt.nlp	25407222	SENT552	24	24	29	29	dextran	YTS	PA449261	8565	0.439
NULL	Nat_Chem_Biol_2013_May_3_9(5)_300-306.nxml.txt.nlp	23455543	SENT98	24	24	12	12	nadh	NNMT	PA164755085	4837	0.439
NULL	Mol_Neurodegener_2010_Nov_10_5_49.nxml.txt.nlp	21067594	SENT168	33	33	36	36	lipase	PTEN	PA450239	5728	0.439
NULL	Cell_Mol_Life_Sci_2012_Jan_11_69(1)_149-163.nxml.txt.nlp	21667063	SENT311	15	15	17	17	curcumin	ATP7A	PA151958596	538	0.439
NULL	Cancer_Manag_Res_2011_May_9_3_117-141.nxml.txt.nlp	21625397	SENT524	0	0	5	5	belinostat	DNAJB1		3337	0.439
NULL	Lab_Anim_Res_2014_Dec_24_30(4)_143-150.nxml.txt.nlp	25628724	SENT79	1	1	6	6	genistein	TRAMP	PA165109660	8718;23471;9189	0.439
NULL	Br_J_Cancer_2014_Jul_15_111(2)_375-385.nxml.txt.nlp	24892448	SENT286	13	13	16	16	nadh	MCT-1	PA164755085	28985	0.439
NULL	Pan_Afr_Med_J_2013_May_18_15_26.nxml.txt.nlp	24009802	SENT86	23	23	3	3	diazepam	Gen	PA449283	348654	0.439
NULL	Oncol_Rep_2012_Apr_14_27(4)_1227-1232.nxml.txt.nlp	22179681	SENT23	10	10	13	13	spermine	SMO	PA164781199	6608;54498	0.439
NULL	Ann_Med_2011_Nov_5_43(7)_531-544.nxml.txt.nlp	21815879	SENT200	0	0	14	14	ticagrelor	ADP	PA165374673	23038	0.439
NULL	Extremophiles_2009_Sep_5_13(5)_769-783.nxml.txt.nlp	19579003	SENT322	1	1	21	21	lipase	PIR	PA450239	8544	0.439
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Sep_24_70(Pt_10)_o1126-o1127.nxml.txt.nlp	25484709	SENT7	18	18	20	20	nitrile	mol	PA450636	90527	0.439
NULL	Asian-Australas_J_Anim_Sci_2013_May_26(5)_683-690.nxml.txt.nlp	25049839	SENT77	21	21	26	26	mannitol	MYP	PA450320	8996	0.439
NULL	Arch_Med_Sci_2011_Dec_31_7(6)_977-983.nxml.txt.nlp	22328880	SENT8	30	30	13	13	heparin	ACT	PA449855	12;11332;9457;641455	0.439
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Nov_17_66(Pt_12)_o3194.nxml.txt.nlp	21589488	SENT60	26	26	23	23	ethanol	mol	PA448073	90527	0.439
NULL	J_Hematol_Oncol_2011_Jan_21_4_5.nxml.txt.nlp	21255411	SENT14	0	0	6	6	paclitaxel	EGFR	PA450761	1956	0.439
NULL	J_Thyroid_Res_2010_Dec_14_2011_675703.nxml.txt.nlp	21209713	SENT47	20	20	17	17	amiodarone	AIT	PA448383	160728	0.439
NULL	J_Mol_Signal_2011_Jul_20_6_7.nxml.txt.nlp	21774804	SENT177	4	4	9	9	dasatinib	p53	PA162372878	7157	0.439
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT1777	12	12	4	4	clarithromycin	ATV	PA449028	4683	0.439
NULL	J_Cancer_2014_Apr_24_5(5)_390-397.nxml.txt.nlp	24799957	SENT46	1	1	18	18	fosaprepitant	CHOP	PA165958390	1649	0.439
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Jan_11_64(Pt_2)_o430.nxml.txt.nlp	21201457	SENT53	28	28	25	25	ethanol	mol	PA448073	90527	0.439
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_321-328.nxml.txt.nlp	21372824	SENT189	3	3	19	19	fluvastatin	STZ	PA449688	6484	0.439
NULL	Child_Adolesc_Psychiatry_Ment_Health_2013_Jun_19_7_19.nxml.txt.nlp	23777626	SENT130	6	6	2	2	methylphenidate	ATX	PA450464	5168;23049	0.439
NULL	Cardiovasc_Diabetol_2005_Oct_5_4_16.nxml.txt.nlp	16207378	SENT103	27	27	10	10	glucosamine	perlecan	PA164747613	3339	0.439
NULL	Clin_Ophthalmol_2014_Aug_18_8_1527-1534.nxml.txt.nlp	25170245	SENT142	22	22	7	7	timolol	TIM	PA451690	7984;8914	0.439
NULL	Nucleic_Acids_Res_2010_Oct_28_38(19)_6418-6432.nxml.txt.nlp	20511593	SENT181	2	2	7	7	collagenase	AP-1	PA449107	2353;3727;2354;3725	0.439
NULL	Breast_Cancer_Res_Treat_2013_Aug_20_141(1)_43-53.nxml.txt.nlp	23959396	SENT25	44	44	7	7	trastuzumab	HER3	PA451743	2065	0.439
NULL	Ann_Clin_Microbiol_Antimicrob_2009_Sep_24_8_26.nxml.txt.nlp	19778428	SENT102	14	14	4	4	chloramphenicol	PEN	PA448927	9933	0.439
NULL	Int_J_Nanomedicine_2008_Sep_3(3)_359-372.nxml.txt.nlp	18990945	SENT327	10	10	2	2	methylprednisolone	CDP	PA450466	1523	0.439
NULL	FEBS_Open_Bio_2013_Dec_30_4_96-104.nxml.txt.nlp	24490130	SENT507	13	13	7	7	cisplatin	BRCA1	PA449014	672	0.439
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_May_15_66(Pt_6)_m656.nxml.txt.nlp	21579301	SENT69	1	1	9	9	copper	mol	PA449114	90527	0.439
NULL	Biomed_Res_Int_2014_Apr_29_2014_186864.nxml.txt.nlp	24877064	SENT108	1	1	20	20	curcumin	IFN	PA151958596	3439	0.439
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Sep_20_64(Pt_10)_o1961-o1962.nxml.txt.nlp	21201163	SENT75	20	20	17	17	ethanol	mol	PA448073	90527	0.439
NULL	Endocrinology_2012_Dec_1_153(12)_5980-5992.nxml.txt.nlp	23117930	SENT380	7	7	16	16	cabergoline	PREB	PA448708	10113	0.438
NULL	J_Hematol_Oncol_2013_Jun_24_6_42.nxml.txt.nlp	23800319	SENT92	26	26	4	4	heparin	NAP-2	PA449855	5473	0.438
NULL	Cell_Commun_Signal_2014_Oct_25_12(1)_59.nxml.txt.nlp	NULL	SENT309	14	14	21	21	cisplatin	mol	PA449014	90527	0.438
NULL	Br_J_Cancer_2003_Mar_10_88(5)_788-795.nxml.txt.nlp	12618891	SENT142	20	20	22	22	bosentan	FasL	PA10034	356	0.438
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Nov_8_64(Pt_12)_o2286-o2287.nxml.txt.nlp	21581265	SENT83	25	25	22	22	ethanol	mol	PA448073	90527	0.438
NULL	J_Immunol_Res_2014_May_12_2014_897249.nxml.txt.nlp	24901013	SENT180	6	6	25	25	natalizumab	PTEN	PA164747191	5728	0.438
NULL	Springerplus_2015_Jan_13_4_17.nxml.txt.nlp	25628983	SENT13	9	9	11	11	thrombin	ADP	PA451674	23038	0.438
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Aug_26_65(Pt_9)_o2234.nxml.txt.nlp	21577633	SENT71	26	26	23	23	ethanol	mol	PA448073	90527	0.438
NULL	Arthritis_Res_Ther_2012_Feb_27_14(1)_R40.nxml.txt.nlp	22369699	SENT248	9	9	3	3	abatacept	CD28	PA164747080	1493;940	0.438
NULL	Bioinform_Biol_Insights_2013_Sep_18_7_289-306.nxml.txt.nlp	24092970	SENT285	6	6	8	8	vincristine	PRAME	PA451879	23532	0.438
NULL	Br_J_Ophthalmol_2012_Jul_26_96(7)_1023-1028.nxml.txt.nlp	22539748	SENT138	11	11	13	13	bevacizumab	REC	PA130232992	84515	0.438
NULL	Breast_Cancer_Res_2008_Dec_18_10(Suppl_4)_S26.nxml.txt.nlp	19128440	SENT61	4	4	11	11	tamoxifen	IMPACT	PA451581	55364	0.438
NULL	Eur_J_Haematol_2008_Feb_80(2)_93-106.nxml.txt.nlp	18081719	SENT50	8	8	3	3	iron	MRI	PA450087	78996	0.438
NULL	Cardiovasc_J_Afr_2008_Apr_19(2)_77-83.nxml.txt.nlp	18516352	SENT166	13	13	9	9	glucose	GLP-1	PA449773	100125288	0.438
NULL	Int_J_Endocrinol_2014_Jul_2_2014_507395.nxml.txt.nlp	25165472	SENT158	14	14	18	18	estradiol	IL-6	PA449503	3569	0.438
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Mar_19_65(Pt_4)_o786.nxml.txt.nlp	21582511	SENT65	21	21	18	18	ethanol	mol	PA448073	90527	0.438
NULL	Exp_Ther_Med_2014_Nov_29_8(5)_1473-1478.nxml.txt.nlp	25289044	SENT101	6	6	8	8	heparin	AZU	PA449855	566	0.438
NULL	Pharmaceuticals_(Basel)_2012_Jun_28_5(7)_690-718.nxml.txt.nlp	24281707	SENT396	22	22	24	24	moxifloxacin	EMB	PA450555	133418	0.438
NULL	Front_Genet_2013_Aug_29_4_163.nxml.txt.nlp	24009622	SENT13	3	3	5	5	cisplatin	DDP	PA449014	1678	0.438
NULL	Int_J_Mol_Sci_2014_Oct_23_15(10)_19265-19280.nxml.txt.nlp	25342321	SENT58	26	26	13	13	cisplatin	CD34	PA449014	947	0.438
NULL	Breast_Cancer_Res_2008_Dec_18_10(Suppl_4)_S26.nxml.txt.nlp	19128440	SENT61	22	22	0	0	tamoxifen	ATAC	PA451581	6375	0.438
NULL	Cell_Death_Dis_2014_Jan_16_5(1)_e997.nxml.txt.nlp	24434520	SENT139	8	8	17	17	cyclosporine	TAK1	PA449167	7182	0.438
NULL	Acta_Pharmacol_Sin_2009_Jul_3_30(7)_889-898.nxml.txt.nlp	19574994	SENT59	29	29	9	9	dpcpx	PP2		4888	0.438
NULL	Cancers_(Basel)_2012_Sep_6_4(3)_873-903.nxml.txt.nlp	24213471	SENT348	22	22	15	15	hyaluronidase	HYAL1	PA164745713	3373	0.438
NULL	Iran_J_Pharm_Res_2014_Autumn_13(4)_1369-1378.nxml.txt.nlp	25587326	SENT102	5	5	8	8	ethanol	LCE	PA448073	79071	0.438
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT213	2	2	4	4	capsaicin	p53	PA448776	7157	0.438
NULL	J_Cell_Biol_2002_Jun_24_157(7)_1267-1278.nxml.txt.nlp	12082084	SENT161	4	4	2	2	thrombin	AC8	PA451674	114	0.438
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Oct_31_70(Pt_11)_435-437.nxml.txt.nlp	25484767	SENT6	1	1	3	3	ethanol	mol	PA448073	90527	0.438
NULL	J_Bras_Pneumol_2014_Sep-Oct_40(5)_495-503.nxml.txt.nlp	25410837	SENT324	13	13	27	27	salmeterol	IL-6	PA451300	3569	0.438
NULL	ScientificWorldJournal_2014_Feb_9_2014_964380.nxml.txt.nlp	24764772	SENT110	19	19	9	9	paliperidone	VIII	PA163518919	1351	0.438
NULL	Neural_Regen_Res_2014_Jul_1_9(13)_1297-1302.nxml.txt.nlp	25221582	SENT116	21	21	24	24	oxygen	ROS	PA450744	6098	0.438
NULL	Braz_J_Med_Biol_Res_2013_Mar_15_46(3)_270-277.nxml.txt.nlp	23532271	SENT145	4	4	6	6	lipase	ATGL	PA450239	57104	0.438
NULL	Oncotarget_2012_Oct_20_3(10)_1068-1111.nxml.txt.nlp	23085539	SENT712	0	0	6	6	metformin	TSC1	PA450395	7248	0.438
NULL	Theranostics_2014_Jan_2_4(2)_119-133.nxml.txt.nlp	24465270	SENT133	28	28	30	30	estradiol	EGF	PA449503	1950	0.438
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2675-2684.nxml.txt.nlp	24129246	SENT278	13	13	4	4	etoposide	p53	PA449552	7157	0.438
NULL	Environ_Health_Perspect_2010_Jun_25_118(6)_864-870.nxml.txt.nlp	20100676	SENT242	3	3	18	18	arsenite	INS-1	PA452638	2305	0.438
NULL	J_Cell_Biol_1984_Mar_1_98(3)_1082-1089.nxml.txt.nlp	6699083	SENT1	19	19	16	16	vasopressin	EGF	PA451858	1950	0.438
NULL	Semin_Immunopathol_2013_Jan_26_35(1)_39-52.nxml.txt.nlp	22829332	SENT197	28	28	30	30	rituximab	CHOP	PA451261	1649	0.438
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Mar_14_65(Pt_4)_o756.nxml.txt.nlp	21582487	SENT61	32	32	29	29	ethanol	mol	PA448073	90527	0.438
NULL	Patient_Prefer_Adherence_2013_Jun_19_7_531-542.nxml.txt.nlp	23814462	SENT218	0	0	4	4	raltegravir	BII		777	0.438
NULL	Clin_Epidemiol_2010_Aug_9_2_145-151.nxml.txt.nlp	20865112	SENT138	9	9	1	1	raltegravir	CD4		920	0.438
NULL	Cell_Res_2013_Jun_21_23(6)_746-758.nxml.txt.nlp	23689277	SENT39	4	4	21	21	resveratrol	AMPK		5563	0.438
NULL	Oxid_Med_Cell_Longev_2013_Dec_5_2013_963520.nxml.txt.nlp	24381719	SENT53	21	21	24	24	oxygen	ROS	PA450744	6098	0.438
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_May_31_70(Pt_6)_m238-m239.nxml.txt.nlp	24940217	SENT7	19	19	21	21	nitrile	mol	PA450636	90527	0.438
NULL	Arthritis_Res_Ther_2011_Dec_9_13(6)_R202.nxml.txt.nlp	22152723	SENT113	2	2	6	6	canakinumab	IL-6	PA165958358	3569	0.438
NULL	Int_J_Biol_Sci_2012_Sep_6_8(8)_1109-1120.nxml.txt.nlp	22991499	SENT152	21	21	18	18	l-arginine	IFN	PA448478	3439	0.438
NULL	Front_Cell_Neurosci_2013_Aug_30_7_139.nxml.txt.nlp	24009559	SENT92	30	30	8	8	pilocarpine	SV2A	PA450962	9900	0.438
NULL	JAKSTAT_2013_Jul_1_2(3)_e24574.nxml.txt.nlp	24069558	SENT56	16	16	24	24	doxycycline	JAK2	PA449415	3717	0.438
NULL	Nat_Commun_2013_Sep_27_4_2519.nxml.txt.nlp	24071738	SENT49	22	22	14	14	tetracycline	SMAD1	PA451640	2617;4086	0.438
NULL	Oncoimmunology_2013_Jan_1_2(1)_e22890.nxml.txt.nlp	23483066	SENT45	0	0	17	17	vemurafenib	IFN	PA165946873	3439	0.438
NULL	Endocrinol_Diabetes_Metab_Case_Rep_2014_Feb_1_2014_130080.nxml.txt.nlp	24683484	SENT37	4	4	36	36	cosyntropin	ACTH	PA164749052	5443	0.438
NULL	Ann_Clin_Microbiol_Antimicrob_2009_Sep_24_8_26.nxml.txt.nlp	19778428	SENT244	14	14	4	4	chloramphenicol	PEN	PA448927	9933	0.438
NULL	Cancer_Cell_Int_2007_Sep_10_7_14.nxml.txt.nlp	17845729	SENT199	30	30	15	15	decitabine	GADD45A	PA164749631	1647	0.438
NULL	Breast_Cancer_Res_2007_Nov_27_9(6)_403.nxml.txt.nlp	18086324	SENT26	21	21	0	0	heparin	HGFIN	PA449855	10457	0.438
NULL	Front_Neuroenergetics_2010_May_21_2_5.nxml.txt.nlp	20725515	SENT213	8	8	26	26	glucose	p38	PA449773	10598;1432;7965	0.438
NULL	EPMA_J_2014_Feb_11_5(Suppl_1)_A42.nxml.txt.nlp	NULL	SENT8	42	42	44	44	cetuximab	KRAS	PA10040	3845	0.438
NULL	Indian_J_Palliat_Care_2009_Jul-Dec_15(2)_132-136.nxml.txt.nlp	20668592	SENT33	7	7	15	15	pregabalin	NNT	PA164754814	23530	0.438
NULL	Int_J_Gen_Med_2013_Jun_7_6_453-464.nxml.txt.nlp	23785241	SENT205	37	37	15	15	nedocromil	IL-6	PA450601	3569	0.438
NULL	Genome_Med_2010_Nov_12_2(11)_81.nxml.txt.nlp	21092148	SENT112	24	24	12	12	tamoxifen	HER2	PA451581	2064	0.438
NULL	J_Mamm_Evol_2010_Dec_14_17(4)_245-264.nxml.txt.nlp	21125025	SENT276	40	40	45	45	oxygen	MIS	PA450744	268	0.438
NULL	J_Hum_Genet_2013_Jun_16_58(6)_353-361.nxml.txt.nlp	23677058	SENT173	27	27	24	24	etoposide	ABCC3	PA449552	8714	0.438
NULL	Pharmaceuticals_(Basel)_2014_Jul_16_7(7)_839-849.nxml.txt.nlp	NULL	SENT62	10	10	13	13	cetuximab	EGFR	PA10040	1956	0.438
NULL	Arthritis_Res_Ther_2005_Oct_29_7(1)_R1-R11.nxml.txt.nlp	15642129	SENT138	31	31	13	13	estradiol	ANOVA	PA449503	4858	0.438
NULL	EJC_Suppl_2013_Sep_5_11(2)_45-59.nxml.txt.nlp	NULL	SENT289	26	26	34	34	capecitabine	CRT	PA448771	811	0.437
NULL	Mycopathologia_2013_Apr_2_175(3-4)_249-254.nxml.txt.nlp	23546772	SENT5	10	10	17	17	sertaconazole	DDC	PA164748328	1644	0.437
NULL	Genome_Announc_2013_Dec_12_1(6)_e01034-13.nxml.txt.nlp	24336372	SENT30	17	17	37	37	trimethoprim	DHPS	PA451788	1725	0.437
NULL	Clin_Psychopharmacol_Neurosci_2011_Apr_30_9(1)_36-43.nxml.txt.nlp	23431025	SENT126	7	7	10	10	haloperidol	FLI	PA449841	2314	0.437
NULL	Nucleic_Acids_Res_2012_Apr_10_40(7)_2925-2939.nxml.txt.nlp	22156375	SENT40	27	27	25	25	heparin	FGF4	PA449855	2249	0.437
NULL	Eur_J_Clin_Pharmacol_2009_Dec_16_65(12)_1211-1228.nxml.txt.nlp	19756557	SENT54	12	12	46	46	infliximab	ACT	PA452639	12;11332;9457;641455	0.437
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Mar_27_66(Pt_4)_o942-o943.nxml.txt.nlp	21580748	SENT78	17	17	14	14	ethanol	mol	PA448073	90527	0.437
NULL	Mol_Cancer_2008_Jan_10_7_4.nxml.txt.nlp	18186929	SENT129	6	6	8	8	imatinib	KIT	PA10804	3815	0.437
NULL	Cancer_2012_Mar_15_118(6)_1486-1497.nxml.txt.nlp	21837674	SENT188	14	14	10	10	ridaforolimus	San	PA165291475	80218	0.437
NULL	J_Med_Chem_2014_Jan_23_57(2)_449-461.nxml.txt.nlp	24387105	SENT47	12	12	10	10	benzaldehyde	ALDH3A1	PA448571	218	0.437
NULL	Acta_Pharmacol_Sin_2012_Jul_18_33(7)_918-923.nxml.txt.nlp	22705728	SENT12	7	7	19	19	estradiol	aromatase	PA449503	1588	0.437
NULL	Int_Semin_Surg_Oncol_2006_Aug_25_3_22.nxml.txt.nlp	16930493	SENT104	0	0	2	2	cimetidine	PSK	PA449001	9344	0.437
NULL	J_Neural_Transm_2014_Mar_27_121(10)_1221-1232.nxml.txt.nlp	24671607	SENT57	6	6	9	9	ethanol	CORT	PA448073	1325	0.437
NULL	Nucleic_Acids_Res_2012_Jun_22_40(11)_5078-5087.nxml.txt.nlp	22362747	SENT114	6	6	11	11	telithromycin	L22	PA10202	6146	0.437
NULL	Mol_Cancer_2012_Oct_22_11_80.nxml.txt.nlp	23088607	SENT215	14	14	16	16	fulvestrant	YC1	PA164747170	5937	0.437
NULL	Cerebrovasc_Dis_Extra_2012_Sep_29_2(1)_52-62.nxml.txt.nlp	23139682	SENT182	9	9	11	11	acetazolamide	CO2	PA448018	4513	0.437
NULL	Adv_Ther_2014_Feb_20_31(3)_333-344.nxml.txt.nlp	24554346	SENT210	14	14	33	33	candesartan	HYPE	PA448765	11153	0.437
NULL	Int_J_Gen_Med_2012_Jul_19_5_603-611.nxml.txt.nlp	22924007	SENT152	21	21	36	36	nitazoxanide	gamma	PA164754874	9913	0.437
NULL	Front_Neurol_2012_Feb_24_3_23.nxml.txt.nlp	22375134	SENT81	11	11	14	14	l-glutamine	B27	PA10090	56246	0.437
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT1753	17	17	20	20	posaconazole	ATV	PA151958574	4683	0.437
NULL	Mol_Cancer_2010_Nov_8_9_291.nxml.txt.nlp	21059223	SENT269	2	2	7	7	zinc	ZNF217	PA451956	7764	0.437
NULL	Crit_Care_2013_Mar_19_17(Suppl_2)_P351.nxml.txt.nlp	NULL	SENT5	32	32	3	3	dalteparin	SAPS	PA165958404	8935	0.437
NULL	Braz_J_Med_Biol_Res_2014_Mar_3_47(3)_245-251.nxml.txt.nlp	24554037	SENT104	6	6	2	2	atorvastatin	IL-6	PA448500	3569	0.437
NULL	Ann_Thorac_Med_2007_Apr-Jun_2(2)_52-57.nxml.txt.nlp	19727346	SENT129	18	18	20	20	aztreonam	CTX	PA448523	1593	0.437
NULL	Osteoporos_Int_2013_Oct_19_24(1)_23-57.nxml.txt.nlp	23079689	SENT973	2	2	26	26	tamoxifen	STAR	PA451581	6770;2984	0.437
NULL	Ann_Clin_Microbiol_Antimicrob_2009_Sep_24_8_26.nxml.txt.nlp	19778428	SENT244	18	18	4	4	ceftriaxone	PEN	PA448866	9933	0.437
NULL	Biochemistry_2013_May_14_52(19)_3194-3196.nxml.txt.nlp	23634976	SENT56	24	24	31	31	cyclosporine	P-gp	PA449167	5243	0.437
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Nov_21_65(Pt_12)_o3132-o3133.nxml.txt.nlp	21578855	SENT68	0	0	17	17	cefazolin	mol	PA448839	90527	0.437
NULL	Front_Microbiol_2012_May_24_3_187.nxml.txt.nlp	22783238	SENT410	0	0	6	6	hydroxyurea	ISC1	PA449942	6610	0.437
NULL	Hum_Genomics_2009_Jan_1_3(2)_128-142.nxml.txt.nlp	19164090	SENT176	8	8	14	14	carboplatin	CD44	PA448803	960	0.437
NULL	EMBO_Mol_Med_2012_Jul_11_4(7)_577-593.nxml.txt.nlp	22496117	SENT6	12	12	10	10	clofazimine	PAP-1	PA164748759	6100	0.437
NULL	Exp_Ther_Med_2015_Feb_8_9(2)_341-344.nxml.txt.nlp	25574195	SENT86	4	4	2	2	hydroquinone	OTC	PA449924	5009	0.437
NULL	Clin_Drug_Investig_2015_Dec_16_35_141-147.nxml.txt.nlp	25511640	SENT71	25	25	23	23	miglitol	GLP-1	PA164776726	100125288	0.437
NULL	Carcinogenesis_2010_Dec_27_31(12)_2049-2057.nxml.txt.nlp	20876285	SENT129	10	10	6	6	tamoxifen	HER2	PA451581	2064	0.437
NULL	Turk_J_Haematol_2012_Dec_5_29(4)_392-396.nxml.txt.nlp	24385727	SENT56	0	0	3	3	fludarabine	CD4	PA449655	920	0.437
NULL	J_Int_Soc_Sports_Nutr_2009_Feb_19_6_6.nxml.txt.nlp	19228401	SENT240	8	8	22	22	creatine	CEE	PA164778930	51608	0.437
NULL	Mol_Biol_Cell_2013_Apr_1_24(7)_923-932.nxml.txt.nlp	23363600	SENT254	27	27	10	10	neomycin	CO2	PA450608	4513	0.437
NULL	Cases_J_2009_Jun_10_2_8183.nxml.txt.nlp	19830060	SENT62	18	18	7	7	vincristine	CHOP	PA451879	1649	0.437
NULL	J_Korean_Med_Sci_2013_Apr_27_28(4)_527-533.nxml.txt.nlp	23580227	SENT46	9	9	11	11	genistein	TRAIL	PA165109660	8743	0.437
NULL	Exp_Ther_Med_2013_Jul_29_6(1)_33-36.nxml.txt.nlp	23935714	SENT95	1	1	9	9	cyclophosphamide	CHOP	PA449165	1649	0.437
NULL	Cough_2007_Oct_31_3_9.nxml.txt.nlp	17971242	SENT8	27	27	20	20	capsaicin	TRPV1	PA448776	7442	0.437
NULL	J_Hematol_Oncol_2013_Jul_9_6_49.nxml.txt.nlp	23837843	SENT222	11	11	18	18	verapamil	Rho	PA451868	29984	0.437
NULL	Carcinogenesis_2008_Sep_9_29(9)_1751-1757.nxml.txt.nlp	18544568	SENT178	29	29	15	15	estradiol	CYP1B1	PA449503	1545	0.437
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT14	0	0	14	14	capsaicin	p53	PA448776	7157	0.437
NULL	Carcinogenesis_2014_May_13_35(5)_1055-1066.nxml.txt.nlp	24419232	SENT485	4	4	9	9	metformin	BRAF	PA450395	673	0.437
NULL	Oxid_Med_Cell_Longev_2012_Aug_22_2012_534705.nxml.txt.nlp	22966415	SENT222	1	1	5	5	riluzole	GLAST	PA451251	6507	0.437
NULL	Mol_Cell_2013_Apr_11_50(1)_149-156.nxml.txt.nlp	23582260	SENT54	10	10	15	15	staurosporine	STAT1	PA165109623	6772	0.437
NULL	Oncotarget_2013_Nov_23_5(1)_196-210.nxml.txt.nlp	24344116	SENT46	7	7	4	4	doxorubicin	p65	PA449412	5970	0.436
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_5_2014_362573.nxml.txt.nlp	25431608	SENT158	7	7	38	38	creatine	HO-1	PA164778930	3162	0.436
NULL	Adv_Biol_Regul_2014_Jan_19_0_197-206.nxml.txt.nlp	24103483	SENT101	2	2	0	0	lipase	PLD2	PA450239	5338	0.436
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_79-96.nxml.txt.nlp	19305789	SENT70	8	8	18	18	capsaicin	TRPV1	PA448776	7442	0.436
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_15_2012_591654.nxml.txt.nlp	23118793	SENT286	13	13	24	24	glimepiride	Met	PA449761	79811	0.436
NULL	Cell_Commun_Signal_2013_Apr_19_11_29.nxml.txt.nlp	23601247	SENT64	25	25	19	19	galactose	CLEC10A	PA449725	10462	0.436
NULL	Br_J_Cancer_2009_Oct_6_101(7)_1162-1167.nxml.txt.nlp	19724276	SENT8	19	19	16	16	gemcitabine	APC	PA449748	324	0.436
NULL	An_Bras_Dermatol_2014_Mar-Apr_89(2)_266-273.nxml.txt.nlp	24770503	SENT182	8	8	6	6	thalidomide	ENL	PA451644	4298	0.436
NULL	Cancer_Cell_Int_2010_Jul_8_10_23.nxml.txt.nlp	20615241	SENT84	2	2	9	9	perifosine	BAR	PA165291471	154;51283	0.436
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_13_2014_849783.nxml.txt.nlp	25477998	SENT104	1	1	9	9	berberine	TLR4	PA165860812	7099	0.436
NULL	Mol_Cancer_2009_Nov_17_8_104.nxml.txt.nlp	19919690	SENT201	26	26	23	23	urokinase	MMP2	PA451836	4313	0.436
NULL	Adipocyte_2014_Jul_1_3(3)_190-196.nxml.txt.nlp	25068085	SENT74	9	9	11	11	estradiol	CCL2	PA449503	6347	0.436
NULL	Front_Mol_Neurosci_2012_Nov_12_5_99.nxml.txt.nlp	23162427	SENT260	15	15	4	4	cocaine	HDAC5	PA449072	10014	0.436
NULL	Turk_J_Haematol_2012_Mar_5_29(1)_55-62.nxml.txt.nlp	24744624	SENT29	7	7	32	32	thrombin	PAR-1	PA451674	2011;2149	0.436
NULL	EMBO_Mol_Med_2012_Jul_11_4(7)_577-593.nxml.txt.nlp	22496117	SENT132	11	11	7	7	clofazimine	PAP-1	PA164748759	6100	0.436
NULL	Exp_Ther_Med_2013_Mar_21_5(3)_987-991.nxml.txt.nlp	23407636	SENT65	2	2	9	9	losartan	IL-8	PA450268	3576	0.436
NULL	Cell_Commun_Signal_2013_Jul_4_11_47.nxml.txt.nlp	23826796	SENT62	5	5	9	9	forskolin	CC2D1A	PA146096022	54862	0.436
NULL	Drugs_Context_2012_Nov_19_2012_212242.nxml.txt.nlp	24432031	SENT306	15	15	17	17	dacarbazine	IL-2	PA449197	3558	0.436
NULL	Diabetes_Care_2010_Oct_13_33(10)_2250-2253.nxml.txt.nlp	20628086	SENT112	38	38	6	6	glucose	DREAM	PA449773	30818	0.436
NULL	Indian_J_Psychiatry_2014_Jan_56(Suppl_1)_S19-S62.nxml.txt.nlp	NULL	SENT1016	27	27	2	2	haloperidol	ANOVA	PA449841	4858	0.436
NULL	J_Cell_Biol_2004_Jun_7_165(5)_641-652.nxml.txt.nlp	15173188	SENT140	4	4	4	4	pp2	PP2		4888	0.436
NULL	Evid_Based_Complement_Alternat_Med_2013_Nov_5_2013_937370.nxml.txt.nlp	24302971	SENT171	14	14	28	28	tacrine	p53	PA451576	7157	0.436
NULL	Indian_J_Med_Res_2013_Nov_138(5)_766-778.nxml.txt.nlp	24434330	SENT31	12	12	5	5	ribavirin	IFN	PA451241	3439	0.436
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_7-17.nxml.txt.nlp	17912633	SENT44	2	2	6	6	aminoglutethimide	aromatase	PA448375	1588	0.436
NULL	Breast_Cancer_Res_2010_Nov_16_12(6)_R95.nxml.txt.nlp	21080930	SENT260	24	24	8	8	cisplatin	BRCA1	PA449014	672	0.436
NULL	Nat_Commun_2013_Oct_25_4_2667.nxml.txt.nlp	24157709	SENT720	21	21	18	18	nutlin-3	mol		90527	0.436
NULL	ScientificWorldJournal_2014_Jul_23_2014_854093.nxml.txt.nlp	25147870	SENT167	2	2	18	18	chlorophyll	gamma	PA448942	9913	0.436
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Nov_13_64(Pt_12)_o2338.nxml.txt.nlp	21581313	SENT73	22	22	19	19	ethanol	mol	PA448073	90527	0.436
NULL	Oncotarget_2013_Nov_24_4(12)_2430-2438.nxml.txt.nlp	24280348	SENT20	8	8	5	5	afatinib	EGFR	PA165981154	1956	0.436
NULL	Cell_Res_2014_Feb_12_24(2)_143-160.nxml.txt.nlp	24217768	SENT67	7	7	21	21	heparin	FGF2	PA449855	2247;2258	0.436
NULL	Pharmaceuticals_(Basel)_2013_Sep_30_6(10)_1195-1220.nxml.txt.nlp	24275848	SENT226	20	20	5	5	sunitinib	S15	PA162372840	6209	0.436
NULL	Front_Endocrinol_(Lausanne)_2014_Sep_26_5_149.nxml.txt.nlp	25309511	SENT76	27	27	24	24	lipase	DPPIV	PA450239	2191;1803	0.436
NULL	Arthritis_Res_Ther_2005_Oct_29_7(1)_R1-R11.nxml.txt.nlp	15642129	SENT137	35	35	11	11	estradiol	ANOVA	PA449503	4858	0.436
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Sep_19_65(Pt_10)_o2496.nxml.txt.nlp	21577946	SENT67	15	15	12	12	ethanol	mol	PA448073	90527	0.436
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Nov_6_66(Pt_12)_o3054-o3055.nxml.txt.nlp	21589366	SENT76	10	10	7	7	ethanol	mol	PA448073	90527	0.436
NULL	Arthritis_Res_Ther_2007_Mar_2_9(2)_R22.nxml.txt.nlp	17335569	SENT122	3	3	8	8	adalimumab	CD36	PA10004	948	0.436
NULL	Bioinorg_Chem_Appl_2014_Sep_15_2014_718175.nxml.txt.nlp	25332694	SENT44	31	31	28	28	ethanol	mol	PA448073	90527	0.436
NULL	Front_Neural_Circuits_2013_Dec_27_7_206.nxml.txt.nlp	24409121	SENT70	16	16	32	32	atropine	CO2	PA448505	4513	0.436
NULL	CNS_Neurosci_Ther_2010_Jun_16(3)_e1-e17.nxml.txt.nlp	20406250	SENT229	25	25	8	8	bupropion	5-HT1A	PA448687	3350	0.436
NULL	BMJ_Open_2014_Oct_31_4(10)_e005781.nxml.txt.nlp	25361837	SENT18	4	4	2	2	prasugrel	ADP	PA154410481	23038	0.436
NULL	Int_J_Mol_Sci_2014_Mar_5_15(3)_3970-3988.nxml.txt.nlp	24603537	SENT99	17	17	19	19	curcumin	MCH	PA151958596	5367	0.436
NULL	Crit_Care_2008_Jun_25_12(3)_R84.nxml.txt.nlp	18578859	SENT97	31	31	26	26	heparin	PF4	PA449855	5196	0.436
NULL	J_Inherit_Metab_Dis_2013_Mar_1_36(2)_293-307.nxml.txt.nlp	23371450	SENT235	22	22	2	2	4-methylumbelliferone	GALNS	PA154081778	2588	0.436
NULL	Br_J_Cancer_2010_Dec_7_103(12)_1898-1900.nxml.txt.nlp	NULL	SENT24	40	40	13	13	vorinostat	KDR	PA164748224	3791	0.436
NULL	Eur_J_Med_Res_2013_Apr_2_18(1)_8.nxml.txt.nlp	23547898	SENT41	12	12	9	9	cyclophosphamide	CHOP	PA449165	1649	0.436
NULL	Ann_Hematol_2014_Sep_12_93(1)_13-32.nxml.txt.nlp	24026426	SENT274	21	21	12	12	posaconazole	BII	PA151958574	777	0.436
NULL	Biochemistry_2008_Jun_10_47(23)_6242-6250.nxml.txt.nlp	18470998	SENT45	17	17	23	23	coumarin	HDAC8	PA134521193	55869	0.436
NULL	Neural_Plast_2013_Dec_30_2013_863970.nxml.txt.nlp	24490088	SENT16	42	42	29	29	fluoxetine	NPAS4	PA449673	266743	0.436
NULL	Clin_Ophthalmol_2010_Oct_5_4_1137-1143.nxml.txt.nlp	20957061	SENT12	21	21	18	18	travoprost	BAK	PA164781371	578	0.436
NULL	Zookeys_2014_Nov_25_(457)_211-225.nxml.txt.nlp	25561838	SENT44	10	10	30	30	ethanol	San	PA448073	80218	0.436
NULL	Cases_J_2009_Aug_24_2_7024.nxml.txt.nlp	19918503	SENT18	3	3	7	7	warfarin	VKORC1	PA451906	79001	0.436
NULL	Psychiatry_Investig_2009_Sep_3_6(3)_222-225.nxml.txt.nlp	20046399	SENT76	5	5	7	7	perospirone	DRD4	PA165291546	1815	0.436
NULL	AIDS_Care_2011_Sep_14_23(9)_1154-1162.nxml.txt.nlp	21500025	SENT140	28	28	2	2	tenofovir	ATV	PA10204	4683	0.436
NULL	Br_J_Cancer_2013_Aug_6_109(3)_686-693.nxml.txt.nlp	23839492	SENT101	5	5	15	15	sunitinib	IL-8	PA162372840	3576	0.436
NULL	Clin_Med_Insights_Oncol_2012_Feb_28_6_125-135.nxml.txt.nlp	22408376	SENT28	17	17	15	15	panitumumab	EGFR	PA162373091	1956	0.436
NULL	J_Oncol_2010_Aug_19_2010_932803.nxml.txt.nlp	20847951	SENT138	15	15	15	15	pp2	PP2		4888	0.436
NULL	J_Exp_Med_1973_May_1_137(5)_1256-1262.nxml.txt.nlp	4540799	SENT5	9	9	17	17	papain	mol	PA450778	90527	0.436
NULL	Korean_J_Anesthesiol_2013_Jan_21_64(1)_47-53.nxml.txt.nlp	23372886	SENT96	8	8	5	5	bupivacaine	IGK	PA135057240	50802	0.436
NULL	Indian_J_Dermatol_2013_May-Jun_58(3)_197-199.nxml.txt.nlp	23723470	SENT36	17	17	21	21	minocycline	ROM	PA450519	6094	0.436
NULL	Arthritis_Res_Ther_2012_Apr_18_14(2)_R80.nxml.txt.nlp	22513098	SENT230	8	8	19	19	hydroxychloroquine	TLR9	PA164777036	54106	0.436
NULL	Oncol_Lett_2014_May_7_7(5)_1439-1442.nxml.txt.nlp	24765152	SENT35	36	36	44	44	ampicillin	CO2	PA448419	4513	0.436
NULL	F1000_Med_Rep_2010_Apr_12_2_28.nxml.txt.nlp	20436921	SENT25	10	10	14	14	azathioprine	NAC	PA448515	22861	0.436
NULL	Front_Cell_Neurosci_2014_Jan_29_8_11.nxml.txt.nlp	24523671	SENT177	9	9	0	0	ethanol	GluA1	PA448073	2890	0.435
NULL	J_Cardiothorac_Surg_2010_Feb_24_5_8.nxml.txt.nlp	20181268	SENT42	9	9	19	19	heparin	ACT	PA449855	12;11332;9457;641455	0.435
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jul_29_65(Pt_8)_o2022.nxml.txt.nlp	21583691	SENT72	21	21	18	18	ethanol	mol	PA448073	90527	0.435
NULL	Brain_2014_Apr_27_137(4)_1145-1155.nxml.txt.nlp	24578545	SENT232	7	7	5	5	oxygen	MRI	PA450744	78996	0.435
NULL	Cancer_Cell_Int_2008_Mar_18_8_3.nxml.txt.nlp	18348720	SENT81	10	10	15	15	gefitinib	EGF	PA131301952	1950	0.435
NULL	J_Cell_Biol_2008_Jan_28_180(2)_417-426.nxml.txt.nlp	18227283	SENT613	2	2	7	7	estradiol	aromatase	PA449503	1588	0.435
NULL	Int_J_Impot_Res_2010_Mar_26_22(2)_120-126.nxml.txt.nlp	19940852	SENT133	14	14	11	11	phenylephrine	mol	PA450935	90527	0.435
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Dec_17_3(12)_e152.nxml.txt.nlp	25518025	SENT249	11	11	7	7	paclitaxel	ABCB1	PA450761	5243	0.435
NULL	Acta_Orthop_2013_Dec_2_84(6)_509-516.nxml.txt.nlp	24171687	SENT80	11	11	4	4	gentamicin	TKR	PA449753	8277	0.435
NULL	ISRN_Neurosci_2013_Sep_30_2013_784520.nxml.txt.nlp	24959566	SENT134	9	9	6	6	vasopressin	AVP	PA451858	114548;551	0.435
NULL	Acta_Pharmacol_Sin_2009_Nov_5_30(11)_1522-1528.nxml.txt.nlp	19890360	SENT31	2	2	15	15	fenoterol	CD14	PA10079	929	0.435
NULL	Eur_J_Clin_Pharmacol_2013_Mar_11_69(3)_327-339.nxml.txt.nlp	22782539	SENT274	27	27	21	21	dabigatran	P-gp		5243	0.435
NULL	Ann_Dermatol_2011_Oct_31_23(Suppl_2)_S169-S174.nxml.txt.nlp	22148042	SENT54	10	10	7	7	cyclophosphamide	CHOP	PA449165	1649	0.435
NULL	Diabetes_2013_Oct_17_62(10)_3547-3552.nxml.txt.nlp	23863812	SENT80	25	25	8	8	pravastatin	adiponectin	PA451089	9370	0.435
NULL	Acta_Pharmacol_Sin_2009_Jul_3_30(7)_889-898.nxml.txt.nlp	19574994	SENT59	9	9	11	11	pp2	PI3K		5290	0.435
NULL	Breast_Cancer_Res_Treat_2013_Aug_20_141(1)_43-53.nxml.txt.nlp	23959396	SENT27	44	44	40	40	pertuzumab	HER3		2065	0.435
NULL	Scientifica_(Cairo)_2014_Apr_6_2014_394270.nxml.txt.nlp	24808974	SENT228	10	10	36	36	halothane	CO2	PA449845	4513	0.435
NULL	Acta_Orthop_2012_Dec_26_83(6)_642-647.nxml.txt.nlp	23140090	SENT98	8	8	20	20	etoricoxib	ANOVA	PA164776853	4858	0.435
NULL	EMBO_Mol_Med_2013_Jun_30_5(6)_935-948.nxml.txt.nlp	23629957	SENT299	20	20	17	17	cisplatin	COL6A3	PA449014	1293	0.435
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT120	0	0	2	2	resveratrol	IL-6		3569	0.435
NULL	Diabetes_2009_Jul_58(7)_1471-1478.nxml.txt.nlp	19564458	SENT151	15	15	24	24	ranibizumab	VEGFR	PA164746012	3791	0.435
NULL	Cancer_Imaging_2008_Nov_25_8(1)_206-215.nxml.txt.nlp	19028613	SENT145	23	23	12	12	trastuzumab	HER2	PA451743	2064	0.435
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_7_2013_219472.nxml.txt.nlp	23662119	SENT243	9	9	16	16	cisplatin	HER2	PA449014	2064	0.435
NULL	Crit_Care_2010_Oct_21_14(5)_1004.nxml.txt.nlp	20979668	SENT22	17	17	14	14	exenatide	GLP-1	PA164749238	100125288	0.435
NULL	Basic_Res_Cardiol_2012_Mar_11_107(2)_245.nxml.txt.nlp	22234702	SENT142	0	0	19	19	cocaine	AP-1	PA449072	2353;3727;2354;3725	0.435
NULL	Oncol_Lett_2014_Jan_6_7(1)_255-259.nxml.txt.nlp	24348859	SENT93	7	7	27	27	cisplatin	DCX	PA449014	1641	0.435
NULL	Cancers_(Basel)_2011_Aug_5_3(3)_3114-3142.nxml.txt.nlp	24212948	SENT820	1	1	8	8	gemcitabine	CD11b	PA449748	3684	0.435
NULL	Clin_Transl_Allergy_2013_Sep_2_3_29.nxml.txt.nlp	24004581	SENT192	2	2	16	16	omalizumab	IL-4	PA164752253	3565	0.435
NULL	Case_Rep_Hematol_2015_Jan_5_2015_321602.nxml.txt.nlp	25628902	SENT4	26	26	7	7	cyclosporine	CTX	PA449167	1593	0.435
NULL	Case_Rep_Ophthalmol_2011_Aug_18_2(2)_283-286.nxml.txt.nlp	21941507	SENT10	3	3	15	15	fluorescein	hole	PA164746009	80757	0.435
NULL	Oxid_Med_Cell_Longev_2013_Mar_18_2013_746432.nxml.txt.nlp	23577226	SENT157	31	31	19	19	curcumin	NRF2	PA151958596	2551;4780	0.435
NULL	Breast_Cancer_Res_Treat_2013_Aug_20_141(1)_43-53.nxml.txt.nlp	23959396	SENT25	44	44	5	5	trastuzumab	HER2	PA451743	2064	0.435
NULL	Front_Pharmacol_2014_Mar_21_5_47.nxml.txt.nlp	24711794	SENT1022	5	5	1	1	atorvastatin	Q10	PA448500	27161	0.435
NULL	AIDS_Res_Ther_2009_Apr_9_6_3.nxml.txt.nlp	19358725	SENT7	31	31	40	40	abacavir	ATV	PA448004	4683	0.435
NULL	Clin_Interv_Aging_2008_Sep_3(3)_453-472.nxml.txt.nlp	18982916	SENT357	3	3	8	8	sulfadiazine	CD4	PA451539	920	0.435
NULL	Bioengineered_2013_May_1_4(3)_153-157.nxml.txt.nlp	23111318	SENT94	25	25	34	34	thrombin	FVIII	PA451674	2157	0.435
NULL	Br_J_Cancer_2001_Sep_85(5)_764-771.nxml.txt.nlp	11531265	SENT3	27	27	19	19	chlorambucil	CPG2	PA448926	23345	0.435
NULL	J_Evol_Biol_2010_May_23(5)_1033-1049.nxml.txt.nlp	20345808	SENT39	18	18	23	23	nadh	ND1	PA164755085	4535;10625	0.435
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_4_2013_592127.nxml.txt.nlp	23662144	SENT8	24	24	30	30	dextran	ZO-1	PA449261	7082	0.435
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT166	0	0	7	7	tacrolimus	IL-6	PA451578	3569	0.435
NULL	Nat_Commun_2013_Oct_7_4_2564.nxml.txt.nlp	24096827	SENT331	27	27	17	17	thrombin	ADP	PA451674	23038	0.435
NULL	Br_J_Cancer_2009_May_19_100(10)_1540-1548.nxml.txt.nlp	19384300	SENT109	13	13	7	7	trypsin	SLPI	PA451806	6590	0.435
NULL	Int_J_Mol_Sci_2014_Jun_18_15(6)_11013-11029.nxml.txt.nlp	24945311	SENT80	22	22	16	16	celecoxib	JAK2	PA448871	3717	0.435
NULL	Am_J_Physiol_Cell_Physiol_2014_Jan_15_306(2)_C89-C97.nxml.txt.nlp	24133067	SENT55	13	13	6	6	hyaluronan	HAS3	PA165958431	3038	0.435
NULL	Oncogenesis_2014_May_12_3(5)_e102.nxml.txt.nlp	24819061	SENT12	23	23	10	10	nadh	p53	PA164755085	7157	0.435
NULL	Mol_Cancer_2012_Apr_26_11_26.nxml.txt.nlp	22537224	SENT124	0	0	19	19	bortezomib	FANCF	PA10252	2188	0.435
NULL	Acta_Pharmacol_Sin_2014_Oct_25_35(10)_1293-1301.nxml.txt.nlp	25152022	SENT98	2	2	4	4	enalapril	NLRP3	PA449456	114548	0.435
NULL	Int_J_Mol_Sci_2014_Jun_5_15(6)_10083-10100.nxml.txt.nlp	24905407	SENT14	16	16	20	20	tetracycline	TRB	PA451640	6957	0.435
NULL	Breast_Cancer_Res_2006_Oct_2_8(5)_R56.nxml.txt.nlp	17014703	SENT159	18	18	38	38	collagenase	COL12A1	PA449107	1303	0.435
NULL	Eur_J_Nutr_2012_Aug_18_51(5)_549-556.nxml.txt.nlp	21850495	SENT39	18	18	7	7	thrombin	ADP	PA451674	23038	0.435
NULL	Zookeys_2014_Nov_25_(457)_1-14.nxml.txt.nlp	25561827	SENT116	36	36	15	15	ethanol	San	PA448073	80218	0.435
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_May_7_67(Pt_6)_m708-m709.nxml.txt.nlp	21754609	SENT63	12	12	9	9	ethanol	mol	PA448073	90527	0.435
NULL	J_Gastroenterol_2014_Sep_25_49(8)_1253-1263.nxml.txt.nlp	24065124	SENT276	7	7	16	16	ribavirin	IL28B	PA451241	282617	0.435
NULL	Iran_J_Pharm_Res_2014_Autumn_13(4)_1183-1190.nxml.txt.nlp	25587306	SENT44	6	6	13	13	rimantadine	mol	PA164748038	90527	0.435
NULL	Cancer_Cell_Int_2005_Jul_7_5_20.nxml.txt.nlp	16001980	SENT132	12	12	7	7	daunorubicin	P-gp	PA449212	5243	0.435
NULL	Mol_Brain_2013_Dec_9_6_54.nxml.txt.nlp	24321245	SENT24	30	30	26	26	potassium	TREK-1	PA451047	3776	0.435
NULL	Environ_Health_Perspect_2005_Nov_14_113(11)_1600-1606.nxml.txt.nlp	16263518	SENT95	14	14	26	26	estradiol	HSD2	PA449503	6060	0.435
NULL	Biochemistry_2012_Sep_25_51(38)_7456-7464.nxml.txt.nlp	22947085	SENT105	10	10	23	23	glutaraldehyde	7B2	PA449777	6447	0.435
NULL	Diabetes_2008_Sep_57(9)_2272-2279.nxml.txt.nlp	18519799	SENT169	9	9	28	28	rosiglitazone	NEFA	PA451283	4925	0.435
NULL	Oncogene_2014_Aug_28_33(35)_4407-4417.nxml.txt.nlp	24469038	SENT123	33	33	11	11	cisplatin	14-3-3	PA449014	10971	0.435
NULL	Crit_Care_2011_Jun_24_15(3)_R153.nxml.txt.nlp	21702944	SENT219	0	0	12	12	dexmedetomidine	PI3K	PA449256	5290	0.435
NULL	J_Cell_Biol_2007_Apr_23_177(2)_343-354.nxml.txt.nlp	17438076	SENT294	24	24	19	19	dextran	EEA1	PA449261	8411	0.435
NULL	Neuroscience_2009_Jun_30_161(2-3)_572-577.nxml.txt.nlp	19327387	SENT17	10	10	22	22	capsaicin	TRPV1	PA448776	7442	0.435
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Feb_17_68(Pt_3)_o700-o701.nxml.txt.nlp	22412590	SENT4	8	8	27	27	erythromycin	mol	PA449493	90527	0.435
NULL	Oxid_Med_Cell_Longev_2011_Sep_21_2011_253529.nxml.txt.nlp	21949898	SENT19	8	8	10	10	decitabine	DAC	PA164749631	13	0.435
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Jul_23_6_103-113.nxml.txt.nlp	25114588	SENT219	17	17	2	2	trastuzumab	DM1	PA451743	338023;1760;28509	0.435
NULL	Biochem_Biophys_Res_Commun_2010_Feb_26_393(1)_50-54.nxml.txt.nlp	20100462	SENT39	28	28	17	17	tetracycline	TRPM2	PA451640	7226	0.435
NULL	Acta_Pharmacol_Sin_2010_Jan_21_31(1)_35-42.nxml.txt.nlp	20023693	SENT140	4	4	14	14	atorvastatin	IL-6	PA448500	3569	0.435
NULL	ScientificWorldJournal_2014_Jan_29_2014_265953.nxml.txt.nlp	24688374	SENT158	10	10	15	15	resveratrol	CMC2		56942	0.435
NULL	Nanoscale_Res_Lett_2009_Apr_25_4(8)_789-793.nxml.txt.nlp	20596333	SENT40	14	14	17	17	copper	TEM	PA449114	64102	0.435
NULL	Drugs_R_D_2013_Jun_16_13(2)_137-143.nxml.txt.nlp	23677811	SENT3	31	31	27	27	eslicarbazepine	API	PA165947475	5345	0.435
NULL	Mol_Cancer_2008_Mar_26_7_27.nxml.txt.nlp	18366759	SENT267	14	14	20	20	etoposide	BAX	PA449552	581	0.434
NULL	Chiropr_Osteopat_2006_Oct_18_14_25.nxml.txt.nlp	17044942	SENT34	9	9	11	11	vasopressin	ACTH	PA451858	5443	0.434
NULL	J_Oncol_2010_Jun_10_2010_943823.nxml.txt.nlp	20628485	SENT176	28	28	22	22	etoposide	MICE	PA449552	4280;23581	0.434
NULL	Front_Oncol_2014_Jun_18_4_159.nxml.txt.nlp	24995161	SENT163	5	5	11	11	estradiol	AKR1C3	PA449503	8644	0.434
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_17_2012_250584.nxml.txt.nlp	23118786	SENT30	13	13	16	16	oxygen	ROS	PA450744	6098	0.434
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2007_Dec_6_64(Pt_1)_o82.nxml.txt.nlp	21200959	SENT65	30	30	15	15	ethanol	mol	PA448073	90527	0.434
NULL	Crit_Care_2008_Oct_14_12(5)_227.nxml.txt.nlp	18983707	SENT98	3	3	5	5	vasopressin	EPO	PA451858	7076;8288;2056	0.434
NULL	J_Asthma_Allergy_2010_Aug_13_3_33-42.nxml.txt.nlp	21437038	SENT111	36	36	22	22	formoterol	FIX	PA134687907	2158	0.434
NULL	Arthritis_Res_Ther_2011_Aug_11_13(4)_R130.nxml.txt.nlp	21835001	SENT279	19	19	23	23	collagenase	ADAMTS5	PA449107	11096	0.434
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jan_31_65(Pt_2)_o427-o428.nxml.txt.nlp	21582014	SENT76	29	29	26	26	acetone	mol	PA448025	90527	0.434
NULL	Mol_Cancer_2012_Dec_12_11_91.nxml.txt.nlp	23234355	SENT200	19	19	14	14	erlotinib	EGFR	PA134687924	1956	0.434
NULL	Cells_2014_Apr_8_3(2)_258-287.nxml.txt.nlp	24717323	SENT102	10	10	7	7	capsaicin	TRPV1	PA448776	7442	0.434
NULL	ScientificWorldJournal_2014_May_13_2014_365974.nxml.txt.nlp	24959610	SENT10	31	31	28	28	exenatide	GLP-1	PA164749238	100125288	0.434
NULL	Clin_Endosc_2013_Nov_19_46(6)_643-646.nxml.txt.nlp	24340258	SENT74	2	2	5	5	triamcinolone	ESD	PA451749	2098	0.434
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT134	4	4	6	6	celecoxib	IL-6	PA448871	3569	0.434
NULL	Interdiscip_Perspect_Infect_Dis_2014_Jan_22_2014_715279.nxml.txt.nlp	24587800	SENT49	21	21	12	12	fluorescein	CD38	PA164746009	952	0.434
NULL	J_Cheminform_2011_May_13_3_14.nxml.txt.nlp	21569515	SENT141	12	12	14	14	trypsin	PRSS1	PA451806	5644	0.434
NULL	Cancer_Metastasis_Rev_2010_Dec_9_29(4)_777-784.nxml.txt.nlp	20936327	SENT180	3	3	19	19	thrombin	PAFR	PA451674	64582	0.434
NULL	Infect_Dis_Obstet_Gynecol_2013_Mar_7_2013_195637.nxml.txt.nlp	23533318	SENT20	15	15	20	20	isoniazid	IPT	PA450112	54802	0.434
NULL	Front_Endocrinol_(Lausanne)_2014_Oct_2_5_158.nxml.txt.nlp	25324831	SENT432	33	33	20	20	ethanol	NPFF	PA448073	8620	0.434
NULL	Lab_Invest_2010_May_8_90(5)_762-773.nxml.txt.nlp	20142804	SENT50	10	10	2	2	papain	NAC	PA450778	22861	0.434
NULL	Br_J_Cancer_2013_May_28_108(10)_2005-2012.nxml.txt.nlp	23632480	SENT58	22	22	16	16	mitoxantrone	CO2	PA450526	4513	0.434
NULL	Cardiovasc_Diabetol_2010_Sep_23_9_57.nxml.txt.nlp	20863381	SENT160	28	28	35	35	pioglitazone	DM2	PA450970	28508	0.434
NULL	J_Korean_Med_Sci_2009_Jan_29_24(Suppl_1)_S170-S175.nxml.txt.nlp	19194548	SENT82	3	3	5	5	cisplatin	EPO	PA449014	7076;8288;2056	0.434
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_May_14_67(Pt_6)_o1431.nxml.txt.nlp	21754810	SENT60	24	24	21	21	ethanol	mol	PA448073	90527	0.434
NULL	Br_J_Cancer_2010_Sep_7_103(6)_759-764.nxml.txt.nlp	20700118	SENT102	3	3	6	6	letrozole	IMPACT	PA450196	55364	0.434
NULL	Acta_Pharmacol_Sin_2009_Jul_3_30(7)_879-888.nxml.txt.nlp	19574993	SENT145	0	0	6	6	rivastigmine	IL-2	PA451262	3558	0.434
NULL	Clin_Genet_2014_Jan_1_86(1)_21-28.nxml.txt.nlp	24684508	SENT106	20	20	26	26	amifostine	TPMT	PA448365	7172	0.434
NULL	Cancer_Cell_Int_2013_Apr_16_13_36.nxml.txt.nlp	23590596	SENT9	33	33	30	30	doxorubicin	TRAIL	PA449412	8743	0.434
NULL	Clin_Ophthalmol_2008_Dec_2(4)_897-905.nxml.txt.nlp	19668444	SENT130	7	7	12	12	travoprost	BAK	PA164781371	578	0.434
NULL	Breast_Cancer_Res_2009_Jun_29_11(3)_R41.nxml.txt.nlp	19563669	SENT12	7	7	5	5	trastuzumab	TRAIL	PA451743	8743	0.434
NULL	Onco_Targets_Ther_2014_May_3_7_655-662.nxml.txt.nlp	24833909	SENT7	30	30	8	8	flavopiridol	RBCK1	PA452627	10616	0.434
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Apr_27_69(Pt_5)_o790-o791.nxml.txt.nlp	23723933	SENT76	22	22	19	19	ethanol	mol	PA448073	90527	0.434
NULL	Front_Chem_2013_Jun_26_1_8.nxml.txt.nlp	24790937	SENT90	8	8	3	3	copper	DMC	PA449114	284340;54808	0.434
NULL	FEBS_Open_Bio_2014_Jul_3_4_602-610.nxml.txt.nlp	25161868	SENT43	31	31	20	20	thrombin	IL-6	PA451674	3569	0.434
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Nov_21_65(Pt_12)_o3132-o3133.nxml.txt.nlp	21578855	SENT68	0	0	7	7	cefazolin	mol	PA448839	90527	0.434
NULL	Breast_Cancer_Res_2006_Oct_16_8(5)_111.nxml.txt.nlp	17049068	SENT57	3	3	27	27	tamoxifen	STAR	PA451581	6770;2984	0.434
NULL	Ther_Clin_Risk_Manag_2006_Sep_2(3)_235-249.nxml.txt.nlp	18360599	SENT340	36	36	38	38	alendronate	PTH	PA448082	5741	0.434
NULL	Acta_Pharmacol_Sin_2012_Jul_18_33(7)_918-923.nxml.txt.nlp	22705728	SENT9	19	19	17	17	estradiol	aromatase	PA449503	1588	0.434
NULL	Breast_Cancer_(Auckl)_2009_Aug_17_3_47-60.nxml.txt.nlp	21556249	SENT281	2	2	26	26	tamoxifen	STAR	PA451581	6770;2984	0.434
NULL	Cardiovasc_Res_2011_Apr_1_90(1)_105-112.nxml.txt.nlp	21123217	SENT146	11	11	28	28	mibefradil	AMN	PA450492	215;81693	0.434
NULL	Int_J_Mol_Sci_2010_May_25_11(5)_2253-2266.nxml.txt.nlp	20559514	SENT32	26	26	35	35	ethanol	SN1	PA448073	10991	0.434
NULL	Int_J_Mol_Sci_2014_Oct_23_15(10)_19265-19280.nxml.txt.nlp	25342321	SENT62	12	12	14	14	sc-560	MVD		4597	0.434
NULL	Oxid_Med_Cell_Longev_2012_Aug_22_2012_534705.nxml.txt.nlp	22966415	SENT277	17	17	13	13	riluzole	GLAST	PA451251	6507	0.434
NULL	Mar_Drugs_2014_Jun_27_12(7)_3818-3837.nxml.txt.nlp	24979269	SENT149	12	12	3	3	calcein	P-gp	PA132595336	5243	0.434
NULL	Exp_Ther_Med_2014_Nov_29_8(5)_1473-1478.nxml.txt.nlp	25289044	SENT187	5	5	7	7	heparin	AZU	PA449855	566	0.434
NULL	Arthritis_Res_Ther_2010_Jan_22_12(1)_R11.nxml.txt.nlp	20096109	SENT178	9	9	11	11	infliximab	IFN	PA452639	3439	0.434
NULL	Clin_Ophthalmol_2014_Feb_7_8_355-362.nxml.txt.nlp	24532965	SENT212	11	11	2	2	triamcinolone	CST	PA451749	9514	0.434
NULL	J_Korean_Med_Sci_2014_Jan_26_29(1)_53-60.nxml.txt.nlp	24431906	SENT142	39	39	41	41	rituximab	CHOP	PA451261	1649	0.434
NULL	Med_Sci_Monit_2013_Oct_21_19_875-882.nxml.txt.nlp	24145180	SENT172	23	23	19	19	bevacizumab	FDG	PA130232992	23583	0.434
NULL	Int_J_Nanomedicine_2008_Jun_3(2)_277-286.nxml.txt.nlp	18686787	SENT32	4	4	2	2	doxorubicin	ADM	PA449412	133	0.434
NULL	BioData_Min_2012_Dec_12_5_21.nxml.txt.nlp	23234571	SENT93	23	23	31	31	fluorouracil	CHN2	PA128406956	1124	0.434
NULL	Acta_Pharmacol_Sin_2012_May_4_33(5)_710-716.nxml.txt.nlp	22555373	SENT119	11	11	14	14	phenylbutazone	DOM	PA450932	6663	0.434
NULL	Case_Rep_Endocrinol_2011_Aug_11_2011_246872.nxml.txt.nlp	22937279	SENT49	12	12	14	14	thyroglobulin	TTF-1	PA164754910	7080	0.434
NULL	Protein_Eng_Des_Sel_2014_Apr_28_27(4)_97-109.nxml.txt.nlp	24586053	SENT249	15	15	12	12	trastuzumab	CEA	PA451743	5670;1087	0.434
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jan_31_65(Pt_2)_o420-o421.nxml.txt.nlp	21582009	SENT68	21	21	18	18	ethanol	mol	PA448073	90527	0.434
NULL	Br_J_Cancer_2009_Mar_24_100(6)_1017.nxml.txt.nlp	19293816	SENT8	41	41	21	21	sn-38	UGT1A1		54658	0.434
NULL	J_Basic_Clin_Pharm_2012_Dec_4(1)_20-24.nxml.txt.nlp	24808665	SENT119	9	9	11	11	loperamide	castor	PA450262	54897	0.433
NULL	Int_J_Mol_Sci_2014_Sep_30_15(10)_17733-17750.nxml.txt.nlp	25272228	SENT70	4	4	7	7	oxygen	ROS	PA450744	6098	0.433
NULL	Interdiscip_Toxicol_2011_Dec_4(4)_211-215.nxml.txt.nlp	22319256	SENT112	2	2	17	17	diazepam	ANOVA	PA449283	4858	0.433
NULL	ACS_Appl_Mater_Interfaces_2014_Feb_26_6(4)_2842-2849.nxml.txt.nlp	24433042	SENT48	16	16	45	45	collagenase	CO2	PA449107	4513	0.433
NULL	Bioinform_Biol_Insights_2009_Oct_5_3_109-127.nxml.txt.nlp	20140064	SENT459	6	6	10	10	tenofovir	P35	PA10204	2220	0.433
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT120	4	4	6	6	curcumin	TRAIL	PA151958596	8743	0.433
NULL	Mol_Vis_2012_Nov_29_18_2839-2846.nxml.txt.nlp	23233786	SENT160	5	5	7	7	geldanamycin	CB2	PA152031327	1269	0.433
NULL	Nat_Commun_2014_Apr_7_5_3554.nxml.txt.nlp	24704861	SENT351	12	12	9	9	sunitinib	PKR	PA162372840	5610	0.433
NULL	Clin_Interv_Aging_2013_Apr_19_8_433-442.nxml.txt.nlp	23626463	SENT152	16	16	18	18	bevacizumab	IFN	PA130232992	3439	0.433
NULL	Natl_J_Maxillofac_Surg_2013_Jan-Jun_4(1)_19-24.nxml.txt.nlp	24163548	SENT172	9	9	16	16	phentolamine	San	PA450926	80218	0.433
NULL	Ther_Clin_Risk_Manag_2006_Mar_2(1)_19-24.nxml.txt.nlp	18360578	SENT54	7	7	17	17	oxybutynin	hole	PA164746030	80757	0.433
NULL	Chin_J_Cancer_2013_Dec_32(12)_640-647.nxml.txt.nlp	23816559	SENT88	6	6	1	1	mitoxantrone	FANCF	PA450526	2188	0.433
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_May_23_68(Pt_6)_o1860.nxml.txt.nlp	22719625	SENT72	19	19	16	16	ethanol	mol	PA448073	90527	0.433
NULL	J_Res_Med_Sci_2010_Nov-Dec_15(6)_331-343.nxml.txt.nlp	21526106	SENT181	9	9	7	7	l-arginine	HDEL	PA448478	10945	0.433
NULL	Nat_Commun_2012_Dec_11_3_1271.nxml.txt.nlp	23232401	SENT151	3	3	9	9	trastuzumab	HRG	PA451743	3084;3273	0.433
NULL	Oncoimmunology_2013_Aug_1_2(8)_e26218.nxml.txt.nlp	24179709	SENT84	19	19	25	25	hyaluronan	IL-6	PA165958431	3569	0.433
NULL	Virol_J_2011_May_17_8_234.nxml.txt.nlp	21575275	SENT6	10	10	8	8	ribavirin	IFN	PA451241	3439	0.433
NULL	FEBS_Open_Bio_2011_Dec_27_2_1-5.nxml.txt.nlp	23650573	SENT296	3	3	9	9	sunitinib	MDM2	PA162372840	4193	0.433
NULL	Arch_Med_Sci_2014_Oct_27_10(5)_1007-1018.nxml.txt.nlp	25395954	SENT225	11	11	14	14	trastuzumab	Yes	PA451743	7525	0.433
NULL	Nucleic_Acids_Res_2011_Sep_7_39(17)_7465-7476.nxml.txt.nlp	21653549	SENT175	12	12	4	4	etoposide	DEK	PA449552	7913	0.433
NULL	Nat_Neurosci_2012_Sep_5_15(9)_1245-1254.nxml.txt.nlp	22864611	SENT38	12	12	33	33	haloperidol	mGlu2	PA449841	2912	0.433
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Mar_28_65(Pt_4)_o885.nxml.txt.nlp	21582594	SENT76	22	22	19	19	ethanol	mol	PA448073	90527	0.433
NULL	Ann_Clin_Microbiol_Antimicrob_2005_Sep_13_4_13.nxml.txt.nlp	16159399	SENT215	12	12	10	10	ribavirin	IFN	PA451241	3439	0.433
NULL	Breast_Cancer_Res_2004_Aug_5_6(5)_R601-R607.nxml.txt.nlp	15318941	SENT40	10	10	8	8	docetaxel	p27	PA449383	5715;10534	0.433
NULL	J_Invest_Dermatol_2014_Apr_19_134(4)_965-974.nxml.txt.nlp	24352044	SENT33	28	28	16	16	hyaluronan	PECAM1	PA165958431	5175	0.433
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Feb_17_68(Pt_3)_o737.nxml.txt.nlp	22412617	SENT68	38	38	35	35	ethanol	mol	PA448073	90527	0.433
NULL	Int_J_Breast_Cancer_2011_Sep_6_2011_352182.nxml.txt.nlp	22295219	SENT129	7	7	5	5	trastuzumab	PTEN	PA451743	5728	0.433
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2007_Dec_6_64(Pt_1)_o191.nxml.txt.nlp	21200756	SENT59	23	23	20	20	ethanol	mol	PA448073	90527	0.433
NULL	Front_Comput_Neurosci_2013_Apr_5_7_22.nxml.txt.nlp	23576979	SENT159	9	9	11	11	propofol	HCN1	PA451141	348980	0.433
NULL	Acta_Histochem_Cytochem_2006_Mar_2_39(1)_1-7.nxml.txt.nlp	17460766	SENT11	5	5	3	3	choline	FGF1	PA448976	2246	0.433
NULL	Diabetes_2011_Mar_21_60(3)_757-765.nxml.txt.nlp	21282370	SENT177	8	8	27	27	isoproterenol	PTRF	PA450121	284119	0.433
NULL	Diabetes_2013_Oct_17_62(10)_3547-3552.nxml.txt.nlp	23863812	SENT107	0	0	12	12	pravastatin	adiponectin	PA451089	9370	0.433
NULL	Clin_Ophthalmol_2012_Feb_20_6_277-282.nxml.txt.nlp	22375096	SENT2	23	23	26	26	triamcinolone	STA	PA451749	2010;2656	0.433
NULL	J_Cell_Mol_Med_2014_Mar_22_18(3)_480-491.nxml.txt.nlp	24450440	SENT61	29	29	6	6	sorafenib	San	PA7000	80218	0.433
NULL	Indian_J_Psychiatry_2012_Oct-Dec_54(4)_394.nxml.txt.nlp	23372255	SENT11	31	31	37	37	lorazepam	B12	PA450267	7126;4709	0.433
NULL	Acta_Pharmacol_Sin_2010_Apr_8_31(4)_461-469.nxml.txt.nlp	20208553	SENT101	1	1	4	4	ethanol	adiponectin	PA448073	9370	0.433
NULL	Acta_Pharmacol_Sin_2011_Jul_20_32(7)_888-894.nxml.txt.nlp	21685926	SENT86	19	19	12	12	nadh	HSC70	PA164755085	3312	0.433
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Jul_26_64(Pt_8)_o1594-o1595.nxml.txt.nlp	21203289	SENT71	28	28	25	25	ethanol	mol	PA448073	90527	0.433
NULL	Europace_2011_Feb_7_13(2)_161-173.nxml.txt.nlp	21138930	SENT9	30	30	16	16	flecainide	CAST	PA449646	10849;26059;831	0.433
NULL	Oxid_Med_Cell_Longev_2009_Jan-Mar_2(1)_52-57.nxml.txt.nlp	20046645	SENT37	19	19	22	22	oxygen	ROS	PA450744	6098	0.433
NULL	Cardiovasc_Drugs_Ther_2010_Dec_13_24(5-6)_391-399.nxml.txt.nlp	20640495	SENT164	8	8	10	10	atorvastatin	DIP	PA448500	23151;1831	0.433
NULL	Aging_(Albany_NY)_2009_May_22_1(6)_557-572.nxml.txt.nlp	20195383	SENT167	6	6	9	9	creatine	ADP	PA164778930	23038	0.433
NULL	Chem_Commun_(Camb)_2013_Jun_21_49(76)_8441-8443.nxml.txt.nlp	23770604	SENT22	15	15	13	13	geldanamycin	Hsp90	PA152031327	3320	0.433
NULL	AIDS_Res_Ther_2006_Jul_22_3_19.nxml.txt.nlp	16859567	SENT134	11	11	14	14	oxygen	ROS	PA450744	6098	0.433
NULL	Arch_Med_Sci_2012_Nov_9_8(5)_907-917.nxml.txt.nlp	23185203	SENT75	9	9	6	6	exenatide	GLP-1	PA164749238	100125288	0.433
NULL	J_Hematol_Oncol_2011_Jun_10_4_27.nxml.txt.nlp	21663651	SENT34	24	24	13	13	cyclosporine	CTX	PA449167	1593	0.433
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT192	43	43	47	47	gefitinib	Yes	PA131301952	7525	0.433
NULL	Int_J_Mol_Sci_2014_Sep_30_15(10)_17686-17704.nxml.txt.nlp	25272226	SENT101	28	28	33	33	cetuximab	EGF	PA10040	1950	0.433
NULL	J_Brachial_Plex_Peripher_Nerve_Inj_2008_Mar_19_3_8.nxml.txt.nlp	18353188	SENT13	1	1	5	5	capsaicin	SSeCKS	PA448776	9590	0.433
NULL	J_Neurol_2011_Jul_2_258(7)_1207-1222.nxml.txt.nlp	21461686	SENT260	15	15	35	35	gabapentin	OPT	PA449720	51430	0.433
NULL	Br_J_Cancer_2009_Mar_24_100(6)_1017.nxml.txt.nlp	19293816	SENT8	18	18	21	21	irinotecan	UGT1A1	PA450085	54658	0.433
NULL	Addict_Health_2009_Summer_1(1)_31-36.nxml.txt.nlp	24494080	SENT90	26	26	22	22	cocaine	LSD	PA449072	1776	0.433
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Feb_27_64(Pt_3)_o630.nxml.txt.nlp	21201961	SENT55	22	22	19	19	ethanol	mol	PA448073	90527	0.433
NULL	Adv_Hematol_2011_Apr_10_2011_960137.nxml.txt.nlp	21547266	SENT9	8	8	25	25	rituximab	NHL	PA451261	51750	0.433
NULL	Drugs_Context_2012_Nov_26_2012_212243.nxml.txt.nlp	24432032	SENT398	2	2	13	13	theophylline	IL-8	PA451647	3576	0.433
NULL	J_Anaesthesiol_Clin_Pharmacol_2012_Jan-Mar_28(1)_92-100.nxml.txt.nlp	22345954	SENT116	6	6	15	15	desflurane	CO2	PA164749136	4513	0.433
NULL	Diabetes_Care_2013_Aug_17_36(Suppl_2)_S127-S138.nxml.txt.nlp	23882037	SENT215	0	0	2	2	metformin	GLP-1	PA450395	100125288	0.433
NULL	Protein_J_2012_Aug_5_31(6)_511-518.nxml.txt.nlp	22763563	SENT130	0	0	7	7	atorvastatin	MSR1	PA448500	4481	0.433
NULL	Braz_J_Med_Biol_Res_2014_Aug_1_47(9)_789-798.nxml.txt.nlp	25098618	SENT18	18	18	15	15	phenylephrine	ANG	PA450935	283	0.433
NULL	Indian_J_Med_Res_2014_May_139(5)_667-674.nxml.txt.nlp	25027075	SENT109	20	20	25	25	tipifarnib	LMNA	PA165110778	4000	0.433
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_21-38.nxml.txt.nlp	19305786	SENT123	25	25	4	4	capsaicin	TRPV1	PA448776	7442	0.433
NULL	Sci_Rep_2014_Dec_12_4_7467.nxml.txt.nlp	25502280	SENT274	6	6	8	8	taurine	spatial	PA451590	219793	0.433
NULL	Int_J_Anal_Chem_2013_Jul_16_2013_419716.nxml.txt.nlp	23956748	SENT187	36	36	21	21	heparin	PF6	PA449855	200162	0.433
NULL	Arthritis_Res_Ther_2008_Sep_18_10(5)_215.nxml.txt.nlp	18828883	SENT79	19	19	16	16	ribavirin	IFN	PA451241	3439	0.432
NULL	FASEB_J_2013_Jan_27(1)_222-231.nxml.txt.nlp	23047895	SENT21	26	26	17	17	rituximab	IFN	PA451261	3439	0.432
NULL	Cancers_(Basel)_2010_Jun_14_2(2)_1288-1311.nxml.txt.nlp	24281116	SENT357	9	9	14	14	oxygen	p53	PA450744	7157	0.432
NULL	Clin_Kidney_J_2013_Feb_1_6(1)_45-49.nxml.txt.nlp	23372940	SENT131	15	15	30	30	tacrolimus	CYP3A5	PA451578	1577	0.432
NULL	Apoptosis_2011_Jul_23_16(7)_708-721.nxml.txt.nlp	21516346	SENT407	35	35	37	37	etoposide	gamma	PA449552	9913	0.432
NULL	J_Exp_Bot_2012_Mar_15_63(5)_1969-1983.nxml.txt.nlp	22174442	SENT257	21	21	14	14	ethanol	NO3	PA448073	4681	0.432
NULL	Indian_J_Pharm_Sci_2008_Jan-Feb_70(1)_102-105.nxml.txt.nlp	20390092	SENT69	19	19	21	21	lansoprazole	DOM	PA450180	6663	0.432
NULL	Br_J_Cancer_2012_Sep_25_107(7)_1009-1016.nxml.txt.nlp	22948724	SENT69	10	10	12	12	sorafenib	IFN	PA7000	3439	0.432
NULL	J_Cardiothorac_Surg_2012_Sep_27_7_97.nxml.txt.nlp	23013706	SENT163	7	7	4	4	warfarin	CYP4F2	PA451906	8529	0.432
NULL	Oncol_Discov_2013_1(4)_10_7243_2052-6199-1-4.nxml.txt.nlp	25383193	SENT247	23	23	18	18	sulindac	NAC	PA451565	22861	0.432
NULL	Bull_Environ_Contam_Toxicol_2010_Sep_25_85(3)_251-255.nxml.txt.nlp	20577871	SENT26	19	19	6	6	ethanol	FAE	PA448073	2178	0.432
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT1777	18	18	4	4	rifampin	ATV	PA451250	4683	0.432
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT192	43	43	46	46	gefitinib	Yes	PA131301952	7525	0.432
NULL	Am_J_Physiol_Cell_Physiol_2014_Jan_15_306(2)_C89-C97.nxml.txt.nlp	24133067	SENT190	7	7	11	11	doxorubicin	PC-3	PA449412	692094	0.432
NULL	Front_Behav_Neurosci_2012_Nov_22_6_78.nxml.txt.nlp	23189046	SENT75	31	31	8	8	ethanol	OX1R	PA448073	3061	0.432
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Aug_28_66(Pt_9)_o2421.nxml.txt.nlp	21588746	SENT63	22	22	19	19	ethanol	mol	PA448073	90527	0.432
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Sep_18_69(Pt_10)_o1545.nxml.txt.nlp	24098230	SENT70	32	32	28	28	ethanol	mol	PA448073	90527	0.432
NULL	Biomed_Res_Int_2014_Apr_29_2014_186864.nxml.txt.nlp	24877064	SENT108	23	23	20	20	ciprofloxacin	IFN	PA449009	3439	0.432
NULL	J_Antimicrob_Chemother_2009_Feb_28_63(2)_389-395.nxml.txt.nlp	19042940	SENT34	34	34	43	43	trimethoprim	UTI	PA451788	259	0.432
NULL	EMBO_J_2009_Aug_19_28(16)_2360-2373.nxml.txt.nlp	19609305	SENT47	6	6	6	6	pp2	PP2		4888	0.432
NULL	Cancer_Cell_Int_2013_Sep_23_13_94.nxml.txt.nlp	24059699	SENT142	26	26	8	8	bevacizumab	VEGFA	PA130232992	7422	0.432
NULL	Acta_Crystallogr_B_Struct_Sci_Cryst_Eng_Mater_2014_Sep_18_70(Pt_5)_820-827.nxml.txt.nlp	25274515	SENT126	8	8	21	21	nitrile	ski	PA450636	55733	0.432
NULL	Oncoimmunology_2014_Jan_17_3_e27572.nxml.txt.nlp	24734216	SENT76	10	10	12	12	zoledronate	IL-2	PA10235	3558	0.432
NULL	Ann_Intensive_Care_2011_Jul_19_1_26.nxml.txt.nlp	21906376	SENT92	9	9	15	15	vancomycin	SAPS	PA451850	8935	0.432
NULL	Exp_Ther_Med_2014_Nov_29_8(5)_1473-1478.nxml.txt.nlp	25289044	SENT190	2	2	4	4	heparin	AZU	PA449855	566	0.432
NULL	Appl_Clin_Genet_2013_Oct_18_6_91-101.nxml.txt.nlp	24159262	SENT18	15	15	12	12	thrombin	FIX	PA451674	2158	0.432
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT166	3	3	34	34	capsaicin	p53	PA448776	7157	0.432
NULL	Breast_Cancer_Res_2006_Oct_2_8(5)_R56.nxml.txt.nlp	17014703	SENT159	18	18	28	28	collagenase	COL6A1	PA449107	1291	0.432
NULL	J_Gastrointest_Cancer_2014_May_18_45(3)_380-382.nxml.txt.nlp	23686662	SENT46	8	8	5	5	cyclophosphamide	CHOP	PA449165	1649	0.432
NULL	Br_J_Cancer_2011_Mar_15_104(6)_899-902.nxml.txt.nlp	21343938	SENT51	16	16	42	42	tamoxifen	ATAC	PA451581	6375	0.432
NULL	J_Exp_Med_1998_Jun_1_187(11)_1885-1892.nxml.txt.nlp	9607928	SENT108	9	9	15	15	thalidomide	IL-2	PA451644	3558	0.432
NULL	J_Cell_Mol_Med_2014_Jul_24_18(7)_1358-1371.nxml.txt.nlp	24758741	SENT371	23	23	13	13	raloxifene	CD31	PA451221	5175	0.432
NULL	Adv_Urol_2012_Nov_1_2012_641689.nxml.txt.nlp	22110494	SENT153	11	11	15	15	docetaxel	CRT	PA449383	811	0.432
NULL	Patient_Prefer_Adherence_2011_Dec_23_6_1-9.nxml.txt.nlp	22272064	SENT1	28	28	24	24	ramipril	ACE	PA451223	1636	0.432
NULL	Cell_Commun_Signal_2011_May_15_9_13.nxml.txt.nlp	21569639	SENT321	0	0	2	2	quinacrine	AKT	PA164745551	207	0.432
NULL	Cancer_Cell_Int_2011_May_15_11_13.nxml.txt.nlp	21569620	SENT126	11	11	3	3	bortezomib	PC-3	PA10252	692094	0.432
NULL	Int_J_Endocrinol_Metab_2013_Jul_1_Summer_11(3)_184-190.nxml.txt.nlp	24348591	SENT179	17	17	20	20	liraglutide	INS-1	PA165958364	2305	0.432
NULL	Ann_Hematol_2014_Sep_12_93(1)_13-32.nxml.txt.nlp	24026426	SENT274	21	21	29	29	posaconazole	BII	PA151958574	777	0.432
NULL	Acta_Pharmacol_Sin_2012_Jan_28_33(1)_75-81.nxml.txt.nlp	22120969	SENT92	0	0	2	2	exenatide	GLP-1	PA164749238	100125288	0.432
NULL	Cases_J_2009_Jun_10_2_8183.nxml.txt.nlp	19830060	SENT62	10	10	7	7	cyclophosphamide	CHOP	PA449165	1649	0.432
NULL	Case_Rep_Ophthalmol_2011_Mar_12_2(1)_105-110.nxml.txt.nlp	22110438	SENT43	5	5	3	3	ribavirin	IFN	PA451241	3439	0.432
NULL	FEBS_Open_Bio_2014_Mar_19_4_301-309.nxml.txt.nlp	24918042	SENT229	10	10	28	28	gentamicin	NOK	PA449753	55359	0.432
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Nov_13_66(Pt_12)_o3142.nxml.txt.nlp	21589441	SENT4	1	1	3	3	ethanol	mol	PA448073	90527	0.432
NULL	Biomed_Res_Int_2014_Apr_27_2014_180428.nxml.txt.nlp	24877063	SENT20	19	19	8	8	bortezomib	TRPV1	PA10252	7442	0.432
NULL	Clin_Ophthalmol_2008_Jun_2(2)_355-368.nxml.txt.nlp	19668727	SENT247	0	0	6	6	nepafenac	COX	PA165958407	1351	0.432
NULL	Clin_Pharmacol_2012_Feb_20_4_13-20.nxml.txt.nlp	22427735	SENT90	8	8	39	39	clopidogrel	PON1	PA449053	5444	0.432
NULL	Braz_J_Med_Biol_Res_2014_Oct_14_47(12)_1068-1074.nxml.txt.nlp	25387674	SENT124	13	13	17	17	taurine	ANOVA	PA451590	4858	0.432
NULL	Crit_Care_2010_Mar_15_14(2)_R30.nxml.txt.nlp	20226064	SENT217	21	21	12	12	thiopental	IL-2	PA451664	3558	0.432
NULL	Nat_Commun_2013_Oct_1_4_2516.nxml.txt.nlp	24084631	SENT114	0	0	5	5	losartan	AK4	PA450268	205	0.432
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_May_15_66(Pt_6)_o1352.nxml.txt.nlp	21579438	SENT64	25	25	22	22	ethanol	mol	PA448073	90527	0.432
NULL	Core_Evid_2009_Jun_15_4_181-189.nxml.txt.nlp	20694074	SENT224	23	23	2	2	methotrexate	ACR	PA450428	49	0.432
NULL	Br_J_Cancer_2010_Jul_27_103(3)_315-323.nxml.txt.nlp	20661248	SENT243	6	6	13	13	bevacizumab	IFL	PA130232992	3439	0.432
NULL	Lab_Invest_2009_Nov_7_89(11)_1275-1290.nxml.txt.nlp	19736547	SENT175	6	6	11	11	curcumin	LOX-1	PA151958596	4973	0.432
NULL	Int_J_Endocrinol_Metab_2013_Jul_1_Summer_11(3)_184-190.nxml.txt.nlp	24348591	SENT201	16	16	21	21	liraglutide	INS-1	PA165958364	2305	0.432
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Apr_13_69(Pt_5)_o732.nxml.txt.nlp	23723884	SENT81	39	39	36	36	ethanol	mol	PA448073	90527	0.432
NULL	Toxins_(Basel)_2010_Oct_26_2(11)_2490-2518.nxml.txt.nlp	22069563	SENT223	7	7	4	4	cisplatin	TLR4	PA449014	7099	0.432
NULL	Iran_Red_Crescent_Med_J_2012_Dec_6_14(12)_782-786.nxml.txt.nlp	23483042	SENT133	4	4	28	28	vancomycin	VISA	PA451850	57506	0.432
NULL	J_Biomed_Biotechnol_2011_Jan_24_2011_250860.nxml.txt.nlp	21318107	SENT218	23	23	15	15	galactose	CCL22	PA449725	6367	0.432
NULL	Breast_Cancer_Res_2006_Jun_28_8(3)_R33.nxml.txt.nlp	16805920	SENT215	2	2	4	4	estradiol	EGF	PA449503	1950	0.432
NULL	Ann_Clin_Microbiol_Antimicrob_2009_Sep_24_8_26.nxml.txt.nlp	19778428	SENT102	10	10	4	4	oxacillin	PEN	PA450725	9933	0.432
NULL	Cancer_Microenviron_2008_Dec_20_1(1)_103-111.nxml.txt.nlp	19308689	SENT68	2	2	4	4	thrombin	PAR-1	PA451674	2011;2149	0.431
NULL	Br_J_Cancer_2011_Mar_15_104(6)_957-967.nxml.txt.nlp	21364585	SENT156	5	5	10	10	vorinostat	Baz	PA164748224	56288	0.431
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT192	3	3	8	8	doxorubicin	B7-H1	PA449412	29126	0.431
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_8_2013_175135.nxml.txt.nlp	23662115	SENT135	12	12	24	24	ethanol	p53	PA448073	7157	0.431
NULL	Oncotarget_2014_Oct_21_5(22)_11252-11268.nxml.txt.nlp	25361004	SENT236	2	2	10	10	metformin	CLIC1	PA450395	1192	0.431
NULL	Br_J_Ophthalmol_2008_Sep_22_92(9)_1275-1282.nxml.txt.nlp	18723745	SENT109	0	0	2	2	latanoprost	BAK	PA164774763	578	0.431
NULL	Crit_Care_1998_Mar_1_2(Suppl_1)_P021.nxml.txt.nlp	NULL	SENT6	15	15	6	6	thrombin	IL-6	PA451674	3569	0.431
NULL	Front_Neural_Circuits_2013_Sep_17_7_146.nxml.txt.nlp	24062648	SENT572	12	12	14	14	diazepam	CA1	PA449283	759	0.431
NULL	Int_J_Environ_Res_Public_Health_2013_Sep_17_10(9)_4352-4389.nxml.txt.nlp	24048206	SENT286	2	2	4	4	betaine	B12	PA448603	7126;4709	0.431
NULL	Biologics_2010_Dec_2_4_315-323.nxml.txt.nlp	21209726	SENT158	1	1	7	7	imatinib	CML	PA10804	613	0.431
NULL	Case_Rep_Endocrinol_2013_Jun_3_2013_190962.nxml.txt.nlp	23862080	SENT42	22	22	15	15	creatine	CO2	PA164778930	4513	0.431
NULL	J_Obes_2010_Feb_9_2010_831901.nxml.txt.nlp	20798858	SENT185	3	3	12	12	metformin	ANOVA	PA450395	4858	0.431
NULL	J_Gen_Physiol_2012_Oct_140(4)_403-419.nxml.txt.nlp	23008434	SENT108	11	11	14	14	phenol	TMX	PA450913	81542	0.431
NULL	Brain_Sci_2013_Jun_14_3(2)_941-963.nxml.txt.nlp	24961432	SENT55	17	17	14	14	ethanol	CYP2E1	PA448073	1571	0.431
NULL	Interdiscip_Toxicol_2011_Dec_4(4)_211-215.nxml.txt.nlp	22319256	SENT115	2	2	17	17	diazepam	ANOVA	PA449283	4858	0.431
NULL	Acta_Physiol_(Oxf)_2007_Sep_191(1)_43-57.nxml.txt.nlp	17524066	SENT12	27	27	6	6	nifedipine	PES	PA450631	23481	0.431
NULL	Org_Biomol_Chem_2014_Jul_28_12(28)_5082-5088.nxml.txt.nlp	24914735	SENT51	23	23	12	12	ethanol	mol	PA448073	90527	0.431
NULL	Int_J_Hypertens_2013_Dec_11_2013_876865.nxml.txt.nlp	24396591	SENT124	21	21	11	11	ezetimibe	SHARP	PA10816	23013	0.431
NULL	Int_J_Environ_Res_Public_Health_2013_Sep_17_10(9)_4352-4389.nxml.txt.nlp	24048206	SENT268	24	24	22	22	choline	B12	PA448976	7126;4709	0.431
NULL	Nat_Commun_2013_Oct_1_4_2516.nxml.txt.nlp	24084631	SENT645	0	0	5	5	losartan	CCN2	PA450268	1490	0.431
NULL	Br_J_Pharmacol_2011_Jul_163(6)_1263-1275.nxml.txt.nlp	21391977	SENT106	23	23	39	39	l-glutamine	FBS	PA10090	64319;26269	0.431
NULL	Curr_Hepat_Rep_2010_May_21_9(2)_75-90.nxml.txt.nlp	20461127	SENT285	13	13	21	21	telbivudine	LAM	PA164760861	7249;7248	0.431
NULL	Chem_Cent_J_2013_Sep_4_7_147.nxml.txt.nlp	24006941	SENT94	31	31	33	33	lipase	LOX	PA450239	4015	0.431
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Mar_10_68(Pt_4)_o998-o999.nxml.txt.nlp	22590047	SENT65	1	1	33	33	piperazine	C15	PA450977	51316	0.431
NULL	Onco_Targets_Ther_2014_Jun_13_7_1033-1042.nxml.txt.nlp	24966685	SENT202	14	14	22	22	gemcitabine	GAPDH	PA449748	2597	0.431
NULL	Br_J_Cancer_2013_Jul_23_109(2)_351-359.nxml.txt.nlp	23799854	SENT108	7	7	5	5	paclitaxel	BLT2	PA450761	56413	0.431
NULL	Front_Pharmacol_2014_Mar_21_5_46.nxml.txt.nlp	24711793	SENT43	11	11	7	7	aprepitant	NK1	PA164747039	11126	0.431
NULL	Cancers_(Basel)_2010_Apr_9_2(2)_397-419.nxml.txt.nlp	24281076	SENT990	1	1	7	7	curcumin	NF-kappaB	PA151958596	4790	0.431
NULL	Oncotarget_2014_Sep_16_5(20)_9930-9938.nxml.txt.nlp	25294819	SENT28	9	9	15	15	plerixafor	CXCR4	PA165958410	7852	0.431
NULL	ScientificWorldJournal_2013_Dec_30_2013_565813.nxml.txt.nlp	24489506	SENT229	15	15	10	10	cisplatin	Q10	PA449014	27161	0.431
NULL	Oncotarget_2013_Apr_13_4(4)_502-530.nxml.txt.nlp	23594434	SENT271	39	39	13	13	nelfinavir	HIF-1	PA450606	29072	0.431
NULL	Case_Rep_Oncol_Med_2013_Jan_16_2013_292301.nxml.txt.nlp	23401819	SENT131	8	8	2	2	vincristine	CHOP	PA451879	1649	0.431
NULL	J_Korean_Med_Sci_2010_Mar_19_25(3)_481-484.nxml.txt.nlp	20191052	SENT75	3	3	11	11	cyclophosphamide	CHOP	PA449165	1649	0.431
NULL	Int_J_Cardiovasc_Imaging_2012_Aug_4_28(6)_1435-1444.nxml.txt.nlp	21968545	SENT270	27	27	6	6	dipyridamole	Bravo	PA449367	4897	0.431
NULL	J_Immune_Based_Ther_Vaccines_2007_Mar_29_5_5.nxml.txt.nlp	17394654	SENT79	27	27	34	34	heparin	San	PA449855	80218	0.431
NULL	Appl_Microbiol_Biotechnol_2014_Feb_18_98(8)_3829-3840.nxml.txt.nlp	24535257	SENT220	4	4	12	12	ethanol	CAT-1	PA448073	6541	0.431
NULL	Braz_J_Med_Biol_Res_2012_Feb_17_45(3)_244-249.nxml.txt.nlp	22331137	SENT92	11	11	8	8	gentamicin	PAG	PA449753	55824	0.431
NULL	Iran_J_Public_Health_2013_Jan_1_42(Supple1)_50-54.nxml.txt.nlp	23865016	SENT136	27	27	11	11	infliximab	CRT	PA452639	811	0.431
NULL	Evid_Based_Complement_Alternat_Med_2013_Mar_14_2013_429706.nxml.txt.nlp	23573127	SENT156	12	12	8	8	indomethacin	IDS	PA449982	3423	0.431
NULL	Curr_Gerontol_Geriatr_Res_2010_May_4_2010_420139.nxml.txt.nlp	20454643	SENT86	19	19	32	32	estradiol	AMPK	PA449503	5563	0.431
NULL	Evid_Based_Complement_Alternat_Med_2014_Jun_16_2014_371475.nxml.txt.nlp	25024728	SENT83	0	0	9	9	naloxone	ADX	PA450586	2230	0.431
NULL	J_Gen_Physiol_2012_Oct_140(4)_403-419.nxml.txt.nlp	23008434	SENT62	26	26	32	32	phenol	TMX	PA450913	81542	0.431
NULL	Curr_Osteoporos_Rep_2010_Dec_1_8(4)_178-184.nxml.txt.nlp	20809203	SENT57	8	8	35	35	rosiglitazone	CTX	PA451283	1593	0.431
NULL	J_Invest_Dermatol_2014_Mar_13_134(3)_791-800.nxml.txt.nlp	24037342	SENT112	27	27	37	37	glutaraldehyde	p53	PA449777	7157	0.431
NULL	J_Cachexia_Sarcopenia_Muscle_2010_Sep_26_1(1)_43-128.nxml.txt.nlp	22477519	SENT748	19	19	11	11	fenfluramine	ghrelin	PA449592	51738	0.431
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jul_31_66(Pt_8)_m1040-m1041.nxml.txt.nlp	21588111	SENT5	1	1	3	3	ethanol	mol	PA448073	90527	0.431
NULL	Aging_(Albany_NY)_2012_Apr_18_4(4)_279-289.nxml.txt.nlp	22529334	SENT11	9	9	12	12	oxygen	ROS	PA450744	6098	0.431
NULL	Cancer_Metab_2013_Dec_23_1_23.nxml.txt.nlp	24359630	SENT10	20	20	23	23	oxygen	ROS	PA450744	6098	0.431
NULL	Int_J_Mol_Sci_2014_Oct_13_15(10)_18333-18348.nxml.txt.nlp	25314297	SENT489	4	4	9	9	collagenase	EMMPRIN	PA449107	682	0.431
NULL	AIDS_Res_Ther_2011_Oct_6_8_36.nxml.txt.nlp	21978457	SENT125	25	25	22	22	zinc	TNF	PA451956	7124	0.431
NULL	Cancer_Manag_Res_2011_May_9_3_117-141.nxml.txt.nlp	21625397	SENT524	0	0	3	3	belinostat	DHRS2		10202	0.431
NULL	Aging_(Albany_NY)_2011_Dec_8_3(11)_1098-1109.nxml.txt.nlp	22156377	SENT306	18	18	16	16	resveratrol	p53		7157	0.431
NULL	Breast_Cancer_Res_2008_Aug_5_10(4)_R68.nxml.txt.nlp	18681966	SENT182	20	20	17	17	fluorescein	PRLR	PA164746009	5618	0.43
NULL	Breast_Cancer_Res_2011_Jan_26_13(1)_R10.nxml.txt.nlp	21269472	SENT196	22	22	7	7	estradiol	PPARGC1B	PA449503	133522	0.43
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Apr_29_67(Pt_5)_o1262-o1263.nxml.txt.nlp	21754550	SENT68	17	17	14	14	ethanol	mol	PA448073	90527	0.43
NULL	J_Cell_Mol_Med_2014_May_14_18(5)_811-823.nxml.txt.nlp	24628949	SENT168	19	19	21	21	docetaxel	FOXM1	PA449383	2305	0.43
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_May_7_65(Pt_6)_o1229.nxml.txt.nlp	21583097	SENT72	30	30	27	27	ethanol	mol	PA448073	90527	0.43
NULL	J_Korean_Med_Sci_2013_Apr_27_28(4)_527-533.nxml.txt.nlp	23580227	SENT106	19	19	21	21	genistein	TRAIL	PA165109660	8743	0.43
NULL	Ann_Rheum_Dis_2011_Sep_12_70(11)_2003-2007.nxml.txt.nlp	21914628	SENT44	23	23	5	5	infliximab	ACR	PA452639	49	0.43
NULL	Front_Cell_Neurosci_2014_Jun_6_8_155.nxml.txt.nlp	24936172	SENT84	20	20	37	37	picrotoxin	HMGB1	PA164777007	3146	0.43
NULL	Int_J_Endocrinol_Metab_2013_Jul_1_Summer_11(3)_184-190.nxml.txt.nlp	24348591	SENT98	12	12	14	14	liraglutide	INS-1	PA165958364	2305	0.43
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Dec_14_70(Pt_1)_o57-o58.nxml.txt.nlp	24526998	SENT83	13	13	10	10	ethanol	mol	PA448073	90527	0.43
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Jul_5_64(Pt_8)_m984-m985.nxml.txt.nlp	21203082	SENT8	12	12	8	8	ethanol	mol	PA448073	90527	0.43
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2007_Dec_6_64(Pt_1)_m12.nxml.txt.nlp	21200479	SENT54	17	17	14	14	ethanol	mol	PA448073	90527	0.43
NULL	Br_J_Cancer_2010_Oct_12_103(8)_1182-1191.nxml.txt.nlp	20842125	SENT13	12	12	8	8	indomethacin	COX	PA449982	1351	0.43
NULL	Crit_Care_2012_Jul_24_16(4)_R134.nxml.txt.nlp	22827994	SENT92	17	17	8	8	metformin	Met	PA450395	79811	0.43
NULL	Iran_J_Pharm_Res_2014_Autumn_13(4)_1393-1401.nxml.txt.nlp	25587329	SENT131	25	25	20	20	celecoxib	MRP1	PA448871	4437	0.43
NULL	Ann_Clin_Microbiol_Antimicrob_2009_Sep_24_8_26.nxml.txt.nlp	19778428	SENT102	22	22	4	4	tetracycline	PEN	PA451640	9933	0.43
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jun_18_67(Pt_7)_o1665.nxml.txt.nlp	21837064	SENT58	10	10	7	7	ethanol	mol	PA448073	90527	0.43
NULL	J_Nat_Med_2014_Feb_19_68(2)_253-266.nxml.txt.nlp	24550097	SENT156	31	31	42	42	ethanol	SREBP-1c	PA448073	6720	0.43
NULL	Mol_Pain_2014_Aug_15_10_53.nxml.txt.nlp	25127716	SENT100	18	18	14	14	paclitaxel	GAPDH	PA450761	2597	0.43
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_May_31_70(Pt_6)_o733-o734.nxml.txt.nlp	24940299	SENT80	14	14	11	11	ethanol	mol	PA448073	90527	0.43
NULL	Arch_Med_Sci_2011_Dec_31_7(6)_977-983.nxml.txt.nlp	22328880	SENT138	2	2	6	6	heparin	PAPP-A	PA449855	5069	0.43
NULL	BMJ_2010_Feb_8_340_c693.nxml.txt.nlp	20142325	SENT258	17	17	45	45	venlafaxine	CYP1A2	PA451866	1544	0.43
NULL	Springerplus_2014_Sep_9_3_510.nxml.txt.nlp	25279302	SENT246	12	12	18	18	creatine	GAMT	PA164778930	2593	0.43
NULL	Crit_Care_2010_Mar_10_14(2)_128.nxml.txt.nlp	20236465	SENT46	30	30	9	9	oxygen	LCT	PA450744	3938	0.43
NULL	Int_J_Biol_Sci_2014_Aug_23_10(8)_921-939.nxml.txt.nlp	25170305	SENT299	17	17	11	11	nadh	EPO	PA164755085	7076;8288;2056	0.43
NULL	Int_Semin_Surg_Oncol_2007_Jul_23_4_18.nxml.txt.nlp	17645796	SENT88	15	15	39	39	tamoxifen	STAR	PA451581	6770;2984	0.43
NULL	Eur_J_Clin_Pharmacol_2014_Oct_8_70(1)_37-45.nxml.txt.nlp	24100471	SENT54	12	12	14	14	midazolam	CYP3A4	PA450496	1576	0.43
NULL	Support_Care_Cancer_2014_Oct_19_22(2)_469-477.nxml.txt.nlp	24141698	SENT60	30	30	33	33	palonosetron	HEC	PA10352	10403	0.43
NULL	Clin_Exp_Metastasis_2014_Sep_17_31(1)_135-147.nxml.txt.nlp	24043563	SENT143	17	17	15	15	trypsin	KLK4	PA451806	9622	0.43
NULL	NDT_Plus_2010_Feb_4_3(1)_37-41.nxml.txt.nlp	20090879	SENT22	16	16	23	23	cinacalcet	PTH	PA164776671	5741	0.43
NULL	Eur_J_Neurosci_2007_Aug_26(4)_935-942.nxml.txt.nlp	17714187	SENT226	12	12	16	16	capsaicin	VR1	PA448776	56664	0.43
NULL	Int_J_Mol_Sci_2014_Mar_5_15(3)_3970-3988.nxml.txt.nlp	24603537	SENT120	4	4	6	6	curcumin	MCH	PA151958596	5367	0.43
NULL	ScientificWorldJournal_2013_Dec_30_2013_565813.nxml.txt.nlp	24489506	SENT226	15	15	10	10	cisplatin	Q10	PA449014	27161	0.43
NULL	Acta_Pharmacol_Sin_2009_Sep_17_30(9)_1351-1358.nxml.txt.nlp	19684608	SENT44	0	0	2	2	rosiglitazone	AP2	PA451283	2971	0.43
NULL	Br_J_Cancer_2003_Mar_10_88(5)_788-795.nxml.txt.nlp	12618891	SENT162	3	3	5	5	bosentan	FasL	PA10034	356	0.43
NULL	Arch_Med_Sci_2013_Aug_30_9(4)_739-744.nxml.txt.nlp	24049538	SENT104	12	12	14	14	candesartan	PC-3	PA448765	692094	0.43
NULL	FEBS_Open_Bio_2014_Jul_3_4_602-610.nxml.txt.nlp	25161868	SENT43	31	31	13	13	thrombin	FABP4	PA451674	2167	0.43
NULL	Infect_Dis_Obstet_Gynecol_2012_Feb_25_2012_157159.nxml.txt.nlp	22505797	SENT122	9	9	11	11	clindamycin	PTB	PA449035	58155	0.43
NULL	Ther_Clin_Risk_Manag_2007_Dec_3(6)_1027-1033.nxml.txt.nlp	18516257	SENT60	34	34	5	5	vincristine	MRC	PA451879	4345	0.43
NULL	Alcohol_Res_2013_35(1)_6-16.nxml.txt.nlp	24313160	SENT83	24	24	31	31	betaine	BHMT	PA448603	635	0.43
NULL	Breast_Cancer_Res_2011_Mar_11_13(2)_R29.nxml.txt.nlp	21396094	SENT156	44	44	8	8	ethanol	HRG	PA448073	3084;3273	0.43
NULL	Oncotarget_2014_Dec_4_5(22)_11365-11380.nxml.txt.nlp	25426548	SENT74	5	5	7	7	nutlin-3	TP53		7157	0.43
NULL	Pharmaceuticals_(Basel)_2011_Jan_26_4(2)_285-342.nxml.txt.nlp	NULL	SENT1324	1	1	21	21	reboxetine	5-HT1A	PA144614921	3350	0.43
NULL	Gut_Pathog_2009_Jun_25_1_13.nxml.txt.nlp	19555480	SENT210	17	17	11	11	ampicillin	LBA	PA448419	987	0.43
NULL	Front_Neurosci_2014_May_22_8_113.nxml.txt.nlp	24904259	SENT53	13	13	2	2	levodopa	COMT	PA450213	1312	0.43
NULL	CNS_Spectr_2014_Oct_3_19(5)_391-402.nxml.txt.nlp	24698103	SENT100	2	2	25	25	citalopram	hang	PA449015	374879	0.43
NULL	Anal_Chem_2014_Jan_7_86(1)_443-452.nxml.txt.nlp	24313826	SENT85	35	35	21	21	diazepam	PKM	PA449283	5315	0.43
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Nov_3_68(Pt_12)_o3272-o3273.nxml.txt.nlp	23468786	SENT90	22	22	19	19	ethanol	mol	PA448073	90527	0.43
NULL	Arch_Toxicol_2014_Sep_3_88(10)_1855-1879.nxml.txt.nlp	25182421	SENT630	29	29	26	26	capsaicin	CO2	PA448776	4513	0.43
NULL	Braz_J_Med_Biol_Res_2012_Feb_17_45(3)_244-249.nxml.txt.nlp	22331137	SENT101	23	23	25	25	gentamicin	PAG	PA449753	55824	0.43
NULL	Clin_Ophthalmol_2014_Feb_10_8_389-399.nxml.txt.nlp	24550667	SENT203	14	14	31	31	timolol	TIM	PA451690	7984;8914	0.43
NULL	J_Radiat_Res_2014_Mar_26_55(2)_205-209.nxml.txt.nlp	23979075	SENT41	0	0	20	20	cyclosporine	CD25	PA449167	3669;3559	0.43
NULL	J_Mol_Med_(Berl)_2013_Aug_17_91(11)_1257-1271.nxml.txt.nlp	23955016	SENT22	1	1	6	6	heparin	SERPIND1	PA449855	3053	0.43
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT193	0	0	5	5	metformin	HIF-1	PA450395	29072	0.43
NULL	Free_Radic_Biol_Med_2013_Dec_65(100)_1521-1532.nxml.txt.nlp	23806384	SENT706	5	5	8	8	spermine	ADP	PA164781199	23038	0.429
NULL	Cell_Death_Dis_2014_Mar_27_5(3)_e1145.nxml.txt.nlp	24675463	SENT116	14	14	11	11	cetuximab	EGFR	PA10040	1956	0.429
NULL	Chem_Cent_J_2014_May_7_8_32.nxml.txt.nlp	24883080	SENT107	20	20	17	17	benzaldehyde	mol	PA448571	90527	0.429
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Jul_3_5_16.nxml.txt.nlp	16817961	SENT122	17	17	22	22	vancomycin	VISA	PA451850	57506	0.429
NULL	Biomed_Res_Int_2013_May_27_2013_526367.nxml.txt.nlp	23762850	SENT77	11	11	30	30	pentobarbital	STZ	PA450859	6484	0.429
NULL	Apoptosis_2013_Jul_31_18(12)_1447-1468.nxml.txt.nlp	23900974	SENT469	21	21	6	6	lapatinib	FGFR2	PA152241907	2263	0.429
NULL	Evid_Based_Complement_Alternat_Med_2011_Mar_13_2011_913898.nxml.txt.nlp	21785639	SENT271	8	8	12	12	curcumin	CYP3A4	PA151958596	1576	0.429
NULL	Acta_Pharmacol_Sin_2013_May_8_34(5)_699-709.nxml.txt.nlp	23564084	SENT146	17	17	14	14	vorinostat	BMP2	PA164748224	650	0.429
NULL	Oncol_Lett_2014_Jul_7_8(1)_258-262.nxml.txt.nlp	24959257	SENT42	34	34	22	22	vincristine	CHOP	PA451879	1649	0.429
NULL	J_Asthma_Allergy_2008_Sep_19_1_19-29.nxml.txt.nlp	21436982	SENT74	9	9	17	17	fexofenadine	OAT3	PA449621	9376	0.429
NULL	J_Adv_Pharm_Technol_Res_2012_Jul-Sep_3(3)_182-187.nxml.txt.nlp	23057005	SENT173	28	28	47	47	diclofenac	Tech	PA449293	57449	0.429
NULL	J_Neural_Transm_2014_Mar_27_121(10)_1221-1232.nxml.txt.nlp	24671607	SENT239	9	9	21	21	ethanol	E14	PA448073	4863	0.429
NULL	Neural_Plast_2007_Dec_11_2007_73079.nxml.txt.nlp	NULL	SENT1137	10	10	12	12	clozapine	GLYB	PA449061	2757	0.429
NULL	Mediators_Inflamm_2010_Jun_29_2010_627803.nxml.txt.nlp	20671920	SENT118	12	12	8	8	estradiol	IL-6	PA449503	3569	0.429
NULL	Brain_Struct_Funct_2015_Oct_16_220_193-203.nxml.txt.nlp	24129767	SENT137	28	28	18	18	levothyroxine	CTRL	PA450221	1506	0.429
NULL	Iran_J_Ped_Hematol_Oncol_2014_Jul_20_4(3)_127-130.nxml.txt.nlp	25254092	SENT106	4	4	6	6	propranolol	IFN	PA451145	3439	0.429
NULL	Nucleic_Acids_Res_2011_Sep_11_39(17)_7455-7464.nxml.txt.nlp	21666254	SENT321	6	6	4	4	cisplatin	zeta	PA449014	9907	0.429
NULL	Angiogenesis_2010_Dec_7_13(4)_305-315.nxml.txt.nlp	20927579	SENT300	5	5	9	9	resveratrol	AP-1		2353;3727;2354;3725	0.429
NULL	Int_J_Mol_Sci_2014_Nov_21_15(11)_21505-21537.nxml.txt.nlp	25421245	SENT222	21	21	28	28	lipase	UCP2	PA450239	7351	0.429
NULL	Br_J_Cancer_2009_Oct_6_101(7)_1114-1123.nxml.txt.nlp	19755995	SENT62	17	17	21	21	l-glutamine	EGF	PA10090	1950	0.429
NULL	Am_J_Physiol_Endocrinol_Metab_2010_Feb_17_298(2)_E278-E286.nxml.txt.nlp	19920213	SENT175	0	0	24	24	pioglitazone	ERK1	PA450970	5595	0.429
NULL	Chemother_Res_Pract_2011_Feb_27_2011_175054.nxml.txt.nlp	22295203	SENT118	3	3	5	5	cisplatin	MBT	PA449014	5657	0.429
NULL	J_Korean_Med_Sci_2009_Jan_29_24(Suppl_1)_S170-S175.nxml.txt.nlp	19194548	SENT129	11	11	13	13	cisplatin	EPO	PA449014	7076;8288;2056	0.429
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Sep_30_67(Pt_10)_o2791.nxml.txt.nlp	22064692	SENT3	9	9	3	3	piperazine	mol	PA450977	90527	0.429
NULL	Oncogene_2013_Sep_26_32(39)_10_1038_onc_2012_491.nxml.txt.nlp	23108394	SENT47	19	19	17	17	epirubicin	FOXM1	PA449476	2305	0.429
NULL	Oncotarget_2014_Aug_19_5(18)_8737-8749.nxml.txt.nlp	25228590	SENT120	10	10	39	39	crizotinib	ANOVA	PA165946122	4858	0.429
NULL	Ann_Rheum_Dis_2008_Nov_24_68(7)_1086-1093.nxml.txt.nlp	19033291	SENT236	11	11	16	16	methotrexate	SMILE	PA450428	160418	0.429
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT39	23	23	20	20	capsaicin	p53	PA448776	7157	0.429
NULL	AMB_Express_2014_Aug_23_4_66.nxml.txt.nlp	25177540	SENT193	29	29	37	37	sugar	GatA	PA451529	55278	0.429
NULL	Drugs_2014_Jul_18_74(11)_1209-1231.nxml.txt.nlp	25034361	SENT419	14	14	26	26	enoxaparin	STARS	PA449463	137735	0.429
NULL	Acta_Pharmacol_Sin_2009_Apr_9_30(4)_467-477.nxml.txt.nlp	19270721	SENT200	30	30	25	25	cisplatin	IL-24	PA449014	11009	0.429
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2009_Jun_1_65(Pt_6)_513-522.nxml.txt.nlp	19465765	SENT57	6	6	14	14	chloramphenicol	THM	PA448927	7063	0.429
NULL	Clin_Med_Cardiol_2009_May_27_3_53-60.nxml.txt.nlp	20407620	SENT51	11	11	20	20	fluorescein	CD34	PA164746009	947	0.429
NULL	Nat_Commun_2014_Jun_20_5_4122.nxml.txt.nlp	24947823	SENT232	28	28	38	38	capsaicin	TRPV1	PA448776	7442	0.429
NULL	Biomed_Res_Int_2013_Jun_17_2013_247152.nxml.txt.nlp	23844359	SENT105	24	24	29	29	vincristine	CHOP	PA451879	1649	0.429
NULL	Case_Rep_Endocrinol_2014_Nov_6_2014_693294.nxml.txt.nlp	25431697	SENT185	47	47	44	44	vasopressin	AVP	PA451858	114548;551	0.429
NULL	Protein_Pept_Lett_2014_Sep_21(7)_679-687.nxml.txt.nlp	24654848	SENT28	28	28	39	39	potassium	DMC1	PA451047	11144;283987	0.429
NULL	Fibrogenesis_Tissue_Repair_2010_Sep_3_3_18.nxml.txt.nlp	20815874	SENT28	12	12	14	14	bleomycin	BLM	PA448645	641	0.429
NULL	Arthritis_Res_Ther_2014_May_28_16(3)_R117.nxml.txt.nlp	24887071	SENT84	25	25	22	22	fluorescein	IFN	PA164746009	3439	0.429
NULL	Exp_Ther_Med_2012_Sep_12_4(3)_475-480.nxml.txt.nlp	23181121	SENT22	7	7	15	15	cyclophosphamide	CHOP	PA449165	1649	0.429
NULL	Acta_Pharmacol_Sin_2011_Apr_28_32(4)_503-511.nxml.txt.nlp	21441948	SENT55	31	31	42	42	gentamicin	CO2	PA449753	4513	0.429
NULL	Biomed_Res_Int_2014_Jan_12_2014_971345.nxml.txt.nlp	24524088	SENT136	36	36	25	25	l-glutamine	CO2	PA10090	4513	0.429
NULL	Appl_Microbiol_Biotechnol_2013_Aug_16_97(18)_7999-8009.nxml.txt.nlp	23948723	SENT79	22	22	20	20	glucose	mol	PA449773	90527	0.429
NULL	Ann_Thorac_Med_2014_Jul-Sep_9(Suppl_1)_S79-S91.nxml.txt.nlp	25077002	SENT279	2	2	6	6	iloprost	STEP	PA164746843	84867	0.429
NULL	Acta_Pharmacol_Sin_2009_Apr_9_30(4)_467-477.nxml.txt.nlp	19270721	SENT200	23	23	25	25	cisplatin	IL-24	PA449014	11009	0.429
NULL	Aging_(Albany_NY)_2012_May_22_4(5)_368-374.nxml.txt.nlp	22626691	SENT164	18	18	36	36	collagenase	AKT	PA449107	207	0.429
NULL	Biomed_Res_Int_2014_Feb_6_2014_323594.nxml.txt.nlp	24689036	SENT378	8	8	23	23	raloxifene	PC3	PA451221	57332;7832;5122	0.429
NULL	Arthritis_Res_Ther_2013_Dec_3_15(6)_R205.nxml.txt.nlp	24295447	SENT138	0	0	9	9	methotrexate	RANK	PA450428	8792	0.429
NULL	J_Int_Soc_Sports_Nutr_2014_Jun_18_11_31.nxml.txt.nlp	24982601	SENT175	1	1	19	19	creatine	IL-8	PA164778930	3576	0.429
NULL	Cardiol_Res_Pract_2013_Feb_19_2013_195456.nxml.txt.nlp	23533940	SENT80	3	3	16	16	cangrelor	IPA	PA165945763	3160	0.429
NULL	Indian_J_Psychiatry_2007_Jan-Mar_49(1)_26-33.nxml.txt.nlp	20640062	SENT147	0	0	9	9	acamprosate	NNT	PA10344	23530	0.429
NULL	Mol_Cancer_2009_Apr_22_8_26.nxml.txt.nlp	19386116	SENT189	24	24	26	26	ritonavir	Bcl-2	PA451260	596	0.429
NULL	Onco_Targets_Ther_2014_Sep_30_7_1641-1645.nxml.txt.nlp	25336968	SENT88	11	11	9	9	chlorthalidone	Yes	PA448970	7525	0.429
NULL	Toxins_(Basel)_2010_Oct_26_2(11)_2490-2518.nxml.txt.nlp	22069563	SENT195	8	8	15	15	cisplatin	IFN	PA449014	3439	0.429
NULL	Ther_Clin_Risk_Manag_2006_Sep_2(3)_281-295.nxml.txt.nlp	18360603	SENT173	4	4	24	24	risedronate	NNT	PA451255	23530	0.429
NULL	Int_J_Mol_Sci_2014_Sep_30_15(10)_17733-17750.nxml.txt.nlp	25272228	SENT157	8	8	23	23	oxygen	HLA-G	PA450744	3135	0.429
NULL	Oncoscience_2014_Mar_12_1(2)_158-166.nxml.txt.nlp	25594008	SENT64	14	14	10	10	dasatinib	IGFBP2	PA162372878	3485	0.429
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Jul_13_69(Pt_8)_o1260.nxml.txt.nlp	24109344	SENT66	31	31	8	8	ethanol	mol	PA448073	90527	0.429
NULL	Ann_N_Y_Acad_Sci_2012_Aug_30_1264(1)_49-63.nxml.txt.nlp	22548651	SENT189	7	7	4	4	glucose	BDNF	PA449773	627	0.429
NULL	Pharmaceutics_2011_Jul_13_3(3)_425-439.nxml.txt.nlp	24310588	SENT350	21	21	0	0	methamphetamine	SERS	PA450403	6301;54938	0.429
NULL	Cancers_(Basel)_2013_Aug_22_5(3)_1086-1102.nxml.txt.nlp	24202335	SENT115	15	15	17	17	imatinib	TERT	PA10804	7015	0.429
NULL	Arthritis_Res_Ther_2014_Oct_30_16(5)_470.nxml.txt.nlp	25606597	SENT173	1	1	18	18	anakinra	TRPV1	PA10799	7442	0.429
NULL	Mol_Syst_Biol_2009_Jul_28_5_288.nxml.txt.nlp	19638969	SENT451	24	24	26	26	resveratrol	HuR		1994	0.429
NULL	Biomed_Res_Int_2014_May_15_2014_703691.nxml.txt.nlp	24959584	SENT136	24	24	30	30	estradiol	AMH	PA449503	268	0.429
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Feb_17_68(Pt_3)_o712-o713.nxml.txt.nlp	22412597	SENT79	24	24	21	21	ethanol	mol	PA448073	90527	0.429
NULL	J_Cell_Biol_1998_Jul_13_142(1)_271-284.nxml.txt.nlp	9660880	SENT100	2	2	8	8	galactose	GAL4	PA449725	3960	0.429
NULL	Tuberc_Respir_Dis_(Seoul)_2014_Mar_29_76(3)_99-104.nxml.txt.nlp	24734096	SENT88	7	7	13	13	nitrogen	CO2	PA450643	4513	0.429
NULL	Iran_J_Reprod_Med_2012_Jul_10(4)_329-336.nxml.txt.nlp	25246894	SENT114	11	11	21	21	protamine	PRM2	PA10366	5620	0.429
NULL	Cancers_(Basel)_2014_Sep_30_6(4)_2035-2048.nxml.txt.nlp	25271833	SENT104	6	6	13	13	gefitinib	IL-2	PA131301952	3558	0.429
NULL	Cancer_Cell_Int_2010_Apr_29_10_12.nxml.txt.nlp	20429927	SENT174	7	7	10	10	bortezomib	HRI	PA10252	27102	0.428
NULL	Clin_Med_Insights_Oncol_2011_Sep_21_5_315-323.nxml.txt.nlp	22084620	SENT138	9	9	11	11	gemcitabine	INF	PA449748	2694	0.428
NULL	Int_J_Cell_Biol_2013_Sep_24_2013_898563.nxml.txt.nlp	24223594	SENT34	6	6	9	9	oxygen	ROS	PA450744	6098	0.428
NULL	Clinics_(Sao_Paulo)_2013_Jul_68(7)_1018-1027.nxml.txt.nlp	23917669	SENT138	27	27	24	24	l-cysteine	NAC	PA449173	22861	0.428
NULL	J_Psychopharmacol_2012_Nov_26(11)_1417-1423.nxml.txt.nlp	22596208	SENT240	11	11	13	13	memantine	spatial	PA10364	219793	0.428
NULL	J_Brachial_Plex_Peripher_Nerve_Inj_2008_Mar_19_3_8.nxml.txt.nlp	18353188	SENT9	22	22	3	3	capsaicin	SSeCKS	PA448776	9590	0.428
NULL	Asian_J_Androl_2014_Dec_16_Jan-Feb_16(1)_39-49.nxml.txt.nlp	24369132	SENT105	25	25	38	38	estradiol	AMH	PA449503	268	0.428
NULL	Front_Mol_Neurosci_2012_Feb_24_5_22.nxml.txt.nlp	22375105	SENT162	13	13	25	25	spermine	GluA2	PA164781199	2891	0.428
NULL	Front_Neurol_2013_Sep_4_4_128.nxml.txt.nlp	24027555	SENT379	7	7	0	0	levodopa	San	PA450213	80218	0.428
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Nov_5_67(Pt_12)_o3175.nxml.txt.nlp	22199699	SENT65	23	23	20	20	ethanol	mol	PA448073	90527	0.428
NULL	Case_Rep_Med_2012_Jul_2_2012_794354.nxml.txt.nlp	22811727	SENT45	9	9	16	16	thyroglobulin	TTF-1	PA164754910	7080	0.428
NULL	J_Immunol_Res_2014_Mar_31_2014_301376.nxml.txt.nlp	24741584	SENT32	7	7	21	21	cisplatin	XIAP	PA449014	331	0.428
NULL	Biomed_Res_Int_2014_Feb_6_2014_323594.nxml.txt.nlp	24689036	SENT237	3	3	13	13	raloxifene	EGFR	PA451221	1956	0.428
NULL	Anal_Bioanal_Chem_2007_Jun_28_388(4)_871-879.nxml.txt.nlp	17468853	SENT1	1	1	4	4	oxygen	ROS	PA450744	6098	0.428
NULL	J_Anaesthesiol_Clin_Pharmacol_2012_Oct-Dec_28(4)_486-490.nxml.txt.nlp	23225930	SENT136	8	8	22	22	neostigmine	TKR	PA450611	8277	0.428
NULL	Brain_Sci_2013_Sep_24_3(3)_1415-1416.nxml.txt.nlp	NULL	SENT10	41	41	17	17	cyclosporine	ghrelin	PA449167	51738	0.428
NULL	Cancer_Med_2012_Dec_30_1(3)_328-337.nxml.txt.nlp	23342282	SENT209	25	25	16	16	tamoxifen	HER-2	PA451581	2064	0.428
NULL	Dermatoendocrinol_2012_Jan_1_4(1)_8-9.nxml.txt.nlp	22870345	SENT36	6	6	25	25	atorvastatin	SR-BI	PA448500	949	0.428
NULL	Mol_Biol_Cell_2013_Apr_1_24(7)_923-932.nxml.txt.nlp	23363600	SENT252	24	24	12	12	l-glutamine	CO2	PA10090	4513	0.428
NULL	Ind_Psychiatry_J_2014_Jan-Jun_23(1)_27-35.nxml.txt.nlp	25535442	SENT15	15	15	6	6	amisulpride	SAPS	PA162565877	8935	0.428
NULL	Exp_Ther_Med_2014_Nov_29_8(5)_1473-1478.nxml.txt.nlp	25289044	SENT124	19	19	21	21	heparin	AZU	PA449855	566	0.428
NULL	Ann_Gen_Psychiatry_2014_Sep_24_13_27.nxml.txt.nlp	25478001	SENT182	25	25	28	28	creatine	SLC6A8	PA164778930	6535	0.428
NULL	Oncologist_2010_Mar_9_15(3)_236-245.nxml.txt.nlp	20215359	SENT82	9	9	11	11	bevacizumab	IFN	PA130232992	3439	0.428
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Apr_25_68(Pt_5)_m664.nxml.txt.nlp	22590148	SENT74	41	41	38	38	ethanol	mol	PA448073	90527	0.428
NULL	Case_Rep_Pathol_2013_Feb_21_2013_687427.nxml.txt.nlp	23533895	SENT104	11	11	9	9	thyroglobulin	TTF-1	PA164754910	7080	0.428
NULL	J_Clin_Biochem_Nutr_2007_Jul_27_41(1)_32-42.nxml.txt.nlp	18392098	SENT581	1	1	5	5	arsenite	ADP	PA452638	23038	0.428
NULL	Crit_Care_2010_Nov_5_14(6)_R200.nxml.txt.nlp	21054850	SENT186	3	3	0	0	vasopressin	AVP	PA451858	114548;551	0.428
NULL	Arthritis_Res_Ther_2008_Oct_11_10(5)_R121.nxml.txt.nlp	18847495	SENT90	21	21	30	30	fluorescein	San	PA164746009	80218	0.428
NULL	Korean_Circ_J_2014_Mar_12_44(2)_97-104.nxml.txt.nlp	24653739	SENT26	24	24	21	21	bosentan	ETB	PA10034	1910	0.428
NULL	Genome_Med_2010_Nov_12_2(11)_81.nxml.txt.nlp	21092148	SENT112	19	19	12	12	letrozole	HER2	PA450196	2064	0.428
NULL	Exp_Ther_Med_2013_Mar_21_5(3)_987-991.nxml.txt.nlp	23407636	SENT74	9	9	11	11	lisinopril	IL-8	PA450242	3576	0.428
NULL	Arthritis_Res_Ther_2009_Aug_24_11(4)_R127.nxml.txt.nlp	19703304	SENT170	24	24	29	29	infliximab	OASIS	PA452639	90993	0.428
NULL	Hum_Genomics_2009_Dec_1_4(2)_91-106.nxml.txt.nlp	20038497	SENT197	25	25	21	21	tacrine	GSTT1	PA451576	2952	0.428
NULL	Curr_Pharm_Des_2011_Feb_17(6)_578-590.nxml.txt.nlp	21391908	SENT224	4	4	39	39	lenalidomide	PI3	PA162363968	5266	0.428
NULL	J_Hematol_Oncol_2012_May_15_5_23.nxml.txt.nlp	22587422	SENT13	16	16	22	22	dasatinib	ALL	PA162372878	613	0.428
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1449-1456.nxml.txt.nlp	24077631	SENT118	16	16	22	22	tolbutamide	CYP2C9	PA451718	1559	0.428
NULL	Front_Genet_2014_May_9_5_112.nxml.txt.nlp	24847353	SENT471	12	12	2	2	ethanol	CHOP	PA448073	1649	0.428
NULL	J_Asthma_Allergy_2014_Feb_27_7_11-21.nxml.txt.nlp	24600237	SENT273	12	12	8	8	tiotropium	FEV	PA164769056	54738	0.428
NULL	J_Oncol_2010_Sep_6_2010_932371.nxml.txt.nlp	19746182	SENT297	27	27	30	30	oxygen	ROS	PA450744	6098	0.428
NULL	Arthritis_Res_Ther_2012_Dec_10_14(6)_R266.nxml.txt.nlp	23217276	SENT58	29	29	39	39	fluorescein	San	PA164746009	80218	0.428
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT85	18	18	10	10	metformin	EGFR	PA450395	1956	0.428
NULL	Biol_Open_2012_May_9_1(6)_607-614.nxml.txt.nlp	23213454	SENT65	11	11	5	5	dextran	EGF	PA449261	1950	0.428
NULL	Breast_Cancer_Res_2012_Mar_9_14(2)_R41.nxml.txt.nlp	22405131	SENT57	41	41	18	18	ethanol	FBS	PA448073	64319;26269	0.428
NULL	Chem_Cent_J_2012_Nov_23_6_140.nxml.txt.nlp	23173949	SENT112	31	31	0	0	ethanol	PERC	PA448073	133522	0.428
NULL	Br_J_Pharmacol_2014_Aug_17_171(15)_3651-3665.nxml.txt.nlp	24712679	SENT256	14	14	11	11	liraglutide	GLP-1	PA165958364	100125288	0.428
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Sep_16_65(Pt_10)_o2483.nxml.txt.nlp	21577934	SENT66	30	30	27	27	ethanol	mol	PA448073	90527	0.428
NULL	Brain_Sci_2014_May_6_4(2)_356-375.nxml.txt.nlp	24961766	SENT27	8	8	10	10	isoflurane	spatial	PA450106	219793	0.428
NULL	Scientifica_(Cairo)_2012_Jul_8_2012_128382.nxml.txt.nlp	24278667	SENT168	22	22	12	12	ribavirin	IFN	PA451241	3439	0.428
NULL	J_Geriatr_Cardiol_2013_Dec_10(4)_377-382.nxml.txt.nlp	24454332	SENT124	0	0	8	8	estradiol	PI3K	PA449503	5290	0.428
NULL	Int_J_Nanomedicine_2012_May_7_7_2307-2314.nxml.txt.nlp	22661887	SENT102	8	8	4	4	gemcitabine	zeta	PA449748	9907	0.428
NULL	Biol_Proced_Online_2004_Dec_16_6_263-267.nxml.txt.nlp	15605107	SENT151	13	13	18	18	collagenase	MCT3	PA449107	9123;23539	0.428
NULL	Biomed_Res_Int_2013_Jul_8_2013_507103.nxml.txt.nlp	23936812	SENT159	7	7	30	30	curcumin	CO2	PA151958596	4513	0.428
NULL	Oncol_Lett_2013_Mar_8_5(3)_805-812.nxml.txt.nlp	23426281	SENT12	7	7	13	13	gemcitabine	B7-H3	PA449748	80381	0.427
NULL	Case_Rep_Gastrointest_Med_2014_Jun_17_2014_906759.nxml.txt.nlp	25031875	SENT20	8	8	18	18	tegafur	CDHP	PA452620	1001	0.427
NULL	Front_Neurosci_2014_Feb_14_8_23.nxml.txt.nlp	24592205	SENT636	11	11	15	15	capsaicin	VR1	PA448776	56664	0.427
NULL	Ann_Microbiol_2013_Feb_14_63(4)_1477-1482.nxml.txt.nlp	24294189	SENT109	2	2	35	35	glucose	ANOVA	PA449773	4858	0.427
NULL	Mol_Cancer_2012_Mar_21_11_13.nxml.txt.nlp	22436134	SENT69	2	2	6	6	doxorubicin	HuR	PA449412	1994	0.427
NULL	AIDS_Res_Ther_2006_Apr_24_3_12.nxml.txt.nlp	16635263	SENT201	17	17	13	13	fluorescein	PEG10	PA164746009	23089	0.427
NULL	Front_Behav_Neurosci_2015_Jan_13_8_452.nxml.txt.nlp	25628548	SENT736	5	5	7	7	chlordiazepoxide	spatial	PA448932	219793	0.427
NULL	J_Biomed_Biotechnol_2007_Feb_20_2007_76087.nxml.txt.nlp	18317518	SENT170	26	26	4	4	fluorescein	CA125	PA164746009	4077;94025	0.427
NULL	Crit_Care_2011_Aug_11_15(4)_226.nxml.txt.nlp	21892977	SENT402	33	33	11	11	vasopressin	IFN	PA451858	3439	0.427
NULL	Iran_J_Neurol_2012_11(2)_70-73.nxml.txt.nlp	24250865	SENT101	13	13	15	15	doxycycline	IFN	PA449415	3439	0.427
NULL	Ann_Gen_Psychiatry_2008_Aug_18_7_11.nxml.txt.nlp	18706108	SENT71	36	36	13	13	bupropion	ANOVA	PA448687	4858	0.427
NULL	Int_J_Nanomedicine_2012_Sep_13_7_4917-4926.nxml.txt.nlp	23028220	SENT237	21	21	17	17	calcein	mol	PA132595336	90527	0.427
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jul_29_65(Pt_8)_o2022.nxml.txt.nlp	21583691	SENT72	35	35	32	32	ethanol	mol	PA448073	90527	0.427
NULL	Anal_Bioanal_Chem_2014_Sep_12_406(28)_7049-7057.nxml.txt.nlp	25213215	SENT273	12	12	15	15	hemin	mol	PA449849	90527	0.427
NULL	Diabetes_2013_Mar_14_62(3)_953-964.nxml.txt.nlp	23223176	SENT149	22	22	24	24	paroxetine	ROS	PA450801	6098	0.427
NULL	Acta_Pharmacol_Sin_2013_Apr_25_34(4)_455-463.nxml.txt.nlp	23524568	SENT213	0	0	7	7	pioglitazone	p65	PA450970	5970	0.427
NULL	J_Inflamm_(Lond)_2006_Jul_12_3_10.nxml.txt.nlp	16834783	SENT161	5	5	9	9	mometasone	IL-5	PA450541	3567	0.427
NULL	Int_J_Surg_Oncol_2012_Jun_12_2012_862879.nxml.txt.nlp	22778941	SENT66	16	16	14	14	cisplatin	MRP2	PA449014	100130958;57626;1244	0.427
NULL	Brain_Sci_2014_Apr_22_4(2)_311-320.nxml.txt.nlp	24961763	SENT294	1	1	10	10	isoflurane	BAX	PA450106	581	0.427
NULL	Glycoconj_J_2008_Feb_2_25(2)_177-185.nxml.txt.nlp	17909966	SENT183	0	0	7	7	heparin	PF4	PA449855	5196	0.427
NULL	Crit_Care_2009_Mar_16_13(2)_R37.nxml.txt.nlp	19291300	SENT84	5	5	10	10	urea	GFR	PA451831	9771	0.427
NULL	J_Exp_Med_2000_May_15_191(10)_1789-1798.nxml.txt.nlp	10811871	SENT471	18	18	14	14	tetracycline	TP53	PA451640	7157	0.427
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT562	11	11	16	16	metformin	HIF-1	PA450395	29072	0.427
NULL	Ann_Oncol_2009_Nov_23_20(11)_1803-1812.nxml.txt.nlp	19549706	SENT194	2	2	4	4	sunitinib	IFN	PA162372840	3439	0.427
NULL	Lab_Invest_2011_Sep_23_91(9)_1396-1409.nxml.txt.nlp	21606925	SENT73	3	3	3	3	pp2	PP2		4888	0.427
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT208	7	7	9	9	bevacizumab	VEGF-A	PA130232992	7422	0.427
NULL	J_Ophthalmic_Inflamm_Infect_2013_Apr_22_3_46.nxml.txt.nlp	23607574	SENT67	0	0	19	19	vancomycin	NAG	PA451850	51594;4669	0.427
NULL	Exp_Neurol_2014_May_255(100)_96-102.nxml.txt.nlp	24613829	SENT458	26	26	13	13	carbamazepine	CTRL	PA448785	1506	0.427
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Sep_26_65(Pt_10)_o2532-o2533.nxml.txt.nlp	21577977	SENT11	1	1	3	3	ethanol	mol	PA448073	90527	0.427
NULL	Cell_Death_Dis_2014_Jan_30_5(1)_e1043.nxml.txt.nlp	24481457	SENT234	9	9	17	17	urokinase	ALDH1A3	PA451836	220	0.427
NULL	Oncogene_2013_Sep_26_32(39)_10_1038_onc_2012_491.nxml.txt.nlp	23108394	SENT299	4	4	17	17	epirubicin	BRIP1	PA449476	64979;83990	0.427
NULL	Clin_Ophthalmol_2009_Jun_2_3_291-295.nxml.txt.nlp	19668581	SENT61	10	10	12	12	latanoprost	BAK	PA164774763	578	0.427
NULL	Breast_Cancer_Res_2010_Jun_28_12(3)_R43.nxml.txt.nlp	20579400	SENT47	35	35	9	9	streptomycin	CO2	PA451512	4513	0.427
NULL	Int_J_Vasc_Med_2012_Jul_24_2012_508416.nxml.txt.nlp	22888436	SENT163	24	24	31	31	pioglitazone	SRC-3	PA450970	8202	0.427
NULL	Oncotarget_2014_Oct_21_5(22)_11252-11268.nxml.txt.nlp	25361004	SENT179	15	15	1	1	metformin	CLIC1	PA450395	1192	0.427
NULL	F1000Res_2014_Aug_19_3_198.nxml.txt.nlp	25400908	SENT533	25	25	11	11	docetaxel	S17	PA449383	6218	0.427
NULL	Nucleic_Acids_Res_2005_Feb_1_33(2)_e22.nxml.txt.nlp	15687380	SENT75	45	45	26	26	l-glutamine	CO2	PA10090	4513	0.427
NULL	Br_J_Cancer_2012_Feb_28_106(5)_858-866.nxml.txt.nlp	22343622	SENT118	17	17	24	24	docetaxel	PD2	PA449383	54623	0.427
NULL	Infect_Dis_Obstet_Gynecol_2014_Sep_25_2014_961375.nxml.txt.nlp	25328370	SENT175	8	8	10	10	atazanavir	ATV	PA10251	4683	0.427
NULL	Cell_Death_Dis_2014_Mar_13_5(3)_e1118.nxml.txt.nlp	24625977	SENT296	10	10	18	18	etoposide	mot-2	PA449552	3313	0.427
NULL	Clin_Mol_Hepatol_2014_Sep_25_20(3)_283-290.nxml.txt.nlp	25320732	SENT96	26	26	23	23	propranolol	EVL	PA451145	51466	0.427
NULL	Arch_Toxicol_2014_Apr_2_88(5)_1109-1126.nxml.txt.nlp	24691702	SENT281	4	4	12	12	geldanamycin	IFN	PA152031327	3439	0.427
NULL	AIDS_Res_Ther_2008_Aug_1_5_17.nxml.txt.nlp	18673571	SENT47	9	9	2	2	nevirapine	CTX	PA450616	1593	0.427
NULL	J_Gen_Physiol_1991_Jun_1_97(6)_1295-1319.nxml.txt.nlp	1714938	SENT0	15	15	1	1	trypsin	Gen	PA451806	348654	0.427
NULL	Clinics_(Sao_Paulo)_2011_Aug_66(8)_1457-1462.nxml.txt.nlp	21915500	SENT110	5	5	16	16	rosuvastatin	eNOS	PA134308647	4846	0.427
NULL	FEBS_Open_Bio_2012_Aug_22_2_279-283.nxml.txt.nlp	23650611	SENT145	0	0	7	7	raloxifene	IFN	PA451221	3439	0.427
NULL	Oncotarget_2011_Jan_25_2(1-2)_8-17.nxml.txt.nlp	21378407	SENT37	4	4	0	0	thrombin	PAR-1	PA451674	2011;2149	0.427
NULL	J_Res_Med_Sci_2010_Nov-Dec_15(6)_331-343.nxml.txt.nlp	21526106	SENT163	21	21	19	19	l-arginine	HDEL	PA448478	10945	0.427
NULL	Avicenna_J_Phytomed_2012_Summer_2(3)_113-117.nxml.txt.nlp	25050239	SENT13	1	1	4	4	oxygen	ROS	PA450744	6098	0.427
NULL	Clin_Ophthalmol_2010_Oct_5_4_1137-1143.nxml.txt.nlp	20957061	SENT13	30	30	27	27	travoprost	BAK	PA164781371	578	0.427
NULL	Lab_Invest_2011_Mar_15_91(3)_363-378.nxml.txt.nlp	21079581	SENT177	34	34	30	30	hyaluronan	HOXC10	PA165958431	3226	0.427
NULL	Front_Pharmacol_2014_Dec_19_5_270.nxml.txt.nlp	25566071	SENT205	30	30	24	24	doxycycline	SOX2	PA449415	6657	0.427
NULL	Adv_Appl_Bioinform_Chem_2012_Sep_6_5_61-79.nxml.txt.nlp	23055752	SENT139	5	5	3	3	thrombin	DHFR	PA451674	1719	0.427
NULL	Indian_J_Pharmacol_2008_Oct_40(Suppl_2)_S66-S91.nxml.txt.nlp	21593982	SENT1471	23	23	30	30	furosemide	HARC	PA449719	55664	0.427
NULL	Nat_Neurosci_2014_Jun_4_17(6)_813-821.nxml.txt.nlp	24793032	SENT314	5	5	18	18	topotecan	E12	PA451729	64100	0.427
NULL	J_Thromb_Haemost_2013_Mar_13_11(3)_529-538.nxml.txt.nlp	23279194	SENT25	18	18	9	9	thrombin	MMP8	PA451674	4317	0.427
NULL	Cancer_Metastasis_Rev_2010_Dec_9_29(4)_777-784.nxml.txt.nlp	20936327	SENT181	7	7	10	10	thrombin	PAR-1	PA451674	2011;2149	0.427
NULL	J_Headache_Pain_2011_Oct_28_12(5)_505-510.nxml.txt.nlp	21710311	SENT77	10	10	32	32	diclofenac	IMPACT	PA449293	55364	0.427
NULL	CNS_Neurosci_Ther_2010_Jun_16(3)_e1-e17.nxml.txt.nlp	20406250	SENT229	16	16	8	8	pramipexole	5-HT1A	PA164742949	3350	0.427
NULL	Cancer_Med_2014_Apr_7_3(2)_362-375.nxml.txt.nlp	24515916	SENT21	16	16	20	20	zoledronate	IL-2	PA10235	3558	0.427
NULL	Diabetes_Care_2011_Jun_20_34(6)_1406-1411.nxml.txt.nlp	21515837	SENT5	13	13	21	21	glucose	LVM	PA449773	23209	0.427
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT345	13	13	11	11	dasatinib	PP2	PA162372878	4888	0.427
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT72	43	43	41	41	vinorelbine	ASC	PA451881	29108	0.427
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT208	5	5	9	9	ranibizumab	VEGF-A	PA164746012	7422	0.427
NULL	Case_Rep_Oncol_2010_Apr_8_3(1)_88-92.nxml.txt.nlp	20740165	SENT21	5	5	11	11	trypsin	p63	PA451806	8626	0.427
NULL	J_Cell_Mol_Med_2013_Sep_24_17(9)_1065-1087.nxml.txt.nlp	24151975	SENT176	5	5	12	12	dextran	CD4	PA449261	920	0.427
NULL	Diabetes_2011_May_23_60(5)_1493-1503.nxml.txt.nlp	21478464	SENT28	20	20	23	23	metformin	AMPK	PA450395	5563	0.427
NULL	J_Cell_Biol_2001_Oct_29_155(3)_427-438.nxml.txt.nlp	11673478	SENT231	9	9	7	7	pp2	PP1		5540;5464	0.427
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Dec_14_68(Pt_1)_o116.nxml.txt.nlp	22259403	SENT73	2	2	24	24	nitrogen	mol	PA450643	90527	0.427
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jan_31_65(Pt_2)_o427-o428.nxml.txt.nlp	21582014	SENT78	9	9	6	6	acetone	mol	PA448025	90527	0.427
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT124	26	26	41	41	sitagliptin	HIP	PA164748978	6767;6159;64399;5068	0.426
NULL	Arthritis_Res_Ther_2011_Feb_16_13(1)_R25.nxml.txt.nlp	21324169	SENT120	2	2	31	31	abatacept	TNF	PA164747080	7124	0.426
NULL	Biomed_Res_Int_2013_Jan_15_2013_786475.nxml.txt.nlp	23484157	SENT210	29	29	25	25	heparin	EGF	PA449855	1950	0.426
NULL	Cell_Death_Dis_2014_Jul_3_5(7)_e1316.nxml.txt.nlp	24991768	SENT100	15	15	13	13	pemetrexed	Mcl-1	PA10810	4170	0.426
NULL	Cytojournal_2014_May_22_11_11.nxml.txt.nlp	24987442	SENT51	27	27	25	25	thyroglobulin	TTF-1	PA164754910	7080	0.426
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Aug_11_67(Pt_9)_o2296.nxml.txt.nlp	22064675	SENT73	0	0	7	7	opipramol	mol	PA144614922	90527	0.426
NULL	Cardiovasc_Res_2011_Apr_1_90(1)_140-147.nxml.txt.nlp	21071431	SENT87	0	0	2	2	resveratrol	DPI		1832	0.426
NULL	AMB_Express_2014_Aug_30_4_63.nxml.txt.nlp	25401066	SENT164	6	6	10	10	ethanol	CO2	PA448073	4513	0.426
NULL	Cell_Death_Dis_2014_Feb_27_5(2)_e1086.nxml.txt.nlp	24577084	SENT101	45	45	10	10	l-glutamine	CO2	PA10090	4513	0.426
NULL	Saudi_J_Anaesth_2013_Jul-Sep_7(3)_296-300.nxml.txt.nlp	24015133	SENT45	24	24	33	33	sevoflurane	CO2	PA451341	4513	0.426
NULL	Indian_J_Ophthalmol_2009_Mar-Apr_57(2)_91-97.nxml.txt.nlp	19237780	SENT172	30	30	13	13	vincristine	CHOP	PA451879	1649	0.426
NULL	Infect_Dis_Obstet_Gynecol_2007_Jun_26_2007_46581.nxml.txt.nlp	17710240	SENT44	32	32	13	13	clindamycin	CO2	PA449035	4513	0.426
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT74	0	0	6	6	curcumin	TRAIL	PA151958596	8743	0.426
NULL	Oncotarget_2010_Oct_30_1(7)_639-650.nxml.txt.nlp	21317459	SENT59	4	4	6	6	nutlin-3	p53		7157	0.426
NULL	J_Am_Heart_Assoc_2013_Aug_23_2(4)_e000170.nxml.txt.nlp	23832325	SENT114	23	23	20	20	warfarin	LEP	PA451906	3952	0.426
NULL	ISRN_Neurosci_2013_Jul_7_2013_179272.nxml.txt.nlp	24967304	SENT142	7	7	18	18	estradiol	OXT	PA449503	5020	0.426
NULL	Biomed_Res_Int_2014_Jun_25_2014_764981.nxml.txt.nlp	25057499	SENT213	23	23	8	8	sorafenib	Mcl-1	PA7000	4170	0.426
NULL	Breast_Cancer_Res_2010_May_10_12(3)_R26.nxml.txt.nlp	20459744	SENT76	5	5	23	23	fluorouracil	HDC	PA128406956	3067;51696	0.426
NULL	J_Carcinog_2013_Dec_31_12_22.nxml.txt.nlp	24574860	SENT6	24	24	32	32	crizotinib	EML4	PA165946122	27436	0.426
NULL	Diabetes_Metab_Syndr_Obes_2014_Jun_24_7_229-239.nxml.txt.nlp	25018644	SENT60	5	5	2	2	exenatide	GLP-1	PA164749238	100125288	0.426
NULL	Mol_Pain_2013_Mar_28_9_17.nxml.txt.nlp	23537369	SENT217	7	7	25	25	etanercept	TNF-alpha	PA449515	7124	0.426
NULL	J_Biomed_Biotechnol_2010_Sep_19_2010_518743.nxml.txt.nlp	20886007	SENT90	20	20	17	17	ethanol	ADP	PA448073	23038	0.426
NULL	Subst_Abuse_Treat_Prev_Policy_2007_Nov_23_2_35.nxml.txt.nlp	18036213	SENT350	7	7	15	15	naltrexone	CD4	PA450588	920	0.426
NULL	Indian_J_Ophthalmol_2011_May-Jun_59(3)_197-200.nxml.txt.nlp	21586839	SENT29	9	9	14	14	methotrexate	mol	PA450428	90527	0.426
NULL	Arthritis_Res_Ther_2004_Dec_5_6(1)_6-7.nxml.txt.nlp	14979925	SENT20	23	23	17	17	hyaluronidase	HAS1	PA164745713	3036	0.426
NULL	Oncoimmunology_2013_Mar_1_2(3)_e23403.nxml.txt.nlp	23802081	SENT88	15	15	17	17	cyclophosphamide	CTX	PA449165	1593	0.426
NULL	Aging_(Albany_NY)_2012_Feb_21_4(2)_133-143.nxml.txt.nlp	22361433	SENT153	25	25	19	19	oxygen	ADP	PA450744	23038	0.426
NULL	Environ_Health_Perspect_2004_Nov_28_112(15)_1512-1518.nxml.txt.nlp	15531436	SENT217	31	31	12	12	coumarin	NAG	PA134521193	51594;4669	0.426
NULL	AMB_Express_2012_Aug_29_2_46.nxml.txt.nlp	22931793	SENT16	2	2	7	7	ethanol	CO2	PA448073	4513	0.426
NULL	Lipids_Health_Dis_2011_Jan_24_10_20.nxml.txt.nlp	21261970	SENT7	27	27	29	29	lipase	ATGL	PA450239	57104	0.426
NULL	Mol_Syst_Biol_2010_Jul_27_6_391.nxml.txt.nlp	20664637	SENT133	3	3	6	6	choline	CHKA	PA448976	1119	0.426
NULL	Crit_Care_2011_Oct_27_15(Suppl_3)_P22.nxml.txt.nlp	NULL	SENT14	0	0	2	2	hyaluronan	syndecan	PA165958431	6382	0.426
NULL	Exp_Ther_Med_2013_Apr_29_5(4)_1093-1096.nxml.txt.nlp	23596475	SENT90	21	21	13	13	ketamine	IL-6	PA450144	3569	0.426
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_May_20_65(Pt_6)_o1356.nxml.txt.nlp	21583207	SENT69	13	13	21	21	ethanol	mol	PA448073	90527	0.426
NULL	Arthritis_Res_Ther_2011_May_25_13(Suppl_1)_S2.nxml.txt.nlp	21624181	SENT65	13	13	28	28	infliximab	ACR	PA452639	49	0.426
NULL	J_Inflamm_(Lond)_2005_Apr_20_2_3.nxml.txt.nlp	15840176	SENT221	13	13	30	30	collagenase	AP-1	PA449107	2353;3727;2354;3725	0.426
NULL	Cancers_(Basel)_2009_Dec_15_1(1)_23-28.nxml.txt.nlp	20535236	SENT133	13	13	20	20	cisplatin	SOD1	PA449014	6647	0.426
NULL	Cell_Death_Differ_2012_Jan_11_19(1)_75-86.nxml.txt.nlp	22075985	SENT269	7	7	4	4	etoposide	RIPK1	PA449552	8737	0.426
NULL	J_Korean_Med_Sci_2011_Jan_22_26(1)_47-52.nxml.txt.nlp	21218029	SENT6	10	10	6	6	creatine	H-FABP	PA164778930	2170	0.426
NULL	Endocrinology_2011_Feb_5_152(2)_405-413.nxml.txt.nlp	21209017	SENT3	0	0	6	6	l-glutamine	GLP-1	PA10090	100125288	0.426
NULL	Adv_Pharmacol_Sci_2013_Dec_14_2013_716073.nxml.txt.nlp	24416041	SENT114	30	30	17	17	glibenclamide	STZ	PA449782	6484	0.426
NULL	Basic_Clin_Neurosci_2013_Autumn_4(4)_323-328.nxml.txt.nlp	25337364	SENT129	14	14	26	26	colchicine	CA1	PA449092	759	0.426
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT28	12	12	19	19	celecoxib	IL-6	PA448871	3569	0.426
NULL	Brain_Sci_2012_Dec_21_3(1)_1-38.nxml.txt.nlp	24961305	SENT1049	4	4	9	9	ethanol	spatial	PA448073	219793	0.426
NULL	Indian_J_Pharmacol_2012_Nov-Dec_44(6)_749-753.nxml.txt.nlp	23248406	SENT4	35	35	45	45	thrombin	FIB	PA451674	2091	0.426
NULL	Proteome_Sci_2010_Apr_8_8_21.nxml.txt.nlp	20377898	SENT64	6	6	1	1	trypsin	K10	PA451806	3858	0.426
NULL	Environ_Health_Perspect_2008_Mar_116(3)_A128a.nxml.txt.nlp	18335087	SENT14	22	22	11	11	lindane	San	PA164754914	80218	0.426
NULL	Tanaffos_2013_12(1)_6-15.nxml.txt.nlp	25191444	SENT60	27	27	5	5	ofloxacin	EMB	PA450684	133418	0.426
NULL	Int_J_Mol_Sci_2014_Oct_8_15(10)_17974-17999.nxml.txt.nlp	25299695	SENT125	2	2	0	0	curcumin	HO-1	PA151958596	3162	0.426
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT132	44	44	41	41	sotalol	NAPA	PA451457	9476;8775	0.426
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Feb_27_64(Pt_3)_o629.nxml.txt.nlp	21201960	SENT55	25	25	22	22	ethanol	mol	PA448073	90527	0.426
NULL	Genome_Announc_2013_Dec_12_1(6)_e01034-13.nxml.txt.nlp	24336372	SENT30	17	17	10	10	trimethoprim	DHFR	PA451788	1719	0.426
NULL	Anal_Chem_2014_Jan_7_86(1)_443-452.nxml.txt.nlp	24313826	SENT85	35	35	30	30	diazepam	NDRG2	PA449283	57447	0.426
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT276	42	42	32	32	cisplatin	UNG	PA449014	7374	0.426
NULL	Diabetes_2011_Jun_21_60(6)_1770-1778.nxml.txt.nlp	21562078	SENT197	3	3	1	1	metformin	STZ	PA450395	6484	0.426
NULL	Eur_J_Nucl_Med_Mol_Imaging_2008_Aug_29_35(8)_1544-1549.nxml.txt.nlp	18509637	SENT199	10	10	20	20	choline	FDG	PA448976	23583	0.425
NULL	J_Gen_Physiol_1962_Nov_1_46(2)_215-223.nxml.txt.nlp	14022111	SENT0	14	14	1	1	creatine	Gen	PA164778930	348654	0.425
NULL	Leukemia_2014_May_29_28(5)_1129-1131.nxml.txt.nlp	24166296	SENT58	20	20	2	2	lenalidomide	CRBN	PA162363968	51185	0.425
NULL	Br_J_Cancer_1990_May_61(5)_749-754.nxml.txt.nlp	1692472	SENT0	17	17	11	11	melphalan	GM-CSF	PA450354	1437	0.425
NULL	J_Ginseng_Res_2011_Sep_35(3)_339-343.nxml.txt.nlp	23717078	SENT14	13	13	16	16	oxygen	ROS	PA450744	6098	0.425
NULL	Mol_Biol_Cell_2013_Aug_1_24(15)_2328-2339.nxml.txt.nlp	23783029	SENT344	7	7	5	5	glucose	GEF	PA449773	56731	0.425
NULL	Angiogenesis_2009_Dec_21_12(4)_303-311.nxml.txt.nlp	19544080	SENT152	26	26	2	2	oxygen	HIF-1	PA450744	29072	0.425
NULL	J_Autom_Methods_Manag_Chem_2008_Apr_5_2008_502953.nxml.txt.nlp	19365566	SENT2703	9	9	3	3	zidovudine	FOR	PA451954	51741	0.425
NULL	Open_Cardiovasc_Med_J_2011_Jun_20_5_136-147.nxml.txt.nlp	21760856	SENT41	34	34	31	31	rosiglitazone	ghrelin	PA451283	51738	0.425
NULL	J_Exp_Med_1994_Oct_1_180(4)_1457-1469.nxml.txt.nlp	7931078	SENT14	1	1	8	8	propranolol	IL-4	PA451145	3565	0.425
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1126-1134.nxml.txt.nlp	21364592	SENT12	15	15	2	2	cisplatin	CYP2A6	PA449014	1548	0.425
NULL	Nucleic_Acids_Res_2005_Dec_13_33(22)_e190.nxml.txt.nlp	16352864	SENT85	34	34	9	9	hydrocortisone	CO2	PA449905	4513	0.425
NULL	ScientificWorldJournal_2014_Jan_30_2014_867839.nxml.txt.nlp	24592194	SENT30	1	1	7	7	nadh	ND2	PA164755085	4536	0.425
NULL	Antibiotics_(Basel)_2014_Jul_1_3(3)_285-316.nxml.txt.nlp	25364574	SENT225	11	11	26	26	ceftazidime	VIM	PA448861	7431	0.425
NULL	Int_J_Environ_Res_Public_Health_2012_Sep_24_9(9)_3051-3068.nxml.txt.nlp	23202670	SENT76	4	4	8	8	l-cysteine	DTNB	PA449173	1838	0.425
NULL	ASN_Neuro_2012_Apr_5_4(3)_e00082.nxml.txt.nlp	22339481	SENT154	0	0	7	7	ceftriaxone	ALS	PA448866	3483	0.425
NULL	Core_Evid_2011_Jan_6_6_13-21.nxml.txt.nlp	21468239	SENT34	21	21	23	23	mitoxantrone	IFN	PA450526	3439	0.425
NULL	ScientificWorldJournal_2013_Jun_24_2013_534807.nxml.txt.nlp	23864826	SENT84	25	25	36	36	diazepam	SNK	PA449283	10769	0.425
NULL	Sci_Rep_2014_Dec_12_4_7467.nxml.txt.nlp	25502280	SENT55	0	0	2	2	taurine	spatial	PA451590	219793	0.425
NULL	Curr_Neuropharmacol_2008_Dec_6(4)_322-328.nxml.txt.nlp	19587853	SENT179	3	3	5	5	methylphenidate	spatial	PA450464	219793	0.425
NULL	Int_J_Chron_Obstruct_Pulmon_Dis_2007_Mar_2(1)_33-40.nxml.txt.nlp	18044064	SENT135	0	0	24	24	tiotropium	TDI	PA164769056	100038246	0.425
NULL	Oncotarget_2014_Oct_21_5(22)_11237-11251.nxml.txt.nlp	25365078	SENT116	17	17	23	23	etoposide	p53	PA449552	7157	0.425
NULL	Oncotarget_2014_Oct_18_5(21)_10206-10221.nxml.txt.nlp	25344914	SENT242	22	22	24	24	vemurafenib	IFN	PA165946873	3439	0.425
NULL	J_Cell_Biol_2001_Mar_5_152(5)_945-958.nxml.txt.nlp	11238451	SENT63	7	7	27	27	phenol	CO2	PA450913	4513	0.425
NULL	J_Basic_Clin_Pharm_2012_Dec_4(1)_20-24.nxml.txt.nlp	24808665	SENT104	9	9	15	15	diazepam	hole	PA449283	80757	0.425
NULL	Cell_J_2012_Dec_22_Winter_13(4)_265-274.nxml.txt.nlp	23507995	SENT26	13	13	5	5	ethanol	CA3	PA448073	761	0.425
NULL	J_Korean_Med_Sci_2010_Apr_19_25(4)_557-563.nxml.txt.nlp	20357998	SENT111	0	0	28	28	rosiglitazone	IFN	PA451283	3439	0.425
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Nov_5_67(Pt_12)_o3215.nxml.txt.nlp	22199732	SENT69	25	25	22	22	ethanol	mol	PA448073	90527	0.425
NULL	Front_Mol_Neurosci_2009_Nov_6_2_24.nxml.txt.nlp	19936315	SENT207	9	9	28	28	tamoxifen	TPH2	PA451581	6999;121278	0.425
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Sep_20_70(Pt_10)_228-230.nxml.txt.nlp	25484659	SENT127	13	13	18	18	trometamol	mol	PA451802	90527	0.425
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jul_1_65(Pt_8)_o1724.nxml.txt.nlp	21583441	SENT82	39	39	36	36	ethanol	mol	PA448073	90527	0.425
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Sep_20_64(Pt_10)_o1972.nxml.txt.nlp	21201172	SENT62	27	27	20	20	ethanol	mol	PA448073	90527	0.425
NULL	Mol_Cell_Biochem_2014_Oct_9_385(1-2)_265-275.nxml.txt.nlp	24104452	SENT106	6	6	14	14	bortezomib	U87	PA10252	677775;641648	0.425
NULL	J_Asthma_Allergy_2010_Dec_30_4_1-12.nxml.txt.nlp	21701574	SENT240	4	4	6	6	budesonide	GM-CSF	PA448681	1437	0.425
NULL	Mar_Drugs_2014_Oct_17_12(10)_5240-5257.nxml.txt.nlp	25329706	SENT236	14	14	25	25	calcein	TES	PA132595336	26136	0.425
NULL	Iran_J_Basic_Med_Sci_2012_Jul-Aug_15(4)_926-936.nxml.txt.nlp	23493641	SENT34	6	6	28	28	methohexital	CO2	PA164784030	4513	0.425
NULL	Br_J_Cancer_2012_Nov_20_107(11)_1833-1839.nxml.txt.nlp	23169336	SENT216	10	10	2	2	cisplatin	ANOVA	PA449014	4858	0.425
NULL	Nucleic_Acids_Res_2011_Dec_31_39(22)_9536-9548.nxml.txt.nlp	21880590	SENT228	20	20	17	17	etoposide	BRCA1	PA449552	672	0.425
NULL	J_Immunol_Res_2014_May_12_2014_897249.nxml.txt.nlp	24901013	SENT36	28	28	23	23	natalizumab	CD4	PA164747191	920	0.425
NULL	Gastric_Cancer_2014_Apr_7_17(1)_1-12.nxml.txt.nlp	23563986	SENT164	4	4	7	7	trastuzumab	HER2	PA451743	2064	0.425
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Mar_17_66(Pt_4)_m410.nxml.txt.nlp	21580509	SENT4	43	43	39	39	nitrile	mol	PA450636	90527	0.425
NULL	Comput_Struct_Biotechnol_J_2012_Oct_29_3_e201210003.nxml.txt.nlp	24688663	SENT119	21	21	24	24	l-alanine	ALAD	PA448055	210	0.425
NULL	Leukemia_2013_Apr_14_27(4)_803-812.nxml.txt.nlp	23238589	SENT127	19	19	22	22	imatinib	IFN	PA10804	3439	0.425
NULL	Front_Physiol_2011_Jan_31_2_1.nxml.txt.nlp	21423411	SENT57	18	18	29	29	paraformaldehyde	OTC	PA450790	5009	0.425
NULL	Brain_Sci_2012_Nov_7_2(4)_589-604.nxml.txt.nlp	24349762	SENT19	17	17	26	26	estradiol	AVP	PA449503	114548;551	0.425
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Aug_12_65(Pt_9)_o2129.nxml.txt.nlp	21577541	SENT3	18	18	22	22	benzaldehyde	mol	PA448571	90527	0.425
NULL	Pain_2012_Apr_153(4)_775-783.nxml.txt.nlp	22325744	SENT159	6	6	18	18	naloxone	P21	PA450586	1026;9338	0.425
NULL	ScientificWorldJournal_2014_May_13_2014_365974.nxml.txt.nlp	24959610	SENT9	21	21	18	18	exenatide	GLP-1	PA164749238	100125288	0.425
NULL	Int_J_Mol_Sci_2014_Jun_25_15(7)_11234-11244.nxml.txt.nlp	24968266	SENT86	1	1	4	4	docetaxel	PC-3	PA449383	692094	0.425
NULL	Am_J_Med_Genet_A_2011_Oct_9_155(10)_2446-2452.nxml.txt.nlp	21910234	SENT24	12	12	18	18	creatine	SLC6A8	PA164778930	6535	0.425
NULL	Diabetes_Metab_Syndr_Obes_2009_May_18_2_37-49.nxml.txt.nlp	20148188	SENT37	28	28	37	37	metformin	GLP-1	PA450395	100125288	0.425
NULL	Eur_J_Haematol_2008_Feb_80(2)_93-106.nxml.txt.nlp	18081719	SENT165	14	14	16	16	glucose	AST	PA449773	26503	0.425
NULL	Clin_Sci_(Lond)_2011_Feb_1_120(Pt_4)_161-167.nxml.txt.nlp	20828371	SENT9	27	27	21	21	propranolol	CTRL	PA451145	1506	0.425
NULL	Blood_Cancer_J_2012_Oct_19_2(10)_e95.nxml.txt.nlp	23085780	SENT173	10	10	21	21	imatinib	CML	PA10804	613	0.425
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Dec_15_67(Pt_1)_o128-o129.nxml.txt.nlp	21522639	SENT68	36	36	33	33	ethanol	mol	PA448073	90527	0.425
NULL	Curr_Neuropharmacol_2013_May_11(3)_298-314.nxml.txt.nlp	24179465	SENT500	9	9	11	11	methylphenidate	spatial	PA450464	219793	0.425
NULL	AMB_Express_2011_Jul_19_1_21.nxml.txt.nlp	21906377	SENT210	17	17	0	0	mannitol	MPN	PA450320	83886	0.425
NULL	BMJ_Open_2014_Apr_19_4(4)_e004487.nxml.txt.nlp	24747790	SENT190	18	18	29	29	cholestyramine	STARS	PA448974	137735	0.424
NULL	Environ_Health_Perspect_2011_Mar_29_119(3)_326-331.nxml.txt.nlp	21036692	SENT42	16	16	11	11	medroxyprogesterone	CEE	PA450344	51608	0.424
NULL	Clin_Psychopharmacol_Neurosci_2012_Aug_31_10(2)_78-87.nxml.txt.nlp	23430971	SENT83	30	30	15	15	olanzapine	FES	PA450688	2242	0.424
NULL	Drug_Healthc_Patient_Saf_2013_Jun_10_5_133-141.nxml.txt.nlp	23788840	SENT143	1	1	19	19	heparin	PF4	PA449855	5196	0.424
NULL	Nat_Genet_2011_Jan_12_43(1)_27-33.nxml.txt.nlp	21151129	SENT91	19	19	46	46	tamoxifen	FOXA1	PA451581	3169	0.424
NULL	J_Oncol_2009_Mar_24_2009_491985.nxml.txt.nlp	19325924	SENT90	31	31	22	22	genistein	CXCL12	PA165109660	6387	0.424
NULL	Eur_J_Inorg_Chem_2013_May_8_2013(14)_2498-2504.nxml.txt.nlp	23794942	SENT147	23	23	15	15	ethanol	NO3	PA448073	4681	0.424
NULL	Protein_Sci_2014_Dec_1_23(12)_1686-1697.nxml.txt.nlp	25200501	SENT185	18	18	13	13	nadh	G6PD	PA164755085	2539	0.424
NULL	Nat_Commun_2013_Apr_9_4_1684.nxml.txt.nlp	23575688	SENT112	6	6	27	27	rolipram	JNK2	PA153906323	5601	0.424
NULL	Adv_Urol_2012_Nov_1_2012_641689.nxml.txt.nlp	22110494	SENT247	16	16	18	18	etoposide	EMP	PA449552	10296	0.424
NULL	Acta_Pharmacol_Sin_2012_May_4_33(5)_710-716.nxml.txt.nlp	22555373	SENT162	12	12	8	8	mexiletine	DOM	PA450488	6663	0.424
NULL	Core_Evid_2010_Oct_21_5_61-76.nxml.txt.nlp	21042543	SENT324	6	6	11	11	leucovorin	IFL	PA450198	3439	0.424
NULL	Exp_Hematol_2014_Dec_42(12)_1053-1058_e1.nxml.txt.nlp	25127743	SENT140	37	37	11	11	iron	KCNQ1	PA450087	3784	0.424
NULL	Pharmaceuticals_(Basel)_2013_Oct_11_6(10)_1287-1303.nxml.txt.nlp	24275850	SENT78	0	0	21	21	glibenclamide	spatial	PA449782	219793	0.424
NULL	Mar_Drugs_2009_Mar_31_7(2)_71-84.nxml.txt.nlp	19597572	SENT125	32	32	35	35	oxygen	ROS	PA450744	6098	0.424
NULL	Proteome_Sci_2010_Mar_18_8_14.nxml.txt.nlp	20298566	SENT323	19	19	23	23	creatine	H41	PA164778930	55573	0.424
NULL	Br_J_Ophthalmol_2008_Sep_22_92(9)_1275-1282.nxml.txt.nlp	18723745	SENT53	0	0	2	2	latanoprost	BAK	PA164774763	578	0.424
NULL	Cancer_Cell_Int_2012_Jun_6_12_22.nxml.txt.nlp	22672528	SENT119	3	3	20	20	epirubicin	DR5	PA449476	8795	0.424
NULL	Front_Chem_2014_Aug_11_2_61.nxml.txt.nlp	25157349	SENT1895	0	0	7	7	nimesulide	SLC6A19	PA137179528	340024	0.424
NULL	Clin_Med_Insights_Arthritis_Musculoskelet_Disord_2014_Feb_17_7_13-20.nxml.txt.nlp	24596471	SENT75	15	15	25	25	chlorhexidine	San	PA164776863	80218	0.424
NULL	Arch_Med_Sci_2012_Nov_9_8(5)_899-906.nxml.txt.nlp	23185202	SENT122	0	0	5	5	acarbose	ADN	PA448010	1675	0.424
NULL	Biomed_Eng_Online_2006_Jun_21_5_42.nxml.txt.nlp	16790065	SENT475	32	32	22	22	dobutamine	FFR	PA449381	738	0.424
NULL	Int_J_Cell_Biol_2013_Feb_17_2013_162094.nxml.txt.nlp	23476651	SENT19	5	5	7	7	hemin	PC-3	PA449849	692094	0.424
NULL	J_Org_Chem_2014_Feb_7_79(3)_1427-1436.nxml.txt.nlp	24428433	SENT275	18	18	24	24	galactose	mol	PA449725	90527	0.424
NULL	Case_Rep_Med_2014_Dec_8_2014_516549.nxml.txt.nlp	25544844	SENT31	33	33	38	38	thyroglobulin	CK20	PA164754910	54474	0.424
NULL	Int_J_Mol_Sci_2014_Sep_2_15(9)_15512-15529.nxml.txt.nlp	25184950	SENT190	10	10	5	5	resveratrol	IL-10		3586	0.424
NULL	Int_J_Biomater_2014_May_27_2014_367265.nxml.txt.nlp	24982676	SENT100	23	23	37	37	ethanol	VCL	PA448073	7414	0.424
NULL	Nat_Med_2014_Apr_16_20(4)_385-397.nxml.txt.nlp	24633305	SENT92	27	27	25	25	glibenclamide	GLP-1	PA449782	100125288	0.424
NULL	Mol_Cancer_2014_Jun_3_13_139.nxml.txt.nlp	24894297	SENT134	14	14	8	8	cisplatin	HES1	PA449014	3280;8209	0.424
NULL	Case_Rep_Oncol_Med_2013_Jan_16_2013_292301.nxml.txt.nlp	23401819	SENT131	20	20	2	2	vincristine	CHOP	PA451879	1649	0.424
NULL	Trials_2012_Jul_26_13_118.nxml.txt.nlp	22834768	SENT209	5	5	21	21	estradiol	PAPP-A	PA449503	5069	0.424
NULL	Am_J_Physiol_Cell_Physiol_2014_Jan_15_306(2)_C89-C97.nxml.txt.nlp	24133067	SENT175	16	16	14	14	trastuzumab	CD44	PA451743	960	0.424
NULL	Indian_J_Ophthalmol_2013_Sep_61(9)_514-515.nxml.txt.nlp	24104712	SENT12	1	1	12	12	fluorescein	PED	PA164746009	8682	0.424
NULL	Oxid_Med_Cell_Longev_2012_Jan_19_2012_390678.nxml.txt.nlp	22315655	SENT101	0	0	2	2	gliclazide	NAC	PA10892	22861	0.424
NULL	Iran_J_Radiol_2011_Mar_30_8(1)_39-41.nxml.txt.nlp	23329915	SENT50	17	17	4	4	bleomycin	CHOP	PA448645	1649	0.424
NULL	Front_Neurosci_2011_Jan_20_5_3.nxml.txt.nlp	21270945	SENT557	0	0	5	5	ethanol	CB1	PA448073	1268	0.424
NULL	Eur_J_Clin_Pharmacol_2012_Jan_8_68(1)_29-37.nxml.txt.nlp	21739267	SENT9	14	14	19	19	aripiprazole	CYP2D6	PA10026	1565	0.424
NULL	Cancer_Med_2014_Oct_2_3(5)_1256-1265.nxml.txt.nlp	24890382	SENT19	0	0	8	8	trastuzumab	San	PA451743	80218	0.424
NULL	J_Inherit_Metab_Dis_2012_May_2_35(3)_399-405.nxml.txt.nlp	22134542	SENT73	7	7	15	15	ethanol	CYP2E1	PA448073	1571	0.424
NULL	Exp_Ther_Med_2014_Nov_29_8(5)_1473-1478.nxml.txt.nlp	25289044	SENT109	12	12	14	14	heparin	AZU	PA449855	566	0.424
NULL	Nucleic_Acids_Res_2013_Dec_4_41(22)_10124-10134.nxml.txt.nlp	24005039	SENT89	13	13	21	21	ethanol	CYC1	PA448073	1537	0.424
NULL	J_Inherit_Metab_Dis_2011_Apr_27_34(2)_357-366.nxml.txt.nlp	20978943	SENT239	6	6	29	29	galactose	AMH	PA449725	268	0.424
NULL	J_Hum_Hypertens_2010_Nov_18_24(11)_730-738.nxml.txt.nlp	20164847	SENT168	36	36	15	15	olmesartan	A10	PA164742950	28870	0.424
NULL	Lancet_2011_Jun_18_377(9783)_2103-2114.nxml.txt.nlp	21641636	SENT192	13	13	8	8	cetuximab	EGFR	PA10040	1956	0.424
NULL	J_Mol_Med_(Berl)_2012_Oct_20_90(10)_1223-1231.nxml.txt.nlp	22527886	SENT76	9	9	7	7	hyaluronan	HAS1	PA165958431	3036	0.424
NULL	Cardiovasc_Diabetol_2013_Mar_23_12_48.nxml.txt.nlp	23522121	SENT4	13	13	24	24	exenatide	GLP-1	PA164749238	100125288	0.424
NULL	Oncotarget_2013_Dec_28_5(6)_1475-1490.nxml.txt.nlp	24721996	SENT222	5	5	10	10	celecoxib	PTEN	PA448871	5728	0.424
NULL	Cell_Commun_Signal_2014_Jan_10_12_3.nxml.txt.nlp	24410813	SENT90	14	14	8	8	tamoxifen	THOC1	PA451581	9984	0.424
NULL	J_Int_Soc_Sports_Nutr_2006_Jun_23_3(1)_60-66.nxml.txt.nlp	18500965	SENT61	7	7	15	15	creatine	AMPK	PA164778930	5563	0.424
NULL	J_Korean_Med_Sci_2009_Jan_29_24(Suppl_1)_S170-S175.nxml.txt.nlp	19194548	SENT86	6	6	12	12	cisplatin	EPO	PA449014	7076;8288;2056	0.424
NULL	Cancer_Cell_Int_2013_May_16_13_44.nxml.txt.nlp	23680357	SENT29	18	18	25	25	zinc	ZEB1	PA451956	6935	0.424
NULL	Exp_Diabetes_Res_2011_Dec_27_2011_604989.nxml.txt.nlp	21253359	SENT139	15	15	17	17	clonidine	GLP-1	PA449051	100125288	0.424
NULL	J_Immunother_2014_Apr_12_37(3)_180-186.nxml.txt.nlp	24598448	SENT192	0	0	5	5	sorafenib	IL-2	PA7000	3558	0.424
NULL	N_Am_J_Med_Sci_2011_Jan_3(1)_13-19.nxml.txt.nlp	22540057	SENT69	1	1	10	10	capsaicin	TRPV1	PA448776	7442	0.424
NULL	Oxid_Med_Cell_Longev_2013_Jul_9_2013_574029.nxml.txt.nlp	23936610	SENT296	4	4	24	24	resveratrol	p38		10598;1432;7965	0.424
NULL	J_Med_Chem_2014_Feb_13_57(3)_701-713.nxml.txt.nlp	24387159	SENT118	6	6	1	1	decitabine	IDH1	PA164749631	3417	0.424
NULL	J_Med_Case_Rep_2013_May_31_7_147.nxml.txt.nlp	23724969	SENT53	17	17	15	15	thyroglobulin	TTF-1	PA164754910	7080	0.424
NULL	Clinics_(Sao_Paulo)_2014_Jan_69(1)_68-74.nxml.txt.nlp	24473562	SENT128	13	13	10	10	nutlin-3	SOCS-1		8651	0.423
NULL	J_Hematol_Oncol_2009_Aug_12_2_36.nxml.txt.nlp	19674465	SENT103	14	14	7	7	rituximab	IFN	PA451261	3439	0.423
NULL	Breast_Cancer_Res_2010_Oct_22_12(Suppl_2)_S1.nxml.txt.nlp	21050422	SENT208	3	3	16	16	pertuzumab	HER2		2064	0.423
NULL	J_Young_Pharm_2011_Oct-Dec_3(4)_310-314.nxml.txt.nlp	22224038	SENT32	21	21	18	18	ethanol	mol	PA448073	90527	0.423
NULL	J_Carcinog_2013_Jan_31_12_1.nxml.txt.nlp	23599683	SENT134	12	12	18	18	cisplatin	gamma	PA449014	9913	0.423
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Feb_17_68(Pt_3)_o700-o701.nxml.txt.nlp	22412590	SENT65	33	33	19	19	erythromycin	API	PA449493	5345	0.423
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Sep_6_64(Pt_10)_o1872.nxml.txt.nlp	21201087	SENT68	20	20	23	23	paraformaldehyde	mol	PA450790	90527	0.423
NULL	Cell_Death_Dis_2010_Sep_23_1(9)_e78.nxml.txt.nlp	21364680	SENT177	22	22	13	13	cisplatin	P31	PA449014	529	0.423
NULL	Drug_Des_Devel_Ther_2014_Sep_18_8_1467-1479.nxml.txt.nlp	25258515	SENT266	15	15	2	2	mebendazole	DSC	PA164776669	1825	0.423
NULL	Evid_Based_Complement_Alternat_Med_2014_Oct_15_2014_169130.nxml.txt.nlp	25386217	SENT69	6	6	9	9	oxygen	ROS	PA450744	6098	0.423
NULL	Mol_Cancer_2008_Jun_5_7_50.nxml.txt.nlp	18534018	SENT130	21	21	6	6	bortezomib	NOXA	PA10252	5366	0.423
NULL	Acta_Pharmacol_Sin_2013_Apr_18_34(4)_555-560.nxml.txt.nlp	23503472	SENT38	25	25	14	14	cyclosporine	CYP3A4	PA449167	1576	0.423
NULL	J_Immunol_Res_2014_Nov_11_2014_659294.nxml.txt.nlp	25436215	SENT378	1	1	8	8	gemcitabine	CD11b	PA449748	3684	0.423
NULL	Case_Rep_Endocrinol_2013_Feb_20_2013_719304.nxml.txt.nlp	23509641	SENT72	14	14	12	12	thyroglobulin	TTF1	PA164754910	7080;7270	0.423
NULL	Nat_Commun_2013_Oct_1_4_2516.nxml.txt.nlp	24084631	SENT39	6	6	30	30	losartan	TSP-1	PA450268	7057	0.423
NULL	Oncotarget_2011_May_16_2(5)_418-421.nxml.txt.nlp	21789791	SENT0	10	10	12	12	bortezomib	TRAIL	PA10252	8743	0.423
NULL	Contemp_Clin_Dent_2011_Oct-Dec_2(4)_278-282.nxml.txt.nlp	22346152	SENT160	12	12	17	17	potassium	GCF	PA451047	6936	0.423
NULL	Exp_Ther_Med_2014_Nov_29_8(5)_1473-1478.nxml.txt.nlp	25289044	SENT178	24	24	26	26	heparin	AZU	PA449855	566	0.423
NULL	J_Am_Heart_Assoc_2013_Aug_23_2(4)_e000249.nxml.txt.nlp	23817469	SENT245	23	23	4	4	creatine	APLN	PA164778930	8862	0.423
NULL	Mol_Cell_Proteomics_2012_Feb_6_11(2)_M111_015222.nxml.txt.nlp	22147731	SENT369	18	18	7	7	cetuximab	EGF	PA10040	1950	0.423
NULL	Biomed_Res_Int_2014_May_18_2014_453707.nxml.txt.nlp	24955358	SENT300	14	14	18	18	colchicine	BAP	PA449092	64374	0.423
NULL	Br_J_Cancer_2013_Jun_25_108(12)_2495-2504.nxml.txt.nlp	23736031	SENT107	0	0	3	3	paclitaxel	mol	PA450761	90527	0.423
NULL	Patient_Prefer_Adherence_2011_Dec_23_6_1-9.nxml.txt.nlp	22272064	SENT1	33	33	24	24	telmisartan	ACE	PA451605	1636	0.423
NULL	J_Vet_Med_Sci_2014_Aug_15_76(8)_1173-1176.nxml.txt.nlp	24829080	SENT48	27	27	18	18	sargramostim	GM-CSF	PA164748631	1437	0.423
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT211	1	1	9	9	methotrexate	MSH2	PA450428	4436	0.423
NULL	Exp_Diabetes_Res_2012_Nov_1_2012_892706.nxml.txt.nlp	23197976	SENT161	12	12	20	20	vildagliptin	GLP-1	PA165958346	100125288	0.423
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Aug_6_64(Pt_9)_o1707.nxml.txt.nlp	21201695	SENT74	21	21	18	18	ethanol	mol	PA448073	90527	0.423
NULL	Cancer_Cell_Int_2006_Aug_9_6_20.nxml.txt.nlp	16899133	SENT65	19	19	10	10	curcumin	p27	PA151958596	5715;10534	0.423
NULL	Arthritis_Res_Ther_2013_Jul_9_15(4)_R73.nxml.txt.nlp	23837669	SENT306	0	0	6	6	colchicine	IL-8	PA449092	3576	0.423
NULL	J_Cell_Biol_2002_Sep_16_158(6)_1051-1066.nxml.txt.nlp	12235123	SENT720	23	23	6	6	staurosporine	DEDD	PA165109623	9191	0.423
NULL	Breast_Cancer_Res_2012_Mar_14_14(2)_R46.nxml.txt.nlp	22417870	SENT84	6	6	32	32	tamoxifen	HER2	PA451581	2064	0.423
NULL	Cancer_Microenviron_2008_Dec_20_1(1)_103-111.nxml.txt.nlp	19308689	SENT226	5	5	8	8	thrombin	PAR-1	PA451674	2011;2149	0.423
NULL	Front_Psychol_2014_May_8_5_392.nxml.txt.nlp	24847296	SENT813	4	4	8	8	vasopressin	AVPR1A	PA451858	552	0.423
NULL	ScientificWorldJournal_2013_Oct_1_2013_986429.nxml.txt.nlp	24198734	SENT35	16	16	25	25	acetone	flower	PA448025	11094	0.423
NULL	Infect_Dis_Obstet_Gynecol_2012_Jun_20_2012_135030.nxml.txt.nlp	22778533	SENT112	9	9	12	12	nevirapine	CD4	PA450616	920	0.423
NULL	Br_J_Cancer_2010_Feb_16_102(4)_658-664.nxml.txt.nlp	20104222	SENT3	7	7	15	15	sunitinib	IFN	PA162372840	3439	0.423
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT206	33	33	22	22	amiodarone	CYP3A4	PA448383	1576	0.423
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_15_2012_591654.nxml.txt.nlp	23118793	SENT181	19	19	15	15	berberine	PPG	PA165860812	5552	0.423
NULL	Br_J_Ophthalmol_2008_Sep_22_92(9)_1275-1282.nxml.txt.nlp	18723745	SENT84	0	0	2	2	latanoprost	BAK	PA164774763	578	0.423
NULL	Int_J_Biol_Sci_2014_Feb_20_10(3)_268-277.nxml.txt.nlp	24644425	SENT19	0	0	26	26	metformin	AMPK	PA450395	5563	0.423
NULL	Neuropsychopharmacology_2009_May_22_34(6)_1482-1493.nxml.txt.nlp	18946467	SENT203	6	6	15	15	pentazocine	DUP	PA164744326	81620;4437	0.423
NULL	J_Invest_Dermatol_2012_Apr_22_132(4)_1253-1262.nxml.txt.nlp	22189789	SENT279	9	9	20	20	capsaicin	TRPM8	PA448776	79054	0.423
NULL	J_Gen_Physiol_2003_Jul_122(1)_45-61.nxml.txt.nlp	12835470	SENT545	11	11	15	15	capsaicin	VR1	PA448776	56664	0.423
NULL	Mol_Cancer_2009_Dec_23_8_128.nxml.txt.nlp	20030805	SENT227	19	19	15	15	hydrocortisone	EGF	PA449905	1950	0.423
NULL	Biofactors_2014_May_6_40(3)_277-283.nxml.txt.nlp	24353111	SENT80	8	8	10	10	choline	PEMT	PA448976	10400	0.423
NULL	Pharmaceuticals_(Basel)_2014_Mar_5_7(3)_311-338.nxml.txt.nlp	24603603	SENT266	2	2	6	6	cetuximab	EGFR	PA10040	1956	0.423
NULL	Int_J_Med_Sci_2013_Feb_18_10(4)_362-376.nxml.txt.nlp	23470960	SENT216	3	3	5	5	glucosamine	NAG	PA164747613	51594;4669	0.423
NULL	Indian_J_Endocrinol_Metab_2012_Dec_16(Suppl_2)_S498-S500.nxml.txt.nlp	23565478	SENT48	10	10	5	5	rosuvastatin	Q10	PA134308647	27161	0.423
NULL	Autoimmun_Rev_2008_Dec_8(2)_147-152.nxml.txt.nlp	18706526	SENT190	13	13	1	1	infliximab	gamma	PA452639	9913	0.423
NULL	Crit_Care_2011_Oct_25_15(5)_R255.nxml.txt.nlp	22026977	SENT167	3	3	0	0	vasopressin	AVP	PA451858	114548;551	0.423
NULL	Oncotarget_2014_Sep_3_5(19)_9362-9381.nxml.txt.nlp	25313139	SENT270	26	26	33	33	orlistat	AMPK	PA164776864	5563	0.423
NULL	Clin_Exp_Gastroenterol_2012_Jul_19_5_139-150.nxml.txt.nlp	22888267	SENT130	12	12	29	29	indomethacin	I-FABP	PA449982	2169	0.422
NULL	Cell_J_2012_Dec_22_Winter_13(4)_265-274.nxml.txt.nlp	23507995	SENT218	13	13	5	5	ethanol	CA3	PA448073	761	0.422
NULL	Aging_(Albany_NY)_2010_Oct_20_2(10)_637-638.nxml.txt.nlp	NULL	SENT16	0	0	25	25	doxorubicin	p53	PA449412	7157	0.422
NULL	Breast_Cancer_Res_2011_Jan_28_13(1)_301.nxml.txt.nlp	21345282	SENT41	17	17	34	34	medroxyprogesterone	RANKL	PA450344	8600	0.422
NULL	Oncol_Lett_2013_Apr_28_5(4)_1149-1154.nxml.txt.nlp	23599754	SENT104	13	13	2	2	cisplatin	Dicer	PA449014	23405	0.422
NULL	J_Korean_Med_Sci_2009_Jan_29_24(Suppl_1)_S170-S175.nxml.txt.nlp	19194548	SENT127	12	12	18	18	cisplatin	EPO	PA449014	7076;8288;2056	0.422
NULL	Pharmaceutics_2011_Nov_18_3(4)_865-913.nxml.txt.nlp	24309312	SENT2232	7	7	22	22	alprazolam	CYP3A4	PA448333	1576	0.422
NULL	J_Korean_Med_Sci_2013_Apr_27_28(4)_527-533.nxml.txt.nlp	23580227	SENT42	2	2	4	4	genistein	TRAIL	PA165109660	8743	0.422
NULL	Front_Genet_2014_Nov_12_5_392.nxml.txt.nlp	25429298	SENT404	0	0	14	14	nilotinib	alpha-synuclein	PA165958345	6622	0.422
NULL	Eur_J_Med_Res_2011_Mar_28_16(3)_115-126.nxml.txt.nlp	21486724	SENT289	3	3	6	6	levofloxacin	Met	PA450214	79811	0.422
NULL	Acta_Pharmacol_Sin_2010_Mar_22_31(3)_329-340.nxml.txt.nlp	20173759	SENT207	6	6	19	19	ethanol	AMPK	PA448073	5563	0.422
NULL	Am_J_Physiol_Cell_Physiol_2014_Jan_15_306(2)_C89-C97.nxml.txt.nlp	24133067	SENT53	29	29	4	4	hyaluronan	HAS1	PA165958431	3036	0.422
NULL	Int_J_Mol_Sci_2013_Apr_11_14(4)_7923-7931.nxml.txt.nlp	23579955	SENT28	12	12	15	15	galactose	CGB	PA449725	1082	0.422
NULL	Arch_Dis_Child_2014_Dec_8_99(12)_1143-1146.nxml.txt.nlp	25202131	SENT58	10	10	2	2	propofol	CYP3A4	PA451141	1576	0.422
NULL	Mol_Cancer_2007_Jun_4_6_35.nxml.txt.nlp	17547754	SENT100	19	19	13	13	vincristine	CHOP	PA451879	1649	0.422
NULL	Int_J_Nanomedicine_2012_Oct_25_7_5565-5575.nxml.txt.nlp	23118538	SENT206	13	13	18	18	cilostazol	SAS	PA164746334	54187	0.422
NULL	Aging_(Albany_NY)_2014_Oct_30_6(10)_788-819.nxml.txt.nlp	25411230	SENT245	7	7	9	9	levodopa	COMT	PA450213	1312	0.422
NULL	Pan_Afr_Med_J_2012_Mar_19_11_50.nxml.txt.nlp	22593786	SENT53	27	27	31	31	isoniazid	IPT	PA450112	54802	0.422
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Feb_24_66(Pt_3)_o682-o683.nxml.txt.nlp	21580426	SENT76	0	0	7	7	orphenadrine	mol	PA450715	90527	0.422
NULL	Clin_Sci_(Lond)_2013_May_1_124(Pt_9)_567-578.nxml.txt.nlp	23113760	SENT301	20	20	27	27	oxygen	ROS	PA450744	6098	0.422
NULL	J_Young_Pharm_2012_Apr-Jun_4(2)_82-87.nxml.txt.nlp	22754259	SENT33	17	17	14	14	ethanol	mol	PA448073	90527	0.422
NULL	J_Radiat_Res_2012_Jul_6_53(4)_633-640.nxml.txt.nlp	22843631	SENT25	10	10	29	29	captopril	AT1	PA448780	9197;185	0.422
NULL	Drugs_Context_2013_Aug_21_2013_212256.nxml.txt.nlp	24432043	SENT37	28	28	19	19	metformin	GLP-1	PA450395	100125288	0.422
NULL	Am_J_Physiol_Cell_Physiol_2014_Jan_15_306(2)_C89-C97.nxml.txt.nlp	24133067	SENT57	3	3	7	7	hyaluronan	CD44	PA165958431	960	0.422
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Nov_5_67(Pt_12)_o3200.nxml.txt.nlp	22199720	SENT3	9	9	3	3	piperazine	mol	PA450977	90527	0.422
NULL	Int_J_Endocrinol_2014_May_20_2014_278316.nxml.txt.nlp	24963291	SENT56	20	20	41	41	l-glutamine	CO2	PA10090	4513	0.422
NULL	Clin_Ophthalmol_2011_Feb_11_5_167-170.nxml.txt.nlp	21383944	SENT77	16	16	4	4	triamcinolone	hole	PA451749	80757	0.422
NULL	Biomed_Res_Int_2014_Aug_6_2014_967826.nxml.txt.nlp	25165721	SENT215	23	23	37	37	cisplatin	TNF-alpha	PA449014	7124	0.422
NULL	Front_Endocrinol_(Lausanne)_2013_Nov_11_4_165.nxml.txt.nlp	24273530	SENT273	12	12	2	2	taurine	GAT2	PA451590	6540	0.422
NULL	Evid_Based_Complement_Alternat_Med_2014_Oct_19_2014_628712.nxml.txt.nlp	25389442	SENT48	19	19	9	9	trypsin	CO2	PA451806	4513	0.422
NULL	Cancer_Inform_2013_Feb_13_12_31-51.nxml.txt.nlp	23470717	SENT335	26	26	16	16	tamoxifen	p38	PA451581	10598;1432;7965	0.422
NULL	Crit_Care_2011_Aug_11_15(4)_226.nxml.txt.nlp	21892977	SENT124	9	9	22	22	vasopressin	AVP	PA451858	114548;551	0.422
NULL	Acta_Pharmacol_Sin_2010_Feb_5_31(2)_137-144.nxml.txt.nlp	20139896	SENT160	4	4	6	6	zileuton	5-LOX	PA451955	240	0.422
NULL	Braz_J_Med_Biol_Res_2012_Feb_17_45(3)_244-249.nxml.txt.nlp	22331137	SENT109	29	29	26	26	gentamicin	PAG	PA449753	55824	0.422
NULL	Pan_Afr_Med_J_2014_May_24_18_77.nxml.txt.nlp	25400844	SENT231	6	6	12	12	iron	B12	PA450087	7126;4709	0.422
NULL	J_Biol_Chem_2013_Feb_15_288(7)_5102-5113.nxml.txt.nlp	23223447	SENT69	10	10	20	20	phenol	CO2	PA450913	4513	0.422
NULL	Protein_Expr_Purif_2009_Aug_66(2)_181-184.nxml.txt.nlp	19269329	SENT166	18	18	13	13	thrombin	AMPK	PA451674	5563	0.422
NULL	Mol_Cancer_2009_Nov_10_8_99.nxml.txt.nlp	19903356	SENT27	7	7	22	22	imatinib	IGFBP3	PA10804	3486	0.422
NULL	Lab_Anim_Res_2012_Jun_26_28(2)_137-140.nxml.txt.nlp	22787488	SENT39	0	0	9	9	carrageenan	IL-6	PA448814	3569	0.422
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2007_Dec_6_64(Pt_1)_o142.nxml.txt.nlp	21200707	SENT63	27	27	11	11	ethanol	mol	PA448073	90527	0.422
NULL	Case_Rep_Endocrinol_2014_Oct_20_2014_851942.nxml.txt.nlp	25386368	SENT109	39	39	24	24	hydrocortisone	ACTH	PA449905	5443	0.422
NULL	J_Parasitol_Res_2011_Oct_9_2011_174614.nxml.txt.nlp	22007287	SENT69	24	24	27	27	oxygen	ROS	PA450744	6098	0.422
NULL	Antimicrob_Resist_Infect_Control_2012_Oct_19_1_33.nxml.txt.nlp	23083541	SENT60	16	16	2	2	vancomycin	HAI	PA451850	6692;6768	0.422
NULL	Iran_Red_Crescent_Med_J_2012_Dec_6_14(12)_822-825.nxml.txt.nlp	23483792	SENT33	10	10	8	8	hydrocortisone	ACTH	PA449905	5443	0.422
NULL	J_Am_Heart_Assoc_2013_Aug_23_2(4)_e000170.nxml.txt.nlp	23832325	SENT104	24	24	11	11	warfarin	LEP	PA451906	3952	0.422
NULL	Acta_Pharmacol_Sin_2012_May_16_33(5)_682-690.nxml.txt.nlp	22504904	SENT191	0	0	25	25	celecoxib	STAT3	PA448871	6774	0.422
NULL	Clin_Psychopharmacol_Neurosci_2014_Apr_24_12(1)_54-64.nxml.txt.nlp	24851122	SENT108	23	23	33	33	methamphetamine	MAPK4	PA450403	5596	0.422
NULL	Indian_J_Pharm_Sci_2011_Nov-Dec_73(6)_621-625.nxml.txt.nlp	23112395	SENT29	21	21	36	36	fluoxetine	STZ	PA449673	6484	0.422
NULL	Front_Behav_Neurosci_2012_Apr_10_6_16.nxml.txt.nlp	22514524	SENT180	20	20	26	26	pentagastrin	ANOVA	PA450849	4858	0.422
NULL	Indian_J_Pharm_Sci_2008_Jul-Aug_70(4)_535-538.nxml.txt.nlp	20046791	SENT38	30	30	27	27	ethanol	mol	PA448073	90527	0.422
NULL	Cardiovasc_Res_2011_Sep_1_91(4)_694-702.nxml.txt.nlp	21606183	SENT199	31	31	27	27	forskolin	AC6	PA146096022	112	0.422
NULL	Core_Evid_2010_Jul_27_5_1-10.nxml.txt.nlp	20694135	SENT130	16	16	19	19	levodopa	CLE	PA450213	51637	0.422
NULL	J_Immunother_Cancer_2013_Jul_15_1_10.nxml.txt.nlp	24829747	SENT56	6	6	9	9	oxygen	ROS	PA450744	6098	0.422
NULL	Mol_Biol_Cell_2012_Nov_1_23(21)_4212-4225.nxml.txt.nlp	22956765	SENT130	15	15	5	5	thrombin	SHP2	PA451674	5781	0.422
NULL	Oncogene_2010_Nov_4_29(44)_5883-5894.nxml.txt.nlp	20697354	SENT235	14	14	18	18	hydrocortisone	EGF	PA449905	1950	0.422
NULL	Acta_Pharmacol_Sin_2010_Mar_22_31(3)_329-340.nxml.txt.nlp	20173759	SENT303	1	1	10	10	ethanol	AMPK	PA448073	5563	0.422
NULL	Br_J_Cancer_2009_Mar_24_100(6)_894-900.nxml.txt.nlp	19240719	SENT154	16	16	6	6	trastuzumab	TTMB	PA451743	399474	0.422
NULL	Ann_Oncol_2014_Sep_13_25(9)_1813-1820.nxml.txt.nlp	24928832	SENT132	8	8	13	13	cetuximab	p16	PA10040	1029	0.422
NULL	Arthritis_Res_Ther_2012_Mar_14_14(2)_R64.nxml.txt.nlp	22417709	SENT70	25	25	30	30	fluorescein	San	PA164746009	80218	0.422
NULL	Cell_Commun_Signal_2013_Sep_18_11_67.nxml.txt.nlp	24047406	SENT90	22	22	31	31	paraformaldehyde	San	PA450790	80218	0.422
NULL	Clin_Ophthalmol_2014_Feb_7_8_355-362.nxml.txt.nlp	24532965	SENT212	17	17	2	2	bevacizumab	CST	PA130232992	9514	0.422
NULL	Iran_J_Public_Health_2013_Jan_1_42(Supple1)_50-54.nxml.txt.nlp	23865016	SENT136	22	22	11	11	etanercept	CRT	PA449515	811	0.421
NULL	Breast_Cancer_Res_2014_Dec_19_16(6)_499.nxml.txt.nlp	25522654	SENT223	28	28	15	15	estradiol	CYP19A1	PA449503	1588	0.421
NULL	J_Hematol_Oncol_2012_Aug_16_5_52.nxml.txt.nlp	22897982	SENT198	22	22	3	3	cetuximab	PTEN	PA10040	5728	0.421
NULL	Exp_Ther_Med_2014_Aug_6_8(2)_585-590.nxml.txt.nlp	25009624	SENT7	6	6	9	9	oxygen	ROS	PA450744	6098	0.421
NULL	Angiogenesis_2013_Apr_10_16(2)_373-386.nxml.txt.nlp	23143659	SENT32	13	13	11	11	cyclophosphamide	LDM	PA449165	1595	0.421
NULL	AIDS_Res_Treat_2011_Jul_6_2011_890308.nxml.txt.nlp	21776380	SENT209	8	8	26	26	lamivudine	KAL	PA450163	5267	0.421
NULL	Adv_Bioinformatics_2012_Jun_6_2012_582765.nxml.txt.nlp	22719757	SENT125	6	6	10	10	thrombin	EGF	PA451674	1950	0.421
NULL	Cell_Res_2010_Apr_9_20(4)_458-469.nxml.txt.nlp	20142842	SENT29	18	18	23	23	doxycycline	BCL2	PA449415	596	0.421
NULL	J_Lipid_Res_2013_Nov_54(11)_3085-3097.nxml.txt.nlp	23883581	SENT221	11	11	13	13	pp2	p38		10598;1432;7965	0.421
NULL	Clinics_(Sao_Paulo)_2009_Nov_64(11)_1113-1119.nxml.txt.nlp	19936186	SENT35	32	32	16	16	choline	B12	PA448976	7126;4709	0.421
NULL	Clin_Ophthalmol_2010_Oct_28_4_1249-1252.nxml.txt.nlp	21151329	SENT63	10	10	2	2	bevacizumab	IVL	PA130232992	3713	0.421
NULL	Exp_Ther_Med_2013_Mar_21_5(3)_987-991.nxml.txt.nlp	23407636	SENT74	7	7	11	11	captopril	IL-8	PA448780	3576	0.421
NULL	Mol_Cell_Biochem_2014_Oct_9_385(1-2)_265-275.nxml.txt.nlp	24104452	SENT123	0	0	6	6	bortezomib	U87	PA10252	677775;641648	0.421
NULL	J_Autom_Methods_Manag_Chem_2008_Apr_5_2008_502953.nxml.txt.nlp	19365566	SENT2008	9	9	12	12	methamphetamine	FAST	PA450403	10922	0.421
NULL	Cell_Death_Dis_2012_May_10_3(5)_e306.nxml.txt.nlp	22573037	SENT108	0	0	2	2	etoposide	CTX	PA449552	1593	0.421
NULL	Behav_Brain_Funct_2005_Apr_22_1_2.nxml.txt.nlp	15916700	SENT222	11	11	13	13	methylphenidate	spatial	PA450464	219793	0.421
NULL	J_Breast_Cancer_2014_Dec_26_17(4)_363-369.nxml.txt.nlp	25548585	SENT20	15	15	10	10	trastuzumab	HER2	PA451743	2064	0.421
NULL	J_Hematol_Oncol_2009_Jul_27_2_31.nxml.txt.nlp	19635146	SENT174	15	15	18	18	etoposide	TRAIL	PA449552	8743	0.421
NULL	Br_J_Cancer_2012_May_8_106(10)_1587-1590.nxml.txt.nlp	22568998	SENT99	27	27	29	29	sunitinib	IFN	PA162372840	3439	0.421
NULL	J_Gynecol_Oncol_2013_Jul_4_24(3)_265-272.nxml.txt.nlp	23875077	SENT148	19	19	14	14	thrombin	IL-6	PA451674	3569	0.421
NULL	J_Asthma_Allergy_2013_Jul_1_6_93-101.nxml.txt.nlp	23843695	SENT199	28	28	2	2	salmeterol	ACT	PA451300	12;11332;9457;641455	0.421
NULL	Indian_J_Nucl_Med_2011_Oct-Dec_26(4)_202-204.nxml.txt.nlp	23559719	SENT15	35	35	27	27	isoniazid	AKT	PA450112	207	0.421
NULL	Adv_Appl_Bioinforma_Chem_2008_Oct_30_1_85-98.nxml.txt.nlp	21918608	SENT68	9	9	3	3	bortezomib	SPARC	PA10252	6678	0.421
NULL	J_Invest_Dermatol_2013_Dec_7_133(12)_10_1038_jid_2013_222.nxml.txt.nlp	23652797	SENT26	25	25	11	11	l-tryptophan	IDO1	PA10323	3620	0.421
NULL	Nat_Commun_2013_Aug_15_4_2130.nxml.txt.nlp	23945651	SENT90	16	16	3	3	etoposide	p62	PA449552	8878;10657;23636	0.421
NULL	Leukemia_2013_Feb_3_27(2)_315-324.nxml.txt.nlp	22751450	SENT91	27	27	8	8	sorafenib	Mcl-1	PA7000	4170	0.421
NULL	Front_Mol_Neurosci_2009_Oct_26_2_19.nxml.txt.nlp	19893758	SENT50	22	22	26	26	l-glutamine	B27	PA10090	56246	0.421
NULL	AAPS_J_2012_May_31_14(3)_601-611.nxml.txt.nlp	22648902	SENT250	17	17	10	10	nevirapine	ASAT	PA450616	22	0.421
NULL	Anat_Cell_Biol_2010_Jun_30_43(2)_132-139.nxml.txt.nlp	21189994	SENT51	8	8	22	22	paraformaldehyde	PLP	PA450790	25824;5744	0.421
NULL	Br_J_Cancer_2011_Apr_12_104(8)_1256-1261.nxml.txt.nlp	21448165	SENT6	4	4	6	6	sorafenib	IL-2	PA7000	3558	0.421
NULL	Exp_Hematol_2014_Dec_42(12)_1053-1058_e1.nxml.txt.nlp	25127743	SENT7	0	0	9	9	potassium	KCNE2	PA451047	9992	0.421
NULL	Breast_Cancer_Res_2012_Mar_9_14(2)_R41.nxml.txt.nlp	22405131	SENT57	41	41	26	26	ethanol	FBS	PA448073	64319;26269	0.421
NULL	Diabetes_2013_Nov_18_62(11)_3909-3919.nxml.txt.nlp	23835339	SENT212	7	7	12	12	gliclazide	SUR1	PA10892	6833	0.421
NULL	Mol_Cell_Biochem_2014_Oct_9_385(1-2)_265-275.nxml.txt.nlp	24104452	SENT128	0	0	8	8	bortezomib	U87	PA10252	677775;641648	0.421
NULL	Front_Physiol_2015_Jan_5_5_501.nxml.txt.nlp	25601838	SENT163	18	18	16	16	thrombin	ADP	PA451674	23038	0.421
NULL	Clin_Transl_Allergy_2014_Feb_2_4_4.nxml.txt.nlp	24484687	SENT121	18	18	24	24	trypsin	San	PA451806	80218	0.421
NULL	Exp_Ther_Med_2014_Aug_6_8(2)_585-590.nxml.txt.nlp	25009624	SENT26	16	16	19	19	oxygen	ROS	PA450744	6098	0.421
NULL	Br_J_Cancer_2013_Sep_3_109(5)_1079-1084.nxml.txt.nlp	23928659	SENT90	11	11	7	7	docetaxel	DES	PA449383	1674	0.421
NULL	Bioinorg_Chem_Appl_2014_Feb_23_2014_276598.nxml.txt.nlp	24707242	SENT71	23	23	20	20	ethanol	mol	PA448073	90527	0.421
NULL	Oncogene_2010_Jul_8_29(27)_3953-3963.nxml.txt.nlp	20440263	SENT275	18	18	8	8	thioguanine	SRF	PA451663	6722	0.421
NULL	J_Phys_Ther_Sci_2013_Oct_20_25(10)_1317-1319.nxml.txt.nlp	24259784	SENT95	26	26	29	29	oxygen	ROS	PA450744	6098	0.421
NULL	JRSM_Cardiovasc_Dis_2012_Sep_24_1(6)_cvd_2012_012015.nxml.txt.nlp	24175073	SENT43	16	16	12	12	clopidogrel	HPR	PA449053	3250	0.421
NULL	J_Cell_Biol_2000_Feb_21_148(4)_811-824.nxml.txt.nlp	10684261	SENT42	14	14	16	16	thrombin	EGF	PA451674	1950	0.421
NULL	Curr_Hepat_Rep_2010_May_21_9(2)_75-90.nxml.txt.nlp	20461127	SENT244	15	15	37	37	telbivudine	LAM	PA164760861	7249;7248	0.421
NULL	Mol_Cancer_2014_Jan_28_13_17.nxml.txt.nlp	24472312	SENT234	10	10	7	7	ponatinib	Mcl-1	PA165980594	4170	0.421
NULL	Exp_Ther_Med_2013_Mar_21_5(3)_987-991.nxml.txt.nlp	23407636	SENT100	16	16	25	25	losartan	CXCR1	PA450268	3577	0.421
NULL	Oncotarget_2010_May_27_1(2)_89-103.nxml.txt.nlp	20671809	SENT237	2	2	5	5	etoposide	CD34	PA449552	947	0.421
NULL	Acta_Pharmacol_Sin_2011_Aug_27_32(8)_1045-1054.nxml.txt.nlp	21706041	SENT82	7	7	40	40	paraformaldehyde	IL-17	PA450790	3605	0.421
NULL	Mol_Brain_2013_Dec_16_6_56.nxml.txt.nlp	24330819	SENT209	0	0	12	12	dantrolene	GluN2D	PA449208	2906	0.42
NULL	Chem_Cent_J_2013_Jan_14_7_7.nxml.txt.nlp	23316845	SENT31	10	10	24	24	flavopiridol	SRM	PA452627	6723;6725	0.42
NULL	Aging_(Albany_NY)_2009_Dec_29_2(1)_63-68.nxml.txt.nlp	20228936	SENT78	20	20	13	13	nadh	SIRT1	PA164755085	23411	0.42
NULL	Br_J_Pharmacol_2014_May_11_171(9)_2385-2398.nxml.txt.nlp	24467222	SENT228	18	18	25	25	roflumilast	CXCL10	PA165948052	3627	0.42
NULL	Acta_Pharmacol_Sin_2013_Oct_7_34(10)_1317-1324.nxml.txt.nlp	23933652	SENT153	24	24	27	27	oxygen	ROS	PA450744	6098	0.42
NULL	Front_Genet_2014_Jul_16_5_201.nxml.txt.nlp	25076963	SENT2227	0	0	12	12	arsenite	CGL-2	PA452638	2999	0.42
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Aug_27_67(Pt_9)_o2502.nxml.txt.nlp	22064274	SENT78	0	0	7	7	triprolidine	mol	PA451797	90527	0.42
NULL	Environ_Health_Perspect_2012_Mar_15_120(3)_379-384.nxml.txt.nlp	22169271	SENT144	22	22	18	18	carbamazepine	HMP	PA448785	10989	0.42
NULL	J_Biomed_Biotechnol_2010_Sep_19_2010_518743.nxml.txt.nlp	20886007	SENT173	31	31	33	33	nadh	ADP	PA164755085	23038	0.42
NULL	Indian_J_Nephrol_2009_Apr_19(2)_82.nxml.txt.nlp	20368932	SENT16	7	7	5	5	cyclophosphamide	CHOP	PA449165	1649	0.42
NULL	Exp_Ther_Med_2013_Nov_6_6(5)_1089-1095.nxml.txt.nlp	24223627	SENT12	19	19	15	15	docetaxel	NAC	PA449383	22861	0.42
NULL	Front_Neurosci_2013_Jun_13_7_97.nxml.txt.nlp	23781167	SENT869	1	1	3	3	methylphenidate	spatial	PA450464	219793	0.42
NULL	Case_Rep_Med_2010_Dec_26_2010_403237.nxml.txt.nlp	21209804	SENT59	25	25	27	27	bortezomib	CHOP	PA10252	1649	0.42
NULL	J_Gen_Physiol_2012_Oct_140(4)_403-419.nxml.txt.nlp	23008434	SENT165	0	0	3	3	phenol	TMX	PA450913	81542	0.42
NULL	Clin_Ophthalmol_2012_Jan_12_6_103-109.nxml.txt.nlp	22275814	SENT2	33	33	25	25	latanoprost	BAK	PA164774763	578	0.42
NULL	Oncogene_2009_Dec_3_28(48)_4237-4248.nxml.txt.nlp	19734937	SENT258	2	2	4	4	collagenase	PAR-1	PA449107	2011;2149	0.42
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT304	0	0	2	2	cisplatin	p38	PA449014	10598;1432;7965	0.42
NULL	Br_J_Cancer_2011_Mar_1_104(5)_769-780.nxml.txt.nlp	21304529	SENT262	12	12	16	16	oxaliplatin	ANOVA	PA131285527	4858	0.42
NULL	Oncotarget_2012_Oct_20_3(10)_1068-1111.nxml.txt.nlp	23085539	SENT209	0	0	5	5	vemurafenib	PTEN	PA165946873	5728	0.42
NULL	Diabetes_Care_2013_May_13_36(5)_1368-1376.nxml.txt.nlp	23275363	SENT251	9	9	2	2	exenatide	Gen	PA164749238	348654	0.42
NULL	Nat_Commun_2012_Feb_14_3_672.nxml.txt.nlp	22334075	SENT108	2	2	23	23	pioglitazone	GAPDH	PA450970	2597	0.42
NULL	J_Ophthalmol_2011_Dec_23_2011_292040.nxml.txt.nlp	21253505	SENT131	4	4	6	6	nilvadipine	rd2	PA165958385	5961	0.42
NULL	Curr_Org_Chem_2013_Aug_17_1710-1723.nxml.txt.nlp	24143126	SENT167	12	12	10	10	nitrile	HCN	PA450636	378938	0.42
NULL	Atten_Defic_Hyperact_Disord_2011_Dec_15_3(4)_351-358.nxml.txt.nlp	22002672	SENT0	16	16	18	18	methylphenidate	spatial	PA450464	219793	0.42
NULL	Mol_Biol_Rep_2013_Sep_28_40(10)_5573-5585.nxml.txt.nlp	24078156	SENT58	41	41	33	33	iron	FPN1	PA450087	30061	0.42
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT116	27	27	23	23	tenofovir	SLC22A6	PA10204	9356	0.42
NULL	Mol_Cancer_2007_Mar_7_6_18.nxml.txt.nlp	17343740	SENT211	5	5	8	8	alendronate	PC3	PA448082	57332;7832;5122	0.42
NULL	Drugs_Context_2012_Nov_19_2012_212242.nxml.txt.nlp	24432031	SENT87	8	8	10	10	temozolomide	IFN	PA451609	3439	0.42
NULL	Exp_Cell_Res_2011_Apr_15_317(7)_1028-1039.nxml.txt.nlp	21237154	SENT116	13	13	11	11	staurosporine	TRAIL	PA165109623	8743	0.42
NULL	J_Headache_Pain_2009_Dec_1_10(6)_395-406.nxml.txt.nlp	19795182	SENT155	3	3	20	20	capsaicin	TRPV1	PA448776	7442	0.42
NULL	ACS_Chem_Biol_2011_Apr_15_6(4)_325-335.nxml.txt.nlp	21175222	SENT132	8	8	15	15	chymotrypsin	L14	PA448994	9045	0.42
NULL	Indian_J_Anaesth_2014_Sep-Oct_58(5)_565-572.nxml.txt.nlp	25535418	SENT192	12	12	14	14	clopidogrel	P2Y12	PA449053	64805	0.42
NULL	Br_J_Haematol_2008_Jun_141(5)_659-671.nxml.txt.nlp	18410446	SENT10	2	2	14	14	cerulenin	JNK	PA164764551	5599	0.42
NULL	Oncogenesis_2014_May_12_3(5)_e102.nxml.txt.nlp	24819061	SENT97	15	15	4	4	nadh	p53	PA164755085	7157	0.42
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT202	4	4	6	6	perifosine	TRAIL	PA165291471	8743	0.42
NULL	Ecancermedicalscience_2011_Apr_28_5_211.nxml.txt.nlp	22276054	SENT114	22	22	24	24	aprepitant	NK-1	PA164747039	27087	0.42
NULL	Front_Physiol_2013_May_10_4_102.nxml.txt.nlp	23675354	SENT776	0	0	7	7	creatine	ADP	PA164778930	23038	0.42
NULL	Biogerontology_2009_Aug_22_10(4)_503-516.nxml.txt.nlp	18720024	SENT426	9	9	12	12	kanamycin	Gen	PA450137	348654	0.42
NULL	Front_Immunol_2013_Nov_12_4_370.nxml.txt.nlp	24273542	SENT392	4	4	11	11	gemcitabine	CD11b	PA449748	3684	0.42
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jun_10_65(Pt_7)_m751-m752.nxml.txt.nlp	21582688	SENT5	22	22	13	13	ethanol	mol	PA448073	90527	0.42
NULL	Front_Endocrinol_(Lausanne)_2011_Nov_10_2_65.nxml.txt.nlp	22649380	SENT42	12	12	14	14	vasopressin	AVP	PA451858	114548;551	0.42
NULL	J_Korean_Med_Sci_2007_Apr_30_22(2)_283-289.nxml.txt.nlp	17449938	SENT106	0	0	9	9	minoxidil	P21	PA450521	1026;9338	0.42
NULL	Clin_Kidney_J_2013_Jun_11_6(3)_287-294.nxml.txt.nlp	23717787	SENT152	8	8	14	14	cinacalcet	PTH	PA164776671	5741	0.42
NULL	Hum_Genomics_2012_Jul_5_6(1)_6.nxml.txt.nlp	23245351	SENT130	17	17	7	7	estradiol	PDIA2	PA449503	64714	0.42
NULL	Arthritis_Res_Ther_2010_Apr_1_12(2)_R60.nxml.txt.nlp	20359365	SENT168	23	23	25	25	bleomycin	SPARC	PA448645	6678	0.42
NULL	Int_J_Vasc_Med_2012_Jul_24_2012_508416.nxml.txt.nlp	22888436	SENT163	27	27	31	31	troglitazone	SRC-3	PA451799	8202	0.42
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT382	2	2	21	21	cetuximab	ACRC	PA10040	93953	0.42
NULL	J_Exp_Med_1994_Oct_1_180(4)_1457-1469.nxml.txt.nlp	7931078	SENT14	1	1	19	19	propranolol	DAG	PA451145	1605	0.42
NULL	J_Inflamm_(Lond)_2008_Dec_5_5_23.nxml.txt.nlp	19061493	SENT174	11	11	5	5	hemin	HO-1	PA449849	3162	0.42
NULL	Oncotarget_2014_Jun_19_5(15)_6540-6551.nxml.txt.nlp	25153728	SENT96	13	13	33	33	paclitaxel	CDK1	PA450761	983	0.42
NULL	Int_Semin_Surg_Oncol_2006_Aug_25_3_22.nxml.txt.nlp	16930493	SENT84	31	31	33	33	cimetidine	PSK	PA449001	9344	0.42
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT148	6	6	17	17	perifosine	JNK	PA165291471	5599	0.42
NULL	Int_J_Endocrinol_2010_Feb_10_2010_625852.nxml.txt.nlp	20169119	SENT105	11	11	15	15	paricalcitol	PTH	PA450798	5741	0.42
NULL	Acta_Pharmacol_Sin_2014_Jun_5_35(6)_716-726.nxml.txt.nlp	24793311	SENT250	0	0	9	9	atorvastatin	PSD-95	PA448500	1742	0.42
NULL	Mol_Cancer_2010_Dec_20_9_317.nxml.txt.nlp	21172025	SENT129	23	23	17	17	tamoxifen	HER2	PA451581	2064	0.42
NULL	J_Mol_Signal_2010_Dec_13_5_20.nxml.txt.nlp	21144036	SENT26	10	10	5	5	pioglitazone	TRG	PA450970	6965	0.42
NULL	Crit_Care_2010_Mar_10_14(2)_128.nxml.txt.nlp	20236465	SENT46	30	30	14	14	oxygen	MCT	PA450744	27349;6566	0.42
NULL	Eur_J_Med_Res_2011_Mar_28_16(3)_115-126.nxml.txt.nlp	21486724	SENT286	2	2	5	5	levofloxacin	Met	PA450214	79811	0.419
NULL	Open_Biochem_J_2011_Sep_23_5_45-51.nxml.txt.nlp	21966325	SENT122	17	17	21	21	diclofenac	IRE1	PA449293	2081	0.419
NULL	Cell_Logist_2012_Apr_1_2(2)_117-125.nxml.txt.nlp	23162743	SENT10	8	8	2	2	curcumin	PAK1	PA151958596	5585;5058	0.419
NULL	Acta_Pharmacol_Sin_2012_Dec_17_33(12)_1441-1458.nxml.txt.nlp	22983389	SENT368	0	0	24	24	perifosine	AMPK	PA165291471	5563	0.419
NULL	Oncol_Lett_2014_Nov_12_8(5)_2203-2208.nxml.txt.nlp	25295109	SENT72	4	4	6	6	celecoxib	GLI1	PA448871	2735	0.419
NULL	J_Cancer_2014_Apr_25_5(6)_398-405.nxml.txt.nlp	24847380	SENT151	12	12	28	28	epirubicin	TDI	PA449476	100038246	0.419
NULL	Mol_Biol_Cell_2013_Aug_1_24(15)_2477-2490.nxml.txt.nlp	23761072	SENT345	13	13	27	27	fluorescein	San	PA164746009	80218	0.419
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Mar_26_3(3)_e107.nxml.txt.nlp	24670388	SENT394	24	24	16	16	midazolam	CYP3A	PA450496	1574	0.419
NULL	J_Nucleic_Acids_2010_Aug_8_2010_201367.nxml.txt.nlp	20811617	SENT289	0	0	2	2	cisplatin	JNK	PA449014	5599	0.419
NULL	Front_Behav_Neurosci_2010_Apr_5_4_14.nxml.txt.nlp	20407577	SENT88	2	2	4	4	zinc	MYT1	PA451956	4661;9088	0.419
NULL	F1000Res_2013_Jul_9_2_150.nxml.txt.nlp	24627787	SENT200	1	1	9	9	clozapine	DIP	PA449061	23151;1831	0.419
NULL	Biomed_Res_Int_2014_Jan_29_2014_831845.nxml.txt.nlp	24605337	SENT150	20	20	13	13	bupivacaine	c-Jun	PA135057240	3725	0.419
NULL	J_Cell_Mol_Med_2014_Apr_22_18(4)_610-623.nxml.txt.nlp	24447545	SENT58	42	42	13	13	l-glutamine	CO2	PA10090	4513	0.419
NULL	Oxid_Med_Cell_Longev_2012_Aug_22_2012_534705.nxml.txt.nlp	22966415	SENT222	1	1	7	7	riluzole	GLT-1	PA451251	6506	0.419
NULL	Environ_Health_Perspect_2007_Dec_8_115(Suppl_1)_129-136.nxml.txt.nlp	18174961	SENT17	0	0	5	5	lindane	Bcl-2	PA164754914	596	0.419
NULL	Cardiovasc_Res_2011_Apr_1_90(1)_105-112.nxml.txt.nlp	21123217	SENT146	20	20	28	28	mibefradil	AMN	PA450492	215;81693	0.419
NULL	Eur_J_Med_Res_2011_Mar_28_16(3)_115-126.nxml.txt.nlp	21486724	SENT288	13	13	16	16	ciprofloxacin	Met	PA449009	79811	0.419
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Aug_31_69(Pt_9)_o1485-o1486.nxml.txt.nlp	24427105	SENT10	15	15	11	11	phenol	mol	PA450913	90527	0.419
NULL	Nat_Med_2013_Mar_10_19(3)_313-321.nxml.txt.nlp	23396211	SENT88	8	8	12	12	amlexanox	TBK1	PA164745310	29110	0.419
NULL	Breast_Cancer_(Auckl)_2011_Oct_9_5_209-226.nxml.txt.nlp	22084574	SENT197	16	16	25	25	tamoxifen	ARNO	PA451581	9266	0.419
NULL	Front_Chem_2013_Dec_31_1_40.nxml.txt.nlp	24790967	SENT28	21	21	3	3	echinacea	flower	PA131550706	11094	0.419
NULL	Front_Immunol_2013_May_15_4_116.nxml.txt.nlp	23720663	SENT15	6	6	11	11	temozolomide	CTX	PA451609	1593	0.419
NULL	Scientifica_(Cairo)_2012_Sep_3_2012_757890.nxml.txt.nlp	24278738	SENT125	7	7	16	16	curcumin	JNK	PA151958596	5599	0.419
NULL	Br_J_Cancer_2012_Sep_4_107(6)_947-955.nxml.txt.nlp	22892392	SENT120	0	0	5	5	lapatinib	ERBB2	PA152241907	2064	0.419
NULL	Can_J_Infect_Dis_Med_Microbiol_2014_Nov-Dec_25(6)_327-343.nxml.txt.nlp	25587296	SENT752	3	3	6	6	itraconazole	CYP3A4	PA450132	1576	0.419
NULL	J_Ginseng_Res_2011_Jun_35(2)_170-175.nxml.txt.nlp	23717059	SENT22	9	9	12	12	oxygen	ROS	PA450744	6098	0.419
NULL	Cell_Death_Dis_2014_Jul_17_5(7)_e1333.nxml.txt.nlp	25032856	SENT34	18	18	12	12	candesartan	EAAC1	PA448765	6505	0.419
NULL	Exp_Diabetes_Res_2012_Sep_6_2012_470302.nxml.txt.nlp	22991506	SENT132	7	7	22	22	paraformaldehyde	P14	PA450790	11102;;6280;56259	0.419
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jul_21_66(Pt_8)_o2077.nxml.txt.nlp	21588377	SENT62	24	24	21	21	ethanol	mol	PA448073	90527	0.419
NULL	Eur_J_Haematol_2008_Feb_80(2)_93-106.nxml.txt.nlp	18081719	SENT190	7	7	23	23	furosemide	ACE	PA449719	1636	0.419
NULL	Cancers_(Basel)_2012_Feb_7_4(1)_88-99.nxml.txt.nlp	24213228	SENT601	14	14	9	9	meloxicam	COX	PA450353	1351	0.419
NULL	Oncotarget_2011_Mar_27_2(3)_209-221.nxml.txt.nlp	21444945	SENT158	12	12	18	18	bortezomib	p53	PA10252	7157	0.419
NULL	EMBO_Mol_Med_2011_Jul_3(7)_367-369.nxml.txt.nlp	21591260	SENT28	18	18	8	8	collagenase	MMP1	PA449107	4312	0.419
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_79-96.nxml.txt.nlp	19305789	SENT130	30	30	36	36	capsaicin	TRPV1	PA448776	7442	0.419
NULL	Eur_J_Endocrinol_2012_Apr_166(4)_657-667.nxml.txt.nlp	22275472	SENT182	24	24	27	27	oxygen	ROS	PA450744	6098	0.419
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT20	9	9	7	7	vinorelbine	ASC	PA451881	29108	0.419
NULL	eLife_2013_Sep_24_2_e00905.nxml.txt.nlp	24069528	SENT212	29	29	36	36	iodixanol	EGFR	PA164783998	1956	0.419
NULL	Clin_Ophthalmol_2012_Jul_31_6_1201-1205.nxml.txt.nlp	22927728	SENT29	19	19	12	12	bevacizumab	San	PA130232992	80218	0.419
NULL	Exp_Diabetes_Res_2012_Oct_15_2012_465282.nxml.txt.nlp	23118742	SENT28	17	17	19	19	metformin	FGF21	PA450395	26291	0.419
NULL	Indian_J_Pharm_Sci_2008_Mar-Apr_70(2)_145-153.nxml.txt.nlp	20046703	SENT191	34	34	44	44	bleomycin	IL-2	PA448645	3558	0.419
NULL	Clin_Cosmet_Investig_Dermatol_2014_Sep_2_7_243-249.nxml.txt.nlp	25214798	SENT129	19	19	2	2	methotrexate	ACR	PA450428	49	0.419
NULL	Front_Oncol_2014_Jun_11_4_145.nxml.txt.nlp	24967214	SENT389	2	2	9	9	gemcitabine	CD11b	PA449748	3684	0.419
NULL	J_Thromb_Haemost_2011_Oct_9(10)_2103-2105.nxml.txt.nlp	21812912	SENT17	25	25	20	20	ticagrelor	mol	PA165374673	90527	0.419
NULL	Korean_J_Anesthesiol_2013_Jun_24_64(6)_494-499.nxml.txt.nlp	23814648	SENT152	46	46	12	12	mepivacaine	G30	PA164748741	282706	0.419
NULL	Front_Pharmacol_2014_Oct_20_5_230.nxml.txt.nlp	25368579	SENT18	3	3	14	14	berberine	IL-6	PA165860812	3569	0.419
NULL	Bioinorg_Chem_Appl_2014_Oct_16_2014_104046.nxml.txt.nlp	25386109	SENT506	29	29	27	27	coumarin	SNO	PA134521193	6498	0.419
NULL	Int_J_Breast_Cancer_2011_Jul_12_2011_232435.nxml.txt.nlp	22295213	SENT90	0	0	2	2	estradiol	EGF	PA449503	1950	0.419
NULL	Curr_Pharm_Des_2008_Dec_14(34)_3637-3655.nxml.txt.nlp	19075740	SENT499	2	2	4	4	chloroquine	MPG	PA448948	4350	0.419
NULL	Ann_Clin_Microbiol_Antimicrob_2009_Sep_24_8_26.nxml.txt.nlp	19778428	SENT244	10	10	4	4	ampicillin	PEN	PA448419	9933	0.419
NULL	Psychiatry_Investig_2012_Jun_30_9(2)_187-190.nxml.txt.nlp	22707971	SENT6	27	27	7	7	capsaicin	POMC	PA448776	5443	0.419
NULL	Lab_Invest_2009_Apr_9_89(4)_456-469.nxml.txt.nlp	19204666	SENT118	8	8	26	26	ethanol	San	PA448073	80218	0.419
NULL	Evid_Based_Complement_Alternat_Med_2011_Feb_14_2011_429843.nxml.txt.nlp	21869897	SENT166	30	30	28	28	ethanol	CORT	PA448073	1325	0.419
NULL	Blood_Cancer_J_2014_Oct_31_4(10)_e256.nxml.txt.nlp	25360902	SENT66	30	30	2	2	rituximab	CHOP	PA451261	1649	0.419
NULL	Int_J_Mol_Sci_2014_Sep_29_15(10)_17411-17441.nxml.txt.nlp	25268615	SENT391	4	4	9	9	collagenase	EMMPRIN	PA449107	682	0.419
NULL	Environ_Health_Perspect_2010_Jan_10_118(1)_108-115.nxml.txt.nlp	20056578	SENT21	22	22	9	9	arsenite	p63	PA452638	8626	0.418
NULL	Nat_Commun_2013_Oct_1_4_2516.nxml.txt.nlp	24084631	SENT701	0	0	10	10	losartan	AK4	PA450268	205	0.418
NULL	Biomed_Res_Int_2014_May_28_2014_726241.nxml.txt.nlp	24982907	SENT14	5	5	8	8	oxygen	ROS	PA450744	6098	0.418
NULL	Support_Care_Cancer_2011_Oct_12_19(10)_1609-1617.nxml.txt.nlp	20835873	SENT33	14	14	32	32	granisetron	HEC	PA449809	10403	0.418
NULL	Biochemistry_2014_May_13_53(18)_2966-2978.nxml.txt.nlp	24724799	SENT416	4	4	11	11	mitoxantrone	USP11	PA450526	8237	0.418
NULL	Diabetes_Metab_Syndr_Obes_2014_Jun_24_7_229-239.nxml.txt.nlp	25018644	SENT27	5	5	2	2	exenatide	GLP-1	PA164749238	100125288	0.418
NULL	Cell_Cycle_2012_Aug_15_11(16)_3067-3078.nxml.txt.nlp	22871739	SENT121	13	13	7	7	cisplatin	E2F1	PA449014	1869	0.418
NULL	Front_Neuroenergetics_2010_Jul_30_2_19.nxml.txt.nlp	20725601	SENT515	4	4	25	25	nadh	spatial	PA164755085	219793	0.418
NULL	Biochemistry_2013_Oct_15_52(41)_7167-7169.nxml.txt.nlp	24083983	SENT42	3	3	32	32	cyclosporine	P-gp	PA449167	5243	0.418
NULL	Islets_2013_May_1_5(3)_111-115.nxml.txt.nlp	23756701	SENT68	4	4	7	7	collagenase	GMP	PA449107	22978	0.418
NULL	J_Med_Case_Reports_2011_Jun_7_5_217.nxml.txt.nlp	21649896	SENT74	11	11	2	2	choline	BCS	PA448976	617	0.418
NULL	J_Korean_Med_Sci_2009_Jan_29_24(Suppl_1)_S170-S175.nxml.txt.nlp	19194548	SENT11	11	11	20	20	cisplatin	EPO	PA449014	7076;8288;2056	0.418
NULL	Acta_Pharmacol_Sin_2012_Jan_28_33(1)_66-74.nxml.txt.nlp	22120966	SENT175	32	32	26	26	genistein	OPG	PA165109660	690	0.418
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Feb_21_65(Pt_3)_o558.nxml.txt.nlp	21582216	SENT53	17	17	28	28	potassium	mol	PA451047	90527	0.418
NULL	Cardiovasc_Drugs_Ther_2014_Aug_28_28(5)_477-488.nxml.txt.nlp	25163464	SENT89	9	9	11	11	vasopressin	ACTH	PA451858	5443	0.418
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Nov_30_67(Pt_12)_m1876.nxml.txt.nlp	22199639	SENT6	1	1	3	3	ethanol	mol	PA448073	90527	0.418
NULL	Eur_J_Dent_2007_Jul_1(3)_158b-166.nxml.txt.nlp	19212560	SENT157	18	18	22	22	ethanol	HEMA	PA448073	2157	0.418
NULL	Oncol_Rep_2014_Feb_29_31(2)_835-841.nxml.txt.nlp	24296978	SENT146	4	4	9	9	celecoxib	survivin	PA448871	332	0.418
NULL	AIDS_Behav_2012_Feb_30_16(2)_396-403.nxml.txt.nlp	21190073	SENT130	8	8	17	17	methamphetamine	San	PA450403	80218	0.418
NULL	J_Adv_Pharm_Technol_Res_2014_Jan-Mar_5(1)_21-27.nxml.txt.nlp	24696814	SENT144	44	44	41	41	ethanol	mol	PA448073	90527	0.418
NULL	Biomed_Res_Int_2014_Aug_6_2014_967826.nxml.txt.nlp	25165721	SENT205	24	24	19	19	cisplatin	MCP-1	PA449014	6347	0.418
NULL	Mol_Cell_Proteomics_2012_Feb_13_11(2)_M111_013904.nxml.txt.nlp	21997733	SENT194	15	15	21	21	trypsin	ITIH2	PA451806	3698	0.418
NULL	Cell_Cycle_2012_Sep_15_11(18)_3472-3480.nxml.txt.nlp	22918244	SENT203	11	11	7	7	cisplatin	VDAC1	PA449014	7416	0.418
NULL	J_Clin_Exp_Pathol_2012_May_17_Suppl_4_7327.nxml.txt.nlp	25379357	SENT192	12	12	9	9	resveratrol	SIRT1		23411	0.418
NULL	J_Biol_Chem_2009_May_1_284(18)_11953-11962.nxml.txt.nlp	19254952	SENT319	17	17	13	13	heparin	EGFR	PA449855	1956	0.418
NULL	Front_Immunol_2012_Jun_22_3_168.nxml.txt.nlp	22737154	SENT41	40	40	25	25	heparin	EGF	PA449855	1950	0.418
NULL	Front_Chem_2013_Dec_31_1_40.nxml.txt.nlp	24790967	SENT28	17	17	3	3	echinacea	flower	PA131550706	11094	0.418
NULL	Iran_J_Pharm_Res_2014_Autumn_13(4)_1369-1378.nxml.txt.nlp	25587326	SENT98	5	5	8	8	ethanol	LCE	PA448073	79071	0.418
NULL	Chonnam_Med_J_2013_Dec_23_49(3)_101-107.nxml.txt.nlp	24400211	SENT65	4	4	7	7	oxygen	ROS	PA450744	6098	0.418
NULL	Diabetes_Care_2013_Jan_11_36(1)_e13.nxml.txt.nlp	23264296	SENT6	42	42	22	22	glucose	GLP-1	PA449773	100125288	0.418
NULL	Mol_Cancer_2009_Aug_25_8_66.nxml.txt.nlp	19706164	SENT114	14	14	11	11	celecoxib	FBS	PA448871	64319;26269	0.418
NULL	Biologics_2009_Oct_12_3_469-474.nxml.txt.nlp	19851472	SENT71	13	13	5	5	montelukast	IL-5	PA450546	3567	0.418
NULL	J_Exerc_Rehabil_2013_Jun_30_9(3)_348-353.nxml.txt.nlp	24278883	SENT46	13	13	8	8	glucose	STZ	PA449773	6484	0.418
NULL	Case_Rep_Nephrol_Urol_2014_Apr_12_4(1)_75-81.nxml.txt.nlp	24847349	SENT6	5	5	9	9	amiodarone	APT	PA448383	653639	0.418
NULL	Clin_Exp_Gastroenterol_2014_Jul_5_7_221-239.nxml.txt.nlp	25045276	SENT248	16	16	39	39	lipase	CB1	PA450239	1268	0.418
NULL	Cancer_Metab_2014_Jul_17_2_10.nxml.txt.nlp	25057353	SENT54	8	8	27	27	nadh	IDH1	PA164755085	3417	0.418
NULL	Cell_Death_Dis_2014_Jan_30_5(1)_e1043.nxml.txt.nlp	24481457	SENT234	9	9	0	0	urokinase	IL1B	PA451836	3553	0.418
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_May_26_68(Pt_6)_o1909-o1910.nxml.txt.nlp	22719664	SENT80	0	0	7	7	ethanol	mol	PA448073	90527	0.418
NULL	Diabetes_2011_May_23_60(5)_1493-1503.nxml.txt.nlp	21478464	SENT195	7	7	10	10	metformin	AMPK	PA450395	5563	0.418
NULL	Clin_Ophthalmol_2014_Feb_10_8_389-399.nxml.txt.nlp	24550667	SENT147	8	8	14	14	timolol	TIM	PA451690	7984;8914	0.418
NULL	Mol_Biol_Cell_2014_Mar_15_25(6)_791-799.nxml.txt.nlp	24451261	SENT59	13	13	17	17	nadh	ADP	PA164755085	23038	0.418
NULL	Arthritis_Res_Ther_2007_Sep_11_9(5)_R92.nxml.txt.nlp	17848196	SENT142	16	16	8	8	galactose	spatial	PA449725	219793	0.418
NULL	Clin_Interv_Aging_2013_May_22_8_565-572.nxml.txt.nlp	23723696	SENT153	24	24	2	2	chlorpromazine	ANOVA	PA448964	4858	0.418
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Sep_14_67(Pt_10)_o2571.nxml.txt.nlp	22058737	SENT71	22	22	16	16	ethanol	mol	PA448073	90527	0.418
NULL	Cancer_Biol_Med_2012_Jun_9(2)_105-110.nxml.txt.nlp	23691463	SENT196	12	12	10	10	cetuximab	LC3	PA10040	84557	0.418
NULL	Mol_Cancer_2012_Aug_8_11_53.nxml.txt.nlp	22871047	SENT13	24	24	8	8	paclitaxel	ES2	PA450761	8220	0.418
NULL	Acta_Pharmacol_Sin_2011_Aug_27_32(8)_1045-1054.nxml.txt.nlp	21706041	SENT82	7	7	34	34	paraformaldehyde	IFN	PA450790	3439	0.418
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT7	21	21	25	25	iloperidone	PRL	PA161199368	5617	0.418
NULL	Clinics_(Sao_Paulo)_2014_Jan_69(1)_68-74.nxml.txt.nlp	24473562	SENT149	12	12	9	9	nutlin-3	SOCS-1		8651	0.418
NULL	Amino_Acids_2011_May_22_40(5)_1369-1383.nxml.txt.nlp	21424716	SENT274	28	28	36	36	creatine	CLC	PA164778930	23529;1178	0.418
NULL	Pharmaceuticals_(Basel)_2014_Jul_24_7(8)_850-865.nxml.txt.nlp	25061796	SENT77	11	11	17	17	etoricoxib	NNT	PA164776853	23530	0.418
NULL	Ann_Hematol_2014_Sep_12_93(1)_13-32.nxml.txt.nlp	24026426	SENT274	21	21	10	10	posaconazole	BII	PA151958574	777	0.418
NULL	Clin_Med_Insights_Oncol_2012_May_16_6_205-217.nxml.txt.nlp	22654526	SENT250	6	6	4	4	imatinib	IL-2	PA10804	3558	0.418
NULL	Int_J_Endocrinol_Metab_2013_Jul_1_Summer_11(3)_184-190.nxml.txt.nlp	24348591	SENT16	2	2	6	6	liraglutide	INS-1	PA165958364	2305	0.418
NULL	Front_Mol_Neurosci_2015_Jan_9_7_103.nxml.txt.nlp	25620909	SENT124	9	9	14	14	choline	B12	PA448976	7126;4709	0.418
NULL	Eur_J_Med_Res_2014_May_13_19(1)_24.nxml.txt.nlp	24887532	SENT30	27	27	25	25	fluorouracil	GEM	PA128406956	2669	0.418
NULL	Cancer_Med_2013_Aug_10_2(4)_545-552.nxml.txt.nlp	24156027	SENT166	30	30	35	35	sirolimus	FDG	PA451365	23583	0.418
NULL	Cancer_Microenviron_2008_Dec_20_1(1)_103-111.nxml.txt.nlp	19308689	SENT93	18	18	21	21	oxygen	TNF	PA450744	7124	0.418
NULL	Oncotarget_2011_Mar_23_2(3)_165-177.nxml.txt.nlp	21444946	SENT171	10	10	22	22	erlotinib	KRAS	PA134687924	3845	0.418
NULL	Mol_Biol_Cell_2014_Mar_1_25(5)_712-727.nxml.txt.nlp	24403601	SENT232	5	5	7	7	lipase	PSM	PA450239	2346	0.418
NULL	Eur_J_Haematol_2014_Feb_25_92(2)_127-136.nxml.txt.nlp	24118452	SENT49	25	25	23	23	anagrelide	CRT	PA164742986	811	0.418
NULL	J_Oncol_2012_Sep_10_2012_370481.nxml.txt.nlp	22997517	SENT158	0	0	18	18	resveratrol	TRAMP		8718;23471;9189	0.418
NULL	Case_Rep_Oncol_2014_Aug_20_7(2)_591-599.nxml.txt.nlp	25298765	SENT40	9	9	15	15	thyroglobulin	TTF1	PA164754910	7080;7270	0.418
NULL	J_Clin_Biochem_Nutr_2007_Jul_27_41(1)_32-42.nxml.txt.nlp	18392098	SENT31	12	12	15	15	oxygen	ROS	PA450744	6098	0.418
NULL	Arthritis_Res_Ther_2008_Jan_16_10(1)_R6.nxml.txt.nlp	18199331	SENT17	0	0	14	14	rosiglitazone	adiponectin	PA451283	9370	0.418
NULL	J_Gen_Physiol_1997_Dec_1_110(6)_643-654.nxml.txt.nlp	9382893	SENT190	14	14	10	10	diazoxide	ADP	PA449285	23038	0.418
NULL	ScientificWorldJournal_2012_Apr_1_2012_491737.nxml.txt.nlp	22547985	SENT140	9	9	7	7	saracatinib	PP1		5540;5464	0.418
NULL	J_Mol_Med_(Berl)_2013_Aug_17_91(11)_1257-1271.nxml.txt.nlp	23955016	SENT199	44	44	38	38	thrombin	p38	PA451674	10598;1432;7965	0.418
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Jun_7_70(Pt_7)_m247-m248.nxml.txt.nlp	25161516	SENT9	1	1	3	3	ethanol	mol	PA448073	90527	0.418
NULL	J_Brachial_Plex_Peripher_Nerve_Inj_2010_Jan_25_5_3.nxml.txt.nlp	20181005	SENT124	19	19	1	1	vincristine	VIII	PA451879	1351	0.418
NULL	Mol_Med_Rep_2015_Jan_16_11(1)_91-98.nxml.txt.nlp	25322694	SENT70	10	10	22	22	fluorescein	San	PA164746009	80218	0.418
NULL	Neural_Regen_Res_2014_Sep_15_9(18)_1723-1728.nxml.txt.nlp	25374596	SENT92	23	23	34	34	capsaicin	TRPM8	PA448776	79054	0.418
NULL	Ann_Gastroenterol_2014_27(1)_9-14.nxml.txt.nlp	24714764	SENT156	3	3	5	5	cetuximab	KRAS	PA10040	3845	0.418
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Apr_30_65(Pt_5)_m595.nxml.txt.nlp	21583817	SENT56	21	21	18	18	ethanol	mol	PA448073	90527	0.418
NULL	Breast_Cancer_Res_2007_Jan_23_9(1)_R7.nxml.txt.nlp	17244352	SENT13	8	8	23	23	tamoxifen	CYP3A5	PA451581	1577	0.417
NULL	Curr_Neuropharmacol_2007_Dec_5(4)_268-277.nxml.txt.nlp	19305743	SENT28	25	25	17	17	lipase	FAAH	PA450239	79152;2166	0.417
NULL	Cell_Death_Dis_2014_Mar_13_5(3)_e1112.nxml.txt.nlp	24625971	SENT146	41	41	8	8	hydrocortisone	San	PA449905	80218	0.417
NULL	Iran_Red_Crescent_Med_J_2011_Apr_1_13(4)_234-238.nxml.txt.nlp	22737471	SENT65	15	15	1	1	amoxicillin	MAX	PA448406	4149	0.417
NULL	Int_J_Endocrinol_Metab_2013_Jul_1_Summer_11(3)_184-190.nxml.txt.nlp	24348591	SENT145	17	17	13	13	liraglutide	PAG	PA165958364	55824	0.417
NULL	Sensors_(Basel)_2010_Nov_1_10(11)_9630-9646.nxml.txt.nlp	22163431	SENT329	6	6	18	18	lipase	DPI	PA450239	1832	0.417
NULL	Am_J_Physiol_Cell_Physiol_2014_Jan_15_306(2)_C89-C97.nxml.txt.nlp	24133067	SENT53	25	25	4	4	hyaluronan	HAS1	PA165958431	3036	0.417
NULL	Adv_Biomed_Res_2012_May_11_1_12.nxml.txt.nlp	23210071	SENT130	15	15	22	22	forskolin	HRG	PA146096022	3084;3273	0.417
NULL	J_Ophthalmol_2010_Jun_22_2010_170393.nxml.txt.nlp	20652047	SENT172	0	0	8	8	atorvastatin	NAC	PA448500	22861	0.417
NULL	Diabetes_Care_2011_Nov_15_34(11)_2464-2470.nxml.txt.nlp	21926281	SENT208	22	22	13	13	estradiol	Men	PA449503	8178	0.417
NULL	Biomed_Res_Int_2014_Apr_29_2014_186864.nxml.txt.nlp	24877064	SENT112	0	0	16	16	curcumin	SPI1	PA151958596	6688	0.417
NULL	Gene_Regul_Syst_Bio_2014_Mar_4_8_63-73.nxml.txt.nlp	24634581	SENT71	0	0	14	14	minocycline	BNIP3	PA450519	664	0.417
NULL	Gynecol_Oncol_Case_Rep_2013_Dec_28_8_4-6.nxml.txt.nlp	24567884	SENT81	9	9	7	7	irinotecan	NAC	PA450085	22861	0.417
NULL	Adv_Ther_2014_Dec_2_31_1228-1246.nxml.txt.nlp	25447269	SENT7	11	11	30	30	timolol	TIM	PA451690	7984;8914	0.417
NULL	Chem_Cent_J_2013_Oct_10_7_165.nxml.txt.nlp	24107599	SENT101	9	9	12	12	ethanol	sit	PA448073	55733	0.417
NULL	Clin_Sci_(Lond)_2012_Jun_1_122(Pt_12)_581-590.nxml.txt.nlp	22216926	SENT35	4	4	19	19	isoflurane	BOC	PA450106	91653	0.417
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_May_2_68(Pt_6)_o1584.nxml.txt.nlp	22719395	SENT76	11	11	17	17	coumarin	mol	PA134521193	90527	0.417
NULL	Cancer_Immunol_Immunother_2008_Jan_6_57(1)_135-142.nxml.txt.nlp	17922124	SENT146	9	9	21	21	l-arginine	NOS2	PA448478	339345;4843	0.417
NULL	Molecules_2013_Dec_16_18(12)_15662-15688.nxml.txt.nlp	24352021	SENT314	24	24	31	31	urea	IFN	PA451831	3439	0.417
NULL	Adv_Urol_2012_Oct_26_2012_812398.nxml.txt.nlp	22110495	SENT43	5	5	3	3	cisplatin	ERCC1	PA449014	2067	0.417
NULL	Braz_J_Med_Biol_Res_2014_Jan_10_47(1)_60-69.nxml.txt.nlp	24519092	SENT13	15	15	19	19	doxorubicin	YWHAZ	PA449412	7534	0.417
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Feb_21_65(Pt_3)_o558.nxml.txt.nlp	21582216	SENT53	17	17	14	14	potassium	mol	PA451047	90527	0.417
NULL	Mol_Cancer_2009_May_15_8_28.nxml.txt.nlp	19445670	SENT8	38	38	16	16	doxorubicin	XIAP	PA449412	331	0.417
NULL	Patient_Prefer_Adherence_2010_Jun_24_4_197-205.nxml.txt.nlp	20622918	SENT167	9	9	2	2	budesonide	BDP	PA448681	10620;152926	0.417
NULL	Iran_J_Pharm_Res_2014_Winter_13(1)_191-198.nxml.txt.nlp	24734071	SENT182	36	36	14	14	phenol	Bcl-2	PA450913	596	0.417
NULL	Oxid_Med_Cell_Longev_2012_Nov_28_2012_162934.nxml.txt.nlp	23251719	SENT71	9	9	18	18	diazepam	TTN	PA449283	7273	0.417
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT112	0	0	2	2	resveratrol	TRAIL		8743	0.417
NULL	Iran_J_Pharm_Res_2014_Autumn_13(4)_1393-1401.nxml.txt.nlp	25587329	SENT100	5	5	11	11	celecoxib	ABCG2	PA448871	9429	0.417
NULL	Nucleic_Acids_Res_2012_Apr_16_40(8)_3641-3652.nxml.txt.nlp	22180534	SENT100	25	25	7	7	galactose	GAL	PA449725	51083	0.417
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Oct_28_65(Pt_11)_o2899.nxml.txt.nlp	21578481	SENT63	15	15	12	12	ethanol	mol	PA448073	90527	0.417
NULL	Acta_Pharmacol_Sin_2011_Jul_20_32(7)_888-894.nxml.txt.nlp	21685926	SENT86	19	19	27	27	nadh	NDUFA10	PA164755085	4705	0.417
NULL	Oncotarget_2011_Dec_22_2(12)_1145-1154.nxml.txt.nlp	22201672	SENT155	26	26	9	9	l-glutamine	CO2	PA10090	4513	0.417
NULL	J_Cell_Biol_1997_Jul_28_138(2)_307-321.nxml.txt.nlp	9230073	SENT51	20	20	45	45	l-glutamine	CO2	PA10090	4513	0.417
NULL	Acta_Neuropathol_Commun_2014_Jan_2_2_1.nxml.txt.nlp	24383468	SENT223	11	11	33	33	nadh	ND5	PA164755085	4540	0.417
NULL	Chem_Cent_J_2012_Nov_23_6_140.nxml.txt.nlp	23173949	SENT112	3	3	0	0	ether	PERC	PA449525	133522	0.417
NULL	Mol_Biol_Cell_2014_Jan_1_25(1)_41-54.nxml.txt.nlp	24196837	SENT333	18	18	12	12	l-glutamine	F12	PA10090	2161	0.417
NULL	Acta_Histochem_Cytochem_2010_May_1_43(2)_61-68.nxml.txt.nlp	20514293	SENT13	19	19	23	23	hyaluronan	LYVE-1	PA165958431	10894	0.417
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT5	0	0	5	5	imatinib	CML	PA10804	613	0.417
NULL	Basic_Clin_Neurosci_2014_Summer_5(3)_182-190.nxml.txt.nlp	25337378	SENT189	8	8	14	14	bupropion	mol	PA448687	90527	0.417
NULL	Mol_Biol_Cell_2014_Aug_1_25(15)_2272-2281.nxml.txt.nlp	24920822	SENT256	41	41	9	9	l-glutamine	CO2	PA10090	4513	0.417
NULL	J_Mol_Med_2009_Nov_16_87(11)_1071-1076.nxml.txt.nlp	19834654	SENT177	15	15	8	8	l-arginine	MCO	PA448478	4178	0.417
NULL	Environ_Health_Perspect_2008_Oct_19_116(10)_1308-1314.nxml.txt.nlp	18941570	SENT37	29	29	23	23	choline	HC3	PA448976	5683;360177	0.417
NULL	Cancer_Med_2013_Aug_2_2(4)_571-582.nxml.txt.nlp	24156030	SENT245	8	8	5	5	curcumin	IL-6	PA151958596	3569	0.417
NULL	Br_J_Anaesth_2014_Jul_22_113(1)_157-167.nxml.txt.nlp	24154701	SENT212	0	0	5	5	sevoflurane	TREK-1	PA451341	3776	0.417
NULL	Chemother_Res_Pract_2011_Dec_18_2011_965826.nxml.txt.nlp	22295208	SENT296	12	12	14	14	azacitidine	ACT	PA451996	12;11332;9457;641455	0.417
NULL	Arthritis_Res_Ther_2012_Jan_30_14(1)_201.nxml.txt.nlp	22293240	SENT71	0	0	11	11	glucosamine	RANKL	PA164747613	8600	0.417
NULL	Cancers_(Basel)_2011_May_11_3(2)_2333-2357.nxml.txt.nlp	24212813	SENT106	18	18	15	15	cyclosporine	ADN	PA449167	1675	0.417
NULL	Br_J_Clin_Pharmacol_2013_Aug_23_76(2)_299-315.nxml.txt.nlp	23701319	SENT208	24	24	20	20	bevacizumab	CRA	PA130232992	51747;10903	0.417
NULL	Cancer_Cell_Int_2011_Aug_2_11_25.nxml.txt.nlp	21810252	SENT109	22	22	20	20	gentamicin	F12	PA449753	2161	0.417
NULL	Eur_J_Clin_Pharmacol_2011_May_9_67(5)_477-482.nxml.txt.nlp	21305273	SENT24	13	13	17	17	dobutamine	DSE	PA449381	29940	0.417
NULL	Iran_Red_Crescent_Med_J_2011_Apr_1_13(4)_234-238.nxml.txt.nlp	22737471	SENT65	13	13	1	1	amikacin	MAX	PA164744372	4149	0.417
NULL	Braz_J_Microbiol_2009_Jun_1_Apr-Jun_40(2)_358-366.nxml.txt.nlp	24031373	SENT53	18	18	15	15	phenol	mol	PA450913	90527	0.417
NULL	Arthritis_Res_Ther_2014_Jan_15_16(1)_R10.nxml.txt.nlp	24423138	SENT285	10	10	12	12	collagenase	TRPV1	PA449107	7442	0.417
NULL	Pediatr_Blood_Cancer_2013_Sep_3_60(9)_1520-1527.nxml.txt.nlp	23733511	SENT101	21	21	23	23	cyclosporine	CD34	PA449167	947	0.417
NULL	Contemp_Clin_Dent_2011_Oct-Dec_2(4)_278-282.nxml.txt.nlp	22346152	SENT11	5	5	9	9	potassium	GCF	PA451047	6936	0.416
NULL	FEBS_Open_Bio_2014_Jun_24_4_627-636.nxml.txt.nlp	25161871	SENT96	28	28	33	33	trypsin	PC3	PA451806	57332;7832;5122	0.416
NULL	Arthritis_Res_Ther_2012_Aug_17_14(4)_R187.nxml.txt.nlp	22901757	SENT163	3	3	5	5	atorvastatin	RANK	PA448500	8792	0.416
NULL	Front_Endocrinol_(Lausanne)_2013_Sep_13_4_122.nxml.txt.nlp	24062725	SENT77	18	18	20	20	forskolin	PRL	PA146096022	5617	0.416
NULL	J_Biol_Eng_2014_Nov_19_8(1)_26.nxml.txt.nlp	NULL	SENT120	10	10	8	8	tetracycline	p14	PA451640	10923;10263;1029;28956	0.416
NULL	Front_Synaptic_Neurosci_2014_Sep_5_6_18.nxml.txt.nlp	25249974	SENT480	25	25	18	18	nicotine	PAM	PA450626	5066;23077	0.416
NULL	Arthritis_Res_Ther_2014_Apr_11_16(2)_R93.nxml.txt.nlp	24725461	SENT156	40	40	30	30	letrozole	CYP1A1	PA450196	1543	0.416
NULL	Int_J_Biol_Sci_2015_Jan_1_11(1)_48-58.nxml.txt.nlp	25552929	SENT36	9	9	6	6	paclitaxel	TSP-1	PA450761	7057	0.416
NULL	Cardiovasc_Diabetol_2007_Oct_24_6_32.nxml.txt.nlp	17958881	SENT25	13	13	24	24	glucose	ADA	PA449773	100	0.416
NULL	Front_Immunol_2014_Aug_22_5_406.nxml.txt.nlp	25202312	SENT306	15	15	23	23	eculizumab	ABO	PA164776637	28	0.416
NULL	Ann_Neurol_2013_Feb_31_73(2)_246-258.nxml.txt.nlp	23281025	SENT190	0	0	2	2	riluzole	NRF2	PA451251	2551;4780	0.416
NULL	Case_Rep_Ophthalmol_Med_2014_Oct_27_2014_326957.nxml.txt.nlp	25400961	SENT40	33	33	29	29	doxycycline	BID	PA449415	637	0.416
NULL	Exp_Diabetes_Res_2012_Oct_15_2012_465282.nxml.txt.nlp	23118742	SENT28	17	17	10	10	metformin	FGF21	PA450395	26291	0.416
NULL	Infect_Ecol_Epidemiol_2014_Jan_15_4_10_3402_iee_v4_23011.nxml.txt.nlp	24455106	SENT54	35	35	25	25	streptomycin	FBS	PA451512	64319;26269	0.416
NULL	Clin_Interv_Aging_2009_Nov_18_4_445-449.nxml.txt.nlp	19966913	SENT6	18	18	9	9	risedronate	HIP	PA451255	6767;6159;64399;5068	0.416
NULL	Cancers_(Basel)_2014_Feb_26_6(1)_436-458.nxml.txt.nlp	24577242	SENT1038	1	1	20	20	forskolin	Bcl-2	PA146096022	596	0.416
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1059-1066.nxml.txt.nlp	21364577	SENT216	6	6	2	2	tamoxifen	ATAC	PA451581	6375	0.416
NULL	Front_Immunol_2012_Mar_21_3_57.nxml.txt.nlp	22566938	SENT54	22	22	18	18	vasopressin	IRAP	PA451858	3557	0.416
NULL	Mol_Cancer_2010_Dec_20_9_317.nxml.txt.nlp	21172025	SENT8	11	11	15	15	tamoxifen	HER2	PA451581	2064	0.416
NULL	Nat_Neurosci_2012_Sep_5_15(9)_1245-1254.nxml.txt.nlp	22864611	SENT461	11	11	2	2	risperidone	mGlu2	PA451257	2912	0.416
NULL	Indian_J_Pharm_Sci_2014_Nov-Dec_76(6)_483-494.nxml.txt.nlp	25593381	SENT252	0	0	4	4	atorvastatin	BCS	PA448500	617	0.416
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Apr_13_69(Pt_5)_m257-m258.nxml.txt.nlp	23723769	SENT3	36	36	28	28	ethanol	mol	PA448073	90527	0.416
NULL	Subst_Abuse_Rehabil_2011_May_15_2_89-102.nxml.txt.nlp	21743792	SENT348	43	43	2	2	methamphetamine	TOB	PA450403	10140	0.416
NULL	Nat_Neurosci_2012_Jun_15(6)_853-861.nxml.txt.nlp	22581185	SENT247	47	47	13	13	l-glutamine	CO2	PA10090	4513	0.416
NULL	EMBO_J_2008_Mar_19_27(6)_876-885.nxml.txt.nlp	18309293	SENT411	36	36	16	16	etoposide	CTRL	PA449552	1506	0.416
NULL	Br_J_Cancer_2011_Dec_6_105(12)_1864-1873.nxml.txt.nlp	22095225	SENT70	7	7	24	24	fluorescein	YB-1	PA164746009	4904	0.416
NULL	Tuberc_Respir_Dis_(Seoul)_2013_Aug_30_75(2)_59-66.nxml.txt.nlp	24023558	SENT168	28	28	15	15	docetaxel	FOXO1	PA449383	2308	0.416
NULL	Iran_J_Basic_Med_Sci_2012_Mar-Apr_15(2)_709-718.nxml.txt.nlp	23493500	SENT151	13	13	42	42	celecoxib	spatial	PA448871	219793	0.416
NULL	Am_J_Trop_Med_Hyg_2014_Oct_1_91(4)_833-843.nxml.txt.nlp	25048375	SENT28	22	22	26	26	lumefantrine	ACT	PA165111722	12;11332;9457;641455	0.416
NULL	Hum_Genomics_2008_Sep_1_3(1)_53-70.nxml.txt.nlp	19129090	SENT194	44	44	29	29	perifosine	PTEN	PA165291471	5728	0.416
NULL	Hum_Genomics_2009_Jan_1_3(2)_128-142.nxml.txt.nlp	19164090	SENT211	25	25	14	14	carboplatin	CD44	PA448803	960	0.416
NULL	Curr_HIV_Res_2014_May_12(3)_174-188.nxml.txt.nlp	24862327	SENT547	28	28	23	23	ethanol	HO-1	PA448073	3162	0.416
NULL	Cancers_(Basel)_2014_Apr_30_6(2)_1031-1046.nxml.txt.nlp	24785146	SENT173	32	32	15	15	geldanamycin	San	PA152031327	80218	0.416
NULL	Cell_Death_Dis_2014_Jan_9_5(1)_e991.nxml.txt.nlp	24407244	SENT119	7	7	19	19	fluorescein	San	PA164746009	80218	0.416
NULL	Behav_Brain_Funct_2005_Aug_9_1_14.nxml.txt.nlp	16091141	SENT298	22	22	8	8	sertindole	CPZ	PA164784002	8532	0.416
NULL	Mol_Biol_Cell_2014_Mar_15_25(6)_791-799.nxml.txt.nlp	24451261	SENT83	10	10	14	14	nadh	ADP	PA164755085	23038	0.416
NULL	Protein_Cell_2014_Jun_19_5(6)_469-479.nxml.txt.nlp	24748116	SENT109	12	12	9	9	paclitaxel	EB1	PA450761	9167;22919;10982	0.416
NULL	Oncotarget_2012_May_23_3(5)_518-524.nxml.txt.nlp	22643838	SENT76	22	22	12	12	imatinib	MYL	PA10804	5371	0.416
NULL	J_Ind_Microbiol_Biotechnol_2013_Jul_30_40(10)_1153-1160.nxml.txt.nlp	23896974	SENT85	30	30	22	22	nadh	mol	PA164755085	90527	0.416
NULL	Indian_J_Pharm_Sci_2008_Sep-Oct_70(5)_658-661.nxml.txt.nlp	21394269	SENT36	7	7	5	5	rabeprazole	RAB	PA451216	3267	0.416
NULL	Sensors_(Basel)_2013_Dec_27_14(1)_458-467.nxml.txt.nlp	24379050	SENT101	33	33	25	25	glucose	MTB	PA449773	54892;4498	0.416
NULL	Oncotarget_2010_May_7_1(1)_59-68.nxml.txt.nlp	20890394	SENT160	3	3	5	5	bortezomib	c-FLIP	PA10252	8837	0.416
NULL	Reprod_Biol_Endocrinol_2003_Oct_3_1_62.nxml.txt.nlp	14567758	SENT172	10	10	41	41	lindane	ANOVA	PA164754914	4858	0.416
NULL	Cancer_Cell_Int_2012_Feb_21_12_5.nxml.txt.nlp	22353776	SENT131	10	10	40	40	sorafenib	TRAIL	PA7000	8743	0.416
NULL	Cancer_Cell_Int_2011_Apr_7_11_8.nxml.txt.nlp	21473769	SENT127	13	13	10	10	nitrogen	ROS	PA450643	6098	0.416
NULL	Free_Radic_Res_2012_Aug_14_46(8)_1011-1018.nxml.txt.nlp	22329629	SENT33	28	28	12	12	neomycin	parkin	PA450608	5071	0.416
NULL	Curr_Neuropharmacol_2011_Dec_9(4)_523-529.nxml.txt.nlp	22654713	SENT227	12	12	27	27	clonidine	GDNF	PA449051	2668	0.416
NULL	Nat_Genet_2011_Jan_12_43(1)_27-33.nxml.txt.nlp	21151129	SENT12	18	18	10	10	tamoxifen	FOXA1	PA451581	3169	0.416
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT106	19	19	11	11	neratinib	HER2	PA165291472	2064	0.416
NULL	Aging_(Albany_NY)_2010_Apr_25_2(4)_238-243.nxml.txt.nlp	20448293	SENT73	42	42	29	29	lipase	AMPK	PA450239	5563	0.416
NULL	Curr_Neuropharmacol_2013_Jul_11(4)_338-378.nxml.txt.nlp	24381528	SENT307	33	33	31	31	curcumin	F18	PA151958596	10046	0.416
NULL	Cell_Death_Dis_2014_Jul_3_5(7)_e1316.nxml.txt.nlp	24991768	SENT94	8	8	18	18	pemetrexed	ATF4	PA10810	468	0.416
NULL	Nat_Commun_2014_5_3065.nxml.txt.nlp	24445279	SENT338	29	29	9	9	creatine	ALX	PA164778930	84941	0.416
NULL	Diabetes_Care_2009_Nov_32(Suppl_2)_S237-S245.nxml.txt.nlp	19875558	SENT250	22	22	33	33	cholestyramine	STARS	PA448974	137735	0.416
NULL	Subst_Abuse_Treat_Prev_Policy_2007_Oct_31_2_32.nxml.txt.nlp	17974020	SENT208	22	22	25	25	methamphetamine	NMU	PA450403	10874	0.416
NULL	FEBS_Open_Bio_2012_Aug_22_2_279-283.nxml.txt.nlp	23650611	SENT102	0	0	5	5	raloxifene	IFN	PA451221	3439	0.416
NULL	Angiogenesis_2009_Dec_21_12(4)_303-311.nxml.txt.nlp	19544080	SENT152	9	9	2	2	oxygen	HIF-1	PA450744	29072	0.416
NULL	Mar_Drugs_2014_Dec_1_12(12)_5764-5787.nxml.txt.nlp	25470180	SENT5	44	44	29	29	ethanol	IL-6	PA448073	3569	0.416
NULL	Alzheimers_Res_Ther_2013_May_14_5(3)_25.nxml.txt.nlp	23673233	SENT374	10	10	5	5	donepezil	spatial	PA449394	219793	0.416
NULL	Cancer_Cell_Int_2006_Nov_8_6_25.nxml.txt.nlp	17092342	SENT258	6	6	4	4	doxorubicin	Yes	PA449412	7525	0.416
NULL	Mol_Cancer_2012_Jul_12_11_45.nxml.txt.nlp	22788833	SENT134	16	16	14	14	cisplatin	EGFR	PA449014	1956	0.416
NULL	J_Thromb_Haemost_2010_Mar_8(3)_577-587.nxml.txt.nlp	20040043	SENT146	10	10	7	7	rosiglitazone	mol	PA451283	90527	0.416
NULL	AIDS_Res_Ther_2006_Apr_24_3_12.nxml.txt.nlp	16635263	SENT261	31	31	27	27	fluorescein	PEG10	PA164746009	23089	0.416
NULL	Nucleic_Acids_Res_2014_Jan_25_42(2)_952-967.nxml.txt.nlp	24163258	SENT92	33	33	24	24	paraformaldehyde	mtSSB	PA450790	6742	0.416
NULL	Mol_Vis_2012_Feb_11_18_439-448.nxml.txt.nlp	22355255	SENT216	14	14	4	4	nadh	mol	PA164755085	90527	0.416
NULL	EJNMMI_Res_2011_Sep_2_1_21.nxml.txt.nlp	22214201	SENT37	1	1	17	17	daunorubicin	NPY	PA449212	4852	0.416
NULL	Breast_Cancer_Res_2009_Oct_28_11(5)_211.nxml.txt.nlp	19889200	SENT74	36	36	5	5	tamoxifen	ARNO	PA451581	9266	0.416
NULL	Ann_Surg_Treat_Res_2014_Feb_22_86(2)_68-75.nxml.txt.nlp	24761411	SENT147	2	2	11	11	resveratrol	survivin		332	0.415
NULL	Curr_Genomics_2013_Nov_14(7)_441-452.nxml.txt.nlp	24396276	SENT394	8	8	1	1	cisplatin	SREBF1	PA449014	6720	0.415
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT42	0	0	6	6	curcumin	TRAIL	PA151958596	8743	0.415
NULL	Ann_Clin_Microbiol_Antimicrob_2009_Sep_24_8_26.nxml.txt.nlp	19778428	SENT176	22	22	4	4	tetracycline	PEN	PA451640	9933	0.415
NULL	Support_Care_Cancer_2012_Jul_27_20(7)_1353-1360.nxml.txt.nlp	22539050	SENT270	13	13	41	41	denosumab	NNT	PA166048634	23530	0.415
NULL	Oncol_Lett_2014_Mar_19_7(3)_674-678.nxml.txt.nlp	24527071	SENT93	7	7	5	5	cisplatin	AKR1C2	PA449014	1646	0.415
NULL	Ann_Rheum_Dis_2014_Sep_2_73(9)_1626-1634.nxml.txt.nlp	24297381	SENT284	37	37	23	23	tocilizumab	IL-6	PA165292659	3569	0.415
NULL	Environ_Health_Perspect_2008_Jan_5_116(1)_1-6.nxml.txt.nlp	18197291	SENT146	45	45	12	12	arsenite	p85	PA452638	5296;5295;54776;23368	0.415
NULL	Biol_Open_2012_May_9_1(6)_597-606.nxml.txt.nlp	23213453	SENT268	20	20	6	6	protamine	BRDT	PA10366	676	0.415
NULL	Fibrogenesis_Tissue_Repair_2012_Jul_23_5_11.nxml.txt.nlp	22824096	SENT335	21	21	23	23	azathioprine	NAC	PA448515	22861	0.415
NULL	Diabetes_Metab_J_2014_Dec_15_38(6)_426-436.nxml.txt.nlp	25541605	SENT109	14	14	9	9	pioglitazone	ACT	PA450970	12;11332;9457;641455	0.415
NULL	Front_Behav_Neurosci_2013_Dec_18_7_203.nxml.txt.nlp	24385956	SENT341	8	8	17	17	memantine	spatial	PA10364	219793	0.415
NULL	Int_J_Mol_Sci_2014_May_12_15(5)_8335-8351.nxml.txt.nlp	24823879	SENT166	3	3	5	5	perifosine	TRAIL	PA165291471	8743	0.415
NULL	Int_J_Nanomedicine_2012_May_7_7_2307-2314.nxml.txt.nlp	22661887	SENT164	7	7	3	3	gemcitabine	zeta	PA449748	9907	0.415
NULL	Cancer_Biol_Med_2013_Dec_10(4)_192-205.nxml.txt.nlp	24349829	SENT101	1	1	7	7	gefitinib	Met	PA131301952	79811	0.415
NULL	Breast_Cancer_Res_2012_Jun_7_14(3)_R89.nxml.txt.nlp	22676470	SENT328	7	7	10	10	geldanamycin	HER2	PA152031327	2064	0.415
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT138	28	28	22	22	trastuzumab	HRG	PA451743	3084;3273	0.415
NULL	Exp_Neurol_2014_May_255(100)_96-102.nxml.txt.nlp	24613829	SENT458	22	22	13	13	propafenone	CTRL	PA451131	1506	0.415
NULL	Daru_2012_Nov_30_20(1)_82.nxml.txt.nlp	23351311	SENT13	3	3	8	8	curcumin	p53	PA151958596	7157	0.415
NULL	Arthritis_Res_Ther_2005_May_18_7(Suppl_3)_S19-S25.nxml.txt.nlp	15960818	SENT165	31	31	29	29	rituximab	CHOP	PA451261	1649	0.415
NULL	Cardiovasc_Diabetol_2013_Nov_4_12_159.nxml.txt.nlp	24180232	SENT27	3	3	19	19	losartan	URAT1	PA450268	116085	0.415
NULL	CNS_Drugs_2014_May_1_28(6)_497-511.nxml.txt.nlp	24788672	SENT29	27	27	24	24	guanfacine	ATX	PA449825	5168;23049	0.415
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Sep_13_70(Pt_10)_199-202.nxml.txt.nlp	25484651	SENT54	25	25	22	22	ethanol	mol	PA448073	90527	0.415
NULL	Comput_Math_Methods_Med_2012_Dec_19_2012_473572.nxml.txt.nlp	23365616	SENT348	33	33	12	12	estradiol	CYP1A1	PA449503	1543	0.415
NULL	Breast_Cancer_(Auckl)_2011_Oct_9_5_209-226.nxml.txt.nlp	22084574	SENT198	20	20	23	23	tamoxifen	ARNO	PA451581	9266	0.415
NULL	Biologics_2010_Dec_2_4_315-323.nxml.txt.nlp	21209726	SENT1	0	0	28	28	imatinib	CML	PA10804	613	0.415
NULL	Int_J_Gen_Med_2009_Jul_30_2_129-140.nxml.txt.nlp	20360896	SENT270	0	0	13	13	tamoxifen	BRCA2	PA451581	675	0.415
NULL	Cell_Death_Dis_2013_Oct_3_4(10)_e830.nxml.txt.nlp	24091673	SENT23	33	33	12	12	doxorubicin	CD95	PA449412	355	0.415
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Nov_17_68(Pt_12)_o3380.nxml.txt.nlp	23476212	SENT5	5	5	7	7	ethanol	mol	PA448073	90527	0.415
NULL	Mol_Cancer_2012_Dec_12_11_91.nxml.txt.nlp	23234355	SENT160	16	16	0	0	cetuximab	CTRL	PA10040	1506	0.415
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Jul_13_69(Pt_8)_o1260.nxml.txt.nlp	24109344	SENT66	31	31	23	23	ethanol	mol	PA448073	90527	0.415
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Feb_17_68(Pt_3)_o764.nxml.txt.nlp	22412639	SENT66	16	16	13	13	ethanol	mol	PA448073	90527	0.415
NULL	J_Cardiothorac_Surg_2010_Nov_3_5_101.nxml.txt.nlp	21047408	SENT169	6	6	16	16	heparin	ACT	PA449855	12;11332;9457;641455	0.415
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_29_2013_590393.nxml.txt.nlp	23737838	SENT313	5	5	7	7	resveratrol	p53		7157	0.415
NULL	Front_Oncol_2014_Apr_9_4_75.nxml.txt.nlp	24782986	SENT203	24	24	8	8	paclitaxel	Oct4	PA450761	5460	0.415
NULL	Arthritis_Res_Ther_2008_Dec_1_10(6)_R139.nxml.txt.nlp	19046432	SENT245	7	7	35	35	rosiglitazone	AP-1	PA451283	2353;3727;2354;3725	0.415
NULL	Core_Evid_2009_Jun_15_4_25-36.nxml.txt.nlp	20694062	SENT325	9	9	13	13	colchicine	ACTH	PA449092	5443	0.415
NULL	Anal_Bioanal_Chem_2014_Sep_12_406(28)_7049-7057.nxml.txt.nlp	25213215	SENT177	6	6	3	3	hemin	mol	PA449849	90527	0.415
NULL	BMB_Rep_2013_Aug_46(8)_410-415.nxml.txt.nlp	23977989	SENT22	3	3	12	12	curcumin	IL-4	PA151958596	3565	0.415
NULL	Indian_J_Pharm_Sci_2012_Jul-Aug_74(4)_302-311.nxml.txt.nlp	23626385	SENT58	6	6	2	2	baclofen	FOR	PA448533	51741	0.415
NULL	Best_Pract_Res_Clin_Endocrinol_Metab_2013_Dec_27(6)_745-762.nxml.txt.nlp	24275187	SENT124	31	31	16	16	lipase	NEFA	PA450239	4925	0.415
NULL	Acta_Pharmacol_Sin_2011_Jun_3_32(6)_805-816.nxml.txt.nlp	21642949	SENT61	15	15	13	13	forskolin	EGF	PA146096022	1950	0.415
NULL	Cancer_Manag_Res_2012_Nov_9_4_383-395.nxml.txt.nlp	23204869	SENT132	20	20	6	6	carmustine	PC-3	PA448810	692094	0.415
NULL	Mol_Neurobiol_2010_Jun_2_41(2-3)_392-409.nxml.txt.nlp	20437209	SENT286	34	34	23	23	curcumin	FDG	PA151958596	23583	0.415
NULL	Nat_Neurosci_2012_Sep_5_15(9)_1245-1254.nxml.txt.nlp	22864611	SENT487	3	3	5	5	clozapine	HDAC2	PA449061	3066	0.415
NULL	Diabetes_Metab_Res_Rev_2011_Jan_7_27(1)_14-27.nxml.txt.nlp	21218504	SENT194	36	36	34	34	glucosamine	GFAT	PA164747613	2673	0.415
NULL	Br_J_Cancer_2014_Nov_25_111(11)_2091-2102.nxml.txt.nlp	25349971	SENT221	9	9	28	28	imatinib	KIT	PA10804	3815	0.415
NULL	Int_J_Mol_Sci_2014_Oct_14_15(10)_18557-18573.nxml.txt.nlp	25318057	SENT177	0	0	2	2	bortezomib	TRAIL	PA10252	8743	0.415
NULL	Case_Rep_Hematol_2014_Dec_11_2014_743856.nxml.txt.nlp	25580315	SENT38	9	9	14	14	vincristine	CHOP	PA451879	1649	0.415
NULL	Breast_Cancer_Res_Treat_2013_Jun_5_139(3)_649-655.nxml.txt.nlp	23736997	SENT38	27	27	17	17	tamoxifen	CYP2C19	PA451581	1557	0.414
NULL	Clin_Ophthalmol_2014_Feb_10_8_389-399.nxml.txt.nlp	24550667	SENT167	8	8	24	24	timolol	TIM	PA451690	7984;8914	0.414
NULL	Oxid_Med_Cell_Longev_2011_Aug_4_2011_471590.nxml.txt.nlp	21904644	SENT185	5	5	16	16	probucol	CA1	PA451107	759	0.414
NULL	Hum_Genomics_Proteomics_2010_Aug_3_2010_159761.nxml.txt.nlp	20981231	SENT292	30	30	19	19	lithium	PDLIM5	PA450243	10611	0.414
NULL	AIDS_Care_2011_Sep_14_23(9)_1154-1162.nxml.txt.nlp	21500025	SENT76	36	36	2	2	tenofovir	ATV	PA10204	4683	0.414
NULL	Eur_J_Clin_Pharmacol_2012_Dec_9_68(12)_1587-1594.nxml.txt.nlp	22569928	SENT179	9	9	0	0	tacrolimus	KCNQ1	PA451578	3784	0.414
NULL	J_Hematol_Oncol_2013_Jan_15_6_5.nxml.txt.nlp	23320987	SENT142	11	11	9	9	heparin	PI-PLC	PA449855	2923	0.414
NULL	Clinics_(Sao_Paulo)_2013_Feb_68(2)_253-262.nxml.txt.nlp	23525324	SENT144	22	22	25	25	genistein	Gen	PA165109660	348654	0.414
NULL	Physiol_Rep_2014_Nov_4_2(11)_e12197.nxml.txt.nlp	25367695	SENT150	6	6	11	11	urea	BAL	PA451831	83666	0.414
NULL	J_Hematol_Oncol_2014_Aug_1_7_52.nxml.txt.nlp	25085632	SENT171	3	3	9	9	sunitinib	KIT	PA162372840	3815	0.414
NULL	Curr_Genomics_2013_Nov_14(7)_453-467.nxml.txt.nlp	24396277	SENT168	26	26	6	6	iron	PCSK1	PA450087	5122	0.414
NULL	Breast_Cancer_Res_2009_Mar_19_11(2)_R16.nxml.txt.nlp	19298655	SENT118	15	15	8	8	lipase	FABP4	PA450239	2167	0.414
NULL	Mol_Cancer_2014_Jul_5_13_165.nxml.txt.nlp	24996221	SENT83	0	0	6	6	docetaxel	HMGB1	PA449383	3146	0.414
NULL	J_Cell_Biol_2001_Aug_6_154(3)_599-610.nxml.txt.nlp	11481345	SENT70	18	18	12	12	tetracycline	ARNO	PA451640	9266	0.414
NULL	Nat_Commun_2013_Sep_27_4_2519.nxml.txt.nlp	24071738	SENT49	22	22	16	16	tetracycline	SMAD3	PA451640	4088	0.414
NULL	Acta_Pharmacol_Sin_2009_Nov_5_30(11)_1522-1528.nxml.txt.nlp	19890360	SENT73	0	0	6	6	fenoterol	CD14	PA10079	929	0.414
NULL	Genome_Biol_2004_Apr_27_5(5)_R34.nxml.txt.nlp	15128448	SENT121	10	10	3	3	urokinase	FGA	PA451836	2243	0.414
NULL	Breast_Cancer_Res_2011_Apr_20_13(2)_307.nxml.txt.nlp	21575280	SENT31	29	29	26	26	tamoxifen	FOXA1	PA451581	3169	0.414
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Sep_26_68(Pt_10)_o3003.nxml.txt.nlp	23125775	SENT72	26	26	23	23	ethanol	mol	PA448073	90527	0.414
NULL	Cell_Death_Dis_2010_Sep_23_1(9)_e78.nxml.txt.nlp	21364680	SENT163	23	23	14	14	cisplatin	P31	PA449014	529	0.414
NULL	Acta_Pharmacol_Sin_2012_Dec_5_33(12)_1502-1510.nxml.txt.nlp	23123644	SENT5	24	24	14	14	losartan	LARG	PA450268	23365	0.414
NULL	Adv_Ther_2013_Oct_25_30(10)_870-884.nxml.txt.nlp	24158787	SENT121	13	13	19	19	everolimus	gamma	PA164746311	9913	0.414
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_4_2013_378657.nxml.txt.nlp	23662132	SENT185	1	1	15	15	ethanol	STZ	PA448073	6484	0.414
NULL	Int_J_Vasc_Med_2014_Jul_22_2014_659617.nxml.txt.nlp	25140254	SENT220	3	3	0	0	vasopressin	AVP	PA451858	114548;551	0.414
NULL	Cases_J_2009_Jun_17_2_7246.nxml.txt.nlp	19829938	SENT65	0	0	22	22	iron	UROD	PA450087	7389	0.414
NULL	J_Exp_Bot_2012_Mar_15_63(5)_1969-1983.nxml.txt.nlp	22174442	SENT432	7	7	28	28	l-alanine	mol	PA448055	90527	0.414
NULL	Asia_Pac_Allergy_2012_Oct_31_2(4)_280-282.nxml.txt.nlp	23130335	SENT32	20	20	7	7	carvedilol	ACE	PA448817	1636	0.414
NULL	Ann_Gen_Psychiatry_2007_Jan_29_6_3.nxml.txt.nlp	17261186	SENT212	28	28	5	5	ziprasidone	Gen	PA451974	348654	0.414
NULL	Front_Genet_2012_Nov_5_3_236.nxml.txt.nlp	23133441	SENT64	6	6	15	15	efavirenz	ABCB1	PA449441	5243	0.414
NULL	Brain_Sci_2013_Jun_14_3(2)_941-963.nxml.txt.nlp	24961432	SENT183	11	11	20	20	ethanol	MAP2	PA448073	4133;10988	0.414
NULL	Breast_Cancer_Res_2011_Jun_14_13(3)_R63.nxml.txt.nlp	21679465	SENT124	9	9	13	13	formaldehyde	SDS	PA449703	51119;10993	0.414
NULL	Ind_Psychiatry_J_2014_Jan-Jun_23(1)_27-35.nxml.txt.nlp	25535442	SENT16	2	2	9	9	olanzapine	SAPS	PA450688	8935	0.414
NULL	Biologics_2012_Dec_17_6_429-464.nxml.txt.nlp	23269860	SENT383	24	24	2	2	methotrexate	ACR	PA450428	49	0.414
NULL	Onco_Targets_Ther_2014_Mar_24_7_491-500.nxml.txt.nlp	24711706	SENT8	20	20	14	14	trastuzumab	HER2	PA451743	2064	0.414
NULL	Anal_Bioanal_Chem_2014_Sep_12_406(28)_7049-7057.nxml.txt.nlp	25213215	SENT64	1	1	7	7	hemin	mol	PA449849	90527	0.414
NULL	Arthritis_Res_2000_Jun_8_2(5)_344-347.nxml.txt.nlp	11094446	SENT91	30	30	32	32	hyaluronan	CD44	PA165958431	960	0.414
NULL	Int_J_Gen_Med_2012_Nov_23_5_983-990.nxml.txt.nlp	23226071	SENT117	29	29	2	2	glucose	ART	PA449773	181	0.414
NULL	Cancer_Cell_Int_2008_Mar_18_8_3.nxml.txt.nlp	18348720	SENT82	10	10	12	12	lapatinib	EGFR	PA152241907	1956	0.414
NULL	J_Cell_Biol_1998_May_4_141(3)_625-636.nxml.txt.nlp	9566964	SENT141	1	1	16	16	ethanol	STK7	PA448073	5586;6790	0.414
NULL	J_Med_Case_Reports_2011_Jul_7_5_292.nxml.txt.nlp	21733193	SENT108	5	5	17	17	vancomycin	VISA	PA451850	57506	0.414
NULL	Alcohol_Res_Health_2008_31(3)_243-246.nxml.txt.nlp	23584867	SENT76	7	7	4	4	ethanol	MRS	PA448073	8011	0.414
NULL	J_Med_Case_Reports_2011_Aug_3_5_345.nxml.txt.nlp	21812958	SENT65	10	10	12	12	temsirolimus	IL-2	PA164746890	3558	0.413
NULL	Ann_Clin_Microbiol_Antimicrob_2009_Sep_24_8_26.nxml.txt.nlp	19778428	SENT176	10	10	4	4	ampicillin	PEN	PA448419	9933	0.413
NULL	Structure_2013_Sep_3_21(9)_1648-1658.nxml.txt.nlp	23932590	SENT190	6	6	11	11	heparin	FANCM	PA449855	57697	0.413
NULL	Biomed_Res_Int_2013_Jul_30_2013_754946.nxml.txt.nlp	23984405	SENT191	16	16	21	21	nadh	ND2	PA164755085	4536	0.413
NULL	Mol_Cancer_2007_Mar_7_6_18.nxml.txt.nlp	17343740	SENT472	11	11	24	24	genistein	RANK	PA165109660	8792	0.413
NULL	Evid_Based_Complement_Alternat_Med_2013_May_28_2013_629750.nxml.txt.nlp	23781265	SENT280	0	0	20	20	capsaicin	GADD153	PA448776	1649	0.413
NULL	Epigenetics_2012_Nov_1_7(11)_1225-1229.nxml.txt.nlp	23069641	SENT52	27	27	17	17	cisplatin	BRCA1	PA449014	672	0.413
NULL	F1000Res_2014_Mar_21_3_40.nxml.txt.nlp	24715979	SENT108	23	23	12	12	pentamidine	mol	PA450850	90527	0.413
NULL	Curr_Neuropharmacol_2009_Jun_7(2)_96-105.nxml.txt.nlp	19949567	SENT40	7	7	20	20	levetiracetam	SV2A	PA450206	9900	0.413
NULL	Ann_Oncol_2009_Nov_23_20(11)_1803-1812.nxml.txt.nlp	19549706	SENT112	7	7	16	16	sunitinib	IFN	PA162372840	3439	0.413
NULL	Acta_Pharmacol_Sin_2011_Apr_28_32(4)_441-448.nxml.txt.nlp	21441944	SENT197	2	2	11	11	sildenafil	STZ	PA451346	6484	0.413
NULL	Evid_Based_Complement_Alternat_Med_2012_May_29_2012_548430.nxml.txt.nlp	22690247	SENT73	5	5	11	11	l-carnitine	UMOD	PA450154	7369	0.413
NULL	Oncol_Lett_2014_Jun_4_7(6)_2175-2179.nxml.txt.nlp	24932311	SENT17	39	39	24	24	choline	CDP	PA448976	1523	0.413
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jan_18_68(Pt_2)_o440.nxml.txt.nlp	22347051	SENT73	15	15	12	12	ethanol	mol	PA448073	90527	0.413
NULL	Indian_J_Pharm_Sci_2008_Nov-Dec_70(6)_803-806.nxml.txt.nlp	21369448	SENT61	7	7	19	19	ethanol	MICE	PA448073	4280;23581	0.413
NULL	Diabetes_Care_2013_Jul_12_36(7)_2015-2019.nxml.txt.nlp	23340883	SENT54	10	10	13	13	glucose	SII	PA449773	6917	0.413
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT166	3	3	10	10	capsaicin	MDM2	PA448776	4193	0.413
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT181	14	14	11	11	capsaicin	p53	PA448776	7157	0.413
NULL	Braz_J_Med_Biol_Res_2013_May_24_46(5)_447-453.nxml.txt.nlp	23739748	SENT174	28	28	34	34	simvastatin	COX	PA451363	1351	0.413
NULL	Drug_Target_Insights_2007_Mar_22_2_83-96.nxml.txt.nlp	21901065	SENT117	12	12	20	20	thrombin	CRT	PA451674	811	0.413
NULL	Allergy_Asthma_Immunol_Res_2010_Jul_19_2(3)_177-182.nxml.txt.nlp	20592916	SENT100	15	15	21	21	tiotropium	ADRB2	PA164769056	154	0.413
NULL	Clin_Ophthalmol_2008_Jun_2(2)_355-368.nxml.txt.nlp	19668727	SENT247	17	17	6	6	amfenac	COX	PA166049186	1351	0.413
NULL	J_Cell_Mol_Med_2014_Feb_5_18(2)_263-273.nxml.txt.nlp	24304472	SENT115	35	35	9	9	prazosin	p38	PA451093	10598;1432;7965	0.413
NULL	Open_Virol_J_2014_Mar_7_8_1-8.nxml.txt.nlp	24799968	SENT5	5	5	25	25	cyclosporine	IFN	PA449167	3439	0.413
NULL	Nat_Commun_2013_Oct_1_4_2516.nxml.txt.nlp	24084631	SENT122	8	8	23	23	losartan	AK4	PA450268	205	0.413
NULL	Cardiovasc_Drugs_Ther_2010_Dec_13_24(5-6)_391-399.nxml.txt.nlp	20640495	SENT165	1	1	3	3	atorvastatin	DIP	PA448500	23151;1831	0.413
NULL	Blood_Cancer_J_2013_Mar_1_3(3)_e103.nxml.txt.nlp	23454896	SENT92	23	23	11	11	bortezomib	P27	PA10252	3429	0.413
NULL	Neural_Dev_2010_Oct_15_5_27.nxml.txt.nlp	20950430	SENT217	18	18	10	10	paraformaldehyde	P21	PA450790	1026;9338	0.413
NULL	Acta_Pharmacol_Sin_2009_Apr_3_30(4)_478-484.nxml.txt.nlp	19343062	SENT131	25	25	30	30	cyclosporine	CYP3A4	PA449167	1576	0.413
NULL	EMBO_Mol_Med_2013_Dec_21_5(12)_1918-1934.nxml.txt.nlp	24293318	SENT193	21	21	10	10	rolipram	ANOVA	PA153906323	4858	0.413
NULL	Front_Neurosci_2014_Apr_22_8_72.nxml.txt.nlp	24795550	SENT104	13	13	3	3	dextran	CTB	PA449261	9468	0.413
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1495-1502.nxml.txt.nlp	21989186	SENT125	17	17	11	11	panitumumab	HSI	PA162373091	57016	0.413
NULL	J_Korean_Med_Sci_2010_Feb_19_25(2)_203-210.nxml.txt.nlp	20119571	SENT72	21	21	4	4	nitrogen	OCT	PA450643	5362	0.413
NULL	Clin_Interv_Aging_2012_Jul_12_7_235-247.nxml.txt.nlp	22866001	SENT17	37	37	40	40	teriparatide	PTH	PA451620	5741	0.413
NULL	Nucleic_Acids_Res_2012_Apr_14_40(7)_2940-2955.nxml.txt.nlp	22169952	SENT384	33	33	30	30	arsenite	p50	PA452638	958;4790	0.413
NULL	J_Ginseng_Res_2011_Nov_35(4)_462-470.nxml.txt.nlp	23717093	SENT203	0	0	7	7	gemcitabine	CD11b	PA449748	3684	0.413
NULL	Br_J_Cancer_2009_Mar_24_100(6)_1017.nxml.txt.nlp	19293816	SENT8	41	41	36	36	sn-38	CES2		8824;1066	0.413
NULL	Acta_Vet_Scand_2008_Jul_4_50(1)_27.nxml.txt.nlp	18601734	SENT3	11	11	29	29	doxorubicin	MTSS1	PA449412	9788	0.413
NULL	Indian_J_Anaesth_2014_Jul-Aug_58(4)_423-429.nxml.txt.nlp	25197110	SENT43	12	12	7	7	ondansetron	ODF	PA450705	8600	0.413
NULL	Cancer_Med_2013_Aug_2_2(4)_571-582.nxml.txt.nlp	24156030	SENT160	0	0	5	5	curcumin	IL-6	PA151958596	3569	0.413
NULL	Arthritis_Res_Ther_2003_Jun_30_5(5)_R262-R268.nxml.txt.nlp	12932289	SENT45	19	19	26	26	fluorescein	San	PA164746009	80218	0.413
NULL	Mol_Cell_Biochem_2014_Oct_9_385(1-2)_265-275.nxml.txt.nlp	24104452	SENT124	29	29	16	16	bortezomib	U87	PA10252	677775;641648	0.413
NULL	Ther_Clin_Risk_Manag_2007_Jun_3(2)_333-339.nxml.txt.nlp	18360642	SENT136	22	22	17	17	aprepitant	NK1	PA164747039	11126	0.413
NULL	Iran_J_Basic_Med_Sci_2012_Mar-Apr_15(2)_709-718.nxml.txt.nlp	23493500	SENT151	32	32	42	42	indomethacin	spatial	PA449982	219793	0.413
NULL	Mol_Cancer_2010_Mar_4_9_49.nxml.txt.nlp	20202195	SENT126	27	27	22	22	vorinostat	HDAC7	PA164748224	51564	0.413
NULL	Cancer_Cell_Int_2008_Mar_18_8_3.nxml.txt.nlp	18348720	SENT82	10	10	15	15	lapatinib	EGF	PA152241907	1950	0.413
NULL	Theranostics_2014_Jan_29_4(4)_399-411.nxml.txt.nlp	24578723	SENT14	25	25	9	9	doxorubicin	NIRF	PA449412	27190;115426	0.413
NULL	Open_Ophthalmol_J_2014_Oct_3_8_67-72.nxml.txt.nlp	25317218	SENT68	23	23	28	28	timolol	BAK	PA451690	578	0.413
NULL	J_Thromb_Thrombolysis_2011_May_13_31(4)_478-492.nxml.txt.nlp	21318583	SENT101	22	22	17	17	thrombin	ADP	PA451674	23038	0.413
NULL	Curr_Neuropharmacol_2014_Jan_12(1)_57-70.nxml.txt.nlp	24533016	SENT188	20	20	9	9	ketamine	Met	PA450144	79811	0.413
NULL	Br_J_Cancer_2013_May_28_108(10)_2063-2069.nxml.txt.nlp	23591198	SENT4	17	17	20	20	gemcitabine	GEM	PA449748	2669	0.413
NULL	Clin_Dev_Immunol_2008_Feb_25_2008_794050.nxml.txt.nlp	18354729	SENT241	26	26	10	10	methotrexate	DPPIV	PA450428	2191;1803	0.413
NULL	Braz_J_Med_Biol_Res_2014_Oct_24_48(1)_51-56.nxml.txt.nlp	25493383	SENT25	18	18	15	15	hyaluronan	MCP-1	PA165958431	6347	0.413
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT606	11	11	16	16	metformin	HIF-1	PA450395	29072	0.413
NULL	Cancers_(Basel)_2013_May_27_5(2)_617-638.nxml.txt.nlp	24216994	SENT319	0	0	24	24	curcumin	PC3	PA151958596	57332;7832;5122	0.413
NULL	J_Gen_Physiol_2003_Nov_122(5)_485-500.nxml.txt.nlp	14581581	SENT8	33	33	18	18	spermine	IRK1	PA164781199	3759	0.413
NULL	Front_Neurol_2014_Jan_31_5_11.nxml.txt.nlp	24550884	SENT78	0	0	2	2	levetiracetam	SV2A	PA450206	9900	0.413
NULL	J_Gen_Physiol_2003_Nov_122(5)_621-639.nxml.txt.nlp	14581586	SENT46	30	30	10	10	streptomycin	F12	PA451512	2161	0.413
NULL	J_Immunol_Res_2014_May_12_2014_897249.nxml.txt.nlp	24901013	SENT142	12	12	7	7	natalizumab	CD4	PA164747191	920	0.413
NULL	Mol_Pain_2012_Sep_15_8_69.nxml.txt.nlp	22978421	SENT467	17	17	25	25	carbamazepine	mol	PA448785	90527	0.412
NULL	Curr_Cardiol_Rev_2011_Nov_7(4)_245-249.nxml.txt.nlp	22758625	SENT61	12	12	23	23	valsartan	CHOP	PA451848	1649	0.412
NULL	J_Cell_Biol_2001_Aug_6_154(3)_599-610.nxml.txt.nlp	11481345	SENT125	30	30	27	27	doxycycline	ARNO	PA449415	9266	0.412
NULL	Indian_J_Endocrinol_Metab_2012_May-Jun_16(3)_343-348.nxml.txt.nlp	22629497	SENT6	34	34	16	16	teriparatide	PTH	PA451620	5741	0.412
NULL	Expert_Opin_Biol_Ther_2013_Aug_7_13(8)_1109-1124.nxml.txt.nlp	23651228	SENT19	23	23	17	17	ribavirin	IFN	PA451241	3439	0.412
NULL	Arch_Med_Sci_2011_Dec_31_7(6)_977-983.nxml.txt.nlp	22328880	SENT147	8	8	13	13	heparin	PAPP-A	PA449855	5069	0.412
NULL	Exp_Diabetes_Res_2012_Sep_6_2012_470302.nxml.txt.nlp	22991506	SENT132	7	7	24	24	paraformaldehyde	P21	PA450790	1026;9338	0.412
NULL	Front_Oncol_2014_May_19_4_113.nxml.txt.nlp	24904827	SENT87	9	9	2	2	cocaine	AGO2	PA449072	27161	0.412
NULL	Angiogenesis_2012_Dec_28_15(4)_623-641.nxml.txt.nlp	22843200	SENT276	12	12	10	10	sunitinib	MVD	PA162372840	4597	0.412
NULL	Indian_J_Dermatol_2008_53(3)_125-128.nxml.txt.nlp	19882010	SENT73	16	16	35	35	fluconazole	ANOVA	PA449653	4858	0.412
NULL	Environ_Health_Perspect_2010_May_22_118(5)_627-634.nxml.txt.nlp	20439172	SENT60	27	27	43	43	l-glutamine	CO2	PA10090	4513	0.412
NULL	EPMA_J_2013_Feb_25_4(1)_7.nxml.txt.nlp	23442211	SENT78	12	12	17	17	trastuzumab	San	PA451743	80218	0.412
NULL	Front_Endocrinol_(Lausanne)_2013_Nov_11_4_165.nxml.txt.nlp	24273530	SENT548	39	39	27	27	taurine	SLC6A13	PA451590	6540	0.412
NULL	Cancers_(Basel)_2014_Jun_27_6(3)_1363-1381.nxml.txt.nlp	24978438	SENT78	12	12	18	18	thrombin	CXCL12	PA451674	6387	0.412
NULL	Exp_Ther_Med_2013_Apr_5_5(4)_1259-1263.nxml.txt.nlp	23596498	SENT4	0	0	18	18	propofol	TRPA1	PA451141	8989	0.412
NULL	Diabetes_2008_Sep_57(9)_2332-2340.nxml.txt.nlp	18567824	SENT46	5	5	11	11	atropine	ghrelin	PA448505	51738	0.412
NULL	Eur_J_Nucl_Med_Mol_Imaging_2009_Oct_30_36(10)_1674-1686.nxml.txt.nlp	19565239	SENT574	12	12	22	22	choline	FDG	PA448976	23583	0.412
NULL	Oxid_Med_Cell_Longev_2012_Apr_5_2012_983427.nxml.txt.nlp	22550557	SENT197	24	24	7	7	ethanol	Bcl-2	PA448073	596	0.412
NULL	Br_J_Ophthalmol_2008_Sep_22_92(9)_1275-1282.nxml.txt.nlp	18723745	SENT60	3	3	5	5	latanoprost	BAK	PA164774763	578	0.412
NULL	Oxid_Med_Cell_Longev_2013_Dec_5_2013_963520.nxml.txt.nlp	24381719	SENT29	11	11	14	14	oxygen	ROS	PA450744	6098	0.412
NULL	Cells_2014_May_23_3(2)_517-545.nxml.txt.nlp	24861977	SENT927	4	4	15	15	capsaicin	TRPM8	PA448776	79054	0.412
NULL	Environ_Health_Perspect_2013_Apr_5_121(4)_480-487.nxml.txt.nlp	23384616	SENT207	18	18	30	30	heparin	PC1	PA449855	5122	0.412
NULL	Arthritis_Res_Ther_2011_May_25_13(Suppl_1)_S2.nxml.txt.nlp	21624181	SENT403	36	36	12	12	infliximab	ACR	PA452639	49	0.412
NULL	Autoimmune_Dis_2013_Aug_28_2013_613086.nxml.txt.nlp	24069534	SENT170	10	10	28	28	etanercept	TNFAIP3	PA449515	7128	0.412
NULL	Environ_Health_Perspect_2007_Dec_8_115(Suppl_1)_129-136.nxml.txt.nlp	18174961	SENT20	14	14	22	22	lindane	Bcl-2	PA164754914	596	0.412
NULL	Diabetes_Care_2009_Sep_19_32(9)_1663-1668.nxml.txt.nlp	19542207	SENT146	12	12	6	6	anakinra	IL-6	PA10799	3569	0.412
NULL	ScientificWorldJournal_2013_Apr_24_2013_928197.nxml.txt.nlp	23737732	SENT59	6	6	18	18	losartan	AMPK	PA450268	5563	0.412
NULL	Int_J_Mol_Sci_2014_Sep_22_15(9)_16787-16799.nxml.txt.nlp	25247577	SENT248	19	19	6	6	ethanol	NPFF	PA448073	8620	0.412
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Feb_8_64(Pt_3)_m464-m465.nxml.txt.nlp	21201856	SENT5	6	6	2	2	acetone	mol	PA448025	90527	0.412
NULL	Int_J_Mol_Sci_2012_Sep_28_13(10)_12428-12460.nxml.txt.nlp	23202907	SENT211	34	34	42	42	lipase	CAL	PA450239	54751;57120	0.412
NULL	Oncol_Lett_2014_Nov_14_8(5)_2086-2092.nxml.txt.nlp	25295095	SENT137	15	15	25	25	gemcitabine	RRM1	PA449748	6240	0.412
NULL	Oncogenesis_2014_May_12_3(5)_e102.nxml.txt.nlp	24819061	SENT243	7	7	19	19	nadh	p53	PA164755085	7157	0.412
NULL	Iran_Red_Crescent_Med_J_2013_Feb_5_15(2)_147-151.nxml.txt.nlp	23682327	SENT5	17	17	24	24	methylprednisolone	IL-6	PA450466	3569	0.412
NULL	Acta_Pharmacol_Sin_2012_Nov_22_33(11)_1395-1400.nxml.txt.nlp	23085738	SENT131	31	31	2	2	prasugrel	CYP2C19	PA154410481	1557	0.412
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Dec_15_67(Pt_1)_o136.nxml.txt.nlp	21522646	SENT61	2	2	20	20	coumarin	C10	PA134521193	113246	0.412
NULL	Ann_Clin_Microbiol_Antimicrob_2009_Sep_24_8_26.nxml.txt.nlp	19778428	SENT244	22	22	4	4	tetracycline	PEN	PA451640	9933	0.412
NULL	J_Cell_Mol_Med_2014_Sep_5_18(9)_1773-1784.nxml.txt.nlp	25091058	SENT155	11	11	4	4	anakinra	IL-17	PA10799	3605	0.412
NULL	Clin_Med_Insights_Oncol_2011_Sep_21_5_315-323.nxml.txt.nlp	22084620	SENT153	0	0	2	2	gemcitabine	IFN	PA449748	3439	0.412
NULL	J_Cancer_2013_Jan_11_4(2)_117-132.nxml.txt.nlp	23386910	SENT153	9	9	12	12	olaparib	BRCA1		672	0.412
NULL	Clin_Interv_Aging_2013_Feb_5_8_131-137.nxml.txt.nlp	23403474	SENT105	18	18	16	16	choline	CDP	PA448976	1523	0.412
NULL	Cancer_Cell_Int_2013_Feb_8_13_11.nxml.txt.nlp	23394616	SENT181	32	32	25	25	geldanamycin	XIAP	PA152031327	331	0.412
NULL	Reprod_Biol_Endocrinol_2013_Jul_11_11_61.nxml.txt.nlp	23844631	SENT9	12	12	7	7	estradiol	AMH	PA449503	268	0.412
NULL	Indian_J_Med_Res_2011_Sep_134(3)_295-301.nxml.txt.nlp	21985811	SENT111	6	6	24	24	phenytoin	CYP2C9	PA450947	1559	0.412
NULL	Front_Comput_Neurosci_2013_Apr_5_7_22.nxml.txt.nlp	23576979	SENT49	20	20	11	11	ketamine	HCN	PA450144	378938	0.412
NULL	Cancer_Biol_Med_2012_Mar_9(1)_18-22.nxml.txt.nlp	23691449	SENT121	24	24	9	9	gefitinib	ABCG2	PA131301952	9429	0.412
NULL	Front_Neurol_2014_Sep_11_5_173.nxml.txt.nlp	25309501	SENT216	6	6	10	10	hyaluronan	HAS2	PA165958431	3037	0.412
NULL	Hum_Mol_Genet_2013_Nov_15_22(22)_4602-4615.nxml.txt.nlp	23814040	SENT207	0	0	13	13	l-cysteine	TRMU	PA449173	55687	0.412
NULL	Oxid_Med_Cell_Longev_2011_Sep_18_2011_942123.nxml.txt.nlp	21941607	SENT203	10	10	1	1	vancomycin	VIII	PA451850	1351	0.412
NULL	Diabetes_2009_Apr_9_58(4)_855-866.nxml.txt.nlp	19136649	SENT10	11	11	27	27	lipase	desnutrin	PA450239	57104	0.412
NULL	eLife_2013_Oct_29_2_e01236.nxml.txt.nlp	24171104	SENT985	0	0	7	7	bortezomib	MM1	PA10252	23654	0.412
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT263	13	13	18	18	doxorubicin	SLK	PA449412	9748;2534	0.412
NULL	Curr_Neuropharmacol_2012_Mar_10(1)_88-95.nxml.txt.nlp	22942882	SENT83	24	24	23	23	haloperidol	FGA	PA449841	2243	0.412
NULL	Cancer_Med_2014_Oct_2_3(5)_1256-1265.nxml.txt.nlp	24890382	SENT21	4	4	0	0	maytansine	DM1	PA165291473	338023;1760;28509	0.412
NULL	Front_Genet_2013_Aug_29_4_163.nxml.txt.nlp	24009622	SENT206	32	32	24	24	ethanol	DDP	PA448073	1678	0.411
NULL	FASEB_J_2013_Jan_27(1)_222-231.nxml.txt.nlp	23047895	SENT21	24	24	17	17	natalizumab	IFN	PA164747191	3439	0.411
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT98	4	4	7	7	methotrexate	MSH2	PA450428	4436	0.411
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Mar_6_66(Pt_4)_o750.nxml.txt.nlp	21580595	SENT6	4	4	9	9	rocuronium	Tuba	PA164754992	23268	0.411
NULL	Arthritis_Res_Ther_2010_Apr_1_12(2)_R60.nxml.txt.nlp	20359365	SENT183	19	19	25	25	bleomycin	SPARC	PA448645	6678	0.411
NULL	Ann_Dermatol_2011_Nov_3_23(4)_504-507.nxml.txt.nlp	22148021	SENT61	22	22	20	20	vinblastine	IFN	PA451877	3439	0.411
NULL	Oncotarget_2014_Mar_13_5(4)_1101-1110.nxml.txt.nlp	24658355	SENT11	9	9	18	18	tamoxifen	MKP-2	PA451581	1846	0.411
NULL	J_Hematol_Oncol_2012_Nov_9_5_70.nxml.txt.nlp	23140144	SENT151	17	17	19	19	maytansine	DM1	PA165291473	338023;1760;28509	0.411
NULL	Br_J_Cancer_2012_Oct_23_107(9)_1488-1497.nxml.txt.nlp	23033007	SENT71	0	0	29	29	gemcitabine	HEMA	PA449748	2157	0.411
NULL	Arch_Med_Sci_2013_Oct_31_9(5)_916-921.nxml.txt.nlp	24273579	SENT107	5	5	2	2	bleomycin	AQP1	PA448645	358	0.411
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Aug_27_67(Pt_9)_o2450.nxml.txt.nlp	22059018	SENT5	16	16	18	18	ethanol	mol	PA448073	90527	0.411
NULL	BMB_Rep_2014_Feb_47(2)_60-68.nxml.txt.nlp	24411465	SENT1099	0	0	7	7	infliximab	IL-23	PA452639	51561	0.411
NULL	Adv_Ther_2014_Dec_2_31_1228-1246.nxml.txt.nlp	25447269	SENT136	8	8	25	25	timolol	TIM	PA451690	7984;8914	0.411
NULL	Case_Rep_Dent_2013_Jul_10_2013_812323.nxml.txt.nlp	23936686	SENT96	18	18	22	22	hyaluronan	CD31	PA165958431	5175	0.411
NULL	Libyan_J_Med_2006_Jul_28_1(1)_42-59.nxml.txt.nlp	21526020	SENT203	25	25	18	18	bevacizumab	IFL	PA130232992	3439	0.411
NULL	Br_J_Cancer_2010_Jul_27_103(3)_315-323.nxml.txt.nlp	20661248	SENT243	8	8	13	13	irinotecan	IFL	PA450085	3439	0.411
NULL	Open_Biomed_Eng_J_2013_Jun_14_7_50-61.nxml.txt.nlp	23847691	SENT244	14	14	25	25	collagenase	CD105	PA449107	2022	0.411
NULL	Br_J_Cancer_2001_Mar_84(5)_670-673.nxml.txt.nlp	11237388	SENT5	22	22	18	18	curcumin	JNK	PA151958596	5599	0.411
NULL	Biomed_Res_Int_2014_Apr_27_2014_565291.nxml.txt.nlp	24877115	SENT312	7	7	15	15	ethanol	CO2	PA448073	4513	0.411
NULL	J_Neurovirol_2013_Jun_4_19(4)_351-358.nxml.txt.nlp	23733308	SENT141	7	7	2	2	mefloquine	SOC	PA450348	91544	0.411
NULL	Int_J_Chron_Obstruct_Pulmon_Dis_2007_Jun_2(2)_169-176.nxml.txt.nlp	18044689	SENT4	22	22	6	6	salmeterol	CEA	PA451300	5670;1087	0.411
NULL	Br_J_Cancer_1994_Jan_69(1)_26-31.nxml.txt.nlp	7506924	SENT9	9	9	23	23	phenol	p53	PA450913	7157	0.411
NULL	Curr_Health_Sci_J_2014_Dec_29_Jan-Mar_40(1)_5-11.nxml.txt.nlp	24791198	SENT82	7	7	43	43	heparin	VEGFR1	PA449855	2321	0.411
NULL	Arthritis_Res_Ther_2011_Apr_4_13(2)_R56.nxml.txt.nlp	21463515	SENT20	14	14	6	6	rituximab	IL-23	PA451261	51561	0.411
NULL	J_Hematol_Oncol_2013_Feb_17_6_17.nxml.txt.nlp	23414938	SENT30	30	30	25	25	ticlopidine	ADP	PA451686	23038	0.411
NULL	Br_J_Cancer_1999_Nov_81(6)_942-951.nxml.txt.nlp	10576649	SENT8	6	6	8	8	vinblastine	P-gp	PA451877	5243	0.411
NULL	Acta_Naturae_2014_Jan-Mar_6(1)_54-60.nxml.txt.nlp	24772327	SENT132	29	29	17	17	choline	MNX1	PA448976	3110	0.411
NULL	J_Anim_Sci_Biotechnol_2013_Dec_18_4(1)_51.nxml.txt.nlp	24344643	SENT127	3	3	5	5	urea	NEFA	PA451831	4925	0.411
NULL	Clin_Mol_Hepatol_2014_Sep_25_20(3)_283-290.nxml.txt.nlp	25320732	SENT5	15	15	12	12	propranolol	EVL	PA451145	51466	0.411
NULL	Cough_2007_Oct_31_3_9.nxml.txt.nlp	17971242	SENT35	0	0	29	29	capsaicin	TRPV1	PA448776	7442	0.411
NULL	Int_J_Nanomedicine_2012_Sep_13_7_4917-4926.nxml.txt.nlp	23028220	SENT225	21	21	17	17	calcein	mol	PA132595336	90527	0.411
NULL	J_Hematol_Oncol_2009_Oct_27_2_45.nxml.txt.nlp	19860903	SENT114	12	12	17	17	temsirolimus	IFN	PA164746890	3439	0.411
NULL	Oncogene_2009_Dec_3_28(48)_4237-4248.nxml.txt.nlp	19734937	SENT12	8	8	10	10	collagenase	PAR-1	PA449107	2011;2149	0.411
NULL	Lipids_Health_Dis_2011_Dec_6_10_229.nxml.txt.nlp	22146099	SENT41	2	2	0	0	rosiglitazone	IL-13	PA451283	3596	0.411
NULL	J_Immunol_Res_2014_May_15_2014_175265.nxml.txt.nlp	24949488	SENT175	18	18	7	7	neomycin	CHS	PA450608	1130	0.411
NULL	J_Biol_Chem_2008_Jun_20_283(25)_17672-17680.nxml.txt.nlp	18420578	SENT245	1	1	23	23	papain	hole	PA450778	80757	0.411
NULL	Front_Oncol_2013_Nov_15_3_281.nxml.txt.nlp	24298448	SENT195	26	26	16	16	panitumumab	KRAS	PA162373091	3845	0.411
NULL	J_Mol_Signal_2010_May_10_5_4.nxml.txt.nlp	20459745	SENT67	7	7	13	13	cisplatin	p53	PA449014	7157	0.411
NULL	J_Autom_Methods_Manag_Chem_2011_Oct_5_2011_263624.nxml.txt.nlp	22007150	SENT40	20	20	15	15	ethanol	mol	PA448073	90527	0.411
NULL	Viruses_2014_Feb_18_6(2)_875-892.nxml.txt.nlp	24553110	SENT188	26	26	34	34	erlotinib	IFN	PA134687924	3439	0.411
NULL	Eur_J_Nucl_Med_Mol_Imaging_2009_Oct_30_36(10)_1674-1686.nxml.txt.nlp	19565239	SENT575	10	10	20	20	choline	FDG	PA448976	23583	0.411
NULL	Amino_Acids_2014_Feb_20_46(5)_1275-1283.nxml.txt.nlp	24553827	SENT86	3	3	6	6	taurine	TAUT	PA451590	6533	0.411
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Oct_3_65(Pt_11)_o2603.nxml.txt.nlp	21578222	SENT6	14	14	19	19	febuxostat	mol	PA165958521	90527	0.411
NULL	J_Cell_Biol_1998_Nov_16_143(4)_1003-1012.nxml.txt.nlp	9817757	SENT120	27	27	7	7	gentamicin	IFN	PA449753	3439	0.411
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT73	39	39	28	28	vinorelbine	ASC	PA451881	29108	0.411
NULL	Environ_Health_Perspect_2009_Feb_8_117(2)_175-180.nxml.txt.nlp	19270784	SENT140	15	15	17	17	doxorubicin	BPA	PA449412	667	0.411
NULL	Br_J_Cancer_1997_75(2)_161-168.nxml.txt.nlp	9010020	SENT0	33	33	29	29	glucose	MRP	PA449773	79971	0.41
NULL	Case_Rep_Transplant_2013_Aug_1_2013_765230.nxml.txt.nlp	23984169	SENT68	14	14	16	16	rituximab	CHOP	PA451261	1649	0.41
NULL	Front_Immunol_2013_Nov_11_4_365.nxml.txt.nlp	24273539	SENT220	12	12	19	19	gemcitabine	CD11b	PA449748	3684	0.41
NULL	Mol_Cancer_2012_Mar_23_11_15.nxml.txt.nlp	22439866	SENT214	3	3	15	15	collagenase	MMP1	PA449107	4312	0.41
NULL	Diabetes_2013_Sep_15_62(9)_3022-3023.nxml.txt.nlp	23970523	SENT18	2	2	9	9	olanzapine	GLP-1	PA450688	100125288	0.41
NULL	Int_J_Fertil_Steril_2014_Nov_1_Oct-Dec_8(3)_243-248.nxml.txt.nlp	25379151	SENT0	21	21	23	23	piroxicam	ART	PA450985	181	0.41
NULL	Int_J_Mol_Sci_2013_Aug_14_14(8)_16719-16731.nxml.txt.nlp	23949634	SENT2	13	13	16	16	thrombin	TPC	PA451674	8030;60386	0.41
NULL	Reprod_Biol_Endocrinol_2003_Oct_3_1_62.nxml.txt.nlp	14567758	SENT121	0	0	23	23	lindane	ANOVA	PA164754914	4858	0.41
NULL	J_Obes_2011_May_18_2011_141024.nxml.txt.nlp	21772998	SENT39	7	7	9	9	calcidiol	PTH	PA164745614	5741	0.41
NULL	Cell_Commun_Signal_2014_Jan_10_12_3.nxml.txt.nlp	24410813	SENT82	3	3	5	5	tamoxifen	THOC5	PA451581	8563	0.41
NULL	ARYA_Atheroscler_2014_Jul_10(4)_192-198.nxml.txt.nlp	25258634	SENT126	33	33	13	13	simvastatin	Q10	PA451363	27161	0.41
NULL	Cancers_(Basel)_2012_Oct_26_4(4)_1106-1146.nxml.txt.nlp	24213501	SENT349	0	0	19	19	camptothecin	PC-3	PA153590860	692094	0.41
NULL	Case_Rep_Pathol_2012_Aug_8_2012_319434.nxml.txt.nlp	22934215	SENT43	11	11	15	15	thyroglobulin	CK20	PA164754910	54474	0.41
NULL	Anal_Bioanal_Chem_2009_Oct_30_395(4)_893-905.nxml.txt.nlp	19484227	SENT142	16	16	18	18	sulfamethazine	OTC	PA451542	5009	0.41
NULL	Case_Rep_Transplant_2013_Aug_1_2013_765230.nxml.txt.nlp	23984169	SENT16	14	14	16	16	rituximab	CHOP	PA451261	1649	0.41
NULL	Clin_Ophthalmol_2014_Feb_10_8_389-399.nxml.txt.nlp	24550667	SENT151	8	8	14	14	timolol	TIM	PA451690	7984;8914	0.41
NULL	Cancer_Metab_2013_Mar_21_1_12.nxml.txt.nlp	24280230	SENT12	12	12	15	15	urea	ASL	PA451831	435	0.41
NULL	Biomed_Res_Int_2013_Dec_10_2013_565218.nxml.txt.nlp	24386638	SENT238	11	11	7	7	imipramine	DIO3	PA449969	1735	0.41
NULL	Curr_Neuropharmacol_2010_Jun_8(2)_128-134.nxml.txt.nlp	21119884	SENT20	37	37	22	22	nadh	ADP	PA164755085	23038	0.41
NULL	Oncotarget_2013_Nov_24_4(12)_2186-2207.nxml.txt.nlp	24327604	SENT140	21	21	31	31	bortezomib	p53	PA10252	7157	0.41
NULL	Virol_J_2010_Nov_27_7_349.nxml.txt.nlp	21110887	SENT131	48	48	29	29	streptomycin	FBS	PA451512	64319;26269	0.41
NULL	J_Vis_Exp_2011_Apr_23_(50)_2621.nxml.txt.nlp	21540824	SENT45	15	15	1	1	ethanol	Msp	PA448073	89782	0.41
NULL	Mol_Cancer_2013_May_24_12_46.nxml.txt.nlp	23705826	SENT144	29	29	16	16	imatinib	FLT3	PA10804	2322	0.41
NULL	Breast_Cancer_Res_2014_Dec_19_16(6)_499.nxml.txt.nlp	25522654	SENT8	27	27	23	23	estradiol	CYP19A1	PA449503	1588	0.41
NULL	Front_Oncol_2014_Mar_3_4_34.nxml.txt.nlp	24624361	SENT252	12	12	14	14	lapatinib	ERBB2	PA152241907	2064	0.41
NULL	J_Vet_Med_Sci_2013_Dec_25_75(12)_1637-1642.nxml.txt.nlp	23884081	SENT24	15	15	40	40	dextran	ZO-1	PA449261	7082	0.41
NULL	Leukemia_2014_Jun_17_28(6)_1216-1226.nxml.txt.nlp	24301524	SENT105	2	2	10	10	bortezomib	p50	PA10252	958;4790	0.41
NULL	Basic_Clin_Neurosci_2014_Winter_5(1)_74-79.nxml.txt.nlp	25436087	SENT110	8	8	12	12	fluoxetine	AQP4	PA449673	361	0.41
NULL	Cancer_Manag_Res_2012_Nov_9_4_383-395.nxml.txt.nlp	23204869	SENT128	2	2	9	9	carmustine	PC-3	PA448810	692094	0.41
NULL	Adv_Hematol_2010_Dec_30_2010_624040.nxml.txt.nlp	21234357	SENT106	9	9	14	14	vincristine	CHOP	PA451879	1649	0.41
NULL	Br_J_Cancer_2010_Jan_19_102(2)_383-391.nxml.txt.nlp	20010943	SENT177	20	20	10	10	cisplatin	P31	PA449014	529	0.41
NULL	Evid_Based_Complement_Alternat_Med_2011_Feb_14_2011_429843.nxml.txt.nlp	21869897	SENT154	17	17	28	28	ethanol	CORT	PA448073	1325	0.41
NULL	J_Adv_Pract_Oncol_2013_Jul_1_Jul-Aug_4(4)_263-268.nxml.txt.nlp	25032007	SENT106	10	10	14	14	tamoxifen	CYP2D6	PA451581	1565	0.41
NULL	Arthritis_Res_Ther_2003_Feb_24_5(Suppl_1)_47.nxml.txt.nlp	NULL	SENT20	11	11	17	17	leflunomide	IL-6	PA450192	3569	0.41
NULL	Oncologist_2011_Jan_6_16(1)_5-24.nxml.txt.nlp	21212434	SENT165	4	4	12	12	aldesleukin	San	PA448081	80218	0.41
NULL	Anal_Bioanal_Chem_2013_Jul_23_405(23)_7337-7345.nxml.txt.nlp	23877175	SENT146	19	19	25	25	pilocarpine	CA3	PA450962	761	0.41
NULL	Nat_Commun_2012_Dec_4_3_1248.nxml.txt.nlp	23212377	SENT197	7	7	11	11	nadh	NADK	PA164755085	65220	0.41
NULL	Breast_Cancer_Res_2003_Oct_9_5(6)_R250-R256.nxml.txt.nlp	14580261	SENT145	21	21	29	29	estradiol	aromatase	PA449503	1588	0.41
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT74	0	0	8	8	curcumin	PC-3	PA151958596	692094	0.41
NULL	Front_Physiol_2013_Nov_14_4_323.nxml.txt.nlp	24294204	SENT589	0	0	5	5	metoprolol	MDC	PA450480	6367	0.41
NULL	Int_J_Chron_Obstruct_Pulmon_Dis_2007_Jun_2(2)_157-167.nxml.txt.nlp	18044688	SENT105	8	8	3	3	tiotropium	TDI	PA164769056	100038246	0.41
NULL	Mol_Neurodegener_2011_Aug_8_6_57.nxml.txt.nlp	21819629	SENT237	16	16	10	10	arsenite	TDP-43	PA452638	23435	0.41
NULL	Mol_Cancer_2010_May_28_9_129.nxml.txt.nlp	20509882	SENT238	14	14	16	16	collagenase	VIII	PA449107	1351	0.41
NULL	Nucleic_Acids_Res_2011_Sep_7_39(17)_7465-7476.nxml.txt.nlp	21653549	SENT178	22	22	13	13	etoposide	DEK	PA449552	7913	0.41
NULL	Indian_J_Psychiatry_2011_Jul-Sep_53(3)_239-243.nxml.txt.nlp	22135443	SENT36	19	19	7	7	paroxetine	IFN	PA450801	3439	0.41
NULL	Indian_J_Pharm_Sci_2008_Jan-Feb_70(1)_102-105.nxml.txt.nlp	20390092	SENT75	2	2	4	4	lansoprazole	DOM	PA450180	6663	0.41
NULL	Ther_Clin_Risk_Manag_2007_Dec_3(6)_1027-1033.nxml.txt.nlp	18516257	SENT60	30	30	37	37	procarbazine	MRC	PA451112	4345	0.41
NULL	Leukemia_2013_Apr_14_27(4)_803-812.nxml.txt.nlp	23238589	SENT126	15	15	17	17	imatinib	IFN	PA10804	3439	0.41
NULL	N_Am_J_Med_Sci_2011_Oct_3(10)_441-450.nxml.txt.nlp	22363081	SENT104	29	29	8	8	cetuximab	EGFR	PA10040	1956	0.41
NULL	J_Hematol_Oncol_2012_Aug_13_5_49.nxml.txt.nlp	22889180	SENT26	9	9	12	12	rituximab	CHOP	PA451261	1649	0.41
NULL	Acta_Pharmacol_Sin_2013_Mar_21_34(3)_432-440.nxml.txt.nlp	23334235	SENT256	13	13	25	25	collagenase	CD11c	PA449107	3687	0.41
NULL	Gut_2011_Sep_9_60(9)_1204-1212.nxml.txt.nlp	21307168	SENT265	8	8	14	14	geldanamycin	beta-catenin	PA152031327	1499	0.41
NULL	Mol_Cancer_2010_Mar_4_9_49.nxml.txt.nlp	20202195	SENT143	15	15	7	7	vorinostat	HOP	PA164748224	84525;10963	0.409
NULL	Int_J_Mol_Sci_2014_Jun_25_15(7)_11234-11244.nxml.txt.nlp	24968266	SENT148	2	2	5	5	docetaxel	PC-3	PA449383	692094	0.409
NULL	J_Res_Med_Sci_2010_Nov-Dec_15(6)_331-343.nxml.txt.nlp	21526106	SENT173	7	7	5	5	l-arginine	HDEL	PA448478	10945	0.409
NULL	Drug_Des_Devel_Ther_2014_Sep_9_8_1257-1267.nxml.txt.nlp	25246767	SENT182	19	19	2	2	haloperidol	NCX	PA449841	3196	0.409
NULL	Mol_Syst_Biol_2010_Feb_16_6_347.nxml.txt.nlp	20160708	SENT259	4	4	6	6	doxycycline	TRF2	PA449415	7014;9519	0.409
NULL	Int_J_Endocrinol_2014_Apr_30_2014_674987.nxml.txt.nlp	24883061	SENT43	28	28	26	26	glucose	DAG	PA449773	1605	0.409
NULL	J_Vet_Med_Sci_2014_Aug_15_76(8)_1119-1127.nxml.txt.nlp	24829081	SENT120	23	23	11	11	trypsin	fractalkine	PA451806	6376	0.409
NULL	J_Vis_Exp_2014_Jun_21_(88)_51243.nxml.txt.nlp	24999032	SENT124	6	6	3	3	l-glutamine	F12	PA10090	2161	0.409
NULL	Clin_Interv_Aging_2013_Feb_11_8_139-148.nxml.txt.nlp	23430672	SENT17	30	30	36	36	fluorescein	IL8	PA164746009	3576	0.409
NULL	Curr_Opin_Endocrinol_Diabetes_Obes_2014_Oct_28_21(5)_394-404.nxml.txt.nlp	25122493	SENT250	7	7	18	18	thyroglobulin	RAI	PA164754910	10848;6050	0.409
NULL	Br_J_Cancer_2012_Feb_28_106(5)_896-903.nxml.txt.nlp	22294186	SENT229	14	14	2	2	cyclophosphamide	BCL7C	PA449165	9274	0.409
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_29_2013_590393.nxml.txt.nlp	23737838	SENT311	3	3	5	5	resveratrol	p53		7157	0.409
NULL	J_Lipid_Res_2012_May_53(5)_1000-1011.nxml.txt.nlp	22368281	SENT218	13	13	11	11	atorvastatin	LPA	PA448500	4018	0.409
NULL	Nat_Med_2014_Jul_8_20(7)_764-768.nxml.txt.nlp	24908571	SENT258	15	15	7	7	imipramine	GRM4	PA449969	2914	0.409
NULL	Pediatr_Infect_Dis_J_2013_Sep_26_32(Suppl_1_Innovative_Treatment_Regimens_for_Severe_Infections_in_Young_Infants)_S33-S38.nxml.txt.nlp	23945574	SENT270	19	19	8	8	amoxicillin	MASS	PA448406	2200	0.409
NULL	Biomed_Res_Int_2014_Jun_26_2014_161346.nxml.txt.nlp	25054130	SENT228	45	45	30	30	curcumin	STZ	PA151958596	6484	0.409
NULL	Cell_Res_2012_Aug_22_22(8)_1227-1245.nxml.txt.nlp	22613949	SENT105	14	14	30	30	bortezomib	KRAS	PA10252	3845	0.409
NULL	Carcinogenesis_2010_Dec_27_31(12)_2049-2057.nxml.txt.nlp	20876285	SENT141	3	3	8	8	tamoxifen	HER2	PA451581	2064	0.409
NULL	Curr_Opin_Obstet_Gynecol_2014_Aug_3_26(4)_226-236.nxml.txt.nlp	24978853	SENT93	11	11	9	9	estradiol	AMH	PA449503	268	0.409
NULL	Acta_Pharmacol_Sin_2012_Oct_17_33(10)_1301-1310.nxml.txt.nlp	22983390	SENT117	9	9	30	30	cisplatin	migfilin	PA449014	54751	0.409
NULL	J_Bras_Pneumol_2013_Jun-Aug_39(4)_495-512.nxml.txt.nlp	24068273	SENT711	15	15	17	17	aztreonam	por	PA448523	64840	0.409
NULL	Indian_J_Anaesth_2013_Jan-Feb_57(1)_41-45.nxml.txt.nlp	23716765	SENT119	2	2	13	13	ondansetron	HERG	PA450705	3757	0.409
NULL	Crit_Care_2010_Feb_8_14(1)_203.nxml.txt.nlp	20236471	SENT136	33	33	13	13	vasopressin	ADM	PA451858	133	0.409
NULL	Oncogenesis_2014_May_12_3(5)_e102.nxml.txt.nlp	24819061	SENT119	5	5	29	29	nadh	p53	PA164755085	7157	0.409
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Nov_26_64(Pt_12)_o2459.nxml.txt.nlp	21581427	SENT63	1	1	11	11	ethanol	mol	PA448073	90527	0.409
NULL	Bone_2011_Dec_49(6)_1232-1241.nxml.txt.nlp	21920485	SENT69	8	8	18	18	ethanol	CT40	PA448073	54457	0.409
NULL	Arthritis_Res_Ther_2014_Apr_11_16(2)_R93.nxml.txt.nlp	24725461	SENT165	13	13	4	4	estradiol	CYP19A1	PA449503	1588	0.409
NULL	Environ_Health_2010_Aug_18_9_50.nxml.txt.nlp	20718963	SENT115	9	9	12	12	permethrin	Yes	PA164743137	7525	0.409
NULL	Cancers_(Basel)_2011_Mar_2_3(1)_971-981.nxml.txt.nlp	24212649	SENT470	10	10	6	6	heparin	MMP7	PA449855	4316	0.409
NULL	Crit_Care_2007_Sep_26_11(Suppl_4)_P31.nxml.txt.nlp	NULL	SENT2	5	5	7	7	vasopressin	AVP	PA451858	114548;551	0.409
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT186	16	16	8	8	tacrolimus	RANKL	PA451578	8600	0.409
NULL	Amino_Acids_2011_May_22_40(5)_1369-1383.nxml.txt.nlp	21424716	SENT183	14	14	25	25	creatine	CEE	PA164778930	51608	0.409
NULL	Open_Med_Chem_J_2009_Nov_18_3_8-13.nxml.txt.nlp	19966921	SENT4	11	11	19	19	l-arginine	NOS	PA448478	4843	0.409
NULL	Drugs_R_D_2012_Sep_18_12(3)_121-126.nxml.txt.nlp	22934754	SENT62	22	22	13	13	sirolimus	San	PA451365	80218	0.409
NULL	J_Adv_Pract_Oncol_2014_May_1_May-Jun_5(3)_193-202.nxml.txt.nlp	25089218	SENT97	0	0	14	14	denosumab	RANKL	PA166048634	8600	0.409
NULL	Cancer_Med_2013_Aug_28_2(4)_468-477.nxml.txt.nlp	24156019	SENT64	10	10	17	17	docetaxel	CLU	PA449383	1191	0.409
NULL	Br_J_Cancer_2010_Jan_19_102(2)_383-391.nxml.txt.nlp	20010943	SENT89	5	5	13	13	cisplatin	P31	PA449014	529	0.409
NULL	Acta_Histochem_Cytochem_2014_Jun_28_47(3)_103-112.nxml.txt.nlp	25320407	SENT362	4	4	12	12	estradiol	SF-1	PA449503	2516	0.409
NULL	Indian_J_Pharmacol_2012_Sep-Oct_44(5)_624-628.nxml.txt.nlp	23112426	SENT71	5	5	7	7	ketoconazole	CYP3A4	PA450146	1576	0.409
NULL	Bioinformation_2006_Apr_4_1(4)_121-126.nxml.txt.nlp	17597870	SENT126	7	7	2	2	trypsin	K15	PA451806	3866	0.409
NULL	Acta_Pharmacol_Sin_2013_Oct_7_34(10)_1292-1300.nxml.txt.nlp	23933651	SENT124	8	8	8	8	pp2	PP2		4888	0.409
NULL	Iran_J_Pharm_Res_2013_Summer_12(3)_457-469.nxml.txt.nlp	24250652	SENT227	6	6	8	8	flutamide	spatial	PA449685	219793	0.409
NULL	Evid_Based_Complement_Alternat_Med_2013_Apr_29_2013_590393.nxml.txt.nlp	23737838	SENT197	12	12	9	9	resveratrol	p53		7157	0.409
NULL	Curr_Opin_Obstet_Gynecol_2014_Aug_3_26(4)_226-236.nxml.txt.nlp	24978853	SENT201	11	11	8	8	estradiol	AMH	PA449503	268	0.409
NULL	Oncol_Lett_2014_May_18_7(5)_1499-1502.nxml.txt.nlp	24765164	SENT91	12	12	5	5	oxaliplatin	GSTP1	PA131285527	2950	0.409
NULL	Mol_Brain_2014_Aug_12_7_58.nxml.txt.nlp	25112718	SENT415	29	29	8	8	chlorpheniramine	E12	PA448960	64100	0.409
NULL	Breast_Cancer_Res_2011_Jan_17_13(1)_R5.nxml.txt.nlp	21241485	SENT33	24	24	12	12	estradiol	NGF	PA449503	4803	0.409
NULL	Arch_Med_Sci_2013_Oct_31_9(5)_916-921.nxml.txt.nlp	24273579	SENT14	10	10	7	7	bleomycin	AQP1	PA448645	358	0.409
NULL	J_Thorac_Oncol_2014_Jun_30_9(6)_825-833.nxml.txt.nlp	24807158	SENT121	31	31	28	28	cisplatin	CRT	PA449014	811	0.408
NULL	Biomed_Res_Int_2013_Jul_24_2013_581684.nxml.txt.nlp	23984383	SENT127	13	13	15	15	lomustine	PHB	PA164749407	5245	0.408
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2619-2628.nxml.txt.nlp	24129235	SENT286	26	26	2	2	paclitaxel	GEM	PA450761	2669	0.408
NULL	Clin_Infect_Dis_2013_Feb_15_56(4)_576-582.nxml.txt.nlp	23097588	SENT115	41	41	30	30	zidovudine	CD4	PA451954	920	0.408
NULL	N_Am_J_Med_Sci_2012_Aug_4(8)_331-335.nxml.txt.nlp	22912940	SENT28	24	24	8	8	creatine	ACR	PA164778930	49	0.408
NULL	Exp_Ther_Med_2014_Nov_29_8(5)_1473-1478.nxml.txt.nlp	25289044	SENT172	8	8	10	10	heparin	AZU	PA449855	566	0.408
NULL	Arthritis_Res_Ther_2010_Apr_1_12(2)_R60.nxml.txt.nlp	20359365	SENT155	23	23	25	25	bleomycin	SPARC	PA448645	6678	0.408
NULL	Mol_Biol_Cell_2012_Nov_1_23(21)_4212-4225.nxml.txt.nlp	22956765	SENT47	6	6	11	11	thrombin	TER	PA451674	9524	0.408
NULL	Cell_Death_Dis_2011_Aug_18_2(8)_e193.nxml.txt.nlp	21850047	SENT61	4	4	1	1	doxazosin	HL-1	PA449407	55600	0.408
NULL	Pain_Res_Manag_2014_Nov-Dec_19(6)_e172-e178.nxml.txt.nlp	24992453	SENT63	35	35	38	38	carrageenan	IPL	PA448814	7262	0.408
NULL	Exp_Ther_Med_2013_Apr_24_5(4)_1105-1112.nxml.txt.nlp	23596478	SENT19	27	27	23	23	cytarabine	IFN	PA449177	3439	0.408
NULL	Breast_Cancer_Res_2011_Apr_14_13(2)_R43.nxml.txt.nlp	21492444	SENT222	36	36	12	12	doxycycline	PTEN	PA449415	5728	0.408
NULL	J_Cardiovasc_Magn_Reson_2014_Sep_27_16(1)_80.nxml.txt.nlp	25270330	SENT224	2	2	5	5	iron	SWI	PA450087	6594	0.408
NULL	Iran_J_Pharm_Res_2013_Summer_12(3)_411-421.nxml.txt.nlp	24250648	SENT131	15	15	4	4	vanillin	ANOVA	PA451852	4858	0.408
NULL	Eur_J_Endocrinol_2011_Jan_164(1)_69-74.nxml.txt.nlp	20961967	SENT4	23	23	18	18	metformin	PPARG	PA450395	5468	0.408
NULL	J_Psychopharmacol_2010_Jan_24(1)_27-38.nxml.txt.nlp	19204064	SENT150	19	19	12	12	amphetamine	NK1R	PA448408	6869	0.408
NULL	Korean_J_Anesthesiol_2013_Mar_19_64(3)_212-217.nxml.txt.nlp	23560185	SENT30	0	0	4	4	aprepitant	NK1	PA164747039	11126	0.408
NULL	Cell_Death_Differ_2009_Aug_20_16(8)_1135-1145.nxml.txt.nlp	19300452	SENT177	2	2	7	7	chloroquine	PUMA	PA448948	27113	0.408
NULL	Br_J_Pharmacol_2011_Oct_164(3)_866-883.nxml.txt.nlp	21323893	SENT43	1	1	4	4	oxygen	ROS	PA450744	6098	0.408
NULL	Zookeys_2014_Nov_25_(457)_1-14.nxml.txt.nlp	25561827	SENT111	36	36	11	11	ethanol	San	PA448073	80218	0.408
NULL	Cardiovasc_Diabetol_2013_Jun_7_12_84.nxml.txt.nlp	23759020	SENT210	4	4	0	0	dipyridamole	LSR	PA449367	51599	0.408
NULL	Case_Rep_Med_2011_Jun_5_2011_743817.nxml.txt.nlp	21687548	SENT125	5	5	34	34	fluorescein	PC7	PA164746009	9159	0.408
NULL	Cancers_(Basel)_2010_Jan_14_2(1)_1-19.nxml.txt.nlp	24281029	SENT695	15	15	25	25	docetaxel	HER2	PA449383	2064	0.408
NULL	Arthritis_Res_Ther_2007_Jun_29_9(Suppl_1)_S5.nxml.txt.nlp	17634144	SENT186	27	27	30	30	denosumab	RANK	PA166048634	8792	0.408
NULL	Oncol_Lett_2013_Feb_7_5(2)_440-446.nxml.txt.nlp	23420122	SENT247	2	2	24	24	gemcitabine	Gem	PA449748	51053	0.408
NULL	Cardiol_Res_Pract_2012_Aug_15_2012_713294.nxml.txt.nlp	22928146	SENT120	1	1	10	10	carvedilol	CARMEN	PA448817	8915	0.408
NULL	Diabetes_Care_2008_Dec_31(12)_2271-2272.nxml.txt.nlp	18782903	SENT38	5	5	21	21	terbutaline	ANOVA	PA451616	4858	0.408
NULL	EMBO_Mol_Med_2012_Dec_15_4(12)_1276-1293.nxml.txt.nlp	23065753	SENT155	14	14	9	9	cisplatin	HK1	PA449014	3098;51361;3739	0.408
NULL	Br_J_Cancer_2009_Mar_10_100(5)_834-839.nxml.txt.nlp	19174821	SENT108	29	29	19	19	nitrofurantoin	TMP	PA450640	2012	0.408
NULL	Environ_Health_Perspect_2010_Sep_28_118(9)_1267-1272.nxml.txt.nlp	20427257	SENT209	7	7	13	13	estradiol	BPA	PA449503	667	0.408
NULL	Acta_Pharmacol_Sin_2012_May_2_33(5)_615-624.nxml.txt.nlp	22465948	SENT97	7	7	11	11	nifedipine	PRG	PA450631	5544	0.408
NULL	Glycobiology_2013_Jul_18_23(7)_853-864.nxml.txt.nlp	23507965	SENT28	2	2	9	9	galactose	MGL	PA449725	11343	0.408
NULL	Cancer_2014_Jun_15_120(12)_1871-1880.nxml.txt.nlp	24634003	SENT131	8	8	10	10	sunitinib	IFN	PA162372840	3439	0.408
NULL	Antimicrob_Agents_Chemother_2014_Feb_58(2)_706-712.nxml.txt.nlp	24217698	SENT248	11	11	7	7	nevirapine	CYP2B6	PA450616	1555	0.408
NULL	Cancers_(Basel)_2014_Jun_27_6(3)_1363-1381.nxml.txt.nlp	24978438	SENT106	10	10	12	12	hyaluronan	IL-8	PA165958431	3576	0.408
NULL	Nat_Neurosci_2012_Sep_5_15(9)_1245-1254.nxml.txt.nlp	22864611	SENT448	10	10	16	16	haloperidol	mGlu2	PA449841	2912	0.408
NULL	J_Cell_Mol_Med_2014_Apr_20_18(4)_624-634.nxml.txt.nlp	24444305	SENT39	26	26	29	29	thrombin	EGF	PA451674	1950	0.408
NULL	Mol_Biol_Cell_2013_Apr_1_24(7)_923-932.nxml.txt.nlp	23363600	SENT254	23	23	10	10	l-glutamine	CO2	PA10090	4513	0.408
NULL	AIDS_Res_Ther_2008_Apr_25_5_8.nxml.txt.nlp	18439274	SENT128	14	14	5	5	nitrogen	OCT	PA450643	5362	0.408
NULL	Curr_Neuropharmacol_2008_Jun_6(2)_151-163.nxml.txt.nlp	19305794	SENT452	1	1	24	24	capsaicin	VR1	PA448776	56664	0.408
NULL	Diabetes_2011_Nov_17_60(11)_2691-2700.nxml.txt.nlp	21896928	SENT222	5	5	21	21	resveratrol	CTRL		1506	0.408
NULL	Crit_Care_2011_Mar_11_15(Suppl_1)_P431.nxml.txt.nlp	NULL	SENT4	15	15	2	2	heparin	VIII	PA449855	1351	0.408
NULL	Exp_Ther_Med_2013_Jun_9_5(6)_1770-1774.nxml.txt.nlp	23837071	SENT26	7	7	40	40	coumarin	c-Jun	PA134521193	3725	0.408
NULL	Clin_Ophthalmol_2014_Feb_10_8_389-399.nxml.txt.nlp	24550667	SENT156	8	8	29	29	timolol	TIM	PA451690	7984;8914	0.408
NULL	Sci_Rep_2014_Dec_2_4_7286.nxml.txt.nlp	25446378	SENT156	12	12	36	36	dextran	HNPP	PA449261	5376	0.408
NULL	Iran_J_Radiol_2012_Jun_30_9(2)_88-92.nxml.txt.nlp	23329970	SENT76	20	20	23	23	rituximab	CHOP	PA451261	1649	0.408
NULL	J_Occup_Med_Toxicol_2007_May_29_2_4.nxml.txt.nlp	17535442	SENT112	14	14	10	10	creatine	Yes	PA164778930	7525	0.408
NULL	Ann_Oncol_2013_Aug_12_24(8)_1994-1999.nxml.txt.nlp	23670096	SENT13	37	37	34	34	tamoxifen	BCS	PA451581	617	0.408
NULL	Cancers_(Basel)_2013_May_3_5(2)_491-510.nxml.txt.nlp	24216987	SENT448	11	11	21	21	choline	FDG	PA448976	23583	0.408
NULL	Colomb_Med_(Cali)_43(3)_221-225.nxml.txt.nlp	24893196	SENT98	9	9	4	4	resveratrol	ACTH		5443	0.408
NULL	Breast_Cancer_Res_2012_Jun_7_14(3)_R89.nxml.txt.nlp	22676470	SENT328	7	7	35	35	geldanamycin	HER2	PA152031327	2064	0.408
NULL	Carcinogenesis_2010_Dec_27_31(12)_2049-2057.nxml.txt.nlp	20876285	SENT7	34	34	2	2	tamoxifen	HER2	PA451581	2064	0.407
NULL	Eur_J_Med_Res_2014_Jun_19_19(Suppl_1)_S25.nxml.txt.nlp	NULL	SENT20	15	15	18	18	oxygen	ROS	PA450744	6098	0.407
NULL	J_Gastroenterol_2014_Mar_27_49(1)_117-125.nxml.txt.nlp	23532638	SENT23	6	6	2	2	heparin	GPC3	PA449855	2719	0.407
NULL	Asia_Pac_Allergy_2014_Oct_29_4(4)_253-256.nxml.txt.nlp	25379485	SENT54	5	5	14	14	lamotrigine	CD56	PA450164	4684	0.407
NULL	J_Korean_Med_Sci_2006_Apr_20_21(2)_188-192.nxml.txt.nlp	16614499	SENT11	5	5	11	11	vancomycin	VISA	PA451850	57506	0.407
NULL	Clin_Exp_Gastroenterol_2014_Jan_24_7_13-23.nxml.txt.nlp	24493931	SENT200	10	10	2	2	dextran	DAI	PA449261	81030	0.407
NULL	Indian_J_Pharm_Sci_2014_Mar-Apr_76(2)_116-124.nxml.txt.nlp	24843184	SENT17	42	42	28	28	methotrexate	TMP	PA450428	2012	0.407
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_13_2014_849783.nxml.txt.nlp	25477998	SENT105	1	1	7	7	berberine	Bcl-2	PA165860812	596	0.407
NULL	Med_Sci_Monit_2013_Jul_22_19_599-605.nxml.txt.nlp	23872600	SENT62	28	28	10	10	cisplatin	EPO	PA449014	7076;8288;2056	0.407
NULL	Clin_Ophthalmol_2010_Oct_28_4_1249-1252.nxml.txt.nlp	21151329	SENT63	5	5	2	2	ranibizumab	IVL	PA164746012	3713	0.407
NULL	Acta_Histochem_Cytochem_2011_Apr_28_44(2)_51-60.nxml.txt.nlp	21614166	SENT462	27	27	22	22	thalidomide	PCNA	PA451644	5111	0.407
NULL	Oncogene_2009_Dec_3_28(48)_4237-4248.nxml.txt.nlp	19734937	SENT41	12	12	14	14	collagenase	PAR-1	PA449107	2011;2149	0.407
NULL	Case_Rep_Endocrinol_2014_Nov_6_2014_693294.nxml.txt.nlp	25431697	SENT185	47	47	0	0	vasopressin	ACTH	PA451858	5443	0.407
NULL	Int_Semin_Surg_Oncol_2008_Apr_28_5_9.nxml.txt.nlp	18442393	SENT146	19	19	2	2	tamoxifen	HER-2	PA451581	2064	0.407
NULL	Exp_Ther_Med_2014_Feb_25_7(2)_417-422.nxml.txt.nlp	24396417	SENT58	21	21	29	29	fluorescein	San	PA164746009	80218	0.407
NULL	Lancet_2011_Dec_17_378(9809)_2081-2087.nxml.txt.nlp	22036019	SENT217	34	34	17	17	aspirin	HNPCC	PA448497	4436;4292	0.407
NULL	J_Cardiothorac_Surg_2012_Dec_7_7_127.nxml.txt.nlp	23217122	SENT58	16	16	22	22	heparin	ACT	PA449855	12;11332;9457;641455	0.407
NULL	Neuropsychologia_2012_Nov_50(13)_3156-3168.nxml.txt.nlp	22884957	SENT160	21	21	23	23	scopolamine	spatial	PA451308	219793	0.407
NULL	Case_Rep_Med_2010_Dec_26_2010_403237.nxml.txt.nlp	21209804	SENT66	3	3	5	5	bortezomib	CHOP	PA10252	1649	0.407
NULL	Leukemia_2014_Apr_14_28(4)_961-964.nxml.txt.nlp	24418991	SENT21	22	22	24	24	nilotinib	P-gp	PA165958345	5243	0.407
NULL	Orthop_Rev_(Pavia)_2012_Sep_4_4(3)_e29.nxml.txt.nlp	23066497	SENT109	6	6	9	9	ibandronate	PTH	PA10270	5741	0.407
NULL	AIDS_Behav_2012_Feb_30_16(2)_396-403.nxml.txt.nlp	21190073	SENT21	3	3	18	18	methamphetamine	San	PA450403	80218	0.407
NULL	Acta_Orthop_2014_Aug_14_85(4)_368-374.nxml.txt.nlp	24875058	SENT187	23	23	13	13	nitrogen	gamma	PA450643	9913	0.407
NULL	Open_Cardiovasc_Med_J_2009_Jun_16_3_57-68.nxml.txt.nlp	19572030	SENT134	19	19	9	9	ezetimibe	SHARP	PA10816	23013	0.407
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_May_3_64(Pt_6)_o960.nxml.txt.nlp	21202690	SENT4	11	11	13	13	ethanol	mol	PA448073	90527	0.407
NULL	Diabetes_Care_2009_Sep_28_32(9)_1649-1655.nxml.txt.nlp	19478198	SENT20	5	5	2	2	glucose	GIP	PA449773	114897;2771;2695	0.407
NULL	Oncotarget_2011_Dec_20_2(12)_1075-1093.nxml.txt.nlp	22185818	SENT123	21	21	23	23	doxorubicin	ANXA2	PA449412	302	0.407
NULL	Carcinogenesis_2013_Nov_10_34(11)_2580-2586.nxml.txt.nlp	23843037	SENT372	4	4	6	6	mesalazine	c-Myc	PA450384	4609	0.407
NULL	J_Hematol_Oncol_2010_Oct_31_3_43.nxml.txt.nlp	21034513	SENT175	0	0	17	17	oxaliplatin	p53	PA131285527	7157	0.407
NULL	J_Adv_Pharm_Technol_Res_2012_Jul-Sep_3(3)_182-187.nxml.txt.nlp	23057005	SENT173	9	9	47	47	orlistat	Tech	PA164776864	57449	0.407
NULL	Acta_Pharmacol_Sin_2010_Feb_21_31(2)_145-149.nxml.txt.nlp	20023694	SENT18	16	16	33	33	vasopressin	SON	PA451858	6651	0.407
NULL	Br_J_Cancer_1998_Apr_77(7)_1149-1154.nxml.txt.nlp	9569054	SENT0	15	15	26	26	cisplatin	GM-CSF	PA449014	1437	0.407
NULL	Cancer_Cell_Int_2013_Nov_14_13_114.nxml.txt.nlp	24228711	SENT15	5	5	7	7	cisplatin	DDP	PA449014	1678	0.407
NULL	Cases_J_2009_Jun_17_2_7246.nxml.txt.nlp	19829938	SENT65	10	10	22	22	iron	UROD	PA450087	7389	0.407
NULL	Mol_Cancer_2013_Apr_22_12_29.nxml.txt.nlp	23601052	SENT62	34	34	25	25	hydroxyurea	ORC2	PA449942	4999	0.406
NULL	Oncotarget_2013_Dec_28_5(6)_1475-1490.nxml.txt.nlp	24721996	SENT118	3	3	12	12	celecoxib	CD44	PA448871	960	0.406
NULL	Clin_Med_Insights_Oncol_2011_Nov_7_5_349-364.nxml.txt.nlp	22174596	SENT177	8	8	12	12	pazopanib	VEGFR	PA165291492	3791	0.406
NULL	Cell_Mol_Life_Sci_2013_Aug_10_70(15)_2713-2741.nxml.txt.nlp	23138638	SENT586	20	20	1	1	tipifarnib	HGPS	PA165110778	4000;10269;64221	0.406
NULL	J_Biol_Chem_2012_Apr_27_287(18)_14644-14658.nxml.txt.nlp	22375002	SENT210	25	25	36	36	forskolin	EGF	PA146096022	1950	0.406
NULL	Front_Neuroendocrinol_2012_Jan_33(1)_45-66.nxml.txt.nlp	21802439	SENT693	10	10	4	4	vasopressin	CXCL12	PA451858	6387	0.406
NULL	Cell_Death_Dis_2013_Oct_3_4(10)_e827.nxml.txt.nlp	24091670	SENT35	11	11	32	32	everolimus	CD38	PA164746311	952	0.406
NULL	Arthritis_Res_Ther_2003_Feb_14_5(2)_94-103.nxml.txt.nlp	12718749	SENT249	6	6	9	9	hyaluronan	BEHAB	PA165958431	63827	0.406
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT105	12	12	8	8	trastuzumab	MUC1	PA451743	4582	0.406
NULL	Br_J_Cancer_2014_Nov_11_111(10)_1888-1898.nxml.txt.nlp	25025958	SENT113	8	8	11	11	everolimus	HER2	PA164746311	2064	0.406
NULL	J_Cell_Biol_1998_Aug_10_142(3)_763-774.nxml.txt.nlp	9700164	SENT67	18	18	24	24	galactose	GAL4	PA449725	3960	0.406
NULL	Case_Rep_Pathol_2013_Jul_14_2013_198643.nxml.txt.nlp	23936709	SENT73	35	35	37	37	thyroglobulin	PTH	PA164754910	5741	0.406
NULL	Iran_J_Pharm_Res_2014_Autumn_13(4)_1369-1378.nxml.txt.nlp	25587326	SENT161	5	5	19	19	ethanol	IL-6	PA448073	3569	0.406
NULL	Mar_Drugs_2012_Aug_22_10(8)_1852-1872.nxml.txt.nlp	23015777	SENT18	17	17	19	19	melphalan	TNF	PA450354	7124	0.406
NULL	Arthritis_Res_Ther_2012_Aug_3_14(4)_R179.nxml.txt.nlp	22863285	SENT120	18	18	34	34	collagenase	IL-6	PA449107	3569	0.406
NULL	Br_J_Cancer_2003_Mar_10_88(5)_788-795.nxml.txt.nlp	12618891	SENT164	3	3	5	5	bosentan	FasL	PA10034	356	0.406
NULL	Environ_Health_Perspect_2010_Dec_12_118(12)_1707-1713.nxml.txt.nlp	20705543	SENT15	28	28	2	2	paclitaxel	XRCC1	PA450761	7515	0.406
NULL	J_Cell_Biol_2001_Aug_6_154(3)_485-490.nxml.txt.nlp	11489912	SENT296	12	12	6	6	glutaraldehyde	COX	PA449777	1351	0.406
NULL	F1000Res_2013_Oct_29_2_229.nxml.txt.nlp	25339983	SENT625	18	18	31	31	collagenase	AP-1	PA449107	2353;3727;2354;3725	0.406
NULL	Drug_Des_Devel_Ther_2014_Oct_31_8_2121-2128.nxml.txt.nlp	25382970	SENT123	12	12	2	2	curcumin	TTR	PA151958596	7276	0.406
NULL	Exp_Ther_Med_2014_Nov_29_8(5)_1473-1478.nxml.txt.nlp	25289044	SENT180	10	10	7	7	heparin	AZU	PA449855	566	0.406
NULL	Onco_Targets_Ther_2014_Nov_21_7_2143-2146.nxml.txt.nlp	25473295	SENT3	13	13	35	35	leucovorin	UGT	PA450198	7361;7355	0.406
NULL	Cancer_Microenviron_2008_Dec_20_1(1)_103-111.nxml.txt.nlp	19308689	SENT226	25	25	28	28	thrombin	PAR-1	PA451674	2011;2149	0.406
NULL	Cancers_(Basel)_2013_Nov_1_5(4)_1379-1412.nxml.txt.nlp	24202450	SENT1346	1	1	8	8	gemcitabine	CD11b	PA449748	3684	0.406
NULL	Pain_Res_Treat_2012_Aug_29_2012_898347.nxml.txt.nlp	22973509	SENT220	9	9	21	21	duloxetine	PLB	PA10066	151056	0.406
NULL	Biochem_Biophys_Res_Commun_2010_Feb_26_393(1)_50-54.nxml.txt.nlp	20100462	SENT39	28	28	12	12	tetracycline	TRPC5	PA451640	7224	0.406
NULL	J_Gastroenterol_2014_Mar_30_49(3)_492-501.nxml.txt.nlp	23543311	SENT239	9	9	18	18	ribavirin	IL28B	PA451241	282617	0.406
NULL	Diabetes_2009_Mar_58(3)_543-549.nxml.txt.nlp	19073775	SENT239	35	35	32	32	l-arginine	MELAS	PA448478	4219	0.406
NULL	Subst_Abuse_Rehabil_2011_May_15_2_89-102.nxml.txt.nlp	21743792	SENT356	43	43	2	2	methamphetamine	TOB	PA450403	10140	0.406
NULL	Scientifica_(Cairo)_2012_Jul_28_2012_723678.nxml.txt.nlp	24278735	SENT140	26	26	9	9	warfarin	CYP2C9	PA451906	1559	0.406
NULL	J_Carcinog_2014_Feb_7_13_2.nxml.txt.nlp	24737950	SENT201	30	30	33	33	oxygen	ROS	PA450744	6098	0.406
NULL	Crit_Care_2009_Jul_22_13(4)_169.nxml.txt.nlp	19664189	SENT39	3	3	0	0	vasopressin	AVP	PA451858	114548;551	0.406
NULL	Afr_J_Infect_Dis_2010_4(2)_29-42.nxml.txt.nlp	23878698	SENT7	17	17	26	26	artemisinin	ACT	PA165111696	12;11332;9457;641455	0.406
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT84	0	0	6	6	doxorubicin	B7-H1	PA449412	29126	0.406
NULL	Curr_Clin_Pharmacol_2013_May_8(2)_135-155.nxml.txt.nlp	23062036	SENT218	8	8	36	36	tamoxifen	SRC3	PA451581	8202	0.406
NULL	J_Biol_Chem_2008_Dec_12_283(50)_34966-34975.nxml.txt.nlp	18940810	SENT45	15	15	11	11	fluorescein	DTNB	PA164746009	1838	0.406
NULL	Front_Behav_Neurosci_2011_Oct_5_5_63.nxml.txt.nlp	22007164	SENT1263	8	8	4	4	sr144528	CB2		1269	0.406
NULL	Exp_Hematol_Oncol_2012_Dec_10_1_39.nxml.txt.nlp	23227903	SENT95	3	3	31	31	clofarabine	CR1	PA164754863	1378	0.405
NULL	Diabetes_Metab_Syndr_Obes_2014_Jun_24_7_229-239.nxml.txt.nlp	25018644	SENT59	5	5	2	2	exenatide	GLP-1	PA164749238	100125288	0.405
NULL	Int_J_Endocrinol_Metab_2013_Jul_1_Summer_11(3)_184-190.nxml.txt.nlp	24348591	SENT126	0	0	4	4	liraglutide	INS-1	PA165958364	2305	0.405
NULL	Contemp_Clin_Dent_2011_Oct-Dec_2(4)_278-282.nxml.txt.nlp	22346152	SENT94	9	9	6	6	potassium	GCF	PA451047	6936	0.405
NULL	Br_J_Cancer_2014_Jul_15_111(2)_375-385.nxml.txt.nlp	24892448	SENT169	7	7	14	14	nadh	MCT-1	PA164755085	28985	0.405
NULL	Cancer_Cell_Int_2009_Aug_18_9_23.nxml.txt.nlp	19689790	SENT244	0	0	5	5	hyperforin	TRPC6	PA165985514	7225	0.405
NULL	Breast_Cancer_Res_Treat_2012_Jul_31_134(1)_199-205.nxml.txt.nlp	22290080	SENT31	15	15	10	10	cetuximab	EGF	PA10040	1950	0.405
NULL	Arthritis_Res_Ther_2014_Jul_24_16(4)_R157.nxml.txt.nlp	25059342	SENT175	6	6	3	3	bleomycin	IL-6	PA448645	3569	0.405
NULL	Int_J_Endocrinol_2011_Dec_20_2011_746482.nxml.txt.nlp	22216029	SENT265	48	48	14	14	nifedipine	K60	PA450631	3576	0.405
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT348	12	12	21	21	cisplatin	DR5	PA449014	8795	0.405
NULL	Biochemistry_2013_Dec_23_52(51)_9269-9274.nxml.txt.nlp	24358934	SENT39	10	10	16	16	lopinavir	p24	PA450264	11261;140767	0.405
NULL	Calcif_Tissue_Int_2011_Aug_3_89(2)_140-150.nxml.txt.nlp	21633782	SENT247	6	6	8	8	heparin	FGF23	PA449855	8074	0.405
NULL	Ther_Clin_Risk_Manag_2006_Sep_2(3)_281-295.nxml.txt.nlp	18360603	SENT173	4	4	32	32	risedronate	NNT	PA451255	23530	0.405
NULL	Oncogenesis_2014_May_12_3(5)_e102.nxml.txt.nlp	24819061	SENT72	9	9	1	1	nadh	p53	PA164755085	7157	0.405
NULL	Neural_Develop_2007_Dec_3_2_26.nxml.txt.nlp	18053187	SENT407	4	4	23	23	tamoxifen	E16	PA451581	8140	0.405
NULL	Brain_Res_2013_Jul_12_1521(100)_1-15.nxml.txt.nlp	22789905	SENT275	0	0	4	4	colchicine	P-gp	PA449092	5243	0.405
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT105	6	6	1	1	methotrexate	MSH2	PA450428	4436	0.405
NULL	Cardiovasc_Res_2011_Apr_1_90(1)_140-147.nxml.txt.nlp	21071431	SENT32	0	0	7	7	resveratrol	DPI		1832	0.405
NULL	Neural_Plast_2012_May_31_2012_456478.nxml.txt.nlp	22701806	SENT161	2	2	9	9	salbutamol	SMN2	PA448068	6607	0.405
NULL	J_Mol_Signal_2010_May_10_5_4.nxml.txt.nlp	20459745	SENT113	0	0	4	4	cisplatin	p53	PA449014	7157	0.405
NULL	Cardiovasc_Diabetol_2006_Aug_30_5_17.nxml.txt.nlp	16939660	SENT105	2	2	4	4	metformin	IL-6	PA450395	3569	0.405
NULL	Fibrogenesis_Tissue_Repair_2011_Feb_1_4_4.nxml.txt.nlp	21284856	SENT246	10	10	25	25	bleomycin	CCN2	PA448645	1490	0.405
NULL	Cancer_Cell_Int_2011_Apr_7_11_8.nxml.txt.nlp	21473769	SENT28	8	8	11	11	oxygen	ROS	PA450744	6098	0.405
NULL	Int_J_Biol_Sci_2014_Aug_23_10(8)_921-939.nxml.txt.nlp	25170305	SENT279	19	19	14	14	nadh	EPO	PA164755085	7076;8288;2056	0.405
NULL	Biochemistry_2013_Oct_15_52(41)_7167-7169.nxml.txt.nlp	24083983	SENT38	14	14	18	18	cyclosporine	P-gp	PA449167	5243	0.405
NULL	N_Am_J_Med_Sci_2013_Mar_5(3)_207-212.nxml.txt.nlp	23626957	SENT34	20	20	23	23	oxygen	ROS	PA450744	6098	0.405
NULL	Pharmacogn_Rev_2010_Jan-Jun_4(7)_42-48.nxml.txt.nlp	22228940	SENT91	16	16	28	28	glucose	STZ	PA449773	6484	0.405
NULL	Nature_2012_Aug_16_488(7411)_394-398.nxml.txt.nlp	22810587	SENT186	21	21	41	41	candesartan	apelin	PA448765	8862	0.405
NULL	Clin_Interv_Aging_2009_Jun_29_4_289-303.nxml.txt.nlp	19750231	SENT72	14	14	24	24	pamidronate	NNT	PA450767	23530	0.405
NULL	Arthritis_Res_Ther_2005_Oct_18_7(6)_R1412-R1420.nxml.txt.nlp	16277694	SENT49	6	6	18	18	fluorescein	San	PA164746009	80218	0.405
NULL	Pharmaceuticals_(Basel)_2013_Nov_11_6(11)_1429-1450.nxml.txt.nlp	24287465	SENT279	11	11	9	9	vismodegib	GLI2		2736	0.405
NULL	Comp_Hepatol_2005_Feb_8_4_2.nxml.txt.nlp	15701172	SENT255	13	13	23	23	ketoconazole	CYP3A	PA450146	1574	0.405
NULL	Bioinformation_2012_Nov_23_8(23)_1132-1138.nxml.txt.nlp	23275709	SENT70	16	16	8	8	tamoxifen	BRCA2	PA451581	675	0.405
NULL	Case_Rep_Oncol_2014_Sep_27_7(3)_681-684.nxml.txt.nlp	25408663	SENT14	27	27	14	14	crizotinib	ALK	PA165946122	238	0.405
NULL	Autophagy_2013_Sep_1_9(9)_1418-1430.nxml.txt.nlp	23748697	SENT289	11	11	8	8	glucose	STS	PA449773	412	0.405
NULL	J_Cardiothorac_Surg_2013_May_13_8_127.nxml.txt.nlp	23668669	SENT142	3	3	5	5	oxycodone	EDA	PA450741	1896	0.405
NULL	Br_J_Cancer_1995_Jul_72(1)_35-40.nxml.txt.nlp	7599064	SENT12	0	0	21	21	trypsin	M-CSF	PA451806	1435	0.405
NULL	ScientificWorldJournal_2012_Apr_1_2012_491737.nxml.txt.nlp	22547985	SENT140	6	6	8	8	dasatinib	PP2	PA162372878	4888	0.405
NULL	Ann_Rheum_Dis_2013_Aug_21_72(8)_1287-1294.nxml.txt.nlp	22915624	SENT8	13	13	15	15	abatacept	MRI	PA164747080	78996	0.405
NULL	Algorithms_Mol_Biol_2010_Jul_15_5_29.nxml.txt.nlp	20633297	SENT233	26	26	29	29	rolipram	PDE4B	PA153906323	5142	0.404
NULL	Oncotarget_2014_May_27_5(19)_9049-9064.nxml.txt.nlp	24979294	SENT269	13	13	21	21	phenol	FBS	PA450913	64319;26269	0.404
NULL	Diabetes_Metab_Syndr_Obes_2014_Jul_17_7_313-319.nxml.txt.nlp	25092992	SENT117	6	6	3	3	pioglitazone	adiponectin	PA450970	9370	0.404
NULL	Curr_Chem_Genomics_2009_Mar_17_3_7-12.nxml.txt.nlp	19936037	SENT111	0	0	2	2	forskolin	NKH	PA146096022	275;2731	0.404
NULL	Aging_(Albany_NY)_2009_Oct_13_1(10)_842-844.nxml.txt.nlp	20157556	SENT26	14	14	17	17	doxorubicin	p53	PA449412	7157	0.404
NULL	Exp_Hematol_2014_Dec_42(12)_1053-1058_e1.nxml.txt.nlp	25127743	SENT16	0	0	9	9	potassium	KCNE2	PA451047	9992	0.404
NULL	Apoptosis_2013_Jul_31_18(12)_1447-1468.nxml.txt.nlp	23900974	SENT469	21	21	13	13	lapatinib	FGFR2	PA152241907	2263	0.404
NULL	Breast_Cancer_Res_2003_Jul_28_5(5)_276-279.nxml.txt.nlp	12927039	SENT18	24	24	7	7	tamoxifen	STAR	PA451581	6770;2984	0.404
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT272	1	1	15	15	resveratrol	ROS		6098	0.404
NULL	Cell_Death_Dis_2014_Jul_17_5(7)_e1338.nxml.txt.nlp	25032861	SENT144	8	8	10	10	pp2	EGF		1950	0.404
NULL	Extremophiles_2009_Sep_5_13(5)_769-783.nxml.txt.nlp	19579003	SENT323	12	12	21	21	lipase	PIR	PA450239	8544	0.404
NULL	J_Exp_Bot_2012_Mar_15_63(5)_1969-1983.nxml.txt.nlp	22174442	SENT282	20	20	14	14	l-alanine	mol	PA448055	90527	0.404
NULL	Indian_J_Med_Res_2011_Sep_134(3)_295-301.nxml.txt.nlp	21985811	SENT106	21	21	18	18	phenytoin	CYP2C9	PA450947	1559	0.404
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Nov_23_69(Pt_12)_o1804-o1805.nxml.txt.nlp	24860293	SENT75	38	38	32	32	nitrile	TLC	PA450636	3933	0.404
NULL	Mediators_Inflamm_2001_Oct_10(5)_253-258.nxml.txt.nlp	11759109	SENT3	27	27	19	19	ribavirin	IFN	PA451241	3439	0.404
NULL	ACS_Chem_Biol_2011_Feb_18_6(2)_169-175.nxml.txt.nlp	20886892	SENT216	25	25	13	13	indomethacin	AKR1C3	PA449982	8644	0.404
NULL	Int_J_Endocrinol_2014_Apr_3_2014_794943.nxml.txt.nlp	24803929	SENT151	23	23	25	25	thyroglobulin	CRP	PA164754910	1401;140913	0.404
NULL	Cancer_2014_Jun_15_120(12)_1871-1880.nxml.txt.nlp	24634003	SENT65	43	43	45	45	sunitinib	IFN	PA162372840	3439	0.404
NULL	Addict_Sci_Clin_Pract_2014_May_22_9(1)_8.nxml.txt.nlp	24886786	SENT23	35	35	20	20	methamphetamine	San	PA450403	80218	0.404
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2619-2628.nxml.txt.nlp	24129235	SENT286	30	30	2	2	irinotecan	GEM	PA450085	2669	0.404
NULL	BMJ_Qual_Saf_2011_Apr_20(Suppl_1)_i67-i68.nxml.txt.nlp	21450776	SENT21	23	23	1	1	zidovudine	San	PA451954	80218	0.404
NULL	Drug_Des_Devel_Ther_2014_Sep_9_8_1307-1314.nxml.txt.nlp	25246772	SENT148	4	4	7	7	cyclosporine	HTX	PA449167	7547	0.404
NULL	Int_J_Endocrinol_Metab_2013_Jul_1_Summer_11(3)_184-190.nxml.txt.nlp	24348591	SENT115	21	21	23	23	liraglutide	INS-1	PA165958364	2305	0.404
NULL	Clin_Pharmacokinet_2014_Sep_3_53(1)_1-16.nxml.txt.nlp	23999929	SENT88	29	29	15	15	rivaroxaban	CYP3A4	PA165958360	1576	0.404
NULL	Clin_Med_Insights_Endocrinol_Diabetes_2011_Jan_12_4_1-12.nxml.txt.nlp	22879789	SENT93	15	15	33	33	saxagliptin	GLP-1	PA165958362	100125288	0.404
NULL	Int_J_Mol_Sci_2014_Jun_17_15(6)_10950-10973.nxml.txt.nlp	24941255	SENT227	4	4	21	21	ethanol	PHB	PA448073	5245	0.404
NULL	J_Cardiothorac_Surg_2014_Feb_17_9_35.nxml.txt.nlp	24533613	SENT172	10	10	17	17	heparin	ACT	PA449855	12;11332;9457;641455	0.404
NULL	Crit_Care_2010_Nov_5_14(6)_R200.nxml.txt.nlp	21054850	SENT186	41	41	0	0	vasopressin	AVP	PA451858	114548;551	0.404
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_May_2_68(Pt_6)_o1584.nxml.txt.nlp	22719395	SENT76	11	11	7	7	coumarin	mol	PA134521193	90527	0.404
NULL	Biomed_Res_Int_2013_Aug_13_2013_659254.nxml.txt.nlp	24000324	SENT20	7	7	11	11	decitabine	DAC	PA164749631	13	0.404
NULL	Angiogenesis_2012_Sep_27_15(3)_361-376.nxml.txt.nlp	22451299	SENT205	7	7	10	10	oxygen	ROS	PA450744	6098	0.404
NULL	J_Immunother_Cancer_2014_Aug_19_2_27.nxml.txt.nlp	25324973	SENT58	17	17	20	20	vindesine	IFN	PA10232	3439	0.404
NULL	Ann_Oncol_2011_Mar_8_22(3)_503-514.nxml.txt.nlp	20616198	SENT299	6	6	10	10	aminoglutethimide	aromatase	PA448375	1588	0.404
NULL	Front_Oncol_2013_Nov_18_3_282.nxml.txt.nlp	24303367	SENT640	5	5	12	12	gemcitabine	Gem	PA449748	51053	0.404
NULL	J_Inherit_Metab_Dis_2010_Oct_2_33(5)_469-477.nxml.txt.nlp	20195903	SENT132	28	28	21	21	lipase	ACTH	PA450239	5443	0.404
NULL	Int_J_Mol_Sci_2014_May_9_15(5)_8256-8279.nxml.txt.nlp	24821544	SENT678	22	22	29	29	choline	ANOVA	PA448976	4858	0.404
NULL	Indian_J_Anaesth_2010_Jul-Aug_54(4)_355-356.nxml.txt.nlp	20882187	SENT10	22	22	17	17	vecuronium	ETO	PA164748865	862	0.404
NULL	Mol_Brain_2013_Aug_19_6_37.nxml.txt.nlp	23958294	SENT252	28	28	30	30	l-glutamine	B27	PA10090	56246	0.404
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_15_2012_726025.nxml.txt.nlp	23118796	SENT140	26	26	29	29	oxygen	ROS	PA450744	6098	0.404
NULL	Mol_Pain_2012_Sep_15_8_69.nxml.txt.nlp	22978421	SENT467	19	19	25	25	riluzole	mol	PA451251	90527	0.404
NULL	Case_Rep_Oncol_Med_2013_Jul_1_2013_793927.nxml.txt.nlp	23936700	SENT74	7	7	3	3	ifosfamide	CTX	PA449964	1593	0.404
NULL	EMBO_Mol_Med_2013_Jun_24_5(6)_904-918.nxml.txt.nlp	23703906	SENT206	3	3	16	16	nadh	Miner1	PA164755085	493856	0.404
NULL	Case_Rep_Ophthalmol_Med_2014_Oct_27_2014_326957.nxml.txt.nlp	25400961	SENT40	5	5	29	29	sulfacetamide	BID	PA451536	637	0.404
NULL	Clin_Infect_Dis_2014_Apr_1_58(7)_928-936.nxml.txt.nlp	24399087	SENT86	32	32	2	2	tenofovir	API	PA10204	5345	0.404
NULL	Appl_Microbiol_Biotechnol_2014_Feb_18_98(8)_3829-3840.nxml.txt.nlp	24535257	SENT8	15	15	18	18	ethanol	CAT-1	PA448073	6541	0.404
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT268	13	13	18	18	paclitaxel	SLK	PA450761	9748;2534	0.404
NULL	Ann_Gen_Psychiatry_2010_Jun_24_9_27.nxml.txt.nlp	20573264	SENT0	18	18	1	1	tropisetron	Gen	PA161925594	348654	0.404
NULL	Hum_Mol_Genet_2012_May_1_21(9)_2111-2123.nxml.txt.nlp	22286170	SENT249	17	17	10	10	l-glutamine	CO2	PA10090	4513	0.404
NULL	Antimicrob_Agents_Chemother_2014_Nov_10_59(1)_490-497.nxml.txt.nlp	25385107	SENT150	17	17	3	3	sulfadiazine	ATV	PA451539	4683	0.403
NULL	Curr_Pain_Headache_Rep_2011_Aug_12_15(4)_271-279.nxml.txt.nlp	21479998	SENT36	16	16	7	7	tramadol	CYP2D6	PA451735	1565	0.403
NULL	Oxid_Med_Cell_Longev_2013_Sep_17_2013_521563.nxml.txt.nlp	24163720	SENT229	43	43	28	28	vasopressin	HO-1	PA451858	3162	0.403
NULL	Cell_Death_Dis_2012_Jul_5_3(7)_e340.nxml.txt.nlp	22764099	SENT76	26	26	11	11	desipramine	SMPD3	PA449233	55512	0.403
NULL	J_Skin_Cancer_2012_Jun_13_2012_410925.nxml.txt.nlp	22745913	SENT100	24	24	28	28	lipase	SERPINF2	PA450239	5345	0.403
NULL	Arthritis_Res_Ther_2008_Dec_1_10(6)_R139.nxml.txt.nlp	19046432	SENT214	0	0	24	24	rosiglitazone	AP-1	PA451283	2353;3727;2354;3725	0.403
NULL	Biomed_Res_Int_2014_Feb_6_2014_323594.nxml.txt.nlp	24689036	SENT237	23	23	13	13	raloxifene	EGFR	PA451221	1956	0.403
NULL	Oxid_Med_Cell_Longev_2013_Nov_14_2013_680545.nxml.txt.nlp	24349614	SENT23	37	37	40	40	oxygen	ROS	PA450744	6098	0.403
NULL	Aging_(Albany_NY)_2010_Apr_30_2(4)_183-184.nxml.txt.nlp	20436227	SENT7	8	8	22	22	dextran	IL-10	PA449261	3586	0.403
NULL	Biotechnol_Res_Int_2013_Dec_1_2013_253286.nxml.txt.nlp	24363937	SENT101	20	20	1	1	ethanol	DAP	PA448073	23549;3375;1611	0.403
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Aug_17_67(Pt_9)_o2351.nxml.txt.nlp	22058967	SENT78	0	0	7	7	tramadol	mol	PA451735	90527	0.403
NULL	Sci_Rep_2015_Jan_6_5_7641.nxml.txt.nlp	25560734	SENT91	9	9	6	6	tamoxifen	CLTC	PA451581	1213	0.403
NULL	J_Gen_Physiol_1984_Mar_1_83(3)_341-369.nxml.txt.nlp	6325586	SENT0	17	17	1	1	amiloride	Gen	PA448368	348654	0.403
NULL	J_Hematol_Oncol_2014_Aug_1_7_52.nxml.txt.nlp	25085632	SENT164	3	3	16	16	sunitinib	KRAS	PA162372840	3845	0.403
NULL	Braz_J_Med_Biol_Res_2014_Oct_14_47(12)_1062-1067.nxml.txt.nlp	25387673	SENT89	18	18	8	8	propofol	IL-6	PA451141	3569	0.403
NULL	Cardiovasc_Drugs_Ther_2013_Feb_29_27(1)_61-68.nxml.txt.nlp	23274937	SENT143	20	20	16	16	nadh	MCU	PA164755085	90550	0.403
NULL	J_Carcinog_2011_Jul_19_10_17.nxml.txt.nlp	21799661	SENT244	12	12	20	20	metformin	Met	PA450395	79811	0.403
NULL	Indian_J_Ophthalmol_2009_Mar-Apr_57(2)_91-97.nxml.txt.nlp	19237780	SENT171	10	10	18	18	cyclophosphamide	CHOP	PA449165	1649	0.403
NULL	Korean_J_Anesthesiol_2013_Jan_21_64(1)_47-53.nxml.txt.nlp	23372886	SENT91	8	8	14	14	bupivacaine	PTG	PA135057240	5507	0.403
NULL	J_Hematol_Oncol_2012_Jun_18_5_31.nxml.txt.nlp	22709792	SENT134	4	4	8	8	lapatinib	HER2	PA152241907	2064	0.403
NULL	Cancer_Metastasis_Rev_2010_Dec_10_29(4)_581-594.nxml.txt.nlp	20830503	SENT367	21	21	24	24	tamoxifen	ARNO	PA451581	9266	0.403
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Aug_14_69(Pt_9)_o1414-o1415.nxml.txt.nlp	24427050	SENT8	1	1	3	3	ethanol	mol	PA448073	90527	0.403
NULL	J_Exp_Med_1961_Oct_31_114(5)_761-778.nxml.txt.nlp	19867206	SENT6	30	30	24	24	nitrogen	ACTH	PA450643	5443	0.403
NULL	Angiogenesis_2012_Jun_3_15(2)_171-185.nxml.txt.nlp	22302382	SENT414	1	1	10	10	heparin	PlGF-2	PA449855	5228	0.403
NULL	Cancers_(Basel)_2010_Apr_13_2(2)_483-497.nxml.txt.nlp	24281078	SENT522	6	6	12	12	resveratrol	AP-1		2353;3727;2354;3725	0.403
NULL	Br_J_Haematol_2009_Nov_2_147(3)_396-410.nxml.txt.nlp	19758122	SENT13	10	10	13	13	chlorambucil	TP53	PA448926	7157	0.403
NULL	Cancer_Cell_Int_2013_May_16_13_44.nxml.txt.nlp	23680357	SENT29	18	18	35	35	zinc	ZEB2	PA451956	9839	0.403
NULL	Biomed_Res_Int_2013_Jul_21_2013_723129.nxml.txt.nlp	23971044	SENT134	1	1	4	4	oxygen	ROS	PA450744	6098	0.403
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Feb_17_68(Pt_3)_o700-o701.nxml.txt.nlp	22412590	SENT4	8	8	34	34	erythromycin	mol	PA449493	90527	0.402
NULL	Front_Synaptic_Neurosci_2014_Mar_18_6_4.nxml.txt.nlp	24672476	SENT974	0	0	5	5	ethanol	5-HT1A	PA448073	3350	0.402
NULL	Mol_Biol_Rep_2013_May_11_40(8)_5013-5026.nxml.txt.nlp	23666059	SENT154	24	24	12	12	resveratrol	p53		7157	0.402
NULL	Indian_J_Med_Paediatr_Oncol_2013_Jul-Sep_34(3)_224-228.nxml.txt.nlp	24516317	SENT43	8	8	5	5	imatinib	FOR	PA10804	51741	0.402
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_21-38.nxml.txt.nlp	19305786	SENT488	6	6	17	17	capsaicin	TRPM8	PA448776	79054	0.402
NULL	Mol_Clin_Oncol_2013_Sep_12_1(5)_911-917.nxml.txt.nlp	24649270	SENT34	22	22	11	11	doxorubicin	CHOP	PA449412	1649	0.402
NULL	Sci_Rep_2014_Dec_19_4_7571.nxml.txt.nlp	25524368	SENT39	8	8	5	5	estradiol	mer	PA449503	10461	0.402
NULL	N_Am_J_Med_Sci_2012_Dec_4(12)_638-640.nxml.txt.nlp	23272306	SENT6	18	18	5	5	pramlintide	GLP-1	PA164781394	100125288	0.402
NULL	Ann_Surg_Oncol_2011_Feb_4_18(2)_321-327.nxml.txt.nlp	21049306	SENT175	16	16	14	14	melphalan	TNF-alpha	PA450354	7124	0.402
NULL	Brain_Sci_2014_May_6_4(2)_356-375.nxml.txt.nlp	24961766	SENT199	18	18	10	10	propofol	GAPDH	PA451141	2597	0.402
NULL	Br_J_Pharmacol_2008_Sep_9_155(1)_127-137.nxml.txt.nlp	18536750	SENT176	16	16	14	14	piroxicam	IL-10	PA450985	3586	0.402
NULL	Sci_Rep_2014_Dec_19_4_7571.nxml.txt.nlp	25524368	SENT37	9	9	6	6	estradiol	mer	PA449503	10461	0.402
NULL	Iran_J_Public_Health_2013_Jan_1_42(Supple1)_50-54.nxml.txt.nlp	23865016	SENT136	20	20	15	15	voriconazole	MAX	PA10233	4149	0.402
NULL	Int_J_Nanomedicine_2012_May_7_7_2307-2314.nxml.txt.nlp	22661887	SENT48	2	2	7	7	gemcitabine	F10	PA449748	2159	0.402
NULL	Prostate_Int_2014_Sep_21_2(3)_147-151.nxml.txt.nlp	25325027	SENT110	16	16	24	24	letrozole	FAST	PA450196	10922	0.402
NULL	J_Hematol_Oncol_2013_Feb_25_6_19.nxml.txt.nlp	23442817	SENT264	14	14	26	26	nadh	NDUFA4L2	PA164755085	56901	0.402
NULL	Int_J_Biol_Sci_2015_Jan_1_11(1)_48-58.nxml.txt.nlp	25552929	SENT166	31	31	28	28	paclitaxel	LDM	PA450761	1595	0.402
NULL	J_Mammary_Gland_Biol_Neoplasia_2012_Jun_1_17(2)_167-188.nxml.txt.nlp	22752723	SENT760	5	5	11	11	cabergoline	PRL	PA448708	5617	0.402
NULL	J_Immunol_Res_2014_Mar_5_2014_987678.nxml.txt.nlp	24741639	SENT81	13	13	46	46	paraformaldehyde	NeuN	PA450790	146713	0.402
NULL	Nat_Genet_2010_Mar_31_42(3)_268-271.nxml.txt.nlp	20101240	SENT58	7	7	11	11	artemisinin	ACT	PA165111696	12;11332;9457;641455	0.402
NULL	Ann_Rheum_Dis_2013_Aug_21_72(8)_1287-1294.nxml.txt.nlp	22915624	SENT20	17	17	5	5	abatacept	MRI	PA164747080	78996	0.402
NULL	J_Cancer_Prev_2014_Dec_19(4)_279-287.nxml.txt.nlp	25574463	SENT221	26	26	22	22	fluorescein	p65	PA164746009	5970	0.402
NULL	Eur_J_Clin_Pharmacol_2013_Mar_5_69(3)_467-475.nxml.txt.nlp	22864379	SENT247	11	11	22	22	warfarin	mol	PA451906	90527	0.402
NULL	Indian_J_Crit_Care_Med_2008_Oct-Dec_12(4)_181-189.nxml.txt.nlp	19742267	SENT200	18	18	14	14	anakinra	ACR	PA10799	49	0.402
NULL	Br_J_Cancer_2011_Apr_12_104(8)_1256-1261.nxml.txt.nlp	21448165	SENT101	6	6	8	8	sorafenib	IL-2	PA7000	3558	0.402
NULL	Breast_Cancer_Res_Treat_2014_Apr_9_145(1)_73-82.nxml.txt.nlp	24715380	SENT103	15	15	8	8	tamoxifen	CXCL10	PA451581	3627	0.402
NULL	Arthritis_Res_Ther_2011_Jun_21_13(3)_R98.nxml.txt.nlp	21693018	SENT34	6	6	8	8	tiludronate	TLN	PA451688	7087	0.402
NULL	Pharmacogn_Mag_2014_Jul-Sep_10(39)_374-383.nxml.txt.nlp	25210328	SENT138	14	14	26	26	evodiamine	PC1	PA165860788	5122	0.402
NULL	Subst_Abuse_Treat_Prev_Policy_2007_Oct_31_2_32.nxml.txt.nlp	17974020	SENT208	6	6	25	25	methamphetamine	NMU	PA450403	10874	0.402
NULL	J_Nucl_Cardiol_2010_Jun_18_17(3)_479-485.nxml.txt.nlp	20238193	SENT170	5	5	28	28	dobutamine	BEST	PA449381	7439	0.402
NULL	J_Inorg_Biochem_2014_Apr_133(100)_33-39.nxml.txt.nlp	24444821	SENT123	16	16	8	8	oxaliplatin	CH1	PA131285527	51430	0.402
NULL	Acta_Pharmacol_Sin_2009_Jan_8_30(1)_125-133.nxml.txt.nlp	19060917	SENT63	12	12	9	9	fluorescein	GK1	PA164746009	2710	0.402
NULL	Mol_Cancer_2009_May_15_8_28.nxml.txt.nlp	19445670	SENT8	38	38	12	12	doxorubicin	Bcl-2	PA449412	596	0.402
NULL	Int_J_Hypertens_2013_Feb_6_2013_382802.nxml.txt.nlp	23476746	SENT107	1	1	6	6	metoprolol	MDC	PA450480	6367	0.402
NULL	Anesth_Pain_Med_2014_Sep_9_4(4)_e14221.nxml.txt.nlp	25599022	SENT80	10	10	6	6	cisplatin	LPO	PA449014	4025	0.402
NULL	Head_Face_Med_2008_Feb_8_4_2.nxml.txt.nlp	18261212	SENT165	14	14	38	38	imiquimod	gamma	PA449972	9913	0.402
NULL	Oncotarget_2013_Dec_24_5(9)_2418-2427.nxml.txt.nlp	24810714	SENT53	18	18	25	25	cisplatin	NAC	PA449014	22861	0.402
NULL	Gene_Regul_Syst_Bio_2014_Mar_4_8_63-73.nxml.txt.nlp	24634581	SENT72	41	41	26	26	minocycline	U87	PA450519	677775;641648	0.402
NULL	J_Appl_Crystallogr_2010_Oct_1_43(Pt_5)_1189-1207.nxml.txt.nlp	22184476	SENT282	0	0	21	21	creatine	ADP	PA164778930	23038	0.402
NULL	Eur_J_Nucl_Med_Mol_Imaging_2008_Aug_29_35(8)_1544-1549.nxml.txt.nlp	18509637	SENT198	12	12	22	22	choline	FDG	PA448976	23583	0.402
NULL	Lipids_Health_Dis_2011_Jan_27_10_24.nxml.txt.nlp	21272342	SENT228	1	1	6	6	lipase	mol	PA450239	90527	0.402
NULL	J_Res_Med_Sci_2011_Jun_16(6)_763-769.nxml.txt.nlp	22091305	SENT43	36	36	22	22	hydroxyprogesterone	PRL	PA449932	5617	0.402
NULL	Neuropsychopharmacology_2009_Jul_11_34(8)_1946-1957.nxml.txt.nlp	19279569	SENT100	28	28	20	20	cocaine	DOR	PA449072	58476	0.401
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_16_2012_395912.nxml.txt.nlp	23118789	SENT75	9	9	38	38	diclofenac	UGT1A4	PA449293	54657	0.401
NULL	Br_J_Cancer_2011_Jul_26_105(3)_407-412.nxml.txt.nlp	21730976	SENT67	19	19	24	24	pha-665752	STAT3		6774	0.401
NULL	Mol_Brain_2014_Aug_12_7_58.nxml.txt.nlp	25112718	SENT415	23	23	8	8	cimetidine	E12	PA449001	64100	0.401
NULL	Int_J_Gen_Med_2012_Oct_25_5_849-859.nxml.txt.nlp	23204853	SENT178	40	40	42	42	hyaluronan	EDA	PA165958431	1896	0.401
NULL	Br_J_Cancer_2013_May_28_108(10)_2039-2044.nxml.txt.nlp	23652306	SENT86	17	17	20	20	tamoxifen	SRC3	PA451581	8202	0.401
NULL	Front_Neurosci_2013_Jan_10_6_191.nxml.txt.nlp	23335875	SENT1455	0	0	3	3	capsaicin	TRPV1	PA448776	7442	0.401
NULL	Indian_J_Pharm_Sci_2013_Nov-Dec_75(6)_707-715.nxml.txt.nlp	24591746	SENT42	0	0	3	3	gemcitabine	GEM	PA449748	2669	0.401
NULL	J_Gen_Physiol_1990_Sep_1_96(3)_473-491.nxml.txt.nlp	2230709	SENT0	11	11	1	1	phenol	Gen	PA450913	348654	0.401
NULL	Crit_Care_2011_Oct_27_15(Suppl_3)_P22.nxml.txt.nlp	NULL	SENT15	0	0	12	12	hyaluronan	IL-6	PA165958431	3569	0.401
NULL	Mar_Drugs_2011_Aug_10_9(8)_1346-1358.nxml.txt.nlp	21892349	SENT17	14	14	11	11	thrombin	ADP	PA451674	23038	0.401
NULL	Behav_Brain_Funct_2010_Aug_30_6_50.nxml.txt.nlp	20799992	SENT163	30	30	7	7	methamphetamine	ACE	PA450403	1636	0.401
NULL	Mol_Vis_2011_Mar_25_17_797-803.nxml.txt.nlp	21528000	SENT30	2	2	6	6	bevacizumab	San	PA130232992	80218	0.401
NULL	Am_J_Physiol_Cell_Physiol_2014_Jan_15_306(2)_C89-C97.nxml.txt.nlp	24133067	SENT53	25	25	9	9	hyaluronan	HAS3	PA165958431	3038	0.401
NULL	Pharmaceutics_2012_Jun_18_4(2)_314-333.nxml.txt.nlp	24300234	SENT265	14	14	32	32	l-glutamine	CO2	PA10090	4513	0.401
NULL	Exp_Hematol_Oncol_2013_Jul_1_2_17.nxml.txt.nlp	23815814	SENT72	12	12	8	8	doxorubicin	ABCB5	PA449412	340273	0.401
NULL	F1000Res_2014_Aug_19_3_198.nxml.txt.nlp	25400908	SENT285	10	10	21	21	cyclophosphamide	HER2	PA449165	2064	0.401
NULL	Amino_Acids_2011_Apr_14_40(4)_1077-1090.nxml.txt.nlp	20839016	SENT222	14	14	16	16	nadh	CO2	PA164755085	4513	0.401
NULL	Indian_J_Endocrinol_Metab_2012_Dec_16(Suppl_3)_S627-S636.nxml.txt.nlp	23565499	SENT184	25	25	27	27	vasopressin	OXT	PA451858	5020	0.401
NULL	Oxid_Med_Cell_Longev_2012_Aug_22_2012_534705.nxml.txt.nlp	22966415	SENT226	1	1	5	5	riluzole	GLAST	PA451251	6507	0.401
NULL	Int_J_Biol_Sci_2015_Jan_1_11(1)_48-58.nxml.txt.nlp	25552929	SENT42	15	15	24	24	paclitaxel	TSP-1	PA450761	7057	0.401
NULL	Clinics_(Sao_Paulo)_2014_Jul_69(7)_500-503.nxml.txt.nlp	25029584	SENT47	19	19	34	34	collagenase	CO2	PA449107	4513	0.401
NULL	Curr_Cardiol_Rev_2012_Aug_8(3)_239-249.nxml.txt.nlp	22935021	SENT9	38	38	34	34	thrombin	PAR-1	PA451674	2011;2149	0.401
NULL	Nucleic_Acids_Res_2005_Jun_9_33(10)_3323-3330.nxml.txt.nlp	15947132	SENT118	21	21	12	12	cisplatin	MSH2	PA449014	4436	0.401
NULL	J_Korean_Med_Sci_2013_Jun_3_28(6)_821-826.nxml.txt.nlp	23772144	SENT37	36	36	16	16	neomycin	CLCNKB	PA450608	1188	0.401
NULL	Med_Sci_Monit_2013_Oct_21_19_875-882.nxml.txt.nlp	24145180	SENT34	19	19	26	26	bevacizumab	FDG	PA130232992	23583	0.401
NULL	Biomed_Res_Int_2014_Jun_26_2014_161346.nxml.txt.nlp	25054130	SENT236	45	45	30	30	curcumin	STZ	PA151958596	6484	0.401
NULL	Nat_Med_2011_Nov_6_17(12)_1685-1691.nxml.txt.nlp	22057348	SENT66	1	1	4	4	oxygen	ROS	PA450744	6098	0.401
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jun_20_68(Pt_7)_o2151.nxml.txt.nlp	22798824	SENT4	20	20	22	22	ethanol	mol	PA448073	90527	0.401
NULL	Evid_Based_Complement_Alternat_Med_2011_Feb_14_2011_429843.nxml.txt.nlp	21869897	SENT180	5	5	3	3	ethanol	CORT	PA448073	1325	0.401
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Oct_17_65(Pt_11)_o2767.nxml.txt.nlp	21578361	SENT63	1	1	11	11	ethanol	mol	PA448073	90527	0.401
NULL	Mol_Cell_Biochem_2014_Oct_9_385(1-2)_265-275.nxml.txt.nlp	24104452	SENT196	11	11	13	13	bortezomib	U87	PA10252	677775;641648	0.401
NULL	Behav_Brain_Funct_2013_Nov_26_9_43.nxml.txt.nlp	24279870	SENT203	33	33	6	6	ethanol	ANOVA	PA448073	4858	0.401
NULL	Stud_Health_Technol_Inform_2013_192_62-66.nxml.txt.nlp	23920516	SENT131	19	19	0	0	cytarabine	DBM	PA449177	1621	0.401
NULL	Oncoscience_2014_Jan_30_1(1)_57-68.nxml.txt.nlp	25593988	SENT215	15	15	3	3	imatinib	TRAIL	PA10804	8743	0.401
NULL	J_Cancer_2013_Aug_28_4(7)_585-596.nxml.txt.nlp	24069069	SENT217	26	26	14	14	verteporfin	Gem	PA451871	51053	0.401
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT317	0	0	2	2	resveratrol	IL-6		3569	0.4
NULL	Breast_Cancer_Res_2012_Jun_19_14(3)_209.nxml.txt.nlp	22713170	SENT61	16	16	19	19	oxygen	ROS	PA450744	6098	0.4
NULL	Int_J_Mol_Sci_2014_Sep_23_15(9)_16975-16997.nxml.txt.nlp	25250913	SENT13	13	13	16	16	oxygen	ROS	PA450744	6098	0.4
NULL	Clinics_(Sao_Paulo)_2012_Jul_67(7)_805-813.nxml.txt.nlp	22892927	SENT70	18	18	42	42	paraformaldehyde	San	PA450790	80218	0.4
NULL	Biomed_Res_Int_2014_Jun_4_2014_237698.nxml.txt.nlp	24995276	SENT147	27	27	13	13	thalidomide	BTD	PA451644	686	0.4
NULL	Adv_Biomed_Res_2013_Jul_30_2_66.nxml.txt.nlp	24223381	SENT49	18	18	22	22	doxepin	Ray	PA449409	26751	0.4
NULL	Exp_Ther_Med_2014_Aug_6_8(2)_585-590.nxml.txt.nlp	25009624	SENT11	5	5	7	7	glucose	ROS	PA449773	6098	0.4
NULL	Mediators_Inflamm_1998_7(3)_195-199.nxml.txt.nlp	9705607	SENT7	12	12	29	29	forskolin	GM-CSF	PA146096022	1437	0.4
NULL	Exp_Transl_Stroke_Med_2010_Jul_20_2_14.nxml.txt.nlp	20646278	SENT0	14	14	26	26	potassium	TASK3	PA451047	51305	0.4
NULL	Endocr_Relat_Cancer_2014_Jun_21(3)_R209-R225.nxml.txt.nlp	24500760	SENT208	12	12	15	15	resveratrol	TRAMP		8718;23471;9189	0.4
NULL	Ecotoxicology_2012_Mar_30_21(2)_439-455.nxml.txt.nlp	22037694	SENT340	26	26	21	21	arsenite	AIRAP	PA452638	90637	0.4
NULL	Mol_Cancer_2014_Jan_13_13_7.nxml.txt.nlp	24418169	SENT239	0	0	5	5	sorafenib	STAT3	PA7000	6774	0.4
NULL	Clin_Ophthalmol_2009_Jun_2_3_291-295.nxml.txt.nlp	19668581	SENT3	28	28	35	35	latanoprost	BAK	PA164774763	578	0.4
NULL	Clin_Psychopharmacol_Neurosci_2013_Aug_26_11(2)_60-66.nxml.txt.nlp	24023549	SENT80	17	17	2	2	aripiprazole	ANOVA	PA10026	4858	0.4
NULL	Front_Behav_Neurosci_2014_Oct_30_8_366.nxml.txt.nlp	25400560	SENT154	7	7	1	1	ethanol	ANOVA	PA448073	4858	0.4
NULL	Diabetes_Care_2009_Aug_26_32(8)_1411-1417.nxml.txt.nlp	19470837	SENT144	6	6	19	19	glucose	PPG	PA449773	5552	0.4
NULL	Oncogene_2009_Dec_3_28(48)_4237-4248.nxml.txt.nlp	19734937	SENT102	22	22	24	24	collagenase	PAR-1	PA449107	2011;2149	0.4
NULL	Head_Face_Med_2006_May_25_2_15.nxml.txt.nlp	16725028	SENT120	21	21	33	33	amitriptyline	ANOVA	PA448385	4858	0.4
NULL	J_Inorg_Biochem_2014_Apr_133(100)_33-39.nxml.txt.nlp	24444821	SENT123	12	12	8	8	cisplatin	CH1	PA449014	51430	0.4
NULL	Pharmaceuticals_(Basel)_2014_Jan_9_7(1)_46-57.nxml.txt.nlp	24451403	SENT116	0	0	4	4	ritonavir	AKT	PA451260	207	0.4
NULL	Exp_Diabetes_Res_2012_Oct_17_2012_420854.nxml.txt.nlp	23118741	SENT120	3	3	11	11	ezetimibe	AKT	PA10816	207	0.4
NULL	Acta_Orthop_2014_Aug_14_85(4)_368-374.nxml.txt.nlp	24875058	SENT49	29	29	19	19	nitrogen	gamma	PA450643	9913	0.4
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT16	45	45	42	42	capsaicin	p53	PA448776	7157	0.4
NULL	Genome_Biol_2003_Jun_30_4(7)_221.nxml.txt.nlp	12844352	SENT21	6	6	3	3	glucose	GOX	PA449773	54363	0.4
NULL	J_Cell_Sci_2014_Mar_15_127(6)_1263-1278.nxml.txt.nlp	24424030	SENT211	21	21	17	17	doxycycline	TDP-43	PA449415	23435	0.4
NULL	Arthritis_Res_Ther_2009_Aug_17_11(4)_R123.nxml.txt.nlp	19686595	SENT215	37	37	27	27	rituximab	CD38	PA451261	952	0.4
NULL	Front_Neurol_2011_Feb_22_2_7.nxml.txt.nlp	21373206	SENT365	4	4	31	31	abciximab	FAST	PA448006	10922	0.4
NULL	Support_Care_Cancer_2014_Oct_19_22(2)_469-477.nxml.txt.nlp	24141698	SENT156	5	5	11	11	palonosetron	HEC	PA10352	10403	0.4
NULL	Ther_Clin_Risk_Manag_2006_Mar_2(1)_87-98.nxml.txt.nlp	18360584	SENT139	14	14	11	11	sorafenib	RDT	PA7000	6598	0.4
NULL	Nat_Commun_2014_Dec_17_5_5774.nxml.txt.nlp	25517944	SENT229	19	19	31	31	paraformaldehyde	HPC-1	PA450790	6804	0.4
NULL	Cancers_(Basel)_2012_Nov_29_4(4)_1252-1299.nxml.txt.nlp	24213506	SENT1075	1	1	4	4	hyaluronan	BEHAB	PA165958431	63827	0.4
NULL	Cell_Mol_Life_Sci_2011_Sep_5_68(18)_3081-3093.nxml.txt.nlp	21207103	SENT50	32	32	22	22	streptomycin	FBS	PA451512	64319;26269	0.4
NULL	Open_Med_Chem_J_2010_May_27_4_3-9.nxml.txt.nlp	20648222	SENT169	40	40	27	27	phencyclidine	San	PA128406980	80218	0.4
NULL	Exp_Diabetes_Res_2012_Oct_11_2012_941868.nxml.txt.nlp	22007193	SENT305	17	17	31	31	rosiglitazone	IL-6	PA451283	3569	0.4
NULL	Acta_Pharmacol_Sin_2010_Jul_28_31(7)_867-873.nxml.txt.nlp	20581857	SENT5	11	11	14	14	docetaxel	PC3	PA449383	57332;7832;5122	0.4
NULL	Arthritis_Res_2001_Sep_18_3(6)_381-388.nxml.txt.nlp	11714393	SENT161	12	12	8	8	collagenase	c-fos	PA449107	2353	0.4
NULL	Anat_Cell_Biol_2011_Sep_29_44(3)_169-175.nxml.txt.nlp	22025968	SENT65	19	19	26	26	ethanol	CLU	PA448073	1191	0.4
NULL	Adv_Ther_2014_Feb_20_31(3)_333-344.nxml.txt.nlp	24554346	SENT210	16	16	33	33	amlodipine	HYPE	PA448388	11153	0.4
NULL	Arthritis_Res_Ther_2007_Oct_19_9(Suppl_3)_P37.nxml.txt.nlp	NULL	SENT10	17	17	25	25	collagenase	CTNNB1	PA449107	1499	0.4
NULL	Mol_Vis_2012_Jun_20_18_1640-1648.nxml.txt.nlp	22773902	SENT26	19	19	30	30	oxygen	RPE	PA450744	6120	0.4
NULL	EMBO_Mol_Med_2013_Jun_30_5(6)_935-948.nxml.txt.nlp	23629957	SENT299	36	36	17	17	cisplatin	COL6A3	PA449014	1293	0.4
NULL	J_Hematol_Oncol_2008_Oct_1_1_16.nxml.txt.nlp	18828924	SENT117	7	7	17	17	tanespimycin	HER2	PA165291490	2064	0.4
NULL	Breast_Cancer_Res_2011_Mar_1_13(2)_R21.nxml.txt.nlp	21362200	SENT281	5	5	7	7	estradiol	PI3K	PA449503	5290	0.4
NULL	Nat_Genet_2010_Sep_15_42(9)_781-785.nxml.txt.nlp	20711177	SENT35	7	7	11	11	hyaluronan	HAS2	PA165958431	3037	0.4
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Aug_23_70(Pt_9)_142-144.nxml.txt.nlp	25309163	SENT7	14	14	16	16	ethanol	mol	PA448073	90527	0.4
NULL	J_Med_Chem_2014_Feb_13_57(3)_701-713.nxml.txt.nlp	24387159	SENT548	17	17	9	9	decitabine	IDH1	PA164749631	3417	0.4
NULL	Appl_Microbiol_Biotechnol_2013_Aug_16_97(18)_7999-8009.nxml.txt.nlp	23948723	SENT96	16	16	6	6	nadh	GAP	PA164755085	5921	0.399
NULL	Int_J_Mol_Sci_2014_Dec_10_15(12)_22887-22901.nxml.txt.nlp	25514242	SENT336	3	3	13	13	urokinase	LRP1	PA451836	10438;4035	0.399
NULL	Food_Dig_2012_Dec_7_3(1-3)_63-77.nxml.txt.nlp	23293684	SENT104	31	31	40	40	lipase	PLRP2	PA450239	5408	0.399
NULL	Curr_Neuropharmacol_2008_Jun_6(2)_151-163.nxml.txt.nlp	19305794	SENT147	15	15	5	5	kanamycin	TRPV1	PA450137	7442	0.399
NULL	Cell_Death_Dis_2013_Jun_27_4(6)_e694.nxml.txt.nlp	23807223	SENT51	21	21	45	45	chloroquine	JNK	PA448948	5599	0.399
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Sep_28_69(Pt_10)_m568-m569.nxml.txt.nlp	24098191	SENT7	1	1	3	3	ethanol	mol	PA448073	90527	0.399
NULL	Clin_Ophthalmol_2014_Feb_10_8_389-399.nxml.txt.nlp	24550667	SENT183	8	8	20	20	timolol	TIM	PA451690	7984;8914	0.399
NULL	J_Health_Popul_Nutr_2011_Feb_29(1)_39-52.nxml.txt.nlp	21528789	SENT47	30	30	15	15	glucose	ADA	PA449773	100	0.399
NULL	Br_J_Cancer_2012_May_8_106(10)_1689-1696.nxml.txt.nlp	22531631	SENT30	30	30	37	37	l-glutamine	CO2	PA10090	4513	0.399
NULL	Indian_J_Anaesth_2014_Jul-Aug_58(4)_423-429.nxml.txt.nlp	25197110	SENT8	14	14	24	24	ondansetron	ODF4	PA450705	146852	0.399
NULL	Mol_Cancer_2010_Nov_8_9_291.nxml.txt.nlp	21059223	SENT146	15	15	9	9	paclitaxel	Bcl-2	PA450761	596	0.399
NULL	Curr_Cardiol_Rev_2009_Aug_5(3)_196-202.nxml.txt.nlp	20676278	SENT34	3	3	12	12	hyaluronan	HMGB1	PA165958431	3146	0.399
NULL	Biomed_Res_Int_2014_May_18_2014_453707.nxml.txt.nlp	24955358	SENT283	15	15	19	19	colchicine	BAP	PA449092	64374	0.399
NULL	Arthritis_Res_Ther_2006_Nov_30_8(1)_R10.nxml.txt.nlp	16356198	SENT31	1	1	17	17	bleomycin	IL-8	PA448645	3576	0.399
NULL	Biomed_Eng_Online_2012_Nov_14_11_84.nxml.txt.nlp	23151049	SENT70	13	13	32	32	alendronate	PTH	PA448082	5741	0.399
NULL	Clin_Ophthalmol_2009_Jun_29_3_381-390.nxml.txt.nlp	19668594	SENT31	1	1	14	14	difluprednate	castor	PA165958405	54897	0.399
NULL	Arch_Med_Sci_2013_Oct_31_9(5)_916-921.nxml.txt.nlp	24273579	SENT15	3	3	0	0	bleomycin	AQP5	PA448645	362	0.399
NULL	Indian_Dermatol_Online_J_2014_Apr-Jun_5(2)_236-237.nxml.txt.nlp	24860779	SENT21	11	11	27	27	tretinoin	CO2	PA451746	4513	0.399
NULL	Breast_Cancer_Res_2011_Mar_1_13(2)_R21.nxml.txt.nlp	21362200	SENT310	14	14	9	9	fulvestrant	PIK3CA	PA164747170	5290	0.399
NULL	Int_J_Tryptophan_Res_2010_Jun_10_3_113-120.nxml.txt.nlp	22084593	SENT34	13	13	6	6	l-tryptophan	TDO	PA10323	6999	0.399
NULL	Part_Fibre_Toxicol_2011_Aug_2_8_23.nxml.txt.nlp	21810225	SENT272	26	26	29	29	oxygen	ROS	PA450744	6098	0.399
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_321-328.nxml.txt.nlp	21372824	SENT173	7	7	16	16	fluvastatin	STZ	PA449688	6484	0.399
NULL	Kidney_Int_Suppl_(2011)_2012_Jun_15_2(2)_186-197.nxml.txt.nlp	25018932	SENT145	12	12	18	18	rituximab	ACTH	PA451261	5443	0.399
NULL	Arthritis_Res_Ther_2007_Jun_29_9(Suppl_1)_S7.nxml.txt.nlp	17634146	SENT121	27	27	30	30	denosumab	RANK	PA166048634	8792	0.399
NULL	J_Korean_Med_Sci_2013_Apr_27_28(4)_527-533.nxml.txt.nlp	23580227	SENT119	9	9	11	11	genistein	TRAIL	PA165109660	8743	0.399
NULL	Eur_J_Clin_Pharmacol_2008_Feb_26_64(2)_133-157.nxml.txt.nlp	18224312	SENT544	11	11	4	4	trimipramine	CYP2D6	PA451791	1565	0.399
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT195	28	28	25	25	sitagliptin	HIP	PA164748978	6767;6159;64399;5068	0.399
NULL	Anat_Cell_Biol_2010_Jun_30_43(2)_97-109.nxml.txt.nlp	21189990	SENT40	19	19	24	24	nadh	ND4	PA164755085	4538	0.399
NULL	Clin_Exp_Reprod_Med_2014_Sep_30_41(3)_120-124.nxml.txt.nlp	25309856	SENT16	6	6	8	8	thyroglobulin	ADAMTS16	PA164754910	170690	0.399
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jul_31_65(Pt_8)_o2057.nxml.txt.nlp	21583719	SENT57	25	25	22	22	ethanol	mol	PA448073	90527	0.399
NULL	J_Cell_Mol_Med_2013_Jul_7_17(7)_901-913.nxml.txt.nlp	23742011	SENT8	6	6	9	9	oxygen	ROS	PA450744	6098	0.399
NULL	F1000Res_2014_Aug_19_3_198.nxml.txt.nlp	25400908	SENT285	8	8	21	21	epirubicin	HER2	PA449476	2064	0.399
NULL	ASN_Neuro_2010_Mar_15_2(2)_e00030.nxml.txt.nlp	20396375	SENT211	20	20	31	31	ethanol	STZ	PA448073	6484	0.399
NULL	Iran_Red_Crescent_Med_J_2014_Feb_7_16(2)_e15277.nxml.txt.nlp	24719748	SENT49	22	22	17	17	clopidogrel	ADP	PA449053	23038	0.399
NULL	Arthritis_Res_2000_Jul_20_2(5)_379-385.nxml.txt.nlp	11094452	SENT205	19	19	13	13	meloxicam	COX	PA450353	1351	0.399
NULL	Springerplus_2013_Jan_11_2_5.nxml.txt.nlp	23520572	SENT127	23	23	15	15	anastrozole	ATAC	PA448432	6375	0.399
NULL	Alcohol_Res_2012_34(3)_367-374.nxml.txt.nlp	23134054	SENT108	16	16	5	5	ethanol	GIRK3	PA448073	3765	0.399
NULL	Biomed_Res_Int_2013_Aug_27_2013_960126.nxml.txt.nlp	24069608	SENT14	14	14	19	19	haloperidol	CA3	PA449841	761	0.399
NULL	Mol_Cancer_2010_Mar_2_9_47.nxml.txt.nlp	20196847	SENT83	17	17	4	4	paclitaxel	SFN	PA450761	25996;2810	0.399
NULL	J_Radiat_Res_2014_Nov_16_55(6)_1171-1177.nxml.txt.nlp	25129557	SENT169	7	7	5	5	capecitabine	CRT	PA448771	811	0.399
NULL	Braz_J_Med_Biol_Res_2013_Aug_13_46(8)_650-658.nxml.txt.nlp	23969971	SENT131	12	12	9	9	cisplatin	STAT3	PA449014	6774	0.399
NULL	Breast_Cancer_Res_2007_Oct_26_9(5)_112.nxml.txt.nlp	17980056	SENT91	41	41	17	17	lapatinib	HER2	PA152241907	2064	0.399
NULL	Surg_Today_2015_Oct_14_45_221-226.nxml.txt.nlp	25734195	SENT122	19	19	17	17	cisplatin	CRT	PA449014	811	0.398
NULL	ISRN_Allergy_2013_Feb_7_2013_971036.nxml.txt.nlp	23738146	SENT246	33	33	20	20	papain	MDC	PA450778	6367	0.398
NULL	Cerebrospinal_Fluid_Res_2010_Aug_12_7_11.nxml.txt.nlp	20704740	SENT166	9	9	22	22	calcein	P-gp	PA132595336	5243	0.398
NULL	Front_Oncol_2013_Oct_29_3_269.nxml.txt.nlp	24195060	SENT251	12	12	4	4	cisplatin	p53	PA449014	7157	0.398
NULL	Subst_Abuse_Rehabil_2011_May_15_2_89-102.nxml.txt.nlp	21743792	SENT344	43	43	2	2	methamphetamine	TOB	PA450403	10140	0.398
NULL	Int_J_Mol_Sci_2014_Jun_18_15(6)_11013-11029.nxml.txt.nlp	24945311	SENT80	22	22	18	18	celecoxib	BCL2	PA448871	596	0.398
NULL	Brain_Sci_2013_Jan_30_3(1)_123-142.nxml.txt.nlp	24961310	SENT159	14	14	9	9	capsaicin	TRPV1	PA448776	7442	0.398
NULL	Int_J_Nanomedicine_2012_Sep_19_7_5053-5065.nxml.txt.nlp	23028227	SENT276	27	27	2	2	doxorubicin	MSLN	PA449412	10232	0.398
NULL	Br_J_Cancer_2011_Mar_15_104(6)_1013-1019.nxml.txt.nlp	21364582	SENT29	15	15	11	11	decitabine	DAC	PA164749631	13	0.398
NULL	Pharmaceuticals_(Basel)_2013_Aug_21_6(8)_988-1038.nxml.txt.nlp	24276379	SENT250	11	11	7	7	sn-38	UGT1A		7361;54658	0.398
NULL	Indian_J_Pharmacol_2014_May-Jun_46(3)_292-297.nxml.txt.nlp	24987176	SENT154	15	15	17	17	udenafil	DES	PA164776753	1674	0.398
NULL	Cells_2013_Jul_18_2(3)_545-573.nxml.txt.nlp	24709797	SENT292	13	13	15	15	decitabine	TRAIL	PA164749631	8743	0.398
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Nov_13_66(Pt_12)_o3178.nxml.txt.nlp	21589473	SENT67	37	37	20	20	ethanol	mol	PA448073	90527	0.398
NULL	J_Exp_Bot_2012_Mar_15_63(5)_1969-1983.nxml.txt.nlp	22174442	SENT432	7	7	16	16	l-alanine	mol	PA448055	90527	0.398
NULL	Cancers_(Basel)_2010_Dec_30_3(1)_106-125.nxml.txt.nlp	24212609	SENT98	11	11	20	20	gemcitabine	MRP5	PA449748	10057	0.398
NULL	J_Cardiothorac_Surg_2014_Nov_18_9(1)_167.nxml.txt.nlp	NULL	SENT47	7	7	15	15	heparin	ACT	PA449855	12;11332;9457;641455	0.398
NULL	Oncotarget_2012_Sep_11_3(9)_1026-1035.nxml.txt.nlp	22976441	SENT31	11	11	14	14	oxygen	ROS	PA450744	6098	0.398
NULL	Mol_Cancer_2007_Jan_19_6_9.nxml.txt.nlp	17233922	SENT167	24	24	35	35	flavopiridol	ARC	PA452627	8996;23237	0.398
NULL	Croat_Med_J_2013_Apr_54(2)_171-179.nxml.txt.nlp	23630144	SENT7	30	30	23	23	taurine	STZ	PA451590	6484	0.398
NULL	EJC_Suppl_2013_Sep_5_11(2)_3-22.nxml.txt.nlp	NULL	SENT1045	18	18	27	27	tamoxifen	ARNO	PA451581	9266	0.398
NULL	Mol_Vis_2012_Apr_11_18_901-908.nxml.txt.nlp	22539869	SENT107	16	16	6	6	curcumin	HO-1	PA151958596	3162	0.398
NULL	ScientificWorldJournal_2014_Mar_11_2014_946265.nxml.txt.nlp	24741367	SENT3	32	32	29	29	exenatide	GLP-1	PA164749238	100125288	0.398
NULL	Mol_Vis_2011_May_4_17_1172-1181.nxml.txt.nlp	21617754	SENT146	19	19	8	8	staurosporine	FKBP51	PA165109623	2289	0.398
NULL	Cancer_Cell_Int_2004_Aug_17_4_5.nxml.txt.nlp	15315711	SENT102	16	16	42	42	genistein	CPP32	PA165109660	836	0.398
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_15_2012_726025.nxml.txt.nlp	23118796	SENT18	22	22	25	25	oxygen	ROS	PA450744	6098	0.398
NULL	Indian_J_Nephrol_2012_May-Jun_22(3)_184-188.nxml.txt.nlp	23087552	SENT37	6	6	3	3	methylprednisolone	ACR	PA450466	49	0.398
NULL	Extremophiles_2009_Sep_5_13(5)_769-783.nxml.txt.nlp	19579003	SENT323	12	12	2	2	lipase	PIR	PA450239	8544	0.398
NULL	Anesth_Essays_Res_2011_Jul-Dec_5(2)_204-206.nxml.txt.nlp	NULL	SENT66	28	28	10	10	bupivacaine	CEA	PA135057240	5670;1087	0.398
NULL	Biomed_Res_Int_2014_Jan_29_2014_831845.nxml.txt.nlp	24605337	SENT207	10	10	17	17	bupivacaine	S6K1	PA135057240	6198	0.398
NULL	EMBO_J_2010_Mar_17_29(6)_1116-1125.nxml.txt.nlp	20186120	SENT147	45	45	12	12	l-glutamine	CO2	PA10090	4513	0.398
NULL	Indian_J_Med_Paediatr_Oncol_2013_Oct-Dec_34(4)_330-332.nxml.txt.nlp	24604969	SENT44	23	23	26	26	oxygen	ROS	PA450744	6098	0.398
NULL	Front_Genet_2012_Nov_12_3_235.nxml.txt.nlp	23162568	SENT146	0	0	2	2	methamphetamine	CYP2D6	PA450403	1565	0.398
NULL	Acta_Naturae_2012_Apr-Jun_4(2)_87-97.nxml.txt.nlp	22880162	SENT49	29	29	10	10	fluorescein	DIF	PA164746009	7124	0.398
NULL	Int_J_Mol_Sci_2013_Aug_13_14(8)_16685-16705.nxml.txt.nlp	23945562	SENT821	11	11	14	14	oxygen	ROS	PA450744	6098	0.398
NULL	Biomed_Res_Int_2014_Feb_10_2014_305610.nxml.txt.nlp	24683545	SENT131	11	11	16	16	naringenin	CPZ	PA151958361	8532	0.398
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Feb_29_68(Pt_3)_m341-m342.nxml.txt.nlp	22412472	SENT68	4	4	13	13	piperazine	C17	PA450977	54360	0.398
NULL	Avicenna_J_Phytomed_2012_Spring_2(2)_72-78.nxml.txt.nlp	25050233	SENT4	28	28	38	38	reserpine	HIC	PA451236	29969	0.398
NULL	Ther_Clin_Risk_Manag_2007_Aug_3(4)_569-578.nxml.txt.nlp	18472978	SENT240	0	0	5	5	metoprolol	MDC	PA450480	6367	0.398
NULL	Diabetes_2013_Nov_18_62(11)_3909-3919.nxml.txt.nlp	23835339	SENT179	6	6	9	9	gliclazide	SUR1	PA10892	6833	0.398
NULL	Allergy_Asthma_Clin_Immunol_2013_Oct_3_9(1)_39.nxml.txt.nlp	24219860	SENT21	5	5	2	2	rituximab	BAFF	PA451261	10673	0.398
NULL	Amyloid_2014_Sep_11_21(3)_175-184.nxml.txt.nlp	24918964	SENT170	22	22	24	24	anakinra	TTR	PA10799	7276	0.398
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Feb_20_69(Pt_3)_o398-o399.nxml.txt.nlp	23476581	SENT79	29	29	23	23	ethanol	mol	PA448073	90527	0.398
NULL	Br_J_Cancer_2012_Feb_28_106(5)_876-882.nxml.txt.nlp	22333597	SENT99	0	0	6	6	everolimus	4E-BP1	PA164746311	1978	0.398
NULL	Iran_J_Parasitol_2014_Mar_9(1)_6-13.nxml.txt.nlp	25642254	SENT44	13	13	19	19	streptomycin	FBS	PA451512	64319;26269	0.398
NULL	Int_J_Womens_Health_2012_Oct_10_4_543-549.nxml.txt.nlp	23091400	SENT61	2	2	19	19	drospirenone	aromatase	PA164749409	1588	0.398
NULL	Behav_Neurol_2014_Nov_16_2014_360978.nxml.txt.nlp	25477708	SENT35	17	17	20	20	oxygen	ROS	PA450744	6098	0.398
NULL	J_Orthop_Surg_2007_May_21_2_9.nxml.txt.nlp	17511887	SENT119	20	20	28	28	alendronate	DPD	PA448082	1806	0.398
NULL	J_Anim_Sci_Biotechnol_2013_Feb_27_4(1)_7.nxml.txt.nlp	23445937	SENT131	18	18	8	8	urea	CO2	PA451831	4513	0.398
NULL	Front_Genet_2014_Nov_14_5_391.nxml.txt.nlp	25452763	SENT908	9	9	24	24	cisplatin	MRP1	PA449014	4437	0.398
NULL	J_Korean_Med_Sci_2013_Apr_27_28(4)_527-533.nxml.txt.nlp	23580227	SENT143	14	14	16	16	genistein	TRAIL	PA165109660	8743	0.398
NULL	Acta_Pharmacol_Sin_2009_Oct_21_30(10)_1392-1398.nxml.txt.nlp	19767766	SENT3	14	14	17	17	oxygen	ROS	PA450744	6098	0.398
NULL	Oncoimmunology_2013_Jul_1_2(7)_e24743.nxml.txt.nlp	24073366	SENT19	22	22	34	34	imiquimod	IL-2	PA449972	3558	0.398
NULL	ScientificWorldJournal_2014_Feb_5_2014_786130.nxml.txt.nlp	24688431	SENT281	15	15	0	0	phenol	TPC	PA450913	8030;60386	0.398
NULL	Oncotarget_2012_Dec_31_3(12)_1669-1687.nxml.txt.nlp	23458731	SENT39	46	46	25	25	imatinib	STAT5A	PA10804	6776	0.398
NULL	Cell_Div_2012_Feb_1_7_1.nxml.txt.nlp	22296825	SENT320	18	18	12	12	galactose	CDC20	PA449725	991	0.398
NULL	Front_Neural_Circuits_2013_Aug_13_7_136.nxml.txt.nlp	23964205	SENT98	6	6	23	23	taurine	WNK1	PA451590	65125	0.397
NULL	Front_Comput_Neurosci_2013_Oct_22_7_144.nxml.txt.nlp	24155715	SENT792	0	0	5	5	ketamine	gamma	PA450144	9913	0.397
NULL	Zookeys_2014_Oct_3_(451)_109-136.nxml.txt.nlp	25493050	SENT280	5	5	0	0	ethanol	ZIN	PA448073	29888;54476	0.397
NULL	Cell_Death_Dis_2013_Oct_3_4(10)_e834.nxml.txt.nlp	24091677	SENT128	38	38	17	17	l-glutamine	CO2	PA10090	4513	0.397
NULL	Ann_Lab_Med_2013_Jan_17_33(1)_52-59.nxml.txt.nlp	23301223	SENT66	21	21	41	41	fluorescein	San	PA164746009	80218	0.397
NULL	Indian_J_Pharm_Sci_2008_Mar-Apr_70(2)_145-153.nxml.txt.nlp	20046703	SENT191	30	30	44	44	methotrexate	IL-2	PA450428	3558	0.397
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Apr_15_9_13.nxml.txt.nlp	20398300	SENT134	14	14	11	11	lansoprazole	LAM	PA450180	7249;7248	0.397
NULL	Cancers_(Basel)_2011_Apr_1_3(2)_1844-1860.nxml.txt.nlp	24212785	SENT525	18	18	0	0	cetuximab	KRAS	PA10040	3845	0.397
NULL	Int_J_Nanomedicine_2012_Sep_13_7_4917-4926.nxml.txt.nlp	23028220	SENT231	23	23	17	17	calcein	mol	PA132595336	90527	0.397
NULL	Ann_Oncol_2009_Nov_23_20(11)_1803-1812.nxml.txt.nlp	19549706	SENT177	21	21	23	23	sunitinib	IFN	PA162372840	3439	0.397
NULL	Mol_Vis_2011_May_4_17_1172-1181.nxml.txt.nlp	21617754	SENT161	2	2	11	11	tacrolimus	FKBP51	PA451578	2289	0.397
NULL	Front_Bioeng_Biotechnol_2014_Oct_1_2_40.nxml.txt.nlp	25325057	SENT549	3	3	6	6	mannitol	CO2	PA450320	4513	0.397
NULL	Iran_Red_Crescent_Med_J_2014_Aug_5_16(8)_e6915.nxml.txt.nlp	25389496	SENT116	14	14	16	16	atorvastatin	adiponectin	PA448500	9370	0.397
NULL	BMB_Rep_2014_Oct_47(10)_575-580.nxml.txt.nlp	24499675	SENT102	21	21	24	24	oxygen	ROS	PA450744	6098	0.397
NULL	Glycobiology_2012_Jan_26_22(1)_134-145.nxml.txt.nlp	21873605	SENT217	13	13	15	15	heparin	IL-8	PA449855	3576	0.397
NULL	Cells_2014_Apr_29_3(2)_331-362.nxml.txt.nlp	24785347	SENT273	0	0	5	5	lidocaine	TRPV1	PA450226	7442	0.397
NULL	Br_J_Cancer_2009_Jul_21_101(2)_320-326.nxml.txt.nlp	19568234	SENT61	11	11	22	22	ethanol	CD133	PA448073	8842	0.397
NULL	Mol_Vis_2011_May_4_17_1172-1181.nxml.txt.nlp	21617754	SENT54	25	25	10	10	staurosporine	FKBP51	PA165109623	2289	0.397
NULL	Mol_Cell_Biochem_2014_Oct_9_385(1-2)_265-275.nxml.txt.nlp	24104452	SENT185	10	10	12	12	bortezomib	U87	PA10252	677775;641648	0.397
NULL	Ann_Rheum_Dis_2013_Apr_21_72(4)_482-492.nxml.txt.nlp	23172750	SENT395	30	30	16	16	tocilizumab	IL-6	PA165292659	3569	0.397
NULL	Small_GTPases_2012_Apr_1_3(2)_71-72.nxml.txt.nlp	NULL	SENT46	10	10	13	13	oxygen	ROS	PA450744	6098	0.397
NULL	J_Cardiothorac_Surg_2014_Nov_18_9(1)_167.nxml.txt.nlp	NULL	SENT34	4	4	21	21	levosimendan	NAG	PA164749138	51594;4669	0.397
NULL	J_Histochem_Cytochem_2012_Oct_60(10)_749-760.nxml.txt.nlp	22821669	SENT34	25	25	19	19	trypsin	TSG-6	PA451806	7130	0.397
NULL	Pain_Res_Treat_2014_Jan_20_2014_902174.nxml.txt.nlp	24579048	SENT185	17	17	7	7	oxygen	SNS	PA450744	6336	0.397
NULL	Aging_(Albany_NY)_2012_Dec_6_4(11)_823-842.nxml.txt.nlp	23235539	SENT180	15	15	17	17	bleomycin	HCA2	PA448645	139081;55811;338442	0.397
NULL	Indian_J_Anaesth_2009_Jun_53(3)_265-267.nxml.txt.nlp	20640132	SENT34	34	34	5	5	heparin	ACT	PA449855	12;11332;9457;641455	0.397
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Oct_22_67(Pt_11)_o2980.nxml.txt.nlp	22220001	SENT5	1	1	3	3	ethanol	mol	PA448073	90527	0.397
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Nov_22_64(Pt_12)_o2408.nxml.txt.nlp	21581377	SENT60	1	1	11	11	ethanol	mol	PA448073	90527	0.397
NULL	Adv_Biomed_Res_2012_May_11_1_12.nxml.txt.nlp	23210071	SENT130	15	15	8	8	forskolin	F12	PA146096022	2161	0.397
NULL	Environ_Health_2009_Feb_18_8_4.nxml.txt.nlp	19226469	SENT241	15	15	0	0	ether	NRC	PA449525	23054	0.397
NULL	Biomed_Res_Int_2014_Feb_6_2014_323594.nxml.txt.nlp	24689036	SENT223	15	15	19	19	raloxifene	PC3	PA451221	57332;7832;5122	0.397
NULL	Indian_J_Nephrol_2008_Jul_18(3)_95-100.nxml.txt.nlp	20142913	SENT60	0	0	11	11	vasopressin	BLM	PA451858	641	0.397
NULL	Mol_Biol_Cell_2012_Nov_1_23(21)_4212-4225.nxml.txt.nlp	22956765	SENT263	13	13	21	21	thrombin	SHP2	PA451674	5781	0.397
NULL	Front_Endocrinol_(Lausanne)_2013_Mar_20_4_31.nxml.txt.nlp	23519101	SENT1244	13	13	15	15	doxorubicin	PC-3	PA449412	692094	0.397
NULL	Oncol_Lett_2014_Jun_8_7(6)_1761-1766.nxml.txt.nlp	24932229	SENT101	16	16	18	18	pazopanib	FGFR3	PA165291492	2261	0.397
NULL	FEBS_Open_Bio_2012_Aug_22_2_279-283.nxml.txt.nlp	23650611	SENT184	0	0	7	7	raloxifene	IFN	PA451221	3439	0.397
NULL	Mol_Clin_Oncol_2013_Sep_12_1(5)_911-917.nxml.txt.nlp	24649270	SENT34	3	3	11	11	cyclophosphamide	CHOP	PA449165	1649	0.397
NULL	Oncogene_2009_Dec_3_28(48)_4237-4248.nxml.txt.nlp	19734937	SENT72	2	2	4	4	collagenase	PAR-1	PA449107	2011;2149	0.397
NULL	J_Clin_Biochem_Nutr_2011_Jul_30_49(1)_20-24.nxml.txt.nlp	21765602	SENT115	5	5	21	21	ethanol	IL-6	PA448073	3569	0.397
NULL	Clin_Ophthalmol_2012_Jan_12_6_103-109.nxml.txt.nlp	22275814	SENT2	36	36	25	25	tafluprost	BAK	PA165958432	578	0.397
NULL	Arthritis_Res_Ther_2007_Jun_29_9(Suppl_1)_S2.nxml.txt.nlp	17634141	SENT128	27	27	30	30	denosumab	RANK	PA166048634	8792	0.397
NULL	J_Gynecol_Oncol_2013_Jan_8_24(1)_83-91.nxml.txt.nlp	23346317	SENT73	32	32	18	18	carboplatin	AGO	PA448803	55294	0.397
NULL	Int_J_Nanomedicine_2012_Sep_13_7_4917-4926.nxml.txt.nlp	23028220	SENT212	21	21	17	17	calcein	mol	PA132595336	90527	0.397
NULL	ISRN_Allergy_2013_Feb_7_2013_971036.nxml.txt.nlp	23738146	SENT246	33	33	15	15	papain	TARC	PA450778	6361	0.397
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Apr_15_9_13.nxml.txt.nlp	20398300	SENT134	14	14	0	0	lansoprazole	LAM	PA450180	7249;7248	0.397
NULL	J_Cell_Biol_2001_Apr_2_153(1)_207-220.nxml.txt.nlp	11285286	SENT163	7	7	9	9	carbachol	DGK	PA448784	8526;1607	0.397
NULL	Br_J_Pharmacol_2014_Feb_24_171(1)_1019-1032.nxml.txt.nlp	24251620	SENT124	16	16	19	19	nifedipine	TRPM3	PA450631	80036	0.397
NULL	Acta_Neuropathol_2011_Dec_29_122(6)_747-761.nxml.txt.nlp	22038545	SENT38	1	1	12	12	dextran	CST	PA449261	9514	0.397
NULL	Case_Rep_Urol_2013_May_8_2013_915874.nxml.txt.nlp	23738191	SENT81	14	14	26	26	methotrexate	ADM	PA450428	133	0.397
NULL	Drug_Des_Devel_Ther_2014_Sep_9_8_1307-1314.nxml.txt.nlp	25246772	SENT154	4	4	7	7	cyclosporine	HTX	PA449167	7547	0.397
NULL	Cardiol_Res_Pract_2011_Jan_2_2011_156326.nxml.txt.nlp	21253517	SENT84	2	2	9	9	heparin	EC-SOD	PA449855	6649	0.397
NULL	Front_Endocrinol_(Lausanne)_2013_Jan_7_3_180.nxml.txt.nlp	23316185	SENT15	24	24	37	37	glucose	CRF2	PA449773	1395	0.397
NULL	Mol_Cell_Biochem_2014_Oct_9_385(1-2)_265-275.nxml.txt.nlp	24104452	SENT108	8	8	16	16	bortezomib	U87	PA10252	677775;641648	0.397
NULL	Comput_Struct_Biotechnol_J_2013_Jan_18_3_e201210019.nxml.txt.nlp	24688679	SENT158	42	42	37	37	ethanol	PHB	PA448073	5245	0.396
NULL	Cancer_Res_Treat_2013_Dec_31_45(4)_251-262.nxml.txt.nlp	24453997	SENT88	20	20	40	40	pemetrexed	TRAIL	PA10810	8743	0.396
NULL	Front_Immunol_2013_Sep_4_4_201.nxml.txt.nlp	24027567	SENT50	9	9	6	6	hyaluronan	TSG-6	PA165958431	7130	0.396
NULL	Arthritis_Res_Ther_2013_Mar_4_15(2)_R39.nxml.txt.nlp	23497717	SENT15	3	3	0	0	imiquimod	TLR7	PA449972	51284	0.396
NULL	Reprod_Biol_Endocrinol_2013_May_15_11_42.nxml.txt.nlp	23675907	SENT123	14	14	17	17	protamine	PRM2	PA10366	5620	0.396
NULL	Gut_Liver_2013_Sep_14_7(5)_585-593.nxml.txt.nlp	24073317	SENT108	36	36	15	15	ribavirin	IFN	PA451241	3439	0.396
NULL	J_Biol_Chem_2013_Jun_28_288(26)_18789-18802.nxml.txt.nlp	23625922	SENT344	8	8	6	6	thrombin	C5a	PA451674	727	0.396
NULL	Hum_Genomics_Proteomics_2010_Aug_3_2010_159761.nxml.txt.nlp	20981231	SENT146	0	0	10	10	lithium	BDNF	PA450243	627	0.396
NULL	FEBS_Open_Bio_2013_Aug_19_3_379-386.nxml.txt.nlp	24251099	SENT580	14	14	8	8	nadh	mol	PA164755085	90527	0.396
NULL	Br_J_Dermatol_2009_Feb_160(2)_438-441.nxml.txt.nlp	19016697	SENT97	16	16	22	22	methotrexate	ATIC	PA450428	471	0.396
NULL	Evid_Based_Complement_Alternat_Med_2013_Aug_20_2013_789067.nxml.txt.nlp	24069055	SENT219	8	8	0	0	lipase	HSL	PA450239	3991	0.396
NULL	Cell_Commun_Signal_2011_May_15_9_13.nxml.txt.nlp	21569639	SENT287	0	0	2	2	quinacrine	p53	PA164745551	7157	0.396
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jan_18_68(Pt_2)_o422.nxml.txt.nlp	22347036	SENT78	22	22	16	16	ethanol	mol	PA448073	90527	0.396
NULL	Cancer_Cell_Int_2004_May_17_4_4.nxml.txt.nlp	15147581	SENT150	4	4	11	11	sulindac	San	PA451565	80218	0.396
NULL	Exp_Ther_Med_2013_Sep_17_6(3)_649-656.nxml.txt.nlp	24137241	SENT194	37	37	17	17	valsartan	MCP-1	PA451848	6347	0.396
NULL	Gut_Liver_2013_Sep_14_7(5)_585-593.nxml.txt.nlp	24073317	SENT153	33	33	31	31	ribavirin	IFN	PA451241	3439	0.396
NULL	J_Inflamm_(Lond)_2008_Sep_22_5_15.nxml.txt.nlp	18808711	SENT335	22	22	7	7	thrombin	PBEF	PA451674	10135	0.396
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_315-322.nxml.txt.nlp	20049735	SENT71	13	13	16	16	cisplatin	PTEN	PA449014	5728	0.396
NULL	Oxid_Med_Cell_Longev_2012_Nov_28_2012_162934.nxml.txt.nlp	23251719	SENT179	4	4	7	7	oxygen	ROS	PA450744	6098	0.396
NULL	Neural_Dev_2010_Oct_1_5_25.nxml.txt.nlp	20920300	SENT76	36	36	15	15	zinc	LIM	PA451956	10611	0.396
NULL	Mol_Cancer_2007_Aug_21_6_53.nxml.txt.nlp	17711579	SENT272	16	16	11	11	cisplatin	IGFBP7	PA449014	3490	0.396
NULL	Open_Biol_2013_Sep_3(9)_130097.nxml.txt.nlp	24004664	SENT223	15	15	20	20	tetracycline	San	PA451640	80218	0.396
NULL	NDT_Plus_2009_Jan_2(Suppl_1)_i3-i8.nxml.txt.nlp	19461857	SENT153	16	16	9	9	iron	ESA	PA450087	2319;4072;5444	0.396
NULL	J_Korean_Med_Sci_2010_Apr_19_25(4)_583-588.nxml.txt.nlp	20358002	SENT79	22	22	25	25	famotidine	ESD	PA449586	2098	0.396
NULL	Scientifica_(Cairo)_2013_Feb_3_2013_125705.nxml.txt.nlp	24278766	SENT268	2	2	7	7	ritonavir	PTH	PA451260	5741	0.396
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_May_25_69(Pt_6)_o959.nxml.txt.nlp	23795117	SENT7	1	1	3	3	ethanol	mol	PA448073	90527	0.396
NULL	Oncogene_2010_Jul_8_29(27)_3953-3963.nxml.txt.nlp	20440263	SENT21	24	24	27	27	oxygen	ROS	PA450744	6098	0.396
NULL	Am_J_Med_Genet_A_2012_May_29_158A(5)_1135-1144.nxml.txt.nlp	22473653	SENT209	5	5	22	22	nicotine	E16	PA450626	8140	0.396
NULL	Mol_Clin_Oncol_2013_Sep_12_1(5)_911-917.nxml.txt.nlp	24649270	SENT34	25	25	11	11	epirubicin	CHOP	PA449476	1649	0.396
NULL	Cardiovasc_Ther_2012_Jun_19_30(3)_e146-e155.nxml.txt.nlp	21167014	SENT24	13	13	9	9	exenatide	GLP	PA164749238	342096	0.396
NULL	J_Hematol_Oncol_2012_Sep_18_5_57.nxml.txt.nlp	22989009	SENT269	9	9	12	12	nutlin-3	HDM2		4193	0.396
NULL	Int_J_Mol_Sci_2012_Sep_26_13(10)_12336-12348.nxml.txt.nlp	23202901	SENT61	17	17	12	12	phenol	P90	PA450913	821	0.396
NULL	Exp_Diabetes_Res_2012_Oct_19_2012_628978.nxml.txt.nlp	22028701	SENT16	17	17	20	20	oxygen	ROS	PA450744	6098	0.396
NULL	Case_Rep_Endocrinol_2014_Feb_10_2014_479641.nxml.txt.nlp	24660072	SENT100	20	20	16	16	cinacalcet	PTH	PA164776671	5741	0.396
NULL	Front_Physiol_2010_Oct_14_1_135.nxml.txt.nlp	21423376	SENT539	12	12	14	14	hyaluronan	CD44	PA165958431	960	0.396
NULL	Biomed_Res_Int_2014_Jan_20_2014_948427.nxml.txt.nlp	24563867	SENT128	10	10	13	13	glucose	STZ	PA449773	6484	0.396
NULL	Carcinogenesis_2010_Dec_27_31(12)_2049-2057.nxml.txt.nlp	20876285	SENT151	7	7	12	12	tamoxifen	HER2	PA451581	2064	0.396
NULL	Clin_Exp_Gastroenterol_2011_Dec_12_4_291-296.nxml.txt.nlp	22235173	SENT22	17	17	13	13	cisplatin	ghrelin	PA449014	51738	0.395
NULL	J_Biol_Chem_2009_Jan_30_284(5)_3136-3147.nxml.txt.nlp	19047043	SENT28	12	12	5	5	heparin	FGF2	PA449855	2247;2258	0.395
NULL	J_Med_Case_Reports_2011_Sep_23_5_476.nxml.txt.nlp	21943040	SENT122	11	11	0	0	vincristine	CHOP	PA451879	1649	0.395
NULL	Environ_Health_2006_Feb_21_5_4.nxml.txt.nlp	16504050	SENT148	18	18	6	6	estradiol	aromatase	PA449503	1588	0.395
NULL	Ann_Rheum_Dis_2011_Jun_27_70(9)_1631-1640.nxml.txt.nlp	21708910	SENT220	43	43	20	20	etanercept	San	PA449515	80218	0.395
NULL	Biomed_Res_Int_2014_Jun_26_2014_161346.nxml.txt.nlp	25054130	SENT232	45	45	30	30	curcumin	STZ	PA151958596	6484	0.395
NULL	Front_Endocrinol_(Lausanne)_2011_Aug_11_2_19.nxml.txt.nlp	22649366	SENT1206	7	7	2	2	ethanol	spatial	PA448073	219793	0.395
NULL	Arthritis_Res_Ther_2007_Jul_5_9(4)_R65.nxml.txt.nlp	17612407	SENT34	39	39	29	29	fluorescein	San	PA164746009	80218	0.395
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2619-2628.nxml.txt.nlp	24129235	SENT286	4	4	2	2	gemcitabine	GEM	PA449748	2669	0.395
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT196	7	7	4	4	sulindac	NAC	PA451565	22861	0.395
NULL	Mol_Cell_Biochem_2014_Oct_9_385(1-2)_265-275.nxml.txt.nlp	24104452	SENT192	22	22	10	10	bortezomib	U87	PA10252	677775;641648	0.395
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT17	0	0	5	5	atorvastatin	KRAS	PA448500	3845	0.395
NULL	Adv_Bioinformatics_2012_Jun_6_2012_582765.nxml.txt.nlp	22719757	SENT126	30	30	32	32	thrombin	EGF	PA451674	1950	0.395
NULL	Sci_Rep_2014_Dec_23_4_7564.nxml.txt.nlp	25532911	SENT421	18	18	2	2	estradiol	GPER	PA449503	2852	0.395
NULL	Cell_Commun_Signal_2011_May_15_9_13.nxml.txt.nlp	21569639	SENT333	27	27	17	17	quinacrine	EGF	PA164745551	1950	0.395
NULL	AIDS_Res_Ther_2013_Dec_13_10_29.nxml.txt.nlp	24330529	SENT193	32	32	15	15	maraviroc	CD4	PA164768835	920	0.395
NULL	Int_J_Biol_Sci_2013_Dec_6_10(1)_25-32.nxml.txt.nlp	24391448	SENT53	22	22	28	28	trastuzumab	San	PA451743	80218	0.395
NULL	Chem_Cent_J_2012_Nov_23_6_140.nxml.txt.nlp	23173949	SENT51	3	3	0	0	ether	PERC	PA449525	133522	0.395
NULL	Oncoimmunology_2014_Jan_1_3_e27358.nxml.txt.nlp	24701373	SENT20	29	29	13	13	glucosamine	TERF2	PA164747613	7014	0.395
NULL	Ann_Thorac_Med_2014_Apr-Jun_9(2)_55-76.nxml.txt.nlp	24791168	SENT724	8	8	30	30	ipratropium	CO2	PA450082	4513	0.395
NULL	Br_J_Cancer_2012_Feb_14_106(4)_646-650.nxml.txt.nlp	22240794	SENT52	20	20	22	22	sunitinib	IFN	PA162372840	3439	0.395
NULL	J_Cell_Biol_1998_May_4_141(3)_839-847.nxml.txt.nlp	9566981	SENT159	13	13	9	9	guanidine	osteoadherin	PA164781028	4958	0.395
NULL	Stroke_Res_Treat_2011_Nov_10_2011_212485.nxml.txt.nlp	22135769	SENT64	14	14	23	23	amlodipine	FGB	PA448388	2244	0.395
NULL	Nucleic_Acids_Res_2013_Nov_27_41(21)_9786-9799.nxml.txt.nlp	23982513	SENT107	4	4	7	7	arsenite	TIAR	PA452638	7073	0.395
NULL	EMBO_Mol_Med_2012_Jul_25_4(7)_545-556.nxml.txt.nlp	22730341	SENT233	2	2	16	16	bortezomib	TRAIL	PA10252	8743	0.395
NULL	Mol_Brain_2014_Aug_12_7_58.nxml.txt.nlp	25112718	SENT415	35	35	8	8	cimetidine	E12	PA449001	64100	0.395
NULL	Oncol_Lett_2013_Feb_27_5(2)_435-439.nxml.txt.nlp	23420613	SENT21	24	24	6	6	carboplatin	EGFR	PA448803	1956	0.395
NULL	Indian_J_Pharm_Sci_2012_Jan-Feb_74(1)_1-17.nxml.txt.nlp	23204616	SENT388	12	12	23	23	gliclazide	CYP2C9	PA10892	1559	0.395
NULL	Arthritis_Res_Ther_2007_Jun_29_9(Suppl_1)_S4.nxml.txt.nlp	17634143	SENT119	27	27	30	30	denosumab	RANK	PA166048634	8792	0.395
NULL	Arch_Dis_Child_2014_Dec_8_99(12)_1143-1146.nxml.txt.nlp	25202131	SENT58	10	10	8	8	propofol	CYP2B6	PA451141	1555	0.395
NULL	Case_Rep_Psychiatry_2014_Apr_10_2014_561092.nxml.txt.nlp	24818034	SENT72	0	0	10	10	disulfiram	DDC	PA449376	1644	0.395
NULL	Cancers_(Basel)_2010_Jun_14_2(2)_1288-1311.nxml.txt.nlp	24281116	SENT147	0	0	13	13	verapamil	MRP	PA451868	79971	0.395
NULL	Eur_J_Dent_2007_Jul_1(3)_158b-166.nxml.txt.nlp	19212560	SENT159	20	20	16	16	ethanol	HEMA	PA448073	2157	0.395
NULL	J_Appl_Oral_Sci_2011_Mar-Apr_19(2)_147-153.nxml.txt.nlp	21552716	SENT3	16	16	18	18	glutaraldehyde	HEMA	PA449777	2157	0.395
NULL	Nat_Commun_2011_Aug_9_2_420.nxml.txt.nlp	21829182	SENT67	16	16	0	0	helium	S12	PA449848	3351;6206;5713;6268	0.395
NULL	Curr_Neuropharmacol_2013_May_11(3)_276-297.nxml.txt.nlp	24179464	SENT136	5	5	8	8	oxygen	ROS	PA450744	6098	0.395
NULL	J_Clin_Biochem_Nutr_2007_Jul_27_41(1)_32-42.nxml.txt.nlp	18392098	SENT9	8	8	11	11	oxygen	ROS	PA450744	6098	0.395
NULL	J_Biol_2008_Nov_7_7(9)_33.nxml.txt.nlp	19014407	SENT102	5	5	2	2	arsenite	ArsB	PA452638	57152	0.395
NULL	Front_Mol_Neurosci_2012_Nov_12_5_99.nxml.txt.nlp	23162427	SENT259	26	26	3	3	cocaine	HDAC5	PA449072	10014	0.395
NULL	Ann_Oncol_2009_Nov_23_20(11)_1803-1812.nxml.txt.nlp	19549706	SENT232	3	3	5	5	sunitinib	IFN	PA162372840	3439	0.395
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_14_2012_127043.nxml.txt.nlp	23227093	SENT3	14	14	4	4	lovastatin	RYR	PA450272	6261	0.395
NULL	Front_Endocrinol_(Lausanne)_2013_Jan_7_3_180.nxml.txt.nlp	23316185	SENT268	9	9	5	5	glucose	CRF2	PA449773	1395	0.395
NULL	J_Cancer_Prev_2013_Jun_18(2)_186-191.nxml.txt.nlp	25337545	SENT73	0	0	8	8	curcumin	CDK4	PA151958596	1019	0.395
NULL	Eur_J_Clin_Pharmacol_2009_Dec_16_65(12)_1211-1228.nxml.txt.nlp	19756557	SENT57	8	8	1	1	infliximab	ACT	PA452639	12;11332;9457;641455	0.395
NULL	Crit_Care_2005_Sep_3_9(1)_23-24.nxml.txt.nlp	15693976	SENT15	4	4	6	6	dantrolene	CHS	PA449208	1130	0.395
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Sep_30_67(Pt_10)_o2809.nxml.txt.nlp	22065239	SENT76	22	22	16	16	ethanol	mol	PA448073	90527	0.395
NULL	Mol_Biol_Cell_2012_Sep_15_23(18)_3499-3510.nxml.txt.nlp	22833567	SENT127	23	23	12	12	arsenite	G3BP	PA452638	10146	0.395
NULL	Breast_Cancer_Res_2011_Jan_28_13(1)_301.nxml.txt.nlp	21345282	SENT41	17	17	36	36	medroxyprogesterone	RANK	PA450344	8792	0.395
NULL	ScientificWorldJournal_2014_Dec_8_2014_959075.nxml.txt.nlp	25548797	SENT140	2	2	14	14	ezetimibe	S17	PA10816	6218	0.395
NULL	Diabetes_Care_2009_Sep_28_32(9)_1649-1655.nxml.txt.nlp	19478198	SENT10	30	30	32	32	glucose	PPG	PA449773	5552	0.395
NULL	Biomed_Res_Int_2014_Feb_6_2014_323594.nxml.txt.nlp	24689036	SENT256	3	3	7	7	raloxifene	PC3	PA451221	57332;7832;5122	0.395
NULL	Int_J_Environ_Res_Public_Health_2005_May_30_2(1)_138-146.nxml.txt.nlp	16708425	SENT281	7	7	3	3	lidocaine	CYP1A2	PA450226	1544	0.395
NULL	J_Immunol_Res_2014_May_6_2014_439530.nxml.txt.nlp	24892036	SENT42	13	13	37	37	cyclosporine	IL-11	PA449167	3589	0.395
NULL	Case_Rep_Gastroenterol_2012_Jan_5_6(1)_5-14.nxml.txt.nlp	22379465	SENT45	18	18	20	20	lipase	gamma	PA450239	9913	0.395
NULL	Eur_J_Clin_Pharmacol_2011_Dec_23_67(12)_1231-1241.nxml.txt.nlp	21698374	SENT34	10	10	6	6	tacrolimus	ABCB1	PA451578	5243	0.395
NULL	J_Korean_Med_Sci_2013_Apr_27_28(4)_527-533.nxml.txt.nlp	23580227	SENT100	20	20	22	22	genistein	TRAIL	PA165109660	8743	0.394
NULL	Diabetes_Care_2013_Aug_17_36(Suppl_2)_S180-S189.nxml.txt.nlp	23882044	SENT210	9	9	4	4	exenatide	GLP-1	PA164749238	100125288	0.394
NULL	Sci_Rep_2014_Nov_28_4_7237.nxml.txt.nlp	25429875	SENT111	12	12	6	6	hesperidin	p38	PA449867	10598;1432;7965	0.394
NULL	Breast_Cancer_Res_2010_Aug_23_12(4)_R64.nxml.txt.nlp	20731819	SENT28	17	17	11	11	tamoxifen	CYP2D6	PA451581	1565	0.394
NULL	Diabetes_2009_Aug_2_58(8)_1902-1913.nxml.txt.nlp	19491211	SENT193	5	5	8	8	fluorescein	P18	PA164746009	7975;10168	0.394
NULL	Oncotarget_2014_Oct_21_5(22)_11709-11722.nxml.txt.nlp	25365944	SENT28	0	0	6	6	metformin	RhoA	PA450395	387	0.394
NULL	EMBO_Mol_Med_2011_Jul_3(7)_367-369.nxml.txt.nlp	21591260	SENT28	18	18	14	14	collagenase	MMP13	PA449107	4322	0.394
NULL	Pharmaceutics_2012_May_14_4(2)_252-275.nxml.txt.nlp	24300231	SENT522	27	27	8	8	etoposide	LDE	PA449552	7957	0.394
NULL	Breast_Cancer_Res_2005_May_24_7(5)_R589-R597.nxml.txt.nlp	16168102	SENT35	36	36	23	23	streptomycin	FBS	PA451512	64319;26269	0.394
NULL	Brain_Behav_2012_Sep_23_2(5)_661-677.nxml.txt.nlp	23139911	SENT397	4	4	6	6	methylphenidate	spatial	PA450464	219793	0.394
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Apr_30_65(Pt_5)_o1161.nxml.txt.nlp	21583964	SENT59	37	37	32	32	ethanol	mol	PA448073	90527	0.394
NULL	Subst_Abuse_Treat_Prev_Policy_2007_Oct_31_2_32.nxml.txt.nlp	17974020	SENT124	20	20	16	16	pemoline	NMU	PA450836	10874	0.394
NULL	Front_Neurosci_2012_May_30_6_77.nxml.txt.nlp	22661925	SENT252	28	28	30	30	ethanol	HEC	PA448073	10403	0.394
NULL	Biomed_Res_Int_2014_Jun_26_2014_321486.nxml.txt.nlp	25054138	SENT165	14	14	3	3	raloxifene	ESR1	PA451221	2099	0.394
NULL	Arthritis_Res_Ther_2010_Jul_8_12(4)_R135.nxml.txt.nlp	20615213	SENT240	0	0	6	6	hyaluronan	TLR4	PA165958431	7099	0.394
NULL	Iran_J_Pharm_Res_2014_Autumn_13(4)_1369-1378.nxml.txt.nlp	25587326	SENT125	5	5	8	8	ethanol	LCE	PA448073	79071	0.394
NULL	AMB_Express_2012_Jul_29_2_38.nxml.txt.nlp	22838397	SENT142	10	10	2	2	ethanol	EPG	PA448073	255324	0.394
NULL	Breast_Cancer_Res_2000_Dec_17_2(1)_10-12.nxml.txt.nlp	11250686	SENT49	36	36	16	16	tamoxifen	STAR	PA451581	6770;2984	0.394
NULL	Neuroscience_2009_Jun_30_161(2-3)_572-577.nxml.txt.nlp	19327387	SENT499	26	26	6	6	capsaicin	TRPV1	PA448776	7442	0.394
NULL	Case_Rep_Oncol_2012_Apr_13_5(1)_173-180.nxml.txt.nlp	22666209	SENT12	34	34	28	28	carboplatin	OSC	PA448803	4047	0.394
NULL	Int_J_Mol_Sci_2014_Nov_7_15(11)_20500-20517.nxml.txt.nlp	25387078	SENT13	0	0	11	11	sorafenib	Mcl-1	PA7000	4170	0.394
NULL	Mol_Cytogenet_2014_Jan_21_7(Suppl_1)_P86.nxml.txt.nlp	NULL	SENT17	10	10	13	13	nadh	MT-ND6	PA164755085	4541	0.394
NULL	Exp_Ther_Med_2013_May_15_5(5)_1327-1331.nxml.txt.nlp	23737873	SENT177	11	11	6	6	imidapril	AQP2	PA452640	359	0.394
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_24_2012_673132.nxml.txt.nlp	23133498	SENT118	2	2	7	7	berberine	MDR1	PA165860812	5243	0.394
NULL	Biochem_Res_Int_2011_Nov_30_2011_850924.nxml.txt.nlp	21151514	SENT161	23	23	13	13	l-cysteine	PLP	PA449173	25824;5744	0.394
NULL	Indian_J_Med_Res_2014_Apr_139(4)_572-578.nxml.txt.nlp	24927344	SENT17	19	19	36	36	warfarin	VKORC1	PA451906	79001	0.394
NULL	J_Cell_Biol_1998_Aug_10_142(3)_723-733.nxml.txt.nlp	9700161	SENT326	28	28	33	33	galactose	TWF1	PA449725	5756	0.394
NULL	Head_Face_Med_2008_Feb_8_4_2.nxml.txt.nlp	18261212	SENT165	17	17	38	38	bleomycin	gamma	PA448645	9913	0.394
NULL	Interdiscip_Toxicol_2011_Dec_4(4)_211-215.nxml.txt.nlp	22319256	SENT118	2	2	17	17	diazepam	ANOVA	PA449283	4858	0.394
NULL	Lipids_Health_Dis_2011_Feb_12_10_31.nxml.txt.nlp	21314960	SENT7	4	4	7	7	hemin	HO-1	PA449849	3162	0.394
NULL	Arthritis_Res_Ther_2009_Jan_26_11(1)_R12.nxml.txt.nlp	19171052	SENT119	15	15	5	5	dipyridamole	POMC	PA449367	5443	0.394
NULL	Diabetes_Metab_J_2012_Aug_20_36(4)_293-299.nxml.txt.nlp	22950061	SENT23	0	0	13	13	metformin	PI3K	PA450395	5290	0.394
NULL	Oxid_Med_Cell_Longev_2012_May_15_2012_890826.nxml.txt.nlp	22666522	SENT22	2	2	5	5	oxygen	ROS	PA450744	6098	0.394
NULL	Mol_Cancer_2014_Jun_14_13_150.nxml.txt.nlp	24927996	SENT122	0	0	3	3	doxorubicin	ADM	PA449412	133	0.394
NULL	Breast_Cancer_Res_2005_Nov_11_7(6)_255-257.nxml.txt.nlp	16457700	SENT10	33	33	14	14	letrozole	ATAC	PA450196	6375	0.394
NULL	Int_J_Gen_Med_2012_Nov_9_5_935-942.nxml.txt.nlp	23204857	SENT4	29	29	43	43	isoflurane	CA3	PA450106	761	0.394
NULL	Evol_Appl_2014_Nov_8_7(9)_1068-1083.nxml.txt.nlp	25553068	SENT93	11	11	17	17	nadh	ND3	PA164755085	4537	0.394
NULL	Exp_Ther_Med_2013_May_15_5(5)_1327-1331.nxml.txt.nlp	23737873	SENT150	10	10	6	6	imidapril	AQP2	PA452640	359	0.394
NULL	Br_J_Cancer_1998_Apr_77(8)_1311-1317.nxml.txt.nlp	9579838	SENT30	21	21	15	15	tamoxifen	IL-2	PA451581	3558	0.394
NULL	EJC_Suppl_2013_Sep_5_11(2)_307-309.nxml.txt.nlp	NULL	SENT40	8	8	13	13	erlotinib	EGFR	PA134687924	1956	0.394
NULL	Aquat_Biosyst_2012_Oct_19_8_26.nxml.txt.nlp	23083531	SENT120	15	15	11	11	oxygen	NO3	PA450744	4681	0.394
NULL	Clin_Drug_Investig_2013_Jun_20_33(6)_419-427.nxml.txt.nlp	23605507	SENT6	29	29	12	12	ciprofloxacin	DPI	PA449009	1832	0.394
NULL	J_Lipid_Res_2014_Oct_55(10)_2103-2112.nxml.txt.nlp	25139399	SENT547	2	2	9	9	atorvastatin	PCSK9	PA448500	255738	0.394
NULL	Arthritis_Res_Ther_2007_Jun_29_9(Suppl_1)_S1.nxml.txt.nlp	17634140	SENT155	27	27	30	30	denosumab	RANK	PA166048634	8792	0.394
NULL	EMBO_Mol_Med_2012_May_4(5)_435-448.nxml.txt.nlp	22359280	SENT138	24	24	7	7	clodronate	HSPB4	PA10239	1409	0.394
NULL	Exp_Anim_2014_Jul_22_63(4)_367-374.nxml.txt.nlp	25048261	SENT71	21	21	15	15	ribavirin	IFN	PA451241	3439	0.394
NULL	J_Immunother_Cancer_2013_Jul_15_1_10.nxml.txt.nlp	24829747	SENT98	27	27	19	19	dextran	AOM	PA449261	315	0.394
NULL	Crit_Care_2007_Mar_22_11(Suppl_2)_P223.nxml.txt.nlp	NULL	SENT3	8	8	17	17	levosimendan	SOC	PA164749138	91544	0.394
NULL	BMB_Rep_2013_Aug_46(8)_410-415.nxml.txt.nlp	23977989	SENT4	0	0	7	7	curcumin	HO-1	PA151958596	3162	0.394
NULL	Int_J_Mol_Sci_2014_Sep_25_15(9)_17148-17161.nxml.txt.nlp	25257533	SENT627	8	8	3	3	estradiol	c-fos	PA449503	2353	0.394
NULL	Contemp_Clin_Dent_2014_Jul-Sep_5(3)_415-418.nxml.txt.nlp	25191086	SENT93	2	2	8	8	dacarbazine	IL-2	PA449197	3558	0.394
NULL	J_Biol_Inorg_Chem_2007_Nov_8_12(8)_1181-1196.nxml.txt.nlp	17828423	SENT533	25	25	19	19	ethanol	NO3	PA448073	4681	0.394
NULL	Eur_J_Clin_Pharmacol_2013_Jan_11_69(6)_1275-1283.nxml.txt.nlp	23307232	SENT82	41	41	34	34	warfarin	VKORC1	PA451906	79001	0.394
NULL	Cardiovasc_Diabetol_2005_Jun_3_4_7.nxml.txt.nlp	15935095	SENT102	8	8	15	15	atorvastatin	ATV	PA448500	4683	0.394
NULL	Clin_Ophthalmol_2010_Oct_28_4_1249-1252.nxml.txt.nlp	21151329	SENT23	10	10	29	29	nepafenac	San	PA165958407	80218	0.394
NULL	J_Lipid_Res_2011_May_52(5)_873-884.nxml.txt.nlp	21324916	SENT586	10	10	15	15	bezafibrate	adiponectin	PA162364313	9370	0.394
NULL	Aging_(Albany_NY)_2009_Jul_31_1(9)_784-802.nxml.txt.nlp	20157567	SENT10	10	10	13	13	oxygen	ROS	PA450744	6098	0.394
NULL	Cancer_Cell_Int_2011_May_15_11_13.nxml.txt.nlp	21569620	SENT133	0	0	11	11	bortezomib	PC-3	PA10252	692094	0.394
NULL	Cardiol_Res_Pract_2012_Jul_5_2012_794762.nxml.txt.nlp	22830072	SENT137	25	25	33	33	citalopram	IPT	PA449015	54802	0.393
NULL	Biomed_Res_Int_2014_Jun_26_2014_161346.nxml.txt.nlp	25054130	SENT216	45	45	30	30	curcumin	STZ	PA151958596	6484	0.393
NULL	Eur_J_Gastroenterol_Hepatol_2014_May_4_26(5)_553-561.nxml.txt.nlp	24589829	SENT34	16	16	25	25	ethanol	gamma	PA448073	9913	0.393
NULL	Arthritis_Res_Ther_2011_Mar_20_13(2)_R46.nxml.txt.nlp	21418601	SENT255	15	15	21	21	hyaluronan	RHAMM	PA165958431	3161	0.393
NULL	Br_J_Cancer_2006_Feb_13_94(3)_407-426.nxml.txt.nlp	16434996	SENT244	5	5	10	10	genistein	BRCA2	PA165109660	675	0.393
NULL	Breast_Cancer_Res_2012_Jul_19_14(4)_R109.nxml.txt.nlp	22812567	SENT111	13	13	26	26	fluorescein	San	PA164746009	80218	0.393
NULL	Crit_Care_2011_Oct_27_15(Suppl_3)_P22.nxml.txt.nlp	NULL	SENT23	9	9	18	18	hyaluronan	IL-6	PA165958431	3569	0.393
NULL	Iran_J_Pharm_Res_2014_Autumn_13(4)_1369-1378.nxml.txt.nlp	25587326	SENT115	5	5	8	8	ethanol	LCE	PA448073	79071	0.393
NULL	Arch_Public_Health_2014_Aug_18_72(1)_27.nxml.txt.nlp	25180082	SENT151	3	3	17	17	iodine	TRH	PA450049	7200	0.393
NULL	Biomed_Imaging_Interv_J_2006_Oct_1_2(4)_e28.nxml.txt.nlp	21614327	SENT110	15	15	21	21	bevacizumab	San	PA130232992	80218	0.393
NULL	Int_J_Gen_Med_2009_Jul_30_2_19-32.nxml.txt.nlp	20360883	SENT239	17	17	2	2	vasopressin	ACTH	PA451858	5443	0.393
NULL	Nat_Neurosci_2012_Sep_5_15(9)_1245-1254.nxml.txt.nlp	22864611	SENT461	17	17	2	2	haloperidol	mGlu2	PA449841	2912	0.393
NULL	Eur_J_Med_Res_2011_Mar_28_16(3)_93-100.nxml.txt.nlp	21486721	SENT87	37	37	43	43	abacavir	ATV	PA448004	4683	0.393
NULL	Mol_Vis_2014_Nov_16_20_1629-1642.nxml.txt.nlp	25489234	SENT296	3	3	7	7	hyaluronan	HAS2	PA165958431	3037	0.393
NULL	Oncogene_2013_Nov_28_32(48)_5458-5470.nxml.txt.nlp	23435420	SENT72	22	22	28	28	bleomycin	53BP1	PA448645	7158	0.393
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT132	12	12	17	17	doxorubicin	B7-H1	PA449412	29126	0.393
NULL	Child_Adolesc_Psychiatry_Ment_Health_2008_Sep_15_2_25.nxml.txt.nlp	18793405	SENT158	4	4	2	2	atomoxetine	ATX	PA134688071	5168;23049	0.393
NULL	J_Emerg_Trauma_Shock_2012_Oct-Dec_5(4)_285-295.nxml.txt.nlp	23248495	SENT116	11	11	16	16	vasopressin	AVP	PA451858	114548;551	0.393
NULL	Indian_J_Med_Res_2014_Jan_139(1)_76-82.nxml.txt.nlp	24604041	SENT45	14	14	16	16	albendazole	STH	PA164746058	246744	0.393
NULL	Zookeys_2014_Nov_25_(457)_1-14.nxml.txt.nlp	25561827	SENT116	36	36	11	11	ethanol	San	PA448073	80218	0.393
NULL	Clin_Mol_Hepatol_2013_Sep_30_19(3)_195-209.nxml.txt.nlp	24133659	SENT296	2	2	29	29	lamivudine	LAM	PA450163	7249;7248	0.393
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Jun_7_70(Pt_7)_m245-m246.nxml.txt.nlp	25161515	SENT80	25	25	35	35	ethanol	PPN	PA448073	64840	0.393
NULL	Front_Neurosci_2012_Feb_8_6_10.nxml.txt.nlp	22347156	SENT1084	3	3	6	6	allopregnanolone	gamma	PA142320763	9913	0.393
NULL	Iran_J_Reprod_Med_2012_Jul_10(4)_329-336.nxml.txt.nlp	25246894	SENT114	11	11	23	23	protamine	TNP2	PA10366	7142	0.393
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Sep_26_65(Pt_10)_o2520.nxml.txt.nlp	21577967	SENT58	18	18	27	27	ethanol	mol	PA448073	90527	0.393
NULL	Curr_Chem_Genomics_2008_Feb_25_1_43-53.nxml.txt.nlp	20161827	SENT266	13	13	15	15	fluorescein	MEK1	PA164746009	5604	0.393
NULL	Cell_Death_Dis_2010_Jan_21_1(1)_e15.nxml.txt.nlp	21364616	SENT130	13	13	7	7	fluorescein	DCX	PA164746009	1641	0.393
NULL	Reprod_Biol_Endocrinol_2004_Aug_4_2_59.nxml.txt.nlp	15294019	SENT16	1	1	3	3	forskolin	EGF	PA146096022	1950	0.393
NULL	Biomed_Res_Int_2014_Apr_10_2014_580852.nxml.txt.nlp	24812624	SENT131	20	20	8	8	resveratrol	PTEN		5728	0.393
NULL	Clin_Sci_(Lond)_2011_Feb_1_120(Pt_4)_161-167.nxml.txt.nlp	20828371	SENT86	17	17	12	12	propranolol	CTRL	PA451145	1506	0.393
NULL	Biol_Open_2012_Sep_24_1(12)_1185-1191.nxml.txt.nlp	23259052	SENT589	20	20	17	17	oxygen	Q10	PA450744	27161	0.393
NULL	Mar_Drugs_2014_Jun_10_12(6)_3516-3559.nxml.txt.nlp	24918453	SENT456	7	7	25	25	trypsin	MS2	PA451806	101	0.393
NULL	Front_Cell_Neurosci_2014_Jul_28_8_209.nxml.txt.nlp	25120433	SENT735	7	7	10	10	potassium	KCNT1	PA451047	57582	0.393
NULL	Orphanet_J_Rare_Dis_2008_Mar_26_3_8.nxml.txt.nlp	18366757	SENT441	26	26	28	28	azathioprine	NAC	PA448515	22861	0.393
NULL	Br_J_Cancer_2013_Jan_15_108(1)_163-169.nxml.txt.nlp	23257899	SENT25	6	6	2	2	urokinase	CD280	PA451836	9902	0.393
NULL	Cancer_Metab_2013_Dec_23_1_23.nxml.txt.nlp	24359630	SENT37	28	28	16	16	sugar	TKT	PA451529	4921;7086	0.393
NULL	Comp_Funct_Genomics_2012_Feb_6_2012_876893.nxml.txt.nlp	22400011	SENT209	22	22	16	16	zinc	CLP	PA451956	23406;810;8048	0.393
NULL	Cancer_Manag_Res_2012_Nov_9_4_383-395.nxml.txt.nlp	23204869	SENT134	4	4	6	6	carmustine	Bcl-2	PA448810	596	0.393
NULL	Cancer_Metab_2013_Feb_4_1_7.nxml.txt.nlp	24280108	SENT30	11	11	14	14	oxygen	ROS	PA450744	6098	0.393
NULL	Arthritis_Res_Ther_2009_Jan_26_11(1)_R12.nxml.txt.nlp	19171052	SENT239	4	4	20	20	dipyridamole	POMC	PA449367	5443	0.393
NULL	Cancers_(Basel)_2009_Dec_15_1(1)_23-28.nxml.txt.nlp	20535236	SENT126	13	13	28	28	cisplatin	SOD1	PA449014	6647	0.393
NULL	Br_J_Cancer_2012_Apr_24_106(9)_1543-1550.nxml.txt.nlp	22531721	SENT160	11	11	22	22	trastuzumab	CD55	PA451743	1604	0.393
NULL	Cancers_(Basel)_2010_Jan_14_2(1)_1-19.nxml.txt.nlp	24281029	SENT695	19	19	25	25	carboplatin	HER2	PA448803	2064	0.393
NULL	Br_J_Cancer_2010_Jun_29_103(1)_61-72.nxml.txt.nlp	20588279	SENT131	15	15	33	33	phenol	EGF	PA450913	1950	0.393
NULL	J_Hematol_Oncol_2013_Mar_29_6_24.nxml.txt.nlp	23547827	SENT222	3	3	25	25	nadh	MT-CYB	PA164755085	4519	0.393
NULL	Diabetes_Care_2013_Aug_11_36(8)_e120.nxml.txt.nlp	23881974	SENT5	31	31	27	27	liraglutide	GLP-1	PA165958364	100125288	0.393
NULL	Ann_Med_Health_Sci_Res_2013_Oct-Dec_3(4)_498-503.nxml.txt.nlp	24379998	SENT87	32	32	37	37	vincristine	CHOP	PA451879	1649	0.393
NULL	Gut_Liver_2012_Oct_18_6(4)_464-470.nxml.txt.nlp	23170151	SENT21	16	16	13	13	propofol	ESD	PA451141	2098	0.393
NULL	Int_J_Nanomedicine_2012_Sep_13_7_4917-4926.nxml.txt.nlp	23028220	SENT218	21	21	17	17	calcein	mol	PA132595336	90527	0.393
NULL	Int_J_Endocrinol_2010_May_26_2010_906163.nxml.txt.nlp	20585352	SENT78	13	13	18	18	octreotide	MEN1	PA450678	4221	0.393
NULL	Br_J_Dermatol_2009_Feb_160(2)_438-441.nxml.txt.nlp	19016697	SENT96	26	26	19	19	methotrexate	FPGS	PA450428	2356	0.393
NULL	Virol_J_2011_May_17_8_234.nxml.txt.nlp	21575275	SENT11	11	11	25	25	ribavirin	RVR	PA451241	9975	0.393
NULL	Acta_Pharmacol_Sin_2011_Jan_20_32(1)_108-115.nxml.txt.nlp	21170082	SENT167	34	34	37	37	phenol	SLB	PA450913	26160	0.393
NULL	Indian_J_Endocrinol_Metab_2013_Jan-Feb_17(1)_91-94.nxml.txt.nlp	23776858	SENT101	24	24	21	21	exenatide	GLP-1	PA164749238	100125288	0.393
NULL	Front_Genet_2014_Dec_22_5_445.nxml.txt.nlp	25566327	SENT259	38	38	18	18	pp2	PP1		5540;5464	0.393
NULL	Oncotarget_2013_Aug_24_4(10)_1618-1631.nxml.txt.nlp	24113128	SENT130	8	8	4	4	sorafenib	p53	PA7000	7157	0.393
NULL	ScientificWorldJournal_2013_Nov_5_2013_383574.nxml.txt.nlp	24298214	SENT137	16	16	0	0	phenol	TIC	PA450913	23550	0.392
NULL	Springerplus_2014_Sep_11_3_516.nxml.txt.nlp	25279308	SENT155	17	17	1	1	ethanol	SHF	PA448073	90525	0.392
NULL	Br_J_Cancer_2009_Mar_24_100(6)_932-940.nxml.txt.nlp	19240717	SENT232	42	42	45	45	oxygen	ROS	PA450744	6098	0.392
NULL	J_Immunol_Res_2014_Oct_12_2014_570685.nxml.txt.nlp	25371908	SENT146	8	8	23	23	levofloxacin	IFN	PA450214	3439	0.392
NULL	J_Carcinog_2011_Jun_17_10_16.nxml.txt.nlp	NULL	SENT209	22	22	10	10	spermine	ODC	PA164781199	4953;89874	0.392
NULL	Curr_Pharm_Biotechnol_2011_Jan_12(1)_35-41.nxml.txt.nlp	20932261	SENT73	25	25	22	22	hyperforin	TRPC6	PA165985514	7225	0.392
NULL	Acta_Pharmacol_Sin_2012_May_4_33(5)_710-716.nxml.txt.nlp	22555373	SENT119	11	11	8	8	phenylbutazone	DOM	PA450932	6663	0.392
NULL	Neuroimage_Clin_2013_Sep_6_3_290-300.nxml.txt.nlp	24273714	SENT114	23	23	32	32	pioglitazone	spatial	PA450970	219793	0.392
NULL	Mediators_Inflamm_2010_Jun_21_2010_194896.nxml.txt.nlp	20652055	SENT48	28	28	32	32	olmesartan	mol	PA164742950	90527	0.392
NULL	Cell_Cycle_2014_Jan_15_13(2)_303-314.nxml.txt.nlp	24247149	SENT133	2	2	16	16	gemcitabine	p53	PA449748	7157	0.392
NULL	Br_J_Cancer_1996_Mar_73(5)_596-602.nxml.txt.nlp	8605092	SENT8	13	13	24	24	doxorubicin	P-gp	PA449412	5243	0.392
NULL	J_Asthma_Allergy_2013_Feb_22_6_31-39.nxml.txt.nlp	23459334	SENT103	5	5	9	9	rupatadine	ANOVA		4858	0.392
NULL	Arthritis_Res_Ther_2012_Dec_7_14(6)_R265.nxml.txt.nlp	23217273	SENT178	14	14	16	16	lenalidomide	CLE	PA162363968	51637	0.392
NULL	Nat_Commun_2014_Apr_23_5_3729.nxml.txt.nlp	24759783	SENT113	21	21	24	24	oxygen	ROS	PA450744	6098	0.392
NULL	Breast_Cancer_(Dove_Med_Press)_2014_Dec_9_6_191-203.nxml.txt.nlp	25525387	SENT202	21	21	2	2	oseltamivir	EGF	PA450721	1950	0.392
NULL	Front_Syst_Neurosci_2014_Feb_4_8_10.nxml.txt.nlp	24550791	SENT817	10	10	12	12	l-arginine	MELAS	PA448478	4219	0.392
NULL	Indian_J_Endocrinol_Metab_2011_Jul-Sep_15(3)_220-223.nxml.txt.nlp	21897903	SENT57	8	8	16	16	cyclophosphamide	CHOP	PA449165	1649	0.392
NULL	Mol_Neurobiol_2007_Oct_10_36(2)_137-151.nxml.txt.nlp	17952658	SENT388	10	10	4	4	vasopressin	CXCL12	PA451858	6387	0.392
NULL	J_Biol_Chem_2009_Oct_9_284(41)_28146-28155.nxml.txt.nlp	19654320	SENT61	16	16	9	9	nadh	ADP	PA164755085	23038	0.392
NULL	Glia_2009_Dec_20_57(16)_1802-1814.nxml.txt.nlp	19459212	SENT59	18	18	10	10	glutaraldehyde	PLP	PA449777	25824;5744	0.392
NULL	Cancer_Med_2012_Oct_16_1(2)_207-217.nxml.txt.nlp	23342270	SENT210	32	32	16	16	saracatinib	PIK3CA		5290	0.392
NULL	Int_J_Endocrinol_2014_Apr_30_2014_674987.nxml.txt.nlp	24883061	SENT63	15	15	6	6	nadh	GAPDH	PA164755085	2597	0.392
NULL	Mol_Neurobiol_2007_Oct_10_36(2)_137-151.nxml.txt.nlp	17952658	SENT388	39	39	33	33	vasopressin	CXCL12	PA451858	6387	0.392
NULL	Open_Virol_J_2014_Mar_7_8_1-8.nxml.txt.nlp	24799968	SENT240	5	5	19	19	ribavirin	IFN	PA451241	3439	0.392
NULL	Behav_Brain_Funct_2009_Jun_4_5_23.nxml.txt.nlp	19497110	SENT76	9	9	23	23	ethanol	P15	PA448073	1030;29107	0.392
NULL	Adv_Appl_Bioinforma_Chem_2008_Oct_30_1_85-98.nxml.txt.nlp	21918608	SENT68	9	9	22	22	bortezomib	SPARC	PA10252	6678	0.392
NULL	J_Antimicrob_Chemother_2011_Apr_25_66(4)_912-919.nxml.txt.nlp	21393205	SENT156	17	17	10	10	daptomycin	CLCR	PA164768820	11330	0.392
NULL	Brain_2014_Feb_24_137(2)_335-353.nxml.txt.nlp	24369379	SENT218	19	19	14	14	galactose	mtSSB	PA449725	6742	0.392
NULL	Breast_Cancer_Res_2003_Jun_5_5(5)_R110-R113.nxml.txt.nlp	12927040	SENT96	9	9	7	7	thyroglobulin	TPO	PA164754910	7066;7173	0.392
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT110	0	0	2	2	resveratrol	IL-6		3569	0.392
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_May_7_64(Pt_6)_o1009.nxml.txt.nlp	21202535	SENT62	1	1	11	11	ethanol	mol	PA448073	90527	0.392
NULL	Pharmaceuticals_(Basel)_2014_Sep_17_7(9)_943-953.nxml.txt.nlp	25232798	SENT19	0	0	13	13	trastuzumab	San	PA451743	80218	0.392
NULL	J_Clin_Biochem_Nutr_2009_Mar_28_44(2)_185-195.nxml.txt.nlp	19308273	SENT13	15	15	18	18	oxygen	ROS	PA450744	6098	0.392
NULL	J_Hum_Genet_2013_Jun_16_58(6)_353-361.nxml.txt.nlp	23677058	SENT157	2	2	7	7	cytarabine	CNT3	PA449177	64078	0.392
NULL	Nucleic_Acids_Res_2014_Jan_25_42(2)_952-967.nxml.txt.nlp	24163258	SENT92	33	33	15	15	paraformaldehyde	mtSSB	PA450790	6742	0.392
NULL	J_Hematol_Oncol_2011_Apr_1_4_13.nxml.txt.nlp	21453545	SENT90	19	19	22	22	oxygen	ROS	PA450744	6098	0.392
NULL	J_Orthop_Surg_2007_May_21_2_9.nxml.txt.nlp	17511887	SENT91	19	19	2	2	alendronate	DPD	PA448082	1806	0.392
NULL	AMB_Express_2011_Jul_13_1_16.nxml.txt.nlp	21906371	SENT9	10	10	15	15	nitrogen	PTS	PA450643	5805	0.391
NULL	Breast_Cancer_Res_2011_Sep_22_13(5)_R93.nxml.txt.nlp	21939528	SENT35	26	26	16	16	tamoxifen	EGFR	PA451581	1956	0.391
NULL	Biomed_Res_Int_2014_Jan_29_2014_196249.nxml.txt.nlp	24605321	SENT207	12	12	26	26	bortezomib	c-Myc	PA10252	4609	0.391
NULL	Eur_J_Histochem_2014_Nov_28_58(4)_2452.nxml.txt.nlp	25578977	SENT237	13	13	10	10	hyaluronidase	PH-20	PA164745713	6677	0.391
NULL	Cancer_Cell_Int_2011_May_15_11_13.nxml.txt.nlp	21569620	SENT144	25	25	28	28	bortezomib	PC-3	PA10252	692094	0.391
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jan_12_67(Pt_2)_o323.nxml.txt.nlp	21523009	SENT66	27	27	6	6	coumarin	C11	PA134521193	1109	0.391
NULL	Arch_Med_Sci_2010_Dec_29_6(6)_829-836.nxml.txt.nlp	22427753	SENT66	16	16	34	34	mitomycin	San	PA450524	80218	0.391
NULL	BMB_Rep_2013_Feb_46(2)_97-102.nxml.txt.nlp	23433112	SENT539	5	5	26	26	decitabine	HDAC1	PA164749631	3065	0.391
NULL	Head_Face_Med_2007_Mar_12_3_14.nxml.txt.nlp	17352809	SENT13	17	17	38	38	bleomycin	gamma	PA448645	9913	0.391
NULL	Mol_Neurodegener_2010_Nov_10_5_49.nxml.txt.nlp	21067594	SENT32	13	13	16	16	oxygen	ROS	PA450744	6098	0.391
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Jun_7_64(Pt_7)_o1230.nxml.txt.nlp	21202867	SENT62	1	1	7	7	coumarin	C10	PA134521193	113246	0.391
NULL	Epigenetics_2012_Nov_1_7(11)_1225-1229.nxml.txt.nlp	23069641	SENT52	27	27	11	11	cisplatin	BRCA1	PA449014	672	0.391
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT616	41	41	21	21	aripiprazole	PRL	PA10026	5617	0.391
NULL	Oncotarget_2014_Aug_19_5(18)_8737-8749.nxml.txt.nlp	25228590	SENT79	0	0	10	10	crizotinib	MYCN	PA165946122	4613	0.391
NULL	Int_J_Chron_Obstruct_Pulmon_Dis_2006_Jun_1(2)_99-106.nxml.txt.nlp	18046886	SENT27	4	4	7	7	oxygen	ROS	PA450744	6098	0.391
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2007_Dec_12_64(Pt_1)_m176.nxml.txt.nlp	21200524	SENT57	17	17	5	5	ciprofloxacin	NO3	PA449009	4681	0.391
NULL	Basic_Res_Cardiol_2011_Sep_20_106(5)_735-747.nxml.txt.nlp	21598086	SENT1	14	14	17	17	oxygen	ROS	PA450744	6098	0.391
NULL	Int_J_Fertil_Steril_2011_Dec_22_Oct-Dec_5(3)_174-185.nxml.txt.nlp	25101162	SENT34	9	9	12	12	oxygen	ROS	PA450744	6098	0.391
NULL	Iran_J_Parasitol_2014_Mar_9(1)_6-13.nxml.txt.nlp	25642254	SENT31	11	11	14	14	oxygen	ROS	PA450744	6098	0.391
NULL	Indian_J_Urol_2009_Oct-Dec_25(4)_427-436.nxml.txt.nlp	19955664	SENT85	19	19	21	21	sunitinib	IFN	PA162372840	3439	0.391
NULL	Acta_Myol_2010_Oct_29(2)_343-350.nxml.txt.nlp	21314017	SENT56	12	12	16	16	choline	CHAT	PA448976	1103	0.391
NULL	Orthop_J_Sports_Med_2014_May_1_2(5)_http_ojs_sagepub_com_content_2_5_2325967114529537_full.nxml.txt.nlp	25401118	SENT256	44	44	41	41	ketorolac	ACL	PA450150	47	0.391
NULL	Plant_Methods_2013_Jul_10_9_25.nxml.txt.nlp	23841995	SENT181	10	10	14	14	mannitol	MGL	PA450320	11343	0.391
NULL	Br_J_Cancer_2013_Jun_25_108(12)_2549-2556.nxml.txt.nlp	23703247	SENT79	19	19	9	9	bevacizumab	TRG	PA130232992	6965	0.391
NULL	Biochimie_2012_Sep_94(9)_1997-2005.nxml.txt.nlp	22659570	SENT55	2	2	6	6	propranolol	DDP	PA451145	1678	0.391
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT33	11	11	13	13	glucose	EGFR	PA449773	1956	0.391
NULL	Breast_Cancer_Res_2014_Sep_25_16(5)_444.nxml.txt.nlp	25252859	SENT406	0	0	5	5	doxycycline	RELA	PA449415	5970	0.391
NULL	Biotechnol_Res_Int_2014_Jun_9_2014_674286.nxml.txt.nlp	25009746	SENT252	21	21	18	18	l-histidine	X11	PA449882	320	0.391
NULL	Vet_Res_Forum_2012_Summer_3(3)_159-165.nxml.txt.nlp	25610563	SENT127	12	12	15	15	lipase	adiponectin	PA450239	9370	0.391
NULL	Cell_Commun_Signal_2013_Feb_20_11_13.nxml.txt.nlp	23425659	SENT290	24	24	10	10	l-glutamine	CO2	PA10090	4513	0.391
NULL	Ann_Thorac_Med_2013_Oct-Dec_8(4)_204-208.nxml.txt.nlp	24250733	SENT58	13	13	15	15	erlotinib	EGFR	PA134687924	1956	0.391
NULL	Case_Rep_Med_2011_Jun_5_2011_743817.nxml.txt.nlp	21687548	SENT125	5	5	28	28	fluorescein	PC5	PA164746009	5125	0.391
NULL	Carcinogenesis_2014_Sep_1_35(9)_1983-1992.nxml.txt.nlp	24692066	SENT173	6	6	15	15	doxycycline	CXCR4	PA449415	7852	0.391
NULL	Arthritis_Res_2002_Sep_16_4(6)_R12.nxml.txt.nlp	12453315	SENT8	41	41	12	12	methotrexate	CRP	PA450428	1401;140913	0.391
NULL	Clin_Med_Insights_Oncol_2011_Sep_21_5_315-323.nxml.txt.nlp	22084620	SENT8	38	38	25	25	gemcitabine	IL-2	PA449748	3558	0.391
NULL	Int_J_Mol_Sci_2014_Oct_8_15(10)_17974-17999.nxml.txt.nlp	25299695	SENT122	26	26	7	7	curcumin	HO-1	PA151958596	3162	0.391
NULL	J_Gen_Physiol_1936_Jul_20_19(6)_991-1007.nxml.txt.nlp	19872978	SENT0	20	20	1	1	trypsin	Gen	PA451806	348654	0.391
NULL	Eur_J_Clin_Pharmacol_2008_Feb_26_64(2)_133-157.nxml.txt.nlp	18224312	SENT182	10	10	7	7	metformin	OCT1	PA450395	5451;6580	0.391
NULL	Exp_Diabetes_Res_2012_Dec_30_2012_256707.nxml.txt.nlp	23346100	SENT34	11	11	6	6	glucosamine	STZ	PA164747613	6484	0.391
NULL	Pharmaceuticals_(Basel)_2011_Oct_27_4(11)_1450-1474.nxml.txt.nlp	NULL	SENT326	13	13	22	22	taurine	NFkappaB	PA451590	4790	0.391
NULL	Environ_Health_Perspect_2008_Mar_13_116(3)_340-348.nxml.txt.nlp	18335101	SENT46	32	32	26	26	choline	HC3	PA448976	5683;360177	0.39
NULL	Br_J_Cancer_2009_Oct_6_101(7)_1155-1161.nxml.txt.nlp	19738614	SENT15	15	15	6	6	gemcitabine	MUC4	PA449748	4585	0.39
NULL	Fibrogenesis_Tissue_Repair_2012_Jan_3_5_1.nxml.txt.nlp	22214245	SENT185	30	30	13	13	ribavirin	IL28B	PA451241	282617	0.39
NULL	Oncotarget_2014_Aug_29_5(18)_8052-8082.nxml.txt.nlp	25211298	SENT409	0	0	5	5	ritonavir	MRP-1	PA451260	928	0.39
NULL	Cell_Mol_Life_Sci_2012_Apr_22_69(8)_1353-1375.nxml.txt.nlp	22105709	SENT281	0	0	8	8	chlorpromazine	AP-2	PA448964	7020	0.39
NULL	Cancer_Immunol_Immunother_2008_Jul_7_57(7)_931-950.nxml.txt.nlp	18256831	SENT429	9	9	11	11	cyclophosphamide	IL-2	PA449165	3558	0.39
NULL	ScientificWorldJournal_2013_Jun_5_2013_704912.nxml.txt.nlp	23844410	SENT273	17	17	35	35	boceprevir	MRB	PA165948902	54538	0.39
NULL	Biomed_Res_Int_2014_Jun_26_2014_161346.nxml.txt.nlp	25054130	SENT240	45	45	30	30	curcumin	STZ	PA151958596	6484	0.39
NULL	Diabetes_Care_2010_Feb_33(2)_453-455.nxml.txt.nlp	20103562	SENT55	0	0	10	10	sitagliptin	HIP	PA164748978	6767;6159;64399;5068	0.39
NULL	Indian_J_Anaesth_2010_Jul-Aug_54(4)_355-356.nxml.txt.nlp	20882187	SENT10	5	5	17	17	propofol	ETO	PA451141	862	0.39
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT394	20	20	12	12	heparin	FGF2	PA449855	2247;2258	0.39
NULL	Ther_Clin_Risk_Manag_2006_Dec_2(4)_365-375.nxml.txt.nlp	18360649	SENT191	11	11	2	2	abatacept	ACR	PA164747080	49	0.39
NULL	J_Exp_Med_1961_Oct_31_114(5)_761-778.nxml.txt.nlp	19867206	SENT6	19	19	24	24	nitrogen	ACTH	PA450643	5443	0.39
NULL	F1000Res_2013_Jul_8_2_148.nxml.txt.nlp	24358859	SENT89	24	24	6	6	trypsin	E16	PA451806	8140	0.39
NULL	Br_J_Pharmacol_2008_Nov_11_155(6)_896-905.nxml.txt.nlp	18695641	SENT111	0	0	25	25	genistein	CTX	PA165109660	1593	0.39
NULL	Allergy_Asthma_Clin_Immunol_2010_Jul_28_6(1)_23.nxml.txt.nlp	20667126	SENT196	9	9	18	18	icatibant	FAST1	PA164749185	8928	0.39
NULL	Front_Zool_2011_Nov_29_8_31.nxml.txt.nlp	22126599	SENT129	33	33	33	33	pp2	PP2		4888	0.39
NULL	Int_J_Mol_Sci_2014_Sep_25_15(9)_17065-17076.nxml.txt.nlp	25257528	SENT56	5	5	7	7	decitabine	DAC	PA164749631	13	0.39
NULL	J_Inflamm_(Lond)_2008_Mar_10_5_4.nxml.txt.nlp	18331642	SENT46	8	8	27	27	dextran	IL-10	PA449261	3586	0.39
NULL	Lab_Invest_2010_Nov_28_90(11)_1573-1581.nxml.txt.nlp	20585312	SENT73	27	27	22	22	telmisartan	MCP-1	PA451605	6347	0.39
NULL	Eur_J_Clin_Pharmacol_2008_Feb_26_64(2)_133-157.nxml.txt.nlp	18224312	SENT544	11	11	38	38	trimipramine	CYP2D6	PA451791	1565	0.39
NULL	Cell_Commun_Signal_2010_Sep_22_8_27.nxml.txt.nlp	20860841	SENT152	7	7	10	10	tetracycline	Wip1	PA451640	8493	0.39
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT27	9	9	12	12	pemetrexed	UNG	PA10810	7374	0.39
NULL	Br_J_Haematol_2008_Jun_141(5)_659-671.nxml.txt.nlp	18410446	SENT34	2	2	17	17	cerulenin	JNK	PA164764551	5599	0.39
NULL	Iran_J_Pharm_Res_2014_Autumn_13(4)_1369-1378.nxml.txt.nlp	25587326	SENT145	5	5	8	8	ethanol	LCE	PA448073	79071	0.39
NULL	Evid_Based_Complement_Alternat_Med_2014_May_14_2014_756406.nxml.txt.nlp	24959191	SENT31	39	39	21	21	cyclophosphamide	CO2	PA449165	4513	0.39
NULL	Front_Oncol_2013_Oct_4_3_241.nxml.txt.nlp	24109588	SENT390	25	25	27	27	temozolomide	gamma	PA451609	9913	0.39
NULL	Nature_2012_Feb_23_482(7386)_524-528.nxml.txt.nlp	22358842	SENT135	7	7	17	17	collagenase	F10	PA449107	2159	0.39
NULL	Acta_Pharmacol_Sin_2009_Oct_21_30(10)_1392-1398.nxml.txt.nlp	19767766	SENT24	1	1	4	4	oxygen	ROS	PA450744	6098	0.39
NULL	Part_Fibre_Toxicol_2011_Aug_2_8_23.nxml.txt.nlp	21810225	SENT329	23	23	14	14	streptomycin	FBS	PA451512	64319;26269	0.39
NULL	Int_J_Endocrinol_2013_Nov_13_2013_686315.nxml.txt.nlp	24324494	SENT72	15	15	23	23	nateglinide	CYP2C8	PA450600	1558	0.39
NULL	Iran_Red_Crescent_Med_J_2014_Aug_5_16(8)_e6915.nxml.txt.nlp	25389496	SENT164	11	11	21	21	rosuvastatin	adiponectin	PA134308647	9370	0.39
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jun_2_68(Pt_7)_o1996.nxml.txt.nlp	22807827	SENT68	30	30	19	19	ethanol	mol	PA448073	90527	0.39
NULL	Indian_J_Pharmacol_2008_Jan-Feb_40(1)_15-18.nxml.txt.nlp	21264155	SENT128	11	11	15	15	ethanol	flower	PA448073	11094	0.39
NULL	Clin_Pract_2012_Sep_3_2(3)_e79.nxml.txt.nlp	24765478	SENT68	14	14	6	6	creatine	ASAT	PA164778930	22	0.39
NULL	Tanaffos_2013_12(1)_6-15.nxml.txt.nlp	25191444	SENT60	27	27	17	17	ofloxacin	PTH	PA450684	5741	0.39
NULL	Front_Neurosci_2012_May_30_6_77.nxml.txt.nlp	22661925	SENT694	12	12	6	6	ethanol	NFkappaB	PA448073	4790	0.39
NULL	J_Cell_Physiol_2012_Apr_26_227(4)_1485-1492.nxml.txt.nlp	21618539	SENT16	2	2	20	20	clozapine	IRS1	PA449061	3667	0.39
NULL	Environ_Health_Perspect_2006_Mar_6_114(3)_404-411.nxml.txt.nlp	16507464	SENT142	2	2	6	6	betaine	BHMT	PA448603	635	0.39
NULL	Clin_Exp_Reprod_Med_2014_Sep_30_41(3)_120-124.nxml.txt.nlp	25309856	SENT10	16	16	18	18	thyroglobulin	ADAMTS16	PA164754910	170690	0.39
NULL	ScientificWorldJournal_2013_Jun_19_2013_174392.nxml.txt.nlp	23853530	SENT156	26	26	28	28	doxazosin	PC-3	PA449407	692094	0.39
NULL	Front_Neurosci_2013_Feb_26_7_22.nxml.txt.nlp	23550229	SENT750	0	0	7	7	estradiol	RFRP	PA449503	64111	0.39
NULL	Exp_Mol_Med_2012_Apr_30_44(4)_281-292.nxml.txt.nlp	22228119	SENT7	14	14	9	9	genistein	activin	PA165109660	83729	0.39
NULL	Drug_Des_Devel_Ther_2014_Sep_9_8_1307-1314.nxml.txt.nlp	25246772	SENT7	29	29	40	40	cyclosporine	HTX	PA449167	7547	0.39
NULL	Clin_Dev_Immunol_2011_Mar_22_2011_790460.nxml.txt.nlp	21603161	SENT409	4	4	7	7	atorvastatin	OED	PA448500	4961	0.389
NULL	Int_J_Environ_Res_Public_Health_2010_Dec_21_7(12)_4281-4304.nxml.txt.nlp	21318009	SENT385	7	7	2	2	ethanol	spatial	PA448073	219793	0.389
NULL	Cancers_(Basel)_2012_Sep_6_4(3)_873-903.nxml.txt.nlp	24213471	SENT665	15	15	3	3	hyaluronidase	HYAL1	PA164745713	3373	0.389
NULL	Biol_Open_2014_May_23_3(6)_494-502.nxml.txt.nlp	24857849	SENT388	1	1	6	6	paclitaxel	PC3	PA450761	57332;7832;5122	0.389
NULL	Oncotarget_2014_Sep_10_5(19)_8924-8936.nxml.txt.nlp	25238040	SENT43	9	9	22	22	decitabine	p53	PA164749631	7157	0.389
NULL	Cells_2014_Apr_29_3(2)_331-362.nxml.txt.nlp	24785347	SENT273	0	0	16	16	lidocaine	TRPA1	PA450226	8989	0.389
NULL	Front_Physiol_2010_Jul_15_1_14.nxml.txt.nlp	21423357	SENT120	24	24	12	12	phenol	C-1	PA450913	5203	0.389
NULL	Iran_J_Neurol_2014_Apr_3_13(2)_108-109.nxml.txt.nlp	25295156	SENT15	14	14	17	17	creatine	AGAT	PA164778930	2628	0.389
NULL	Pain_Res_Treat_2013_Jan_27_2013_960270.nxml.txt.nlp	NULL	SENT4	7	7	20	20	milnacipran	NNT	PA164752812	23530	0.389
NULL	Ann_Intensive_Care_2011_Mar_21_1_3.nxml.txt.nlp	21906325	SENT111	7	7	11	11	cisplatin	EPO	PA449014	7076;8288;2056	0.389
NULL	Chromatographia_2011_Jan_9_73(1-2)_123-128.nxml.txt.nlp	21423319	SENT32	0	0	3	3	formaldehyde	CAS	PA449703	1434;9564	0.389
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2007_Dec_6_64(Pt_1)_o82.nxml.txt.nlp	21200959	SENT65	30	30	24	24	ethanol	mol	PA448073	90527	0.389
NULL	Contemp_Clin_Dent_2011_Oct-Dec_2(4)_278-282.nxml.txt.nlp	22346152	SENT94	16	16	6	6	potassium	GCF	PA451047	6936	0.389
NULL	Cell_Death_Dis_2014_Mar_13_5(3)_e1118.nxml.txt.nlp	24625977	SENT284	24	24	28	28	etoposide	UBXN2A	PA449552	165324	0.389
NULL	Cancer_Med_2013_Feb_3_2(1)_11-20.nxml.txt.nlp	24133623	SENT277	13	13	15	15	irinotecan	KRAS	PA450085	3845	0.389
NULL	Oncoscience_2014_Mar_12_1(2)_158-166.nxml.txt.nlp	25594008	SENT64	14	14	6	6	dasatinib	ANXA1	PA162372878	301	0.389
NULL	Biomed_Res_Int_2014_Jan_20_2014_948427.nxml.txt.nlp	24563867	SENT81	18	18	21	21	urea	STZ	PA451831	6484	0.389
NULL	Amino_Acids_2012_May_25_42(5)_1529-1539.nxml.txt.nlp	21437784	SENT92	2	2	26	26	taurine	LOX-1	PA451590	4973	0.389
NULL	Crit_Care_2011_Aug_11_15(4)_226.nxml.txt.nlp	21892977	SENT402	33	33	0	0	vasopressin	ACTH	PA451858	5443	0.389
NULL	J_Ophthalmol_2011_Jun_12_2011_742020.nxml.txt.nlp	21772985	SENT119	15	15	6	6	ranibizumab	CRT	PA164746012	811	0.389
NULL	Springerplus_2014_Sep_9_3_510.nxml.txt.nlp	25279302	SENT35	4	4	21	21	creatine	SLC6A8	PA164778930	6535	0.389
NULL	Crit_Care_2007_Mar_22_11(Suppl_2)_P423.nxml.txt.nlp	NULL	SENT5	31	31	26	26	midazolam	SOC	PA450496	91544	0.389
NULL	J_Cell_Biol_1998_May_4_141(3)_839-847.nxml.txt.nlp	9566981	SENT81	13	13	9	9	guanidine	osteoadherin	PA164781028	4958	0.389
NULL	Front_Synaptic_Neurosci_2014_Sep_5_6_18.nxml.txt.nlp	25249974	SENT480	22	22	18	18	galantamine	PAM	PA449726	5066;23077	0.389
NULL	Arch_Dis_Child_2014_Dec_8_99(12)_1143-1146.nxml.txt.nlp	25202131	SENT58	7	7	5	5	theophylline	CYP1A2	PA451647	1544	0.389
NULL	Nucleic_Acids_Res_2005_Oct_6_33(18)_e154.nxml.txt.nlp	16214805	SENT116	24	24	30	30	ampicillin	SOC	PA448419	91544	0.389
NULL	Mol_Biol_Cell_2014_Jan_1_25(1)_184-195.nxml.txt.nlp	24196835	SENT277	26	26	21	21	l-glutamine	FBS	PA10090	64319;26269	0.389
NULL	Oncol_Rep_2012_Apr_30_27(4)_923-928.nxml.txt.nlp	22209766	SENT127	5	5	19	19	erlotinib	EGFR	PA134687924	1956	0.389
NULL	Front_Oncol_2014_Jun_12_4_144.nxml.txt.nlp	24971229	SENT59	2	2	33	33	cisplatin	MLH1	PA449014	4292	0.389
NULL	Nucleic_Acids_Res_2011_Mar_4_39(5)_1843-1854.nxml.txt.nlp	21051342	SENT198	35	35	14	14	carbenicillin	IFN	PA448788	3439	0.389
NULL	Korean_J_Anesthesiol_2013_Jun_24_64(6)_494-499.nxml.txt.nlp	23814648	SENT152	22	22	12	12	mepivacaine	G30	PA164748741	282706	0.389
NULL	Adv_Ther_2013_Oct_25_30(10)_870-884.nxml.txt.nlp	24158787	SENT121	16	16	19	19	exemestane	gamma	PA449563	9913	0.389
NULL	Breast_Cancer_Res_2008_Dec_18_10(Suppl_4)_S26.nxml.txt.nlp	19128440	SENT61	19	19	11	11	anastrozole	IMPACT	PA448432	55364	0.389
NULL	Int_J_Anal_Chem_2013_Jul_16_2013_419716.nxml.txt.nlp	23956748	SENT72	10	10	26	26	ethanol	PF6	PA448073	200162	0.389
NULL	Ann_Surg_Oncol_2010_Apr_20_17(4)_1168-1176.nxml.txt.nlp	19936839	SENT204	13	13	15	15	irinotecan	KRAS	PA450085	3845	0.389
NULL	J_Korean_Assoc_Oral_Maxillofac_Surg_2014_Dec_26_40(6)_291-296.nxml.txt.nlp	25551094	SENT45	15	15	9	9	l-glutamine	CO2	PA10090	4513	0.388
NULL	Int_J_Gen_Med_2012_Jul_19_5_603-611.nxml.txt.nlp	22924007	SENT152	14	14	36	36	albendazole	gamma	PA164746058	9913	0.388
NULL	Aging_(Albany_NY)_2009_Mar_31_1(4)_412-424.nxml.txt.nlp	20195491	SENT29	0	0	7	7	resveratrol	TXNIP		10628	0.388
NULL	Cancer_Med_2014_Jun_8_3(3)_681-692.nxml.txt.nlp	24711160	SENT151	8	8	1	1	bevacizumab	San	PA130232992	80218	0.388
NULL	Cell_Cycle_2012_Nov_1_11(21)_3983-3996.nxml.txt.nlp	22987153	SENT204	18	18	14	14	mitomycin	DNA-PKcs	PA450524	5591	0.388
NULL	Int_J_Endocrinol_2014_Apr_30_2014_674987.nxml.txt.nlp	24883061	SENT66	6	6	11	11	acetone	DAG	PA448025	1605	0.388
NULL	Mol_Cancer_2012_Dec_12_11_91.nxml.txt.nlp	23234355	SENT200	19	19	16	16	erlotinib	HER2	PA134687924	2064	0.388
NULL	Diabetes_Obes_Metab_2012_Apr_14(4)_304-314.nxml.txt.nlp	22051096	SENT185	13	13	0	0	exenatide	San	PA164749238	80218	0.388
NULL	Cells_2014_Jun_11_3(2)_592-615.nxml.txt.nlp	24921185	SENT203	17	17	20	20	oxygen	ROS	PA450744	6098	0.388
NULL	Case_Rep_Endocrinol_2011_Aug_11_2011_246872.nxml.txt.nlp	22937279	SENT37	5	5	11	11	thyroglobulin	TTF-1	PA164754910	7080	0.388
NULL	Exp_Ther_Med_2013_Apr_29_5(4)_1093-1096.nxml.txt.nlp	23596475	SENT79	37	37	29	29	ketamine	IL-6	PA450144	3569	0.388
NULL	Endocrinology_2014_Nov_21_155(11)_4380-4390.nxml.txt.nlp	25144923	SENT465	5	5	3	3	vasopressin	CREB3L1	PA451858	90993	0.388
NULL	Biomed_Res_Int_2013_Jan_27_2013_456352.nxml.txt.nlp	23509724	SENT149	1	1	5	5	galactose	MGL	PA449725	11343	0.388
NULL	Case_Rep_Neurol_Med_2012_Jul_24_2012_183252.nxml.txt.nlp	22953086	SENT73	23	23	10	10	amitriptyline	CYP2C8	PA448385	1558	0.388
NULL	Biologics_2014_Apr_22_8_193-198.nxml.txt.nlp	24790412	SENT126	22	22	43	43	methotrexate	Yes	PA450428	7525	0.388
NULL	Breast_Cancer_Res_2007_Dec_20_9(Suppl_2)_S22.nxml.txt.nlp	NULL	SENT86	3	3	28	28	raloxifene	STAR	PA451221	6770;2984	0.388
NULL	Oncotarget_2014_Jun_4_5(18)_8284-8305.nxml.txt.nlp	25268740	SENT254	46	46	33	33	l-glutamine	FBS	PA10090	64319;26269	0.388
NULL	Coron_Artery_Dis_2014_Sep_6_25(6)_510-515.nxml.txt.nlp	24859356	SENT171	14	14	9	9	dalteparin	ACT	PA165958404	12;11332;9457;641455	0.388
NULL	Gut_Liver_2013_Nov_14_7(6)_696-703.nxml.txt.nlp	24312711	SENT128	19	19	1	1	sorafenib	SHARP	PA7000	23013	0.388
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_16_2012_395912.nxml.txt.nlp	23118789	SENT75	9	9	22	22	diclofenac	UGT1A3	PA449293	54659	0.388
NULL	Diabetes_2013_Oct_17_62(10)_3547-3552.nxml.txt.nlp	23863812	SENT80	47	47	8	8	valsartan	adiponectin	PA451848	9370	0.388
NULL	Exp_Hematol_2014_Dec_42(12)_1053-1058_e1.nxml.txt.nlp	25127743	SENT17	22	22	15	15	potassium	KCNQ1	PA451047	3784	0.388
NULL	Br_J_Pharmacol_2008_Nov_11_155(6)_896-905.nxml.txt.nlp	18695641	SENT36	5	5	25	25	genistein	OPG	PA165109660	690	0.388
NULL	Ann_Indian_Acad_Neurol_2011_Jul_14(Suppl1)_S11-S13.nxml.txt.nlp	21847317	SENT8	33	33	39	39	rasagiline	COMT	PA164764584	1312	0.388
NULL	Crit_Care_2007_Mar_22_11(Suppl_2)_P423.nxml.txt.nlp	NULL	SENT5	29	29	26	26	propofol	SOC	PA451141	91544	0.388
NULL	Acta_Pharmacol_Sin_2011_Jul_9_32(7)_879-887.nxml.txt.nlp	21552292	SENT12	2	2	11	11	metformin	AKT	PA450395	207	0.388
NULL	Front_Genet_2014_Jun_30_5_189.nxml.txt.nlp	25071820	SENT725	7	7	3	3	oxygen	HMGA1	PA450744	3159	0.388
NULL	Front_Physiol_2013_Dec_24_4_386.nxml.txt.nlp	24399968	SENT368	10	10	29	29	diazoxide	ABCC8	PA449285	6833	0.388
NULL	Front_Neurol_2014_Sep_11_5_173.nxml.txt.nlp	25309501	SENT242	29	29	17	17	hyaluronidase	HYAL1	PA164745713	3373	0.388
NULL	Oncoimmunology_2013_Feb_1_2(2)_e23080.nxml.txt.nlp	23525357	SENT46	7	7	12	12	imatinib	IL-2	PA10804	3558	0.388
NULL	Neuroscience_2010_Feb_17_165(4)_1412-1419.nxml.txt.nlp	19961905	SENT165	34	34	37	37	capsaicin	TRPV1	PA448776	7442	0.388
NULL	Exp_Ther_Med_2014_Jul_8_8(1)_291-301.nxml.txt.nlp	24944637	SENT90	27	27	18	18	fluorescein	San	PA164746009	80218	0.388
NULL	Biomed_Res_Int_2013_Jan_28_2013_612369.nxml.txt.nlp	23509753	SENT38	23	23	26	26	oxygen	ROS	PA450744	6098	0.388
NULL	J_Gen_Physiol_2003_Jul_122(1)_45-61.nxml.txt.nlp	12835470	SENT550	0	0	7	7	capsaicin	VR1	PA448776	56664	0.388
NULL	Front_Chem_2013_Dec_31_1_40.nxml.txt.nlp	24790967	SENT28	24	24	3	3	echinacea	flower	PA131550706	11094	0.388
NULL	Arch_Drug_Inf_2008_Jul_1(1)_14-22.nxml.txt.nlp	20157364	SENT109	7	7	13	13	pravastatin	IL-6	PA451089	3569	0.388
NULL	Mol_Cell_Proteomics_2012_Feb_13_11(2)_M111_013904.nxml.txt.nlp	21997733	SENT122	24	24	28	28	trypsin	ITIH2	PA451806	3698	0.388
NULL	Acta_Pharmacol_Sin_2014_Jun_4_35(6)_752-757.nxml.txt.nlp	24902786	SENT160	23	23	1	1	tamoxifen	STZ	PA451581	6484	0.388
NULL	Oncotarget_2014_Oct_16_5(20)_9546-9563.nxml.txt.nlp	25337673	SENT108	44	44	28	28	lapatinib	AXL	PA152241907	558	0.388
NULL	Alcohol_Alcohol_2011_Nov_6_46(6)_661-671.nxml.txt.nlp	21896551	SENT147	22	22	35	35	ethanol	ANOVA	PA448073	4858	0.388
NULL	Biomed_Res_Int_2014_Jun_26_2014_161346.nxml.txt.nlp	25054130	SENT225	45	45	30	30	curcumin	STZ	PA151958596	6484	0.388
NULL	Mol_Cell_Biol_2014_Sep_34(17)_3305-3320.nxml.txt.nlp	24958099	SENT767	3	3	16	16	oltipraz	NRF2		2551;4780	0.388
NULL	J_Allergy_(Cairo)_2011_Apr_6_2011_479129.nxml.txt.nlp	21603171	SENT62	0	0	37	37	tacrolimus	GM-CSF	PA451578	1437	0.388
NULL	Genome_Biol_2003_Jun_30_4(7)_221.nxml.txt.nlp	12844352	SENT21	0	0	3	3	glucose	GOX	PA449773	54363	0.388
NULL	Environ_Health_Perspect_2012_Jul_11_120(7)_1029-1035.nxml.txt.nlp	22494775	SENT229	13	13	13	13	pp2	PP2		4888	0.388
NULL	J_Cell_Mol_Med_2014_Jan_19_18(1)_156-169.nxml.txt.nlp	24251962	SENT201	15	15	18	18	bleomycin	BLM	PA448645	641	0.388
NULL	Tuberc_Respir_Dis_(Seoul)_2013_Aug_30_75(2)_47-51.nxml.txt.nlp	24023556	SENT53	2	2	7	7	azathioprine	NAC	PA448515	22861	0.388
NULL	Front_Immunol_2013_Sep_9_4_269.nxml.txt.nlp	24058364	SENT21	9	9	12	12	oxygen	ROS	PA450744	6098	0.388
NULL	Int_J_Mol_Sci_2012_Sep_20_13(9)_12000-12016.nxml.txt.nlp	23109896	SENT297	4	4	15	15	erlotinib	EGFR	PA134687924	1956	0.388
NULL	Breast_Cancer_Res_2010_Jul_1_12(4)_R45.nxml.txt.nlp	20594311	SENT133	0	0	4	4	tamoxifen	BiP	PA451581	3309	0.388
NULL	Nat_Commun_2012_Dec_27_3_1316.nxml.txt.nlp	23271650	SENT507	21	21	24	24	tamoxifen	E16	PA451581	8140	0.388
NULL	Br_J_Cancer_2010_Feb_16_102(4)_658-664.nxml.txt.nlp	20104222	SENT94	16	16	18	18	sunitinib	IFN	PA162372840	3439	0.388
NULL	Arthritis_Rheum_2011_Oct_63(10)_2854-2864.nxml.txt.nlp	21618201	SENT275	17	17	24	24	abatacept	ACR	PA164747080	49	0.387
NULL	Ther_Clin_Risk_Manag_2006_Dec_2(4)_365-375.nxml.txt.nlp	18360649	SENT194	11	11	2	2	abatacept	ACR	PA164747080	49	0.387
NULL	Front_Chem_2013_Dec_31_1_40.nxml.txt.nlp	24790967	SENT30	28	28	8	8	echinacea	flower	PA131550706	11094	0.387
NULL	Cardiovasc_Diabetol_2010_Oct_22_9_66.nxml.txt.nlp	20969783	SENT24	20	20	23	23	oxygen	ROS	PA450744	6098	0.387
NULL	Hum_Mol_Genet_2011_May_15_20(10)_2037-2047.nxml.txt.nlp	21372148	SENT32	16	16	19	19	oxygen	ROS	PA450744	6098	0.387
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Apr_15_9_13.nxml.txt.nlp	20398300	SENT97	21	21	18	18	lansoprazole	LAM	PA450180	7249;7248	0.387
NULL	Biosensors_(Basel)_2013_Nov_13_3(4)_374-384.nxml.txt.nlp	25586413	SENT79	8	8	20	20	ethanol	NHS	PA448073	4810	0.387
NULL	ScientificWorldJournal_2012_Jan_2_11_2613-2619.nxml.txt.nlp	22262949	SENT112	2	2	12	12	ticarcillin	CPZ	PA451684	8532	0.387
NULL	Arthritis_Res_Ther_2003_May_15_5(4)_R214-R225.nxml.txt.nlp	12823857	SENT116	4	4	9	9	dextran	CD14	PA449261	929	0.387
NULL	Int_J_Surg_Case_Rep_2014_Oct_23_5(12)_979-983.nxml.txt.nlp	25460452	SENT171	25	25	18	18	carboplatin	CK20	PA448803	54474	0.387
NULL	Exp_Diabetes_Res_2012_Jan_29_2012_159874.nxml.txt.nlp	22319521	SENT237	33	33	22	22	telmisartan	VEGF-A	PA451605	7422	0.387
NULL	Clin_Ophthalmol_2011_May_24_5_697-704.nxml.txt.nlp	21629577	SENT134	1	1	13	13	bevacizumab	San	PA130232992	80218	0.387
NULL	Biomed_Res_Int_2014_May_12_2014_989101.nxml.txt.nlp	24901006	SENT30	11	11	40	40	l-glutamine	CO2	PA10090	4513	0.387
NULL	Breast_Cancer_Res_2012_Jul_19_14(4)_210.nxml.txt.nlp	22809143	SENT92	8	8	15	15	estradiol	AREG	PA449503	374	0.387
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Mar_27_66(Pt_4)_m463-m464.nxml.txt.nlp	21580548	SENT7	3	3	5	5	phenol	mol	PA450913	90527	0.387
NULL	Br_J_Psychiatry_2009_Jun_194(6)_535-540.nxml.txt.nlp	19478294	SENT78	14	14	25	25	citalopram	ANOVA	PA449015	4858	0.387
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT192	35	35	30	30	cetuximab	Yes	PA10040	7525	0.387
NULL	J_Gen_Physiol_2013_Apr_141(4)_409-411.nxml.txt.nlp	23478994	SENT100	18	18	14	14	potassium	HERG	PA451047	3757	0.387
NULL	J_Am_Heart_Assoc_2013_Dec_19_2(6)_e000433.nxml.txt.nlp	24275630	SENT272	14	14	16	16	lipase	CD36	PA450239	948	0.387
NULL	Am_J_Physiol_Cell_Physiol_2014_Jan_15_306(2)_C89-C97.nxml.txt.nlp	24133067	SENT53	29	29	9	9	hyaluronan	HAS3	PA165958431	3038	0.387
NULL	EJNMMI_Res_2011_Aug_17_1_15.nxml.txt.nlp	22214307	SENT32	10	10	35	35	trastuzumab	Hsp90	PA451743	3320	0.387
NULL	Front_Neurosci_2014_Jun_3_8_128.nxml.txt.nlp	24917782	SENT778	17	17	8	8	ethanol	POMC	PA448073	5443	0.387
NULL	AIDS_Res_Treat_2012_May_14_2012_246280.nxml.txt.nlp	22675613	SENT179	48	48	7	7	tenofovir	ATV	PA10204	4683	0.387
NULL	Hematol_Rep_2011_Nov_21_3(3)_e27.nxml.txt.nlp	22593818	SENT116	5	5	7	7	hydroxyurea	IFN	PA449942	3439	0.387
NULL	Cancers_(Basel)_2013_Oct_22_5(4)_1271-1305.nxml.txt.nlp	24202446	SENT323	21	21	14	14	paclitaxel	TRAIL	PA450761	8743	0.387
NULL	J_Biol_Chem_2013_Nov_29_288(48)_34502-34513.nxml.txt.nlp	24133206	SENT131	42	42	32	32	paraformaldehyde	CO2	PA450790	4513	0.387
NULL	Nature_2012_Aug_16_488(7411)_394-398.nxml.txt.nlp	22810587	SENT80	20	20	6	6	candesartan	APJ	PA448765	187	0.387
NULL	Iran_J_Reprod_Med_2013_Mar_11(3)_235-242.nxml.txt.nlp	24639751	SENT42	10	10	23	23	collagenase	CO2	PA449107	4513	0.387
NULL	Mol_Biol_Rep_2013_Sep_28_40(10)_5573-5585.nxml.txt.nlp	24078156	SENT249	11	11	14	14	oxygen	ROS	PA450744	6098	0.387
NULL	Br_J_Cancer_2010_Feb_16_102(4)_658-664.nxml.txt.nlp	20104222	SENT88	14	14	16	16	sunitinib	IFN	PA162372840	3439	0.387
NULL	Cell_Res_2013_Jun_21_23(6)_746-758.nxml.txt.nlp	23689277	SENT39	4	4	27	27	resveratrol	PI3K		5290	0.387
NULL	Mol_Cancer_2010_Oct_12_9_269.nxml.txt.nlp	20939893	SENT7	21	21	13	13	isoproterenol	AP-1	PA450121	2353;3727;2354;3725	0.387
NULL	Arthritis_Res_Ther_2010_Dec_17_12(6)_221.nxml.txt.nlp	21205283	SENT125	10	10	18	18	etanercept	ACR	PA449515	49	0.387
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_13_2014_849783.nxml.txt.nlp	25477998	SENT104	1	1	7	7	berberine	HMGB1	PA165860812	3146	0.387
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Aug_23_69(Pt_9)_m520-m521.nxml.txt.nlp	24427008	SENT71	14	14	29	29	ethanol	mol	PA448073	90527	0.387
NULL	Int_J_Fertil_Steril_2013_Jul_31_Jul-Sep_7(2)_138-141.nxml.txt.nlp	24520477	SENT17	16	16	1	1	estradiol	ART	PA449503	181	0.387
NULL	Int_J_Vasc_Med_2014_Jul_22_2014_659617.nxml.txt.nlp	25140254	SENT230	3	3	0	0	vasopressin	AVP	PA451858	114548;551	0.387
NULL	Nucleic_Acids_Res_2007_Jan_1_35(Database_issue)_D178-D182.nxml.txt.nlp	17145715	SENT74	0	0	5	5	taurine	TUG1	PA451590	55000	0.387
NULL	Br_J_Cancer_2009_Jul_21_101(2)_238-243.nxml.txt.nlp	19568242	SENT123	30	30	32	32	bevacizumab	IFN	PA130232992	3439	0.387
NULL	Mol_Cancer_2014_Jun_12_13_148.nxml.txt.nlp	24924916	SENT145	3	3	6	6	oxygen	ROS	PA450744	6098	0.387
NULL	Aging_(Albany_NY)_2010_Dec_20_2(12)_959-968.nxml.txt.nlp	21191146	SENT224	17	17	9	9	cisplatin	LKB1	PA449014	6794	0.387
NULL	Iran_Red_Crescent_Med_J_2013_Feb_5_15(2)_147-151.nxml.txt.nlp	23682327	SENT5	17	17	29	29	methylprednisolone	IL-10	PA450466	3586	0.387
NULL	Orphanet_J_Rare_Dis_2014_Dec_10_9(1)_183.nxml.txt.nlp	NULL	SENT213	5	5	7	7	nadh	COX	PA164755085	1351	0.387
NULL	Curr_Neuropharmacol_2013_May_11(3)_276-297.nxml.txt.nlp	24179464	SENT850	1	1	12	12	zinc	CA1	PA451956	759	0.387
NULL	Drug_Des_Devel_Ther_2014_Sep_9_8_1307-1314.nxml.txt.nlp	25246772	SENT151	4	4	7	7	cyclosporine	HTX	PA449167	7547	0.387
NULL	Crit_Care_2012_Nov_14_16(Suppl_3)_P10.nxml.txt.nlp	NULL	SENT6	20	20	2	2	heparin	HMGB1	PA449855	3146	0.387
NULL	Cancers_(Basel)_2013_May_27_5(2)_617-638.nxml.txt.nlp	24216994	SENT223	15	15	9	9	curcumin	PC3	PA151958596	57332;7832;5122	0.387
NULL	Med_Sci_Monit_2013_Nov_29_19_1080-1088.nxml.txt.nlp	24287619	SENT229	2	2	9	9	estradiol	ACL	PA449503	47	0.387
NULL	ScientificWorldJournal_2013_Nov_5_2013_383574.nxml.txt.nlp	24298214	SENT137	16	16	13	13	phenol	TPC	PA450913	8030;60386	0.386
NULL	Mol_Biol_Rep_2012_May_20_39(5)_5253-5267.nxml.txt.nlp	22183301	SENT77	31	31	29	29	gliclazide	NAC	PA10892	22861	0.386
NULL	Br_J_Clin_Pharmacol_2012_Apr_7_73(4)_518-535.nxml.txt.nlp	22053916	SENT146	0	0	8	8	pitavastatin	LOX-1	PA142650384	4973	0.386
NULL	Diabetes_2009_Jul_58(7)_1471-1478.nxml.txt.nlp	19564458	SENT151	17	17	24	24	pegaptanib	VEGFR	PA164771236	3791	0.386
NULL	Support_Care_Cancer_2014_Oct_19_22(2)_469-477.nxml.txt.nlp	24141698	SENT181	12	12	15	15	doxorubicin	URCC	PA449412	54894	0.386
NULL	J_Adv_Pharm_Technol_Res_2012_Jul-Sep_3(3)_182-187.nxml.txt.nlp	23057005	SENT173	43	43	47	47	cefdinir	Tech	PA164768739	57449	0.386
NULL	Neural_Dev_2012_Dec_8_7_39.nxml.txt.nlp	23217170	SENT199	2	2	20	20	tamoxifen	E14	PA451581	4863	0.386
NULL	Cancer_Cell_Int_2013_Sep_23_13_94.nxml.txt.nlp	24059699	SENT155	20	20	16	16	bevacizumab	VEGFA	PA130232992	7422	0.386
NULL	Tob_Induc_Dis_2003_Sep_15_1(3)_197.nxml.txt.nlp	19570260	SENT40	19	19	26	26	collagenase	NAT2	PA449107	10;81539	0.386
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_75-89.nxml.txt.nlp	17912638	SENT372	33	33	40	40	tamoxifen	ATAC	PA451581	6375	0.386
NULL	Int_J_Biol_Sci_2011_Jul_7_7(6)_823-836.nxml.txt.nlp	21814479	SENT36	17	17	20	20	oxygen	ROS	PA450744	6098	0.386
NULL	Oncotarget_2013_Nov_24_4(12)_2186-2207.nxml.txt.nlp	24327604	SENT140	21	21	16	16	bortezomib	MDM2	PA10252	4193	0.386
NULL	Biomed_Res_Int_2013_Sep_8_2013_639725.nxml.txt.nlp	24083233	SENT23	27	27	30	30	oxygen	ROS	PA450744	6098	0.386
NULL	Biologics_2009_Oct_12_3_469-474.nxml.txt.nlp	19851472	SENT84	16	16	10	10	desloratadine	IL-4	PA164776964	3565	0.386
NULL	J_RNAi_Gene_Silencing_2010_May_29_6(1)_386-400.nxml.txt.nlp	20628499	SENT189	7	7	9	9	flavopiridol	Dicer	PA452627	23405	0.386
NULL	Indian_J_Pharm_Sci_2014_Jul-Aug_76(4)_315-322.nxml.txt.nlp	25284929	SENT112	34	34	17	17	ethanol	STZ	PA448073	6484	0.386
NULL	Aging_(Albany_NY)_2009_May_12_1(5)_481-489.nxml.txt.nlp	20195487	SENT14	6	6	9	9	oxygen	ROS	PA450744	6098	0.386
NULL	J_Biomed_Opt_2013_Jun_7_18(6)_060501.nxml.txt.nlp	23748699	SENT57	20	20	27	27	nadh	ANOVA	PA164755085	4858	0.386
NULL	Curr_Opin_Endocrinol_Diabetes_Obes_2014_Oct_28_21(5)_394-404.nxml.txt.nlp	25122493	SENT133	13	13	17	17	thyroglobulin	RAI	PA164754910	10848;6050	0.386
NULL	J_Exerc_Rehabil_2014_Apr_30_10(2)_60-68.nxml.txt.nlp	24877039	SENT22	3	3	16	16	fenofibrate	adiponectin	PA449594	9370	0.386
NULL	J_Inflamm_(Lond)_2006_May_4_3_8.nxml.txt.nlp	16674821	SENT86	9	9	11	11	pp2	SKI-1		8720	0.386
NULL	Int_J_Environ_Res_Public_Health_2010_May_27_7(5)_1872-1888.nxml.txt.nlp	20622998	SENT60	8	8	16	16	ethanol	ADH1B	PA448073	125	0.386
NULL	Acta_Vet_Scand_2008_Jul_4_50(1)_27.nxml.txt.nlp	18601734	SENT3	11	11	25	25	doxorubicin	CLPTM1	PA449412	1209	0.386
NULL	Mol_Cancer_2014_Jun_19_13_154.nxml.txt.nlp	24941944	SENT265	2	2	18	18	dacarbazine	GMP	PA449197	22978	0.386
NULL	Mol_Cancer_2013_Mar_5_12_17.nxml.txt.nlp	23497256	SENT274	6	6	10	10	tetracycline	p53	PA451640	7157	0.386
NULL	Mol_Cells_2014_Mar_31_37(3)_234-240.nxml.txt.nlp	24642709	SENT120	10	10	5	5	cisplatin	HO-1	PA449014	3162	0.386
NULL	J_Headache_Pain_2012_Jul_19_13(5)_419-423.nxml.txt.nlp	22527033	SENT87	7	7	3	3	acetazolamide	CACNA1A	PA448018	773	0.386
NULL	Cardiovasc_Diabetol_2013_Jun_18_12_88.nxml.txt.nlp	23773268	SENT192	11	11	16	16	bezafibrate	adiponectin	PA162364313	9370	0.386
NULL	Nucleic_Acids_Res_2005_Jun_9_33(10)_3323-3330.nxml.txt.nlp	15947132	SENT256	19	19	16	16	cisplatin	MSH2	PA449014	4436	0.386
NULL	Mol_Biol_Cell_2012_Nov_1_23(21)_4203-4211.nxml.txt.nlp	22933573	SENT46	19	19	6	6	galactose	DIA2	PA449725	1730	0.386
NULL	J_Biomed_Sci_2012_Oct_30_19(1)_92.nxml.txt.nlp	23110561	SENT66	12	12	15	15	oxygen	ROS	PA450744	6098	0.386
NULL	J_Cardiothorac_Surg_2012_Jun_20_7_57.nxml.txt.nlp	22716287	SENT119	15	15	0	0	rosiglitazone	ROS1	PA451283	6098	0.386
NULL	Multidiscip_Respir_Med_2010_Jun_30_5(3)_173-182.nxml.txt.nlp	22958334	SENT171	20	20	12	12	sulfasalazine	DIP	PA451547	23151;1831	0.386
NULL	J_Brachial_Plex_Peripher_Nerve_Inj_2008_Nov_26_3_25.nxml.txt.nlp	19036161	SENT69	12	12	23	23	celecoxib	NF-kappaB	PA448871	4790	0.386
NULL	Adv_Hematol_2012_Mar_25_2012_302570.nxml.txt.nlp	22536253	SENT199	28	28	24	24	nutlin-3	MDM2		4193	0.386
NULL	J_Biol_2003_Sep_24_2(4)_28.nxml.txt.nlp	14511394	SENT96	7	7	15	15	phenformin	MO25	PA1000	51719	0.386
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Sep_8_68(Pt_10)_o2897-o2898.nxml.txt.nlp	23125693	SENT88	42	42	36	36	ethanol	mol	PA448073	90527	0.386
NULL	J_Korean_Med_Sci_2013_Apr_27_28(4)_527-533.nxml.txt.nlp	23580227	SENT105	6	6	8	8	genistein	TRAIL	PA165109660	8743	0.386
NULL	Curr_HIV_Res_2014_May_12(3)_174-188.nxml.txt.nlp	24862327	SENT127	1	1	4	4	ethanol	HO-1	PA448073	3162	0.386
NULL	Behav_Neurol_2014_Nov_16_2014_360978.nxml.txt.nlp	25477708	SENT35	12	12	20	20	nicotine	ROS	PA450626	6098	0.386
NULL	Biomed_Res_Int_2014_May_12_2014_651831.nxml.txt.nlp	24900976	SENT102	21	21	40	40	l-glutamine	CO2	PA10090	4513	0.386
NULL	Evid_Based_Complement_Alternat_Med_2013_Aug_20_2013_789067.nxml.txt.nlp	24069055	SENT223	8	8	0	0	lipase	HSL	PA450239	3991	0.386
NULL	Iran_Red_Crescent_Med_J_2014_Aug_5_16(8)_e19282.nxml.txt.nlp	25389488	SENT173	10	10	1	1	methamphetamine	Gen	PA450403	348654	0.386
NULL	Acta_Pharmacol_Sin_2010_Oct_13_31(10)_1324-1328.nxml.txt.nlp	20835265	SENT24	13	13	9	9	l-arginine	NOS	PA448478	4843	0.386
NULL	Ann_Oncol_2009_Nov_23_20(11)_1803-1812.nxml.txt.nlp	19549706	SENT176	21	21	23	23	sunitinib	IFN	PA162372840	3439	0.386
NULL	Curr_Hypertens_Rep_2010_Aug_8_12(4)_267-275.nxml.txt.nlp	20532699	SENT71	7	7	21	21	nebivolol	AT1	PA151958426	9197;185	0.386
NULL	Breast_Cancer_Res_2007_Jan_23_9(1)_R7.nxml.txt.nlp	17244352	SENT42	25	25	9	9	tamoxifen	CYP2D6	PA451581	1565	0.386
NULL	Atherosclerosis_2011_Nov_219(1)_109-115.nxml.txt.nlp	21820657	SENT183	21	21	16	16	probucol	CETP	PA451107	1071	0.386
NULL	Mol_Vis_2007_Dec_17_13_2282-2288.nxml.txt.nlp	18199969	SENT205	12	12	15	15	oxygen	ROS	PA450744	6098	0.386
NULL	Asian-Australas_J_Anim_Sci_2013_Nov_26(11)_1545-1552.nxml.txt.nlp	25049740	SENT23	0	0	4	4	hyaluronan	HAS2	PA165958431	3037	0.386
NULL	Br_J_Cancer_2012_Apr_24_106(9)_1543-1550.nxml.txt.nlp	22531721	SENT160	11	11	24	24	trastuzumab	CD59	PA451743	966	0.386
NULL	Chem_Cent_J_2013_Sep_4_7_147.nxml.txt.nlp	24006941	SENT132	8	8	10	10	lipase	LOX	PA450239	4015	0.386
NULL	Br_J_Pharmacol_2011_Oct_164(3)_866-883.nxml.txt.nlp	21323893	SENT8	6	6	9	9	oxygen	ROS	PA450744	6098	0.386
NULL	Int_J_Cell_Biol_2014_Feb_27_2014_152645.nxml.txt.nlp	24719618	SENT42	18	18	21	21	oxygen	ROS	PA450744	6098	0.386
NULL	Amino_Acids_2011_May_22_40(5)_1369-1383.nxml.txt.nlp	21424716	SENT183	21	21	25	25	creatine	CEE	PA164778930	51608	0.386
NULL	J_Gastrointest_Cancer_2010_Mar_28_41(1)_60-70.nxml.txt.nlp	19946763	SENT316	34	34	19	19	imatinib	MDR1	PA10804	5243	0.385
NULL	Int_J_Microbiol_2014_Sep_22_2014_758942.nxml.txt.nlp	25332721	SENT89	17	17	19	19	ethanol	CO2	PA448073	4513	0.385
NULL	Iran_J_Public_Health_2010_Mar_31_39(1)_57-63.nxml.txt.nlp	23112990	SENT31	4	4	7	7	oxygen	ROS	PA450744	6098	0.385
NULL	Oncoimmunology_2013_Dec_1_2(12)_e27058.nxml.txt.nlp	24498564	SENT33	15	15	44	44	cyclophosphamide	HMGB1	PA449165	3146	0.385
NULL	Drug_Des_Devel_Ther_2014_Oct_8_8_1781-1788.nxml.txt.nlp	25336921	SENT29	0	0	19	19	valsartan	AT1	PA451848	9197;185	0.385
NULL	Oncotarget_2011_Sep_9_2(9)_658-668.nxml.txt.nlp	21911919	SENT153	41	41	13	13	l-glutamine	CO2	PA10090	4513	0.385
NULL	Hum_Mol_Genet_2011_Oct_15_20(R2)_R198-R205.nxml.txt.nlp	21875899	SENT39	5	5	3	3	lipase	LIPA	PA450239	3988;10648	0.385
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jun_5_66(Pt_7)_o1574.nxml.txt.nlp	21587815	SENT58	31	31	16	16	ethanol	mol	PA448073	90527	0.385
NULL	J_Inherit_Metab_Dis_2013_Jan_23_36(1)_29-34.nxml.txt.nlp	22729817	SENT133	20	20	26	26	estradiol	AMH	PA449503	268	0.385
NULL	Breast_Cancer_Res_2012_Jun_12_14(3)_R92.nxml.txt.nlp	22691413	SENT184	11	11	15	15	estradiol	HSD1	PA449503	26871	0.385
NULL	Basic_Clin_Neurosci_2014_Winter_5(1)_31-41.nxml.txt.nlp	25436082	SENT122	28	28	23	23	bupropion	mol	PA448687	90527	0.385
NULL	Nucleic_Acids_Res_2011_Mar_18_39(5)_1647-1655.nxml.txt.nlp	21097466	SENT138	9	9	0	0	camptothecin	Yes	PA153590860	7525	0.385
NULL	Int_J_Nanomedicine_2008_Mar_3(1)_51-57.nxml.txt.nlp	18488415	SENT13	10	10	13	13	oxygen	ROS	PA450744	6098	0.385
NULL	Br_J_Cancer_2011_Aug_23_105(5)_658-665.nxml.txt.nlp	21829201	SENT30	8	8	11	11	oxygen	ROS	PA450744	6098	0.385
NULL	Exp_Ther_Med_2014_Feb_4_7(2)_478-482.nxml.txt.nlp	24396429	SENT8	14	14	17	17	oxygen	ROS	PA450744	6098	0.385
NULL	Cardiovasc_Drugs_Ther_2010_Feb_13_24(1)_33-40.nxml.txt.nlp	20229056	SENT113	4	4	1	1	eprosartan	TDI	PA449481	100038246	0.385
NULL	Arthritis_Res_Ther_2010_Aug_24_12(4)_214.nxml.txt.nlp	20735862	SENT192	43	43	31	31	tocilizumab	TBC	PA165292659	23216	0.385
NULL	Trials_2012_Dec_13_13_239.nxml.txt.nlp	23237631	SENT269	14	14	36	36	warfarin	CYP2C9	PA451906	1559	0.385
NULL	Eur_J_Neurosci_2008_Jun_27(11)_2783-2802.nxml.txt.nlp	18588525	SENT654	18	18	5	5	potassium	GMP	PA451047	22978	0.385
NULL	Int_J_Nanomedicine_2012_Sep_21_7_5091-5106.nxml.txt.nlp	23049256	SENT75	16	16	14	14	heparin	SOD1	PA449855	6647	0.385
NULL	BMJ_2010_Jan_21_340_b5500.nxml.txt.nlp	20093284	SENT269	1	1	19	19	ethanol	CYP24A1	PA448073	1591	0.385
NULL	Indian_J_Ophthalmol_2012_May-Jun_60(3)_234-235.nxml.txt.nlp	22569393	SENT4	11	11	24	24	bevacizumab	San	PA130232992	80218	0.385
NULL	J_Cell_Biol_1998_Nov_16_143(4)_1003-1012.nxml.txt.nlp	9817757	SENT137	8	8	17	17	gentamicin	IFN	PA449753	3439	0.385
NULL	Drug_Target_Insights_2007_Mar_22_2_83-96.nxml.txt.nlp	21901065	SENT111	4	4	11	11	thrombin	CRT	PA451674	811	0.385
NULL	J_Skin_Cancer_2013_Apr_21_2013_423829.nxml.txt.nlp	23738073	SENT22	28	28	23	23	dacarbazine	IL-2	PA449197	3558	0.385
NULL	Oncoscience_2014_Mar_12_1(2)_167-179.nxml.txt.nlp	25126591	SENT248	18	18	22	22	sorafenib	c-Myc	PA7000	4609	0.385
NULL	Head_Face_Med_2007_Mar_12_3_14.nxml.txt.nlp	17352809	SENT13	14	14	38	38	imiquimod	gamma	PA449972	9913	0.385
NULL	Exp_Diabetes_Res_2011_Jul_17_2011_835932.nxml.txt.nlp	21792353	SENT264	15	15	5	5	atropine	STZ	PA448505	6484	0.385
NULL	Case_Rep_Pathol_2014_Sep_9_2014_301780.nxml.txt.nlp	25295208	SENT56	4	4	2	2	thyroglobulin	TTF-1	PA164754910	7080	0.385
NULL	Evid_Based_Complement_Alternat_Med_2014_Jul_1_2014_423751.nxml.txt.nlp	25101132	SENT184	39	39	24	24	chloramphenicol	Met	PA448927	79811	0.385
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT110	1	1	33	33	curcumin	PC-3	PA151958596	692094	0.385
NULL	J_Geriatr_Cardiol_2014_Sep_11(3)_200-205.nxml.txt.nlp	25278967	SENT104	15	15	0	0	heparin	CRT	PA449855	811	0.385
NULL	Evid_Based_Complement_Alternat_Med_2014_Jul_1_2014_423751.nxml.txt.nlp	25101132	SENT188	22	22	16	16	ciprofloxacin	Met	PA449009	79811	0.385
NULL	Biomed_Res_Int_2014_Feb_19_2014_162314.nxml.txt.nlp	24701564	SENT37	12	12	15	15	lansoprazole	NHE	PA450180	285335	0.385
NULL	Indian_J_Endocrinol_Metab_2012_May-Jun_16(3)_343-348.nxml.txt.nlp	22629497	SENT28	33	33	12	12	teriparatide	PTH	PA451620	5741	0.385
NULL	Br_J_Cancer_2002_Dec_2_87(12)_1454-1461.nxml.txt.nlp	12454777	SENT56	1	1	30	30	fluorescein	San	PA164746009	80218	0.385
NULL	Br_J_Pharmacol_2011_Oct_164(3)_866-883.nxml.txt.nlp	21323893	SENT23	8	8	11	11	oxygen	ROS	PA450744	6098	0.385
NULL	Biologics_2009_Sep_15_3_429-441.nxml.txt.nlp	19774210	SENT90	7	7	14	14	panitumumab	KRAS	PA162373091	3845	0.385
NULL	J_Med_Case_Reports_2011_Aug_19_5_397.nxml.txt.nlp	21854566	SENT65	14	14	23	23	colchicine	ACTH	PA449092	5443	0.385
NULL	Cardiovasc_Res_2010_Oct_1_88(1)_51-57.nxml.txt.nlp	20558439	SENT98	21	21	19	19	ethanol	ALDH2	PA448073	217	0.385
NULL	Case_Rep_Pathol_2013_Jul_14_2013_198643.nxml.txt.nlp	23936709	SENT73	18	18	16	16	thyroglobulin	TTF-1	PA164754910	7080	0.385
NULL	Int_J_Mol_Sci_2014_Jun_25_15(7)_11234-11244.nxml.txt.nlp	24968266	SENT64	18	18	21	21	docetaxel	PC-3	PA449383	692094	0.385
NULL	Biomed_Res_Int_2014_Aug_7_2014_191967.nxml.txt.nlp	25165691	SENT187	39	39	16	16	levamisole	IFN	PA450205	3439	0.385
NULL	Braz_J_Microbiol_2014_May_19_45(1)_111-115.nxml.txt.nlp	24948921	SENT42	7	7	0	0	gentamicin	VAN	PA449753	10318	0.385
NULL	Clin_Psychopharmacol_Neurosci_2014_Apr_24_12(1)_54-64.nxml.txt.nlp	24851122	SENT108	23	23	37	37	methamphetamine	MRO	PA450403	83876	0.385
NULL	J_Exp_Bot_2012_Jan_20_63(2)_739-755.nxml.txt.nlp	22016425	SENT77	26	26	6	6	ethanol	mol	PA448073	90527	0.384
NULL	Infect_Drug_Resist_2009_Apr_24_2_13-26.nxml.txt.nlp	21694884	SENT312	2	2	5	5	tenofovir	TDF	PA10204	6736	0.384
NULL	Biomed_Res_Int_2013_Aug_6_2013_909613.nxml.txt.nlp	24027765	SENT378	18	18	4	4	metronidazole	EEN	PA450484	6455	0.384
NULL	Iran_Red_Crescent_Med_J_2014_Aug_5_16(8)_e12106.nxml.txt.nlp	25389471	SENT166	18	18	3	3	nitrogen	AST	PA450643	26503	0.384
NULL	AMB_Express_2014_Jan_10_4_2.nxml.txt.nlp	24410804	SENT98	27	27	35	35	phenol	CO2	PA450913	4513	0.384
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT3	20	20	17	17	trastuzumab	IL-6	PA451743	3569	0.384
NULL	Patient_Prefer_Adherence_2013_Jul_4_7_653-666.nxml.txt.nlp	23869169	SENT262	27	27	2	2	methotrexate	ACR	PA450428	49	0.384
NULL	Cardiovasc_Diabetol_2011_Dec_22_10_115.nxml.txt.nlp	22189184	SENT15	0	0	6	6	miglitol	GLP-1	PA164776726	100125288	0.384
NULL	Oncotarget_2013_Jul_25_4(10)_1592-1605.nxml.txt.nlp	24009064	SENT56	0	0	8	8	neratinib	HER2	PA165291472	2064	0.384
NULL	Cancers_(Basel)_2010_Apr_9_2(2)_397-419.nxml.txt.nlp	24281076	SENT156	14	14	18	18	cisplatin	IFN	PA449014	3439	0.384
NULL	J_Med_Internet_Res_2001_Jan_31_3(1)_e2.nxml.txt.nlp	11720944	SENT448	9	9	6	6	sildenafil	IBP	PA451346	706;50619	0.384
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jan_8_67(Pt_2)_o301.nxml.txt.nlp	21522991	SENT63	1	1	11	11	ethanol	mol	PA448073	90527	0.384
NULL	Ther_Clin_Risk_Manag_2007_Jun_3(3)_467-474.nxml.txt.nlp	18488080	SENT7	0	0	12	12	rasagiline	CYP1A2	PA164764584	1544	0.384
NULL	Biomed_Res_Int_2014_Jan_22_2014_947606.nxml.txt.nlp	24587999	SENT81	12	12	21	21	trypsin	San	PA451806	80218	0.384
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT21	39	39	24	24	pemetrexed	UNG	PA10810	7374	0.384
NULL	Br_J_Cancer_2010_Jun_29_103(1)_61-72.nxml.txt.nlp	20588279	SENT197	6	6	45	45	trastuzumab	RhoB	PA451743	388	0.384
NULL	Hum_Mol_Genet_2014_Aug_1_23(15)_4077-4085.nxml.txt.nlp	24670599	SENT33	9	9	5	5	lipase	PNPLA3	PA450239	80339	0.384
NULL	Carcinogenesis_2010_Dec_27_31(12)_2049-2057.nxml.txt.nlp	20876285	SENT183	27	27	20	20	tamoxifen	HER2	PA451581	2064	0.384
NULL	Support_Care_Cancer_2007_Mar_31_15(3)_279-286.nxml.txt.nlp	16944218	SENT265	22	22	35	35	cisplatin	AID	PA449014	57379	0.384
NULL	Reprod_Biol_Endocrinol_2013_May_10_11_36.nxml.txt.nlp	23663257	SENT5	24	24	16	16	estradiol	ghrelin	PA449503	51738	0.384
NULL	Cancer_Cell_Int_2013_Oct_11_13_97.nxml.txt.nlp	24119761	SENT124	24	24	0	0	trastuzumab	EGF	PA451743	1950	0.384
NULL	Oncotarget_2014_Nov_3_5(20)_10127-10139.nxml.txt.nlp	25333256	SENT145	25	25	28	28	vemurafenib	TRIM16	PA165946873	10626	0.384
NULL	Int_J_Fertil_Steril_2012_Dec_17_Oct-Dec_6(3)_185-188.nxml.txt.nlp	24520437	SENT29	27	27	33	33	creatine	ADP	PA164778930	23038	0.384
NULL	J_Cell_Mol_Med_2014_Jan_4_18(1)_38-48.nxml.txt.nlp	24188742	SENT227	4	4	9	9	hyaluronan	RHAMM	PA165958431	3161	0.384
NULL	Indian_J_Pharmacol_2008_Oct_40(Suppl_2)_S221-S236.nxml.txt.nlp	21593976	SENT863	26	26	23	23	haloperidol	EPM	PA449841	2054	0.384
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_39-54.nxml.txt.nlp	19305787	SENT119	26	26	15	15	ethanol	NR1	PA448073	27158	0.384
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jan_8_67(Pt_2)_o300.nxml.txt.nlp	21522990	SENT61	1	1	11	11	ethanol	mol	PA448073	90527	0.384
NULL	Chem_Cent_J_2012_Mar_17_6_18.nxml.txt.nlp	22424056	SENT14	11	11	14	14	oxygen	ROS	PA450744	6098	0.384
NULL	Exp_Neurol_2014_Nov_261_654-665.nxml.txt.nlp	25158309	SENT471	0	0	21	21	minocycline	KCC2	PA450519	57468	0.384
NULL	Case_Rep_Endocrinol_2013_May_8_2013_636175.nxml.txt.nlp	23738155	SENT100	0	0	25	25	everolimus	JNK	PA164746311	5599	0.384
NULL	Mol_Cancer_2014_Aug_16_13(1)_193.nxml.txt.nlp	NULL	SENT33	19	19	15	15	cisplatin	RKIP	PA449014	5037	0.384
NULL	Mol_Vis_2012_Nov_12_18_2687-2699.nxml.txt.nlp	23170061	SENT42	2	2	7	7	nadh	ND1	PA164755085	4535;10625	0.384
NULL	Ther_Clin_Risk_Manag_2007_Oct_3(5)_741-749.nxml.txt.nlp	18472999	SENT235	10	10	5	5	naltrexone	Gen	PA450588	348654	0.384
NULL	Neural_Regen_Res_2013_May_5_8(13)_1180-1189.nxml.txt.nlp	25206412	SENT50	17	17	27	27	fasudil	RhoA	PA165946121	387	0.384
NULL	Acta_Neuropathol_Commun_2014_Jan_2_2_3.nxml.txt.nlp	24383546	SENT267	3	3	5	5	resveratrol	SIRT1		23411	0.384
NULL	Int_J_Tryptophan_Res_2009_Apr_28_2_71-79.nxml.txt.nlp	22084583	SENT40	2	2	0	0	l-tryptophan	TDO	PA10323	6999	0.384
NULL	Front_Behav_Neurosci_2013_Dec_23_7_211.nxml.txt.nlp	24391566	SENT141	0	0	15	15	propranolol	CA1	PA451145	759	0.384
NULL	Cancer_Cell_2013_Aug_12_24(2)_167-181.nxml.txt.nlp	23948297	SENT66	9	9	12	12	doxycycline	CDK6	PA449415	1021	0.384
NULL	Subst_Abuse_Rehabil_2011_May_15_2_89-102.nxml.txt.nlp	21743792	SENT352	43	43	2	2	methamphetamine	TOB	PA450403	10140	0.384
NULL	Int_J_Biol_Sci_2014_Aug_23_10(8)_921-939.nxml.txt.nlp	25170305	SENT311	24	24	15	15	nadh	EPO	PA164755085	7076;8288;2056	0.384
NULL	Cancer_Cell_Int_2013_Jun_26_13_63.nxml.txt.nlp	23800022	SENT115	0	0	16	16	genistein	MDM2	PA165109660	4193	0.383
NULL	Arthritis_Res_Ther_2009_Aug_24_11(4)_R127.nxml.txt.nlp	19703304	SENT115	5	5	7	7	adalimumab	OASIS	PA10004	90993	0.383
NULL	Pharmacogn_Rev_2010_Jan-Jun_4(7)_42-48.nxml.txt.nlp	22228940	SENT76	1	1	4	4	oxygen	ROS	PA450744	6098	0.383
NULL	Environ_Health_Perspect_2008_Jan_5_116(1)_1-6.nxml.txt.nlp	18197291	SENT168	1	1	4	4	oxygen	ROS	PA450744	6098	0.383
NULL	Psychiatry_Investig_2011_Jun_15_8(2)_77-88.nxml.txt.nlp	21852982	SENT155	38	38	20	20	collagenase	MMP9	PA449107	4318	0.383
NULL	Curr_Cardiol_Rev_2010_Nov_6(4)_298-308.nxml.txt.nlp	22043206	SENT81	1	1	4	4	oxygen	ROS	PA450744	6098	0.383
NULL	Korean_J_Anesthesiol_2013_Jun_24_64(6)_494-499.nxml.txt.nlp	23814648	SENT152	34	34	12	12	mepivacaine	G30	PA164748741	282706	0.383
NULL	Curr_HIV_Res_2011_Jan_9(1)_40-53.nxml.txt.nlp	21198432	SENT130	47	47	21	21	efavirenz	AST	PA449441	26503	0.383
NULL	Gut_Liver_2015_Jan_9(1)_18-27.nxml.txt.nlp	NULL	SENT52	14	14	9	9	infliximab	ACT	PA452639	12;11332;9457;641455	0.383
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_May_29_65(Pt_6)_m697.nxml.txt.nlp	21583052	SENT3	39	39	23	23	phenol	NO3	PA450913	4681	0.383
NULL	Oncotarget_2014_Oct_21_5(22)_11709-11722.nxml.txt.nlp	25365944	SENT29	38	38	33	33	metformin	Rho	PA450395	29984	0.383
NULL	Oxid_Med_Cell_Longev_2012_Aug_22_2012_534705.nxml.txt.nlp	22966415	SENT226	1	1	7	7	riluzole	GLT-1	PA451251	6506	0.383
NULL	Curr_Pharm_Des_2012_Apr_18(11)_1519-1530.nxml.txt.nlp	22364136	SENT109	0	0	14	14	simvastatin	MCP-1	PA451363	6347	0.383
NULL	ScientificWorldJournal_2013_Jun_5_2013_704912.nxml.txt.nlp	23844410	SENT273	13	13	35	35	telaprevir	MRB	PA165958354	54538	0.383
NULL	Breast_Cancer_Res_2005_Mar_4_7(3)_R345-R352.nxml.txt.nlp	15987429	SENT221	37	37	17	17	ns-398	CARB		9482	0.383
NULL	Pharmaceuticals_(Basel)_2014_Sep_17_7(9)_943-953.nxml.txt.nlp	25232798	SENT152	6	6	19	19	trastuzumab	HER2	PA451743	2064	0.383
NULL	Cancer_Metastasis_Rev_2010_Dec_10_29(4)_581-594.nxml.txt.nlp	20830503	SENT345	22	22	31	31	tamoxifen	ARNO	PA451581	9266	0.383
NULL	Clin_Psychopharmacol_Neurosci_2011_Apr_30_9(1)_36-43.nxml.txt.nlp	23431025	SENT103	46	46	40	40	aripiprazole	FLI	PA10026	2314	0.383
NULL	Core_Evid_2009_Jun_15_4_49-65.nxml.txt.nlp	20694065	SENT111	26	26	29	29	eptifibatide	IMPACT	PA449483	55364	0.383
NULL	Clin_Ophthalmol_2007_Dec_1(4)_367-371.nxml.txt.nlp	19668513	SENT57	0	0	8	8	ketorolac	PRK	PA450150	1263	0.383
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT204	3	3	7	7	methotrexate	MSH2	PA450428	4436	0.383
NULL	Int_J_Mol_Sci_2012_Sep_26_13(10)_12336-12348.nxml.txt.nlp	23202901	SENT60	27	27	20	20	phenol	P90	PA450913	821	0.383
NULL	Cell_Commun_Signal_2013_Oct_3_11_75.nxml.txt.nlp	24090133	SENT167	24	24	20	20	heparin	syndecan	PA449855	6382	0.383
NULL	F1000Res_2013_Nov_13_2_203.nxml.txt.nlp	24555099	SENT195	8	8	14	14	nadh	castor	PA164755085	54897	0.383
NULL	Leukemia_2013_Jan_11_27(1)_32-40.nxml.txt.nlp	22781593	SENT121	1	1	3	3	ponatinib	ZNF112	PA165980594	7771	0.383
NULL	J_Clin_Biochem_Nutr_2008_Jul_1_43(1)_6-12.nxml.txt.nlp	18648659	SENT25	28	28	31	31	oxygen	ROS	PA450744	6098	0.383
NULL	Breast_Cancer_Res_2010_Oct_22_12(Suppl_2)_S1.nxml.txt.nlp	21050422	SENT128	17	17	19	19	carboplatin	TRN	PA448803	3842	0.383
NULL	Diabetes_2013_May_16_62(5)_1537-1546.nxml.txt.nlp	23321073	SENT91	22	22	35	35	fluorescein	San	PA164746009	80218	0.383
NULL	Diabetes_Metab_Syndr_Obes_2014_Jul_17_7_313-319.nxml.txt.nlp	25092992	SENT17	14	14	11	11	pioglitazone	adiponectin	PA450970	9370	0.383
NULL	Cancer_Immunol_Immunother_2008_Oct_20_57(10)_1439-1449.nxml.txt.nlp	18286285	SENT304	10	10	13	13	hyaluronan	CD44	PA165958431	960	0.383
NULL	Hum_Mol_Genet_2013_Sep_15_22(18)_3667-3679.nxml.txt.nlp	23669347	SENT95	15	15	10	10	chloroquine	BMPR-II	PA448948	659	0.383
NULL	Oncotarget_2014_Oct_21_5(22)_11252-11268.nxml.txt.nlp	25361004	SENT69	3	3	0	0	metformin	CLIC1	PA450395	1192	0.383
NULL	Mol_Vis_2011_Feb_1_17_332-340.nxml.txt.nlp	21297899	SENT14	2	2	7	7	telmisartan	NAC	PA451605	22861	0.383
NULL	Int_J_Mol_Imaging_2011_Oct_26_2011_874585.nxml.txt.nlp	21490735	SENT48	42	42	32	32	streptomycin	FBS	PA451512	64319;26269	0.383
NULL	J_Immigr_Minor_Health_2012_Apr_26_14(2)_281-286.nxml.txt.nlp	21442300	SENT106	24	24	22	22	methamphetamine	San	PA450403	80218	0.383
NULL	Reprod_Biol_Endocrinol_2003_Apr_24_1_38.nxml.txt.nlp	12756058	SENT7	19	19	22	22	estradiol	IFN	PA449503	3439	0.383
NULL	Br_J_Pharmacol_2014_Jan_23_171(2)_523-535.nxml.txt.nlp	24372553	SENT144	2	2	15	15	metformin	Bcl-2	PA450395	596	0.383
NULL	J_Cell_Biol_2002_Nov_11_159(3)_453-463.nxml.txt.nlp	12427868	SENT160	8	8	2	2	urokinase	EGF	PA451836	1950	0.383
NULL	Mol_Microbiol_2014_May_28_92(3)_453-470.nxml.txt.nlp	24533860	SENT317	18	18	13	13	tetracycline	HMI	PA451640	3160	0.383
NULL	Arthritis_Res_Ther_2007_Jun_29_9(Suppl_1)_S6.nxml.txt.nlp	17634145	SENT172	27	27	30	30	denosumab	RANK	PA166048634	8792	0.383
NULL	Carcinogenesis_2012_Jan_10_33(1)_197-202.nxml.txt.nlp	22080572	SENT32	19	19	33	33	starch	AOM	PA451492	315	0.382
NULL	Front_Microbiol_2013_Aug_19_4_241.nxml.txt.nlp	23966991	SENT1436	8	8	5	5	ceftriaxone	GLT-1	PA448866	6506	0.382
NULL	Indian_J_Pharm_Sci_2013_May-Jun_75(3)_284-290.nxml.txt.nlp	24082344	SENT18	14	14	17	17	fexofenadine	FEX	PA449621	8549	0.382
NULL	Pain_Res_Treat_2012_Apr_23_2012_295926.nxml.txt.nlp	22577544	SENT60	17	17	32	32	dicyclomine	DLD	PA164744928	1738	0.382
NULL	Arthritis_Res_Ther_2009_Mar_10_11(2)_R37.nxml.txt.nlp	19284557	SENT80	17	17	6	6	glucose	CRP	PA449773	1401;140913	0.382
NULL	Org_Med_Chem_Lett_2012_Oct_24_2_33.nxml.txt.nlp	23095284	SENT133	4	4	7	7	galactose	flower	PA449725	11094	0.382
NULL	Indian_J_Nephrol_2011_Jan-Mar_21(1)_37-40.nxml.txt.nlp	21655168	SENT11	1	1	4	4	oxygen	ROS	PA450744	6098	0.382
NULL	Multidiscip_Respir_Med_2011_Oct_31_6(5)_291-298.nxml.txt.nlp	22958759	SENT134	33	33	4	4	methacholine	ACT	PA165958382	12;11332;9457;641455	0.382
NULL	Cancer_Metab_2014_Aug_18_2_13.nxml.txt.nlp	25225614	SENT271	28	28	45	45	lipase	HSL	PA450239	3991	0.382
NULL	Nat_Neurosci_2012_Sep_5_15(9)_1245-1254.nxml.txt.nlp	22864611	SENT38	31	31	33	33	clozapine	mGlu2	PA449061	2912	0.382
NULL	Diabetes_Obes_Metab_2011_Nov_13(11)_982-989.nxml.txt.nlp	21615670	SENT26	39	39	36	36	sitagliptin	PPG	PA164748978	5552	0.382
NULL	Mol_Cancer_2008_Oct_23_7_82.nxml.txt.nlp	18947424	SENT680	9	9	32	32	doxorubicin	P-gp	PA449412	5243	0.382
NULL	Arthritis_Res_Ther_2006_Nov_30_8(1)_R10.nxml.txt.nlp	16356198	SENT31	1	1	29	29	bleomycin	IFN	PA448645	3439	0.382
NULL	Clin_Ophthalmol_2011_Jul_26_5_1043-1049.nxml.txt.nlp	21845032	SENT11	7	7	22	22	triamcinolone	San	PA451749	80218	0.382
NULL	Front_Neurol_2011_Feb_22_2_7.nxml.txt.nlp	21373206	SENT355	0	0	15	15	streptokinase	ASK	PA164754919	10926	0.382
NULL	Breast_Cancer_Res_2000_Mar_7_2(3)_203-210.nxml.txt.nlp	11250711	SENT215	5	5	10	10	thrombin	LPA	PA451674	4018	0.382
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jun_26_66(Pt_7)_o1794.nxml.txt.nlp	21588004	SENT60	31	31	16	16	ethanol	mol	PA448073	90527	0.382
NULL	Arthritis_Rheum_2011_Oct_63(10)_2854-2864.nxml.txt.nlp	21618201	SENT275	2	2	24	24	abatacept	ACR	PA164747080	49	0.382
NULL	Viruses_2009_Nov_4_1(3)_689-712.nxml.txt.nlp	20221421	SENT202	32	32	20	20	papain	ADP	PA450778	23038	0.382
NULL	Brain_Struct_Funct_2014_Mar_12_219(3)_751-776.nxml.txt.nlp	23479178	SENT337	14	14	17	17	choline	CHAT	PA448976	1103	0.382
NULL	Kidney_Int_Suppl_(2011)_2012_Jun_15_2(2)_186-197.nxml.txt.nlp	25018932	SENT300	12	12	15	15	rituximab	ACTH	PA451261	5443	0.382
NULL	J_Obes_2011_Dec_15_2011_928165.nxml.txt.nlp	21197151	SENT169	43	43	38	38	liraglutide	GLP-1	PA165958364	100125288	0.382
NULL	AMB_Express_2012_Jul_29_2_38.nxml.txt.nlp	22838397	SENT134	7	7	9	9	ethanol	EPG	PA448073	255324	0.382
NULL	Curr_Nutr_Rep_2014_Dec_15_3(1)_22-34.nxml.txt.nlp	24563822	SENT131	10	10	13	13	oxygen	ROS	PA450744	6098	0.382
NULL	Evid_Based_Complement_Alternat_Med_2014_Oct_20_2014_192749.nxml.txt.nlp	25389441	SENT62	46	46	36	36	streptomycin	FBS	PA451512	64319;26269	0.382
NULL	Kidney_Int_Suppl_(2011)_2012_Jun_15_2(2)_186-197.nxml.txt.nlp	25018932	SENT270	5	5	8	8	rituximab	ACTH	PA451261	5443	0.382
NULL	J_Gen_Physiol_2009_Sep_134(3)_243-258.nxml.txt.nlp	19720962	SENT626	1	1	8	8	capsaicin	VR1	PA448776	56664	0.382
NULL	Brain_Sci_2013_Mar_7_3(1)_215-238.nxml.txt.nlp	23667741	SENT77	17	17	11	11	glibenclamide	CTR	PA449782	799	0.382
NULL	Acta_Pharmacol_Sin_2014_Jun_4_35(6)_752-757.nxml.txt.nlp	24902786	SENT160	15	15	1	1	flutamide	STZ	PA449685	6484	0.382
NULL	J_Aging_Res_2012_Mar_15_2012_510801.nxml.txt.nlp	22506112	SENT65	15	15	18	18	oxygen	ROS	PA450744	6098	0.382
NULL	Mol_Cell_Proteomics_2012_Feb_13_11(2)_M111_013904.nxml.txt.nlp	21997733	SENT194	15	15	19	19	trypsin	ITIH1	PA451806	3697	0.382
NULL	Cell_Death_Dis_2014_Apr_17_5(4)_e1188.nxml.txt.nlp	24743743	SENT78	29	29	10	10	dantrolene	IRE1	PA449208	2081	0.382
NULL	Br_J_Cancer_2011_Mar_15_104(6)_899-902.nxml.txt.nlp	21343938	SENT51	21	21	42	42	anastrozole	ATAC	PA448432	6375	0.382
NULL	Ann_Dermatol_2012_Nov_8_24(4)_474-475.nxml.txt.nlp	23197918	SENT26	11	11	14	14	lipase	LIPH	PA450239	200879	0.382
NULL	Adv_Hematol_2012_Sep_19_2012_879368.nxml.txt.nlp	21941554	SENT164	30	30	10	10	hyaluronan	TLR4	PA165958431	7099	0.382
NULL	Indian_J_Med_Res_2010_Dec_132(6)_676-682.nxml.txt.nlp	21245614	SENT94	9	9	2	2	zinc	p53	PA451956	7157	0.382
NULL	Oncoscience_2014_Oct_5_1(10)_624-633.nxml.txt.nlp	25593992	SENT52	23	23	18	18	tetracycline	PCTAIRE1	PA451640	5127	0.382
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jun_16_66(Pt_7)_m771.nxml.txt.nlp	21587701	SENT4	1	1	3	3	ethanol	mol	PA448073	90527	0.382
NULL	Biomed_Res_Int_2013_Mar_17_2013_315980.nxml.txt.nlp	23586031	SENT25	23	23	36	36	warfarin	CYP2C9	PA451906	1559	0.382
NULL	J_Gastroenterol_2013_Feb_22_48(2)_222-237.nxml.txt.nlp	22722906	SENT167	4	4	11	11	ethanol	ANOVA	PA448073	4858	0.381
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2009_Jun_1_65(Pt_6)_513-522.nxml.txt.nlp	19465765	SENT13	20	20	26	26	chloramphenicol	CLS	PA448927	1210	0.381
NULL	Crit_Care_2011_Jun_24_15(3)_R153.nxml.txt.nlp	21702944	SENT161	0	0	6	6	dexmedetomidine	TLR4	PA449256	7099	0.381
NULL	Brain_Sci_2012_Nov_7_2(4)_589-604.nxml.txt.nlp	24349762	SENT19	17	17	36	36	estradiol	PRL	PA449503	5617	0.381
NULL	Cell_Death_Dis_2010_Oct_21_1(10)_e86.nxml.txt.nlp	21368859	SENT105	3	3	5	5	doxorubicin	TRAIL	PA449412	8743	0.381
NULL	Aging_(Albany_NY)_2009_Sep_25_1(10)_845-854.nxml.txt.nlp	20157557	SENT194	16	16	6	6	doxorubicin	p53	PA449412	7157	0.381
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2009_Jun_1_65(Pt_6)_513-522.nxml.txt.nlp	19465765	SENT57	6	6	9	9	chloramphenicol	CLB	PA448927	171425	0.381
NULL	Indian_J_Med_Res_2012_Apr_135(4)_494-499.nxml.txt.nlp	22664496	SENT31	11	11	16	16	artemisinin	ACT	PA165111696	12;11332;9457;641455	0.381
NULL	Evid_Based_Complement_Alternat_Med_2006_Mar_3(1)_71-77.nxml.txt.nlp	16550226	SENT130	2	2	14	14	staurosporine	NAC	PA165109623	22861	0.381
NULL	Evid_Based_Complement_Alternat_Med_2014_May_8_2014_364819.nxml.txt.nlp	24899907	SENT8	9	9	19	19	tacrolimus	FKBP52	PA451578	2288	0.381
NULL	Diabetes_2013_Mar_14_62(3)_953-964.nxml.txt.nlp	23223176	SENT158	15	15	39	39	paroxetine	ROS	PA450801	6098	0.381
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Apr_15_9_13.nxml.txt.nlp	20398300	SENT108	21	21	18	18	lansoprazole	LAM	PA450180	7249;7248	0.381
NULL	Exp_Mol_Med_2012_Feb_29_44(2)_149-158.nxml.txt.nlp	22113134	SENT176	3	3	6	6	oxygen	ROS	PA450744	6098	0.381
NULL	Br_J_Cancer_1994_Jun_69(6)_1171-1175.nxml.txt.nlp	8198987	SENT0	11	11	15	15	aminoglutethimide	aromatase	PA448375	1588	0.381
NULL	Acta_Pharmacol_Sin_2010_Sep_16_31(9)_1075-1084.nxml.txt.nlp	20711221	SENT142	13	13	16	16	oxygen	ROS	PA450744	6098	0.381
NULL	Int_J_Mol_Sci_2014_May_12_15(5)_8372-8392.nxml.txt.nlp	24823882	SENT81	2	2	5	5	oxygen	ROS	PA450744	6098	0.381
NULL	Clin_Ophthalmol_2012_Oct_9_6_1645-1649.nxml.txt.nlp	23091370	SENT72	9	9	12	12	fluorescein	AMN	PA164746009	215;81693	0.381
NULL	Int_J_Mol_Sci_2014_Jun_17_15(6)_10868-10891.nxml.txt.nlp	24941250	SENT135	1	1	4	4	oxygen	ROS	PA450744	6098	0.381
NULL	Cancer_Cell_Int_2011_Apr_7_11_8.nxml.txt.nlp	21473769	SENT131	13	13	10	10	nitrogen	ROS	PA450643	6098	0.381
NULL	EMBO_Rep_2013_Jan_30_14(1)_49-56.nxml.txt.nlp	23196367	SENT58	25	25	28	28	granisetron	5-HT3R	PA449809	3359	0.381
NULL	Mol_Cancer_2008_Jun_3_7_47.nxml.txt.nlp	18519000	SENT264	9	9	0	0	urokinase	EGFR	PA451836	1956	0.381
NULL	Br_J_Cancer_2013_May_14_108(9)_1854-1861.nxml.txt.nlp	23591195	SENT55	27	27	42	42	phenol	CO2	PA450913	4513	0.381
NULL	J_Int_AIDS_Soc_2012_Oct_22_15(Suppl_3)_18439.nxml.txt.nlp	NULL	SENT683	8	8	12	12	isoniazid	IPT	PA450112	54802	0.381
NULL	J_Exp_Bot_2012_Jun_13_63(10)_3935-3951.nxml.txt.nlp	22442420	SENT43	13	13	16	16	oxygen	ROS	PA450744	6098	0.381
NULL	Diabetes_2013_Mar_14_62(3)_953-964.nxml.txt.nlp	23223176	SENT2	29	29	32	32	oxygen	ROS	PA450744	6098	0.381
NULL	Biol_Open_2012_May_9_1(6)_607-614.nxml.txt.nlp	23213454	SENT48	44	44	20	20	dextran	EGF	PA449261	1950	0.381
NULL	Indian_J_Psychiatry_2012_Oct-Dec_54(4)_394.nxml.txt.nlp	23372255	SENT11	14	14	37	37	quetiapine	B12	PA451201	7126;4709	0.381
NULL	Osteoporos_Int_2011_Aug_30_22(8)_2337-2345.nxml.txt.nlp	21116816	SENT196	4	4	9	9	fluvastatin	IL-6	PA449688	3569	0.381
NULL	J_Invest_Dermatol_2014_Mar_13_134(3)_791-800.nxml.txt.nlp	24037342	SENT115	10	10	3	3	glutaraldehyde	p53	PA449777	7157	0.381
NULL	Oxid_Med_Cell_Longev_2013_Jun_16_2013_194546.nxml.txt.nlp	23844272	SENT182	23	23	31	31	glibenclamide	SUR1	PA449782	6833	0.381
NULL	Indian_J_Med_Res_2012_Apr_135(4)_456-458.nxml.txt.nlp	22664491	SENT30	36	36	24	24	lumefantrine	ACT	PA165111722	12;11332;9457;641455	0.381
NULL	Clin_Ophthalmol_2014_Feb_10_8_389-399.nxml.txt.nlp	24550667	SENT172	11	11	32	32	timolol	TIM	PA451690	7984;8914	0.381
NULL	Hum_Genomics_2010_Apr_1_4(4)_238-249.nxml.txt.nlp	20511137	SENT5	21	21	6	6	irinotecan	UGT1A1	PA450085	54658	0.381
NULL	Tuberc_Respir_Dis_(Seoul)_2012_Aug_31_73(2)_115-121.nxml.txt.nlp	23166544	SENT126	6	6	0	0	doxorubicin	CHOP	PA449412	1649	0.381
NULL	J_Hematol_Oncol_2010_Mar_23_3_11.nxml.txt.nlp	20331897	SENT161	28	28	34	34	capecitabine	CRT	PA448771	811	0.381
NULL	Ayu_2013_Jul-Sep_34(3)_297-301.nxml.txt.nlp	24501527	SENT11	4	4	22	22	carrageenan	LPO	PA448814	4025	0.381
NULL	Diabetes_Obes_Metab_2012_Apr_14(4)_304-314.nxml.txt.nlp	22051096	SENT141	31	31	25	25	liraglutide	PPG	PA165958364	5552	0.381
NULL	J_Immunol_Res_2014_Sep_18_2014_689492.nxml.txt.nlp	25309932	SENT53	16	16	19	19	oxygen	ROS	PA450744	6098	0.381
NULL	EJNMMI_Res_2011_Sep_2_1_21.nxml.txt.nlp	22214201	SENT37	1	1	5	5	daunorubicin	NPY	PA449212	4852	0.381
NULL	Int_Arch_Med_2014_Aug_15_7_39.nxml.txt.nlp	25143784	SENT44	12	12	17	17	glucose	G6PD	PA449773	2539	0.38
NULL	Br_J_Cancer_2009_Nov_17_101(10)_1676-1682.nxml.txt.nlp	19844234	SENT131	11	11	15	15	lapatinib	HER2	PA152241907	2064	0.38
NULL	Oxid_Med_Cell_Longev_2012_Jan_19_2012_390678.nxml.txt.nlp	22315655	SENT173	9	9	11	11	gliclazide	NAC	PA10892	22861	0.38
NULL	Biomed_Res_Int_2013_Sep_8_2013_843748.nxml.txt.nlp	24083244	SENT99	4	4	27	27	colchicine	CN2	PA449092	55748	0.38
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT124	3	3	22	22	metformin	HIP	PA450395	6767;6159;64399;5068	0.38
NULL	Mol_Biol_Rep_2013_May_1_40(5)_3493-3502.nxml.txt.nlp	23277395	SENT239	16	16	29	29	heparin	HBEGF	PA449855	1839	0.38
NULL	J_Biomed_Biotechnol_2010_Nov_30_2010_484987.nxml.txt.nlp	20011071	SENT90	26	26	9	9	dextran	JAM-A	PA449261	50848	0.38
NULL	Cells_2012_Jun_25_1(3)_204-247.nxml.txt.nlp	24710474	SENT2524	10	10	4	4	geldanamycin	NFkappaB	PA152031327	4790	0.38
NULL	Curr_Cardiol_Rev_2011_Nov_7(4)_245-249.nxml.txt.nlp	22758625	SENT60	23	23	31	31	cyclophosphamide	CHOP	PA449165	1649	0.38
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT123	31	31	33	33	perifosine	TRAIL	PA165291471	8743	0.38
NULL	Oncol_Lett_2013_Jun_4_5(6)_1915-1920.nxml.txt.nlp	23833666	SENT100	10	10	19	19	cetuximab	TRPM6	PA10040	140803	0.38
NULL	Tob_Induc_Dis_2003_Sep_15_1(1)_18.nxml.txt.nlp	NULL	SENT40	19	19	26	26	collagenase	NAT2	PA449107	10;81539	0.38
NULL	Biosci_Rep_2013_Jun_11_33(3)_e00044.nxml.txt.nlp	23662735	SENT121	19	19	7	7	hydroxyurea	ADP	PA449942	23038	0.38
NULL	Lipids_Health_Dis_2011_Feb_12_10_31.nxml.txt.nlp	21314960	SENT7	4	4	0	0	hemin	HO-1	PA449849	3162	0.38
NULL	Osteoarthritis_Cartilage_2013_Sep_21(9)_1336-1345.nxml.txt.nlp	23973148	SENT164	3	3	5	5	triamcinolone	MIA	PA451749	8190	0.38
NULL	Int_J_Mol_Sci_2014_Sep_30_15(10)_17733-17750.nxml.txt.nlp	25272228	SENT30	16	16	28	28	oxygen	PI3K	PA450744	5290	0.38
NULL	Environ_Health_2013_Aug_20_12_66.nxml.txt.nlp	23962309	SENT36	3	3	7	7	phenobarbital	CYP2B	PA450911	1554;1556	0.38
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT200	3	3	11	11	tacrolimus	IL-6	PA451578	3569	0.38
NULL	Oncoimmunology_2014_Jun_3_3_e29030.nxml.txt.nlp	25083328	SENT43	23	23	25	25	rituximab	NHL	PA451261	51750	0.38
NULL	Diabetes_2008_Sep_57(9)_2332-2340.nxml.txt.nlp	18567824	SENT11	6	6	12	12	atropine	ghrelin	PA448505	51738	0.38
NULL	Anal_Bioanal_Chem_2012_Dec_4_404(10)_3071-3080.nxml.txt.nlp	23052869	SENT108	10	10	25	25	pilocarpine	CA1	PA450962	759	0.38
NULL	Front_Behav_Neurosci_2009_Sep_15_3_25.nxml.txt.nlp	19826497	SENT580	5	5	9	9	vasopressin	spatial	PA451858	219793	0.38
NULL	Indian_Dermatol_Online_J_2014_Apr-Jun_5(2)_236-237.nxml.txt.nlp	24860779	SENT21	15	15	27	27	tazarotene	CO2	PA164746821	4513	0.38
NULL	Niger_Med_J_2013_Mar-Apr_54(2)_100-106.nxml.txt.nlp	23798795	SENT5	20	20	22	22	indomethacin	PTEN	PA449982	5728	0.38
NULL	Indian_J_Pharmacol_2012_Nov-Dec_44(6)_749-753.nxml.txt.nlp	23248406	SENT77	22	22	32	32	thrombin	FIB	PA451674	2091	0.38
NULL	Int_J_Mol_Sci_2014_Sep_30_15(10)_17733-17750.nxml.txt.nlp	25272228	SENT30	16	16	19	19	oxygen	ROS	PA450744	6098	0.38
NULL	Br_J_Cancer_2003_Jun_16_88(12)_1963-1970.nxml.txt.nlp	12799644	SENT6	19	19	7	7	gemcitabine	TK2	PA449748	7084	0.38
NULL	Contemp_Clin_Dent_2011_Oct-Dec_2(4)_278-282.nxml.txt.nlp	22346152	SENT89	13	13	3	3	potassium	GCF	PA451047	6936	0.38
NULL	AIDS_Res_Ther_2009_Apr_9_6_3.nxml.txt.nlp	19358725	SENT39	0	0	3	3	atazanavir	ATV	PA10251	4683	0.38
NULL	Diabetes_2009_Apr_9_58(4)_965-974.nxml.txt.nlp	19136651	SENT11	23	23	18	18	nadh	NQO1	PA164755085	1728	0.38
NULL	Diabetes_Care_2010_Apr_12_33(4)_861-868.nxml.txt.nlp	20067962	SENT155	11	11	14	14	hyaluronan	HSP60	PA165958431	3329	0.38
NULL	Mol_Biol_Rep_2012_May_20_39(5)_5253-5267.nxml.txt.nlp	22183301	SENT230	6	6	4	4	gliclazide	NAC	PA10892	22861	0.38
NULL	Br_J_Cancer_2012_May_8_106(10)_1689-1696.nxml.txt.nlp	22531631	SENT83	0	0	12	12	pravastatin	PC-3	PA451089	692094	0.38
NULL	J_Biomed_Sci_2013_Oct_29_20(1)_82.nxml.txt.nlp	24165293	SENT31	0	0	12	12	tacrolimus	FKBP12	PA451578	2280	0.379
NULL	Dev_Immunol_2000_7(2-4)_209-225.nxml.txt.nlp	11097213	SENT12	3	3	5	5	hyaluronan	RHAMM	PA165958431	3161	0.379
NULL	Arthritis_Res_Ther_2007_Jun_29_9(Suppl_1)_S3.nxml.txt.nlp	17634142	SENT165	27	27	30	30	denosumab	RANK	PA166048634	8792	0.379
NULL	Crit_Care_2011_Dec_15_15(6)_1020.nxml.txt.nlp	22182777	SENT15	1	1	9	9	urokinase	CD87	PA451836	5329	0.379
NULL	Diabetes_Care_2010_Apr_12_33(4)_861-868.nxml.txt.nlp	20067962	SENT160	9	9	12	12	hyaluronan	HSP60	PA165958431	3329	0.379
NULL	Arthritis_Res_Ther_2005_Aug_25_7(6)_R1208-R1220.nxml.txt.nlp	16277673	SENT356	15	15	13	13	fluorescein	CD11b	PA164746009	3684	0.379
NULL	Crit_Care_2007_Feb_15_11(1)_R18.nxml.txt.nlp	17302971	SENT90	26	26	17	17	heparin	ACT	PA449855	12;11332;9457;641455	0.379
NULL	Cancer_Res_Treat_2013_Dec_31_45(4)_251-262.nxml.txt.nlp	24453997	SENT88	21	21	40	40	cytarabine	TRAIL	PA449177	8743	0.379
NULL	Mol_Biol_Rep_2013_Sep_28_40(10)_5573-5585.nxml.txt.nlp	24078156	SENT249	18	18	14	14	oxygen	ROS	PA450744	6098	0.379
NULL	Int_J_Biol_Sci_2005_Apr_1_1(2)_51-66.nxml.txt.nlp	15951850	SENT83	8	8	17	17	thrombin	PAR1	PA451674	79581;2149	0.379
NULL	ScientificWorldJournal_2013_Oct_24_2013_726912.nxml.txt.nlp	24282387	SENT163	21	21	29	29	fluorescein	AVP	PA164746009	114548;551	0.379
NULL	Carcinogenesis_2012_Jan_10_33(1)_197-202.nxml.txt.nlp	22080572	SENT5	14	14	28	28	starch	AOM	PA451492	315	0.379
NULL	J_RNAi_Gene_Silencing_2009_Mar_9_5(1)_321-330.nxml.txt.nlp	19771229	SENT215	33	33	38	38	hydroxyurea	RRM2	PA449942	6241	0.379
NULL	J_Hum_Genet_2013_Jun_16_58(6)_353-361.nxml.txt.nlp	23677058	SENT175	14	14	11	11	cytarabine	CNT3	PA449177	64078	0.379
NULL	Cancers_(Basel)_2010_Dec_23_3(1)_17-42.nxml.txt.nlp	24212604	SENT697	7	7	12	12	paclitaxel	PPX	PA450761	5531	0.379
NULL	Breast_Cancer_Res_2009_Jul_15_11(4)_207.nxml.txt.nlp	19664181	SENT226	16	16	37	37	docetaxel	PTEN	PA449383	5728	0.379
NULL	Cell_J_2011_Aug_24_Summer_13(2)_117-126.nxml.txt.nlp	23508136	SENT42	6	6	18	18	heparin	BMP2	PA449855	650	0.379
NULL	J_Antimicrob_Chemother_2009_Sep_4_64(3)_515-523.nxml.txt.nlp	19578178	SENT215	15	15	2	2	isoniazid	THP1	PA450112	2736	0.379
NULL	Asia_Pac_Allergy_2013_Oct_31_3(4)_231-240.nxml.txt.nlp	24260728	SENT34	20	20	24	24	theophylline	CYP1A2	PA451647	1544	0.379
NULL	Acta_Pharmacol_Sin_2014_Sep_25_35(9)_1215-1225.nxml.txt.nlp	25152023	SENT32	17	17	37	37	simvastatin	STZ	PA451363	6484	0.379
NULL	ScientificWorldJournal_2012_Apr_1_2012_274219.nxml.txt.nlp	22566763	SENT42	11	11	3	3	cefixime	SMAC	PA164768821	56616	0.379
NULL	J_Mol_Signal_2010_May_10_5_4.nxml.txt.nlp	20459745	SENT57	0	0	7	7	cisplatin	p53	PA449014	7157	0.379
NULL	J_Phys_Ther_Sci_2014_Nov_13_26(11)_1723-1727.nxml.txt.nlp	25435686	SENT74	6	6	11	11	glucose	DTD	PA449773	1728	0.379
NULL	Int_J_Gen_Med_2012_Nov_9_5_935-942.nxml.txt.nlp	23204857	SENT94	0	0	10	10	isoflurane	CA3	PA450106	761	0.379
NULL	Core_Evid_2011_Mar_17_6_31-42.nxml.txt.nlp	21468241	SENT108	26	26	8	8	clopidogrel	IPA	PA449053	3160	0.379
NULL	Front_Genet_2014_Nov_14_5_391.nxml.txt.nlp	25452763	SENT434	5	5	23	23	docetaxel	UGT1A1	PA449383	54658	0.379
NULL	Mol_Biol_Evol_2013_Nov_16_30(11)_2531-2540.nxml.txt.nlp	23955518	SENT142	4	4	15	15	nadh	ND2	PA164755085	4536	0.379
NULL	Br_J_Haematol_2008_Aug_28_142(4)_505-514.nxml.txt.nlp	18510682	SENT149	0	0	21	21	alemtuzumab	B19	PA164783958	59271	0.379
NULL	Carcinogenesis_2014_Sep_1_35(9)_1983-1992.nxml.txt.nlp	24692066	SENT173	3	3	15	15	tetracycline	CXCR4	PA451640	7852	0.379
NULL	Hum_Genomics_2010_Apr_1_4(4)_238-249.nxml.txt.nlp	20511137	SENT231	0	0	2	2	irinotecan	UGT1A1	PA450085	54658	0.379
NULL	Clin_Ophthalmol_2014_Jun_26_8_1213-1219.nxml.txt.nlp	25061267	SENT13	0	0	13	13	tetracaine	PRK	PA451638	1263	0.379
NULL	J_Immunother_Cancer_2013_Nov_18_1_19.nxml.txt.nlp	24829755	SENT223	14	14	20	20	temozolomide	IL-2	PA451609	3558	0.379
NULL	Curr_Nutr_Rep_2014_Dec_15_3(1)_22-34.nxml.txt.nlp	24563822	SENT285	1	1	4	4	oxygen	ROS	PA450744	6098	0.379
NULL	Clin_Med_Insights_Arthritis_Musculoskelet_Disord_2010_Dec_19_3_81-89.nxml.txt.nlp	21234291	SENT34	19	19	22	22	tocilizumab	ACR	PA165292659	49	0.379
NULL	Surg_Neurol_Int_2014_May_28_5_79.nxml.txt.nlp	24949222	SENT101	32	32	26	26	octreotide	FDG	PA450678	23583	0.379
NULL	Pharmaceuticals_(Basel)_2012_Mar_21_5(3)_325-338.nxml.txt.nlp	24281382	SENT125	15	15	12	12	timolol	CRA	PA451690	51747;10903	0.379
NULL	J_Cell_Biol_1998_Aug_10_142(3)_625-633.nxml.txt.nlp	9700154	SENT101	27	27	18	18	estradiol	Raf-1	PA449503	5894	0.379
NULL	Biologics_2009_Oct_12_3_469-474.nxml.txt.nlp	19851472	SENT71	20	20	27	27	desloratadine	IL-5	PA164776964	3567	0.379
NULL	Cardiovasc_Ultrasound_2012_Aug_17_10_35.nxml.txt.nlp	22898340	SENT175	30	30	17	17	dobutamine	A-2	PA449381	27239	0.379
NULL	Eur_J_Med_Res_2014_Jun_19_19(Suppl_1)_S21.nxml.txt.nlp	NULL	SENT26	4	4	7	7	oxygen	ROS	PA450744	6098	0.379
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Apr_30_69(Pt_5)_m296-m297.nxml.txt.nlp	23723791	SENT5	27	27	29	29	nitrile	mol	PA450636	90527	0.379
NULL	Eur_J_Appl_Physiol_2011_Feb_24_111(2)_275-283.nxml.txt.nlp	20865425	SENT105	9	9	26	26	glucose	APE	PA449773	55704;328	0.379
NULL	Pharmaceuticals_(Basel)_2012_Aug_17_5(8)_837-852.nxml.txt.nlp	24280677	SENT378	6	6	10	10	capsaicin	TRPV1	PA448776	7442	0.378
NULL	Mol_Cells_2014_Sep_30_37(9)_637-643.nxml.txt.nlp	24957212	SENT134	7	7	3	3	bleomycin	HIF-1	PA448645	29072	0.378
NULL	Basic_Res_Cardiol_2011_Sep_20_106(5)_735-747.nxml.txt.nlp	21598086	SENT8	1	1	4	4	oxygen	ROS	PA450744	6098	0.378
NULL	Nucleic_Acids_Res_2013_Apr_17_41(7)_4129-4143.nxml.txt.nlp	23420868	SENT97	29	29	43	43	l-glutamine	IL-3	PA10090	3562	0.378
NULL	Clin_Exp_Otorhinolaryngol_2011_Mar_17_4(1)_18-23.nxml.txt.nlp	21461058	SENT77	14	14	5	5	furosemide	KCC2	PA449719	57468	0.378
NULL	J_Mol_Signal_2013_Apr_23_8_5.nxml.txt.nlp	23618372	SENT72	17	17	20	20	taurine	TAUT	PA451590	6533	0.378
NULL	Fibrogenesis_Tissue_Repair_2011_Feb_1_4_4.nxml.txt.nlp	21284856	SENT121	5	5	9	9	bleomycin	ANOVA	PA448645	4858	0.378
NULL	Biomed_Res_Int_2013_Apr_27_2013_780145.nxml.txt.nlp	23710459	SENT268	22	22	26	26	resveratrol	CHS		1130	0.378
NULL	Orphanet_J_Rare_Dis_2014_Nov_7_9(1)_166.nxml.txt.nlp	NULL	SENT118	5	5	2	2	trypsin	AIT	PA451806	160728	0.378
NULL	Int_J_Mol_Sci_2014_Sep_23_15(9)_16975-16997.nxml.txt.nlp	25250913	SENT2	16	16	19	19	oxygen	ROS	PA450744	6098	0.378
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT195	28	28	30	30	sitagliptin	HIP	PA164748978	6767;6159;64399;5068	0.378
NULL	Oxid_Med_Cell_Longev_2011_Aug_23_2011_329643.nxml.txt.nlp	21904641	SENT106	17	17	3	3	l-cysteine	NAC	PA449173	22861	0.378
NULL	Clin_Med_Insights_Blood_Disord_2014_Aug_14_7_7-16.nxml.txt.nlp	25512719	SENT126	4	4	2	2	lenalidomide	RPS14	PA162363968	6208	0.378
NULL	Eur_J_Appl_Physiol_2011_Feb_24_111(2)_275-283.nxml.txt.nlp	20865425	SENT59	16	16	24	24	glucose	APE	PA449773	55704;328	0.378
NULL	Diabetes_Care_2011_Aug_16_34(8)_1854-1859.nxml.txt.nlp	21715518	SENT165	29	29	22	22	estradiol	aromatase	PA449503	1588	0.378
NULL	Oxid_Med_Cell_Longev_2013_Nov_4_2013_564902.nxml.txt.nlp	24303086	SENT19	17	17	20	20	oxygen	ROS	PA450744	6098	0.378
NULL	Case_Rep_Gastroenterol_2012_Dec_22_6(3)_803-809.nxml.txt.nlp	23341805	SENT52	4	4	12	12	cyclophosphamide	CHOP	PA449165	1649	0.378
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Aug_27_67(Pt_9)_o2505-o2506.nxml.txt.nlp	22059051	SENT75	16	16	21	21	phenol	C17	PA450913	54360	0.378
NULL	Cancers_(Basel)_2010_Jun_14_2(2)_1288-1311.nxml.txt.nlp	24281116	SENT2	7	7	10	10	oxygen	ROS	PA450744	6098	0.378
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Sep_15_68(Pt_10)_o2941.nxml.txt.nlp	23125726	SENT66	30	30	23	23	ethanol	mol	PA448073	90527	0.378
NULL	J_Cancer_Prev_2013_Sep_18(3)_201-208.nxml.txt.nlp	25337547	SENT74	5	5	8	8	oxygen	ROS	PA450744	6098	0.378
NULL	J_Hematol_Oncol_2012_Jun_8_5_29.nxml.txt.nlp	22682059	SENT218	3	3	19	19	imatinib	CR1	PA10804	1378	0.378
NULL	Front_Oncol_2013_Apr_17_3_91.nxml.txt.nlp	23616949	SENT268	23	23	12	12	paraformaldehyde	CSK	PA450790	1445	0.378
NULL	Case_Rep_Urol_2013_May_8_2013_915874.nxml.txt.nlp	23738191	SENT81	10	10	26	26	cisplatin	ADM	PA449014	133	0.378
NULL	Oxid_Med_Cell_Longev_2013_Nov_14_2013_680545.nxml.txt.nlp	24349614	SENT52	33	33	23	23	streptomycin	FBS	PA451512	64319;26269	0.378
NULL	Curr_Hepat_Rep_2010_May_21_9(2)_75-90.nxml.txt.nlp	20461127	SENT284	20	20	22	22	telbivudine	LAM	PA164760861	7249;7248	0.378
NULL	Ann_Rehabil_Med_2012_Aug_27_36(4)_466-473.nxml.txt.nlp	22977771	SENT145	2	2	33	33	triamcinolone	TLF	PA451749	9519	0.378
NULL	Oncotarget_2013_Aug_24_4(10)_1618-1631.nxml.txt.nlp	24113128	SENT203	9	9	6	6	sorafenib	p53	PA7000	7157	0.378
NULL	Mol_Pain_2014_Apr_18_10_27.nxml.txt.nlp	24742127	SENT235	1	1	19	19	paclitaxel	CD11b	PA450761	3684	0.378
NULL	Pharmaceutics_2011_Jul_13_3(3)_425-439.nxml.txt.nlp	24310588	SENT355	34	34	0	0	vicodin	SERS		6301;54938	0.378
NULL	Diabetes_Metab_J_2014_Apr_18_38(2)_100-106.nxml.txt.nlp	24851203	SENT101	3	3	0	0	glucose	MET	PA449773	4233	0.378
NULL	Case_Rep_Med_2014_Jun_4_2014_292468.nxml.txt.nlp	24991217	SENT124	0	0	15	15	warfarin	PTR	PA451906	374308	0.378
NULL	Aging_(Albany_NY)_2009_Dec_29_2(1)_63-68.nxml.txt.nlp	20228936	SENT92	21	21	13	13	nadh	SIRT1	PA164755085	23411	0.378
NULL	Mol_Cancer_2003_Nov_2_2_35.nxml.txt.nlp	14613584	SENT196	11	11	32	32	fluorescein	San	PA164746009	80218	0.378
NULL	Clin_Pharmacol_2010_Sep_17_2_185-198.nxml.txt.nlp	22291504	SENT84	0	0	7	7	creatine	ADP	PA164778930	23038	0.378
NULL	Cancer_Manag_Res_2013_Aug_27_5_225-233.nxml.txt.nlp	24023523	SENT159	17	17	15	15	ofatumumab	CD52	PA165291493	1043	0.378
NULL	Mol_Cancer_2010_Nov_8_9_291.nxml.txt.nlp	21059223	SENT183	26	26	9	9	paclitaxel	ZNF217	PA450761	7764	0.378
NULL	Mol_Cancer_2009_Nov_19_8_108.nxml.txt.nlp	19925669	SENT121	25	25	10	10	doxorubicin	CTRL	PA449412	1506	0.378
NULL	J_Physiol_2009_Feb_15_587(Pt_4)_731-744.nxml.txt.nlp	19074966	SENT114	1	1	4	4	taurine	PAT1	PA451590	10513;206358	0.378
NULL	J_Geriatr_Cardiol_2014_Jun_11(2)_151-157.nxml.txt.nlp	25009566	SENT122	6	6	8	8	cilostazol	CDP	PA164746334	1523	0.378
NULL	Br_J_Cancer_2011_Aug_23_105(5)_618-627.nxml.txt.nlp	21829197	SENT177	16	16	13	13	lapatinib	CRT	PA152241907	811	0.378
NULL	Int_J_Mol_Sci_2014_Sep_23_15(9)_16975-16997.nxml.txt.nlp	25250913	SENT251	11	11	14	14	oxygen	ROS	PA450744	6098	0.378
NULL	Bone_Marrow_Transplant_2012_Feb_28_47(2)_203-211.nxml.txt.nlp	21441963	SENT106	11	11	1	1	fludarabine	NMA	PA449655	25805	0.377
NULL	Amino_Acids_2011_May_30_40(5)_1271-1296.nxml.txt.nlp	21448658	SENT197	33	33	36	36	oxygen	ROS	PA450744	6098	0.377
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Dec_22_69(Pt_1)_o127-o128.nxml.txt.nlp	23476388	SENT64	14	14	34	34	antipyrine	NO3	PA448453	4681	0.377
NULL	Nat_Neurosci_2012_Mar_4_15(4)_565-573.nxml.txt.nlp	22388960	SENT447	36	36	27	27	isoflurane	Hv1	PA450106	84329	0.377
NULL	Front_Neural_Circuits_2013_Aug_1_7_129.nxml.txt.nlp	23914157	SENT220	21	21	6	6	ethanol	CEA	PA448073	5670;1087	0.377
NULL	Curr_Hepat_Rep_2010_May_21_9(2)_75-90.nxml.txt.nlp	20461127	SENT270	19	19	23	23	telbivudine	LAM	PA164760861	7249;7248	0.377
NULL	Br_J_Ophthalmol_2008_Sep_22_92(9)_1275-1282.nxml.txt.nlp	18723745	SENT66	0	0	2	2	latanoprost	BAK	PA164774763	578	0.377
NULL	Ann_R_Coll_Surg_Engl_2012_Nov_94(8)_e251-e253.nxml.txt.nlp	23131217	SENT71	6	6	2	2	octreotide	ACTH	PA450678	5443	0.377
NULL	Blood_Cancer_J_2013_Aug_2_3(8)_e129.nxml.txt.nlp	23912609	SENT271	14	14	2	2	fluorescein	APC	PA164746009	324	0.377
NULL	J_Antimicrob_Chemother_2012_Feb_17_67(2)_404-414.nxml.txt.nlp	22101217	SENT135	6	6	12	12	chloramphenicol	EMB	PA448927	133418	0.377
NULL	Comput_Struct_Biotechnol_J_2012_Oct_29_3_e201210002.nxml.txt.nlp	24688662	SENT147	20	20	13	13	ethanol	CO2	PA448073	4513	0.377
NULL	Ann_Surg_Oncol_2010_Apr_20_17(4)_1168-1176.nxml.txt.nlp	19936839	SENT212	39	39	24	24	cetuximab	ACRC	PA10040	93953	0.377
NULL	Paediatr_Drugs_2013_Apr_20_15(2)_119-131.nxml.txt.nlp	23512128	SENT311	4	4	21	21	rabeprazole	MPG	PA451216	4350	0.377
NULL	Acta_Pharmacol_Sin_2014_Jun_4_35(6)_752-757.nxml.txt.nlp	24902786	SENT160	19	19	1	1	letrozole	STZ	PA450196	6484	0.377
NULL	AIDS_Res_Ther_2008_Sep_17_5_21.nxml.txt.nlp	18799008	SENT192	15	15	34	34	lopinavir	SGC	PA450264	6443	0.377
NULL	Int_J_Tryptophan_Res_2008_Aug_14_1_3-12.nxml.txt.nlp	22084577	SENT28	40	40	20	20	flumazenil	CO2	PA449659	4513	0.377
NULL	Ann_Med_Health_Sci_Res_2013_Oct-Dec_3(4)_498-503.nxml.txt.nlp	24379998	SENT87	28	28	37	37	cyclophosphamide	CHOP	PA449165	1649	0.377
NULL	Clin_Mol_Hepatol_2013_Sep_30_19(3)_320-323.nxml.txt.nlp	24133672	SENT55	8	8	15	15	cyclophosphamide	CHOP	PA449165	1649	0.377
NULL	Ann_Gen_Psychiatry_2013_Jan_24_12_1.nxml.txt.nlp	23347694	SENT149	26	26	33	33	ziprasidone	MRS	PA451974	8011	0.377
NULL	Diabetes_Care_2011_Oct_15_34(10)_2279-2284.nxml.txt.nlp	21949222	SENT91	18	18	15	15	metformin	FFM	PA450395	24	0.377
NULL	Nucleic_Acids_Res_2012_Jul_30_40(13)_6319-6337.nxml.txt.nlp	22467215	SENT275	23	23	31	31	cisplatin	Bcl-2	PA449014	596	0.377
NULL	EMBO_Mol_Med_2012_Oct_30_4(10)_1087-1096.nxml.txt.nlp	22933245	SENT133	12	12	18	18	olaparib	ANOVA		4858	0.377
NULL	Oncogene_2009_Dec_3_28(48)_4237-4248.nxml.txt.nlp	19734937	SENT75	4	4	6	6	collagenase	PAR-1	PA449107	2011;2149	0.377
NULL	Front_Neurol_2014_Sep_11_5_173.nxml.txt.nlp	25309501	SENT41	2	2	42	42	hyaluronan	TLR-4	PA165958431	7099	0.377
NULL	Front_Neurosci_2012_May_30_6_77.nxml.txt.nlp	22661925	SENT342	12	12	6	6	rolipram	HEC	PA153906323	10403	0.377
NULL	Environ_Health_2006_Feb_21_5_4.nxml.txt.nlp	16504050	SENT146	20	20	6	6	estradiol	aromatase	PA449503	1588	0.377
NULL	Biosensors_(Basel)_2013_Nov_13_3(4)_374-384.nxml.txt.nlp	25586413	SENT82	3	3	13	13	capsaicin	NHS	PA448776	4810	0.377
NULL	Front_Chem_2013_Dec_31_1_40.nxml.txt.nlp	24790967	SENT30	37	37	8	8	echinacea	flower	PA131550706	11094	0.377
NULL	Environ_Health_Perspect_2012_Apr_3_120(4)_583-589.nxml.txt.nlp	22476201	SENT185	16	16	19	19	oxygen	ROS	PA450744	6098	0.377
NULL	Evid_Based_Complement_Alternat_Med_2014_Oct_15_2014_169130.nxml.txt.nlp	25386217	SENT55	20	20	23	23	oxygen	ROS	PA450744	6098	0.377
NULL	Mol_Cancer_2012_Mar_25_11_16.nxml.txt.nlp	22443473	SENT419	10	10	23	23	imatinib	Rho	PA10804	29984	0.377
NULL	Br_J_Cancer_2010_Jun_29_103(1)_61-72.nxml.txt.nlp	20588279	SENT196	3	3	0	0	trastuzumab	RhoB	PA451743	388	0.376
NULL	Genome_Biol_2003_Oct_27_4(11)_232.nxml.txt.nlp	14611649	SENT24	25	25	9	9	l-arginine	SLC7A2	PA448478	6542	0.376
NULL	J_Bras_Pneumol_2014_Jul-Aug_40(4)_327-363.nxml.txt.nlp	25210957	SENT1708	18	18	10	10	propofol	por	PA451141	64840	0.376
NULL	eLife_2014_May_23_3_e02286.nxml.txt.nlp	24859755	SENT1329	3	3	7	7	nadh	ND3	PA164755085	4537	0.376
NULL	Br_J_Cancer_1984_Jun_49(6)_779-786.nxml.txt.nlp	6203548	SENT2	15	15	7	7	mitomycin	ADM	PA450524	133	0.376
NULL	Zookeys_2014_Nov_25_(457)_1-14.nxml.txt.nlp	25561827	SENT121	36	36	11	11	ethanol	San	PA448073	80218	0.376
NULL	Int_J_Med_Sci_2012_Jun_8_9(4)_311-315.nxml.txt.nlp	22701339	SENT49	30	30	17	17	sevoflurane	DAP	PA451341	23549;3375;1611	0.376
NULL	Acta_Vet_Scand_2014_May_20_56(1)_33.nxml.txt.nlp	24884817	SENT11	24	24	20	20	heparin	IL-17A	PA449855	3605	0.376
NULL	Br_J_Cancer_1980_Jun_41(6)_946-955.nxml.txt.nlp	7426319	SENT3	0	0	7	7	spermine	PAO	PA164781199	196743;54498	0.376
NULL	Biomed_Opt_Express_2011_May_16_2(6)_1576-1583.nxml.txt.nlp	21698020	SENT147	16	16	13	13	nadh	TPEF	PA164755085	23671	0.376
NULL	Br_J_Cancer_2006_Feb_13_94(3)_407-426.nxml.txt.nlp	16434996	SENT119	0	0	10	10	genistein	BRCA1	PA165109660	672	0.376
NULL	Oncotarget_2014_Aug_6_5(18)_8416-8428.nxml.txt.nlp	25261365	SENT258	0	0	12	12	fluorescein	San	PA164746009	80218	0.376
NULL	Breast_Cancer_Res_2014_May_27_16(3)_R52.nxml.txt.nlp	24887554	SENT83	4	4	24	24	phenol	EGF	PA450913	1950	0.376
NULL	Cancers_(Basel)_2013_Aug_9_5(3)_998-1019.nxml.txt.nlp	24202331	SENT72	7	7	23	23	docetaxel	PC3	PA449383	57332;7832;5122	0.376
NULL	J_Immunother_Cancer_2013_Jul_15_1_10.nxml.txt.nlp	24829747	SENT63	7	7	10	10	oxygen	ROS	PA450744	6098	0.376
NULL	Nat_Commun_2013_Oct_1_4_2516.nxml.txt.nlp	24084631	SENT68	2	2	9	9	lisinopril	AK4	PA450242	205	0.376
NULL	Case_Rep_Oncol_2013_Jan_8_6(1)_1-5.nxml.txt.nlp	23466482	SENT23	33	33	46	46	epirubicin	NAC	PA449476	22861	0.376
NULL	Anesth_Pain_Med_2014_Sep_9_4(4)_e14221.nxml.txt.nlp	25599022	SENT79	0	0	6	6	cisplatin	LPO	PA449014	4025	0.376
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_2_2012_701261.nxml.txt.nlp	23082084	SENT57	34	34	23	23	lipase	DTNB	PA450239	1838	0.376
NULL	Biofactors_2014_May_6_40(3)_277-283.nxml.txt.nlp	24353111	SENT34	32	32	21	21	choline	MTHFR	PA448976	4524	0.376
NULL	J_Ginseng_Res_2011_Jun_35(2)_191-199.nxml.txt.nlp	23717061	SENT218	8	8	3	3	naringenin	HERG	PA151958361	3757	0.376
NULL	Mar_Drugs_2012_Aug_22_10(8)_1852-1872.nxml.txt.nlp	23015777	SENT28	22	22	25	25	oxygen	ROS	PA450744	6098	0.376
NULL	Clin_Med_Insights_Oncol_2012_Aug_21_6_305-314.nxml.txt.nlp	23032692	SENT191	3	3	5	5	methotrexate	C10	PA450428	113246	0.376
NULL	Front_Plant_Sci_2011_Dec_26_2_101.nxml.txt.nlp	22639623	SENT124	17	17	25	25	erlotinib	ORP7	PA134687924	114881	0.376
NULL	Case_Rep_Med_2010_Dec_27_2010_807434.nxml.txt.nlp	21209733	SENT35	9	9	14	14	lipase	LMF1	PA450239	64788	0.376
NULL	Oxid_Med_Cell_Longev_2012_Aug_8_2012_920932.nxml.txt.nlp	22919442	SENT20	7	7	10	10	oxygen	ROS	PA450744	6098	0.376
NULL	Chem_Cent_J_2012_Jun_20_6_58.nxml.txt.nlp	22716299	SENT162	31	31	36	36	genistein	Gen	PA165109660	348654	0.376
NULL	Autoimmune_Dis_2012_Aug_1_2012_207190.nxml.txt.nlp	22900150	SENT78	0	0	2	2	hyaluronan	CD44	PA165958431	960	0.376
NULL	Clin_Ophthalmol_2012_Nov_8_6_1855-1858.nxml.txt.nlp	23152666	SENT68	8	8	13	13	bevacizumab	San	PA130232992	80218	0.376
NULL	Neural_Plast_2012_May_20_2012_569149.nxml.txt.nlp	22685677	SENT35	25	25	7	7	lipase	cPLA2	PA450239	10524	0.376
NULL	Biomed_Eng_Online_2003_Sep_18_2_15.nxml.txt.nlp	14561228	SENT264	6	6	13	13	ethanol	HEMA	PA448073	2157	0.376
NULL	Int_J_Mol_Sci_2014_Oct_6_15(10)_17886-17900.nxml.txt.nlp	25290095	SENT3	29	29	20	20	resveratrol	OPG		690	0.376
NULL	Dermatoendocrinol_2013_Apr_1_5(2)_252-263.nxml.txt.nlp	24194965	SENT316	7	7	31	31	pemetrexed	AMPK	PA10810	5563	0.376
NULL	Cell_Death_Dis_2011_Apr_28_2(4)_e152.nxml.txt.nlp	21525939	SENT16	1	1	4	4	oxygen	ROS	PA450744	6098	0.376
NULL	J_Clin_Biochem_Nutr_2011_Jan_28_48(1)_40-45.nxml.txt.nlp	21297910	SENT98	8	8	15	15	metformin	SeP	PA450395	6414	0.376
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jan_21_68(Pt_2)_o469.nxml.txt.nlp	22347077	SENT70	13	13	22	22	acetone	mol	PA448025	90527	0.376
NULL	Plant_Methods_2013_Jul_10_9_25.nxml.txt.nlp	23841995	SENT181	20	20	14	14	spectinomycin	MGL	PA164781342	11343	0.376
NULL	Mol_Vis_2010_Oct_8_16_2033-2042.nxml.txt.nlp	21042558	SENT121	4	4	8	8	genistein	STZ	PA165109660	6484	0.376
NULL	Int_J_Hypertens_2011_May_25_2011_417594.nxml.txt.nlp	21747977	SENT190	19	19	24	24	carvedilol	BEST	PA448817	7439	0.376
NULL	Pharmacogn_Rev_2010_Jan-Jun_4(7)_42-48.nxml.txt.nlp	22228940	SENT91	21	21	28	28	glucose	STZ	PA449773	6484	0.375
NULL	Oncogenesis_2014_May_12_3(5)_e102.nxml.txt.nlp	24819061	SENT143	19	19	4	4	nadh	SIRT1	PA164755085	23411	0.375
NULL	Mol_Cancer_2012_Mar_21_11_13.nxml.txt.nlp	22436134	SENT17	42	42	36	36	doxorubicin	HuR	PA449412	1994	0.375
NULL	Indian_J_Med_Res_2012_Apr_135(4)_456-458.nxml.txt.nlp	22664491	SENT30	39	39	24	24	artemether	ACT	PA165111698	12;11332;9457;641455	0.375
NULL	N_Am_J_Med_Sci_2013_May_5(5)_309-315.nxml.txt.nlp	23814761	SENT195	18	18	10	10	hyaluronan	BOP	PA165958431	611;150572	0.375
NULL	Aquat_Biosyst_2012_Aug_31_8_19.nxml.txt.nlp	22938529	SENT28	27	27	37	37	oxygen	PAM	PA450744	5066;23077	0.375
NULL	Cell_Death_Dis_2014_Mar_13_5(3)_e1118.nxml.txt.nlp	24625977	SENT81	36	36	31	31	etoposide	p53	PA449552	7157	0.375
NULL	J_Geriatr_Cardiol_2014_Jun_11(2)_151-157.nxml.txt.nlp	25009566	SENT133	3	3	5	5	cilostazol	CDP	PA164746334	1523	0.375
NULL	Ann_Indian_Acad_Neurol_2012_Jul-Sep_15(3)_181-185.nxml.txt.nlp	22919189	SENT5	15	15	21	21	trypsin	ITIH4	PA451806	3700	0.375
NULL	Ann_Neurosci_2012_Jan_19(1)_31-39.nxml.txt.nlp	25205961	SENT166	24	24	28	28	amiloride	TRAAK	PA448368	50801	0.375
NULL	Br_J_Cancer_2003_Mar_24_88(6)_822-827.nxml.txt.nlp	12644816	SENT118	17	17	14	14	thalidomide	PSA	PA451644	29968;9520;354	0.375
NULL	J_Adv_Pract_Oncol_2012_Jul_1_Jul-Aug_3(4)_249-257.nxml.txt.nlp	25031953	SENT36	46	46	24	24	calcidiol	CYP2R1	PA164745614	120227	0.375
NULL	Hematol_Rep_2011_Oct_28_3(3_Suppl)_e4.nxml.txt.nlp	22586512	SENT32	6	6	8	8	doxorubicin	CHOP	PA449412	1649	0.375
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT1777	6	6	4	4	clarithromycin	ATV	PA449028	4683	0.375
NULL	Int_J_Lab_Hematol_2013_Dec_30_35(6)_652-657.nxml.txt.nlp	23718922	SENT8	26	26	30	30	thrombin	TGT	PA451674	9097;81890	0.375
NULL	Int_J_Mol_Sci_2014_Sep_30_15(10)_17733-17750.nxml.txt.nlp	25272228	SENT6	7	7	10	10	oxygen	ROS	PA450744	6098	0.375
NULL	Int_J_Mol_Sci_2013_Aug_14_14(8)_16719-16731.nxml.txt.nlp	23949634	SENT211	12	12	2	2	thrombin	c-Jun	PA451674	3725	0.375
NULL	Indian_J_Endocrinol_Metab_2013_Oct_17(Suppl1)_S289-S291.nxml.txt.nlp	24251189	SENT56	5	5	19	19	galactose	GDH	PA449725	51084;2746	0.375
NULL	Pharmaceuticals_(Basel)_2013_Dec_23_7(1)_1-17.nxml.txt.nlp	24366113	SENT322	16	16	3	3	cyclosporine	IL-17	PA449167	3605	0.375
NULL	Clin_Epidemiol_2010_Aug_9_2_57-66.nxml.txt.nlp	20865104	SENT200	5	5	9	9	isoniazid	IPT	PA450112	54802	0.375
NULL	Int_J_Med_Sci_2013_Jun_15_10(8)_1003-1014.nxml.txt.nlp	23801887	SENT68	11	11	15	15	isoniazid	IPT	PA450112	54802	0.375
NULL	Indian_J_Endocrinol_Metab_2014_Jan-Feb_18(1)_32-38.nxml.txt.nlp	24701427	SENT44	11	11	16	16	phosphorus	ALP	PA450954	6590;10850;27295;80150;470;26033	0.375
NULL	Arthritis_Res_Ther_2010_Aug_24_12(4)_214.nxml.txt.nlp	20735862	SENT192	20	20	31	31	methotrexate	TBC	PA450428	23216	0.375
NULL	Environ_Health_Perspect_2009_Jul_23_117(7)_1155-1161.nxml.txt.nlp	19654927	SENT90	17	17	32	32	phenol	FBS	PA450913	64319;26269	0.375
NULL	BMJ_2010_Feb_8_340_c693.nxml.txt.nlp	20142325	SENT258	17	17	41	41	venlafaxine	CYP3A4	PA451866	1576	0.375
NULL	Indian_J_Crit_Care_Med_2008_Oct-Dec_12(4)_181-189.nxml.txt.nlp	19742267	SENT202	25	25	21	21	anakinra	ACR	PA10799	49	0.375
NULL	J_Exp_Bot_2012_Mar_15_63(5)_1969-1983.nxml.txt.nlp	22174442	SENT432	7	7	13	13	l-alanine	NO3	PA448055	4681	0.375
NULL	Ther_Clin_Risk_Manag_2006_Sep_2(3)_235-249.nxml.txt.nlp	18360599	SENT292	0	0	7	7	teriparatide	PTH	PA451620	5741	0.375
NULL	Indian_J_Endocrinol_Metab_2012_Jul-Aug_16(4)_654-656.nxml.txt.nlp	22837937	SENT25	9	9	22	22	estradiol	PTH	PA449503	5741	0.375
NULL	HSR_Proc_Intensive_Care_Cardiovasc_Anesth_2009_1(4)_34-43.nxml.txt.nlp	23439516	SENT41	2	2	28	28	desflurane	CEA	PA164749136	5670;1087	0.375
NULL	Breast_Cancer_Res_2014_Jul_29_16(4)_412.nxml.txt.nlp	25410383	SENT291	6	6	8	8	ribavirin	ESR1	PA451241	2099	0.375
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT27	20	20	26	26	resveratrol	TRAIL		8743	0.375
NULL	Eur_J_Endocrinol_2011_Jan_164(1)_69-74.nxml.txt.nlp	20961967	SENT106	3	3	12	12	pioglitazone	OPG	PA450970	690	0.375
NULL	Nucleic_Acids_Res_2005_Aug_9_33(14)_4536-4543.nxml.txt.nlp	16091631	SENT104	19	19	15	15	tetracycline	TERT	PA451640	7015	0.375
NULL	Mol_Vis_2011_Sep_27_17_2495-2506.nxml.txt.nlp	21976960	SENT31	0	0	7	7	sirolimus	RAPA	PA451365	55809	0.375
NULL	Chin_J_Cancer_2011_Aug_30(8)_508-525.nxml.txt.nlp	21801600	SENT168	9	9	13	13	nadh	ND1	PA164755085	4535;10625	0.375
NULL	Arthritis_Res_Ther_2012_May_1_14(3)_R99.nxml.txt.nlp	22546542	SENT112	5	5	22	22	infliximab	IL-6	PA452639	3569	0.375
NULL	Breast_Cancer_Res_2010_Jul_19_12(4)_R51.nxml.txt.nlp	20642837	SENT45	20	20	26	26	hydrocortisone	EGF	PA449905	1950	0.375
NULL	Mediators_Inflamm_2011_Jul_3_2011_296069.nxml.txt.nlp	21765615	SENT140	8	8	11	11	oxygen	ROS	PA450744	6098	0.375
NULL	Open_Ophthalmol_J_2008_Jun_30_2_119-122.nxml.txt.nlp	19517032	SENT105	6	6	25	25	triamcinolone	MYOC	PA451749	4653	0.375
NULL	Mol_Biol_Cell_2014_Aug_1_25(15)_2272-2281.nxml.txt.nlp	24920822	SENT256	15	15	9	9	tetracycline	CO2	PA451640	4513	0.374
NULL	Indian_J_Nucl_Med_2010_Jul-Sep_25(3)_78-87.nxml.txt.nlp	NULL	SENT310	2	2	8	8	budesonide	gamma	PA448681	9913	0.374
NULL	Ann_Oncol_2009_Nov_23_20(11)_1803-1812.nxml.txt.nlp	19549706	SENT113	14	14	18	18	sunitinib	IFN	PA162372840	3439	0.374
NULL	J_Clin_Biochem_Nutr_2011_Jan_28_48(1)_8-19.nxml.txt.nlp	21297906	SENT92	2	2	8	8	creatine	GAPDH	PA164778930	2597	0.374
NULL	Chin_J_Cancer_2012_Feb_31(2)_58-72.nxml.txt.nlp	22098952	SENT112	32	32	30	30	vinblastine	MRP2	PA451877	100130958;57626;1244	0.374
NULL	J_Mol_Signal_2006_Dec_6_1_8.nxml.txt.nlp	17224083	SENT87	7	7	10	10	thrombin	Rho	PA451674	29984	0.374
NULL	Front_Neurol_2012_Feb_7_3_11.nxml.txt.nlp	22347210	SENT126	22	22	17	17	vasopressin	AVP	PA451858	114548;551	0.374
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT137	7	7	5	5	sulindac	survivin	PA451565	332	0.374
NULL	Blood_Res_2013_Mar_25_48(1)_40-45.nxml.txt.nlp	23589794	SENT52	9	9	34	34	iron	ALP	PA450087	6590;10850;27295;80150;470;26033	0.374
NULL	Onco_Targets_Ther_2014_Jun_13_7_1033-1042.nxml.txt.nlp	24966685	SENT202	14	14	16	16	gemcitabine	AKT	PA449748	207	0.374
NULL	Ann_Surg_Oncol_2014_Feb_13_21(5)_1575-1582.nxml.txt.nlp	24522992	SENT174	22	22	29	29	tamoxifen	IMPACT	PA451581	55364	0.374
NULL	Diabetes_Care_2011_Jun_20_34(6)_1406-1411.nxml.txt.nlp	21515837	SENT5	5	5	21	21	glucose	LVM	PA449773	23209	0.374
NULL	J_Cell_Biol_2003_Sep_1_162(5)_773-780.nxml.txt.nlp	12952931	SENT17	38	38	6	6	tetracycline	AAK1	PA451640	22848	0.374
NULL	Clin_Med_Oncol_2008_Jun_11_2_469-470.nxml.txt.nlp	21892319	SENT32	17	17	34	34	doxorubicin	HER-2	PA449412	2064	0.374
NULL	J_Mol_Signal_2014_Aug_8_9_8.nxml.txt.nlp	25237386	SENT279	34	34	21	21	streptomycin	FBS	PA451512	64319;26269	0.374
NULL	Allergy_Rhinol_(Providence)_2011_Apr-Jun_2(2)_e51-e53.nxml.txt.nlp	22852117	SENT54	1	1	18	18	curcumin	GM-CSF	PA151958596	1437	0.374
NULL	Diabetes_2011_Jun_21_60(6)_1797-1804.nxml.txt.nlp	21536946	SENT33	8	8	18	18	diazoxide	ABCC8	PA449285	6833	0.374
NULL	Front_Neurol_2014_Nov_3_5_215.nxml.txt.nlp	25404927	SENT222	16	16	31	31	streptokinase	ASK	PA164754919	10926	0.374
NULL	Chem_Cent_J_2012_Apr_27_6_35.nxml.txt.nlp	22540963	SENT85	11	11	5	5	ethanol	flower	PA448073	11094	0.374
NULL	Clin_Infect_Dis_2011_Mar_1_52(5)_621-623.nxml.txt.nlp	21292667	SENT53	25	25	11	11	primaquine	RDT	PA451103	6598	0.374
NULL	J_Pregnancy_2012_Sep_17_2012_482690.nxml.txt.nlp	23029616	SENT24	21	21	24	24	oxygen	ROS	PA450744	6098	0.374
NULL	Oncol_Lett_2014_Nov_10_8(5)_2333-2339.nxml.txt.nlp	25295120	SENT172	10	10	13	13	cyclosporine	ADM	PA449167	133	0.374
NULL	Indian_J_Endocrinol_Metab_2012_May-Jun_16(3)_343-348.nxml.txt.nlp	22629497	SENT28	15	15	12	12	preotact	PTH	PA165958355	5741	0.374
NULL	Emerg_Infect_Dis_2012_Mar_18(3)_392-400.nxml.txt.nlp	22377231	SENT191	0	0	11	11	metronidazole	NAP1	PA450484	4673;64343;9476;3576;51531	0.374
NULL	Arch_Drug_Inf_2009_Mar_2(1)_8-16.nxml.txt.nlp	19381336	SENT30	19	19	23	23	rifampin	CYP3A4	PA451250	1576	0.374
NULL	Neural_Regen_Res_2014_Oct_1_9(19)_1731-1739.nxml.txt.nlp	25422633	SENT193	14	14	6	6	scopolamine	NeuN	PA451308	146713	0.374
NULL	Mol_Biol_Cell_2014_Sep_15_25(18)_2866-2881.nxml.txt.nlp	25057015	SENT259	11	11	16	16	protamine	CAF-1	PA10366	10036;8208	0.374
NULL	Nat_Commun_2014_Jul_16_5_4425.nxml.txt.nlp	25028121	SENT96	13	13	17	17	creatine	p47	PA164778930	3621;55968	0.374
NULL	Int_J_Anal_Chem_2013_Jul_16_2013_419716.nxml.txt.nlp	23956748	SENT148	29	29	16	16	heparin	PF6	PA449855	200162	0.374
NULL	Diabetes_Care_2013_Jul_12_36(7)_1926-1932.nxml.txt.nlp	23378624	SENT148	11	11	9	9	tacrolimus	RTR	PA451578	2649	0.374
NULL	Diabetes_2009_Jun_31_58(6)_1434-1439.nxml.txt.nlp	19336679	SENT6	12	12	10	10	metformin	SLC22A1	PA450395	6580	0.374
NULL	Arthritis_Res_Ther_2009_Jun_5_11(3)_R85.nxml.txt.nlp	19500336	SENT35	1	1	19	19	hyaluronan	CD106	PA165958431	7412	0.374
NULL	J_Viral_Hepat_2010_Feb_17(2)_139-147.nxml.txt.nlp	19674282	SENT77	25	25	8	8	ribavirin	RVR	PA451241	9975	0.374
NULL	Acta_Vet_Scand_2008_Jul_4_50(1)_27.nxml.txt.nlp	18601734	SENT3	11	11	23	23	doxorubicin	MTSS1	PA449412	9788	0.374
NULL	Pharmaceuticals_(Basel)_2012_Jan_5_5(1)_79-93.nxml.txt.nlp	24288044	SENT60	17	17	25	25	trastuzumab	HER2	PA451743	2064	0.374
NULL	J_Neuroinflammation_2010_Nov_18_7_81.nxml.txt.nlp	21087489	SENT52	33	33	22	22	pilocarpine	DAI	PA450962	81030	0.374
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT120	4	4	1	1	curcumin	PC-3	PA151958596	692094	0.374
NULL	Nat_Med_2011_Oct_2_17(10)_1304-1309.nxml.txt.nlp	21963515	SENT34	0	0	25	25	tacrolimus	TRPV5	PA451578	56302	0.374
NULL	Mol_Cancer_2010_Mar_9_9_54.nxml.txt.nlp	20214788	SENT52	15	15	17	17	tetracycline	JDP2	PA451640	122953	0.374
NULL	Cell_Mol_Life_Sci_2011_May_26_68(10)_1785-1798.nxml.txt.nlp	20976523	SENT220	2	2	17	17	collagenase	AP-1	PA449107	2353;3727;2354;3725	0.373
NULL	Int_J_Biol_Sci_2014_Feb_21_10(3)_285-295.nxml.txt.nlp	24643130	SENT153	16	16	14	14	capsaicin	TP53	PA448776	7157	0.373
NULL	Br_J_Cancer_2000_Sep_17_83(6)_707-714.nxml.txt.nlp	10952772	SENT1	11	11	15	15	gemcitabine	Gem	PA449748	51053	0.373
NULL	Mol_Biol_Cell_2013_Jun_15_24(12)_1996-2007.nxml.txt.nlp	23637462	SENT305	10	10	19	19	phenol	TGN	PA450913	7038	0.373
NULL	FEBS_Open_Bio_2014_Jun_7_4_554-559.nxml.txt.nlp	25009769	SENT248	15	15	3	3	hyaluronidase	HYAL1	PA164745713	3373	0.373
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT91	9	9	4	4	imatinib	ABCB1	PA10804	5243	0.373
NULL	Acta_Orthop_2009_Feb_26_80(1)_46-50.nxml.txt.nlp	19234885	SENT102	23	23	8	8	celecoxib	TKR	PA448871	8277	0.373
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jan_11_68(Pt_2)_o349-o350.nxml.txt.nlp	22346978	SENT3	25	25	21	21	ethanol	mol	PA448073	90527	0.373
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Mar_13_69(Pt_4)_o530.nxml.txt.nlp	23634071	SENT5	31	31	27	27	ethanol	mol	PA448073	90527	0.373
NULL	Acta_Naturae_2011_Jan-Mar_3(1)_93-98.nxml.txt.nlp	22649677	SENT96	7	7	2	2	lipase	hole	PA450239	80757	0.373
NULL	J_Anim_Sci_Biotechnol_2013_Dec_18_4(1)_51.nxml.txt.nlp	24344643	SENT125	5	5	7	7	urea	NEFA	PA451831	4925	0.373
NULL	Angiogenesis_2012_Sep_27_15(3)_361-376.nxml.txt.nlp	22451299	SENT96	3	3	6	6	oxygen	ROS	PA450744	6098	0.373
NULL	Front_Genet_2014_Nov_14_5_391.nxml.txt.nlp	25452763	SENT434	5	5	21	21	docetaxel	XRCC3	PA449383	7517	0.373
NULL	Biol_Open_2012_Nov_23_2(2)_183-190.nxml.txt.nlp	23429853	SENT8	17	17	20	20	oxygen	ROS	PA450744	6098	0.373
NULL	Biol_Open_2012_Nov_23_2(2)_183-190.nxml.txt.nlp	23429853	SENT152	18	18	21	21	oxygen	ROS	PA450744	6098	0.373
NULL	Pediatr_Gastroenterol_Hepatol_Nutr_2013_Dec_31_16(4)_233-239.nxml.txt.nlp	24511519	SENT113	16	16	0	0	succimer	BAL	PA451521	83666	0.373
NULL	Psychiatry_Investig_2012_Jun_30_9(2)_187-190.nxml.txt.nlp	22707971	SENT6	22	22	7	7	capsaicin	POMC	PA448776	5443	0.373
NULL	Oncotarget_2013_Aug_8_4(8)_1130-1142.nxml.txt.nlp	24029073	SENT10	11	11	14	14	oxygen	ROS	PA450744	6098	0.373
NULL	Avicenna_J_Med_Biotechnol_2009_Apr-Jun_1(1)_9-17.nxml.txt.nlp	23407612	SENT109	7	7	10	10	oxygen	ROS	PA450744	6098	0.373
NULL	J_Carcinog_2011_Nov_30_10_25.nxml.txt.nlp	22190867	SENT245	10	10	8	8	tamoxifen	SMRT	PA451581	9612	0.373
NULL	Chem_Cent_J_2013_Sep_4_7_147.nxml.txt.nlp	24006941	SENT85	9	9	11	11	lipase	LOX	PA450239	4015	0.373
NULL	Tumour_Biol_2013_Dec_26_34(6)_4033-4057.nxml.txt.nlp	24068570	SENT218	3	3	36	36	thyroglobulin	B12	PA164754910	7126;4709	0.373
NULL	Clin_Interv_Aging_2009_Dec_29_4_463-472.nxml.txt.nlp	20054411	SENT56	20	20	36	36	vardenafil	SEP2	PA10229	23176;23157	0.373
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Mar_25_65(Pt_4)_o840.nxml.txt.nlp	21582559	SENT65	33	33	26	26	ethanol	mol	PA448073	90527	0.373
NULL	Ann_Clin_Microbiol_Antimicrob_2009_Dec_16_8_35.nxml.txt.nlp	20015394	SENT76	2	2	9	9	ceftazidime	CTX	PA448861	1593	0.373
NULL	Biomed_Res_Int_2013_Jan_27_2013_456352.nxml.txt.nlp	23509724	SENT114	1	1	5	5	galactose	MGL	PA449725	11343	0.373
NULL	Pain_Res_Treat_2013_Nov_4_2013_742407.nxml.txt.nlp	24303215	SENT52	29	29	24	24	l-tryptophan	TDO	PA10323	6999	0.373
NULL	Indian_J_Med_Res_2013_Feb_137(2)_283-294.nxml.txt.nlp	23563371	SENT215	11	11	15	15	isoniazid	IPT	PA450112	54802	0.373
NULL	Exp_Anim_2014_Feb_7_63(1)_45-53.nxml.txt.nlp	24521862	SENT13	15	15	7	7	trypsin	SPINK1	PA451806	6690	0.373
NULL	J_Inherit_Metab_Dis_2011_Aug_8_34(4)_859-867.nxml.txt.nlp	21384228	SENT182	10	10	7	7	creatine	SRD5A3	PA164778930	79644	0.373
NULL	Exp_Diabetes_Res_2012_Dec_26_2012_230624.nxml.txt.nlp	23365557	SENT255	7	7	21	21	metformin	Rog	PA450395	27033	0.373
NULL	Acta_Vet_Scand_2010_Jul_30_52(1)_47.nxml.txt.nlp	20670455	SENT103	19	19	37	37	spectinomycin	TMP	PA164781342	2012	0.373
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_May_3_64(Pt_6)_o961.nxml.txt.nlp	21202691	SENT3	20	20	22	22	ethanol	mol	PA448073	90527	0.373
NULL	Cardiovasc_Drugs_Ther_2013_Feb_29_27(1)_61-68.nxml.txt.nlp	23274937	SENT158	1	1	16	16	ranolazine	HERG	PA164746007	3757	0.373
NULL	Front_Comput_Neurosci_2012_Aug_6_6_57.nxml.txt.nlp	22888318	SENT528	0	0	5	5	ketamine	gamma	PA450144	9913	0.373
NULL	Acta_Histochem_Cytochem_2006_Dec_28_39(6)_163-172.nxml.txt.nlp	17327903	SENT36	0	0	12	12	isoflurane	ERK	PA450106	5594	0.372
NULL	Cell_Commun_Signal_2013_Apr_19_11_29.nxml.txt.nlp	23601247	SENT64	25	25	38	38	galactose	MRC1	PA449725	4360	0.372
NULL	Br_J_Cancer_2003_Mar_10_88(5)_788-795.nxml.txt.nlp	12618891	SENT175	4	4	6	6	bosentan	FasL	PA10034	356	0.372
NULL	Cardiovasc_J_Afr_2010_Oct_21(5)_280-285.nxml.txt.nlp	20972517	SENT185	12	12	18	18	naringenin	HERG	PA151958361	3757	0.372
NULL	Biochemistry_2012_Oct_9_51(40)_8027-8038.nxml.txt.nlp	22989207	SENT292	20	20	17	17	l-serine	PGDH	PA451330	26227	0.372
NULL	J_Oncol_2012_Aug_8_2012_635614.nxml.txt.nlp	22927847	SENT214	12	12	30	30	rosiglitazone	PTEN	PA451283	5728	0.372
NULL	AIDS_Res_Treat_2011_Jul_6_2011_890308.nxml.txt.nlp	21776380	SENT209	4	4	26	26	zidovudine	KAL	PA451954	5267	0.372
NULL	Oncoimmunology_2013_Jan_1_2(1)_e22890.nxml.txt.nlp	23483066	SENT50	8	8	20	20	vemurafenib	B2M	PA165946873	567	0.372
NULL	Genome_Announc_2013_Dec_5_1(6)_e00987-13.nxml.txt.nlp	24309735	SENT10	6	6	9	9	oxygen	ROS	PA450744	6098	0.372
NULL	Acta_Neuropathol_2012_Mar_16_123(3)_369-380.nxml.txt.nlp	22083253	SENT134	18	18	20	20	imatinib	NF1	PA10804	4763	0.372
NULL	Mol_Vis_2012_Jun_20_18_1640-1648.nxml.txt.nlp	22773902	SENT26	19	19	22	22	oxygen	ROS	PA450744	6098	0.372
NULL	Hum_Mol_Genet_2013_Nov_15_22(22)_4602-4615.nxml.txt.nlp	23814040	SENT206	2	2	10	10	l-cysteine	TRMU	PA449173	55687	0.372
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT192	31	31	33	33	trastuzumab	Yes	PA451743	7525	0.372
NULL	Int_J_Vasc_Med_2012_Sep_26_2012_794898.nxml.txt.nlp	23056947	SENT159	18	18	38	38	nadh	SDHD	PA164755085	6392	0.372
NULL	Acta_Pharmacol_Sin_2011_Aug_18_32(8)_991-998.nxml.txt.nlp	21765445	SENT50	17	17	4	4	trypsin	FBS	PA451806	64319;26269	0.372
NULL	Indian_J_Endocrinol_Metab_2013_Sep-Oct_17(5)_835-843.nxml.txt.nlp	24083164	SENT127	18	18	13	13	exenatide	GLP-1	PA164749238	100125288	0.372
NULL	Indian_J_Ophthalmol_2014_May_62(5)_606-609.nxml.txt.nlp	24881610	SENT27	24	24	12	12	amfenac	COX	PA166049186	1351	0.372
NULL	J_Exp_Bot_2012_Jan_6_63(1)_489-502.nxml.txt.nlp	21984647	SENT189	32	32	19	19	xanthophyll	NPQ	PA164748318	80763	0.372
NULL	Breast_Cancer_Res_2010_Feb_10_12(1)_R11.nxml.txt.nlp	20146798	SENT66	18	18	21	21	fluorescein	FDG	PA164746009	23583	0.372
NULL	J_Cell_Biol_1984_Feb_1_98(2)_748-760.nxml.txt.nlp	6229546	SENT6	22	22	9	9	thrombin	PF4	PA451674	5196	0.372
NULL	Evid_Based_Complement_Alternat_Med_2011_Feb_20_2011_675397.nxml.txt.nlp	19584081	SENT15	6	6	9	9	oxygen	ROS	PA450744	6098	0.372
NULL	Int_J_Endocrinol_2011_Dec_20_2011_746482.nxml.txt.nlp	22216029	SENT255	25	25	14	14	forskolin	K60	PA146096022	3576	0.372
NULL	Biomed_Res_Int_2013_Aug_27_2013_960126.nxml.txt.nlp	24069608	SENT137	6	6	11	11	haloperidol	MAP2	PA449841	4133;10988	0.372
NULL	J_Infect_Chemother_2012_Oct_28_18(5)_753-755.nxml.txt.nlp	22203121	SENT26	12	12	15	15	doxorubicin	ADM	PA449412	133	0.372
NULL	Biomed_Res_Int_2013_Jan_28_2013_612369.nxml.txt.nlp	23509753	SENT59	23	23	26	26	oxygen	ROS	PA450744	6098	0.372
NULL	J_Adv_Pharm_Technol_Res_2010_Jul-Sep_1(3)_354-357.nxml.txt.nlp	22247871	SENT42	14	14	18	18	nitrogen	GAS1	PA450643	2619	0.372
NULL	Biosci_Rep_2014_Jun_25_34(3)_e00115.nxml.txt.nlp	24877606	SENT997	5	5	2	2	lovastatin	Rho	PA450272	29984	0.372
NULL	Indian_J_Pharm_Sci_2012_Jan-Feb_74(1)_1-17.nxml.txt.nlp	23204616	SENT388	12	12	31	31	gliclazide	CYP2C19	PA10892	1557	0.372
NULL	Cardiovasc_Diabetol_2013_Nov_2_12_158.nxml.txt.nlp	24180212	SENT0	27	27	30	30	oxygen	ROS	PA450744	6098	0.372
NULL	Nucleic_Acids_Res_2007_Jan_7_35(1)_143-151.nxml.txt.nlp	17158165	SENT52	1	1	35	35	cidofovir	San	PA448997	80218	0.372
NULL	Arch_Med_Sci_2011_Feb_8_7(1)_134-137.nxml.txt.nlp	22291746	SENT17	30	30	5	5	s-adenosylmethionine	MTHFR	PA164754994	4524	0.372
NULL	Nature_2012_Aug_9_488(7410)_231-235.nxml.txt.nlp	22722852	SENT96	34	34	20	20	l-glutamine	CO2	PA10090	4513	0.372
NULL	Cell_Biochem_Biophys_2013_Mar_12_67(2)_695-702.nxml.txt.nlp	23479335	SENT21	24	24	20	20	lipase	PLTP	PA450239	5360	0.371
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Apr_20_69(Pt_5)_o761.nxml.txt.nlp	23723907	SENT78	11	11	3	3	piperazine	C11	PA450977	1109	0.371
NULL	Mol_Cancer_2010_Mar_4_9_49.nxml.txt.nlp	20202195	SENT63	5	5	8	8	vorinostat	HOP	PA164748224	84525;10963	0.371
NULL	J_Biomed_Biotechnol_2011_Jan_26_2011_797383.nxml.txt.nlp	21331361	SENT373	27	27	16	16	milrinone	PI3K	PA164749171	5290	0.371
NULL	Crit_Care_2011_Dec_5_15(6)_236.nxml.txt.nlp	22146601	SENT33	9	9	18	18	vasopressin	AVP	PA451858	114548;551	0.371
NULL	Cancer_Cell_Int_2011_Dec_29_11_44.nxml.txt.nlp	22206574	SENT67	10	10	12	12	sorafenib	c-Raf	PA7000	5894	0.371
NULL	Chin_J_Cancer_2011_May_30(5)_287-292.nxml.txt.nlp	21527061	SENT54	13	13	26	26	paclitaxel	ERCC1	PA450761	2067	0.371
NULL	Eur_J_Psychotraumatol_2013_Jun_4_4_10_3402_ejpt_v4i0_21127.nxml.txt.nlp	NULL	SENT878	0	0	11	11	hydrocortisone	ACTH	PA449905	5443	0.371
NULL	Breast_Cancer_Res_2004_Oct_28_6(1)_E1.nxml.txt.nlp	14680487	SENT22	19	19	26	26	tamoxifen	ATAC	PA451581	6375	0.371
NULL	JRSM_Cardiovasc_Dis_2012_Sep_24_1(6)_cvd_2012_012015.nxml.txt.nlp	24175073	SENT53	10	10	2	2	clopidogrel	CYP2C19	PA449053	1557	0.371
NULL	Arch_Osteoporos_2013_Oct_11_8(1-2)_136.nxml.txt.nlp	24113837	SENT3131	19	19	21	21	teriparatide	PTH	PA451620	5741	0.371
NULL	Pharm_Methods_2011_Jan-Mar_2(1)_9-14.nxml.txt.nlp	23781423	SENT36	13	13	18	18	ethanol	IPA	PA448073	3160	0.371
NULL	F1000_Med_Rep_2009_Dec_15_1_96.nxml.txt.nlp	20948681	SENT29	0	0	7	7	teriparatide	PTH	PA451620	5741	0.371
NULL	Front_Physiol_2013_Feb_4_4_10.nxml.txt.nlp	23382716	SENT581	2	2	6	6	hyaluronan	HAS2	PA165958431	3037	0.371
NULL	Iran_J_Public_Health_2013_Jan_1_42(Supple1)_50-54.nxml.txt.nlp	23865016	SENT136	32	32	11	11	pregabalin	CRT	PA164754814	811	0.371
NULL	Mult_Scler_Int_2014_Apr_14_2014_539854.nxml.txt.nlp	24834356	SENT26	17	17	20	20	oxygen	ROS	PA450744	6098	0.371
NULL	Orphanet_J_Rare_Dis_2013_Dec_17_8_192.nxml.txt.nlp	24341803	SENT199	6	6	16	16	ethanol	PDH	PA448073	54704	0.371
NULL	Mol_Biol_Evol_2013_Nov_16_30(11)_2531-2540.nxml.txt.nlp	23955518	SENT142	4	4	9	9	nadh	ND1	PA164755085	4535;10625	0.371
NULL	Eur_J_Clin_Pharmacol_2011_May_9_67(5)_477-482.nxml.txt.nlp	21305273	SENT103	32	32	28	28	atropine	DSE	PA448505	29940	0.371
NULL	EMBO_J_2013_Aug_14_32(16)_2275-2286.nxml.txt.nlp	23881097	SENT36	0	0	22	22	diazepam	P14	PA449283	11102;;6280;56259	0.371
NULL	Mol_Cell_Biochem_2014_Jan_3_389(1-2)_177-185.nxml.txt.nlp	24385108	SENT55	22	22	16	16	l-glutamine	FBS	PA10090	64319;26269	0.371
NULL	Virol_J_2010_Jun_30_7_144.nxml.txt.nlp	20591132	SENT165	9	9	7	7	guanidine	mol	PA164781028	90527	0.371
NULL	Onco_Targets_Ther_2014_Jun_13_7_1033-1042.nxml.txt.nlp	24966685	SENT187	21	21	29	29	gemcitabine	GAPDH	PA449748	2597	0.371
NULL	Int_Semin_Surg_Oncol_2006_Sep_14_3_29.nxml.txt.nlp	16972993	SENT88	35	35	6	6	tamoxifen	ANOVA	PA451581	4858	0.371
NULL	Clin_Ophthalmol_2014_Jun_3_8_1057-1064.nxml.txt.nlp	24940042	SENT110	12	12	25	25	bevacizumab	CST	PA130232992	9514	0.371
NULL	Mol_Immunol_2010_Feb_47(5)_1098-1105.nxml.txt.nlp	19959238	SENT52	26	26	9	9	nitrogen	OCT	PA450643	5362	0.371
NULL	Br_J_Cancer_2011_Mar_1_104(5)_750-755.nxml.txt.nlp	21326243	SENT174	18	18	11	11	olaparib	MPG		4350	0.371
NULL	Int_J_Nanomedicine_2009_Dec_29_4_299-319.nxml.txt.nlp	20054434	SENT395	7	7	11	11	salbutamol	DPI	PA448068	1832	0.371
NULL	J_Cancer_Res_Clin_Oncol_2010_May_11_136(5)_737-743.nxml.txt.nlp	19904559	SENT40	31	31	15	15	bevacizumab	IFL	PA130232992	3439	0.371
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Oct_4_70(Pt_11)_269-271.nxml.txt.nlp	25484720	SENT22	26	26	28	28	nitrile	mol	PA450636	90527	0.371
NULL	Indian_J_Pharmacol_2013_Jan-Feb_45(1)_49-53.nxml.txt.nlp	23543858	SENT112	16	16	3	3	buspirone	ANOVA	PA448689	4858	0.371
NULL	J_Biol_Chem_2008_Nov_14_283(46)_31679-31689.nxml.txt.nlp	18755684	SENT153	23	23	16	16	iron	FTL	PA450087	2512	0.371
NULL	Arthritis_Res_2002_Sep_16_4(6)_R12.nxml.txt.nlp	12453315	SENT91	4	4	2	2	glucose	CRP	PA449773	1401;140913	0.371
NULL	Aging_Cell_2013_Jun_27_12(3)_435-445.nxml.txt.nlp	23448364	SENT272	5	5	1	1	doxorubicin	p66	PA449412	6464	0.371
NULL	Eur_J_Nutr_2013_Feb_3_52(1)_203-215.nxml.txt.nlp	22302614	SENT190	28	28	46	46	estradiol	PTH	PA449503	5741	0.371
NULL	Mol_Vis_2012_May_1_18_1115-1122.nxml.txt.nlp	22605923	SENT104	18	18	24	24	estradiol	IL-6	PA449503	3569	0.371
NULL	Diabetes_2008_Sep_57(9)_2332-2340.nxml.txt.nlp	18567824	SENT7	14	14	16	16	atropine	ghrelin	PA448505	51738	0.371
NULL	J_Parasitol_Res_2013_Apr_3_2013_429736.nxml.txt.nlp	23691276	SENT124	4	4	8	8	artemisinin	ACT	PA165111696	12;11332;9457;641455	0.371
NULL	Oxid_Med_Cell_Longev_2013_Nov_14_2013_680545.nxml.txt.nlp	24349614	SENT12	11	11	14	14	oxygen	ROS	PA450744	6098	0.371
NULL	Br_J_Cancer_2013_May_14_108(9)_1846-1853.nxml.txt.nlp	23579209	SENT93	3	3	13	13	trypsin	A1BG	PA451806	1	0.371
NULL	Mol_Cell_Neurosci_2013_Jul_55(100)_62-76.nxml.txt.nlp	22960139	SENT191	17	17	12	12	galactose	OPA1	PA449725	4976;9968	0.371
NULL	Patient_Prefer_Adherence_2013_Jun_19_7_531-542.nxml.txt.nlp	23814462	SENT210	1	1	8	8	efavirenz	HLA-B	PA449441	3106	0.371
NULL	J_Neurovirol_2013_Jun_4_19(4)_351-358.nxml.txt.nlp	23733308	SENT81	8	8	10	10	mefloquine	SOC	PA450348	91544	0.371
NULL	Pain_2012_Apr_153(4)_775-783.nxml.txt.nlp	22325744	SENT158	12	12	15	15	naloxone	P14	PA450586	11102;;6280;56259	0.37
NULL	Clin_Interv_Aging_2010_Dec_3_5_381-393.nxml.txt.nlp	21152240	SENT220	21	21	2	2	carvedilol	BEST	PA448817	7439	0.37
NULL	Nature_2012_Feb_23_482(7386)_524-528.nxml.txt.nlp	22358842	SENT79	7	7	17	17	collagenase	F10	PA449107	2159	0.37
NULL	Acta_Pharmacol_Sin_2011_Aug_18_32(8)_991-998.nxml.txt.nlp	21765445	SENT8	2	2	5	5	oxygen	ROS	PA450744	6098	0.37
NULL	BMJ_2013_Feb_5_346_e5793.nxml.txt.nlp	23386361	SENT251	25	25	14	14	warfarin	CYP2C9	PA451906	1559	0.37
NULL	J_Gen_Physiol_2012_Nov_140(5)_469-479.nxml.txt.nlp	23071265	SENT313	1	1	8	8	capsaicin	VR1	PA448776	56664	0.37
NULL	Front_Zool_2011_Nov_29_8_31.nxml.txt.nlp	22126599	SENT124	12	12	10	10	pp2	PP1		5540;5464	0.37
NULL	Mol_Cancer_2010_Mar_4_9_49.nxml.txt.nlp	20202195	SENT148	35	35	27	27	vorinostat	HOP	PA164748224	84525;10963	0.37
NULL	Acta_Orthop_2013_Jun_31_84(3)_319-322.nxml.txt.nlp	23594224	SENT20	5	5	13	13	cefuroxime	DOS	PA448868	255057	0.37
NULL	Autoimmune_Dis_2013_Oct_7_2013_183487.nxml.txt.nlp	24222845	SENT160	13	13	20	20	methotrexate	ACPA	PA450428	5657	0.37
NULL	Front_Neurosci_2014_Jun_24_8_171.nxml.txt.nlp	25009457	SENT590	5	5	9	9	vasopressin	spatial	PA451858	219793	0.37
NULL	Diabetes_2013_Mar_14_62(3)_762-774.nxml.txt.nlp	23238297	SENT7	6	6	17	17	telmisartan	AS160	PA451605	9882	0.37
NULL	Lancet_2011_Jun_18_377(9783)_2103-2114.nxml.txt.nlp	21641636	SENT25	0	0	16	16	cetuximab	KRAS	PA10040	3845	0.37
NULL	Sci_Rep_2014_Dec_16_4_7500.nxml.txt.nlp	25511254	SENT162	12	12	20	20	hyperforin	NHE	PA165985514	285335	0.37
NULL	Acta_Neuropathol_Commun_2014_Jan_2_2_1.nxml.txt.nlp	24383468	SENT223	11	11	39	39	nadh	ND6	PA164755085	4541	0.37
NULL	Iran_J_Pharm_Res_2014_Winter_13(1)_95-101.nxml.txt.nlp	24734060	SENT142	7	7	10	10	ethanol	mol	PA448073	90527	0.37
NULL	Int_J_Surg_Case_Rep_2014_Oct_23_5(12)_979-983.nxml.txt.nlp	25460452	SENT171	23	23	18	18	paclitaxel	CK20	PA450761	54474	0.37
NULL	J_Cell_Biol_2004_Dec_6_167(5)_915-924.nxml.txt.nlp	15569710	SENT478	4	4	9	9	nadh	ND3	PA164755085	4537	0.37
NULL	Oncogenesis_2014_May_12_3(5)_e102.nxml.txt.nlp	24819061	SENT247	19	19	5	5	nadh	p53	PA164755085	7157	0.37
NULL	Anal_Bioanal_Chem_2007_Jun_28_388(4)_871-879.nxml.txt.nlp	17468853	SENT18	19	19	22	22	oxygen	ROS	PA450744	6098	0.37
NULL	Bioinformation_2012_Mar_31_8(6)_276-280.nxml.txt.nlp	22493536	SENT29	10	10	6	6	choline	ACHE	PA448976	43	0.37
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Mar_10_68(Pt_4)_o1037-o1038.nxml.txt.nlp	22589908	SENT80	0	0	7	7	triprolidine	mol	PA451797	90527	0.37
NULL	Crit_Care_2007_May_24_11(3)_R61.nxml.txt.nlp	17524133	SENT155	33	33	24	24	glucose	RAI	PA449773	10848;6050	0.37
NULL	Eur_J_Clin_Pharmacol_2011_Mar_12_67(3)_317-318.nxml.txt.nlp	20963403	SENT13	8	8	16	16	meropenem	GM-CSF	PA164764445	1437	0.37
NULL	Diabetes_Care_2010_Jul_33(7)_e85-e89.nxml.txt.nlp	20587709	SENT109	33	33	38	38	thrombin	PAR-1	PA451674	2011;2149	0.37
NULL	Cancer_Manag_Res_2012_Nov_9_4_383-395.nxml.txt.nlp	23204869	SENT94	25	25	31	31	carmustine	PC-3	PA448810	692094	0.37
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2008_Sep_1_64(Pt_9)_977-984.nxml.txt.nlp	18703847	SENT51	15	15	8	8	thrombin	DHFR	PA451674	1719	0.37
NULL	Part_Fibre_Toxicol_2011_Aug_2_8_23.nxml.txt.nlp	21810225	SENT305	5	5	2	2	deferoxamine	NAC	PA164746490	22861	0.37
NULL	Cardiovasc_Diabetol_2010_Oct_22_9_66.nxml.txt.nlp	20969783	SENT6	1	1	4	4	oxygen	ROS	PA450744	6098	0.37
NULL	Crit_Care_2011_Jun_24_15(3)_R153.nxml.txt.nlp	21702944	SENT109	24	24	16	16	dexmedetomidine	HK2	PA449256	3796;3099;29911;3741	0.37
NULL	J_Hematol_Oncol_2009_Jan_21_2_2.nxml.txt.nlp	19159467	SENT102	5	5	3	3	cetuximab	EGFR	PA10040	1956	0.37
NULL	Trials_2014_Jan_7_15_9.nxml.txt.nlp	24398143	SENT3	31	31	27	27	sirolimus	PES	PA451365	23481	0.37
NULL	Clin_Epidemiol_2010_Aug_9_2_57-66.nxml.txt.nlp	20865104	SENT198	8	8	12	12	isoniazid	IPT	PA450112	54802	0.37
NULL	Eur_J_Appl_Physiol_2011_Feb_24_111(2)_275-283.nxml.txt.nlp	20865425	SENT102	10	10	20	20	glucose	APE	PA449773	55704;328	0.37
NULL	Br_J_Cancer_2011_Jun_28_105(1)_53-57.nxml.txt.nlp	21654688	SENT5	6	6	19	19	sn-38	UGT1A1		54658	0.37
NULL	Breast_Cancer_Res_2007_Oct_19_9(5)_111.nxml.txt.nlp	17983482	SENT75	30	30	5	5	gefitinib	HER2	PA131301952	2064	0.37
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Feb_24_68(Pt_3)_o807-o808.nxml.txt.nlp	22412674	SENT80	17	17	24	24	guanidine	mol	PA164781028	90527	0.37
NULL	Arthritis_Res_2002_Sep_16_4(6)_R12.nxml.txt.nlp	12453315	SENT132	19	19	25	25	methotrexate	CRP	PA450428	1401;140913	0.37
NULL	Hum_Genomics_2008_Sep_1_3(1)_71-78.nxml.txt.nlp	19129091	SENT32	13	13	22	22	nadh	ND1	PA164755085	4535;10625	0.369
NULL	Oncologist_2010_Nov_4_15(11)_1135-1146.nxml.txt.nlp	21051659	SENT181	2	2	5	5	temsirolimus	IFN	PA164746890	3439	0.369
NULL	Front_Physiol_2015_Jan_15_5_531.nxml.txt.nlp	25642195	SENT66	6	6	9	9	oxygen	ROS	PA450744	6098	0.369
NULL	Br_J_Cancer_2012_Feb_14_106(4)_646-650.nxml.txt.nlp	22240794	SENT45	7	7	9	9	sunitinib	IFN	PA162372840	3439	0.369
NULL	J_Parasitol_Res_2011_Oct_9_2011_174614.nxml.txt.nlp	22007287	SENT6	29	29	32	32	oxygen	ROS	PA450744	6098	0.369
NULL	Front_Neurol_2011_Feb_22_2_7.nxml.txt.nlp	21373206	SENT365	24	24	31	31	abciximab	FAST	PA448006	10922	0.369
NULL	Exp_Hematol_Oncol_2013_Jan_10_2_2.nxml.txt.nlp	23305345	SENT178	21	21	23	23	rituximab	BTZ	PA451261	22794	0.369
NULL	Curr_Biol_2012_Mar_6_22(5)_397-402.nxml.txt.nlp	22305751	SENT331	14	14	10	10	physostigmine	spatial	PA450957	219793	0.369
NULL	Eur_J_Haematol_2014_Feb_25_92(2)_127-136.nxml.txt.nlp	24118452	SENT36	15	15	19	19	anagrelide	CRT	PA164742986	811	0.369
NULL	Int_J_Biol_Sci_2014_Sep_13_10(9)_1072-1083.nxml.txt.nlp	25285039	SENT175	11	11	5	5	doxorubicin	SPP1	PA449412	30827;6696	0.369
NULL	Extremophiles_2009_Sep_5_13(5)_769-783.nxml.txt.nlp	19579003	SENT322	12	12	21	21	lipase	PIR	PA450239	8544	0.369
NULL	Acta_Pharmacol_Sin_2014_Aug_30_35(8)_1045-1054.nxml.txt.nlp	24976155	SENT95	1	1	10	10	resveratrol	STAT3		6774	0.369
NULL	Br_J_Cancer_2010_Dec_7_103(12)_1822-1830.nxml.txt.nlp	21063405	SENT158	29	29	33	33	cisplatin	NBS1	PA449014	55655	0.369
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT32	7	7	13	13	curcumin	TRAIL	PA151958596	8743	0.369
NULL	ScientificWorldJournal_2013_Dec_30_2013_565813.nxml.txt.nlp	24489506	SENT232	15	15	10	10	cisplatin	Q10	PA449014	27161	0.369
NULL	Air_Qual_Atmos_Health_2012_Jun_1_5(2)_243-258.nxml.txt.nlp	22662024	SENT109	8	8	15	15	sulfur	TSP	PA451558	7057	0.369
NULL	Stud_Health_Technol_Inform_2013_192_62-66.nxml.txt.nlp	23920516	SENT131	6	6	8	8	hydroxyurea	IFNA	PA449942	3440	0.369
NULL	Antimicrob_Agents_Chemother_2014_Aug_58(8)_4971-4973.nxml.txt.nlp	24913169	SENT2	21	21	27	27	primaquine	G6PD	PA451103	2539	0.369
NULL	Arq_Bras_Cardiol_2013_Nov_101(5)_466-471.nxml.txt.nlp	24100694	SENT75	47	47	20	20	aspirin	NAT	PA448497	6046	0.369
NULL	Cases_J_2009_Oct_16_2_156.nxml.txt.nlp	19946527	SENT119	19	19	11	11	protamine	PTH	PA10366	5741	0.369
NULL	Int_J_Environ_Res_Public_Health_2010_Dec_21_7(12)_4281-4304.nxml.txt.nlp	21318009	SENT158	1	1	7	7	ethanol	spatial	PA448073	219793	0.369
NULL	Breast_Cancer_Res_2011_Apr_20_13(2)_307.nxml.txt.nlp	21575280	SENT26	4	4	19	19	tamoxifen	FOXA1	PA451581	3169	0.369
NULL	J_Biomed_Biotechnol_2011_Feb_14_2011_792362.nxml.txt.nlp	21490705	SENT344	0	0	24	24	choline	PEMT	PA448976	10400	0.369
NULL	Hum_Genet_2013_Jul_3_132(10)_1077-1130.nxml.txt.nlp	23820649	SENT683	12	12	24	24	trypsin	PRSS1	PA451806	5644	0.369
NULL	Mol_Pain_2013_Jun_10_9_27.nxml.txt.nlp	23758830	SENT195	4	4	11	11	lidocaine	TRPV1	PA450226	7442	0.369
NULL	Indian_J_Anaesth_2012_Jan-Feb_56(1)_49-54.nxml.txt.nlp	22529420	SENT37	21	21	25	25	pregabalin	P150	PA164754814	10036	0.369
NULL	Diabetes_Care_2010_Dec_30_33(12)_2549-2551.nxml.txt.nlp	20805256	SENT45	2	2	5	5	metformin	ADM	PA450395	133	0.369
NULL	Mol_Brain_2013_Jan_2_6_1.nxml.txt.nlp	23281934	SENT372	1	1	4	4	oxygen	ROS	PA450744	6098	0.369
NULL	Indian_J_Pharm_Sci_2013_Mar-Apr_75(2)_156-161.nxml.txt.nlp	24019563	SENT131	13	13	16	16	oxygen	ROS	PA450744	6098	0.369
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Dec_13_65(Pt_1)_o106.nxml.txt.nlp	21581569	SENT66	24	24	11	11	ethanol	mol	PA448073	90527	0.369
NULL	Arthritis_Res_Ther_2009_Nov_13_11(6)_R172.nxml.txt.nlp	19912653	SENT2	30	30	32	32	simvastatin	IVD	PA451363	3712	0.369
NULL	EMBO_Mol_Med_2012_Sep_20_4(9)_1008-1014.nxml.txt.nlp	22903887	SENT97	16	16	18	18	metronidazole	NAC	PA450484	22861	0.369
NULL	Front_Neural_Circuits_2013_Aug_13_7_136.nxml.txt.nlp	23964205	SENT98	6	6	33	33	taurine	KCC2	PA451590	57468	0.368
NULL	Int_J_Breast_Cancer_2012_May_9_2012_415170.nxml.txt.nlp	22649737	SENT131	24	24	21	21	maytansine	DM1	PA165291473	338023;1760;28509	0.368
NULL	Hum_Genomics_Proteomics_2010_Aug_3_2010_159761.nxml.txt.nlp	20981231	SENT130	3	3	32	32	lithium	HDAC	PA450243	9734	0.368
NULL	Acta_Vet_Scand_2010_Jul_30_52(1)_47.nxml.txt.nlp	20670455	SENT103	2	2	37	37	ampicillin	TMP	PA448419	2012	0.368
NULL	Mol_Neurodegener_2011_Jan_13_6_4.nxml.txt.nlp	21232114	SENT240	2	2	4	4	brimonidine	CTB	PA448665	9468	0.368
NULL	Exp_Ther_Med_2014_Feb_4_7(2)_478-482.nxml.txt.nlp	24396429	SENT23	6	6	9	9	oxygen	ROS	PA450744	6098	0.368
NULL	Int_Arch_Med_2008_May_12_1_6.nxml.txt.nlp	18474088	SENT40	13	13	8	8	lipase	HLP	PA450239	6499;9001;3002	0.368
NULL	Aging_(Albany_NY)_2009_Feb_18_1(3)_335-349.nxml.txt.nlp	20195489	SENT192	3	3	5	5	etoposide	p65	PA449552	5970	0.368
NULL	Braz_J_Med_Biol_Res_2012_Mar_9_45(4)_357-365.nxml.txt.nlp	22392189	SENT125	17	17	27	27	capsaicin	TRPV1	PA448776	7442	0.368
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT192	35	35	33	33	cetuximab	Yes	PA10040	7525	0.368
NULL	Acta_Pharmacol_Sin_2010_Aug_19_31(8)_963-969.nxml.txt.nlp	20644547	SENT98	11	11	8	8	fenofibrate	PDX-1	PA449594	3651	0.368
NULL	J_Gen_Physiol_1980_Mar_1_75(3)_345-350.nxml.txt.nlp	7189771	SENT0	19	19	1	1	trypsin	Gen	PA451806	348654	0.368
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Jul_19_70(Pt_8)_80-83.nxml.txt.nlp	25249860	SENT8	11	11	7	7	ethanol	mol	PA448073	90527	0.368
NULL	Curr_Neuropharmacol_2012_Jun_10(2)_97-123.nxml.txt.nlp	23204981	SENT752	44	44	10	10	agomelatine	IL-2	PA165958363	3558	0.368
NULL	Indian_J_Anaesth_2014_Jul-Aug_58(4)_423-429.nxml.txt.nlp	25197110	SENT8	14	14	18	18	ondansetron	ODF	PA450705	8600	0.368
NULL	Br_J_Cancer_2013_Aug_6_109(3)_686-693.nxml.txt.nlp	23839492	SENT101	1	1	15	15	sunitinib	IL-8	PA162372840	3576	0.368
NULL	Clin_Med_Insights_Blood_Disord_2013_Nov_14_6_23-27.nxml.txt.nlp	25512717	SENT21	33	33	30	30	rituximab	CHOP	PA451261	1649	0.368
NULL	J_Nat_Sci_Biol_Med_2012_Jan-Jun_3(1)_84-86.nxml.txt.nlp	22690058	SENT24	14	14	38	38	diclofenac	OTC	PA449293	5009	0.368
NULL	Mol_Cell_Proteomics_2012_Apr_9_11(4)_M111_014647.nxml.txt.nlp	22159717	SENT292	0	0	6	6	hyaluronan	HAPLN1	PA165958431	1404	0.368
NULL	Indian_J_Anaesth_2010_Jan-Feb_54(1)_40-44.nxml.txt.nlp	20532071	SENT94	19	19	27	27	propofol	ISO1	PA451141	63826;10209	0.368
NULL	Asian-Australas_J_Anim_Sci_2013_Feb_26(2)_266-274.nxml.txt.nlp	25049786	SENT226	3	3	0	0	ginseng	FA1	PA164781150	8788	0.368
NULL	Cancers_(Basel)_2010_Jun_4_2(2)_1125-1154.nxml.txt.nlp	24281110	SENT185	3	3	0	0	trypsin	SPINK1	PA451806	6690	0.368
NULL	Drugs_2014_Feb_25_74(4)_423-441.nxml.txt.nlp	24566842	SENT221	8	8	12	12	ustekinumab	ACR	PA166048654	49	0.368
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_39-54.nxml.txt.nlp	19305787	SENT126	23	23	8	8	ethanol	NR1	PA448073	27158	0.368
NULL	Cases_J_2009_Mar_10_2_6464.nxml.txt.nlp	20181162	SENT74	15	15	12	12	ribavirin	IFN	PA451241	3439	0.368
NULL	Cancer_Res_Treat_2014_Jan_15_46(1)_2-18.nxml.txt.nlp	24520218	SENT42	29	29	12	12	dextran	COX	PA449261	1351	0.368
NULL	Basic_Res_Cardiol_2012_Jul_24_107(4)_273.nxml.txt.nlp	22622703	SENT229	25	25	17	17	nadh	SIRT1	PA164755085	23411	0.368
NULL	Int_J_Biol_Sci_2015_Jan_1_11(1)_48-58.nxml.txt.nlp	25552929	SENT13	14	14	6	6	paclitaxel	TSP-1	PA450761	7057	0.368
NULL	Exp_Ther_Med_2014_May_21_7(5)_1388-1392.nxml.txt.nlp	24940444	SENT85	6	6	9	9	oxygen	ROS	PA450744	6098	0.368
NULL	Br_J_Cancer_2014_Aug_26_111(5)_817-822.nxml.txt.nlp	24755884	SENT53	9	9	2	2	tamoxifen	p110	PA451581	9733	0.368
NULL	Cell_Commun_Signal_2014_Jan_10_12_3.nxml.txt.nlp	24410813	SENT82	3	3	12	12	tamoxifen	THOC5	PA451581	8563	0.368
NULL	J_Geriatr_Cardiol_2013_Jun_10(2)_151-158.nxml.txt.nlp	23888175	SENT40	13	13	15	15	rosuvastatin	ACE2	PA134308647	59272	0.368
NULL	Arthritis_Res_2002_Sep_16_4(6)_R12.nxml.txt.nlp	12453315	SENT98	4	4	15	15	methotrexate	CRP	PA450428	1401;140913	0.368
NULL	Cancer_Microenviron_2009_Sep_26_2(Suppl_1)_19-204.nxml.txt.nlp	NULL	SENT3486	27	27	18	18	sunitinib	U87	PA162372840	677775;641648	0.368
NULL	Breed_Sci_2012_Mar_20_62(1)_78-86.nxml.txt.nlp	23136517	SENT18	7	7	10	10	oxygen	ROS	PA450744	6098	0.368
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Sep_20_64(Pt_10)_m1276-m1277.nxml.txt.nlp	21201026	SENT9	7	7	4	4	ethanol	mol	PA448073	90527	0.368
NULL	J_Ophthalmol_2009_Feb_8_2009_567693.nxml.txt.nlp	20339461	SENT102	24	24	7	7	cyclosporine	ERG	PA449167	2078	0.368
NULL	Mol_Cancer_2012_Jun_26_11_43.nxml.txt.nlp	22731636	SENT125	19	19	19	19	pp2	PP2		4888	0.367
NULL	Case_Rep_Dermatol_2012_Sep_16_4(3)_256-260.nxml.txt.nlp	23275770	SENT5	18	18	28	28	isotretinoin	OMG	PA450128	4974	0.367
NULL	Open_Dent_J_2014_May_30_8_109-124.nxml.txt.nlp	24976875	SENT662	6	6	1	1	doxycycline	Tech	PA449415	57449	0.367
NULL	Indian_J_Psychol_Med_2012_Oct-Dec_34(4)_313-317.nxml.txt.nlp	23723537	SENT144	21	21	9	9	diazepam	PDF	PA449283	64146;9518	0.367
NULL	Indian_J_Pharm_Sci_2011_Sep-Oct_73(5)_569-572.nxml.txt.nlp	22923871	SENT14	0	0	3	3	eprosartan	EPM	PA449481	2054	0.367
NULL	Blood_Res_2014_Dec_23_49(4)_253-258.nxml.txt.nlp	25548759	SENT75	15	15	17	17	doxorubicin	CHOP	PA449412	1649	0.367
NULL	Acta_Neuropathol_Commun_2014_Jan_2_2_1.nxml.txt.nlp	24383468	SENT251	6	6	10	10	nadh	ND1	PA164755085	4535;10625	0.367
NULL	Springerplus_2014_Sep_11_3_516.nxml.txt.nlp	25279308	SENT222	7	7	1	1	ethanol	SHF	PA448073	90525	0.367
NULL	Chemother_Res_Pract_2011_Sep_25_2011_730360.nxml.txt.nlp	22295205	SENT57	10	10	16	16	tamoxifen	ATAC	PA451581	6375	0.367
NULL	Braz_J_Microbiol_2012_Jun_1_Apr-Jun_43(2)_506-516.nxml.txt.nlp	24031858	SENT7	6	6	10	10	ethanol	mol	PA448073	90527	0.367
NULL	Brain_Struct_Funct_2013_Jan_14_218(1)_59-72.nxml.txt.nlp	22246100	SENT223	15	15	40	40	pilocarpine	ANOVA	PA450962	4858	0.367
NULL	Acta_Pharmacol_Sin_2013_Nov_5_34(11)_1457-1466.nxml.txt.nlp	24056707	SENT71	35	35	11	11	paraformaldehyde	M-CSF	PA450790	1435	0.367
NULL	Chin_J_Cancer_2012_Sep_31(9)_413-420.nxml.txt.nlp	22776233	SENT57	4	4	7	7	oxygen	ROS	PA450744	6098	0.367
NULL	Crit_Care_2012_Mar_2_16(2)_R37.nxml.txt.nlp	22386062	SENT99	7	7	42	42	oxygen	CENPV	PA450744	201161	0.367
NULL	Front_Neuroenergetics_2009_Nov_18_1_7.nxml.txt.nlp	20027233	SENT65	23	23	36	36	nadh	ADP	PA164755085	23038	0.367
NULL	AIDS_Res_Ther_2013_May_1_10_10.nxml.txt.nlp	23634877	SENT187	30	30	25	25	lovastatin	CCL3	PA450272	6348	0.367
NULL	Infect_Drug_Resist_2009_Apr_24_2_13-26.nxml.txt.nlp	21694884	SENT233	8	8	11	11	tenofovir	TDF	PA10204	6736	0.367
NULL	Evid_Based_Complement_Alternat_Med_2014_Jul_1_2014_423751.nxml.txt.nlp	25101132	SENT180	22	22	16	16	ciprofloxacin	Met	PA449009	79811	0.367
NULL	Open_Orthop_J_2008_Oct_24_2_137-144.nxml.txt.nlp	19478889	SENT124	3	3	7	7	heparin	PTN	PA449855	5764	0.367
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Nov_27_66(Pt_12)_o3316.nxml.txt.nlp	21589593	SENT57	31	31	16	16	ethanol	mol	PA448073	90527	0.367
NULL	Case_Rep_Oncol_2013_Jan_8_6(1)_1-5.nxml.txt.nlp	23466482	SENT23	37	37	46	46	cyclophosphamide	NAC	PA449165	22861	0.367
NULL	Genet_Mol_Biol_2009_Mar_27_Apr-Jun_32(2)_414-422.nxml.txt.nlp	21637700	SENT3	25	25	30	30	nadh	ND4	PA164755085	4538	0.367
NULL	Mol_Brain_2014_Aug_12_7_58.nxml.txt.nlp	25112718	SENT415	19	19	8	8	chlorpheniramine	E12	PA448960	64100	0.367
NULL	Exp_Hematol_2012_Feb_40(2)_97-106.nxml.txt.nlp	22085453	SENT42	23	23	11	11	abatacept	MR1	PA164747080	3140	0.367
NULL	Front_Oncol_2013_Sep_23_3_250.nxml.txt.nlp	24069582	SENT428	11	11	20	20	metformin	HER-2	PA450395	2064	0.367
NULL	Oncotarget_2012_May_4_3(4)_395-398.nxml.txt.nlp	22565037	SENT1	18	18	20	20	trastuzumab	HER2	PA451743	2064	0.367
NULL	J_Cell_Biol_2002_Mar_18_156(6)_951-957.nxml.txt.nlp	11901164	SENT11	9	9	9	9	pp2	PP2		4888	0.367
NULL	Bioconjug_Chem_2014_Feb_19_25(2)_269-275.nxml.txt.nlp	24437976	SENT98	9	9	12	12	ethanol	CS2	PA448073	64084	0.367
NULL	Orthop_Rev_(Pavia)_2010_Mar_20_2(1)_e9.nxml.txt.nlp	21808704	SENT30	13	13	41	41	fentanyl	EDA	PA449599	1896	0.367
NULL	Cancers_(Basel)_2010_Jun_14_2(2)_1288-1311.nxml.txt.nlp	24281116	SENT229	1	1	4	4	oxygen	ROS	PA450744	6098	0.367
NULL	J_Clin_Biochem_Nutr_2009_May_25_44(3)_239-246.nxml.txt.nlp	19430612	SENT77	1	1	4	4	oxygen	ROS	PA450744	6098	0.367
NULL	Acta_Neuropathol_Commun_2014_Nov_7_2(1)_158.nxml.txt.nlp	NULL	SENT127	19	19	22	22	oxygen	ROS	PA450744	6098	0.367
NULL	J_Cell_Biol_2000_Feb_21_148(4)_791-800.nxml.txt.nlp	10684259	SENT198	9	9	12	12	estradiol	Raf-1	PA449503	5894	0.367
NULL	Allergy_Asthma_Immunol_Res_2014_Nov_19_6(6)_548-557.nxml.txt.nlp	25374755	SENT96	0	0	14	14	lovastatin	CCL24	PA450272	6369	0.367
NULL	Infect_Dis_Obstet_Gynecol_2013_Mar_7_2013_195637.nxml.txt.nlp	23533318	SENT120	2	2	19	19	lamivudine	IPT	PA450163	54802	0.367
NULL	Exp_Hematol_2014_Dec_42(12)_1053-1058_e1.nxml.txt.nlp	25127743	SENT7	31	31	25	25	potassium	KCNQ1	PA451047	3784	0.367
NULL	AIDS_Res_Treat_2011_Jul_6_2011_890308.nxml.txt.nlp	21776380	SENT209	16	16	26	26	nevirapine	KAL	PA450616	5267	0.367
NULL	eLife_2014_May_7_3_e02444.nxml.txt.nlp	24894464	SENT522	29	29	19	19	bexarotene	ABCA1	PA164752250	19	0.367
NULL	Breast_Cancer_Res_2012_Mar_15_14(2)_R47.nxml.txt.nlp	22420423	SENT23	31	31	7	7	mitomycin	TP53	PA450524	7157	0.367
NULL	J_Interv_Card_Electrophysiol_2012_Aug_28_34(2)_115-123.nxml.txt.nlp	22367051	SENT57	11	11	31	31	heparin	ACT	PA449855	12;11332;9457;641455	0.367
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jul_10_68(Pt_8)_o2398.nxml.txt.nlp	22904855	SENT74	17	17	24	24	guanidine	mol	PA164781028	90527	0.367
NULL	Acta_Orthop_2009_Feb_26_80(1)_46-50.nxml.txt.nlp	19234885	SENT102	14	14	8	8	celecoxib	TKR	PA448871	8277	0.367
NULL	Evid_Based_Complement_Alternat_Med_2014_May_14_2014_756406.nxml.txt.nlp	24959191	SENT4	8	8	11	11	cyclophosphamide	CTX	PA449165	1593	0.367
NULL	Korean_J_Urol_2010_Jul_20_51(7)_477-482.nxml.txt.nlp	20664781	SENT149	29	29	25	25	sugar	FBS	PA451529	64319;26269	0.367
NULL	Biomed_Res_Int_2013_Aug_6_2013_909613.nxml.txt.nlp	24027765	SENT367	17	17	9	9	metronidazole	EEN	PA450484	6455	0.367
NULL	Arq_Bras_Cardiol_2013_Nov_101(5)_466-471.nxml.txt.nlp	24100694	SENT55	42	42	15	15	warfarin	MBP	PA451906	5553;4155	0.367
NULL	Clin_Psychopharmacol_Neurosci_2014_Apr_24_12(1)_54-64.nxml.txt.nlp	24851122	SENT117	25	25	33	33	methamphetamine	MRO	PA450403	83876	0.367
NULL	Clinics_(Sao_Paulo)_2011_Jul_66(7)_1237-1245.nxml.txt.nlp	21876981	SENT150	14	14	27	27	creatine	ADP	PA164778930	23038	0.367
NULL	Orphanet_J_Rare_Dis_2008_Sep_16_3_25.nxml.txt.nlp	18796155	SENT297	14	14	35	35	cyclophosphamide	RIBA	PA449165	6014	0.367
NULL	Cardiovasc_Diabetol_2005_Oct_5_4_16.nxml.txt.nlp	16207378	SENT8	19	19	16	16	heparin	perlecan	PA449855	3339	0.367
NULL	Cancers_(Basel)_2011_Aug_5_3(3)_3114-3142.nxml.txt.nlp	24212948	SENT949	28	28	21	21	paclitaxel	HER-2	PA450761	2064	0.367
NULL	Antimicrob_Agents_Chemother_2014_Oct_58(10)_6032-6043.nxml.txt.nlp	25070106	SENT19	1	1	5	5	artemisinin	ACT	PA165111696	12;11332;9457;641455	0.366
NULL	J_Invest_Dermatol_2014_Jul_4_134(7)_1971-1980.nxml.txt.nlp	24496235	SENT99	3	3	7	7	nadh	ND6	PA164755085	4541	0.366
NULL	Angiogenesis_2010_Dec_15_13(4)_281-292.nxml.txt.nlp	20842454	SENT90	5	5	13	13	bevacizumab	San	PA130232992	80218	0.366
NULL	Diabetes_2011_May_23_60(5)_1493-1503.nxml.txt.nlp	21478464	SENT13	5	5	8	8	metformin	AMPK	PA450395	5563	0.366
NULL	Mult_Scler_Int_2013_Mar_10_2013_189624.nxml.txt.nlp	23555057	SENT191	33	33	7	7	mitoxantrone	IFN	PA450526	3439	0.366
NULL	Case_Rep_Infect_Dis_2012_Aug_16_2012_640104.nxml.txt.nlp	22953083	SENT77	17	17	26	26	doxorubicin	CHOP	PA449412	1649	0.366
NULL	Core_Evid_2008_Jun_3(1)_31-43.nxml.txt.nlp	20694082	SENT112	16	16	12	12	nesiritide	VMAC	PA164781045	400673	0.366
NULL	J_Cell_Biol_2001_Mar_19_152(6)_1135-1144.nxml.txt.nlp	11257115	SENT39	12	12	7	7	lipase	HLAL	PA450239	8513	0.366
NULL	Front_Behav_Neurosci_2014_Sep_3_8_291.nxml.txt.nlp	25232308	SENT308	0	0	5	5	ethanol	5-HT1A	PA448073	3350	0.366
NULL	Front_Behav_Neurosci_2010_Apr_5_4_14.nxml.txt.nlp	20407577	SENT88	2	2	20	20	zinc	RED	PA451956	8444	0.366
NULL	Diabetes_2011_Mar_21_60(3)_981-992.nxml.txt.nlp	21282369	SENT5	9	9	15	15	metformin	HIF-1	PA450395	29072	0.366
NULL	Arq_Bras_Cardiol_2013_Nov_101(5)_466-471.nxml.txt.nlp	24100694	SENT55	42	42	20	20	warfarin	NAT	PA451906	6046	0.366
NULL	Braz_J_Med_Biol_Res_2014_Apr_4_47(5)_411-418.nxml.txt.nlp	24820225	SENT174	4	4	40	40	prazosin	mol	PA451093	90527	0.366
NULL	Cancer_Cell_Int_2010_May_11_10_16.nxml.txt.nlp	20459793	SENT97	2	2	6	6	cisplatin	ABCC1	PA449014	4363	0.366
NULL	Int_J_Hypertens_2013_Feb_6_2013_382802.nxml.txt.nlp	23476746	SENT107	10	10	6	6	metoprolol	MDC	PA450480	6367	0.366
NULL	Biochem_Biophys_Res_Commun_2010_Jan_1_391(1)_437-442.nxml.txt.nlp	19914210	SENT66	19	19	10	10	bacitracin	HBB	PA448531	85344;3043	0.366
NULL	Diabetologia_2010_Jun_27_53(6)_1142-1150.nxml.txt.nlp	20349036	SENT250	0	0	15	15	spermine	AMPK	PA164781199	5563	0.366
NULL	J_Cancer_2013_Aug_28_4(7)_585-596.nxml.txt.nlp	24069069	SENT126	4	4	9	9	gemcitabine	p62	PA449748	8878;10657;23636	0.366
NULL	Acta_Histochem_Cytochem_2012_Oct_31_45(5)_251-259.nxml.txt.nlp	23209334	SENT120	10	10	16	16	vasopressin	AQP2	PA451858	359	0.366
NULL	Indian_J_Med_Res_2010_Dec_132(6)_676-682.nxml.txt.nlp	21245614	SENT77	9	9	12	12	oxygen	ROS	PA450744	6098	0.366
NULL	Oncogene_2009_Jan_29_28(4)_479-491.nxml.txt.nlp	18978811	SENT145	26	26	20	20	tetracycline	DPPIV	PA451640	2191;1803	0.366
NULL	J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.nxml.txt.nlp	21874297	SENT165	16	16	25	25	nadh	COX	PA164755085	1351	0.366
NULL	Front_Aging_Neurosci_2010_Feb_3_2_2.nxml.txt.nlp	20552042	SENT514	2	2	9	9	estradiol	CA1	PA449503	759	0.366
NULL	Cell_Cycle_2014_Mar_15_13(6)_873-874.nxml.txt.nlp	24552825	SENT17	19	19	26	26	glucose	STZ	PA449773	6484	0.366
NULL	Oxid_Med_Cell_Longev_2013_Dec_5_2013_963520.nxml.txt.nlp	24381719	SENT18	6	6	9	9	oxygen	ROS	PA450744	6098	0.366
NULL	Pharmaceuticals_(Basel)_2011_Nov_10_4(11)_1488-1502.nxml.txt.nlp	NULL	SENT242	0	0	10	10	geldanamycin	HER2	PA152031327	2064	0.366
NULL	Mol_Cells_2014_Sep_30_37(9)_637-643.nxml.txt.nlp	24957212	SENT134	7	7	21	21	bleomycin	HIF-1	PA448645	29072	0.366
NULL	Cancers_(Basel)_2010_Dec_23_3(1)_17-42.nxml.txt.nlp	24212604	SENT734	5	5	10	10	paclitaxel	PPX	PA450761	5531	0.366
NULL	Breast_Cancer_Res_2011_Jan_17_13(1)_R5.nxml.txt.nlp	21241485	SENT33	24	24	19	19	estradiol	EGF	PA449503	1950	0.366
NULL	Oncoimmunology_2014_Jan_1_3_e27358.nxml.txt.nlp	24701373	SENT28	30	30	35	35	glucosamine	HS3ST4	PA164747613	9951	0.366
NULL	Breast_Cancer_Res_2011_Mar_4_13(2)_R23.nxml.txt.nlp	21375726	SENT225	12	12	9	9	tamoxifen	AP-2	PA451581	7020	0.366
NULL	Mol_Cancer_2012_Aug_13_11_54.nxml.txt.nlp	22888789	SENT75	7	7	2	2	nutlin-3	p53		7157	0.366
NULL	Glycobiology_2012_Jan_26_22(1)_134-145.nxml.txt.nlp	21873605	SENT142	13	13	15	15	heparin	IL-8	PA449855	3576	0.366
NULL	Br_J_Cancer_2010_Jul_27_103(3)_315-323.nxml.txt.nlp	20661248	SENT22	8	8	22	22	sn-38	UGT		7361;7355	0.366
NULL	J_Cardiothorac_Surg_2013_Jun_10_8_149.nxml.txt.nlp	23759026	SENT3	32	32	22	22	cisplatin	ERCC1	PA449014	2067	0.366
NULL	Mycobiology_2013_Jun_30_41(2)_67-72.nxml.txt.nlp	23874127	SENT38	14	14	10	10	lipase	LIP1	PA450239	114790;55835	0.366
NULL	Eur_J_Endocrinol_2011_Jan_164(1)_69-74.nxml.txt.nlp	20961967	SENT80	8	8	5	5	pioglitazone	OPG	PA450970	690	0.366
NULL	CNS_Drugs_2014_Jun_24_28(10)_875-886.nxml.txt.nlp	24958205	SENT318	11	11	6	6	ethanol	NPY	PA448073	4852	0.366
NULL	Oncotarget_2014_Sep_10_5(19)_8924-8936.nxml.txt.nlp	25238040	SENT43	9	9	15	15	decitabine	p53	PA164749631	7157	0.366
NULL	Pharmaceuticals_(Basel)_2011_Oct_10_4(10)_1295-1314.nxml.txt.nlp	NULL	SENT165	7	7	22	22	l-arginine	NOS	PA448478	4843	0.366
NULL	Nat_Genet_2013_Nov_29_45(11)_10_1038_ng_2771.nxml.txt.nlp	24076601	SENT107	27	27	20	20	streptomycin	FBS	PA451512	64319;26269	0.366
NULL	Crit_Care_2010_Oct_21_14(5)_1004.nxml.txt.nlp	20979668	SENT7	22	22	18	18	exenatide	GLP-1	PA164749238	100125288	0.366
NULL	Colomb_Med_(Cali)_43(3)_221-225.nxml.txt.nlp	24893196	SENT21	19	19	12	12	resveratrol	ACTH		5443	0.366
NULL	Toxins_(Basel)_2010_Oct_22_2(10)_2428-2466.nxml.txt.nlp	22069560	SENT1117	13	13	6	6	ethanol	NF-kappaB	PA448073	4790	0.366
NULL	Evid_Based_Complement_Alternat_Med_2014_Jul_1_2014_423751.nxml.txt.nlp	25101132	SENT180	31	31	16	16	chloramphenicol	Met	PA448927	79811	0.366
NULL	Eur_J_Clin_Pharmacol_2011_May_9_67(5)_477-482.nxml.txt.nlp	21305273	SENT103	32	32	22	22	atropine	DBP	PA448505	3295;1628;2638	0.366
NULL	Breast_Cancer_Res_2002_Aug_27_4(6)_213-217.nxml.txt.nlp	12473165	SENT12	15	15	21	21	tamoxifen	ATAC	PA451581	6375	0.366
NULL	Arch_Med_Sci_2014_Aug_29_10(4)_684-691.nxml.txt.nlp	25276151	SENT162	10	10	19	19	dobutamine	CRT	PA449381	811	0.366
NULL	Eur_J_Endocrinol_2011_Jan_164(1)_69-74.nxml.txt.nlp	20961967	SENT17	6	6	15	15	pioglitazone	OPG	PA450970	690	0.366
NULL	Mar_Drugs_2011_Feb_8_9(2)_196-223.nxml.txt.nlp	21566795	SENT241	4	4	15	15	carrageenan	TLR4	PA448814	7099	0.365
NULL	Front_Synaptic_Neurosci_2012_Sep_27_4_4.nxml.txt.nlp	23133416	SENT144	11	11	4	4	spermine	GluA2	PA164781199	2891	0.365
NULL	Mol_Cancer_2014_Jun_26_13_158.nxml.txt.nlp	24965046	SENT253	7	7	38	38	cyclophosphamide	VEGFR2	PA449165	3791	0.365
NULL	Cell_Rep_2012_Aug_30_2(2)_419-431.nxml.txt.nlp	22902405	SENT317	19	19	6	6	nadh	ALDOB	PA164755085	229	0.365
NULL	Cases_J_2009_Jun_9_2_8099.nxml.txt.nlp	19918269	SENT15	18	18	7	7	trastuzumab	HER-2	PA451743	2064	0.365
NULL	Cancer_Cell_Int_2013_Nov_8_13_111.nxml.txt.nlp	24209962	SENT122	8	8	16	16	fluvastatin	A20	PA449688	7128;28935	0.365
NULL	Mol_Cancer_2012_Dec_12_11_91.nxml.txt.nlp	23234355	SENT42	14	14	11	11	erlotinib	HER2	PA134687924	2064	0.365
NULL	Curr_Biol_2012_Dec_18_22(24)_2285-2293.nxml.txt.nlp	23142042	SENT77	8	8	10	10	riluzole	SNA	PA451251	6615	0.365
NULL	Biomed_Res_Int_2014_Aug_6_2014_621827.nxml.txt.nlp	25165710	SENT302	6	6	7	7	dexmedetomidine	CD68	PA449256	968	0.365
NULL	Breast_Cancer_Res_2013_Sep_25_15(5)_R88.nxml.txt.nlp	24063698	SENT177	8	8	32	32	paclitaxel	SOC	PA450761	91544	0.365
NULL	Infect_Dis_Obstet_Gynecol_2013_Mar_7_2013_195637.nxml.txt.nlp	23533318	SENT120	11	11	19	19	zidovudine	IPT	PA451954	54802	0.365
NULL	Front_Cell_Neurosci_2014_Jan_22_8_2.nxml.txt.nlp	24478627	SENT86	11	11	5	5	picrotoxin	BIM	PA164777007	10018	0.365
NULL	Iran_J_Pharm_Res_2013_Winter_12(1)_47-56.nxml.txt.nlp	24250571	SENT216	3	3	15	15	curcumin	AP-1	PA151958596	2353;3727;2354;3725	0.365
NULL	Clin_Ophthalmol_2014_Dec_30_9_43-49.nxml.txt.nlp	25565767	SENT36	0	0	16	16	fluorescein	RPE	PA164746009	6120	0.365
NULL	Ann_Intensive_Care_2011_Mar_21_1_3.nxml.txt.nlp	21906325	SENT111	7	7	30	30	cisplatin	EPO	PA449014	7076;8288;2056	0.365
NULL	Neuropsychopharmacology_2009_May_3_34(6)_1504-1513.nxml.txt.nlp	19052543	SENT235	9	9	18	18	cocaine	CNR1	PA449072	1268;56117;56144	0.365
NULL	Clin_Dev_Immunol_2013_Oct_10_2013_524204.nxml.txt.nlp	24223605	SENT110	29	29	10	10	methotrexate	CRP	PA450428	1401;140913	0.365
NULL	eLife_2014_May_27_3_e02439.nxml.txt.nlp	24867641	SENT347	25	25	32	32	l-glutamine	San	PA10090	80218	0.365
NULL	Cancers_(Basel)_2012_Apr_5_4(2)_354-378.nxml.txt.nlp	24213315	SENT1018	1	1	9	9	curcumin	TRAIL	PA151958596	8743	0.365
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Sep_30_67(Pt_10)_o2720.nxml.txt.nlp	22065500	SENT68	28	28	24	24	ethanol	mol	PA448073	90527	0.365
NULL	F1000_Med_Rep_2009_Feb_24_1_13.nxml.txt.nlp	20948769	SENT32	22	22	24	24	rituximab	CHOP	PA451261	1649	0.365
NULL	Cell_Mol_Life_Sci_2011_May_26_68(10)_1785-1798.nxml.txt.nlp	20976523	SENT220	2	2	7	7	collagenase	AP-1	PA449107	2353;3727;2354;3725	0.365
NULL	Tuberc_Respir_Dis_(Seoul)_2012_Aug_31_73(2)_115-121.nxml.txt.nlp	23166544	SENT105	7	7	22	22	cyclophosphamide	CHOP	PA449165	1649	0.365
NULL	Cancer_Immunol_Immunother_2012_Oct_16_61(10)_1781-1790.nxml.txt.nlp	22422103	SENT197	33	33	20	20	cyclophosphamide	LAK	PA449165	10123	0.365
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT66	9	9	12	12	gefitinib	KRAS	PA131301952	3845	0.365
NULL	Acta_Orthop_2010_Apr_6_81(2)_263-267.nxml.txt.nlp	20148646	SENT4	0	0	10	10	taurine	LIR	PA451590	10871	0.365
NULL	Indian_J_Urol_2010_Jan-Mar_26(1)_26-35.nxml.txt.nlp	20535281	SENT42	31	31	27	27	lipase	FAAH	PA450239	79152;2166	0.365
NULL	Front_Bioeng_Biotechnol_2014_May_2_2_12.nxml.txt.nlp	25152885	SENT223	3	3	6	6	mannitol	CO2	PA450320	4513	0.365
NULL	Cell_Death_Dis_2013_Sep_26_4(9)_e814.nxml.txt.nlp	24071646	SENT277	6	6	11	11	atorvastatin	p110	PA448500	9733	0.365
NULL	Clin_Interv_Aging_2010_Dec_3_5_381-393.nxml.txt.nlp	21152240	SENT220	15	15	2	2	bisoprolol	BEST	PA448641	7439	0.365
NULL	Enzyme_Res_2010_Jun_1_2010_170549.nxml.txt.nlp	21048861	SENT180	37	37	10	10	galactose	mol	PA449725	90527	0.365
NULL	Oncoimmunology_2013_Oct_1_2(10)_e25997.nxml.txt.nlp	24404422	SENT34	10	10	26	26	imiquimod	ICAM1	PA449972	3383	0.365
NULL	Open_Med_Chem_J_2010_May_27_4_10-19.nxml.txt.nlp	21253021	SENT202	18	18	23	23	perospirone	5-HT1A	PA165291546	3350	0.365
NULL	Front_Neurol_2014_May_20_5_77.nxml.txt.nlp	24904521	SENT291	16	16	24	24	estradiol	CA1	PA449503	759	0.365
NULL	ScientificWorldJournal_2014_Jul_21_2014_610635.nxml.txt.nlp	25140337	SENT233	23	23	17	17	metronidazole	CPZ	PA450484	8532	0.365
NULL	Cardiovasc_Diabetol_2013_Jun_8_12_86.nxml.txt.nlp	23758640	SENT91	25	25	15	15	glucose	CAD	PA449773	1677;790	0.365
NULL	Hum_Genomics_2009_Jan_1_3(2)_128-142.nxml.txt.nlp	19164090	SENT175	11	11	22	22	carboplatin	C8orf76	PA448803	84933	0.365
NULL	Cancers_(Basel)_2011_Apr_1_3(2)_1844-1860.nxml.txt.nlp	24212785	SENT46	2	2	10	10	panitumumab	EGFR	PA162373091	1956	0.365
NULL	Biomed_Res_Int_2013_Jul_16_2013_953520.nxml.txt.nlp	23957013	SENT44	6	6	18	18	cyclosporine	EXP	PA449167	4154	0.365
NULL	J_Neurovirol_2013_Jun_4_19(4)_351-358.nxml.txt.nlp	23733308	SENT111	28	28	23	23	mefloquine	SOC	PA450348	91544	0.365
NULL	Cancer_Cell_Int_2004_Aug_17_4_5.nxml.txt.nlp	15315711	SENT100	9	9	17	17	genistein	CPP32	PA165109660	836	0.365
NULL	Curr_Chem_Genomics_2008_Dec_19_2_62-75.nxml.txt.nlp	19768139	SENT287	15	15	9	9	fluvoxamine	NAC	PA449690	22861	0.365
NULL	Oncoscience_2014_Mar_16_1(2)_132-157.nxml.txt.nlp	25594007	SENT376	5	5	0	0	cetuximab	CTRL	PA10040	1506	0.364
NULL	Biosci_Rep_2013_Aug_14_33(4)_e00057.nxml.txt.nlp	23837802	SENT120	22	22	31	31	cisplatin	STAT3	PA449014	6774	0.364
NULL	Oncoimmunology_2013_Dec_1_2(12)_e27058.nxml.txt.nlp	24498564	SENT33	15	15	26	26	cyclophosphamide	CRT	PA449165	811	0.364
NULL	Clin_Ophthalmol_2010_Oct_5_4_1137-1143.nxml.txt.nlp	20957061	SENT9	19	19	28	28	latanoprost	BAK	PA164774763	578	0.364
NULL	Breast_Cancer_Res_2003_Feb_3_5(2)_89-95.nxml.txt.nlp	12631387	SENT127	27	27	19	19	collagenase	CK19	PA449107	3880	0.364
NULL	ScientificWorldJournal_2014_May_11_2014_964172.nxml.txt.nlp	24955428	SENT16	10	10	13	13	oxygen	ROS	PA450744	6098	0.364
NULL	Nat_Commun_2010_Aug_1(5)_1-8.nxml.txt.nlp	20975714	SENT1120	11	11	26	26	isoniazid	EMB	PA450112	133418	0.364
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_15_2012_591654.nxml.txt.nlp	23118793	SENT290	13	13	24	24	berberine	Met	PA165860812	79811	0.364
NULL	Breast_Cancer_Res_2012_Mar_14_14(2)_R45.nxml.txt.nlp	22417809	SENT244	9	9	6	6	tamoxifen	CLU	PA451581	1191	0.364
NULL	Acta_Pharmacol_Sin_2010_Jul_28_31(7)_861-866.nxml.txt.nlp	20581850	SENT44	0	0	19	19	fluorescein	CD95	PA164746009	355	0.364
NULL	Carcinogenesis_2010_Dec_27_31(12)_2049-2057.nxml.txt.nlp	20876285	SENT217	33	33	24	24	tamoxifen	HER2	PA451581	2064	0.364
NULL	Front_Physiol_2011_Oct_11_2_70.nxml.txt.nlp	22013424	SENT97	24	24	27	27	trifluoperazine	TFP	PA451771	7034	0.364
NULL	J_Int_Soc_Sports_Nutr_2014_Aug_13_11_38.nxml.txt.nlp	25132809	SENT170	7	7	14	14	l-leucine	MSTN	PA450197	2660	0.364
NULL	Acta_Pharmacol_Sin_2011_Aug_18_32(8)_991-998.nxml.txt.nlp	21765445	SENT82	4	4	7	7	oxygen	ROS	PA450744	6098	0.364
NULL	Evid_Based_Complement_Alternat_Med_2014_Jul_1_2014_423751.nxml.txt.nlp	25101132	SENT180	35	35	16	16	kanamycin	Met	PA450137	79811	0.364
NULL	Mol_Pain_2013_Dec_30_9_68.nxml.txt.nlp	24377488	SENT25	12	12	36	36	capsaicin	TRPV1	PA448776	7442	0.364
NULL	Acta_Pharmacol_Sin_2013_May_18_34(5)_667-673.nxml.txt.nlp	23503475	SENT51	9	9	30	30	paraformaldehyde	OCT	PA450790	5362	0.364
NULL	Nat_Commun_2013_Sep_4_4_2338.nxml.txt.nlp	24005565	SENT8	18	18	3	3	mitomycin	HELQ	PA450524	113510	0.364
NULL	Springerplus_2014_Sep_9_3_510.nxml.txt.nlp	25279302	SENT13	20	20	5	5	creatine	GATM	PA164778930	2628	0.364
NULL	F1000Res_2014_Aug_19_3_198.nxml.txt.nlp	25400908	SENT524	34	34	41	41	tamoxifen	IMPACT	PA451581	55364	0.364
NULL	Pharmaceuticals_(Basel)_2013_Dec_23_7(1)_1-17.nxml.txt.nlp	24366113	SENT322	16	16	9	9	cyclosporine	IL-15	PA449167	3600	0.364
NULL	Croat_Med_J_2013_Apr_54(2)_171-179.nxml.txt.nlp	23630144	SENT70	10	10	6	6	taurine	STZ	PA451590	6484	0.364
NULL	Clin_Pract_2012_Sep_3_2(3)_e79.nxml.txt.nlp	24765478	SENT68	24	24	6	6	thrombin	ASAT	PA451674	22	0.364
NULL	Asian-Australas_J_Anim_Sci_2013_Feb_26(2)_233-240.nxml.txt.nlp	25049781	SENT18	0	0	7	7	l-carnitine	SDH	PA450154	1757;10993	0.364
NULL	Oxid_Med_Cell_Longev_2012_May_13_2012_250825.nxml.txt.nlp	22666518	SENT13	27	27	30	30	oxygen	ROS	PA450744	6098	0.364
NULL	J_Cell_Mol_Med_2014_May_14_18(5)_811-823.nxml.txt.nlp	24628949	SENT162	8	8	22	22	docetaxel	MCAK	PA449383	11004	0.364
NULL	Appl_Microbiol_Biotechnol_2014_Feb_18_98(8)_3829-3840.nxml.txt.nlp	24535257	SENT8	15	15	20	20	ethanol	PE-2	PA448073	2077	0.364
NULL	Exp_Hematol_Oncol_2013_Apr_10_2_11.nxml.txt.nlp	23574711	SENT9	19	19	12	12	l-arginine	OTC	PA448478	5009	0.364
NULL	Semin_Cancer_Biol_2014_Jun_26(100)_89-98.nxml.txt.nlp	24316494	SENT48	13	13	15	15	zidovudine	IFN	PA451954	3439	0.364
NULL	Indian_J_Dermatol_2010_Jul-Sep_55(3)_281-283.nxml.txt.nlp	21063527	SENT20	15	15	26	26	dipyridamole	IFN	PA449367	3439	0.364
NULL	Front_Oncol_2014_Jun_18_4_153.nxml.txt.nlp	24995158	SENT554	23	23	25	25	paclitaxel	ERK2	PA450761	5594	0.364
NULL	Crit_Care_2012_Mar_2_16(2)_R37.nxml.txt.nlp	22386062	SENT7	10	10	4	4	iron	CENPV	PA450087	201161	0.364
NULL	Int_J_Med_Sci_2012_Jun_8_9(4)_311-315.nxml.txt.nlp	22701339	SENT49	30	30	10	10	sevoflurane	SAP	PA451341	4068;325	0.364
NULL	Eur_J_Med_Res_2010_Sep_24_15(9)_369-376.nxml.txt.nlp	20952345	SENT90	25	25	23	23	atazanavir	ATV	PA10251	4683	0.364
NULL	Arthritis_Res_Ther_2007_Oct_10_9(5)_R105.nxml.txt.nlp	17927818	SENT120	6	6	6	6	pp2	PP2		4888	0.364
NULL	Springerplus_2013_Jul_18_2_323.nxml.txt.nlp	23961397	SENT51	12	12	6	6	ethanol	mol	PA448073	90527	0.364
NULL	Br_J_Cancer_2013_Oct_15_109(8)_2079-2086.nxml.txt.nlp	24045669	SENT201	26	26	2	2	tegafur	CDHP	PA452620	1001	0.364
NULL	Eur_J_Med_Res_2009_Dec_7_14(Suppl_4)_71-77.nxml.txt.nlp	20156730	SENT91	0	0	14	14	tobramycin	PARI	PA451704	55010	0.364
NULL	Arthritis_Res_Ther_2010_Aug_24_12(4)_214.nxml.txt.nlp	20735862	SENT192	6	6	31	31	anakinra	TBC	PA10799	23216	0.364
NULL	Basic_Clin_Neurosci_2014_Winter_5(1)_74-79.nxml.txt.nlp	25436087	SENT115	0	0	3	3	fluoxetine	AQP4	PA449673	361	0.364
NULL	Cancer_Cell_Int_2010_May_11_10_16.nxml.txt.nlp	20459793	SENT85	2	2	13	13	cisplatin	CDKN1A	PA449014	1026	0.364
NULL	Eur_J_Med_Res_2011_Mar_28_16(3)_93-100.nxml.txt.nlp	21486721	SENT87	29	29	43	43	zidovudine	ATV	PA451954	4683	0.364
NULL	Lab_Invest_2009_Nov_7_89(11)_1275-1290.nxml.txt.nlp	19736547	SENT10	0	0	10	10	curcumin	LOX-1	PA151958596	4973	0.363
NULL	Acta_Pharmacol_Sin_2010_Sep_16_31(9)_1075-1084.nxml.txt.nlp	20711221	SENT150	12	12	8	8	glucose	HEC	PA449773	10403	0.363
NULL	Int_J_Vasc_Med_2012_Feb_29_2012_453264.nxml.txt.nlp	22489272	SENT100	10	10	13	13	oxygen	ROS	PA450744	6098	0.363
NULL	Ann_Rheum_Dis_2008_Nov_14_67(11)_1516-1523.nxml.txt.nlp	18625622	SENT23	11	11	22	22	methotrexate	TNF	PA450428	7124	0.363
NULL	Cardiol_Res_Pract_2012_Apr_22_2012_181394.nxml.txt.nlp	22577589	SENT277	5	5	8	8	dextran	HMGB1	PA449261	3146	0.363
NULL	Case_Rep_Ophthalmol_2013_Aug_15_4(2)_81-86.nxml.txt.nlp	24019791	SENT6	7	7	15	15	fluorescein	NIR	PA164746009	26155	0.363
NULL	Blood_Cancer_J_2012_Jun_22_2(6)_e75.nxml.txt.nlp	22829977	SENT3	6	6	11	11	rituximab	San	PA451261	80218	0.363
NULL	J_Korean_Med_Sci_2013_Apr_27_28(4)_527-533.nxml.txt.nlp	23580227	SENT142	8	8	10	10	genistein	TRAIL	PA165109660	8743	0.363
NULL	Int_J_Mol_Sci_2010_Nov_18_11(11)_4673-4686.nxml.txt.nlp	21151463	SENT228	34	34	18	18	trypsin	EGF	PA451806	1950	0.363
NULL	Front_Neurosci_2011_Jan_14_4_207.nxml.txt.nlp	21258618	SENT171	15	15	17	17	ethanol	CRF1	PA448073	1394	0.363
NULL	Cancer_Metab_2014_Aug_18_2_13.nxml.txt.nlp	25225614	SENT271	28	28	38	38	lipase	ACSL1	PA450239	2180	0.363
NULL	Front_Genet_2012_Nov_22_3_249.nxml.txt.nlp	23189085	SENT805	25	25	19	19	methotrexate	MTHFR	PA450428	4524	0.363
NULL	Front_Neuroengineering_2011_Apr_28_4_6.nxml.txt.nlp	21577249	SENT94	17	17	20	20	diphenhydramine	S24	PA449349	6229	0.363
NULL	Acta_Histochem_Cytochem_2013_Dec_28_46(6)_187-197.nxml.txt.nlp	24610966	SENT146	11	11	8	8	pilocarpine	AQP5	PA450962	362	0.363
NULL	Front_Mol_Neurosci_2014_Dec_16_7_85.nxml.txt.nlp	25565954	SENT511	0	0	5	5	ethanol	5-HT1A	PA448073	3350	0.363
NULL	Infect_Drug_Resist_2009_Apr_24_2_13-26.nxml.txt.nlp	21694884	SENT300	8	8	5	5	emtricitabine	TDF	PA10069	6736	0.363
NULL	Clin_Med_Insights_Oncol_2011_Nov_7_5_349-364.nxml.txt.nlp	22174596	SENT174	13	13	9	9	everolimus	VEGFR	PA164746311	3791	0.363
NULL	Patient_Prefer_Adherence_2009_Nov_3_3_205-211.nxml.txt.nlp	19936163	SENT2	1	1	4	4	etonogestrel	ENG	PA164771231	2022	0.363
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT276	42	42	11	11	cisplatin	UNG	PA449014	7374	0.363
NULL	Arthritis_Res_Ther_2009_Dec_11_11(6)_R187.nxml.txt.nlp	20003323	SENT8	35	35	44	44	anakinra	OPG	PA10799	690	0.363
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_15_2012_591654.nxml.txt.nlp	23118793	SENT286	17	17	24	24	glipizide	Met	PA449762	79811	0.363
NULL	Eur_J_Med_Res_2010_Sep_24_15(9)_369-376.nxml.txt.nlp	20952345	SENT90	29	29	23	23	fosamprenavir	ATV	PA10084	4683	0.363
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Nov_20_64(Pt_12)_o2385.nxml.txt.nlp	21581356	SENT62	33	33	26	26	ethanol	mol	PA448073	90527	0.363
NULL	Mol_Cancer_2008_Mar_26_7_27.nxml.txt.nlp	18366759	SENT267	14	14	30	30	etoposide	CLK1	PA449552	1195	0.363
NULL	Br_J_Cancer_2010_Feb_16_102(4)_658-664.nxml.txt.nlp	20104222	SENT105	17	17	19	19	sunitinib	IFN	PA162372840	3439	0.363
NULL	Exp_Ther_Med_2013_Apr_29_5(4)_1093-1096.nxml.txt.nlp	23596475	SENT12	4	4	17	17	ketamine	IL-6	PA450144	3569	0.363
NULL	Virchows_Arch_2012_Feb_16_460(2)_141-149.nxml.txt.nlp	22173329	SENT226	15	15	17	17	irinotecan	KRAS	PA450085	3845	0.363
NULL	Allergy_Asthma_Immunol_Res_2014_Nov_28_6(6)_567-572.nxml.txt.nlp	25374757	SENT137	6	6	8	8	fexofenadine	IL-6	PA449621	3569	0.363
NULL	Arthritis_Res_Ther_2004_Apr_26_6(3)_R264-R272.nxml.txt.nlp	15142273	SENT31	24	24	10	10	methotrexate	ACR	PA450428	49	0.363
NULL	Biologics_2009_Sep_15_3_429-441.nxml.txt.nlp	19774210	SENT24	47	47	21	21	bevacizumab	IFL	PA130232992	3439	0.363
NULL	Mol_Imaging_Radionucl_Ther_2011_Dec_1_20(3)_75-93.nxml.txt.nlp	23487016	SENT325	0	0	35	35	atorvastatin	ARTS	PA448500	5414	0.363
NULL	Cancer_Metab_2014_Jul_17_2_10.nxml.txt.nlp	25057353	SENT54	8	8	29	29	nadh	IDH2	PA164755085	3418	0.363
NULL	Saline_Systems_2005_Aug_19_1_7.nxml.txt.nlp	16176596	SENT151	19	19	7	7	nadh	CB1	PA164755085	1268	0.363
NULL	Br_J_Cancer_1978_Aug_38(2)_325-328.nxml.txt.nlp	698049	SENT5	40	40	38	38	thioguanine	AMPH	PA451663	273	0.363
NULL	J_Oncol_2011_Mar_30_2011_456743.nxml.txt.nlp	21541211	SENT78	12	12	4	4	urokinase	SLURP1	PA451836	57152	0.363
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Sep_30_70(Pt_10)_265-268.nxml.txt.nlp	25484670	SENT26	33	33	17	17	nitrile	PF6	PA450636	200162	0.363
NULL	Ann_Gen_Psychiatry_2011_May_15_10_17.nxml.txt.nlp	21569624	SENT0	13	13	1	1	buprenorphine	Gen	PA448685	348654	0.363
NULL	Front_Genet_2014_Aug_26_5_285.nxml.txt.nlp	25206361	SENT495	1	1	17	17	choline	POMC	PA448976	5443	0.363
NULL	J_Korean_Neurosurg_Soc_2014_Jul_31_56(1)_66-70.nxml.txt.nlp	25289130	SENT39	16	16	8	8	mepivacaine	SGB	PA164748741	2719	0.363
NULL	Nat_Med_2013_Dec_10_19(12)_10_1038_nm_3385.nxml.txt.nlp	24216752	SENT113	18	18	25	25	thrombin	PAR4	PA451674	9002;5074	0.363
NULL	Blood_Res_2013_Mar_25_48(1)_40-45.nxml.txt.nlp	23589794	SENT52	12	12	34	34	iron	ALP	PA450087	6590;10850;27295;80150;470;26033	0.363
NULL	Carcinogenesis_2010_Dec_27_31(12)_2049-2057.nxml.txt.nlp	20876285	SENT7	34	34	23	23	tamoxifen	HER2	PA451581	2064	0.363
NULL	Viruses_2009_Aug_11_1(2)_126-143.nxml.txt.nlp	21994542	SENT184	13	13	16	16	oxygen	ROS	PA450744	6098	0.363
NULL	Case_Rep_Dermatol_2011_Feb_23_3(1)_42-48.nxml.txt.nlp	21487460	SENT17	20	20	27	27	tegafur	CDHP	PA452620	1001	0.363
NULL	Front_Neuroanat_2014_Nov_20_8_136.nxml.txt.nlp	25477789	SENT179	19	19	14	14	diazepam	c-fos	PA449283	2353	0.363
NULL	Ann_Rheum_Dis_2011_Apr_22_70(8)_1395-1400.nxml.txt.nlp	21515602	SENT180	12	12	10	10	warfarin	VKORC1	PA451906	79001	0.362
NULL	J_Cell_Mol_Med_2014_Aug_1_18(8)_1599-1611.nxml.txt.nlp	24889822	SENT235	3	3	15	15	resveratrol	SIRT1		23411	0.362
NULL	J_Adv_Pract_Oncol_2014_Mar_1_Mar-Apr_5(2)_134-139.nxml.txt.nlp	25032047	SENT38	2	2	9	9	trastuzumab	DM1	PA451743	338023;1760;28509	0.362
NULL	Breast_Cancer_Res_2012_Apr_4_14(2)_R57.nxml.txt.nlp	22475046	SENT190	4	4	0	0	tamoxifen	ATAC	PA451581	6375	0.362
NULL	Indian_J_Pharmacol_2014_Nov-Dec_46(6)_590-595.nxml.txt.nlp	25538328	SENT84	4	4	15	15	colchicine	IL-6	PA449092	3569	0.362
NULL	Infect_Drug_Resist_2009_Apr_24_2_13-26.nxml.txt.nlp	21694884	SENT227	8	8	11	11	tenofovir	TDF	PA10204	6736	0.362
NULL	J_Oncol_2013_Feb_17_2013_872957.nxml.txt.nlp	23476648	SENT212	8	8	4	4	cisplatin	SFN	PA449014	25996;2810	0.362
NULL	Biomed_Res_Int_2014_Jun_26_2014_161346.nxml.txt.nlp	25054130	SENT240	11	11	30	30	curcumin	STZ	PA151958596	6484	0.362
NULL	Int_J_Mol_Sci_2014_Sep_30_15(10)_17733-17750.nxml.txt.nlp	25272228	SENT378	0	0	8	8	oxygen	HIF-1	PA450744	29072	0.362
NULL	Breast_Cancer_Res_Treat_2008_Jan_13_107(2)_249-257.nxml.txt.nlp	17431762	SENT175	4	4	8	8	heparin	IL-8	PA449855	3576	0.362
NULL	ISRN_Allergy_2011_Dec_29_2011_195846.nxml.txt.nlp	23724224	SENT148	0	0	16	16	omalizumab	CD23	PA164752253	2208	0.362
NULL	J_Appl_Oral_Sci_2011_Mar-Apr_19(2)_147-153.nxml.txt.nlp	21552716	SENT148	3	3	5	5	glutaraldehyde	HEMA	PA449777	2157	0.362
NULL	Mol_Cancer_2013_Nov_13_12_137.nxml.txt.nlp	24225025	SENT531	33	33	27	27	doxorubicin	CRT	PA449412	811	0.362
NULL	Oncologist_2010_Nov_4_15(11)_1135-1146.nxml.txt.nlp	21051659	SENT139	19	19	21	21	sorafenib	IFN	PA7000	3439	0.362
NULL	Am_J_Clin_Nutr_2010_Aug_16_92(2)_450-457.nxml.txt.nlp	20554790	SENT61	10	10	21	21	heparin	PTH	PA449855	5741	0.362
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Jan_26_69(Pt_2)_o292.nxml.txt.nlp	23424561	SENT56	9	9	15	15	guanidine	CO2	PA164781028	4513	0.362
NULL	Arthritis_Res_Ther_2009_Jun_2_11(3)_R80.nxml.txt.nlp	19490621	SENT160	23	23	9	9	chloroquine	RGM	PA448948	56963	0.362
NULL	Braz_J_Med_Biol_Res_2014_Jan_10_47(1)_60-69.nxml.txt.nlp	24519092	SENT118	10	10	7	7	doxorubicin	YWHAZ	PA449412	7534	0.362
NULL	Biomed_Res_Int_2013_Aug_6_2013_909613.nxml.txt.nlp	24027765	SENT347	12	12	4	4	metronidazole	EEN	PA450484	6455	0.362
NULL	Acta_Pharmacol_Sin_2011_Jan_6_32(1)_133-138.nxml.txt.nlp	21131997	SENT8	24	24	28	28	heparin	HSI	PA449855	57016	0.362
NULL	Clin_Psychopharmacol_Neurosci_2011_Apr_30_9(1)_36-43.nxml.txt.nlp	23431025	SENT19	4	4	6	6	aripiprazole	FLI	PA10026	2314	0.362
NULL	Int_J_Environ_Res_Public_Health_2010_Jan_20_7(1)_269-283.nxml.txt.nlp	20195444	SENT47	33	33	27	27	ethanol	ARG	PA448073	473;27	0.362
NULL	Case_Rep_Med_2014_Dec_8_2014_516549.nxml.txt.nlp	25544844	SENT19	17	17	24	24	thyroglobulin	CK20	PA164754910	54474	0.362
NULL	Cancer_Inform_2014_Apr_2_13_67-76.nxml.txt.nlp	24737930	SENT214	35	35	2	2	nadh	TPEF	PA164755085	23671	0.362
NULL	J_Oncol_2012_Sep_5_2012_128608.nxml.txt.nlp	21904549	SENT203	15	15	9	9	bevacizumab	CA1	PA130232992	759	0.362
NULL	J_Biomed_Sci_2013_Aug_3_20(1)_56.nxml.txt.nlp	23915320	SENT162	26	26	6	6	phenylephrine	CIP4	PA450935	9322	0.362
NULL	Mol_Cancer_2010_Nov_2_9_289.nxml.txt.nlp	21044322	SENT149	11	11	6	6	cisplatin	RGS2	PA449014	5997	0.362
NULL	Arthritis_Res_Ther_2008_Dec_1_10(6)_R139.nxml.txt.nlp	19046432	SENT333	42	42	32	32	rosiglitazone	AP-1	PA451283	2353;3727;2354;3725	0.362
NULL	Eur_J_Med_Res_2013_Feb_22_18(1)_4.nxml.txt.nlp	23432977	SENT70	15	15	47	47	fluorescein	FIB	PA164746009	2091	0.362
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Jun_7_70(Pt_7)_m247-m248.nxml.txt.nlp	25161516	SENT10	13	13	15	15	ethanol	mol	PA448073	90527	0.362
NULL	Leukemia_2014_Aug_7_28(8)_1636-1646.nxml.txt.nlp	24418989	SENT37	10	10	21	21	flavopiridol	ACTB	PA452627	60	0.362
NULL	Arthritis_Res_Ther_2009_Aug_24_11(4)_R127.nxml.txt.nlp	19703304	SENT143	6	6	8	8	adalimumab	OASIS	PA10004	90993	0.362
NULL	Carcinogenesis_2010_Dec_27_31(12)_2049-2057.nxml.txt.nlp	20876285	SENT127	2	2	11	11	tamoxifen	HER2	PA451581	2064	0.362
NULL	Appl_Clin_Genet_2011_Mar_31_4_55-65.nxml.txt.nlp	23776367	SENT18	9	9	6	6	trypsin	AAT	PA451806	5265	0.362
NULL	Biomed_Res_Int_2013_Aug_6_2013_909613.nxml.txt.nlp	24027765	SENT378	2	2	4	4	hydrocortisone	EEN	PA449905	6455	0.362
NULL	Front_Pharmacol_2014_Nov_25_5_256.nxml.txt.nlp	25505414	SENT281	19	19	14	14	diazepam	c-fos	PA449283	2353	0.362
NULL	Oxid_Med_Cell_Longev_2012_May_28_2012_632959.nxml.txt.nlp	22690272	SENT139	13	13	5	5	genistein	PSA	PA165109660	29968;9520;354	0.362
NULL	Oncotarget_2013_Dec_28_5(6)_1475-1490.nxml.txt.nlp	24721996	SENT3	2	2	7	7	celecoxib	CD133	PA448871	8842	0.362
NULL	Oncoimmunology_2013_Jul_1_2(7)_e24743.nxml.txt.nlp	24073366	SENT19	22	22	18	18	imiquimod	TLR7	PA449972	51284	0.362
NULL	Basic_Clin_Neurosci_2014_Winter_5(1)_66-73.nxml.txt.nlp	25436086	SENT117	0	0	2	2	lidocaine	LHA	PA450226	1081	0.362
NULL	Appl_Plant_Sci_2015_Jan_5_3(1)_apps_1400086.nxml.txt.nlp	25606353	SENT65	28	28	38	38	cefotaxime	BAM	PA448852	9126	0.362
NULL	Mol_Pain_2013_Feb_28_9_7.nxml.txt.nlp	23448290	SENT261	2	2	34	34	capsaicin	TRPV1	PA448776	7442	0.362
NULL	Oncol_Lett_2014_Oct_9_8(4)_1551-1556.nxml.txt.nlp	25202366	SENT97	32	32	34	34	rituximab	PLB	PA451261	151056	0.362
NULL	Support_Care_Cancer_2012_Sep_17_20(9)_1991-1997.nxml.txt.nlp	22089428	SENT135	9	9	29	29	paclitaxel	HER-2	PA450761	2064	0.362
NULL	Avicenna_J_Phytomed_2012_Spring_2(2)_72-78.nxml.txt.nlp	25050233	SENT29	23	23	33	33	reserpine	HIC	PA451236	29969	0.361
NULL	AIDS_Res_Treat_2013_Oct_8_2013_279876.nxml.txt.nlp	24222846	SENT89	2	2	6	6	isoniazid	IPT	PA450112	54802	0.361
NULL	J_Gen_Physiol_1997_Dec_1_110(6)_643-654.nxml.txt.nlp	9382893	SENT44	17	17	15	15	diazoxide	SUR1	PA449285	6833	0.361
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_55-66.nxml.txt.nlp	17912636	SENT119	5	5	12	12	tamoxifen	ATAC	PA451581	6375	0.361
NULL	Breast_Cancer_Res_2011_Aug_31_13(4)_R84.nxml.txt.nlp	21884573	SENT251	14	14	0	0	trastuzumab	EGFR	PA451743	1956	0.361
NULL	Clin_Sci_(Lond)_2012_May_1_122(Pt_10)_473-483.nxml.txt.nlp	22150224	SENT393	8	8	4	4	liraglutide	GLP-1	PA165958364	100125288	0.361
NULL	Evid_Based_Complement_Alternat_Med_2014_Jul_1_2014_423751.nxml.txt.nlp	25101132	SENT184	26	26	24	24	metronidazole	Met	PA450484	79811	0.361
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT319	15	15	18	18	paliperidone	PRL	PA163518919	5617	0.361
NULL	Oncol_Lett_2014_May_26_7(5)_1345-1351.nxml.txt.nlp	24765136	SENT108	14	14	22	22	sorafenib	Mcl-1	PA7000	4170	0.361
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT842	37	37	22	22	resveratrol	SIRT1		23411	0.361
NULL	Evid_Based_Complement_Alternat_Med_2013_Aug_20_2013_789067.nxml.txt.nlp	24069055	SENT223	3	3	0	0	lipase	HSL	PA450239	3991	0.361
NULL	J_Vis_Exp_2009_Jun_9_(28)_1305.nxml.txt.nlp	19513018	SENT27	18	18	15	15	papain	sit	PA450778	55733	0.361
NULL	Oncotarget_2014_Sep_3_5(19)_9362-9381.nxml.txt.nlp	25313139	SENT258	8	8	10	10	orlistat	PC-3	PA164776864	692094	0.361
NULL	Mol_Cancer_2010_Dec_20_9_315.nxml.txt.nlp	21172010	SENT201	9	9	11	11	perifosine	TRAIL	PA165291471	8743	0.361
NULL	J_Antimicrob_Chemother_2009_Nov_18_64(5)_910-928.nxml.txt.nlp	19767318	SENT122	3	3	9	9	raltegravir	CD4		920	0.361
NULL	Oncotarget_2014_Sep_8_5(19)_9498-9513.nxml.txt.nlp	25237769	SENT104	27	27	24	24	cisplatin	mol	PA449014	90527	0.361
NULL	J_Cheminform_2012_Mar_8_4_6.nxml.txt.nlp	22401035	SENT116	14	14	19	19	troglitazone	PPARG	PA451799	5468	0.361
NULL	Front_Chem_2014_Dec_23_2_113.nxml.txt.nlp	25566531	SENT170	2	2	7	7	curcumin	PTPN1	PA151958596	5770	0.361
NULL	ScientificWorldJournal_2014_Feb_5_2014_786130.nxml.txt.nlp	24688431	SENT55	1	1	4	4	phenol	TPC	PA450913	8030;60386	0.361
NULL	Oncotarget_2014_Jun_6_5(13)_4935-4944.nxml.txt.nlp	24952732	SENT288	5	5	18	18	thioridazine	AKT	PA451666	207	0.361
NULL	Clin_Ophthalmol_2010_Oct_21_4_1217-1222.nxml.txt.nlp	21060675	SENT7	26	26	39	39	dorzolamide	BAK	PA164748765	578	0.361
NULL	Cancer_Imaging_2011_Oct_3_11(1A)_S65-S69.nxml.txt.nlp	22187133	SENT70	9	9	14	14	octreotide	FDG	PA450678	23583	0.361
NULL	Diabetes_2013_Nov_18_62(11)_3909-3919.nxml.txt.nlp	23835339	SENT234	3	3	8	8	gliclazide	SUR1	PA10892	6833	0.361
NULL	J_Cell_Biol_1999_Jan_11_144(1)_175-184.nxml.txt.nlp	9885253	SENT131	33	33	12	12	thrombin	PI3K	PA451674	5290	0.361
NULL	Front_Behav_Neurosci_2012_Jul_24_6_32.nxml.txt.nlp	22837741	SENT238	7	7	27	27	carbachol	CA1	PA448784	759	0.361
NULL	Sensors_(Basel)_2013_Dec_27_14(1)_458-467.nxml.txt.nlp	24379050	SENT84	13	13	15	15	glucose	MTB	PA449773	54892;4498	0.361
NULL	Acta_Pharmacol_Sin_2009_Jan_8_30(1)_1-24.nxml.txt.nlp	19060915	SENT338	10	10	21	21	sildenafil	PKG	PA451346	5592	0.361
NULL	Anesth_Pain_Med_2014_Aug_2_4(3)_e17620.nxml.txt.nlp	25237638	SENT137	14	14	6	6	dexmedetomidine	AAP	PA449256	5345	0.361
NULL	Nat_Commun_2013_4_2720.nxml.txt.nlp	24193139	SENT164	26	26	24	24	methamphetamine	AMPH	PA450403	273	0.361
NULL	J_Oncol_2010_Dec_24_2010_497429.nxml.txt.nlp	20066162	SENT164	2	2	8	8	paclitaxel	GEM	PA450761	2669	0.361
NULL	Drug_Target_Insights_2006_Oct_23_1_5-10.nxml.txt.nlp	21901053	SENT68	11	11	17	17	thrombin	CRT	PA451674	811	0.361
NULL	Oncotarget_2013_Nov_23_5(1)_196-210.nxml.txt.nlp	24344116	SENT108	11	11	7	7	doxorubicin	p50	PA449412	958;4790	0.361
NULL	Indian_J_Ophthalmol_2010_Nov-Dec_58(6)_477-481.nxml.txt.nlp	20952830	SENT42	15	15	33	33	timolol	HEC	PA451690	10403	0.361
NULL	Breast_Cancer_Res_2011_Nov_24_13(6)_R120.nxml.txt.nlp	22115051	SENT171	41	41	14	14	tamoxifen	HER-2	PA451581	2064	0.361
NULL	J_Int_Soc_Sports_Nutr_2009_Feb_19_6_6.nxml.txt.nlp	19228401	SENT163	4	4	7	7	creatine	CRT	PA164778930	811	0.361
NULL	Evid_Based_Complement_Alternat_Med_2011_Feb_20_2011_838172.nxml.txt.nlp	19861509	SENT38	6	6	24	24	paraformaldehyde	NAC	PA450790	22861	0.361
NULL	Br_J_Ophthalmol_2012_Jul_26_96(7)_1023-1028.nxml.txt.nlp	22539748	SENT165	11	11	16	16	bevacizumab	RPE	PA130232992	6120	0.361
NULL	Lab_Anim_Res_2011_Sep_30_27(3)_245-250.nxml.txt.nlp	21998614	SENT130	5	5	10	10	mannitol	EPO	PA450320	7076;8288;2056	0.36
NULL	Am_J_Trop_Med_Hyg_2012_Nov_7_87(5_Suppl)_21-29.nxml.txt.nlp	23136274	SENT6	30	30	34	34	artemisinin	ACT	PA165111696	12;11332;9457;641455	0.36
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Jul_26_64(Pt_8)_o1586.nxml.txt.nlp	21203284	SENT64	33	33	26	26	ethanol	mol	PA448073	90527	0.36
NULL	Iran_J_Pharm_Res_2014_Spring_13(2)_583-590.nxml.txt.nlp	25237354	SENT115	6	6	8	8	heparin	IL-6	PA449855	3569	0.36
NULL	J_Cell_Biol_2003_Dec_8_163(5)_1099-1109.nxml.txt.nlp	14662748	SENT6	0	0	9	9	vasopressin	AQP2	PA451858	359	0.36
NULL	ScientificWorldJournal_2014_Dec_9_2014_808320.nxml.txt.nlp	25548793	SENT93	4	4	1	1	heparin	ACT	PA449855	12;11332;9457;641455	0.36
NULL	Arthritis_Res_Ther_2013_Jul_24_15(4)_R76.nxml.txt.nlp	23883591	SENT274	28	28	19	19	hyaluronan	MRP5	PA165958431	10057	0.36
NULL	Ann_Intensive_Care_2011_Jul_19_1_26.nxml.txt.nlp	21906376	SENT38	36	36	30	30	vancomycin	SAPS	PA451850	8935	0.36
NULL	Exp_Hematol_2014_Dec_42(12)_1053-1058_e1.nxml.txt.nlp	25127743	SENT7	31	31	9	9	potassium	KCNE2	PA451047	9992	0.36
NULL	Antimicrob_Agents_Chemother_2014_Jun_58(6)_3354-3359.nxml.txt.nlp	24687509	SENT176	1	1	9	9	chloroquine	G6PD	PA448948	2539	0.36
NULL	Front_Endocrinol_(Lausanne)_2015_Jan_9_5_235.nxml.txt.nlp	25620956	SENT44	32	32	27	27	glucosamine	OGT	PA164747613	8473	0.36
NULL	Ann_Indian_Acad_Neurol_2011_Jul_14(Suppl1)_S2-S6.nxml.txt.nlp	21847323	SENT77	18	18	30	30	tetrabenazine	DIP	PA140222719	23151;1831	0.36
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_15_2012_591654.nxml.txt.nlp	23118793	SENT290	26	26	24	24	metformin	Met	PA450395	79811	0.36
NULL	Environ_Health_Perspect_2009_Feb_26_117(2)_254-260.nxml.txt.nlp	19270796	SENT206	8	8	13	13	l-arginine	AGAT	PA448478	2628	0.36
NULL	Alzheimers_Res_Ther_2013_May_14_5(3)_25.nxml.txt.nlp	23673233	SENT468	20	20	9	9	donepezil	spatial	PA449394	219793	0.36
NULL	Crit_Care_2006_Feb_3_10(1)_R24.nxml.txt.nlp	16469128	SENT193	20	20	27	27	heparin	MARS	PA449855	4141	0.36
NULL	Emerg_Infect_Dis_2011_Jun_17(6)_1099-1102.nxml.txt.nlp	21749780	SENT105	34	34	6	6	vancomycin	San	PA451850	80218	0.36
NULL	Bioconjug_Chem_2013_Oct_16_24(10)_1750-1759.nxml.txt.nlp	24011174	SENT50	10	10	39	39	l-lysine	CO2	PA450280	4513	0.36
NULL	Nucleic_Acids_Res_2005_Dec_7_33(21)_6861-6867.nxml.txt.nlp	16396834	SENT68	28	28	5	5	aprotinin	NTN	PA448472	4902;6376	0.36
NULL	Lab_Invest_2011_Sep_23_91(9)_1396-1409.nxml.txt.nlp	21606925	SENT138	15	15	15	15	pp2	PP2		4888	0.36
NULL	Comput_Math_Methods_Med_2013_Mar_20_2013_802512.nxml.txt.nlp	23573174	SENT77	42	42	39	39	tetracycline	MYC	PA451640	4609	0.36
NULL	Int_J_Mol_Sci_2014_Sep_30_15(10)_17733-17750.nxml.txt.nlp	25272228	SENT378	3	3	8	8	oxygen	HIF-1	PA450744	29072	0.36
NULL	Alcohol_Res_2013_35(1)_6-16.nxml.txt.nlp	24313160	SENT242	20	20	2	2	betaine	MTHFR	PA448603	4524	0.36
NULL	Cancer_Med_2014_Jun_16_3(3)_537-549.nxml.txt.nlp	24737780	SENT316	6	6	9	9	oxygen	ROS	PA450744	6098	0.36
NULL	Int_J_Breast_Cancer_2011_Oct_19_2011_867152.nxml.txt.nlp	22295235	SENT80	19	19	22	22	hyaluronan	LYVE-1	PA165958431	10894	0.36
NULL	Gut_2011_Jan_27_60(1)_26-33.nxml.txt.nlp	20980342	SENT28	8	8	4	4	fluorescein	CLE	PA164746009	51637	0.36
NULL	Drugs_2014_Jul_18_74(11)_1209-1231.nxml.txt.nlp	25034361	SENT177	5	5	2	2	warfarin	TTR	PA451906	7276	0.36
NULL	Neural_Regen_Res_2014_Mar_15_9(6)_622-629.nxml.txt.nlp	25206865	SENT87	0	0	6	6	vasopressin	p38	PA451858	10598;1432;7965	0.36
NULL	J_Asthma_Allergy_2010_Aug_13_3_33-42.nxml.txt.nlp	21437038	SENT111	43	43	22	22	formoterol	FIX	PA134687907	2158	0.36
NULL	Front_Oncol_2013_Sep_9_3_235.nxml.txt.nlp	24058902	SENT68	7	7	15	15	vorinostat	BIM	PA164748224	10018	0.36
NULL	Neural_Plast_2012_Oct_24_2012_832757.nxml.txt.nlp	23150836	SENT190	23	23	6	6	heparin	MMP2	PA449855	4313	0.36
NULL	Aging_(Albany_NY)_2010_Jan_26_2(1)_3-6.nxml.txt.nlp	20228938	SENT49	27	27	7	7	busulfan	SCP3	PA448691	10217	0.36
NULL	Cancer_Microenviron_2008_Dec_20_1(1)_103-111.nxml.txt.nlp	19308689	SENT35	13	13	24	24	thrombin	VWF	PA451674	7450	0.36
NULL	Int_J_Vasc_Med_2014_Nov_17_2014_254270.nxml.txt.nlp	25485154	SENT4	14	14	22	22	phenol	HMGB1	PA450913	3146	0.36
NULL	AIDS_Res_Treat_2012_May_14_2012_246280.nxml.txt.nlp	22675613	SENT179	13	13	7	7	efavirenz	ATV	PA449441	4683	0.36
NULL	Nucleic_Acids_Res_2012_Jul_15_40(12)_e91.nxml.txt.nlp	22422839	SENT146	8	8	0	0	mannitol	ETM	PA450320	2112	0.36
NULL	Evid_Based_Complement_Alternat_Med_2014_Oct_15_2014_169130.nxml.txt.nlp	25386217	SENT445	5	5	21	21	sulfadiazine	BCR	PA451539	613	0.36
NULL	Front_Comput_Neurosci_2012_Aug_17_6_59.nxml.txt.nlp	22912614	SENT178	7	7	30	30	taurine	CA3	PA451590	761	0.36
NULL	J_Res_Med_Sci_2010_Nov-Dec_15(6)_331-343.nxml.txt.nlp	21526106	SENT163	11	11	19	19	l-arginine	HDEL	PA448478	10945	0.36
NULL	Diabetes_Metab_Syndr_Obes_2014_Jul_17_7_313-319.nxml.txt.nlp	25092992	SENT17	1	1	11	11	pioglitazone	adiponectin	PA450970	9370	0.36
NULL	J_Mol_Signal_2008_Dec_1_3_18.nxml.txt.nlp	19046439	SENT113	35	35	28	28	metformin	Met	PA450395	79811	0.36
NULL	Hum_Mol_Genet_2011_Jan_1_20(1)_80-89.nxml.txt.nlp	20926450	SENT107	6	6	9	9	oxygen	ROS	PA450744	6098	0.36
NULL	Front_Aging_Neurosci_2010_May_21_2_21.nxml.txt.nlp	20725514	SENT135	0	0	7	7	rosiglitazone	PS1	PA451283	5663	0.36
NULL	Acta_Pharmacol_Sin_2011_Aug_18_32(8)_991-998.nxml.txt.nlp	21765445	SENT83	2	2	5	5	oxygen	ROS	PA450744	6098	0.36
NULL	Ann_Rheum_Dis_2009_Dec_1_68(12)_1819-1826.nxml.txt.nlp	19054822	SENT2	14	14	19	19	abatacept	CDP	PA164747080	1523	0.359
NULL	Crit_Care_2003_Mar_3_7(Suppl_2)_P223.nxml.txt.nlp	NULL	SENT16	14	14	17	17	furosemide	ANOVA	PA449719	4858	0.359
NULL	Indian_J_Med_Paediatr_Oncol_2013_Oct-Dec_34(4)_309-312.nxml.txt.nlp	24604963	SENT12	18	18	11	11	cisplatin	PLAP	PA449014	4012;9373	0.359
NULL	Breast_Cancer_Res_2014_Dec_19_16(6)_499.nxml.txt.nlp	25522654	SENT223	20	20	15	15	estradiol	CYP19A1	PA449503	1588	0.359
NULL	ScientificWorldJournal_2013_Aug_19_2013_157527.nxml.txt.nlp	24089600	SENT124	11	11	5	5	ethanol	TPC	PA448073	8030;60386	0.359
NULL	J_Clin_Biochem_Nutr_2008_Sep_30_43(2)_75-81.nxml.txt.nlp	18818756	SENT56	13	13	8	8	estradiol	ACTH	PA449503	5443	0.359
NULL	Curr_HIV_Res_2011_Jan_9(1)_40-53.nxml.txt.nlp	21198432	SENT130	36	36	21	21	raltegravir	AST		26503	0.359
NULL	Clin_Ophthalmol_2014_Feb_10_8_389-399.nxml.txt.nlp	24550667	SENT161	8	8	29	29	timolol	TIM	PA451690	7984;8914	0.359
NULL	Aging_(Albany_NY)_2012_Jan_29_4(1)_13-27.nxml.txt.nlp	22291164	SENT137	32	32	46	46	ether	TLC	PA449525	3933	0.359
NULL	Exp_Hematol_2014_Dec_42(12)_1053-1058_e1.nxml.txt.nlp	25127743	SENT7	0	0	25	25	potassium	KCNQ1	PA451047	3784	0.359
NULL	Br_J_Cancer_1985_Oct_52(4)_599-605.nxml.txt.nlp	4063135	SENT13	11	11	24	24	vincristine	PMI	PA451879	8834;5373	0.359
NULL	Biomed_Res_Int_2014_Aug_4_2014_592868.nxml.txt.nlp	25165708	SENT345	14	14	8	8	docetaxel	GEM	PA449383	2669	0.359
NULL	Lancet_2008_May_1_371(9625)_1685-1694.nxml.txt.nlp	18486741	SENT37	45	45	40	40	vinorelbine	MVP	PA451881	9961	0.359
NULL	Arch_Med_Sci_2011_Aug_2_7(4)_713-719.nxml.txt.nlp	22291810	SENT123	32	32	9	9	cyclosporine	IL-20	PA449167	27190;50604	0.359
NULL	Cancers_(Basel)_2010_Dec_30_3(1)_106-125.nxml.txt.nlp	24212609	SENT322	18	18	4	4	gemcitabine	HuR	PA449748	1994	0.359
NULL	Arch_Trauma_Res_2013_Aug_1_2(2)_97-98.nxml.txt.nlp	24396803	SENT16	12	12	22	22	meperidine	P-gp	PA450369	5243	0.359
NULL	J_Cardiothorac_Surg_2012_Nov_15_7_123.nxml.txt.nlp	23151309	SENT171	10	10	17	17	heparin	ACT	PA449855	12;11332;9457;641455	0.359
NULL	eLife_2013_Oct_29_2_e01236.nxml.txt.nlp	24171104	SENT349	17	17	19	19	bortezomib	MM1	PA10252	23654	0.359
NULL	Front_Oncol_2014_Nov_14_4_323.nxml.txt.nlp	25452936	SENT78	3	3	15	15	thrombin	MCH	PA451674	5367	0.359
NULL	Case_Rep_Oncol_2013_Jan_8_6(1)_1-5.nxml.txt.nlp	23466482	SENT23	22	22	46	46	paclitaxel	NAC	PA450761	22861	0.359
NULL	Int_J_Cell_Biol_2014_Jan_22_2014_709828.nxml.txt.nlp	24578708	SENT76	32	32	37	37	choline	CTL1	PA448976	23446	0.359
NULL	J_Radiat_Res_2014_Mar_8_55(2)_265-276.nxml.txt.nlp	24105709	SENT21	24	24	27	27	oxygen	ROS	PA450744	6098	0.359
NULL	J_Hematol_Oncol_2009_Nov_22_2_49.nxml.txt.nlp	19930611	SENT50	15	15	21	21	doxorubicin	CHOP	PA449412	1649	0.359
NULL	J_Clin_Biochem_Nutr_2007_May_25_40(3)_203-209.nxml.txt.nlp	18398497	SENT46	4	4	24	24	fluorescein	D5S346	PA164746009	7905	0.359
NULL	Alcohol_Res_Health_2007_30(1)_38-47.nxml.txt.nlp	17718399	SENT182	14	14	17	17	oxygen	ROS	PA450744	6098	0.359
NULL	Oncotarget_2014_Aug_12_5(20)_9710-9726.nxml.txt.nlp	25339152	SENT199	17	17	17	17	pp2	PP2		4888	0.359
NULL	Mol_Cancer_2009_Aug_25_8_66.nxml.txt.nlp	19706164	SENT273	28	28	34	34	phenol	BRL	PA450913	23774	0.359
NULL	Br_J_Pharmacol_2011_Oct_164(3)_866-883.nxml.txt.nlp	21323893	SENT43	14	14	4	4	nitrogen	ROS	PA450643	6098	0.359
NULL	Toxins_(Basel)_2010_Oct_26_2(11)_2490-2518.nxml.txt.nlp	22069563	SENT135	33	33	7	7	cisplatin	p53	PA449014	7157	0.359
NULL	Cell_Biosci_2011_Oct_28_1_35.nxml.txt.nlp	22035495	SENT21	2	2	37	37	lipase	UCP1	PA450239	7350	0.359
NULL	Case_Rep_Ophthalmol_2011_Sep_6_2(3)_296-301.nxml.txt.nlp	22087103	SENT35	20	20	31	31	fluorescein	ERG	PA164746009	2078	0.359
NULL	Oncoimmunology_2014_Jan_1_3_e27358.nxml.txt.nlp	24701373	SENT20	29	29	34	34	glucosamine	HS3ST4	PA164747613	9951	0.359
NULL	Breast_Cancer_Res_2011_Mar_14_13(2)_205.nxml.txt.nlp	21457526	SENT27	9	9	15	15	tamoxifen	ATAC	PA451581	6375	0.359
NULL	Br_J_Ophthalmol_2008_Sep_22_92(9)_1275-1282.nxml.txt.nlp	18723745	SENT56	27	27	42	42	tafluprost	BAK	PA165958432	578	0.359
NULL	Clinics_(Sao_Paulo)_2014_Jun_69(6)_438-446.nxml.txt.nlp	24964310	SENT48	0	0	5	5	clodronate	ST2	PA10239	9173;6761	0.359
NULL	Biosci_Rep_2013_Nov_25_33(6)_e00081.nxml.txt.nlp	24070327	SENT435	12	12	7	7	imatinib	MCM7	PA10804	4176	0.359
NULL	Alzheimers_Res_Ther_2013_Oct_24_5(5)_50.nxml.txt.nlp	24401551	SENT28	0	0	6	6	donepezil	STZ	PA449394	6484	0.359
NULL	Cancer_Cell_Int_2013_Mar_4_13_21.nxml.txt.nlp	23497288	SENT308	13	13	19	19	doxorubicin	GAPDH	PA449412	2597	0.359
NULL	Mol_Cancer_2010_Mar_2_9_46.nxml.txt.nlp	20196838	SENT67	7	7	14	14	ketoconazole	SFN	PA450146	25996;2810	0.359
NULL	Behav_Neurol_2014_Nov_16_2014_360978.nxml.txt.nlp	25477708	SENT151	4	4	1	1	nicotine	EPM	PA450626	2054	0.359
NULL	Mol_Vis_2010_Oct_8_16_2007-2015.nxml.txt.nlp	21042563	SENT101	23	23	14	14	galactose	GALK1	PA449725	2584	0.359
NULL	Oncotarget_2013_Nov_7_4(12)_2550-2566.nxml.txt.nlp	24334291	SENT207	33	33	36	36	dasatinib	p53	PA162372878	7157	0.359
NULL	Mediators_Inflamm_2010_Mar_14_2010_903295.nxml.txt.nlp	20300540	SENT263	17	17	29	29	creatine	G6PD	PA164778930	2539	0.358
NULL	Adv_Urol_2010_Jul_20_2010_687043.nxml.txt.nlp	20721275	SENT95	19	19	16	16	bevacizumab	VEGF-A	PA130232992	7422	0.358
NULL	Cell_Commun_Signal_2014_Aug_1_12_50.nxml.txt.nlp	25081034	SENT5	6	6	9	9	oxygen	ROS	PA450744	6098	0.358
NULL	Oncol_Lett_2014_Nov_14_8(5)_2086-2092.nxml.txt.nlp	25295095	SENT137	15	15	13	13	gemcitabine	LKB1	PA449748	6794	0.358
NULL	Leukemia_2014_Apr_14_28(4)_961-964.nxml.txt.nlp	24418991	SENT6	17	17	22	22	nilotinib	P-gp	PA165958345	5243	0.358
NULL	Nucleic_Acids_Res_2013_May_3_41(10)_e107.nxml.txt.nlp	23558748	SENT462	17	17	6	6	tetracycline	APRT	PA451640	353	0.358
NULL	J_Anim_Sci_Biotechnol_2014_Aug_28_5(1)_42.nxml.txt.nlp	25343027	SENT145	3	3	14	14	creatine	NEFA	PA164778930	4925	0.358
NULL	Hum_Genomics_2008_Sep_1_3(1)_71-78.nxml.txt.nlp	19129091	SENT32	17	17	22	22	nadh	ND1	PA164755085	4535;10625	0.358
NULL	Ann_Clin_Microbiol_Antimicrob_2015_Jan_17_14(1)_5.nxml.txt.nlp	NULL	SENT94	23	23	17	17	ceftriaxone	CTX	PA448866	1593	0.358
NULL	Alcohol_Res_2012_34(4)_484-494.nxml.txt.nlp	23584114	SENT146	18	18	9	9	vasopressin	ACTH	PA451858	5443	0.358
NULL	Front_Neuroenergetics_2010_May_21_2_5.nxml.txt.nlp	20725515	SENT214	1	1	4	4	oxygen	ROS	PA450744	6098	0.358
NULL	Front_Hum_Neurosci_2010_Nov_2_4_204.nxml.txt.nlp	21120136	SENT170	11	11	19	19	fluoxetine	spatial	PA449673	219793	0.358
NULL	J_Biol_Chem_2008_Nov_14_283(46)_31679-31689.nxml.txt.nlp	18755684	SENT153	11	11	16	16	iron	FTL	PA450087	2512	0.358
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_55-66.nxml.txt.nlp	17912636	SENT119	23	23	12	12	tamoxifen	ATAC	PA451581	6375	0.358
NULL	Biomed_Res_Int_2013_Jul_9_2013_281230.nxml.txt.nlp	23936784	SENT274	17	17	23	23	gemcitabine	MGLL	PA449748	11343	0.358
NULL	Acta_Neuropathol_Commun_2014_Jan_2_2_1.nxml.txt.nlp	24383468	SENT223	11	11	27	27	nadh	ND4	PA164755085	4538	0.358
NULL	Indian_J_Med_Paediatr_Oncol_2014_Jan-Mar_35(1)_103-105.nxml.txt.nlp	25006297	SENT33	21	21	6	6	vincristine	NACT	PA451879	284111	0.358
NULL	Clin_Interv_Aging_2012_Sep_17_7_363-372.nxml.txt.nlp	23049248	SENT106	3	3	0	0	denosumab	Men	PA166048634	8178	0.358
NULL	Clin_Ophthalmol_2013_Dec_31_7_39-45.nxml.txt.nlp	23308037	SENT36	8	8	31	31	fluorescein	San	PA164746009	80218	0.358
NULL	J_Thromb_Haemost_2010_Mar_8(3)_577-587.nxml.txt.nlp	20040043	SENT172	9	9	14	14	rosiglitazone	GPVI	PA451283	51206	0.358
NULL	Bioinformation_2010_Mar_31_4(9)_399-404.nxml.txt.nlp	20975889	SENT23	25	25	28	28	oxygen	ROS	PA450744	6098	0.358
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1563-1573.nxml.txt.nlp	22015557	SENT141	18	18	8	8	sunitinib	c-Myc	PA162372840	4609	0.358
NULL	F1000Res_2013_Jul_9_2_151.nxml.txt.nlp	24555069	SENT371	15	15	17	17	memantine	spatial	PA10364	219793	0.358
NULL	Genome_Announc_2014_Jul_24_2(4)_e00449-14.nxml.txt.nlp	25059856	SENT10	16	16	10	10	vancomycin	VISA	PA451850	57506	0.358
NULL	Chin_J_Cancer_2011_May_30(5)_287-292.nxml.txt.nlp	21527061	SENT54	13	13	20	20	paclitaxel	CYP3A5	PA450761	1577	0.358
NULL	Front_Endocrinol_(Lausanne)_2014_Dec_18_5_218.nxml.txt.nlp	25566190	SENT337	10	10	20	20	oxygen	BIM	PA450744	10018	0.358
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jul_18_65(Pt_8)_o1900.nxml.txt.nlp	21583590	SENT64	1	1	14	14	ethanol	mol	PA448073	90527	0.358
NULL	Indian_J_Endocrinol_Metab_2012_Mar-Apr_16(2)_324-325.nxml.txt.nlp	22470884	SENT11	40	40	37	37	exenatide	GLP-1	PA164749238	100125288	0.358
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Dec_17_65(Pt_1)_m82-m83.nxml.txt.nlp	21581547	SENT73	1	1	15	15	ethanol	mol	PA448073	90527	0.358
NULL	Diabetes_2013_Oct_17_62(10)_3373-3383.nxml.txt.nlp	23835335	SENT264	17	17	3	3	glucose	POMC	PA449773	5443	0.358
NULL	Cardiovasc_Drugs_Ther_2010_Apr_20_24(2)_175-180.nxml.txt.nlp	20490906	SENT30	15	15	9	9	terutroban	APOE	PA165980596	348	0.358
NULL	Bioinformation_2012_Nov_13_8(22)_1114-1118.nxml.txt.nlp	23251047	SENT46	10	10	24	24	pyrimethamine	DHFR	PA451193	1719	0.358
NULL	Oncol_Rep_2012_Apr_14_27(4)_1227-1232.nxml.txt.nlp	22179681	SENT23	10	10	19	19	spermine	PAO	PA164781199	196743;54498	0.358
NULL	Mucosal_Immunol_2014_May_16_7(3)_589-601.nxml.txt.nlp	24129165	SENT354	10	10	2	2	dextran	spatial	PA449261	219793	0.358
NULL	Lancet_2012_Aug_11_380(9841)_572-580.nxml.txt.nlp	22607825	SENT10	17	17	20	20	lipase	LIPG	PA450239	9388	0.357
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT340	6	6	15	15	risperidone	PRL	PA451257	5617	0.357
NULL	Int_J_Cell_Biol_2012_Sep_9_2012_683897.nxml.txt.nlp	22991514	SENT32	11	11	14	14	oxygen	ROS	PA450744	6098	0.357
NULL	Cell_Commun_Signal_2013_Feb_27_11_15.nxml.txt.nlp	23445664	SENT198	12	12	18	18	calcein	CPU	PA132595336	1361	0.357
NULL	J_Biomed_Sci_2014_Apr_22_21(1)_32.nxml.txt.nlp	24750591	SENT128	15	15	26	26	mannitol	PTER	PA450320	9317	0.357
NULL	J_Cell_Biol_1971_Nov_1_51(2)_396-404.nxml.txt.nlp	4329615	SENT5	19	19	30	30	choline	PLP	PA448976	25824;5744	0.357
NULL	Mol_Cells_2014_Mar_31_37(3)_234-240.nxml.txt.nlp	24642709	SENT96	26	26	11	11	capsaicin	TLR4	PA448776	7099	0.357
NULL	Nat_Commun_2013_Oct_1_4_2516.nxml.txt.nlp	24084631	SENT67	13	13	24	24	lisinopril	AT1	PA450242	9197;185	0.357
NULL	Ann_Rheum_Dis_2008_Nov_14_67(11)_1516-1523.nxml.txt.nlp	18625622	SENT160	28	28	24	24	tocilizumab	IL-6	PA165292659	3569	0.357
NULL	Tuberc_Respir_Dis_(Seoul)_2013_Aug_30_75(2)_47-51.nxml.txt.nlp	24023556	SENT83	15	15	17	17	azathioprine	NAC	PA448515	22861	0.357
NULL	Biomed_Res_Int_2013_Aug_6_2013_909613.nxml.txt.nlp	24027765	SENT397	7	7	9	9	hydrocortisone	EEN	PA449905	6455	0.357
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_May_20_65(Pt_6)_o1356.nxml.txt.nlp	21583207	SENT69	13	13	16	16	ethanol	mol	PA448073	90527	0.357
NULL	Breast_Cancer_Res_2009_Oct_28_11(5)_211.nxml.txt.nlp	19889200	SENT26	3	3	10	10	tamoxifen	ATAC	PA451581	6375	0.357
NULL	Environ_Health_Perspect_2004_Nov_22_112(16)_1636-1644.nxml.txt.nlp	15598615	SENT114	16	16	34	34	nadh	COX	PA164755085	1351	0.357
NULL	Br_J_Pharmacol_2011_Feb_162(4)_989-999.nxml.txt.nlp	21054342	SENT86	8	8	14	14	pargyline	COMT	PA450797	1312	0.357
NULL	Iran_J_Pharm_Res_2014_Autumn_13(4)_1369-1378.nxml.txt.nlp	25587326	SENT39	3	3	6	6	ethanol	LCE	PA448073	79071	0.357
NULL	Hum_Mol_Genet_2008_Dec_15_17(24)_3847-3853.nxml.txt.nlp	18801880	SENT82	13	13	16	16	lipase	DAGLA	PA450239	747	0.357
NULL	Cancer_Cell_Int_2013_Mar_4_13_21.nxml.txt.nlp	23497288	SENT308	13	13	4	4	doxorubicin	EWS	PA449412	2130	0.357
NULL	Neuroimage_Clin_2013_Sep_6_3_290-300.nxml.txt.nlp	24273714	SENT282	0	0	5	5	pioglitazone	spatial	PA450970	219793	0.357
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_21-38.nxml.txt.nlp	19305786	SENT582	6	6	10	10	capsaicin	TRPV1	PA448776	7442	0.357
NULL	Chemother_Res_Pract_2011_Sep_21_2011_839742.nxml.txt.nlp	22295206	SENT101	0	0	8	8	bevacizumab	CRT	PA130232992	811	0.357
NULL	J_Mol_Signal_2008_Dec_1_3_18.nxml.txt.nlp	19046439	SENT77	12	12	17	17	metformin	Met	PA450395	79811	0.357
NULL	Clin_Ophthalmol_2010_Oct_21_4_1165-1171.nxml.txt.nlp	21060666	SENT121	4	4	28	28	travoprost	BAK	PA164781371	578	0.357
NULL	Evid_Based_Complement_Alternat_Med_2014_Jul_1_2014_423751.nxml.txt.nlp	25101132	SENT188	31	31	16	16	chloramphenicol	Met	PA448927	79811	0.357
NULL	Springerplus_2014_Sep_9_3_510.nxml.txt.nlp	25279302	SENT246	12	12	27	27	creatine	SLC6A8	PA164778930	6535	0.357
NULL	J_Cell_Biol_1998_Nov_16_143(4)_1087-1099.nxml.txt.nlp	9817764	SENT148	15	15	10	10	collagenase	AP-1	PA449107	2353;3727;2354;3725	0.357
NULL	Cancer_Metab_2013_Feb_4_1_7.nxml.txt.nlp	24280108	SENT10	13	13	16	16	oxygen	ROS	PA450744	6098	0.357
NULL	Hum_Mol_Genet_2013_Dec_1_22(23)_4784-4804.nxml.txt.nlp	23922229	SENT462	17	17	20	20	paraformaldehyde	PLP	PA450790	25824;5744	0.357
NULL	J_Immunol_Res_2014_Sep_18_2014_689492.nxml.txt.nlp	25309932	SENT186	9	9	12	12	oxygen	ROS	PA450744	6098	0.357
NULL	Exp_Ther_Med_2014_May_21_7(5)_1388-1392.nxml.txt.nlp	24940444	SENT16	13	13	16	16	oxygen	ROS	PA450744	6098	0.357
NULL	Org_Biomol_Chem_2014_Jul_28_12(28)_5082-5088.nxml.txt.nlp	24914735	SENT51	23	23	19	19	ethanol	mol	PA448073	90527	0.357
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2008_Jun_1_64(Pt_6)_611-619.nxml.txt.nlp	18560148	SENT204	4	4	9	9	heparin	IP-10	PA449855	3627	0.357
NULL	ScientificWorldJournal_2014_Jan_30_2014_867839.nxml.txt.nlp	24592194	SENT118	6	6	11	11	nadh	ND2	PA164755085	4536	0.357
NULL	Biosci_Rep_2012_Apr_1_32(Pt_2)_105-112.nxml.txt.nlp	22115362	SENT108	9	9	22	22	infliximab	TNFRSF1A	PA452639	7132	0.357
NULL	Arthritis_Res_Ther_2008_Jan_7_10(1)_R1.nxml.txt.nlp	18179697	SENT17	12	12	26	26	oxaliplatin	HMGB1	PA131285527	3146	0.357
NULL	Front_Endocrinol_(Lausanne)_2014_Feb_25_5_22.nxml.txt.nlp	24611062	SENT239	21	21	7	7	estradiol	PTEN	PA449503	5728	0.357
NULL	Cardiovasc_Diabetol_2010_Oct_22_9_66.nxml.txt.nlp	20969783	SENT8	12	12	15	15	oxygen	ROS	PA450744	6098	0.357
NULL	Eur_J_Med_Res_2011_Mar_28_16(3)_93-100.nxml.txt.nlp	21486721	SENT87	41	41	43	43	lopinavir	ATV	PA450264	4683	0.357
NULL	Biomed_Res_Int_2014_Jan_20_2014_948427.nxml.txt.nlp	24563867	SENT121	5	5	13	13	buspirone	STZ	PA448689	6484	0.357
NULL	Cancers_(Basel)_2014_Feb_7_6(1)_333-365.nxml.txt.nlp	24514166	SENT1291	1	1	7	7	cisplatin	HSP27	PA449014	3315	0.357
NULL	Ann_Intensive_Care_2012_Jul_2_2_22.nxml.txt.nlp	22747633	SENT253	2	2	26	26	ceftazidime	MCC	PA448861	4163	0.357
NULL	Front_Immunol_2013_Oct_31_4_351.nxml.txt.nlp	24198817	SENT400	15	15	22	22	anakinra	PAPA	PA10799	2737;5069	0.357
NULL	J_Vis_Exp_2009_Jun_9_(28)_1305.nxml.txt.nlp	19513018	SENT25	23	23	20	20	hyaluronidase	sit	PA164745713	55733	0.357
NULL	Aquat_Biosyst_2012_Oct_19_8_26.nxml.txt.nlp	23083531	SENT126	3	3	14	14	oxygen	NPP	PA450744	5443	0.357
NULL	Evid_Based_Complement_Alternat_Med_2014_Jul_1_2014_423751.nxml.txt.nlp	25101132	SENT188	35	35	16	16	kanamycin	Met	PA450137	79811	0.357
NULL	Avicenna_J_Med_Biotechnol_2013_Oct-Dec_5(4)_241-250.nxml.txt.nlp	24285999	SENT62	30	30	6	6	ethanol	SDS	PA448073	51119;10993	0.357
NULL	Int_J_Mol_Sci_2014_Oct_23_15(10)_19239-19252.nxml.txt.nlp	25342319	SENT41	9	9	16	16	heparin	SERS	PA449855	6301;54938	0.357
NULL	Biomed_Res_Int_2013_Jul_17_2013_489032.nxml.txt.nlp	23956986	SENT212	1	1	4	4	oxygen	ROS	PA450744	6098	0.356
NULL	J_Gen_Physiol_2003_Nov_122(5)_621-639.nxml.txt.nlp	14581586	SENT46	22	22	10	10	l-glutamine	F12	PA10090	2161	0.356
NULL	Amino_Acids_2011_May_22_40(5)_1369-1383.nxml.txt.nlp	21424716	SENT274	22	22	36	36	creatine	CLC	PA164778930	23529;1178	0.356
NULL	Exp_Ther_Med_2013_Mar_21_5(3)_987-991.nxml.txt.nlp	23407636	SENT146	3	3	11	11	losartan	IL-8	PA450268	3576	0.356
NULL	Curr_Med_Chem_2013_Nov_20(33)_4163-4176.nxml.txt.nlp	23992307	SENT203	7	7	10	10	nadh	tNOX	PA164755085	10495	0.356
NULL	Adv_Pharmacol_Sci_2013_Jun_24_2013_987692.nxml.txt.nlp	23864853	SENT106	15	15	7	7	acetaminophen	AST	PA448015	26503	0.356
NULL	Indian_J_Ophthalmol_2012_Mar-Apr_60(2)_162b-163.nxml.txt.nlp	22446925	SENT8	20	20	15	15	fluorescein	PED	PA164746009	8682	0.356
NULL	Arch_Med_Sci_2012_Nov_9_8(5)_907-917.nxml.txt.nlp	23185203	SENT75	0	0	6	6	metformin	GLP-1	PA450395	100125288	0.356
NULL	Oncotarget_2013_Jul_13_4(7)_958-971.nxml.txt.nlp	23948487	SENT120	6	6	13	13	cisplatin	p53	PA449014	7157	0.356
NULL	J_Antimicrob_Chemother_2009_May_5_63(5)_1034-1042.nxml.txt.nlp	19264792	SENT36	29	29	44	44	gentamicin	CLCR	PA449753	11330	0.356
NULL	Asian_J_Transfus_Sci_2014_Jul-Dec_8(2)_100-104.nxml.txt.nlp	25161348	SENT164	20	20	16	16	dextran	San	PA449261	80218	0.356
NULL	J_Neurovirol_2013_Jun_4_19(4)_351-358.nxml.txt.nlp	23733308	SENT72	21	21	19	19	mefloquine	SOC	PA450348	91544	0.356
NULL	Mol_Cancer_2007_Jan_14_6_5.nxml.txt.nlp	17222355	SENT25	23	23	33	33	doxorubicin	HMGA2	PA449412	8091	0.356
NULL	Case_Rep_Endocrinol_2013_May_8_2013_636175.nxml.txt.nlp	23738155	SENT100	0	0	18	18	everolimus	AMPK	PA164746311	5563	0.356
NULL	ScientificWorldJournal_2012_May_1_2012_495970.nxml.txt.nlp	22623901	SENT46	24	24	15	15	ethanol	mol	PA448073	90527	0.356
NULL	Oncogene_2014_Oct_23_33(43)_5109-5120.nxml.txt.nlp	24858043	SENT279	28	28	23	23	pp2	PP2		4888	0.356
NULL	Breast_Cancer_Res_2012_Apr_4_14(2)_R57.nxml.txt.nlp	22475046	SENT190	4	4	38	38	tamoxifen	TTR	PA451581	7276	0.356
NULL	Contemp_Clin_Dent_2011_Oct-Dec_2(4)_278-282.nxml.txt.nlp	22346152	SENT88	4	4	21	21	potassium	GCF	PA451047	6936	0.356
NULL	Drugs_R_D_2014_Dec_18_14(4)_233-239.nxml.txt.nlp	25231707	SENT67	9	9	35	35	creatine	COD	PA164778930	6628	0.356
NULL	Diabetes_2009_Jun_31_58(6)_1434-1439.nxml.txt.nlp	19336679	SENT186	17	17	14	14	metformin	OCT1	PA450395	5451;6580	0.356
NULL	Int_J_Mol_Sci_2012_Aug_21_13(8)_10424-10431.nxml.txt.nlp	22949871	SENT58	0	0	4	4	trypsin	MCH	PA451806	5367	0.356
NULL	Arch_Med_Sci_2010_Dec_29_6(6)_964-970.nxml.txt.nlp	22427774	SENT122	32	32	9	9	cyclosporine	IL-20	PA449167	27190;50604	0.356
NULL	Neural_Dev_2011_Apr_5_6_12.nxml.txt.nlp	21466690	SENT96	18	18	15	15	tamoxifen	P21	PA451581	1026;9338	0.356
NULL	Structure_2012_Jul_3_20-20(7)_1212-1222.nxml.txt.nlp	22658747	SENT179	12	12	14	14	papain	JBS	PA450778	3719	0.356
NULL	Breast_Cancer_Res_2012_Mar_9_14(2)_R41.nxml.txt.nlp	22405131	SENT120	0	0	6	6	estradiol	IL-17RA	PA449503	23765	0.356
NULL	Evid_Based_Complement_Alternat_Med_2012_Dec_31_2012_364604.nxml.txt.nlp	23365596	SENT30	23	23	10	10	raloxifene	PTH	PA451221	5741	0.356
NULL	Evid_Based_Complement_Alternat_Med_2014_May_28_2014_716509.nxml.txt.nlp	24987433	SENT184	14	14	0	0	ciprofloxacin	TTR	PA449009	7276	0.356
NULL	Mol_Cancer_2014_Jun_14_13_151.nxml.txt.nlp	24929818	SENT230	39	39	12	12	hydrocortisone	CO2	PA449905	4513	0.356
NULL	J_Biol_2008_Dec_15_7(10)_38.nxml.txt.nlp	19090980	SENT47	10	10	5	5	artemisinin	API	PA165111696	5345	0.356
NULL	Crit_Care_2008_Mar_13_12(Suppl_2)_P387.nxml.txt.nlp	NULL	SENT3	12	12	15	15	oxygen	ROS	PA450744	6098	0.356
NULL	Behav_Brain_Funct_2009_Jan_23_5_6.nxml.txt.nlp	19166576	SENT47	2	2	6	6	chlorpromazine	CPZ	PA448964	8532	0.356
NULL	Indian_J_Pharm_Sci_2008_Sep-Oct_70(5)_591-595.nxml.txt.nlp	21394254	SENT19	0	0	3	3	nebivolol	NEB	PA151958426	4703	0.356
NULL	Exp_Diabetes_Res_2011_Dec_27_2011_604989.nxml.txt.nlp	21253359	SENT188	0	0	21	21	clonidine	GLP-1	PA449051	100125288	0.356
NULL	Iran_J_Neurol_2012_11(4)_140-145.nxml.txt.nlp	24250883	SENT82	4	4	16	16	estradiol	CA1	PA449503	759	0.356
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_15_2012_591654.nxml.txt.nlp	23118793	SENT286	9	9	24	24	berberine	Met	PA165860812	79811	0.356
NULL	J_Gen_Physiol_2000_Jun_1_115(6)_685-696.nxml.txt.nlp	10828243	SENT114	7	7	4	4	genistein	OLF	PA165109660	83857	0.356
NULL	Mol_Cancer_2012_Aug_23_11_60.nxml.txt.nlp	22917272	SENT76	26	26	9	9	nadh	COX	PA164755085	1351	0.356
NULL	Biologics_2009_Sep_15_3_429-441.nxml.txt.nlp	19774210	SENT90	5	5	14	14	cetuximab	KRAS	PA10040	3845	0.356
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT110	1	1	30	30	curcumin	cIAP2	PA151958596	330	0.355
NULL	Exp_Diabetes_Res_2012_Dec_26_2012_230624.nxml.txt.nlp	23365557	SENT255	27	27	5	5	pioglitazone	Met	PA450970	79811	0.355
NULL	Mol_Pain_2013_Feb_28_9_7.nxml.txt.nlp	23448290	SENT261	2	2	26	26	capsaicin	TRPA1	PA448776	8989	0.355
NULL	Nat_Chem_Biol_2010_Apr_28_6(4)_291-299.nxml.txt.nlp	20190765	SENT76	11	11	24	24	dasatinib	EGFR	PA162372878	1956	0.355
NULL	Biomed_Res_Int_2014_Jun_26_2014_161346.nxml.txt.nlp	25054130	SENT216	11	11	30	30	curcumin	STZ	PA151958596	6484	0.355
NULL	Ann_Lab_Med_2014_Jan_6_34(1)_1-6.nxml.txt.nlp	24422188	SENT109	2	2	23	23	vancomycin	VISA	PA451850	57506	0.355
NULL	BMJ_2010_Feb_8_340_c693.nxml.txt.nlp	20142325	SENT220	9	9	5	5	paroxetine	CYP2D6	PA450801	1565	0.355
NULL	Ann_Med_2011_Nov_5_43(7)_531-544.nxml.txt.nlp	21815879	SENT83	12	12	15	15	clopidogrel	ABCB1	PA449053	5243	0.355
NULL	Acta_Pharmacol_Sin_2010_Feb_5_31(2)_137-144.nxml.txt.nlp	20139896	SENT26	6	6	9	9	oxygen	ROS	PA450744	6098	0.355
NULL	J_Cancer_2014_Apr_25_5(6)_398-405.nxml.txt.nlp	24847380	SENT151	37	37	28	28	doxorubicin	TDI	PA449412	100038246	0.355
NULL	J_Int_Soc_Sports_Nutr_2009_Feb_19_6_6.nxml.txt.nlp	19228401	SENT5	17	17	28	28	creatine	CEE	PA164778930	51608	0.355
NULL	J_Neurosci_Res_2010_Jun_88(8)_1829-1840.nxml.txt.nlp	20091774	SENT3	4	4	33	33	l-serine	DAO	PA451330	26;1610	0.355
NULL	Cancer_Cell_Int_2014_Apr_17_14_34.nxml.txt.nlp	24739220	SENT176	7	7	16	16	paclitaxel	ELAVL1	PA450761	1994	0.355
NULL	Adv_Urol_2012_Nov_1_2012_641689.nxml.txt.nlp	22110494	SENT247	30	30	18	18	mitoxantrone	EMP	PA450526	10296	0.355
NULL	Clin_Ophthalmol_2008_Sep_2(3)_613-621.nxml.txt.nlp	19668762	SENT136	6	6	3	3	travoprost	BAK	PA164781371	578	0.355
NULL	J_Korean_Med_Sci_2013_Apr_27_28(4)_527-533.nxml.txt.nlp	23580227	SENT35	15	15	17	17	genistein	TRAIL	PA165109660	8743	0.355
NULL	Acta_Inform_Med_2013_Dec_4_21(4)_270-273.nxml.txt.nlp	24554804	SENT45	14	14	22	22	estradiol	PAPP-A	PA449503	5069	0.355
NULL	Infect_Drug_Resist_2009_Jun_8_2_27-40.nxml.txt.nlp	21694885	SENT164	19	19	38	38	mupirocin	San	PA164764568	80218	0.355
NULL	J_Cell_Biol_2002_Mar_18_156(6)_951-957.nxml.txt.nlp	11901164	SENT40	11	11	11	11	pp2	PP2		4888	0.355
NULL	J_Physiol_2011_Mar_1_589(Pt_5)_1081-1093.nxml.txt.nlp	21224236	SENT201	35	35	25	25	diazoxide	GLP-1	PA449285	100125288	0.355
NULL	Mol_Cancer_2012_Sep_25_11_73.nxml.txt.nlp	23009336	SENT118	30	30	15	15	gefitinib	EGFR	PA131301952	1956	0.355
NULL	J_Korean_Med_Sci_2010_Aug_21_25(8)_1222-1227.nxml.txt.nlp	20676337	SENT54	26	26	13	13	propofol	ANOVA	PA451141	4858	0.355
NULL	Crit_Care_2007_Sep_26_11(Suppl_4)_P19.nxml.txt.nlp	NULL	SENT2	0	0	8	8	vasopressin	AVP	PA451858	114548;551	0.355
NULL	Korean_J_Anesthesiol_2013_Jun_24_64(6)_494-499.nxml.txt.nlp	23814648	SENT152	10	10	12	12	mepivacaine	G30	PA164748741	282706	0.355
NULL	Core_Evid_2011_Feb_8_6_23-29.nxml.txt.nlp	21468240	SENT17	12	12	5	5	plerixafor	CXCR4	PA165958410	7852	0.355
NULL	Clin_Oral_Investig_2012_Aug_20_16(4)_1237-1242.nxml.txt.nlp	22012468	SENT124	10	10	5	5	tolbutamide	DM2	PA451718	28508	0.355
NULL	J_Young_Pharm_2010_Jul-Sep_2(3)_311-314.nxml.txt.nlp	21042492	SENT42	17	17	5	5	heparin	PRG	PA449855	5544	0.355
NULL	Biomed_Res_Int_2013_Mar_17_2013_315980.nxml.txt.nlp	23586031	SENT25	32	32	36	36	warfarin	CYP2C9	PA451906	1559	0.355
NULL	Diabetes_Care_2011_Jun_20_34(6)_1406-1411.nxml.txt.nlp	21515837	SENT163	25	25	27	27	glucose	LVM	PA449773	23209	0.355
NULL	J_Headache_Pain_2002_Apr_3(1)_1-5.nxml.txt.nlp	NULL	SENT11	11	11	15	15	capsaicin	CGRP	PA448776	6283	0.355
NULL	Mol_Brain_2013_Jan_2_6_1.nxml.txt.nlp	23281934	SENT261	4	4	7	7	oxygen	ROS	PA450744	6098	0.355
NULL	Case_Rep_Oncol_2013_Aug_14_6(2)_430-433.nxml.txt.nlp	24019783	SENT32	18	18	19	19	erlotinib	Met	PA134687924	79811	0.355
NULL	Crit_Care_2012_Jul_26_16(4)_R137.nxml.txt.nlp	22835277	SENT269	24	24	27	27	oxygen	ROS	PA450744	6098	0.355
NULL	Brain_Sci_2013_Mar_20_3(1)_360-395.nxml.txt.nlp	24961318	SENT321	1	1	6	6	taurine	TUG1	PA451590	55000	0.355
NULL	Int_J_Endocrinol_2014_Apr_30_2014_674987.nxml.txt.nlp	24883061	SENT39	17	17	22	22	fructose	SDH	PA449716	1757;10993	0.355
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_75-89.nxml.txt.nlp	17912638	SENT56	17	17	24	24	tamoxifen	ATAC	PA451581	6375	0.355
NULL	Front_Endocrinol_(Lausanne)_2014_Oct_24_5_177.nxml.txt.nlp	25386165	SENT543	0	0	5	5	estradiol	RFRP	PA449503	64111	0.355
NULL	Breast_Cancer_Res_Treat_2012_Jul_28_134(1)_267-276.nxml.txt.nlp	22453754	SENT199	10	10	17	17	tamoxifen	ATAC	PA451581	6375	0.355
NULL	Infect_Ecol_Epidemiol_2013_Aug_30_3_10_3402_iee_v3i0_19839.nxml.txt.nlp	24003364	SENT95	12	12	23	23	heparin	DC-SIGN	PA449855	30835	0.355
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_May_14_65(Pt_6)_o1257.nxml.txt.nlp	21583122	SENT58	15	15	21	21	ethanol	mol	PA448073	90527	0.354
NULL	Asian-Australas_J_Anim_Sci_2013_Feb_26(2)_266-274.nxml.txt.nlp	25049786	SENT231	3	3	0	0	ginseng	FA1	PA164781150	8788	0.354
NULL	Brain_Sci_2013_Jun_19_3(2)_964-991.nxml.txt.nlp	24961433	SENT1292	2	2	18	18	choline	POMC	PA448976	5443	0.354
NULL	Oncotarget_2013_Dec_18_5(2)_375-385.nxml.txt.nlp	24495868	SENT263	8	8	4	4	fludarabine	p53	PA449655	7157	0.354
NULL	J_Biol_Chem_2012_Apr_13_287(16)_12952-12965.nxml.txt.nlp	22371491	SENT63	16	16	12	12	vasopressin	MCP-1	PA451858	6347	0.354
NULL	Cardiovasc_Diabetol_2011_Dec_22_10_115.nxml.txt.nlp	22189184	SENT120	3	3	24	24	sitagliptin	GLP-1	PA164748978	100125288	0.354
NULL	ScientificWorldJournal_2014_Jul_21_2014_610635.nxml.txt.nlp	25140337	SENT233	27	27	17	17	ceftriaxone	CPZ	PA448866	8532	0.354
NULL	Int_J_Cell_Biol_2010_Jan_17_2010_529376.nxml.txt.nlp	21274427	SENT47	42	42	17	17	l-glutamine	CO2	PA10090	4513	0.354
NULL	Lipids_Health_Dis_2011_Feb_28_10_38.nxml.txt.nlp	21352602	SENT111	9	9	15	15	ezetimibe	PCSK9	PA10816	255738	0.354
NULL	Sensors_(Basel)_2008_Nov_1_8(11)_6791-6809.nxml.txt.nlp	NULL	SENT217	8	8	3	3	sertraline	CYP2D6	PA451333	1565	0.354
NULL	Front_Neurosci_2011_Apr_4_5_47.nxml.txt.nlp	21519376	SENT158	40	40	16	16	creatine	CTX	PA164778930	1593	0.354
NULL	J_Biomed_Biotechnol_2011_Dec_6_2011_974701.nxml.txt.nlp	21188174	SENT161	31	31	19	19	taurine	MS2	PA451590	101	0.354
NULL	Diabetes_Obes_Metab_2010_May_12(5)_437-441.nxml.txt.nlp	20415692	SENT8	27	27	20	20	metformin	GLA	PA450395	9027;2717	0.354
NULL	Nucleic_Acids_Res_2014_Jan_26_42(2)_e14.nxml.txt.nlp	24165879	SENT51	14	14	4	4	paraformaldehyde	E14	PA450790	4863	0.354
NULL	Front_Mol_Neurosci_2014_Dec_1_7_94.nxml.txt.nlp	25520615	SENT98	0	0	3	3	ketamine	REST	PA450144	5978	0.354
NULL	HSR_Proc_Intensive_Care_Cardiovasc_Anesth_2009_1(4)_34-43.nxml.txt.nlp	23439516	SENT41	6	6	28	28	sevoflurane	CEA	PA451341	5670;1087	0.354
NULL	Mol_Cancer_2013_Sep_3_12_100.nxml.txt.nlp	24004603	SENT248	8	8	15	15	camptothecin	TPT	PA153590860	23590;6469	0.354
NULL	Evid_Based_Complement_Alternat_Med_2012_Sep_27_2012_251362.nxml.txt.nlp	23056140	SENT49	33	33	17	17	gentamicin	CO2	PA449753	4513	0.354
NULL	J_Cell_Mol_Med_2014_Aug_1_18(8)_1599-1611.nxml.txt.nlp	24889822	SENT9	5	5	26	26	resveratrol	SIRT1		23411	0.354
NULL	Oncotarget_2014_Sep_10_5(20)_9877-9888.nxml.txt.nlp	25245676	SENT101	4	4	9	9	cetuximab	EGFR	PA10040	1956	0.354
NULL	Genome_Biol_2007_Sep_26_8(9)_227.nxml.txt.nlp	17903313	SENT31	2	2	6	6	protamine	PRM1	PA10366	5619	0.354
NULL	ISRN_AIDS_2012_Jul_12_2012_485307.nxml.txt.nlp	24052874	SENT100	4	4	10	10	tenofovir	PTH	PA10204	5741	0.354
NULL	Neural_Regen_Res_2014_Mar_15_9(6)_661-672.nxml.txt.nlp	25206870	SENT234	35	35	27	27	choline	B12	PA448976	7126;4709	0.354
NULL	Breast_Cancer_Res_2010_Jul_13_12(4)_R48.nxml.txt.nlp	20626886	SENT224	17	17	5	5	doxorubicin	B7-H1	PA449412	29126	0.354
NULL	J_Physiol_2011_Aug_1_589(Pt_15)_3691-3702.nxml.txt.nlp	21669978	SENT80	26	26	29	29	choline	CHAT	PA448976	1103	0.354
NULL	Breast_Cancer_Res_2008_Dec_18_10(Suppl_4)_S26.nxml.txt.nlp	19128440	SENT61	4	4	0	0	tamoxifen	ATAC	PA451581	6375	0.354
NULL	Chem_Cent_J_2013_Sep_16_7_156.nxml.txt.nlp	24041151	SENT114	8	8	11	11	oxygen	LPP	PA450744	4026	0.353
NULL	J_Int_Soc_Sports_Nutr_2012_Nov_19_9(Suppl_1)_P21.nxml.txt.nlp	NULL	SENT9	13	13	27	27	echinacea	EPO	PA131550706	7076;8288;2056	0.353
NULL	Mol_Brain_2014_Mar_19_7_19.nxml.txt.nlp	24642214	SENT129	9	9	11	11	paraformaldehyde	P21	PA450790	1026;9338	0.353
NULL	Eur_J_Endocrinol_2011_Jan_164(1)_69-74.nxml.txt.nlp	20961967	SENT15	7	7	4	4	pioglitazone	OPG	PA450970	690	0.353
NULL	Int_J_Mol_Sci_2012_Apr_19_13(4)_4982-4992.nxml.txt.nlp	22606024	SENT350	23	23	6	6	cefaclor	NO3	PA164749137	4681	0.353
NULL	Int_J_Mol_Sci_2014_Mar_20_15(3)_4946-4964.nxml.txt.nlp	24658439	SENT123	39	39	29	29	capsaicin	GBF	PA448776	1316	0.353
NULL	Mol_Neurobiol_2007_Oct_10_36(2)_137-151.nxml.txt.nlp	17952658	SENT388	44	44	33	33	vasopressin	CXCL12	PA451858	6387	0.353
NULL	Cell_Death_Dis_2014_Feb_13_5(2)_e1059.nxml.txt.nlp	24525735	SENT138	8	8	16	16	paraformaldehyde	CD31	PA450790	5175	0.353
NULL	Evol_Appl_2012_Nov_5(7)_664-676.nxml.txt.nlp	23144654	SENT45	4	4	9	9	nadh	ND4	PA164755085	4538	0.353
NULL	Cancer_Growth_Metastasis_2014_Jun_19_7_27-32.nxml.txt.nlp	25002816	SENT122	18	18	8	8	ethanol	LLC1	PA448073	128602	0.353
NULL	Chemother_Res_Pract_2011_Dec_18_2011_965826.nxml.txt.nlp	22295208	SENT296	16	16	4	4	azacitidine	DAC	PA451996	13	0.353
NULL	Cardiovasc_Diabetol_2007_Feb_20_6_7.nxml.txt.nlp	17311679	SENT0	29	29	32	32	glucose	slim	PA449773	23008	0.353
NULL	Calcif_Tissue_Int_2011_Aug_3_89(2)_91-104.nxml.txt.nlp	21637997	SENT51	7	7	31	31	risedronate	HIP	PA451255	6767;6159;64399;5068	0.353
NULL	Breast_Cancer_Res_Treat_2014_Sep_25_148(1)_81-90.nxml.txt.nlp	25253174	SENT186	21	21	16	16	metformin	adiponectin	PA450395	9370	0.353
NULL	Mol_Neurodegener_2011_Aug_8_6_57.nxml.txt.nlp	21819629	SENT236	8	8	0	0	arsenite	JNK	PA452638	5599	0.353
NULL	Acta_Pharmacol_Sin_2009_Dec_4_30(12)_1601-1606.nxml.txt.nlp	19960006	SENT36	13	13	28	28	mannitol	DPI	PA450320	1832	0.353
NULL	Int_J_Mol_Sci_2014_Nov_24_15(11)_21587-21602.nxml.txt.nlp	25421248	SENT174	19	19	7	7	ethanol	mol	PA448073	90527	0.353
NULL	Behav_Brain_Funct_2012_May_16_8_22.nxml.txt.nlp	22591463	SENT152	8	8	35	35	methylphenidate	COMT	PA450464	1312	0.353
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_May_3_64(Pt_6)_m768.nxml.txt.nlp	21202460	SENT3	31	31	26	26	nitrile	NO3	PA450636	4681	0.353
NULL	Cancer_Cell_Int_2004_Aug_17_4_5.nxml.txt.nlp	15315711	SENT102	16	16	47	47	genistein	PC3	PA165109660	57332;7832;5122	0.353
NULL	Breast_Cancer_Res_Treat_2012_Apr_3_132(3)_895-915.nxml.txt.nlp	22048814	SENT354	22	22	29	29	tamoxifen	IMPACT	PA451581	55364	0.353
NULL	Curr_Dermatol_Rep_2014_Nov_28_3(1)_13-22.nxml.txt.nlp	24587975	SENT156	32	32	17	17	calcipotriol	IL-2	PA448714	3558	0.353
NULL	J_Oncol_2010_Dec_24_2010_497429.nxml.txt.nlp	20066162	SENT178	2	2	4	4	carboplatin	GEM	PA448803	2669	0.353
NULL	Eur_Radiol_2014_Aug_6_24(12)_3277-3288.nxml.txt.nlp	25097126	SENT51	7	7	16	16	abciximab	AIDA	PA448006	64853	0.353
NULL	Mol_Cancer_2006_Sep_5_5_34.nxml.txt.nlp	16953886	SENT62	15	15	13	13	doxorubicin	TRAIL	PA449412	8743	0.353
NULL	Cardiol_Ther_2013_Jun_27_2(1)_1-16.nxml.txt.nlp	25135285	SENT135	26	26	34	34	pioglitazone	GLP-1	PA450970	100125288	0.353
NULL	Adv_Hematol_2010_Dec_30_2010_624040.nxml.txt.nlp	21234357	SENT106	7	7	14	14	doxorubicin	CHOP	PA449412	1649	0.353
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT192	35	35	37	37	cetuximab	Yes	PA10040	7525	0.353
NULL	Ann_Oncol_2011_Aug_27_22(8)_1736-1747.nxml.txt.nlp	21709140	SENT316	34	34	10	10	paclitaxel	EGF	PA450761	1950	0.353
NULL	Aquat_Biosyst_2012_Oct_19_8_26.nxml.txt.nlp	23083531	SENT203	28	28	36	36	nitrogen	NPP	PA450643	5443	0.352
NULL	ScientificWorldJournal_2013_Dec_24_2013_958724.nxml.txt.nlp	24453930	SENT4	19	19	8	8	bevacizumab	ERM	PA130232992	2119	0.352
NULL	Biomed_Res_Int_2014_Jan_21_2014_296063.nxml.txt.nlp	24579078	SENT9	13	13	16	16	phenol	TPC	PA450913	8030;60386	0.352
NULL	Indian_J_Med_Res_2012_Jul_136(1)_46-53.nxml.txt.nlp	22885263	SENT46	24	24	32	32	urea	ACR	PA451831	49	0.352
NULL	Antimicrob_Agents_Chemother_2014_Dec_58(12)_7164-7170.nxml.txt.nlp	25224007	SENT26	21	21	9	9	isoniazid	NAT2	PA450112	10;81539	0.352
NULL	Front_Neuroanat_2011_Jul_12_5_38.nxml.txt.nlp	21808606	SENT114	3	3	9	9	haloperidol	DARPP-32	PA449841	84152	0.352
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_16_2012_395912.nxml.txt.nlp	23118789	SENT75	9	9	11	11	diclofenac	UGT1A1	PA449293	54658	0.352
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2009_Jun_1_65(Pt_6)_513-522.nxml.txt.nlp	19465765	SENT57	0	0	9	9	chloramphenicol	CLB	PA448927	171425	0.352
NULL	Indian_J_Occup_Environ_Med_2008_Dec_12(3)_103-106.nxml.txt.nlp	20040966	SENT40	16	16	8	8	nitrogen	GFR	PA450643	9771	0.352
NULL	Environ_Health_Perspect_2004_Nov_112(15)_A896b-A897.nxml.txt.nlp	NULL	SENT19	31	31	26	26	estradiol	DES	PA449503	1674	0.352
NULL	Indian_J_Dermatol_2013_May-Jun_58(3)_197-199.nxml.txt.nlp	23723470	SENT36	12	12	21	21	ofloxacin	ROM	PA450684	6094	0.352
NULL	Nucleic_Acids_Res_2005_Jun_9_33(10)_3323-3330.nxml.txt.nlp	15947132	SENT113	11	11	8	8	cisplatin	MSH2	PA449014	4436	0.352
NULL	Pharmaceuticals_(Basel)_2014_Jan_27_7(2)_169-191.nxml.txt.nlp	24473270	SENT978	21	21	19	19	gemcitabine	ABCC5	PA449748	10057	0.352
NULL	BMJ_2014_Nov_5_349_g6427.nxml.txt.nlp	25378023	SENT138	30	30	33	33	everolimus	DES	PA164746311	1674	0.352
NULL	Clin_Ophthalmol_2007_Sep_1(3)_273-284.nxml.txt.nlp	19668481	SENT178	17	17	8	8	bevacizumab	CRT	PA130232992	811	0.352
NULL	Adipocyte_2013_Jan_1_2(1)_28-32.nxml.txt.nlp	23700549	SENT24	2	2	35	35	valsartan	JNK	PA451848	5599	0.352
NULL	Front_Neurol_2013_May_15_4_53.nxml.txt.nlp	23720649	SENT339	34	34	22	22	nadh	SOD1	PA164755085	6647	0.352
NULL	J_Physiol_2013_Feb_15_591(4)_1063-1080.nxml.txt.nlp	23207594	SENT253	7	7	10	10	forskolin	PER2	PA146096022	8864	0.352
NULL	Biomed_Opt_Express_2014_Jul_14_5(8)_2614-2619.nxml.txt.nlp	25136489	SENT4	10	10	26	26	fluorescein	LTA	PA164746009	4049	0.352
NULL	Paediatr_Drugs_2014_Feb_27_16(3)_199-211.nxml.txt.nlp	24574047	SENT139	15	15	17	17	doxylamine	PLP	PA449419	25824;5744	0.352
NULL	Int_J_Biol_Sci_2011_Nov_5_8(1)_1-14.nxml.txt.nlp	22211100	SENT255	2	2	4	4	evodiamine	Gem	PA165860788	51053	0.352
NULL	Arthritis_Rheum_2009_Jun_60(6)_1807-1814.nxml.txt.nlp	19479859	SENT46	8	8	27	27	creatine	CMAS	PA164778930	55907	0.352
NULL	J_Headache_Pain_2013_Feb_21_14(Suppl_1)_P75.nxml.txt.nlp	NULL	SENT10	42	42	20	20	sumatriptan	5-HT1B	PA451566	3351	0.352
NULL	J_Immunol_Res_2014_Aug_18_2014_937987.nxml.txt.nlp	25202711	SENT168	2	2	20	20	hydroquinone	PF4	PA449924	5196	0.352
NULL	Patient_Prefer_Adherence_2008_Feb_2_2_167-175.nxml.txt.nlp	19920959	SENT6	10	10	15	15	clopidogrel	DES	PA449053	1674	0.352
NULL	Arthritis_Res_Ther_2003_Apr_15_5(4)_157-159.nxml.txt.nlp	12823844	SENT23	5	5	11	11	rituximab	San	PA451261	80218	0.352
NULL	Front_Neurol_2013_May_1_4_10.nxml.txt.nlp	23641231	SENT178	34	34	23	23	natalizumab	IFN	PA164747191	3439	0.352
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT203	7	7	4	4	sulindac	survivin	PA451565	332	0.352
NULL	Gut_Liver_2013_Sep_11_7(5)_560-568.nxml.txt.nlp	24073314	SENT161	13	13	10	10	lansoprazole	ATP4A	PA450180	495	0.352
NULL	Nucleic_Acids_Res_2012_Jun_22_40(11)_4861-4878.nxml.txt.nlp	22362753	SENT391	16	16	12	12	guanidine	NPM3	PA164781028	10360	0.352
NULL	Int_J_Biol_Sci_2011_Nov_5_8(1)_1-14.nxml.txt.nlp	22211100	SENT222	16	16	14	14	gemcitabine	Gem	PA449748	51053	0.352
NULL	Eur_J_Clin_Pharmacol_2011_Apr_26_67(4)_371-381.nxml.txt.nlp	21110013	SENT59	39	39	34	34	nitrogen	ESI	PA450643	5266	0.352
NULL	J_Cell_Biol_2003_Dec_22_163(6)_1385-1395.nxml.txt.nlp	14676308	SENT264	30	30	28	28	thrombin	RhoA	PA451674	387	0.352
NULL	Oncogene_2013_Nov_28_32(48)_5458-5470.nxml.txt.nlp	23435420	SENT278	19	19	13	13	bleomycin	53BP1	PA448645	7158	0.352
NULL	Viruses_2013_Mar_22_5(3)_998-1022.nxml.txt.nlp	23524390	SENT253	29	29	32	32	oxygen	ROS	PA450744	6098	0.352
NULL	Exp_Diabetes_Res_2012_Oct_19_2012_628978.nxml.txt.nlp	22028701	SENT269	3	3	26	26	oxygen	AMPK	PA450744	5563	0.352
NULL	J_Ayurveda_Integr_Med_2013_Apr-Jun_4(2)_99-106.nxml.txt.nlp	23930042	SENT135	17	17	31	31	glipizide	PPG	PA449762	5552	0.352
NULL	Ann_Rehabil_Med_2012_Aug_27_36(4)_466-473.nxml.txt.nlp	22977771	SENT15	23	23	8	8	bupivacaine	ILEI	PA135057240	10447	0.352
NULL	Environ_Health_Perspect_2009_Nov_29_117(11)_1682-1689.nxml.txt.nlp	20049117	SENT113	0	0	19	19	creatine	A1AT	PA164778930	5265	0.352
NULL	J_Inherit_Metab_Dis_2011_Apr_3_34(2)_367-376.nxml.txt.nlp	21290187	SENT28	16	16	10	10	galactose	GALT	PA449725	2592	0.352
NULL	J_Orthop_Traumatol_2013_Jun_1_14(2)_109-114.nxml.txt.nlp	23456483	SENT32	13	13	8	8	hyaluronan	ACP	PA165958431	4706	0.352
NULL	Arthritis_Rheum_2013_Sep_26_65(9)_2290-2300.nxml.txt.nlp	23740547	SENT180	17	17	9	9	doxycycline	IL-23	PA449415	51561	0.352
NULL	Oncoimmunology_2013_Nov_1_2(11)_e27010.nxml.txt.nlp	24498547	SENT27	14	14	11	11	tegafur	GEM	PA452620	2669	0.352
NULL	Oncotarget_2014_Aug_16_5(17)_7342-7356.nxml.txt.nlp	25277177	SENT377	31	31	13	13	l-glutamine	CO2	PA10090	4513	0.352
NULL	Br_J_Cancer_2011_Apr_12_104(8)_1319-1324.nxml.txt.nlp	21427725	SENT25	13	13	17	17	nadh	ND2	PA164755085	4536	0.352
NULL	Braz_J_Microbiol_2010_Jun_1_Apr-Jun_41(2)_286-294.nxml.txt.nlp	24031493	SENT99	14	14	16	16	galactose	MAL	PA449725	57591;4118	0.352
NULL	Korean_J_Urol_2010_Jul_20_51(7)_477-482.nxml.txt.nlp	20664781	SENT149	29	29	19	19	sugar	DBP	PA451529	3295;1628;2638	0.351
NULL	South_Asian_J_Cancer_2014_Jan-Mar_3(1)_71-73.nxml.txt.nlp	24665452	SENT54	0	0	11	11	tamoxifen	BRCA1	PA451581	672	0.351
NULL	Vet_Res_2013_Sep_26_44(1)_83.nxml.txt.nlp	24070317	SENT40	43	43	24	24	gentamicin	F12	PA449753	2161	0.351
NULL	BMJ_2013_Nov_8_347_f6625.nxml.txt.nlp	24212107	SENT128	19	19	23	23	everolimus	NNT	PA164746311	23530	0.351
NULL	Indian_Pacing_Electrophysiol_J_2014_May_25_14(3)_133-149.nxml.txt.nlp	24948852	SENT204	10	10	18	18	potassium	SCN5A	PA451047	6331	0.351
NULL	Part_Fibre_Toxicol_2011_Aug_2_8_23.nxml.txt.nlp	21810225	SENT7	6	6	9	9	oxygen	ROS	PA450744	6098	0.351
NULL	J_Exp_Clin_Cancer_Res_2009_Jan_7_28(1)_3.nxml.txt.nlp	19128503	SENT34	0	0	14	14	sirolimus	FKBP-12	PA451365	2280	0.351
NULL	Exp_Ther_Med_2013_Nov_6_6(5)_1089-1095.nxml.txt.nlp	24223627	SENT46	7	7	5	5	epirubicin	NAC	PA449476	22861	0.351
NULL	Chemother_Res_Pract_2011_Apr_18_2011_619321.nxml.txt.nlp	22312555	SENT157	2	2	4	4	daptomycin	VAN	PA164768820	10318	0.351
NULL	Cardiovasc_Diabetol_2005_Jun_3_4_7.nxml.txt.nlp	15935095	SENT102	4	4	15	15	rosuvastatin	ATV	PA134308647	4683	0.351
NULL	Oncotarget_2014_Aug_29_5(18)_8052-8082.nxml.txt.nlp	25211298	SENT409	2	2	5	5	etoposide	MRP-1	PA449552	928	0.351
NULL	Behav_Brain_Funct_2010_Aug_30_6_50.nxml.txt.nlp	20799992	SENT163	30	30	9	9	methamphetamine	AGT	PA450403	183;189	0.351
NULL	Front_Cell_Neurosci_2013_Apr_10_7_38.nxml.txt.nlp	23596393	SENT328	4	4	7	7	oxygen	ROS	PA450744	6098	0.351
NULL	Exp_Diabetes_Res_2012_Mar_1_2012_895185.nxml.txt.nlp	22474429	SENT93	23	23	26	26	oxygen	ROS	PA450744	6098	0.351
NULL	ScientificWorldJournal_2013_Oct_24_2013_726912.nxml.txt.nlp	24282387	SENT26	1	1	7	7	fluorescein	AVP	PA164746009	114548;551	0.351
NULL	Front_Genet_2014_Jun_2_5_162.nxml.txt.nlp	24917882	SENT997	13	13	15	15	irinotecan	KRAS	PA450085	3845	0.351
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT87	0	0	5	5	resveratrol	TRAIL		8743	0.351
NULL	Clin_Dev_Immunol_2013_Sep_24_2013_814973.nxml.txt.nlp	24174972	SENT176	5	5	13	13	cyclophosphamide	CHOP	PA449165	1649	0.351
NULL	Ann_Neurosci_2010_Jul_17(3)_113-119.nxml.txt.nlp	25205886	SENT27	2	2	19	19	resveratrol	DTNB		1838	0.351
NULL	Arthritis_Res_Ther_2006_Nov_8_8(6)_R167.nxml.txt.nlp	17092341	SENT98	34	34	11	11	rituximab	BAFF	PA451261	10673	0.351
NULL	Indian_J_Pharmacol_2013_Jan-Feb_45(1)_44-48.nxml.txt.nlp	23543849	SENT84	20	20	30	30	ethanol	LPO	PA448073	4025	0.351
NULL	Mol_Biol_Cell_2014_Jul_1_25(13)_1995-2005.nxml.txt.nlp	24807907	SENT10	19	19	7	7	guanidine	CGNL1	PA164781028	84952	0.351
NULL	Front_Mol_Neurosci_2013_Aug_5_6_19.nxml.txt.nlp	23935565	SENT335	3	3	13	13	memantine	GDNF	PA10364	2668	0.351
NULL	J_Int_Soc_Sports_Nutr_2006_Jun_23_3(1)_60-66.nxml.txt.nlp	18500965	SENT32	26	26	14	14	creatine	ADP	PA164778930	23038	0.351
NULL	Arq_Bras_Cardiol_2013_Nov_101(5)_466-471.nxml.txt.nlp	24100694	SENT55	42	42	10	10	warfarin	ABP	PA451906	6462	0.351
NULL	J_Cardiothorac_Surg_2013_May_13_8_127.nxml.txt.nlp	23668669	SENT108	27	27	14	14	oxycodone	CPP	PA450741	340451	0.351
NULL	Biogerontology_2009_Aug_22_10(4)_503-516.nxml.txt.nlp	18720024	SENT426	29	29	12	12	kanamycin	Gen	PA450137	348654	0.351
NULL	Br_J_Cancer_2010_Oct_12_103(8)_1201-1208.nxml.txt.nlp	20877360	SENT14	27	27	39	39	trypsin	AHSG	PA451806	197	0.351
NULL	Extremophiles_2009_Sep_5_13(5)_769-783.nxml.txt.nlp	19579003	SENT322	31	31	21	21	lipase	PIR	PA450239	8544	0.35
NULL	Indian_J_Pharm_Sci_2008_Sep-Oct_70(5)_591-595.nxml.txt.nlp	21394254	SENT126	4	4	7	7	nebivolol	NEB	PA151958426	4703	0.35
NULL	Diabetes_2011_Nov_17_60(11)_2701-2709.nxml.txt.nlp	21885869	SENT208	8	8	18	18	yohimbine	PPG	PA451946	5552	0.35
NULL	Cell_Death_Dis_2014_Feb_27_5(2)_e1088.nxml.txt.nlp	24577086	SENT125	16	16	11	11	metformin	Bcl-2	PA450395	596	0.35
NULL	Br_J_Pharmacol_2014_Oct_26_171(20)_4785-4796.nxml.txt.nlp	25074741	SENT192	0	0	5	5	guanfacine	NK1R	PA449825	6869	0.35
NULL	Int_J_Nephrol_2010_Dec_15_2011_194910.nxml.txt.nlp	21197109	SENT174	19	19	11	11	nesiritide	VMAC	PA164781045	400673	0.35
NULL	Mol_Cancer_2010_Nov_2_9_289.nxml.txt.nlp	21044322	SENT179	7	7	5	5	vincristine	RGS17	PA451879	26575	0.35
NULL	Arch_Med_Sci_2011_Dec_31_7(6)_1067-1075.nxml.txt.nlp	22328892	SENT61	37	37	28	28	clopidogrel	DES	PA449053	1674	0.35
NULL	Br_J_Cancer_2009_Mar_24_100(6)_1017.nxml.txt.nlp	19293816	SENT8	32	32	36	36	sn-38	CES2		8824;1066	0.35
NULL	Curr_Cardiol_Rev_2011_Nov_7(4)_245-249.nxml.txt.nlp	22758625	SENT60	25	25	31	31	doxorubicin	CHOP	PA449412	1649	0.35
NULL	Avicenna_J_Med_Biotechnol_2013_Oct-Dec_5(4)_241-250.nxml.txt.nlp	24285999	SENT62	0	0	6	6	betaine	SDS	PA448603	51119;10993	0.35
NULL	Iran_J_Pharm_Res_2014_Summer_13(3)_893-898.nxml.txt.nlp	25276189	SENT26	12	12	5	5	ethanol	DTNB	PA448073	1838	0.35
NULL	Breast_Cancer_Res_2008_Dec_18_10(Suppl_4)_S24.nxml.txt.nlp	19128438	SENT64	16	16	12	12	anastrozole	IMPACT	PA448432	55364	0.35
NULL	Oncogene_2010_Sep_2_29(35)_4905-4913.nxml.txt.nlp	20581869	SENT253	6	6	20	20	carboplatin	CA125	PA448803	4077;94025	0.35
NULL	Biomed_Res_Int_2014_Jun_26_2014_161346.nxml.txt.nlp	25054130	SENT228	11	11	30	30	curcumin	STZ	PA151958596	6484	0.35
NULL	Br_J_Cancer_2003_Mar_10_88(5)_788-795.nxml.txt.nlp	12618891	SENT170	34	34	36	36	bosentan	FasL	PA10034	356	0.35
NULL	Br_J_Cancer_2010_Mar_2_102(5)_815-826.nxml.txt.nlp	20145614	SENT263	5	5	23	23	fluorescein	IGFBP7	PA164746009	3490	0.35
NULL	Biomed_Res_Int_2014_Jun_26_2014_161346.nxml.txt.nlp	25054130	SENT225	11	11	30	30	curcumin	STZ	PA151958596	6484	0.35
NULL	Front_Mol_Neurosci_2012_Nov_12_5_99.nxml.txt.nlp	23162427	SENT259	26	26	17	17	cocaine	HDAC5	PA449072	10014	0.35
NULL	Clin_Ophthalmol_2012_Sep_5_6_1433-1440.nxml.txt.nlp	23055659	SENT153	27	27	29	29	timolol	BAK	PA451690	578	0.35
NULL	Indian_J_Pharmacol_2008_Oct_40(Suppl_2)_S66-S91.nxml.txt.nlp	21593982	SENT684	8	8	5	5	dextran	flower	PA449261	11094	0.35
NULL	Amino_Acids_2011_May_22_40(5)_1369-1383.nxml.txt.nlp	21424716	SENT183	4	4	25	25	creatine	CEE	PA164778930	51608	0.35
NULL	Front_Genet_2014_Jan_24_5_3.nxml.txt.nlp	24478792	SENT570	11	11	2	2	flecainide	MiRP1	PA449646	9992	0.35
NULL	Croat_Med_J_2013_Apr_54(2)_171-179.nxml.txt.nlp	23630144	SENT7	18	18	23	23	taurine	STZ	PA451590	6484	0.35
NULL	Front_Hum_Neurosci_2013_Jul_31_7_392.nxml.txt.nlp	23914164	SENT89	28	28	9	9	copper	GES	PA449114	28954	0.35
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_15_2012_591654.nxml.txt.nlp	23118793	SENT290	17	17	24	24	glipizide	Met	PA449762	79811	0.35
NULL	Mol_Neurodegener_2011_Aug_8_6_57.nxml.txt.nlp	21819629	SENT236	8	8	3	3	arsenite	TDP-43	PA452638	23435	0.35
NULL	Avicenna_J_Phytomed_2014_Jul-Aug_4(4)_231-238.nxml.txt.nlp	25068137	SENT91	23	23	13	13	ethanol	flower	PA448073	11094	0.35
NULL	Indian_J_Med_Paediatr_Oncol_2014_Jan-Mar_35(1)_118-119.nxml.txt.nlp	25006302	SENT29	0	0	8	8	cyclophosphamide	CHOP	PA449165	1649	0.35
NULL	Arch_Osteoporos_2013_Sep_13_8(1-2)_144.nxml.txt.nlp	24030479	SENT1004	32	32	30	30	teriparatide	PTH	PA451620	5741	0.35
NULL	Oxid_Med_Cell_Longev_2012_Jul_22_2012_785743.nxml.txt.nlp	22919441	SENT252	11	11	26	26	fluorescein	GAPDH	PA164746009	2597	0.35
NULL	F1000_Med_Rep_2010_Apr_27_2_29.nxml.txt.nlp	20948857	SENT44	10	10	30	30	paclitaxel	HER-2	PA450761	2064	0.35
NULL	Int_J_Appl_Basic_Med_Res_2013_Jan-Jun_3(1)_3-10.nxml.txt.nlp	23776832	SENT39	23	23	29	29	vancomycin	VISA	PA451850	57506	0.35
NULL	Infect_Drug_Resist_2010_Aug_9_3_87-94.nxml.txt.nlp	21694897	SENT79	11	11	3	3	artemisinin	ACT	PA165111696	12;11332;9457;641455	0.35
NULL	Int_J_Mol_Sci_2007_Jan_30_8(1)_42-50.nxml.txt.nlp	NULL	SENT124	4	4	22	22	camptothecin	SERS	PA153590860	6301;54938	0.35
NULL	Clin_Med_Insights_Circ_Respir_Pulm_Med_2013_Nov_13_7_61-77.nxml.txt.nlp	24324354	SENT7	0	0	13	13	tobramycin	DPI	PA451704	1832	0.35
NULL	F1000Res_2014_Aug_19_3_198.nxml.txt.nlp	25400908	SENT533	30	30	11	11	cyclophosphamide	S17	PA449165	6218	0.35
NULL	Indian_J_Pharmacol_2009_Dec_41(6)_252-254.nxml.txt.nlp	20407554	SENT55	0	0	10	10	irbesartan	STZ	PA450084	6484	0.35
NULL	Eur_J_Dent_2011_Jan_5(1)_77-83.nxml.txt.nlp	21228958	SENT158	9	9	5	5	chlorhexidine	HEMA	PA164776863	2157	0.35
NULL	Clin_Ophthalmol_2010_May_14_4_437-445.nxml.txt.nlp	20505836	SENT12	22	22	19	19	travoprost	BAK	PA164781371	578	0.35
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT44	28	28	7	7	pertuzumab	HER-2		2064	0.35
NULL	Int_J_Mol_Sci_2014_May_7_15(5)_8004-8023.nxml.txt.nlp	24810691	SENT496	9	9	13	13	betaine	BHMT	PA448603	635	0.35
NULL	J_Exp_Clin_Cancer_Res_2009_Feb_16_28(1)_21.nxml.txt.nlp	19216806	SENT4	13	13	25	25	hyaluronan	VEGFR	PA165958431	3791	0.349
NULL	Cardiovasc_Diabetol_2013_Jun_18_12_88.nxml.txt.nlp	23773268	SENT192	13	13	16	16	fenofibrate	adiponectin	PA449594	9370	0.349
NULL	Neuropsychologia_2012_Nov_50(13)_3156-3168.nxml.txt.nlp	22884957	SENT425	25	25	21	21	scopolamine	spatial	PA451308	219793	0.349
NULL	Mol_Pain_2014_Apr_9_10_24.nxml.txt.nlp	24716552	SENT216	28	28	31	31	isoflurane	P18	PA450106	7975;10168	0.349
NULL	Int_J_Anal_Chem_2013_Jul_16_2013_419716.nxml.txt.nlp	23956748	SENT104	1	1	18	18	heparin	PF6	PA449855	200162	0.349
NULL	Cells_2014_Jun_26_3(3)_662-673.nxml.txt.nlp	24971848	SENT77	2	2	10	10	capsaicin	TRPV1	PA448776	7442	0.349
NULL	Nucleic_Acids_Res_2012_Apr_16_40(8)_3641-3652.nxml.txt.nlp	22180534	SENT180	15	15	9	9	galactose	GAL	PA449725	51083	0.349
NULL	Ann_Hematol_2014_Mar_18_93(8)_1335-1344.nxml.txt.nlp	24638841	SENT6	16	16	5	5	rituximab	CLB	PA451261	171425	0.349
NULL	Physiol_Rep_2014_Aug_19_2(8)_e12109.nxml.txt.nlp	25138789	SENT5	10	10	5	5	lipase	ANGPTL4	PA450239	51129	0.349
NULL	J_Cell_Mol_Med_2014_Aug_3_18(8)_1631-1643.nxml.txt.nlp	24894806	SENT9	26	26	15	15	dextran	ZO-1	PA449261	7082	0.349
NULL	Int_J_Environ_Res_Public_Health_2010_May_27_7(5)_1872-1888.nxml.txt.nlp	20622998	SENT60	8	8	22	22	ethanol	ALDH2	PA448073	217	0.349
NULL	Eur_J_Appl_Physiol_2011_Feb_24_111(2)_275-283.nxml.txt.nlp	20865425	SENT59	11	11	24	24	glucose	APE	PA449773	55704;328	0.349
NULL	Part_Fibre_Toxicol_2012_May_31_9_18.nxml.txt.nlp	22650444	SENT66	4	4	7	7	oxygen	ROS	PA450744	6098	0.349
NULL	Trials_2013_Aug_19_14_261.nxml.txt.nlp	23958221	SENT314	8	8	15	15	pp2	HER2		2064	0.349
NULL	Indian_J_Endocrinol_Metab_2012_Mar_16(Suppl1)_S57-S59.nxml.txt.nlp	22701845	SENT74	1	1	4	4	protamine	ZPI	PA10366	51156	0.349
NULL	Cells_2014_Sep_12_3(3)_914-938.nxml.txt.nlp	25222270	SENT621	6	6	10	10	capsaicin	TRPV1	PA448776	7442	0.349
NULL	Contemp_Clin_Dent_2011_Oct-Dec_2(4)_278-282.nxml.txt.nlp	22346152	SENT86	4	4	21	21	potassium	GCF	PA451047	6936	0.349
NULL	Br_J_Pharmacol_2011_Apr_162(8)_1832-1842.nxml.txt.nlp	21232033	SENT161	8	8	10	10	resveratrol	SAP97		1739	0.349
NULL	Acta_Vet_Scand_2010_Jul_30_52(1)_47.nxml.txt.nlp	20670455	SENT103	15	15	37	37	gentamicin	TMP	PA449753	2012	0.349
NULL	Clin_Dev_Immunol_2011_Nov_3_2011_609579.nxml.txt.nlp	22110526	SENT124	13	13	5	5	oxaliplatin	HMGB1	PA131285527	3146	0.349
NULL	J_Geriatr_Cardiol_2012_Jun_9(2)_209-210.nxml.txt.nlp	23097648	SENT20	40	40	23	23	warfarin	CYP4F2	PA451906	8529	0.349
NULL	Hum_Mol_Genet_2008_Jul_15_17(14)_2101-2107.nxml.txt.nlp	18413323	SENT112	1	1	7	7	ezetimibe	NPC1L1	PA10816	29881	0.349
NULL	Indian_J_Pharm_Sci_2008_Sep-Oct_70(5)_591-595.nxml.txt.nlp	21394254	SENT120	9	9	12	12	nebivolol	NEB	PA151958426	4703	0.349
NULL	Ann_Oncol_2011_Mar_8_22(3)_503-514.nxml.txt.nlp	20616198	SENT315	16	16	25	25	tamoxifen	ARNO	PA451581	9266	0.349
NULL	Infect_Dis_Obstet_Gynecol_2006_Oct_1_2006_18182.nxml.txt.nlp	17485797	SENT154	26	26	12	12	metronidazole	NOV	PA450484	4856;5361;6134	0.349
NULL	J_Am_Heart_Assoc_2013_Apr_24_2(2)_e000131.nxml.txt.nlp	23537811	SENT13	0	0	16	16	clopidogrel	ADP	PA449053	23038	0.349
NULL	Toxins_(Basel)_2010_Oct_26_2(11)_2490-2518.nxml.txt.nlp	22069563	SENT135	33	33	30	30	cisplatin	p53	PA449014	7157	0.349
NULL	Oncoimmunology_2013_Dec_1_2(12)_e26689.nxml.txt.nlp	24527364	SENT23	37	37	21	21	lapatinib	IFN	PA152241907	3439	0.349
NULL	Diabetes_2011_May_23_60(5)_1458-1466.nxml.txt.nlp	21464445	SENT28	21	21	14	14	lipase	ATGL	PA450239	57104	0.349
NULL	J_Int_Soc_Sports_Nutr_2014_Aug_13_11_38.nxml.txt.nlp	25132809	SENT166	13	13	10	10	creatine	MSTN	PA164778930	2660	0.349
NULL	Korean_J_Anesthesiol_2013_Jan_21_64(1)_47-53.nxml.txt.nlp	23372886	SENT78	14	14	9	9	bupivacaine	PTG	PA135057240	5507	0.349
NULL	J_Mol_Signal_2012_Sep_8_7_15.nxml.txt.nlp	22958338	SENT121	30	30	30	30	pp2	PP2		4888	0.349
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2009_Jun_1_65(Pt_6)_513-522.nxml.txt.nlp	19465765	SENT57	0	0	14	14	chloramphenicol	THM	PA448927	7063	0.349
NULL	Drugs_R_D_2010_Sep_27_10(3)_203-210.nxml.txt.nlp	20945949	SENT11	38	38	32	32	ribavirin	SOC	PA451241	91544	0.349
NULL	FEBS_Open_Bio_2013_Aug_17_3_352-356.nxml.txt.nlp	24251095	SENT166	6	6	11	11	hyaluronan	HARE	PA165958431	55576	0.349
NULL	Springerplus_2014_Sep_11_3_516.nxml.txt.nlp	25279308	SENT161	29	29	13	13	ethanol	CS-3	PA448073	91977	0.349
NULL	Patient_Prefer_Adherence_2013_Jul_4_7_653-666.nxml.txt.nlp	23869169	SENT262	31	31	2	2	tocilizumab	ACR	PA165292659	49	0.349
NULL	Br_J_Cancer_2009_Mar_24_100(6)_1017.nxml.txt.nlp	19293816	SENT8	18	18	36	36	irinotecan	CES2	PA450085	8824;1066	0.349
NULL	Nucleic_Acids_Res_2011_Nov_5_39(21)_9130-9138.nxml.txt.nlp	21821657	SENT267	4	4	9	9	iron	K12	PA450087	6398;3859	0.349
NULL	Cell_Mol_Life_Sci_2011_Mar_6_68(5)_903-917.nxml.txt.nlp	20820851	SENT452	4	4	15	15	chloroquine	mol	PA448948	90527	0.349
NULL	Case_Rep_Pediatr_2013_May_16_2013_207907.nxml.txt.nlp	23762715	SENT20	26	26	22	22	dexmedetomidine	ACTH	PA449256	5443	0.349
NULL	Br_J_Cancer_2011_Aug_9_105(4)_513-522.nxml.txt.nlp	21829205	SENT53	11	11	30	30	indinavir	ATV	PA449977	4683	0.349
NULL	J_Exp_Clin_Cancer_Res_2009_Jun_23_28(1)_88.nxml.txt.nlp	19545454	SENT43	25	25	27	27	paclitaxel	Gem	PA450761	51053	0.349
NULL	Acta_Pharmacol_Sin_2010_Nov_18_31(11)_1447-1453.nxml.txt.nlp	20953204	SENT10	14	14	8	8	rimonabant	CB1	PA152407999	1268	0.349
NULL	Arch_Med_Sci_2014_May_12_10(2)_213-221.nxml.txt.nlp	24904652	SENT24	26	26	31	31	paclitaxel	PES	PA450761	23481	0.349
NULL	Mol_Cancer_2013_Oct_8_12_119.nxml.txt.nlp	24103454	SENT4	26	26	23	23	etoposide	TOP2A	PA449552	7153	0.348
NULL	Biosci_Rep_2014_Oct_2_34(5)_e00141.nxml.txt.nlp	25195639	SENT152	13	13	22	22	lipase	BSCL2	PA450239	26580	0.348
NULL	Br_J_Cancer_1984_Jun_49(6)_779-786.nxml.txt.nlp	6203548	SENT2	15	15	12	12	mitomycin	BLM	PA450524	641	0.348
NULL	Mol_Pain_2012_Sep_24_8_73.nxml.txt.nlp	23006841	SENT32	0	0	9	9	ketoconazole	CPZ	PA450146	8532	0.348
NULL	J_Obes_2011_Nov_11_2011_806896.nxml.txt.nlp	21113309	SENT0	10	10	30	30	orlistat	GU2	PA164776864	79009	0.348
NULL	Environ_Health_Perspect_2008_Mar_11_116(3)_297-302.nxml.txt.nlp	18335094	SENT133	19	19	34	34	permethrin	OTC	PA164743137	5009	0.348
NULL	Calcif_Tissue_Int_2014_Aug_21_94(2)_170-175.nxml.txt.nlp	23963633	SENT151	3	3	9	9	teriparatide	PTH	PA451620	5741	0.348
NULL	Acta_Pharmacol_Sin_2011_Jan_6_32(1)_133-138.nxml.txt.nlp	21131997	SENT8	24	24	16	16	heparin	ACT	PA449855	12;11332;9457;641455	0.348
NULL	J_Korean_Med_Sci_2001_Dec_16(6)_712-718.nxml.txt.nlp	11748350	SENT2	7	7	10	10	oxygen	ROS	PA450744	6098	0.348
NULL	Genome_Med_2010_Mar_1_2(3)_17.nxml.txt.nlp	20487506	SENT163	19	19	24	24	glucosamine	HS3ST3A1	PA164747613	9955	0.348
NULL	Curr_Chem_Genomics_2011_Jan_6_5_1-12.nxml.txt.nlp	21643505	SENT18	22	22	25	25	oxygen	ROS	PA450744	6098	0.348
NULL	Front_Neurol_2011_Dec_26_2_83.nxml.txt.nlp	22363312	SENT123	14	14	25	25	clopidogrel	LTA	PA449053	4049	0.348
NULL	Arq_Bras_Cardiol_2013_Nov_101(5)_466-471.nxml.txt.nlp	24100694	SENT75	47	47	15	15	aspirin	MBP	PA448497	5553;4155	0.348
NULL	Exp_Diabetes_Res_2011_Jul_17_2011_835932.nxml.txt.nlp	21792353	SENT264	11	11	5	5	metipranolol	STZ	PA164748727	6484	0.348
NULL	Diabetologia_2010_Jun_27_53(6)_1142-1150.nxml.txt.nlp	20349036	SENT21	0	0	8	8	spermine	AMPK	PA164781199	5563	0.348
NULL	Cell_Commun_Signal_2013_Jan_11_11_2.nxml.txt.nlp	23305203	SENT262	12	12	1	1	thrombin	RACK1	PA451674	10399	0.348
NULL	Curr_Opin_Clin_Nutr_Metab_Care_2015_Jan_4_18(1)_71-77.nxml.txt.nlp	25474014	SENT131	15	15	26	26	lipase	FOXO1	PA450239	2308	0.348
NULL	Indian_J_Pharm_Sci_2012_Jul-Aug_74(4)_292-301.nxml.txt.nlp	23626384	SENT17	0	0	3	3	propranolol	PPN	PA451145	64840	0.348
NULL	Cardiovasc_Diabetol_2013_Nov_2_12_158.nxml.txt.nlp	24180212	SENT0	27	27	17	17	oxygen	PERK	PA450744	9451	0.348
NULL	Adv_Hematol_2010_Dec_30_2010_624040.nxml.txt.nlp	21234357	SENT106	5	5	14	14	cyclophosphamide	CHOP	PA449165	1649	0.348
NULL	Emerg_Infect_Dis_2013_Nov_19(11)_1803-1810.nxml.txt.nlp	24188126	SENT107	10	10	8	8	cefotaxime	CTX	PA448852	1593	0.348
NULL	Ann_Clin_Transl_Neurol_2014_Dec_21_1(12)_996-1005.nxml.txt.nlp	25574474	SENT20	39	39	19	19	riluzole	P-gp	PA451251	5243	0.348
NULL	Core_Evid_2007_Nov_30_2(2)_121-129.nxml.txt.nlp	21221180	SENT117	20	20	7	7	rituximab	EFS	PA451261	10278	0.348
NULL	Breast_Cancer_(Auckl)_2011_Jul_27_5_175-199.nxml.txt.nlp	21863131	SENT508	16	16	1	1	cetuximab	Met	PA10040	79811	0.347
NULL	ScientificWorldJournal_2013_Dec_29_2013_162750.nxml.txt.nlp	24470791	SENT343	21	21	3	3	naringenin	CHS	PA151958361	1130	0.347
NULL	Nat_Neurosci_2012_Sep_5_15(9)_1245-1254.nxml.txt.nlp	22864611	SENT87	3	3	9	9	clozapine	HDAC2	PA449061	3066	0.347
NULL	Biologics_2012_Dec_17_6_429-464.nxml.txt.nlp	23269860	SENT246	6	6	8	8	tocilizumab	ACR	PA165292659	49	0.347
NULL	Adv_Virol_2012_Jul_19_2012_267483.nxml.txt.nlp	22851970	SENT88	7	7	43	43	ribavirin	IFN	PA451241	3439	0.347
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT138	25	25	29	29	metformin	HIP	PA450395	6767;6159;64399;5068	0.347
NULL	J_Res_Med_Sci_2010_Nov-Dec_15(6)_331-343.nxml.txt.nlp	21526106	SENT152	10	10	0	0	l-arginine	HDEL	PA448478	10945	0.347
NULL	Exp_Ther_Med_2013_Jan_10_5(1)_11-16.nxml.txt.nlp	23251234	SENT37	17	17	6	6	cetuximab	EGFR	PA10040	1956	0.347
NULL	Biomed_Res_Int_2014_Aug_4_2014_592868.nxml.txt.nlp	25165708	SENT345	6	6	8	8	ifosfamide	GEM	PA449964	2669	0.347
NULL	AIDS_Res_Treat_2011_Jul_6_2011_890308.nxml.txt.nlp	21776380	SENT209	20	20	26	26	stavudine	KAL	PA451494	5267	0.347
NULL	BMB_Rep_2014_Jul_47(7)_388-392.nxml.txt.nlp	24286329	SENT33	0	0	5	5	berberine	AP-1	PA165860812	2353;3727;2354;3725	0.347
NULL	Int_J_Mol_Sci_2014_Sep_2_15(9)_15512-15529.nxml.txt.nlp	25184950	SENT197	8	8	5	5	resveratrol	IL-10		3586	0.347
NULL	Springerplus_2014_Sep_9_3_510.nxml.txt.nlp	25279302	SENT13	14	14	5	5	creatine	GATM	PA164778930	2628	0.347
NULL	Breast_Cancer_Res_2007_Apr_13_9(2)_103.nxml.txt.nlp	17433116	SENT23	35	35	9	9	tamoxifen	CYP2D6	PA451581	1565	0.347
NULL	Biomed_Res_Int_2013_Jul_8_2013_507103.nxml.txt.nlp	23936812	SENT150	14	14	28	28	curcumin	CO2	PA151958596	4513	0.347
NULL	Chem_Cent_J_2012_Oct_26_6_123.nxml.txt.nlp	23098128	SENT65	1	1	4	4	phenol	TPC	PA450913	8030;60386	0.347
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Oct_31_65(Pt_11)_o2953.nxml.txt.nlp	21578526	SENT68	26	26	21	21	ethanol	mol	PA448073	90527	0.347
NULL	Int_J_Mol_Sci_2012_Apr_19_13(4)_4982-4992.nxml.txt.nlp	22606024	SENT350	15	15	6	6	linezolid	NO3	PA450233	4681	0.347
NULL	Acta_Pharmacol_Sin_2011_Jan_6_32(1)_133-138.nxml.txt.nlp	21131997	SENT50	24	24	12	12	heparin	HSI	PA449855	57016	0.347
NULL	Iran_J_Public_Health_2010_Mar_31_39(1)_57-63.nxml.txt.nlp	23112990	SENT8	3	3	6	6	oxygen	ROS	PA450744	6098	0.347
NULL	Nanoscale_Res_Lett_2010_Jul_18_5(10)_1578-1584.nxml.txt.nlp	21076709	SENT28	15	15	20	20	ethanol	NO3	PA448073	4681	0.347
NULL	Nucleic_Acids_Res_2012_Apr_16_40(8)_3641-3652.nxml.txt.nlp	22180534	SENT100	25	25	28	28	galactose	GAL	PA449725	51083	0.347
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Nov_22_64(Pt_12)_o2420.nxml.txt.nlp	21581388	SENT69	5	5	15	15	ethanol	mol	PA448073	90527	0.347
NULL	Int_J_Endocrinol_2009_Nov_3_2009_687259.nxml.txt.nlp	20011060	SENT173	10	10	23	23	estradiol	aromatase	PA449503	1588	0.347
NULL	Breast_Cancer_Res_Treat_2014_Apr_9_145(1)_73-82.nxml.txt.nlp	24715380	SENT103	15	15	10	10	tamoxifen	CXCR3	PA451581	2833	0.347
NULL	J_Korean_Med_Sci_2010_Jul_17_25(7)_1017-1023.nxml.txt.nlp	20592892	SENT32	23	23	18	18	ampicillin	FBS	PA448419	64319;26269	0.347
NULL	Gut_Liver_2013_Sep_14_7(5)_585-593.nxml.txt.nlp	24073317	SENT108	36	36	34	34	ribavirin	IFN	PA451241	3439	0.347
NULL	Front_Oncol_2014_Jun_4_4_133.nxml.txt.nlp	24926436	SENT32	5	5	8	8	oxygen	ROS	PA450744	6098	0.347
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_May_5_68(Pt_6)_m731.nxml.txt.nlp	22719295	SENT5	11	11	13	13	ethanol	mol	PA448073	90527	0.347
NULL	Cardiovasc_Res_2011_Sep_1_91(4)_694-702.nxml.txt.nlp	21606183	SENT199	31	31	7	7	forskolin	AC6	PA146096022	112	0.347
NULL	Arch_Orthop_Trauma_Surg_2009_Nov_7_129(11)_1495-1504.nxml.txt.nlp	18989686	SENT216	5	5	11	11	daptomycin	VISA	PA164768820	57506	0.347
NULL	AIDS_Behav_2012_Feb_30_16(2)_396-403.nxml.txt.nlp	21190073	SENT130	31	31	17	17	methamphetamine	San	PA450403	80218	0.347
NULL	Eur_J_Med_Res_2011_Mar_28_16(3)_93-100.nxml.txt.nlp	21486721	SENT87	21	21	43	43	tenofovir	ATV	PA10204	4683	0.347
NULL	J_Mol_Med_2011_Jul_23_89(7)_667-676.nxml.txt.nlp	21431325	SENT43	15	15	32	32	metformin	IL-6	PA450395	3569	0.346
NULL	Mol_Vis_2007_Jun_7_13_804-812.nxml.txt.nlp	17615541	SENT41	19	19	40	40	fluorescein	ERG	PA164746009	2078	0.346
NULL	Crit_Care_2012_Jul_24_16(4)_R134.nxml.txt.nlp	22827994	SENT92	4	4	8	8	metformin	Met	PA450395	79811	0.346
NULL	Mol_Cancer_2012_Dec_12_11_90.nxml.txt.nlp	23234329	SENT165	24	24	26	26	doxycycline	CCSP	PA449415	7356	0.346
NULL	J_Health_Popul_Nutr_2011_Feb_29(1)_39-52.nxml.txt.nlp	21528789	SENT47	24	24	15	15	glucose	ADA	PA449773	100	0.346
NULL	Oxid_Med_Cell_Longev_2013_Oct_7_2013_920257.nxml.txt.nlp	24223236	SENT73	4	4	1	1	resveratrol	CRT		811	0.346
NULL	Ther_Clin_Risk_Manag_2006_Dec_2(4)_389-400.nxml.txt.nlp	18360651	SENT136	17	17	24	24	infliximab	IMPACT	PA452639	55364	0.346
NULL	Diabetes_Care_2013_Jun_15_36(6)_1779-1788.nxml.txt.nlp	23704680	SENT248	21	21	18	18	metformin	OCT1	PA450395	5451;6580	0.346
NULL	Med_Sci_Monit_2013_Oct_21_19_875-882.nxml.txt.nlp	24145180	SENT172	23	23	8	8	bevacizumab	CXCL8	PA130232992	3576	0.346
NULL	Case_Rep_Infect_Dis_2013_May_12_2013_761793.nxml.txt.nlp	23762676	SENT50	25	25	31	31	rifampin	TMX	PA451250	81542	0.346
NULL	Evid_Based_Complement_Alternat_Med_2014_Jul_1_2014_423751.nxml.txt.nlp	25101132	SENT184	30	30	24	24	ciprofloxacin	Met	PA449009	79811	0.346
NULL	Mol_Cancer_2012_Apr_5_11_20.nxml.txt.nlp	22480225	SENT572	7	7	9	9	temozolomide	SPARC	PA451609	6678	0.346
NULL	Br_J_Ophthalmol_2014_Aug_10_98(8)_1036-1041.nxml.txt.nlp	24723616	SENT9	4	4	17	17	bevacizumab	CRT	PA130232992	811	0.346
NULL	Pain_Res_Treat_2012_Aug_29_2012_898347.nxml.txt.nlp	22973509	SENT228	8	8	21	21	duloxetine	PLB	PA10066	151056	0.346
NULL	Case_Rep_Psychiatry_2013_Feb_28_2013_718950.nxml.txt.nlp	23533901	SENT60	30	30	38	38	aripiprazole	5-HT2A	PA10026	3356	0.346
NULL	Front_Pharmacol_2014_Mar_5_5_27.nxml.txt.nlp	24634658	SENT74	17	17	2	2	capsaicin	TRPV1	PA448776	7442	0.346
NULL	Indian_J_Dermatol_2011_Sep-Oct_56(5)_497-500.nxml.txt.nlp	22121262	SENT34	16	16	1	1	heparin	HLA-A	PA449855	3105	0.346
NULL	Br_J_Clin_Pharmacol_2014_Aug_17_78(2)_353-363.nxml.txt.nlp	24528331	SENT51	6	6	26	26	warfarin	VKORC1	PA451906	79001	0.346
NULL	Lipids_Health_Dis_2011_Feb_11_10_30.nxml.txt.nlp	21310091	SENT167	3	3	0	0	phenol	TPC	PA450913	8030;60386	0.346
NULL	Paediatr_Drugs_2013_Apr_20_15(2)_119-131.nxml.txt.nlp	23512128	SENT399	4	4	28	28	pantoprazole	MPG	PA450774	4350	0.346
NULL	AIDS_Res_Treat_2011_Jul_6_2011_890308.nxml.txt.nlp	21776380	SENT209	24	24	26	26	abacavir	KAL	PA448004	5267	0.346
NULL	Oxid_Med_Cell_Longev_2014_Dec_9_2014_425496.nxml.txt.nlp	25574337	SENT626	0	0	15	15	resveratrol	p53		7157	0.346
NULL	Autoimmune_Dis_2013_Aug_28_2013_613086.nxml.txt.nlp	24069534	SENT170	15	15	28	28	adalimumab	TNFAIP3	PA10004	7128	0.346
NULL	Iran_J_Pharm_Res_2014_Winter_13(1)_253-262.nxml.txt.nlp	24734078	SENT90	0	0	6	6	propofol	LPO	PA451141	4025	0.346
NULL	Br_J_Cancer_2014_May_27_110(11)_2716-2727.nxml.txt.nlp	24800946	SENT158	17	17	20	20	panitumumab	KRAS	PA162373091	3845	0.346
NULL	Orphanet_J_Rare_Dis_2011_Jan_14_6_1.nxml.txt.nlp	21235735	SENT126	32	32	18	18	creatine	ASAT	PA164778930	22	0.346
NULL	Mol_Cancer_2007_Aug_21_6_53.nxml.txt.nlp	17711579	SENT211	10	10	8	8	cisplatin	p53	PA449014	7157	0.346
NULL	Indian_J_Urol_2011_Apr-Jun_27(2)_252-261.nxml.txt.nlp	21814318	SENT182	2	2	4	4	doxorubicin	ADM	PA449412	133	0.346
NULL	Ann_Med_2014_Nov_21_46(7)_475-489.nxml.txt.nlp	25045928	SENT165	12	12	15	15	clopidogrel	ABCB1	PA449053	5243	0.346
NULL	Biomed_Res_Int_2014_Jan_6_2014_476789.nxml.txt.nlp	24511533	SENT33	9	9	18	18	ethanol	mol	PA448073	90527	0.346
NULL	Br_J_Cancer_2012_Oct_23_107(9)_1488-1497.nxml.txt.nlp	23033007	SENT71	0	0	17	17	gemcitabine	NAC	PA449748	22861	0.346
NULL	Clin_Med_Insights_Circ_Respir_Pulm_Med_2013_Nov_13_7_61-77.nxml.txt.nlp	24324354	SENT98	4	4	7	7	tobramycin	TIP	PA451704	81533;79828	0.346
NULL	Br_J_Cancer_2009_Oct_20_101(8)_1461-1468.nxml.txt.nlp	19738611	SENT125	33	33	30	30	imatinib	ABL1	PA10804	25	0.346
NULL	Int_J_Mol_Sci_2014_Sep_23_15(9)_16911-16935.nxml.txt.nlp	25250910	SENT124	2	2	7	7	nitrile	mol	PA450636	90527	0.346
NULL	Diabetes_2013_Jul_14_62(7)_2530-2538.nxml.txt.nlp	23423570	SENT118	5	5	11	11	mannitol	IL-8	PA450320	3576	0.346
NULL	J_Asthma_Allergy_2008_Sep_19_1_19-29.nxml.txt.nlp	21436982	SENT192	30	30	14	14	fexofenadine	CRT	PA449621	811	0.345
NULL	Front_Endocrinol_(Lausanne)_2013_Oct_11_4_140.nxml.txt.nlp	24130552	SENT87	9	9	13	13	paraformaldehyde	P35	PA450790	2220	0.345
NULL	Asia_Pac_Allergy_2013_Oct_31_3(4)_231-240.nxml.txt.nlp	24260728	SENT34	20	20	26	26	theophylline	CYP2E1	PA451647	1571	0.345
NULL	Case_Rep_Oncol_Med_2013_Jan_16_2013_292301.nxml.txt.nlp	23401819	SENT131	4	4	2	2	cyclophosphamide	CHOP	PA449165	1649	0.345
NULL	Exp_Cell_Res_2009_Nov_15_315(19)_3433-3441.nxml.txt.nlp	19716819	SENT196	33	33	10	10	hyaluronidase	IL-8	PA164745713	3576	0.345
NULL	J_Int_Soc_Sports_Nutr_2013_Dec_6_10(Suppl_1)_P7.nxml.txt.nlp	NULL	SENT10	19	19	17	17	glucose	FBS	PA449773	64319;26269	0.345
NULL	Front_Immunol_2012_Jun_11_3_144.nxml.txt.nlp	22701453	SENT64	21	21	14	14	imiquimod	MPL	PA449972	4352	0.345
NULL	Oncol_Lett_2014_Oct_9_8(4)_1551-1556.nxml.txt.nlp	25202366	SENT97	19	19	34	34	rituximab	PLB	PA451261	151056	0.345
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT45	9	9	5	5	pemetrexed	UNG	PA10810	7374	0.345
NULL	Indian_J_Med_Paediatr_Oncol_2013_Apr-Jun_34(2)_96-98.nxml.txt.nlp	24049295	SENT54	8	8	12	12	vincristine	CHOP	PA451879	1649	0.345
NULL	Br_J_Cancer_2013_Feb_5_108(2)_245-249.nxml.txt.nlp	23169279	SENT60	10	10	19	19	doxorubicin	RAIDD	PA449412	8738	0.345
NULL	Exp_Cell_Res_2011_Apr_15_317(7)_1028-1039.nxml.txt.nlp	21237154	SENT362	10	10	6	6	paclitaxel	PP1	PA450761	5540;5464	0.345
NULL	Arthritis_Res_Ther_2009_Jun_5_11(3)_R85.nxml.txt.nlp	19500336	SENT35	1	1	30	30	hyaluronan	CD102	PA165958431	3384	0.345
NULL	Indian_J_Pharm_Sci_2008_Sep-Oct_70(5)_591-595.nxml.txt.nlp	21394254	SENT17	0	0	3	3	nebivolol	NEB	PA151958426	4703	0.345
NULL	J_Cell_Biol_1966_Apr_1_29(1)_176-180.nxml.txt.nlp	5920193	SENT0	18	18	15	15	colchicine	MAST	PA449092	51324	0.345
NULL	Clin_Mol_Allergy_2004_Jul_14_2_9.nxml.txt.nlp	15253771	SENT220	35	35	32	32	medroxyprogesterone	CEE	PA450344	51608	0.345
NULL	Arthritis_Res_Ther_2010_Jan_8_12(1)_R4.nxml.txt.nlp	20064200	SENT218	16	16	8	8	fluorescein	COX2	PA164746009	4513;5743	0.345
NULL	Neuroscience_2011_Aug_25_189(1-2)_316-329.nxml.txt.nlp	21616128	SENT212	21	21	18	18	pilocarpine	CA1	PA450962	759	0.345
NULL	Nat_Commun_2013_4_1332.nxml.txt.nlp	23299882	SENT215	8	8	18	18	pilocarpine	DGKH	PA450962	160851	0.345
NULL	Aging_(Albany_NY)_2009_Aug_15_1(9)_771-783.nxml.txt.nlp	20157566	SENT133	13	13	16	16	nadh	AMPK	PA164755085	5563	0.345
NULL	Mar_Drugs_2014_Nov_19_12(11)_5468-5502.nxml.txt.nlp	25415349	SENT1446	2	2	7	7	glucosamine	ADP	PA164747613	23038	0.345
NULL	Oncoimmunology_2013_Feb_1_2(2)_e23080.nxml.txt.nlp	23525357	SENT23	31	31	28	28	imatinib	CTX	PA10804	1593	0.345
NULL	J_Res_Med_Sci_2010_Nov-Dec_15(6)_331-343.nxml.txt.nlp	21526106	SENT46	10	10	0	0	l-arginine	HDEL	PA448478	10945	0.345
NULL	J_Antimicrob_Chemother_2011_Jun_25_66(6)_1332-1339.nxml.txt.nlp	21441248	SENT202	9	9	5	5	nevirapine	CYP2B6	PA450616	1555	0.345
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Dec_17_3(12)_e152.nxml.txt.nlp	25518025	SENT63	27	27	25	25	oxycodone	CYP3A4	PA450741	1576	0.345
NULL	Biomed_Res_Int_2014_Jun_4_2014_237698.nxml.txt.nlp	24995276	SENT147	17	17	13	13	thalidomide	BTD	PA451644	686	0.345
NULL	Br_J_Cancer_2009_Jun_2_100(11)_1739-1745.nxml.txt.nlp	19436299	SENT106	6	6	20	20	everolimus	FDG	PA164746311	23583	0.345
NULL	Br_J_Pharmacol_2014_Apr_28_171(8)_1798-1817.nxml.txt.nlp	24116962	SENT37	3	3	24	24	nadh	Q10	PA164755085	27161	0.345
NULL	J_Clin_Biochem_Nutr_2007_Jul_27_41(1)_32-42.nxml.txt.nlp	18392098	SENT44	18	18	6	6	streptomycin	FBS	PA451512	64319;26269	0.345
NULL	Oncogene_2009_Jan_29_28(4)_479-491.nxml.txt.nlp	18978811	SENT145	26	26	7	7	tetracycline	DPPIV	PA451640	2191;1803	0.345
NULL	Exp_Diabetes_Res_2012_Dec_26_2012_230624.nxml.txt.nlp	23365557	SENT255	27	27	21	21	pioglitazone	Rog	PA450970	27033	0.345
NULL	Tuberculosis_(Edinb)_2013_Mar_93(2)_143-149.nxml.txt.nlp	23410889	SENT183	10	10	14	14	isoniazid	IPT	PA450112	54802	0.345
NULL	Acta_Vet_Scand_2008_Jul_4_50(1)_27.nxml.txt.nlp	18601734	SENT3	11	11	31	31	doxorubicin	SMYD2	PA449412	56950	0.345
NULL	Infection_2014_Oct_22_42(1)_61-71.nxml.txt.nlp	24146352	SENT94	6	6	31	31	maraviroc	CD4	PA164768835	920	0.345
NULL	Mol_Biol_Cell_2013_Sep_15_24(18)_2943-2953.nxml.txt.nlp	23904269	SENT287	23	23	19	19	paraformaldehyde	CSK	PA450790	1445	0.345
NULL	J_Geriatr_Cardiol_2014_Mar_11(1)_63-73.nxml.txt.nlp	24748884	SENT122	8	8	21	21	potassium	AST	PA451047	26503	0.345
NULL	Ann_Rheum_Dis_2011_Jun_27_70(9)_1631-1640.nxml.txt.nlp	21708910	SENT220	43	43	10	10	etanercept	ACR	PA449515	49	0.345
NULL	eLife_2013_Oct_29_2_e01236.nxml.txt.nlp	24171104	SENT995	12	12	14	14	bortezomib	MM1	PA10252	23654	0.345
NULL	Int_J_Mol_Sci_2014_Nov_5_15(11)_20134-20157.nxml.txt.nlp	25380521	SENT140	16	16	7	7	porfimer	BTC	PA164752658	685	0.345
NULL	J_Oncol_2013_Feb_17_2013_872957.nxml.txt.nlp	23476648	SENT204	8	8	4	4	cisplatin	SFN	PA449014	25996;2810	0.345
NULL	J_Oncol_2010_Dec_24_2010_497429.nxml.txt.nlp	20066162	SENT164	6	6	8	8	carboplatin	GEM	PA448803	2669	0.345
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2009_Jun_1_65(Pt_6)_513-522.nxml.txt.nlp	19465765	SENT57	6	6	3	3	chloramphenicol	CLS	PA448927	1210	0.345
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Dec_24_67(Pt_1)_o203-o204.nxml.txt.nlp	21522705	SENT7	1	1	3	3	ethanol	mol	PA448073	90527	0.344
NULL	Chin_J_Cancer_2012_Jun_31(6)_266-280.nxml.txt.nlp	22313597	SENT222	30	30	11	11	lipase	PTH	PA450239	5741	0.344
NULL	Int_J_Biol_Sci_2011_Nov_5_8(1)_1-14.nxml.txt.nlp	22211100	SENT222	12	12	14	14	evodiamine	Gem	PA165860788	51053	0.344
NULL	Front_Neural_Circuits_2014_Jun_30_8_72.nxml.txt.nlp	25071453	SENT275	10	10	22	22	taurine	spatial	PA451590	219793	0.344
NULL	Case_Rep_Urol_2013_May_8_2013_915874.nxml.txt.nlp	23738191	SENT81	18	18	26	26	tegafur	ADM	PA452620	133	0.344
NULL	Cases_J_2008_Dec_30_1_426.nxml.txt.nlp	19116013	SENT58	17	17	28	28	vincristine	CHOP	PA451879	1649	0.344
NULL	Crit_Care_2012_Oct_14_16(5)_R191.nxml.txt.nlp	23062276	SENT140	17	17	13	13	propofol	POD1	PA451141	6943	0.344
NULL	Stroke_Res_Treat_2009_Dec_20_2010_386389.nxml.txt.nlp	20700422	SENT162	17	17	19	19	ebselen	NAC	PA161660841	22861	0.344
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_39-54.nxml.txt.nlp	19305787	SENT320	40	40	34	34	ethanol	NRSF	PA448073	5978	0.344
NULL	Iran_J_Pharm_Res_2014_Winter_13(1)_253-262.nxml.txt.nlp	24734078	SENT86	0	0	6	6	propofol	LPO	PA451141	4025	0.344
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT225	0	0	6	6	sitagliptin	HIP	PA164748978	6767;6159;64399;5068	0.344
NULL	Mol_Cancer_2010_Dec_20_9_316.nxml.txt.nlp	21172016	SENT163	22	22	24	24	heparin	CCL21	PA449855	6366	0.344
NULL	Environ_Health_Perspect_2008_Mar_26_116(3)_322-328.nxml.txt.nlp	18335098	SENT177	31	31	42	42	estradiol	FES	PA449503	2242	0.344
NULL	Br_J_Cancer_2009_May_19_100(10)_1540-1548.nxml.txt.nlp	19384300	SENT144	1	1	4	4	trypsin	TATI	PA451806	6690	0.344
NULL	Proteome_Sci_2010_Feb_4_8_5.nxml.txt.nlp	20181094	SENT204	6	6	38	38	trypsin	Met	PA451806	79811	0.344
NULL	Neural_Regen_Res_2014_May_1_9(9)_951-958.nxml.txt.nlp	25206917	SENT148	4	4	7	7	oxygen	ROS	PA450744	6098	0.344
NULL	Front_Immunol_2012_Jan_25_3_7.nxml.txt.nlp	22566893	SENT250	5	5	29	29	tranilast	EGF	PA131890628	1950	0.344
NULL	AIDS_Res_Treat_2011_Jul_6_2011_890308.nxml.txt.nlp	21776380	SENT209	12	12	26	26	efavirenz	KAL	PA449441	5267	0.344
NULL	Mol_Vis_2011_Feb_1_17_332-340.nxml.txt.nlp	21297899	SENT193	36	36	41	41	telmisartan	DPI	PA451605	1832	0.344
NULL	Cancer_Med_2013_Feb_3_2(1)_108-115.nxml.txt.nlp	24279005	SENT145	5	5	27	27	raloxifene	STAR	PA451221	6770;2984	0.344
NULL	Biochem_Res_Int_2011_Oct_28_2011_191670.nxml.txt.nlp	21152183	SENT176	35	35	2	2	urokinase	MT6-MMP	PA451836	64386	0.344
NULL	AMB_Express_2012_Jan_12_2_5.nxml.txt.nlp	22239856	SENT116	37	37	28	28	trypsin	San	PA451806	80218	0.344
NULL	EMBO_Mol_Med_2012_Sep_7_4(9)_896-909.nxml.txt.nlp	22887866	SENT132	2	2	6	6	lovastatin	c-Myc	PA450272	4609	0.344
NULL	Int_J_Biol_Sci_2011_Jul_7_7(6)_823-836.nxml.txt.nlp	21814479	SENT11	2	2	5	5	oxygen	ROS	PA450744	6098	0.344
NULL	Mol_Cancer_2013_Nov_13_12_137.nxml.txt.nlp	24225025	SENT531	33	33	15	15	doxorubicin	SREBP2	PA449412	6721	0.344
NULL	Br_J_Cancer_2010_Sep_7_103(6)_812-819.nxml.txt.nlp	20700124	SENT195	22	22	9	9	rituximab	IL-2	PA451261	3558	0.344
NULL	Br_J_Cancer_2010_Jun_8_102(12)_1699-1706.nxml.txt.nlp	20485286	SENT80	27	27	14	14	sunitinib	San	PA162372840	80218	0.344
NULL	Cancer_Med_2014_Oct_2_3(5)_1256-1265.nxml.txt.nlp	24890382	SENT7	10	10	28	28	trastuzumab	HER2	PA451743	2064	0.344
NULL	Br_J_Cancer_2000_Apr_6_82(7)_1305-1311.nxml.txt.nlp	10755406	SENT14	0	0	13	13	mitomycin	NQO1	PA450524	1728	0.343
NULL	Eur_J_Pharmacol_2014_Apr_15_729(100)_75-85.nxml.txt.nlp	24534492	SENT36	19	19	9	9	fluorescein	CD194	PA164746009	1233	0.343
NULL	Carcinogenesis_2010_Dec_27_31(12)_2049-2057.nxml.txt.nlp	20876285	SENT7	6	6	23	23	tamoxifen	HER2	PA451581	2064	0.343
NULL	Evid_Based_Complement_Alternat_Med_2014_Jul_1_2014_423751.nxml.txt.nlp	25101132	SENT188	14	14	16	16	tetracycline	Met	PA451640	79811	0.343
NULL	Cancer_Manag_Res_2012_Nov_9_4_383-395.nxml.txt.nlp	23204869	SENT114	16	16	8	8	carmustine	PC-3	PA448810	692094	0.343
NULL	Acta_Physiol_(Oxf)_2013_Feb_6_207(2)_212-225.nxml.txt.nlp	23126245	SENT106	22	22	13	13	vasopressin	EP4	PA451858	5734	0.343
NULL	Neural_Regen_Res_2014_Oct_1_9(19)_1731-1739.nxml.txt.nlp	25422633	SENT184	8	8	15	15	scopolamine	GCL	PA451308	64396;25801	0.343
NULL	Adv_Biomed_Res_2014_Aug_19_3_173.nxml.txt.nlp	25250287	SENT65	3	3	19	19	glucose	STZ	PA449773	6484	0.343
NULL	Mol_Neurobiol_2007_Oct_10_36(2)_137-151.nxml.txt.nlp	17952658	SENT388	44	44	4	4	vasopressin	CXCL12	PA451858	6387	0.343
NULL	AIDS_Res_Ther_2008_Sep_17_5_21.nxml.txt.nlp	18799008	SENT192	32	32	34	34	ritonavir	SGC	PA451260	6443	0.343
NULL	J_Psychopharmacol_2014_Sep_28(9)_837-846.nxml.txt.nlp	25035246	SENT114	9	9	7	7	atomoxetine	ATX	PA134688071	5168;23049	0.343
NULL	Cancer_Immunol_Immunother_2015_Oct_7_64_61-73.nxml.txt.nlp	25287778	SENT196	17	17	3	3	lenalidomide	IL-2	PA162363968	3558	0.343
NULL	Int_J_Biol_Sci_2014_Aug_23_10(8)_921-939.nxml.txt.nlp	25170305	SENT308	8	8	11	11	nadh	EPO	PA164755085	7076;8288;2056	0.343
NULL	F1000Res_2013_Feb_28_2_65.nxml.txt.nlp	24358861	SENT433	29	29	39	39	naltrexone	TLR4	PA450588	7099	0.343
NULL	Biomed_Res_Int_2013_Dec_30_2013_735835.nxml.txt.nlp	24490170	SENT43	0	0	3	3	fexofenadine	FEX	PA449621	8549	0.343
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_75-89.nxml.txt.nlp	17912638	SENT377	26	26	33	33	tamoxifen	ATAC	PA451581	6375	0.343
NULL	Drugs_R_D_2011_Jun_27_11(2)_113-126.nxml.txt.nlp	21679004	SENT94	0	0	33	33	axitinib	UGT	PA164924493	7361;7355	0.343
NULL	Ann_Clin_Microbiol_Antimicrob_2015_Jan_17_14(1)_5.nxml.txt.nlp	NULL	SENT94	15	15	17	17	imipenem	CTX	PA449968	1593	0.343
NULL	Indian_J_Med_Res_2014_Jul_140(1)_109-115.nxml.txt.nlp	25222785	SENT8	1	1	6	6	celecoxib	DMC	PA448871	284340;54808	0.343
NULL	Diabetes_Care_2011_May_22_34(Suppl_2)_S202-S209.nxml.txt.nlp	21525456	SENT132	3	3	1	1	rosiglitazone	DREAM	PA451283	30818	0.343
NULL	Br_J_Cancer_2010_Jun_29_103(1)_52-60.nxml.txt.nlp	20531411	SENT20	10	10	6	6	gemcitabine	MTD	PA449748	4493	0.343
NULL	J_Cardiothorac_Surg_2012_Sep_27_7_97.nxml.txt.nlp	23013706	SENT177	16	16	13	13	warfarin	CYP4F2	PA451906	8529	0.343
NULL	Korean_J_Anesthesiol_2013_Jan_21_64(1)_47-53.nxml.txt.nlp	23372886	SENT14	11	11	18	18	bupivacaine	PTG	PA135057240	5507	0.343
NULL	Int_J_Environ_Res_Public_Health_2013_Sep_17_10(9)_4352-4389.nxml.txt.nlp	24048206	SENT1281	6	6	14	14	choline	SHMT1	PA448976	6470	0.343
NULL	Ann_Hematol_2014_Mar_18_93(8)_1335-1344.nxml.txt.nlp	24638841	SENT22	12	12	6	6	fludarabine	CLB	PA449655	171425	0.343
NULL	Arch_Med_Sci_2012_Jul_4_8(3)_575-577.nxml.txt.nlp	22852018	SENT10	7	7	35	35	levothyroxine	WBS	PA450221	2006	0.343
NULL	Indian_J_Urol_2009_Apr-Jun_25(2)_161-168.nxml.txt.nlp	19672339	SENT89	8	8	13	13	rituximab	CHOP	PA451261	1649	0.343
NULL	Acta_Pharmacol_Sin_2011_Jan_6_32(1)_133-138.nxml.txt.nlp	21131997	SENT50	24	24	14	14	heparin	HSI	PA449855	57016	0.343
NULL	Ther_Clin_Risk_Manag_2007_Oct_3(5)_741-749.nxml.txt.nlp	18472999	SENT235	1	1	5	5	naltrexone	Gen	PA450588	348654	0.343
NULL	F1000Res_2014_Aug_19_3_198.nxml.txt.nlp	25400908	SENT285	16	16	21	21	paclitaxel	HER2	PA450761	2064	0.343
NULL	J_Adv_Pract_Oncol_2014_May_1_May-Jun_5(3)_205-210.nxml.txt.nlp	25089219	SENT123	9	9	16	16	capecitabine	DPD	PA448771	1806	0.343
NULL	Acta_Otorhinolaryngol_Ital_2014_Apr_34(2)_146-149.nxml.txt.nlp	24843227	SENT49	21	21	19	19	cyclophosphamide	CHOP	PA449165	1649	0.343
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Sep_30_70(Pt_10)_265-268.nxml.txt.nlp	25484670	SENT51	18	18	29	29	nitrile	PF6	PA450636	200162	0.343
NULL	Sensors_(Basel)_2008_Mar_27_8(4)_2043-2081.nxml.txt.nlp	NULL	SENT277	14	14	26	26	glutaraldehyde	ITO	PA449777	3160	0.343
NULL	Protein_Cell_2014_May_26_5(5)_343-347.nxml.txt.nlp	24668462	SENT76	26	26	28	28	heparin	FGF1	PA449855	2246	0.343
NULL	Acta_Physiol_(Oxf)_2008_Apr_192(4)_505-517.nxml.txt.nlp	17973950	SENT243	11	11	16	16	propranolol	LQT3	PA451145	6331	0.343
NULL	Kidney_Int_Suppl_(2011)_2013_Dec_27_3(5)_436-441.nxml.txt.nlp	25019026	SENT7	19	19	37	37	cinacalcet	PTH	PA164776671	5741	0.343
NULL	Evid_Based_Complement_Alternat_Med_2014_Jul_1_2014_423751.nxml.txt.nlp	25101132	SENT184	43	43	24	24	kanamycin	Met	PA450137	79811	0.342
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT4312	24	24	9	9	acetaminophen	SOD2	PA448015	6648	0.342
NULL	ScientificWorldJournal_2012_Jan_2_11_2613-2619.nxml.txt.nlp	22262949	SENT112	14	14	12	12	cefoperazone	CPZ	PA448849	8532	0.342
NULL	Evid_Based_Complement_Alternat_Med_2014_Oct_13_2014_926423.nxml.txt.nlp	25371698	SENT94	14	14	11	11	potassium	HERG	PA451047	3757	0.342
NULL	J_Biol_Chem_2012_Apr_6_287(15)_12433-12444.nxml.txt.nlp	22351758	SENT418	10	10	15	15	trypsin	ITIH	PA451806	3697	0.342
NULL	Int_J_Breast_Cancer_2011_Oct_19_2011_867152.nxml.txt.nlp	22295235	SENT9	23	23	26	26	hyaluronan	LYVE-1	PA165958431	10894	0.342
NULL	Arch_Trauma_Res_2012_Oct_14_Autumn_1(3)_126-130.nxml.txt.nlp	24396761	SENT9	12	12	5	5	oxygen	GCS	PA450744	2729;7357	0.342
NULL	Arthritis_Res_Ther_2008_Dec_1_10(6)_R139.nxml.txt.nlp	19046432	SENT272	0	0	22	22	rosiglitazone	AP-1	PA451283	2353;3727;2354;3725	0.342
NULL	Mol_Cancer_2013_Oct_7_12_116.nxml.txt.nlp	24098916	SENT139	39	39	15	15	hydrocortisone	F12	PA449905	2161	0.342
NULL	Chin_J_Cancer_2011_May_30(5)_287-292.nxml.txt.nlp	21527061	SENT54	13	13	28	28	paclitaxel	ERCC2	PA450761	2068	0.342
NULL	J_Korean_Med_Sci_2010_Nov_26_25(11)_1683-1687.nxml.txt.nlp	21060764	SENT40	13	13	10	10	thyroglobulin	TTF-1	PA164754910	7080	0.342
NULL	Eur_J_Endocrinol_2011_Jan_164(1)_69-74.nxml.txt.nlp	20961967	SENT77	23	23	20	20	pioglitazone	OPG	PA450970	690	0.342
NULL	Patient_Prefer_Adherence_2010_Jun_24_4_197-205.nxml.txt.nlp	20622918	SENT167	41	41	2	2	mometasone	BDP	PA450541	10620;152926	0.342
NULL	J_Invest_Dermatol_2013_Aug_133(8)_1928-1929.nxml.txt.nlp	23856932	SENT34	7	7	5	5	vemurafenib	PAX3	PA165946873	5077	0.342
NULL	Osteoporos_Int_2011_Oct_27_22(10)_2709-2719.nxml.txt.nlp	21113576	SENT220	12	12	15	15	teriparatide	PDF	PA451620	64146;9518	0.342
NULL	Open_Cardiovasc_Med_J_2009_Jun_16_3_57-68.nxml.txt.nlp	19572030	SENT134	17	17	9	9	simvastatin	SHARP	PA451363	23013	0.342
NULL	Nat_Med_2011_Aug_7_17(9)_1116-1120.nxml.txt.nlp	21822287	SENT38	18	18	39	39	doxycycline	p110	PA449415	9733	0.342
NULL	Brain_Sci_2014_May_6_4(2)_356-375.nxml.txt.nlp	24961766	SENT293	8	8	12	12	propofol	G18	PA451141	1154;63940	0.342
NULL	Mol_Vis_2011_Dec_15_17_3254-3261.nxml.txt.nlp	22194651	SENT207	14	14	11	11	vasopressin	AVP	PA451858	114548;551	0.342
NULL	Cancers_(Basel)_2011_Aug_5_3(3)_3114-3142.nxml.txt.nlp	24212948	SENT1559	0	0	6	6	cyclophosphamide	CD4	PA449165	920	0.342
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Apr_15_9_13.nxml.txt.nlp	20398300	SENT74	3	3	0	0	lansoprazole	LAM	PA450180	7249;7248	0.342
NULL	Indian_J_Pharm_Sci_2013_Sep-Oct_75(5)_523-532.nxml.txt.nlp	24403652	SENT26	0	0	3	3	atorvastatin	ATV	PA448500	4683	0.342
NULL	Anesth_Pain_Med_2014_Sep_9_4(4)_e14221.nxml.txt.nlp	25599022	SENT138	4	4	11	11	cisplatin	LPO	PA449014	4025	0.342
NULL	Front_Behav_Neurosci_2009_Aug_27_3_17.nxml.txt.nlp	19753327	SENT38	9	9	3	3	vasopressin	AVP	PA451858	114548;551	0.342
NULL	Nucleic_Acids_Res_2011_May_16_39(10)_e71.nxml.txt.nlp	21415007	SENT285	28	28	30	30	tetracycline	SMN2	PA451640	6607	0.342
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT151	15	15	9	9	glucose	EGFR	PA449773	1956	0.342
NULL	Arch_Osteoporos_2009_Dec_18_4(1-2)_1-8.nxml.txt.nlp	20234790	SENT150	30	30	40	40	raloxifene	PTH	PA451221	5741	0.342
NULL	Open_Biochem_J_2007_Jun_15_1_1-6.nxml.txt.nlp	18949066	SENT21	12	12	15	15	ciclopirox	CPX	PA164747060	1371;10682;1377	0.342
NULL	Cardiovasc_Diabetol_2010_Jun_24_9_27.nxml.txt.nlp	20576156	SENT4	26	26	11	11	dobutamine	HEC	PA449381	10403	0.342
NULL	Ann_Clin_Microbiol_Antimicrob_2010_Apr_15_9_13.nxml.txt.nlp	20398300	SENT72	3	3	0	0	lansoprazole	LAM	PA450180	7249;7248	0.342
NULL	J_Cell_Biol_1999_Feb_8_144(3)_459-471.nxml.txt.nlp	9971741	SENT78	22	22	32	32	mannitol	TMT	PA450320	25823	0.342
NULL	Exp_Transl_Stroke_Med_2012_May_16_4_10.nxml.txt.nlp	22591588	SENT134	6	6	13	13	alteplase	San	PA164776730	80218	0.342
NULL	Indian_J_Anaesth_2013_Jan-Feb_57(1)_66-68.nxml.txt.nlp	23716770	SENT35	9	9	5	5	ephedrine	IBP	PA449466	706;50619	0.342
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT203	2	2	13	13	pp2	p38		10598;1432;7965	0.342
NULL	BMJ_Open_2013_Aug_9_3(8)_e003268.nxml.txt.nlp	23943777	SENT136	11	11	32	32	creatine	ACR	PA164778930	49	0.342
NULL	JAKSTAT_2013_Jul_1_2(3)_e24812.nxml.txt.nlp	24069562	SENT8	2	2	2	2	pp2	PP2		4888	0.342
NULL	Environ_Health_Perspect_2008_Mar_19_116(3)_315-321.nxml.txt.nlp	18335097	SENT212	15	15	20	20	betaine	BHMT	PA448603	635	0.342
NULL	Front_Aging_Neurosci_2014_Sep_25_6_256.nxml.txt.nlp	25309433	SENT105	27	27	1	1	glucose	Yes	PA449773	7525	0.342
NULL	J_Int_AIDS_Soc_2013_Apr_30_16(1)_18059.nxml.txt.nlp	23639243	SENT132	9	9	11	11	zidovudine	CTX	PA451954	1593	0.342
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Feb_28_65(Pt_3)_m337-m338.nxml.txt.nlp	21582105	SENT57	33	33	26	26	ethanol	NO3	PA448073	4681	0.342
NULL	Ther_Clin_Risk_Manag_2007_Aug_3(4)_675-684.nxml.txt.nlp	18472990	SENT81	38	38	16	16	vancomycin	MIC1	PA451850	29919;9518	0.342
NULL	Reprod_Biol_Endocrinol_2004_Aug_4_2_59.nxml.txt.nlp	15294019	SENT49	11	11	21	21	forskolin	EGF	PA146096022	1950	0.342
NULL	Cases_J_2008_Dec_30_1_426.nxml.txt.nlp	19116013	SENT11	18	18	29	29	vincristine	CHOP	PA451879	1649	0.342
NULL	Evid_Based_Complement_Alternat_Med_2014_Sep_2_2014_627181.nxml.txt.nlp	25258643	SENT263	30	30	32	32	phenylephrine	TMP	PA450935	2012	0.342
NULL	Int_J_Biol_Sci_2011_Nov_5_8(1)_1-14.nxml.txt.nlp	22211100	SENT268	2	2	4	4	evodiamine	Gem	PA165860788	51053	0.342
NULL	Am_J_Trop_Med_Hyg_2009_Jan_80(1)_126-132.nxml.txt.nlp	19141850	SENT53	22	22	8	8	artesunate	SRM	PA165111697	6723;6725	0.342
NULL	Int_J_Hypertens_2013_Jun_17_2013_627938.nxml.txt.nlp	23844279	SENT138	31	31	6	6	telmisartan	A10	PA451605	28870	0.342
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Feb_28_65(Pt_3)_o634.nxml.txt.nlp	21582283	SENT5	30	30	32	32	ethanol	mol	PA448073	90527	0.342
NULL	Front_Genet_2014_Sep_25_5_339.nxml.txt.nlp	25309584	SENT701	10	10	2	2	dextran	spatial	PA449261	219793	0.342
NULL	AMB_Express_2012_Jan_31_2_11.nxml.txt.nlp	22293122	SENT186	5	5	10	10	nadh	GDH	PA164755085	51084;2746	0.342
NULL	AIDS_Res_Ther_2013_Dec_13_10_33.nxml.txt.nlp	24330617	SENT147	20	20	38	38	atazanavir	ATV	PA10251	4683	0.341
NULL	Front_Pharmacol_2014_Dec_19_5_270.nxml.txt.nlp	25566071	SENT205	30	30	22	22	doxycycline	KLF4	PA449415	9314	0.341
NULL	Osteoporos_Int_2013_Aug_31_24(8)_2365-2369.nxml.txt.nlp	23371327	SENT123	3	3	9	9	teriparatide	PTH	PA451620	5741	0.341
NULL	Mol_Cancer_2014_Jun_19_13_154.nxml.txt.nlp	24941944	SENT265	6	6	18	18	temozolomide	GMP	PA451609	22978	0.341
NULL	Int_J_Mol_Cell_Med_2013_Spring_2(2)_50-57.nxml.txt.nlp	24551791	SENT56	5	5	32	32	creatine	DGCR8	PA164778930	54487	0.341
NULL	Breast_Cancer_Res_2014_May_7_16(3)_207.nxml.txt.nlp	25223380	SENT163	22	22	36	36	letrozole	HER2	PA450196	2064	0.341
NULL	Brain_Sci_2013_Jun_14_3(2)_941-963.nxml.txt.nlp	24961432	SENT34	4	4	20	20	ethanol	CA3	PA448073	761	0.341
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT124	26	26	22	22	sitagliptin	HIP	PA164748978	6767;6159;64399;5068	0.341
NULL	Indian_J_Med_Res_2012_Jul_136(1)_46-53.nxml.txt.nlp	22885263	SENT46	24	24	14	14	urea	PPG	PA451831	5552	0.341
NULL	Crit_Care_2008_Jun_25_12(3)_R84.nxml.txt.nlp	18578859	SENT62	17	17	7	7	heparin	PF4	PA449855	5196	0.341
NULL	Chem_Cent_J_2012_Nov_23_6_140.nxml.txt.nlp	23173949	SENT20	5	5	8	8	oxygen	ROS	PA450744	6098	0.341
NULL	Indian_J_Med_Paediatr_Oncol_2013_Apr-Jun_34(2)_96-98.nxml.txt.nlp	24049295	SENT54	4	4	12	12	cyclophosphamide	CHOP	PA449165	1649	0.341
NULL	Small_GTPases_2012_Jan_1_3(1)_53-59.nxml.txt.nlp	22714418	SENT27	3	3	6	6	hyaluronan	LYVE-1	PA165958431	10894	0.341
NULL	Int_J_Nanomedicine_2007_Sep_2(3)_407-418.nxml.txt.nlp	18019839	SENT271	17	17	5	5	ciprofloxacin	AVT2	PA449009	151258	0.341
NULL	Breast_Cancer_Res_2003_Jul_28_5(5)_276-279.nxml.txt.nlp	12927039	SENT80	19	19	26	26	tamoxifen	ATAC	PA451581	6375	0.341
NULL	Int_J_Biol_Sci_2015_Jan_1_11(1)_48-58.nxml.txt.nlp	25552929	SENT141	10	10	8	8	paclitaxel	LDM	PA450761	1595	0.341
NULL	Crit_Care_2011_Aug_11_15(4)_226.nxml.txt.nlp	21892977	SENT28	12	12	9	9	vasopressin	ACTH	PA451858	5443	0.341
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT118	0	0	10	10	methotrexate	MSH2	PA450428	4436	0.341
NULL	Lab_Invest_2011_Sep_23_91(9)_1396-1409.nxml.txt.nlp	21606925	SENT287	21	21	21	21	pp2	PP2		4888	0.341
NULL	J_Int_Soc_Sports_Nutr_2014_Jun_18_11_31.nxml.txt.nlp	24982601	SENT175	1	1	27	27	creatine	MCP-1	PA164778930	6347	0.341
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jul_28_68(Pt_8)_o2566.nxml.txt.nlp	22904994	SENT8	4	4	6	6	ethanol	mol	PA448073	90527	0.341
NULL	Pharm_Pract_(Granada)_2011_Mar_15_Jan-Mar_9(1)_1-10.nxml.txt.nlp	25132883	SENT170	4	4	1	1	warfarin	SPAF	PA451906	166378	0.341
NULL	Breast_Cancer_Res_2003_Feb_5_5(2)_113-116.nxml.txt.nlp	12631392	SENT33	19	19	26	26	tamoxifen	ATAC	PA451581	6375	0.341
NULL	Ann_Rheum_Dis_2009_Jul_4_68(7)_1220-1227.nxml.txt.nlp	18772191	SENT117	15	15	7	7	abatacept	CD68	PA164747080	968	0.341
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Nov_22_64(Pt_12)_o2408.nxml.txt.nlp	21581377	SENT60	1	1	17	17	ethanol	mol	PA448073	90527	0.34
NULL	Biologics_2012_Dec_17_6_429-464.nxml.txt.nlp	23269860	SENT246	6	6	15	15	tocilizumab	ACR	PA165292659	49	0.34
NULL	Acta_Vet_Scand_2010_Jul_30_52(1)_47.nxml.txt.nlp	20670455	SENT103	35	35	37	37	tetracycline	TMP	PA451640	2012	0.34
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Sep_30_67(Pt_10)_o2749.nxml.txt.nlp	22058807	SENT55	20	20	15	15	ethanol	mol	PA448073	90527	0.34
NULL	Mol_Pain_2014_Apr_18_10_27.nxml.txt.nlp	24742127	SENT284	31	31	42	42	paclitaxel	CD11b	PA450761	3684	0.34
NULL	Int_J_Fertil_Steril_2014_Nov_1_Oct-Dec_8(3)_243-248.nxml.txt.nlp	25379151	SENT47	18	18	24	24	piroxicam	ART	PA450985	181	0.34
NULL	Arch_Med_Sci_2013_Oct_31_9(5)_916-921.nxml.txt.nlp	24273579	SENT108	10	10	5	5	bleomycin	AQP1	PA448645	358	0.34
NULL	Br_J_Cancer_2013_May_28_108(10)_2063-2069.nxml.txt.nlp	23591198	SENT36	0	0	3	3	gemcitabine	GEM	PA449748	2669	0.34
NULL	J_Biol_Chem_2013_Oct_11_288(41)_29642-29653.nxml.txt.nlp	24005673	SENT623	12	12	9	9	hyaluronan	TSG-6	PA165958431	7130	0.34
NULL	Oncotarget_2014_Oct_21_5(22)_11252-11268.nxml.txt.nlp	25361004	SENT221	20	20	24	24	metformin	CLIC1	PA450395	1192	0.34
NULL	Neuroscience_2011_Dec_1_197(1)_280-292.nxml.txt.nlp	21945033	SENT60	11	11	5	5	mecamylamine	AP-5	PA450334	91056	0.34
NULL	Mol_Vis_2007_Dec_17_13_2282-2288.nxml.txt.nlp	18199969	SENT34	47	47	31	31	streptomycin	FBS	PA451512	64319;26269	0.34
NULL	J_Cancer_Prev_2014_Mar_19(1)_39-46.nxml.txt.nlp	25337571	SENT19	35	35	22	22	ethanol	JNK	PA448073	5599	0.34
NULL	Br_J_Pharmacol_2014_Apr_28_171(8)_1798-1817.nxml.txt.nlp	24116962	SENT43	2	2	24	24	nadh	COX	PA164755085	1351	0.34
NULL	J_Med_Chem_2014_Jan_23_57(2)_449-461.nxml.txt.nlp	24387105	SENT8	10	10	12	12	cyclophosphamide	ALDH3A1	PA449165	218	0.34
NULL	Br_J_Cancer_2011_Sep_6_105(6)_778-786.nxml.txt.nlp	21847128	SENT216	22	22	24	24	zoledronate	IL-2	PA10235	3558	0.34
NULL	Arthritis_Res_Ther_2010_Aug_24_12(4)_214.nxml.txt.nlp	20735862	SENT192	29	29	31	31	rituximab	TBC	PA451261	23216	0.34
NULL	Front_Endocrinol_(Lausanne)_2013_May_10_4_52.nxml.txt.nlp	23675368	SENT1116	12	12	23	23	isoproterenol	IL-6	PA450121	3569	0.34
NULL	Biomed_Res_Int_2013_Dec_31_2013_795103.nxml.txt.nlp	23710462	SENT169	9	9	18	18	fenofibrate	ACR	PA449594	49	0.34
NULL	Biomed_Res_Int_2013_Aug_6_2013_909613.nxml.txt.nlp	24027765	SENT357	18	18	10	10	metronidazole	EEN	PA450484	6455	0.34
NULL	Int_J_Endocrinol_2014_Apr_30_2014_674987.nxml.txt.nlp	24883061	SENT37	11	11	14	14	oxygen	ROS	PA450744	6098	0.34
NULL	Ther_Clin_Risk_Manag_2006_Sep_2(3)_281-295.nxml.txt.nlp	18360603	SENT303	6	6	3	3	teriparatide	PTH	PA451620	5741	0.34
NULL	Mol_Cells_2014_Jan_31_37(1)_66-73.nxml.txt.nlp	24552712	SENT40	14	14	23	23	ribavirin	RVR	PA451241	9975	0.34
NULL	Breast_Cancer_(Auckl)_2011_Jul_27_5_175-199.nxml.txt.nlp	21863131	SENT491	13	13	1	1	cetuximab	Met	PA10040	79811	0.34
NULL	Biomed_Res_Int_2014_Feb_6_2014_323594.nxml.txt.nlp	24689036	SENT210	10	10	12	12	raloxifene	PC3	PA451221	57332;7832;5122	0.34
NULL	Endocrinology_2012_Jan_15_153(1)_200-211.nxml.txt.nlp	22087024	SENT204	9	9	15	15	methylprednisolone	ACTH	PA450466	5443	0.34
NULL	Bioinformation_2012_Nov_13_8(22)_1114-1118.nxml.txt.nlp	23251047	SENT81	0	0	6	6	amodiaquine	ACT	PA448404	12;11332;9457;641455	0.34
NULL	Arthritis_Res_Ther_2014_Oct_29_16(5)_469.nxml.txt.nlp	25606596	SENT201	20	20	32	32	methotrexate	p40	PA450428	3921;339541;10314	0.34
NULL	BMJ_Open_2014_Sep_2_4(9)_e005864.nxml.txt.nlp	25183709	SENT33	4	4	13	13	warfarin	TTR	PA451906	7276	0.34
NULL	Evid_Based_Complement_Alternat_Med_2014_May_28_2014_716509.nxml.txt.nlp	24987433	SENT184	10	10	0	0	gentamicin	TTR	PA449753	7276	0.34
NULL	Oxid_Med_Cell_Longev_2013_Jun_2_2013_793525.nxml.txt.nlp	23819014	SENT126	8	8	14	14	resveratrol	SGBS		2719	0.34
NULL	J_Geriatr_Cardiol_2014_Mar_11(1)_63-73.nxml.txt.nlp	24748884	SENT157	12	12	4	4	fenoldopam	DR5	PA164784034	8795	0.34
NULL	Exp_Neurol_2011_May_229(1)_2-9.nxml.txt.nlp	20816825	SENT110	19	19	17	17	forskolin	FGF2	PA146096022	2247;2258	0.34
NULL	Cancer_Microenviron_2008_Dec_20_1(1)_103-111.nxml.txt.nlp	19308689	SENT3	3	3	14	14	thrombin	PAR-1	PA451674	2011;2149	0.34
NULL	ISRN_Nutr_2014_Mar_16_2014_280837.nxml.txt.nlp	24967265	SENT164	12	12	22	22	trypsin	HCN	PA451806	378938	0.34
NULL	Evid_Based_Complement_Alternat_Med_2014_Jul_1_2014_423751.nxml.txt.nlp	25101132	SENT184	18	18	24	24	erythromycin	Met	PA449493	79811	0.34
NULL	Arq_Bras_Cardiol_2014_Jun_102(6)_529-538.nxml.txt.nlp	25004414	SENT104	13	13	22	22	everolimus	PES	PA164746311	23481	0.34
NULL	Front_Neurosci_2014_Apr_22_8_72.nxml.txt.nlp	24795550	SENT130	39	39	13	13	dextran	CTB	PA449261	9468	0.34
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT616	41	41	39	39	aripiprazole	PRL	PA10026	5617	0.34
NULL	Int_J_Biol_Sci_2011_Nov_5_8(1)_1-14.nxml.txt.nlp	22211100	SENT234	2	2	4	4	evodiamine	Gem	PA165860788	51053	0.34
NULL	Oxid_Med_Cell_Longev_2012_May_28_2012_632959.nxml.txt.nlp	22690272	SENT52	9	9	1	1	curcumin	PC-3	PA151958596	692094	0.34
NULL	Int_J_Womens_Health_2014_Aug_11_6_745-757.nxml.txt.nlp	25143757	SENT63	24	24	17	17	estradiol	CEE	PA449503	51608	0.34
NULL	J_Res_Med_Sci_2010_Nov-Dec_15(6)_331-343.nxml.txt.nlp	21526106	SENT145	10	10	0	0	l-arginine	HDEL	PA448478	10945	0.339
NULL	Int_J_Biol_Sci_2011_Nov_5_8(1)_1-14.nxml.txt.nlp	22211100	SENT262	6	6	4	4	gemcitabine	Gem	PA449748	51053	0.339
NULL	J_Cell_Biol_2001_Aug_6_154(3)_585-598.nxml.txt.nlp	11489918	SENT59	16	16	19	19	trifluoperazine	TFP	PA451771	7034	0.339
NULL	Exp_Diabetes_Res_2012_Dec_6_2012_386041.nxml.txt.nlp	23304116	SENT31	9	9	12	12	oxygen	ROS	PA450744	6098	0.339
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_Jul_9_3(7)_e124.nxml.txt.nlp	25006781	SENT320	4	4	38	38	rosuvastatin	OATP1B1	PA134308647	10599	0.339
NULL	Ann_Clin_Microbiol_Antimicrob_2015_Jan_17_14(1)_5.nxml.txt.nlp	NULL	SENT94	19	19	17	17	cefotaxime	CTX	PA448852	1593	0.339
NULL	Nat_Commun_2013_Oct_1_4_2516.nxml.txt.nlp	24084631	SENT665	9	9	14	14	hyaluronan	AT2	PA165958431	186	0.339
NULL	Diabetes_2013_Oct_17_62(10)_3324-3328.nxml.txt.nlp	24065789	SENT0	20	20	38	38	glucose	San	PA449773	80218	0.339
NULL	Acta_Pharmacol_Sin_2010_Jun_4_31(6)_649-664.nxml.txt.nlp	20523337	SENT241	8	8	14	14	scopolamine	spatial	PA451308	219793	0.339
NULL	J_Adv_Pharm_Technol_Res_2010_Jul-Sep_1(3)_354-357.nxml.txt.nlp	22247871	SENT42	14	14	24	24	nitrogen	GAS2	PA450643	2620	0.339
NULL	Curr_Neuropharmacol_2010_Dec_8(4)_367-381.nxml.txt.nlp	21629444	SENT547	21	21	5	5	midazolam	spatial	PA450496	219793	0.339
NULL	Mol_Cancer_2014_Apr_17_13_85.nxml.txt.nlp	24741998	SENT173	20	20	24	24	rituximab	CD40L	PA451261	959	0.339
NULL	Biomed_Res_Int_2014_Feb_4_2014_975927.nxml.txt.nlp	24689066	SENT122	7	7	4	4	teriparatide	PTH	PA451620	5741	0.339
NULL	ISRN_Neurol_2013_Sep_10_2013_748127.nxml.txt.nlp	24109519	SENT32	14	14	21	21	rituximab	HERMES	PA451261	11030	0.339
NULL	Front_Plant_Sci_2011_Aug_29_2_42.nxml.txt.nlp	22639593	SENT62	20	20	0	0	chloramphenicol	p35	PA448927	3592;80761	0.339
NULL	Cells_2013_Jul_18_2(3)_545-573.nxml.txt.nlp	24709797	SENT293	26	26	24	24	decitabine	FasL	PA164749631	356	0.339
NULL	Cancer_Metab_2013_Mar_21_1_12.nxml.txt.nlp	24280230	SENT38	18	18	24	24	urea	ASL	PA451831	435	0.339
NULL	Cell_Death_Dis_2013_Sep_19_4(9)_e808.nxml.txt.nlp	24052076	SENT304	4	4	11	11	ethanol	CD31	PA448073	5175	0.339
NULL	Acta_Neuropathol_Commun_2014_Jan_2_2_1.nxml.txt.nlp	24383468	SENT53	21	21	25	25	nadh	ND6	PA164755085	4541	0.339
NULL	Oncogene_2013_Sep_12_32(37)_4355-4365.nxml.txt.nlp	23108409	SENT7	6	6	15	15	hyaluronan	HAS2	PA165958431	3037	0.339
NULL	Cell_Death_Dis_2014_Apr_17_5(4)_e1182.nxml.txt.nlp	24743737	SENT69	10	10	3	3	capsaicin	TRPV1	PA448776	7442	0.339
NULL	Reprod_Biol_Endocrinol_2003_Aug_6_1_54.nxml.txt.nlp	12932297	SENT287	22	22	25	25	hyaluronidase	SPAM1	PA164745713	6677	0.339
NULL	Front_Oncol_2013_Sep_23_3_250.nxml.txt.nlp	24069582	SENT338	16	16	38	38	raloxifene	STAR	PA451221	6770;2984	0.339
NULL	Mol_Cancer_2012_Jun_26_11_43.nxml.txt.nlp	22731636	SENT198	4	4	4	4	pp2	PP2		4888	0.339
NULL	J_Mol_Signal_2008_Dec_1_3_18.nxml.txt.nlp	19046439	SENT109	14	14	7	7	metformin	Met	PA450395	79811	0.339
NULL	Mol_Pain_2014_Aug_15_10_53.nxml.txt.nlp	25127716	SENT92	24	24	6	6	paclitaxel	CCL3	PA450761	6348	0.339
NULL	Cancers_(Basel)_2010_Feb_23_2(1)_88-113.nxml.txt.nlp	24281034	SENT430	0	0	22	22	sorafenib	SHARP	PA7000	23013	0.339
NULL	EMBO_Mol_Med_2012_Oct_30_4(10)_1087-1096.nxml.txt.nlp	22933245	SENT65	13	13	10	10	olaparib	NAMPT		10135	0.339
NULL	Br_J_Cancer_2006_Feb_13_94(3)_407-426.nxml.txt.nlp	16434996	SENT148	24	24	32	32	genistein	BRCA2	PA165109660	675	0.339
NULL	Curr_Pathobiol_Rep_2014_Oct_17_2(4)_257-267.nxml.txt.nlp	25401052	SENT199	15	15	20	20	ebselen	DPI	PA161660841	1832	0.339
NULL	Pain_Res_Treat_2012_Aug_29_2012_898347.nxml.txt.nlp	22973509	SENT215	2	2	16	16	duloxetine	PLB	PA10066	151056	0.339
NULL	Oncotarget_2014_Feb_25_5(5)_1304-1314.nxml.txt.nlp	24675421	SENT105	7	7	12	12	cisplatin	RIP1	PA449014	10928;7386	0.339
NULL	Case_Rep_Ophthalmol_2010_Jun_11_1(1)_14-19.nxml.txt.nlp	20737054	SENT60	31	31	11	11	infliximab	ERG	PA452639	2078	0.339
NULL	J_Psychopharmacol_2014_Sep_28(9)_837-846.nxml.txt.nlp	25035246	SENT100	16	16	14	14	atomoxetine	ATX	PA134688071	5168;23049	0.339
NULL	Int_J_Biol_Sci_2015_Jan_1_11(1)_38-47.nxml.txt.nlp	25552928	SENT273	2	2	10	10	creatine	IL-6	PA164778930	3569	0.339
NULL	Eur_J_Med_Res_2011_Mar_28_16(3)_93-100.nxml.txt.nlp	21486721	SENT87	33	33	43	43	lamivudine	ATV	PA450163	4683	0.339
NULL	Ann_Rheum_Dis_2008_Jul_22_68(8)_1303-1309.nxml.txt.nlp	18647851	SENT141	12	12	9	9	adalimumab	MMP13	PA10004	4322	0.338
NULL	Braz_J_Microbiol_2010_Jun_1_Apr-Jun_41(2)_286-294.nxml.txt.nlp	24031493	SENT99	14	14	12	12	galactose	GAL	PA449725	51083	0.338
NULL	Clin_Transl_Allergy_2014_Jul_18_4(Suppl_3)_P113.nxml.txt.nlp	NULL	SENT0	20	20	33	33	piperacillin	MRC	PA450975	4345	0.338
NULL	J_Hematol_Oncol_2008_Jul_21_1_9.nxml.txt.nlp	18644156	SENT223	0	0	14	14	fluorescein	PC5	PA164746009	5125	0.338
NULL	Arch_Med_Sci_2011_Oct_8_7(5)_767-775.nxml.txt.nlp	22291820	SENT4	26	26	20	20	ezetimibe	STAT2	PA10816	6773	0.338
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2007_Jan_1_63(Pt_1)_1-8.nxml.txt.nlp	17164520	SENT43	30	30	33	33	trypsin	PTI	PA451806	5269	0.338
NULL	EMBO_Mol_Med_2013_Jun_24_5(6)_904-918.nxml.txt.nlp	23703906	SENT301	9	9	0	0	nadh	Miner1	PA164755085	493856	0.338
NULL	Indian_J_Ophthalmol_2010_Nov-Dec_58(6)_477-481.nxml.txt.nlp	20952830	SENT54	4	4	24	24	timolol	HEC	PA451690	10403	0.338
NULL	Mol_Cancer_2013_Nov_27_12_150.nxml.txt.nlp	24279793	SENT99	22	22	19	19	creatine	TNNI2	PA164778930	7136	0.338
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jun_30_66(Pt_7)_o1880.nxml.txt.nlp	21588074	SENT63	15	15	27	27	ethanol	mol	PA448073	90527	0.338
NULL	Orphanet_J_Rare_Dis_2008_Sep_16_3_25.nxml.txt.nlp	18796155	SENT297	14	14	12	12	cyclophosphamide	CPX	PA449165	1371;10682;1377	0.338
NULL	Mol_Cancer_2013_Sep_11_12_104.nxml.txt.nlp	24025152	SENT211	5	5	2	2	gemcitabine	STAT3	PA449748	6774	0.338
NULL	Sensors_(Basel)_2013_Mar_6_13(3)_3169-3203.nxml.txt.nlp	23467031	SENT321	37	37	32	32	cyclophosphamide	ACT	PA449165	12;11332;9457;641455	0.338
NULL	ISRN_Obstet_Gynecol_2011_Nov_23_2011_489281.nxml.txt.nlp	22191046	SENT41	17	17	29	29	nitrogen	MRI	PA450643	78996	0.338
NULL	Arthritis_Res_Ther_2004_Dec_5_6(1)_6-7.nxml.txt.nlp	14979925	SENT20	14	14	19	19	hyaluronan	HAS3	PA165958431	3038	0.338
NULL	Crit_Care_2011_Mar_11_15(Suppl_1)_P278.nxml.txt.nlp	NULL	SENT2	10	10	6	6	collagenase	MMP8	PA449107	4317	0.338
NULL	Oncotarget_2014_Oct_11_5(21)_10886-10900.nxml.txt.nlp	25350971	SENT288	29	29	20	20	hydrocortisone	EGF	PA449905	1950	0.338
NULL	Am_J_Pathol_2013_Apr_182(4)_1448-1458.nxml.txt.nlp	23410520	SENT86	40	40	43	43	dextran	mol	PA449261	90527	0.338
NULL	Int_J_Biol_Sci_2015_Jan_1_11(1)_48-58.nxml.txt.nlp	25552929	SENT12	5	5	3	3	paclitaxel	LDM	PA450761	1595	0.338
NULL	Korean_Circ_J_2013_Mar_31_43(3)_174-181.nxml.txt.nlp	23613694	SENT36	20	20	11	11	doxorubicin	NAC	PA449412	22861	0.338
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Dec_12_66(Pt_1)_m39.nxml.txt.nlp	21579937	SENT64	26	26	8	8	phenol	NO3	PA450913	4681	0.338
NULL	Biologics_2013_Apr_15_7_77-90.nxml.txt.nlp	23723688	SENT116	34	34	16	16	cetuximab	CRT	PA10040	811	0.338
NULL	Carbon_Balance_Manag_2010_Jun_17_5_3.nxml.txt.nlp	20565736	SENT170	27	27	31	31	ethanol	CO2	PA448073	4513	0.338
NULL	Int_J_Nanomedicine_2007_Jun_2(2)_241-252.nxml.txt.nlp	17722552	SENT215	26	26	20	20	dextran	HEMA	PA449261	2157	0.338
NULL	Crit_Care_2007_May_18_11(3)_R58.nxml.txt.nlp	17509156	SENT135	1	1	26	26	nadh	EPO	PA164755085	7076;8288;2056	0.338
NULL	Indian_J_Occup_Environ_Med_2008_Dec_12(3)_103-106.nxml.txt.nlp	20040966	SENT40	15	15	8	8	urea	GFR	PA451831	9771	0.338
NULL	Neural_Regen_Res_2014_Mar_15_9(6)_630-636.nxml.txt.nlp	25206866	SENT64	20	20	0	0	deferoxamine	DMT1	PA164746490	4891;1761	0.337
NULL	Adv_Bioinformatics_2012_Jun_6_2012_582765.nxml.txt.nlp	22719757	SENT124	36	36	21	21	thrombin	EGF	PA451674	1950	0.337
NULL	Tuberc_Respir_Dis_(Seoul)_2012_Dec_28_73(6)_303-311.nxml.txt.nlp	23319992	SENT43	20	20	15	15	gefitinib	EGFR	PA131301952	1956	0.337
NULL	Int_J_Anal_Chem_2013_Jul_16_2013_419716.nxml.txt.nlp	23956748	SENT146	1	1	15	15	ethanol	PF6	PA448073	200162	0.337
NULL	Pharmaceuticals_(Basel)_2011_Nov_11_4(11)_1503-1517.nxml.txt.nlp	NULL	SENT116	30	30	33	33	capsaicin	TRPV1	PA448776	7442	0.337
NULL	Chem_Cent_J_2012_Jun_20_6_58.nxml.txt.nlp	22716299	SENT162	31	31	40	40	genistein	Gen	PA165109660	348654	0.337
NULL	Aquat_Biosyst_2012_Oct_19_8_26.nxml.txt.nlp	23083531	SENT203	23	23	36	36	oxygen	NPP	PA450744	5443	0.337
NULL	Breast_Cancer_Res_2014_May_7_16(3)_207.nxml.txt.nlp	25223380	SENT163	24	24	36	36	letrozole	HER2	PA450196	2064	0.337
NULL	Glia_2009_Dec_20_57(16)_1802-1814.nxml.txt.nlp	19459212	SENT59	14	14	10	10	paraformaldehyde	PLP	PA450790	25824;5744	0.337
NULL	Clin_Med_Insights_Circ_Respir_Pulm_Med_2013_Nov_13_7_61-77.nxml.txt.nlp	24324354	SENT7	0	0	4	4	tobramycin	TIP	PA451704	81533;79828	0.337
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Sep_28_69(Pt_10)_m568-m569.nxml.txt.nlp	24098191	SENT3	41	41	43	43	ethanol	mol	PA448073	90527	0.337
NULL	Indian_J_Med_Res_2012_Mar_135(3)_407-413.nxml.txt.nlp	22561630	SENT12	3	3	21	21	omeprazole	LPO	PA450704	4025	0.337
NULL	Brain_Sci_2014_May_6_4(2)_356-375.nxml.txt.nlp	24961766	SENT99	4	4	23	23	propofol	NeuN	PA451141	146713	0.337
NULL	Front_Genet_2014_Jun_2_5_161.nxml.txt.nlp	24917881	SENT304	1	1	17	17	choline	POMC	PA448976	5443	0.337
NULL	Comp_Funct_Genomics_2008_Jun_1_2008_623145.nxml.txt.nlp	18528528	SENT225	18	18	11	11	potassium	p34	PA451047	902;79719	0.337
NULL	Asian_J_Androl_2014_Dec_16_Jan-Feb_16(1)_39-49.nxml.txt.nlp	24369132	SENT105	45	45	38	38	estradiol	AMH	PA449503	268	0.337
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1059-1066.nxml.txt.nlp	21364577	SENT88	2	2	9	9	tamoxifen	ATAC	PA451581	6375	0.337
NULL	Eur_J_Med_Res_2011_Mar_28_16(3)_93-100.nxml.txt.nlp	21486721	SENT87	25	25	43	43	emtricitabine	ATV	PA10069	4683	0.337
NULL	Case_Rep_Urol_2013_May_8_2013_915874.nxml.txt.nlp	23738191	SENT81	24	24	26	26	etoposide	ADM	PA449552	133	0.337
NULL	Biomed_Res_Int_2013_Aug_6_2013_909613.nxml.txt.nlp	24027765	SENT367	7	7	9	9	hydrocortisone	EEN	PA449905	6455	0.337
NULL	Breast_Cancer_Res_2004_May_7_6(4)_R338-R351.nxml.txt.nlp	15217501	SENT30	8	8	14	14	estradiol	CYP1A2	PA449503	1544	0.337
NULL	Cancers_(Basel)_2013_May_27_5(2)_617-638.nxml.txt.nlp	24216994	SENT142	0	0	8	8	curcumin	PC3	PA151958596	57332;7832;5122	0.337
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jan_31_68(Pt_2)_o541.nxml.txt.nlp	22347135	SENT66	30	30	23	23	ethanol	mol	PA448073	90527	0.337
NULL	Biomed_Res_Int_2013_Aug_6_2013_909613.nxml.txt.nlp	24027765	SENT357	8	8	10	10	hydrocortisone	EEN	PA449905	6455	0.337
NULL	Front_Microbiol_2015_Jan_6_5_751.nxml.txt.nlp	25610435	SENT362	8	8	13	13	l-threonine	B12	PA451673	7126;4709	0.337
NULL	Diabetes_2013_Mar_14_62(3)_789-800.nxml.txt.nlp	22966074	SENT338	6	6	22	22	oltipraz	NRF2		2551;4780	0.337
NULL	Orphanet_J_Rare_Dis_2008_Sep_16_3_25.nxml.txt.nlp	18796155	SENT297	37	37	35	35	ribavirin	RIBA	PA451241	6014	0.337
NULL	Arthritis_Res_Ther_2009_Aug_24_11(4)_R127.nxml.txt.nlp	19703304	SENT104	18	18	10	10	adalimumab	OASIS	PA10004	90993	0.337
NULL	Neural_Regen_Res_2014_Oct_1_9(19)_1731-1739.nxml.txt.nlp	25422633	SENT121	2	2	9	9	scopolamine	GCL	PA451308	64396;25801	0.337
NULL	Breast_Cancer_Res_2008_Dec_18_10(Suppl_4)_S25.nxml.txt.nlp	19128439	SENT12	10	10	17	17	tamoxifen	ATAC	PA451581	6375	0.337
NULL	Mol_Cancer_2010_May_18_9_110.nxml.txt.nlp	20482802	SENT184	14	14	11	11	bortezomib	CHOP	PA10252	1649	0.337
NULL	Front_Mol_Neurosci_2009_Aug_4_2_10.nxml.txt.nlp	19680469	SENT1250	3	3	12	12	retigabine	KCNQ2	PA144997862	3785	0.337
NULL	Lab_Invest_2012_Jul_7_92(7)_988-998.nxml.txt.nlp	22565576	SENT63	4	4	10	10	bevacizumab	San	PA130232992	80218	0.337
NULL	Evid_Based_Complement_Alternat_Med_2011_Mar_10_2011_481625.nxml.txt.nlp	21785626	SENT139	22	22	18	18	ethanol	IFN	PA448073	3439	0.337
NULL	Ann_Gen_Psychiatry_2008_Aug_28_7_16.nxml.txt.nlp	18755025	SENT0	14	14	1	1	paliperidone	Gen	PA163518919	348654	0.337
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Aug_3_69(Pt_9)_o1377-o1378.nxml.txt.nlp	24427021	SENT9	15	15	17	17	ethanol	mol	PA448073	90527	0.337
NULL	J_Lipid_Res_2011_May_52(5)_873-884.nxml.txt.nlp	21324916	SENT586	12	12	15	15	fenofibrate	adiponectin	PA449594	9370	0.337
NULL	Int_J_Med_Sci_2012_Aug_10_9(6)_472-479.nxml.txt.nlp	22927772	SENT115	16	16	23	23	warfarin	CYP2C9	PA451906	1559	0.336
NULL	J_Appl_Oral_Sci_2010_Sep-Oct_18(5)_503-508.nxml.txt.nlp	21085807	SENT41	22	22	16	16	ethanol	HEMA	PA448073	2157	0.336
NULL	Tuberc_Respir_Dis_(Seoul)_2012_Aug_31_73(2)_115-121.nxml.txt.nlp	23166544	SENT105	11	11	22	22	doxorubicin	CHOP	PA449412	1649	0.336
NULL	Mol_Cancer_2009_Dec_23_8_129.nxml.txt.nlp	20030852	SENT175	4	4	2	2	curcumin	ABCA1	PA151958596	19	0.336
NULL	Cancer_Growth_Metastasis_2014_Aug_10_7_33-42.nxml.txt.nlp	25187738	SENT192	10	10	7	7	bortezomib	OCN	PA10252	632	0.336
NULL	Br_J_Ophthalmol_2008_Sep_22_92(9)_1275-1282.nxml.txt.nlp	18723745	SENT4	16	16	23	23	latanoprost	BAK	PA164774763	578	0.336
NULL	ScientificWorldJournal_2012_Jan_2_11_2613-2619.nxml.txt.nlp	22262949	SENT112	22	22	12	12	ceftriaxone	CPZ	PA448866	8532	0.336
NULL	Neuropsychopharmacology_2009_Jul_25_34(8)_1968-1978.nxml.txt.nlp	19322168	SENT5	17	17	12	12	clozapine	PI3K	PA449061	5290	0.336
NULL	Breast_Cancer_Res_2012_Apr_4_14(2)_R57.nxml.txt.nlp	22475046	SENT22	3	3	10	10	tamoxifen	ATAC	PA451581	6375	0.336
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_May_8_66(Pt_6)_m606.nxml.txt.nlp	21579268	SENT61	23	23	32	32	ethanol	NO3	PA448073	4681	0.336
NULL	Ecancermedicalscience_2009_Oct_12_3_161.nxml.txt.nlp	22276022	SENT142	1	1	9	9	trastuzumab	HER-2	PA451743	2064	0.336
NULL	Int_J_Biol_Sci_2006_Mar_4_2(1)_17-22.nxml.txt.nlp	16585949	SENT69	7	7	17	17	guanethidine	ANOVA	PA449823	4858	0.336
NULL	Front_Endocrinol_(Lausanne)_2013_Jan_7_3_180.nxml.txt.nlp	23316185	SENT247	16	16	11	11	glucose	CRF2	PA449773	1395	0.336
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jun_26_66(Pt_7)_m853-m854.nxml.txt.nlp	21587762	SENT4	6	6	8	8	ethanol	mol	PA448073	90527	0.336
NULL	Breast_Cancer_Res_2014_Sep_9_16(5)_433.nxml.txt.nlp	25212966	SENT275	15	15	7	7	thrombin	ILEI	PA451674	10447	0.336
NULL	Endocrinology_2014_Aug_30_155(8)_2976-2985.nxml.txt.nlp	24877623	SENT391	0	0	8	8	estradiol	TSPO	PA449503	706	0.336
NULL	Ann_Maxillofac_Surg_2011_Jul-Dec_1(2)_145-149.nxml.txt.nlp	23482687	SENT35	13	13	9	9	collagenase	EMMPRIN	PA449107	682	0.336
NULL	Exp_Ther_Med_2013_Jan_19_5(1)_295-299.nxml.txt.nlp	23251286	SENT53	7	7	10	10	guanidine	GIT	PA164781028	5034	0.336
NULL	Onco_Targets_Ther_2014_Jun_13_7_1033-1042.nxml.txt.nlp	24966685	SENT158	21	21	23	23	gemcitabine	GAPDH	PA449748	2597	0.336
NULL	Front_Aging_Neurosci_2009_Nov_27_1_2.nxml.txt.nlp	20552053	SENT1043	2	2	9	9	estradiol	CA1	PA449503	759	0.336
NULL	Pharmaceuticals_(Basel)_2012_Jul_25_5(8)_779-801.nxml.txt.nlp	24280675	SENT85	6	6	18	18	hydroquinone	Hsp90	PA449924	3320	0.336
NULL	Nucleic_Acids_Res_2011_Oct_8_39(18)_e122.nxml.txt.nlp	21742759	SENT39	15	15	28	28	thrombin	CEA	PA451674	5670;1087	0.336
NULL	Gut_2012_May_3_61(5)_695-705.nxml.txt.nlp	21813473	SENT329	18	18	10	10	dextran	spatial	PA449261	219793	0.336
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT46	2	2	13	13	curcumin	PC-3	PA151958596	692094	0.336
NULL	Mol_Vis_2012_Nov_12_18_2687-2699.nxml.txt.nlp	23170061	SENT41	14	14	19	19	nadh	ND4	PA164755085	4538	0.336
NULL	J_Cell_Mol_Med_2014_Aug_9_18(8)_1549-1561.nxml.txt.nlp	24913911	SENT115	28	28	41	41	ketamine	ADX	PA450144	2230	0.336
NULL	Int_J_Chron_Obstruct_Pulmon_Dis_2008_Jun_3(2)_205-216.nxml.txt.nlp	18686730	SENT49	0	0	18	18	formoterol	DPI	PA134687907	1832	0.336
NULL	J_Biol_Chem_2012_Aug_17_287(34)_28932-28942.nxml.txt.nlp	22718751	SENT136	18	18	18	18	pp2	PP2		4888	0.336
NULL	Hum_Mol_Genet_2013_Jul_1_22(13)_2603-2611.nxml.txt.nlp	23459933	SENT231	17	17	9	9	papain	E16	PA450778	8140	0.336
NULL	Andrology_(Los_Angel)_2013_Nov_4_2_108.nxml.txt.nlp	24900949	SENT25	5	5	11	11	l-arginine	NOS	PA448478	4843	0.336
NULL	J_Korean_Med_Sci_2013_Apr_27_28(4)_527-533.nxml.txt.nlp	23580227	SENT91	22	22	24	24	genistein	TRAIL	PA165109660	8743	0.336
NULL	Biomed_Res_Int_2014_Jan_12_2014_560183.nxml.txt.nlp	24524080	SENT210	8	8	18	18	betaine	MTHFR	PA448603	4524	0.336
NULL	Clin_Cosmet_Investig_Dermatol_2012_May_24_5_43-51.nxml.txt.nlp	22791995	SENT50	19	19	34	34	thrombin	B19	PA451674	59271	0.336
NULL	J_Lipid_Res_2014_Apr_55(4)_645-658.nxml.txt.nlp	24493834	SENT353	14	14	6	6	lipase	HSL	PA450239	3991	0.336
NULL	Mol_Biol_Cell_2013_Jul_15_24(14)_2285-2298.nxml.txt.nlp	23720763	SENT139	10	10	23	23	trypsin	CPZ	PA451806	8532	0.336
NULL	Glycoconj_J_2012_Apr_14_29(2-3)_93-105.nxml.txt.nlp	22246380	SENT174	26	26	8	8	galactose	DARC	PA449725	2532	0.336
NULL	Front_Neuroendocrinol_2012_Jan_33(1)_45-66.nxml.txt.nlp	21802439	SENT2052	11	11	8	8	vasopressin	AVP	PA451858	114548;551	0.335
NULL	Mol_Cancer_2009_Dec_31_8_131.nxml.txt.nlp	20042122	SENT252	2	2	24	24	choline	PDK1	PA448976	5170;5163	0.335
NULL	Genome_Med_2010_Nov_12_2(11)_81.nxml.txt.nlp	21092148	SENT112	17	17	12	12	letrozole	HER2	PA450196	2064	0.335
NULL	Virol_J_2009_May_25_6_63.nxml.txt.nlp	19467157	SENT52	19	19	17	17	lamivudine	LAM	PA450163	7249;7248	0.335
NULL	Int_J_Biol_Sci_2011_Nov_5_8(1)_1-14.nxml.txt.nlp	22211100	SENT244	6	6	4	4	gemcitabine	Gem	PA449748	51053	0.335
NULL	Oncogene_2009_Dec_3_28(48)_4237-4248.nxml.txt.nlp	19734937	SENT36	7	7	21	21	collagenase	PAR-1	PA449107	2011;2149	0.335
NULL	J_Neuroinflammation_2010_Sep_7_7_51.nxml.txt.nlp	20822529	SENT210	8	8	4	4	hemin	HO-1	PA449849	3162	0.335
NULL	Int_J_Biol_Sci_2014_Aug_23_10(8)_921-939.nxml.txt.nlp	25170305	SENT332	6	6	10	10	nadh	AMPK	PA164755085	5563	0.335
NULL	Acta_Vet_Scand_2010_Jul_30_52(1)_47.nxml.txt.nlp	20670455	SENT103	31	31	37	37	sulfamethoxazole	TMP	PA451544	2012	0.335
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jun_26_66(Pt_7)_o1790.nxml.txt.nlp	21588000	SENT6	15	15	17	17	ethanol	mol	PA448073	90527	0.335
NULL	Ann_Rehabil_Med_2012_Aug_27_36(4)_466-473.nxml.txt.nlp	22977771	SENT15	17	17	8	8	triamcinolone	ILEI	PA451749	10447	0.335
NULL	Ann_Thorac_Med_2011_Apr-Jun_6(2)_101-102.nxml.txt.nlp	21572702	SENT12	33	33	36	36	oxygen	PSO2	PA450744	9937	0.335
NULL	Indian_J_Med_Res_2013_Jan_137(1)_125-129.nxml.txt.nlp	23481061	SENT59	2	2	6	6	cisplatin	GSTP1	PA449014	2950	0.335
NULL	Indian_J_Med_Res_2014_Apr_139(4)_572-578.nxml.txt.nlp	24927344	SENT17	19	19	42	42	warfarin	CYP2C9	PA451906	1559	0.335
NULL	Inflammopharmacology_2011_Dec_2_19(6)_327-334.nxml.txt.nlp	20596897	SENT36	7	7	16	16	phenol	DTNB	PA450913	1838	0.335
NULL	Br_J_Cancer_2006_Feb_13_94(3)_407-426.nxml.txt.nlp	16434996	SENT148	24	24	14	14	genistein	BRCA2	PA165109660	675	0.335
NULL	Arthritis_Res_Ther_2008_Oct_18_10(5)_R123.nxml.txt.nlp	18928561	SENT65	15	15	34	34	creatine	PTH	PA164778930	5741	0.335
NULL	Br_J_Cancer_2013_Jul_9_109(1)_68-75.nxml.txt.nlp	23807173	SENT217	10	10	7	7	cisplatin	ERCC1	PA449014	2067	0.335
NULL	Biol_Open_2012_Nov_23_2(2)_183-190.nxml.txt.nlp	23429853	SENT45	20	20	23	23	oxygen	ROS	PA450744	6098	0.335
NULL	J_Cardiothorac_Surg_2011_Apr_8_6_44.nxml.txt.nlp	21477293	SENT81	26	26	23	23	heparin	PF4	PA449855	5196	0.335
NULL	Drug_Target_Insights_2006_Dec_12_1_29-34.nxml.txt.nlp	21901056	SENT106	18	18	26	26	doxorubicin	HER2	PA449412	2064	0.335
NULL	Cancer_Imaging_2005_Jul_25_5(1)_78-84.nxml.txt.nlp	16154824	SENT66	10	10	3	3	choline	MRS	PA448976	8011	0.335
NULL	Mol_Pain_2012_Sep_27_8_75.nxml.txt.nlp	23013719	SENT375	30	30	39	39	capsaicin	TRPA1	PA448776	8989	0.335
NULL	Springerplus_2014_Sep_11_3_516.nxml.txt.nlp	25279308	SENT165	4	4	13	13	ethanol	SHF	PA448073	90525	0.335
NULL	J_Exp_Clin_Cancer_Res_2009_Feb_16_28(1)_21.nxml.txt.nlp	19216806	SENT4	13	13	16	16	hyaluronan	LYVE-1	PA165958431	10894	0.335
NULL	Ann_Rheum_Dis_2008_Apr_20_67(4)_511-517.nxml.txt.nlp	17644552	SENT123	4	4	10	10	infliximab	IL-6	PA452639	3569	0.335
NULL	J_Geriatr_Cardiol_2014_Mar_11(1)_63-73.nxml.txt.nlp	24748884	SENT101	30	30	22	22	levodopa	PKD	PA450213	5587	0.335
NULL	J_Anaesthesiol_Clin_Pharmacol_2012_Jan-Mar_28(1)_11-16.nxml.txt.nlp	22345938	SENT150	1	1	5	5	acetazolamide	CO2	PA448018	4513	0.335
NULL	Behav_Brain_Funct_2009_Jun_4_5_23.nxml.txt.nlp	19497110	SENT66	19	19	28	28	ethanol	P90	PA448073	821	0.335
NULL	Mol_Vis_2014_Sep_19_20_1271-1280.nxml.txt.nlp	25352736	SENT80	8	8	12	12	tropicamide	ERG	PA164749389	2078	0.335
NULL	Exp_Ther_Med_2015_Jan_12_9(1)_77-83.nxml.txt.nlp	25452779	SENT107	8	8	14	14	trypsin	ITIH4	PA451806	3700	0.335
NULL	Crit_Care_2009_Dec_22_13(6)_R208.nxml.txt.nlp	20028511	SENT47	25	25	13	13	thrombin	ADP	PA451674	23038	0.335
NULL	Arthritis_Rheumatol_2014_Apr_28_66(4)_979-989.nxml.txt.nlp	24757149	SENT7	24	24	18	18	collagenase	OSM	PA449107	5008	0.335
NULL	Int_J_Mol_Sci_2014_Jun_25_15(7)_11234-11244.nxml.txt.nlp	24968266	SENT71	16	16	10	10	docetaxel	PC-3	PA449383	692094	0.335
NULL	Case_Rep_Endocrinol_2014_Aug_10_2014_680876.nxml.txt.nlp	25177504	SENT90	9	9	15	15	thyroglobulin	TTF-1	PA164754910	7080	0.335
NULL	Emerg_Infect_Dis_2012_Jul_18(7)_1072-1080.nxml.txt.nlp	22709685	SENT254	8	8	16	16	vancomycin	VISA	PA451850	57506	0.335
NULL	Acta_Pharmacol_Sin_2012_Jan_3_33(1)_49-56.nxml.txt.nlp	22212430	SENT17	0	0	3	3	thrombin	PAR-1	PA451674	2011;2149	0.335
NULL	Exp_Ther_Med_2013_Nov_6_6(5)_1089-1095.nxml.txt.nlp	24223627	SENT12	17	17	15	15	epirubicin	NAC	PA449476	22861	0.334
NULL	J_Anaesthesiol_Clin_Pharmacol_2012_Oct-Dec_28(4)_486-490.nxml.txt.nlp	23225930	SENT4	13	13	34	34	neostigmine	TKR	PA450611	8277	0.334
NULL	Gut_Liver_2014_Jan_5_8(1)_49-57.nxml.txt.nlp	24516701	SENT151	7	7	4	4	diclofenac	cPLA2	PA449293	10524	0.334
NULL	Brain_Sci_2014_May_6_4(2)_356-375.nxml.txt.nlp	24961766	SENT125	13	13	4	4	propofol	P28	PA451141	9446;7802;9527	0.334
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jan_8_67(Pt_2)_o301.nxml.txt.nlp	21522991	SENT63	1	1	17	17	ethanol	mol	PA448073	90527	0.334
NULL	J_Midlife_Health_2013_Jul-Sep_4(3)_147-152.nxml.txt.nlp	24672186	SENT40	8	8	13	13	teriparatide	PTH	PA451620	5741	0.334
NULL	Arthritis_Res_Ther_2012_Nov_22_14(6)_R253.nxml.txt.nlp	23171658	SENT203	9	9	6	6	collagenase	MMP13	PA449107	4322	0.334
NULL	Mycobiology_2008_Jun_30_36(2)_88-92.nxml.txt.nlp	23990739	SENT125	10	10	20	20	galactose	Mal	PA449725	114609	0.334
NULL	Biomed_Res_Int_2014_Aug_4_2014_592868.nxml.txt.nlp	25165708	SENT345	10	10	8	8	gemcitabine	GEM	PA449748	2669	0.334
NULL	Br_J_Cancer_2011_Oct_11_105(8)_1131-1136.nxml.txt.nlp	21915126	SENT154	19	19	6	6	neratinib	EGFR	PA165291472	1956	0.334
NULL	Amino_Acids_2012_May_25_42(5)_1529-1539.nxml.txt.nlp	21437784	SENT92	2	2	10	10	taurine	STZ	PA451590	6484	0.334
NULL	Case_Rep_Urol_2013_May_8_2013_915874.nxml.txt.nlp	23738191	SENT81	32	32	26	26	cyclophosphamide	ADM	PA449165	133	0.334
NULL	Ann_Neurosci_2011_Jan_18(1)_8-13.nxml.txt.nlp	25205911	SENT23	24	24	13	13	diazepam	spatial	PA449283	219793	0.334
NULL	Cancer_Res_Treat_2015_Jan_27_47(1)_90-100.nxml.txt.nlp	25520153	SENT11	8	8	5	5	sulindac	survivin	PA451565	332	0.334
NULL	Cell_Death_Differ_2009_Jan_10_16(1)_175-183.nxml.txt.nlp	18846108	SENT165	9	9	13	13	betaine	BHMT	PA448603	635	0.334
NULL	J_Exp_Med_1998_Jun_1_187(11)_1885-1892.nxml.txt.nlp	9607928	SENT112	5	5	9	9	thalidomide	IL-2	PA451644	3558	0.334
NULL	Cancers_(Basel)_2014_Sep_30_6(4)_2035-2048.nxml.txt.nlp	25271833	SENT104	11	11	13	13	gefitinib	IL-2	PA131301952	3558	0.334
NULL	Bone_Marrow_Transplant_2009_Dec_20_44(11)_739-748.nxml.txt.nlp	19377515	SENT64	12	12	9	9	sulfamethoxazole	TMP	PA451544	2012	0.334
NULL	J_Cell_Biol_1998_Jun_15_141(6)_1349-1356.nxml.txt.nlp	9628891	SENT54	43	43	39	39	fluorescein	MRC	PA164746009	4345	0.334
NULL	J_Immunol_Res_2014_May_12_2014_897249.nxml.txt.nlp	24901013	SENT131	18	18	28	28	natalizumab	E2F1	PA164747191	1869	0.334
NULL	Breast_Cancer_Res_2008_Dec_18_10(Suppl_4)_S25.nxml.txt.nlp	19128439	SENT10	4	4	11	11	anastrozole	IMPACT	PA448432	55364	0.334
NULL	Chemother_Res_Pract_2011_Apr_18_2011_619321.nxml.txt.nlp	22312555	SENT157	6	6	4	4	vancomycin	VAN	PA451850	10318	0.334
NULL	Adv_Urol_2012_Nov_1_2012_641689.nxml.txt.nlp	22110494	SENT247	12	12	18	18	paclitaxel	EMP	PA450761	10296	0.334
NULL	Clin_J_Gastroenterol_2012_Oct_22_5(6)_407-412.nxml.txt.nlp	24672586	SENT58	10	10	7	7	sorafenib	DLST	PA7000	1743	0.334
NULL	Med_Sci_Monit_2012_Jun_1_18(6)_BR247-BR252.nxml.txt.nlp	22648246	SENT56	20	20	17	17	indomethacin	IBP	PA449982	706;50619	0.334
NULL	Adv_Nutr_2013_Mar_6_4(2)_226-235.nxml.txt.nlp	23493539	SENT162	14	14	10	10	nadh	ADH1B	PA164755085	125	0.334
NULL	Diabetes_Care_2010_Apr_12_33(4)_861-868.nxml.txt.nlp	20067962	SENT31	26	26	11	11	hyaluronan	HMGB1	PA165958431	3146	0.334
NULL	Mol_Biol_Cell_2012_Nov_1_23(21)_4212-4225.nxml.txt.nlp	22956765	SENT11	4	4	20	20	thrombin	SHP2	PA451674	5781	0.334
NULL	Diabetes_2013_Oct_17_62(10)_3547-3552.nxml.txt.nlp	23863812	SENT79	23	23	7	7	pravastatin	adiponectin	PA451089	9370	0.334
NULL	J_Hematol_Oncol_2013_Oct_1_6_75.nxml.txt.nlp	24279871	SENT243	6	6	4	4	cyclophosphamide	CTX	PA449165	1593	0.334
NULL	J_Cardiothorac_Surg_2013_Nov_21_8_215.nxml.txt.nlp	24261787	SENT38	24	24	14	14	fluorouracil	CRT	PA128406956	811	0.334
NULL	Indian_J_Pharmacol_2008_Jun_40(3)_95-102.nxml.txt.nlp	20040934	SENT262	3	3	17	17	etanercept	CCL20	PA449515	6364	0.334
NULL	J_Phys_Ther_Sci_2013_Oct_20_25(10)_1317-1319.nxml.txt.nlp	24259784	SENT15	22	22	30	30	oxygen	ADP	PA450744	23038	0.334
NULL	Adv_Ther_2014_Dec_2_31_1228-1246.nxml.txt.nlp	25447269	SENT119	8	8	28	28	timolol	TIM	PA451690	7984;8914	0.334
NULL	Clin_Ophthalmol_2014_Aug_18_8_1527-1534.nxml.txt.nlp	25170245	SENT4	36	36	40	40	timolol	TIM	PA451690	7984;8914	0.334
NULL	Crit_Care_2008_Jun_25_12(3)_R84.nxml.txt.nlp	18578859	SENT97	23	23	18	18	heparin	PF4	PA449855	5196	0.334
NULL	Nucleic_Acids_Res_2012_Jul_30_40(13)_6319-6337.nxml.txt.nlp	22467215	SENT275	35	35	31	31	cisplatin	Bcl-2	PA449014	596	0.334
NULL	Cases_J_2008_Dec_30_1_426.nxml.txt.nlp	19116013	SENT58	7	7	28	28	cyclophosphamide	CHOP	PA449165	1649	0.334
NULL	Vet_Res_2014_Dec_16_45(1)_123.nxml.txt.nlp	25512064	SENT145	31	31	35	35	zinc	MZF1	PA451956	7593	0.333
NULL	Ann_Indian_Acad_Neurol_2012_Jul-Sep_15(3)_181-185.nxml.txt.nlp	22919189	SENT31	14	14	20	20	trypsin	ITIH4	PA451806	3700	0.333
NULL	Trials_2012_Jul_26_13_118.nxml.txt.nlp	22834768	SENT120	16	16	27	27	estradiol	PAPP-A	PA449503	5069	0.333
NULL	J_Pain_Res_2014_Aug_1_7_449-454.nxml.txt.nlp	25120375	SENT91	5	5	2	2	fentanyl	TFP	PA449599	7034	0.333
NULL	Clin_Interv_Aging_2010_Dec_3_5_381-393.nxml.txt.nlp	21152240	SENT220	29	29	2	2	metoprolol	BEST	PA450480	7439	0.333
NULL	Behav_Brain_Funct_2013_Jan_7_9_1.nxml.txt.nlp	23295062	SENT42	20	20	33	33	methylphenidate	GRM7	PA450464	2917	0.333
NULL	Front_Genet_2014_Jan_24_5_3.nxml.txt.nlp	24478792	SENT570	11	11	4	4	flecainide	DPP6	PA449646	1804	0.333
NULL	J_Oncol_2010_Aug_19_2010_932803.nxml.txt.nlp	20847951	SENT242	16	16	7	7	pp2	U87		677775;641648	0.333
NULL	Braz_J_Med_Biol_Res_2013_Sep_6_46(9)_746-751.nxml.txt.nlp	24036910	SENT71	0	0	18	18	genistein	PP1	PA165109660	5540;5464	0.333
NULL	ScientificWorldJournal_2013_Aug_19_2013_157527.nxml.txt.nlp	24089600	SENT122	11	11	5	5	ethanol	TPC	PA448073	8030;60386	0.333
NULL	Cancer_Cell_Int_2013_Aug_21_13_85.nxml.txt.nlp	23961808	SENT225	8	8	36	36	temozolomide	MELK	PA451609	9833	0.333
NULL	Pharmaceuticals_(Basel)_2011_Jan_12_4(1)_187-201.nxml.txt.nlp	NULL	SENT155	10	10	23	23	l-arginine	ARG	PA448478	473;27	0.333
NULL	Exp_Ther_Med_2013_Aug_6_6(2)_427-434.nxml.txt.nlp	24137203	SENT237	35	35	4	4	fosinopril	MCP-1	PA449710	6347	0.333
NULL	Cell_Tissue_Res_2012_Jul_14_349(1)_375-395.nxml.txt.nlp	22411698	SENT182	5	5	15	15	dextran	CST	PA449261	9514	0.333
NULL	Front_Neuroeng_2014_Oct_10_7_39.nxml.txt.nlp	25346683	SENT240	25	25	21	21	platinum	ITO	PA150595617	3160	0.333
NULL	Arthritis_Res_2001_Jan_26_3(Suppl_A)_P094.nxml.txt.nlp	NULL	SENT5	8	8	5	5	pamidronate	OPG	PA450767	690	0.333
NULL	Cancers_(Basel)_2011_Mar_29_3(2)_1732-1743.nxml.txt.nlp	21738852	SENT87	10	10	7	7	thyroglobulin	TPO	PA164754910	7066;7173	0.333
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2685-2695.nxml.txt.nlp	24136147	SENT348	18	18	21	21	nutlin-3	DR5		8795	0.333
NULL	J_Cell_Biol_2005_Jan_31_168(3)_501-511.nxml.txt.nlp	15684035	SENT540	12	12	17	17	urokinase	CD87	PA451836	5329	0.333
NULL	Breast_Cancer_Res_2009_Mar_19_11(2)_R16.nxml.txt.nlp	19298655	SENT118	26	26	8	8	lipase	FABP4	PA450239	2167	0.333
NULL	Acta_Pharmacol_Sin_2011_Mar_4_32(3)_399-407.nxml.txt.nlp	21372830	SENT142	4	4	8	8	erlotinib	CYP3A	PA134687924	1574	0.333
NULL	Indian_J_Med_Res_2011_Nov_134(5)_704-708.nxml.txt.nlp	22199111	SENT22	1	1	7	7	vancomycin	VISA	PA451850	57506	0.333
NULL	Indian_J_Med_Res_2012_Jul_136(1)_54-59.nxml.txt.nlp	22885264	SENT106	0	0	10	10	cisplatin	IFN	PA449014	3439	0.333
NULL	Arthritis_Res_2001_May_3_3(4)_214-215.nxml.txt.nlp	NULL	SENT44	6	6	8	8	collagenase	TIMP1	PA449107	7076	0.333
NULL	Front_Behav_Neurosci_2012_Jun_13_6_24.nxml.txt.nlp	22707936	SENT1671	0	0	13	13	chlordiazepoxide	spatial	PA448932	219793	0.333
NULL	Cardiovasc_Diabetol_2008_Feb_26_7_3.nxml.txt.nlp	18302760	SENT196	10	10	2	2	rosiglitazone	CD36	PA451283	948	0.333
NULL	Curr_Med_Chem_2012_Aug_19(22)_3763-3778.nxml.txt.nlp	22680930	SENT58	22	22	27	27	celecoxib	5-LOX	PA448871	240	0.333
NULL	Oncotarget_2011_Nov_9_2(11)_850-861.nxml.txt.nlp	22081665	SENT181	9	9	11	11	daunorubicin	DNMT3A	PA449212	1788	0.333
NULL	Biologics_2013_Apr_15_7_77-90.nxml.txt.nlp	23723688	SENT116	18	18	27	27	cetuximab	CRT	PA10040	811	0.333
NULL	Breast_Cancer_Res_2011_Jan_28_13(1)_301.nxml.txt.nlp	21345282	SENT41	17	17	25	25	medroxyprogesterone	RANK	PA450344	8792	0.333
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jun_2_68(Pt_7)_o1996.nxml.txt.nlp	22807827	SENT68	30	30	12	12	ethanol	mol	PA448073	90527	0.333
NULL	Clin_Exp_Reprod_Med_2014_Sep_30_41(3)_120-124.nxml.txt.nlp	25309856	SENT0	23	23	25	25	thyroglobulin	ADAMTS16	PA164754910	170690	0.333
NULL	Breast_Cancer_Res_2011_Nov_24_13(6)_R120.nxml.txt.nlp	22115051	SENT117	39	39	14	14	tamoxifen	HER-2	PA451581	2064	0.333
NULL	Appl_Plant_Sci_2015_Jan_5_3(1)_apps_1400086.nxml.txt.nlp	25606353	SENT65	36	36	38	38	chloramphenicol	BAM	PA448927	9126	0.333
NULL	Chem_Cent_J_2012_Oct_26_6_123.nxml.txt.nlp	23098128	SENT167	1	1	4	4	phenol	TPC	PA450913	8030;60386	0.333
NULL	Ann_Clin_Microbiol_Antimicrob_2005_Sep_13_4_13.nxml.txt.nlp	16159399	SENT137	35	35	33	33	lamivudine	LAM	PA450163	7249;7248	0.333
NULL	Case_Rep_Gastroenterol_2011_Oct_7_5(3)_610-616.nxml.txt.nlp	22110423	SENT8	22	22	14	14	mesalazine	DLST	PA450384	1743	0.332
NULL	Iran_J_Radiol_2012_Jun_30_9(2)_88-92.nxml.txt.nlp	23329970	SENT75	5	5	9	9	vincristine	CHOP	PA451879	1649	0.332
NULL	Cancer_Cell_Int_2012_Jul_18_12_34.nxml.txt.nlp	22809533	SENT69	0	0	5	5	cisplatin	HK1	PA449014	3098;51361;3739	0.332
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT185	10	10	12	12	paclitaxel	ABCB1	PA450761	5243	0.332
NULL	Exp_Diabetes_Res_2012_Dec_26_2012_230624.nxml.txt.nlp	23365557	SENT255	36	36	21	21	liraglutide	Rog	PA165958364	27033	0.332
NULL	Mol_Cancer_2007_Sep_26_6_61.nxml.txt.nlp	17894897	SENT273	8	8	18	18	etoposide	p53	PA449552	7157	0.332
NULL	Breast_Cancer_Res_2011_Nov_24_13(6)_R120.nxml.txt.nlp	22115051	SENT99	2	2	11	11	tamoxifen	HER-2	PA451581	2064	0.332
NULL	Crit_Care_2011_Aug_10_15(4)_R192.nxml.txt.nlp	21831302	SENT222	20	20	27	27	oxygen	PRC	PA450744	23082	0.332
NULL	ScientificWorldJournal_2013_Aug_19_2013_157527.nxml.txt.nlp	24089600	SENT126	12	12	6	6	ethanol	TPC	PA448073	8030;60386	0.332
NULL	Neural_Regen_Res_2014_Oct_1_9(19)_1731-1739.nxml.txt.nlp	25422633	SENT116	2	2	4	4	scopolamine	GCL	PA451308	64396;25801	0.332
NULL	Allergy_Asthma_Immunol_Res_2013_Jul_3_5(4)_232-238.nxml.txt.nlp	23814677	SENT36	28	28	9	9	methacholine	MAST	PA165958382	51324	0.332
NULL	Springerplus_2013_Dec_7_2_659.nxml.txt.nlp	24353977	SENT210	25	25	31	31	ketotifen	MSU	PA450152	593	0.332
NULL	Evid_Based_Complement_Alternat_Med_2013_Aug_20_2013_789067.nxml.txt.nlp	24069055	SENT219	3	3	0	0	lipase	HSL	PA450239	3991	0.332
NULL	Int_J_Cell_Biol_2010_Jan_18_2010_207420.nxml.txt.nlp	20145726	SENT39	0	0	17	17	trypsin	NAC	PA451806	22861	0.332
NULL	Br_J_Ophthalmol_2014_Jul_98(Suppl_2)_ii24-ii29.nxml.txt.nlp	24934220	SENT44	14	14	6	6	fluorescein	OCT	PA164746009	5362	0.332
NULL	Ann_Indian_Acad_Neurol_2012_Jul-Sep_15(3)_169.nxml.txt.nlp	NULL	SENT10	22	22	28	28	trypsin	ITIH4	PA451806	3700	0.332
NULL	Braz_J_Med_Biol_Res_2012_Mar_30_45(4)_314-320.nxml.txt.nlp	22450372	SENT102	2	2	18	18	fluoxetine	PAG	PA449673	55824	0.332
NULL	Genome_Announc_2013_Dec_5_1(6)_e01011-13.nxml.txt.nlp	24309740	SENT8	23	23	14	14	vancomycin	VISA	PA451850	57506	0.332
NULL	Autoimmune_Dis_2012_Feb_2_2012_374635.nxml.txt.nlp	22400102	SENT76	6	6	8	8	thyroglobulin	TPO	PA164754910	7066;7173	0.332
NULL	Cancers_(Basel)_2010_Dec_30_3(1)_106-125.nxml.txt.nlp	24212609	SENT322	18	18	12	12	gemcitabine	HuR	PA449748	1994	0.332
NULL	EMBO_J_2014_Jul_17_33(14)_1514-1526.nxml.txt.nlp	24872509	SENT281	7	7	17	17	zinc	MBNL1	PA451956	4154	0.332
NULL	J_Invest_Dermatol_2012_Feb_20_132(2)_421-428.nxml.txt.nlp	22011905	SENT197	16	16	22	22	nadh	ND3	PA164755085	4537	0.332
NULL	Br_J_Cancer_2010_Jun_8_102(12)_1707-1716.nxml.txt.nlp	20461078	SENT9	21	21	18	18	bortezomib	TRAIL	PA10252	8743	0.332
NULL	Mol_Cell_Proteomics_2014_Apr_6_13(4)_1050-1064.nxml.txt.nlp	24505114	SENT201	26	26	35	35	trypsin	ITIH4	PA451806	3700	0.332
NULL	J_Inflamm_(Lond)_2008_Dec_5_5_23.nxml.txt.nlp	19061493	SENT158	24	24	5	5	hemin	HO-1	PA449849	3162	0.332
NULL	Cancer_Metastasis_Rev_2007_Dec_24_26(3-4)_489-502.nxml.txt.nlp	17717633	SENT279	9	9	12	12	hyaluronan	LYVE-1	PA165958431	10894	0.332
NULL	J_Korean_Med_Sci_2011_Jan_22_26(1)_33-41.nxml.txt.nlp	21218027	SENT36	30	30	19	19	linezolid	DST	PA450233	667	0.332
NULL	Tuberc_Respir_Dis_(Seoul)_2012_Aug_31_73(2)_115-121.nxml.txt.nlp	23166544	SENT126	11	11	0	0	vincristine	CHOP	PA451879	1649	0.332
NULL	Curr_Control_Trials_Cardiovasc_Med_2001_Feb_2_2(1)_20-23.nxml.txt.nlp	11806769	SENT70	0	0	5	5	bucindolol	BEST	PA165945764	7439	0.332
NULL	EMBO_Mol_Med_2012_Jul_21_4(7)_594-602.nxml.txt.nlp	22359342	SENT66	17	17	5	5	tetracycline	p53	PA451640	7157	0.332
NULL	Biomed_Res_Int_2014_Jun_25_2014_203693.nxml.txt.nlp	25089265	SENT194	17	17	13	13	sorafenib	SHARP	PA7000	23013	0.332
NULL	Mol_Neurodegener_2011_Jan_13_6_4.nxml.txt.nlp	21232114	SENT240	2	2	37	37	brimonidine	PI3K	PA448665	5290	0.332
NULL	J_Adv_Pharm_Technol_Res_2012_Jul-Sep_3(3)_188-192.nxml.txt.nlp	23057006	SENT28	2	2	13	13	fenofibrate	TMP	PA449594	2012	0.332
NULL	Biologics_2014_Mar_17_8_91-105.nxml.txt.nlp	24669185	SENT39	0	0	11	11	dasatinib	CD117	PA162372878	3815	0.332
NULL	Ann_Saudi_Med_2011_Mar-Apr_31(2)_140-144.nxml.txt.nlp	21403409	SENT14	3	3	8	8	glucose	G6PD	PA449773	2539	0.332
NULL	Int_J_Anal_Chem_2013_Jul_16_2013_419716.nxml.txt.nlp	23956748	SENT92	8	8	22	22	ethanol	PF6	PA448073	200162	0.332
NULL	Front_Neuroenergetics_2014_Jan_9_5_13.nxml.txt.nlp	24409143	SENT230	9	9	19	19	ketamine	FDG	PA450144	23583	0.332
NULL	Clin_Ophthalmol_2010_Oct_21_4_1217-1222.nxml.txt.nlp	21060675	SENT7	16	16	39	39	timolol	BAK	PA451690	578	0.332
NULL	Mol_Cancer_2009_Aug_28_8_68.nxml.txt.nlp	19715609	SENT132	13	13	16	16	oxygen	ROS	PA450744	6098	0.332
NULL	Front_Behav_Neurosci_2014_Oct_30_8_366.nxml.txt.nlp	25400560	SENT247	17	17	9	9	ethanol	GLAST	PA448073	6507	0.332
NULL	Crit_Care_2008_Jun_25_12(3)_R84.nxml.txt.nlp	18578859	SENT97	31	31	18	18	heparin	PF4	PA449855	5196	0.331
NULL	Clin_Infect_Dis_2012_Sep_15_55(6)_816-824.nxml.txt.nlp	22700830	SENT67	14	14	18	18	gentamicin	GBA	PA449753	2629	0.331
NULL	Arch_Gynecol_Obstet_2011_Aug_24_284(2)_343-355.nxml.txt.nlp	21431845	SENT174	26	26	23	23	medroxyprogesterone	CEE	PA450344	51608	0.331
NULL	Ann_Oncol_2011_Mar_8_22(3)_503-514.nxml.txt.nlp	20616198	SENT302	21	21	28	28	tamoxifen	IMPACT	PA451581	55364	0.331
NULL	Mol_Cell_Biochem_2014_Oct_9_385(1-2)_265-275.nxml.txt.nlp	24104452	SENT145	8	8	19	19	bortezomib	U87	PA10252	677775;641648	0.331
NULL	Front_Genet_2013_Aug_29_4_163.nxml.txt.nlp	24009622	SENT37	17	17	13	13	ethanol	DDP	PA448073	1678	0.331
NULL	J_Cell_Biol_2002_Mar_18_156(6)_951-957.nxml.txt.nlp	11901164	SENT56	13	13	13	13	pp2	PP2		4888	0.331
NULL	J_Geriatr_Cardiol_2014_Mar_11(1)_63-73.nxml.txt.nlp	24748884	SENT101	18	18	22	22	levodopa	PKD	PA450213	5587	0.331
NULL	Cell_Death_Dis_2010_May_13_1(5)_e41.nxml.txt.nlp	21364648	SENT111	15	15	17	17	etoposide	FasL	PA449552	356	0.331
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Oct_17_65(Pt_11)_o2767.nxml.txt.nlp	21578361	SENT63	1	1	23	23	ethanol	mol	PA448073	90527	0.331
NULL	Aging_(Albany_NY)_2009_Dec_29_2(1)_63-68.nxml.txt.nlp	20228936	SENT36	25	25	18	18	nadh	CYB5R3	PA164755085	1727	0.331
NULL	Neural_Regen_Res_2014_Oct_1_9(19)_1731-1739.nxml.txt.nlp	25422633	SENT165	6	6	13	13	scopolamine	GCL	PA451308	64396;25801	0.331
NULL	Evid_Based_Complement_Alternat_Med_2014_Jul_1_2014_423751.nxml.txt.nlp	25101132	SENT184	22	22	24	24	tetracycline	Met	PA451640	79811	0.331
NULL	Genome_Biol_2007_Sep_26_8(9)_227.nxml.txt.nlp	17903313	SENT31	25	25	29	29	protamine	PRM2	PA10366	5620	0.331
NULL	J_Immunol_Res_2014_May_8_2014_565320.nxml.txt.nlp	24901010	SENT68	36	36	43	43	fosphenytoin	HLA-B	PA164746820	3106	0.331
NULL	Breast_Cancer_Res_2006_Nov_6_8(6)_215.nxml.txt.nlp	17096862	SENT14	0	0	26	26	trastuzumab	PTEN	PA451743	5728	0.331
NULL	Exp_Diabetes_Res_2012_Sep_20_2012_936518.nxml.txt.nlp	23049542	SENT35	7	7	9	9	glucose	TRPV4	PA449773	59341	0.331
NULL	Nanoscale_Res_Lett_2012_Jul_24_7(1)_417.nxml.txt.nlp	22827911	SENT71	22	22	13	13	ethanol	NO3	PA448073	4681	0.331
NULL	Cancers_(Basel)_2011_Oct_26_3(4)_4024-4045.nxml.txt.nlp	24213123	SENT179	26	26	15	15	resveratrol	PTEN		5728	0.331
NULL	Eur_Respir_J_2012_Jun_17_39(6)_1511-1519.nxml.txt.nlp	22005918	SENT108	34	34	0	0	pyrazinamide	DST	PA451182	667	0.331
NULL	Eur_J_Haematol_2014_Feb_25_92(2)_127-136.nxml.txt.nlp	24118452	SENT14	15	15	11	11	anagrelide	CRT	PA164742986	811	0.331
NULL	Acta_Pharmacol_Sin_2010_Jun_4_31(6)_709-717.nxml.txt.nlp	20523342	SENT45	17	17	20	20	glucose	PPG	PA449773	5552	0.331
NULL	Nat_Biotechnol_2008_Mar_24_26(3)_343-351.nxml.txt.nlp	18297058	SENT196	33	33	27	27	phenol	San	PA450913	80218	0.331
NULL	Vet_Res_2013_Dec_5_44(1)_119.nxml.txt.nlp	24308795	SENT84	42	42	23	23	nitrogen	OCT	PA450643	5362	0.331
NULL	JRSM_Short_Rep_2010_Dec_1_1(7)_58.nxml.txt.nlp	21234130	SENT64	16	16	1	1	isotretinoin	Gen	PA450128	348654	0.331
NULL	Oncol_Lett_2013_Oct_24_6(4)_970-976.nxml.txt.nlp	24137447	SENT15	22	22	15	15	ifosfamide	ADM	PA449964	133	0.331
NULL	J_Med_Life_2011_Feb_15_4(1)_11-20.nxml.txt.nlp	21505570	SENT46	26	26	17	17	lipase	FAAH	PA450239	79152;2166	0.331
NULL	Mol_Cancer_2009_Dec_31_8_131.nxml.txt.nlp	20042122	SENT252	9	9	24	24	choline	PDK1	PA448976	5170;5163	0.331
NULL	Case_Rep_Oncol_2012_Mar_17_5(1)_125-133.nxml.txt.nlp	22666200	SENT74	20	20	26	26	cyclophosphamide	ACTH	PA449165	5443	0.331
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT1	14	14	17	17	tacrolimus	IL-6	PA451578	3569	0.331
NULL	Cancers_(Basel)_2010_Nov_2_2(4)_1830-1837.nxml.txt.nlp	24281203	SENT58	13	13	8	8	lipase	PRSS2	PA450239	5645	0.331
NULL	ScientificWorldJournal_2012_Jan_2_11_2613-2619.nxml.txt.nlp	22262949	SENT112	10	10	12	12	ampicillin	CPZ	PA448419	8532	0.331
NULL	Am_J_Transplant_2014_Nov_2_14(11)_2595-2606.nxml.txt.nlp	25278159	SENT168	11	11	28	28	collagenase	NB1	PA449107	57126	0.331
NULL	Int_J_Inflam_2011_Aug_11_2011_514623.nxml.txt.nlp	21860805	SENT108	14	14	26	26	thrombin	ADP	PA451674	23038	0.331
NULL	Breast_Cancer_Res_2003_Feb_5_5(2)_109-112.nxml.txt.nlp	12631391	SENT104	14	14	18	18	urokinase	UPA	PA451836	118471;5328	0.33
NULL	Pak_J_Med_Sci_2013_Sep-Oct_29(5)_1167-1172.nxml.txt.nlp	24353713	SENT34	0	0	5	5	artemisinin	ACT	PA165111696	12;11332;9457;641455	0.33
NULL	Nucleic_Acids_Res_2011_Mar_18_39(5)_1647-1655.nxml.txt.nlp	21097466	SENT138	9	9	4	4	camptothecin	Yes	PA153590860	7525	0.33
NULL	Arthritis_Res_Ther_2011_Apr_28_13(2)_215.nxml.txt.nlp	21539724	SENT69	30	30	27	27	denosumab	RANKL	PA166048634	8600	0.33
NULL	Cell_Commun_Signal_2013_Dec_23_11_100.nxml.txt.nlp	24364863	SENT173	16	16	28	28	erlotinib	PP2	PA134687924	4888	0.33
NULL	J_Orthop_Surg_2007_May_21_2_9.nxml.txt.nlp	17511887	SENT89	19	19	15	15	alendronate	DPD	PA448082	1806	0.33
NULL	Osteoporos_Int_2014_Oct_10_25(3)_1173-1180.nxml.txt.nlp	24108429	SENT206	2	2	8	8	teriparatide	PTH	PA451620	5741	0.33
NULL	J_Cancer_Res_Clin_Oncol_2010_May_11_136(5)_737-743.nxml.txt.nlp	19904559	SENT40	23	23	15	15	bevacizumab	IFL	PA130232992	3439	0.33
NULL	Mol_Vis_2011_Aug_25_17_2297-2310.nxml.txt.nlp	21921981	SENT153	16	16	10	10	estradiol	HSD17B1	PA449503	3292	0.33
NULL	Cancer_Manag_Res_2012_Nov_9_4_383-395.nxml.txt.nlp	23204869	SENT144	11	11	16	16	carmustine	PC-3	PA448810	692094	0.33
NULL	Cancer_Gene_Ther_2013_Jul_14_20(7)_394-402.nxml.txt.nlp	23764901	SENT228	37	37	22	22	bicalutamide	PC3	PA164746255	57332;7832;5122	0.33
NULL	Cell_Host_Microbe_2014_Sep_10_16(3)_291-303.nxml.txt.nlp	25211072	SENT554	36	36	36	36	pp2	PP2		4888	0.33
NULL	J_Immunol_Res_2014_May_12_2014_897249.nxml.txt.nlp	24901013	SENT254	14	14	10	10	natalizumab	CD49d	PA164747191	3676	0.33
NULL	J_Exp_Clin_Cancer_Res_2009_Jun_23_28(1)_88.nxml.txt.nlp	19545454	SENT43	29	29	27	27	gemcitabine	Gem	PA449748	51053	0.33
NULL	Mol_Biol_Cell_2013_Apr_15_24(8)_1208-1221.nxml.txt.nlp	23427269	SENT394	7	7	22	22	paraformaldehyde	CSK	PA450790	1445	0.33
NULL	Cell_Regen_(Lond)_2012_Jun_28_1(1)_3.nxml.txt.nlp	25408866	SENT193	5	5	13	13	oxygen	MSC	PA450744	9242	0.33
NULL	Br_J_Cancer_2013_Jun_25_108(12)_2505-2515.nxml.txt.nlp	23736036	SENT275	18	18	8	8	capecitabine	CDA	PA448771	978	0.33
NULL	Neural_Plast_2012_May_20_2012_569149.nxml.txt.nlp	22685677	SENT35	25	25	13	13	lipase	iPLA2	PA450239	8398	0.33
NULL	J_Lipid_Res_2015_Jan_56(1)_109-121.nxml.txt.nlp	25421061	SENT24	23	23	13	13	lipase	ATGL	PA450239	57104	0.33
NULL	F1000Res_2014_Mar_18_3_74.nxml.txt.nlp	25580222	SENT108	13	13	9	9	ciprofloxacin	TOX	PA449009	9760	0.33
NULL	Adv_Hematol_2011_Oct_15_2011_196135.nxml.txt.nlp	22013445	SENT194	0	0	4	4	thrombin	TGT	PA451674	9097;81890	0.33
NULL	Int_J_Mol_Sci_2014_Jun_18_15(6)_11013-11029.nxml.txt.nlp	24945311	SENT622	0	0	10	10	rituximab	STAT3	PA451261	6774	0.33
NULL	Arq_Bras_Cardiol_2013_Nov_101(5)_466-471.nxml.txt.nlp	24100694	SENT75	47	47	10	10	aspirin	ABP	PA448497	6462	0.33
NULL	Cholesterol_2011_Feb_22_2011_503028.nxml.txt.nlp	21490773	SENT5	1	1	11	11	methotrexate	COX	PA450428	1351	0.33
NULL	J_Cardiothorac_Surg_2014_May_9_9_81.nxml.txt.nlp	24885948	SENT153	6	6	20	20	sorafenib	GATA4	PA7000	2626	0.33
NULL	Ann_Rheum_Dis_2008_Apr_20_67(4)_511-517.nxml.txt.nlp	17644552	SENT142	2	2	15	15	infliximab	IL-6	PA452639	3569	0.33
NULL	Iran_J_Pharm_Res_2014_Spring_13(2)_683-693.nxml.txt.nlp	25237365	SENT157	3	3	7	7	tranilast	CXCR4	PA131890628	7852	0.33
NULL	Iran_J_Pharm_Res_2015_Winter_14(1)_321-328.nxml.txt.nlp	25561938	SENT141	37	37	33	33	forskolin	PGD2	PA146096022	27306	0.33
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Oct_15_70(Pt_11)_o1158-o1159.nxml.txt.nlp	25484802	SENT92	31	31	24	24	ethanol	mol	PA448073	90527	0.33
NULL	Arthritis_Res_Ther_2009_Aug_24_11(4)_R127.nxml.txt.nlp	19703304	SENT56	18	18	10	10	adalimumab	OASIS	PA10004	90993	0.33
NULL	Viruses_2009_Nov_4_1(3)_689-712.nxml.txt.nlp	20221421	SENT202	32	32	36	36	papain	PLP	PA450778	25824;5744	0.33
NULL	Cancer_Med_2013_Dec_22_2(6)_862-871.nxml.txt.nlp	24403259	SENT78	27	27	20	20	everolimus	4E-BP1	PA164746311	1978	0.33
NULL	J_Cell_Mol_Med_2014_Mar_22_18(3)_422-433.nxml.txt.nlp	24450475	SENT26	12	12	15	15	hyaluronan	LYVE-1	PA165958431	10894	0.33
NULL	Breast_Cancer_Res_Treat_2008_Jun_28_109(3)_567-572.nxml.txt.nlp	17661169	SENT127	10	10	17	17	tamoxifen	ATAC	PA451581	6375	0.33
NULL	J_Invest_Dermatol_2011_Nov_30_131(11)_2306-2315.nxml.txt.nlp	21716326	SENT42	39	39	39	39	pp2	PP2		4888	0.33
NULL	J_Interv_Card_Electrophysiol_2013_Oct_8_38(3)_147-153.nxml.txt.nlp	24101149	SENT59	11	11	31	31	heparin	ACT	PA449855	12;11332;9457;641455	0.33
NULL	Chemother_Res_Pract_2011_Dec_18_2011_965826.nxml.txt.nlp	22295208	SENT296	16	16	14	14	azacitidine	ACT	PA451996	12;11332;9457;641455	0.33
NULL	Biomed_Res_Int_2013_Jul_30_2013_754946.nxml.txt.nlp	23984405	SENT191	16	16	29	29	nadh	CYTB	PA164755085	4519	0.33
NULL	J_Headache_Pain_2011_Jun_8_12(3)_295-302.nxml.txt.nlp	21301922	SENT31	2	2	12	12	creatine	ADP	PA164778930	23038	0.33
NULL	Front_Genet_2014_Jun_2_5_154.nxml.txt.nlp	24917878	SENT305	1	1	17	17	choline	POMC	PA448976	5443	0.33
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_15_2012_591654.nxml.txt.nlp	23118793	SENT286	30	30	24	24	rosiglitazone	Met	PA451283	79811	0.329
NULL	Gene_Regul_Syst_Bio_2013_Nov_4_7_139-152.nxml.txt.nlp	24250222	SENT95	12	12	9	9	nadh	COX	PA164755085	1351	0.329
NULL	J_Asthma_Allergy_2014_Feb_27_7_11-21.nxml.txt.nlp	24600237	SENT262	18	18	4	4	tiotropium	FEV	PA164769056	54738	0.329
NULL	J_Oncol_2009_Mar_24_2009_491985.nxml.txt.nlp	19325924	SENT75	0	0	4	4	genistein	CXCL12	PA165109660	6387	0.329
NULL	Front_Mol_Neurosci_2015_Jan_9_7_103.nxml.txt.nlp	25620909	SENT1383	0	0	9	9	choline	spatial	PA448976	219793	0.329
NULL	Hum_Mol_Genet_2010_Feb_15_19(4)_623-633.nxml.txt.nlp	19955119	SENT241	38	38	24	24	phenol	NO3	PA450913	4681	0.329
NULL	EMBO_Mol_Med_2013_Dec_21_5(12)_1918-1934.nxml.txt.nlp	24293318	SENT193	5	5	10	10	rolipram	ANOVA	PA153906323	4858	0.329
NULL	Oncogenesis_2014_May_12_3(5)_e102.nxml.txt.nlp	24819061	SENT247	19	19	11	11	nadh	p53	PA164755085	7157	0.329
NULL	Genetics_2014_Oct_1_198(2)_431-434.nxml.txt.nlp	25316778	SENT56	26	26	17	17	nitrogen	NSF	PA450643	4905	0.329
NULL	Arthritis_Res_Ther_2003_Feb_28_5(3)_105-115.nxml.txt.nlp	12723975	SENT200	27	27	25	25	neomycin	CD44	PA450608	960	0.329
NULL	Indian_J_Med_Res_2010_Dec_132(6)_676-682.nxml.txt.nlp	21245614	SENT94	0	0	2	2	zinc	p53	PA451956	7157	0.329
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT123	0	0	11	11	methotrexate	MSH2	PA450428	4436	0.329
NULL	Mol_Med_Rep_2015_Feb_29_11(2)_924-930.nxml.txt.nlp	25351620	SENT8	2	2	15	15	paclitaxel	PI3K	PA450761	5290	0.329
NULL	Cancers_(Basel)_2010_Jun_14_2(2)_1288-1311.nxml.txt.nlp	24281116	SENT9	4	4	7	7	oxygen	ROS	PA450744	6098	0.329
NULL	J_Korean_Med_Sci_2013_Apr_27_28(4)_527-533.nxml.txt.nlp	23580227	SENT104	24	24	26	26	genistein	TRAIL	PA165109660	8743	0.329
NULL	Alzheimers_Res_Ther_2013_May_14_5(3)_25.nxml.txt.nlp	23673233	SENT468	4	4	9	9	donepezil	spatial	PA449394	219793	0.329
NULL	J_Cell_Biol_2005_May_23_169(4)_657-667.nxml.txt.nlp	15911880	SENT73	6	6	6	6	pp2	PP2		4888	0.329
NULL	Gastric_Cancer_2013_Dec_14_16(4)_513-520.nxml.txt.nlp	23238856	SENT133	12	12	15	15	hyaluronan	LYVE-1	PA165958431	10894	0.329
NULL	J_Biomed_Biotechnol_2006_May_28_2006_82323.nxml.txt.nlp	17047315	SENT52	3	3	6	6	oxygen	ROS	PA450744	6098	0.329
NULL	Int_J_Biol_Sci_2011_Nov_5_8(1)_1-14.nxml.txt.nlp	22211100	SENT234	6	6	4	4	gemcitabine	Gem	PA449748	51053	0.329
NULL	Reprod_Biol_Endocrinol_2003_Oct_7_1_71.nxml.txt.nlp	14577832	SENT110	1	1	20	20	cisplatin	JNK	PA449014	5599	0.329
NULL	Indian_J_Med_Res_2013_Jan_137(1)_125-129.nxml.txt.nlp	23481061	SENT59	2	2	8	8	cisplatin	GSTT1	PA449014	2952	0.329
NULL	Int_J_Biol_Sci_2011_Nov_5_8(1)_1-14.nxml.txt.nlp	22211100	SENT210	2	2	4	4	evodiamine	Gem	PA165860788	51053	0.329
NULL	Core_Evid_2009_Jun_15_4_83-92.nxml.txt.nlp	20694067	SENT11	0	0	9	9	conivaptan	AVP	PA164742939	114548;551	0.329
NULL	Case_Rep_Urol_2013_May_8_2013_915874.nxml.txt.nlp	23738191	SENT81	36	36	26	26	mitomycin	ADM	PA450524	133	0.329
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Nov_15_5_27.nxml.txt.nlp	17107610	SENT39	22	22	4	4	rifabutin	CPX	PA451249	1371;10682;1377	0.329
NULL	Mar_Drugs_2014_Jun_27_12(7)_3818-3837.nxml.txt.nlp	24979269	SENT157	14	14	16	16	calcein	MRP1	PA132595336	4437	0.329
NULL	Indian_J_Pharm_Sci_2008_Sep-Oct_70(5)_591-595.nxml.txt.nlp	21394254	SENT123	9	9	12	12	nebivolol	NEB	PA151958426	4703	0.329
NULL	Clin_Ophthalmol_2008_Dec_2(4)_727-733.nxml.txt.nlp	19668423	SENT137	19	19	7	7	bevacizumab	CRT	PA130232992	811	0.329
NULL	Diabetes_Metab_Res_Rev_2011_Jan_7_27(1)_14-27.nxml.txt.nlp	21218504	SENT194	36	36	42	42	glucosamine	GNPDA	PA164747613	10007	0.329
NULL	Cancers_(Basel)_2013_Aug_9_5(3)_998-1019.nxml.txt.nlp	24202331	SENT72	7	7	11	11	docetaxel	PC3	PA449383	57332;7832;5122	0.329
NULL	Int_J_Med_Sci_2013_Jun_13_10(8)_981-987.nxml.txt.nlp	23801884	SENT32	12	12	16	16	trypsin	SPINK1	PA451806	6690	0.329
NULL	Open_Biochem_J_2009_Dec_11_3_78-84.nxml.txt.nlp	20111725	SENT4	27	27	30	30	morphine	GPI	PA450550	10007;2821	0.329
NULL	Indian_J_Med_Res_2012_Apr_135(4)_456-458.nxml.txt.nlp	22664491	SENT30	31	31	24	24	artemisinin	ACT	PA165111696	12;11332;9457;641455	0.329
NULL	Neural_Regen_Res_2014_Mar_15_9(6)_622-629.nxml.txt.nlp	25206865	SENT73	0	0	3	3	vasopressin	c-Jun	PA451858	3725	0.329
NULL	J_Hematol_Oncol_2011_Nov_4_4_44.nxml.txt.nlp	22053759	SENT97	9	9	17	17	clopidogrel	ACS	PA449053	55902;84680	0.329
NULL	Oncotarget_2014_Oct_18_5(20)_10058-10069.nxml.txt.nlp	25375203	SENT213	15	15	6	6	isoproterenol	EGF	PA450121	1950	0.329
NULL	Oncotarget_2014_Mar_14_5(5)_1149-1156.nxml.txt.nlp	24658419	SENT57	10	10	7	7	doxorubicin	p53	PA449412	7157	0.329
NULL	Neural_Regen_Res_2014_Oct_1_9(19)_1731-1739.nxml.txt.nlp	25422633	SENT173	12	12	6	6	scopolamine	DCX	PA451308	1641	0.328
NULL	Acta_Neuropathol_Commun_2014_Jan_2_2_1.nxml.txt.nlp	24383468	SENT140	28	28	32	32	nadh	ND5	PA164755085	4540	0.328
NULL	J_Hum_Genet_2013_Jun_16_58(6)_353-361.nxml.txt.nlp	23677058	SENT124	36	36	34	34	etoposide	ABCC3	PA449552	8714	0.328
NULL	Front_Pharmacol_2014_Dec_19_5_270.nxml.txt.nlp	25566071	SENT205	30	30	20	20	doxycycline	Oct4	PA449415	5460	0.328
NULL	Indian_J_Ophthalmol_2013_Mar_61(3)_136-138.nxml.txt.nlp	23514656	SENT14	30	30	16	16	fluorescein	PED	PA164746009	8682	0.328
NULL	Front_Neurosci_2012_May_30_6_77.nxml.txt.nlp	22661925	SENT160	0	0	7	7	ethanol	HEC	PA448073	10403	0.328
NULL	Breast_Cancer_Res_2007_Aug_8_9(4)_R50.nxml.txt.nlp	17686159	SENT183	3	3	9	9	gefitinib	HRG	PA131301952	3084;3273	0.328
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Mar_31_68(Pt_4)_m508.nxml.txt.nlp	22589860	SENT62	22	22	12	12	ethanol	mol	PA448073	90527	0.328
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2751-2762.nxml.txt.nlp	24169358	SENT208	21	21	33	33	letrozole	HER2	PA450196	2064	0.328
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_75-89.nxml.txt.nlp	17912638	SENT375	25	25	32	32	tamoxifen	ATAC	PA451581	6375	0.328
NULL	Arthritis_Res_Ther_2010_Aug_24_12(4)_214.nxml.txt.nlp	20735862	SENT192	2	2	31	31	abatacept	TBC	PA164747080	23216	0.328
NULL	Lab_Anim_Res_2012_Jun_26_28(2)_123-129.nxml.txt.nlp	22787486	SENT19	17	17	40	40	lipase	CB1	PA450239	1268	0.328
NULL	Acta_Vet_Scand_2010_Jun_12_52(1)_39.nxml.txt.nlp	20540788	SENT88	15	15	12	12	creatine	ASAT	PA164778930	22	0.328
NULL	Int_J_Mol_Sci_2010_Sep_13_11(9)_3195-3208.nxml.txt.nlp	20957088	SENT219	6	6	5	5	lipase	AT2	PA450239	186	0.328
NULL	Cancer_Metastasis_Rev_2010_Dec_10_29(4)_581-594.nxml.txt.nlp	20830503	SENT313	2	2	9	9	tamoxifen	ATAC	PA451581	6375	0.328
NULL	Mol_Cancer_2009_Jun_8_8_34.nxml.txt.nlp	19500427	SENT73	13	13	11	11	gemcitabine	Gem	PA449748	51053	0.328
NULL	F1000_Med_Rep_2009_Feb_24_1_13.nxml.txt.nlp	20948769	SENT8	22	22	31	31	cyclophosphamide	CHOP	PA449165	1649	0.328
NULL	Int_J_Biol_Sci_2011_Nov_5_8(1)_1-14.nxml.txt.nlp	22211100	SENT244	2	2	4	4	evodiamine	Gem	PA165860788	51053	0.328
NULL	J_Hematol_Oncol_2011_Jun_10_4_27.nxml.txt.nlp	21663651	SENT54	24	24	22	22	cyclophosphamide	CTX	PA449165	1593	0.328
NULL	Front_Neurol_2013_Nov_13_4_184.nxml.txt.nlp	24312073	SENT237	14	14	23	23	fluoxetine	FLAME	PA449673	8837	0.328
NULL	J_Geriatr_Cardiol_2011_Sep_8(3)_184-194.nxml.txt.nlp	22783304	SENT132	36	36	41	41	procainamide	NAPA	PA451108	9476;8775	0.328
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jul_3_66(Pt_8)_o1911.nxml.txt.nlp	21588243	SENT56	18	18	28	28	ethanol	mol	PA448073	90527	0.328
NULL	Aging_(Albany_NY)_2011_Jan_18_3(1)_33-43.nxml.txt.nlp	21248371	SENT210	0	0	5	5	zinc	HIF-1	PA451956	29072	0.328
NULL	Front_Neurol_2013_Nov_6_4_176.nxml.txt.nlp	24223570	SENT319	0	0	5	5	carbachol	PPN	PA448784	64840	0.328
NULL	Cancers_(Basel)_2013_Jan_21_5(1)_64-91.nxml.txt.nlp	24216699	SENT1146	29	29	6	6	lapatinib	HER2	PA152241907	2064	0.328
NULL	Cardiovasc_Res_2011_Feb_15_89(3)_604-613.nxml.txt.nlp	21088116	SENT156	12	12	12	12	pp2	PP2		4888	0.328
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Mar_25_65(Pt_4)_o839.nxml.txt.nlp	21582558	SENT5	35	35	37	37	ethanol	mol	PA448073	90527	0.328
NULL	Front_Oncol_2014_Apr_10_4_76.nxml.txt.nlp	24782987	SENT118	18	18	37	37	rituximab	PRIMA	PA451261	145270	0.327
NULL	Ann_Indian_Acad_Neurol_2013_Apr-Jun_16(2)_208-210.nxml.txt.nlp	23956565	SENT68	23	23	33	33	choline	GFPT1	PA448976	2673	0.327
NULL	Br_J_Cancer_2014_Jan_21_110(2)_520-529.nxml.txt.nlp	24335922	SENT138	7	7	12	12	collagenase	MMP10	PA449107	4319	0.327
NULL	Cancer_Res_Treat_2014_Jan_15_46(1)_48-54.nxml.txt.nlp	24520223	SENT122	11	11	16	16	mitomycin	MAX	PA450524	4149	0.327
NULL	Clin_Pharmacokinet_2014_Sep_3_53(1)_1-16.nxml.txt.nlp	23999929	SENT118	10	10	24	24	rivaroxaban	CLCR	PA165958360	11330	0.327
NULL	Environ_Health_Perspect_2009_Nov_29_117(11)_1682-1689.nxml.txt.nlp	20049117	SENT113	0	0	36	36	creatine	FIB	PA164778930	2091	0.327
NULL	Iran_J_Pharm_Res_2014_Spring_13(2)_459-469.nxml.txt.nlp	25237341	SENT51	27	27	24	24	ethanol	mol	PA448073	90527	0.327
NULL	J_Cell_Biol_2000_Jul_10_150(1)_145-154.nxml.txt.nlp	10893263	SENT48	4	4	24	24	tetracycline	San	PA451640	80218	0.327
NULL	J_Oncol_2010_Feb_22_2010_891059.nxml.txt.nlp	20182637	SENT148	25	25	23	23	cisplatin	BRCA1	PA449014	672	0.327
NULL	J_Gen_Physiol_2009_Jun_133(6)_623-625.nxml.txt.nlp	19468076	SENT16	22	22	14	14	sulfur	TRPA1	PA451558	8989	0.327
NULL	Int_J_Cell_Biol_2014_Jan_22_2014_709828.nxml.txt.nlp	24578708	SENT94	11	11	9	9	choline	CTL1	PA448976	23446	0.327
NULL	J_Adv_Pharm_Technol_Res_2012_Jul-Sep_3(3)_188-192.nxml.txt.nlp	23057006	SENT28	0	0	13	13	clofibrate	TMP	PA449045	2012	0.327
NULL	Fibrogenesis_Tissue_Repair_2012_Jul_23_5_11.nxml.txt.nlp	22824096	SENT178	13	13	33	33	bleomycin	FasL	PA448645	356	0.327
NULL	Mar_Drugs_2009_Jul_17_7(3)_331-340.nxml.txt.nlp	19841717	SENT3	41	41	9	9	trabectedin	FDG	PA165958349	23583	0.327
NULL	Pharmaceuticals_(Basel)_2014_Mar_5_7(3)_311-338.nxml.txt.nlp	24603603	SENT229	4	4	6	6	cetuximab	EGFR	PA10040	1956	0.327
NULL	J_Korean_Med_Sci_2010_Aug_21_25(8)_1222-1227.nxml.txt.nlp	20676337	SENT18	5	5	18	18	propofol	LPA	PA451141	4018	0.327
NULL	Nucleic_Acids_Res_2010_Oct_28_38(19)_6418-6432.nxml.txt.nlp	20511593	SENT231	43	43	47	47	collagenase	AP-1	PA449107	2353;3727;2354;3725	0.327
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Nov_19_67(Pt_12)_o3378.nxml.txt.nlp	22199869	SENT56	20	20	15	15	ethanol	mol	PA448073	90527	0.327
NULL	Open_Ophthalmol_J_2012_Jul_24_6_65-72.nxml.txt.nlp	22888383	SENT97	0	0	5	5	fluorescein	ERG	PA164746009	2078	0.327
NULL	Biologics_2013_Apr_15_7_77-90.nxml.txt.nlp	23723688	SENT116	34	34	27	27	cetuximab	CRT	PA10040	811	0.327
NULL	Biomed_Res_Int_2013_Aug_6_2013_909613.nxml.txt.nlp	24027765	SENT347	2	2	4	4	hydrocortisone	EEN	PA449905	6455	0.327
NULL	J_Cardiothorac_Surg_2011_Aug_10_6_96.nxml.txt.nlp	21831274	SENT61	6	6	11	11	colchicine	COPE	PA449092	11316	0.327
NULL	AIDS_Res_Treat_2012_May_14_2012_246280.nxml.txt.nlp	22675613	SENT179	31	31	7	7	nevirapine	ATV	PA450616	4683	0.327
NULL	Acta_Diabetol_2012_Feb_15_49(1)_17-24.nxml.txt.nlp	21234613	SENT213	11	11	13	13	isoproterenol	TNF-alpha	PA450121	7124	0.327
NULL	Eur_J_Med_Res_2010_Sep_24_15(9)_369-376.nxml.txt.nlp	20952345	SENT90	21	21	23	23	lopinavir	ATV	PA450264	4683	0.327
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Aug_6_64(Pt_9)_o1710.nxml.txt.nlp	21201697	SENT62	33	33	26	26	ethanol	mol	PA448073	90527	0.327
NULL	J_Immune_Based_Ther_Vaccines_2006_Mar_17_4_1.nxml.txt.nlp	16545119	SENT119	10	10	22	22	oxygen	CD95	PA450744	355	0.327
NULL	Mol_Cancer_2008_Sep_12_7_69.nxml.txt.nlp	18789131	SENT136	14	14	14	14	pp2	PP2		4888	0.327
NULL	Emerg_Microbes_Infect_2014_Mar_12_3(3)_e17.nxml.txt.nlp	NULL	SENT112	17	17	22	22	daptomycin	VAN	PA164768820	10318	0.327
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Nov_26_64(Pt_12)_o2445.nxml.txt.nlp	21581413	SENT4	1	1	3	3	ethanol	mol	PA448073	90527	0.327
NULL	Endocr_Connect_2012_Jul_21_1(1)_37-47.nxml.txt.nlp	23781302	SENT131	33	33	4	4	mitotane	CYP3A4	PA164746157	1576	0.326
NULL	Arthritis_Res_Ther_2011_Jun_21_13(3)_R98.nxml.txt.nlp	21693018	SENT76	13	13	9	9	mannitol	TLN	PA450320	7087	0.326
NULL	Biomed_Res_Int_2014_May_27_2014_986594.nxml.txt.nlp	24971366	SENT195	0	0	27	27	hyaluronan	HA-8	PA165958431	9933	0.326
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_May_31_69(Pt_6)_m345.nxml.txt.nlp	23795005	SENT9	17	17	19	19	ethanol	mol	PA448073	90527	0.326
NULL	Curr_Control_Trials_Cardiovasc_Med_2001_Jun_26_2(4)_151-155.nxml.txt.nlp	11806788	SENT32	9	9	12	12	ramipril	AIRE	PA451223	326	0.326
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2009_Jun_1_65(Pt_6)_513-522.nxml.txt.nlp	19465765	SENT57	0	0	3	3	chloramphenicol	CLS	PA448927	1210	0.326
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Nov_19_70(Pt_12)_519-521.nxml.txt.nlp	25552981	SENT34	0	0	7	7	ethanol	NO3	PA448073	4681	0.326
NULL	Behav_Brain_Funct_2008_May_24_4_22.nxml.txt.nlp	18501011	SENT97	15	15	13	13	nifedipine	NIF	PA450631	6280	0.326
NULL	J_Gen_Physiol_1997_Dec_1_110(6)_693-715.nxml.txt.nlp	9382897	SENT220	39	39	36	36	choline	EAOH	PA448976	54840	0.326
NULL	Contemp_Clin_Dent_2011_Oct-Dec_2(4)_278-282.nxml.txt.nlp	22346152	SENT95	10	10	20	20	potassium	GCF	PA451047	6936	0.326
NULL	Neuropsychologia_2012_Nov_50(13)_3156-3168.nxml.txt.nlp	22884957	SENT243	28	28	4	4	scopolamine	CA1	PA451308	759	0.326
NULL	Osteoporos_Int_2014_May_8_25(9)_2323-2324.nxml.txt.nlp	24807627	SENT36	3	3	9	9	teriparatide	PTH	PA451620	5741	0.326
NULL	Eur_J_Haematol_2014_Feb_25_92(2)_127-136.nxml.txt.nlp	24118452	SENT14	36	36	11	11	anagrelide	CRT	PA164742986	811	0.326
NULL	Biomed_Res_Int_2013_Aug_28_2013_532720.nxml.txt.nlp	24066291	SENT184	19	19	22	22	choline	NF-M	PA448976	4741	0.326
NULL	Genet_Mol_Biol_2009_Mar_27_Apr-Jun_32(2)_414-422.nxml.txt.nlp	21637700	SENT31	6	6	11	11	nadh	ND4	PA164755085	4538	0.326
NULL	Open_Cardiovasc_Med_J_2011_Jun_20_5_136-147.nxml.txt.nlp	21760856	SENT127	27	27	16	16	metformin	adiponectin	PA450395	9370	0.326
NULL	Pak_J_Med_Sci_2013_Nov-Dec_29(6)_1465-1467.nxml.txt.nlp	24550978	SENT43	9	9	24	24	methylprednisolone	CTX	PA450466	1593	0.326
NULL	J_Korean_Med_Sci_2009_Oct_24_24(5)_910-917.nxml.txt.nlp	19794992	SENT23	10	10	13	13	paclitaxel	HER2	PA450761	2064	0.326
NULL	Eur_J_Cancer_2014_Sep_50(14)_2367-2374.nxml.txt.nlp	25027307	SENT289	9	9	6	6	estradiol	AMH	PA449503	268	0.326
NULL	Oncotarget_2014_Mar_13_5(4)_1101-1110.nxml.txt.nlp	24658355	SENT161	6	6	3	3	tamoxifen	MKP-2	PA451581	1846	0.326
NULL	Nat_Genet_2014_Feb_15_46(2)_152-160.nxml.txt.nlp	24336168	SENT36	15	15	9	9	galactose	TDP-43	PA449725	23435	0.326
NULL	J_Mol_Signal_2010_May_10_5_4.nxml.txt.nlp	20459745	SENT113	0	0	16	16	cisplatin	p53	PA449014	7157	0.326
NULL	AIDS_Res_Treat_2010_Sep_26_2010_856542.nxml.txt.nlp	21490905	SENT21	24	24	20	20	maraviroc	CCR5	PA164768835	1234	0.326
NULL	Int_J_Hypertens_2013_Jun_17_2013_627938.nxml.txt.nlp	23844279	SENT146	31	31	6	6	telmisartan	A10	PA451605	28870	0.326
NULL	Indian_J_Med_Res_2014_Mar_139(3)_349-370.nxml.txt.nlp	24820829	SENT138	3	3	15	15	urokinase	CI-B18	PA451836	4713	0.326
NULL	Front_Neurosci_2012_May_30_6_77.nxml.txt.nlp	22661925	SENT206	0	0	7	7	ethanol	HEC	PA448073	10403	0.326
NULL	Tech_Coloproctol_2014_Sep_13_18(4)_373-380.nxml.txt.nlp	24030782	SENT256	8	8	33	33	bupivacaine	AAP	PA135057240	5345	0.326
NULL	Cardiovasc_Ultrasound_2013_Aug_2_11_27.nxml.txt.nlp	23915276	SENT164	8	8	6	6	dipyridamole	DIP	PA449367	23151;1831	0.326
NULL	Eur_J_Med_Res_2011_Mar_28_16(3)_93-100.nxml.txt.nlp	21486721	SENT87	45	45	43	43	atazanavir	ATV	PA10251	4683	0.326
NULL	Cell_Commun_Signal_2014_Aug_1_12_50.nxml.txt.nlp	25081034	SENT249	3	3	0	0	oxygen	ROS	PA450744	6098	0.326
NULL	Mol_Cell_Biochem_2014_Oct_9_385(1-2)_265-275.nxml.txt.nlp	24104452	SENT124	29	29	44	44	bortezomib	U87	PA10252	677775;641648	0.326
NULL	Clin_Ophthalmol_2008_Mar_2(1)_31-55.nxml.txt.nlp	19668387	SENT174	11	11	14	14	fluorescein	SPK	PA164746009	55872;8189	0.326
NULL	Curr_Cardiol_Rev_2010_Aug_6(3)_238-244.nxml.txt.nlp	21804783	SENT187	0	0	22	22	simvastatin	CXCR4	PA451363	7852	0.326
NULL	Carcinogenesis_2010_Mar_25_31(3)_446-454.nxml.txt.nlp	19942609	SENT210	19	19	12	12	doxycycline	DLD	PA449415	1738	0.326
NULL	Free_Radic_Biol_Med_2014_Oct_75_48-59.nxml.txt.nlp	25048970	SENT118	40	40	23	23	paraformaldehyde	CTB	PA450790	9468	0.326
NULL	Breast_Cancer_Res_2008_Dec_18_10(Suppl_4)_S26.nxml.txt.nlp	19128440	SENT61	19	19	0	0	anastrozole	ATAC	PA448432	6375	0.326
NULL	Proteome_Sci_2010_Nov_17_8_58.nxml.txt.nlp	21083881	SENT163	11	11	14	14	galactose	CGB	PA449725	1082	0.326
NULL	J_Cell_Biol_2003_Aug_18_162(4)_661-671.nxml.txt.nlp	12925710	SENT126	30	30	30	30	pp2	PP2		4888	0.326
NULL	Amino_Acids_2014_Jul_19_46(1)_7-20.nxml.txt.nlp	22810731	SENT112	0	0	22	22	taurine	HO-1	PA451590	3162	0.325
NULL	Br_J_Cancer_2010_Jan_5_102(1)_80-86.nxml.txt.nlp	19920817	SENT4	0	0	6	6	bevacizumab	IFN	PA130232992	3439	0.325
NULL	Bioinorg_Chem_Appl_2014_Oct_12_2014_354138.nxml.txt.nlp	25371657	SENT99	7	7	15	15	ethanol	NO3	PA448073	4681	0.325
NULL	Mol_Cancer_2010_Nov_2_9_289.nxml.txt.nlp	21044322	SENT149	11	11	17	17	cisplatin	RGS10	PA449014	6001	0.325
NULL	Cancer_Metastasis_Rev_2010_Dec_10_29(4)_581-594.nxml.txt.nlp	20830503	SENT352	30	30	37	37	tamoxifen	ATAC	PA451581	6375	0.325
NULL	J_Oncol_2010_Dec_24_2010_497429.nxml.txt.nlp	20066162	SENT178	6	6	4	4	gemcitabine	GEM	PA449748	2669	0.325
NULL	Int_J_Mol_Sci_2007_Feb_23_8(2)_145-155.nxml.txt.nlp	NULL	SENT12	2	2	14	14	methazolamide	CA-II	PA450413	760	0.325
NULL	J_Biomed_Biotechnol_2008_Jul_8_2008_597913.nxml.txt.nlp	18629230	SENT78	20	20	11	11	ethanol	PFK-1	PA448073	5213	0.325
NULL	Cancer_Cell_Int_2013_Nov_8_13_111.nxml.txt.nlp	24209962	SENT151	2	2	8	8	fluvastatin	A20	PA449688	7128;28935	0.325
NULL	Int_J_Nanomedicine_2012_May_7_7_2307-2314.nxml.txt.nlp	22661887	SENT109	6	6	11	11	gemcitabine	F10	PA449748	2159	0.325
NULL	Diabetes_2009_Apr_9_58(4)_965-974.nxml.txt.nlp	19136651	SENT11	12	12	18	18	nadh	NQO1	PA164755085	1728	0.325
NULL	Crit_Care_2009_Dec_22_13(6)_R208.nxml.txt.nlp	20028511	SENT47	21	21	13	13	thrombin	ADP	PA451674	23038	0.325
NULL	Osteoporos_Int_2008_Apr_12_19(4)_399-428.nxml.txt.nlp	18266020	SENT879	5	5	27	27	raloxifene	STAR	PA451221	6770;2984	0.325
NULL	Int_J_Mol_Sci_2014_Nov_6_15(11)_20290-20305.nxml.txt.nlp	25383674	SENT368	0	0	16	16	oltipraz	NRF2		2551;4780	0.325
NULL	Clin_Med_Insights_Oncol_2011_Sep_21_5_265-314.nxml.txt.nlp	22084619	SENT1292	9	9	6	6	glucosamine	C-1	PA164747613	5203	0.325
NULL	Br_J_Haematol_2014_Jan_28_164(2)_233-244.nxml.txt.nlp	24206017	SENT18	25	25	23	23	thalidomide	DDB1	PA451644	1642	0.325
NULL	Diabetes_2008_Sep_57(9)_2272-2279.nxml.txt.nlp	18519799	SENT134	3	3	6	6	rosiglitazone	PDK4	PA451283	5166	0.325
NULL	Diabetol_Metab_Syndr_2014_Sep_23_6(1)_102.nxml.txt.nlp	NULL	SENT5	0	0	13	13	atorvastatin	RAGE	PA448500	177	0.325
NULL	J_Cell_Biol_1980_Feb_1_84(2)_294-297.nxml.txt.nlp	7380884	SENT5	1	1	7	7	creatine	CMIP	PA164778930	80790	0.325
NULL	Case_Rep_Urol_2012_Feb_28_2012_259193.nxml.txt.nlp	22606633	SENT25	22	22	4	4	cisplatin	API	PA449014	5345	0.325
NULL	Diabetes_Obes_Metab_2012_Dec_19_14(12)_1097-1103.nxml.txt.nlp	22734440	SENT196	10	10	0	0	exenatide	San	PA164749238	80218	0.325
NULL	Aging_(Albany_NY)_2010_Apr_30_2(4)_183-184.nxml.txt.nlp	20436227	SENT10	2	2	27	27	resveratrol	IL-6		3569	0.325
NULL	J_Cell_Biol_2002_Mar_18_156(6)_951-957.nxml.txt.nlp	11901164	SENT220	11	11	11	11	pp2	PP2		4888	0.325
NULL	Breast_Cancer_Res_2011_Mar_8_13(2)_R25.nxml.txt.nlp	21385452	SENT314	7	7	0	0	galactose	ACTB	PA449725	60	0.325
NULL	Cancer_Inform_2014_Oct_14_13(Suppl_1)_103-111.nxml.txt.nlp	25392688	SENT212	7	7	13	13	carboplatin	CD95	PA448803	355	0.325
NULL	Proteome_Sci_2009_Oct_27_7_39.nxml.txt.nlp	19860894	SENT229	13	13	19	19	trypsin	ITIH4	PA451806	3700	0.325
NULL	Contemp_Clin_Dent_2011_Oct-Dec_2(4)_278-282.nxml.txt.nlp	22346152	SENT53	12	12	17	17	potassium	GCF	PA451047	6936	0.325
NULL	Mol_Cytogenet_2014_Feb_27_7_15.nxml.txt.nlp	24576355	SENT30	10	10	15	15	phenol	CYP2E1	PA450913	1571	0.325
NULL	Indian_J_Endocrinol_Metab_2013_May-Jun_17(3)_430-441.nxml.txt.nlp	23869298	SENT224	2	2	5	5	lipase	MODY8	PA450239	1056	0.325
NULL	AIDS_Res_Treat_2012_May_14_2012_246280.nxml.txt.nlp	22675613	SENT179	9	9	7	7	atazanavir	ATV	PA10251	4683	0.325
NULL	Toxins_(Basel)_2010_Oct_26_2(11)_2490-2518.nxml.txt.nlp	22069563	SENT135	33	33	3	3	cisplatin	p53	PA449014	7157	0.324
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Aug_11_68(Pt_9)_o2694.nxml.txt.nlp	22969586	SENT63	19	19	29	29	ethanol	mol	PA448073	90527	0.324
NULL	Oncogene_2010_Sep_2_29(35)_4905-4913.nxml.txt.nlp	20581869	SENT253	2	2	11	11	paclitaxel	CA125	PA450761	4077;94025	0.324
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT383	24	24	24	24	pp2	PP2		4888	0.324
NULL	Cardiovasc_Diabetol_2013_Oct_17_12_150.nxml.txt.nlp	24134550	SENT106	3	3	7	7	pioglitazone	activin	PA450970	83729	0.324
NULL	Indian_J_Pharm_Sci_2008_Sep-Oct_70(5)_664-667.nxml.txt.nlp	21394271	SENT35	8	8	6	6	nystatin	FOR	PA450666	51741	0.324
NULL	Exp_Mol_Med_2012_Jun_30_44(6)_378-386.nxml.txt.nlp	22391335	SENT87	21	21	18	18	dextran	BLT2	PA449261	56413	0.324
NULL	Exp_Ther_Med_2013_Jun_9_5(6)_1770-1774.nxml.txt.nlp	23837071	SENT137	1	1	15	15	coumarin	TRAIL	PA134521193	8743	0.324
NULL	J_Inherit_Metab_Dis_2012_Jan_10_35(1)_141-149.nxml.txt.nlp	21556832	SENT20	6	6	1	1	creatine	AGAT	PA164778930	2628	0.324
NULL	J_Biomed_Biotechnol_2001_1(1)_38-44.nxml.txt.nlp	12488625	SENT131	10	10	8	8	genistein	Gen	PA165109660	348654	0.324
NULL	Korean_J_Anesthesiol_2013_Jan_21_64(1)_47-53.nxml.txt.nlp	23372886	SENT83	1	1	4	4	bupivacaine	PTG	PA135057240	5507	0.324
NULL	CPT_Pharmacometrics_Syst_Pharmacol_2014_May_21_3(5)_e115.nxml.txt.nlp	24850445	SENT221	10	10	30	30	paclitaxel	HER-2	PA450761	2064	0.324
NULL	J_Vet_Med_Sci_2013_Dec_25_75(12)_1637-1642.nxml.txt.nlp	23884081	SENT8	10	10	29	29	dextran	JNK	PA449261	5599	0.324
NULL	Ann_Rheum_Dis_2008_Aug_5_68(5)_702-709.nxml.txt.nlp	18684743	SENT249	25	25	31	31	infliximab	IMPACT	PA452639	55364	0.324
NULL	Biomed_Res_Int_2014_Jun_4_2014_237698.nxml.txt.nlp	24995276	SENT147	23	23	13	13	melphalan	BTD	PA450354	686	0.324
NULL	Open_Cardiovasc_Med_J_2010_Feb_23_4_71-77.nxml.txt.nlp	20360979	SENT89	5	5	10	10	thrombin	TAFI	PA451674	1361	0.324
NULL	Endocrinol_Metab_(Seoul)_2013_Dec_12_28(4)_275-279.nxml.txt.nlp	24396691	SENT42	31	31	24	24	iodine	ATD	PA450049	465	0.324
NULL	Ann_Rheum_Dis_2011_Oct_12_71(4)_541-548.nxml.txt.nlp	21994233	SENT220	25	25	32	32	infliximab	IMPACT	PA452639	55364	0.324
NULL	Ann_Oncol_2010_Mar_28_21(3)_498-505.nxml.txt.nlp	19717534	SENT219	3	3	10	10	tamoxifen	ATAC	PA451581	6375	0.324
NULL	Cancer_Med_2013_Aug_30_2(4)_457-467.nxml.txt.nlp	24156018	SENT112	23	23	16	16	marimastat	U87	PA164748329	677775;641648	0.324
NULL	Cancers_(Basel)_2012_Sep_6_4(3)_873-903.nxml.txt.nlp	24213471	SENT1558	5	5	10	10	hyaluronidase	HYAL1	PA164745713	3373	0.324
NULL	Nucleic_Acids_Res_2010_Oct_28_38(19)_6418-6432.nxml.txt.nlp	20511593	SENT175	41	41	45	45	collagenase	AP-1	PA449107	2353;3727;2354;3725	0.324
NULL	Iran_J_Pharm_Res_2014_Autumn_13(4)_1393-1401.nxml.txt.nlp	25587329	SENT109	6	6	14	14	celecoxib	ABCG2	PA448871	9429	0.324
NULL	Int_J_Mol_Sci_2014_Oct_8_15(10)_17974-17999.nxml.txt.nlp	25299695	SENT268	0	0	4	4	curcumin	NAC	PA151958596	22861	0.324
NULL	Iran_Red_Crescent_Med_J_2014_Aug_5_16(8)_e6915.nxml.txt.nlp	25389496	SENT165	14	14	16	16	rosuvastatin	adiponectin	PA134308647	9370	0.324
NULL	Cell_Death_Dis_2013_Jun_13_4(6)_e665.nxml.txt.nlp	23764846	SENT228	0	0	4	4	sorafenib	BLM	PA7000	641	0.324
NULL	Clin_Dev_Immunol_2013_Sep_3_2013_206298.nxml.txt.nlp	24082908	SENT140	19	19	17	17	cyclophosphamide	CTX	PA449165	1593	0.324
NULL	Arthritis_Res_Ther_2014_Apr_30_16(2)_R90.nxml.txt.nlp	25167216	SENT218	42	42	7	7	tocilizumab	CXCL13	PA165292659	10563	0.324
NULL	Breast_Cancer_Res_2012_Jan_19_14(1)_202.nxml.txt.nlp	22264257	SENT87	17	17	15	15	letrozole	FOXC2	PA450196	2303	0.324
NULL	J_Cardiovasc_Thorac_Res_2014_Jun_30_6(2)_97-100.nxml.txt.nlp	25031824	SENT30	39	39	34	34	heparin	ACT	PA449855	12;11332;9457;641455	0.323
NULL	Mol_Cancer_2009_Dec_23_8_129.nxml.txt.nlp	20030852	SENT171	4	4	2	2	curcumin	ABCA1	PA151958596	19	0.323
NULL	Evid_Based_Complement_Alternat_Med_2014_Jul_1_2014_423751.nxml.txt.nlp	25101132	SENT188	18	18	16	16	metronidazole	Met	PA450484	79811	0.323
NULL	Cancer_Immunol_Immunother_2008_Jan_6_57(1)_135-142.nxml.txt.nlp	17922124	SENT146	9	9	29	29	l-arginine	ARG	PA448478	473;27	0.323
NULL	Case_Rep_Med_2010_Feb_28_2010_352417.nxml.txt.nlp	20204071	SENT62	13	13	18	18	colchicine	COPE	PA449092	11316	0.323
NULL	Psychiatry_Investig_2012_Jun_30_9(2)_187-190.nxml.txt.nlp	22707971	SENT30	24	24	8	8	capsaicin	POMC	PA448776	5443	0.323
NULL	Pan_Afr_Med_J_2014_May_5_18_17.nxml.txt.nlp	25360201	SENT88	35	35	13	13	ceftazidime	UGD	PA448861	80146	0.323
NULL	Clin_Ophthalmol_2009_Jun_2_3_189-194.nxml.txt.nlp	19668564	SENT19	7	7	28	28	brimonidine	BAK	PA448665	578	0.323
NULL	Am_J_Physiol_Cell_Physiol_2014_Jan_15_306(2)_C89-C97.nxml.txt.nlp	24133067	SENT53	15	15	4	4	hyaluronan	HAS1	PA165958431	3036	0.323
NULL	Arch_Toxicol_2014_Apr_2_88(5)_1109-1126.nxml.txt.nlp	24691702	SENT376	23	23	36	36	chlorpromazine	IFN	PA448964	3439	0.323
NULL	Exp_Ther_Med_2013_Jan_22_5(1)_247-252.nxml.txt.nlp	23251277	SENT154	31	31	16	16	alendronate	F12	PA448082	2161	0.323
NULL	Indian_J_Endocrinol_Metab_2013_Oct_17(Suppl1)_S301-S303.nxml.txt.nlp	24251194	SENT63	24	24	20	20	liraglutide	GLP-1	PA165958364	100125288	0.323
NULL	Oxid_Med_Cell_Longev_2014_Apr_3_2014_763061.nxml.txt.nlp	24803985	SENT4	12	12	37	37	urea	CAT	PA451831	847	0.323
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT107	0	0	16	16	resveratrol	PARP		142	0.323
NULL	Mycobiology_2008_Sep_30_36(3)_152-156.nxml.txt.nlp	23997616	SENT104	10	10	20	20	galactose	Mal	PA449725	114609	0.323
NULL	Biomed_Res_Int_2014_Jun_25_2014_203693.nxml.txt.nlp	25089265	SENT194	6	6	13	13	sorafenib	SHARP	PA7000	23013	0.323
NULL	Environ_Health_Perspect_2006_May_2_114(5)_746-751.nxml.txt.nlp	16675431	SENT174	9	9	12	12	choline	ANOVA	PA448976	4858	0.323
NULL	J_Int_Soc_Sports_Nutr_2013_Aug_22_10_39.nxml.txt.nlp	23967897	SENT34	15	15	12	12	betaine	Met	PA448603	79811	0.323
NULL	Acta_Pharmacol_Sin_2014_Jul_3_35(7)_945-956.nxml.txt.nlp	24989254	SENT36	4	4	17	17	tetracycline	GDNF	PA451640	2668	0.323
NULL	Cardiovasc_Diabetol_2013_Oct_17_12_150.nxml.txt.nlp	24134550	SENT110	24	24	10	10	pioglitazone	activin	PA450970	83729	0.323
NULL	Trials_2014_Oct_21_15(1)_400.nxml.txt.nlp	NULL	SENT461	11	11	5	5	ropivacaine	TAP	PA451271	8615;2317;10482;23541	0.323
NULL	Adv_Bioinformatics_2012_Jun_6_2012_582765.nxml.txt.nlp	22719757	SENT124	13	13	21	21	thrombin	EGF	PA451674	1950	0.323
NULL	J_Org_Chem_2014_Feb_7_79(3)_1427-1436.nxml.txt.nlp	24428433	SENT275	18	18	32	32	galactose	PF6	PA449725	200162	0.323
NULL	J_Hematol_Oncol_2013_Feb_8_6_15.nxml.txt.nlp	23394705	SENT74	14	14	19	19	fluorescein	FISH	PA164746009	9644	0.323
NULL	Adv_Ther_2014_Dec_2_31_1228-1246.nxml.txt.nlp	25447269	SENT140	8	8	40	40	timolol	TIM	PA451690	7984;8914	0.323
NULL	Med_Sci_Monit_2013_Nov_29_19_1080-1088.nxml.txt.nlp	24287619	SENT44	11	11	14	14	estradiol	ACL	PA449503	47	0.323
NULL	Indian_J_Endocrinol_Metab_2014_Jan-Feb_18(1)_32-38.nxml.txt.nlp	24701427	SENT44	11	11	25	25	phosphorus	CCT1	PA450954	6950	0.322
NULL	Mol_Cancer_2007_Apr_2_6_25.nxml.txt.nlp	17407558	SENT201	0	0	13	13	bevacizumab	KDR	PA130232992	3791	0.322
NULL	Int_J_Biol_Sci_2011_Nov_5_8(1)_1-14.nxml.txt.nlp	22211100	SENT255	6	6	4	4	gemcitabine	Gem	PA449748	51053	0.322
NULL	Cancer_Cell_Int_2005_Jul_24_5_22.nxml.txt.nlp	16042792	SENT77	14	14	23	23	vincristine	NAC	PA451879	22861	0.322
NULL	Evid_Based_Complement_Alternat_Med_2013_Nov_5_2013_937370.nxml.txt.nlp	24302971	SENT79	2	2	5	5	oxygen	ROS	PA450744	6098	0.322
NULL	Evid_Based_Complement_Alternat_Med_2012_Dec_19_2012_703034.nxml.txt.nlp	22216058	SENT154	20	20	11	11	calcein	U87	PA132595336	677775;641648	0.322
NULL	Brain_Sci_2013_Apr_26_3(2)_670-703.nxml.txt.nlp	24961420	SENT159	33	33	36	36	ethanol	P21	PA448073	1026;9338	0.322
NULL	Evid_Based_Complement_Alternat_Med_2014_Jul_1_2014_423751.nxml.txt.nlp	25101132	SENT188	10	10	16	16	erythromycin	Met	PA449493	79811	0.322
NULL	AIDS_Res_Treat_2013_Sep_17_2013_231956.nxml.txt.nlp	24159383	SENT118	23	23	18	18	buprenorphine	OAT	PA448685	4942	0.322
NULL	Biologics_2013_Apr_15_7_77-90.nxml.txt.nlp	23723688	SENT116	18	18	11	11	cetuximab	CRT	PA10040	811	0.322
NULL	Nat_Neurosci_2012_Sep_5_15(9)_1245-1254.nxml.txt.nlp	22864611	SENT522	3	3	5	5	clozapine	HDAC2	PA449061	3066	0.322
NULL	Carcinogenesis_2014_May_13_35(5)_1055-1066.nxml.txt.nlp	24419232	SENT200	0	0	5	5	metformin	AMPK	PA450395	5563	0.322
NULL	Allergy_Asthma_Clin_Immunol_2011_Mar_1_7(1)_4.nxml.txt.nlp	21362188	SENT27	13	13	34	34	salmeterol	IL-5	PA451300	3567	0.322
NULL	Nat_Commun_2013_Oct_1_4_2516.nxml.txt.nlp	24084631	SENT663	9	9	14	14	hyaluronan	AT1	PA165958431	9197;185	0.322
NULL	Breast_Cancer_(Auckl)_2011_Jul_27_5_175-199.nxml.txt.nlp	21863131	SENT497	10	10	1	1	carboplatin	Met	PA448803	79811	0.322
NULL	J_Antimicrob_Chemother_2009_Nov_18_64(5)_910-928.nxml.txt.nlp	19767318	SENT97	27	27	36	36	efavirenz	CD4	PA449441	920	0.322
NULL	Indian_J_Nephrol_2013_Nov-Dec_23(6)_413-414.nxml.txt.nlp	24339517	SENT11	12	12	10	10	cyclosporine	IL2RA	PA449167	3559	0.322
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jan_8_67(Pt_2)_o300.nxml.txt.nlp	21522990	SENT61	1	1	17	17	ethanol	mol	PA448073	90527	0.322
NULL	Eur_J_Med_Res_2011_Mar_28_16(3)_115-126.nxml.txt.nlp	21486724	SENT285	39	39	42	42	ciprofloxacin	Met	PA449009	79811	0.322
NULL	J_Antimicrob_Chemother_2014_Mar_29_69(3)_643-650.nxml.txt.nlp	24169580	SENT114	44	44	39	39	chlorpromazine	CPZ	PA448964	8532	0.322
NULL	Front_Physiol_2012_Oct_19_3_56.nxml.txt.nlp	23091461	SENT330	36	36	39	39	clodronate	CD11b	PA10239	3684	0.322
NULL	J_Cell_Biol_2000_Jul_10_150(1)_27-40.nxml.txt.nlp	10893254	SENT293	9	9	12	12	collagenase	MMP1	PA449107	4312	0.322
NULL	Nat_Chem_Biol_2010_Apr_14_6(4)_258-260.nxml.txt.nlp	20228793	SENT75	16	16	19	19	oxygen	ROS	PA450744	6098	0.322
NULL	Eur_J_Med_Res_2011_Mar_28_16(3)_115-126.nxml.txt.nlp	21486724	SENT84	33	33	36	36	ciprofloxacin	Met	PA449009	79811	0.322
NULL	Cancer_Cell_Int_2013_Mar_4_13_21.nxml.txt.nlp	23497288	SENT308	13	13	15	15	doxorubicin	P-gp	PA449412	5243	0.322
NULL	Mol_Vis_2011_Dec_31_17_3574-3582.nxml.txt.nlp	22219653	SENT169	20	20	23	23	lipase	LIPC	PA450239	3990	0.321
NULL	Adv_Pharmacol_Sci_2013_Jan_17_2013_192408.nxml.txt.nlp	23401679	SENT290	12	12	10	10	drospirenone	API	PA164749409	5345	0.321
NULL	Mol_Biol_Evol_2013_Nov_16_30(11)_2531-2540.nxml.txt.nlp	23955518	SENT30	19	19	24	24	nadh	ND6	PA164755085	4541	0.321
NULL	Diabetes_2009_Jun_31_58(6)_1434-1439.nxml.txt.nlp	19336679	SENT153	13	13	17	17	metformin	OCT2	PA450395	6582;5452	0.321
NULL	J_Oncol_2012_Sep_29_2012_879623.nxml.txt.nlp	21977033	SENT503	18	18	21	21	genistein	NAC	PA165109660	22861	0.321
NULL	Support_Care_Cancer_2009_Sep_10_17(9)_1187-1193.nxml.txt.nlp	19205754	SENT134	22	22	34	34	aprepitant	CYP2D6	PA164747039	1565	0.321
NULL	ScientificWorldJournal_2012_Apr_1_2012_671728.nxml.txt.nlp	22547992	SENT190	17	17	24	24	fluvastatin	NO3	PA449688	4681	0.321
NULL	Indian_J_Endocrinol_Metab_2013_Mar-Apr_17(2)_332-335.nxml.txt.nlp	23776915	SENT101	23	23	26	26	iodine	NIS	PA450049	6528	0.321
NULL	Mol_Cancer_2013_Sep_3_12_100.nxml.txt.nlp	24004603	SENT248	21	21	15	15	irinotecan	TPT	PA450085	23590;6469	0.321
NULL	Biochemistry_2009_Oct_27_48(42)_10078-10088.nxml.txt.nlp	19754156	SENT93	44	44	28	28	amikacin	NO3	PA164744372	4681	0.321
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT646	8	8	4	4	resveratrol	nrs		83985	0.321
NULL	Indian_J_Anaesth_2009_Jun_53(3)_265-267.nxml.txt.nlp	20640132	SENT34	8	8	5	5	heparin	ACT	PA449855	12;11332;9457;641455	0.321
NULL	Iran_J_Microbiol_2013_Sep_5(3)_203-208.nxml.txt.nlp	24475324	SENT46	2	2	5	5	gentamicin	MAST	PA449753	51324	0.321
NULL	J_Breast_Cancer_2013_Jun_28_16(2)_220-228.nxml.txt.nlp	23843857	SENT168	14	14	21	21	tamoxifen	ATAC	PA451581	6375	0.321
NULL	Aging_(Albany_NY)_2012_Mar_12_4(3)_146-158.nxml.txt.nlp	22436213	SENT51	2	2	35	35	resveratrol	SIRT1		23411	0.321
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Dec_13_65(Pt_1)_o106.nxml.txt.nlp	21581569	SENT66	24	24	34	34	ethanol	mol	PA448073	90527	0.321
NULL	Oncol_Lett_2014_Nov_10_8(5)_2333-2339.nxml.txt.nlp	25295120	SENT149	0	0	13	13	cyclosporine	ADM	PA449167	133	0.321
NULL	Biochemistry_2012_Jan_10_51(1)_149-158.nxml.txt.nlp	22122402	SENT264	20	20	16	16	nadh	NQO2	PA164755085	4835	0.321
NULL	ScientificWorldJournal_2012_Sep_17_2012_637953.nxml.txt.nlp	23028251	SENT503	0	0	6	6	curcumin	CYP3A4	PA151958596	1576	0.321
NULL	Biomed_Res_Int_2014_Jun_26_2014_161346.nxml.txt.nlp	25054130	SENT232	11	11	30	30	curcumin	STZ	PA151958596	6484	0.321
NULL	Apoptosis_2012_Sep_30_17(9)_989-997.nxml.txt.nlp	22460505	SENT221	5	5	17	17	thioridazine	AKT	PA451666	207	0.321
NULL	Mol_Biol_Rep_2013_Sep_28_40(10)_5573-5585.nxml.txt.nlp	24078156	SENT58	30	30	33	33	iron	FPN1	PA450087	30061	0.321
NULL	Front_Oncol_2014_Mar_14_4_52.nxml.txt.nlp	24672773	SENT170	21	21	8	8	collagenase	mol	PA449107	90527	0.32
NULL	Diabetologia_2010_Jan_6_53(1)_1-6.nxml.txt.nlp	19894028	SENT121	8	8	14	14	sitagliptin	HIP	PA164748978	6767;6159;64399;5068	0.32
NULL	Angiogenesis_2013_Apr_10_16(2)_373-386.nxml.txt.nlp	23143659	SENT32	37	37	11	11	cyclophosphamide	LDM	PA449165	1595	0.32
NULL	Mar_Drugs_2008_Nov_3_6(4)_595-606.nxml.txt.nlp	19172197	SENT38	38	38	32	32	hydrocortisone	F12	PA449905	2161	0.32
NULL	Nat_Neurosci_2012_Jun_15(6)_905-912.nxml.txt.nlp	22561455	SENT55	30	30	20	20	dextran	TRN	PA449261	3842	0.32
NULL	Case_Rep_Oncol_2012_Jul_3_5(2)_339-346.nxml.txt.nlp	22807902	SENT53	17	17	22	22	vincristine	CHOP	PA451879	1649	0.32
NULL	Adv_Ther_2014_Dec_2_31_1228-1246.nxml.txt.nlp	25447269	SENT204	8	8	19	19	timolol	TIM	PA451690	7984;8914	0.32
NULL	J_Geriatr_Cardiol_2014_Mar_11(1)_63-73.nxml.txt.nlp	24748884	SENT101	14	14	22	22	levodopa	PKD	PA450213	5587	0.32
NULL	Arthritis_Res_Ther_2009_Feb_3_11(1)_R15.nxml.txt.nlp	19192274	SENT225	15	15	26	26	chloroquine	MIP-3	PA448948	6368	0.32
NULL	J_Oncol_2011_May_31_2011_561862.nxml.txt.nlp	21772844	SENT98	3	3	6	6	oxygen	ROS	PA450744	6098	0.32
NULL	Curr_Med_Chem_2011_Jun_18(18)_2686-2714.nxml.txt.nlp	21649578	SENT214	33	33	34	34	erlotinib	EGFR	PA134687924	1956	0.32
NULL	ScientificWorldJournal_2012_Jan_2_11_2613-2619.nxml.txt.nlp	22262949	SENT112	18	18	12	12	cefepime	CPZ	PA164754876	8532	0.32
NULL	Ann_Indian_Acad_Neurol_2012_Jul-Sep_15(3)_181-185.nxml.txt.nlp	22919189	SENT75	20	20	26	26	trypsin	ITIH4	PA451806	3700	0.32
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_17_2012_250584.nxml.txt.nlp	23118786	SENT287	5	5	14	14	nicotine	TEF	PA450626	7008	0.32
NULL	Indian_J_Pharm_Sci_2011_Sep-Oct_73(5)_569-572.nxml.txt.nlp	22923871	SENT24	3	3	6	6	eprosartan	EPM	PA449481	2054	0.32
NULL	Ther_Clin_Risk_Manag_2006_Dec_2(4)_389-400.nxml.txt.nlp	18360651	SENT124	17	17	24	24	infliximab	IMPACT	PA452639	55364	0.32
NULL	J_Neuroinflammation_2011_Aug_29_8_108.nxml.txt.nlp	21871134	SENT50	6	6	25	25	paraformaldehyde	PLP	PA450790	25824;5744	0.32
NULL	Indian_J_Med_Paediatr_Oncol_2013_Oct-Dec_34(4)_336-337.nxml.txt.nlp	24604973	SENT9	13	13	19	19	heparin	PF4	PA449855	5196	0.32
NULL	DNA_Res_2013_Aug_19_20(4)_315-324.nxml.txt.nlp	23604098	SENT115	38	38	20	20	kanamycin	NMT	PA450137	4836	0.32
NULL	Case_Rep_Hematol_2013_Oct_9_2013_458303.nxml.txt.nlp	24224106	SENT63	19	19	10	10	hydroxyurea	CEL	PA449942	1056	0.32
NULL	Infect_Drug_Resist_2009_Apr_24_2_13-26.nxml.txt.nlp	21694884	SENT36	34	34	9	9	lamivudine	IFN	PA450163	3439	0.32
NULL	Curr_Control_Trials_Cardiovasc_Med_2001_Jul_6_2(4)_155-159.nxml.txt.nlp	11806789	SENT131	8	8	11	11	ramipril	AIRE	PA451223	326	0.32
NULL	Arch_Plast_Surg_2013_May_16_40(3)_291-294.nxml.txt.nlp	23730618	SENT17	9	9	18	18	cyclophosphamide	CHOP	PA449165	1649	0.32
NULL	Cardiovasc_Res_2011_Apr_1_90(1)_140-147.nxml.txt.nlp	21071431	SENT32	0	0	12	12	resveratrol	NAC		22861	0.32
NULL	J_Gen_Physiol_2000_Dec_1_116(6)_755-768.nxml.txt.nlp	11099345	SENT185	21	21	19	19	tetracaine	DAG	PA451638	1605	0.32
NULL	J_Ophthalmol_2011_Jun_12_2011_742020.nxml.txt.nlp	21772985	SENT142	9	9	11	11	ranibizumab	CRT	PA164746012	811	0.32
NULL	J_Cancer_Res_Clin_Oncol_2010_May_11_136(5)_737-743.nxml.txt.nlp	19904559	SENT40	9	9	15	15	bevacizumab	IFL	PA130232992	3439	0.32
NULL	Clin_Ophthalmol_2007_Dec_1(4)_383-391.nxml.txt.nlp	19668515	SENT143	9	9	29	29	pegaptanib	San	PA164771236	80218	0.32
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT21	11	11	24	24	pemetrexed	UNG	PA10810	7374	0.32
NULL	Environ_Health_Perspect_1986_Sep_68_39-44.nxml.txt.nlp	3780630	SENT6	26	26	23	23	hydrocortisone	EGF	PA449905	1950	0.32
NULL	Ann_Clin_Microbiol_Antimicrob_2007_May_23_6_5.nxml.txt.nlp	17521424	SENT72	22	22	4	4	erythromycin	TOB	PA449493	10140	0.32
NULL	J_R_Soc_Interface_2008_Aug_6_5(25)_855-863.nxml.txt.nlp	18077244	SENT245	2	2	4	4	potassium	TREK-1	PA451047	3776	0.32
NULL	Comp_Funct_Genomics_2008_May_19_2008_609684.nxml.txt.nlp	18509488	SENT121	14	14	22	22	creatine	SLC6A8	PA164778930	6535	0.32
NULL	J_Oncol_2010_Nov_19_2010_568938.nxml.txt.nlp	20037743	SENT35	11	11	3	3	heparin	LPA	PA449855	4018	0.32
NULL	Clin_Med_Oncol_2009_May_1_3_63-70.nxml.txt.nlp	20689611	SENT123	8	8	2	2	etoposide	DDP	PA449552	1678	0.32
NULL	ScientificWorldJournal_2012_Dec_27_2012_740308.nxml.txt.nlp	23346021	SENT181	26	26	19	19	ethanol	NAC	PA448073	22861	0.32
NULL	J_Immunol_Res_2014_Sep_18_2014_689492.nxml.txt.nlp	25309932	SENT234	10	10	4	4	lipase	FIAF	PA450239	51129	0.319
NULL	Breast_Cancer_Res_2000_Mar_25_2(3)_184-190.nxml.txt.nlp	11250708	SENT20	13	13	10	10	thrombin	LPA	PA451674	4018	0.319
NULL	Clin_Med_Insights_Cardiol_2010_Dec_1_4_117-128.nxml.txt.nlp	21151850	SENT311	12	12	5	5	clopidogrel	P-gp	PA449053	5243	0.319
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Dec_22_69(Pt_1)_o127-o128.nxml.txt.nlp	23476388	SENT64	30	30	34	34	antipyrine	NO3	PA448453	4681	0.319
NULL	Front_Behav_Neurosci_2014_Oct_30_8_366.nxml.txt.nlp	25400560	SENT245	25	25	13	13	ethanol	GLAST	PA448073	6507	0.319
NULL	Alcohol_Res_Health_2007_30(1)_38-47.nxml.txt.nlp	17718399	SENT28	13	13	3	3	ethanol	ADH	PA448073	551	0.319
NULL	Front_Cell_Neurosci_2014_Jan_24_8_7.nxml.txt.nlp	24478630	SENT437	3	3	6	6	potassium	KCC2	PA451047	57468	0.319
NULL	J_Clin_Biochem_Nutr_2009_Sep_28_45(2)_178-184.nxml.txt.nlp	19794926	SENT21	15	15	24	24	collagenase	AP-1	PA449107	2353;3727;2354;3725	0.319
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Sep_25_66(Pt_10)_m1290.nxml.txt.nlp	21587432	SENT66	2	2	22	22	ethanol	mol	PA448073	90527	0.319
NULL	J_Oncol_2012_Feb_6_2012_737981.nxml.txt.nlp	22481932	SENT106	18	18	22	22	sunitinib	STAT3	PA162372840	6774	0.319
NULL	Curr_Gerontol_Geriatr_Res_2012_Mar_21_2012_302875.nxml.txt.nlp	22536229	SENT6	9	9	6	6	choline	NNMT	PA448976	4837	0.319
NULL	Arthritis_Res_Ther_2009_Aug_24_11(4)_R127.nxml.txt.nlp	19703304	SENT144	38	38	22	22	adalimumab	OASIS	PA10004	90993	0.319
NULL	Chemother_Res_Pract_2011_Apr_18_2011_619321.nxml.txt.nlp	22312555	SENT157	10	10	4	4	daptomycin	VAN	PA164768820	10318	0.319
NULL	J_Gen_Physiol_2003_Nov_122(5)_621-639.nxml.txt.nlp	14581586	SENT46	35	35	10	10	gentamicin	F12	PA449753	2161	0.319
NULL	Br_J_Cancer_2011_Jun_28_105(1)_53-57.nxml.txt.nlp	21654688	SENT29	6	6	22	22	sn-38	UGT		7361;7355	0.319
NULL	Exp_Neurobiol_2013_Jun_27_22(2)_96-106.nxml.txt.nlp	23833558	SENT149	11	11	26	26	curcumin	OAT	PA151958596	4942	0.319
NULL	Gut_Pathog_2011_May_23_3_8.nxml.txt.nlp	21605455	SENT153	30	30	22	22	mannitol	FIAF	PA450320	51129	0.319
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Aug_1_68(Pt_9)_o2608.nxml.txt.nlp	22969512	SENT5	26	26	28	28	ethanol	mol	PA448073	90527	0.319
NULL	Mol_Vis_2011_Feb_1_17_332-340.nxml.txt.nlp	21297899	SENT152	0	0	4	4	telmisartan	DPI	PA451605	1832	0.319
NULL	Adipocyte_2012_Jan_1_1(1)_25-37.nxml.txt.nlp	23700508	SENT177	18	18	24	24	lipase	ATGL	PA450239	57104	0.319
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT106	3	3	13	13	methotrexate	MSH2	PA450428	4436	0.319
NULL	Brain_Sci_2013_Sep_23_3(3)_1395-1414.nxml.txt.nlp	24961534	SENT868	0	0	9	9	fluoxetine	FLAME	PA449673	8837	0.319
NULL	Cardiovasc_Ultrasound_2012_Aug_17_10_35.nxml.txt.nlp	22898340	SENT175	14	14	17	17	dobutamine	A-2	PA449381	27239	0.319
NULL	J_Int_Soc_Sports_Nutr_2009_Feb_19_6_6.nxml.txt.nlp	19228401	SENT5	17	17	20	20	creatine	CRT	PA164778930	811	0.319
NULL	Eur_Respir_J_2012_Apr_39(4)_807-819.nxml.txt.nlp	22467723	SENT502	22	22	26	26	isoniazid	IPT	PA450112	54802	0.319
NULL	Niger_Med_J_2011_Oct-Dec_52(4)_239-243.nxml.txt.nlp	22529506	SENT95	24	24	14	14	vancomycin	HAI	PA451850	6692;6768	0.319
NULL	Biomed_Res_Int_2013_Jul_8_2013_507103.nxml.txt.nlp	23936812	SENT159	16	16	30	30	curcumin	CO2	PA151958596	4513	0.319
NULL	Crit_Care_2010_Mar_1_14(Suppl_1)_P568.nxml.txt.nlp	NULL	SENT5	12	12	27	27	glucose	BGL	PA449773	987	0.319
NULL	Iran_J_Reprod_Med_2012_Nov_10(6)_531-536.nxml.txt.nlp	25246922	SENT106	16	16	21	21	tamoxifen	6-16	PA451581	2537	0.319
NULL	J_Oncol_2012_Sep_29_2012_879623.nxml.txt.nlp	21977033	SENT503	6	6	21	21	celecoxib	NAC	PA448871	22861	0.319
NULL	Acta_Crystallogr_Sect_F_Struct_Biol_Cryst_Commun_2010_Sep_23_66(Pt_10)_1326-1334.nxml.txt.nlp	20944229	SENT185	0	0	3	3	l-tryptophan	TrpRS	PA10323	10352	0.319
NULL	Oncogene_2010_Sep_2_29(35)_4905-4913.nxml.txt.nlp	20581869	SENT253	2	2	20	20	paclitaxel	CA125	PA450761	4077;94025	0.319
NULL	Angew_Chem_Int_Ed_Engl_2013_Jan_2_52(1)_325-330.nxml.txt.nlp	23080482	SENT33	35	35	26	26	thrombin	PAR-1	PA451674	2011;2149	0.319
NULL	Curr_Gerontol_Geriatr_Res_2011_Aug_18_2011_316386.nxml.txt.nlp	21869884	SENT154	6	6	25	25	estradiol	spatial	PA449503	219793	0.319
NULL	Int_J_Biol_Sci_2011_Nov_5_8(1)_1-14.nxml.txt.nlp	22211100	SENT210	6	6	4	4	gemcitabine	Gem	PA449748	51053	0.319
NULL	Indian_J_Nucl_Med_2010_Oct-Dec_25(4)_173-175.nxml.txt.nlp	21712915	SENT12	30	30	8	8	thyroglobulin	FDG	PA164754910	23583	0.319
NULL	Front_Oncol_2013_Sep_4_3_212.nxml.txt.nlp	24027671	SENT261	1	1	20	20	rituximab	PRIMA	PA451261	145270	0.319
NULL	Neuroreport_2013_Dec_18_24(18)_1010-1015.nxml.txt.nlp	24257248	SENT42	4	4	22	22	trypsin	F12	PA451806	2161	0.319
NULL	Diabetes_2009_Jul_29_58(7)_1604-1615.nxml.txt.nlp	19403868	SENT126	0	0	13	13	metformin	HIP	PA450395	6767;6159;64399;5068	0.319
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Sep_11_66(Pt_10)_o2548-o2549.nxml.txt.nlp	21587537	SENT73	29	29	22	22	ethanol	mol	PA448073	90527	0.319
NULL	Front_Cell_Neurosci_2013_Dec_6_7_245.nxml.txt.nlp	24367291	SENT492	9	9	11	11	naproxen	P2X3	PA450595	5024	0.319
NULL	J_Cell_Biol_2003_Aug_18_162(4)_661-671.nxml.txt.nlp	12925710	SENT114	17	17	17	17	pp2	PP2		4888	0.319
NULL	Exp_Cell_Res_2011_Feb_1_317(3)_330-337.nxml.txt.nlp	21056556	SENT71	19	19	15	15	phenol	CO2	PA450913	4513	0.318
NULL	Eur_J_Clin_Pharmacol_2014_Oct_8_70(12)_1433-1441.nxml.txt.nlp	25291992	SENT141	31	31	6	6	olanzapine	FES	PA450688	2242	0.318
NULL	Breast_Cancer_Res_2011_Nov_24_13(6)_R120.nxml.txt.nlp	22115051	SENT129	23	23	32	32	tamoxifen	HER-2	PA451581	2064	0.318
NULL	J_Gen_Physiol_2010_Apr_135(4)_333-353.nxml.txt.nlp	20231374	SENT362	15	15	15	15	pp2	PP2		4888	0.318
NULL	South_Asian_J_Cancer_2014_Jan-Mar_3(1)_71-73.nxml.txt.nlp	24665452	SENT54	0	0	16	16	tamoxifen	BRCA2	PA451581	675	0.318
NULL	Oncotarget_2012_Nov_8_3(11)_1472-1482.nxml.txt.nlp	23178531	SENT6	1	1	6	6	iron	IRP1	PA450087	48	0.318
NULL	Basic_Res_Cardiol_2012_Jul_24_107(4)_273.nxml.txt.nlp	22622703	SENT229	25	25	13	13	nadh	AMPK	PA164755085	5563	0.318
NULL	Arthritis_Res_Ther_2005_Apr_28_7(4)_R844-R851.nxml.txt.nlp	15987486	SENT21	25	25	21	21	nitrogen	ROS	PA450643	6098	0.318
NULL	Exp_Ther_Med_2013_Jan_22_5(1)_247-252.nxml.txt.nlp	23251277	SENT152	16	16	13	13	alendronate	GAPDH	PA448082	2597	0.318
NULL	Allergy_Asthma_Immunol_Res_2010_Apr_24_2(2)_65-76.nxml.txt.nlp	20358020	SENT213	45	45	19	19	azelastine	ARIA	PA448517	641700	0.318
NULL	Oncogene_2014_Oct_9_33(41)_4941-4951.nxml.txt.nlp	24681952	SENT70	4	4	7	7	metformin	HNF4	PA450395	3172	0.318
NULL	J_Anaesthesiol_Clin_Pharmacol_2012_Apr-Jun_28(2)_178-184.nxml.txt.nlp	22557739	SENT45	29	29	22	22	propofol	LDP	PA451141	10404	0.318
NULL	Osteoporos_Int_2014_Aug_15_25(10)_2359-2381.nxml.txt.nlp	25182228	SENT809	15	15	37	37	raloxifene	STAR	PA451221	6770;2984	0.318
NULL	Arthritis_Res_Ther_2013_Jan_4_15(1)_R1.nxml.txt.nlp	23286772	SENT173	8	8	0	0	methotrexate	GML	PA450428	2765	0.318
NULL	Acta_Vet_Scand_2010_Jul_30_52(1)_47.nxml.txt.nlp	20670455	SENT103	12	12	37	37	chloramphenicol	TMP	PA448927	2012	0.318
NULL	Arthritis_Res_Ther_2005_Jun_23_7(5)_R1023-R1033.nxml.txt.nlp	16207318	SENT22	18	18	9	9	collagenase	EMMPRIN	PA449107	682	0.318
NULL	Int_J_Endocrinol_Metab_2013_Jul_1_Summer_11(3)_184-190.nxml.txt.nlp	24348591	SENT145	11	11	13	13	liraglutide	PAG	PA165958364	55824	0.318
NULL	Orphanet_J_Rare_Dis_2008_Sep_16_3_25.nxml.txt.nlp	18796155	SENT297	37	37	12	12	ribavirin	CPX	PA451241	1371;10682;1377	0.318
NULL	Mol_Vis_2011_Aug_18_17_2221-2227.nxml.txt.nlp	21897744	SENT6	21	21	27	27	l-arginine	GBA	PA448478	2629	0.318
NULL	Adv_Pharmacol_Sci_2013_Jan_17_2013_192408.nxml.txt.nlp	23401679	SENT294	12	12	10	10	drospirenone	API	PA164749409	5345	0.318
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT101	0	0	12	12	resveratrol	DR5		8795	0.318
NULL	J_Inherit_Metab_Dis_2013_Mar_5_36(2)_385-394.nxml.txt.nlp	22669363	SENT167	36	36	37	37	galsulfase	ERT	PA164746235	1999	0.318
NULL	Mol_Microbiol_2014_May_28_92(3)_453-470.nxml.txt.nlp	24533860	SENT317	11	11	13	13	tetracycline	HMI	PA451640	3160	0.318
NULL	J_Cardiothorac_Surg_2013_Nov_21_8_215.nxml.txt.nlp	24261787	SENT38	9	9	14	14	fluorouracil	CRT	PA128406956	811	0.318
NULL	Front_Neurol_2014_Apr_22_5_57.nxml.txt.nlp	24795694	SENT150	2	2	11	11	fluoxetine	FLAME	PA449673	8837	0.318
NULL	Onco_Targets_Ther_2014_Jun_12_7_1001-1014.nxml.txt.nlp	24959087	SENT136	14	14	18	18	mitoxantrone	Men	PA450526	8178	0.318
NULL	Tech_Coloproctol_2014_Sep_13_18(4)_373-380.nxml.txt.nlp	24030782	SENT255	2	2	28	28	lidocaine	AAP	PA450226	5345	0.318
NULL	J_Gen_Physiol_2009_Jun_133(6)_623-625.nxml.txt.nlp	19468076	SENT16	7	7	14	14	sulfur	TRPA1	PA451558	8989	0.318
NULL	Int_J_Endocrinol_2014_Mar_4_2014_690704.nxml.txt.nlp	24723949	SENT21	25	25	22	22	thyroglobulin	TPO	PA164754910	7066;7173	0.318
NULL	Case_Rep_Crit_Care_2014_Nov_6_2014_214970.nxml.txt.nlp	25431684	SENT86	1	1	12	12	cyclophosphamide	CHOP	PA449165	1649	0.318
NULL	Int_J_Anal_Chem_2013_Jul_16_2013_419716.nxml.txt.nlp	23956748	SENT100	1	1	16	16	heparin	PF6	PA449855	200162	0.318
NULL	Braz_J_Microbiol_2009_Jun_1_Apr-Jun_40(2)_358-366.nxml.txt.nlp	24031373	SENT247	1	1	5	5	lipase	por	PA450239	64840	0.318
NULL	J_Inherit_Metab_Dis_2012_Jan_10_35(1)_141-149.nxml.txt.nlp	21556832	SENT49	9	9	13	13	creatine	GAMT	PA164778930	2593	0.318
NULL	Biomed_Res_Int_2014_Jun_4_2014_237698.nxml.txt.nlp	24995276	SENT147	7	7	13	13	vincristine	BTD	PA451879	686	0.318
NULL	Biomed_Res_Int_2013_Jun_13_2013_493643.nxml.txt.nlp	23841073	SENT103	1	1	6	6	estradiol	ACTH	PA449503	5443	0.317
NULL	Biomed_Res_Int_2014_May_20_2014_235426.nxml.txt.nlp	24971321	SENT6	11	11	14	14	vasopressin	AVP	PA451858	114548;551	0.317
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1013.nxml.txt.nlp	24457957	SENT138	8	8	6	6	bortezomib	NOXA	PA10252	5366	0.317
NULL	Environ_Health_Perspect_2011_Aug_30_119(8)_1047-1052.nxml.txt.nlp	21118785	SENT21	17	17	14	14	genistein	DES	PA165109660	1674	0.317
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Nov_17_68(Pt_12)_o3380.nxml.txt.nlp	23476212	SENT6	5	5	7	7	ethanol	mol	PA448073	90527	0.317
NULL	Antimicrob_Agents_Chemother_2014_Nov_10_59(1)_490-497.nxml.txt.nlp	25385107	SENT37	5	5	9	9	artemisinin	ACT	PA165111696	12;11332;9457;641455	0.317
NULL	Emerg_Infect_Dis_2013_Nov_19(11)_1803-1810.nxml.txt.nlp	24188126	SENT107	14	14	8	8	ceftazidime	CTX	PA448861	1593	0.317
NULL	Cancer_Biol_Med_2012_Mar_9(1)_18-22.nxml.txt.nlp	23691449	SENT181	18	18	8	8	sn-38	ABCG2		9429	0.317
NULL	Osteoporos_Int_2014_Dec_18_25(3)_1163-1172.nxml.txt.nlp	24345886	SENT251	2	2	8	8	teriparatide	PTH	PA451620	5741	0.317
NULL	Front_Neuroeng_2013_Feb_25_6_1.nxml.txt.nlp	23443302	SENT66	14	14	16	16	remifentanil	gamma	PA451232	9913	0.317
NULL	Int_J_Mol_Sci_2014_Oct_29_15(11)_19700-19728.nxml.txt.nlp	25356505	SENT131	30	30	25	25	thrombin	LPA	PA451674	4018	0.317
NULL	Lancet_2010_Dec_11_376(9757)_2009-2017.nxml.txt.nlp	21131038	SENT261	0	0	16	16	idarubicin	TP1	PA449961	7011	0.317
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT473	9	9	17	17	iloperidone	PRL	PA161199368	5617	0.317
NULL	Pan_Afr_Med_J_2013_Apr_1_14_127.nxml.txt.nlp	23734272	SENT17	39	39	10	10	cetuximab	EGFR	PA10040	1956	0.317
NULL	Arthritis_Res_Ther_2014_Apr_30_16(2)_R90.nxml.txt.nlp	25167216	SENT415	34	34	16	16	adalimumab	CXCL13	PA10004	10563	0.317
NULL	Case_Rep_Ophthalmol_Med_2013_Apr_24_2013_461758.nxml.txt.nlp	23710397	SENT9	12	12	9	9	fluorescein	FAF	PA164746009	8239;2188	0.317
NULL	Alzheimers_Res_Ther_2013_May_14_5(3)_25.nxml.txt.nlp	23673233	SENT386	24	24	13	13	donepezil	spatial	PA449394	219793	0.317
NULL	J_Headache_Pain_2008_Oct_31_9(5)_277-288.nxml.txt.nlp	18668199	SENT220	32	32	13	13	vasopressin	EDRF	PA451858	51327	0.317
NULL	Brain_Struct_Funct_2008_Sep_13_213(1-2)_93-118.nxml.txt.nlp	18704495	SENT545	34	34	19	19	scopolamine	Gen	PA451308	348654	0.317
NULL	Int_J_Emerg_Med_2012_Jan_20_5_5.nxml.txt.nlp	22264348	SENT16	0	0	16	16	capsaicin	SNS	PA448776	6336	0.317
NULL	Acta_Pharmacol_Sin_2009_Jun_5_30(6)_859-867.nxml.txt.nlp	19498425	SENT26	5	5	22	22	carbachol	CA1	PA448784	759	0.317
NULL	Anal_Bioanal_Chem_2011_Sep_14_401(4)_1109-1125.nxml.txt.nlp	21755271	SENT141	2	2	6	6	sugar	FBP	PA451529	8880;51552	0.317
NULL	Evid_Based_Complement_Alternat_Med_2014_Jun_10_2014_645812.nxml.txt.nlp	25013446	SENT4	6	6	27	27	ethanol	AMPK	PA448073	5563	0.317
NULL	Cancer_Imaging_2008_Sep_10_8(1)_159-162.nxml.txt.nlp	18818134	SENT26	9	9	16	16	thyroglobulin	WBS	PA164754910	2006	0.317
NULL	Biomed_Res_Int_2013_Feb_24_2013_794643.nxml.txt.nlp	23555097	SENT258	11	11	1	1	ciprofloxacin	Gen	PA449009	348654	0.317
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2009_Jun_1_65(Pt_6)_513-522.nxml.txt.nlp	19465765	SENT33	3	3	6	6	chloramphenicol	CLS	PA448927	1210	0.317
NULL	Br_J_Pharmacol_2011_Mar_162(5)_1029-1044.nxml.txt.nlp	20958290	SENT145	20	20	31	31	carbachol	NMS	PA448784	129521	0.317
NULL	Front_Synaptic_Neurosci_2014_Sep_5_6_18.nxml.txt.nlp	25249974	SENT758	1	1	11	11	choline	VIP	PA448976	27151;7432	0.317
NULL	Oxid_Med_Cell_Longev_2012_Nov_28_2012_162934.nxml.txt.nlp	23251719	SENT71	9	9	13	13	diazepam	DBI	PA449283	1622;706	0.317
NULL	Clin_Ophthalmol_2012_Aug_15_6_1315-1319.nxml.txt.nlp	22969276	SENT2	17	17	13	13	travoprost	BAK	PA164781371	578	0.317
NULL	J_Ginseng_Res_2011_Jun_35(2)_170-175.nxml.txt.nlp	23717059	SENT22	17	17	12	12	phenol	ROS	PA450913	6098	0.316
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Jan_9_69(Pt_2)_o211.nxml.txt.nlp	23424493	SENT64	2	2	11	11	ethanol	mol	PA448073	90527	0.316
NULL	Genetics_2012_Jul_191(3)_765-780.nxml.txt.nlp	22505622	SENT47	19	19	4	4	ethanol	Tra1	PA448073	8295	0.316
NULL	Int_J_Inflam_2011_Aug_11_2011_514623.nxml.txt.nlp	21860805	SENT169	14	14	26	26	thrombin	ADP	PA451674	23038	0.316
NULL	Ann_Hematol_2014_Mar_18_93(8)_1335-1344.nxml.txt.nlp	24638841	SENT22	9	9	6	6	rituximab	CLB	PA451261	171425	0.316
NULL	Cardiovasc_Diabetol_2013_Jan_9_12_10.nxml.txt.nlp	23302697	SENT249	15	15	34	34	fenofibrate	NDR	PA449594	11329;55363	0.316
NULL	Crit_Care_2012_Oct_15_16(5)_R193.nxml.txt.nlp	23068293	SENT69	30	30	26	26	pentobarbital	NMB	PA450859	10457;4828	0.316
NULL	Pharmaceuticals_(Basel)_2013_Aug_2_6(8)_915-928.nxml.txt.nlp	24276376	SENT133	0	0	4	4	thrombin	TRAP	PA451674	959;54;57410	0.316
NULL	Infect_Drug_Resist_2010_Aug_9_3_87-94.nxml.txt.nlp	21694897	SENT61	2	2	6	6	artemisinin	ACT	PA165111696	12;11332;9457;641455	0.316
NULL	Int_J_Biol_Sci_2014_Aug_23_10(8)_921-939.nxml.txt.nlp	25170305	SENT345	18	18	0	0	nadh	EPO	PA164755085	7076;8288;2056	0.316
NULL	Curr_Chem_Genomics_2010_Mar_1_4_1-8.nxml.txt.nlp	20448812	SENT142	2	2	32	32	fluorescein	OATP1B3	PA164746009	28234	0.316
NULL	Eur_Respir_J_2012_Jun_17_39(6)_1511-1519.nxml.txt.nlp	22005918	SENT108	38	38	0	0	ethambutol	DST	PA164784021	667	0.316
NULL	Osteoporos_Int_2010_Oct_18_21(10)_1657-1680.nxml.txt.nlp	20480148	SENT590	6	6	28	28	raloxifene	STAR	PA451221	6770;2984	0.316
NULL	Cardiovasc_Diabetol_2003_May_16_2_5.nxml.txt.nlp	12793907	SENT130	25	25	10	10	metformin	IL-8	PA450395	3576	0.316
NULL	J_Oncol_2010_Dec_24_2010_497429.nxml.txt.nlp	20066162	SENT164	10	10	8	8	gemcitabine	GEM	PA449748	2669	0.316
NULL	Evid_Based_Complement_Alternat_Med_2014_Jul_1_2014_423751.nxml.txt.nlp	25101132	SENT180	14	14	16	16	tetracycline	Met	PA451640	79811	0.316
NULL	Pan_Afr_Med_J_2013_Jan_31_14_44.nxml.txt.nlp	23560127	SENT131	26	26	5	5	ribavirin	IFN	PA451241	3439	0.316
NULL	Ann_Intensive_Care_2012_May_30_2_13.nxml.txt.nlp	22647340	SENT99	4	4	0	0	urea	ANOVA	PA451831	4858	0.316
NULL	Front_Chem_2013_Dec_16_1_36.nxml.txt.nlp	24790964	SENT162	14	14	12	12	phenol	COD	PA450913	6628	0.316
NULL	Arthritis_Res_Ther_2012_Mar_30_14(2)_114.nxml.txt.nlp	22494450	SENT36	16	16	0	0	methotrexate	CCR5	PA450428	1234	0.316
NULL	J_Korean_Med_Sci_2005_Aug_31_20(4)_548-554.nxml.txt.nlp	16100442	SENT34	42	42	37	37	streptomycin	FBS	PA451512	64319;26269	0.315
NULL	Mol_Neurobiol_2007_Oct_10_36(2)_137-151.nxml.txt.nlp	17952658	SENT388	15	15	4	4	vasopressin	CXCL12	PA451858	6387	0.315
NULL	Front_Immunol_2012_Mar_15_3_46.nxml.txt.nlp	22566928	SENT54	23	23	23	23	pp2	PP2		4888	0.315
NULL	J_Gen_Physiol_1972_Feb_1_59(2)_135-154.nxml.txt.nlp	4333612	SENT5	18	18	27	27	nadh	ADP	PA164755085	23038	0.315
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_75-89.nxml.txt.nlp	17912638	SENT370	30	30	37	37	tamoxifen	ATAC	PA451581	6375	0.315
NULL	J_Korean_Med_Sci_2013_Apr_27_28(4)_527-533.nxml.txt.nlp	23580227	SENT101	18	18	20	20	genistein	TRAIL	PA165109660	8743	0.315
NULL	Mol_Vis_2014_Nov_5_20_1557-1568.nxml.txt.nlp	25489228	SENT99	15	15	23	23	collagenase	CO2	PA449107	4513	0.315
NULL	Carcinogenesis_2010_Dec_27_31(12)_2049-2057.nxml.txt.nlp	20876285	SENT10	6	6	15	15	tamoxifen	HER2	PA451581	2064	0.315
NULL	Emerg_Infect_Dis_2012_Jul_18(7)_1072-1080.nxml.txt.nlp	22709685	SENT254	19	19	16	16	vancomycin	VISA	PA451850	57506	0.315
NULL	Pan_Afr_Med_J_2014_May_5_18_17.nxml.txt.nlp	25360201	SENT88	44	44	13	13	chloramphenicol	UGD	PA448927	80146	0.315
NULL	Brain_Struct_Funct_2008_Sep_13_213(1-2)_93-118.nxml.txt.nlp	18704495	SENT545	11	11	19	19	scopolamine	Gen	PA451308	348654	0.315
NULL	Mol_Cancer_2012_Jun_18_11_41.nxml.txt.nlp	22709873	SENT279	15	15	20	20	lapatinib	PAX9	PA152241907	5083	0.315
NULL	Eur_Arch_Otorhinolaryngol_2013_Mar_18_270(4)_1513-1520.nxml.txt.nlp	23179931	SENT37	18	18	35	35	ebselen	NAC	PA161660841	22861	0.315
NULL	Ann_Rheum_Dis_2014_Jan_8_73(1)_6-16.nxml.txt.nlp	23749611	SENT342	24	24	31	31	infliximab	IMPACT	PA452639	55364	0.315
NULL	Crit_Care_2013_Mar_19_17(Suppl_2)_P356.nxml.txt.nlp	NULL	SENT27	8	8	2	2	heparin	OASIS	PA449855	90993	0.315
NULL	Indian_J_Ophthalmol_2013_Apr_61(4)_145-147.nxml.txt.nlp	23685485	SENT6	19	19	16	16	fluorescein	FAF	PA164746009	8239;2188	0.315
NULL	Int_J_Biol_Sci_2015_Jan_1_11(1)_38-47.nxml.txt.nlp	25552928	SENT288	2	2	17	17	creatine	LCX	PA164778930	80312	0.315
NULL	Med_Sci_Monit_2013_Oct_21_19_875-882.nxml.txt.nlp	24145180	SENT34	19	19	8	8	bevacizumab	IL8	PA130232992	3576	0.315
NULL	Pak_J_Med_Sci_2013_May-Jun_29(3)_788-792.nxml.txt.nlp	24353629	SENT28	12	12	15	15	iron	MAST	PA450087	51324	0.315
NULL	Braz_J_Med_Biol_Res_2012_Mar_16_45(6)_488-496.nxml.txt.nlp	22415117	SENT190	2	2	33	33	creatine	UST	PA164778930	10090	0.315
NULL	Biomed_Res_Int_2013_Aug_6_2013_909613.nxml.txt.nlp	24027765	SENT397	17	17	9	9	metronidazole	EEN	PA450484	6455	0.315
NULL	Biomed_Res_Int_2014_May_28_2014_726241.nxml.txt.nlp	24982907	SENT14	12	12	8	8	nitrogen	ROS	PA450643	6098	0.315
NULL	Exp_Diabetes_Res_2012_Dec_26_2012_230624.nxml.txt.nlp	23365557	SENT255	23	23	5	5	rosiglitazone	Met	PA451283	79811	0.315
NULL	Iran_J_Basic_Med_Sci_2012_Mar-Apr_15(2)_725-738.nxml.txt.nlp	23493747	SENT35	5	5	10	10	vancomycin	VISA	PA451850	57506	0.315
NULL	Mar_Drugs_2009_Aug_11_7(3)_361-366.nxml.txt.nlp	19841720	SENT75	10	10	0	0	ethanol	HEX	PA448073	3087	0.315
NULL	Nanoscale_Res_Lett_2014_Feb_18_9(1)_86.nxml.txt.nlp	24548613	SENT197	8	8	23	23	fluorescein	NIR	PA164746009	26155	0.315
NULL	FASEB_J_2012_Mar_26(3)_1052-1063.nxml.txt.nlp	22094718	SENT55	24	24	13	13	neomycin	HET	PA450608	6294	0.314
NULL	Int_J_Fertil_Steril_2014_Jul_8_Jul-Sep_8(2)_193-206.nxml.txt.nlp	25083185	SENT16	8	8	5	5	estradiol	PRL	PA449503	5617	0.314
NULL	J_Korean_Med_Sci_2010_Dec_24_25(12)_1766-1770.nxml.txt.nlp	21165292	SENT39	2	2	16	16	glucose	CRP	PA449773	1401;140913	0.314
NULL	J_Cell_Biol_2003_Aug_18_162(4)_661-671.nxml.txt.nlp	12925710	SENT141	17	17	17	17	pp2	PP2		4888	0.314
NULL	Nucleic_Acids_Res_2005_Aug_5_33(14)_4412-4424.nxml.txt.nlp	16085752	SENT143	15	15	21	21	fluorescein	FDG	PA164746009	23583	0.314
NULL	Br_J_Haematol_2008_Jun_141(5)_659-671.nxml.txt.nlp	18410446	SENT31	0	0	27	27	cerulenin	IL-6	PA164764551	3569	0.314
NULL	J_Brachial_Plex_Peripher_Nerve_Inj_2008_Mar_19_3_8.nxml.txt.nlp	18353188	SENT205	3	3	12	12	capsaicin	SSeCKS	PA448776	9590	0.314
NULL	Evid_Based_Complement_Alternat_Med_2014_May_28_2014_716509.nxml.txt.nlp	24987433	SENT184	6	6	0	0	ampicillin	TTR	PA448419	7276	0.314
NULL	Arthritis_Res_Ther_2011_Apr_4_13(2)_R56.nxml.txt.nlp	21463515	SENT20	8	8	6	6	ustekinumab	IL-23	PA166048654	51561	0.314
NULL	Crit_Care_2006_Feb_3_10(1)_R24.nxml.txt.nlp	16469128	SENT116	26	26	28	28	heparin	MARS	PA449855	4141	0.314
NULL	Curr_Opin_Lipidol_2014_Oct_4_25(5)_387-393.nxml.txt.nlp	25110901	SENT191	28	28	18	18	berberine	PCSK9	PA165860812	255738	0.314
NULL	Biologics_2012_Dec_17_6_429-464.nxml.txt.nlp	23269860	SENT160	13	13	10	10	rituximab	ACR	PA451261	49	0.314
NULL	Iran_Red_Crescent_Med_J_2012_Jul_30_14(7)_442-446.nxml.txt.nlp	22997561	SENT23	23	23	20	20	sugar	HBM	PA451529	3042;4041	0.314
NULL	Mol_Brain_2014_Nov_19_7(1)_80.nxml.txt.nlp	NULL	SENT26	33	33	28	28	halothane	TASK-3	PA449845	51305	0.314
NULL	BioDrugs_2013_Aug_27_27(5)_541-543.nxml.txt.nlp	NULL	SENT65	1	1	19	19	capecitabine	TPC	PA448771	8030;60386	0.314
NULL	Int_J_Biol_Sci_2013_Aug_14_9(8)_766-777.nxml.txt.nlp	23983610	SENT25	22	22	24	24	curcumin	B19	PA151958596	59271	0.314
NULL	Nucleic_Acids_Res_2005_Jun_7_33(10)_e92.nxml.txt.nlp	15942024	SENT65	14	14	26	26	fluorescein	Raf-1	PA164746009	5894	0.314
NULL	J_Cell_Biol_2008_Jul_28_182(2)_367-379.nxml.txt.nlp	18644892	SENT83	14	14	14	14	pp2	PP2		4888	0.314
NULL	Asian-Australas_J_Anim_Sci_2012_Jan_25(1)_75-85.nxml.txt.nlp	25049481	SENT169	26	26	11	11	lipase	NEFA	PA450239	4925	0.314
NULL	F1000Res_2013_Oct_8_2_173.nxml.txt.nlp	24555085	SENT66	6	6	3	3	triamcinolone	BDP	PA451749	10620;152926	0.314
NULL	Mol_Cancer_2010_Mar_4_9_49.nxml.txt.nlp	20202195	SENT148	35	35	38	38	vorinostat	HOP	PA164748224	84525;10963	0.314
NULL	Breast_Cancer_Res_Treat_2007_Oct_3_105(Suppl_1)_75-89.nxml.txt.nlp	17912638	SENT372	30	30	40	40	anastrozole	ATAC	PA448432	6375	0.314
NULL	J_Hum_Hypertens_2010_Nov_18_24(11)_730-738.nxml.txt.nlp	20164847	SENT168	34	34	15	15	amlodipine	A10	PA448388	28870	0.314
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Nov_15_5_27.nxml.txt.nlp	17107610	SENT39	26	26	8	8	clarithromycin	EMB	PA449028	133418	0.314
NULL	J_Midlife_Health_2013_Jan-Mar_4(1)_66-67.nxml.txt.nlp	23833542	SENT13	5	5	19	19	estradiol	KDR	PA449503	3791	0.314
NULL	JAKSTAT_2013_Jan_1_2(1)_e22925.nxml.txt.nlp	24058789	SENT324	2	2	18	18	curcumin	STAT3	PA151958596	6774	0.314
NULL	Case_Rep_Oncol_Med_2012_Oct_17_2012_962305.nxml.txt.nlp	23119207	SENT130	8	8	5	5	trypsin	SPINK1	PA451806	6690	0.314
NULL	Gastric_Cancer_2013_Dec_14_16(4)_513-520.nxml.txt.nlp	23238856	SENT113	13	13	16	16	hyaluronan	LYVE-1	PA165958431	10894	0.314
NULL	Viruses_2013_Mar_21_5(3)_954-980.nxml.txt.nlp	23518579	SENT186	3	3	8	8	resveratrol	NAC		22861	0.314
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Oct_3_65(Pt_11)_o2611-o2612.nxml.txt.nlp	21578228	SENT65	16	16	12	12	ethanol	mol	PA448073	90527	0.314
NULL	J_Vet_Med_Sci_2014_Jul_18_76(7)_937-945.nxml.txt.nlp	24646457	SENT91	30	30	40	40	gentamicin	OTC	PA449753	5009	0.314
NULL	Breast_Cancer_Res_2011_Jan_24_13(1)_401.nxml.txt.nlp	21349137	SENT39	37	37	33	33	lapatinib	HER2	PA152241907	2064	0.314
NULL	Biomed_Res_Int_2014_Jun_26_2014_161346.nxml.txt.nlp	25054130	SENT236	11	11	30	30	curcumin	STZ	PA151958596	6484	0.314
NULL	Lancet_2010_Dec_11_376(9757)_2009-2017.nxml.txt.nlp	21131038	SENT261	4	4	16	16	mitoxantrone	TP1	PA450526	7011	0.314
NULL	Gut_Liver_2011_Jun_24_5(2)_117-132.nxml.txt.nlp	21814590	SENT16	21	21	13	13	ribavirin	IFN	PA451241	3439	0.314
NULL	Diabetes_2013_Oct_17_62(10)_3547-3552.nxml.txt.nlp	23863812	SENT79	45	45	7	7	valsartan	adiponectin	PA451848	9370	0.313
NULL	Mol_Cancer_2013_Sep_3_12_100.nxml.txt.nlp	24004603	SENT248	17	17	15	15	topotecan	TPT	PA451729	23590;6469	0.313
NULL	Cancers_(Basel)_2013_Oct_23_5(4)_1306-1331.nxml.txt.nlp	24202447	SENT929	1	1	5	5	zinc	MAZ	PA451956	4150	0.313
NULL	Oncol_Lett_2014_Jun_4_7(6)_2175-2179.nxml.txt.nlp	24932311	SENT17	27	27	24	24	choline	CDP	PA448976	1523	0.313
NULL	Ann_Clin_Microbiol_Antimicrob_2007_May_23_6_5.nxml.txt.nlp	17521424	SENT72	14	14	4	4	tetracycline	TOB	PA451640	10140	0.313
NULL	Crit_Care_2000_Oct_13_4(Suppl_2)_S21-S25.nxml.txt.nlp	11255595	SENT68	8	8	5	5	furosemide	STP	PA449719	9322	0.313
NULL	Biochemistry_2013_Dec_17_52(50)_9059-9067.nxml.txt.nlp	24266852	SENT114	11	11	11	11	pp2	PP2		4888	0.313
NULL	Int_J_Biol_Sci_2014_Aug_23_10(8)_909-920.nxml.txt.nlp	25170304	SENT49	10	10	29	29	galactose	DC-SIGN	PA449725	30835	0.313
NULL	Indian_J_Pharm_Sci_2013_May-Jun_75(3)_284-290.nxml.txt.nlp	24082344	SENT13	0	0	3	3	fexofenadine	FEX	PA449621	8549	0.313
NULL	Mol_Biol_Cell_2012_Mar_15_23(6)_1115-1128.nxml.txt.nlp	22262462	SENT302	37	37	6	6	paraformaldehyde	CSK	PA450790	1445	0.313
NULL	Mol_Biol_Rep_2013_May_1_40(5)_3493-3502.nxml.txt.nlp	23277395	SENT239	16	16	22	22	heparin	HBEGF	PA449855	1839	0.313
NULL	Diabetologia_2010_Jan_6_53(1)_1-6.nxml.txt.nlp	19894028	SENT121	2	2	14	14	metformin	HIP	PA450395	6767;6159;64399;5068	0.313
NULL	Iran_Red_Crescent_Med_J_2011_Apr_1_13(4)_234-238.nxml.txt.nlp	22737471	SENT65	3	3	1	1	cefazolin	MAX	PA448839	4149	0.313
NULL	Cancers_(Basel)_2010_Nov_2_2(4)_1830-1837.nxml.txt.nlp	24281203	SENT58	13	13	17	17	lipase	PLRP1	PA450239	5407	0.313
NULL	Biomed_Res_Int_2013_Feb_24_2013_794643.nxml.txt.nlp	23555097	SENT258	15	15	1	1	ampicillin	Gen	PA448419	348654	0.313
NULL	Breast_Cancer_Res_2011_Aug_31_13(4)_R84.nxml.txt.nlp	21884573	SENT251	18	18	0	0	lapatinib	EGFR	PA152241907	1956	0.313
NULL	Glycobiology_2013_Jul_18_23(7)_853-864.nxml.txt.nlp	23507965	SENT28	6	6	9	9	galactose	MGL	PA449725	11343	0.313
NULL	Aging_(Albany_NY)_2012_Dec_29_5(1)_37-50.nxml.txt.nlp	23449538	SENT68	34	34	38	38	doxycycline	p53	PA449415	7157	0.313
NULL	Front_Genet_2012_Nov_5_3_236.nxml.txt.nlp	23133441	SENT40	19	19	16	16	efavirenz	ABCB1	PA449441	5243	0.313
NULL	Mol_Cancer_2014_Jun_26_13_158.nxml.txt.nlp	24965046	SENT253	7	7	34	34	cyclophosphamide	TSP1	PA449165	7057	0.313
NULL	J_Anaesthesiol_Clin_Pharmacol_2012_Jan-Mar_28(1)_106-110.nxml.txt.nlp	22345956	SENT61	31	31	28	28	heparin	PF4	PA449855	5196	0.313
NULL	Cell_Commun_Signal_2004_Jun_25_2_5.nxml.txt.nlp	15219238	SENT128	0	0	8	8	resveratrol	PC3		57332;7832;5122	0.313
NULL	Int_J_Biol_Sci_2014_Aug_23_10(8)_921-939.nxml.txt.nlp	25170305	SENT462	10	10	5	5	nadh	EPO	PA164755085	7076;8288;2056	0.313
NULL	Front_Neurosci_2014_May_27_8_129.nxml.txt.nlp	24904269	SENT261	5	5	18	18	ethanol	GIRK2	PA448073	3763	0.313
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Mar_21_68(Pt_4)_o1129.nxml.txt.nlp	22589984	SENT65	3	3	36	36	acetone	mol	PA448025	90527	0.313
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Sep_19_65(Pt_10)_o2508-o2509.nxml.txt.nlp	21577956	SENT75	5	5	9	9	guanidine	mol	PA164781028	90527	0.313
NULL	Ann_Gen_Psychiatry_2010_Apr_22_9(Suppl_1)_S157.nxml.txt.nlp	NULL	SENT4	9	9	16	16	risperidone	gamma	PA451257	9913	0.313
NULL	Open_Virol_J_2010_Jun_18_4_123-156.nxml.txt.nlp	20835362	SENT23	31	31	16	16	heparin	CD111	PA449855	5818	0.313
NULL	Neural_Dev_2012_Dec_8_7_39.nxml.txt.nlp	23217170	SENT196	28	28	30	30	tamoxifen	E12	PA451581	64100	0.313
NULL	Cell_Biol_Int_Rep_(2010)_2012_Jun_21_19(1)_e00017.nxml.txt.nlp	23124518	SENT164	2	2	4	4	etoposide	TRAIL	PA449552	8743	0.313
NULL	Clin_Ophthalmol_2008_Jun_2(2)_461-463.nxml.txt.nlp	19668738	SENT7	10	10	15	15	fluorescein	ERG	PA164746009	2078	0.313
NULL	Clin_Med_Insights_Oncol_2011_May_10_5_131-144.nxml.txt.nlp	21695100	SENT198	2	2	7	7	cetuximab	EGFR	PA10040	1956	0.313
NULL	J_Infect_Dis_2011_May_1_203(9)_1204-1214.nxml.txt.nlp	21459813	SENT7	14	14	11	11	raltegravir	INI		84844	0.312
NULL	Acta_Vet_Scand_2010_Jul_30_52(1)_47.nxml.txt.nlp	20670455	SENT103	39	39	37	37	trimethoprim	TMP	PA451788	2012	0.312
NULL	Curr_Genomics_2013_Nov_14(7)_453-467.nxml.txt.nlp	24396277	SENT168	26	26	16	16	iron	FURIN	PA450087	5045	0.312
NULL	Neural_Regen_Res_2012_Oct_5_7(28)_2227-2239.nxml.txt.nlp	25538744	SENT194	23	23	29	29	estradiol	spatial	PA449503	219793	0.312
NULL	Cardiovasc_Diabetol_2013_Jun_7_12_84.nxml.txt.nlp	23759020	SENT174	14	14	9	9	dipyridamole	LSR	PA449367	51599	0.312
NULL	Arthritis_Res_Ther_2008_Jun_3_10(3)_R64.nxml.txt.nlp	18522745	SENT27	22	22	9	9	carrageenan	MSU	PA448814	593	0.312
NULL	Behav_Brain_Funct_2013_Nov_26_9_43.nxml.txt.nlp	24279870	SENT203	24	24	6	6	ethanol	ANOVA	PA448073	4858	0.312
NULL	Br_J_Cancer_2012_Jun_26_107(1)_43-52.nxml.txt.nlp	22644306	SENT144	12	12	10	10	tamoxifen	LY6E	PA451581	4061	0.312
NULL	J_Vet_Med_Sci_2014_May_10_76(5)_719-722.nxml.txt.nlp	24419873	SENT39	0	0	14	14	phenoxybenzamine	PRL	PA450919	5617	0.312
NULL	Biologics_2012_Jul_12_6_201-206.nxml.txt.nlp	22904612	SENT132	17	17	24	24	infliximab	IMPACT	PA452639	55364	0.312
NULL	J_Cell_Biol_2008_Jun_16_181(6)_1013-1026.nxml.txt.nlp	18541700	SENT190	11	11	11	11	pp2	PP2		4888	0.312
NULL	Int_J_Biol_Sci_2011_Nov_5_8(1)_1-14.nxml.txt.nlp	22211100	SENT262	2	2	4	4	evodiamine	Gem	PA165860788	51053	0.312
NULL	Cancer_Med_2013_Aug_2_2(4)_571-582.nxml.txt.nlp	24156030	SENT168	4	4	6	6	curcumin	IL-6	PA151958596	3569	0.312
NULL	Exp_Ther_Med_2013_Apr_5_5(4)_1259-1263.nxml.txt.nlp	23596498	SENT21	1	1	10	10	capsaicin	TRPV1	PA448776	7442	0.312
NULL	Arch_Osteoporos_2013_Mar_29_8(1-2)_131.nxml.txt.nlp	23539323	SENT63	3	3	9	9	teriparatide	PTH	PA451620	5741	0.312
NULL	J_Geriatr_Cardiol_2014_Jun_11(2)_151-157.nxml.txt.nlp	25009566	SENT121	8	8	0	0	cilostazol	CDP	PA164746334	1523	0.312
NULL	ScientificWorldJournal_2013_Oct_24_2013_726912.nxml.txt.nlp	24282387	SENT4	0	0	8	8	fluorescein	AVP	PA164746009	114548;551	0.312
NULL	Arthritis_Res_Ther_2012_Aug_3_14(4)_R179.nxml.txt.nlp	22863285	SENT120	18	18	46	46	collagenase	GAPDH	PA449107	2597	0.312
NULL	Ann_Rheum_Dis_2010_Feb_7_69(2)_394-399.nxml.txt.nlp	19815494	SENT152	22	22	29	29	infliximab	IMPACT	PA452639	55364	0.312
NULL	Avicenna_J_Med_2012_Jul-Sep_2(3)_65-70.nxml.txt.nlp	23826549	SENT61	2	2	8	8	amiodarone	ARCH	PA448383	339487	0.311
NULL	Adv_Ther_2014_Dec_2_31_1228-1246.nxml.txt.nlp	25447269	SENT64	27	27	24	24	timolol	TIM	PA451690	7984;8914	0.311
NULL	Neural_Plast_2007_Dec_11_2007_73079.nxml.txt.nlp	NULL	SENT1137	16	16	12	12	haloperidol	GLYB	PA449841	2757	0.311
NULL	Br_J_Cancer_2014_Nov_25_111(11)_2091-2102.nxml.txt.nlp	25349971	SENT221	9	9	7	7	imatinib	PTPN18	PA10804	26469	0.311
NULL	J_Carcinog_2011_Mar_24_10_8.nxml.txt.nlp	21483656	SENT48	16	16	19	19	spermine	SSAT	PA164781199	6303	0.311
NULL	Br_J_Cancer_2009_May_19_100(10)_1540-1548.nxml.txt.nlp	19384300	SENT142	16	16	19	19	trypsin	TATI	PA451806	6690	0.311
NULL	Mol_Med_Rep_2015_Jan_17_11(1)_43-52.nxml.txt.nlp	25333456	SENT266	21	21	39	39	vincristine	ADM	PA451879	133	0.311
NULL	Clin_Kidney_J_2013_Jun_11_6(3)_287-294.nxml.txt.nlp	23717787	SENT4	2	2	7	7	cinacalcet	PTH	PA164776671	5741	0.311
NULL	Indian_J_Psychiatry_2010_Jan_52(Suppl1)_S317-S340.nxml.txt.nlp	21836703	SENT106	25	25	27	27	thiothixene	TFP	PA451669	7034	0.311
NULL	Crit_Care_2010_Oct_22_14(5)_R189.nxml.txt.nlp	20969752	SENT75	22	22	18	18	oxygen	PVR	PA450744	5817	0.311
NULL	J_Cell_Biol_2000_Jul_10_150(1)_27-40.nxml.txt.nlp	10893254	SENT293	9	9	17	17	collagenase	MMP3	PA449107	4314	0.311
NULL	Evid_Based_Complement_Alternat_Med_2014_Jul_1_2014_423751.nxml.txt.nlp	25101132	SENT180	10	10	16	16	erythromycin	Met	PA449493	79811	0.311
NULL	Alzheimers_Res_Ther_2013_May_14_5(3)_25.nxml.txt.nlp	23673233	SENT386	8	8	13	13	donepezil	spatial	PA449394	219793	0.311
NULL	Afr_J_Infect_Dis_2010_4(2)_20-28.nxml.txt.nlp	23878697	SENT23	0	0	4	4	artemisinin	ACT	PA165111696	12;11332;9457;641455	0.311
NULL	J_Pain_Res_2014_Nov_24_7_639-643.nxml.txt.nlp	25473307	SENT55	37	37	22	22	lidocaine	LNP	PA450226	80856;51203	0.311
NULL	Front_Neurosci_2011_Jan_14_4_207.nxml.txt.nlp	21258618	SENT172	12	12	14	14	ethanol	CRF1	PA448073	1394	0.311
NULL	Mol_Vis_2007_Jan_24_13_57-65.nxml.txt.nlp	17277739	SENT7	14	14	24	24	heparin	FGF2	PA449855	2247;2258	0.311
NULL	Tob_Induc_Dis_2004_Mar_15_2(1)_2.nxml.txt.nlp	NULL	SENT9	36	36	31	31	thrombin	ADP	PA451674	23038	0.311
NULL	J_Young_Pharm_2010_Apr-Jun_2(2)_183-189.nxml.txt.nlp	21264123	SENT55	15	15	23	23	valsartan	API	PA451848	5345	0.311
NULL	Environ_Health_Perspect_1995_Jul-Aug_103(7-8)_708-713.nxml.txt.nlp	7588483	SENT3	18	18	15	15	genistein	DES	PA165109660	1674	0.311
NULL	Pain_Res_Treat_2012_Apr_23_2012_295926.nxml.txt.nlp	22577544	SENT60	28	28	32	32	dicyclomine	DLD	PA164744928	1738	0.311
NULL	Stud_Health_Technol_Inform_2013_192_62-66.nxml.txt.nlp	23920516	SENT131	6	6	0	0	hydroxyurea	DBM	PA449942	1621	0.311
NULL	Arthritis_Res_Ther_2013_Feb_13_15(1)_R26.nxml.txt.nlp	23406906	SENT203	22	22	18	18	tacrolimus	SOCS3	PA451578	9021	0.311
NULL	Front_Neurol_2014_Feb_18_5_17.nxml.txt.nlp	24600432	SENT113	0	0	7	7	levetiracetam	C17	PA450206	54360	0.311
NULL	Biologics_2013_Apr_15_7_77-90.nxml.txt.nlp	23723688	SENT116	34	34	11	11	cetuximab	CRT	PA10040	811	0.311
NULL	Open_Biochem_J_2007_Jun_15_1_1-6.nxml.txt.nlp	18949066	SENT6	4	4	7	7	ciclopirox	CPX	PA164747060	1371;10682;1377	0.311
NULL	Mol_Vis_2011_Aug_18_17_2241-2247.nxml.txt.nlp	21897746	SENT5	16	16	13	13	fluorescein	ERG	PA164746009	2078	0.311
NULL	Exp_Diabetes_Res_2010_Jan_5_2010_974681.nxml.txt.nlp	21318189	SENT60	18	18	20	20	paraformaldehyde	PBSF	PA450790	6387	0.311
NULL	Nucleic_Acids_Res_2012_Jul_20_40(13)_6270-6289.nxml.txt.nlp	22434888	SENT155	35	35	20	20	galactose	UTP6	PA449725	55813	0.311
NULL	J_Biomed_Biotechnol_2010_Oct_27_2010_948543.nxml.txt.nlp	21048930	SENT48	0	0	27	27	nystatin	MDC	PA450666	6367	0.311
NULL	Int_J_Nanomedicine_2012_May_7_7_2307-2314.nxml.txt.nlp	22661887	SENT72	20	20	8	8	gemcitabine	zeta	PA449748	9907	0.311
NULL	Springerplus_2013_Jan_11_2_5.nxml.txt.nlp	23520572	SENT127	7	7	15	15	tamoxifen	ATAC	PA451581	6375	0.311
NULL	Oncol_Lett_2013_Mar_19_5(3)_923-928.nxml.txt.nlp	23426648	SENT147	11	11	8	8	sc-560	MVD		4597	0.311
NULL	Crit_Care_2011_Jul_18_15(4)_R171.nxml.txt.nlp	21767409	SENT187	2	2	5	5	creatine	SAPS	PA164778930	8935	0.31
NULL	Cancer_Metab_2013_Feb_4_1_7.nxml.txt.nlp	24280108	SENT41	6	6	29	29	glucose	FBS	PA449773	64319;26269	0.31
NULL	Oncogene_2010_Nov_4_29(44)_5883-5894.nxml.txt.nlp	20697354	SENT235	14	14	5	5	hydrocortisone	F12	PA449905	2161	0.31
NULL	Chem_Cent_J_2014_Sep_17_8(1)_59.nxml.txt.nlp	NULL	SENT3	15	15	18	18	moxifloxacin	MOX	PA450555	26002	0.31
NULL	Niger_Med_J_2011_Oct-Dec_52(4)_239-243.nxml.txt.nlp	22529506	SENT95	19	19	14	14	vancomycin	HAI	PA451850	6692;6768	0.31
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Sep_25_66(Pt_10)_m1290.nxml.txt.nlp	21587432	SENT66	2	2	33	33	ethanol	mol	PA448073	90527	0.31
NULL	Clin_Ophthalmol_2010_Oct_5_4_1137-1143.nxml.txt.nlp	20957061	SENT9	32	32	28	28	travoprost	BAK	PA164781371	578	0.31
NULL	Oncotarget_2012_Aug_31_3(9)_998-1010.nxml.txt.nlp	22948175	SENT58	38	38	33	33	doxorubicin	MAX	PA449412	4149	0.31
NULL	Indian_J_Ophthalmol_2014_Jul_62(7)_761-767.nxml.txt.nlp	25116765	SENT121	41	41	35	35	bevacizumab	CRT	PA130232992	811	0.31
NULL	Diabetes_Care_2010_Oct_33(10)_2277-2284.nxml.txt.nlp	20876708	SENT29	21	21	27	27	lipase	FIAF	PA450239	51129	0.31
NULL	Oncol_Lett_2014_May_4_7(5)_1352-1362.nxml.txt.nlp	24765137	SENT98	12	12	8	8	cisplatin	ERCC2	PA449014	2068	0.31
NULL	J_Signal_Transduct_2010_Sep_1_2010_643642.nxml.txt.nlp	21637354	SENT152	11	11	11	11	pp2	PP2		4888	0.31
NULL	Endocrinol_Diabetes_Metab_Case_Rep_2014_Feb_1_2014_130080.nxml.txt.nlp	24683484	SENT37	4	4	19	19	cosyntropin	ACTH	PA164749052	5443	0.31
NULL	Arthritis_Res_Ther_2004_Dec_5_6(1)_6-7.nxml.txt.nlp	14979925	SENT20	14	14	17	17	hyaluronan	HAS1	PA165958431	3036	0.31
NULL	Mol_Med_Rep_2015_Jan_17_11(1)_43-52.nxml.txt.nlp	25333456	SENT266	35	35	39	39	cisplatin	ADM	PA449014	133	0.31
NULL	Acta_Pharmacol_Sin_2011_Jan_6_32(1)_133-138.nxml.txt.nlp	21131997	SENT50	24	24	18	18	heparin	ACT	PA449855	12;11332;9457;641455	0.31
NULL	Arch_Med_Sci_2010_Dec_29_6(6)_964-970.nxml.txt.nlp	22427774	SENT122	25	25	9	9	calcipotriol	IL-20	PA448714	27190;50604	0.31
NULL	Mol_Cancer_2007_Oct_25_6_67.nxml.txt.nlp	17958915	SENT307	32	32	10	10	imatinib	GM-CSF	PA10804	1437	0.31
NULL	Nat_Neurosci_2012_Jun_15(6)_853-861.nxml.txt.nlp	22581185	SENT247	43	43	13	13	gentamicin	CO2	PA449753	4513	0.31
NULL	Arthritis_Res_Ther_2012_Mar_12_14(2)_R57.nxml.txt.nlp	22409963	SENT98	13	13	8	8	rituximab	BAFF	PA451261	10673	0.31
NULL	Int_J_Mol_Sci_2014_Sep_5_15(9)_15754-15765.nxml.txt.nlp	25198898	SENT108	0	0	9	9	curcumin	NAC	PA151958596	22861	0.31
NULL	Physiol_Rep_2014_Sep_11_2(9)_e12144.nxml.txt.nlp	25214522	SENT8	10	10	31	31	resveratrol	RVR		9975	0.31
NULL	Curr_Neuropharmacol_2013_Jul_11(4)_338-378.nxml.txt.nlp	24381528	SENT307	33	33	22	22	curcumin	FDG	PA151958596	23583	0.31
NULL	EMBO_Mol_Med_2011_Oct_3(10)_593-604.nxml.txt.nlp	21786422	SENT179	6	6	12	12	fluorescein	FDG	PA164746009	23583	0.31
NULL	J_Geriatr_Cardiol_2014_Mar_11(1)_20-25.nxml.txt.nlp	24748877	SENT112	6	6	0	0	haloperidol	CPZ	PA449841	8532	0.31
NULL	Ann_Rheum_Dis_2014_Sep_19_73(9)_1689-1694.nxml.txt.nlp	24748630	SENT151	28	28	35	35	infliximab	IMPACT	PA452639	55364	0.31
NULL	J_Antimicrob_Chemother_2012_Feb_17_67(2)_404-414.nxml.txt.nlp	22101217	SENT135	14	14	12	12	ethambutol	EMB	PA164784021	133418	0.31
NULL	Cardiol_Res_Pract_2011_Jan_2_2011_156326.nxml.txt.nlp	21253517	SENT84	29	29	9	9	heparin	EC-SOD	PA449855	6649	0.31
NULL	Bioinformation_2012_Nov_13_8(22)_1114-1118.nxml.txt.nlp	23251047	SENT46	10	10	31	31	pyrimethamine	DHPS	PA451193	1725	0.31
NULL	Oncotarget_2013_Mar_26_4(3)_397-412.nxml.txt.nlp	23651630	SENT308	34	34	32	32	doxorubicin	CHOP	PA449412	1649	0.31
NULL	Evid_Based_Complement_Alternat_Med_2012_Oct_15_2012_591654.nxml.txt.nlp	23118793	SENT286	26	26	24	24	metformin	Met	PA450395	79811	0.31
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Mar_27_66(Pt_4)_m463-m464.nxml.txt.nlp	21580548	SENT71	7	7	10	10	phenol	C48	PA450913	55755	0.31
NULL	Infect_Dis_Obstet_Gynecol_2006_Oct_1_2006_18182.nxml.txt.nlp	17485797	SENT154	6	6	12	12	kanamycin	NOV	PA450137	4856;5361;6134	0.31
NULL	J_Cardiothorac_Surg_2014_Mar_31_9_63.nxml.txt.nlp	24685284	SENT108	42	42	14	14	vancomycin	IL6	PA451850	3569	0.31
NULL	Anal_Bioanal_Chem_2011_Sep_14_401(4)_1109-1125.nxml.txt.nlp	21755271	SENT141	3	3	6	6	fructose	FBP	PA449716	8880;51552	0.309
NULL	Diabetes_Care_2013_Aug_17_36(Suppl_2)_S127-S138.nxml.txt.nlp	23882037	SENT215	5	5	2	2	pioglitazone	GLP-1	PA450970	100125288	0.309
NULL	Biomed_Res_Int_2013_Aug_5_2013_462589.nxml.txt.nlp	23998124	SENT63	9	9	13	13	bleomycin	BLM	PA448645	641	0.309
NULL	Braz_J_Med_Biol_Res_2012_Mar_16_45(6)_488-496.nxml.txt.nlp	22415117	SENT140	0	0	33	33	creatine	UST	PA164778930	10090	0.309
NULL	Cancers_(Basel)_2011_May_18_3(2)_2444-2461.nxml.txt.nlp	24212818	SENT150	25	25	20	20	thrombin	LPA	PA451674	4018	0.309
NULL	Physiol_Rep_2014_Nov_4_2(11)_e12193.nxml.txt.nlp	25367694	SENT43	6	6	23	23	gentamicin	FBS	PA449753	64319;26269	0.309
NULL	Reprod_Biol_Endocrinol_2003_Aug_27_1_59.nxml.txt.nlp	12967350	SENT137	4	4	6	6	estradiol	XIAP	PA449503	331	0.309
NULL	Nucleic_Acids_Res_2012_Apr_16_40(8)_3641-3652.nxml.txt.nlp	22180534	SENT102	21	21	8	8	galactose	GAL	PA449725	51083	0.309
NULL	Clin_Ophthalmol_2014_Jan_13_8_219-228.nxml.txt.nlp	24531757	SENT145	27	27	9	9	timolol	TIM	PA451690	7984;8914	0.309
NULL	Acta_Histochem_Cytochem_2011_Apr_28_44(2)_81-90.nxml.txt.nlp	21614169	SENT14	10	10	13	13	hyaluronan	LYVE-1	PA165958431	10894	0.309
NULL	Pharmaceuticals_(Basel)_2013_Aug_6_6(8)_929-959.nxml.txt.nlp	24276377	SENT105	25	25	39	39	oxaliplatin	PC3	PA131285527	57332;7832;5122	0.309
NULL	Indian_J_Dermatol_2013_May-Jun_58(3)_197-199.nxml.txt.nlp	23723470	SENT6	8	8	17	17	ofloxacin	ROM	PA450684	6094	0.309
NULL	J_Geriatr_Cardiol_2014_Jun_11(2)_151-157.nxml.txt.nlp	25009566	SENT136	8	8	0	0	cilostazol	CDP	PA164746334	1523	0.309
NULL	Int_J_Hypertens_2013_Jun_17_2013_627938.nxml.txt.nlp	23844279	SENT154	37	37	6	6	telmisartan	A10	PA451605	28870	0.309
NULL	Infect_Dis_Ther_2014_Dec_12_3(2)_103-122.nxml.txt.nlp	25388760	SENT92	25	25	21	21	maraviroc	CCR5	PA164768835	1234	0.309
NULL	J_Cell_Biol_2004_Apr_12_165(1)_77-86.nxml.txt.nlp	15067018	SENT249	2	2	5	5	collagenase	MMP13	PA449107	4322	0.309
NULL	Cancers_(Basel)_2009_Dec_15_1(1)_23-28.nxml.txt.nlp	20535236	SENT311	5	5	3	3	cisplatin	MRP4	PA449014	10257	0.309
NULL	Indian_J_Endocrinol_Metab_2013_Oct_17(Suppl1)_S358-S359.nxml.txt.nlp	24251214	SENT13	31	31	35	35	protamine	PZI	PA10366	51156	0.309
NULL	Mol_Biol_Evol_2013_Nov_16_30(11)_2531-2540.nxml.txt.nlp	23955518	SENT142	4	4	21	21	nadh	ND3	PA164755085	4537	0.309
NULL	Int_J_Biol_Sci_2011_Nov_5_8(1)_1-14.nxml.txt.nlp	22211100	SENT268	6	6	4	4	gemcitabine	Gem	PA449748	51053	0.309
NULL	J_Geriatr_Cardiol_2014_Mar_11(1)_63-73.nxml.txt.nlp	24748884	SENT122	2	2	21	21	urea	AST	PA451831	26503	0.309
NULL	Clin_Med_Insights_Oncol_2011_Jul_20_5_213-221.nxml.txt.nlp	21836817	SENT212	5	5	7	7	sunitinib	FDG	PA162372840	23583	0.309
NULL	Front_Neuroenergetics_2013_Dec_26_5_11.nxml.txt.nlp	24421768	SENT177	12	12	9	9	glucose	BAT	PA449773	570	0.309
NULL	Oncotarget_2014_Aug_4_5(15)_6526-6539.nxml.txt.nlp	25153727	SENT300	4	4	16	16	fluorescein	TRAIL	PA164746009	8743	0.309
NULL	Clin_Dev_Immunol_2013_Nov_21_2013_923107.nxml.txt.nlp	24348684	SENT109	8	8	11	11	imatinib	CML	PA10804	613	0.309
NULL	Case_Rep_Rheumatol_2014_Nov_11_2014_536856.nxml.txt.nlp	25436167	SENT40	28	28	31	31	iron	MRI	PA450087	78996	0.309
NULL	F1000Res_2013_Nov_13_2_203.nxml.txt.nlp	24555099	SENT11	6	6	12	12	nadh	CBR1	PA164755085	873	0.309
NULL	Chem_Res_Toxicol_2010_Jul_19_23(7)_1151-1162.nxml.txt.nlp	20536192	SENT615	6	6	10	10	mitomycin	p53	PA450524	7157	0.309
NULL	Oncotarget_2014_Sep_10_5(20)_9877-9888.nxml.txt.nlp	25245676	SENT23	10	10	21	21	cetuximab	EGFR	PA10040	1956	0.309
NULL	Front_Oncol_2014_May_16_4_107.nxml.txt.nlp	24904823	SENT406	19	19	15	15	sirolimus	RAPA	PA451365	55809	0.308
NULL	Int_J_Hypertens_2011_May_25_2011_417594.nxml.txt.nlp	21747977	SENT190	36	36	24	24	metoprolol	BEST	PA450480	7439	0.308
NULL	Behav_Brain_Funct_2008_May_24_4_22.nxml.txt.nlp	18501011	SENT97	11	11	13	13	l-arginine	NIF	PA448478	6280	0.308
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1126-1134.nxml.txt.nlp	21364592	SENT12	15	15	4	4	cisplatin	ERCC1	PA449014	2067	0.308
NULL	Alcohol_Res_Health_2007_30(1)_38-47.nxml.txt.nlp	17718399	SENT14	41	41	26	26	oxygen	ADH	PA450744	551	0.308
NULL	Cancer_Immunol_Immunother_2013_May_16_62(5)_897-908.nxml.txt.nlp	23589107	SENT21	4	4	24	24	cyclophosphamide	CTX	PA449165	1593	0.308
NULL	J_Korean_Med_Sci_2014_Aug_30_29(8)_1042-1053.nxml.txt.nlp	25120312	SENT40	5	5	2	2	ng-monomethyl-l-arginine	NAC		22861	0.308
NULL	J_Biol_Chem_2008_May_30_283(22)_15419-15430.nxml.txt.nlp	18378687	SENT89	19	19	19	19	pp2	PP2		4888	0.308
NULL	J_Inherit_Metab_Dis_2013_Mar_5_36(2)_385-394.nxml.txt.nlp	22669363	SENT26	29	29	16	16	galsulfase	ERT	PA164746235	1999	0.308
NULL	Mol_Vis_2011_Feb_1_17_332-340.nxml.txt.nlp	21297899	SENT152	0	0	10	10	telmisartan	NAC	PA451605	22861	0.308
NULL	Hum_Genomics_2008_Sep_1_3(1)_7-16.nxml.txt.nlp	19129086	SENT150	5	5	17	17	rosiglitazone	CYP2C8	PA451283	1558	0.308
NULL	J_Cell_Mol_Med_2014_Mar_22_18(3)_480-491.nxml.txt.nlp	24450440	SENT61	14	14	6	6	sunitinib	San	PA162372840	80218	0.308
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Nov_15_5_27.nxml.txt.nlp	17107610	SENT39	22	22	8	8	rifabutin	EMB	PA451249	133418	0.308
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Nov_15_5_27.nxml.txt.nlp	17107610	SENT39	26	26	4	4	clarithromycin	CPX	PA449028	1371;10682;1377	0.308
NULL	Pan_Afr_Med_J_2013_Jan_20_14_28.nxml.txt.nlp	23504148	SENT49	10	10	13	13	cefotaxime	CTX	PA448852	1593	0.308
NULL	Clin_Med_Insights_Womens_Health_2013_Jan_22_6_1-11.nxml.txt.nlp	24665209	SENT61	4	4	11	11	tamoxifen	ATAC	PA451581	6375	0.308
NULL	Daru_2011_19(6)_433-439.nxml.txt.nlp	23008689	SENT22	0	0	12	12	flurbiprofen	BCS	PA449683	617	0.308
NULL	Evid_Based_Complement_Alternat_Med_2014_Jun_17_2014_860180.nxml.txt.nlp	25045391	SENT43	0	0	28	28	scopolamine	DTNB	PA451308	1838	0.308
NULL	Case_Rep_Med_2014_May_4_2014_964082.nxml.txt.nlp	24876846	SENT42	7	7	4	4	doxorubicin	BOR	PA449412	55143	0.308
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Nov_15_5_27.nxml.txt.nlp	17107610	SENT39	14	14	4	4	dapsone	CPX	PA449211	1371;10682;1377	0.308
NULL	Breast_Cancer_Res_2011_Nov_24_13(6)_R120.nxml.txt.nlp	22115051	SENT171	45	45	14	14	tamoxifen	HER-2	PA451581	2064	0.308
NULL	Nanoscale_Res_Lett_2010_Aug_18_6(1)_1.nxml.txt.nlp	21711573	SENT49	38	38	15	15	ethanol	NO3	PA448073	4681	0.308
NULL	Avicenna_J_Phytomed_2012_Spring_2(2)_72-78.nxml.txt.nlp	25050233	SENT4	28	28	25	25	reserpine	FST	PA451236	10468	0.308
NULL	Breast_Cancer_Res_2003_Feb_5_5(2)_113-116.nxml.txt.nlp	12631392	SENT100	26	26	33	33	tamoxifen	ATAC	PA451581	6375	0.308
NULL	Avicenna_J_Phytomed_2012_Spring_2(2)_72-78.nxml.txt.nlp	25050233	SENT29	23	23	20	20	reserpine	FST	PA451236	10468	0.308
NULL	Mol_Vis_2011_Aug_6_17_2080-2092.nxml.txt.nlp	21850184	SENT288	42	42	45	45	lipase	LIPC	PA450239	3990	0.308
NULL	Cancer_Microenviron_2013_Jan_22_6(3)_231-240.nxml.txt.nlp	23335094	SENT81	0	0	7	7	simvastatin	PC-3	PA451363	692094	0.308
NULL	Nat_Genet_2011_Jan_12_43(1)_27-33.nxml.txt.nlp	21151129	SENT91	19	19	5	5	tamoxifen	FOXA1	PA451581	3169	0.308
NULL	Case_Rep_Crit_Care_2014_Nov_6_2014_214970.nxml.txt.nlp	25431684	SENT86	5	5	12	12	doxorubicin	CHOP	PA449412	1649	0.308
NULL	Endosc_Ultrasound_2012_Apr-Jun_1(1)_41-47.nxml.txt.nlp	24949334	SENT64	17	17	24	24	lipase	CEA	PA450239	5670;1087	0.308
NULL	Bioinorg_Chem_Appl_2014_Sep_15_2014_718175.nxml.txt.nlp	25332694	SENT3	8	8	32	32	ethanol	HL1	PA448073	1767	0.308
NULL	Neuroscience_2011_Dec_1_197(1)_280-292.nxml.txt.nlp	21945033	SENT60	8	8	5	5	galantamine	AP-5	PA449726	91056	0.307
NULL	Exp_Diabetes_Res_2012_Dec_26_2012_230624.nxml.txt.nlp	23365557	SENT255	7	7	5	5	metformin	Met	PA450395	79811	0.307
NULL	Ann_Rheum_Dis_2014_Sep_19_73(9)_1689-1694.nxml.txt.nlp	24748630	SENT150	18	18	25	25	infliximab	IMPACT	PA452639	55364	0.307
NULL	Mol_Cancer_2014_Apr_30_13_98.nxml.txt.nlp	24779770	SENT196	12	12	15	15	oxygen	ROS	PA450744	6098	0.307
NULL	Contemp_Clin_Dent_2011_Oct-Dec_2(4)_278-282.nxml.txt.nlp	22346152	SENT93	4	4	21	21	potassium	GCF	PA451047	6936	0.307
NULL	Int_J_Biol_Sci_2014_Aug_23_10(8)_921-939.nxml.txt.nlp	25170305	SENT332	6	6	0	0	nadh	EPO	PA164755085	7076;8288;2056	0.307
NULL	Clin_Ophthalmol_2014_Jan_13_8_219-228.nxml.txt.nlp	24531757	SENT153	22	22	4	4	timolol	TIM	PA451690	7984;8914	0.307
NULL	BioDrugs_2013_May_9_27(5)_469-478.nxml.txt.nlp	23658121	SENT98	1	1	40	40	capecitabine	TPC	PA448771	8030;60386	0.307
NULL	Front_Immunol_2012_May_11_3_109.nxml.txt.nlp	22593757	SENT238	14	14	20	20	abatacept	DST	PA164747080	667	0.307
NULL	Gut_Liver_2012_Apr_17_6(2)_139-148.nxml.txt.nlp	22570744	SENT149	1	1	8	8	sorafenib	SHARP	PA7000	23013	0.307
NULL	Genome_Biol_2008_May_28_9(5)_R91.nxml.txt.nlp	18507838	SENT186	9	9	20	20	trypsin	L11	PA451806	90861;6135	0.307
NULL	Br_J_Pharmacol_2010_Aug_160(8)_1997-2007.nxml.txt.nlp	20649597	SENT120	8	8	8	8	pp2	PP2		4888	0.307
NULL	Diabetes_Metab_J_2013_Aug_14_37(4)_240-248.nxml.txt.nlp	23991401	SENT65	8	8	1	1	ezetimibe	NPC1L1	PA10816	29881	0.307
NULL	Nucleic_Acids_Res_2012_Jul_20_40(13)_6270-6289.nxml.txt.nlp	22434888	SENT155	35	35	14	14	galactose	GAL	PA449725	51083	0.307
NULL	Aging_(Albany_NY)_2011_Jan_18_3(1)_33-43.nxml.txt.nlp	21248371	SENT219	0	0	8	8	zinc	HIF-1	PA451956	29072	0.307
NULL	Ann_Clin_Microbiol_Antimicrob_2007_May_23_6_5.nxml.txt.nlp	17521424	SENT72	6	6	4	4	tobramycin	TOB	PA451704	10140	0.307
NULL	Int_J_Mol_Sci_2014_Jun_26_15(7)_11416-11434.nxml.txt.nlp	24972137	SENT33	1	1	6	6	sitagliptin	GLP-1	PA164748978	100125288	0.307
NULL	Mol_Vis_2012_Jan_18_18_121-127.nxml.txt.nlp	22275803	SENT153	17	17	20	20	lipase	LIPC	PA450239	3990	0.307
NULL	Int_J_Biol_Sci_2012_Feb_9_8(3)_310-327.nxml.txt.nlp	22355267	SENT395	27	27	9	9	atorvastatin	SREBP2	PA448500	6721	0.307
NULL	Biomed_Res_Int_2014_Mar_9_2014_687835.nxml.txt.nlp	24734239	SENT59	10	10	19	19	ethanol	CO2	PA448073	4513	0.307
NULL	Ann_Neurosci_2014_Jul_21(3)_97-103.nxml.txt.nlp	25206073	SENT51	14	14	26	26	bumetanide	HSN2	PA448682	378465	0.307
NULL	Clinics_(Sao_Paulo)_2009_Apr_64(4)_295-302.nxml.txt.nlp	19488585	SENT207	35	35	41	41	ciprofloxacin	Gen	PA449009	348654	0.307
NULL	AIDS_Res_Ther_2011_Oct_6_8_36.nxml.txt.nlp	21978457	SENT6	47	47	14	14	zinc	TNF	PA451956	7124	0.307
NULL	Mol_Biol_Cell_2013_Aug_1_24(15)_2389-2397.nxml.txt.nlp	23741049	SENT137	16	16	7	7	iodixanol	LDM	PA164783998	1595	0.307
NULL	Front_Pharmacol_2014_Dec_15_5_277.nxml.txt.nlp	25566074	SENT697	3	3	6	6	scopolamine	spatial	PA451308	219793	0.306
NULL	Clin_Med_Insights_Oncol_2012_Nov_26_6_395-405.nxml.txt.nlp	23239932	SENT10	15	15	19	19	daunorubicin	CHOP	PA449212	1649	0.306
NULL	Crit_Care_2011_Feb_7_15(1)_R53.nxml.txt.nlp	21299901	SENT27	24	24	15	15	vasopressin	ACTH	PA451858	5443	0.306
NULL	Case_Rep_Urol_2012_Feb_28_2012_259193.nxml.txt.nlp	22606633	SENT25	12	12	4	4	ifosfamide	API	PA449964	5345	0.306
NULL	Mol_Biol_Cell_2013_Sep_1_24(17)_2678-2688.nxml.txt.nlp	23864716	SENT82	28	28	28	28	pp2	PP2		4888	0.306
NULL	Diabetes_Care_2009_Aug_32(8)_e94-e98.nxml.txt.nlp	19638520	SENT149	12	12	21	21	metformin	HER-2	PA450395	2064	0.306
NULL	Pain_2012_Apr_153(4)_775-783.nxml.txt.nlp	22325744	SENT78	13	13	5	5	isoflurane	P14	PA450106	11102;;6280;56259	0.306
NULL	AIDS_Res_Treat_2011_Aug_15_2011_562790.nxml.txt.nlp	21860787	SENT217	20	20	0	0	tenofovir	OAT	PA10204	4942	0.306
NULL	Pediatr_Infect_Dis_J_2013_Sep_26_32(Suppl_1_Innovative_Treatment_Regimens_for_Severe_Infections_in_Young_Infants)_S33-S38.nxml.txt.nlp	23945574	SENT270	3	3	8	8	amoxicillin	MASS	PA448406	2200	0.306
NULL	Adv_Hematol_2013_Dec_11_2013_237351.nxml.txt.nlp	24396346	SENT182	9	9	13	13	thrombin	TGT	PA451674	9097;81890	0.306
NULL	Mol_Vis_2012_Jun_20_18_1668-1683.nxml.txt.nlp	22773905	SENT26	22	22	28	28	nadh	ND4	PA164755085	4538	0.306
NULL	Mol_Pain_2014_Apr_12_10_25.nxml.txt.nlp	24725960	SENT158	31	31	20	20	carrageenan	SDH	PA448814	1757;10993	0.306
NULL	Iran_J_Basic_Med_Sci_2013_Dec_16(12)_1276-1281.nxml.txt.nlp	24570835	SENT30	0	0	12	12	trypsin	F12	PA451806	2161	0.306
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_May_31_70(Pt_6)_m238-m239.nxml.txt.nlp	24940217	SENT86	19	19	30	30	nitrile	PF6	PA450636	200162	0.306
NULL	J_Hum_Hypertens_2010_Nov_18_24(11)_730-738.nxml.txt.nlp	20164847	SENT168	23	23	15	15	olmesartan	A10	PA164742950	28870	0.306
NULL	Indian_J_Anaesth_2014_May-Jun_58(3)_372-382.nxml.txt.nlp	NULL	SENT132	5	5	9	9	pregabalin	P150	PA164754814	10036	0.306
NULL	Pan_Afr_Med_J_2014_May_5_18_17.nxml.txt.nlp	25360201	SENT88	38	38	13	13	ceftriaxone	UGD	PA448866	80146	0.306
NULL	Front_Psychol_2012_Apr_24_3_117.nxml.txt.nlp	22536191	SENT786	0	0	9	9	fluoxetine	FLAME	PA449673	8837	0.306
NULL	Oncotarget_2014_Aug_27_5(21)_10486-10502.nxml.txt.nlp	25401222	SENT132	24	24	19	19	gefitinib	PP2	PA131301952	4888	0.305
NULL	Sensors_(Basel)_2008_Sep_3_8(9)_5386-5396.nxml.txt.nlp	NULL	SENT18	8	8	23	23	procaine	ITO	PA451110	3160	0.305
NULL	Eur_J_Cancer_2014_Sep_50(14)_2367-2374.nxml.txt.nlp	25027307	SENT299	15	15	12	12	estradiol	AMH	PA449503	268	0.305
NULL	J_Neurosci_Rural_Pract_2012_Sep-Dec_3(3)_429-430.nxml.txt.nlp	23189026	SENT54	19	19	7	7	semaxanib	IFN	PA131887911	3439	0.305
NULL	Neural_Regen_Res_2014_Oct_1_9(19)_1731-1739.nxml.txt.nlp	25422633	SENT165	6	6	0	0	scopolamine	DCX	PA451308	1641	0.305
NULL	Environ_Health_Perspect_2013_Apr_5_121(4)_459-466.nxml.txt.nlp	23384675	SENT89	10	10	14	14	phenol	F12	PA450913	2161	0.305
NULL	Case_Rep_Dermatol_2013_Dec_7_5(3)_363-367.nxml.txt.nlp	24474919	SENT15	2	2	5	5	lipase	LIPH	PA450239	200879	0.305
NULL	Iran_J_Public_Health_2013_Jan_1_42(Supple1)_50-54.nxml.txt.nlp	23865016	SENT136	20	20	11	11	voriconazole	CRT	PA10233	811	0.305
NULL	Front_Neurosci_2012_May_30_6_77.nxml.txt.nlp	22661925	SENT172	0	0	10	10	ethanol	HEC	PA448073	10403	0.305
NULL	Diabetes_Obes_Metab_2012_Apr_14(4)_304-314.nxml.txt.nlp	22051096	SENT141	28	28	25	25	liraglutide	PPG	PA165958364	5552	0.305
NULL	F1000Res_2014_Sep_29_3_228.nxml.txt.nlp	25485098	SENT289	23	23	28	28	creatine	SLC6A8	PA164778930	6535	0.305
NULL	Molecules_2010_Mar_30_15(4)_2302-2318.nxml.txt.nlp	20428043	SENT15	0	0	4	4	artemisinin	ACT	PA165111696	12;11332;9457;641455	0.305
NULL	Int_Semin_Surg_Oncol_2007_Jul_23_4_18.nxml.txt.nlp	17645796	SENT88	17	17	39	39	raloxifene	STAR	PA451221	6770;2984	0.305
NULL	Braz_J_Microbiol_2010_Sep_1_Jul-Sep_41(3)_819-823.nxml.txt.nlp	24031561	SENT54	34	34	0	0	mannitol	MAL	PA450320	57591;4118	0.305
NULL	Int_J_Environ_Res_Public_Health_2010_Apr_25_7(4)_1285-1301.nxml.txt.nlp	20617031	SENT141	34	34	30	30	ethanol	ALDH2	PA448073	217	0.305
NULL	Mol_Neurobiol_2010_Jun_2_41(2-3)_392-409.nxml.txt.nlp	20437209	SENT215	13	13	10	10	nadh	G6PD	PA164755085	2539	0.305
NULL	Orphanet_J_Rare_Dis_2007_Jan_8_2_3.nxml.txt.nlp	17210076	SENT216	26	26	39	39	anagrelide	IFN	PA164742986	3439	0.305
NULL	Alcohol_Res_2012_34(4)_441-447.nxml.txt.nlp	23584110	SENT28	7	7	22	22	vasopressin	ACTH	PA451858	5443	0.305
NULL	Evid_Based_Complement_Alternat_Med_2014_Jul_1_2014_423751.nxml.txt.nlp	25101132	SENT180	18	18	16	16	metronidazole	Met	PA450484	79811	0.305
NULL	Exp_Mol_Med_2012_Jul_31_44(7)_448-456.nxml.txt.nlp	22581380	SENT115	14	14	6	6	ethanol	San	PA448073	80218	0.305
NULL	J_Cardiothorac_Surg_2012_Sep_27_7_95.nxml.txt.nlp	23013647	SENT154	24	24	26	26	aprotinin	EPO	PA448472	7076;8288;2056	0.305
NULL	BMJ_2014_Nov_5_349_g6427.nxml.txt.nlp	25378023	SENT128	21	21	25	25	everolimus	DES	PA164746311	1674	0.305
NULL	Oncotarget_2012_Mar_31_3(3)_236-260.nxml.txt.nlp	22470194	SENT9	13	13	19	19	sorafenib	SHARP	PA7000	23013	0.305
NULL	Int_J_Hypertens_2013_Jun_17_2013_627938.nxml.txt.nlp	23844279	SENT154	8	8	6	6	amlodipine	A10	PA448388	28870	0.305
NULL	Cost_Eff_Resour_Alloc_2008_Jan_23_6_2.nxml.txt.nlp	18215255	SENT250	11	11	9	9	isoniazid	IPT	PA450112	54802	0.304
NULL	Int_J_Mol_Sci_2012_Aug_16_13(8)_10257-10267.nxml.txt.nlp	22949859	SENT293	3	3	6	6	phenol	TPC	PA450913	8030;60386	0.304
NULL	Neural_Regen_Res_2014_Oct_1_9(19)_1731-1739.nxml.txt.nlp	25422633	SENT173	12	12	0	0	scopolamine	ROD	PA451308	9735	0.304
NULL	Cardiovasc_J_Afr_2009_Apr_20(2)_127-134.nxml.txt.nlp	19421649	SENT163	10	10	18	18	perindopril	NNT	PA450877	23530	0.304
NULL	Int_J_Endocrinol_2014_Apr_30_2014_674987.nxml.txt.nlp	24883061	SENT51	10	10	14	14	fructose	GFAT	PA449716	2673	0.304
NULL	Environ_Health_2013_Aug_20_12_66.nxml.txt.nlp	23962309	SENT36	3	3	10	10	phenobarbital	PCB	PA450911	5091	0.304
NULL	Front_Neurosci_2012_May_30_6_77.nxml.txt.nlp	22661925	SENT305	3	3	8	8	ethanol	HEC	PA448073	10403	0.304
NULL	Case_Rep_Hematol_2013_Nov_3_2013_849168.nxml.txt.nlp	24307958	SENT31	41	41	22	22	heparin	PF4	PA449855	5196	0.304
NULL	Front_Genet_2012_Nov_5_3_236.nxml.txt.nlp	23133441	SENT11	17	17	13	13	efavirenz	ABCB1	PA449441	5243	0.304
NULL	Eur_Respir_J_2012_Jun_17_39(6)_1511-1519.nxml.txt.nlp	22005918	SENT108	26	26	0	0	isoniazid	DST	PA450112	667	0.304
NULL	Eur_J_Appl_Physiol_2011_Feb_24_111(2)_275-283.nxml.txt.nlp	20865425	SENT102	22	22	20	20	glucose	APE	PA449773	55704;328	0.304
NULL	Crit_Care_2005_Sep_3_9(1)_23-24.nxml.txt.nlp	15693976	SENT11	13	13	16	16	dantrolene	CHS	PA449208	1130	0.304
NULL	J_Neural_Transm_2014_Mar_27_121(10)_1221-1232.nxml.txt.nlp	24671607	SENT199	17	17	24	24	ethanol	CORT	PA448073	1325	0.304
NULL	Indian_J_Med_Res_2013_Jan_137(1)_125-129.nxml.txt.nlp	23481061	SENT59	2	2	10	10	cisplatin	GSTM1	PA449014	2944	0.304
NULL	Biomed_Res_Int_2014_Jan_12_2014_560183.nxml.txt.nlp	24524080	SENT210	8	8	6	6	betaine	BHMT	PA448603	635	0.304
NULL	Mycology_2014_Jul_3_5(3)_1305-144.nxml.txt.nlp	25379337	SENT275	15	15	9	9	guanidine	ADP	PA164781028	23038	0.304
NULL	Arthritis_Res_Ther_2009_Feb_3_11(1)_R15.nxml.txt.nlp	19192274	SENT225	18	18	26	26	diclofenac	MIP-3	PA449293	6368	0.304
NULL	F1000Res_2014_Jul_30_3_103.nxml.txt.nlp	25285204	SENT35	19	19	11	11	thrombin	VWF	PA451674	7450	0.304
NULL	Ann_Surg_Oncol_2013_Jun_19_20(Suppl_3)_348-359.nxml.txt.nlp	22711178	SENT212	5	5	7	7	hyaluronan	CD44	PA165958431	960	0.304
NULL	Ann_Thorac_Med_2011_Apr-Jun_6(2)_101-102.nxml.txt.nlp	21572702	SENT12	41	41	36	36	oxygen	PSO2	PA450744	9937	0.304
NULL	J_Vet_Med_Sci_2014_Jan_4_76(1)_113-117.nxml.txt.nlp	24004933	SENT71	22	22	25	25	sevoflurane	BAR	PA451341	154;51283	0.304
NULL	Indian_J_Med_Res_2012_Dec_136(6)_907-925.nxml.txt.nlp	23391787	SENT165	0	0	4	4	artemisinin	ACT	PA165111696	12;11332;9457;641455	0.304
NULL	Mol_Pain_2013_Dec_30_9_68.nxml.txt.nlp	24377488	SENT25	12	12	24	24	capsaicin	TRPV1	PA448776	7442	0.304
NULL	Clinics_(Sao_Paulo)_2009_Apr_64(4)_295-302.nxml.txt.nlp	19488585	SENT207	31	31	41	41	clindamycin	Gen	PA449035	348654	0.303
NULL	BMJ_Open_Respir_Res_2014_Jan_3_1(1)_e000010.nxml.txt.nlp	25478169	SENT47	24	24	26	26	azathioprine	NAC	PA448515	22861	0.303
NULL	Breast_Cancer_(Auckl)_2009_Aug_17_3_47-60.nxml.txt.nlp	21556249	SENT281	4	4	26	26	raloxifene	STAR	PA451221	6770;2984	0.303
NULL	Curr_Genomics_2013_Nov_14(7)_453-467.nxml.txt.nlp	24396277	SENT154	8	8	6	6	iron	PCSK7	PA450087	9159	0.303
NULL	Braz_J_Microbiol_2014_May_19_45(1)_111-115.nxml.txt.nlp	24948921	SENT42	2	2	0	0	vancomycin	VAN	PA451850	10318	0.303
NULL	Leukemia_2014_Aug_7_28(8)_1636-1646.nxml.txt.nlp	24418989	SENT37	0	0	21	21	chloroquine	ACTB	PA448948	60	0.303
NULL	Eur_J_Neurosci_2007_Feb_25(3)_837-846.nxml.txt.nlp	17313573	SENT321	4	4	11	11	colchicine	spatial	PA449092	219793	0.303
NULL	J_Cell_Mol_Med_2014_Jan_19_18(1)_156-169.nxml.txt.nlp	24251962	SENT223	24	24	27	27	bleomycin	BLM	PA448645	641	0.303
NULL	Front_Immunol_2012_Jan_24_3_3.nxml.txt.nlp	22566889	SENT109	14	14	12	12	rituximab	IL-2	PA451261	3558	0.303
NULL	Exp_Hematol_Oncol_2013_Jan_10_2_2.nxml.txt.nlp	23305345	SENT138	8	8	23	23	rituximab	BTZ	PA451261	22794	0.303
NULL	Oxid_Med_Cell_Longev_2013_Jun_2_2013_793525.nxml.txt.nlp	23819014	SENT104	3	3	9	9	resveratrol	SGBS		2719	0.303
NULL	Core_Evid_2014_Sep_19_9_99-112.nxml.txt.nlp	25278817	SENT116	0	0	5	5	colistimethate	DPI	PA164749509	1832	0.303
NULL	J_Biomed_Sci_2014_Aug_19_21(1)_70.nxml.txt.nlp	25134966	SENT79	20	20	16	16	ethanol	DTNB	PA448073	1838	0.303
NULL	Osteoporos_Int_2013_Jan_24_24(1)_219-226.nxml.txt.nlp	23093347	SENT187	2	2	8	8	teriparatide	PTH	PA451620	5741	0.303
NULL	Eur_J_Clin_Pharmacol_2013_Mar_11_69(3)_327-339.nxml.txt.nlp	22782539	SENT193	7	7	28	28	dabigatran	IPA		3160	0.303
NULL	Clin_Ophthalmol_2010_Oct_5_4_1137-1143.nxml.txt.nlp	20957061	SENT9	13	13	28	28	bimatoprost	BAK	PA164748867	578	0.303
NULL	Oncotarget_2011_Nov_9_2(11)_850-861.nxml.txt.nlp	22081665	SENT139	8	8	14	14	daunorubicin	DNMT3A	PA449212	1788	0.303
NULL	Crit_Care_2011_Feb_7_15(1)_R53.nxml.txt.nlp	21299901	SENT8	15	15	6	6	vasopressin	ACTH	PA451858	5443	0.303
NULL	Can_J_Anaesth_2011_Feb_31_58(2)_206-215.nxml.txt.nlp	21194017	SENT253	5	5	24	24	etomidate	mol	PA164743987	90527	0.303
NULL	Eur_J_Dent_2009_Jan_3(1)_3-9.nxml.txt.nlp	19262725	SENT101	31	31	33	33	glutaraldehyde	HEMA	PA449777	2157	0.303
NULL	Br_J_Cancer_1978_Aug_38(2)_325-328.nxml.txt.nlp	698049	SENT5	40	40	33	33	thioguanine	AMPH	PA451663	273	0.303
NULL	Nature_2012_Feb_15_482(7386)_519-523.nxml.txt.nlp	22343898	SENT179	7	7	9	9	ethanol	CO2	PA448073	4513	0.303
NULL	Exp_Diabetes_Res_2012_Oct_19_2012_628978.nxml.txt.nlp	22028701	SENT269	3	3	0	0	oxygen	ROS	PA450744	6098	0.302
NULL	Cancer_Cell_Int_2011_Jun_29_11_22.nxml.txt.nlp	21714887	SENT325	2	2	20	20	guanidine	PLD1	PA164781028	5337	0.302
NULL	J_Mol_Signal_2012_Sep_8_7_15.nxml.txt.nlp	22958338	SENT39	5	5	5	5	pp2	PP2		4888	0.302
NULL	Case_Rep_Urol_2012_Feb_28_2012_259193.nxml.txt.nlp	22606633	SENT25	17	17	4	4	mesna	API	PA450385	5345	0.302
NULL	Oncotarget_2011_Nov_9_2(11)_850-861.nxml.txt.nlp	22081665	SENT161	22	22	0	0	idarubicin	NPM1	PA449961	4869	0.302
NULL	Clin_Med_Insights_Oncol_2012_Nov_26_6_395-405.nxml.txt.nlp	23239932	SENT10	11	11	19	19	cyclophosphamide	CHOP	PA449165	1649	0.302
NULL	Mycobiology_2008_Mar_31_36(1)_28-33.nxml.txt.nlp	23997604	SENT142	10	10	20	20	galactose	Mal	PA449725	114609	0.302
NULL	Arch_Osteoporos_2013_Oct_11_8(1-2)_136.nxml.txt.nlp	24113837	SENT2910	13	13	18	18	ibandronate	PTH	PA10270	5741	0.302
NULL	J_Hematol_Oncol_2014_Apr_4_7_30.nxml.txt.nlp	24708874	SENT169	16	16	10	10	hyaluronan	CD147	PA165958431	682	0.302
NULL	Clin_Ophthalmol_2014_Jan_13_8_219-228.nxml.txt.nlp	24531757	SENT181	27	27	9	9	timolol	TIM	PA451690	7984;8914	0.302
NULL	Br_J_Cancer_2011_Apr_12_104(8)_1278-1287.nxml.txt.nlp	21487429	SENT150	17	17	19	19	cisplatin	TRAIL	PA449014	8743	0.302
NULL	Mol_Cancer_2010_Dec_20_9_317.nxml.txt.nlp	21172025	SENT154	18	18	40	40	tamoxifen	HER2	PA451581	2064	0.302
NULL	ISRN_Obstet_Gynecol_2011_Nov_23_2011_489281.nxml.txt.nlp	22191046	SENT41	16	16	29	29	urea	MRI	PA451831	78996	0.302
NULL	Br_J_Cancer_1996_Mar_73(6)_735-743.nxml.txt.nlp	8611373	SENT0	23	23	13	13	tamoxifen	pS2	PA451581	7031	0.302
NULL	J_Phys_Ther_Sci_2013_Oct_20_25(10)_1317-1319.nxml.txt.nlp	24259784	SENT15	11	11	30	30	oxygen	ADP	PA450744	23038	0.302
NULL	Adv_Pharmacol_Sci_2013_Jan_17_2013_192408.nxml.txt.nlp	23401679	SENT286	12	12	10	10	drospirenone	API	PA164749409	5345	0.302
NULL	Front_Neuroendocrinol_2012_Jan_33(1)_45-66.nxml.txt.nlp	21802439	SENT693	15	15	4	4	vasopressin	CXCL12	PA451858	6387	0.302
NULL	Clin_Med_Insights_Oncol_2012_Feb_28_6_125-135.nxml.txt.nlp	22408376	SENT182	1	1	9	9	panitumumab	KRAS	PA162373091	3845	0.302
NULL	Biomed_Res_Int_2014_Jun_30_2014_480725.nxml.txt.nlp	25093169	SENT209	2	2	0	0	bicalutamide	BIC	PA164746255	114614	0.302
NULL	Acta_Pharmacol_Sin_2012_Jan_3_33(1)_49-56.nxml.txt.nlp	22212430	SENT117	13	13	16	16	thrombin	PAR-1	PA451674	2011;2149	0.302
NULL	Libyan_J_Med_2006_Sep_19_1(2)_176-184.nxml.txt.nlp	21526016	SENT94	27	27	5	5	sitagliptin	GLP-1	PA164748978	100125288	0.302
NULL	Front_Genet_2013_Aug_30_4_166.nxml.txt.nlp	24009623	SENT506	7	7	3	3	estradiol	BTG2	PA449503	7832	0.302
NULL	Mol_Vis_2010_Oct_8_16_2033-2042.nxml.txt.nlp	21042558	SENT73	14	14	30	30	trypsin	F12	PA451806	2161	0.302
NULL	J_Int_Soc_Sports_Nutr_2010_Jul_7_7_26.nxml.txt.nlp	20609257	SENT244	24	24	0	0	creatine	ANOVA	PA164778930	4858	0.302
NULL	Cell_Cycle_2012_Aug_15_11(16)_3097-3108.nxml.txt.nlp	22871741	SENT8	15	15	19	19	hyaluronan	HAS2	PA165958431	3037	0.301
NULL	Front_Oncol_2014_Nov_14_4_323.nxml.txt.nlp	25452936	SENT78	0	0	15	15	thrombin	MCH	PA451674	5367	0.301
NULL	Breast_Cancer_Res_2013_Nov_29_15(6)_R114.nxml.txt.nlp	24289103	SENT332	6	6	6	6	pp2	PP2		4888	0.301
NULL	J_Parasitol_Res_2011_Nov_17_2011_104954.nxml.txt.nlp	22174990	SENT42	34	34	38	38	chloroquine	DD2	PA448948	1646	0.301
NULL	Curr_Opin_Endocrinol_Diabetes_Obes_2014_Oct_28_21(5)_394-404.nxml.txt.nlp	25122493	SENT144	20	20	23	23	thyroglobulin	RAI	PA164754910	10848;6050	0.301
NULL	Int_J_Anal_Chem_2013_Jul_16_2013_419716.nxml.txt.nlp	23956748	SENT195	4	4	21	21	heparin	PF6	PA449855	200162	0.301
NULL	Amino_Acids_2011_May_22_40(5)_1369-1383.nxml.txt.nlp	21424716	SENT183	14	14	17	17	creatine	CRT	PA164778930	811	0.301
NULL	Clin_Psychopharmacol_Neurosci_2013_Aug_26_11(2)_60-66.nxml.txt.nlp	24023549	SENT90	4	4	14	14	aripiprazole	URI	PA10026	8725	0.301
NULL	Clin_Ophthalmol_2014_Jan_13_8_219-228.nxml.txt.nlp	24531757	SENT157	22	22	4	4	timolol	TIM	PA451690	7984;8914	0.301
NULL	Evid_Based_Complement_Alternat_Med_2013_Nov_5_2013_937370.nxml.txt.nlp	24302971	SENT42	18	18	15	15	zinc	DTNB	PA451956	1838	0.301
NULL	Crit_Care_2005_Sep_3_9(1)_23-24.nxml.txt.nlp	15693976	SENT19	7	7	10	10	dantrolene	CHS	PA449208	1130	0.301
NULL	Int_J_Fertil_Steril_2014_Nov_1_Oct-Dec_8(3)_243-248.nxml.txt.nlp	25379151	SENT9	12	12	21	21	piroxicam	ART	PA450985	181	0.301
NULL	Breast_Cancer_Res_2014_Sep_9_16(5)_433.nxml.txt.nlp	25212966	SENT282	25	25	12	12	thrombin	ILEI	PA451674	10447	0.301
NULL	J_Vet_Med_Sci_2014_Jul_18_76(7)_937-945.nxml.txt.nlp	24646457	SENT103	6	6	41	41	amoxicillin	OTC	PA448406	5009	0.301
NULL	J_Geriatr_Cardiol_2014_Mar_11(1)_20-25.nxml.txt.nlp	24748877	SENT67	6	6	0	0	risperidone	CPZ	PA451257	8532	0.301
NULL	Clin_Ophthalmol_2014_Jan_13_8_219-228.nxml.txt.nlp	24531757	SENT174	22	22	4	4	timolol	TIM	PA451690	7984;8914	0.301
NULL	Clin_Med_Insights_Circ_Respir_Pulm_Med_2013_Apr_9_7_7-15.nxml.txt.nlp	23641160	SENT107	20	20	14	14	salbutamol	TDI	PA448068	100038246	0.301
NULL	J_Biomed_Biotechnol_2004_Apr_27_2004(1)_52-60.nxml.txt.nlp	15123888	SENT104	2	2	0	0	genistein	Gen	PA165109660	348654	0.301
NULL	J_Exp_Bot_2012_Mar_15_63(5)_1969-1983.nxml.txt.nlp	22174442	SENT257	21	21	25	25	ethanol	mol	PA448073	90527	0.301
NULL	Br_J_Cancer_2013_Oct_15_109(8)_2131-2141.nxml.txt.nlp	24052043	SENT7	5	5	7	7	docetaxel	PC-3	PA449383	692094	0.301
NULL	J_Biol_Chem_2009_Sep_18_284(38)_26096-26105.nxml.txt.nlp	19628870	SENT272	23	23	23	23	pp2	PP2		4888	0.301
NULL	Arq_Bras_Cardiol_2014_Nov_103(5)_403-409.nxml.txt.nlp	25229355	SENT61	2	2	0	0	pazopanib	PZP	PA165291492	5858	0.301
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT88	15	15	19	19	methotrexate	MSH2	PA450428	4436	0.301
NULL	J_Phys_Ther_Sci_2014_Nov_13_26(11)_1723-1727.nxml.txt.nlp	25435686	SENT30	41	41	9	9	oxygen	adiponectin	PA450744	9370	0.301
NULL	Arthritis_Res_Ther_2007_Oct_10_9(5)_R105.nxml.txt.nlp	17927818	SENT50	17	17	17	17	pp2	PP2		4888	0.3
NULL	Indian_J_Crit_Care_Med_2010_Oct-Dec_14(4)_188-195.nxml.txt.nlp	21572750	SENT176	33	33	23	23	warfarin	ACT	PA451906	12;11332;9457;641455	0.3
NULL	J_Geriatr_Cardiol_2014_Jun_11(2)_151-157.nxml.txt.nlp	25009566	SENT142	8	8	0	0	cilostazol	CDP	PA164746334	1523	0.3
NULL	F1000Res_2014_Sep_29_3_228.nxml.txt.nlp	25485098	SENT310	2	2	5	5	creatine	SLC6A8	PA164778930	6535	0.3
NULL	Clin_Ophthalmol_2014_Jan_13_8_219-228.nxml.txt.nlp	24531757	SENT166	22	22	4	4	timolol	TIM	PA451690	7984;8914	0.3
NULL	Am_J_Trop_Med_Hyg_2010_Apr_82(4)_566-573.nxml.txt.nlp	20348500	SENT0	27	27	29	29	permethrin	DDT	PA164743137	1652	0.3
NULL	Mol_Imaging_Radionucl_Ther_2012_Apr_1_21(1)_1-5.nxml.txt.nlp	23487481	SENT73	31	31	26	26	sulfur	SLN	PA451558	6588	0.3
NULL	Arch_Med_Sci_2011_Aug_2_7(4)_713-719.nxml.txt.nlp	22291810	SENT123	25	25	9	9	calcipotriol	IL-20	PA448714	27190;50604	0.3
NULL	Orphanet_J_Rare_Dis_2012_Oct_23_7_82.nxml.txt.nlp	23092449	SENT301	46	46	6	6	creatine	BMD	PA164778930	1756;7439	0.3
NULL	Ann_Pediatr_Cardiol_2008_Jan-Jun_1(1)_70-74.nxml.txt.nlp	20300245	SENT28	0	0	9	9	sildenafil	ADP	PA451346	23038	0.3
NULL	J_Inflamm_(Lond)_2008_Dec_5_5_23.nxml.txt.nlp	19061493	SENT158	24	24	21	21	hemin	HO-1	PA449849	3162	0.3
NULL	Theranostics_2013_Nov_30_3(12)_943-952.nxml.txt.nlp	24396505	SENT69	11	11	22	22	thyroglobulin	CEA	PA164754910	5670;1087	0.3
NULL	Br_J_Cancer_2013_Jan_15_108(1)_82-90.nxml.txt.nlp	23321512	SENT156	11	11	9	9	paclitaxel	TUBB3	PA450761	10381	0.3
NULL	Ther_Clin_Risk_Manag_2006_Sep_2(3)_281-295.nxml.txt.nlp	18360603	SENT220	19	19	14	14	medroxyprogesterone	CEE	PA450344	51608	0.3
NULL	J_Radiat_Res_2014_Mar_8_55(2)_265-276.nxml.txt.nlp	24105709	SENT8	30	30	33	33	oxygen	ROS	PA450744	6098	0.3
NULL	Hum_Genomics_2004_Nov_1_1(6)_444-455.nxml.txt.nlp	15606999	SENT88	32	32	40	40	lipase	LIPG	PA450239	9388	0.3
NULL	Exp_Hematol_Oncol_2013_Jan_10_2_2.nxml.txt.nlp	23305345	SENT2	9	9	20	20	rituximab	BTZ	PA451261	22794	0.3
NULL	Cell_Host_Microbe_2014_Sep_10_16(3)_291-303.nxml.txt.nlp	25211072	SENT84	19	19	19	19	pp2	PP2		4888	0.3
NULL	Diabetes_2009_Mar_58(3)_579-589.nxml.txt.nlp	19074989	SENT12	12	12	21	21	lipase	ANGPTL4	PA450239	51129	0.3
NULL	Front_Neural_Circuits_2014_Jun_17_8_65.nxml.txt.nlp	24987336	SENT54	25	25	37	37	paraformaldehyde	CO2	PA450790	4513	0.3
NULL	Br_J_Cancer_2013_Nov_12_109(10)_2751-2762.nxml.txt.nlp	24169358	SENT208	19	19	33	33	letrozole	HER2	PA450196	2064	0.3
NULL	Biologics_2013_Apr_15_7_77-90.nxml.txt.nlp	23723688	SENT116	18	18	32	32	cetuximab	CRT	PA10040	811	0.3
NULL	Front_Neurosci_2012_May_30_6_77.nxml.txt.nlp	22661925	SENT147	0	0	11	11	ethanol	HEC	PA448073	10403	0.3
NULL	Nat_Commun_2013_Oct_1_4_2516.nxml.txt.nlp	24084631	SENT91	0	0	16	16	losartan	AK4	PA450268	205	0.3
NULL	Cardiovasc_Diabetol_2010_Sep_23_9_57.nxml.txt.nlp	20863381	SENT162	10	10	5	5	pioglitazone	DM2	PA450970	28508	0.3
NULL	Chemother_Res_Pract_2012_Aug_12_2012_549170.nxml.txt.nlp	22924129	SENT145	10	10	35	35	paclitaxel	CRT	PA450761	811	0.3
NULL	Evid_Based_Complement_Alternat_Med_2012_Nov_19_2012_967573.nxml.txt.nlp	23304232	SENT4	9	9	23	23	ethanol	MSU	PA448073	593	0.3
NULL	Hum_Genomics_2011_Mar_1_5(3)_170-191.nxml.txt.nlp	21504868	SENT427	29	29	15	15	lipase	E-FABP	PA450239	2171	0.3
NULL	Front_Immunol_2013_Sep_17_4_281.nxml.txt.nlp	24062747	SENT381	8	8	4	4	atorvastatin	IFN	PA448500	3439	0.3
NULL	Comp_Hepatol_2006_Jan_11_5_1.nxml.txt.nlp	16405720	SENT56	2	2	0	0	lamivudine	LAM	PA450163	7249;7248	0.3
NULL	Mol_Cancer_2009_Jun_8_8_34.nxml.txt.nlp	19500427	SENT104	2	2	0	0	gemcitabine	Gem	PA449748	51053	0.3
NULL	Basic_Res_Cardiol_2012_Mar_11_107(2)_245.nxml.txt.nlp	22234702	SENT347	1	1	20	20	cocaine	mol	PA449072	90527	0.3
NULL	Target_Oncol_2009_Sep_16_4(3)_235-252.nxml.txt.nlp	19756916	SENT208	9	9	7	7	gefitinib	PI3K	PA131301952	5290	0.3
NULL	Oncotarget_2013_Nov_7_4(12)_2550-2566.nxml.txt.nlp	24334291	SENT209	17	17	12	12	dasatinib	p53	PA162372878	7157	0.3
NULL	Korean_J_Radiol_2010_Feb_22_Mar-Apr_11(2)_234-238.nxml.txt.nlp	20191072	SENT62	30	30	33	33	etoposide	CHOP	PA449552	1649	0.3
NULL	J_Int_AIDS_Soc_2012_Oct_22_15(Suppl_3)_18442.nxml.txt.nlp	NULL	SENT2282	13	13	17	17	isoniazid	IPT	PA450112	54802	0.3
NULL	Mol_Vis_2007_Dec_17_13_2282-2288.nxml.txt.nlp	18199969	SENT34	6	6	31	31	glucose	FBS	PA449773	64319;26269	0.3
NULL	Breast_Cancer_Res_2006_Oct_16_8(5)_111.nxml.txt.nlp	17049068	SENT57	5	5	27	27	raloxifene	STAR	PA451221	6770;2984	0.3
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_May_7_64(Pt_6)_o1009.nxml.txt.nlp	21202535	SENT62	1	1	17	17	ethanol	mol	PA448073	90527	0.3
NULL	Oncol_Rep_2014_Jan_13_31(1)_376-383.nxml.txt.nlp	24220856	SENT100	27	27	11	11	paclitaxel	PA1	PA450761	79447	0.3
NULL	Indian_J_Med_Paediatr_Oncol_2013_Oct-Dec_34(4)_292-298.nxml.txt.nlp	24604960	SENT20	0	0	14	14	rituximab	CHOP	PA451261	1649	0.3
NULL	J_Hematol_Oncol_2013_Nov_5_6_83.nxml.txt.nlp	24283248	SENT76	4	4	10	10	nutlin-3	TP53		7157	0.299
NULL	J_Ophthalmol_2010_Mar_3_2010_354645.nxml.txt.nlp	21461356	SENT89	26	26	20	20	guanidine	RAGE	PA164781028	177	0.299
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Feb_29_68(Pt_3)_m341-m342.nxml.txt.nlp	22412472	SENT62	11	11	33	33	ciprofloxacin	NO3	PA449009	4681	0.299
NULL	Clin_Mol_Hepatol_2014_Sep_25_20(3)_283-290.nxml.txt.nlp	25320732	SENT62	17	17	15	15	propranolol	EVL	PA451145	51466	0.299
NULL	Mol_Imaging_Radionucl_Ther_2012_Apr_1_21(1)_1-5.nxml.txt.nlp	23487481	SENT73	31	31	34	34	sulfur	TSC	PA451558	54997	0.299
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT4	24	24	31	31	imatinib	CML	PA10804	613	0.299
NULL	Tob_Induc_Dis_2004_Mar_15_2(1)_27-33.nxml.txt.nlp	19570268	SENT9	36	36	31	31	thrombin	ADP	PA451674	23038	0.299
NULL	Braz_J_Med_Biol_Res_2012_Mar_2_45(3)_250-255.nxml.txt.nlp	22370705	SENT109	3	3	25	25	vasopressin	ADM	PA451858	133	0.299
NULL	J_Int_Soc_Sports_Nutr_2014_Jun_25_11_33.nxml.txt.nlp	25053925	SENT198	8	8	11	11	creatine	BEST	PA164778930	7439	0.299
NULL	J_Oncol_2012_Sep_29_2012_879623.nxml.txt.nlp	21977033	SENT503	24	24	21	21	oltipraz	NAC		22861	0.299
NULL	Int_J_Hypertens_2013_Jun_17_2013_627938.nxml.txt.nlp	23844279	SENT154	43	43	6	6	telmisartan	A10	PA451605	28870	0.299
NULL	Asian_Spine_J_2012_Dec_14_6(4)_274-278.nxml.txt.nlp	23275811	SENT90	14	14	46	46	cefdinir	CTX	PA164768739	1593	0.299
NULL	Oncotarget_2012_Oct_20_3(10)_1236-1245.nxml.txt.nlp	23100449	SENT78	0	0	4	4	doxorubicin	NGAL	PA449412	3934	0.299
NULL	Med_Sci_Monit_2013_Mar_15_19_194-201.nxml.txt.nlp	23492458	SENT23	19	19	12	12	ropivacaine	SGB	PA451271	2719	0.299
NULL	Br_J_Cancer_1988_Mar_57(3)_304-307.nxml.txt.nlp	3162682	SENT5	1	1	4	4	trypsin	TATI	PA451806	6690	0.299
NULL	Breast_Cancer_(Auckl)_2009_Sep_2_3_61-75.nxml.txt.nlp	19809577	SENT91	13	13	11	11	curcumin	BRCA1	PA151958596	672	0.299
NULL	Diabetes_Care_2009_Sep_29_32(9)_1620-1625.nxml.txt.nlp	19564453	SENT177	9	9	18	18	metformin	HER-2	PA450395	2064	0.299
NULL	Breast_Cancer_Res_2011_Dec_9_13(6)_R127.nxml.txt.nlp	22151997	SENT47	9	9	32	32	phenol	San	PA450913	80218	0.299
NULL	Case_Rep_Crit_Care_2014_Nov_6_2014_214970.nxml.txt.nlp	25431684	SENT86	8	8	12	12	vincristine	CHOP	PA451879	1649	0.299
NULL	J_Cell_Mol_Med_2014_Jan_19_18(1)_156-169.nxml.txt.nlp	24251962	SENT129	2	2	0	0	bleomycin	BLM	PA448645	641	0.299
NULL	AIDS_Behav_2008_Jul_9_12(4)_662-669.nxml.txt.nlp	17487577	SENT347	9	9	11	11	methamphetamine	San	PA450403	80218	0.299
NULL	Biosci_Rep_2014_Aug_6_34(4)_e00131.nxml.txt.nlp	24975826	SENT187	6	6	8	8	pp2	TRPV1		7442	0.299
NULL	J_Cell_Biol_2005_May_23_169(4)_657-667.nxml.txt.nlp	15911880	SENT65	17	17	17	17	pp2	PP2		4888	0.299
NULL	ScientificWorldJournal_2012_Jan_29_2012_454059.nxml.txt.nlp	22666124	SENT79	11	11	16	16	gentamicin	TMP	PA449753	2012	0.299
NULL	Lab_Anim_Res_2013_Jun_24_29(2)_84-95.nxml.txt.nlp	23825481	SENT100	30	30	27	27	nifedipine	INS-1	PA450631	2305	0.299
NULL	Front_Plant_Sci_2012_Mar_16_3_50.nxml.txt.nlp	22645589	SENT223	4	4	7	7	oxygen	ROS	PA450744	6098	0.299
NULL	Curr_Neuropharmacol_2013_Dec_11(6)_606-620.nxml.txt.nlp	24396337	SENT676	5	5	7	7	mibefradil	CYP3A4	PA450492	1576	0.299
NULL	Curr_Genomics_2013_Nov_14(7)_453-467.nxml.txt.nlp	24396277	SENT168	26	26	20	20	iron	PCSK6	PA450087	5046	0.299
NULL	Indian_J_Med_Res_2010_Dec_132(6)_676-682.nxml.txt.nlp	21245614	SENT77	4	4	12	12	zinc	ROS	PA451956	6098	0.299
NULL	Adv_Ther_2014_Dec_2_31_1228-1246.nxml.txt.nlp	25447269	SENT148	8	8	16	16	timolol	TIM	PA451690	7984;8914	0.299
NULL	Crit_Care_2012_Oct_14_16(5)_R191.nxml.txt.nlp	23062276	SENT117	9	9	1	1	sevoflurane	POD1	PA451341	6943	0.298
NULL	Stroke_Res_Treat_2011_Nov_10_2011_212485.nxml.txt.nlp	22135769	SENT118	28	28	12	12	warfarin	GGCX	PA451906	2677	0.298
NULL	Crit_Care_2012_Oct_15_16(5)_R193.nxml.txt.nlp	23068293	SENT69	12	12	26	26	mannitol	NMB	PA450320	10457;4828	0.298
NULL	Biomed_Res_Int_2014_May_18_2014_453707.nxml.txt.nlp	24955358	SENT291	15	15	17	17	colchicine	BAP	PA449092	64374	0.298
NULL	Eur_J_Clin_Pharmacol_2013_Jan_11_69(6)_1275-1283.nxml.txt.nlp	23307232	SENT82	41	41	8	8	warfarin	CYP2C9	PA451906	1559	0.298
NULL	Cancer_Cell_Int_2003_Jul_23_3_12.nxml.txt.nlp	12914669	SENT132	20	20	17	17	doxycycline	PP1	PA449415	5540;5464	0.298
NULL	Springerplus_2014_Sep_9_3_510.nxml.txt.nlp	25279302	SENT13	14	14	12	12	creatine	GAMT	PA164778930	2593	0.298
NULL	Biomed_Res_Int_2013_Feb_24_2013_794643.nxml.txt.nlp	23555097	SENT258	23	23	1	1	erythromycin	Gen	PA449493	348654	0.298
NULL	Oncotarget_2012_Oct_20_3(10)_1068-1111.nxml.txt.nlp	23085539	SENT29	5	5	12	12	sorafenib	SHARP	PA7000	23013	0.298
NULL	Mol_Vis_2011_Jun_9_17_1564-1576.nxml.txt.nlp	21738386	SENT40	10	10	3	3	trypsin	EMB	PA451806	133418	0.298
NULL	Infect_Drug_Resist_2009_Apr_24_2_13-26.nxml.txt.nlp	21694884	SENT1	7	7	11	11	tenofovir	TDF	PA10204	6736	0.298
NULL	Nat_Med_2013_Oct_15_19(10)_1331-1337.nxml.txt.nlp	24037094	SENT164	11	11	21	21	collagenase	San	PA449107	80218	0.298
NULL	Arq_Bras_Cardiol_2014_Nov_103(5)_403-409.nxml.txt.nlp	25229355	SENT78	2	2	0	0	pazopanib	PZP	PA165291492	5858	0.298
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT826	8	8	4	4	resveratrol	SHK		23729	0.298
NULL	Bioinformation_2012_Jan_6_8(1)_13-19.nxml.txt.nlp	22359429	SENT143	4	4	8	8	curcumin	MRP1	PA151958596	4437	0.298
NULL	Nanoscale_Res_Lett_2014_Aug_28_9(1)_447.nxml.txt.nlp	25221463	SENT5	8	8	21	21	rituximab	DC8	PA451261	25936	0.298
NULL	Cost_Eff_Resour_Alloc_2008_Jan_23_6_2.nxml.txt.nlp	18215255	SENT211	11	11	9	9	isoniazid	IPT	PA450112	54802	0.298
NULL	Cancer_Cell_Int_2013_Sep_23_13_94.nxml.txt.nlp	24059699	SENT142	26	26	24	24	bevacizumab	VEGFR2	PA130232992	3791	0.298
NULL	Iran_Red_Crescent_Med_J_2011_Apr_1_13(4)_234-238.nxml.txt.nlp	22737471	SENT65	7	7	1	1	erythromycin	MAX	PA449493	4149	0.298
NULL	Br_J_Cancer_2012_Jan_17_106(2)_284-289.nxml.txt.nlp	22215065	SENT160	31	31	28	28	atrasentan	IFN	PA143414738	3439	0.298
NULL	Cancers_(Basel)_2010_Dec_30_3(1)_106-125.nxml.txt.nlp	24212609	SENT322	6	6	12	12	gemcitabine	HuR	PA449748	1994	0.298
NULL	Mol_Cancer_2012_Sep_14_11_69.nxml.txt.nlp	22978347	SENT175	12	12	10	10	letrozole	TRAP1	PA450196	9392;10131	0.297
NULL	Mol_Cancer_2014_Apr_30_13_98.nxml.txt.nlp	24779770	SENT196	12	12	18	18	oxygen	HCC	PA450744	84668	0.297
NULL	Oxid_Med_Cell_Longev_2011_Oct_12_2011_596240.nxml.txt.nlp	22013497	SENT11	14	14	17	17	oxygen	ROS	PA450744	6098	0.297
NULL	Breast_Cancer_Res_2011_May_25_13(3)_309.nxml.txt.nlp	21672285	SENT20	16	16	26	26	sorafenib	CD24	PA7000	100133941	0.297
NULL	Arch_Med_Sci_2013_Aug_30_9(4)_739-744.nxml.txt.nlp	24049538	SENT12	15	15	24	24	candesartan	PC-3	PA448765	692094	0.297
NULL	Acta_Pharmacol_Sin_2009_Jun_5_30(6)_859-867.nxml.txt.nlp	19498425	SENT26	34	34	22	22	carbachol	CA1	PA448784	759	0.297
NULL	Int_J_Hypertens_2013_Jun_17_2013_627938.nxml.txt.nlp	23844279	SENT142	25	25	0	0	telmisartan	A10	PA451605	28870	0.297
NULL	Int_J_Biol_Sci_2014_Aug_23_10(8)_921-939.nxml.txt.nlp	25170305	SENT463	13	13	0	0	nadh	EPO	PA164755085	7076;8288;2056	0.297
NULL	Ann_Rheum_Dis_2014_Jan_8_73(1)_6-16.nxml.txt.nlp	23749611	SENT418	25	25	32	32	infliximab	IMPACT	PA452639	55364	0.297
NULL	Front_Genet_2012_Nov_5_3_236.nxml.txt.nlp	23133441	SENT396	14	14	4	4	efavirenz	ABCB1	PA449441	5243	0.297
NULL	Clin_Exp_Reprod_Med_2014_Sep_30_41(3)_120-124.nxml.txt.nlp	25309856	SENT13	16	16	18	18	thyroglobulin	ADAMTS16	PA164754910	170690	0.297
NULL	J_Oncol_2012_Sep_29_2012_879623.nxml.txt.nlp	21977033	SENT503	30	30	21	21	sulindac	NAC	PA451565	22861	0.297
NULL	Int_J_Mol_Sci_2014_Sep_22_15(9)_16848-16884.nxml.txt.nlp	25247581	SENT270	8	8	22	22	resveratrol	SIRT1		23411	0.297
NULL	Iran_J_Pharm_Res_2014_Autumn_13(4)_1369-1378.nxml.txt.nlp	25587326	SENT161	5	5	0	0	ethanol	LCE	PA448073	79071	0.297
NULL	Arthritis_2014_Feb_11_2014_432463.nxml.txt.nlp	24678419	SENT180	14	14	12	12	glucosamine	GFAT	PA164747613	2673	0.297
NULL	Cell_Res_2013_Sep_25_23(9)_1075-1090.nxml.txt.nlp	23797856	SENT98	16	16	7	7	tamoxifen	E12	PA451581	64100	0.297
NULL	Iran_J_Pharm_Res_2014_Autumn_13(4)_1183-1190.nxml.txt.nlp	25587306	SENT44	6	6	4	4	rimantadine	mol	PA164748038	90527	0.297
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT7	0	0	17	17	resveratrol	DR4		8797	0.297
NULL	Int_J_Appl_Basic_Med_Res_2012_Jul-Dec_2(2)_84-91.nxml.txt.nlp	23776818	SENT145	4	4	9	9	oxacillin	OSSA	PA450725	23196	0.297
NULL	AIDS_Behav_2011_Oct_1_15(7)_1546-1553.nxml.txt.nlp	21197598	SENT175	8	8	10	10	methamphetamine	San	PA450403	80218	0.297
NULL	J_Hum_Hypertens_2010_Nov_18_24(11)_730-738.nxml.txt.nlp	20164847	SENT168	17	17	15	15	amlodipine	A10	PA448388	28870	0.297
NULL	Oxid_Med_Cell_Longev_2013_Nov_14_2013_680545.nxml.txt.nlp	24349614	SENT23	37	37	20	20	oxygen	TNF	PA450744	7124	0.297
NULL	Int_Ophthalmol_2012_Dec_31_32(6)_577-582.nxml.txt.nlp	22847248	SENT17	22	22	32	32	acetazolamide	ALPI	PA448018	248	0.297
NULL	Cancer_Inform_2013_Feb_13_12_31-51.nxml.txt.nlp	23470717	SENT335	11	11	16	16	epirubicin	p38	PA449476	10598;1432;7965	0.297
NULL	Indian_J_Med_Res_2012_Dec_136(6)_907-925.nxml.txt.nlp	23391787	SENT152	7	7	11	11	lumefantrine	ACT	PA165111722	12;11332;9457;641455	0.297
NULL	Curr_Chem_Genomics_2008_Jul_11_1_70-78.nxml.txt.nlp	20161830	SENT146	22	22	18	18	vasopressin	FFAR1	PA451858	2864	0.296
NULL	Clin_Med_Insights_Circ_Respir_Pulm_Med_2013_Nov_13_7_61-77.nxml.txt.nlp	24324354	SENT91	3	3	8	8	tobramycin	TIP	PA451704	81533;79828	0.296
NULL	Patient_Prefer_Adherence_2014_Apr_8_8_463-471.nxml.txt.nlp	24748775	SENT102	3	3	5	5	denosumab	BMD	PA166048634	1756;7439	0.296
NULL	Biomed_Res_Int_2013_Jun_17_2013_312656.nxml.txt.nlp	23844360	SENT174	7	7	5	5	natalizumab	CD49d	PA164747191	3676	0.296
NULL	Int_J_Alzheimers_Dis_2010_Dec_27_2011_231595.nxml.txt.nlp	21234401	SENT21	29	29	16	16	iron	HFE	PA450087	3077	0.296
NULL	Cancer_Metab_2014_May_28_2(Suppl_1)_O24.nxml.txt.nlp	NULL	SENT8	3	3	8	8	metformin	PC3	PA450395	57332;7832;5122	0.296
NULL	Cost_Eff_Resour_Alloc_2008_Jan_23_6_2.nxml.txt.nlp	18215255	SENT243	11	11	9	9	isoniazid	IPT	PA450112	54802	0.296
NULL	Oncol_Lett_2014_Jul_7_8(1)_258-262.nxml.txt.nlp	24959257	SENT42	26	26	22	22	cyclophosphamide	CHOP	PA449165	1649	0.296
NULL	Can_J_Anaesth_2011_Feb_31_58(2)_206-215.nxml.txt.nlp	21194017	SENT259	3	3	14	14	propofol	mol	PA451141	90527	0.296
NULL	Diabetes_2009_Jan_58(1)_243-249.nxml.txt.nlp	18840785	SENT6	17	17	12	12	glucose	GLP-1	PA449773	100125288	0.296
NULL	Indian_J_Dermatol_2010_Jul-Sep_55(3)_281-283.nxml.txt.nlp	21063527	SENT20	29	29	26	26	vincristine	IFN	PA451879	3439	0.296
NULL	Front_Neural_Circuits_2014_Jun_30_8_72.nxml.txt.nlp	25071453	SENT275	17	17	22	22	picrotoxin	spatial	PA164777007	219793	0.296
NULL	Int_J_Biol_Sci_2014_Aug_23_10(8)_921-939.nxml.txt.nlp	25170305	SENT345	18	18	12	12	nadh	EPO	PA164755085	7076;8288;2056	0.296
NULL	Arthritis_Res_2001_Aug_2_3(5)_311-318.nxml.txt.nlp	11549373	SENT56	28	28	22	22	chloramphenicol	COL1A2	PA448927	1278	0.296
NULL	Int_J_Hypertens_2013_Jun_17_2013_627938.nxml.txt.nlp	23844279	SENT138	37	37	6	6	telmisartan	A10	PA451605	28870	0.296
NULL	Oncotarget_2014_Feb_25_5(5)_1304-1314.nxml.txt.nlp	24675421	SENT70	11	11	19	19	cisplatin	RIP1	PA449014	10928;7386	0.296
NULL	Br_J_Pharmacol_2011_Apr_162(8)_1832-1842.nxml.txt.nlp	21232033	SENT188	6	6	13	13	resveratrol	SAP97		1739	0.296
NULL	J_Int_AIDS_Soc_2013_Apr_30_16(1)_18059.nxml.txt.nlp	23639243	SENT36	34	34	38	38	isoniazid	IPT	PA450112	54802	0.296
NULL	BioDrugs_2013_May_9_27(5)_469-478.nxml.txt.nlp	23658121	SENT121	1	1	19	19	capecitabine	TPC	PA448771	8030;60386	0.296
NULL	Anal_Chem_Insights_2011_Feb_23_6_7-14.nxml.txt.nlp	21760705	SENT6	26	26	31	31	meropenem	API	PA164764445	5345	0.296
NULL	Mol_Cancer_2008_Sep_12_7_69.nxml.txt.nlp	18789131	SENT98	6	6	6	6	pp2	PP2		4888	0.296
NULL	Diabetes_2009_Jan_58(1)_243-249.nxml.txt.nlp	18840785	SENT148	16	16	6	6	glucose	GLP-1	PA449773	100125288	0.296
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Nov_15_5_27.nxml.txt.nlp	17107610	SENT39	18	18	4	4	rifampin	CPX	PA451250	1371;10682;1377	0.296
NULL	Crit_Care_2004_Mar_15_8(Suppl_1)_P91.nxml.txt.nlp	NULL	SENT7	31	31	25	25	oxygen	PVR	PA450744	5817	0.296
NULL	Open_Biochem_J_2009_Dec_11_3_78-84.nxml.txt.nlp	20111725	SENT25	31	31	34	34	morphine	GPI	PA450550	10007;2821	0.295
NULL	Mucosal_Immunol_2012_Jan_16_5(1)_7-18.nxml.txt.nlp	22089028	SENT83	13	13	5	5	trypsin	A1AT	PA451806	5265	0.295
NULL	Int_J_Endocrinol_2013_Nov_13_2013_686315.nxml.txt.nlp	24324494	SENT72	15	15	8	8	nateglinide	CYP2C9	PA450600	1559	0.295
NULL	Front_Oncol_2014_Jun_18_4_159.nxml.txt.nlp	24995161	SENT152	9	9	5	5	estradiol	AKR1C3	PA449503	8644	0.295
NULL	J_Mol_Signal_2010_May_10_5_4.nxml.txt.nlp	20459745	SENT182	20	20	18	18	cisplatin	p53	PA449014	7157	0.295
NULL	Ann_Rheum_Dis_2014_Jan_13_73(1)_48-55.nxml.txt.nlp	23942868	SENT229	24	24	31	31	infliximab	IMPACT	PA452639	55364	0.295
NULL	Biomed_Res_Int_2013_Aug_28_2013_532720.nxml.txt.nlp	24066291	SENT184	19	19	5	5	choline	GAP43	PA448976	2596	0.295
NULL	Anal_Chem_Insights_2010_May_19_5_25-36.nxml.txt.nlp	20520741	SENT93	24	24	29	29	staurosporine	San	PA165109623	80218	0.295
NULL	Acta_Pharmacol_Sin_2010_Sep_16_31(9)_1075-1084.nxml.txt.nlp	20711221	SENT102	18	18	23	23	l-arginine	NOS	PA448478	4843	0.295
NULL	Infect_Dis_Obstet_Gynecol_2006_Oct_1_2006_18182.nxml.txt.nlp	17485797	SENT154	6	6	20	20	kanamycin	VAN	PA450137	10318	0.295
NULL	Mol_Cancer_2012_Dec_12_11_91.nxml.txt.nlp	23234355	SENT160	14	14	0	0	erlotinib	CTRL	PA134687924	1506	0.295
NULL	Breast_Cancer_Res_2012_May_23_14(3)_R84.nxml.txt.nlp	22621373	SENT415	22	22	24	24	hyaluronan	CD44	PA165958431	960	0.295
NULL	J_Biol_Chem_2010_Aug_20_285(34)_26406-26416.nxml.txt.nlp	20530490	SENT177	10	10	18	18	nadh	ADP	PA164755085	23038	0.295
NULL	J_Cell_Biol_1999_Jul_12_146(1)_233-242.nxml.txt.nlp	10402473	SENT117	15	15	17	17	glutaraldehyde	CSK	PA449777	1445	0.295
NULL	Exp_Mol_Med_2012_Feb_29_44(2)_81-88.nxml.txt.nlp	22257883	SENT110	14	14	17	17	oxygen	ROS	PA450744	6098	0.295
NULL	Arthritis_Res_2002_Sep_16_4(6)_R12.nxml.txt.nlp	12453315	SENT132	8	8	25	25	glucose	CRP	PA449773	1401;140913	0.295
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT122	17	17	19	19	glucose	EGFR	PA449773	1956	0.295
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1126-1134.nxml.txt.nlp	21364592	SENT4	46	46	20	20	cisplatin	ERCC1	PA449014	2067	0.295
NULL	Cancer_Causes_Control_2012_Oct_21_23(10)_1739-1744.nxml.txt.nlp	22907422	SENT30	20	20	22	22	sulindac	CRA	PA451565	51747;10903	0.295
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT7	0	0	21	21	resveratrol	DR5		8795	0.295
NULL	J_Biol_Chem_2008_Nov_14_283(46)_31679-31689.nxml.txt.nlp	18755684	SENT319	1	1	23	23	iron	FTH1	PA450087	2495	0.295
NULL	Biol_Open_2012_Nov_23_2(2)_183-190.nxml.txt.nlp	23429853	SENT159	9	9	12	12	oxygen	ROS	PA450744	6098	0.295
NULL	Indian_J_Nucl_Med_2010_Oct-Dec_25(4)_173-175.nxml.txt.nlp	21712915	SENT12	30	30	21	21	thyroglobulin	FDG	PA164754910	23583	0.295
NULL	Nat_Neurosci_2012_Sep_5_15(9)_1245-1254.nxml.txt.nlp	22864611	SENT461	5	5	2	2	clozapine	mGlu2	PA449061	2912	0.295
NULL	Iran_Red_Crescent_Med_J_2012_Jul_30_14(7)_442-446.nxml.txt.nlp	22997561	SENT3	24	24	21	21	sugar	HBM	PA451529	3042;4041	0.294
NULL	Tuberc_Respir_Dis_(Seoul)_2013_Aug_30_75(2)_59-66.nxml.txt.nlp	24023558	SENT181	20	20	2	2	gefitinib	PTEN	PA131301952	5728	0.294
NULL	Int_J_Tryptophan_Res_2013_Jul_21_6(Suppl_1)_55-65.nxml.txt.nlp	23922503	SENT4	2	2	5	5	l-tryptophan	TDO	PA10323	6999	0.294
NULL	Mol_Cancer_2010_Oct_12_9_269.nxml.txt.nlp	20939893	SENT118	22	22	9	9	isoproterenol	c-Jun	PA450121	3725	0.294
NULL	Indian_J_Anaesth_2013_Sep-Oct_57(5)_438-445.nxml.txt.nlp	24249876	SENT25	26	26	29	29	oxygen	BOC	PA450744	91653	0.294
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT184	7	7	7	7	pp2	PP2		4888	0.294
NULL	ScientificWorldJournal_2013_Nov_5_2013_383574.nxml.txt.nlp	24298214	SENT5	11	11	14	14	phenol	TPC	PA450913	8030;60386	0.294
NULL	Exp_Ther_Med_2013_Mar_21_5(3)_987-991.nxml.txt.nlp	23407636	SENT100	16	16	21	21	losartan	CXCR1	PA450268	3577	0.294
NULL	Brain_2013_Jul_24_136(7)_2279-2297.nxml.txt.nlp	23801741	SENT34	26	26	15	15	tamoxifen	NRG1	PA451581	3084	0.294
NULL	Acta_Pharmacol_Sin_2010_Sep_23_31(9)_1208-1212.nxml.txt.nlp	20729871	SENT121	13	13	7	7	creatine	GAMT	PA164778930	2593	0.294
NULL	Toxins_(Basel)_2010_Jun_9_2(6)_1381-1398.nxml.txt.nlp	22069643	SENT278	16	16	11	11	thrombin	BSP	PA451674	3381	0.294
NULL	Neuropsychopharmacology_2009_Apr_2_34(5)_1135-1148.nxml.txt.nlp	18596687	SENT330	5	5	8	8	cocaine	CRF	PA449072	1392;10882	0.294
NULL	Core_Evid_2009_Jun_15_4_83-92.nxml.txt.nlp	20694067	SENT11	0	0	4	4	conivaptan	AVP	PA164742939	114548;551	0.294
NULL	Breast_Cancer_Res_2011_Nov_24_13(6)_R120.nxml.txt.nlp	22115051	SENT99	6	6	11	11	tamoxifen	HER-2	PA451581	2064	0.294
NULL	Mol_Cancer_2009_Aug_28_8_68.nxml.txt.nlp	19715609	SENT132	13	13	19	19	oxygen	PC3	PA450744	57332;7832;5122	0.294
NULL	Cost_Eff_Resour_Alloc_2008_Jan_23_6_2.nxml.txt.nlp	18215255	SENT195	9	9	7	7	isoniazid	IPT	PA450112	54802	0.294
NULL	Ann_Oncol_2011_Mar_8_22(3)_503-514.nxml.txt.nlp	20616198	SENT330	15	15	39	39	exemestane	San	PA449563	80218	0.294
NULL	Cell_Commun_Signal_2013_Jan_22_11_6.nxml.txt.nlp	23339737	SENT160	19	19	19	19	pp2	PP2		4888	0.294
NULL	Mol_Microbiol_2014_May_28_92(3)_453-470.nxml.txt.nlp	24533860	SENT99	33	33	35	35	tetracycline	HMI	PA451640	3160	0.294
NULL	J_Geriatr_Cardiol_2014_Dec_11(4)_303-310.nxml.txt.nlp	25593579	SENT211	19	19	0	0	creatine	BIM	PA164778930	10018	0.294
NULL	Int_J_Hypertens_2013_Jun_17_2013_627938.nxml.txt.nlp	23844279	SENT146	37	37	6	6	telmisartan	A10	PA451605	28870	0.294
NULL	ScientificWorldJournal_2013_Jun_19_2013_174392.nxml.txt.nlp	23853530	SENT3	12	12	17	17	doxazosin	PC-3	PA449407	692094	0.294
NULL	Ann_Rheum_Dis_2008_Apr_20_67(4)_511-517.nxml.txt.nlp	17644552	SENT164	30	30	17	17	infliximab	IL-6	PA452639	3569	0.294
NULL	Adv_Pharmacol_Sci_2013_Jun_24_2013_987692.nxml.txt.nlp	23864853	SENT106	15	15	12	12	acetaminophen	ALP	PA448015	6590;10850;27295;80150;470;26033	0.294
NULL	Cell_Death_Dis_2014_Jan_16_5(1)_e994.nxml.txt.nlp	24434517	SENT82	40	40	33	33	chloroquine	DD2	PA448948	1646	0.294
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT202	8	8	16	16	resveratrol	PC-3		692094	0.294
NULL	Cell_Death_Dis_2010_Oct_21_1(10)_e86.nxml.txt.nlp	21368859	SENT76	20	20	18	18	doxorubicin	TRAIL	PA449412	8743	0.294
NULL	Iran_J_Microbiol_2013_Sep_5(3)_227-232.nxml.txt.nlp	24475328	SENT87	16	16	30	30	levofloxacin	Gen	PA450214	348654	0.294
NULL	Front_Immunol_2013_Oct_28_4_346.nxml.txt.nlp	24194739	SENT170	1	1	6	6	vemurafenib	BRAF	PA165946873	673	0.293
NULL	Syst_Synth_Biol_2011_Jun_26_5(1-2)_21-31.nxml.txt.nlp	21949673	SENT37	1	1	7	7	fluorescein	FDG	PA164746009	23583	0.293
NULL	J_Geriatr_Cardiol_2014_Mar_11(1)_20-25.nxml.txt.nlp	24748877	SENT112	2	2	0	0	chlorpromazine	CPZ	PA448964	8532	0.293
NULL	J_Biol_Chem_2009_Oct_16_284(42)_29193-29204.nxml.txt.nlp	19641227	SENT80	17	17	19	19	paraformaldehyde	CSK	PA450790	1445	0.293
NULL	Indian_J_Anaesth_2011_May-Jun_55(3)_318-320.nxml.txt.nlp	21808420	SENT45	17	17	12	12	tramadol	CO2	PA451735	4513	0.293
NULL	Reprod_Biol_Endocrinol_2003_Feb_5_1_7.nxml.txt.nlp	12646074	SENT7	21	21	18	18	medroxyprogesterone	CEE	PA450344	51608	0.293
NULL	Exp_Hematol_Oncol_2013_Jan_10_2_2.nxml.txt.nlp	23305345	SENT248	2	2	0	0	bortezomib	BTZ	PA10252	22794	0.293
NULL	Am_J_Physiol_Cell_Physiol_2014_Jan_15_306(2)_C89-C97.nxml.txt.nlp	24133067	SENT53	15	15	9	9	hyaluronan	HAS3	PA165958431	3038	0.293
NULL	Oxid_Med_Cell_Longev_2013_Jun_2_2013_793525.nxml.txt.nlp	23819014	SENT237	0	0	7	7	resveratrol	SGBS		2719	0.293
NULL	Ann_Rheum_Dis_2009_Nov_29_69(5)_862-867.nxml.txt.nlp	19948521	SENT209	24	24	31	31	infliximab	IMPACT	PA452639	55364	0.293
NULL	Arthritis_Res_Ther_2004_Jun_21_6(Suppl_2)_S12-S18.nxml.txt.nlp	15228616	SENT207	41	41	20	20	infliximab	ACR	PA452639	49	0.293
NULL	Clin_Ophthalmol_2014_Jan_13_8_219-228.nxml.txt.nlp	24531757	SENT150	22	22	4	4	timolol	TIM	PA451690	7984;8914	0.293
NULL	J_Psychopharmacol_2014_Sep_28(9)_837-846.nxml.txt.nlp	25035246	SENT134	2	2	0	0	atomoxetine	ATX	PA134688071	5168;23049	0.293
NULL	Alcohol_Alcohol_2011_Nov_6_46(6)_651-660.nxml.txt.nlp	21896552	SENT51	7	7	5	5	nadh	mol	PA164755085	90527	0.293
NULL	Mol_Pain_2013_Apr_9_9_20.nxml.txt.nlp	23570317	SENT164	11	11	9	9	irinotecan	UGT1A1	PA450085	54658	0.293
NULL	Br_J_Cancer_2001_Aug_85(4)_618-624.nxml.txt.nlp	11506505	SENT8	8	8	13	13	genistein	c-fos	PA165109660	2353	0.293
NULL	Clin_Ophthalmol_2014_Jan_13_8_219-228.nxml.txt.nlp	24531757	SENT141	22	22	4	4	timolol	TIM	PA451690	7984;8914	0.293
NULL	J_Exp_Clin_Cancer_Res_2009_Jul_9_28(1)_98.nxml.txt.nlp	19589137	SENT6	18	18	21	21	hyaluronan	LYVE-1	PA165958431	10894	0.292
NULL	Breast_Cancer_Res_2014_Nov_26_16(6)_472.nxml.txt.nlp	25425314	SENT32	22	22	17	17	l-glutamine	F12	PA10090	2161	0.292
NULL	Neuropsychopharmacology_2009_Sep_13_34(10)_2197-2207.nxml.txt.nlp	19440190	SENT244	4	4	7	7	fluoxetine	EPM	PA449673	2054	0.292
NULL	Mol_Microbiol_2014_Mar_23_91(5)_918-934.nxml.txt.nlp	24372851	SENT6	15	15	19	19	artemisinin	ACT	PA165111696	12;11332;9457;641455	0.292
NULL	Oncogenesis_2014_May_12_3(5)_e102.nxml.txt.nlp	24819061	SENT119	14	14	19	19	nadh	p53	PA164755085	7157	0.292
NULL	Iran_J_Microbiol_2013_Sep_5(3)_227-232.nxml.txt.nlp	24475328	SENT87	24	24	30	30	tetracycline	Gen	PA451640	348654	0.292
NULL	Front_Neurol_2014_Sep_11_5_173.nxml.txt.nlp	25309501	SENT122	6	6	9	9	hyaluronidase	HYAL1	PA164745713	3373	0.292
NULL	Br_J_Dermatol_2009_Feb_160(2)_438-441.nxml.txt.nlp	19016697	SENT98	27	27	25	25	methotrexate	FPGS	PA450428	2356	0.292
NULL	Cancer_Cell_Int_2005_Apr_27_5_10.nxml.txt.nlp	15857509	SENT107	11	11	9	9	cisplatin	p53	PA449014	7157	0.292
NULL	Acta_Pharmacol_Sin_2014_Jun_4_35(6)_792-805.nxml.txt.nlp	24902787	SENT338	22	22	27	27	pravastatin	INS-1	PA451089	2305	0.292
NULL	Clinics_(Sao_Paulo)_2009_Apr_64(4)_295-302.nxml.txt.nlp	19488585	SENT207	27	27	41	41	erythromycin	Gen	PA449493	348654	0.292
NULL	J_Int_Soc_Sports_Nutr_2010_Jul_7_7_26.nxml.txt.nlp	20609257	SENT244	19	19	0	0	creatine	ANOVA	PA164778930	4858	0.292
NULL	Ann_Rheum_Dis_2014_Sep_19_73(9)_1689-1694.nxml.txt.nlp	24748630	SENT42	8	8	4	4	methotrexate	ACR	PA450428	49	0.292
NULL	Acta_Neuropathol_Commun_2013_Jul_1_1_29.nxml.txt.nlp	24252466	SENT274	26	26	5	5	chloroquine	TDP-43	PA448948	23435	0.292
NULL	Curr_Gerontol_Geriatr_Res_2010_Jun_8_2010_915296.nxml.txt.nlp	20631897	SENT166	25	25	1	1	atorvastatin	SAGE	PA448500	55511	0.292
NULL	Ann_Hematol_2014_Mar_18_93(8)_1335-1344.nxml.txt.nlp	24638841	SENT6	9	9	5	5	rituximab	CLB	PA451261	171425	0.292
NULL	Cost_Eff_Resour_Alloc_2008_Jan_23_6_2.nxml.txt.nlp	18215255	SENT169	11	11	9	9	isoniazid	IPT	PA450112	54802	0.292
NULL	Alzheimers_Res_Ther_2010_Nov_30_2(6)_32.nxml.txt.nlp	21122172	SENT54	7	7	25	25	oxygen	TNF	PA450744	7124	0.292
NULL	J_Radiat_Res_2014_Jan_16_55(1)_146-153.nxml.txt.nlp	23955053	SENT51	6	6	4	4	fructose	BPA	PA449716	667	0.292
NULL	Oxid_Med_Cell_Longev_2013_Mar_5_2013_264935.nxml.txt.nlp	23533686	SENT122	22	22	24	24	hemin	HO-1	PA449849	3162	0.292
NULL	J_Ophthalmol_2011_Dec_23_2011_292040.nxml.txt.nlp	21253505	SENT128	4	4	6	6	nilvadipine	rd1	PA165958385	5158	0.292
NULL	FEBS_Open_Bio_2014_Jan_6_4_77-89.nxml.txt.nlp	24490132	SENT178	14	14	11	11	ebselen	NAC	PA161660841	22861	0.292
NULL	Mycobiology_2009_Dec_31_37(4)_258-266.nxml.txt.nlp	23983545	SENT169	10	10	20	20	galactose	Mal	PA449725	114609	0.292
NULL	Clin_Epigenetics_2011_Dec_5_3(1)_8.nxml.txt.nlp	22414275	SENT186	37	37	0	0	s-adenosylmethionine	ESR1	PA164754994	2099	0.292
NULL	Eur_J_Appl_Physiol_2011_Feb_24_111(2)_275-283.nxml.txt.nlp	20865425	SENT102	30	30	20	20	glucose	APE	PA449773	55704;328	0.292
NULL	J_Mol_Signal_2007_Aug_24_2_7.nxml.txt.nlp	17718901	SENT97	0	0	4	4	resveratrol	DR4		8797	0.292
NULL	Br_J_Cancer_2013_Aug_6_109(3)_686-693.nxml.txt.nlp	23839492	SENT101	7	7	15	15	everolimus	IL-8	PA164746311	3576	0.292
NULL	Ann_Clin_Microbiol_Antimicrob_2007_May_23_6_5.nxml.txt.nlp	17521424	SENT72	26	26	4	4	lincomycin	TOB	PA164749212	10140	0.291
NULL	Int_J_Biol_Sci_2013_Feb_12_9(2)_209-218.nxml.txt.nlp	23459330	SENT42	15	15	29	29	propylthiouracil	P15	PA451156	1030;29107	0.291
NULL	Oncotarget_2014_Oct_4_5(20)_10140-10150.nxml.txt.nlp	25294812	SENT1	0	0	3	3	ciclopirox	CPX	PA164747060	1371;10682;1377	0.291
NULL	J_Mol_Signal_2010_May_10_5_4.nxml.txt.nlp	20459745	SENT12	0	0	6	6	cisplatin	p53	PA449014	7157	0.291
NULL	Clin_Interv_Aging_2009_May_14_4_121-136.nxml.txt.nlp	19503775	SENT375	4	4	26	26	raloxifene	STAR	PA451221	6770;2984	0.291
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_39-54.nxml.txt.nlp	19305787	SENT148	18	18	6	6	ethanol	NR1	PA448073	27158	0.291
NULL	J_Oncol_2013_Apr_29_2013_854121.nxml.txt.nlp	23737784	SENT74	14	14	16	16	trastuzumab	BCS	PA451743	617	0.291
NULL	Cancer_Med_2012_Aug_31_1(1)_89-95.nxml.txt.nlp	23342258	SENT49	17	17	36	36	estradiol	CEA	PA449503	5670;1087	0.291
NULL	J_Med_Case_Reports_2011_Sep_12_5_455.nxml.txt.nlp	21910879	SENT93	8	8	6	6	cyclophosphamide	CHOP	PA449165	1649	0.291
NULL	Cardiovasc_Diabetol_2013_Oct_17_12_150.nxml.txt.nlp	24134550	SENT106	5	5	7	7	metformin	activin	PA450395	83729	0.291
NULL	Osteoporos_Int_2013_Oct_19_24(1)_23-57.nxml.txt.nlp	23079689	SENT973	4	4	26	26	raloxifene	STAR	PA451221	6770;2984	0.291
NULL	Mycobiology_2009_Jun_30_37(2)_103-108.nxml.txt.nlp	23983517	SENT117	6	6	16	16	galactose	Mal	PA449725	114609	0.291
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Nov_26_64(Pt_12)_o2459.nxml.txt.nlp	21581427	SENT63	1	1	17	17	ethanol	mol	PA448073	90527	0.291
NULL	Exp_Neurol_2012_Jun_235(2)_528-538.nxml.txt.nlp	22417924	SENT263	11	11	20	20	troglitazone	PPARgamma	PA451799	5468	0.291
NULL	J_Cardiovasc_Magn_Reson_2014_Sep_27_16(1)_80.nxml.txt.nlp	25270330	SENT5	14	14	26	26	iron	MRI	PA450087	78996	0.291
NULL	Braz_J_Microbiol_2010_Jun_1_Apr-Jun_41(2)_316-320.nxml.txt.nlp	24031498	SENT35	21	21	25	25	oxacillin	OST	PA450725	1650;23263	0.291
NULL	Oncotarget_2014_Nov_4_5(21)_10503-10517.nxml.txt.nlp	25361177	SENT36	4	4	11	11	metformin	PTEN	PA450395	5728	0.291
NULL	Indian_J_Med_Res_2014_Feb_139(2)_205-215.nxml.txt.nlp	24718394	SENT77	0	0	4	4	artemisinin	ACT	PA165111696	12;11332;9457;641455	0.291
NULL	J_Cardiothorac_Surg_2014_Mar_31_9_63.nxml.txt.nlp	24685284	SENT108	42	42	40	40	vancomycin	VISA	PA451850	57506	0.291
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Jul_20_69(Pt_8)_o1276.nxml.txt.nlp	24109358	SENT72	32	32	28	28	ethanol	mol	PA448073	90527	0.291
NULL	J_Cell_Mol_Med_2014_Jan_19_18(1)_156-169.nxml.txt.nlp	24251962	SENT290	2	2	0	0	bleomycin	BLM	PA448645	641	0.29
NULL	Indian_J_Pharm_Sci_2011_Sep-Oct_73(5)_527-536.nxml.txt.nlp	22923865	SENT180	3	3	2	2	carvedilol	FOR	PA448817	51741	0.29
NULL	Clin_Interv_Aging_2010_Nov_19_5_355-362.nxml.txt.nlp	21228901	SENT42	23	23	19	19	teriparatide	PTH	PA451620	5741	0.29
NULL	Chem_Cent_J_2013_Sep_4_7_147.nxml.txt.nlp	24006941	SENT89	12	12	14	14	lipase	LOX	PA450239	4015	0.29
NULL	Infect_Dis_Obstet_Gynecol_2006_Oct_1_2006_18182.nxml.txt.nlp	17485797	SENT154	26	26	20	20	metronidazole	VAN	PA450484	10318	0.29
NULL	Behav_Brain_Funct_2009_Jan_15_5_3.nxml.txt.nlp	19146665	SENT223	8	8	26	26	ethanol	P90	PA448073	821	0.29
NULL	Case_Rep_Med_2010_Mar_30_2010_836214.nxml.txt.nlp	20369069	SENT29	3	3	21	21	aripiprazole	CD4	PA10026	920	0.29
NULL	J_Hematol_Oncol_2009_Aug_12_2_36.nxml.txt.nlp	19674465	SENT22	0	0	11	11	thalidomide	ENL	PA451644	4298	0.29
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT69	2	2	10	10	curcumin	PC-3	PA151958596	692094	0.29
NULL	Cancer_Manag_Res_2012_Nov_9_4_383-395.nxml.txt.nlp	23204869	SENT100	21	21	27	27	carmustine	PC-3	PA448810	692094	0.29
NULL	J_Ginseng_Res_2012_Apr_36(2)_169-175.nxml.txt.nlp	23717117	SENT34	17	17	15	15	phenol	CO2	PA450913	4513	0.29
NULL	Adv_Ther_2014_Dec_2_31_1228-1246.nxml.txt.nlp	25447269	SENT199	8	8	23	23	timolol	TIM	PA451690	7984;8914	0.29
NULL	Case_Rep_Infect_Dis_2012_Aug_16_2012_640104.nxml.txt.nlp	22953083	SENT62	12	12	9	9	sulfamethoxazole	TMP	PA451544	2012	0.29
NULL	Front_Microbiol_2014_Sep_9_5_476.nxml.txt.nlp	25250024	SENT221	6	6	37	37	nadh	10C	PA164755085	64333	0.29
NULL	Case_Rep_Ophthalmol_2012_Mar_26_3(1)_96-103.nxml.txt.nlp	23008695	SENT7	11	11	8	8	fluorescein	FAF	PA164746009	8239;2188	0.29
NULL	F1000Res_2013_Oct_8_2_173.nxml.txt.nlp	24555085	SENT38	12	12	9	9	triamcinolone	BDP	PA451749	10620;152926	0.29
NULL	Springerplus_2014_Sep_11_3_516.nxml.txt.nlp	25279308	SENT161	21	21	13	13	ethanol	CS-3	PA448073	91977	0.29
NULL	Exp_Diabetes_Res_2012_Sep_20_2012_936518.nxml.txt.nlp	23049542	SENT131	6	6	8	8	glucose	TRPV4	PA449773	59341	0.29
NULL	Cell_Death_Dis_2010_May_13_1(5)_e41.nxml.txt.nlp	21364648	SENT78	8	8	6	6	etoposide	p53	PA449552	7157	0.29
NULL	Front_Aging_Neurosci_2010_Mar_12_2_9.nxml.txt.nlp	20552047	SENT515	0	0	7	7	pentoxifylline	spatial	PA450864	219793	0.29
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Nov_15_5_27.nxml.txt.nlp	17107610	SENT39	18	18	8	8	rifampin	EMB	PA451250	133418	0.29
NULL	Exp_Diabetes_Res_2012_Dec_26_2012_230624.nxml.txt.nlp	23365557	SENT255	23	23	21	21	rosiglitazone	Rog	PA451283	27033	0.289
NULL	Basic_Clin_Neurosci_2014_Winter_5(1)_66-73.nxml.txt.nlp	25436086	SENT130	19	19	23	23	lidocaine	LHA	PA450226	1081	0.289
NULL	Mol_Cancer_2010_Mar_2_9_47.nxml.txt.nlp	20196847	SENT90	6	6	0	0	paclitaxel	SFN	PA450761	25996;2810	0.289
NULL	Biochemistry_2013_Dec_17_52(50)_9059-9067.nxml.txt.nlp	24266852	SENT104	8	8	8	8	pp2	PP2		4888	0.289
NULL	Hum_Genet_2013_Jul_3_132(10)_1077-1130.nxml.txt.nlp	23820649	SENT683	12	12	16	16	trypsin	SPINK1	PA451806	6690	0.289
NULL	Hematol_Rep_2013_Apr_4_5(1)_21-25.nxml.txt.nlp	23888242	SENT97	23	23	30	30	allopurinol	GM-CSF	PA448320	1437	0.289
NULL	J_Hum_Genet_2013_Jun_16_58(6)_353-361.nxml.txt.nlp	23677058	SENT175	25	25	11	11	cytarabine	CNT3	PA449177	64078	0.289
NULL	Chemother_Res_Pract_2012_Aug_12_2012_549170.nxml.txt.nlp	22924129	SENT145	14	14	35	35	carboplatin	CRT	PA448803	811	0.289
NULL	Mar_Drugs_2010_Oct_29_8(11)_2733-2743.nxml.txt.nlp	21139841	SENT124	20	20	25	25	ethanol	CO2	PA448073	4513	0.289
NULL	Mol_Cancer_2009_Jun_8_8_34.nxml.txt.nlp	19500427	SENT142	2	2	0	0	gemcitabine	Gem	PA449748	51053	0.289
NULL	Int_J_Biomed_Sci_2014_Sep_10(3)_217-220.nxml.txt.nlp	25324704	SENT18	0	0	4	4	amiodarone	APT	PA448383	653639	0.289
NULL	Biomed_Digit_Libr_2005_Jun_27_2_4.nxml.txt.nlp	15982415	SENT70	36	36	10	10	genistein	DTD	PA165109660	1728	0.289
NULL	J_Viral_Hepat_2007_Nov_14(11)_788-796.nxml.txt.nlp	17927615	SENT227	20	20	11	11	ribavirin	GT1	PA451241	4635	0.289
NULL	Infect_Dis_Obstet_Gynecol_2013_Mar_7_2013_195637.nxml.txt.nlp	23533318	SENT120	21	21	19	19	isoniazid	IPT	PA450112	54802	0.289
NULL	Int_J_Chron_Obstruct_Pulmon_Dis_2008_Jun_3(2)_205-216.nxml.txt.nlp	18686730	SENT188	14	14	15	15	formoterol	DPI	PA134687907	1832	0.289
NULL	Oxid_Med_Cell_Longev_2011_Dec_18_2011_734319.nxml.txt.nlp	22220218	SENT160	20	20	47	47	gentamicin	CO2	PA449753	4513	0.289
NULL	Carcinogenesis_2010_Dec_27_31(12)_2049-2057.nxml.txt.nlp	20876285	SENT174	10	10	21	21	tamoxifen	HER2	PA451581	2064	0.289
NULL	Mol_Biol_Cell_2014_Mar_15_25(6)_739-752.nxml.txt.nlp	24430869	SENT142	13	13	13	13	pp2	PP2		4888	0.288
NULL	Oncotarget_2014_Aug_29_5(18)_8052-8082.nxml.txt.nlp	25211298	SENT569	23	23	26	26	temozolomide	U87	PA451609	677775;641648	0.288
NULL	Exp_Anim_2014_Feb_7_63(1)_45-53.nxml.txt.nlp	24521862	SENT19	19	19	22	22	trypsin	TATI	PA451806	6690	0.288
NULL	Nat_Genet_2013_Nov_15_45(11)_1366-1370.nxml.txt.nlp	24036952	SENT282	16	16	19	19	lipase	LIPC	PA450239	3990	0.288
NULL	Orphanet_J_Rare_Dis_2010_Jan_29_5_2.nxml.txt.nlp	20113479	SENT395	13	13	24	24	doxorubicin	RTS	PA449412	1387	0.288
NULL	Br_J_Psychiatry_2009_Jun_194(6)_535-540.nxml.txt.nlp	19478294	SENT78	38	38	25	25	citalopram	ANOVA	PA449015	4858	0.288
NULL	Arch_Drug_Inf_2009_Mar_2(1)_8-16.nxml.txt.nlp	19381336	SENT30	26	26	23	23	saquinavir	CYP3A4	PA451305	1576	0.288
NULL	Int_J_Mol_Sci_2014_Sep_30_15(10)_17733-17750.nxml.txt.nlp	25272228	SENT53	2	2	5	5	oxygen	ROS	PA450744	6098	0.288
NULL	Clin_Ophthalmol_2014_Jun_19_8_1179-1183.nxml.txt.nlp	24970996	SENT79	11	11	7	7	travoprost	BAK	PA164781371	578	0.288
NULL	Oncotarget_2014_Jun_1_5(13)_4881-4894.nxml.txt.nlp	24952679	SENT97	9	9	5	5	bortezomib	B10	PA10252	5169	0.288
NULL	J_Obes_2011_Apr_28_2011_587495.nxml.txt.nlp	21603273	SENT145	19	19	22	22	lipase	ATGL	PA450239	57104	0.288
NULL	Case_Rep_Dermatol_2012_Sep_16_4(3)_256-260.nxml.txt.nlp	23275770	SENT13	13	13	25	25	pyridostigmine	OMG	PA451185	4974	0.288
NULL	Toxins_(Basel)_2010_Oct_26_2(11)_2490-2518.nxml.txt.nlp	22069563	SENT135	33	33	14	14	cisplatin	PUMA	PA449014	27113	0.288
NULL	Int_J_Nanomedicine_2012_Oct_25_7_5565-5575.nxml.txt.nlp	23118538	SENT227	9	9	16	16	atorvastatin	SAS	PA448500	54187	0.288
NULL	Cancers_(Basel)_2014_Sep_5_6(3)_1769-1792.nxml.txt.nlp	25198391	SENT672	16	16	14	14	imatinib	STAT3	PA10804	6774	0.288
NULL	F1000Res_2014_Aug_19_3_198.nxml.txt.nlp	25400908	SENT476	8	8	11	11	pertuzumab	HER2		2064	0.288
NULL	Oncogenesis_2014_May_12_3(5)_e102.nxml.txt.nlp	24819061	SENT242	5	5	11	11	nadh	p53	PA164755085	7157	0.288
NULL	J_Med_Case_Reports_2011_Sep_23_5_476.nxml.txt.nlp	21943040	SENT122	2	2	0	0	cyclophosphamide	CHOP	PA449165	1649	0.288
NULL	J_Korean_Med_Sci_2013_Apr_27_28(4)_527-533.nxml.txt.nlp	23580227	SENT97	20	20	22	22	genistein	TRAIL	PA165109660	8743	0.288
NULL	Cancer_Med_2014_Oct_10_3(5)_1377-1384.nxml.txt.nlp	25045139	SENT24	26	26	42	42	hyaluronan	SMRP	PA165958431	10057	0.288
NULL	Br_J_Haematol_2014_Mar_6_164(6)_759-766.nxml.txt.nlp	24387053	SENT107	20	20	11	11	rituximab	PEX	PA451261	5251	0.287
NULL	Arthritis_Res_Ther_2008_Sep_9_10(5)_R107.nxml.txt.nlp	18782442	SENT36	15	15	18	18	oxygen	ROS	PA450744	6098	0.287
NULL	Environ_Health_Perspect_2009_Jul_11_117(7)_1053-1058.nxml.txt.nlp	19654912	SENT62	2	2	28	28	forskolin	San	PA146096022	80218	0.287
NULL	J_Obes_2011_Dec_12_2011_179674.nxml.txt.nlp	21197148	SENT178	21	21	33	33	liraglutide	5-HT2C	PA165958364	3358	0.287
NULL	Oncogenesis_2014_May_12_3(5)_e102.nxml.txt.nlp	24819061	SENT242	5	5	21	21	nadh	p53	PA164755085	7157	0.287
NULL	Lab_Invest_2013_Feb_19_93(2)_181-193.nxml.txt.nlp	23212100	SENT220	2	2	5	5	cyclophosphamide	CTX	PA449165	1593	0.287
NULL	Oper_Res_Health_Care_2012_Jun_1(2-3)_45-53.nxml.txt.nlp	24501697	SENT228	23	23	20	20	isoniazid	IPT	PA450112	54802	0.287
NULL	J_Geriatr_Cardiol_2014_Jun_11(2)_151-157.nxml.txt.nlp	25009566	SENT55	0	0	10	10	cyclosporine	CDP	PA449167	1523	0.287
NULL	Case_Rep_Ophthalmol_2013_Jan_26_4(1)_11-16.nxml.txt.nlp	23467270	SENT7	7	7	23	23	fluorescein	FAF	PA164746009	8239;2188	0.287
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Nov_15_5_27.nxml.txt.nlp	17107610	SENT39	10	10	4	4	ethambutol	CPX	PA164784021	1371;10682;1377	0.287
NULL	Open_Dent_J_2014_May_30_8_109-124.nxml.txt.nlp	24976875	SENT247	12	12	30	30	tetracycline	MIDAS	PA451640	64083	0.287
NULL	Clin_Ophthalmol_2012_Dec_11_6_2049-2057.nxml.txt.nlp	23271885	SENT47	16	16	25	25	cyclophosphamide	CHOP	PA449165	1649	0.287
NULL	Drugs_R_D_2010_Nov_25_10(4)_219-224.nxml.txt.nlp	21171668	SENT4	12	12	9	9	clopidogrel	LTA	PA449053	4049	0.287
NULL	Clin_Mol_Hepatol_2014_Sep_25_20(3)_283-290.nxml.txt.nlp	25320732	SENT105	22	22	20	20	propranolol	EVL	PA451145	51466	0.287
NULL	J_Thromb_Haemost_2011_Oct_9(10)_2103-2105.nxml.txt.nlp	21812912	SENT18	33	33	31	31	ticagrelor	ADP	PA165374673	23038	0.287
NULL	Braz_J_Med_Biol_Res_2012_Jul_27_45(10)_948-954.nxml.txt.nlp	22832600	SENT134	14	14	17	17	fluoxetine	ANOVA	PA449673	4858	0.287
NULL	Clinics_(Sao_Paulo)_2009_Apr_64(4)_295-302.nxml.txt.nlp	19488585	SENT207	19	19	41	41	oxacillin	Gen	PA450725	348654	0.287
NULL	J_Biomed_Biotechnol_2004_Apr_27_2004(1)_52-60.nxml.txt.nlp	15123888	SENT115	2	2	0	0	genistein	Gen	PA165109660	348654	0.286
NULL	Biomed_Res_Int_2014_Jan_6_2014_476789.nxml.txt.nlp	24511533	SENT33	14	14	18	18	phenol	mol	PA450913	90527	0.286
NULL	J_Pain_Res_2014_Aug_1_7_449-454.nxml.txt.nlp	25120375	SENT4	7	7	10	10	fentanyl	TFP	PA449599	7034	0.286
NULL	Drugs_2014_Feb_25_74(4)_423-441.nxml.txt.nlp	24566842	SENT455	17	17	24	24	infliximab	IMPACT	PA452639	55364	0.286
NULL	Behav_Brain_Funct_2009_Jan_15_5_3.nxml.txt.nlp	19146665	SENT264	7	7	10	10	ethanol	P15	PA448073	1030;29107	0.286
NULL	Nat_Commun_2013_Oct_1_4_2516.nxml.txt.nlp	24084631	SENT67	13	13	29	29	lisinopril	AT2	PA450242	186	0.286
NULL	Acta_Pharmacol_Sin_2013_Oct_7_34(10)_1292-1300.nxml.txt.nlp	23933651	SENT13	14	14	14	14	pp2	PP2		4888	0.286
NULL	Case_Rep_Infect_Dis_2012_Aug_16_2012_640104.nxml.txt.nlp	22953083	SENT77	12	12	26	26	cyclophosphamide	CHOP	PA449165	1649	0.286
NULL	Case_Rep_Endocrinol_2013_May_8_2013_636175.nxml.txt.nlp	23738155	SENT100	0	0	21	21	everolimus	c-Jun	PA164746311	3725	0.286
NULL	Comp_Funct_Genomics_2008_May_19_2008_609684.nxml.txt.nlp	18509488	SENT72	29	29	33	33	creatine	SLC6A8	PA164778930	6535	0.286
NULL	J_Cell_Mol_Med_2014_Jan_19_18(1)_156-169.nxml.txt.nlp	24251962	SENT263	2	2	0	0	bleomycin	BLM	PA448645	641	0.286
NULL	Cancer_Cell_Int_2004_Aug_17_4_5.nxml.txt.nlp	15315711	SENT15	11	11	30	30	genistein	PC3	PA165109660	57332;7832;5122	0.286
NULL	Ann_Rehabil_Med_2012_Aug_27_36(4)_466-473.nxml.txt.nlp	22977771	SENT15	13	13	8	8	hyaluronidase	ILEI	PA164745713	10447	0.286
NULL	Oncogene_2014_Jul_17_33(29)_3784-3793.nxml.txt.nlp	24013225	SENT230	20	20	13	13	heparin	EGF	PA449855	1950	0.286
NULL	Breast_Cancer_Res_2011_Mar_1_13(2)_R21.nxml.txt.nlp	21362200	SENT6	9	9	11	11	fulvestrant	PI3K	PA164747170	5290	0.286
NULL	Braz_J_Med_Biol_Res_2012_Apr_13_45(5)_466-472.nxml.txt.nlp	22488224	SENT36	18	18	21	21	hyaluronan	LYVE-1	PA165958431	10894	0.286
NULL	Biomed_Res_Int_2013_Aug_5_2013_462589.nxml.txt.nlp	23998124	SENT63	3	3	13	13	bleomycin	BLM	PA448645	641	0.286
NULL	Indian_J_Med_Res_2012_Dec_136(6)_907-925.nxml.txt.nlp	23391787	SENT162	12	12	16	16	artemisinin	ACT	PA165111696	12;11332;9457;641455	0.286
NULL	Indian_J_Pharmacol_2008_Oct_40(Suppl_2)_S221-S236.nxml.txt.nlp	21593976	SENT866	16	16	8	8	haloperidol	EPM	PA449841	2054	0.286
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT273	13	13	9	9	glucose	EGFR	PA449773	1956	0.286
NULL	Clin_Res_Cardiol_2009_Jun_20_98(6)_391-399.nxml.txt.nlp	19301059	SENT184	30	30	44	44	pantoprazole	mol	PA450774	90527	0.286
NULL	Int_J_Hypertens_2013_Jun_17_2013_627938.nxml.txt.nlp	23844279	SENT138	2	2	6	6	amlodipine	A10	PA448388	28870	0.286
NULL	Int_J_Environ_Res_Public_Health_2011_Jul_14_8(7)_2876-2894.nxml.txt.nlp	21845163	SENT265	5	5	9	9	ethanol	TTF1	PA448073	7080;7270	0.286
NULL	Front_Neurosci_2012_May_30_6_77.nxml.txt.nlp	22661925	SENT230	0	0	5	5	ethanol	HEC	PA448073	10403	0.286
NULL	Cancer_Cell_Int_2005_Jul_24_5_22.nxml.txt.nlp	16042792	SENT64	7	7	4	4	vincristine	NAC	PA451879	22861	0.286
NULL	Indian_J_Med_Res_2012_Apr_135(4)_456-458.nxml.txt.nlp	22664491	SENT30	19	19	24	24	artemisinin	ACT	PA165111696	12;11332;9457;641455	0.286
NULL	Mol_Syst_Biol_2009_Jul_28_5_288.nxml.txt.nlp	19638969	SENT441	11	11	9	9	resveratrol	HuR		1994	0.286
NULL	Mol_Cancer_2012_Dec_12_11_91.nxml.txt.nlp	23234355	SENT160	6	6	0	0	erlotinib	CTRL	PA134687924	1506	0.286
NULL	Toxins_(Basel)_2010_Oct_26_2(11)_2490-2518.nxml.txt.nlp	22069563	SENT139	9	9	7	7	cisplatin	p53	PA449014	7157	0.285
NULL	Infect_Dis_Obstet_Gynecol_2006_Oct_1_2006_18182.nxml.txt.nlp	17485797	SENT154	22	22	12	12	vancomycin	NOV	PA451850	4856;5361;6134	0.285
NULL	J_Oncol_2012_Feb_16_2012_204946.nxml.txt.nlp	22481918	SENT50	8	8	11	11	hyaluronan	LYVE-1	PA165958431	10894	0.285
NULL	Ann_Intensive_Care_2011_Dec_30_1_53.nxml.txt.nlp	22208725	SENT29	24	24	19	19	vasopressin	ACTH	PA451858	5443	0.285
NULL	Cardiovasc_Diabetol_2008_Feb_26_7_3.nxml.txt.nlp	18302760	SENT89	34	34	14	14	ethanol	PAPC	PA448073	5100	0.285
NULL	J_Res_Med_Sci_2010_Nov-Dec_15(6)_331-343.nxml.txt.nlp	21526106	SENT163	11	11	9	9	l-arginine	HDEL	PA448478	10945	0.285
NULL	J_Geriatr_Cardiol_2014_Mar_11(1)_20-25.nxml.txt.nlp	24748877	SENT67	2	2	0	0	chlorpromazine	CPZ	PA448964	8532	0.285
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1126-1134.nxml.txt.nlp	21364592	SENT4	46	46	29	29	cisplatin	XRCC1	PA449014	7515	0.285
NULL	ScientificWorldJournal_2012_Jan_29_2012_454059.nxml.txt.nlp	22666124	SENT79	4	4	16	16	ciprofloxacin	TMP	PA449009	2012	0.285
NULL	Exp_Ther_Med_2013_Aug_6_6(2)_427-434.nxml.txt.nlp	24137203	SENT227	35	35	7	7	fosinopril	MCP-1	PA449710	6347	0.285
NULL	Case_Rep_Oncol_2013_Aug_14_6(2)_430-433.nxml.txt.nlp	24019783	SENT9	15	15	16	16	erlotinib	Met	PA134687924	79811	0.285
NULL	J_Biol_Chem_2008_Dec_19_283(51)_35419-35427.nxml.txt.nlp	18955485	SENT215	44	44	44	44	pp2	PP2		4888	0.285
NULL	Int_J_Mol_Sci_2014_Nov_25_15(12)_21703-21722.nxml.txt.nlp	25429431	SENT135	3	3	23	23	curcumin	FANCD2	PA151958596	2177	0.285
NULL	J_Vet_Med_Sci_2014_Jul_18_76(7)_937-945.nxml.txt.nlp	24646457	SENT103	43	43	41	41	oxytetracycline	OTC	PA450757	5009	0.285
NULL	Br_J_Cancer_2003_Mar_10_88(5)_788-795.nxml.txt.nlp	12618891	SENT156	26	26	28	28	bosentan	FasL	PA10034	356	0.285
NULL	Pharmaceutics_2011_Nov_18_3(4)_865-913.nxml.txt.nlp	24309312	SENT2232	24	24	22	22	alprazolam	CYP3A4	PA448333	1576	0.285
NULL	Eur_J_Cancer_2013_Oct_49(15)_3366-3375.nxml.txt.nlp	23790465	SENT85	12	12	16	16	sorafenib	HCC1	PA7000	9584	0.285
NULL	ScientificWorldJournal_2013_Jun_6_2013_943539.nxml.txt.nlp	23843741	SENT38	13	13	27	27	taurine	NEAT1	PA451590	283131	0.285
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT16	2	2	2	2	pp2	PP2		4888	0.285
NULL	Clin_Ophthalmol_2011_Aug_15_5_1127-1133.nxml.txt.nlp	21887094	SENT162	33	33	36	36	lipase	LIPC	PA450239	3990	0.284
NULL	Pain_Res_Treat_2011_Jun_22_2011_239501.nxml.txt.nlp	22110921	SENT44	7	7	12	12	hydromorphone	HOP	PA449918	84525;10963	0.284
NULL	Behav_Brain_Funct_2013_Nov_26_9_43.nxml.txt.nlp	24279870	SENT132	18	18	6	6	ethanol	ANOVA	PA448073	4858	0.284
NULL	Breast_Cancer_Res_2012_Feb_14_14(1)_R31.nxml.txt.nlp	22333393	SENT244	8	8	6	6	tamoxifen	HOXB7	PA451581	3217	0.284
NULL	Clin_Mol_Hepatol_2014_Sep_25_20(3)_283-290.nxml.txt.nlp	25320732	SENT98	13	13	11	11	propranolol	EVL	PA451145	51466	0.284
NULL	Cancer_Inform_2007_Feb_10_3_93-114.nxml.txt.nlp	19455237	SENT337	0	0	5	5	chymotrypsin	CTRL	PA448994	1506	0.284
NULL	Hum_Mol_Genet_2014_Aug_1_23(15)_4077-4085.nxml.txt.nlp	24670599	SENT19	6	6	3	3	lipase	PNPLA3	PA450239	80339	0.284
NULL	J_Inflamm_(Lond)_2006_May_4_3_8.nxml.txt.nlp	16674821	SENT196	6	6	15	15	pp2	p38		10598;1432;7965	0.284
NULL	Proteome_Sci_2010_Jul_9_8_38.nxml.txt.nlp	20618950	SENT237	9	9	15	15	nadh	PDH	PA164755085	54704	0.284
NULL	Genet_Vaccines_Ther_2003_Sep_16_1_2.nxml.txt.nlp	14606963	SENT41	13	13	16	16	creatine	CKM	PA164778930	1158	0.284
NULL	Mol_Cancer_2010_Dec_20_9_316.nxml.txt.nlp	21172016	SENT163	7	7	45	45	heparin	CCL21	PA449855	6366	0.284
NULL	AMB_Express_2014_Mar_20_4_31.nxml.txt.nlp	24949266	SENT110	26	26	29	29	sugar	C-1	PA451529	5203	0.284
NULL	Ann_Dermatol_2011_Dec_27_23(Suppl_3)_S290-S295.nxml.txt.nlp	22346260	SENT70	19	19	15	15	dapsone	G6PD	PA449211	2539	0.284
NULL	Breast_Cancer_Res_2014_Sep_9_16(5)_433.nxml.txt.nlp	25212966	SENT282	25	25	8	8	thrombin	ILEI	PA451674	10447	0.284
NULL	Clin_Mol_Hepatol_2014_Sep_25_20(3)_283-290.nxml.txt.nlp	25320732	SENT8	16	16	14	14	propranolol	EVL	PA451145	51466	0.284
NULL	Ann_Gen_Psychiatry_2014_Dec_4_13(1)_37.nxml.txt.nlp	NULL	SENT0	17	17	1	1	pregabalin	Gen	PA164754814	348654	0.284
NULL	Mycobiology_2006_Jun_30_34(2)_73-78.nxml.txt.nlp	24039474	SENT50	26	26	17	17	glucose	MYG	PA449773	60314	0.284
NULL	J_Asthma_Allergy_2014_Apr_11_7_53-65.nxml.txt.nlp	24748808	SENT90	17	17	7	7	omalizumab	IL-2	PA164752253	3558	0.284
NULL	J_Korean_Med_Sci_2013_Apr_27_28(4)_527-533.nxml.txt.nlp	23580227	SENT118	14	14	16	16	genistein	TRAIL	PA165109660	8743	0.284
NULL	Curr_HIV_Res_2013_Oct_11(7)_570-575.nxml.txt.nlp	24467642	SENT144	17	17	21	21	ritonavir	ARTEMIS	PA451260	64421	0.283
NULL	Biosci_Rep_2014_Dec_12_34(6)_e00162.nxml.txt.nlp	25385088	SENT167	16	16	18	18	chymotrypsin	XPA	PA448994	7507	0.283
NULL	Biosci_Rep_2009_Sep_2_29(Pt_6)_397-404.nxml.txt.nlp	19527224	SENT0	34	34	23	23	glucose	SPCA1	PA449773	27032	0.283
NULL	J_Oncol_2012_Sep_29_2012_879623.nxml.txt.nlp	21977033	SENT503	7	7	21	21	curcumin	NAC	PA151958596	22861	0.283
NULL	Virol_J_2011_May_17_8_234.nxml.txt.nlp	21575275	SENT108	45	45	0	0	ribavirin	RVR	PA451241	9975	0.283
NULL	Nat_Med_2014_Jun_11_20(6)_616-623.nxml.txt.nlp	24813252	SENT330	10	10	4	4	galactose	BTHS	PA449725	6901	0.283
NULL	Evid_Based_Complement_Alternat_Med_2013_Aug_22_2013_423164.nxml.txt.nlp	24027594	SENT160	5	5	7	7	berberine	AP-1	PA165860812	2353;3727;2354;3725	0.283
NULL	Biomed_Res_Int_2013_Feb_24_2013_794643.nxml.txt.nlp	23555097	SENT258	3	3	1	1	gentamicin	Gen	PA449753	348654	0.283
NULL	Gut_Pathog_2014_Jul_29_6_33.nxml.txt.nlp	25110521	SENT200	26	26	14	14	dextran	IL-6	PA449261	3569	0.283
NULL	Tuberc_Respir_Dis_(Seoul)_2012_Aug_31_73(2)_115-121.nxml.txt.nlp	23166544	SENT105	16	16	22	22	vincristine	CHOP	PA451879	1649	0.283
NULL	Cancer_Biol_Med_2012_Mar_9(1)_18-22.nxml.txt.nlp	23691449	SENT170	16	16	14	14	gefitinib	EGR1	PA131301952	1958	0.283
NULL	Mol_Cancer_2014_Jan_28_13_17.nxml.txt.nlp	24472312	SENT125	3	3	6	6	ponatinib	Mcl-1	PA165980594	4170	0.283
NULL	CNS_Drugs_2013_Aug_23_27(11)_943-953.nxml.txt.nlp	23975660	SENT3	8	8	17	17	guanfacine	ATX	PA449825	5168;23049	0.283
NULL	Biomed_Res_Int_2013_Feb_24_2013_794643.nxml.txt.nlp	23555097	SENT258	19	19	1	1	tetracycline	Gen	PA451640	348654	0.283
NULL	Oncogene_2010_Sep_2_29(35)_4905-4913.nxml.txt.nlp	20581869	SENT253	6	6	11	11	carboplatin	CA125	PA448803	4077;94025	0.283
NULL	Biologics_2009_Oct_12_3_469-474.nxml.txt.nlp	19851472	SENT71	20	20	5	5	desloratadine	IL-5	PA164776964	3567	0.283
NULL	Environ_Health_Perspect_2010_Jul_3_118(7)_936-942.nxml.txt.nlp	20199942	SENT157	2	2	7	7	arsenite	p53	PA452638	7157	0.283
NULL	Arch_Toxicol_2013_Aug_23_87(8)_1315-1530.nxml.txt.nlp	23974980	SENT789	18	18	20	20	imatinib	CML	PA10804	613	0.283
NULL	Environ_Health_Perspect_1995_May_103(Suppl_4)_19-25.nxml.txt.nlp	7556019	SENT9	4	4	6	6	estradiol	DES	PA449503	1674	0.282
NULL	Biosci_Rep_2012_Dec_6_33(1)_e00006.nxml.txt.nlp	23050906	SENT248	11	11	16	16	lovastatin	DHCR24	PA450272	1718	0.282
NULL	Parasit_Vectors_2013_Oct_10_6_292.nxml.txt.nlp	24457085	SENT95	28	28	33	33	nadh	ND4	PA164755085	4538	0.282
NULL	Mol_Vis_2014_Dec_31_20_1796-1805.nxml.txt.nlp	25593507	SENT35	4	4	22	22	l-glutamine	CNTF	PA10090	1270	0.282
NULL	Evid_Based_Complement_Alternat_Med_2012_Aug_29_2012_417953.nxml.txt.nlp	22973401	SENT52	3	3	0	0	ethanol	TPC	PA448073	8030;60386	0.282
NULL	J_Hum_Genet_2013_Jun_16_58(6)_353-361.nxml.txt.nlp	23677058	SENT153	17	17	11	11	cytarabine	CNT3	PA449177	64078	0.282
NULL	Asian_Spine_J_2012_Dec_14_6(4)_274-278.nxml.txt.nlp	23275811	SENT90	32	32	46	46	isoniazid	CTX	PA450112	1593	0.282
NULL	Biomed_Res_Int_2014_Jan_23_2014_312647.nxml.txt.nlp	24587984	SENT150	28	28	24	24	infliximab	ABCG1	PA452639	9619	0.282
NULL	J_Cancer_2014_Apr_24_5(5)_390-397.nxml.txt.nlp	24799957	SENT46	20	20	18	18	granisetron	CHOP	PA449809	1649	0.282
NULL	J_Cell_Biol_2001_Mar_19_152(6)_1135-1144.nxml.txt.nlp	11257115	SENT166	4	4	3	3	lipase	DAG	PA450239	1605	0.282
NULL	Neural_Regen_Res_2014_Jul_1_9(13)_1297-1302.nxml.txt.nlp	25221582	SENT116	21	21	14	14	oxygen	CAT	PA450744	847	0.282
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT373	24	24	24	24	pp2	PP2		4888	0.282
NULL	eLife_2014_May_13_3_e02242.nxml.txt.nlp	24843020	SENT196	0	0	24	24	metformin	CA9	PA450395	768	0.282
NULL	J_Mol_Signal_2010_May_10_5_4.nxml.txt.nlp	20459745	SENT66	6	6	12	12	cisplatin	p53	PA449014	7157	0.282
NULL	Front_Behav_Neurosci_2014_Oct_30_8_366.nxml.txt.nlp	25400560	SENT208	34	34	23	23	ethanol	GAPDH	PA448073	2597	0.282
NULL	Int_J_Environ_Res_Public_Health_2013_Sep_17_10(9)_4352-4389.nxml.txt.nlp	24048206	SENT154	21	21	18	18	betaine	BHMT	PA448603	635	0.282
NULL	Oncotarget_2014_Oct_18_5(20)_10058-10069.nxml.txt.nlp	25375203	SENT213	9	9	6	6	hydrocortisone	EGF	PA449905	1950	0.282
NULL	Front_Cell_Neurosci_2014_Jun_6_8_155.nxml.txt.nlp	24936172	SENT83	14	14	2	2	picrotoxin	HMGB1	PA164777007	3146	0.282
NULL	Oxid_Med_Cell_Longev_2013_Jun_13_2013_694014.nxml.txt.nlp	23844277	SENT69	22	22	17	17	ethanol	TMP	PA448073	2012	0.282
NULL	Biomed_Res_Int_2014_Apr_10_2014_151405.nxml.txt.nlp	24818127	SENT198	7	7	0	0	l-arginine	NO3	PA448478	4681	0.282
NULL	Support_Care_Cancer_2009_Sep_10_17(9)_1187-1193.nxml.txt.nlp	19205754	SENT65	2	2	25	25	dolasetron	CYP2D6	PA449390	1565	0.281
NULL	Mol_Med_Rep_2015_Jan_17_11(1)_43-52.nxml.txt.nlp	25333456	SENT266	25	25	39	39	mitomycin	ADM	PA450524	133	0.281
NULL	Int_J_Hypertens_2013_Jun_17_2013_627938.nxml.txt.nlp	23844279	SENT142	31	31	0	0	telmisartan	A10	PA451605	28870	0.281
NULL	J_Lipid_Res_2014_Feb_55(2)_307-312.nxml.txt.nlp	24262094	SENT220	6	6	9	9	lipase	PNLIP	PA450239	5406	0.281
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2007_Dec_6_64(Pt_1)_o142.nxml.txt.nlp	21200707	SENT63	27	27	23	23	ethanol	mol	PA448073	90527	0.281
NULL	Infect_Drug_Resist_2010_Oct_13_3_103-114.nxml.txt.nlp	21694899	SENT58	15	15	4	4	raltegravir	CD4		920	0.281
NULL	Mol_Biol_Cell_2012_Oct_15_23(20)_3957-3969.nxml.txt.nlp	22918950	SENT334	32	32	5	5	ampicillin	LBA	PA448419	987	0.281
NULL	Carcinogenesis_2010_Dec_27_31(12)_2049-2057.nxml.txt.nlp	20876285	SENT179	12	12	17	17	tamoxifen	HER2	PA451581	2064	0.281
NULL	Orphanet_J_Rare_Dis_2012_Oct_23_7_82.nxml.txt.nlp	23092449	SENT301	46	46	0	0	creatine	DMD	PA164778930	1756	0.281
NULL	AIDS_Res_Ther_2009_Apr_9_6_3.nxml.txt.nlp	19358725	SENT56	24	24	28	28	tenofovir	TDF	PA10204	6736	0.281
NULL	Indian_J_Psychiatry_2010_Jan_52(Suppl1)_S317-S340.nxml.txt.nlp	21836703	SENT115	26	26	24	24	triflupromazine	CPZ	PA451773	8532	0.281
NULL	Calcif_Tissue_Int_2011_Aug_3_89(2)_91-104.nxml.txt.nlp	21637997	SENT181	25	25	18	18	raloxifene	STAR	PA451221	6770;2984	0.281
NULL	Arthritis_Res_Ther_2007_Oct_10_9(5)_R105.nxml.txt.nlp	17927818	SENT116	41	41	41	41	pp2	PP2		4888	0.281
NULL	Br_J_Cancer_2011_Jul_26_105(3)_353-359.nxml.txt.nlp	21750549	SENT119	7	7	12	12	sorafenib	STEP	PA7000	84867	0.281
NULL	Adv_Hematol_2012_Aug_2_2012_842945.nxml.txt.nlp	22919394	SENT165	20	20	18	18	lenalidomide	CRBN	PA162363968	51185	0.281
NULL	Viruses_2009_Nov_4_1(3)_689-712.nxml.txt.nlp	20221421	SENT202	32	32	27	27	papain	ADRP	PA450778	123	0.281
NULL	BMB_Rep_2014_Oct_47(10)_575-580.nxml.txt.nlp	24499675	SENT102	21	21	17	17	oxygen	SSB	PA450744	6741	0.281
NULL	J_Exp_Clin_Cancer_Res_2009_Jul_9_28(1)_98.nxml.txt.nlp	19589137	SENT22	4	4	7	7	hyaluronan	LYVE-1	PA165958431	10894	0.281
NULL	Clin_Interv_Aging_2011_Jun_21_6_151-160.nxml.txt.nlp	21753870	SENT177	4	4	26	26	raloxifene	STAR	PA451221	6770;2984	0.281
NULL	Nat_Med_2012_Mar_4_18(4)_572-579.nxml.txt.nlp	22388089	SENT30	4	4	24	24	choline	DDC	PA448976	1644	0.28
NULL	Int_J_Mol_Sci_2014_Sep_1_15(9)_15456-15474.nxml.txt.nlp	25257525	SENT258	15	15	22	22	ethanol	CO2	PA448073	4513	0.28
NULL	Int_J_Hypertens_2013_Jun_17_2013_627938.nxml.txt.nlp	23844279	SENT146	2	2	6	6	amlodipine	A10	PA448388	28870	0.28
NULL	J_Korean_Med_Sci_2013_Apr_27_28(4)_527-533.nxml.txt.nlp	23580227	SENT136	17	17	19	19	genistein	TRAIL	PA165109660	8743	0.28
NULL	Cardiovasc_Diabetol_2011_Feb_11_10_18.nxml.txt.nlp	21314919	SENT90	33	33	17	17	glibenclamide	Met	PA449782	79811	0.28
NULL	Int_J_Biol_Sci_2014_Aug_23_10(8)_921-939.nxml.txt.nlp	25170305	SENT311	24	24	11	11	nadh	EPO	PA164755085	7076;8288;2056	0.28
NULL	Mol_Biol_Cell_2013_Sep_1_24(17)_2678-2688.nxml.txt.nlp	23864716	SENT79	28	28	28	28	pp2	PP2		4888	0.28
NULL	AIDS_Res_Ther_2011_Oct_6_8_36.nxml.txt.nlp	21978457	SENT6	29	29	14	14	zinc	TNF	PA451956	7124	0.28
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Oct_23_66(Pt_11)_m1445.nxml.txt.nlp	21588866	SENT70	20	20	11	11	ethanol	NO3	PA448073	4681	0.28
NULL	J_Vet_Med_Sci_2014_Jul_18_76(7)_937-945.nxml.txt.nlp	24646457	SENT103	2	2	41	41	ampicillin	OTC	PA448419	5009	0.28
NULL	Ann_Gen_Psychiatry_2013_Jul_11_12_22.nxml.txt.nlp	23845018	SENT0	18	18	1	1	paliperidone	Gen	PA163518919	348654	0.28
NULL	Cells_2014_Jun_10_3(2)_563-591.nxml.txt.nlp	24918976	SENT333	2	2	9	9	lapatinib	AKT	PA152241907	207	0.28
NULL	Cancers_(Basel)_2013_May_27_5(2)_617-638.nxml.txt.nlp	24216994	SENT138	0	0	11	11	curcumin	PC3	PA151958596	57332;7832;5122	0.28
NULL	Mol_Brain_2014_Aug_21_7_59.nxml.txt.nlp	25139109	SENT83	24	24	10	10	chloroquine	TLR4	PA448948	7099	0.28
NULL	Mol_Pain_2012_Sep_27_8_75.nxml.txt.nlp	23013719	SENT375	30	30	0	0	capsaicin	TRPA1	PA448776	8989	0.279
NULL	BMJ_2014_Nov_5_349_g6427.nxml.txt.nlp	25378023	SENT133	25	25	28	28	everolimus	DES	PA164746311	1674	0.279
NULL	Avicenna_J_Med_Biotechnol_2011_Apr-Jun_3(2)_87-93.nxml.txt.nlp	23408139	SENT40	4	4	7	7	ethanol	TMT	PA448073	25823	0.279
NULL	Mol_Biol_Cell_2014_Sep_15_25(18)_2695-2709.nxml.txt.nlp	25057021	SENT380	15	15	22	22	paraformaldehyde	OTC	PA450790	5009	0.279
NULL	J_Anaesthesiol_Clin_Pharmacol_2012_Oct-Dec_28(4)_486-490.nxml.txt.nlp	23225930	SENT28	12	12	33	33	neostigmine	TKR	PA450611	8277	0.279
NULL	Clin_Ophthalmol_2014_Apr_11_8_733-738.nxml.txt.nlp	24748768	SENT38	0	0	19	19	fluorescein	CRA	PA164746009	51747;10903	0.279
NULL	Arthritis_Res_Ther_2014_Apr_30_16(2)_R90.nxml.txt.nlp	25167216	SENT218	36	36	7	7	adalimumab	CXCL13	PA10004	10563	0.279
NULL	Hum_Mol_Genet_2011_Sep_15_20(18)_3699-3709.nxml.txt.nlp	21665990	SENT348	16	16	19	19	lipase	LIPC	PA450239	3990	0.279
NULL	Br_J_Cancer_2013_Oct_15_109(8)_2072-2078.nxml.txt.nlp	24045661	SENT24	14	14	21	21	sorafenib	SHARP	PA7000	23013	0.279
NULL	J_Oncol_2012_Sep_29_2012_879623.nxml.txt.nlp	21977033	SENT503	25	25	21	21	resveratrol	NAC		22861	0.279
NULL	Apoptosis_2013_Jul_31_18(12)_1447-1468.nxml.txt.nlp	23900974	SENT452	14	14	7	7	heparin	FGF9	PA449855	2254	0.279
NULL	Surg_Today_2012_Jan_6_42(1)_8-28.nxml.txt.nlp	22139128	SENT430	7	7	13	13	cisplatin	PSK	PA449014	9344	0.279
NULL	Chemother_Res_Pract_2012_Aug_12_2012_549170.nxml.txt.nlp	22924129	SENT145	2	2	35	35	docetaxel	CRT	PA449383	811	0.279
NULL	Cancers_(Basel)_2010_Dec_30_3(1)_106-125.nxml.txt.nlp	24212609	SENT322	6	6	4	4	gemcitabine	HuR	PA449748	1994	0.279
NULL	Breast_Cancer_Res_2011_Jun_29_13(3)_R70.nxml.txt.nlp	21707964	SENT172	13	13	5	5	tamoxifen	14-3-3	PA451581	10971	0.279
NULL	Oncotarget_2013_Nov_24_4(12)_2186-2207.nxml.txt.nlp	24327604	SENT140	21	21	10	10	bortezomib	USP7	PA10252	7874	0.279
NULL	Contemp_Oncol_(Pozn)_2012_Nov_20_16(5)_416-419.nxml.txt.nlp	23788920	SENT12	15	15	8	8	enoxaparin	CRT	PA449463	811	0.279
NULL	eLife_2014_May_29_3_e02811.nxml.txt.nlp	24876128	SENT141	26	26	15	15	neomycin	TAF7L	PA450608	54457	0.278
NULL	ScientificWorldJournal_2014_Feb_12_2014_378950.nxml.txt.nlp	24688382	SENT4	4	4	7	7	oxygen	ROS	PA450744	6098	0.278
NULL	Am_J_Trop_Med_Hyg_2012_Nov_7_87(5_Suppl)_92-96.nxml.txt.nlp	23136283	SENT127	22	22	26	26	artemisinin	ACT	PA165111696	12;11332;9457;641455	0.278
NULL	Gastroenterol_Hepatol_Bed_Bench_2011_Spring_4(2)_43-52.nxml.txt.nlp	24834156	SENT83	18	18	22	22	trypsin	TATI	PA451806	6690	0.278
NULL	J_Immune_Based_Ther_Vaccines_2005_Sep_2_3_6.nxml.txt.nlp	16138929	SENT127	1	1	8	8	infliximab	IMPACT	PA452639	55364	0.278
NULL	J_Ophthalmol_2011_Dec_23_2011_292040.nxml.txt.nlp	21253505	SENT132	5	5	7	7	diltiazem	rd1	PA449334	5158	0.278
NULL	J_Vet_Med_Sci_2014_Jul_18_76(7)_937-945.nxml.txt.nlp	24646457	SENT91	18	18	40	40	cefpodoxime	OTC	PA164746385	5009	0.278
NULL	Infect_Dis_Obstet_Gynecol_2006_Oct_1_2006_18182.nxml.txt.nlp	17485797	SENT154	10	10	20	20	norfloxacin	VAN	PA450654	10318	0.278
NULL	Infect_Dis_Obstet_Gynecol_2006_Oct_1_2006_18182.nxml.txt.nlp	17485797	SENT154	10	10	12	12	norfloxacin	NOV	PA450654	4856;5361;6134	0.278
NULL	Clin_Interv_Aging_2009_Nov_18_4_435-444.nxml.txt.nlp	19966912	SENT253	3	3	6	6	ramipril	AIRE	PA451223	326	0.278
NULL	Behav_Brain_Funct_2005_Jul_15_1_9.nxml.txt.nlp	16022733	SENT37	0	0	4	4	methylphenidate	spatial	PA450464	219793	0.278
NULL	Arthritis_Res_2002_Sep_16_4(6)_R12.nxml.txt.nlp	12453315	SENT98	4	4	29	29	methotrexate	CRP	PA450428	1401;140913	0.278
NULL	Int_J_Biol_Sci_2014_Aug_23_10(8)_909-920.nxml.txt.nlp	25170304	SENT49	10	10	14	14	galactose	MGL	PA449725	11343	0.278
NULL	Med_Sci_Monit_2012_Jun_1_18(6)_BR247-BR252.nxml.txt.nlp	22648246	SENT56	8	8	17	17	celecoxib	IBP	PA448871	706;50619	0.278
NULL	Clin_Med_Insights_Case_Rep_2011_Jan_12_4_1-6.nxml.txt.nlp	21769259	SENT5	11	11	7	7	warfarin	OAT	PA451906	4942	0.278
NULL	Br_J_Haematol_2014_Mar_6_164(6)_759-766.nxml.txt.nlp	24387053	SENT182	26	26	10	10	eculizumab	DGKE	PA164776637	8526	0.278
NULL	Cancer_Manag_Res_2012_Nov_9_4_383-395.nxml.txt.nlp	23204869	SENT105	7	7	1	1	carmustine	PC-3	PA448810	692094	0.278
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT178	3	3	6	6	methotrexate	MSH2	PA450428	4436	0.278
NULL	Carcinogenesis_2010_Dec_27_31(12)_2049-2057.nxml.txt.nlp	20876285	SENT184	11	11	17	17	tamoxifen	HER2	PA451581	2064	0.277
NULL	Mol_Cancer_2012_Dec_12_11_91.nxml.txt.nlp	23234355	SENT160	10	10	0	0	cetuximab	CTRL	PA10040	1506	0.277
NULL	Korean_Circ_J_2013_Jun_30_43(6)_400-407.nxml.txt.nlp	23882289	SENT142	37	37	35	35	doxorubicin	survivin	PA449412	332	0.277
NULL	J_Invest_Dermatol_2013_Sep_31_133(9)_2247-2254.nxml.txt.nlp	23370537	SENT136	26	26	24	24	chloroquine	PUMA	PA448948	27113	0.277
NULL	Biomed_Res_Int_2013_Jul_30_2013_754946.nxml.txt.nlp	23984405	SENT191	16	16	36	36	nadh	B2M	PA164755085	567	0.277
NULL	J_Cancer_Res_Clin_Oncol_2012_Sep_3_138(9)_1569-1577.nxml.txt.nlp	22552718	SENT165	7	7	2	2	risedronate	aromatase	PA451255	1588	0.277
NULL	Nat_Neurosci_2012_Sep_5_15(9)_1245-1254.nxml.txt.nlp	22864611	SENT103	7	7	9	9	clozapine	HDAC2	PA449061	3066	0.277
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Mar_2_69(Pt_4)_o464-o465.nxml.txt.nlp	23634024	SENT7	18	18	20	20	ethanol	mol	PA448073	90527	0.277
NULL	Biomed_Res_Int_2014_Jun_3_2014_263604.nxml.txt.nlp	24995280	SENT316	21	21	19	19	cyclosporine	castor	PA449167	54897	0.277
NULL	Pain_Ther_2014_Jun_6_3(1)_1-15.nxml.txt.nlp	25135384	SENT72	0	0	21	21	naloxone	UGT	PA450586	7361;7355	0.277
NULL	Lab_Anim_Res_2013_Jun_24_29(2)_84-95.nxml.txt.nlp	23825481	SENT118	30	30	27	27	nifedipine	INS-1	PA450631	2305	0.277
NULL	Springerplus_2013_Dec_7_2_659.nxml.txt.nlp	24353977	SENT74	5	5	7	7	ketotifen	MSU	PA450152	593	0.277
NULL	Behav_Brain_Funct_2010_Aug_30_6_50.nxml.txt.nlp	20799992	SENT163	30	30	5	5	methamphetamine	DRD2	PA450403	1813	0.277
NULL	Acta_Pharmacol_Sin_2010_Sep_16_31(9)_1075-1084.nxml.txt.nlp	20711221	SENT140	13	13	16	16	oxygen	ROS	PA450744	6098	0.277
NULL	Oncogenesis_2014_May_12_3(5)_e102.nxml.txt.nlp	24819061	SENT119	14	14	29	29	nadh	p53	PA164755085	7157	0.277
NULL	Acta_Pharmacol_Sin_2010_Dec_22_31(12)_1593-1603.nxml.txt.nlp	21102482	SENT156	24	24	24	24	pp2	PP2		4888	0.277
NULL	F1000Res_2014_Aug_19_3_198.nxml.txt.nlp	25400908	SENT285	18	18	21	21	trastuzumab	HER2	PA451743	2064	0.277
NULL	ScientificWorldJournal_2012_Dec_27_2012_740308.nxml.txt.nlp	23346021	SENT144	5	5	1	1	ethanol	GM-CSF	PA448073	1437	0.276
NULL	Ann_Clin_Microbiol_Antimicrob_2007_May_23_6_5.nxml.txt.nlp	17521424	SENT72	34	34	4	4	ciprofloxacin	TOB	PA449009	10140	0.276
NULL	Clin_Ophthalmol_2014_Jun_10_8_1097-1104.nxml.txt.nlp	24959067	SENT38	29	29	25	25	travoprost	BAK	PA164781371	578	0.276
NULL	Cancer_Cell_Int_2005_Jul_7_5_20.nxml.txt.nlp	16001980	SENT132	10	10	7	7	vinblastine	P-gp	PA451877	5243	0.276
NULL	Clin_Res_Cardiol_2009_Jun_20_98(6)_391-399.nxml.txt.nlp	19301059	SENT184	30	30	21	21	pantoprazole	mol	PA450774	90527	0.276
NULL	Br_J_Cancer_2012_Nov_6_107(10)_1737-1744.nxml.txt.nlp	23037715	SENT236	23	23	23	23	pp2	PP2		4888	0.276
NULL	Eur_J_Hum_Genet_2011_Feb_27_19(2)_200-207.nxml.txt.nlp	20978534	SENT122	12	12	17	17	nadh	MT-ND6	PA164755085	4541	0.276
NULL	Comp_Hepatol_2006_Jan_11_5_1.nxml.txt.nlp	16405720	SENT56	11	11	0	0	tenofovir	LAM	PA10204	7249;7248	0.275
NULL	Chem_Cent_J_2013_Jul_18_7_125.nxml.txt.nlp	23866063	SENT93	23	23	25	25	phenol	C-1	PA450913	5203	0.275
NULL	Vet_Res_2013_Sep_26_44(1)_83.nxml.txt.nlp	24070317	SENT40	36	36	24	24	l-glutamine	F12	PA10090	2161	0.275
NULL	Ann_Surg_Oncol_2012_Feb_23_19(2)_620-626.nxml.txt.nlp	21861214	SENT134	25	25	7	7	bevacizumab	CEA	PA130232992	5670;1087	0.275
NULL	Iran_J_Microbiol_2013_Sep_5(3)_227-232.nxml.txt.nlp	24475328	SENT87	20	20	30	30	ciprofloxacin	Gen	PA449009	348654	0.275
NULL	Br_J_Cancer_1990_Feb_61(2)_327-329.nxml.txt.nlp	2310684	SENT0	7	7	10	10	trypsin	TATI	PA451806	6690	0.275
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Nov_15_5_27.nxml.txt.nlp	17107610	SENT39	14	14	8	8	dapsone	EMB	PA449211	133418	0.275
NULL	Front_Neurosci_2008_Dec_15_2(2)_135-136.nxml.txt.nlp	19225584	SENT17	28	28	15	15	choline	spatial	PA448976	219793	0.275
NULL	J_Vet_Med_Sci_2014_Jul_18_76(7)_937-945.nxml.txt.nlp	24646457	SENT91	2	2	40	40	ampicillin	OTC	PA448419	5009	0.275
NULL	Tuberc_Res_Treat_2014_Aug_27_2014_182836.nxml.txt.nlp	25243086	SENT27	19	19	23	23	isoniazid	IPT	PA450112	54802	0.275
NULL	ScientificWorldJournal_2013_Oct_24_2013_726912.nxml.txt.nlp	24282387	SENT40	22	22	29	29	fluorescein	AVP	PA164746009	114548;551	0.275
NULL	Indian_J_Pharmacol_2013_Jan-Feb_45(1)_9-12.nxml.txt.nlp	23543259	SENT21	10	10	20	20	oxygen	eNOS	PA450744	4846	0.275
NULL	Pharmaceuticals_(Basel)_2011_Oct_10_4(10)_1295-1314.nxml.txt.nlp	NULL	SENT556	4	4	17	17	nitrogen	gamma	PA450643	9913	0.275
NULL	Addict_Health_2014_Winter-Spring_6(1-2)_54-64.nxml.txt.nlp	25140218	SENT84	13	13	16	16	pentobarbital	spatial	PA450859	219793	0.275
NULL	Biotechnol_Res_Int_2013_Dec_1_2013_253286.nxml.txt.nlp	24363937	SENT54	13	13	18	18	urea	DAP	PA451831	23549;3375;1611	0.275
NULL	Breast_Cancer_Res_2014_Jul_29_16(4)_412.nxml.txt.nlp	25410383	SENT291	6	6	15	15	ribavirin	ESR1	PA451241	2099	0.275
NULL	Case_Rep_Obstet_Gynecol_2013_Apr_22_2013_807205.nxml.txt.nlp	23710391	SENT63	39	39	28	28	medroxyprogesterone	RDT	PA450344	6598	0.274
NULL	Cell_Commun_Signal_2012_Mar_3_10_5.nxml.txt.nlp	22385615	SENT279	3	3	3	3	pp2	PP2		4888	0.274
NULL	Asian_Spine_J_2012_Dec_14_6(4)_274-278.nxml.txt.nlp	23275811	SENT90	20	20	46	46	cefotiam	CTX	PA164749298	1593	0.274
NULL	Int_J_Mol_Sci_2014_Jun_18_15(6)_11013-11029.nxml.txt.nlp	24945311	SENT80	22	22	20	20	celecoxib	c-Myc	PA448871	4609	0.274
NULL	Cancer_Med_2014_Dec_1_3(6)_1493-1501.nxml.txt.nlp	25081631	SENT33	27	27	2	2	erlotinib	FDG	PA134687924	23583	0.274
NULL	Crit_Care_2012_Jun_29_16(3)_135.nxml.txt.nlp	22748073	SENT40	10	10	17	17	thrombin	PAR4	PA451674	9002;5074	0.274
NULL	J_Biol_Chem_2012_Dec_14_287(51)_43094-43107.nxml.txt.nlp	23118219	SENT339	13	13	15	15	hyaluronan	CD44	PA165958431	960	0.274
NULL	Mol_Cancer_2010_Dec_20_9_317.nxml.txt.nlp	21172025	SENT9	23	23	12	12	tamoxifen	HER2	PA451581	2064	0.274
NULL	Biomed_Res_Int_2014_Jun_30_2014_921296.nxml.txt.nlp	25101299	SENT161	0	0	3	3	bleomycin	BLMH	PA448645	642	0.274
NULL	Iran_J_Microbiol_2013_Sep_5(3)_227-232.nxml.txt.nlp	24475328	SENT87	4	4	30	30	oxacillin	Gen	PA450725	348654	0.274
NULL	ScientificWorldJournal_2013_Jun_6_2013_943539.nxml.txt.nlp	23843741	SENT38	13	13	17	17	taurine	TUG1	PA451590	55000	0.274
NULL	AIDS_Behav_2011_Aug_8_15(6)_1153-1160.nxml.txt.nlp	20532606	SENT2	3	3	28	28	methamphetamine	San	PA450403	80218	0.274
NULL	Mucosal_Immunol_2012_Mar_14_5(2)_150-160.nxml.txt.nlp	22166938	SENT195	18	18	12	12	collagenase	B55	PA449107	50488	0.273
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT326	2	2	6	6	risperidone	PRL	PA451257	5617	0.273
NULL	Nat_Cell_Biol_2014_Jan_8_16(1)_10_1038_ncb2886.nxml.txt.nlp	24316673	SENT99	12	12	9	9	chloroquine	p62	PA448948	8878;10657;23636	0.273
NULL	Int_J_Mol_Sci_2012_Aug_16_13(8)_10257-10267.nxml.txt.nlp	22949859	SENT115	2	2	5	5	phenol	TPC	PA450913	8030;60386	0.273
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT276	42	42	40	40	cisplatin	UNG	PA449014	7374	0.273
NULL	Aging_(Albany_NY)_2012_Mar_4_4(3)_144-145.nxml.txt.nlp	22388573	SENT11	8	8	6	6	resveratrol	AMPK		5563	0.273
NULL	AIDS_Res_Treat_2012_Jul_30_2012_197501.nxml.txt.nlp	22900154	SENT226	6	6	0	0	ribavirin	IFN	PA451241	3439	0.273
NULL	Crit_Care_2008_Jun_25_12(3)_R84.nxml.txt.nlp	18578859	SENT116	12	12	0	0	heparin	PF4	PA449855	5196	0.273
NULL	Acta_Vet_Scand_2009_Aug_25_51(1)_35.nxml.txt.nlp	19703311	SENT99	7	7	9	9	kanamycin	OTC	PA450137	5009	0.273
NULL	Carcinogenesis_2010_Dec_27_31(12)_2049-2057.nxml.txt.nlp	20876285	SENT160	7	7	12	12	tamoxifen	HER2	PA451581	2064	0.273
NULL	Open_Virol_J_2010_Jun_23_4_157-162.nxml.txt.nlp	20835359	SENT153	13	13	13	13	pp2	PP2		4888	0.273
NULL	J_Gen_Physiol_2004_Apr_123(4)_427-439.nxml.txt.nlp	15024039	SENT20	7	7	7	7	pp2	PP2		4888	0.273
NULL	Indian_J_Dermatol_2013_Sep-Oct_58(5)_410d.nxml.txt.nlp	24082224	SENT38	21	21	31	31	dapsone	G6PD	PA449211	2539	0.273
NULL	Int_J_Hypertens_2013_Jun_17_2013_627938.nxml.txt.nlp	23844279	SENT154	2	2	6	6	amlodipine	A10	PA448388	28870	0.273
NULL	Ther_Clin_Risk_Manag_2007_Dec_3(6)_1027-1033.nxml.txt.nlp	18516257	SENT60	30	30	5	5	procarbazine	MRC	PA451112	4345	0.273
NULL	Enzyme_Res_2010_Jun_28_2010_734182.nxml.txt.nlp	21048869	SENT70	9	9	12	12	oxygen	COD	PA450744	6628	0.273
NULL	Bioinformation_2012_Jan_6_8(1)_13-19.nxml.txt.nlp	22359429	SENT169	8	8	6	6	curcumin	MRP1	PA151958596	4437	0.273
NULL	Patient_Prefer_Adherence_2009_Nov_3_3_305-309.nxml.txt.nlp	19936173	SENT18	19	19	41	41	risperidone	DAI	PA451257	81030	0.273
NULL	Iran_J_Radiol_2011_Mar_30_8(1)_39-41.nxml.txt.nlp	23329915	SENT50	11	11	4	4	cyclophosphamide	CHOP	PA449165	1649	0.272
NULL	Br_J_Cancer_2011_Sep_27_105(7)_945-952.nxml.txt.nlp	21863030	SENT37	17	17	24	24	sorafenib	SHARP	PA7000	23013	0.272
NULL	J_Korean_Med_Sci_2013_Dec_26_28(12)_1774-1780.nxml.txt.nlp	24339708	SENT24	4	4	8	8	octreotide	OST	PA450678	1650;23263	0.272
NULL	Biosci_Rep_2014_Jul_29_34(4)_e00126.nxml.txt.nlp	24935351	SENT373	9	9	14	14	dasatinib	TP53	PA162372878	7157	0.272
NULL	Biomed_Res_Int_2013_Jun_17_2013_312656.nxml.txt.nlp	23844360	SENT172	1	1	6	6	plerixafor	HSPC	PA165958410	5688	0.272
NULL	Osteoporos_Int_2014_Oct_10_25(3)_1173-1180.nxml.txt.nlp	24108429	SENT26	8	8	4	4	teriparatide	PTH	PA451620	5741	0.272
NULL	J_Ophthalmol_2011_Dec_23_2011_292040.nxml.txt.nlp	21253505	SENT124	1	1	3	3	diltiazem	rd1	PA449334	5158	0.272
NULL	Arch_Med_Sci_2012_Nov_9_8(5)_899-906.nxml.txt.nlp	23185202	SENT97	11	11	8	8	miglitol	PPG	PA164776726	5552	0.272
NULL	Int_J_Hypertens_2013_Jun_17_2013_627938.nxml.txt.nlp	23844279	SENT162	41	41	0	0	telmisartan	A10	PA451605	28870	0.272
NULL	Int_J_Hypertens_2013_Jun_17_2013_627938.nxml.txt.nlp	23844279	SENT146	8	8	6	6	amlodipine	A10	PA448388	28870	0.272
NULL	Ann_Oncol_2009_Aug_17_20(8)_1319-1329.nxml.txt.nlp	19535820	SENT330	15	15	24	24	trastuzumab	San	PA451743	80218	0.272
NULL	Brain_Sci_2014_Mar_14_4(1)_136-149.nxml.txt.nlp	24961704	SENT357	8	8	11	11	isoflurane	spatial	PA450106	219793	0.272
NULL	J_Biol_Chem_2009_May_1_284(18)_11953-11962.nxml.txt.nlp	19254952	SENT233	10	10	10	10	pp2	PP2		4888	0.272
NULL	Environ_Health_Perspect_2004_Apr_112(5)_620-625.nxml.txt.nlp	15064171	SENT6	10	10	4	4	creatine	MRS	PA164778930	8011	0.272
NULL	Int_J_Hypertens_2013_Jun_17_2013_627938.nxml.txt.nlp	23844279	SENT138	8	8	6	6	amlodipine	A10	PA448388	28870	0.272
NULL	Allergy_Asthma_Immunol_Res_2012_Mar_25_4(2)_68-79.nxml.txt.nlp	22379601	SENT32	27	27	47	47	zinc	FOG	PA451956	161882	0.272
NULL	Nat_Genet_2010_Oct_5_42(10)_851-858.nxml.txt.nlp	20818383	SENT322	1	1	11	11	nadh	NDUFS8	PA164755085	4728	0.272
NULL	Cardiovasc_J_Afr_2011_Apr_22(2)_79-84.nxml.txt.nlp	21556450	SENT161	6	6	9	9	ramipril	AIRE	PA451223	326	0.272
NULL	N_Am_J_Med_Sci_2014_Aug_6(8)_351-358.nxml.txt.nlp	25210667	SENT107	25	25	20	20	tetracycline	TGP	PA451640	7047	0.272
NULL	Brain_Tumor_Res_Treat_2013_Oct_31_1(2)_71-77.nxml.txt.nlp	24904895	SENT189	6	6	0	0	bromocriptine	PRL	PA448671	5617	0.271
NULL	Nat_Commun_2014_Jun_20_5_4122.nxml.txt.nlp	24947823	SENT389	25	25	37	37	capsaicin	TRPV1	PA448776	7442	0.271
NULL	Case_Rep_Med_2014_May_4_2014_964082.nxml.txt.nlp	24876846	SENT113	2	2	0	0	bortezomib	BOR	PA10252	55143	0.271
NULL	Korean_J_Anesthesiol_2013_Jan_21_64(1)_47-53.nxml.txt.nlp	23372886	SENT166	2	2	15	15	bupivacaine	PTG	PA135057240	5507	0.271
NULL	J_Cell_Biol_2003_Dec_22_163(6)_1339-1349.nxml.txt.nlp	14691141	SENT67	3	3	3	3	pp2	PP2		4888	0.271
NULL	J_Mol_Signal_2007_Oct_4_2_10.nxml.txt.nlp	17916240	SENT42	0	0	8	8	curcumin	PC-3	PA151958596	692094	0.271
NULL	Clin_Mol_Allergy_2004_Mar_16_2_4.nxml.txt.nlp	15023231	SENT34	29	29	21	21	clarithromycin	MUC5AC	PA449028	4586	0.271
NULL	Front_Neurosci_2010_Jun_28_4_41.nxml.txt.nlp	20661453	SENT78	38	38	36	36	ethanol	AKT	PA448073	207	0.271
NULL	Acta_Pharmacol_Sin_2009_Jul_3_30(7)_889-898.nxml.txt.nlp	19574994	SENT114	21	21	21	21	pp2	PP2		4888	0.271
NULL	Ann_Gen_Psychiatry_2012_Jul_2_11_18.nxml.txt.nlp	22747533	SENT0	15	15	1	1	paliperidone	Gen	PA163518919	348654	0.271
NULL	J_Biol_Chem_2012_Dec_14_287(51)_43094-43107.nxml.txt.nlp	23118219	SENT15	13	13	15	15	hyaluronan	CD44	PA165958431	960	0.271
NULL	J_Biomed_Sci_2014_Mar_29_21(1)_26.nxml.txt.nlp	24679334	SENT184	24	24	12	12	nadh	FES	PA164755085	2242	0.271
NULL	Mol_Cancer_2012_Apr_26_11_25.nxml.txt.nlp	22537194	SENT345	2	2	20	20	pemetrexed	NAC	PA10810	22861	0.271
NULL	Part_Fibre_Toxicol_2011_Jun_9_8_19.nxml.txt.nlp	21658250	SENT252	12	12	45	45	fluorescein	ZO-1	PA164746009	7082	0.271
NULL	Avicenna_J_Med_Biotechnol_2014_Jul-Sep_6(3)_156-162.nxml.txt.nlp	25215179	SENT47	11	11	25	25	collagenase	CO2	PA449107	4513	0.271
NULL	Libyan_J_Med_2007_Jun_1_2(2)_99-102.nxml.txt.nlp	21503261	SENT73	2	2	40	40	etanercept	Yes	PA449515	7525	0.271
NULL	Oncol_Lett_2013_Aug_20_6(2)_329-335.nxml.txt.nlp	24137325	SENT35	7	7	7	7	pp2	PP2		4888	0.271
NULL	Asian_Spine_J_2012_Dec_14_6(4)_274-278.nxml.txt.nlp	23275811	SENT90	48	48	46	46	cefotaxime	CTX	PA448852	1593	0.271
NULL	Cancers_(Basel)_2012_Apr_5_4(2)_354-378.nxml.txt.nlp	24213315	SENT1018	1	1	24	24	curcumin	DR5	PA151958596	8795	0.27
NULL	Indian_J_Psychiatry_2008_Oct-Dec_50(4)_229-232.nxml.txt.nlp	19823604	SENT99	13	13	4	4	rimonabant	CB1	PA152407999	1268	0.27
NULL	J_Orthop_Surg_2007_May_21_2_9.nxml.txt.nlp	17511887	SENT91	19	19	45	45	alendronate	DPD	PA448082	1806	0.27
NULL	Braz_J_Med_Biol_Res_2013_Dec_10_46(12)_1033-1039.nxml.txt.nlp	24345912	SENT119	12	12	5	5	ethanol	IL-10	PA448073	3586	0.27
NULL	J_Cell_Biol_2000_Jul_24_150(2)_321-334.nxml.txt.nlp	10908575	SENT194	4	4	10	10	staurosporine	ICAD	PA165109623	1676	0.27
NULL	Acta_Vet_Scand_2009_Aug_25_51(1)_35.nxml.txt.nlp	19703311	SENT99	7	7	13	13	kanamycin	TMP	PA450137	2012	0.27
NULL	Breast_Cancer_Res_2012_Feb_14_14(1)_R30.nxml.txt.nlp	22333315	SENT171	8	8	13	13	celecoxib	CXCL9	PA448871	4283	0.27
NULL	J_Biol_Chem_2012_Apr_6_287(15)_12433-12444.nxml.txt.nlp	22351758	SENT504	21	21	12	12	trypsin	TSG-6	PA451806	7130	0.27
NULL	J_Biol_Chem_2011_Oct_7_286(40)_34998-35006.nxml.txt.nlp	21757733	SENT34	27	27	30	30	lipase	ATGL	PA450239	57104	0.27
NULL	Aging_Cell_2012_Aug_11(4)_579-587.nxml.txt.nlp	22435726	SENT128	6	6	8	8	etoposide	IL-15	PA449552	3600	0.27
NULL	J_Exp_Med_1998_Jun_1_187(11)_1885-1892.nxml.txt.nlp	9607928	SENT205	10	10	5	5	thalidomide	IL-2	PA451644	3558	0.269
NULL	Oncogene_2009_Apr_23_28(16)_1821-1832.nxml.txt.nlp	19305428	SENT73	18	18	18	18	pp2	PP2		4888	0.269
NULL	Korean_J_Anesthesiol_2013_Jan_21_64(1)_47-53.nxml.txt.nlp	23372886	SENT85	16	16	10	10	bupivacaine	PTG	PA135057240	5507	0.269
NULL	Gut_Liver_2013_Jul_20_7(4)_458-461.nxml.txt.nlp	23898387	SENT16	12	12	9	9	ribavirin	IFN	PA451241	3439	0.269
NULL	Asian_Spine_J_2012_Dec_14_6(4)_274-278.nxml.txt.nlp	23275811	SENT90	24	24	46	46	minocycline	CTX	PA450519	1593	0.269
NULL	AIDS_Res_Ther_2011_Oct_6_8_36.nxml.txt.nlp	21978457	SENT6	18	18	14	14	zinc	TNF	PA451956	7124	0.269
NULL	Br_J_Cancer_2010_Jun_29_103(1)_52-60.nxml.txt.nlp	20531411	SENT123	17	17	16	16	gemcitabine	MTD	PA449748	4493	0.269
NULL	Indian_J_Nucl_Med_2012_Oct-Dec_27(4)_254-256.nxml.txt.nlp	24019658	SENT61	11	11	9	9	thyroglobulin	PAX8	PA164754910	7849	0.269
NULL	Br_J_Cancer_2011_Oct_11_105(8)_1131-1136.nxml.txt.nlp	21915126	SENT154	19	19	13	13	neratinib	EGFR	PA165291472	1956	0.269
NULL	Asian_Spine_J_2012_Dec_14_6(4)_274-278.nxml.txt.nlp	23275811	SENT90	28	28	46	46	meropenem	CTX	PA164764445	1593	0.269
NULL	J_Vet_Med_Sci_2014_Jul_18_76(7)_937-945.nxml.txt.nlp	24646457	SENT103	35	35	41	41	kanamycin	OTC	PA450137	5009	0.269
NULL	Mol_Cancer_2014_Jun_3_13_139.nxml.txt.nlp	24894297	SENT131	9	9	7	7	cisplatin	HES1	PA449014	3280;8209	0.269
NULL	Cardiovasc_Ther_2009_27(4)_259-274.nxml.txt.nlp	19604248	SENT213	2	2	0	0	ticagrelor	IPA	PA165374673	3160	0.269
NULL	Korean_J_Anesthesiol_2013_Jan_21_64(1)_54-60.nxml.txt.nlp	23372887	SENT168	27	27	29	29	esmolol	CRT	PA449500	811	0.269
NULL	Oncoscience_2014_Jan_30_1(1)_57-68.nxml.txt.nlp	25593988	SENT215	19	19	3	3	ponatinib	TRAIL	PA165980594	8743	0.269
NULL	J_Automat_Chem_1981_3(3)_155-157.nxml.txt.nlp	18927804	SENT0	26	26	19	19	aminophenazone	SMAC	PA164748135	56616	0.269
NULL	Evid_Based_Complement_Alternat_Med_2011_Mar_9_2011_201953.nxml.txt.nlp	21607012	SENT64	2	2	5	5	phenol	TPC	PA450913	8030;60386	0.268
NULL	Nat_Commun_2013_Nov_27_4_2821.nxml.txt.nlp	24281726	SENT165	18	18	18	18	pp2	PP2		4888	0.268
NULL	J_Vis_Exp_2010_Aug_1_(42)_2036.nxml.txt.nlp	20729802	SENT19	22	22	25	25	collagenase	KSR	PA449107	10256	0.268
NULL	Mol_Biol_Cell_2012_Jun_15_23(12)_2373-2387.nxml.txt.nlp	22535521	SENT339	39	39	11	11	gentamicin	F12	PA449753	2161	0.268
NULL	Eur_J_Appl_Physiol_2011_Feb_24_111(2)_275-283.nxml.txt.nlp	20865425	SENT105	14	14	26	26	glucose	APE	PA449773	55704;328	0.268
NULL	Libyan_J_Med_2006_Sep_19_1(2)_176-184.nxml.txt.nlp	21526016	SENT94	12	12	5	5	liraglutide	GLP-1	PA165958364	100125288	0.268
NULL	Libyan_J_Med_2008_Mar_1_3(1)_42-48.nxml.txt.nlp	21499481	SENT4	11	11	15	15	artemisinin	ACT	PA165111696	12;11332;9457;641455	0.268
NULL	J_Vet_Med_Sci_2014_Jul_18_76(7)_937-945.nxml.txt.nlp	24646457	SENT103	14	14	41	41	chloramphenicol	OTC	PA448927	5009	0.268
NULL	Pharmaceuticals_(Basel)_2013_Aug_6_6(8)_929-959.nxml.txt.nlp	24276377	SENT105	25	25	19	19	oxaliplatin	TRAIL	PA131285527	8743	0.268
NULL	Br_J_Cancer_2009_Oct_20_101(8)_1290-1297.nxml.txt.nlp	19755992	SENT92	1	1	5	5	oxaliplatin	CC3	PA131285527	10553	0.268
NULL	J_Biol_2003_Sep_24_2(4)_28.nxml.txt.nlp	14511394	SENT96	7	7	13	13	phenformin	STRAD	PA1000	92335	0.268
NULL	Acta_Naturae_2014_Apr-Jun_6(2)_110-118.nxml.txt.nlp	25093118	SENT20	7	7	26	26	nadh	LPO	PA164755085	4025	0.268
NULL	Korean_J_Anesthesiol_2013_Jan_21_64(1)_54-60.nxml.txt.nlp	23372887	SENT156	6	6	4	4	hydrocortisone	CRT	PA449905	811	0.268
NULL	Hum_Reprod_Update_2009_Jan_27_May-Jun_15(3)_323-339.nxml.txt.nlp	19174449	SENT196	25	25	33	33	estradiol	AMH	PA449503	268	0.268
NULL	Cost_Eff_Resour_Alloc_2008_Jan_23_6_2.nxml.txt.nlp	18215255	SENT238	11	11	9	9	isoniazid	IPT	PA450112	54802	0.268
NULL	Ayu_2013_Oct-Dec_34(4)_339-345.nxml.txt.nlp	24696569	SENT47	11	11	4	4	urea	FBS	PA451831	64319;26269	0.268
NULL	Front_Genet_2014_Oct_28_5_364.nxml.txt.nlp	25389432	SENT101	34	34	25	25	curcumin	APOE	PA151958596	348	0.268
NULL	Brain_Sci_2013_Apr_29_3(2)_704-727.nxml.txt.nlp	24027632	SENT246	21	21	28	28	ethanol	spatial	PA448073	219793	0.267
NULL	Int_J_Hypertens_2012_Feb_8_2012_189512.nxml.txt.nlp	22518281	SENT178	13	13	4	4	hemin	RVR	PA449849	9975	0.267
NULL	Front_Cell_Neurosci_2014_Jul_18_8_185.nxml.txt.nlp	25100946	SENT381	16	16	16	16	pp2	PP2		4888	0.267
NULL	Clin_Drug_Investig_2013_Jun_20_33(6)_419-427.nxml.txt.nlp	23605507	SENT36	8	8	9	9	ciprofloxacin	DPI	PA449009	1832	0.267
NULL	Braz_J_Microbiol_2009_Dec_1_Oct-Dec_40(4)_747-756.nxml.txt.nlp	24031421	SENT59	19	19	22	22	lipase	mol	PA450239	90527	0.267
NULL	Arthritis_Res_Ther_2007_Oct_10_9(5)_R105.nxml.txt.nlp	17927818	SENT152	20	20	20	20	pp2	PP2		4888	0.267
NULL	Ann_Med_2011_Nov_5_43(7)_531-544.nxml.txt.nlp	21815879	SENT34	13	13	15	15	thrombin	PAR-1	PA451674	2011;2149	0.267
NULL	J_Vet_Med_Sci_2014_Jul_18_76(7)_937-945.nxml.txt.nlp	24646457	SENT91	34	34	40	40	kanamycin	OTC	PA450137	5009	0.267
NULL	Acta_Vet_Scand_2009_Aug_25_51(1)_35.nxml.txt.nlp	19703311	SENT99	11	11	13	13	oxytetracycline	TMP	PA450757	2012	0.267
NULL	J_Obes_2011_Dec_12_2011_179674.nxml.txt.nlp	21197148	SENT190	7	7	3	3	liraglutide	GLP1	PA165958364	100125288;2641	0.267
NULL	Cent_European_J_Urol_2011_Dec_9_64(4)_256-257.nxml.txt.nlp	24578906	SENT62	20	20	17	17	doxazosin	CD133	PA449407	8842	0.267
NULL	Mol_Cancer_2007_Jun_4_6_35.nxml.txt.nlp	17547754	SENT100	15	15	13	13	cyclophosphamide	CHOP	PA449165	1649	0.267
NULL	Iran_J_Microbiol_2013_Sep_5(3)_227-232.nxml.txt.nlp	24475328	SENT87	8	8	30	30	vancomycin	Gen	PA451850	348654	0.267
NULL	Front_Behav_Neurosci_2011_Sep_13_5_57.nxml.txt.nlp	21949506	SENT620	5	5	7	7	nabilone	spatial	PA164746998	219793	0.266
NULL	Eur_J_Nutr_2013_Feb_3_52(1)_203-215.nxml.txt.nlp	22302614	SENT190	28	28	34	34	estradiol	PTH	PA449503	5741	0.266
NULL	Breast_Cancer_Res_2012_Jun_12_14(3)_R92.nxml.txt.nlp	22691413	SENT33	12	12	10	10	estradiol	HSD1	PA449503	26871	0.266
NULL	Mol_Pain_2013_Jun_10_9_27.nxml.txt.nlp	23758830	SENT164	10	10	15	15	tetracaine	ASIC3	PA451638	9311	0.266
NULL	Nat_Commun_2012_Dec_27_3_1316.nxml.txt.nlp	23271650	SENT531	34	34	23	23	tamoxifen	E12	PA451581	64100	0.266
NULL	AIDS_Res_Ther_2013_May_1_10_10.nxml.txt.nlp	23634877	SENT6	27	27	31	31	lovastatin	CXCR4	PA450272	7852	0.266
NULL	Oncogene_2009_Jan_15_28(2)_279-288.nxml.txt.nlp	18836480	SENT262	16	16	16	16	pp2	PP2		4888	0.266
NULL	Oncotarget_2014_Feb_14_5(3)_841-852.nxml.txt.nlp	24553354	SENT310	9	9	14	14	arsenite	AP-1	PA452638	2353;3727;2354;3725	0.266
NULL	Mol_Cancer_2010_Dec_20_9_317.nxml.txt.nlp	21172025	SENT128	8	8	25	25	tamoxifen	HER2	PA451581	2064	0.266
NULL	Nucleic_Acids_Res_2013_Nov_26_41(21)_9779-9785.nxml.txt.nlp	23980031	SENT38	4	4	17	17	ethanol	SOC	PA448073	91544	0.266
NULL	Front_Cell_Neurosci_2014_Jul_18_8_185.nxml.txt.nlp	25100946	SENT380	26	26	26	26	pp2	PP2		4888	0.266
NULL	Indian_J_Pharm_Sci_2013_May-Jun_75(3)_302-309.nxml.txt.nlp	24082346	SENT188	5	5	10	10	diclofenac	SRMS	PA449293	6725	0.266
NULL	J_Inflamm_(Lond)_2008_Dec_5_5_23.nxml.txt.nlp	19061493	SENT151	4	4	2	2	hemin	HO-1	PA449849	3162	0.266
NULL	Mol_Vis_2011_Jun_9_17_1564-1576.nxml.txt.nlp	21738386	SENT40	0	0	3	3	ethambutol	EMB	PA164784021	133418	0.266
NULL	Arthritis_Res_Ther_2007_Oct_10_9(5)_R105.nxml.txt.nlp	17927818	SENT135	17	17	17	17	pp2	PP2		4888	0.266
NULL	Psychiatry_Investig_2010_Jun_4_7(2)_79-85.nxml.txt.nlp	20577615	SENT116	7	7	5	5	chlorpromazine	CPZ	PA448964	8532	0.266
NULL	Diabetes_2013_Jun_17_62(6)_1996-2003.nxml.txt.nlp	23349483	SENT105	17	17	17	17	pp2	PP2		4888	0.266
NULL	Breast_Cancer_Res_2006_Jul_19_8(4)_R42.nxml.txt.nlp	16859511	SENT423	27	27	27	27	pp2	PP2		4888	0.266
NULL	J_Interv_Cardiol_2014_Feb_13_27(1)_1-11.nxml.txt.nlp	24329756	SENT80	5	5	8	8	thrombin	ACT	PA451674	12;11332;9457;641455	0.266
NULL	Biomed_Res_Int_2013_Feb_24_2013_794643.nxml.txt.nlp	23555097	SENT258	27	27	1	1	metronidazole	Gen	PA450484	348654	0.266
NULL	AIDS_Res_Ther_2009_Apr_9_6_3.nxml.txt.nlp	19358725	SENT115	2	2	10	10	abacavir	ATV	PA448004	4683	0.266
NULL	Korean_J_Anesthesiol_2013_Jan_21_64(1)_54-60.nxml.txt.nlp	23372887	SENT168	31	31	29	29	hydrocortisone	CRT	PA449905	811	0.266
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2009_Jun_1_65(Pt_6)_513-522.nxml.txt.nlp	19465765	SENT13	23	23	26	26	chloramphenicol	CLS	PA448927	1210	0.265
NULL	Mol_Vis_2011_Apr_19_17_965-970.nxml.txt.nlp	21541270	SENT79	12	12	5	5	thyroglobulin	EGF	PA164754910	1950	0.265
NULL	Arthritis_Res_Ther_2007_Oct_10_9(5)_R105.nxml.txt.nlp	17927818	SENT143	20	20	20	20	pp2	PP2		4888	0.265
NULL	Neural_Develop_2007_Dec_3_2_26.nxml.txt.nlp	18053187	SENT407	4	4	8	8	tamoxifen	E12	PA451581	64100	0.265
NULL	Acta_Histochem_Cytochem_2013_Dec_28_46(6)_187-197.nxml.txt.nlp	24610966	SENT402	5	5	3	3	pilocarpine	AQP5	PA450962	362	0.265
NULL	Tuberc_Res_Treat_2014_Aug_27_2014_182836.nxml.txt.nlp	25243086	SENT229	14	14	12	12	isoniazid	IPT	PA450112	54802	0.265
NULL	Mar_Drugs_2009_Jul_17_7(3)_331-340.nxml.txt.nlp	19841717	SENT116	6	6	3	3	imatinib	FDG	PA10804	23583	0.265
NULL	J_Cell_Biol_2003_Aug_18_162(4)_661-671.nxml.txt.nlp	12925710	SENT80	14	14	14	14	pp2	PP2		4888	0.265
NULL	Int_J_Hypertens_2013_Jun_17_2013_627938.nxml.txt.nlp	23844279	SENT142	2	2	0	0	amlodipine	A10	PA448388	28870	0.265
NULL	Mol_Cancer_2010_Oct_12_9_269.nxml.txt.nlp	20939893	SENT7	21	21	19	19	isoproterenol	STAT3	PA450121	6774	0.265
NULL	Open_Virol_J_2010_Jun_23_4_157-162.nxml.txt.nlp	20835359	SENT86	25	25	25	25	pp2	PP2		4888	0.264
NULL	J_Cancer_Prev_2014_Mar_19(1)_39-46.nxml.txt.nlp	25337571	SENT97	7	7	5	5	ethanol	p53	PA448073	7157	0.264
NULL	Front_Cell_Neurosci_2014_Jan_24_8_7.nxml.txt.nlp	24478630	SENT14	10	10	15	15	potassium	KCC2	PA451047	57468	0.264
NULL	Br_J_Cancer_2009_Oct_6_101(7)_1100-1106.nxml.txt.nlp	19738610	SENT54	17	17	20	20	hyaluronan	LYVE-1	PA165958431	10894	0.264
NULL	Int_J_Hypertens_2011_May_25_2011_417594.nxml.txt.nlp	21747977	SENT190	16	16	24	24	carvedilol	BEST	PA448817	7439	0.264
NULL	Amyloid_2014_Sep_11_21(3)_175-184.nxml.txt.nlp	24918964	SENT199	9	9	13	13	anakinra	TTR	PA10799	7276	0.264
NULL	Acta_Otorhinolaryngol_Ital_2013_Dec_33(6)_398-404.nxml.txt.nlp	24376296	SENT70	11	11	15	15	ethanol	CO2	PA448073	4513	0.264
NULL	Cell_Host_Microbe_2014_Sep_10_16(3)_291-303.nxml.txt.nlp	25211072	SENT568	29	29	29	29	pp2	PP2		4888	0.264
NULL	Cases_J_2009_Jul_9_2_7466.nxml.txt.nlp	19829971	SENT18	10	10	14	14	dobutamine	DST	PA449381	667	0.264
NULL	Oncogene_2010_May_27_29(21)_3054-3066.nxml.txt.nlp	20228839	SENT35	11	11	11	11	pp2	PP2		4888	0.264
NULL	Br_J_Ophthalmol_2012_Jul_26_96(7)_1023-1028.nxml.txt.nlp	22539748	SENT164	18	18	21	21	ranibizumab	RPE	PA164746012	6120	0.264
NULL	Mol_Cancer_2008_Sep_12_7_69.nxml.txt.nlp	18789131	SENT130	19	19	19	19	pp2	PP2		4888	0.264
NULL	Diabetes_2013_Jun_17_62(6)_1990-1995.nxml.txt.nlp	23378611	SENT43	41	41	14	14	rosiglitazone	F12	PA451283	2161	0.264
NULL	Front_Cell_Neurosci_2014_Jul_18_8_185.nxml.txt.nlp	25100946	SENT132	33	33	33	33	pp2	PP2		4888	0.264
NULL	Crit_Care_2008_Mar_13_12(Suppl_2)_P272.nxml.txt.nlp	NULL	SENT3	21	21	15	15	etomidate	RAI	PA164743987	10848;6050	0.264
NULL	Trials_2014_Oct_21_15(1)_400.nxml.txt.nlp	NULL	SENT98	23	23	28	28	morphine	PCA	PA450550	28982	0.264
NULL	Psychiatry_Investig_2012_Jun_22_9(2)_166-173.nxml.txt.nlp	22707968	SENT61	20	20	15	15	memantine	ANOVA	PA10364	4858	0.264
NULL	Curr_Cardiol_Rev_2014_May_10(2)_161-171.nxml.txt.nlp	24527681	SENT244	22	22	29	29	losartan	CYP2D6	PA450268	1565	0.263
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Nov_4_65(Pt_12)_o2995.nxml.txt.nlp	21578735	SENT67	32	32	21	21	ethanol	NO3	PA448073	4681	0.263
NULL	Br_J_Cancer_2004_May_17_90(10)_2032-2041.nxml.txt.nlp	15138490	SENT244	10	10	26	26	trastuzumab	HER-2	PA451743	2064	0.263
NULL	Acta_Pharmacol_Sin_2010_Apr_8_31(4)_461-469.nxml.txt.nlp	20208553	SENT215	11	11	16	16	ethanol	adiponectin	PA448073	9370	0.263
NULL	Biologics_2013_Apr_15_7_77-90.nxml.txt.nlp	23723688	SENT116	34	34	32	32	cetuximab	CRT	PA10040	811	0.263
NULL	Indian_J_Med_Res_2014_Jul_140(1)_109-115.nxml.txt.nlp	25222785	SENT123	1	1	6	6	celecoxib	DMC	PA448871	284340;54808	0.263
NULL	J_Cancer_2014_Apr_24_5(5)_390-397.nxml.txt.nlp	24799957	SENT46	10	10	18	18	palonosetron	CHOP	PA10352	1649	0.263
NULL	Breast_Cancer_Res_2006_Jul_19_8(4)_R42.nxml.txt.nlp	16859511	SENT107	44	44	44	44	pp2	PP2		4888	0.263
NULL	Biomed_Res_Int_2013_Nov_6_2013_798164.nxml.txt.nlp	24308005	SENT78	20	20	39	39	paraformaldehyde	IL-21	PA450790	59067;50616;27189	0.263
NULL	Exp_Diabetes_Res_2012_Dec_26_2012_230624.nxml.txt.nlp	23365557	SENT255	36	36	5	5	liraglutide	Met	PA165958364	79811	0.262
NULL	Evid_Based_Complement_Alternat_Med_2014_Dec_24_2014_975450.nxml.txt.nlp	25610488	SENT59	2	2	5	5	phenol	TPC	PA450913	8030;60386	0.262
NULL	Amino_Acids_2014_Feb_20_46(5)_1275-1283.nxml.txt.nlp	24553827	SENT4	30	30	23	23	taurine	CDO	PA451590	50937	0.262
NULL	Clin_Med_Insights_Oncol_2012_May_16_6_205-217.nxml.txt.nlp	22654526	SENT248	16	16	17	17	tigecycline	EGFR	PA164746412	1956	0.262
NULL	Int_J_Hypertens_2013_Jun_17_2013_627938.nxml.txt.nlp	23844279	SENT162	35	35	0	0	telmisartan	A10	PA451605	28870	0.262
NULL	Sensors_(Basel)_2013_Dec_3_13(12)_16591-16610.nxml.txt.nlp	24300599	SENT498	20	20	25	25	fluorescein	PLIF	PA164746009	2495	0.262
NULL	Int_J_Endocrinol_Metab_2013_Jul_1_Summer_11(3)_184-190.nxml.txt.nlp	24348591	SENT140	0	0	4	4	liraglutide	INS-1	PA165958364	2305	0.262
NULL	J_Young_Pharm_2012_Jan-Mar_4(1)_3-12.nxml.txt.nlp	22523453	SENT47	7	7	4	4	cephalexin	API	PA448883	5345	0.262
NULL	J_Cell_Biol_2005_Nov_7_171(3)_505-516.nxml.txt.nlp	16275754	SENT143	33	33	33	33	pp2	PP2		4888	0.262
NULL	Cardiovasc_Diabetol_2010_Sep_23_9_57.nxml.txt.nlp	20863381	SENT159	8	8	5	5	rosiglitazone	DM2	PA451283	28508	0.262
NULL	Korean_J_Anesthesiol_2013_Jan_21_64(1)_47-53.nxml.txt.nlp	23372886	SENT122	12	12	10	10	bupivacaine	PTG	PA135057240	5507	0.262
NULL	Int_J_Environ_Res_Public_Health_2012_Oct_17_9(10)_3724-3739.nxml.txt.nlp	23202770	SENT162	3	3	6	6	oxygen	BOD	PA450744	10018	0.262
NULL	ARYA_Atheroscler_2012_Winter_7(4)_133-137.nxml.txt.nlp	23205044	SENT112	2	2	5	5	pentoxifylline	fractalkine	PA450864	6376	0.262
NULL	Arthritis_Res_Ther_2014_Apr_30_16(2)_R90.nxml.txt.nlp	25167216	SENT402	12	12	7	7	adalimumab	STEPP	PA10004	222659	0.262
NULL	Brain_Sci_2012_Dec_21_3(1)_1-38.nxml.txt.nlp	24961305	SENT1049	7	7	9	9	allopregnanolone	spatial	PA142320763	219793	0.261
NULL	Chemother_Res_Pract_2014_Dec_11_2014_936526.nxml.txt.nlp	25574394	SENT442	6	6	0	0	melphalan	CTRL	PA450354	1506	0.261
NULL	J_Cardiothorac_Surg_2014_Feb_17_9_35.nxml.txt.nlp	24533613	SENT172	10	10	13	13	heparin	ACT	PA449855	12;11332;9457;641455	0.261
NULL	J_Cell_Biol_2005_Nov_7_171(3)_505-516.nxml.txt.nlp	16275754	SENT212	6	6	6	6	pp2	PP2		4888	0.261
NULL	Mol_Cancer_2012_Jun_26_11_43.nxml.txt.nlp	22731636	SENT86	28	28	28	28	pp2	PP2		4888	0.261
NULL	Curr_Genomics_2013_Nov_14(7)_453-467.nxml.txt.nlp	24396277	SENT168	26	26	8	8	iron	PCSK2	PA450087	5126	0.261
NULL	J_Vet_Med_Sci_2014_Jul_18_76(7)_937-945.nxml.txt.nlp	24646457	SENT91	6	6	40	40	amoxicillin	OTC	PA448406	5009	0.261
NULL	Oncol_Lett_2013_Apr_5_5(4)_1123-1128.nxml.txt.nlp	23599750	SENT81	10	10	9	9	docetaxel	LDM	PA449383	1595	0.261
NULL	Arthritis_Res_Ther_2007_Oct_10_9(5)_R105.nxml.txt.nlp	17927818	SENT127	20	20	20	20	pp2	PP2		4888	0.261
NULL	Case_Rep_Med_2012_Aug_8_2012_980920.nxml.txt.nlp	22924050	SENT58	8	8	6	6	diethylstilbestrol	DES	PA449307	1674	0.261
NULL	Cell_Tissue_Res_2012_Jul_14_349(1)_375-395.nxml.txt.nlp	22411698	SENT297	2	2	14	14	dextran	cst	PA449261	54897	0.261
NULL	Br_J_Cancer_2009_Jul_21_101(2)_327-334.nxml.txt.nlp	19568240	SENT117	21	21	21	21	pp2	PP2		4888	0.261
NULL	J_Pregnancy_2012_Nov_1_2012_379271.nxml.txt.nlp	22132339	SENT215	0	0	4	4	isoniazid	IPT	PA450112	54802	0.26
NULL	Arthritis_Res_Ther_2010_Mar_24_12(2)_R52.nxml.txt.nlp	20334640	SENT272	13	13	0	0	fluorescein	ANOVA	PA164746009	4858	0.26
NULL	J_Korean_Med_Sci_2013_Dec_26_28(12)_1774-1780.nxml.txt.nlp	24339708	SENT200	14	14	18	18	octreotide	OST	PA450678	1650;23263	0.26
NULL	ScientificWorldJournal_2013_Jun_5_2013_704912.nxml.txt.nlp	23844410	SENT251	2	2	0	0	boceprevir	BOC	PA165948902	91653	0.26
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT134	12	12	12	12	pp2	PP2		4888	0.26
NULL	Clin_Infect_Dis_2013_Mar_1_56(5)_e48-e58.nxml.txt.nlp	23175556	SENT30	5	5	8	8	artemisinin	ACT	PA165111696	12;11332;9457;641455	0.26
NULL	Front_Genet_2014_Nov_14_5_391.nxml.txt.nlp	25452763	SENT908	9	9	5	5	cisplatin	ATP7B	PA449014	540	0.26
NULL	Breast_Cancer_Res_2011_Nov_24_13(6)_R120.nxml.txt.nlp	22115051	SENT129	27	27	32	32	tamoxifen	HER-2	PA451581	2064	0.26
NULL	Int_J_Mol_Sci_2012_Sep_6_13(9)_11102-11129.nxml.txt.nlp	23109841	SENT348	0	0	12	12	dexmedetomidine	AKT	PA449256	207	0.26
NULL	Int_J_Mol_Sci_2010_Sep_13_11(9)_3195-3208.nxml.txt.nlp	20957088	SENT53	6	6	5	5	lipase	AT2	PA450239	186	0.259
NULL	Mol_Cancer_2014_Jun_3_13_139.nxml.txt.nlp	24894297	SENT134	10	10	8	8	cisplatin	HES1	PA449014	3280;8209	0.259
NULL	Clin_Interv_Aging_2012_Jul_12_7_235-247.nxml.txt.nlp	22866001	SENT17	37	37	33	33	teriparatide	PTH	PA451620	5741	0.259
NULL	Indian_J_Pharm_Sci_2013_Sep-Oct_75(5)_540-544.nxml.txt.nlp	24403654	SENT50	17	17	15	15	ciprofloxacin	LBA	PA449009	987	0.259
NULL	Open_Virol_J_2010_Jun_23_4_157-162.nxml.txt.nlp	20835359	SENT84	16	16	16	16	pp2	PP2		4888	0.259
NULL	Mol_Biol_Rep_2013_Sep_28_40(10)_5573-5585.nxml.txt.nlp	24078156	SENT319	7	7	5	5	iron	HFE2	PA450087	148738	0.259
NULL	J_Physiol_2014_Nov_15_592(22)_5093-5107.nxml.txt.nlp	25239460	SENT210	8	8	7	7	sc-560	PAG		55824	0.259
NULL	Tuberc_Respir_Dis_(Seoul)_2012_Aug_31_73(2)_115-121.nxml.txt.nlp	23166544	SENT126	2	2	0	0	cyclophosphamide	CHOP	PA449165	1649	0.259
NULL	Protein_Cell_2014_Jul_10_5(7)_532-543.nxml.txt.nlp	24715268	SENT123	21	21	21	21	pp2	PP2		4888	0.259
NULL	Neuroscience_2008_Sep_22_156(1)_175-183.nxml.txt.nlp	18694808	SENT390	8	8	8	8	pp2	PP2		4888	0.259
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Mar_13_69(Pt_4)_o530.nxml.txt.nlp	23634071	SENT5	31	31	33	33	ethanol	mol	PA448073	90527	0.259
NULL	Int_J_Endocrinol_Metab_2013_Jul_1_Summer_11(3)_184-190.nxml.txt.nlp	24348591	SENT105	0	0	5	5	liraglutide	INS-1	PA165958364	2305	0.259
NULL	Protein_Cell_2014_Jul_10_5(7)_532-543.nxml.txt.nlp	24715268	SENT120	24	24	24	24	pp2	PP2		4888	0.259
NULL	Mol_Neurobiol_2007_Oct_10_36(2)_137-151.nxml.txt.nlp	17952658	SENT388	15	15	33	33	vasopressin	CXCL12	PA451858	6387	0.258
NULL	Chonnam_Med_J_2014_Dec_17_50(3)_102-111.nxml.txt.nlp	25568846	SENT126	12	12	10	10	imatinib	ABCG2	PA10804	9429	0.258
NULL	Crit_Care_2011_Jun_24_15(3)_R153.nxml.txt.nlp	21702944	SENT198	3	3	8	8	dexmedetomidine	TLR-4	PA449256	7099	0.258
NULL	Cancers_(Basel)_2012_Sep_6_4(3)_873-903.nxml.txt.nlp	24213471	SENT635	1	1	4	4	hyaluronidase	HYAL3	PA164745713	8372	0.258
NULL	Front_Neuroengineering_2011_Apr_28_4_6.nxml.txt.nlp	21577249	SENT94	23	23	20	20	diphenhydramine	S24	PA449349	6229	0.258
NULL	Cost_Eff_Resour_Alloc_2008_Jan_23_6_2.nxml.txt.nlp	18215255	SENT31	0	0	4	4	isoniazid	IPT	PA450112	54802	0.258
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT244	5	5	5	5	pp2	PP2		4888	0.258
NULL	J_Cancer_2014_Apr_24_5(5)_390-397.nxml.txt.nlp	24799957	SENT47	30	30	28	28	granisetron	CHOP	PA449809	1649	0.258
NULL	J_Vet_Med_Sci_2014_Jul_18_76(7)_937-945.nxml.txt.nlp	24646457	SENT91	42	42	40	40	oxytetracycline	OTC	PA450757	5009	0.258
NULL	Int_J_Mol_Sci_2010_Nov_24_11(12)_4796-4813.nxml.txt.nlp	21614174	SENT348	6	6	3	3	epirubicin	GAS1	PA449476	2619	0.258
NULL	Oncotarget_2013_Apr_8_4(4)_584-599.nxml.txt.nlp	23603840	SENT122	33	33	31	31	doxycycline	AMPK	PA449415	5563	0.258
NULL	Diabetol_Metab_Syndr_2014_May_20_6_57.nxml.txt.nlp	24920962	SENT220	38	38	41	41	telmisartan	STZ	PA451605	6484	0.258
NULL	J_Biol_Chem_2008_Dec_19_283(51)_35419-35427.nxml.txt.nlp	18955485	SENT213	25	25	25	25	pp2	PP2		4888	0.258
NULL	J_Geriatr_Cardiol_2014_Mar_11(1)_63-73.nxml.txt.nlp	24748884	SENT210	17	17	19	19	levodopa	PKD	PA450213	5587	0.258
NULL	Br_J_Cancer_2010_Jun_29_103(1)_61-72.nxml.txt.nlp	20588279	SENT191	3	3	5	5	trastuzumab	RhoB	PA451743	388	0.258
NULL	Eur_Respir_J_2013_May_27_41(5)_1107-1115.nxml.txt.nlp	23018904	SENT6	21	21	22	22	ciprofloxacin	DPI	PA449009	1832	0.258
NULL	Biosensors_(Basel)_2013_Nov_13_3(4)_374-384.nxml.txt.nlp	25586413	SENT189	20	20	24	24	capsaicin	SPR	PA448776	6697;6869	0.257
NULL	Curr_Neuropharmacol_2012_Mar_10(1)_2-11.nxml.txt.nlp	22942875	SENT214	8	8	25	25	ketamine	FDG	PA450144	23583	0.257
NULL	Mol_Cancer_2010_Dec_20_9_317.nxml.txt.nlp	21172025	SENT102	14	14	18	18	tamoxifen	HER2	PA451581	2064	0.257
NULL	J_Antimicrob_Chemother_2009_Nov_18_64(5)_910-928.nxml.txt.nlp	19767318	SENT122	16	16	9	9	efavirenz	CD4	PA449441	920	0.257
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Jul_11_70(Pt_8)_m298-m299.nxml.txt.nlp	25249881	SENT75	20	20	25	25	ethanol	NO3	PA448073	4681	0.257
NULL	Alcohol_Res_Health_2007_30(1)_38-47.nxml.txt.nlp	17718399	SENT14	41	41	38	38	oxygen	CYP2E1	PA450744	1571	0.257
NULL	Case_Rep_Oncol_Med_2013_Nov_25_2013_416713.nxml.txt.nlp	24371534	SENT36	18	18	29	29	lipase	CEA	PA450239	5670;1087	0.257
NULL	Nat_Commun_2012_Dec_27_3_1316.nxml.txt.nlp	23271650	SENT518	26	26	15	15	tamoxifen	E12	PA451581	64100	0.257
NULL	ASN_Neuro_2009_Apr_14_1(1)_e00005.nxml.txt.nlp	19570022	SENT35	37	37	37	37	pp2	PP2		4888	0.257
NULL	ScientificWorldJournal_2013_Jun_19_2013_174392.nxml.txt.nlp	23853530	SENT3	12	12	10	10	doxazosin	c-FLIP	PA449407	8837	0.257
NULL	Mol_Cancer_2012_Jun_26_11_43.nxml.txt.nlp	22731636	SENT122	9	9	9	9	pp2	PP2		4888	0.257
NULL	J_Cell_Biol_2007_Apr_23_177(2)_317-328.nxml.txt.nlp	17452533	SENT239	5	5	5	5	pp2	PP2		4888	0.257
NULL	EMBO_Mol_Med_2009_Sep_1(6-7)_323-337.nxml.txt.nlp	20049736	SENT154	2	2	5	5	methotrexate	MSH2	PA450428	4436	0.257
NULL	Biomed_Res_Int_2013_Jul_8_2013_507103.nxml.txt.nlp	23936812	SENT159	10	10	30	30	curcumin	CO2	PA151958596	4513	0.256
NULL	JAKSTAT_2013_Jul_1_2(3)_e24812.nxml.txt.nlp	24069562	SENT38	16	16	16	16	pp2	PP2		4888	0.256
NULL	Int_J_Mol_Sci_2012_Aug_29_13(9)_10771-10806.nxml.txt.nlp	23109822	SENT250	19	19	10	10	nadh	SIRT1	PA164755085	23411	0.256
NULL	J_Vet_Med_Sci_2014_Jul_18_76(7)_937-945.nxml.txt.nlp	24646457	SENT103	30	30	41	41	gentamicin	OTC	PA449753	5009	0.256
NULL	Oncoscience_2014_Mar_12_1(2)_158-166.nxml.txt.nlp	25594008	SENT64	14	14	12	12	dasatinib	PTRF	PA162372878	284119	0.256
NULL	Cancer_Biol_Med_2012_Mar_9(1)_1-8.nxml.txt.nlp	23691447	SENT241	13	13	11	11	cisplatin	p53	PA449014	7157	0.256
NULL	Toxins_(Basel)_2010_Oct_26_2(11)_2490-2518.nxml.txt.nlp	22069563	SENT1778	3	3	1	1	cisplatin	TLR9	PA449014	54106	0.256
NULL	Int_J_Anal_Chem_2013_Jul_16_2013_419716.nxml.txt.nlp	23956748	SENT72	34	34	26	26	ethanol	PF6	PA448073	200162	0.256
NULL	Iran_J_Microbiol_2013_Sep_5(3)_227-232.nxml.txt.nlp	24475328	SENT87	36	36	30	30	clindamycin	Gen	PA449035	348654	0.256
NULL	Biomed_Res_Int_2013_Feb_24_2013_794643.nxml.txt.nlp	23555097	SENT258	7	7	1	1	chloramphenicol	Gen	PA448927	348654	0.256
NULL	Cancers_(Basel)_2010_Dec_30_3(1)_106-125.nxml.txt.nlp	24212609	SENT396	21	21	19	19	gemcitabine	ABCC5	PA449748	10057	0.256
NULL	Front_Endocrinol_(Lausanne)_2013_Mar_12_4_26.nxml.txt.nlp	23486926	SENT1581	0	0	6	6	vasopressin	ACTH	PA451858	5443	0.256
NULL	Mol_Vis_2011_Apr_6_17_864-875.nxml.txt.nlp	21527996	SENT6	25	25	40	40	dextran	ERG	PA449261	2078	0.255
NULL	Sensors_(Basel)_2012_Dec_27_13(1)_334-366.nxml.txt.nlp	23271600	SENT1274	16	16	19	19	lipase	LIP	PA450239	23049	0.255
NULL	Oper_Res_Health_Care_2012_Jun_1(2-3)_45-53.nxml.txt.nlp	24501697	SENT228	16	16	20	20	isoniazid	IPT	PA450112	54802	0.255
NULL	Clin_Mol_Hepatol_2014_Sep_25_20(3)_283-290.nxml.txt.nlp	25320732	SENT97	24	24	22	22	propranolol	EVL	PA451145	51466	0.255
NULL	Cell_Commun_Signal_2012_Mar_3_10_5.nxml.txt.nlp	22385615	SENT137	17	17	17	17	pp2	PP2		4888	0.255
NULL	Respir_Med_Case_Rep_2013_Aug_8_10_27-30.nxml.txt.nlp	NULL	SENT84	11	11	13	13	everolimus	DLST	PA164746311	1743	0.255
NULL	Br_J_Cancer_2011_May_10_104(10)_1628-1640.nxml.txt.nlp	21505453	SENT138	3	3	3	3	pp2	PP2		4888	0.255
NULL	Mol_Cancer_2010_Dec_20_9_317.nxml.txt.nlp	21172025	SENT99	18	18	22	22	tamoxifen	HER2	PA451581	2064	0.255
NULL	J_Ophthalmol_2011_Dec_23_2011_292040.nxml.txt.nlp	21253505	SENT125	4	4	6	6	diltiazem	rd1	PA449334	5158	0.255
NULL	Cogn_Neuropsychiatry_2011_Jul_6_16(4)_364-381.nxml.txt.nlp	21302161	SENT468	7	7	24	24	ketamine	FDG	PA450144	23583	0.255
NULL	Facts_Views_Vis_Obgyn_2013_5(1)_72-81.nxml.txt.nlp	24753931	SENT49	34	34	39	39	guanidine	GEF	PA164781028	56731	0.255
NULL	J_Vet_Med_Sci_2014_Jul_18_76(7)_937-945.nxml.txt.nlp	24646457	SENT103	18	18	41	41	cefpodoxime	OTC	PA164746385	5009	0.255
NULL	Cancers_(Basel)_2014_Apr_16_6(2)_879-896.nxml.txt.nlp	24743776	SENT53	14	14	18	18	paraformaldehyde	PLP	PA450790	25824;5744	0.255
NULL	Open_Microbiol_J_2009_Aug_13_3_128-135.nxml.txt.nlp	19707523	SENT12	22	22	7	7	betaine	HSL	PA448603	3991	0.255
NULL	Breast_Cancer_Res_2012_Jul_20_14(4)_R111.nxml.txt.nlp	22817771	SENT105	7	7	33	33	phenol	PRL	PA450913	5617	0.255
NULL	Arthritis_Res_Ther_2007_Oct_10_9(5)_R105.nxml.txt.nlp	17927818	SENT163	21	21	21	21	pp2	PP2		4888	0.255
NULL	Allergy_Asthma_Clin_Immunol_2013_Aug_12_9(1)_29.nxml.txt.nlp	23937903	SENT81	12	12	0	0	icatibant	C1-INH	PA164749185	710	0.255
NULL	Cancer_Metab_2013_Feb_4_1_7.nxml.txt.nlp	24280108	SENT10	13	13	5	5	oxygen	ROS	PA450744	6098	0.255
NULL	Ann_Rheum_Dis_2014_Jan_13_73(1)_233-237.nxml.txt.nlp	23942869	SENT141	8	8	15	15	infliximab	IMPACT	PA452639	55364	0.254
NULL	J_Cell_Biol_2002_Mar_18_156(6)_969-981.nxml.txt.nlp	11901165	SENT62	17	17	15	15	colchicine	Nop52	PA449092	8568	0.254
NULL	JSLS_2012_Apr-Jun_16(2)_202-207.nxml.txt.nlp	23477166	SENT37	17	17	21	21	morphine	MED	PA450550	1298;1299;1311	0.254
NULL	Ann_Oncol_2009_Aug_17_20(8)_1319-1329.nxml.txt.nlp	19535820	SENT330	15	15	18	18	trastuzumab	San	PA451743	80218	0.254
NULL	Oncol_Lett_2013_Feb_22_5(2)_641-644.nxml.txt.nlp	23419988	SENT120	2	2	3	3	paclitaxel	CT2	PA450761	85413	0.254
NULL	Acta_Neuropathol_2013_Mar_27_125(3)_395-412.nxml.txt.nlp	23269317	SENT61	9	9	10	10	collagenase	VIII	PA449107	1351	0.254
NULL	Cost_Eff_Resour_Alloc_2008_Jan_23_6_2.nxml.txt.nlp	18215255	SENT174	11	11	9	9	isoniazid	IPT	PA450112	54802	0.254
NULL	Adv_Hematol_2011_Apr_10_2011_960137.nxml.txt.nlp	21547266	SENT53	4	4	6	6	rituximab	NHL	PA451261	51750	0.254
NULL	Toxins_(Basel)_2010_Oct_26_2(11)_2490-2518.nxml.txt.nlp	22069563	SENT1069	7	7	5	5	cisplatin	p53	PA449014	7157	0.254
NULL	Environ_Health_Perspect_2012_Mar_15_120(3)_379-384.nxml.txt.nlp	22169271	SENT86	28	28	32	32	pancrelipase	OTC	PA448428	5009	0.254
NULL	Cancer_Biol_Med_2012_Mar_9(1)_1-8.nxml.txt.nlp	23691447	SENT241	13	13	22	22	cisplatin	p53	PA449014	7157	0.254
NULL	Mol_Cancer_2010_Dec_20_9_317.nxml.txt.nlp	21172025	SENT154	18	18	22	22	tamoxifen	HER2	PA451581	2064	0.254
NULL	Chemother_Res_Pract_2012_Aug_12_2012_549170.nxml.txt.nlp	22924129	SENT145	6	6	35	35	cisplatin	CRT	PA449014	811	0.254
NULL	Curr_Neuropharmacol_2014_Jul_12(4)_365-379.nxml.txt.nlp	25342944	SENT447	39	39	20	20	paroxetine	5-HT2B	PA450801	3357	0.254
NULL	Int_J_Environ_Res_Public_Health_2005_May_30_2(1)_138-146.nxml.txt.nlp	16708425	SENT281	7	7	5	5	lidocaine	CYP3A4	PA450226	1576	0.254
NULL	Carcinogenesis_2010_Dec_27_31(12)_2049-2057.nxml.txt.nlp	20876285	SENT153	15	15	24	24	tamoxifen	HER2	PA451581	2064	0.254
NULL	J_Int_Soc_Sports_Nutr_2014_Aug_13_11_38.nxml.txt.nlp	25132809	SENT170	11	11	14	14	creatine	MSTN	PA164778930	2660	0.253
NULL	J_Cell_Biol_2008_Jul_14_182(1)_157-169.nxml.txt.nlp	18606851	SENT161	17	17	17	17	pp2	PP2		4888	0.253
NULL	Front_Behav_Neurosci_2012_Nov_22_6_78.nxml.txt.nlp	23189046	SENT84	12	12	10	10	ethanol	OX2R	PA448073	3062;131450	0.253
NULL	Curr_Chem_Genomics_2010_Mar_1_4_1-8.nxml.txt.nlp	20448812	SENT142	2	2	25	25	fluorescein	OATP1B1	PA164746009	10599	0.253
NULL	Br_J_Cancer_1995_Apr_71(4)_670-675.nxml.txt.nlp	7710927	SENT11	16	16	23	23	daunorubicin	P-gp	PA449212	5243	0.253
NULL	ScientificWorldJournal_2013_Aug_21_2013_186505.nxml.txt.nlp	24027439	SENT49	2	2	5	5	ethanol	CEE	PA448073	51608	0.253
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Mar_13_66(Pt_4)_o814.nxml.txt.nlp	21580646	SENT61	38	38	26	26	ethanol	NO3	PA448073	4681	0.253
NULL	Drugs_2014_Feb_25_74(4)_423-441.nxml.txt.nlp	24566842	SENT456	1	1	8	8	infliximab	IMPACT	PA452639	55364	0.253
NULL	Ann_Gen_Psychiatry_2010_Sep_17_9_35.nxml.txt.nlp	20849577	SENT212	3	3	6	6	aripiprazole	STAR	PA10026	6770;2984	0.253
NULL	Cell_Death_Dis_2010_Sep_23_1(9)_e78.nxml.txt.nlp	21364680	SENT8	4	4	1	1	cisplatin	P31	PA449014	529	0.253
NULL	Infect_Drug_Resist_2009_Apr_24_2_13-26.nxml.txt.nlp	21694884	SENT287	2	2	6	6	tenofovir	TDF	PA10204	6736	0.253
NULL	Mol_Cancer_2010_Dec_20_9_317.nxml.txt.nlp	21172025	SENT40	1	1	16	16	tamoxifen	HER2	PA451581	2064	0.253
NULL	Stroke_Res_Treat_2011_Nov_10_2011_212485.nxml.txt.nlp	22135769	SENT118	28	28	17	17	warfarin	CALU	PA451906	813	0.252
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT133	17	17	17	17	pp2	PP2		4888	0.252
NULL	Cardiovasc_Res_2012_Dec_1_96(3)_466-475.nxml.txt.nlp	22915766	SENT17	2	2	5	5	creatine	HL-1	PA164778930	55600	0.252
NULL	Exp_Ther_Med_2013_Mar_21_5(3)_987-991.nxml.txt.nlp	23407636	SENT54	5	5	7	7	losartan	IL-8	PA450268	3576	0.252
NULL	Front_Genet_2014_Aug_4_5_265.nxml.txt.nlp	25136353	SENT391	10	10	8	8	taurine	GLAST	PA451590	6507	0.252
NULL	Arthritis_Res_Ther_2007_Oct_10_9(5)_R105.nxml.txt.nlp	17927818	SENT181	23	23	23	23	pp2	PP2		4888	0.252
NULL	Case_Rep_Oncol_Med_2013_Jan_16_2013_292301.nxml.txt.nlp	23401819	SENT131	14	14	2	2	rituximab	CHOP	PA451261	1649	0.252
NULL	Open_Biochem_J_2013_Feb_22_7_19-23.nxml.txt.nlp	23526382	SENT21	0	0	15	15	repaglinide	DM2	PA451234	28508	0.252
NULL	Breast_Cancer_Res_2012_Jan_19_14(1)_202.nxml.txt.nlp	22264257	SENT87	17	17	10	10	letrozole	VIM	PA450196	7431	0.251
NULL	Arthritis_Res_Ther_2006_Jul_26_8(4)_R132.nxml.txt.nlp	16872482	SENT215	9	9	9	9	pp2	PP2		4888	0.251
NULL	Tuberc_Respir_Dis_(Seoul)_2013_Nov_29_75(5)_188-198.nxml.txt.nlp	24348666	SENT135	10	10	8	8	gefitinib	IGF1R	PA131301952	3480	0.251
NULL	Front_Endocrinol_(Lausanne)_2013_Mar_20_4_31.nxml.txt.nlp	23519101	SENT900	0	0	10	10	rosiglitazone	PC-3	PA451283	692094	0.251
NULL	Int_J_Mol_Sci_2014_Oct_14_15(10)_18557-18573.nxml.txt.nlp	25318057	SENT981	1	1	3	3	bortezomib	TRAIL	PA10252	8743	0.251
NULL	Int_J_Endocrinol_Metab_2013_Jul_1_Summer_11(3)_184-190.nxml.txt.nlp	24348591	SENT94	0	0	4	4	liraglutide	INS-1	PA165958364	2305	0.251
NULL	Br_J_Cancer_2001_Aug_85(4)_600-607.nxml.txt.nlp	11506502	SENT2	17	17	21	21	hyaluronan	HAS2	PA165958431	3037	0.251
NULL	Cancers_(Basel)_2011_Aug_19_3(3)_3370-3393.nxml.txt.nlp	24212958	SENT47	9	9	12	12	maytansine	DM1	PA165291473	338023;1760;28509	0.251
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Nov_15_5_27.nxml.txt.nlp	17107610	SENT39	10	10	8	8	ethambutol	EMB	PA164784021	133418	0.251
NULL	Biologics_2013_Apr_15_7_77-90.nxml.txt.nlp	23723688	SENT116	18	18	16	16	cetuximab	CRT	PA10040	811	0.251
NULL	Biochem_Res_Int_2011_Apr_18_2011_459839.nxml.txt.nlp	21547085	SENT131	19	19	34	34	ethanol	EMP	PA448073	10296	0.251
NULL	J_Mol_Signal_2012_Sep_8_7_15.nxml.txt.nlp	22958338	SENT103	2	2	2	2	pp2	PP2		4888	0.251
NULL	J_Asthma_Allergy_2011_Mar_25_4_19-25.nxml.txt.nlp	21660177	SENT191	4	4	16	16	glutaraldehyde	MPL	PA449777	4352	0.251
NULL	J_Neurochem_2013_Oct_22_127(2)_199-208.nxml.txt.nlp	23895321	SENT78	22	22	6	6	gentamicin	F12	PA449753	2161	0.251
NULL	J_Biomed_Biotechnol_2010_Jun_30_2010_485468.nxml.txt.nlp	20671927	SENT7	3	3	6	6	hyaluronan	HAS3	PA165958431	3038	0.251
NULL	Mol_Cancer_2012_Dec_12_11_91.nxml.txt.nlp	23234355	SENT61	11	11	9	9	erlotinib	HER2	PA134687924	2064	0.251
NULL	Ann_Gen_Psychiatry_2012_Jul_2_11_18.nxml.txt.nlp	22747533	SENT0	15	15	3	3	paliperidone	Gen	PA163518919	348654	0.251
NULL	J_Vet_Med_Sci_2014_Jul_18_76(7)_937-945.nxml.txt.nlp	24646457	SENT103	39	39	41	41	cephalexin	OTC	PA448883	5009	0.251
NULL	Curr_Control_Trials_Cardiovasc_Med_2001_Jun_26_2(4)_151-155.nxml.txt.nlp	11806788	SENT32	16	16	12	12	trandolapril	AIRE	PA451737	326	0.251
NULL	Croat_Med_J_2012_Aug_53(4)_314-320.nxml.txt.nlp	22911523	SENT186	5	5	8	8	debrisoquine	CYP2D	PA452616	1565	0.25
NULL	Drug_Healthc_Patient_Saf_2014_Oct_20_6_145-149.nxml.txt.nlp	25364275	SENT20	0	0	4	4	isoniazid	IPT	PA450112	54802	0.25
NULL	Front_Synaptic_Neurosci_2013_Sep_18_5_6.nxml.txt.nlp	24065916	SENT104	7	7	3	3	amphetamine	DCC	PA448408	1630	0.25
NULL	Br_J_Cancer_2011_Jun_7_104(12)_1805-1809.nxml.txt.nlp	21587260	SENT123	37	37	30	30	plerixafor	CXCR4	PA165958410	7852	0.25
NULL	Clin_Ophthalmol_2010_May_14_4_437-445.nxml.txt.nlp	20505836	SENT11	27	27	23	23	travoprost	BAK	PA164781371	578	0.25
NULL	Evid_Based_Complement_Alternat_Med_2011_Feb_14_2011_429843.nxml.txt.nlp	21869897	SENT187	15	15	13	13	ethanol	CEA	PA448073	5670;1087	0.25
NULL	Curr_Neuropharmacol_2008_Mar_6(1)_21-38.nxml.txt.nlp	19305786	SENT553	15	15	11	11	capsaicin	VRL-1	PA448776	51393	0.25
NULL	Viruses_2009_Dec_11_1(3)_1209-1239.nxml.txt.nlp	21994591	SENT166	15	15	22	22	darunavir	TMC	PA163522472	3703	0.25
NULL	Behav_Brain_Funct_2012_Jun_20_8_32.nxml.txt.nlp	22716128	SENT262	23	23	7	7	ethanol	spatial	PA448073	219793	0.249
NULL	Nucleic_Acids_Res_2005_Oct_12_33(18)_5728-5739.nxml.txt.nlp	16221974	SENT156	22	22	15	15	galactose	GAL	PA449725	51083	0.249
NULL	Environ_Health_Perspect_2005_Feb_8_113(2)_186-191.nxml.txt.nlp	15687056	SENT113	2	2	6	6	arsenite	ArsB	PA452638	57152	0.249
NULL	Database_(Oxford)_2013_Aug_9_2013_bat059.nxml.txt.nlp	23935056	SENT103	8	8	11	11	ethanol	FBA	PA448073	26273	0.249
NULL	ISRN_Obstet_Gynecol_2011_Aug_25_2011_354861.nxml.txt.nlp	21876817	SENT75	18	18	21	21	hyaluronan	LYVE-1	PA165958431	10894	0.249
NULL	Front_Genet_2013_Aug_29_4_163.nxml.txt.nlp	24009622	SENT13	13	13	5	5	ethanol	DDP	PA448073	1678	0.249
NULL	Drug_Healthc_Patient_Saf_2014_Oct_20_6_145-149.nxml.txt.nlp	25364275	SENT4	0	0	4	4	isoniazid	IPT	PA450112	54802	0.249
NULL	Iran_J_Radiol_2012_Jun_30_9(2)_88-92.nxml.txt.nlp	23329970	SENT75	1	1	9	9	cyclophosphamide	CHOP	PA449165	1649	0.248
NULL	J_Hematol_Oncol_2011_Jan_21_4_5.nxml.txt.nlp	21255411	SENT272	35	35	46	46	erlotinib	CLC	PA134687924	23529;1178	0.248
NULL	Int_J_Cell_Biol_2014_Aug_14_2014_236246.nxml.txt.nlp	25197279	SENT148	3	3	2	2	erlotinib	RANKL	PA134687924	8600	0.248
NULL	Curr_Clin_Pharmacol_2013_May_8(2)_135-155.nxml.txt.nlp	23062036	SENT218	8	8	38	38	tamoxifen	AIB1	PA451581	8202	0.248
NULL	Arthritis_Res_Ther_2007_Oct_10_9(5)_R105.nxml.txt.nlp	17927818	SENT123	23	23	23	23	pp2	PP2		4888	0.248
NULL	Mol_Vis_2012_Jan_17_18_114-120.nxml.txt.nlp	22275802	SENT24	18	18	29	29	nadh	SIRT1	PA164755085	23411	0.248
NULL	J_Cell_Biol_2003_Sep_29_162(7)_1189-1196.nxml.txt.nlp	14517202	SENT150	15	15	15	15	pp2	PP2		4888	0.248
NULL	J_Cell_Mol_Med_2014_Jan_19_18(1)_156-169.nxml.txt.nlp	24251962	SENT157	2	2	0	0	bleomycin	BLM	PA448645	641	0.248
NULL	Clin_Drug_Investig_2013_Jun_20_33(6)_419-427.nxml.txt.nlp	23605507	SENT154	20	20	21	21	ciprofloxacin	DPI	PA449009	1832	0.247
NULL	Nat_Commun_2012_Dec_27_3_1316.nxml.txt.nlp	23271650	SENT531	20	20	23	23	tamoxifen	E12	PA451581	64100	0.247
NULL	Nanoscale_Res_Lett_2010_Jul_28_5(11)_1749-1754.nxml.txt.nlp	21124643	SENT39	6	6	13	13	ethanol	NO3	PA448073	4681	0.247
NULL	Int_J_Biol_Sci_2015_Jan_1_11(1)_48-58.nxml.txt.nlp	25552929	SENT197	10	10	8	8	paclitaxel	TSP-1	PA450761	7057	0.247
NULL	Mol_Cancer_2010_Dec_20_9_316.nxml.txt.nlp	21172016	SENT428	7	7	3	3	heparin	CCL21	PA449855	6366	0.247
NULL	Carcinogenesis_2010_Dec_27_31(12)_2049-2057.nxml.txt.nlp	20876285	SENT7	6	6	2	2	tamoxifen	HER2	PA451581	2064	0.247
NULL	Br_J_Cancer_2012_Jan_3_106(1)_6-13.nxml.txt.nlp	22215104	SENT18	8	8	9	9	trastuzumab	DM1	PA451743	338023;1760;28509	0.247
NULL	J_Hematol_Oncol_2013_Aug_2_6_56.nxml.txt.nlp	23915951	SENT48	36	36	36	36	pp2	PP2		4888	0.247
NULL	Br_J_Anaesth_2014_Jul_22_113(1)_157-167.nxml.txt.nlp	24154701	SENT61	9	9	7	7	sevoflurane	TREK-1	PA451341	3776	0.247
NULL	Nat_Struct_Mol_Biol_2014_Oct_7_21(10)_884-892.nxml.txt.nlp	25195051	SENT169	25	25	19	19	ethanol	TMP	PA448073	2012	0.247
NULL	Mol_Vis_2012_Nov_12_18_2673-2686.nxml.txt.nlp	23170060	SENT46	27	27	5	5	taurine	CDO	PA451590	50937	0.247
NULL	Korean_J_Anesthesiol_2013_Jan_21_64(1)_47-53.nxml.txt.nlp	23372886	SENT14	11	11	9	9	bupivacaine	PTG	PA135057240	5507	0.247
NULL	Open_Virol_J_2009_Apr_1_3_21-25.nxml.txt.nlp	19572053	SENT58	10	10	10	10	pp2	PP2		4888	0.246
NULL	Nucleic_Acids_Res_2012_Apr_14_40(7)_2940-2955.nxml.txt.nlp	22169952	SENT384	33	33	31	31	arsenite	NF-kappaB	PA452638	4790	0.246
NULL	Clinics_(Sao_Paulo)_2013_May_68(5)_628-631.nxml.txt.nlp	23778422	SENT120	6	6	4	4	cyclophosphamide	CTX	PA449165	1593	0.246
NULL	Chem_Commun_(Camb)_2009_Sep_14_(34)_5091-5093.nxml.txt.nlp	20448956	SENT23	29	29	33	33	fluorescein	p53	PA164746009	7157	0.246
NULL	J_Cancer_2014_Apr_24_5(5)_390-397.nxml.txt.nlp	24799957	SENT47	20	20	28	28	palonosetron	CHOP	PA10352	1649	0.246
NULL	Korean_J_Anesthesiol_2013_Jan_21_64(1)_47-53.nxml.txt.nlp	23372886	SENT99	27	27	21	21	bupivacaine	PTG	PA135057240	5507	0.246
NULL	Cell_Commun_Signal_2013_Nov_4_11_82.nxml.txt.nlp	24188565	SENT337	24	24	24	24	pp2	PP2		4888	0.245
NULL	Chemother_Res_Pract_2011_Apr_7_2011_393976.nxml.txt.nlp	22312553	SENT26	16	16	20	20	artemisinin	ACT	PA165111696	12;11332;9457;641455	0.245
NULL	Mucosal_Immunol_2011_May_10_4(3)_304-313.nxml.txt.nlp	21068720	SENT146	18	18	17	17	collagenase	VIII	PA449107	1351	0.245
NULL	J_Cell_Biol_2005_May_9_169(3)_503-514.nxml.txt.nlp	15883200	SENT176	16	16	16	16	pp2	PP2		4888	0.245
NULL	Exp_Diabetes_Res_2012_Nov_1_2012_892706.nxml.txt.nlp	23197976	SENT159	15	15	5	5	vildagliptin	GLP-1	PA165958346	100125288	0.245
NULL	Cancer_Cell_Int_2011_Jun_29_11_22.nxml.txt.nlp	21714887	SENT325	2	2	0	0	guanidine	GEF	PA164781028	56731	0.245
NULL	Open_AIDS_J_2009_Dec_31_3_63-70.nxml.txt.nlp	20148061	SENT147	20	20	24	24	isoniazid	IPT	PA450112	54802	0.244
NULL	Crit_Care_2008_Jun_25_12(3)_R84.nxml.txt.nlp	18578859	SENT62	17	17	10	10	heparin	PF4	PA449855	5196	0.244
NULL	J_Asthma_Allergy_2008_Sep_19_1_19-29.nxml.txt.nlp	21436982	SENT117	10	10	7	7	fexofenadine	CBF1	PA449621	3516	0.244
NULL	J_Cell_Biol_2008_Jul_14_182(1)_157-169.nxml.txt.nlp	18606851	SENT146	10	10	10	10	pp2	PP2		4888	0.244
NULL	Pharmaceuticals_(Basel)_2014_Apr_10_7(4)_433-452.nxml.txt.nlp	24727459	SENT50	0	0	3	3	cyclosporine	P-gp	PA449167	5243	0.244
NULL	JAKSTAT_2013_Jan_1_2(1)_e23010.nxml.txt.nlp	24058791	SENT53	10	10	7	7	zinc	STAT3	PA451956	6774	0.244
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Oct_23_66(Pt_11)_m1445.nxml.txt.nlp	21588866	SENT70	29	29	11	11	ethanol	NO3	PA448073	4681	0.244
NULL	Mol_Cancer_2010_Dec_20_9_317.nxml.txt.nlp	21172025	SENT128	17	17	25	25	tamoxifen	HER2	PA451581	2064	0.244
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Mar_19_67(Pt_4)_m463.nxml.txt.nlp	21753979	SENT69	7	7	14	14	ethanol	NO3	PA448073	4681	0.244
NULL	Curr_Opin_Biotechnol_2011_Dec_22(6)_793-799.nxml.txt.nlp	21354781	SENT93	3	3	12	12	lipase	PPL	PA450239	5493	0.243
NULL	Br_J_Cancer_2011_Mar_29_104(7)_1126-1134.nxml.txt.nlp	21364592	SENT4	46	46	11	11	cisplatin	CYP2A6	PA449014	1548	0.243
NULL	Br_J_Clin_Pharmacol_2010_Jan_69(1)_23-26.nxml.txt.nlp	20078609	SENT86	15	15	17	17	sitaxentan	CYP3A4	PA165958361	1576	0.243
NULL	Biomed_Res_Int_2014_Jun_4_2014_237698.nxml.txt.nlp	24995276	SENT147	15	15	13	13	bortezomib	BTD	PA10252	686	0.243
NULL	Cancer_Metab_2013_Mar_21_1_12.nxml.txt.nlp	24280230	SENT9	16	16	22	22	urea	ASL	PA451831	435	0.243
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_May_11_69(Pt_6)_o870.nxml.txt.nlp	23795049	SENT68	13	13	26	26	ethanol	mol	PA448073	90527	0.243
NULL	J_Cardiothorac_Surg_2012_Nov_15_7_123.nxml.txt.nlp	23151309	SENT171	10	10	13	13	heparin	ACT	PA449855	12;11332;9457;641455	0.243
NULL	Nanoscale_Res_Lett_2010_May_16_5(7)_1195-1203.nxml.txt.nlp	20596515	SENT49	19	19	16	16	ethanol	NO3	PA448073	4681	0.243
NULL	Int_J_Breast_Cancer_2013_Dec_12_2013_659723.nxml.txt.nlp	24416595	SENT148	2	2	0	0	metformin	Met	PA450395	79811	0.243
NULL	J_Oncol_2012_Sep_29_2012_879623.nxml.txt.nlp	21977033	SENT503	23	23	21	21	naringenin	NAC	PA151958361	22861	0.243
NULL	Contemp_Clin_Dent_2011_Oct-Dec_2(4)_278-282.nxml.txt.nlp	22346152	SENT95	17	17	20	20	potassium	GCF	PA451047	6936	0.243
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT239	22	22	22	22	pp2	PP2		4888	0.243
NULL	Infect_Dis_Obstet_Gynecol_2006_Oct_1_2006_18182.nxml.txt.nlp	17485797	SENT154	22	22	20	20	vancomycin	VAN	PA451850	10318	0.243
NULL	Biomed_Res_Int_2014_Aug_6_2014_967826.nxml.txt.nlp	25165721	SENT356	0	0	5	5	nadh	NQO1	PA164755085	1728	0.242
NULL	Core_Evid_2008_Jun_3(1)_31-43.nxml.txt.nlp	20694082	SENT4	3	3	15	15	vasopressin	AVP	PA451858	114548;551	0.242
NULL	Br_J_Cancer_2011_May_10_104(10)_1628-1640.nxml.txt.nlp	21505453	SENT45	16	16	16	16	pp2	PP2		4888	0.242
NULL	Colomb_Med_(Cali)_43(3)_221-225.nxml.txt.nlp	24893196	SENT98	7	7	4	4	resveratrol	ACTH		5443	0.242
NULL	Int_J_Anal_Chem_2013_Jul_16_2013_419716.nxml.txt.nlp	23956748	SENT182	39	39	17	17	ethanol	PF6	PA448073	200162	0.242
NULL	Evid_Based_Complement_Alternat_Med_2013_Mar_13_2013_685642.nxml.txt.nlp	23573144	SENT10	10	10	13	13	streptozocin	STZ	PA451514	6484	0.242
NULL	J_Vet_Med_Sci_2014_May_16_76(5)_645-651.nxml.txt.nlp	24430661	SENT294	10	10	8	8	dextran	ZO-1	PA449261	7082	0.242
NULL	Oncogene_2014_Oct_23_33(43)_5109-5120.nxml.txt.nlp	24858043	SENT81	32	32	32	32	pp2	PP2		4888	0.242
NULL	Evid_Based_Complement_Alternat_Med_2014_May_14_2014_756406.nxml.txt.nlp	24959191	SENT31	39	39	42	42	cyclophosphamide	CTX	PA449165	1593	0.242
NULL	Clinics_(Sao_Paulo)_2009_Apr_64(4)_295-302.nxml.txt.nlp	19488585	SENT207	43	43	41	41	gentamicin	Gen	PA449753	348654	0.242
NULL	Oncotarget_2013_Jun_30_4(7)_1037-1049.nxml.txt.nlp	23900414	SENT167	9	9	9	9	pp2	PP2		4888	0.242
NULL	Pharmaceuticals_(Basel)_2011_Jan_12_4(1)_187-201.nxml.txt.nlp	NULL	SENT155	10	10	29	29	l-arginine	OTC	PA448478	5009	0.241
NULL	Korean_Circ_J_2013_Jun_30_43(6)_400-407.nxml.txt.nlp	23882289	SENT106	13	13	11	11	doxorubicin	Bcl-2	PA449412	596	0.241
NULL	Neural_Comput_Appl_2010_Jul_9_19(5)_667-676.nxml.txt.nlp	20651904	SENT248	17	17	20	20	oxygen	COD	PA450744	6628	0.241
NULL	Bioinorg_Chem_Appl_2014_Sep_15_2014_718175.nxml.txt.nlp	25332694	SENT47	14	14	12	12	ethanol	HL1	PA448073	1767	0.241
NULL	Libyan_J_Med_2008_Mar_1_3(1)_42-48.nxml.txt.nlp	21499481	SENT47	4	4	8	8	artemisinin	ACT	PA165111696	12;11332;9457;641455	0.241
NULL	Breast_Cancer_Res_2006_Jul_19_8(4)_R42.nxml.txt.nlp	16859511	SENT409	28	28	28	28	pp2	PP2		4888	0.24
NULL	Front_Immunol_2012_Jul_4_3_181.nxml.txt.nlp	22783255	SENT82	25	25	20	20	l-glutamine	HL-1	PA10090	55600	0.24
NULL	J_Biol_Chem_2009_Sep_11_284(37)_25388-25403.nxml.txt.nlp	19574212	SENT409	4	4	8	8	heparin	FGF1	PA449855	2246	0.24
NULL	Infect_Dis_Obstet_Gynecol_2006_Oct_1_2006_18182.nxml.txt.nlp	17485797	SENT154	14	14	20	20	novobiocin	VAN	PA164768819	10318	0.24
NULL	Int_J_Hypertens_2013_Jun_17_2013_627938.nxml.txt.nlp	23844279	SENT162	2	2	0	0	amlodipine	A10	PA448388	28870	0.24
NULL	Contemp_Clin_Dent_2011_Oct-Dec_2(4)_278-282.nxml.txt.nlp	22346152	SENT86	11	11	21	21	potassium	GCF	PA451047	6936	0.24
NULL	Arthritis_Res_Ther_2009_Jan_26_11(1)_R12.nxml.txt.nlp	19171052	SENT239	4	4	26	26	dipyridamole	ACTH	PA449367	5443	0.24
NULL	J_Hematol_Oncol_2013_Oct_23_6_80.nxml.txt.nlp	24283946	SENT173	20	20	7	7	letrozole	aromatase	PA450196	1588	0.24
NULL	Atten_Defic_Hyperact_Disord_2009_Dec_23_1(2)_201-210.nxml.txt.nlp	20234828	SENT26	4	4	1	1	atomoxetine	CYP2D6	PA134688071	1565	0.24
NULL	Biomed_Res_Int_2013_Sep_9_2013_796362.nxml.txt.nlp	24089688	SENT71	4	4	1	1	ketamine	ERG	PA450144	2078	0.24
NULL	Infect_Dis_Obstet_Gynecol_2006_Oct_1_2006_18182.nxml.txt.nlp	17485797	SENT154	14	14	12	12	novobiocin	NOV	PA164768819	4856;5361;6134	0.24
NULL	Curr_Cardiol_Rev_2011_Nov_7(4)_221-233.nxml.txt.nlp	22758623	SENT334	9	9	8	8	nilotinib	DDR1	PA165958345	780	0.239
NULL	Nano_Rev_2010_Feb_22_1_10_3402_nano_v1i0_4883.nxml.txt.nlp	22110854	SENT159	22	22	32	32	iron	MRI	PA450087	78996	0.239
NULL	Arthritis_Res_Ther_2012_Jan_31_14(1)_202.nxml.txt.nlp	22293173	SENT180	12	12	5	5	hydroxychloroquine	BOR	PA164777036	55143	0.239
NULL	Cardiovasc_Diabetol_2005_Jun_3_4_7.nxml.txt.nlp	15935095	SENT102	13	13	15	15	rosuvastatin	ATV	PA134308647	4683	0.239
NULL	Cancer_Cell_Int_2013_Feb_14_13_16.nxml.txt.nlp	23409704	SENT77	20	20	20	20	pp2	PP2		4888	0.239
NULL	Biomed_Res_Int_2014_Aug_6_2014_967826.nxml.txt.nlp	25165721	SENT357	0	0	6	6	nadh	NQO1	PA164755085	1728	0.239
NULL	Libyan_J_Med_2007_Jun_1_2(2)_99-102.nxml.txt.nlp	21503261	SENT73	6	6	40	40	infliximab	Yes	PA452639	7525	0.238
NULL	Int_J_Alzheimers_Dis_2012_Apr_4_2012_258454.nxml.txt.nlp	22548198	SENT223	13	13	29	29	estradiol	alpha-synuclein	PA449503	6622	0.238
NULL	Exp_Diabetes_Res_2012_Sep_20_2012_936518.nxml.txt.nlp	23049542	SENT133	8	8	5	5	glucose	TRPV4	PA449773	59341	0.238
NULL	Crit_Care_2012_Mar_2_16(2)_R37.nxml.txt.nlp	22386062	SENT12	19	19	0	0	oxygen	CENPV	PA450744	201161	0.238
NULL	Ann_Clin_Microbiol_Antimicrob_2007_May_23_6_5.nxml.txt.nlp	17521424	SENT72	2	2	4	4	kanamycin	TOB	PA450137	10140	0.238
NULL	Cell_Commun_Signal_2013_Jan_22_11_6.nxml.txt.nlp	23339737	SENT66	6	6	6	6	pp2	PP2		4888	0.238
NULL	Anesth_Essays_Res_2013_May-Aug_7(2)_147-154.nxml.txt.nlp	NULL	SENT46	4	4	2	2	hydrocortisone	ACTH	PA449905	5443	0.238
NULL	Arthritis_Res_Ther_2009_Apr_30_11(2)_R58.nxml.txt.nlp	19405951	SENT123	10	10	11	11	alendronate	RANKL	PA448082	8600	0.238
NULL	Cancer_Causes_Control_2013_Aug_18_24(8)_1605-1614.nxml.txt.nlp	23775025	SENT64	33	33	32	32	doxorubicin	ABCB1	PA449412	5243	0.238
NULL	Nucleic_Acids_Res_2012_Sep_4_40(16)_7806-7820.nxml.txt.nlp	22669901	SENT133	15	15	5	5	ethanol	ARC	PA448073	8996;23237	0.238
NULL	Iran_J_Reprod_Med_2012_Jul_10(4)_329-336.nxml.txt.nlp	25246894	SENT114	11	11	19	19	protamine	PRM1	PA10366	5619	0.238
NULL	Korean_J_Anesthesiol_2013_Jan_21_64(1)_54-60.nxml.txt.nlp	23372887	SENT165	6	6	4	4	hydrocortisone	CRT	PA449905	811	0.237
NULL	J_Asthma_Allergy_2009_Jul_30_2_63-72.nxml.txt.nlp	21437145	SENT162	8	8	9	9	fluticasone/salmeterol	DPI	PA165290926	1832	0.237
NULL	Curr_Pharm_Des_2011_Dec_17(35)_3846-3853.nxml.txt.nlp	21933140	SENT68	6	6	5	5	creatine	ADP	PA164778930	23038	0.237
NULL	J_Biomed_Sci_2014_Jul_22_21(1)_65.nxml.txt.nlp	25047949	SENT118	9	9	11	11	docetaxel	PC-3	PA449383	692094	0.237
NULL	Oncogene_2010_May_27_29(21)_3054-3066.nxml.txt.nlp	20228839	SENT49	7	7	7	7	pp2	PP2		4888	0.237
NULL	Mol_Microbiol_2014_Mar_23_91(5)_918-934.nxml.txt.nlp	24372851	SENT16	1	1	5	5	artemisinin	ACT	PA165111696	12;11332;9457;641455	0.237
NULL	Cell_Death_Dis_2014_Jan_16_5(1)_e994.nxml.txt.nlp	24434517	SENT82	30	30	33	33	mefloquine	DD2	PA450348	1646	0.237
NULL	J_Am_Heart_Assoc_2013_Apr_24_2(2)_e000131.nxml.txt.nlp	23537811	SENT25	36	36	31	31	clopidogrel	VASP	PA449053	7408	0.237
NULL	J_Mol_Signal_2008_Mar_31_3_8.nxml.txt.nlp	18377662	SENT131	13	13	13	13	pp2	PP2		4888	0.237
NULL	Open_AIDS_J_2010_May_14_4_105-115.nxml.txt.nlp	20657829	SENT78	0	0	8	8	methamphetamine	San	PA450403	80218	0.237
NULL	Acta_Pharmacol_Sin_2009_Jan_8_30(1)_1-24.nxml.txt.nlp	19060915	SENT338	1	1	21	21	isoproterenol	PKG	PA450121	5592	0.236
NULL	CNS_Drugs_2014_Mar_28_28(5)_421-453.nxml.txt.nlp	24677189	SENT857	25	25	28	28	aripiprazole	STAR	PA10026	6770;2984	0.236
NULL	Int_J_Mol_Sci_2010_Sep_13_11(9)_3195-3208.nxml.txt.nlp	20957088	SENT82	1	1	0	0	lipase	AT2	PA450239	186	0.236
NULL	Infect_Drug_Resist_2009_Apr_24_2_13-26.nxml.txt.nlp	21694884	SENT285	3	3	7	7	tenofovir	TDF	PA10204	6736	0.236
NULL	J_Psychopharmacol_2010_Jan_24(1)_27-38.nxml.txt.nlp	19204064	SENT150	19	19	9	9	amphetamine	NK1R	PA448408	6869	0.236
NULL	Mol_Cancer_2010_Dec_20_9_317.nxml.txt.nlp	21172025	SENT139	19	19	23	23	tamoxifen	HER2	PA451581	2064	0.236
NULL	J_Gen_Physiol_2008_Nov_132(5)_507-520.nxml.txt.nlp	18955593	SENT533	6	6	8	8	dofetilide	HERG	PA449389	3757	0.236
NULL	Drugs_2009_Mar_17_69(5)_549-565.nxml.txt.nlp	19368417	SENT13	14	14	15	15	formoterol	DPI	PA134687907	1832	0.236
NULL	Neuropsychopharmacology_2009_Jul_11_34(8)_1946-1957.nxml.txt.nlp	19279569	SENT11	12	12	10	10	cocaine	DOR	PA449072	58476	0.235
NULL	Cardiovasc_Diabetol_2005_Jun_3_4_7.nxml.txt.nlp	15935095	SENT102	17	17	15	15	atorvastatin	ATV	PA448500	4683	0.235
NULL	Acta_Histochem_Cytochem_2013_Dec_28_46(6)_187-197.nxml.txt.nlp	24610966	SENT395	5	5	3	3	pilocarpine	AQP5	PA450962	362	0.235
NULL	Oxid_Med_Cell_Longev_2012_Aug_13_2012_741468.nxml.txt.nlp	22928085	SENT238	10	10	4	4	nadh	SIRT1	PA164755085	23411	0.235
NULL	Nucleic_Acids_Res_2012_Jul_20_40(13)_6270-6289.nxml.txt.nlp	22434888	SENT155	35	35	22	22	galactose	GAL	PA449725	51083	0.235
NULL	Int_J_Biol_Sci_2006_Mar_1_2(1)_1-9.nxml.txt.nlp	16585947	SENT53	6	6	6	6	pp2	PP2		4888	0.235
NULL	Can_J_Anaesth_2011_Feb_31_58(2)_206-215.nxml.txt.nlp	21194017	SENT253	19	19	24	24	etomidate	mol	PA164743987	90527	0.235
NULL	J_Thromb_Haemost_2011_Oct_9(10)_2103-2105.nxml.txt.nlp	21812912	SENT17	25	25	23	23	ticagrelor	ADP	PA165374673	23038	0.235
NULL	Oxid_Med_Cell_Longev_2012_Aug_22_2012_534705.nxml.txt.nlp	22966415	SENT277	17	17	15	15	riluzole	GLT-1	PA451251	6506	0.235
NULL	Nat_Methods_2011_Nov_6_8(12)_1041-1043.nxml.txt.nlp	22056677	SENT56	26	26	24	24	trypsin	CTCF	PA451806	10664	0.235
NULL	Biomed_Res_Int_2014_Aug_6_2014_967826.nxml.txt.nlp	25165721	SENT205	24	24	22	22	cisplatin	RANTES	PA449014	6352	0.235
NULL	Mol_Cancer_2010_Dec_20_9_316.nxml.txt.nlp	21172016	SENT163	7	7	24	24	heparin	CCL21	PA449855	6366	0.234
NULL	Oncogene_2014_May_8_33(19)_2478-2486.nxml.txt.nlp	23752180	SENT95	3	3	8	8	guanidine	RAPGEF3	PA164781028	10411	0.234
NULL	Asian_Spine_J_2012_Dec_14_6(4)_274-278.nxml.txt.nlp	23275811	SENT90	44	44	46	46	ciprofloxacin	CTX	PA449009	1593	0.234
NULL	Nat_Commun_2012_Dec_27_3_1316.nxml.txt.nlp	23271650	SENT518	12	12	15	15	tamoxifen	E12	PA451581	64100	0.234
NULL	Clinics_(Sao_Paulo)_2009_Apr_64(4)_295-302.nxml.txt.nlp	19488585	SENT207	39	39	41	41	cefoxitin	Gen	PA448856	348654	0.234
NULL	Cardiol_Res_Pract_2012_Jul_26_2012_545219.nxml.txt.nlp	22900226	SENT57	7	7	11	11	hyaluronan	HABP	PA165958431	3026	0.234
NULL	Springerplus_2014_Sep_9_3_510.nxml.txt.nlp	25279302	SENT13	20	20	18	18	creatine	CKM	PA164778930	1158	0.234
NULL	Curr_Neuropharmacol_2014_Jan_12(1)_57-70.nxml.txt.nlp	24533016	SENT44	0	0	5	5	ketamine	LIGHT	PA450144	8740	0.234
NULL	Int_J_Biol_Sci_2015_Jan_1_11(1)_48-58.nxml.txt.nlp	25552929	SENT25	12	12	10	10	paclitaxel	TSP-1	PA450761	7057	0.234
NULL	Mol_Vis_2011_Aug_18_17_2221-2227.nxml.txt.nlp	21897744	SENT6	21	21	37	37	l-arginine	NAC	PA448478	22861	0.233
NULL	Front_Psychol_2014_Jun_27_5_658.nxml.txt.nlp	25018744	SENT970	4	4	7	7	galactose	GALM	PA449725	130589	0.233
NULL	F1000Res_2014_Sep_29_3_228.nxml.txt.nlp	25485098	SENT24	20	20	24	24	l-arginine	AGAT	PA448478	2628	0.233
NULL	Oncotarget_2014_Jun_26_5(18)_8317-8329.nxml.txt.nlp	25327561	SENT105	12	12	10	10	trastuzumab	MUC4	PA451743	4585	0.233
NULL	Genetics_2012_Sep_192(1)_55-66.nxml.txt.nlp	22964837	SENT353	21	21	16	16	zinc	HER-2	PA451956	2064	0.233
NULL	Acta_Vet_Scand_2009_Aug_25_51(1)_35.nxml.txt.nlp	19703311	SENT99	11	11	9	9	oxytetracycline	OTC	PA450757	5009	0.233
NULL	Br_J_Cancer_2010_Sep_7_103(6)_796-801.nxml.txt.nlp	20823888	SENT106	40	40	39	39	sirolimus	D29	PA451365	55520	0.232
NULL	Asian-Australas_J_Anim_Sci_2012_Jun_25(6)_800-805.nxml.txt.nlp	25049629	SENT65	10	10	17	17	ethanol	CO2	PA448073	4513	0.232
NULL	Bioinformation_2012_Nov_23_8(23)_1132-1138.nxml.txt.nlp	23275709	SENT120	5	5	3	3	tamoxifen	BRCA2	PA451581	675	0.232
NULL	Biol_Direct_2010_Nov_2_5_61.nxml.txt.nlp	21040590	SENT275	10	10	10	10	pp2	PP2		4888	0.232
NULL	Curr_Med_Chem_2009_Aug_16(23)_2952-2964.nxml.txt.nlp	19689276	SENT99	6	6	9	9	lipase	ATGL	PA450239	57104	0.232
NULL	Springerplus_2014_Sep_9_3_510.nxml.txt.nlp	25279302	SENT13	0	0	12	12	l-arginine	GAMT	PA448478	2593	0.232
NULL	Br_J_Haematol_2011_Aug_14_154(3)_378-386.nxml.txt.nlp	21671895	SENT173	23	23	21	21	heparin	PF4	PA449855	5196	0.231
NULL	J_Vet_Med_Sci_2014_Jul_18_76(7)_937-945.nxml.txt.nlp	24646457	SENT103	10	10	41	41	cefazolin	OTC	PA448839	5009	0.231
NULL	J_Ophthalmol_2011_Dec_23_2011_292040.nxml.txt.nlp	21253505	SENT133	4	4	6	6	diltiazem	rd1	PA449334	5158	0.231
NULL	Eur_Respir_J_2013_May_27_41(5)_1107-1115.nxml.txt.nlp	23018904	SENT27	19	19	20	20	ciprofloxacin	DPI	PA449009	1832	0.231
NULL	Front_Cell_Neurosci_2014_Jul_18_8_185.nxml.txt.nlp	25100946	SENT367	10	10	10	10	pp2	PP2		4888	0.231
NULL	Brain_Sci_2012_Dec_21_3(1)_1-38.nxml.txt.nlp	24961305	SENT1052	6	6	9	9	ethanol	spatial	PA448073	219793	0.231
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_May_7_67(Pt_6)_m706-m707.nxml.txt.nlp	21754608	SENT77	13	13	6	6	ethanol	NO3	PA448073	4681	0.23
NULL	Crit_Care_2008_Dec_17_12(6)_R159.nxml.txt.nlp	19091080	SENT71	0	0	5	5	rolipram	San	PA153906323	80218	0.23
NULL	Mol_Immunol_2009_Mar_46(6)_1229-1239.nxml.txt.nlp	19135256	SENT175	17	17	25	25	trypsin	DC2	PA451806	58505	0.23
NULL	J_Vet_Med_Sci_2014_Jul_18_76(7)_937-945.nxml.txt.nlp	24646457	SENT91	10	10	40	40	cefazolin	OTC	PA448839	5009	0.23
NULL	Diabetes_2008_Sep_57(9)_2272-2279.nxml.txt.nlp	18519799	SENT9	5	5	9	9	rosiglitazone	PDK4	PA451283	5166	0.23
NULL	Diabetes_Care_2013_Jul_12_36(7)_1926-1932.nxml.txt.nlp	23378624	SENT162	14	14	12	12	tacrolimus	RTR	PA451578	2649	0.23
NULL	Clin_Drug_Investig_2013_Jun_20_33(6)_419-427.nxml.txt.nlp	23605507	SENT91	23	23	24	24	ciprofloxacin	DPI	PA449009	1832	0.23
NULL	Environ_Health_Perspect_2013_May_22_121(5)_551-557.nxml.txt.nlp	23434795	SENT176	23	23	22	22	hyaluronan	BAL	PA165958431	83666	0.23
NULL	F1000Res_2014_Jul_30_3_103.nxml.txt.nlp	25285204	SENT35	19	19	14	14	thrombin	ADAMTS13	PA451674	11093	0.229
NULL	Mol_Cancer_2012_Jun_26_11_43.nxml.txt.nlp	22731636	SENT130	27	27	27	27	pp2	PP2		4888	0.229
NULL	EMBO_Mol_Med_2013_Jun_30_5(6)_870-890.nxml.txt.nlp	23630012	SENT157	10	10	14	14	betaine	BHMT	PA448603	635	0.229
NULL	Curr_Genomics_2013_Nov_14(7)_453-467.nxml.txt.nlp	24396277	SENT168	26	26	24	24	iron	PCSK7	PA450087	9159	0.229
NULL	BMJ_Open_2014_Feb_27_4(2)_e004071.nxml.txt.nlp	24578536	SENT109	5	5	3	3	warfarin	TTR	PA451906	7276	0.229
NULL	Indian_J_Endocrinol_Metab_2013_Jan-Feb_17(1)_69-75.nxml.txt.nlp	23776855	SENT28	24	24	23	23	ribavirin	IFN	PA451241	3439	0.228
NULL	Angew_Chem_Int_Ed_Engl_2012_Feb_13_51(7)_1572-1575.nxml.txt.nlp	22213572	SENT22	9	9	7	7	ethanol	CO2	PA448073	4513	0.228
NULL	J_Adv_Pract_Oncol_2014_Mar_1_Mar-Apr_5(2)_144-150.nxml.txt.nlp	25032048	SENT82	18	18	22	22	granisetron	GTS	PA449809	2973	0.228
NULL	Int_J_Anal_Chem_2013_Jul_16_2013_419716.nxml.txt.nlp	23956748	SENT187	28	28	21	21	ethanol	PF6	PA448073	200162	0.228
NULL	Iran_J_Public_Health_2012_Jan_31_41(1)_59-65.nxml.txt.nlp	23113123	SENT25	3	3	6	6	lipase	LIPC	PA450239	3990	0.228
NULL	Mol_Cancer_2010_Dec_20_9_317.nxml.txt.nlp	21172025	SENT113	4	4	12	12	tamoxifen	HER2	PA451581	2064	0.228
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT116	27	27	25	25	tenofovir	SLC22A8	PA10204	9376	0.228
NULL	Daru_2012_Nov_28_20(1)_81.nxml.txt.nlp	23351280	SENT344	3	3	5	5	atropine	MARK	PA448505	4139	0.228
NULL	J_Oncol_2009_May_6_2009_567486.nxml.txt.nlp	19424511	SENT135	1	1	7	7	sorafenib	SHARP	PA7000	23013	0.228
NULL	Exp_Ther_Med_2013_Aug_5_6(2)_305-309.nxml.txt.nlp	24137179	SENT157	5	5	8	8	ethanol	PES	PA448073	23481	0.228
NULL	Contemp_Clin_Dent_2011_Oct-Dec_2(4)_278-282.nxml.txt.nlp	22346152	SENT93	11	11	21	21	potassium	GCF	PA451047	6936	0.227
NULL	Cancer_Res_Treat_2012_Sep_30_44(3)_195-201.nxml.txt.nlp	23091446	SENT161	10	10	7	7	irinotecan	JNK	PA450085	5599	0.227
NULL	Mol_Cancer_2012_Jun_26_11_43.nxml.txt.nlp	22731636	SENT81	13	13	13	13	pp2	PP2		4888	0.227
NULL	Ann_Rheum_Dis_2011_Oct_12_71(4)_541-548.nxml.txt.nlp	21994233	SENT221	8	8	15	15	infliximab	IMPACT	PA452639	55364	0.227
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R91.nxml.txt.nlp	22541814	SENT194	18	18	18	18	pp2	PP2		4888	0.227
NULL	Cell_Commun_Signal_2009_Feb_26_7(Suppl_1)_A63.nxml.txt.nlp	NULL	SENT20	9	9	9	9	pp2	PP2		4888	0.227
NULL	Toxins_(Basel)_2010_Oct_26_2(11)_2490-2518.nxml.txt.nlp	22069563	SENT135	33	33	25	25	cisplatin	PIDD	PA449014	55367	0.227
NULL	Front_Chem_2014_Apr_1_2_15.nxml.txt.nlp	24790983	SENT103	5	5	9	9	chloramphenicol	UPRT	PA448927	139596	0.227
NULL	Afr_J_Infect_Dis_2010_4(2)_29-42.nxml.txt.nlp	23878698	SENT7	17	17	21	21	artemisinin	ACT	PA165111696	12;11332;9457;641455	0.227
NULL	J_Cancer_Prev_2014_Sep_19(3)_153-160.nxml.txt.nlp	25337584	SENT29	12	12	5	5	dextran	MICE	PA449261	4280;23581	0.226
NULL	Iran_J_Basic_Med_Sci_2013_Apr_16(4)_610-614.nxml.txt.nlp	24250937	SENT2	5	5	8	8	coumarin	CYP2A6	PA134521193	1548	0.226
NULL	J_Gynecol_Oncol_2013_Jul_4_24(3)_265-272.nxml.txt.nlp	23875077	SENT148	19	19	17	17	thrombin	IL-8	PA451674	3576	0.226
NULL	Diabetes_Metab_J_2013_Oct_17_37(5)_343-348.nxml.txt.nlp	24199163	SENT76	17	17	17	17	pp2	PP2		4888	0.226
NULL	Exp_Ther_Med_2014_Aug_11_8(2)_671-675.nxml.txt.nlp	25009638	SENT176	11	11	2	2	scopolamine	FAE	PA451308	2178	0.226
NULL	Crit_Care_2010_Mar_1_14(Suppl_1)_P568.nxml.txt.nlp	NULL	SENT5	24	24	27	27	glucose	BGL	PA449773	987	0.226
NULL	J_Geriatr_Cardiol_2014_Jun_11(2)_151-157.nxml.txt.nlp	25009566	SENT142	12	12	0	0	cyclosporine	CDP	PA449167	1523	0.226
NULL	Europace_2012_Dec_6_14(12)_1700-1707.nxml.txt.nlp	22772054	SENT128	16	16	17	17	heparin	Yes	PA449855	7525	0.226
NULL	Alcohol_Res_2012_34(3)_367-374.nxml.txt.nlp	23134054	SENT53	31	31	29	29	ethanol	MPDZ	PA448073	8777;84708	0.226
NULL	Brain_Sci_2014_May_6_4(2)_356-375.nxml.txt.nlp	24961766	SENT344	4	4	11	11	propofol	G18	PA451141	1154;63940	0.226
NULL	Allergy_Asthma_Immunol_Res_2010_Apr_24_2(2)_134-140.nxml.txt.nlp	20358028	SENT98	9	9	10	10	methacholine	AHR	PA165958382	196	0.226
NULL	Br_J_Cancer_2009_Jul_21_101(2)_312-319.nxml.txt.nlp	19568237	SENT107	4	4	4	4	pp2	PP2		4888	0.226
NULL	Br_J_Cancer_2009_Jul_21_101(2)_327-334.nxml.txt.nlp	19568240	SENT217	8	8	8	8	pp2	PP2		4888	0.226
NULL	Evid_Based_Complement_Alternat_Med_2014_Jun_16_2014_319436.nxml.txt.nlp	25031604	SENT20	11	11	14	14	choline	CHAT	PA448976	1103	0.226
NULL	Mol_Cancer_2010_Dec_20_9_317.nxml.txt.nlp	21172025	SENT103	5	5	9	9	tamoxifen	HER2	PA451581	2064	0.225
NULL	Brain_Behav_2011_Sep_1(1)_44-54.nxml.txt.nlp	22398980	SENT89	15	15	13	13	cocaine	AIS	PA449072	367	0.225
NULL	Int_J_Endocrinol_2014_Aug_11_2014_312452.nxml.txt.nlp	25183970	SENT128	8	8	6	6	liraglutide	PI3K	PA165958364	5290	0.225
NULL	Clin_Ophthalmol_2014_Feb_10_8_389-399.nxml.txt.nlp	24550667	SENT4	11	11	27	27	timolol	TIM	PA451690	7984;8914	0.225
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Feb_9_69(Pt_3)_m142.nxml.txt.nlp	23476490	SENT66	13	13	18	18	ethanol	NO3	PA448073	4681	0.225
NULL	N_Am_J_Med_Sci_2011_Mar_3(3)_129-136.nxml.txt.nlp	22540078	SENT164	35	35	42	42	tetracycline	SMG	PA451640	23034	0.225
NULL	Contemp_Clin_Dent_2011_Oct-Dec_2(4)_278-282.nxml.txt.nlp	22346152	SENT84	3	3	6	6	potassium	GCF	PA451047	6936	0.225
NULL	Structure_2014_Feb_4_22(2)_337-344.nxml.txt.nlp	24389026	SENT87	20	20	29	29	oxygen	FANCL	PA450744	55120	0.225
NULL	Front_Immunol_2013_Sep_17_4_280.nxml.txt.nlp	24062746	SENT500	15	15	13	13	dextran	ZO-1	PA449261	7082	0.225
NULL	J_Mol_Signal_2008_Mar_31_3_8.nxml.txt.nlp	18377662	SENT69	9	9	9	9	pp2	PP2		4888	0.225
NULL	J_Am_Heart_Assoc_2013_Aug_23_2(4)_e000264.nxml.txt.nlp	23896681	SENT146	17	17	5	5	thrombin	FVIII	PA451674	2157	0.225
NULL	JRSM_Cardiovasc_Dis_2012_Sep_24_1(6)_cvd_2012_012015.nxml.txt.nlp	24175073	SENT57	27	27	5	5	clopidogrel	CYP2C19	PA449053	1557	0.225
NULL	Ann_Gen_Psychiatry_2010_Mar_6_9_11.nxml.txt.nlp	20205742	SENT67	3	3	6	6	aripiprazole	STAR	PA10026	6770;2984	0.224
NULL	Int_J_Environ_Res_Public_Health_2006_Jun_30_3(2)_121-128.nxml.txt.nlp	16823085	SENT467	1	1	0	0	arsenite	Yes	PA452638	7525	0.224
NULL	Toxins_(Basel)_2010_Oct_26_2(11)_2490-2518.nxml.txt.nlp	22069563	SENT320	9	9	7	7	cisplatin	TLR4	PA449014	7099	0.224
NULL	J_Cancer_Prev_2014_Sep_19(3)_153-160.nxml.txt.nlp	25337584	SENT29	12	12	9	9	dextran	AOM	PA449261	315	0.223
NULL	ACS_Nano_2011_Jul_26_5(7)_5300-5311.nxml.txt.nlp	21682329	SENT282	30	30	18	18	fluorescein	San	PA164746009	80218	0.223
NULL	J_Cell_Biol_2007_Apr_23_177(2)_317-328.nxml.txt.nlp	17452533	SENT345	15	15	15	15	pp2	PP2		4888	0.223
NULL	Br_J_Cancer_1995_May_71(5)_1051-1054.nxml.txt.nlp	7734298	SENT3	11	11	14	14	trypsin	TATI	PA451806	6690	0.223
NULL	Int_J_Mol_Sci_2010_Sep_13_11(9)_3195-3208.nxml.txt.nlp	20957088	SENT49	5	5	4	4	lipase	AT2	PA450239	186	0.223
NULL	Environ_Sci_Technol_2013_Jan_15_47(2)_661-677.nxml.txt.nlp	23227929	SENT168	14	14	10	10	carbamazepine	STP	PA448785	9322	0.223
NULL	J_Mol_Signal_2008_Mar_31_3_8.nxml.txt.nlp	18377662	SENT129	7	7	7	7	pp2	PP2		4888	0.223
NULL	Int_J_Mol_Sci_2010_Sep_13_11(9)_3195-3208.nxml.txt.nlp	20957088	SENT96	3	3	2	2	lipase	AT2	PA450239	186	0.222
NULL	J_Vet_Med_Sci_2014_Jul_18_76(7)_937-945.nxml.txt.nlp	24646457	SENT91	38	38	40	40	cephalexin	OTC	PA448883	5009	0.222
NULL	Indian_J_Psychiatry_2010_Jan_52(Suppl1)_S317-S340.nxml.txt.nlp	21836703	SENT118	23	23	13	13	thioproperazine	TFP	PA164754875	7034	0.222
NULL	Cell_Death_Dis_2014_Mar_13_5(3)_e1118.nxml.txt.nlp	24625977	SENT296	10	10	7	7	etoposide	mot-2	PA449552	3313	0.222
NULL	J_Biol_Chem_2008_Jun_20_283(25)_17194-17204.nxml.txt.nlp	18442977	SENT254	13	13	13	13	pp2	PP2		4888	0.222
NULL	Osteoporos_Int_2015_Sep_19_26_361-372.nxml.txt.nlp	25236877	SENT137	28	28	25	25	teriparatide	PTH	PA451620	5741	0.222
NULL	Clin_Dev_Immunol_2013_May_29_2013_296031.nxml.txt.nlp	23818913	SENT38	16	16	8	8	fluorescein	San	PA164746009	80218	0.222
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT91	26	26	26	26	pp2	PP2		4888	0.221
NULL	Brain_Behav_2011_Sep_1(1)_44-54.nxml.txt.nlp	22398980	SENT81	14	14	11	11	cocaine	MRI	PA449072	78996	0.221
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT206	5	5	5	5	pp2	PP2		4888	0.221
NULL	Arthritis_Res_Ther_2007_Oct_10_9(5)_R105.nxml.txt.nlp	17927818	SENT118	15	15	15	15	pp2	PP2		4888	0.221
NULL	J_Korean_Med_Sci_2013_Dec_26_28(12)_1774-1780.nxml.txt.nlp	24339708	SENT7	32	32	36	36	octreotide	OST	PA450678	1650;23263	0.221
NULL	Diabetologia_2011_Apr_25_54(4)_783-788.nxml.txt.nlp	21188353	SENT92	10	10	5	5	zinc	ZMAT4	PA451956	79698	0.221
NULL	Mol_Biol_Cell_2013_Sep_1_24(17)_2678-2688.nxml.txt.nlp	23864716	SENT84	22	22	22	22	pp2	PP2		4888	0.221
NULL	EMBO_J_2009_Apr_22_28(8)_1043-1054.nxml.txt.nlp	19300439	SENT119	29	29	29	29	pp2	PP2		4888	0.221
NULL	Clin_Ophthalmol_2010_Nov_23_4_1355-1359.nxml.txt.nlp	21179218	SENT65	22	22	23	23	travoprost	BAK	PA164781371	578	0.221
NULL	Cell_Commun_Signal_2013_Dec_23_11_100.nxml.txt.nlp	24364863	SENT338	27	27	27	27	pp2	PP2		4888	0.221
NULL	J_Gen_Physiol_2000_Mar_1_115(3)_229-240.nxml.txt.nlp	10694252	SENT340	6	6	8	8	dofetilide	HERG	PA449389	3757	0.221
NULL	Front_Physiol_2013_May_15_4_103.nxml.txt.nlp	23720630	SENT127	4	4	9	9	simvastatin	ADP	PA451363	23038	0.221
NULL	Genome_Biol_2008_Mar_10_9(3)_R51.nxml.txt.nlp	18331628	SENT135	31	31	42	42	nadh	ADP	PA164755085	23038	0.221
NULL	Int_J_Biol_Sci_2014_May_14_10(5)_566-575.nxml.txt.nlp	24910535	SENT232	19	19	22	22	nadh	BRCA1	PA164755085	672	0.22
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT122	5	5	5	5	pp2	PP2		4888	0.22
NULL	Int_J_Mol_Sci_2010_Sep_13_11(9)_3195-3208.nxml.txt.nlp	20957088	SENT77	7	7	6	6	lipase	AT2	PA450239	186	0.22
NULL	J_Cell_Biol_1994_Aug_1_126(3)_801-810.nxml.txt.nlp	8045941	SENT1	12	12	8	8	thrombin	LPA	PA451674	4018	0.22
NULL	Front_Physiol_2013_May_15_4_103.nxml.txt.nlp	23720630	SENT94	2	2	4	4	simvastatin	ADP	PA451363	23038	0.22
NULL	Exp_Ther_Med_2014_Feb_4_7(2)_478-482.nxml.txt.nlp	24396429	SENT131	22	22	29	29	glucose	GMD	PA449773	2762	0.22
NULL	Korean_J_Anesthesiol_2013_Jan_21_64(1)_47-53.nxml.txt.nlp	23372886	SENT127	25	25	23	23	bupivacaine	PTG	PA135057240	5507	0.22
NULL	Mucosal_Immunol_2014_Mar_24_7(2)_335-347.nxml.txt.nlp	23881354	SENT299	6	6	2	2	dextran	GAL	PA449261	51083	0.22
NULL	Int_J_Biol_Sci_2015_Jan_1_11(1)_48-58.nxml.txt.nlp	25552929	SENT15	12	12	9	9	paclitaxel	TSP-1	PA450761	7057	0.22
NULL	Contemp_Clin_Dent_2011_Oct-Dec_2(4)_278-282.nxml.txt.nlp	22346152	SENT88	11	11	21	21	potassium	GCF	PA451047	6936	0.22
NULL	Front_Behav_Neurosci_2010_Apr_5_4_14.nxml.txt.nlp	20407577	SENT835	5	5	3	3	cocaine	BDNF	PA449072	627	0.22
NULL	Mucosal_Immunol_2011_Sep_2_4(5)_528-538.nxml.txt.nlp	21289616	SENT179	14	14	13	13	collagenase	VIII	PA449107	1351	0.22
NULL	Aging_(Albany_NY)_2009_Dec_29_2(1)_63-68.nxml.txt.nlp	20228936	SENT51	31	31	9	9	nadh	CYB5R3	PA164755085	1727	0.22
NULL	Front_Hum_Neurosci_2012_Oct_19_6_288.nxml.txt.nlp	23091456	SENT148	10	10	12	12	ethanol	CO2	PA448073	4513	0.22
NULL	Cancers_(Basel)_2012_Oct_12_4(4)_989-1035.nxml.txt.nlp	24213498	SENT793	9	9	7	7	sorafenib	Mcl-1	PA7000	4170	0.22
NULL	J_Infect_Dis_2013_Sep_15_208(6)_1008-1019.nxml.txt.nlp	23776192	SENT28	15	15	11	11	ribavirin	IFN	PA451241	3439	0.22
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_May_26_68(Pt_6)_o1879-o1880.nxml.txt.nlp	22719639	SENT75	19	19	16	16	ethanol	mol	PA448073	90527	0.219
NULL	J_Cell_Biol_2008_Jul_28_182(2)_367-379.nxml.txt.nlp	18644892	SENT204	13	13	13	13	pp2	PP2		4888	0.219
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT134	23	23	23	23	pp2	PP2		4888	0.219
NULL	Crit_Care_2011_Mar_11_15(Suppl_1)_P433.nxml.txt.nlp	NULL	SENT2	11	11	17	17	warfarin	WICH	PA451906	147179	0.219
NULL	Mol_Cancer_2010_Dec_20_9_317.nxml.txt.nlp	21172025	SENT40	1	1	5	5	tamoxifen	HER2	PA451581	2064	0.219
NULL	AIDS_Behav_2008_Jul_9_12(4)_662-669.nxml.txt.nlp	17487577	SENT348	8	8	10	10	methamphetamine	San	PA450403	80218	0.219
NULL	Ther_Clin_Risk_Manag_2007_Aug_3(4)_569-578.nxml.txt.nlp	18472978	SENT122	6	6	10	10	metoprolol	MDC	PA450480	6367	0.219
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Jul_13_69(Pt_8)_o1242.nxml.txt.nlp	24109332	SENT64	5	5	4	4	indomethacin	mol	PA449982	90527	0.218
NULL	Cancer_Metab_2014_Aug_18_2_13.nxml.txt.nlp	25225614	SENT271	28	28	31	31	lipase	DAGLA	PA450239	747	0.218
NULL	J_Biol_Chem_2012_Aug_17_287(34)_28932-28942.nxml.txt.nlp	22718751	SENT143	16	16	16	16	pp2	PP2		4888	0.218
NULL	Mol_Cancer_2010_Dec_20_9_317.nxml.txt.nlp	21172025	SENT115	29	29	25	25	tamoxifen	EVL	PA451581	51466	0.217
NULL	Subst_Abuse_Treat_Prev_Policy_2009_Apr_17_4_6.nxml.txt.nlp	19374740	SENT48	32	32	37	37	diazepam	OST	PA449283	1650;23263	0.217
NULL	Diabetes_2011_Jan_28_60(1)_74-79.nxml.txt.nlp	20876712	SENT192	24	24	10	10	ethanol	adiponectin	PA448073	9370	0.217
NULL	Lab_Invest_2011_Sep_23_91(9)_1396-1409.nxml.txt.nlp	21606925	SENT11	2	2	2	2	pp2	PP2		4888	0.216
NULL	Int_J_Mol_Sci_2010_Sep_13_11(9)_3195-3208.nxml.txt.nlp	20957088	SENT54	1	1	0	0	lipase	AT2	PA450239	186	0.216
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Nov_15_5_27.nxml.txt.nlp	17107610	SENT39	6	6	4	4	ciprofloxacin	CPX	PA449009	1371;10682;1377	0.216
NULL	Onco_Targets_Ther_2014_Mar_6_7_395-404.nxml.txt.nlp	24623982	SENT82	13	13	9	9	imatinib	CR1	PA10804	1378	0.216
NULL	Cancer_Cell_Int_2013_Feb_14_13_16.nxml.txt.nlp	23409704	SENT79	20	20	20	20	pp2	PP2		4888	0.216
NULL	Extremophiles_2009_Nov_23_13(6)_885-894.nxml.txt.nlp	19701714	SENT133	29	29	28	28	ethanol	mol	PA448073	90527	0.216
NULL	Curr_Cardiol_Rev_2014_May_10(2)_161-171.nxml.txt.nlp	24527681	SENT244	27	27	24	24	nebivolol	CYP2C9	PA151958426	1559	0.216
NULL	Core_Evid_2007_Nov_30_2(2)_81-88.nxml.txt.nlp	21221177	SENT204	6	6	7	7	panitumumab	EGFR	PA162373091	1956	0.215
NULL	Biochem_Res_Int_2011_Apr_18_2011_459839.nxml.txt.nlp	21547085	SENT131	36	36	34	34	ethanol	EMP	PA448073	10296	0.215
NULL	Front_Behav_Neurosci_2014_Oct_30_8_366.nxml.txt.nlp	25400560	SENT208	27	27	23	23	ethanol	GAPDH	PA448073	2597	0.215
NULL	J_Inorg_Biochem_2014_Apr_133(100)_33-39.nxml.txt.nlp	24444821	SENT123	1	1	8	8	cisplatin	CH1	PA449014	51430	0.215
NULL	J_Oncol_2012_Feb_6_2012_737981.nxml.txt.nlp	22481932	SENT106	18	18	20	20	sunitinib	IL-6	PA162372840	3569	0.214
NULL	Int_J_Trop_Dis_Health_2014_4(5)_582-594.nxml.txt.nlp	25414840	SENT46	15	15	19	19	artemisinin	ACT	PA165111696	12;11332;9457;641455	0.214
NULL	J_Cancer_2012_Sep_26_3_404-420.nxml.txt.nlp	23074381	SENT300	15	15	0	0	nadh	PDH	PA164755085	54704	0.214
NULL	Cardiovasc_Res_2012_Dec_1_96(3)_466-475.nxml.txt.nlp	22915766	SENT204	0	0	3	3	creatine	HL-1	PA164778930	55600	0.214
NULL	Nat_Methods_2012_Nov_14_9(11)_1113-1119.nxml.txt.nlp	23064517	SENT173	3	3	3	3	pp2	PP2		4888	0.214
NULL	J_Signal_Transduct_2011_Dec_19_2011_636951.nxml.txt.nlp	21258655	SENT142	15	15	15	15	pp2	PP2		4888	0.213
NULL	Case_Rep_Dermatol_2013_Dec_7_5(3)_363-367.nxml.txt.nlp	24474919	SENT7	16	16	20	20	lipase	LIPH	PA450239	200879	0.213
NULL	Clin_Ophthalmol_2008_Sep_2(3)_613-621.nxml.txt.nlp	19668762	SENT113	11	11	12	12	travoprost	BAK	PA164781371	578	0.213
NULL	Br_J_Ophthalmol_2012_Jul_26_96(7)_1023-1028.nxml.txt.nlp	22539748	SENT164	15	15	21	21	bevacizumab	RPE	PA130232992	6120	0.213
NULL	Front_Physiol_2013_May_15_4_103.nxml.txt.nlp	23720630	SENT101	2	2	4	4	simvastatin	ADP	PA451363	23038	0.212
NULL	Diabetes_2008_Sep_57(9)_2272-2279.nxml.txt.nlp	18519799	SENT9	5	5	7	7	rosiglitazone	PDK2	PA451283	5164	0.212
NULL	Eur_Arch_Psychiatry_Clin_Neurosci_2010_Mar_12_260(2)_101-111.nxml.txt.nlp	19856012	SENT53	21	21	24	24	chlorpromazine	CPE	PA448964	1363	0.212
NULL	Br_J_Cancer_2009_May_19_100(10)_1540-1548.nxml.txt.nlp	19384300	SENT138	31	31	34	34	trypsin	TATI	PA451806	6690	0.212
NULL	Indian_J_Psychiatry_2010_Jan_52(Suppl1)_S317-S340.nxml.txt.nlp	21836703	SENT118	29	29	13	13	triflupromazine	TFP	PA451773	7034	0.212
NULL	J_Geriatr_Cardiol_2014_Jun_11(2)_151-157.nxml.txt.nlp	25009566	SENT136	12	12	0	0	cyclosporine	CDP	PA449167	1523	0.212
NULL	J_Inflamm_(Lond)_2006_May_4_3_8.nxml.txt.nlp	16674821	SENT209	25	25	25	25	pp2	PP2		4888	0.212
NULL	F1000Res_2014_Sep_29_3_228.nxml.txt.nlp	25485098	SENT24	20	20	31	31	l-arginine	GAMT	PA448478	2593	0.212
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Dec_13_65(Pt_1)_o106.nxml.txt.nlp	21581569	SENT66	24	24	21	21	ethanol	mol	PA448073	90527	0.211
NULL	Int_J_Mol_Sci_2014_Mar_5_15(3)_3970-3988.nxml.txt.nlp	24603537	SENT303	1	1	22	22	curcumin	IFN	PA151958596	3439	0.211
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Mar_19_67(Pt_4)_m463.nxml.txt.nlp	21753979	SENT69	20	20	14	14	ethanol	NO3	PA448073	4681	0.211
NULL	Br_J_Cancer_2009_Jul_21_101(2)_312-319.nxml.txt.nlp	19568237	SENT108	23	23	23	23	pp2	PP2		4888	0.211
NULL	J_Biol_Chem_2013_Dec_6_288(49)_35387-35395.nxml.txt.nlp	24142790	SENT156	37	37	30	30	meclizine	mol	PA450338	90527	0.211
NULL	J_Geriatr_Cardiol_2014_Jun_11(2)_151-157.nxml.txt.nlp	25009566	SENT121	12	12	0	0	cyclosporine	CDP	PA449167	1523	0.211
NULL	Curr_Cardiol_Rev_2014_May_10(2)_161-171.nxml.txt.nlp	24527681	SENT244	27	27	29	29	nebivolol	CYP2D6	PA151958426	1565	0.211
NULL	Clin_Mol_Hepatol_2014_Sep_25_20(3)_283-290.nxml.txt.nlp	25320732	SENT97	11	11	22	22	propranolol	EVL	PA451145	51466	0.21
NULL	Clin_Drug_Investig_2013_Jun_20_33(6)_419-427.nxml.txt.nlp	23605507	SENT177	4	4	5	5	ciprofloxacin	DPI	PA449009	1832	0.21
NULL	Front_Oncol_2011_Jun_17_1_10.nxml.txt.nlp	22655230	SENT1127	22	22	8	8	carboplatin	ERCC1	PA448803	2067	0.21
NULL	Clin_Drug_Investig_2013_Jun_20_33(6)_419-427.nxml.txt.nlp	23605507	SENT107	28	28	29	29	ciprofloxacin	DPI	PA449009	1832	0.209
NULL	Clin_Mol_Hepatol_2014_Sep_25_20(3)_283-290.nxml.txt.nlp	25320732	SENT98	17	17	11	11	propranolol	EVL	PA451145	51466	0.209
NULL	Cell_Microbiol_2013_Mar_20_15(3)_430-445.nxml.txt.nlp	23126643	SENT297	4	4	20	20	phenol	CD81	PA450913	975	0.209
NULL	Colomb_Med_(Cali)_43(3)_221-225.nxml.txt.nlp	24893196	SENT9	18	18	14	14	resveratrol	ACTH		5443	0.209
NULL	Springerplus_2014_Sep_9_3_510.nxml.txt.nlp	25279302	SENT13	0	0	5	5	l-arginine	GATM	PA448478	2628	0.209
NULL	Clin_Oncol_(R_Coll_Radiol)_2014_Sep_26(9)_581-596.nxml.txt.nlp	24998430	SENT226	31	31	4	4	erlotinib	CRT	PA134687924	811	0.209
NULL	Clin_Ophthalmol_2014_Aug_18_8_1527-1534.nxml.txt.nlp	25170245	SENT4	16	16	40	40	timolol	TIM	PA451690	7984;8914	0.209
NULL	Diabetes_2009_Apr_9_58(4)_965-974.nxml.txt.nlp	19136651	SENT32	0	0	6	6	nadh	NQO1	PA164755085	1728	0.208
NULL	Int_J_Anal_Chem_2013_Jul_16_2013_419716.nxml.txt.nlp	23956748	SENT182	39	39	35	35	ethanol	PF6	PA448073	200162	0.208
NULL	Breast_Cancer_Res_Treat_2014_Nov_11_148(3)_563-570.nxml.txt.nlp	25385180	SENT58	11	11	10	10	pertuzumab	PTH		5741	0.208
NULL	Mol_Cancer_2008_Sep_12_7_69.nxml.txt.nlp	18789131	SENT58	11	11	11	11	pp2	PP2		4888	0.208
NULL	Cancer_Cell_Int_2008_Mar_18_8_3.nxml.txt.nlp	18348720	SENT101	14	14	33	33	gefitinib	PC3	PA131301952	57332;7832;5122	0.208
NULL	Cell_Death_Dis_2010_May_27_1(5)_e46.nxml.txt.nlp	21364652	SENT66	16	16	15	15	choline	CDP	PA448976	1523	0.208
NULL	Indian_J_Med_Res_2014_Feb_139(2)_205-215.nxml.txt.nlp	24718394	SENT77	9	9	4	4	artemisinin	ACT	PA165111696	12;11332;9457;641455	0.208
NULL	Cell_Host_Microbe_2014_Sep_10_16(3)_291-303.nxml.txt.nlp	25211072	SENT209	23	23	23	23	pp2	PP2		4888	0.207
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT49	5	5	5	5	pp2	PP2		4888	0.207
NULL	J_Mol_Signal_2008_Mar_31_3_8.nxml.txt.nlp	18377662	SENT80	6	6	6	6	pp2	PP2		4888	0.207
NULL	BMJ_Open_2014_Oct_10_4(10)_e005708.nxml.txt.nlp	25304189	SENT48	14	14	13	13	haloperidol	FGA	PA449841	2243	0.206
NULL	Cell_Commun_Signal_2013_May_29_11_38.nxml.txt.nlp	23718910	SENT382	11	11	11	11	pp2	PP2		4888	0.206
NULL	J_Hematol_Oncol_2013_Jun_11_6_39.nxml.txt.nlp	23759001	SENT58	19	19	6	6	sorafenib	CR1	PA7000	1378	0.206
NULL	Int_J_Trop_Dis_Health_2014_4(5)_582-594.nxml.txt.nlp	25414840	SENT46	15	15	7	7	artemisinin	G6PD	PA165111696	2539	0.206
NULL	Mol_Biol_Cell_2014_Apr_1_25(7)_1151-1158.nxml.txt.nlp	24501422	SENT84	24	24	24	24	pp2	PP2		4888	0.206
NULL	Front_Endocrinol_(Lausanne)_2013_Oct_29_4_162.nxml.txt.nlp	24194733	SENT453	28	28	14	14	darapladib	ATV	PA165884699	4683	0.206
NULL	EMBO_Mol_Med_2012_Oct_30_4(10)_1087-1096.nxml.txt.nlp	22933245	SENT5	2	2	20	20	olaparib	NAMPT		10135	0.205
NULL	Int_J_Environ_Res_Public_Health_2011_Jul_30_8(7)_2747-2757.nxml.txt.nlp	21845156	SENT56	0	0	3	3	chymotrypsin	CTRC	PA448994	11330	0.205
NULL	Curr_Neuropharmacol_2013_Jan_11(1)_102-108.nxml.txt.nlp	23814542	SENT225	25	25	24	24	rivastigmine	Yes	PA451262	7525	0.205
NULL	Ann_Hematol_2014_Mar_18_93(8)_1335-1344.nxml.txt.nlp	24638841	SENT92	20	20	19	19	cyclophosphamide	CHOP	PA449165	1649	0.205
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R91.nxml.txt.nlp	22541814	SENT163	22	22	22	22	pp2	PP2		4888	0.205
NULL	Br_J_Cancer_2009_May_19_100(10)_1540-1548.nxml.txt.nlp	19384300	SENT2	4	4	7	7	trypsin	TATI	PA451806	6690	0.205
NULL	BMJ_2011_Feb_22_342_d636.nxml.txt.nlp	21343206	SENT321	36	36	22	22	ethanol	adiponectin	PA448073	9370	0.204
NULL	Neural_Comput_Appl_2010_Jul_9_19(5)_667-676.nxml.txt.nlp	20651904	SENT6	10	10	13	13	oxygen	BOD	PA450744	10018	0.204
NULL	Cell_Commun_Signal_2013_May_29_11_38.nxml.txt.nlp	23718910	SENT117	10	10	10	10	pp2	PP2		4888	0.204
NULL	Br_J_Cancer_2014_Jul_15_111(2)_318-325.nxml.txt.nlp	24874484	SENT140	12	12	11	11	choline	CDP	PA448976	1523	0.204
NULL	Ann_Clin_Microbiol_Antimicrob_2006_Nov_15_5_27.nxml.txt.nlp	17107610	SENT39	6	6	8	8	ciprofloxacin	EMB	PA449009	133418	0.204
NULL	Springerplus_2014_Sep_9_3_510.nxml.txt.nlp	25279302	SENT13	7	7	18	18	s-adenosylmethionine	CKM	PA164754994	1158	0.204
NULL	Mol_Neurodegener_2011_Aug_8_6_57.nxml.txt.nlp	21819629	SENT239	8	8	10	10	arsenite	TDP-43	PA452638	23435	0.204
NULL	Pharmaceuticals_(Basel)_2013_Aug_2_6(8)_915-928.nxml.txt.nlp	24276376	SENT202	22	22	20	20	thrombin	PAR-1	PA451674	2011;2149	0.204
NULL	Infect_Dis_Obstet_Gynecol_2012_Mar_15_2012_950650.nxml.txt.nlp	22496602	SENT98	6	6	10	10	isoniazid	IPT	PA450112	54802	0.204
NULL	Mol_Cell_Proteomics_2014_May_20_13(5)_1184-1197.nxml.txt.nlp	24556848	SENT307	42	42	42	42	pp2	PP2		4888	0.203
NULL	Int_J_Mol_Sci_2010_Sep_13_11(9)_3195-3208.nxml.txt.nlp	20957088	SENT217	1	1	0	0	lipase	AT2	PA450239	186	0.203
NULL	Biofactors_2014_May_6_40(3)_277-283.nxml.txt.nlp	24353111	SENT46	6	6	11	11	betaine	BHMT	PA448603	635	0.203
NULL	J_Cell_Biol_2005_May_23_169(4)_657-667.nxml.txt.nlp	15911880	SENT82	28	28	28	28	pp2	PP2		4888	0.203
NULL	Oncogenesis_2014_May_12_3(5)_e102.nxml.txt.nlp	24819061	SENT245	24	24	30	30	nadh	p53	PA164755085	7157	0.202
NULL	Virol_J_2011_May_17_8_234.nxml.txt.nlp	21575275	SENT2	25	25	23	23	ribavirin	IFN	PA451241	3439	0.202
NULL	Front_Immunol_2012_Jul_18_3_198.nxml.txt.nlp	22826708	SENT99	19	19	18	18	aldesleukin	IL-2	PA448081	3558	0.202
NULL	J_Nutr_Biochem_2012_Jan_23(1)_39-50.nxml.txt.nlp	21414768	SENT47	18	18	23	23	phenol	F12	PA450913	2161	0.202
NULL	Mol_Cancer_2010_Dec_20_9_317.nxml.txt.nlp	21172025	SENT209	11	11	15	15	tamoxifen	HER2	PA451581	2064	0.201
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT306	37	37	37	37	pp2	PP2		4888	0.201
NULL	BMB_Rep_2014_Sep_47(9)_494-499.nxml.txt.nlp	24393524	SENT2	0	0	6	6	nadh	NQO1	PA164755085	1728	0.201
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Mar_31_68(Pt_4)_m508.nxml.txt.nlp	22589860	SENT62	22	22	19	19	ethanol	mol	PA448073	90527	0.201
NULL	J_Cell_Biol_2008_Jul_28_182(2)_367-379.nxml.txt.nlp	18644892	SENT136	6	6	6	6	pp2	PP2		4888	0.201
NULL	Oncol_Lett_2013_Apr_5_5(4)_1123-1128.nxml.txt.nlp	23599750	SENT4	20	20	18	18	docetaxel	LDM	PA449383	1595	0.2
NULL	Biomed_Res_Int_2014_Jun_30_2014_121254.nxml.txt.nlp	25197630	SENT97	7	7	7	7	pp2	PP2		4888	0.2
NULL	Int_J_Surg_Case_Rep_2014_Oct_23_5(12)_979-983.nxml.txt.nlp	25460452	SENT172	23	23	18	18	paclitaxel	CK20	PA450761	54474	0.2
NULL	Biosci_Rep_2013_Jun_11_33(3)_e00042.nxml.txt.nlp	23634903	SENT548	7	7	10	10	trypsin	TATI	PA451806	6690	0.199
NULL	J_Gen_Physiol_2009_Jul_134(1)_79.nxml.txt.nlp	NULL	SENT363	23	23	23	23	pp2	PP2		4888	0.199
NULL	Mol_Biol_Cell_2013_Jul_1_24(13)_2134-2145.nxml.txt.nlp	23657817	SENT140	4	4	4	4	pp2	PP2		4888	0.199
NULL	Cell_Cycle_2013_Apr_15_12(8)_1303-1315.nxml.txt.nlp	23535298	SENT351	20	20	20	20	pp2	PP2		4888	0.199
NULL	Clin_Mol_Hepatol_2014_Sep_25_20(3)_283-290.nxml.txt.nlp	25320732	SENT105	13	13	20	20	propranolol	EVL	PA451145	51466	0.199
NULL	Br_J_Cancer_2013_Jun_25_108(12)_2505-2515.nxml.txt.nlp	23736036	SENT275	18	18	6	6	capecitabine	MTHFR	PA448771	4524	0.199
NULL	Braz_J_Microbiol_2009_Jun_1_Apr-Jun_40(2)_358-366.nxml.txt.nlp	24031373	SENT457	5	5	16	16	lipase	castor	PA450239	54897	0.199
NULL	Br_J_Cancer_2014_Jul_15_111(2)_318-325.nxml.txt.nlp	24874484	SENT73	27	27	26	26	choline	CDP	PA448976	1523	0.198
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT53	12	12	12	12	pp2	PP2		4888	0.198
NULL	Structure_2013_Jun_4_21(6)_1051-1058.nxml.txt.nlp	23665170	SENT65	9	9	2	2	oxygen	L29	PA450744	6159	0.198
NULL	Int_J_Ayurveda_Res_2010_Jan-Mar_1(1)_25-29.nxml.txt.nlp	20532094	SENT114	1	1	1	1	pp2	PP2		4888	0.198
NULL	Case_Rep_Psychiatry_2012_Jun_5_2012_496364.nxml.txt.nlp	22934218	SENT51	18	18	17	17	perphenazine	FGA	PA450882	2243	0.198
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT533	27	27	27	27	pp2	PP2		4888	0.197
NULL	Oncotarget_2014_Oct_18_5(22)_11604-11619.nxml.txt.nlp	25344099	SENT150	4	4	9	9	cisplatin	p53	PA449014	7157	0.196
NULL	Int_J_Anal_Chem_2013_Jul_16_2013_419716.nxml.txt.nlp	23956748	SENT184	18	18	14	14	ethanol	PF6	PA448073	200162	0.196
NULL	Front_Genet_2011_Nov_3_2_78.nxml.txt.nlp	22114584	SENT104	24	24	20	20	guanidine	TIAM1	PA164781028	7074	0.196
NULL	Cell_Death_Dis_2014_Jul_17_5(7)_e1336.nxml.txt.nlp	25032859	SENT71	11	11	3	3	nadh	ADP	PA164755085	23038	0.196
NULL	Oncol_Lett_2013_Aug_20_6(2)_329-335.nxml.txt.nlp	24137325	SENT100	22	22	22	22	pp2	PP2		4888	0.195
NULL	Nat_Commun_2013_Nov_27_4_2821.nxml.txt.nlp	24281726	SENT778	13	13	13	13	pp2	PP2		4888	0.195
NULL	Appl_Clin_Genet_2014_Nov_10_7_209-220.nxml.txt.nlp	25419154	SENT191	9	9	8	8	aldesleukin	IL-2	PA448081	3558	0.195
NULL	Nutr_J_2014_Jan_24_13_11.nxml.txt.nlp	24461029	SENT158	13	13	9	9	curcumin	CTR	PA151958596	799	0.195
NULL	J_Vis_Exp_2010_Jan_28_(35)_1488.nxml.txt.nlp	20110936	SENT72	18	18	11	11	choline	CD5	PA448976	921	0.194
NULL	Allergy_Asthma_Immunol_Res_2014_Mar_15_6(2)_126-130.nxml.txt.nlp	24587948	SENT111	10	10	12	12	salbutamol	TTN	PA448068	7273	0.194
NULL	J_Signal_Transduct_2010_Sep_1_2010_643642.nxml.txt.nlp	21637354	SENT56	25	25	25	25	pp2	PP2		4888	0.194
NULL	J_Biol_Chem_2008_Dec_19_283(51)_35419-35427.nxml.txt.nlp	18955485	SENT219	25	25	25	25	pp2	PP2		4888	0.194
NULL	Br_J_Pharmacol_2010_Sep_161(2)_241-270.nxml.txt.nlp	20735414	SENT141	4	4	7	7	lipase	LIPH	PA450239	200879	0.194
NULL	Cancer_Metastasis_Rev_2014_Jan_17_33(1)_217-229.nxml.txt.nlp	24436017	SENT58	13	13	35	35	nadh	SIRT1	PA164755085	23411	0.194
NULL	Springerplus_2014_Sep_9_3_510.nxml.txt.nlp	25279302	SENT13	0	0	18	18	l-arginine	CKM	PA448478	1158	0.193
NULL	Springerplus_2014_Sep_9_3_510.nxml.txt.nlp	25279302	SENT13	7	7	12	12	s-adenosylmethionine	GAMT	PA164754994	2593	0.193
NULL	Case_Rep_Rheumatol_2012_Dec_12_2012_517424.nxml.txt.nlp	23304614	SENT11	6	6	5	5	tocilizumab	IL-6	PA165292659	3569	0.193
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Nov_13_66(Pt_12)_o3178.nxml.txt.nlp	21589473	SENT67	37	37	34	34	ethanol	mol	PA448073	90527	0.193
NULL	Int_J_Mol_Sci_2012_Apr_17_13(4)_4839-4859.nxml.txt.nlp	22606013	SENT530	19	19	22	22	simvastatin	CCL2	PA451363	6347	0.193
NULL	Environ_Health_Perspect_2012_Jul_11_120(7)_1029-1035.nxml.txt.nlp	22494775	SENT65	12	12	12	12	pp2	PP2		4888	0.192
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT178	12	12	12	12	pp2	PP2		4888	0.192
NULL	Exp_Diabetes_Res_2012_Apr_26_2012_316384.nxml.txt.nlp	22611373	SENT5	17	17	20	20	streptozocin	STZ	PA451514	6484	0.192
NULL	J_Biol_Chem_2009_Sep_18_284(38)_26096-26105.nxml.txt.nlp	19628870	SENT193	15	15	15	15	pp2	PP2		4888	0.192
NULL	J_Cell_Biol_2008_Jul_14_182(1)_157-169.nxml.txt.nlp	18606851	SENT167	10	10	10	10	pp2	PP2		4888	0.192
NULL	J_Vet_Med_Sci_2014_Jul_18_76(7)_937-945.nxml.txt.nlp	24646457	SENT91	14	14	40	40	chloramphenicol	OTC	PA448927	5009	0.191
NULL	AIDS_Res_Ther_2013_May_1_10_10.nxml.txt.nlp	23634877	SENT6	27	27	29	29	lovastatin	CCR5	PA450272	1234	0.191
NULL	Int_J_Mol_Sci_2010_Sep_13_11(9)_3195-3208.nxml.txt.nlp	20957088	SENT52	5	5	4	4	lipase	AT2	PA450239	186	0.19
NULL	J_Radiat_Res_2012_Jul_12_53(4)_551-557.nxml.txt.nlp	22843620	SENT130	18	18	18	18	pp2	PP2		4888	0.19
NULL	J_Physiol_2008_Oct_1_586(Pt_19)_4693-4707.nxml.txt.nlp	18703578	SENT165	24	24	24	24	pp2	PP2		4888	0.19
NULL	Arthritis_Res_2000_Jun_8_2(5)_348-355.nxml.txt.nlp	11094447	SENT169	6	6	10	10	heparin	perlecan	PA449855	3339	0.189
NULL	Curr_Oncol_2010_Jul_17(Suppl_1)_S3-S17.nxml.txt.nlp	20680105	SENT160	4	4	3	3	cetuximab	FOR	PA10040	51741	0.189
NULL	eLife_2014_Apr_25_3_e02057.nxml.txt.nlp	24771768	SENT824	19	19	4	4	resveratrol	SHK		23729	0.189
NULL	Clin_Drug_Investig_2013_Jun_20_33(6)_419-427.nxml.txt.nlp	23605507	SENT58	4	4	5	5	ciprofloxacin	DPI	PA449009	1832	0.189
NULL	Aging_(Albany_NY)_2012_Mar_4_4(3)_144-145.nxml.txt.nlp	22388573	SENT11	8	8	18	18	resveratrol	AMPK		5563	0.189
NULL	Virol_J_2011_Oct_4_8_460.nxml.txt.nlp	21967756	SENT95	23	23	17	17	l-cysteine	NAC	PA449173	22861	0.189
NULL	J_Signal_Transduct_2010_Sep_1_2010_643642.nxml.txt.nlp	21637354	SENT89	15	15	15	15	pp2	PP2		4888	0.189
NULL	Clin_Med_Oncol_2008_Oct_30_2_539-545.nxml.txt.nlp	21892329	SENT97	2	2	2	2	pp2	PP2		4888	0.188
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT234	7	7	7	7	pp2	PP2		4888	0.188
NULL	J_Cell_Biol_2001_Jul_9_154(1)_177-186.nxml.txt.nlp	11448999	SENT105	15	15	15	15	pp2	PP2		4888	0.188
NULL	J_Biol_Chem_2009_May_1_284(18)_11953-11962.nxml.txt.nlp	19254952	SENT231	13	13	13	13	pp2	PP2		4888	0.187
NULL	Front_Physiol_2013_Jul_15_4_179.nxml.txt.nlp	23874304	SENT154	19	19	13	13	flecainide	KCNJ8	PA449646	3764	0.187
NULL	Br_J_Cancer_1988_Mar_57(3)_304-307.nxml.txt.nlp	3162682	SENT0	9	9	12	12	trypsin	TATI	PA451806	6690	0.187
NULL	Int_J_Health_Geogr_2013_Mar_21_12_17.nxml.txt.nlp	23518004	SENT231	9	9	12	12	creatine	ACR	PA164778930	49	0.186
NULL	J_Cell_Biol_2003_Aug_18_162(4)_661-671.nxml.txt.nlp	12925710	SENT60	18	18	18	18	pp2	PP2		4888	0.186
NULL	Springerplus_2014_Sep_11_3_516.nxml.txt.nlp	25279308	SENT160	17	17	20	20	ethanol	SHF	PA448073	90525	0.185
NULL	J_Cell_Biol_2008_Jul_28_182(2)_367-379.nxml.txt.nlp	18644892	SENT144	32	32	32	32	pp2	PP2		4888	0.185
NULL	Cancers_(Basel)_2014_Sep_29_6(4)_1925-1952.nxml.txt.nlp	25268163	SENT74	8	8	12	12	mitoxantrone	MXR	PA450526	9429	0.184
NULL	Nucleic_Acids_Res_2012_Jul_20_40(13)_6270-6289.nxml.txt.nlp	22434888	SENT155	35	35	38	38	galactose	GAL	PA449725	51083	0.184
NULL	Clin_Ophthalmol_2014_Sep_26_8_1967-1985.nxml.txt.nlp	25328381	SENT121	10	10	9	9	tafluprost	BAK	PA165958432	578	0.184
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Nov_27_66(Pt_12)_o3316.nxml.txt.nlp	21589593	SENT57	31	31	28	28	ethanol	mol	PA448073	90527	0.184
NULL	Cardiovasc_Diabetol_2011_Feb_11_10_18.nxml.txt.nlp	21314919	SENT90	22	22	17	17	glimepiride	Met	PA449761	79811	0.184
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Mar_31_68(Pt_4)_o1263.nxml.txt.nlp	22606192	SENT13	1	1	2	2	exemestane	aromatase	PA449563	1588	0.184
NULL	Br_J_Cancer_1990_Dec_62(6)_954-958.nxml.txt.nlp	2257226	SENT0	10	10	13	13	trypsin	PSTI	PA451806	6690	0.184
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT1706	5	5	4	4	fosamprenavir	ATV	PA10084	4683	0.183
NULL	Indian_J_Dermatol_2014_Nov-Dec_59(6)_634b.nxml.txt.nlp	25484430	SENT53	4	4	7	7	lipase	LIPH	PA450239	200879	0.183
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT91	5	5	5	5	pp2	PP2		4888	0.183
NULL	Curr_Chem_Genomics_2011_Aug_22_5_72-84.nxml.txt.nlp	21966347	SENT142	21	21	14	14	suramin	SIRT1	PA10292	23411	0.183
NULL	Open_Virol_J_2009_Apr_1_3_21-25.nxml.txt.nlp	19572053	SENT104	20	20	20	20	pp2	PP2		4888	0.182
NULL	Biochemistry_2011_Oct_11_50(40)_8664-8673.nxml.txt.nlp	21905705	SENT141	38	38	38	38	pp2	PP2		4888	0.182
NULL	J_Cell_Biol_2002_Mar_18_156(6)_951-957.nxml.txt.nlp	11901164	SENT95	11	11	11	11	pp2	PP2		4888	0.182
NULL	Acta_Pharmacol_Sin_2011_Jan_6_32(1)_133-138.nxml.txt.nlp	21131997	SENT50	24	24	21	21	heparin	ACT	PA449855	12;11332;9457;641455	0.182
NULL	Oncogenesis_2014_May_12_3(5)_e102.nxml.txt.nlp	24819061	SENT143	19	19	11	11	nadh	SIRT1	PA164755085	23411	0.182
NULL	Open_Virol_J_2010_Jun_23_4_157-162.nxml.txt.nlp	20835359	SENT154	39	39	39	39	pp2	PP2		4888	0.182
NULL	Support_Care_Cancer_2010_May_27_18(5)_529-541.nxml.txt.nlp	20191292	SENT62	1	1	0	0	cyclophosphamide	CHOP	PA449165	1649	0.181
NULL	Breast_Cancer_Res_2006_Jul_19_8(4)_R42.nxml.txt.nlp	16859511	SENT419	32	32	32	32	pp2	PP2		4888	0.181
NULL	Brain_2014_Feb_24_137(2)_335-353.nxml.txt.nlp	24369379	SENT218	19	19	16	16	galactose	NRF1	PA449725	4899;4779	0.181
NULL	Oncogene_2009_Apr_23_28(16)_1821-1832.nxml.txt.nlp	19305428	SENT176	2	2	2	2	pp2	PP2		4888	0.181
NULL	Br_J_Cancer_2014_Jul_15_111(2)_318-325.nxml.txt.nlp	24874484	SENT59	12	12	11	11	choline	CDP	PA448976	1523	0.18
NULL	Breast_Cancer_Res_2006_Jul_19_8(4)_R42.nxml.txt.nlp	16859511	SENT405	12	12	12	12	pp2	PP2		4888	0.18
NULL	Ann_Gen_Psychiatry_2010_Apr_24_9_18.nxml.txt.nlp	20416097	SENT0	13	13	1	1	fluvoxamine	Gen	PA449690	348654	0.18
NULL	Nat_Commun_2013_Nov_27_4_2821.nxml.txt.nlp	24281726	SENT779	14	14	14	14	pp2	PP2		4888	0.18
NULL	Breast_Cancer_Res_2009_Sep_9_11(5)_R68.nxml.txt.nlp	19740433	SENT49	37	37	37	37	pp2	PP2		4888	0.18
NULL	Cancer_Cell_Int_2013_Feb_14_13_16.nxml.txt.nlp	23409704	SENT73	32	32	32	32	pp2	PP2		4888	0.18
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT349	27	27	27	27	pp2	PP2		4888	0.18
NULL	Diabetes_Care_2009_Oct_23_32(10)_1887-1889.nxml.txt.nlp	19549731	SENT22	14	14	15	15	collagenase	NB1	PA449107	57126	0.179
NULL	Indian_J_Psychiatry_1996_Oct-Dec_38(4)_271b-272.nxml.txt.nlp	21709854	SENT2	9	9	8	8	clozapine	FOR	PA449061	51741	0.179
NULL	J_Cell_Biol_2003_Aug_18_162(4)_661-671.nxml.txt.nlp	12925710	SENT181	19	19	19	19	pp2	PP2		4888	0.179
NULL	Ann_Gen_Psychiatry_2013_Jul_11_12_22.nxml.txt.nlp	23845018	SENT0	18	18	3	3	paliperidone	Gen	PA163518919	348654	0.179
NULL	J_Anaesthesiol_Clin_Pharmacol_2012_Jan-Mar_28(1)_106-110.nxml.txt.nlp	22345956	SENT80	27	27	28	28	kaolin	ACT	PA10457	12;11332;9457;641455	0.178
NULL	Oncol_Lett_2013_Aug_20_6(2)_329-335.nxml.txt.nlp	24137325	SENT48	36	36	36	36	pp2	PP2		4888	0.178
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT108	9	9	9	9	pp2	PP2		4888	0.178
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT352	23	23	23	23	pp2	PP2		4888	0.178
NULL	Curr_Neuropharmacol_2008_Jun_6(2)_151-163.nxml.txt.nlp	19305794	SENT452	1	1	2	2	capsaicin	VR1	PA448776	56664	0.178
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jul_30_67(Pt_8)_o2144.nxml.txt.nlp	22091160	SENT80	18	18	15	15	ethanol	mol	PA448073	90527	0.178
NULL	Cell_Commun_Signal_2013_Apr_24_11_31.nxml.txt.nlp	23618389	SENT134	15	15	15	15	pp2	PP2		4888	0.178
NULL	J_Gen_Physiol_2004_Apr_123(4)_427-439.nxml.txt.nlp	15024039	SENT289	18	18	18	18	pp2	PP2		4888	0.177
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT1699	3	3	2	2	fosamprenavir	ATV	PA10084	4683	0.177
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jun_26_66(Pt_7)_o1794.nxml.txt.nlp	21588004	SENT60	31	31	28	28	ethanol	mol	PA448073	90527	0.177
NULL	Oxid_Med_Cell_Longev_2013_Nov_4_2013_564902.nxml.txt.nlp	24303086	SENT200	7	7	19	19	glucose	STZ	PA449773	6484	0.177
NULL	Arthritis_Res_Ther_2007_Oct_10_9(5)_R105.nxml.txt.nlp	17927818	SENT173	5	5	5	5	pp2	PP2		4888	0.177
NULL	J_Physiol_2008_Oct_1_586(Pt_19)_4693-4707.nxml.txt.nlp	18703578	SENT225	6	6	6	6	pp2	PP2		4888	0.176
NULL	Indian_J_Pharmacol_2008_Jun_40(3)_95-102.nxml.txt.nlp	20040934	SENT122	3	3	5	5	efalizumab	LFA-1	PA164748817	3683;3689	0.176
NULL	Angew_Chem_Int_Ed_Engl_2012_Nov_5_51(45)_11249-11253.nxml.txt.nlp	22893362	SENT98	15	15	21	21	dextran	mol	PA449261	90527	0.176
NULL	Indian_J_Pharm_Sci_2012_May-Jun_74(3)_271-274.nxml.txt.nlp	23439934	SENT68	7	7	6	6	atenolol	FOR	PA448499	51741	0.176
NULL	Indian_J_Pharm_Sci_2014_Sep-Oct_76(5)_407-414.nxml.txt.nlp	25425754	SENT52	3	3	2	2	sitagliptin	FOR	PA164748978	51741	0.175
NULL	Br_J_Cancer_2012_Nov_6_107(10)_1737-1744.nxml.txt.nlp	23037715	SENT241	10	10	10	10	pp2	PP2		4888	0.175
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_May_11_69(Pt_6)_o870.nxml.txt.nlp	23795049	SENT68	13	13	10	10	ethanol	mol	PA448073	90527	0.175
NULL	J_Inflamm_(Lond)_2006_May_4_3_8.nxml.txt.nlp	16674821	SENT140	13	13	13	13	pp2	PP2		4888	0.175
NULL	J_Biol_Chem_2008_Dec_19_283(51)_35419-35427.nxml.txt.nlp	18955485	SENT248	21	21	21	21	pp2	PP2		4888	0.175
NULL	Anal_Chem_Insights_2011_Feb_23_6_7-14.nxml.txt.nlp	21760705	SENT82	14	14	15	15	meropenem	API	PA164764445	5345	0.174
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT347	27	27	27	27	pp2	PP2		4888	0.173
NULL	Clin_Drug_Investig_2013_Jun_20_33(6)_419-427.nxml.txt.nlp	23605507	SENT150	7	7	8	8	ciprofloxacin	DPI	PA449009	1832	0.173
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT107	4	4	4	4	pp2	PP2		4888	0.173
NULL	Eur_J_Clin_Invest_2012_Jan_42(1)_49-60.nxml.txt.nlp	21749368	SENT87	36	36	36	36	pp2	PP2		4888	0.173
NULL	Acta_Neuropathol_2012_Mar_16_123(3)_369-380.nxml.txt.nlp	22083253	SENT316	20	20	25	25	lovastatin	NF1	PA450272	4763	0.173
NULL	J_Inflamm_(Lond)_2006_May_4_3_8.nxml.txt.nlp	16674821	SENT127	11	11	11	11	pp2	PP2		4888	0.172
NULL	J_Immunol_Methods_2009_Jan_1_340(1)_11-24.nxml.txt.nlp	18929568	SENT61	23	23	23	23	pp2	PP2		4888	0.172
NULL	Nat_Commun_2014_Jul_16_5_4425.nxml.txt.nlp	25028121	SENT26	30	30	30	30	pp2	PP2		4888	0.172
NULL	Cell_Commun_Signal_2013_Jan_22_11_6.nxml.txt.nlp	23339737	SENT76	11	11	11	11	pp2	PP2		4888	0.172
NULL	Int_J_Biol_Sci_2015_Jan_1_11(1)_48-58.nxml.txt.nlp	25552929	SENT152	6	6	7	7	paclitaxel	LDM	PA450761	1595	0.171
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT537	26	26	26	26	pp2	PP2		4888	0.171
NULL	Biochemistry_2013_Dec_17_52(50)_9059-9067.nxml.txt.nlp	24266852	SENT108	16	16	16	16	pp2	PP2		4888	0.171
NULL	Br_J_Cancer_2001_Aug_85(4)_618-624.nxml.txt.nlp	11506505	SENT8	8	8	21	21	genistein	AP-1	PA165109660	2353;3727;2354;3725	0.17
NULL	Clin_Drug_Investig_2013_Jun_20_33(6)_419-427.nxml.txt.nlp	23605507	SENT174	4	4	5	5	ciprofloxacin	DPI	PA449009	1832	0.17
NULL	Br_J_Cancer_2013_Jan_15_108(1)_183-187.nxml.txt.nlp	23299529	SENT106	41	41	34	34	choline	B12	PA448976	7126;4709	0.17
NULL	Structure_2014_Feb_4_22(2)_337-344.nxml.txt.nlp	24389026	SENT87	20	20	24	24	oxygen	FANCL	PA450744	55120	0.169
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT535	31	31	31	31	pp2	PP2		4888	0.169
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT225	20	20	20	20	pp2	PP2		4888	0.169
NULL	Asian_J_Androl_2014_Jan_7_May-Jun_16(3)_341-347.nxml.txt.nlp	24435057	SENT21	13	13	25	25	denosumab	RANKL	PA166048634	8600	0.169
NULL	Mol_Vis_2010_Sep_4_16_1823-1831.nxml.txt.nlp	21045919	SENT247	8	8	11	11	l-carnitine	OCTN2	PA450154	6584	0.169
NULL	Mol_Pain_2013_May_20_9_25.nxml.txt.nlp	23688027	SENT240	4	4	7	7	carrageenan	STZ	PA448814	6484	0.168
NULL	Mol_Biol_Cell_2012_Nov_1_23(21)_4212-4225.nxml.txt.nlp	22956765	SENT325	17	17	17	17	pp2	PP2		4888	0.168
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT121	32	32	32	32	pp2	PP2		4888	0.168
NULL	Mol_Cancer_2003_Sep_23_2_33.nxml.txt.nlp	14572313	SENT163	10	10	10	10	pp2	PP2		4888	0.168
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT280	18	18	18	18	pp2	PP2		4888	0.168
NULL	Br_J_Cancer_2011_Nov_8_105(10)_1563-1573.nxml.txt.nlp	22015557	SENT169	5	5	13	13	sunitinib	c-Myc	PA162372840	4609	0.168
NULL	Br_J_Cancer_2011_May_10_104(10)_1628-1640.nxml.txt.nlp	21505453	SENT152	17	17	17	17	pp2	PP2		4888	0.168
NULL	Oncol_Lett_2013_Aug_20_6(2)_329-335.nxml.txt.nlp	24137325	SENT77	6	6	6	6	pp2	PP2		4888	0.167
NULL	ASN_Neuro_2009_Apr_14_1(1)_e00005.nxml.txt.nlp	19570022	SENT128	5	5	5	5	pp2	PP2		4888	0.167
NULL	Facts_Views_Vis_Obgyn_2013_5(1)_72-81.nxml.txt.nlp	24753931	SENT134	5	5	10	10	guanidine	GEF	PA164781028	56731	0.167
NULL	Eur_J_Cancer_2014_Sep_50(14)_2367-2374.nxml.txt.nlp	25027307	SENT300	12	12	8	8	estradiol	AMH	PA449503	268	0.167
NULL	Cell_Commun_Signal_2013_May_29_11_38.nxml.txt.nlp	23718910	SENT113	11	11	11	11	pp2	PP2		4888	0.166
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT71	34	34	34	34	pp2	PP2		4888	0.166
NULL	Oncol_Lett_2013_Aug_20_6(2)_329-335.nxml.txt.nlp	24137325	SENT129	6	6	6	6	pp2	PP2		4888	0.166
NULL	J_Cell_Biol_2005_Jul_18_170(2)_285-294.nxml.txt.nlp	16027224	SENT342	12	12	12	12	pp2	PP2		4888	0.166
NULL	Cardiovasc_Diabetol_2011_Feb_11_10_18.nxml.txt.nlp	21314919	SENT90	27	27	17	17	gliclazide	Met	PA10892	79811	0.165
NULL	Biomed_Res_Int_2013_May_8_2013_703130.nxml.txt.nlp	23738330	SENT160	26	26	1	1	lipase	ARM	PA450239	80210	0.165
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jun_5_66(Pt_7)_o1574.nxml.txt.nlp	21587815	SENT58	31	31	28	28	ethanol	mol	PA448073	90527	0.165
NULL	Clin_Drug_Investig_2013_Jun_20_33(6)_419-427.nxml.txt.nlp	23605507	SENT16	19	19	20	20	ciprofloxacin	DPI	PA449009	1832	0.164
NULL	J_Clin_Biochem_Nutr_2010_Jan_29_46(1)_1-13.nxml.txt.nlp	20104259	SENT85	33	33	33	33	pp2	PP2		4888	0.164
NULL	J_Physiol_2008_Jul_1_586(Pt_13)_3087-3095.nxml.txt.nlp	18467363	SENT156	18	18	17	17	lipase	DAG	PA450239	1605	0.164
NULL	Cell_Commun_Signal_2013_May_29_11_38.nxml.txt.nlp	23718910	SENT180	27	27	27	27	pp2	PP2		4888	0.164
NULL	Breast_Cancer_Res_2009_Sep_9_11(5)_R68.nxml.txt.nlp	19740433	SENT115	6	6	6	6	pp2	PP2		4888	0.164
NULL	Mol_Biol_Int_2011_Feb_24_2011_137459.nxml.txt.nlp	22091395	SENT84	7	7	8	8	arsenite	PRMT3	PA452638	10196	0.164
NULL	Clin_Ophthalmol_2012_Dec_13_6_1-4.nxml.txt.nlp	22259229	SENT72	11	11	12	12	travoprost	BAK	PA164781371	578	0.163
NULL	Cell_Death_Dis_2014_Mar_13_5(3)_e1118.nxml.txt.nlp	24625977	SENT81	36	36	33	33	etoposide	mot-2	PA449552	3313	0.163
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT71	24	24	24	24	pp2	PP2		4888	0.163
NULL	Clin_Drug_Investig_2013_Jun_20_33(6)_419-427.nxml.txt.nlp	23605507	SENT11	17	17	18	18	ciprofloxacin	DPI	PA449009	1832	0.163
NULL	Crit_Care_1997_Nov_26_1(2)_85-87.nxml.txt.nlp	11094466	SENT49	3	3	2	2	estradiol	CPBP	PA449503	1316	0.163
NULL	Cell_Commun_Signal_2013_May_29_11_38.nxml.txt.nlp	23718910	SENT186	11	11	11	11	pp2	PP2		4888	0.163
NULL	Br_J_Cancer_2011_May_10_104(10)_1628-1640.nxml.txt.nlp	21505453	SENT214	38	38	38	38	pp2	PP2		4888	0.163
NULL	Mol_Cancer_2013_Sep_24_12_109.nxml.txt.nlp	24063540	SENT174	5	5	26	26	collagenase	VIII	PA449107	1351	0.162
NULL	Biochemistry_2013_Dec_17_52(50)_9059-9067.nxml.txt.nlp	24266852	SENT96	16	16	16	16	pp2	PP2		4888	0.162
NULL	Front_Physiol_2013_May_15_4_103.nxml.txt.nlp	23720630	SENT119	4	4	6	6	simvastatin	ADP	PA451363	23038	0.161
NULL	J_Exp_Med_1953_Feb_28_97(3)_345-355.nxml.txt.nlp	13052805	SENT0	18	18	17	17	spermine	FOR	PA164781199	51741	0.161
NULL	Springerplus_2014_Sep_9_3_510.nxml.txt.nlp	25279302	SENT13	7	7	5	5	s-adenosylmethionine	GATM	PA164754994	2628	0.161
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT154	21	21	21	21	pp2	PP2		4888	0.16
NULL	J_Inflamm_(Lond)_2006_May_4_3_8.nxml.txt.nlp	16674821	SENT196	6	6	23	23	pp2	p38		10598;1432;7965	0.16
NULL	Cell_Commun_Signal_2011_May_20_9_14.nxml.txt.nlp	21599982	SENT73	22	22	22	22	pp2	PP2		4888	0.16
NULL	Evid_Based_Complement_Alternat_Med_2014_Nov_3_2014_473213.nxml.txt.nlp	25538791	SENT182	9	9	14	14	ethanol	CYP3A	PA448073	1574	0.16
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT192	10	10	9	9	lapatinib	Yes	PA152241907	7525	0.16
NULL	Br_J_Cancer_2010_Jun_29_103(1)_52-60.nxml.txt.nlp	20531411	SENT116	23	23	22	22	gemcitabine	MTD	PA449748	4493	0.16
NULL	Am_J_Transplant_2014_Nov_2_14(11)_2595-2606.nxml.txt.nlp	25278159	SENT61	12	12	11	11	collagenase	NB1	PA449107	57126	0.159
NULL	Ann_Gen_Psychiatry_2014_Dec_4_13(1)_37.nxml.txt.nlp	NULL	SENT0	17	17	3	3	pregabalin	Gen	PA164754814	348654	0.159
NULL	J_Mol_Signal_2012_Sep_8_7_15.nxml.txt.nlp	22958338	SENT171	12	12	12	12	pp2	PP2		4888	0.159
NULL	Clin_Interv_Aging_2013_Feb_5_8_131-137.nxml.txt.nlp	23403474	SENT35	5	5	4	4	choline	CDP	PA448976	1523	0.159
NULL	Cell_Commun_Signal_2013_May_29_11_38.nxml.txt.nlp	23718910	SENT313	2	2	2	2	pp2	PP2		4888	0.159
NULL	J_Biol_Chem_2009_May_1_284(18)_11953-11962.nxml.txt.nlp	19254952	SENT273	12	12	12	12	pp2	PP2		4888	0.159
NULL	Ann_Gen_Psychiatry_2013_Jul_11_12_22.nxml.txt.nlp	23845018	SENT0	14	14	1	1	paliperidone	Gen	PA163518919	348654	0.159
NULL	Clin_Med_Insights_Oncol_2013_Jul_4_7_159-163.nxml.txt.nlp	23885182	SENT86	13	13	27	27	doxorubicin	CHOP	PA449412	1649	0.159
NULL	Clin_Drug_Investig_2013_Jun_20_33(6)_419-427.nxml.txt.nlp	23605507	SENT98	8	8	9	9	ciprofloxacin	DPI	PA449009	1832	0.158
NULL	Cell_Commun_Signal_2013_Jan_22_11_6.nxml.txt.nlp	23339737	SENT83	17	17	17	17	pp2	PP2		4888	0.158
NULL	Ann_Ib_Postgrad_Med_2012_Jun_10(1)_25-30.nxml.txt.nlp	25161403	SENT0	27	27	15	15	glucose	ARD	PA449773	55256	0.158
NULL	J_Gen_Physiol_2004_Apr_123(4)_427-439.nxml.txt.nlp	15024039	SENT478	19	19	19	19	pp2	PP2		4888	0.158
NULL	Clin_Drug_Investig_2013_Jun_20_33(6)_419-427.nxml.txt.nlp	23605507	SENT144	15	15	16	16	ciprofloxacin	DPI	PA449009	1832	0.158
NULL	J_Cell_Biol_2001_Mar_19_152(6)_1135-1144.nxml.txt.nlp	11257115	SENT224	21	21	20	20	lipase	DAG	PA450239	1605	0.158
NULL	Arthritis_Res_Ther_2007_Oct_10_9(5)_R105.nxml.txt.nlp	17927818	SENT124	35	35	35	35	pp2	PP2		4888	0.158
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT172	22	22	22	22	pp2	PP2		4888	0.158
NULL	Case_Rep_Psychiatry_2012_Jun_5_2012_496364.nxml.txt.nlp	22934218	SENT46	20	20	19	19	levomepromazine	FGA	PA134687942	2243	0.157
NULL	Eur_Respir_J_2013_May_27_41(5)_1107-1115.nxml.txt.nlp	23018904	SENT213	4	4	5	5	ciprofloxacin	DPI	PA449009	1832	0.157
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT238	0	0	0	0	pp2	PP2		4888	0.157
NULL	JAKSTAT_2013_Jul_1_2(3)_e24812.nxml.txt.nlp	24069562	SENT11	16	16	16	16	pp2	PP2		4888	0.157
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT174	8	8	8	8	pp2	PP2		4888	0.157
NULL	Front_Cell_Neurosci_2014_Jul_18_8_185.nxml.txt.nlp	25100946	SENT494	32	32	32	32	pp2	PP2		4888	0.157
NULL	Arthritis_Res_Ther_2007_Oct_10_9(5)_R105.nxml.txt.nlp	17927818	SENT169	4	4	4	4	pp2	PP2		4888	0.157
NULL	Clin_Drug_Investig_2013_Jun_20_33(6)_419-427.nxml.txt.nlp	23605507	SENT110	18	18	19	19	ciprofloxacin	DPI	PA449009	1832	0.156
NULL	J_Mol_Signal_2008_Mar_31_3_8.nxml.txt.nlp	18377662	SENT167	13	13	13	13	pp2	PP2		4888	0.156
NULL	Cerebellum_2012_Sep_24_11(3)_651-665.nxml.txt.nlp	20734177	SENT128	20	20	20	20	pp2	PP2		4888	0.155
NULL	Acta_Pharmacol_Sin_2010_Dec_22_31(12)_1593-1603.nxml.txt.nlp	21102482	SENT157	0	0	0	0	pp2	PP2		4888	0.155
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT192	21	21	20	20	cetuximab	Yes	PA10040	7525	0.155
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT102	2	2	2	2	pp2	PP2		4888	0.154
NULL	Mol_Cancer_2012_Jun_26_11_43.nxml.txt.nlp	22731636	SENT124	7	7	7	7	pp2	PP2		4888	0.154
NULL	Int_J_Mol_Sci_2010_Sep_13_11(9)_3195-3208.nxml.txt.nlp	20957088	SENT42	12	12	11	11	lipase	AT2	PA450239	186	0.154
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT181	6	6	6	6	pp2	PP2		4888	0.153
NULL	Acta_Pharmacol_Sin_2010_Dec_22_31(12)_1593-1603.nxml.txt.nlp	21102482	SENT194	27	27	27	27	pp2	PP2		4888	0.153
NULL	Mol_Biol_Cell_2013_Feb_15_24(4)_495-509.nxml.txt.nlp	23408788	SENT357	21	21	21	21	pp2	PP2		4888	0.153
NULL	J_Cell_Biol_2001_Oct_29_155(3)_447-458.nxml.txt.nlp	11684709	SENT314	6	6	6	6	pp2	PP2		4888	0.153
NULL	J_Cell_Biol_2005_Oct_10_171(1)_121-131.nxml.txt.nlp	16203859	SENT97	26	26	26	26	pp2	PP2		4888	0.152
NULL	Front_Cell_Neurosci_2014_Jul_18_8_185.nxml.txt.nlp	25100946	SENT234	5	5	5	5	pp2	PP2		4888	0.152
NULL	Cell_Commun_Signal_2013_May_29_11_38.nxml.txt.nlp	23718910	SENT119	9	9	9	9	pp2	PP2		4888	0.152
NULL	Biomed_Res_Int_2013_Dec_10_2013_783698.nxml.txt.nlp	24386640	SENT137	16	16	17	17	isoniazid	DST	PA450112	667	0.152
NULL	Clin_Microbiol_Infect_2014_Jun_21_20(6)_536-541.nxml.txt.nlp	24107197	SENT14	6	6	7	7	isoniazid	DST	PA450112	667	0.152
NULL	J_Immunol_Methods_2009_Jan_1_340(1)_11-24.nxml.txt.nlp	18929568	SENT128	4	4	4	4	pp2	PP2		4888	0.151
NULL	J_Gen_Physiol_2004_Apr_123(4)_427-439.nxml.txt.nlp	15024039	SENT287	2	2	2	2	pp2	PP2		4888	0.151
NULL	J_Cell_Biol_2001_Oct_29_155(3)_447-458.nxml.txt.nlp	11684709	SENT319	7	7	7	7	pp2	PP2		4888	0.151
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT126	11	11	11	11	pp2	PP2		4888	0.151
NULL	J_Gen_Physiol_2003_Nov_122(5)_511-519.nxml.txt.nlp	14557401	SENT48	34	34	29	29	choline	NO3	PA448976	4681	0.151
NULL	Int_J_Biol_Sci_2015_Jan_1_11(1)_48-58.nxml.txt.nlp	25552929	SENT180	6	6	7	7	paclitaxel	LDM	PA450761	1595	0.151
NULL	Int_J_Biol_Sci_2015_Jan_1_11(1)_48-58.nxml.txt.nlp	25552929	SENT299	1	1	0	0	paclitaxel	LDM	PA450761	1595	0.15
NULL	Case_Rep_Endocrinol_2013_Oct_22_2013_815821.nxml.txt.nlp	24251048	SENT54	16	16	15	15	loxapine	PRN	PA450273	64428	0.15
NULL	Ann_Gen_Psychiatry_2013_Jul_11_12_22.nxml.txt.nlp	23845018	SENT0	14	14	3	3	paliperidone	Gen	PA163518919	348654	0.15
NULL	Clin_Microbiol_Infect_2014_Jun_21_20(6)_536-541.nxml.txt.nlp	24107197	SENT38	10	10	11	11	isoniazid	DST	PA450112	667	0.15
NULL	Arthritis_Res_Ther_2007_Oct_10_9(5)_R105.nxml.txt.nlp	17927818	SENT204	4	4	4	4	pp2	PP2		4888	0.15
NULL	Exp_Ther_Med_2014_Aug_11_8(2)_671-675.nxml.txt.nlp	25009638	SENT142	12	12	9	9	scopolamine	FAE	PA451308	2178	0.15
NULL	Br_J_Cancer_2010_Oct_26_103(9)_1325-1330.nxml.txt.nlp	20940720	SENT156	12	12	13	13	etoposide	CRT	PA449552	811	0.15
NULL	Mol_Cancer_2012_Sep_25_11_73.nxml.txt.nlp	23009336	SENT256	23	23	23	23	pp2	PP2		4888	0.15
NULL	Arthritis_Res_Ther_2007_Oct_10_9(5)_R105.nxml.txt.nlp	17927818	SENT160	29	29	29	29	pp2	PP2		4888	0.149
NULL	J_Physiol_2008_Oct_1_586(Pt_19)_4693-4707.nxml.txt.nlp	18703578	SENT171	7	7	7	7	pp2	PP2		4888	0.149
NULL	Breast_Cancer_Res_2006_Jul_19_8(4)_R42.nxml.txt.nlp	16859511	SENT222	8	8	8	8	pp2	PP2		4888	0.148
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2014_Jun_29_70(Pt_7)_1944-1953.nxml.txt.nlp	25004971	SENT137	3	3	20	20	guanidine	RASSF5	PA164781028	83593	0.148
NULL	Clin_Microbiol_Infect_2014_Jun_21_20(6)_536-541.nxml.txt.nlp	24107197	SENT72	2	2	3	3	isoniazid	DST	PA450112	667	0.148
NULL	J_Adv_Pract_Oncol_2014_Mar_1_Mar-Apr_5(2)_144-150.nxml.txt.nlp	25032048	SENT77	5	5	9	9	granisetron	GTS	PA449809	2973	0.147
NULL	Clin_Drug_Investig_2013_Jun_20_33(6)_419-427.nxml.txt.nlp	23605507	SENT170	5	5	6	6	ciprofloxacin	DPI	PA449009	1832	0.146
NULL	Curr_Oncol_2008_Oct_15(5)_229-233.nxml.txt.nlp	19008997	SENT136	12	12	13	13	fludarabine	Yes	PA449655	7525	0.146
NULL	Cell_Commun_Signal_2011_Sep_13_9_18.nxml.txt.nlp	21914164	SENT122	15	15	15	15	pp2	PP2		4888	0.146
NULL	J_Cancer_Prev_2014_Jun_19(2)_111-117.nxml.txt.nlp	25337579	SENT76	1	1	10	10	doxorubicin	ADM	PA449412	133	0.146
NULL	Arthritis_Res_Ther_2007_Oct_10_9(5)_R105.nxml.txt.nlp	17927818	SENT39	12	12	12	12	pp2	PP2		4888	0.146
NULL	Mol_Biotechnol_2013_Jun_28_54(2)_724-736.nxml.txt.nlp	22843325	SENT408	3	3	9	9	omeprazole	OCTN2	PA450704	6584	0.145
NULL	Neuroscience_2008_Sep_22_156(1)_175-183.nxml.txt.nlp	18694808	SENT8	4	4	4	4	pp2	PP2		4888	0.145
NULL	Structure_2013_Jun_4_21(6)_1051-1058.nxml.txt.nlp	23665170	SENT12	13	13	22	22	oxygen	hole	PA450744	80757	0.144
NULL	J_Biol_Chem_2012_Aug_17_287(34)_28932-28942.nxml.txt.nlp	22718751	SENT253	16	16	16	16	pp2	PP2		4888	0.144
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT253	7	7	7	7	pp2	PP2		4888	0.144
NULL	Int_J_Environ_Res_Public_Health_2012_Aug_14_9(8)_2875-2893.nxml.txt.nlp	23066403	SENT235	27	27	27	27	pp2	PP2		4888	0.144
NULL	Nat_Med_2013_Dec_10_19(12)_10_1038_nm_3385.nxml.txt.nlp	24216752	SENT98	22	22	21	21	thrombin	PAR4	PA451674	9002;5074	0.144
NULL	JAKSTAT_2013_Jul_1_2(3)_e24812.nxml.txt.nlp	24069562	SENT61	21	21	21	21	pp2	PP2		4888	0.143
NULL	Eur_Respir_J_2013_May_27_41(5)_1107-1115.nxml.txt.nlp	23018904	SENT190	17	17	18	18	ciprofloxacin	DPI	PA449009	1832	0.143
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT258	11	11	11	11	pp2	PP2		4888	0.143
NULL	Case_Rep_Infect_Dis_2013_May_12_2013_761793.nxml.txt.nlp	23762676	SENT50	25	25	22	22	rifampin	TMX	PA451250	81542	0.143
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT123	21	21	21	21	pp2	PP2		4888	0.143
NULL	Acta_Crystallogr_D_Biol_Crystallogr_2014_Jun_29_70(Pt_7)_1944-1953.nxml.txt.nlp	25004971	SENT137	3	3	7	7	guanidine	MST1	PA164781028	6789;4485	0.142
NULL	JAKSTAT_2013_Jul_1_2(3)_e24812.nxml.txt.nlp	24069562	SENT54	3	3	3	3	pp2	PP2		4888	0.142
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT149	4	4	4	4	pp2	PP2		4888	0.141
NULL	Anal_Bioanal_Chem_2011_Jan_3_399(2)_527-539.nxml.txt.nlp	20814668	SENT159	32	32	33	33	heparin	API	PA449855	5345	0.141
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT106	13	13	13	13	pp2	PP2		4888	0.141
NULL	J_Cell_Biol_2001_Oct_29_155(3)_447-458.nxml.txt.nlp	11684709	SENT166	8	8	8	8	pp2	PP2		4888	0.141
NULL	Biomed_Res_Int_2013_May_8_2013_703130.nxml.txt.nlp	23738330	SENT181	2	2	1	1	lipase	ARM	PA450239	80210	0.141
NULL	Structure_2013_Jun_4_21(6)_1051-1058.nxml.txt.nlp	23665170	SENT128	4	4	13	13	oxygen	hole	PA450744	80757	0.141
NULL	Br_J_Cancer_2014_Jul_15_111(2)_318-325.nxml.txt.nlp	24874484	SENT139	12	12	11	11	choline	CDP	PA448976	1523	0.141
NULL	Clin_Interv_Aging_2008_Sep_3(3)_453-472.nxml.txt.nlp	18982916	SENT344	12	12	13	13	clarithromycin	CD4	PA449028	920	0.141
NULL	Arthritis_Res_Ther_2010_Apr_14_12(2)_R67.nxml.txt.nlp	20398273	SENT175	28	28	29	29	abatacept	CDP	PA164747080	1523	0.14
NULL	Br_J_Cancer_2010_Jun_29_103(1)_52-60.nxml.txt.nlp	20531411	SENT158	1	1	0	0	gemcitabine	MTD	PA449748	4493	0.14
NULL	ScientificWorldJournal_2012_Apr_22_2012_643904.nxml.txt.nlp	22619632	SENT237	3	3	3	3	pp2	PP2		4888	0.14
NULL	J_Hematol_Oncol_2011_Jun_10_4_27.nxml.txt.nlp	21663651	SENT34	12	12	13	13	cyclophosphamide	CTX	PA449165	1593	0.14
NULL	Nat_Commun_2013_4_1957.nxml.txt.nlp	23748852	SENT205	34	34	35	35	collagenase	VIII	PA449107	1351	0.14
NULL	J_Cell_Biol_2003_Aug_18_162(4)_661-671.nxml.txt.nlp	12925710	SENT55	2	2	2	2	pp2	PP2		4888	0.139
NULL	Evid_Based_Complement_Alternat_Med_2012_Dec_20_2012_908601.nxml.txt.nlp	23326293	SENT27	31	31	28	28	oxaliplatin	EMT	PA131285527	3702;6581	0.139
NULL	Mol_Cell_Endocrinol_2011_Jan_15_331(2)_194-204.nxml.txt.nlp	20688134	SENT889	19	19	20	20	buserelin	Yes	PA10253	7525	0.139
NULL	Oncotarget_2014_Feb_7_5(3)_775-787.nxml.txt.nlp	24519956	SENT122	25	25	26	26	dasatinib	PC3	PA162372878	57332;7832;5122	0.139
NULL	Br_J_Cancer_2010_Jun_29_103(1)_52-60.nxml.txt.nlp	20531411	SENT7	11	11	10	10	gemcitabine	MTD	PA449748	4493	0.138
NULL	Arthritis_Res_Ther_2010_Apr_14_12(2)_R67.nxml.txt.nlp	20398273	SENT73	21	21	22	22	abatacept	CDP	PA164747080	1523	0.138
NULL	Clin_Drug_Investig_2013_Jun_20_33(6)_419-427.nxml.txt.nlp	23605507	SENT171	4	4	5	5	ciprofloxacin	DPI	PA449009	1832	0.138
NULL	Br_J_Cancer_2014_Jul_15_111(2)_318-325.nxml.txt.nlp	24874484	SENT62	7	7	6	6	choline	CDP	PA448976	1523	0.138
NULL	Dent_Res_J_(Isfahan)_2009_Spring_6(1)_29-37.nxml.txt.nlp	21528027	SENT52	19	19	10	10	ethanol	HEMA	PA448073	2157	0.138
NULL	Br_J_Cancer_1998_Sep_78(5)_625-630.nxml.txt.nlp	9744503	SENT10	23	23	22	22	tegafur	mol	PA452620	90527	0.137
NULL	J_Signal_Transduct_2010_Sep_1_2010_643642.nxml.txt.nlp	21637354	SENT85	5	5	5	5	pp2	PP2		4888	0.137
NULL	Int_J_Mol_Sci_2012_Feb_17_13(2)_2176-2195.nxml.txt.nlp	22408446	SENT103	32	32	14	14	phenol	mol	PA450913	90527	0.137
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT163	27	27	42	42	glucose	Yes	PA449773	7525	0.137
NULL	Mol_Vis_2014_Oct_17_20_1443-1455.nxml.txt.nlp	25352750	SENT194	19	19	16	16	trypsin	CD31	PA451806	5175	0.137
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Apr_20_69(Pt_5)_o752-o753.nxml.txt.nlp	23723900	SENT3	11	11	12	12	olanzapine	mol	PA450688	90527	0.137
NULL	Cell_Commun_Signal_2013_May_29_11_38.nxml.txt.nlp	23718910	SENT254	3	3	3	3	pp2	PP2		4888	0.137
NULL	Structure_2013_Jun_4_21(6)_1051-1058.nxml.txt.nlp	23665170	SENT62	2	2	11	11	oxygen	hole	PA450744	80757	0.137
NULL	Arthritis_Res_Ther_2007_Oct_10_9(5)_R105.nxml.txt.nlp	17927818	SENT210	21	21	21	21	pp2	PP2		4888	0.137
NULL	Anal_Chem_Insights_2011_Feb_23_6_7-14.nxml.txt.nlp	21760705	SENT87	4	4	5	5	meropenem	API	PA164764445	5345	0.136
NULL	J_Cell_Biol_2005_May_9_169(3)_503-514.nxml.txt.nlp	15883200	SENT299	18	18	18	18	pp2	PP2		4888	0.136
NULL	Brain_Behav_2014_Mar_13_4(2)_105-107.nxml.txt.nlp	24683505	SENT51	7	7	6	6	hyaluronan	CD44	PA165958431	960	0.136
NULL	Acta_Pharmacol_Sin_2010_Dec_22_31(12)_1593-1603.nxml.txt.nlp	21102482	SENT220	6	6	6	6	pp2	PP2		4888	0.136
NULL	Ann_Gen_Psychiatry_2010_Apr_22_9(Suppl_1)_S158.nxml.txt.nlp	NULL	SENT0	11	11	1	1	amisulpride	Gen	PA162565877	348654	0.136
NULL	J_Cell_Biol_2008_Jul_28_182(2)_367-379.nxml.txt.nlp	18644892	SENT140	12	12	12	12	pp2	PP2		4888	0.136
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT20	12	12	12	12	pp2	PP2		4888	0.136
NULL	Anal_Chem_Insights_2011_Feb_23_6_7-14.nxml.txt.nlp	21760705	SENT73	7	7	8	8	meropenem	API	PA164764445	5345	0.136
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R91.nxml.txt.nlp	22541814	SENT52	7	7	7	7	pp2	PP2		4888	0.135
NULL	Front_Zool_2011_Nov_29_8_31.nxml.txt.nlp	22126599	SENT129	3	3	3	3	pp2	PP2		4888	0.135
NULL	Pain_Res_Treat_2013_Jan_27_2013_960270.nxml.txt.nlp	NULL	SENT4	19	19	20	20	duloxetine	NNT	PA10066	23530	0.135
NULL	Indian_J_Pharm_Sci_2014_Mar-Apr_76(2)_138-147.nxml.txt.nlp	24843187	SENT150	3	3	4	4	phenacetin	FOR	PA450897	51741	0.135
NULL	Nat_Commun_2014_Nov_21_5_5456.nxml.txt.nlp	25413232	SENT459	27	27	27	27	pp2	PP2		4888	0.134
NULL	Int_J_Mol_Sci_2010_Sep_13_11(9)_3195-3208.nxml.txt.nlp	20957088	SENT46	8	8	9	9	lipase	AT2	PA450239	186	0.134
NULL	Mol_Biol_Cell_2014_Feb_15_25(4)_470-480.nxml.txt.nlp	24356448	SENT180	6	6	10	10	calcein	AQP4	PA132595336	361	0.134
NULL	Tuberc_Respir_Dis_(Seoul)_2013_Aug_30_75(2)_59-66.nxml.txt.nlp	24023558	SENT181	20	20	18	18	gefitinib	TRAIL	PA131301952	8743	0.134
NULL	Acta_Pharmacol_Sin_2010_Dec_22_31(12)_1593-1603.nxml.txt.nlp	21102482	SENT51	0	0	0	0	pp2	PP2		4888	0.134
NULL	Clin_Drug_Investig_2013_Jun_20_33(6)_419-427.nxml.txt.nlp	23605507	SENT47	14	14	15	15	ciprofloxacin	DPI	PA449009	1832	0.133
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT246	2	2	2	2	pp2	PP2		4888	0.133
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT106	30	30	30	30	pp2	PP2		4888	0.133
NULL	Int_J_Biol_Sci_2015_Jan_1_11(1)_48-58.nxml.txt.nlp	25552929	SENT34	7	7	8	8	paclitaxel	LDM	PA450761	1595	0.132
NULL	Oncol_Lett_2013_Apr_5_5(4)_1123-1128.nxml.txt.nlp	23599750	SENT79	13	13	12	12	docetaxel	LDM	PA449383	1595	0.132
NULL	J_Cell_Biol_2005_May_9_169(3)_503-514.nxml.txt.nlp	15883200	SENT235	21	21	21	21	pp2	PP2		4888	0.132
NULL	BMJ_2010_Feb_5_340_c279.nxml.txt.nlp	20139217	SENT239	19	19	20	20	trimethoprim	HC1	PA451788	342358	0.132
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Feb_4_65(Pt_3)_m246.nxml.txt.nlp	21582040	SENT6	11	11	12	12	ethanol	mol	PA448073	90527	0.132
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1068.nxml.txt.nlp	24556683	SENT58	9	9	9	9	pp2	PP2		4888	0.131
NULL	Eur_J_Pediatr_2011_Jun_8_170(6)_709-718.nxml.txt.nlp	20931226	SENT179	28	28	29	29	budesonide	DPI	PA448681	1832	0.131
NULL	Oncol_Lett_2013_Aug_20_6(2)_329-335.nxml.txt.nlp	24137325	SENT261	10	10	10	10	pp2	PP2		4888	0.131
NULL	J_Gen_Physiol_2004_Apr_123(4)_427-439.nxml.txt.nlp	15024039	SENT280	7	7	7	7	pp2	PP2		4888	0.131
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT212	10	10	10	10	pp2	PP2		4888	0.131
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT273	13	13	13	13	pp2	PP2		4888	0.131
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT142	2	2	2	2	pp2	PP2		4888	0.131
NULL	Arthritis_Res_Ther_2007_Oct_10_9(5)_R105.nxml.txt.nlp	17927818	SENT7	9	9	9	9	pp2	PP2		4888	0.131
NULL	Front_Cell_Neurosci_2014_Feb_24_8_52.nxml.txt.nlp	24605085	SENT609	9	9	8	8	capsaicin	TRPV1	PA448776	7442	0.13
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT20	30	30	30	30	pp2	PP2		4888	0.13
NULL	J_Signal_Transduct_2011_Dec_19_2011_636951.nxml.txt.nlp	21258655	SENT265	10	10	10	10	pp2	PP2		4888	0.13
NULL	Clin_Drug_Investig_2013_Jun_20_33(6)_419-427.nxml.txt.nlp	23605507	SENT168	13	13	14	14	ciprofloxacin	DPI	PA449009	1832	0.13
NULL	J_Young_Pharm_2011_Jul-Sep_3(3)_216-220.nxml.txt.nlp	21897661	SENT105	8	8	9	9	ramipril	SLN	PA451223	6588	0.13
NULL	Exp_Ther_Med_2015_Feb_8_9(2)_341-344.nxml.txt.nlp	25574195	SENT87	16	16	15	15	hydroquinone	OTC	PA449924	5009	0.13
NULL	Acta_Pharmacol_Sin_2009_Jul_3_30(7)_889-898.nxml.txt.nlp	19574994	SENT172	23	23	23	23	pp2	PP2		4888	0.13
NULL	Mediators_Inflamm_2010_Jun_21_2010_194896.nxml.txt.nlp	20652055	SENT195	11	11	15	15	berberine	CCL2	PA165860812	6347	0.13
NULL	Mol_Cancer_2012_Jun_26_11_43.nxml.txt.nlp	22731636	SENT126	5	5	5	5	pp2	PP2		4888	0.13
NULL	J_Mol_Signal_2008_Mar_31_3_8.nxml.txt.nlp	18377662	SENT72	29	29	29	29	pp2	PP2		4888	0.129
NULL	J_Cell_Mol_Med_2013_Sep_11_17(9)_1160-1172.nxml.txt.nlp	23844832	SENT264	15	15	15	15	pp2	PP2		4888	0.129
NULL	Pediatr_Cardiol_2010_Jan_14_31(1)_90-95.nxml.txt.nlp	19915892	SENT104	27	27	28	28	palivizumab	Era	PA164748781	2099	0.129
NULL	Front_Genet_2014_May_9_5_125.nxml.txt.nlp	24847357	SENT245	4	4	5	5	lipase	PNPLA5	PA450239	150379	0.129
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Jul_19_70(Pt_8)_80-83.nxml.txt.nlp	25249860	SENT141	10	10	11	11	ethanol	mol	PA448073	90527	0.129
NULL	Arthritis_Res_Ther_2007_Oct_10_9(5)_R105.nxml.txt.nlp	17927818	SENT132	12	12	12	12	pp2	PP2		4888	0.128
NULL	Environ_Health_Perspect_2013_May_22_121(5)_551-557.nxml.txt.nlp	23434795	SENT174	7	7	6	6	hyaluronan	BAL	PA165958431	83666	0.128
NULL	Eur_Respir_J_2013_May_27_41(5)_1107-1115.nxml.txt.nlp	23018904	SENT136	16	16	17	17	ciprofloxacin	DPI	PA449009	1832	0.128
NULL	Cancers_(Basel)_2014_Nov_25_6(4)_2313-2329.nxml.txt.nlp	25534569	SENT170	1	1	0	0	crizotinib	HGF	PA165946122	3569;6654;3082	0.128
NULL	J_Gen_Physiol_2005_Jul_126(1)_1.nxml.txt.nlp	NULL	SENT2737	14	14	14	14	pp2	PP2		4888	0.128
NULL	Br_J_Pharmacol_2014_Oct_26_171(20)_4785-4796.nxml.txt.nlp	25074741	SENT20	3	3	4	4	methylphenidate	NK1	PA450464	11126	0.128
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT258	28	28	28	28	pp2	PP2		4888	0.128
NULL	Br_J_Cancer_2011_May_10_104(10)_1628-1640.nxml.txt.nlp	21505453	SENT154	10	10	10	10	pp2	PP2		4888	0.128
NULL	J_Biol_Chem_2009_Apr_24_284(17)_11572-11578.nxml.txt.nlp	19244244	SENT105	20	20	21	21	lipase	ATGL	PA450239	57104	0.127
NULL	Emerg_Infect_Dis_2015_Jan_21(1)_164-166.nxml.txt.nlp	25531800	SENT7	12	12	11	11	artesunate	GMP	PA165111697	22978	0.127
NULL	Front_Immunol_2012_May_9_3_115.nxml.txt.nlp	22582078	SENT46	15	15	15	15	pp2	PP2		4888	0.127
NULL	J_Physiol_2008_Jul_1_586(Pt_13)_3087-3095.nxml.txt.nlp	18467363	SENT98	10	10	9	9	lipase	DAG	PA450239	1605	0.127
NULL	Biosci_Rep_2014_Aug_6_34(4)_e00131.nxml.txt.nlp	24975826	SENT141	2	2	2	2	pp2	PP2		4888	0.127
NULL	J_Cell_Biol_2005_Nov_7_171(3)_505-516.nxml.txt.nlp	16275754	SENT134	17	17	17	17	pp2	PP2		4888	0.127
NULL	Br_J_Cancer_2011_May_10_104(10)_1628-1640.nxml.txt.nlp	21505453	SENT10	29	29	29	29	pp2	PP2		4888	0.127
NULL	Eur_J_Clin_Pharmacol_2014_Oct_6_70(1)_29-35.nxml.txt.nlp	24096683	SENT25	18	18	17	17	raltegravir	INI		84844	0.126
NULL	J_Cell_Biol_2008_Jul_28_182(2)_367-379.nxml.txt.nlp	18644892	SENT70	5	5	5	5	pp2	PP2		4888	0.126
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Mar_10_68(Pt_4)_o1011.nxml.txt.nlp	22589885	SENT5	7	7	8	8	chlordiazepoxide	mol	PA448932	90527	0.126
NULL	Br_J_Cancer_2010_Jun_29_103(1)_52-60.nxml.txt.nlp	20531411	SENT176	17	17	16	16	gemcitabine	MTD	PA449748	4493	0.126
NULL	Br_J_Cancer_2010_Jun_29_103(1)_52-60.nxml.txt.nlp	20531411	SENT114	2	2	1	1	gemcitabine	MTD	PA449748	4493	0.126
NULL	Mol_Biol_Cell_2012_Nov_1_23(21)_4212-4225.nxml.txt.nlp	22956765	SENT98	16	16	16	16	pp2	PP2		4888	0.126
NULL	Environ_Health_Perspect_2004_Nov_28_112(15)_1481-1487.nxml.txt.nlp	15531431	SENT95	0	0	0	0	pp2	PP2		4888	0.124
NULL	Chem_Rev_2011_Oct_12_111(10)_5899-5921.nxml.txt.nlp	21923193	SENT404	1	1	0	0	lipase	MAG	PA450239	2068;4099	0.124
NULL	Environ_Health_Perspect_2013_Aug_4_121(8)_878-885.nxml.txt.nlp	23735422	SENT71	10	10	11	11	tetracycline	ARG	PA451640	473;27	0.124
NULL	Int_J_Biol_Sci_2015_Jan_1_11(1)_48-58.nxml.txt.nlp	25552929	SENT171	4	4	5	5	paclitaxel	LDM	PA450761	1595	0.124
NULL	Mol_Biol_Cell_2013_Feb_15_24(4)_495-509.nxml.txt.nlp	23408788	SENT159	29	29	29	29	pp2	PP2		4888	0.123
NULL	Arthritis_Res_Ther_2007_Oct_10_9(5)_R105.nxml.txt.nlp	17927818	SENT155	7	7	7	7	pp2	PP2		4888	0.123
NULL	Neuroscience_2008_Sep_22_156(1)_175-183.nxml.txt.nlp	18694808	SENT105	5	5	5	5	pp2	PP2		4888	0.122
NULL	J_Cell_Biol_2001_Oct_1_155(1)_133-144.nxml.txt.nlp	11581290	SENT268	8	8	8	8	pp2	PP2		4888	0.122
NULL	J_Cell_Biol_2003_Sep_29_162(7)_1189-1196.nxml.txt.nlp	14517202	SENT133	23	23	23	23	pp2	PP2		4888	0.122
NULL	EMBO_J_2009_Aug_19_28(16)_2360-2373.nxml.txt.nlp	19609305	SENT364	14	14	14	14	pp2	PP2		4888	0.122
NULL	J_Inflamm_(Lond)_2006_May_4_3_8.nxml.txt.nlp	16674821	SENT98	2	2	2	2	pp2	PP2		4888	0.121
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT126	32	32	32	32	pp2	PP2		4888	0.121
NULL	Int_J_Biol_Sci_2015_Jan_1_11(1)_48-58.nxml.txt.nlp	25552929	SENT196	8	8	9	9	paclitaxel	LDM	PA450761	1595	0.121
NULL	J_Cell_Biol_2001_Mar_19_152(6)_1135-1144.nxml.txt.nlp	11257115	SENT39	12	12	11	11	lipase	DAG	PA450239	1605	0.121
NULL	Epigenetics_Chromatin_2014_Jan_20_7_2.nxml.txt.nlp	24443974	SENT64	12	12	13	13	protamine	PRM1	PA10366	5619	0.121
NULL	Indian_J_Pharm_Sci_2008_Jul-Aug_70(4)_502-503.nxml.txt.nlp	20046780	SENT55	5	5	4	4	duloxetine	FOR	PA10066	51741	0.121
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Jun_15_69(Pt_7)_o1100.nxml.txt.nlp	24046661	SENT8	6	6	7	7	ethanol	mol	PA448073	90527	0.121
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT105	16	16	16	16	pp2	PP2		4888	0.12
NULL	Int_J_Biol_Sci_2015_Jan_1_11(1)_48-58.nxml.txt.nlp	25552929	SENT207	10	10	11	11	paclitaxel	LDM	PA450761	1595	0.12
NULL	Clin_Drug_Investig_2013_Jun_20_33(6)_419-427.nxml.txt.nlp	23605507	SENT153	5	5	6	6	ciprofloxacin	DPI	PA449009	1832	0.12
NULL	J_Cell_Biol_2005_Nov_7_171(3)_505-516.nxml.txt.nlp	16275754	SENT131	15	15	15	15	pp2	PP2		4888	0.12
NULL	Mol_Cancer_2012_Jun_26_11_43.nxml.txt.nlp	22731636	SENT124	18	18	18	18	pp2	PP2		4888	0.12
NULL	Eur_J_Dent_2014_Oct-Dec_8(4)_475-480.nxml.txt.nlp	25512727	SENT5	6	6	7	7	warfarin	OAT	PA451906	4942	0.12
NULL	Curr_Genomics_2014_Jun_15(3)_217-230.nxml.txt.nlp	24955029	SENT13	0	0	7	7	oxygen	FOR	PA450744	51741	0.119
NULL	Pediatr_Cardiol_2010_Jan_14_31(1)_90-95.nxml.txt.nlp	19915892	SENT62	35	35	36	36	palivizumab	Era	PA164748781	2099	0.119
NULL	J_Cell_Biol_2005_Jul_18_170(2)_285-294.nxml.txt.nlp	16027224	SENT165	11	11	11	11	pp2	PP2		4888	0.119
NULL	J_Inflamm_(Lond)_2006_May_4_3_8.nxml.txt.nlp	16674821	SENT91	2	2	2	2	pp2	PP2		4888	0.119
NULL	J_Exp_Med_1964_Jun_1_119(6)_1027-1049.nxml.txt.nlp	14176290	SENT0	12	12	11	11	hydrocortisone	FOR	PA449905	51741	0.119
NULL	Indian_J_Psychiatry_1996_Oct-Dec_38(4)_271a.nxml.txt.nlp	21709853	SENT0	17	17	16	16	clozapine	FOR	PA449061	51741	0.118
NULL	Front_Plant_Sci_2012_Mar_2_3_39.nxml.txt.nlp	22645583	SENT203	8	8	8	8	pp2	PP2		4888	0.118
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT126	28	28	28	28	pp2	PP2		4888	0.118
NULL	J_Young_Pharm_2011_Jul-Sep_3(3)_216-220.nxml.txt.nlp	21897661	SENT109	8	8	9	9	ramipril	SLN	PA451223	6588	0.118
NULL	Front_Cell_Neurosci_2014_Jul_18_8_185.nxml.txt.nlp	25100946	SENT224	25	25	25	25	pp2	PP2		4888	0.118
NULL	Front_Endocrinol_(Lausanne)_2013_Sep_17_4_125.nxml.txt.nlp	24062727	SENT118	10	10	9	9	lipase	DAG	PA450239	1605	0.118
NULL	Br_J_Cancer_2010_Jun_29_103(1)_52-60.nxml.txt.nlp	20531411	SENT101	18	18	17	17	gemcitabine	MTD	PA449748	4493	0.118
NULL	Biomed_Res_Int_2014_Jan_15_2014_859871.nxml.txt.nlp	24527460	SENT110	14	14	15	15	oxaliplatin	IL-4	PA131285527	3565	0.118
NULL	J_Mol_Signal_2008_Mar_31_3_8.nxml.txt.nlp	18377662	SENT121	9	9	9	9	pp2	PP2		4888	0.117
NULL	Chem_Rev_2011_Oct_12_111(10)_5899-5921.nxml.txt.nlp	21923193	SENT43	7	7	6	6	lipase	MAG	PA450239	2068;4099	0.117
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Aug_1_70(Pt_9)_m314-m315.nxml.txt.nlp	25309177	SENT6	13	13	14	14	ethanol	mol	PA448073	90527	0.117
NULL	Exp_Diabetes_Res_2011_Apr_26_2011_215764.nxml.txt.nlp	21584276	SENT142	5	5	4	4	exenatide	Yes	PA164749238	7525	0.116
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT105	23	23	23	23	pp2	PP2		4888	0.116
NULL	Br_J_Cancer_2011_May_10_104(10)_1628-1640.nxml.txt.nlp	21505453	SENT256	17	17	17	17	pp2	PP2		4888	0.116
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT281	17	17	17	17	pp2	PP2		4888	0.116
NULL	Int_J_Biol_Sci_2015_Jan_1_11(1)_48-58.nxml.txt.nlp	25552929	SENT35	5	5	6	6	paclitaxel	LDM	PA450761	1595	0.116
NULL	Anal_Chem_Insights_2011_Mar_10_6_21-28.nxml.txt.nlp	21760706	SENT56	15	15	16	16	emtricitabine	API	PA10069	5345	0.115
NULL	Eur_Respir_J_2013_May_27_41(5)_1107-1115.nxml.txt.nlp	23018904	SENT161	8	8	9	9	ciprofloxacin	DPI	PA449009	1832	0.115
NULL	Mol_Biol_Cell_2014_Mar_15_25(6)_739-752.nxml.txt.nlp	24430869	SENT154	9	9	9	9	pp2	PP2		4888	0.115
NULL	Oncogene_2010_May_27_29(21)_3054-3066.nxml.txt.nlp	20228839	SENT209	26	26	26	26	pp2	PP2		4888	0.115
NULL	Mol_Vis_2012_May_6_18_1189-1196.nxml.txt.nlp	22605930	SENT212	15	15	16	16	latanoprost	BAK	PA164774763	578	0.115
NULL	Chem_Res_Toxicol_2008_Jul_21_21(7)_1359-1367.nxml.txt.nlp	18549251	SENT217	4	4	3	3	hydroquinone	PCB	PA449924	5091	0.115
NULL	Appl_Microbiol_Biotechnol_2012_Feb_11_93(4)_1377-1387.nxml.txt.nlp	22234536	SENT158	26	26	25	25	nadh	mol	PA164755085	90527	0.115
NULL	Nat_Med_2011_Jun_26_17(7)_875-882.nxml.txt.nlp	21706030	SENT241	18	18	17	17	doxycycline	PARP-1	PA449415	25976	0.115
NULL	Cell_Commun_Signal_2011_May_20_9_14.nxml.txt.nlp	21599982	SENT19	14	14	14	14	pp2	PP2		4888	0.115
NULL	Biologics_2009_Jul_13_3_77-97.nxml.txt.nlp	19707398	SENT466	3	3	4	4	infliximab	CDP	PA452639	1523	0.114
NULL	Eur_J_Dent_2013_Apr-Jun_7(2)_246-250.nxml.txt.nlp	24883036	SENT46	16	16	13	13	tretinoin	MAF	PA451746	4094	0.114
NULL	Clin_Drug_Investig_2013_Jun_20_33(6)_419-427.nxml.txt.nlp	23605507	SENT57	0	0	1	1	ciprofloxacin	DPI	PA449009	1832	0.114
NULL	Int_J_Mol_Sci_2010_Sep_13_11(9)_3195-3208.nxml.txt.nlp	20957088	SENT211	2	2	1	1	lipase	AT2	PA450239	186	0.114
NULL	Br_J_Cancer_2010_Jun_29_103(1)_52-60.nxml.txt.nlp	20531411	SENT102	10	10	9	9	gemcitabine	MTD	PA449748	4493	0.114
NULL	Eur_Respir_J_2013_May_27_41(5)_1107-1115.nxml.txt.nlp	23018904	SENT71	24	24	25	25	ciprofloxacin	DPI	PA449009	1832	0.113
NULL	Mol_Cancer_2008_Sep_12_7_69.nxml.txt.nlp	18789131	SENT171	16	16	16	16	pp2	PP2		4888	0.113
NULL	Mol_Cancer_2012_Jun_26_11_43.nxml.txt.nlp	22731636	SENT242	29	29	29	29	pp2	PP2		4888	0.113
NULL	Mol_Biol_Cell_2014_Mar_15_25(6)_739-752.nxml.txt.nlp	24430869	SENT288	5	5	5	5	pp2	PP2		4888	0.113
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Sep_25_69(Pt_10)_o1586-o1587.nxml.txt.nlp	24098262	SENT7	26	26	27	27	ethanol	mol	PA448073	90527	0.113
NULL	Chem_Rev_2011_Oct_12_111(10)_5899-5921.nxml.txt.nlp	21923193	SENT374	22	22	21	21	lipase	MAG	PA450239	2068;4099	0.113
NULL	Cardiovasc_Drugs_Ther_2010_Dec_13_24(5-6)_391-399.nxml.txt.nlp	20640495	SENT108	12	12	11	11	dipyridamole	DIP	PA449367	23151;1831	0.112
NULL	Chem_Rev_2011_Oct_12_111(10)_5899-5921.nxml.txt.nlp	21923193	SENT402	5	5	4	4	lipase	MAG	PA450239	2068;4099	0.112
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT95	17	17	17	17	pp2	PP2		4888	0.112
NULL	Cell_Commun_Signal_2009_Feb_26_7(Suppl_1)_A63.nxml.txt.nlp	NULL	SENT19	28	28	28	28	pp2	PP2		4888	0.112
NULL	J_Cell_Biol_2005_May_9_169(3)_503-514.nxml.txt.nlp	15883200	SENT185	3	3	3	3	pp2	PP2		4888	0.112
NULL	Oncotarget_2013_Jun_30_4(7)_1037-1049.nxml.txt.nlp	23900414	SENT183	2	2	2	2	pp2	PP2		4888	0.111
NULL	Exp_Hematol_2014_Dec_42(12)_1053-1058_e1.nxml.txt.nlp	25127743	SENT94	2	2	1	1	potassium	KCNE2	PA451047	9992	0.111
NULL	J_Signal_Transduct_2011_Dec_19_2011_636951.nxml.txt.nlp	21258655	SENT118	16	16	16	16	pp2	PP2		4888	0.111
NULL	Biosci_Rep_2014_Aug_6_34(4)_e00131.nxml.txt.nlp	24975826	SENT153	11	11	11	11	pp2	PP2		4888	0.111
NULL	J_Biol_Chem_2009_Feb_6_284(6)_3985-3997.nxml.txt.nlp	19038967	SENT222	37	37	30	30	oxygen	hole	PA450744	80757	0.111
NULL	Pediatr_Cardiol_2010_Jan_14_31(1)_90-95.nxml.txt.nlp	19915892	SENT152	32	32	33	33	palivizumab	Era	PA164748781	2099	0.11
NULL	Clin_Interv_Aging_2013_Feb_5_8_131-137.nxml.txt.nlp	23403474	SENT96	25	25	24	24	choline	CDP	PA448976	1523	0.11
NULL	Int_J_Biol_Sci_2015_Jan_1_11(1)_48-58.nxml.txt.nlp	25552929	SENT167	9	9	10	10	paclitaxel	LDM	PA450761	1595	0.11
NULL	Endocrinol_Metab_(Seoul)_2014_Sep_25_29(3)_211-216.nxml.txt.nlp	25309777	SENT66	23	23	28	28	thyroglobulin	PTC	PA164754910	5979;8030	0.11
NULL	Oncogene_2010_May_27_29(21)_3054-3066.nxml.txt.nlp	20228839	SENT132	10	10	10	10	pp2	PP2		4888	0.109
NULL	Biol_Open_2014_Nov_21_3(12)_1207-1216.nxml.txt.nlp	25416063	SENT36	6	6	5	5	zinc	NANOS2	PA451956	339345	0.109
NULL	Breast_Cancer_Res_2007_Oct_10_9(5)_R69.nxml.txt.nlp	17925034	SENT225	3	3	3	3	pp2	PP2		4888	0.109
NULL	J_Gen_Physiol_1956_Sep_20_40(1)_27-35.nxml.txt.nlp	13357735	SENT0	15	15	14	14	glucose	FOR	PA449773	51741	0.109
NULL	J_Cell_Biol_2001_Oct_1_155(1)_133-144.nxml.txt.nlp	11581290	SENT200	9	9	9	9	pp2	PP2		4888	0.109
NULL	Biosci_Rep_2014_Aug_6_34(4)_e00131.nxml.txt.nlp	24975826	SENT156	5	5	5	5	pp2	PP2		4888	0.108
NULL	Cancers_(Basel)_2011_Aug_9_3(3)_3189-3205.nxml.txt.nlp	24212952	SENT820	2	2	1	1	hyaluronidase	HYAL1	PA164745713	3373	0.108
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT11	18	18	18	18	pp2	PP2		4888	0.108
NULL	Eur_Respir_J_2013_May_27_41(5)_1107-1115.nxml.txt.nlp	23018904	SENT201	16	16	17	17	ciprofloxacin	DPI	PA449009	1832	0.108
NULL	Bioinform_Biol_Insights_2008_Nov_19_2_383-400.nxml.txt.nlp	19812790	SENT460	3	3	2	2	hyaluronan	HABP4	PA165958431	22927	0.107
NULL	Chem_Rev_2011_Oct_12_111(10)_5899-5921.nxml.txt.nlp	21923193	SENT373	17	17	16	16	lipase	MAG	PA450239	2068;4099	0.107
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT40	9	9	9	9	pp2	PP2		4888	0.107
NULL	J_Cell_Biol_2005_Nov_7_171(3)_505-516.nxml.txt.nlp	16275754	SENT126	17	17	17	17	pp2	PP2		4888	0.106
NULL	Cell_Commun_Signal_2013_May_29_11_38.nxml.txt.nlp	23718910	SENT253	2	2	2	2	pp2	PP2		4888	0.106
NULL	Environ_Health_Perspect_2013_May_22_121(5)_551-557.nxml.txt.nlp	23434795	SENT176	3	3	2	2	hyaluronan	BAL	PA165958431	83666	0.106
NULL	Cell_Commun_Signal_2013_May_29_11_38.nxml.txt.nlp	23718910	SENT10	0	0	0	0	pp2	PP2		4888	0.106
NULL	J_Cell_Sci_2012_Jun_15_125(12)_2940-2953.nxml.txt.nlp	22366451	SENT278	9	9	9	9	pp2	PP2		4888	0.106
NULL	Clin_Drug_Investig_2013_Jun_20_33(6)_419-427.nxml.txt.nlp	23605507	SENT20	4	4	5	5	ciprofloxacin	DPI	PA449009	1832	0.106
NULL	Front_Pharmacol_2014_Nov_11_5_248.nxml.txt.nlp	25426075	SENT53	12	12	13	13	nevirapine	ABCG2	PA450616	9429	0.106
NULL	Chem_Res_Toxicol_2008_Jul_21_21(7)_1359-1367.nxml.txt.nlp	18549251	SENT123	6	6	5	5	hydroquinone	PCB	PA449924	5091	0.106
NULL	Int_J_Biol_Sci_2015_Jan_1_11(1)_48-58.nxml.txt.nlp	25552929	SENT246	11	11	12	12	paclitaxel	LDM	PA450761	1595	0.106
NULL	Eur_Respir_J_2013_May_27_41(5)_1107-1115.nxml.txt.nlp	23018904	SENT205	19	19	20	20	ciprofloxacin	DPI	PA449009	1832	0.106
NULL	Anal_Bioanal_Chem_2011_Jan_3_399(2)_527-539.nxml.txt.nlp	20814668	SENT173	8	8	9	9	heparin	API	PA449855	5345	0.106
NULL	Cancers_(Basel)_2010_Jun_4_2(2)_1125-1154.nxml.txt.nlp	24281110	SENT1708	8	8	7	7	trypsin	SPINK1	PA451806	6690	0.106
NULL	Anesth_Essays_Res_2014_Sep-Dec_8(3)_283-290.nxml.txt.nlp	NULL	SENT196	4	4	3	3	ketamine	FOR	PA450144	51741	0.106
NULL	Indian_J_Anaesth_2014_Sep-Oct_58(5)_665-671.nxml.txt.nlp	25535433	SENT166	2	2	1	1	heparin	FOR	PA449855	51741	0.106
NULL	J_Cell_Sci_2012_Jun_15_125(12)_2940-2953.nxml.txt.nlp	22366451	SENT374	2	2	2	2	pp2	PP2		4888	0.105
NULL	Pediatr_Cardiol_2010_Jan_14_31(1)_90-95.nxml.txt.nlp	19915892	SENT98	14	14	15	15	palivizumab	Era	PA164748781	2099	0.105
NULL	J_Hematol_Oncol_2014_Aug_1_7_52.nxml.txt.nlp	25085632	SENT75	1	1	0	0	gemcitabine	Gem	PA449748	51053	0.105
NULL	Evid_Based_Complement_Alternat_Med_2014_Dec_24_2014_975450.nxml.txt.nlp	25610488	SENT434	4	4	5	5	ether	TPC	PA449525	8030;60386	0.105
NULL	J_Inflamm_(Lond)_2006_May_4_3_8.nxml.txt.nlp	16674821	SENT205	26	26	26	26	pp2	PP2		4888	0.105
NULL	Int_J_Biol_Sci_2015_Jan_1_11(1)_48-58.nxml.txt.nlp	25552929	SENT301	16	16	17	17	paclitaxel	LDM	PA450761	1595	0.105
NULL	Mar_Drugs_2014_Nov_13_12(11)_5408-5424.nxml.txt.nlp	25402829	SENT218	5	5	5	5	pp2	PP2		4888	0.105
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT12	13	13	13	13	pp2	PP2		4888	0.105
NULL	Diabetes_2013_Jun_20_62(6)_2122-2129.nxml.txt.nlp	23378607	SENT309	15	15	16	16	l-tyrosine	PPARgamma	PA451822	5468	0.104
NULL	J_Mol_Signal_2008_Mar_31_3_8.nxml.txt.nlp	18377662	SENT122	20	20	20	20	pp2	PP2		4888	0.104
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT48	1	1	1	1	pp2	PP2		4888	0.104
NULL	Int_J_Mol_Sci_2014_Nov_21_15(11)_21433-21454.nxml.txt.nlp	25421240	SENT240	15	15	15	15	pp2	PP2		4888	0.104
NULL	Kidney_Int_Suppl_(2011)_2013_Jan_28_3(1)_19-62.nxml.txt.nlp	25018975	SENT635	42	42	43	43	iohexol	GFR	PA450061	9771	0.104
NULL	Eur_Respir_J_2013_May_27_41(5)_1107-1115.nxml.txt.nlp	23018904	SENT192	8	8	9	9	ciprofloxacin	DPI	PA449009	1832	0.104
NULL	Indian_J_Pharm_Sci_2008_Nov-Dec_70(6)_825-827.nxml.txt.nlp	21369455	SENT62	3	3	2	2	duloxetine	FOR	PA10066	51741	0.104
NULL	Mediators_Inflamm_2010_Jun_21_2010_194896.nxml.txt.nlp	20652055	SENT48	13	13	12	12	rosuvastatin	mol	PA134308647	90527	0.103
NULL	Mol_Cancer_2012_Jun_26_11_43.nxml.txt.nlp	22731636	SENT227	1	1	1	1	pp2	PP2		4888	0.103
NULL	Am_J_Pathol_2011_Apr_178(4)_1782-1791.nxml.txt.nlp	21435458	SENT66	10	10	9	9	fluorescein	CD133	PA164746009	8842	0.103
NULL	J_Mol_Signal_2008_Mar_31_3_8.nxml.txt.nlp	18377662	SENT141	7	7	7	7	pp2	PP2		4888	0.103
NULL	Br_J_Pharmacol_2010_Aug_160(8)_1997-2007.nxml.txt.nlp	20649597	SENT208	5	5	5	5	pp2	PP2		4888	0.103
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT186	3	3	3	3	pp2	PP2		4888	0.103
NULL	J_Gynecol_Oncol_2014_Jul_3_25(3)_236-248.nxml.txt.nlp	25045437	SENT206	2	2	3	3	bevacizumab	FOR	PA130232992	51741	0.103
NULL	CNS_Drugs_2013_Aug_23_27(11)_943-953.nxml.txt.nlp	23975660	SENT129	11	11	10	10	atomoxetine	ATX	PA134688071	5168;23049	0.103
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT120	36	36	36	36	pp2	PP2		4888	0.102
NULL	Arthritis_Res_Ther_2007_Nov_9_9(6)_R117.nxml.txt.nlp	17996099	SENT196	12	12	11	11	heparin	OPG	PA449855	690	0.102
NULL	Cells_2014_Apr_8_3(2)_258-287.nxml.txt.nlp	24717323	SENT298	14	14	14	14	pp2	PP2		4888	0.102
NULL	Br_J_Cancer_2012_May_22_106(11)_1807-1815.nxml.txt.nlp	22531632	SENT173	3	3	3	3	pp2	PP2		4888	0.102
NULL	Breast_Cancer_Res_2005_Nov_16_7(6)_R1141-R1152.nxml.txt.nlp	16457694	SENT303	21	21	22	22	tamoxifen	Yes	PA451581	7525	0.102
NULL	Mol_Biol_Cell_2014_Apr_1_25(7)_1151-1158.nxml.txt.nlp	24501422	SENT93	16	16	16	16	pp2	PP2		4888	0.102
NULL	Cancer_Causes_Control_2013_Aug_18_24(8)_1605-1614.nxml.txt.nlp	23775025	SENT64	38	38	39	39	epirubicin	GSTM1	PA449476	2944	0.101
NULL	Arthritis_Res_Ther_2007_Oct_10_9(5)_R105.nxml.txt.nlp	17927818	SENT50	43	43	43	43	pp2	PP2		4888	0.101
NULL	J_Gen_Physiol_2010_Apr_135(4)_333-353.nxml.txt.nlp	20231374	SENT363	7	7	7	7	pp2	PP2		4888	0.101
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT18	6	6	6	6	pp2	PP2		4888	0.101
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R91.nxml.txt.nlp	22541814	SENT239	6	6	6	6	pp2	PP2		4888	0.101
NULL	Indian_J_Pharm_Sci_2008_Nov-Dec_70(6)_825-827.nxml.txt.nlp	21369455	SENT57	6	6	5	5	duloxetine	FOR	PA10066	51741	0.101
NULL	Front_Cell_Neurosci_2014_Jul_18_8_185.nxml.txt.nlp	25100946	SENT225	6	6	6	6	pp2	PP2		4888	0.1
NULL	Parasit_Vectors_2013_Oct_8_6_290.nxml.txt.nlp	24192424	SENT107	6	6	12	12	nadh	ND5	PA164755085	4540	0.1
NULL	J_Mol_Signal_2008_Mar_31_3_8.nxml.txt.nlp	18377662	SENT140	7	7	7	7	pp2	PP2		4888	0.1
NULL	Protein_Cell_2014_Jul_10_5(7)_532-543.nxml.txt.nlp	24715268	SENT126	6	6	6	6	pp2	PP2		4888	0.1
NULL	Anticancer_Agents_Med_Chem_2010_Dec_10(10)_753-768.nxml.txt.nlp	21269250	SENT612	14	14	13	13	procarbazine	PCB	PA451112	5091	0.1
NULL	Oncogene_2014_Oct_23_33(43)_5109-5120.nxml.txt.nlp	24858043	SENT79	3	3	3	3	pp2	PP2		4888	0.1
NULL	Oncogene_2010_May_27_29(21)_3054-3066.nxml.txt.nlp	20228839	SENT217	25	25	25	25	pp2	PP2		4888	0.1
NULL	Cancer_Cell_Int_2013_Feb_14_13_16.nxml.txt.nlp	23409704	SENT81	2	2	2	2	pp2	PP2		4888	0.1
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT141	7	7	7	7	pp2	PP2		4888	0.1
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jan_21_68(Pt_2)_o464.nxml.txt.nlp	22347073	SENT7	8	8	9	9	ethanol	mol	PA448073	90527	0.1
NULL	Nat_Commun_2014_Jul_16_5_4425.nxml.txt.nlp	25028121	SENT43	5	5	5	5	pp2	PP2		4888	0.1
NULL	Biochimie_2012_Sep_94(9)_1997-2005.nxml.txt.nlp	22659570	SENT149	0	0	0	0	pp2	PP2		4888	0.1
NULL	Int_J_Biol_Sci_2015_Jan_1_11(1)_48-58.nxml.txt.nlp	25552929	SENT142	14	14	13	13	paclitaxel	LDM	PA450761	1595	0.099
NULL	Indian_J_Pharm_Sci_2008_Jan-Feb_70(1)_124-128.nxml.txt.nlp	20390099	SENT100	5	5	4	4	venlafaxine	FOR	PA451866	51741	0.099
NULL	Int_J_Endocrinol_Metab_2013_Oct_1_11(4)_e6721.nxml.txt.nlp	24719628	SENT151	10	10	9	9	orlistat	por	PA164776864	64840	0.099
NULL	Acta_Pharmacol_Sin_2010_Dec_22_31(12)_1593-1603.nxml.txt.nlp	21102482	SENT240	0	0	0	0	pp2	PP2		4888	0.099
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Feb_4_65(Pt_3)_m246.nxml.txt.nlp	21582040	SENT7	5	5	6	6	ethanol	mol	PA448073	90527	0.099
NULL	J_Cell_Biol_2001_Oct_1_155(1)_133-144.nxml.txt.nlp	11581290	SENT196	38	38	38	38	pp2	PP2		4888	0.099
NULL	Chem_Rev_2011_Oct_12_111(10)_5899-5921.nxml.txt.nlp	21923193	SENT50	22	22	21	21	lipase	MAG	PA450239	2068;4099	0.099
NULL	Mol_Cancer_2008_Sep_12_7_69.nxml.txt.nlp	18789131	SENT112	3	3	3	3	pp2	PP2		4888	0.099
NULL	Oncol_Rep_2014_Jul_15_32(1)_45-49.nxml.txt.nlp	24841138	SENT10	8	8	8	8	pp2	PP2		4888	0.099
NULL	J_Biol_Chem_2010_Apr_23_285(17)_12979-12989.nxml.txt.nlp	20189985	SENT221	6	6	5	5	forskolin	IP3R2	PA146096022	3709	0.098
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT122	14	14	14	14	pp2	PP2		4888	0.098
NULL	J_Cell_Biol_2005_Nov_7_171(3)_505-516.nxml.txt.nlp	16275754	SENT316	8	8	8	8	pp2	PP2		4888	0.098
NULL	J_Mol_Signal_2008_Mar_31_3_8.nxml.txt.nlp	18377662	SENT63	3	3	3	3	pp2	PP2		4888	0.098
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT120	29	29	29	29	pp2	PP2		4888	0.098
NULL	Biologics_2013_Apr_15_7_77-90.nxml.txt.nlp	23723688	SENT97	26	26	27	27	hydroxyurea	CRT	PA449942	811	0.098
NULL	Int_J_Biol_Sci_2015_Jan_1_11(1)_48-58.nxml.txt.nlp	25552929	SENT224	14	14	15	15	paclitaxel	LDM	PA450761	1595	0.097
NULL	Eur_Respir_J_2013_May_27_41(5)_1107-1115.nxml.txt.nlp	23018904	SENT97	6	6	7	7	ciprofloxacin	DPI	PA449009	1832	0.097
NULL	Int_J_Mol_Sci_2010_Sep_13_11(9)_3195-3208.nxml.txt.nlp	20957088	SENT57	3	3	2	2	lipase	AT2	PA450239	186	0.097
NULL	Arthritis_Res_Ther_2010_Apr_14_12(2)_R67.nxml.txt.nlp	20398273	SENT123	35	35	36	36	abatacept	CDP	PA164747080	1523	0.097
NULL	Mol_Cancer_2012_Jun_26_11_43.nxml.txt.nlp	22731636	SENT78	17	17	17	17	pp2	PP2		4888	0.097
NULL	J_Cell_Biol_2005_Nov_7_171(3)_505-516.nxml.txt.nlp	16275754	SENT219	5	5	5	5	pp2	PP2		4888	0.097
NULL	Indian_J_Psychiatry_1986_Apr-Jun_28(2)_159-161.nxml.txt.nlp	21927163	SENT0	11	11	10	10	lithium	FOR	PA450243	51741	0.097
NULL	Biosci_Rep_2012_Nov_22_33(1)_e00001.nxml.txt.nlp	23033902	SENT97	14	14	15	15	lipase	ATGL	PA450239	57104	0.097
NULL	Indian_J_Dermatol_2010_Apr-Jun_55(2)_198-199.nxml.txt.nlp	20606897	SENT0	21	21	22	22	itraconazole	FOR	PA450132	51741	0.097
NULL	Exp_Hematol_Oncol_2013_Aug_6_2_20.nxml.txt.nlp	23919448	SENT122	12	12	11	11	decitabine	DAC	PA164749631	13	0.096
NULL	Pediatr_Cardiol_2010_Jan_14_31(1)_90-95.nxml.txt.nlp	19915892	SENT107	31	31	32	32	palivizumab	Era	PA164748781	2099	0.096
NULL	Biosci_Rep_2014_Aug_6_34(4)_e00131.nxml.txt.nlp	24975826	SENT149	8	8	8	8	pp2	PP2		4888	0.096
NULL	J_Biol_Chem_2008_May_30_283(22)_15419-15430.nxml.txt.nlp	18378687	SENT201	25	25	25	25	pp2	PP2		4888	0.096
NULL	Oncogene_2009_Jan_15_28(2)_279-288.nxml.txt.nlp	18836480	SENT113	3	3	3	3	pp2	PP2		4888	0.096
NULL	Nat_Biotechnol_2010_Jul_27_28(7)_743-747.nxml.txt.nlp	20581846	SENT162	23	23	23	23	pp2	PP2		4888	0.096
NULL	JAKSTAT_2013_Jul_1_2(3)_e24812.nxml.txt.nlp	24069562	SENT42	4	4	4	4	pp2	PP2		4888	0.096
NULL	Eur_Respir_J_2013_May_27_41(5)_1107-1115.nxml.txt.nlp	23018904	SENT155	18	18	19	19	ciprofloxacin	DPI	PA449009	1832	0.096
NULL	CNS_Drugs_2013_Aug_23_27(11)_943-953.nxml.txt.nlp	23975660	SENT148	13	13	12	12	atomoxetine	ATX	PA134688071	5168;23049	0.096
NULL	Curr_Cardiol_Rev_2012_May_8(2)_158-165.nxml.txt.nlp	22708914	SENT283	3	3	18	18	warfarin	NNT	PA451906	23530	0.095
NULL	J_R_Soc_Interface_2008_Aug_6_5(25)_855-863.nxml.txt.nlp	18077244	SENT212	13	13	12	12	potassium	TREK-1	PA451047	3776	0.095
NULL	J_Exp_Bot_2012_Jun_13_63(10)_3617-3629.nxml.txt.nlp	22442421	SENT59	22	22	23	23	betaine	DPI	PA448603	1832	0.095
NULL	Int_J_Biol_Sci_2015_Jan_1_11(1)_48-58.nxml.txt.nlp	25552929	SENT298	16	16	17	17	paclitaxel	LDM	PA450761	1595	0.095
NULL	Oncotarget_2014_Aug_12_5(20)_9710-9726.nxml.txt.nlp	25339152	SENT217	3	3	3	3	pp2	PP2		4888	0.095
NULL	Open_Virol_J_2009_Apr_1_3_21-25.nxml.txt.nlp	19572053	SENT27	36	36	36	36	pp2	PP2		4888	0.095
NULL	J_Biol_Chem_2008_May_30_283(22)_15419-15430.nxml.txt.nlp	18378687	SENT152	7	7	7	7	pp2	PP2		4888	0.095
NULL	ScientificWorldJournal_2012_Apr_1_2012_179782.nxml.txt.nlp	22545008	SENT155	17	17	17	17	pp2	PP2		4888	0.095
NULL	Extremophiles_2014_May_3_18(4)_653-664.nxml.txt.nlp	24794034	SENT56	19	19	20	20	heparin	TSK	PA449855	25987	0.095
NULL	J_Biomed_Biotechnol_2010_Jun_7_2010_150960.nxml.txt.nlp	20617134	SENT215	1	1	0	0	panitumumab	KRAS	PA162373091	3845	0.094
NULL	Eur_Respir_J_2013_May_27_41(5)_1107-1115.nxml.txt.nlp	23018904	SENT8	3	3	4	4	ciprofloxacin	DPI	PA449009	1832	0.094
NULL	Cell_Mol_Neurobiol_2012_Jul_24_32(5)_725-735.nxml.txt.nlp	22113371	SENT60	1	1	0	0	vasopressin	AVP	PA451858	114548;551	0.094
NULL	Eur_Respir_J_2013_May_27_41(5)_1107-1115.nxml.txt.nlp	23018904	SENT162	15	15	16	16	ciprofloxacin	DPI	PA449009	1832	0.094
NULL	Mol_Biol_Cell_2013_Jul_1_24(13)_2134-2145.nxml.txt.nlp	23657817	SENT80	9	9	9	9	pp2	PP2		4888	0.094
NULL	Arthritis_Res_Ther_2010_Apr_14_12(2)_R67.nxml.txt.nlp	20398273	SENT119	21	21	22	22	abatacept	CDP	PA164747080	1523	0.094
NULL	Br_J_Cancer_2012_Jan_3_106(1)_18-24.nxml.txt.nlp	22108516	SENT167	16	16	17	17	irinotecan	Yes	PA450085	7525	0.093
NULL	Int_J_Environ_Res_Public_Health_2011_Oct_29_8(10)_3889-3921.nxml.txt.nlp	22073019	SENT225	3	3	0	0	glucosamine	STZ	PA164747613	6484	0.093
NULL	J_Mol_Signal_2012_Sep_8_7_15.nxml.txt.nlp	22958338	SENT170	20	20	20	20	pp2	PP2		4888	0.093
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT307	22	22	22	22	pp2	PP2		4888	0.093
NULL	Int_J_Mol_Sci_2010_Sep_13_11(9)_3195-3208.nxml.txt.nlp	20957088	SENT88	9	9	8	8	lipase	AT2	PA450239	186	0.093
NULL	Br_J_Cancer_2010_Jun_29_103(1)_52-60.nxml.txt.nlp	20531411	SENT109	7	7	6	6	gemcitabine	MTD	PA449748	4493	0.093
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT41	12	12	12	12	pp2	PP2		4888	0.093
NULL	Protein_Cell_2014_Jul_10_5(7)_532-543.nxml.txt.nlp	24715268	SENT201	0	0	0	0	pp2	PP2		4888	0.093
NULL	J_Exp_Bot_2008_Oct_59(13)_3721-3728.nxml.txt.nlp	18820260	SENT184	31	31	31	31	pp2	PP2		4888	0.093
NULL	Protein_Cell_2014_Jul_10_5(7)_532-543.nxml.txt.nlp	24715268	SENT106	16	16	16	16	pp2	PP2		4888	0.093
NULL	Eur_Respir_J_2013_May_27_41(5)_1107-1115.nxml.txt.nlp	23018904	SENT90	6	6	7	7	ciprofloxacin	DPI	PA449009	1832	0.092
NULL	J_Ophthalmic_Inflamm_Infect_2011_Nov_6_2(1)_21-28.nxml.txt.nlp	22057810	SENT101	14	14	13	13	cyclophosphamide	CTX	PA449165	1593	0.092
NULL	CNS_Drugs_2013_Aug_23_27(11)_943-953.nxml.txt.nlp	23975660	SENT141	11	11	10	10	atomoxetine	ATX	PA134688071	5168;23049	0.092
NULL	Cancer_Cell_Int_2013_Feb_14_13_16.nxml.txt.nlp	23409704	SENT179	0	0	0	0	pp2	PP2		4888	0.092
NULL	Appl_Microbiol_Biotechnol_2013_Jan_1_97(1)_143-152.nxml.txt.nlp	22851018	SENT109	9	9	8	8	nadh	mol	PA164755085	90527	0.092
NULL	Cases_J_2009_Aug_24_2_8823.nxml.txt.nlp	19918403	SENT72	4	4	3	3	naproxen	OTC	PA450595	5009	0.092
NULL	Mol_Cancer_2008_Sep_12_7_69.nxml.txt.nlp	18789131	SENT101	27	27	27	27	pp2	PP2		4888	0.092
NULL	Int_J_Mol_Sci_2010_Sep_13_11(9)_3195-3208.nxml.txt.nlp	20957088	SENT4	3	3	2	2	lipase	AT2	PA450239	186	0.092
NULL	J_Ophthalmic_Inflamm_Infect_2011_Nov_6_2(1)_21-28.nxml.txt.nlp	22057810	SENT92	14	14	13	13	cyclophosphamide	CTX	PA449165	1593	0.092
NULL	Acta_Pharmacol_Sin_2009_Dec_4_30(12)_1585-1593.nxml.txt.nlp	19960004	SENT147	7	7	6	6	prazosin	mol	PA451093	90527	0.091
NULL	Eur_J_Dent_2014_Oct-Dec_8(4)_475-480.nxml.txt.nlp	25512727	SENT38	18	18	19	19	warfarin	OAT	PA451906	4942	0.091
NULL	Int_J_Biol_Sci_2015_Jan_1_11(1)_48-58.nxml.txt.nlp	25552929	SENT198	14	14	15	15	paclitaxel	LDM	PA450761	1595	0.091
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT376	19	19	19	19	pp2	PP2		4888	0.091
NULL	Clin_Drug_Investig_2013_Jun_20_33(6)_419-427.nxml.txt.nlp	23605507	SENT15	0	0	1	1	ciprofloxacin	DPI	PA449009	1832	0.091
NULL	Genome_Announc_2013_Jun_27_1(4)_e00379-13.nxml.txt.nlp	23814106	SENT14	14	14	13	13	lipase	VIII	PA450239	1351	0.091
NULL	Int_J_Mol_Sci_2010_Sep_13_11(9)_3195-3208.nxml.txt.nlp	20957088	SENT83	5	5	4	4	lipase	AT2	PA450239	186	0.091
NULL	Arthritis_Res_Ther_2007_Oct_10_9(5)_R105.nxml.txt.nlp	17927818	SENT218	19	19	19	19	pp2	PP2		4888	0.091
NULL	Neuroscience_2008_Sep_22_156(1)_175-183.nxml.txt.nlp	18694808	SENT7	38	38	38	38	pp2	PP2		4888	0.091
NULL	Nucleic_Acids_Res_2006_Jul_1_34(Web_Server_issue)_W75-W78.nxml.txt.nlp	16845113	SENT41	0	0	0	0	pp2	PP2		4888	0.091
NULL	Br_J_Cancer_2014_Jul_15_111(2)_318-325.nxml.txt.nlp	24874484	SENT67	9	9	8	8	choline	CDP	PA448976	1523	0.091
NULL	J_Cell_Biol_2008_Jun_16_181(6)_985-998.nxml.txt.nlp	18541705	SENT591	12	12	13	13	collagenase	MT1-MMP	PA449107	4323	0.091
NULL	Infect_Dis_Ther_2014_Jun_20_3(1)_1-17.nxml.txt.nlp	25134808	SENT130	4	4	3	3	atazanavir	ATV	PA10251	4683	0.09
NULL	BMB_Rep_2014_May_47(5)_268-273.nxml.txt.nlp	24286315	SENT368	11	11	12	12	lapatinib	mol	PA152241907	90527	0.09
NULL	Nat_Commun_2013_Nov_27_4_2821.nxml.txt.nlp	24281726	SENT243	0	0	0	0	pp2	PP2		4888	0.09
NULL	Infect_Dis_Obstet_Gynecol_2014_May_20_2014_258291.nxml.txt.nlp	24963269	SENT214	3	3	4	4	tenofovir	Yes	PA10204	7525	0.09
NULL	Eur_Respir_J_2013_May_27_41(5)_1107-1115.nxml.txt.nlp	23018904	SENT193	24	24	25	25	ciprofloxacin	DPI	PA449009	1832	0.09
NULL	Oncogene_2009_Apr_23_28(16)_1821-1832.nxml.txt.nlp	19305428	SENT77	7	7	7	7	pp2	PP2		4888	0.09
NULL	J_Biol_Chem_2009_Sep_18_284(38)_26096-26105.nxml.txt.nlp	19628870	SENT235	8	8	8	8	pp2	PP2		4888	0.09
NULL	Biomed_Eng_Online_2010_Mar_9_9_15.nxml.txt.nlp	20214774	SENT71	29	29	30	30	paclitaxel	DES	PA450761	1674	0.09
NULL	Vet_Res_2012_Oct_26_43(1)_72.nxml.txt.nlp	23101660	SENT46	36	36	36	36	pp2	PP2		4888	0.089
NULL	Breast_Cancer_Res_2008_Mar_31_10(2)_205.nxml.txt.nlp	18394187	SENT158	11	11	12	12	collagenase	MMP8	PA449107	4317	0.089
NULL	Indian_J_Pharm_Sci_2014_Nov-Dec_76(6)_483-494.nxml.txt.nlp	25593381	SENT122	8	8	7	7	atorvastatin	FOR	PA448500	51741	0.089
NULL	Indian_J_Palliat_Care_2014_Jan-Apr_20(1)_66-87.nxml.txt.nlp	NULL	SENT355	6	6	7	7	nalbuphine	FOR	PA164745372	51741	0.089
NULL	Anal_Chem_Insights_2011_Mar_10_6_21-28.nxml.txt.nlp	21760706	SENT50	12	12	13	13	emtricitabine	API	PA10069	5345	0.089
NULL	Eur_Respir_J_2013_May_27_41(5)_1107-1115.nxml.txt.nlp	23018904	SENT212	0	0	1	1	ciprofloxacin	DPI	PA449009	1832	0.089
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT14	8	8	8	8	pp2	PP2		4888	0.089
NULL	JAKSTAT_2013_Jul_1_2(3)_e24812.nxml.txt.nlp	24069562	SENT60	4	4	4	4	pp2	PP2		4888	0.089
NULL	Clin_Drug_Investig_2013_Jun_20_33(6)_419-427.nxml.txt.nlp	23605507	SENT139	0	0	1	1	ciprofloxacin	DPI	PA449009	1832	0.089
NULL	CNS_Drugs_2014_May_1_28(6)_497-511.nxml.txt.nlp	24788672	SENT107	6	6	5	5	atomoxetine	ATX	PA134688071	5168;23049	0.089
NULL	CNS_Drugs_2013_Aug_20_27(12)_1081-1092.nxml.txt.nlp	23959815	SENT191	1	1	0	0	atomoxetine	ATX	PA134688071	5168;23049	0.089
NULL	J_Cell_Biol_2008_Jul_14_182(1)_157-169.nxml.txt.nlp	18606851	SENT283	0	0	0	0	pp2	PP2		4888	0.088
NULL	Pediatr_Cardiol_2010_Jan_14_31(1)_90-95.nxml.txt.nlp	19915892	SENT111	8	8	9	9	palivizumab	Era	PA164748781	2099	0.088
NULL	Indian_J_Pharm_Sci_2014_Nov-Dec_76(6)_557-559.nxml.txt.nlp	25593392	SENT56	4	4	3	3	raltegravir	FOR		51741	0.088
NULL	Nat_Commun_2014_Jul_16_5_4425.nxml.txt.nlp	25028121	SENT156	0	0	0	0	pp2	PP2		4888	0.088
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT307	29	29	29	29	pp2	PP2		4888	0.088
NULL	Int_J_Mol_Sci_2010_Sep_13_11(9)_3195-3208.nxml.txt.nlp	20957088	SENT213	12	12	11	11	lipase	AT2	PA450239	186	0.088
NULL	Br_J_Cancer_2012_Jan_3_106(1)_6-13.nxml.txt.nlp	22215104	SENT163	39	39	40	40	trastuzumab	DM1	PA451743	338023;1760;28509	0.088
NULL	Onco_Targets_Ther_2014_Sep_30_7_1641-1645.nxml.txt.nlp	25336968	SENT88	11	11	10	10	chlorthalidone	Yes	PA448970	7525	0.088
NULL	J_Exp_Med_2003_Dec_1_198(11)_1643-1652.nxml.txt.nlp	14638845	SENT47	25	25	26	26	collagenase	VIII	PA449107	1351	0.088
NULL	Oncol_Lett_2013_Aug_20_6(2)_329-335.nxml.txt.nlp	24137325	SENT175	2	2	2	2	pp2	PP2		4888	0.088
NULL	Arthritis_Res_Ther_2009_Jan_30_11(1)_206.nxml.txt.nlp	19232066	SENT318	2	2	1	1	denosumab	RANKL	PA166048634	8600	0.088
NULL	Int_J_Biol_Sci_2015_Jan_1_11(1)_48-58.nxml.txt.nlp	25552929	SENT210	19	19	20	20	paclitaxel	LDM	PA450761	1595	0.088
NULL	J_Inflamm_(Lond)_2006_May_4_3_8.nxml.txt.nlp	16674821	SENT151	10	10	10	10	pp2	PP2		4888	0.088
NULL	J_Ophthalmic_Inflamm_Infect_2011_Nov_6_2(1)_21-28.nxml.txt.nlp	22057810	SENT112	14	14	13	13	cyclophosphamide	CTX	PA449165	1593	0.088
NULL	Cancers_(Basel)_2012_Sep_6_4(3)_873-903.nxml.txt.nlp	24213471	SENT1651	2	2	1	1	hyaluronidase	HYAL1	PA164745713	3373	0.088
NULL	Arthritis_Res_Ther_2010_Apr_14_12(2)_R67.nxml.txt.nlp	20398273	SENT111	17	17	18	18	abatacept	CDP	PA164747080	1523	0.087
NULL	Kidney_Int_Suppl_(2011)_2013_Jan_28_3(1)_19-62.nxml.txt.nlp	25018975	SENT635	30	30	31	31	iohexol	GFR	PA450061	9771	0.087
NULL	Mol_Cancer_2009_May_15_8_28.nxml.txt.nlp	19445670	SENT8	38	38	37	37	doxorubicin	mol	PA449412	90527	0.087
NULL	J_Cell_Biol_2001_Oct_1_155(1)_133-144.nxml.txt.nlp	11581290	SENT196	34	34	34	34	pp2	PP2		4888	0.087
NULL	Neural_Plast_2003_10(4)_267-278.nxml.txt.nlp	15152981	SENT5	25	25	24	24	methoxamine	mol	PA450431	90527	0.087
NULL	J_Cell_Biol_2003_Aug_18_162(4)_661-671.nxml.txt.nlp	12925710	SENT59	5	5	5	5	pp2	PP2		4888	0.087
NULL	Int_J_Mol_Sci_2010_Sep_13_11(9)_3195-3208.nxml.txt.nlp	20957088	SENT35	10	10	9	9	lipase	AT2	PA450239	186	0.087
NULL	Genetics_2013_Jan_193(1)_1-50.nxml.txt.nlp	23275493	SENT409	20	20	19	19	lipase	DAG	PA450239	1605	0.087
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT190	0	0	0	0	pp2	PP2		4888	0.087
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT249	4	4	4	4	pp2	PP2		4888	0.087
NULL	Br_J_Cancer_2010_Jun_29_103(1)_52-60.nxml.txt.nlp	20531411	SENT210	10	10	9	9	gemcitabine	MTD	PA449748	4493	0.087
NULL	ASN_Neuro_2009_Apr_14_1(1)_e00005.nxml.txt.nlp	19570022	SENT126	2	2	2	2	pp2	PP2		4888	0.087
NULL	Br_J_Cancer_2010_Jun_29_103(1)_52-60.nxml.txt.nlp	20531411	SENT203	10	10	9	9	gemcitabine	MTD	PA449748	4493	0.086
NULL	Clin_Drug_Investig_2013_Jun_20_33(6)_419-427.nxml.txt.nlp	23605507	SENT145	0	0	1	1	ciprofloxacin	DPI	PA449009	1832	0.086
NULL	Mol_Cancer_2012_Jun_26_11_43.nxml.txt.nlp	22731636	SENT118	12	12	12	12	pp2	PP2		4888	0.086
NULL	J_Inflamm_(Lond)_2006_May_4_3_8.nxml.txt.nlp	16674821	SENT47	0	0	0	0	pp2	PP2		4888	0.086
NULL	Br_J_Cancer_2010_Jun_29_103(1)_52-60.nxml.txt.nlp	20531411	SENT159	4	4	3	3	gemcitabine	MTD	PA449748	4493	0.086
NULL	JAKSTAT_2013_Jul_1_2(3)_e24812.nxml.txt.nlp	24069562	SENT59	23	23	23	23	pp2	PP2		4888	0.086
NULL	J_Cell_Biol_2001_Jul_9_154(1)_177-186.nxml.txt.nlp	11448999	SENT306	0	0	0	0	pp2	PP2		4888	0.086
NULL	J_Cell_Biol_2003_Aug_18_162(4)_661-671.nxml.txt.nlp	12925710	SENT340	8	8	8	8	pp2	PP2		4888	0.086
NULL	Neuroscience_2008_Sep_22_156(1)_175-183.nxml.txt.nlp	18694808	SENT49	3	3	3	3	pp2	PP2		4888	0.086
NULL	J_Gastrointest_Cancer_2014_Dec_17_45(2)_190-201.nxml.txt.nlp	24343588	SENT236	1	1	0	0	gemcitabine	Gem	PA449748	51053	0.086
NULL	J_Adv_Pharm_Technol_Res_2010_Oct-Dec_1(4)_396-400.nxml.txt.nlp	22247879	SENT45	15	15	14	14	benzaldehyde	mol	PA448571	90527	0.086
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT122	23	23	23	23	pp2	PP2		4888	0.086
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT141	21	21	21	21	pp2	PP2		4888	0.086
NULL	Oncogene_2009_Jan_15_28(2)_279-288.nxml.txt.nlp	18836480	SENT119	3	3	3	3	pp2	PP2		4888	0.085
NULL	J_R_Soc_Interface_2008_Aug_6_5(25)_855-863.nxml.txt.nlp	18077244	SENT203	14	14	13	13	potassium	TREK-1	PA451047	3776	0.085
NULL	Int_J_Biol_Sci_2015_Jan_1_11(1)_48-58.nxml.txt.nlp	25552929	SENT140	4	4	5	5	paclitaxel	LDM	PA450761	1595	0.085
NULL	BioData_Min_2014_Oct_26_7_21.nxml.txt.nlp	25368670	SENT139	8	8	9	9	lipase	LIPE	PA450239	3991	0.085
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT366	18	18	18	18	pp2	PP2		4888	0.085
NULL	Indian_J_Psychiatry_2009_Jan_51(Suppl1)_S44-S51.nxml.txt.nlp	21416016	SENT237	4	4	3	3	choline	CDP	PA448976	1523	0.085
NULL	Angiogenesis_2011_Mar_4_14(1)_17-27.nxml.txt.nlp	21049284	SENT141	23	23	22	22	thrombin	PAR-1	PA451674	2011;2149	0.085
NULL	CNS_Drugs_2013_Aug_20_27(12)_1081-1092.nxml.txt.nlp	23959815	SENT131	1	1	0	0	atomoxetine	ATX	PA134688071	5168;23049	0.085
NULL	Pharmaceutics_2011_Feb_7_3(1)_53-72.nxml.txt.nlp	24310425	SENT856	29	29	28	28	carbamazepine	CYP3A	PA448785	1574	0.085
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1051.nxml.txt.nlp	24503543	SENT144	24	24	23	23	tamoxifen	Yes	PA451581	7525	0.085
NULL	J_Cell_Biol_2003_Aug_18_162(4)_661-671.nxml.txt.nlp	12925710	SENT101	4	4	4	4	pp2	PP2		4888	0.085
NULL	Diabetes_Care_2012_Jul_12_35(7)_1429-1435.nxml.txt.nlp	22723581	SENT235	7	7	6	6	pioglitazone	CRN	PA450970	10699;51340	0.085
NULL	J_Exp_Bot_2008_Oct_59(13)_3721-3728.nxml.txt.nlp	18820260	SENT25	14	14	14	14	pp2	PP2		4888	0.085
NULL	Int_J_Mol_Sci_2010_Sep_13_11(9)_3195-3208.nxml.txt.nlp	20957088	SENT98	4	4	3	3	lipase	AT2	PA450239	186	0.085
NULL	Br_J_Cancer_2014_Jul_15_111(2)_318-325.nxml.txt.nlp	24874484	SENT37	41	41	40	40	choline	CDP	PA448976	1523	0.085
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT176	22	22	22	22	pp2	PP2		4888	0.084
NULL	Biosci_Rep_2014_Aug_6_34(4)_e00131.nxml.txt.nlp	24975826	SENT147	19	19	19	19	pp2	PP2		4888	0.084
NULL	CNS_Drugs_2014_Jul_20_28(11)_1059-1069.nxml.txt.nlp	25038977	SENT131	1	1	0	0	atomoxetine	ATX	PA134688071	5168;23049	0.084
NULL	Clin_Kidney_J_2013_Aug_6(4)_421-425.nxml.txt.nlp	24422172	SENT78	20	20	19	19	fluorescein	CD46	PA164746009	4179	0.084
NULL	Eur_Respir_J_2013_May_27_41(5)_1107-1115.nxml.txt.nlp	23018904	SENT176	6	6	7	7	ciprofloxacin	DPI	PA449009	1832	0.084
NULL	Core_Evid_2009_Jun_15_4_113-129.nxml.txt.nlp	20694069	SENT380	11	11	12	12	teriparatide	PTH	PA451620	5741	0.084
NULL	Lab_Invest_2011_Sep_23_91(9)_1396-1409.nxml.txt.nlp	21606925	SENT183	15	15	15	15	pp2	PP2		4888	0.084
NULL	J_Biol_Chem_2013_Feb_15_288(7)_5127-5135.nxml.txt.nlp	23264619	SENT138	27	27	27	27	pp2	PP2		4888	0.084
NULL	FASEB_J_2012_Oct_26(10)_4198-4209.nxml.txt.nlp	22750516	SENT330	8	8	9	9	hyaluronidase	PH-20	PA164745713	6677	0.084
NULL	CNS_Drugs_2014_Jul_20_28(11)_1059-1069.nxml.txt.nlp	25038977	SENT107	10	10	9	9	atomoxetine	ATX	PA134688071	5168;23049	0.083
NULL	Ann_Hematol_2014_Mar_18_93(8)_1335-1344.nxml.txt.nlp	24638841	SENT107	7	7	6	6	chlorambucil	CLB	PA448926	171425	0.083
NULL	Pediatr_Cardiol_2010_Jan_14_31(1)_90-95.nxml.txt.nlp	19915892	SENT108	28	28	29	29	palivizumab	Era	PA164748781	2099	0.083
NULL	J_Biol_Chem_2012_Aug_17_287(34)_28932-28942.nxml.txt.nlp	22718751	SENT145	21	21	21	21	pp2	PP2		4888	0.083
NULL	Mol_Biol_Cell_2013_Jul_1_24(13)_2134-2145.nxml.txt.nlp	23657817	SENT182	23	23	23	23	pp2	PP2		4888	0.083
NULL	Clin_Drug_Investig_2013_Jun_20_33(6)_419-427.nxml.txt.nlp	23605507	SENT176	12	12	13	13	ciprofloxacin	DPI	PA449009	1832	0.083
NULL	Int_J_Mol_Sci_2010_Sep_13_11(9)_3195-3208.nxml.txt.nlp	20957088	SENT135	3	3	2	2	lipase	AT2	PA450239	186	0.083
NULL	Mol_Biol_Cell_2014_Jul_1_25(13)_1995-2005.nxml.txt.nlp	24807907	SENT10	19	19	18	18	guanidine	RhoA	PA164781028	387	0.083
NULL	Angiogenesis_2013_Apr_10_16(2)_373-386.nxml.txt.nlp	23143659	SENT223	25	25	24	24	cyclophosphamide	LDM	PA449165	1595	0.083
NULL	Arthritis_Res_Ther_2010_Apr_14_12(2)_R67.nxml.txt.nlp	20398273	SENT143	10	10	11	11	abatacept	CDP	PA164747080	1523	0.083
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT370	18	18	18	18	pp2	PP2		4888	0.083
NULL	J_Cell_Biol_2001_Oct_1_155(1)_133-144.nxml.txt.nlp	11581290	SENT195	5	5	5	5	pp2	PP2		4888	0.083
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Apr_20_69(Pt_5)_m280.nxml.txt.nlp	23723782	SENT5	2	2	3	3	nitrile	mol	PA450636	90527	0.083
NULL	J_Cell_Biol_1998_Nov_30_143(5)_1167-1182.nxml.txt.nlp	9832547	SENT105	39	39	38	38	glucose	mol	PA449773	90527	0.083
NULL	J_Gen_Physiol_2005_Jul_126(1)_1.nxml.txt.nlp	NULL	SENT2720	16	16	16	16	pp2	PP2		4888	0.083
NULL	J_Ophthalmic_Inflamm_Infect_2011_Nov_6_2(1)_21-28.nxml.txt.nlp	22057810	SENT81	14	14	13	13	cyclophosphamide	CTX	PA449165	1593	0.083
NULL	EMBO_J_2009_Apr_22_28(8)_1043-1054.nxml.txt.nlp	19300439	SENT116	24	24	24	24	pp2	PP2		4888	0.083
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT156	2	2	2	2	pp2	PP2		4888	0.082
NULL	Biomed_Res_Int_2014_Jun_3_2014_656370.nxml.txt.nlp	24995318	SENT79	15	15	14	14	perphenazine	FGA	PA450882	2243	0.082
NULL	Emerg_Infect_Dis_2015_Jan_21(1)_164-166.nxml.txt.nlp	25531800	SENT8	12	12	11	11	artesunate	GMP	PA165111697	22978	0.082
NULL	Indian_J_Pharm_Sci_2012_Nov-Dec_74(6)_527-534.nxml.txt.nlp	23798778	SENT62	2	2	1	1	simvastatin	FOR	PA451363	51741	0.082
NULL	Asian-Australas_J_Anim_Sci_2013_Aug_26(8)_1189-1196.nxml.txt.nlp	25049900	SENT64	16	16	15	15	nadh	mol	PA164755085	90527	0.082
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT94	5	5	5	5	pp2	PP2		4888	0.082
NULL	CNS_Drugs_2013_Aug_20_27(12)_1081-1092.nxml.txt.nlp	23959815	SENT156	1	1	0	0	atomoxetine	ATX	PA134688071	5168;23049	0.082
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT380	5	5	5	5	pp2	PP2		4888	0.082
NULL	J_Clin_Biochem_Nutr_2007_Jan_27_40(1)_49-55.nxml.txt.nlp	18437213	SENT383	20	20	19	19	creatine	mol	PA164778930	90527	0.082
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT236	17	17	17	17	pp2	PP2		4888	0.082
NULL	J_Ophthalmic_Inflamm_Infect_2011_Nov_6_2(1)_21-28.nxml.txt.nlp	22057810	SENT76	14	14	13	13	cyclophosphamide	CTX	PA449165	1593	0.082
NULL	J_Gastroenterol_2013_Feb_23_48(12)_1373-1383.nxml.txt.nlp	23435670	SENT160	12	12	11	11	lamivudine	LAM	PA450163	7249;7248	0.082
NULL	Eur_Respir_J_2013_May_27_41(5)_1107-1115.nxml.txt.nlp	23018904	SENT31	13	13	14	14	ciprofloxacin	DPI	PA449009	1832	0.082
NULL	Biochemistry_2013_Dec_17_52(50)_9059-9067.nxml.txt.nlp	24266852	SENT6	11	11	11	11	pp2	PP2		4888	0.082
NULL	Mar_Drugs_2010_Oct_11_8(10)_2605-2618.nxml.txt.nlp	21116409	SENT217	7	7	8	8	hydrocortisone	IL-6	PA449905	3569	0.082
NULL	CNS_Drugs_2013_Aug_20_27(12)_1081-1092.nxml.txt.nlp	23959815	SENT168	18	18	17	17	atomoxetine	ATX	PA134688071	5168;23049	0.082
NULL	Exp_Ther_Med_2013_Mar_21_5(3)_987-991.nxml.txt.nlp	23407636	SENT140	13	13	14	14	losartan	CXCR1	PA450268	3577	0.082
NULL	Arthritis_Res_Ther_2007_Oct_10_9(5)_R105.nxml.txt.nlp	17927818	SENT219	4	4	4	4	pp2	PP2		4888	0.081
NULL	Clin_Microbiol_Infect_2014_Jun_21_20(6)_536-541.nxml.txt.nlp	24107197	SENT8	15	15	16	16	isoniazid	DST	PA450112	667	0.081
NULL	J_Cell_Biol_2001_Oct_29_155(3)_427-438.nxml.txt.nlp	11673478	SENT239	4	4	4	4	pp2	PP2		4888	0.081
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT149	7	7	7	7	pp2	PP2		4888	0.081
NULL	Indian_J_Pharm_Sci_2012_Jul-Aug_74(4)_302-311.nxml.txt.nlp	23626385	SENT208	7	7	6	6	baclofen	FOR	PA448533	51741	0.081
NULL	Eur_Respir_J_2013_May_27_41(5)_1107-1115.nxml.txt.nlp	23018904	SENT208	0	0	1	1	ciprofloxacin	DPI	PA449009	1832	0.081
NULL	Ann_Rheum_Dis_2009_Dec_1_68(12)_1819-1826.nxml.txt.nlp	19054822	SENT41	3	3	4	4	abatacept	CDP	PA164747080	1523	0.081
NULL	Cancer_Causes_Control_2013_Aug_18_24(8)_1605-1614.nxml.txt.nlp	23775025	SENT64	3	3	4	4	cyclophosphamide	CYP1A1	PA449165	1543	0.081
NULL	Oncotarget_2013_Jun_30_4(7)_1037-1049.nxml.txt.nlp	23900414	SENT181	37	37	37	37	pp2	PP2		4888	0.081
NULL	Biomed_Res_Int_2014_Jan_29_2014_361020.nxml.txt.nlp	24605326	SENT223	7	7	8	8	flavopiridol	CDK1	PA452627	983	0.081
NULL	Oncogene_2009_Jan_15_28(2)_279-288.nxml.txt.nlp	18836480	SENT200	0	0	0	0	pp2	PP2		4888	0.081
NULL	Br_J_Cancer_2010_Jun_29_103(1)_52-60.nxml.txt.nlp	20531411	SENT9	3	3	2	2	gemcitabine	MTD	PA449748	4493	0.081
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT89	4	4	4	4	pp2	PP2		4888	0.081
NULL	Semin_Immunopathol_2013_Jan_26_35(1)_39-52.nxml.txt.nlp	22829332	SENT197	19	19	18	18	cyclophosphamide	CHOP	PA449165	1649	0.081
NULL	Mol_Vis_2007_Jan_19_13_47-56.nxml.txt.nlp	17277743	SENT220	34	34	33	33	heparin	VEGF-A	PA449855	7422	0.081
NULL	Biochem_Res_Int_2012_Mar_4_2012_875742.nxml.txt.nlp	22500233	SENT125	3	3	4	4	collagenase	MMP8	PA449107	4317	0.081
NULL	Arthritis_Res_Ther_2010_Apr_14_12(2)_R67.nxml.txt.nlp	20398273	SENT139	8	8	9	9	abatacept	CDP	PA164747080	1523	0.081
NULL	Biol_Proced_Online_2001_Dec_11_3_43-53.nxml.txt.nlp	12734580	SENT166	12	12	13	13	collagenase	CLS	PA449107	1210	0.081
NULL	Cancers_(Basel)_2012_Sep_6_4(3)_873-903.nxml.txt.nlp	24213471	SENT677	5	5	6	6	hyaluronidase	PH-20	PA164745713	6677	0.081
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT367	7	7	7	7	pp2	PP2		4888	0.08
NULL	Arthritis_Res_Ther_2010_Apr_14_12(2)_R67.nxml.txt.nlp	20398273	SENT206	9	9	10	10	abatacept	CDP	PA164747080	1523	0.08
NULL	Mol_Cancer_2013_May_9_12_39.nxml.txt.nlp	23656719	SENT164	29	29	29	29	pp2	PP2		4888	0.08
NULL	Front_Genet_2012_Oct_26_3_213.nxml.txt.nlp	23112805	SENT608	40	40	39	39	midazolam	CYP3A4	PA450496	1576	0.08
NULL	Front_Mol_Neurosci_2012_Nov_12_5_99.nxml.txt.nlp	23162427	SENT259	26	26	27	27	cocaine	CPP	PA449072	340451	0.08
NULL	Arthritis_Res_Ther_2010_Apr_14_12(2)_R67.nxml.txt.nlp	20398273	SENT42	6	6	7	7	abatacept	CDP	PA164747080	1523	0.08
NULL	Chem_Mater_2012_Oct_9_24(19)_3674-3683.nxml.txt.nlp	23503160	SENT36	21	21	20	20	ethanol	mol	PA448073	90527	0.08
NULL	EMBO_J_2009_Aug_19_28(16)_2360-2373.nxml.txt.nlp	19609305	SENT48	19	19	19	19	pp2	PP2		4888	0.08
NULL	Int_J_Cardiovasc_Imaging_2012_Mar_27_28(3)_455-465.nxml.txt.nlp	21359834	SENT25	5	5	4	4	glipizide	GLP	PA449762	342096	0.08
NULL	Clin_Drug_Investig_2013_Jun_20_33(6)_419-427.nxml.txt.nlp	23605507	SENT6	11	11	12	12	ciprofloxacin	DPI	PA449009	1832	0.08
NULL	Int_J_Breast_Cancer_2012_Nov_2_2012_217185.nxml.txt.nlp	22295242	SENT203	24	24	25	25	cetuximab	PI3K	PA10040	5290	0.08
NULL	Chem_Rev_2011_Oct_12_111(10)_5899-5921.nxml.txt.nlp	21923193	SENT337	14	14	13	13	lipase	MAG	PA450239	2068;4099	0.08
NULL	J_Biol_Chem_2008_May_30_283(22)_15419-15430.nxml.txt.nlp	18378687	SENT201	3	3	3	3	pp2	PP2		4888	0.08
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_May_4_69(Pt_6)_o827.nxml.txt.nlp	23795017	SENT9	6	6	7	7	phenol	mol	PA450913	90527	0.08
NULL	Oncoimmunology_2013_Jun_1_2(6)_e24614.nxml.txt.nlp	23894721	SENT28	8	8	7	7	trabectedin	CCL2	PA165958349	6347	0.08
NULL	Cell_Host_Microbe_2014_Sep_10_16(3)_291-303.nxml.txt.nlp	25211072	SENT86	9	9	9	9	pp2	PP2		4888	0.08
NULL	J_Cell_Biol_2005_Nov_7_171(3)_505-516.nxml.txt.nlp	16275754	SENT296	13	13	13	13	pp2	PP2		4888	0.08
NULL	Cancers_(Basel)_2012_Sep_6_4(3)_873-903.nxml.txt.nlp	24213471	SENT1568	12	12	11	11	hyaluronidase	HYAL1	PA164745713	3373	0.08
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT148	7	7	7	7	pp2	PP2		4888	0.08
NULL	Eur_Respir_J_2013_May_27_41(5)_1107-1115.nxml.txt.nlp	23018904	SENT144	30	30	31	31	ciprofloxacin	DPI	PA449009	1832	0.08
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT1706	22	22	23	23	ritonavir	ATV	PA451260	4683	0.079
NULL	Mol_Cancer_2008_Sep_12_7_69.nxml.txt.nlp	18789131	SENT99	12	12	12	12	pp2	PP2		4888	0.079
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jul_25_68(Pt_8)_m1107-m1108.nxml.txt.nlp	22904762	SENT7	6	6	7	7	ethanol	mol	PA448073	90527	0.079
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT42	29	29	29	29	pp2	PP2		4888	0.079
NULL	Ann_Hematol_2014_Mar_18_93(8)_1335-1344.nxml.txt.nlp	24638841	SENT84	40	40	39	39	chlorambucil	CLB	PA448926	171425	0.079
NULL	Indian_J_Pharm_Sci_2013_Mar-Apr_75(2)_230-233.nxml.txt.nlp	24019575	SENT85	31	31	32	32	tadalafil	API	PA10333	5345	0.079
NULL	Drugs_2014_Jun_25_74(10)_1063-1072.nxml.txt.nlp	24962424	SENT118	1	1	0	0	ethambutol	EMB	PA164784021	133418	0.079
NULL	Cell_Commun_Signal_2013_Dec_13_11_94.nxml.txt.nlp	24330678	SENT120	20	20	19	19	lipase	DAG	PA450239	1605	0.079
NULL	Eur_J_Appl_Physiol_2011_Feb_24_111(2)_275-283.nxml.txt.nlp	20865425	SENT156	15	15	16	16	glucose	APE	PA449773	55704;328	0.079
NULL	Arch_Orthop_Trauma_Surg_2009_Nov_7_129(11)_1495-1504.nxml.txt.nlp	18989686	SENT183	26	26	25	25	vancomycin	VAN	PA451850	10318	0.079
NULL	Ann_Rheum_Dis_2009_Dec_1_68(12)_1819-1826.nxml.txt.nlp	19054822	SENT167	24	24	25	25	abatacept	CDP	PA164747080	1523	0.079
NULL	CNS_Drugs_2013_Aug_20_27(12)_1081-1092.nxml.txt.nlp	23959815	SENT135	11	11	10	10	atomoxetine	ATX	PA134688071	5168;23049	0.079
NULL	J_Radiat_Res_2012_Jul_12_53(4)_551-557.nxml.txt.nlp	22843620	SENT141	34	34	34	34	pp2	PP2		4888	0.078
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT13	2	2	2	2	pp2	PP2		4888	0.078
NULL	CNS_Drugs_2014_May_1_28(6)_497-511.nxml.txt.nlp	24788672	SENT103	1	1	0	0	atomoxetine	ATX	PA134688071	5168;23049	0.078
NULL	Drugs_2014_Jun_25_74(10)_1063-1072.nxml.txt.nlp	24962424	SENT153	4	4	3	3	ethambutol	EMB	PA164784021	133418	0.078
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT240	13	13	13	13	pp2	PP2		4888	0.078
NULL	Exp_Diabetes_Res_2011_Apr_26_2011_215764.nxml.txt.nlp	21584276	SENT145	7	7	6	6	exenatide	Yes	PA164749238	7525	0.078
NULL	Cancers_(Basel)_2011_Aug_9_3(3)_3189-3205.nxml.txt.nlp	24212952	SENT779	12	12	11	11	hyaluronidase	HYAL1	PA164745713	3373	0.078
NULL	J_Gen_Physiol_1938_Nov_20_22(2)_207-237.nxml.txt.nlp	19873101	SENT8	5	5	4	4	chymotrypsin	gamma	PA448994	9913	0.078
NULL	Int_J_Mol_Sci_2010_Sep_13_11(9)_3195-3208.nxml.txt.nlp	20957088	SENT79	16	16	15	15	lipase	AT2	PA450239	186	0.078
NULL	Cancer_Immunol_Immunother_2013_Jul_20_62(9)_1533-1545.nxml.txt.nlp	23873089	SENT154	8	8	7	7	gemcitabine	Gem	PA449748	51053	0.078
NULL	Eur_J_Appl_Physiol_2011_Feb_24_111(2)_275-283.nxml.txt.nlp	20865425	SENT83	23	23	24	24	glucose	APE	PA449773	55704;328	0.078
NULL	Front_Immunol_2012_Jan_11_2_95.nxml.txt.nlp	22566884	SENT198	16	16	16	16	pp2	PP2		4888	0.078
NULL	Clin_Drug_Investig_2013_Jun_20_33(6)_419-427.nxml.txt.nlp	23605507	SENT6	29	29	30	30	ciprofloxacin	DPI	PA449009	1832	0.078
NULL	ScientificWorldJournal_2012_Apr_1_2012_491737.nxml.txt.nlp	22547985	SENT140	8	8	7	7	pp2	PP1		5540;5464	0.078
NULL	Breast_Cancer_Res_2012_Aug_8_14(4)_R116.nxml.txt.nlp	22873525	SENT145	9	9	10	10	trastuzumab	HER2	PA451743	2064	0.078
NULL	Anal_Chem_Insights_2011_Mar_10_6_21-28.nxml.txt.nlp	21760706	SENT6	16	16	17	17	emtricitabine	API	PA10069	5345	0.078
NULL	J_Cell_Biol_2007_Apr_23_177(2)_317-328.nxml.txt.nlp	17452533	SENT247	6	6	6	6	pp2	PP2		4888	0.078
NULL	Glycobiology_2011_Apr_2_21(4)_410-425.nxml.txt.nlp	21045009	SENT364	18	18	17	17	nadh	mol	PA164755085	90527	0.077
NULL	Pan_Afr_Med_J_2012_Mar_24_11_56.nxml.txt.nlp	22593792	SENT26	8	8	7	7	cyclophosphamide	CHOP	PA449165	1649	0.077
NULL	ScientificWorldJournal_2012_Apr_1_2012_491737.nxml.txt.nlp	22547985	SENT142	1	1	0	0	pp2	PP1		5540;5464	0.077
NULL	Iran_J_Pharm_Res_2015_Winter_14(1)_167-175.nxml.txt.nlp	25561923	SENT112	23	23	24	24	propofol	Yes	PA451141	7525	0.077
NULL	Crit_Care_2007_Aug_22_11(4)_226.nxml.txt.nlp	17764582	SENT96	29	29	30	30	haloperidol	Yes	PA449841	7525	0.077
NULL	J_Cancer_2014_Jan_5_5(2)_86-97.nxml.txt.nlp	24494026	SENT339	15	15	14	14	gefitinib	EGFR	PA131301952	1956	0.077
NULL	Arthritis_Res_Ther_2010_Apr_14_12(2)_R67.nxml.txt.nlp	20398273	SENT189	19	19	20	20	abatacept	CDP	PA164747080	1523	0.077
NULL	Ann_Neurol_2014_Feb_24_75(2)_303-308.nxml.txt.nlp	24740641	SENT53	10	10	11	11	thrombin	ACPP	PA451674	55	0.077
NULL	Cell_Mol_Life_Sci_2013_Aug_10_70(15)_2713-2741.nxml.txt.nlp	23138638	SENT342	8	8	8	8	pp2	PP2		4888	0.077
NULL	J_Hematol_Oncol_2011_Nov_4_4_44.nxml.txt.nlp	22053759	SENT115	6	6	5	5	thrombin	PAR1	PA451674	79581;2149	0.077
NULL	Pain_Res_Treat_2013_Jan_30_2013_217864.nxml.txt.nlp	23431433	SENT178	20	20	20	20	pp2	PP2		4888	0.077
NULL	Cancer_Causes_Control_2013_Aug_18_24(8)_1605-1614.nxml.txt.nlp	23775025	SENT64	25	25	24	24	methotrexate	GSTP1	PA450428	2950	0.077
NULL	J_Biol_Chem_2008_Dec_19_283(51)_35419-35427.nxml.txt.nlp	18955485	SENT235	16	16	16	16	pp2	PP2		4888	0.076
NULL	Biosci_Rep_2014_Aug_6_34(4)_e00131.nxml.txt.nlp	24975826	SENT147	13	13	13	13	pp2	PP2		4888	0.076
NULL	CNS_Drugs_2013_Aug_20_27(12)_1081-1092.nxml.txt.nlp	23959815	SENT177	1	1	0	0	atomoxetine	ATX	PA134688071	5168;23049	0.076
NULL	Anal_Bioanal_Chem_2011_Jan_3_399(2)_527-539.nxml.txt.nlp	20814668	SENT204	5	5	6	6	heparin	API	PA449855	5345	0.076
NULL	Clin_Med_Insights_Oncol_2013_Jul_28_7_165-172.nxml.txt.nlp	23926442	SENT43	29	29	28	28	fluorescein	CD25	PA164746009	3669;3559	0.076
NULL	Clin_Dev_Immunol_2013_May_29_2013_289458.nxml.txt.nlp	23818912	SENT221	6	6	7	7	denosumab	RANKL	PA166048634	8600	0.076
NULL	Braz_J_Microbiol_2014_Jan_15_44(3)_807-812.nxml.txt.nlp	24516449	SENT133	17	17	18	18	cefoxitin	CTX	PA448856	1593	0.076
NULL	Evid_Based_Complement_Alternat_Med_2011_Mar_1_2011_207034.nxml.txt.nlp	21423686	SENT82	18	18	17	17	fluorescein	PAC-1	PA164746009	1844	0.076
NULL	Pharm_Pract_(Granada)_2011_Mar_15_Jan-Mar_9(1)_1-10.nxml.txt.nlp	25132883	SENT162	20	20	19	19	dabigatran	SPAF		166378	0.076
NULL	Arch_Dis_Child_2014_Dec_8_99(12)_1143-1146.nxml.txt.nlp	25202131	SENT58	16	16	17	17	omeprazole	CYP2D6	PA450704	1565	0.076
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT196	4	4	4	4	pp2	PP2		4888	0.076
NULL	Front_Genet_2012_Oct_26_3_213.nxml.txt.nlp	23112805	SENT608	25	25	24	24	diclofenac	CYP2C9	PA449293	1559	0.076
NULL	Reprod_Biol_Endocrinol_2003_Aug_6_1_54.nxml.txt.nlp	12932297	SENT320	25	25	26	26	hyaluronidase	PH-20	PA164745713	6677	0.076
NULL	J_Cell_Biol_2003_Dec_22_163(6)_1339-1349.nxml.txt.nlp	14691141	SENT74	20	20	20	20	pp2	PP2		4888	0.076
NULL	Cancer_Cell_Int_2013_Feb_14_13_16.nxml.txt.nlp	23409704	SENT89	20	20	20	20	pp2	PP2		4888	0.076
NULL	Oncol_Rep_2014_Jul_15_32(1)_45-49.nxml.txt.nlp	24841138	SENT55	9	9	9	9	pp2	PP2		4888	0.076
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1049.nxml.txt.nlp	24503541	SENT8	27	27	27	27	pp2	PP2		4888	0.076
NULL	CNS_Drugs_2014_May_1_28(6)_497-511.nxml.txt.nlp	24788672	SENT68	1	1	0	0	atomoxetine	ATX	PA134688071	5168;23049	0.076
NULL	Front_Oncol_2013_Aug_30_3_222.nxml.txt.nlp	24010121	SENT119	25	25	26	26	docetaxel	PC-3	PA449383	692094	0.076
NULL	Int_J_Mol_Sci_2010_Sep_13_11(9)_3195-3208.nxml.txt.nlp	20957088	SENT39	18	18	17	17	lipase	AT2	PA450239	186	0.075
NULL	Clin_Interv_Aging_2008_Sep_3(3)_453-472.nxml.txt.nlp	18982916	SENT357	7	7	8	8	leucovorin	CD4	PA450198	920	0.075
NULL	Cardiol_Res_Pract_2012_May_24_2012_437623.nxml.txt.nlp	22675647	SENT178	13	13	14	14	collagenase	MMP13	PA449107	4322	0.075
NULL	J_Inflamm_(Lond)_2006_May_4_3_8.nxml.txt.nlp	16674821	SENT88	5	5	5	5	pp2	PP2		4888	0.075
NULL	Eur_Respir_J_2013_May_27_41(5)_1107-1115.nxml.txt.nlp	23018904	SENT83	7	7	8	8	ciprofloxacin	DPI	PA449009	1832	0.075
NULL	J_Cell_Biol_2003_Sep_29_162(7)_1189-1196.nxml.txt.nlp	14517202	SENT148	28	28	28	28	pp2	PP2		4888	0.075
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1051.nxml.txt.nlp	24503543	SENT144	28	28	27	27	erlotinib	Yes	PA134687924	7525	0.075
NULL	Arthritis_Res_Ther_2010_Apr_14_12(2)_R67.nxml.txt.nlp	20398273	SENT105	2	2	3	3	abatacept	CDP	PA164747080	1523	0.075
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Feb_9_67(Pt_3)_o581-o582.nxml.txt.nlp	21522343	SENT7	37	37	38	38	ethanol	mol	PA448073	90527	0.075
NULL	Biochemistry_2013_Dec_17_52(50)_9059-9067.nxml.txt.nlp	24266852	SENT7	25	25	25	25	pp2	PP2		4888	0.074
NULL	Br_J_Cancer_2009_Jul_21_101(2)_312-319.nxml.txt.nlp	19568237	SENT110	31	31	31	31	pp2	PP2		4888	0.074
NULL	Eur_J_Haematol_2008_Feb_80(2)_93-106.nxml.txt.nlp	18081719	SENT325	1	1	2	2	iron	MRI	PA450087	78996	0.074
NULL	Ann_Rheum_Dis_2009_Dec_1_68(12)_1819-1826.nxml.txt.nlp	19054822	SENT80	8	8	9	9	abatacept	CDP	PA164747080	1523	0.074
NULL	Acta_Pharmacol_Sin_2010_Dec_22_31(12)_1593-1603.nxml.txt.nlp	21102482	SENT158	22	22	22	22	pp2	PP2		4888	0.074
NULL	Curr_Oncol_2008_Oct_15(5)_229-233.nxml.txt.nlp	19008997	SENT136	21	21	22	22	chlorambucil	Yes	PA448926	7525	0.074
NULL	J_Gastroenterol_2013_Feb_23_48(12)_1373-1383.nxml.txt.nlp	23435670	SENT156	9	9	8	8	lamivudine	LAM	PA450163	7249;7248	0.074
NULL	JAKSTAT_2013_Jul_1_2(3)_e24812.nxml.txt.nlp	24069562	SENT55	33	33	33	33	pp2	PP2		4888	0.074
NULL	Cell_Cycle_2013_Feb_15_12(4)_543.nxml.txt.nlp	23370388	SENT18	14	14	15	15	lipase	LIPC	PA450239	3990	0.074
NULL	Int_J_Biol_Sci_2015_Jan_1_11(1)_48-58.nxml.txt.nlp	25552929	SENT13	14	14	13	13	paclitaxel	LDM	PA450761	1595	0.074
NULL	Br_J_Cancer_2012_Jan_3_106(1)_6-13.nxml.txt.nlp	22215104	SENT171	12	12	13	13	trastuzumab	DM1	PA451743	338023;1760;28509	0.074
NULL	Br_J_Cancer_2014_Jul_15_111(2)_318-325.nxml.txt.nlp	24874484	SENT201	10	10	9	9	choline	CDP	PA448976	1523	0.074
NULL	Diabetes_2011_Jan_7_60(1)_127-137.nxml.txt.nlp	20929976	SENT315	24	24	24	24	pp2	PP2		4888	0.074
NULL	Biomed_Res_Int_2014_Jan_29_2014_361020.nxml.txt.nlp	24605326	SENT223	1	1	2	2	staurosporine	CDK1	PA165109623	983	0.074
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1051.nxml.txt.nlp	24503543	SENT144	16	16	15	15	sorafenib	Yes	PA7000	7525	0.074
NULL	Chem_Rev_2011_Oct_12_111(10)_5899-5921.nxml.txt.nlp	21923193	SENT370	6	6	5	5	lipase	MAG	PA450239	2068;4099	0.074
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT13	30	30	30	30	pp2	PP2		4888	0.074
NULL	Biomed_Res_Int_2013_Dec_10_2013_783698.nxml.txt.nlp	24386640	SENT63	28	28	29	29	rifampin	DST	PA451250	667	0.074
NULL	Acta_Pharmacol_Sin_2010_Dec_22_31(12)_1593-1603.nxml.txt.nlp	21102482	SENT195	4	4	4	4	pp2	PP2		4888	0.073
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_May_23_65(Pt_6)_o1364-o1365.nxml.txt.nlp	21583215	SENT5	9	9	10	10	metoprolol	mol	PA450480	90527	0.073
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT374	5	5	5	5	pp2	PP2		4888	0.073
NULL	Epigenetics_Chromatin_2014_Jan_20_7_2.nxml.txt.nlp	24443974	SENT24	25	25	24	24	protamine	PRM2	PA10366	5620	0.073
NULL	Drugs_2012_Jul_6_72(11)_1495-1520.nxml.txt.nlp	22818015	SENT38	28	28	29	29	phenol	B28	PA450913	54069	0.073
NULL	Indian_J_Med_Paediatr_Oncol_2013_Jul-Sep_34(3)_224-228.nxml.txt.nlp	24516317	SENT61	7	7	6	6	imatinib	FOR	PA10804	51741	0.073
NULL	Oncogene_2010_May_27_29(21)_3054-3066.nxml.txt.nlp	20228839	SENT204	14	14	14	14	pp2	PP2		4888	0.073
NULL	Eur_Respir_J_2013_May_27_41(5)_1107-1115.nxml.txt.nlp	23018904	SENT12	0	0	1	1	ciprofloxacin	DPI	PA449009	1832	0.073
NULL	Infect_Dis_Ther_2013_Dec_3_2(2)_111-122.nxml.txt.nlp	25134475	SENT96	1	1	0	0	atazanavir	ATV	PA10251	4683	0.073
NULL	Br_J_Cancer_2014_Jul_15_111(2)_318-325.nxml.txt.nlp	24874484	SENT68	15	15	14	14	choline	CDP	PA448976	1523	0.073
NULL	Br_J_Cancer_2010_Sep_7_103(6)_796-801.nxml.txt.nlp	20823888	SENT172	39	39	38	38	sirolimus	D29	PA451365	55520	0.073
NULL	EMBO_J_2009_Aug_19_28(16)_2360-2373.nxml.txt.nlp	19609305	SENT77	9	9	9	9	pp2	PP2		4888	0.073
NULL	Br_J_Cancer_2000_Jul_3_83(3)_375-383.nxml.txt.nlp	10917554	SENT4	9	9	8	8	vinblastine	MRP2	PA451877	100130958;57626;1244	0.073
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT158	13	13	13	13	pp2	PP2		4888	0.073
NULL	Biomed_Res_Int_2013_Aug_6_2013_687575.nxml.txt.nlp	23986909	SENT273	4	4	5	5	vasopressin	AVP	PA451858	114548;551	0.073
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT86	5	5	5	5	pp2	PP2		4888	0.073
NULL	Arthritis_Res_Ther_2007_Oct_10_9(5)_R105.nxml.txt.nlp	17927818	SENT140	19	19	19	19	pp2	PP2		4888	0.073
NULL	Eur_Respir_J_2013_May_27_41(5)_1107-1115.nxml.txt.nlp	23018904	SENT152	12	12	13	13	ciprofloxacin	DPI	PA449009	1832	0.072
NULL	Comput_Struct_Biotechnol_J_2012_Oct_30_3_e201210004.nxml.txt.nlp	24688664	SENT158	17	17	16	16	l-methionine	mol	PA450423	90527	0.072
NULL	Eur_Respir_J_2013_May_27_41(5)_1107-1115.nxml.txt.nlp	23018904	SENT160	15	15	16	16	ciprofloxacin	DPI	PA449009	1832	0.072
NULL	Clin_Transl_Allergy_2013_Sep_2_3_29.nxml.txt.nlp	24004581	SENT208	19	19	31	31	omalizumab	IL-4	PA164752253	3565	0.072
NULL	Iran_J_Pharm_Res_2015_Winter_14(1)_167-175.nxml.txt.nlp	25561923	SENT118	12	12	13	13	clonidine	Yes	PA449051	7525	0.072
NULL	Oncotarget_2013_Jun_30_4(7)_1037-1049.nxml.txt.nlp	23900414	SENT183	32	32	32	32	pp2	PP2		4888	0.072
NULL	Br_J_Cancer_2014_Jul_15_111(2)_318-325.nxml.txt.nlp	24874484	SENT81	1	1	0	0	choline	CDP	PA448976	1523	0.072
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Mar_11_65(Pt_4)_o727-o728.nxml.txt.nlp	21582462	SENT5	12	12	13	13	ethanol	mol	PA448073	90527	0.072
NULL	Springerplus_2014_Sep_11_3_516.nxml.txt.nlp	25279308	SENT152	1	1	0	0	ethanol	SHF	PA448073	90525	0.072
NULL	Ann_Rheum_Dis_2009_Dec_1_68(12)_1819-1826.nxml.txt.nlp	19054822	SENT12	20	20	21	21	abatacept	CDP	PA164747080	1523	0.072
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jun_13_68(Pt_7)_o2091-o2092.nxml.txt.nlp	22798771	SENT4	3	3	4	4	chlordiazepoxide	mol	PA448932	90527	0.072
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Oct_22_67(Pt_11)_m1565.nxml.txt.nlp	22219803	SENT4	1	1	2	2	ethanol	mol	PA448073	90527	0.072
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT361	7	7	7	7	pp2	PP2		4888	0.072
NULL	J_Gen_Physiol_2005_Jul_126(1)_1.nxml.txt.nlp	NULL	SENT2722	20	20	20	20	pp2	PP2		4888	0.072
NULL	Clin_Med_Insights_Oncol_2011_Mar_16_5_35-43.nxml.txt.nlp	21499557	SENT269	22	22	23	23	doxorubicin	IFF	PA449412	3456	0.072
NULL	Cost_Eff_Resour_Alloc_2008_Jan_23_6_2.nxml.txt.nlp	18215255	SENT319	1	1	0	0	isoniazid	IPT	PA450112	54802	0.072
NULL	Ann_Rheum_Dis_2009_Dec_1_68(12)_1819-1826.nxml.txt.nlp	19054822	SENT66	4	4	5	5	abatacept	CDP	PA164747080	1523	0.072
NULL	Ann_Rheum_Dis_2009_Dec_1_68(12)_1819-1826.nxml.txt.nlp	19054822	SENT45	7	7	8	8	abatacept	CDP	PA164747080	1523	0.072
NULL	Cell_Commun_Signal_2008_Oct_9_6_7.nxml.txt.nlp	18844995	SENT116	27	27	27	27	pp2	PP2		4888	0.071
NULL	Eur_Respir_J_2013_May_27_41(5)_1107-1115.nxml.txt.nlp	23018904	SENT209	25	25	26	26	ciprofloxacin	DPI	PA449009	1832	0.071
NULL	Neuroscience_2008_Sep_22_156(1)_175-183.nxml.txt.nlp	18694808	SENT95	11	11	11	11	pp2	PP2		4888	0.071
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Mar_15_70(Pt_4)_o450.nxml.txt.nlp	24826152	SENT10	30	30	31	31	phenol	mol	PA450913	90527	0.071
NULL	Arthritis_Res_Ther_2010_Apr_14_12(2)_R67.nxml.txt.nlp	20398273	SENT181	1	1	2	2	abatacept	CDP	PA164747080	1523	0.071
NULL	Oncol_Lett_2013_Aug_20_6(2)_329-335.nxml.txt.nlp	24137325	SENT112	7	7	7	7	pp2	PP2		4888	0.071
NULL	Eur_Respir_J_2013_May_27_41(5)_1107-1115.nxml.txt.nlp	23018904	SENT44	4	4	5	5	ciprofloxacin	DPI	PA449009	1832	0.071
NULL	J_Psychosom_Res_2012_Sep_73(3)_197-204.nxml.txt.nlp	22850260	SENT347	7	7	6	6	olanzapine	ANOVA	PA450688	4858	0.071
NULL	Lab_Invest_2011_Sep_23_91(9)_1396-1409.nxml.txt.nlp	21606925	SENT297	10	10	10	10	pp2	PP2		4888	0.071
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT165	2	2	2	2	pp2	PP2		4888	0.071
NULL	Arthritis_Res_Ther_2010_Apr_14_12(2)_R67.nxml.txt.nlp	20398273	SENT102	4	4	5	5	abatacept	CDP	PA164747080	1523	0.071
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT109	31	31	31	31	pp2	PP2		4888	0.071
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT377	18	18	18	18	pp2	PP2		4888	0.071
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Sep_17_67(Pt_10)_m1395.nxml.txt.nlp	22064629	SENT8	25	25	26	26	ether	mol	PA449525	90527	0.071
NULL	Clin_Med_Oncol_2008_Feb_9_2_103-108.nxml.txt.nlp	21892271	SENT102	25	25	26	26	trastuzumab	Era	PA451743	2099	0.071
NULL	Diabetes_Care_2011_Sep_19_34(9)_e140-e145.nxml.txt.nlp	21868769	SENT203	11	11	10	10	pioglitazone	CRN	PA450970	10699;51340	0.071
NULL	CNS_Drugs_2013_Aug_20_27(12)_1081-1092.nxml.txt.nlp	23959815	SENT70	1	1	0	0	atomoxetine	ATX	PA134688071	5168;23049	0.071
NULL	Eur_Respir_J_2013_May_27_41(5)_1107-1115.nxml.txt.nlp	23018904	SENT211	0	0	1	1	ciprofloxacin	DPI	PA449009	1832	0.071
NULL	Int_J_Mol_Sci_2014_Jun_3_15(6)_9924-9944.nxml.txt.nlp	24897026	SENT1088	2	2	1	1	pioglitazone	CRN	PA450970	10699;51340	0.071
NULL	Br_J_Cancer_2010_Jun_29_103(1)_52-60.nxml.txt.nlp	20531411	SENT45	8	8	7	7	gemcitabine	MTD	PA449748	4493	0.071
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT146	2	2	2	2	pp2	PP2		4888	0.071
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT120	7	7	7	7	pp2	PP2		4888	0.071
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT126	21	21	21	21	pp2	PP2		4888	0.071
NULL	Adv_Ther_2013_Jun_29_30(6)_607-622.nxml.txt.nlp	23812875	SENT102	6	6	5	5	metformin	Met	PA450395	79811	0.071
NULL	Chem_Res_Toxicol_2008_Jul_21_21(7)_1359-1367.nxml.txt.nlp	18549251	SENT77	4	4	3	3	hydroquinone	PCB	PA449924	5091	0.07
NULL	Infect_Dis_Ther_2013_Dec_3_2(2)_111-122.nxml.txt.nlp	25134475	SENT65	1	1	0	0	atazanavir	ATV	PA10251	4683	0.07
NULL	J_Cell_Biol_2008_Jul_28_182(2)_367-379.nxml.txt.nlp	18644892	SENT226	12	12	12	12	pp2	PP2		4888	0.07
NULL	Br_J_Cancer_2010_Jun_29_103(1)_52-60.nxml.txt.nlp	20531411	SENT117	7	7	6	6	gemcitabine	MTD	PA449748	4493	0.07
NULL	CNS_Drugs_2013_Aug_23_27(11)_943-953.nxml.txt.nlp	23975660	SENT158	11	11	10	10	atomoxetine	ATX	PA134688071	5168;23049	0.07
NULL	Pediatr_Cardiol_2010_Jan_14_31(1)_90-95.nxml.txt.nlp	19915892	SENT40	35	35	36	36	palivizumab	Era	PA164748781	2099	0.07
NULL	Front_Oncol_2013_Aug_30_3_222.nxml.txt.nlp	24010121	SENT118	8	8	9	9	geldanamycin	PC-3	PA152031327	692094	0.07
NULL	Cell_Cycle_2013_Apr_15_12(8)_1303-1315.nxml.txt.nlp	23535298	SENT397	0	0	0	0	pp2	PP2		4888	0.07
NULL	J_Oncol_2010_Aug_19_2010_932803.nxml.txt.nlp	20847951	SENT8	11	11	11	11	pp2	PP2		4888	0.07
NULL	Pharmaceutics_2012_Dec_20_5(1)_1-22.nxml.txt.nlp	24300394	SENT40	0	0	1	1	efavirenz	API	PA449441	5345	0.07
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT100	9	9	9	9	pp2	PP2		4888	0.07
NULL	Drugs_2009_Mar_17_69(5)_549-565.nxml.txt.nlp	19368417	SENT78	28	28	29	29	formoterol	DPI	PA134687907	1832	0.07
NULL	Cancers_(Basel)_2014_Dec_16_6(4)_2387-2403.nxml.txt.nlp	25521854	SENT112	5	5	6	6	cabozantinib	Met	PA165906891	79811	0.07
NULL	Clin_Ophthalmol_2008_Sep_2(3)_613-621.nxml.txt.nlp	19668762	SENT15	5	5	6	6	travoprost	BAK	PA164781371	578	0.07
NULL	J_Cell_Biol_2003_Aug_18_162(4)_661-671.nxml.txt.nlp	12925710	SENT9	15	15	15	15	pp2	PP2		4888	0.07
NULL	Breast_Cancer_Res_2006_Jul_19_8(4)_R42.nxml.txt.nlp	16859511	SENT227	10	10	10	10	pp2	PP2		4888	0.07
NULL	Eur_Respir_J_2013_May_27_41(5)_1107-1115.nxml.txt.nlp	23018904	SENT145	15	15	16	16	ciprofloxacin	DPI	PA449009	1832	0.069
NULL	CNS_Drugs_2013_Aug_20_27(12)_1081-1092.nxml.txt.nlp	23959815	SENT59	5	5	4	4	atomoxetine	ATX	PA134688071	5168;23049	0.069
NULL	Nat_Med_2013_Dec_10_19(12)_10_1038_nm_3385.nxml.txt.nlp	24216752	SENT8	1	1	0	0	thrombin	PAR4	PA451674	9002;5074	0.069
NULL	Sci_Rep_2015_Jan_15_5_7817.nxml.txt.nlp	25588710	SENT179	12	12	11	11	hyaluronan	TSG-6	PA165958431	7130	0.069
NULL	Cell_Commun_Signal_2012_Mar_3_10_5.nxml.txt.nlp	22385615	SENT147	22	22	22	22	pp2	PP2		4888	0.069
NULL	Iran_J_Pharm_Res_2015_Winter_14(1)_167-175.nxml.txt.nlp	25561923	SENT118	23	23	24	24	propofol	Yes	PA451141	7525	0.069
NULL	J_Biol_Chem_2009_Sep_18_284(38)_26096-26105.nxml.txt.nlp	19628870	SENT117	1	1	1	1	pp2	PP2		4888	0.069
NULL	Mediators_Inflamm_2010_Jun_21_2010_194896.nxml.txt.nlp	20652055	SENT48	33	33	32	32	telmisartan	mol	PA451605	90527	0.069
NULL	Neural_Plast_2007_Dec_11_2007_73079.nxml.txt.nlp	NULL	SENT3499	5	5	4	4	paroxetine	NOT	PA450801	4929	0.069
NULL	Mediators_Inflamm_2010_Jun_21_2010_194896.nxml.txt.nlp	20652055	SENT48	18	18	17	17	fluvastatin	mol	PA449688	90527	0.069
NULL	Int_J_Biol_Sci_2015_Jan_1_11(1)_48-58.nxml.txt.nlp	25552929	SENT269	17	17	18	18	paclitaxel	LDM	PA450761	1595	0.069
NULL	Front_Hum_Neurosci_2013_May_23_7_214.nxml.txt.nlp	23734119	SENT90	9	9	10	10	xenon	CPU	PA451935	1361	0.069
NULL	J_Immunol_Res_2014_Jul_16_2014_696812.nxml.txt.nlp	25133198	SENT190	1	1	2	2	rifaximin	TLR2	PA164752443	7097	0.068
NULL	AMB_Express_2012_Jun_25_2_32.nxml.txt.nlp	22731626	SENT84	18	18	17	17	nadh	mol	PA164755085	90527	0.068
NULL	Oncotarget_2014_Aug_12_5(20)_9710-9726.nxml.txt.nlp	25339152	SENT173	5	5	5	5	pp2	PP2		4888	0.068
NULL	Mol_Cell_Endocrinol_2011_Jan_15_331(2)_194-204.nxml.txt.nlp	20688134	SENT889	23	23	24	24	cetrorelix	Yes	PA164764506	7525	0.068
NULL	Neuroscience_2008_Sep_22_156(1)_175-183.nxml.txt.nlp	18694808	SENT137	29	29	29	29	pp2	PP2		4888	0.068
NULL	Ann_Hematol_2014_Mar_18_93(8)_1335-1344.nxml.txt.nlp	24638841	SENT123	5	5	4	4	chlorambucil	CLB	PA448926	171425	0.068
NULL	Int_J_Anal_Chem_2011_Oct_10_2011_124917.nxml.txt.nlp	22007220	SENT60	17	17	18	18	risperidone	API	PA451257	5345	0.068
NULL	J_Exp_Bot_2012_Mar_15_63(5)_1969-1983.nxml.txt.nlp	22174442	SENT257	21	21	20	20	ethanol	NO3	PA448073	4681	0.068
NULL	J_Gen_Physiol_2004_Apr_123(4)_427-439.nxml.txt.nlp	15024039	SENT23	4	4	4	4	pp2	PP2		4888	0.068
NULL	Oncotarget_2013_Jun_30_4(7)_1037-1049.nxml.txt.nlp	23900414	SENT177	25	25	25	25	pp2	PP2		4888	0.068
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT18	11	11	11	11	pp2	PP2		4888	0.068
NULL	Am_J_Physiol_Endocrinol_Metab_2008_Nov_5_295(5)_E1047-E1055.nxml.txt.nlp	18682536	SENT274	25	25	25	25	pp2	PP2		4888	0.068
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Nov_8_64(Pt_12)_o2297.nxml.txt.nlp	21581275	SENT64	9	9	8	8	benzaldehyde	mol	PA448571	90527	0.068
NULL	J_Antimicrob_Chemother_2011_Oct_21_66(10)_2240-2247.nxml.txt.nlp	21778195	SENT102	3	3	4	4	ethambutol	DST	PA164784021	667	0.068
NULL	J_Cell_Biol_2003_Aug_18_162(4)_661-671.nxml.txt.nlp	12925710	SENT50	5	5	5	5	pp2	PP2		4888	0.068
NULL	J_Brachial_Plex_Peripher_Nerve_Inj_2008_Oct_25_3_22.nxml.txt.nlp	18950516	SENT79	6	6	7	7	bupivacaine	SGB	PA135057240	2719	0.068
NULL	J_Vis_Exp_2011_Jun_24_(52)_3094.nxml.txt.nlp	21730945	SENT111	42	42	41	41	ethambutol	EMB	PA164784021	133418	0.068
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT39	10	10	10	10	pp2	PP2		4888	0.068
NULL	J_Hematol_Oncol_2013_Sep_6_6_67.nxml.txt.nlp	24010981	SENT54	13	13	12	12	gemcitabine	Gem	PA449748	51053	0.068
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT7	9	9	9	9	pp2	PP2		4888	0.068
NULL	Br_J_Cancer_2014_Jan_21_110(2)_520-529.nxml.txt.nlp	24335922	SENT138	7	7	8	8	collagenase	MMP1	PA449107	4312	0.068
NULL	Cell_Logist_2012_Apr_1_2(2)_117-125.nxml.txt.nlp	23162743	SENT88	4	4	4	4	pp2	PP2		4888	0.068
NULL	BMB_Rep_2013_Apr_46(4)_230-235.nxml.txt.nlp	23615266	SENT85	21	21	21	21	pp2	PP2		4888	0.067
NULL	Biomed_Eng_Online_2010_Mar_9_9_15.nxml.txt.nlp	20214774	SENT71	17	17	18	18	everolimus	DES	PA164746311	1674	0.067
NULL	Biochimie_2012_Sep_94(9)_1997-2005.nxml.txt.nlp	22659570	SENT178	10	10	10	10	pp2	PP2		4888	0.067
NULL	Exp_Anim_2014_Jun_27_63(4)_357-365.nxml.txt.nlp	24974794	SENT203	5	5	6	6	hyaluronidase	PH-20	PA164745713	6677	0.067
NULL	Arthritis_Res_Ther_2007_Oct_10_9(5)_R105.nxml.txt.nlp	17927818	SENT86	7	7	7	7	pp2	PP2		4888	0.067
NULL	Arthritis_Res_Ther_2006_Jul_26_8(4)_R132.nxml.txt.nlp	16872482	SENT387	15	15	15	15	pp2	PP2		4888	0.067
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Oct_12_67(Pt_11)_o2920.nxml.txt.nlp	22219952	SENT8	13	13	14	14	guanidine	mol	PA164781028	90527	0.067
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Dec_20_65(Pt_1)_m100-m101.nxml.txt.nlp	21581468	SENT4	10	10	11	11	ethanol	mol	PA448073	90527	0.067
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT1753	19	19	20	20	ritonavir	ATV	PA451260	4683	0.067
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1051.nxml.txt.nlp	24503543	SENT144	20	20	19	19	mitoxantrone	Yes	PA450526	7525	0.067
NULL	Biologics_2009_Sep_15_3_377-383.nxml.txt.nlp	19774205	SENT216	19	19	18	18	oseltamivir	Yes	PA450721	7525	0.067
NULL	Oncol_Lett_2013_Aug_20_6(2)_329-335.nxml.txt.nlp	24137325	SENT244	8	8	8	8	pp2	PP2		4888	0.067
NULL	J_Mol_Signal_2012_Sep_8_7_15.nxml.txt.nlp	22958338	SENT102	30	30	30	30	pp2	PP2		4888	0.067
NULL	Oncol_Rep_2014_Jul_15_32(1)_45-49.nxml.txt.nlp	24841138	SENT61	15	15	15	15	pp2	PP2		4888	0.067
NULL	Eur_Arch_Psychiatry_Clin_Neurosci_2012_Aug_9_262(5)_415-423.nxml.txt.nlp	22318337	SENT108	19	19	18	18	chlorpromazine	CPZ	PA448964	8532	0.067
NULL	J_Mol_Signal_2012_Sep_8_7_15.nxml.txt.nlp	22958338	SENT110	19	19	19	19	pp2	PP2		4888	0.067
NULL	Oncogene_2010_May_27_29(21)_3054-3066.nxml.txt.nlp	20228839	SENT13	4	4	4	4	pp2	PP2		4888	0.066
NULL	Clin_Pharmacokinet_2014_Sep_3_53(1)_1-16.nxml.txt.nlp	23999929	SENT284	11	11	10	10	fluconazole	P-gp	PA449653	5243	0.066
NULL	J_Gen_Physiol_2004_Apr_123(4)_427-439.nxml.txt.nlp	15024039	SENT294	2	2	2	2	pp2	PP2		4888	0.066
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT242	30	30	30	30	pp2	PP2		4888	0.066
NULL	Biochemistry_2013_Dec_17_52(50)_9059-9067.nxml.txt.nlp	24266852	SENT122	5	5	5	5	pp2	PP2		4888	0.066
NULL	J_Cell_Biol_2005_Nov_7_171(3)_505-516.nxml.txt.nlp	16275754	SENT129	25	25	25	25	pp2	PP2		4888	0.066
NULL	Adipocyte_2012_Jul_1_1(3)_132-181.nxml.txt.nlp	23700522	SENT157	25	25	26	26	lipase	HSL	PA450239	3991	0.066
NULL	Mol_Cancer_2008_Sep_12_7_69.nxml.txt.nlp	18789131	SENT100	13	13	13	13	pp2	PP2		4888	0.066
NULL	Environ_Health_Perspect_2012_Jul_11_120(7)_1029-1035.nxml.txt.nlp	22494775	SENT175	19	19	19	19	pp2	PP2		4888	0.066
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT142	1	1	1	1	pp2	PP2		4888	0.066
NULL	Oncogene_2009_Jan_15_28(2)_279-288.nxml.txt.nlp	18836480	SENT116	16	16	16	16	pp2	PP2		4888	0.066
NULL	Cardiovasc_Diabetol_2003_Feb_12_2_2.nxml.txt.nlp	12628022	SENT138	1	1	2	2	l-arginine	ARM	PA448478	80210	0.066
NULL	Curr_Med_Chem_2013_Jan_20(3)_438-447.nxml.txt.nlp	23157636	SENT453	5	5	6	6	haloperidol	FGA	PA449841	2243	0.066
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Nov_24_68(Pt_12)_o3421-o3422.nxml.txt.nlp	23476241	SENT8	11	11	12	12	coumarin	mol	PA134521193	90527	0.066
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Feb_24_68(Pt_3)_o792-o793.nxml.txt.nlp	22412664	SENT11	17	17	18	18	deferasirox	mol	PA164760843	90527	0.066
NULL	CNS_Drugs_2013_Aug_23_27(11)_943-953.nxml.txt.nlp	23975660	SENT164	11	11	10	10	atomoxetine	ATX	PA134688071	5168;23049	0.066
NULL	Ann_Microbiol_2011_Jun_12_61(2)_257-265.nxml.txt.nlp	21654921	SENT90	16	16	15	15	nadh	mol	PA164755085	90527	0.066
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R91.nxml.txt.nlp	22541814	SENT162	36	36	36	36	pp2	PP2		4888	0.065
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT150	11	11	11	11	pp2	PP2		4888	0.065
NULL	Br_J_Cancer_2009_Jul_21_101(2)_312-319.nxml.txt.nlp	19568237	SENT141	24	24	24	24	pp2	PP2		4888	0.065
NULL	Cancers_(Basel)_2014_Apr_16_6(2)_926-957.nxml.txt.nlp	24743778	SENT2079	5	5	5	5	pp2	PP2		4888	0.065
NULL	Oncogene_2009_Apr_23_28(16)_1821-1832.nxml.txt.nlp	19305428	SENT76	5	5	5	5	pp2	PP2		4888	0.065
NULL	Mol_Cancer_2010_Aug_16_9_217.nxml.txt.nlp	20712901	SENT40	8	8	7	7	curcumin	STAT3	PA151958596	6774	0.065
NULL	Oncogene_2009_Jan_15_28(2)_279-288.nxml.txt.nlp	18836480	SENT262	12	12	12	12	pp2	PP2		4888	0.065
NULL	Eur_Respir_J_2013_May_27_41(5)_1107-1115.nxml.txt.nlp	23018904	SENT85	21	21	22	22	ciprofloxacin	DPI	PA449009	1832	0.065
NULL	Oncogene_2009_Jan_15_28(2)_279-288.nxml.txt.nlp	18836480	SENT117	28	28	28	28	pp2	PP2		4888	0.065
NULL	Clin_Drug_Investig_2013_Jun_20_33(6)_419-427.nxml.txt.nlp	23605507	SENT161	14	14	15	15	ciprofloxacin	DPI	PA449009	1832	0.065
NULL	J_Exp_Med_1994_May_1_179(5)_1737-1741.nxml.txt.nlp	8163952	SENT8	6	6	5	5	thrombin	gamma	PA451674	9913	0.065
NULL	J_Cell_Biol_2001_Oct_29_155(3)_447-458.nxml.txt.nlp	11684709	SENT79	15	15	15	15	pp2	PP2		4888	0.065
NULL	Cardiovasc_Res_2008_Dec_1_80(3)_453-462.nxml.txt.nlp	18682436	SENT22	16	16	16	16	pp2	PP2		4888	0.065
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT365	9	9	9	9	pp2	PP2		4888	0.065
NULL	Br_J_Cancer_2011_May_10_104(10)_1628-1640.nxml.txt.nlp	21505453	SENT199	20	20	20	20	pp2	PP2		4888	0.065
NULL	EMBO_Mol_Med_2013_Jul_30_5(7)_932-948.nxml.txt.nlp	23723167	SENT381	7	7	8	8	collagenase	MMP13	PA449107	4322	0.065
NULL	Biosci_Rep_2014_Aug_6_34(4)_e00131.nxml.txt.nlp	24975826	SENT152	4	4	4	4	pp2	PP2		4888	0.065
NULL	J_Cell_Biol_2005_May_9_169(3)_503-514.nxml.txt.nlp	15883200	SENT198	8	8	8	8	pp2	PP2		4888	0.065
NULL	Br_J_Pharmacol_2010_Aug_160(8)_1997-2007.nxml.txt.nlp	20649597	SENT15	32	32	32	32	pp2	PP2		4888	0.065
NULL	Curr_Neuropharmacol_2013_Jan_11(1)_102-108.nxml.txt.nlp	23814542	SENT224	42	42	41	41	curcumin	Yes	PA151958596	7525	0.065
NULL	Biochemistry_2013_Dec_17_52(50)_9059-9067.nxml.txt.nlp	24266852	SENT113	12	12	12	12	pp2	PP2		4888	0.065
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT171	0	0	0	0	pp2	PP2		4888	0.064
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jan_11_68(Pt_2)_o349-o350.nxml.txt.nlp	22346978	SENT7	1	1	2	2	ethanol	mol	PA448073	90527	0.064
NULL	Cardiovasc_Res_2008_Dec_1_80(3)_453-462.nxml.txt.nlp	18682436	SENT178	27	27	27	27	pp2	PP2		4888	0.064
NULL	Mol_Cancer_2008_Sep_12_7_69.nxml.txt.nlp	18789131	SENT103	12	12	12	12	pp2	PP2		4888	0.064
NULL	Ann_Rheum_Dis_2009_Dec_1_68(12)_1819-1826.nxml.txt.nlp	19054822	SENT73	9	9	10	10	abatacept	CDP	PA164747080	1523	0.064
NULL	Cancers_(Basel)_2014_Dec_16_6(4)_2387-2403.nxml.txt.nlp	25521854	SENT110	4	4	5	5	cabozantinib	Met	PA165906891	79811	0.064
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Aug_27_67(Pt_9)_o2450.nxml.txt.nlp	22059018	SENT10	26	26	27	27	ethanol	mol	PA448073	90527	0.064
NULL	JAKSTAT_2013_Jul_1_2(3)_e24812.nxml.txt.nlp	24069562	SENT62	35	35	35	35	pp2	PP2		4888	0.064
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT9	8	8	8	8	pp2	PP2		4888	0.064
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Nov_24_66(Pt_12)_o3270.nxml.txt.nlp	21589553	SENT4	12	12	13	13	benzaldehyde	mol	PA448571	90527	0.064
NULL	Acta_Pharmacol_Sin_2010_Dec_22_31(12)_1593-1603.nxml.txt.nlp	21102482	SENT225	7	7	7	7	pp2	PP2		4888	0.064
NULL	Oncoimmunology_2012_Jul_1_1(4)_493-506.nxml.txt.nlp	22754768	SENT38	36	36	35	35	aldesleukin	IL-2	PA448081	3558	0.064
NULL	Mol_Cancer_2008_Sep_12_7_69.nxml.txt.nlp	18789131	SENT12	16	16	16	16	pp2	PP2		4888	0.064
NULL	F1000_Biol_Rep_2009_Sep_8_1_70.nxml.txt.nlp	20948617	SENT27	1	1	0	0	denosumab	RANKL	PA166048634	8600	0.064
NULL	Eur_Respir_J_2013_May_27_41(5)_1107-1115.nxml.txt.nlp	23018904	SENT160	34	34	35	35	ciprofloxacin	DPI	PA449009	1832	0.064
NULL	Biochem_Res_Int_2012_Mar_4_2012_875742.nxml.txt.nlp	22500233	SENT126	1	1	2	2	collagenase	MMP13	PA449107	4322	0.064
NULL	Curr_Cardiol_Rev_2008_Nov_4(4)_309-322.nxml.txt.nlp	20066139	SENT236	6	6	6	6	pp2	PP2		4888	0.064
NULL	ScientificWorldJournal_2012_Apr_1_2012_491737.nxml.txt.nlp	22547985	SENT140	9	9	8	8	saracatinib	PP2		4888	0.064
NULL	Br_J_Cancer_2010_Jun_29_103(1)_52-60.nxml.txt.nlp	20531411	SENT126	7	7	6	6	gemcitabine	MTD	PA449748	4493	0.064
NULL	J_Gen_Physiol_2004_Apr_123(4)_427-439.nxml.txt.nlp	15024039	SENT486	9	9	9	9	pp2	PP2		4888	0.064
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT273	20	20	20	20	pp2	PP2		4888	0.064
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Jun_8_69(Pt_7)_o1044.nxml.txt.nlp	24046620	SENT5	12	12	13	13	phenol	mol	PA450913	90527	0.064
NULL	Arthritis_Res_Ther_2007_Oct_10_9(5)_R105.nxml.txt.nlp	17927818	SENT122	5	5	5	5	pp2	PP2		4888	0.064
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT97	6	6	6	6	pp2	PP2		4888	0.064
NULL	ScientificWorldJournal_2012_Apr_22_2012_643904.nxml.txt.nlp	22619632	SENT215	14	14	14	14	pp2	PP2		4888	0.063
NULL	Neuroscience_2008_Sep_22_156(1)_175-183.nxml.txt.nlp	18694808	SENT84	2	2	2	2	pp2	PP2		4888	0.063
NULL	Int_J_Biol_Sci_2015_Jan_1_11(1)_48-58.nxml.txt.nlp	25552929	SENT219	28	28	29	29	paclitaxel	LDM	PA450761	1595	0.063
NULL	Eur_Respir_J_2013_May_27_41(5)_1107-1115.nxml.txt.nlp	23018904	SENT194	24	24	25	25	ciprofloxacin	DPI	PA449009	1832	0.063
NULL	Oncol_Rep_2014_Jul_15_32(1)_45-49.nxml.txt.nlp	24841138	SENT6	19	19	19	19	pp2	PP2		4888	0.063
NULL	ScientificWorldJournal_2012_Apr_22_2012_643904.nxml.txt.nlp	22619632	SENT212	15	15	15	15	pp2	PP2		4888	0.063
NULL	Biochemistry_2013_Dec_17_52(50)_9059-9067.nxml.txt.nlp	24266852	SENT117	9	9	9	9	pp2	PP2		4888	0.063
NULL	Blood_Cancer_J_2014_Apr_25_4(4)_e206.nxml.txt.nlp	24769647	SENT21	11	11	11	11	pp2	PP2		4888	0.063
NULL	Acta_Pharmacol_Sin_2009_Jul_3_30(7)_889-898.nxml.txt.nlp	19574994	SENT279	25	25	25	25	pp2	PP2		4888	0.063
NULL	Oncol_Lett_2013_Aug_20_6(2)_329-335.nxml.txt.nlp	24137325	SENT135	24	24	24	24	pp2	PP2		4888	0.063
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT88	6	6	6	6	pp2	PP2		4888	0.063
NULL	Clin_Drug_Investig_2013_Jun_20_33(6)_419-427.nxml.txt.nlp	23605507	SENT85	36	36	37	37	ciprofloxacin	DPI	PA449009	1832	0.063
NULL	J_Gen_Physiol_2004_Apr_123(4)_427-439.nxml.txt.nlp	15024039	SENT301	2	2	2	2	pp2	PP2		4888	0.063
NULL	ScientificWorldJournal_2012_Apr_22_2012_643904.nxml.txt.nlp	22619632	SENT202	6	6	6	6	pp2	PP2		4888	0.063
NULL	J_Cell_Biol_2003_Sep_29_162(7)_1189-1196.nxml.txt.nlp	14517202	SENT149	11	11	11	11	pp2	PP2		4888	0.063
NULL	J_Gen_Physiol_2008_Nov_132(5)_481-486.nxml.txt.nlp	18955590	SENT253	1	1	0	0	lipase	DAG	PA450239	1605	0.063
NULL	Oncol_Rep_2014_Jul_15_32(1)_45-49.nxml.txt.nlp	24841138	SENT169	21	21	21	21	pp2	PP2		4888	0.063
NULL	Oncotarget_2014_Aug_27_5(21)_10486-10502.nxml.txt.nlp	25401222	SENT124	31	31	31	31	pp2	PP2		4888	0.063
NULL	Arthritis_Res_Ther_2007_Oct_10_9(5)_R105.nxml.txt.nlp	17927818	SENT200	5	5	5	5	pp2	PP2		4888	0.062
NULL	Mol_Cancer_2012_Jun_26_11_43.nxml.txt.nlp	22731636	SENT73	17	17	17	17	pp2	PP2		4888	0.062
NULL	Mol_Biol_Cell_2014_Mar_15_25(6)_739-752.nxml.txt.nlp	24430869	SENT153	22	22	22	22	pp2	PP2		4888	0.062
NULL	Lab_Invest_2011_Sep_23_91(9)_1396-1409.nxml.txt.nlp	21606925	SENT301	10	10	10	10	pp2	PP2		4888	0.062
NULL	Ann_Hematol_2014_Sep_12_93(1)_13-32.nxml.txt.nlp	24026426	SENT283	13	13	14	14	voriconazole	BII	PA10233	777	0.062
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Feb_5_70(Pt_3)_m80-m81.nxml.txt.nlp	24764946	SENT6	8	8	9	9	nitrile	mol	PA450636	90527	0.062
NULL	EMBO_J_2009_Apr_22_28(8)_1043-1054.nxml.txt.nlp	19300439	SENT121	14	14	14	14	pp2	PP2		4888	0.062
NULL	J_Autom_Methods_Manag_Chem_2008_Apr_5_2008_502953.nxml.txt.nlp	19365566	SENT530	6	6	7	7	cefepime	FOR	PA164754876	51741	0.062
NULL	J_Cell_Biol_2002_Mar_18_156(6)_951-957.nxml.txt.nlp	11901164	SENT169	0	0	0	0	pp2	PP2		4888	0.062
NULL	Arthritis_Res_Ther_2007_Oct_10_9(5)_R105.nxml.txt.nlp	17927818	SENT198	7	7	7	7	pp2	PP2		4888	0.062
NULL	Eur_J_Clin_Pharmacol_2014_Oct_8_70(12)_1433-1441.nxml.txt.nlp	25291992	SENT84	6	6	5	5	chlorpromazine	CPZ	PA448964	8532	0.062
NULL	Br_J_Cancer_2010_Jun_29_103(1)_52-60.nxml.txt.nlp	20531411	SENT94	3	3	2	2	gemcitabine	MTD	PA449748	4493	0.062
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1051.nxml.txt.nlp	24503543	SENT144	12	12	11	11	sunitinib	Yes	PA162372840	7525	0.062
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Feb_13_69(Pt_3)_o378-o379.nxml.txt.nlp	23476565	SENT7	18	18	19	19	fluconazole	mol	PA449653	90527	0.062
NULL	Oncol_Rep_2014_Jul_15_32(1)_45-49.nxml.txt.nlp	24841138	SENT149	15	15	15	15	pp2	PP2		4888	0.061
NULL	Int_J_Biol_Sci_2015_Jan_1_11(1)_48-58.nxml.txt.nlp	25552929	SENT194	7	7	8	8	paclitaxel	LDM	PA450761	1595	0.061
NULL	J_Cell_Biol_2003_Aug_18_162(4)_661-671.nxml.txt.nlp	12925710	SENT51	38	38	38	38	pp2	PP2		4888	0.061
NULL	Cell_Commun_Signal_2013_May_29_11_38.nxml.txt.nlp	23718910	SENT302	3	3	3	3	pp2	PP2		4888	0.061
NULL	Environ_Health_Perspect_2013_May_22_121(5)_551-557.nxml.txt.nlp	23434795	SENT175	6	6	5	5	hyaluronan	BAL	PA165958431	83666	0.061
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Sep_30_70(Pt_10)_265-268.nxml.txt.nlp	25484670	SENT41	3	3	4	4	nitrile	mol	PA450636	90527	0.061
NULL	Braz_J_Microbiol_2008_Dec_1_Oct-Dec_39(4)_676-681.nxml.txt.nlp	24031288	SENT140	9	9	10	10	lipase	por	PA450239	64840	0.061
NULL	Cardiol_Ther_2013_Jun_28_2(1)_47-56.nxml.txt.nlp	25135288	SENT32	2	2	1	1	clopidogrel	OASIS	PA449053	90993	0.061
NULL	Int_J_Mol_Sci_2010_Sep_13_11(9)_3195-3208.nxml.txt.nlp	20957088	SENT121	6	6	5	5	lipase	AT2	PA450239	186	0.061
NULL	Oncol_Lett_2013_Aug_20_6(2)_329-335.nxml.txt.nlp	24137325	SENT174	16	16	16	16	pp2	PP2		4888	0.061
NULL	Drugs_2014_Jun_25_74(10)_1063-1072.nxml.txt.nlp	24962424	SENT70	4	4	3	3	ethambutol	EMB	PA164784021	133418	0.061
NULL	Anal_Bioanal_Chem_2011_Jan_3_399(2)_527-539.nxml.txt.nlp	20814668	SENT172	34	34	35	35	heparin	API	PA449855	5345	0.061
NULL	J_Mol_Signal_2008_Mar_31_3_8.nxml.txt.nlp	18377662	SENT234	12	12	12	12	pp2	PP2		4888	0.061
NULL	Oncogene_2009_Jan_15_28(2)_279-288.nxml.txt.nlp	18836480	SENT66	8	8	8	8	pp2	PP2		4888	0.061
NULL	Mol_Cancer_2008_Sep_12_7_69.nxml.txt.nlp	18789131	SENT129	12	12	12	12	pp2	PP2		4888	0.061
NULL	J_Gen_Physiol_2004_Apr_123(4)_427-439.nxml.txt.nlp	15024039	SENT533	13	13	13	13	pp2	PP2		4888	0.061
NULL	Oncol_Lett_2013_Apr_5_5(4)_1123-1128.nxml.txt.nlp	23599750	SENT25	18	18	17	17	docetaxel	LDM	PA449383	1595	0.061
NULL	Biosci_Rep_2014_Aug_6_34(4)_e00131.nxml.txt.nlp	24975826	SENT183	20	20	20	20	pp2	PP2		4888	0.061
NULL	J_Cell_Biol_2005_Nov_7_171(3)_505-516.nxml.txt.nlp	16275754	SENT146	4	4	4	4	pp2	PP2		4888	0.061
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jan_23_66(Pt_2)_m193-m194.nxml.txt.nlp	21579659	SENT5	6	6	7	7	l-alanine	mol	PA448055	90527	0.061
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT231	19	19	19	19	pp2	PP2		4888	0.06
NULL	Appl_Microbiol_Biotechnol_2013_Jan_1_97(1)_143-152.nxml.txt.nlp	22851018	SENT112	9	9	8	8	nadh	mol	PA164755085	90527	0.06
NULL	Eur_J_Clin_Invest_2012_Jan_42(1)_49-60.nxml.txt.nlp	21749368	SENT173	12	12	12	12	pp2	PP2		4888	0.06
NULL	Mediators_Inflamm_2010_Jun_21_2010_194896.nxml.txt.nlp	20652055	SENT48	28	28	27	27	olmesartan	mol	PA164742950	90527	0.06
NULL	Mol_Cancer_2012_Jun_26_11_43.nxml.txt.nlp	22731636	SENT131	12	12	12	12	pp2	PP2		4888	0.06
NULL	Sensors_(Basel)_2010_Mar_25_10(4)_2626-2637.nxml.txt.nlp	22319264	SENT130	39	39	38	38	ethanol	mol	PA448073	90527	0.06
NULL	Cell_Death_Dis_2014_Jan_23_5(1)_e1023.nxml.txt.nlp	24457967	SENT69	9	9	9	9	pp2	PP2		4888	0.06
NULL	Mol_Cancer_2012_Sep_25_11_73.nxml.txt.nlp	23009336	SENT167	30	30	30	30	pp2	PP2		4888	0.06
NULL	Genetics_2013_Jan_193(1)_1-50.nxml.txt.nlp	23275493	SENT190	14	14	13	13	lipase	DAG	PA450239	1605	0.06
NULL	Oncol_Rep_2014_Jul_15_32(1)_45-49.nxml.txt.nlp	24841138	SENT40	30	30	30	30	pp2	PP2		4888	0.06
NULL	Iran_J_Pharm_Res_2014_Summer_13(3)_975-985.nxml.txt.nlp	25276199	SENT181	15	15	14	14	vasopressin	SON	PA451858	6651	0.06
NULL	J_Cell_Biol_2001_Oct_29_155(3)_427-438.nxml.txt.nlp	11673478	SENT177	7	7	7	7	pp2	PP2		4888	0.06
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT201	25	25	25	25	pp2	PP2		4888	0.06
NULL	Arch_Dis_Child_2014_Dec_8_99(12)_1143-1146.nxml.txt.nlp	25202131	SENT58	7	7	8	8	theophylline	CYP2B6	PA451647	1555	0.06
NULL	Environ_Health_Perspect_2004_Nov_28_112(15)_1481-1487.nxml.txt.nlp	15531431	SENT109	35	35	35	35	pp2	PP2		4888	0.06
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Sep_30_66(Pt_10)_o2656.nxml.txt.nlp	21587627	SENT4	8	8	9	9	betaine	mol	PA448603	90527	0.059
NULL	Basic_Clin_Pharmacol_Toxicol_2013_Feb_5_112(2)_132-137.nxml.txt.nlp	22900583	SENT13	9	9	10	10	prasugrel	CYP3A4	PA154410481	1576	0.059
NULL	Oncol_Lett_2013_Apr_5_5(4)_1123-1128.nxml.txt.nlp	23599750	SENT110	18	18	17	17	docetaxel	LDM	PA449383	1595	0.059
NULL	Clin_Ophthalmol_2012_Dec_13_6_1-4.nxml.txt.nlp	22259229	SENT71	24	24	25	25	travoprost	BAK	PA164781371	578	0.059
NULL	Br_J_Cancer_2009_Jul_21_101(2)_312-319.nxml.txt.nlp	19568237	SENT109	27	27	27	27	pp2	PP2		4888	0.059
NULL	Eur_Respir_J_2013_May_27_41(5)_1107-1115.nxml.txt.nlp	23018904	SENT104	8	8	9	9	ciprofloxacin	DPI	PA449009	1832	0.059
NULL	Biochemistry_2013_Dec_17_52(50)_9059-9067.nxml.txt.nlp	24266852	SENT88	25	25	25	25	pp2	PP2		4888	0.059
NULL	JAKSTAT_2013_Jul_1_2(3)_e24812.nxml.txt.nlp	24069562	SENT10	22	22	22	22	pp2	PP2		4888	0.059
NULL	Br_J_Cancer_2014_Jul_15_111(2)_318-325.nxml.txt.nlp	24874484	SENT112	31	31	30	30	choline	CDP	PA448976	1523	0.059
NULL	Mol_Biol_Cell_2013_Sep_1_24(17)_2678-2688.nxml.txt.nlp	23864716	SENT74	4	4	4	4	pp2	PP2		4888	0.059
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Jul_11_70(Pt_8)_m296-m297.nxml.txt.nlp	25249880	SENT6	11	11	12	12	benzaldehyde	mol	PA448571	90527	0.059
NULL	Int_J_Environ_Res_Public_Health_2011_Jul_30_8(7)_2747-2757.nxml.txt.nlp	21845156	SENT139	9	9	8	8	trypsin	SPINK1	PA451806	6690	0.059
NULL	J_Mol_Signal_2008_Mar_31_3_8.nxml.txt.nlp	18377662	SENT63	30	30	30	30	pp2	PP2		4888	0.059
NULL	Lab_Invest_2011_Sep_23_91(9)_1396-1409.nxml.txt.nlp	21606925	SENT292	28	28	28	28	pp2	PP2		4888	0.059
NULL	Lab_Invest_2011_Sep_23_91(9)_1396-1409.nxml.txt.nlp	21606925	SENT53	9	9	9	9	pp2	PP2		4888	0.059
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT174	12	12	12	12	pp2	PP2		4888	0.059
NULL	Lab_Invest_2011_Sep_23_91(9)_1396-1409.nxml.txt.nlp	21606925	SENT218	16	16	16	16	pp2	PP2		4888	0.059
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Feb_13_66(Pt_3)_m285.nxml.txt.nlp	21580230	SENT4	11	11	12	12	ethanol	mol	PA448073	90527	0.059
NULL	J_Gen_Physiol_2004_Apr_123(4)_427-439.nxml.txt.nlp	15024039	SENT490	14	14	14	14	pp2	PP2		4888	0.058
NULL	Clin_Microbiol_Infect_2014_Jun_21_20(6)_536-541.nxml.txt.nlp	24107197	SENT12	21	21	22	22	isoniazid	DST	PA450112	667	0.058
NULL	Breast_Cancer_Res_2006_Jul_19_8(4)_R42.nxml.txt.nlp	16859511	SENT218	12	12	12	12	pp2	PP2		4888	0.058
NULL	Oncotarget_2011_Nov_30_2(11)_874-885.nxml.txt.nlp	22141136	SENT228	10	10	10	10	pp2	PP2		4888	0.058
NULL	Oncogene_2014_Oct_23_33(43)_5109-5120.nxml.txt.nlp	24858043	SENT82	25	25	25	25	pp2	PP2		4888	0.058
NULL	Arthritis_Res_Ther_2009_Jan_30_11(1)_206.nxml.txt.nlp	19232066	SENT325	5	5	4	4	maraviroc	CCR5	PA164768835	1234	0.058
NULL	Int_J_Biol_Sci_2015_Jan_1_11(1)_48-58.nxml.txt.nlp	25552929	SENT24	0	0	1	1	paclitaxel	LDM	PA450761	1595	0.058
NULL	Biosci_Rep_2014_Aug_6_34(4)_e00131.nxml.txt.nlp	24975826	SENT11	9	9	9	9	pp2	PP2		4888	0.058
NULL	Mol_Cancer_2012_Jul_25_11_47.nxml.txt.nlp	22830443	SENT91	3	3	4	4	panitumumab	EGFR	PA162373091	1956	0.058
NULL	Oncotarget_2014_Aug_12_5(20)_9710-9726.nxml.txt.nlp	25339152	SENT230	11	11	11	11	pp2	PP2		4888	0.058
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Apr_21_66(Pt_5)_o1125-o1126.nxml.txt.nlp	21579175	SENT5	6	6	7	7	ethanol	mol	PA448073	90527	0.058
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Feb_8_70(Pt_3)_m90-m91.nxml.txt.nlp	24764952	SENT4	25	25	26	26	ethanol	mol	PA448073	90527	0.058
NULL	Oncotarget_2014_Aug_12_5(20)_9710-9726.nxml.txt.nlp	25339152	SENT213	8	8	8	8	pp2	PP2		4888	0.058
NULL	Acta_Pharmacol_Sin_2009_Jul_3_30(7)_889-898.nxml.txt.nlp	19574994	SENT149	37	37	37	37	pp2	PP2		4888	0.058
NULL	Oncol_Lett_2013_Apr_5_5(4)_1123-1128.nxml.txt.nlp	23599750	SENT118	19	19	18	18	docetaxel	LDM	PA449383	1595	0.058
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R91.nxml.txt.nlp	22541814	SENT187	19	19	19	19	pp2	PP2		4888	0.058
NULL	Biologics_2009_Sep_15_3_377-383.nxml.txt.nlp	19774205	SENT216	14	14	13	13	rimantadine	Yes	PA164748038	7525	0.058
NULL	Ann_Hematol_2014_Sep_12_93(1)_13-32.nxml.txt.nlp	24026426	SENT274	11	11	10	10	posaconazole	BII	PA151958574	777	0.058
NULL	Eur_Respir_J_2013_May_27_41(5)_1107-1115.nxml.txt.nlp	23018904	SENT173	14	14	15	15	ciprofloxacin	DPI	PA449009	1832	0.058
NULL	Cardiovasc_Res_2008_Dec_1_80(3)_453-462.nxml.txt.nlp	18682436	SENT17	11	11	11	11	pp2	PP2		4888	0.058
NULL	ScientificWorldJournal_2012_Apr_1_2012_491737.nxml.txt.nlp	22547985	SENT140	6	6	7	7	dasatinib	PP1	PA162372878	5540;5464	0.058
NULL	Mol_Cancer_2008_Sep_12_7_69.nxml.txt.nlp	18789131	SENT96	3	3	3	3	pp2	PP2		4888	0.058
NULL	Cancer_Med_2014_Aug_10_3(4)_759-774.nxml.txt.nlp	24723436	SENT429	25	25	25	25	pp2	PP2		4888	0.058
NULL	Int_J_Biol_Sci_2015_Jan_1_11(1)_48-58.nxml.txt.nlp	25552929	SENT268	0	0	1	1	paclitaxel	LDM	PA450761	1595	0.057
NULL	Br_J_Cancer_2009_Jul_21_101(2)_327-334.nxml.txt.nlp	19568240	SENT217	36	36	36	36	pp2	PP2		4888	0.057
NULL	Eur_Respir_J_2013_May_27_41(5)_1107-1115.nxml.txt.nlp	23018904	SENT214	11	11	12	12	ciprofloxacin	DPI	PA449009	1832	0.057
NULL	Oncol_Rep_2014_Jul_15_32(1)_45-49.nxml.txt.nlp	24841138	SENT94	21	21	21	21	pp2	PP2		4888	0.057
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT67	2	2	2	2	pp2	PP2		4888	0.057
NULL	Trials_2014_Oct_21_15(1)_400.nxml.txt.nlp	NULL	SENT323	4	4	5	5	morphine	PCA	PA450550	28982	0.057
NULL	Mol_Biol_Cell_2014_Apr_1_25(7)_1151-1158.nxml.txt.nlp	24501422	SENT83	18	18	18	18	pp2	PP2		4888	0.057
NULL	Case_Rep_Med_2012_Mar_26_2012_973279.nxml.txt.nlp	22536267	SENT114	2	2	3	3	rosuvastatin	Yes	PA134308647	7525	0.057
NULL	Biosci_Rep_2014_Aug_6_34(4)_e00131.nxml.txt.nlp	24975826	SENT184	9	9	9	9	pp2	PP2		4888	0.057
NULL	Biosci_Rep_2014_Aug_6_34(4)_e00131.nxml.txt.nlp	24975826	SENT140	23	23	23	23	pp2	PP2		4888	0.057
NULL	Mol_Biol_Cell_2012_Nov_1_23(21)_4212-4225.nxml.txt.nlp	22956765	SENT99	0	0	0	0	pp2	PP2		4888	0.057
NULL	Mol_Cancer_2012_Jun_26_11_43.nxml.txt.nlp	22731636	SENT242	17	17	17	17	pp2	PP2		4888	0.057
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT72	14	14	14	14	pp2	PP2		4888	0.057
NULL	Oncotarget_2013_Jun_30_4(7)_1037-1049.nxml.txt.nlp	23900414	SENT184	14	14	14	14	pp2	PP2		4888	0.057
NULL	Thorax_2008_Nov_4_63(11)_974-980.nxml.txt.nlp	18678704	SENT99	14	14	13	13	methacholine	mol	PA165958382	90527	0.057
NULL	Environ_Health_Perspect_2012_Mar_15_120(3)_379-384.nxml.txt.nlp	22169271	SENT159	10	10	9	9	ranitidine	OTC	PA451224	5009	0.057
NULL	Sci_Rep_2014_Dec_19_4_7571.nxml.txt.nlp	25524368	SENT22	23	23	22	22	oxytetracycline	mer	PA450757	10461	0.057
NULL	J_Cell_Biol_2001_Oct_29_155(3)_427-438.nxml.txt.nlp	11673478	SENT235	41	41	41	41	pp2	PP2		4888	0.057
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT155	8	8	8	8	pp2	PP2		4888	0.057
NULL	Open_Virol_J_2010_Jun_23_4_157-162.nxml.txt.nlp	20835359	SENT85	22	22	22	22	pp2	PP2		4888	0.056
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Sep_17_64(Pt_10)_o1954.nxml.txt.nlp	21201158	SENT5	6	6	7	7	levamisole	mol	PA450205	90527	0.056
NULL	Chromatographia_2009_Jun_26_69(Suppl_2)_167-173.nxml.txt.nlp	19554204	SENT119	8	8	9	9	resveratrol	MS2		101	0.056
NULL	Oncol_Lett_2013_Apr_5_5(4)_1123-1128.nxml.txt.nlp	23599750	SENT5	13	13	12	12	docetaxel	LDM	PA449383	1595	0.056
NULL	Oncol_Rep_2014_Jul_15_32(1)_45-49.nxml.txt.nlp	24841138	SENT124	12	12	12	12	pp2	PP2		4888	0.056
NULL	Arthritis_Res_Ther_2010_Apr_14_12(2)_R67.nxml.txt.nlp	20398273	SENT87	8	8	9	9	abatacept	CDP	PA164747080	1523	0.056
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Feb_17_68(Pt_3)_o700-o701.nxml.txt.nlp	22412590	SENT10	4	4	5	5	erythromycin	mol	PA449493	90527	0.056
NULL	Cancer_Metastasis_Rev_2009_Dec_16_28(3-4)_305-316.nxml.txt.nlp	20013032	SENT438	4	4	4	4	pp2	PP2		4888	0.056
NULL	J_Cell_Biol_2005_Jul_18_170(2)_285-294.nxml.txt.nlp	16027224	SENT173	12	12	12	12	pp2	PP2		4888	0.056
NULL	Oncol_Lett_2013_Apr_5_5(4)_1123-1128.nxml.txt.nlp	23599750	SENT23	20	20	19	19	docetaxel	LDM	PA449383	1595	0.056
NULL	Cardiovasc_Res_2008_Dec_1_80(3)_453-462.nxml.txt.nlp	18682436	SENT126	15	15	15	15	pp2	PP2		4888	0.056
NULL	Blood_Res_2014_Sep_25_49(3)_170-176.nxml.txt.nlp	25325036	SENT32	23	23	22	22	rituximab	CHOP	PA451261	1649	0.056
NULL	J_Inflamm_(Lond)_2006_May_4_3_8.nxml.txt.nlp	16674821	SENT121	13	13	13	13	pp2	PP2		4888	0.056
NULL	J_Gen_Physiol_2009_Nov_134(5)_369-384.nxml.txt.nlp	19858357	SENT730	16	16	15	15	lipase	DAG	PA450239	1605	0.056
NULL	Arthritis_Res_Ther_2007_Oct_10_9(5)_R105.nxml.txt.nlp	17927818	SENT157	0	0	0	0	pp2	PP2		4888	0.056
NULL	Lab_Invest_2011_Sep_23_91(9)_1396-1409.nxml.txt.nlp	21606925	SENT217	13	13	13	13	pp2	PP2		4888	0.056
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Sep_30_70(Pt_10)_265-268.nxml.txt.nlp	25484670	SENT59	14	14	15	15	nitrile	mol	PA450636	90527	0.056
NULL	Oncol_Lett_2013_Aug_20_6(2)_329-335.nxml.txt.nlp	24137325	SENT114	13	13	13	13	pp2	PP2		4888	0.056
NULL	Arthritis_Res_Ther_2005_Apr_4_7(4)_R756-R768.nxml.txt.nlp	15987477	SENT232	7	7	8	8	hyaluronidase	PH-20	PA164745713	6677	0.055
NULL	Neuroscience_2008_Sep_22_156(1)_175-183.nxml.txt.nlp	18694808	SENT88	25	25	25	25	pp2	PP2		4888	0.055
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Feb_24_68(Pt_3)_o792-o793.nxml.txt.nlp	22412664	SENT10	4	4	5	5	deferasirox	mol	PA164760843	90527	0.055
NULL	Lab_Invest_2011_Sep_23_91(9)_1396-1409.nxml.txt.nlp	21606925	SENT144	24	24	24	24	pp2	PP2		4888	0.055
NULL	Mol_Cancer_2014_Apr_17_13_85.nxml.txt.nlp	24741998	SENT149	24	24	23	23	rituximab	CD40L	PA451261	959	0.055
NULL	Anal_Chem_Insights_2011_Mar_10_6_21-28.nxml.txt.nlp	21760706	SENT131	12	12	13	13	emtricitabine	API	PA10069	5345	0.055
NULL	Biologics_2014_Apr_22_8_193-198.nxml.txt.nlp	24790412	SENT126	22	22	21	21	methotrexate	Yes	PA450428	7525	0.055
NULL	J_Cell_Biol_2001_Jul_9_154(1)_177-186.nxml.txt.nlp	11448999	SENT250	15	15	15	15	pp2	PP2		4888	0.055
NULL	Oncogene_2010_May_27_29(21)_3054-3066.nxml.txt.nlp	20228839	SENT214	31	31	31	31	pp2	PP2		4888	0.055
NULL	Oncol_Rep_2014_Jul_15_32(1)_45-49.nxml.txt.nlp	24841138	SENT11	16	16	16	16	pp2	PP2		4888	0.055
NULL	Oncotarget_2013_Jun_30_4(7)_1037-1049.nxml.txt.nlp	23900414	SENT159	30	30	30	30	pp2	PP2		4888	0.055
NULL	Target_Oncol_2013_Jun_27_8(2)_127-136.nxml.txt.nlp	23625191	SENT85	6	6	5	5	panitumumab	KRAS	PA162373091	3845	0.055
NULL	FEBS_Open_Bio_2014_Jul_10_4_617-626.nxml.txt.nlp	25161870	SENT207	9	9	8	8	nadh	mol	PA164755085	90527	0.055
NULL	J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.nxml.txt.nlp	21874297	SENT165	16	16	15	15	nadh	mol	PA164755085	90527	0.055
NULL	Nat_Commun_2013_Nov_27_4_2821.nxml.txt.nlp	24281726	SENT164	20	20	20	20	pp2	PP2		4888	0.055
NULL	Nat_Med_2014_May_20_20(5)_524-530.nxml.txt.nlp	24747744	SENT160	46	46	47	47	collagenase	VIII	PA449107	1351	0.055
NULL	JAKSTAT_2013_Jul_1_2(3)_e24812.nxml.txt.nlp	24069562	SENT22	24	24	24	24	pp2	PP2		4888	0.055
NULL	Clin_Genet_2014_Jan_1_86(1)_21-28.nxml.txt.nlp	24684508	SENT90	9	9	10	10	warfarin	CYP2C9	PA451906	1559	0.055
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jun_10_65(Pt_7)_m753.nxml.txt.nlp	21582689	SENT5	10	10	11	11	ethanol	mol	PA448073	90527	0.055
NULL	BMB_Rep_2013_Apr_46(4)_230-235.nxml.txt.nlp	23615266	SENT18	16	16	16	16	pp2	PP2		4888	0.055
NULL	Breast_Cancer_Res_2007_Oct_10_9(5)_R69.nxml.txt.nlp	17925034	SENT215	20	20	20	20	pp2	PP2		4888	0.055
NULL	Oncotarget_2014_Aug_12_5(20)_9710-9726.nxml.txt.nlp	25339152	SENT234	24	24	24	24	pp2	PP2		4888	0.055
NULL	Lab_Invest_2011_Sep_23_91(9)_1396-1409.nxml.txt.nlp	21606925	SENT155	7	7	7	7	pp2	PP2		4888	0.055
NULL	Arthritis_Res_Ther_2007_Oct_10_9(5)_R105.nxml.txt.nlp	17927818	SENT131	20	20	20	20	pp2	PP2		4888	0.055
NULL	Pharmaceutics_2012_Sep_12_4(3)_430-441.nxml.txt.nlp	24300301	SENT79	1	1	2	2	efavirenz	API	PA449441	5345	0.055
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jul_1_65(Pt_8)_m847.nxml.txt.nlp	21583317	SENT5	13	13	14	14	ethanol	mol	PA448073	90527	0.055
NULL	Cell_Commun_Signal_2012_Mar_3_10_5.nxml.txt.nlp	22385615	SENT136	12	12	12	12	pp2	PP2		4888	0.054
NULL	Drugs_2009_Mar_17_69(5)_549-565.nxml.txt.nlp	19368417	SENT76	5	5	6	6	formoterol	DPI	PA134687907	1832	0.054
NULL	J_Gen_Physiol_2009_Nov_134(5)_363-367.nxml.txt.nlp	19858356	SENT260	17	17	16	16	lipase	DAG	PA450239	1605	0.054
NULL	Mol_Cancer_2008_Sep_12_7_69.nxml.txt.nlp	18789131	SENT104	8	8	8	8	pp2	PP2		4888	0.054
NULL	J_Cell_Biol_2001_Oct_29_155(3)_447-458.nxml.txt.nlp	11684709	SENT192	12	12	12	12	pp2	PP2		4888	0.054
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT55	20	20	20	20	pp2	PP2		4888	0.054
NULL	Oncotarget_2014_Feb_13_5(3)_577-586.nxml.txt.nlp	24583697	SENT167	17	17	16	16	methotrexate	ATG5	PA450428	9474	0.054
NULL	Oncogene_2009_Jan_15_28(2)_279-288.nxml.txt.nlp	18836480	SENT280	19	19	19	19	pp2	PP2		4888	0.054
NULL	Arthritis_Res_Ther_2007_Sep_11_9(5)_R92.nxml.txt.nlp	17848196	SENT165	11	11	12	12	galactose	spatial	PA449725	219793	0.054
NULL	Lab_Invest_2011_Sep_23_91(9)_1396-1409.nxml.txt.nlp	21606925	SENT145	16	16	16	16	pp2	PP2		4888	0.054
NULL	J_Occup_Med_Toxicol_2007_May_29_2_4.nxml.txt.nlp	17535442	SENT112	14	14	15	15	creatine	Yes	PA164778930	7525	0.054
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT89	14	14	14	14	pp2	PP2		4888	0.054
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT67	16	16	16	16	pp2	PP2		4888	0.054
NULL	Cardiovasc_Res_2008_Dec_1_80(3)_453-462.nxml.txt.nlp	18682436	SENT201	18	18	18	18	pp2	PP2		4888	0.054
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Jun_13_64(Pt_7)_m909-m910.nxml.txt.nlp	21202771	SENT7	1	1	2	2	ethanol	mol	PA448073	90527	0.054
NULL	Cell_Commun_Signal_2013_Nov_4_11_82.nxml.txt.nlp	24188565	SENT178	26	26	26	26	pp2	PP2		4888	0.054
NULL	Oncol_Lett_2013_Aug_20_6(2)_329-335.nxml.txt.nlp	24137325	SENT132	9	9	9	9	pp2	PP2		4888	0.054
NULL	Nucleic_Acids_Res_2010_Oct_28_38(19)_6418-6432.nxml.txt.nlp	20511593	SENT177	17	17	18	18	collagenase	AP-1	PA449107	2353;3727;2354;3725	0.054
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jul_25_65(Pt_8)_o1984.nxml.txt.nlp	21583660	SENT3	22	22	23	23	ethanol	mol	PA448073	90527	0.053
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1045.nxml.txt.nlp	24503537	SENT23	26	26	27	27	pemetrexed	UNG	PA10810	7374	0.053
NULL	Arthritis_Res_Ther_2007_Oct_10_9(5)_R105.nxml.txt.nlp	17927818	SENT214	19	19	19	19	pp2	PP2		4888	0.053
NULL	Mol_Cancer_2012_Sep_25_11_73.nxml.txt.nlp	23009336	SENT255	0	0	0	0	pp2	PP2		4888	0.053
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Feb_22_70(Pt_3)_o333.nxml.txt.nlp	24765028	SENT7	17	17	18	18	nitrile	mol	PA450636	90527	0.053
NULL	J_Cell_Biol_2008_Jul_28_182(2)_367-379.nxml.txt.nlp	18644892	SENT142	20	20	20	20	pp2	PP2		4888	0.053
NULL	Mol_Cancer_2012_Sep_25_11_73.nxml.txt.nlp	23009336	SENT168	12	12	12	12	pp2	PP2		4888	0.053
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT61	8	8	8	8	pp2	PP2		4888	0.053
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT168	0	0	0	0	pp2	PP2		4888	0.053
NULL	CNS_Drugs_2014_Jul_20_28(11)_1059-1069.nxml.txt.nlp	25038977	SENT118	10	10	9	9	atomoxetine	ATX	PA134688071	5168;23049	0.053
NULL	Br_J_Cancer_2009_Jul_21_101(2)_327-334.nxml.txt.nlp	19568240	SENT152	7	7	7	7	pp2	PP2		4888	0.053
NULL	Hum_Mol_Genet_2014_Aug_1_23(15)_4077-4085.nxml.txt.nlp	24670599	SENT90	3	3	2	2	lipase	PNPLA3	PA450239	80339	0.053
NULL	Br_J_Cancer_2010_Jun_29_103(1)_52-60.nxml.txt.nlp	20531411	SENT108	19	19	18	18	gemcitabine	MTD	PA449748	4493	0.053
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jul_25_68(Pt_8)_m1107-m1108.nxml.txt.nlp	22904762	SENT3	30	30	31	31	ethanol	mol	PA448073	90527	0.053
NULL	Bioinformation_2006_Dec_23_1(8)_314-320.nxml.txt.nlp	17597912	SENT156	8	8	9	9	indinavir	ACE	PA449977	1636	0.053
NULL	Arthritis_Res_Ther_2007_Nov_9_9(6)_R117.nxml.txt.nlp	17996099	SENT202	18	18	17	17	heparin	OPG	PA449855	690	0.053
NULL	J_Signal_Transduct_2011_Apr_4_2011_865819.nxml.txt.nlp	21776389	SENT168	7	7	7	7	pp2	PP2		4888	0.053
NULL	Cell_Regen_(Lond)_2012_Jun_28_1(1)_3.nxml.txt.nlp	25408866	SENT166	28	28	27	27	oxygen	MSC	PA450744	9242	0.053
NULL	J_Headache_Pain_2011_Aug_29_12(4)_411-417.nxml.txt.nlp	21626018	SENT70	18	18	17	17	capsaicin	mol	PA448776	90527	0.053
NULL	Oncotarget_2013_Jun_30_4(7)_1037-1049.nxml.txt.nlp	23900414	SENT166	27	27	27	27	pp2	PP2		4888	0.053
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R91.nxml.txt.nlp	22541814	SENT197	21	21	21	21	pp2	PP2		4888	0.053
NULL	Am_J_Physiol_Endocrinol_Metab_2008_Nov_5_295(5)_E1047-E1055.nxml.txt.nlp	18682536	SENT51	5	5	5	5	pp2	PP2		4888	0.053
NULL	J_Cell_Biol_2001_Oct_29_155(3)_427-438.nxml.txt.nlp	11673478	SENT152	46	46	46	46	pp2	PP2		4888	0.053
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT218	27	27	27	27	pp2	PP2		4888	0.053
NULL	Clin_Nutr_Res_2013_Jul_23_2(2)_100-106.nxml.txt.nlp	23908976	SENT84	17	17	17	17	pp2	PP2		4888	0.053
NULL	Front_Neurol_2013_Oct_28_4_167.nxml.txt.nlp	24191153	SENT37	38	38	38	38	pp2	PP2		4888	0.053
NULL	Biochem_Biophys_Res_Commun_2009_Aug_14_386(1)_111-117.nxml.txt.nlp	19501051	SENT279	4	4	3	3	potassium	HERG	PA451047	3757	0.053
NULL	Oncotarget_2014_Aug_12_5(20)_9710-9726.nxml.txt.nlp	25339152	SENT228	14	14	14	14	pp2	PP2		4888	0.053
NULL	Pediatr_Cardiol_2011_Mar_6_32(3)_329-333.nxml.txt.nlp	21210089	SENT66	3	3	3	3	pp2	PP2		4888	0.053
NULL	Front_Cell_Neurosci_2014_Jul_18_8_185.nxml.txt.nlp	25100946	SENT404	19	19	19	19	pp2	PP2		4888	0.053
NULL	Oxid_Med_Cell_Longev_2013_May_28_2013_587826.nxml.txt.nlp	23781296	SENT95	11	11	10	10	guanidine	mol	PA164781028	90527	0.053
NULL	J_Cell_Biol_2008_Jul_28_182(2)_367-379.nxml.txt.nlp	18644892	SENT226	0	0	0	0	pp2	PP2		4888	0.053
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Jan_19_69(Pt_2)_m119-m120.nxml.txt.nlp	23424411	SENT7	1	1	2	2	ethanol	mol	PA448073	90527	0.053
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Apr_8_65(Pt_5)_o970-o971.nxml.txt.nlp	21584012	SENT4	5	5	6	6	torasemide	mol	PA451733	90527	0.052
NULL	Clin_Nutr_Res_2013_Jul_23_2(2)_100-106.nxml.txt.nlp	23908976	SENT71	13	13	13	13	pp2	PP2		4888	0.052
NULL	Oncogene_2009_Apr_23_28(16)_1821-1832.nxml.txt.nlp	19305428	SENT219	29	29	29	29	pp2	PP2		4888	0.052
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Feb_9_67(Pt_3)_o581-o582.nxml.txt.nlp	21522343	SENT8	4	4	5	5	ethanol	mol	PA448073	90527	0.052
NULL	Mol_Cancer_2008_Sep_12_7_69.nxml.txt.nlp	18789131	SENT125	9	9	9	9	pp2	PP2		4888	0.052
NULL	Mol_Cancer_2012_Jun_26_11_43.nxml.txt.nlp	22731636	SENT119	9	9	9	9	pp2	PP2		4888	0.052
NULL	Mol_Cancer_2012_Apr_26_11_24.nxml.txt.nlp	22537161	SENT139	15	15	15	15	pp2	PP2		4888	0.052
NULL	J_Cell_Biol_1998_Nov_30_143(5)_1167-1182.nxml.txt.nlp	9832547	SENT419	11	11	10	10	glucose	mol	PA449773	90527	0.052
NULL	Eur_Respir_J_2013_May_27_41(5)_1107-1115.nxml.txt.nlp	23018904	SENT175	31	31	32	32	ciprofloxacin	DPI	PA449009	1832	0.052
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jun_26_66(Pt_7)_m853-m854.nxml.txt.nlp	21587762	SENT5	2	2	3	3	ethanol	mol	PA448073	90527	0.052
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT117	12	12	12	12	pp2	PP2		4888	0.052
NULL	Oncol_Rep_2014_Jul_15_32(1)_45-49.nxml.txt.nlp	24841138	SENT100	31	31	31	31	pp2	PP2		4888	0.052
NULL	Curr_Neuropharmacol_2008_Sep_6(3)_193-202.nxml.txt.nlp	19506720	SENT352	6	6	5	5	clozapine	p75	PA449061	7133;11168	0.052
NULL	Eur_Respir_J_2013_May_27_41(5)_1107-1115.nxml.txt.nlp	23018904	SENT174	11	11	12	12	ciprofloxacin	DPI	PA449009	1832	0.052
NULL	Environ_Health_Perspect_2012_Mar_15_120(3)_379-384.nxml.txt.nlp	22169271	SENT100	8	8	7	7	ranitidine	OTC	PA451224	5009	0.052
NULL	Pharmaceutics_2011_Oct_21_3(4)_745-781.nxml.txt.nlp	24309307	SENT1699	1	1	2	2	ritonavir	ATV	PA451260	4683	0.052
NULL	Mol_Cancer_2014_Apr_17_13_85.nxml.txt.nlp	24741998	SENT151	24	24	23	23	rituximab	CD40L	PA451261	959	0.052
NULL	J_Biol_Chem_2009_Sep_18_284(38)_26096-26105.nxml.txt.nlp	19628870	SENT172	3	3	3	3	pp2	PP2		4888	0.052
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT93	0	0	0	0	pp2	PP2		4888	0.052
NULL	Arthritis_Res_Ther_2012_Jul_4_14(4)_R159.nxml.txt.nlp	22762273	SENT328	23	23	23	23	pp2	PP2		4888	0.052
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT11	0	0	0	0	pp2	PP2		4888	0.052
NULL	Mol_Biol_Cell_2012_Nov_1_23(21)_4212-4225.nxml.txt.nlp	22956765	SENT87	5	5	5	5	pp2	PP2		4888	0.052
NULL	J_Adv_Pharm_Technol_Res_2011_Oct-Dec_2(4)_266-273.nxml.txt.nlp	22247895	SENT70	3	3	4	4	cinnarizine	FAST	PA164749342	10922	0.052
NULL	Cancer_Metastasis_Rev_2009_Dec_16_28(3-4)_305-316.nxml.txt.nlp	20013032	SENT436	6	6	6	6	pp2	PP2		4888	0.052
NULL	Eur_Respir_J_2013_May_27_41(5)_1107-1115.nxml.txt.nlp	23018904	SENT154	12	12	13	13	ciprofloxacin	DPI	PA449009	1832	0.052
NULL	Nat_Commun_2014_Jul_16_5_4425.nxml.txt.nlp	25028121	SENT33	25	25	25	25	pp2	PP2		4888	0.052
NULL	Cardiovasc_Res_2008_Dec_1_80(3)_453-462.nxml.txt.nlp	18682436	SENT183	27	27	27	27	pp2	PP2		4888	0.051
NULL	J_Cell_Biol_2001_Oct_29_155(3)_427-438.nxml.txt.nlp	11673478	SENT216	13	13	13	13	pp2	PP2		4888	0.051
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Mar_27_66(Pt_4)_m463-m464.nxml.txt.nlp	21580548	SENT6	10	10	11	11	phenol	mol	PA450913	90527	0.051
NULL	J_Mol_Signal_2008_Mar_31_3_8.nxml.txt.nlp	18377662	SENT247	13	13	13	13	pp2	PP2		4888	0.051
NULL	Arthritis_Res_Ther_2010_Apr_14_12(2)_R67.nxml.txt.nlp	20398273	SENT126	12	12	13	13	abatacept	CDP	PA164747080	1523	0.051
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_May_4_69(Pt_6)_o827.nxml.txt.nlp	23795017	SENT8	18	18	19	19	phenol	mol	PA450913	90527	0.051
NULL	Acta_Pharmacol_Sin_2010_Dec_22_31(12)_1593-1603.nxml.txt.nlp	21102482	SENT196	15	15	15	15	pp2	PP2		4888	0.051
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Mar_27_66(Pt_4)_m463-m464.nxml.txt.nlp	21580548	SENT5	7	7	8	8	phenol	mol	PA450913	90527	0.051
NULL	J_Cell_Biol_2001_Oct_1_155(1)_133-144.nxml.txt.nlp	11581290	SENT148	17	17	17	17	pp2	PP2		4888	0.051
NULL	Arthritis_Res_Ther_2010_Apr_14_12(2)_R67.nxml.txt.nlp	20398273	SENT152	21	21	22	22	abatacept	CDP	PA164747080	1523	0.051
NULL	Eur_Respir_J_2013_May_27_41(5)_1107-1115.nxml.txt.nlp	23018904	SENT153	12	12	13	13	ciprofloxacin	DPI	PA449009	1832	0.051
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Feb_9_69(Pt_3)_o362.nxml.txt.nlp	23476552	SENT3	27	27	28	28	phenol	mol	PA450913	90527	0.051
NULL	Br_J_Cancer_2009_Jul_21_101(2)_327-334.nxml.txt.nlp	19568240	SENT223	40	40	40	40	pp2	PP2		4888	0.051
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Feb_8_70(Pt_3)_m90-m91.nxml.txt.nlp	24764952	SENT6	15	15	16	16	ethanol	mol	PA448073	90527	0.051
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Apr_10_64(Pt_5)_o829.nxml.txt.nlp	21202318	SENT4	1	1	2	2	eplerenone	mol	PA164749044	90527	0.051
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT166	0	0	0	0	pp2	PP2		4888	0.051
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_May_20_67(Pt_6)_o1438.nxml.txt.nlp	21754816	SENT6	13	13	14	14	phenol	mol	PA450913	90527	0.051
NULL	Int_J_Endocrinol_2010_May_26_2010_906163.nxml.txt.nlp	20585352	SENT67	11	11	12	12	cinacalcet	PTH	PA164776671	5741	0.051
NULL	Target_Oncol_2013_Jun_27_8(2)_127-136.nxml.txt.nlp	23625191	SENT89	6	6	5	5	panitumumab	KRAS	PA162373091	3845	0.05
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT121	41	41	41	41	pp2	PP2		4888	0.05
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Jan_12_69(Pt_2)_o234.nxml.txt.nlp	23424513	SENT4	11	11	12	12	sulfamethazine	mol	PA451542	90527	0.05
NULL	Clin_Nutr_Res_2013_Jul_23_2(2)_100-106.nxml.txt.nlp	23908976	SENT69	18	18	18	18	pp2	PP2		4888	0.05
NULL	Oncotarget_2013_Jun_30_4(7)_1037-1049.nxml.txt.nlp	23900414	SENT164	14	14	14	14	pp2	PP2		4888	0.05
NULL	J_Mol_Signal_2012_Sep_8_7_15.nxml.txt.nlp	22958338	SENT111	10	10	10	10	pp2	PP2		4888	0.05
NULL	Am_J_Physiol_Endocrinol_Metab_2008_Nov_5_295(5)_E1047-E1055.nxml.txt.nlp	18682536	SENT123	24	24	24	24	pp2	PP2		4888	0.05
NULL	Clin_Med_Insights_Oncol_2012_Feb_28_6_125-135.nxml.txt.nlp	22408376	SENT28	17	17	18	18	panitumumab	EGFR	PA162373091	1956	0.05
NULL	Eur_Respir_J_2013_May_27_41(5)_1107-1115.nxml.txt.nlp	23018904	SENT126	40	40	41	41	ciprofloxacin	DPI	PA449009	1832	0.05
NULL	ScientificWorldJournal_2012_Apr_22_2012_643904.nxml.txt.nlp	22619632	SENT305	25	25	25	25	pp2	PP2		4888	0.05
NULL	Nucleic_Acids_Res_2010_Oct_28_38(19)_6418-6432.nxml.txt.nlp	20511593	SENT181	2	2	3	3	collagenase	AP-1	PA449107	2353;3727;2354;3725	0.05
NULL	Front_Mol_Neurosci_2012_Nov_12_5_99.nxml.txt.nlp	23162427	SENT144	23	23	24	24	morphine	CPP	PA450550	340451	0.05
NULL	Int_J_Mol_Sci_2014_Oct_29_15(11)_19700-19728.nxml.txt.nlp	25356505	SENT191	10	10	10	10	pp2	PP2		4888	0.05
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_May_11_67(Pt_6)_o1383.nxml.txt.nlp	21754773	SENT5	5	5	6	6	ethanol	mol	PA448073	90527	0.05
NULL	J_Cell_Biol_2001_Oct_1_155(1)_133-144.nxml.txt.nlp	11581290	SENT150	0	0	0	0	pp2	PP2		4888	0.05
NULL	Int_J_Biol_Sci_2015_Jan_1_11(1)_48-58.nxml.txt.nlp	25552929	SENT165	4	4	5	5	paclitaxel	LDM	PA450761	1595	0.05
NULL	J_Mol_Signal_2013_Aug_7_8_8.nxml.txt.nlp	23924390	SENT58	20	20	20	20	pp2	PP2		4888	0.05
NULL	Eur_Respir_J_2013_May_27_41(5)_1107-1115.nxml.txt.nlp	23018904	SENT10	2	2	3	3	ciprofloxacin	DPI	PA449009	1832	0.05
NULL	Front_Chem_2013_Dec_31_1_40.nxml.txt.nlp	24790967	SENT197	1	1	2	2	echinacea	flower	PA131550706	11094	0.05
NULL	J_Cell_Biol_2001_Jul_9_154(1)_177-186.nxml.txt.nlp	11448999	SENT11	24	24	24	24	pp2	PP2		4888	0.05
NULL	Acta_Physiol_(Oxf)_2012_Feb_204(2)_227-237.nxml.txt.nlp	21624095	SENT72	32	32	31	31	lipase	DAG	PA450239	1605	0.05
NULL	J_Cardiothorac_Surg_2010_Nov_3_5_101.nxml.txt.nlp	21047408	SENT173	18	18	19	19	heparin	ACT	PA449855	12;11332;9457;641455	0.05
NULL	Clin_Med_Oncol_2008_Feb_9_2_63-72.nxml.txt.nlp	21892267	SENT202	7	7	6	6	guanidine	Rho	PA164781028	29984	0.05
NULL	ASN_Neuro_2012_Aug_16_4(5)_e00095.nxml.txt.nlp	22817638	SENT193	20	20	20	20	pp2	PP2		4888	0.05
NULL	Adv_Ther_2014_Jan_30_31(2)_202-216.nxml.txt.nlp	24477354	SENT208	8	8	9	9	exenatide	BID	PA164749238	637	0.05
NULL	J_Cancer_2014_Jan_5_5(2)_86-97.nxml.txt.nlp	24494026	SENT346	7	7	6	6	cetuximab	EGFR	PA10040	1956	0.05
NULL	ScientificWorldJournal_2012_Apr_22_2012_643904.nxml.txt.nlp	22619632	SENT240	11	11	11	11	pp2	PP2		4888	0.049
NULL	Cardiovasc_Res_2008_Dec_1_80(3)_453-462.nxml.txt.nlp	18682436	SENT121	20	20	20	20	pp2	PP2		4888	0.049
NULL	J_Gen_Physiol_2004_Apr_123(4)_427-439.nxml.txt.nlp	15024039	SENT488	16	16	16	16	pp2	PP2		4888	0.049
NULL	ScientificWorldJournal_2012_Apr_22_2012_643904.nxml.txt.nlp	22619632	SENT142	7	7	7	7	pp2	PP2		4888	0.049
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Sep_17_64(Pt_10)_m1273-m1274.nxml.txt.nlp	21201024	SENT3	25	25	26	26	betaine	mol	PA448603	90527	0.049
NULL	Nat_Commun_2013_Nov_27_4_2821.nxml.txt.nlp	24281726	SENT788	10	10	10	10	pp2	PP2		4888	0.049
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Feb_8_64(Pt_3)_m464-m465.nxml.txt.nlp	21201856	SENT5	6	6	7	7	acetone	mol	PA448025	90527	0.049
NULL	Oncol_Lett_2013_Apr_5_5(4)_1123-1128.nxml.txt.nlp	23599750	SENT109	14	14	13	13	docetaxel	LDM	PA449383	1595	0.049
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT22	6	6	6	6	pp2	PP2		4888	0.049
NULL	Int_J_Mol_Sci_2014_Oct_29_15(11)_19700-19728.nxml.txt.nlp	25356505	SENT117	10	10	10	10	pp2	PP2		4888	0.049
NULL	J_Gen_Physiol_2004_Apr_123(4)_427-439.nxml.txt.nlp	15024039	SENT529	30	30	30	30	pp2	PP2		4888	0.049
NULL	Lab_Invest_2011_Sep_23_91(9)_1396-1409.nxml.txt.nlp	21606925	SENT141	2	2	2	2	pp2	PP2		4888	0.049
NULL	Eur_Respir_J_2013_May_27_41(5)_1107-1115.nxml.txt.nlp	23018904	SENT132	7	7	8	8	ciprofloxacin	DPI	PA449009	1832	0.049
NULL	Int_J_Biol_Sci_2015_Jan_1_11(1)_48-58.nxml.txt.nlp	25552929	SENT148	2	2	3	3	paclitaxel	LDM	PA450761	1595	0.049
NULL	J_Oncol_2010_Aug_19_2010_932803.nxml.txt.nlp	20847951	SENT51	0	0	0	0	pp2	PP2		4888	0.049
NULL	EMBO_J_2009_Apr_22_28(8)_1043-1054.nxml.txt.nlp	19300439	SENT149	5	5	5	5	pp2	PP2		4888	0.049
NULL	Open_Biochem_J_2008_Apr_29_2_49-59.nxml.txt.nlp	18949075	SENT127	9	9	9	9	pp2	PP2		4888	0.049
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Nov_14_65(Pt_12)_o3070.nxml.txt.nlp	21578800	SENT6	17	17	18	18	l-proline	mol	PA451125	90527	0.049
NULL	Arthritis_Res_Ther_2007_Oct_10_9(5)_R105.nxml.txt.nlp	17927818	SENT73	11	11	11	11	pp2	PP2		4888	0.049
NULL	Angew_Chem_Int_Ed_Engl_2013_Jan_2_52(1)_325-330.nxml.txt.nlp	23080482	SENT19	5	5	6	6	thrombin	ACPP	PA451674	55	0.048
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT311	13	13	13	13	pp2	PP2		4888	0.048
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R91.nxml.txt.nlp	22541814	SENT246	15	15	15	15	pp2	PP2		4888	0.048
NULL	Cell_Commun_Signal_2008_Oct_9_6_7.nxml.txt.nlp	18844995	SENT111	11	11	11	11	pp2	PP2		4888	0.048
NULL	Oncotarget_2014_Aug_12_5(20)_9710-9726.nxml.txt.nlp	25339152	SENT214	3	3	3	3	pp2	PP2		4888	0.048
NULL	Oncol_Lett_2013_Apr_5_5(4)_1123-1128.nxml.txt.nlp	23599750	SENT126	36	36	35	35	docetaxel	LDM	PA449383	1595	0.048
NULL	J_Mol_Signal_2008_Mar_31_3_8.nxml.txt.nlp	18377662	SENT124	25	25	25	25	pp2	PP2		4888	0.048
NULL	Mar_Drugs_2010_Mar_15_8(3)_629-657.nxml.txt.nlp	20411119	SENT3	17	17	17	17	pp2	PP2		4888	0.048
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_May_20_67(Pt_6)_o1438.nxml.txt.nlp	21754816	SENT4	6	6	7	7	phenol	mol	PA450913	90527	0.048
NULL	Br_J_Pharmacol_2010_Aug_160(8)_1997-2007.nxml.txt.nlp	20649597	SENT119	7	7	7	7	pp2	PP2		4888	0.048
NULL	Int_J_Mol_Sci_2014_Nov_21_15(11)_21433-21454.nxml.txt.nlp	25421240	SENT99	4	4	4	4	pp2	PP2		4888	0.048
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT10	13	13	13	13	pp2	PP2		4888	0.048
NULL	Int_J_Breast_Cancer_2012_Jan_24_2012_385978.nxml.txt.nlp	22461984	SENT163	8	8	9	9	cisplatin	BRCA1	PA449014	672	0.048
NULL	Mol_Cancer_2012_Jun_26_11_43.nxml.txt.nlp	22731636	SENT79	10	10	10	10	pp2	PP2		4888	0.048
NULL	Br_J_Cancer_2010_Jun_29_103(1)_52-60.nxml.txt.nlp	20531411	SENT105	15	15	14	14	gemcitabine	MTD	PA449748	4493	0.048
NULL	Acta_Neurochir_(Wien)_2010_Jan_4_152(1)_163-168.nxml.txt.nlp	19578806	SENT22	43	43	42	42	temozolomide	TMX	PA451609	81542	0.048
NULL	Chemother_Res_Pract_2011_Sep_21_2011_839742.nxml.txt.nlp	22295206	SENT146	16	16	17	17	tegafur	CRT	PA452620	811	0.048
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT397	15	15	15	15	pp2	PP2		4888	0.048
NULL	J_Biol_Chem_2008_Dec_19_283(51)_35419-35427.nxml.txt.nlp	18955485	SENT241	18	18	18	18	pp2	PP2		4888	0.048
NULL	J_Biol_Chem_2012_Aug_17_287(34)_28932-28942.nxml.txt.nlp	22718751	SENT114	29	29	29	29	pp2	PP2		4888	0.048
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Oct_3_65(Pt_11)_o2603.nxml.txt.nlp	21578222	SENT5	10	10	11	11	febuxostat	mol	PA165958521	90527	0.048
NULL	Anal_Bioanal_Chem_2011_Jan_3_399(2)_527-539.nxml.txt.nlp	20814668	SENT74	18	18	19	19	heparin	API	PA449855	5345	0.047
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jul_31_66(Pt_8)_m1038-m1039.nxml.txt.nlp	21588110	SENT6	1	1	2	2	ethanol	mol	PA448073	90527	0.047
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT157	42	42	42	42	pp2	PP2		4888	0.047
NULL	Arch_Dis_Child_2014_Dec_8_99(12)_1143-1146.nxml.txt.nlp	25202131	SENT58	10	10	11	11	propofol	CYP2C9	PA451141	1559	0.047
NULL	Environ_Health_Perspect_2013_May_22_121(5)_551-557.nxml.txt.nlp	23434795	SENT175	30	30	29	29	hyaluronan	BAL	PA165958431	83666	0.047
NULL	Environ_Health_Perspect_2004_Nov_28_112(15)_1481-1487.nxml.txt.nlp	15531431	SENT185	11	11	11	11	pp2	PP2		4888	0.047
NULL	Int_J_Mol_Sci_2010_Sep_13_11(9)_3195-3208.nxml.txt.nlp	20957088	SENT41	8	8	7	7	lipase	AT2	PA450239	186	0.047
NULL	Front_Endocrinol_(Lausanne)_2013_May_16_4_57.nxml.txt.nlp	23730297	SENT79	26	26	25	25	lipase	DAG	PA450239	1605	0.047
NULL	J_Gen_Physiol_2005_Jul_126(1)_1.nxml.txt.nlp	NULL	SENT2724	35	35	35	35	pp2	PP2		4888	0.047
NULL	Mol_Vis_2012_Feb_11_18_439-448.nxml.txt.nlp	22355255	SENT216	14	14	13	13	nadh	mol	PA164755085	90527	0.047
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT236	34	34	34	34	pp2	PP2		4888	0.047
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT157	8	8	8	8	pp2	PP2		4888	0.047
NULL	Oncol_Rep_2014_Jul_15_32(1)_45-49.nxml.txt.nlp	24841138	SENT90	13	13	13	13	pp2	PP2		4888	0.047
NULL	Br_J_Cancer_2011_May_10_104(10)_1628-1640.nxml.txt.nlp	21505453	SENT259	18	18	18	18	pp2	PP2		4888	0.047
NULL	Br_J_Cancer_2009_Jul_21_101(2)_327-334.nxml.txt.nlp	19568240	SENT230	36	36	36	36	pp2	PP2		4888	0.047
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT154	0	0	0	0	pp2	PP2		4888	0.047
NULL	Mol_Biol_Cell_2013_Sep_1_24(17)_2678-2688.nxml.txt.nlp	23864716	SENT72	19	19	19	19	pp2	PP2		4888	0.047
NULL	Iran_J_Pharm_Res_2015_Winter_14(1)_167-175.nxml.txt.nlp	25561923	SENT112	12	12	13	13	clonidine	Yes	PA449051	7525	0.047
NULL	Breast_Cancer_Res_2009_Sep_9_11(5)_R68.nxml.txt.nlp	19740433	SENT116	3	3	3	3	pp2	PP2		4888	0.047
NULL	Eur_Respir_J_2013_May_27_41(5)_1107-1115.nxml.txt.nlp	23018904	SENT124	28	28	29	29	ciprofloxacin	DPI	PA449009	1832	0.047
NULL	EMBO_J_2009_Aug_19_28(16)_2360-2373.nxml.txt.nlp	19609305	SENT83	8	8	8	8	pp2	PP2		4888	0.047
NULL	Biosci_Rep_2014_Aug_6_34(4)_e00131.nxml.txt.nlp	24975826	SENT142	15	15	15	15	pp2	PP2		4888	0.047
NULL	Int_J_Mol_Sci_2014_Nov_21_15(11)_21433-21454.nxml.txt.nlp	25421240	SENT253	15	15	15	15	pp2	PP2		4888	0.047
NULL	Arthritis_Res_Ther_2007_Oct_10_9(5)_R105.nxml.txt.nlp	17927818	SENT160	4	4	4	4	pp2	PP2		4888	0.047
NULL	J_Mol_Signal_2008_Mar_31_3_8.nxml.txt.nlp	18377662	SENT221	0	0	0	0	pp2	PP2		4888	0.047
NULL	Open_Biochem_J_2008_Apr_29_2_49-59.nxml.txt.nlp	18949075	SENT175	10	10	10	10	pp2	PP2		4888	0.047
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R91.nxml.txt.nlp	22541814	SENT210	7	7	7	7	pp2	PP2		4888	0.047
NULL	Cells_2014_Feb_14_3(1)_92-111.nxml.txt.nlp	24709904	SENT214	4	4	4	4	pp2	PP2		4888	0.047
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT132	13	13	13	13	pp2	PP2		4888	0.046
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Sep_6_64(Pt_10)_m1232.nxml.txt.nlp	21200992	SENT5	27	27	28	28	ethanol	mol	PA448073	90527	0.046
NULL	Arthritis_Res_Ther_2013_Nov_1_15(6)_R176.nxml.txt.nlp	24456929	SENT80	31	31	31	31	pp2	PP2		4888	0.046
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT191	35	35	35	35	pp2	PP2		4888	0.046
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Jul_10_69(Pt_8)_m446-m447.nxml.txt.nlp	24109273	SENT6	2	2	3	3	benzaldehyde	mol	PA448571	90527	0.046
NULL	Curr_Cardiol_Rev_2010_Feb_6(1)_31-40.nxml.txt.nlp	21286276	SENT192	5	5	5	5	pp2	PP2		4888	0.046
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Apr_10_64(Pt_5)_o829.nxml.txt.nlp	21202318	SENT7	5	5	6	6	eplerenone	mol	PA164749044	90527	0.046
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT208	22	22	22	22	pp2	PP2		4888	0.046
NULL	Biomed_Res_Int_2013_Dec_10_2013_783698.nxml.txt.nlp	24386640	SENT63	11	11	12	12	rifampin	DST	PA451250	667	0.046
NULL	Biosci_Rep_2014_Aug_6_34(4)_e00131.nxml.txt.nlp	24975826	SENT10	13	13	13	13	pp2	PP2		4888	0.046
NULL	Clin_Microbiol_Infect_2014_Jun_21_20(6)_536-541.nxml.txt.nlp	24107197	SENT11	22	22	23	23	isoniazid	DST	PA450112	667	0.046
NULL	Cell_Death_Dis_2014_Jul_17_5(7)_e1338.nxml.txt.nlp	25032861	SENT112	15	15	15	15	pp2	PP2		4888	0.046
NULL	Neuroscience_2008_Sep_22_156(1)_175-183.nxml.txt.nlp	18694808	SENT393	19	19	19	19	pp2	PP2		4888	0.046
NULL	Front_Pharmacol_2014_Dec_18_5_280.nxml.txt.nlp	25566076	SENT263	6	6	6	6	pp2	PP2		4888	0.046
NULL	Environ_Health_Perspect_2004_Nov_28_112(15)_1481-1487.nxml.txt.nlp	15531431	SENT108	13	13	13	13	pp2	PP2		4888	0.046
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jan_21_68(Pt_2)_o494.nxml.txt.nlp	22347096	SENT4	4	4	5	5	dapsone	mol	PA449211	90527	0.046
NULL	Biochem_Res_Int_2012_Mar_4_2012_875742.nxml.txt.nlp	22500233	SENT142	12	12	13	13	collagenase	MMP8	PA449107	4317	0.046
NULL	Cell_Commun_Signal_2008_Oct_9_6_7.nxml.txt.nlp	18844995	SENT110	8	8	8	8	pp2	PP2		4888	0.046
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT147	42	42	42	42	pp2	PP2		4888	0.046
NULL	J_Gen_Physiol_2004_Apr_123(4)_427-439.nxml.txt.nlp	15024039	SENT502	5	5	5	5	pp2	PP2		4888	0.046
NULL	J_Mol_Signal_2008_Mar_31_3_8.nxml.txt.nlp	18377662	SENT187	18	18	18	18	pp2	PP2		4888	0.046
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Oct_2_69(Pt_11)_m577-m578.nxml.txt.nlp	24454021	SENT5	5	5	6	6	ethanol	mol	PA448073	90527	0.046
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Oct_9_66(Pt_11)_o2790.nxml.txt.nlp	21588987	SENT9	2	2	3	3	ethanol	mol	PA448073	90527	0.046
NULL	Mol_Biol_Cell_2013_Sep_1_24(17)_2678-2688.nxml.txt.nlp	23864716	SENT235	12	12	12	12	pp2	PP2		4888	0.045
NULL	Acta_Pharmacol_Sin_2013_Oct_7_34(10)_1292-1300.nxml.txt.nlp	23933651	SENT149	9	9	9	9	pp2	PP2		4888	0.045
NULL	Oncogene_2009_Jan_15_28(2)_279-288.nxml.txt.nlp	18836480	SENT66	38	38	38	38	pp2	PP2		4888	0.045
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT247	21	21	21	21	pp2	PP2		4888	0.045
NULL	J_Cell_Mol_Med_2013_Sep_11_17(9)_1160-1172.nxml.txt.nlp	23844832	SENT263	18	18	18	18	pp2	PP2		4888	0.045
NULL	Cancers_(Basel)_2012_Jul_25_4(3)_743-762.nxml.txt.nlp	24213464	SENT459	14	14	15	15	collagenase	MT1-MMP	PA449107	4323	0.045
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT147	31	31	31	31	pp2	PP2		4888	0.045
NULL	J_Gen_Physiol_2004_Apr_123(4)_427-439.nxml.txt.nlp	15024039	SENT436	16	16	16	16	pp2	PP2		4888	0.045
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Sep_30_70(Pt_10)_265-268.nxml.txt.nlp	25484670	SENT61	3	3	4	4	nitrile	mol	PA450636	90527	0.045
NULL	Oncotarget_2013_Jun_30_4(7)_1037-1049.nxml.txt.nlp	23900414	SENT7	6	6	6	6	pp2	PP2		4888	0.045
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Sep_25_66(Pt_10)_m1290.nxml.txt.nlp	21587432	SENT5	26	26	27	27	ethanol	mol	PA448073	90527	0.045
NULL	Nat_Commun_2013_Nov_27_4_2821.nxml.txt.nlp	24281726	SENT786	10	10	10	10	pp2	PP2		4888	0.045
NULL	Arthritis_Res_Ther_2007_Oct_10_9(5)_R105.nxml.txt.nlp	17927818	SENT215	23	23	23	23	pp2	PP2		4888	0.045
NULL	Nucleic_Acids_Res_2006_Jul_1_34(Web_Server_issue)_W75-W78.nxml.txt.nlp	16845113	SENT66	4	4	4	4	pp2	PP2		4888	0.045
NULL	Int_J_Emerg_Med_2012_Jan_20_5_5.nxml.txt.nlp	22264348	SENT48	30	30	29	29	capsaicin	VR1	PA448776	56664	0.045
NULL	Oncogene_2009_Jan_15_28(2)_279-288.nxml.txt.nlp	18836480	SENT219	18	18	18	18	pp2	PP2		4888	0.045
NULL	Br_J_Pharmacol_2010_Aug_160(8)_1997-2007.nxml.txt.nlp	20649597	SENT122	9	9	9	9	pp2	PP2		4888	0.045
NULL	Eur_J_Clin_Invest_2012_Jan_42(1)_49-60.nxml.txt.nlp	21749368	SENT181	13	13	13	13	pp2	PP2		4888	0.045
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT358	5	5	5	5	pp2	PP2		4888	0.044
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Oct_29_67(Pt_11)_o3041.nxml.txt.nlp	22220053	SENT3	13	13	14	14	l-asparagine	mol	PA164776968	90527	0.044
NULL	J_Mol_Signal_2008_Mar_31_3_8.nxml.txt.nlp	18377662	SENT258	11	11	11	11	pp2	PP2		4888	0.044
NULL	Arthritis_Res_Ther_2007_Oct_10_9(5)_R105.nxml.txt.nlp	17927818	SENT11	7	7	7	7	pp2	PP2		4888	0.044
NULL	Nat_Commun_2013_Nov_27_4_2821.nxml.txt.nlp	24281726	SENT776	12	12	12	12	pp2	PP2		4888	0.044
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Mar_2_69(Pt_4)_o464-o465.nxml.txt.nlp	23634024	SENT11	31	31	32	32	ethanol	mol	PA448073	90527	0.044
NULL	J_Cell_Biol_2005_May_9_169(3)_503-514.nxml.txt.nlp	15883200	SENT234	8	8	8	8	pp2	PP2		4888	0.044
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Jun_13_64(Pt_7)_m909-m910.nxml.txt.nlp	21202771	SENT5	38	38	39	39	ethanol	mol	PA448073	90527	0.044
NULL	Arthritis_Res_Ther_2013_Nov_1_15(6)_R176.nxml.txt.nlp	24456929	SENT274	8	8	8	8	pp2	PP2		4888	0.044
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT128	0	0	0	0	pp2	PP2		4888	0.044
NULL	J_Thromb_Thrombolysis_2009_Nov_6_28(4)_410-417.nxml.txt.nlp	19504052	SENT113	1	1	0	0	paclitaxel	PES	PA450761	23481	0.044
NULL	Nucleic_Acids_Res_2006_Jul_1_34(Web_Server_issue)_W75-W78.nxml.txt.nlp	16845113	SENT111	1	1	1	1	pp2	PP2		4888	0.044
NULL	Ann_Hematol_2014_Sep_12_93(1)_13-32.nxml.txt.nlp	24026426	SENT274	11	11	12	12	posaconazole	BII	PA151958574	777	0.044
NULL	Cancers_(Basel)_2012_Feb_21_4(1)_165-183.nxml.txt.nlp	24213234	SENT686	17	17	18	18	sorafenib	Era	PA7000	2099	0.044
NULL	Evid_Based_Complement_Alternat_Med_2012_Sep_27_2012_934258.nxml.txt.nlp	23056144	SENT167	3	3	4	4	ethanol	flower	PA448073	11094	0.044
NULL	J_Lipid_Res_2013_Nov_54(11)_3085-3097.nxml.txt.nlp	23883581	SENT221	11	11	11	11	pp2	PP2		4888	0.044
NULL	Oncol_Lett_2013_Apr_5_5(4)_1123-1128.nxml.txt.nlp	23599750	SENT21	1	1	0	0	docetaxel	LDM	PA449383	1595	0.044
NULL	Cancer_Cell_Int_2013_Feb_14_13_16.nxml.txt.nlp	23409704	SENT91	0	0	0	0	pp2	PP2		4888	0.044
NULL	Arthritis_Res_2002_Feb_4_4(Suppl_1)_44.nxml.txt.nlp	NULL	SENT4	6	6	6	6	pp2	PP2		4888	0.044
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jul_3_66(Pt_8)_o1893-o1894.nxml.txt.nlp	21588228	SENT3	45	45	46	46	guanidine	mol	PA164781028	90527	0.044
NULL	Diabetes_Metab_J_2013_Feb_15_37(1)_72-80.nxml.txt.nlp	23439802	SENT80	24	24	24	24	pp2	PP2		4888	0.044
NULL	Trials_2014_Oct_21_15(1)_400.nxml.txt.nlp	NULL	SENT326	1	1	2	2	morphine	PCA	PA450550	28982	0.044
NULL	Clin_Interv_Aging_2008_Sep_3(3)_453-472.nxml.txt.nlp	18982916	SENT362	7	7	8	8	ganciclovir	CD4	PA449733	920	0.044
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Sep_26_68(Pt_10)_o2996.nxml.txt.nlp	23125768	SENT7	5	5	6	6	guanidine	mol	PA164781028	90527	0.043
NULL	J_Cell_Biol_2003_Aug_18_162(4)_661-671.nxml.txt.nlp	12925710	SENT53	4	4	4	4	pp2	PP2		4888	0.043
NULL	Genet_Mol_Biol_2010_Dec_1_Oct-Dec_33(4)_750-755.nxml.txt.nlp	21637586	SENT16	8	8	8	8	pp2	PP2		4888	0.043
NULL	J_Cell_Biol_2002_Mar_18_156(6)_951-957.nxml.txt.nlp	11901164	SENT97	6	6	6	6	pp2	PP2		4888	0.043
NULL	J_Inflamm_(Lond)_2006_May_4_3_8.nxml.txt.nlp	16674821	SENT194	3	3	3	3	pp2	PP2		4888	0.043
NULL	J_Gen_Physiol_2004_Apr_123(4)_427-439.nxml.txt.nlp	15024039	SENT283	11	11	11	11	pp2	PP2		4888	0.043
NULL	Front_Cell_Neurosci_2014_Jul_18_8_185.nxml.txt.nlp	25100946	SENT399	21	21	21	21	pp2	PP2		4888	0.043
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Oct_2_69(Pt_11)_m577-m578.nxml.txt.nlp	24454021	SENT6	5	5	6	6	ethanol	mol	PA448073	90527	0.043
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT188	0	0	0	0	pp2	PP2		4888	0.043
NULL	Anal_Bioanal_Chem_2011_Jan_3_399(2)_527-539.nxml.txt.nlp	20814668	SENT56	14	14	15	15	heparin	API	PA449855	5345	0.043
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Nov_21_70(Pt_12)_566-572.nxml.txt.nlp	25552994	SENT19	8	8	9	9	ethanol	mol	PA448073	90527	0.043
NULL	Eur_Respir_J_2013_May_27_41(5)_1107-1115.nxml.txt.nlp	23018904	SENT204	23	23	24	24	ciprofloxacin	DPI	PA449009	1832	0.043
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT145	5	5	5	5	pp2	PP2		4888	0.043
NULL	Biomed_Res_Int_2014_Jan_29_2014_361020.nxml.txt.nlp	24605326	SENT223	7	7	6	6	flavopiridol	CDK4	PA452627	1019	0.043
NULL	Cancer_Cell_Int_2013_Feb_14_13_16.nxml.txt.nlp	23409704	SENT103	32	32	32	32	pp2	PP2		4888	0.043
NULL	Mol_Cancer_2008_Sep_12_7_69.nxml.txt.nlp	18789131	SENT10	8	8	8	8	pp2	PP2		4888	0.043
NULL	Oncotarget_2014_Aug_12_5(20)_9710-9726.nxml.txt.nlp	25339152	SENT223	16	16	16	16	pp2	PP2		4888	0.043
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT87	8	8	8	8	pp2	PP2		4888	0.043
NULL	Int_J_Biol_Sci_2015_Jan_1_11(1)_48-58.nxml.txt.nlp	25552929	SENT218	11	11	12	12	paclitaxel	LDM	PA450761	1595	0.043
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT122	31	31	31	31	pp2	PP2		4888	0.043
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Apr_30_65(Pt_5)_m579.nxml.txt.nlp	21583807	SENT8	2	2	3	3	theophylline	mol	PA451647	90527	0.043
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Nov_5_67(Pt_12)_o3168.nxml.txt.nlp	22199692	SENT6	1	1	2	2	vanillin	mol	PA451852	90527	0.043
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jun_26_66(Pt_7)_o1790.nxml.txt.nlp	21588000	SENT8	5	5	6	6	ethanol	mol	PA448073	90527	0.043
NULL	Arthritis_Res_Ther_2007_Oct_10_9(5)_R105.nxml.txt.nlp	17927818	SENT170	6	6	6	6	pp2	PP2		4888	0.043
NULL	Turk_J_Haematol_2012_Sep_5_29(3)_233-241.nxml.txt.nlp	24744666	SENT134	26	26	25	25	mannitol	SAG	PA450320	9616;6295	0.043
NULL	Oncol_Lett_2013_Apr_5_5(4)_1123-1128.nxml.txt.nlp	23599750	SENT121	18	18	17	17	docetaxel	LDM	PA449383	1595	0.043
NULL	Allergy_Asthma_Clin_Immunol_2010_Sep_16_6(1)_27.nxml.txt.nlp	20846390	SENT147	4	4	5	5	methacholine	BRI	PA165958382	9445	0.043
NULL	Cancer_Med_2013_Aug_29_2(4)_478-487.nxml.txt.nlp	24156020	SENT51	9	9	8	8	fluorescein	CD4	PA164746009	920	0.043
NULL	Ann_Rheum_Dis_2009_Dec_1_68(12)_1819-1826.nxml.txt.nlp	19054822	SENT161	1	1	2	2	abatacept	CDP	PA164747080	1523	0.043
NULL	Cell_Commun_Signal_2013_Nov_4_11_82.nxml.txt.nlp	24188565	SENT396	18	18	18	18	pp2	PP2		4888	0.043
NULL	J_Cell_Biol_2001_Oct_29_155(3)_427-438.nxml.txt.nlp	11673478	SENT178	16	16	16	16	pp2	PP2		4888	0.043
NULL	J_Cell_Biol_2007_Apr_23_177(2)_317-328.nxml.txt.nlp	17452533	SENT254	9	9	9	9	pp2	PP2		4888	0.043
NULL	Eur_Respir_J_2013_May_27_41(5)_1107-1115.nxml.txt.nlp	23018904	SENT100	36	36	37	37	ciprofloxacin	DPI	PA449009	1832	0.043
NULL	Curr_Med_Chem_2013_Jan_20(3)_438-447.nxml.txt.nlp	23157636	SENT453	11	11	12	12	zuclopenthixol	FGA	PA452629	2243	0.042
NULL	J_Physiol_2008_Oct_1_586(Pt_19)_4693-4707.nxml.txt.nlp	18703578	SENT28	34	34	34	34	pp2	PP2		4888	0.042
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Dec_10_65(Pt_1)_o66-o67.nxml.txt.nlp	21581706	SENT5	31	31	32	32	ethanol	mol	PA448073	90527	0.042
NULL	Clin_Drug_Investig_2013_Jun_20_33(6)_419-427.nxml.txt.nlp	23605507	SENT112	11	11	12	12	ciprofloxacin	DPI	PA449009	1832	0.042
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT345	11	11	11	11	pp2	PP2		4888	0.042
NULL	J_Mol_Signal_2008_Mar_31_3_8.nxml.txt.nlp	18377662	SENT190	16	16	16	16	pp2	PP2		4888	0.042
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Jan_19_69(Pt_2)_m119-m120.nxml.txt.nlp	23424411	SENT8	12	12	13	13	ethanol	mol	PA448073	90527	0.042
NULL	J_Cell_Biol_2001_Oct_29_155(3)_427-438.nxml.txt.nlp	11673478	SENT231	9	9	9	9	pp2	PP2		4888	0.042
NULL	Int_J_Biol_Sci_2015_Jan_1_11(1)_48-58.nxml.txt.nlp	25552929	SENT164	0	0	1	1	paclitaxel	LDM	PA450761	1595	0.042
NULL	J_Cell_Biol_2003_Aug_18_162(4)_661-671.nxml.txt.nlp	12925710	SENT291	29	29	29	29	pp2	PP2		4888	0.042
NULL	Clin_Nutr_Res_2013_Jul_23_2(2)_100-106.nxml.txt.nlp	23908976	SENT61	4	4	4	4	pp2	PP2		4888	0.042
NULL	Eur_Respir_J_2013_May_27_41(5)_1107-1115.nxml.txt.nlp	23018904	SENT105	23	23	24	24	ciprofloxacin	DPI	PA449009	1832	0.042
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Oct_13_68(Pt_11)_m1365-m1366.nxml.txt.nlp	23284346	SENT4	30	30	31	31	ethanol	mol	PA448073	90527	0.042
NULL	Arthritis_Res_Ther_2007_Oct_10_9(5)_R105.nxml.txt.nlp	17927818	SENT132	27	27	27	27	pp2	PP2		4888	0.042
NULL	Int_J_Biol_Sci_2015_Jan_1_11(1)_48-58.nxml.txt.nlp	25552929	SENT15	12	12	13	13	paclitaxel	LDM	PA450761	1595	0.042
NULL	J_Cell_Sci_2012_Jun_15_125(12)_2940-2953.nxml.txt.nlp	22366451	SENT294	17	17	17	17	pp2	PP2		4888	0.042
NULL	Environ_Health_Perspect_2004_Nov_28_112(15)_1481-1487.nxml.txt.nlp	15531431	SENT193	11	11	11	11	pp2	PP2		4888	0.042
NULL	Bioinformation_2006_Dec_23_1(8)_314-320.nxml.txt.nlp	17597912	SENT156	10	10	9	9	captopril	ACE	PA448780	1636	0.042
NULL	Clin_Nutr_Res_2013_Jul_23_2(2)_100-106.nxml.txt.nlp	23908976	SENT74	18	18	18	18	pp2	PP2		4888	0.041
NULL	Environ_Health_Perspect_2004_Nov_28_112(15)_1481-1487.nxml.txt.nlp	15531431	SENT177	11	11	11	11	pp2	PP2		4888	0.041
NULL	Br_J_Cancer_2014_Jul_15_111(2)_318-325.nxml.txt.nlp	24874484	SENT66	32	32	31	31	choline	CDP	PA448976	1523	0.041
NULL	Oncol_Lett_2013_Aug_20_6(2)_329-335.nxml.txt.nlp	24137325	SENT247	18	18	18	18	pp2	PP2		4888	0.041
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R91.nxml.txt.nlp	22541814	SENT248	10	10	10	10	pp2	PP2		4888	0.041
NULL	J_Cell_Biol_2005_May_9_169(3)_503-514.nxml.txt.nlp	15883200	SENT186	20	20	20	20	pp2	PP2		4888	0.041
NULL	Mol_Biol_Cell_2013_Jul_1_24(13)_2134-2145.nxml.txt.nlp	23657817	SENT162	8	8	8	8	pp2	PP2		4888	0.041
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT357	27	27	27	27	pp2	PP2		4888	0.041
NULL	Oncol_Lett_2013_Aug_20_6(2)_329-335.nxml.txt.nlp	24137325	SENT131	11	11	11	11	pp2	PP2		4888	0.041
NULL	Theranostics_2014_Feb_22_4(5)_514-533.nxml.txt.nlp	24672583	SENT455	30	30	31	31	everolimus	DES	PA164746311	1674	0.041
NULL	Oncogene_2009_Jan_15_28(2)_279-288.nxml.txt.nlp	18836480	SENT114	0	0	0	0	pp2	PP2		4888	0.041
NULL	Arthritis_Res_Ther_2007_Oct_10_9(5)_R105.nxml.txt.nlp	17927818	SENT138	25	25	25	25	pp2	PP2		4888	0.041
NULL	Mol_Cancer_2012_Apr_26_11_24.nxml.txt.nlp	22537161	SENT139	36	36	36	36	pp2	PP2		4888	0.041
NULL	J_Physiol_2008_Oct_1_586(Pt_19)_4693-4707.nxml.txt.nlp	18703578	SENT9	14	14	14	14	pp2	PP2		4888	0.041
NULL	Mol_Cancer_2012_Jun_26_11_43.nxml.txt.nlp	22731636	SENT242	1	1	1	1	pp2	PP2		4888	0.041
NULL	Oncol_Rep_2014_Jul_15_32(1)_45-49.nxml.txt.nlp	24841138	SENT145	9	9	9	9	pp2	PP2		4888	0.041
NULL	Cell_Death_Dis_2014_Jul_17_5(7)_e1338.nxml.txt.nlp	25032861	SENT89	12	12	12	12	pp2	PP2		4888	0.041
NULL	Nat_Commun_2014_Jul_16_5_4425.nxml.txt.nlp	25028121	SENT309	8	8	8	8	pp2	PP2		4888	0.041
NULL	Front_Microbiol_2015_Jan_12_5_776.nxml.txt.nlp	25628615	SENT248	22	22	21	21	nitrogen	DSE	PA450643	29940	0.041
NULL	Child_Adolesc_Psychiatry_Ment_Health_2013_Jun_19_7_19.nxml.txt.nlp	23777626	SENT130	3	3	2	2	atomoxetine	ATX	PA134688071	5168;23049	0.041
NULL	Sensors_(Basel)_2010_Oct_12_10(10)_9155-9162.nxml.txt.nlp	22163401	SENT31	29	29	29	29	pp2	PP2		4888	0.041
NULL	J_Gen_Physiol_2004_Apr_123(4)_427-439.nxml.txt.nlp	15024039	SENT296	23	23	23	23	pp2	PP2		4888	0.041
NULL	Arthritis_Res_Ther_2007_Oct_10_9(5)_R105.nxml.txt.nlp	17927818	SENT8	3	3	3	3	pp2	PP2		4888	0.041
NULL	ASN_Neuro_2009_Apr_14_1(1)_e00005.nxml.txt.nlp	19570022	SENT127	39	39	39	39	pp2	PP2		4888	0.04
NULL	Neuroscience_2008_Sep_22_156(1)_175-183.nxml.txt.nlp	18694808	SENT419	1	1	1	1	pp2	PP2		4888	0.04
NULL	Cell_Mol_Life_Sci_2011_May_26_68(10)_1785-1798.nxml.txt.nlp	20976523	SENT220	2	2	3	3	collagenase	AP-1	PA449107	2353;3727;2354;3725	0.04
NULL	Oncol_Lett_2013_Aug_20_6(2)_329-335.nxml.txt.nlp	24137325	SENT104	0	0	0	0	pp2	PP2		4888	0.04
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Apr_13_67(Pt_5)_m573-m574.nxml.txt.nlp	21754301	SENT5	4	4	5	5	gabapentin	mol	PA449720	90527	0.04
NULL	Int_J_Biol_Sci_2015_Jan_1_11(1)_48-58.nxml.txt.nlp	25552929	SENT197	10	10	11	11	paclitaxel	LDM	PA450761	1595	0.04
NULL	J_Biol_Chem_2012_Aug_17_287(34)_28932-28942.nxml.txt.nlp	22718751	SENT138	0	0	0	0	pp2	PP2		4888	0.04
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT157	31	31	31	31	pp2	PP2		4888	0.04
NULL	Trials_2013_Aug_19_14_261.nxml.txt.nlp	23958221	SENT320	7	7	7	7	pp2	PP2		4888	0.04
NULL	Int_J_Biol_Sci_2015_Jan_1_11(1)_48-58.nxml.txt.nlp	25552929	SENT223	10	10	11	11	paclitaxel	LDM	PA450761	1595	0.04
NULL	J_Carcinog_Mutagen_2014_May_31_5(3)_1000176.nxml.txt.nlp	25264496	SENT192	31	31	30	30	trastuzumab	Yes	PA451743	7525	0.04
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Jul_10_69(Pt_8)_m446-m447.nxml.txt.nlp	24109273	SENT7	23	23	24	24	benzaldehyde	mol	PA448571	90527	0.04
NULL	J_Cell_Biol_2008_Jun_16_181(6)_1013-1026.nxml.txt.nlp	18541700	SENT196	16	16	16	16	pp2	PP2		4888	0.04
NULL	Child_Adolesc_Psychiatry_Ment_Health_2013_Jun_19_7_19.nxml.txt.nlp	23777626	SENT109	3	3	2	2	atomoxetine	ATX	PA134688071	5168;23049	0.04
NULL	Eur_Heart_J_2014_Jan_21_35(4)_209-215.nxml.txt.nlp	24067509	SENT121	11	11	10	10	thrombin	PAR-1	PA451674	2011;2149	0.04
NULL	Front_Zool_2011_Nov_29_8_31.nxml.txt.nlp	22126599	SENT124	12	12	12	12	pp2	PP2		4888	0.04
NULL	Nat_Commun_2013_Nov_27_4_2821.nxml.txt.nlp	24281726	SENT242	9	9	9	9	pp2	PP2		4888	0.04
NULL	Oncol_Lett_2013_Aug_20_6(2)_329-335.nxml.txt.nlp	24137325	SENT101	0	0	0	0	pp2	PP2		4888	0.04
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT88	10	10	10	10	pp2	PP2		4888	0.04
NULL	Mol_Cancer_2012_Apr_26_11_24.nxml.txt.nlp	22537161	SENT138	28	28	28	28	pp2	PP2		4888	0.039
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Feb_10_68(Pt_3)_o669.nxml.txt.nlp	22412568	SENT4	10	10	11	11	dapsone	mol	PA449211	90527	0.039
NULL	Oncogene_2014_Oct_23_33(43)_5109-5120.nxml.txt.nlp	24858043	SENT280	9	9	9	9	pp2	PP2		4888	0.039
NULL	J_Cell_Biol_2001_Oct_29_155(3)_427-438.nxml.txt.nlp	11673478	SENT11	19	19	19	19	pp2	PP2		4888	0.039
NULL	Open_Biochem_J_2008_Apr_29_2_49-59.nxml.txt.nlp	18949075	SENT181	12	12	12	12	pp2	PP2		4888	0.039
NULL	Mol_Biol_Cell_2013_Sep_1_24(17)_2678-2688.nxml.txt.nlp	23864716	SENT85	14	14	14	14	pp2	PP2		4888	0.039
NULL	Int_J_Mol_Sci_2010_Sep_13_11(9)_3195-3208.nxml.txt.nlp	20957088	SENT117	5	5	4	4	lipase	AT2	PA450239	186	0.039
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Sep_28_69(Pt_10)_m568-m569.nxml.txt.nlp	24098191	SENT5	36	36	37	37	ethanol	mol	PA448073	90527	0.039
NULL	Mol_Cancer_2012_Jun_26_11_43.nxml.txt.nlp	22731636	SENT207	21	21	21	21	pp2	PP2		4888	0.039
NULL	Oncol_Lett_2013_Aug_20_6(2)_329-335.nxml.txt.nlp	24137325	SENT233	19	19	19	19	pp2	PP2		4888	0.039
NULL	Arthritis_Res_Ther_2007_Oct_10_9(5)_R105.nxml.txt.nlp	17927818	SENT172	4	4	4	4	pp2	PP2		4888	0.039
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT110	1	1	1	1	pp2	PP2		4888	0.039
NULL	Eur_Respir_J_2013_May_27_41(5)_1107-1115.nxml.txt.nlp	23018904	SENT131	4	4	5	5	ciprofloxacin	DPI	PA449009	1832	0.039
NULL	ScientificWorldJournal_2012_Apr_22_2012_643904.nxml.txt.nlp	22619632	SENT100	3	3	3	3	pp2	PP2		4888	0.039
NULL	Biochem_Res_Int_2012_Mar_4_2012_875742.nxml.txt.nlp	22500233	SENT214	14	14	15	15	collagenase	MMP1	PA449107	4312	0.039
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT154	30	30	30	30	pp2	PP2		4888	0.039
NULL	J_Cell_Biol_2007_Apr_23_177(2)_317-328.nxml.txt.nlp	17452533	SENT8	8	8	8	8	pp2	PP2		4888	0.039
NULL	Neural_Plast_2007_Dec_11_2007_73079.nxml.txt.nlp	NULL	SENT1137	16	16	15	15	haloperidol	NOT	PA449841	4929	0.039
NULL	Mol_Cancer_2012_Jun_26_11_43.nxml.txt.nlp	22731636	SENT134	4	4	4	4	pp2	PP2		4888	0.039
NULL	Oncol_Lett_2013_Aug_20_6(2)_329-335.nxml.txt.nlp	24137325	SENT111	7	7	7	7	pp2	PP2		4888	0.038
NULL	Mol_Biol_Cell_2013_Sep_1_24(17)_2678-2688.nxml.txt.nlp	23864716	SENT75	11	11	11	11	pp2	PP2		4888	0.038
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT164	0	0	0	0	pp2	PP2		4888	0.038
NULL	J_Cell_Biol_2008_Jul_14_182(1)_157-169.nxml.txt.nlp	18606851	SENT162	12	12	12	12	pp2	PP2		4888	0.038
NULL	Curr_Genomics_2014_Jun_15(3)_190-202.nxml.txt.nlp	24955027	SENT77	15	15	15	15	pp2	PP2		4888	0.038
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT138	10	10	10	10	pp2	PP2		4888	0.038
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2007_Dec_18_64(Pt_1)_m219-m220.nxml.txt.nlp	21200566	SENT3	30	30	31	31	ethanol	mol	PA448073	90527	0.038
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT166	31	31	31	31	pp2	PP2		4888	0.038
NULL	Oncotarget_2014_Aug_12_5(20)_9710-9726.nxml.txt.nlp	25339152	SENT226	2	2	2	2	pp2	PP2		4888	0.038
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Dec_24_67(Pt_1)_m128.nxml.txt.nlp	21522539	SENT3	24	24	25	25	ethanol	mol	PA448073	90527	0.038
NULL	ScientificWorldJournal_2012_Apr_22_2012_643904.nxml.txt.nlp	22619632	SENT133	26	26	26	26	pp2	PP2		4888	0.038
NULL	Br_J_Cancer_2009_Jul_21_101(2)_312-319.nxml.txt.nlp	19568237	SENT143	4	4	4	4	pp2	PP2		4888	0.038
NULL	J_Gen_Physiol_2004_Apr_123(4)_427-439.nxml.txt.nlp	15024039	SENT307	13	13	13	13	pp2	PP2		4888	0.038
NULL	Breast_Cancer_Res_2007_Oct_10_9(5)_R69.nxml.txt.nlp	17925034	SENT78	14	14	14	14	pp2	PP2		4888	0.038
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT200	11	11	11	11	pp2	PP2		4888	0.038
NULL	J_Cell_Biol_2004_Jan_19_164(2)_291-300.nxml.txt.nlp	14718519	SENT128	8	8	8	8	pp2	PP2		4888	0.038
NULL	Arthritis_Res_Ther_2007_Oct_10_9(5)_R105.nxml.txt.nlp	17927818	SENT146	3	3	3	3	pp2	PP2		4888	0.038
NULL	J_Cell_Biol_2002_Mar_18_156(6)_951-957.nxml.txt.nlp	11901164	SENT104	8	8	8	8	pp2	PP2		4888	0.038
NULL	Cell_Commun_Signal_2013_May_29_11_38.nxml.txt.nlp	23718910	SENT186	24	24	24	24	pp2	PP2		4888	0.038
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Nov_6_66(Pt_12)_m1520.nxml.txt.nlp	21589222	SENT4	31	31	32	32	ethanol	mol	PA448073	90527	0.038
NULL	J_Inflamm_(Lond)_2006_May_4_3_8.nxml.txt.nlp	16674821	SENT195	0	0	0	0	pp2	PP2		4888	0.037
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT72	1	1	1	1	pp2	PP2		4888	0.037
NULL	Environ_Health_Perspect_2004_Nov_28_112(15)_1481-1487.nxml.txt.nlp	15531431	SENT52	15	15	15	15	pp2	PP2		4888	0.037
NULL	JAKSTAT_2013_Jul_1_2(3)_e24812.nxml.txt.nlp	24069562	SENT45	17	17	17	17	pp2	PP2		4888	0.037
NULL	Pain_Res_Treat_2013_Jan_27_2013_960270.nxml.txt.nlp	NULL	SENT4	7	7	8	8	milnacipran	NNT	PA164752812	23530	0.037
NULL	Int_J_Mol_Sci_2010_Sep_13_11(9)_3195-3208.nxml.txt.nlp	20957088	SENT29	6	6	7	7	lipase	AT2	PA450239	186	0.037
NULL	J_Cell_Biol_2001_Oct_29_155(3)_427-438.nxml.txt.nlp	11673478	SENT179	0	0	0	0	pp2	PP2		4888	0.037
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT147	8	8	8	8	pp2	PP2		4888	0.037
NULL	Cancer_Cell_Int_2013_Feb_14_13_16.nxml.txt.nlp	23409704	SENT101	28	28	28	28	pp2	PP2		4888	0.037
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT99	0	0	0	0	pp2	PP2		4888	0.037
NULL	J_Cell_Biol_2005_Jul_18_170(2)_285-294.nxml.txt.nlp	16027224	SENT166	2	2	2	2	pp2	PP2		4888	0.037
NULL	Arthritis_Res_Ther_2007_Oct_10_9(5)_R105.nxml.txt.nlp	17927818	SENT148	11	11	11	11	pp2	PP2		4888	0.037
NULL	Lab_Invest_2011_Sep_23_91(9)_1396-1409.nxml.txt.nlp	21606925	SENT223	9	9	9	9	pp2	PP2		4888	0.037
NULL	Nucleic_Acids_Res_2006_Jul_1_34(Web_Server_issue)_W75-W78.nxml.txt.nlp	16845113	SENT110	1	1	1	1	pp2	PP2		4888	0.037
NULL	J_Signal_Transduct_2011_Dec_19_2011_636951.nxml.txt.nlp	21258655	SENT140	22	22	22	22	pp2	PP2		4888	0.037
NULL	Sensors_(Basel)_2013_Feb_28_13(3)_2895-2910.nxml.txt.nlp	23449119	SENT123	17	17	17	17	pp2	PP2		4888	0.037
NULL	ASN_Neuro_2009_Apr_14_1(1)_e00005.nxml.txt.nlp	19570022	SENT120	24	24	24	24	pp2	PP2		4888	0.037
NULL	Asian-Australas_J_Anim_Sci_2012_Apr_25(4)_471-478.nxml.txt.nlp	25049587	SENT157	9	9	9	9	pp2	PP2		4888	0.037
NULL	Lab_Invest_2011_Sep_23_91(9)_1396-1409.nxml.txt.nlp	21606925	SENT140	0	0	0	0	pp2	PP2		4888	0.037
NULL	J_Cell_Biol_2001_Jul_9_154(1)_177-186.nxml.txt.nlp	11448999	SENT106	0	0	0	0	pp2	PP2		4888	0.037
NULL	J_Signal_Transduct_2010_Sep_1_2010_643642.nxml.txt.nlp	21637354	SENT112	38	38	38	38	pp2	PP2		4888	0.037
NULL	Arthritis_Res_Ther_2007_Oct_10_9(5)_R105.nxml.txt.nlp	17927818	SENT186	9	9	9	9	pp2	PP2		4888	0.036
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT166	8	8	8	8	pp2	PP2		4888	0.036
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Mar_2_69(Pt_4)_m182-m183.nxml.txt.nlp	23633987	SENT5	10	10	11	11	ethanol	mol	PA448073	90527	0.036
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Aug_11_66(Pt_9)_o2297-o2298.nxml.txt.nlp	21588649	SENT5	1	1	2	2	nifedipine	mol	PA450631	90527	0.036
NULL	Oncogene_2010_May_27_29(21)_3054-3066.nxml.txt.nlp	20228839	SENT211	15	15	15	15	pp2	PP2		4888	0.036
NULL	Clin_Interv_Aging_2008_Sep_3(3)_453-472.nxml.txt.nlp	18982916	SENT366	3	3	4	4	fluconazole	CD4	PA449653	920	0.036
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_May_23_65(Pt_6)_o1364-o1365.nxml.txt.nlp	21583215	SENT4	29	29	30	30	metoprolol	mol	PA450480	90527	0.036
NULL	Front_Genet_2014_May_7_5_115.nxml.txt.nlp	24847354	SENT64	20	20	20	20	pp2	PP2		4888	0.036
NULL	Int_J_Biol_Sci_2015_Jan_1_11(1)_48-58.nxml.txt.nlp	25552929	SENT209	0	0	1	1	paclitaxel	LDM	PA450761	1595	0.036
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT218	4	4	4	4	pp2	PP2		4888	0.036
NULL	Lab_Invest_2011_Sep_23_91(9)_1396-1409.nxml.txt.nlp	21606925	SENT143	17	17	17	17	pp2	PP2		4888	0.036
NULL	Br_J_Cancer_2009_Jul_21_101(2)_312-319.nxml.txt.nlp	19568237	SENT106	25	25	25	25	pp2	PP2		4888	0.036
NULL	J_Cell_Biol_2001_Oct_1_155(1)_133-144.nxml.txt.nlp	11581290	SENT175	2	2	2	2	pp2	PP2		4888	0.036
NULL	Oncol_Lett_2013_Aug_20_6(2)_329-335.nxml.txt.nlp	24137325	SENT134	18	18	18	18	pp2	PP2		4888	0.036
NULL	Int_J_Biol_Sci_2015_Jan_1_11(1)_48-58.nxml.txt.nlp	25552929	SENT302	6	6	7	7	paclitaxel	LDM	PA450761	1595	0.036
NULL	Sensors_(Basel)_2013_Feb_28_13(3)_2895-2910.nxml.txt.nlp	23449119	SENT124	9	9	9	9	pp2	PP2		4888	0.036
NULL	Acta_Pharmacol_Sin_2009_Jul_3_30(7)_889-898.nxml.txt.nlp	19574994	SENT261	14	14	14	14	pp2	PP2		4888	0.036
NULL	Mol_Biol_Cell_2014_Sep_15_25(18)_2774-2787.nxml.txt.nlp	25057014	SENT47	30	30	30	30	pp2	PP2		4888	0.036
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_May_3_64(Pt_6)_o961.nxml.txt.nlp	21202691	SENT4	6	6	7	7	ethanol	mol	PA448073	90527	0.036
NULL	Int_J_Biol_Sci_2015_Jan_1_11(1)_48-58.nxml.txt.nlp	25552929	SENT25	12	12	13	13	paclitaxel	LDM	PA450761	1595	0.036
NULL	Oncoimmunology_2012_Mar_1_1(2)_129-140.nxml.txt.nlp	22720234	SENT352	11	11	11	11	pp2	PP2		4888	0.035
NULL	Environ_Health_Perspect_2004_Nov_28_112(15)_1481-1487.nxml.txt.nlp	15531431	SENT114	11	11	11	11	pp2	PP2		4888	0.035
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT265	9	9	9	9	pp2	PP2		4888	0.035
NULL	Eur_J_Dent_2010_Jul_4(3)_341-347.nxml.txt.nlp	20613926	SENT27	5	5	5	5	pp2	PP2		4888	0.035
NULL	Oncotarget_2014_Aug_12_5(20)_9710-9726.nxml.txt.nlp	25339152	SENT225	0	0	0	0	pp2	PP2		4888	0.035
NULL	Nat_Commun_2014_Jul_16_5_4425.nxml.txt.nlp	25028121	SENT31	24	24	24	24	pp2	PP2		4888	0.035
NULL	J_Biol_Chem_2008_Jun_20_283(25)_17194-17204.nxml.txt.nlp	18442977	SENT253	43	43	43	43	pp2	PP2		4888	0.035
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT146	8	8	8	8	pp2	PP2		4888	0.035
NULL	Breast_Cancer_Res_2006_Jul_19_8(4)_R42.nxml.txt.nlp	16859511	SENT229	17	17	17	17	pp2	PP2		4888	0.035
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1049.nxml.txt.nlp	24503541	SENT59	6	6	6	6	pp2	PP2		4888	0.035
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT166	42	42	42	42	pp2	PP2		4888	0.035
NULL	Mol_Biol_Cell_2013_Jul_1_24(13)_2134-2145.nxml.txt.nlp	23657817	SENT191	18	18	18	18	pp2	PP2		4888	0.035
NULL	J_Gen_Physiol_2004_Apr_123(4)_427-439.nxml.txt.nlp	15024039	SENT336	13	13	13	13	pp2	PP2		4888	0.035
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT196	9	9	9	9	pp2	PP2		4888	0.035
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT223	17	17	17	17	pp2	PP2		4888	0.035
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Oct_31_70(Pt_11)_435-437.nxml.txt.nlp	25484767	SENT27	1	1	2	2	ethanol	mol	PA448073	90527	0.035
NULL	J_Cell_Biol_2001_Oct_29_155(3)_427-438.nxml.txt.nlp	11673478	SENT230	5	5	5	5	pp2	PP2		4888	0.035
NULL	Genet_Mol_Biol_2009_Sep_1_Jul-Sep_32(3)_582-593.nxml.txt.nlp	21637523	SENT152	24	24	24	24	pp2	PP2		4888	0.034
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT287	0	0	0	0	pp2	PP2		4888	0.034
NULL	Cell_Logist_2012_Apr_1_2(2)_117-125.nxml.txt.nlp	23162743	SENT103	26	26	26	26	pp2	PP2		4888	0.034
NULL	J_Neuroinflammation_2010_Nov_8_7_75.nxml.txt.nlp	21059245	SENT127	6	6	6	6	pp2	PP2		4888	0.034
NULL	Nat_Commun_2013_Nov_27_4_2821.nxml.txt.nlp	24281726	SENT787	10	10	10	10	pp2	PP2		4888	0.034
NULL	Arthritis_Res_Ther_2007_Oct_10_9(5)_R105.nxml.txt.nlp	17927818	SENT145	0	0	0	0	pp2	PP2		4888	0.034
NULL	Int_J_Biol_Sci_2015_Jan_1_11(1)_48-58.nxml.txt.nlp	25552929	SENT41	14	14	15	15	paclitaxel	LDM	PA450761	1595	0.034
NULL	Cancer_Med_2014_Aug_10_3(4)_759-774.nxml.txt.nlp	24723436	SENT429	11	11	11	11	pp2	PP2		4888	0.034
NULL	J_Biol_Chem_2009_Sep_18_284(38)_26096-26105.nxml.txt.nlp	19628870	SENT118	3	3	3	3	pp2	PP2		4888	0.034
NULL	Mol_Cancer_2007_Dec_21_6_81.nxml.txt.nlp	18096084	SENT57	4	4	4	4	pp2	PP2		4888	0.034
NULL	Biochem_Biophys_Res_Commun_2009_Aug_14_386(1)_111-117.nxml.txt.nlp	19501051	SENT302	11	11	10	10	potassium	HERG	PA451047	3757	0.034
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT230	15	15	15	15	pp2	PP2		4888	0.034
NULL	Acta_Pharmacol_Sin_2013_Oct_7_34(10)_1292-1300.nxml.txt.nlp	23933651	SENT150	0	0	0	0	pp2	PP2		4888	0.034
NULL	Front_Immunol_2012_Jan_10_2_91.nxml.txt.nlp	22566880	SENT61	11	11	11	11	pp2	PP2		4888	0.034
NULL	Nucleic_Acids_Res_2006_Jul_1_34(Web_Server_issue)_W75-W78.nxml.txt.nlp	16845113	SENT58	8	8	8	8	pp2	PP2		4888	0.034
NULL	Oncotarget_2014_Aug_12_5(20)_9710-9726.nxml.txt.nlp	25339152	SENT219	9	9	9	9	pp2	PP2		4888	0.034
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Feb_20_69(Pt_3)_m162-m163.nxml.txt.nlp	23476505	SENT4	1	1	2	2	ethanol	mol	PA448073	90527	0.034
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT163	30	30	30	30	pp2	PP2		4888	0.034
NULL	J_Oncol_2010_Jun_6_2010_921682.nxml.txt.nlp	20628483	SENT77	5	5	5	5	pp2	PP2		4888	0.033
NULL	Curr_Cardiol_Rev_2010_Feb_6(1)_31-40.nxml.txt.nlp	21286276	SENT187	29	29	29	29	pp2	PP2		4888	0.033
NULL	Cell_Death_Dis_2014_Jul_17_5(7)_e1338.nxml.txt.nlp	25032861	SENT144	8	8	8	8	pp2	PP2		4888	0.033
NULL	Mol_Cancer_2012_Apr_26_11_24.nxml.txt.nlp	22537161	SENT222	34	34	34	34	pp2	PP2		4888	0.033
NULL	Oncotarget_2014_Aug_12_5(20)_9710-9726.nxml.txt.nlp	25339152	SENT218	0	0	0	0	pp2	PP2		4888	0.033
NULL	J_Gen_Physiol_2013_Apr_141(4)_409-411.nxml.txt.nlp	23478994	SENT91	10	10	9	9	potassium	HERG	PA451047	3757	0.033
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT189	15	15	15	15	pp2	PP2		4888	0.033
NULL	Int_J_Biol_Sci_2015_Jan_1_11(1)_48-58.nxml.txt.nlp	25552929	SENT36	9	9	10	10	paclitaxel	LDM	PA450761	1595	0.033
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT192	14	14	14	14	pp2	PP2		4888	0.033
NULL	Arthritis_Res_Ther_2013_Nov_1_15(6)_R176.nxml.txt.nlp	24456929	SENT101	31	31	31	31	pp2	PP2		4888	0.033
NULL	Osteoarthritis_Cartilage_2010_Apr_18(4)_555-562.nxml.txt.nlp	20060953	SENT141	30	30	31	31	clenbuterol	MNX	PA164745640	3892	0.033
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Dec_23_68(Pt_1)_m77-m78.nxml.txt.nlp	22259372	SENT7	6	6	7	7	ethanol	mol	PA448073	90527	0.033
NULL	Biomed_Res_Int_2014_Mar_9_2014_238485.nxml.txt.nlp	24734229	SENT145	14	14	14	14	pp2	PP2		4888	0.033
NULL	Apoptosis_2012_Jun_9_17(6)_566-578.nxml.txt.nlp	22402981	SENT166	18	18	18	18	pp2	PP2		4888	0.033
NULL	Br_J_Cancer_2009_Jul_21_101(2)_327-334.nxml.txt.nlp	19568240	SENT13	7	7	7	7	pp2	PP2		4888	0.033
NULL	Int_J_Biol_Sci_2015_Jan_1_11(1)_48-58.nxml.txt.nlp	25552929	SENT42	15	15	16	16	paclitaxel	LDM	PA450761	1595	0.033
NULL	J_Cell_Biol_2001_Oct_1_155(1)_133-144.nxml.txt.nlp	11581290	SENT196	16	16	16	16	pp2	PP2		4888	0.033
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT220	0	0	0	0	pp2	PP2		4888	0.033
NULL	Int_J_Biol_Sci_2015_Jan_1_11(1)_48-58.nxml.txt.nlp	25552929	SENT149	9	9	10	10	paclitaxel	LDM	PA450761	1595	0.033
NULL	Cardiovasc_Res_2008_Dec_1_80(3)_453-462.nxml.txt.nlp	18682436	SENT44	2	2	2	2	pp2	PP2		4888	0.033
NULL	Oncol_Lett_2013_Aug_20_6(2)_329-335.nxml.txt.nlp	24137325	SENT113	0	0	0	0	pp2	PP2		4888	0.033
NULL	Mediators_Inflamm_2010_Mar_30_2010_280464.nxml.txt.nlp	20369000	SENT78	4	4	4	4	pp2	PP2		4888	0.033
NULL	J_Inflamm_(Lond)_2006_May_4_3_8.nxml.txt.nlp	16674821	SENT86	9	9	9	9	pp2	PP2		4888	0.033
NULL	Arthritis_Res_Ther_2007_Oct_10_9(5)_R105.nxml.txt.nlp	17927818	SENT40	6	6	6	6	pp2	PP2		4888	0.033
NULL	Cell_Commun_Signal_2011_May_20_9_14.nxml.txt.nlp	21599982	SENT74	5	5	5	5	pp2	PP2		4888	0.033
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jan_21_68(Pt_2)_o494.nxml.txt.nlp	22347096	SENT6	9	9	10	10	dapsone	mol	PA449211	90527	0.033
NULL	Lab_Invest_2011_Sep_23_91(9)_1396-1409.nxml.txt.nlp	21606925	SENT335	21	21	21	21	pp2	PP2		4888	0.033
NULL	J_Cell_Biol_2003_Aug_18_162(4)_661-671.nxml.txt.nlp	12925710	SENT92	20	20	20	20	pp2	PP2		4888	0.033
NULL	Breast_Cancer_Res_2006_Jul_19_8(4)_R42.nxml.txt.nlp	16859511	SENT221	8	8	8	8	pp2	PP2		4888	0.033
NULL	Cell_Commun_Signal_2013_May_29_11_38.nxml.txt.nlp	23718910	SENT109	0	0	0	0	pp2	PP2		4888	0.032
NULL	Cell_Commun_Signal_2011_May_20_9_14.nxml.txt.nlp	21599982	SENT24	7	7	7	7	pp2	PP2		4888	0.032
NULL	J_Cell_Biol_2001_Oct_29_155(3)_447-458.nxml.txt.nlp	11684709	SENT9	7	7	7	7	pp2	PP2		4888	0.032
NULL	Oncol_Lett_2013_Aug_20_6(2)_329-335.nxml.txt.nlp	24137325	SENT160	20	20	20	20	pp2	PP2		4888	0.032
NULL	Mol_Cancer_2003_Sep_23_2_33.nxml.txt.nlp	14572313	SENT157	4	4	4	4	pp2	PP2		4888	0.032
NULL	J_Cell_Biol_2008_Jul_28_182(2)_367-379.nxml.txt.nlp	18644892	SENT74	4	4	4	4	pp2	PP2		4888	0.032
NULL	J_Biol_Chem_2008_Dec_19_283(51)_35419-35427.nxml.txt.nlp	18955485	SENT240	20	20	20	20	pp2	PP2		4888	0.032
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Mar_16_69(Pt_4)_m221.nxml.txt.nlp	23634014	SENT4	15	15	16	16	ethanol	mol	PA448073	90527	0.032
NULL	JAKSTAT_2013_Jul_1_2(3)_e24812.nxml.txt.nlp	24069562	SENT86	20	20	20	20	pp2	PP2		4888	0.032
NULL	Apoptosis_2012_Jun_9_17(6)_566-578.nxml.txt.nlp	22402981	SENT180	26	26	26	26	pp2	PP2		4888	0.032
NULL	Oncol_Lett_2013_Aug_20_6(2)_329-335.nxml.txt.nlp	24137325	SENT246	5	5	5	5	pp2	PP2		4888	0.032
NULL	J_Biol_Chem_2009_Sep_18_284(38)_26096-26105.nxml.txt.nlp	19628870	SENT247	9	9	9	9	pp2	PP2		4888	0.031
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT183	16	16	16	16	pp2	PP2		4888	0.031
NULL	Oncogene_2009_Jan_15_28(2)_279-288.nxml.txt.nlp	18836480	SENT117	2	2	2	2	pp2	PP2		4888	0.031
NULL	Cancers_(Basel)_2014_Apr_16_6(2)_926-957.nxml.txt.nlp	24743778	SENT327	4	4	4	4	pp2	PP2		4888	0.031
NULL	Arthritis_Res_Ther_2007_Oct_10_9(5)_R105.nxml.txt.nlp	17927818	SENT129	15	15	15	15	pp2	PP2		4888	0.031
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT143	0	0	0	0	pp2	PP2		4888	0.031
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT226	13	13	13	13	pp2	PP2		4888	0.031
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT285	28	28	28	28	pp2	PP2		4888	0.031
NULL	Nucleic_Acids_Res_2006_Jul_1_34(Web_Server_issue)_W75-W78.nxml.txt.nlp	16845113	SENT216	3	3	3	3	pp2	PP2		4888	0.031
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Apr_13_69(Pt_5)_m257-m258.nxml.txt.nlp	23723769	SENT3	36	36	37	37	ethanol	mol	PA448073	90527	0.031
NULL	Oncol_Lett_2013_Aug_20_6(2)_329-335.nxml.txt.nlp	24137325	SENT232	0	0	0	0	pp2	PP2		4888	0.031
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT151	2	2	2	2	pp2	PP2		4888	0.031
NULL	Oncotarget_2013_Jun_30_4(7)_1037-1049.nxml.txt.nlp	23900414	SENT242	5	5	5	5	pp2	PP2		4888	0.031
NULL	Sensors_(Basel)_2013_Feb_28_13(3)_2895-2910.nxml.txt.nlp	23449119	SENT122	9	9	9	9	pp2	PP2		4888	0.031
NULL	Biochimie_2012_Sep_94(9)_1997-2005.nxml.txt.nlp	22659570	SENT184	9	9	9	9	pp2	PP2		4888	0.031
NULL	ScientificWorldJournal_2012_Apr_22_2012_643904.nxml.txt.nlp	22619632	SENT197	1	1	1	1	pp2	PP2		4888	0.031
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT203	2	2	2	2	pp2	PP2		4888	0.031
NULL	Nucleic_Acids_Res_2006_Jul_1_34(Web_Server_issue)_W75-W78.nxml.txt.nlp	16845113	SENT74	13	13	13	13	pp2	PP2		4888	0.031
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Sep_30_67(Pt_10)_o2772.nxml.txt.nlp	22064727	SENT4	17	17	18	18	bupropion	mol	PA448687	90527	0.03
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT194	19	19	19	19	pp2	PP2		4888	0.03
NULL	Arthritis_Res_Ther_2007_Oct_10_9(5)_R105.nxml.txt.nlp	17927818	SENT166	0	0	0	0	pp2	PP2		4888	0.03
NULL	J_Gen_Physiol_2004_Apr_123(4)_427-439.nxml.txt.nlp	15024039	SENT288	7	7	7	7	pp2	PP2		4888	0.03
NULL	J_Mol_Signal_2008_Mar_31_3_8.nxml.txt.nlp	18377662	SENT64	6	6	6	6	pp2	PP2		4888	0.03
NULL	Neuroscience_2008_Sep_22_156(1)_175-183.nxml.txt.nlp	18694808	SENT85	0	0	0	0	pp2	PP2		4888	0.03
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Jul_19_70(Pt_8)_80-83.nxml.txt.nlp	25249860	SENT8	11	11	12	12	ethanol	mol	PA448073	90527	0.03
NULL	J_Cell_Biol_2003_Aug_18_162(4)_661-671.nxml.txt.nlp	12925710	SENT137	16	16	16	16	pp2	PP2		4888	0.03
NULL	J_Cell_Biol_2001_Oct_29_155(3)_427-438.nxml.txt.nlp	11673478	SENT217	7	7	7	7	pp2	PP2		4888	0.03
NULL	J_Cell_Biol_2001_Jul_9_154(1)_177-186.nxml.txt.nlp	11448999	SENT104	13	13	13	13	pp2	PP2		4888	0.03
NULL	J_Biol_Chem_2012_Aug_17_287(34)_28932-28942.nxml.txt.nlp	22718751	SENT240	17	17	17	17	pp2	PP2		4888	0.029
NULL	J_Cell_Biol_2008_Jul_14_182(1)_157-169.nxml.txt.nlp	18606851	SENT304	12	12	12	12	pp2	PP2		4888	0.029
NULL	J_Cell_Biol_2001_Oct_1_155(1)_133-144.nxml.txt.nlp	11581290	SENT187	10	10	10	10	pp2	PP2		4888	0.029
NULL	Mediators_Inflamm_2010_Mar_30_2010_280464.nxml.txt.nlp	20369000	SENT6	23	23	23	23	pp2	PP2		4888	0.029
NULL	Breast_Cancer_Res_2006_Jul_19_8(4)_R42.nxml.txt.nlp	16859511	SENT220	3	3	3	3	pp2	PP2		4888	0.029
NULL	Arthritis_Res_Ther_2007_Oct_10_9(5)_R105.nxml.txt.nlp	17927818	SENT162	0	0	0	0	pp2	PP2		4888	0.029
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Mar_12_70(Pt_4)_o413-o414.nxml.txt.nlp	24826127	SENT9	4	4	5	5	phenol	mol	PA450913	90527	0.029
NULL	FEBS_Open_Bio_2012_Jun_20_2_151-158.nxml.txt.nlp	23650594	SENT27	17	17	17	17	pp2	PP2		4888	0.029
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Oct_3_65(Pt_11)_o2603.nxml.txt.nlp	21578222	SENT6	14	14	15	15	febuxostat	mol	PA165958521	90527	0.029
NULL	Int_J_Biol_Sci_2015_Jan_1_11(1)_48-58.nxml.txt.nlp	25552929	SENT294	0	0	1	1	paclitaxel	LDM	PA450761	1595	0.029
NULL	Oncol_Lett_2013_Aug_20_6(2)_329-335.nxml.txt.nlp	24137325	SENT102	0	0	0	0	pp2	PP2		4888	0.029
NULL	Nucleic_Acids_Res_2006_Jul_1_34(Web_Server_issue)_W75-W78.nxml.txt.nlp	16845113	SENT213	3	3	3	3	pp2	PP2		4888	0.029
NULL	J_Cell_Sci_2012_Jun_15_125(12)_2940-2953.nxml.txt.nlp	22366451	SENT289	10	10	10	10	pp2	PP2		4888	0.029
NULL	J_Cell_Biol_2008_Jul_14_182(1)_157-169.nxml.txt.nlp	18606851	SENT148	9	9	9	9	pp2	PP2		4888	0.029
NULL	Cell_Commun_Signal_2013_May_29_11_38.nxml.txt.nlp	23718910	SENT108	2	2	2	2	pp2	PP2		4888	0.029
NULL	Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jan_11_68(Pt_2)_o349-o350.nxml.txt.nlp	22346978	SENT3	25	25	26	26	ethanol	mol	PA448073	90527	0.029
NULL	Exp_Hematol_Oncol_2013_Feb_19_2_4.nxml.txt.nlp	23422267	SENT144	2	2	2	2	pp2	PP2		4888	0.028
NULL	Nat_Commun_2013_Nov_27_4_2821.nxml.txt.nlp	24281726	SENT244	0	0	0	0	pp2	PP2		4888	0.028
NULL	Cell_Commun_Signal_2013_Jan_22_11_6.nxml.txt.nlp	23339737	SENT84	30	30	30	30	pp2	PP2		4888	0.028
NULL	Mol_Cancer_2012_Sep_25_11_73.nxml.txt.nlp	23009336	SENT143	24	24	24	24	pp2	PP2		4888	0.028
NULL	Cell_Commun_Signal_2013_Jan_22_11_6.nxml.txt.nlp	23339737	SENT233	16	16	16	16	pp2	PP2		4888	0.028
NULL	J_Gen_Physiol_2010_Jul_136(1)_83-99.nxml.txt.nlp	20584892	SENT617	9	9	8	8	potassium	HERG	PA451047	3757	0.028
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT359	2	2	2	2	pp2	PP2		4888	0.028
NULL	Cell_Commun_Signal_2008_Oct_9_6_7.nxml.txt.nlp	18844995	SENT107	26	26	26	26	pp2	PP2		4888	0.028
NULL	J_Oncol_2010_Aug_19_2010_932803.nxml.txt.nlp	20847951	SENT243	3	3	3	3	pp2	PP2		4888	0.028
NULL	Open_Biochem_J_2008_Apr_29_2_49-59.nxml.txt.nlp	18949075	SENT182	2	2	2	2	pp2	PP2		4888	0.028
NULL	J_Gen_Physiol_2004_Apr_123(4)_427-439.nxml.txt.nlp	15024039	SENT296	15	15	15	15	pp2	PP2		4888	0.028
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT381	8	8	8	8	pp2	PP2		4888	0.028
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R91.nxml.txt.nlp	22541814	SENT182	9	9	9	9	pp2	PP2		4888	0.028
NULL	Nucleic_Acids_Res_2006_Jul_1_34(Web_Server_issue)_W75-W78.nxml.txt.nlp	16845113	SENT44	0	0	0	0	pp2	PP2		4888	0.028
NULL	Nucleic_Acids_Res_2006_Jul_1_34(Web_Server_issue)_W75-W78.nxml.txt.nlp	16845113	SENT14	0	0	0	0	pp2	PP2		4888	0.028
NULL	Mol_Cancer_2012_Apr_26_11_24.nxml.txt.nlp	22537161	SENT222	21	21	21	21	pp2	PP2		4888	0.028
NULL	Arthritis_Res_Ther_2007_Oct_10_9(5)_R105.nxml.txt.nlp	17927818	SENT164	0	0	0	0	pp2	PP2		4888	0.028
NULL	Nat_Commun_2013_Nov_27_4_2821.nxml.txt.nlp	24281726	SENT243	26	26	26	26	pp2	PP2		4888	0.028
NULL	Front_Immunol_2012_Jan_10_2_91.nxml.txt.nlp	22566880	SENT58	13	13	13	13	pp2	PP2		4888	0.028
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT378	22	22	22	22	pp2	PP2		4888	0.028
NULL	Eur_J_Popul_2012_Nov_25_28(4)_385-416.nxml.txt.nlp	23162180	SENT623	1	1	1	1	pp2	PP2		4888	0.027
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT251	9	9	9	9	pp2	PP2		4888	0.027
NULL	ScientificWorldJournal_2012_Apr_22_2012_643904.nxml.txt.nlp	22619632	SENT206	9	9	9	9	pp2	PP2		4888	0.027
NULL	Clin_Ophthalmol_2012_Dec_13_6_1-4.nxml.txt.nlp	22259229	SENT70	32	32	33	33	travoprost	BAK	PA164781371	578	0.027
NULL	ScientificWorldJournal_2014_Jul_22_2014_643715.nxml.txt.nlp	25147856	SENT160	21	21	21	21	pp2	PP2		4888	0.027
NULL	J_Cell_Biol_2008_Jul_28_182(2)_367-379.nxml.txt.nlp	18644892	SENT205	14	14	14	14	pp2	PP2		4888	0.027
NULL	Nat_Commun_2014_Jul_16_5_4425.nxml.txt.nlp	25028121	SENT47	40	40	40	40	pp2	PP2		4888	0.027
NULL	Mol_Biol_Cell_2013_Feb_15_24(4)_495-509.nxml.txt.nlp	23408788	SENT125	24	24	24	24	pp2	PP2		4888	0.027
NULL	J_Biol_Chem_2012_Aug_17_287(34)_28932-28942.nxml.txt.nlp	22718751	SENT144	8	8	8	8	pp2	PP2		4888	0.027
NULL	Biomed_Res_Int_2013_Jan_22_2013_346480.nxml.txt.nlp	23484111	SENT124	15	15	15	15	pp2	PP2		4888	0.027
NULL	Cancers_(Basel)_2014_Feb_17_6(1)_416-435.nxml.txt.nlp	24549119	SENT759	8	8	9	9	collagenase	MT1-MMP	PA449107	4323	0.027
NULL	ScientificWorldJournal_2012_Apr_1_2012_491737.nxml.txt.nlp	22547985	SENT142	1	1	1	1	pp2	PP2		4888	0.027
NULL	Cell_Commun_Signal_2009_Aug_27_7_20.nxml.txt.nlp	19712465	SENT308	34	34	34	34	pp2	PP2		4888	0.027
NULL	Front_Hum_Neurosci_2013_Aug_20_7_451.nxml.txt.nlp	23970859	SENT173	16	16	16	16	pp2	PP2		4888	0.027
NULL	Br_J_Cancer_2009_Jul_21_101(2)_327-334.nxml.txt.nlp	19568240	SENT49	0	0	0	0	pp2	PP2		4888	0.027
NULL	Med_Sci_Monit_2012_Mar_1_18(3)_CR154-CR159.nxml.txt.nlp	22367126	SENT109	14	14	14	14	pp2	PP2		4888	0.026
NULL	Cells_2012_Aug_23_1(3)_558-575.nxml.txt.nlp	24710490	SENT1078	13	13	13	13	pp2	PP2		4888	0.026
NULL	Cancer_Cell_Int_2013_Feb_14_13_16.nxml.txt.nlp	23409704	SENT102	11	11	11	11	pp2	PP2		4888	0.026
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT243	17	17	17	17	pp2	PP2		4888	0.026
NULL	Diabetes_Metab_J_2013_Oct_17_37(5)_343-348.nxml.txt.nlp	24199163	SENT134	6	6	6	6	pp2	PP2		4888	0.026
NULL	Mol_Biol_Cell_2014_Mar_15_25(6)_739-752.nxml.txt.nlp	24430869	SENT287	9	9	9	9	pp2	PP2		4888	0.026
NULL	Nucleic_Acids_Res_2006_Jul_1_34(Web_Server_issue)_W75-W78.nxml.txt.nlp	16845113	SENT65	0	0	0	0	pp2	PP2		4888	0.026
NULL	Biosci_Rep_2014_Aug_6_34(4)_e00131.nxml.txt.nlp	24975826	SENT150	2	2	2	2	pp2	PP2		4888	0.026
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT364	20	20	20	20	pp2	PP2		4888	0.026
NULL	Apoptosis_2012_Jun_9_17(6)_566-578.nxml.txt.nlp	22402981	SENT167	20	20	20	20	pp2	PP2		4888	0.026
NULL	J_Inflamm_(Lond)_2006_May_4_3_8.nxml.txt.nlp	16674821	SENT14	15	15	15	15	pp2	PP2		4888	0.026
NULL	J_Cell_Biol_2004_Jun_7_165(5)_641-652.nxml.txt.nlp	15173188	SENT123	18	18	18	18	pp2	PP2		4888	0.026
NULL	Nucleic_Acids_Res_2006_Jul_1_34(Web_Server_issue)_W75-W78.nxml.txt.nlp	16845113	SENT215	0	0	0	0	pp2	PP2		4888	0.026
NULL	Apoptosis_2012_Jun_9_17(6)_566-578.nxml.txt.nlp	22402981	SENT171	21	21	21	21	pp2	PP2		4888	0.026
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT197	6	6	6	6	pp2	PP2		4888	0.026
NULL	Mol_Biol_Cell_2013_Jul_1_24(13)_2134-2145.nxml.txt.nlp	23657817	SENT256	4	4	4	4	pp2	PP2		4888	0.026
NULL	Cell_Death_Dis_2014_Feb_6_5(2)_e1049.nxml.txt.nlp	24503541	SENT127	2	2	2	2	pp2	PP2		4888	0.026
NULL	Arthritis_Res_Ther_2007_Oct_10_9(5)_R105.nxml.txt.nlp	17927818	SENT139	2	2	2	2	pp2	PP2		4888	0.026
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT185	17	17	17	17	pp2	PP2		4888	0.026
NULL	Oncol_Lett_2013_Aug_20_6(2)_329-335.nxml.txt.nlp	24137325	SENT136	2	2	2	2	pp2	PP2		4888	0.026
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT199	16	16	16	16	pp2	PP2		4888	0.026
NULL	Biochemistry_2013_Dec_17_52(50)_9059-9067.nxml.txt.nlp	24266852	SENT8	13	13	13	13	pp2	PP2		4888	0.026
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT167	20	20	20	20	pp2	PP2		4888	0.026
NULL	Int_J_Biol_Sci_2015_Jan_1_11(1)_48-58.nxml.txt.nlp	25552929	SENT18	30	30	31	31	paclitaxel	LDM	PA450761	1595	0.026
NULL	J_Cell_Biol_2001_Oct_1_155(1)_133-144.nxml.txt.nlp	11581290	SENT280	14	14	14	14	pp2	PP2		4888	0.026
NULL	J_Oncol_2010_Mar_29_2010_351679.nxml.txt.nlp	20369062	SENT287	30	30	30	30	pp2	PP2		4888	0.025
NULL	Biosci_Rep_2014_Aug_6_34(4)_e00131.nxml.txt.nlp	24975826	SENT186	10	10	10	10	pp2	PP2		4888	0.025
NULL	J_Oncol_2010_Aug_19_2010_932803.nxml.txt.nlp	20847951	SENT242	16	16	16	16	pp2	PP2		4888	0.025
NULL	Cardiovasc_Res_2008_Dec_1_80(3)_453-462.nxml.txt.nlp	18682436	SENT173	0	0	0	0	pp2	PP2		4888	0.025
NULL	J_Cell_Biol_2005_Oct_10_171(1)_121-131.nxml.txt.nlp	16203859	SENT99	2	2	2	2	pp2	PP2		4888	0.025
NULL	J_Cell_Biol_2008_Jul_14_182(1)_157-169.nxml.txt.nlp	18606851	SENT306	26	26	26	26	pp2	PP2		4888	0.025
NULL	Oncogene_2009_Jan_15_28(2)_279-288.nxml.txt.nlp	18836480	SENT115	8	8	8	8	pp2	PP2		4888	0.025
NULL	J_Cell_Biol_2008_Jul_28_182(2)_367-379.nxml.txt.nlp	18644892	SENT205	29	29	29	29	pp2	PP2		4888	0.025
NULL	ScientificWorldJournal_2012_Apr_22_2012_643904.nxml.txt.nlp	22619632	SENT140	2	2	2	2	pp2	PP2		4888	0.025
NULL	Environ_Health_Perspect_2012_Jul_11_120(7)_1029-1035.nxml.txt.nlp	22494775	SENT170	8	8	8	8	pp2	PP2		4888	0.025
NULL	J_Inflamm_(Lond)_2006_May_4_3_8.nxml.txt.nlp	16674821	SENT40	13	13	13	13	pp2	PP2		4888	0.025
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT210	10	10	10	10	pp2	PP2		4888	0.025
NULL	Diabetes_2013_Jun_17_62(6)_1996-2003.nxml.txt.nlp	23349483	SENT106	32	32	32	32	pp2	PP2		4888	0.025
NULL	Acta_Pharmacol_Sin_2010_Dec_22_31(12)_1593-1603.nxml.txt.nlp	21102482	SENT159	3	3	3	3	pp2	PP2		4888	0.025
NULL	Cancer_Cell_Int_2013_Feb_14_13_16.nxml.txt.nlp	23409704	SENT90	3	3	3	3	pp2	PP2		4888	0.025
NULL	Oncogene_2014_Oct_23_33(43)_5109-5120.nxml.txt.nlp	24858043	SENT281	3	3	3	3	pp2	PP2		4888	0.025
NULL	Breast_Cancer_Res_2006_Jul_19_8(4)_R42.nxml.txt.nlp	16859511	SENT230	3	3	3	3	pp2	PP2		4888	0.025
NULL	Nat_Biotechnol_2010_Jul_27_28(7)_743-747.nxml.txt.nlp	20581846	SENT86	9	9	9	9	pp2	PP2		4888	0.025
NULL	Behav_Brain_Funct_2011_Dec_31_7_50.nxml.txt.nlp	22208616	SENT159	0	0	0	0	pp2	PP2		4888	0.024
NULL	Iran_J_Reprod_Med_2013_May_11(5)_355-364.nxml.txt.nlp	24639766	SENT126	6	6	7	7	doxorubicin	LPO	PA449412	4025	0.024
NULL	Lab_Invest_2010_Oct_28_90(10)_1415-1424.nxml.txt.nlp	20585313	SENT107	14	14	14	14	pp2	PP2		4888	0.024
NULL	J_Biol_Chem_2009_Sep_18_284(38)_26096-26105.nxml.txt.nlp	19628870	SENT118	24	24	24	24	pp2	PP2		4888	0.024
NULL	Curr_Genomics_2014_Jun_15(3)_190-202.nxml.txt.nlp	24955027	SENT78	2	2	2	2	pp2	PP2		4888	0.024
NULL	J_Biol_Chem_2008_Dec_19_283(51)_35419-35427.nxml.txt.nlp	18955485	SENT65	19	19	19	19	pp2	PP2		4888	0.024
NULL	Arthritis_Res_Ther_2007_Oct_10_9(5)_R105.nxml.txt.nlp	17927818	SENT112	7	7	7	7	pp2	PP2		4888	0.024
NULL	Arthritis_Res_Ther_2007_Oct_10_9(5)_R105.nxml.txt.nlp	17927818	SENT134	0	0	0	0	pp2	PP2		4888	0.024
NULL	J_Hematol_Oncol_2013_Aug_2_6_56.nxml.txt.nlp	23915951	SENT44	29	29	29	29	pp2	PP2		4888	0.024
NULL	Arthritis_Res_Ther_2014_Mar_13_16(2)_R68.nxml.txt.nlp	24620998	SENT186	15	15	15	15	pp2	PP2		4888	0.024
NULL	Cell_Commun_Signal_2013_Aug_15_11_59.nxml.txt.nlp	23947369	SENT54	28	28	28	28	pp2	PP2		4888	0.023
NULL	J_Cell_Biol_2002_Mar_18_156(6)_951-957.nxml.txt.nlp	11901164	SENT96	0	0	0	0	pp2	PP2		4888	0.023
NULL	JAKSTAT_2013_Jul_1_2(3)_e24812.nxml.txt.nlp	24069562	SENT37	3	3	3	3	pp2	PP2		4888	0.023
NULL	Sensors_(Basel)_2013_Feb_28_13(3)_2895-2910.nxml.txt.nlp	23449119	SENT133	10	10	10	10	pp2	PP2		4888	0.023
NULL	J_Gen_Physiol_2004_Apr_123(4)_427-439.nxml.txt.nlp	15024039	SENT284	0	0	0	0	pp2	PP2		4888	0.023
NULL	Oncol_Lett_2013_Aug_20_6(2)_329-335.nxml.txt.nlp	24137325	SENT133	3	3	3	3	pp2	PP2		4888	0.023
NULL	Oncol_Lett_2013_Aug_20_6(2)_329-335.nxml.txt.nlp	24137325	SENT233	3	3	3	3	pp2	PP2		4888	0.023
NULL	Int_J_Biol_Sci_2006_Mar_1_2(1)_1-9.nxml.txt.nlp	16585947	SENT53	19	19	19	19	pp2	PP2		4888	0.023
NULL	Mol_Cancer_2012_Jun_26_11_43.nxml.txt.nlp	22731636	SENT132	6	6	6	6	pp2	PP2		4888	0.023
NULL	J_Cell_Sci_2012_Jun_15_125(12)_2940-2953.nxml.txt.nlp	22366451	SENT292	16	16	16	16	pp2	PP2		4888	0.023
NULL	J_Cell_Biol_2001_Oct_29_155(3)_427-438.nxml.txt.nlp	11673478	SENT191	15	15	15	15	pp2	PP2		4888	0.023
NULL	Front_Cell_Neurosci_2014_Jul_18_8_185.nxml.txt.nlp	25100946	SENT103	14	14	14	14	pp2	PP2		4888	0.023
NULL	Front_Zool_2011_Nov_29_8_31.nxml.txt.nlp	22126599	SENT128	0	0	0	0	pp2	PP2		4888	0.023
NULL	Curr_Genomics_2014_Jun_15(3)_190-202.nxml.txt.nlp	24955027	SENT76	9	9	9	9	pp2	PP2		4888	0.023
NULL	Cell_Death_Dis_2014_Feb_20_5(2)_e1068.nxml.txt.nlp	24556683	SENT126	11	11	11	11	pp2	PP2		4888	0.023
NULL	Arthritis_Res_Ther_2007_Oct_10_9(5)_R105.nxml.txt.nlp	17927818	SENT41	6	6	6	6	pp2	PP2		4888	0.022
NULL	Nat_Biotechnol_2010_Jul_27_28(7)_743-747.nxml.txt.nlp	20581846	SENT163	0	0	0	0	pp2	PP2		4888	0.022
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT250	0	0	0	0	pp2	PP2		4888	0.022
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT375	23	23	23	23	pp2	PP2		4888	0.022
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT371	0	0	0	0	pp2	PP2		4888	0.022
NULL	Apoptosis_2012_Jun_9_17(6)_566-578.nxml.txt.nlp	22402981	SENT166	35	35	35	35	pp2	PP2		4888	0.022
NULL	Arthritis_Res_Ther_2007_Oct_10_9(5)_R105.nxml.txt.nlp	17927818	SENT151	0	0	0	0	pp2	PP2		4888	0.022
NULL	Curr_Neuropharmacol_2013_Jul_11(4)_338-378.nxml.txt.nlp	24381528	SENT217	8	8	8	8	pp2	PP2		4888	0.022
NULL	Mol_Cancer_2012_Jun_26_11_43.nxml.txt.nlp	22731636	SENT8	6	6	6	6	pp2	PP2		4888	0.022
NULL	Arthritis_Res_Ther_2007_Oct_10_9(5)_R105.nxml.txt.nlp	17927818	SENT142	0	0	0	0	pp2	PP2		4888	0.022
NULL	Nucleic_Acids_Res_2010_Oct_27_38(18)_6247-6264.nxml.txt.nlp	20507916	SENT256	5	5	5	5	pp2	PP2		4888	0.021
NULL	Oncogene_2014_Oct_23_33(43)_5109-5120.nxml.txt.nlp	24858043	SENT279	28	28	28	28	pp2	PP2		4888	0.021
NULL	Oncol_Rep_2014_Jul_15_32(1)_45-49.nxml.txt.nlp	24841138	SENT42	27	27	27	27	pp2	PP2		4888	0.021
NULL	J_Cell_Biol_2005_Nov_7_171(3)_505-516.nxml.txt.nlp	16275754	SENT333	18	18	18	18	pp2	PP2		4888	0.021
NULL	Biosci_Rep_2014_Aug_6_34(4)_e00131.nxml.txt.nlp	24975826	SENT187	6	6	6	6	pp2	PP2		4888	0.021
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT368	24	24	24	24	pp2	PP2		4888	0.021
NULL	Asian-Australas_J_Anim_Sci_2012_Apr_25(4)_471-478.nxml.txt.nlp	25049587	SENT37	31	31	31	31	pp2	PP2		4888	0.021
NULL	J_Inflamm_(Lond)_2006_May_4_3_8.nxml.txt.nlp	16674821	SENT56	4	4	4	4	pp2	PP2		4888	0.021
NULL	J_Cell_Biol_2007_Apr_23_177(2)_317-328.nxml.txt.nlp	17452533	SENT242	7	7	7	7	pp2	PP2		4888	0.021
NULL	Br_J_Cancer_2011_May_10_104(10)_1628-1640.nxml.txt.nlp	21505453	SENT255	21	21	21	21	pp2	PP2		4888	0.021
NULL	ScientificWorldJournal_2012_Apr_22_2012_643904.nxml.txt.nlp	22619632	SENT209	6	6	6	6	pp2	PP2		4888	0.021
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT362	2	2	2	2	pp2	PP2		4888	0.021
NULL	Front_Genet_2014_Dec_22_5_445.nxml.txt.nlp	25566327	SENT259	38	38	38	38	pp2	PP2		4888	0.021
NULL	Arthritis_Res_Ther_2007_Oct_10_9(5)_R105.nxml.txt.nlp	17927818	SENT9	2	2	2	2	pp2	PP2		4888	0.021
NULL	J_Cell_Biol_2008_Jul_28_182(2)_367-379.nxml.txt.nlp	18644892	SENT71	6	6	6	6	pp2	PP2		4888	0.021
NULL	Biosci_Rep_2014_Aug_6_34(4)_e00131.nxml.txt.nlp	24975826	SENT157	22	22	22	22	pp2	PP2		4888	0.02
NULL	Breast_Cancer_Res_2014_Sep_30_16(5)_429.nxml.txt.nlp	25266665	SENT360	14	14	14	14	pp2	PP2		4888	0.02
NULL	Arthritis_Res_Ther_2006_Nov_27_8(6)_R176.nxml.txt.nlp	17129374	SENT232	31	31	31	31	pp2	PP2		4888	0.02
NULL	Nucleic_Acids_Res_2006_Jul_1_34(Web_Server_issue)_W75-W78.nxml.txt.nlp	16845113	SENT76	0	0	0	0	pp2	PP2		4888	0.02
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT85	0	0	0	0	pp2	PP2		4888	0.02
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT183	37	37	37	37	pp2	PP2		4888	0.02
NULL	Apoptosis_2012_Jun_9_17(6)_566-578.nxml.txt.nlp	22402981	SENT167	24	24	24	24	pp2	PP2		4888	0.02
NULL	Mol_Cancer_2009_Nov_19_8_108.nxml.txt.nlp	19925669	SENT342	10	10	9	9	nadh	mol	PA164755085	90527	0.02
NULL	Nucleic_Acids_Res_2010_Oct_27_38(18)_6247-6264.nxml.txt.nlp	20507916	SENT164	4	4	4	4	pp2	PP2		4888	0.02
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT72	6	6	6	6	pp2	PP2		4888	0.02
NULL	Cell_Commun_Signal_2013_Dec_23_11_100.nxml.txt.nlp	24364863	SENT377	16	16	16	16	pp2	PP2		4888	0.02
NULL	Biochimie_2012_Sep_94(9)_1997-2005.nxml.txt.nlp	22659570	SENT54	14	14	14	14	pp2	PP2		4888	0.02
NULL	Cell_Cycle_2013_Apr_15_12(8)_1303-1315.nxml.txt.nlp	23535298	SENT398	7	7	7	7	pp2	PP2		4888	0.02
NULL	Mol_Cancer_2009_Dec_31_8_132.nxml.txt.nlp	20043832	SENT274	11	11	11	11	pp2	PP2		4888	0.019
NULL	Cell_Commun_Signal_2013_Dec_23_11_100.nxml.txt.nlp	24364863	SENT183	28	28	28	28	pp2	PP2		4888	0.019
NULL	BMB_Rep_2013_Apr_46(4)_230-235.nxml.txt.nlp	23615266	SENT155	12	12	12	12	pp2	PP2		4888	0.019
NULL	Int_J_Mol_Sci_2010_Sep_13_11(9)_3195-3208.nxml.txt.nlp	20957088	SENT225	7	7	6	6	lipase	AT2	PA450239	186	0.019
NULL	Arthritis_Res_Ther_2007_Oct_10_9(5)_R105.nxml.txt.nlp	17927818	SENT126	0	0	0	0	pp2	PP2		4888	0.019
NULL	ScientificWorldJournal_2012_Apr_1_2012_491737.nxml.txt.nlp	22547985	SENT140	8	8	8	8	pp2	PP2		4888	0.019
NULL	J_Biol_Chem_2012_Aug_17_287(34)_28932-28942.nxml.txt.nlp	22718751	SENT48	20	20	20	20	pp2	PP2		4888	0.019
NULL	Mol_Cancer_2012_Jun_26_11_43.nxml.txt.nlp	22731636	SENT85	24	24	24	24	pp2	PP2		4888	0.019
NULL	Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.nxml.txt.nlp	23864846	SENT108	0	0	0	0	pp2	PP2		4888	0.019
NULL	Acta_Pharmacol_Sin_2009_Jul_3_30(7)_889-898.nxml.txt.nlp	19574994	SENT265	24	24	24	24	pp2	PP2		4888	0.018
NULL	J_Gen_Physiol_2004_Apr_123(4)_427-439.nxml.txt.nlp	15024039	SENT80	17	17	17	17	pp2	PP2		4888	0.018
NULL	Apoptosis_2012_Jun_9_17(6)_566-578.nxml.txt.nlp	22402981	SENT166	39	39	39	39	pp2	PP2		4888	0.018
NULL	Nucleic_Acids_Res_2010_Oct_27_38(18)_6247-6264.nxml.txt.nlp	20507916	SENT207	3	3	3	3	pp2	PP2		4888	0.018
NULL	Nucleic_Acids_Res_2006_Jul_1_34(Web_Server_issue)_W75-W78.nxml.txt.nlp	16845113	SENT40	14	14	14	14	pp2	PP2		4888	0.018
NULL	Breast_Cancer_Res_2007_Oct_10_9(5)_R69.nxml.txt.nlp	17925034	SENT77	5	5	5	5	pp2	PP2		4888	0.018
NULL	Cancer_Cell_Int_2013_Feb_14_13_16.nxml.txt.nlp	23409704	SENT78	11	11	11	11	pp2	PP2		4888	0.018
NULL	BMB_Rep_2013_Apr_46(4)_230-235.nxml.txt.nlp	23615266	SENT83	32	32	32	32	pp2	PP2		4888	0.018
NULL	J_Gen_Physiol_2013_Apr_141(4)_409-411.nxml.txt.nlp	23478994	SENT114	9	9	8	8	potassium	HERG	PA451047	3757	0.018
NULL	Apoptosis_2012_Jun_9_17(6)_566-578.nxml.txt.nlp	22402981	SENT166	22	22	22	22	pp2	PP2		4888	0.018
NULL	J_Cell_Biol_2005_May_9_169(3)_503-514.nxml.txt.nlp	15883200	SENT178	2	2	2	2	pp2	PP2		4888	0.018
NULL	Arthritis_Res_Ther_2013_Nov_1_15(6)_R176.nxml.txt.nlp	24456929	SENT274	21	21	21	21	pp2	PP2		4888	0.018
NULL	BMB_Rep_2013_Apr_46(4)_230-235.nxml.txt.nlp	23615266	SENT106	14	14	14	14	pp2	PP2		4888	0.017
NULL	Acta_Pharmacol_Sin_2009_Jul_3_30(7)_889-898.nxml.txt.nlp	19574994	SENT150	0	0	0	0	pp2	PP2		4888	0.017
NULL	Trials_2013_Aug_19_14_261.nxml.txt.nlp	23958221	SENT314	8	8	8	8	pp2	PP2		4888	0.017
NULL	Mol_Biol_Cell_2013_Feb_15_24(4)_495-509.nxml.txt.nlp	23408788	SENT116	5	5	5	5	pp2	PP2		4888	0.017
NULL	Acta_Pharmacol_Sin_2009_Jul_3_30(7)_889-898.nxml.txt.nlp	19574994	SENT269	12	12	12	12	pp2	PP2		4888	0.017
NULL	Nat_Commun_2013_4_1494.nxml.txt.nlp	23422662	SENT146	29	29	29	29	pp2	PP2		4888	0.017
NULL	Br_J_Cancer_2011_May_10_104(10)_1628-1640.nxml.txt.nlp	21505453	SENT200	0	0	0	0	pp2	PP2		4888	0.016
NULL	Behav_Brain_Funct_2011_Dec_31_7_50.nxml.txt.nlp	22208616	SENT152	14	14	14	14	pp2	PP2		4888	0.016
NULL	Arthritis_Res_Ther_2012_Apr_27_14(2)_R91.nxml.txt.nlp	22541814	SENT17	22	22	22	22	pp2	PP2		4888	0.016
NULL	ScientificWorldJournal_2012_Apr_22_2012_643904.nxml.txt.nlp	22619632	SENT136	5	5	5	5	pp2	PP2		4888	0.016
NULL	Mol_Biol_Cell_2014_Apr_1_25(7)_1151-1158.nxml.txt.nlp	24501422	SENT94	25	25	25	25	pp2	PP2		4888	0.016
NULL	Front_Genet_2014_Dec_22_5_445.nxml.txt.nlp	25566327	SENT274	13	13	13	13	pp2	PP2		4888	0.015
NULL	Mol_Biol_Cell_2014_Aug_1_25(15)_2291-2304.nxml.txt.nlp	24870032	SENT241	23	23	23	23	pp2	PP2		4888	0.015
NULL	Diabetes_2013_Nov_18_62(11)_3874-3886.nxml.txt.nlp	23942551	SENT208	0	0	0	0	pp2	PP2		4888	0.015
NULL	Oncotarget_2014_Aug_27_5(21)_10486-10502.nxml.txt.nlp	25401222	SENT132	19	19	19	19	pp2	PP2		4888	0.015
NULL	Cell_Commun_Signal_2012_Mar_3_10_5.nxml.txt.nlp	22385615	SENT159	21	21	21	21	pp2	PP2		4888	0.015
NULL	ASN_Neuro_2009_Apr_14_1(1)_e00005.nxml.txt.nlp	19570022	SENT6	11	11	11	11	pp2	PP2		4888	0.015
NULL	Anat_Cell_Biol_2013_Sep_30_46(3)_198-202.nxml.txt.nlp	24179695	SENT130	4	4	4	4	pp2	PP2		4888	0.015
NULL	Apoptosis_2012_Jun_9_17(6)_566-578.nxml.txt.nlp	22402981	SENT161	2	2	2	2	pp2	PP2		4888	0.014
NULL	Mol_Cancer_2003_Sep_23_2_33.nxml.txt.nlp	14572313	SENT154	23	23	23	23	pp2	PP2		4888	0.014
NULL	Nat_Commun_2014_Jul_16_5_4425.nxml.txt.nlp	25028121	SENT294	13	13	13	13	pp2	PP2		4888	0.014
NULL	Clin_Nutr_Res_2013_Jul_23_2(2)_100-106.nxml.txt.nlp	23908976	SENT97	12	12	12	12	pp2	PP2		4888	0.014
NULL	Biosci_Rep_2014_Aug_6_34(4)_e00131.nxml.txt.nlp	24975826	SENT143	0	0	0	0	pp2	PP2		4888	0.014
NULL	Arthritis_Res_Ther_2007_Oct_10_9(5)_R105.nxml.txt.nlp	17927818	SENT53	36	36	36	36	pp2	PP2		4888	0.014
NULL	Nucleic_Acids_Res_2006_Jul_1_34(Web_Server_issue)_W75-W78.nxml.txt.nlp	16845113	SENT11	4	4	4	4	pp2	PP2		4888	0.014
NULL	Cell_Commun_Signal_2013_Jan_22_11_6.nxml.txt.nlp	23339737	SENT85	25	25	25	25	pp2	PP2		4888	0.014
NULL	Oncogene_2014_Oct_23_33(43)_5109-5120.nxml.txt.nlp	24858043	SENT78	19	19	19	19	pp2	PP2		4888	0.014
NULL	Theor_Biol_Med_Model_2005_May_20_2_19.nxml.txt.nlp	15907212	SENT105	13	13	13	13	pp2	PP2		4888	0.014
NULL	Theor_Biol_Med_Model_2005_May_20_2_19.nxml.txt.nlp	15907212	SENT296	16	16	16	16	pp2	PP2		4888	0.014
NULL	Front_Cell_Neurosci_2014_Jul_18_8_185.nxml.txt.nlp	25100946	SENT404	37	37	37	37	pp2	PP2		4888	0.013
NULL	Cell_Commun_Signal_2013_Dec_23_11_100.nxml.txt.nlp	24364863	SENT173	28	28	28	28	pp2	PP2		4888	0.013
NULL	Diabetes_Metab_J_2013_Feb_15_37(1)_72-80.nxml.txt.nlp	23439802	SENT142	27	27	27	27	pp2	PP2		4888	0.013
NULL	Diabetes_Metab_J_2013_Oct_17_37(5)_343-348.nxml.txt.nlp	24199163	SENT52	21	21	21	21	pp2	PP2		4888	0.012
NULL	J_Gynecol_Oncol_2014_Jul_3_25(3)_236-248.nxml.txt.nlp	25045437	SENT22	0	0	5	5	bevacizumab	FOR	PA130232992	51741	0.012
NULL	J_Cell_Biol_2001_Oct_29_155(3)_427-438.nxml.txt.nlp	11673478	SENT271	17	17	17	17	pp2	PP2		4888	0.012
NULL	Mol_Biol_Cell_2013_Feb_15_24(4)_495-509.nxml.txt.nlp	23408788	SENT171	25	25	25	25	pp2	PP2		4888	0.012
NULL	Clin_Nutr_Res_2013_Jul_23_2(2)_100-106.nxml.txt.nlp	23908976	SENT37	11	11	11	11	pp2	PP2		4888	0.012
NULL	Front_Cell_Neurosci_2014_Jul_18_8_185.nxml.txt.nlp	25100946	SENT403	16	16	16	16	pp2	PP2		4888	0.011
NULL	J_Biol_Chem_2012_Apr_27_287(18)_14644-14658.nxml.txt.nlp	22375002	SENT62	34	34	34	34	pp2	PP2		4888	0.011
NULL	Mol_Biol_Cell_2013_Feb_15_24(4)_495-509.nxml.txt.nlp	23408788	SENT159	3	3	3	3	pp2	PP2		4888	0.011
NULL	Am_J_Physiol_Endocrinol_Metab_2008_Nov_5_295(5)_E1047-E1055.nxml.txt.nlp	18682536	SENT31	38	38	38	38	pp2	PP2		4888	0.011
NULL	BMB_Rep_2013_Apr_46(4)_230-235.nxml.txt.nlp	23615266	SENT107	14	14	14	14	pp2	PP2		4888	0.011
NULL	Mol_Biol_Cell_2014_Mar_15_25(6)_739-752.nxml.txt.nlp	24430869	SENT271	0	0	0	0	pp2	PP2		4888	0.011
NULL	Daru_2012_Dec_26_20(1)_100.nxml.txt.nlp	23351304	SENT20	27	27	27	27	pp2	PP2		4888	0.011
NULL	Cancer_Med_2014_Aug_10_3(4)_759-774.nxml.txt.nlp	24723436	SENT218	24	24	24	24	pp2	PP2		4888	0.011
NULL	Br_J_Cancer_2011_May_10_104(10)_1628-1640.nxml.txt.nlp	21505453	SENT149	31	31	31	31	pp2	PP2		4888	0.01
NULL	Cardiovasc_Res_2008_Dec_1_80(3)_453-462.nxml.txt.nlp	18682436	SENT170	8	8	8	8	pp2	PP2		4888	0.01
NULL	Curr_Genomics_2014_Jun_15(3)_190-202.nxml.txt.nlp	24955027	SENT464	28	28	28	28	pp2	PP2		4888	0.01
NULL	Clin_Nutr_Res_2013_Jul_23_2(2)_100-106.nxml.txt.nlp	23908976	SENT113	6	6	6	6	pp2	PP2		4888	0.01
NULL	Acta_Pharmacol_Sin_2009_Jul_3_30(7)_889-898.nxml.txt.nlp	19574994	SENT59	9	9	9	9	pp2	PP2		4888	0.008
NULL	Diabetes_Metab_J_2013_Feb_15_37(1)_72-80.nxml.txt.nlp	23439802	SENT138	33	33	33	33	pp2	PP2		4888	0.008
NULL	Cell_Mol_Life_Sci_2011_Dec_2_68(23)_3933-3947.nxml.txt.nlp	21533980	SENT213	40	40	40	40	pp2	PP2		4888	0.007
NULL	J_Inflamm_(Lond)_2006_May_4_3_8.nxml.txt.nlp	16674821	SENT196	6	6	6	6	pp2	PP2		4888	0.006
NULL	Braz_J_Microbiol_2010_Sep_1_Jul-Sep_41(3)_668-675.nxml.txt.nlp	24031542	SENT267	7	7	7	7	pp2	PP2		4888	0.006
NULL	Diabetes_Metab_J_2013_Feb_15_37(1)_72-80.nxml.txt.nlp	23439802	SENT145	5	5	5	5	pp2	PP2		4888	0.005
NULL	Oncogene_2014_Oct_23_33(43)_5109-5120.nxml.txt.nlp	24858043	SENT279	23	23	23	23	pp2	PP2		4888	0.004
NULL	Mol_Cancer_2012_Jun_26_11_43.nxml.txt.nlp	22731636	SENT130	13	13	13	13	pp2	PP2		4888	0.004
NULL	Cell_Commun_Signal_2009_Feb_26_7(Suppl_1)_A63.nxml.txt.nlp	NULL	SENT20	11	11	11	11	pp2	PP2		4888	0.003
NULL	Kidney_Int_Suppl_(2011)_2012_Mar_29_2(1)_37-68.nxml.txt.nlp	25018919	SENT306	0	0	1	1	fenoldopam	FOR	PA164784034	51741	0.002
NULL	J_Gynecol_Oncol_2014_Jul_3_25(3)_236-248.nxml.txt.nlp	25045437	SENT214	0	0	1	1	metformin	FOR	PA450395	51741	0.002
NULL	J_Clin_Neonatol_2012_Oct-Dec_1(4)_171-175.nxml.txt.nlp	24027721	SENT39	0	0	1	1	sildenafil	FOR	PA451346	51741	0.002